PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Schmidt, SK; Ebel, S; Keil, E; Woite, C; Ernst, JF; Benzin, AE; Rupp, J; Daubener, W				Schmidt, Silvia K.; Ebel, Sebastian; Keil, Eric; Woite, Claudia; Ernst, Joachim F.; Benzin, Anika E.; Rupp, Jan; Daeubener, Walter			Regulation of IDO Activity by Oxygen Supply: Inhibitory Effects on Antimicrobial and Immunoregulatory Functions	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; ARYL-HYDROCARBON RECEPTOR; INDUCIBLE FACTOR-I; INDOLEAMINE 2,3-DIOXYGENASE; STAPHYLOCOCCUS-AUREUS; IFN-GAMMA; HYPOXIA; CELLS; HIF-1-ALPHA; INFECTION	Tryptophan is an essential amino acid for human beings as well as for some microorganisms. In human cells the interferon-gamma (IFN-gamma) inducible enzyme indoleamine 2,3-dioxygenase (IDO) reduces local tryptophan levels and is therefore able to mediate broad-spectrum effector functions: IDO activity restricts the growth of various clinically relevant pathogens such as bacteria, parasites and viruses. On the other hand, it has been observed that IDO has immunoregulatory functions as it efficiently controls the activation and survival of T-cells. Although these important effects have been analysed in much detail, they have been observed in vitro using cells cultured in the presence of 20% O-2 (normoxia). Such high oxygen concentrations are not present in vivo especially within infected and inflamed tissues. We therefore analysed IDO-mediated effects under lower oxygen concentrations in vitro and observed that the function of IDO is substantially impaired in tumour cells as well as in native cells. Hypoxia led to reduced IDO expression and as a result to reduced production of kynurenine, the downstream product of tryptophan degradation. Consequently, effector functions of IDO were abrogated under hypoxic conditions: in different human cell lines such as tumour cells (glioblastoma, HeLa) but also in native cells (human foreskin fibroblasts; HFF) IDO lost the capacity to inhibit the growth of bacteria (Staphylococcus aureus), parasites (Toxoplasma gondii) or viruses (herpes simplex virus type 1). Additionally, IDO could no longer efficiently control the proliferation of T-cells that have been co-cultured with IDO expressing HFF cells in vitro. In conclusion, the potent antimicrobial as well as immunoregulatory functions of IDO were substantially impaired under hypoxic conditions that pathophysiologically occurs in vivo.	[Schmidt, Silvia K.; Ebel, Sebastian; Keil, Eric; Woite, Claudia; Daeubener, Walter] Univ Dusseldorf, Inst Med Microbiol & Hosp Hyg, D-40225 Dusseldorf, Germany; [Ernst, Joachim F.] Univ Dusseldorf, Inst Mol Mycol, D-40225 Dusseldorf, Germany; [Benzin, Anika E.; Rupp, Jan] Med Univ Lubeck, Inst Med Microbiol & Hyg, D-23538 Lubeck, Germany; [Rupp, Jan] Med Clin III UK SH, Lubeck, Germany	Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf; University of Lubeck	Daubener, W (corresponding author), Univ Dusseldorf, Inst Med Microbiol & Hosp Hyg, D-40225 Dusseldorf, Germany.	daeubene@uni-duesseldorf.de	Rupp, Jan/C-8794-2011	Rupp, Jan/0000-0001-8722-1233	German Federal Ministry of Education BMBF [01KI1002E, 01GN0951]; German Research Concil (DFG) [RU729]; Manchot Graduate School "Molecules of Infection" (GS MOI); Forschungsforderung UKD	German Federal Ministry of Education BMBF(Federal Ministry of Education & Research (BMBF)); German Research Concil (DFG); Manchot Graduate School "Molecules of Infection" (GS MOI); Forschungsforderung UKD	This study was supported by German Federal Ministry of Education BMBF grant 01KI1002E and 01GN0951 (WD), German Research Concil (DFG) grant RU729 (WD), Manchot Graduate School "Molecules of Infection" (GS MOI) (WD) and Forschungsforderung UKD (WD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aghi MK, 2009, MOL THER, V17, P51, DOI 10.1038/mt.2008.232; Anand RJ, 2007, J LEUKOCYTE BIOL, V82, P1257, DOI 10.1189/jlb.0307195; Atkuri KR, 2007, P NATL ACAD SCI USA, V104, P4547, DOI 10.1073/pnas.0611732104; Baffert F, 2010, MOL CANCER THER, V9, P1945, DOI 10.1158/1535-7163.MCT-10-0053; BILZER T, 1991, VIRCHOWS ARCH A, V418, P281, DOI 10.1007/BF01600156; Blader IJ, 2001, J BIOL CHEM, V276, P24223, DOI 10.1074/jbc.M100951200; Clambey ET, 2012, P NATL ACAD SCI USA, V109, pE2784, DOI 10.1073/pnas.1202366109; Cramton SE, 2001, INFECT IMMUN, V69, P4079, DOI 10.1128/IAI.69.6.4079-4085.2001; Daubener W, 2009, THROMB HAEMOSTASIS, V102, P1110, DOI 10.1160/TH09-04-0250; Darcy CJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021185; DAUBENER W, 1993, J NEUROIMMUNOL, V43, P31, DOI 10.1016/0165-5728(93)90072-7; DAUBENER W, 1994, J IMMUNOL METHODS, V168, P39, DOI 10.1016/0022-1759(94)90207-0; Davis DA, 2001, BLOOD, V97, P3244, DOI 10.1182/blood.V97.10.3244; Eza DE, 2006, HIV MED, V7, P415, DOI 10.1111/j.1468-1293.2006.00393.x; Fallarino F, 2012, EUR J IMMUNOL, V42, P1932, DOI 10.1002/eji.201242572; Fallarino I, 2002, CELL DEATH DIFFER, V9, P1069, DOI 10.1038/sj.cdd.4401073; Fluckiger U, 2001, Ther Umsch, V58, P614, DOI 10.1024/0040-5930.58.10.614; Fukuda I, 2009, CHEM BIOL, V16, P133, DOI 10.1016/j.chembiol.2009.01.009; GREEN GM, 1964, J CLIN INVEST, V43, P769, DOI 10.1172/JCI104961; Herbert A, 2011, BRIT J DERMATOL, V164, P308, DOI 10.1111/j.1365-2133.2010.10086.x; Hucke C, 2004, INFECT IMMUN, V72, P2723, DOI 10.1128/IAI.72.5.2723-2730.2004; Huttunen R, 2010, SHOCK, V33, P149, DOI 10.1097/SHK.0b013e3181ad3195; Innocentin YLS, 2011, CELL, V147, P629, DOI 10.1016/j.cell.2011.09.025; JONSSON K, 1988, ANN SURG, V208, P783; Kempf VAJ, 2005, CIRCULATION, V111, P1054, DOI 10.1161/01.CIR.0000155608.07691.B7; MacKenzie CR, 2007, CURR DRUG METAB, V8, P237, DOI 10.2174/138920007780362518; Monteleone I, 2011, GASTROENTEROLOGY, V141, P237, DOI 10.1053/j.gastro.2011.04.007; Muccio CF, 2008, RADIOL MED, V113, P747, DOI 10.1007/s11547-008-0254-9; Munn DH, 1998, SCIENCE, V281, P1191, DOI 10.1126/science.281.5380.1191; Nizet V, 2009, NAT REV IMMUNOL, V9, P609, DOI 10.1038/nri2607; O'Shea JJ, 2012, IMMUNITY, V36, P542, DOI 10.1016/j.immuni.2012.03.014; Opitz CA, 2011, NATURE, V478, P197, DOI 10.1038/nature10491; Peyssonnaux C, 2005, J CLIN INVEST, V115, P1806, DOI 10.1172/JCI23865; Robinson MA, 2011, FREE RADICAL BIO MED, V51, P1952, DOI 10.1016/j.freeradbiomed.2011.08.034; Roth A, 2010, P NATL ACAD SCI USA, V107, P19502, DOI 10.1073/pnas.1008178107; Sakiniene E, 1997, CLIN EXP IMMUNOL, V110, P370, DOI 10.1046/j.1365-2249.1997.4431456.x; Sasaki S, 1998, INFECT IMMUN, V66, P1017, DOI 10.1128/IAI.66.3.1017-1022.1998; Schmidt SK, 2009, EUR J IMMUNOL, V39, P2755, DOI 10.1002/eji.200939535; Spear W, 2006, CELL MICROBIOL, V8, P339, DOI 10.1111/j.1462-5822.2005.00628.x; Stichternoth C, 2011, EUKARYOT CELL, V10, P502, DOI 10.1128/EC.00289-10; Thiel M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000853; Tsubuki S, 1996, J BIOCHEM-TOKYO, V119, P572, DOI 10.1093/oxfordjournals.jbchem.a021280; Walmsley SR, 2005, J EXP MED, V201, P105, DOI 10.1084/jem.20040624; Weidemann A, 2008, CELL DEATH DIFFER, V15, P621, DOI 10.1038/cdd.2008.12; Whitley RJ, 2006, ANTIVIR RES, V71, P141, DOI 10.1016/j.antiviral.2006.04.002; Wiese M, 2012, INFECT IMMUN, V80, P1455, DOI 10.1128/IAI.05972-11; Zinkernagel AS, 2007, J MOL MED, V85, P1339, DOI 10.1007/s00109-007-0282-2	47	31	31	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2013	8	5							e63301	10.1371/journal.pone.0063301	http://dx.doi.org/10.1371/journal.pone.0063301			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145RZ	23675474	Green Published, Green Submitted, gold			2022-12-27	WOS:000319036100035
J	Block, JP; Subramanian, SV; Christakis, NA; O'Malley, AJ				Block, Jason P.; Subramanian, S. V.; Christakis, Nicholas A.; O'Malley, A. James			Population Trends and Variation in Body Mass Index from 1971 to 2008 in the Framingham Heart Study Offspring Cohort	PLOS ONE			English	Article							US ADULTS; MULTILEVEL; OBESITY; DISADVANTAGE; PREVALENCE	Objective: We examined body mass index (BMI) across place and time to determine the pattern of BMI mean and standard deviation trajectories. Methods: We included participants in the Framingham Heart Study (FHS) Offspring Cohort over eight waves of follow-up, from 1971 to 2008. After exclusions, the final sample size was 4569 subjects with 28,625 observations. We used multi-level models to examine population means and variation at the individual and neighborhood (census tracts) levels across time with measured BMI as the outcome, controlling for individual demographics and behaviors and neighborhood poverty. Because neighborhoods accounted for limited BMI variance, we removed this level as a source of variation in final models. We examined sex-stratified models with all subjects and models stratified by sex and baseline weight classification. Results: Mean BMI increased from 24.0 kg/m(2) at Wave 1 to 27.7 at Wave 8 for women and from 26.6 kg/m(2) to 29.0 for men. In final models, BMI variation also increased from Waves 1 to 8, with the standard deviation increasing from 4.18 kg/m(2) to 6.15 for women and 3.31 kg/m(2) to 4.73 for men. BMI means increased in parallel across most baseline BMI weight classifications, except for more rapid increases through middle-age for obese women followed by declines in the last wave. BMI standard deviations also increased in parallel across baseline BMI classifications for women, with greater divergence of BMI variance for obese men compared to other weight classifications. Conclusion: Over nearly 40 years, BMI mean and variation increased in parallel across most baseline weight classifications in our sample. Individual-level characteristics, especially baseline BMI, were the primary factors in rising BMI. These findings have important implications not only for understanding the sources of the obesity epidemic in the United States but also for the targeting of interventions to address the epidemic.	[Block, Jason P.] Harvard Univ, Sch Med, Harvard Pilgrim Hlth Care Inst, Obes Prevent Program,Dept Populat Med, Boston, MA 02115 USA; [Subramanian, S. V.] Harvard Univ, Sch Publ Hlth, Dept Social & Behav Sci, Boston, MA 02115 USA; [Christakis, Nicholas A.; O'Malley, A. James] Harvard Univ, Sch Med, Dept Hlth Care Policy, Boston, MA 02115 USA	Harvard Pilgrim Health Care; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard Medical School	Block, JP (corresponding author), Harvard Univ, Sch Med, Harvard Pilgrim Hlth Care Inst, Obes Prevent Program,Dept Populat Med, Boston, MA 02115 USA.	jason_block@harvardpilgrim.org			National Institute of Aging [P01 AG031093]; National Heart, Lung, and Blood Institute [R01 HL109263, N01-HC-25195, P30 HL101312, K25 HL081275]; Robert Wood Johnson Health and Society Scholars Program at the Harvard School of Public Health; Robert Wood Johnson Foundation Investigator Award in Health Policy Research; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC025195] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL109263, K25HL081275, P30HL101312] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG031093] Funding Source: NIH RePORTER	National Institute of Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Robert Wood Johnson Health and Society Scholars Program at the Harvard School of Public Health; Robert Wood Johnson Foundation Investigator Award in Health Policy Research(Robert Wood Johnson Foundation (RWJF)); DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the National Institute of Aging (P01 AG031093, Christakis, PI), the National Heart, Lung, and Blood Institute (R01 HL109263, O'Malley, PI) and by a contract from the National Heart, Lung, and Blood Institute (N01-HC-25195) to the Framingham Heart Study. Jason P. Block received support from the National Heart, Lung, and Blood Institute (P30 HL101312, Gillman, PI) and was supported by the Robert Wood Johnson Health and Society Scholars Program at the Harvard School of Public Health. S. V. Subramanian was supported by a National Heart, Lung, and Blood Institute Career Development Award (K25 HL081275) and the Robert Wood Johnson Foundation Investigator Award in Health Policy Research. The funders had no role in study design, data analysis, decision to publish, or preparation of the manuscript.	Braumoeller BF, 2006, POLIT ANAL, V14, P268, DOI 10.1093/pan/mpj009; Browne WJ, 2012, MCMC ESTIMATION MLWI; Davidoff F, 2009, JAMA-J AM MED ASSOC, V302, P2580, DOI 10.1001/jama.2009.1845; Davis N, 1994, CLIN PROTOCAOL MANUA; de Kroon MLA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013966; DOWNS GW, 1979, AM J POLIT SCI, V23, P816, DOI 10.2307/2110809; Flegal KM, 2012, JAMA-J AM MED ASSOC, V307, P491, DOI 10.1001/jama.2012.39; Flegal KM, 2010, JAMA-J AM MED ASSOC, V303, P235, DOI 10.1001/jama.2009.2014; Harrington DW, 2009, SOC SCI MED, V68, P593, DOI 10.1016/j.socscimed.2008.11.021; King T, 2006, INT J OBESITY, V30, P281, DOI 10.1038/sj.ijo.0803176; Malhotra R, 2013, OBESITY; Merlo J, 2009, J EPIDEMIOL COMMUN H, V63, P1043, DOI 10.1136/jech.2009.088310; Ogden CL, 2004, ADV DATA VITAL HLTH, V347; Ogden CL, 2010, HLTH E STATS PREVALE; Rasbash J., 2009, USERS GUIDE MLWIN VE; Razak F, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001367; Regidor E, 2008, J EPIDEMIOL COMMUN H, V62, P231, DOI 10.1136/jech.2006.059360; Robert SA, 2004, SOC SCI MED, V59, P2421, DOI 10.1016/j.socscimed.2004.03.034; Stafford M, 2010, AM J PREV MED, V39, P130, DOI 10.1016/j.amepre.2010.03.021; Sturm R, 1038, INT J OBES LOND, P159; Sund ER, 2010, SOC SCI MED, V70, P1194, DOI 10.1016/j.socscimed.2010.01.007	21	25	28	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2013	8	5							e63217	10.1371/journal.pone.0063217	http://dx.doi.org/10.1371/journal.pone.0063217			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	143FO	23675464	Green Submitted, Green Published, gold			2022-12-27	WOS:000318852400030
J	Chatterjee, S; Alsaeedi, N; Hou, J; Bandaru, VVR; Wu, L; Halushka, MK; Pili, R; Ndikuyeze, G; Haughey, NJ				Chatterjee, Subroto; Alsaeedi, Nezar; Hou, Jennifer; Bandaru, Veera Venkata Ratnam; Wu, Lan; Halushka, Marc K.; Pili, Roberto; Ndikuyeze, Georges; Haughey, Norman J.			Use of a Glycolipid Inhibitor to Ameliorate Renal Cancer in a Mouse Model	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; C-FOS EXPRESSION; SPHINGOLIPID METABOLISM; GLYCOSPHINGOLIPID BIOSYNTHESIS; GLUCOSYLCERAMIDE SYNTHASE; LACTOSYLCERAMIDE; CELLS; RECEPTOR; CHOLESTEROL; ADHESION	In a xenograft model wherein, live renal cancer cells were implanted under the kidney capsule in mice, revealed a 30-fold increase in tumor volume over a period of 26 days and this was accompanied with a 32-fold increase in the level of lactosylceramide (LacCer). Mice fed D-threo-1-phenyl-2-decanoylamino-3-morpholino-1-propanol (D-PDMP), an inhibitor of glucosylceramide synthase and lactosylceramide synthase (LCS: b-1,4-GalT-V), showed marked reduction in tumor volume. This was accompanied by a decrease in the mass of lactosylceramide and an increase in glucosylceramide (GlcCer) level. Mechanistic studies revealed that D-PDMP inhibited cell proliferation and angiogenesis by inhibiting p44MAPK, p-AKT-1 pathway and mammalian target for rapamycin (mTOR). By linking glycosphingolipid synthesis with tumor growth, renal cancer progression and regression can be evaluated. Thus inhibiting glycosphingolipid synthesis can be a bonafide target to prevent the progression of other types of cancer.	[Chatterjee, Subroto; Alsaeedi, Nezar; Hou, Jennifer; Wu, Lan] Johns Hopkins Med Inst, Dept Pediat, Div Pediat Cardiol, Baltimore, MD 21205 USA; [Bandaru, Veera Venkata Ratnam; Haughey, Norman J.] Johns Hopkins Med Inst, Dept Neurol, Baltimore, MD 21205 USA; [Halushka, Marc K.] Johns Hopkins Med Inst, Dept Pathol, Baltimore, MD 21205 USA; [Pili, Roberto] Roswell Pk Canc Inst, Dept Med, Buffalo, NY 14263 USA; [Ndikuyeze, Georges] Johns Hopkins Med Inst, Dept Oncol, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Roswell Park Cancer Institute; Johns Hopkins University; Johns Hopkins Medicine	Chatterjee, S (corresponding author), Johns Hopkins Med Inst, Dept Pediat, Div Pediat Cardiol, Baltimore, MD 21205 USA.	schatte2@jhmi.edu		Halushka, Marc/0000-0002-7112-7389; Hou, Jennifer/0000-0003-4022-2452	National Institutes of Health [PO-1-HL-107153-01]; TEDCO, State of Maryland grant, Johns Hopkins University; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL107153] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK090868] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P30MH075673, R21MH072534, R01MH077542] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG023471] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); TEDCO, State of Maryland grant, Johns Hopkins University; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This project was funded through TEDCO, State of Maryland grant, Johns Hopkins University institutional support and a National Institutes of Health grant PO-1-HL-107153-01. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe A, 1996, J BIOL CHEM, V271, P14383, DOI 10.1074/jbc.271.24.14383; Bandaru VVR, 2009, NEUROBIOL AGING, V30, P591, DOI 10.1016/j.neurobiolaging.2007.07.024; Bhunia AK, 1996, J BIOL CHEM, V271, P10660, DOI 10.1074/jbc.271.18.10660; Bhunia AK, 1998, J BIOL CHEM, V273, P34349, DOI 10.1074/jbc.273.51.34349; Bietrix F, 2010, ARTERIOSCL THROM VAS, V30, P931, DOI 10.1161/ATVBAHA.109.201673; Bischoff SC, 2007, NAT REV IMMUNOL, V7, P93, DOI 10.1038/nri2018; Cabot MC, 2002, CERAMIDE SIGNALING; Chatteriee S, 2008, BBA-GEN SUBJECTS, V1780, P370, DOI 10.1016/j.bbagen.2007.08.010; Chatterjee S, 1996, GLYCOCONJUGATE J, V13, P481, DOI 10.1007/BF00731481; Chatterjee S, 1997, GLYCOBIOLOGY, V7, P703, DOI 10.1093/glycob/7.5.703; Chatterjee S, 1996, J LIPID RES, V37, P1334; CHATTERJEE S, 1993, BIOCHIM BIOPHYS ACTA, V1167, P339, DOI 10.1016/0005-2760(93)90238-5; Chatterjee S, 2000, METHOD ENZYMOL, V311, P73; Chatterjee S, 2009, United States patent, Patent No. [US 20090202439, 20090202439]; Glaros EN, 2005, J BIOL CHEM, V280, P24515, DOI 10.1074/jbc.M413862200; Haughey NJ, 2004, ANN NEUROL, V55, P257, DOI 10.1002/ana.10828; INOKUCHI J, 1987, CANCER LETT, V38, P23, DOI 10.1016/0304-3835(87)90196-0; INOKUCHI J, 1990, CANCER RES, V50, P6731; Iwamoto T, 2001, J BIOL CHEM, V276, P46031, DOI 10.1074/jbc.M104464200; Jiang JH, 2006, GLYCOBIOLOGY, V16, P1045, DOI 10.1093/glycob/cwl027; KARLSSON KA, 1973, BIOCHIM BIOPHYS ACTA, V306, P307, DOI 10.1016/0005-2760(73)90236-1; Karman J, 2010, INT IMMUNOL, V22, P593, DOI 10.1093/intimm/dxq044; Kolmakova A, 2009, GLYCOCONJUGATE J, V26, P547, DOI 10.1007/s10719-008-9206-9; Lloyd Mark C, 2010, J Pathol Inform, V1, P29, DOI 10.4103/2153-3539.74186; Natoli TA, 2010, NAT MED, V16, P788, DOI 10.1038/nm.2171; Pannu R, 2004, J NEUROSCI, V24, P5942, DOI 10.1523/JNEUROSCI.1271-04.2004; RADIN NS, 1993, ADV LIPID RES, V26, P183; Rajesh M, 2005, CIRC RES, V97, P796, DOI 10.1161/01.RES.0000185327.45463.A8; RANI CSS, 1995, J BIOL CHEM, V270, P2859, DOI 10.1074/jbc.270.6.2859; Rusciani A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014010; Selvin E, 2010, ATHEROSCLEROSIS, V208, P69, DOI 10.1016/j.atherosclerosis.2009.06.025; SHUKLA GS, 1991, BIOCHIM BIOPHYS ACTA, V1083, P101, DOI 10.1016/0005-2760(91)90130-A; Stancevic B, 2010, FEBS LETT, V584, P1728, DOI 10.1016/j.febslet.2010.02.026; Tamboli IY, 2005, J BIOL CHEM, V280, P28110, DOI 10.1074/jbc.M414525200; Veldman RJ, 2002, FASEB J, V16, P1111, DOI 10.1096/fj.01-0863fje; Wang F, 1999, J BIOL CHEM, V274, P35343, DOI 10.1074/jbc.274.50.35343; Wei YY, 2010, J BIOCHEM, V148, P263, DOI 10.1093/jb/mvq061; Wei YY, 2010, BIOCHEM BIOPH RES CO, V396, P602, DOI 10.1016/j.bbrc.2010.04.110; Yeh LH, 2001, J VASC RES, V38, P551, DOI 10.1159/000051091	39	20	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2013	8	5							e63726	10.1371/journal.pone.0063726	http://dx.doi.org/10.1371/journal.pone.0063726			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	155HD	23671696	gold, Green Submitted, Green Published			2022-12-27	WOS:000319737700058
J	Jin, AZ; Koh, WP; Chow, KY; Yuan, JM; Jafar, TH				Jin, Aizhen; Koh, Woon-Puay; Chow, Khuan Yew; Yuan, Jian-Min; Jafar, Tazeen Hasan			Smoking and Risk of Kidney Failure in the Singapore Chinese Health Study	PLOS ONE			English	Article							STAGE RENAL-DISEASE; BLOOD-PRESSURE; MYOCARDIAL-INFARCTION; ETHNIC-DIFFERENCES; CARE; HYPERTENSION; PROGRESSION; PREVALENCE; MANAGEMENT; MORTALITY	Background: The relationship between smoking and risk of kidney failure, especially in people of Chinese origin, is not clear. We analyzed data from the Singapore Chinese Health Study to investigate whether smoking increases the risk of kidney failure. Methods: The Singapore Chinese Health Study is a population-based cohort of 63,257 Chinese adults enrolled between 1993 and 1998. Information on smoking status was collected at baseline. Incidence of kidney failure was identified via record linkage with the nationwide Singapore Renal Registry until 2008. Kidney failure was defined by one of the following: 1) serum creatinine level of more than or equal to 500 mmol/l (5.7 mg/dl), 2) estimated glomerular filtration rate of less than 15 ml/min/1.73 m(2), 3) undergoing hemodialysis or peritoneal dialysis, 4) undergone kidney transplantation. Cox proportional hazard regression analysis was performed for the outcome of kidney failure after adjusting for age, education, dialect, herbal medications, body mass index, sex, physician-diagnosed hypertension and diabetes mellitus. Results: The mean age of subjects was 55.6 years at baseline, and 44% were men. Overall 30.6% were ever smokers (current or former) at baseline. A total of 674 incident cases of kidney failure occurred during a median follow-up of 13.3 years. Among men, smokers had a significant increase in the adjusted risk of kidney failure [hazard ratio (HR): 1.29; 95% CI: 1.02-1.64] compared to never smokers. There was a strong dose-dependent association between number of years of smoking and kidney failure, (p for trend = 0.011). The risk decreased with prolonged cessation (quitting >= 10 years since baseline). The number of women smokers was too few for conclusive relationship. Limitation: Information on baseline kidney function was not available. Conclusions: Cigarette smoking is associated with increased risk of kidney failure among Chinese men. The risk appears to be dose- and duration-dependent and modifiable after long duration of cessation.	[Jin, Aizhen; Chow, Khuan Yew] Hlth Promot Board, Natl Registry Dis Off, Singapore, Singapore; [Koh, Woon-Puay] Duke NUS Grad Med Sch, Off Clin Sci, Singapore, Singapore; [Koh, Woon-Puay] Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Dept Epidemiol, Singapore 117548, Singapore; [Yuan, Jian-Min] Univ Pittsburgh, Inst Canc, Div Canc Control & Populat Sci, Pittsburgh, PA USA; [Yuan, Jian-Min] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Epidemiol, Pittsburgh, PA USA; [Jafar, Tazeen Hasan] Duke NUS Grad Med Sch, Lab Cardiovasc & Renal Risk Reduct Hlth Serv & Sy, Singapore, Singapore	National University of Singapore; National University of Singapore; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; National University of Singapore	Jafar, TH (corresponding author), Duke NUS Grad Med Sch, Lab Cardiovasc & Renal Risk Reduct Hlth Serv & Sy, Singapore, Singapore.	tazeen.jafar@duke-nus.edu.sg		Yuan, Jian-Min/0000-0002-4620-3108	National Institutes of Health, USA [RO1 CA55069, R35 CA53890, R01 CA80205, R01 CA144034]; NATIONAL CANCER INSTITUTE [R01CA144034, R01CA080205, R35CA053890, R01CA055069] Funding Source: NIH RePORTER	National Institutes of Health, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The study was funded by National Institutes of Health, USA (RO1 CA55069, R35 CA53890, R01 CA80205, and R01 CA144034). No funding bodies had any role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cravedi P, 2008, KIDNEY INT, V74, pS2, DOI 10.1038/ki.2008.511; DOLL R, 1976, BRIT MED J, V2, P1525, DOI 10.1136/bmj.2.6051.1525; EVANS RW, 1985, NEW ENGL J MED, V312, P553, DOI 10.1056/NEJM198502283120905; Fischbacher CM, 2003, DIABETIC MED, V20, P31, DOI 10.1046/j.1464-5491.2003.00822.x; Hallan SI, 2011, KIDNEY INT, V80, P516, DOI 10.1038/ki.2011.157; Hankin JH, 2001, NUTR CANCER, V39, P187, DOI 10.1207/S15327914nc392_5; Hossain MP, 2009, AM J KIDNEY DIS, V53, P166, DOI 10.1053/j.ajkd.2007.10.047; Hwang SJ, 2010, NEPHROLOGY, V15, P3, DOI 10.1111/j.1440-1797.2010.01304.x; Ikeda F, 2012, TOB CONTROL, V21, P416, DOI 10.1136/tc.2010.039362; Jafar TH, 2003, ANN INTERN MED, V139, P244, DOI 10.7326/0003-4819-139-4-200308190-00006; Johnson S, 2008, J HEALTH CARE POOR U, V19, P90, DOI 10.1353/hpu.2008.0007; Klag MJ, 1996, NEW ENGL J MED, V334, P13, DOI 10.1056/NEJM199601043340103; Lai MN, 2009, NEPHROLOGY, V14, P227, DOI 10.1111/j.1440-1797.2008.01061.x; Lash JP, 2006, AM J KIDNEY DIS, V47, P956, DOI 10.1053/j.ajkd.2006.02.175; Levey AS, 2012, LANCET, V379, P165, DOI 10.1016/S0140-6736(11)60178-5; Lim SH, 2011, TOB CONTROL; Lopez AD, 2006, LANCET, V367, P1747, DOI 10.1016/S0140-6736(06)68770-9; MCALISTER NH, 1986, BRIT MED J, V293, P670, DOI 10.1136/bmj.293.6548.670; Mudur G, 2005, BRIT MED J, V330, P920, DOI 10.1136/bmj.330.7497.920-a; Muntner P, 2003, J AM SOC NEPHROL, V14, P1568, DOI 10.1097/01.ASN.0000067420.83632.C1; Pinto-Sietsma SJ, 2000, ANN INTERN MED, V133, P585, DOI 10.7326/0003-4819-133-8-200010170-00008; Powe NR, 2005, MED CLIN N AM, V89, P475, DOI 10.1016/j.mcna.2004.11.004; ROSENBERG L, 1990, NEW ENGL J MED, V322, P213, DOI 10.1056/NEJM199001253220401; Tamura MK, 2009, NEW ENGL J MED, V361, P1539, DOI 10.1056/NEJMoa0904655; Tsuchiya M, 2002, CIRCULATION, V105, P1155, DOI 10.1161/hc1002.105935; Xue JL, 2007, J AM SOC NEPHROL, V18, P1299, DOI 10.1681/ASN.2006050524; Yach D, 2003, LANCET, V361, P611, DOI 10.1016/S0140-6736(03)12532-9; Yang GH, 2010, BIOMED ENVIRON SCI, V23, P422, DOI 10.1016/S0895-3988(11)60002-0; Zhang LX, 2012, LANCET, V379, P815, DOI 10.1016/S0140-6736(12)60033-6	29	16	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2013	8	5							e62962	10.1371/journal.pone.0062962	http://dx.doi.org/10.1371/journal.pone.0062962			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	155HD	23671645	Green Published, gold, Green Accepted			2022-12-27	WOS:000319737700029
J	Koike, M; Tanida, I; Nanao, T; Tada, N; Iwata, J; Ueno, T; Kominami, E; Uchiyama, Y				Koike, Masato; Tanida, Isei; Nanao, Tomohisa; Tada, Norihiro; Iwata, Jun-ichi; Ueno, Takashi; Kominami, Eiki; Uchiyama, Yasuo			Enrichment of GABARAP Relative to LC3 in the Axonal Initial Segments of Neurons	PLOS ONE			English	Article							LYSOSOMAL TURNOVER; MOUSE MODELS; PROTEIN; RECEPTOR; AUTOPHAGY; TRANSPORT; EXPRESSION; GATE-16; CONJUGATION; DEFICIENT	GABA(A) receptor-associated protein (GABARAP) was initially identified as a protein that interacts with GABA(A) receptor. Although LC3 (microtubule-associated protein 1 light chain 3), a GABARAP homolog, has been localized in the dendrites and cell bodies of neurons under normal conditions, the subcellular distribution of GABARAP in neurons remains unclear. Subcellular fractionation indicated that endogenous GABARAP was localized to the microsome-enriched and synaptic vesicle-enriched fractions of mouse brain as GABARAP-I, an unlipidated form. To investigate the distribution of GABARAP in neurons, we generated GFP-GABARAP transgenic mice. Immunohistochemistry in these transgenic mice showed that positive signals for GFP-GABARAP were widely distributed in neurons in various brain regions, including the hippocampus and cerebellum. Interestingly, intense diffuse and/or fibrillary expression of GFP-GABARAP was detected along the axonal initial segments (AIS) of hippocampal pyramidal neurons and cerebellar Purkinje cells, in addition to the cell bodies and dendrites of these neurons. In contrast, only slight amounts of LC3 were detected along the AIS of these neurons, while diffuse and/or fibrillary staining for LC3 was mainly detected in their cell bodies and dendrites. These results indicated that, compared with LC3, GABARAP is enriched in the AIS, in addition to the cell bodies and dendrites, of these hippocampal pyramidal neurons and cerebellar Purkinje cells.	[Koike, Masato; Nanao, Tomohisa; Uchiyama, Yasuo] Juntendo Univ, Sch Med, Dept Cell Biol & Neurosci, Tokyo 113, Japan; [Tanida, Isei; Iwata, Jun-ichi; Ueno, Takashi; Kominami, Eiki] Juntendo Univ, Sch Med, Dept Biochem, Tokyo 113, Japan; [Tanida, Isei] Natl Inst Infect Dis, Dept Biochem & Cell Biol, Shinjuku Ku, Tokyo 1628640, Japan; [Tada, Norihiro] Juntendo Univ, Sch Med, Res Inst Dis Old Ages, Div Genome Res, Tokyo 113, Japan	Juntendo University; Juntendo University; National Institute of Infectious Diseases (NIID); Juntendo University	Tanida, I (corresponding author), Juntendo Univ, Sch Med, Dept Biochem, Tokyo 113, Japan.	tanida@nih.go.jp; y-uchi@juntendo.ac.jp	Koike, Masato/F-9584-2010	Koike, Masato/0000-0002-3174-5684; Tanida, Isei/0000-0001-8999-3990	Ministry of Health, Labor, and Welfare of Japan; Ministry of Education, Science, Sports and Culture, Japan (MEXT) [23659102]; MEXT-supported Program for the Strategic Research Foundation at Private Universities; Research Grant from the Takeda Science Foundation;  [14380308];  [16370063]	Ministry of Health, Labor, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Ministry of Education, Science, Sports and Culture, Japan (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); MEXT-supported Program for the Strategic Research Foundation at Private Universities(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Research Grant from the Takeda Science Foundation; ; 	This study was supported, in part, by grants-in-aid from the Ministry of Health, Labor, and Welfare of Japan (IT, TU, HK, and EK), Grants-in-aid for Scientific Research (B) (14380308 and 16370063 to TU), Grants-in-Aid for Scientific Research on Priority Areas "Proteolysis in the Regulation of Biological Processes'' (to IT, MK, and TU), and challenging Exploratory Research (23659102 to YU) from the Ministry of Education, Science, Sports and Culture, Japan (MEXT). TU and YU were supported by MEXT-supported Program for the Strategic Research Foundation at Private Universities. TU was supported by a Research Grant from the Takeda Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Buffington SA, 2011, EUR J NEUROSCI, V34, P1609, DOI 10.1111/j.1460-9568.2011.07875.x; Chen CG, 2011, J BIOL CHEM, V286, P15106, DOI 10.1074/jbc.M111.230896; Chen L, 2000, P NATL ACAD SCI USA, V97, P11557, DOI 10.1073/pnas.190133497; Chen ZW, 2007, J NEUROCHEM, V100, P279, DOI 10.1111/j.1471-4159.2006.04206.x; Clark BD, 2009, NEUROSCIENTIST, V15, P651, DOI 10.1177/1073858409341973; Cook JL, 2008, CIRC RES, V102, P1539, DOI 10.1161/CIRCRESAHA.108.176594; DEFELIPE J, 1985, J COMP NEUROL, V231, P364, DOI 10.1002/cne.902310307; Green F, 2002, FEBS LETT, V518, P101, DOI 10.1016/S0014-5793(02)02655-8; Hell JW, 2005, CELL BIOL 4 VOLUME S, P85; Iwakura A, 2012, J NEUROSCI, V32, P9438, DOI 10.1523/JNEUROSCI.1651-12.2012; Kabeya Y, 2004, J CELL SCI, V117, P2805, DOI 10.1242/jcs.01131; Kanematsu T, 2002, EMBO J, V21, P1004, DOI 10.1093/emboj/21.5.1004; Kittler JT, 2001, MOL CELL NEUROSCI, V18, P13, DOI 10.1006/mcne.2001.1005; Kneussel M, 2000, P NATL ACAD SCI USA, V97, P8594, DOI 10.1073/pnas.97.15.8594; Koike M, 2005, AM J PATHOL, V167, P1713, DOI 10.1016/S0002-9440(10)61253-9; Koike M, 2008, AM J PATHOL, V172, P454, DOI 10.2353/ajpath.2008.070876; Komatsu M, 2007, CELL, V131, P1149, DOI 10.1016/j.cell.2007.10.035; KORDELI E, 1995, J BIOL CHEM, V270, P2352, DOI 10.1074/jbc.270.5.2352; Kouno T, 2005, J BIOL CHEM, V280, P24610, DOI 10.1074/jbc.M413565200; Lainez S, 2010, FASEB J, V24, P1958, DOI 10.1096/fj.09-151472; Legesse-Miller A, 1998, J BIOL CHEM, V273, P3105, DOI 10.1074/jbc.273.5.3105; Marino G, 2007, J BIOL CHEM, V282, P18573, DOI 10.1074/jbc.M701194200; Mizushima N, 2004, MOL BIOL CELL, V15, P1101, DOI 10.1091/mbc.E03-09-0704; Nakajima K, 2012, NEURON, V76, P945, DOI 10.1016/j.neuron.2012.10.012; Nakata T, 2003, J CELL BIOL, V162, P1045, DOI 10.1083/jcb.200302175; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Nusser Z, 1996, P NATL ACAD SCI USA, V93, P11939, DOI 10.1073/pnas.93.21.11939; Nusser Z, 2009, TRENDS NEUROSCI, V32, P267, DOI 10.1016/j.tins.2009.01.003; O'Sullivan GA, 2005, EUR J NEUROSCI, V22, P2644, DOI 10.1111/j.1460-9568.2005.04448.x; Okazaki N, 2000, MOL BRAIN RES, V85, P1, DOI 10.1016/S0169-328X(00)00218-7; Reining SC, 2009, AM J PHYSIOL-RENAL, V296, pF1118, DOI 10.1152/ajprenal.90492.2008; Sagiv Y, 2000, EMBO J, V19, P1494, DOI 10.1093/emboj/19.7.1494; Schwarten M, 2009, AUTOPHAGY, V5, P690, DOI 10.4161/auto.5.5.8494; Sou Y, 2006, J BIOL CHEM, V281, P3017, DOI 10.1074/jbc.M505888200; Takagi-Akiba M, 2012, AM J PHYSIOL-RENAL, V302, pF380, DOI 10.1152/ajprenal.00502.2010; Tanida I, 2004, J BIOL CHEM, V279, P36268, DOI 10.1074/jbc.M401461200; Tanida I, 2003, BIOCHEM BIOPH RES CO, V300, P637, DOI 10.1016/S0006-291X(02)02907-8; Tanida I, 2002, J BIOL CHEM, V277, P13739, DOI 10.1074/jbc.M200385200; Tanida I, 2001, J BIOL CHEM, V276, P1701, DOI 10.1074/jbc.C000752200; Tanida I, 2004, INT J BIOCHEM CELL B, V36, P2503, DOI 10.1016/j.biocel.2004.05.009; Tanida I, 2006, AUTOPHAGY, V2, P264, DOI 10.4161/auto.2871; Tanida I, 2006, FEBS J, V273, P2553, DOI 10.1111/j.1742-4658.2006.05260.x; Tanida I, 2005, AUTOPHAGY, V1, P84, DOI 10.4161/auto.1.2.1697; Vernier-Magnin S, 2001, BIOCHEM BIOPH RES CO, V284, P118, DOI 10.1006/bbrc.2001.4908; Wang HB, 1999, NATURE, V397, P69, DOI 10.1038/16264; Yue ZY, 2009, METHOD ENZYMOL, V453, P159, DOI 10.1016/S0076-6879(08)04008-1	46	15	15	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2013	8	5							e63568	10.1371/journal.pone.0063568	http://dx.doi.org/10.1371/journal.pone.0063568			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	155HD	23671684	gold, Green Published, Green Submitted			2022-12-27	WOS:000319737700053
J	Kurahashi, I; Fujita, Y; Arao, T; Kurata, T; Koh, Y; Sakai, K; Matsumoto, K; Tanioka, M; Takeda, K; Takiguchi, Y; Yamamoto, N; Tsuya, A; Matsubara, N; Mukai, H; Minami, H; Chayahara, N; Yamanaka, Y; Miwa, K; Takahashi, S; Takahashi, S; Nakagawa, K; Nishio, K				Kurahashi, Issei; Fujita, Yoshihiko; Arao, Tokuzo; Kurata, Takayasu; Koh, Yasuhiro; Sakai, Kazuko; Matsumoto, Koji; Tanioka, Maki; Takeda, Koji; Takiguchi, Yuichi; Yamamoto, Nobuyuki; Tsuya, Asuka; Matsubara, Nobuaki; Mukai, Hirofumi; Minami, Hironobu; Chayahara, Naoko; Yamanaka, Yasuhiro; Miwa, Keisuke; Takahashi, Shin; Takahashi, Shunji; Nakagawa, Kazuhiko; Nishio, Kazuto			A Microarray-Based Gene Expression Analysis to Identify Diagnostic Biomarkers for Unknown Primary Cancer	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; DEPENDENT PROTEIN-KINASE; PHASE-II TRIAL; MOLECULAR CLASSIFICATION; RIBOSOMAL BIOGENESIS; PRIMARY SITE; METASTASIS; CARCINOMA; CELLS; ORIGIN	Background: The biological basis for cancer of unknown primary (CUP) at the molecular level remains largely unknown, with no evidence of whether a common biological entity exists. Here, we assessed the possibility of identifying a common diagnostic biomarker for CUP using a microarray gene expression analysis. Methods: Tumor mRNA samples from 60 patients with CUP were analyzed using the Affymetrix U133A Plus 2.0 GeneChip and were normalized by asinh (hyperbolic arc sine) transformation to construct a mean gene-expression profile specific to CUP. A gene-expression profile specific to non-CUP group was constructed using publicly available raw microarray datasets. The t-tests were performed to compare the CUP with non-CUP groups and the top 59 CUP specific genes with the highest fold change were selected (p-value<0.001). Results: Among the 44 genes that were up-regulated in the CUP group, 6 genes for ribosomal proteins were identified. Two of these genes (RPS7 and RPL11) are known to be involved in the Mdm2-p53 pathway. We also identified several genes related to metastasis and apoptosis, suggesting a biological attribute of CUP. Conclusions: The protein products of the up-regulated and down-regulated genes identified in this study may be clinically useful as unique biomarkers for CUP.	[Kurahashi, Issei] Univ Tokyo, Dept Planning Informat & Management, Tokyo, Japan; [Fujita, Yoshihiko; Arao, Tokuzo; Sakai, Kazuko; Nishio, Kazuto] Kinki Univ, Sch Med, Dept Genome Biol, Osaka 589, Japan; [Kurata, Takayasu; Nakagawa, Kazuhiko] Kinki Univ, Sch Med, Dept Med Oncol, Osaka 589, Japan; [Koh, Yasuhiro] Shizuoka Canc Ctr, Res Inst, Div Drug Discovery & Dev, Shizuoka, Japan; [Matsumoto, Koji; Tanioka, Maki] Hyogo Canc Ctr, Div Med Oncol, Akashi, Hyogo, Japan; [Takeda, Koji; Tsuya, Asuka] Osaka City Gen Hosp, Dept Clin Oncol, Osaka, Japan; [Takiguchi, Yuichi] Chiba Univ, Grad Sch Med, Dept Med Oncol, Chiba, Japan; [Yamamoto, Nobuyuki] Shizuoka Canc Ctr, Div Thorac Oncol, Shizuoka, Japan; [Matsubara, Nobuaki; Mukai, Hirofumi] Natl Canc Ctr Hosp East, Div Hematol & Oncol, Chiba, Japan; [Minami, Hironobu; Chayahara, Naoko] Kobe Univ, Grad Sch Med, Div Med Oncol Hematol, Kobe, Hyogo 657, Japan; [Yamanaka, Yasuhiro] Tochigi Canc Ctr, Dept Med Oncol, Utsunomiya, Tochigi, Japan; [Miwa, Keisuke] Saitama Med Univ, Dept Med Oncol, Ctr Comprehens Canc, Int Med Ctr, Saitama, Japan; [Takahashi, Shin] Tohoku Univ, Dept Clin Oncol, Inst Dev Aging & Canc, Sendai, Miyagi 980, Japan; [Takahashi, Shunji] Canc Inst Hosp, Div Med Oncol, Tokyo, Japan	University of Tokyo; Kindai University (Kinki University); Kindai University (Kinki University); Shizuoka Cancer Center; Hyogo Cancer Center; Osaka City General Hospital; Chiba University; Shizuoka Cancer Center; National Cancer Center - Japan; Kobe University; Tochigi Prefectural Cancer Center; Saitama Medical University; Tohoku University; Japanese Foundation for Cancer Research	Nishio, K (corresponding author), Kinki Univ, Sch Med, Dept Genome Biol, Osaka 589, Japan.	knishio@med.kindai.ac.jp	Takahashi, Shin/AAE-5011-2019; Matsumoto, Koji/GVT-8176-2022; Matsumoto, Koji/AHB-3532-2022	Takahashi, Shin/0000-0001-6695-3099; Matsumoto, Koji/0000-0003-1907-0247; Tanioka, Maki/0000-0002-6558-2246	Ministry of Health, Labour and Welfare; Grants-in-Aid for Scientific Research [25462006, 24591186, 23591136] Funding Source: KAKEN	Ministry of Health, Labour and Welfare(Ministry of Health, Labour and Welfare, Japan); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the grant-in-aid for Scientific Research from the Ministry of Health, Labour and Welfare. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABBRUZZESE JL, 1995, J CLIN ONCOL, V13, P2094, DOI 10.1200/JCO.1995.13.8.2094; ABBRUZZESE JL, 1994, J CLIN ONCOL, V12, P1272, DOI 10.1200/JCO.1994.12.6.1272; Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Anderberg M. R., 1973, CLUSTER ANAL APPL; Bandres E, 2004, ONCOL REP, V12, P287; Banh A, 2011, CANCER RES, V71, P4423, DOI 10.1158/0008-5472.CAN-10-4157; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bloom G, 2004, AM J PATHOL, V164, P9, DOI 10.1016/S0002-9440(10)63090-8; Dai MS, 2008, J CELL BIOCHEM, V105, P670, DOI 10.1002/jcb.21895; de Marval PM, 2011, CANCER PREV RES, V4, P851, DOI 10.1158/1940-6207.CAPR-10-0360; Dennis JL, 2005, CLIN CANCER RES, V11, P3766, DOI 10.1158/1078-0432.CCR-04-2236; Durbin B, 2003, BIOINFORMATICS, V19, P1360, DOI 10.1093/bioinformatics/btg178; Fu ZY, 2011, BIOMED PHARMACOTHER, V65, P163, DOI 10.1016/j.biopha.2011.02.004; Giordano TJ, 2001, AM J PATHOL, V159, P1231, DOI 10.1016/S0002-9440(10)62509-6; Greco FA, 2002, J CLIN ONCOL, V20, P1651, DOI 10.1200/JCO.20.6.1651; Hainsworth JD, 2007, J CLIN ONCOL, V25, P1747, DOI 10.1200/JCO.2006.09.3047; Hastie T., 2017, ELEMENT STAT LEARNIN; Huber Wolfgang, 2002, Bioinformatics, V18 Suppl 1, pS96; Iurisci I, 2009, ANTICANCER RES, V29, P403; Ivaska J, 2007, EXP CELL RES, V313, P2050, DOI 10.1016/j.yexcr.2007.03.040; Jiffar T, 2011, ONCOGENE, V30, P3163, DOI 10.1038/onc.2011.39; Kumar MS, 2009, GENE DEV, V23, P2700, DOI 10.1101/gad.1848209; Kurahashi I, 2007, J JAPAN STAT SOC, V36, P147; Kwee TC, 2009, EUR RADIOL, V19, P731, DOI 10.1007/s00330-008-1194-4; LAIRD NM, 1982, BIOMETRICS, V38, P963, DOI 10.2307/2529876; Li XJ, 2011, CANCER RES, V71, P3162, DOI 10.1158/0008-5472.CAN-10-3557; Macha MA, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-655; Maelandsmo GM, 1997, INT J CANCER, V74, P464, DOI 10.1002/(SICI)1097-0215(19970822)74:4<464::AID-IJC19>3.0.CO;2-9; Maier HJ, 2010, CANCER LETT, V295, P214, DOI 10.1016/j.canlet.2010.03.003; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Mao P, 2011, J BIOL CHEM, V286, P19381, DOI 10.1074/jbc.M111.218040; Matta A, 2012, EXPERT OPIN THER TAR, V16, P515, DOI 10.1517/14728222.2012.668185; Melle C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003767; Park Jong Sun, 2011, BMC Res Notes, V4, P56, DOI 10.1186/1756-0500-4-56; Pavlidis N, 2003, EUR J CANCER, V39, P1990, DOI 10.1016/S0959-8049(03)00547-1; Pimiento JM, 2007, AM J SURG, V194, P833, DOI 10.1016/j.amjsurg.2007.08.039; Raj L, 2011, NATURE, V475, P231, DOI 10.1038/nature10167; Ramaswamy S, 2001, P NATL ACAD SCI USA, V98, P15149, DOI 10.1073/pnas.211566398; Rodnina MV, 2009, CURR OPIN CELL BIOL, V21, P435, DOI 10.1016/j.ceb.2009.01.023; Ruggero D, 2003, NAT REV CANCER, V3, P179, DOI 10.1038/nrc1015; Schafer BW, 1996, TRENDS BIOCHEM SCI, V21, P134, DOI 10.1016/S0968-0004(96)80167-8; Schneider BJ, 2007, CANCER-AM CANCER SOC, V110, P770, DOI 10.1002/cncr.22857; Shedden KA, 2003, AM J PATHOL, V163, P1985, DOI 10.1016/S0002-9440(10)63557-2; Singh A, 2009, CANCER CELL, V15, P489, DOI 10.1016/j.ccr.2009.03.022; Sokol JP, 2005, BREAST CANCER RES, V7, pR844, DOI 10.1186/bcr1312; Soucy Teresa A, 2010, Genes Cancer, V1, P708, DOI 10.1177/1947601910382898; STRUTZ F, 1995, J CELL BIOL, V130, P393, DOI 10.1083/jcb.130.2.393; Su AI, 2001, CANCER RES, V61, P7388; Sun XX, 2010, J BIOL CHEM, V285, P25812, DOI 10.1074/jbc.M109.098442; Tang DJ, 2010, HEPATOLOGY, V51, P1255, DOI 10.1002/hep.23451; Tothill RW, 2005, CANCER RES, V65, P4031, DOI 10.1158/0008-5472.CAN-04-3617; Um JH, 2004, J PHARMACOL EXP THER, V311, P1062, DOI 10.1124/jpet.104.070938; Varadhachary GR, 2008, LANCET ONCOL, V9, P596, DOI 10.1016/S1470-2045(08)70151-7; Zhao Y, 2006, CANCER RES, V66, P5354, DOI 10.1158/0008-5472.CAN-05-4275; Zhu Y, 2009, MOL CELL, V35, P316, DOI 10.1016/j.molcel.2009.07.014	55	19	20	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2013	8	5							e63249	10.1371/journal.pone.0063249	http://dx.doi.org/10.1371/journal.pone.0063249			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	155HD	23671674	Green Published, gold, Green Submitted			2022-12-27	WOS:000319737700050
J	Nichols, TA; Spraker, TR; Rigg, TD; Meyerett-Reid, C; Hoover, C; Michel, B; Bian, JF; Hoover, E; Gidlewski, T; Balachandran, A; O'Rourke, K; Telling, GC; Bowen, R; Zabel, MD; VerCauteren, KC				Nichols, Tracy A.; Spraker, Terry R.; Rigg, Tara D.; Meyerett-Reid, Crystal; Hoover, Clare; Michel, Brady; Bian, Jifeng; Hoover, Edward; Gidlewski, Thomas; Balachandran, Aru; O'Rourke, Katherine; Telling, Glenn C.; Bowen, Richard; Zabel, Mark D.; VerCauteren, Kurt C.			Intranasal Inoculation of White-Tailed Deer (Odocoileus virginianus) with Lyophilized Chronic Wasting Disease Prion Particulate Complexed to Montmorillonite Clay	PLOS ONE			English	Article							DENDRITIC CELLS; MULE DEER; NASAL-MUCOSA; ORAL-TRANSMISSION; INFECTIOUS PRIONS; PROTEIN; TRANSPORT; HEMIONUS; PATHWAYS; DELIVERY	Chronic wasting disease (CWD), the only known prion disease endemic in wildlife, is a persistent problem in both wild and captive North American cervid populations. This disease continues to spread and cases are found in new areas each year. Indirect transmission can occur via the environment and is thought to occur by the oral and/or intranasal route. Oral transmission has been experimentally demonstrated and although intranasal transmission has been postulated, it has not been tested in a natural host until recently. Prions have been shown to adsorb strongly to clay particles and upon oral inoculation the prion/clay combination exhibits increased infectivity in rodent models. Deer and elk undoubtedly and chronically inhale dust particles routinely while living in the landscape while foraging and rutting. We therefore hypothesized that dust represents a viable vehicle for intranasal CWD prion exposure. To test this hypothesis, CWD-positive brain homogenate was mixed with montmorillonite clay (Mte), lyophilized, pulverized and inoculated intranasally into white-tailed deer once a week for 6 weeks. Deer were euthanized at 95, 105, 120 and 175 days post final inoculation and tissues examined for CWD-associated prion proteins by immunohistochemistry. Our results demonstrate that CWD can be efficiently transmitted utilizing Mte particles as a prion carrier and intranasal exposure.	[Nichols, Tracy A.; Rigg, Tara D.; Gidlewski, Thomas; VerCauteren, Kurt C.] US Anim & Plant Hlth Inspect Serv, Natl Wildlife Res Ctr, USDA, Wildlife Serv, Ft Collins, CO USA; [Spraker, Terry R.] Colorado State Univ, Diagnost Lab, Ft Collins, CO 80523 USA; [Spraker, Terry R.; Meyerett-Reid, Crystal; Hoover, Clare; Michel, Brady; Bian, Jifeng; Hoover, Edward; Telling, Glenn C.; Zabel, Mark D.] Colorado State Univ, Prion Res Ctr, Ft Collins, CO 80523 USA; [Spraker, Terry R.; Meyerett-Reid, Crystal; Hoover, Clare; Michel, Brady; Bian, Jifeng; Hoover, Edward; Telling, Glenn C.; Zabel, Mark D.] Colorado State Univ, Prion Res Ctr, Dept Microbiol Immunol & Pathol, Coll Vet Med & Biomed Sci, Ft Collins, CO 80523 USA; [Bowen, Richard] Colorado State Univ, Coll Vet Med & Biomed Sci, Dept Biomed Sci, Ft Collins, CO 80523 USA; [Balachandran, Aru] Canadian Food Inspect Agcy, Natl & OIE Reference Lab Scrapie & Chron Wasting, Ottawa, ON, Canada; [O'Rourke, Katherine] USDA, ARS, Pullman, WA USA	United States Department of Agriculture (USDA); Colorado State University; Colorado State University; Colorado State University; Colorado State University; Canadian Food Inspection Agency; United States Department of Agriculture (USDA)	Nichols, TA (corresponding author), US Anim & Plant Hlth Inspect Serv, Natl Wildlife Res Ctr, USDA, Wildlife Serv, Ft Collins, CO USA.	tracy.a.nichols@aphis.usda.gov	Bian, Jifeng/AAE-6262-2019; Telling, Glenn C/G-1217-2019	Bian, Jifeng/0000-0001-6838-9938; Telling, Glenn C/0000-0002-6294-1805	U.S. Department of Agriculture, Animal and Plant Health Inspection Service, Veterinary Services (VS)	U.S. Department of Agriculture, Animal and Plant Health Inspection Service, Veterinary Services (VS)	Funding was provided by U.S. Department of Agriculture, Animal and Plant Health Inspection Service, Veterinary Services (VS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Annacker O, 2005, J EXP MED, V202, P1051, DOI 10.1084/jem.20040662; ARTHUR WJ, 1979, J RANGE MANAGE, V32, P67, DOI 10.2307/3897389; Bessen RA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000837; Bessen RA, 2009, J VIROL, V83, P6435, DOI 10.1128/JVI.00018-09; Bian JF, 2010, J VIROL, V84, P8322, DOI 10.1128/JVI.00633-10; Denkers ND, 2013, J VIROL, V87, P1890, DOI 10.1128/JVI.02852-12; Donaldson DS, 2012, MUCOSAL IMMUNOL, V5, P216, DOI 10.1038/mi.2011.68; Dong YC, 2005, BIOMATERIALS, V26, P6068, DOI 10.1016/j.biomaterials.2005.03.021; ESIRI MM, 1984, J NEUROL SCI, V64, P213, DOI 10.1016/0022-510X(84)90039-X; Feng SS, 2009, BIOMATERIALS, V30, P3297, DOI 10.1016/j.biomaterials.2009.02.045; FLEXNER S, 1913, P SOC EXP BIOL MED, V10, P1; Fox KA, 2006, J GEN VIROL, V87, P3451, DOI 10.1099/vir.0.81999-0; Gee G.W., 1986, METHODS SOIL ANAL 1, P399; Haley NJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004848; Hartmann E, 2006, CLIN VACCINE IMMUNOL, V13, P1278, DOI 10.1128/CVI.00172-06; Heppner FL, 2001, NAT MED, V7, P976, DOI 10.1038/nm0901-976; Hewitt D G., 2011, BIOL MANGAMENT WHITE; HOLT PG, 1989, CLIN EXP ALLERGY, V19, P597, DOI 10.1111/j.1365-2222.1989.tb02752.x; Holt PG, 2000, J ALLERGY CLIN IMMUN, V105, P421, DOI 10.1067/mai.2000.105010; Huang FP, 2004, ADV DRUG DELIVER REV, V56, P901, DOI 10.1016/j.addr.2003.09.006; Huang FP, 2002, J GEN VIROL, V83, P267, DOI 10.1099/0022-1317-83-1-267; JANI PU, 1992, INT J PHARMACEUT, V86, P239, DOI 10.1016/0378-5173(92)90202-D; Jepson MA, 1996, J ANAT, V189, P507; Johnson CJ, 2007, PLOS PATHOG, V3, P874, DOI 10.1371/journal.ppat.0030093; Johnson CJ, 2006, PLOS PATHOG, V2, P296, DOI 10.1371/journal.ppat.0020032; Karberg NJ, 2009, BIOL INVASIONS, V11, P761, DOI 10.1007/s10530-008-9290-6; Kawase M, 2004, BIOL PHARM BULL, V27, P2049, DOI 10.1248/bpb.27.2049; Keeler Shamus P., 2011, Journal of the Pennsylvania Academy of Science, V85, P183; Kelly AC, 2008, PRION, V2, P28, DOI 10.4161/pri.2.1.6321; Kincaid AE, 2007, J VIROL, V81, P4482, DOI 10.1128/JVI.02649-06; Kincaid AE, 2012, J VIROL, V86, P12731, DOI 10.1128/JVI.01930-12; Klaassen C.D., 2001, CASARETT DOULLS TOXI; KleinJan A, 2006, J ALLERGY CLIN IMMUN, V118, P1117, DOI 10.1016/j.jaci.2006.05.030; KleinJan A, 2011, CURR OPIN ALLERGY CL, V11, P12, DOI 10.1097/ACI.0b013e328342335f; LAFAY F, 1991, VIROLOGY, V183, P320, DOI 10.1016/0042-6822(91)90145-2; Larsson P, 2000, TOXICOL SCI, V55, P383, DOI 10.1093/toxsci/55.2.383; Le Pichon CE, 2008, J COMP NEUROL, V508, P487, DOI 10.1002/cne.21698; Mabbott NA, 2012, PRION, V6, P322, DOI 10.4161/pri.20676; Mathiason CK, 2006, SCIENCE, V314, P133, DOI 10.1126/science.1132661; Mathiason CK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005916; MCWILLIAM AS, 1995, IMMUNOL CELL BIOL, V73, P405, DOI 10.1038/icb.1995.63; Michel B, 2012, SCI REP-UK, V2, DOI 10.1038/srep00440; Miller MW, 2012, J WILDLIFE DIS, V48, P526, DOI 10.7589/0090-3558-48.2.526; Miller MW, 2003, NATURE, V425, P35, DOI 10.1038/425035a; Miller MW, 2004, EMERG INFECT DIS, V10, P1003, DOI 10.3201/eid1006.040010; Nelson HS, 2007, J ALLERGY CLIN IMMUN, V119, P872, DOI 10.1016/j.jaci.2006.12.613; Nichols TA, 2009, PRION, V3, P171, DOI 10.4161/pri.3.3.9819; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; Pulford B, 2012, J WILDLIFE DIS, V48, P425, DOI 10.7589/0090-3558-48.2.425; Rajapaksa TE, 2010, J CONTROL RELEASE, V142, P196, DOI 10.1016/j.jconrel.2009.10.033; Rescigno M, 2001, NAT IMMUNOL, V2, P361, DOI 10.1038/86373; Rigou P, 2006, ENVIRON SCI TECHNOL, V40, P1497, DOI 10.1021/es0516965; Robinson SJ, 2012, ECOL APPL, V22, P1050, DOI 10.1890/11-0907.1; Sansonetti PJ, 1999, SEMIN IMMUNOL, V11, P193, DOI 10.1006/smim.1999.0175; Saunders SE, 2012, EMERG INFECT DIS, V18, P369, DOI 10.3201/eid1803.110685; Saunders SE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018752; Sbriccoli M, 2009, ACTA NEUROPATHOL, V117, P175, DOI 10.1007/s00401-008-0474-z; Sigurdson CJ, 1999, J GEN VIROL, V80, P2757, DOI 10.1099/0022-1317-80-10-2757; Sigurdson CJ, 2002, J GEN VIROL, V83, P2617, DOI 10.1099/0022-1317-83-10-2617; Spraker TR, 2002, J VET DIAGN INVEST, V14, P3, DOI 10.1177/104063870201400102; Strotmann J, 2001, CELL MOL LIFE SCI, V58, P531, DOI 10.1007/PL00000878; Takano K, 2005, J HISTOCHEM CYTOCHEM, V53, P611, DOI 10.1369/jhc.4A6539.2005; Tweill DEaT JW, 2002, N AM ELK ECOLOGY MAN; Upham JW, 2003, RESPIROLOGY, V8, P140, DOI 10.1046/j.1440-1843.2003.00465.x; Wiggins RC, 2009, NEUROCHEM RES, V34, P158, DOI 10.1007/s11064-008-9741-6; XIA WJ, 1995, J EXP MED, V181, P1275, DOI 10.1084/jem.181.4.1275; Yeo NK, 2010, INHAL TOXICOL, V22, P1038, DOI 10.3109/08958378.2010.516282	67	32	32	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2013	8	5							e62455	10.1371/journal.pone.0062455	http://dx.doi.org/10.1371/journal.pone.0062455			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	155HD	23671598	Green Published, gold, Green Submitted			2022-12-27	WOS:000319737700011
J	Stoffels, K; Allix-Beguec, C; Groenen, G; Wanlin, M; Berkvens, D; Mathys, V; Supply, P; Fauville-Dufaux, M				Stoffels, Karolien; Allix-Beguec, Caroline; Groenen, Guido; Wanlin, Maryse; Berkvens, Dirk; Mathys, Vanessa; Supply, Philip; Fauville-Dufaux, Maryse			From Multidrug- to Extensively Drug-Resistant Tuberculosis: Upward Trends as Seen from a 15-Year Nationwide Study	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; MEROPENEM-CLAVULANATE; MIRU-VNTRPLUS; XDR-TB; IDENTIFICATION; EPIDEMIOLOGY; COMBINATION; EMERGENCE	Background: Emergence of extensively drug-resistant tuberculosis (XDR-TB) represents an enormous challenge to Public Health globally. Methods: Progression towards XDR-TB was investigated in Belgium, a country with a typically low TB incidence, by analyzing the magnitude, characteristics, and treatment success of multidrug-resistant tuberculosis (MDR-TB) through a population-based study from 1994 to 2008. Results: Among the 174 MDR-TB patients, 81% were foreign-born, 48% of these being asylum seekers. Although the number of MDR-TB patients remained stable through the study period at around 15 new cases annually, frequencies of resistance of the patients' first MDR-TB isolate to second-line drugs increased, as well as the total number of antibiotics it was resistant to (p<0.001). XDR-TB cases were detected from 2002 onwards. For 24 patients, additional resistance to several second-line drugs was acquired during treatment. Molecular-guided investigations indicated little to no contribution of in-country clonal spread or exogenous re-infection. The increase of pre-XDR and XDR cases could be attributed to rising proportions of patients from Asia and Central and Eastern Europe (p<0.001) and an increase in the isolation of Beijing strains in these groups (p<0.001). Despite augmented resistance, the treatment success rate improved from 63.0% to 75.8% (p = 0.080) after implementation in 2005 of improved surveillance measures and therapeutic access. Conclusions: Increasing severity in drug resistance patterns leading to more XDR- and "panresistant" TB cases in a country with a low TB incidence like Belgium represents a strong alert on worsening situations in other world regions and requires intense public health measures.	[Stoffels, Karolien; Allix-Beguec, Caroline; Mathys, Vanessa; Fauville-Dufaux, Maryse] Natl Reference Ctr TB & Mycobacteria Communicable, Sci Inst Publ Hlth, Brussels, Belgium; [Allix-Beguec, Caroline] Genoscreen, Lille, France; [Groenen, Guido; Wanlin, Maryse] Belgian Lung & TB Assoc, Brussels, Belgium; [Berkvens, Dirk] Inst Trop Med, Dept Biomed Sci, B-2000 Antwerp, Belgium; [Supply, Philip] INSERM, U1019, F-59045 Lille, France; [Supply, Philip] Inst Pasteur, Ctr Immunol & Biol Parasitaire, CNRS, UMR 8204, F-59019 Lille, France; [Supply, Philip] Inst Pasteur, Ctr Infect & Immun Lille, F-59019 Lille, France; [Supply, Philip] Univ Lille Nord France, Lille, France	Institute of Tropical Medicine (ITM); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; Universite de Lille; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille; Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille; Universite de Lille - ISITE; Universite de Lille	Mathys, V (corresponding author), Natl Reference Ctr TB & Mycobacteria Communicable, Sci Inst Publ Hlth, Brussels, Belgium.	vmathys@wiv-isp.be; maryse.fauville@gmail.com	Allix-Béguec, Caroline/AAI-4645-2021; Supply, Philip/A-9580-2019	Allix-Béguec, Caroline/0000-0001-7642-4844; Supply, Philip/0000-0003-3690-3853	Belgian Federal Science Policy Office	Belgian Federal Science Policy Office(Belgian Federal Science Policy Office)	This work was supported by the Belgian Federal Science Policy Office granted to the Scientific Institute of Public Health, Belgium, for Karolien Stoffels. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbate E, 2012, J ANTIMICROB CHEMOTH, V67, P473, DOI 10.1093/jac/dkr500; Allix C, 2004, CLIN INFECT DIS, V39, P783, DOI 10.1086/423383; Allix-Beguec C, 2008, J CLIN MICROBIOL, V46, P2692, DOI 10.1128/JCM.00540-08; Amaral Leonard, 2011, Recent Pat Antiinfect Drug Discov, V6, P84; Banerjee R, 2008, CLIN INFECT DIS, V47, P450, DOI 10.1086/590009; Bonnet M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023081; Brudey K, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-23; CANETTI G, 1963, B WORLD HEALTH ORGAN, V29, P565; Centers for Disease Control and Prevention (CDC), 2006, MMWR Morb Mortal Wkly Rep, V55, P301; Cox H, 2012, INT J TUBERC LUNG D, V16, P447, DOI 10.5588/ijtld.11.0451; Cox HS, 2008, NEW ENGL J MED, V359, P2398, DOI 10.1056/NEJMc0805644; ECDC, 2012, TUB SURV MON EUR 201; Fonds des Affections Respiratoires (FARES), 2008, REG BELG TUB 2008; Fonds des Affections Respiratoires (FARES)/Vlaamse Vereniging voor Respir-atoire Gezondheidzorg en Tuberculosebestrijding (VRGT), 2010, DIAGN TREATM TUB PRA; Herrera-Leon L, 2005, ANTIMICROB AGENTS CH, V49, P144, DOI 10.1128/AAC.49.1.144-147.2005; Hugonnet JE, 2009, SCIENCE, V323, P1215, DOI 10.1126/science.1167498; Jacob V, 2009, ACTA CLIN BELG, V64, P113, DOI 10.1179/acb.2009.020; Kamerbeek J, 1997, J CLIN MICROBIOL, V35, P907, DOI 10.1128/JCM.35.4.907-914.1997; Kim DH, 2010, AM J RESP CRIT CARE, V182, P113, DOI 10.1164/rccm.200911-1656OC; Migliori GB, 2007, EUR RESPIR J, V29, P423, DOI 10.1183/09031936.00001307; Migliori GB, 2007, EUROSURVEILLANCE, V12; Niemann S, 2010, J CLIN MICROBIOL, V48, P3544, DOI 10.1128/JCM.00715-10; Payen MC, 2012, INT J TUBERC LUNG D, V16, P558, DOI 10.5588/ijtld.11.0414; Pfyffer GE, 1999, J CLIN MICROBIOL, V37, P3179, DOI 10.1128/JCM.37.10.3179-3186.1999; Scorpio A, 1997, ANTIMICROB AGENTS CH, V41, P540, DOI 10.1128/AAC.41.3.540; Shah NS, 2008, JAMA-J AM MED ASSOC, V300, P2153, DOI 10.1001/jama.300.18.2153; Sotgiu G, 2009, EUR RESPIR J, V33, P871, DOI 10.1183/09031936.00168008; StataCorp, 2021, STATA STAT SOFTWARE; Stoffels K, 2012, ANTIMICROB AGENTS CH, V56, P5186, DOI 10.1128/AAC.05385-11; Supply P, 2006, J CLIN MICROBIOL, V44, P4498, DOI 10.1128/JCM.01392-06; Udwadia ZF, 2012, CLIN INFECT DIS, V54, P579, DOI 10.1093/cid/cir889; Van Rie A, 2006, LANCET, V368, P1554, DOI 10.1016/S0140-6736(06)69575-5; VANEMBDEN JDA, 1993, J CLIN MICROBIOL, V31, P406, DOI 10.1128/JCM.31.2.406-409.1993; Velayati AA, 2009, CHEST, V136, P420, DOI 10.1378/chest.08-2427; Weniger T, 2010, NUCLEIC ACIDS RES, V38, pW326, DOI 10.1093/nar/gkq351; World Health Organisation, 2008, WHOHTMTB2008402; World Health Organisation, 2011, WHOHTMTB201116; World Health Organization, 2010, WHOHTMTB20103	38	23	24	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2013	8	5							e63128	10.1371/journal.pone.0063128	http://dx.doi.org/10.1371/journal.pone.0063128			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	155HD	23671662	gold, Green Published, Green Submitted			2022-12-27	WOS:000319737700041
J	Wang, LX; Mei, ZY; Zhou, JH; Yao, YS; Li, YH; Xu, YH; Li, JX; Gao, XN; Zhou, MH; Jiang, MM; Gao, L; Ding, Y; Lu, XC; Shi, JL; Luo, XF; Wang, J; Wang, LL; Qu, CF; Bai, XF; Yu, L				Wang, Li-Xin; Mei, Zhen-Yang; Zhou, Ji-Hao; Yao, Yu-Shi; Li, Yong-Hui; Xu, Yi-Han; Li, Jing-Xin; Gao, Xiao-Ning; Zhou, Min-Hang; Jiang, Meng-Meng; Gao, Li; Ding, Yi; Lu, Xue-Chun; Shi, Jin-Long; Luo, Xu-Feng; Wang, Jia; Wang, Li-Li; Qu, Chunfeng; Bai, Xue-Feng; Yu, Li			Low Dose Decitabine Treatment Induces CD80 Expression in Cancer Cells and Stimulates Tumor Specific Cytotoxic T Lymphocyte Responses	PLOS ONE			English	Article							CLASS-I ANTIGENS; MHC CLASS-I; UP-REGULATION; TESTIS ANTIGENS; 5-AZA-2'-DEOXYCYTIDINE; MELANOMA; COSTIMULATION; MOLECULES; INDUCTION; REJECTION	Lack of immunogenicity of cancer cells has been considered a major reason for their failure in induction of a tumor specific T cell response. In this paper, we present evidence that decitabine (DAC), a DNA methylation inhibitor that is currently used for the treatment of myelodysplastic syndrome (MDS), acute myeloid leukemia (AML) and other malignant neoplasms, is capable of eliciting an anti-tumor cytotoxic T lymphocyte (CTL) response in mouse EL4 tumor model. C57BL/6 mice with established EL4 tumors were treated with DAC (1.0 mg/kg body weight) once daily for 5 days. We found that DAC treatment resulted in infiltration of IFN-gamma producing T lymphocytes into tumors and caused tumor rejection. Depletion of CD8(+), but not CD4(+) T cells resumed tumor growth. DAC-induced CTL response appeared to be elicited by the induction of CD80 expression on tumor cells. Epigenetic evidence suggests that DAC induces CD80 expression in EL4 cells via demethylation of CpG dinucleotide sites in the promoter of CD80 gene. In addition, we also showed that a transient, low-dose DAC treatment can induce CD80 gene expression in a variety of human cancer cells. This study provides the first evidence that epigenetic modulation can induce the expression of a major T cell co-stimulatory molecule on cancer cells, which can overcome immune tolerance, and induce an efficient anti-tumor CTL response. The results have important implications in designing DAC-based cancer immunotherapy.	[Wang, Li-Xin; Mei, Zhen-Yang; Zhou, Ji-Hao; Yao, Yu-Shi; Li, Yong-Hui; Xu, Yi-Han; Li, Jing-Xin; Gao, Xiao-Ning; Zhou, Min-Hang; Jiang, Meng-Meng; Gao, Li; Ding, Yi; Lu, Xue-Chun; Shi, Jin-Long; Luo, Xu-Feng; Wang, Jia; Wang, Li-Li; Yu, Li] Chinese Peoples Liberat Army Gen Hosp, Dept Hematol, Beijing, Peoples R China; [Wang, Li-Xin] Navy Gen Hosp, Dept Hematol, Beijing, Peoples R China; [Wang, Li-Xin; Bai, Xue-Feng] Ohio State Univ, Med Ctr, Dept Pathol, Columbus, OH 43210 USA; [Wang, Li-Xin; Bai, Xue-Feng] Ohio State Univ, Med Ctr, Ctr Comprehens Canc, Columbus, OH 43210 USA; [Qu, Chunfeng] Chinese Acad Med Sci, State Key Lab Mol Oncol, Canc Inst Hosp, Beijing 100730, Peoples R China	Chinese People's Liberation Army General Hospital; Sixth Medical Center of Chinese PLA General Hospital; University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS	Bai, XF (corresponding author), Ohio State Univ, Med Ctr, Dept Pathol, Columbus, OH 43210 USA.	Xue-Feng.Bai@osumc.edu; chunhuiliyu@yahoo.com	Bai, Xue-Feng/H-5164-2013; wang, lili/HDL-7210-2022; Bai, Xue-feng/E-2681-2011	Bai, Xue-Feng/0000-0001-9476-8376; Yu, Li/0000-0001-6872-2665	National Basic Research Program of China [2005CB522400]; National Natural Science Foundation of China [90919044, 30971297, 81000221, 81170518]; High and New Technology Program of PLA [2010gxjs091]; Capital Medical Development Scientific Research Fund [2007-2040]; NATIONAL CANCER INSTITUTE [R01CA138427] Funding Source: NIH RePORTER	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); High and New Technology Program of PLA; Capital Medical Development Scientific Research Fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grants from the National Basic Research Program of China (2005CB522400), National Natural Science Foundation of China (90919044, 30971297, 81000221, and 81170518), High and New Technology Program of PLA (2010gxjs091), Capital Medical Development Scientific Research Fund (No. 2007-2040). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai XF, 2001, CANCER RES, V61, P6860; Bai XF, 2001, J IMMUNOL, V167, P3936, DOI 10.4049/jimmunol.167.7.3936; Blum W, 2007, J CLIN ONCOL, V25, P3884, DOI 10.1200/JCO.2006.09.4169; Calabro L, 2005, J CELL PHYSIOL, V202, P474, DOI 10.1002/jcp.20133; Cashen AF, 2010, J CLIN ONCOL, V28, P556, DOI 10.1200/JCO.2009.23.9178; CHEN LP, 1992, CELL, V71, P1093, DOI 10.1016/S0092-8674(05)80059-5; Coral S, 1999, J IMMUNOTHER, V22, P16, DOI 10.1097/00002371-199901000-00003; Coral S, 2002, CLIN CANCER RES, V8, P2690; Dubovsky JA, 2009, CLIN CANCER RES, V15, P3406, DOI 10.1158/1078-0432.CCR-08-2099; Fonsatti E, 2007, CLIN CANCER RES, V13, P3333, DOI 10.1158/1078-0432.CCR-06-3091; Gollob JA, 2007, CLIN CANCER RES, V13, P5219, DOI 10.1158/1078-0432.CCR-07-0816; Guo ZS, 2006, CANCER RES, V66, P1105, DOI 10.1158/0008-5472.CAN-05-3020; Issa JPJ, 2004, BLOOD, V103, P1635, DOI 10.1182/blood-2003-03-0687; JONES PA, 1980, CELL, V20, P85, DOI 10.1016/0092-8674(80)90237-8; Juergens RA, 2011, CANCER DISCOV, V1, P598, DOI 10.1158/2159-8290.CD-11-0214; Kantarjian H, 2006, CANCER-AM CANCER SOC, V106, P1794, DOI 10.1002/cncr.21792; Konkankit VV, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-192; Maeda T, 2000, BLOOD, V96, P3847, DOI 10.1182/blood.V96.12.3847.h8003847_3847_3856; Magner WJ, 2000, J IMMUNOL, V165, P7017, DOI 10.4049/jimmunol.165.12.7017; Mapara MY, 2004, J CLIN ONCOL, V22, P1136, DOI 10.1200/JCO.2004.10.041; Odobasic D, 2008, IMMUNOLOGY, V124, P503, DOI 10.1111/j.1365-2567.2007.02802.x; Oki Y, 2008, BLOOD, V111, P2382, DOI 10.1182/blood-2007-07-103960; Rabinovich GA, 2007, ANNU REV IMMUNOL, V25, P267, DOI 10.1146/annurev.immunol.25.022106.141609; RAMARATHINAM L, 1994, J EXP MED, V179, P1205, DOI 10.1084/jem.179.4.1205; REITER H, 1979, CANCER RES, V39, P4856; Seliger B, 1997, IMMUNOL TODAY, V18, P292, DOI 10.1016/S0167-5699(97)01052-9; Serrano A, 2001, INT J CANCER, V94, P243, DOI 10.1002/ijc.1452; Sigalotti L, 2005, SEMIN ONCOL, V32, P473, DOI 10.1053/j.seminoncol.2005.07.005; Silverman LR, 2002, J CLIN ONCOL, V20, P2429, DOI 10.1200/JCO.2002.04.117; Thurner B, 1999, J EXP MED, V190, P1669, DOI 10.1084/jem.190.11.1669; TOWNSEND SE, 1993, SCIENCE, V259, P368, DOI 10.1126/science.7678351; Tsai HC, 2012, CANCER CELL, V21, P430, DOI 10.1016/j.ccr.2011.12.029; UYTTENHOVE C, 1983, J EXP MED, V157, P1040, DOI 10.1084/jem.157.3.1040; Wang LX, 2012, SCAND J IMMUNOL, V75, P273, DOI 10.1111/j.1365-3083.2011.02662.x; WEBER J, 1994, CANCER RES, V54, P1766; WU TC, 1995, J EXP MED, V182, P1415, DOI 10.1084/jem.182.5.1415; Yee C, 2002, P NATL ACAD SCI USA, V99, P16168, DOI 10.1073/pnas.242600099; Zheng P, 1998, NATURE, V396, P373, DOI 10.1038/24628; Zou WP, 2008, NAT REV IMMUNOL, V8, P467, DOI 10.1038/nri2326; Zou WP, 2005, NAT REV CANCER, V5, P263, DOI 10.1038/nrc1586	40	86	96	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2013	8	5							e62924	10.1371/journal.pone.0062924	http://dx.doi.org/10.1371/journal.pone.0062924			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	155HD	23671644	Green Submitted, Green Published, gold			2022-12-27	WOS:000319737700028
J	He, K; Wen, XY; Li, AL; Li, T; Wang, J; Wang, HX; Wang, N				He, Kun; Wen, Xin-Yu; Li, Ai-Ling; Li, Tao; Wang, Jie; Wang, Hong-Xia; Wang, Na			Serum Peptidome Variations in a Healthy Population: Reference to Identify Cancer-Specific Peptides	PLOS ONE			English	Article							FLIGHT MASS-SPECTROMETRY; PROTEOMIC PATTERNS; PANCREATIC-CANCER; LASER-DESORPTION; BREAST-CANCER; PROTEIN; TIME; IDENTIFICATION; DIAGNOSIS; IONIZATION	The emergence of mass spectrometry (MS)-based signatures as biomarkers has generated considerable enthusiasm among oncologists. However, variations in normal individuals also exist, and a better understanding of serum peptide patterns of healthy individuals will be important for further exploring disease-specific serum peptide patterns. Following development of a serum peptide pattern platform, we analyzed 500 serum samples obtained from healthy individuals. Samples from breast (n = 84), lung (n = 70), and rectal (n = 30) cancer patients were also examined. Extensive data analysis revealed negligible contributions of age to serum peptide patterns except in healthy individuals between 20-30 and 60+ years of age. Gender-related variations in the serum patterns of healthy individuals were only observed in 20-30 year-old individuals. Our results revealed substantial variation in individual peptide profiles, but 65 peptides were detected at a 20% higher frequency in the healthy population. A peptide profile was developed for each type of cancer, containing 10 discriminating peptides not prevalent in healthy individuals. Sequence identification of 111 signature peptides revealed that they fell into several tight clusters and most were exopeptidase products of serum resident proteins. We have obtained a MS-based serum peptide profile for healthy individuals, providing a reference for observing the occurrence of cancer-specific peptides.	[He, Kun; Li, Ai-Ling; Li, Tao; Wang, Jie; Wang, Hong-Xia; Wang, Na] Natl Ctr Biomed Anal, Inst Basic Med Sci, Beijing, Peoples R China; [Wen, Xin-Yu] 301 Gen Hosp, Beijing, Peoples R China		Wang, N (corresponding author), Natl Ctr Biomed Anal, Inst Basic Med Sci, Beijing, Peoples R China.	wn@proteomics.cn		Li, Tao/0000-0002-0746-8322	National Key Technology R D Program [2009BAK61B04]; Innovation of Methodology [2010IM030300]; National Natural Science Foundation of China [21007092]; National Science and Technology Major Project [2008ZX10002-016]	National Key Technology R D Program(National Key Technology R&D Program); Innovation of Methodology; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science and Technology Major Project	This work was supported by grants from National Key Technology R& D Program (2009BAK61B04), Innovation of Methodology (2010IM030300), National Natural Science Foundation of China (21007092), and grants from National Science and Technology Major Project (2008ZX10002-016). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agranoff D, 2006, LANCET, V368, P1012, DOI 10.1016/S0140-6736(06)69342-2; Baumann S, 2005, CLIN CHEM, V51, P973, DOI 10.1373/clinchem.2004.047308; Bergquist J, 2002, MASS SPECTROM REV, V21, P2, DOI 10.1002/mas.10016; Cheng AJ, 2005, CLIN CHEM, V51, P2236, DOI 10.1373/clinchem.2005.052324; Colquhoun DR, 2006, APPL ENVIRON MICROB, V72, P2749, DOI 10.1128/AEM.72.4.2749-2755.2006; Coon JJ, 2005, BIOTECHNIQUES, V38, P519, DOI 10.2144/05384TE01; Dekker LJ, 2005, MOL CELL PROTEOMICS, V4, P1341, DOI 10.1074/mcp.M500081-MCP200; Ho DWY, 2006, CANCER-AM CANCER SOC, V107, P99, DOI 10.1002/cncr.21970; Honda K, 2005, CANCER RES, V65, P10613, DOI 10.1158/0008-5472.CAN-05-1851; Johnson KL, 2004, ANAL CHEM, V76, P5097, DOI 10.1021/ac0497003; Koomen JM, 2005, CLIN CANCER RES, V11, P1110; Koopmann J, 2004, CLIN CANCER RES, V10, P860, DOI 10.1158/1078-0432.CCR-1167-3; Li JN, 2002, CLIN CHEM, V48, P1296; Liang TT, 2010, PROTEOMICS, V10, P90, DOI 10.1002/pmic.200900513; Mian S, 2005, J CLIN ONCOL, V23, P5088, DOI 10.1200/JCO.2005.03.164; Nedelkov D, 2006, MOL CELL PROTEOMICS, V5, P1811, DOI 10.1074/mcp.R600006-MCP200; Novak K, 2006, NAT REV CANCER, V6, P92, DOI 10.1038/nrc1807; Petricoin EF, 2002, LANCET, V359, P572, DOI 10.1016/S0140-6736(02)07746-2; Petricoin EF, 2006, NAT REV CANCER, V6, P961, DOI 10.1038/nrc2011; Semmes OJ, 2005, CLIN CHEM, V51, P102, DOI 10.1373/clinchem.2004.038950; Soltys SG, 2004, CLIN CANCER RES, V10, P4806, DOI 10.1158/1078-0432.CCR-03-0469; Villanueva J, 2006, J CLIN INVEST, V116, P271, DOI 10.1172/JCI26022; Villanueva J, 2004, ANAL CHEM, V76, P1560, DOI 10.1021/ac0352171; Villanueva J, 2006, MOL CELL PROTEOMICS, V5, P1840, DOI 10.1074/mcp.M600229-MCP200; Wang N, 2007, ACTA CHIM SINICA, V65, P344; Ward DG, 2006, BRIT J CANCER, V94, P1898, DOI 10.1038/sj.bjc.6603188; Wu J, 2010, RAPID COMMUN MASS SP, V24, P1971, DOI 10.1002/rcm.4601	27	9	9	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2013	8	5							e63724	10.1371/journal.pone.0063724	http://dx.doi.org/10.1371/journal.pone.0063724			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145YI	23667664	Green Submitted, gold, Green Published			2022-12-27	WOS:000319055600071
J	Ng, SSM; Li, A; Pavlakis, GN; Ozato, K; Kino, T				Ng, Sinnie Sin Man; Li, Andrew; Pavlakis, George N.; Ozato, Keiko; Kino, Tomoshige			Viral Infection Increases Glucocorticoid-Induced Interleukin-10 Production through ERK-Mediated Phosphorylation of the Glucocorticoid Receptor in Dendritic Cells: Potential Clinical Implications	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; DOUBLE-STRANDED-RNA; STRESS HORMONES; GENE-EXPRESSION; INNATE IMMUNITY; IL-10 GENE; IN-VIVO; INDUCTION; RESPONSES; INFLAMMATION	The hypothalamic-pituitary-adrenal axis plays a central role in the adaptive response to stress including infection of pathogens through glucocorticoids. Physical and/or mental stress alter susceptibility to viral infection possibly by affecting this regulatory system, thus we explored potential cellular targets and mechanisms that underlie this phenomenon in key immune components dendritic cells (DCs). Dexamethasone (DEX) treatment and subsequent Newcastle disease virus (NDV) infection most significantly and cooperatively stimulated mRNA expression of the interleukin (IL)-10 in murine bone marrow-derived DCs among 89 genes involved in the Toll-like receptor signaling pathways. NDV increased DEX-induced IL-10 mRNA and protein expression by 7- and 3-fold, respectively, which was observed from 3 hours after infection. Conventional DCs (cDCs), but not plasmacytoid DCs (pDCs) were major sources of IL-10 in bone marrow-derived DCs treated with DEX and/or infected with NDV. Murine cytomegalovirus and DEX increased serum IL-10 cooperatively in female mice. Pre-treatment of DCs with the extracellular signal-regulated kinase (ERK) inhibitor U0126 abolished cooperative induction of IL-10 by DEX and NDV. Further, ERK overexpression increased IL-10 promoter activity stimulated by wild-type human GR but not by its mutant defective in serine 203, whereas ERK knockdown abolished NDV/DEX cooperation on IL-10 mRNA and phosphorylation of the mouse GR at serine 213. NDV also increased DEX-induced mRNA expression of three known glucocorticoid-responsive genes unrelated to the Toll-like receptor signaling pathways in DCs. These results indicate that virus and glucocorticoids cooperatively increase production of anti-inflammatory cytokine IL-10 by potentiating the transcriptional activity of GR in DCs, through which virus appears to facilitate its own propagation in infected hosts. The results may further underlie in part known exacerbation of IL-10/T helper-2-related allergic disorders by stress and viral infection.	[Ng, Sinnie Sin Man; Li, Andrew; Kino, Tomoshige] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Unit Mol Hormone Act, Program Reprod & Adult Endocrinol, NIH, Bethesda, MD USA; [Ng, Sinnie Sin Man] Chinese Univ Hong Kong, Fac Med, Sch Biomed Sci, Shatin, Hong Kong, Peoples R China; [Ng, Sinnie Sin Man; Pavlakis, George N.] NCI, Human Retrovirus Pathogenesis Sect, Vaccine Branch, Ctr Canc Res, Frederick, MD 21701 USA; [Ozato, Keiko] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Lab Mol Growth & Regulat, NIH, Bethesda, MD USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Chinese University of Hong Kong; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Kino, T (corresponding author), Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Unit Mol Hormone Act, Program Reprod & Adult Endocrinol, NIH, Bethesda, MD USA.	kinot@mail.nih.gov			Eunice Kennedy Shriver National Institute of Child Health, Bethesda, MD; National Cancer Institute, Frederick, MD; National Institutes of Health; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD008732, ZIAHD001310, ZIAHD000615] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [ZIABC010749, ZIABC010750] Funding Source: NIH RePORTER	Eunice Kennedy Shriver National Institute of Child Health, Bethesda, MD; National Cancer Institute, Frederick, MD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was funded by the intramural research program of the Eunice Kennedy Shriver National Institute of Child Health, Bethesda, MD, and the National Cancer Institute, Frederick, MD, the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal SK, 1998, J INTERF CYTOK RES, V18, P1059, DOI 10.1089/jir.1998.18.1059; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Boonstra A, 2006, J IMMUNOL, V177, P7551, DOI 10.4049/jimmunol.177.11.7551; BOUMPAS DT, 1993, ANN INTERN MED, V119, P1198, DOI 10.7326/0003-4819-119-12-199312150-00007; Bowie AG, 2008, NAT REV IMMUNOL, V8, P911, DOI 10.1038/nri2436; Busse WW, 2010, LANCET, V376, P826, DOI 10.1016/S0140-6736(10)61380-3; Chrousos GP, 2009, ANN NY ACAD SCI, V1179, P153, DOI 10.1111/j.1749-6632.2009.04988.x; Chrousos GP, 2005, J INFECT DIS, V192, P551, DOI 10.1086/432135; Couper KN, 2008, J IMMUNOL, V180, P5771, DOI 10.4049/jimmunol.180.9.5771; Dillon S, 2004, J IMMUNOL, V172, P4733, DOI 10.4049/jimmunol.172.8.4733; Ejrnaes M, 2006, J EXP MED, V203, P2461, DOI 10.1084/jem.20061462; Elenkov IJ, 1999, TRENDS ENDOCRIN MET, V10, P359, DOI 10.1016/S1043-2760(99)00188-5; Elenkov IJ, 2004, ANN NY ACAD SCI, V1024, P138, DOI 10.1196/annals.1321.010; Godbout JP, 2006, J NEUROIMMUNE PHARM, V1, P421, DOI 10.1007/s11481-006-9036-0; Goldsmith M, 2009, MOL IMMUNOL, V46, P1979, DOI 10.1016/j.molimm.2009.03.009; Hinzey A, 2011, ENDOCRINOLOGY, V152, P483, DOI 10.1210/en.2010-0774; Honda K, 2003, P NATL ACAD SCI USA, V100, P10872, DOI 10.1073/pnas.1934678100; Honer C, 2003, MOL PHARMACOL, V63, P1012, DOI 10.1124/mol.63.5.1012; Jung ID, 2010, INT IMMUNOPHARMACOL, V10, P760, DOI 10.1016/j.intimp.2010.04.006; Kino T, 2007, HORM METAB RES, V39, P420, DOI 10.1055/s-2007-980193; Kino T, 2007, MOL ENDOCRINOL, V21, P1552, DOI 10.1210/me.2006-0345; Kino T, 2007, TRENDS ENDOCRIN MET, V18, P159, DOI 10.1016/j.tem.2007.03.003; Lu NZ, 2006, PHARMACOL REV, V58, P782, DOI 10.1124/pr.58.4.9; Luft T, 2002, BLOOD, V100, P1362, DOI 10.1182/blood-2001-12-0360; Maggi LB, 2003, J BIOL CHEM, V278, P16683, DOI 10.1074/jbc.M211744200; Mallia P, 2006, CHEST, V130, P1203, DOI 10.1378/chest.130.4.1203; Marshall GD, 2000, ALLERGY ASTHMA PROC, V21, P241, DOI 10.2500/108854100778248917; Medzhitov R, 2010, CELL, V140, P771, DOI 10.1016/j.cell.2010.03.006; Mege JL, 2006, LANCET INFECT DIS, V6, P557, DOI 10.1016/S1473-3099(06)70577-1; Menconi M, 2008, J CELL BIOCHEM, V105, P353, DOI 10.1002/jcb.21833; Monick MM, 2005, J BIOL CHEM, V280, P2147, DOI 10.1074/jbc.M408745200; Monick MM, 2001, J IMMUNOL, V166, P2681, DOI 10.4049/jimmunol.166.4.2681; Morelli AE, 2003, TRENDS IMMUNOL, V24, P108, DOI 10.1016/S1471-4906(03)00023-1; Murray PJ, 2006, CURR OPIN PHARMACOL, V6, P379, DOI 10.1016/j.coph.2006.01.010; Nader N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0026751; Nader N, 2010, MOL ENDOCRINOL, V24, P1748, DOI 10.1210/me.2010-0192; Park JM, 2005, IMMUNITY, V23, P319, DOI 10.1016/j.immuni.2005.08.010; Redpath S, 1999, J IMMUNOL, V162, P6701; Rosenkranz MA, 2005, P NATL ACAD SCI USA, V102, P13319, DOI 10.1073/pnas.0504365102; Sacher T, 2012, EUR J CELL BIOL, V91, P70, DOI 10.1016/j.ejcb.2011.02.002; Samarasinghe R, 2006, J INTERF CYTOK RES, V26, P893, DOI 10.1089/jir.2006.26.893; Sapolsky RM, 2000, ENDOCR REV, V21, P55, DOI 10.1210/er.21.1.55; Schroder K, 2004, J LEUKOCYTE BIOL, V75, P163, DOI 10.1189/jlb.0603252; Smit JJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001720; Steinman RM, 2006, CURR TOP MICROBIOL, V311, P17; Steinman RM, 2007, NATURE, V449, P419, DOI 10.1038/nature06175; Tailor P, 2007, IMMUNITY, V27, P228, DOI 10.1016/j.immuni.2007.06.009; Takayama T, 2001, TRANSPLANTATION, V71, P1334, DOI 10.1097/00007890-200105150-00027; Tamassia N, 2008, J IMMUNOL, V181, P6563, DOI 10.4049/jimmunol.181.9.6563; Tarrega C, 2005, J BIOL CHEM, V280, P37885, DOI 10.1074/jbc.M504366200; Tone M, 2000, J IMMUNOL, V165, P286, DOI 10.4049/jimmunol.165.1.286; Unterberger C, 2008, MOL IMMUNOL, V45, P3230, DOI 10.1016/j.molimm.2008.02.020; Xiang LB, 2011, NEUROIMMUNOMODULAT, V18, P1, DOI 10.1159/000311450; Xu YK, 2007, J IMMUNOL, V179, P7577, DOI 10.4049/jimmunol.179.11.7577; Yoneyama M, 2007, J BIOL CHEM, V282, P15315, DOI 10.1074/jbc.R700007200	55	17	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2013	8	5							e63587	10.1371/journal.pone.0063587	http://dx.doi.org/10.1371/journal.pone.0063587			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145YI	23667643	Green Submitted, Green Published, gold			2022-12-27	WOS:000319055600065
J	Swamy, BPM; Ahmed, HU; Henry, A; Mauleon, R; Dixit, S; Vikram, P; Tilatto, R; Verulkar, SB; Perraju, P; Mandal, NP; Variar, M; Robin, S; Chandrababu, R; Singh, ON; Dwivedi, JL; Das, SP; Mishra, KK; Yadaw, RB; Aditya, TL; Karmakar, B; Satoh, K; Moumeni, A; Kikuchi, S; Leung, H; Kumar, A				Swamy, Mallikarjuna B. P.; Ahmed, Helal Uddin; Henry, Amelia; Mauleon, Ramil; Dixit, Shalabh; Vikram, Prashant; Tilatto, Ram; Verulkar, Satish B.; Perraju, Puvvada; Mandal, Nimai P.; Variar, Mukund; Robin, S.; Chandrababu, Ranganath; Singh, Onkar N.; Dwivedi, Jawaharlal L.; Das, Sankar Prasad; Mishra, Krishna K.; Yadaw, Ram B.; Aditya, Tamal Lata; Karmakar, Biswajit; Satoh, Kouji; Moumeni, Ali; Kikuchi, Shoshi; Leung, Hei; Kumar, Arvind			Genetic, Physiological, and Gene Expression Analyses Reveal That Multiple QTL Enhance Yield of Rice Mega-Variety IR64 under Drought	PLOS ONE			English	Article							NEAR-ISOGENIC-LINES; QUANTITATIVE TRAIT LOCI; GRAIN-YIELD; REPRODUCTIVE-STAGE; INBRED POPULATION; UPLAND; RESISTANCE; STRESS; TOLERANCE; SELECTION	Background: Rice (Oryza sativa L.) is a highly drought sensitive crop, and most semi dwarf rice varieties suffer severe yield losses from reproductive stage drought stress. The genetic complexity of drought tolerance has deterred the identification of agronomically relevant quantitative trait loci (QTL) that can be deployed to improve rice yield under drought in rice. Convergent evidence from physiological characterization, genetic mapping, and multi-location field evaluation was used to address this challenge. Methodology/Principal Findings: Two pairs of backcross inbred lines (BILs) from a cross between drought-tolerant donor Aday Sel and high-yielding but drought-susceptible rice variety IR64 were produced. From six BC4F3 mapping populations produced by crossing the +QTL BILs with the -QTL BILs and IR64, four major-effect QTL - one each on chromosomes 2, 4, 9, and 10 - were identified. Meta-analysis of transcriptome data from the +QTL/-QTL BILs identified differentially expressed genes (DEGs) significantly associated with QTL on chromosomes 2, 4, 9, and 10. Physiological characterization of BILs showed increased water uptake ability under drought. The enrichment of DEGs associated with root traits points to differential regulation of root development and function as contributing to drought tolerance in these BILs. BC4F3-derived lines with the QTL conferred yield advantages of 528 to 1875 kg ha(-1) over IR64 under reproductive-stage drought stress in the targeted ecosystems of South Asia. Conclusions/Significance: Given the importance of rice in daily food consumption and the popularity of IR64, the BC4F3 lines with multiple QTL could provide higher livelihood security to farmers in drought-prone environments. Candidate genes were shortlisted for further characterization to confirm their role in drought tolerance. Differential yield advantages of different combinations of the four QTL reported here indicate that future research should include optimizing QTL combinations in different genetic backgrounds to maximize yield advantage under drought.	[Swamy, Mallikarjuna B. P.; Ahmed, Helal Uddin; Henry, Amelia; Mauleon, Ramil; Dixit, Shalabh; Vikram, Prashant; Leung, Hei; Kumar, Arvind] Int Rice Res Inst, Los Banos, Laguna, Philippines; [Tilatto, Ram] DRR, Hyderabad, Andhra Pradesh, India; [Verulkar, Satish B.] IGKV, Raipur, Chattishgarh, India; [Perraju, Puvvada] Jawaharlal Nehru Krishi Vishwavidyalaya JNKVV, Jabalpur, Madhya Pradesh, India; [Mandal, Nimai P.; Variar, Mukund] CRURRS, Hazaribagh, India; [Robin, S.; Chandrababu, Ranganath] Tamil Nadu Agr Univ, Coimbatore 641003, Tamil Nadu, India; [Singh, Onkar N.] Cent Rice Res Inst, Cuttack 753006, Orissa, India; [Dwivedi, Jawaharlal L.] NDUAT, Faizabad, Uttar Pradesh, India; [Das, Sankar Prasad] Tripura Ctr ICARNEHR, ICAR Res Complex NEH Reg, Agartala, India; [Mishra, Krishna K.] RARS, Nepalganj, Nepal; [Yadaw, Ram B.] Natl Rice Res Program, Hardinath, Nepal; [Aditya, Tamal Lata; Karmakar, Biswajit] Bangladesh Rice Res Inst, Gazipur, Bangladesh; [Satoh, Kouji; Moumeni, Ali; Kikuchi, Shoshi] Natl Inst Agrobiol Sci, Plant Genome Res Unit, Agrogen Res Ctr, Tsukuba, Ibaraki, Japan	CGIAR; International Rice Research Institute (IRRI); Indian Council of Agricultural Research (ICAR); ICAR - National Rice Research Institute; Tamil Nadu Agricultural University; Indian Council of Agricultural Research (ICAR); ICAR - National Rice Research Institute; Indian Council of Agricultural Research (ICAR); ICAR - ICAR Research Complex for NEH Region; Bangladesh Rice Research Institute (BRRI); National Institute of Agrobiological Sciences - Japan	Kumar, A (corresponding author), Int Rice Res Inst, Los Banos, Laguna, Philippines.	A.kumar@irri.org	Moumeni, Ali/S-2693-2016; Mauleon, Ramil/AAW-1697-2020; Karmakar, Biswajit/AAX-4669-2020; Kumar, Arvind/N-3181-2017	Moumeni, Ali/0000-0002-1366-3802; Mauleon, Ramil/0000-0001-8512-144X; Kumar, Arvind/0000-0002-5488-9410; Vikram, Prashant/0000-0002-3740-6608; Henry, Amelia/0000-0001-6255-5480	Bill & Melinda Gates Foundation (BMGF), USA; Generation Challenge Program (GCP), Mexico	Bill & Melinda Gates Foundation (BMGF), USA; Generation Challenge Program (GCP), Mexico	The authors thank the Bill & Melinda Gates Foundation (BMGF), USA, and Generation Challenge Program (GCP), Mexico, for providing financial support to this study. The funders had no role in study design, data collection, and analysis, decision to publish, or preparation of the manuscript.	Akkareddy Srividya, 2010, International Journal of Plant Breeding and Genetics, V4, P210, DOI 10.3923/ijpbg.2010.210.227; Babu RC, 2003, CROP SCI, V43, P1457, DOI 10.2135/cropsci2003.1457; Bernier J, 2007, CROP SCI, V47, P507, DOI 10.2135/cropsci2006.07.0495; Blum A., 1988, PLANT BREEDING STRES, DOI 10.1201/9781351075718; Brondani C, 2002, THEOR APPL GENET, V104, P1192, DOI 10.1007/s00122-002-0869-5; Bruce M, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-129; Courtois B, 2000, MOL BREEDING, V6, P55, DOI 10.1023/A:1009652326121; Dixit S, 2012, THEOR APPL GENET, V125, P155, DOI 10.1007/s00122-012-1823-9; Henry A, 2011, FIELD CROP RES, V120, P205, DOI 10.1016/j.fcr.2010.10.003; Hittalmani S, 2003, THEOR APPL GENET, V107, P679, DOI 10.1007/s00122-003-1269-1; IRRI (International Rice Research Institute), 1996, SES STAND EV SYST RI; Jourjon MF, 2005, BIOINFORMATICS, V21, P128, DOI 10.1093/bioinformatics/bth481; Kumar A, 2008, FIELD CROP RES, V107, P221, DOI 10.1016/j.fcr.2008.02.007; Kumar R, 2007, FIELD CROP RES, V103, P42, DOI 10.1016/j.fcr.2007.04.013; Lafitte HR, 2007, J EXP BOT, V58, P169, DOI 10.1093/jxb/erl101; Lafitte HR, 2004, THEOR APPL GENET, V109, P1237, DOI 10.1007/s00122-004-1731-8; Lanceras JC, 2004, PLANT PHYSIOL, V135, P384, DOI 10.1104/pp.103.035527; Lin MengHuei, 2007, Crop, Environment & Bioinformatics, V4, P65; Mackill D.J., 1996, RAINFED LOWLAND RICE; Mandal NP, 2010, FIELD CROP RES, V118, P135, DOI 10.1016/j.fcr.2010.05.004; McNally KL, 2009, P NATL ACAD SCI USA, V106, P12273, DOI 10.1073/pnas.0900992106; Moumeni A, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-174; Nelson JC, 1997, MOL BREEDING, V3, P239, DOI 10.1023/A:1009604312050; Nguyen HT, 1997, CROP SCI, V37, P1426, DOI 10.2135/cropsci1997.0011183X003700050002x; O'Toole J. C., 1982, Drought resistance in crops with emphasis on rice, P195; Price AH, 2000, THEOR APPL GENET, V100, P49, DOI 10.1007/s001220050007; R Development Core Team, 2008, LANG ENV STAT COMP; Robin S, 2003, THEOR APPL GENET, V107, P1288, DOI 10.1007/s00122-003-1360-7; SAS Institute Inc, 2004, SAS ONL DOC 9 1 3; Shen L, 2001, THEOR APPL GENET, V103, P75, DOI 10.1007/s001220100538; Sinclair TR, 2011, TRENDS PLANT SCI, V16, P289, DOI 10.1016/j.tplants.2011.02.008; Steele KA, 2007, FIELD CROP RES, V101, P180, DOI 10.1016/j.fcr.2006.11.002; Steele KA, 2006, THEOR APPL GENET, V112, P208, DOI 10.1007/s00122-005-0110-4; Tanksley SD, 1996, THEOR APPL GENET, V92, P191, DOI 10.1007/BF00223376; Thomson MJ, 2003, THEOR APPL GENET, V107, P479, DOI 10.1007/s00122-003-1270-8; Venuprasad R, 2011, FIELD CROP RES, V123, P38, DOI 10.1016/j.fcr.2011.04.009; Venuprasad R, 2009, EUPHYTICA, V167, P261, DOI 10.1007/s10681-009-9898-3; Venuprasad R, 2009, THEOR APPL GENET, V120, P177, DOI 10.1007/s00122-009-1168-1; Verulkar SB, 2010, FIELD CROP RES, V117, P197, DOI 10.1016/j.fcr.2010.03.005; Vikram P, 2011, BMC GENET, V12, DOI 10.1186/1471-2156-12-89; Wang S., 2010, WINDOWS QTL CARTOGRA; Xiao J, 1996, THEOR APPL GENET, V92, P230, DOI 10.1007/BF00223380; Yue B, 2005, THEOR APPL GENET, V111, P1127, DOI 10.1007/s00122-005-0040-1; Zhang J, 2001, THEOR APPL GENET, V103, P19, DOI 10.1007/s001220000534; Zou GH, 2005, THEOR APPL GENET, V112, P106, DOI 10.1007/s00122-005-0111-3	45	109	110	2	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2013	8	5							e62795	10.1371/journal.pone.0062795	http://dx.doi.org/10.1371/journal.pone.0062795			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145YI	23667521	gold, Green Submitted, Green Published			2022-12-27	WOS:000319055600044
J	Lima, FM; Souza, RT; Santori, FR; Santos, MF; Cortez, DR; Barros, RM; Cano, MI; Valadares, HMS; Macedo, AM; Mortara, RA; da Silveira, JF				Lima, Fabio Mitsuo; Souza, Renata Torres; Santori, Fabio Rinaldo; Santos, Michele Fernandes; Cortez, Danielle Rodrigues; Barros, Roberto Moraes; Cano, Maria Isabel; Silva Valadares, Helder Magno; Macedo, Andrea Mara; Mortara, Renato Arruda; da Silveira, Jose Franco			Interclonal Variations in the Molecular Karyotype of Trypanosoma cruzi: Chromosome Rearrangements in a Single Cell-Derived Clone of the G Strain	PLOS ONE			English	Article							POPULATION-STRUCTURE; CHAGAS-DISEASE; SIZE; GENES; DNA; VARIABILITY; TELOMERE; RNA; TRYPOMASTIGOTES; IDENTIFICATION	Trypanosoma cruzi comprises a pool of populations which are genetically diverse in terms of DNA content, growth and infectivity. Inter- and intra-strain karyotype heterogeneities have been reported, suggesting that chromosomal rearrangements occurred during the evolution of this parasite. Clone D11 is a single-cell-derived clone of the T. cruzi G strain selected by the minimal dilution method and by infecting Vero cells with metacyclic trypomastigotes. Here we report that the karyotype of clone D11 differs from that of the G strain in both number and size of chromosomal bands. Large chromosomal rearrangement was observed in the chromosomes carrying the tubulin loci. However, most of the chromosome length polymorphisms were of small amplitude, and the absence of one band in clone D11 in relation to its reference position in the G strain could be correlated to the presence of a novel band migrating above or below this position. Despite the presence of chromosomal polymorphism, large syntenic groups were conserved between the isolates. The appearance of new chromosomal bands in clone D11 could be explained by chromosome fusion followed by a chromosome break or interchromosomal exchange of large DNA segments. Our results also suggest that telomeric regions are involved in this process. The variant represented by clone D11 could have been induced by the stress of the cloning procedure or could, as has been suggested for Leishmania infantum, have emerged from a multiclonal, mosaic parasite population submitted to frequent DNA amplification/deletion events, leading to a 'mosaic' structure with different individuals having differently sized versions of the same chromosomes. If this is the case, the variant represented by clone D11 would be better adapted to survive the stress induced by cloning, which includes intracellular development in the mammalian cell. Karyotype polymorphism could be part of the T. cruzi arsenal for responding to environmental pressure.	[Lima, Fabio Mitsuo; Souza, Renata Torres; Santos, Michele Fernandes; Cortez, Danielle Rodrigues; Barros, Roberto Moraes; Mortara, Renato Arruda; da Silveira, Jose Franco] Univ Fed Sao Paulo, Escola Paulista Med, Dept Microbiol Imunol & Parasitol, Sao Paulo, Brazil; [Santori, Fabio Rinaldo] NYU, Sch Med, Ctr Canc, Skirball Inst Biomol Med, New York, NY USA; [Cano, Maria Isabel] Univ Estadual Paulista, Inst Biociencias, Dept Genet, Botucatu, SP, Brazil; [Silva Valadares, Helder Magno; Macedo, Andrea Mara] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Bioquim & Imunol, Belo Horizonte, MG, Brazil; [Silva Valadares, Helder Magno] Univ Fed Sao Joao del Rey, Divinopolis, MG, Brazil	Universidade Federal de Sao Paulo (UNIFESP); New York University; Universidade Estadual Paulista; Universidade Federal de Minas Gerais; Universidade Federal de Sao Joao del-Rei	da Silveira, JF (corresponding author), Univ Fed Sao Paulo, Escola Paulista Med, Dept Microbiol Imunol & Parasitol, Sao Paulo, Brazil.	jose.franco@unifesp.br	Cano, Maria Isabel/M-7691-2019; de Moraes Barros, Roberto Rudge/F-4973-2018; Macedo, Andréa M/C-1506-2013; Cano, Maria Isabel/A-4020-2008; da Silveira, Jose Franco/F-5390-2012; Mortara, Renato A./C-1864-2012; Lima, Fabio Mitsuo/GQH-9488-2022; Santori, Fabio/GRF-1002-2022; Lima, Fabio Mitsuo/AHD-6582-2022; Lima, Fabio M/C-9018-2013	Cano, Maria Isabel/0000-0001-9798-6627; de Moraes Barros, Roberto Rudge/0000-0002-0155-8431; Mortara, Renato A./0000-0002-2311-8349; Lima, Fabio Mitsuo/0000-0002-1953-2950; Lima, Fabio Mitsuo/0000-0002-1953-2950; Lima, Fabio M/0000-0002-1953-2950; Santori, Fabio/0000-0002-0220-8935	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo/FAPESP; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico/CNPq; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior/CAPES (Brazil); CAPES-REUNI; FAPESP	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo/FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico/CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior/CAPES (Brazil)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CAPES-REUNI(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was supported by grants from Fundacao de Amparo a Pesquisa do Estado de Sao Paulo/FAPESP (www.fapesp.br), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico/CNPq (www.cnpq.br) and Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior/CAPES (www.capes.gov.br) (Brazil) to JFS. FML and DRC were awarded postdoctoral and doctoral fellowships by CAPES-REUNI and FAPESP, respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Argueso JL, 2008, P NATL ACAD SCI USA, V105, P11845, DOI 10.1073/pnas.0804529105; Barnabe C, 2000, PARASITOLOGY, V120, P513, DOI 10.1017/S0031182099005661; BASTIEN P, 1990, MOL BIOCHEM PARASIT, V40, P53, DOI 10.1016/0166-6851(90)90079-2; Campos RMF, 1996, MEM I OSWALDO CRUZ, V91, P795, DOI 10.1590/S0074-02761996000600029; CANO MI, 1995, MOL BIOCHEM PARASIT, V71, P273, DOI 10.1016/0166-6851(95)00066-A; COMEAU AM, 1986, MOL BIOCHEM PARASIT, V21, P161, DOI 10.1016/0166-6851(86)90019-8; DEGRAVE W, 1988, MOL BIOCHEM PARASIT, V27, P63, DOI 10.1016/0166-6851(88)90025-4; DVORAK JA, 1982, J PROTOZOOL, V29, P430, DOI 10.1111/j.1550-7408.1982.tb05427.x; El-Sayed NM, 2005, SCIENCE, V309, P409, DOI 10.1126/science.1112631; Freitas-Junior LH, 2000, NATURE, V407, P1018, DOI 10.1038/35039531; Freitas-Junior LHG, 1999, NUCLEIC ACIDS RES, V27, P2451, DOI 10.1093/nar/27.12.2451; Frias C, 2012, FRONT BIOSCI-LANDMRK, V17, P2181, DOI 10.2741/4044; Galindo M, 2007, FEBS LETT, V581, P2022, DOI 10.1016/j.febslet.2007.03.093; HENRIKSSON J, 1990, MOL BIOCHEM PARASIT, V42, P213, DOI 10.1016/0166-6851(90)90164-H; Henriksson J, 1996, PARASITOL TODAY, V12, P108, DOI 10.1016/0169-4758(96)80670-3; Henriksson J, 2002, PARASITOLOGY, V124, P277, DOI 10.1017/S0031182001001093; HENRIKSSON J, 1993, EXP PARASITOL, V77, P334, DOI 10.1006/expr.1993.1091; Kim D, 2005, GENE, V346, P153, DOI 10.1016/j.gene.2004.10.014; LANAR DE, 1981, MOL BIOCHEM PARASIT, V3, P327, DOI 10.1016/0166-6851(81)90006-2; LEBLANCQ SM, 1991, NUCLEIC ACIDS RES, V19, P4405, DOI 10.1093/nar/19.16.4405; Lephart PR, 2005, EUKARYOT CELL, V4, P733, DOI 10.1128/EC.4.4.733-741.2005; Lewis MD, 2009, INT J PARASITOL, V39, P1305, DOI 10.1016/j.ijpara.2009.04.001; Lima FM, 2010, NEW BIOTECHNOL, V27, P837, DOI 10.1016/j.nbt.2010.02.003; LIMA MF, 1989, MOL BIOCHEM PARASIT, V33, P159, DOI 10.1016/0166-6851(89)90030-3; Llewellyn MS, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000410; MAINGON R, 1988, EUR J BIOCHEM, V171, P285, DOI 10.1111/j.1432-1033.1988.tb13788.x; MCDANIEL JP, 1993, MOL BIOCHEM PARASIT, V57, P213, DOI 10.1016/0166-6851(93)90197-6; Minning TA, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-139; Mortara RA, 2005, AN ACAD BRAS CIENC, V77, P77, DOI 10.1590/S0001-37652005000100006; Mortara RA, 1999, MEM I OSWALDO CRUZ, V94, P135, DOI 10.1590/S0074-02761999000700014; MORTARA RA, 1991, EXP PARASITOL, V73, P1, DOI 10.1016/0014-4894(91)90002-E; Oliveira RP, 1998, P NATL ACAD SCI USA, V95, P3776, DOI 10.1073/pnas.95.7.3776; PAGES M, 1989, MOL BIOCHEM PARASIT, V36, P161, DOI 10.1016/0166-6851(89)90188-6; Palm W, 2008, ANNU REV GENET, V42, P301, DOI 10.1146/annurev.genet.41.110306.130350; Pedroso A, 2003, MOL BIOCHEM PARASIT, V129, P79, DOI 10.1016/S0166-6851(03)00096-3; PONZI M, 1990, MOL BIOCHEM PARASIT, V41, P73, DOI 10.1016/0166-6851(90)90098-7; ROVAI L, 1992, MOL BIOCHEM PARASIT, V50, P115, DOI 10.1016/0166-6851(92)90249-J; Santori F.R., 1991, CHARACTERIZATION PRO; Valadares HMS, 2008, INT J PARASITOL, V38, P839, DOI 10.1016/j.ijpara.2007.10.017; Souto RP, 1996, MOL BIOCHEM PARASIT, V83, P141, DOI 10.1016/S0166-6851(96)02755-7; Souza RT, 2007, EUKARYOT CELL, V6, P1228, DOI 10.1128/EC.00036-07; Souza RT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023042; Upcroft JA, 2005, EUKARYOT CELL, V4, P484, DOI 10.1128/EC.4.2.484-486.2005; Vargas N, 2004, MOL BIOCHEM PARASIT, V138, P131, DOI 10.1016/j.molbiopara.2004.08.005; Weatherly DB, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-255; YOSHIDA N, 1983, INFECT IMMUN, V40, P836, DOI 10.1128/IAI.40.2.836-839.1983; Zingales B, 2012, INFECT GENET EVOL, V12, P240, DOI 10.1016/j.meegid.2011.12.009	47	16	16	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e63738	10.1371/journal.pone.0063738	http://dx.doi.org/10.1371/journal.pone.0063738			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667668	Green Submitted, gold, Green Published			2022-12-27	WOS:000319654700183
J	Maliwal, BP; Fudala, R; Raut, S; Kokate, R; Sorensen, TJ; Laursen, BW; Gryczynski, Z; Gryczynski, I				Maliwal, Badri P.; Fudala, Rafal; Raut, Sangram; Kokate, Rutika; Sorensen, Thomas J.; Laursen, Bo W.; Gryczynski, Zygmunt; Gryczynski, Ignacy			Long-Lived Bright Red Emitting Azaoxa-Triangulenium Fluorophores	PLOS ONE			English	Article							ORGANIC-DYES; LIPID-MEMBRANES; FLUORESCENT; DIPHENYLHEXATRIENE; DYNAMICS; FLUIDITY; PROBES; ACIDS	The fluorescence lifetimes of most red emitting organic probes are under 4 nanoseconds, which is a limiting factor in studying interactions and conformational dynamics of macromolecules. In addition, the nanosecond background autofluorescence is a significant interference during fluorescence measurements in cellular environment. Therefore, red fluorophores with longer lifetimes will be immensely helpful. Azaoxa-triangulenium fluorophores ADOTA and DAOTA are red emitting small organic molecules with high quantum yield, long fluorescence lifetime and high limiting anisotropy. In aqueous environment, ADOTA and DAOTA absorption and emission maxima are respectively 540 nm and 556 nm, and 556 nm and 589 nm. Their emission extends beyond 700 nm. Both probes have the limiting anisotropy between 0.36-0.38 at their absorption peak. In both protic and aprotic solvents, their lifetimes are around 20 ns, making them among the longest-lived red emitting organic fluorophores. Upon labeling of avidin, streptavidin and immunoglobulin their absorption and fluorescence are red-shifted. Unlike in free form, the protein-conjugated probes have heterogeneous fluorescence decays, with the presence of both significantly quenched and unquenched populations. Despite the presence of significant local motions due to a flexible trimethylene linker, we successfully measured both intermediate nanosecond intra-protein motions and slower rotational correlation times approaching 100 ns. Their long lifetimes are unaffected by the cell membrane (hexadecyl-ADOTA) and the intra-cellular (DAOTA-Arginine) localization. Their long lifetimes also enabled successful time-gating of the cellular autofluorescence resulting in background-free fluorescence lifetime based images. ADOTA and DAOTA retain a long fluorescence lifetime when free, as protein conjugate, in membranes and inside the cell. Our successful measurements of intermediate nanosecond internal motions and long correlations times of large proteins suggest that these probes will be highly useful to study slower intra-molecular motions and interactions among macromolecules. The fluorescence lifetime facilitated gating of cellular nanosecond autofluorescence should be of considerable help in in vitro and in vivo applications.	[Maliwal, Badri P.; Fudala, Rafal; Raut, Sangram; Gryczynski, Ignacy] Univ N Texas, Hlth Sci Ctr, Dept Mol Biol & Immunol, Ctr Commercializat Fluorescence Technol, Ft Worth, TX USA; [Kokate, Rutika] Univ N Texas, Hlth Sci Ctr, Dept Mol Biol & Immunol, Ft Worth, TX USA; [Sorensen, Thomas J.; Laursen, Bo W.] Univ Copenhagen, Nanosci Ctr, Copenhagen, Denmark; [Sorensen, Thomas J.; Laursen, Bo W.] Univ Copenhagen, Dept Chem, Copenhagen, Denmark; [Gryczynski, Zygmunt] Texas Christian Univ, Dept Phys, Ft Worth, TX 76129 USA; [Gryczynski, Zygmunt] Texas Christian Univ, Dept Astron, Ft Worth, TX 76129 USA; [Gryczynski, Ignacy] Univ N Texas, Hlth Sci Ctr, Dept Cell Biol & Anat, Ft Worth, TX USA	University of North Texas System; University of North Texas Health Science Center; University of North Texas System; University of North Texas Health Science Center; University of Copenhagen; University of Copenhagen; Texas Christian University; Texas Christian University; University of North Texas System; University of North Texas Health Science Center	Maliwal, BP (corresponding author), Univ N Texas, Hlth Sci Ctr, Dept Mol Biol & Immunol, Ctr Commercializat Fluorescence Technol, Ft Worth, TX USA.	bpmal001@gmail.com; Ignacy.Gryczynski@unthsc.edu	Laursen, Bo/B-4453-2015; Raut, Sangram/P-6921-2014; Sørensen, Thomas Just/C-2521-2013; Raut, Sangram/I-9788-2019	Laursen, Bo/0000-0002-1120-3191; Sørensen, Thomas Just/0000-0003-1491-5116; Raut, Sangram/0000-0002-1219-3968	National Institutes of Health [R01EB12003-01]; Danish Council for Independent Research, Technology and Production Sciences [10-093546]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB012003] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Danish Council for Independent Research, Technology and Production Sciences(Det Frie Forskningsrad (DFF)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was supported by National Institutes of Health grants R01EB12003-01 (ZG) (http://nih.gov/) and the Danish Council for Independent Research, Technology and Production Sciences (http://fivu.dk) grant 10-093546 (TJS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achilefu S, 2010, CHEM REV, V110, P2575, DOI 10.1021/cr1001113; [Anonymous], 2010, MOL PROBES HDB GUIDE, P11; BENNETT WS, 1984, CRC CR REV BIOCH MOL, V15, P291, DOI 10.3109/10409238409117796; Berlman I. B., 1971, HDB FLUORESCENCE SPE; BEST L, 1987, EUR BIOPHYS J BIOPHY, V15, P87, DOI 10.1007/BF00257502; Brand L, 2008, METHOD ENZYMOL, V450, P1; Bunzli JCG, 2010, CHEM REV, V110, P2729, DOI 10.1021/cr900362e; Chen HM, 2010, J AM CHEM SOC, V132, P7244, DOI 10.1021/ja100500k; DALE RE, 1977, J BIOL CHEM, V252, P7500; Dileesh S, 2004, J PHOTOCH PHOTOBIO A, V162, P115, DOI 10.1016/S1010-6030(03)00318-6; Doose S, 2005, CHEMPHYSCHEM, V6, P2277, DOI 10.1002/cphc.200500191; Germain RN, 2012, SCIENCE, V336, P1676, DOI 10.1126/science.1221063; GERSTEIN M, 1994, BIOCHEMISTRY-US, V33, P6739, DOI 10.1021/bi00188a001; Goldys EM, 2009, FLUORESCENCE APPL BI, P367; Gonzalez MW, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002819; Jameson DM, 2010, CHEM REV, V110, P2685, DOI 10.1021/cr900267p; Laursen BW, 2001, CHEM-EUR J, V7, P1773; LENTZ BR, 1989, CHEM PHYS LIPIDS, V50, P171, DOI 10.1016/0009-3084(89)90049-2; Marme N, 2003, BIOCONJUGATE CHEM, V14, P1133, DOI 10.1021/bc0341324; MARTIN JC, 1964, J AM CHEM SOC, V86, P2252, DOI 10.1021/ja01065a030; Mateo CR, 1996, BIOPHYS J, V71, P2177, DOI 10.1016/S0006-3495(96)79419-5; Michalet X, 2003, ANNU REV BIOPH BIOM, V32, P161, DOI 10.1146/annurev.biophys.32.110601.142525; PAP EHW, 1994, BIOPHYS CHEM, V48, P337, DOI 10.1016/0301-4622(93)E0069-H; Reynisson J, 2002, PHOTOCH PHOTOBIO SCI, V1, P763, DOI 10.1039/b204954f; Rich RM, 2013, ANAL BIOANAL CHEM, V405, P2065, DOI 10.1007/s00216-012-6623-1; Selvin PR, 2002, ANNU REV BIOPH BIOM, V31, P275, DOI 10.1146/annurev.biophys.31.101101.140927; Shi D, 2012, LANGMUIR, V28, P8608, DOI 10.1021/la301454y; SKLAR LA, 1977, BIOCHEMISTRY-US, V16, P819, DOI 10.1021/bi00624a002; Sorensen TJ, 2009, CHEM PHYS LETT, V476, P46, DOI 10.1016/j.cplett.2009.05.064; Sorensen TJ, 2013, METHODS APPL FLUORES, V1, DOI 10.1088/2050-6120/1/2/025001; Sun QF, 2012, J PHYS CHEM B, V116, P660, DOI 10.1021/jp2100304; Thyrhaug E, 2013, J PHYS CHEM A, V117, P2160, DOI 10.1021/jp312376k; Viallet PM, 2005, METH MOL B, V300, P165; Westerlund F, 2011, PHOTOCH PHOTOBIO SCI, V10, P1963, DOI 10.1039/c1pp05253e	34	41	41	0	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e63043	10.1371/journal.pone.0063043	http://dx.doi.org/10.1371/journal.pone.0063043			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667570	Green Published, Green Submitted, gold			2022-12-27	WOS:000319654700102
J	Tanikawa, C; Okada, Y; Takahashi, A; Oda, K; Kamatani, N; Kubo, M; Nakamura, Y; Matsuda, K				Tanikawa, Chizu; Okada, Yukinori; Takahashi, Atsushi; Oda, Katsutoshi; Kamatani, Naoyuki; Kubo, Michiaki; Nakamura, Yusuke; Matsuda, Koichi			Genome Wide Association Study of Age at Menarche in the Japanese Population	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; ESTROGEN-RECEPTOR-ALPHA; SEQUENCE VARIANTS; LINKAGE SCAN; RISK-FACTORS; METAANALYSIS; PUBERTY; IDENTIFICATION; POLYMORPHISMS; COMPONENTS	Age at menarche (AAM) is a complex trait involving both genetic and environmental factors. To identify the genetic factors associated with AAM, we conducted a large-scale meta-analysis of genome-wide association studies using more than 15,000 Japanese female samples. Here, we identified an association between SNP (single nucleotide polymorphism) rs364663 at the LIN28B locus and AAM, with a P-value of 5.49x10(-7) and an effect size of 0.089 (year). We also evaluated 33 SNPs that were previously reported to be associated with AAM in women of European ancestry. Among them, two SNPs rs4452860 and rs7028916 in TMEM38B indicated significant association with AAM in the same directions as reported in previous studies (P = 0.0013 with an effect size of 0.051) even after Bonferroni correction for the 33 SNPs. In addition, six loci in or near CCDC85A, LOC100421670, CA10, ZNF483, ARNTL, and RXRG exhibited suggestive association with AAM (P<0.05). Our findings elucidated the impact of genetic variations on AAM in the Japanese population.	[Tanikawa, Chizu; Nakamura, Yusuke; Matsuda, Koichi] Univ Tokyo, Inst Med Sci, Ctr Human Genome, Mol Med Lab, Tokyo, Japan; [Okada, Yukinori; Takahashi, Atsushi; Kamatani, Naoyuki; Kubo, Michiaki] Inst Phys & Chem Res RIKEN, Ctr Genom Med, Kanagawa, Japan; [Okada, Yukinori] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Rheumatol Immunol & Allergy, Boston, MA 02115 USA; [Okada, Yukinori] Broad Inst, Program Med & Populat Genet, Cambridge, MA USA; [Oda, Katsutoshi] Univ Tokyo, Fac Med, Dept Obstet & Gynecol, Tokyo 113, Japan; [Nakamura, Yusuke] Univ Chicago, Dept Med, Chicago, IL 60637 USA; [Nakamura, Yusuke] Univ Chicago, Dept Surg, Chicago, IL 60637 USA; [Nakamura, Yusuke] Univ Chicago, Ctr Personalized Therapeut, Chicago, IL 60637 USA	University of Tokyo; RIKEN; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University of Tokyo; University of Chicago; University of Chicago; University of Chicago	Matsuda, K (corresponding author), Univ Tokyo, Inst Med Sci, Ctr Human Genome, Mol Med Lab, Tokyo, Japan.	koichima@ims.u-tokyo.ac.jp	Kubo, Michiaki/N-7947-2015; Matsuda, Koichi/D-4597-2011	Matsuda, Koichi/0000-0001-7292-2686	Ministry of Education, Culture, Sports, Science and Technology of the Japanese government; Ministry of Education, Culture, Sports, Science and Technology; Shiseido female researcher science grant	Ministry of Education, Culture, Sports, Science and Technology of the Japanese government(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Shiseido female researcher science grant(Shiseido Company, Limited)	This work was conducted as a part of the BioBank Japan Project that was supported by the Ministry of Education, Culture, Sports, Science and Technology of the Japanese government. This work was also supported by grant from the Ministry of Education, Culture, Sports, Science and Technology (C. Tanikawa and K. Matsuda) and Shiseido female researcher science grant (C. Tanikawa). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMBROS V, 1984, SCIENCE, V226, P409, DOI 10.1126/science.6494891; Anderson CA, 2008, J CLIN ENDOCR METAB, V93, P3965, DOI 10.1210/jc.2007-2568; Anderson CA, 2007, BEHAV GENET, V37, P668, DOI 10.1007/s10519-007-9163-2; Bhalla K, 2008, AM J HUM GENET, V83, P703, DOI 10.1016/j.ajhg.2008.10.020; Cooper GS, 1999, EPIDEMIOLOGY, V10, P255, DOI 10.1097/00001648-199905000-00011; Cui R, 2011, GUT, V60, P799, DOI 10.1136/gut.2010.215947; Elks CE, 2010, NAT GENET, V42, P1077, DOI 10.1038/ng.714; Eriksson N, 2012, BMC MED GENET, V13, DOI 10.1186/1471-2350-13-53; Freedman David S, 2003, BMC Pediatr, V3, P3, DOI 10.1186/1471-2431-3-3; Fujiwara S, 1997, J BONE MINER RES, V12, P998, DOI 10.1359/jbmr.1997.12.7.998; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Gudbjartsson DF, 2008, NAT GENET, V40, P609, DOI 10.1038/ng.122; Guerin A, 2012, AM J MED GENETICS A; Guo Y, 2006, J CLIN ENDOCR METAB, V91, P1009, DOI 10.1210/jc.2005-2179; Guo Y, 2006, HUM MOL GENET, V15, P2401, DOI 10.1093/hmg/ddl155; Guo YQ, 2006, GENE, V384, P51, DOI 10.1016/j.gene.2006.07.011; He CY, 2010, HUM GENET, V128, P515, DOI 10.1007/s00439-010-0878-4; He CY, 2009, NAT GENET, V41, P724, DOI 10.1038/ng.385; Heo I, 2008, MOL CELL, V32, P276, DOI 10.1016/j.molcel.2008.09.014; Kaltiala-Heino R, 2003, J ADOLESCENCE, V26, P531, DOI 10.1016/S0140-1971(03)00053-8; Kaltiala-Heino R, 2001, J ADOLESCENT HEALTH, V28, P346, DOI 10.1016/S1054-139X(01)00195-1; KJAER K, 1992, J CLIN ENDOCR METAB, V75, P524, DOI 10.1210/jc.75.2.524; Krude H, 2002, J CLIN INVEST, V109, P475, DOI 10.1172/JC1200214341; Kumar V, 2011, NAT GENET IN PRESS; Kumar V, 2011, NAT GENET, V43, P455, DOI 10.1038/ng.809; Lettre G, 2008, NAT GENET, V40, P584, DOI 10.1038/ng.125; Li J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034486; Li Y, 2009, ANNU REV GENOM HUM G, V10, P387, DOI 10.1146/annurev.genom.9.081307.164242; Mbarek H, 2011, HUM MOL GENET, V20, P3884, DOI 10.1093/hmg/ddr301; Melzer D, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000072; Nakamura Yusuke, 2007, Clin Adv Hematol Oncol, V5, P696; Okada Y, 2012, NAT GENET, V44, P904, DOI 10.1038/ng.2352; Okada Y, 2012, NAT GENET, V44, P302, DOI 10.1038/ng.1086; Okada Y, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002067; Okada Y, 2011, HUM MOL GENET, V20, P1224, DOI 10.1093/hmg/ddq551; Okada Y, 2010, HUM MOL GENET, V19, P2303, DOI 10.1093/hmg/ddq091; Okada Y, 2010, HUM MOL GENET, V19, P2079, DOI 10.1093/hmg/ddq080; Ong KK, 2009, NAT GENET, V41, P729, DOI 10.1038/ng.382; Onland-Moret NC, 2005, AM J EPIDEMIOL, V162, P623, DOI 10.1093/aje/kwi260; Parent AS, 2003, ENDOCR REV, V24, P668, DOI 10.1210/er.2002-0019; Perry JRB, 2009, NAT GENET, V41, P648, DOI 10.1038/ng.386; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Rothenbuhler A, 2006, J CLIN ENDOCR METAB, V91, P3534, DOI 10.1210/jc.2006-0150; Stavrou I, 2006, HUM REPROD, V21, P554, DOI 10.1093/humrep/dei326; Stavrou I, 2002, HUM REPROD, V17, P1101, DOI 10.1093/humrep/17.4.1101; Sulem P, 2009, NAT GENET, V41, P734, DOI 10.1038/ng.383; SUSMAN EJ, 1985, J YOUTH ADOLESCENCE, V14, P245, DOI 10.1007/BF02090322; Tanikawa C, 2012, NAT GENET IN PRESS; Tena-Sempere M, 2006, HUM REPROD UPDATE, V12, P631, DOI 10.1093/humupd/dml023; Towne B, 2005, AM J PHYS ANTHROPOL, V128, P210, DOI 10.1002/ajpa.20106; TRELOAR SA, 1990, AM J HUM GENET, V47, P137; Urabe Y, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002541; Velie Ellen M, 2005, Breast Dis, V24, P17; Viswanathan SR, 2008, SCIENCE, V320, P97, DOI 10.1126/science.1154040; Volodarsky M, 2013, HUM MUTAT; Xita N, 2005, MOL HUM REPROD, V11, P459, DOI 10.1093/molehr/gah178; Yamaguchi-Kabata Y, 2008, AM J HUM GENET, V83, P445, DOI 10.1016/j.ajhg.2008.08.019; Yazawa M, 2007, NATURE, V448, P78, DOI 10.1038/nature05928; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zhu H, 2010, NAT GENET, V42, P626, DOI 10.1038/ng.593	60	29	32	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e63821	10.1371/journal.pone.0063821	http://dx.doi.org/10.1371/journal.pone.0063821			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667675	Green Published, Green Submitted, gold			2022-12-27	WOS:000319654700187
J	von Alvensleben, N; Stookey, K; Magnusson, M; Heimann, K				von Alvensleben, Nicolas; Stookey, Katherine; Magnusson, Marie; Heimann, Kirsten			Salinity Tolerance of Picochlorum atomus and the Use of Salinity for Contamination Control by the Freshwater Cyanobacterium Pseudanabaena limnetica	PLOS ONE			English	Article							FATTY-ACID-COMPOSITION; BIOFUEL PRODUCTION; TETRASELMIS-CHUI; NITROGEN-SOURCES; LIPID-CONTENT; NITRIC-OXIDE; GREEN-ALGAE; MICROALGAE; GROWTH; NITRATE	Microalgae are ideal candidates for waste-gas and -water remediation. However, salinity often varies between different sites. A cosmopolitan microalga with large salinity tolerance and consistent biochemical profiles would be ideal for standardised cultivation across various remediation sites. The aims of this study were to determine the effects of salinity on Picochlorum atomus growth, biomass productivity, nutrient uptake and biochemical profiles. To determine if target end-products could be manipulated, the effects of 4-day nutrient limitation were also determined. Culture salinity had no effect on growth, biomass productivity, phosphate, nitrate and total nitrogen uptake at 2, 8, 18, 28 and 36 ppt. 11 ppt, however, initiated a significantly higher total nitrogen uptake. While salinity had only minor effects on biochemical composition, nutrient depletion was a major driver for changes in biomass quality, leading to significant increases in total lipid, fatty acid and carbohydrate quantities. Fatty acid composition was also significantly affected by nutrient depletion, with an increased proportion of saturated and mono-unsaturated fatty acids. Having established that P. atomus is a euryhaline microalga, the effects of culture salinity on the development of the freshwater cyanobacterial contaminant Pseudanabaena limnetica were determined. Salinity at 28 and 36 ppt significantly inhibited establishment of P. limnetica in P. atomus cultures. In conclusion, P. atomus can be deployed for bioremediation at sites with highly variable salinities without effects on end-product potential. Nutrient status critically affected biochemical profiles - an important consideration for end-product development by microalgal industries. 28 and 36 ppt slow the establishment of the freshwater cyanobacterium P. limnetica, allowing for harvest of low contaminant containing biomass.	[von Alvensleben, Nicolas; Stookey, Katherine; Magnusson, Marie; Heimann, Kirsten] James Cook Univ, Sch Marine & Trop Biol, Townsville, Qld 4811, Australia; [von Alvensleben, Nicolas; Stookey, Katherine; Magnusson, Marie; Heimann, Kirsten] James Cook Univ, Ctr Sustainable Fisheries & Aquaculture, Townsville, Qld 4811, Australia; [Heimann, Kirsten] James Cook Univ, Comparat Genom Ctr, Townsville, Qld 4811, Australia; [Heimann, Kirsten] James Cook Univ, Ctr Biodiscovery & Mol Dev Therapeut, Townsville, Qld 4811, Australia	James Cook University; James Cook University; James Cook University; James Cook University	Heimann, K (corresponding author), James Cook Univ, Sch Marine & Trop Biol, Townsville, Qld 4811, Australia.	Kirsten.heimann@jcu.edu.au	Heimann, Kirsten/N-1512-2013; Heimann, Kirsten/M-4814-2019; Magnusson, Marie/D-8996-2012	Heimann, Kirsten/0000-0003-2691-9659; Heimann, Kirsten/0000-0003-2691-9659; Magnusson, Marie/0000-0002-3141-8544	Advanced Manufacturing Cooperative Research Centre, Melbourne, Australia; AMCRC PhD scholarship	Advanced Manufacturing Cooperative Research Centre, Melbourne, Australia(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme); AMCRC PhD scholarship(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme)	This work was funded through the Advanced Manufacturing Cooperative Research Centre, Melbourne, Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research is part of the MBD Energy Research and Development program for Biological Carbon Capture and Storage. Nicolas von Alvensleben was supported by an AMCRC PhD scholarship.	Acinas SG, 2009, ISME J, V3, P31, DOI 10.1038/ismej.2008.78; Ahlgren G, 2003, J PHYCOL, V39, P906, DOI 10.1046/j.1529-8817.2003.02026.x; Andersen R. A., 2005, ALGAL CULTURING TECH, P429, DOI DOI 10.1016/B978-012088426-1/50027-5; Arbib Z, 2012, INT J PHYTOREMEDIAT, V14, P714, DOI 10.1080/15226514.2011.619237; BAREA JL, 1975, ARCH MICROBIOL, V105, P21, DOI 10.1007/BF00447107; Becker EW, 2007, BIOTECHNOL ADV, V25, P207, DOI 10.1016/j.biotechadv.2006.11.002; Becker E.W., 1994, MICROALGAE BIOTECHNO; BENAMOTZ A, 1985, J PHYCOL, V21, P72; Borowitzka M.A., 2005, ALGAL CULTURING TECH, P205; BROWN LM, 1982, J PHYCOL, V18, P483; Cha TS, 2011, BIORESOURCE TECHNOL, V102, P10633, DOI 10.1016/j.biortech.2011.09.042; Chen TY, 2012, AQUACULTURE, V338, P82, DOI 10.1016/j.aquaculture.2012.01.011; Chiang IZ, 2004, J PHYCOL, V40, P474, DOI 10.1111/j.1529-8817.2004.03096.x; Cho SH, 2007, FISHERIES SCI, V73, P1050, DOI 10.1111/j.1444-2906.2007.01435.x; Churro C, 2010, HYDROBIOLOGIA, V649, P195, DOI 10.1007/s10750-010-0245-4; COHEN Z, 1988, J PHYCOL, V24, P328, DOI 10.1111/j.1529-8817.1988.tb04474.x; de la Vega M, 2011, BIOTECHNOL PROGR, V27, P1535, DOI 10.1002/btpr.686; de Morais MG, 2007, ENERG CONVERS MANAGE, V48, P2169, DOI 10.1016/j.enconman.2006.12.011; DORTCH Q, 1984, MAR BIOL, V81, P237, DOI 10.1007/BF00393218; DUBOIS M, 1956, ANAL CHEM, V28, P350, DOI 10.1021/ac60111a017; Geider RJ, 1998, EUR J PHYCOL, V33, P315, DOI 10.1080/09670269810001736813; Gosch BJ, 2012, GCB BIOENERGY, V4, P919, DOI 10.1111/j.1757-1707.2012.01175.x; Gronlund E, 2004, ECOL ENG, V22, P155, DOI 10.1016/j.ecoleng.2004.03.002; HA KS, 1991, PLANT PHYSIOL, V97, P921, DOI 10.1104/pp.97.3.921; Harikrishnan R, 2010, AQUACULTURE, V309, P1, DOI 10.1016/j.aquaculture.2010.09.011; Hay ME, 2009, ANNU REV MAR SCI, V1, P193, DOI 10.1146/annurev.marine.010908.163708; Henley WJ, 2004, PHYCOLOGIA, V43, P641, DOI 10.2216/i0031-8884-43-6-641.1; Hu Q, 2008, PLANT J, V54, P621, DOI 10.1111/j.1365-313X.2008.03492.x; Huerlimann R, 2010, BIOTECHNOL BIOENG, V107, P245, DOI 10.1002/bit.22809; Huertas E, 2000, AQUACULT ENG, V22, P181, DOI 10.1016/S0144-8609(99)00038-2; IGNARRO LJ, 1993, P NATL ACAD SCI USA, V90, P8103, DOI 10.1073/pnas.90.17.8103; Jarvie HP, 2006, SCI TOTAL ENVIRON, V360, P246, DOI 10.1016/j.scitotenv.2005.08.038; Joint I, 2002, AQUAT MICROB ECOL, V29, P145, DOI 10.3354/ame029145; KIRST GO, 1990, ANNU REV PLANT PHYS, V41, P21, DOI 10.1146/annurev.pp.41.060190.000321; Komarek J, 2003, HYDROBIOLOGIA, V502, P367, DOI 10.1023/B:HYDR.0000004294.17755.fe; LEVASSEUR M, 1993, J PHYCOL, V29, P587, DOI 10.1111/j.0022-3646.1993.00587.x; Lewis T, 2000, J MICROBIOL METH, V43, P107, DOI 10.1016/S0167-7012(00)00217-7; Li YQ, 2008, APPL MICROBIOL BIOT, V81, P629, DOI 10.1007/s00253-008-1681-1; Lim DKY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040751; LINCOLN EP, 1983, AQUACULTURE, V32, P331, DOI 10.1016/0044-8486(83)90230-2; MacIntyre H.L., 2005, ALGAL CULTURING TECH, P287, DOI [10.1016/B978-012088426-1/50020-2, DOI 10.1016/B978-012088426-1/50020-2, 10.1007/s10811-017-1254-8]; Malerba ME, 2012, LIMNOL OCEANOGR, V57, P1555, DOI 10.4319/lo.2012.57.5.1555; Meseck SL, 2007, J SHELLFISH RES, V26, P1071, DOI 10.2983/0730-8000(2007)26[1071:IOACCL]2.0.CO;2; Meseck SL, 2007, AQUACULTURE, V273, P566, DOI 10.1016/j.aquaculture.2007.10.043; Mischke U, 2003, ACTA OECOL, V24, pS11, DOI 10.1016/S1146-609X(03)00003-1; Nagase H, 2001, BIOCHEM ENG J, V7, P241, DOI 10.1016/S1369-703X(00)00122-4; NEGORO M, 1991, APPL BIOCHEM BIOTECH, V28-9, P877, DOI 10.1007/BF02922657; PIORRECK M, 1984, PHYTOCHEMISTRY, V23, P207, DOI 10.1016/S0031-9422(00)80304-0; RAI LC, 1991, J PLANT PHYSIOL, V138, P68, DOI 10.1016/S0176-1617(11)80732-7; RAJASEKHAR VK, 1987, PHYSIOL PLANTARUM, V71, P517, DOI 10.1111/j.1399-3054.1987.tb02893.x; REITAN KI, 1994, J PHYCOL, V30, P972, DOI 10.1111/j.0022-3646.1994.00972.x; Rodriguez-Ruiz J, 1998, BIOTECHNOL TECH, V12, P689, DOI 10.1023/A:1008812904017; ROESSLER PG, 1990, J PHYCOL, V26, P393, DOI 10.1111/j.0022-3646.1990.00393.x; Roncarati A, 2004, J WORLD AQUACULT SOC, V35, P401, DOI 10.1111/j.1749-7345.2004.tb00104.x; Sandra P., 2002, AGILENT TECHNOLOGIES; Schenk PM, 2008, BIOENERG RES, V1, P20, DOI 10.1007/s12155-008-9008-8; Sharma KK, 2012, ENERGIES, V5, P1532, DOI 10.3390/en5051532; SHIFRIN NS, 1981, J PHYCOL, V17, P374, DOI 10.1111/j.0022-3646.1981.00374.x; Simopoulos AP, 2002, BIOMED PHARMACOTHER, V56, P365, DOI 10.1016/S0753-3322(02)00253-6; SIMS GG, 1978, J SCI FOOD AGR, V29, P281, DOI 10.1002/jsfa.2740290314; Stephens E, 2010, TRENDS PLANT SCI, V15, P554, DOI 10.1016/j.tplants.2010.06.003; Su CH, 2011, J APPL PHYCOL, V23, P903, DOI 10.1007/s10811-010-9609-4; Sunda WG, 2007, LIMNOL OCEANOGR, V52, P2496, DOI 10.4319/lo.2007.52.6.2496; Sydney EB, 2011, APPL ENERG, V88, P3291, DOI 10.1016/j.apenergy.2010.11.024; VOLKMAN JK, 1989, J EXP MAR BIOL ECOL, V128, P219, DOI 10.1016/0022-0981(89)90029-4; Wang B, 2011, BIORESOURCE TECHNOL, V102, P5639, DOI 10.1016/j.biortech.2011.02.054; Willame R, 2006, J PHYCOL, V42, P1312, DOI 10.1111/j.1529-8817.2006.00284.x; WITT U, 1981, AQUACULTURE, V23, P171, DOI 10.1016/0044-8486(81)90012-0	68	61	62	3	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e63569	10.1371/journal.pone.0063569	http://dx.doi.org/10.1371/journal.pone.0063569			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667639	Green Published, Green Accepted, gold			2022-12-27	WOS:000319654700162
J	Wang, J; Wang, L; Xia, B; Yang, CH; Lai, HW; Chen, XD				Wang, Jie; Wang, Li; Xia, Bing; Yang, Chuanhong; Lai, Huangwen; Chen, Xiaodong			BSP Gene Silencing Inhibits Migration, Invasion, and Bone Metastasis of MDA-MB-231BO Human Breast Cancer Cells	PLOS ONE			English	Article							SIALOPROTEIN-II; COLONY FORMATION; IN-VIVO; EXPRESSION; ANTIBODY; OSTEOPONTIN; ADHESION; BINDING; ALPHA-V-BETA-3; PROLIFERATION	Bone sialoprotein (BSP) has been implicated in a variety of physiological and pathophysiological events, including tumor cell invasion, bone homing, adhesion, and matrix degradation. To explore the potential involvement of BSP in human breast cancer cell invasion and metastasis, we used retrovirus-mediated RNAi to deplete BSP levels in the human bone-seeking breast cancer cell line MDA-MB-231BO (231BO) and established the 231BO-BSP27 and 231BO-BSP81 cell clones. Cell proliferation, colony formation, wound healing, and the ability to invade into matrigel of these BSP-depleted clones were all decreased. Both 231BO-BSP27 cells and 231BO-BSP81 cells showed a significant (15.4% and 28.6% respectively) reduction of bone metastatic potential following intracardiac injection as determined by X-ray detection and by hematoxylin and eosin staining. Moreover, the expression of integrins alpha v beta 3 and beta 3 was decreased in the BSP-silenced cells whereas ectopic BSP expression increased the integrins alpha v beta 3 and beta 3 levels. These results together suggest that BSP silencing decreased the integrin alpha v beta 3 and beta 3 levels, in turn inhibiting cell migration and invasion and decreasing the ability of the cells to metastasize to bone.	[Wang, Jie; Wang, Li; Xia, Bing; Yang, Chuanhong; Lai, Huangwen] Guangzhou Gen Hosp Guangzhou Mil Command, Dept Med Res, Guangzhou, Guangdong, Peoples R China; [Chen, Xiaodong] Guangzhou Gen Hosp Guangzhou Mil Command, Dept Pathol, Guangzhou, Guangdong, Peoples R China	Southern Theater Command General Hospital; Southern Theater Command General Hospital	Wang, J (corresponding author), Guangzhou Gen Hosp Guangzhou Mil Command, Dept Med Res, Guangzhou, Guangdong, Peoples R China.	jiew@tom.com		Wang, Li/0000-0001-8321-102X	Guangdong Natural Science Foundation, China [06104396]	Guangdong Natural Science Foundation, China(National Natural Science Foundation of Guangdong Province)	This work was supported by Guangdong Natural Science Foundation (06104396), China (http://gdsf.gdstc.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The study design, data collection and analysis were supported by Guangdong Natural Science Foundation (06104396), China. We also want to thank Fred Bogott, M.D., Ph.D., at Austin Medical Center, Austin of Minnesota, and Dr. D. Joshua Liao at Hormel Institute, Austin of Minnesota, for their excellent English editing of this manuscript.	Adorno M, 2009, CELL, V137, P87, DOI 10.1016/j.cell.2009.01.039; Adwan H, 2004, INT J ONCOL, V24, P1235; Adwan H, 2004, CANCER GENE THER, V11, P109, DOI 10.1038/sj.cgt.7700659; Bauerle T, 2006, INT J ONCOL, V28, P573; Bauerle T, 2005, INT J CANCER, V115, P177, DOI 10.1002/ijc.20840; BELLAHCENE A, 1994, CANCER RES, V54, P2823; Bellahcene A, 1996, J BONE MINER RES, V11, P665; Bellahcene A, 2008, NAT REV CANCER, V8, P212, DOI 10.1038/nrc2345; Boudiffa M, 2010, J BONE MINER RES, V25, P2393, DOI 10.1002/jbmr.245; Byzova TV, 2000, EXP CELL RES, V254, P299, DOI 10.1006/excr.1999.4765; Cogan G, 2004, CONNECT TISSUE RES, V45, P60, DOI 10.1080/03008200490278151; Diel IJ, 1999, CLIN CANCER RES, V5, P3914; Elazar V, 2010, INT J CANCER, V126, P1749, DOI 10.1002/ijc.24890; Goldberg HA, 2001, CONNECT TISSUE RES, V42, P25, DOI 10.3109/03008200109014246; Gordon JAR, 2009, J CELL BIOCHEM, V107, P1118, DOI 10.1002/jcb.22211; Guise TA, 1996, J CLIN INVEST, V98, P1544, DOI 10.1172/JCI118947; Harris NL, 2000, BONE, V27, P795, DOI 10.1016/S8756-3282(00)00392-6; Jensen AO, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-29; Liu DB, 2011, J BIOL CHEM, V286, P24500, DOI 10.1074/jbc.M110.211847; Liu H, 2012, NAT CELL BIOL, V14, P567, DOI 10.1038/ncb2491; Onishi T, 2010, NAT REV CLIN ONCOL, V7, P641, DOI 10.1038/nrclinonc.2010.134; Pecheur I, 2002, FASEB J, V16, P1266, DOI 10.1096/fj.01-0911fje; Peterschmitt J, 2007, CLIN EXP METASTAS, V24, P449, DOI 10.1007/s10585-007-9082-x; Sterling JA, 2011, BONE, V48, P6, DOI 10.1016/j.bone.2010.07.015; Sung V, 1998, J CELL PHYSIOL, V176, P482, DOI 10.1002/(SICI)1097-4652(199809)176:3<482::AID-JCP5>3.0.CO;2-K; Talmadge JE, 2010, CANCER RES, V70, P5649, DOI 10.1158/0008-5472.CAN-10-1040; Tu QS, 2009, J CELL PHYSIOL, V218, P135, DOI 10.1002/jcp.21576; Wang Li, 2011, Sheng Wu Gong Cheng Xue Bao, V27, P233; Wu YJ, 2012, J NEURO-ONCOL, V110, P27, DOI 10.1007/s11060-012-0942-0; Wuttke M, 2001, J BIOL CHEM, V276, P36839, DOI 10.1074/jbc.M105689200; Yoneda T, 1998, EUR J CANCER, V34, P240, DOI 10.1016/S0959-8049(97)10132-0; Yoneda T, 2001, J BONE MINER RES, V16, P1486, DOI 10.1359/jbmr.2001.16.8.1486; Zhang JH, 2003, INT J ONCOL, V23, P1043	33	18	21	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e62936	10.1371/journal.pone.0062936	http://dx.doi.org/10.1371/journal.pone.0062936			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667544	gold, Green Published, Green Submitted			2022-12-27	WOS:000319654700083
J	Aleixandre, P; Montoya, JH; Mila, B				Aleixandre, Pau; Hernandez Montoya, Julio; Mila, Borja			Speciation on Oceanic Islands: Rapid Adaptive Divergence vs. Cryptic Speciation in a Guadalupe Island Songbird (Aves: Junco)	PLOS ONE			English	Article							GENETIC DIVERSITY; MORPHOLOGICAL DIVERSIFICATION; PHENOTYPIC DIVERGENCE; MAINLAND POPULATIONS; EVOLUTION; BIRDS; RADIATION; WARBLER; DNA; DIFFERENTIATION	The evolutionary divergence of island populations, and in particular the tempo and relative importance of neutral and selective factors, is of central interest to the study of speciation. The rate of phenotypic evolution upon island colonization can vary greatly among taxa, and cases of convergent evolution can further confound the inference of correct evolutionary histories. Given the potential lability of phenotypic characters, molecular dating of insular lineages analyzed in a phylogenetic framework provides a critical tool to test hypotheses of phenotypic divergence since colonization. The Guadalupe junco is the only insular form of the polymorphic dark-eyed junco (Junco hyemalis), and shares eye and plumage color with continental morphs, yet presents an enlarged bill and reduced body size. Here we use variation in mtDNA sequence, morphological traits and song variables to test whether the Guadalupe junco evolved rapidly following a recent colonization by a mainland form of the dark-eyed junco, or instead represents a well-differentiated "cryptic" lineage adapted to the insular environment through long-term isolation, with plumage coloration a result of evolutionary convergence. We found high mtDNA divergence of the island lineage with respect to both continental J. hyemalis and J. phaeonotus, representing a history of isolation of about 600,000 years. The island lineage was also significantly differentiated in morphological and male song variables. Moreover, and contrary to predictions regarding diversity loss on small oceanic islands, we document relatively high levels of both haplotypic and song-unit diversity on Guadalupe Island despite long-term isolation in a very small geographic area. In contrast to prevailing taxonomy, the Guadalupe junco is an old, well-differentiated evolutionary lineage, whose similarity to mainland juncos in plumage and eye color is due to evolutionary convergence. Our findings confirm the role of remote islands in driving divergence and speciation, but also their potential role as repositories of ancestral diversity.	[Aleixandre, Pau; Mila, Borja] Spanish Res Council CSIC, Natl Museum Nat Sci, Madrid, Spain; [Hernandez Montoya, Julio] GECI, Ensenada, Baja California, Mexico; [Mila, Borja] Univ Calif Los Angeles, Ctr Trop Res, Inst Environm & Sustainabil, Los Angeles, CA USA	Consejo Superior de Investigaciones Cientificas (CSIC); University of California System; University of California Los Angeles	Aleixandre, P (corresponding author), Spanish Res Council CSIC, Natl Museum Nat Sci, Madrid, Spain.	pau.aleixandre.mallol@gmail.com	Mila, Borja/L-4867-2014	Mila, Borja/0000-0002-6446-0079	Spanish Ministry of Science and Innovation [CGL2011-25866]	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	This research was funded by a grant from the Spanish Ministry of Science and Innovation (CGL2011-25866) to BM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anonymous, 1973, Auk, V90, P411; Baker MC, 1996, ANIM BEHAV, V51, P853, DOI 10.1006/anbe.1996.0089; Baker MC, 2006, BIOL J LINN SOC, V89, P331, DOI 10.1111/j.1095-8312.2006.00677.x; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Benkman CW, 2003, EVOLUTION, V57, P1176; Boessenkool S, 2007, CONSERV GENET, V8, P705, DOI 10.1007/s10592-006-9219-5; Brekke P, 2011, MOL ECOL, V20, P29, DOI 10.1111/j.1365-294X.2010.04923.x; Bryant WE, 1887, ADDITIONS ORNITHOLOG, P269; Buckley TR, 2009, P ROY SOC B-BIOL SCI, V276, P1055, DOI 10.1098/rspb.2008.1552; CARSON HL, 1976, ANNU REV ECOL SYST, V7, P311, DOI 10.1146/annurev.es.07.110176.001523; Charif R. A., 2008, RAVEN PRO 1 3 USERS; Chaves JA, 2012, J EVOLUTION BIOL, V25, P509, DOI 10.1111/j.1420-9101.2011.02447.x; Clegg SM, 2002, EVOLUTION, V56, P2090; Clegg SM, 2010, PHILOS T R SOC B, V365, P1077, DOI 10.1098/rstb.2009.0281; Coyne J.A., 2004, SPECIATION; DEGNAN SM, 1993, EVOLUTION, V47, P1105, DOI 10.1111/j.1558-5646.1993.tb02139.x; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Dwight J, 1918, B AM MUS NAT HIST, V38, P0269; Emerson BC, 2001, TRENDS ECOL EVOL, V16, P707, DOI 10.1016/S0169-5347(01)02305-9; Emerson BC, 2008, TRENDS ECOL EVOL, V23, P619, DOI 10.1016/j.tree.2008.07.005; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Fleischer RC, 2008, CURR BIOL, V18, P1927, DOI 10.1016/j.cub.2008.10.051; Frankham R, 1997, HEREDITY, V78, P311, DOI 10.1038/hdy.1997.46; Fu YX, 1997, GENETICS, V147, P915; Grant P.R., 1999, RECOGNITION STATES L, V2; Grant P.R., 2007, WHY SPECIES MULTIPLY; Grant PR, 2001, OIKOS, V92, P385, DOI 10.1034/j.1600-0706.2001.920301.x; Grant PR, 1998, EVOLUTION ISLANDS; Hamao S, 2000, J ETHOL, V18, P53, DOI 10.1007/s101640070025; Hargreaves S, 2010, CONSERV GENET, V11, P1317, DOI 10.1007/s10592-009-9960-7; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; Hebert PDN, 2004, PLOS BIOL, V2, P1657, DOI 10.1371/journal.pbio.0020312; Hendry AP, 2006, P R SOC B, V273, P1887, DOI 10.1098/rspb.2006.3534; Hey J., 2011, DOCUMENTATION IMA2; Ho SYW, 2005, MOL BIOL EVOL, V22, P1561, DOI 10.1093/molbev/msi145; Howell T. R., 1954, Condor, V56, P283, DOI 10.2307/1364852; Illera JC, 2007, MOL ECOL, V16, P4599, DOI 10.1111/j.1365-294X.2007.03543.x; JEHL J R JR, 1985, Transactions of the San Diego Society of Natural History, V20, P313; Johnson JA, 2009, MOL ECOL, V18, P54, DOI [10.1111/j.1365-294X.2009.04240.x, 10.1111/j.1365-294X.2008.04012.x]; Keogh JS, 2005, EVOLUTION, V59, P226; Losos JB, 2009, NATURE, V457, P830, DOI 10.1038/nature07893; Lovette IJ, 2002, P ROY SOC B-BIOL SCI, V269, P37, DOI 10.1098/rspb.2001.1789; Lovette IJ, 2010, MOL PHYLOGENET EVOL, V57, P753, DOI 10.1016/j.ympev.2010.07.018; MANI GS, 1990, PROC R SOC SER B-BIO, V240, P29, DOI 10.1098/rspb.1990.0025; MARLER P., 1961, WILSON BULL, V73, P193; Mason RAB, 2011, CONSERV GENET, V12, P91, DOI 10.1007/s10592-009-9993-y; Mathys BA, 2011, P ROY SOC B-BIOL SCI, V278, P2392, DOI 10.1098/rspb.2010.2302; McCormack JE, 2008, P ROY SOC B-BIOL SCI, V275, P2155, DOI 10.1098/rspb.2008.0470; Mila B, 2008, CONDOR, V110, P335, DOI 10.1525/cond.2008.8396; Mila B, 2007, P R SOC B, V274, P2653, DOI 10.1098/rspb.2007.0852; Mila B, 2007, MOL ECOL, V16, P159, DOI 10.1111/j.1365-294X.2006.03119.x; Mila B, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-158; Miller A. H., 1941, University of California Publications in Zoology, V44, P173; Millien V, 2006, PLOS BIOL, V4, P1863, DOI 10.1371/journal.pbio.0040321; MIRSKY EN, 1976, CONDOR, V78, P230, DOI 10.2307/1366858; Nei M., 1987, MOL EVOLUTIONARY GEN; Nolan V, 2002, DARK EYED JUNCO JUNC; Odeen A, 2003, MOL ECOL, V12, P2113, DOI 10.1046/j.1365-294X.2003.01883.x; Omland KE, 1999, MOL PHYLOGENET EVOL, V12, P224, DOI 10.1006/mpev.1999.0611; Phillimore AB, 2008, MOL ECOL, V17, P2839, DOI 10.1111/j.1365-294X.2008.03794.x; Pieplow ND, 2011, WILSON J ORNITHOL, V123, P464, DOI 10.1676/10-126.1; Price T, 2008, SPECIATION BIRDS; Rambaut A., 2007, TRACER V1 4; Randall JM, 2008, ISLA GUADALUPE RESTA, P231; Rasner CA, 2004, MOL ECOL, V13, P671, DOI 10.1046/j.1365-294X.2004.02104.x; Ribas CC, 2006, AUK, V123, P660, DOI 10.1642/0004-8038(2006)123[660:MSAPOD]2.0.CO;2; Ridgway R, 1877, BIRDS GUADALUPE ISLA; Rocamora GJ, 2003, IBIS, V145, pE34, DOI 10.1046/j.1474-919X.2003.00140.x; Ruber L, 2001, J EVOLUTION BIOL, V14, P325, DOI 10.1046/j.1420-9101.2001.00269.x; Sanaa A, 2010, SCI HORTIC-AMSTERDAM, V125, P740, DOI 10.1016/j.scienta.2010.05.014; Scott SN, 2003, EVOLUTION, V57, P2147; Sorenson MD, 1999, MOL PHYLOGENET EVOL, V12, P105, DOI 10.1006/mpev.1998.0602; TARR CL, 1995, MOL ECOL, V4, P527, DOI 10.1111/j.1365-294X.1995.tb00251.x; Tayer OB, 1908, CONDOR, V10, P101; Tinghitella RM, 2011, J EVOLUTION BIOL, V24, P1199, DOI 10.1111/j.1420-9101.2011.02255.x; Tzika AC, 2008, MOL ECOL, V17, P4943, DOI 10.1111/j.1365-294X.2008.03967.x; Weir JT, 2008, MOL ECOL, V17, P2321, DOI 10.1111/j.1365-294X.2008.03742.x; Whittaker R. J., 2007, ISLAND BIOGEOGRAPHY; WILSON AC, 1985, BIOL J LINN SOC, V26, P375, DOI 10.1111/j.1095-8312.1985.tb02048.x	79	22	22	1	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2013	8	5							e63242	10.1371/journal.pone.0063242	http://dx.doi.org/10.1371/journal.pone.0063242			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	143FO	23675466	gold, Green Published, Green Submitted			2022-12-27	WOS:000318852400032
J	Barbadoro, P; Santarelli, L; Croce, N; Bracci, M; Vincitorio, D; Prospero, E; Minelli, A				Barbadoro, Pamela; Santarelli, Lory; Croce, Nicola; Bracci, Massimo; Vincitorio, Daniela; Prospero, Emilia; Minelli, Andrea			Rotating Shift-Work as an Independent Risk Factor for Overweight Italian Workers: A Cross-Sectional Study	PLOS ONE			English	Article							BODY-MASS INDEX; METABOLIC SYNDROME; PHYSICAL-ACTIVITY; WEIGHT-GAIN; CARDIOVASCULAR-DISEASE; OBESITY; HEALTH; IMPACT; CANCER; TIME	Background: A job-related factor is attracting a growing interest as a possible determinant of body weight gain in shift-workers. Objective: The aim of the study was to reinvestigate the issue of overweight between rotating shift workers and daytime workers, taking into consideration possible confounding covariate factors. Methods: This is a cross-sectional study, conducted by reviewing data from subjects participating in an occupational surveillance program in 2008. Participants answered a self-administered questionnaire to retrieve information about sociodemographic factors and working conditions (job schedule type, job-related physical activity, time in job), subjective health status, health care visits during the previous year, and lifestyle factors (dietary habits, leisure time physical activity, alcohol consumption). Participants underwent a medical examination for measurement of BMI, and acquisition of medical history. Results: Compared to daytime workers (N = 229), rotating shift workers (N = 110) displayed higher BMI (mean BMI was 27.6+/-3.9 and 26.7+/-3.6 for shift workers, and daytime workers, respectively; p<0.05). Logistic regression analysis allowed to highlight the role of rotating shift-work as an independent risk factor for increased body weight (OR 1.93, 95% CI 1.01-3.71), being aged between 35 and 54 years was a major determinant of increased BMI (OR 2.39, 95% CI 1.14-5.00). In addition, family history of obesity was the strongest determinant of overweight/obesity (OR 9.79, 95% CI 1.28-74.74). Interestingly, no significant association was found between overweight and other potentially relevant factors, such as diet quality and food choices, alcohol consumption, levels of occupational and leisure-time physical activity. Conclusions: Present findings seem to support the notion that rotating shift work is an independent risk factor for overweight, regardless of workers' dietary habits and physical activity levels.	[Barbadoro, Pamela; Vincitorio, Daniela; Prospero, Emilia] Univ Politecn Marche, Sch Med, Dept Biomed Sci & Publ Hlth, Ancona, Italy; [Santarelli, Lory; Croce, Nicola; Bracci, Massimo] Univ Politecn Marche, Sch Med, Dept Mol & Clin Sci, Ancona, Italy; [Minelli, Andrea] Univ Urbino Carlo Bo, Dept Earth Life & Environm Sci, Urbino, Italy	Marche Polytechnic University; Marche Polytechnic University; University of Urbino	Prospero, E (corresponding author), Univ Politecn Marche, Sch Med, Dept Biomed Sci & Publ Hlth, Ancona, Italy.	e.prospero@univpm.it	Santarelli, Lory/AAU-4494-2020; barbadoro, pamela/AAC-5041-2022; Bracci, Massimo/K-1192-2018	Bracci, Massimo/0000-0003-3901-5376; santarelli, lory/0000-0003-1015-7098; Prospero, Emilia/0000-0002-2387-8639; BARBADORO, Pamela/0000-0003-1495-0165	Universita Politecnica delle Marche	Universita Politecnica delle Marche	Funding provided by Universita Politecnica delle Marche. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antunes LC, 2010, NUTR RES REV, V23, P155, DOI 10.1017/S0954422410000016; Artinian NT, 2004, PUBLIC HEALTH NURS, V21, P425, DOI 10.1111/j.0737-1209.2004.21506.x; Atkinson G, 2007, PHYSIOL BEHAV, V90, P229, DOI 10.1016/j.physbeh.2006.09.015; Barness LA, 2007, AM J MED GENET A, V143A, P3016, DOI 10.1002/ajmg.a.32035; Biggi N, 2008, CHRONOBIOL INT, V25, P443, DOI 10.1080/07420520802114193; Birch LL, 1999, ANNU REV NUTR, V19, P41, DOI 10.1146/annurev.nutr.19.1.41; Chau JY, 2012, PREV MED, V54, P195, DOI 10.1016/j.ypmed.2011.12.020; Contento IR, 2006, J ADOLESCENT HEALTH, V38, P575, DOI 10.1016/j.jadohealth.2005.05.025; Costa G, 2003, OCCUP MED-OXFORD, V53, P83, DOI 10.1093/occmed/kqg045; Costa G, 2010, SCAND J WORK ENV HEA, V36, P163, DOI 10.5271/sjweh.2899; Croce N, 2007, G Ital Med Lav Ergon, V29, P488; de Assis MAA, 2003, J HUM NUTR DIET, V16, P283, DOI 10.1046/j.1365-277X.2003.00448.x; Dina C, 2007, NAT GENET, V39, P724, DOI 10.1038/ng2048; Eurispes istituto di studi politici economici e sociali, 2004, LAV NOTT SCELT NEC R; Fonken LK, 2010, P NATL ACAD SCI USA, V107, P18664, DOI 10.1073/pnas.1008734107; GANS KM, 1993, J NUTR EDUC, V25, P29; Garaulet M, 2010, INT J OBESITY, V34, P1667, DOI 10.1038/ijo.2010.118; Istituto nazionale di Statistica (ISTAT), 2010, VIT QUOT 2009 IND MU; Karlsson B, 2001, OCCUP ENVIRON MED, V58, P747, DOI 10.1136/oem.58.11.747; Karlsson BH, 2003, INT ARCH OCC ENV HEA, V76, P424, DOI 10.1007/s00420-003-0440-y; Kim M., 2000, NUTR CLIN CARE, V3, P163, DOI [10.1046/j.1523-5408.2000.00045.x, DOI 10.1046/J.1523-5408.2000.00045.X]; Knutsson A, 2003, OCCUP MED-OXFORD, V53, P103, DOI 10.1093/occmed/kqg048; Knutsson Anders, 2002, Nutrition and Health (Bicester), V16, P133; Kwak L, 2011, SCAND J WORK ENV HEA, V37, P6, DOI 10.5271/sjweh.3085; Lowden A, 2010, SCAND J WORK ENV HEA, V36, P150, DOI 10.5271/sjweh.2898; Macagnan J, 2012, CHRONOBIOL INT, V29, P336, DOI 10.3109/07420528.2011.653851; Manenschijn L, 2011, J CLIN ENDOCR METAB, V96, pE1862, DOI 10.1210/jc.2011-1551; Morikawa Y, 2007, SCAND J WORK ENV HEA, V33, P45, DOI 10.5271/sjweh.1063; Niedhammer I, 1996, INT J OBESITY, V20, P625; Pan A, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001141; Pereira M A, 1997, Med Sci Sports Exerc, V29, pS1; Puttonen S, 2010, SCAND J WORK ENV HEA, V36, P96, DOI 10.5271/sjweh.2894; Scheer FAJL, 2009, P NATL ACAD SCI USA, V106, P4453, DOI 10.1073/pnas.0808180106; Schousboe K, 2004, INT J OBESITY, V28, P39, DOI 10.1038/sj.ijo.0802524; Sookoian S, 2007, J INTERN MED, V261, P285, DOI 10.1111/j.1365-2796.2007.01766.x; Stevens RG, 2011, OCCUP ENVIRON MED, V68, P154, DOI 10.1136/oem.2009.053512; Sudo N, 2001, INT J FOOD SCI NUTR, V52, P367, DOI 10.1080/09637480120057530; Suter PM, 2005, CRIT REV CL LAB SCI, V42, P197, DOI 10.1080/10408360590913542; Suwazono Y, 2008, OBESITY, V16, P1887, DOI 10.1038/oby.2008.298; Trost SG, 2003, AM J PREV MED, V25, P277, DOI 10.1016/S0749-3797(03)00217-4; van Amelsvoort LGPM, 2004, J OCCUP ENVIRON MED, V46, P699, DOI 10.1097/01.jom.0000131794.83723.45; van Drongelen A, 2011, SCAND J WORK ENV HEA, V37, P263, DOI 10.5271/sjweh.3143; van Duijvenbode DC, 2009, INT J OBESITY, V33, P807, DOI 10.1038/ijo.2009.121; van Uffelen JGZ, 2010, AM J PREV MED, V39, P379, DOI 10.1016/j.amepre.2010.05.024; Wang XS, 2011, OCCUP MED-OXFORD, V61, P78, DOI 10.1093/occmed/kqr001; Wells JCK, 2009, INT J OBESITY, V33, P1331, DOI 10.1038/ijo.2009.175; World Health Organization, 2004, OB PREV MAN GLOB EP; World Health Organization, 2000, NONC DIS MENT HLTH C; Zhao I, 2012, J OCCUP ENVIRON MED, V54, P525, DOI 10.1097/JOM.0b013e31824e1073; Zhao I, 2011, J OCCUP ENVIRON MED, V53, P153, DOI 10.1097/JOM.0b013e318205e1e8	50	48	49	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2013	8	5							e63289	10.1371/journal.pone.0063289	http://dx.doi.org/10.1371/journal.pone.0063289			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	143FO	23675472	Green Submitted, Green Published, gold			2022-12-27	WOS:000318852400034
J	Tartof, S; Cohn, A; Tarbangdo, F; Djingarey, MH; Messonnier, N; Clark, TA; Kambou, JL; Novak, R; Diomande, FVK; Medah, I; Jackson, ML				Tartof, Sara; Cohn, Amanda; Tarbangdo, Felix; Djingarey, Mamoudou H.; Messonnier, Nancy; Clark, Thomas A.; Kambou, Jean Ludovic; Novak, Ryan; Diomande, Fabien V. K.; Medah, Isaie; Jackson, Michael L.			Identifying Optimal Vaccination Strategies for Serogroup A Neisseria meningitidis Conjugate Vaccine in the African Meningitis Belt	PLOS ONE			English	Article							SUB-SAHARAN AFRICA; MENINGOCOCCAL CARRIAGE; UNITED-KINGDOM; ANTIBODY PERSISTENCE; EPIDEMIC MENINGITIS; DISEASE; IMPACT; MODEL; IMMUNOGENICITY; TRANSMISSION	Objective: The optimal long-term vaccination strategies to provide population-level protection against serogroup A Neisseria meningitidis (MenA) are unknown. We developed an age-structured mathematical model of MenA transmission, colonization, and disease in the African meningitis belt, and used this model to explore the impact of various vaccination strategies. Methods: The model stratifies the simulated population into groups based on age, infection status, and MenA antibody levels. We defined the model parameters (such as birth and death rates, age-specific incidence rates, and age-specific duration of protection) using published data and maximum likelihood estimation. We assessed the validity of the model by comparing simulated incidence of invasive MenA and prevalence of MenA carriage to observed incidence and carriage data. Results: The model fit well to observed age-and season-specific prevalence of carriage (mean pseudo-R2 0.84) and incidence of invasive disease (mean R2 0.89). The model is able to reproduce the observed dynamics of MenA epidemics in the African meningitis belt, including seasonal increases in incidence, with large epidemics occurring every eight to twelve years. Following a mass vaccination campaign of all persons 1-29 years of age, the most effective modeled vaccination strategy is to conduct mass vaccination campaigns every 5 years for children 1-5 years of age. Less frequent campaigns covering broader age groups would also be effective, although somewhat less so. Introducing conjugate MenA vaccine into the EPI vaccination schedule at 9 months of age results in higher predicted incidence than periodic mass campaigns. Discussion: We have developed the first mathematical model of MenA in Africa to incorporate age structures and progressively waning protection over time. Our model accurately reproduces key features of MenA epidemiology in the African meningitis belt. This model can help policy makers consider vaccine program effectiveness when determining the feasibility and benefits of MenA vaccination strategies.	[Tartof, Sara; Cohn, Amanda; Messonnier, Nancy; Clark, Thomas A.; Novak, Ryan; Diomande, Fabien V. K.] Ctr Dis Control & Prevent, Meningitis & Vaccine Preventable Dis Branch, Atlanta, GA 30333 USA; [Tarbangdo, Felix; Kambou, Jean Ludovic; Medah, Isaie] Minist Sante, Direct Lutte Malad, Ouagadougou, Burkina Faso; [Djingarey, Mamoudou H.; Diomande, Fabien V. K.] WHO, Intercountry Support Team West Africa, Ouagadougou, Burkina Faso; [Jackson, Michael L.] Grp Hlth Cooperat Puget Sound, Grp Hlth Res Inst, Seattle, WA USA	Centers for Disease Control & Prevention - USA; World Health Organization; Group Health Cooperative	Tartof, S (corresponding author), Ctr Dis Control & Prevent, Meningitis & Vaccine Preventable Dis Branch, Atlanta, GA 30333 USA.	startof@gmail.com		Tartof, Sara/0000-0003-2336-8476	Centers for Disease Control and Prevention [797VE0001]; Modeling Vaccination Strategies for Serogroup A Meningococcal Disease in Africa	Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Modeling Vaccination Strategies for Serogroup A Meningococcal Disease in Africa	This work was funded by the Centers for Disease Control and Prevention under contract #797VE0001, Modeling Vaccination Strategies for Serogroup A Meningococcal Disease in Africa. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON RM, 1985, J HYG-CAMBRIDGE, V94, P365, DOI 10.1017/S002217240006160X; Andrews N, 2003, CLIN DIAGN LAB IMMUN, V10, P780, DOI 10.1128/CDLI.10.5.780-786.2003; Bicaba A, 2009, BMC INT HEALTH HUM R, V9, DOI 10.1186/1472-698X-9-S1-S12; BLAKEBROUGH IS, 1982, J INFECT DIS, V146, P626, DOI 10.1093/infdis/146.5.626; Borrow R, 2010, CLIN VACCINE IMMUNOL, V17, P154, DOI 10.1128/CVI.00384-09; Campagne G, 1999, B WORLD HEALTH ORGAN, V77, P499; Coen PG, 1999, EPIDEMIOL INFECT, V123, P389, DOI 10.1017/S0950268899002952; Djingarey M, 2008, 16 INT PATH NEISS C; Frasch CE, 2009, VACCINE, V27, pB112, DOI 10.1016/j.vaccine.2009.04.065; Goldstein Susan, 2011, Morbidity and Mortality Weekly Report, V60, P1520; GREENWOOD BM, 1985, LANCET, V2, P829, DOI 10.1016/S0140-6736(85)90812-8; Irving TJ, 2011, EPIDEMIOL INFECT, P1; Jackson ML, 2012, EMERG INFECT DIS, V18, P13, DOI 10.3201/eid1801.110336; Jodar L, 2003, LANCET, V361, P1902, DOI 10.1016/S0140-6736(03)13494-0; Kristiansen PA, 2012, CLIN INFECT IN PRESS; Kristiansen PA, 2011, CLIN VACCINE IMMUNOL, V18, P435, DOI 10.1128/CVI.00479-10; Kshirsagar N, 2007, VACCINE, V25, pA101, DOI 10.1016/j.vaccine.2007.04.050; LaForce FM, 2007, VACCINE, V25, pA97, DOI 10.1016/j.vaccine.2007.04.049; LAPEYSSONNIE L, 1963, Bull World Health Organ, V28 Suppl, P1; Maiden MCJ, 2008, J INFECT DIS, V197, P737, DOI 10.1086/527401; Mcveron J, 2008, EPIDEMIOL INFECT, V136, P800, DOI 10.1017/S0950268807009168; Molesworth AM, 2003, EMERG INFECT DIS, V9, P1287; Molesworth AM, 2002, T ROY SOC TROP MED H, V96, P242, DOI 10.1016/S0035-9203(02)90089-1; MOORE PS, 1992, CLIN INFECT DIS, V14, P515, DOI 10.1093/clinids/14.2.515; MOORE PS, 1989, LANCET, V2, P260; Mueller JE, 2010, INT J INFECT DIS, V14, pE553, DOI 10.1016/j.ijid.2009.08.013; Novak RT, 2012, LANCET INFECT DIS; Odusanya OO, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-381; Ouandaogo CR, 2012, VACCINE; Perrett KP, 2010, CLIN INFECT DIS, V50, P1601, DOI 10.1086/652765; Roberts L, 2008, SCIENCE, V320, P1710, DOI 10.1126/science.320.5884.1710; SIDAK Z, 1967, J AM STAT ASSOC, V62, P626, DOI 10.2307/2283989; Snape MD, 2008, BRIT MED J, V336, P1487, DOI 10.1136/bmj.39563.545255.AE; Sow SO, 2011, NEW ENGL J MED, V364, P2293, DOI 10.1056/NEJMoa1003812; Stephens DS, 2007, LANCET, V369, P2196, DOI 10.1016/S0140-6736(07)61016-2; Taha MK, 2002, TRENDS MICROBIOL, V10, P376, DOI 10.1016/S0966-842X(02)02402-2; Teyssou R, 2007, VACCINE, V25, pA3, DOI 10.1016/j.vaccine.2007.04.032; Trotter CL, 2006, EPIDEMIOL INFECT, V134, P556, DOI 10.1017/S0950268805005339; Trotter CL, 2007, LANCET INFECT DIS, V7, P797, DOI 10.1016/S1473-3099(07)70288-8; Trotter CL, 2005, AM J EPIDEMIOL, V162, P89, DOI 10.1093/aje/kwi160; Trotter CL, 2004, LANCET, V364, P365, DOI 10.1016/S0140-6736(04)16725-1; *WHO, 1998, WHOEMCBAC983; World Health Organization, 2011, WHO MEN WEEKL REP; World Health Organization, 2012, WHO MEN WEEKL REP	44	31	31	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2013	8	5							e63605	10.1371/journal.pone.0063605	http://dx.doi.org/10.1371/journal.pone.0063605			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	155HD	23671685	gold, Green Submitted, Green Published			2022-12-27	WOS:000319737700054
J	Leclerc, M; Dore, T; Gilligan, CA; Lucas, P; Filipe, JAN				Leclerc, Melen; Dore, Thierry; Gilligan, Christopher A.; Lucas, Philippe; Filipe, Joao A. N.			Host Growth Can Cause Invasive Spread of Crops by Soilborne Pathogens	PLOS ONE			English	Article							RHIZOCTONIA-SOLANI; BIOLOGICAL-CONTROL; DISEASE EPIDEMICS; ROOT-ROT; DYNAMICS; BEHAVIOR; MODELS; PERSISTENCE; DISPERSAL; PROBABILITY	Invasive soilborne plant pathogens cause substantial damage to crops and natural populations, but our understanding of how to prevent their epidemics or reduce their damage is limited. A key and experimentally-tested concept in the epidemiology of soilborne plant diseases is that of a threshold spacing between hosts below which epidemics (invasive spread) can occur. We extend this paradigm by examining how plant-root growth may alter the conditions for occurrence of soilborne pathogen epidemics in plant populations. We hypothesise that host-root growth can 1) increase the probability of pathogen transmission between neighbouring plants and, consequently, 2) decrease the threshold spacing for epidemics to occur. We predict that, in systems initially below their threshold conditions, root growth can trigger soilborne pathogen epidemics through a switch from non-invasive to invasive behaviour, while in systems above threshold conditions root growth can enhance epidemic development. As an example pathosystem, we studied the fungus Rhizoctonia solani on sugar beet in field experiments. To address hypothesis 1, we recorded infections within inoculum-donor and host-recipient pairs of plants with differing spacing. We translated these observations into the individual-level concept of pathozone, a host-centred form of dispersal kernel. To test hypothesis 2 and our prediction, we used the pathozone to parameterise a stochastic model of pathogen spread in a host population, contrasting scenarios of spread with and without host growth. Our results support our hypotheses and prediction. We suggest that practitioners of agriculture and arboriculture account for root system expansion in order to reduce the risk of soilborne-disease epidemics. We discuss changes in crop design, including increasing plant spacing and using crop mixtures, for boosting crop resilience to invasion and damage by soilborne pathogens. We speculate that the disease-induced root growth observed in some pathosystems could be a pathogen strategy to increase its population through host manipulation.	[Leclerc, Melen; Lucas, Philippe] Univ Rennes 1, Agrocampus Ouest, INRA, Inst Genet Environm & Plant Protect, Le Rheu, France; [Dore, Thierry] AgroParisTech, Agron Grp, Thiverval Grignon, France; [Dore, Thierry] INRA, Agron Grp, F-78850 Thiverval Grignon, France; [Gilligan, Christopher A.; Filipe, Joao A. N.] Univ Cambridge, Dept Plant Sci, Epidemiol & Modelling Grp, Cambridge, England	INRAE; Institut Agro; Agrocampus Ouest; Universite de Rennes; AgroParisTech; UDICE-French Research Universities; Universite Paris Saclay; AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay; University of Cambridge	Leclerc, M (corresponding author), Univ Rennes 1, Agrocampus Ouest, INRA, Inst Genet Environm & Plant Protect, Le Rheu, France.	melenleclerc@gmail.com		Leclerc, Melen/0000-0002-5314-461X; Filipe, Joao/0000-0002-2353-7981	Institut Technique francais de la Betterave industrielle (ITB); UK's Biotechnology and Biological Sciences Research Council (BBSRC)	Institut Technique francais de la Betterave industrielle (ITB); UK's Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	ML thanks the Institut Technique francais de la Betterave industrielle (ITB) for funding this project. CAG and JANF were funded by the UK's Biotechnology and Biological Sciences Research Council (BBSRC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON RM, 1986, PHILOS T ROY SOC B, V314, P533, DOI 10.1098/rstb.1986.0072; Aoyagi T, 1998, PLANT DIS, V82, P857, DOI 10.1094/PDIS.1998.82.8.857; Arnott SA, 2000, P ROY SOC B-BIOL SCI, V267, P657, DOI 10.1098/rspb.2000.1052; Bailey DJ, 2000, NEW PHYTOL, V146, P535, DOI 10.1046/j.1469-8137.2000.00660.x; Bailey DJ, 1997, NEW PHYTOL, V136, P359, DOI 10.1046/j.1469-8137.1997.00774.x; Bailey DJ, 2004, PHYTOPATHOLOGY, V94, P535, DOI 10.1094/PHYTO.2004.94.5.535; Bailey NTJ, 1975, MATH THEORY INFECT D; Bolton MD, 2010, PHYTOPATHOLOGY, V100, P689, DOI 10.1094/PHYTO-100-7-0689; Boswell GP, 2007, B MATH BIOL, V69, P605, DOI 10.1007/s11538-005-9056-6; Brown DH, 2004, B MATH BIOL, V66, P341, DOI 10.1016/j.bulm.2003.08.006; Burdon JJ, 2006, ANNU REV PHYTOPATHOL, V44, P19, DOI 10.1146/annurev.phyto.43.040204.140238; BURDON JJ, 1982, ANNU REV PHYTOPATHOL, V20, P143, DOI 10.1146/annurev.py.20.090182.001043; Cairney JWG, 2005, MYCOL RES, V109, P7, DOI 10.1017/S0953756204001753; Cobb RC, 2012, J ECOL, V100, P712, DOI 10.1111/j.1365-2745.2012.01960.x; Ferrandino FJ, 2008, PHYTOPATHOLOGY, V98, P492, DOI 10.1094/PHYTO-98-5-0492; FERRISS RS, 1981, PHYTOPATHOLOGY, V71, P1229; Filipe JAN, 2004, B MATH BIOL, V66, P373, DOI 10.1016/j.bulm.2003.09.002; Filipe JAN, 2001, B MATH BIOL, V63, P603, DOI 10.1006/bulm.2001.0234; Filipe JAN, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002328; Gibson GJ, 2006, STAT COMPUT, V16, P391, DOI 10.1007/s11222-006-0019-z; Gilligan C. A., 1997, New Phytologist, V136, P343, DOI 10.1046/j.1469-8137.1997.00768.x; GILLIGAN CA, 1985, PHYTOPATHOLOGY, V75, P61, DOI 10.1094/Phyto-75-61; GRASSBERGER P, 1983, MATH BIOSCI, V63, P157, DOI 10.1016/0025-5564(82)90036-0; HORDIJK PL, 1992, NEUROSCI LETT, V136, P193, DOI 10.1016/0304-3940(92)90047-B; Jacobs H, 2004, MYCOL RES, V108, P453, DOI 10.1017/S0953756204009840; Jeger MJ, 2004, ANNU REV PHYTOPATHOL, V42, P61, DOI 10.1146/annurev.phyto.42.040803.140427; JEGER MJ, 1987, NEW PHYTOL, V107, P459, DOI 10.1111/j.1469-8137.1987.tb00197.x; JEGER MJ, 1986, PLANT PATHOL, V35, P355, DOI 10.1111/j.1365-3059.1986.tb02026.x; Kleczkowski A, 1997, P ROY SOC B-BIOL SCI, V264, P979, DOI 10.1098/rspb.1997.0135; Kohl M, 2007, PLANT SOIL, V298, P145, DOI 10.1007/s11104-007-9347-9; Kot M, 1996, ECOLOGY, V77, P2027, DOI 10.2307/2265698; Lannou C, 2012, ANNU REV PHYTOPATHOL, V50, P319, DOI 10.1146/annurev-phyto-081211-173031; Lion S, 2006, P ROY SOC B-BIOL SCI, V273, P1063, DOI 10.1098/rspb.2005.3412; Lunn D, 2009, STAT MED, V28, P3049, DOI 10.1002/sim.3680; Mack RN, 2000, ECOL APPL, V10, P689, DOI 10.1890/1051-0761(2000)010[0689:BICEGC]2.0.CO;2; Madden L. V., 2007, STUDY PLANT DIS EPID; Minogue KP, 1989, SPATIAL COMPONENTS P; Mordecai EA, 2011, ECOL MONOGR, V81, P429, DOI 10.1890/10-2241.1; Motisi N, 2013, PLANT PATHOL, V62, P69, DOI 10.1111/j.1365-3059.2012.02618.x; Motisi N, 2009, FIELD CROP RES, V113, P238, DOI 10.1016/j.fcr.2009.05.011; Mundt CC, 2002, ANNU REV PHYTOPATHOL, V40, P381, DOI 10.1146/annurev.phyto.40.011402.113723; Nandris D, 1996, EUR J FOREST PATHOL, V26, P25; NEWTON AC, 2009, DIS CONTROL CROPS BI, P162; Nilsson O, 1997, PHYSIOL PLANTARUM, V100, P463, DOI [10.1111/j.1399-3054.1997.tb03050.x, 10.1034/j.1399-3054.1997.1000307.x]; OGOSHI A, 1987, ANNU REV PHYTOPATHOL, V25, P125, DOI 10.1146/annurev.py.25.090187.001013; Otten W, 2005, ECOLOGY, V86, P1948, DOI 10.1890/04-1122; Park AW, 2001, OIKOS, V94, P162, DOI 10.1034/j.1600-0706.2001.10489.x; R Core Team, 2018, R LANG ENV STAT COMP; Raaijmakers JM, 2009, PLANT SOIL, V321, P341, DOI 10.1007/s11104-008-9568-6; RITZ K, 1995, FEMS MICROBIOL ECOL, V16, P269, DOI 10.1016/0168-6496(94)00090-J; ROBINSON D, 1994, NEW PHYTOL, V127, P635, DOI 10.1111/j.1469-8137.1994.tb02969.x; Sapoukhina N, 2010, ECOL MODEL, V221, P2793, DOI 10.1016/j.ecolmodel.2010.08.020; Stacey AJ, 2001, NEW PHYTOL, V150, P169, DOI 10.1046/j.1469-8137.2001.00082.x; Thrall PH, 1997, J ECOL, V85, P313, DOI 10.2307/2960504; Wilkinso D.J., 2006, STOCHASTIC MODELLING	56	7	7	0	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2013	8	5							e63003	10.1371/journal.pone.0063003	http://dx.doi.org/10.1371/journal.pone.0063003			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145YI	23667560	Green Published, Green Submitted, gold			2022-12-27	WOS:000319055600050
J	van Knippenberg, I; Fragkoudis, R; Elliott, RM				van Knippenberg, Ingeborg; Fragkoudis, Rennos; Elliott, Richard M.			The Transient Nature of Bunyamwera Orthobunyavirus NSs Protein Expression: Effects of Increased Stability of NSs Protein on Virus Replication	PLOS ONE			English	Article							INTERFERON REGULATORY FACTOR-3; UBIQUITIN-PROTEASOME SYSTEM; CULTURED-CELLS; MOSQUITO CELLS; INHIBITION; INDUCTION; PRODUCT; STAT2; PHOSPHORYLATION; PARAMYXOVIRUSES	The NSs proteins of bunyaviruses are the viral interferon antagonists, counteracting the host's antiviral response to infection. During high-multiplicity infection of cultured mammalian cells with Bunyamwera orthobunyavirus (BUNV), NSs is rapidly degraded after reaching peak levels of expression at 12hpi. Through the use of inhibitors this was shown to be the result of proteasomal degradation. A recombinant virus (rBUN4KR), in which all four lysine residues in NSs were replaced by arginine residues, expresses an NSs protein (NSs4KR) that is resistant to degradation, confirming that degradation is lysine-dependent. However, despite repeated attempts, no direct ubiquitylation of NSs in infected cells could be demonstrated. This suggests that degradation of NSs, although lysine-dependent, may be achieved through an indirect mechanism. Infection of cultured mammalian cells or mice indicated no disadvantage for the virus in having a non-degradable NSs protein: in fact rBUN4KR had a slight growth advantage over wtBUNV in interferon-competent cells, presumably due to the increased and prolonged presence of NSs. In cultured mosquito cells there was no difference in growth between wild-type BUNV and rBUN4KR, but surprisingly NSs4KR was not stabilised compared to the wild-type NSs protein.	[van Knippenberg, Ingeborg; Elliott, Richard M.] Univ St Andrews, Biomed Sci Res Ctr, St Andrews, Fife, Scotland; [Fragkoudis, Rennos] Univ Edinburgh, Roslin Inst, Edinburgh, Midlothian, Scotland; [Fragkoudis, Rennos] Univ Edinburgh, Ctr Infect Dis, Edinburgh, Midlothian, Scotland	University of St Andrews; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh; University of Edinburgh	Elliott, RM (corresponding author), Univ Glasgow, MRC, Ctr Virus Res, Glasgow, Lanark, Scotland.	richard.elliott@glasgow.ac.uk			Wellcome Trust [079810, 099220]; BBSRC [BBS/E/I/00001735, BBS/E/I/00001699] Funding Source: UKRI; MRC [G0801822] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/I/00001699, BBS/E/I/00001735] Funding Source: researchfish; Medical Research Council [G0801822] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was funded by the Wellcome Trust (Programme Grant 079810 and Senior Investigator Award 099220 to RME). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bridgen A, 1996, P NATL ACAD SCI USA, V93, P15400, DOI 10.1073/pnas.93.26.15400; Bridgen A, 2001, P NATL ACAD SCI USA, V98, P664, DOI 10.1073/pnas.98.2.664; Brower CS, 2002, P NATL ACAD SCI USA, V99, P10353, DOI 10.1073/pnas.162424199; Buchholz UJ, 1999, J VIROL, V73, P251, DOI 10.1128/JVI.73.1.251-259.1999; Chen YI, 2008, J VIROL METHODS, V151, P95, DOI 10.1016/j.jviromet.2008.03.016; Colon-Ramos DA, 2003, MOL BIOL CELL, V14, P4162, DOI 10.1091/mbc.E03-03-0139; Contin R, 2011, J VIROL, V85, P2781, DOI 10.1128/JVI.01631-10; Coux O, 1996, ANNU REV BIOCHEM, V65, P801, DOI 10.1146/annurev.bi.65.070196.004101; Delboy MG, 2008, J VIROL, V82, P3381, DOI 10.1128/JVI.02296-07; Elliott J, 2007, J VIROL, V81, P3428, DOI 10.1128/JVI.02303-06; Elliott RM, 2009, VIRUSES-BASEL, V1, P1003, DOI 10.3390/v1031003; Elliott RM, 2011, MOL BIOL ORTHOBUNYAV; Fernandez-Garcia MD, 2011, J VIROL, V85, P2980, DOI 10.1128/JVI.02483-10; Fragkoudis R, 2007, J GEN VIROL, V88, P3373, DOI 10.1099/vir.0.83191-0; Garigliany MM, 2012, ANTIVIR RES, V95, P82, DOI 10.1016/j.antiviral.2012.05.014; Hale BG, 2009, VIROLOGY, V383, P6, DOI 10.1016/j.virol.2008.10.002; Hart TJ, 2009, ZOONOSES PUBLIC HLTH, V56, P285, DOI 10.1111/j.1863-2378.2008.01166.x; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hilton L, 2006, J VIROL, V80, P11723, DOI 10.1128/JVI.01145-06; Kerscher O, 2006, ANNU REV CELL DEV BI, V22, P159, DOI 10.1146/annurev.cellbio.22.010605.093503; Khor R, 2003, TRAFFIC, V4, P857, DOI 10.1046/j.1398-9219.2003.0140.x; Killip MJ, 2012, J GEN VIROL, V93, P299, DOI 10.1099/vir.0.037531-0; Kohl A, 2003, J VIROL, V77, P7999, DOI 10.1128/JVI.77.14.7999-8008.2003; Leonard VHJ, 2006, J VIROL, V80, P9667, DOI 10.1128/JVI.00822-06; Liu J, 2007, VIRUS GENES, V35, P719, DOI 10.1007/s11262-007-0147-3; Lopez T, 2011, J VIROL, V85, P11964, DOI 10.1128/JVI.05286-11; Lowen AC, 2005, J VIROL, V79, P6940, DOI 10.1128/JVI.79.11.6940-6946.2005; Lowen AC, 2004, VIROLOGY, V330, P493, DOI 10.1016/j.virol.2004.10.009; Lupfer C, 2010, VIRUS RES, V149, P36, DOI 10.1016/j.virusres.2009.12.010; Neznanov N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001887; Nichol ST, 2001, CH49 BUN; Ohh M, 2002, EMBO REP, V3, P177, DOI 10.1093/embo-reports/kvf028; PATEL AH, 1992, J GEN VIROL, V73, P389, DOI 10.1099/0022-1317-73-2-389; Precious B, 2005, J VIROL, V79, P13434, DOI 10.1128/JVI.79.21.13434-13441.2005; Precious B, 2005, J GEN VIROL, V86, P151, DOI 10.1099/vir.0.80263-0; Raaben M, 2010, J VIROL, V84, P7869, DOI 10.1128/JVI.00485-10; SCALLAN MF, 1992, J GEN VIROL, V73, P53, DOI 10.1099/0022-1317-73-1-53; Seago J, 2010, J GEN VIROL, V91, P721, DOI 10.1099/vir.0.015545-0; Soucy TA, 2009, NATURE, V458, P732, DOI 10.1038/nature07884; Szemiel AM, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001823; Teale A, 2009, J VIROL, V83, P2099, DOI 10.1128/JVI.01753-08; Thomas D, 2004, J BIOL CHEM, V279, P31471, DOI 10.1074/jbc.M400938200; van Knippenberg I, 2010, J GEN VIROL, V91, P2002, DOI 10.1099/vir.0.021774-0; Wang HB, 2010, NAT GENET, V42, P83, DOI 10.1038/ng.498; Weber F, 2002, J VIROL, V76, P7949, DOI 10.1128/JVI.76.16.7949-7955.2002; Weber F, 2001, VIROLOGY, V281, P67, DOI 10.1006/viro.2000.0774; Yang YL, 2007, CANCER RES, V67, P9472, DOI 10.1158/0008-5472.CAN-07-0568; Young JA, 2011, J BIOL CHEM, V286, P6521, DOI 10.1074/jbc.M110.172288; Zhadina M, 2007, P NATL ACAD SCI USA, V104, P20031, DOI 10.1073/pnas.0708002104	49	8	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2013	8	5							e64137	10.1371/journal.pone.0064137	http://dx.doi.org/10.1371/journal.pone.0064137			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145YI	23667701	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000319055600086
J	Monson, BB; Han, S; Purves, D				Monson, Brian B.; Han, Shui'Er; Purves, Dale			Are Auditory Percepts Determined by Experience?	PLOS ONE			English	Article							BASILAR-MEMBRANE; LOUDNESS; PITCH; STATISTICS; FREQUENCY; INTENSITY; RESPONSES; SPEECH; TONES; SOUND	Audition-what listeners hear-is generally studied in terms of the physical properties of sound stimuli and physiological properties of the auditory system. Based on recent work in vision, we here consider an alternative perspective that sensory percepts are based on past experience. In this framework, basic auditory qualities (e.g., loudness and pitch) are based on the frequency of occurrence of stimulus patterns in natural acoustic stimuli. To explore this concept of audition, we examined five well-documented psychophysical functions. The frequency of occurrence of acoustic patterns in a database of natural sound stimuli (speech) predicts some qualitative aspects of these functions, but with substantial quantitative discrepancies. This approach may offer a rationale for auditory phenomena that are difficult to explain in terms of the physical attributes of the stimuli as such.	[Monson, Brian B.; Han, Shui'Er; Purves, Dale] Duke NUS Grad Med Sch, Neurosci & Behav Disorders Program, Singapore, Singapore; [Purves, Dale] Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA; [Purves, Dale] Duke Univ, Ctr Cognit Neurosci, Durham, NC USA	National University of Singapore; Duke University; Duke University	Monson, BB (corresponding author), Duke NUS Grad Med Sch, Neurosci & Behav Disorders Program, Singapore, Singapore.	brian.monson@duke-nus.edu.sg		Monson, Brian/0000-0002-0179-8179	NSF [0924181]; Duke-NUS Block Grant	NSF(National Science Foundation (NSF)); Duke-NUS Block Grant	This work was funded in part by NSF Award 0924181 and part of the study was funded by a Duke-NUS Block Grant awarded to author DP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2003, AC NORM EQ LOUDN LEV; ANSI, 2007, PROC COMP LOUDN STEA; Attias H, 1997, ADV NEUR IN, V9, P27; BECK J, 1961, AM J PSYCHOL, V74, P242, DOI 10.2307/1419409; BELL AJ, 1995, NEURAL COMPUT, V7, P1129, DOI 10.1162/neco.1995.7.6.1129; Boersma P., 1993, IFA P, V17, P97; Buus S, 1998, J ACOUST SOC AM, V104, P399, DOI 10.1121/1.423295; COHEN A, 1961, J ACOUST SOC AM, V33, P1363, DOI 10.1121/1.1908441; Cousineau M, 2010, J ACOUST SOC AM, V128, pEL236, DOI 10.1121/1.3499701; Fletcher H, 1934, J ACOUST SOC AM, V6, P59, DOI 10.1121/1.1915704; Fletcher H, 1933, J ACOUST SOC AM, V5, P82, DOI 10.1121/1.1915637; FLETCHER H, 1950, J ACOUST SOC AM, V22, P89, DOI 10.1121/1.1906605; Geisler WS, 2002, NAT NEUROSCI, V5, P508, DOI 10.1038/nn0602-508; Helmholtz Hv, 1924, HELMHOLTZS TREATISE; Houtsma AJM, 1995, PITCH PERCEPTION, P267; Jesteadt W, 2011, SPRINGER HANDB AUDIT, V37, P109, DOI 10.1007/978-1-4419-6712-1_5; Koohler W, 1947, GESTALT PSYCHOL INTR, V5, P3; LADEFOGED P, 1957, J ACOUST SOC AM, V29, P98, DOI 10.1121/1.1908694; LAUGHLIN S, 1981, Z NATURFORSCH C, V36, P910; Lewicki MS, 2002, NAT NEUROSCI, V5, P356, DOI 10.1038/nn831; Lotto AJ, 2006, PERCEPT PSYCHOPHYS, V68, P178, DOI 10.3758/BF03193667; Lythgoe JN, 1979, ECOLOGY VISION, Vxii; McDermott JH, 2011, NEURON, V71, P926, DOI 10.1016/j.neuron.2011.06.032; Miskiewicz A, 2012, J ACOUST SOC AM, V131, P987, DOI 10.1121/1.3651094; Monson BB, 2012, J ACOUST SOC AM, V132, P1754, DOI 10.1121/1.4742724; Moore BC, 2012, INTRO PSYCHOL HEARIN; Moore BCJ, 1997, J AUDIO ENG SOC, V45, P224; Moore BCJ, 2003, OTOL NEUROTOL, V24, P243, DOI 10.1097/00129492-200303000-00019; Moore BCJ, 2002, HEARING RES, V163, P101, DOI 10.1016/S0378-5955(01)00390-2; MORGAN CT, 1951, J ACOUST SOC AM, V23, P658, DOI 10.1121/1.1906817; Plack CJ, 2005, SPR HDB AUD, V24, P7; POLLACK I, 1952, J ACOUST SOC AM, V24, P323, DOI 10.1121/1.1906900; Purves D, 2011, P NATL ACAD SCI USA, V108, P15588, DOI 10.1073/pnas.1012178108; Purves D, 2011, WHY WE SEE WHAT WE DO REDUX: A WHOLLY EMPIRICAL THEORY OF VISION, P1; Relkin EM, 1997, J ACOUST SOC AM, V101, P2735, DOI 10.1121/1.418561; Ruggero M A, 1992, Curr Opin Neurobiol, V2, P449, DOI 10.1016/0959-4388(92)90179-O; Ruggero MA, 1997, J ACOUST SOC AM, V101, P2151, DOI 10.1121/1.418265; Russell IJ, 1997, P NATL ACAD SCI USA, V94, P2660, DOI 10.1073/pnas.94.6.2660; Schwartz DA, 2004, HEARING RES, V194, P31, DOI 10.1016/j.heares.2004.01.019; Smith EC, 2006, NATURE, V439, P978, DOI 10.1038/nature04485; Stevens SS, 1941, AM J PSYCHOL, V53, P329; Stevens SS, 1936, PSYCHOL REV, V43, P405, DOI 10.1037/h0058773; Stevens SS, 1935, J ACOUST SOC AM, V6, P150, DOI 10.1121/1.1915715; STEVENS SS, 1970, SCIENCE, V170, P1043, DOI 10.1126/science.170.3962.1043; Suzuki Y, 2004, J ACOUST SOC AM, V116, P918, DOI 10.1121/1.1763601; WARREN RM, 1974, COGNITIVE PSYCHOL, V6, P237, DOI 10.1016/0010-0285(74)90012-7; WEHNER R, 1987, J COMP PHYSIOL A, V161, P511, DOI 10.1007/BF00603659; ZENG FG, 1994, SCIENCE, V264, P564, DOI 10.1126/science.8160013; ZWICKER E, 1965, PSYCHOL REV, V72, P3, DOI 10.1037/h0021703	49	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e63728	10.1371/journal.pone.0063728	http://dx.doi.org/10.1371/journal.pone.0063728			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667666	gold, Green Published, Green Submitted			2022-12-27	WOS:000319654700182
J	Smith, TC; Gebreyes, WA; Abley, MJ; Harper, AL; Forshey, BM; Male, MJ; Martin, HW; Molla, BZ; Sreevatsan, S; Thakur, S; Thiruvengadam, M; Davies, PR				Smith, Tara C.; Gebreyes, Wondwossen A.; Abley, Melanie J.; Harper, Abby L.; Forshey, Brett M.; Male, Michael J.; Martin, H. Wayne; Molla, Bayleyegn Z.; Sreevatsan, Srinand; Thakur, Siddhartha; Thiruvengadam, Madhumathi; Davies, Peter R.			Methicillin-Resistant Staphylococcus aureus in Pigs and Farm Workers on Conventional and Antibiotic-Free Swine Farms in the USA	PLOS ONE			English	Article							BLOOD-STREAM INFECTIONS; HIGH PREVALENCE; NASAL CARRIAGE; ST398; MRSA; COLONIZATION; EPIDEMIOLOGY; TRANSMISSION; PNEUMONIA; EMERGENCE	Much uncertainty remains about the origin and public health implications of livestock-associated methicillin-resistant Staphylococcus aureus (LA-MRSA). This study aimed to investigate the occurrence and prevalence of MRSA in general and LA-MRSA in particular in pigs and farm workers in five states. We collected nasal swabs from pigs and farm workers at 45 swine herds (21 antibiotic-free herds; 24 conventional herds) in Illinois, Iowa, Minnesota, North Carolina and Ohio. MRSA was isolated from 50 of 1085 pigs (4.6%) and 31 of 148 (20.9%) of farm workers. MRSA-positive pigs and people were clustered in four conventional swine farms in Iowa and Illinois. Based on genotyping, spa type t034, a common livestock associated variant, was predominant among both human and swine isolates. These results confirm the presence of LA-MRSA in pigs and swine farm workers in the USA, but the prevalence found is relatively low compared with European studies.	[Smith, Tara C.; Harper, Abby L.; Forshey, Brett M.; Male, Michael J.] Univ Iowa, Coll Publ Hlth, Dept Epidemiol, Ctr Emerging Infect Dis, Iowa City, IA 52242 USA; [Gebreyes, Wondwossen A.; Abley, Melanie J.; Molla, Bayleyegn Z.] Ohio State Univ, Dept Vet Prevent Med, Columbus, OH 43210 USA; [Martin, H. Wayne; Sreevatsan, Srinand; Thiruvengadam, Madhumathi; Davies, Peter R.] Univ Minnesota, Coll Vet Med, Dept Vet Populat Med, St Paul, MN 55108 USA; [Thakur, Siddhartha] N Carolina State Univ, Coll Vet Med, Dept Populat Hlth & Pathobiol, Raleigh, NC USA	University of Iowa; University System of Ohio; Ohio State University; University of Minnesota System; University of Minnesota Twin Cities; University of North Carolina; North Carolina State University	Smith, TC (corresponding author), Univ Iowa, Coll Publ Hlth, Dept Epidemiol, Ctr Emerging Infect Dis, Iowa City, IA 52242 USA.	tara-smith@uiowa.edu	Sreevatsan, Srinand/V-6808-2019	Sreevatsan, Srinand/0000-0002-5162-2403; Smith, Tara C./0000-0003-3747-1116; Thakur, Siddhartha/0000-0003-3787-9939	National Pork Board [08-178, 08-179, 08-180]	National Pork Board	Funded under grants 08-178, 08-179, and 08-180 from the National Pork Board (http://www.pork.org/Home.aspx#.UBgPJ7pCN8E). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarestrup FM, 2010, VET MICROBIOL, V142, P455, DOI 10.1016/j.vetmic.2009.10.021; Cavaco LM, 2010, ANTIMICROB AGENTS CH, V54, P3605, DOI 10.1128/AAC.00058-10; Cavaco LM, 2011, VET MICROBIOL, V150, P344, DOI 10.1016/j.vetmic.2011.02.014; Cosgrove SE, 2003, CLIN INFECT DIS, V36, P53, DOI 10.1086/345476; Cuny C, 2010, INT J MED MICROBIOL, V300, P109, DOI 10.1016/j.ijmm.2009.11.002; David MZ, 2010, CLIN MICROBIOL REV, V23, P616, DOI 10.1128/CMR.00081-09; Davies PR, 2011, EMERG INFECT DIS, V17, P1152, DOI [10.3201/eid/1706.101394, 10.3201/eid1706.101394]; de Neeling AJ, 2007, VET MICROBIOL, V122, P366, DOI 10.1016/j.vetmic.2007.01.027; Ekkelenkamp M B, 2006, Ned Tijdschr Geneeskd, V150, P2442; European Food Safety Authority (EFSA), 2009, EFSA J, V993, P1, DOI [10.2903/j.efsa.2009.993, DOI 10.2903/J.EFSA.2009.993]; Gibbs SG, 2006, ENVIRON HEALTH PERSP, V114, P1032, DOI 10.1289/ehp.8910; Graham PL, 2006, ANN INTERN MED, V144, P318, DOI 10.7326/0003-4819-144-5-200603070-00006; Graveland H, 2011, INT J MED MICROBIOL, V301, P630, DOI 10.1016/j.ijmm.2011.09.004; Graveland H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016830; Hartmeyer GN, 2010, SCAND J INFECT DIS, V42, P318, DOI 10.3109/00365540903510708; HUIJSDENS XW, 2009, EURO SURVEILL, V14; Khanna T, 2008, VET MICROBIOL, V128, P298, DOI 10.1016/j.vetmic.2007.10.006; Kluytmans J, 1997, CLIN MICROBIOL REV, V10, P505, DOI 10.1128/CMR.10.3.505; Koreen L, 2004, J CLIN MICROBIOL, V42, P792, DOI 10.1128/JCM.42.2.792-799.2004; Laupland KB, 2008, J INFECT DIS, V198, P336, DOI 10.1086/589717; Mammina C, 2010, SCAND J INFECT DIS, V42, P955, DOI 10.3109/00365548.2010.524662; Price LB, 2012, MBIO, V3, DOI 10.1128/mBio.00305-11; Shopsin B, 1999, J CLIN MICROBIOL, V37, P3556, DOI 10.1128/JCM.37.11.3556-3563.1999; Smith TC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004258; Stefani S, 2010, INT J INFECT DIS, V14, pS19, DOI 10.1016/j.ijid.2010.05.009; van Cleef BAGL, 2010, EPIDEMIOL INFECT, V138, P756, DOI 10.1017/S0950268810000245; van Cleef BAGL, 2011, EMERG INFECT DIS, V17, P502, DOI 10.3201/eid1703.101036; van Cleef BAGL, 2011, J CLIN MICROBIOL, V49, P1030, DOI 10.1128/JCM.00493-10; van der Mee-Marquet N, 2011, CLIN INFECT DIS, V52, P152, DOI 10.1093/cid/ciq053; van Duijkeren E, 2008, VET MICROBIOL, V126, P383, DOI 10.1016/j.vetmic.2007.07.021; Vandendriessche S, 2011, J ANTIMICROB CHEMOTH, V66, P2455, DOI 10.1093/jac/dkr348; Voss A, 2005, EMERG INFECT DIS, V11, P1965, DOI 10.3201/eid1112.050428; Weese JS, 2011, ZOONOSES PUBLIC HLTH, V58, P238, DOI 10.1111/j.1863-2378.2010.01340.x; Weese JS, 2010, ILAR J, V51, P233, DOI 10.1093/ilar.51.3.233; Wertheim HFL, 2005, LANCET INFECT DIS, V5, P751, DOI 10.1016/S1473-3099(05)70295-4; Wulf MWH, 2008, CLIN MICROBIOL INFEC, V14, P29, DOI 10.1111/j.1469-0691.2007.01873.x; Wulf MWH, 2012, EUR J CLIN MICROBIOL, V31, P61, DOI 10.1007/s10096-011-1269-z	37	89	93	2	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e63704	10.1371/journal.pone.0063704	http://dx.doi.org/10.1371/journal.pone.0063704			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667659	Green Published, gold, Green Submitted			2022-12-27	WOS:000319654700177
J	Turdi, S; Hu, N; Ren, J				Turdi, Subat; Hu, Nan; Ren, Jun			Tauroursodeoxycholic Acid Mitigates High Fat Diet-Induced Cardiomyocyte Contractile and Intracellular Ca2+ Anomalies	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; ACTIVATED PROTEIN-KINASE; ER STRESS; URSODEOXYCHOLIC ACID; ISCHEMIA/REPERFUSION INJURY; CARDIOVASCULAR-DISEASE; CHEMICAL CHAPERONES; INSULIN-RESISTANCE; ADIPOSE-TISSUE; IN-VIVO	Objectives: The endoplasmic reticulum (ER) chaperone tauroursodeoxycholic acid (TUDCA) has exhibited promises in the treatment of obesity, although its impact on obesity-induced cardiac dysfunction is unknown. This study examined the effect of TUDCA on cardiomyocyte function in high-fat diet-induced obesity. Methods: Adult mice were fed low or high fat diet for 5 months prior to treatment of TUDCA (300 mg/kg. i.p., for 15d). Intraperitoneal glucose tolerance test (IPGTT), cardiomyocyte mechanical and intracellular Ca2+ property, insulin signaling molecules including IRS-1, Akt, AMPK, ACC, GSK-3 beta, c-Jun, ERK and c-Jun N terminal kinase (JNK) as well as ER stress and intracellular Ca2+ regulatory proteins were examined. Myocardial ultrastructure was evaluated using transmission electron microscopy (TEM). Results: High-fat diet depressed peak shortening (PS) and maximal velocity of shortening/relengthenin as well as prolonged relengthening duration. TUDCA reversed or overtly ameliorated high fat diet-induced cardiomyocyte dysfunction including prolongation in relengthening. TUDCA alleviated high-fat diet-induced decrease in SERCA2a and phosphorylation of phospholamban, increase in ER stress (GRP78/BiP, CHOP, phosphorylation of PERK, IRE1 alpha and eIF2 alpha), ultrastructural changes and mitochondrial permeation pore opening. High-fat diet feeding inhibited phosphorylation of AMPK and promoted phosphorylation of GSK-3 beta. TUDCA prevented high fat-induced dephosphorylation of AMPK but not GSK-3 beta. High fat diet promoted phosphorylation of IRS-1 (Ser(307)), JNK, and ERK without affecting c-Jun phosphorylation, the effect of which with the exception of ERK phosphorylation was attenuated by TUDCA. Conclusions: These data depict that TUDCA may ameliorate high fat diet feeding-induced cardiomyocyte contractile and intracellular Ca2+ defects through mechanisms associated with mitochondrial integrity, AMPK, JNK and IRS-1 serine phosphorylation.	[Turdi, Subat; Hu, Nan; Ren, Jun] Univ Wyoming, Coll Hlth Sci, Div Pharmaceut Sci, Ctr Cardiovasc Res & Alternat Med, Laramie, WY 82071 USA	University of Wyoming	Ren, J (corresponding author), Univ Wyoming, Coll Hlth Sci, Div Pharmaceut Sci, Ctr Cardiovasc Res & Alternat Med, Laramie, WY 82071 USA.	jren@uwyo.edu	Ren, Jun/ACG-5366-2022	Ren, Jun/0000-0002-0275-0783	American Diabetes Association [7-08-RA-130]; National Institutes of Health (NIH)/National Center for Research Resource (NCRR) [P20 RR016474]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016474] Funding Source: NIH RePORTER	American Diabetes Association(American Diabetes Association); National Institutes of Health (NIH)/National Center for Research Resource (NCRR); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by American Diabetes Association 7-08-RA-130 and National Institutes of Health (NIH)/National Center for Research Resource (NCRR) P20 RR016474. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azfer A, 2006, AM J PHYSIOL-HEART C, V291, pH1411, DOI 10.1152/ajpheart.01378.2005; Boden G, 2008, DIABETES, V57, P2438, DOI 10.2337/db08-0604; Cardozo AK, 2005, DIABETES, V54, P452, DOI 10.2337/diabetes.54.2.452; Centers for Disease Control and Prevention, 2011, NAT DIAB FACT SHEET; Ceylan-Isik AF, 2011, J MOL CELL CARDIOL, V50, P107, DOI 10.1016/j.yjmcc.2010.10.023; Ceylan-Isik AF, 2010, J MOL CELL CARDIOL, V48, P367, DOI 10.1016/j.yjmcc.2009.11.003; Chen Y, 2008, AM J NEPHROL, V28, P1014, DOI 10.1159/000148209; Dong F, 2007, DIABETES, V56, P2201, DOI 10.2337/db06-1596; Dong F, 2009, OBESITY, V17, P262, DOI 10.1038/oby.2008.545; Dong YZ, 2010, DIABETES, V59, P1386, DOI 10.2337/db09-1637; Eizirik DL, 2008, ENDOCR REV, V29, P42, DOI 10.1210/er.2007-0015; Eldar-Finkelman H, 1999, DIABETES, V48, P1662, DOI 10.2337/diabetes.48.8.1662; Engin F, 2010, DIABETES OBES METAB, V12, P108, DOI 10.1111/j.1463-1326.2010.01282.x; Fang YW, 2007, MOL PHARMACOL, V71, P1122, DOI 10.1124/mol.106.032060; Fu HY, 2008, CARDIOVASC RES, V79, P600, DOI 10.1093/cvr/cvn128; Groenendyk J, 2010, CIRC RES, V107, P1185, DOI 10.1161/CIRCRESAHA.110.227033; Guo R, 2009, J MOL CELL CARDIOL, V47, P228, DOI 10.1016/j.yjmcc.2009.03.018; Hardie DG, 2004, J CLIN INVEST, V114, P465, DOI 10.1172/JCI200422683; Hintz KK, 2003, INT J OBESITY, V27, P1196, DOI 10.1038/sj.ijo.0802389; Hwang JH, 2009, DIABETES, V58, P965, DOI 10.2337/db08-1183; Ikegami T, 2008, HEPATOL RES, V38, P123, DOI 10.1111/j.1872-034X.2007.00297.x; Kars M, 2010, DIABETES, V59, P1899, DOI 10.2337/db10-0308; Kim DS, 2007, BIOCHEM BIOPH RES CO, V363, P140, DOI 10.1016/j.bbrc.2007.08.151; Liu XH, 2008, SHOCK, V30, P422, DOI 10.1097/SHK.0b013e318164ca29; Martindale JJ, 2006, CIRC RES, V98, P1186, DOI 10.1161/01.RES.0000220643.65941.8d; Miki T, 2009, DIABETES, V58, P2863, DOI 10.2337/db09-0158; Minamino T, 2010, J MOL CELL CARDIOL, V48, P1105, DOI 10.1016/j.yjmcc.2009.10.026; Nickson P, 2007, CARDIOVASC RES, V73, P48, DOI 10.1016/j.cardiores.2006.10.001; Ozcan U, 2006, SCIENCE, V313, P1137, DOI 10.1126/science.1128294; Oka S, 2011, CELL METAB, V14, P598, DOI 10.1016/j.cmet.2011.10.001; Okada K, 2004, CIRCULATION, V110, P705, DOI 10.1161/01.CIR.0000137836.95625.D4; Ouwens DM, 2007, DIABETOLOGIA, V50, P1938, DOI 10.1007/s00125-007-0735-8; Ozcan U, 2004, SCIENCE, V306, P457, DOI 10.1126/science.1103160; Ren J, 2009, OBESITY, V17, P1114, DOI 10.1038/oby.2009.8; Sohn J, 2003, CANCER LETT, V191, P83, DOI 10.1016/S0304-3835(02)00624-9; SULLIVAN PW, 2008, OBESITY SILVER SPRIN; Sussman MA, 2011, PHYSIOL REV, V91, P1023, DOI 10.1152/physrev.00024.2010; Szegezdi E, 2006, BIOCHEM BIOPH RES CO, V349, P1406, DOI 10.1016/j.bbrc.2006.09.009; Terai K, 2005, MOL CELL BIOL, V25, P9554, DOI 10.1128/MCB.25.21.9554-9575.2005; Toth Ambrus, 2007, Cardiovascular & Hematological Disorders - Drug Targets, V7, P205, DOI 10.2174/187152907781745260; Turdi S, 2011, J MOL CELL CARDIOL, V50, P712, DOI 10.1016/j.yjmcc.2010.12.007; Wilson CR, 2007, BIOCHEM J, V406, P457, DOI 10.1042/BJ20070392; Xu CY, 2005, J CLIN INVEST, V115, P2656, DOI 10.1172/JCI26373; Yie Q, 2002, HEPATOLOGY, V36, P592, DOI 10.1053/jhep.2002.35441; Yoshida H, 2007, FEBS J, V274, P630, DOI 10.1111/j.1742-4658.2007.05639.x; Zalesin KC, 2008, ENDOCRIN METAB CLIN, V37, P663, DOI 10.1016/j.ecl.2008.06.004; Zhu JA, 2011, AM J PHYSIOL-HEART C, V300, pH922, DOI 10.1152/ajpheart.00860.2010	47	26	26	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e63615	10.1371/journal.pone.0063615	http://dx.doi.org/10.1371/journal.pone.0063615			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667647	Green Published, gold, Green Submitted			2022-12-27	WOS:000319654700168
J	Neto, JOB; Gesser, RL; Steglich, V; Ferreira, APB; Gandhi, M; Vissoci, JRN; Pietrobon, R				Bruggemann Neto, Jose Osni; Gesser, Rafael Lehmkuhl; Steglich, Valdir; Bonilauri Ferreira, Ana Paula; Gandhi, Mihir; Nickenig Vissoci, Joao Ricardo; Pietrobon, Ricardo			Validation of the Simple Shoulder Test in a Portuguese-Brazilian Population. Is the Latent Variable Structure and Validation of the Simple Shoulder Test Stable across Cultures?	PLOS ONE			English	Article							DISABILITY INDEX; PAIN; RESPONSIVENESS; RELIABILITY; SCALES; ADAPTATION; CALIFORNIA; UNIVERSITY; VERSION; SINGLE	Background: The validation of widely used scales facilitates the comparison across international patient samples. The objective of this study was to translate, culturally adapt and validate the Simple Shoulder Test into Brazilian Portuguese. Also we test the stability of factor analysis across different cultures. Objective: The objective of this study was to translate, culturally adapt and validate the Simple Shoulder Test into Brazilian Portuguese. Also we test the stability of factor analysis across different cultures. Methods: The Simple Shoulder Test was translated from English into Brazilian Portuguese, translated back into English, and evaluated for accuracy by an expert committee. It was then administered to 100 patients with shoulder conditions. Psychometric properties were analyzed including factor analysis, internal reliability, test-retest reliability at seven days, and construct validity in relation to the Short Form 36 health survey (SF-36). Results: Factor analysis demonstrated a three factor solution. Cronbach's alpha was 0.82. Test-retest reliability index as measured by intra-class correlation coefficient (ICC) was 0.84. Associations were observed in the hypothesized direction with all subscales of SF-36 questionnaire. Conclusion: The Simple Shoulder Test translation and cultural adaptation to Brazilian-Portuguese demonstrated adequate factor structure, internal reliability, and validity, ultimately allowing for its use in the comparison with international patient samples.	[Bruggemann Neto, Jose Osni; Gesser, Rafael Lehmkuhl; Steglich, Valdir] Orthoped & Traumatol Inst IOT, Joinville, SC, Brazil; [Steglich, Valdir; Bonilauri Ferreira, Ana Paula] Univ Joinville Reg UNIVILLE, Dept Dent, Joinville, SC, Brazil; [Bonilauri Ferreira, Ana Paula; Gandhi, Mihir; Nickenig Vissoci, Joao Ricardo; Pietrobon, Ricardo] Duke Univ Hlth Syst, Res Res Grp, Durham, NC 27710 USA; [Gandhi, Mihir] Duke NUS Grad Med Sch, Singapore, Singapore; [Gandhi, Mihir] Singapore Clin Res Inst, Singapore, Singapore; [Nickenig Vissoci, Joao Ricardo] Fac Inga, Dept Med, Maringa, Parana, Brazil; [Pietrobon, Ricardo] Duke Univ Hlth Syst, Dept Surg, Durham, NC USA	Universidade da Regiao de Joinville; Duke University; National University of Singapore; Singapore Clinical Research Institute; Centro Universitario Inga (UNINGA); Duke University	Pietrobon, R (corresponding author), Duke Univ Hlth Syst, Res Res Grp, Durham, NC 27710 USA.	rpietro@duke.edu						[Anonymous], LANG ENV STAT COMP; Beaton D, 1998, J SHOULDER ELB SURG, V7, P565, DOI 10.1016/S1058-2746(98)90002-7; Borgmastars N, 2010, CLIN ORTHOP RELAT R, V468, P2678, DOI 10.1007/s11999-010-1403-8; Burbank KM, 2008, AM FAM PHYSICIAN, V77, P453; CATTELL RB, 1966, MULTIVAR BEHAV RES, V1, P245, DOI 10.1207/s15327906mbr0102_10; Ciconelli RM, 1999, REV BRAS REUMATOL, V39, P143, DOI DOI 10.1590/S0482-50042010000300005; Godfrey J, 2007, J SHOULDER ELB SURG, V16, P260, DOI 10.1016/j.jse.2006.07.003; Gorsuch RL, 1983, FACTOR ANAL; Hagberg M, 2002, J OCCUP REHABIL, V12, P151, DOI 10.1023/A:1016890527520; Hooftman WE, 2008, SCAND J WORK ENV HEA, V34, P107, DOI 10.5271/sjweh.1221; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Huygen F, 2010, PAIN PRACT, V10, P318, DOI 10.1111/j.1533-2500.2010.00389.x; LIPPITT SB, 1993, SHOULDER : A BALANCE OF MOBILITY AND STABILITY, P501; MacCallum RC, 1999, PSYCHOL METHODS, V4, P84, DOI 10.1037/1082-989x.4.1.84; MacDermid JC, 2006, J SHOULDER ELB SURG, V15, P407, DOI 10.1016/j.jse.2005.09.005; Marchese C, 2012, ACTA OTORHINOLARYNGO, V32, P12; Matsen F A 3rd, 1995, J Shoulder Elbow Surg, V4, P345, DOI 10.1016/S1058-2746(95)80018-2; Matsen FA, 2005, SIMPLE SHOULDER TEST; Mousavi SJ, 2008, CLIN REHABIL, V22, P749, DOI 10.1177/0269215508085821; Nunnally JC, 1994, PSYCHOMETRIC THEORY, V3rd, DOI DOI 10.1037/018882; Oh JH, 2009, AM J SPORT MED, V37, P1161, DOI 10.1177/0363546508330135; Pietrobon Ricardo, 2004, BMC Med Res Methodol, V4, P29, DOI 10.1186/1471-2288-4-29; Roddey TS, 2000, PHYS THER, V80, P759, DOI 10.1093/ptj/80.8.759; Romeo AA, 2004, CLIN ORTHOP RELAT R, P107, DOI 10.1097/01.blo.0000142624.05526.dd; Roy JS, 2009, ARTHRIT RHEUM-ARTHR, V61, P623, DOI 10.1002/art.24396; Ryliskis S., 2008, ACTA MED LITUANICA, V15, P163; Saccomanni B, 2009, CLIN RHEUMATOL, V28, P495, DOI 10.1007/s10067-009-1109-z; Salaffi F, 2010, JCR-J CLIN RHEUMATOL, V16, P105, DOI 10.1097/RHU.0b013e3181cf8392; Schermelleh-Engel K, 2003, METHODS PSYCHOL RES, V8, P23, DOI DOI 10.1002/0470010940; Schreiber JB, 2006, J EDUC RES, V99, P323, DOI 10.3200/JOER.99.6.323-338; Shah J, 2009, ACAD MED, V84, P511, DOI 10.1097/ACM.0b013e31819a8c3c; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; Steiger JH, 2007, PERS INDIV DIFFER, V42, P893, DOI 10.1016/j.paid.2006.09.017; Streiner DL., 2001, HLTH MEASUREMENT SCA, V2nd; Tashjian RZ, 2010, AM J SPORT MED, V38, P2435, DOI 10.1177/0363546510382835; Travassos Cláudia, 2002, Rev Panam Salud Publica, V11, P365, DOI 10.1590/S1020-49892002000500011; van Kampen DA, 2012, J SHOULDER ELB SURG, V21, P808, DOI 10.1016/j.jse.2011.09.026; Yilmaz F, 2008, CLIN RHEUMATOL, V27, P327, DOI 10.1007/s10067-007-0717-8; Yuan KH, 2004, BRIT J MATH STAT PSY, V57, P151, DOI 10.1348/000711004849231	39	17	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2013	8	5							e62890	10.1371/journal.pone.0062890	http://dx.doi.org/10.1371/journal.pone.0062890			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	145RZ	23675436	gold, Green Published, Green Submitted			2022-12-27	WOS:000319036100017
J	Risher, ML; Fleming, RL; Boutros, N; Semenova, S; Wilson, WA; Levin, ED; Markou, A; Swartzwelder, HS; Acheson, SK				Risher, Mary-Louise; Fleming, Rebekah L.; Boutros, Nathalie; Semenova, Svetlana; Wilson, Wilkie A.; Levin, Edward D.; Markou, Athina; Swartzwelder, H. Scott; Acheson, Shawn K.			Long-Term Effects of Chronic Intermittent Ethanol Exposure in Adolescent and Adult Rats: Radial-Arm Maze Performance and Operant Food Reinforced Responding	PLOS ONE			English	Article							SPRAGUE-DAWLEY RATS; COLLEGE BINGE DRINKING; ALCOHOL-USE DISORDERS; ELEVATED PLUS-MAZE; SPATIAL MEMORY; DEVELOPMENTAL DIFFERENCES; CONFIDENCE-INTERVALS; MATURE HIPPOCAMPUS; TESTING HYPOTHESES; POWER CALCULATIONS	Background: Adolescence is not only a critical period of late-stage neurological development in humans, but is also a period in which ethanol consumption is often at its highest. Given the prevalence of ethanol use during this vulnerable developmental period we assessed the long-term effects of chronic intermittent ethanol (CIE) exposure during adolescence, compared to adulthood, on performance in the radial-arm maze (RAM) and operant food-reinforced responding in male rats. Methodology/Principal Findings: Male Sprague Dawley rats were exposed to CIE (or saline) and then allowed to recover. Animals were then trained in either the RAM task or an operant task using fixed-and progressive-ratio schedules. After baseline testing was completed all animals received an acute ethanol challenge while blood ethanol levels (BECs) were monitored in a subset of animals. CIE exposure during adolescence, but not adulthood decreased the amount of time that animals spent in the open portions of the RAM arms (reminiscent of deficits in risk-reward integration) and rendered animals more susceptible to the acute effects of an ethanol challenge on working memory tasks. The operant food reinforced task showed that these effects were not due to altered food motivation or to differential sensitivity to the nonspecific performance-disrupting effects of ethanol. However, CIE pre-treated animals had lower BEC levels than controls during the acute ethanol challenges indicating persistent pharmacokinetic tolerance to ethanol after the CIE treatment. There was little evidence of enduring effects of CIE alone on traditional measures of spatial and working memory. Conclusions/Significance: These effects indicate that adolescence is a time of selective vulnerability to the long-term effects of repeated ethanol exposure on neurobehavioral function and acute ethanol sensitivity. The positive and negative findings reported here help to further define the nature and extent of the impairments observed after adolescent CIE and provide direction for future research.	[Risher, Mary-Louise; Fleming, Rebekah L.; Levin, Edward D.; Swartzwelder, H. Scott; Acheson, Shawn K.] Duke Univ, Med Ctr, Dept Psychiat & Behav Sci, Durham, NC 27710 USA; [Risher, Mary-Louise; Fleming, Rebekah L.; Swartzwelder, H. Scott; Acheson, Shawn K.] Durham Vet Affairs Med Ctr, Neurobiol Res Lab, Durham, NC USA; [Wilson, Wilkie A.] Duke Univ, Social Sci Res Inst, Durham, NC USA; [Boutros, Nathalie; Semenova, Svetlana; Markou, Athina] Univ Calif San Diego, La Jolla, CA 92093 USA	Duke University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Durham VA Medical Center; Duke University; University of California System; University of California San Diego	Acheson, SK (corresponding author), Duke Univ, Med Ctr, Dept Psychiat & Behav Sci, Durham, NC 27710 USA.	shawn.acheson@duke.edu	Acheson, Shawn/A-3299-2016; Levin, Edward/GLV-2991-2022; Risher, Louise/AAP-2646-2020	Risher, Louise/0000-0002-3139-4378	NIAAA [U01-AA019925-01-NADIA, U01-AA019970-NADIA, I01BX007080, 2-010-10S]; Bristol-Myers Squibb Co.; Pfizer; Astra-Zeneca; Abbott GmbH and Company; AstraZeneca; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [U01AA019970, U01AA019925] Funding Source: NIH RePORTER; Veterans Affairs [IK2BX001267] Funding Source: NIH RePORTER	NIAAA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); Bristol-Myers Squibb Co.(Bristol-Myers Squibb); Pfizer(Pfizer); Astra-Zeneca(AstraZeneca); Abbott GmbH and Company; AstraZeneca(AstraZeneca); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported by the NIAAA grant U01-AA019925-01-NADIA to HSS; U01-AA019970-NADIA to AM; Veteran Affairs Senior Research Career Scientist awards to HSS; VA Career Development Award I01BX007080 to SKA; VA Career Development Award 2-010-10S to RLF. The NIH and VA had no further role in the study design, collection, analysis, and interpretation of data, writing of the report, or decision to submit the article for publication.; AM has received contract research support from Bristol-Myers Squibb Co., Pfizer, and Astra-Zeneca, and honoraria/consulting fees from Abbott GmbH and Company, AstraZeneca, and Pfizer during the past 3 years. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials. The remaining authors report no financial conflicts of interests. There are no actual or potential financial conflicts of interest.	Acheson SK, 1999, ALCOHOL, V18, P23, DOI 10.1016/S0741-8329(98)00063-9; Acheson SK, 1998, ALCOHOL CLIN EXP RES, V22, P1437, DOI 10.1111/j.1530-0277.1998.tb03932.x; Acheson SK, 2001, ALCOHOL, V23, P167, DOI 10.1016/S0741-8329(01)00127-6; ALTMAN DG, 1995, BRIT MED J, V311, P485, DOI 10.1136/bmj.311.7003.485; Anderson RI, 2010, ALCOHOL CLIN EXP RES, V34, P2106, DOI 10.1111/j.1530-0277.2010.01307.x; BEHAR D, 1983, ALCOHOL CLIN EXP RES, V7, P404, DOI 10.1111/j.1530-0277.1983.tb05495.x; Bisby JA, 2010, BIOL PSYCHIAT, V68, P280, DOI 10.1016/j.biopsych.2010.01.010; Bisby JA, 2010, PSYCHOPHARMACOLOGY, V208, P67, DOI 10.1007/s00213-009-1709-y; Brasser SM, 2002, BEHAV NEUROSCI, V116, P305, DOI 10.1037//0735-7044.116.2.305; Broadwater M, 2011, ALCOHOL CLIN EXP RES, V35, P1392, DOI 10.1111/j.1530-0277.2011.01474.x; Chin VS, 2011, ALCOHOL, V45, P473, DOI 10.1016/j.alcohol.2011.03.001; Colegrave N, 2003, BEHAV ECOL, V14, P446, DOI 10.1093/beheco/14.3.446; Crews FT, 2000, ALCOHOL CLIN EXP RES, V24, P1712, DOI 10.1111/j.1530-0277.2000.tb01973.x; Dawson DA, 2004, J STUD ALCOHOL, V65, P477, DOI 10.15288/jsa.2004.65.477; Doremus TL, 2004, ANN NY ACAD SCI, V1021, P427, DOI 10.1196/annals.1308.057; Doremus TL, 2003, PHARMACOL BIOCHEM BE, V75, P411, DOI 10.1016/S0091-3057(03)00134-5; Doremus-Fitzwater TL, 2007, ALCOHOL CLIN EXP RES, V31, P1516, DOI 10.1111/j.1530-0277.2007.00457.x; Faul F, 2009, BEHAV RES METHODS, V41, P1149, DOI 10.3758/BRM.41.4.1149; Fleming RL, 2007, J NEUROPHYSIOL, V97, P3806, DOI 10.1152/jn.00101.2007; Fleming RL, 2012, ALCOHOL CLIN EXP RES, V36, P279, DOI 10.1111/j.1530-0277.2011.01615.x; Fleming RL, 2013, ALCOHOL CLI IN PRESS; Giedd JN, 2008, J ADOLESCENT HEALTH, V42, P335, DOI 10.1016/j.jadohealth.2008.01.007; Ginsburg BC, 2008, PHYSIOL BEHAV, V94, P374, DOI 10.1016/j.physbeh.2008.01.026; Gogtay N, 2004, P NATL ACAD SCI USA, V101, P8174, DOI 10.1073/pnas.0402680101; Hefner K, 2007, PSYCHOPHARMACOLOGY, V191, P311, DOI 10.1007/s00213-006-0646-2; HODOS W, 1961, SCIENCE, V134, P943, DOI 10.1126/science.134.3483.943; Hoenig JM, 2001, AM STAT, V55, P19, DOI 10.1198/000313001300339897; Huynh H., 1970, J AM STAT ASSOC, V65, P1582, DOI DOI 10.1080/01621459.1970.10481187; Keselman HJ, 2008, PSYCHOL METHODS, V13, P110, DOI 10.1037/1082-989X.13.2.110; Lesaffre E, 2001, EUR HEART J, V22, P898, DOI 10.1053/euhj.2000.2323; Li TK, 2004, BIOL PSYCHIAT, V56, P718, DOI 10.1016/j.biopsych.2004.03.006; Little PJ, 1996, ALCOHOL CLIN EXP RES, V20, P1346, DOI 10.1111/j.1530-0277.1996.tb01133.x; Lopez MF, 2003, ADDICT BIOL, V8, P419, DOI 10.1080/13556210310001648176; MAJCHROWICZ E, 1975, PSYCHOPHARMACOLOGIA, V43, P245, DOI 10.1007/BF00429258; MARKOU A, 1993, PSYCHOPHARMACOLOGY, V112, P163, DOI 10.1007/BF02244907; Markwiese BJ, 1998, ALCOHOL CLIN EXP RES, V22, P416, DOI 10.1111/j.1530-0277.1998.tb03668.x; Matthews DB, 2008, ALCOHOL, V42, P617, DOI 10.1016/j.alcohol.2008.09.001; McLaughlin PJ, 2008, PHARMACOL BIOCHEM BE, V89, P304, DOI 10.1016/j.pbb.2008.01.002; Morris SA, 2010, ALCOHOL, V44, P89, DOI 10.1016/j.alcohol.2009.10.017; Moy SS, 1998, ALCOHOL CLIN EXP RES, V22, P1485, DOI 10.1111/j.1530-0277.1998.tb03940.x; Novier A, 2012, NEUROSCI LETT, V512, P38, DOI 10.1016/j.neulet.2012.01.059; Onwuegbuzie A.J., 2004, UNDERSTANDING STAT, V3, P201, DOI DOI 10.1207/S15328031US0304_1; Pascual M, 2007, EUR J NEUROSCI, V25, P541, DOI 10.1111/j.1460-9568.2006.05298.x; Paus T, 2005, TRENDS COGN SCI, V9, P60, DOI 10.1016/j.tics.2004.12.008; PELLOW S, 1985, J NEUROSCI METH, V14, P149, DOI 10.1016/0165-0270(85)90031-7; Pyapali GK, 1999, ALCOHOL, V19, P107, DOI 10.1016/S0741-8329(99)00021-X; Quoilin C, 2010, PSYCHOPHARMACOLOGY, V212, P501, DOI 10.1007/s00213-010-1971-z; Rajendran P, 2004, ANN NY ACAD SCI, V1021, P441, DOI 10.1196/annals.1308.060; Ramirez RL, 2010, PHARMACOL BIOCHEM BE, V95, P242, DOI 10.1016/j.pbb.2010.01.013; Ramos A, 2008, TRENDS PHARMACOL SCI, V29, P493, DOI 10.1016/j.tips.2008.07.005; Ranstam J, 2008, ACTA RADIOL, V49, P521, DOI 10.1080/02841850802075058; Ristuccia RC, 2005, ALCOHOL CLIN EXP RES, V29, P1809, DOI 10.1097/01.alc.0000183010.72764.cd; Ristuccia RC, 2008, ALCOHOL, V42, P623, DOI 10.1016/j.alcohol.2008.08.002; Rohde P, 1996, J AM ACAD CHILD PSY, V35, P101, DOI 10.1097/00004583-199601000-00018; Schramm-Sapyta NL, 2010, ALCOHOL CLIN EXP RES, V34, P2061, DOI 10.1111/j.1530-0277.2010.01302.x; Semenova S, 2012, PSYCHOPHARMACOLOGY, V219, P433, DOI 10.1007/s00213-011-2458-2; Sher KJ, 1999, DEV PSYCHOPATHOL, V11, P933, DOI 10.1017/S0954579499002394; Silveri MM, 1998, ALCOHOL CLIN EXP RES, V22, P670, DOI 10.1111/j.1530-0277.1998.tb04310.x; Silvers JM, 2006, ALCOHOL, V39, P151, DOI 10.1016/j.alcohol.2006.09.001; Silvers JM, 2003, ALCOHOL CLIN EXP RES, V27, P1606, DOI 10.1097/01.ALC.0000090141.66526.22; Simon NW, 2011, J NEUROSCI, V31, P17460, DOI 10.1523/JNEUROSCI.3772-11.2011; Sklar AL, 2012, ALCOHOLISM CLIN EXPT; Slawecki CJ, 2006, BEHAV PHARMACOL, V17, P605, DOI 10.1097/01.fbp.0000236272.10418.62; Smithson M., 2012, SCRIPTS SOFTWARE NON; Smithson M., 2003, CONFIDENCE INTERVALS; Sowell ER, 1999, NAT NEUROSCI, V2, P859, DOI 10.1038/13154; Steinberg L, 2004, ANN NY ACAD SCI, V1021, P51, DOI 10.1196/annals.1308.005; STRUBE MJ, 1989, J APPL PSYCHOL, V74, P247, DOI 10.1037/0021-9010.74.2.247; Swartzwelder HS, 1998, ALCOHOL, V15, P311, DOI 10.1016/S0741-8329(97)00135-3; Swartzwelder HS, 1995, ALCOHOL CLIN EXP RES, V19, P1480, DOI 10.1111/j.1530-0277.1995.tb01011.x; SWARTZWELDER HS, 1995, ALCOHOL CLIN EXP RES, V19, P320, DOI 10.1111/j.1530-0277.1995.tb01509.x; Terry AV, 2008, NEUROSCIENCE, V156, P1005, DOI 10.1016/j.neuroscience.2008.08.030; Varlinskaya EI, 2004, ALCOHOL CLIN EXP RES, V28, P40, DOI 10.1097/01.ALC.0000108655.51087.DF; Vetter-O'Hagen C, 2009, ALCOHOL ALCOHOLISM, V44, P547, DOI 10.1093/alcalc/agp048; Wechsler H, 2000, J AM COLL HEALTH, V48, P199, DOI 10.1080/07448480009599305; Wechsler H, 2002, J AM COLL HEALTH, V50, P203, DOI 10.1080/07448480209595713; White AM, 2000, ALCOHOL CLIN EXP RES, V24, P1251, DOI 10.1111/j.1530-0277.2000.tb02091.x; White AM, 2002, PHARMACOL BIOCHEM BE, V73, P673, DOI 10.1016/S0091-3057(02)00860-2; Williams BR, 1999, DEV PSYCHOL, V35, P205, DOI 10.1037/0012-1649.35.1.205; Wills TA, 2008, ALCOHOL CLIN EXP RES, V32, P1350, DOI 10.1111/j.1530-0277.2008.00709.x	80	50	50	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2013	8	5							e62940	10.1371/journal.pone.0062940	http://dx.doi.org/10.1371/journal.pone.0062940			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145RZ	23675442	Green Submitted, gold, Green Published			2022-12-27	WOS:000319036100023
J	Zhou, W; Wang, HD; Zhu, XX; Shan, JJ; Yin, AL; Cai, BC; Di, LQ				Zhou, Wei; Wang, Haidan; Zhu, Xuanxuan; Shan, Jinjun; Yin, Ailing; Cai, Baochang; Di, Liuqing			Improvement of Intestinal Absorption of Forsythoside A and Chlorogenic Acid by Different Carboxymethyl Chitosan and Chito-oligosaccharide, Application to Flos Lonicerae - Fructus Forsythiae Herb Couple Preparations	PLOS ONE			English	Article							IN-SITU; DELIVERY-SYSTEMS; DRUG-DELIVERY; ENHANCERS; RATS; TRANSPORT; INSULIN; ANTIOXIDANT; MECHANISM; PERFUSION	The current study aims to investigate the effect of chitosan derivatives on the intestinal absorption and bioavailabilities of forsythoside A (FTA) and Chlorogenic acid (CHA), the major active components in Flos Lonicerae - Fructus Forsythiae herb couple. Biopharmaceutics and pharmacokinetics properties of the two compounds have been characterized in vitro, in situ as well as in rats. Based on the identified biopharmaceutics characteristics of the two compounds, the effect of chitosan derivatives as an absorption enhancer on the intestinal absorption and pharmacokinetics of FTA and CHA in pure compound form as well as extract form were investigated in vitro, in situ and in vivo. Both FTA and CHA demonstrated very limited intestinal permeabilities, leading to oral bioavailabilities being only 0.50% and 0.13% in rats, respectively. Results from both in vitro, in situ as well as in vivo studies consistently indicated that Chito-oligosaccharide (COS) at dosage of 25 mg/kg could enhance intestinal permeabilities significantly as well as the in vivo bioavailabilities of both FTA and CHA than CMCs in Flos Lonicerae - Fructus Forsythiae herb couple preparations, and was safe for gastrointestine from morphological observation. Besides, treatment with Flos Lonicerae - Fructus Forsythiae herb couple preparations with COS at the dosage of 25 mg/kg prevented MDCK damage after influenza virus propagation, which was significantly better than control. The current findings not only identified the usefulness of COS for the improved delivery of Flos Lonicerae - Fructus Forsythiae preparations but also demonstrated the importance of biopharmaceutical characterization in the dosage form development of traditional Chinese medicine.	[Zhou, Wei; Yin, Ailing; Cai, Baochang; Di, Liuqing] Nanjing Univ Chinese Med, Coll Pharm, Nanjing, Jiangsu, Peoples R China; [Zhou, Wei; Di, Liuqing] Jiangsu Engn Res Ctr Efficient Delivery Syst TCM, Nanjing, Jiangsu, Peoples R China; [Zhou, Wei; Di, Liuqing] Nanjing Engn Res Ctr Industrializat Chinese Med P, Nanjing, Jiangsu, Peoples R China; [Wang, Haidan; Zhu, Xuanxuan] Nanjing Univ Chinese Med, Dept Pharmacol, Affiliated Hosp, Nanjing, Jiangsu, Peoples R China; [Shan, Jinjun] Nanjing Univ Chinese Med, Med Coll 1, Nanjing, Jiangsu, Peoples R China	Nanjing University of Chinese Medicine; Nanjing University of Chinese Medicine; Nanjing University of Chinese Medicine	Di, LQ (corresponding author), Nanjing Univ Chinese Med, Coll Pharm, Nanjing, Jiangsu, Peoples R China.	diliuqing@hotmail.com	wang, haidan/HGC-7982-2022; Zhou, Wei/I-5964-2014		National Natural Science Foundation of China [81073071, 81273655]; "Qing Lan" Project from Jiangsu Provincial Technology Innovation Team Support Scheme; priority Academic Program Development of Jiangsu Higher Education Institution [ysxk-2010]; program sponsored for scientific innovation research of college graduate in the Jiangsu province [623]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); "Qing Lan" Project from Jiangsu Provincial Technology Innovation Team Support Scheme; priority Academic Program Development of Jiangsu Higher Education Institution; program sponsored for scientific innovation research of college graduate in the Jiangsu province	The present study is supported financially by the National Natural Science Foundation of China (81073071, 81273655), "Qing Lan" Project from Jiangsu Provincial Technology Innovation Team Support Scheme, the priority Academic Program Development of Jiangsu Higher Education Institution (No.ysxk-2010) and a 2012 program sponsored for scientific innovation research of college graduate in the Jiangsu province (623). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Artursson P, 1994, PHARM RES, V11, P358; BARRY BW, 1983, DERMATOLOGICAL FORMU, P127; Bernkop-Schnurch A, 2012, EUR J PHARM BIOPHARM, V81, P463, DOI 10.1016/j.ejpb.2012.04.007; Du Qiu, 2009, Yaoxue Xuebao, V44, P922; Fetih G, 2005, J CONTROL RELEASE, V106, P287, DOI 10.1016/j.jconrel.2005.05.017; Gao Y, 2008, INT J PHARM, V359, P70, DOI 10.1016/j.ijpharm.2008.03.016; Hejazi R, 2003, J CONTROL RELEASE, V89, P151, DOI 10.1016/S0168-3659(03)00126-3; Hu K. J., 2001, J HARBIN MED U, V35, P430; ILLUM L, 1994, PHARMACEUT RES, V11, P1186, DOI 10.1023/A:1018901302450; Jonker C, 2002, INT J PHARMACEUT, V238, P205, DOI 10.1016/S0378-5173(02)00068-6; Konishi Y, 2004, J AGR FOOD CHEM, V52, P2518, DOI 10.1021/jf035407c; Kuang Hai-Xue, 2009, Chinese Journal of Natural Medicines, V7, P278, DOI 10.3724/SP.J.1009.2009.00278; [刘碧源 Liu Biyuan], 2003, [中国生化药物杂志, Chinese Journal of Biochemical Pharmaceutics], V24, P73; Ma YuanYuan, 2010, Scientia Agricultura Sinica, V43, P3237; Mehrbod P, 2009, DARU, V17, P88; Qu HH, 2008, J PHARM PHARMACOL, V60, P261, DOI 10.1211/jpp.60.2.0016; RAFTER JJ, 1986, GUT, V27, P1320, DOI 10.1136/gut.27.11.1320; Salama NN, 2006, ADV DRUG DELIVER REV, V58, P15, DOI 10.1016/j.addr.2006.01.003; Schipper NGM, 1997, PHARMACEUT RES, V14, P923, DOI 10.1023/A:1012160102740; Shang XF, 2011, J ETHNOPHARMACOL, V138, P1, DOI 10.1016/j.jep.2011.08.016; THOMSON ABR, 1986, J CLIN INVEST, V77, P279, DOI 10.1172/JCI112288; Uchiyama T, 1999, J PHARM PHARMACOL, V51, P1241, DOI 10.1211/0022357991776976; Wang GN, 2010, J CHROMATOGR B, V878, P102, DOI 10.1016/j.jchromb.2009.11.029; Yamamoto A, 1996, J PHARM PHARMACOL, V48, P1285, DOI 10.1111/j.2042-7158.1996.tb03937.x; Ye JX, 2010, J PHARMACEUT BIOMED, V52, P625, DOI 10.1016/j.jpba.2010.01.035; Yuan W., 2007, FOOD RES DEV, V28, P185; Zhang LW, 2002, EXTRACTION METHOD BI; Zhou W, 2012, PHYTOMEDICINE, V20, P47, DOI 10.1016/j.phymed.2012.09.014; Zhou W, 2012, ACTA PHARMACOL SIN, V33, P1069, DOI 10.1038/aps.2012.58; Zou YX, 2012, INT J MOL SCI, V13, P16544, DOI 10.3390/ijms131216544	30	22	25	3	70	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2013	8	5							e63348	10.1371/journal.pone.0063348	http://dx.doi.org/10.1371/journal.pone.0063348			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145RZ	23675483	Green Published, gold, Green Submitted			2022-12-27	WOS:000319036100041
J	Smoothey, AF				Smoothey, Amy F.			Habitat-Associations of Turban Snails on Intertidal and Subtidal Rocky Reefs	PLOS ONE			English	Article							NORTHERN NEW-ZEALAND; NEW-SOUTH-WALES; PYURA-STOLONIFERA HELLER; ALGAL ASSEMBLAGES; MACROINVERTEBRATE COMMUNITIES; MUSCULISTA-SENHOUSIA; MARINE-INVERTEBRATES; SPATIAL-PATTERNS; CORALLINE ALGAE; HARD SUBSTRATA	Patchiness of habitat has important influences on distributions and abundances of organisms. Given the increasing threat of loss and alteration of habitats due to pressures associated with humans, there is a need for ecologists to understand species' requirements for habitat and to predict changes to taxa under various future environmental conditions. This study tested hypotheses about the generality of patterns described for one species of marine intertidal turban snail for a different, yet closely-related species in subtidal habitats along the coast of New South Wales, Australia. These two closely-related species live in similar habitats, yet under quite different conditions, which provided an opportunity to investigate how similar types of habitats influence patterns of distribution, abundance and size-structure in intertidal versus subtidal environments. For each species, there were similar associations between biogenically structured habitat and densities. The intertidal species, Turbo undulates, were more abundant, with greater proportions of small individuals in habitats formed by the canopy-forming alga, Hormosira banksii, the solitary ascidian, Pyura stolonifera or the turfing red alga, Corallina officinalis compared to simple habitat (bare rock). Similarly, more Turbo torquatus were found in biogenically structured subtidal habitat, i.e. canopy-forming algae, Ecklonia radiata, mixed algal communities ('fringe'), or turfing red algae (Corallina officinalis and Amphiroa aniceps) than where habitat is simple (barrens). Small T. torquatus were more abundant in areas of turf and 'fringe', while large snails were more abundant in areas of kelp and barrens. These patterns were found at each location sampled (i.e. eight intertidal and two subtidal rocky reefs) and at all times of sampling, across each environment. This study highlighted the consistent influence of biogenically structured habitats on the distribution, abundance and size-structure of intertidal and subtidal turban snails and forms a basis for increasing the understanding of the potential underlying processes causing such patterns.	[Smoothey, Amy F.] Univ Sydney, Sch Biol Sci, Ctr Res Ecol Impacts Coastal Cities, Marine Ecol Labs A11, Sydney, NSW 2006, Australia	University of Sydney	Smoothey, AF (corresponding author), Cronulla Fisheries Res Ctr Excellence, NSW Dept Primary Ind, Cronulla, NSW, Australia.	amy.smoothey@dpi.nsw.gov.au			Australian Postgraduate Award; Australian Research Council through the Centre for Research on Ecological Impacts of Coastal Cities	Australian Postgraduate Award(Australian Government); Australian Research Council through the Centre for Research on Ecological Impacts of Coastal Cities(Australian Research Council)	The research in this manuscript was funded by an Australian Postgraduate Award (AFS) and the Australian Research Council through the Centre for Research on Ecological Impacts of Coastal Cities. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfaro AC, 2007, ESTUAR COAST, V30, P431, DOI 10.1007/BF02819389; Alfaro AC, 2006, ESTUARIES COASTS, V29, P731, DOI 10.1007/BF02786524; Beck MW, 1998, MAR ECOL PROG SER, V169, P165, DOI 10.3354/meps169165; Beck MW, 1997, OIKOS, V78, P265, DOI 10.2307/3546293; Bertness MD, 1997, ECOLOGY, V78, P1976, DOI 10.1890/0012-9658(1997)078[1976:TROPII]2.0.CO;2; Blount C, 2004, THESIS SYDNEY U SYDN; Castilla JC, 2004, MAR ECOL PROG SER, V268, P119, DOI 10.3354/meps268119; Chapman MG, 2000, J EXP MAR BIOL ECOL, V244, P181, DOI 10.1016/S0022-0981(99)00140-9; CHAPMAN MG, 1994, AUST J MAR FRESH RES, V45, P635; Chapman MG, 1998, J EXP MAR BIOL ECOL, V224, P265, DOI 10.1016/S0022-0981(97)00202-5; CHOAT JH, 1982, J EXP MAR BIOL ECOL, V60, P129, DOI 10.1016/0022-0981(82)90155-1; Cole VJ, 2007, J EXP MAR BIOL ECOL, V348, P191, DOI 10.1016/j.jembe.2007.05.001; Coleman MA, 2002, J EXP MAR BIOL ECOL, V267, P53, DOI 10.1016/S0022-0981(01)00358-6; Crooks JA, 1999, J EXP MAR BIOL ECOL, V240, P53, DOI 10.1016/S0022-0981(99)00041-6; Crooks JA, 1998, MAR ECOL PROG SER, V162, P137, DOI 10.3354/meps162137; Crowe T, 1996, J EXP MAR BIOL ECOL, V206, P83, DOI 10.1016/S0022-0981(96)02615-9; Crowe T. P., 2000, Journal of Aquatic Ecosystem Stress and Recovery, V7, P273, DOI 10.1023/A:1009911928100; Crowe TP, 1999, J EXP MAR BIOL ECOL, V237, P31, DOI 10.1016/S0022-0981(98)00211-1; Dumont C, 2004, MAR ECOL PROG SER, V276, P93, DOI 10.3354/meps276093; Ettinger-Epstein P, 2008, AUSTRAL ECOL, V33, P594, DOI 10.1111/j.1442-9993.2007.01824.x; Fairweather Peter G., 2007, P1; FIELDING PJ, 1994, S AFR J ZOOL, V29, P46; Firth LB, 2010, OECOLOGIA, V162, P163, DOI 10.1007/s00442-009-1441-7; FLETCHER WJ, 1987, ECOL MONOGR, V57, P89, DOI 10.2307/1942640; Foster M.S., 1988, MEMOIRS CALIFORNIA A, V9, P1; FOSTER MS, 1990, HYDROBIOLOGIA, V192, P21, DOI 10.1007/BF00006225; Fowler-Walker MJ, 2002, MAR ECOL PROG SER, V240, P49, DOI 10.3354/meps240049; Gee JM, 1996, J MAR BIOL ASSOC UK, V76, P177, DOI 10.1017/S0025315400029106; Goodsell PJ, 2009, MAR ECOL PROG SER, V384, P23, DOI 10.3354/meps08037; Gosselin LA, 1997, MAR ECOL PROG SER, V146, P265, DOI 10.3354/meps146265; HARVEY M, 1995, LIMNOL OCEANOGR, V40, P94, DOI 10.4319/lo.1995.40.1.0094; Jeffery CJ, 2001, J EXP MAR BIOL ECOL, V256, P85, DOI 10.1016/S0022-0981(00)00307-5; Jenkins SR, 2001, MAR ECOL PROG SER, V217, P207, DOI 10.3354/meps217207; JOLL LM, 1980, AUST J MAR FRESH RES, V31, P319, DOI 10.1071/MF9800319; JONES GP, 1990, AUST J ECOL, V15, P505, DOI 10.1111/j.1442-9993.1990.tb01474.x; Kelaher BP, 2003, J EXP MAR BIOL ECOL, V282, P23, DOI 10.1016/S0022-0981(02)00443-4; Kelaher BP, 2001, J MAR BIOL ASSOC UK, V81, P917, DOI 10.1017/S0025315401004842; Kelaher BP, 2007, REV CHIL HIST NAT, V80, P173; Kendrick GA, 1999, HYDROBIOLOGIA, V399, P275; KENNELLY SJ, 1983, J EXP MAR BIOL ECOL, V68, P257, DOI 10.1016/0022-0981(83)90057-6; KEOUGH MJ, 1982, OECOLOGIA, V54, P348, DOI 10.1007/BF00380003; KOLASA J, 1991, ECOLOGICAL HETEROGEN; Lawton JH, 1999, OIKOS, V84, P177, DOI 10.2307/3546712; LEVIN SA, 1992, ECOLOGY, V73, P1943, DOI 10.2307/1941447; Lewis J. R., 1964, ECOLOGY ROCKY SHORES; Lilley SA, 2006, OECOLOGIA, V148, P672, DOI 10.1007/s00442-006-0411-6; MARTINEZ E, 1993, ECOL APPL, V3, P417, DOI 10.2307/1941911; Melville AJ, 2001, AUSTRAL ECOL, V26, P102, DOI 10.1111/j.1442-9993.2001.01089.pp.x; Menge BA, 2001, MARINE COMMUNITY ECOLOGY, P221; Monteiro SM, 2002, J EXP MAR BIOL ECOL, V270, P171, DOI 10.1016/S0022-0981(02)00020-5; O'Connor NE, 2007, J MAR BIOL ASSOC UK, V87, P551, DOI 10.1017/S0025315407050503; PETERS RH, 1991, CRITIQUE ECOLOGY; POVEY A, 1991, OIKOS, V61, P355, DOI 10.2307/3545243; RAFFAELLI DG, 1978, J ANIM ECOL, V47, P71, DOI 10.2307/3923; Ricciardi A, 1997, CAN J FISH AQUAT SCI, V54, P2596, DOI 10.1139/cjfas-54-11-2596; SCHIEL DR, 1986, OCEANOGR MAR BIOL, V24, P265; Steneck RS, 2001, MARINE COMMUNITY ECOLOGY, P445; Thompson RC, 2002, ENVIRON CONSERV, V29, P168, DOI 10.1017/S0376892902000115; Tilman D., 1989, P89; Underwood A.J., 1984, P151; Underwood A.J., 1997, EXPT ECOLOGY THEIR L, DOI DOI 10.1017/CBO9780511806407; UNDERWOOD AJ, 1990, J EXP MAR BIOL ECOL, V137, P25, DOI 10.1016/0022-0981(90)90058-K; UNDERWOOD AJ, 1991, AUST J ECOL, V16, P231, DOI 10.1111/j.1442-9993.1991.tb01050.x; Underwood AJ, 1996, OECOLOGIA, V107, P212, DOI 10.1007/BF00327905; Underwood AJ, 2000, J EXP MAR BIOL ECOL, V250, P51, DOI 10.1016/S0022-0981(00)00179-9; Underwood AJ, 1993, SPECIES DIVERSITY EC, P38; Vanderklift MA, 2004, MAR FRESHWATER RES, V55, P93, DOI 10.1071/MF03057; WALSBY JR, 1977, NEW ZEAL J MAR FRESH, V11, P211, DOI 10.1080/00288330.1977.9515674; WEINER J, 1995, J ECOL, V83, P153, DOI 10.2307/2261159; Wernberg T, 2008, MAR ECOL PROG SER, V362, P169, DOI 10.3354/meps07416; WIENS JA, 1976, ANNU REV ECOL SYST, V7, P81, DOI 10.1146/annurev.es.07.110176.000501; Witman JD, 2001, MARINE COMMUNITY ECOLOGY, P339; WORTHINGTON DG, 1989, J EXP MAR BIOL ECOL, V129, P61, DOI 10.1016/0022-0981(89)90063-4	73	17	17	1	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2013	8	5							e61257	10.1371/journal.pone.0061257	http://dx.doi.org/10.1371/journal.pone.0061257			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	143FO	23675409	Green Submitted, gold, Green Published			2022-12-27	WOS:000318852400005
J	Bowens, SR; Glatt, DP; Pratt, SC				Bowens, Sean R.; Glatt, Daniel P.; Pratt, Stephen C.			Visual Navigation during Colony Emigration by the Ant Temnothorax rugatulus	PLOS ONE			English	Article							NEST-SITE SELECTION; DECISION-MAKING; LEPTOTHORAX-UNIFASCIATUS; ORIENTATION; RECRUITMENT; MEMORY; CUES; HYMENOPTERA; MECHANISMS; LANDMARKS	Many ants rely on both visual cues and self-generated chemical signals for navigation, but their relative importance varies across species and context. We evaluated the roles of both modalities during colony emigration by Temnothorax rugatulus. Colonies were induced to move from an old nest in the center of an arena to a new nest at the arena edge. In the midst of the emigration the arena floor was rotated 60 degrees around the old nest entrance, thus displacing any substrate-bound odor cues while leaving visual cues unchanged. This manipulation had no effect on orientation, suggesting little influence of substrate cues on navigation. When this rotation was accompanied by the blocking of most visual cues, the ants became highly disoriented, suggesting that they did not fall back on substrate cues even when deprived of visual information. Finally, when the substrate was left in place but the visual surround was rotated, the ants' subsequent headings were strongly rotated in the same direction, showing a clear role for visual navigation. Combined with earlier studies, these results suggest that chemical signals deposited by Temnothorax ants serve more for marking of familiar territory than for orientation. The ants instead navigate visually, showing the importance of this modality even for species with small eyes and coarse visual acuity.	[Bowens, Sean R.; Pratt, Stephen C.] Arizona State Univ, Sch Life Sci, Tempe, AZ 85287 USA; [Glatt, Daniel P.] Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA	Arizona State University; Arizona State University-Tempe; Princeton University	Pratt, SC (corresponding author), Arizona State Univ, Sch Life Sci, Tempe, AZ 85287 USA.	stephen.pratt@asu.edu			Pew Charitable Trusts [2000-002558]	Pew Charitable Trusts	Funding was provided by Pew Charitable Trusts (award 2000-002558), www.pewtrusts.org. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARON S, 1988, INSECT SOC, V35, P355, DOI 10.1007/BF02225811; ARON S, 1986, INSECT SOC, V33, P338, DOI 10.1007/BF02224249; ARON S, 1993, INSECT SOC, V40, P369, DOI 10.1007/BF01253900; Aron S, 1999, P ROY SOC B-BIOL SCI, V266, P173, DOI 10.1098/rspb.1999.0618; Cammaerts MC, 1996, BEHAV PROCESS, V37, P21, DOI 10.1016/0376-6357(95)00064-X; Cheng K, 2009, BEHAV PROCESS, V80, P261, DOI 10.1016/j.beproc.2008.10.015; Collett M, 2000, BIOL CYBERN, V83, P245, DOI 10.1007/s004220000168; Collett M, 2010, P NATL ACAD SCI USA, V107, P11638, DOI 10.1073/pnas.1001401107; Collett TS, 2006, ADV STUD BEHAV, V36, P123, DOI 10.1016/S0065-3454(06)36003-2; Collett TS, 1997, EXS, V84, P41; CREIGHTON W. S., 1950, BULL MUS COMP ZOOL HARVARD UNIV, V104, P1; Czaczkes TJ, 2013, J EXP BIOL, V216, P188, DOI 10.1242/jeb.076570; Czaczkes TJ, 2011, BIOL LETTERS, V7, P521, DOI 10.1098/rsbl.2011.0067; Devigne C, 2004, ANIM BEHAV, V67, P1023, DOI 10.1016/j.anbehav.2003.09.012; Durier V, 2003, CURR BIOL, V13, P1614, DOI 10.1016/j.cub.2003.08.024; Gruter C, 2011, BEHAV ECOL SOCIOBIOL, V65, P141, DOI 10.1007/s00265-010-1020-2; HARRISON JF, 1989, ANIM BEHAV, V37, P869, DOI 10.1016/0003-3472(89)90076-6; Headley A. E., 1943, ANN ENT SOC AMERICA, V36, P743; HOLLDOBLER B, 1976, BEHAV ECOL SOCIOBIOL, V1, P3, DOI 10.1007/BF00299951; Holldobler B., 1990, pi; Lenoir A, 2009, J CHEM ECOL, V35, P913, DOI 10.1007/s10886-009-9669-6; Mallon EB, 2001, BEHAV ECOL SOCIOBIOL, V50, P352, DOI 10.1007/s002650100377; MASCHWITZ U, 1986, EXPERIENTIA, V42, P1173, DOI 10.1007/BF01941298; McLeman MA, 2002, INSECT SOC, V49, P203, DOI 10.1007/s00040-002-8302-2; MOGLICH M, 1978, INSECT SOC, V25, P205, DOI 10.1007/BF02224742; Philippides A, 2011, J EXP BIOL, V214, P445, DOI 10.1242/jeb.046755; Pratt SC, 2005, INSECT SOC, V52, P383, DOI 10.1007/s00040-005-0823-z; Pratt SC, 2001, ETHOLOGY, V107, P1125, DOI 10.1046/j.1439-0310.2001.00749.x; Pratt SC, 2001, ANIM BEHAV, V62, P281, DOI 10.1006/anbe.2001.1777; R Core Team, 2021, R LANGUAGE ENV STAT; Richardson TO, 2007, CURR BIOL, V17, P1520, DOI 10.1016/j.cub.2007.08.032; ROSENGREN R, 1986, INSECT SOC, V33, P306, DOI 10.1007/BF02224248; Salo O, 2001, ETHOLOGY, V107, P737, DOI 10.1046/j.1439-0310.2001.00702.x; Stroeymeyt N, 2011, J EXP BIOL, V214, P3046, DOI 10.1242/jeb.059188; Visscher PK, 2007, ANNU REV ENTOMOL, V52, P255, DOI 10.1146/annurev.ento.51.110104.151025; Wehner R, 2009, MYRMECOL NEWS, V12, P85; Wystrach A, 2012, ANIM BEHAV, V84, P13, DOI 10.1016/j.anbehav.2012.04.017	37	10	10	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2013	8	5							e64367	10.1371/journal.pone.0064367	http://dx.doi.org/10.1371/journal.pone.0064367			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	155HD	23671713	Green Published, gold			2022-12-27	WOS:000319737700071
J	Huang, L; Han, YT; Zhou, Y; Gutscher, H; Bi, J				Huang, Lei; Han, Yuting; Zhou, Ying; Gutscher, Heinz; Bi, Jun			How Do the Chinese Perceive Ecological Risk in Freshwater Lakes?	PLOS ONE			English	Article							PSYCHOMETRIC PARADIGM; ENVIRONMENTAL-HEALTH; PUBLIC PERCEPTIONS; LOCAL ACCEPTANCE; NUCLEAR; COMMUNICATION; WILLINGNESS; BELIEFS; PEOPLE; TAIHU	In this study, we explore the potential contributions of a risk perception framework in understanding public perceptions of unstable ecosystems. In doing so, we characterize one type of common ecological risk-harmful algal blooms (HABs)-in four of the most seriously eutrophicated freshwater lakes in China. These lakes include Chaohu, Dianchi, Hongze, and Taihu, where a total of 2000 residents living near these sites were interviewed. Regional discrepancies existed in the pilot study regarding public perceptions of ecological changes and public concerns for ecological risk. Comparing HABs and other kinds of risks (earthquake, nuclear, and public traffic) through the psychometric paradigm method, Knowledge, Effect, and Trust were three key factors formulating the risk perception model. The results indicated that Knowledge and risk tolerance levels had significant negative correlations in the higher economic situation while correlations in the lower economic situation were significantly positive. Effect and risk tolerance levels had significant negative correlations in the high and middle education situation while correlations in the low education situation were close to zero or insignificant. For residents from Taihu with comparatively higher economic and educational levels, more investment in risk prevention measures and stronger policies are needed. And for residents from Hongze and Dianchi with comparatively low economic and educational levels, improvement of the government's credibility (Trust) was the most important factor of risk tolerance, so efforts to eliminate ecological problems with the stepwise development of economic and educational levels should be implemented and gradually strengthened. In turn, this could prevent public discontent and ensure support for ecological protection policies.	[Huang, Lei; Han, Yuting; Bi, Jun] Nanjing Univ, State Key Lab Pollut Control & Resource Reuse, Sch Environm, Nanjing 210008, Jiangsu, Peoples R China; [Zhou, Ying] Emory Univ, Rollins Sch Publ Hlth, Dept Environm Hlth, Atlanta, GA 30322 USA; [Gutscher, Heinz] Univ Zurich, Dept Psychol, Zurich, Switzerland	Nanjing University; Emory University; Rollins School Public Health; University of Zurich	Bi, J (corresponding author), Nanjing Univ, State Key Lab Pollut Control & Resource Reuse, Sch Environm, Nanjing 210008, Jiangsu, Peoples R China.	jbi@nju.edu.cn	Han, Yu/GZA-9220-2022	Huang, Lei/0000-0002-9279-878X	Chinese Natural Sciences Foundation [41271014, 41171411]; Sino-America Collaborative Research Program [2010DFA91910]; 863 Program [2013AA06A309]	Chinese Natural Sciences Foundation(National Natural Science Foundation of China (NSFC)); Sino-America Collaborative Research Program; 863 Program(National High Technology Research and Development Program of China)	This research was supported by Chinese Natural Sciences Foundation (41271014 and 41171411), the Sino-America Collaborative Research Program (2010DFA91910) and 863 Program (2013AA06A309). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anhui Statistical Bureau, 2010, ANH STAT YB; [Anonymous], 2002, ENV QUAL STAND SURF; [Anonymous], 2004, STAT ENV CHIN 2003; Arvai J, 2003, ENVIRON SCI TECHNOL, V37, P1469, DOI 10.1021/es020762p; Backer LC, 2010, TOXICON, V55, P909, DOI 10.1016/j.toxicon.2009.07.006; Bi J., 1996, GeoJournal, V40, P9; Brewer NT, 2004, ANN BEHAV MED, V27, P125, DOI 10.1207/s15324796abm2702_7; Bronfman NC, 2003, RISK ANAL, V23, P1271, DOI 10.1111/j.0272-4332.2003.00400.x; Bronfman NC, 2007, J RISK RES, V10, P527, DOI 10.1080/13669870701315872; Cabrera NL, 2009, HISPANIC J BEHAV SCI, V31, P258, DOI 10.1177/0739986309331877; Cervantes O, 2008, ENVIRON MANAGE, V42, P249, DOI 10.1007/s00267-008-9104-8; Chen J, 2009, SCI TOTAL ENVIRON, V407, P3317, DOI 10.1016/j.scitotenv.2009.02.005; Chung JB, 2008, RISK ANAL, V28, P1021, DOI 10.1111/j.1539-6924.2008.01074.x; de Groot JIM, 2010, RISK ANAL, V30, P1363, DOI 10.1111/j.1539-6924.2010.01419.x; Dorevitch S, 2012, ENVIRON HEALTH PERSP, V120, P192, DOI 10.1289/ehp.1103934; Grothmann T, 2006, NAT HAZARDS, V38, P101, DOI 10.1007/s11069-005-8604-6; Guo L, 2007, SCIENCE, V317, P1166, DOI 10.1126/science.317.5842.1166; Hammitt JK, 2004, J RISK UNCERTAINTY, V28, P73, DOI 10.1023/B:RISK.0000009437.24783.e1; Ho MC, 2008, RISK ANAL, V28, P635, DOI 10.1111/j.1539-6924.2008.01040.x; Hohl K, 2008, RISK ANAL, V28, P311, DOI 10.1111/j.1539-6924.2008.01021.x; Huang L, 2010, ENVIRON MANAGE, V45, P1065, DOI 10.1007/s00267-010-9480-8; Huang L, 2010, HUM ECOL RISK ASSESS, V16, P365, DOI 10.1080/10807031003670394; Huang L, 2010, FRONT ENVIRON SCI EN, V4, P73, DOI 10.1007/s11783-009-0151-z; Hunter PD, 2012, SCI TOTAL ENVIRON, V426, P32, DOI 10.1016/j.scitotenv.2012.02.017; J XC, 1995, ENV CHINESE LAKES; Jiangsu Statical Bureau, 2010, JIANGS STAT YB; Katsuya T, 2002, POLIT PSYCHOL, V23, P191, DOI 10.1111/0162-895X.00277; Kosenius AK, 2010, ECOL ECON, V69, P528, DOI 10.1016/j.ecolecon.2009.08.030; Kuhar SE, 2009, RISK ANAL, V29, P963, DOI 10.1111/j.1539-6924.2009.01228.x; Lazo JK, 2000, RISK ANAL, V20, P179, DOI 10.1111/0272-4332.202019; Lind N, 2002, RELIAB ENG SYST SAFE, V78, P21, DOI 10.1016/S0951-8320(02)00051-0; Marchwinska-Wyrwal E, 2012, EUR J PUBLIC HEALTH, V22, P742, DOI 10.1093/eurpub/ckr109; May H, 1996, RISK ANAL, V16, P459, DOI 10.1111/j.1539-6924.1996.tb01093.x; MCCALL CH, 1982, SAMPLING STAT HDB RE; MCDANIELS T, 1995, RISK ANAL, V15, P575, DOI 10.1111/j.1539-6924.1995.tb00754.x; McFarlane BL, 2008, RISK ANAL, V28, P203, DOI 10.1111/j.1539-6924.2008.01013.x; Mrozek JR, 2002, J POLICY ANAL MANAG, V21, P253, DOI 10.1002/pam.10026; PARKER GR, 1989, PUBLIC OPIN QUART, V53, P175, DOI 10.1086/269502; Peters E, 1996, J APPL SOC PSYCHOL, V26, P1427, DOI 10.1111/j.1559-1816.1996.tb00079.x; Petty R. E., 1981, ATTITUDES PERSUASION; Purvis-Roberts KL, 2007, RISK ANAL, V27, P291, DOI 10.1111/j.1539-6924.2007.00882.x; Qu CS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046793; Rizak SN, 2006, ENVIRON SCI TECHNOL, V40, P5244, DOI 10.1021/es0520417; Rogers GO, 1985, DETERMINING PUBLIC A, P483; Salihoglu G, 2004, ENVIRON MANAGE, V33, P899, DOI 10.1007/s00267-004-2864-x; Siegrist M, 2005, RISK ANAL, V25, P211, DOI 10.1111/j.0272-4332.2005.00580.x; Sjoberg L, 2004, RISK ANAL, V24, P737, DOI 10.1111/j.0272-4332.2004.00472.x; Slimak MW, 2006, RISK ANAL, V26, P1689, DOI 10.1111/j.1539-6924.2006.00832.x; SLOVIC P, 1987, SCIENCE, V236, P280, DOI 10.1126/science.3563507; Slovic P., 1980, SOC RISK ASSESSMENT, P181, DOI [10.1007/978-1-4899-0445-4_9, DOI 10.1007/978-1-4899-0445-4_9]; Slovic P, 1989, TRUST EMOTION SEX PO, P277; Sukharomana R, 1998, AGR EC, V46; Viscusi WK, 2003, J RISK UNCERTAINTY, V27, P5, DOI 10.1023/A:1025598106257; Wallquist L, 2010, ENVIRON SCI TECHNOL, V44, P6557, DOI 10.1021/es1005412; Willis HH, 2007, RISK ANAL, V27, P1365, DOI 10.1111/j.1539-6924.2007.00958.x; You M, 2012, ENV LAW REPORTER NEW, V42, P10482; Yunnan Statistical Bureau, 2010, YUNN STAT YB	58	7	8	4	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2013	8	5							e62486	10.1371/journal.pone.0062486	http://dx.doi.org/10.1371/journal.pone.0062486			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	155HD	23671602	Green Published, gold, Green Submitted			2022-12-27	WOS:000319737700013
J	Snodgrass, SM; Cihil, KM; Cornuet, PK; Myerburg, MM; Swiatecka-Urban, A				Snodgrass, Steven M.; Cihil, Kristine M.; Cornuet, Pamela K.; Myerburg, Michael M.; Swiatecka-Urban, Agnieszka			Tgf-beta 1 Inhibits Cftr Biogenesis and Prevents Functional Rescue of Delta F508-Cftr in Primary Differentiated Human Bronchial Epithelial Cells	PLOS ONE			English	Article							TRANSMEMBRANE CONDUCTANCE REGULATOR; GROWTH-FACTOR-BETA; CYSTIC-FIBROSIS LUNG; FLUID TRANSPORT; GENE-EXPRESSION; ION-TRANSPORT; INFLAMMATION; PATHOPHYSIOLOGY; IDENTIFICATION; DEGRADATION	CFTR is an integral transmembrane glycoprotein and a cAMP-activated Cl- channel. Mutations in the CFTR gene lead to Cystic Fibrosis (CF)-an autosomal recessive disease with majority of the morbidity and mortality resulting from airway infection, inflammation, and fibrosis. The most common disease-associated mutation in the CFTR gene-deletion of Phe508 (Delta F508) leads to a biosynthetic processing defect of CFTR. Correction of the defect and delivery of Delta F508-CFTR to the cell surface has been highly anticipated as a disease modifying therapy. Compared to promising results in cultured cell this approach was much less effective in CF patients in an early clinical trial. Although the cause of failure to rescue Delta F508-CFTR in the clinical trial has not been determined, presence of factor(s) that interfere with the rescue in vivo could be considered. The cytokine TGF-beta 1 is frequently elevated in CF patients. TGF-b1 has pleiotropic effects in different disease models and genetic backgrounds and little is known about TGF-beta 1 effects on CFTR in human airway epithelial cells. Moreover, there are no published studies examining TGF-beta 1 effects on the functional rescue of Delta F508-CFTR. Here we found that TGF-beta 1 inhibits CFTR biogenesis by reducing mRNA levels and protein abundance in primary differentiated human bronchial epithelial (HBE) cells from non-CF individuals. TGF-beta 1 inhibits CFTR biogenesis without compromising the epithelial phenotype or integrity of HBE cells. TGF-beta 1 also inhibits biogenesis and impairs the functional rescue of Delta F508-CFTR in HBE cells from patients homozygous for the Delta F508 mutation. Our data indicate that activation of TGF-b1 signaling may inhibit CFTR function in non-CF individuals and may interfere with therapies directed at correcting the processing defect of Delta F508-CFTR in CF patients.	[Snodgrass, Steven M.] Childrens Hosp Pittsburgh, Div Pediat Pulmonol, Pittsburgh, PA 15213 USA; [Cihil, Kristine M.; Cornuet, Pamela K.; Myerburg, Michael M.; Swiatecka-Urban, Agnieszka] Univ Pittsburgh, Sch Med, Dept Cell Biol & Physiol, Pittsburgh, PA 15260 USA; [Myerburg, Michael M.] Univ Pittsburgh, Sch Med, Div Pulm Allergy & Crit Care Med, Pittsburgh, PA USA; [Swiatecka-Urban, Agnieszka] Childrens Hosp Pittsburgh, Div Pediat Nephrol, Pittsburgh, PA 15213 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Swiatecka-Urban, A (corresponding author), Univ Pittsburgh, Sch Med, Dept Cell Biol & Physiol, Pittsburgh, PA 15260 USA.	asurban@pitt.edu	Swiatecka-Urban, Agnieszka/AAP-6041-2020; SWIATECKA-URBAN, AGNIESZKA/H-6494-2015	SWIATECKA-URBAN, AGNIESZKA/0000-0002-6575-0334	National Institutes of Health [R01HL090767, R01HL090767-02S1, P30DK072506]; Cystic Fibrosis Foundation Research Development Program Grant [R883-CR07]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL112863, R01HL090767] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK072506] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cystic Fibrosis Foundation Research Development Program Grant; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by the National Institutes of Health Grants R01HL090767, R01HL090767-02S1 (to A.S-U.), P30DK072506 (Joseph M. Pilewski, Cystic Fibrosis Research Center Epithelial Cell Core at the University of Pittsburgh School of Medicine, Pittsburgh, PA), and the Cystic Fibrosis Foundation Research Development Program Grant R883-CR07 (to S.M.S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahner A, 2013, MOL BIOL CELL, V24, P74, DOI 10.1091/mbc.E12-09-0678; Bartram U, 2004, CHEST, V125, P754, DOI 10.1378/chest.125.2.754; Bertrand CA, 2003, AM J PHYSIOL-CELL PH, V285, pC1, DOI 10.1152/ajpcell.00554.2002; BESANCON F, 1994, AM J PHYSIOL-CELL PH, V267, pC1398, DOI 10.1152/ajpcell.1994.267.5.C1398; Boucher RC, 2004, EUR RESPIR J, V23, P146, DOI 10.1183/09031936.03.00057003; Brazova J, 2006, CLIN IMMUNOL, V121, P350, DOI 10.1016/j.clim.2006.08.015; Brouillard F, 2001, J BIOL CHEM, V276, P9486, DOI 10.1074/jbc.M006636200; Celliere G, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-184; Cihil KM, 2012, J BIOL CHEM, V287, P15087, DOI 10.1074/jbc.M112.341875; Clancy JP, 2012, THORAX, V67, P12, DOI 10.1136/thoraxjnl-2011-200393; Collaco JM, 2008, CURR OPIN PULM MED, V14, P559, DOI 10.1097/MCP.0b013e3283121cdc; Cutting GR, 2010, ANN NY ACAD SCI, V1214, P57, DOI 10.1111/j.1749-6632.2010.05879.x; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Devor DC, 2000, AM J PHYSIOL-CELL PH, V279, pC461, DOI 10.1152/ajpcell.2000.279.2.C461; Dorfman R, 2008, J CLIN INVEST, V118, P1040, DOI [10.1172/JCI337S4, 10.1172/JCI33754]; Frank J, 2003, J BIOL CHEM, V278, P43939, DOI 10.1074/jbc.M304882200; Galietta LJV, 2002, J IMMUNOL, V168, P839, DOI 10.4049/jimmunol.168.2.839; Gibson RL, 2003, AM J RESP CRIT CARE, V168, P918, DOI 10.1164/rccm.200304-505SO; Grainger DJ, 1999, HUM MOL GENET, V8, P93, DOI 10.1093/hmg/8.1.93; Gravdal K, 2007, CLIN CANCER RES, V13, P7003, DOI 10.1158/1078-0432.CCR-07-1263; Gray T, 2004, AM J PHYSIOL-LUNG C, V286, pL320, DOI 10.1152/ajplung.00440.2002; Guggino WB, 2006, NAT REV MOL CELL BIO, V7, P426, DOI 10.1038/nrm1949; Harris WT, 2011, PEDIATR PULM, V46, P688, DOI 10.1002/ppul.21430; Harris WT, 2009, PEDIATR PULM, V44, P1057, DOI 10.1002/ppul.21079; He L, 2012, FASEB J; Hilliard TN, 2007, THORAX, V62, P1074, DOI 10.1136/thx.2006.074641; Howard M, 2000, AM J PHYSIOL-CELL PH, V279, pC375, DOI 10.1152/ajpcell.2000.279.2.C375; Howe KL, 2004, EXP CELL RES, V298, P473, DOI 10.1016/j.yexcr.2004.04.026; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Kim IY, 2005, J BIOCHEM MOL BIOL, V38, P1; Lubamba B, 2012, CLIN BIOCHEM, V45, P1132, DOI 10.1016/j.clinbiochem.2012.05.034; Molina-Molina M, 2006, ARCH BRONCONEUMOL, V42, P380, DOI 10.1016/S1579-2129(06)60550-8; Molinski S, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00160; Murphy SJ, 2004, MOL BIOL CELL, V15, P2853, DOI 10.1091/mbc.E04-02-0097; Myerburg MM, 2010, AM J RESP CELL MOL, V42, P676, DOI 10.1165/2009-0147OC; Myerburg MM, 2007, AM J PHYSIOL-LUNG C, V292, pL1352, DOI 10.1152/ajplung.00328.2006; Nichols D, 2008, CLIN REV ALLERG IMMU, V34, P146, DOI 10.1007/s12016-007-8039-9; Pruliere-Escabasse V, 2005, AM J PHYSIOL-LUNG C, V288, pL77, DOI 10.1152/ajplung.00048.2004; Riordan JR, 2008, ANNU REV BIOCHEM, V77, P701, DOI 10.1146/annurev.biochem.75.103004.142532; RIORDAN JR, 1989, SCIENCE, V245, P1066; ROMMENS JM, 1989, SCIENCE, V245, P1059, DOI 10.1126/science.2772657; Roux J, 2010, J BIOL CHEM, V285, P4278, DOI 10.1074/jbc.M109.036731; Ryder MI, 2002, ORAL MICROBIOL IMMUN, V17, P331, DOI 10.1034/j.1399-302X.2002.170601.x; Skowron-Zwarg M, 2007, EXP CELL RES, V313, P2695, DOI 10.1016/j.yexcr.2007.02.035; Tarran R, 2006, ANNU REV PHYSIOL, V68, P543, DOI 10.1146/annurev.physiol.68.072304.112754; ten Dijke P, 2004, TRENDS BIOCHEM SCI, V29, P265, DOI 10.1016/j.tibs.2004.03.008; Van Goor F, 2011, P NATL ACAD SCI USA, V108, P18843, DOI 10.1073/pnas.1105787108; Wang XW, 2012, NUCLEIC ACIDS RES, V40, pD1144, DOI 10.1093/nar/gkr1013; Willis BC, 2007, AM J PHYSIOL-LUNG C, V293, pL525, DOI 10.1152/ajplung.00163.2007; Yang YC, 2012, ALLERGY, V67, P1193, DOI 10.1111/j.1398-9995.2012.02880.x; Ye SY, 2010, J BIOL CHEM, V285, P27008, DOI 10.1074/jbc.M110.139881; Zeisberg M, 2009, J CLIN INVEST, V119, P1429, DOI 10.1172/JCI36183; Zieba A, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.013482	53	50	50	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2013	8	5							e63167	10.1371/journal.pone.0063167	http://dx.doi.org/10.1371/journal.pone.0063167			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	155HD	23671668	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000319737700046
J	Chatterjee, S; Wang, Y; Duncan, MK; Naik, UP				Chatterjee, Sharmila; Wang, Yan; Duncan, Melinda K.; Naik, Ulhas P.			Junctional Adhesion Molecule-A Regulates Vascular Endothelial Growth Factor Receptor-2 Signaling-Dependent Mouse Corneal Wound Healing	PLOS ONE			English	Article							VEGF-A; JAM-A; EXPRESSION; NEOVASCULARIZATION; FIBROBLAST; CELL; ANGIOGENESIS; NEUTROPHIL; INHIBITION; RELEASE	Inflammation and angiogenesis are integral parts of wound healing. However, excessive and persistent wound-induced inflammation and angiogenesis in an avascular tissue such as the cornea may be associated with scarring and visual impairment. Junctional adhesion molecule A (Jam-A) is a tight junction protein that regulates leukocyte transmigration as well as fibroblast growth factor-2 (FGF-2)-induced angiogenesis. However its function in wound-induced inflammation and angiogenesis is still unknown. In this study, we report spontaneous corneal opacity in Jam-A deficient mice associated with inflammation, angiogenesis and the presence of myofibroblasts. Since wounds and/or corneal infections cause corneal opacities, we tested the role of Jam-A in wound-induced inflammation, angiogenesis and scarring by subjecting Jam-A deficient mice to full thickness corneal wounding. Analysis of these wounds demonstrated increased inflammation, angiogenesis, and increased number of myofibroblasts thereby indicating that Jam-A regulates the wound-healing response by controlling wound-induced inflammation, angiogenesis and scarring in the cornea. These effects were not due to inflammation alone since the inflammation-induced wound-healing response in Jam-A deficient mice was similar to wild type mice. In order to determine the molecular mechanism associated with the observed aberrant corneal wound healing in Jam-A deficient mice, we assessed the expression of the components of vascular endothelial growth factor A (VEGF-A)/vascular endothelial growth factor receptor-2 (VEGFR-2) signaling pathway. Interestingly, we observed increased levels of VEGF-A mRNA in Jam-A deficient eyes. We also observed nuclear localization of phosphorylated SMAD3 (pSMAD3) indicative of TGF beta pathway activation in the Jam-A deficient eyes. Furthermore the increased wound-induced corneal inflammation, angiogenesis, and scarring in Jam-A deficient mice was attenuated by treatment with DC101, an anti-vascular endothelial growth factor receptor-2 (VEGFR-2) antibody. Our results suggest that in the absence of Jam-A, the VEGF-A/VEGFR-2 pathway is upregulated, thereby augmenting wound induced corneal inflammation, angiogenesis, and myofibroblast accumulation leading to scarring.	[Chatterjee, Sharmila; Wang, Yan; Duncan, Melinda K.; Naik, Ulhas P.] Univ Delaware, Dept Biol Sci, Newark, DE 19716 USA; [Naik, Ulhas P.] Univ Delaware, Dept Biochem & Chem, Newark, DE USA; [Naik, Ulhas P.] Univ Delaware, Delaware Cardiovasc Res Ctr, Newark, DE USA; [Naik, Ulhas P.] Univ Delaware, Delaware Biotechnol Inst, Newark, DE USA	University of Delaware; University of Delaware; University of Delaware; University of Delaware	Naik, UP (corresponding author), Univ Delaware, Dept Biol Sci, Newark, DE 19716 USA.	unaik@udel.edu		Duncan, Melinda/0000-0003-1570-322X	National Institutes of Health [HL63960, EY12221]; INBRE program [P20 RR16472]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016472] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY012221] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL063960, R01HL119374] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); INBRE program; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health grant HL63960 to UPN, EY12221 to MKD, and INBRE program grant P20 RR16472 supporting the University of Delaware Core Imaging facility. The funders had no role in study deign, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambati BK, 2006, NATURE, V443, P993, DOI 10.1038/nature05249; Aramwit P, 2009, J BIOSCI BIOENG, V107, P556, DOI 10.1016/j.jbiosc.2008.12.012; Ardi VC, 2007, P NATL ACAD SCI USA, V104, P20262, DOI 10.1073/pnas.0706438104; Bao Philip, 2009, J Surg Res, V153, P347, DOI 10.1016/j.jss.2008.04.023; Blanco-Mezquita JT, 2011, INVEST OPHTH VIS SCI, V52, P8505, DOI 10.1167/iovs.11-8194; Burgu B, 2006, BJU INT, V98, P217, DOI 10.1111/j.1464-410X.2006.06215.x; Bystrom B, 2007, HISTOCHEM CELL BIOL, V127, P657, DOI 10.1007/s00418-007-0288-4; Cera MR, 2009, J CELL SCI, V122, P268, DOI 10.1242/jcs.037127; Christoffersson G, 2012, BLOOD; Cooke VG, 2006, ARTERIOSCL THROM VAS, V26, P2005, DOI 10.1161/01.ATV.0000234923.79173.99; Cursiefen C, 2004, J CLIN INVEST, V113, P1040, DOI 10.1172/JCI200420465; Fini ME, 1999, PROG RETIN EYE RES, V18, P529, DOI 10.1016/S1350-9462(98)00033-0; Ford KM, 2012, INVEST OPHTH VIS SCI, V53, P7520, DOI 10.1167/iovs.12-10098; Franco M, 2011, BLOOD, V118, P2906, DOI 10.1182/blood-2011-01-331694; Gan LS, 2004, ACTA OPHTHALMOL SCAN, V82, P557, DOI 10.1111/j.1600-0420.2004.00312.x; Gong Y, 2010, CELL TISSUE RES, V339, P437, DOI 10.1007/s00441-009-0908-5; Hood JD, 2003, J CELL BIOL, V162, P933, DOI 10.1083/jcb.200304105; Hosseini H, 2007, CLIN EXP OPHTHALMOL, V35, P745, DOI 10.1111/j.1442-9071.2007.01572.x; Jester JV, 1999, PROG RETIN EYE RES, V18, P311, DOI 10.1016/S1350-9462(98)00021-4; Kang LI, 2007, INT J BIOCHEM CELL B, V39, P576, DOI 10.1016/j.biocel.2006.10.016; Lee KS, 2008, EUR RESPIR J, V31, P523, DOI 10.1183/09031936.00125007; Li DM, 2009, MICROVASC RES, V77, P134, DOI 10.1016/j.mvr.2008.09.007; Li ZQ, 2009, INVEST OPHTH VIS SCI, V50, P5217, DOI 10.1167/iovs.08-2662; Lim JY, 2012, J CELL PHYSIOL, V227, P1081, DOI 10.1002/jcp.22824; Lin TC, 2005, ANESTH ANALG, V100, P1554, DOI 10.1213/01.ANE.0000154307.92060.84; Mak P, 2010, CANCER CELL, V17, P319, DOI 10.1016/j.ccr.2010.02.030; Mandell KJ, 2007, INVEST OPHTH VIS SCI, V48, P3928, DOI 10.1167/iovs.06-1536; Matsuda A, 1999, INVEST OPHTH VIS SCI, V40, P1071; Mochida Y, 2009, MATRIX BIOL, V28, P44, DOI 10.1016/j.matbio.2008.11.003; Mohan RR, 2011, CURR MOL MED, V11, P110; Moldovan NI, 2000, CIRC RES, V87, P378; Murakami M, 2011, J CLIN INVEST, V121, P2668, DOI 10.1172/JCI44762; Myrna KE, 2012, INVEST OPHTH VIS SCI, V53, P811, DOI 10.1167/iovs.11-7982; Naik MU, 2006, J CELL SCI, V119, P490, DOI 10.1242/jcs.02771; Naik MU, 2003, BLOOD, V102, P2108, DOI 10.1182/blood-2003-04-1114; Naik MU, 2003, ARTERIOSCL THROM VAS, V23, P2165, DOI 10.1161/01.ATV.0000093982.84451.87; Nupponen I, 2001, PEDIATRICS, V108, DOI 10.1542/peds.108.1.e12; Orosz ZZ, 2011, CLIN CHIM ACTA, V412, P271, DOI 10.1016/j.cca.2010.10.017; Pal-Ghosh S, 2011, J CELL SCI, V124, P2666, DOI 10.1242/jcs.085480; Perez-Santonja JJ, 2010, AM J OPHTHALMOL, V150, P519, DOI 10.1016/j.ajo.2010.04.024; Phillipson M, 2011, NAT MED, V17, P1381, DOI 10.1038/nm.2514; Reed NA, 2001, J IMMUNOL METHODS, V253, P243, DOI 10.1016/S0022-1759(01)00374-X; Retini C, 1996, INFECT IMMUN, V64, P2897, DOI 10.1128/IAI.64.8.2897-2903.1996; Russell REK, 2002, AM J RESP CELL MOL, V26, P602, DOI 10.1165/ajrcmb.26.5.4685; Sakimoto T, 2012, EXP EYE RES, V97, P98, DOI 10.1016/j.exer.2012.02.015; Samolov B, 2005, EXP EYE RES, V80, P159, DOI 10.1016/j.exer.2004.08.023; Seghezzi G, 1998, J CELL BIOL, V141, P1659, DOI 10.1083/jcb.141.7.1659; Shi L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032128; Shibuya Masabumi, 2011, Genes Cancer, V2, P1097, DOI 10.1177/1947601911423031; Stalmans I, 2010, Verh K Acad Geneeskd Belg, V72, P41; Tandon A, 2010, CURR MOL MED, V10, P565; Vial C, 2011, J BIOL CHEM, V286, P24242, DOI 10.1074/jbc.M110.189365; Vosseler S, 2005, CANCER RES, V65, P1294, DOI 10.1158/0008-5472.CAN-03-3986; West-Mays JA, 2006, INT J BIOCHEM CELL B, V38, P1625, DOI 10.1016/j.biocel.2006.03.010; Whitcher JP, 2001, B WORLD HEALTH ORGAN, V79, P214; Wilson K, 1997, Nurs Crit Care, V2, P291; Zhang C, 2012, AM J PHYSIOL-CELL PH, V302, pC1213, DOI 10.1152/ajpcell.00179.2011; Zhang Z, 2010, CELL DEATH DIFFER, V17, P499, DOI 10.1038/cdd.2009.152	58	11	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2013	8	5							e63674	10.1371/journal.pone.0063674	http://dx.doi.org/10.1371/journal.pone.0063674			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145YI	23667656	Green Published, Green Submitted, gold			2022-12-27	WOS:000319055600067
J	Shao, L; Oshima, S; Duong, B; Advincula, R; Barrera, J; Malynn, BA; Ma, A				Shao, Ling; Oshima, Shigeru; Duong, Bao; Advincula, Rommel; Barrera, Julio; Malynn, Barbara A.; Ma, Averil			A20 Restricts Wnt Signaling in Intestinal Epithelial Cells and Suppresses Colon Carcinogenesis	PLOS ONE			English	Article							NF-KAPPA-B; COLORECTAL-CANCER; BETA-CATENIN; ENZYME A20; TNFAIP3; UBIQUITIN; INFLAMMATION; ASSOCIATION; ACTIVATION; MUTATIONS	Colon carcinogenesis consists of a multistep process during which a series of genetic and epigenetic adaptations occur that lead to malignant transformation. Here, we have studied the role of A20 (also known as TNFAIP3), a ubiquitin-editing enzyme that restricts NF kappa B and cell death signaling, in intestinal homeostasis and tumorigenesis. We have found that A20 expression is consistently reduced in human colonic adenomas than in normal colonic tissues. To further investigate A20's potential roles in regulating colon carcinogenesis, we have generated mice lacking A20 specifically in intestinal epithelial cells and interbred these with mice harboring a mutation in the adenomatous polyposis coli gene (APC(min)). While A20(FL/FL) villin-Cre mice exhibit uninflamed intestines without polyps, A20(FL/FL) villin-Cre APC(min/+) mice contain far greater numbers and larger colonic polyps than control APC(min) mice. We find that A20 binds to the beta-catenin destruction complex and restricts canonical wnt signaling by supporting ubiquitination and degradation of beta-catenin in intestinal epithelial cells. Moreover, acute deletion of A20 from intestinal epithelial cells in vivo leads to enhanced expression of the beta-catenin dependent genes cyclinD1 and c-myc, known promoters of colon cancer. Taken together, these findings demonstrate new roles for A20 in restricting beta-catenin signaling and preventing colon tumorigenesis.	[Shao, Ling; Duong, Bao; Advincula, Rommel; Barrera, Julio; Malynn, Barbara A.; Ma, Averil] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Oshima, Shigeru] Tokyo Med & Dent Univ, Dept Adv Therapeut Gastrointestinal Dis, Tokyo, Japan	University of California System; University of California San Francisco; Tokyo Medical & Dental University (TMDU)	Ma, A (corresponding author), Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA.	averil.ma@ucsf.edu	Oshima, Shigeru/C-9865-2015	Oshima, Shigeru/0000-0003-1186-9177	National Institutes of Health; histopathology core of the University of California San Francisco Liver Center; Crohn's and Colitis Foundation of America;  [T32 DK007007]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007007, R01DK095693, P30DK026743] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); histopathology core of the University of California San Francisco Liver Center; Crohn's and Colitis Foundation of America; ; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grants from the National Institutes of Health (AM), by the histopathology core of the University of California San Francisco Liver Center. LS was partly supported by T32 DK007007. SO was partly supported by a career development award from the Crohn's and Colitis Foundation of America. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adrianto I, 2011, NAT GENET, V43, P253, DOI 10.1038/ng.766; Barrett T, 2011, NUCLEIC ACIDS RES, V39, pD1005, DOI 10.1093/nar/gkq1184; Bavi P, 2011, CLIN EPIGENETICS, V2, P417, DOI 10.1007/s13148-011-0049-z; Beyaert R, 2000, BIOCHEM PHARMACOL, V60, P1143, DOI 10.1016/S0006-2952(00)00404-4; Boone DL, 2004, NAT IMMUNOL, V5, P1052, DOI 10.1038/ni1110; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Clevers H, 2012, CELL, V149, P1192, DOI 10.1016/j.cell.2012.05.012; da Costa LT, 1999, ONCOGENE, V18, P5010, DOI 10.1038/sj.onc.1202872; DeValck D, 1996, FEBS LETT, V384, P61, DOI 10.1016/0014-5793(96)00283-9; EKBOM A, 1990, LANCET, V336, P357, DOI 10.1016/0140-6736(90)91889-I; EKBOM A, 1990, NEW ENGL J MED, V323, P1228, DOI 10.1056/NEJM199011013231802; El Marjou F, 2004, GENESIS, V39, P186, DOI 10.1002/gene.20042; EVANS GS, 1992, J CELL SCI, V101, P219; Fung EYMG, 2009, GENES IMMUN, V10, P188, DOI 10.1038/gene.2008.99; Graham RR, 2008, NAT GENET, V40, P1059, DOI 10.1038/ng.200; Greten FR, 2004, CELL, V118, P285, DOI 10.1016/j.cell.2004.07.013; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; He KL, 2002, MOL CELL BIOL, V22, P6034, DOI 10.1128/MCB.22.17.6034-6045.2002; Hitotsumatsu O, 2008, IMMUNITY, V28, P381, DOI 10.1016/j.immuni.2008.02.002; KINZLER KW, 1991, SCIENCE, V253, P661, DOI 10.1126/science.1651562; Kolodziej LE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026352; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Lee EG, 2000, SCIENCE, V289, P2350, DOI 10.1126/science.289.5488.2350; Ma A, 2012, NAT REV IMMUNOL, V12, P774, DOI 10.1038/nri3313; Malynn BA, 2009, J EXP MED, V206, P977, DOI 10.1084/jem.20090765; Metzger D, 2001, METHODS, V24, P71, DOI 10.1006/meth.2001.1159; Morin PJ, 1997, SCIENCE, V275, P1787, DOI 10.1126/science.275.5307.1787; MOSER AR, 1995, DEV DYNAM, V203, P422, DOI 10.1002/aja.1002030405; MOSER AR, 1990, SCIENCE, V247, P322, DOI 10.1126/science.2296722; MUNEMITSU S, 1995, P NATL ACAD SCI USA, V92, P3046, DOI 10.1073/pnas.92.7.3046; Musone SL, 2011, GENES IMMUN, V12, P176, DOI 10.1038/gene.2010.64; Musone SL, 2008, NAT GENET, V40, P1062, DOI 10.1038/ng.202; NISHISHO I, 1991, SCIENCE, V253, P665, DOI 10.1126/science.1651563; Plenge RM, 2007, NAT GENET, V39, P1477, DOI 10.1038/ng.2007.27; POWELL SM, 1992, NATURE, V359, P235, DOI 10.1038/359235a0; Rhee L, 2012, AM J PHYSIOL-GASTR L, V303, pG220, DOI 10.1152/ajpgi.00077.2012; Sabates-Beliver J, 2007, MOL CANCER RES, V5, P1263, DOI 10.1158/1541-7786.MCR-07-0267; Sanjana NE, 2012, NAT PROTOC, V7, P171, DOI 10.1038/nprot.2011.431; Tauriello DVF, 2010, CELL CYCLE, V9, P3700, DOI 10.4161/cc.9.18.13204; Tavares RM, 2010, IMMUNITY, V33, P181, DOI 10.1016/j.immuni.2010.07.017; Thomson W, 2007, NAT GENET, V39, P1431, DOI 10.1038/ng.2007.32; Turer EE, 2008, J EXP MED, V205, P451, DOI 10.1084/jem.20071108; Ullman TA, 2011, GASTROENTEROLOGY, V140, P1807, DOI 10.1053/j.gastro.2011.01.057; Ungerback J, 2012, CARCINOGENESIS, V33, P2126, DOI 10.1093/carcin/bgs256; Vereecke L, 2010, J EXP MED, V207, P1513, DOI 10.1084/jem.20092474; Vlantis K, 2011, J CLIN INVEST, V121, P2781, DOI 10.1172/JCI45349; Wertz IE, 2004, NATURE, V430, P694, DOI 10.1038/nature02794	47	34	35	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2013	8	5							e62223	10.1371/journal.pone.0062223	http://dx.doi.org/10.1371/journal.pone.0062223			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	177QL	23671587	Green Published, Green Submitted, gold			2022-12-27	WOS:000321390200016
J	Aelterman, J; Goossens, B; De Vylder, J; Pizurica, A; Philips, W				Aelterman, Jan; Goossens, Bart; De Vylder, Jonas; Pizurica, Aleksandra; Philips, Wilfried			Computationally Efficient Locally Adaptive Demosaicing of Color Filter Array Images Using the Dual-Tree Complex Wavelet Packet Transform	PLOS ONE			English	Article							PLANE INTERPOLATION; SIGNAL	Most digital cameras use an array of alternating color filters to capture the varied colors in a scene with a single sensor chip. Reconstruction of a full color image from such a color mosaic is what constitutes demosaicing. In this paper, a technique is proposed that performs this demosaicing in a way that incurs a very low computational cost. This is done through a (dual-tree complex) wavelet interpretation of the demosaicing problem. By using a novel locally adaptive approach for demosaicing (complex) wavelet coefficients, we show that many of the common demosaicing artifacts can be avoided in an efficient way. Results demonstrate that the proposed method is competitive with respect to the current state of the art, but incurs a lower computational cost. The wavelet approach also allows for computationally effective denoising or deblurring approaches.	[Aelterman, Jan; Goossens, Bart; De Vylder, Jonas; Pizurica, Aleksandra; Philips, Wilfried] Univ Ghent, IPI TELIN IMINDS, B-9000 Ghent, Belgium	Ghent University; IMEC	Aelterman, J (corresponding author), Univ Ghent, IPI TELIN IMINDS, B-9000 Ghent, Belgium.	jaelterm@telin.ugent.be	Goossens, Bart/H-4772-2018; Pizurica, Aleksandra/K-6866-2015; Pizurica, Aleksandra/AAG-4687-2021	Goossens, Bart/0000-0002-1666-5483; Pizurica, Aleksandra/0000-0002-9322-4999; Aelterman, Jan/0000-0002-5543-2631	iMinds	iMinds	This work was funded as a part of the 3DTV project (more information can be found here: http://www.iminds.be/en/research/overview-projects/p/detail/4) of iMinds (http://www.iminds.be/en/about-us). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS JE, 1995, P SOC PHOTO-OPT INS, V2416, P144; Alleysson D, 2005, IEEE T IMAGE PROCESS, V14, P439, DOI 10.1109/TIP.2004.841200; Alleysson D, 2008, P SPIE, V6822; Bayer B, 1976, U.S. Patent, Patent No. [3,971,065, 3971065]; Buades A, 2009, IEEE T IMAGE PROCESS, V18, P1192, DOI 10.1109/TIP.2009.2017171; Chang S.G., 1998, IEEE INT C IM PROC; DONOHO DL, 1995, IEEE T INFORM THEORY, V41, P613, DOI 10.1109/18.382009; Driesen J, 2004, P INT C IM PROC ICIP; Dubois E, 2005, IEEE SIGNAL PROC LET, V12, P847, DOI 10.1109/LSP.2005.859503; FIELD DJ, 1987, J OPT SOC AM A, V4, P2379, DOI 10.1364/JOSAA.4.002379; Goossens B, 2009, IEEE IMAGE PROC, P3805, DOI 10.1109/ICIP.2009.5414309; Gunturk BK, 2002, IEEE T IMAGE PROCESS, V11, P997, DOI 10.1109/TIP.2002.801121; Hel-Or J, 2002, HPL2002206R1; Hirakawa K, 2007, INT CONF ACOUST SPEE, P597; Jack K, 2007, VIDEO DEMYSTIFIED HD; Kingsbury N, 2001, APPL COMPUT HARMON A, V10, P234, DOI 10.1006/acha.2000.0343; Livingstone M., 2002, VISION ART BIOL SEEI; Lu YM, 2010, IEEE T IMAGE PROCESS, V19, P2085, DOI 10.1109/TIP.2010.2045710; Lukac R, 2003, ELECTRON LETT, V39, P1805, DOI 10.1049/el:20031199; Lukac R, 2009, IMAGE PROCESS SER, P1; MALLAT SG, 1989, IEEE T PATTERN ANAL, V11, P674, DOI 10.1109/34.192463; Menon D, 2007, P IEEE INT C IM PROC; Menon D, 2007, IEEE T IMAGE PROCESS, V16, P132, DOI 10.1109/TIP.2006.884928; Paliy D, 2008, P SPIE IS T ELECTRON; Paliy D, 2007, INT J IMAG SYST TECH, V17, P105, DOI 10.1002/ima.20109; Pizurica A, 2006, IEEE T IMAGE PROCESS, V15, P654, DOI 10.1109/TIP.2005.863698; RUDERMAN DL, 1994, NETWORK-COMP NEURAL, V5, P517, DOI 10.1088/0954-898X/5/4/006; Selesnick IW, 2005, IEEE SIGNAL PROC MAG, V22, P123, DOI 10.1109/MSP.2005.1550194; Simoncelli E, 1996, P IEEE INT C IM PROC; Strang G., 1996, WAVELETS FILTER BANK; Zhang L, 2005, IEEE T IMAGE PROCESS, V14, P2167, DOI 10.1109/TIP.2005.857260	32	5	5	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2013	8	5							e61846	10.1371/journal.pone.0061846	http://dx.doi.org/10.1371/journal.pone.0061846			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175AS	23671575	Green Published, gold			2022-12-27	WOS:000321202100002
J	Gao, TP; Shih, CK; Rasnitsyn, AP; Ren, D				Gao, Taiping; Shih, Chungkun; Rasnitsyn, Alexandr P.; Ren, Dong			Hoplitolyda duolunica gen. et sp nov (Insecta, Hymenoptera, Praesiricidae), the Hitherto Largest Sawfly from the Mesozoic of China	PLOS ONE			English	Article							INNER-MONGOLIA; BODY-SIZE; OXYGEN; PELECINIDAE; DISPERSAL; EVOLUTION; GROWTH	Background: Large body size of an insect, in general, enhances its capability of predation, competition, and defense, resulting in better survivability and reproduction. Hymenopterans, most being phytophagous or parasitic, have a relatively small to medium body size, typically under 50.0 mm in body length. Principal Findings: Herein, we describe Hoplitolyda duolunica gen. et sp. nov., assigned to Praesiricidae, from the Early Cretaceous Yixian Formation of China. This new species is the largest fossil hymenopteran hitherto with body estimated >55.0 mm long and wing span >92.0 mm. H. duolunica is, to our knowledge, the only sawfly with Sc present in the hind wing but not in the forewing. Its Rs1 and M1 meeting each other at 145 degrees angle represents an intermediate in the transition from "Y" to "T" shapes. Even though Hoplitolyda differs significantly from all previously described genera in two subfamilies of Praesricidae, we leave the new genus unplaced in existing subfamilies, pending discovery of material with more taxonomic structure. Conclusions/Significance: Hoplitolyda has many unique and interesting characters which might have benefitted its competition, survival, and reproduction: large body size and head with robust and strong mandibles for defense and/or sexual selection, unique wing venation and setal arrangements for flight capability and mobility, dense hairs on body and legs for sensing and protection, etc. Considering the reported ferocious predators of feathered dinosaurs, pterosaurs, birds, and mammals coexisting in the same eco-system, Hoplitolyda is an interesting case of "survival of the fittest" in facing its evolutionary challenges.	[Gao, Taiping; Shih, Chungkun; Ren, Dong] Capital Normal Univ, Coll Life Sci, Beijing, Peoples R China; [Rasnitsyn, Alexandr P.] Russian Acad Sci, Inst Paleontol, Moscow, Russia; [Rasnitsyn, Alexandr P.] Nat Hist Museum, Dept Palaeontol, London SW7 5BD, England	Capital Normal University; Russian Academy of Sciences; Natural History Museum London	Ren, D (corresponding author), Capital Normal Univ, Coll Life Sci, Beijing, Peoples R China.	rendong@mail.cnu.edu.cn	Rasnitsyn, Alexandr/P-2393-2015; Gao, Taiping/Z-3987-2019	Rasnitsyn, Alexandr/0000-0002-6350-0040	National Basic Research Program of China (973 Program) [2012CB821906]; National Natural Science Foundation of China [31230065, 31272352, 41272006]; Project of Great Wall Scholar; Beijing Municipal Commission of Education [KZ201310028033]; China Geological Survey [1212011120115]; Presidium RAS Program "Origin and evolution of the geo-biological system"	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Project of Great Wall Scholar; Beijing Municipal Commission of Education(Beijing Municipal Commission of Education); China Geological Survey(China Geological Survey); Presidium RAS Program "Origin and evolution of the geo-biological system"	This research is supported by the National Basic Research Program of China (973 Program) (grant 2012CB821906), the National Natural Science Foundation of China (grants 31230065, 31272352, 41272006), Project of Great Wall Scholar and KEY project of Beijing Municipal Commission of Education Project (grants KZ201310028033), China Geological Survey (grant 1212011120115) to DR, and the Presidium RAS Program "Origin and evolution of the geo-biological system", to RAS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Archibald SB, 2011, P ROY SOC B-BIOL SCI, V278, P3679, DOI 10.1098/rspb.2011.0729; Bradbury J. W., 2011, PRINCIPLES ANIMAL CO; Callier V, 2011, P NATL ACAD SCI USA, V108, P14664, DOI 10.1073/pnas.1106556108; Chang MM, 2008, JEHOL FOSSILS: THE EMERGENCE OF FEATHERED DINOSAURS, BEAKED BIRDS AND FLOWERING PLANTS, P11; DAMUTH J, 1981, NATURE, V290, P699, DOI 10.1038/290699a0; Dudley R, 1998, J EXP BIOL, V201, P1043; Emlen DJ, 2012, SCIENCE, V337, P860, DOI 10.1126/science.1224286; Gao TP, 2012, CURR BIOL, V22, P732, DOI 10.1016/j.cub.2012.03.012; Gao TP, 2010, ANN SOC ENTOMOL FR, V46, P148, DOI 10.1080/00379271.2010.10697650; Harrison JF, 2011, ANNU REV PHYSIOL, V73, P95, DOI 10.1146/annurev-physiol-012110-142155; Hu YM, 2005, NATURE, V433, P149, DOI 10.1038/nature03102; Huber TH, 1993, HYMENOPTERA WORLD ID; McNab BK, 2001, J MAMMAL, V82, P709, DOI 10.1644/1545-1542(2001)082<0709:SDASOE>2.0.CO;2; Rasnitsyn A.P., 1980, Trudy Paleontologicheskogo Instituta, V174, P1; Rasnitsyn A.P., 1977, PALEONTOL ZH, V3, P98; Rasnitsyn A.P., 1969, T PALEONTOL I ACAD S, V123, P1; Rasnitsyn A.P., 1968, JURASSIC INSECTS KAR; Rasnitsyn AP, 2006, PALAEONTOLOGY, V49, P907, DOI 10.1111/j.1475-4983.2006.00574.x; Rasnitsyn AP, 1983, PALEONTOLOGICHESKIY, V2, P54; Ren D., 1995, FAUNAE STRATIGRAPHY; Ren D., 2010, SILENT STORIES INSEC; SHEAR WA, 1990, CAN J ZOOL, V68, P1807, DOI 10.1139/z90-262; Shih CK, 2010, ANN ENTOMOL SOC AM, V103, P875, DOI 10.1603/AN09043; Shih CK, 2009, ANN ENTOMOL SOC AM, V102, P20, DOI 10.1603/008.102.0103; Swisher CC, 1999, NATURE, V400, P58, DOI 10.1038/21872; Taeger A, 2010, ZOOTAXA, P1, DOI 10.11646/zootaxa.2580.1.1; Wan XQ, 2007, ACTA GEOL SIN-ENGL, V81, P957; Wang XL, 2005, NATURE, V437, P875, DOI 10.1038/nature03982; Xu X, 2010, NATURE, V464, P1338, DOI 10.1038/nature08965; Zhou ZH, 2005, P NATL ACAD SCI USA, V102, P18998, DOI 10.1073/pnas.0507106102; Zhou ZH, 2003, NATURE, V421, P807, DOI 10.1038/nature01420	31	15	15	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2013	8	5							e62420	10.1371/journal.pone.0062420	http://dx.doi.org/10.1371/journal.pone.0062420			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175AS	23671596	gold, Green Published, Green Submitted			2022-12-27	WOS:000321202100008
J	Villabona-Arenas, CJ; Zanotto, PMD				Villabona-Arenas, Christian Julian; de Andrade Zanotto, Paolo Marinho			Worldwide Spread of Dengue Virus Type 1	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; MOLECULAR EVOLUTION; POPULATION-DYNAMICS; FEVER; PHYLOGEOGRAPHY; EPIDEMIOLOGY; SEROTYPE-3; OUTBREAK; TRANSMISSION; PHILIPPINES	Background: DENV-1 is one of the four viral serotypes that causes Dengue, the most common mosquito-borne viral disease of humans. The prevalence of these viruses has grown in recent decades and is now present in more than 100 countries. Limited studies document the spread of DENV-1 over the world despite its importance for human health. Methodology/Principal Findings: We used representative DENV-1 envelope gene sequences to unravel the dynamics of viral diffusion under a Bayesian phylogeographic approach. Data included strains from 45 distinct geographic locations isolated from 1944 to 2009. The estimated mean rate of nucleotide substitution was 6.56x10(-4) substitutions/site/year. The larger genotypes (I, IV and V) had a distinctive phylogenetic structure and since 1990 they experienced effective population size oscillations. Thailand and Indonesia represented the main sources of strains for neighboring countries. Besides, Asia broadcast lineages into the Americas and the Pacific region that diverged in isolation. Also, a transmission network analysis revealed the pivotal role of Indochina in the global diffusion of DENV-1 and of the Caribbean in the diffusion over the Americas. Conclusions/Significance: The study summarizes the spatiotemporal DENV-1 worldwide spread that may help disease control.	[Villabona-Arenas, Christian Julian; de Andrade Zanotto, Paolo Marinho] Univ Sao Paulo, Dept Microbiol, Inst Biomed Sci, Lab Mol Evolut & Bioinformat, Sao Paulo, Brazil	Universidade de Sao Paulo	Zanotto, PMD (corresponding author), Univ Sao Paulo, Dept Microbiol, Inst Biomed Sci, Lab Mol Evolut & Bioinformat, Sao Paulo, Brazil.	pzanotto@usp.br	de A. Zanotto, Paolo M./B-9286-2019	de A. Zanotto, Paolo M./0000-0002-8167-0625; Villabona Arenas, Christian Julian/0000-0001-9928-3968	FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo) [2010/19059-7]; FAPESP [2011/17071-2]; CNPq - PQ	FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq - PQ(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo) grant 2010/19059-7. CJVA holds the FAPESP scholarship 2011/17071-2 and PMAZ holds a CNPq - PQ scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	A-Nuegoonpipat A, 2004, VIROLOGY, V329, P505, DOI 10.1016/j.virol.2004.08.029; Allicock OM, 2012, MOL BIOL EVOL, V29, P1533, DOI 10.1093/molbev/msr320; Amarasinghe A, 2011, EMERG INFECT DIS, V17, P1349, DOI 10.3201/eid1708.101515; Araujo JMG, 2009, INFECT GENET EVOL, V9, P716, DOI 10.1016/j.meegid.2008.10.005; Aviles G, 2002, ARCH VIROL, V147, P2075, DOI 10.1007/s00705-002-0886-3; Baillie GJ, 2008, MOL PHYLOGENET EVOL, V47, P717, DOI 10.1016/j.ympev.2008.02.015; Barrero PR, 2004, VIRUS RES, V101, P135, DOI 10.1016/j.virusres.2003.12.033; Bielejec F, 2011, BIOINFORMATICS, V27, P2910, DOI 10.1093/bioinformatics/btr481; Bruen TC, 2006, GENETICS, V172, P2665, DOI 10.1534/genetics.105.048975; Caceres C, 2008, ARCH VIROL, V153, P1967, DOI 10.1007/s00705-008-0200-0; Carvalho SES, 2010, VIRUS GENES, V40, P60, DOI 10.1007/s11262-009-0428-0; CDC, 2011, NEGL TROP DIS; Chen RB, 2011, VIRUSES-BASEL, V3, P1562, DOI 10.3390/v3091562; Chen SP, 2011, INFECT GENET EVOL, V11, P1183, DOI 10.1016/j.meegid.2011.03.025; de A Zanotto PM, 2002, MOL EPIDEMIOLOGY HUM, P167; de Laval F, 2012, EMERG INFECT DIS, V18, P342, DOI 10.3201/eid1802.111333; Domingo C, 2011, J TRAVEL MED, V18, P183, DOI 10.1111/j.1708-8305.2011.00501.x; Downs WG, 1973, ARTHROPOD BORNE VIRU; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Duncombe J, 2012, AM J TROP MED HYG, V86, P753, DOI 10.4269/ajtmh.2012.11-0650; Duong V, 2011, INFECT GENET EVOL J, P1; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Effler PV, 2005, EMERG INFECT DIS, V11, P742; FAGBAMI AH, 1977, T ROY SOC TROP MED H, V71, P60, DOI 10.1016/0035-9203(77)90210-3; Fisher RP, 2011, INT J HEALTH GEOGR, V10, DOI 10.1186/1476-072X-10-15; Foster JE, 2004, VIROLOGY, V324, P48, DOI 10.1016/j.virol.2004.03.020; Foster JE, 2003, VIROLOGY, V306, P126, DOI 10.1016/S0042-6822(02)00033-8; Gibbons RV, 2012, EMERG INFECT DIS, V18, P623, DOI 10.3201/eid1804.110134; Goncalvez AP, 2002, VIROLOGY, V303, P110, DOI 10.1006/viro.2002.1686; Gubler D.J., 1998, EMERG INFECT DIS, V1, P1; GUZMAN MG, 1990, AM J TROP MED HYG, V42, P179, DOI 10.4269/ajtmh.1990.42.179; Halasa YA, 2012, AM J TROP MED HYG, V86, P745, DOI 10.4269/ajtmh.2012.11-0784; HAMMON WM, 1960, SCIENCE, V131, P1102, DOI 10.1126/science.131.3407.1102; HENCHAL EA, 1990, CLIN MICROBIOL REV, V3, P376, DOI 10.1128/CMR.3.4.376-396.1990; Hirschler B, 2012, REUTERS; Holmes EC, 2004, MOL ECOL, V13, P745, DOI 10.1046/j.1365-294X.2003.02051.x; Holmes EC, 2008, ANNU REV MICROBIOL, V62, P307, DOI 10.1146/annurev.micro.62.081307.162912; HOTTA S, 1952, J INFECT DIS, V90, P1, DOI 10.1093/infdis/90.1.1; Imrie A, 2006, ANN TROP MED PARASIT, V100, P327, DOI 10.1179/136485906X105589; Ito M, 2007, J TRAVEL MED, V14, P233, DOI 10.1111/j.1708-8305.2007.00130.x; Itrat A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002620; Jansen CC, 2010, MICROBES INFECT, V12, P272, DOI 10.1016/j.micinf.2009.12.011; Jenkins GM, 2002, J MOL EVOL, V54, P156, DOI 10.1007/s00239-001-0064-3; Kantachuvessiri Aree, 2002, Southeast Asian Journal of Tropical Medicine and Public Health, V33, P56; Karabatsos N, 1985, INT CATALOGUE ARBO S; Lambrechts L, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-160; Leal ED, 2000, MEM I OSWALDO CRUZ, V95, P193; Lemey P, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000520; Lepers C, 2002, DEN 1 OUTBREAK PACIF; San Martin JL, 2010, AM J TROP MED HYG, V82, P128, DOI 10.4269/ajtmh.2010.09-0346; May FJ, 2011, J VIROL, V85, P2964, DOI 10.1128/JVI.01963-10; Messer WB, 2003, EMERG INFECT DIS, V9, P800; Mizuno Y, 2012, TRAVEL MED INFECT DI, V10, P86, DOI 10.1016/j.tmaid.2012.02.005; Mondini A, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000448; Pagel M, 2004, SYST BIOL, V53, P673, DOI 10.1080/10635150490522232; PAHO, 1981, EPIDEMIOLOGICAL B, V2, P9; PAHO, 2012, NUMB REP CAS DENG FI; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Raghwani J, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002064; RICOHESSE R, 1990, VIROLOGY, V174, P479, DOI 10.1016/0042-6822(90)90102-W; Ronquist F, 2011, ANNU REV ECOL EVOL S, V42, P441, DOI 10.1146/annurev-ecolsys-102209-144710; SABIN ALBERT B., 1952, AMER JOUR TROP MED AND HYG, V1, P30; Salda LTD, 2005, AM J TROP MED HYG, V73, P796, DOI 10.4269/ajtmh.2005.73.796; Schatzmayr HG, 1986, MEM I O CRUZ, V81, P245, DOI [10.1590/S0074-02761986000200019, DOI 10.1590/S0074-]; SEARO, 2012, REP CAS DF DHF SEL C; Setiati T. E., 2006, Dengue Bulletin, V30, P1; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shepard DS, 2011, AM J TROP MED HYG, V84, P200, DOI 10.4269/ajtmh.2011.10-0503; Simmons CP, 2012, NEW ENGL J MED, V366, P1423, DOI 10.1056/NEJMra1110265; Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675; Stoddard ST, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000481; Strimmer K, 1997, P NATL ACAD SCI USA, V94, P6815, DOI 10.1073/pnas.94.13.6815; Teoh BT, 2010, EMERG INFECT DIS, V16, P1783, DOI 10.3201/eid1611.100721; Thu HM, 2004, EMERG INFECT DIS, V10, P593, DOI 10.3201/eid1004.030216; Twiddy SS, 2003, INFECT GENET EVOL, V3, P87, DOI 10.1016/S1567-1348(02)00153-3; Villabona-Arenas CJ, 2011, INFECT GENET EVOL, V11, P878, DOI 10.1016/j.meegid.2011.02.007; Wang EY, 2000, J VIROL, V74, P3227, DOI 10.1128/JVI.74.7.3227-3234.2000; Weaver SC, 2009, INFECT GENET EVOL, V9, P523, DOI 10.1016/j.meegid.2009.02.003; WHO, 2013, DENGUE; WHO, 2013, 17 NEGL TROP DIS; Wichmann O, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000996; Wilder-Smith A, 2008, MED CLIN N AM, V92, P1377, DOI 10.1016/j.mcna.2008.07.002; WPRO, 2012, DENG SIT UPD; Wu JY, 2010, AM J TROP MED HYG, V83, P664, DOI 10.4269/ajtmh.2010.09-0755; Yamanaka A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027322; Zanotto PMD, 1996, P NATL ACAD SCI USA, V93, P548, DOI 10.1073/pnas.93.2.548; Zhang CL, 2005, J VIROL, V79, P15123, DOI 10.1128/JVI.79.24.15123-15130.2005; Zwickl D. J, 2006, GENETIC ALGORITHM AP	90	57	66	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2013	8	5							e62649	10.1371/journal.pone.0062649	http://dx.doi.org/10.1371/journal.pone.0062649			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145RZ	23675416	Green Published, gold, Green Submitted			2022-12-27	WOS:000319036100005
J	Kaufman, HW; Blatt, AJ; Huang, XH; Odeh, MA; Superko, HR				Kaufman, Harvey W.; Blatt, Amy J.; Huang, Xiaohua; Odeh, Mouneer A.; Superko, H. Robert			Blood Cholesterol Trends 2001-2011 in the United States: Analysis of 105 Million Patient Records	PLOS ONE			English	Article							DENSITY-LIPOPROTEIN CHOLESTEROL; CARDIOVASCULAR-DISEASE PREVENTION; MYOCARDIAL-INFARCTION; CORONARY-DISEASE; NATIONAL-HEALTH; US ADULTS; WOMEN; SIMVASTATIN; PRAVASTATIN; PLASMA	Objectives: We report annual trends in low density lipoprotein cholesterol (LDL-C) from an in-care patient population of nearly 105 million adults across the United States (U. S.), from 2001 through 2011. Background: Average blood cholesterol values have declined in the U. S. since at least 1960. The National Health and Nutrition Examination Survey (NHANES) reported declining blood cholesterol values from 1999 through 2010. In the absence of more recent published data, we examined LDL-C values from a single clinical laboratory database to determine whether these values continued to decline through 2011. Methods and Results: We extracted almost 247 million LDL-C results from nearly 105 million adults who received diagnostic testing from a single national clinical laboratory. Annual age-adjusted mean LDL-C values were calculated, and analyzed by gender. Piecewise regression analysis of the total study population indicates a breakpoint, or change in slope, in the years following 2008 (F = 163.13; p<0.05). Between 2001 and 2008, the average rate of annual decline was -2.05 mg/dL (95% CI [-2.35, -1.75]). After 2008, mean LDL-C levels flattened out, with a slope not statistically different from zero (slope = -0.10 mg/dL/year; 95% CI [-1.46, 1.26]). This stabilization was observed in both genders and all age ranges, and was also reflected in the percentage of results in low-and high-risk categories. Conclusions: The trends reported suggest historical progress in decreasing LDL-C levels, observed from 2001-2008, may have stalled in recent years. Further research is needed to determine the cause of the observed trends and develop new strategies to reduce lipid-based cardiovascular risk further.	[Kaufman, Harvey W.; Odeh, Mouneer A.] Quest Diagnost, Madison, NJ USA; [Blatt, Amy J.; Huang, Xiaohua] Quest Diagnost, West Norriton, PA USA; [Superko, H. Robert] Celera, Alameda, CA USA; [Superko, H. Robert] St Josephs Hosp Atlanta, Atlanta, GA USA		Kaufman, HW (corresponding author), Quest Diagnost, Madison, NJ USA.	Harvey.W.Kaufman@QuestDiagnostics.com	Blatt, Amy/AAO-8058-2020	Superko, H. Robert/0000-0002-3542-0393; Huang, Xiaohua/0000-0003-4150-0477				Bender R, 2001, J CLIN EPIDEMIOL, V54, P343, DOI 10.1016/S0895-4356(00)00314-0; Briel M, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b92; Carroll MD, 2012, JAMA-J AM MED ASSOC, V308, P1545, DOI 10.1001/jama.2012.13260; Carroll MD, 2011, AM J CARDIOL, V107, P1868, DOI 10.1016/j.amjcard.2011.03.047; Cheung BMY, 2004, BRIT J CLIN PHARMACO, V57, P640, DOI 10.1111/j.1365-2125.2003.02060.x; CLIFTON PM, 1994, ATHEROSCLEROSIS, V110, P25, DOI 10.1016/0021-9150(94)90064-7; Ford ES, 2007, NEW ENGL J MED, V356, P2388, DOI 10.1056/NEJMsa053935; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Hague W, 2003, AM HEART J, V145, P643, DOI 10.1067/mhj.2003.1; Hyre AD, 2007, ANN EPIDEMIOL, V17, P548, DOI 10.1016/j.annepidem.2007.01.032; JACOBSON TA, 1994, AM J MED, V96, pS64, DOI 10.1016/0002-9343(94)90234-8; Klein RJ, 2001, STAT NOTES; Kuklina EV, 2009, JAMA-J AM MED ASSOC, V302, P2104, DOI 10.1001/jama.2009.1672; LaRosa JC, 1999, JAMA-J AM MED ASSOC, V282, P2340, DOI 10.1001/jama.282.24.2340; Lewis SJ, 1998, J AM COLL CARDIOL, V32, P140, DOI 10.1016/S0735-1097(98)00202-2; Lloyd-Jones DM, 2010, CIRCULATION, V121, P586, DOI 10.1161/CIRCULATIONAHA.109.192703; Miettinen TA, 1997, CIRCULATION, V96, P4211; Mosca L, 1999, CIRCULATION, V99, P2480, DOI 10.1161/01.CIR.99.18.2480; Mosca L, 2007, J AM COLL CARDIOL, V49, P1230, DOI 10.1016/j.jacc.2007.02.020; Mosca L, 2011, CIRCULATION, V124, P2145, DOI 10.1161/CIRCULATIONAHA.110.968792; Nakajima K, 1999, CLIN THER, V21, P2047, DOI 10.1016/S0149-2918(00)87236-7; Roger VL, 2011, CIRCULATION, V123, pE18, DOI 10.1161/CIR.0b013e3182009701; Shay CM, 2012, CIRCULATION, V125, P45, DOI 10.1161/CIRCULATIONAHA.111.035733; Shepherd J, 2002, LANCET, V360, P1623, DOI 10.1016/S0140-6736(02)11600-X; SUPERKO HR, 1986, JAMA-J AM MED ASSOC, V256, P2714, DOI 10.1001/jama.256.19.2714; U.S. Census Bureau, 2001, CENS 2000 SUMM FIL 1; Vesper HW, 2012, JAMA-J AM MED ASSOC, V307, P562, DOI 10.1001/jama.2012.112	28	18	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2013	8	5							e63416	10.1371/journal.pone.0063416	http://dx.doi.org/10.1371/journal.pone.0063416			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	143FO	23675484	Green Published, Green Submitted, gold			2022-12-27	WOS:000318852400039
J	Lin, YY; Kao, HW; Li, JJ; Hwang, JJ; Tseng, YL; Lin, WJ; Lin, MH; Ting, G; Wang, HE				Lin, Yi-Yu; Kao, Hao-Wen; Li, Jia-Je; Hwang, Jeng-Jong; Tseng, Yun-Long; Lin, Wuu-Jyh; Lin, Ming-Hsien; Ting, Gann; Wang, Hsin-Ell			Tumor Burden Talks in Cancer Treatment with PEGylated Liposomal Drugs	PLOS ONE			English	Article							CELL LUNG-CANCER; X-RAY-SENSITIVITY; AUGER-ELECTRON; THERAPEUTIC-EFFICACY; MONOCLONAL-ANTIBODIES; COLON-CARCINOMA; XENOGRAFT MODEL; HAMSTER-CELLS; BREAST-CANCER; MOUSE MODEL	Purpose: PEGylated liposomes are important drug carriers that can passively target tumor by enhanced permeability and retention (EPR) effect in neoplasm lesions. This study demonstrated that tumor burden determines the tumor uptake, and also the tumor response, in cancer treatment with PEGylated liposomal drugs in a C26/tk-luc colon carcinoma-bearing mouse model. Methods: Empty PEGylated liposomes (NanoX) and those encapsulated with VNB (NanoVNB) were labeled with In-111 to obtain InNanoX and InVNBL in high labeling yield and radiochemical purity (all >90%). BALB/c mice bearing either small (58.4 +/- 8.0 mm(3)) or large (102.4 +/- 22.0 mm(3)) C26/tk-luc tumors in the right dorsal flank were intravenously administered with NanoVNB, InNanoX, InVNBL, or NanoX as a control, every 7 days for 3 times. The therapeutic efficacy was evaluated by body weight loss, tumor growth inhibition (using calipers and bioluminescence imaging) and survival fraction. The scintigraphic imaging of tumor mouse was performed during and after treatment. Results: The biodistribution study of InVNBL revealed a clear inverse correlation (r(2)=0.9336) between the tumor uptake and the tumor mass ranged from 27.6 to 623.9 mg. All three liposomal drugs showed better therapeutic efficacy in small-tumor mice than in large-tumor mice. Tumor-bearing mice treated with InVNBL (a combination drug) showed the highest tumor growth inhibition rate and survival fraction compared to those treated with NanoVNB (chemodrug only) and InNanoX (radionuclide only). Specific tumor targeting and significantly increased tumor uptake after periodical treatment with InVNBL were evidenced by scintigraphic imaging, especially in mice bearing small tumors. Conclusion: The significant differences in the outcomes of cancer treatment and molecular imaging between animals bearing small and large tumors revealed that tumor burden is a critical and discriminative factor in cancer therapy using PEGylated liposomal drugs.	[Lin, Yi-Yu; Kao, Hao-Wen; Li, Jia-Je; Hwang, Jeng-Jong; Wang, Hsin-Ell] Natl Yang Ming Univ, Taipei 112, Taiwan; [Tseng, Yun-Long] Taiwan Liposome Co, Taipei, Taiwan; [Lin, Wuu-Jyh] Inst Nucl Energy Res, Tao Yuan, Taiwan; [Lin, Ming-Hsien] Taipei City Hosp, Zhongxiao Branch, Taipei, Taiwan; [Ting, Gann] Natl Hlth Res Inst, Miaoli, Taiwan	National Yang Ming Chiao Tung University; Institute of Nuclear Energy Research - Taiwan; Taipei City Hospital; National Health Research Institutes - Taiwan	Wang, HE (corresponding author), Natl Yang Ming Univ, Taipei 112, Taiwan.	hewang@ym.edu.tw			National Health Research Institutes (Miaoli, Taiwan, ROC) [97A1-NMPP01-007]; Department of Health, Taipei City Government [99001-62-034, 10001-62-013]	National Health Research Institutes (Miaoli, Taiwan, ROC)(National Health Research Institutes - Taiwan); Department of Health, Taipei City Government	This study was supported by grants from the National Health Research Institutes (Miaoli, Taiwan, ROC) (97A1-NMPP01-007) and the Department of Health, Taipei City Government (99001-62-034 and 10001-62-013). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu Lila AS, 2012, INT J PHARMACEUT, V438, P176, DOI 10.1016/j.ijpharm.2012.08.030; Allen TM, 2004, SCIENCE, V303, P1818, DOI 10.1126/science.1095833; Bajetta E, 1996, J CLIN ONCOL, V14, P2546, DOI 10.1200/JCO.1996.14.9.2546; BEANEY RP, 1984, LANCET, V1, P131; Behr TM, 2000, EUR J NUCL MED, V27, P753, DOI 10.1007/s002590000272; Bradley AJ, 1998, ARCH BIOCHEM BIOPHYS, V357, P185, DOI 10.1006/abbi.1998.0798; Chang CH, 2006, ANTICANCER RES, V26, P159; Chang YJ, 2010, NUCL MED BIOL, V37, P95, DOI 10.1016/j.nucmedbio.2009.08.006; Chen CC, 2007, NUCL INSTRUM METH A, V571, P437, DOI 10.1016/j.nima.2006.10.129; Chen LC, 2008, NUCL MED BIOL, V35, P883, DOI 10.1016/j.nucmedbio.2008.09.005; Chen P, 2003, J NUCL MED, V44, P1469; Cheng WWK, 2008, J CONTROL RELEASE, V126, P50, DOI 10.1016/j.jconrel.2007.11.005; Chow TH, 2008, NUCL MED BIOL, V35, P623, DOI 10.1016/j.nucmedbio.2008.04.001; Chow TH, 2009, J NUCL MED, V50, P2073, DOI 10.2967/jnumed.109.063503; Conroy T, 1996, J CLIN ONCOL, V14, P164, DOI 10.1200/JCO.1996.14.1.164; Dancey JE, 2006, NAT REV DRUG DISCOV, V5, P649, DOI 10.1038/nrd2089; DILLEHAY LE, 1995, INT J RADIAT ONCOL, V33, P417, DOI 10.1016/0360-3016(95)00182-X; Edelstein MP, 1996, SEMIN ONCOL, V23, P41; Fukuoka K, 2001, LUNG CANCER-J IASLC, V34, P451, DOI 10.1016/S0169-5002(01)00265-3; GABIZON A, 1994, CANCER RES, V54, P987; GonzalezCid M, 1997, ANTI-CANCER DRUG, V8, P529, DOI 10.1097/00001813-199706000-00017; GUTMANN R, 1992, CANCER RES, V52, P1993; Harrington KJ, 2000, BRIT J CANCER, V83, P684, DOI 10.1054/bjoc.2000.1320; HILMAS DE, 1974, CANCER, V33, P103, DOI 10.1002/1097-0142(197401)33:1<103::AID-CNCR2820330116>3.0.CO;2-7; HOWELL RW, 1993, RADIAT RES, V134, P71, DOI 10.2307/3578503; Huber PE, 2005, CANCER RES, V65, P3643, DOI 10.1158/0008-5472.CAN-04-1668; JAIN RK, 1990, CANCER RES, V50, pS814; JAIN RK, 1988, CANCER RES, V48, P7022; Jenkins DE, 2003, CLIN EXP METASTAS, V20, P733, DOI 10.1023/B:CLIN.0000006815.49932.98; KEREIAKES JG, 1992, MED PHYS, V19, P1359, DOI 10.1118/1.596925; LASIC DD, 1995, SCIENCE, V267, P1275, DOI 10.1126/science.7871422; Lin YY, 2009, CANCER BIOTHER RADIO, V24, P453, DOI 10.1089/cbr.2008.0572; Mariani G, 2000, J NUCL MED, V41, P1519; Massoud TF, 2003, GENE DEV, V17, P545, DOI 10.1101/gad.1047403; Morgillo F, 2007, CLIN CANCER RES, V13, P2795, DOI 10.1158/1078-0432.CCR-06-2077; Peracchia MT, 1999, J CONTROL RELEASE, V60, P121, DOI 10.1016/S0168-3659(99)00063-2; POTIER P, 1989, SEMIN ONCOL, V16, P2; SENIOR J, 1991, BIOCHIM BIOPHYS ACTA, V1062, P77, DOI 10.1016/0005-2736(91)90337-8; Sgouros G, 2005, J NUCL MED, V46, p18S; SINCLAIR WK, 1966, RADIAT RES, V29, P450, DOI 10.2307/3572025; Stathopoulos GT, 2008, CLIN EXP METASTAS, V25, P43, DOI 10.1007/s10585-007-9100-z; Tan YY, 1999, CLIN CANCER RES, V5, P2157; TERASIMA T, 1963, SCIENCE, V140, P490, DOI 10.1126/science.140.3566.490; Torchilin VP, 2005, NAT REV DRUG DISCOV, V4, P145, DOI 10.1038/nrd1632; Uusijarvi H, 2006, MED PHYS, V33, P3260, DOI 10.1118/1.2229428; Vogel C, 1999, ANN ONCOL, V10, P397, DOI 10.1023/A:1008364222793; Yoshimoto M, 2006, NUCL MED BIOL, V33, P963, DOI 10.1016/j.nucmedbio.2006.08.006	47	21	22	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2013	8	5							e63078	10.1371/journal.pone.0063078	http://dx.doi.org/10.1371/journal.pone.0063078			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	143FO	23675454	gold, Green Submitted, Green Published			2022-12-27	WOS:000318852400023
J	Mullins, PD; Bondarenko, VE				Mullins, Paula D.; Bondarenko, Vladimir E.			A Mathematical Model of the Mouse Ventricular Myocyte Contraction	PLOS ONE			English	Article							FORCE-FREQUENCY-RELATIONSHIP; TRANSGENIC MICE; CARDIAC-MUSCLE; TROPONIN-I; SARCOMERE-LENGTH; CA2+; MECHANISMS; PHOSPHORYLATION; REPOLARIZATION; RELAXATION	Mathematical models of cardiac function at the cellular level include three major components, such as electrical activity, Ca2+ dynamics, and cellular shortening. We developed a model for mouse ventricular myocyte contraction which is based on our previously published comprehensive models of action potential and Ca2+ handling mechanisms. The model was verified with extensive experimental data on mouse myocyte contraction at room temperature. In the model, we implemented variable sarcomere length and indirect modulation of the tropomyosin transition rates by Ca2+ and troponin. The resulting model described well steady-state force-calcium relationships, dependence of the contraction force on the sarcomere length, time course of the contraction force and myocyte shortening, frequency dependence of the contraction force and cellular contraction, and experimentally measured derivatives of the myocyte length variation. We emphasized the importance of the inclusion of variable sarcomere length into a model for ventricular myocyte contraction. Differences in contraction force and cell shortening for epicardial and endocardial ventricular myocytes were investigated. Model applicability for the experimental studies and model limitations were discussed.	[Mullins, Paula D.; Bondarenko, Vladimir E.] Georgia State Univ, Dept Math & Stat, Atlanta, GA 30303 USA; [Bondarenko, Vladimir E.] Georgia State Univ, Inst Neurosci, Atlanta, GA 30303 USA	University System of Georgia; Georgia State University; University System of Georgia; Georgia State University	Bondarenko, VE (corresponding author), Georgia State Univ, Dept Math & Stat, Atlanta, GA 30303 USA.	vbondarenko@gsu.edu			American Heart Association [10GRNT4720012]; Georgia State University Seed Grant from Brain and Behavior Program; Research Initiation Grant	American Heart Association(American Heart Association); Georgia State University Seed Grant from Brain and Behavior Program; Research Initiation Grant	This work was supported by the American Heart Association (10GRNT4720012) (www.heart.org), Georgia State University Seed Grant from Brain and Behavior Program (www.gsu.edu), and Research Initiation Grant to V. E. Bondarenko. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bader PL, 2011, P NATL ACAD SCI USA, V108, P15432, DOI 10.1073/pnas.1112667108; Bers DM, 2001, EXCITATION CONTRACTI; Bondarenko VE, 2004, AM J PHYSIOL-HEART C, V287, pH1378, DOI 10.1152/ajpheart.00185.2003; Bondarenko VE, 2007, AM J PHYSIOL-HEART C, V293, pH1816, DOI 10.1152/ajpheart.00471.2007; Bondarenko VE, 2010, AM J PHYSIOL-HEART C, V299, pH454, DOI 10.1152/ajpheart.00907.2009; Brunet S, 2004, J PHYSIOL-LONDON, V559, P103, DOI 10.1113/jphysiol.2004.063347; Campbell SG, 2008, PHILOS T R SOC A, V366, P3361, DOI 10.1098/rsta.2008.0088; Chu GX, 2002, CARDIOVASC RES, V54, P105, DOI 10.1016/S0008-6363(02)00230-4; Cortassa S, 2006, BIOPHYS J, V91, P1564, DOI [10.1529/biophysj.105.076174, 10.1529/biophysj.106.076174]; Dilly KW, 2006, J PHYSIOL-LONDON, V572, P227, DOI 10.1113/jphysiol.2005.102020; F'entzke RC, 1999, J PHYSIOL-LONDON, V517, P143, DOI 10.1111/j.1469-7793.1999.0143z.x; Flagg TP, 2009, CIRC RES, V104, P95, DOI 10.1161/CIRCRESAHA.108.186809; Fox JJ, 2002, AM J PHYSIOL-HEART C, V282, pH516, DOI 10.1152/ajpheart.00612.2001; Gao WD, 1999, J CLIN INVEST, V103, P661, DOI 10.1172/JCI5220; Glukhov AV, 2010, CIRC RES, V106, P981, DOI 10.1161/CIRCRESAHA.109.204891; Huang L, 2001, AM J PHYSIOL-CELL PH, V280, pC1114, DOI 10.1152/ajpcell.2001.280.5.C1114; HUXLEY AF, 1957, PROG BIOPHYS MOL BIO, V7, P255, DOI 10.1016/S0096-4174(18)30128-8; Ito K, 2000, CIRC RES, V87, P588, DOI 10.1161/01.RES.87.7.588; Ito K, 2001, CIRC RES, V89, P422, DOI 10.1161/hh1701.095522; Jones LR, 1998, J CLIN INVEST, V101, P1385, DOI 10.1172/JCI1362; Jouven X, 2005, NEW ENGL J MED, V352, P1951, DOI 10.1056/NEJMoa043012; Keener J, 2009, MATH PHYSL, VII; Kirchhefer U, 2003, CARDIOVASC RES, V59, P369, DOI 10.1016/S0008-6363(03)00432-2; Kogler H, 2001, AM J PHYSIOL-HEART C, V280, pH2623, DOI 10.1152/ajpheart.2001.280.6.H2623; Konhilas JP, 2003, J PHYSIOL-LONDON, V547, P951, DOI 10.1113/jphysiol.2002.038117; Kushnir A, 2010, P NATL ACAD SCI USA, V107, P10274, DOI 10.1073/pnas.1005843107; Land S, 2012, J PHYSIOL-LONDON, V590, P4553, DOI 10.1113/jphysiol.2012.231928; London B, 2007, J PHYSIOL-LONDON, V578, P115, DOI 10.1113/jphysiol.2006.122622; Matsuoka S, 2004, PROG BIOPHYS MOL BIO, V85, P279, DOI 10.1016/j.pbiomolbio.2004.01.006; McCloskey DT, 2008, AM J PHYSIOL-HEART C, V294, pH205, DOI 10.1152/ajpheart.00829.2007; McCloskey DT, 2003, J MOL CELL CARDIOL, V35, P1207, DOI 10.1016/S0022-2828(03)00227-X; Mohler PJ, 2003, NATURE, V421, P634, DOI 10.1038/nature01335; ORCHARD CH, 1991, CIRC RES, V68, P69, DOI 10.1161/01.RES.68.1.69; Petkova-Kirova PS, 2012, AM J PHYSIOL-HEART C, V302, pH934, DOI 10.1152/ajpheart.00493.2011; Prabhakar R, 2001, J MOL CELL CARDIOL, V33, P1815, DOI 10.1006/jmcc.2001.1445; Preckel B, 2000, ANESTH ANALG, V91, P1327, DOI 10.1097/00000539-200012000-00003; Ramirez-Correa GA, 2010, J MOL CELL CARDIOL, V48, P943, DOI 10.1016/j.yjmcc.2010.01.004; Rice JJ, 1999, AM J PHYSIOL-HEART C, V276, pH1734, DOI 10.1152/ajpheart.1999.276.5.H1734; Rice JJ, 2000, AM J PHYSIOL-HEART C, V278, pH913, DOI 10.1152/ajpheart.2000.278.3.H913; Rice JJ, 2008, BIOPHYS J, V95, P2368, DOI 10.1529/biophysj.107.119487; Schneider NS, 2006, J MOL CELL CARDIOL, V41, P522, DOI 10.1016/j.yjmcc.2006.06.003; Splawski I, 2004, CELL, V119, P19, DOI 10.1016/j.cell.2004.09.011; Stuyvers BD, 2002, J PHYSIOL-LONDON, V544, P817, DOI 10.1113/jphysiol.2002.024430; Trayanova NA, 2011, FRONT PHYSIOL, V2, DOI 10.3389/fphys.2011.00043; Valverde CA, 2006, CARDIOVASC RES, V70, P335, DOI 10.1016/j.cardiores.2006.01.018	45	26	26	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2013	8	5							e63141	10.1371/journal.pone.0063141	http://dx.doi.org/10.1371/journal.pone.0063141			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	155HD	23671664	Green Published, gold			2022-12-27	WOS:000319737700042
J	Mustafa, M; Farooq, MA; Hayat, T; Alsaedi, A				Mustafa, Meraj; Farooq, Muhammad A.; Hayat, Tasawar; Alsaedi, Ahmed			Numerical and Series Solutions for Stagnation-Point Flow of Nanofluid over an Exponentially Stretching Sheet	PLOS ONE			English	Article							BOUNDARY-LAYER-FLOW; MASS-TRANSFER; HEAT-TRANSFER; VISCOELASTIC FLUID; THERMAL-RADIATION; POROUS-MEDIUM; SURFACE	This investigation is concerned with the stagnation-point flow of nanofluid past an exponentially stretching sheet. The presence of Brownian motion and thermophoretic effects yields a coupled nonlinear boundary-value problem (BVP). Similarity transformations are invoked to reduce the partial differential equations into ordinary ones. Local similarity solutions are obtained by homotopy analysis method (HAM), which enables us to investigate the effects of parameters at a fixed location above the sheet. The numerical solutions are also derived using the built-in solver bvp4c of the software MATLAB. The results indicate that temperature and the thermal boundary layer thickness appreciably increase when the Brownian motion and thermophoresis effects are strengthened. Moreover the nanoparticles volume fraction is found to increase when the thermophoretic effect intensifies.	[Mustafa, Meraj] Natl Univ Sci & Technol, Res Ctr Modeling & Simulat, Islamabad, Pakistan; [Farooq, Muhammad A.] Natl Univ Sci & Technol, Ctr Adv Math & Phys, Islamabad, Pakistan; [Hayat, Tasawar] Quaid I Azam Univ, Dept Math, Islamabad, Pakistan; [Hayat, Tasawar; Alsaedi, Ahmed] King Abdulaziz Univ, Dept Math, Fac Sci, Jeddah 21413, Saudi Arabia	National University of Sciences & Technology - Pakistan; National University of Sciences & Technology - Pakistan; Quaid I Azam University; King Abdulaziz University	Mustafa, M (corresponding author), Natl Univ Sci & Technol, Res Ctr Modeling & Simulat, Islamabad, Pakistan.	meraj_mm@hotmail.com	Alsaedi, Ahmed/A-2094-2013; Hayat, Tasawar/A-3853-2013; Farooq, Muhammad Asif/W-6601-2019; Hayat, Tasawar/Y-2524-2019; Mustafa Hashmi, Meraj/P-1769-2014; Hayat, Tasawar/E-9449-2015	Alsaedi, Ahmed/0000-0003-3452-8922; Farooq, Muhammad Asif/0000-0001-6262-145X; 	King Abdulaziz University (KAU) [10-130/1433]	King Abdulaziz University (KAU)	The paper was funded by the Deanship of Scientific Research, King Abdulaziz University (KAU), under grant no. (10-130/1433 Hi Ci). The authors, therefore, acknowledge the technical and financial support of KAU. The support is in the form of project for academic research at KAU. This is to certify that this work is not funded through any external source/research organization including industry etc. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbasbandy S, 2012, INT J NUMER METH FL, V70, P1324, DOI 10.1002/fld.2752; Abbasbandy S, 2011, COMMUN NONLINEAR SCI, V16, P112, DOI 10.1016/j.cnsns.2010.04.004; Bachok N, 2010, PHYS LETT A, V374, P4075, DOI 10.1016/j.physleta.2010.08.032; Bachok N, 2010, INT J THERM SCI, V49, P1663, DOI 10.1016/j.ijthermalsci.2010.01.026; Blasius H., 1908, GRENZSCHICHTEN FLUSS, V1256; Cortell R, 2007, CHEM ENG PROCESS, V46, P721, DOI 10.1016/j.cep.2006.09.008; CRANE LJ, 1970, Z ANGEW MATH PHYS, V21, P645, DOI 10.1007/BF01587695; Daungthongsuk W, 2007, RENEW SUST ENERG REV, V11, P797, DOI 10.1016/j.rser.2005.06.005; Elbashbeshy E. M. A., 2001, Archives of Mechanics, V53, P643; Fang TG, 2012, APPL MATH COMPUT, V218, P7241, DOI 10.1016/j.amc.2011.12.094; Hayat T, 2011, APPL MATH MECH-ENGL, V32, P167, DOI 10.1007/s10483-011-1403-7; Hayat T, 2010, NONLINEAR ANAL-REAL, V11, P3186, DOI 10.1016/j.nonrwa.2009.11.012; Kakac S, 2009, INT J HEAT MASS TRAN, V52, P3187, DOI 10.1016/j.ijheatmasstransfer.2009.02.006; Khan SK, 2005, INT J HEAT MASS TRAN, V48, P1534, DOI 10.1016/j.ijheatmasstransfer.2004.10.032; Khan WA, 2010, INT J HEAT MASS TRAN, V53, P2477, DOI 10.1016/j.ijheatmasstransfer.2010.01.032; Kuznetsov AV, 2010, INT J THERM SCI, V49, P243, DOI 10.1016/j.ijthermalsci.2009.07.015; Liao SJ, 2010, COMMUN NONLINEAR SCI, V15, P2003, DOI 10.1016/j.cnsns.2009.09.002; Liao SJ, 2010, COMMUN NONLINEAR SCI, V15, P1421, DOI 10.1016/j.cnsns.2009.06.008; Liao SJ, 2009, COMMUN NONLINEAR SCI, V14, P983, DOI 10.1016/j.cnsns.2008.04.013; Magyari E, 1999, J PHYS D APPL PHYS, V32, P577, DOI 10.1088/0022-3727/32/5/012; Mahapatra TR, 2004, INT J NONLINEAR MECH, V39, P811, DOI 10.1016/S0020-7462(03)00044-1; Makinde OD, 2011, INT J THERM SCI, V50, P1326, DOI 10.1016/j.ijthermalsci.2011.02.019; Mustafa M, 2012, MECCANICA, V47, P1581, DOI 10.1007/s11012-012-9536-3; Mustafa M, 2012, J APPL MECH-T ASME, V79, DOI 10.1115/1.4005560; Mustafa M, 2011, INT J HEAT MASS TRAN, V54, P5588, DOI 10.1016/j.ijheatmasstransfer.2011.07.021; Mustafa M, 2012, Z NATURFORSCH A, V67, P70, DOI 10.5560/ZNA.2011-0057; Nadeem S, 2010, Z NATURFORSCH A, V65, P495, DOI 10.1515/zna-2010-6-703; Nield DA, 2009, INT J HEAT MASS TRAN, V52, P5792, DOI 10.1016/j.ijheatmasstransfer.2009.07.024; RAJAGOPAL KR, 1984, RHEOL ACTA, V23, P213, DOI 10.1007/BF01332078; Rana P, 2012, COMMUN NONLINEAR SCI, V17, P212, DOI 10.1016/j.cnsns.2011.05.009; Rashidi MM, 2011, COMMUN NONLINEAR SCI, V16, P1874, DOI 10.1016/j.cnsns.2010.08.016; Sajid M, 2008, INT COMMUN HEAT MASS, V35, P347, DOI 10.1016/j.icheatmasstransfer.2007.08.006; SAKIADIS BC, 1961, AICHE J, V7, P26, DOI 10.1002/aic.690070108; Shampine LF, 2003, SOLVING BOUNDARY VAL; Wang XQ, 2008, BRAZ J CHEM ENG, V25, P631, DOI 10.1590/S0104-66322008000400002; Wang XQ, 2008, BRAZ J CHEM ENG, V25, P613, DOI 10.1590/S0104-66322008000400001; Yacob NA, 2011, INT COMMUN HEAT MASS, V38, P149, DOI 10.1016/j.icheatmasstransfer.2010.12.003	37	40	40	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2013	8	5							e61859	10.1371/journal.pone.0061859	http://dx.doi.org/10.1371/journal.pone.0061859			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	155HD	23671576	gold, Green Submitted, Green Published			2022-12-27	WOS:000319737700007
J	Parker, JC; Thavagnanam, S; Skibinski, G; Lyons, J; Bell, J; Heaney, LG; Shields, MD				Parker, Jeremy C.; Thavagnanam, Surendran; Skibinski, Grzegorz; Lyons, Jeremy; Bell, Jennifer; Heaney, Liam G.; Shields, Michael D.			Chronic IL9 and IL-13 Exposure Leads to an Altered Differentiation of Ciliated Cells in a Well-Differentiated Paediatric Bronchial Epithelial Cell Model	PLOS ONE			English	Article							ASTHMA; INFLAMMATION; PATHOGENESIS; CULTURE	Asthma is a chronic inflammatory disease characterised by airways remodelling. In mouse models IL-9 and IL-13 have been implicated in airways remodelling including mucus hypersecretion and goblet cell hyperplasia. Their role, especially that of IL-9, has been much less studied in authentic human ex vivo models of the bronchial epithelium from normal and asthmatic children. We assessed the effects of IL-9, IL-13 and an IL-9/IL-13 combination, during differentiation of bronchial epithelial cells from normal (n = 6) and asthmatic (n = 8) children. Cultures were analysed for morphological markers and factors associated with altered differentiation (MUC5AC, SPDEF and MMP-7). IL-9, IL-9/IL-13 combination and IL-13 stimulated bronchial epithelial cells from normal children had fewer ciliated cells [14.8% (SD 8.9), p = 0.048, 12.4 (SD 6.1), p = 0.016 and 7.3% (SD 6.6), p = 0.031] respectively compared with unstimulated [(21.4% (SD 9.6)]. IL-9 stimulation had no effect on goblet cell number in either group whereas IL-9/IL-13 combination and IL-13 significantly increased goblet cell number [24.8% (SD 8.8), p = 0.02), 32.9% (SD 8.6), p = 0.007] compared with unstimulated normal bronchial cells [(18.6% (SD 6.2)]. All stimulations increased MUC5AC mRNA in bronchial epithelial cells from normal children and increased MUC5AC mucin secretion. MMP-7 localisation was dysregulated in normal bronchial epithelium stimulated with Th2 cytokines which resembled the unstimulated bronchial epithelium of asthmatic children. All stimulations resulted in a significant reduction in transepithelial electrical resistance values over time suggesting a role in altered tight junction formation. We conclude that IL-9 does not increase goblet cell numbers in bronchial epithelial cell cultures from normal or asthmatic children. IL-9 and IL-13 alone and in combination, reduce ciliated cell numbers and transepithelial electrical resistance during differentiation of normal epithelium, which clinically could inhibit mucociliary clearance and drive an altered repair mechanism. This suggests an alternative role for IL-9 in airways remodelling and reaffirms IL-9 as a potential therapeutic target.	[Parker, Jeremy C.; Skibinski, Grzegorz; Bell, Jennifer; Heaney, Liam G.; Shields, Michael D.] Queens Univ Belfast, Ctr Infect & Immun, Belfast, Antrim, North Ireland; [Shields, Michael D.] Belfast Hlth & Social Care Trust, Royal Belfast Hosp Sick Children, Belfast, Antrim, North Ireland; [Lyons, Jeremy] Belfast Hlth & Social Care Trust, Royal Hosp, Belfast, Antrim, North Ireland; [Thavagnanam, Surendran] Univ Malaya, Med Ctr, Dept Paediat, Kuala Lumpur, Malaysia	Queens University Belfast; Universiti Malaya	Heaney, LG (corresponding author), Queens Univ Belfast, Ctr Infect & Immun, Belfast, Antrim, North Ireland.	l.heaney@qub.ac.uk		thavagnanam, surendran/0000-0002-4414-7915; Parker, Jeremy/0000-0002-3935-7563	Northern Ireland Chest Heart and Stroke Association [200546]; The Royal Belfast Hospital for Sick Children; The Irish Thoracic Society Boehringer Ingleheim Research Fellowship; Medimmune; Novartis UK; Genentech Inc; Glaxo Smith Kline; Merck Sharpe Dohme; Nycomed; Novartis; Astra Zeneca; Chiesi; Public Health Agency [RRG/3244/05] Funding Source: researchfish	Northern Ireland Chest Heart and Stroke Association; The Royal Belfast Hospital for Sick Children; The Irish Thoracic Society Boehringer Ingleheim Research Fellowship; Medimmune(AstraZenecaMedimmune); Novartis UK(Novartis); Genentech Inc(Roche HoldingGenentech); Glaxo Smith Kline(GlaxoSmithKline); Merck Sharpe Dohme(Merck & Company); Nycomed; Novartis(Novartis); Astra Zeneca(AstraZeneca); Chiesi(Chiesi Pharmaceuticals Inc); Public Health Agency	This work was supported by the Northern Ireland Chest Heart and Stroke Association (grant number 200546), The Royal Belfast Hospital for Sick Children and The Irish Thoracic Society Boehringer Ingleheim Research Fellowship. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The following authors have declared that no competing interests exist: Jeremy Parker, Surendran Thavagnanam, Grzegorz Skibinski, Jennifer Bell, Jeremy Lyons. The authors have read the journal's policy and have the following conflicts: Liam Heaney has received grant funding from Medimmune, Novartis UK, Genentech Inc, and Glaxo Smith Kline, has taken part in Advisory Boards and given lectures at meetings supported by Glaxo Smith Kline, Merck Sharpe & Dohme, Nycomed, Novartis and Astra Zeneca. He has received support funding to attend International Respiratory meetings (Astra Zeneca, Chiesi, Novartis and Glaxo Smith Kline) and has taken part in asthma clinical trials (GSK and Genentech) for which his Institution was remunerated. None of these activities have any direct relationship to the content of this manuscript. Michael Shields has no direct competing interests relating to this study but does declare that he has delivered lectures at educational events and received honoraria from GlaxoSmithKline, AstraZeneca, Merck Sharp & Dohme, Novartis and Alk Abello. In addition, he has received educational grant support to attend the British Thoracic and European Respiratory Societies annual meetings from Novartis and GlaxoSmithKline. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Bateman ED, 2008, ALLERGY, V63, P932, DOI 10.1111/j.1398-9995.2008.01724.x; Bousquet J, 2000, AM J RESP CRIT CARE, V161, P1720, DOI 10.1164/ajrccm.161.5.9903102; Coyle PV, 2004, BMC MICROBIOL, V4, DOI 10.1186/1471-2180-4-41; Cutz E, 2002, Histopathology, V41, P22; Doherty GM, 2003, CLIN EXP ALLERGY, V33, P1221, DOI 10.1046/j.1365-2222.2003.01752.x; Fulcher M Leslie, 2005, Methods Mol Med, V107, P183; Global Initiative for Asthma (GINA), 2011, GLOB STRAT ASTHM MAN; Gray TE, 1996, AM J RESP CELL MOL, V14, P104, DOI 10.1165/ajrcmb.14.1.8534481; Haitchi HM, 2011, AM J RESP CRIT CARE, V183, pA2771; Holgate ST, 2007, J ALLERGY CLIN IMMUN, V120, P1233, DOI 10.1016/j.jaci.2007.10.025; Holgate ST, 2010, DISCOV MED, V9, P439; Holgate ST, 2009, IMMUNITY, V31, P362, DOI 10.1016/j.immuni.2009.08.013; Jeffery PK, 2001, AM J RESP CRIT CARE, V164, pS28, DOI 10.1164/ajrccm.164.supplement_2.2106061; Lenney W, 2012, MEDICINE, V40, P238; Longphre M, 1999, J CLIN INVEST, V104, P1375, DOI 10.1172/JCI6097; Nicolaides NC, 1997, P NATL ACAD SCI USA, V94, P13175, DOI 10.1073/pnas.94.24.13175; Parker J, 2010, PEDIATR RES, V67, P17, DOI 10.1203/PDR.0b013e3181c0b200; Parker JM, 2011, BMC PULM MED, V11, DOI 10.1186/1471-2466-11-14; Pezzulo AA, 2011, AM J PHYSIOL-LUNG C, V300, pL25, DOI 10.1152/ajplung.00256.2010; Pohunek P, 2005, PEDIAT ALLERG IMM-UK, V16, P43, DOI 10.1111/j.1399-3038.2005.00239.x; Takeyama K, 1999, P NATL ACAD SCI USA, V96, P3081, DOI 10.1073/pnas.96.6.3081; Temann UA, 2007, INT IMMUNOL, V19, P1, DOI 10.1093/intimm/dxl117; Thavagnanam S, 2011, PEDIATR RES, V69, P95, DOI 10.1203/PDR.0b013e318204edb5; Thomas B, 2010, J ALLERGY CLIN IMMUN, V126, P722, DOI 10.1016/j.jaci.2010.05.046; Vermeer PD, 2003, AM J RESP CELL MOL, V28, P286, DOI 10.1165/rcmb.4887; Wadsworth SJ, 2010, J ALLERGY CLIN IMMUN, V126, P366, DOI 10.1016/j.jaci.2010.05.015; Xiang LL, 2008, AM J RESP CELL MOL, V38, P310, DOI 10.1165/rcmb.2007-0078OC; Xiao C, 2011, J ALLERGY CLIN IMMUN, V128, P549, DOI 10.1016/j.jaci.2011.05.038; Xing JC, 2011, J ASTHMA, V48, P115, DOI 10.3109/02770903.2011.554944; Zhou YH, 2001, RESP RES, V2, P80, DOI 10.1186/rr42	30	34	37	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2013	8	5							e61023	10.1371/journal.pone.0061023	http://dx.doi.org/10.1371/journal.pone.0061023			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	155HD	23671562	Green Submitted, Green Published, gold			2022-12-27	WOS:000319737700001
J	Qin, Z; Lv, HJ; Zhu, XL; Meng, C; Quan, TY; Wang, MC; Xia, GM				Qin, Zhen; Lv, Hongjun; Zhu, Xinlei; Meng, Chen; Quan, Taiyong; Wang, Mengcheng; Xia, Guangmin			Ectopic Expression of a Wheat WRKY Transcription Factor Gene TaWRKY71-1 Results in Hyponastic Leaves in Arabidopsis thaliana	PLOS ONE			English	Article							AUXIN HOMEOSTASIS; AGROPYRON-ELONGATUM; LEAF; GROWTH; OSWRKY71; MUTATION; MUTANTS; ENCODES	Leaf type is an important trait that closely associates with crop yield. WRKY transcription factors exert diverse regulatory effects in plants, but their roles in the determination of leaf type have not been reported so far. In this work, we isolated a WRKY transcription factor gene TaWRKY71-1 from a wheat introgression line SR3, which has larger leaves, superior growth capacity and higher yield than its parent common wheat JN177. TaWRKY71-1 specifically expressed in leaves, and produced more mRNA in SR3 than in JN177. TaWRKY71-1 localized in the nucleus and had no transcriptional activation activity. TaWRKY71-1 overexpression in Arabidopsis resulted in hyponastic rosette leaves, and the hyponastic strength was closely correlative with the transcription level of the transgene. The spongy mesophyll cells at abaxial side of leaves were drastically compacted by TaWRKY71-1 overexpression. In TaWRKY71-1 overexpression Arabidopsis, the expression of IAMT1 that encodes a methyltransferase converting free indole-3-acetic acid (IAA) to methyl-IAA ester (MeIAA) to alter auxin homeostatic level was induced, and the induction level was dependent on the abundance of TaWRKY71-1 transcripts. Besides, several TCP genes that had found to be restricted by IAMT1 had lower expression levels as well. Our results suggest that TaWRKY71-1 causes hyponastic leaves through altering auxin homeostatic level by promoting the conversion of IAA to MeIAA.	[Qin, Zhen; Lv, Hongjun; Zhu, Xinlei; Meng, Chen; Quan, Taiyong; Wang, Mengcheng; Xia, Guangmin] Shandong Univ, Sch Life Sci, Minist Educ, Key Lab Plant Cell Engn & Germplasm Innovat, Jinan 250100, Shandong, Peoples R China	Shandong University	Wang, MC (corresponding author), Shandong Univ, Sch Life Sci, Minist Educ, Key Lab Plant Cell Engn & Germplasm Innovat, Jinan 250100, Shandong, Peoples R China.	wangmc@sdu.edu.cn; xiagm@sdu.edu.cn			National Transgenic Project [2011ZX08002-002]; National Basic Research 973 Program of China [2012CB114204, 2009CB118300]; Natural Science Foundation of China [31030053, 31171175]; Excellent Young Scientist Award Foundation of Shandong Province [BS2009SW023]; College Innovation Foundation of Jinan City [200906021]	National Transgenic Project; National Basic Research 973 Program of China(National Basic Research Program of China); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Excellent Young Scientist Award Foundation of Shandong Province; College Innovation Foundation of Jinan City	This work was supported by National Transgenic Project (2011ZX08002-002), National Basic Research 973 Program of China (2012CB114204; 2009CB118300), Major Program of Natural Science Foundation of China (31030053), Natural Science Foundation of China (31171175), Excellent Young Scientist Award Foundation of Shandong Province (BS2009SW023), College Innovation Foundation of Jinan City (200906021). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barlier I, 2000, P NATL ACAD SCI USA, V97, P14819, DOI 10.1073/pnas.260502697; Chen Z, 2001, JIANGSU AGR RES, V22, P81; Cheng YF, 2007, PLANT CELL, V19, P2430, DOI 10.1105/tpc.107.053009; Chujo T, 2008, BIOSCI BIOTECH BIOCH, V72, P240, DOI 10.1271/bbb.70553; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; D'Auria JC, 2003, RECENT ADV PHYTOCHEM, V37, P95, DOI DOI 10.1016/S0079-9920(03)80026-6; Delarue M, 1998, PLANT J, V14, P603, DOI 10.1046/j.1365-313X.1998.00163.x; Govaerts YM, 1996, APPL OPTICS, V35, P6585, DOI 10.1364/AO.35.006585; Harper RM, 2000, PLANT CELL, V12, P757, DOI 10.1105/tpc.12.5.757; Jackson RG, 2002, PLANT J, V32, P573, DOI 10.1046/j.1365-313X.2002.01445.x; Kiehl TR, 2011, CYTOM PART A, V79A, P560, DOI 10.1002/cyto.a.21076; King JJ, 1995, PLANT CELL, V7, P2023, DOI 10.1105/tpc.7.12.2023; Kosugi S, 2003, PLANT PHYSIOL, V132, P2012, DOI 10.1104/pp.103.025080; Lang YouZhong, 2004, Acta Agronomica Sinica, V30, P883; Lee SS, 2003, PLANT J, V33, P825, DOI 10.1046/j.1365-313X.2003.01672.x; Li LC, 2008, NEW PHYTOL, V179, P751, DOI 10.1111/j.1469-8137.2008.02514.x; Li X, 2008, PLANT MOL BIOL, V66, P315, DOI 10.1007/s11103-007-9272-6; LINCOLN C, 1990, PLANT CELL, V2, P1071, DOI 10.1105/tpc.2.11.1071; Liu SW, 2008, THEOR APPL GENET, V116, P325, DOI 10.1007/s00122-007-0669-z; Liu XQ, 2007, J PLANT PHYSIOL, V164, P969, DOI 10.1016/j.jplph.2006.07.006; Nath U, 2003, SCIENCE, V299, P1404, DOI 10.1126/science.1079354; Qin GJ, 2005, PLANT CELL, V17, P2693, DOI 10.1105/tpc.105.034959; ROMANO CP, 1995, PLANT MOL BIOL, V27, P1071, DOI 10.1007/BF00020881; Rushton PJ, 2010, TRENDS PLANT SCI, V15, P247, DOI 10.1016/j.tplants.2010.02.006; Tadege M, 2011, PLANT CELL, V23, P2125, DOI 10.1105/tpc.111.085340; Tao Q, 2013, PLANT CELL, DOI tpc.113.109223; Ulmasov T, 1999, P NATL ACAD SCI USA, V96, P5844, DOI 10.1073/pnas.96.10.5844; Varaud E, 2011, PLANT CELL, V23, P973, DOI 10.1105/tpc.110.081653; Xia GM, 2003, THEOR APPL GENET, V107, P299, DOI 10.1007/s00122-003-1247-7; Yoo SD, 2007, NAT PROTOC, V2, P1565, DOI 10.1038/nprot.2007.199; Yuan L.P., 1997, HYBRID RICE, V12, P1, DOI DOI 10.16267/J.CNKI.1005-3956.1997.06.001; Zhao YD, 2001, SCIENCE, V291, P306, DOI 10.1126/science.291.5502.306; Zubieta C, 2003, PLANT CELL, V15, P1704, DOI 10.1105/tpc.014548	33	14	19	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2013	8	5							e63033	10.1371/journal.pone.0063033	http://dx.doi.org/10.1371/journal.pone.0063033			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	155HD	23671653	gold, Green Submitted, Green Published			2022-12-27	WOS:000319737700035
J	Chen, K; Hsu, LT; Wu, CY; Chang, SY; Huang, HT; Chen, W				Chen, Kevin; Hsu, Lih-Tao; Wu, Cheng-Yi; Chang, Shiun-Yin; Huang, Hui-Ting; Chen, Wannhsin			CBARA1 Plays a Role in Stemness and Proliferation of Human Embryonic Stem Cells	PLOS ONE			English	Article							SELF-RENEWAL; ADHESION MOLECULE; CA2+ UPTAKE; DIFFERENTIATION; PLURIPOTENCY; MAINTENANCE; CULTURE; COMPLEX; PROTEIN; GROWTH	Human embryonic stem cells (hESCs) are capable of unlimited self-renewal and can generate almost all of the cells in the body. Although some pluripotency factors have been identified, much remains unclear regarding the molecules and mechanisms that regulate hESC self-renewal and pluripotency. In this study, we identified a mitochondrial gene, CBARA1, that is expressed in undifferentiated hESCs and that is down-regulated rapidly after cellular differentiation. To study its role in hESCs, endogenous CBARA1 expression was knocked down using shRNA. CBARA1 knockdown in hESCs resulted in down-regulation of Oct4 and Nanog expression, attenuated cell growth, and G0/G1 phase cell cycle arrest; however, knockdown did not noticeably affect apoptosis. Taken together, these results suggest that CBARA1 is a marker for undifferentiated hESCs that plays a role in maintaining stemness, cell cycle progression, and proliferation.	[Chen, Kevin; Hsu, Lih-Tao; Wu, Cheng-Yi; Chang, Shiun-Yin; Huang, Hui-Ting; Chen, Wannhsin] Ind Technol Res Inst, Fac Biomed Technol & Device Res, Dept Tissue Regenerat Prod Technol, Hsinchu, Taiwan	Industrial Technology Research Institute - Taiwan	Chen, K (corresponding author), Ind Technol Res Inst, Fac Biomed Technol & Device Res, Dept Tissue Regenerat Prod Technol, Hsinchu, Taiwan.	k.chen@itri.org.tw			Ministry of Economic Affairs of Taiwan	Ministry of Economic Affairs of Taiwan(Ministry of Economic Affairs, Taiwan)	This research was supported by funding from the Advanced Research Program Fund from the Ministry of Economic Affairs of Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aichberger KJ, 2005, J IMMUNOL, V175, P1286, DOI 10.4049/jimmunol.175.2.1286; Armstrong L, 2006, HUM MOL GENET, V15, P1894, DOI 10.1093/hmg/ddl112; Bendall SC, 2007, NATURE, V448, P1015, DOI 10.1038/nature06027; Besser D, 2004, J BIOL CHEM, V279, P45076, DOI 10.1074/jbc.M404979200; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Bruce SJ, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-365; Cai JL, 2006, STEM CELLS, V24, P516, DOI 10.1634/stemcells.2005-0143; Chen ACH, 2012, CELL TISSUE RES, V350, P289, DOI 10.1007/s00441-012-1476-7; Chen HF, 2010, TISSUE ENG PT A, V16, P2901, DOI 10.1089/ten.tea.2009.0722; Cheng EH, 2008, REPROD BIOMED ONLINE, V17, P436, DOI 10.1016/S1472-6483(10)60229-5; Chew JL, 2005, MOL CELL BIOL, V25, P6031, DOI 10.1128/MCB.25.14.6031-6046.2005; De Stefani D, 2011, NATURE, V476, P336, DOI 10.1038/nature10230; Eiselleova L, 2009, STEM CELLS, V27, P1847, DOI 10.1002/stem.128; Forristal CE, 2010, REPRODUCTION, V139, P85, DOI 10.1530/REP-09-0300; Gerrard L, 2005, STEM CELLS, V23, P1234, DOI 10.1634/stemcells.2005-0110; Hyslop L, 2005, STEM CELLS, V23, P1035, DOI 10.1634/stemcells.2005-0080; Levenstein ME, 2006, STEM CELLS, V24, P568, DOI 10.1634/stemcells.2005-0247; Li J, 2007, DIFFERENTIATION, V75, P299, DOI 10.1111/j.1432-0436.2006.00143.x; Li L, 2012, CELL ADHES MIGR, V6, P59, DOI 10.4161/cam.19583; Lu TY, 2010, J BIOL CHEM, V285, P8719, DOI 10.1074/jbc.M109.077081; Ludwig TE, 2006, NAT METHODS, V3, P637, DOI 10.1038/NMETH902; Mandal S, 2011, STEM CELLS, V29, P486, DOI 10.1002/stem.590; Matin MM, 2004, STEM CELLS, V22, P659, DOI 10.1634/stemcells.22-5-659; Nunez L, 2006, J PHYSIOL-LONDON, V571, P57, DOI 10.1113/jphysiol.2005.100586; Perocchi F, 2010, NATURE, V467, P291, DOI 10.1038/nature09358; Prigione A, 2010, STEM CELLS, V28, P721, DOI 10.1002/stem.404; Richards M, 2002, NAT BIOTECHNOL, V20, P933, DOI 10.1038/nbt726; Schieke SM, 2008, J BIOL CHEM, V283, P28506, DOI 10.1074/jbc.M802763200; Shen JH, 2011, MOL CELL BIOL, V31, P4902, DOI 10.1128/MCB.05629-11; Son YS, 2011, STEM CELLS, V29, P2094, DOI 10.1002/stem.754; Spitkovsky D, 2004, FASEB J, V18, P1300, DOI 10.1096/fj.03-0520fje; Tan SM, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm704; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Todd LR, 2010, AUTOPHAGY, V6, P821, DOI 10.1091/mbc.E09-11-0937; Vallier L, 2005, J CELL SCI, V118, P4495, DOI 10.1242/jcs.02553; Varum S, 2009, STEM CELL RES, V3, P142, DOI 10.1016/j.scr.2009.07.002; Wong CK, 2012, J CELL PHYSIOL, V227, P2519, DOI 10.1002/jcp.22990; Wong Raymond C B, 2012, Methods Mol Biol, V874, P167, DOI 10.1007/978-1-61779-800-9_13	38	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2013	8	5							e63653	10.1371/journal.pone.0063653	http://dx.doi.org/10.1371/journal.pone.0063653			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145YI	23667653	Green Published, Green Submitted, gold			2022-12-27	WOS:000319055600066
J	Krotova, O; Starodubova, E; Petkov, S; Kostic, L; Agapkina, J; Hallengard, D; Viklund, A; Latyshev, O; Gelius, E; Dillenbeck, T; Karpov, V; Gottikh, M; Belyakov, IM; Lukashov, V; Isaguliants, MG				Krotova, Olga; Starodubova, Elizaveta; Petkov, Stefan; Kostic, Linda; Agapkina, Julia; Hallengard, David; Viklund, Alecia; Latyshev, Oleg; Gelius, Eva; Dillenbeck, Tomas; Karpov, Vadim; Gottikh, Marina; Belyakov, Igor M.; Lukashov, Vladimir; Isaguliants, Maria G.			Consensus HIV-1 FSU-A Integrase Gene Variants Electroporated into Mice Induce Polyfunctional Antigen-Specific CD4+and CD8+T Cells	PLOS ONE			English	Article							CD4(+) T-CELLS; DRUG-RESISTANCE MUTATIONS; HIGH-LEVEL EXPRESSION; DNA VACCINE; REVERSE-TRANSCRIPTASE; LYMPHOCYTE RESPONSES; PARTIAL PROTECTION; IMMUNE-RESPONSES; IMMUNOGENICITY; IDENTIFICATION	Our objective is to create gene immunogens targeted against drug-resistant HIV-1, focusing on HIV-1 enzymes as critical components in viral replication and drug resistance. Consensus-based gene vaccines are specifically fit for variable pathogens such as HIV-1 and have many advantages over viral genes and their expression-optimized variants. With this in mind, we designed the consensus integrase (IN) of the HIV-1 clade A strain predominant in the territory of the former Soviet Union and its inactivated derivative with and without mutations conferring resistance to elvitegravir. Humanized IN gene was synthesized; and inactivated derivatives (with 64D in the active site mutated to V) with and without elvitegravir-resistance mutations were generated by site-mutagenesis. Activity tests of IN variants expressed in E coli showed the consensus IN to be active, while both D64V-variants were devoid of specific activities. IN genes cloned in the DNA-immunization vector pVax1 (pVaxIN plasmids) were highly expressed in human and murine cell lines (>0.7 ng/cell). Injection of BALB/c mice with pVaxIN plasmids followed by electroporation generated potent IFN-gamma and IL-2 responses registered in PBMC by day 15 and in splenocytes by day 23 after immunization. Multiparametric FACS demonstrated that CD8+ and CD4+ T cells of gene-immunized mice stimulated with IN-derived peptides secreted IFN-gamma, IL-2, and TNF-alpha. The multi-cytokine responses of CD8+ and CD4+ T-cells correlated with the loss of in vivo activity of the luciferase reporter gene co-delivered with pVaxIN plasmids. This indicated the capacity of IN-specific CD4+ and CD8+ T-cells to clear IN/reporter coexpressing cells from the injection sites. Thus, the synthetic HIV-1 clade A integrase genes acted as potent immunogens generating polyfunctional Th1-type CD4+ and CD8+ T cells. Generation of such response is highly desirable for an effective HIV-1 vaccine as it offers a possibility to attack virus-infected cells via both MHC class I and II pathways.	[Krotova, Olga; Starodubova, Elizaveta; Petkov, Stefan; Kostic, Linda; Hallengard, David; Viklund, Alecia; Isaguliants, Maria G.] Karolinska Inst, Dept Microbiol Tumor & Cell Biol, Stockholm, Sweden; [Krotova, Olga; Latyshev, Oleg; Lukashov, Vladimir; Isaguliants, Maria G.] DI Ivanovskii Inst Virol, Moscow, Russia; [Krotova, Olga; Starodubova, Elizaveta; Agapkina, Julia; Karpov, Vadim] WA Engelhardt Inst Mol Biol, Moscow, Russia; [Gelius, Eva; Dillenbeck, Tomas] Mabtech AB, Stockholm, Sweden; [Gottikh, Marina] Moscow MV Lomonosov State Univ, Belozersky Inst Physicochem Biol, Moscow, Russia; [Belyakov, Igor M.] Univ Michigan, Sch Med, Michigan Nanotechnol Inst Med & Biol Sci, Ann Arbor, MI USA; [Belyakov, Igor M.] Univ Michigan, Sch Med, Dept Internal Med, Ann Arbor, MI USA; [Lukashov, Vladimir] Univ Amsterdam, Acad Med Ctr, Dept Med Microbiol, NL-1105 AZ Amsterdam, Netherlands	Karolinska Institutet; Russian Academy of Medical Sciences; Gamaleya National Research Center for Epidemiology & Microbiology, RAMS; Russian Academy of Sciences; Engelhardt Institute of Molecular Biology, RAS; Lomonosov Moscow State University; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Amsterdam; Academic Medical Center Amsterdam	Isaguliants, MG (corresponding author), Karolinska Inst, Dept Microbiol Tumor & Cell Biol, Stockholm, Sweden.	Maria.Issagouliantis@ki.se	Gottikh, Marina/D-7575-2012; Agapkina, Julia/I-5558-2012; Starodubova, Elizaveta S/Q-4439-2016; , ISSAGOULIANTIS/AAI-3148-2021; Eliseeva, Olesia/AGN-6838-2022; Karpov, Vadim/G-7932-2014	Starodubova, Elizaveta S/0000-0003-2183-0858; , ISSAGOULIANTIS/0000-0001-9382-2254; Latyshev, Oleg/0000-0002-5757-3809	Swedish Research Council [K2011-79X-21744-01-6]; Swedish Institute; Russian Foundation for Basic Research [11-04-01569-a]; Russian Federal Agency for Science and Innovation [02.512.11.2291]; Russian Federation for young PhDs [MK-5287.2011.4]	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Institute; Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); Russian Federal Agency for Science and Innovation(Federal Agency for Science & Innovations (FASI)); Russian Federation for young PhDs	Financial support in the form of Swedish Research Council grant K2011-79X-21744-01-6 (www.vr.se); the New Visby program of the Swedish Institute (http://www.studyinsweden.se/Scholarships/SI-scholarships/Visby-Program/); Russian Foundation for Basic Research (http://www.rfbr.ru/rffi/ru/) grant 11-04-01569-a; Russian Federal Agency for Science and Innovation (http://www.fasi.gov.ru/), grant 02.512.11.2291; and a grant from the President of the Russian Federation for young PhDs (http://grants.extech.ru/z_otch2004.php?mlevel = 100/) MK-5287.2011.4 are gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdulhaqq SA, 2008, IMMUNOL RES, V42, P219, DOI 10.1007/s12026-008-8076-3; Agapkina J, 2006, J BIOL CHEM, V281, P11530, DOI 10.1074/jbc.M512271200; Almeida JR, 2007, J EXP MED, V204, P2473, DOI 10.1084/jem.20070784; Almeida JR, 2009, BLOOD, V113, P6351, DOI 10.1182/blood-2009-02-206557; [Anonymous], 2012, GLOB REP UNAIDS REP; Arenas M, 2010, CURR HIV RES, V8, P613, DOI 10.2174/157016210794088263; Asante-Appiah E, 1999, ADV VIRUS RES, V52, P351, DOI 10.1016/S0065-3527(08)60306-1; Azzi S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0016001; Bahloul C, 2006, VACCINE, V24, P1063, DOI 10.1016/j.vaccine.2005.09.016; Barouch DH, 2010, ANNU REV MED, V61, P153, DOI 10.1146/annurev.med.042508.093728; Belyakov IM, 2006, BLOOD, V107, P3258, DOI 10.1182/blood-2005-11-4374; Belz GT, 2001, J IMMUNOL, V166, P4627, DOI 10.4049/jimmunol.166.7.4627; Betts MR, 2006, BLOOD, V107, P4781, DOI 10.1182/blood-2005-12-4818; Blanco JL, 2011, J INFECT DIS, V203, P1204, DOI 10.1093/infdis/jir025; Boberg A, 2008, EXPERT REV VACCINES, V7, P131, DOI 10.1586/14760584.7.1.131; Bobkov AF, 2004, J MED VIROL, V74, P191, DOI 10.1002/jmv.20177; Boyd SD, 2011, ANTIVIR THER, V16, P257, DOI 10.3851/IMP1749; Breathnach CC, 2006, VACCINE, V24, P1180, DOI 10.1016/j.vaccine.2005.08.091; Brown DM, 2012, J VIROL, V86, P6792, DOI 10.1128/JVI.07172-11; Brown DM, 2009, CELL IMMUNOL, V257, P69, DOI 10.1016/j.cellimm.2009.03.002; Buchbinder SP, 2008, LANCET, V372, P1881, DOI 10.1016/S0140-6736(08)61591-3; Casimiro DR, 2002, J VIROL, V76, P185, DOI 10.1128/JVI.76.1.185-194.2002; Ceccherini-Silberstein F, 2009, AIDS REV, V11, P17; Cherepanov P, 2000, FASEB J, V14, P1389, DOI 10.1096/fj.14.10.1389; Darrah PA, 2007, NAT MED, V13, P843, DOI 10.1038/nm1592; Delelis O, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-114; Dooms H, 2007, J EXP MED, V204, P547, DOI 10.1084/jem.20062381; DRELICH M, 1992, VIROLOGY, V188, P459, DOI 10.1016/0042-6822(92)90499-F; Durali D, 1998, J VIROL, V72, P3547, DOI 10.1128/JVI.72.5.3547-3553.1998; Fioretti D, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/174378; Fonseca SG, 2006, AIDS, V20, P2263, DOI 10.1097/01.aids.0000253353.48331.5f; Forbes EK, 2008, J IMMUNOL, V181, P4955, DOI 10.4049/jimmunol.181.7.4955; Frahm N., 2008, HIV MOL IMMUNOLOGY, V2008, P3; Gea-Banacloche JC, 2000, J IMMUNOL, V165, P1082, DOI 10.4049/jimmunol.165.2.1082; Geretti AM, 2012, CURR OPIN INFECT DIS, V25, P677, DOI 10.1097/QCO.0b013e32835a1de7; Haas G, 1998, AIDS, V12, P1427, DOI 10.1097/00002030-199812000-00004; Harro CD, 2009, AIDS RES HUM RETROV, V25, P103, DOI 10.1089/aid.2008.0212; Havlir D, 2012, NEW ENGL J MED, V367, P685, DOI 10.1056/NEJMp1207138; Hurt CB, 2011, ANTIVIR THER, V16, P137, DOI 10.3851/IMP1750; Hutnick NA, 2012, VACCINE, V30, P3202, DOI 10.1016/j.vaccine.2012.02.069; Isaguliants MG, 2004, AIDS RES HUM RETROV, V20, P191, DOI 10.1089/088922204773004914; Johnson JA, 2008, PLOS MED, V5, P1112, DOI 10.1371/journal.pmed.0050158; Keefer MC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041936; Klimov NA, 2010, RUSSIAN J AIDS CANC, V13; Klingstrom J, 2004, VACCINE, V22, P4029, DOI 10.1016/j.vaccine.2004.03.045; KOZAK M, 1986, CELL, V44, P283, DOI 10.1016/0092-8674(86)90762-2; KULKOSKY J, 1992, MOL CELL BIOL, V12, P2331, DOI 10.1128/MCB.12.5.2331; La Gruta NL, 2004, J IMMUNOL, V172, P5553, DOI 10.4049/jimmunol.172.9.5553; Leh H, 2000, BIOCHEMISTRY-US, V39, P9285, DOI 10.1021/bi000398b; Letvin NL, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002351; Li FS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020479; Li JZ, 2011, JAMA-J AM MED ASSOC, V305, P1327, DOI 10.1001/jama.2011.375; Lichterfeld M, 2004, BLOOD, V104, P487, DOI 10.1182/blood-2003-12-4341; Limberis MP, 2009, GENE THER, V16, P441, DOI 10.1038/gt.2008.177; Lloyd AG, 2007, VIROLOGY, V360, P129, DOI 10.1016/j.virol.2006.10.007; Masopust D, 2009, J INTERN MED, V265, P125, DOI 10.1111/j.1365-2796.2008.02054.x; McElrath MJ, 2008, LANCET, V372, P1894, DOI 10.1016/S0140-6736(08)61592-5; Mouscadet JF, 2010, DRUG RESIST UPDATE, V13, P139, DOI 10.1016/j.drup.2010.05.001; Mulder LCF, 2000, J BIOL CHEM, V275, P29749, DOI 10.1074/jbc.M004670200; Murashev Boris, 2007, Biotechnology Journal, V2, P871, DOI 10.1002/biot.200700024; Mwau M, 2004, J GEN VIROL, V85, P911, DOI 10.1099/vir.0.19701-0; Myers RE, 2008, J VIROL, V82, P9228, DOI 10.1128/JVI.01535-07; Nelson MH, 2011, J REPROD IMMUNOL, V89, P10, DOI 10.1016/j.jri.2011.01.013; Owen RE, 2010, AIDS, V24, P1095, DOI 10.1097/QAD.0b013e3283377a1e; Pendri A, 2011, EXPERT OPIN THER PAT, V21, P1173, DOI 10.1517/13543776.2011.586631; Precopio ML, 2007, J EXP MED, V204, P1405, DOI 10.1084/jem.20062363; Propato A, 2001, HUM IMMUNOL, V62, P561, DOI 10.1016/S0198-8859(01)00245-2; Puigbo P, 2007, NUCLEIC ACIDS RES, V35, pW126, DOI 10.1093/nar/gkm219; Rhee SY, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-74; Rodriguez William R, 2004, J Transl Med, V2, P15, DOI 10.1186/1479-5876-2-15; Roos AK, 2009, MOL THER, V17, P1637, DOI 10.1038/mt.2009.120; Rumyantseva OA, 2009, AIDS RES HUM RETROV, V25, P931, DOI 10.1089/aid.2009.0075; Sabado RL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004256; Sabbaj S, 2003, JAIDS-J ACQ IMM DEF, V33, P426, DOI 10.1097/00126334-200308010-00003; Sacha JB, 2009, P NATL ACAD SCI USA, V106, P9791, DOI 10.1073/pnas.0813106106; Samri A, 2000, J VIROL, V74, P9306, DOI 10.1128/JVI.74.19.9306-9312.2000; Santra S, 2008, P NATL ACAD SCI USA, V105, P10489, DOI 10.1073/pnas.0803352105; Seder RA, 2008, NAT REV IMMUNOL, V8, P247, DOI 10.1038/nri2274; Sierra-Aragon S, 2012, INTERVIROLOGY, V55, P84, DOI 10.1159/000331995; Soghoian DZ, 2010, EXPERT REV VACCINES, V9, P1453, DOI 10.1586/ERV.10.132; Starodubova E, 2012, MOL IMAGING, V11, P471, DOI 10.2310/7290.2012.00011; Stephenson KE, 2012, J VIROL, V86, P11434, DOI 10.1128/JVI.01779-12; Stratov I, 2005, J VIROL, V79, P7728, DOI 10.1128/JVI.79.12.7728-7737.2005; Swain SL, 2012, NAT REV IMMUNOL, V12, P136, DOI 10.1038/nri3152; Tena-Coki NG, 2010, AM J RESP CRIT CARE, V182, P120, DOI 10.1164/rccm.200912-1862OC; Thomson MM, 2009, JAIDS-J ACQ IMM DEF, V51, P332, DOI 10.1097/QAI.0b013e31819c1757; Varshavsky A., 2011, PROTEIN SCI; Watanabe T, 2011, MICROBES INFECT, V13, P160, DOI 10.1016/j.micinf.2010.10.006; Weaver EA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018314; Weiner DB, 2010, VACCINE, V28, P1893, DOI 10.1016/j.vaccine.2010.01.052; Williams MA, 2006, NATURE, V441, P890, DOI 10.1038/nature04790; Wilson CC, 2001, J VIROL, V75, P4195, DOI 10.1128/JVI.75.9.4195-4207.2001; Yan J, 2011, VACCINE, V29, P7173, DOI 10.1016/j.vaccine.2011.05.076; Young B, 2011, ANTIVIR THER, V16, P253, DOI 10.3851/IMP1748; Zheng N, 2009, J VIROL, V83, P7668, DOI 10.1128/JVI.00513-09	95	10	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2013	8	5							e62720	10.1371/journal.pone.0062720	http://dx.doi.org/10.1371/journal.pone.0062720			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145YI	23667513	Green Published, gold, Green Submitted			2022-12-27	WOS:000319055600041
J	Mita, P; Savas, JN; Ha, S; Djouder, N; Yates, JR; Logan, SK				Mita, Paolo; Savas, Jeffrey N.; Ha, Susan; Djouder, Nabil; Yates, John R., III; Logan, Susan K.			Analysis of URI Nuclear Interaction with RPB5 and Components of the R2TP/Prefoldin-Like Complex	PLOS ONE			English	Article							RNA-POLYMERASE-II; RPB5-MEDIATING PROTEIN; CYTOSOLIC CHAPERONIN; CANCER CELLS; IN-VIVO; TRANSCRIPTION; PREFOLDIN; RECEPTOR; PHOSPHORYLATION; IDENTIFICATIONS	Unconventional prefoldin RPB5 Interactor (URI) was identified as a transcriptional repressor that binds RNA polymerase II (pol II) through interaction with the RPB5/POLR2E subunit. Despite the fact that many other proteins involved in transcription regulation have been shown to interact with URI, its nuclear function still remains elusive. Previous mass spectrometry analyses reported that URI is part of a novel protein complex called R2TP/prefoldin-like complex responsible for the cytoplasmic assembly of RNA polymerase II. We performed a mass spectrometry (MS)-based proteomic analysis to identify nuclear proteins interacting with URI in prostate cells. We identified all the components of the R2TP/prefoldin-like complex as nuclear URI interactors and we showed that URI binds and regulates RPB5 protein stability and transcription. Moreover, we validated the interaction of URI to the P53 and DNA damage-Regulated Gene 1 (PDRG1) and show that PDRG1 protein is also stabilized by URI binding. We present data demonstrating that URI nuclear/cytoplasmic shuttling is affected by compounds that stall pol II on the DNA (alpha-amanitin and actinomycin-D) and by leptomycin B, an inhibitor of the CRM1 exportin that mediates the nuclear export of pol II subunits. These data suggest that URI, and probably the entire R2TP/prefoldin-like complex is exported from the nucleus through CRM1. Finally we identified putative URI sites of phosphorylation and acetylation and confirmed URI sites of post-transcriptional modification identified in previous large-scale analyses the importance of which is largely unknown. However URI post-transcriptional modification was shown to be essential for URI function and therefore characterization of novel sites of URI modification will be important to the understanding of URI function.	[Mita, Paolo; Logan, Susan K.] New York Univ Sch Med, Dept Biochem & Mol Pharmacol, New York, NY USA; [Savas, Jeffrey N.; Yates, John R., III] Scripps Res Inst CA, Dept Physiol Chem, La Jolla, CA USA; [Ha, Susan] New York Univ Sch Med, Dept Urol, New York, NY USA; [Djouder, Nabil] Fdn Banco Bilbao Vizcaya F BBVA CNIO Canc Cell Bi, CNIO, Madrid, Spain	New York University; New York University; Centro Nacional de Investigaciones Oncologicas (CNIO)	Logan, SK (corresponding author), New York Univ Sch Med, Dept Biochem & Mol Pharmacol, New York, NY USA.	susan.logan@nyumc.org		Logan, Susan/0000-0002-7904-5927	National Institute of Health [R01 CA112226, W81XWH-10-1-0431, P41 GM103533, R01 MH067880]; National Institute of Aging fellowship [F32AG039127]; Urology department at New York University School of Medicine; NATIONAL CANCER INSTITUTE [F31CA113285, R01CA112226] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103533] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH067880] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [F32AG039127] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Aging fellowship; Urology department at New York University School of Medicine; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Grant support was received from the National Institute of Health (R01 CA112226 [S.K.L.], W81XWH-10-1-0431 [P.M.] P41 GM103533 and R01 MH067880 [J.R.Y.]), the National Institute of Aging fellowship (F32AG039127 [J.N.S.]) and the Urology department at New York University School of Medicine (S.K.L). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boulon S, 2010, MOL CELL, V39, P912, DOI 10.1016/j.molcel.2010.08.023; Cloutier P, 2009, METHODS, V48, P381, DOI 10.1016/j.ymeth.2009.05.005; Cociorva Daniel, 2007, Curr Protoc Bioinformatics, VChapter 13, DOI 10.1002/0471250953.bi1304s16; Delgermaa L, 2004, MOL CELL BIOL, V24, P8556, DOI 10.1128/MCB.24.19.8556-8566.2004; Dephoure N, 2008, P NATL ACAD SCI USA, V105, P10762, DOI 10.1073/pnas.0805139105; Djouder N, 2007, MOL CELL, V28, P28, DOI 10.1016/j.molcel.2007.08.010; Dorjsuren D, 1998, MOL CELL BIOL, V18, P7546, DOI 10.1128/MCB.18.12.7546; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Fornerod M, 1997, CELL, V90, P1051, DOI 10.1016/S0092-8674(00)80371-2; Gallant P, 2007, TRENDS CELL BIOL, V17, P187, DOI 10.1016/j.tcb.2007.02.005; Gstaiger M, 2003, SCIENCE, V302, P1208, DOI 10.1126/science.1088401; Izumi N, 2012, NUCLEUS-PHILA, V3, P29, DOI 10.4161/nucl.18926; Izumi N, 2012, CANCER SCI, V103, P50, DOI 10.1111/j.1349-7006.2011.02112.x; Jiang LY, 2011, CANCER BIOL THER, V11, P567, DOI 10.4161/cbt.11.6.14412; Luo XQ, 2003, ONCOGENE, V22, P7247, DOI 10.1038/sj.onc.1207010; Martin-Benito J, 2002, EMBO J, V21, P6377, DOI 10.1093/emboj/cdf640; McDonald WH, 2004, RAPID COMMUN MASS SP, V18, P2162, DOI 10.1002/rcm.1603; Mita P, 2011, MOL CELL BIOL, V31, P3639, DOI 10.1128/MCB.05429-11; Nguyen VT, 1996, NUCLEIC ACIDS RES, V24, P2924, DOI 10.1093/nar/24.15.2924; Nwachukwu JC, 2009, CANCER RES, V69, P3140, DOI 10.1158/0008-5472.CAN-08-3738; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; Peng JM, 2003, J PROTEOME RES, V2, P43, DOI 10.1021/pr025556v; Sadygov RG, 2002, J PROTEOME RES, V1, P211, DOI 10.1021/pr015514r; Sardiu ME, 2008, P NATL ACAD SCI USA, V105, P1454, DOI 10.1073/pnas.0706983105; Tabb DL, 2002, J PROTEOME RES, V1, P21, DOI 10.1021/pr015504q; Theurillat JP, 2011, CANCER CELL, V19, P317, DOI 10.1016/j.ccr.2011.01.019; Vainberg IE, 1998, CELL, V93, P863, DOI 10.1016/S0092-8674(00)81446-4; Wei WX, 2003, CELL RES, V13, P111, DOI 10.1038/sj.cr.7290155; Yang Y, 2000, Zhonghua Gan Zang Bing Za Zhi, V8, P15; Yart A, 2005, MOL CELL BIOL, V25, P5052, DOI 10.1128/MCB.25.12.5052-5060.2005	30	42	43	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2013	8	5							e63879	10.1371/journal.pone.0063879	http://dx.doi.org/10.1371/journal.pone.0063879			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145YI	23667685	Green Published, gold, Green Submitted			2022-12-27	WOS:000319055600079
J	Mowrey, D; Chen, Q; Liang, YH; Liang, J; Xu, Y; Tang, P				Mowrey, David; Chen, Qiang; Liang, Yuhe; Liang, Jie; Xu, Yan; Tang, Pei			Signal Transduction Pathways in the Pentameric Ligand-Gated Ion Channels	PLOS ONE			English	Article							NICOTINIC ACETYLCHOLINE-RECEPTOR; TRANSMEMBRANE DOMAIN INTERFACE; AGONIST-BINDING-SITES; CYS-LOOP; PROPAGATION; COUPLES; PRE-M1	The mechanisms of allosteric action within pentameric ligand-gated ion channels (pLGICs) remain to be determined. Using crystallography, site-directed mutagenesis, and two-electrode voltage clamp measurements, we identified two functionally relevant sites in the extracellular (EC) domain of the bacterial pLGIC from Gloeobacter violaceus (GLIC). One site is at the C-loop region, where the NQN mutation (D91N, E177Q, and D178N) eliminated inter-subunit salt bridges in the open-channel GLIC structure and thereby shifted the channel activation to a higher agonist concentration. The other site is below the C-loop, where binding of the anesthetic ketamine inhibited GLIC currents in a concentration dependent manner. To understand how a perturbation signal in the EC domain, either resulting from the NQN mutation or ketamine binding, is transduced to the channel gate, we have used the Perturbation-based Markovian Transmission (PMT) model to determine dynamic responses of the GLIC channel and signaling pathways upon initial perturbations in the EC domain of GLIC. Despite the existence of many possible routes for the initial perturbation signal to reach the channel gate, the PMT model in combination with Yen's algorithm revealed that perturbation signals with the highest probability flow travel either via the beta 1-beta 2 loop or through pre-TM1. The beta 1-beta 2 loop occurs in either intra- or inter-subunit pathways, while pre-TM1 occurs exclusively in inter-subunit pathways. Residues involved in both types of pathways are well supported by previous experimental data on nAChR. The direct coupling between pre-TM1 and TM2 of the adjacent subunit adds new insight into the allosteric signaling mechanism in pLGICs.	[Mowrey, David; Chen, Qiang; Liang, Yuhe; Xu, Yan; Tang, Pei] Univ Pittsburgh, Sch Med, Dept Anesthesiol, Pittsburgh, PA 15261 USA; [Xu, Yan; Tang, Pei] Univ Pittsburgh, Sch Med, Dept Chem Biol & Pharmacol, Pittsburgh, PA USA; [Xu, Yan] Univ Pittsburgh, Sch Med, Dept Biol Struct, Pittsburgh, PA USA; [Mowrey, David; Tang, Pei] Univ Pittsburgh, Sch Med, Dept Computat & Syst Biol, Pittsburgh, PA USA; [Liang, Jie] Univ Illinois, Dept Bioengn, Chicago, IL USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Tang, P (corresponding author), Univ Pittsburgh, Sch Med, Dept Anesthesiol, Pittsburgh, PA 15261 USA.	TangP@anes.upmc.edu		Tang, Pei/0000-0002-2869-2737; Xu, Yan/0000-0003-2773-8024	National Institutes of Health [R01GM066358, R01GM056257, R37GM049202]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056257, R37GM049202, R01GM066358] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by grants from the National Institutes of Health (R01GM066358, R01GM056257, and R37GM049202). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Andersen N, 2011, J NEUROSCI, V31, P3662, DOI 10.1523/JNEUROSCI.5940-10.2011; Auerbach A, 2010, J PHYSIOL-LONDON, V588, P573, DOI 10.1113/jphysiol.2009.182774; Bafna PA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002515; Bocquet N, 2007, NATURE, V445, P116, DOI 10.1038/nature05371; Bocquet N, 2009, NATURE, V457, P111, DOI 10.1038/nature07462; Bouzat C, 2004, NATURE, V430, P896, DOI 10.1038/nature02753; Cadugan DJ, 2010, BIOPHYS J, V99, P798, DOI 10.1016/j.bpj.2010.05.008; Chakrapani S, 2004, J GEN PHYSIOL, V123, P341, DOI 10.1085/jgp.200309004; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chennubhotla C, 2007, PLOS COMPUT BIOL, V3, P1716, DOI 10.1371/journal.pcbi.0030172; Chennubhotla C, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100075; del Sol A, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-r92; del Sol A, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100063; Dellisanti CD, 2007, NAT NEUROSCI, V10, P953, DOI 10.1038/nn1942; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Grosman C, 2000, NATURE, V403, P773, DOI 10.1038/35001586; Haliloglu T, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000164; Hilf RJC, 2009, NATURE, V457, P115, DOI 10.1038/nature07461; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jansen M, 2008, J GEN PHYSIOL, V131, P137, DOI 10.1085/jgp.200709896; Jha A, 2007, J GEN PHYSIOL, V130, P547, DOI 10.1085/jgp.200709856; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P133, DOI 10.1107/S0907444909047374; Kash TL, 2003, NATURE, V421, P272, DOI 10.1038/nature01280; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lee WY, 2009, J NEUROSCI, V29, P3189, DOI 10.1523/JNEUROSCI.6185-08.2009; Lee WY, 2005, NATURE, V438, P243, DOI 10.1038/nature04156; Lu HM, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000526; Miller PS, 2010, TRENDS PHARMACOL SCI, V31, P161, DOI 10.1016/j.tips.2009.12.005; Mowrey D, 2013, J AM CHEM SOC; Mowrey D, 2010, J PHYS CHEM B, V114, P7649, DOI 10.1021/jp1009675; Mukhtasimova N, 2013, BIOPHYS J, V104, P355, DOI 10.1016/j.bpj.2012.12.013; Nury H, 2011, NATURE, V469, P428, DOI 10.1038/nature09647; Pan JJ, 2012, STRUCTURE, V20, P1463, DOI 10.1016/j.str.2012.08.009; Park K, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-S1-S23; Prevost MS, 2012, NAT STRUCT MOL BIOL, V19, P642, DOI 10.1038/nsmb.2307; Purohit P, 2007, J GEN PHYSIOL, V130, P559, DOI 10.1085/jgp.200709857; Purohit P, 2007, J GEN PHYSIOL, V130, P569, DOI 10.1085/jgp.200709858; Purohit P, 2010, J GEN PHYSIOL, V135, P321, DOI 10.1085/jgp.200910384; Schrodinger L., 2020, PYMOL; Sidje RB, 1999, COMPUT STAT DATA AN, V29, P345, DOI 10.1016/S0167-9473(98)00062-0; Tassonyi E, 2002, BRAIN RES BULL, V57, P133, DOI 10.1016/S0361-9230(01)00740-7; Thompson AJ, 2010, Q REV BIOPHYS, V43, P449, DOI 10.1017/S0033583510000168; Unwin N, 2005, J MOL BIOL, V346, P967, DOI 10.1016/j.jmb.2004.12.031; Weng Y, 2010, ANESTH ANALG, V110, P59, DOI 10.1213/ANE.0b013e3181c4bc69; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Xiu XN, 2005, J BIOL CHEM, V280, P41655, DOI 10.1074/jbc.M508635200; YEN JY, 1971, MANAGE SCI, V17, P712, DOI 10.1287/mnsc.17.11.712	49	16	16	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2013	8	5							e64326	10.1371/journal.pone.0064326	http://dx.doi.org/10.1371/journal.pone.0064326			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145YI	23667707	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000319055600089
J	Thies, FG; Laurindo, MFL; Perez, EC; Brito, RRNE; Mariano, M; Popi, AF				Thies, Felipe Garutti; Lucatelli Laurindo, Maria Fernanda; Perez, Elizabeth Cristina; Novaes e Brito, Ronni Romulo; Mariano, Mario; Popi, Ana Flavia			Cross Talk between Peritoneal Macrophages and B-1 Cells In Vitro	PLOS ONE			English	Article							B-CELLS; AUTOIMMUNE-DISEASE; IMMUNE-SYSTEM; T-CELLS; MICE; IL-6; INTERLEUKIN-10; INFECTION; KINETICS; LUPUS	B-1 cells constitute a distinct B cell population with unique phenotypic and functional characteristics. They represent the main B cell population found in mouse peritoneal and pleural cavities. The communication between B-1 cells and peritoneal macrophages has been previously studied, and the effect this interaction has on macrophages has been previously described. Using an in vitro co-culture model, herein we demonstrated that peritoneal macrophages were able to increase survival rates and to stimulate proliferation of B-1 cells. IL-6 was also found to be important in B-1 cell survival; recombinant IL-6 increases the percentage of viable B-1 cells in culture. Furthermore, molecules involved in the IL-6 signaling pathway, such as STAT-3 and Bcl-2, were highly expressed in B-1 cells after co-culture with peritoneal macrophages. IL-6-deficient peritoneal macrophages were not able to increase B-1 cell survival, confirming the importance of this cytokine. Altogether, our results indicate a novel mechanism in which peritoneal macrophages are able to regulate the B-1 population via IL-6 secretion.	[Thies, Felipe Garutti; Lucatelli Laurindo, Maria Fernanda; Perez, Elizabeth Cristina; Novaes e Brito, Ronni Romulo; Mariano, Mario; Popi, Ana Flavia] Univ Fed Sao Paulo, Dept Microbiol Immunol & Parasitol, Discipline Immunol, Sao Paulo, Brazil; [Perez, Elizabeth Cristina; Mariano, Mario] Univ Paulista UNIP, Sao Paulo, Brazil	Universidade Federal de Sao Paulo (UNIFESP); Universidade Paulista	Popi, AF (corresponding author), Univ Fed Sao Paulo, Dept Microbiol Immunol & Parasitol, Discipline Immunol, Sao Paulo, Brazil.	afpopi@unifesp.br	Pérez, Elizabeth C/E-8057-2012; Popi, Ana Flavia/V-4437-2019; Mariano, Mario/L-2557-2015; Novaes e Brito, Ronni Romulo/F-2419-2012	Pérez, Elizabeth C/0000-0003-3038-9902; Popi, Ana Flavia/0000-0001-9814-4181; Novaes e Brito, Ronni Romulo/0000-0002-4870-4133	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2008/58561-0, 2011/50256-6]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This research received financial support from Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) (2008/58561-0 and 2011/50256-6) and Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahao TB, 2003, IMMUNOBIOLOGY, V208, P401, DOI 10.1078/0171-2985-00287; Almeida SR, 2001, INT IMMUNOL, V13, P1193, DOI 10.1093/intimm/13.9.1193; Berland R, 2002, ANNU REV IMMUNOL, V20, P253, DOI 10.1146/annurev.immunol.20.100301.064833; Bogsan CSB, 2005, INT J EXP PATHOL, V86, P257, DOI 10.1111/j.0959-9673.2005.00433.x; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; De Lorenzo BHP, 2007, IMMUNOL LETT, V114, P110, DOI 10.1016/j.imlet.2007.09.013; Dempsey PW, 2003, CELL MOL LIFE SCI, V60, P2604, DOI 10.1007/s00018-003-3180-y; Diehl S, 2002, MOL IMMUNOL, V39, P531, DOI 10.1016/S0161-5890(02)00210-9; Duan B, 2006, AUTOIMMUN REV, V5, P403, DOI 10.1016/j.autrev.2005.10.007; GODIN IE, 1993, NATURE, V364, P67, DOI 10.1038/364067a0; Hayakawa K, 2000, CURR OPIN IMMUNOL, V12, P346, DOI 10.1016/S0952-7915(00)00098-4; HAYAKAWA K, 1986, EUR J IMMUNOL, V16, P450, DOI 10.1002/eji.1830160423; HAYAKAWA K, 1983, J EXP MED, V157, P202, DOI 10.1084/jem.157.1.202; Heinrich PC, 2003, BIOCHEM J, V374, P1, DOI 10.1042/BJ20030407; HERZENBERG LA, 1986, IMMUNOL REV, V93, P81, DOI 10.1111/j.1600-065X.1986.tb01503.x; Hirano T, 1998, Int Rev Immunol, V16, P249; Huang H, 2005, FRONT BIOSCI-LANDMRK, V10, P192, DOI 10.2741/1521; Ishihara K, 2002, CYTOKINE GROWTH F R, V13, P357, DOI 10.1016/S1359-6101(02)00027-8; KANNO K, 1993, AUTOIMMUNITY, V14, P205, DOI 10.3109/08916939309077367; KANTOR AB, 1993, ANNU REV IMMUNOL, V11, P501, DOI 10.1146/annurev.immunol.11.1.501; KHAN WN, 1995, IMMUNITY, V3, P283, DOI 10.1016/1074-7613(95)90114-0; Laurindo MF, 2012, IMMUNOBIOLOGY; Moroni L, 2012, AUTOIMMUN REV, V11, pA386, DOI 10.1016/j.autrev.2011.11.012; Mussalem JS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033955; Neurath MF, 2011, CYTOKINE GROWTH F R, V22, P83, DOI 10.1016/j.cytogfr.2011.02.003; Nogueira-Martins MF, 2010, IMMUNOBIOLOGY, V215, P264, DOI 10.1016/j.imbio.2009.05.007; OGARRA A, 1992, EUR J IMMUNOL, V22, P711, DOI 10.1002/eji.1830220314; Oliveira HC, 2010, IMMUNOBIOLOGY, V215, P215, DOI 10.1016/j.imbio.2009.03.009; Otero DC, 2006, J IMMUNOL, V177, P6593, DOI 10.4049/jimmunol.177.10.6593; Palos MC, 2012, INFLAMM RES, V61, P1187, DOI 10.1007/s00011-012-0514-y; Parkin J, 2001, LANCET, V357, P1777, DOI 10.1016/S0140-6736(00)04904-7; Perez EC, 2008, CANCER SCI, V99, P920, DOI 10.1111/j.1349-7006.2008.00776.x; Popi AF, 2004, IMMUNOLOGY, V113, P348, DOI 10.1111/j.1365-2567.2004.01969.x; Popi AF, 2008, MICROBES INFECT, V10, P817, DOI 10.1016/j.micinf.2008.04.012; Russo RT, 2010, IMMUNOBIOLOGY, V215, P1005, DOI 10.1016/j.imbio.2010.01.003; Ryan GA, 2010, J IMMUNOL, V185, P2800, DOI 10.4049/jimmunol.1000856; SWAAK AJ, 1988, SCAND J RHEUMATOL, V17, P469, DOI 10.3109/03009748809098809; THEOFILOPOULOS AN, 1985, ADV IMMUNOL, V37, P269, DOI 10.1016/S0065-2776(08)60342-9; VAUX DL, 1988, NATURE, V335, P440, DOI 10.1038/335440a0; Wang Y, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00281; Wong SC, 2010, EUR J IMMUNOL, V40, P2296, DOI 10.1002/eji.200940288; Yamanishi S, 2006, INFECT IMMUN, V74, P248, DOI 10.1128/IAI.74.1.248-256.2006; Yue C, 2010, RHEUMATOL INT, V30, P1553, DOI 10.1007/s00296-009-1179-x	43	14	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2013	8	5							e62805	10.1371/journal.pone.0062805	http://dx.doi.org/10.1371/journal.pone.0062805			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145YI	23667522	gold, Green Submitted, Green Published			2022-12-27	WOS:000319055600045
J	Kateete, DP; Kabugo, U; Baluku, H; Nyakarahuka, L; Kyobe, S; Okee, M; Najjuka, CF; Joloba, ML				Kateete, David Patrick; Kabugo, Usuf; Baluku, Hannington; Nyakarahuka, Luke; Kyobe, Samuel; Okee, Moses; Najjuka, Christine Florence; Joloba, Moses Lutaakome			Prevalence and Antimicrobial Susceptibility Patterns of Bacteria from Milkmen and Cows with Clinical Mastitis in and around Kampala, Uganda	PLOS ONE			English	Article							COAGULASE-NEGATIVE STAPHYLOCOCCI; AUTOMATED MICROBIOLOGY SYSTEM; BOVINE MASTITIS; UDDER PATHOGENS; DAIRY-COWS; IDENTIFICATION; AUREUS; RESISTANCE; CATTLE; ENTEROBACTERIACEAE	Background: Identification of pathogens associated with bovine mastitis is helpful in treatment and management decisions. However, such data from sub-Saharan Africa is scarce. Here we describe the distribution and antimicrobial susceptibility patterns of bacteria from cows with clinical mastitis in Kampala, Uganda. Due to high concern of zoonotic infections, isolates from milkmen are also described. Methodology/Principal Findings: Ninety seven milk samples from cows with clinical mastitis and 31 nasal swabs from milkmen were collected (one sample per cow/human). Fifty eight (60%) Gram-positive isolates namely Staphylococci (21), Enterococci (16), Streptococci (13), Lactococci (5), Micrococci (2) and Arcanobacteria (1) were detected in cows; only one grew Staphylococcus aureus. Furthermore, 24 (25%) coliforms namely Escherichia coli (12), Klebsiella oxytoca (5), Proteus vulgaris (2), Serratia (2), Citrobacter (1), Cedecea (1) and Leclercia (1) were identified. From humans, 24 Gram-positive bacteria grew, of which 11 were Staphylococci (35%) including four Staphylococcus aureus. Upon susceptibility testing, methicillin-resistant coagulase-negative staphylococci (CoNS) were prevalent; 57%, 12/21 in cows and 64%, 7/11 in humans. However, methicillin-resistant Staphylococcus aureus was not detected. Furthermore, methicillin and vancomycin resistant CoNS were detected in cows (Staphylococcus hominis, Staphylococcus lugdunensis) and humans (Staphylococcus scuiri). Also, vancomycin and daptomycin resistant Enterococci (Enterococcus faecalis and Enterococcus faecium, respectively) were detected in cows. Coliforms were less resistant with three pan-susceptible isolates. However, multidrug resistant Klebsiella, Proteus, Serratia, Cedecea, and Citrobacter were detected. Lastly, similar species grew from human and bovine samples but on genotyping, the isolates were found to be different. Interestingly, human and bovine Staphylococcus aureus were genetically similar (spa-CC435, spa-type t645 corresponding to ST121) but with different susceptibility patterns. Conclusions/Significance: CoNS, Enterococci, Streptococci, and Escherichia coli are the predominant pathogens associated with clinical bovine-mastitis in Kampala, Uganda. Multidrug resistant bacteria are also prevalent. While similar species occurred in humans and cows, transmission was not detected.	[Kateete, David Patrick; Kabugo, Usuf; Baluku, Hannington; Kyobe, Samuel; Okee, Moses; Najjuka, Christine Florence; Joloba, Moses Lutaakome] Makerere Univ, Coll Hlth Sci, Sch Biomed Sci, Dept Med Microbiol, Kampala, Uganda; [Kabugo, Usuf; Nyakarahuka, Luke] Makerere Univ, Coll Vet Med & Biosecur, Kampala, Uganda	Makerere University; Makerere University	Kateete, DP (corresponding author), Makerere Univ, Coll Hlth Sci, Sch Biomed Sci, Dept Med Microbiol, Kampala, Uganda.	davidkateete@gmail.com	Nyakarahuka, Luke/AGH-2432-2022; Nyakarahuka, Luke/W-8164-2019; Kateete, David Patrick/HCH-5603-2022	Nyakarahuka, Luke/0000-0002-2944-9157; Nyakarahuka, Luke/0000-0002-2944-9157; Kateete, David Patrick/0000-0001-8075-3069; Joloba, Moses/0000-0002-0334-9983	Swedish International Development Cooperation (Sida) through Makerere University School of Graduate Studies; National Institutes of Health [RO3 AI062849, RO1 AI075637]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R03AI062849, R01AI075637] Funding Source: NIH RePORTER	Swedish International Development Cooperation (Sida) through Makerere University School of Graduate Studies; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The Phoenix 100 ID/AST BDexpert system was purchased with support from the Swedish International Development Cooperation (Sida) through Makerere University School of Graduate Studies. Activities in the Laboratories of the Department of Medical Microbiology have been funded by the National Institutes of Health (Grant #s RO3 AI062849 and RO1 AI075637). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahmsen M, 2012, PREVALENCE SUBCLINIC; Bakir M, 2011, VET WORLD, V4, P537, DOI 10.5455/vetworld.2011.537-541; Bengtsson B, 2009, VET MICROBIOL, V136, P142, DOI 10.1016/j.vetmic.2008.10.024; Blanco R, 2011, J CLIN MICROBIOL, V49, P433, DOI 10.1128/JCM.02201-10; Bradley AJ, 2007, VET REC, V160, P253, DOI 10.1136/vr.160.8.253; Bradley AJ, 2002, VET J, V164, P116, DOI 10.1053/tvjl.2002.0724; Byarugaba DK, 2008, LIVESTOCK RES RURAL, V20; Carroll KC, 2006, J CLIN MICROBIOL, V44, P3506, DOI 10.1128/JCM.00994-06; Carroll KC, 2006, J CLIN MICROBIOL, V44, P2072, DOI 10.1128/JCM.02636-05; Cheng DR, 2010, AFR J MICROBIOL RES, V4, P1110; Claesson C, 2012, STAPHYLOCOCCI ENTERO; DEVRIESE LA, 1987, INT J SYST BACTERIOL, V37, P257, DOI 10.1099/00207713-37-3-257; Fessler AT, 2010, J ANTIMICROB CHEMOTH, V65, P1576, DOI 10.1093/jac/dkq172; Gaze W, 2008, ADV APPL MICROBIOL, V63, P249, DOI 10.1016/S0065-2164(07)00007-X; Hagnestam-Nielsen C, 2009, ANIMAL, V3, P315, DOI 10.1017/S1751731108003352; Harmsen D, 2003, J CLIN MICROBIOL, V41, P5442, DOI 10.1128/JCM.41.12.5442-5448.2003; Hendriksen RS, 2008, ACTA VET SCAND, V50, DOI 10.1186/1751-0147-50-28; Hijazin M, 2011, J DAIRY SCI, V94, P1813, DOI 10.3168/jds.2010-3678; HONKANENBUZALSKI T, 1994, J VET MED B, V41, P344, DOI 10.1111/j.1439-0450.1994.tb00237.x; Huber H, 2011, BMC VET RES, V7, DOI 10.1186/1746-6148-7-6; Huijsdens Xander W, 2006, Ann Clin Microbiol Antimicrob, V5, P26, DOI 10.1186/1476-0711-5-26; Human Research Affairs/Research Management, 2007, PAYM HUM SUBJ PART R; Kalmus P, 2011, ACTA VET SCAND, V53, DOI 10.1186/1751-0147-53-4; Kateete David P, 2011, BMC Res Notes, V4, P326, DOI 10.1186/1756-0500-4-326; Kateete DP, 2010, ANN CLIN MICROB ANTI, V9, DOI 10.1186/1476-0711-9-23; Koneman EW, 1997, COLOUR ATLAS TXB DIA, V6 th, P171; Krause DO, 2011, ZOONOTIC PATHOGENS IN THE FOOD CHAIN, P1; Madut N. A., 2009, Journal of Cell and Animal Biology, V3, P071; Makita K, 2011, BMC VET RES, V7, DOI 10.1186/1746-6148-7-60; MAYER L W, 1988, Clinical Microbiology Reviews, V1, P228; McCarthy AJ, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-104; O'Hara CM, 2006, J CLIN MICROBIOL, V44, P928, DOI 10.1128/JCM.44.3.928-933.2006; Persson Y, 2011, ACTA VET SCAND, V53, DOI 10.1186/1751-0147-53-36; Pyorala S, 2009, VET MICROBIOL, V134, P3, DOI 10.1016/j.vetmic.2008.09.015; Reinoso E, 2004, MICROBIOL RES, V159, P245, DOI 10.1016/j.micres.2004.04.002; Ruegg PL, 2011, TREATMENT CLIN MASTI; Schroeder J, 2012, BOVINE MASTITIS MILK; Seni J, 2012, THESIS MAKERERE U KA; Shearer JES, 2011, G3-GENES GENOM GENET, V1, P581, DOI 10.1534/g3.111.000760; Sumathi BR, 2008, VET WORLD, V1, P37; Taponen S, 2009, VET MICROBIOL, V134, P29, DOI 10.1016/j.vetmic.2008.09.011; Thomson K, 2008, BMC VET RES, V4, DOI 10.1186/1746-6148-4-15; Zadoks RN, 2011, J MAMMARY GLAND BIOL, V16, P357, DOI 10.1007/s10911-011-9236-y	43	56	59	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e63413	10.1371/journal.pone.0063413	http://dx.doi.org/10.1371/journal.pone.0063413			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667611	Green Submitted, Green Published, gold			2022-12-27	WOS:000319654700139
J	Lee, IR; Yang, LT; Sebetso, G; Allen, R; Doan, THN; Blundell, R; Lui, EYL; Morrow, CA; Fraser, JA				Lee, I. Russel; Yang, Liting; Sebetso, Gaseene; Allen, Rebecca; Doan, Thi H. N.; Blundell, Ross; Lui, Edmund Y. L.; Morrow, Carl A.; Fraser, James A.			Characterization of the Complete Uric Acid Degradation Pathway in the Fungal Pathogen Cryptococcus neoformans	PLOS ONE			English	Article							URATE OXIDASE REACTION; ASPERGILLUS-NIDULANS; SACCHAROMYCES-CEREVISIAE; CAENORHABDITIS-ELEGANS; FUNCTIONAL-ANALYSIS; GENETIC-ANALYSIS; SEXUAL CYCLE; PROTEIN; VIRULENCE; IDENTIFICATION	Degradation of purines to uric acid is generally conserved among organisms, however, the end product of uric acid degradation varies from species to species depending on the presence of active catabolic enzymes. In humans, most higher primates and birds, the urate oxidase gene is non-functional and hence uric acid is not further broken down. Uric acid in human blood plasma serves as an antioxidant and an immune enhancer; conversely, excessive amounts cause the common affliction gout. In contrast, uric acid is completely degraded to ammonia in most fungi. Currently, relatively little is known about uric acid catabolism in the fungal pathogen Cryptococcus neoformans even though this yeast is commonly isolated from uric acid-rich pigeon guano. In addition, uric acid utilization enhances the production of the cryptococcal virulence factors capsule and urease, and may potentially modulate the host immune response during infection. Based on these important observations, we employed both Agrobacterium-mediated insertional mutagenesis and bioinformatics to predict all the uric acid catabolic enzyme-encoding genes in the H99 genome. The candidate C. neoformans uric acid catabolic genes identified were named: URO1 (urate oxidase), URO2 (HIU hydrolase), URO3 (OHCU decarboxylase), DAL1 (allantoinase), DAL2,3,3 (allantoicase- ureidoglycolate hydrolase fusion protein), and URE1 (urease). All six ORFs were then deleted via homologous recombination; assaying of the deletion mutants' ability to assimilate uric acid and its pathway intermediates as the sole nitrogen source validated their enzymatic functions. While Uro1, Uro2, Uro3, Dal1 and Dal2,3,3 were demonstrated to be dispensable for virulence, the significance of using a modified animal model system of cryptococcosis for improved mimicking of human pathogenicity is discussed.	[Lee, I. Russel; Yang, Liting; Sebetso, Gaseene; Allen, Rebecca; Doan, Thi H. N.; Blundell, Ross; Lui, Edmund Y. L.; Morrow, Carl A.; Fraser, James A.] Univ Queensland, Australian Infect Dis Res Ctr, Brisbane, Qld, Australia; [Lee, I. Russel; Yang, Liting; Sebetso, Gaseene; Allen, Rebecca; Doan, Thi H. N.; Blundell, Ross; Lui, Edmund Y. L.; Morrow, Carl A.; Fraser, James A.] Univ Queensland, Sch Chem & Mol Biosci, Brisbane, Qld, Australia	University of Queensland; University of Queensland	Fraser, JA (corresponding author), Univ Queensland, Australian Infect Dis Res Ctr, Brisbane, Qld, Australia.	jafraser@uq.edu.au	Fraser, James A/B-4918-2012; Lee, Russel/HDN-2358-2022	Fraser, James A/0000-0001-5724-5285; Morrow, Carl/0000-0002-3650-0117	University of Queensland International Research Tuition Award (UQIRTA); University of Queensland Research Scholarship (UQRS); National Health and Medical Research Council (NHMRC) [CDA 569673]	University of Queensland International Research Tuition Award (UQIRTA); University of Queensland Research Scholarship (UQRS)(University of Queensland); National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by the University of Queensland International Research Tuition Award (UQIRTA) and University of Queensland Research Scholarship (UQRS) awarded to IRL, and the National Health and Medical Research Council (NHMRC) CDA 569673 grant awarded to JF. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; AMES BN, 1981, P NATL ACAD SCI-BIOL, V78, P6858, DOI 10.1073/pnas.78.11.6858; Behrens MD, 2008, BLOOD, V111, P1472, DOI 10.1182/blood-2007-10-117184; BRENNER S, 1974, GENETICS, V77, P71; Casadevall A, 1998, CRYPTOCOCCUS NEOFORM; Cox GM, 2000, INFECT IMMUN, V68, P443, DOI 10.1128/IAI.68.2.443-448.2000; Cusa E, 1999, J BACTERIOL, V181, P7479, DOI 10.1128/JB.181.24.7479-7484.1999; D'Souza CA, 2001, MOL CELL BIOL, V21, P3179, DOI 10.1128/MCB.21.9.3179-3191.2001; Davidson RC, 2002, MICROBIOL-SGM, V148, P2607, DOI 10.1099/00221287-148-8-2607; DRIFT CVD, 1970, ARCH BIOCHEM BIOPHYS, V136, P273, DOI 10.1016/0003-9861(70)90351-6; Dueber JE, 2009, NAT BIOTECHNOL, V27, P753, DOI 10.1038/nbt.1557; ELION GB, 1989, SCIENCE, V244, P41, DOI 10.1126/science.2649979; Enright AJ, 1999, NATURE, V402, P86, DOI 10.1038/47056; Fraser JA, 2003, EUKARYOT CELL, V2, P1036, DOI 10.1128/EC.2.5.1036-1045.2003; Garsin DA, 2001, P NATL ACAD SCI USA, V98, P10892, DOI 10.1073/pnas.191378698; Gournas C, 2011, FUNGAL GENET BIOL, V48, P840, DOI 10.1016/j.fgb.2011.03.004; HALL AP, 1967, AM J MED, V42, P27, DOI 10.1016/0002-9343(67)90004-6; HAWKINS AR, 1987, CURR GENET, V11, P491, DOI 10.1007/BF00384611; Hayashi S, 2000, CELL BIOCHEM BIOPHYS, V32, P123, DOI 10.1385/CBB:32:1-3:123; Heitman Joseph, 2011, Fungal Biology Reviews, V25, P48, DOI 10.1016/j.fbr.2011.01.003; Hennebry SC, 2006, J MOL BIOL, V359, P1389, DOI 10.1016/j.jmb.2006.04.057; HONDA S, 1993, J GERONTOL, V48, pB57, DOI 10.1093/geronj/48.2.B57; Hynes MJ, 2008, GENETICS, V178, P1355, DOI 10.1534/genetics.107.085795; Idnurm A, 2005, PLOS BIOL, V3, P615, DOI 10.1371/journal.pbio.0030095; Idnurm A, 2004, EUKARYOT CELL, V3, P420, DOI 10.1128/EC.3.2.420-429.2004; Jung DK, 2006, P NATL ACAD SCI USA, V103, P9790, DOI 10.1073/pnas.0600523103; Jung WH, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040045; Kahn K, 1997, J AM CHEM SOC, V119, P5435, DOI 10.1021/ja970375t; Kahn K, 1998, BIOCHEMISTRY-US, V37, P11651, DOI 10.1021/bi980446g; KWONCHUNG KJ, 1982, A VAN LEEUW J MICROB, V48, P25, DOI 10.1007/BF00399484; LAWTHER RP, 1974, J BACTERIOL, V119, P461, DOI 10.1128/JB.119.2.461-468.1974; Lee IR, 2011, GENETICS, V188, P309, DOI 10.1534/genetics.111.128538; Lee Y, 2005, FEBS LETT, V579, P4769, DOI 10.1016/j.febslet.2005.07.056; Magasanik B, 2000, P NATL ACAD SCI USA, V97, P14044, DOI 10.1073/pnas.97.26.14044; Marcotte EM, 1999, NATURE, V402, P83, DOI 10.1038/47048; Marzluf GA, 1997, MICROBIOL MOL BIOL R, V61, P17, DOI 10.1128/.61.1.17-32.1997; MODRIC N, 1992, TETRAHEDRON LETT, V33, P6691, DOI 10.1016/S0040-4039(00)61021-3; Munoz A, 2001, PLANT PHYSIOL, V125, P828, DOI 10.1104/pp.125.2.828; Mylonakis E, 2002, P NATL ACAD SCI USA, V99, P15675, DOI 10.1073/pnas.232568599; Navarathna DHMLP, 2010, FEMS YEAST RES, V10, P209, DOI 10.1111/j.1567-1364.2010.00602.x; Nielsen K, 2007, EUKARYOT CELL, V6, P949, DOI 10.1128/EC.00097-07; Oda M, 2002, MOL BIOL EVOL, V19, P640, DOI 10.1093/oxfordjournals.molbev.a004123; Olszewski MA, 2004, AM J PATHOL, V164, P1761, DOI 10.1016/S0002-9440(10)63734-0; Park BJ, 2009, AIDS, V23, P525, DOI 10.1097/QAD.0b013e328322ffac; Ramazzina I, 2006, NAT CHEM BIOL, V2, P144, DOI 10.1038/nchembio768; Reumann S, 2007, PLANT CELL, V19, P3170, DOI 10.1105/tpc.107.050989; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Schultz AC, 2001, J BACTERIOL, V183, P3293, DOI 10.1128/JB.183.11.3293-3302.2001; Schwartz J, 2003, SEMIN HEMATOL, V40, P87, DOI 10.1053/shem.2003.50007; SGRAVENMADE EJ, 1970, BIOCHIM BIOPHYS ACTA, V198, P569, DOI 10.1016/0005-2744(70)90134-8; Shi MQ, 2010, J CLIN INVEST, V120, P1683, DOI 10.1172/JCI41963; Southern E, 2006, NAT PROTOC, V1, P518, DOI 10.1038/nprot.2006.73; STAIB F, 1978, MYCOPATHOLOGIA, V65, P73, DOI 10.1007/BF00447178; STAIB F, 1976, ZBL BAKT-INT J MED M, V236, P374; Tavazzi B, 2005, CLIN BIOCHEM, V38, P997, DOI 10.1016/j.clinbiochem.2005.08.002; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Todd CD, 2006, J EXP BOT, V57, P5, DOI 10.1093/jxb/erj013; VOGELS GD, 1976, BACTERIOL REV, V40, P403, DOI 10.1128/MMBR.40.2.403-468.1976; Walker UA, 2006, AIDS, V20, P1556, DOI 10.1097/01.aids.0000237374.16068.de; Werner AK, 2008, PLANT PHYSIOL, V146, P418, DOI 10.1104/pp.107.110809; Werner AK, 2010, NAT CHEM BIOL, V6, P19, DOI [10.1038/NCHEMBIO.265, 10.1038/nchembio.265]; WILLIAMSON PR, 1994, J BACTERIOL, V176, P656, DOI 10.1128/jb.176.3.656-664.1994; WINKLER RG, 1988, PLANT PHYSIOL, V86, P1084, DOI 10.1104/pp.86.4.1084; Wong KH, 2008, EUKARYOT CELL, V7, P917, DOI 10.1128/EC.00076-08; Wong S, 2005, NAT GENET, V37, P777, DOI 10.1038/ng1584; WU XW, 1994, P NATL ACAD SCI USA, V91, P742, DOI 10.1073/pnas.91.2.742; Xue CY, 2007, CELL HOST MICROBE, V1, P263, DOI 10.1016/j.chom.2007.05.005; Zanotti G, 2006, J MOL BIOL, V363, P1, DOI 10.1016/j.jmb.2006.07.079	68	27	27	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e64292	10.1371/journal.pone.0064292	http://dx.doi.org/10.1371/journal.pone.0064292			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667704	Green Submitted, Green Published, gold			2022-12-27	WOS:000319654700206
J	Torella, A; Fanin, M; Mutarelli, M; Peterle, E; Blanco, FD; Rispoli, R; Savarese, M; Garofalo, A; Piluso, G; Morandi, L; Ricci, G; Siciliano, G; Angelini, C; Nigro, V				Torella, Annalaura; Fanin, Marina; Mutarelli, Margherita; Peterle, Enrico; Blanco, Francesca Del Vecchio; Rispoli, Rossella; Savarese, Marco; Garofalo, Arcomaria; Piluso, Giulio; Morandi, Lucia; Ricci, Giulia; Siciliano, Gabriele; Angelini, Corrado; Nigro, Vincenzo			Next-Generation Sequencing Identifies Transportin 3 as the Causative Gene for LGMD1F	PLOS ONE			English	Article							GIRDLE MUSCULAR-DYSTROPHY; PROTEIN; MUTATIONS; DOMAIN; VARIANTS; RECEPTOR; DATABASE; SR	Limb-girdle muscular dystrophies (LGMD) are genetically and clinically heterogeneous conditions. We investigated a large family with autosomal dominant transmission pattern, previously classified as LGMD1F and mapped to chromosome 7q32. Affected members are characterized by muscle weakness affecting earlier the pelvic girdle and the ileopsoas muscles. We sequenced the whole exome of four family members and identified a shared heterozygous frame-shift variant in the Transportin 3 (TNPO3) gene, encoding a member of the importin-beta super-family. The TNPO3 gene is mapped within the LGMD1F critical interval and its 923-amino acid human gene product is also expressed in skeletal muscle. In addition, we identified an isolated case of LGMD with a new missense mutation in the same gene. We localized the mutant TNPO3 around the nucleus, but not inside. The involvement of gene related to the nuclear transport suggests a novel disease mechanism leading to muscular dystrophy.	[Torella, Annalaura; Mutarelli, Margherita; Rispoli, Rossella; Savarese, Marco; Nigro, Vincenzo] TIGEM Telethon Inst Genet & Med, Naples, Italy; [Torella, Annalaura; Blanco, Francesca Del Vecchio; Savarese, Marco; Garofalo, Arcomaria; Piluso, Giulio; Nigro, Vincenzo] Univ Naples 2, Dipartimento Biochim Biofis & Patol Gen, Naples, Italy; [Fanin, Marina; Peterle, Enrico; Angelini, Corrado] Univ Padua, Dipartimento Neurosci, Padua, Italy; [Rispoli, Rossella] Canc Res UK, London, England; [Morandi, Lucia] Fdn IRCCS Ist Neurol C Besta, Milan, Italy; [Ricci, Giulia; Siciliano, Gabriele] Univ Pisa, Dipartimento Med Clin & Sperimentale, Pisa, Italy; [Angelini, Corrado] IRCSS S Camillo, Venice, Italy	Fondazione Telethon; Telethon Institute of Genetics & Medicine (TIGEM); Universita della Campania Vanvitelli; University of Padua; Cancer Research UK; IRCCS Istituto Neurologico Besta; University of Pisa; IRCCS Ospedale San Camillo	Nigro, V (corresponding author), TIGEM Telethon Inst Genet & Med, Naples, Italy.	vincenzo.nigro@unina2.it	Nigro, Vincenzo/AAB-2274-2022; Ricci, Giulia/K-6731-2016; Mutarelli, Margherita/K-1910-2019; Angelini, Corrado I/J-3655-2019; PILUSO, Giulio/AAA-3400-2019; Piluso, Giulio/AAA-3661-2019; Savarese, Marco/J-8307-2016	Ricci, Giulia/0000-0002-6612-5995; Angelini, Corrado I/0000-0002-9554-8794; PILUSO, Giulio/0000-0001-9418-125X; Savarese, Marco/0000-0002-2591-244X; Torella, Annalaura/0000-0003-2479-6018; Nigro, Vincenzo/0000-0002-3378-5006; Mutarelli, Margherita/0000-0002-2168-5059	Telethon, Italy [TGM11Z06, GTB12001]; Telethon-UILDM (Unione Italiana Lotta alla Distrofia Muscolare) [GUP 10006, GUP11006]; Association Francaise contre les Myopathies [13859, 14999/16216]; TIGEM Bioinformatics Core; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [UC2HL102923, RC2HL102926, RC2HL102924, RC2HL103010, RC2HL102925, UC2HL102925, UC2HL103010, RC2HL102923, UC2HL102926, UC2HL102924] Funding Source: NIH RePORTER	Telethon, Italy(Fondazione Telethon); Telethon-UILDM (Unione Italiana Lotta alla Distrofia Muscolare)(Fondazione Telethon); Association Francaise contre les Myopathies(Association Francaise contre les Myopathies); TIGEM Bioinformatics Core; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was mainly supported by grants from Telethon, Italy (TGM11Z06 to V.N. and GTB12001 to C.A.) and Telethon-UILDM (Unione Italiana Lotta alla Distrofia Muscolare) (GUP 10006 and GUP11006 to V.N.). This work was also supported by grants from the Association Francaise contre les Myopathies (13859 to M.F. and 14999/16216 to C.A.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank all the patients and their families for their contribution to this work. We acknowledge the Neuromuscular Bank of Tissues and DNA samples (NMTB) for collecting samples (C.A. and M.F.), Stefania Crispi and Luigi Leone at the IGB Facility of Next Generation Sequencing using the SOLID platform, and Anna Cuomo and Rosalba Erpice for Sanger sequencing. The authors would like to thank the NHLBI GO Exome Sequencing Project and its ongoing studies which produced and provided exome variant calls for comparison: the Lung GO Sequencing Project (HL-102923), the WHI Sequencing Project (HL-102924), the Broad GO Sequencing Project (HL-102925), the Seattle GO Sequencing Project (HL-102926) and the Heart GO Sequencing Project (HL-103010). We also thank Gopuraja Dharmalingam and the TIGEM Bioinformatics Core for support in exome data analysis and Giuseppina Di Fruscio for the analysis of isolated cases of LGMD and Marina Mora for helpful suggestions.	Adzhubei Ivan, 2013, Curr Protoc Hum Genet, VChapter 7, DOI 10.1002/0471142905.hg0720s76; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Cenacchi G, 2012, NEUROPATHOLOGY; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Fanin M, 2009, NEUROLOGY, V72, P1432, DOI 10.1212/WNL.0b013e3181a1885e; Gamez J, 2001, NEUROLOGY, V56, P450, DOI 10.1212/WNL.56.4.450; Goode DL, 2010, GENOME RES, V20, P301, DOI 10.1101/gr.102210.109; Harms MB, 2012, ANN NEUROL, V71, P407, DOI 10.1002/ana.22683; Hirschfield GM, 2010, NAT GENET, V42, P655, DOI 10.1038/ng.631; Kataoka N, 1999, J CELL BIOL, V145, P1145, DOI 10.1083/jcb.145.6.1145; Kley RA, 2012, BRAIN, V135, P2642, DOI 10.1093/brain/aws200; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Lai MC, 2000, J BIOL CHEM, V275, P7950, DOI 10.1074/jbc.275.11.7950; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liu XM, 2011, HUM MUTAT, V32, P894, DOI 10.1002/humu.21517; Logue EC, 2011, J VIROL, V85, P12950, DOI 10.1128/JVI.05384-11; Mamanova L, 2010, NAT METHODS, V7, P111, DOI 10.1038/nmeth.1419; Mercuri E, 2005, NEUROMUSCULAR DISORD, V15, P164, DOI 10.1016/j.nmd.2004.10.008; Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626; Ng SB, 2010, NAT GENET, V42, P30, DOI 10.1038/ng.499; Nigro V, 2003, Acta Myol, V22, P35; Nigro V, 2011, CURR OPIN NEUROL, V24, P429, DOI 10.1097/WCO.0b013e32834aa38d; Palenzuela L, 2003, NEUROLOGY, V61, P404, DOI 10.1212/01.WNL.0000073984.46546.4F; Pollard KS, 2010, GENOME RES, V20, P110, DOI 10.1101/gr.097857.109; Pollard VW, 1996, CELL, V86, P985, DOI 10.1016/S0092-8674(00)80173-7; Pruitt KD, 2012, NUCLEIC ACIDS RES, V40, pD130, DOI 10.1093/nar/gkr1079; Sarparanta J, 2012, NAT GENET, V44, P450, DOI 10.1038/ng.1103; Schwarz JM, 2010, NAT METHODS, V7, P575, DOI 10.1038/nmeth0810-575; Shamsher MK, 2002, P NATL ACAD SCI USA, V99, P14195, DOI 10.1073/pnas.212518199; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; ten Dam L, 2012, NEUROLOGY, V79, P1716, DOI 10.1212/WNL.0b013e31826e9b73; Thorvaldsdottir H, 2012, BRIEF BIOINFORM; Vorgerd M, 2005, AM J HUM GENET, V77, P297, DOI 10.1086/431959; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Wattjes MP, 2010, EUR RADIOL, V20, P2447, DOI 10.1007/s00330-010-1799-2	35	47	48	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e63536	10.1371/journal.pone.0063536	http://dx.doi.org/10.1371/journal.pone.0063536			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667635	Green Published, Green Submitted, gold			2022-12-27	WOS:000319654700159
J	Winkvist, A; Bertz, F; Ellegard, L; Bosaeus, I; Brekke, HK				Winkvist, Anna; Bertz, Fredrik; Ellegard, Lars; Bosaeus, Ingvar; Brekke, Hilde K.			Metabolic Risk Profile among Overweight and Obese Lactating Women in Sweden	PLOS ONE			English	Article							INSULIN-RESISTANCE; MATERNAL OBESITY; LIPID-METABOLISM; WEIGHT-GAIN; US ADULTS; PREVALENCE; PREGNANCY; GLUCOSE; PARITY; HEALTH	Background: Obesity and cardiovascular diseases are increasing globally and any association between reproduction and these conditions is of concern. Unfortunately, little is known about normal levels of metabolic risk factors in women of different body mass index throughout the reproductive cycle. This study is one of the first to describe the metabolic risk profile of lactating overweight or obese women at 8-12 weeks postpartum. Methods: During 2007-2009, 66 overweight or obese Swedish lactating women without known diseases underwent detailed measurements of their metabolic profiles, dietary intake and general health before entering a lifestyle intervention trial. Baseline measurements took place between 8-12 wk postpartum. Almost all women were exclusively breastfeeding their term infants. Results: The women were regarded as healthy, as reflected in the absence of diagnosed diseases, their own perceptions and in normal hemoglobin, albumin and fasting plasma glucose values. Four women were diagnosed with metabolic syndrome. In these cases, underlying conditions included large waist circumference, low HDL cholesterol values, high triglyceride values and relatively high blood pressure. The metabolic profile differed between overweight and obese women; obese women had significantly higher levels of fasting insulin (p = 0.017), borderline higher HOMA values (p = 0.057) and significantly higher triglyceride values (p = 0.029), as well as larger waist and hip circumferences (p<0.001 and p<0.001). However, no significant differences between overweight and obese women were detected for LDL or total cholesterol levels. Overweight and obese women reported similar total energy and macronutrient intakes, but obese women tended to be less physically active (p = 0.081). Conclusions: Among generally healthy lactating women, obesity as compared to overweight is associated with increased metabolic risk. This cut-off is thus important also in the early postpartum period, and obesity among these women should warrant proper health investigation. Macronutrient intake did not differ between the groups and, hence, cannot explain these differences.	[Winkvist, Anna; Bertz, Fredrik; Ellegard, Lars; Bosaeus, Ingvar; Brekke, Hilde K.] Univ Gothenburg, Sahlgrenska Acad, Dept Internal Med & Clin Nutr, Gothenburg, Sweden	University of Gothenburg	Winkvist, A (corresponding author), Univ Gothenburg, Sahlgrenska Acad, Dept Internal Med & Clin Nutr, Gothenburg, Sweden.	anna.winkvist@nutrition.gu.se	Winkvist, Anna/AAC-6178-2021; Ellegard, Lars H/E-6191-2016	Winkvist, Anna/0000-0001-9122-7240; Ellegard, Lars H/0000-0002-2787-4336	Swedish Research Council [K2009-70X-21091-01-03]; Swedish Council for Working Life and Social Research [2006-0339, 2007-1958]	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Council for Working Life and Social Research(Swedish Research CouncilSwedish Research Council for Health Working Life & Welfare (Forte))	The study was supported by grants from the Swedish Research Council (K2009-70X-21091-01-03; www.vr.se) and the Swedish Council for Working Life and Social Research (www.fas.se; 2006-0339 and 2007-1958). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cameron AJ, 2004, ENDOCRIN METAB CLIN, V33, P351, DOI 10.1016/j.ecl.2004.03.005; DARMADY JM, 1982, BRIT J OBSTET GYNAEC, V89, P211, DOI 10.1111/j.1471-0528.1982.tb03616.x; FAHRAEUS L, 1985, OBSTET GYNECOL, V66, P468; Flegal KM, 2010, JAMA-J AM MED ASSOC, V303, P235, DOI 10.1001/jama.2009.2014; Ford ES, 2002, JAMA-J AM MED ASSOC, V287, P356, DOI 10.1001/jama.287.3.356; Guelinckx I, 2008, OBES REV, V9, P140, DOI 10.1111/j.1467-789X.2007.00464.x; Gunderson EP, 2012, DIABETES CARE, V35, P50, DOI 10.2337/dc11-1409; Gunderson EP, 2009, AM J OBSTET GYNECOL, V201, DOI 10.1016/j.ajog.2009.03.031; *I MED NAT RES COU, 2009, WEIGHT GAIN PREGN RE; KJOS SL, 1993, OBSTET GYNECOL, V82, P451; Kuh D, 2002, LIFE COURSE APPROACH; Lain KY, 2007, CLIN OBSTET GYNECOL, V50, P938, DOI 10.1097/GRF.0b013e31815a5494; Lao XQ, 2006, CLIN ENDOCRINOL, V65, P460, DOI 10.1111/j.1365-2265.2006.02615.x; Lawlor DA, 2003, CIRCULATION, V107, P1260, DOI 10.1161/01.CIR.0000053441.43495.1A; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Parikh NI, 2010, AM HEART J, V159, DOI 10.1016/j.ahj.2009.11.017; Pollock ML, 1998, MED SCI SPORT EXER, V30, P975, DOI 10.1097/00005768-199806000-00032; Ramsay JE, 2002, J CLIN ENDOCR METAB, V87, P4231, DOI 10.1210/jc.2002-020311; Rasmussen KM, 2010, OBSTET GYNECOL, V116, P1191, DOI 10.1097/AOG.0b013e3181f60da7; Talayero Beatriz G, 2011, Curr Cardiol Rep, V13, P544, DOI 10.1007/s11886-011-0220-3; Trayhurn P, 2004, BRIT J NUTR, V92, P347, DOI 10.1079/BJN20041213; Vahratian A, 2010, OBSTET GYNECOL, V116, P107, DOI 10.1097/AOG.0b013e3181e45d23; World Health Organization, 2006, DEF DIAGN DIAB MELL; World Health Organization, 2000, WHO TECHN REP SER, V894, P252	24	5	7	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e63629	10.1371/journal.pone.0063629	http://dx.doi.org/10.1371/journal.pone.0063629			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667649	Green Published, gold, Green Submitted			2022-12-27	WOS:000319654700170
J	Rosado, LA; Vasconcelos, IB; Palma, MS; Frappier, V; Najmanovich, RJ; Santos, DS; Basso, LA				Rosado, Leonardo Astolfi; Vasconcelos, Igor Bordin; Palma, Mario Sergio; Frappier, Vincent; Najmanovich, Rafael Josef; Santos, Diogenes Santiago; Basso, Luiz Augusto			The Mode of Action of Recombinant Mycobacterium tuberculosis Shikimate Kinase: Kinetics and Thermodynamics Analyses	PLOS ONE			English	Article							HEAT-CAPACITY; CRYSTAL-STRUCTURE; LIGAND-BINDING; PATHWAY; ENZYMES; ACID; GENOME; QUANTITIES; MAGNESIUM; PROTEINS	Tuberculosis remains as one of the main cause of mortality worldwide due to a single infectious agent, Mycobacterium tuberculosis. The aroK-encoded M. tuberculosis Shikimate Kinase (MtSK), shown to be essential for survival of bacilli, catalyzes the phosphoryl transfer from ATP to the carbon-3 hydroxyl group of shikimate (SKH), yielding shikimate-3-phosphate and ADP. Here we present purification to homogeneity, and oligomeric state determination of recombinant MtSK. Biochemical and biophysical data suggest that the chemical reaction catalyzed by monomeric MtSK follows a rapid-equilibrium random order of substrate binding, and ordered product release. Isothermal titration calorimetry (ITC) for binding of ligands to MtSK provided thermodynamic signatures of non-covalent interactions to each process. A comparison of steady-state kinetics parameters and equilibrium dissociation constant value determined by ITC showed that ATP binding does not increase the affinity of MtSK for SKH. We suggest that MtSK would more appropriately be described as an aroL-encoded type II shikimate kinase. Our manuscript also gives thermodynamic description of SKH binding to MtSK and data for the number of protons exchanged during this bimolecular interaction. The negative value for the change in constant pressure heat capacity (Delta C-p) and molecular homology model building suggest a pronounced contribution of desolvation of non-polar groups upon binary complex formation. Thermodynamic parameters were deconvoluted into hydrophobic and vibrational contributions upon MtSK:SKH binary complex formation. Data for the number of protons exchanged during this bimolecular interaction are interpreted in light of a structural model to try to propose the likely amino acid side chains that are the proton donors to bulk solvent following MtSK:SKH complex formation.	[Rosado, Leonardo Astolfi; Vasconcelos, Igor Bordin; Santos, Diogenes Santiago; Basso, Luiz Augusto] Pontificia Univ Catolica Rio Grande do Sul, INCT TB, CPBMF, Porto Alegre, RS, Brazil; [Santos, Diogenes Santiago; Basso, Luiz Augusto] Pontificia Univ Catolica Rio Grande do Sul, Programa Posgrad Med & Ciencias Saude, Porto Alegre, RS, Brazil; [Rosado, Leonardo Astolfi; Vasconcelos, Igor Bordin; Santos, Diogenes Santiago; Basso, Luiz Augusto] Pontificia Univ Catolica Rio Grande do Sul, Programa Posgrad Biol Celular & Mol, Porto Alegre, RS, Brazil; [Palma, Mario Sergio] Univ Estadual Paulista UNESP, Inst Biociencias Rio Claro, Ctr Estudos Insetos Sociais, Lab Biol Estrutural & Zooquim,Dept Biol, Rio Claro, SP, Brazil; [Frappier, Vincent; Najmanovich, Rafael Josef] Univ Sherbrooke, Fac Med, Dept Biochem, Sherbrooke, PQ, Canada	Pontificia Universidade Catolica Do Rio Grande Do Sul; Pontificia Universidade Catolica Do Rio Grande Do Sul; Pontificia Universidade Catolica Do Rio Grande Do Sul; Universidade Estadual Paulista; University of Sherbrooke	Santos, DS (corresponding author), Pontificia Univ Catolica Rio Grande do Sul, INCT TB, CPBMF, Porto Alegre, RS, Brazil.	diogenes@pucrs.br; luiz.basso@pucrs.br	Palma, Mario/N-3903-2019; Basso, Luiz Augusto/T-9308-2019; Fapesp, Biota/F-8655-2017; Palma, Mario Sergio/E-7800-2012; Tuberculose, Inct/K-2302-2013	Basso, Luiz Augusto/0000-0003-0903-2407; Fapesp, Biota/0000-0002-9887-8449; Palma, Mario Sergio/0000-0002-7363-8211; Najmanovich, Rafael/0000-0002-6971-7224; Astolfi Rosado, Leonardo/0000-0002-4349-0244	Decit/SCTIE/MS-MCT-CNPq-FNDCT-CAPES; FAPERGS-CNPq-PRONEX-2009; National Research Council of Brazil (CNPq) [520182/99-5, 304051/1975-06, 500079/90-0]; CNPq	Decit/SCTIE/MS-MCT-CNPq-FNDCT-CAPES; FAPERGS-CNPq-PRONEX-2009; National Research Council of Brazil (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by funds awarded by Decit/SCTIE/MS-MCT-CNPq-FNDCT-CAPES to National Institute of Science and Technology on Tuberculosis (INCT-TB) to D.S.S. and L.A.B. L.A.B. and D.S.S. also acknowledge financial support awarded by FAPERGS-CNPq-PRONEX-2009. L.A.B. (CNPq, 520182/99-5), D.S.S. (CNPq, 304051/1975-06), and M.S.P. (CNPq, 500079/90-0) are Research Career Awardees of the National Research Council of Brazil (CNPq). R.J.N. is part of Centre de Recherche Clinique Etienne-Le Bel and a member of the Institut de Pharmacologie de Sherbrooke and PROTEO, the Quebec network for research on protein function, structure and engineering. L.A.R. has been supported by a scholarship awarded by CNPq. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almonacid DE, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000700; [Anonymous], 2010, MULTIDRUG EXTENSIVEL; Balganesh TS, 2008, TRENDS PHARMACOL SCI, V29, P576, DOI 10.1016/j.tips.2008.08.001; BENTLEY R, 1990, CRIT REV BIOCHEM MOL, V25, P307, DOI 10.3109/10409239009090615; Dias MVB, 2007, ACTA CRYSTALLOGR F, V63, P1, DOI 10.1107/S1744309106046823; Bianconi ML, 2007, BIOPHYS CHEM, V126, P59, DOI 10.1016/j.bpc.2006.05.017; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Campbell SA, 2004, INT J PARASITOL, V34, P5, DOI 10.1016/j.ijpara.2003.10.006; Chassaigne H, 1998, ANALYST, V123, P2125, DOI 10.1039/a804713h; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Cook PF, 2007, GARLAND SCI, P19; Cooper A, 2005, BIOPHYS CHEM, V115, P89, DOI 10.1016/j.bpc.2004.12.011; Dhaliwal B, 2004, FEBS LETT, V574, P49, DOI 10.1016/j.febslet.2004.08.005; Ducati RG, 2007, CURR DRUG TARGETS, V8, P423, DOI 10.2174/138945007780059004; EDMAN P, 1967, EUR J BIOCHEM, V1, P80, DOI 10.1111/j.1432-1033.1967.tb00047.x; Edsall JT, 1935, J AM CHEM SOC, V57, P1506, DOI 10.1021/ja01311a501; Engel P.C., 1977, ENZYME KINETICS; ESWAR N, 2006, CURR PROTOC BIOINF S, V15; Fukada H, 1998, PROTEINS, V33, P159, DOI 10.1002/(SICI)1097-0134(19981101)33:2<159::AID-PROT2>3.0.CO;2-E; Gan JH, 2006, BIOCHEMISTRY-US, V45, P8539, DOI 10.1021/bi0606290; GILL SJ, 1976, P NATL ACAD SCI USA, V73, P2955, DOI 10.1073/pnas.73.9.2955; Goldberg RN, 2002, J PHYS CHEM REF DATA, V31, P231, DOI 10.1063/1.1416902; Gu YJ, 2002, J MOL BIOL, V319, P779, DOI 10.1016/S0022-2836(02)00339-X; Gurney R.W., 1953, IONIC PROCESSES SOLU; Hartmann MD, 2006, J MOL BIOL, V364, P411, DOI 10.1016/j.jmb.2006.09.001; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; HIREL PH, 1989, P NATL ACAD SCI USA, V86, P8247, DOI 10.1073/pnas.86.21.8247; Irudayam SJ, 2009, J PHYS CHEM B, V113, P5871, DOI 10.1021/jp809968p; Jencks W. P., 1975, CATALYSIS CHEM ENZYM; KAUZMANN W, 1959, ADV PROTEIN CHEM, V14, P1, DOI 10.1016/S0065-3233(08)60608-7; Keeling PJ, 1999, NATURE, V397, P219, DOI 10.1038/16618; Krell T, 2001, PROTEIN SCI, V10, P1137, DOI 10.1110/ps.52501; Ladbury JE, 2010, NAT REV DRUG DISCOV, V9, P23, DOI 10.1038/nrd3054; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Maguire ME, 2002, BIOMETALS, V15, P203, DOI 10.1023/A:1016058229972; McConkey BJ, 2002, BIOINFORMATICS, V18, P1365, DOI 10.1093/bioinformatics/18.10.1365; McConkey GA, 2004, TRENDS PARASITOL, V20, P60, DOI 10.1016/j.pt.2003.11.001; McConkey GA, 1999, ANTIMICROB AGENTS CH, V43, P175, DOI 10.1128/AAC.43.1.175; McFadden GI, 1996, NATURE, V381, P482, DOI 10.1038/381482a0; MILLAR G, 1986, BIOCHEM J, V237, P427, DOI 10.1042/bj2370427; O'Brien R, 2004, BIOCALORIMETRY 2 APP; Oliveira JS, 2001, PROTEIN EXPRES PURIF, V22, P430, DOI 10.1006/prep.2001.1457; Parish T, 2002, MICROBIOL-SGM, V148, P3069, DOI 10.1099/00221287-148-10-3069; Pereira JH, 2004, ACTA CRYSTALLOGR D, V60, P2310, DOI 10.1107/S090744490402517X; PITTARD AJ, 1996, ESCHERICHIA COLI SAL; Roberts CW, 2002, J INFECT DIS, V185, pS25, DOI 10.1086/338004; Roberts F, 1998, NATURE, V393, P801, DOI 10.1038/31723; Robertson JG, 2007, CURR OPIN STRUC BIOL, V17, P674, DOI 10.1016/j.sbi.2007.08.008; Robertson JG, 2005, BIOCHEMISTRY-US, V44, P5561, DOI 10.1021/bi050247e; Segel IH., 1993, ENZYME KINETICS BEHA; Starcevic A, 2008, P NATL ACAD SCI USA, V105, P2533, DOI 10.1073/pnas.0707388105; STURTEVANT JM, 1977, P NATL ACAD SCI USA, V74, P2236, DOI 10.1073/pnas.74.6.2236; TAKAHASHI K, 1985, BIOCHEMISTRY-US, V24, P297, DOI 10.1021/bi00323a009; Velayati AA, 2009, EUR RESPIR J, V34, P1202, DOI 10.1183/09031936.00081909; VONRHEIN C, 1995, STRUCTURE, V3, P483, DOI 10.1016/S0969-2126(01)00181-2; Weber G, 1975, Adv Protein Chem, V29, P1, DOI 10.1016/S0065-3233(08)60410-6; WHIPP MJ, 1995, J BACTERIOL, V177, P1627, DOI 10.1128/jb.177.6.1627-1629.1995; WHO, 2010, GLOB TUB CONTR 2010; Zhang YJ, 2006, CURR OPIN CHEM BIOL, V10, P658, DOI 10.1016/j.cbpa.2006.09.020	59	11	11	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2013	8	5							e61918	10.1371/journal.pone.0061918	http://dx.doi.org/10.1371/journal.pone.0061918			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	177QL	23671579	Green Published, Green Submitted, gold			2022-12-27	WOS:000321390200012
J	Henshaw, H; Ferguson, MA				Henshaw, Helen; Ferguson, Melanie A.			Efficacy of Individual Computer-Based Auditory Training for People with Hearing Loss: A Systematic Review of the Evidence	PLOS ONE			English	Review							SPEECH-IN-NOISE; COCHLEAR IMPLANT; RECOGNITION PERFORMANCE; HANDICAP INVENTORY; OLDER-PEOPLE; ADULT USERS; YOUNG; IMPAIRMENT; RECEPTION; DISCOURSE	Background: Auditory training involves active listening to auditory stimuli and aims to improve performance in auditory tasks. As such, auditory training is a potential intervention for the management of people with hearing loss. Objective: This systematic review (PROSPERO 2011: CRD42011001406) evaluated the published evidence-base for the efficacy of individual computer-based auditory training to improve speech intelligibility, cognition and communication abilities in adults with hearing loss, with or without hearing aids or cochlear implants. Methods: A systematic search of eight databases and key journals identified 229 articles published since 1996, 13 of which met the inclusion criteria. Data were independently extracted and reviewed by the two authors. Study quality was assessed using ten pre-defined scientific and intervention-specific measures. Results: Auditory training resulted in improved performance for trained tasks in 9/10 articles that reported on-task outcomes. Although significant generalisation of learning was shown to untrained measures of speech intelligibility (11/13 articles), cognition (1/1 articles) and self-reported hearing abilities (1/2 articles), improvements were small and not robust. Where reported, compliance with computer-based auditory training was high, and retention of learning was shown at post-training follow-ups. Published evidence was of very-low to moderate study quality. Conclusions: Our findings demonstrate that published evidence for the efficacy of individual computer-based auditory training for adults with hearing loss is not robust and therefore cannot be reliably used to guide intervention at this time. We identify a need for high-quality evidence to further examine the efficacy of computer-based auditory training for people with hearing loss.	[Henshaw, Helen; Ferguson, Melanie A.] NIHR Nottingham Hearing Biomed Res Unit, Nottingham, England		Henshaw, H (corresponding author), NIHR Nottingham Hearing Biomed Res Unit, Nottingham, England.	helen.henshaw@nottingham.ac.uk	Ferguson, Melanie/AAY-3525-2021; Henshaw, Helen/C-2375-2018	Henshaw, Helen/0000-0002-0547-4403	National Institute for Health Research (NIHR)	National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR))	This research was funded by the National Institute for Health Research (NIHR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Action on Hearing Loss, 2011, STAT DEAFNESS HEARIN; Amitay S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009816; [Anonymous], 1969, IEEE T ACOUST SPEECH, VAU17, P225; Banh J, 2012, J AM ACAD AUDIOL, V23, P81, DOI 10.3766/jaaa.23.2.2; Barcroft J, 2011, INT J AUDIOL, V50, P802, DOI 10.3109/14992027.2011.599868; Bastiaanse R., 2002, VERB SENTENCE TEST; Bench J, 1979, Br J Audiol, V13, P108, DOI 10.3109/03005367909078884; Bode D L, 1970, J Speech Hear Res, V13, P839; Boothroyd A, 1985, SENTENCE TEST SPEECH; Boothroyd A, 2010, J AM ACAD AUDIOL, V21, P601, DOI 10.3766/jaaa.21.9.6; BSA, 2012, PRACT GUID COMM PRIN; Burk MH, 2008, J SPEECH LANG HEAR R, V51, P759, DOI 10.1044/1092-4388(2008/054); Burk MH, 2006, EAR HEARING, V27, P263, DOI 10.1097/01.aud.0000215980.21158.a2; Centre for Reviews and Dissemination, 2008, SYST REV CRDS GUID U; Chisolm T., 2012, EVIDENCE BASED PRACT, P237; Cochrane, 2012, COCHRANE LIB; COX RM, 1987, EAR HEARING, V8, pS119, DOI 10.1097/00003446-198710001-00010; Davis A, 2007, HLTH TECHNOLOGY ASSE, P11; Davis AC, 1995, HEARING IN ADULTS; Davis H., 1978, HEARING AND DEAFNESS; Delamothe T, 2004, BMJ-BRIT MED J, V328, P1, DOI 10.1136/bmj.328.7430.1; DUBNO JR, 1981, J ACOUST SOC AM, V69, P249, DOI 10.1121/1.385345; Dunn CC, 2005, J SPEECH LANG HEAR R, V48, P668, DOI 10.1044/1092-4388(2005/046); Ferguson MA, 2012, INT J AUDIOL, V51, P220; Fu Qian-Jie, 2004, Cochlear Implants Int, V5 Suppl 1, P84, DOI 10.1179/cim.2004.5.Supplement-1.84; Garofolo J., 1993, NASA STIRECON TECHNI, V93, P27403, DOI DOI 10.6028/NIST.IR.4930; Gatehouse S, 2004, INT J AUDIOL, V43, P85, DOI 10.1080/14992020400050014; GREENWALD AG, 1991, PSYCHOL SCI, V2, P119, DOI 10.1111/j.1467-9280.1991.tb00112.x; Henshaw H, 2012, J MED INTERNET RES, V14, P211, DOI 10.2196/jmir.2036; HETU R, 1993, AUDIOLOGY, V32, P363; HILLENBRAND J, 1995, J ACOUST SOC AM, V97, P3099, DOI 10.1121/1.411872; Hirsh IJ, 1952, J SPEECH HEAR DISORD, V17, P321, DOI 10.1044/jshd.1703.321; Humes LE, 2009, EAR HEARING, V30, P613, DOI 10.1097/AUD.0b013e3181b00d90; Ingvalson EM, 2012, J SPEECH LANGUAGE HE; KALIKOW DN, 1977, J ACOUST SOC AM, V61, P1337, DOI 10.1121/1.381436; Kaplan H, 1997, J Am Acad Audiol, V8, P203; Kiessling J, 2003, INT J AUDIOL, V42, pS92; Killion MC, 2004, J ACOUST SOC AM, V116, P2395, DOI 10.1121/1.1784440; Kirkham JJ, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c365; Kochkin S, 2008, HEARING REV, V16, P12; Kricos P B, 1996, J Am Acad Audiol, V7, P219; KRICOS PB, 1992, J ACAD R, V25, P69; McArthur G, 2007, DYSLEXIA, V13, P240, DOI 10.1002/dys.355; Miller James D, 2008, Proc Meet Acoust, V2, P1; Miller James D, 2007, J Acoust Soc Am, V122, P3063; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Moher David, 2010, BMJ, V340, pc869, DOI [10.1016/j.jclinepi.2010.03.004, 10.1136/bmj.c869]; MONTGOMERY AA, 1984, EAR HEARING, V5, P30, DOI 10.1097/00003446-198401000-00007; NEWMAN CW, 1990, EAR HEARING, V11, P430, DOI 10.1097/00003446-199012000-00004; NILSSON M, 1994, J ACOUST SOC AM, V95, P1085, DOI 10.1121/1.408469; Oba SI, 2011, EAR HEARING, V32, P573, DOI 10.1097/AUD.0b013e31820fc821; PETERSON GE, 1962, J SPEECH HEAR DISORD, V27, P62, DOI 10.1044/jshd.2701.62; PICHORAFULLER MK, 1995, J ACOUST SOC AM, V97, P593, DOI 10.1121/1.412282; Robinson K, 1996, ANN OTO RHINOL LARYN, V105, P415, DOI 10.1177/000348949610500601; Ronnberg J, 2008, INT J AUDIOL, V47, pS99, DOI 10.1080/14992020802301167; RUBINSTEIN A, 1987, J SPEECH HEAR RES, V30, P153, DOI 10.1044/jshr.3002.153; Scarinci N, 2008, INT J AUDIOL, V47, P141, DOI 10.1080/14992020701689696; Schneider BA, 2000, PSYCHOL AGING, V15, P110, DOI 10.1037//0882-7974.15.1.110; Schow R. L, 2007, INTRO AUDIOLOGIC REH; Shannon RV, 1999, J ACOUSTICAL SOC AM, P106; Shinn-Cunningham Barbara G, 2008, Trends Amplif, V12, P283, DOI 10.1177/1084713808325306; Shipstead Z, 2012, PSYCHOL BULL, V138, P628, DOI 10.1037/a0027473; Smeeth L, 2002, LANCET, V359, P1466, DOI 10.1016/S0140-6736(02)08433-7; Song JH, 2012, CEREB CORTEX, V22, P1180, DOI 10.1093/cercor/bhr196; Spahr AJ, 2012, EAR HEARING, V33, P112, DOI 10.1097/AUD.0b013e31822c2549; Stacey PC, 2010, INT J AUDIOL, V49, P347, DOI 10.3109/14992020903397838; Stecker GC, 2006, J REHABIL RES DEV, V43, P537, DOI 10.1682/JRRD.2005.11.0171; STUDEBAKER GA, 1985, J SPEECH HEAR RES, V28, P455, DOI 10.1044/jshr.2803.455; Sweetow R, 2009, INTEGRATING LACE BUS; Sweetow Robert, 2005, J Am Acad Audiol, V16, P494, DOI 10.3766/jaaa.16.7.9; Sweetow RW, 2006, J AM ACAD AUDIOL, V17, P538, DOI 10.3766/jaaa.17.8.2; Sweetow RW, 2010, J AM ACAD AUDIOL, V21, P586, DOI 10.3766/jaaa.21.9.4; Tillman T W, 1966, Tech Rep SAM-TR, P1; Tremblay K, 1998, NEUROREPORT, V9, P3557, DOI 10.1097/00001756-199811160-00003; Tremblay Kelly L., 2007, Seminars in Hearing, V28, P120, DOI 10.1055/s-2007-973438; Turner CW, 2004, J ACOUST SOC AM, V115, P1729, DOI 10.1121/1.1687425; Tye-Murray N, 2008, INT J AUDIOL, V47, pS31, DOI 10.1080/14992020802301662; Tyler RS, 2006, INT J AUDIOL, V45, pS113, DOI 10.1080/14992020600783095; Tyler RS, 2010, J AM ACAD AUDIOL, V21, P390, DOI 10.3766/jaaa.21.6.4; Uttl B, 1997, J CLIN EXP NEUROPSYC, V19, P405, DOI 10.1080/01688639708403869; VENTRY IM, 1982, EAR HEARING, V3, P128, DOI 10.1097/00003446-198205000-00006; WALDEN BE, 1981, J SPEECH HEAR RES, V24, P207, DOI 10.1044/jshr.2402.207; Wilson RH, 2012, J AM ACAD AUDIOL, V23, P590, DOI 10.3766/jaaa.23.7.9; World Health Organization, 2008, The global burden of disease: 2004 update; Wright BA, 2010, J SPEECH LANG HEAR R, V56, P31; Wright BA, 2009, PHILOS T R SOC B, V364, P301, DOI 10.1098/rstb.2008.0262; Yund EW, 2010, EAR HEARING, V31, P769, DOI 10.1097/AUD.0b013e3181e68e4a; Zhang T, 2012, EAR HEARING, V33, pE70, DOI 10.1097/AUD.0b013e318259e5dd	88	123	134	0	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2013	8	5							e62836	10.1371/journal.pone.0062836	http://dx.doi.org/10.1371/journal.pone.0062836			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	143FO	23675431	Green Published, Green Submitted, gold			2022-12-27	WOS:000318852400013
J	Shi, F; Wang, L; Peng, ZW; Wee, CY; Shen, DG				Shi, Feng; Wang, Li; Peng, Ziwen; Wee, Chong-Yaw; Shen, Dinggang			Altered Modular Organization of Structural Cortical Networks in Children with Autism	PLOS ONE			English	Article							SPECTRUM DISORDERS; BRAIN-DEVELOPMENT; CEREBRAL-CORTEX; THICKNESS; MRI; VOLUME; SCHIZOPHRENIA; CONNECTIVITY; NEUROANATOMY; ANATOMY	Autism is a complex developmental disability that characterized by deficits in social interaction, language skills, repetitive stereotyped behaviors and restricted interests. Although great heterogeneity exists, previous findings suggest that autism has atypical brain connectivity patterns and disrupted small-world network properties. However, the organizational alterations in the autistic brain network are still poorly understood. We explored possible organizational alterations of 49 autistic children and 51 typically developing controls, by investigating their brain network metrics that are constructed upon cortical thickness correlations. Three modules were identified in controls, including cortical regions associated with brain functions of executive strategic, spatial/auditory/visual, and self-reference/episodic memory. There are also three modules found in autistic children with similar patterns. Compared with controls, autism demonstrates significantly reduced gross network modularity, and a larger number of inter-module connections. However, the autistic brain network demonstrates increased intra-and inter-module connectivity in brain regions including middle frontal gyrus, inferior parietal gyrus, and cingulate, suggesting one underlying compensatory mechanism associated with brain functions of self-reference and episodic memory. Results also show that there is increased correlation strength between regions inside frontal lobe, as well as impaired correlation strength between frontotemporal and frontoparietal regions. This alteration of correlation strength may contribute to the organization alteration of network structures in autistic brains.	[Shi, Feng; Wang, Li; Peng, Ziwen; Wee, Chong-Yaw; Shen, Dinggang] Univ N Carolina, Dept Radiol, Chapel Hill, NC 27515 USA; [Shi, Feng; Wang, Li; Peng, Ziwen; Wee, Chong-Yaw; Shen, Dinggang] Univ N Carolina, BRIC, Chapel Hill, NC USA; [Peng, Ziwen] S China Normal Univ, Dept Psychol, Guangzhou, Guangdong, Peoples R China; [Shen, Dinggang] Korea Univ, Dept Brain & Cognit Engn, Seoul, South Korea	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; South China Normal University; Korea University	Shen, DG (corresponding author), Univ N Carolina, Dept Radiol, Chapel Hill, NC 27515 USA.	dgshen@med.unc.edu	Shen, Dinggang/ABF-6812-2020; wang, li/O-1425-2015	Shen, Dinggang/0000-0002-7934-5698; wang, li/0000-0001-8927-6772	National Institutes of Health (NIH) [EB006733, EB008374, EB009634, AG041721]; National Natural Science Foundation of China [81201049]; University of North Carolina at Chapel Hill's Libraries; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB008374, R01EB009634, R01EB006733] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG041721] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); University of North Carolina at Chapel Hill's Libraries; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported in part by National Institutes of Health (NIH) grants EB006733, EB008374, EB009634, AG041721, and National Natural Science Foundation of China (81201049). The University of North Carolina at Chapel Hill's Libraries provided support for open access publication. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achard S, 2007, PLOS COMPUT BIOL, V3, P174, DOI 10.1371/journal.pcbi.0030017; Amaral DG, 2008, TRENDS NEUROSCI, V31, P137, DOI 10.1016/j.tins.2007.12.005; Anagnostou E, 2011, MOL AUTISM, V2, DOI 10.1186/2040-2392-2-4; Baio Jon, 2012, Morbidity and Mortality Weekly Report, V61, P1; Baron-Cohen S., 2005, LOST SELF PATHOLOGIE, P166, DOI [10.1093/acprof:oso/9780195173413.003.0011, DOI 10.1093/ACPROF:OSO/9780195173413.003.0011]; Barttfeld P, 2011, NEUROPSYCHOLOGIA, V49, P254, DOI 10.1016/j.neuropsychologia.2010.11.024; Ben Shalom D, 2006, J AUTISM DEV DISORD, V36, P395, DOI 10.1007/s10803-006-0077-2; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Castelli F, 2002, BRAIN, V125, P1839, DOI 10.1093/brain/awf189; Chen ZJ, 2008, CEREB CORTEX, V18, P2374, DOI 10.1093/cercor/bhn003; Chen ZJ, 2011, NEUROIMAGE, V56, P235, DOI 10.1016/j.neuroimage.2011.01.010; Cohen J., 2013, APPL MULTIPLE CORREL, DOI DOI 10.4324/9780203774441; Courchesne E, 2005, CURR OPIN NEUROBIOL, V15, P225, DOI 10.1016/j.conb.2005.03.001; COURCHESNE E, 1993, AM J ROENTGENOL, V160, P387, DOI 10.2214/ajr.160.2.8424359; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; Dawson G, 2002, DEV PSYCHOPATHOL, V14, P581, DOI 10.1017/S0954579402003103; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; Fair DA, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000381; FERRER I, 1995, NEUROSCIENCE, V66, P189, DOI 10.1016/0306-4522(94)00584-R; Genovese CR, 2002, NEUROIMAGE, V15, P870, DOI 10.1006/nimg.2001.1037; Geschwind DH, 2007, CURR OPIN NEUROBIOL, V17, P103, DOI 10.1016/j.conb.2007.01.009; Gong GL, 2012, NEUROIMAGE, V59, P1239, DOI 10.1016/j.neuroimage.2011.08.017; Guimera R, 2005, NATURE, V433, P895, DOI 10.1038/nature03288; Hall Dan, 2012, Neuroinformatics, V10, P331, DOI 10.1007/s12021-012-9151-4; Han X, 2006, NEUROIMAGE, V32, P180, DOI 10.1016/j.neuroimage.2006.02.051; Hardan AY, 2009, BIOL PSYCHIAT, V66, P320, DOI 10.1016/j.biopsych.2009.04.024; Hartwell LH, 1999, NATURE, V402, pC47, DOI 10.1038/35011540; He Y, 2008, J NEUROSCI, V28, P4756, DOI 10.1523/JNEUROSCI.0141-08.2008; He Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005226; Herbert MR, 2004, ANN NEUROL, V55, P530, DOI 10.1002/ana.20032; HUGHES C, 1994, NEUROPSYCHOLOGIA, V32, P477, DOI 10.1016/0028-3932(94)90092-2; Jovicich J, 2009, NEUROIMAGE, V46, P177, DOI 10.1016/j.neuroimage.2009.02.010; Kana RK, 2011, PHYS LIFE REV; Kashtan N, 2005, P NATL ACAD SCI USA, V102, P13773, DOI 10.1073/pnas.0503610102; Kwon H, 2004, DEV MED CHILD NEUROL, V46, P760, DOI 10.1017/S0012162204001306; Lerch JP, 2006, NEUROIMAGE, V31, P993, DOI 10.1016/j.neuroimage.2006.01.042; Lind SE, 2010, J ABNORM PSYCHOL, V119, P896, DOI 10.1037/a0020631; Lombardo MV, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000883; McAlonan GM, 2005, BRAIN, V128, P268, DOI 10.1093/brain/awh332; Mechelli A, 2005, J NEUROSCI, V25, P8303, DOI 10.1523/JNEUROSCI.0357-05.2005; Meunier D, 2010, FRONT NEUROSCI-SWITZ, V4, DOI 10.3389/fnins.2010.00200; Meunier D, 2009, NEUROIMAGE, V44, P715, DOI 10.1016/j.neuroimage.2008.09.062; Miles JH, 2011, GENET MED, V13, P278, DOI 10.1097/GIM.0b013e3181ff67ba; Newman MEJ, 2004, PHYS REV E, V70, DOI [10.1103/PhysRevE.70.056131, 10.1103/PhysRevE.69.026113]; OZONOFF S, 1991, J CHILD PSYCHOL PSYC, V32, P1081, DOI 10.1111/j.1469-7610.1991.tb00351.x; Ramachandran V. S., 2007, SCI AM, V17, P20; Raznahan A, 2010, CEREB CORTEX, V20, P1332, DOI 10.1093/cercor/bhp198; Redies C, 2001, BIOESSAYS, V23, P1100, DOI 10.1002/bies.10014; Rojas DC, 2005, J AUTISM DEV DISORD, V35, P479, DOI 10.1007/s10803-005-5038-7; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Shaw P, 2006, NATURE, V440, P676, DOI 10.1038/nature04513; Shi F, 2012, NEUROIMAGE, V62, P1622, DOI 10.1016/j.neuroimage.2012.05.026; Sporns O, 2011, ANN NY ACAD SCI, V1224, P109, DOI 10.1111/j.1749-6632.2010.05888.x; Tsatsanis KD, 2003, BIOL PSYCHIAT, V53, P121, DOI 10.1016/S0006-3223(02)01530-5; van den Heuvel MP, 2010, J NEUROSCI, V30, P15915, DOI 10.1523/JNEUROSCI.2874-10.2010; Waber DP, 2007, J INT NEUROPSYCH SOC, V13, P729, DOI 10.1017/S1355617707070841; Wallace GL, 2010, BRAIN, V133, P3745, DOI 10.1093/brain/awq279; Zalesky A, 2010, NEUROIMAGE, V50, P970, DOI 10.1016/j.neuroimage.2009.12.027	59	35	37	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2013	8	5							e63131	10.1371/journal.pone.0063131	http://dx.doi.org/10.1371/journal.pone.0063131			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	143FO	23675456	Green Published, gold, Green Submitted			2022-12-27	WOS:000318852400024
J	Firmat, C; Alibert, P; Losseau, M; Baroiller, JF; Schliewen, UK				Firmat, Cyril; Alibert, Paul; Losseau, Michele; Baroiller, Jean-Francois; Schliewen, Ulrich K.			Successive Invasion-Mediated Interspecific Hybridizations and Population Structure in the Endangered Cichlid Oreochromis mossambicus	PLOS ONE			English	Article							NILE TILAPIA; GENETIC-STRUCTURE; INTROGRESSIVE HYBRIDIZATION; TEMPORAL VARIATION; GENOTYPING ERRORS; NILOTICUS PISCES; LIMPOPO RIVER; MITOCHONDRIAL; HYBRIDS; EVOLUTION	Hybridization between invasive and native species accounts among the major and pernicious threats to biodiversity. The Mozambique tilapia Oreochromis mossambicus, a widely used freshwater aquaculture species, is especially imperiled by this phenomenon since it is recognized by the IUCN as an endangered taxon due to genetic admixture with O. niloticus an invasive congeneric species. The Lower Limpopo and the intermittent Changane River (Mozambique) drain large wetlands of potentially great importance for conservation of O. mossambicus, but their populations have remained unstudied until today. Therefore we aimed (1) to estimate the autochthonous diversity and population structure among genetically pure O. mossambicus populations to provide a baseline for the conservation genetics of this endangered species, (2) to quantify and describe genetic variation of the invasive populations and investigate the most likely factors influencing their spread, (3) to identify O. mossambicus populations unaffected by hybridization. Bayesian assignment tests based on 423 AFLP loci and the distribution of 36 species-specific mitochondrial haplotypes both indicate a low frequency of invasive and hybrid genotypes throughout the system, but nevertheless reveal evidence for limited expansion of two alien species (O. niloticus and O. andersonii) and their hybrids in the Lower Limpopo. O. mossambicus populations with no traces of hybridization are identified. They exhibit a significant genetic structure. This contrasts with previously published estimates and provides rather promising auspices for the conservation of O. mossambicus. Especially, parts of the Upper Changane drainage and surrounding wetlands are identified as refugial zones for O. mossambicus populations. They should therefore receive high conservation priority and could represent valuable candidates for the development of aquaculture strains based on local genetic resources.	[Firmat, Cyril; Alibert, Paul] Univ Bourgogne, UMR CNRS Biogeosci 6282, Dijon, France; [Firmat, Cyril] Norwegian Univ Sci & Technol NTNU, Dept Biol, CBD, Trondheim, Norway; [Losseau, Michele] Polana Canico A, Maputo, Mozambique; [Baroiller, Jean-Francois] UMR110 Cirad Ifremer INTREPID, Montpellier, France; [Schliewen, Ulrich K.] Bavarian State Collect Zool ZSM, Dept Ichthyol, Munich, Germany	Universite de Bourgogne; Norwegian University of Science & Technology (NTNU); CIRAD	Firmat, C (corresponding author), Univ Bourgogne, UMR CNRS Biogeosci 6282, Dijon, France.	cyril.firmat@ntnu.no	Baroiller, Jean-Francois/I-3455-2013	baroiller, jean-francois/0000-0002-0992-1725	BQR from University of Burgundy [nu2009 BQRl 01 4]; PARI grant from the Region Bourgogne [079]; Rotary International travel grant; German Academic Exchange Service (DAAD); Laboratory Biogeosciences	BQR from University of Burgundy; PARI grant from the Region Bourgogne(Region Bourgogne-Franche-Comte); Rotary International travel grant; German Academic Exchange Service (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD)); Laboratory Biogeosciences	This study was funded by a BQR grant nu2009 BQRl 01 4 from the University of Burgundy (www.u-bourgogne.fr), a PARI grant no079 from the Region Bourgogne (www.region-bourgogne.fr), a Rotary International travel grant, a German Academic Exchange Service (DAAD, www.daad.de) travel grant and financial support from the Laboratory Biogeosciences (http://biogeosciences.u-bourgogne.fr, Team BioME). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnese J-F, 1998, GENETICS AQUACULTURE; Agnese JF, 2008, MAR GENOM, V1, P103, DOI 10.1016/j.margen.2008.10.004; Agustin LQ, 1997, TILAPIA AQUACULTURE, P75; Allendorf FW, 2001, TRENDS ECOL EVOL, V16, P613, DOI 10.1016/S0169-5347(01)02290-X; Anderson EC, 2002, GENETICS, V160, P1217; Anderson EC, 2008, PHILOS T R SOC B, V363, P2841, DOI 10.1098/rstb.2008.0043; Angienda PO, 2011, CONSERV GENET, V12, P243, DOI 10.1007/s10592-010-0136-2; Baird NA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003376; Bezault E, 2012, INT J EVOLUTIONARY B, V2012, P7; Bezault E, 2012, INT J EVOLUTIONARY B, V2012, P10; Bezault E, 2011, BMC GENET, V12, DOI 10.1186/1471-2156-12-102; Bonin A, 2004, MOL ECOL, V13, P3261, DOI 10.1111/j.1365-294X.2004.02346.x; Brummett RE, 2009, REV FISH SCI, V17, P70, DOI 10.1080/10641260802083174; BRUMMETT RE, 2008, WORLD AQUACULTURE, V39, P46; Cambray JA., 2007, IUCN RED LIST THREAT, DOI http://doi.org/10.2305/IUCN.UK.2007.RLTS.T63338A12659743.en; Canonico GC, 2005, AQUAT CONSERV, V15, P463, DOI 10.1002/aqc.699; Consuegra S, 2011, EVOL APPL, V4, P660, DOI 10.1111/j.1752-4571.2011.00189.x; Costa-Pierce BA, 2003, BIOL INVASIONS, V5, P71, DOI 10.1023/A:1024094606326; Crispo E, 2011, BIOESSAYS, V33, P508, DOI 10.1002/bies.201000154; Crispo E, 2010, J HERED, V101, P97, DOI 10.1093/jhered/esp078; D'Amato ME, 2007, CONSERV GENET, V8, P475, DOI 10.1007/s10592-006-9186-x; DAGET J, 1981, Bulletin du Museum National d'Histoire Naturelle Section A Zoologie Biologie et Ecologie Animales, V3, P689; Darling JA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017828; Desprez D, 2006, AQUACULTURE, V251, P231, DOI 10.1016/j.aquaculture.2005.06.024; Eknath AE, 2009, REV AQUACULT, V1, P197, DOI 10.1111/j.1753-5131.2009.01017.x; Ellstrand NC, 2000, P NATL ACAD SCI USA, V97, P7043, DOI 10.1073/pnas.97.13.7043; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; EXCOFFIER L, 1992, GENETICS, V131, P479; Facon B, 2005, J EVOLUTION BIOL, V18, P524, DOI 10.1111/j.1420-9101.2005.00887.x; Facon B, 2008, CURR BIOL, V18, P363, DOI 10.1016/j.cub.2008.01.063; Falush D, 2007, MOL ECOL NOTES, V7, P574, DOI 10.1111/j.1471-8286.2007.01758.x; FAO Subregional Office for Southern and East Africa Harare, 2004, DROUGHT IMP MIT PREV; Firmat C, 2012, BIOL J LINN SOC, V105, P369, DOI 10.1111/j.1095-8312.2011.01802.x; Gregg RE, 1998, J FISH BIOL, V52, P1, DOI 10.1111/j.1095-8649.1998.tb01547.x; Guillot G, 2011, OPEN STAT PROBABILIT, V3, P7, DOI DOI 10.2174/1876527001103010007; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Herder F, 2008, EVOLUTION, V62, P2178, DOI 10.1111/j.1558-5646.2008.00447.x; Hohenlohe PA, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000862; Hubisz MJ, 2009, MOL ECOL RESOUR, V9, P1322, DOI 10.1111/j.1755-0998.2009.02591.x; Hugues RH, 1992, DIRECTORY AFRICAN WE; Hulata G., 1995, Aquaculture Research, V26, P765, DOI 10.1111/j.1365-2109.1995.tb00869.x; Klett V, 2002, MOL BIOL EVOL, V19, P865, DOI 10.1093/oxfordjournals.molbev.a004144; Kumar S, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-357; Lind CE, 2012, REV AQUACULT, V4, P125, DOI 10.1111/j.1753-5131.2012.01068.x; Lockwood JL, 2005, TRENDS ECOL EVOL, V20, P223, DOI 10.1016/j.tree.2005.02.004; Lowe S, 2000, COMMUNICATION; MAIR GC, 1991, THEOR APPL GENET, V82, P153, DOI 10.1007/BF00226206; Mateo D., 2004, New dimensions on farmed tilapia. Proceedings, 6th International Symposium on Tilapia in Aquaculture, Manila, Philippines, 12-16 September, 2004, P426; McKinna EM, 2010, AQUAC RES, V41, pe730, DOI 10.1111/j.1365-2109.2010.02539.x; Miller MR, 2007, GENOME RES, V17, P240, DOI 10.1101/gr.5681207; Moor de IJ, 1978, ATLAS ALIEN TRANSLOC; Moralee RD, 2000, WATER SA, V26, P263; Muhlfeld CC, 2009, BIOL LETTERS, V5, P328, DOI 10.1098/rsbl.2009.0033; Nagl S, 2001, MOL PHYLOGENET EVOL, V20, P361, DOI 10.1006/mpev.2001.0979; Nei M., 1987, MOL EVOLUTIONARY GEN; Nolte AW, 2010, TRENDS GENET, V26, P54, DOI 10.1016/j.tig.2009.12.001; Nolte AW, 2005, P ROY SOC B-BIOL SCI, V272, P2379, DOI 10.1098/rspb.2005.3231; Nyingi DW, 2007, J FISH BIOL, V70, P148, DOI 10.1111/j.1095-8649.2007.01327.x; Paradis E, 2010, BIOINFORMATICS, V26, P419, DOI 10.1093/bioinformatics/btp696; Pompanon F, 2005, NAT REV GENET, V6, P847, DOI 10.1038/nrg1707; Prentis PJ, 2008, TRENDS PLANT SCI, V13, P288, DOI 10.1016/j.tplants.2008.03.004; Pritchard JK, 2000, GENETICS, V155, P945; Pullin RSV, 1988, INT CTR LIV AQ RES M; R Development Core Team, 2008, R LANG ENV STAT COMP; Rhymer JM, 1996, ANNU REV ECOL SYST, V27, P83, DOI 10.1146/annurev.ecolsys.27.1.83; Rognon X, 2003, MOL ECOL, V12, P435, DOI 10.1046/j.1365-294X.2003.01739.x; Schliewen Ulrich K, 2004, Front Zool, V1, P5, DOI 10.1186/1742-9994-1-5; Schneider MF, 2003, B INVESTIGACAO FLORE, V2003, P31; Seehausen O, 2004, TRENDS ECOL EVOL, V19, P198, DOI 10.1016/j.tree.2004.01.003; Seehausen O, 2008, MOL ECOL, V17, P30, DOI 10.1111/j.1365-294X.2007.03529.x; Sievers C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038404; Simberloff D, 2009, ANNU REV ECOL EVOL S, V40, P81, DOI 10.1146/annurev.ecolsys.110308.120304; Simler I, 2005, 192 IFPRI FCND; Skelton P.H., 2001, COMPLETE GUTIDE FRES, V2nd ed.; TEMPLETON AR, 1992, GENETICS, V132, P619; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Trewavas E., 1983, TILAPIINE FISHES GEN, DOI [DOI 10.5962/BHL.TITLE.123198, 10.1016/j.foodcont.2016.07.004]; Tweddle D, 2007, FINAL REPORT PREPARE; van der Bank F. H., 2007, African Journal of Aquatic Science, V32, P193, DOI 10.2989/AJAS.2007.32.2.11.265; van der Waal BCW, 2000, S AFR J SCI, V96, P47; Vekemans X, 2002, MOL ECOL, V11, P139, DOI 10.1046/j.0962-1083.2001.01415.x; Verhoeven KJF, 2011, P ROY SOC B-BIOL SCI, V278, P2, DOI 10.1098/rspb.2010.1272; VOS P, 1995, NUCLEIC ACIDS RES, V23, P4407, DOI 10.1093/nar/23.21.4407; Watanabe WO, 2006, TILAPIA BIOL CULTURE; Weyl OLF, 2008, AQUAT CONSERV, V18, P839, DOI 10.1002/aqc.897; WorldFish Center, 2002, NAIR DECL CONS AQ BI; Zengeya TA, 2013, AQUAT CONSERV, V23, P51, DOI 10.1002/aqc.2258; Zengeya TA, 2011, ENVIRON BIOL FISH, V92, P479, DOI 10.1007/s10641-011-9865-4; Zhivotovsky LA, 1999, MOL ECOL, V8, P907, DOI 10.1046/j.1365-294x.1999.00620.x	89	34	36	0	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2013	8	5							e63880	10.1371/journal.pone.0063880	http://dx.doi.org/10.1371/journal.pone.0063880			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	155HD	23671704	gold, Green Published, Green Accepted, Green Submitted			2022-12-27	WOS:000319737700062
J	Liu, CG; Liu, LM; Chen, XJ; Shen, JJ; Shan, JJ; Xu, YM; Yang, Z; Wu, L; Xia, F; Bie, P; Cui, YH; Bian, XW; Qian, C				Liu, Chungang; Liu, Limei; Chen, Xuejiao; Shen, Junjie; Shan, Juanjuan; Xu, Yanmin; Yang, Zhi; Wu, Lin; Xia, Feng; Bie, Ping; Cui, Youhong; Bian, Xiu-wu; Qian, Cheng			Decrease of 5-Hydroxymethylcytosine Is Associated with Progression of Hepatocellular Carcinoma through Downregulation of TET1	PLOS ONE			English	Article							PROTEINS; 5-METHYLCYTOSINE; CONVERSION; 5HMC; 5MC	DNA methylation is an important epigenetic modification and is frequently altered in cancer. Convert of 5-methylcytosine (5 mC) to 5-hydroxymethylcytosine (5 hmC) by ten-eleven translocation (TET) family enzymes plays important biological functions in embryonic stem cells, development, aging and disease. Recent reports showed that level of 5 hmC was altered in various types of cancers. However, the change of 5 hmC level in hepatocellular carcinoma (HCC) and association with clinical outcome were not well defined. Here, we reported that level of 5 hmC was decreased in HCC tissues, as compared with non-tumor tissues. Clincopathological analysis showed the decreased level of 5 hmC in HCC was associated with tumor size, AFP level and poor overall survival. We also found that the decreased level of 5 hmC in non-tumor tissues was associated with tumor recurrence in the first year after surgical resection. In an animal model with carcinogen DEN-induced HCC, we found that the level of 5 hmC was gradually decreased in the livers during the period of induction. There was further reduction of 5 hmC in tumor tissues when tumors were developed. In contrast, level of 5 mC was increased in HCC tissues and the increased 5 mC level was associated with capsular invasion, vascular thrombosis, tumor recurrence and overall survival. Furthermore, our data showed that expression of TET1, but not TET2 and TET3, was downregulated in HCC. Taken together, our data indicated 5 hmC may be served as a prognostic marker for HCC and the decreased expression of TET1 is likely one of the mechanisms underlying 5 hmC loss in HCC.	[Liu, Chungang; Liu, Limei; Chen, Xuejiao; Shen, Junjie; Shan, Juanjuan; Xu, Yanmin; Yang, Zhi; Cui, Youhong; Bian, Xiu-wu; Qian, Cheng] Third Mil Med Univ, Southwest Hosp, Inst Pathol, Chongqing, Peoples R China; [Liu, Chungang; Liu, Limei; Chen, Xuejiao; Shen, Junjie; Shan, Juanjuan; Xu, Yanmin; Yang, Zhi; Cui, Youhong; Bian, Xiu-wu; Qian, Cheng] Third Mil Med Univ, Southwest Hosp, Southwest Canc Ctr, Chongqing, Peoples R China; [Wu, Lin; Xia, Feng; Bie, Ping] Third Mil Med Univ, Southwest Hosp, Inst Hepatobiliary Surg, Chongqing, Peoples R China	Army Medical University; Army Medical University; Army Medical University	Qian, C (corresponding author), Third Mil Med Univ, Southwest Hosp, Inst Pathol, Chongqing, Peoples R China.	cqian3184@yahoo.com.cn	Bian, Xiu-Wu/D-4736-2017	Bian, Xiu-Wu/0000-0003-4383-0197	National Natural Sciences Foundation of China [81090423, 81020108026, 81000966, 81101630]; National Basic Research Program of China (973 Program) [2010CB529406]	National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China (973 Program)(National Basic Research Program of China)	This work was supported by funds from National Natural Sciences Foundation of China (No. 81090423, 81020108026, 81000966 and 81101630) and National Basic Research Program of China (973 Program, No.2010CB529406). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Esteller M, 2008, NEW ENGL J MED, V358, P1148, DOI 10.1056/NEJMra072067; Figueroa ME, 2010, CANCER CELL, V18, P553, DOI 10.1016/j.ccr.2010.11.015; Globisch D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015367; Haffner MC, 2011, ONCOTARGET, V2, P627; He YF, 2011, SCIENCE, V333, P1303, DOI 10.1126/science.1210944; Ito S, 2011, SCIENCE, V333, P1300, DOI 10.1126/science.1210597; Ito S, 2010, NATURE, V466, P1129, DOI 10.1038/nature09303; Iyer LM, 2009, CELL CYCLE, V8, P1698, DOI 10.4161/cc.8.11.8580; Lee S, 2003, AM J PATHOL, V163, P1371, DOI 10.1016/S0002-9440(10)63495-5; Lian CG, 2012, CELL, V150, P1135, DOI 10.1016/j.cell.2012.07.033; Llovet JM, 2003, LANCET, V362, P1907, DOI 10.1016/S0140-6736(03)14964-1; Noushmehr H, 2010, CANCER CELL, V17, P510, DOI 10.1016/j.ccr.2010.03.017; Shan JJ, 2012, HEPATOLOGY, V56, P1004, DOI 10.1002/hep.25745; Song CX, 2011, NAT BIOTECHNOL, V29, P68, DOI 10.1038/nbt.1732; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Tan L, 2012, DEVELOPMENT, V139, P1895, DOI 10.1242/dev.070771; Xu W, 2011, CANCER CELL, V19, P17, DOI 10.1016/j.ccr.2010.12.014; Xu YF, 2011, MOL CELL, V42, P451, DOI 10.1016/j.molcel.2011.04.005; Yang H, 2013, ONCOGENE, V32, P663, DOI 10.1038/onc.2012.67	19	58	65	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2013	8	5							e62828	10.1371/journal.pone.0062828	http://dx.doi.org/10.1371/journal.pone.0062828			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	155HD	23671639	Green Submitted, Green Published, gold			2022-12-27	WOS:000319737700024
J	Parikh, NA; Lasky, RE; Kennedy, KA; McDavid, G; Tyson, JE				Parikh, Nehal A.; Lasky, Robert E.; Kennedy, Kathleen A.; McDavid, Georgia; Tyson, Jon E.			Perinatal Factors and Regional Brain Volume Abnormalities at Term in a Cohort of Extremely Low Birth Weight Infants	PLOS ONE			English	Article							PATENT DUCTUS-ARTERIOSUS; WEEKS GESTATIONAL-AGE; PRETERM INFANTS; NEURODEVELOPMENTAL OUTCOMES; INDOMETHACIN PROPHYLAXIS; EQUIVALENT AGE; CHILDREN; INJURY; PREMATURITY; DISABILITY	Our objective was to investigate diverse clinical antecedents of total and regional brain volume abnormalities and white matter hyperintensity volume on term MRI in extremely low birth weight (birth weight <= 1000 g) survivors. A consecutive cohort of extremely low birth weight infants who survived to 38 weeks postmenstrual age (n = 122) and a control group of 16 healthy term newborns underwent brain MRI at term-equivalent age. Brain volumes were measured using semi-automated and manual segmentation methods. Using multivariable linear regression, clinical antecedents were correlated with volumes of total brain tissue, white matter hyperintensities, and regional tissues/structures, adjusted for age at MRI, total cranial volume, and total tissue volume. Regional brain volumes were markedly reduced in extremely low birth weight infants as compared to term newborns (relative difference range: -11.0%, -35.9%). Significant adverse clinical associations for total brain tissue volume included: small for gestational age, seizures, caffeine therapy/apnea of prematurity, duration of parenteral nutrition, pulmonary hemorrhage, and white matter injury (p<0.01 for each; relative difference range: -1.4% to -15.0%). Surgery for retinopathy of prematurity and surgery for necrotizing enterocolitis or spontaneous intestinal perforation were significantly associated with increasing volume of white matter hyperintensities. Regional brain volumes are sensitive to multiple perinatal factors and neonatal morbidities or interventions. Brain growth measurements in extremely low birth weight infants can advance our understanding of perinatal brain injury and development.	[Parikh, Nehal A.; Lasky, Robert E.; Kennedy, Kathleen A.; McDavid, Georgia; Tyson, Jon E.] Univ Texas Houston, Sch Med, Dept Pediat, Houston, TX 77030 USA; [Parikh, Nehal A.; Lasky, Robert E.; Kennedy, Kathleen A.; McDavid, Georgia; Tyson, Jon E.] Childrens Mem Hermann Hosp, Houston, TX USA; [Parikh, Nehal A.] Nationwide Childrens Hosp, Res Inst, Ctr Perinatal Res, Columbus, OH USA; [Parikh, Nehal A.] Ohio State Univ, Coll Med, Columbus, OH 43210 USA; [Lasky, Robert E.; Kennedy, Kathleen A.; Tyson, Jon E.] Univ Texas Houston, Sch Med, Ctr Clin Res & Evidence Based Med, Houston, TX USA	University of Texas System; University of Texas Health Science Center Houston; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital; University System of Ohio; Ohio State University; University of Texas System; University of Texas Health Science Center Houston	Parikh, NA (corresponding author), Univ Texas Houston, Sch Med, Dept Pediat, Houston, TX 77030 USA.	nehal.parikh@nationwidechildrens.org	Parikh, Nehal/AAB-9981-2022	Parikh, Nehal/0000-0002-1375-1247	National Institutes of Health [K23-NS048152]; National Institute of Neurological Disorders and Stroke [UL1 RR024148]; National Center for Research Resources; University of Texas Health Science Center at Houston Center for Clinical and Translational Sciences; Clinical Investigator Award from the Center for Clinical Research and Evidence-Based Medicine at the University of Texas Houston Medical School; Eunice Shriver National Institute of Child Health & Human Development Neonatal Research Network [U10 HD021373]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U10HD021373] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024148] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K23NS048152] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); University of Texas Health Science Center at Houston Center for Clinical and Translational Sciences; Clinical Investigator Award from the Center for Clinical Research and Evidence-Based Medicine at the University of Texas Houston Medical School; Eunice Shriver National Institute of Child Health & Human Development Neonatal Research Network; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Supported by a National Institutes of Health grant K23-NS048152, National Institute of Neurological Disorders and Stroke grant UL1 RR024148, National Center for Research Resources and University of Texas Health Science Center at Houston Center for Clinical and Translational Sciences, a Clinical Investigator Award from the Center for Clinical Research and Evidence-Based Medicine at the University of Texas Houston Medical School (NAP), and the Eunice Shriver National Institute of Child Health & Human Development Neonatal Research Network grant U10 HD021373 (KAK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badr LK, 2009, EARLY HUM DEV, V85, P279, DOI 10.1016/j.earlhumdev.2008.11.005; Boardman JP, 2007, ANN NEUROL, V62, P185, DOI 10.1002/ana.21171; Bonifacio SL, 2010, J PEDIATR-US, V157, P726, DOI 10.1016/j.jpeds.2010.05.026; Buyse M, 2010, NAT REV CLIN ONCOL, V7, P309, DOI 10.1038/nrclinonc.2010.43; Clouchoux C, 2012, AM J OBSTET GYNECOL, V206, DOI 10.1016/j.ajog.2011.10.002; Counsell SJ, 2008, BRAIN, V131, P3201, DOI 10.1093/brain/awn268; Doyle LW, 2001, PEDIATRICS, V108, P134, DOI 10.1542/peds.108.1.134; Dyet LE, 2006, PEDIATRICS, V118, P536, DOI 10.1542/peds.2005-1866; Fanaroff AA, 2003, SEMIN PERINATOL, V27, P281, DOI 10.1016/S0146-0005(03)00055-7; Hack M, 2005, PEDIATRICS, V116, P333, DOI 10.1542/peds.2005-0173; Hintz SR, 2005, PEDIATRICS, V115, P1645, DOI 10.1542/peds.2004-2215; Inder TE, 2005, PEDIATRICS, V115, P286, DOI 10.1542/peds.2004-0326; Iwata S, 2012, PEDIATRICS, V129, pE1138, DOI 10.1542/peds.2011-1735; Judas M, 2005, AM J NEURORADIOL, V26, P2671; Kabra NS, 2007, J PEDIATR-US, V150, P229, DOI 10.1016/j.jpeds.2006.11.039; Keihaninejad S, 2010, NEUROIMAGE, V50, P1427, DOI 10.1016/j.neuroimage.2010.01.064; Kidokoro H, 2011, AM J NEURORADIOL, V32, P2005, DOI 10.3174/ajnr.A2703; Lind A, 2010, EUR CHILD ADOLES PSY, V19, P407, DOI 10.1007/s00787-009-0070-3; Littman A, 2006, ACAD RADIOL, V13, P1; Lodygensky GA, 2008, PEDIATR RES, V63, P438, DOI 10.1203/PDR.0b013e318165c005; Lorenz JM, 1998, ARCH PEDIAT ADOL MED, V152, P425, DOI 10.1001/archpedi.152.5.425; Maalouf EF, 1999, J PEDIATR-US, V135, P351, DOI 10.1016/S0022-3476(99)70133-2; Madan JC, 2009, PEDIATRICS, V123, P674, DOI 10.1542/peds.2007-2781; Ment LR, 2009, LANCET NEUROL, V8, P1042, DOI 10.1016/S1474-4422(09)70257-1; Nisari M, 2012, SURG RADIOL ANAT, V34, P825, DOI 10.1007/s00276-012-0971-6; Nosarti C, 2008, BRAIN, V131, P205, DOI 10.1093/brain/awm282; Parikh NA, 2007, PEDIATRICS, V119, P265, DOI 10.1542/peds.2006-1354; Peterson BS, 2000, JAMA-J AM MED ASSOC, V284, P1939, DOI 10.1001/jama.284.15.1939; Peterson BS, 2003, PEDIATRICS, V111, P939, DOI 10.1542/peds.111.5.939; Reiman M, 2008, J PEDIATR-US, V152, P642, DOI 10.1016/j.jpeds.2007.09.051; Roberts G, 2010, ARCH DIS CHILD-FETAL, V95, pF90, DOI 10.1136/adc.2009.165480; Schmidt B, 2003, JAMA-J AM MED ASSOC, V289, P1124, DOI 10.1001/jama.289.9.1124; Schulzke SM, 2007, ARCH PEDIAT ADOL MED, V161, P583, DOI 10.1001/archpedi.161.6.583; Srinivasan L, 2007, PEDIATRICS, V119, P759, DOI 10.1542/peds.2006-2508; Tam EWY, 2011, J PEDIATR-US, V158, P245, DOI 10.1016/j.jpeds.2010.07.049; Thompson DK, 2008, ANN NEUROL, V63, P642, DOI 10.1002/ana.21367; Thompson DK, 2007, BRAIN, V130, P667, DOI 10.1093/brain/awl277; Tyson JE, 2008, NEW ENGL J MED, V358, P1672, DOI 10.1056/NEJMoa073059; Volpe JJ, 2009, LANCET NEUROL, V8, P110, DOI 10.1016/S1474-4422(08)70294-1; Wilson-Costello D, 2005, PEDIATRICS, V115, P997, DOI 10.1542/peds.2004-0221; Woodward LJ, 2005, BRAIN, V128, P2578, DOI 10.1093/brain/awh618; Yu XT, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013874	42	40	41	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2013	8	5							e62804	10.1371/journal.pone.0062804	http://dx.doi.org/10.1371/journal.pone.0062804			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	155HD	23671636	Green Published, Green Submitted, gold			2022-12-27	WOS:000319737700021
J	Sakai, H; Sato, T; Sakurai, H; Yamamoto, T; Hanaoka, K; Montarras, D; Sehara-Fujisawa, A				Sakai, Hiroshi; Sato, Takahiko; Sakurai, Hidetoshi; Yamamoto, Takuya; Hanaoka, Kazunori; Montarras, Didier; Sehara-Fujisawa, Atsuko			Fetal Skeletal Muscle Progenitors Have Regenerative Capacity after Intramuscular Engraftment in Dystrophin Deficient Mice	PLOS ONE			English	Article							STEM-CELL FUNCTION; SATELLITE CELLS; MYOGENIC PROGENITORS; SELF-RENEWAL; ADULT MUSCLE; DETERMINATION GENE; HIGHLY EFFICIENT; SOMITIC ORIGIN; QUIESCENT; MYF5	Muscle satellite cells (SCs) are stem cells that reside in skeletal muscles and contribute to regeneration upon muscle injury. SCs arise from skeletal muscle progenitors expressing transcription factors Pax3 and/or Pax7 during embryogenesis in mice. However, it is unclear whether these fetal progenitors possess regenerative ability when transplanted in adult muscle. Here we address this question by investigating whether fetal skeletal muscle progenitors (FMPs) isolated from Pax3(GFP/+) embryos have the capacity to regenerate muscle after engraftment into Dystrophin-deficient mice, a model of Duchenne muscular dystrophy. The capacity of FMPs to engraft and enter the myogenic program in regenerating muscle was compared with that of SCs derived from adult Pax3(GFP/+) mice. Transplanted FMPs contributed to the reconstitution of damaged myofibers in Dystrophin-deficient mice. However, despite FMPs and SCs having similar myogenic ability in culture, the regenerative ability of FMPs was less than that of SCs in vivo. FMPs that had activated MyoD engrafted more efficiently to regenerate myofibers than MyoD-negative FMPs. Transcriptome and surface marker analyses of these cells suggest the importance of myogenic priming for the efficient myogenic engraftment. Our findings suggest the regenerative capability of FMPs in the context of muscle repair and cell therapy for degenerative muscle disease.	[Sakai, Hiroshi; Sato, Takahiko; Sehara-Fujisawa, Atsuko] Kyoto Univ, Inst Frontier Med Sci, Dept Growth Regulat, Kyoto, Japan; [Sakurai, Hidetoshi] Kyoto Univ, Dept Clin Applicat, Ctr iPS Cell Res & Applicat, Kyoto, Japan; [Yamamoto, Takuya] Kyoto Univ, Dept Reprogramming Sci, Ctr iPS Cell Res & Applicat, Kyoto, Japan; [Hanaoka, Kazunori] Kitasato Univ, Sch Sci, Dept Biosci, Mol Embryol Lab, Kanagawa, Japan; [Montarras, Didier] Inst Pasteur, Paris, France	Kyoto University; Kyoto University; Kyoto University; Kitasato University; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Sato, T (corresponding author), Kyoto Univ, Inst Frontier Med Sci, Dept Growth Regulat, Kyoto, Japan.	takahiko@frontier.kyoto-u.ac.jp; asehara@frontier.kyoto-u.ac.jp	Yamamoto, Takuya/H-2792-2017; Hiroshi, SAKAI/B-1450-2016	Yamamoto, Takuya/0000-0002-0022-3947; Hiroshi, SAKAI/0000-0001-9456-0911; Sato, Takahiko/0000-0003-3836-7978	Ministry of Health, Labor, and Welfare; Ministry of Education, Culture, Sports, Science and Technology (MEXT); Center for Frontier Medicine of the Kyoto University Global COE Program; Grants-in-Aid for Scientific Research [22122007] Funding Source: KAKEN	Ministry of Health, Labor, and Welfare(Ministry of Health, Labour and Welfare, Japan); Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Center for Frontier Medicine of the Kyoto University Global COE Program; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a Research Grant for Nervous and Mental Disorders from the Ministry of Health, Labor, and Welfare (A. S), grants-in-aid from the Ministry of Education, Culture, Sports, Science and Technology (MEXT), the project for realization of Regenerative Medicine (H.Sakurai and A. S.), and molecular mechanisms underlying reconstruction of 3D structures during regeneration (T. S.). H.Sakai and T. S. were supported by a research assistantship and postdoctoral fellowship from the Center for Frontier Medicine of the Kyoto University Global COE Program, respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auda-Boucher G, 2003, J HISTOCHEM CYTOCHEM, V51, P1255, DOI 10.1177/002215540305101002; Beauchamp JR, 2000, J CELL BIOL, V151, P1221, DOI 10.1083/jcb.151.6.1221; Buckingham M, 2007, ANNU REV CELL DEV BI, V23, P645, DOI 10.1146/annurev.cellbio.23.090506.123438; Cerletti M, 2008, CELL, V134, P37, DOI 10.1016/j.cell.2008.05.049; Cheung TH, 2012, NATURE, V482, P524, DOI 10.1038/nature10834; Collins CA, 2005, CELL, V122, P289, DOI 10.1016/j.cell.2005.05.010; Cornelison DDW, 1997, DEV BIOL, V191, P270, DOI 10.1006/dbio.1997.8721; Crist CG, 2012, CELL STEM CELL, V11, P118, DOI 10.1016/j.stem.2012.03.011; Darabi R, 2008, NAT MED, V14, P134, DOI 10.1038/nm1705; Darabi R, 2012, CELL STEM CELL, V10, P610, DOI 10.1016/j.stem.2012.02.015; Djian-Zaouche J, 2012, PIGM CELL MELANOMA R, V25, P545, DOI 10.1111/j.1755-148X.2012.01024.x; Emery AEH, 2002, LANCET, V359, P687, DOI 10.1016/S0140-6736(02)07815-7; Fukada SI, 2007, STEM CELLS, V25, P2448, DOI 10.1634/stemcells.2007-0019; Gayraud-Morel B, 2007, DEV BIOL, V312, P13, DOI 10.1016/j.ydbio.2007.08.059; Gilbert PM, 2010, SCIENCE, V329, P1078, DOI 10.1126/science.1191035; Gros J, 2005, NATURE, V435, P954, DOI 10.1038/nature03572; HOFFMAN EP, 1987, CELL, V51, P919, DOI 10.1016/0092-8674(87)90579-4; Hutcheson DA, 2009, GENE DEV, V23, P997, DOI 10.1101/gad.1769009; Kanisicak O, 2009, DEV BIOL, V332, P131, DOI 10.1016/j.ydbio.2009.05.554; Kassar-Duchossoy L, 2005, GENE DEV, V19, P1426, DOI 10.1101/gad.345505; Kudoh H, 2005, BIOCHEM BIOPH RES CO, V328, P507, DOI 10.1016/j.bbrc.2004.12.191; Lepper C, 2011, DEVELOPMENT, V138, P3639, DOI 10.1242/dev.067595; MAURO A, 1961, J BIOPHYS BIOCHEM CY, V9, P493, DOI 10.1083/jcb.9.2.493; Megeney LA, 1996, GENE DEV, V10, P1173, DOI 10.1101/gad.10.10.1173; Mitchell PO, 2005, DEV BIOL, V283, P240, DOI 10.1016/j.ydbio.2005.04.016; Montarras D, 2005, SCIENCE, V309, P2064, DOI 10.1126/science.1114758; Mummery CL, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000558; Muntoni F, 2003, LANCET NEUROL, V2, P731, DOI 10.1016/S1474-4422(03)00585-4; Murphy MM, 2011, DEVELOPMENT, V138, P3625, DOI 10.1242/dev.064162; Neal A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037950; Pallafacchina G, 2010, STEM CELL RES, V4, P77, DOI 10.1016/j.scr.2009.10.003; Parker MH, 2012, STEM CELLS, V30, P2212, DOI 10.1002/stem.1181; PARTRIDGE TA, 1989, NATURE, V337, P176, DOI 10.1038/337176a0; Peault B, 2007, MOL THER, V15, P867, DOI 10.1038/mt.sj.6300145; Pichavant C, 2011, MOL THER, V19, P830, DOI 10.1038/mt.2011.59; Relaix F, 2005, NATURE, V435, P948, DOI 10.1038/nature03594; Relaix F, 2006, J CELL BIOL, V172, P91, DOI 10.1083/jcb.200508044; Sacco A, 2008, NATURE, V456, P502, DOI 10.1038/nature07384; Sambasivan R, 2011, DEVELOPMENT, V138, P3647, DOI 10.1242/dev.067587; Schienda J, 2006, P NATL ACAD SCI USA, V103, P945, DOI 10.1073/pnas.0510164103; Seale P, 2000, CELL, V102, P777, DOI 10.1016/S0092-8674(00)00066-0; Sherwood RI, 2004, CELL, V119, P543, DOI 10.1016/j.cell.2004.10.021; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tedesco FS, 2010, J CLIN INVEST, V120, P11, DOI 10.1172/JCI40373; Ustanina S, 2007, STEM CELLS, V25, P2006, DOI 10.1634/stemcells.2006-0736; Wang YX, 2012, NAT REV MOL CELL BIO, V13, P127, DOI 10.1038/nrm3265; Warming S, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni035	47	8	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2013	8	5							e63016	10.1371/journal.pone.0063016	http://dx.doi.org/10.1371/journal.pone.0063016			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	155HD	23671652	Green Published, Green Submitted, gold			2022-12-27	WOS:000319737700034
J	Ezzat, L; Merle, PL; Furla, P; Buttler, A; Ferrier-Pages, C				Ezzat, Leila; Merle, Pierre-Laurent; Furla, Paola; Buttler, Alexandre; Ferrier-Pages, Christine			The Response of the Mediterranean Gorgonian Eunicella singularis to Thermal Stress Is Independent of Its Nutritional Regime	PLOS ONE			English	Article							CORAL CLADOCORA-CAESPITOSA; BENTHIC SUSPENSION FEEDERS; MASS-MORTALITY; PARAMURICEA-CLAVATA; PROLONGED DARKNESS; STYLOPHORA-PISTILLATA; SCLERACTINIAN CORALS; OCULINA-PATAGONICA; DIATOM MORTALITY; TEMPERATE CORAL	Over the last few decades, sessile benthic organisms from the Mediterranean Sea have suffered from the global warming of the world's oceans, and several mass mortality events were observed during warm summers. It has been hypothesized that mortality could have been due to a nutrient (food) shortage following the stratification of the water column. However, the symbiotic gorgonian Eunicella singularis has also presented a locally exceptional mortality, despite its autotrophic capacities through the photosynthesis of its dinoflagellate symbionts. Thus, this study has experimentally investigated the response of E. singularis to a thermal stress (temperature increase from 18 to 26 degrees C), with colonies maintained more than 2 months under four nutritional diets: autotrophy only (AO), autotrophy and inorganic nitrogen addition (AN), autotrophy and heterotrophy (AH), heterotrophy only (HO). At 18 degrees C, and contrary to many other anthozoans, supplementation of autotrophy with either inorganic nitrogen or food (heterotrophy) had no effect on the rates of respiration, photosynthesis, as well as in the chlorophyll, lipid and protein content. In the dark, heterotrophy maintained the gorgonian's metabolism, except a bleaching (loss of pigments), which did not affect the rates of photosynthesis. At 24 degrees C, rates of respiration, and photosynthesis significantly decreased in all treatments. At 26 degrees C, in addition to a decrease in the lipid content of all treatments, a bleaching was observed after 1 week in the AO treatment, while the AH and AN treatments resisted three weeks before bleaching. These last results suggest that, temperatures above 24 degrees C impair the energetic reserves of this species and might explain the mortality events in the Mediterranean.	[Ezzat, Leila; Buttler, Alexandre] Ecole Polytech Fed Lausanne, Sch Architecture Civil & Environm Engn ENAC, CH-1015 Lausanne, Switzerland; [Merle, Pierre-Laurent; Furla, Paola] Univ Nice Sophia Antipolis, UMR UNS UPMC CNRS Equipe Symbiose Marine SYMAR 71, Nice, France; [Ezzat, Leila; Ferrier-Pages, Christine] Ctr Sci Monaco, Ecophysiol Team, Monaco, Monaco; [Buttler, Alexandre] Swiss Fed Inst Forest Snow & Landscape Res WSL, Lausanne, Switzerland; [Buttler, Alexandre] Univ Franche Comte, UMR CNRS 6249, Lab Chronoenvironm, F-25030 Besancon, France	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; UDICE-French Research Universities; Sorbonne Universite; Universite Cote d'Azur; Swiss Federal Institutes of Technology Domain; Swiss Federal Institute for Forest, Snow & Landscape Research; Universite de Franche-Comte	Ezzat, L (corresponding author), Ecole Polytech Fed Lausanne, Sch Architecture Civil & Environm Engn ENAC, CH-1015 Lausanne, Switzerland.	Leila.Ezzat@gmail.com	Buttler, Alexandre AB/K-1137-2012	Furla, Paola/0000-0001-9899-942X; Ferrier-Pages, Christine/0000-0002-0357-4486	Government of the Principality of Monaco through the Centre Scientifique de Monaco; Centre Scientifique de Monaco	Government of the Principality of Monaco through the Centre Scientifique de Monaco; Centre Scientifique de Monaco	This study was funded by the Government of the Principality of Monaco through the Centre Scientifique de Monaco. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank S. Sikorski, C. Rottier and T. Zamoum for laboratory assistance, Rodolphe Schlaepfer (EPFL), P. Tremblay, J-O Irisson (Laboratoire d'Oceanographie de Villefranche-sur-Mer), E. Beraud for statistical advices, and D. Allemand, Director of the Centre Scientifique de Monaco, for financial and scientific support. Many thanks to the undergraduate students: A. Degli-Albizi, S. Tahiri and L. Monticelli, who participated in soluble protein extraction and in algal density determination. Finally, we wish to thank two anonymous reviewers for providing constructive and helpful comments.	Anthony KRN, 2000, J EXP MAR BIOL ECOL, V252, P221, DOI 10.1016/S0022-0981(00)00237-9; Bally M, 2007, GLOBAL CHANGE BIOL, V13, P2078, DOI 10.1111/j.1365-2486.2007.01423.x; BEARDALL J, 1994, J PLANKTON RES, V16, P1401, DOI 10.1093/plankt/16.10.1401; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Borell EM, 2008, J EXP MAR BIOL ECOL, V364, P116, DOI 10.1016/j.jembe.2008.07.033; BROWN BE, 1990, CORAL REEFS, V8, P163, DOI 10.1007/BF00265007; BUDDEMEIER RW, 1993, BIOSCIENCE, V43, P320, DOI 10.2307/1312064; Cerrano C, 2000, ECOL LETT, V3, P284, DOI 10.1046/j.1461-0248.2000.00152.x; Cerrano C, 2005, AQUAT CONSERV, V15, P147, DOI 10.1002/aqc.661; COLES SL, 1991, CORAL REEFS, V9, P231, DOI 10.1007/BF00290427; Coma R, 2003, OIKOS, V101, P205, DOI 10.1034/j.1600-0706.2003.12028.x; Coma R, 2002, LIMNOL OCEANOGR, V47, P324, DOI 10.4319/lo.2002.47.1.0324; COMA R, 1994, MAR ECOL PROG SER, V115, P257, DOI 10.3354/meps115257; Coma R, 2006, MAR ECOL PROG SER, V327, P51, DOI 10.3354/meps327051; Deventer B, 1996, AQUAT SCI, V58, P241, DOI 10.1007/BF00877511; Ferrier-Pages C, 2010, J EXP MAR BIOL ECOL, V390, P118, DOI 10.1016/j.jembe.2010.05.007; Ferrier-Pages C, 2009, J EXP BIOL, V212, P3007, DOI 10.1242/jeb.031823; Garrabou J, 2009, GLOBAL CHANGE BIOL, V15, P1090, DOI 10.1111/j.1365-2486.2008.01823.x; Garrabou J, 2001, MASS MORTALITY EVENT, P217; GATES RD, 1992, BIOL BULL, V182, P324, DOI 10.2307/1542252; GLYNN PW, 1993, CORAL REEFS, V12, P1, DOI 10.1007/BF00303779; Gori A, 2007, MAR BIOL, V151, P1571, DOI 10.1007/s00227-006-0595-7; Gori A, 2012, MAR BIOL, V159, P1485, DOI 10.1007/s00227-012-1928-3; Grottoli AG, 2006, NATURE, V440, P1186, DOI 10.1038/nature04565; Harvell CD, 1999, SCIENCE, V285, P1505, DOI 10.1126/science.285.5433.1505; Harvell D, 2004, FRONT ECOL ENVIRON, V2, P375, DOI 10.1890/1540-9295(2004)002[0375:TRTOOD]2.0.CO;2; Hoogenboom M, 2010, J EXP BIOL, V213, P2399, DOI 10.1242/jeb.040147; Houlbreque F, 2009, BIOL REV, V84, P1, DOI 10.1111/j.1469-185X.2008.00058.x; JEFFREY SW, 1975, BIOCHEM PHYSIOL PFL, V167, P191, DOI 10.1016/s0015-3796(17)30778-3; Jones RJ, 2001, PLANT CELL ENVIRON, V24, P89, DOI 10.1046/j.1365-3040.2001.00648.x; KEVIN KM, 1979, J EXP MAR BIOL ECOL, V36, P157, DOI 10.1016/0022-0981(79)90106-0; Lesser MP, 2007, P NATL ACAD SCI USA, V104, P5259, DOI 10.1073/pnas.0700910104; Linares C, 2005, IMMEDIATE DELAYED EF; Linares C, 2008, J APPL ECOL, V45, P688, DOI 10.1111/j.1365-2664.2007.01419.x; Marubini F, 1996, MAR BIOL, V127, P319, DOI 10.1007/BF00942117; MILLER MW, 1995, MAR ECOL PROG SER, V122, P217, DOI 10.3354/meps122217; MUSCATINE L, 1981, LIMNOL OCEANOGR, V26, P601, DOI 10.4319/lo.1981.26.4.0601; ODUM HT, 1955, ECOL MONOGR, V25, P291, DOI 10.2307/1943285; Perez T, 2000, CR ACAD SCI III-VIE, V323, P853, DOI 10.1016/S0764-4469(00)01237-3; Peters E, 1996, J EXP MAR BIOL ECOL, V207, P25, DOI 10.1016/S0022-0981(96)02520-8; Peters E, 1996, J EXP MAR BIOL ECOL, V207, P43, DOI 10.1016/0022-0981(95)02519-7; Pey A, 2011, J EXP MAR BIOL ECOL, V404, P73, DOI 10.1016/j.jembe.2011.05.007; Portner HO, 2010, J EXP BIOL, V213, P881, DOI 10.1242/jeb.037523; Previati M, 2010, J EXP MAR BIOL ECOL, V390, P39, DOI 10.1016/j.jembe.2010.04.025; Ritchie RJ, 2006, PHOTOSYNTH RES, V89, P27, DOI 10.1007/s11120-006-9065-9; Rodolfo-Metalpa R, 2008, CORAL REEFS, V27, P17, DOI 10.1007/s00338-007-0283-1; Rodolfo-Metalpa R, 2008, MAR ECOL PROG SER, V369, P103, DOI 10.3354/meps07608; Rodolfo-Metalpa R, 2008, J EXP BIOL, V211, P1579, DOI 10.1242/jeb.016345; Rodolfo-Metalpa R, 2006, MAR BIOL, V150, P45, DOI 10.1007/s00227-006-0329-x; Rossi S, 2004, MAR BIOL, V144, P89, DOI 10.1007/s00227-003-1168-7; Rossi S, 2006, MAR BIOL, V149, P643, DOI 10.1007/s00227-005-0229-5; SCHREIBER U, 1986, PHOTOSYNTH RES, V10, P51, DOI 10.1007/BF00024185; Stambler N, 1998, SYMBIOSIS, V24, P127; Suggett DJ, 2008, J PHYCOL, V44, P948, DOI 10.1111/j.1529-8817.2008.00537.x; Titlyanov E, 2000, MAR BIOL, V137, P463, DOI 10.1007/s002270000370; Tremblay P, 2012, J EXP BIOL, V215, P1384, DOI 10.1242/jeb.065201; WEINBERG S, 1979, BIJDR DIERKD, V48, P127, DOI 10.1163/26660644-04802003; Weinberg S, 1991, FAUT IL PROTEGER GOR, P47; WENDT P H, 1985, Journal of the Elisha Mitchell Scientific Society, V101, P187; Wild C, 2004, NATURE, V428, P66, DOI 10.1038/nature02344; Williams E, 1990, ATOLL RES B, V335, P77; Younes WAN, 2003, OCEANOL ACTA, V26, P311, DOI 10.1016/S0399-1784(03)00037-9; Zehr JP, 2009, SCIENCE, V326, P945, DOI 10.1126/science.1181277	63	21	22	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2013	8	5							e64370	10.1371/journal.pone.0064370	http://dx.doi.org/10.1371/journal.pone.0064370			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145YI	23667711	Green Published, Green Submitted, gold			2022-12-27	WOS:000319055600091
J	Lee, YJ; Shi, RH; Witt, SN				Lee, Yong Joo; Shi, Runhua; Witt, Stephan N.			The Small Molecule Triclabendazole Decreases the Intracellular Level of Cyclic AMP and Increases Resistance to Stress in Saccharomyces cerevisiae	PLOS ONE			English	Article							DEPENDENT PROTEIN-KINASE; CHRONOLOGICAL LIFE-SPAN; MAMMALIAN ADENYLYL-CYCLASE; P-SITE INHIBITION; ALPHA-SYNUCLEIN; REGULATORY SUBUNIT; INDUCED APOPTOSIS; BINDING-AFFINITY; STATIONARY-PHASE; KINETIC-ANALYSIS	The Ras-adenylyl cyclase-protein kinase A nutrient-sensing pathway controls metabolism, proliferation and resistance to stress in Saccharomyces cerevisiae. The genetic disruption of this pathway increases resistance to a variety of stresses. We show here that the pharmacological inhibition of this pathway by the drug triclabendazole increases resistance to oxidants, heat stress and extends the chronological life. Evidence is presented that triclabendazole decreases the intracellular level of cyclic AMP by inhibiting adenylyl cyclase and triggers the parallel rapid translocation of the stress-resistance transcription factor Msn2 from the cytosol into the nucleus, as deduced from experiments employing a strain in which MSN2 is replaced with MSN2-GFP (GFP, green fluorescent protein). Msn2 and Msn4 are responsible for activating the transcription of numerous genes that encode proteins that protect cells from stress. The results are consistent with triclabendazole either inhibiting the association of Ras with adenylyl cyclase or directly inhibiting adenylyl cyclase, which in turn triggers Msn2/4 to enter the nucleus and activate stress-responsible element gene expression.	[Lee, Yong Joo; Witt, Stephan N.] Louisiana State Univ, Hlth Sci Ctr Shreveport, Dept Biochem & Mol Biol, Shreveport, LA 71105 USA; [Shi, Runhua] Louisiana State Univ, Hlth Sci Ctr Shreveport, Feist Weiller Canc Ctr, Shreveport, LA 71105 USA	Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport; Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport	Witt, SN (corresponding author), Louisiana State Univ, Hlth Sci Ctr Shreveport, Dept Biochem & Mol Biol, Shreveport, LA 71105 USA.		Witt, Stephan N/M-7922-2013	Witt, Stephan N/0000-0002-6462-2840	National Institutes of Health [NS057656]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS057656] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This research was supported by grant NS057656 (to SNW) from the National Institutes of Health (http://www.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bharucha JP, 2008, MOL BIOL CELL, V19, P1032, DOI 10.1091/mbc.E07-05-0499; BHATTACHARYA S, 1995, P NATL ACAD SCI USA, V92, P2984, DOI 10.1073/pnas.92.7.2984; Bonawitz ND, 2007, CELL METAB, V5, P265, DOI 10.1016/j.cmet.2007.02.009; BROEK D, 1985, CELL, V41, P763, DOI 10.1016/S0092-8674(85)80057-X; Dessauer CW, 1997, J BIOL CHEM, V272, P27787, DOI 10.1074/jbc.272.44.27787; Dong CM, 2011, J BIOL CHEM, V286, P43361, DOI 10.1074/jbc.M111.267286; ENGELBERG D, 1990, EMBO J, V9, P641, DOI 10.1002/j.1460-2075.1990.tb08156.x; Fabrizio P, 2004, J CELL BIOL, V166, P1055, DOI 10.1083/jcb.200404002; Fabrizio P, 2003, GENETICS, V163, P35; Fabrizio P, 2001, SCIENCE, V292, P288, DOI 10.1126/science.1059497; Fairweather I, 1999, VET J, V158, P81, DOI 10.1053/tvjl.1999.0377; Flower TR, 2005, J MOL BIOL, V351, P1081, DOI 10.1016/j.jmb.2005.06.060; Gitler AD, 2009, NAT GENET, V41, P308, DOI 10.1038/ng.300; Granot D, 2003, FEMS YEAST RES, V4, P7, DOI 10.1016/S1567-1356(03)00154-5; GRANOT D, 1991, P NATL ACAD SCI USA, V88, P5724, DOI 10.1073/pnas.88.13.5724; GREGA DS, 1987, J NEUROSCI, V7, P700; Hampsey M, 1997, YEAST, V13, P1099, DOI 10.1002/(SICI)1097-0061(19970930)13:12<1099::AID-YEA177>3.3.CO;2-Z; Hurley JH, 1999, J BIOL CHEM, V274, P7599, DOI 10.1074/jbc.274.12.7599; Jourdain I, 2009, CELL MOTIL CYTOSKEL, V66, P509, DOI 10.1002/cm.20351; Keiser J, 2005, EXPERT OPIN INV DRUG, V14, P1513, DOI 10.1517/13543784.14.12.1513; KURET J, 1988, J BIOL CHEM, V263, P9149; Lee YJ, 2011, BIOCHEM BIOPH RES CO, V414, P205, DOI 10.1016/j.bbrc.2011.09.057; Lee YJ, 2011, J BIOL CHEM, V286, P20267, DOI 10.1074/jbc.M110.209379; Lee YJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015946; Lin SJ, 2000, SCIENCE, V289, P2126, DOI 10.1126/science.289.5487.2126; Longo VD, 2012, CELL METAB, V16, P18, DOI 10.1016/j.cmet.2012.06.002; LOUTAN L, 1989, LANCET, V2, P383; LUBEGA GW, 1991, EXP PARASITOL, V73, P203, DOI 10.1016/0014-4894(91)90023-P; Madia F, 2009, J CELL BIOL, V186, P509, DOI 10.1083/jcb.200906011; MATSUMOTO K, 1984, J BACTERIOL, V157, P277, DOI 10.1128/JB.157.1.277-282.1984; MATSUMOTO K, 1982, P NATL ACAD SCI-BIOL, V79, P2355, DOI 10.1073/pnas.79.7.2355; MITSUZAWA H, 1989, GENETICS, V123, P739; NEAL SE, 1988, J BIOL CHEM, V263, P19718; Pan Y, 2011, CELL METAB, V13, P668, DOI 10.1016/j.cmet.2011.03.018; Park JI, 2005, J BIOL CHEM, V280, P2529, DOI 10.1074/jbc.M407900200; Parrou JL, 1997, ANAL BIOCHEM, V248, P186, DOI 10.1006/abio.1997.2138; Pierre S, 2009, NAT REV DRUG DISCOV, V8, P321, DOI 10.1038/nrd2827; Powers RW, 2006, GENE DEV, V20, P174, DOI 10.1101/gad.1381406; Reinders A, 1998, GENE DEV, V12, P2943, DOI 10.1101/gad.12.18.2943; Roosen J, 2005, MOL MICROBIOL, V55, P862, DOI 10.1111/j.1365-2958.2004.04429.x; Saint-Marc C, 2009, GENETICS, V183, P529, DOI 10.1534/genetics.109.105858; Snyder SH, 2011, P NATL ACAD SCI USA, V108, P18869, DOI 10.1073/pnas.1114346108; TATCHELL K, 1985, P NATL ACAD SCI USA, V82, P3785, DOI 10.1073/pnas.82.11.3785; Tesmer JJG, 2000, BIOCHEMISTRY-US, V39, P14464, DOI 10.1021/bi0015562; TODA T, 1987, MOL CELL BIOL, V7, P1371, DOI 10.1128/MCB.7.4.1371; TODA T, 1987, CELL, V50, P277, DOI 10.1016/0092-8674(87)90223-6; TODA T, 1985, CELL, V40, P27, DOI 10.1016/0092-8674(85)90305-8; Villegas F, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001720; Wang C, 2009, GENETICS, V183, P1373, DOI 10.1534/genetics.109.107797; Wang SX, 2012, P NATL ACAD SCI USA, V109, P16119, DOI 10.1073/pnas.1206286109; WIEGN P, 1993, ANAL BIOCHEM, V208, P217, DOI 10.1006/abio.1993.1035	51	16	17	4	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2013	8	5							e64337	10.1371/journal.pone.0064337	http://dx.doi.org/10.1371/journal.pone.0064337			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145YI	23667708	Green Published, gold, Green Submitted			2022-12-27	WOS:000319055600090
J	Kaimori, JY; Iwai, S; Hatanaka, M; Teratani, T; Obi, Y; Tsuda, H; Isaka, Y; Yokawa, T; Kuroda, K; Ichimaru, N; Okumi, M; Yazawa, K; Rakugi, H; Nonomura, N; Takahara, S; Kobayashi, E				Kaimori, Jun-Ya; Iwai, Satomi; Hatanaka, Masaki; Teratani, Takumi; Obi, Yoshitsugu; Tsuda, Hidetoshi; Isaka, Yoshitaka; Yokawa, Takashi; Kuroda, Kagayaki; Ichimaru, Naotsugu; Okumi, Masayoshi; Yazawa, Koji; Rakugi, Hiromi; Nonomura, Norio; Takahara, Shiro; Kobayashi, Eiji			Non-Invasive Magnetic Resonance Imaging in Rats for Prediction of the Fate of Grafted Kidneys from Cardiac Death Donors	PLOS ONE			English	Article							ACUTE-RENAL-FAILURE; NORMOTHERMIC RECIRCULATION; PLASMINOGEN-ACTIVATOR; DIFFUSION; ISCHEMIA; PRESERVATION; PERFUSION; PATHOGENESIS; OBSTRUCTION; INJURY	The main objective of this study was to assess cardiac death (CD) kidney grafts before transplantation to determine whether blood oxygen level-dependent (BOLD) and diffusion MRI techniques can predict damage to these grafts after transplantation. We assessed CD kidney tissue by BOLD and diffusion MRI. We also examined pathological and gene expression changes in CD kidney grafts before and after transplantation. Although there was significantly more red cell congestion (RCC) in the inner stripe of the outer medulla (IS) in both 1 h after cardiac death (CD1h) and CD2h kidneys destined for grafts before transplantation compared with CD0h (p<0.05), CD2h, but not CD1h, kidney grafts had significantly different RCC in the IS 2 days after transplantation (p<0.05). Consistent with these pathological findings, tissue plasminogen activator (tPA) gene expression was increased only in the cortex and medulla of CD2h kidney grafts after transplantation. BOLD MRI successfully and non-invasively imaged and quantified RCC in the IS in both CD1h and CD2h kidney grafts (p<0.05). Diffusion MRI also non-invasively assessed increased the apparent diffusion coefficient in the IS and decreased it in the outer stripe (OS) of CD2h grafts, in concordance with interstitial edema in the IS and tubule cellular edema in the OS. These two types of edema in the outer medulla could explain the prolonged RCC in the IS only of CD2h kidney grafts, creating part of a vicious cycle inhibiting red cells coming out of capillary vessels in the IS. Perfusion with University of Wisconsin solution before MRI measurements did not diminish the difference in tissue damage between CD1h and CD2h kidney grafts. BOLD and diffusion MRI, which are readily available non-invasive tools for evaluating CD kidney grafts tissue damage, can predict prolonged organ damage, and therefore the outcome, of transplanted CD kidney grafts.	[Kaimori, Jun-Ya; Tsuda, Hidetoshi; Ichimaru, Naotsugu; Takahara, Shiro] Osaka Univ, Grad Sch Med, Dept Adv Technol Transplantat, Osaka, Japan; [Iwai, Satomi] Kitasato Univ, Sch Vet Med, Lab Small Anim Surg 1, Aomori, Japan; [Kaimori, Jun-Ya; Hatanaka, Masaki; Obi, Yoshitsugu; Isaka, Yoshitaka; Rakugi, Hiromi] Osaka Univ, Grad Sch Med, Dept Geriatr & Nephrol, Osaka, Japan; [Teratani, Takumi; Kobayashi, Eiji] Jichi Med Univ, Ctr Dev Adv Med Technol, Shimotsuke, Tochigi, Japan; [Yokawa, Takashi] BioView, Tokyo, Japan; [Kuroda, Kagayaki] Tokai Univ, Dept Human & Informat Sci, Sch Informat Sci & Technol, Hiratsuka, Kanagawa 25912, Japan; [Okumi, Masayoshi; Yazawa, Koji; Nonomura, Norio] Osaka Univ, Grad Sch Med, Dept Specif Organ Regulat Urol, Osaka, Japan	Osaka University; Kitasato University; Osaka University; Jichi Medical University; Tokai University; Osaka University	Isaka, Y (corresponding author), Osaka Univ, Grad Sch Med, Dept Geriatr & Nephrol, Osaka, Japan.	isaka@kid.med.osaka-u.ac.jp	Obi, Yoshitsugu/G-5764-2017	Obi, Yoshitsugu/0000-0001-7032-4383; Kuroda, Kagayaki/0000-0001-7065-1464; Rakugi, Hiromi/0000-0001-6508-4338	Ministry of Health, Labor, and Welfare of Japan; Japan Society for Organ Preservation, Medical Biology; JSPS [24659714]	Ministry of Health, Labor, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Japan Society for Organ Preservation, Medical Biology; JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This study was suported by a Grant-in-Aid for Progressive Renal Disease Research from the Ministry of Health, Labor, and Welfare of Japan, a research promoting grant of the Japan Society for Organ Preservation, Medical Biology and JSPS Grant-in-Aid for Challenging Exploratory Research Grant Number 24659714. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bock HA, 1997, NEPHRON, V76, P130; BOHLE A, 1990, AM J NEPHROL, V10, P374, DOI 10.1159/000168153; Garcia-Valdecasas JC, 2010, CURR OPIN ORGAN TRAN, V15, P173, DOI 10.1097/MOT.0b013e3283373488; Fondevila C, 2007, AM J TRANSPLANT, V7, P1849, DOI 10.1111/j.1600-6143.2007.01846.x; Gueler F, 2008, J IMMUNOL, V181, P1179, DOI 10.4049/jimmunol.181.2.1179; HELLBERG POA, 1990, KIDNEY INT, V37, P1240, DOI 10.1038/ki.1990.107; Iwai S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033157; KRISTENSEN P, 1984, FEBS LETT, V168, P33, DOI 10.1016/0014-5793(84)80201-X; LEBIHAN D, 1986, RADIOLOGY, V161, P401, DOI 10.1148/radiology.161.2.3763909; LEBIHAN D, 1988, RADIOLOGY, V168, P497, DOI 10.1148/radiology.168.2.3393671; LORENZ CH, 1991, MAGN RESON MED, V19, P254, DOI 10.1002/mrm.1910190211; Maathuis MHJ, 2007, TRANSPLANTATION, V83, P1289, DOI 10.1097/01.tp.0000265586.66475.cc; MASON J, 1987, KIDNEY INT, V31, P65, DOI 10.1038/ki.1987.10; Matthews PM, 2004, J NEUROL NEUROSUR PS, V75, P6; Moers C, 2010, NEPHROL DIAL TRANSPL, V25, P666, DOI 10.1093/ndt/gfp717; Moers C, 2012, TRANSPL INT, V25, P210, DOI 10.1111/j.1432-2277.2011.01383.x; MULLER MF, 1994, RADIOLOGY, V193, P711; Net M, 2005, AM J TRANSPLANT, V5, P2385, DOI 10.1111/j.1600-6143.2005.01052.x; OJTEG G, 1987, ACTA PHYSIOL SCAND, V129, P295, DOI 10.1111/j.1748-1716.1987.tb08072.x; Prasad PV, 2006, AM J PHYSIOL-RENAL, V290, pF958, DOI 10.1152/ajprenal.00114.2005; Ries M, 2003, J MAGN RESON IMAGING, V17, P104, DOI 10.1002/jmri.10224; Togao O, 2010, RADIOLOGY, V255, P772, DOI 10.1148/radiol.10091735; Valero R, 2000, TRANSPLANT INT, V13, P303, DOI 10.1111/j.1432-2277.2000.tb01086.x; WOLGAST M, 1991, KLIN WOCHENSCHR, V69, P1077, DOI 10.1007/BF01645162	24	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e63573	10.1371/journal.pone.0063573	http://dx.doi.org/10.1371/journal.pone.0063573			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667641	Green Published, Green Submitted, gold			2022-12-27	WOS:000319654700164
J	Kassing, V; Engelmann, J; Kurtz, R				Kassing, Vanessa; Engelmann, Jacob; Kurtz, Rafael			Monitoring of Single-Cell Responses in the Optic Tectum of Adult Zebrafish with Dextran-Coupled Calcium Dyes Delivered via Local Electroporation	PLOS ONE			English	Article							STARBURST AMACRINE CELLS; LARVAL ZEBRAFISH; IN-VIVO; DIRECTION SELECTIVITY; NEURAL CIRCUIT; VISUAL-SYSTEM; NEURONS; GOLDFISH; UNITS; FLY	The zebrafish (Danio rerio) has become one of the major animal models for in vivo examination of sensory and neuronal computation. Similar to Xenopus tadpoles neural activity in the optic tectum, the major region controlling visually guided behavior, can be examined in zebrafish larvae by optical imaging. Prerequisites of these approaches are usually the transparency of larvae up to a certain age and the use of two-photon microscopy. This principle of fluorescence excitation was necessary to suppress crosstalk between signals from individual neurons, which is a critical issue when using membrane-permeant dyes. This makes the equipment to study neuronal processing costly and limits the approach to the study of larvae. Thus there is lack of knowledge about the properties of neurons in the optic tectum of adult animals. We established a procedure to circumvent these problems, enabling in vivo calcium imaging in the optic tectum of adult zebrafish. Following local application of dextran-coupled dyes single-neuron activity of adult zebrafish can be monitored with conventional widefield microscopy, because dye labeling remains restricted to tens of neurons or less. Among the neurons characterized with our technique we found neurons that were selective for a certain pattern orientation as well as neurons that responded in a direction-selective way to visual motion. These findings are consistent with previous studies and indicate that the functional integrity of neuronal circuits in the optic tectum of adult zebrafish is preserved with our staining technique. Overall, our protocol for in vivo calcium imaging provides a useful approach to monitor visual responses of individual neurons in the optic tectum of adult zebrafish even when only widefield microscopy is available. This approach will help to obtain valuable insight into the principles of visual computation in adult vertebrates and thus complement previous work on developing visual circuits.	[Kassing, Vanessa; Engelmann, Jacob] Univ Bielefeld, AG Act Sensing, D-33615 Bielefeld, Germany; [Kassing, Vanessa; Engelmann, Jacob] Univ Bielefeld, Ctr Excellence Cognit Interact Technol, D-33615 Bielefeld, Germany; [Kurtz, Rafael] Univ Bielefeld, Dept Neurobiol, D-33615 Bielefeld, Germany	University of Bielefeld; University of Bielefeld; University of Bielefeld	Kurtz, R (corresponding author), Univ Bielefeld, Dept Neurobiol, D-33615 Bielefeld, Germany.	rafael.kurtz@uni-bielefeld.de	Kurtz, Rafael/G-4782-2011		Deutsche Forschungsgemeinschaft (DFG) - Excellence Cluster 277: Cognitive Interaction Technology (CITEC); Deutsche Forschungsgemeinschaft; Open Access Publication Funds of Bielefeld University Library	Deutsche Forschungsgemeinschaft (DFG) - Excellence Cluster 277: Cognitive Interaction Technology (CITEC); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Open Access Publication Funds of Bielefeld University Library	VK was funded by a scholarship of the "Deutsche Forschungsgemeinschaft (DFG) - Excellence Cluster 277: Cognitive Interaction Technology (CITEC)," http://www.dfg.de/en/research_funding/programmes/list/projectdetails/index.jsp?id = 39113330. The authors acknowledge support for the article processing charge by the Deutsche Forschungsgemeinschaft and the Open Access Publication Funds of Bielefeld University Library. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson T, 2009, THESIS STANFORD U; Baier H, 2009, CURR OPIN NEUROBIOL, V19, P553, DOI 10.1016/j.conb.2009.08.001; Batschelet E, 1981, CIRCULAR STAT BIOL; Bell CC, 2008, ANNU REV NEUROSCI, V31, P1, DOI 10.1146/annurev.neuro.30.051606.094225; Bollmann JH, 2009, NEURON, V61, P895, DOI 10.1016/j.neuron.2009.01.018; BURRILL JD, 1994, J COMP NEUROL, V346, P583, DOI 10.1002/cne.903460410; CHANG HT, 1993, BRAIN RES BULL, V30, P115, DOI 10.1016/0361-9230(93)90046-E; Del Bene F, 2010, SCIENCE, V330, P669, DOI 10.1126/science.1192949; DENK W, 1990, SCIENCE, V248, P73, DOI 10.1126/science.2321027; Euler T, 2002, NATURE, V418, P845, DOI 10.1038/nature00931; Friedrich RW, 2010, CURR BIOL, V20, pR371, DOI 10.1016/j.cub.2010.02.039; Fujiwara T, 2009, NEUROREPORT, V20, P1061, DOI 10.1097/WNR.0b013e32832e7d93; Gabriel JP, 2012, NEURON, V76, P1147, DOI 10.1016/j.neuron.2012.12.003; Gahtan E, 2005, J NEUROSCI, V25, P9294, DOI 10.1523/JNEUROSCI.2678-05.2005; Garaschuk O, 2006, PFLUG ARCH EUR J PHY, V453, P385, DOI 10.1007/s00424-006-0150-x; Grama A, 2012, FRONT NEURAL CIRCUIT, V6, DOI [10.3389/fncir.2012.00125, 10.3389/fncir.2012.00059]; Haas K, 2001, NEURON, V29, P583, DOI 10.1016/S0896-6273(01)00235-5; Hama H, 2011, NAT NEUROSCI, V14, P1481, DOI 10.1038/nn.2928; Hausselt SE, 2007, PLOS BIOL, V5, P1474, DOI 10.1371/journal.pbio.0050185; Hennig P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003092; HSU SM, 1981, J HISTOCHEM CYTOCHEM, V29, P577, DOI 10.1177/29.4.6166661; Jia HB, 2010, NATURE, V464, P1307, DOI 10.1038/nature08947; Kelsh RN, 1996, DEVELOPMENT, V123, P369; KIRSCHBAUM F, 1975, Wilhelm Roux's Archives of Developmental Biology, V177, P129, DOI 10.1007/BF00848526; Kobbert C, 2000, PROG NEUROBIOL, V62, P327, DOI 10.1016/S0301-0082(00)00019-8; Li ZR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040132; Lister JA, 1999, DEVELOPMENT, V126, P3757; Maurer CM, 2011, REV NEUROSCIENCE, V22, P5, DOI 10.1515/RNS.2011.003; Maximov V, 2005, ANN NY ACAD SCI, V1048, P198, DOI 10.1196/annals.1342.018; Mobbs P., 1994, MICROELECTRODE TECHN, V2nd, P361; Nevian T, 2007, PFLUG ARCH EUR J PHY, V454, P675, DOI 10.1007/s00424-007-0234-2; Nevin LM, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-126; Niell CM, 2005, NEURON, V45, P941, DOI 10.1016/j.neuron.2005.01.047; Nieuwenhuys R., 1998, CENTRAL NERVOUS SYST; Nikolaou N, 2012, NEURON, V76, P317, DOI 10.1016/j.neuron.2012.08.040; OBENAR JD, 1976, BRAIN RES BULL, V1, P529, DOI 10.1016/0361-9230(76)90080-0; Podgorski K, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001236; Ramdya P, 2008, NAT NEUROSCI, V11, P1083, DOI 10.1038/nn.2166; Renninger SL, 2011, NEUROGENETICS, V12, P97, DOI 10.1007/s10048-011-0273-x; Robles E, 2011, FRONT NEURAL CIRCUIT, V5, DOI 10.3389/fncir.2011.00001; Roeser T, 2003, J NEUROSCI, V23, P3726; SAJOVIC P, 1983, BRAIN RES, V271, P227, DOI 10.1016/0006-8993(83)90285-8; SAJOVIC P, 1982, NEUROSCIENCE, V7, P2407, DOI 10.1016/0306-4522(82)90204-4; SAJOVIC P, 1982, NEUROSCIENCE, V7, P2427, DOI 10.1016/0306-4522(82)90205-6; SCHELLART NAM, 1979, VISION RES, V19, P459, DOI 10.1016/0042-6989(79)90113-5; SCHMUED LC, 1993, J HISTOCHEM CYTOCHEM, V41, P777, DOI 10.1177/41.5.7682231; Scott EK, 2009, FRONT NEURAL CIRCUIT, V3, DOI 10.3389/neuro.04.013.2009; Spalthoff C, 2012, FRONT NEURAL CIRCUIT, V6, P1, DOI 10.3389/fncir.2012.00072; Spalthoff C, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-36; Stosiek C, 2003, P NATL ACAD SCI USA, V100, P7319, DOI 10.1073/pnas.1232232100; Straw Andrew D, 2008, Front Neuroinform, V2, P4, DOI 10.3389/neuro.11.004.2008; Sumbre G, 2008, NATURE, V456, P102, DOI 10.1038/nature07351; Walker AS, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00034; WARTZOK D, 1973, J NEUROPHYSIOL, V36, P588, DOI 10.1152/jn.1973.36.4.588	54	10	11	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e62846	10.1371/journal.pone.0062846	http://dx.doi.org/10.1371/journal.pone.0062846			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667529	Green Submitted, Green Published, gold			2022-12-27	WOS:000319654700068
J	Liu, CC; Sun, S; Sui, SF				Liu, Cui-Cui; Sun, Shan; Sui, Sen-Fang			The Role of the N-D1 Linker of the N-Ethylmaleimide-Sensitive Factor in the SNARE Disassembly	PLOS ONE			English	Article							NSF ATTACHMENT PROTEINS; INTERPROTOMER MOTION-TRANSMISSION; AAA ATPASE P97; FUSION PROTEIN; MEMBRANE-FUSION; CRYSTAL-STRUCTURE; VESICULAR TRANSPORT; TERMINAL DOMAIN; COMPLEX; BINDING	N-ethylmaleimide-sensitive factor (NSF) is a member of the type II AAA+ (ATPase associated with various cellular activities) family. It plays a critical role in intracellular membrane trafficking by disassembling soluble NSF attachment protein receptor (SNARE) complexes. Each NSF protomer consists of an N-terminal domain (N domain) followed by two AAA ATPase domains (D1 and D2) in tandem. The N domain is required for SNARE/alpha-SNAP binding and the D1 domain accounts for the majority of ATP hydrolysis. Little is known about the role of the N-D1 linker in the NSF function. This study presents detailed mutagenesis analyses of NSF N-D1 linker, dissecting its role in the SNARE disassembly, the SNARE/alpha-SNAP complex binding, the basal ATPase activity and the SNARE/alpha-SNAP stimulated ATPase activity. Our results show that the N-terminal region of the N-D1 linker associated mutants cause severe defect in SNARE complex disassembly, but little effects on the SNARE/alpha-SNAP complex binding, the basal and the SNARE/alpha-SNAP stimulated ATPase activity, suggesting this region may be involved in the motion transmission from D1 to N domain. Mutating the residues in middle and C-terminal region of the N-D1 linker increases the basal ATPase activity, indicating it may play a role in autoinhibiting NSF activity until it encounters SNARE/alpha-SNAP complex substrate. Moreover, mutations at the C-terminal sequence GIGG exhibit completely abolished or severely reduced activities of the substrate binding, suggesting that the flexibility of N-D1 linker is critical for the movement of the N domain that is required for the substrate binding. Taken together, these data suggest that the whole N-D1 linker is critical for the biological function of NSF to disassemble SNARE complex substrate with different regions responsible for different roles.	[Liu, Cui-Cui; Sun, Shan; Sui, Sen-Fang] Tsinghua Univ, Sch Life Sci, Struct Biol Ctr, State Key Lab Biomembrane & Membrane Biotechnol, Beijing 100084, Peoples R China	Tsinghua University	Sun, S (corresponding author), Tsinghua Univ, Sch Life Sci, Struct Biol Ctr, State Key Lab Biomembrane & Membrane Biotechnol, Beijing 100084, Peoples R China.	shansun@mail.tsinghua.edu.cn; suisf@mail.tsinghua.edu.cn			National Basic Research Program of China [2011CB910500/2010CB833706]; National Natural Science Foundation of China [31230016]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Basic Research Program of China (2011CB910500/2010CB833706) and the National Natural Science Foundation of China (31230016). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antonin W, 2002, NAT STRUCT BIOL, V9, P107, DOI 10.1038/nsb746; BLOCK MR, 1988, P NATL ACAD SCI USA, V85, P7852, DOI 10.1073/pnas.85.21.7852; Chang LF, 2012, NAT STRUCT MOL BIOL, V19, P268, DOI 10.1038/nsmb.2237; CLARY DO, 1990, CELL, V61, P709, DOI 10.1016/0092-8674(90)90482-T; Fleming KG, 1998, J BIOL CHEM, V273, P15675, DOI 10.1074/jbc.273.25.15675; Huang CD, 2012, P NATL ACAD SCI USA, V109, P9792, DOI 10.1073/pnas.1205853109; Jahn R, 1999, ANNU REV BIOCHEM, V68, P863, DOI 10.1146/annurev.biochem.68.1.863; LANZETTA PA, 1979, ANAL BIOCHEM, V100, P95, DOI 10.1016/0003-2697(79)90115-5; Li GT, 2012, P NATL ACAD SCI USA, V109, P3737, DOI 10.1073/pnas.1200255109; Manno A, 2010, GENES CELLS, V15, P911, DOI 10.1111/j.1365-2443.2010.01428.x; Matveeva E, 1998, FEBS LETT, V435, P211, DOI 10.1016/S0014-5793(98)01071-0; Matveeva EA, 1997, J BIOL CHEM, V272, P26413, DOI 10.1074/jbc.272.42.26413; Matveeva EA, 2002, BIOCHEMISTRY-US, V41, P530, DOI 10.1021/bi015632s; May AP, 2001, J BIOL CHEM, V276, P21991, DOI 10.1074/jbc.R100013200; Merrill SA, 2010, J BIOL CHEM, V285, P35428, DOI 10.1074/jbc.M110.126318; Moeller A, 2012, J STRUCT BIOL, V177, P335, DOI 10.1016/j.jsb.2011.12.018; MORGAN A, 1994, J BIOL CHEM, V269, P29347; NAGIEC EE, 1995, J BIOL CHEM, V270, P29182, DOI 10.1074/jbc.270.49.29182; Niwa H, 2012, J BIOL CHEM, V287, P8561, DOI 10.1074/jbc.M111.302778; Smith GR, 2004, J STRUCT BIOL, V146, P189, DOI 10.1016/j.jsb.2003.11.022; SOLLNER T, 1993, NATURE, V362, P318, DOI 10.1038/362318a0; Steel GJ, 1998, FEBS LETT, V423, P113, DOI 10.1016/S0014-5793(98)00072-6; Stein A, 2009, NATURE, V460, P525, DOI 10.1038/nature08156; SUMIDA M, 1994, J BIOL CHEM, V269, P20636; Sutton RB, 1998, NATURE, V395, P347, DOI 10.1038/26412; TAGAYA M, 1993, J BIOL CHEM, V268, P2662; Tang WK, 2010, EMBO J, V29, P2217, DOI 10.1038/emboj.2010.104; Weber T, 1998, CELL, V92, P759, DOI 10.1016/S0092-8674(00)81404-X; WHITEHEART SW, 1994, J CELL BIOL, V126, P945, DOI 10.1083/jcb.126.4.945; Whiteheart SW, 2004, J STRUCT BIOL, V146, P32, DOI 10.1016/j.jsb.2003.09.015; Yu RC, 1999, MOL CELL, V4, P97, DOI 10.1016/S1097-2765(00)80191-4; Zhang T, 2012, PROTEINS, V80, P2758, DOI 10.1002/prot.24159; Zhang XD, 2000, MOL CELL, V6, P1473, DOI 10.1016/S1097-2765(00)00143-X; Zhao CX, 2007, FEBS LETT, V581, P2140, DOI 10.1016/j.febslet.2007.03.032; Zhao CX, 2012, BBA-MOL CELL RES, V1823, P159, DOI 10.1016/j.bbamcr.2011.06.003; Zhao CX, 2010, J BIOL CHEM, V285, P761, DOI 10.1074/jbc.M109.056739	36	5	5	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e64346	10.1371/journal.pone.0064346	http://dx.doi.org/10.1371/journal.pone.0064346			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667709	Green Published, Green Submitted, gold			2022-12-27	WOS:000319654700207
J	Noor, AM; Alegana, VA; Kamwi, RN; Hansford, CF; Ntomwa, B; Katokele, S; Snow, RW				Noor, Abdisalan M.; Alegana, Victor A.; Kamwi, Richard N.; Hansford, Clifford F.; Ntomwa, Benson; Katokele, Stark; Snow, Robert W.			Malaria Control and the Intensity of Plasmodium falciparum Transmission in Namibia 1969-1992	PLOS ONE			English	Article							LIMITS	Background: Historical evidence of the levels of intervention scale up and its relationships to changing malaria risks provides important contextual information for current ambitions to eliminate malaria in various regions of Africa today. Methods: Community-based Plasmodium falciparum prevalence data from 3,260 geo-coded time-space locations between 1969 and 1992 were assembled from archives covering an examination of 230,174 individuals located in northern Namibia. These data were standardized the age-range 2 to less than 10 years and used within a Bayesian model-based geo-statistical framework to examine the changes of malaria risk in the years 1969, 1974, 1979, 1984 and 1989 at 565 km spatial resolution. This changing risk was described against rainfall seasons and the wide-scale use of indoor-residual house-spraying and mass drug administration. Results: Most areas of Northern Namibia experienced low intensity transmission during a ten-year period of wide-scale control activities between 1969 and 1979. As control efforts waned, flooding occurred, drug resistance emerged and the war for independence intensified the spatial extent of moderate-to-high malaria transmission expanded reaching a peak in the late 1980s. Conclusions: Targeting vectors and parasite in northern Namibia was likely to have successfully sustained a situation of low intensity transmission, but unraveled quickly to a peak of transmission intensity following a sequence of events by the early 1990s.	[Noor, Abdisalan M.; Alegana, Victor A.; Snow, Robert W.] Kenya Govt Med Res Ctr, Wellcome Trust Res Programme, Malaria Publ Hlth Dept, Nairobi, Kenya; [Noor, Abdisalan M.; Snow, Robert W.] Univ Oxford, Nuffield Dept Clin Med, Ctr Trop Med, Oxford, England; [Kamwi, Richard N.] Minist Hlth & Social Serv, Off Minister, Windhoek, Namibia; [Hansford, Clifford F.] Natl Inst Trop Dis, Tzaneen, South Africa; [Ntomwa, Benson; Katokele, Stark] Minist Hlth & Social Serv, Directorate Special Programmes, Natl Vectorborne Dis Control Programme, Windhoek, Namibia	Kenya Medical Research Institute; University of Oxford	Noor, AM (corresponding author), Kenya Govt Med Res Ctr, Wellcome Trust Res Programme, Malaria Publ Hlth Dept, Nairobi, Kenya.	anoor@nairobi.kemri-wellcome.org	Snow, Robert William/AFR-1436-2022; Alegana, Victor/P-6579-2019	Snow, Robert William/0000-0003-3725-6088; Alegana, Victor/0000-0001-5177-9227	Wellcome Trust [Intermediate Research Fellowship] [095127]; Principal Research Fellowship [079080]; Wellcome Trust Major Overseas Programme [092654]	Wellcome Trust [Intermediate Research Fellowship](Wellcome Trust); Principal Research Fellowship; Wellcome Trust Major Overseas Programme(Wellcome Trust)	This work was supported by the Wellcome Trust [Intermediate Research Fellowship grant to AMN (#095127) and a Principal Research Fellowship grant (#079080) to RWS]. Programmatic support for this study was also provided through a Wellcome Trust Major Overseas Programme grant to the Kenya Medical Research Institute/Wellcome Trust Research Programme (#092654). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], LEAPS REGRESSION SUB; Banerjee S, 2004, MONOGRAPHS STAT APPL, V101; Botha L., HIST DROUGHTS NAMIBI; Cohen JM, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-213; De Meillon B., 1951, Bulletin of the World Health Organization, V4, P333; Diggle P, 2002, J R STAT SOC C-APPL, V51, P493, DOI 10.1111/1467-9876.00283; Gething PW, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-378; Gething PW, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-92; Gosoniu L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009322; Guerra CA, 2008, PLOS MED, V5, P300, DOI 10.1371/journal.pmed.0050038; Hansford CF, 1990, MALARIA CONTRO UNPUB; Hay SI, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000048; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; ISAACS EH, 1989, APPL GEOSTATISTICS; Kamwi RN, 2005, THESIS U NAMIBIA NAM; Kazembe LN, 2006, INT J HEALTH GEOGR, V5, pe41; Mabaso MLH, 2004, TROP MED INT HEALTH, V9, P846, DOI 10.1111/j.1365-3156.2004.01263.x; Mendelsohn JM, 2002, ATLAS NAMIBIA COMPRE; Miller AJ, 2002, SUBSET SELECTION REG, DOI DOI 10.1201/9781420035933; Ministry of Health and Social Services, 2010, NAT VECT BORN DIS CO; Ministry of Health and Social Services, 1995, NAT POL STRAT MAL CO; Ministry of Health and Social Services, 2005, NAT MAL POL; Noor AM, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-180; Noor AM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002081; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Smith DL, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-131; Snow R.W., 2010, ESTIMATING DISTRIBUT; Snow RW, 2012, ADV PARASIT, V78, P169, DOI 10.1016/B978-0-12-394303-3.00010-4	28	13	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e63350	10.1371/journal.pone.0063350	http://dx.doi.org/10.1371/journal.pone.0063350			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667604	Green Submitted, gold, Green Published			2022-12-27	WOS:000319654700133
J	O'Farrell, B; Benzie, JAH; McGinnity, P; de Eyto, E; Dillane, E; Coughlan, J; Cross, TF				O'Farrell, Brian; Benzie, John A. H.; McGinnity, Phil; de Eyto, Elvira; Dillane, Eileen; Coughlan, James; Cross, Tom F.			Selection and Phylogenetics of Salmonid MHC Class I: Wild Brown Trout (Salmo trutta) Differ from a Non-Native Introduced Strain	PLOS ONE			English	Article							MAJOR HISTOCOMPATIBILITY COMPLEX; PEPTIDE-BINDING REGION; RAINBOW-TROUT; NATURAL-SELECTION; ONCORHYNCHUS-MYKISS; PARASITE RESISTANCE; BALANCING SELECTION; GENETIC DIVERSITY; MATE CHOICE; POLYMORPHISM	We tested how variation at a gene of adaptive importance, MHC class I (UBA), in a wild, endemic Salmo trutta population compared to that in both a previously studied non-native S. trutta population and a co-habiting Salmo salar population ( a sister species). High allelic diversity is observed and allelic divergence is much higher than that noted previously for cohabiting S. salar. Recombination was found to be important to population-level divergence. The alpha 1 and alpha 2 domains of UBA demonstrate ancient lineages but novel lineages are also identified at both domains in this work. We also find examples of recombination between UBA and the non-classical locus, ULA. Evidence for strong diversifying selection was found at a discrete suite of S. trutta UBA amino acid sites. The pattern was found to contrast with that found in re-analysed UBA data from an artificially stocked S. trutta population.	[O'Farrell, Brian; Benzie, John A. H.] Natl Univ Ireland Univ Coll Cork, Environm Res Inst, Cork, Ireland; [Benzie, John A. H.; McGinnity, Phil; Dillane, Eileen; Coughlan, James; Cross, Tom F.] Natl Univ Ireland Univ Coll Cork, Aquaculture & Fisheries Dev Ctr, Sch Biol Earth & Environm Sci, Cork, Ireland; [McGinnity, Phil; de Eyto, Elvira] Inst Marine, Newport, County Mayo, Ireland	University College Cork; University College Cork; Marine Institute Ireland	O'Farrell, B (corresponding author), Natl Univ Ireland Univ Coll Cork, Environm Res Inst, Cork, Ireland.	Eb.ofarrell@ucc.ie	Benzie, John A.H./L-6208-2018; McGinnity, Philip/P-6781-2015	Benzie, John/0000-0001-9599-8683; de Eyto, Elvira/0000-0003-2281-2491; McGinnity, Philip/0000-0001-5199-5632	Higher Education Authority Programme for Research in Third-Level Institutions; Beaufort Marine Research Award: Fish population genetics	Higher Education Authority Programme for Research in Third-Level Institutions; Beaufort Marine Research Award: Fish population genetics	Funding provided by the Higher Education Authority Programme for Research in Third-Level Institutions Cycle 3; Beaufort Marine Research Award: Fish population genetics. Irish Government National Development Plan (2007-2014) administered by the Marine Institute; Science Foundation Ireland (Microbial Phylogeography 05/FE1/B882). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; Aoyagi K, 2002, J IMMUNOL, V168, P260, DOI 10.4049/jimmunol.168.1.260; Bernatchez L, 2003, J EVOLUTION BIOL, V16, P363, DOI 10.1046/j.1420-9101.2003.00531.x; Bos DH, 2006, MOL BIOL EVOL, V23, P137, DOI 10.1093/molbev/msj016; Carroll LS, 2002, P NATL ACAD SCI USA, V99, P2187, DOI 10.1073/pnas.042244899; CLARKE B, 1966, NATURE, V211, P999, DOI 10.1038/211999a0; Collins EJ, 2008, IMMUNOL RES, V41, P267, DOI 10.1007/s12026-008-8040-2; Consuegra S, 2005, IMMUNOGENETICS, V57, P16, DOI 10.1007/s00251-004-0765-z; Consuegra S, 2005, MOL BIOL EVOL, V22, P1095, DOI 10.1093/molbev/msi096; Consuegra S, 2008, P ROY SOC B-BIOL SCI, V275, P1397, DOI 10.1098/rspb.2008.0066; Coughlan J, 2006, ICES J MAR SCI, V63, P1248, DOI 10.1016/j.icesjms.2006.03.025; DOHERTY PC, 1975, NATURE, V256, P50, DOI 10.1038/256050a0; Felsenstein J., 1993, PHYLIP PHYLOGENY INF; Garrigan D, 2003, EVOLUTION, V57, P1707; Gebremedhin B, 2009, ANIM CONSERV, V12, P107, DOI 10.1111/j.1469-1795.2009.00255.x; Go Y, 2003, IMMUNOGENETICS, V55, P450, DOI 10.1007/s00251-003-0613-6; Grimholt U, 2002, IMMUNOGENETICS, V54, P570, DOI 10.1007/s00251-002-0499-8; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; HAMILTON WD, 1982, SCIENCE, V218, P384, DOI 10.1126/science.7123238; Hansen JD, 1999, J IMMUNOL, V163, P774; Hansen JD, 1996, DEV COMP IMMUNOL, V20, P417, DOI 10.1016/S0145-305X(96)00030-4; HUGHES AL, 1988, NATURE, V335, P167, DOI 10.1038/335167a0; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Kaufman J, 1999, IMMUNOGENETICS, V50, P228, DOI 10.1007/s002510050597; Kiryu I, 2005, FISH SHELLFISH IMMUN, V18, P243, DOI 10.1016/j.fsi.2004.07.007; Klein J, 1998, ANNU REV ECOL SYST, V29, P1, DOI 10.1146/annurev.ecolsys.29.1.1; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; Kurtz J, 2004, P ROY SOC B-BIOL SCI, V271, P197, DOI 10.1098/rspb.2003.2567; Landry C, 2001, P ROY SOC B-BIOL SCI, V268, P1279, DOI 10.1098/rspb.2001.1659; Lenz TL, 2011, EVOLUTION, V65, P2380, DOI 10.1111/j.1558-5646.2011.01288.x; Martin DP, 2005, BIOINFORMATICS, V21, P260, DOI 10.1093/bioinformatics/bth490; Miller HC, 2004, MOL ECOL, V13, P3709, DOI 10.1111/j.1365-294X.2004.02368.x; Miller KM, 2001, GENETICA, V111, P237, DOI 10.1023/A:1013716020351; Miller KM, 2006, IMMUNOGENETICS, V58, P571, DOI 10.1007/s00251-006-0125-2; Muirhead CA, 2001, EVOLUTION, V55, P1532; Neff BD, 2008, HEREDITY, V101, P175, DOI 10.1038/hdy.2008.43; O'Farrell B, 2012, J FISH BIOL, V81, P1357, DOI 10.1111/j.1095-8649.2012.03421.x; O'Farrell B, 2012, HEREDITY, V108, P403, DOI 10.1038/hdy.2011.87; OBRIEN SJ, 1988, TRENDS ECOL EVOL, V3, P254, DOI 10.1016/0169-5347(88)90058-4; Phillips RB, 2003, IMMUNOGENETICS, V55, P561, DOI 10.1007/s00251-003-0615-4; Pitcher TE, 2006, MOL ECOL, V15, P2357, DOI 10.1111/j.1365-294X.2006.02942.x; R Core Team, 2018, R LANG ENV STAT COMP; Roach JC, 2010, SCIENCE, V328, P636, DOI 10.1126/science.1186802; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Sette A, 2003, IMMUNOGENETICS, V54, P830, DOI 10.1007/s00251-002-0530-0; Shiina T, 2005, IMMUNOGENETICS, V56, P878, DOI 10.1007/s00251-004-0755-1; Shum BP, 1999, IMMUNOGENETICS, V49, P479, DOI 10.1007/s002510050524; Shum BP, 2002, IMMUNOGENETICS, V54, P193, DOI 10.1007/s00251-002-0450-z; Shum BP, 2001, J IMMUNOL, V166, P3297, DOI 10.4049/jimmunol.166.5.3297; Sidney J, 2008, BMC IMMUNOL, V9, DOI 10.1186/1471-2172-9-1; SLADE RW, 1992, GENETICS, V132, P861; Spurgin LG, 2010, P ROY SOC B-BIOL SCI, V277, P979, DOI 10.1098/rspb.2009.2084; Stet RJM, 2002, IMMUNOGENETICS, V54, P320, DOI 10.1007/s00251-002-0477-1; Stewart-Jones GBE, 2005, J IMMUNOL, V175, P2459, DOI 10.4049/jimmunol.175.4.2459; Takahata N, 1998, GENETICA, V102-3, P157, DOI 10.1023/A:1017029613342; Trivers R. L., 1972, SEXUAL SELECTION DES, P136, DOI DOI 10.1002/AJPA.1330400226; Tynan FE, 2005, NAT IMMUNOL, V6, P1114, DOI 10.1038/ni1257; van Oosterhout C, 2009, P ROY SOC B-BIOL SCI, V276, P657, DOI 10.1098/rspb.2008.1299; WAKELAND EK, 1990, IMMUNOL RES, V9, P115, DOI 10.1007/BF02918202; WATTERSON GA, 1975, THEOR POPUL BIOL, V7, P256, DOI 10.1016/0040-5809(75)90020-9; Weber DS, 2004, MOL ECOL, V13, P711, DOI 10.1111/j.1365-294X.2004.02095.x; Wilson DJ, 2006, GENETICS, V172, P1411, DOI 10.1534/genetics.105.044917; Xia C, 2002, FISH SHELLFISH IMMUN, V12, P287, DOI 10.1006/fsim.2001.0371; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555; Yeager M, 1999, IMMUNOL REV, V167, P45, DOI 10.1111/j.1600-065X.1999.tb01381.x; Yeager M, 1997, MOL BIOL EVOL, V14, P1035, DOI 10.1093/oxfordjournals.molbev.a025709; Zhu M, 1999, NATURE, V397, P607, DOI 10.1038/17594	68	3	3	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e63035	10.1371/journal.pone.0063035	http://dx.doi.org/10.1371/journal.pone.0063035			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667568	Green Published, Green Submitted, gold			2022-12-27	WOS:000319654700100
J	Tang, XY; Liu, T; Zang, XF; Liu, H; Wang, DH; Chen, H; Zhang, B				Tang, Xiaoyi; Liu, Ting; Zang, Xuefeng; Liu, Hao; Wang, Danhong; Chen, Hu; Zhang, Bin			Adoptive Cellular Immunotherapy in Metastatic Renal Cell Carcinoma: A Systematic Review and Meta-Analysis	PLOS ONE			English	Review							INDUCED KILLER-CELL; CANCER-IMMUNOTHERAPY; THERAPY; INTERLEUKIN-2; TRIAL	Purpose: Metastatic renal cell carcinoma (mRCC), as one of the most immunogenic tumors has been the focus of adoptive cellular immunotherapy (ACI), but the effects of ACI on objective response and survival in patients with mRCC are still controversial. Therefore, a systematic review and meta-analysis was performed to address this issue. Methods: A search was conducted in the PubMed database for randomized clinical trials (RCTs) with ACI in mRCC. All included articles in this study were assessed according to the selection criteria and were divided into two groups: ACI versus no ACI. Outcomes were toxicity, objective response, 1-, 3- and 5-year survival. Risk ratio (RR) and 95% confidence intervals (CI) were calculated using a fixed-effects meta-analysis. Heterogeneity was measured by value of I-2 or P. Results: 4 studies (469 patients) were included. Most of ACI-related adverse reactions were grade 1 or 2 and reversible. ACI provided significant benefit in terms of objective response (RR = 1.65; 95% CI, 1.15 to 2.38; P = 0.007, I-2 = 49%), 1-year survival (RR = 1.30; 95% CI, 1.12 to 1.52; P = 0.0008, I-2 = 0%), 3-year survival (RR = 2.76; 95% CI, 1.85 to 4.14; P<0.00001, I-2 = 46%) and 5-year survival (RR = 2.42; 95% CI, 1.21 to 4.83; P = 0.01, I-2 = 28%). Conclusions: ACI may be a safe and effective treatment for improving objective response, 1-, 3- and 5-year survival in patients with mRCC. Besides, five obstacles for ACI, including high degree of personalization, unsuitable WHO/RECIST response criteria, inadequate identification of tumor-associated antigens (TAAs), lack of effective combination treatments and less attention paid to the quality of ACI products, should be overcome during the successful development of more potent ACI for cancer in the future.	[Tang, Xiaoyi; Liu, Ting; Zang, Xuefeng; Liu, Hao; Wang, Danhong; Chen, Hu; Zhang, Bin] Acad Mil Med Sci, Affiliated Hosp, Dept Hematopoiet Stem Cell Transplantat, Beijing, Peoples R China; [Tang, Xiaoyi; Liu, Ting; Zang, Xuefeng; Liu, Hao; Wang, Danhong; Chen, Hu; Zhang, Bin] Acad Mil Med Sci, Cell & Gene Therapy Ctr, Beijing, Peoples R China; [Zang, Xuefeng] Chinese Peoples Liberat Army, Gen Hosp, Mil Postgrad Med Coll, Beijing, Peoples R China	Academy of Military Medical Sciences - China; Academy of Military Medical Sciences - China; Chinese People's Liberation Army General Hospital	Chen, H (corresponding author), Acad Mil Med Sci, Affiliated Hosp, Dept Hematopoiet Stem Cell Transplantat, Beijing, Peoples R China.	chenhu217@yahoo.com.cn; zb307ctc@163.com			Key New Drug Creation and Manufacturing Program of the "Twelfth Five-year Plan" [2011ZX09102-001-29]	Key New Drug Creation and Manufacturing Program of the "Twelfth Five-year Plan"	This work was supported by the Key New Drug Creation and Manufacturing Program of the "Twelfth Five-year Plan" (No. 2011ZX09102-001-29). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong AC, 2001, BMJ-BRIT MED J, V323, P1289, DOI 10.1136/bmj.323.7324.1289; Coppin C., 2005, COCHRANE DB SYST REV, V25; Figlin RA, 1999, J CLIN ONCOL, V17, P2521, DOI 10.1200/JCO.1999.17.8.2521; Fu GF, 2012, INT IMMUNOL, V24, P197, DOI 10.1093/intimm/dxr124; Hodi FS, 2010, NEW ENGL J MED, V363, P711, DOI 10.1056/NEJMoa1003466; Hoos A, 2010, JNCI-J NATL CANCER I, V102, P1388, DOI 10.1093/jnci/djq310; Itsumi M, 2010, CLIN DEV IMMUNOL, DOI 10.1155/2010/284581; June C, 2012, NAT BIOTECHNOL, V30, P611, DOI 10.1038/nbt.2305; Kantoff PW, 2010, NEW ENGL J MED, V363, P411, DOI 10.1056/NEJMoa1001294; LAW TM, 1995, CANCER-AM CANCER SOC, V76, P824, DOI 10.1002/1097-0142(19950901)76:5<824::AID-CNCR2820760517>3.0.CO;2-N; Liu L, 2012, CLIN CANCER RES, V18, P1751, DOI 10.1158/1078-0432.CCR-11-2442; Marten A, 2001, HAEMATOLOGICA, V86, P1029; Okur FV, 2010, METHODS MOL BIOL, V651, P319, DOI 10.1007/978-1-60761-786-0_19; OSBAND ME, 1990, LANCET, V335, P994, DOI 10.1016/0140-6736(90)91064-H; Palucka K, 2012, NAT REV CANCER, V12, P265, DOI 10.1038/nrc3258; Pedrazzoli P, 2012, BONE MARROW TRANSPL, V47, P1013, DOI 10.1038/bmt.2011.155; Porter DL, 2011, NEW ENGL J MED, V365, P725, DOI 10.1056/NEJMoa1103849; Ranieri E, 2007, CLIN EXP IMMUNOL, V147, P395, DOI 10.1111/j.1365-2249.2006.03305.x; Restifo NP, 2012, NAT REV IMMUNOL, V12, P269, DOI 10.1038/nri3191; Rini BI, 2009, LANCET, V373, P1119, DOI 10.1016/S0140-6736(09)60229-4; Rosenberg SA, 2008, NAT REV CANCER, V8, P299, DOI 10.1038/nrc2355; Shablak A, 2009, CLIN CANCER RES, V15, P6503, DOI 10.1158/1078-0432.CCR-09-1605; Thurnher M, 2006, HDB DENDRITIC CELLS, P1155; Weber J, 2011, CLIN CANCER RES, V17, P1664, DOI 10.1158/1078-0432.CCR-10-2272; Wolchok JD, 2009, CLIN CANCER RES, V15, P7412, DOI 10.1158/1078-0432.CCR-09-1624; Xie F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042879	26	18	21	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e62847	10.1371/journal.pone.0062847	http://dx.doi.org/10.1371/journal.pone.0062847			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667530	Green Published, Green Submitted, gold			2022-12-27	WOS:000319654700069
J	Wu, LB; Jiang, X; Huang, LF; Chen, SL				Wu, Labin; Jiang, Xue; Huang, Linfang; Chen, Shilin			Processing Technology Investigation of Loquat (Eriobotrya japonica) Leaf by Ultra-Performance Liquid Chromatography-Quadrupole Time-of-Flight Mass Spectrometry Combined with Chemometrics	PLOS ONE			English	Article							CONSTITUENTS; TRITERPENOIDS; MACROPHAGES; LINDL.; LEAVES; LINES; ACID	Ultra-performance liquid chromatography-quadrupole time-of-flight mass spectrometry (UPLC-QTOF/MS) and multivariate statistical analysis were used to investigate the processing technology of Loquat (Eriobotrya japonica) leaf (pipaye, PPY). The differences in samples processed using different methods were revealed by unsupervised principal component analysis (PCA). In the scores plot of PCA, honey-processed PPY (PPPY), crude PPY (CPPY), and heated PPY (HPPY) were clearly discriminated. Furthermore, samples processed at different temperatures could also be distinguished; indeed, our PCA results demonstrated the importance of temperature during processing. Two unique marker ions were found to discriminate between PPPY and CPPY by orthogonal partial least squares discriminant analysis (OPLS-DA), which could be used as potential chemical markers. The method was further confirmed by a verification test with commercial PPY. The orthogonal array experiment revealed an optimized processing condition with 50% honey at 140 degrees C for 20 min after 4 h of moistening time, a process that provides significant information for standardized production.	[Huang, Linfang] Chinese Acad Med Sci, Inst Med Plant Dev, Beijing 100730, Peoples R China; Peking Union Med Coll, Beijing 100021, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Medicinal Plant Development - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Huang, LF (corresponding author), Chinese Acad Med Sci, Inst Med Plant Dev, Beijing 100730, Peoples R China.	lfhuang@implad.ac.cn			National Natural Science Foundation of China [81274013]; Key National Natural Science Foundation of China [81130069]; Chinese National S&T Special Project on Major New Drug Innovation [2011ZX09307-002-01]; program for Changjiang Scholars and Innovative Research Team in University of Ministry of Education of China [IRT1150]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese National S&T Special Project on Major New Drug Innovation; program for Changjiang Scholars and Innovative Research Team in University of Ministry of Education of China	The study was supported by grants from the National Natural Science Foundation of China (No. 81274013), Key National Natural Science Foundation of China (81130069), and The Chinese National S&T Special Project on Major New Drug Innovation (2011ZX09307-002-01). The program for Changjiang Scholars and Innovative Research Team in University of Ministry of Education of China (IRT1150). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez ME, 2000, FARMACO, V55, P502, DOI 10.1016/S0014-827X(00)00067-7; Banno N, 2005, BIOL PHARM BULL, V28, P1995, DOI 10.1248/bpb.28.1995; [陈飞平 Chen Feiping], 2012, [食品科学, Food Science], V33, P336; Chen J, 2008, PHYTOMEDICINE, V15, P98, DOI 10.1016/j.phymed.2006.12.014; Chen JM, 1987, BEN CAO MENG QUAN; Chiang LC, 2003, AM J CHINESE MED, V31, P37, DOI 10.1142/S0192415X03000825; Churchwell MI, 2005, J CHROMATOGR B, V825, P134, DOI 10.1016/j.jchromb.2005.05.037; Cunha WR, 2003, PLANTA MED, V69, P470, DOI 10.1055/s-2003-39719; DETOMMASI N, 1991, PLANTA MED, V57, P414, DOI 10.1055/s-2006-960137; Diaz AM, 2000, BIOL PHARM BULL, V23, P1307, DOI 10.1248/bpb.23.1307; Farina C, 1998, FARMACO, V53, P22, DOI 10.1016/S0014-827X(97)00013-X; Guo Y, 2007, STUDIES CHEM REFEREN; Ito H, 2000, CHEM PHARM BULL, V48, P687, DOI 10.1248/cpb.48.687; Jeong HG, 1999, TOXICOL LETT, V105, P215, DOI 10.1016/S0378-4274(99)00004-1; [鞠建华 Ju Jianhua], 2003, [中国药学杂志, Chinese Pharmaceutical Journal], V38, P752; Kim SH, 2009, TOXICOL IN VITRO, V23, P1215, DOI 10.1016/j.tiv.2009.07.036; Li EN, 2009, PHYTOCHEM ANALYSIS, V20, P338, DOI 10.1002/pca.1134; Li SC, 1958, LEI GONG PAO ZHI YAO; Li SL, 2010, J PHARMACEUT BIOMED, V52, P468, DOI 10.1016/j.jpba.2010.01.032; Lin GM, 2010, CHINESE J EXPT TRADI, V16, P21; Lin JY, 2008, FOOD CHEM, V107, P1587, DOI 10.1016/j.foodchem.2007.10.025; Lin SQ, 2007, ACTA HORTIC, P37, DOI 10.17660/ActaHortic.2007.750.2; Qi YanFei, 2011, Zhongcaoyao = Chinese Traditional and Herbal Drugs, V42, P1217; Shao M, 2012, J ASIAN NAT PROD RES, V14, P348, DOI 10.1080/10286020.2011.653964; SHIMIZU M, 1986, CHEM PHARM BULL, V34, P2614; State Pharmacopoeia Committee, 2010, PHARM PEOPL REP CHIN; Su J., 1981, XIN XIU BEN CAO; Taniguchi S, 2002, PHYTOCHEMISTRY, V59, P315, DOI 10.1016/S0031-9422(01)00455-1; Wang A, 1997, BEN CAO BEI YAO; Woldemichael GM, 2003, Z NATURFORSCH C, V58, P70; Woo SS, 2004, PHYTOCHEMISTRY, V65, P2751, DOI 10.1016/j.phytochem.2004.08.039; Wu YL, 1958, BEN CAO CONG XIN; You HJ, 2001, FEBS LETT, V509, P156, DOI 10.1016/S0014-5793(01)03161-1; Zheng WH, 2005, PROG CHEM, V17, P122; Zhou W, 2010, MOLECULES, V15, P6217, DOI 10.3390/molecules15096217	35	8	10	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e64178	10.1371/journal.pone.0064178	http://dx.doi.org/10.1371/journal.pone.0064178			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667702	Green Published, gold, Green Submitted			2022-12-27	WOS:000319654700204
J	Yun, JH; Ko, S; Lee, CK; Cheong, HK; Cheong, C; Yoon, JB; Lee, W				Yun, Ji-Hye; Ko, Sunggeon; Lee, Chung-Kyung; Cheong, Hae-Kap; Cheong, Chaejoon; Yoon, Jong-Bok; Lee, Weontae			Solution Structure and Rpn1 Interaction of the UBL Domain of Human RNA Polymerase II C-Terminal Domain Phosphatase	PLOS ONE			English	Article							UBIQUITIN-PROTEASOME SYSTEM; 26S PROTEASOME; CHEMICAL-SHIFT; SOLUTION NMR; PROTEINS; RELAXATION; SUBUNIT; FAMILY; PROGRAM; PATHWAY	The ubiquitin-like modifier (UBL) domain of ubiquitin-like domain proteins (UDPs) interacts specifically with subunits of the 26 S proteasome. A novel UDP, ubiquitin-like domain-containing C-terminal domain phosphatase (UBLCP1), has been identified as an interacting partner of the 26 S proteasome. We determined the high-resolution solution structure of the UBL domain of human UBLCP1 by nuclear magnetic resonance spectroscopy. The UBL domain of hUBLCP1 has a unique beta-strand (beta 3) and beta 3-alpha 2 loop, instead of the canonical beta 4 observed in other UBL domains. The molecular topology and secondary structures are different from those of known UBL domains including that of fly UBLCP1. Data from backbone dynamics shows that the beta 3-alpha 2 loop is relatively rigid although it might have intrinsic dynamic profile. The positively charged residues of the beta 3-alpha 2 loop are involved in interacting with the C-terminal leucine-rich repeat-like domain of Rpn1.	[Yun, Ji-Hye; Ko, Sunggeon; Yoon, Jong-Bok; Lee, Weontae] Yonsei Univ, Dept Biochem, Coll Life Sci & Biotechnol, Seoul 120749, South Korea; [Lee, Chung-Kyung; Cheong, Hae-Kap; Cheong, Chaejoon] KBSI, Div Magnet Resonance, Cheongwon, Chungbuk, South Korea	Yonsei University; Korea Basic Science Institute (KBSI)	Lee, W (corresponding author), Yonsei Univ, Dept Biochem, Coll Life Sci & Biotechnol, Seoul 120749, South Korea.	wlee@spin.yonsei.ac.kr	LEE, WEON TAE/AAQ-9088-2021; Cheong, Chaejoon/GWC-3135-2022	Lee, Weontae/0000-0003-2347-1262; Yoon, Jong-Bok/0000-0002-3563-0702	Korea Research Foundation Grant [KRF-2008-313-C00524]; WCU (World Class University) program [R33-2009-000-10123-0]; High Field NMR Research Program of Korea Basic Science Institute	Korea Research Foundation Grant(National Research Foundation of Korea); WCU (World Class University) program; High Field NMR Research Program of Korea Basic Science Institute	This work was supported by Korea Research Foundation Grant (KRF-2008-313-C00524 to W. L.), WCU (World Class University) program (R33-2009-000-10123-0) and High Field NMR Research Program of Korea Basic Science Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cho H, 1999, GENE DEV, V13, P1540, DOI 10.1101/gad.13.12.1540; Ciechanover A, 1998, EMBO J, V17, P7151, DOI 10.1093/emboj/17.24.7151; Cole R, 2003, J BIOMOL NMR, V26, P203, DOI 10.1023/A:1023808801134; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Elsasser S, 2002, NAT CELL BIOL, V4, P725, DOI 10.1038/ncb845; FARROW NA, 1994, BIOCHEMISTRY-US, V33, P5984, DOI 10.1021/bi00185a040; Gomes AV, 2006, CIRC RES, V99, P362, DOI 10.1161/01.RES.0000237386.98506.f7; GRZESIEK S, 1992, BIOCHEMISTRY-US, V31, P8180, DOI 10.1021/bi00150a009; GRZESIEK S, 1993, J AM CHEM SOC, V115, P12593, DOI 10.1021/ja00079a052; Guntert Peter, 2004, Methods Mol Biol, V278, P353; Guo X, 2011, P NATL ACAD SCI USA, V108, P18649, DOI 10.1073/pnas.1113170108; Hartmann-Petersen R, 2004, SEMIN CELL DEV BIOL, V15, P247, DOI 10.1016/j.semcdb.2003.12.006; Hartmann-Petersen R, 2004, CELL MOL LIFE SCI, V61, P1589, DOI 10.1007/s00018-004-4132-x; Jentsch S, 2000, TRENDS CELL BIOL, V10, P335, DOI 10.1016/S0962-8924(00)01785-2; Ko S, 2009, B KOREAN CHEM SOC, V30, P1039; Ko S, 2009, BIOCHEMISTRY-US, V48, P827, DOI 10.1021/bi801270g; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Lehman NL, 2009, ACTA NEUROPATHOL, V118, P329, DOI 10.1007/s00401-009-0560-x; Mueller TD, 2003, EMBO J, V22, P4634, DOI 10.1093/emboj/cdg467; Ottiger M, 1998, J MAGN RESON, V131, P373, DOI 10.1006/jmre.1998.1361; Pervushin K, 1997, P NATL ACAD SCI USA, V94, P12366, DOI 10.1073/pnas.94.23.12366; Sakata E, 2003, EMBO REP, V4, P301, DOI 10.1038/sj.embor.embor764; Sass HJ, 2000, J BIOMOL NMR, V18, P303, DOI 10.1023/A:1026703605147; Schauber C, 1998, NATURE, V391, P715, DOI 10.1038/35661; Valafar H, 2004, J MAGN RESON, V167, P228, DOI 10.1016/j.jmr.2003.12.012; Walters KJ, 2002, BIOCHEMISTRY-US, V41, P1767, DOI 10.1021/bi011892y; Wilkinson CRM, 2001, NAT CELL BIOL, V3, P939, DOI 10.1038/ncb1001-939; Zheng HR, 2005, BIOCHEM BIOPH RES CO, V331, P1401, DOI 10.1016/j.bbrc.2005.04.065; Zong C, 2006, CIRC RES, V99, P372, DOI 10.1161/01.RES.0000237389.40000.02	31	6	6	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e62981	10.1371/journal.pone.0062981	http://dx.doi.org/10.1371/journal.pone.0062981			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667555	Green Published, Green Submitted, gold			2022-12-27	WOS:000319654700093
J	Yang, Y; Yan, XL; Duan, WX; Yan, JJ; Yi, W; Liang, ZX; Wang, N; Li, Y; Chen, WS; Yu, SQ; Jin, ZX; Yi, DH				Yang, Yang; Yan, Xiaolong; Duan, Weixun; Yan, Juanjuan; Yi, Wei; Liang, Zhenxin; Wang, Ning; Li, Yue; Chen, Wensheng; Yu, Shiqiang; Jin, Zhenxiao; Yi, Dinghua			Pterostilbene Exerts Antitumor Activity via the Notch1 Signaling Pathway in Human Lung Adenocarcinoma Cells	PLOS ONE			English	Article							CANCER CELLS; INHIBITION; APOPTOSIS; ACTIVATION; RESVERATROL; INDUCTION; TARGET; GROWTH; TUMORS; MICE	Although pterostilbene (PTE) has been shown to have potent antitumor activities against various cancer types, the molecular mechanisms of these activities remain unclear. In this study, we investigated the antitumor activity of PTE against human lung adenocarcinoma in vitro and in vivo and explored the role of the Notch1 signaling pathway in this process. PTE treatment resulted in a dose-and time-dependent decrease in the viability of A549 cells. Additionally, PTE exhibited strong antitumor activity, as evidenced not only by a reduced mitochondrial membrane potential (MMP) and a decreased intracellular glutathione content but also by increases in the apoptotic index and the level of reactive oxygen species (ROS). Furthermore, PTE treatment induced the activation of the Notch1 Intracellular Domain (NICD) protein and activated Hes1. DAPT (a gamma secretase inhibitor) and Notch1 siRNA prevented the induction of NICD and Hes1 activation by PTE treatment and sensitized the cells to PTE treatment. The down-regulation of Notch signaling also prevented the activation of pro-survival pathways (most notably the PI3K/Akt pathway) after PTE treatment. In summary, lung adenocarcinoma cells may enhance Notch1 activation as a protective mechanism in response to PTE treatment. Combining a gamma secretase inhibitor with PTE treatment may represent a novel approach for treating lung adenocarcinoma by inhibiting the survival pathways of cancer cells.	[Yang, Yang; Duan, Weixun; Yi, Wei; Liang, Zhenxin; Wang, Ning; Li, Yue; Chen, Wensheng; Yu, Shiqiang; Jin, Zhenxiao; Yi, Dinghua] Fourth Mil Med Univ, Xijing Hosp, Dept Cardiovasc Surg, Xian 710032, Peoples R China; [Yan, Xiaolong] Fourth Mil Med Univ, Tangdu Hosp, Dept Thorac Surg, Xian 710032, Peoples R China; [Yan, Juanjuan] Fourth Mil Med Univ, Sch Stomatol, Dept Prosthodont, Xian 710032, Peoples R China	Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University	Jin, ZX (corresponding author), Fourth Mil Med Univ, Xijing Hosp, Dept Cardiovasc Surg, Xian 710032, Peoples R China.	zhenxiaojin210@126.com; dinghuayi210@126.com	Jin, Zhenxiao/AAJ-5777-2020; Li, Yue/AAU-1580-2021	Yu, Shiqiang/0000-0003-3519-0943; Yi, Wei/0000-0002-4349-910X; Yan, Xiaolong/0000-0003-2419-9707	12th National Five Years Supporting Project of China [2011BAI11B20]; National Natural Science Foundation of China [81102687, 81070198]; Academic Promotion Project of Xijing Hospital [XJZT09 M16, XJZT10 M12]; Social Development Project of Shaanxi Province [2012JQ4001]	12th National Five Years Supporting Project of China(Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Academic Promotion Project of Xijing Hospital; Social Development Project of Shaanxi Province	This study was supported by grants from the 12th National Five Years Supporting Project of China (2011BAI11B20), the National Natural Science Foundation of China (81102687 and 81070198), the Academic Promotion Project of Xijing Hospital (XJZT09 M16 and XJZT10 M12), and Social Development Project of Shaanxi Province (2012JQ4001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyoshi T, 2008, GASTROENTEROLOGY, V134, P131, DOI 10.1053/j.gastro.2007.10.008; Allen TD, 2011, CANCER RES, V71, P6010, DOI 10.1158/0008-5472.CAN-11-0595; Androutsellis-Theotokis A, 2006, NATURE, V442, P823, DOI 10.1038/nature04940; Chakraborty A, 2012, MOL CELL ENDOCRINOL, V355, P25, DOI 10.1016/j.mce.2012.01.009; Chan SM, 2007, BLOOD, V110, P278, DOI 10.1182/blood-2006-08-039883; Chen YB, 2007, CANCER RES, V67, P7954, DOI 10.1158/0008-5472.CAN-07-1229; Chen YQ, 2011, CANCER BIOL THER, V11, P14, DOI 10.4161/cbt.11.1.13730; Cichocki M, 2008, MOL NUTR FOOD RES, V52, pS62, DOI 10.1002/mnfr.200700466; Franko-Tobin LG, 2012, ONCOLOGIST, V17, P220, DOI 10.1634/theoncologist.2011-0269; Guo DM, 2011, LEUKEMIA LYMPHOMA, V52, P1200, DOI 10.3109/10428194.2011.564696; Huang PH, 2011, J MOL CELL CARDIOL, V51, P109, DOI 10.1016/j.yjmcc.2011.03.008; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Ji XM, 2011, J CELL BIOCHEM, V112, P2773, DOI 10.1002/jcb.23184; Li YY, 2011, J NUTR BIOCHEM, V22, P799, DOI 10.1016/j.jnutbio.2010.11.001; Lin H, 2011, ONCOL REP, V26, P925, DOI 10.3892/or.2011.1380; Lin VCH, 2012, J AGR FOOD CHEM, V60, P6399, DOI 10.1021/jf301499e; Liu ZJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037841; McAuliffe SM, 2012, P NATL ACAD SCI USA, V109, pE2939, DOI 10.1073/pnas.1206400109; McCormack D, 2012, J SURG RES, V173, pE53, DOI 10.1016/j.jss.2011.09.054; Mena S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044524; Meng RD, 2009, CANCER RES, V69, P573, DOI 10.1158/0008-5472.CAN-08-2088; Moon D, 2013, J SURG RES, V180, P208, DOI 10.1016/j.jss.2012.04.027; Mungamuri SK, 2006, CANCER RES, V66, P4715, DOI 10.1158/0008-5472.CAN-05-3830; Muto J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033431; Naganuma S, 2012, AM J CANCER RES, V2, P459; Nair P, 2003, J VIROL, V77, P7106, DOI 10.1128/JVI.77.12.7106-7112.2003; Pan MH, 2009, CARCINOGENESIS, V30, P1234, DOI 10.1093/carcin/bgp121; Ren XL, 2009, CANCER LETT, V281, P134, DOI 10.1016/j.canlet.2009.02.036; Ruiz MJ, 2009, J AGR FOOD CHEM, V57, P3180, DOI 10.1021/jf803579e; Sade H, 2004, J BIOL CHEM, V279, P2937, DOI 10.1074/jbc.M309924200; Shen XJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041773; Somasundaram K, 2005, ONCOGENE, V24, P7073, DOI 10.1038/sj.onc.1208865; Stylianou S, 2006, CANCER RES, V66, P1517, DOI 10.1158/0008-5472.CAN-05-3054; Truong M, 2011, ANN SURG ONCOL, V18, P1506, DOI 10.1245/s10434-010-1488-z; Wang H, 2013, MODERN PATHOL, V26, P139, DOI 10.1038/modpathol.2012.143; Westhoff B, 2009, P NATL ACAD SCI USA, V106, P22293, DOI 10.1073/pnas.0907781106; Zhang W, 2011, J MED CHEM, V54, P1288, DOI 10.1021/jm101248v; Zhao YF, 2012, EUR J PHARMACOL, V688, P6, DOI 10.1016/j.ejphar.2012.05.003	38	7	7	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2013	8	5							e62652	10.1371/journal.pone.0062652	http://dx.doi.org/10.1371/journal.pone.0062652			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175AS	23671619	Green Published, Green Submitted, gold			2022-12-27	WOS:000321202100028
J	Benowitz-Fredericks, ZM; Kitaysky, AS; Welcker, J; Hatch, SA				Benowitz-Fredericks, Z. M.; Kitaysky, Alexander S.; Welcker, Jorg; Hatch, Scott A.			Effects of Food Availability on Yolk Androgen Deposition in the Black-Legged Kittiwake (Rissa tridactyla), a Seabird with Facultative Brood Reduction	PLOS ONE			English	Article							TESTOSTERONE LEVELS; MATERNAL CONDITION; STRESS HORMONES; EGGS; IMMUNITY; GROWTH; CONSEQUENCES; AGGRESSION; ASYMMETRY; MECHANISM	In birds with facultative brood reduction, survival of the junior chick is thought to be regulated primarily by food availability. In black-legged kittiwakes (Rissa tridactyla) where parents and chicks are provided with unlimited access to supplemental food during the breeding season, brood reduction still occurs and varies interannually. Survival of the junior chick is therefore affected by factors in addition to the amount of food directly available to them. Maternally deposited yolk androgens affect competitive dynamics within a brood, and may be one of the mechanisms by which mothers mediate brood reduction in response to a suite of environmental and physiological cues. The goal of this study was to determine whether food supplementation during the pre-lay period affected patterns of yolk androgen deposition in free-living kittiwakes in two years (2003 and 2004) that varied in natural food availability. Chick survival was measured concurrently in other nests where eggs were not collected. In both years, supplemental feeding increased female investment in eggs by increasing egg mass. First-laid ("A") eggs were heavier but contained less testosterone and androstenedione than second-laid ("B") eggs across years and treatments. Yolk testosterone was higher in 2003 (the year with higher B chick survival) across treatments. The difference in yolk testosterone levels between eggs within a clutch varied among years and treatments such that it was relatively small when B chick experienced the lowest and the highest survival probabilities, and increased with intermediate B chick survival probabilities. The magnitude of testosterone asymmetry in a clutch may allow females to optimize fitness by either predisposing a brood for reduction or facilitating survival of younger chicks.	[Benowitz-Fredericks, Z. M.] Bucknell Univ, Dept Biol, Lewisburg, PA 17837 USA; [Kitaysky, Alexander S.; Welcker, Jorg] Univ Alaska Fairbanks, Dept Biol & Wildlife, Inst Arctic Biol, Fairbanks, AK USA; [Welcker, Jorg] Norwegian Polar Res Inst, Tromso, Norway; [Hatch, Scott A.] US Geol Survey, Alaska Sci Ctr, Anchorage, AK USA	Bucknell University; University of Alaska System; University of Alaska Fairbanks; Norwegian Polar Institute; United States Department of the Interior; United States Geological Survey	Benowitz-Fredericks, ZM (corresponding author), Bucknell Univ, Dept Biol, Lewisburg, PA 17837 USA.	zmbf001@bucknell.edu	Benowitz-Fredericks, Morgan/AAV-3931-2021	Benowitz-Fredericks, Morgan/0000-0002-9265-3169	United States Geological Survey; National Science Foundation (NSF); Alaska EPSCoR (NSF) [EPS-0346770]	United States Geological Survey(United States Geological Survey); National Science Foundation (NSF)(National Science Foundation (NSF)); Alaska EPSCoR (NSF)	This research was supported by the United States Geological Survey (to SAH), a National Science Foundation (NSF) pre doctoral fellowship (to ZMBF), and Alaska EPSCoR (to ASK and ZMBF; NSF #EPS-0346770). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addison B, 2008, GEN COMP ENDOCR, V158, P5, DOI 10.1016/j.ygcen.2008.05.020; Anderson DR, 2000, J WILDLIFE MANAGE, V64, P912, DOI 10.2307/3803199; Andersson S, 2004, J EVOLUTION BIOL, V17, P501, DOI 10.1111/j.1420-9101.2004.00706.x; [Anonymous], 2009, R LANG ENV STAT COMP; BRAUN BM, 1983, AUK, V100, P469, DOI 10.1093/auk/100.2.469; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Cam E, 1998, ECOLOGY, V79, P2917, DOI 10.1890/0012-9658(1998)079[2917:AANPPT]2.0.CO;2; Cam E, 2003, J ANIM ECOL, V72, P411, DOI 10.1046/j.1365-2656.2003.00708.x; Cook MI, 2000, BEHAV ECOL, V11, P282, DOI 10.1093/beheco/11.3.282; Dentressangle F, 2008, BEHAV ECOL SOCIOBIOL, V62, P1899, DOI 10.1007/s00265-008-0620-6; Drummond H, 2003, BEHAV ECOL SOCIOBIOL, V53, P287, DOI 10.1007/s00265-002-0571-2; Eising CM, 2001, P ROY SOC B-BIOL SCI, V268, P839, DOI 10.1098/rspb.2001.1594; Eising CM, 2003, J EXP BIOL, V206, P3211, DOI 10.1242/jeb.00552; Eising CM, 2003, ANIM BEHAV, V66, P1027, DOI 10.1006/anbe.2003.2287; Elf PK, 2002, J EXP ZOOL, V293, P594, DOI 10.1002/jez.10169; Erikstad KE, 1998, ECOLOGY, V79, P1781; FORBES LS, 1991, OIKOS, V62, P325, DOI 10.2307/3545497; FORBES LS, 1990, J THEOR BIOL, V147, P345, DOI 10.1016/S0022-5193(05)80492-8; French JB, 2001, COMP BIOCHEM PHYS C, V128, P91, DOI 10.1016/S1532-0456(00)00181-2; Gasparini J, 2007, J EVOLUTION BIOL, V20, P874, DOI 10.1111/j.1420-9101.2007.01315.x; Gill V, 2002, IBIS; Gill VA, 2002, J AVIAN BIOL, V33, P113, DOI 10.1034/j.1600-048X.2002.330201.x; Groothuis TGG, 2005, NEUROSCI BIOBEHAV R, V29, P329, DOI 10.1016/j.neubiorev.2004.12.002; Guillemain M, 2008, IBIS, V150, P172; Hatch SA, 2013, MAR ECOL PROG SER, V477, P271, DOI 10.3354/meps10161; Hinde CA, 2010, SCIENCE, V327, P1373, DOI 10.1126/science.1186056; Kitaysky AS, 2007, MAR ECOL PROG SER, V352, P245, DOI 10.3354/meps07074; Kitaysky AS, 2006, P ROY SOC B-BIOL SCI, V273, P445, DOI 10.1098/rspb.2005.3351; Lack D., 1954, P343; Lipar JL, 2001, J AVIAN BIOL, V32, P231, DOI 10.1111/j.0908-8857.2001.320305.x; Love OP, 2009, GEN COMP ENDOCR, V163, P169, DOI 10.1016/j.ygcen.2008.10.001; Love OP, 2005, AM NAT, V166, P751, DOI 10.1086/497440; Machmer MM, 1998, CAN J ZOOL, V76, P181, DOI 10.1139/cjz-76-1-181; Marshall DJ, 2007, OIKOS, V116, P1957, DOI 10.1111/j.2007.0030-1299.16203.x; MOCK DW, 1986, EVOLUTION, V40, P459, DOI 10.1111/j.1558-5646.1986.tb00499.x; MOCK DW, 1995, TRENDS ECOL EVOL, V10, P130, DOI 10.1016/S0169-5347(00)89014-X; Muller MS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047763; Muller W, 2007, AM NAT, V169, pE84, DOI 10.1086/511962; Muller W, 2010, BEHAV ECOL, V21, P493, DOI 10.1093/beheco/arq010; Navara KJ, 2005, PHYSIOL BIOCHEM ZOOL, V78, P570, DOI 10.1086/430689; Okuliarova M, 2007, ACTA VET BRNO, V76, P325, DOI 10.2754/avb200776030325; Okuliarova M, 2011, AM NAT, V177, P824, DOI 10.1086/659996; Paitz RT, 2011, P ROY SOC B-BIOL SCI, V278, P99, DOI 10.1098/rspb.2010.0813; Phillips RA, 1996, IBIS, V138, P410, DOI 10.1111/j.1474-919X.1996.tb08059.x; Pilz KM, 2004, HORM BEHAV, V46, P179, DOI 10.1016/j.yhbeh.2004.03.004; Pilz KM, 2004, FUNCT ECOL, V18, P58, DOI 10.1111/j.1365-2435.2004.00811.x; Pilz KM, 2003, ANIM BEHAV, V65, P841, DOI 10.1006/anbe.2003.2094; Poisbleau M, 2011, BIOL LETTERS, V7, P605, DOI 10.1098/rsbl.2010.1134; Reed WL, 2001, OECOLOGIA, V128, P164, DOI 10.1007/s004420100642; Royle NJ, 2001, BEHAV ECOL, V12, P381, DOI 10.1093/beheco/12.4.381; Rubolini D, 2006, BEHAV ECOL SOCIOBIOL, V59, P344, DOI 10.1007/s00265-005-0057-0; Rutstein AN, 2005, BEHAV ECOL, V16, P62, DOI 10.1093/beheco/arh123; Schwabl H, 1997, NATURE, V386, P231, DOI 10.1038/386231a0; SCHWABL H, 1993, P NATL ACAD SCI USA, V90, P11446, DOI 10.1073/pnas.90.24.11446; Shultz MT, 2009, MAR ECOL PROG SER, V393, P247, DOI 10.3354/meps08136; Sockman KW, 2000, P ROY SOC B-BIOL SCI, V267, P1451, DOI 10.1098/rspb.2000.1163; Tschirren B, 2009, AM NAT, V174, P557, DOI 10.1086/605379; Verboven N, 2003, P ROY SOC B-BIOL SCI, V270, P2223, DOI 10.1098/rspb.2003.2496; White J, 2010, ANIM BEHAV, V79, P1095, DOI 10.1016/j.anbehav.2010.02.003; Williams TD, 2004, GEN COMP ENDOCR, V136, P346, DOI 10.1016/j.ygcen.2004.01.010	60	19	19	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2013	8	5							e62949	10.1371/journal.pone.0062949	http://dx.doi.org/10.1371/journal.pone.0062949			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145RZ	23675443	Green Published, Green Submitted, gold			2022-12-27	WOS:000319036100024
J	Meng, NN; Zhang, P; Huang, HD; Ma, JL; Zhang, Y; Li, H; Qu, Y				Meng, Nana; Zhang, Ping; Huang, Huadong; Ma, Jinlan; Zhang, Yue; Li, Hao; Qu, Yi			Color Doppler Imaging Analysis of Retrobulbar Blood Flow Velocities in Primary Open-Angle Glaucomatous Eyes: A Meta-Analysis	PLOS ONE			English	Article							OCULAR PERFUSION-PRESSURE; EXTRAOCULAR VESSELS; DUPLEX-DOPPLER; HEMODYNAMICS; TENSION; CIRCULATION; HEALTHY; ASSOCIATION; PARAMETERS; ARTERY	Background: To analyze the diagnostic value of color Doppler imaging (CDI) of blood flow in the retrobulbar vessels of eyes with primary open-angle glaucoma (POAG). Methods: Pertinent publications were retrieved from the Cochrane Central Register of Controlled Trials, PubMed and the ISI Web of Knowledge up to October 2012. Changes in peak systolic velocity (PSV), end diastolic velocity (EDV) and resistive index (RI) of the ophthalmic artery (OA), central retinal artery (CRA) and short posterior ciliary artery (SPCA) of POAG eyes and normal controls were evaluated by CDI. Subgroup analyses were conducted according to whether patients received IOP-lowering drugs treatment and were defined as treated and untreated. Results: PSV and EDV were statistically significantly reduced in the OA of POAG eyes (P=0.0002; P<0.00001; respectively), with significant heterogeneity (P-heterogeneity<0.00001, I-2 = 94%; P-heterogeneity<0.00001, I-2 = 85%; respectively). Similar results were demonstrated for the CRA (P<0.00001; respectively) and SPCA (P = 0.005; P<0.00001; respectively), with significant heterogeneities for both the CRA (P-heterogeneity<0.00001, I-2 = 81%; P-heterogeneity<0.00001, I-2 = 98%; respectively) and the SPCA (P-heterogeneity<0.00001, I-2 = 96%; P-heterogeneity<0.00001, I-2 = 93%; respectively). Significant increases in RI were found in all retrobulbar vessels (P<0.00001; respectively), with significant heterogeneities (P-heterogeneity<0.00001, I-2 = 95%; P-heterogeneity<0.00001, I-2 = 94%; P-heterogeneity<0.00001, I-2 = 97%; respectively). Conclusions: This meta-analysis suggests that CDI is a potential diagnostic tool for POAG.	[Meng, Nana; Zhang, Ping; Ma, Jinlan; Zhang, Yue; Li, Hao; Qu, Yi] Shandong Univ, Qilu Hosp, Dept Hlth Care, Jinan 250100, Peoples R China; [Huang, Huadong] Qihe Country Hosp, Dept Ophthalmol, Qihe, Peoples R China	Shandong University	Qu, Y (corresponding author), Shandong Univ, Qilu Hosp, Dept Hlth Care, Jinan 250100, Peoples R China.	drquyi@gmail.com			Shandong Science and Technology Developing Project [2012GSF12121]; Shandong Provincial Natural Science Foundation [Y2008C78]; Independent innovation foundation of Shandong University [IIFSDU 2012ZD025]	Shandong Science and Technology Developing Project; Shandong Provincial Natural Science Foundation(Natural Science Foundation of Shandong Province); Independent innovation foundation of Shandong University	This study was supported partly by Shandong Science and Technology Developing Project (2012GSF12121), Shandong Provincial Natural Science Foundation (Y2008C78) and Independent innovation foundation of Shandong University (IIFSDU 2012ZD025). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abegao Pinto L, 2012, ACTA OPHTHALMOL; Akarsu C, 2004, GRAEF ARCH CLIN EXP, V242, P125, DOI 10.1007/s00417-003-0809-3; BAXTER GM, 1992, INVEST OPHTH VIS SCI, V33, P604; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Birinci H, 2002, OPHTHALMOLOGICA, V216, P434, DOI 10.1159/000067553; Brusini P, 2008, EYE, V22, P406, DOI 10.1038/sj.eye.6702654; Butt Z, 1997, INVEST OPHTH VIS SCI, V38, P690; BUTT Z, 1995, EYE, V9, P29, DOI 10.1038/eye.1995.4; Cellini M, 1996, OPHTHALMOLOGICA, V210, P200, DOI 10.1159/000310708; Chung HS, 1999, BRIT J OPHTHALMOL, V83, P466, DOI 10.1136/bjo.83.4.466; Costa VP, 2003, PROG RETIN EYE RES, V22, P769, DOI 10.1016/S1350-9462(03)00064-8; Detorakis ET, 2007, GRAEF ARCH CLIN EXP, V245, P516, DOI 10.1007/s00417-006-0439-7; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; ERICKSON SJ, 1989, RADIOLOGY, V173, P511, DOI 10.1148/radiology.173.2.2678264; Flammer J, 2002, PROG RETIN EYE RES, V21, P359, DOI 10.1016/S1350-9462(02)00008-3; Galambos P, 2006, OPHTHALMOLOGY, V113, P1832, DOI 10.1016/j.ophtha.2006.05.030; Galassi F, 2008, GRAEF ARCH CLIN EXP, V246, P411, DOI 10.1007/s00417-007-0709-z; Garhofer G, 2010, INVEST OPHTH VIS SCI, V51, P6652, DOI 10.1167/iovs.10-5490; Gherghel D, 2000, AM J OPHTHALMOL, V130, P597, DOI 10.1016/S0002-9394(00)00766-2; Gugleta K, 1999, CURR EYE RES, V19, P496, DOI 10.1076/ceyr.19.6.496.5286; HANSEN NB, 1983, PEDIATRICS, V72, P526; HARRIS A, 1994, AM J OPHTHALMOL, V118, P642, DOI 10.1016/S0002-9394(14)76579-1; HAYREH SS, 1970, BRIT J OPHTHALMOL, V54, P461, DOI 10.1136/bjo.54.7.461; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hosking SL, 2004, BRIT J OPHTHALMOL, V88, P406, DOI 10.1136/bjo.2002.008995; Januleviciene I, 2008, ACTA OPHTHALMOL, V86, P552, DOI 10.1111/j.1600-0420.2007.01091.x; Kaiser HJ, 1996, AM J OPHTHALMOL, V122, P364, DOI 10.1016/S0002-9394(14)72063-X; Kaiser HJ, 1997, AM J OPHTHALMOL, V123, P320, DOI 10.1016/S0002-9394(14)70127-8; Langham M E, 1994, Surv Ophthalmol, V38 Suppl, pS161, DOI 10.1016/0039-6257(94)90061-2; Leske MC, 2007, OPHTHALMOLOGY, V114, P1965, DOI 10.1016/j.ophtha.2007.03.016; LIEB WE, 1991, ARCH OPHTHALMOL-CHIC, V109, P527, DOI 10.1001/archopht.1991.01080040095036; Liu CJ, 1999, ACTA OPHTHALMOL SCAN, V77, P658, DOI 10.1034/j.1600-0420.1999.770610.x; Liu X, 1998, Yan Ke Xue Bao, V14, P138; Michelson G, 1996, J GLAUCOMA, V5, P91; Pemp B, 2012, ACTA OPHTHALMOL, V90, P139, DOI 10.1111/j.1755-3768.2010.01878.x; Pinto LA, 2012, ACTA OPHTHALMOL, V90, pe214, DOI 10.1111/j.1755-3768.2011.02335.x; PLANIOL T, 1972, REV NEUROL-FRANCE, V126, P127; PLATT JF, 1990, AM J ROENTGENOL, V154, P1223, DOI 10.2214/ajr.154.6.2110732; Quigley HA, 2006, BRIT J OPHTHALMOL, V90, P262, DOI 10.1136/bjo.2005.081224; RANKIN SJA, 1995, AM J OPHTHALMOL, V119, P685, DOI 10.1016/S0002-9394(14)72771-0; Resch H, 2009, ACTA OPHTHALMOL, V87, P4, DOI 10.1111/j.1755-3768.2007.01167.x; RIFKIN MD, 1987, AM J ROENTGENOL, V148, P759, DOI 10.2214/ajr.148.4.759; Sekeroglu MA, 2011, ACTA OPHTHALMOL, V89, P429, DOI 10.1111/j.1755-3768.2009.01713.x; Sihota R, 2006, INVEST OPHTH VIS SCI, V47, P2006, DOI 10.1167/iovs.05-1102; Simsek T, 2006, J OCUL PHARMACOL TH, V22, P79, DOI 10.1089/jop.2006.22.79; Stalmans I, 2009, EUR J OPHTHALMOL, V19, P580, DOI 10.1177/112067210901900410; STEIGERWALT RD, 1993, EYE, V7, P403, DOI 10.1038/eye.1993.79; TAYLOR GA, 1990, RADIOLOGY, V176, P231, DOI 10.1148/radiology.176.1.2112768; TREW DR, 1991, BRIT J OPHTHALMOL, V75, P71, DOI 10.1136/bjo.75.2.71; VANBUSKIRK EM, 1992, AM J OPHTHALMOL, V113, P447, DOI 10.1016/S0002-9394(14)76171-9; WOLF S, 1993, OPHTHALMOLOGY, V100, P1561; Yuksel N, 2001, OPHTHALMOLOGICA, V215, P424, DOI 10.1159/000050902; Zhong YS, 2009, DOC OPHTHALMOL, V119, P171, DOI 10.1007/s10633-009-9192-7	53	90	92	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2013	8	5							e62723	10.1371/journal.pone.0062723	http://dx.doi.org/10.1371/journal.pone.0062723			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145RZ	23675419	Green Published, gold, Green Submitted			2022-12-27	WOS:000319036100008
J	Yang, X; Kendrick, KM; Wu, QZ; Chen, TL; Lama, S; Cheng, BC; Li, SG; Huang, XQ; Gong, QY				Yang, Xun; Kendrick, Keith Maurice; Wu, Qizhu; Chen, Taolin; Lama, Sunima; Cheng, Bochao; Li, Shiguang; Huang, Xiaoqi; Gong, Qiyong			Structural and Functional Connectivity Changes in the Brain Associated with Shyness but Not with Social Anxiety	PLOS ONE			English	Article							POSTTRAUMATIC-STRESS-DISORDER; VOXEL-BASED MORPHOMETRY; PERSONALLY FAMILIAR FACES; SUPERIOR TEMPORAL SULCUS; RESTING STATE NETWORKS; PREFRONTAL CORTEX; GENETIC INFLUENCES; CHINESE VERSION; RHESUS-MONKEY; FEARFUL FACES	Shyness and social anxiety are correlated to some extent and both are associated with hyper-responsivity to social stimuli in the frontal cortex and limbic system. However to date no studies have investigated whether common structural and functional connectivity differences in the brain may contribute to these traits. We addressed this issue in a cohort of 61 healthy adult subjects. Subjects were first assessed for their levels of shyness (Cheek and Buss Shyness scale) and social anxiety (Liebowitz Social Anxiety scale) and trait anxiety. They were then given MRI scans and voxel-based morphometry and seed-based, resting-state functional connectivity analysis investigated correlations with shyness and anxiety scores. Shyness scores were positively correlated with gray matter density in the cerebellum, bilateral superior temporal gyri and parahippocampal gyri and right insula. Functional connectivity correlations with shyness were found between the superior temporal gyrus, parahippocampal gyrus and the frontal gyri, between the insula and precentral gyrus and inferior parietal lobule, and between the cerebellum and precuneus. Additional correlations were found for amygdala connectivity with the medial frontal gyrus, superior frontal gyrus and inferior parietal lobule, despite the absence of any structural correlation. By contrast no structural or functional connectivity measures correlated with social or trait anxiety. Our findings show that shyness is specifically associated with structural and functional connectivity changes in cortical and limbic regions involved with processing social stimuli. These associations are not found with social or trait anxiety in healthy subjects despite some behavioral correlations with shyness.	[Yang, Xun; Kendrick, Keith Maurice; Wu, Qizhu; Chen, Taolin; Lama, Sunima; Cheng, Bochao; Li, Shiguang; Huang, Xiaoqi; Gong, Qiyong] Sichuan Univ, West China Hosp, Dept Radiol, Huaxi MR Res Ctr, Chengdu 610064, Peoples R China; [Yang, Xun] Sichuan Univ, West China Hosp, State Key Lab Biotherapy, Dept Psychiat, Chengdu 610064, Peoples R China; [Kendrick, Keith Maurice] Univ Elect Sci & Technol China, Key Lab Neuroinformat, Sch Life Sci & Technol, Chengdu 610054, Peoples R China	Sichuan University; Sichuan University; University of Electronic Science & Technology of China	Gong, QY (corresponding author), Sichuan Univ, West China Hosp, Dept Radiol, Huaxi MR Res Ctr, Chengdu 610064, Peoples R China.	qiyonggong@hmrrc.org.cn	Gong, Qiyong/W-3052-2019; Huang, Xiaoqi/O-7904-2017; Chen, Taolin/AAG-1561-2019	Gong, Qiyong/0000-0002-5912-4871; Huang, Xiaoqi/0000-0001-8686-5010; Chen, Taolin/0000-0003-0877-4943; Cheng, Bochao/0000-0002-9923-5509; Kendrick, Keith/0000-0002-0371-5904	National Natural Science Foundation [81030027, 81227002, 81220108013, 30900362, 81171488, 91132720]; National Key Technologies R&D Program of China [2012BAI01B03]; CMB Distinguished Professorship Award [F510000/G16916411]	National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); National Key Technologies R&D Program of China(National Key Technology R&D Program); CMB Distinguished Professorship Award	This study was supported by the National Natural Science Foundation (Grant Nos. 81030027, 81227002, 81220108013, 30900362, 81171488 and 91132720) and National Key Technologies R&D Program of China (Program No. 2012BAI01B03). Dr. Qiyong Gong acknowledges the support from his CMB Distinguished Professorship Award (Award No. F510000/G16916411) administered by the Institute of International Education, USA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adelstein JS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027633; Arnsten AFT, 2009, NAT REV NEUROSCI, V10, P410, DOI 10.1038/nrn2648; Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007; Baldacara L, 2008, REV BRAS PSIQUIATR, V30, P281, DOI 10.1590/S1516-44462008000300016; Barnes LLB, 2002, EDUC PSYCHOL MEAS, V62, P603, DOI 10.1177/0013164402062004005; Battaglia M, 2005, ARCH GEN PSYCHIAT, V62, P85, DOI 10.1001/archpsyc.62.1.85; Beaton EA, 2008, BEHAV NEUROSCI, V122, P704, DOI 10.1037/0735-7044.122.3.704; Beaton EA, 2010, PERS INDIV DIFFER, V49, P755, DOI 10.1016/j.paid.2010.06.021; Beaton EA, 2009, SOC NEUROSCI-UK, V4, P308, DOI 10.1080/17470910902801021; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Bonne O, 2003, BIOL PSYCHIAT, V54, P1077, DOI 10.1016/S0006-3223(03)00525-0; Booth JR, 2003, NEUROIMAGE, V20, P737, DOI 10.1016/S1053-8119(03)00404-X; BRUCH MA, 1989, J PERS SOC PSYCHOL, V57, P904, DOI 10.1037/0022-3514.57.5.904; Bruhl AB, 2011, BRAIN RES, V1378, P72, DOI 10.1016/j.brainres.2010.12.084; Brunetti M, 2010, NEUROSCIENCE, V168, P670, DOI 10.1016/j.neuroscience.2010.04.024; Bryant RA, 2008, HUM BRAIN MAPP, V29, P517, DOI 10.1002/hbm.20415; Chavira DA, 2002, J ANXIETY DISORD, V16, P585, DOI 10.1016/S0887-6185(02)00124-X; Cheek J.M., 1990, HDB SOCIAL EVALUATIO, P47; CHEEK JM, 1981, J PERS SOC PSYCHOL, V41, P330, DOI 10.1037/0022-3514.41.2.330; Cheek JM, 1983, REVIESD CHEEK UNPUB; Chen SH, 2012, NEUROIMAGE, V60, P299, DOI 10.1016/j.neuroimage.2011.11.092; Chou KL, 2005, AGING MENT HEALTH, V9, P456, DOI 10.1080/13607860500142820; Cox CL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012296; Crozier WR, 2005, PERS INDIV DIFFER, V38, P1947, DOI 10.1016/j.paid.2004.12.002; Davis F.C., 2012, CEREB CORTEX; De Luca M, 2006, NEUROIMAGE, V29, P1359, DOI 10.1016/j.neuroimage.2005.08.035; Denissen JJA, 2008, J PERS, V76, P67, DOI 10.1111/j.1467-6494.2007.00480.x; DeYoung CG, 2010, PSYCHOL SCI, V21, P820, DOI 10.1177/0956797610370159; Draganski B, 2004, NATURE, V427, P311, DOI 10.1038/427311a; Eysenck H.J., 1967, BIOL BASIS PERSONALI; Fernandez M, 2001, NEUROSCI LETT, V297, P101, DOI 10.1016/S0304-3940(00)01674-8; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; Fox MD, 2009, J NEUROPHYSIOL, V101, P3270, DOI 10.1152/jn.90777.2008; Fox NA, 2005, PSYCHOL SCI, V16, P921, DOI 10.1111/j.1467-9280.2005.01637.x; Freitas-Ferrari MC, 2010, PROG NEURO-PSYCHOPH, V34, P565, DOI 10.1016/j.pnpbp.2010.02.028; Fresco DM, 2001, PSYCHOL MED, V31, P1025, DOI 10.1017/S0033291701004056; Fukunaga M, 2006, MAGN RESON IMAGING, V24, P979, DOI 10.1016/j.mri.2006.04.018; Gardini S, 2009, BRAIN RES BULL, V79, P265, DOI 10.1016/j.brainresbull.2009.03.005; Ghashghaei HT, 2002, NEUROSCIENCE, V115, P1261, DOI 10.1016/S0306-4522(02)00446-3; Gong YX, 1984, PSYCHOL SCI NEWSLETT, V4, P11; Graziano MSA, 2002, NEURON, V34, P841, DOI 10.1016/S0896-6273(02)00698-0; Hahn A, 2011, NEUROIMAGE, V56, P881, DOI 10.1016/j.neuroimage.2011.02.064; Heiser NA, 2009, J ANXIETY DISORD, V23, P469, DOI 10.1016/j.janxdis.2008.10.002; Henderson HA, 2010, DEV NEUROPSYCHOL, V35, P177, DOI 10.1080/87565640903526538; Henderson L, 2002, PERS INDIV DIFFER, V32, P79, DOI 10.1016/S0191-8869(01)00007-1; Hirsch CR, 2004, CLIN PSYCHOL REV, V24, P799, DOI 10.1016/j.cpr.2004.07.005; Hoehn M, 2012, EXP NEUROL; Iancu I, 2011, COMPR PSYCHIAT, V52, P708, DOI 10.1016/j.comppsych.2010.11.011; Irle E, 2010, J PSYCHIATR NEUROSCI, V35, P126, DOI 10.1503/jpn.090041; Jetha MK, 2009, INT J NEUROSCI, V119, P847, DOI 10.1080/00207450701242966; Kaasinen V, 2005, NEUROIMAGE, V24, P315, DOI 10.1016/j.neuroimage.2004.09.017; Kanai R, 2012, P ROY SOC B-BIOL SCI, V279, P1327, DOI 10.1098/rspb.2011.1959; Kim MJ, 2011, BEHAV BRAIN RES, V223, P403, DOI 10.1016/j.bbr.2011.04.025; Klumpp H, 2012, BIOL PSYCHOL, V89, P273, DOI 10.1016/j.biopsycho.2011.10.010; Kosaka H, 2010, NEUROIMAGE, V50, P1357, DOI 10.1016/j.neuroimage.2010.01.085; Lesch KP, 1996, SCIENCE, V274, P1527, DOI 10.1126/science.274.5292.1527; Liao W, 2011, BRAIN RES, V1388, P167, DOI 10.1016/j.brainres.2011.03.018; Liao W, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015238; Liao W, 2010, NEUROIMAGE, V52, P1549, DOI 10.1016/j.neuroimage.2010.05.010; Liddell BJ, 2005, NEUROIMAGE, V24, P235, DOI 10.1016/j.neuroimage.2004.08.016; Lui S, 2011, AM J PSYCHIAT, V168, P642, DOI 10.1176/appi.ajp.2010.10101419; Lui S, 2009, AM J PSYCHIAT, V166, P196, DOI 10.1176/appi.ajp.2008.08020183; Majak K, 2003, EUR J NEUROSCI, V18, P1652, DOI 10.1046/j.1460-9568.2003.02854.x; Maldjian JA, 2003, NEUROIMAGE, V19, P1233, DOI 10.1016/S1053-8119(03)00169-1; Middleton FA, 2001, J NEUROSCI, V21, P700, DOI 10.1523/JNEUROSCI.21-02-00700.2001; Miskovic V, 2012, NEUROSCI BIOBEHAV R, V36, P459, DOI 10.1016/j.neubiorev.2011.08.002; Mukherjee P, 2012, SCHIZOPHR RES, V134, P118, DOI 10.1016/j.schres.2011.09.033; [潘集阳 PAN Jiyang], 2006, [中国神经精神疾病杂志, Chinese Journal of Nervous and Mental Diseases], V32, P206; Paulus MP, 2006, BIOL PSYCHIAT, V60, P383, DOI 10.1016/j.biopsych.2006.03.042; Peper JS, 2007, HUM BRAIN MAPP, V28, P464, DOI 10.1002/hbm.20398; POTTS NLS, 1994, PSYCHIAT RES, V52, P35, DOI 10.1016/0165-1781(94)90118-X; Raichle ME, 2011, BRAIN CONNECT, V1, P3, DOI 10.1089/brain.2011.0019; Raj BA, 2001, MED CLIN N AM, V85, P711, DOI 10.1016/S0025-7125(05)70337-0; Redcay E, 2008, NEUROSCI BIOBEHAV R, V32, P123, DOI 10.1016/j.neubiorev.2007.06.004; Schmahmann JD, 2006, BRAIN, V129, P290, DOI 10.1093/brain/awh729; SCHMAHMANN JD, 1991, J COMP NEUROL, V308, P224, DOI 10.1002/cne.903080209; Schmidt LA, 1999, PSYCHOL SCI, V10, P316, DOI 10.1111/1467-9280.00161; Schmidt LA, 2008, PEDIATRICS, V122, pE181, DOI 10.1542/peds.2007-3747; Scholz J, 2009, NAT NEUROSCI, V12, P1370, DOI 10.1038/nn.2412; Schwartz CE, 2003, SCIENCE, V300, P1952, DOI 10.1126/science.1083703; Sen S, 2004, AM J MED GENET B, V127B, P85, DOI 10.1002/ajmg.b.20158; Shehzad Z, 2009, CEREB CORTEX, V19, P2209, DOI 10.1093/cercor/bhn256; SHEK DTL, 1993, J CLIN PSYCHOL, V49, P349, DOI 10.1002/1097-4679(199305)49:3<349::AID-JCLP2270490308>3.0.CO;2-J; SHEK DTL, 1988, J PSYCHOPATHOL BEHAV, V10, P303, DOI 10.1007/BF00960624; Shin LM, 2005, ARCH GEN PSYCHIAT, V62, P273, DOI 10.1001/archpsyc.62.3.273; Simmons WK, 2012, SOC COGN AFFECT NEUR, V7, P467, DOI 10.1093/scan/nsr018; Suomi S. J., 2004, RES HUMAN DEV, V1, P205, DOI DOI 10.1207/S15427617RHD0103_5; Thomas AG, 2009, NEUROIMAGE, V48, P117, DOI 10.1016/j.neuroimage.2009.05.097; Thompson PM, 2001, NAT NEUROSCI, V4, P1253, DOI 10.1038/nn758; Tillfors M, 2002, BIOL PSYCHIAT, V52, P1113, DOI 10.1016/S0006-3223(02)01396-3; Van Schuerbeek P, 2011, BRAIN RES, V1371, P32, DOI 10.1016/j.brainres.2010.11.073; van Strien NM, 2009, NAT REV NEUROSCI, V10, P272, DOI 10.1038/nrn2614; Wong D. F. K., 2006, HONG KONG J PSYCHIAT, V16, P50; Yassa MA, 2009, NEUROIMAGE, V44, P319, DOI 10.1016/j.neuroimage.2008.09.016; Zimbardo P. G., 1977, SHYNESS WHAT IS IT W	97	12	16	0	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2013	8	5							e63151	10.1371/journal.pone.0063151	http://dx.doi.org/10.1371/journal.pone.0063151			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	143FO	23675458	Green Published, gold, Green Submitted			2022-12-27	WOS:000318852400026
J	Weicksel, SE; Xu, J; Sagerstrom, CG				Weicksel, Steven E.; Xu, Jia; Sagerstroem, Charles G.			Dynamic Nucleosome Organization at hox Promoters during Zebrafish Embryogenesis	PLOS ONE			English	Article							NUCLEAR REORGANIZATION; CHROMATIN-STRUCTURE; RETINOIC ACID; SACCHAROMYCES-CEREVISIAE; EMBRYONIC-DEVELOPMENT; GENE-EXPRESSION; HIGH-RESOLUTION; GENOME-WIDE; DNA; TRANSCRIPTION	Nucleosome organization at promoter regions plays an important role in regulating gene activity. Genome-wide studies in yeast, flies, worms, mammalian embryonic stem cells and transformed cell lines have found well-positioned nucleosomes flanking a nucleosome depleted region (NDR) at transcription start sites. This nucleosome arrangement depends on DNA sequence (cis-elements) as well as DNA binding factors and ATP-dependent chromatin modifiers (trans-factors). However, little is understood about how the nascent embryonic genome positions nucleosomes during development. This is particularly intriguing since the embryonic genome must undergo a broad reprogramming event upon fusion of sperm and oocyte. Using four stages of early embryonic zebrafish development, we map nucleosome positions at the promoter region of 37 zebrafish hox genes. We find that nucleosome arrangement at the hox promoters is a progressive process that takes place over several stages. At stages immediately after fertilization, nucleosomes appear to be largely disordered at hox promoter regions. At stages after activation of the embryonic genome, nucleosomes are detectable at hox promoters, with positions becoming more uniform and more highly occupied. Since the genomic sequence is invariant during embryogenesis, this progressive change in nucleosome arrangement suggests that trans-factors play an important role in organizing nucleosomes during embryogenesis. Separating hox genes into expressed and non-expressed groups shows that expressed promoters have better positioned and occupied nucleosomes, as well as distinct NDRs, than non-expressed promoters. Finally, by blocking the retinoic acid-signaling pathway, we disrupt early hox gene transcription, but observe no effect on nucleosome positions, suggesting that active hox transcription is not a driving force behind the arrangement of nucleosomes at the promoters of hox genes during early development.	[Weicksel, Steven E.; Sagerstroem, Charles G.] Univ Massachusetts, Sch Med, Dept Biochem & Mol Pharmacol, Worcester, MA 01605 USA; [Xu, Jia] Univ Massachusetts, Sch Med, Bioinformat Core, Worcester, MA USA	University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester	Sagerstrom, CG (corresponding author), Univ Massachusetts, Sch Med, Dept Biochem & Mol Pharmacol, Worcester, MA 01605 USA.	charles.sagerstrom@umassmed.edu	Weicksel, Steven/AAN-8698-2021	Weicksel, Steven/0000-0002-1679-9684	National Institutes of Health [NS038183]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS038183, R56NS038183] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health grant NS038183 to CGS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert I, 2007, NATURE, V446, P572, DOI 10.1038/nature05632; ALMER A, 1986, EMBO J, V5, P2689, DOI 10.1002/j.1460-2075.1986.tb04552.x; Anderson JD, 2000, J MOL BIOL, V296, P979, DOI 10.1006/jmbi.2000.3531; Andreu-Vieyra C, 2011, MOL CELL BIOL, V31, P4648, DOI 10.1128/MCB.05934-11; Badis G, 2008, MOL CELL, V32, P878, DOI 10.1016/j.molcel.2008.11.020; Bai L, 2011, MOL CELL, V42, P465, DOI 10.1016/j.molcel.2011.03.028; Berkes CA, 2004, MOL CELL, V14, P465, DOI 10.1016/S1097-2765(04)00260-6; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Chambeyron S, 2005, DEVELOPMENT, V132, P2215, DOI 10.1242/dev.01813; Chambeyron S, 2004, GENE DEV, V18, P1119, DOI 10.1101/gad.292104; Dennis JH, 2007, GENOME RES, V17, P928, DOI 10.1101/gr.5636607; Ercan S, 2011, GENOME RES, V21, P237, DOI 10.1101/gr.115931.110; FEDOR MJ, 1989, MOL CELL BIOL, V9, P1721, DOI 10.1128/MCB.9.4.1721; Fu YT, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000138; Gilchrist DA, 2008, GENE DEV, V22, P1921, DOI 10.1101/gad.1643208; Gilchrist DA, 2010, CELL, V143, P540, DOI 10.1016/j.cell.2010.10.004; Hargreaves DC, 2011, CELL RES, V21, P396, DOI 10.1038/cr.2011.32; Hughes AL, 2012, MOL CELL, V48, P5, DOI 10.1016/j.molcel.2012.07.003; Ioshikhes I, 1996, J MOL BIOL, V262, P129, DOI 10.1006/jmbi.1996.0503; Ioshikhes IP, 2006, NAT GENET, V38, P1210, DOI 10.1038/ng1878; IYER V, 1995, EMBO J, V14, P2570, DOI 10.1002/j.1460-2075.1995.tb07255.x; Jin CY, 2007, GENE DEV, V21, P1519, DOI 10.1101/gad.1547707; Johnson SM, 2006, GENOME RES, V16, P1505, DOI 10.1101/gr.5560806; Kaplan N, 2009, NATURE, V458, P362, DOI 10.1038/nature07667; Kharchenko PV, 2008, GENOME RES, V18, P1554, DOI 10.1101/gr.075952.107; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Koide T, 2001, GENE DEV, V15, P2111, DOI 10.1101/gad.908801; Kornberg RD, 1999, CELL, V98, P285, DOI 10.1016/S0092-8674(00)81958-3; KRUMLAUF R, 1994, CELL, V78, P191, DOI 10.1016/0092-8674(94)90290-9; Lee CK, 2004, NAT GENET, V36, P900, DOI 10.1038/ng1400; Lee W, 2007, NAT GENET, V39, P1235, DOI 10.1038/ng2117; LEWIS EB, 1978, NATURE, V276, P565, DOI 10.1038/276565a0; Li M, 2010, MOL CELL BIOL, V30, P1067, DOI 10.1128/MCB.00183-09; Mahony S, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-1-r2; Maves L, 2005, DEV BIOL, V285, P593, DOI 10.1016/j.ydbio.2005.07.015; Mavrich TN, 2008, GENOME RES, V18, P1073, DOI 10.1101/gr.078261.108; Mavrich TN, 2008, NATURE, V453, P358, DOI 10.1038/nature06929; MCPHERSON CE, 1993, CELL, V75, P387, DOI 10.1016/0092-8674(93)80079-T; Mito Y, 2005, NAT GENET, V37, P1090, DOI 10.1038/ng1637; Morey C, 2007, DEVELOPMENT, V134, P909, DOI 10.1242/dev.02779; Noordermeer D, 2011, SCIENCE, V334, P222, DOI 10.1126/science.1207194; Ozsolak F, 2007, NAT BIOTECHNOL, V25, P244, DOI 10.1038/nbt1279; Pauli A, 2012, GENOME RES, V22, P577, DOI 10.1101/gr.133009.111; Peckham HE, 2007, GENOME RES, V17, P1170, DOI 10.1101/gr.6101007; Pengelly AR, 2013, SCIENCE, V339, P698, DOI 10.1126/science.1231382; Perissi V, 2010, NAT REV GENET, V11, P109, DOI 10.1038/nrg2736; Perz-Edwards A, 2001, DEV BIOL, V229, P89, DOI 10.1006/dbio.2000.9979; Sasaki S, 2009, SCIENCE, V323, P401, DOI 10.1126/science.1163183; Schier AF, 2005, ANNU REV GENET, V39, P561, DOI 10.1146/annurev.genet.37.110801.143752; Schones DE, 2008, CELL, V132, P887, DOI 10.1016/j.cell.2008.02.022; Schuettengruber B, 2007, CELL, V128, P735, DOI 10.1016/j.cell.2007.02.009; Segal E, 2006, NATURE, V442, P772, DOI 10.1038/nature04979; Shim EY, 1998, GENE DEV, V12, P5, DOI 10.1101/gad.12.1.5; Suter B, 2000, NUCLEIC ACIDS RES, V28, P4083, DOI 10.1093/nar/28.21.4083; Thastrom A, 1999, J MOL BIOL, V288, P213, DOI 10.1006/jmbi.1999.2686; Tillo D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009129; Tirosh I, 2008, GENOME RES, V18, P1084, DOI 10.1101/gr.076059.108; Valouev A, 2008, GENOME RES, V18, P1051, DOI 10.1101/gr.076463.108; Vastenhouw NL, 2010, NATURE, V464, P922, DOI 10.1038/nature08866; Weiner A, 2010, GENOME RES, V20, P90, DOI 10.1101/gr.098509.109; Widom J, 1998, ANNU REV BIOPH BIOM, V27, P285, DOI 10.1146/annurev.biophys.27.1.285; Xi YX, 2011, GENOME RES, V21, P718, DOI 10.1101/gr.117101.110; Xiao H, 2001, MOL CELL, V8, P531, DOI 10.1016/S1097-2765(01)00345-8; Yuan GC, 2005, SCIENCE, V309, P626, DOI 10.1126/science.1112178; Yuan GC, 2008, PLOS COMPUT BIOL, V4, DOI [10.1371/journal.pcbi.0040013, 10.1371/journal.pcbi.0040013.eor]	65	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2013	8	5							e63175	10.1371/journal.pone.0063175	http://dx.doi.org/10.1371/journal.pone.0063175			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	155HD	23671670	gold, Green Published, Green Submitted			2022-12-27	WOS:000319737700048
J	Armas, P; Margarit, E; Mouguelar, VS; Allende, ML; Calcaterra, NB				Armas, Pablo; Margarit, Ezequiel; Mouguelar, Valeria S.; Allende, Miguel L.; Calcaterra, Nora B.			Beyond the Binding Site: In Vivo Identification of tbx2, smarca5 and wnt5b as Molecular Targets of CNBP during Embryonic Development	PLOS ONE			English	Article							MYOTONIC-DYSTROPHY; PROTEIN; GENES; PROLIFERATION; EXPRESSION; DNA; REPRESSES; EXPANSION; YEAST	CNBP is a nucleic acid chaperone implicated in vertebrate craniofacial development, as well as in myotonic dystrophy type 2 (DM2) and sporadic inclusion body myositis (sIBM) human muscle diseases. CNBP is highly conserved among vertebrates and has been implicated in transcriptional regulation; however, its DNA binding sites and molecular targets remain elusive. The main goal of this work was to identify CNBP DNA binding sites that might reveal target genes involved in vertebrate embryonic development. To accomplish this, we used a recently described yeast one-hybrid assay to identify DNA sequences bound in vivo by CNBP. Bioinformatic analyses revealed that these sequences are G-enriched and show high frequency of putative G-quadruplex DNA secondary structure. Moreover, an in silico approach enabled us to establish the CNBP DNA-binding site and to predict CNBP putative targets based on gene ontology terms and synexpression with CNBP. The direct interaction between CNBP and candidate genes was proved by EMSA and ChIP assays. Besides, the role of CNBP upon the identified genes was validated in loss-of-function experiments in developing zebrafish. We successfully confirmed that CNBP up-regulates tbx2b and smarca5, and down-regulates wnt5b gene expression. The highly stringent strategy used in this work allowed us to identify new CNBP target genes functionally important in different contexts of vertebrate embryonic development. Furthermore, it represents a novel approach toward understanding the biological function and regulatory networks involving CNBP in the biology of vertebrates.	[Armas, Pablo; Margarit, Ezequiel; Mouguelar, Valeria S.; Calcaterra, Nora B.] Univ Nacl Rosario, Inst Biol Mol & Celular Rosario IBR, Consejo Nacl Invest Cient & Tecn CONICET, Fac Ciencias Bioquim & Farmaceut, RA-2000 Rosario, Santa Fe, Argentina; [Allende, Miguel L.] Univ Chile, Fac Ciencias, FONDAP Ctr Genome Regulat, Santiago, Chile	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Rosario; Universidad de Chile	Calcaterra, NB (corresponding author), Univ Nacl Rosario, Inst Biol Mol & Celular Rosario IBR, Consejo Nacl Invest Cient & Tecn CONICET, Fac Ciencias Bioquim & Farmaceut, S2000FHQ, RA-2000 Rosario, Santa Fe, Argentina.	calcaterra@ibr-conicet.gov.ar	Calcaterra, Nora/AAP-7469-2021; Allende, Miguel L/C-5167-2008	Allende, Miguel L/0000-0002-2783-2152; Margarit, Ezequiel/0000-0003-0031-2779; Armas, Pablo/0000-0002-0454-1424; , Nora/0000-0003-4259-9800	FONDAP [15090007]; ICGEB [CRP/CHI11-01]; ANPCyT [PICT 07-00648, PICT 11-1540]; CONICET [PIP 00480, PIP 00773]	FONDAP; ICGEB; ANPCyT(ANPCyT); CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET))	The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. MLA was funded by FONDAP (15090007) and ICGEB (CRP/CHI11-01). NBC and PA were funded by ANPCyT (PICT 07-00648 and PICT 11-1540) and CONICET (PIP 00480 and PIP 00773).	Abe Y, 2006, DEV BIOL, V295, P116, DOI 10.1016/j.ydbio.2006.03.012; Abrahams A, 2010, IUBMB LIFE, V62, P92, DOI 10.1002/iub.275; Amsterdam A, 2004, P NATL ACAD SCI USA, V101, P12792, DOI 10.1073/pnas.0403929101; Armas P, 2004, GENE, V337, P151, DOI 10.1016/j.gene.2004.04.031; Armas P, 2008, J MOL BIOL, V382, P1043, DOI 10.1016/j.jmb.2008.07.079; Armas P, 2008, J CELL BIOCHEM, V103, P1013, DOI 10.1002/jcb.21474; Askanas V, 2007, CURR OPIN RHEUMATOL, V19, P550, DOI 10.1097/BOR.0b013e3282efdc7c; Bailey TL, 2006, NUCLEIC ACIDS RES, V34, pW369, DOI 10.1093/nar/gkl198; Borgognone M, 2010, BIOCHEM J, V428, P491, DOI 10.1042/BJ20100038; Bradley EW, 2011, J CELL PHYSIOL, V226, P1683, DOI 10.1002/jcp.22499; Calcaterra NB, 2010, IUBMB LIFE, V62, P707, DOI 10.1002/iub.379; Chen W, 2003, DEVELOPMENT, V130, P1367, DOI 10.1242/dev.00349; Dale RM, 2009, ZEBRAFISH, V6, P9, DOI 10.1089/zeb.2008.0563; Dheen T, 1999, DEVELOPMENT, V126, P2703; Fernando H, 2009, NUCLEIC ACIDS RES, V37, P6716, DOI 10.1093/nar/gkp740; Hertz GZ, 1999, BIOINFORMATICS, V15, P563, DOI 10.1093/bioinformatics/15.7.563; Huichalaf C, 2009, J NEUROSCI, V29, P9042, DOI 10.1523/JNEUROSCI.1983-09.2009; Hulsen T, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-488; Kilian B, 2003, MECH DEVELOP, V120, P467, DOI 10.1016/S0925-4773(03)00004-2; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kudoh T, 2001, GENOME RES, V11, P1979, DOI 10.1101/gr.209601; LAWRENCE CE, 1993, SCIENCE, V262, P208, DOI 10.1126/science.8211139; Li J, 2006, J NEUROPATH EXP NEUR, V65, P826, DOI 10.1097/01.jnen.0000228204.19915.69; Lindeman LC, 2009, METHODS MOL BIOL, V567, P75, DOI 10.1007/978-1-60327-414-2_5; Liquori CL, 2001, SCIENCE, V293, P864, DOI 10.1126/science.1062125; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Lu JA, 2010, BBA-REV CANCER, V1806, P268, DOI 10.1016/j.bbcan.2010.07.001; Maere S, 2005, BIOINFORMATICS, V21, P3448, DOI 10.1093/bioinformatics/bti551; Milla LA, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-2; Niedowicz DM, 2010, NEUROSCI LETT, V482, P57, DOI 10.1016/j.neulet.2010.07.006; Nojima H, 2010, DEVELOPMENT, V137, P923, DOI 10.1242/dev.046425; Prince S, 2004, CANCER RES, V64, P1669, DOI 10.1158/0008-5472.CAN-03-3286; Ranum LPW, 2004, AM J HUM GENET, V74, P793, DOI 10.1086/383590; Rauch GJ, 1997, COLD SPRING HARB SYM, V62, P227, DOI 10.1101/SQB.1997.062.01.028; Redmond KL, 2010, ONCOGENE, V29, P3252, DOI 10.1038/onc.2010.84; Robu ME, 2007, PLOS GENET, V3, P787, DOI 10.1371/journal.pgen.0030078; Scherrer T, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-1-r3; Schneider-Gold C, 2010, REV NEUROSCIENCE, V21, P19; Showell C, 2004, DEV DYNAM, V229, P201, DOI 10.1002/dvdy.10480; Sun HC, 2010, BIOINFORMATICS, V26, P405, DOI 10.1093/bioinformatics/btp681; Tang RY, 2007, ACTA BIOCH BIOPH SIN, V39, P384, DOI 10.1111/j.1745-7270.2007.00283.x; Thisse C, 2008, NAT PROTOC, V3, P59, DOI 10.1038/nprot.2007.514; Weiner AMJ, 2007, J CELL BIOCHEM, V102, P1553, DOI 10.1002/jcb.21380; Weiner AMJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029574; Weiner AMJ, 2011, DEV GROWTH DIFFER, V53, P934, DOI 10.1111/j.1440-169X.2011.01298.x; Westerfield M., 1995, ZEBRAFISH BOOK GUIDE; Zeng J, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkm1117	47	11	11	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e63234	10.1371/journal.pone.0063234	http://dx.doi.org/10.1371/journal.pone.0063234			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667590	Green Published, gold, Green Submitted			2022-12-27	WOS:000319654700120
J	Hauer, D; Schelling, G; Gola, H; Campolongo, P; Morath, J; Roozendaal, B; Hamuni, G; Karabatsiakis, A; Atsak, P; Vogeser, M; Kolassa, IT				Hauer, Daniela; Schelling, Gustav; Gola, Hannah; Campolongo, Patrizia; Morath, Julia; Roozendaal, Benno; Hamuni, Gilava; Karabatsiakis, Alexander; Atsak, Piray; Vogeser, Michael; Kolassa, Iris-Tatjana			Plasma Concentrations of Endocannabinoids and Related Primary Fatty Acid Amides in Patients with Post-Traumatic Stress Disorder	PLOS ONE			English	Article							RISK-FACTORS; SYSTEM; ANANDAMIDE; VALIDATION; DISEASE; MEMORY; OBESE; PTSD	Background: Endocannabinoids (ECs) and related N-acyl-ethanolamides (NAEs) play important roles in stress response regulation, anxiety and traumatic memories. In view of the evidence that circulating EC levels are elevated under acute mild stressful conditions in humans, we hypothesized that individuals with traumatic stress exposure and post-traumatic stress disorder (PTSD), an anxiety disorder characterized by the inappropriate persistence and uncontrolled retrieval of traumatic memories, show measurable alterations in plasma EC and NAE concentrations. Methods: We determined plasma concentrations of the ECs anandamide (ANA) and 2-arachidonoylglycerol (2-AG) and the NAEs palmitoylethanolamide (PEA), oleoylethanolamide (OEA), stearoylethanolamine (SEA), and N-oleoyldopamine (OLDA) by HPLC-MS-MS in patients with PTSD (n = 10), trauma-exposed individuals without evidence of PTSD (n = 9) and in healthy control subjects (n = 29). PTSD was diagnosed according to DSM-IV criteria by administering the Clinician Administered PTSD Scale (CAPS), which also assesses traumatic events. Results: Individuals with PTSD showed significantly higher plasma concentrations of ANA (0.48 +/- 0.11 vs. 0.36 +/- 0.14 ng/ml, p = 0.01), 2-AG (8.93 +/- 3.20 vs. 6.2 +/- 62.10 ng/ml, p<0.01), OEA (5.90 +/- 2.10 vs. 3.88 +/- 1.85 ng/ml, p<0.01), SEA (2.70 +/- 3.37 vs. 0.83 +/- 0.47, ng/ml, p<0.05) and significantly lower plasma levels of OLDA (0.12 +/- 0.05 vs. 0.45 +/- 0.59 ng/ml, p<0.05) than healthy controls. Moreover, PTSD patients had higher 2-AG plasma levels (8.93 +/- 3.20 vs. 6.01 +/- 1.32 ng/ml, p = 0.03) and also higher plasma concentrations of PEA (4.06 +/- 1.87 vs. 2.63 +/- 1.34 ng/ml, p<0.05) than trauma-exposed individuals without evidence of PTSD. CAPS scores in trauma-exposed individuals with and without PTSD (n = 19) correlated positively with PEA (r = 0.55, p = 0.02) and negatively with OLDA plasma levels (r = -0.68, p<0.01). CAPS subscores for intrusions (r = -0.65, p<0.01), avoidance (r = -0.60, p<0.01) and hyperarousal (r = -0.66, p<0.01) were all negatively related to OLDA plasma concentrations. Conclusions: PTSD appears to be associated with changes in plasma EC/NAE concentrations. This may have pathophysiological and diagnostic consequences but will need to be reproduced in larger cohorts.	[Hauer, Daniela; Schelling, Gustav] Univ Munich, Dept Anaesthesiol, Munich, Germany; [Karabatsiakis, Alexander] Univ Ulm, Dept Clin & Biol Psychol, Inst Psychol & Educ, D-89069 Ulm, Germany; [Campolongo, Patrizia] Univ Roma La Sapienza, Dept Physiol & Pharmacol, Rome, Italy; [Gola, Hannah; Morath, Julia; Hamuni, Gilava; Kolassa, Iris-Tatjana] Univ Konstanz, Dept Psychol, Dept Clin & Neuropsychol, Constance, Germany; [Roozendaal, Benno; Atsak, Piray] Radboud Univ Nijmegen, Dept Cognit Neurosci, Med Ctr, NL-6525 ED Nijmegen, Netherlands; [Roozendaal, Benno; Atsak, Piray] Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, NL-6525 ED Nijmegen, Netherlands; [Vogeser, Michael] Univ Munich, Dept Clin Chem, Munich, Germany	University of Munich; Ulm University; Sapienza University Rome; University of Konstanz; Radboud University Nijmegen; Radboud University Nijmegen; University of Munich	Schelling, G (corresponding author), Univ Munich, Dept Anaesthesiol, Munich, Germany.	gustav.schelling@med.uni-muenchen.de	Atsak, Piray/GPX-9702-2022; Roozendaal, Benno/B-8403-2013; Atsak, piray/I-5880-2013; Kolassa, Iris Tatjana/Y-3032-2018; Schelling, Gustav/U-2603-2018; Atsak, Piray/AAB-1451-2019; Campolongo, Patrizia/D-4628-2009; Karabatsiakis, Alexander/AAY-7114-2020	Schelling, Gustav/0000-0002-6538-0652; Atsak, Piray/0000-0003-1828-2061; Campolongo, Patrizia/0000-0002-2827-8755; Karabatsiakis, Alexander/0000-0002-5822-0108	Department of Anaesthesiology of the University of Munich	Department of Anaesthesiology of the University of Munich	The study was financed by departmental funds from the Department of Anaesthesiology of the University of Munich. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atsak P, 2012, P NATL ACAD SCI USA, V109, P3504, DOI 10.1073/pnas.1200742109; Balvers MGJ, 2009, J CHROMATOGR B, V877, P1583, DOI 10.1016/j.jchromb.2009.04.010; BLAKE DD, 1995, J TRAUMA STRESS, V8, P75, DOI 10.1007/BF02105408; Boscarino JA, 2008, PSYCHOSOM MED, V70, P668, DOI 10.1097/PSY.0b013e31817bccaf; Campolongo P, 2009, P NATL ACAD SCI USA, V106, P8027, DOI 10.1073/pnas.0903038106; Campolongo P, 2009, P NATL ACAD SCI USA, V106, P4888, DOI 10.1073/pnas.0900835106; Centonze D, 2008, CURR PHARM DESIGN, V14, P2370, DOI 10.2174/138161208785740018; Chouker A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010752; Cornelius JR, 2010, ADDICT BEHAV, V35, P91, DOI 10.1016/j.addbeh.2009.09.007; Cote M, 2007, INT J OBESITY, V31, P692, DOI 10.1038/sj.ijo.0803539; De Petrocellis L, 2004, BRIT J PHARMACOL, V141, P765, DOI 10.1038/sj.bjp.0705666; Despres JP, 2005, NEW ENGL J MED, V353, P2121, DOI 10.1056/NEJMoa044537; Di Filippo M, 2008, J NEUROL NEUROSUR PS, V79, P1224, DOI 10.1136/jnnp.2007.139071; Di Marzo V, 2009, EUR J ENDOCRINOL, V161, P715, DOI 10.1530/EJE-09-0643; Dlugos A, 2012, NEUROPSYCHOPHARMACOL, V37, P2416, DOI 10.1038/npp.2012.100; Fanelli F, 2012, J LIPID RES, V53, P481, DOI 10.1194/jlr.M021378; Feuerecker M, 2012, EUR J APPL PHYSIOL, V112, P2777, DOI 10.1007/s00421-011-2237-0; Fraser GA, 2009, CNS NEUROSCI THER, V15, P84, DOI 10.1111/j.1755-5949.2008.00071.x; Ganon-Elazar E, 2012, NEUROPSYCHOPHARMACOL, V37, P456, DOI 10.1038/npp.2011.204; Glaser ST, 2006, J PHARMACOL EXP THER, V316, P1088, DOI 10.1124/jpet.105.094748; Grimaldi C, 2011, CURR MED CHEM, V18, P1575, DOI 10.2174/092986711795471374; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; Hauer D, 2008, ANESTHESIOLOGY, V109, pA1015; Hauer D, 2012, REV NEUROSCIENCE, V23, P681, DOI 10.1515/revneuro-2012-0058; Heyman E, 2012, PSYCHONEUROENDOCRINO, V37, P844, DOI 10.1016/j.psyneuen.2011.09.017; Hill MN, 2008, PHARMACOPSYCHIATRY, V41, P48, DOI 10.1055/s-2007-993211; Hill MN, 2010, P NATL ACAD SCI USA, V107, P9406, DOI 10.1073/pnas.0914661107; Hill MN, 2009, NEUROPSYCHOPHARMACOL, V34, P2733, DOI 10.1038/npp.2009.114; Hill MN, 2009, PSYCHONEUROENDOCRINO, V34, P1257, DOI 10.1016/j.psyneuen.2009.03.013; Jean-Gilles L, 2010, IMMUNOBIOLOGY, V215, P606, DOI 10.1016/j.imbio.2009.12.006; Kulisch C, 2013, BEHAV BRAIN RES, V236, P344, DOI 10.1016/j.bbr.2012.09.003; Maccarrone M, 2002, MOL CELL NEUROSCI, V21, P126, DOI 10.1006/mcne.2002.1164; Marsicano G, 2002, NATURE, V418, P530, DOI 10.1038/nature00839; Moreira FA, 2010, CURR TOP BEHAV NEURO, V2, P429, DOI 10.1007/7854_2009_16; Pacher P, 2009, SEMIN IMMUNOPATHOL, V31, P63, DOI 10.1007/s00281-009-0145-8; Patel S, 2008, EUR J NEUROSCI, V27, P2821, DOI 10.1111/j.1460-9568.2008.06266.x; Rief W, 2003, PSYCHOSOMATICS, V44, P492, DOI 10.1176/appi.psy.44.6.492; Schauer M, 2011, NARRATIVE EXPOSURE T, P77; Schmidt A, 2006, BIOMED CHROMATOGR, V20, P336, DOI 10.1002/bmc.568; Schwarz Emanuel, 2011, Front Biosci (Elite Ed), V3, P308, DOI 10.2741/e246; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P34, DOI 10.4088/JCP.09m05305whi; Stoll C, 1999, INTENS CARE MED, V25, P697, DOI 10.1007/s001340050932; Sugamura K, 2009, CIRCULATION, V119, P28, DOI 10.1161/CIRCULATIONAHA.108.811992; Vogeser M, 2006, CLIN CHEM LAB MED, V44, P488, DOI 10.1515/CCLM.2006.065; Vogeser M, 2007, CLIN CHEM LAB MED, V45, P1023, DOI 10.1515/CCLM.2007.197; Weis F, 2010, BRIT J ANAESTH, V105, P139, DOI 10.1093/bja/aeq117	46	119	122	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e62741	10.1371/journal.pone.0062741	http://dx.doi.org/10.1371/journal.pone.0062741			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667516	gold, Green Submitted, Green Published			2022-12-27	WOS:000319654700060
J	Kunz, LIZ; Strebus, J; Budulac, SE; Lapperre, TS; Sterk, PJ; Postma, DS; Mauad, T; Timens, W; Hiemstra, PS				Kunz, Lisette I. Z.; Strebus, Jolanda; Budulac, Simona E.; Lapperre, Therese S.; Sterk, Peter J.; Postma, Dirkje S.; Mauad, Thais; Timens, Wim; Hiemstra, Pieter S.		GLUCOLD Groningen Leiden Univ	Inhaled Steroids Modulate Extracellular Matrix Composition in Bronchial Biopsies of COPD Patients: A Randomized, Controlled Trial	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; FIBROBLAST PROTEOGLYCAN PRODUCTION; GENE-EXPRESSION; CIGARETTE-SMOKE; PATHOGENESIS; ELASTIN; TISSUE; AIRWAY; MACROPHAGES; ALVEOLI	Rationale: Smoking and inflammation contribute to the pathogenesis of chronic obstructive pulmonary disease (COPD), which involves changes in extracellular matrix. This is thought to contribute to airway remodeling and airflow obstruction. We have previously observed that long-term treatment with inhaled corticosteroids can not only reduce bronchial inflammation, but can also attenuate lung function decline in moderate-severe COPD. We hypothesized that inhaled corticosteroids and current smoking modulate bronchial extracellular matrix components in COPD. Objective: To compare major extracellular matrix components (elastic fibers; proteoglycans [versican, decorin]; collagens type I and III) in bronchial biopsies 1) after 30-months inhaled steroids treatment or placebo; and 2) between current and exsmokers with COPD. Methods: We included 64 moderate-severe, steroid-naive COPD patients (24/40 (ex)-smokers, 62 +/- 7 years, 46 (31-54) packyears, post-bronchodilator forced expiratory volume in one second (FEV1) 62 +/- 9% predicted) at baseline in this randomized, controlled trial. 19 and 13 patients received 30-months treatment with fluticasone or placebo, respectively. Bronchial biopsies collected at baseline and after 30 months were studied using (immuno) histochemistry to evaluate extracellular matrix content. Percentage and density of stained area were calculated by digital image analysis. Results: 30-Months inhaled steroids increased the percentage stained area of versican (9.6% [CI 0.9 to 18.3%]; p = 0.03) and collagen III (20.6% [CI 3.8 to 37.4%]; p = 0.02) compared to placebo. Increased collagen I staining density correlated with increased post-bronchodilator FEV1 after inhaled steroids treatment (Rs = 0.45, p = 0.04). There were no differences between smokers and ex-smokers with COPD in percentages and densities for all extracellular matrix proteins. Conclusions: These data show that long-term inhaled corticosteroids treatment partially changes the composition of extracellular matrix in moderate-severe COPD. This is associated with increased lung function, suggesting that long-term inhaled steroids modulate airway remodeling thereby potentially preventing airway collapse in COPD. Smoking status is not associated with bronchial extracellular matrix proteins.	[Kunz, Lisette I. Z.; Strebus, Jolanda; Lapperre, Therese S.; Hiemstra, Pieter S.] Leiden Univ Med Ctr, Dept Pulmonol, Leiden, Netherlands; [Budulac, Simona E.] Univ Groningen, Univ Med Ctr Groningen, Dept Epidemiol, Groningen, Netherlands; [Sterk, Peter J.] Univ Amsterdam, Acad Med Ctr, Dept Resp Med, NL-1105 AZ Amsterdam, Netherlands; [Postma, Dirkje S.] Univ Groningen, Univ Med Ctr Groningen, Dept Pulmonol, Groningen, Netherlands; [Mauad, Thais] Univ Sao Paulo, Sch Med, Dept Pathol, Sao Paulo, Brazil; [Timens, Wim] Univ Groningen, Univ Med Ctr Groningen, Dept Pathol, Groningen, Netherlands	Leiden University; Leiden University Medical Center (LUMC); University of Groningen; University of Amsterdam; Academic Medical Center Amsterdam; University of Groningen; Universidade de Sao Paulo; University of Groningen	Kunz, LIZ (corresponding author), Leiden Univ Med Ctr, Dept Pulmonol, Leiden, Netherlands.	L.I.Z.Kunz@lumc.nl	Hiemstra, Pieter S/K-8587-2018; Timens, Wim/K-5570-2013; Sont, Jacob K/J-8071-2015; /V-8478-2019; Sterk, P.J./AAK-8175-2020	Hiemstra, Pieter S/0000-0002-0238-5982; Timens, Wim/0000-0002-4146-6363; Sont, Jacob K/0000-0002-5840-0651; Kerstjens, Huib/0000-0001-7705-7927; Lapperre, Therese/0000-0002-5176-0101	Netherlands Organization for Scientific Research (NWO) [940-35-033]; Netherlands Asthma Foundation (NAF) [93.96.3]; Stichting Astma Bestrijding (SAB); GlaxoSmithKline (GSK) of The Netherlands [SCO107656]; University Medical Center Groningen (UMCG); Leiden University Medical Center (LUMC); Brazilian National Council for Scientific and Technological Development (CNPq); GlaxoSmithKline; Netherlands Organisation for Scientific Research (NWO); Netherlands Asthma Foundation; Leiden University Medical Center; University Medical Center Groningen; AstraZeneca; Nycomed	Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Netherlands Asthma Foundation (NAF); Stichting Astma Bestrijding (SAB); GlaxoSmithKline (GSK) of The Netherlands(GlaxoSmithKline); University Medical Center Groningen (UMCG); Leiden University Medical Center (LUMC); Brazilian National Council for Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); GlaxoSmithKline(GlaxoSmithKline); Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Netherlands Asthma Foundation; Leiden University Medical Center; University Medical Center Groningen; AstraZeneca(AstraZeneca); Nycomed	This study was funded by The Netherlands Organization for Scientific Research (NWO) (grant number 940-35-033), The Netherlands Asthma Foundation (NAF) (grant number 93.96.3), Stichting Astma Bestrijding (SAB), GlaxoSmithKline (GSK) of The Netherlands (grant number SCO107656), University Medical Center Groningen (UMCG), Leiden University Medical Center (LUMC), and Brazilian National Council for Scientific and Technological Development (CNPq). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Mrs. Kunz, Mrs. Strebus, and Mrs. Budulac have no relationships that present a potential conflict of interest. Mrs. Lapperre received payments for a lecture at GlaxoSmithKline. Prof. Sterk, Prof. Postma, Prof. Timens and Prof. Hiemstra received unrestricted grants for the GLUCOLD project from GlaxoSmithKline, The Netherlands Organisation for Scientific Research (NWO), The Netherlands Asthma Foundation, Stichting Astma Bestrijding (SAB), Leiden University Medical Center and University Medical Center Groningen. Prof. Sterk received a grant from Innovative Medicines Initiative (IMI), an EU publicprivate grant supported by 10 pharmaceutical industries. Prof. Postma has been a consultant to AstraZeneca, Boehringer Ingelheim, Chiesi, GlaxoSmithKline, Nycomed, and TEVA. She has received funding from AstraZeneca, GlaxoSmithKline, and Nycomed. Travel to ERS or ATS has been partially funded by AstraZeneca, GlaxoSmithKline, Chiesi, and Nycomed. Prof. Mauad received a grant from Brazilian National Council for Scientific and Technological Development (CNPq) for the GLUCOLD project. Prof. Timens received a grant from The Netherlands Asthma Foundation, an unrestricted grant from Merck Sharp Dohme and payments for lectures at GlaxoSmithKline. In addition, he received travel expenses for invited lectures at British Division of the International Academy of Pathology, University of Giessen Lung Center, University of Graz, European Respiratory Society, and Menarini Diagnostics. Prof. Hiemstra received grants from Boehringer Ingelheim, Centocor, and Galapagos. The authors have no patents and products in development to declare. The authors did use fluticasone propionate and salmeterol (either the combination or fluticasone alone), which is marketed by GlaxoSmithKline, for our investigator-initiated study. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials. There are no other employments, patents and products in development or modified products to declare.	Annoni R, 2012, EUR RESPIR J, V40, P1362, DOI 10.1183/09031936.00192611; Black PN, 2008, EUR RESPIR J, V31, P998, DOI 10.1183/09031936.00017207; Brusselle GG, 2011, LANCET, V378, P1015, DOI 10.1016/S0140-6736(11)60988-4; Budulac SE, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-60; CHRZANOWSKI P, 1980, AM J MED, V69, P351, DOI 10.1016/0002-9343(80)90004-2; Churg A, 2009, AM J RESP CELL MOL, V40, P268, DOI 10.1165/rcmb.2007-0367OC; Deslee G, 2009, EUR RESPIR J, V34, P324, DOI 10.1183/09031936.00123008; Fernandes DJ, 2006, CURR DRUG TARGETS, V7, P567, DOI 10.2174/138945006776818700; Gao S, 2005, TOXICOL SCI, V87, P197, DOI 10.1093/toxsci/kfi212; GODFREY RWA, 1995, EUR RESPIR J, V8, P922; Gosselink JV, 2010, AM J RESP CRIT CARE, V181, P1329, DOI 10.1164/rccm.200812-1902OC; Hallgren O, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-55; Hogg JC, 2009, ANNU REV PATHOL-MECH, V4, P435, DOI 10.1146/annurev.pathol.4.110807.092145; Hsia CCW, 2010, AM J RESP CRIT CARE, V181, P394, DOI 10.1164/rccm.200809-1522ST; Jeffery P, 2003, AM J RESP CRIT CARE, V168, pS1, DOI 10.1164/rccm.200202-150WS; Kelly EA, 2003, CURR OPIN PULM MED, V9, P28, DOI 10.1097/00063198-200301000-00005; Krimmer DI, 2011, AM J RESP CELL MOL B; Kunz LIZ, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-34; Lapperre TS, 2009, ANN INTERN MED, V151, P517, DOI 10.7326/0003-4819-151-8-200910200-00004; Lapperre TS, 2006, THORAX, V61, P115, DOI 10.1136/thx.2005.040519; Merrilees MJ, 2008, RESP RES, V9, DOI 10.1186/1465-9921-9-41; Ning W, 2004, P NATL ACAD SCI USA, V101, P14895, DOI 10.1073/pnas.0401168101; QUANJER PH, 1993, EUR RESPIR J, V6, P5, DOI 10.1183/09041950.005s1693; Rabe KF, 2007, AM J RESP CRIT CARE, V176, P532, DOI 10.1164/rccm.200703-456SO; Rufino Rogerio, 2007, J. bras. pneumol., V33, P502, DOI 10.1590/S1806-37132007000500004; Russell REK, 2002, AM J RESP CELL MOL, V26, P602, DOI 10.1165/ajrcmb.26.5.4685; STERK PJ, 1993, EUR RESPIR J, V6, P53, DOI 10.1183/09041950.053s1693; Suki B, 2008, RESP PHYSIOL NEUROBI, V163, P33, DOI 10.1016/j.resp.2008.03.015; Takizawa H, 2001, AM J RESP CRIT CARE, V163, P1476, DOI 10.1164/ajrccm.163.6.9908135; Todorova L, 2006, AM J RESP CELL MOL, V34, P92, DOI 10.1165/rcmb.2005-0048OC; van Straaten JFM, 1999, MODERN PATHOL, V12, P697; Wang HJ, 2003, AM J PHYSIOL-LUNG C, V284, pL205, DOI 10.1152/ajplung.00042.2002; Wright JL, 2007, INHAL TOXICOL, V19, P915, DOI 10.1080/08958370701515563; Zandvoort A, 2008, RESP RES, V9, DOI 10.1186/1465-9921-9-83	34	16	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e63430	10.1371/journal.pone.0063430	http://dx.doi.org/10.1371/journal.pone.0063430			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667615	gold, Green Published, Green Submitted			2022-12-27	WOS:000319654700142
J	Li, Q; Cui, N; Du, YJ; Ma, HJ; Zhang, Y				Li, Qian; Cui, Na; Du, Yuanjie; Ma, Huijie; Zhang, Yi			Anandamide Reduces Intracellular Ca2+ Concentration through Suppression of Na+/Ca2+ Exchanger Current in Rat Cardiac Myocytes	PLOS ONE			English	Article							ISCHEMIA-REPERFUSION INJURY; VENTRICULAR MYOCYTES; CANNABINOID RECEPTOR; ISOLATED HEARTS; SODIUM/CALCIUM EXCHANGER; INTERMITTENT HYPOXIA; HYPERTENSIVE-RATS; INFARCT SIZE; CALCIUM; CB1	Purpose: Anandamide, one of the endocannabinoids, has been reported to exhibit cardioprotective properties, particularly in its ability to limit the damage produced by ischemia reperfusion injury. However, the mechanisms underlying the effect are not well known. This study is to investigate whether anandamide alter Na+/Ca2+ exchanger and the intracellular free Ca2+ concentration ([Ca2+](i)). Methods: Na+/Ca2+ exchanger current (I-NCX) was recorded and analysed by using whole-cell patch-clamp technique and [Ca2+](i) was measured by loading myocytes with the fluorescent Ca2+ indicator Fura-2/AM. Results: We found that I-NCX was enhanced significantly after perfusion with simulated ischemic external solution; [Ca2+](i) was also significantly increased by simulated ischemic solution. The reversal potential of I-NCX was shifted to negative potentials in simulated ischemic external solution. Anandamide (1-100 nM) failed to affect I-NCX and [Ca2+](i) in normal solution. However, anandamide (1-100 nM) suppressed the increase in INCX in simulated ischemic external solution concentration-dependently and normalized I-NCX reversal potential. Furthermore, anandamide (100 nM) significantly attenuated the increase in [Ca2+](i) in simulated ischemic solution. Blocking CB1 receptors with the specific antagonist AM251 (500 nM) failed to affect the effects of anandamide on I-NCX and [Ca2+](i) in simulated ischemic solution. CB2 receptor antagonist AM630 (100 nM) eliminated the effects of anandamide on I-NCX and [Ca2+](i) in simulated ischemic solution, and CB2 receptor agonist JWH133 (100 nM) simulated the effects of anandamide that suppressed the increase in I-NCX and [Ca2+](i) in simulated ischemic solution. In addition, pretreatment with the Gi/o-specific inhibitor pertussis toxin (PTX, 500 ng/ml) eliminated the effects of anandamide and JWH133 on I-NCX in simulated ischemic solution. Conclusions: Collectively, these findings suggest that anandamide suppresses calcium overload through inhibition of I-NCX during perfusion with simulated ischemic solution; the effects may be mediated by CB2 receptor via PTX-sensitive Gi/o proteins. This mechanism is importantly involved in the anti-ischemia injury caused by endocannabinoids.	[Li, Qian; Ma, Huijie; Zhang, Yi] Hebei Med Univ, Dept Physiol, Shijiazhuang, Peoples R China; [Cui, Na; Du, Yuanjie] Hebei Med Univ, Hosp 2, Dept Reprod, Shijiazhuang, Peoples R China	Hebei Medical University; Hebei Medical University	Zhang, Y (corresponding author), Hebei Med Univ, Dept Physiol, Shijiazhuang, Peoples R China.	zhyhenry@hotmail.com			National Natural Science Funds of China [31100823]; Hebei Province Health Bureau Scientific Research Funds [20110039]; Hebei Provincial Universities Outstanding Youth Science Funds [Y2012022]	National Natural Science Funds of China(National Natural Science Foundation of China (NSFC)); Hebei Province Health Bureau Scientific Research Funds; Hebei Provincial Universities Outstanding Youth Science Funds	This work was supported by the National Natural Science Funds of China (NO: 31100823); Hebei Province Health Bureau Scientific Research Funds (NO: 20110039), and Hebei Provincial Universities Outstanding Youth Science Funds (NO: Y2012022). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bonz A, 2003, J CARDIOVASC PHARM, V41, P657, DOI 10.1097/00005344-200304000-00020; Chen L, 2006, AM J PHYSIOL-CELL PH, V290, pC1221, DOI 10.1152/ajpcell.00526.2005; CORDEIRO JM, 1994, CARDIOVASC RES, V28, P1794, DOI 10.1093/cvr/28.12.1794; Currie S, 2008, J MOL CELL CARDIOL, V45, P804, DOI 10.1016/j.yjmcc.2008.07.005; Dipolo R, 2006, PHYSIOL REV, V86, P155, DOI 10.1152/physrev.00018.2005; Egger M, 1999, J MEMBRANE BIOL, V168, P107, DOI 10.1007/s002329900502; Evans RM, 2004, BRIT J PHARMACOL, V141, P1223, DOI 10.1038/sj.bjp.0705723; Felder CC, 1998, ANNU REV PHARMACOL, V38, P179, DOI 10.1146/annurev.pharmtox.38.1.179; Ford WR, 2002, BRIT J PHARMACOL, V135, P1191, DOI 10.1038/sj.bjp.0704565; Gardiner SM, 2001, BRIT J PHARMACOL, V133, P445, DOI 10.1038/sj.bjp.0704100; Grant I, 2005, CLIN NEUROSCI RES, V5, P185, DOI 10.1016/j.cnr.2005.08.015; Grynkiewicz G, 1985, J BIOL CHEM, V260, P3440; Hiley CR, 2009, J CARDIOVASC PHARM, V53, P267, DOI 10.1097/FJC.0b013e318192671d; Hiley CR, 2004, BIOL REV, V79, P187, DOI 10.1017/S1464793103006201; Imahashi K, 2005, CIRC RES, V97, P916, DOI 10.1161/01.RES.0000187456.06162.cb; KIEDROWSKI L, 1994, NEURON, V12, P295, DOI 10.1016/0896-6273(94)90272-0; Krylatov A. V., 2002, Eksperimental'naya i Klinicheskaya Farmakologiya, V65, P6; Krylatov AV, 2002, B EXP BIOL MED+, V133, P122, DOI 10.1023/A:1015574100494; Lake KD, 1997, HYPERTENSION, V29, P1204, DOI 10.1161/01.HYP.29.5.1204; Layland J, 2002, J PHYSIOL-LONDON, V540, P457, DOI 10.1113/jphysiol.2001.014126; Lee BK, 2012, J NEUROSCI RES, V90, P860, DOI 10.1002/jnr.22818; Lepicier P, 2003, BRIT J PHARMACOL, V139, P805, DOI 10.1038/sj.bjp.0705313; Lepicier P, 2007, LIFE SCI, V81, P1373, DOI 10.1016/j.lfs.2007.08.042; Li Q, 2012, AM J PHYSIOL-CELL PH, V302, pC924, DOI 10.1152/ajpcell.00228.2011; Li Q, 2009, BRIT J PHARMACOL, V158, P2022, DOI 10.1111/j.1476-5381.2009.00518.x; Mato S, 2009, GLIA, V57, P295, DOI 10.1002/glia.20757; MATSUDA LA, 1990, NATURE, V346, P561, DOI 10.1038/346561a0; Montecucco F, 2009, J MOL CELL CARDIOL, V46, P612, DOI 10.1016/j.yjmcc.2008.12.014; MUNRO S, 1993, NATURE, V365, P61, DOI 10.1038/365061a0; MURPHY E, 1991, CIRC RES, V68, P1250, DOI 10.1161/01.RES.68.5.1250; Murphy E, 1999, CIRC RES, V84, P1469; Murphy E, 2008, PHYSIOL REV, V88, P581, DOI 10.1152/physrev.00024.2007; Namekata I, 2006, EUR J PHARMACOL, V543, P108, DOI 10.1016/j.ejphar.2006.06.012; Pacher P, 2008, BRIT J PHARMACOL, V153, P252, DOI 10.1038/sj.bjp.0707582; Patterson M, 2007, J GEN PHYSIOL, V129, P29, DOI 10.1085/jgp.200609660; Pertwee RG, 1997, PHARMACOL THERAPEUT, V74, P129, DOI 10.1016/S0163-7258(97)82001-3; Ralevic V, 2002, LIFE SCI, V71, P2577, DOI 10.1016/S0024-3205(02)02086-6; Stein EA, 1996, BRIT J PHARMACOL, V119, P107, DOI 10.1111/j.1476-5381.1996.tb15683.x; Sterin-Borda L, 2005, BIOCHEM PHARMACOL, V69, P1705, DOI 10.1016/j.bcp.2005.03.027; Stojilkovic SS, 2009, ANN NY ACAD SCI, V1152, P174, DOI 10.1111/j.1749-6632.2008.03994.x; Tang Q, 2012, PFLUG ARCH EUR J PHY, V463, P513, DOI 10.1007/s00424-011-1070-y; Taniguchi S, 2004, J CARDIOVASC PHARM, V43, P629, DOI 10.1097/00005344-200405000-00004; Ugdyzhekova DS, 2001, B EXP BIOL MED+, V131, P251, DOI 10.1023/A:1017651432193; Underdown NJ, 2005, BRIT J PHARMACOL, V146, P809, DOI 10.1038/sj.bjp.0706391; Wang J, 2007, PHYSIOL RES, V56, P17, DOI 10.33549/physiolres.930894; Wang YG, 2003, CIRC RES, V93, P776, DOI 10.1161/01.RES.0000094746.24774.DC; Yamamoto W, 2008, EUR J PHARMACOL, V583, P56, DOI 10.1016/j.ejphar.2008.01.010; Yu SP, 1997, EUR J NEUROSCI, V9, P1273, DOI 10.1111/j.1460-9568.1997.tb01482.x; Zhang Y, 2000, LIFE SCI, V67, P2465, DOI 10.1016/S0024-3205(00)00832-8	49	15	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e63386	10.1371/journal.pone.0063386	http://dx.doi.org/10.1371/journal.pone.0063386			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667607	Green Published, gold, Green Submitted			2022-12-27	WOS:000319654700136
J	Ma, YN; Wang, J; Dong, GH; Liu, MM; Wang, D; Liu, YQ; Zhao, Y; Ren, WH; Lee, YL; Zhao, YD; He, QC				Ma, Ya-Nan; Wang, Jing; Dong, Guang-Hui; Liu, Miao-Miao; Wang, Da; Liu, Yu-Qin; Zhao, Yang; Ren, Wan-Hui; Lee, Yungling Leo; Zhao, Ya-Dong; He, Qin-Cheng			Predictive Equations Using Regression Analysis of Pulmonary Function for Healthy Children in Northeast China	PLOS ONE			English	Article							SPIROMETRIC REFERENCE VALUES; ASTHMA-RELATED SYMPTOMS; LUNG-FUNCTION; HONG-KONG; ADOLESCENTS; STANDARDIZATION; GAP	Background: There have been few published studies on spirometric reference values for healthy children in China. We hypothesize that there would have been changes in lung function that would not have been precisely predicted by the existing spirometric reference equations. The objective of the study was to develop more accurate predictive equations for spirometric reference values for children aged 9 to 15 years in Northeast China. Methodology/Principal Findings: Spirometric measurements were obtained from 3,922 children, including 1,974 boys and 1,948 girls, who were randomly selected from five cities of Liaoning province, Northeast China, using the ATS (American Thoracic Society) and ERS (European Respiratory Society) standards. The data was then randomly split into a training subset containing 2078 cases and a validation subset containing 1844 cases. Predictive equations used multiple linear regression techniques with three predictor variables: height, age and weight. Model goodness of fit was examined using the coefficient of determination or the R-2 and adjusted R-2. The predicted values were compared with those obtained from the existing spirometric reference equations. The results showed the prediction equations using linear regression analysis performed well for most spirometric parameters. Paired t-tests were used to compare the predicted values obtained from the developed and existing spirometric reference equations based on the validation subset. The t-test for males was not statistically significant (p>0.01). The predictive accuracy of the developed equations was higher than the existing equations and the predictive ability of the model was also validated. Conclusion/Significance: We developed prediction equations using linear regression analysis of spirometric parameters for children aged 9-15 years in Northeast China. These equations represent the first attempt at predicting lung function for Chinese children following the ATS/ERS Task Force 2005 guidelines on spirometry standardization.	[Ma, Ya-Nan; Dong, Guang-Hui; Liu, Miao-Miao; Wang, Da; Liu, Yu-Qin; Zhao, Yang; He, Qin-Cheng] China Med Univ, Sch Publ Hlth, Dept Biostat & Epidemiol, Shenyang, Liaoning Provin, Peoples R China; [Wang, Jing] St Louis Univ, Dept Biostat, Sch Publ Hlth, St Louis, MO 63103 USA; [Ren, Wan-Hui] Shenyang Environm Monitoring Ctr, Dept Ambient Air Pollut Monitor, Shenyang, Liaoning Provin, Peoples R China; [Lee, Yungling Leo] Natl Taiwan Univ, Coll Publ Hlth, Inst Epidemiol & Prevent Med, Taipei 100, Taiwan; [Zhao, Ya-Dong] China Med Univ, Affiliated Hosp 1, Inst Resp Dis, Shenyang, Liaoning Provin, Peoples R China	China Medical University; Saint Louis University; National Taiwan University; China Medical University	Dong, GH (corresponding author), China Med Univ, Sch Publ Hlth, Dept Biostat & Epidemiol, Shenyang, Liaoning Provin, Peoples R China.	ghdong@mail.cmu.edu.cn; qche@mail.cmu.edu.cn	Lee, Yungling/S-7011-2018; Dong, Guanghui/AAN-4630-2020	Lee, Yungling/0000-0002-2234-9479; Dong, Guang-Hui/0000-0002-2578-3369; Liu, Miao/0000-0002-7975-6702	Liaoning Province Science and Technology Foundation [2005225003-1]; China Environmental Protection Foundation [CEPF2008-123-1-5, CEPF2010-123-1-3]	Liaoning Province Science and Technology Foundation; China Environmental Protection Foundation	This research was supported by grants from Liaoning Province Science and Technology Foundation (No. 2005225003-1) and grants from China Environmental Protection Foundation (CEPF2008-123-1-5; CEPF2010-123-1-3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexandraki S, 2010, IN VIVO, V24, P195; [Anonymous], 1995, AM J RESP CRIT CARE, V152, P1107, DOI 10.1164/ajrccm.152.3.7663792; Blonshine S, 2012, GLOBAL LUNGS INITIAT; Boskabady MH, 2004, RESPIROLOGY, V9, P535, DOI 10.1111/j.1440-1843.2004.00623.x; Chhabra S K, 2012, Indian J Chest Dis Allied Sci, V54, P59; CONNETT GJ, 1994, THORAX, V49, P901, DOI 10.1136/thx.49.9.901; Dong GH, 2008, J INVEST ALLERG CLIN, V18, P207; Enright P, 2008, MT SINAI J MED, V75, P109, DOI 10.1002/msj.20027; Feng K, 2011, J KOREAN MED SCI, V26, P1469, DOI 10.3346/jkms.2011.26.11.1469; Ferguson GT, 2000, CHEST, V117, P1146, DOI 10.1378/chest.117.4.1146; Gao Y, 2012, ARCH DIS CH IN PRESS, V12; Golshan M, 2003, EUR RESPIR J, V22, P529, DOI 10.1183/09031936.03.00003603; GREENOUGH A, 1991, PEDIATR PULM, V11, P207, DOI 10.1002/ppul.1950110305; Hankinson JL, 1999, AM J RESP CRIT CARE, V159, P179, DOI 10.1164/ajrccm.159.1.9712108; Harik-Khan RI, 2001, AM J RESP CRIT CARE, V164, P1647, DOI 10.1164/ajrccm.164.9.2106075; Ip MSM, 2000, AM J RESP CRIT CARE, V162, P424, DOI 10.1164/ajrccm.162.2.9905057; Ip MSM, 2000, AM J RESP CRIT CARE, V162, P430, DOI 10.1164/ajrccm.162.2.9905058; Jeng MJ, 2009, PEDIATR PULM, V44, P676, DOI 10.1002/ppul.21038; Liang BM, 2012, RESPIROLOGY, V17, P611, DOI 10.1111/j.1440-1843.2012.02149.x; Liu GH, 1990, NATL NORMAL VALUES P, P10; Musafiri S, 2012, RESPIRATION IN PRESS, V11; National Bureau of Statistics of China, 2010, 6 NAT CENS DAT; Nysom K, 1997, EUR RESPIR J, V10, P1591, DOI 10.1183/09031936.97.10071591; Pellegrino R, 2005, EUR RESPIR J, V26, P948, DOI 10.1183/09031936.05.00035205; Salo PM, 2004, ANN EPIDEMIOL, V14, P543, DOI 10.1016/j.annepidem.2003.09.015; Stanojevic S, 2010, EUR RESPIR J, V36, P12, DOI 10.1183/09031936.00143209; Subbarao P, 2004, PEDIATR PULM, V37, P515, DOI 10.1002/ppul.20015; Tabka Z, 1995, Tunis Med, V73, P125; Takase M, 2012, PEDIAT PULMONOL, V19, P1; TAUSSIG LM, 1980, J PEDIATR-US, V97, P668, DOI 10.1016/S0022-3476(80)80039-4; Tsai MC, 2010, J CHIN MED ASSOC, V73, P21, DOI 10.1016/S1726-4901(10)70017-4; Vijayan V K, 2000, Indian J Chest Dis Allied Sci, V42, P147; *WHO, 1995, TECHN REP SER WHO, V854; Wu YH, 2009, J OCCUP HEALTH, V51, P471, DOI 10.1539/joh.L9006; Zhang JF, 2002, ENVIRON HEALTH PERSP, V110, P961, DOI 10.1289/ehp.02110961	35	28	28	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e63875	10.1371/journal.pone.0063875	http://dx.doi.org/10.1371/journal.pone.0063875			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667682	Green Submitted, gold, Green Published			2022-12-27	WOS:000319654700192
J	Merz, K; Lie, DC				Merz, Katharina; Lie, D. Chichung			Evidence that Doublecortin Is Dispensable for the Development of Adult Born Neurons in Mice	PLOS ONE			English	Article							SUBCORTICAL LAMINAR HETEROTOPIA; MICROTUBULE-ASSOCIATED PROTEIN; OLFACTORY-BULB; HIPPOCAMPAL NEUROGENESIS; MAMMALIAN BRAIN; GRANULE CELLS; KNOCKOUT MICE; MIGRATION; EXPRESSION; MATURATION	In mammals, adult neural stem cells give rise to new hippocampal dentate granule neurons and interneurons of the olfactory bulb throughout life. The microtubule associated protein Doublecortin (DCX) is expressed by migrating neuroblasts and immature neurons, and is widely used as a stage-specific marker of adult neurogenesis and as a marker to identify neurogenic activity in the adult brain per se. Mutations in the DCX gene have been causally linked to human lissencephalic syndromes. Moreover, embryonic loss of DCX function interferes with neuronal migration and dendritic patterning in a species- and region-specific manner. A putative function of DCX in adult neurogenesis has not been directly explored. Here we show that overexpression of DCX in newly generated dentate granule neurons of the adult mouse brain has no effect on morphological maturation or migration. We also show that micro (mi) RNA-mediated retroviral knockdown of DCX does not alter morphological maturation of adult born dentate granule cells or migration of new neurons in either adult neurogenic niche. Thus, the present data indicate that DCX is dispensable for the development of new neurons in adult mice.	[Merz, Katharina; Lie, D. Chichung] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Dev Genet, Res Grp Adult Neurogenesis & Neural Stem Cells, Munich, Germany; [Lie, D. Chichung] Univ Erlangen Nurnberg, Inst Biochem, Emil Fischer Ctr, D-91054 Erlangen, Germany	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Erlangen Nuremberg	Lie, DC (corresponding author), German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Dev Genet, Res Grp Adult Neurogenesis & Neural Stem Cells, Munich, Germany.	c.lie@biochem.uni-erlangen.de	Lie, Dieter Chichung/S-7914-2017; Lie, Dieter Chichung/AAS-8604-2020	Lie, Dieter Chichung/0000-0002-6035-6442; Lie, Dieter Chichung/0000-0002-6035-6442	European Young Investigator Award of the European Science Foundation [DFG 858/6-3]; Marie Curie Excellence Team Program of the European Union; Marie Curie Reintegration Program of the European Union; Bavarian Research Network on Adult Neural Stem Cells "FORNEUROCELL"; Helmholtz Alliance for Mental Health in an Ageing Society; BMBF Network "Cell Based Regenerative Medicine''; European Commission Coordination Action ENINET (Network of European Neuroscience Institutes) [LSHM-CT-2005-19063]	European Young Investigator Award of the European Science Foundation; Marie Curie Excellence Team Program of the European Union; Marie Curie Reintegration Program of the European Union; Bavarian Research Network on Adult Neural Stem Cells "FORNEUROCELL"; Helmholtz Alliance for Mental Health in an Ageing Society; BMBF Network "Cell Based Regenerative Medicine''; European Commission Coordination Action ENINET (Network of European Neuroscience Institutes)	This work was supported by the European Young Investigator Award of the European Science Foundation (DFG 858/6-3), the Marie Curie Excellence Team Program and the Marie Curie Reintegration Program of the European Union, the Bavarian Research Network on Adult Neural Stem Cells "FORNEUROCELL'', the Helmholtz Alliance for Mental Health in an Ageing Society, the BMBF Network "Cell Based Regenerative Medicine'', and the European Commission Coordination Action ENINET (Network of European Neuroscience Institutes; contract number LSHM-CT-2005-19063). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai JL, 2003, NAT NEUROSCI, V6, P1277, DOI 10.1038/nn1153; Belvindrah R, 2011, J NEUROSCI, V31, P7551, DOI 10.1523/JNEUROSCI.6716-10.2011; Brandt MD, 2003, MOL CELL NEUROSCI, V24, P603, DOI 10.1016/S1044-7431(03)00207-0; Corbo JC, 2002, J NEUROSCI, V22, P7548; Couillard-Despres S, 2005, EUR J NEUROSCI, V21, P1, DOI 10.1111/j.1460-9568.2004.03813.x; Couillard-Despres S, 2006, EUR J NEUROSCI, V24, P1535, DOI 10.1111/j.1460-9568.2006.05039.x; des Portes V, 1998, HUM MOL GENET, V7, P1063, DOI 10.1093/hmg/7.7.1063; des Portes V, 1998, CELL, V92, P51; Deuel TAS, 2006, NEURON, V49, P41, DOI 10.1016/j.neuron.2005.10.038; Dijkmans Thomas Frederik, 2010, Central Nervous System Agents in Medicinal Chemistry, V10, P32; Ehm O, 2010, J NEUROSCI, V30, P13794, DOI 10.1523/JNEUROSCI.1567-10.2010; Francis F, 1999, NEURON, V23, P247, DOI 10.1016/S0896-6273(00)80777-1; Gleeson JG, 1999, NEURON, V23, P257, DOI 10.1016/S0896-6273(00)80778-3; Hack MA, 2005, NAT NEUROSCI, V8, P865, DOI 10.1038/nn1479; Jagasia R, 2009, J NEUROSCI, V29, P7966, DOI 10.1523/JNEUROSCI.1054-09.2009; Jessberger S, 2007, J NEUROSCI, V27, P9400, DOI 10.1523/JNEUROSCI.2002-07.2007; Kappeler C, 2006, HUM MOL GENET, V15, P1387, DOI 10.1093/hmg/ddl062; Kempermann G, 2004, TRENDS NEUROSCI, V27, P447, DOI 10.1016/j.tins.2004.05.013; Kim JY, 2009, NEURON, V63, P761, DOI 10.1016/j.neuron.2009.08.008; Kim MH, 2003, NAT STRUCT BIOL, V10, P324, DOI 10.1038/nsb918; Klempin F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025760; Koizumi H, 2006, NEURON, V49, P55, DOI 10.1016/j.neuron.2005.10.040; Koizumi H, 2006, NAT NEUROSCI, V9, P779, DOI 10.1038/nn1704; Lemasson M, 2005, J NEUROSCI, V25, P6816, DOI 10.1523/JNEUROSCI.1114-05.2005; LOIS C, 1994, SCIENCE, V264, P1145, DOI 10.1126/science.8178174; Mathews EA, 2010, J COMP NEUROL, V518, P4479, DOI 10.1002/cne.22489; Ming GL, 2011, NEURON, V70, P687, DOI 10.1016/j.neuron.2011.05.001; Mu LF, 2012, J NEUROSCI, V32, P3067, DOI 10.1523/JNEUROSCI.4679-11.2012; Overstreet-Wadiche LS, 2006, J NEUROSCI, V26, P4095, DOI 10.1523/JNEUROSCI.5508-05.2006; Parent JM, 1997, J NEUROSCI, V17, P3727; Petreanu L, 2002, J NEUROSCI, V22, P6106; Piatti VC, 2011, J NEUROSCI, V31, P7715, DOI 10.1523/JNEUROSCI.1380-11.2011; Ramos RL, 2006, CEREB CORTEX, V16, P1323, DOI 10.1093/cercor/bhj074; Reiner O, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-188; Rottach A, 2008, HYBRIDOMA, V27, P337, DOI 10.1089/hyb.2008.0031; Saaltink DJ, 2012, J COMP NEUROL, V520, P2805, DOI 10.1002/cne.23144; Tanaka T, 2006, CEREB CORTEX, V16, pI69, DOI 10.1093/cercor/bhk005; Tashiro A, 2006, NATURE, V442, P929, DOI 10.1038/nature05028; Tuy FPD, 2008, DEV NEUROSCI-BASEL, V30, P171, DOI 10.1159/000109861; Zhao CM, 2006, J NEUROSCI, V26, P3, DOI 10.1523/JNEUROSCI.3648-05.2006	40	15	16	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e62693	10.1371/journal.pone.0062693	http://dx.doi.org/10.1371/journal.pone.0062693			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667508	Green Published, gold, Green Submitted			2022-12-27	WOS:000319654700056
J	Park, EY; Lim, MK; Oh, JK; Cho, H; Bae, MJ; Yun, EH; Kim, DI; Shin, HR				Park, Eun Young; Lim, Min Kyung; Oh, Jin-Kyoung; Cho, Heeyoun; Bae, Mi Jin; Yun, E. Hwa; Kim, Dong-il; Shin, Hai-Rim			Independent and Supra-Additive Effects of Alcohol Consumption, Cigarette Smoking, and Metabolic Syndrome on the Elevation of Serum Liver Enzyme Levels	PLOS ONE			English	Article							GAMMA-GLUTAMYL-TRANSFERASE; FATTY LIVER; ALANINE AMINOTRANSFERASE; CARDIOVASCULAR-DISEASE; SOCIOECONOMIC-STATUS; HEPATIC STEATOSIS; NATURAL-HISTORY; RISK; PREVALENCE; PREDICTOR	We investigated the independent and combined effects of alcohol consumption, cigarette smoking and metabolic syndrome on abnormal liver function, i.e., the elevation of serum liver enzyme levels. Participants of a Korean populationbased prospective cohort aged >= 30 years without liver disease, diabetes, or cardiovascular diseases were included. Information on alcohol consumption, smoking status, and metabolic syndrome, defined as per the criteria of the Adult Treatment Panel III, were applied to evaluate their impact on serum levels of aspartate aminotransferase (AST), alanine aminotransferase (ALT), and gamma-glutamyl transferase (GGT). Alcohol consumption, cigarette smoking and metabolic syndrome were the significant individual factors that elevated serum liver enzyme levels. Supra-additive effects of metabolic syndrome and either alcohol consumption or cigarette smoking were also identified. The combination of heavy drinking (>= 24 g/day) and metabolic syndrome conferred an effect that was higher than the sum of the two individual effects (Synergic Index (SI): AST, 2.37 [1.20-4.67]; GGT, 1.91 [1.17-3.13]). Only GGT level (odds ratio 6.04 [3.68-9.94], SI 2.33 [1.24-4.41]) was significantly elevated when the effect of moderate drinking (<24 g/day) and metabolic syndrome was combined. The combined effect of any level of alcohol consumption and cigarette smoking was also supra-additive on the elevation of GGT level with SIs of 5.57 for drinking <24 g/day and smoking <= 20 pack years, 5.12 for <24 g/day and >20 pack years, 1.80 for >= 24 g/day and <= 20 pack years, 2.03 for >= 24 g/day and >20 pack years, while only the combined effect of drinking >= 24 g/day and smoking >20 pack years elevated the AST level (SI 4.55 [3.12-6.61]). The combined effect of cigarette smoking and metabolic syndrome was not supra-additive. To prevent fatty liver disease and other related diseases, a multifactorial prevention strategy that includes limited alcohol consumption, smoking cessation and rectification of adverse metabolic profiles is required.	[Park, Eun Young; Lim, Min Kyung; Oh, Jin-Kyoung; Cho, Heeyoun; Bae, Mi Jin; Yun, E. Hwa; Shin, Hai-Rim] Natl Canc Ctr, Natl Canc Control Inst, Goyang, South Korea; [Park, Eun Young] Seoul Natl Univ, Coll Med, Dept Prevent Med, Seoul, South Korea; [Kim, Dong-il] Sungkunkwan Univ, Sch Med, Samsung Med Ctr, Dept Occupat & Environm Med, Suwon, South Korea; [Shin, Hai-Rim] WHO, Western Pacific Reg Off, Non Communicable Dis & Hlth Promot, Manila, Philippines	National Cancer Center - Korea (NCC); Seoul National University (SNU); Sungkyunkwan University (SKKU); Samsung Medical Center; WHO Western Pacific Regional Office; World Health Organization	Lim, MK (corresponding author), Natl Canc Ctr, Natl Canc Control Inst, Goyang, South Korea.	mickey@ncc.re.kr	Lim, Min Kyung/AAL-5271-2020	Lim, Min Kyung/0000-0002-8224-2171; Oh, Jin-Kyoung/0000-0001-9331-3054	National Cancer Center, Korea	National Cancer Center, Korea	The sole supporter of this study was the intramural research fund of the National Cancer Center, Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams LA, 2008, J GASTROEN HEPATOL, V23, P1089, DOI 10.1111/j.1440-1746.2008.05451.x; Andersson T, 2005, EUR J EPIDEMIOL, V20, P575, DOI 10.1007/s10654-005-7835-x; Azzalini L, 2010, HEPATOLOGY, V51, P1567, DOI 10.1002/hep.23516; Barba C, 2004, LANCET, V363, P157, DOI 10.1016/S0140-6736(03)15268-3; Bataller R, 2006, HEPATOLOGY, V44, P1394, DOI 10.1002/hep.21484; Bedogni G, 2005, HEPATOLOGY, V42, P44, DOI 10.1002/hep.20734; Bellentani S, 1997, GUT, V41, P845, DOI 10.1136/gut.41.6.845; BELLENTANI S, 1994, HEPATOLOGY, V20, P1442, DOI 10.1002/hep.1840200611; Bellentani S, 2010, DIGEST DIS, V28, P155, DOI 10.1159/000282080; Bellentani S, 2009, ANN HEPATOL, V8, pS4, DOI 10.1016/S1665-2681(19)31820-4; Blachier M, 2013, J HEPATOL, V58, P593, DOI 10.1016/j.jhep.2012.12.005; Breitling LP, 2009, HEPATOLOGY, V49, P802, DOI 10.1002/hep.22727; Browning JD, 2004, HEPATOLOGY, V40, P1387, DOI 10.1002/hep.20466; Browning JD, 2004, J CLIN INVEST, V114, P147, DOI 10.1172/JCI200422422; Clark JM, 2002, GASTROENTEROLOGY, V122, P1649, DOI 10.1053/gast.2002.33573; Clark JM, 2003, AM J GASTROENTEROL, V98, P960, DOI [10.1016/S0002-9270(03)00265-X, 10.1111/j.1572-0241.2003.07486.x]; El-Zayadi AR, 2006, WORLD J GASTROENTERO, V12, P6098, DOI 10.3748/wjg.v12.i38.6098; Farrell GC, 2013, NAFLD ASIA AS COMMON; Gami AS, 2007, J AM COLL CARDIOL, V49, P403, DOI 10.1016/j.jacc.2006.09.032; Gunji T, 2009, AM J GASTROENTEROL, V104, P2189, DOI 10.1038/ajg.2009.361; Hamabe A, 2011, J GASTROENTEROL, V46, P769, DOI 10.1007/s00535-011-0376-z; Hamaguchi M, 2007, WORLD J GASTROENTERO, V13, P1579, DOI 10.3748/wjg.v13.i10.1579; Hamaguchi M, 2012, WORLD J GASTROENTERO, V18, P156, DOI 10.3748/wjg.v18.i2.156; Haren MT, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-454; Hiramine Y, 2011, J GASTROENTEROL, V46, P519, DOI 10.1007/s00535-010-0336-z; Hsieh MH, 2009, INT J OBESITY, V33, P1309, DOI 10.1038/ijo.2009.172; Kim HC, 2004, BMJ-BRIT MED J, V328, P983, DOI 10.1136/bmj.38050.593634.63; Koh WP, 2011, BRIT J CANCER, V105, P1430, DOI 10.1038/bjc.2011.360; Lakka HM, 2002, JAMA-J AM MED ASSOC, V288, P2709, DOI 10.1001/jama.288.21.2709; Lanthier N, 2009, CURR OPIN CLIN NUTR, V12, P404, DOI 10.1097/MCO.0b013e32832c7819; Lee DH, 2001, INT J EPIDEMIOL, V30, P766, DOI 10.1093/ije/30.4.766; Li M, 2009, OBESITY, V17, P809, DOI 10.1038/oby.2008.617; Lim H, 2012, DIABETES CARE, V35, P2028, DOI 10.2337/dc11-1841; Liou I, 2006, J CLIN GASTROENTEROL, V40, pS11; McClain CJ, 2004, ALCOHOL, V34, P67, DOI 10.1016/j.alcohol.2004.07.007; Meisinger C, 2006, ATHEROSCLEROSIS, V189, P297, DOI 10.1016/j.atherosclerosis.2006.01.010; National Cholesterol Education Program, 2002, DET EV TREATM HIGH B; National Institute on Alcohol Abuse and Alcoholism, 1992, MOD DRINK ALC AL NO; Nobili V, 2009, WORLD J GASTROENTERO, V15, P6017, DOI 10.3748/wjg.15.6017; Oh SY, 2006, METABOLISM, V55, P1604, DOI 10.1016/j.metabol.2006.07.021; Park SJ, 2012, DIABETES RES CLIN PR, V96, P400, DOI 10.1016/j.diabres.2011.12.025; Pessione F, 2001, HEPATOLOGY, V34, P121, DOI 10.1053/jhep.2001.25385; Puukka K, 2006, AM J CLIN NUTR, V83, P1351, DOI 10.1093/ajcn/83.6.1351; Sakugawa H, 2004, WORLD J GASTROENTERO, V10, P1052; Sattar N, 2007, DIABETES, V56, P984, DOI 10.2337/db06-1256; Schindhelm RK, 2007, ATHEROSCLEROSIS, V191, P391, DOI 10.1016/j.atherosclerosis.2006.04.006; Schwimmer JB, 2010, GASTROENTEROLOGY, V138, P1357, DOI 10.1053/j.gastro.2009.12.052; Shin A, 2009, J AM DIET ASSOC, V109, P633, DOI 10.1016/j.jada.2008.12.015; Wilson PWF, 2005, CIRCULATION, V112, P3066, DOI 10.1161/CIRCULATIONAHA.105.539528; Yoon YS, 2006, OBESITY, V14, P909, DOI 10.1038/oby.2006.105; Zheng MH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043736	51	29	30	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e63439	10.1371/journal.pone.0063439	http://dx.doi.org/10.1371/journal.pone.0063439			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667618	Green Published, Green Submitted, gold			2022-12-27	WOS:000319654700145
J	Katayama, M; Ohmura, K; Yukawa, N; Terao, C; Hashimoto, M; Yoshifuji, H; Kawabata, D; Fujii, T; Iwakura, Y; Mimori, T				Katayama, Masaki; Ohmura, Koichiro; Yukawa, Naoichiro; Terao, Chikashi; Hashimoto, Motomu; Yoshifuji, Hajime; Kawabata, Daisuke; Fujii, Takao; Iwakura, Yoichiro; Mimori, Tsuneyo			Neutrophils Are Essential as a Source of IL-17 in the Effector Phase of Arthritis	PLOS ONE			English	Article							AUTOANTIBODY-INDUCED ARTHRITIS; COLLAGEN-INDUCED ARTHRITIS; T-CELLS; RHEUMATOID-ARTHRITIS; MAST-CELLS; INTERLEUKIN-17; INITIATION; CYTOKINES; RECEPTOR; DISEASE	Objective: Th17 has been shown to have a pivotal role in the development of arthritis. However, the role of IL-17 in the T cell-independent effector phase has not fully been examined. We investigated whether IL-17 is involved in the effector phase of arthritis by using K/BxN serum-induced arthritis model. Methods: K/BxN serum was transferred into IL-17 knockout (KO) mice, SCID mice and their control mice, and arthritis was evaluated over time. In order to clarify the source of IL-17 in the effector phase, neutrophils or CD4+ T cells collected from IL-17 KO or control mice were injected into IL-17 KO recipient mice together with K/BxN serum. To examine if neutrophils secrete IL-17 upon stimulation, neutrophils were stimulated with immune complex in vitro and IL-17 in the supernatant was measured by ELISA. Results: K/BxN serum-induced arthritis was much less severe in IL-17 KO mice than in WT mice. Since K/BxN serum-transferred SCID mice developed severe arthritis with high serum IL-17 concentration, we speculated neutrophils are the responsible player as an IL-17 source. When wild type (WT) but not IL-17 KO neutrophils were co-injected with K/BxN serum into IL-17 KO mice, arthritis was exacerbated, whereas co-injection of WT CD4+ T cells had no effect. In vitro, stimulation of neutrophils with immune complexcaused IL-17 secretion. Conclusions: Neutrophils are essential as a source of IL-17 in the effector phase of arthritis. The trigger of secreting IL-17 from neutrophils may be immune complex.	[Katayama, Masaki; Ohmura, Koichiro; Yukawa, Naoichiro; Terao, Chikashi; Yoshifuji, Hajime; Kawabata, Daisuke; Mimori, Tsuneyo] Kyoto Univ, Grad Sch Med, Dept Rheumatol & Clin Immunol, Kyoto, Japan; [Terao, Chikashi] Kyoto Univ, Grad Sch Med, Ctr Genet Med, Kyoto, Japan; [Hashimoto, Motomu; Fujii, Takao] Kyoto Univ, Grad Sch Med, Dept Control Rheumat Dis, Kyoto, Japan; [Iwakura, Yoichiro] Univ Tokyo, Inst Med Sci, Ctr Expt Med & Syst Biol, Tokyo, Japan	Kyoto University; Kyoto University; Kyoto University; University of Tokyo	Ohmura, K (corresponding author), Kyoto Univ, Grad Sch Med, Dept Rheumatol & Clin Immunol, Kyoto, Japan.	ohmurako@kuhp.kyoto-u.ac.jp	Iwakura, Yoichiro/E-5457-2011; Yoshifuji, Hajime/AAZ-1657-2020	Iwakura, Yoichiro/0000-0002-9934-5775; 	Japan Society for Promotion of Science; Ministry of Health and Welfare of Japan; Grants-in-Aid for Scientific Research [24659274] Funding Source: KAKEN	Japan Society for Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Health and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by grants from the Japan Society for Promotion of Science and the Ministry of Health and Welfare of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chabaud M, 1999, ARTHRITIS RHEUM-US, V42, P963, DOI 10.1002/1529-0131(199905)42:5<963::AID-ANR15>3.0.CO;2-E; Ferretti S, 2003, J IMMUNOL, V170, P2106, DOI 10.4049/jimmunol.170.4.2106; Fossiez F, 1996, J EXP MED, V183, P2593, DOI 10.1084/jem.183.6.2593; Hoshino A, 2008, J AUTOIMMUN, V31, P79, DOI 10.1016/j.jaut.2008.03.006; Hueber AJ, 2010, J IMMUNOL, V184, P3336, DOI 10.4049/jimmunol.0903566; Ito Y, 2009, ARTHRITIS RHEUM-US, V60, P2294, DOI 10.1002/art.24687; Jacobs JP, 2009, P NATL ACAD SCI USA, V106, P21789, DOI 10.1073/pnas.0912152106; Ji H, 2002, IMMUNITY, V16, P157, DOI 10.1016/S1074-7613(02)00275-3; Ji H, 2002, J EXP MED, V196, P77, DOI 10.1084/jem.20020439; Jovanovic DV, 1998, J IMMUNOL, V160, P3513; Korganow AS, 1999, IMMUNITY, V10, P451, DOI 10.1016/S1074-7613(00)80045-X; Kouskoff V, 1996, CELL, V87, P811, DOI 10.1016/S0092-8674(00)81989-3; Lee DM, 2002, SCIENCE, V297, P1689, DOI 10.1126/science.1073176; Li L, 2010, J CLIN INVEST, V120, P331, DOI 10.1172/JCI38702; Lin AM, 2011, J IMMUNOL, V187, P490, DOI 10.4049/jimmunol.1100123; Lockhart E, 2006, J IMMUNOL, V177, P4662, DOI 10.4049/jimmunol.177.7.4662; Matsumoto I, 1999, SCIENCE, V286, P1732, DOI 10.1126/science.286.5445.1732; Michel ML, 2008, P NATL ACAD SCI USA, V105, P19845, DOI 10.1073/pnas.0806472105; Nakae S, 2003, J IMMUNOL, V171, P6173, DOI 10.4049/jimmunol.171.11.6173; Nakae S, 2003, P NATL ACAD SCI USA, V100, P5986, DOI 10.1073/pnas.1035999100; Sadik CD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026342; Sutton CE, 2009, IMMUNITY, V31, P331, DOI 10.1016/j.immuni.2009.08.001; Wipke BT, 2004, J IMMUNOL, V172, P7694, DOI 10.4049/jimmunol.172.12.7694; Wipke BT, 2001, J IMMUNOL, V167, P1601, DOI 10.4049/jimmunol.167.3.1601; Yao ZB, 1995, IMMUNITY, V3, P811, DOI 10.1016/1074-7613(95)90070-5	25	60	63	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2013	8	5							e62231	10.1371/journal.pone.0062231	http://dx.doi.org/10.1371/journal.pone.0062231			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	177QL	23671588	Green Published, Green Submitted, gold			2022-12-27	WOS:000321390200017
J	de Marco, R; Pesce, G; Marcon, A; Accordini, S; Antonicelli, L; Bugiani, M; Casali, L; Ferrari, M; Nicolini, G; Panico, MG; Pirina, P; Zanolin, ME; Cerveri, I; Verlato, G				de Marco, Roberto; Pesce, Giancarlo; Marcon, Alessandro; Accordini, Simone; Antonicelli, Leonardo; Bugiani, Massimiliano; Casali, Lucio; Ferrari, Marcello; Nicolini, Gabriele; Panico, Maria Grazia; Pirina, Pietro; Zanolin, Maria Elisabetta; Cerveri, Isa; Verlato, Giuseppe			The Coexistence of Asthma and Chronic Obstructive Pulmonary Disease (COPD): Prevalence and Risk Factors in Young, Middle-aged and Elderly People from the General Population	PLOS ONE			English	Article							ALLERGIC RHINITIS; DIAGNOSED COPD; LUNG-DISEASE; ADULTS; SEVERITY; SMOKING; BURDEN; COHORT	Background: The joint distribution of asthma and chronic obstructive pulmonary disease (COPD) has not been well described. This study aims at determining the prevalence of self-reported physician diagnoses of asthma, COPD and of the asthma-COPD overlap syndrome and to assess whether these conditions share a common set of risk factors. Methods: A screening questionnaire on respiratory symptoms, diagnoses and risk factors was administered by mail or phone to random samples of the general Italian population aged 20-44 (n = 5163) 45-64 (n = 2167) and 65-84 (n = 1030) in the frame of the multicentre Gene Environment Interactions in Respiratory Diseases (GEIRD) study. Results: A physician diagnosis of asthma or COPD (emphysema/chronic bronchitis/COPD) was reported by 13% and 21% of subjects aged <65 and 65-84 years respectively. Aging was associated with a marked decrease in the prevalence of diagnosed asthma (from 8.2% to 1.6%) and with a marked increase in the prevalence of diagnosed COPD (from 3.3% to 13.3%). The prevalence of the overlap of asthma and COPD was 1.6% (1.3%-2.0%), 2.1% (1.5%-2.8%) and 4.5% (3.2%-5.9%) in the 20-44, 45-64 and 65-84 age groups. Subjects with both asthma and COPD diagnoses were more likely to have respiratory symptoms, physical impairment, and to report hospital admissions compared to asthma or COPD alone (p<0.01). Age, sex, education and smoking showed different and sometimes opposite associations with the three conditions. Conclusion: Asthma and COPD are common in the general population, and they coexist in a substantial proportion of subjects. The asthma-COPD overlap syndrome represents an important clinical phenotype that deserves more medical attention and further research.	[de Marco, Roberto; Pesce, Giancarlo; Marcon, Alessandro; Accordini, Simone; Zanolin, Maria Elisabetta; Verlato, Giuseppe] Univ Verona, Unit Epidemiol & Med Stat, I-37100 Verona, Italy; [Antonicelli, Leonardo] Osped Riuniti Ancona, Allergy Unit, Dept Immunoallerg & Resp Dis, Ancona, Italy; [Bugiani, Massimiliano] ASL TO 2, Resp Med Unit, Turin, Italy; [Casali, Lucio] Univ Perugia, Dept Internal Med, Unit Resp Dis, I-06100 Perugia, Italy; [Ferrari, Marcello] Univ Verona, Unit Internal Med, I-37100 Verona, Italy; [Nicolini, Gabriele] Chiesi Farmaceut, Med Affairs Dept, Parma, Italy; [Panico, Maria Grazia] ASL SA 2, Epidemiol Unit, Salerno, Italy; [Pirina, Pietro] Univ Sassari, Inst Resp Dis, I-07100 Sassari, Italy; [Cerveri, Isa] Univ Pavia, Unit Resp Dis, IRCCS Policlin San Matteo, I-27100 Pavia, Italy	University of Verona; University of Perugia; University of Verona; Chiesi Pharmaceuticals Inc; University of Sassari; IRCCS Fondazione San Matteo; University of Pavia	de Marco, R (corresponding author), Univ Verona, Unit Epidemiol & Med Stat, I-37100 Verona, Italy.	roberto.demarco@univr.it	Pesce, Giancarlo/K-2804-2019; Pesce, Giancarlo/K-4539-2019; pesce, giancarlo/G-3644-2013; Marcon, Alessandro/C-3349-2012; de Marco, Roberto/A-5470-2008	Pesce, Giancarlo/0000-0003-4925-6325; Marcon, Alessandro/0000-0002-2778-658X; Cerveri, Isa/0000-0003-0337-043X	Cariverona Foundation; Italian Ministry of Health; Italian Medicines Agency (AIFA); Chiesi Farmaceutici, Parma, Italy; Chiesi Farmaceutici	Cariverona Foundation(Fondazione Cariverona); Italian Ministry of Health(Ministry of Health, Italy); Italian Medicines Agency (AIFA); Chiesi Farmaceutici, Parma, Italy(Chiesi Pharmaceuticals Inc); Chiesi Farmaceutici(Chiesi Pharmaceuticals Inc)	The GEIRD project was funded by: the Cariverona Foundation, the Italian Ministry of Health, Chiesi Farmaceutici, and the Italian Medicines Agency (AIFA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors confirm that Gabriele Nicolini is an employe of the "Chiesi Farmaceutici, Parma, Italy,'' one of the commercial funders of this research. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Accordini S, 2012, CURR ALLERGY ASTHM R, V12, P185, DOI 10.1007/s11882-012-0260-9; Bahadori Katayoun, 2009, BMC Pulm Med, V9, P24, DOI 10.1186/1471-2466-9-24; Basagana X, 2004, AM J EPIDEMIOL, V160, P178, DOI 10.1093/aje/kwh186; Beasley R, 1998, LANCET, V351, P1225, DOI 10.1016/S0140-6736(97)07302-9; Bednarek M, 2008, THORAX, V63, P402, DOI 10.1136/thx.2007.085456; Braback L, 2005, EUR RESPIR J, V26, P1064, DOI 10.1183/09031936.05.00022105; Bugiani M, 2005, ALLERGY, V60, P165, DOI 10.1111/j.1398-9995.2005.00659.x; Buist AS, 2007, LANCET, V370, P741, DOI 10.1016/S0140-6736(07)61377-4; Burney P, 1996, EUR RESPIR J, V9, P687; Cazzola M, 2011, RESP MED, V105, P386, DOI 10.1016/j.rmed.2010.09.022; Cerveri I, 2012, INT ARCH ALLERGY IMM, V158, P175, DOI 10.1159/000330900; de Marco R, 1999, EUR RESPIR J, V14, P1044, DOI 10.1183/09031936.99.14510449; de Marco R, 2004, THORAX, V59, P120, DOI 10.1136/thorax.2003.011163; de Marco R, 2012, EUR RESPIR J, V39, P883, DOI 10.1183/09031936.00061611; de Marco R, 2010, INT ARCH ALLERGY IMM, V152, P255, DOI 10.1159/000283034; de Marco R, 2000, AM J RESP CRIT CARE, V162, P68, DOI 10.1164/ajrccm.162.1.9907008; de Marco R, 2007, AM J RESP CRIT CARE, V175, P32, DOI 10.1164/rccm.200603-381OC; Diaz-Guzman E, 2011, COPD, V8, P400, DOI 10.3109/15412555.2011.611200; Gershon A, 2012, J ALLERGY CLIN IMMUN, V129, P679, DOI 10.1016/j.jaci.2011.11.014; Gibson PG, 2010, LANCET, V376, P803, DOI 10.1016/S0140-6736(10)61087-2; Guerra S, 2005, CURR OPIN PULM MED, V11, P7; Hajiro T, 1999, CHEST, V116, P1632, DOI 10.1378/chest.116.6.1632; Halbert RJ, 2006, EUR RESPIR J, V28, P523, DOI 10.1183/09031936.06.00124605; Hanania NA, 2011, J ALLERGY CLIN IMMUN, V128, pS4, DOI 10.1016/j.jaci.2011.06.048; Hardin M, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-127; Hersh Craig P, 2007, COPD, V4, P331, DOI 10.1080/15412550701601274; Lange P, 1998, NEW ENGL J MED, V339, P1194, DOI 10.1056/NEJM199810223391703; Leigh R, 2006, EUR RESPIR J, V27, P964, DOI 10.1183/09031936.06.00072105; Mannino DM, 2000, ARCH INTERN MED, V160, P1683, DOI 10.1001/archinte.160.11.1683; Melbye H, 2011, INT J CHRONIC OBSTR, V6, P597, DOI 10.2147/COPD.S25955; Miravitlles M, 2012, BRIT J GEN PRACT, V62, DOI 10.3399/bjgp12X625111; Salvi SS, 2009, LANCET, V374, P733, DOI 10.1016/S0140-6736(09)61303-9; Schnell K, 2012, BMC PULM MED, V12, DOI 10.1186/1471-2466-12-26; Shaya FT, 2008, CHEST, V134, P14, DOI 10.1378/chest.07-2317; Silva GE, 2004, CHEST, V126, P59, DOI 10.1378/chest.126.1.59; Soriano JB, 2005, CHEST, V128, P2099, DOI 10.1378/chest.128.4.2099; Viegi G, 2004, CHEST, V126, P1093, DOI 10.1378/chest.126.4.1093; Walters JA, 2011, PRIM CARE RESP J, V20, P396, DOI 10.4104/pcrj.2011.00039; Wardlaw AJ, 2002, CLIN SCI, V103, P201; Zeki Amir A, 2011, J Allergy (Cairo), V2011, P861926, DOI 10.1155/2011/861926	40	226	231	0	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2013	8	5							e62985	10.1371/journal.pone.0062985	http://dx.doi.org/10.1371/journal.pone.0062985			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	143FO	23675448	Green Submitted, Green Published, gold			2022-12-27	WOS:000318852400018
J	Sato, Y; Saito, N; Utsumi, A; Aizawa, E; Shoji, T; Izumiyama, M; Mushiake, H; Hongo, M; Fukudo, S				Sato, Yasuhiro; Saito, Naohiro; Utsumi, Atsushi; Aizawa, Emiko; Shoji, Tomotaka; Izumiyama, Masahiro; Mushiake, Hajime; Hongo, Michio; Fukudo, Shin			Neural Basis of Impaired Cognitive Flexibility in Patients with Anorexia Nervosa	PLOS ONE			English	Article							CARD SORTING TEST; INFERIOR PREFRONTAL CORTEX; SET-SHIFTING ABILITY; BODY-IMAGE; TRANSIENT ACTIVATION; BULIMIA-NERVOSA; WORKING-MEMORY; PERFORMANCE; BRAIN; DISORDERS	Background: Impaired cognitive flexibility in anorexia nervosa (AN) causes clinical problems and makes the disease hard to treat, but its neural basis has yet to be fully elucidated. The purpose of this study was to evaluate the brain activity of individuals with AN while performing a task requiring cognitive flexibility on the Wisconsin Card Sorting Test (WCST), which is one of the most frequently used neurocognitive measures of cognitive flexibility and problem-solving ability. Methods: Participants were 15 female AN patients and 15 age-and intelligence quotient-matched healthy control women. Participants completed the WCST while their brain activity was measured by functional magnetic resonance imaging during the task. Brain activation in response to set shifting error feedback and the correlation between such brain activity and set shifting performance were analyzed. Results: The correct rate on the WCST was significantly poorer for AN patients than for controls. Patients showed poorer activity in the right ventrolateral prefrontal cortex and bilateral parahippocampal cortex on set shifting than controls. Controls showed a positive correlation between correct rate and ventrolateral prefrontal activity in response to set shifting whereas patients did not. Conclusion: These findings suggest dysfunction of the ventrolateral prefrontal cortex and parahippocampal cortex as a cause of impaired cognitive flexibility in AN patients.	[Sato, Yasuhiro; Shoji, Tomotaka; Fukudo, Shin] Tohoku Univ Hosp, Dept Psychosomat Med, Sendai, Miyagi, Japan; [Saito, Naohiro] Yamagata Univ, Dept Clin Neurosci, Grad Sch Med Sci, Yamagata 990, Japan; [Utsumi, Atsushi] Stress Care Clin Lumeto, Natori, Miyagi, Japan; [Aizawa, Emiko] Natl Ctr Neurol & Psychiat, Dept Mental Disorder Res, Natl Inst Neurosci, Tokyo, Japan; [Izumiyama, Masahiro] Sendai Nakae Hosp, Sendai, Miyagi, Japan; [Mushiake, Hajime] Tohoku Univ, Dept Physiol, Grad Sch Med, Sendai, Miyagi 980, Japan; [Hongo, Michio] Kurokawa Hosp, Taiwa, Miyagi, Japan; [Hongo, Michio] Tohoku Univ Hosp, Dept Comprehens Med, Sendai, Miyagi, Japan; [Fukudo, Shin] Tohoku Univ, Dept Behav Med, Grad Sch Med, Sendai, Miyagi 980, Japan	Tohoku University; Yamagata University; National Center for Neurology & Psychiatry - Japan; Tohoku University; Tohoku University; Tohoku University	Fukudo, S (corresponding author), Tohoku Univ Hosp, Dept Psychosomat Med, Sendai, Miyagi, Japan.	sfukudo@med.tohoku.ac.jp	Fukudo, Shin/J-4813-2014; Sato, Yasuhiro/AAE-1855-2019	Mushiake, Hajime/0000-0002-5130-4720	Ministry of Health, Labor and Welfare of Japan [17B-1]	Ministry of Health, Labor and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan)	This study was funded by Research Grant No. 17B-1 for Nervous and Mental Disorders from the Ministry of Health, Labor and Welfare of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors disclose no financial arrangement (e.g., consultancies, stock ownership, equity interests, parent-licensing arrangements, research support, major honoraria) they may have with a company whose product figures prominently in the submitted manuscript.	Abbate-Daga G, 2011, BMC PSYCHIATRY, V11, DOI 10.1186/1471-244X-11-162; Aizawa E, 2012, GASTROENTEROLOGY, V143, P1188, DOI 10.1053/j.gastro.2012.07.104; American Psychiatric Association, 2000, DIAGN STAT MAN MENT, V4th; Asari T, 2005, NEUROIMAGE, V26, P694, DOI 10.1016/j.neuroimage.2004.12.063; Barker MJ, 2004, CNS DRUGS, V18, P37, DOI 10.2165/00023210-200418010-00004; BERMAN KF, 1995, NEUROPSYCHOLOGIA, V33, P1027, DOI 10.1016/0028-3932(95)00035-2; Brett M., 2002, 8 INT C FUNCT MAPP H, DOI DOI 10.1016/S1053-8119(02)90010-8; Castro-Fornieles J, 2010, NEUROPSYCHOLOGIA, V48, P4111, DOI 10.1016/j.neuropsychologia.2010.10.003; Cools R, 2002, J NEUROSCI, V22, P4563, DOI 10.1523/JNEUROSCI.22-11-04563.2002; Fassino S, 2002, INT J EAT DISORDER, V31, P274, DOI 10.1002/eat.10028; Fladung AK, 2010, AM J PSYCHIAT, V167, P206, DOI 10.1176/appi.ajp.2009.09010071; Friederich HC, 2010, NEUROPSYCHOLOGIA, V48, P2878, DOI 10.1016/j.neuropsychologia.2010.04.036; GARNER DM, 1981, CAN J PSYCHIAT, V26, P224, DOI 10.1177/070674378102600404; Giel KE, 2012, PSYCHIAT RES, V200, P538, DOI 10.1016/j.psychres.2012.06.004; Godt K, 2008, EUR EAT DISORD REV, V16, P94, DOI 10.1002/erv.844; Gonzalez-Hernandez JA, 2002, HUM BRAIN MAPP, V17, P37, DOI 10.1002/hbm.10051; GRANT DA, 1948, J EXP PSYCHOL, V38, P404, DOI 10.1037/h0059831; Green MW, 1996, J PSYCHIAT RES, V30, P401, DOI 10.1016/0022-3956(96)00026-X; Holliday J, 2005, AM J PSYCHIAT, V162, P2269, DOI 10.1176/appi.ajp.162.12.2269; JONES BP, 1991, J CLIN EXP NEUROPSYC, V13, P711, DOI 10.1080/01688639108401085; Kaye WH, 2004, AM J PSYCHIAT, V161, P2215, DOI 10.1176/appi.ajp.161.12.2215; Kingston K, 1996, PSYCHOL MED, V26, P15, DOI 10.1017/S0033291700033687; Konishi S, 1999, BRAIN, V122, P981, DOI 10.1093/brain/122.5.981; Konishi S, 1998, NAT NEUROSCI, V1, P80, DOI 10.1038/283; Konishi S, 1999, CEREB CORTEX, V9, P745, DOI 10.1093/cercor/9.7.745; Konishi S, 2008, NEUROIMAGE, V41, P575, DOI 10.1016/j.neuroimage.2008.02.037; Lie CH, 2006, NEUROIMAGE, V30, P1038, DOI 10.1016/j.neuroimage.2005.10.031; Linden DEJ, 2006, MOL PSYCHIATR, V11, P528, DOI 10.1038/sj.mp.4001816; Lock J, 2011, AM J PSYCHIAT, V168, P55, DOI 10.1176/appi.ajp.2010.10010056; Malson H, 2011, EUR EAT DISORD REV, V19, P25, DOI 10.1002/erv.1011; McAnarney ER, 2011, J ADOLESCENT HEALTH, V49, P99, DOI 10.1016/j.jadohealth.2010.11.259; MILNER B, 1963, ARCH NEUROL-CHICAGO, V9, P90, DOI 10.1001/archneur.1963.00460070100010; Miyake A, 2000, COGNITIVE PSYCHOL, V41, P49, DOI 10.1006/cogp.1999.0734; Miyake Y, 2010, PSYCHIAT RES-NEUROIM, V181, P183, DOI 10.1016/j.pscychresns.2009.09.001; Mohr HM, 2010, PSYCHOL MED, V40, P1519, DOI 10.1017/S0033291709991826; Monchi O, 2001, J NEUROSCI, V21, P7733, DOI 10.1523/JNEUROSCI.21-19-07733.2001; Nagahama Y, 1996, BRAIN, V119, P1667, DOI 10.1093/brain/119.5.1667; Nakazato M, 2009, PSYCHOL MED, V39, P1029, DOI 10.1017/S0033291708004108; Nakazato M, 2010, ANN GEN PSYCHIATR, V9, DOI 10.1186/1744-859X-9-29; NELSON HE, 1976, CORTEX, V12, P313, DOI 10.1016/S0010-9452(76)80035-4; New Japan Committee of MMPI, 1997, STUD STAND NEW JAP M; Nikendei C, 2011, PSYCHOL MED, V41, P829, DOI 10.1017/S0033291710001121; Nose I, 2009, NEUROIMAGE, V44, P1380, DOI 10.1016/j.neuroimage.2008.11.002; Nyhus E, 2009, BRAIN COGNITION, V71, P437, DOI 10.1016/j.bandc.2009.03.005; O'Brien KM, 2003, CLIN PSYCHOL REV, V23, P57, DOI 10.1016/S0272-7358(02)00201-5; Oberndorfer TA, 2011, INT J EAT DISORDER, V44, P1, DOI 10.1002/eat.20750; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; PALAZIDOU E, 1990, PSYCHOL MED, V20, P521, DOI 10.1017/S0033291700017037; Peters KM, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0015974, 10.1371/journal.pone.0022259]; ROBBE HWJ, 1995, EUR NEUROPSYCHOPHARM, V5, P35, DOI 10.1016/0924-977X(94)00130-4; Roberts M, 2010, J PSYCHIAT RES; Roberts ME, 2007, PSYCHOL MED, V37, P1075, DOI 10.1017/S0033291707009877; Rocca WA, 2006, NEUROEPIDEMIOLOGY, V26, P119, DOI 10.1159/000091019; Schacter DL, 2009, PHILOS T R SOC B, V364, P1245, DOI 10.1098/rstb.2008.0308; Schmidt U, 2006, BRIT J CLIN PSYCHOL, V45, P343, DOI 10.1348/014466505X53902; Seed JA, 2000, EUR ARCH PSY CLIN N, V250, P11, DOI 10.1007/PL00007533; Shafritz KM, 2005, NEUROIMAGE, V25, P600, DOI 10.1016/j.neuroimage.2004.12.054; Steinglass JE, 2006, J INT NEUROPSYCH SOC, V12, P431, DOI 10.1017/S1355617706060528; Stewart SA, 2005, J CLIN PSYCHIAT, V66, P9; Stuss DT, 2000, NEUROPSYCHOLOGIA, V38, P388, DOI 10.1016/S0028-3932(99)00093-7; SZMUKLER GI, 1992, J CLIN EXP NEUROPSYC, V14, P347, DOI 10.1080/01688639208402834; Tchanturia K, 2005, INT J EAT DISORDER, V37, pS72, DOI 10.1002/eat.20119; Tchanturia K, 2004, J PSYCHIATR RES, V38, P545, DOI 10.1016/j.jpsychires.2004.03.001; Tchanturia K, 2004, J INT NEUROPSYCH SOC, V10, P513, DOI 10.1017/S1355617704104086; Tchanturia K, 2001, J BEHAV THER EXP PSY, V32, P107, DOI 10.1016/S0005-7916(01)00025-8; Tchanturia K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028331; Uher R, 2005, BIOL PSYCHIAT, V58, P990, DOI 10.1016/j.biopsych.2005.06.001; Uher R, 2003, BIOL PSYCHIAT, V54, P934, DOI 10.1016/S0006-3223(03)00172-0; van Holstein M, 2011, PSYCHOPHARMACOLOGY, V218, P567, DOI 10.1007/s00213-011-2340-2; Vocks S, 2010, J PSYCHIATR NEUROSCI, V35, P163, DOI 10.1503/jpn.090048; Wagner A, 2003, NEUROREPORT, V14, P2193, DOI 10.1097/00001756-200312020-00012; Wagner A, 2008, NEUROPSYCHOPHARMACOL, V33, P513, DOI 10.1038/sj.npp.1301443; Wagner A, 2007, AM J PSYCHIAT, V164, P1842, DOI 10.1176/appi.ajp.2007.07040575; Zastrow A, 2009, AM J PSYCHIAT, V166, P608, DOI 10.1176/appi.ajp.2008.08050775	74	67	69	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2013	8	5							e61108	10.1371/journal.pone.0061108	http://dx.doi.org/10.1371/journal.pone.0061108			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	143FO	23675408	Green Published, gold, Green Submitted			2022-12-27	WOS:000318852400004
J	Betous, R; Glick, GG; Zhao, RX; Cortez, D				Betous, Remy; Glick, Gloria G.; Zhao, Runxiang; Cortez, David			Identification and Characterization of SMARCAL1 Protein Complexes	PLOS ONE			English	Article							WERNER-SYNDROME PROTEIN; REPLICATION FORK; HELICASE ACTIVITY; GENOME STABILITY; SYNDROME GENE; DNA-DAMAGE; IN-VIVO; WRN; PHOSPHORYLATION; DOMAIN	SMARCAL1 is an ATPase in the SNF2 family that functions at damaged replication forks to promote their stability and restart. It acts by translocating on DNA to catalyze DNA strand annealing, branch migration, and fork regression. Many SNF2 enzymes work as motor subunits of large protein complexes. To determine if SMARCAL1 is also a member of a protein complex and to further understand how it functions in the replication stress response, we used a proteomics approach to identify interacting proteins. In addition to the previously characterized interaction with replication protein A (RPA), we found that SMARCAL1 forms complexes with several additional proteins including DNA-PKcs and the WRN helicase. SMARCAL1 and WRN co-localize at stalled replication forks independently of one another. The SMARCAL1 interaction with WRN is indirect and is mediated by RPA acting as a scaffold. SMARCAL1 and WRN act independently to prevent MUS81 cleavage of the stalled fork. Biochemical experiments indicate that both catalyze fork regression with SMARCAL1 acting more efficiently and independently of WRN. These data suggest that RPA brings a complex of SMARCAL1 and WRN to stalled forks, but that they may act in different pathways to promote fork repair and restart.	[Betous, Remy; Glick, Gloria G.; Zhao, Runxiang; Cortez, David] Vanderbilt Univ, Sch Med, Dept Biochem, Nashville, TN 37212 USA	Vanderbilt University	Cortez, D (corresponding author), Vanderbilt Univ, Sch Med, Dept Biochem, Nashville, TN 37212 USA.	david.cortez@vanderbilt.edu	Bétous, Rémy/ABF-4789-2020; Classen, Scott/AAY-8176-2020	Bétous, Rémy/0000-0003-0518-1763; 	National Institutes of Health [R01 CA136933, R01GM160342]; Department of Defense Breast Cancer Research Program post-doctoral fellowship [W81XWH-10-1-0581]; NATIONAL CANCER INSTITUTE [P01CA092584, R01CA160432, R01CA136933] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense Breast Cancer Research Program post-doctoral fellowship(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health grants R01 CA136933 and R01GM160342 to D.C., and a Department of Defense Breast Cancer Research Program post-doctoral fellowship W81XWH-10-1-0581 to R.B. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ammazzalorso F, 2010, EMBO J, V29, P3156, DOI 10.1038/emboj.2010.205; Ball HL, 2007, MOL CELL BIOL, V27, P3367, DOI 10.1128/MCB.02238-06; Ball HL, 2005, MOL BIOL CELL, V16, P2372, DOI 10.1091/mbc.e04-11-1006; Bansbach CE, 2009, GENE DEV, V23, P2405, DOI 10.1101/gad.1839909; Baradaran-Heravi A, 2012, AM J MED GENET A, V158A, P2204, DOI 10.1002/ajmg.a.35532; Betous R, 2012, GENE DEV, V26, P151, DOI 10.1101/gad.178459.111; Boerkoel CF, 2002, NAT GENET, V30, P215, DOI 10.1038/ng821; Bohr VA, 2000, EXP GERONTOL, V35, P695, DOI 10.1016/S0531-5565(00)00145-5; Branzei D, 2010, NAT REV MOL CELL BIO, V11, P208, DOI 10.1038/nrm2852; Brosh RM, 1999, J BIOL CHEM, V274, P18341, DOI 10.1074/jbc.274.26.18341; Carroll C, 2013, PEDIAT BLOO IN PRESS; Chu WK, 2009, NAT REV CANCER, V9, P644, DOI 10.1038/nrc2682; Ciccia A, 2012, MOL CELL; Ciccia A, 2009, GENE DEV, V23, P2415, DOI 10.1101/gad.1832309; Cimprich KA, 2008, NAT REV MOL CELL BIO, V9, P616, DOI 10.1038/nrm2450; Constantinou A, 2000, EMBO REP, V1, P80, DOI 10.1093/embo-reports/kvd004; Damerla RR, 2012, CELL CYCLE, V11, P3036, DOI 10.4161/cc.21399; Doherty KM, 2005, J BIOL CHEM, V280, P29494, DOI 10.1074/jbc.M500653200; Flaus A, 2006, NUCLEIC ACIDS RES, V34, P2887, DOI 10.1093/nar/gkl295; Franchitto A, 2008, J CELL BIOL, V183, P241, DOI 10.1083/jcb.200803173; Karmakar P, 2002, J BIOL CHEM, V277, P18291, DOI 10.1074/jbc.M111523200; Lee SJ, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000801; Machwe A, 2006, BIOCHEMISTRY-US, V45, P13939, DOI 10.1021/bi0615487; Mirkin EV, 2007, MICROBIOL MOL BIOL R, V71, P13, DOI 10.1128/MMBR.00030-06; Murfuni I, 2012, CARCINOGENESIS, V33, P1655, DOI 10.1093/carcin/bgs206; Pichierri P, 2003, ONCOGENE, V22, P1491, DOI 10.1038/sj.onc.1206169; Pirzio LM, 2008, J CELL BIOL, V180, P305, DOI 10.1083/jcb.200705126; Postow L, 2009, J BIOL CHEM, V284, P35951, DOI 10.1074/jbc.M109.048330; Shao RG, 1999, EMBO J, V18, P1397, DOI 10.1093/emboj/18.5.1397; Shen JC, 2003, MECH AGEING DEV, V124, P921, DOI 10.1016/S0047-6374(03)00164-7; Yan H, 1998, NAT GENET, V19, P375, DOI 10.1038/1263; Yu CE, 1996, SCIENCE, V272, P258, DOI 10.1126/science.272.5259.258; Yuan JS, 2009, GENE DEV, V23, P2394, DOI 10.1101/gad.1836409; Yusufzai T, 2008, SCIENCE, V322, P748, DOI 10.1126/science.1161233; Yusufzai T, 2009, GENE DEV, V23, P2400, DOI 10.1101/gad.1831509	35	21	22	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2013	8	5							e63149	10.1371/journal.pone.0063149	http://dx.doi.org/10.1371/journal.pone.0063149			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	155HD	23671665	gold, Green Published, Green Submitted			2022-12-27	WOS:000319737700043
J	Kasera, R; Singh, AB; Lavasa, S; Nagendra, K; Arora, N				Kasera, Ramkrashan; Singh, Anand Bahadur; Lavasa, Shakuntala; Nagendra, Komarla; Arora, Naveen			Purification and Immunobiochemical Characterization of a 31 kDa Cross-Reactive Allergen from Phaseolus vulgaris (Kidney Bean)	PLOS ONE			English	Article							LIPID TRANSFER PROTEIN; MAJOR PEANUT ALLERGEN; BIRCH POLLEN; ATOPIC-DERMATITIS; IDENTIFICATION; RHINITIS; IMMUNOTHERAPY; BLACKGRAM; BET-V-1; VICILIN	Background: Legumes are a rich source of proteins but are also potential elicitors of IgE-mediated food allergy. This study aimed to isolate and characterize a major allergen of Phaseolus vulgaris (kidney bean) and determine its allergenicity. Methodology: Kidney bean allergen was purified using Q Sepharose column (anion exchanger) and eluates with high intensity were pooled to purify protein using Superdex 75 (gel filtration) and C-18 column (RP-HPLC). Patients with history of kidney bean allergy were skin prick tested (SPT) with crude kidney bean extract and the purified protein. Specific IgE was estimated in sera by enzyme-linked immunosorbent assay (ELISA). Characterization of purified protein and its cross-reactivity was investigated by immunobiochemical methods. Identification of purified protein was carried out by tandem mass spectrometry. Principal Findings: Purified protein appeared as a single band at 31 kDa on SDS-PAGE and showed IgE binding to 88% patients' sera by ELISA and immunoblotting. SPT with purified protein identified 78% hypersensitive patients of kidney bean. Significant release of histamine from sensitized basophils was observed after challenge with purified protein. PAS staining suggested it to be a glycoprotein, but no change in IgE binding was observed after periodate oxidation. The 31 kDa protein remained stable for 60 min on incubation with pepsin. The purified protein had high allergenic potential since it required only 102 ng of self protein for 50% IgE inhibition. Mass spectrometric analysis identified it as Phytohemagglutinin. It also showed hemagglutination with human RBCs. Cross-reactivity was observed with peanut and black gram with IC50 of 185 and 228 ng respectively. Conclusion/Significance: A 31 kDa major allergen of kidney bean was purified and identified as phytohemagglutinin with cross-reactivity to peanut and black gram.	[Kasera, Ramkrashan; Singh, Anand Bahadur; Arora, Naveen] CSIR Inst Genom & Integrat Biol, Allergy & Immunol Sect, Delhi, India; [Kasera, Ramkrashan; Arora, Naveen] Univ Pune, Pune, Maharashtra, India; [Lavasa, Shakuntala] USLavasa Med & Res Ctr, Chandigarh, India; [Nagendra, Komarla] Bengaluru Allergy Ctr, Bangalore, Karnataka, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Genomics & Integrative Biology (IGIB); Savitribai Phule Pune University	Arora, N (corresponding author), CSIR Inst Genom & Integrat Biol, Allergy & Immunol Sect, Delhi, India.	naveen@igib.res.in						Akkerdaas J, 2012, INT ARCH ALLERGY IMM, V157, P51, DOI 10.1159/000324946; [Anonymous], 1991, AM REV RESPIR DIS, V144, P1202, DOI 10.1164/ajrccm/144.5.1202; Blanc F, 2008, MOL NUTR FOOD RES, V52, pS166, DOI 10.1002/mnfr.200700283; BLUM H, 1987, ELECTROPHORESIS, V8, P93, DOI 10.1002/elps.1150080203; Bollen MA, 2007, MOL NUTR FOOD RES, V51, P1527, DOI 10.1002/mnfr.200700119; Bousquet J, 2001, J ALLERGY CLIN IMMUN, V108, pS147, DOI 10.1067/mai.2001.118891; Bublin M, 2010, J ALLERGY CLIN IMMUN, V125, P687, DOI 10.1016/j.jaci.2009.10.017; BURKS AW, 1992, J ALLERGY CLIN IMMUN, V90, P962, DOI 10.1016/0091-6749(92)90469-I; BURKS AW, 1991, J ALLERGY CLIN IMMUN, V88, P172, DOI 10.1016/0091-6749(91)90325-I; Carvalho LMJ, 2012, FOOD NUTR RES, V56, DOI 10.3402/fnr.v56i0.15618; Chanana V, 2004, ACTA CRYSTALLOGR D, V60, P2100, DOI 10.1107/S0907444904023868; Food and Agriculture Organization [FAO], 1993, FOOD AGR ORG FAO PRO, V26; Hamilton RG, 2004, J ALLERGY CLIN IMMUN, V114, P213, DOI 10.1016/j.jaci.2004.06.046; Hoffmann-Sommergruber K, 2008, MOL NUTR FOOD RES, V52, pS159, DOI 10.1002/mnfr.200800466; Ibanez MD, 2003, ALLERGOL IMMUNOPATH, V31, P1511; Kasera R, 2012, FOOD CHEM TOXICOL, V50, P3456, DOI 10.1016/j.fct.2012.07.031; Kasera R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027193; Kleber-Janke T, 1999, INT ARCH ALLERGY IMM, V119, P265, DOI 10.1159/000024203; Kumar R, 2007, IMMUNOBIOLOGY, V212, P141, DOI 10.1016/j.imbio.2006.11.006; Kumari D, 2006, ALLERGY, V61, P104, DOI 10.1111/j.1398-9995.2006.00990.x; Kumari D, 2012, IMMUNOBIOLOGY, V217, P895, DOI 10.1016/j.imbio.2011.12.011; Larche M, 2006, NAT REV IMMUNOL, V6, P761, DOI 10.1038/nri1934; Lauer I, 2009, CLIN EXP ALLERGY, V39, P1427, DOI 10.1111/j.1365-2222.2009.03312.x; Liu B, 2012, APPL MICROBIOL BIOT, V94, P1337, DOI 10.1007/s00253-012-4006-3; Lopez-Torrejon G, 2003, J ALLERGY CLIN IMMUN, V112, P1208, DOI 10.1016/j.jaci.2003.08.035; Marsh J, 2008, MOL NUTR FOOD RES, V52, pS272, DOI 10.1002/mnfr.200700524; Misra A, 2010, FOOD CHEM TOXICOL, V48, P2725, DOI 10.1016/j.fct.2010.06.047; Misra A, 2009, IMMUNOPHARM IMMUNOT, V31, P186, DOI 10.1080/08923970802578782; Mittag D, 2005, CLIN EXP ALLERGY, V35, P1049, DOI 10.1111/j.1365-2222.2005.02309.x; Mittag D, 2004, J ALLERGY CLIN IMMUN, V114, P1410, DOI 10.1016/j.jaci.2004.09.014; Moverare R, 2002, ALLERGY, V57, P423, DOI 10.1034/j.1398-9995.2002.13248.x; PARIHAR H, 1984, Indian Journal of Pediatrics, V51, P7, DOI 10.1007/BF02753518; Pereira M J, 2002, Allergol Immunopathol (Madr), V30, P346; Pons L, 2002, ALLERGY, V57, P88, DOI 10.1034/j.1398-9995.57.s72.16.x; Qureshi IA, 2006, ACTA CRYSTALLOGR F, V62, P869, DOI 10.1107/S1744309106028077; Rabjohn P, 1999, J CLIN INVEST, V103, P535, DOI 10.1172/JCI5349; Rigby NM, 2008, MOL NUTR FOOD RES, V52, pS251, DOI 10.1002/mnfr.200800083; Rouge P, 2011, ALLERGY, V66, P301, DOI 10.1111/j.1398-9995.2010.02466.x; SCHIAVINO D, 1992, ALLERGY, V47, P121, DOI 10.1111/j.1398-9995.1992.tb05099.x; Sharman Jyotsna, 2000, Indian Journal of Pediatrics, V67, P713, DOI 10.1007/BF02723925; SINGH BP, 1992, BIOCHEM INT, V27, P477; Singh S, 2012, J PROTEOME RES; Treudler R, 2012, CURR ALLERGY ASTHM R; Tsuji H, 1997, BIOSCI BIOTECH BIOCH, V61, P942, DOI 10.1271/bbb.61.942; Valenta R, 2002, NAT REV IMMUNOL, V2, P446, DOI 10.1038/nri824; Verma AK, 2012, TOXICOL LETT, V210, P24, DOI 10.1016/j.toxlet.2012.01.011; Zoccatelli G, 2010, MOL IMMUNOL, V47, P1561, DOI 10.1016/j.molimm.2010.01.009	47	12	13	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2013	8	5							e63063	10.1371/journal.pone.0063063	http://dx.doi.org/10.1371/journal.pone.0063063			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	155HD	23671655	Green Published, Green Submitted, gold			2022-12-27	WOS:000319737700036
J	Lammens, A; Baehner, M; Kohnert, U; Niewoehner, J; von Proff, L; Schraeml, M; Lammens, K; Hopfner, KP				Lammens, Alfred; Baehner, Monika; Kohnert, Ulrich; Niewoehner, Jens; von Proff, Leopold; Schraeml, Michael; Lammens, Katja; Hopfner, Karl-Peter			Crystal Structure of Human TWEAK in Complex with the Fab Fragment of a Neutralizing Antibody Reveals Insights into Receptor Binding	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; NF-KAPPA-B; FIBROBLAST GROWTH FACTOR-INDUCIBLE-14; CYSTEINE-RICH DOMAIN; WEAK INDUCER; PATHWAY ACTIVATION; CELL-PROLIFERATION; FUNCTIONAL EXPRESSION; SIGNAL-TRANSDUCTION; SUPERFAMILY MEMBER	The tumor necrosis factor-like weak inducer of apoptosis (TWEAK) is a multifunctional cytokine playing a key role in tissue regeneration and remodeling. Dysregulation of TWEAK signaling is involved in various pathological processes like autoimmune diseases and cancer. The unique interaction with its cognate receptor Fn14 makes both ligand and receptor promising targets for novel therapeutics. To gain insights into this important signaling pathway, we determined the structure of soluble human TWEAK in complex with the Fab fragment of an antibody selected for inhibition of receptor binding. In the crystallized complex TWEAK is bound by three Fab fragments of the neutralizing antibody. Homology modeling shows that Fab binding overlaps with the putative Fn14 binding site of TWEAK. Docking of the Fn14 cysteine rich domain (CRD) to that site generates a highly complementary interface with perfectly opposing charged and hydrophobic residues. Taken together the presented structure provides new insights into the biology of TWEAK and the TWEAK/Fn14 pathway, which will help to optimize the therapeutic strategy for treatment of related cancer types and autoimmune diseases.	[Lammens, Alfred; Hopfner, Karl-Peter] Ctr Integrated Prot Sci CIPSM, Munich, Germany; [Lammens, Alfred; Lammens, Katja; Hopfner, Karl-Peter] Univ Munich, Dept Biochem, Munich, Germany; [Lammens, Alfred; Lammens, Katja; Hopfner, Karl-Peter] Univ Munich, Gene Ctr, Munich, Germany; [Baehner, Monika; Kohnert, Ulrich; Niewoehner, Jens] Roche Pharma Res & Early Dev pRED, Biol Res, Penzberg, Germany; [von Proff, Leopold; Schraeml, Michael] Roche Profess Diagnost, Res & Dev, Penzberg, Germany	University of Munich; University of Munich; University of Munich	Hopfner, KP (corresponding author), Ctr Integrated Prot Sci CIPSM, Munich, Germany.	hopfner@lmb.uni-muenchen.de	Hopfner, Karl-Peter/B-6864-2014	Hopfner, Karl-Peter/0000-0002-4528-8357	DFG [Sonderforschungsbereich 684]; German Excellence Initiative (CIPSM cluster);  [SFB 1054]	DFG(German Research Foundation (DFG)); German Excellence Initiative (CIPSM cluster); 	KPH is supported by the DFG (Sonderforschungsbereich 684) and the German Excellence Initiative (CIPSM cluster). KPH and KL acknowledge support by the SFB 1054. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afonine PV, 2005, ACTA CRYSTALLOGR D, V61, P850, DOI 10.1107/S0907444905007894; Bossen C, 2008, BLOOD, V111, P1004, DOI 10.1182/blood-2007-09-110874; Brown SA, J BIOL CHEM, V285, P17432; Brown SAN, 2003, BIOCHEM J, V371, P395, DOI 10.1042/BJ20021730; Brown SAN, 2006, BIOCHEM J, V397, P297, DOI 10.1042/BJ20051362; Brunger AT, 2007, NAT PROTOC, V2, P2728, DOI 10.1038/nprot.2007.406; Burkly LC, 2007, CYTOKINE, V40, P1, DOI 10.1016/j.cyto.2007.09.007; Chicheportiche Y, 1997, J BIOL CHEM, V272, P32401, DOI 10.1074/jbc.272.51.32401; Dai L, 2009, CANCER LETT, V283, P159, DOI 10.1016/j.canlet.2009.03.036; Davies DR, 1996, P NATL ACAD SCI USA, V93, P7, DOI 10.1073/pnas.93.1.7; Desplat-Jego S, 2009, J LEUKOCYTE BIOL, V85, P132, DOI 10.1189/jlb.0608347; Dogra C, 2007, J BIOL CHEM, V282, P15000, DOI 10.1074/jbc.M608668200; Dohi T, 2009, GASTROENTEROLOGY, V136, P912, DOI 10.1053/j.gastro.2008.11.017; Donohue PJ, 2003, ARTERIOSCL THROM VAS, V23, P594, DOI 10.1161/01.ATV.0000062883.93715.37; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Felli N, 2005, J IMMUNOL, V175, P1464, DOI 10.4049/jimmunol.175.3.1464; Feng SLY, 2000, AM J PATHOL, V156, P1253, DOI 10.1016/S0002-9440(10)64996-6; Fick A, 2012, J BIOL CHEM, V287, P484, DOI 10.1074/jbc.M111.287656; Girgenrath M, 2006, EMBO J, V25, P5826, DOI 10.1038/sj.emboj.7601441; GRELL M, 1995, CELL, V83, P793, DOI 10.1016/0092-8674(95)90192-2; Haile WB, 2010, NEUROSCIENCE, V171, P1256, DOI 10.1016/j.neuroscience.2010.10.029; Haile WB, 2010, NEUROSCIENCE; Han SY, 2003, BIOCHEM BIOPH RES CO, V305, P789, DOI 10.1016/S0006-291X(03)00852-0; Harada N, 2002, BIOCHEM BIOPH RES CO, V299, P488, DOI 10.1016/S0006-291X(02)02670-0; He F, 2009, PROTEIN SCI, V18, P650, DOI 10.1002/pro.49; Hendriks J, 2005, CELL DEATH DIFFER, V12, P637, DOI 10.1038/sj.cdd.4401647; Ho DH, 2004, CANCER RES, V64, P8968, DOI 10.1158/0008-5472.CAN-04-1879; Huard B, 2008, J CLIN INVEST, V118, P2887, DOI 10.1172/JCI33760; Ingold K, 2005, J EXP MED, V201, P1375, DOI 10.1084/jem.20042309; Inta I, 2008, J NEUROL SCI, V275, P117, DOI 10.1016/j.jns.2008.08.005; Iocca HA, 2008, J NEUROIMMUNOL, V194, P97, DOI 10.1016/j.jneuroim.2007.12.003; Jakubowski A, 2005, J CLIN INVEST, V115, P2330, DOI 10.1172/JCI23486; Jones S, 1996, P NATL ACAD SCI USA, V93, P13, DOI 10.1073/pnas.93.1.13; KABSCH W, 1988, J APPL CRYSTALLOGR, V21, P916, DOI 10.1107/S0021889888007903; Kamata K, 2006, J IMMUNOL, V177, P6433, DOI 10.4049/jimmunol.177.9.6433; Kaplan MJ, 2002, J IMMUNOL, V169, P6020, DOI 10.4049/jimmunol.169.10.6020; Kawakita T, 2005, INT J ONCOL, V26, P87; Kawakita T, 2004, BIOCHEM BIOPH RES CO, V318, P726, DOI 10.1016/j.bbrc.2004.04.084; Kimberley FC, 2009, FASEB J, V23, P1584, DOI 10.1096/fj.08-124669; LEE B, 1971, J MOL BIOL, V55, P379, DOI 10.1016/0022-2836(71)90324-X; Leng RX, 2010, MOL BIOL REP; Lynch CN, 1999, J BIOL CHEM, V274, P8455, DOI 10.1074/jbc.274.13.8455; Maecker H, 2005, CELL, V123, P931, DOI 10.1016/j.cell.2005.09.022; Marsters SA, 1998, CURR BIOL, V8, P525, DOI 10.1016/S0960-9822(98)70204-0; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Meighan-Mantha RL, 1999, J BIOL CHEM, V274, P33166, DOI 10.1074/jbc.274.46.33166; Michaelson JS, 2005, ONCOGENE, V24, P2613, DOI 10.1038/sj.onc.1208208; Mittel A, 2010, AM J PATHOL, V177, P1732, DOI 10.2353/ajpath.2010.100335; Munoz-Garcia B, 2009, ARTERIOSCL THROM VAS, V29, P2061, DOI 10.1161/ATVBAHA.109.194852; Novoyatleva T, 2010, CARDIOVASC RES, V85, P681, DOI 10.1093/cvr/cvp360; Perper SJ, 2006, J IMMUNOL, V177, P2610, DOI 10.4049/jimmunol.177.4.2610; Polavarapu R, 2005, J NEUROSCI, V25, P10094, DOI 10.1523/JNEUROSCI.3382-05.2005; Polek TC, 2003, J BIOL CHEM, V278, P32317, DOI 10.1074/jbc.M302518200; Potrovita I, 2004, J NEUROSCI, V24, P8237, DOI 10.1523/JNEUROSCI.1089-04.2004; Roos C, 2010, J IMMUNOL, V185, P1593, DOI 10.4049/jimmunol.0903555; Saitoh T, 2003, J BIOL CHEM, V278, P36005, DOI 10.1074/jbc.M304266200; Sakurai D, 2007, BLOOD, V109, P2961, DOI 10.1182/blood-2006-08-041772; Sanz AB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008955; Schneider P, 1998, J EXP MED, V187, P1205, DOI 10.1084/jem.187.8.1205; Serafini B, 2008, J NEUROPATH EXP NEUR, V67, P1137, DOI 10.1097/NEN.0b013e31818dab90; Tanabe K, 2003, J NEUROSCI, V23, P9675; Terwilliger TC, 2008, ACTA CRYSTALLOGR D, V64, P61, DOI 10.1107/S090744490705024X; Tirnitz-Parker JEE, 2010, HEPATOLOGY, V52, P291, DOI 10.1002/hep.23663; Tran NL, 2005, J BIOL CHEM, V280, P3483, DOI 10.1074/jbc.M409906200; Tran NL, 2003, AM J PATHOL, V162, P1313, DOI 10.1016/S0002-9440(10)63927-2; Vendrell J, 2010, J CLIN ENDOCR METAB, V95, P2983, DOI 10.1210/jc.2009-2481; Wajant H, 2001, ONCOGENE, V20, P4101, DOI 10.1038/sj.onc.1204558; Wako M, 2008, SPINE, V33, P2489, DOI 10.1097/BRS.0b013e318186b343; Wang DF, 2010, CANCER LETT, V294, P91, DOI 10.1016/j.canlet.2010.01.027; Whitsett TG, 2012, AM J PATHOL, V181, P111, DOI 10.1016/j.ajpath.2012.03.026; Wiley SR, 2001, IMMUNITY, V15, P837, DOI 10.1016/S1074-7613(01)00232-1; Willis AL, 2008, MOL CANCER RES, V6, P725, DOI 10.1158/1541-7786.MCR-08-0005; Winkles JA, 2006, CANCER LETT, V235, P11, DOI 10.1016/j.canlet.2005.03.048	73	18	19	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2013	8	5							e62697	10.1371/journal.pone.0062697	http://dx.doi.org/10.1371/journal.pone.0062697			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145YI	23667509	Green Published, gold, Green Submitted			2022-12-27	WOS:000319055600039
J	Phillips, PPJ; Fielding, K; Nunn, AJ				Phillips, Patrick P. J.; Fielding, Katherine; Nunn, Andrew J.			An Evaluation of Culture Results during Treatment for Tuberculosis as Surrogate Endpoints for Treatment Failure and Relapse	PLOS ONE			English	Article							PULMONARY TUBERCULOSIS; CLINICAL-TRIALS; MYCOBACTERIUM-TUBERCULOSIS; DESIGN ISSUES; PHASE-III; MOXIFLOXACIN; MULTICENTER; BIOMARKERS; SPUTUM; TB	It is widely acknowledged that new regimens are urgently needed for the treatment of tuberculosis. The primary endpoint in the Phase III trials is a composite outcome of failure at the end of treatment or relapse after stopping treatment. Such trials are usually both long and expensive. Valid surrogate endpoints measured during or at the end of treatment could dramatically reduce both the time and cost of assessing the effectiveness of new regimens. The objective of this study was to evaluate sputum culture results on solid media during treatment as surrogate endpoints for poor outcome. Data were obtained from twelve randomised controlled trials conducted by the British Medical Research Council in the 1970s and 80s in East Africa and East Asia, consisting of 6974 participants and 49 different treatment regimens. The month two culture result was shown to be a poor surrogate in East Africa but a good surrogate in Hong Kong. In contrast, the month three culture was a good surrogate in trials conducted in East Africa but not in Hong Kong. As well as differences in location, ethnicity and probable strain of Mycobacteria tuberculosis, Hong Kong trials more often evaluated regimens with rifampicin throughout and intermittent regimens, and patients in East African trials more often presented with extensive cavitation and were slower to convert to culture negative during treatment. An endpoint that is a summary measure of the longitudinal profile of culture results over time or that is able to detect the presence of M. tuberculosis later in treatment is more likely to be a better endpoint for a phase II trial than a culture result at a single time point and may prove to be an acceptable surrogate. More data are needed before any endpoint can be used as a surrogate in a confirmatory phase III trial.	[Phillips, Patrick P. J.; Nunn, Andrew J.] Med Res Council Clin Trials Unit, London, England; [Fielding, Katherine] London Sch Hyg & Trop Med, London WC1, England	Medical Research Council Clinical Trials Unit; University of London; London School of Hygiene & Tropical Medicine	Phillips, PPJ (corresponding author), Med Res Council Clin Trials Unit, London, England.	patrick.phillips@ctu.mrc.ac.uk	Phillips, Patrick/B-6347-2008	Phillips, Patrick/0000-0002-6336-7024; Nunn, Andrew/0000-0002-9158-4595; Fielding, Katherine/0000-0002-6524-3754	British Medical Research Council PhD studentship; MRC [MC_EX_G0800814, MC_U122888469] Funding Source: UKRI; Medical Research Council [MC_EX_G0800814, MR/K012126/1, MC_U122888469] Funding Source: researchfish	British Medical Research Council PhD studentship(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was funded by a British Medical Research Council PhD studentship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aber V R, 1978, Bull Int Union Tuberc, V53, P276; [Anonymous], 2011, GLOB TUB CONTR 2011; Atkinson AJ, 2001, CLIN PHARMACOL THER, V69, P89, DOI 10.1067/mcp.2000.113989; Baker Stuart G, 2003, BMC Med Res Methodol, V3, P16, DOI 10.1186/1471-2288-3-16; Barry C, 2001, TUBERCULOSIS, V81, P1, DOI 10.1054/tube.2001.0288; Benator D, 2002, LANCET, V360, P528, DOI 10.1016/S0140-6736(02)09742-8; Blakemore R, 2011, AM J RESP CRIT CARE, V184, P1076, DOI 10.1164/rccm.201103-0536OC; Burman WJ, 2009, EMERG INFECT DIS, V15, P1061, DOI 10.3201/eid1507.081253; Burzykowski T, 2005, EVALUATION SURROGATE; Chaisson RE, 2010, J INFECT DIS, V201, P653, DOI 10.1086/650531; Christie DA, 2005, SHORT COURS CHEM TUB; Daniels MJ, 1997, STAT MED, V16, P1965, DOI 10.1002/(SICI)1097-0258(19970915)16:17<1965::AID-SIM630>3.3.CO;2-D; Davies GR, 2010, TUBERCULOSIS, V90, P171, DOI 10.1016/j.tube.2010.03.007; DESOPO ND, 1982, AM REV RESPIR DIS, V125, P85; Dorman SE, 2009, AM J RESP CRIT CARE, V180, P273, DOI 10.1164/rccm.200901-0078OC; *E CENTR AFR BRIT, 1983, TUBERCLE, V64, P153; Fox W, 1999, INT J TUBERC LUNG D, V3, pS231; Honeyborne I, 2011, J CLIN MICROBIOL, V49, P3905, DOI 10.1128/JCM.00547-11; Horne DJ, 2010, LANCET INFECT DIS, V10, P387, DOI 10.1016/S1473-3099(10)70071-2; Jindani A, 2004, LANCET, V364, P1244, DOI 10.1016/S0140-6736(04)17141-9; Karim SSA, 2009, LANCET, V374, P921, DOI 10.1016/S0140-6736(09)60916-8; Lambert ML, 2003, LANCET INFECT DIS, V3, P282, DOI 10.1016/S1473-3099(03)00607-8; Mac Kenzie WR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018358; Madras Tuberculosis Chemotherapy Centre, 1960, B WORLD HEALTH ORGAN, V23, P535; Merle CSC, 2012, TRIALS, V13, DOI 10.1186/1745-6215-13-61; Mitchison D A, 1996, Soc Appl Bacteriol Symp Ser, V25, p72S; MITCHISON DA, 1993, AM REV RESPIR DIS, V147, P1062, DOI 10.1164/ajrccm/147.4.1062; Mukamolova GV, 2010, AM J RESP CRIT CARE, V181, P174, DOI 10.1164/rccm.200905-0661OC; Nahid P, 2011, AM J RESP CRIT CARE; Nahid P, 2011, AM J RESP CRIT CARE, V184, P972, DOI 10.1164/rccm.201105-0827WS; Nahid P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010753; Nunn AJ, 2008, TUBERCULOSIS, V88, pS85, DOI 10.1016/S1472-9792(08)70039-8; Perrin FMR, 2007, LANCET INFECT DIS, V7, P481, DOI 10.1016/S1473-3099(07)70112-3; Phillips PPJ, 2010, FUTURE MED CHEM, V2, P1273, DOI 10.4155/FMC.10.221; Phillips PP, 2012, J INFECT DIS; PRENTICE RL, 1989, STAT MED, V8, P431, DOI 10.1002/sim.4780080407; Rachow A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020458; Rustomjee R, 2008, INT J TUBERC LUNG D, V12, P128; SIMON G, 1966, BMJ-BRIT MED J, V2, P491, DOI 10.1136/bmj.2.5512.491; Sirgel FA, 2000, J ANTIMICROB CHEMOTH, V45, P859, DOI 10.1093/jac/45.6.859; Spigelman MK, 2007, J INFECT DIS, V196, pS28, DOI 10.1086/518663; Wallis RS, 2007, EXPERT REV ANTI-INFE, V5, P163, DOI 10.1586/14787210.5.2.163; Wallis RS, 2010, LANCET INFECT DIS, V10, P68, DOI 10.1016/S1473-3099(10)70003-7; Youmans GP, 1979, TUBERCULOSIS; ZUMLA A, 2008, JOINT TDR EC EXPERT	46	56	56	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2013	8	5							e63840	10.1371/journal.pone.0063840	http://dx.doi.org/10.1371/journal.pone.0063840			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145YI	23667677	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000319055600076
J	Yang, XY; Barton, HJ; Wan, ZW; Li, Q; Ma, ZK; Li, MQ; Zhang, D; Wei, J				Yang, Xiaoyan; Barton, Huw J.; Wan, Zhiwei; Li, Quan; Ma, Zhikun; Li, Mingqi; Zhang, Dan; Wei, Jun			Sago-Type Palms Were an Important Plant Food Prior to Rice in Southern Subtropical China	PLOS ONE			English	Article							EXPRESS-TRAIN	Poor preservation of plant macroremains in the acid soils of southern subtropical China has hampered understanding of prehistoric diets in the region and of the spread of domesticated rice southwards from the Yangtze River region. According to records in ancient books and archaeological discoveries from historical sites, it is presumed that roots and tubers were the staple plant foods in this region before rice agriculture was widely practiced. But no direct evidences provided to test the hypothesis. Here we present evidence from starch and phytolith analyses of samples obtained during systematic excavations at the site of Xincun on the southern coast of China, demonstrating that during 3,350-2,470 aBC humans exploited sago palms, bananas, freshwater roots and tubers, fern roots, acorns, Job's-tears as well as wild rice. A dominance of starches and phytoliths from palms suggest that the sago-type palms were an important plant food prior to the rice in south subtropical China. We also believe that because of their reliance on a wide range of starch-rich plant foods, the transition towards labour intensive rice agriculture was a slow process.	[Yang, Xiaoyan; Wan, Zhiwei; Li, Quan; Ma, Zhikun; Li, Mingqi; Zhang, Dan] Chinese Acad Sci, Inst Geog Sci & Nat Resources Res, Beijing, Peoples R China; [Barton, Huw J.] Univ Leicester, Sch Archaeol & Ancient Hist, Leicester, Leics, England; [Wan, Zhiwei; Ma, Zhikun] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China; [Wei, Jun] Guangdong Prov Museum, Guangzhou, Guangdong, Peoples R China	Chinese Academy of Sciences; Institute of Geographic Sciences & Natural Resources Research, CAS; University of Leicester; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Yang, XY (corresponding author), Chinese Acad Sci, Inst Geog Sci & Nat Resources Res, Beijing, Peoples R China.	yangxy@igsnrr.ac.cn; hjb15@leicester.ac.uk		Yang, Xiaoyan/0000-0002-9088-1838	Royal Society (UK)-China NSFC International Joint Projects [41011130159]; National Natural Science Foundation of China [41072140]; CAS Strategic Priority Research Program [XDA05130603]	Royal Society (UK)-China NSFC International Joint Projects; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); CAS Strategic Priority Research Program	Funding for this research was provided in part by the Royal Society (UK)-China NSFC International Joint Projects (Grant No. 41011130159), the National Natural Science Foundation of China (Grant No. 41072140), and the CAS Strategic Priority Research Program (Grant No. XDA05130603). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Austin CC, 1999, NATURE, V397, P113, DOI 10.1038/16365; Barker G, 2011, WHY CULTIVATE ANTHR, P61; Barker G, 2013, J ARCHAEOL METHOD TH, V20, P256, DOI 10.1007/s10816-012-9150-7; Barton H., 2011, WHY CULTIVATE ANTHR, P17; Barton H, 2012, QUATERN INT, V249, P96, DOI 10.1016/j.quaint.2011.03.037; Bellwood P, 2004, 1 FARMERS ORIGIN AGR; Brandt S, 1997, TREE HUNTER ENSET BA; Brosius J. Peter, 1986, SARAWAK MUS J, V57, P173; Chi Z, 2010, ANTIQUITY, V84, P11, DOI 10.1017/S0003598X00099737; Denham TP, 2003, SCIENCE, V301, P189, DOI 10.1126/science.1085255; Diamond J, 2003, SCIENCE, V300, P597, DOI 10.1126/science.1078208; DIAMOND JM, 1988, NATURE, V336, P307, DOI 10.1038/336307a0; Ellen R, 2004, ECON BOT, V58, P601, DOI 10.1663/0013-0001(2004)058[0601:PMSRAA]2.0.CO;2; Fuller D. Q., 2009, ETHNOBOTANY RES APPL, V7, P333, DOI DOI 10.17348/ERA.7.0.333-351; Fuller DQ, 2010, ARCHAEOL ANTHROP SCI, V2, P115, DOI 10.1007/s12520-010-0035-y; Gray RD, 2000, NATURE, V405, P1052, DOI 10.1038/35016575; Groff G., 1923, LINGNAN AGR REV, V1, P27; Henderson A, 2009, PALMS SO ASIA; Hildebrand EA, 2003, J ANTHROPOL ARCHAEOL, V22, P358, DOI 10.1016/S0278-4165(03)00031-X; Ishige N, 2009, SENRI ETHNOLOGICAL S, P263; Lentfer C., 2009, ETHNOBOT RES APPL, V7, P217; LI HL, 1970, ECON BOT, V24, P3, DOI 10.1007/BF02860628; Madella M, 2005, ANN BOT-LONDON, V96, P253, DOI 10.1093/aob/mci172; Morris HS, 1993, OYA MELANAU; Pearsall DM., 2015, PALEOETHNOBOTANY HDB; Perrier X, 2011, P NATL ACAD SCI USA, V108, P11311, DOI 10.1073/pnas.1102001108; Piperno D.R., 2006, PHYTOLITH COMPREHENS; Piperno D.R., 1988, PHYTOLITH ANAL ARCHA; Piperno DR, 2000, NATURE, V407, P894, DOI 10.1038/35038055; Reichert E.T, 1913, DIFFERENTIATION SPEC; Roscoe P, 2002, CURR ANTHROPOL, V43, P153, DOI 10.1086/338289; Ruddle K, 1978, PALM SAGO TROPICAL S; South China Botanic Institute of Chinese Academy of Sciences, 1962, WILD EC PLANTS S CHI; Tong E., 2004, SO CIVILIZATION, P126; Torrence R., 2006, ANCIENT STARCH RES, P1; Wu D.-L., 2000, FLORA CHINA, V24, P297; Yang XY, 2012, P NATL ACAD SCI USA, V109, P3726, DOI 10.1073/pnas.1115430109; Zhao Z, 2005, ARCHAEOLOGY CHINA NE, P86; Zhao ZJ, 2010, ARCHAEOL ANTHROP SCI, V2, P99, DOI 10.1007/s12520-010-0028-x	39	41	45	3	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2013	8	5							e63148	10.1371/journal.pone.0063148	http://dx.doi.org/10.1371/journal.pone.0063148			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145YI	23667584	Green Submitted, Green Published, gold			2022-12-27	WOS:000319055600056
J	Zhang, HJ; An, XL; Zhou, YY; Zhang, BZ; Zhang, S; Li, D; Chen, ZR; Li, Y; Bai, SJ; Lv, JL; Zheng, W; Tian, Y; Zheng, TL				Zhang, Huajun; An, Xinli; Zhou, Yanyan; Zhang, Bangzhou; Zhang, Su; Li, Dong; Chen, Zhangran; Li, Yi; Bai, Shijie; Lv, Jinglin; Zheng, Wei; Tian, Yun; Zheng, Tianling			Effect of Oxidative Stress Induced by Brevibacterium sp BS01 on a HAB Causing Species-Alexandrium tamarense	PLOS ONE			English	Article							RED-TIDE; GENE-EXPRESSION; ANTIOXIDANT RESPONSES; CORALLINA-PILULIFERA; OPTICAL-PROPERTIES; CYANOBACTERIA; ALGA; PHAEOCYSTIS; INHIBITION; DAMAGE	Harmful algal blooms occur all over the world, destroying aquatic ecosystems and threatening other organisms. The culture supernatant of the marine algicidal actinomycete BS01 was able to lysis dinoagellate Alexandrium tamarense ATGD98-006. Physiological and biochemical responses to oxidative stress in A. tamarense were investigated to elucidate the mechanism involved in BS01 inhibition of algal growth. Transmission electron microscope analysis revealed that there were some chloroplast abnormalities in response to BS01 supernatant. The decrease in cellular-soluble protein content suggested that cell growth was greatly inhibited at high concentration of BS01 supernatant. The increase in the levels of reactive oxygen species (ROS) and malondialdehyde contents following exposure to BS01 supernatant indicated that algal cells suffered from oxidative damage. The content of pigment was significantly decreased after 12 h treatment, which indicated that the accumulation of ROS destroyed pigment synthesis. Moreover, the decrease of Fv/Fm ratio suggested that in the photosynthetic system, the dominant sites producing ROS were destroyed by the supernatant of the BS01 culture. The activities of the antioxidant enzymes including superoxide dismutase and peroxidase increased in a short time and decreased slightly with increasing exposure time. A real-time PCR assay showed changes in the transcript abundances of two photosynthetic genes, psbA and psbD. The results showed that BS01 supernatant reduced the expression of the psbA gene after 2 h exposure, but the expression of the psbD gene was increased at concentrations of 1.0 and 1.5%. Our results demonstrated that the expression of the psbA gene was inhibited by the BS01 supernatant, which might block the electron transport chain, significantly enhancing ROS level and excess activity of the antioxidant system. The accumulation of ROS destoryed pigment synthesis and membrane integrity, and inhibited or ultimately killed the algal cells.	[Zhang, Huajun; An, Xinli; Zhou, Yanyan; Zhang, Bangzhou; Zhang, Su; Li, Dong; Chen, Zhangran; Li, Yi; Bai, Shijie; Lv, Jinglin; Zheng, Wei; Tian, Yun; Zheng, Tianling] Xiamen Univ, Sch Life Sci, State Key Lab Marine Environm Sci, Xiamen, Peoples R China; [Zhang, Huajun; An, Xinli; Zhou, Yanyan; Zhang, Bangzhou; Zhang, Su; Li, Dong; Chen, Zhangran; Li, Yi; Bai, Shijie; Lv, Jinglin; Zheng, Wei; Tian, Yun; Zheng, Tianling] Xiamen Univ, Sch Life Sci, Key Lab Minist Educ Coastal & Wetland Ecosyst, Xiamen, Peoples R China; [Li, Dong] Huaqiao Univ, Coll Chem Engn, Xiamen, Peoples R China	Xiamen University; Xiamen University; Huaqiao University	Tian, Y (corresponding author), Xiamen Univ, Sch Life Sci, State Key Lab Marine Environm Sci, Xiamen, Peoples R China.	tianyun@xmu.edu.cn; microzh@xmu.edu.cn			National Nature Science Foundation of China [40930847]; Special Fund for Ph.D. Program in University [20120121130001]; Public Science and Technology Research Funds Projects of Ocean [201305016, 201305041, 201305022];  [MELRI1003]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Special Fund for Ph.D. Program in University; Public Science and Technology Research Funds Projects of Ocean; 	National Nature Science Foundation of China (40930847) http://isis.nsfc.gov.cn/portal/Proj_List.asp, Special Fund for Ph.D. Program in University (20120121130001) http://211.68.23.117/SSO/loginshow?u=null, Public Science and Technology Research Funds Projects of Ocean (201305016, 201305041, 201305022) http://www.soanbu.com/and MELRI1003. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alboresi A, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-62; Allen JF, 2001, TRENDS PLANT SCI, V6, P317, DOI 10.1016/S1360-1385(01)02010-6; Anderson DM, 1997, NATURE, V388, P513, DOI 10.1038/41415; Anderson DM, 1997, LIMNOL OCEANOGR, V42, P1009, DOI 10.4319/lo.1997.42.5_part_2.1009; Apel K, 2004, ANNU REV PLANT BIOL, V55, P373, DOI 10.1146/annurev.arplant.55.031903.141701; Bai SJJ, 2011, CURR MICROBIOL, V62, P1774, DOI 10.1007/s00284-011-9927-z; Berger J, 2004, BIOLOGIA, V59, P9; BORNMAN JF, 1991, J EXP BOT, V42, P547, DOI 10.1093/jxb/42.4.547; Brussaard CPD, 2007, BIOGEOCHEMISTRY, V83, P201, DOI 10.1007/s10533-007-9096-0; Cai WW, 2011, APPL ENVIRON MICROB, V77, P7837, DOI 10.1128/AEM.05783-11; Choi HJ, 2005, BIOL CONTROL, V33, P335, DOI 10.1016/j.biocontrol.2005.03.007; Doucette GJ, 1999, J PHYCOL, V35, P1447, DOI 10.1046/j.1529-8817.1999.3561447.x; Drabkova M, 2007, ENVIRON SCI TECHNOL, V41, P309, DOI 10.1021/es060746i; ERICKSON JM, 1986, EMBO J, V5, P1745, DOI 10.1002/j.1460-2075.1986.tb04422.x; Perez-Perez ME, 2012, PLANT PHYSIOL, V160, P156, DOI 10.1104/pp.112.199992; Perez-Perez ME, 2012, AUTOPHAGY, V8, P376, DOI 10.4161/auto.18864; Gallacher S, 1997, APPL ENVIRON MICROB, V63, P239, DOI 10.1128/AEM.63.1.239-245.1997; Guillard R.R.L., 1975, CULTURE MARINE INVER, P29, DOI [10.1007/978-1-4615-8714-9_3, DOI 10.1007/978-1-4615-8714-9_3]; He YY, 2002, J PHOTOCH PHOTOBIO B, V66, P73, DOI 10.1016/S1011-1344(01)00278-0; Hong Y, 2009, AQUAT TOXICOL, V91, P262, DOI 10.1016/j.aquatox.2008.11.014; INSKEEP WP, 1985, PLANT PHYSIOL, V77, P483, DOI 10.1104/pp.77.2.483; Jeong JH, 2000, J APPL PHYCOL, V12, P37, DOI 10.1023/A:1008139129057; Kim JD, 2007, BIOL CONTROL, V41, P296, DOI 10.1016/j.biocontrol.2007.02.010; Kommalapati M, 2007, PHOTOSYNTH RES, V92, P315, DOI 10.1007/s11120-007-9186-9; Kumar M, 2011, ENVIRON EXP BOT, V72, P194, DOI 10.1016/j.envexpbot.2011.03.007; Kwok CT, 2012, HARMFUL ALGAE, V13, P40, DOI 10.1016/j.hal.2011.10.001; Leitao MAD, 2003, ARCH ENVIRON CON TOX, V45, P59, DOI 10.1007/s00244-002-0208-5; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luo MB, 2011, J EXP MAR BIOL ECOL, V409, P223, DOI 10.1016/j.jembe.2011.08.023; Miyazono A, 2012, HARMFUL ALGAE, V16, P81, DOI 10.1016/j.hal.2012.02.001; Moss VA, 1977, BR HOM J, V66, P169, DOI [10.1016/S0007-0785(77)80010-0, DOI 10.1016/S0007-0785(77)80010-0]; Mu RM, 2007, J ENVIRON SCI-CHINA, V19, P1336, DOI 10.1016/S1001-0742(07)60218-6; Nakashima T, 2006, APPL MICROBIOL BIOT, V73, P684, DOI 10.1007/s00253-006-0507-2; Ni LX, 2012, CHEMOSPHERE, V88, P1051, DOI 10.1016/j.chemosphere.2012.05.009; Paerl HW, 2008, SCIENCE, V320, P57, DOI 10.1126/science.1155398; Parkhill JP, 1999, J PLANKTON RES, V21, P939, DOI 10.1093/plankt/21.5.939; Pei HY, 2005, J ENVIRON SCI-CHINA, V17, P205; Pierce RH, 2004, HARMFUL ALGAE, V3, P141, DOI 10.1016/j.hal.2003.09.003; Qian HF, 2008, AQUAT TOXICOL, V88, P301, DOI 10.1016/j.aquatox.2008.05.009; Qian HF, 2009, CHEMOSPHERE, V75, P368, DOI 10.1016/j.chemosphere.2008.12.040; Ryu B, 2009, RADIAT PHYS CHEM, V78, P98, DOI 10.1016/j.radphyschem.2008.09.001; Schoemann V, 2005, J SEA RES, V53, P43, DOI 10.1016/j.seares.2004.01.008; Sengco MR, 2004, J EUKARYOT MICROBIOL, V51, P169, DOI 10.1111/j.1550-7408.2004.tb00541.x; Shao JH, 2009, CHEMOSPHERE, V75, P924, DOI 10.1016/j.chemosphere.2009.01.021; Solovchenko AE, 2011, RUSS J PLANT PHYSL+, V58, P9, DOI 10.1134/S1021443710061056; Srivastava A, 1998, BBA-BIOENERGETICS, V1364, P326, DOI 10.1016/S0005-2728(98)00014-0; Su JQ, 2011, BIOL CONTROL, V56, P132, DOI 10.1016/j.biocontrol.2010.10.004; Su RQ, 2007, HARMFUL ALGAE, V6, P799, DOI 10.1016/j.hal.2007.04.004; Suikkanen S, 2004, J EXP MAR BIOL ECOL, V308, P85, DOI 10.1016/j.jembe.2004.02.012; van Rijssel M, 2000, J SEA RES, V43, P297, DOI 10.1016/S1385-1101(00)00013-7; Wang BX, 2010, LETT APPL MICROBIOL, V51, P552, DOI 10.1111/j.1472-765X.2010.02936.x; Wang BX, 2012, HARMFUL ALGAE, V13, P83, DOI 10.1016/j.hal.2011.10.006; Wang X, 2010, BIOL CONTROL, V52, P123, DOI 10.1016/j.biocontrol.2009.10.004; WHYTE LG, 1985, J APPL BACTERIOL, V58, P195, DOI 10.1111/j.1365-2672.1985.tb01447.x; Yang CY, 2011, PESTIC BIOCHEM PHYS, V100, P93, DOI 10.1016/j.pestbp.2011.02.014; Yin LY, 2005, TOXICON, V46, P507, DOI 10.1016/j.toxicon.2005.06.015; Yoshinaga I, 1997, FISHERIES SCI, V63, P94, DOI 10.2331/fishsci.63.94; Zhang SL, 2011, J PLANT PHYSIOL, V168, P639, DOI 10.1016/j.jplph.2010.10.005	58	41	46	2	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2013	8	5							e63018	10.1371/journal.pone.0063018	http://dx.doi.org/10.1371/journal.pone.0063018			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145YI	23667564	gold, Green Published, Green Submitted			2022-12-27	WOS:000319055600053
J	Poggi, A; Boero, S; Musso, A; Zocchi, MR				Poggi, Alessandro; Boero, Silvia; Musso, Alessandra; Zocchi, Maria Raffaella			Selective Role of Mevalonate Pathway in Regulating Perforin but Not FasL and TNFalpha Release in Human Natural Killer Cells	PLOS ONE			English	Article							LIPID-LOWERING DRUGS; CALCIUM-CHANNELS; LEUKEMIA-CELLS; STATINS; CYTOTOXICITY; APOPTOSIS; CANCER; ACTIVATION; RECEPTORS; RITUXIMAB	We have analyzed the effects of fluvastatin, an inhibitor of the enzyme 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase involved in mevalonate synthesis, on human NK cell-mediated anti-tumor cytolysis. Fluvastatin inhibited the activation of the small guanosin triphosphate binding protein (GTP) RhoA and the consequent actin redistribution induced by ligation of LFA1 involved in NK-tumor target cell adhesion. Also, fluvastatin reduced ganglioside M1 rafts formation triggered through the engagement of NK cell activating receptors as Fc gamma RIIIA (CD16), NKG2D and DNAM1. Cytolysis of tumor targets was inhibited up to 90% when NK cells were cultured with fluvastatin by affecting i) receptor-mediated increase of the intracellular free calcium concentration, ii) activation of akt1/PKB and iii) perforin and granzyme release. Fluvastatin displayed a stronger inhibiting effect on NKG2D, DNAM1, 2B4, NKp30, NKp44 and NKp46 than on CD16-mediated NK cell triggering. This was in line with the impairment of surface expression of all these receptors but not of CD16. Remarkably, fluvastatin did not affect the expression of the inhibiting receptors CD94, KIR2D and LAIR1. FasL release elicited by either NK-tumor cell interaction or CD16 or NKG2D engagement, as well as FasL-mediated killing, were not sensitive to fluvastatin. Moreover, TNF alpha secretion triggered in NK cells upon incubation with tumor target cells or engagement of NKG2D receptor was not impaired in fluvastatin-treated NK cells. Likewise, antibody dependent cellular cytotoxicity (ADCC) triggered through Fc gamma RIIIA engagement with the humanized monoclonal antibody rituximab or trastuzumab was only marginally affected in fluvastatin-treated NK cells. Altogether these findings suggest that interference with mevalonate synthesis impairs activation and assembly of cytoskeleton, degranulation and cytotoxic effect of perforins and granzyme but not FasL- and TNF alpha-mediated cytotoxicity.	[Poggi, Alessandro; Boero, Silvia; Musso, Alessandra] IRCCS AOU San Martino IST Natl Inst Canc Res, Mol Oncol & Angiogenesis Unit, Genoa, Italy; [Zocchi, Maria Raffaella] Ist Sci San Raffaele, Div Immunol Transplants & Infect Dis, I-20132 Milan, Italy	University of Genoa; IRCCS AOU San Martino IST; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele	Poggi, A (corresponding author), IRCCS AOU San Martino IST Natl Inst Canc Res, Mol Oncol & Angiogenesis Unit, Genoa, Italy.	alessandro.poggi@istge.it	Poggi, Alessandro/K-6664-2016	Poggi, Alessandro/0000-0002-1860-430X; Zocchi, Maria Raffaella/0000-0002-0022-8385	Italian Association for cancer Research (AIRC) [IG8761, IG8727]; Compagnia di San Paolo [2007.2065, 2010.2065]	Italian Association for cancer Research (AIRC)(Fondazione AIRC per la ricerca sul cancro); Compagnia di San Paolo(Compagnia di San Paolo)	This work was partially supported by grants from the Italian Association for cancer Research (AIRC) 2009 to AP (IG8761) and to MRZ (IG8727), Compagnia di San Paolo n. 2007.2065 and 2010.2065 to AP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beum PV, 2004, J IMMUNOL METHODS, V289, P97, DOI 10.1016/j.jim.2004.03.012; Bryceson YT, 2006, IMMUNOL REV, V214, P73, DOI 10.1111/j.1600-065X.2006.00457.x; Chapman-Shimshoni D, 2003, EXP HEMATOL, V31, P779, DOI 10.1016/S0301-472X(03)00192-9; Chichili GR, 2009, CELL MOL LIFE SCI, V66, P2319, DOI 10.1007/s00018-009-0022-6; Contini P, 2007, LEUKEMIA, V21, P253, DOI 10.1038/sj.leu.2404494; Ferris RL, 2010, J CLIN ONCOL, V28, P4390, DOI 10.1200/JCO.2009.27.6360; Fildes JE, 2009, CANCER IMMUNOL IMMUN, V58, P461, DOI 10.1007/s00262-008-0541-2; Greenwood J, 2006, NAT REV IMMUNOL, V6, P358, DOI 10.1038/nri1839; Gruenbacher G, 2010, CANCER; Hindler K, 2006, ONCOLOGIST, V11, P306, DOI 10.1634/theoncologist.11-3-306; Jiang K, 2000, NAT IMMUNOL, V1, P419, DOI 10.1038/80859; Kotamraju S, 2007, CANCER RES, V67, P7386, DOI 10.1158/0008-5472.CAN-07-0993; Kute T, 2012, ONCOIMMUNOLOGY, V1, P810, DOI 10.4161/onci.20447; Kwak BR, 2003, AUTOIMMUN REV, V2, P332, DOI 10.1016/S1568-9972(03)00049-1; Li HY, 2003, BLOOD, V101, P3628, DOI 10.1182/blood-2002-07-2283; Liu DF, 2009, IMMUNITY, V31, P99, DOI 10.1016/j.immuni.2009.05.009; Moretta A, 2001, ANNU REV IMMUNOL, V19, P197, DOI 10.1146/annurev.immunol.19.1.197; Murtola TJ, 2011, EUR J PHARMACOL, V673, P96, DOI 10.1016/j.ejphar.2011.10.022; Musso A, 2011, HAEMATOL-HEMATOL J, V96, P16, DOI 10.3324/haematol.2010.031633; Pahan K, 2006, CELL MOL LIFE SCI, V63, P1165, DOI 10.1007/s00018-005-5406-7; PAN HY, 1990, J CLIN PHARMACOL, V30, P1128, DOI 10.1002/j.1552-4604.1990.tb01856.x; Pani B, 2009, CELL CALCIUM, V45, P625, DOI 10.1016/j.ceca.2009.02.009; Pasvolsky R, 2008, J IMMUNOL, V180, P2815, DOI 10.4049/jimmunol.180.5.2815; Patra D, 2013, NANOSCALE, V5, P1273, DOI 10.1039/c2nr32600k; Pedersen TR, 2009, CURR ATHEROSCLER REP, V11, P350, DOI 10.1007/s11883-009-0053-3; Pende D, 2002, CANCER RES, V62, P6178; POGGI A, 1989, EUR J IMMUNOL, V19, P2069, DOI 10.1002/eji.1830191115; Poggi A, 2005, J IMMUNOL, V175, P6352, DOI 10.4049/jimmunol.175.10.6352; Poggi A, 2011, CURR MED CHEM, V18, P5196, DOI 10.2174/092986711798184244; Poggi A, 2009, LEUKEMIA, V23, P641, DOI 10.1038/leu.2008.354; Poggi A, 1998, J BIOL CHEM, V273, P7205, DOI 10.1074/jbc.273.13.7205; Raemer PC, 2009, EUR J IMMUNOL, V39, P1456, DOI 10.1002/eji.200838863; Regazzi MB, 2005, THER DRUG MONIT, V27, P785, DOI 10.1097/01.ftd.0000184162.60197.c1; Salih HR, 2003, BLOOD, V102, P1389, DOI 10.1182/blood-2003-01-0019; Sassano A, 2007, CANCER RES, V67, P4524, DOI 10.1158/0008-5472.CAN-06-3686; Shibuya A, 1996, IMMUNITY, V4, P573, DOI 10.1016/S1074-7613(00)70060-4; Spaggiari GM, 2002, BLOOD, V99, P1706, DOI 10.1182/blood.V99.5.1706; Spaggiari GM, 2002, BLOOD, V100, P4098, DOI 10.1182/blood-2002-04-1284; Sun JC, 2011, NAT REV IMMUNOL, V11, P645, DOI 10.1038/nri3044; Tanaka T, 2007, INT IMMUNOL, V19, P163, DOI 10.1093/intimm/dxl133; TASWELL C, 1981, J IMMUNOL, V126, P1614; Tokuyama H, 2008, INT J CANCER, V122, P2526, DOI 10.1002/ijc.23365; TRINCHIERI G, 1989, ADV IMMUNOL, V47, P187, DOI 10.1016/S0065-2776(08)60664-1; Vivier E, 2008, NAT IMMUNOL, V9, P503, DOI 10.1038/ni1582; Winiarska M, 2008, PLOS MED, V5, DOI 10.1371/journal.pmed.0050064; Wong WWL, 2002, LEUKEMIA, V16, P508, DOI 10.1038/sj.leu.2402476; Zocchi MR, 1998, J IMMUNOL, V161, P2938	47	15	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e62932	10.1371/journal.pone.0062932	http://dx.doi.org/10.1371/journal.pone.0062932			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667543	Green Submitted, gold, Green Published			2022-12-27	WOS:000319654700082
J	Vazquez, A				Vazquez, Alexei			Metabolic States Following Accumulation of Intracellular Aggregates: Implications for Neurodegenerative Diseases	PLOS ONE			English	Article							MITOCHONDRIAL ATP PRODUCTION; INCLUSION-BODY MYOSITIS; PROTEIN AGGREGATION; HUNTINGTONS-DISEASE; ALZHEIMERS-DISEASE; SKELETAL-MUSCLE; NEURAL ACTIVITY; GENOME-SCALE; BRAIN; CELL	The formation of intracellular aggregates is a common etiology of several neurodegenerative diseases. Mitochondrial defects and oxidative stress has been pointed as the major mechanistic links between the accumulation of intracellular aggregates and cell death. In this work we propose a "metabolic cell death by overcrowding" as an alternative hypothesis. Using a model of neuron metabolism, we predict that as the concentration of protein aggregates increases the neurons transit through three different metabolic phases. The first phase (0-6 mM) corresponds with the normal neuron state, where the neuronal activity is sustained by the oxidative phosphorylation of lactate. The second phase (6-8.6 mM) is characterized by a mixed utilization of lactate and glucose as energy substrates and a switch from ammonia uptake to ammonia release by neurons. In the third phase (8.6-9.3 mM) neurons are predicted to support their energy demands from glycolysis and an alternative pathway for energy generation, involving reactions from serine synthesis, one carbon metabolism and the glycine cleavage system. The model also predicts a decrease in the maximum neuronal capacity for energy generation with increasing the concentration of protein aggregates. Ultimately this maximum capacity becomes zero when the protein aggregates reach a concentration of about 9.3 mM, predicting the cessation of neuronal activity.	[Vazquez, Alexei] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Canc Inst New Jersey, Dept Radiat Oncol, New Brunswick, NJ USA; [Vazquez, Alexei] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Canc Inst New Jersey, Ctr Syst Biol, New Brunswick, NJ USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers Cancer Institute of New Jersey; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers Cancer Institute of New Jersey	Vazquez, A (corresponding author), Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Canc Inst New Jersey, Dept Radiat Oncol, New Brunswick, NJ USA.	vazqueal@umdnj.edu						Alberts B., 2008, MOL BIOL CELL, Vxxxiii; Alberts B, 2008, MOL BIOL CELL; Askanas V, 2002, CURR OPIN NEUROL, V15, P525, DOI 10.1097/00019052-200210000-00002; Baloyannis Stavros J, 2004, Am J Alzheimers Dis Other Demen, V19, P89, DOI 10.1177/153331750401900205; Brocchieri L, 2005, NUCLEIC ACIDS RES, V33, P3390, DOI 10.1093/nar/gki615; Ceru S, 2010, BIOL CELL, V102, P319, DOI 10.1042/BC20090163; FRAME KK, 1990, BIOTECHNOL BIOENG, V36, P191, DOI 10.1002/bit.260360211; GLAS U, 1966, J CELL BIOL, V29, P507, DOI 10.1083/jcb.29.3.507; Harms L, 1997, J NEUROL NEUROSUR PS, V62, P27, DOI 10.1136/jnnp.62.1.27; Hirai K, 2001, J NEUROSCI, V21, P3017, DOI 10.1523/JNEUROSCI.21-09-03017.2001; Hoffner G, 2002, BIOCHIMIE, V84, P273, DOI 10.1016/S0300-9084(02)01398-6; Hou XY, 2002, CLIN PHYSIOL FUNCT I, V22, P226, DOI 10.1046/j.1475-097X.2002.00423.x; HOYER S, 1990, NEUROSCI LETT, V117, P358, DOI 10.1016/0304-3940(90)90691-2; Hu YB, 1997, J NEUROCHEM, V69, P1484; Irvine GB, 2008, MOL MED, V14, P451, DOI 10.2119/2007-00100.Irvine; JENKINS BG, 1993, NEUROLOGY, V43, P2689, DOI 10.1212/WNL.43.12.2689; Jerby L, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.56; Kasischke KA, 2004, SCIENCE, V305, P99, DOI 10.1126/science.1096485; Kim J, 2010, HUM MOL GENET, V19, P3919, DOI 10.1093/hmg/ddq306; Kopeikina KJ, 2011, AM J PATHOL, V179, P2071, DOI 10.1016/j.ajpath.2011.07.004; LEE B, 1983, P NATL ACAD SCI USA, V80, P622, DOI 10.1073/pnas.80.2.622; Lewis NE, 2010, NAT BIOTECHNOL, V28, P1279, DOI 10.1038/nbt.1711; Maisonneuve E, 2008, J BACTERIOL, V190, P6070, DOI 10.1128/JB.00736-08; Mangia S, 2003, NEUROSCIENCE, V118, P7, DOI 10.1016/S0306-4522(02)00792-3; Minton AP, 2001, J BIOL CHEM, V276, P10577, DOI 10.1074/jbc.R100005200; Mo ML, 2007, MOL BIOSYST, V3, P598, DOI 10.1039/b705597h; Princiotta MF, 2003, IMMUNITY, V18, P343, DOI 10.1016/S1074-7613(03)00051-7; Roos PM, 2011, ACTA NEUROL SCAND, V124, P215, DOI 10.1111/j.1600-0404.2010.01461.x; Ross CA, 2004, NAT MED, V10, pS10, DOI 10.1038/nm1066; Roth J, 2008, HISTOCHEM CELL BIOL, V129, P163, DOI 10.1007/s00418-007-0366-7; SAVINELL JM, 1992, J THEOR BIOL, V154, P421, DOI 10.1016/S0022-5193(05)80161-4; Schomburg I, 2002, NUCLEIC ACIDS RES, V30, P47, DOI 10.1093/nar/30.1.47; SCHWERZMANN K, 1989, P NATL ACAD SCI USA, V86, P1583, DOI 10.1073/pnas.86.5.1583; Seiler N, 2002, NEUROCHEM INT, V41, P189, DOI 10.1016/S0197-0186(02)00041-4; Sheikh K, 2005, BIOTECHNOL PROGR, V21, P112, DOI 10.1021/bp0498138; Sheng BY, 2012, J NEUROCHEM, V120, P419, DOI 10.1111/j.1471-4159.2011.07581.x; Shlomi T, 2008, NAT BIOTECHNOL, V26, P1003, DOI 10.1038/nbt.1487; Short KR, 2001, AM J PHYSIOL-ENDOC M, V280, pE761, DOI 10.1152/ajpendo.2001.280.5.E761; Trojanowski JQ, 1998, CELL DEATH DIFFER, V5, P832, DOI 10.1038/sj.cdd.4400432; Trushina E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032737; Vazquez A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025881; Vazquez A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019538; Vazquez A, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-58; Vazquez A, 2010, J THEOR BIOL, V264, P356, DOI 10.1016/j.jtbi.2010.02.024; Vazquez A, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000195; Wanker EE, 2000, BIOL CHEM, V381, P937, DOI 10.1515/BC.2000.114; WIBOM R, 1992, J APPL PHYSIOL, V73, P2004, DOI 10.1152/jappl.1992.73.5.2004; Yang E, 2003, GENOME RES, V13, P1863, DOI 10.1101/gr.1272403; Zhou EH, 2009, P NATL ACAD SCI USA, V106, P10632, DOI 10.1073/pnas.0901462106; ZIMMERMAN SB, 1991, J MOL BIOL, V222, P599, DOI 10.1016/0022-2836(91)90499-V	50	15	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e63822	10.1371/journal.pone.0063822	http://dx.doi.org/10.1371/journal.pone.0063822			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667676	Green Submitted, Green Published, gold			2022-12-27	WOS:000319654700188
J	Brasseur, S; Gregoire, J; Bourdu, R; Mikolajczak, M				Brasseur, Sophie; Gregoire, Jacques; Bourdu, Romain; Mikolajczak, Moira			The Profile of Emotional Competence (PEC): Development and Validation of a Self-Reported Measure that Fits Dimensions of Emotional Competence Theory	PLOS ONE			English	Article							INTELLIGENCE QUESTIONNAIRE; PSYCHOMETRIC PROPERTIES; INCREMENTAL VALIDITY; OCCUPATIONAL STRESS; SOCIAL-INTERACTION; METAANALYSIS; PERFORMANCE; ALEXITHYMIA; RELIABILITY; CONSTRUCT	Emotional Competence (EC), which refers to individual differences in the identification, understanding, expression, regulation and use of one's own emotions and those of others, has been found to be an important predictor of individuals' adaptation to their environment. Higher EC is associated with greater happiness, better mental and physical health, more satisfying social and marital relationships and greater occupational success. While it is well-known that EC (as a whole) predicts a number of important outcomes, it is unclear so far which specific competency(ies) participate(s) in a given outcome. This is because no measure of EC distinctly measures each of the five core emotional competences, separately for one's own and others' emotions. This lack of information is problematic both theoretically (we do not understand the processes at stake) and practically (we cannot develop customized interventions). This paper aims to address this issue. We developed and validated in four steps a complete (albeit short: 50 items) self-reported measure of EC: the Profile of Emotional Competence. Analyses performed on a representative sample of 5676 subjects revealed promising psychometric properties. The internal consistency of scales and subscales alike was satisfying, factorial structure was as expected, and concurrent/discriminant validity was good.	[Brasseur, Sophie] Univ Namur, Dept Educ & Technol, Namur, Belgium; [Gregoire, Jacques; Mikolajczak, Moira] Catholic Univ Louvain, Dept Psychol, B-1348 Louvain, Belgium; [Bourdu, Romain] Univ Catholique Paris, Ecole Psychol Praticiens Paris, Paris, France	University of Namur; Universite Catholique Louvain	Brasseur, S (corresponding author), Univ Namur, Dept Educ & Technol, Namur, Belgium.	sophie.brasseur@unamur.be		Mikolajczak, Moira/0000-0002-7333-1578				Austin EJ, 2004, PERS INDIV DIFFER, V36, P555, DOI 10.1016/S0191-8869(03)00114-4; Bar-On R, 2000, PERS INDIV DIFFER, V28, P1107, DOI 10.1016/S0191-8869(99)00160-9; Bar-On R, 2006, PSICOTHEMA, V18, P13; Brackett MA, 2003, PERS SOC PSYCHOL B, V29, P1147, DOI 10.1177/0146167203254596; Brasseur S., 2010, ENFANCE, V1, P59; Cooper A, 2010, J PERS ASSESS, V92, P449, DOI 10.1080/00223891.2010.497426; Deltour JJ, 1993, STANDARD PROGR MATRI; FEINGOLD A, 1994, PSYCHOL BULL, V116, P429, DOI 10.1037/0033-2909.116.3.429; Furnham A, 2003, SOC BEHAV PERSONAL, V31, P815, DOI 10.2224/sbp.2003.31.8.815; Gallagher EN, 2008, PERS INDIV DIFFER, V44, P1551, DOI 10.1016/j.paid.2008.01.011; Joseph DL, 2010, J APPL PSYCHOL, V95, P54, DOI 10.1037/a0017286; Kotsou I, 2011, J APPL PSYCHOL, V96, P827, DOI 10.1037/a0023047; Kray LJ, 2005, RES ORGAN BEHAV, V26, P103, DOI 10.1016/S0191-3085(04)26004-X; Kunzmann U, 2005, PSYCHOL AGING, V20, P144, DOI 10.1037/0882-7974.20.1.144; Leroy V, 2012, LEARN INDIVID DIFFER, V22, P263, DOI 10.1016/j.lindif.2011.10.003; Lopes PN, 2005, EMOTION, V5, P113, DOI 10.1037/1528-3542.5.1.113; Lopes PN, 2004, PERS SOC PSYCHOL B, V30, P1018, DOI 10.1177/0146167204264762; Lumley MA, 2005, EMOTION, V5, P329, DOI 10.1037/1528-3542.5.3.329; Lyubomirsky S, 1999, SOC INDIC RES, V46, P137, DOI 10.1023/A:1006824100041; Martins A, 2010, PERS INDIV DIFFER, V49, P554, DOI 10.1016/j.paid.2010.05.029; Mayer J., 2000, HDB EMOTIONAL INTELL, P92; Mayer J. D., 1997, EMOTIONAL DEV EMOTIO, P3, DOI DOI 10.1177/1066480710387486; Mikolajczak M., 2009, E J APPL PSYCHOL, V5, P25; Mikolajczak M., 2009, COMPETENCES EMOTIONN; Mikolajczak M, 2007, J RES PERS, V41, P1107, DOI 10.1016/j.jrp.2007.01.003; Mikolajczak M, 2007, PSYCHONEUROENDOCRINO, V32, P1000, DOI 10.1016/j.psyneuen.2007.07.009; Mikolajczak M, 2007, J PERS ASSESS, V88, P338, DOI 10.1080/00223890701333431; Mikolajczak M, 2009, INT J CLIN HLTH PSYC, V9, P455; Nelis D, 2011, EMOTION, V11, P354, DOI 10.1037/a0021554; PARKER JDA, 1993, EUR J PERSONALITY, V7, P221, DOI 10.1002/per.2410070403; Pease, 2016, WHY MEN DONT LISTEN; Petrides KV, 2009, SPRINGER SER HUM EXC, P85, DOI 10.1007/978-0-387-88370-0_5; Petrides KV, 2004, PERS INDIV DIFFER, V36, P277, DOI 10.1016/S0191-8869(03)00084-9; Petrides KV, 2003, EUR J PERSONALITY, V17, P39, DOI 10.1002/per.466; Petrides KV, 2001, EUR J PERSONALITY, V15, P425, DOI 10.1002/per.416; Salovey P., 1995, EMOTION DISCLOSURE H, P125; Schutte NS, 2007, PERS INDIV DIFFER, V42, P921, DOI 10.1016/j.paid.2006.09.003; Schutte NS, 2002, COGNITION EMOTION, V16, P769, DOI 10.1080/02699930143000482; Schutte NS, 1998, PERS INDIV DIFFER, V25, P167, DOI 10.1016/S0191-8869(98)00001-4; Schutte NS, 2001, J SOC PSYCHOL, V141, P523, DOI 10.1080/00224540109600569; Senecal CB, 1992, EUR REV APPL PSYCHOL, V42, P315; Trinidad DR, 2002, PERS INDIV DIFFER, V32, P95, DOI 10.1016/S0191-8869(01)00008-3; Van Rooy DL, 2004, J VOCAT BEHAV, V65, P71, DOI 10.1016/S0001-8791(03)00076-9; Zeidner M, 2005, INTELLIGENCE, V33, P369, DOI 10.1016/j.intell.2005.03.001	44	149	153	5	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2013	8	5							e62635	10.1371/journal.pone.0062635	http://dx.doi.org/10.1371/journal.pone.0062635			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	177QL	23671616	Green Published, gold, Green Submitted			2022-12-27	WOS:000321390200032
J	Turton, P; Arrowsmith, S; Prescott, J; Ballard, C; Bricker, L; Neilson, J; Wray, S				Turton, Peter; Arrowsmith, Sarah; Prescott, Jonathan; Ballard, Celia; Bricker, Leanne; Neilson, James; Wray, Susan			A Comparison of the Contractile Properties of Myometrium from Singleton and Twin Pregnancies	PLOS ONE			English	Article							UTERINE SMOOTH-MUSCLE; MESSENGER-RIBONUCLEIC-ACID; OXYTOCIN RECEPTOR; SARCOPLASMIC-RETICULUM; METABOLIC INHIBITION; MULTIPLE-GESTATIONS; MECHANICAL STRETCH; PRETERM DELIVERY; RAT MYOMETRIUM; EXPRESSION	Objective: Over half of twin pregnancies in US and UK deliver prematurely but the reasons for this are unclear. The contractility of myometrium from twin pregnancies has not been directly investigated. The objective of this research was to determine if there are differences in the contractile activity and response to oxytocin, between myometrium from singleton and twin pregnancies, across a range of gestational ages. Furthermore, we wished to determine if contractile activity correlates with increasing level of stretch, using neonatal birth weights as a marker of uterine stretch. Methods: This was an in vitro, laboratory based study of myometrial contractility in women pregnant with one or two babies, using biopsies obtained from non-labouring women undergoing Caesarean section. Spontaneous, oxytocin-stimulated and depolarization induced contractile activity was compared. Results: Direct measurements of myometrial contractility under controlled conditions show that the frequency of contractions and responses to oxytocin are significantly increased in twins compared to singletons. The duration of contraction however was significantly reduced. We find that contractile activity correlates with increasing levels of stretch, using neonatal birth weights as a surrogate for uterine stretch, with response to oxytocin being significantly positively correlated with birth weight. Conclusions: We have found significant differences in contractile properties between myometrium from singleton and twin pregnancies and that increasing uterine stretch can alter the contractile properties of myometrium. We discuss the implication of these findings to preterm delivery and future studies.	[Turton, Peter; Arrowsmith, Sarah; Prescott, Jonathan; Ballard, Celia; Wray, Susan] Univ Liverpool, Inst Translat Med, Dept Cellular & Mol Physiol, Liverpool L69 3BX, Merseyside, England; [Bricker, Leanne] Liverpool Womens NHS Fdn Trust, Liverpool, Merseyside, England; [Neilson, James] Univ Liverpool, Inst Translat Med, Dept Womens & Childrens Hlth, Liverpool L69 3BX, Merseyside, England	University of Liverpool; University of Liverpool	Wray, S (corresponding author), Univ Liverpool, Inst Translat Med, Dept Cellular & Mol Physiol, Liverpool L69 3BX, Merseyside, England.	s.wray@liv.ac.uk	Turton, Peter/AAR-9490-2020; wray, susan/B-1197-2009	Arrowsmith, Sarah/0000-0003-1102-1934; Bricker, Leanne/0000-0001-7713-2771; Wray, Susan/0000-0002-0086-1359	SPARKS, UK; LWH Trust RD; Wolfson bursary; Rosetrees Trust, UK; Sparks Charity [11LIV02] Funding Source: researchfish	SPARKS, UK; LWH Trust RD; Wolfson bursary; Rosetrees Trust, UK(Rosetrees Trust); Sparks Charity	SA was funded by SPARKS, UK and LWH Trust R&D. PT was the recipient of a Wolfson bursary. JP was funded by Rosetrees Trust, UK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Qahtani S, 2012, DIABETOLOGIA, V55, P489, DOI 10.1007/s00125-011-2371-6; Arrowsmith S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036787; Bakker PCAM, 2007, J PERINAT MED, V35, P468, DOI 10.1515/JPM.2007.116; Berghella V, 2004, AM J OBSTET GYNECOL, V191, P1253, DOI 10.1016/j.ajog.2004.03.012; Blanks AM, 2007, BEST PRACT RES CL OB, V21, P807, DOI 10.1016/j.bpobgyn.2007.03.003; Burdyga T, 2009, EUR J OBSTET GYN R B, V144, pS25, DOI 10.1016/j.ejogrb.2009.02.017; Buxton ILO, 2011, ACTA PHARMACOL SIN, V32, P758, DOI 10.1038/aps.2011.62; CRICHTON CA, 1993, J PHYSIOL-LONDON, V465, P629, DOI 10.1113/jphysiol.1993.sp019697; Floyd R, 2007, CELL CALCIUM, V42, P467, DOI 10.1016/j.ceca.2007.05.011; FUCHS AR, 1984, AM J OBSTET GYNECOL, V150, P734, DOI 10.1016/0002-9378(84)90677-X; HEATON RC, 1993, J PHYSIOL-LONDON, V465, P43, DOI 10.1113/jphysiol.1993.sp019665; Hernandez AR, 2008, AM J OBSTET GYNECOL, V198, pE28, DOI 10.1016/j.ajog.2007.10.781; Iams JD, 2002, NEW ENGL J MED, V346, P250, DOI 10.1056/NEJMoa002868; Jones K, 2004, PFLUG ARCH EUR J PHY, V448, P36, DOI 10.1007/s00424-003-1224-7; Kupittayanant S, 2002, BJOG-INT J OBSTET GY, V109, P289, DOI 10.1016/S1470-0328(02)01110-2; Liedman R, 2009, GYNECOL ENDOCRINOL, V25, P188, DOI 10.1080/09513590802573213; Luckas MJM, 2000, BRIT J OBSTET GYNAEC, V107, P1309, DOI 10.1111/j.1471-0528.2000.tb11626.x; Lyall F, 2002, J SOC GYNECOL INVEST, V9, P299, DOI 10.1016/S1071-5576(02)00175-2; MOKGOKONG ET, 1974, S AFR MED J, V48, P799; Monaghan K, 2011, J PHYSIOL-LONDON, V589, P1221, DOI 10.1113/jphysiol.2010.203869; Morrison JC, 2005, J REPROD MED, V50, P923; Neilson JP, 2003, BRIT MED BULL, V67, P191, DOI 10.1093/bmb/ldg018; Newman R. B., 1997, Acta Geneticae Medicae et Gemellologiae, V46, P1; NEWMAN RB, 1989, OBSTET GYNECOL, V73, P695; Noble K, 2010, CELL CALCIUM, V47, P47, DOI 10.1016/j.ceca.2009.11.004; Oppenheimer Lawrence W, 2002, J Perinatol, V22, P149, DOI 10.1038/sj.jp.7210622; Ou CW, 1998, BIOL REPROD, V59, P1055, DOI 10.1095/biolreprod59.5.1055; Parry LJ, 1997, BIOL REPROD, V56, P200, DOI 10.1095/biolreprod56.1.200; Quenby S, 2011, BJOG-INT J OBSTET GY, V118, P1499, DOI 10.1111/j.1471-0528.2011.03064.x; Reichmann JP, 2009, J REPROD MED, V54, P559; Sfakianaki AK, 2008, AM J OBSTET GYNECOLO, V198; Shmigol AV, 1999, J PHYSIOL-LONDON, V520, P153, DOI 10.1111/j.1469-7793.1999.00153.x; Shmygol A, 2007, J PHYSIOL-LONDON, V581, P445, DOI 10.1113/jphysiol.2007.129452; Shynlova O, 2004, BIOL REPROD, V70, P986, DOI 10.1095/biolreprod.103.023648; Sokolowski P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011037; Taggart MJ, 1997, J PHYSIOL-LONDON, V499, P485, DOI 10.1113/jphysiol.1997.sp021943; Terzidou V, 2005, J CLIN ENDOCR METAB, V90, P237, DOI 10.1210/jc.2004-0277; Tichenor JN, 2005, P W PHARMACOL SOC, V48, P44; Turton P, 2009, EUR J OBSTET GYN R B, V144, pS40, DOI 10.1016/j.ejogrb.2009.02.011; Wray S, 2007, EXP PHYSIOL, V92, P621, DOI 10.1113/expphysiol.2007.038125; Wu WX, 1999, ENDOCRINOLOGY, V140, P5712, DOI 10.1210/en.140.12.5712; Zhang J, 2007, REPROD SCI, V14, P456, DOI 10.1177/1933719107306229	42	22	24	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2013	8	5							e63800	10.1371/journal.pone.0063800	http://dx.doi.org/10.1371/journal.pone.0063800			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	177QL	23671701	Green Published, gold, Green Submitted			2022-12-27	WOS:000321390200061
J	Wie, SH; So, BH; Song, JY; Cheong, HJ; Seo, YB; Choi, SH; Noh, JY; Baek, JH; Lee, JS; Kim, HY; Kim, YK; Choi, WS; Lee, J; Jeong, HW; Kim, WJ				Wie, Seong-Heon; So, Byung Hak; Song, Joon Young; Cheong, Hee Jin; Seo, Yu Bin; Choi, Sung Hyuk; Noh, Ji Yun; Baek, Ji Hyeon; Lee, Jin Soo; Kim, Hyo Youl; Kim, Young Keun; Choi, Won Suk; Lee, Jacob; Jeong, Hye Won; Kim, Woo Joo			A Comparison of the Clinical and Epidemiological Characteristics of Adult Patients with Laboratory-Confirmed Influenza A or B during the 2011-2012 Influenza Season in Korea: A Multi-Center Study	PLOS ONE			English	Article							MORTALITY; VIRUS; SEVERITY; HOSPITALIZATION; COCIRCULATION; PREDICTORS; EVOLUTION; LINEAGES	Background: During the 2011/2012 winter influenza season in the Republic of Korea, influenza A (H3N2) was the predominant virus in the first peak period of influenza activity during the second half of January 2012. On the other hand, influenza B was the predominant virus in the second peak period of influenza activity during the second half of March 2012. The objectives of this study were to compare the clinical and epidemiological characteristics of patients with laboratory-confirmed influenza A or influenza B. Methodology/Principal Findings: We analyzed data from 2,129 adult patients with influenza-like illnesses who visited the emergency rooms of seven university hospitals in Korea from October 2011 to May 2012. Of 850 patients with laboratory-confirmed influenza, 656 (77.2%) had influenza A (H3N2), and 194 (22.8%) influenza B. Age, and the frequencies of cardiovascular disorders, diabetes, hypertension were significantly higher in patients with influenza A (H3N2) (P<0.05). The frequencies of leukopenia or thrombocytopenia in patients with influenza B at initial presentation were statistically higher than those in patients with influenza A (H3N2) (P<0.05). The rate of hospitalization, and length of hospital stay were statistically higher in patients with influenza A (H3N2) (P<0.05), and of the 79 hospitalized patients, the frequency of diabetes, hypertension, cases having at least one of the comorbid conditions, and the proportion of elderly were significantly higher in patients with influenza A (H3N2) (P<0.05). Conclusions: The proportion of males to females and elderly population were significantly higher for influenza A (H3N2) patients group compared with influenza B group. Hypertension, diabetes, chronic lung diseases, cardiovascular disorders, and neuromuscular diseases were independently associated with hospitalization due to influenza. Physicians should assess and treat the underlying comorbid conditions as well as influenza viral infections for the appropriate management of patients with influenza.	[Wie, Seong-Heon] Catholic Univ Korea, Coll Med, St Vincents Hosp, Dept Internal Med,Div Infect Dis, Seoul, South Korea; [So, Byung Hak] Catholic Univ Korea, Coll Med, St Vincents Hosp, Dept Emergency Med, Seoul, South Korea; [Song, Joon Young; Cheong, Hee Jin; Seo, Yu Bin; Kim, Woo Joo] Korea Univ, Coll Med, Korea Univ Guro Hosp, Dept Internal Med,Div Infect Dis, Seoul 136705, South Korea; [Choi, Sung Hyuk] Korea Univ, Coll Med, Korea Univ Guro Hosp, Dept Emergency Med, Seoul 136705, South Korea; [Noh, Ji Yun] Korea Univ, Coll Med, Dept Microbiol, Seoul 136705, South Korea; [Baek, Ji Hyeon; Lee, Jin Soo] Inha Univ, Sch Med, Inha Univ Hosp, Dept Internal Med,Div Infect Dis, Inchon, South Korea; [Kim, Hyo Youl; Kim, Young Keun] Yonsei Univ, Wonju Coll Med, Wonju Christian Hosp, Dept Internal Med,Div Infect Dis, Wonju, South Korea; [Choi, Won Suk] Korea Univ, Coll Med, Korea Univ Ansan Hosp, Dept Internal Med,Div Infect Dis, Seoul 136705, South Korea; [Lee, Jacob] Hallym Univ, Coll Med, Kangnam Sacred Heart Hosp, Dept Internal Med,Div Infect DIs, Seoul, South Korea; [Jeong, Hye Won] Chungbuk Natl Univ, Coll Med, Chungbuk Univ Hosp, Dept Internal Med,Div Infect Dis, Cheongju, South Korea	Catholic University of Korea; Catholic University of Korea; Korea University; Korea University Medicine (KU Medicine); Korea University; Korea University Medicine (KU Medicine); Korea University; Korea University Medicine (KU Medicine); Inha University; Inha University Hospital; Yonsei University; Korea University; Korea University Medicine (KU Medicine); Hallym University; Chungbuk National University	Kim, WJ (corresponding author), Korea Univ, Coll Med, Korea Univ Guro Hosp, Dept Internal Med,Div Infect Dis, Seoul 136705, South Korea.	wjkim@medimail.co.kr	Choi, Won Suk/V-2730-2017; Kim, Woo Joo/D-2733-2015	Choi, Won Suk/0000-0001-5874-4764; Song, Joon Young/0000-0002-0148-7194; So, Byung Hak/0000-0003-0383-9197; Cheong, Hee Jin/0000-0002-2532-1463; Choi, Sung-Hyuk/0000-0002-6686-6937; Kim, Young Keun/0000-0002-2120-6265; Kim, Woo Joo/0000-0002-4546-3880	Korea Healthcare technology R&D Project Ministry of Health & Welfare Republic of Korea [A103001]	Korea Healthcare technology R&D Project Ministry of Health & Welfare Republic of Korea	This study was supported by a grant of the Korea Healthcare technology R&D Project Ministry of Health & Welfare Republic of Korea (Grant No. : A103001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aebi T, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-308; [Anonymous], 2012, Wkly Epidemiol Rec, V87, P233; Chen RB, 2008, J MOL EVOL, V66, P655, DOI 10.1007/s00239-008-9119-z; Chi XS, 2003, J CLIN MICROBIOL, V41, P5770, DOI 10.1128/JCM.41.12.5770-5773.2003; Cohen C, 2010, CLIN INFECT DIS, V51, P1362, DOI 10.1086/657314; Dai XQ, 2012, BIOMED ENVIRON SCI, V25, P61, DOI 10.3967/0895-3988.2012.01.009; Gutierrez-Pizarraya A, 2012, J INFECTION, V65, P423, DOI 10.1016/j.jinf.2012.07.004; Kim YH, 2009, VIRAL IMMUNOL, V22, P423, DOI 10.1089/vim.2009.0045; Korea Centers for Disease Control and Prevention, INFL SENT SURV REP; Matsuzaki Y, 2004, J MED VIROL, V74, P132, DOI 10.1002/jmv.20156; Nicholson KG, 2003, LANCET, V362, P1733, DOI 10.1016/S0140-6736(03)14854-4; Osterlund P, 2012, J VIROL, V86, P11183, DOI 10.1128/JVI.01050-12; Simonsen L, 1997, AM J PUBLIC HEALTH, V87, P1944, DOI 10.2105/AJPH.87.12.1944; Thompson WW, 2009, AM J PUBLIC HEALTH, V99, pS225, DOI 10.2105/AJPH.2008.151944; van Asten L, 2012, J INFECT DIS, V206, P628, DOI 10.1093/infdis/jis415; van den Wijngaard CC, 2010, AM J PUBLIC HEALTH, V100, P2248, DOI 10.2105/AJPH.2009.168245; Woolpert T, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-129; YAMASHITA M, 1988, VIROLOGY, V163, P112, DOI 10.1016/0042-6822(88)90238-3; Yang JR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047179; Yang XH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028786	20	39	40	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2013	8	5							e62685	10.1371/journal.pone.0062685	http://dx.doi.org/10.1371/journal.pone.0062685			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175AS	23671624	Green Submitted, Green Published, gold			2022-12-27	WOS:000321202100033
J	Buque, A; Aresti, U; Calvo, B; Muhialdin, JS; Munoz, A; Carrera, S; Azkona, E; Rubio, I; Lopez-Vivanco, G				Buque, Aitziber; Aresti, Unai; Calvo, Begona; Muhialdin, Jangi Sh.; Munoz, Alberto; Carrera, Sergio; Azkona, Eider; Rubio, Itziar; Lopez-Vivanco, Guillermo			Thymidylate Synthase Expression Determines Pemetrexed Targets and Resistance Development in Tumour Cells	PLOS ONE			English	Article							SYNERGISTIC INTERACTION; MAMMALIAN TARGET; IN-VITRO; CANCER; CISPLATIN; GROWTH; AMPK; INHIBITION; RAPAMYCIN; PATHWAYS	Although treatment options for cancer patients are increasing every year, the drug resistance problem remains very present. It is very difficult to find a drug that acts equally on tumours of the same histology as the individual's genetic characteristics often determine the response to treatment. Furthermore, tumours that initially respond to anti-tumour therapy are able to adapt and develop resistance to the drug, while others do not. In addition, this usually implies resistance development to agents to which the cells have not been exposed, a phenomenon called cross-resistance or multidrug resistance. Given this situation, it has been suggested that the most appropriate treatment would be able to act in parallel on multiple pathways constitutively altered in tumour cells. Pemetrexed is a multitargeted antifolate that exerts its activity against folate-dependent enzymes involved in de novo pyrimidine and purine synthesis. It is currently in use in combination with cisplatin against malignant pleural mesothelioma and non-squamous non-small cell lung cancer with favourable results. By real-time RT-PCR gene expression assays and restoration viability assays we demonstrated that Pemetrexed targets folate-dependent enzymes involved in de novo biosynthesis of purines differently depending on the intrinsic genetic characteristics of the tumour. These differences did not, however, interfere either with the initial response to the drug or with the activation of apoptotic pathways. In addition, these genetic fingerprints can differentiate two groups of tumours: those capable of developing resistance to antifolate, and not capable. These results may be useful to employ targets gene expression as resistance markers, a valuable tool for identifying patients likely to receive combination therapy to prevent the development of resistance.	[Buque, Aitziber; Aresti, Unai; Calvo, Begona; Muhialdin, Jangi Sh.] Cruces Univ Hosp, Med Oncol Res Lab, Bizkaia, Spain; [Munoz, Alberto; Carrera, Sergio; Azkona, Eider; Rubio, Itziar; Lopez-Vivanco, Guillermo] Cruces Univ Hosp, Dept Med Oncol, Bizkaia, Spain	Hospital Universitario Cruces; Hospital Universitario Cruces	Buque, A (corresponding author), Cruces Univ Hosp, Med Oncol Res Lab, Bizkaia, Spain.	aitziber.buquemartinez@osakidetza.net	Lopez, Guillermo/F-3435-2012	, Aitziber/0000-0002-7698-8778				Adjei Alex A, 2004, Clin Lung Cancer, V5 Suppl 2, pS51; Beckers A, 2006, MOL CANCER THER, V5, P2211, DOI 10.1158/1535-7163.MCT-06-0001; Buque A, 2012, MOL CANCER, V11, DOI 10.1186/1476-4598-11-25; Eberle J, 2008, CURR GENOMICS, V9, P409, DOI 10.2174/138920208785699571; Giovannetti E, 2005, MOL PHARMACOL, V68, P110, DOI 10.1124/mol.104.009373; Gonen N, 2012, DRUG RESIST UPDATE, V15, P183, DOI 10.1016/j.drup.2012.07.002; Hahn-Windgassen A, 2005, J BIOL CHEM, V280, P32081, DOI 10.1074/jbc.M502876200; Hanauske AR, 2007, INVEST NEW DRUG, V25, P417, DOI 10.1007/s10637-007-9060-9; Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2; Lasithiotakis KG, 2008, J INVEST DERMATOL, V128, P2013, DOI 10.1038/jid.2008.44; Meier F, 2007, BRIT J DERMATOL, V156, P1204, DOI 10.1111/j.1365-2133.2007.07821.x; Mills JR, 2008, P NATL ACAD SCI USA, V105, P10853, DOI 10.1073/pnas.0804821105; Nannizzi S, 2010, CANCER CHEMOTH PHARM, V66, P547, DOI 10.1007/s00280-009-1195-2; Ozasa H, 2010, CANCER SCI, V101, P161, DOI 10.1111/j.1349-7006.2009.01358.x; Persidis A, 2000, NAT BIOTECHNOL, V18, pIT18; Plas DR, 2005, ONCOGENE, V24, P7435, DOI 10.1038/sj.onc.1209097; Racanelli AC, 2009, CANCER RES, V69, P5467, DOI 10.1158/0008-5472.CAN-08-4979; Rattan R, 2005, J BIOL CHEM, V280, P39582, DOI 10.1074/jbc.M507443200; Rothbart SB, 2010, CANCER RES, V70, P10299, DOI 10.1158/0008-5472.CAN-10-1873; Sen T, 2011, CANCER RES, V71, P1167, DOI 10.1158/0008-5472.CAN-10-1481; Sinnberg T, 2009, J INVEST DERMATOL, V129, P1500, DOI 10.1038/jid.2008.379; Tekle C, 2008, BRIT J CANCER, V99, P750, DOI 10.1038/sj.bjc.6604566; Van Triest B, 2000, ANN ONCOL, V11, P385, DOI 10.1023/A:1008351221345; Yang XK, 2006, CANCER RES, V66, P3126, DOI 10.1158/0008-5472.CAN-05-0425	24	19	19	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2013	8	5							e63338	10.1371/journal.pone.0063338	http://dx.doi.org/10.1371/journal.pone.0063338			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145RZ	23675481	Green Published, gold, Green Submitted			2022-12-27	WOS:000319036100040
J	Martorell, P; Bataller, E; Llopis, S; Gonzalez, N; Alvarez, B; Monton, F; Ortiz, P; Ramon, D; Genoves, S				Martorell, Patricia; Bataller, Esther; Llopis, Silvia; Gonzalez, Nuria; Alvarez, Beatriz; Monton, Fernando; Ortiz, Pepa; Ramon, Daniel; Genoves, Salvador			A Cocoa Peptide Protects Caenorhabditis elegans from Oxidative Stress and beta-Amyloid Peptide Toxicity	PLOS ONE			English	Article							THEOBROMA-CACAO L.; ALZHEIMERS-DISEASE; ANTIOXIDATIVE PEPTIDES; MODEL; GENE; ENDOPEPTIDASE; EXPRESSION; CHOCOLATE; EXTRACT; FOOD	Background: Cocoa and cocoa-based products contain different compounds with beneficial properties for human health. Polyphenols are the most frequently studied, and display antioxidant properties. Moreover, protein content is a very interesting source of antioxidant bioactive peptides, which can be used therapeutically for the prevention of age-related diseases. Methodology/Principal Findings: A bioactive peptide, 13L (DNYDNSAGKWWVT), was obtained from a hydrolyzed cocoa by-product by chromatography. The in vitro inhibition of prolyl endopeptidase (PEP) was used as screening method to select the suitable fraction for peptide identification. Functional analysis of 13L peptide was achieved using the transgenic Caenorhabditis elegans strain CL4176 expressing the human A beta(1-42) peptide as a pre-clinical in vivo model for Alzheimer's disease. Among the peptides isolated, peptide 13L (1 mg/mL) showed the highest antioxidant activity (P <= 0.001) in the wildtype strain (N2). Furthermore, 13L produced a significant delay in body paralysis in strain CL4176, especially in the 24-47 h period after A beta(1-42) peptide induction (P <= 0.0001). This observation is in accordance with the reduction of A beta deposits in CL4176 by western blot. Finally, transcriptomic analysis in wild-type nematodes treated with 13L revealed modulation of the proteosomal and synaptic functions as the main metabolic targets of the peptide. Conclusions/Significance: These findings suggest that the cocoa 13L peptide has antioxidant activity and may reduce A beta deposition in a C. elegans model of Alzheimer's disease; and therefore has a putative therapeutic potential for prevention of age-related diseases. Further studies in murine models and humans will be essential to analyze the effectiveness of the 13L peptide in higher animals.	[Martorell, Patricia; Bataller, Esther; Llopis, Silvia; Gonzalez, Nuria; Monton, Fernando; Ortiz, Pepa; Ramon, Daniel; Genoves, Salvador] Biopolis SL, Cell Biol Lab, Dept Food Biotechnol, Valencia, Spain; [Alvarez, Beatriz] Biopolis SL, Mol Biol Lab, Microbial Biotechnol Dept, Valencia, Spain		Genoves, S (corresponding author), Biopolis SL, Cell Biol Lab, Dept Food Biotechnol, Valencia, Spain.	salvador.genoves@biopolis.es	Martorell, Patricia/ABC-8717-2021; Bataller, Esther/Z-4687-2019	Bataller, Esther/0000-0003-3903-2918; Martorell, Patricia/0000-0001-5689-8399	Biopolis SL. from the Spanish Ministry of Science and Innovation; Biopolis SL	Biopolis SL. from the Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)); Biopolis SL	This work was funded by Biopolis SL. within the framework of the e-CENIT Project SENIFOOD from the Spanish Ministry of Science and Innovation(http://www.cdti.es). The funders played a role as all authors are employees of Biopolis SL.; All authors are employees of the commercial funder of this research, Biopolis SL. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Alavez S, 2011, NATURE, V472, P226, DOI 10.1038/nature09873; Alkema MJ, 2005, NEURON, V46, P247, DOI 10.1016/j.neuron.2005.02.024; Arya U, 2009, EXP GERONTOL, V44, P462, DOI 10.1016/j.exger.2009.02.010; Barelli H, 1999, BIOCHEM BIOPH RES CO, V257, P657, DOI 10.1006/bbrc.1999.0366; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Brock TJ, 2007, GENETICS, V176, P865, DOI 10.1534/genetics.107.071860; Bubber P, 2005, ANN NEUROL, V57, P695, DOI 10.1002/ana.20474; Calahorro F, 2011, INVERTEBR NEUROSCI, V11, P73, DOI 10.1007/s10158-011-0126-1; Checler F, 2000, BBA-MOL BASIS DIS, V1502, P133, DOI 10.1016/S0925-4439(00)00039-9; Chou JL, 2011, J PROTEOMICS, V74, P466, DOI 10.1016/j.jprot.2010.12.012; Dillinger TL, 2000, J NUTR, V130, p2057S, DOI 10.1093/jn/130.8.2057S; Dostal V, 2010, GENETICS, V186, P857, DOI 10.1534/genetics.110.120436; Ewald CY, 2010, BRAIN STRUCT FUNCT, V214, P263, DOI 10.1007/s00429-009-0235-3; Galleano M, 2009, J CARDIOVASC PHARM, V54, P483, DOI 10.1097/FJC.0b013e3181b76787; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; Gutierrez-Zepeda A, 2005, BMC NEUROSCI, V6, DOI 10.1186/1471-2202-6-54; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Hare EE, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-24; Hassan WM, 2009, HUM MOL GENET, V18, P2739, DOI 10.1093/hmg/ddp209; Hornsten A, 2007, P NATL ACAD SCI USA, V104, P1971, DOI 10.1073/pnas.0603997104; Imahori K, 2010, P JPN ACAD B-PHYS, V86, P54, DOI 10.2183/pjab.86.54; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Katz DL, 2011, ANTIOXID REDOX SIGN, V15, P2779, DOI 10.1089/ars.2010.3697; Kim SK, 2001, J AGR FOOD CHEM, V49, P1984, DOI 10.1021/jf000494j; Klompong V, 2009, J FOOD SCI, V74, pC126, DOI 10.1111/j.1750-3841.2009.01047.x; LINK CD, 1995, P NATL ACAD SCI USA, V92, P9368, DOI 10.1073/pnas.92.20.9368; Link CD, 2001, NEUROBIOL AGING, V22, P217, DOI 10.1016/S0197-4580(00)00237-2; Luo Y, 2006, LIFE SCI, V78, P2066, DOI 10.1016/j.lfs.2005.12.004; Martorell P, 2012, J AGR FOOD CHEM, V60, P11071, DOI 10.1021/jf3031138; Martorell P, 2011, J AGR FOOD CHEM, V59, P2077, DOI 10.1021/jf104217g; Montaner D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010348; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Morales R, 2011, MOL PSYCHIATR, DOI [10.1038/mp.2011.120, DOI 10.1038/MP.2011.120.[]; Nehlig A, 2012, BR J CLIN PHARM, V10, DOI [10.1111/j.1365-2125.2012.04378.x, DOI 10.1111/J.1365-2125.2012.04378.X.[]; Oxenkrug GF, 2010, ANN NY ACAD SCI, V1199, P1, DOI 10.1111/j.1749-6632.2009.05356.x; Phelps ME, 2010, P NATL ACAD SCI USA, V107, P17459, DOI 10.1073/pnas.1012684107; Preza AM, 2010, BMC COMPLEM ALTERN M, V10, DOI 10.1186/1472-6882-10-61; Reddy PH, 2008, TRENDS MOL MED, V14, P45, DOI 10.1016/j.molmed.2007.12.002; Rusconi M, 2010, PHARMACOL RES, V61, P5, DOI 10.1016/j.phrs.2009.08.008; Sarmadi BH, 2010, PEPTIDES, V31, P1949, DOI 10.1016/j.peptides.2010.06.020; Sartor MA, 2009, BIOINFORMATICS, V25, P211, DOI 10.1093/bioinformatics/btn592; Selkoe DJ, 1997, SCIENCE, V275, P630, DOI 10.1126/science.275.5300.630; SHERRINGTON R, 1995, NATURE, V375, P754, DOI 10.1038/375754a0; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Steinberg FM, 2003, J AM DIET ASSOC, V103, P215, DOI 10.1053/jada.2003.50028; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Summa C, 2008, MOL NUTR FOOD RES, V52, P342, DOI 10.1002/mnfr.200700403; Sze JY, 2000, NATURE, V403, P560, DOI 10.1038/35000609; Teschendorf D, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-38; Verri M, 2012, INT J IMMUNOPATH PH, V25, P345, DOI 10.1177/039463201202500204; Wu YJ, 2006, J NEUROSCI, V26, P13102, DOI 10.1523/JNEUROSCI.3448-06.2006; YOSHIMOTO T, 1987, J PHARMACOBIO-DYNAM, V10, P730, DOI 10.1248/bpb1978.10.730; YOSHIMOTO T, 1980, J BIOL CHEM, V255, P4786	53	53	59	2	98	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2013	8	5							e63283	10.1371/journal.pone.0063283	http://dx.doi.org/10.1371/journal.pone.0063283			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145RZ	23675471	Green Submitted, Green Published, gold			2022-12-27	WOS:000319036100034
J	Schepens, J; Dijkstra, T; Grootjen, F; van Heuven, WJB				Schepens, Job; Dijkstra, Ton; Grootjen, Franc; van Heuven, Walter J. B.			Cross-Language Distributions of High Frequency and Phonetically Similar Cognates	PLOS ONE			English	Article							NORMS	The coinciding form and meaning similarity of cognates, e. g. 'flamme' (French), 'Flamme' (German), 'vlam' (Dutch), meaning 'flame' in English, facilitates learning of additional languages. The cross-language frequency and similarity distributions of cognates vary according to evolutionary change and language contact. We compare frequency and orthographic (O), phonetic (P), and semantic similarity of cognates, automatically identified in semi-complete lexicons of six widely spoken languages. Comparisons of P and O similarity reveal inconsistent mappings in language pairs with deep orthographies. The frequency distributions show that cognate frequency is reduced in less closely related language pairs as compared to more closely related languages (e. g., French-English vs. German-English). These frequency and similarity patterns may support a better understanding of cognate processing in natural and experimental settings. The automatically identified cognates are available in the supplementary materials, including the frequency and similarity measurements.	[Schepens, Job; Dijkstra, Ton; Grootjen, Franc] Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, NL-6525 ED Nijmegen, Netherlands; [Schepens, Job; Dijkstra, Ton] Radboud Univ Nijmegen, Ctr Language Studies, NL-6525 ED Nijmegen, Netherlands; [van Heuven, Walter J. B.] Univ Nottingham, Sch Psychol, Nottingham NG7 2RD, England	Radboud University Nijmegen; Radboud University Nijmegen; University of Nottingham	Schepens, J (corresponding author), Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, NL-6525 ED Nijmegen, Netherlands.	jobschepens@gmail.com	van Heuven, Walter J B/K-9034-2013; Schepens, Job/AAB-8753-2019; Schepens, Job/HHS-5741-2022; Dijkstra, Ton/A-7042-2010	van Heuven, Walter J B/0000-0003-3183-4449; Schepens, Job/0000-0003-1271-2526; 	Donders Institute for Brain, Cognition & Behaviour, Centre for Cognition	Donders Institute for Brain, Cognition & Behaviour, Centre for Cognition	This work was funded by the Donders Institute for Brain, Cognition & Behaviour, Centre for Cognition (http://www.ru.nl/donders). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], HDB INT PHON ASS IPA; Baayen R. H., 1993, CELEX LEXICAL DATABA; bil, 2012, BIL; Bouckaert R, 2012, SCIENCE, V337, P957, DOI 10.1126/science.1219669; Brown CH, 2008, STUF-LANG TYPOL UNIV, V61, P285; Brysbaert M, 2009, BEHAV RES METHODS, V41, P977, DOI 10.3758/BRM.41.4.977; Burkey J, 2012, LOWESS LOCALLY WEIGH; Coltheart M., 1977, ATTENTION PERFORMANC, VVI; Cuetos Vega F, 2000, LEXESP LEXICO INFORM; Davis CJ, 2005, BEHAV RES METHODS, V37, P665, DOI 10.3758/BF03192738; Dijkstra T, 1999, J MEM LANG, V41, P496, DOI 10.1006/jmla.1999.2654; Dijkstra T, 2010, J MEM LANG, V62, P284, DOI 10.1016/j.jml.2009.12.003; DYEN I, 1992, T AM PHILOS SOC, V82, P1; Ellis NC, 2004, READ RES QUART, V39, P438, DOI 10.1598/RRQ.39.4.5; Ellison TM, 2006, COLING/ACL 2006, VOLS 1 AND 2, PROCEEDINGS OF THE CONFERENCE, P273; Gray RD, 2003, NATURE, V426, P435, DOI 10.1038/nature02029; Heeringa W, 2010, LANGUAGE CONTACT NEW, P131; Heeringa W.J., 2004, MEASURING DIALECT PR; Kessler B., 2007, P 9 M ACL SPEC INT G, P6, DOI DOI 10.3115/1626516.1626518; Kessler B, 2007, BETTER CHANCE RANDOM; Kessler Brett., 2006, PHYLOGENETIC METHODS, P33; Kondrak G, 2001, 2ND MEETING OF THE NORTH AMERICAN CHAPTER OF THE ASSOCIATION FOR COMPUTATIONAL LINGUISTICS, PROCEEDINGS OF THE CONFERENCE, P103; Kondrak G., 2006, P COLING ACL WORKSH, P43, DOI [10.3115/1641976.1641983, DOI 10.3115/1641976.1641983]; Kondrak Grzegorz, 2000, P 1 N AM CHAPT ASS C, P288; Ladefoged P., 2011, COURSE PHONETICS, V6th; Laudanna A., 1995, 3 GIORNATE INT, V1, P103; Levenshtein VI, 1966, SOV PHYS DOKL, V10, P707; Lohr M., 2000, TIME DEPTH HIST LING, V1, P209; Mackay Wesley, 2005, P 9 C COMPUTATIONAL, P40; Mann GS, 2001, 2ND MEETING OF THE NORTH AMERICAN CHAPTER OF THE ASSOCIATION FOR COMPUTATIONAL LINGUISTICS, PROCEEDINGS OF THE CONFERENCE, P151; Marian V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043230; McMahon A, 2003, T PHILOL SOC, V101, P7, DOI 10.1111/1467-968X.00108; McMahon A., 2005, LANGUAGE CLASSIFICAT; Murray WS, 2004, PSYCHOL REV, V111, P721, DOI 10.1037/0033-295X.111.3.721; New B, 2004, BEHAV RES METH INS C, V36, P516, DOI 10.3758/BF03195598; Nickerson RS, 1981, PERCEPTION PRINT REA, P257; Oxford Dictionaries, 2010, OXF PAR IT DICT; Pagel M, 2007, NATURE, V449, P717, DOI 10.1038/nature06176; Pagel M, 2009, NAT REV GENET, V10, P405, DOI 10.1038/nrg2560; Pompei S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020109; Protopapas A, 2009, BEHAV RES METHODS, V41, P991, DOI 10.3758/BRM.41.4.991; Ringbom Hakan, 2007, MULTILINGUAL MATTERS; Schepens J, 2012, BILING-LANG COGN, V15, P157, DOI 10.1017/S1366728910000623; Swadesh M., 1952, P AM PHILOS SOC, V96, P452, DOI DOI 10.2307/3143802; Tokowicz N, 2002, BEHAV RES METH INS C, V34, P435, DOI 10.3758/BF03195472; Van den Bosch A., 1994, J QUANT LINGUIST, V1, P178, DOI [10.1080/09296179408590015, DOI 10.1080/09296179408590015]; Vitevitch MS, 2012, BILING-LANG COGN, V15, P167, DOI 10.1017/S1366728911000149; Yarkoni T, 2008, PSYCHON B REV, V15, P971, DOI 10.3758/PBR.15.5.971; Zipf G. K., 1949, HUMAN BEHAV PRINCIPL	49	46	48	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2013	8	5							e63006	10.1371/journal.pone.0063006	http://dx.doi.org/10.1371/journal.pone.0063006			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	143FO	23675449	Green Submitted, gold, Green Published			2022-12-27	WOS:000318852400019
J	Hoover, DJ; Zhu, V; Chen, R; Briley, K; Rameshwar, P; Cohen, S; Coffman, FD				Hoover, Daniel J.; Zhu, Viola; Chen, Ru; Briley, Ken; Rameshwar, Pranela; Cohen, Stanley; Coffman, Frederick D.			Expression of the Chitinase Family Glycoprotein YKL-40 in Undifferentiated, Differentiated and Trans-Differentiated Mesenchymal Stem Cells	PLOS ONE			English	Article							MARROW STROMAL CELLS; HUMAN CARTILAGE GP-39; SERUM YKL-40; BONE-MARROW; IN-VITRO; RHEUMATOID-ARTHRITIS; PLASMA YKL-40; PROTEIN; MARKER; CHI3L1	The glycoprotein YKL-40 (CHI3L1) is a secreted chitinase family protein that induces angiogenesis, cell survival, and cell proliferation, and plays roles in tissue remodeling and immune regulation. It is expressed primarily in cells of mesenchymal origin, is overexpressed in numerous aggressive carcinomas and sarcomas, but is rarely expressed in normal ectodermal tissues. Bone marrow-derived mesenchymal stem cells (MSCs) can be induced to differentiate into various mesenchymal tissues and trans-differentiate into some non-mesenchymal cell types. Since YKL-40 has been used as a mesenchymal marker, we followed YKL-40 expression as undifferentiated MSCs were induced to differentiate into bone, cartilage, and neural phenotypes. Undifferentiated MSCs contain significant levels of YKL-40 mRNA but do not synthesize detectable levels of YKL-40 protein. MSCs induced to differentiate into chondrocytes and osteocytes soon began to express and secrete YKL-40 protein, as do ex vivo cultured chondrocytes and primary osteocytes. In contrast, MSCs induced to trans-differentiate into neurons did not synthesize YKL-40 protein, consistent with the general absence of YKL-40 protein in normal CNS parenchyma. However, these trans-differentiated neurons retained significant levels of YKL-40 mRNA, suggesting the mechanisms which prevented YKL-40 translation in undifferentiated MSCs remained in place, and that these trans-differentiated neurons differ in at least this way from neurons derived from neuronal stem cells. Utilization of a differentiation protocol containing beta-mercaptoethanol resulted in cells that expressed significant amounts of intracellular YKL-40 protein that was not secreted, which is not seen in normal cells. Thus the synthesis of YKL-40 protein is a marker for MSC differentiation into mature mesenchymal phenotypes, and the presence of untranslated YKL-40 mRNA in non-mesenchymal cells derived from MSCs reflects differences between differentiated and trans-differentiated phenotypes.	[Hoover, Daniel J.; Cohen, Stanley; Coffman, Frederick D.] UMDNJ NJMS, Ctr Biophys Pathol, Newark, NJ USA; [Zhu, Viola] BU Med Ctr, Dept Med, Div Hematol Oncol, Boston, MA USA; [Chen, Ru] Ethicon Endosurg, Cincinnati, OH USA; [Briley, Ken] Univ Penn, Dept Microbiol, Philadelphia, PA 19104 USA; [Rameshwar, Pranela] UMDNJ NJMS, Dept Med, Newark, NJ USA; [Coffman, Frederick D.] UMDNJ NJMS, Dept Pathol & Lab Med, Newark, NJ USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; Johnson & Johnson; Johnson & Johnson USA; University of Pennsylvania; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center	Coffman, FD (corresponding author), UMDNJ NJMS, Ctr Biophys Pathol, Newark, NJ USA.	coffmafd@umdnj.edu			Department of Pathology developmental funds; New Jersey Medical School	Department of Pathology developmental funds; New Jersey Medical School	This project was funded by Department of Pathology developmental funds that were made available by the Chair, and by intramural funds from the New Jersey Medical School supplied to the Center for Biophysical Pathology for research support. No funding was supplied by for-profit companies or entities, nor were there any stipulations or limitations that accompanied the funding that was received. The study design, data collection and analysis, decision to publish, and manuscript preparation were performed solely by the authors of this manuscript, with no input or control of any sort from the Pathology Department or the Center for Biophysical Pathology or the Medical School. Neither the authors (or their families), nor the Department, nor the Center for Biophysical Pathology, nor the Medical School, have any financial interest in this study, nor any financial interest that would be impacted in any way by this study.	Ahmad M, 1999, BIOMATERIALS, V20, P211, DOI 10.1016/S0142-9612(98)00152-5; Bae S, 2009, CELL TISSUE RES, V335, P565, DOI 10.1007/s00441-008-0729-y; Barnabe GF, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005222; Bonneh-Barkay D, 2008, AM J PATHOL, V173, P130, DOI 10.2353/ajpath.2008.080045; Bonneh-Barkay D, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-34; Choi KS, 2005, BIOCHEM BIOPH RES CO, V330, P1299, DOI 10.1016/j.bbrc.2005.03.111; Chupp GL, 2007, NEW ENGL J MED, V357, P2016, DOI 10.1056/NEJMoa073600; Cintin C, 1999, BRIT J CANCER, V79, P1494, DOI 10.1038/sj.bjc.6690238; Cintin C, 2002, CANCER-AM CANCER SOC, V95, P267, DOI 10.1002/cncr.10644; Coffman F, 2008, CRIT REV CL LAB SCI, V45, P531, DOI [10.1080/10408360802334743, 10.1080/10408360802334743 ]; Connor JR, 2000, OSTEOARTHR CARTILAGE, V8, P87, DOI 10.1053/joca.1999.0276; Eberhardt M, 2006, BIOCHEM BIOPH RES CO, V345, P1167, DOI 10.1016/j.bbrc.2006.05.016; Francescone RA, 2011, J BIOL CHEM, V286, P15332, DOI 10.1074/jbc.M110.212514; Greco SJ, 2007, STEM CELLS DEV, V16, P811, DOI 10.1089/scd.2007.0011; Guo L, 2011, EXP HEMATOL, V39, P608, DOI 10.1016/j.exphem.2011.01.011; HAKALA BE, 1993, J BIOL CHEM, V268, P25803; Hogdall EVS, 2003, ONCOL REP, V10, P1535; Jacques C, 2007, OSTEOARTHR CARTILAGE, V15, P138, DOI 10.1016/j.joca.2006.07.003; Jensen BV, 2003, CLIN CANCER RES, V9, P4423; Jeon SJ, 2007, MOL CELL NEUROSCI, V34, P59, DOI 10.1016/j.mcn.2006.10.003; Johansen JS, 2000, J HEPATOL, V32, P911, DOI 10.1016/S0168-8278(00)80095-1; Johansen JS, 2003, BREAST CANCER RES TR, V80, P15, DOI 10.1023/A:1024431000710; Johansen JS, 1996, BRIT J RHEUMATOL, V35, P553; Johansen JS, 1997, SCAND J GASTROENTERO, V32, P582, DOI 10.3109/00365529709025104; Johansen JS, 2007, J HISTOCHEM CYTOCHEM, V55, P1213, DOI 10.1369/jhc.7A7245.2007; Johansen JS, 2006, DAN MED BULL, V53, P172; Kim Steve H, 2007, World J Surg Oncol, V5, P17, DOI 10.1186/1477-7819-5-17; Ku BM, 2011, INT J CANCER, V128, P1316, DOI 10.1002/ijc.25466; Kubo H, 2009, GENES CELLS, V14, P407, DOI 10.1111/j.1365-2443.2009.01281.x; Liu QH, 2009, J NEURO-ONCOL, V94, P1, DOI 10.1007/s11060-009-9919-z; Ong SY, 2006, BIOMATERIALS, V27, P4087, DOI 10.1016/j.biomaterials.2006.03.022; Pelloski CE, 2005, CLIN CANCER RES, V11, P3326, DOI 10.1158/1078-0432.CCR-04-1765; Prockop DJ, 1997, SCIENCE, V276, P71, DOI 10.1126/science.276.5309.71; Recklies AD, 2005, J BIOL CHEM, V280, P41213, DOI 10.1074/jbc.M510146200; Recklies AD, 2002, BIOCHEM J, V365, P119, DOI 10.1042/BJ20020075; Rehli M, 1997, GENOMICS, V43, P221, DOI 10.1006/geno.1997.4778; Salmena L, 2011, CELL, V146, P353, DOI 10.1016/j.cell.2011.07.014; Shao R, 2009, ONCOGENE, V28, P4456, DOI 10.1038/onc.2009.292; Si YL, 2011, AGEING RES REV, V10, P93, DOI 10.1016/j.arr.2010.08.005; Steenbakkers PGA, 2003, J IMMUNOL, V170, P5719, DOI 10.4049/jimmunol.170.11.5719; Tanwar MK, 2002, CANCER RES, V62, P4364; Vij R, 2012, TRANSL RES, V159, P218, DOI 10.1016/j.trsl.2012.01.012; Volck B, 2001, OSTEOARTHR CARTILAGE, V9, P203, DOI 10.1053/joca.2000.0377; Woodbury D, 2000, J NEUROSCI RES, V61, P364, DOI 10.1002/1097-4547(20000815)61:4<364::AID-JNR2>3.0.CO;2-C; Xu Y, 2007, BIOCHEM BIOPH RES CO, V359, P311, DOI 10.1016/j.bbrc.2007.05.098; Zurita M, 2008, NEUROSCI RES, V60, P275, DOI 10.1016/j.neures.2007.11.006	46	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2013	8	5							e62491	10.1371/journal.pone.0062491	http://dx.doi.org/10.1371/journal.pone.0062491			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	155HD	23671604	Green Published, Green Submitted, gold			2022-12-27	WOS:000319737700014
J	Kikusato, M; Toyomizu, M				Kikusato, Motoi; Toyomizu, Masaaki			Crucial Role of Membrane Potential in Heat Stress-Induced Overproduction of Reactive Oxygen Species in Avian Skeletal Muscle Mitochondria	PLOS ONE			English	Article							SUPEROXIDE-PRODUCTION; UNCOUPLING PROTEIN; OXIDATIVE-PHOSPHORYLATION; PROTON CONDUCTANCE; RADICAL GENERATION; FATTY-ACIDS; COMPLEX-I; RAT; SUBSTANCES; MECHANISM	Heat stress is an environmental factor that causes oxidative stress. We found previously that acute heat stress stimulates the production of reactive oxygen species (ROS) in the skeletal muscle mitochondria of birds, and that this was accompanied by an increase of the mitochondrial membrane potential (Delta Psi) due to increased substrate oxidation by the electron transport chain. We also showed that avian uncoupling protein (avUCP) expression is decreased by the heat exposure. The present study clarifies whether Delta Psi is a major determinant of the overproduction of ROS due to acute heat stress, and if the decrease in avUCP expression is responsible for the elevation in Delta Psi. Control (24 degrees C) and acute heat-stressed (34 degrees C for 12 h) birds exhibited increased succinate-driven mitochondrial ROS production as indicated by an elevation of Delta Psi, with this increase being significantly higher in the heat-stressed group compared with the control group. In glutamate/malate-energized mitochondria, no difference in the ROS production between the groups was observed, though the mitochondrial Delta Psi was significantly higher in the heat-stressed groups compared with the control group. Furthermore, mitochondria energized with either succinate/glutamate or succinate/malate showed increased ROS production and Delta Psi in the heat-stressed group compared with mitochondria from the control group. These results suggest that succinate oxidation could play an important role in the heat stress-induced overproduction of mitochondrial ROS in skeletal muscle. In agreement with the notion of a decrease in avUCP expression in response to heat stress, proton leak, which was likely mediated by UCP (that part which is GDP-inhibited and arachidonic acid-sensitive), was reduced in the heat-exposed group. We suggest that the acute heat stress-induced overproduction of mitochondrial ROS may depend on Delta Psi, which may in turn result not only from increased substrate oxidation but also from a decrease in the mitochondrial avUCP content.	[Kikusato, Motoi; Toyomizu, Masaaki] Tohoku Univ, Grad Sch Agr Sci, Sendai, Miyagi 980, Japan	Tohoku University	Toyomizu, M (corresponding author), Tohoku Univ, Grad Sch Agr Sci, Sendai, Miyagi 980, Japan.	toyomizu@bios.tohoku.ac.jp	Toyomizu, Masaaki/AAE-3439-2019; Toyomizu, Masaaki/AAM-6168-2020	Toyomizu, Masaaki/0000-0003-4157-2817	Japan Society for the Promotion of Science (JSPS) [21380165, 08J07429]; Tohoku University Institute for International Advanced Research and Education	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Tohoku University Institute for International Advanced Research and Education	This work was supported by a Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (JSPS, http://www.jsps.go.jp/english/e-grants/index.html) (No. 21380165, M.T.; No. 08J07429, M.K.), and by Tohoku University Institute for International Advanced Research and Education (http://www.iiare.tohoku.ac.jp/e/education/index.html, M.K.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altan O, 2003, BRIT POULTRY SCI, V44, P545, DOI 10.1080/00071660310001618334; ANDREYEV AY, 1989, EUR J BIOCHEM, V182, P585, DOI 10.1111/j.1432-1033.1989.tb14867.x; Brand MD, 2010, EXP GERONTOL, V45, P466, DOI 10.1016/j.exger.2010.01.003; Brand MD, 2000, EXP GERONTOL, V35, P811, DOI 10.1016/S0531-5565(00)00135-2; BROWN RE, 1989, ANAL BIOCHEM, V180, P136, DOI 10.1016/0003-2697(89)90101-2; Cadenas E, 2000, FREE RADICAL BIO MED, V29, P222, DOI 10.1016/S0891-5849(00)00317-8; Cadenas S, 2002, J BIOL CHEM, V277, P2773, DOI 10.1074/jbc.M109736200; Echtay KS, 2002, NATURE, V415, P96, DOI 10.1038/415096a; Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687; Goglia F, 2003, FASEB J, V17, P1585, DOI 10.1096/fj.03-0159hyp; Haak JL, 2009, AM J PHYSIOL-REG I, V296, pR812, DOI 10.1152/ajpregu.90708.2008; Hansford RG, 1997, J BIOENERG BIOMEMBR, V29, P89, DOI 10.1023/A:1022420007908; Kasanuma Y, 1998, TOHOKU J EXP MED, V185, P79, DOI 10.1620/tjem.185.79; Kikusato M, 2010, FEBS LETT, V584, P3143, DOI 10.1016/j.febslet.2010.05.057; Klingenberg M, 2001, BIOCHEM SOC T, V29, P806; Korshunov SS, 1997, FEBS LETT, V416, P15, DOI 10.1016/S0014-5793(97)01159-9; Lambert AJ, 2004, J BIOL CHEM, V279, P39414, DOI 10.1074/jbc.M406576200; LEVINE RL, 1990, METHOD ENZYMOL, V186, P464; Lombardi A, 2008, BBA-BIOENERGETICS, V1777, P826, DOI 10.1016/j.bbabio.2008.04.019; Lombardi A, 2010, J BIOL CHEM, V285, P16599, DOI 10.1074/jbc.M110.102699; Miwa S, 2003, FREE RADICAL BIO MED, V35, P938, DOI 10.1016/S0891-5849(03)00464-7; Mujahid A, 2006, POULTRY SCI, V85, P1259, DOI 10.1093/ps/85.7.1259; Mujahid A, 2005, POULTRY SCI, V84, P307, DOI 10.1093/ps/84.2.307; Mujahid Ahmad, 2007, Journal of Poultry Science, V44, P439, DOI 10.2141/jpsa.44.439; Mujahid A, 2007, FEBS LETT, V581, P3461, DOI 10.1016/j.febslet.2007.06.051; Mujahid A, 2009, AM J PHYSIOL-REG I, V297, pR690, DOI 10.1152/ajpregu.90974.2008; Muller FL, 2008, BIOCHEM J, V409, P491, DOI 10.1042/BJ20071162; Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386; Papa S, 1997, MOL CELL BIOCHEM, V174, P305, DOI 10.1023/A:1006873518427; Rey Benjamin, 2010, BMC Physiology, V10, P5, DOI 10.1186/1472-6793-10-5; REYNAFARJE B, 1985, ANAL BIOCHEM, V145, P406, DOI 10.1016/0003-2697(85)90381-1; Ricquier D, 2000, BIOCHEM J, V345, P161, DOI 10.1042/0264-6021:3450161; ROLFE DFS, 1994, BBA-BIOENERGETICS, V1188, P405, DOI 10.1016/0005-2728(94)90062-0; ROTTENBERG H, 1983, P NATL ACAD SCI-BIOL, V80, P3313, DOI 10.1073/pnas.80.11.3313; Sanz A, 2006, FASEB J, V20, P1064, DOI 10.1096/fj.05-5568com; SKULACHEV VP, 1991, FEBS LETT, V294, P158, DOI 10.1016/0014-5793(91)80658-P; Skulachev VP, 1996, Q REV BIOPHYS, V29, P169, DOI 10.1017/S0033583500005795; St-Pierre J, 2002, J BIOL CHEM, V277, P44784, DOI 10.1074/jbc.M207217200; Talbot DA, 2004, J PHYSIOL-LONDON, V558, P123, DOI 10.1113/jphysiol.2004.063768; Toime LJ, 2010, FREE RADICAL BIO MED, V49, P606, DOI 10.1016/j.freeradbiomed.2010.05.010; Toyomizu M, 2011, COMP BIOCHEM PHYS A, V159, P75, DOI 10.1016/j.cbpa.2011.01.020; Tretter L, 2004, J NEUROSCI, V24, P7771, DOI 10.1523/JNEUROSCI.1842-04.2004; Turrens JF, 2003, J PHYSIOL-LONDON, V552, P335, DOI 10.1113/jphysiol.2003.049478; Votyakova TV, 2001, J NEUROCHEM, V79, P266, DOI 10.1046/j.1471-4159.2001.00548.x	44	68	71	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2013	8	5							e64412	10.1371/journal.pone.0064412	http://dx.doi.org/10.1371/journal.pone.0064412			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	155HD	23671714	Green Published, Green Submitted, gold			2022-12-27	WOS:000319737700072
J	Kitano, S; Myers, J; Nakamura, J; Yamane, A; Yamashita, M; Nakayama, M; Tsukahara, Y; Ushida, H; Liu, WQ; Ratain, MJ; Amano, M				Kitano, Shiro; Myers, Jamie; Nakamura, Junko; Yamane, Akio; Yamashita, Mami; Nakayama, Masato; Tsukahara, Yusuke; Ushida, Hiroshi; Liu, Wanqing; Ratain, Mark J.; Amano, Masahiko			A Novel Fully Automated Molecular Diagnostic System (AMDS) for Colorectal Cancer Mutation Detection	PLOS ONE			English	Article							KRAS; PIK3CA; RAS; PANITUMUMAB; CETUXIMAB; ASSAY; EGFR	Background: KRAS, BRAF and PIK3CA mutations are frequently observed in colorectal cancer (CRC). In particular, KRAS mutations are strong predictors for clinical outcomes of EGFR-targeted treatments such as cetuximab and panitumumab in metastatic colorectal cancer (mCRC). For mutation analysis, the current methods are time-consuming, and not readily available to all oncologists and pathologists. We have developed a novel, simple, sensitive and fully automated molecular diagnostic system (AMDS) for point of care testing (POCT). Here we report the results of a comparison study between AMDS and direct sequencing (DS) in the detection of KRAS, BRAF and PI3KCA somatic mutations. Methodology/Principal Finding: DNA was extracted from a slice of either frozen (n = 89) or formalin-fixed and paraffin-embedded (FFPE) CRC tissue (n = 70), and then used for mutation analysis by AMDS and DS. All mutations (n = 41 among frozen and 27 among FFPE samples) detected by DS were also successfully (100%) detected by the AMDS. However, 8 frozen and 6 FFPE samples detected as wild-type in the DS analysis were shown as mutants in the AMDS analysis. By cloning-sequencing assays, these discordant samples were confirmed as true mutants. One sample had simultaneous "hot spot'' mutations of KRAS and PIK3CA, and cloning assay comfirmed that E542K and E545K were not on the same allele. Genotyping call rates for DS were 100.0% (89/89) and 74.3% (52/70) in frozen and FFPE samples, respectively, for the first attempt; whereas that of AMDS was 100.0% for both sample sets. For automated DNA extraction and mutation detection by AMDS, frozen tissues (n = 41) were successfully detected all mutations within 70 minutes. Conclusions/Significance: AMDS has superior sensitivity and accuracy over DS, and is much easier to execute than conventional labor intensive manual mutation analysis. AMDS has great potential for POCT equipment for mutation analysis.	[Kitano, Shiro; Nakamura, Junko; Yamane, Akio; Yamashita, Mami; Nakayama, Masato; Ushida, Hiroshi; Amano, Masahiko] Toppan Printing Co Ltd, Tech Res Inst, Chiba, Japan; [Myers, Jamie; Liu, Wanqing; Ratain, Mark J.] Univ Chicago, Dept Med, Hematol Oncol Sect, Chicago, IL 60637 USA	Toppan Printing Co Ltd; University of Chicago	Kitano, S (corresponding author), Toppan Printing Co Ltd, Tech Res Inst, Chiba, Japan.	shiro.kitano@toppan.co.jp		Liu, Wanqing/0000-0001-7727-6900	TOPPAN PRINTING CO., LTD.	TOPPAN PRINTING CO., LTD.	This research was funded by the authors' company (TOPPAN PRINTING CO., LTD.). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amado RG, 2008, J CLIN ONCOL, V26, P1626, DOI 10.1200/JCO.2007.14.7116; Amicarelli G, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm809; Bamford S, 2004, BRIT J CANCER, V91, P355, DOI 10.1038/sj.bjc.6601894; Barault L, 2008, INT J CANCER, V122, P2255, DOI 10.1002/ijc.23388; BOOM R, 1990, J CLIN MICROBIOL, V28, P495, DOI 10.1128/JCM.28.3.495-503.1990; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; Cross J, 2008, PHARMACOGENOMICS, V9, P463, DOI 10.2217/14622416.9.4.463; De Roock W, 2010, JAMA-J AM MED ASSOC, V304, P1812, DOI 10.1001/jama.2010.1535; Di Nicolantonio F, 2008, J CLIN ONCOL, V26, P5705, DOI 10.1200/JCO.2008.18.0786; Do H, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-142; Edkins S, 2006, CANCER BIOL THER, V5, P928, DOI 10.4161/cbt.5.8.3251; Gupta S, 2007, CELL, V129, P957, DOI 10.1016/j.cell.2007.03.051; Hoshi K, 2007, CLIN CANCER RES, V13, P4974, DOI 10.1158/1078-0432.CCR-07-0509; Janku F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022769; Janne PA, 2006, CLIN CANCER RES, V12, P751, DOI 10.1158/1078-0432.CCR-05-2047; Jhawer M, 2008, CANCER RES, V68, P1953, DOI 10.1158/0008-5472.CAN-07-5659; Karapetis CS, 2008, NEW ENGL J MED, V359, P1757, DOI 10.1056/NEJMoa0804385; Kotoula V, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007746; Kwiatkowski RW, 1999, MOL DIAGN, V4, P353, DOI 10.1016/S1084-8592(99)80012-5; Lyamichev V, 1999, NAT BIOTECHNOL, V17, P292, DOI 10.1038/7044; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Melzak KA, 1996, J COLLOID INTERF SCI, V181, P635, DOI 10.1006/jcis.1996.0421; Ogino S, 2005, J MOL DIAGN, V7, P413, DOI 10.1016/S1525-1578(10)60571-5; Ogino S, 2009, J CLIN ONCOL, V27, P1477, DOI 10.1200/JCO.2008.18.6544; Oliner K, 2010, DIAGN PATHOL, V5, DOI 10.1186/1746-1596-5-23; Russo A, 2005, ANN ONCOL, V16, P44, DOI 10.1093/annonc/mdi907; Samuels Y, 2004, CELL CYCLE, V3, P1221, DOI 10.4161/cc.3.10.1164; Samuels Y, 2004, SCIENCE, V304, P554, DOI 10.1126/science.1096502; Soulieres D, 2010, CURR ONCOL, V17, pS31; Tatsumi K, 2008, J MOL DIAGN, V10, P520, DOI 10.2353/jmoldx.2008.080024; Yuan TL, 2008, ONCOGENE, V27, P5497, DOI 10.1038/onc.2008.245	31	6	6	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2013	8	5							e62989	10.1371/journal.pone.0062989	http://dx.doi.org/10.1371/journal.pone.0062989			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	155HD	23671647	Green Published, gold, Green Submitted			2022-12-27	WOS:000319737700030
J	Bargagna-Mohan, P; Deokule, SP; Thompson, K; Wizeman, J; Srinivasan, C; Vooturi, S; Kompella, UB; Mohan, R				Bargagna-Mohan, Paola; Deokule, Sunil P.; Thompson, Kyle; Wizeman, John; Srinivasan, Cidambi; Vooturi, Sunil; Kompella, Uday B.; Mohan, Royce			Withaferin A Effectively Targets Soluble Vimentin in the Glaucoma Filtration Surgical Model of Fibrosis	PLOS ONE			English	Article							INTERMEDIATE-FILAMENT NETWORKS; FIBRILLARY ACIDIC PROTEIN; P27(KIP1) DEGRADATION; CAPSULE FIBROBLASTS; TRABECULAR MESHWORK; CELL ARCHITECTURE; GROWTH-FACTOR; LIVING CELLS; IN-VIVO; SURGERY	Withaferin A (WFA) is a natural product that binds to soluble forms of the type III intermediate filament (IF) vimentin. Currently, it is unknown under what pathophysiological contexts vimentin is druggable, as cytoskeltal vimentin-IFs are abundantly expressed. To investigate druggability of vimentin, we exploited rabbit Tenon's capsule fibroblast (RbTCF) cell cultures and the rabbit glaucoma filtration surgical (GFS) model of fibrosis. WFA potently caused G(0)/G(1) cell cycle inhibition (IC50 25 nM) in RbTCFs, downregulating ubiquitin E3 ligase skp2 and inducing p27(Kip1) expression. Transforming growth factor (TGF)-beta-induced myofibroblast transformation caused development of cell spheroids with numerous elongated invadopodia, which WFA blocked potently by downregulating soluble vimentin and alpha-smooth muscle actin (SMA) expression. In the pilot proof-of-concept study using the GFS model, subconjunctival injections of a low WFA dose reduced skp2 expression in Tenon's capsule and increased p27(Kip1) expression without significant alteration to vimentin-IFs. This treatment maintains significant nanomolar WFA concentrations in anterior segment tissues that correspond to WFA's cell cycle targeting activity. A ten-fold higher WFA dose caused potent downregulation of soluble vimentin and skp2 expression, but as found in cell cultures, no further increase in p27(Kip1) expression was observed. Instead, this high WFA dose potently induced vimentin-IF disruption and downregulated alpha-SMA expression that mimicked WFA activity in TGF-beta-treated RbTCFs that blocked cell contractile activity at submicromolar concentrations. These findings illuminate that localized WFA injection to ocular tissues exerts pharmacological control over the skp2-p27(Kip1) pathway by targeting of soluble vimentin in a model of surgical fibrosis.	[Bargagna-Mohan, Paola; Wizeman, John; Mohan, Royce] Univ Connecticut Hlth Ctr, Farmington, CT USA; [Deokule, Sunil P.; Thompson, Kyle; Srinivasan, Cidambi] Univ Kentucky, Lexington, KY USA; [Vooturi, Sunil; Kompella, Uday B.] Univ Colorado Denver, Aurora, CO USA	University of Connecticut; University of Kentucky; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus	Mohan, R (corresponding author), Univ Connecticut Hlth Ctr, Farmington, CT USA.	MOHAN@uchc.edu			National Institutes of Health (NIH) [R01EY016782, R01 CA131059, R01EY018940]; Susan Hart through the University of Connecticut Foundation; John A. and Florence Mattern Solomon Endowed Chair foundation grants; NATIONAL CANCER INSTITUTE [R01CA131059] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY016782, R01EY018940] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Susan Hart through the University of Connecticut Foundation; John A. and Florence Mattern Solomon Endowed Chair foundation grants; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This research was funded in part by National Institutes of Health (NIH) grants R01EY016782 and R01 CA131059 and John A. and Florence Mattern Solomon Endowed Chair foundation grants and a private donation from Susan Hart through the University of Connecticut Foundation to R.M. This research was also partly supported by an NIH grant R01EY018940 to U.B.K. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auld CA, 2007, J CELL PHYSIOL, V211, P101, DOI 10.1002/jcp.20915; Bar H, 2005, P NATL ACAD SCI USA, V102, P15099, DOI 10.1073/pnas.0504568102; Bargagna-Mohan P, 2007, CHEM BIOL, V14, P623, DOI 10.1016/j.chembiol.2007.04.010; Bargagna-Mohan P, 2006, INVEST OPHTH VIS SCI, V47, P4138, DOI 10.1167/iovs.05-1452; Bargagna-Mohan P, 2012, J BIOL CHEM, V287, P989, DOI 10.1074/jbc.M111.297150; Bargagna-Mohan P, 2010, J BIOL CHEM, V285, P7657, DOI 10.1074/jbc.M109.093765; Blanch R J, 2009, J R Army Med Corps, V155, P279; Burns WC, 2010, EXPERT REV MOL MED, V12, DOI 10.1017/S1462399410001481; CARY RB, 1994, J CELL SCI, V107, P1609; Challa AA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042989; Chou YH, 2007, EXP CELL RES, V313, P2236, DOI 10.1016/j.yexcr.2007.04.008; Clarke EJ, 2002, CURR BIOL, V12, pR596, DOI 10.1016/S0960-9822(02)01102-8; Colakoglu G, 2009, J CELL BIOL; Crowston JG, 1998, INVEST OPHTH VIS SCI, V39, P449; Dinsdale D, 2004, AM J PATHOL, V164, P395, DOI 10.1016/S0002-9440(10)63130-6; Eckes B, 1998, J CELL SCI, V111, P1897; Eckes B, 2000, J CELL SCI, V113, P2455; Eriksson JE, 2004, J CELL SCI, V117, P919, DOI 10.1242/jcs.00906; Esson DW, 2004, INVEST OPHTH VIS SCI, V45, P4450, DOI 10.1167/iovs.04-0375; Esson DW, 2004, INVEST OPHTH VIS SCI, V45, P485, DOI 10.1167/iovs.03-0485; FRANKE WW, 1982, CELL, V30, P103, DOI 10.1016/0092-8674(82)90016-2; Galichon P, 2011, FIBROGENESIS TISSUE, V4, DOI 10.1186/1755-1536-4-11; Gaudana R, 2010, AAPS J, V12, P348, DOI 10.1208/s12248-010-9183-3; Goldman RD, 2008, CURR OPIN CELL BIOL, V20, P28, DOI 10.1016/j.ceb.2007.11.003; Grin B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039065; Guarino M, 2009, HUM PATHOL, V40, P1365, DOI 10.1016/j.humpath.2009.02.020; Helfand BT, 2011, MOL BIOL CELL, V22, P1274, DOI 10.1091/mbc.E10-08-0699; Herrmann H, 2007, NAT REV MOL CELL BIO, V8, P562, DOI 10.1038/nrm2197; Herrmann H, 2009, J CLIN INVEST, V119, P1772, DOI 10.1172/JCI38214; Iliev ME, 1997, EXP EYE RES, V64, P1013, DOI 10.1006/exer.1997.0300; Inuzuka H, 2012, CELL, V150, P179, DOI 10.1016/j.cell.2012.05.038; Ivaska Johanna, 2011, Small GTPases, V2, P51; Izawa I, 2006, CANCER SCI, V97, P167, DOI 10.1111/j.1349-7006.2006.00161.x; JAMPEL HD, 1988, ARCH OPHTHALMOL-CHIC, V106, P89; Johnson CP, 2007, SCIENCE, V317, P663, DOI 10.1126/science.1139857; Kadam RS, 2010, J PHARMACOL EXP THER, V332, P1107, DOI 10.1124/jpet.109.161570; KHAW PT, 1992, ARCH OPHTHALMOL-CHIC, V110, P1150, DOI 10.1001/archopht.1992.01080200130040; Korff T, 1998, J CELL BIOL, V143, P1341, DOI 10.1083/jcb.143.5.1341; Kossatz U, 2004, GENE DEV, V18, P2602, DOI 10.1101/gad.321004; Lahat G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010105; Lynch CD, 2013, MOL BIOL CELL, V24, P21, DOI 10.1091/mbc.E12-05-0377; Maxwell SA, 2011, LEUKEMIA LYMPHOMA, V52, P849, DOI 10.3109/10428194.2010.551793; Mead AL, 2003, INVEST OPHTH VIS SCI, V44, P3394, DOI 10.1167/iovs.02-0978; Mendez MG, 2010, FASEB J, V24, P1838, DOI 10.1096/fj.09-151639; Middeldorp J, 2011, PROG NEUROBIOL, V93, P421, DOI 10.1016/j.pneurobio.2011.01.005; Mohan Royce, 2004, Angiogenesis, V7, P115, DOI 10.1007/s10456-004-1026-3; Mucke N, 2004, J MOL BIOL, V340, P97, DOI 10.1016/j.jmb.2004.04.039; Pekny M, 2004, J PATHOL, V204, P428, DOI 10.1002/path.1645; Perng MD, 2008, MOL BIOL CELL, V19, P4521, DOI 10.1091/mbc.E08-03-0284; Phua DCY, 2009, MOL BIOL CELL, V20, P2841, DOI 10.1091/mbc.E08-02-0199; Plodinec M, 2011, J STRUCT BIOL, V174, P476, DOI 10.1016/j.jsb.2011.03.011; Prahlad V, 1998, J CELL BIOL, V143, P159, DOI 10.1083/jcb.143.1.159; Prendes MA, 2013, BR J OPHTHALMOL; Pucilowska JB, 2000, AM J PHYSIOL-GASTR L, V279, pG653; Quinlan Roy, 2002, Prog Mol Subcell Biol, V28, P219; Robertson J, 2003, J CELL BIOL, V160, P939, DOI 10.1083/jcb.200205027; Rogel MR, 2011, FASEB J; Sakamoto Y, 2013, J CELL BIOL, V200, P249, DOI 10.1083/jcb.201206010; Salim S, 2012, CURR OPIN OPHTHALMOL, V23, P89, DOI 10.1097/ICU.0b013e32834ff401; Schoumacher M, 2010, J CELL BIOL, V189, P541, DOI 10.1083/jcb.200909113; Sherwood Mark Brian, 2006, Trans Am Ophthalmol Soc, V104, P478; SOELLNER P, 1985, P NATL ACAD SCI USA, V82, P7929, DOI 10.1073/pnas.82.23.7929; Stahnke T, 2012, EXP EYE RES, V100, P88, DOI 10.1016/j.exer.2012.04.015; Stevens C, 2012, GUT; Suzuki S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036249; Thaiparambil JT, 2011, INT J CANC; Thakur A, 2011, DRUG METAB DISPOS, V39, P771, DOI 10.1124/dmd.110.037408; Wang F, 2010, INVEST OPHTH VIS SCI, V51, P1475, DOI 10.1167/iovs.09-4363; Wu YZ, 2007, BBA-MOL CELL RES, V1773, P427, DOI 10.1016/j.bbamcr.2006.11.017; Yang JG, 2009, ACTA PHARMACOL SIN, V30, P413, DOI 10.1038/aps.2009.23; Yokota Y, 2006, BIOORG MED CHEM LETT, V16, P2603, DOI 10.1016/j.bmcl.2006.02.039; Yoon M, 1998, J CELL BIOL, V143, P147, DOI 10.1083/jcb.143.1.147; Yoshida K, 2002, INVEST OPHTH VIS SCI, V43, P364; Zhao XJ, 2004, INVEST OPHTH VIS SCI, V45, P4023, DOI 10.1167/iovs.04-0535	74	26	29	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2013	8	5							e63881	10.1371/journal.pone.0063881	http://dx.doi.org/10.1371/journal.pone.0063881			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145YI	23667686	gold, Green Published, Green Submitted			2022-12-27	WOS:000319055600080
J	Lippert, MT; Takagaki, K; Kayser, C; Ohl, FW				Lippert, Michael T.; Takagaki, Kentaroh; Kayser, Christoph; Ohl, Frank W.			Asymmetric Multisensory Interactions of Visual and Somatosensory Responses in a Region of the Rat Parietal Cortex	PLOS ONE			English	Article							SUPERIOR COLLICULUS NEURONS; PRIMARY AUDITORY-CORTEX; SOURCE-DENSITY ANALYSIS; POSTERIOR PARIETAL; HEMODYNAMIC-RESPONSES; SYNAPTIC ACTIVITY; NEURAL ACTIVITY; INTEGRATION; NEOCORTEX; ORGANIZATION	Perception greatly benefits from integrating multiple sensory cues into a unified percept. To study the neural mechanisms of sensory integration, model systems are required that allow the simultaneous assessment of activity and the use of techniques to affect individual neural processes in behaving animals. While rodents qualify for these requirements, little is known about multisensory integration and areas involved for this purpose in the rodent. Using optical imaging combined with laminar electrophysiological recordings, the rat parietal cortex was identified as an area where visual and somatosensory inputs converge and interact. Our results reveal similar response patterns to visual and somatosensory stimuli at the level of current source density (CSD) responses and multi-unit responses within a strip in parietal cortex. Surprisingly, a selective asymmetry was observed in multisensory interactions: when the somatosensory response preceded the visual response, supra-linear summation of CSD was observed, but the reverse stimulus order resulted in sub-linear effects in the CSD. This asymmetry was not present in multi-unit activity however, which showed consistently sub-linear interactions. These interactions were restricted to a specific temporal window, and pharmacological tests revealed significant local intra-cortical contributions to this phenomenon. Our results highlight the rodent parietal cortex as a system to model the neural underpinnings of multisensory processing in behaving animals and at the cellular level.	[Lippert, Michael T.; Takagaki, Kentaroh; Ohl, Frank W.] Leibniz Inst Neurobiol, Dept Syst Physiol Learning, Magdeburg, Germany; [Kayser, Christoph] Max Planck Inst Biol Cybernet, Dept Physiol Cognit Proc, D-72076 Tubingen, Germany; [Kayser, Christoph] Univ Glasgow, Inst Neurosci & Psychol, Glasgow, Lanark, Scotland; [Lippert, Michael T.; Ohl, Frank W.] Otto von Guericke Univ, Inst Biol, Magdeburg, Germany; [Ohl, Frank W.] Ctr Behav Brain Sci, Magdeburg, Germany	Leibniz Institut fur Neurobiologie (LIN); Max Planck Society; University of Glasgow; Otto von Guericke University	Lippert, MT (corresponding author), Leibniz Inst Neurobiol, Dept Syst Physiol Learning, Magdeburg, Germany.	mlippert@lin-magdeburg.de	Takagaki, Kentaroh/A-9829-2009; Kayser, Christoph/A-3203-2012	Takagaki, Kentaroh/0000-0002-1852-529X; Kayser, Christoph/0000-0001-7362-5704	Deutsche Forschungsgemeinschaft DFG [SFB 779, SFB TRR 31]; federal state of Saxony-Anhalt; a(sic)oeEuropean Regional Developement Funda(sic)oe (ERDF); Center for Behavioral Brain Sciences (CBBS) [FKZ: 1211080005]; Max-Planck-Society; Alexander von Humboldt-Foundation	Deutsche Forschungsgemeinschaft DFG(German Research Foundation (DFG)); federal state of Saxony-Anhalt; a(sic)oeEuropean Regional Developement Funda(sic)oe (ERDF); Center for Behavioral Brain Sciences (CBBS); Max-Planck-Society(Max Planck Society); Alexander von Humboldt-Foundation(Alexander von Humboldt Foundation)	This work was supported by the Deutsche Forschungsgemeinschaft DFG (SFB 779 and SFB TRR 31), by the federal state of Saxony-Anhalt and the a(sic)oeEuropean Regional Developement Funda(sic)oe (ERDF 2007-2013), Center for Behavioral Brain Sciences (CBBS) FKZ: 1211080005 and by the Max-Planck-Society. K. Takagaki was supported by a fellowship from the Alexander von Humboldt-Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2004, BEHAV LAB RAT HDB TE; Avillac M, 2005, NAT NEUROSCI, V8, P941, DOI 10.1038/nn1480; Avillac M, 2007, J NEUROSCI, V27, P1922, DOI 10.1523/JNEUROSCI.2646-06.2007; Beauchamp MS, 2004, NAT NEUROSCI, V7, P1190, DOI 10.1038/nn1333; Bizley JK, 2009, HEARING RES, V258, P55, DOI 10.1016/j.heares.2009.06.017; Blanke O, 2012, NAT REV NEUROSCI, V13, P556, DOI 10.1038/nrn3292; Brett-Green B, 2003, J COMP NEUROL, V460, P223, DOI 10.1002/cne.10637; Broussard J, 2006, NEUROSCIENCE, V143, P407, DOI 10.1016/j.neuroscience.2006.08.030; Budinger E, 2000, EUR J NEUROSCI, V12, P2425, DOI 10.1046/j.1460-9568.2000.00142.x; Cahill L, 1996, NEUROBIOL LEARN MEM, V65, P213, DOI 10.1006/nlme.1996.0026; Calvert GA, 2001, CEREB CORTEX, V11, P1110, DOI 10.1093/cercor/11.12.1110; Clement EA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002004; COLAVITA FB, 1974, PERCEPT PSYCHOPHYS, V16, P409, DOI 10.3758/BF03203962; CRAGG BG, 1971, BRAIN RES, V34, P53, DOI 10.1016/0006-8993(71)90350-7; Dahl CD, 2009, J NEUROSCI, V29, P11924, DOI 10.1523/JNEUROSCI.3437-09.2009; Dehner LR, 2004, CEREB CORTEX, V14, P387, DOI 10.1093/cercor/bhg135; Deisseroth K, 2011, NAT METHODS, V8, P26, DOI 10.1038/NMETH.F.324; Douglas RJ, 2004, ANNU REV NEUROSCI, V27, P419, DOI 10.1146/annurev.neuro.27.070203.144152; Douglas RJ, 2007, CURR BIOL, V17, pR496, DOI 10.1016/j.cub.2007.04.024; Driver J, 2008, NEURON, V57, P11, DOI 10.1016/j.neuron.2007.12.013; Felsen G, 2008, NEURON, V60, P137, DOI 10.1016/j.neuron.2008.09.019; Ferezou I, 2007, NEURON, V56, P907, DOI 10.1016/j.neuron.2007.10.007; Fetsch CR, 2012, NAT NEUROSCI, V15, P146, DOI 10.1038/nn.2983; Flusberg BA, 2008, NAT METHODS, V5, P935, DOI 10.1038/nmeth.1256; Foxe JJ, 2005, NEUROREPORT, V16, P419, DOI 10.1097/00001756-200504040-00001; Foxworthy WA, 2013, J COMP NEUROL, V521, P1867, DOI 10.1002/cne.23264; Foxworthy WA, 2013, EUR J NEUROSCI, V37, P910, DOI 10.1111/ejn.12085; Frostig RD, 2008, J NEUROSCI, V28, P13274, DOI 10.1523/JNEUROSCI.4074-08.2008; Fujisaki W, 2004, NAT NEUROSCI, V7, P773, DOI 10.1038/nn1268; GAREY LJ, 1971, PROC R SOC SER B-BIO, V179, P41, DOI 10.1098/rspb.1971.0080; Ghazanfar AA, 2006, TRENDS COGN SCI, V10, P278, DOI 10.1016/j.tics.2006.04.008; GIVRE SJ, 1994, VISION RES, V34, P415, DOI 10.1016/0042-6989(94)90156-2; Gleiss S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045677; Green AM, 2010, CURR OPIN NEUROBIOL, V20, P353, DOI 10.1016/j.conb.2010.04.009; Greenberg DS, 2008, NAT NEUROSCI, V11, P749, DOI 10.1038/nn.2140; Gu Y, 2008, NAT NEUROSCI, V11, P1201, DOI 10.1038/nn.2191; Gu Y, 2011, NEURON, V71, P750, DOI 10.1016/j.neuron.2011.06.015; Happel MFK, 2010, J NEUROSCI, V30, P11114, DOI 10.1523/JNEUROSCI.0689-10.2010; Harvey CD, 2012, NATURE, V484, P62, DOI 10.1038/nature10918; Hirokawa J, 2008, NEUROSCIENCE, V153, P1402, DOI 10.1016/j.neuroscience.2008.01.011; Ionta S, 2011, NEURON, V70, P363, DOI 10.1016/j.neuron.2011.03.009; Iurilli G, 2012, NEURON, V73, P814, DOI 10.1016/j.neuron.2011.12.026; Kayser C, 2008, CEREB CORTEX, V18, P1560, DOI 10.1093/cercor/bhm187; Kayser C, 2007, BRAIN STRUCT FUNCT, V212, P121, DOI 10.1007/s00429-007-0154-0; Kayser C, 2010, CURR BIOL, V20, P19, DOI 10.1016/j.cub.2009.10.068; KENANVAKNIN G, 1994, BRAIN RES, V635, P37, DOI 10.1016/0006-8993(94)91421-4; KOLB B, 1994, CEREB CORTEX, V4, P664, DOI 10.1093/cercor/4.6.664; Kurt S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001735; Lakatos P, 2007, NEURON, V53, P279, DOI 10.1016/j.neuron.2006.12.011; Laurienti PJ, 2005, EXP BRAIN RES, V166, P289, DOI 10.1007/s00221-005-2370-2; Lemus L, 2010, NEURON, V67, P335, DOI 10.1016/j.neuron.2010.06.015; Lewis R, 2010, J NEUROSCI, V30, P12329, DOI 10.1523/JNEUROSCI.5745-09.2010; Lippert M, 2007, BRAIN RES, V1173, P102, DOI 10.1016/j.brainres.2007.07.050; Lippert MT, 2010, MAGN RESON IMAGING, V28, P1087, DOI 10.1016/j.mri.2009.12.028; Ludvig N, 2012, BRAIN RES, V1441, P1, DOI 10.1016/j.brainres.2011.12.050; MEANEY MJ, 1981, ANIM BEHAV, V29, P34, DOI 10.1016/S0003-3472(81)80149-2; Menzel RR, 2005, CEREB CORTEX, V15, P1690, DOI 10.1093/cercor/bhi045; Meredith MA, 2009, NEUROREPORT, V20, P126, DOI 10.1097/WNR.0b013e32831d7bb6; MEREDITH MA, 1987, J NEUROSCI, V7, P3215; Meredith MA, 1996, J NEUROPHYSIOL, V75, P1843, DOI 10.1152/jn.1996.75.5.1843; MEREDITH MA, 1983, SCIENCE, V221, P389, DOI 10.1126/science.6867718; MILLER MW, 1984, J COMP NEUROL, V226, P184, DOI 10.1002/cne.902260204; Miyawaki A, 2003, NAT CELL BIOL, pS1, DOI 10.1038/ncb1031; Montemurro MA, 2007, J NEUROPHYSIOL, V98, P1871, DOI 10.1152/jn.00593.2007; Nemoto M, 2004, J NEUROSCI, V24, P3850, DOI 10.1523/JNEUROSCI.4870-03.2004; NICHOLSON C, 1975, J NEUROPHYSIOL, V38, P356, DOI 10.1152/jn.1975.38.2.356; Ohshiro T, 2011, NAT NEUROSCI, V14, P775, DOI 10.1038/nn.2815; Otazu GH, 2009, NAT NEUROSCI, V12, P646, DOI 10.1038/nn.2306; Pasalar S, 2010, EUR J NEUROSCI, V31, P1783, DOI 10.1111/j.1460-9568.2010.07193.x; Paxinos G., 2004, RAT BRAIN STEREOTAXI; PINTOHAMUY T, 1987, BEHAV BRAIN RES, V25, P221, DOI 10.1016/0166-4328(87)90070-2; Pitts W.H., 1952, CYBERNETICS, P159; Raposo D, 2012, J NEUROSCI, V32, P3726, DOI 10.1523/JNEUROSCI.4998-11.2012; Sakata S, 2009, NEURON, V64, P404, DOI 10.1016/j.neuron.2009.09.020; Schei JL, 2009, APPL OPTICS, V48, pD121, DOI 10.1364/AO.48.00D121; Schulz D, 2011, NAT METHODS, V8, P347, DOI [10.1038/nmeth.1582, 10.1038/NMETH.1582]; Sirotin YB, 2009, P NATL ACAD SCI USA, V106, P18390, DOI 10.1073/pnas.0905509106; Spence C, 2009, PROG BRAIN RES, V176, P245, DOI 10.1016/S0079-6123(09)17615-X; Stanford TR, 2007, NEUROREPORT, V18, P787, DOI 10.1097/WNR.0b013e3280c1e315; Stein BE, 2008, NAT REV NEUROSCI, V9, P255, DOI 10.1038/nrn2331; Stein BE, 2010, EUR J NEUROSCI, V31, P1713, DOI 10.1111/j.1460-9568.2010.07206.x; Stein BE, 2009, EXP BRAIN RES, V198, P113, DOI 10.1007/s00221-009-1880-8; Stein BE., 1993, MERGING SENSES; Sugihara T, 2006, J NEUROSCI, V26, P11138, DOI 10.1523/JNEUROSCI.3550-06.2006; Takagaki K, 2008, NEUROSCI LETT, V431, P191, DOI 10.1016/j.neulet.2007.11.069; Tees RC, 1999, BEHAV BRAIN RES, V106, P55, DOI 10.1016/S0166-4328(99)00092-3; TOLDI J, 1986, NEUROSCIENCE, V18, P461, DOI 10.1016/0306-4522(86)90166-1; Wallace MT, 2004, P NATL ACAD SCI USA, V101, P2167, DOI 10.1073/pnas.0305697101; Wilent WB, 2005, NAT NEUROSCI, V8, P1364, DOI 10.1038/nn1545; Winters BD, 2010, J NEUROSCI, V30, P6253, DOI 10.1523/JNEUROSCI.6073-09.2010; Xu WF, 2007, NEURON, V55, P119, DOI 10.1016/j.neuron.2007.06.016; Yamauchi T, 2000, EUR J NEUROSCI, V12, P3433, DOI 10.1046/j.1460-9568.2000.00248.x; Yang Y, 2008, NAT NEUROSCI, V11, P1262, DOI 10.1038/nn.2211	93	26	26	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e63631	10.1371/journal.pone.0063631	http://dx.doi.org/10.1371/journal.pone.0063631			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667650	Green Submitted, Green Accepted, Green Published, gold			2022-12-27	WOS:000319654700171
J	Ma, JX; Wang, ZW; Zhu, CW; Liu, SM; Wang, QY; Wu, ZC				Ma, Jinxing; Wang, Zhiwei; Zhu, Chaowei; Liu, Shumeng; Wang, Qiaoying; Wu, Zhichao			Analysis of Nitrification Efficiency and Microbial Community in a Membrane Bioreactor Fed with Low COD/N-Ratio Wastewater	PLOS ONE			English	Article							ACTIVATED-SLUDGE; HETEROTROPHIC BACTERIA; BIOFILM REACTORS; NITROGEN REMOVAL; RETENTION TIME; ORGANIC-CARBON; PERFORMANCE; POPULATION; AMMONIUM; RECOVERY	In this study, an approach using influent COD/N ratio reduction was employed to improve process performance and nitrification efficiency in a membrane bioreactor (MBR). Besides sludge reduction, membrane fouling alleviation was observed during 330 d operation, which was attributed to the decreased production of soluble microbial products (SMP) and efficient carbon metabolism in the autotrophic nitrifying community. 454 high-throughput 16S rRNA gene pyrosequencing revealed that the diversity of microbial sequences was mainly determined by the feed characteristics, and that microbes could derive energy by switching to a more autotrophic metabolism to resist the environmental stress. The enrichment of nitrifiers in an MBR with a low COD/N-ratio demonstrated that this condition stimulated nitrification, and that the community distribution of ammonia oxidizing bacteria (AOB) and nitrite oxidizing bacteria (NOB) resulted in faster nitrite uptake rates. Further, ammonia oxidation was the rate-limiting step during the full nitrification.	[Ma, Jinxing; Wang, Zhiwei; Liu, Shumeng; Wang, Qiaoying; Wu, Zhichao] Tongji Univ, Sch Environm Sci & Engn, State Key Lab Pollut Control & Resource Reuse, Shanghai 200092, Peoples R China; [Zhu, Chaowei] Chinese Res Inst Environm Sci, Beijing, Peoples R China	Tongji University; Chinese Research Academy of Environmental Sciences	Wang, ZW (corresponding author), Tongji Univ, Sch Environm Sci & Engn, State Key Lab Pollut Control & Resource Reuse, Shanghai 200092, Peoples R China.	zwwang@tongji.edu.cn	Wang, Zhiwei/F-5666-2012; Wang, Qiaoying/AAN-6945-2020; Ma, Jinxing/D-9981-2013	Wang, Zhiwei/0000-0001-6729-2237; Ma, Jinxing/0000-0002-5087-3972	Sino-French Scientific and Technological Cooperation Project in the Domain of Water [2011DFA90400]; National Natural Science Foundation of China [51008217]; Fundamental Research Funds for the Central Universities	Sino-French Scientific and Technological Cooperation Project in the Domain of Water; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was financially supported by the Sino-French Scientific and Technological Cooperation Project in the Domain of Water (2011DFA90400), the National Natural Science Foundation of China (grant No. 51008217) and by the Fundamental Research Funds for the Central Universities. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn JH, 2011, ENVIRON SCI TECHNOL, V45, P2734, DOI 10.1021/es103534g; American Public Health Association (APHA), 2012, STANDARD METHODS EXA, DOI [10.2105/SMWW.2882?gclid=CjwKCAiA25v_BRBNEiwAZb4-ZRdKz6ceq6, DOI 10.2105/SMWW.2882?GCLID=CJWKCAIA25V_BRBNEIWAZB4-ZRDKZ6CEQ6]; Bassin JP, 2012, ENVIRON SCI TECHNOL, V46, P1546, DOI 10.1021/es203356z; Bengtsson MM, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-261; Butler MD, 2009, WATER RES, V43, P1265, DOI 10.1016/j.watres.2008.12.027; Cho BD, 2002, J MEMBRANE SCI, V209, P391, DOI 10.1016/S0376-7388(02)00321-6; DUBOIS M, 1956, ANAL CHEM, V28, P350, DOI 10.1021/ac60111a017; Han SS, 2005, PROCESS BIOCHEM, V40, P2393, DOI 10.1016/j.procbio.2004.09.017; HARTREE EF, 1972, ANAL BIOCHEM, V48, P422, DOI 10.1016/0003-2697(72)90094-2; He Z, 2009, ENVIRON SCI TECHNOL, V43, P3391, DOI 10.1021/es803492c; Hocaoglu SM, 2011, BIORESOURCE TECHNOL, V102, P6665, DOI 10.1016/j.biortech.2011.03.096; Huang ZH, 2010, WATER RES, V44, P4351, DOI 10.1016/j.watres.2010.05.037; Judd S, 2006, MBR BOOK; Keskes S, 2012, BIORESOURCE TECHNOL, V103, P28, DOI 10.1016/j.biortech.2011.09.063; Kindaichi T, 2004, APPL ENVIRON MICROB, V70, P1641, DOI 10.1128/AEM.70.3.1641-1650.2004; Kragelund C, 2007, FEMS MICROBIOL ECOL, V59, P671, DOI 10.1111/j.1574-6941.2006.00251.x; Lee LY, 2004, BIORESOURCE TECHNOL, V95, P209, DOI 10.1016/j.biortech.2003.05.004; Li F, 2006, WATER SA, V32, P199; Lu L, 2012, WATER RES, V46, P2425, DOI 10.1016/j.watres.2012.02.005; Ma JX, 2013, CHEM ENG J, V219, P190, DOI 10.1016/j.cej.2012.12.085; Ma JX, 2013, WATER RES, V47, P859, DOI 10.1016/j.watres.2012.11.013; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Nogueira R, 2002, WATER RES, V36, P469, DOI 10.1016/S0043-1354(01)00229-9; Ohashi A, 1995, WATER SCI TECHNOL, V32, P75, DOI 10.1016/0273-1223(96)00010-8; Racz L, 2010, BIORESOURCE TECHNOL, V101, P6454, DOI 10.1016/j.biortech.2010.03.058; Ramdani A, 2010, WATER RES, V44, P2179, DOI 10.1016/j.watres.2009.12.037; VERHAGEN FJM, 1991, APPL ENVIRON MICROB, V57, P3255, DOI 10.1128/AEM.57.11.3255-3263.1991; Virdis B, 2008, WATER RES, V42, P3013, DOI 10.1016/j.watres.2008.03.017; Wang P, 2011, J MEMBRANE SCI, V382, P60, DOI 10.1016/j.memsci.2011.07.044; Wang QY, 2011, CHEM ENG J, V172, P929, DOI 10.1016/j.cej.2011.07.004; Wang ZW, 2009, CHEM ENG J, V150, P396, DOI 10.1016/j.cej.2009.01.018; Ye L, 2011, WATER RES, V45, P4390, DOI 10.1016/j.watres.2011.05.028; Yuan Z, 2003, FOCUS BIOTECHNOL, V3C, P187	33	17	20	0	151	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e63059	10.1371/journal.pone.0063059	http://dx.doi.org/10.1371/journal.pone.0063059			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667573	Green Published, gold, Green Submitted			2022-12-27	WOS:000319654700105
J	Neto, JM; Gordinho, L; Belda, EJ; Marin, M; Monros, JS; Fearon, P; Crates, R				Neto, Julio M.; Gordinho, Luis; Belda, Eduardo J.; Marin, Marcial; Monros, Juan S.; Fearon, Peter; Crates, Ross			Phenotypic Divergence among West European Populations of Reed Bunting Emberiza schoeniclus: The Effects of Migratory and Foraging Behaviours	PLOS ONE			English	Article							BILL SIZE; SEXUAL-DIMORPHISM; WING-LENGTH; BODY-SIZE; MORPHOLOGY; SPECIATION; EVOLUTION; TRAITS; SHAPE; PASSERINES	Divergent selection and local adaptation are responsible for many phenotypic differences between populations, potentially leading to speciation through the evolution of reproductive barriers. Here we evaluated the morphometric divergence among west European populations of Reed Bunting in order to determine the extent of local adaptation relative to two important selection pressures often associated with speciation in birds: migration and diet. We show that, as expected by theory, migratory E. s. schoeniclus had longer and more pointed wings and a slightly smaller body mass than the resident subspecies, with the exception of E. s. lusitanica, which despite having rounder wings was the smallest of all subspecies. Tail length, however, did not vary according to the expectation (shorter tails in migrants) probably because it is strongly correlated with wing length and might take longer to evolve. E. s. witherbyi, which feed on insects hiding inside reed stems during the winter, had a very thick, stubby bill. In contrast, northern populations, which feed on seeds, had thinner bills. Despite being much smaller, the southern E. s. lusitanica had a significantly thicker, longer bill than migratory E. s. schoeniclus, whereas birds from the UK population had significantly shorter, thinner bills. Geometric morphometric analyses revealed that the southern subspecies have a more convex culmen than E. s. schoeniclus, and E. s. lusitanica differs from the nominate subspecies in bill shape to a greater extent than in linear bill measurements, especially in males. Birds with a more convex culmen are thought to exert a greater strength at the bill tip, which is in agreement with their feeding technique. Overall, the three subspecies occurring in Western Europe differ in a variety of traits following the patterns predicted from their migratory and foraging behaviours, strongly suggesting that these birds have became locally adapted through natural selection.	[Neto, Julio M.; Gordinho, Luis] Lund Univ, Dept Biol, MEMEG, Mol Ecol & Evolut Lab, Lund, Sweden; [Neto, Julio M.; Gordinho, Luis] Univ Porto, CIBIO UP Ctr Invest Biodiversidade & Recursos Gen, Vairao, Portugal; [Belda, Eduardo J.; Marin, Marcial] Univ Politecn Valencia, Inst Invest Gest Integrada Zonas Costeras, E-46071 Valencia, Spain; [Monros, Juan S.] Univ Valencia, Inst Cavanilles Biodivers & Evolutionary Biol, Paterna, Spain; [Fearon, Peter] Bootle, Liverpool, Merseyside, England; [Crates, Ross] Univ Oxford, Dept Zool, Edward Grey Inst, Oxford OX1 3PS, England	Lund University; Universidade do Porto; Universitat Politecnica de Valencia; University of Valencia; University of Oxford	Neto, JM (corresponding author), Lund Univ, Dept Biol, MEMEG, Mol Ecol & Evolut Lab, Lund, Sweden.	julio.m.neto@gmail.com	Neto, Júlio Manuel/D-1853-2009; Monros, Juan/AAA-3726-2020; Belda, Eduardo/A-6684-2013; de Oliveira Gordinho, Luís/C-9164-2009; Monros, Juan S/L-9750-2014; Crates, Ross/AAG-2161-2021	Neto, Júlio Manuel/0000-0002-4855-3988; Monros, Juan/0000-0002-0952-2089; Belda, Eduardo/0000-0003-1995-1271; de Oliveira Gordinho, Luís/0000-0003-0413-6346; Monros, Juan S/0000-0002-0952-2089; 	ICETA, University of Porto; Portuguese Foundation for Science and Technology [SFRH/BD/64645/2009, SFRH/BPD/40667/2007]; Ministerio de Ciencia e Innovacion (Spain) [CGL2005-02041/BOS, CGL2010-21933-C02-02]	ICETA, University of Porto; Portuguese Foundation for Science and Technology(Portuguese Foundation for Science and Technology); Ministerio de Ciencia e Innovacion (Spain)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	Some fieldwork in Portugal was supported financially by ICETA, University of Porto. LG and JMN were supported financially by the Portuguese Foundation for Science and Technology through grants SFRH/BD/64645/2009 and SFRH/BPD/40667/2007, respectively. JSM and EJB were funded by the projects CGL2005-02041/BOS and CGL2010-21933-C02-02 granted by Ministerio de Ciencia e Innovacion (Spain). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atienza JC, 2006, ESCRIBANO PALUSTRE E; Baldwin MW, 2010, J EVOLUTION BIOL, V23, P1050, DOI 10.1111/j.1420-9101.2010.01975.x; Ballentine B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010229; Bearhop S, 2005, SCIENCE, V310, P502, DOI 10.1126/science.1115661; Belda EJ, 2009, ARDEOLA, V56, P85; Benkman CW, 2003, EVOLUTION, V57, P1176; Bensch S, 2009, MOL ECOL, V18, P3087, DOI 10.1111/j.1365-294X.2009.04210.x; Berns CM, 2010, AUK, V127, P626, DOI 10.1525/auk.2010.09213; Byers C, 1995, SPARROWS BUNTINGS GU; Clements J.F., 2011, CLEMENTS CHECKLIST B; Cooper IA, 2011, EVOLUTION, V65, P2553, DOI 10.1111/j.1558-5646.2011.01332.x; Copete JL, 1999, BIRD STUDY, V46, P100, DOI 10.1080/00063659909461119; Cramp S., 1994, HDB BIRDS EUROPE MID, V9; De La Puente Javier, 2001, Ringing and Migration, V20, P221; del Hoyo J., 2011, HDB BIRDS WORLD; Forschler MI, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018732; Foster DJ, 2008, J EVOLUTION BIOL, V21, P263, DOI 10.1111/j.1420-9101.2007.01449.x; Funk DJ, 2006, P NATL ACAD SCI USA, V103, P3209, DOI 10.1073/pnas.0508653103; Gosler AG, 1998, BIRD STUDY, V45, P92, DOI 10.1080/00063659809461082; Grant PR, 2002, SCIENCE, V296, P707, DOI 10.1126/science.1070315; Grapputo A, 1998, MOL ECOL, V7, P1173, DOI 10.1046/j.1365-294x.1998.00441.x; Greenberg R, 2012, EVOLUTION, V66, P3825, DOI 10.1111/j.1558-5646.2012.01726.x; Greenberg R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040933; Greenberg R, 2012, ECOGRAPHY, V35, P146, DOI 10.1111/j.1600-0587.2011.07002.x; Greenberg R, 2010, ECOLOGY, V91, P2428, DOI 10.1890/09-1136.1; Hedenstrom A, 2008, PHILOS T R SOC B, V363, P287, DOI 10.1098/rstb.2007.2140; IBM Corp, 2011, IBM SPSS STAT WIND V; Irwin Darren E., 2005, P27; JENNI L, 1989, BIRD STUDY, V36, P1, DOI 10.1080/00063658909476996; KAISER A, 1993, J FIELD ORNITHOL, V64, P246; Kaliontzopoulou A, 2007, J MORPHOL, V268, P152, DOI 10.1002/jmor.10494; Keller LF, 2001, HEREDITY, V87, P325, DOI 10.1046/j.1365-2540.2001.00900.x; Klingenberg CP, 1996, NATO ADV SCI INST SE, V284, P23; Kozak GM, 2011, P ROY SOC B-BIOL SCI, V278, P2604, DOI 10.1098/rspb.2010.2466; Kvist L, 2011, J ORNITHOL, V152, P681, DOI 10.1007/s10336-011-0646-9; Lleonart J, 2000, J THEOR BIOL, V205, P85, DOI 10.1006/jtbi.2000.2043; Marcus LF, 1996, NATO ASI SERIES A; Matessi G, 2000, J AVIAN BIOL, V31, P96, DOI 10.1034/j.1600-048X.2000.310113.x; Matessi G, 2002, BIOL J LINN SOC, V75, P21, DOI 10.1046/j.1095-8312.2002.00003.x; Mila B, 2008, CONDOR, V110, P335, DOI 10.1525/cond.2008.8396; Navarro J, 2009, ZOOLOGY, V112, P128, DOI 10.1016/j.zool.2008.05.001; Orlowski G, 2007, AGR ECOSYST ENVIRON, V118, P244, DOI 10.1016/j.agee.2006.05.026; Orlowski G, 2013, BIOL J LINN SOC, V108, P429, DOI 10.1111/j.1095-8312.2012.02026.x; Perez-Tris J, 2003, BIRD STUDY, V50, P146, DOI 10.1080/00063650309461306; Podos J, 2001, NATURE, V409, P185, DOI 10.1038/35051570; Prys-Jones R.P., 1984, Gerfaut, V74, P15; Rohlf F. J., 2010, MORPHOMETRICS SUNY S; Rohlf F. J., 2003, TPSSMALL VERSION 1 2; ROHLF F. J., 2010, TPSDIG SUNY STONY BR; ROHLF FJ, 1990, SYST ZOOL, V39, P40, DOI 10.2307/2992207; ROHLF FJ, 1993, TRENDS ECOL EVOL, V8, P129, DOI 10.1016/0169-5347(93)90024-J; Rohlf FJ, 1999, J CLASSIF, V16, P197, DOI 10.1007/s003579900054; Rohlf FJ, 2010, TPS UTILITY PROGRAM; Rohlf FJ, 2010, TPSDIG VERSION 2 16; Rohwer S, 2011, AUK, V128, P419, DOI 10.1525/auk.2011.10176; Ruegg KC, 2002, P ROY SOC B-BIOL SCI, V269, P1375, DOI 10.1098/rspb.2002.2032; Ryan PG, 2007, SCIENCE, V315, P1420, DOI 10.1126/science.1138829; Servedio MR, 2011, TRENDS ECOL EVOL, V26, P389, DOI 10.1016/j.tree.2011.04.005; Shaw KL, 2011, GENETICA, V139, P649, DOI 10.1007/s10709-011-9562-4; STEINBACHER F., 1930, JOUR ORNITHOLOGIE, V78, P471, DOI 10.1007/BF01953149; Svensson L., 1992, IDENTIFICATION GUIDE; Tarka M, 2012, THESIS LUND U SWEDEN; Tarka M, 2010, P ROY SOC B-BIOL SCI, V277, P2361, DOI 10.1098/rspb.2010.0033; van Doorn GS, 2009, SCIENCE, V326, P1704, DOI 10.1126/science.1181661; VAURIE CHARLES, 1956, AMER MUS NOVITATES, V1795, P1; VAURIE CHARLES, 1958, AMER MUS NOVITATES, V1898., P1; Via S, 2009, P NATL ACAD SCI USA, V106, P9939, DOI 10.1073/pnas.0901397106; Wernham C., 2002, MIGRATION ATLAS MOVE; Whitlock MC, 2008, MOL ECOL, V17, P1885, DOI 10.1111/j.1365-294X.2008.03712.x; Winker Kevin, 2010, Ornithological Monographs, V67, P6; Zelditch M. L., 2004, GEOMETRIC MORPHOMETR; Zink RM, 2008, J ORNITHOL, V149, P399, DOI 10.1007/s10336-008-0276-z	72	17	20	0	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e63248	10.1371/journal.pone.0063248	http://dx.doi.org/10.1371/journal.pone.0063248			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667594	Green Submitted, Green Published, gold			2022-12-27	WOS:000319654700124
J	Shimmura-Tomita, M; Wang, MC; Taniguchi, H; Akiba, H; Yagita, H; Hori, J				Shimmura-Tomita, Machiko; Wang, Mingcong; Taniguchi, Hiroko; Akiba, Hisaya; Yagita, Hideo; Hori, Junko			Galectin-9-Mediated Protection from Allo-Specific T Cells as a Mechanism of Immune Privilege of Corneal Allografts	PLOS ONE			English	Article							ALLOIMMUNE RESPONSES; ANTERIOR-CHAMBER; GRAFT FAILURE; AQUEOUS-HUMOR; FAS LIGAND; TIM-3; INDUCTION; APOPTOSIS; ANTIGENS; MICE	The eye is an immune-privileged organ, and corneal transplantation is therefore one of the most successful organ transplantation. The immunosuppressive intraocular microenvironment is known as one of the mechanisms underlying immune privilege in the eye. T-cell immunoglobulin and mucin domain (Tim)-3 is a regulatory molecule for T-cell function, and galectin (Gal)-9 is a Tim-3 ligand. We investigated the role of this pathway in establishing the immune-privileged status of corneal allografts in mice. Gal-9 is constitutively expressed on the corneal epithelium, endothelium and iris-ciliary body in normal mouse eyes and eyes bearing surviving allografts, and Tim-3 was expressed on CD8 T cells infiltrating the allografts. Allograft survival in recipients treated with anti-Tim-3 monoclonal antibody (mAb) or anti-Gal-9 mAb was significantly shorter than that in control recipients. In vitro, destruction of corneal endothelial cells by allo-reactive T cells was enhanced when the cornea was pretreated with anti-Gal-9 mAb. Blockade of Tim-3 or Gal-9 did not abolish anterior chamber-associated immune deviation. We propose that constitutive expression of Gal-9 plays an immunosuppressive role in corneal allografts. Gal-9 expressed on corneal endothelial cells protects them from destruction by allo-reactive T cells within the cornea.	[Shimmura-Tomita, Machiko; Wang, Mingcong; Taniguchi, Hiroko; Hori, Junko] Nippon Med Sch, Dept Ophthalmol, Tokyo 113, Japan; [Shimmura-Tomita, Machiko] Jichi Med Univ, Saitama Med Ctr, Dept Ophthalmol, Saitama, Japan; [Shimmura-Tomita, Machiko] Ichikawa Gen Hosp, Tokyo Dent Coll, Dept Ophthalmol, Ichikawa, Chiba, Japan; [Akiba, Hisaya; Yagita, Hideo] Juntendo Univ, Sch Med, Dept Immunol, Tokyo 113, Japan	Nippon Medical School; Jichi Medical University; Tokyo Dental College; Juntendo University	Shimmura-Tomita, M (corresponding author), Nippon Med Sch, Dept Ophthalmol, 1-1-5 Sendagi, Tokyo 113, Japan.	machiko@jichi.ac.jp	Hori, Junko/AAB-9857-2019	Hori, Junko/0000-0002-4248-5742; TANIGUCHI, HIROKO/0000-0002-1473-6276	Japan society for the promotion of science [23592619]; Grants-in-Aid for Scientific Research [25461503] Funding Source: KAKEN	Japan society for the promotion of science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work had supported by Grant-in-Aid for Scientific Research (KAKENHI) from the Japan society for the promotion of science. The grant number is 23592619 and the URL is http://www.jsps.go.jp/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson AC, 2007, SCIENCE, V318, P1141, DOI 10.1126/science.1148536; Apte RS, 1998, J IMMUNOL, V160, P5693; BARKER CF, 1977, ADV IMMUNOL, V25, P1; BOISJOLY HM, 1993, OPHTHALMOLOGY, V100, P1728; Fukushima A, 2008, INT ARCH ALLERGY IMM, V146, P36, DOI 10.1159/000112501; Geng H, 2006, J IMMUNOL, V176, P1411, DOI 10.4049/jimmunol.176.3.1411; GRIFFITH TS, 1995, SCIENCE, V270, P1189, DOI 10.1126/science.270.5239.1189; Gupta S, 2012, J CLIN INVEST; Gupta S, 2012, J CLIN INVEST, V122, P2395, DOI 10.1172/JCI45138; Hamrah P, 2002, INVEST OPHTH VIS SCI, V43, P639; Hirashima M, 2002, GLYCOCONJUGATE J, V19, P593, DOI 10.1023/B:GLYC.0000014090.63206.2f; Hirofumi A, 2002, J IMMUNOL, V169, P5912, DOI 10.4049/jimmunol.169.10.5912; Hori J, 2000, INVEST OPHTH VIS SCI, V41, P3032; Hori J, 2003, STEM CELLS, V21, P405, DOI 10.1634/stemcells.21-4-405; Hori J, 2001, INVEST OPHTH VIS SCI, V42, P1820; Hori J, 2000, INVEST OPHTH VIS SCI, V41, P443; Hori J, 2006, J IMMUNOL, V177, P5928, DOI 10.4049/jimmunol.177.9.5928; Hori J, 2010, INVEST OPHTH VIS SCI, V51, P6556, DOI 10.1167/iovs.09-4959; Kaiser C J, 1989, Reg Immunol, V2, P42; KAPLAN HJ, 1977, J IMMUNOL, V118, P809; KENNEDY MC, 1995, J CLIN INVEST, V95, P82, DOI 10.1172/JCI117679; MEDAWAR PB, 1948, BRIT J EXP PATHOL, V29, P58; Monney L, 2002, NATURE, V415, P536, DOI 10.1038/415536a; Namba K, 2002, J LEUKOCYTE BIOL, V72, P946; Niederkorn J Y, 1990, Adv Immunol, V48, P191, DOI 10.1016/S0065-2776(08)60755-5; Oikawa T, 2006, J IMMUNOL, V177, P4281, DOI 10.4049/jimmunol.177.7.4281; Rodriguez-Manzanet R, 2009, IMMUNOL REV, V229, P259, DOI 10.1111/j.1600-065X.2009.00772.x; Sabatos CA, 2003, NAT IMMUNOL, V4, P1102, DOI 10.1038/ni988; Sanchez-Fueyo A, 2003, NAT IMMUNOL, V4, P1093, DOI 10.1038/ni987; Sehrawat S, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000882; Sehrawat S, 2009, J IMMUNOL, V182, P3191, DOI 10.4049/jimmunol.0803673; Seki M, 2008, CLIN IMMUNOL, V127, P78, DOI 10.1016/j.clim.2008.01.006; Seki M, 2007, ARTHRITIS RHEUM-US, V56, P3968, DOI 10.1002/art.23076; Sheibani N, 2000, BIOCHEM BIOPH RES CO, V267, P257, DOI 10.1006/bbrc.1999.1903; Sohn JH, 2000, INVEST OPHTH VIS SCI, V41, P4195; SONODA Y, 1993, J IMMUNOL, V150, P1727; SONODA Y, 1992, TRANSPLANTATION, V54, P694, DOI 10.1097/00007890-199210000-00026; Sosnova M, 2005, STEM CELLS, V23, P507, DOI 10.1634/stemcells.2004-0291; STREILEIN JW, 1979, NATURE, V282, P326, DOI 10.1038/282326a0; STREILEIN JW, 1987, FASEB J, V1, P199, DOI 10.1096/fasebj.1.3.2957263; Stuart PM, 1997, J CLIN INVEST, V99, P396, DOI 10.1172/JCI119173; Sugita S, 2000, BRIT J OPHTHALMOL, V84, P1130, DOI 10.1136/bjo.84.10.1130; Taylor AW, 1998, INVEST OPHTH VIS SCI, V39, P1372; TRESELER PA, 1986, TRANSPLANTATION, V41, P248, DOI 10.1097/00007890-198602000-00022; Ueno T, 2008, J CLIN INVEST, V118, P742, DOI 10.1172/JCI32451; Vaitaitis GM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038708; WANG HM, 1987, INVEST OPHTH VIS SCI, V28, P1383; WHITSETT CF, 1984, INVEST OPHTH VIS SCI, V25, P519; WILBANKS GA, 1992, EUR J IMMUNOL, V22, P165, DOI 10.1002/eji.1830220125; WILLIAMS KA, 1992, OPHTHALMOLOGY, V99, P403; WILLIAMS KA, 1985, INVEST OPHTH VIS SCI, V26, P23; WILSON SE, 1990, SURV OPHTHALMOL, V34, P325, DOI 10.1016/0039-6257(90)90110-H; Xiao S, 2007, J EXP MED, V204, P1691, DOI 10.1084/jem.20062498; Zhou Q, 2011, BLOOD, V117, P4501, DOI 10.1182/blood-2010-10-310425; Zhu C, 2005, NAT IMMUNOL, V6, P1245, DOI 10.1038/ni1271	55	26	30	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e63620	10.1371/journal.pone.0063620	http://dx.doi.org/10.1371/journal.pone.0063620			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667648	Green Published, gold			2022-12-27	WOS:000319654700169
J	Andrade, BB; Kumar, NP; Mayer-Barber, KD; Barber, DL; Sridhar, R; Rekha, VVB; Jawahar, MS; Nutman, TB; Sher, A; Babu, S				Andrade, Bruno B.; Kumar, Nathella Pavan; Mayer-Barber, Katrin D.; Barber, Daniel L.; Sridhar, Rathinam; Rekha, Vaithilingam V. Banu; Jawahar, Mohideen S.; Nutman, Thomas B.; Sher, Alan; Babu, Subash			Plasma Heme Oxygenase-1 Levels Distinguish Latent or Successfully Treated Human Tuberculosis from Active Disease	PLOS ONE			English	Article							PULMONARY TUBERCULOSIS; CARBON-MONOXIDE; INFECTION; DIAGNOSIS; NEOPTERIN; PROMOTES	Background: Tuberculosis (TB) is associated with oxidative stress and the induction of host anti-oxidants to counteract this response. Heme oxygenase-1 (HO-1) is a critical promoter of cytoprotection in diverse disease models including mycobacterial infection. Nevertheless, the pattern of expression of HO-1 in human tuberculosis has not been studied. Here, we examine expression of HO-1 in M. tuberculosis-exposed and -infected individuals and test its ability to distinguish active from latent and successfully treated TB cases. In addition, we assess correlations between plasma levels of HO-1 and cytokines closely associated with the immunopathogenesis of TB. Methods: Cross-sectional and longitudinal analyses of levels of HO-1, acute phase proteins and pro-inflammatory cytokines were performed in plasma samples from individuals with active pulmonary, extra-pulmonary or latent TB infection and healthy controls as part of a prospective cohort study in South India. Results: Systemic levels of HO-1 were dramatically increased in individuals with active pulmonary and extra-pulmonary tuberculosis and particularly those with bilateral lung lesions and elevated bacillary loads in sputum. HO-1 levels effectively discriminated active from latent tuberculosis with higher predictive values than either C-reactive protein or serum amyloid protein. Moreover, there was a marked reduction in HO-1 levels in active TB cases following anti-tuberculous therapy but not in those who failed treatment. Pulmonary TB patients displaying the highest concentrations of HO-1 in plasma exhibited significantly elevated plasma levels of interleukin (IL)-10, interferon (IFN)-gamma and IL-17 and diminished levels of tumor necrosis factor (TNF)-alpha. Conclusion: These findings establish HO-1 levels as a potentially useful parameter for distinguishing active from latent or treated pulmonary tuberculosis, that is superior in this respect to the measurement of other acute inflammatory proteins.	[Andrade, Bruno B.; Mayer-Barber, Katrin D.; Barber, Daniel L.; Nutman, Thomas B.; Sher, Alan; Babu, Subash] NIH, Parasit Dis Lab, Bethesda, MD 20892 USA; [Kumar, Nathella Pavan; Babu, Subash] Int Ctr Excellence Res, Natl Inst Hlth, Madras, Tamil Nadu, India; [Sridhar, Rathinam] Govt Stanley Med Hosp, Madras, Tamil Nadu, India; [Rekha, Vaithilingam V. Banu; Jawahar, Mohideen S.] Natl Inst Res TB, Madras, Tamil Nadu, India; [Babu, Subash] NCI, Sci Applicat Int Corp, Frederick, MD 21701 USA	National Institutes of Health (NIH) - USA; Indian Council of Medical Research (ICMR); ICMR - National Institute for Research in Tuberculosis (NIRT); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC)	Andrade, BB (corresponding author), NIH, Parasit Dis Lab, Bethesda, MD 20892 USA.	bruno.andrade@nih.gov	Babu, Subash/GXG-4746-2022; Andrade, Bruno/J-9111-2012; Kumar, Nathella Pavan/AAU-2328-2021; Andrade, Bruno/AAI-2248-2020	Andrade, Bruno/0000-0001-6833-3811; 	Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001065, T32AI007610, ZIAAI000843, ZIAAI000197] Funding Source: NIH RePORTER	Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health. The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the US Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azzurri A, 2005, MICROBES INFECT, V7, P1, DOI 10.1016/j.micinf.2004.09.004; Cannas A, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-333; CHAN CHS, 1995, EUR RESPIR J, V8, P70, DOI 10.1183/09031936.95.08010070; Davies PDO, 2008, INT J TUBERC LUNG D, V12, P1226; DEBEER FC, 1984, THORAX, V39, P196, DOI 10.1136/thx.39.3.196; Demir T, 2002, INT J TUBERC LUNG D, V6, P155; Deveci F, 2005, MEDIAT INFLAMM, P256, DOI 10.1155/MI.2005.256; Flynn JL, 1998, J IMMUNOL, V160, P1796; Frahm M, 2011, TUBERCULOSIS, V91, P250, DOI 10.1016/j.tube.2011.02.006; Gopi PG, 2003, INT J TUBERC LUNG D, V7, P1154; Gozzelino R, 2010, ANNU REV PHARMACOL, V50, P323, DOI 10.1146/annurev.pharmtox.010909.105600; Hosp M, 1997, LUNG, V175, P265, DOI 10.1007/PL00007573; Immanuel C, 2001, INT J TUBERC LUNG D, V5, P185; Kumar A, 2008, J BIOL CHEM, V283, P18032, DOI 10.1074/jbc.M802274200; Lagrange PH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043739; Lee TS, 2002, NAT MED, V8, P240, DOI 10.1038/nm0302-240; Luz NF, 2012, J IMMUNOL, V188, P4460, DOI 10.4049/jimmunol.1103072; Madebo T, 2003, AM J CLIN NUTR, V78, P117, DOI 10.1093/ajcn/78.1.117; Mazurek Gerald H., 2005, Morbidity and Mortality Weekly Report, V54, P49; Mendonca VRR, 2012, INFECT IMMUN, V80, P1445, DOI 10.1128/IAI.05933-11; Morse D, 2005, AM J RESP CRIT CARE, V172, P660, DOI 10.1164/rccm.200404-465SO; Pai M, 2007, CLIN INFECT DIS, V44, P74, DOI 10.1086/509927; Redford PS, 2011, MUCOSAL IMMUNOL, V4, P261, DOI 10.1038/mi.2011.7; Regev D, 2012, LAB INVEST, V92, P1541, DOI 10.1038/labinvest.2012.125; Saukkonen K, 2010, SHOCK, V34, P558, DOI 10.1097/SHK.0b013e3181e14de9; Shiloh MU, 2008, CELL HOST MICROBE, V3, P323, DOI 10.1016/j.chom.2008.03.007; Taylor Z, 2000, INT J TUBERC LUNG D, V4, P931; TENHUNEN R, 1968, P NATL ACAD SCI USA, V61, P748, DOI 10.1073/pnas.61.2.748; Verbon A, 1999, CLIN EXP IMMUNOL, V115, P110; Wallis RS, 2009, LANCET INFECT DIS, V9, P162, DOI 10.1016/S1473-3099(09)70042-8; WHO, 2010, TREATMENT OF TUBERCULOSIS: GUIDELINES, FOURTH EDITION, P1; WHO, 2012, WHO GLOB TUB REP 201	32	48	48	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2013	8	5							e62618	10.1371/journal.pone.0062618	http://dx.doi.org/10.1371/journal.pone.0062618			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	177QL	23671613	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000321390200031
J	Corcoran, AJ; Wagner, RD; Conner, WE				Corcoran, Aaron J.; Wagner, Ryan D.; Conner, William E.			Optimal Predator Risk Assessment by the Sonar-Jamming Arctiine Moth Bertholdia trigona	PLOS ONE			English	Article							BIG BROWN BAT; FLIGHT-INITIATION DISTANCE; PERCEIVED ECHO AMPLITUDES; SKINK EUMECES LATICEPS; AUTOMATIC GAIN-CONTROL; DOGBANE TIGER MOTH; ECHOLOCATING BATS; EPTESICUS-FUSCUS; BEHAVIOR; THREAT	Nearly all animals face a tradeoff between seeking food and mates and avoiding predation. Optimal escape theory holds that an animal confronted with a predator should only flee when benefits of flight (increased survival) outweigh the costs (energetic costs, lost foraging time, etc.). We propose a model for prey risk assessment based on the predator's stage of attack. Risk level should increase rapidly from when the predator detects the prey to when it commits to the attack. We tested this hypothesis using a predator - the echolocating bat - whose active biosonar reveals its stage of attack. We used a prey defense - clicking used for sonar jamming by the tiger moth Bertholdia trigona-that can be readily studied in the field and laboratory and is enacted simultaneously with evasive flight. We predicted that prey employ defenses soon after being detected and targeted, and that prey defensive thresholds discriminate between legitimate predatory threats and false threats where a nearby prey is attacked. Laboratory and field experiments using playbacks of ultrasound signals and naturally behaving bats, respectively, confirmed our predictions. Moths clicked soon after bats detected and targeted them. Also, B. trigona clicking thresholds closely matched predicted optimal thresholds for discriminating legitimate and false predator threats for bats using search and approach phase echolocation - the period when bats are searching for and assessing prey. To our knowledge, this is the first quantitative study to correlate the sensory stimuli that trigger defensive behaviors with measurements of signals provided by predators during natural attacks in the field. We propose theoretical models for explaining prey risk assessment depending on the availability of cues that reveal a predator's stage of attack.	[Corcoran, Aaron J.; Wagner, Ryan D.; Conner, William E.] Wake Forest Univ, Dept Biol, Winston Salem, NC 27109 USA	Wake Forest University	Corcoran, AJ (corresponding author), Wake Forest Univ, Dept Biol, Winston Salem, NC 27109 USA.	corcaj8@wfu.edu			National Science Foundation [IOS-0615164, IOS-0951160]	National Science Foundation(National Science Foundation (NSF))	Funding was provided by National Science Foundation (www.nsf.gov) grant number IOS-0615164 and IOS-0951160 to W. E. C. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, R LANG ENV STAT COMP; Barber JR, 2006, J EXP BIOL, V209, P2637, DOI 10.1242/jeb.02295; Barber JR, 2007, P NATL ACAD SCI USA, V104, P9331, DOI 10.1073/pnas.0703627104; Barber JR, 2009, J EXP BIOL, V212, P2141, DOI 10.1242/jeb.029991; Bateman PW, 2011, J ZOOL, V285, P316, DOI 10.1111/j.1469-7998.2011.00846.x; Bazley E, 1976, AC74 NAT PHYS LAB AC; Blumstein DT, 2010, BEHAV ECOL, V21, P440, DOI 10.1093/beheco/arq030; Blumstein DT, 2005, J APPL ECOL, V42, P943, DOI 10.1111/j.1365-2664.2005.01071.x; Blumstein DT, 2003, J WILDLIFE MANAGE, V67, P852, DOI 10.2307/3802692; Boonman A, 2002, J EXP BIOL, V205, P2865; Bradley AP, 1997, PATTERN RECOGN, V30, P1145, DOI 10.1016/S0031-3203(96)00142-2; Broom M, 2005, BEHAV ECOL, V16, P534, DOI 10.1093/beheco/ari024; Caro Tim, 2005, pXIII; Conner WE, 2012, ANNU REV ENTOMOL, V57, P21, DOI 10.1146/annurev-ento-121510-133537; Cooper WE, 1997, COPEIA, P613, DOI 10.2307/1447569; Cooper WE, 2005, CAN J ZOOL, V83, P1045, DOI 10.1139/Z05-104; Cooper WE, 1997, HERPETOLOGICA, V53, P464; Cooper WE, 1998, BEHAVIOUR, V135, P55; Cooper WE, 2007, J THEOR BIOL, V244, P59, DOI 10.1016/j.jtbi.2006.07.011; William EC, 2006, ETHOLOGY, V112, P858, DOI 10.1111/j.1439-0310.2006.01240.x; Cooper WE, 2012, BEHAV ECOL, V23, P790, DOI 10.1093/beheco/ars032; Cooper William E. Jr., 2009, Current Zoology, V55, P123; Corcoran A. J., 2007, THESIS HUMBOLDT STAT; Corcoran AJ, 2012, J EXP BIOL, V215, P4278, DOI 10.1242/jeb.076943; Corcoran AJ, 2011, J EXP BIOL, V214, P2416, DOI 10.1242/jeb.054783; Corcoran AJ, 2010, CURR ZOOL, V56, P358, DOI 10.1093/czoolo/56.3.358; Corcoran AJ, 2009, SCIENCE, V325, P325, DOI 10.1126/science.1174096; Elemans CPH, 2011, SCIENCE, V333, P1885, DOI 10.1126/science.1207309; Endler JA., 1986, PREDATORPREY RELATIO, P169; Fullard JH, 2007, J EXP BIOL, V210, P2481, DOI 10.1242/jeb.001909; Fullard JH, 2003, J EXP BIOL, V206, P281, DOI 10.1242/jeb.00085; FULLARD JH, 1984, J COMP PHYSIOL, V154, P249, DOI 10.1007/BF00604990; FULLARD JH, 1979, J COMP PHYSIOL, V129, P79, DOI 10.1007/BF00679914; FULLARD JH, 1994, J EXP BIOL, V194, P285; Ghose K, 2003, J ACOUST SOC AM, V114, P1120, DOI 10.1121/1.1589754; Goerlitz HR, 2010, CURR BIOL, V20, P1568, DOI 10.1016/j.cub.2010.07.046; Griffin D. R., 1960, Animal Behaviour, V8, P141, DOI 10.1016/0003-3472(60)90022-1; HARTLEY DJ, 1992, J ACOUST SOC AM, V91, P1120, DOI 10.1121/1.402639; HARTLEY DJ, 1992, J ACOUST SOC AM, V91, P1133, DOI 10.1121/1.402640; HARTLEY DJ, 1989, J ACOUST SOC AM, V85, P1348, DOI 10.1121/1.397466; Helfman GS, 1997, ETHOLOGY, V103, P369; HELFMAN GS, 1989, BEHAV ECOL SOCIOBIOL, V24, P47, DOI 10.1007/BF00300117; Hiryu S, 2007, J ACOUST SOC AM, V121, P1749, DOI 10.1121/1.2431337; Holderied MW, 2003, P ROY SOC B-BIOL SCI, V270, P2293, DOI 10.1098/rspb.2003.2487; Hoy RR, 1998, SPR HDB AUD, V10, P1; Hristov NI, 2005, NATURWISSENSCHAFTEN, V92, P164, DOI 10.1007/s00114-005-0611-7; Jakobsen L, 2010, P NATL ACAD SCI USA, V107, P13930, DOI 10.1073/pnas.1006630107; KICK SA, 1984, J NEUROSCI, V4, P2725; LIMA SL, 1990, CAN J ZOOL, V68, P619, DOI 10.1139/z90-092; Moss CF, 2001, J ACOUST SOC AM, V110, P2207, DOI 10.1121/1.1398051; Pinhiero J., 2009, NLME LINEAR NONLINEA, P1; Ratcliffe JM, 2005, J EXP BIOL, V208, P4689, DOI 10.1242/jeb.01927; Ratcliffe JM, 2008, NATURE, V455, P96, DOI 10.1038/nature07087; Ratcliffe JM, 2009, BIOL LETTERS, V5, P368, DOI 10.1098/rsbl.2009.0079; Roeder KD, 1967, NERVE CELLS INSECT B; Sokal RR, 1994, BIOMETRY PRINCIPLES, V3rd; Stankowich T, 2005, P ROY SOC B-BIOL SCI, V272, P2627, DOI 10.1098/rspb.2005.3251; Stankowich T, 2006, BEHAV ECOL, V17, P246, DOI 10.1093/beheco/arj020; STAPELLS DR, 1982, J ACOUST SOC AM, V72, P74, DOI 10.1121/1.388026; Svoboda T, 2005, PRESENCE-VIRTUAL AUG, V14, P407, DOI 10.1162/105474605774785325; Tabachnick B.G., 2007, USING MULTIVARIATE S, VVolume 5, P481; YDENBERG RC, 1986, ADV STUD BEHAV, V16, P229, DOI 10.1016/S0065-3454(08)60192-8; Zuur Alain F., 2009, P1	63	15	15	2	81	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2013	8	5							e63609	10.1371/journal.pone.0063609	http://dx.doi.org/10.1371/journal.pone.0063609			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	177QL	23671686	Green Submitted, gold, Green Published			2022-12-27	WOS:000321390200052
J	Baker, M; Reynolds, LE; Robinson, SD; Lees, DM; Parsons, M; Elia, G; Hodivala-Dilke, K				Baker, Marianne; Reynolds, Louise E.; Robinson, Stephen D.; Lees, Delphine M.; Parsons, Maddy; Elia, George; Hodivala-Dilke, Kairbaan			Stromal Claudin14-Heterozygosity, but Not Deletion, Increases Tumour Blood Leakage without Affecting Tumour Growth	PLOS ONE			English	Article							TIGHT JUNCTION; VE-CADHERIN; SUBCELLULAR-LOCALIZATION; CLAUDIN-5 EXPRESSION; CELL-PROLIFERATION; ENDOTHELIAL-CELLS; ANGIOGENESIS; CANCER; GENE; MICE	The maintenance of endothelial cell-cell junctions is vital for the control of blood vessel leakage and is known to be important in the growth and maturation of new blood vessels during angiogenesis. Here we have investigated the role of a tight junction molecule, Claudin14, in tumour blood vessel leakage, angiogenesis and tumour growth. Using syngeneic tumour models our results showed that genetic ablation of Claudin14 was not sufficient to affect tumour blood vessel morphology or function. However, and surprisingly, Claudin14-heterozygous mice displayed several blood vessel-related phenotypes including: disruption of ZO-1-positive cell-cell junctions in tumour blood vessels; abnormal distribution of basement membrane laminin around tumour blood vessels; increased intratumoural leakage and decreased intratumoural hypoxia. Additionally, although total numbers of tumour blood vessels were increased in Claudin14-heterozygous mice, and in VEGF-stimulated angiogenesis ex vivo, the number of lumenated vessels was not changed between genotypes and this correlated with no difference in syngeneic tumour growth between wild-type, Claudin14-heterozygous and Claudin14-null mice. Lastly, Claudin14-heterozygosity, but not complete deficiency, also enhanced endothelial cell proliferation significantly. These data establish a new role for Claudin14 in the regulation of tumour blood vessel integrity and angiogenesis that is evident only after the partial loss of this molecule in Claudin14-heterozyous mice but not in Claudin14-null mice.	[Baker, Marianne; Reynolds, Louise E.; Lees, Delphine M.; Elia, George; Hodivala-Dilke, Kairbaan] Queen Mary Univ London, Barts Canc Inst, Ctr Tumour Biol, London, England; [Robinson, Stephen D.] Univ E Anglia, Sch Biol Sci, Norwich NR4 7TJ, Norfolk, England; [Parsons, Maddy] Kings Coll London, Randall Div Cell & Mol Biophys, London WC2R 2LS, England	University of London; Queen Mary University London; University of East Anglia; University of London; King's College London	Hodivala-Dilke, K (corresponding author), Queen Mary Univ London, Barts Canc Inst, Ctr Tumour Biol, London, England.	k.hodivala-dilke@qmul.ac.uk	Parsons, Maddy/B-2203-2013	Parsons, Maddy/0000-0002-2021-8379; Robinson, Stephen/0000-0002-6606-7588; Hodivala-Dilke, Kairbaan/0000-0002-2859-749X; Lees, Delphine M/0000-0002-2119-3978	Cancer Research UK [C8218/A12007]; Medical Research Council [G0901609]; Cancer Research UK [12007] Funding Source: researchfish; Worldwide Cancer Research [12-1068] Funding Source: researchfish; MRC [G0901609] Funding Source: UKRI	Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); Worldwide Cancer Research; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This study was supported by the Cancer Research UK, C8218/A12007 and the Medical Research Council G0901609. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrass CK, 2010, AM J PATHOL, V176, P839, DOI 10.2353/ajpath.2010.090570; Aurrand-Lions M, 2001, BLOOD, V98, P3699, DOI 10.1182/blood.V98.13.3699; Baker M, 2012, NAT PROTOC, V7, P89, DOI 10.1038/nprot.2011.435; Balda MS, 2009, BBA-BIOMEMBRANES, V1788, P761, DOI 10.1016/j.bbamem.2008.11.024; Belguith H, 2009, BIOCHEM BIOPH RES CO, V385, P1, DOI 10.1016/j.bbrc.2009.02.125; Ben-Yosef T, 2003, HUM MOL GENET, V12, P2049, DOI 10.1093/hmg/ddg210; Bertout JA, 2008, NAT REV CANCER, V8, P967, DOI 10.1038/nrc2540; Carmeliet P, 2005, ONCOLOGY-BASEL, V69, P4, DOI 10.1159/000088478; Carmeliet P, 1999, CELL, V98, P147, DOI 10.1016/S0092-8674(00)81010-7; Carmeliet P, 2000, NATURE, V407, P249, DOI 10.1038/35025220; Cattelino A, 2003, J CELL BIOL, V162, P1111, DOI 10.1083/jcb.200212157; Chouaib S, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00021; Delbaldo C, 2012, THER ADV MED ONCOL, V4, P9, DOI 10.1177/1758834011428147; DiPersio CM, 1997, J CELL BIOL, V137, P729, DOI 10.1083/jcb.137.3.729; Dorfel MJ, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/807356; Dudley AC, 2012, COLD SPRING HARB PER, V2, P1; Gavard J, 2008, NAT CELL BIOL, V10, P883, DOI 10.1038/ncb0808-883; Gerhardt H, 2003, CELL TISSUE RES, V314, P15, DOI 10.1007/s00441-003-0745-x; Glienke J, 2000, EUR J BIOCHEM, V267, P2820, DOI 10.1046/j.1432-1327.2000.01325.x; Gonzalez-Mariscal L, 2003, PROG BIOPHYS MOL BIO, V81, P1, DOI 10.1016/S0079-6107(02)00037-8; Gonzalez-Mariscal L, 2008, BBA-BIOMEMBRANES, V1778, P729, DOI 10.1016/j.bbamem.2007.08.018; Gonzalez-Mariscal L, 2007, PROG HISTOCHEM CYTO, V42, P1, DOI 10.1016/j.proghi.2007.01.001; Hall AP, 2006, TOXICOL PATHOL, V34, P763, DOI 10.1080/01926230600936290; Hou JH, 2012, ANN NY ACAD SCI, V1258, P185, DOI 10.1111/j.1749-6632.2012.06529.x; Kohler K, 2005, BIOL CELL, V97, P659; Kumar P, 2009, EXPERT REV MOL MED, V11, DOI 10.1017/S1462399409001112; Lamalice L, 2007, CIRC RES, V100, P782, DOI 10.1161/01.RES.0000259593.07661.1e; LESERVE AW, 1972, BRIT MED J, V1, P597, DOI 10.1136/bmj.1.5800.597; Liebner S, 2000, ACTA NEUROPATHOL, V100, P323, DOI 10.1007/s004010000180; Mandel I, 2012, J CELL MOL MED, V16, P765, DOI 10.1111/j.1582-4934.2011.01380.x; Marchiando AM, 2010, J CELL BIOL, V189, P111, DOI 10.1083/jcb.200902153; Morin PJ, 2005, CANCER RES, V65, P9603, DOI 10.1158/0008-5472.CAN-05-2782; Morita K, 1999, J CELL BIOL, V147, P185, DOI 10.1083/jcb.147.1.185; Nitta T, 2003, J CELL BIOL, V161, P653, DOI 10.1083/jcb.200302070; Osada T, 2011, J CEREBR BLOOD F MET, V31, P1972, DOI 10.1038/jcbfm.2011.99; Peters K, 2002, MICROVASC RES, V64, P334, DOI 10.1006/mvre.2002.2438; Rahner C, 2001, GASTROENTEROLOGY, V120, P411, DOI 10.1053/gast.2001.21736; Reynolds LE, 2006, METH MOLEC MED, V120, P503; Taddei A, 2008, NAT CELL BIOL, V10, P923, DOI 10.1038/ncb1752; Thomlinson R H, 1977, J Clin Pathol Suppl (R Coll Pathol), V11, P105; Tlsty TD, 2006, ANNU REV PATHOL-MECH, V1, P119, DOI 10.1146/annurev.pathol.1.110304.100224; Amerongen GPV, 2007, ARTERIOSCL THROM VAS, V27, P2332, DOI 10.1161/ATVBAHA.107.152322; Varia MA, 1998, GYNECOL ONCOL, V71, P270, DOI 10.1006/gyno.1998.5163; Zicha D, 1997, Methods Mol Biol, V75, P449	44	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2013	8	5							e62516	10.1371/journal.pone.0062516	http://dx.doi.org/10.1371/journal.pone.0062516			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145RZ	23675413	Green Published, gold, Green Submitted			2022-12-27	WOS:000319036100004
J	Chen, XM; Ding, GP; Gao, QH; Sun, J; Zhang, QQ; Du, LJ; Qiu, ZN; Wang, CJ; Zheng, F; Sun, BW; Ni, J; Feng, ZQ; Zhu, J				Chen, Ximin; Ding, Guipeng; Gao, Qihe; Sun, Jian; Zhang, Qianqian; Du, Lijian; Qiu, Zhenning; Wang, Changjun; Zheng, Feng; Sun, Bowang; Ni, Jian; Feng, Zhenqing; Zhu, Jin			A Human Anti-c-Met Fab Fragment Conjugated with Doxorubicin as Targeted Chemotherapy for Hepatocellular Carcinoma	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; DRUG CONJUGATE; MONOCLONAL-ANTIBODY; CANCER-THERAPY; DELIVERY; EXPRESSION; LIPOSOMES; IMMUNOCONJUGATE; CONSTRUCTION; INHIBITOR	c-Met is over-expressed in hepatocellular carcinoma(HCC) but is absent or expressed at low levels in normal tissues. Therefore we generated a novel conjugate of a human anti-c-Met Fab fragment (MetFab) with doxorubicin (DOX) and assessed whether it had targeted antitumor activity against HCC and reduced the side-effects of DOX. The MetFab was screened from human phage library, conjugated with DOX via chemical synthesis, and the conjugation MetFab-DOX was confirmed by HPLC. The drug release patterns, the binding efficacy, and cellular distribution of MetFab-DOX were assessed. MetFab-DOX was stable at pH7.2 PBS while release doxorubicin quickly at pH4.0, the binding efficacy of MetFab-DOX was similarly as MetFab, and the cellular distribution of the MetFab-DOX is distinct from free DOX. The cytotoxicity of MetFab-DOX was analyzed by the MTT method and the nude mouse HCC model. The MetFab-DOX demonstrated cytotoxic effects on c-Met expressing-tumor cells, but not on the cells without c-Met expression. MetFab-DOX exerted anti-tumor effect and significantly reduced the side effect of free DOX in mice model. Furthermore, the localization of conjugate was confirmed by immunofluorescence staining of tumor tissue sections and optical tumor imaging, respectively, and the tissue-distribution of drug was compared between free DOX and MetFab-DOX treatment by spectrofluorometer. MetFab-DOX can localize to the tumor tissue, and the concentration of doxorubicin in the tumor was higher after MetFab-DOX administration than after DOX administration. In summary, MetFab-DOX can target c-Met expressing HCC cells effectively and have obvious antitumor activity with decreased side-effects in preclinical models of HCC.	[Chen, Ximin; Ding, Guipeng; Zhang, Qianqian; Du, Lijian; Qiu, Zhenning; Feng, Zhenqing; Zhu, Jin] Nanjing Med Univ, Key Lab Antibody Tech, Minist Hlth, Dept Pathol, Nanjing, Jiangsu, Peoples R China; [Wang, Changjun; Zheng, Feng; Zhu, Jin] Huadong Med Inst Biotech, Nanjing, Jiangsu, Peoples R China; [Gao, Qihe; Sun, Jian; Sun, Bowang] Southeast Univ, Sch Chem & Chem Engn, Nanjing, Jiangsu, Peoples R China; [Ni, Jian] Nanjing Med Univ, Affiliated Hosp 2, Nanjing, Jiangsu, Peoples R China; [Feng, Zhenqing] Nanjing Med Univ, Jiangsu Key Lab Canc Biomarkers Prevent & Treatme, Ctr Canc, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University; Southeast University - China; Nanjing Medical University; Nanjing Medical University	Feng, ZQ (corresponding author), Nanjing Med Univ, Key Lab Antibody Tech, Minist Hlth, Dept Pathol, Nanjing, Jiangsu, Peoples R China.	fengzhenqing@njmu.edu.cn; zjsimmons@yahoo.com.cn			State Major Basic Research Development Program of China (973 Project) [2010CB933902]; Health Department of Jiangsu Province [H200938]	State Major Basic Research Development Program of China (973 Project)(National Basic Research Program of China); Health Department of Jiangsu Province	This work was supported by a grant from State Major Basic Research Development Program of China (973 Project, No. 2010CB933902) and a grant from Health Department of Jiangsu Province (H200938). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHMAD I, 1993, CANCER RES, V53, P1484; Alley SC, 2010, CURR OPIN CHEM BIOL, V14, P529, DOI 10.1016/j.cbpa.2010.06.170; Ayla Sule, 2011, Int J Cell Biol, V2011, P390238, DOI 10.1155/2011/390238; Blanc V, 2011, CLIN CANCER RES, V17, P6448, DOI 10.1158/1078-0432.CCR-11-0485; Bruix J, 2009, LANCET, V373, P614, DOI 10.1016/S0140-6736(09)60381-0; Burris HA, 2011, J CLIN ONCOL, V29, P398, DOI 10.1200/JCO.2010.29.5865; Cardillo TM, 2011, CLIN CANCER RES, V17, P3157, DOI 10.1158/1078-0432.CCR-10-2939; Carter PJ, 2008, CANCER J, V14, P154, DOI 10.1097/PPO.0b013e318172d704; Chari RVJ, 2008, ACCOUNTS CHEM RES, V41, P98, DOI 10.1021/ar700108g; Choueiri TK, 2013, J CLIN ONCOL, V31, P181, DOI 10.1200/JCO.2012.43.3383; de Claro RA, 2012, CLIN CANCER RES, V18, P5845, DOI 10.1158/1078-0432.CCR-12-1803; DiJoseph JF, 2005, CANCER IMMUNOL IMMUN, V54, P11, DOI 10.1007/s00262-004-0572-2; Eder JP, 2009, CLIN CANCER RES, V15, P2207, DOI 10.1158/1078-0432.CCR-08-1306; Erickson HK, 2010, BIOCONJUGATE CHEM, V21, P84, DOI 10.1021/bc900315y; Etrych T, 2007, J CONTROL RELEASE, V122, P31, DOI 10.1016/j.jconrel.2007.06.007; Feldman DR, 2013, INVEST NEW DRUGS; Fiume L, 2005, J HEPATOL, V43, P645, DOI 10.1016/j.jhep.2005.02.045; Goyal L, 2013, CLIN CANC RES; Hao HY, 2006, ANTICANCER RES, V26, P1947; Hay RV, 2005, CLIN CANCER RES, V11, p7064S, DOI 10.1158/1078-0432.CCR-1004-0014; Huan ML, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044116; Huang YF, 2009, CHEMBIOCHEM, V10, P862, DOI 10.1002/cbic.200800805; Inoh K, 2006, JPN J CLIN ONCOL, V36, P207, DOI 10.1093/jjco/hyl004; Iyer U, 2011, J PHARMACOL TOX MET, V64, P207, DOI 10.1016/j.vascn.2011.07.005; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jo MJ, 2000, J BIOL CHEM, V275, P8806, DOI 10.1074/jbc.275.12.8806; Knudsen BS, 2009, APPL IMMUNOHISTO M M, V17, P57, DOI 10.1097/PAI.0b013e3181816ae2; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lee HS, 1998, J BIOMED SCI, V5, P180, DOI 10.1159/000025329; Lee RJ, 2013, CANCER J, V19, P90, DOI 10.1097/PPO.0b013e318281e280; Liao YJ, 2005, MOL BIOTECHNOL, V31, P41, DOI 10.1385/MB:31:1:041; Lindegren S, 2011, CURR RADIOPHARM, V4, P248, DOI 10.2174/1874471011104030248; Liu XJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019848; Liu Z, 2013, IMMUNOL LETT, V149, P30, DOI 10.1016/j.imlet.2012.09.006; Llovet JM, 2003, LANCET, V362, P1907, DOI 10.1016/S0140-6736(03)14964-1; Lukyanov AN, 2004, J CONTROL RELEASE, V100, P135, DOI 10.1016/j.jconrel.2004.08.007; Mathew J, 2011, CURR OPIN ONCOL, V23, P594, DOI 10.1097/CCO.0b013e32834b895c; Matsudaira H, 2010, INT J ONCOL, V36, P77, DOI 10.3892/ijo_00000477; Perz JF, 2006, J HEPATOL, V45, P529, DOI 10.1016/j.jhep.2006.05.013; Petruzzi NJ, 2013, J VASC INTERV RADIOL, V24, P266, DOI 10.1016/j.jvir.2012.10.025; Polakis P, 2005, CURR OPIN PHARMACOL, V5, P382, DOI 10.1016/j.coph.2005.04.008; Polson AG, 2010, LEUKEMIA, V24, P1566, DOI 10.1038/leu.2010.141; Prajapati HJ, 2012, J VASC INTERV RADIOL, V23, P1286, DOI 10.1016/j.jvir.2012.07.003; Qin LX, 2004, J CANCER RES CLIN, V130, P497, DOI 10.1007/s00432-004-0572-9; Qin W, 2010, J BIOMED RES, V24, P145, DOI 10.1016/S1674-8301(10)60023-1; Qin YL, 2012, ANTI-CANCER DRUG, V23, P1047, DOI 10.1097/CAD.0b013e3283569759; Rodon J, 2008, CANCER CHEMOTH PHARM, V62, P911, DOI 10.1007/s00280-007-0672-8; Ross HJ, 2006, LUNG CANCER, V54, P69, DOI 10.1016/j.lungcan.2006.05.020; Sharkey RM, 2012, MOL CANCER THER, V11, P224, DOI 10.1158/1535-7163.MCT-11-0632; Steiner M, 2011, CLIN CANCER RES, V17, P6406, DOI 10.1158/1078-0432.CCR-11-0483; Sun B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030143; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Wan JY, 2008, ACTA U MED NANJING N, V6, P697; Wang SW, 2007, CANCER LETT, V257, P87, DOI 10.1016/j.canlet.2007.07.002; Wang SY, 2004, J HEPATOL, V41, P267, DOI 10.1016/j.jhep.2004.04.013; Wang XN, 2011, MOL CANCER THER, V10, P1728, DOI 10.1158/1535-7163.MCT-11-0191; Weyergang A, 2011, LASER SURG MED, V43, P721, DOI 10.1002/lsm.21084; Zeglis BM, 2011, BIOCONJUGATE CHEM, V22, P2048, DOI 10.1021/bc200288d; Zhou XJ, 2012, INT J NANOMED, V7, P5465, DOI 10.2147/IJN.S33965; Zhu J, 2007, PROG BIOCHEM BIOPHYS, V34, P73	60	22	22	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2013	8	5							e63093	10.1371/journal.pone.0063093	http://dx.doi.org/10.1371/journal.pone.0063093			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145RZ	23675455	Green Published, gold, Green Submitted			2022-12-27	WOS:000319036100028
J	Kermani, N; Abu-Hassan, ZA; Dieng, H; Ismail, NF; Attia, M; Ghani, IA				Kermani, Nadia; Abu-Hassan, Zainal-Abidin; Dieng, Hamady; Ismail, Noor Farehan; Attia, Mansour; Ghani, Idris Abd			Pathogenicity of Nosema sp (Microsporidia) in the Diamondback Moth, Plutella xylostella (Lepidoptera: Plutellidae)	PLOS ONE			English	Article							LYMANTRIA-DISPAR; GYPSY-MOTH; IMPACT; RESISTANCE; PYRAUSTA; HATCH; PESTS	Biological control using pathogenic microsporidia could be an alternative to chemical control of the diamondback moth (DBM) Plutella xylostella (Lepidoptera: Plutellidae). The microsporidium Nosema bombycis (NB) is one of the numerous pathogens that can be used in the Integrated Pest Management (IPM) of DBM. However, its pathogenicity or effectiveness can be influenced by various factors, particularly temperature. This study was therefore conducted to investigate the effect of temperature on NB infection of DBM larvae. Second-instar larvae at different doses (spore concentration: 0, 1x10(2),1x10(3),1x10(4), and 1x10(5)) at 15 degrees, 20 degrees, 25 degrees, 30 degrees and 35 degrees C and a relative humidity(RH) of 65% and light dark cycle (L: D) of 12:12. Larval mortality was recorded at 24 h intervals until the larvae had either died or pupated. The results showed that the spore concentration had a significant negative effect on larval survival at all temperatures, although this effect was more pronounced (92%) at 35 degrees C compared with that at 20 and 30 degrees C (similar or equal to 50%) and 25 degrees C (26%). Histological observations showed that Nosema preferentially infected the adipose tissue and epithelial cells of the midgut, resulting in marked vacuolization of the cytoplasm. These findings suggest that Nosema damaged the midgut epithelial cells. Our results suggest that Nosema had a direct adverse effect on DBM, and could be utilized as an important biopesticide alternative to chemical insecticides in IPM.	[Kermani, Nadia; Ismail, Noor Farehan; Attia, Mansour; Ghani, Idris Abd] Univ Kebangsaan Malaysia, Sch Environm & Nat Resource Sci, Bangi 43600, Selangor, Malaysia; [Abu-Hassan, Zainal-Abidin] Univ Teknol MARA, Fac Med, Shah Alam, Selangor, Malaysia; [Dieng, Hamady] Univ Sains Malaysia, Sch Biol Sci, George Town, Malaysia	Universiti Kebangsaan Malaysia; Universiti Teknologi MARA; Universiti Sains Malaysia	Ghani, IA (corresponding author), Univ Kebangsaan Malaysia, Sch Environm & Nat Resource Sci, Bangi 43600, Selangor, Malaysia.	idrisgh@ukm.my	KERMANI, NADIA/ABH-4897-2020	KERMANI, NADIA/0000-0003-1914-1068	Ministry of Sciences, Technology and Innovation, Malaysia (MOSTI) [02-01-02 -SF0601, 05-01-02-SF1019]; Research University Grant (OUP) [OUP-2012-043, OUP-2013-043]	Ministry of Sciences, Technology and Innovation, Malaysia (MOSTI); Research University Grant (OUP)	This research was funded by grant No. (02-01-02 -SF0601) and (05-01-02-SF1019) from the Ministry of Sciences, Technology and Innovation, Malaysia (MOSTI) and Research University Grant (OUP): OUP-2012-043, OUP-2013-043. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bansal A. K., 1997, SERICOLOGIA, V37, P11; BAUER LS, 1989, ENVIRON ENTOMOL, V18, P261, DOI 10.1093/ee/18.2.261; Becnel James J., 1999, P447; Becnel JJ, 2000, BIOL CONTROL, V18, P39, DOI 10.1006/bcon.1999.0805; Bruck DJ, 2001, J INVERTEBR PATHOL, V78, P210, DOI 10.1006/jipa.2001.5062; CANTWELL G E, 1970, American Bee Journal, V110, P222; Diss AL, 1996, OECOLOGIA, V106, P470, DOI 10.1007/BF00329704; Finney D.J., 1971, PROBIT ANAL; FUXA JR, 1981, J ECON ENTOMOL, V74, P99, DOI 10.1093/jee/74.1.99; Goertz D, 2004, J INVERTEBR PATHOL, V87, P105, DOI 10.1016/j.jip.2004.07.006; Goertz D, 2008, BIOCONTROL SCI TECHN, V18, P419, DOI 10.1080/09583150801993212; Haque MA, 1999, B ENTOMOL RES, V89, P147, DOI 10.1017/S0007485399000231; Humason G., 1967, ANIMAL TISSUE TECHNI; Idris AB, 2004, MANAGEMENT OF DIAMONDBACK MOTH AND OTHER CRUCIFER PESTS, P295; Inglis GD, 2003, J ECON ENTOMOL, V96, P12, DOI 10.1603/0022-0493-96.1.12; Jolly M.S., 1972, Indian Journal of Sericulture, V11, P52; Lakshmi Velide, 2011, Journal of Applied Biosciences, V44, P2994; Rath SS, 2003, J INVERTEBR PATHOL, V83, P1, DOI 10.1016/S0022-2011(03)00038-7; Remadevi O. K., 2010, International Journal of Tropical Insect Science, V30, P138, DOI 10.1017/S1742758410000214; Salkeld EH, 1951, J CAN ENT, P8339; Shabir Ahmad B, 2009, AFRICAN J AGR RES, V13, P1519; SHELTON AM, 1993, J ECON ENTOMOL, V86, P11, DOI 10.1093/jee/86.1.11; SOLTER LF, 1990, J INVERTEBR PATHOL, V55, P337, DOI 10.1016/0022-2011(90)90076-I; Undeen Albert H., 1997, P117, DOI 10.1016/B978-012432555-5/50010-5; Wiwat C, 2000, J INVERTEBR PATHOL, V76, P270, DOI 10.1006/jipa.2000.4976; Yu CG, 1997, APPL ENVIRON MICROB, V63, P532, DOI 10.1128/AEM.63.2.532-536.1997; Zalucki MP, 2012, J ECON ENTOMOL, V105, P1115, DOI 10.1603/EC12107; Zhao JZ, 2002, J ECON ENTOMOL, V95, P430, DOI 10.1603/0022-0493-95.2.430	28	15	17	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2013	8	5							e62884	10.1371/journal.pone.0062884	http://dx.doi.org/10.1371/journal.pone.0062884			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145RZ	23675435	Green Published, gold, Green Submitted			2022-12-27	WOS:000319036100016
J	Dai, CY; Sun, FF; Zhu, CP; Hu, X				Dai, Chunyan; Sun, Feifei; Zhu, Chunpeng; Hu, Xun			Tumor Environmental Factors Glucose Deprivation and Lactic Acidosis Induce Mitotic Chromosomal Instability - An Implication in Aneuploid Human Tumors	PLOS ONE			English	Article							CHECKPOINT GENES BUB1; IN-SITU HYBRIDIZATION; CENTROSOME AMPLIFICATION; MULTIPLE CENTROSOMES; CANCER-CELLS; LOW PH; OVEREXPRESSION; LACTATE; RISK; TUMORIGENESIS	Mitotic chromosomal instability (CIN) plays important roles in tumor progression, but what causes CIN is incompletely understood. In general, tumor CIN arises from abnormal mitosis, which is caused by either intrinsic or extrinsic factors. While intrinsic factors such as mitotic checkpoint genes have been intensively studied, the impact of tumor microenvironmental factors on tumor CIN is largely unknown. We investigate if glucose deprivation and lactic acidosis - two tumor microenvironmental factors - could induce cancer cell CIN. We show that glucose deprivation with lactic acidosis significantly increases CIN in 4T1, MCF-7 and HCT116 scored by micronuclei, or aneuploidy, or abnormal mitosis, potentially via damaging DNA, up-regulating mitotic checkpoint genes, and/or amplifying centrosome. Of note, the feature of CIN induced by glucose deprivation with lactic acidosis is similar to that of aneuploid human tumors. We conclude that tumor environmental factors glucose deprivation and lactic acidosis can induce tumor CIN and propose that they are potentially responsible for human tumor aneuploidy.	[Dai, Chunyan; Zhu, Chunpeng; Hu, Xun] Zhejiang Univ, Inst Canc, Affiliated Hosp 1, Sch Med, Hangzhou 310003, Zhejiang, Peoples R China; [Sun, Feifei] Sun Yat Sen Univ, State Key Lab Oncol South China, Ctr Canc, Guangzhou 510275, Guangdong, Peoples R China	Zhejiang University; State Key Lab Oncology South China; Sun Yat Sen University	Hu, X (corresponding author), Zhejiang Univ, Inst Canc, Affiliated Hosp 1, Sch Med, Hangzhou 310003, Zhejiang, Peoples R China.	huxun@zju.edu.cn		Zhu, Chunpeng/0000-0003-4861-985X	National 863 project [2007AA02Z143]; China Natural Sciences Foundation [30772544, 81071802]; Fundamental Research Funds for the Central Universities, National Ministry of Education, China	National 863 project(National High Technology Research and Development Program of China); China Natural Sciences Foundation(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities, National Ministry of Education, China	This work was supported in part by National 863 project (2007AA02Z143), China Natural Sciences Foundation projects (30772544, 81071802), and the Fundamental Research Funds for the Central Universities, National Ministry of Education, China, to X Hu. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Annibaldi A, 2010, CURR OPIN CLIN NUTR, V13, P466, DOI 10.1097/MCO.0b013e32833a5577; Bergers G, 2003, NAT REV CANCER, V3, P401, DOI 10.1038/nrc1093; Borel F, 2002, P NATL ACAD SCI USA, V99, P9819, DOI 10.1073/pnas.152205299; Brendle A, 2009, EUR J CANCER, V45, P435, DOI 10.1016/j.ejca.2008.10.001; Brizel DM, 2001, INT J RADIAT ONCOL, V51, P349, DOI 10.1016/S0360-3016(01)01630-3; Camps J, 2005, FASEB J, V19, P828, DOI 10.1096/fj.04-2276fje; Carter SL, 2006, NAT GENET, V38, P1043, DOI 10.1038/ng1861; Chen JLY, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000293; Choi CM, 2009, LUNG CANCER, V64, P66, DOI 10.1016/j.lungcan.2008.07.016; Denko NC, 2008, NAT REV CANCER, V8, P705, DOI 10.1038/nrc2468; Diaz-Rodriguez E, 2008, P NATL ACAD SCI USA, V105, P16719, DOI 10.1073/pnas.0803504105; Dobles M, 2000, CELL, V101, P635, DOI 10.1016/S0092-8674(00)80875-2; FENECH M, 1985, MUTAT RES, V147, P29, DOI 10.1016/0165-1161(85)90015-9; Fenech M, 2007, NAT PROTOC, V2, P1084, DOI 10.1038/nprot.2007.77; Fleming RA HK, 2008, EORTC NCI AACR INT C; Fukasawa K, 2005, CANCER LETT, V230, P6, DOI 10.1016/j.canlet.2004.12.028; Fukumura D, 2007, MICROVASC RES, V74, P72, DOI 10.1016/j.mvr.2007.05.003; Gallagher FA, 2008, NATURE, V453, P940, DOI 10.1038/nature07017; Ganem NJ, 2009, NATURE, V460, P278, DOI 10.1038/nature08136; Gatenby RA, 2004, NAT REV CANCER, V4, P891, DOI 10.1038/nrc1478; Gergely F, 2008, GENE DEV, V22, P2291, DOI 10.1101/gad.1715208; Grabsch H, 2003, J PATHOL, V200, P16, DOI 10.1002/path.1324; Harrington EA, 2004, NAT MED, V10, P262, DOI 10.1038/nm1003; Hastings PJ, 2000, CELL, V103, P723, DOI 10.1016/S0092-8674(00)00176-8; Hirayama A, 2009, CANCER RES, V69, P4918, DOI 10.1158/0008-5472.CAN-08-4806; HOLROYDE CP, 1979, CANCER RES, V39, P4900; Huyen Y, 2004, NATURE, V432, P406, DOI 10.1038/nature03114; Karpinets TV, 2005, CARCINOGENESIS, V26, P1323, DOI 10.1093/carcin/bgi079; LEVINE DS, 1991, GASTROENTEROLOGY, V101, P1198, DOI 10.1016/0016-5085(91)90068-V; Lingle WL, 2002, P NATL ACAD SCI USA, V99, P1978, DOI 10.1073/pnas.032479999; Lukas C, 2011, NAT CELL BIOL, V13, P243, DOI 10.1038/ncb2201; MORITA T, 1992, MUTAT RES, V268, P297, DOI 10.1016/0027-5107(92)90235-T; MORITA T, 1995, MUTAT RES-ENVIR MUTA, V334, P301, DOI 10.1016/0165-1161(95)90067-5; Pihan GA, 2003, CANCER RES, V63, P1398; Pihan GA, 1998, CANCER RES, V58, P3974; Pinto M, 2008, CELL ONCOL, V30, P389, DOI 10.3233/CLO-2008-0439; Rajagopalan H, 2004, NATURE, V432, P338, DOI 10.1038/nature03099; REID BJ, 1987, GASTROENTEROLOGY, V93, P1; Reynolds TY, 1996, CANCER RES, V56, P5754; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Schvartzman JM, 2010, NAT REV CANCER, V10, P102, DOI 10.1038/nrc2781; Silkworth WT, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006564; SKINNER SA, 1990, CANCER RES, V50, P2411; Sotillo R, 2007, CANCER CELL, V11, P9, DOI 10.1016/j.ccr.2006.10.019; THISTLETHWAITE AJ, 1985, INT J RADIAT ONCOL, V11, P1647, DOI 10.1016/0360-3016(85)90217-2; Thompson SL, 2010, CURR BIOL, V20, pR285, DOI 10.1016/j.cub.2010.01.034; Tredan O, 2007, J NATL CANCER I, V99, P1441, DOI 10.1093/jnci/djm135; van Sluis R, 1999, MAGN RESON MED, V41, P743, DOI 10.1002/(SICI)1522-2594(199904)41:4<743::AID-MRM13>3.0.CO;2-Z; VORAVUD N, 1993, CANCER RES, V53, P2874; Wada N, 2008, ANTICANCER RES, V28, P139; WALDMAN FM, 1991, CANCER RES, V51, P3807; Walenta S, 2004, SEMIN RADIAT ONCOL, V14, P267, DOI 10.1016/j.semradonc.2004.04.004; Walenta S, 2000, CANCER RES, V60, P916; Weihua Z, 2008, CANCER CELL, V13, P385, DOI 10.1016/j.ccr.2008.03.015; Wu H, 2012, J PATHOL, V227, P189, DOI 10.1002/path.3978; Xu B, 2001, MOL CELL BIOL, V21, P3445, DOI 10.1128/MCB.21.10.3445-3450.2001	56	27	27	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2013	8	5							e63054	10.1371/journal.pone.0063054	http://dx.doi.org/10.1371/journal.pone.0063054			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	143FO	23675453	Green Published, gold, Green Submitted			2022-12-27	WOS:000318852400022
J	Wang, H; Li, NN; Zhu, HD; Xu, SM; Lu, H; Feng, ZC				Wang, Heng; Li, NianNian; Zhu, Haidi; Xu, Shuman; Lu, Hua; Feng, ZhanChun			Prescription Pattern and Its Influencing Factors in Chinese County Hospitals: A Retrospective Cross-Sectional Study	PLOS ONE			English	Article							RATIONAL DRUG-USE; FACILITIES; CARE	Objective: This study aimed to investigate prescription patterns and influencing factors in Chinese county hospitals. Methods: Prescription quality was evaluated by five indicators proposed by WHO/INRUD. A questionnaire for doctors was designed by our research group. All internists, surgeons, obstetricians, gynecologists and pediatricians from 10 county hospitals in Anhui province were asked to fill the questionnaire. Their prescriptions from May 2011 to April 2012 were analyzed. Results: Three-hundred and thirty-seven doctors completed valid questionnaires, and 5099 prescriptions were analyzed. The average number of drugs per prescription was 3.52+/-2.31; the average percentage of generic drugs, antibiotic usage, injection drug usage, and drugs prescribed from the national essential drug list were 96.12%, 29.90%, 20.02% and 48.85%, respectively. Differences in final academic degree and specialty led to differences in all of the five prescription quality indicators. The older doctors tended to use more antibiotics. Doctors with more education, more training on rational drug use, and better acquisition of medicine knowledge prescribe a lower percentage of generic drugs. Moreover, the more supportive the doctor's attitude to national essential medicine policy, the higher the percentage of generic drugs were prescribed. A higher level of medical knowledge was associated with a higher percentage of drugs prescribed from the essential drugs list. Conclusions: Promoting the education of medical knowledge on doctors, reinforcing the publicity of rational drug use to doctors, and initiating the performance evaluation for doctors are effective ways for improving prescription quality in Chinese county hospitals.	[Wang, Heng; Zhu, Haidi; Feng, ZhanChun] Huazhong Univ Sci & Technol, Wuhan 430074, Hubei, Peoples R China; [Wang, Heng; Li, NianNian] Anhui Med Univ, Affiliated Hosp 1, Hefei, Anhui, Peoples R China; [Xu, Shuman; Lu, Hua] Anhui Med Univ, Social Sci & Hlth Management Sch, Hefei, Anhui, Peoples R China	Huazhong University of Science & Technology; Anhui Medical University; Anhui Medical University	Feng, ZC (corresponding author), Huazhong Univ Sci & Technol, Wuhan 430074, Hubei, Peoples R China.	zcfeng@mails.tjmu.edu.cn			soft science planning project of Anhui province [12020503084]; Humanities Social Science Planning Project of Ministry of Education [12YJA630121]	soft science planning project of Anhui province; Humanities Social Science Planning Project of Ministry of Education	This study was supported by grants from soft science planning project of Anhui province (12020503084) (http://www.ahkjt.gov.cn/) and the Humanities Social Science Planning Project of Ministry of Education (12YJA630121), (http://www.moe.edu.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adebayo ET, 2010, ANN AFR MED, V9, P152, DOI 10.4103/1596-3519.68366; Andersen M, 2006, JAMA-J AM MED ASSOC, V295, P2759, DOI 10.1001/jama.295.23.2759; Bashrahil K. A., 2010, Eastern Mediterranean Health Journal, V16, P151; Daohai C, 2012, EVALUATION ANAL DRUG, V12, P373; Figueiras A, 2001, J EVAL CLIN PRACT, V7, P223, DOI 10.1046/j.1365-2753.2001.00234.x; GREENHALGH T, 1987, SOC SCI MED, V25, P307, DOI 10.1016/0277-9536(87)90233-4; HOGERZEIL HV, 1995, BRIT J CLIN PHARMACO, V39, P1; HOGERZEIL HV, 1993, LANCET, V342, P1408, DOI 10.1016/0140-6736(93)92760-Q; Hua L, 2009, EVALUATION ANAL DRUG, V9, P280; Irshaid YM, 2004, SAUDI MED J, V25, P1864; Keohavong B, 2006, PHARMACOEPIDEM DR S, V15, P344, DOI 10.1002/pds.1169; Kun Y, 2002, CHIN J HOSP ADM, V18, P92; Lianzhen C, 2003, CHINA PHARM, V14, P156; Mahajan R, 2010, J PHARM BIOALLIED SC, V2, P132, DOI 10.4103/0975-7406.67008; MELVILLE A, 1980, SOC SCI MED-MED SOC, V14, P495, DOI 10.1016/0160-7979(80)90050-8; Menik HL, 2011, J PHARM BIOALLIED SC, V3, P165, DOI 10.4103/0975-7406.76502; Orzella L, 2010, HEALTH POLICY, V95, P236, DOI 10.1016/j.healthpol.2009.12.005; Trap B, 2002, HEALTH POLICY PLANN, V17, P288, DOI 10.1093/heapol/17.3.288; Uzochukwu BS, 2002, HEALTH POLICY PLANN, V17, P378, DOI 10.1093/heapol/17.4.378; Vallano A, 2004, EUR J CLIN PHARMACOL, V60, P725, DOI 10.1007/s00228-004-0802-8; Weihui D, 2009, ANAL INFLUENCE FACTO; WHO, 1993, ACT PROGR ESS DRUGS, P1; WHO, 2003, WHO TECH REP SER, V914; WHO Website, 2010, WHO WEBS 10 FACTS ES; World Health Organization, 2004, EQ ACC ESS MED FRAM; World Health Organization, 2011, WORLD MED SIT 2011 M; Xinyi Z, 2010, CHINESE J PHARMACOVI, V7, P755; Younis MZ, 2009, PHARMACOECONOMICS OU, V9, P243	28	33	34	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2013	8	5							e63225	10.1371/journal.pone.0063225	http://dx.doi.org/10.1371/journal.pone.0063225			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	143FO	23675465	Green Submitted, Green Published, gold			2022-12-27	WOS:000318852400031
J	Wood, EM; Pidgeon, AM; Radeloff, VC; Keuler, NS				Wood, Eric M.; Pidgeon, Anna M.; Radeloff, Volker C.; Keuler, Nicholas S.			Image Texture Predicts Avian Density and Species Richness	PLOS ONE			English	Article							VEGETATION STRUCTURE; GRASSLAND BIRDS; HABITAT SELECTION; SATELLITE IMAGERY; AIRBORNE LIDAR; BIODIVERSITY; DIVERSITY; PATTERNS; ENCROACHMENT; ASSOCIATIONS	For decades, ecologists have measured habitat attributes in the field to understand and predict patterns of animal distribution and abundance. However, the scale of inference possible from field measured data is typically limited because large-scale data collection is rarely feasible. This is problematic given that conservation and management typical require data that are fine grained yet broad in extent. Recent advances in remote sensing methodology offer alternative tools for efficiently characterizing wildlife habitat across broad areas. We explored the use of remotely sensed image texture, which is a surrogate for vegetation structure, calculated from both an air photo and from a Landsat TM satellite image, compared with field-measured vegetation structure, characterized by foliage-height diversity and horizontal vegetation structure, to predict avian density and species richness within grassland, savanna, and woodland habitats at Fort McCoy Military Installation, Wisconsin, USA. Image texture calculated from the air photo best predicted density of a grassland associated species, grasshopper sparrow (Ammodramus savannarum), within grassland habitat (R-2 = 0.52, p-value <0.001), and avian species richness among habitats (R-2 = 0.54, p-value <0.001). Density of field sparrow (Spizella pusilla), a savanna associated species, was not particularly well captured by either field-measured or remotely sensed vegetation structure variables, but was best predicted by air photo image texture (R-2 = 0.13, p-value = 0.002). Density of ovenbird (Seiurus aurocapillus), a woodland associated species, was best predicted by pixel-level satellite data (mean NDVI, R-2 = 0.54, p-value <0.001). Surprisingly and interestingly, remotely sensed vegetation structure measures (i.e., image texture) were often better predictors of avian density and species richness than field-measured vegetation structure, and thus show promise as a valuable tool for mapping habitat quality and characterizing biodiversity across broad areas.	[Wood, Eric M.; Pidgeon, Anna M.; Radeloff, Volker C.; Keuler, Nicholas S.] Univ Wisconsin Madison, Dept Forest & Wildlife Ecol, Madison, WI USA; [Keuler, Nicholas S.] Univ Wisconsin Madison, Dept Stat, Madison, WI USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Wood, EM (corresponding author), Univ Wisconsin Madison, Dept Forest & Wildlife Ecol, Madison, WI USA.	emwood@wisc.edu	Radeloff, Volker C/B-6124-2016	Radeloff, Volker C/0000-0001-9004-221X; Wood, Eric/0000-0003-2787-6451	U.S. Strategic Environmental Research and Development Program [RC-1438]	U.S. Strategic Environmental Research and Development Program	Eric Wood and Anna Pidgeon received financial support from the U.S. Strategic Environmental Research and Development Program, Project RC-1438 (http://www.serdp.org/). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AUGUST PV, 1983, ECOLOGY, V64, P1495, DOI 10.2307/1937504; Bellis LM, 2008, ECOL APPL, V18, P1956, DOI 10.1890/07-0243.1; Bergen KM, 2009, J GEOPHYS RES-BIOGEO, V114, DOI 10.1029/2008JG000883; BEST LB, 1977, CONDOR, V79, P192, DOI 10.2307/1367162; Bestelmeyer BT, 2001, ECOL APPL, V11, P1123, DOI 10.1890/1051-0761(2001)011[1123:ABISLM]2.0.CO;2; Beyer HL, 2004, HAWTHS ANAL TOOLS AR; Bock CE, 2004, FRONT ECOL ENVIRON, V2, P403, DOI 10.2307/3868428; Bradbury RB, 2005, IBIS, V147, P443, DOI 10.1111/j.1474-919x.2005.00438.x; Buckland S.T., 2001, pi; Burley F.W., 1988, P227; California USA, 2006, ARCGIS 9 1; Canty A, 2011, J AM STAT ASSOC, V88, P486; Clawges R, 2008, REMOTE SENS ENVIRON, V112, P2064, DOI 10.1016/j.rse.2007.08.023; Cody M.L., 1985, HABITATS SELECTION B; CODY ML, 1981, BIOSCIENCE, V31, P107, DOI 10.2307/1308252; Coops NC, 2009, J BIOGEOGR, V36, P905, DOI 10.1111/j.1365-2699.2008.02053.x; Culbert PD, 2012, REMOTE SENS ENVIRON, V118, P140, DOI 10.1016/j.rse.2011.11.004; Curtis JT, 1959, VEGETATION WISCONSIN; Estades CF, 1997, CONDOR, V99, P719, DOI 10.2307/1370483; Estes LD, 2008, REMOTE SENS ENVIRON, V112, P2033, DOI 10.1016/j.rse.2008.01.004; Estes LD, 2010, REMOTE SENS ENVIRON, V114, P792, DOI 10.1016/j.rse.2009.11.016; GAUSMAN HW, 1977, REMOTE SENS ENVIRON, V6, P1, DOI 10.1016/0034-4257(77)90015-3; GREENSTONE MH, 1984, OECOLOGIA, V62, P299, DOI 10.1007/BF00384260; Grundel R, 2007, AUK, V124, P969, DOI 10.1642/0004-8038(2007)124[969:DUAVOM]2.0.CO;2; Hall-Beyer M., 2007, GLCM TUTORIAL HOME P; HARALICK RM, 1979, P IEEE, V67, P786, DOI 10.1109/PROC.1979.11328; HARALICK RM, 1973, IEEE T SYST MAN CYB, VSMC3, P610, DOI 10.1109/TSMC.1973.4309314; Hepinstall JA, 1997, PHOTOGRAMM ENG REM S, V63, P1231; Hothorn T, 2011, ECOL MONOGR, V81, P329, DOI 10.1890/10-0602.1; Hudak AT, 1998, REMOTE SENS ENVIRON, V66, P317, DOI 10.1016/S0034-4257(98)00078-9; Hudak AT, 2001, INT J REMOTE SENS, V22, P2731, DOI 10.1080/01431160152518660; HUTTO RL, 1986, AUK, V103, P593, DOI 10.1093/auk/103.3.593; Johnson DH, 2001, AUK, V118, P24, DOI 10.1642/0004-8038(2001)118[0024:AROGBA]2.0.CO;2; KARR JR, 1971, AM NAT, V105, P423, DOI 10.1086/282735; Laurent EJ, 2005, REMOTE SENS ENVIRON, V97, P249, DOI 10.1016/j.rse.2005.04.015; LEGENDRE P, 1989, VEGETATIO, V80, P107, DOI 10.1007/BF00048036; MAC NALLY RC, 1990, AUST J ECOL, V15, P321, DOI 10.1111/j.1442-9993.1990.tb01036.x; MACARTHUR R, 1961, ECOLOGY, V42, P594, DOI 10.2307/1932254; Martin T. E., 1997, BBIRD FIELD PROTOCOL; McKee JK, 2004, BIOL CONSERV, V115, P161, DOI 10.1016/S0006-3207(03)00099-5; MURDOCH WW, 1972, ECOLOGY, V53, P819, DOI 10.2307/1934297; Nagendra H, 2001, INT J REMOTE SENS, V22, P2377, DOI 10.1080/01431160117096; Pasher J, 2007, REMOTE SENS ENVIRON, V107, P471, DOI 10.1016/j.rse.2006.09.022; Patterson MP, 1996, AM MIDL NAT, V135, P153, DOI 10.2307/2426881; Pidgeon AM, 2001, CONSERV BIOL, V15, P1772, DOI 10.1046/j.1523-1739.2001.00073.x; R Core Team, 2012, LANG ENV STAT COMP; RALPH CJ, 1995, MONITORING BIRD POPU, P161; Ribic CA, 2001, AM MIDL NAT, V146, P105, DOI 10.1674/0003-0031(2001)146[0105:AOGBWL]2.0.CO;2; Ribic CA, 2009, AUK, V126, P233, DOI 10.1525/auk.2009.1409; Rosenzweig Michael L., 1995, DOI 10.1017/CBO9780511623387.002; ROTENBERRY JT, 1985, OECOLOGIA, V67, P213, DOI 10.1007/BF00384286; ROTENBERRY JT, 1980, ECOLOGY, V61, P1228, DOI 10.2307/1936840; ROUGHGARDEN J, 1991, ECOLOGY, V72, P1918, DOI 10.2307/1941546; St-Louis V, 2006, REMOTE SENS ENVIRON, V105, P299, DOI 10.1016/j.rse.2006.07.003; St-Louis V, 2009, ECOGRAPHY, V32, P468, DOI 10.1111/j.1600-0587.2008.05512.x; STENGER JUDITH, 1958, AUK, V75, P335; STOMS DM, 1993, INT J REMOTE SENS, V14, P1839, DOI 10.1080/01431169308954007; Sutherland W., 2000, CONSERVATION HDB RES; SZARO RC, 1996, BIODIVERSITY MANAGED; Thomas L., 2004, DISTANCE 4 1 RELEASE; TUCKER CJ, 1979, REMOTE SENS ENVIRON, V8, P127, DOI 10.1016/0034-4257(79)90013-0; Turner W, 2003, TRENDS ECOL EVOL, V18, P306, DOI 10.1016/S0169-5347(03)00070-3; Tuttle EM, 2006, GLOBAL ECOL BIOGEOGR, V15, P349, DOI 10.1111/j.1466-822x.2006.00232.x; Vie J-C, 2009, WILDLIFE CHANGING WO; Vierling KT, 2008, FRONT ECOL ENVIRON, V6, P90, DOI 10.1890/070001; WIENS JA, 1981, ECOL MONOGR, V51, P21, DOI 10.2307/2937305; WIENS JA, 1973, ECOLOGY, V54, P877, DOI 10.2307/1935683; WILLIAMS PH, 1994, BIOL CONSERV, V67, P211, DOI 10.1016/0006-3207(94)90612-2; Wood EM, 2012, REMOTE SENS ENVIRON, V121, P516, DOI 10.1016/j.rse.2012.01.003; Wood EM, 2011, BIOL CONSERV, V144, P3117, DOI 10.1016/j.biocon.2011.10.010	70	47	49	1	106	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2013	8	5							e63211	10.1371/journal.pone.0063211	http://dx.doi.org/10.1371/journal.pone.0063211			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	143FO	23675463	Green Published, Green Submitted, gold			2022-12-27	WOS:000318852400029
J	Xu, S; Hayashi, Y; Takagishi, Y; Itoh, M; Murata, Y				Xu, Sai; Hayashi, Yoshitaka; Takagishi, Yoshiko; Itoh, Mariko; Murata, Yoshiharu			Aristaless-Related Homeobox Plays a Key Role in Hyperplasia of the Pancreas Islet alpha-Like Cells in Mice Deficient in Proglucagon-Derived Peptides	PLOS ONE			English	Article							GLUCAGON DEFICIENCY; ENDOCRINE PANCREAS; ARX; EXPRESSION; GENE; HYPERGLUCAGONEMIA; PHENOTYPES; MUTATION; RECEPTOR; GLUCOSE	Defects in glucagon action can cause hyperplasia of islet alpha-cells, however, the underlying mechanisms remain largely to be elucidated. Mice homozygous for a glucagon-GFP knock-in allele (Gcg(gfp/gfp)) completely lack proglucagon-derived peptides and exhibit hyperplasia of GFP-positive alpha-like cells. Expression of the transcription factor, aristaless-related homeobox (ARX), is also increased in the Gcg(gfp/gfp) pancreas. Here, we sought to elucidate the role of ARX in the hyperplasia of alpha-like cells through analyses of two Arx mutant alleles (Arx(P355L/Y) and Arx([330insGCG]7/Y)) that have different levels of impairment of their function. Expression of Gfp and Arx genes was higher and the size and number of islets increased in the Gcg(gfp/gfp) pancreas compared to and Gcg(gfp/+) pancreas at 2 weeks of age. In male Gcg(gfp/gfp) mice that are hemizygous for the Arx(P355L/Y) mutation that results in a protein with a P355L amino acid substitution, expression of Gfp mRNA in the pancreas was comparable to that in control Gcg(gfp/+)Arx(+/Y) mice. The increases in islet size and number were also reduced in these mice. Immunohistochemical analysis showed that the number of GFP-positive cells was comparable in Gcg(gfp/gfp) Arx(P355L/Y) and Gcg(gfp/+)Arx(+/Y) mice. These results indicate that the hyperplasia is reduced by introduction of an Arx mutation. Arx(P355L/Y) mice appeared to be phenotypically normal; however, Arx([330insGCG]7/Y) mice that have a mutant ARX protein with expansion of the polyalanine tract had a reduced body size and shortened life span. The number of GFP-positive cells was further reduced in the Gcg(gfp/gfp) Arx([330insGCG]7/Y) mice. Taken together, our findings show that the function of ARX is one of the key modifiers for hyperplasia of islet alpha-like cells in the absence of proglucagon-derived peptides.	[Xu, Sai; Hayashi, Yoshitaka; Takagishi, Yoshiko; Murata, Yoshiharu] Nagoya Univ, Environm Med Res Inst, Dept Genet, Div Stress Adaptat & Protect, Nagoya, Aichi 464, Japan; [Itoh, Mariko] Nagoya Univ, Environm Med Res Inst, Tech Dept, Nagoya, Aichi 464, Japan	Nagoya University; Nagoya University	Hayashi, Y (corresponding author), Nagoya Univ, Environm Med Res Inst, Dept Genet, Div Stress Adaptat & Protect, Nagoya, Aichi 464, Japan.	hayashiy@riem.nagoya-u.ac.jp	Hayashi, Yoshitaka/I-6168-2014	Hayashi, Yoshitaka/0000-0002-7557-4303	Japan Society for the Promotion of Science [23591351, 24659451]; Ministry of Education, Culture, Sports, Science and Technology [23122507]; Grants-in-Aid for Scientific Research [23591351] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	Grants-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (grant number 23591351 to YM and grant number 24659451 to YH) and a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology (grant number 23122507 to YH) [http://kaken.nii.ac.jp/d/p/23591351.en.html; http://kaken.nii.ac.jp/d/p/24659451.en.html; http://kaken.nii.ac.jp/d/p/23122507.en.html; http://www.jsps.go.jp/english/; http://www.mext.go.jp/english/]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali S, 2011, J CLIN INVEST, V121, P1917, DOI 10.1172/JCI43615; Baggio LL, 2007, GASTROENTEROLOGY, V132, P2131, DOI 10.1053/j.gastro.2007.03.054; Bock T, 2003, DIABETES, V52, P1716, DOI 10.2337/diabetes.52.7.1716; Collombat P, 2003, GENE DEV, V17, P2591, DOI 10.1101/gad.269003; Collombat P, 2007, J CLIN INVEST, V117, P961, DOI 10.1172/JCI29115; Ellingsgaard H, 2008, P NATL ACAD SCI USA, V105, P13163, DOI 10.1073/pnas.0801059105; Fukami A, 2013, DIABETES, V62, P510, DOI 10.2337/db12-0294; Furuta M, 1997, P NATL ACAD SCI USA, V94, P6646, DOI 10.1073/pnas.94.13.6646; Futaki S, 2003, J BIOL CHEM, V278, P50691, DOI 10.1074/jbc.M304985200; Gecz J, 2006, CURR OPIN GENET DEV, V16, P308, DOI 10.1016/j.gde.2006.04.003; Gelling RW, 2003, P NATL ACAD SCI USA, V100, P1438, DOI 10.1073/pnas.0237106100; Habener JF, 2012, TRENDS ENDOCRINOL ME; Hancock AS, 2010, MOL ENDOCRINOL, V24, P1605, DOI 10.1210/me.2010-0120; Hayashi Y, 2011, DIABETES OBES METAB, V13, P151, DOI 10.1111/j.1463-1326.2011.01456.x; Hayashi Y, 2009, MOL ENDOCRINOL, V23, P1990, DOI 10.1210/me.2009-0296; Itoh M, 2010, DIFFERENTIATION, V80, P118, DOI 10.1016/j.diff.2010.05.003; Kitamura K, 2002, NAT GENET, V32, P359, DOI 10.1038/ng1009; Kitamura K, 2009, HUM MOL GENET, V18, P3708, DOI 10.1093/hmg/ddp318; Longuet C, 2012, DIABETES; Miura H, 1997, MECH DEVELOP, V65, P99, DOI 10.1016/S0925-4773(97)00062-2; Sugiyama C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043745; Unger RH, 2012, J CLIN INVEST, V122, P4, DOI 10.1172/JCI60016; Watanabe C, 2012, DIABETES, V61, P74, DOI 10.2337/db11-0739; Zhou CQ, 2009, PANCREAS, V38, P941, DOI 10.1097/MPA.0b013e3181b2bb03	24	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2013	8	5							e64415	10.1371/journal.pone.0064415	http://dx.doi.org/10.1371/journal.pone.0064415			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	155HD	23671715	Green Published, gold, Green Submitted			2022-12-27	WOS:000319737700073
J	Ditroilo, M; Watsford, M; Murphy, A; De Vito, G				Ditroilo, Massimiliano; Watsford, Mark; Murphy, Aron; De Vito, Giuseppe			Sources of Variability in Musculo-Articular Stiffness Measurement	PLOS ONE			English	Article							MUSCULOTENDINOUS STIFFNESS; ACTIVE STIFFNESS; MUSCLE-STIFFNESS; RELIABILITY; INJURY; ANKLE; LEG	The assessment of musculo-articular stiffness (MAS) with the free-oscillation technique is a popular method with a variety of applications. This study examined the sources of variability (load applied and frequency of oscillation) when MAS is assessed. Over two testing occasions, 14 healthy men (27.7 +/- 5.2 yr, 1.82 +/- 0.04 m, 79.5 +/- 8.4 kg) were measured for isometric maximum voluntary contraction and MAS of the knee flexors using submaximal loads relative to the individual's maximum voluntary contraction (MAS(%MVC)) and a single absolute load (MAS(ABS)). As assessment load increased, MAS(%MVC) (coefficient of variation (CV) = 8.1-12.1%; standard error of measurement (SEM) = 51.6-98.8 Nm(-1)) and frequency (CV = 4.8-7.0%; SEM = 0.060-0.075 s(-1)) variability increased consequently. Further, similar levels of variability arising from load (CV = 6.7%) and frequency (CV = 4.8-7.0%) contributed to the overall MAS(%MVC) variability. The single absolute load condition yielded better reliability scores for MAS(ABS) (CV = 6.5%; SEM = 40.2 Nm(-1)) and frequency (CV = 3.3%; SEM = 0.039 s(-1)). Low and constant loads for MAS assessment, which are particularly relevant in the clinical setting, exhibited superior reliability compared to higher loads expressed as a percentage of maximum voluntary contraction, which are more suitable for sporting situations. Appropriate sample size and minimum detectable change can therefore be determined when prospective studies are carried out.	[Ditroilo, Massimiliano; De Vito, Giuseppe] Univ Coll Dublin, Sch Publ Hlth Physiotherapy & Populat Sci, Dublin 2, Ireland; [Ditroilo, Massimiliano] Univ Hull, Fac Sci, Dept Sport Hlth & Exercise Sci, Kingston Upon Hull HU6 7RX, N Humberside, England; [Watsford, Mark; Murphy, Aron] Univ Technol Sydney, UTS Hlth, Sport & Exercise Grp, Sydney, NSW 2007, Australia; [De Vito, Giuseppe] Univ Coll Dublin, Inst Sport & Hlth, Dublin 2, Ireland	University College Dublin; University of Hull; University of Technology Sydney; University College Dublin	Ditroilo, M (corresponding author), Univ Coll Dublin, Sch Publ Hlth Physiotherapy & Populat Sci, Dublin 2, Ireland.	m.ditroilo@hull.ac.uk	Ditroilo, Massimiliano/X-5394-2019; De Vito, Giuseppe/J-4499-2012	Ditroilo, Massimiliano/0000-0003-1021-0362; De Vito, Giuseppe/0000-0002-6855-9180				Atkinson G, 1998, SPORTS MED, V26, P217, DOI 10.2165/00007256-199826040-00002; Bell DR, 2012, KNEE SURG SPORT TR A, V20, P361, DOI 10.1007/s00167-011-1577-y; Blackburn JT, 2004, CLIN BIOMECH, V19, P36, DOI 10.1016/j.clinbiomech.2003.09.003; Coveney VA, 2001, J BIOMECH, V34, P827, DOI 10.1016/S0021-9290(01)00017-3; Ditroilo M, 2011, SPORTS MED, V41, P1019, DOI 10.2165/11591470-000000000-00000; Ditroilo M, 2011, J ELECTROMYOGR KINES, V21, P492, DOI 10.1016/j.jelekin.2010.11.004; Ditroilo M, 2011, MED SCI SPORT EXER, V43, P837, DOI 10.1249/MSS.0b013e3182012261; Faria A, 2009, CLIN BIOMECH, V24, P866, DOI 10.1016/j.clinbiomech.2009.07.015; Granata KP, 2004, J ELECTROMYOGR KINES, V14, P599, DOI 10.1016/j.jelekin.2004.03.005; Jaskolski A, 2007, J ELECTROMYOGR KINES, V17, P568, DOI 10.1016/j.jelekin.2006.05.002; Jennings AG, 1998, CLIN BIOMECH, V13, P138, DOI 10.1016/S0268-0033(97)00085-5; McLachlan KA, 2006, J APPL BIOMECH, V22, P296, DOI 10.1123/jab.22.4.296; MCNAIR PJ, 1992, CLIN BIOMECH, V7, P131, DOI 10.1016/0268-0033(92)90027-2; Missenard O, 2009, MUSCLE NERVE, V40, P1019, DOI 10.1002/mus.21331; Murphy AJ, 2003, PHYS THER SPORT, V4, P175, DOI 10.1016/S1466-853X(03)00077-4; Panjabi MM, 2001, BIOMECHANICS MUSCULO, P131; Shorten MR, 1987, MED SPORT SCI, V25, P1; Spurrs RW, 2003, EUR J APPL PHYSIOL, V89, P1, DOI 10.1007/s00421-002-0741-y; Taylor J. R., 1982, INTRO ERROR ANAL, P40; Walshe AD, 1996, EUR J APPL PHYSIOL O, V73, P332, DOI 10.1007/BF02425495; Watsford M, 2010, MED SCI SPORT EXER, V42, P1324, DOI 10.1249/MSS.0b013e3181ce509d; Watsford ML, 2010, AM J SPORT MED, V38, P2058, DOI 10.1177/0363546510370197; Weir JP, 2005, J STRENGTH COND RES, V19, P231, DOI 10.1519/15184.1; WILSON GJ, 1991, INT J SPORTS MED, V12, P403, DOI 10.1055/s-2007-1024702; Winter D. A., 2005, BIOMECHANICS MOTOR C, P59	25	3	3	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2013	8	5							e63719	10.1371/journal.pone.0063719	http://dx.doi.org/10.1371/journal.pone.0063719			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145YI	23667662	gold, Green Published, Green Submitted			2022-12-27	WOS:000319055600070
J	Rahman, MM; Azirun, SM; Boyce, AN				Rahman, Motior M.; Azirun, Sofian M.; Boyce, Amru N.			Enhanced Accumulation of Copper and Lead in Amaranth (Amaranthus paniculatus), Indian Mustard (Brassica juncea) and Sunflower (Helianthus annuus)	PLOS ONE			English	Article							HEAVY-METALS; PHYTOEXTRACTION CAPACITY; CONTAMINATED SOIL; ELEMENTAL SULFUR; CADMIUM UPTAKE; SOLUBILITY; PLANTS; ZINC; CD; PHYTOREMEDIATION	Background: Soil contamination by copper (Cu) and lead (Pb) is a widespread environmental problem. For phytoextraction to be successful and viable in environmental remediation, strategies that can improve plant uptake must be identified. In the present study we investigated the use of nitrogen (N) fertilizer as an efficient way to enhance accumulation of Cu and Pb from contaminated industrial soils into amaranth, Indian mustard and sunflower. Methods/Principal Findings: Plants were grown in a greenhouse and fertilized with N fertilizer at rates of 0, 190 and 380 mg kg(-1) soil. Shoots, roots and total accumulation of Cu and Pb, transfer factor (TF), translocation index were assessed to evaluate the transport and translocation ability of tested plants. Addition of N fertilizer acidified the industrial soil and caused the pH to decrease to 5.5 from an initial pH of 6.9. Industrial soil amended with N fertilizer resulted in the highest accumulation of Pb and Cu (for Pb 10.1-15.5 mg kg(-1), for Cu 11.6-16.8 mg kg(-1)) in the shoots, which was two to four folds higher relative to the concentration in roots in all the three plants used. Sunflower removed significantly higher Pb (50-54%) and Cu (34-38%) followed by amaranth and Indian mustard from industrial soils with the application of N fertilizer. The TF was <1 while the shoot and root concentration (SC/RC) ratios of Pb and Cu were between 1.3-4.3 and 1.8-3.8, respectively, regardless of plant species. Conclusions: Sunflower is the best plant species to carry out phytoextraction of Pb and Cu. In contrast, Pb and Cu removal by Indian mustard and amaranth shows great potential as quick and short duration vegetable crops. The results suggest that the application of N fertilizer in contaminated industrial soil is an effective amendment for the phytoextraction of Pb and Cu from contaminated industrial soils.	[Rahman, Motior M.; Azirun, Sofian M.; Boyce, Amru N.] Univ Malaya, Inst Biol Sci, Fac Sci, Kuala Lumpur, Malaysia	Universiti Malaya	Rahman, MM (corresponding author), Univ Malaya, Inst Biol Sci, Fac Sci, Kuala Lumpur, Malaysia.	mmotiorrahman@gmail.com	RAHMAN, DR. MD. MOTIOR/B-8988-2010; AZIRUN, MOHD SOFIAN/B-9127-2010; NASRULHAQ BOYCE, AMRU/B-8224-2010	Rahman, Md Motior/0000-0002-2847-1870	University of Malaya, Kuala Lumpur, Malaysia	University of Malaya, Kuala Lumpur, Malaysia(Universiti Malaya)	This research work was financially supported by the University of Malaya, Kuala Lumpur, Malaysia. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adriano D. C, 2003, TRACE ELEMENTS TERRE; [Anonymous], 2001, TRACE METALS SOILS P; BC MOE, 1989, CRIT MAN CONT SOILS; Blaylock MJ, 2000, PHYTOREMEDIATION OF TOXIC METALS, P53; BROWN SL, 1995, SOIL SCI SOC AM J, V59, P125, DOI 10.2136/sssaj1995.03615995005900010020x; Chaney RL, 2005, Z NATURFORSCH C, V60, P190; Cieslinski G, 1996, PLANT SOIL, V182, P115, DOI 10.1007/BF00011000; Cobb GP, 2000, ENVIRON TOXICOL CHEM, V19, P600, DOI [10.1002/etc.5620190311, 10.1897/1551-5028(2000)019&lt;0600:AOHMBV&gt;2.3.CO;2]; Cui YS, 2004, COMMUN SOIL SCI PLAN, V35, P2905, DOI 10.1081/LCSS-200036494; Cui YS, 2004, ENVIRON INT, V30, P323, DOI 10.1016/S0160-4120(03)00182-X; Cunningham SD, 2000, PHYTOREMEDIATION OF CONTAMINATED SOIL AND WATER, P359; Dede G, 2012, INT J ENVIRON SCI TE, V9, P559, DOI 10.1007/s13762-012-0058-2; Demirezen D, 2007, CHEMOSPHERE, V66, P553, DOI 10.1016/j.chemosphere.2006.05.045; do Nascimento CWA, 2006, SCI AGR, V63, P299, DOI 10.1590/S0103-90162006000300014; Eriksson J., 1997, 4778 SWED ENV PROT A; Garbisu C, 2001, BIORESOURCE TECHNOL, V77, P229, DOI 10.1016/S0960-8524(00)00108-5; Ghosh M., 2005, Applied Ecology and Environmental Research, V3, P67; Gupta AK, 2007, BIORESOURCE TECHNOL, V98, P442, DOI 10.1016/j.biortech.2006.01.015; Gupta AK, 2007, BIORESOURCE TECHNOL, V98, P1788, DOI 10.1016/j.biortech.2006.06.028; HOLMGREN GGS, 1993, J ENVIRON QUAL, V22, P335, DOI 10.2134/jeq1993.00472425002200020015x; Jarup L, 2003, BRIT MED BULL, V68, P167, DOI 10.1093/bmb/ldg032; Kaplan M, 2005, AGR ECOSYST ENVIRON, V111, P41, DOI 10.1016/j.agee.2005.04.023; Khan S, 2008, ENVIRON POLLUT, V152, P686, DOI 10.1016/j.envpol.2007.06.056; Kirpichtchikova TA, 2006, GEOCHIM COSMOCHIM AC, V70, P2163, DOI 10.1016/j.gca.2006.02.006; Lasat M. M., 1999, J HAZARD SUBSTANCE R, V2, P1, DOI 10.4148/1090-7025.1015; Lin CC, 2009, ENVIRON EXP BOT, V65, P410, DOI 10.1016/j.envexpbot.2008.12.003; Ling W, 2007, AUST J SOIL RES, V45, P618, DOI 10.1071/SR07079; Liu XM, 2005, INT J PHYTOREMEDIAT, V7, P43, DOI 10.1080/16226510590915800; LUBBEN S, 1991, WATER AIR SOIL POLL, V57-8, P239, DOI 10.1007/BF00282887; Luo CL, 2005, CHEMOSPHERE, V59, P1, DOI 10.1016/j.chemosphere.2004.09.100; Madejon E, 2006, ENVIRON POLLUT, V139, P40, DOI 10.1016/j.envpol.2005.04.034; Maimon A., 2009, Advances in Environmental Biology, V3, P314; Martens SN, 2000, ECOL MODEL, V126, P79, DOI 10.1016/S0304-3800(99)00188-X; Martinez CE, 2000, ENVIRON POLLUT, V107, P153, DOI 10.1016/S0269-7491(99)00111-6; Maslin P., 2000, BIOREMEDIAT J, V4, P295, DOI [10.1080/10889860091114266, DOI 10.1080/10889860091114266]; McBride M. B., 1994, ENV CHEM SOILS; McLaughlin MJ, 2000, COMMUN SOIL SCI PLAN, V31, P1661, DOI 10.1080/00103620009370531; Mun HW, 2008, J ENVIRON SCI, V20, P1341, DOI 10.1016/S1001-0742(08)62231-7; Nowack B, 2006, ENVIRON SCI TECHNOL, V40, P5225, DOI 10.1021/es0604919; Pais I., 2000, HDB TRACE ELEMENTS; Paiva Haroldo Nogueira de, 2002, Rev. Árvore, V26, P467, DOI 10.1590/S0100-67622002000400009; Putnam DH, 1990, OPLINGER ES PUBLIC A, VA3005; Rahman MM, 2011, AUST J CROP SCI, V5, P347; Rosen CJ, 2002, LEAD HOME GARDEN URB; Salt DE, 1998, ANNU REV PLANT PHYS, V49, P643, DOI 10.1146/annurev.arplant.49.1.643; SAS 2003 SAS Institute, 2002, SAS I SAS VERS 9 1 2, P449; Schmidt U, 2003, J ENVIRON QUAL, V32, P1939, DOI 10.2134/jeq2003.1939; Singh BP, 1992, 2 INT S SPEC EX VEG; Syakalima MS, 2001, B ENVIRON CONTAM TOX, V67, P438; Thomas G.W., 1996, SOIL PH SOIL ACIDI 3, P475, DOI DOI 10.2136/SSSABOOKSER5.3.C16; Turgut C, 2004, ENVIRON POLLUT, V131, P147, DOI 10.1016/j.envpol.2004.01.017; Wang AS, 2006, PLANT SOIL, V281, P325, DOI 10.1007/s11104-005-4642-9; Wu LH, 2004, ENVIRON GEOCHEM HLTH, V26, P331, DOI 10.1023/B:EGAH.0000039598.24033.4e; Wuana RA, 2011, ISRN ECOL, V2011, P1, DOI [10.5402/2011/402647, DOI 10.5402/2011/402647]; XIAN XF, 1989, WATER AIR SOIL POLL, V45, P265, DOI 10.1007/BF00283457; [杨兵 Yang Bing], 2005, [生态学报, Acta Ecologica Sinica], V25, P45; Zaurov DE, 1999, J PLANT NUTR, V22, P977, DOI 10.1080/01904169909365687; Zhang MK, 2010, COMMUN SOIL SCI PLAN, V41, P820, DOI 10.1080/00103621003592341; Zhou Q, 2003, B ENVIRON CONTAM TOX, V71, P338, DOI 10.1007/s00128-003-0169-z	59	32	34	2	124	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2013	8	5							e62941	10.1371/journal.pone.0062941	http://dx.doi.org/10.1371/journal.pone.0062941			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145YI	23667546	Green Submitted, Green Published, gold			2022-12-27	WOS:000319055600048
J	Wildgruber, D; Szameitat, DP; Ethofer, T; Bruck, C; Alter, K; Grodd, W; Kreifelts, B				Wildgruber, Dirk; Szameitat, Diana P.; Ethofer, Thomas; Brueck, Carolin; Alter, Kai; Grodd, Wolfgang; Kreifelts, Benjamin			Different Types of Laughter Modulate Connectivity within Distinct Parts of the Laughter Perception Network	PLOS ONE			English	Article							ANTERIOR CINGULATE CORTEX; EMOTIONAL PROSODY; WORKING-MEMORY; BRAIN-REGIONS; RESPONSE CONFLICT; SOCIAL COGNITION; RIGHT-HEMISPHERE; FACE PERCEPTION; FMRI; AMYGDALA	Laughter is an ancient signal of social communication among humans and non-human primates. Laughter types with complex social functions (e.g., taunt and joy) presumably evolved from the unequivocal and reflex-like social bonding signal of tickling laughter already present in non-human primates. Here, we investigated the modulations of cerebral connectivity associated with different laughter types as well as the effects of attention shifts between implicit and explicit processing of social information conveyed by laughter using functional magnetic resonance imaging (fMRI). Complex social laughter types and tickling laughter were found to modulate connectivity in two distinguishable but partially overlapping parts of the laughter perception network irrespective of task instructions. Connectivity changes, presumably related to the higher acoustic complexity of tickling laughter, occurred between areas in the prefrontal cortex and the auditory association cortex, potentially reflecting higher demands on acoustic analysis associated with increased information load on auditory attention, working memory, evaluation and response selection processes. In contrast, the higher degree of socio-relational information in complex social laughter types was linked to increases of connectivity between auditory association cortices, the right dorsolateral prefrontal cortex and brain areas associated with mentalizing as well as areas in the visual associative cortex. These modulations might reflect automatic analysis of acoustic features, attention direction to informative aspects of the laughter signal and the retention of those in working memory during evaluation processes. These processes may be associated with visual imagery supporting the formation of inferences on the intentions of our social counterparts. Here, the right dorsolateral precentral cortex appears as a network node potentially linking the functions of auditory and visual associative sensory cortices with those of the mentalizing-associated anterior mediofrontal cortex during the decoding of social information in laughter.	[Wildgruber, Dirk; Szameitat, Diana P.; Ethofer, Thomas; Brueck, Carolin; Kreifelts, Benjamin] Univ Tubingen, Dept Psychiat & Psychotherapy, Tubingen, Germany; [Alter, Kai] Newcastle Univ, Inst Neurosci, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Wildgruber, Dirk; Ethofer, Thomas] Univ Tubingen, Dept Biomed Magnet Resonance, Tubingen, Germany; [Grodd, Wolfgang] Univ Aachen, Dept Psychiat & Psychotherapy, Aachen, Germany	Eberhard Karls University of Tubingen; Newcastle University - UK; Eberhard Karls University of Tubingen; RWTH Aachen University	Kreifelts, B (corresponding author), Univ Tubingen, Dept Psychiat & Psychotherapy, Tubingen, Germany.	benjamin.kreifelts@med.uni-tuebingen.de		Kreifelts, Benjamin/0000-0002-9233-3800; Alter, Kai/0000-0003-4575-9494	German Research Foundation [DFG WI 2101/2-1, DFG SZ 267/1-1]; Open Access Publishing Fund of Tuebingen University	German Research Foundation(German Research Foundation (DFG)); Open Access Publishing Fund of Tuebingen University	This study was financially supported by the German Research Foundation (DFG WI 2101/2-1 and DFG SZ 267/1-1; ULR: http://www.dfg.de) and the Open Access Publishing Fund of Tuebingen University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amodio DM, 2006, NAT REV NEUROSCI, V7, P268, DOI 10.1038/nrn1884; Bea J. A., 2003, Entropy, V5, DOI 10.3390/e5020205; Belin P, 2004, TRENDS COGN SCI, V8, P129, DOI 10.1016/j.tics.2004.01.008; Braver TS, 2001, CEREB CORTEX, V11, P825, DOI 10.1093/cercor/11.9.825; Bruck C, 2011, PHYS LIFE REV, V8, P383, DOI 10.1016/j.plrev.2011.10.002; Brunet E, 2000, NEUROIMAGE, V11, P157, DOI 10.1006/nimg.1999.0525; Buchanan TW, 2007, PSYCHOL BULL, V133, P761, DOI 10.1037/0033-2909.133.5.761; Buchanan TW, 2000, COGNITIVE BRAIN RES, V9, P227, DOI 10.1016/S0926-6410(99)00060-9; Bunge SA, 2002, NEUROIMAGE, V17, P1562, DOI 10.1006/nimg.2002.1252; Carter CS, 1998, SCIENCE, V280, P747, DOI 10.1126/science.280.5364.747; Casey BJ, 2000, P NATL ACAD SCI USA, V97, P8728, DOI 10.1073/pnas.97.15.8728; Chen JL, 2008, J COGNITIVE NEUROSCI, V20, P226, DOI 10.1162/jocn.2008.20018; COLLINS DL, 1994, J COMPUT ASSIST TOMO, V18, P192, DOI 10.1097/00004728-199403000-00005; Davila-Ross M, 2011, EMOTION, V11, P1013, DOI 10.1037/a0022594; DAVITZ JR, 1964, COMMUNICATION EMOTIO, P13; Ekman M, 2012, P NATL ACAD SCI USA, V109, P16714, DOI 10.1073/pnas.1207523109; Ethofer T, 2006, NEUROIMAGE, V30, P580, DOI 10.1016/j.neuroimage.2005.09.059; Ethofer T, 2009, J COGNITIVE NEUROSCI, V21, P1255, DOI 10.1162/jocn.2009.21099; Ethofer T, 2009, CURR BIOL, V19, P1028, DOI 10.1016/j.cub.2009.04.054; Fecteau S, 2007, NEUROIMAGE, V36, P480, DOI 10.1016/j.neuroimage.2007.02.043; Friston K J, 1994, Hum Brain Mapp, V1, P210, DOI 10.1002/hbm.460010306; Friston KJ, 2002, NEUROIMAGE, V16, P484, DOI 10.1006/nimg.2002.1091; Friston KJ, 1997, NEUROIMAGE, V6, P218, DOI 10.1006/nimg.1997.0291; GEISSER S, 1958, ANN MATH STAT, V29, P885, DOI 10.1214/aoms/1177706545; George MS, 1996, ARCH NEUROL-CHICAGO, V53, P665, DOI 10.1001/archneur.1996.00550070103017; Gervais M, 2005, Q REV BIOL, V80, P395, DOI 10.1086/498281; Gitelman DR, 2003, NEUROIMAGE, V19, P200, DOI 10.1016/S1053-8119(03)00058-2; Gruber O, 2000, NEUROREPORT, V11, P1689, DOI 10.1097/00001756-200006050-00019; Guye M, 2008, CURR OPIN NEUROL, V21, P393, DOI 10.1097/WCO.0b013e3283065cfb; Haxby JV, 2000, TRENDS COGN SCI, V4, P223, DOI 10.1016/S1364-6613(00)01482-0; Ishai A, 2010, ARCH ITAL BIOL, V148, P1; Jancke L, 2002, NEUROIMAGE, V15, P733, DOI 10.1006/nimg.2001.1027; Kampe KKW, 2003, J NEUROSCI, V23, P5258; Kanwisher N, 1997, J NEUROSCI, V17, P4302; Kotz SA, 2012, HUM BRAIN M IN PRESS; Leitman DI, 2011, FRONT HUM NEUROSCI, V5, DOI [10.3389/fnhum.2011.00096, 10.3389/fnhum.2010.00019]; Mar RA, 2011, ANNU REV PSYCHOL, V62, P103, DOI 10.1146/annurev-psych-120709-145406; Marrelec G, 2006, J PHYSIOL-PARIS, V100, P171, DOI 10.1016/j.jphysparis.2007.01.003; Meyer M, 2005, COGNITIVE BRAIN RES, V24, P291, DOI 10.1016/j.cogbrainres.2005.02.008; Meyer M, 2007, BEHAV BRAIN RES, V182, P245, DOI 10.1016/j.bbr.2007.04.023; Mitchell JP, 2005, NEUROIMAGE, V28, P757, DOI 10.1016/j.neuroimage.2005.03.011; Mitchell RLC, 2007, NEUROIMAGE, V36, P1015, DOI 10.1016/j.neuroimage.2007.03.016; Nakai Toshiharu, 2005, Magn Reson Med Sci, V4, P75, DOI 10.2463/mrms.4.75; Nichols T, 2005, NEUROIMAGE, V25, P653, DOI 10.1016/j.neuroimage.2004.12.005; O'Craven KM, 2000, J COGNITIVE NEUROSCI, V12, P1013, DOI 10.1162/08989290051137549; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Panksepp A, 2000, CURR DIR PSYCHOL SCI, V9, P183; Panksepp J, 2003, PHYSIOL BEHAV, V79, P533, DOI 10.1016/S0031-9384(03)00159-8; Price CJ, 2010, ANN NY ACAD SCI, V1191, P62, DOI 10.1111/j.1749-6632.2010.05444.x; Purdon PL, 1998, HUM BRAIN MAPP, V6, P239, DOI 10.1002/(SICI)1097-0193(1998)6:4<239::AID-HBM4>3.3.CO;2-0; Rama P, 2005, NEUROIMAGE, V24, P224, DOI 10.1016/j.neuroimage.2004.08.024; Ross MD, 2009, CURR BIOL, V19, P1106, DOI 10.1016/j.cub.2009.05.028; Sander K, 2005, J COGNITIVE NEUROSCI, V17, P1519, DOI 10.1162/089892905774597227; Sander K, 2003, BRAIN RES PROTOC, V11, P81, DOI 10.1016/S1385-299X(03)00018-7; Sander K, 2001, COGNITIVE BRAIN RES, V12, P181, DOI 10.1016/S0926-6410(01)00045-3; SCHERER KR, 1985, ADV STUD BEHAV, V15, P189, DOI 10.1016/S0065-3454(08)60490-8; Schirmer A, 2006, TRENDS COGN SCI, V10, P24, DOI 10.1016/j.tics.2005.11.009; Szameitat DP, 2010, NEUROIMAGE, V53, P1264, DOI 10.1016/j.neuroimage.2010.06.028; Szameitat DP, 2009, J ACOUST SOC AM, V126, P354, DOI 10.1121/1.3139899; Szameitat DP, 2009, EMOTION, V9, P397, DOI 10.1037/a0015692; Tschacher W, 2010, PSYCHOTHER RES, V20, P576, DOI 10.1080/10503307.2010.493538; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Van Overwalle F, 2009, NEUROIMAGE, V48, P564, DOI 10.1016/j.neuroimage.2009.06.009; von Kriegstein K, 2006, PLOS BIOL, V4, P1809, DOI 10.1371/journal.pbio.0040326; Walter H, 2004, J COGNITIVE NEUROSCI, V16, P1854, DOI 10.1162/0898929042947838; Wiethoff S, 2008, NEUROIMAGE, V39, P885, DOI 10.1016/j.neuroimage.2007.09.028; Wildgruber D, 2006, PROG BRAIN RES, V156, P249, DOI 10.1016/S0079-6123(06)56013-3; Wildgruber D, 2005, NEUROIMAGE, V24, P1233, DOI 10.1016/j.neuroimage.2004.10.034; Wildgruber D., 2009, INT J SPEECH-LANG PA, V11, P277, DOI [10.1080/17549500902943043, DOI 10.1080/17549500902943043]; Worsley KJ, 1996, HUM BRAIN MAPP, V4, P74, DOI 10.1002/(SICI)1097-0193(1996)4:1<74::AID-HBM5>3.0.CO;2-M	70	19	19	2	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2013	8	5							e63441	10.1371/journal.pone.0063441	http://dx.doi.org/10.1371/journal.pone.0063441			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	145YI	23667619	Green Submitted, Green Published, gold			2022-12-27	WOS:000319055600060
J	Heller, R; Chikhi, L; Siegismund, HR				Heller, Rasmus; Chikhi, Lounes; Siegismund, Hans Redlef			The Confounding Effect of Population Structure on Bayesian Skyline Plot Inferences of Demographic History	PLOS ONE			English	Article							GENE FLOW; DIVERSITY; MEGAFAUNA; REVEALS; DECLINE; HUMANS; SIZE	Many coalescent-based methods aiming to infer the demographic history of populations assume a single, isolated and panmictic population (i.e. a Wright-Fisher model). While this assumption may be reasonable under many conditions, several recent studies have shown that the results can be misleading when it is violated. Among the most widely applied demographic inference methods are Bayesian skyline plots (BSPs), which are used across a range of biological fields. Violations of the panmixia assumption are to be expected in many biological systems, but the consequences for skyline plot inferences have so far not been addressed and quantified. We simulated DNA sequence data under a variety of scenarios involving structured populations with variable levels of gene flow and analysed them using BSPs as implemented in the software package BEAST. Results revealed that BSPs can show false signals of population decline under biologically plausible combinations of population structure and sampling strategy, suggesting that the interpretation of several previous studies may need to be re-evaluated. We found that a balanced sampling strategy whereby samples are distributed on several populations provides the best scheme for inferring demographic change over a typical time scale. Analyses of data from a structured African buffalo population demonstrate how BSP results can be strengthened by simulations. We recommend that sample selection should be carefully considered in relation to population structure previous to BSP analyses, and that alternative scenarios should be evaluated when interpreting signals of population size change.	[Heller, Rasmus; Chikhi, Lounes] Gulbenkian Inst Sci, Oeiras, Portugal; [Heller, Rasmus; Siegismund, Hans Redlef] Univ Copenhagen, Dept Biol, Copenhagen, Denmark	University of Copenhagen	Heller, R (corresponding author), Gulbenkian Inst Sci, Oeiras, Portugal.	rheller@bio.ku.dk	Heller, Rasmus/M-2580-2014; Siegismund, Hans R./K-4332-2014	Heller, Rasmus/0000-0001-6583-6923; Siegismund, Hans R./0000-0001-5757-3131; Chikhi, Lounes/0000-0002-1140-0718	Danish Council for Independent Research \ Natural Sciences; Laboratoire d'Excellence (LABEX) [ANR-10-LABX-41]; Portuguese Science Foundation (Fundacao para a Ciencia e a Tecnologia) [PTDC/BIA-BEC/100176/2008]; Fundação para a Ciência e a Tecnologia [PTDC/BIA-BEC/100176/2008] Funding Source: FCT	Danish Council for Independent Research \ Natural Sciences(Det Frie Forskningsrad (DFF)); Laboratoire d'Excellence (LABEX); Portuguese Science Foundation (Fundacao para a Ciencia e a Tecnologia)(Portuguese Foundation for Science and Technology); Fundação para a Ciência e a Tecnologia	RH and HRS were supported by The Danish Council for Independent Research vertical bar Natural Sciences. LC was supported by the "Laboratoire d'Excellence (LABEX)" entitled TULIP (ANR-10-LABX-41) and by the Portuguese Science Foundation (Fundacao para a Ciencia e a Tecnologia, project ref. PTDC/BIA-BEC/100176/2008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2002, MODERN DEV THEORETIC; Atkinson QD, 2008, MOL BIOL EVOL, V25, P468, DOI 10.1093/molbev/msm277; Beaumont MA, 1999, GENETICS, V153, P2013; Beaumont MA, 2004, HEREDITY, V92, P365, DOI 10.1038/sj.hdy.6800447; Campos PF, 2010, P NATL ACAD SCI USA, V107, P5675, DOI 10.1073/pnas.0907189107; Chan YL, 2006, PLOS GENET, V2, P451, DOI 10.1371/journal.pgen.0020059; Chikhi L, 2010, GENETICS, V186, P983, DOI 10.1534/genetics.110.118661; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Fagundes NJR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003157; Gignoux CR, 2011, P NATL ACAD SCI USA, V108, P6044, DOI 10.1073/pnas.0914274108; Heled J, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-289; Heller R, 2008, MOL ECOL, V17, P4845, DOI 10.1111/j.1365-294X.2008.03961.x; Heller R, 2012, MOL ECOL, V21, P3947, DOI 10.1111/j.1365-294X.2012.05671.x; Hey J, 2007, P NATL ACAD SCI USA, V104, P2785, DOI 10.1073/pnas.0611164104; Ho SYW, 2011, MOL ECOL RESOUR, V11, P423, DOI 10.1111/j.1755-0998.2011.02988.x; HUDSON RR, 1992, GENETICS, V132, P583; Kuhner MK, 2006, BIOINFORMATICS, V22, P768, DOI 10.1093/bioinformatics/btk051; Lorenzen ED, 2011, NATURE, V479, P359, DOI 10.1038/nature10574; Nielsen R, 2009, MOL ECOL, V18, P1034, DOI 10.1111/j.1365-294X.2008.04059.x; Pannell JR, 2003, EVOLUTION, V57, P949; Peter BM, 2010, MOL ECOL, V19, P4648, DOI 10.1111/j.1365-294X.2010.04783.x; Pybus OG, 2000, GENETICS, V155, P1429; Ray N, 2003, MOL BIOL EVOL, V20, P76, DOI 10.1093/molbev/msg009; Rosenberg NA, 2002, NAT REV GENET, V3, P380, DOI 10.1038/nrg795; Shapiro B, 2004, SCIENCE, V306, P1561, DOI 10.1126/science.1101074; Sjodin P, 2005, GENETICS, V169, P1061, DOI 10.1534/genetics.104.026799; Smitz N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056235; Stadler T, 2009, GENETICS, V182, P205, DOI 10.1534/genetics.108.094904; Wakeley J, 1999, GENETICS, V153, P1863; Wakeley J., 2009, COALESCENT THEORY; Whitlock MC, 1999, HEREDITY, V82, P117, DOI 10.1038/sj.hdy.6884960	31	216	218	0	76	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e62992	10.1371/journal.pone.0062992	http://dx.doi.org/10.1371/journal.pone.0062992			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667558	Green Published, gold, Green Submitted			2022-12-27	WOS:000319654700095
J	Igawa, T; Maeda, A; Haraya, K; Tachibana, T; Iwayanagi, Y; Mimoto, F; Higuchi, Y; Ishii, S; Tamba, S; Hironiwa, N; Nagano, K; Wakabayashi, T; Tsunoda, H; Hattori, K				Igawa, Tomoyuki; Maeda, Atsuhiko; Haraya, Kenta; Tachibana, Tatsuhiko; Iwayanagi, Yuki; Mimoto, Futa; Higuchi, Yoshinobu; Ishii, Shinya; Tamba, Shigero; Hironiwa, Naoka; Nagano, Kozue; Wakabayashi, Tetsuya; Tsunoda, Hiroyuki; Hattori, Kunihiro			Engineered Monoclonal Antibody with Novel Antigen-Sweeping Activity In Vivo	PLOS ONE			English	Article							NEONATAL FC-RECEPTOR; THERAPEUTIC ANTIBODIES; HUMAN IGG1; HALF-LIFE; LIGAND INTERACTIONS; CYNOMOLGUS MONKEYS; IMMUNOGLOBULIN-G; AFFINITY; PHARMACOKINETICS; BINDING	Monoclonal antibodies are widely used to target disease-related antigens. However, because conventional antibody binds to the antigen but cannot eliminate the antigen from plasma, and rather increases the plasma antigen concentration by reducing the clearance of the antigen, some clinically important antigens are still difficult to target with monoclonal antibodies because of the huge dosages required. While conventional antibody can only bind to the antigen, some natural endocytic receptors not only bind to the ligands but also continuously eliminate them from plasma by pH-dependent dissociation of the ligands within the acidic endosome and subsequent receptor recycling to the cell surface. Here, we demonstrate that an engineered antibody, named sweeping antibody, having both pH-dependent antigen binding (to mimic the receptor-ligand interaction) and increased binding to cell surface neonatal Fc receptor (FcRn) at neutral pH (to mimic the cell-bound form of the receptor), selectively eliminated the antigen from plasma. With this novel antigen-sweeping activity, antibody without in vitro neutralizing activity exerted in vivo efficacy by directly eliminating the antigen from plasma. Moreover, conversion of conventional antibody with in vitro neutralizing activity into sweeping antibody further potentiated the in vivo efficacy. Depending on the binding affinity to FcRn at neutral pH, sweeping antibody reduced antigen concentration 50- to 1000-fold compared to conventional antibody. Thereby, sweeping antibody antagonized excess amounts of antigen in plasma against which conventional antibody was completely ineffective, and could afford marked reduction of dosage to a level that conventional antibody can never achieve. Thus, the novel mode of action of sweeping antibody provides potential advantages over conventional antibody and may allow access to the target antigens which were previously undruggable by conventional antibody.	[Igawa, Tomoyuki; Maeda, Atsuhiko; Haraya, Kenta; Tachibana, Tatsuhiko; Iwayanagi, Yuki; Mimoto, Futa; Higuchi, Yoshinobu; Ishii, Shinya; Tamba, Shigero; Hironiwa, Naoka; Nagano, Kozue; Wakabayashi, Tetsuya; Tsunoda, Hiroyuki; Hattori, Kunihiro] Chugai Pharmaceut Co Ltd, Div Res, Shizuoka, Japan	Chugai Pharmaceutical Co., Ltd.; Roche Holding	Igawa, T (corresponding author), Chugai Pharmaceut Co Ltd, Div Res, Shizuoka, Japan.	igawatmy@chugai-pharm.co.jp	HARAYA, KENTA/AAW-4267-2020	HARAYA, KENTA/0000-0002-9142-5607; Tachibana, Tatsuhiko/0000-0001-8339-3986				Betts AM, 2010, J PHARMACOL EXP THER, V333, P2, DOI 10.1124/jpet.109.164129; Byrd JC, 2007, CLIN CANCER RES, V13, P4448, DOI 10.1158/1078-0432.CCR-06-1463; Chan AC, 2010, NAT REV IMMUNOL, V10, P301, DOI 10.1038/nri2761; Dall'Acqua WF, 2002, J IMMUNOL, V169, P5171, DOI 10.4049/jimmunol.169.9.5171; Dall'Acqua WF, 2006, J BIOL CHEM, V281, P23514, DOI 10.1074/jbc.M604292200; Datta-Mannan A, 2007, J BIOL CHEM, V282, P1709, DOI 10.1074/jbc.M607161200; Davda JP, 2010, MABS-AUSTIN, V2, P576, DOI 10.4161/mabs.2.5.12833; Davis CB, 1999, DRUG DELIV, V6, P171, DOI 10.1080/107175499266922; Deng R, 2012, MABS-AUSTIN, V4, P101, DOI 10.4161/mabs.4.1.18543; Deng R, 2010, DRUG METAB DISPOS, V38, P600, DOI 10.1124/dmd.109.031310; Feinberg H, 2000, J BIOL CHEM, V275, P35176, DOI 10.1074/jbc.M005557200; Finch DK, 2011, J MOL BIOL, V411, P791, DOI 10.1016/j.jmb.2011.06.031; FINKELMAN FD, 1993, J IMMUNOL, V151, P1235; FRENCH AR, 1995, J BIOL CHEM, V270, P4334, DOI 10.1074/jbc.270.9.4334; Haringman JJ, 2006, ARTHRITIS RHEUM, V54, P2387, DOI 10.1002/art.21975; Hinton PR, 2006, J IMMUNOL, V176, P346, DOI 10.4049/jimmunol.176.1.346; Igawa T, 2010, NAT BIOTECHNOL, V28, P1203, DOI 10.1038/nbt.1691; Jayson GC, 2005, EUR J CANCER, V41, P555, DOI 10.1016/j.ejca.2004.11.021; Jostock T, 2001, EUR J BIOCHEM, V268, P160, DOI 10.1046/j.1432-1327.2001.01867.x; Martin PL, 2005, J IMMUNOTOXICOL, V3, P131; Ober RJ, 2001, INT IMMUNOL, V13, P1551, DOI 10.1093/intimm/13.12.1551; Okazaki M, 2002, IMMUNOL LETT, V84, P231, DOI 10.1016/S0165-2478(02)00202-X; Ozbek S, 2001, ONCOGENE, V20, P972, DOI 10.1038/sj.onc.1204180; Petkova SB, 2006, INT IMMUNOL, V18, P1759, DOI 10.1093/intimm/dxl110; Preithner S, 2006, MOL IMMUNOL, V43, P1183, DOI 10.1016/j.molimm.2005.07.010; RASHID A, 1992, J IMMUNOL, V148, P1382; Rathanaswami P, 2005, BIOCHEM BIOPH RES CO, V334, P1004, DOI 10.1016/j.bbrc.2005.07.002; Roopenian DC, 2010, METHODS MOL BIOL, V602, P93, DOI 10.1007/978-1-60761-058-8_6; Vaccaro C, 2005, NAT BIOTECHNOL, V23, P1283, DOI 10.1038/nbt1143; Weiner LM, 2010, NAT REV IMMUNOL, V10, P317, DOI 10.1038/nri2744; Xiao JJ, 2010, AAPS J, V12, P646, DOI 10.1208/s12248-010-9222-0; Yamamoto T, 2008, BIOCHEMISTRY-US, V47, P11647, DOI 10.1021/bi801117t; Yeung YA, 2009, J IMMUNOL, V182, P7663, DOI 10.4049/jimmunol.0804182; Zalevsky J, 2010, NAT BIOTECHNOL, V28, P157, DOI 10.1038/nbt.1601; Zareba KM, 2007, DRUGS TODAY, V43, P539, DOI 10.1358/dot.2007.43.8.1130446	35	55	77	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e63236	10.1371/journal.pone.0063236	http://dx.doi.org/10.1371/journal.pone.0063236			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667591	gold, Green Published, Green Submitted			2022-12-27	WOS:000319654700121
J	Isaksson, L; Mayzel, M; Saline, M; Pedersen, A; Rosenlow, J; Brutscher, B; Karlsson, BG; Orekhov, VY				Isaksson, Linnea; Mayzel, Maxim; Saline, Maria; Pedersen, Anders; Rosenlow, Joakim; Brutscher, Bernhard; Karlsson, B. Goran; Orekhov, Vladislav Y.			Highly Efficient NMR Assignment of Intrinsically Disordered Proteins: Application to B- and T Cell Receptor Domains	PLOS ONE			English	Article							COMPLETE SEQUENCE; ACTIVATION MOTIF; CHEMICAL-SHIFTS; SPECTROSCOPY; VALIDATION; EXPRESSION; INITIATION; RECOGNITION; MODELS; SYSTEM	We present an integrated approach for efficient characterization of intrinsically disordered proteins. Batch cell-free expression, fast data acquisition, automated analysis, and statistical validation with data resampling have been combined for achieving cost-effective protein expression, and rapid automated backbone assignment. The new methodology is applied for characterization of five cytosolic domains from T- and B-cell receptors in solution.	[Isaksson, Linnea; Mayzel, Maxim; Saline, Maria; Pedersen, Anders; Rosenlow, Joakim; Karlsson, B. Goran; Orekhov, Vladislav Y.] Univ Gothenburg, Swedish NMR Ctr, Gothenburg, Sweden; [Brutscher, Bernhard] Univ Grenoble, Inst Biol Struct, CEA, CNRS, Grenoble, France	University of Gothenburg; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS)	Orekhov, VY (corresponding author), Univ Gothenburg, Swedish NMR Ctr, Gothenburg, Sweden.	vladislav.orekhov@nmr.gu.se	Orekhov, Vladislav/AAD-8464-2019; Mayzel, Maksim/AAM-1393-2020; Karlsson, Göran/E-8686-2011; Pedersen, Anders/N-3888-2014; Orekhov, Vladislav/AAC-8357-2022	Orekhov, Vladislav/0000-0002-7892-6896; Pedersen, Anders/0000-0001-8704-5129; Karlsson, Goran/0000-0002-1821-4715	Swedish Research Council [621-2005-2951, 2011-5994]; Wenner-Gren Foundation (Stockholm); European Commis-sion (FP7-I3-Bio-NMR project) [261863]; European Commis-sion (FP7-ITN-IDPbyNMR) [264257]	Swedish Research Council(Swedish Research CouncilEuropean Commission); Wenner-Gren Foundation (Stockholm); European Commis-sion (FP7-I3-Bio-NMR project); European Commis-sion (FP7-ITN-IDPbyNMR)	The work was supported by the Swedish Research Council (621-2005-2951, 2011-5994), Wenner-Gren Foundation (Stockholm), and the European Commis-sion (FP7-I3-Bio-NMR project No. 261863 and FP7-ITN-IDPbyNMR contract No. 264257). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bagaria A, 2012, PROTEIN SCI, V21, P229, DOI 10.1002/pro.2007; Bermel W, 2006, J AM CHEM SOC, V128, P3918, DOI 10.1021/ja0582206; BRUNGER AT, 1993, SCIENCE, V261, P328, DOI 10.1126/science.8332897; Buck M, 1998, Q REV BIOPHYS, V31, P297, DOI 10.1017/S003358359800345X; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DYSON HJ, 1992, J MOL BIOL, V226, P819, DOI 10.1016/0022-2836(92)90634-V; DYSON HJ, 1992, J MOL BIOL, V226, P795, DOI 10.1016/0022-2836(92)90633-U; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; Efron B, 1993, INTRO BOOTSTRAP, Vxvi; Efron B, 1982, JACKKNIFE BOOTSTRAP, Vvii; Favier A, 2011, J BIOMOL NMR, V49, P9, DOI 10.1007/s10858-010-9461-5; Gaul BS, 2000, J BIOL CHEM, V275, P16174, DOI 10.1074/jbc.M909044199; Hiller S, 2008, SCIENCE, V321, P1206, DOI 10.1126/science.1161302; Jaravine V, 2006, NAT METHODS, V3, P605, DOI 10.1038/NMETH900; Jaravine VA, 2008, J AM CHEM SOC, V130, P3927, DOI 10.1021/ja077282o; Jaravine VA, 2006, J AM CHEM SOC, V128, P13421, DOI 10.1021/ja062146p; Kanter G, 2007, BLOOD, V109, P3393, DOI 10.1182/blood-2006-07-030593; Kazimierczuk K, 2011, ANGEW CHEM INT EDIT, V50, P5556, DOI 10.1002/anie.201100370; Kigawa T, 1999, FEBS LETT, V442, P15, DOI 10.1016/S0014-5793(98)01620-2; Kjaergaard M, 2012, PROG NUCL MAG RES SP, V60, P42, DOI 10.1016/j.pnmrs.2011.10.001; Klammt C, 2004, EUR J BIOCHEM, V271, P568, DOI 10.1111/j.1432-1033.2003.03959.x; Kurotani A, 2010, FASEB J, V24, P1095, DOI 10.1096/fj.09-139527; Mantylahti S, 2010, J BIOMOL NMR, V47, P171, DOI 10.1007/s10858-010-9421-0; Mittag T, 2007, CURR OPIN STRUC BIOL, V17, P3, DOI 10.1016/j.sbi.2007.01.009; Modig K, 2007, FEBS LETT, V581, P4965, DOI 10.1016/j.febslet.2007.09.027; Moseley HNB, 2004, J BIOMOL NMR, V28, P341, DOI 10.1023/B:JNMR.0000015420.44364.06; Motackova V, 2010, J BIOMOL NMR, V48, P169, DOI 10.1007/s10858-010-9447-3; Narayanan RL, 2010, J AM CHEM SOC, V132, P11906, DOI 10.1021/ja105657f; Orekhov VY, 2011, PROG NUCL MAG RES SP, V59, P271, DOI 10.1016/j.pnmrs.2011.02.002; Orekhov VY, 2001, J BIOMOL NMR, V20, P49, DOI 10.1023/A:1011234126930; Ozawa K, 2004, EUR J BIOCHEM, V271, P4084, DOI 10.1111/j.1432-1033.2004.04346.x; Pedersen A, 2011, NEW BIOTECHNOL, V28, P218, DOI 10.1016/j.nbt.2010.06.015; Salmon L, 2010, J AM CHEM SOC, V132, P8407, DOI 10.1021/ja101645g; SEGAWA S, 1991, BIOPOLYMERS, V31, P497, DOI 10.1002/bip.360310505; Sigalov A, 2004, BIOCHEMISTRY-US, V43, P2049, DOI 10.1021/bi035900h; Sigalov AB, 2006, BIOCHEMISTRY-US, V45, P15731, DOI 10.1021/bi061108f; Solyom Z, 2013, J BIOMOL NM IN PRESS, DOI [10.1007/s10858-013-9715-0, DOI 10.1007/S10858-013-9715-0:IN]; Stein A, 2009, FEBS J, V276, P5390, DOI 10.1111/j.1742-4658.2009.07251.x; Tompa P, 2010, STRUCTURE FUNCTION I, Vxxvii; Tugarinov V, 2005, CHEMBIOCHEM, V6, P1567, DOI 10.1002/cbic.200500110; Tzakos AG, 2006, ANNU REV BIOPH BIOM, V35, P319, DOI 10.1146/annurev.biophys.35.040405.102034; Uversky VN, 2010, BBA-PROTEINS PROTEOM, V1804, P1231, DOI 10.1016/j.bbapap.2010.01.017; van den Berg S, 2006, J BIOTECHNOL, V121, P291, DOI 10.1016/j.jbiotec.2005.08.006; Vinarov DA, 2004, NAT METHODS, V1, P149, DOI 10.1038/NMETH716; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; Wang BW, 2010, J BIOMOL NMR, V47, P85, DOI 10.1007/s10858-010-9407-y; Woodrow KA, 2006, J PROTEOME RES, V5, P3288, DOI 10.1021/pr050459y; Zhang HY, 2003, J BIOMOL NMR, V25, P173, DOI 10.1023/A:1022836027055	48	37	37	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e62947	10.1371/journal.pone.0062947	http://dx.doi.org/10.1371/journal.pone.0062947			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667548	Green Published, gold, Green Submitted			2022-12-27	WOS:000319654700086
J	Song, JY; Qin, W; Liu, Y; Duan, YY; Liu, JQ; He, XX; Li, KC; Zhang, XQ; Jiang, TZ; Yu, CS				Song, Jinyu; Qin, Wen; Liu, Yong; Duan, Yunyun; Liu, Jieqiong; He, Xiaoxi; Li, Kuncheng; Zhang, Xinqing; Jiang, Tianzi; Yu, Chunshui			Aberrant Functional Organization within and between Resting-State Networks in AD	PLOS ONE			English	Article							MILD COGNITIVE IMPAIRMENT; DEFAULT-MODE NETWORK; DISTINCT BRAIN NETWORKS; ALZHEIMERS-DISEASE; CONNECTIVITY NETWORKS; POSTERIOR CINGULATE; VISUAL-ATTENTION; MRI DATA; FMRI; DEMENTIA	Altered functional characteristics have been reported in amnestic mild cognitive impairment (aMCI) and Alzheimer's disease (AD); nonetheless, comprehensive analyses of the resting-state networks (RSNs) are rare. This study combined multiple imaging modalities to investigate the functional and structural changes within each RSN and between RSNs in aMCI/AD patients. Eight RSNs were identified from functional MRI data from 35 AD, 18 aMCI and 21 normal control subjects using independent component analysis. We compared functional connectivity (FC) within each RSN and found decreased FC in the several cognitive-related RSNs in AD, including the bilateral precuneus of the precuneus network, the posterior cingulate cortex and left precuneus of the posterior default mode network (DMN), and the left superior parietal lobule of the left frontoparietal network (LFP). We further compared the grey matter volumes and amplitudes of low-frequency fluctuations of these regions and found decreases in these measures in AD. Importantly, we found decreased inter-network connectivity between the visual network and the LFP and between the anterior and posterior DMNs in AD. All indices in aMCI patients were numerically between those of controls and AD patients. These results suggest that the brain networks supporting complex cognitive processes are specifically and progressively impaired over the course of AD, and the FC impairments are present not only within networks but also between networks.	[Song, Jinyu; Qin, Wen; He, Xiaoxi; Yu, Chunshui] Tianjin Med Univ, Gen Hosp, Dept Radiol, Tianjin, Peoples R China; [Liu, Yong; Jiang, Tianzi] Chinese Acad Sci, Inst Automat, Natl Lab Pattern Recognit, Beijing, Peoples R China; [Liu, Jieqiong; Zhang, Xinqing] Capital Med Univ, Xuanwu Hosp, Dept Neurol, Beijing, Peoples R China; [Duan, Yunyun; Li, Kuncheng] Capital Med Univ, Xuanwu Hosp, Dept Radiol, Beijing, Peoples R China	Tianjin Medical University; Chinese Academy of Sciences; Institute of Automation, CAS; Capital Medical University; Capital Medical University	Zhang, XQ (corresponding author), Capital Med Univ, Xuanwu Hosp, Dept Neurol, Beijing, Peoples R China.	xinqingzhang@263.net; jiangtz@nlpr.ia.ac.cn; chunshuiyu@yahoo.cn	Jiang, Tianzi/I-4256-2012; Liu, Yong/F-2682-2011; QIN, WEN/F-3783-2015	Jiang, Tianzi/0000-0001-9531-291X; Liu, Yong/0000-0002-1862-3121; QIN, WEN/0000-0002-9121-8296; Yu, Chunshui/0000-0001-5648-5199	Natural Science Foundation of Tianjin [11JCZDJC19300]; National Basic Research Program of China (973 program) [2011CB707801]; Natural Science Foundation of China [81271551, 60831004, 30900476]; International Cooperation and Exchanges NSFC [30370434]	Natural Science Foundation of Tianjin(Natural Science Foundation of Tianjin); National Basic Research Program of China (973 program)(National Basic Research Program of China); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); International Cooperation and Exchanges NSFC	This work was supported by the Natural Science Foundation of Tianjin (No. 11JCZDJC19300), the National Basic Research Program of China (973 program, No. 2011CB707801), the Natural Science Foundation of China (Nos. 81271551, 60831004, 30900476), and the International Cooperation and Exchanges NSFC (No. 30370434). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agosta F, 2012, NEUROBIOL AGING, V33, P1564, DOI 10.1016/j.neurobiolaging.2011.06.007; Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007; Bai F, 2008, NEUROSCI LETT, V438, P111, DOI 10.1016/j.neulet.2008.04.021; Bai F, 2012, CORTEX, V48, P604, DOI 10.1016/j.cortex.2011.02.011; Bai F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024271; Bai F, 2009, BRAIN RES, V1302, P167, DOI 10.1016/j.brainres.2009.09.028; Binnewijzend MAA, 2012, NEUROBIOL AGING, V33, P2018, DOI 10.1016/j.neurobiolaging.2011.07.003; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Bokde ALW, 2008, PSYCHIAT RES-NEUROIM, V163, P248, DOI 10.1016/j.pscychresns.2007.08.013; Brier MR, 2012, J NEUROSCI, V32, P8890, DOI 10.1523/JNEUROSCI.5698-11.2012; Broyd SJ, 2009, NEUROSCI BIOBEHAV R, V33, P279, DOI 10.1016/j.neubiorev.2008.09.002; Buckner RL, 2005, J NEUROSCI, V25, P7709, DOI 10.1523/JNEUROSCI.2177-05.2005; Buckner RL, 2004, NEURON, V44, P195, DOI 10.1016/j.neuron.2004.09.006; Buzsaki G, 2004, SCIENCE, V304, P1926, DOI 10.1126/science.1099745; Calhoun VD, 2001, HUM BRAIN MAPP, V13, P43, DOI 10.1002/hbm.1024; Calhoun VD, 2001, HUM BRAIN MAPP, V14, P140, DOI 10.1002/hbm.1048; Chadick JZ, 2011, NAT NEUROSCI, V14, P830, DOI 10.1038/nn.2823; Corbetta M, 1998, P NATL ACAD SCI USA, V95, P831, DOI 10.1073/pnas.95.3.831; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Corbetta M, 2008, NEURON, V58, P306, DOI 10.1016/j.neuron.2008.04.017; Damoiseaux JS, 2008, CEREB CORTEX, V18, P1856, DOI 10.1093/cercor/bhm207; Damoiseaux JS, 2006, P NATL ACAD SCI USA, V103, P13848, DOI 10.1073/pnas.0601417103; Damoiseaux JS, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.06.024; De Luca M, 2006, NEUROIMAGE, V29, P1359, DOI 10.1016/j.neuroimage.2005.08.035; Dorfel D, 2009, EUR J NEUROSCI, V30, P1947, DOI 10.1111/j.1460-9568.2009.06973.x; Dosenbach NUF, 2007, P NATL ACAD SCI USA, V104, P11073, DOI 10.1073/pnas.0704320104; Edison P, 2007, NEUROLOGY, V68, P501, DOI 10.1212/01.wnl.0000244749.20056.d4; FAZEKAS F, 1987, AM J ROENTGENOL, V149, P351, DOI 10.2214/ajr.149.2.351; Fita IG, 2011, ROM J MORPHOL EMBRYO, V52, P975; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Fox MD, 2006, P NATL ACAD SCI USA, V103, P10046, DOI 10.1073/pnas.0604187103; Fransson P, 2005, HUM BRAIN MAPP, V26, P15, DOI 10.1002/hbm.20113; Galvin JE, 2011, NEUROLOGY, V76, P1797, DOI 10.1212/WNL.0b013e31821ccc83; Greicius MD, 2004, J COGNITIVE NEUROSCI, V16, P1484, DOI 10.1162/0898929042568532; Greicius MD, 2004, P NATL ACAD SCI USA, V101, P4637, DOI 10.1073/pnas.0308627101; Hanggi J, 2011, J ALZHEIMERS DIS, V26, P719, DOI 10.3233/JAD-2011-101260; Han SH, 2004, HUM BRAIN MAPP, V22, P321, DOI 10.1002/hbm.20044; Hao J, 2005, NEUROSCI LETT, V385, P18, DOI 10.1016/j.neulet.2005.05.028; He Y, 2009, NEUROSCIENTIST, V15, P333, DOI 10.1177/1073858409334423; Hedden T, 2006, NAT NEUROSCI, V9, P863, DOI 10.1038/nn0706-863; Jafri MJ, 2008, NEUROIMAGE, V39, P1666, DOI 10.1016/j.neuroimage.2007.11.001; Jin MW, 2012, MAGN RESON IMAGING, V30, P48, DOI 10.1016/j.mri.2011.07.007; Karas G, 2007, NEURORADIOLOGY, V49, P967, DOI 10.1007/s00234-007-0269-2; Kastner S, 2001, NEUROPSYCHOLOGIA, V39, P1263, DOI 10.1016/S0028-3932(01)00116-6; KAWASHIMA R, 1995, CEREB CORTEX, V5, P111, DOI 10.1093/cercor/5.2.111; Kjaer TW, 2002, NEUROIMAGE, V17, P1080, DOI 10.1006/nimg.2002.1230; Kjaer TW, 2001, CONSCIOUS COGN, V10, P356, DOI 10.1006/ccog.2001.0509; Koechlin E, 2007, TRENDS COGN SCI, V11, P229, DOI 10.1016/j.tics.2007.04.005; Li R, 2012, AJNR AM J N IN PRESS; Li R, 2012, HUM BRAIN MAPP, V33, P1076, DOI 10.1002/hbm.21269; Liao W, 2010, NEUROIMAGE, V52, P1549, DOI 10.1016/j.neuroimage.2010.05.010; Liao W, 2010, BIOL CYBERN, V102, P57, DOI 10.1007/s00422-009-0350-5; Lou HC, 2004, P NATL ACAD SCI USA, V101, P6827, DOI 10.1073/pnas.0400049101; Lowe MJ, 1998, NEUROIMAGE, V7, P119, DOI 10.1006/nimg.1997.0315; Lundstrom BN, 2005, NEUROIMAGE, V27, P824, DOI 10.1016/j.neuroimage.2005.05.008; Lundstrom BN, 2003, NEUROIMAGE, V20, P1934, DOI 10.1016/j.neuroimage.2003.07.017; Lustig C, 2003, P NATL ACAD SCI USA, V100, P14504, DOI 10.1073/pnas.2235925100; Mantini D, 2007, P NATL ACAD SCI USA, V104, P13170, DOI 10.1073/pnas.0700668104; Mason MF, 2007, SCIENCE, V315, P393, DOI 10.1126/science.1131295; McKeown MJ, 1998, HUM BRAIN MAPP, V6, P160, DOI 10.1002/(SICI)1097-0193(1998)6:3<160::AID-HBM5>3.0.CO;2-1; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; MORRIS JC, 1993, NEUROLOGY, V43, P2412, DOI 10.1212/WNL.43.11.2412-a; Neufang S, 2011, J ALZHEIMERS DIS, V25, P309, DOI 10.3233/JAD-2011-102154; Onoda K, 2012, J COGN NEUR IN PRESS; Perry RJ, 1999, BRAIN, V122, P383, DOI 10.1093/brain/122.3.383; Perry RJ, 2000, NEUROPSYCHOLOGIA, V38, P252, DOI 10.1016/S0028-3932(99)00079-2; Petersen R C, 1997, Int Psychogeriatr, V9 Suppl 1, P65, DOI 10.1017/S1041610297004717; Petersen RC, 2001, ARCH NEUROL-CHICAGO, V58, P1985, DOI 10.1001/archneur.58.12.1985; Petersen RC, 1999, ARCH NEUROL-CHICAGO, V56, P303, DOI 10.1001/archneur.56.3.303; Petrella JR, 2011, NEUROLOGY, V76, P511, DOI 10.1212/WNL.0b013e31820af94e; Petrella JR, 2007, RADIOLOGY, V245, P224, DOI 10.1148/radiol.2451061847; Pignatti R, 2005, J CLIN EXP NEUROPSYC, V27, P436, DOI 10.1080/13803390490520427; Putcha D, 2011, J NEUROSCI, V31, P17680, DOI 10.1523/JNEUROSCI.4740-11.2011; Qi ZG, 2010, NEUROIMAGE, V50, P48, DOI 10.1016/j.neuroimage.2009.12.025; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Rajapakse JC, 1997, IEEE T MED IMAGING, V16, P176, DOI 10.1109/42.563663; Reid W, 1996, ARCH NEUROL-CHICAGO, V53, P1056, DOI 10.1001/archneur.1996.00550100142023; Rombouts SARB, 2009, HUM BRAIN MAPP, V30, P256, DOI 10.1002/hbm.20505; Roosendaal SD, 2010, BRAIN, V133, P1612, DOI 10.1093/brain/awq058; Rosler A, 2005, CORTEX, V41, P512, DOI 10.1016/S0010-9452(08)70191-6; Schwindt GC, 2012, CEREB CORTE IN PRESS; Seeley WW, 2007, J NEUROSCI, V27, P2349, DOI 10.1523/JNEUROSCI.5587-06.2007; Seeley WW, 2009, NEURON, V62, P42, DOI 10.1016/j.neuron.2009.03.024; Sheline YI, 2010, BIOL PSYCHIAT, V67, P584, DOI 10.1016/j.biopsych.2009.08.024; Shomstein S, 2012, NEUROPSYCHOLOGIA, V50, P1202, DOI 10.1016/j.neuropsychologia.2012.02.009; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Smith SM, 2009, P NATL ACAD SCI USA, V106, P13040, DOI 10.1073/pnas.0905267106; Sorg C, 2007, P NATL ACAD SCI USA, V104, P18760, DOI 10.1073/pnas.0708803104; Steffener J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044421; Supekar K, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000100; Tales A, 2002, NEUROPSYCHOLOGIA, V40, P2000, DOI 10.1016/S0028-3932(02)00057-X; van de Ven V, 2008, HUM BRAIN MAPP, V29, P1450, DOI 10.1002/hbm.20479; Van Essen DC, 2005, NEUROIMAGE, V28, P635, DOI 10.1016/j.neuroimage.2005.06.058; Vannini P, 2007, PSYCHIAT RES-NEUROIM, V156, P43, DOI 10.1016/j.pscychresns.2007.02.003; Veer IM, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00041; Vincent JL, 2008, J NEUROPHYSIOL, V100, P3328, DOI 10.1152/jn.90355.2008; Vogt BA, 2005, PROG BRAIN RES, V150, P205, DOI 10.1016/S0079-6123(05)50015-3; Wang ZQ, 2011, HUM BRAIN MAPP, V32, P1720, DOI 10.1002/hbm.21140; Weintraub S, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006171; Wenderoth N, 2005, EUR J NEUROSCI, V22, P235, DOI 10.1111/j.1460-9568.2005.04176.x; Yan CG, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00013; Zang YF, 2007, BRAIN DEV-JPN, V29, P83, DOI 10.1016/j.braindev.2006.07.002; Zhang H, 2010, NEUROIMAGE, V51, P1414, DOI 10.1016/j.neuroimage.2010.03.039; Zhang HY, 2009, BEHAV BRAIN RES, V197, P103, DOI 10.1016/j.bbr.2008.08.012; Zhou J, 2010, BRAIN, V133, P1352, DOI 10.1093/brain/awq075	105	42	47	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e63727	10.1371/journal.pone.0063727	http://dx.doi.org/10.1371/journal.pone.0063727			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667665	Green Submitted, Green Published, gold			2022-12-27	WOS:000319654700181
J	Struck, TH				Struck, Torsten H.			The Impact of Paralogy on Phylogenomic Studies - A Case Study on Annelid Relationships	PLOS ONE			English	Article							18S RDNA; SEQUENCE DATA; MITOCHONDRIAL GENOME; MOLECULAR PHYLOGENY; BILATERIAN ANIMALS; DATA SUPPORT; SISTER GROUP; 28S RDNA; POLYCHAETA; COELOMATA	Phylogenomic studies based on hundreds of genes derived from expressed sequence tags libraries are increasingly used to reveal the phylogeny of taxa. A prerequisite for these studies is the assignment of genes into clusters of orthologous sequences. Sophisticated methods of orthology prediction are used in such analyses, but it is rarely assessed whether paralogous sequences have been erroneously grouped together as orthologous sequences after the prediction, and whether this had an impact on the phylogenetic reconstruction using a super-matrix approach. Herein, I tested the impact of paralogous sequences on the reconstruction of annelid relationships based on phylogenomic datasets. Using single-partition analyses, screening for bootstrap support, blast searches and pruning of sequences in the supermatrix, wrongly assigned paralogous sequences were found in eight partitions and the placement of five taxa (the annelids Owenia, Scoloplos, Sthenelais and Eurythoe and the nemertean Cerebratulus) including the robust bootstrap support could be attributed to the presence of paralogous sequences in two partitions. Excluding these sequences resulted in a different, weaker supported placement for these taxa. Moreover, the analyses revealed that paralogous sequences impacted the reconstruction when only a single taxon represented a previously supported higher taxon such as a polychaete family. One possibility of a priori detection of wrongly assigned paralogous sequences could combine 1) a screening of single-partition analyses based on criteria such as nodal support or internal branch length with 2) blast searches of suspicious cases as presented herein. Also possible are a posteriori approaches in which support for specific clades is investigated by comparing alternative hypotheses based on differences in per-site likelihoods. Increasing the sizes of EST libraries will also decrease the likelihood of wrongly assigned paralogous sequences, and in the case of orthology prediction methods like HaMStR it is likewise decreased by using more than one reference taxon.	Zool Res Museum Alexander Koenig, Bonn, Germany	Zoologisches Forschungsmuseum Alexander Koenig (ZFMK)	Struck, TH (corresponding author), Zool Res Museum Alexander Koenig, Bonn, Germany.	torsten.struck.zfmk@uni-bonn.de			German Science Foundation DFG [STR-683/7-1]; DFG [STR-683/8-1]	German Science Foundation DFG(German Research Foundation (DFG)); DFG(German Research Foundation (DFG))	The German Science Foundation DFG STR-683/7-1 and DFG STR-683/8-1 funded this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrade SCS, 2012, CLADISTICS, V28, P141, DOI 10.1111/j.1096-0031.2011.00376.x; [Anonymous], 2010, RIBOSOMAL PROTEIN GE; Birney E, 2004, GENOME RES, V14, P988, DOI 10.1101/gr.1865504; Bleidorn C, 2006, GENE, V370, P96, DOI 10.1016/j.gene.2005.11.018; Bleidorn C, 2003, J ZOOL SYST EVOL RES, V41, P186, DOI 10.1046/j.1439-0469.2003.00212.x; Bleidorn C, 2003, MOL PHYLOGENET EVOL, V29, P279, DOI 10.1016/S1055-7903(03)00107-6; Bleidorn C, 2005, ZOOL J LINN SOC-LOND, V144, P59, DOI 10.1111/j.1096-3642.2005.00160.x; Bleidorn C, 2007, MOL BIOL EVOL, V24, P1690, DOI 10.1093/molbev/msm086; Brown S, 1999, AUST J ZOOL, V47, P499, DOI 10.1071/ZO99026; Campbell LI, 2011, P NATL ACAD SCI USA, V108, P15920, DOI 10.1073/pnas.1105499108; Colgan DJ, 2006, ORG DIVERS EVOL, V6, P220, DOI 10.1016/j.ode.2005.11.002; Dordel J, 2010, J ZOOL SYST EVOL RES, V48, P197, DOI 10.1111/j.1439-0469.2010.00567.x; Dunn CW, 2008, NATURE, V452, P745, DOI 10.1038/nature06614; Ebersberger I, 2007, MOL BIOL EVOL, V24, P2266, DOI 10.1093/molbev/msm156; Ebersberger I, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-157; Enright AJ, 2002, NUCLEIC ACIDS RES, V30, P1575, DOI 10.1093/nar/30.7.1575; Erseus C, 2004, ZOOL SCR, V33, P187, DOI 10.1111/j.1463-6409.2004.00146.x; Evans NM, 2010, MOL BIOL EVOL, V27, P2733, DOI 10.1093/molbev/msq159; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; FISHER EMC, 1990, CELL, V63, P1205, DOI 10.1016/0092-8674(90)90416-C; FITCH WM, 1970, SYST ZOOL, V19, P99, DOI 10.2307/2412448; Gee H, 2003, NATURE, V425, P782, DOI 10.1038/425782a; Hall KA, 2004, J MAR BIOL ASSOC UK, V84, P949, DOI 10.1017/S0025315404010240h; Hallstrom BM, 2007, MOL BIOL EVOL, V24, P2059, DOI 10.1093/molbev/msm136; Hartmann S, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-95; Hausdorf B, 2007, MOL BIOL EVOL, V24, P2723, DOI 10.1093/molbev/msm214; Hejnol A, 2009, P ROY SOC B-BIOL SCI, V276, P4261, DOI 10.1098/rspb.2009.0896; Holton TA, 2010, GENOME BIOL EVOL, V2, P310, DOI 10.1093/gbe/evq016; Irimia M, 2007, MOL BIOL EVOL, V24, P1604, DOI 10.1093/molbev/msm105; Jamieson Barrie G.M., 2006, P235; Jeffroy O, 2006, TRENDS GENET, V22, P225, DOI 10.1016/j.tig.2006.02.003; Jordens J, 2004, J ZOOL SYST EVOL RES, V42, P270, DOI 10.1111/j.1439-0469.2004.00265.x; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; Kim K, 2011, BIOINFORMATICS, V27, P1731, DOI 10.1093/bioinformatics/btr259; Kocot KM, 2011, NATURE, V477, P452, DOI 10.1038/nature10382; Kojima S, 1998, MOL PHYLOGENET EVOL, V9, P255, DOI 10.1006/mpev.1997.0472; Kuck P, 2010, MOL PHYLOGENET EVOL, V56, P1115, DOI 10.1016/j.ympev.2010.04.024; Kumar S, 2012, MOL BIOL EVOL, V29, P457, DOI 10.1093/molbev/msr202; Lanterbecq D, 2006, SYST BIOL, V55, P208, DOI 10.1080/10635150500481317; Lartillot N, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-S1-S4; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Marletaz F, 2006, CURR BIOL, V16, pR577, DOI 10.1016/j.cub.2006.07.016; Martin P, 2001, P ROY SOC B-BIOL SCI, V268, P1089, DOI 10.1098/rspb.2001.1616; McHugh D, 2000, CAN J ZOOL, V78, P1873, DOI 10.1139/cjz-78-11-1873; McHugh D, 2005, HYDROBIOLOGIA, V535, P309, DOI 10.1007/s10750-004-4414-1; McHugh D, 1997, P NATL ACAD SCI USA, V94, P8006, DOI 10.1073/pnas.94.15.8006; Meusemann K, 2010, MOL BIOL EVOL, V27, P2451, DOI 10.1093/molbev/msq130; Nesnidal MP, 2010, MOL BIOL EVOL, V27, P2095, DOI 10.1093/molbev/msq097; Paps J, 2009, MOL BIOL EVOL, V26, P2397, DOI 10.1093/molbev/msp150; Paps J, 2009, P ROY SOC B-BIOL SCI, V276, P1245, DOI 10.1098/rspb.2008.1574; Passamaneck Y, 2006, MOL PHYLOGENET EVOL, V40, P20, DOI 10.1016/j.ympev.2006.02.001; Passamaneck YJ, 2004, MOL PHYLOGENET EVOL, V32, P25, DOI 10.1016/j.ympev.2003.12.016; Philip GK, 2005, MOL BIOL EVOL, V22, P1175, DOI 10.1093/molbev/msi102; Philippe H, 2005, MOL BIOL EVOL, V22, P1246, DOI 10.1093/molbev/msi111; Philippe H, 2004, MOL BIOL EVOL, V21, P1740, DOI 10.1093/molbev/msh182; Philippe H, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000717; Philippe H, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000602; Philippe H, 2011, NATURE, V470, P255, DOI 10.1038/nature09676; Philippe H, 2009, CURR BIOL, V19, P706, DOI 10.1016/j.cub.2009.02.052; Rodriguez-Ezpeleta N, 2007, CURR BIOL, V17, P1420, DOI 10.1016/j.cub.2007.07.036; Roeding F, 2007, MOL PHYLOGENET EVOL, V45, P942, DOI 10.1016/j.ympev.2007.09.002; Rota-Stabelli O, 2011, P ROY SOC B-BIOL SCI, V278, P298, DOI 10.1098/rspb.2010.0590; Rouse GW, 1997, ZOOL SCR, V26, P139, DOI 10.1111/j.1463-6409.1997.tb00412.x; Rousset V, 2007, CLADISTICS, V23, P41, DOI 10.1111/j.1096-0031.2006.00128.x; Roy SW, 2008, MOL BIOL EVOL, V25, P620, DOI 10.1093/molbev/msn035; Roy SW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004568; Roy SW, 2005, P NATL ACAD SCI USA, V102, P4403, DOI 10.1073/pnas.0409891102; Ruiz-Trillo I, 2002, P NATL ACAD SCI USA, V99, P11246, DOI 10.1073/pnas.172390199; Ruiz-Trillo I, 2008, MOL BIOL EVOL, V25, P664, DOI 10.1093/molbev/msn006; Sanderson MJ, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-155; Schulze A, 2007, MOL PHYLOGENET EVOL, V42, P171, DOI 10.1016/j.ympev.2006.06.012; Shi GQ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020892; Smith SA, 2008, BIOINFORMATICS, V24, P715, DOI 10.1093/bioinformatics/btm619; Smith SA, 2011, NATURE, V480, P364, DOI 10.1038/nature10526; Sperling EA, 2009, MOL BIOL EVOL, V26, P2261, DOI 10.1093/molbev/msp148; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Struck TH, 2005, MAR BIOL RES, V1, P243, DOI 10.1080/17451000500261951; Struck TH, 2008, MOL PHYLOGENET EVOL, V48, P628, DOI 10.1016/j.ympev.2008.05.015; Struck TH, 2008, MOL BIOL EVOL, V25, P728, DOI 10.1093/molbev/msn019; Struck TH, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-57; Struck TH, 2011, NATURE, V471, P95, DOI 10.1038/nature09864; von Reumont BM, 2012, MOL BIOL EVOL, V29, P1031, DOI 10.1093/molbev/msr270; Wiklund H, 2005, MOL PHYLOGENET EVOL, V37, P494, DOI 10.1016/j.ympev.2005.07.005; Wolf YI, 2004, GENOME RES, V14, P29, DOI 10.1101/gr.1347404; Zrzavy J, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-189	86	46	46	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e62892	10.1371/journal.pone.0062892	http://dx.doi.org/10.1371/journal.pone.0062892			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667537	Green Published, Green Submitted, gold			2022-12-27	WOS:000319654700076
J	Zhao, XS; Yang, CH; Simon, MA				Zhao, Xuesong; Yang, Chung-hui; Simon, Michael A.			The Drosophila Cadherin Fat Regulates Tissue Size and Planar Cell Polarity through Different Domains	PLOS ONE			English	Article							HIPPO SIGNALING PATHWAY; TUMOR-SUPPRESSOR GENE; IMAGINAL DISC GROWTH; PROMOTES APOPTOSIS; IN-VIVO; PROLIFERATION ARREST; PROTEIN-KINASE; CYCLE EXIT; EYE; EXPRESSION	The Drosophila Cadherin Fat (Ft) has been identified as a crucial regulator of tissue size and Planar Cell Polarity (PCP). However, the precise mechanism by which Ft regulates these processes remains unclear. In order to advance our understanding of the action of Ft, we have sought to identify the crucial Ft effector domains. Here we report that a small region of the Ft cytoplasmic domain (H2 region) is both necessary and sufficient, when membrane localized, to support viability and prevent tissue overgrowth. Interestingly, the H2 region is dispensable for regulating PCP signaling, whereas the mutant Ft lacking the H2 region is fully capable of directing PCP. This result suggests that Ft's roles in PCP signaling and tissue size control are separable, and each can be carried out independently. Surprisingly, the crucial regions of Ft identified in our structure-function study do not overlap with the previously reported interaction regions with Atrophin, Dco, or Lowfat.	[Zhao, Xuesong; Yang, Chung-hui; Simon, Michael A.] Stanford Univ, Dept Biol, Stanford, CA 94305 USA	Stanford University	Simon, MA (corresponding author), Stanford Univ, Dept Biol, Stanford, CA 94305 USA.	msimon@stanford.edu	Zhao, Xuesong/B-2762-2012	Zhao, Xuesong/0000-0003-3007-7124	National Institutes of Health (NIH) [R01 GM069923]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069923] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported by National Institutes of Health (NIH) grant R01 GM069923 to MAS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Axelrod JD, 2009, SEMIN CELL DEV BIOL, V20, P964, DOI 10.1016/j.semcdb.2009.08.001; Bayly R, 2011, NAT REV GENET, V12, P385, DOI 10.1038/nrg2956; Bennett FC, 2006, CURR BIOL, V16, P2101, DOI 10.1016/j.cub.2006.09.045; BRAND AH, 1993, DEVELOPMENT, V118, P401; BRYANT PJ, 1988, DEV BIOL, V129, P541, DOI 10.1016/0012-1606(88)90399-5; Buckles GR, 2001, DEVELOPMENT, V128, P3533; Cho E, 2006, NAT GENET, V38, P1142, DOI 10.1038/ng1887; Cooper MTD, 1999, NATURE, V397, P526, DOI 10.1038/17395; Dong JX, 2007, CELL, V130, P1120, DOI 10.1016/j.cell.2007.07.019; Edgar BA, 2006, CELL, V124, P267, DOI 10.1016/j.cell.2006.01.005; Fanto M, 2003, DEVELOPMENT, V130, P763, DOI 10.1242/dev.00304; Feng YQ, 2007, P NATL ACAD SCI USA, V104, P20362, DOI 10.1073/pnas.0706722105; Feng YQ, 2009, P NATL ACAD SCI USA, V106, P11989, DOI 10.1073/pnas.0811540106; Garoia F, 2000, MECH DEVELOP, V94, P95, DOI 10.1016/S0925-4773(00)00306-3; Hariharan IK, 2006, CURR BIOL, V16, pR1037, DOI 10.1016/j.cub.2006.11.012; Hariharan IK, 2006, ANNU REV GENET, V40, P335, DOI 10.1146/annurev.genet.39.073003.100738; Harvey KF, 2003, CELL, V114, P457, DOI 10.1016/S0092-8674(03)00557-9; Harvey KF, 2012, COLD SPRING HARB PER; Huang JB, 2005, CELL, V122, P421, DOI 10.1016/j.cell.2005.06.007; Ishiuchi T, 2009, J CELL BIOL, V185, P959, DOI 10.1083/jcb.200811030; Jia JH, 2003, GENE DEV, V17, P2514, DOI 10.1101/gad.1134003; JUSTICE RW, 1995, GENE DEV, V9, P534, DOI 10.1101/gad.9.5.534; Kango-Singh M, 2002, DEVELOPMENT, V129, P5719, DOI 10.1242/dev.00168; Lai ZC, 2005, CELL, V120, P675, DOI 10.1016/j.cell.2004.12.036; Lawrence PA, 1999, DEVELOPMENT, V126, P2441; Lawrence PA, 2007, NAT REV GENET, V8, P555, DOI 10.1038/nrg2125; Lee TM, 2001, TRENDS NEUROSCI, V24, P251, DOI 10.1016/S0166-2236(00)01791-4; Ma D, 2003, NATURE, V421, P543, DOI 10.1038/nature01366; MAHONEY PA, 1991, CELL, V67, P853, DOI 10.1016/0092-8674(91)90359-7; Mao YP, 2006, DEVELOPMENT, V133, P2539, DOI 10.1242/dev.02427; Mao Y, 2009, DEVELOPMENT, V136, P3223, DOI 10.1242/dev.036152; Matakatsu H, 2004, DEVELOPMENT, V131, P3785, DOI 10.1242/dev.01254; Matakatsu H, 2008, CURR BIOL, V18, P1390, DOI 10.1016/j.cub.2008.07.067; Matakatsu H, 2006, DEVELOPMENT, V133, P2315, DOI 10.1242/dev.02401; Matakatsu H, 2012, DEVELOPMENT, V139, P1498, DOI 10.1242/dev.070367; Oh H, 2008, DEVELOPMENT, V135, P1081, DOI 10.1242/dev.015255; Pan DJ, 2010, DEV CELL, V19, P491, DOI 10.1016/j.devcel.2010.09.011; Pan GH, 2013, DEVELOPMENT, V140, P831, DOI 10.1242/dev.088534; Pantalacci S, 2003, NAT CELL BIOL, V5, P921, DOI 10.1038/ncb1051; Rorth P, 1998, MECH DEVELOP, V78, P113, DOI 10.1016/S0925-4773(98)00157-9; Schroeder MC, 2012, SEMIN CELL DEV BIOL; Silva E, 2006, CURR BIOL, V16, P2081, DOI 10.1016/j.cub.2006.09.004; Simon MA, 2004, DEVELOPMENT, V131, P6175, DOI 10.1242/dev.01550; Sopko R, 2009, CURR BIOL, V19, P1112, DOI 10.1016/j.cub.2009.05.049; Staley BK, 2012, DEV DYNAM, V241, P3, DOI 10.1002/dvdy.22723; Struhl G, 1998, CELL, V93, P649, DOI 10.1016/S0092-8674(00)81193-9; STRUHL G, 1993, CELL, V74, P331, DOI 10.1016/0092-8674(93)90424-O; Strutt D, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a000489; Tang CY, 2002, GENESIS, V34, P39, DOI 10.1002/gene.10135; Tapon N, 2002, CELL, V110, P467, DOI 10.1016/S0092-8674(02)00824-3; Thomas C, 2012, DEV DYNAM, V241, P27, DOI 10.1002/dvdy.22736; TOMLINSON A, 1987, DEV BIOL, V123, P264, DOI 10.1016/0012-1606(87)90448-9; Tree DRP, 2002, SEMIN CELL DEV BIOL, V13, P217, DOI 10.1016/S1084-9521(02)00042-3; Tyler D, 2006, GENES AFFECTING CELL; Tyler DM, 2007, DEV BIOL, V305, P187, DOI 10.1016/j.ydbio.2007.02.004; Udan RS, 2003, NAT CELL BIOL, V5, P914, DOI 10.1038/ncb1050; Willecke M, 2006, CURR BIOL, V16, P2090, DOI 10.1016/j.cub.2006.09.005; Wu S, 2003, CELL, V114, P445, DOI 10.1016/S0092-8674(03)00549-X; XU T, 1993, DEVELOPMENT, V117, P1223; XU TA, 1995, DEVELOPMENT, V121, P1053; Yang CH, 2002, CELL, V108, P675, DOI 10.1016/S0092-8674(02)00658-X	61	14	15	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e62998	10.1371/journal.pone.0062998	http://dx.doi.org/10.1371/journal.pone.0062998			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667559	Green Submitted, gold, Green Published			2022-12-27	WOS:000319654700096
J	Lai, PS; Hofmann, O; Baron, RM; Cernadas, M; Meng, QR; Bresler, HS; Brass, DM; Yang, IV; Schwartz, DA; Christiani, DC; Hide, W				Lai, Peggy S.; Hofmann, Oliver; Baron, Rebecca M.; Cernadas, Manuela; Meng, Quanxin Ryan; Bresler, Herbert S.; Brass, David M.; Yang, Ivana V.; Schwartz, David A.; Christiani, David C.; Hide, Winston			Integrating Murine Gene Expression Studies to Understand Obstructive Lung Disease Due to Chronic Inhaled Endotoxin	PLOS ONE			English	Article							CIGARETTE-SMOKE; PULMONARY-DISEASE; FOLLOW-UP; COPD; ASTHMA; LIPOPOLYSACCHARIDE; RISK; EMPHYSEMA; EXPOSURE; ACCUMULATION	Rationale: Endotoxin is a near ubiquitous environmental exposure that that has been associated with both asthma and chronic obstructive pulmonary disease (COPD). These obstructive lung diseases have a complex pathophysiology, making them difficult to study comprehensively in the context of endotoxin. Genome-wide gene expression studies have been used to identify a molecular snapshot of the response to environmental exposures. Identification of differentially expressed genes shared across all published murine models of chronic inhaled endotoxin will provide insight into the biology underlying endotoxin-associated lung disease. Methods: We identified three published murine models with gene expression profiling after repeated low-dose inhaled endotoxin. All array data from these experiments were re-analyzed, annotated consistently, and tested for shared genes found to be differentially expressed. Additional functional comparison was conducted by testing for significant enrichment of differentially expressed genes in known pathways. The importance of this gene signature in smoking-related lung disease was assessed using hierarchical clustering in an independent experiment where mice were exposed to endotoxin, smoke, and endotoxin plus smoke. Results: A 101-gene signature was detected in three murine models, more than expected by chance. The three model systems exhibit additional similarity beyond shared genes when compared at the pathway level, with increasing enrichment of inflammatory pathways associated with longer duration of endotoxin exposure. Genes and pathways important in both asthma and COPD were shared across all endotoxin models. Mice exposed to endotoxin, smoke, and smoke plus endotoxin were accurately classified with the endotoxin gene signature. Conclusions: Despite the differences in laboratory, duration of exposure, and strain of mouse used in three experimental models of chronic inhaled endotoxin, surprising similarities in gene expression were observed. The endotoxin component of tobacco smoke may play an important role in disease development.	[Lai, Peggy S.; Christiani, David C.] Massachusetts Gen Hosp, Boston, MA 02114 USA; [Lai, Peggy S.; Hofmann, Oliver; Christiani, David C.; Hide, Winston] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; [Baron, Rebecca M.; Cernadas, Manuela] Brigham & Womens Hosp, Div Pulm & Crit Care Med, Boston, MA 02115 USA; [Meng, Quanxin Ryan; Bresler, Herbert S.] Battelle Mem Inst, Columbus, OH USA; [Brass, David M.] Duke Univ, Med Ctr, Dept Pediat Neonatol, Durham, NC USA; [Yang, Ivana V.; Schwartz, David A.] Natl Jewish Hlth, Ctr Genes Environm & Hlth, Denver, CO USA; [Yang, Ivana V.; Schwartz, David A.] Univ Colorado, Dept Med, Aurora, CO USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Battelle Memorial Institute; Duke University; National Jewish Health; University of Colorado System; University of Colorado Anschutz Medical Campus	Lai, PS (corresponding author), Massachusetts Gen Hosp, Boston, MA 02114 USA.	plai@partners.org	Hide, Winston/R-3815-2019; Yang, Ivana V/P-3059-2018; Hide, Winston A/V-2727-2017; Hide, Winston Hide/C-7217-2009; Hofmann, Oliver/F-1800-2013	Hide, Winston/0000-0002-8621-3271; Yang, Ivana V/0000-0002-1018-489X; Hide, Winston A/0000-0002-8621-3271; Hide, Winston Hide/0000-0002-8621-3271; Hofmann, Oliver/0000-0002-7738-1513; Lai, Peggy/0000-0001-9501-8606	National Institute of Environmental Health Sciences [ES00002, P30 ES00002, P01 ES18181, F32 ES020082]; Battelle Memorial Institute; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P01ES018181, P30ES000002, F32ES020082] Funding Source: NIH RePORTER	National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Battelle Memorial Institute; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	Support was provided by ES00002, P30 ES00002, and P01 ES18181 from the National Institute of Environmental Health Sciences for generation of primary microarray data for the Lai and Brass et al studies, Battelle Memorial Institute's Corporate Science & Technology Program for generation of microarray data for the Meng et al study, and F32 ES020082 from the National Institute of Environmental Health Sciences to PL as a career development award. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of Environmental Health Sciences or the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Behrendt CE, 2005, CHEST, V128, P1239, DOI 10.1378/chest.128.3.1239; BENDITT EP, 1989, J EXP MED, V169, P1841, DOI 10.1084/jem.169.5.1841; Biswas SK, 2009, TRENDS IMMUNOL, V30, P475, DOI 10.1016/j.it.2009.07.009; Bozinovski S, 2012, P NATL ACAD SCI USA, V109, P935, DOI 10.1073/pnas.1109382109; Brass DM, 2008, AM J RESP CELL MOL, V39, P584, DOI 10.1165/rcmb.2007-0448OC; Brass DM, 2008, IMMUNOGENETICS, V60, P353, DOI 10.1007/s00251-008-0293-3; Brass DM, 2003, AM J PHYSIOL-LUNG C, V285, pL755, DOI 10.1152/ajplung.00001.2003; Braun-Fahrlander C, 2002, NEW ENGL J MED, V347, P869, DOI 10.1056/NEJMoa020057; Chuaqui RF, 2002, NAT GENET, V32, P509, DOI 10.1038/ng1034; Coxson HO, 2009, AM J RESP CRIT CARE, V180, P588, DOI 10.1164/rccm.200901-0159PP; Croft D, 2011, NUCLEIC ACIDS RES, V39, pD691, DOI 10.1093/nar/gkq1018; Demedts IK, 2007, AM J RESP CRIT CARE, V175, P998, DOI 10.1164/rccm.200608-1113OC; Draghici S, 2006, TRENDS GENET, V22, P101, DOI 10.1016/j.tig.2005.12.005; Espinassous Q, 2009, J IMMUNOL, V183, P1446, DOI 10.4049/jimmunol.0803067; Gaschler Gordon J., 2007, V14, P126, DOI 10.1159/000107059; Gibson PG, 2009, THORAX, V64, P728, DOI 10.1136/thx.2008.108027; Hasday JD, 1999, CHEST, V115, P829, DOI 10.1378/chest.115.3.829; Hautamaki RD, 1997, SCIENCE, V277, P2002, DOI 10.1126/science.277.5334.2002; Hunninghake GM, 2009, NEW ENGL J MED, V361, P2599, DOI 10.1056/NEJMoa0904006; Kandasamy K, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-1-r3; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Kauffmann Audrey, 2009, Bioinformatics, V25, P415, DOI 10.1093/bioinformatics/btn647; Kelder T, 2012, NUCLEIC ACIDS RES, V40, pD1301, DOI 10.1093/nar/gkr1074; Kupershmidt I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013066; Kurmi OP, 2010, THORAX, V65, P221, DOI 10.1136/thx.2009.124644; Lai PS, 2012, AM J RESP CELL MOL, V47, P209, DOI 10.1165/rcmb.2011-0447OC; Lamprecht B, 2011, CHEST, V139, P752, DOI 10.1378/chest.10-1253; LANTZ RC, 1985, EXP MOL PATHOL, V43, P305, DOI 10.1016/0014-4800(85)90068-1; Leclerc O, 2006, EUR RESPIR J, V27, P1102, DOI 10.1183/09031936.06.00076905; Liebers V, 2008, ARCH TOXICOL, V82, P203, DOI 10.1007/s00204-008-0290-1; Lu YC, 2008, CYTOKINE, V42, P145, DOI 10.1016/j.cyto.2008.01.006; Matesic LE, 1999, GENOMICS, V62, P34, DOI 10.1006/geno.1999.5986; Meng QR, 2006, INHAL TOXICOL, V18, P555, DOI 10.1080/08958370600686226; MILTON DK, 1990, AM REV RESPIR DIS, V142, P184, DOI 10.1164/ajrccm/142.1.184; Ober C, 2008, NEW ENGL J MED, V358, P1682, DOI 10.1056/NEJMoa0708801; Prefontaine D, 2010, J ALLERGY CLIN IMMUN, V125, P752, DOI 10.1016/j.jaci.2009.12.935; Prefontaine D, 2009, J IMMUNOL, V183, P5094, DOI 10.4049/jimmunol.0802387; RYLANDER R, 1976, BRIT J IND MED, V33, P175; Rylander R, 1985, INFLAMMATION RES; Salvi SS, 2009, LANCET, V374, P733, DOI 10.1016/S0140-6736(09)61303-9; Schromm AB, 1998, J IMMUNOL, V161, P5464; Semple S, 2010, ENVIRON HEALTH PERSP, V118, P988, DOI 10.1289/ehp.0901605; Shi J, 2010, AM J RESP CRIT CARE, V182, P200, DOI 10.1164/rccm.200903-0329OC; Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675; STOLK J, 1992, J PATHOL, V167, P349, DOI 10.1002/path.1711670314; Thorne PS, 2005, AM J RESP CRIT CARE, V172, P1371, DOI 10.1164/rccm.200505-758OC; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Vassallo R, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-45; Wilkerson MD, 2010, BIOINFORMATICS, V26, P1572, DOI 10.1093/bioinformatics/btq170; Wilson CL, 2005, BIOINFORMATICS, V21, P3683, DOI 10.1093/bioinformatics/bti605; Yang HN, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003724	51	1	1	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2013	8	5							e62910	10.1371/journal.pone.0062910	http://dx.doi.org/10.1371/journal.pone.0062910			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145RZ	23675439	Green Submitted, Green Published, gold			2022-12-27	WOS:000319036100020
J	Mpagama, SG; Heysell, SK; Ndusilo, ND; Kumburu, HH; Lekule, IA; Kisonga, RM; Gratz, J; Boeree, MJ; Houpt, ER; Kibiki, GS				Mpagama, Stellah G.; Heysell, Scott K.; Ndusilo, Nora D.; Kumburu, Happiness H.; Lekule, Isack A.; Kisonga, Riziki M.; Gratz, Jean; Boeree, Martin J.; Houpt, Eric R.; Kibiki, Gibson S.			Diagnosis and Interim Treatment Outcomes from the First Cohort of Multidrug-Resistant Tuberculosis Patients in Tanzania	PLOS ONE			English	Article							RURAL SOUTH-AFRICA; MDR-TB; HIV; COMMUNITY	Setting: Kibong'oto National Tuberculosis Hospital (KNTH), Kilimanjaro, Tanzania. Objective: Characterize the diagnostic process and interim treatment outcomes from patients treated for multidrug-resistant tuberculosis (MDR-TB) in Tanzania. Design: A retrospective cohort study was performed among all patients treated at KNTH for pulmonary MDR-TB between November 2009 and September 2011. Results: Sixty-one culture-positive MDR-TB patients initiated therapy, 60 (98%) with a prior history of TB treatment. Forty-one (67%) were male and 9 (14%) were HIV infected with a mean CD4 count of 424 (+/- 106) cells/mu l. The median time from specimen collection to MDR-TB diagnosis and from diagnosis to initiation of MDR-TB treatment was 138 days (IQR 101-159) and 131 days (IQR 32-233), respectively. Following treatment initiation four (7%) patients died (all HIV negative), 3 (5%) defaulted, and the remaining 54 (89%) completed the intensive phase. Most adverse drug reactions were mild to moderate and did not require discontinuation of treatment. Median time to culture conversion was 2 months (IQR 1-3) and did not vary by HIV status. In 28 isolates available for additional second-line drug susceptibility testing, fluoroquinolone, aminoglycoside and para-aminosalicylic acid resistance was rare yet ethionamide resistance was present in 9 (32%). Conclusion: The majority of MDR-TB patients from this cohort had survived a prolonged referral process, had multiple episodes of prior TB treatment, but did not have advanced AIDS and converted to culture negative early while completing an intensive inpatient regimen without serious adverse event. Further study is required to determine the clinical impact of second-line drug susceptibility testing and the feasibility of alternatives to prolonged hospitalization.	[Mpagama, Stellah G.; Lekule, Isack A.; Kisonga, Riziki M.] Kibongoto Natl TB Hosp, Kilimanjaro, Tanzania; [Mpagama, Stellah G.; Ndusilo, Nora D.; Kumburu, Happiness H.; Gratz, Jean; Kibiki, Gibson S.] Kilimanjaro Christian Med Ctr, Kilimanjaro Clin Res Inst, Moshi, Tanzania; [Heysell, Scott K.; Gratz, Jean; Houpt, Eric R.] Univ Virginia, Charlottesville, VA USA; [Boeree, Martin J.] UCCZ Dekkerswald, UMC St Radboud, Nijmegen, Netherlands	Kilimanjaro Christian Medical Centre; University of Virginia; Radboud University Nijmegen	Mpagama, SG (corresponding author), Kibongoto Natl TB Hosp, Kilimanjaro, Tanzania.	s.mpagama@kcri.ac.tz	Boeree, Martin J./G-6132-2010		Pan African Consortium for the Evaluation of Antituberculosis Antibiotics (PanACEA); National Institutes of Health/Fogarty training grant [D43 TW008270]; National Institutes of Health [R01AI093358, K23AI099019]; Virginia Department of Health; Burroughs Wellcome Fund/American Society of Tropical Medicine and Hygiene; FOGARTY INTERNATIONAL CENTER [D43TW008270] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K23AI099019, R01AI093358, T32AI007046] Funding Source: NIH RePORTER	Pan African Consortium for the Evaluation of Antituberculosis Antibiotics (PanACEA); National Institutes of Health/Fogarty training grant; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Virginia Department of Health; Burroughs Wellcome Fund/American Society of Tropical Medicine and Hygiene(Burroughs Wellcome Fund); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	SGM was supported by an award from the Pan African Consortium for the Evaluation of Antituberculosis Antibiotics (PanACEA) and the National Institutes of Health/Fogarty training grant (D43 TW008270) awarded to ERH and GSK. ERH was also supported in part by National Institutes of Health grant R01AI093358 and the Virginia Department of Health. SKH was supported by National Institutes of Health grant K23AI099019 and the Burroughs Wellcome Fund/American Society of Tropical Medicine and Hygiene. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brust JCM, 2012, INT J TUBERC LUNG D, V16, P998, DOI 10.5588/ijtld.11.0713; Brust JCM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015841; Caminero JA, 2010, LANCET INFECT DIS, V10, P621, DOI 10.1016/S1473-3099(10)70139-0; Chiang CY, 2006, EUR RESPIR J, V28, P980, DOI 10.1183/09031936.06.00125705; Chonde TM, 2010, INT J TUBERC LUNG D, V14, P967; Dhingra V K, 2008, Indian J Tuberc, V55, P15; Diacon AH, 2009, NEW ENGL J MED, V360, P2397, DOI 10.1056/NEJMoa0808427; [Francis J Curry National Tuberculosis Center California Department of Health], 2008, DRUG RES TUB SURV GU, P86; Furin JJ, 2001, INT J TUBERC LUNG D, V5, P648; Gandhi NR, 2010, LANCET, V375, P1830, DOI 10.1016/S0140-6736(10)60410-2; Heysell SK, 2011, ANTIMICROB AGENTS CH, V55, P5819, DOI 10.1128/AAC.05561-11; Holtz TH, 2006, ANN INTERN MED, V144, P650, DOI 10.7326/0003-4819-144-9-200605020-00008; Kibiki GS, 2007, CLIN EXP IMMUNOL, V148, P254, DOI 10.1111/j.1365-2249.2007.03330.x; Kruuner A, 2003, ANTIMICROB AGENTS CH, V47, P2971, DOI 10.1128/AAC.47.9.2971-2973.2003; Loveday M, 2012, INT J TUBERC LUNG D, V16, P209, DOI 10.5588/ijtld.11.0401; *MIN HLTH TANZ, 2009, HLTH SECT STRAT PLAN; Ministry of Health Tanzania, 2010, OP GUID MAN DRUG RES; Nathanson E, 2004, INT J TUBERC LUNG D, V8, P1382; Satti H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046943; Seung KJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007186; Shenoi S, 2009, CURR OPIN INFECT DIS, V22, P11, DOI 10.1097/QCO.0b013e3283210020; Thomas TA, 2010, INT J TUBERC LUNG D, V14, P1244; Torun T, 2005, INT J TUBERC LUNG D, V9, P1373; World Health Organization, 2011, GUID PROGR MAN DRUG; World Health Organization, 2010, GLOB TUB CONTR	25	30	30	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2013	8	5							e62034	10.1371/journal.pone.0062034	http://dx.doi.org/10.1371/journal.pone.0062034			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145RZ	23675411	Green Published, gold, Green Submitted			2022-12-27	WOS:000319036100002
J	Tymofiyeva, O; Hess, CP; Ziv, E; Lee, PN; Glass, HC; Ferriero, DM; Barkovich, AJ; Xu, D				Tymofiyeva, Olga; Hess, Christopher P.; Ziv, Etay; Lee, Patricia N.; Glass, Hannah C.; Ferriero, Donna M.; Barkovich, A. James; Xu, Duan			A DTI-Based Template-Free Cortical Connectome Study of Brain Maturation	PLOS ONE			English	Article							STRUCTURAL CONNECTIVITY; NETWORKS; TRACTOGRAPHY	Improved understanding of how the human brain is "wired" on a macroscale may now be possible due to the emerging field of MRI connectomics. However, mapping the rapidly developing infant brain networks poses challenges. In this study, we applied an automated template-free "baby connectome" framework using diffusion MRI to non-invasively map the structural brain networks in subjects of different ages, including premature neonates, term-born neonates, six-month-old infants, and adults. We observed increasing brain network integration and decreasing segregation with age in term-born subjects. We also explored how the equal area nodes can be grouped into modules without any prior anatomical information - an important step toward a fully network-driven registration and analysis of brain connectivity.	[Tymofiyeva, Olga; Hess, Christopher P.; Ziv, Etay; Lee, Patricia N.; Barkovich, A. James; Xu, Duan] Univ Calif San Francisco, Dept Radiol & Biomed Imaging, San Francisco, CA 94143 USA; [Glass, Hannah C.; Ferriero, Donna M.; Barkovich, A. James] Univ Calif San Francisco, Dept Neurol, San Francisco, CA USA; [Glass, Hannah C.; Ferriero, Donna M.; Barkovich, A. James] Univ Calif San Francisco, Dept Pediat, San Francisco, CA USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Xu, D (corresponding author), Univ Calif San Francisco, Dept Radiol & Biomed Imaging, San Francisco, CA 94143 USA.	Duan.Xu@ucsf.edu	Xu, Duan/B-3197-2013; Xu, Duan/GMW-4195-2022	Xu, Duan/0000-0003-0550-4235; Hess, Christopher/0000-0002-5132-5302	National Institutes of Health (NIH) [UL1RR024131, R01 HD072074, R01 NS35902, NS46432, EB009756];  [K23NS066137]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD072074] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024131] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB009756] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS035902, K23NS066137, R01NS046432] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported in part by National Institutes of Health (NIH) grants UL1RR024131 (UCSF-CTSI), R01 HD072074, R01 NS35902, NS46432 and EB009756 (www.nih.gov). H. C. G. is supported by K23NS066137 (www.nih.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ball G, 2012, CORTEX; Batalle D, 2012, NEUROIMAGE, V60, P1352, DOI 10.1016/j.neuroimage.2012.01.059; Bells S, 2011, P INT SOC MAG RESON; Brodmann K, 1905, J PSYCHOL NEUROL LEI, V4, P177; Brodmann K, 1909, VERGLEICHENDE LOKALI; Cheng H, 2012, NEUROIMAGE, V61, P1153, DOI 10.1016/j.neuroimage.2012.03.036; Dennis EL, 2013, NEUROIMAGE, V64, P671, DOI 10.1016/j.neuroimage.2012.09.004; Fan Y, 2011, NEUROIMAGE, V54, P1862, DOI 10.1016/j.neuroimage.2010.07.025; Gong GL, 2009, J NEUROSCI, V29, P15684, DOI 10.1523/JNEUROSCI.2308-09.2009; Hagmann P, 2010, P NATL ACAD SCI USA, V107, P19067, DOI 10.1073/pnas.1009073107; Hagmann P, 2008, PLOS BIOL, V6, P1479, DOI 10.1371/journal.pbio.0060159; Hagmann P, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000597; Jones D.K., 2010, IMAGING MED, V2, P341, DOI [10.2217/iim.10.21, DOI 10.2217/IIM.10.21]; Kaiser M, 2011, NEUROIMAGE, V57, P892, DOI 10.1016/j.neuroimage.2011.05.025; Khundrakpam BS, 2013, CEREB CORTEX, V23, P2072, DOI 10.1093/cercor/bhs187; Knickmeyer RC, 2008, J NEUROSCI, V28, P12176, DOI 10.1523/JNEUROSCI.3479-08.2008; Leopardi P, 2006, ELECTRON T NUMER ANA, V25, P309; Li YH, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000395; Lo CY, 2010, J NEUROSCI, V30, P16876, DOI 10.1523/JNEUROSCI.4136-10.2010; March of Dimes PMNCH Save The Children WHO, 2012, GLOB ACT REP PRET BI, DOI DOI 10.1016/S0140-6736(12)61970-9; Mukherjee P, 2008, AM J NEURORADIOL, V29, P632, DOI 10.3174/ajnr.A1051; Newman MEJ, 2006, P NATL ACAD SCI USA, V103, P8577, DOI 10.1073/pnas.0601602103; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Scahill RI, 2003, ARCH NEUROL-CHICAGO, V60, P989, DOI 10.1001/archneur.60.7.989; Sporns O., 2010, NETWORKS BRAIN; Tymofiyeva O, P OHBM 2012; Tymofiyeva O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031029; Yan CG, 2011, CEREB CORTEX, V21, P449, DOI 10.1093/cercor/bhq111; Yap PT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024678; Zilles K, 2010, NAT REV NEUROSCI, V11, P139, DOI 10.1038/nrn2776	31	53	54	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2013	8	5							e63310	10.1371/journal.pone.0063310	http://dx.doi.org/10.1371/journal.pone.0063310			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145RZ	23675475	Green Published, gold			2022-12-27	WOS:000319036100036
J	Xin, W; Lin, ZQ; Li, XY				Xin, Wei; Lin, Zhiqin; Li, Xiaoying			Orthostatic Hypotension and the Risk of Congestive Heart Failure: A Meta-Analysis of Prospective Cohort Studies	PLOS ONE			English	Article							BLOOD-PRESSURE RESPONSE; ATHEROSCLEROSIS RISK; CARDIOVASCULAR-DISEASE; PREDICTS MORTALITY; TASK-FORCE; DIAGNOSIS; ADULTS; COLLABORATION; HETEROGENEITY; GUIDELINES	Background: Orthostatic hypotension (OH) has been related to the increased risk of future congestive heart failure (CHF) events. However, the overall quantitative estimate of predictive ability of OH for CHF has not been determined. We therefore performed a meta-analysis to investigate the association between OH and incident CHF. Methods: Prospective cohort studies relevant to the aim of the study were identified by searching of Medline and Embase databases up to December 25, 2012 without restrictions and by reviewing the reference lists from retrieved articles. Results: A total of 51270 subjects and 3603 incident CHF cases from 4 prospective cohorts were included in the meta-analysis. Using random effect model, the pooled result indicated that presence of OH at baseline was significantly associated with an increased risk for future CHF outcomes (adjusted hazard ratio: 1.30, 95% confidence interval 1.09-1.55; p = 0.004). Results of stratified analysis suggested that the association between OH and CHF incidence seemed to be significant in middle-age subjects, or the individuals with hypertension and diabetes at baseline, but did not significant in the elderly subjects or those without hypertension or diabetes. Conclusions: Our meta-analysis confirmed that presence of OH is related to a significant increased risk for development of CHF in the future. Studies are needed to explore the potential mechanisms underlying this association. More importantly, screen for OH may be of great clinical significance for the early identification of subjects at higher risk for development of CHF.	[Xin, Wei; Li, Xiaoying] Chinese Peoples Liberat Army Gen Hosp, Dept Geriatr Cardiovasc Med 1, Beijing, Peoples R China; [Lin, Zhiqin] Guiyang Med Coll, Dept Cardiovasc Med, Affiliated Hosp, Guizhou, Peoples R China	Chinese People's Liberation Army General Hospital; Guizhou Medical University	Li, XY (corresponding author), Chinese Peoples Liberat Army Gen Hosp, Dept Geriatr Cardiovasc Med 1, Beijing, Peoples R China.	lixy301@163.com						[Anonymous], 1996, CLIN AUTON RES, V6, P125; [Anonymous], 2016, NEWCASTLEOTTAWA SCAL; Benvenuto LJ, 2011, AM J HYPERTENS, V24, P135, DOI 10.1038/ajh.2010.146; Bibbins-Domingo K, 2004, CIRCULATION, V110, P1424, DOI 10.1161/01.CIR.0000141726.01302.83; Bisognano JD, 2009, J CARD FAIL, V15, pS63, DOI 10.1016/j.cardfail.2009.06.191; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Eguchi K, 2004, HYPERTENS RES, V27, P235, DOI 10.1291/hypres.27.235; Fan XH, 2010, AM J HYPERTENS, V23, P829, DOI 10.1038/ajh.2010.76; Fedorowski A, 2012, J HYPERTENS, V30, P522, DOI 10.1097/HJH.0b013e32834fa860; Fedorowski A, 2010, AM J HYPERTENS, V23, P1209, DOI 10.1038/ajh.2010.150; Fedorowski A, 2010, EUR HEART J, V31, P85, DOI 10.1093/eurheartj/ehp329; Georgakopoulos D, 2011, J CARD FAIL, V17, P167, DOI 10.1016/j.cardfail.2010.09.004; Gottdiener JS, 2000, J AM COLL CARDIOL, V35, P1628, DOI 10.1016/S0735-1097(00)00582-9; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Higgins J, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.ED000049; Hosokawa K, 2012, CIRCULATION, V126, P1278, DOI 10.1161/CIRCULATIONAHA.112.108357; Hunt SA, 2009, J AM COLL CARDIOL, V53, pE1, DOI 10.1016/j.jacc.2008.11.013; Jones CD, 2012, HYPERTENSION, V59, P913, DOI 10.1161/HYPERTENSIONAHA.111.188151; Kario K, 2002, J AM COLL CARDIOL, V40, P133, DOI 10.1016/S0735-1097(02)01923-X; Lee DS, 2009, CIRCULATION, V119, P3070, DOI 10.1161/CIRCULATIONAHA.108.815944; Lin Zhong-Qiu, 2011, Zhonghua Yi Xue Za Zhi, V91, P2530; Logan IC, 2012, AGE AGEING, V41, P587, DOI 10.1093/ageing/afs061; Masaki KH, 1998, CIRCULATION, V98, P2290, DOI 10.1161/01.CIR.98.21.2290; Mattace-Raso FUS, 2006, J HYPERTENS, V24, P339, DOI 10.1097/01.hjh.0000202816.25706.64; McMurray JJV, 2012, EUR J HEART FAIL, V14, P803, DOI 10.1093/eurjhf/hfs105; Patsopoulos NA, 2008, INT J EPIDEMIOL, V37, P1148, DOI 10.1093/ije/dyn065; Robertson D, 2008, CLIN AUTON RES, V18, P2, DOI 10.1007/s10286-007-1004-0; Rose KM, 2006, CIRCULATION, V114, P630, DOI 10.1161/CIRCULATIONAHA.105.598722; Rose KM, 2000, AM J HYPERTENS, V13, P571, DOI 10.1016/S0895-7061(99)00257-5; Sabbah HN, 2012, CURR CARDIOL REP, V14, P326, DOI 10.1007/s11886-012-0265-y; Sabbah HN, 2011, CIRC-HEART FAIL, V4, P65, DOI 10.1161/CIRCHEARTFAILURE.110.955013; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Verwoert GC, 2008, J AM GERIATR SOC, V56, P1816, DOI 10.1111/j.1532-5415.2008.01946.x; Voichanski S, 2012, AM J HYPERTENS, V25, P159, DOI 10.1038/ajh.2011.191	34	24	25	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2013	8	5							e63169	10.1371/journal.pone.0063169	http://dx.doi.org/10.1371/journal.pone.0063169			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145RZ	23675460	Green Published, Green Submitted, gold			2022-12-27	WOS:000319036100029
J	Guy, L; Jernberg, C; Norling, JA; Ivarsson, S; Hedenstrom, I; Melefors, O; Liljedahl, U; Engstrand, L; Andersson, SGE				Guy, Lionel; Jernberg, Cecilia; Norling, Jenny Arven; Ivarsson, Sofie; Hedenstrom, Ingela; Melefors, Ojar; Liljedahl, Ulrika; Engstrand, Lars; Andersson, Siv G. E.			Adaptive Mutations and Replacements of Virulence Traits in the Escherichia coli O104:H4 Outbreak Population	PLOS ONE			English	Article							BURROWS-WHEELER TRANSFORM; HEMOLYTIC-UREMIC SYNDROME; E.-COLI; GENOMIC ANALYSIS; READ ALIGNMENT; RNA GENES; SEQUENCE; O104/H4; K-12; ANNOTATION	The sequencing of highly virulent Escherichia coli O104:H4 strains isolated during the outbreak of bloody diarrhea and hemolytic uremic syndrome in Europe in 2011 revealed a genome that contained a Shiga toxin encoding prophage and a plasmid encoding enteroaggregative fimbriae. Here, we present the draft genome sequence of a strain isolated in Sweden from a patient who had travelled to Tunisia in 2010 (E112/10) and was found to differ from the outbreak strains by only 38 SNPs in non-repetitive regions, 16 of which were mapped to the branch to the outbreak strain. We identified putatively adaptive mutations in genes for transporters, outer surface proteins and enzymes involved in the metabolism of carbohydrates. A comparative analysis with other historical strains showed that E112/10 contained Shiga toxin prophage genes of the same genotype as the outbreak strain, while these genes have been replaced by a different genotype in two otherwise very closely related strains isolated in the Republic of Georgia in 2009. We also present the genome sequences of two enteroaggregative E. coli strains affiliated with phylogroup A (C43/90 and C48/93) that contain the agg genes for the AAF/I-type fimbriae characteristic of the outbreak population. Interestingly, C43/90 also contained a tet/mer antibiotic resistance island that was nearly identical in sequence to that of the outbreak strain, while the corresponding island in the Georgian strains was most similar to E. coli strains of other serotypes. We conclude that the pan-genome of the outbreak population is shared with strains of the A phylogroup and that its evolutionary history is littered with gene replacement events, including most recently independent acquisitions of antibiotic resistance genes in the outbreak strains and its nearest neighbors. The results are summarized in a refined evolutionary model for the emergence of the O104:H4 outbreak population.	[Guy, Lionel; Norling, Jenny Arven; Andersson, Siv G. E.] Uppsala Univ, Dept Mol Evolut Cell & Mol Biol, Sci Life Lab, Biomed Ctr, Uppsala, Sweden; [Jernberg, Cecilia; Ivarsson, Sofie; Hedenstrom, Ingela; Melefors, Ojar; Engstrand, Lars] Swedish Inst Communicable Dis Control, Dept Preparedness, Solna, Sweden; [Melefors, Ojar; Engstrand, Lars] Karolinska Inst, Dept Microbiol Tumor & Cell Biol, Stockholm, Sweden; [Liljedahl, Ulrika] Uppsala Univ, Dept Med Sci, Uppsala, Sweden	Uppsala University; Swedish Institute for Infectious Disease Control; Karolinska Institutet; Uppsala University	Andersson, SGE (corresponding author), Uppsala Univ, Dept Mol Evolut Cell & Mol Biol, Sci Life Lab, Biomed Ctr, Uppsala, Sweden.	siv.andersson@icm.uu.se	Guy, Lionel/B-4501-2008; Melefors, Öjar/N-6164-2015	Guy, Lionel/0000-0001-8354-2398; Melefors, Öjar/0000-0003-4115-1190	Swiss National Science Foundation [PA00P3_131491]; Swedish Research Council; Science for Life Laboratory	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Swedish Research Council(Swedish Research CouncilEuropean Commission); Science for Life Laboratory	This work was supported by grants from the Swiss National Science Foundation (grant PA00P3_131491 to L. G.), the Swedish Research Council (to L. E. and S. G. E. A) and Science for Life Laboratory (to S. G. E. A.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed SA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048228; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bielaszewska M, 2011, LANCET INFECT DIS, V11, P671, DOI 10.1016/S1473-3099(11)70165-7; Brondijk THC, 2004, BIOCHEM J, V379, P47, DOI 10.1042/BJ20031115; Buchholz U, 2011, NEW ENGL J MED, V365, P1763, DOI 10.1056/NEJMoa1106482; Carver TJ, 2005, BIOINFORMATICS, V21, P3422, DOI 10.1093/bioinformatics/bti553; Chibba A, 2012, ORG BIOMOL CHEM, V10, P7103, DOI 10.1039/c2ob26105g; European Centre for Disease Prevention and Control and European Food Safety Authority, 2011, SHIG TOX VER PROD ES; Ferrandez A, 1997, J BACTERIOL, V179, P2573, DOI 10.1128/jb.179.8.2573-2581.1997; Frank C, 2011, NEW ENGL J MED, V365, P1771, DOI 10.1056/NEJMoa1106483; Guy L, 2012, P NATL ACAD SCI USA, V109, pE3627, DOI 10.1073/pnas.1206246110; Guy L, 2010, BIOINFORMATICS, V26, P2334, DOI 10.1093/bioinformatics/btq413; Hyatt D, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-119; Karch H, 2012, EMBO MOL MED, V4, P841, DOI 10.1002/emmm.201201662; Katoh K, 2008, BRIEF BIOINFORM, V9, P286, DOI 10.1093/bib/bbn013; Kupferschmidt K, 2011, SCIENCE, V332, P1249, DOI 10.1126/science.332.6035.1249; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; L'Abee-Lund TM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031413; Lagesen K, 2007, NUCLEIC ACIDS RES, V35, P3100, DOI 10.1093/nar/gkm160; Lee H, 2012, P NATL ACAD SCI USA, V109, pE2774, DOI 10.1073/pnas.1210309109; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Ma D, 2012, NATURE, V483, P632, DOI 10.1038/nature10917; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; MEIERDIETER U, 1990, J BIOL CHEM, V265, P13490; Mellmann A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022751; Pandya GA, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-213; Poirier K, 2008, INFECT IMMUN, V76, P4814, DOI 10.1128/IAI.00446-08; Rasko DA, 2008, J BACTERIOL, V190, P6881, DOI 10.1128/JB.00619-08; Rasko DA, 2011, NEW ENGL J MED, V365, P709, DOI 10.1056/NEJMoa1106920; Rohde H, 2011, NEW ENGL J MED, V365, P718, DOI 10.1056/NEJMoa1107643; Sadowsky MJ, 1998, J BACTERIOL, V180, P152, DOI 10.1128/JB.180.1.152-158.1998; Scheutz F, 2011, EURO SURVEILL, V16; Schiffer G, 1999, J BIOL CHEM, V274, P32031, DOI 10.1074/jbc.274.45.32031; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Stewart AC, 2009, BIOINFORMATICS, V25, P962, DOI 10.1093/bioinformatics/btp097; Tau NP, 2012, EMERG INFECT DIS, V18, P1314, DOI 10.3201/eid1808.111616; Touchon M, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000344; Vanderpool CK, 2007, CURR OPIN MICROBIOL, V10, P146, DOI 10.1016/j.mib.2007.03.011; Yang KC, 2009, J BACTERIOL, V191, P4667, DOI 10.1128/JB.00235-09; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	43	9	10	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2013	8	5							e63027	10.1371/journal.pone.0063027	http://dx.doi.org/10.1371/journal.pone.0063027			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	143FO	23675451	Green Published, gold, Green Submitted			2022-12-27	WOS:000318852400020
J	Wang, JP; Ai, XL; Mei, H; Fu, Y; Chen, B; Yu, ZN; He, J				Wang, Jieping; Ai, Xulu; Mei, Han; Fu, Yang; Chen, Bo; Yu, Ziniu; He, Jin			High-Throughput Identification of Promoters and Screening of Highly Active Promoter-5 '-UTR DNA Region with Different Characteristics from Bacillus thuringiensis	PLOS ONE			English	Article							TRANSCRIPTION START SITES; COMPLETE GENOME SEQUENCE; ESCHERICHIA-COLI; RNA-POLYMERASE; EXPRESSION; SUBTILIS; SPORULATION; PROTEIN; RECOGNITION; SECRETION	In bacteria, both promoters and 5'-untranslated regions (5'-UTRs) of mRNAs play vital regulatory roles in gene expression. In this study, we identified 1203 active promoter candidates in Bacillus thuringiensis through analysis of the genome-wide TSSs based on the transcriptome data. There were 11 types of sigma-factor and 34 types of transcription factor binding sites found in 723 and 1097 active promoter candidates, respectively. Moreover, within the 1203 transcriptional units (TUs), most (52%) of the 5'-UTRs were 10-50 nucleotides in length, 12.8% of the TUs had a long 5'-UTR greater than 100 nucleotides in length, and 16.3% of the TUs were leaderless. We then selected 20 active promoter candidates combined with the corresponding 5'-UTR DNA regions to screen the highly active promoter-5'-UTR DNA region complexes with different characteristics. Our results demonstrate that among the 20 selected complexes, six were able to exert their functions throughout the life cycle, six were specifically induced during the early-stationary phase, and four were specifically activated during the mid-stationary phase. We found a direct corresponding relationship between sigma-factor-recognized consensus sequences and complex activity features: the great majority of complexes acting throughout the life cycle possess sigma(A)-like consensus sequences; the maximum activities of the sigma(F)-, sigma-(E), sigma(G)-, and sigma(K)-dependent complexes appeared at 10, 14, 16, and 22 h under our experimental conditions, respectively. In particular, complex Phj3 exhibited the strongest activity. Several lines of evidence showed that complex Phj3 possessed three independent promoter regions located at -251 similar to-98, -113 similar to-31, and -54 similar to+14, and that the 5'-UTR +1 similar to+118 DNA region might be particularly beneficial to both the stability and translation of its downstream mRNA. Moreover, Phj3 successfully overexpressed the active beta-galactosidase and turbo-RFP, indicating that Phj3 could be a proper regulatory element for overexpression of proteins in B. thuringiensis. Therefore, our efforts contribute to molecular biology research and the biotechnological application of B. thuringiensis.	[Wang, Jieping; Ai, Xulu; Mei, Han; Fu, Yang; Chen, Bo; Yu, Ziniu; He, Jin] Huazhong Agr Univ, State Key Lab Agr Microbiol, Coll Life Sci & Technol, Wuhan, Hubei, Peoples R China	Huazhong Agricultural University	He, J (corresponding author), Huazhong Agr Univ, State Key Lab Agr Microbiol, Coll Life Sci & Technol, Wuhan, Hubei, Peoples R China.	hejin@mail.hzau.edu.cn		Mei, Han/0000-0002-2567-5464	Chinese National Natural Science Funds [31270105, 30930004]; National Basic Research Program of China (973 Program) [2010CB126105]; National High-tech R&D Program of China [2011AA10A205]; Fundamental Research Funds for Central Universities of China [2011PY092]	Chinese National Natural Science Funds(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China (973 Program)(National Basic Research Program of China); National High-tech R&D Program of China(National High Technology Research and Development Program of China); Fundamental Research Funds for Central Universities of China	This work was supported by the Chinese National Natural Science Funds (grants 31270105 and 30930004), the National Basic Research Program of China (973 Program, grant 2010CB126105), the National High-tech R&D Program of China (No. 2011AA10A205) and the Fundamental Research Funds for Central Universities of China (grant 2011PY092). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abee T, 2011, FOOD MICROBIOL, V28, P199, DOI 10.1016/j.fm.2010.03.015; AGAISSE H, 1994, J BACTERIOL, V176, P4734, DOI 10.1128/JB.176.15.4734-4741.1994; Aronson A, 2002, CELL MOL LIFE SCI, V59, P417, DOI 10.1007/s00018-002-8434-6; Berg L, 2012, J BIOTECHNOL, V158, P224, DOI 10.1016/j.jbiotec.2011.07.012; Bongrand C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032862; Bron S, 1998, J BIOTECHNOL, V64, P3, DOI 10.1016/S0168-1656(98)00099-6; Browning DF, 2004, NAT REV MICROBIOL, V2, P57, DOI 10.1038/nrmicro787; De Lay N, 2012, MOL MICROBIOL, V86, P524, DOI 10.1111/j.1365-2958.2012.08209.x; Gardner PP, 2009, NUCLEIC ACIDS RES, V37, pD136, DOI 10.1093/nar/gkn766; Garst AD, 2009, BBA-GENE REGUL MECH, V1789, P584, DOI 10.1016/j.bbagrm.2009.06.004; Gutierrez-Preciado A, 2009, MICROBIOL MOL BIOL R, V73, P36, DOI 10.1128/MMBR.00026-08; Haugen SP, 2008, NAT REV MICROBIOL, V6, P507, DOI 10.1038/nrmicro1912; Haugen SP, 2006, CELL, V125, P1069, DOI 10.1016/j.cell.2006.04.034; He J, 2011, J BACTERIOL, V193, P3407, DOI 10.1128/JB.05085-11; He J, 2010, J BACTERIOL, V192, P4074, DOI 10.1128/JB.00562-10; Higgins D, 2012, FEMS MICROBIOL REV, V36, P131, DOI 10.1111/j.1574-6976.2011.00310.x; Ibrahim Mohamed A, 2010, Bioeng Bugs, V1, P31, DOI 10.4161/bbug.1.1.10519; Kang JoongNam, 2005, International Journal of Industrial Entomology, V11, P125; Lale R, 2011, APPL ENVIRON MICROB, V77, P2648, DOI 10.1128/AEM.02091-10; Lioliou E, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002782; Loh E, 2012, NUCLEIC ACIDS RES, V40, P1818, DOI 10.1093/nar/gkr850; Mathew R, 2006, TRENDS MICROBIOL, V14, P450, DOI 10.1016/j.tim.2006.08.002; McGrath PT, 2007, NAT BIOTECHNOL, V25, P584, DOI 10.1038/nbt1294; Mendoza-Vargas A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007526; Miller JH., 1972, EXPT MOL GENETICS; Mitschke J, 2011, P NATL ACAD SCI USA, V108, P2124, DOI 10.1073/pnas.1015154108; NICKERSON KW, 1974, APPL MICROBIOL, V28, P129, DOI 10.1128/AEM.28.1.129-132.1974; Paredes-Sabja D, 2011, TRENDS MICROBIOL, V19, P85, DOI 10.1016/j.tim.2010.10.004; Peng D, 2009, J APPL MICROBIOL, V106, P1849, DOI 10.1111/j.1365-2672.2009.04151.x; Phadtare S, 2004, CURR ISSUES MOL BIOL, V6, P125; Sachs R, 2012, RNA, V18, P65, DOI 10.1261/rna.02809212; Sanahuja G, 2011, PLANT BIOTECHNOL J, V9, P283, DOI 10.1111/j.1467-7652.2011.00595.x; Sharma CM, 2010, NATURE, V464, P250, DOI 10.1038/nature08756; Sierro N, 2008, NUCLEIC ACIDS RES, V36, pD93, DOI 10.1093/nar/gkm910; Sorek R, 2010, NAT REV GENET, V11, P9, DOI 10.1038/nrg2695; Terpe K, 2006, APPL MICROBIOL BIOT, V72, P211, DOI 10.1007/s00253-006-0465-8; van Frankenhuyzen K, 2009, J INVERTEBR PATHOL, V101, P1, DOI 10.1016/j.jip.2009.02.009; Wang JP, 2013, MOL CELL PROTEOMICS, V12, P1363, DOI 10.1074/mcp.M112.023986; Waters LS, 2009, CELL, V136, P615, DOI 10.1016/j.cell.2009.01.043; WONG SL, 1995, CURR OPIN BIOTECH, V6, P517, DOI 10.1016/0958-1669(95)80085-9; Yoder-Himes DR, 2009, P NATL ACAD SCI USA, V106, P3976, DOI 10.1073/pnas.0813403106; Zhong CY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016025; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	43	27	30	2	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2013	8	5							e62960	10.1371/journal.pone.0062960	http://dx.doi.org/10.1371/journal.pone.0062960			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	143FO	23675447	Green Published, gold, Green Submitted			2022-12-27	WOS:000318852400017
J	Childs, KS; Randall, RE; Goodbourn, S				Childs, Kay S.; Randall, Richard E.; Goodbourn, Stephen			LGP2 Plays a Critical Role in Sensitizing mda-5 to Activation by Double-Stranded RNA	PLOS ONE			English	Article							PARAMYXOVIRUS V-PROTEINS; INDUCIBLE GENE-I; INNATE IMMUNE SENSOR; IFN-BETA PROMOTER; RIG-I; ANTIVIRAL RESPONSES; HELICASE LGP2; SIGNAL-TRANSDUCTION; INTERFERON-BETA; RECOGNITION	The DExD/H box RNA helicases retinoic acid-inducible gene-I (RIG-I) and melanoma differentiation associated gene-5 (mda-5) sense viral RNA in the cytoplasm of infected cells and activate signal transduction pathways that trigger the production of type I interferons (IFNs). Laboratory of genetics and physiology 2 (LGP2) is thought to influence IFN production by regulating the activity of RIG-I and mda-5, although its mechanism of action is not known and its function is controversial. Here we show that expression of LGP2 potentiates IFN induction by polyinosinic-polycytidylic acid [poly(I:C)], commonly used as a synthetic mimic of viral dsRNA, and that this is particularly significant at limited levels of the inducer. The observed enhancement is mediated through co-operation with mda-5, which depends upon LGP2 for maximal activation in response to poly(I:C). This co-operation is dependent upon dsRNA binding by LGP2, and the presence of helicase domain IV, both of which are required for LGP2 to interact with mda-5. In contrast, although RIG-I can also be activated by poly(I:C), LGP2 does not have the ability to enhance IFN induction by RIG-I, and instead acts as an inhibitor of RIG-I-dependent poly(I:C) signaling. Thus the level of LGP2 expression is a critical factor in determining the cellular sensitivity to induction by dsRNA, and this may be important for rapid activation of the IFN response at early times post-infection when the levels of inducer are low.	[Childs, Kay S.; Goodbourn, Stephen] Univ London, Div Biomed Sci, London, England; [Randall, Richard E.] Univ St Andrews, Sch Biol, St Andrews, Fife, Scotland	University of London; University of St Andrews	Goodbourn, S (corresponding author), Univ London, Div Biomed Sci, London, England.	s.goodbourn@sgul.ac.uk		Goodbourn, Stephen/0000-0002-4530-1179; Randall, Richard/0000-0002-9304-6678; Childs, Kay/0000-0003-1564-3503	Wellcome Trust [AL087751/B, 087751/A/08/Z]	Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by The Wellcome Trust (Grant Numbers AL087751/B to SG and 087751/A/08/Z to RER). (http://www.wellcome.ac.uk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrejeva J, 2004, P NATL ACAD SCI USA, V101, P17264, DOI 10.1073/pnas.0407639101; Bamming D, 2009, J BIOL CHEM, V284, P9700, DOI 10.1074/jbc.M807365200; Berke IC, 2012, P NATL ACAD SCI USA, V109, P18437, DOI 10.1073/pnas.1212186109; Berke IC, 2012, EMBO J, V31, P1714, DOI 10.1038/emboj.2012.19; Binder M, 2011, J BIOL CHEM, V286, P27278, DOI 10.1074/jbc.M111.256974; Bruns AM, 2013, J BIOL CHEM, V288, P938, DOI 10.1074/jbc.M112.424416; Childs KS, 2009, J VIROL, V83, P1465, DOI 10.1128/JVI.01768-08; Childs K, 2007, VIROLOGY, V359, P190, DOI 10.1016/j.virol.2006.09.023; Childs K, 2012, J VIROL, V86, P3411, DOI 10.1128/JVI.06405-11; Didcock L, 1999, J VIROL, V73, P9928, DOI 10.1128/JVI.73.12.9928-9933.1999; Goodbourn S, 2009, J INTERF CYTOK RES, V29, P539, DOI 10.1089/jir.2009.0071; Hornung V, 2006, SCIENCE, V314, P994, DOI 10.1126/science.1132505; JOHNSTON MD, 1981, J GEN VIROL, V56, P175, DOI 10.1099/0022-1317-56-1-175; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Kato H, 2008, J EXP MED, V205, P1601, DOI 10.1084/jem.20080091; Killip MJ, 2011, VIROLOGY, V415, P39, DOI 10.1016/j.virol.2011.03.027; Killip MJ, 2013, J VIROL IN PRESS; KING P, 1994, J BIOL CHEM, V269, P30609; Komuro A, 2006, J VIROL, V80, P12332, DOI 10.1128/JVI.01325-06; Kumagai Y, 2010, J ALLERGY CLIN IMMUN, V125, P985, DOI 10.1016/j.jaci.2010.01.058; Lennon G, 1996, GENOMICS, V33, P151, DOI 10.1006/geno.1996.0177; Leung DW, 2012, CURR OPIN STRUC BIOL, V22, P297, DOI 10.1016/j.sbi.2012.03.011; Levy DE, 2011, CURR OPIN VIROL, V1, P476, DOI 10.1016/j.coviro.2011.11.001; Li XJ, 2009, J BIOL CHEM, V284, P13881, DOI 10.1074/jbc.M900818200; Loo YM, 2008, J VIROL, V82, P335, DOI 10.1128/JVI.01080-07; Loo YM, 2011, IMMUNITY, V34, P680, DOI 10.1016/j.immuni.2011.05.003; MARAIS R, 1995, EMBO J, V14, P3136, DOI 10.1002/j.1460-2075.1995.tb07316.x; MASSON N, 1992, MOL CELL BIOL, V12, P1096, DOI 10.1128/MCB.12.3.1096; Peisley A, 2011, P NATL ACAD SCI USA, V108, P21010, DOI 10.1073/pnas.1113651108; Pichlmair A, 2006, SCIENCE, V314, P997, DOI 10.1126/science.1132998; Pichlmair A, 2009, J VIROL, V83, P10761, DOI 10.1128/JVI.00770-09; Pippig DA, 2009, NUCLEIC ACIDS RES, V37, P2014, DOI 10.1093/nar/gkp059; Randall RE, 2008, J GEN VIROL, V89, P1, DOI 10.1099/vir.0.83391-0; Rothenfusser S, 2005, J IMMUNOL, V175, P5260, DOI 10.4049/jimmunol.175.8.5260; Satoh T, 2010, P NATL ACAD SCI USA, V107, P1512, DOI 10.1073/pnas.0912986107; Schlee M, 2009, IMMUNITY, V31, P25, DOI 10.1016/j.immuni.2009.05.008; Strahle L, 2006, VIROLOGY, V351, P101, DOI 10.1016/j.virol.2006.03.022; Venkataraman T, 2007, J IMMUNOL, V178, P6444, DOI 10.4049/jimmunol.178.10.6444; Yoneyama M, 2005, J IMMUNOL, V175, P2851, DOI 10.4049/jimmunol.175.5.2851	39	72	74	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2013	8	5							e64202	10.1371/journal.pone.0064202	http://dx.doi.org/10.1371/journal.pone.0064202			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	155HD	23671710	Green Published, Green Accepted, gold			2022-12-27	WOS:000319737700068
J	Devhare, PB; Chatterjee, SN; Arankalle, VA; Lole, KS				Devhare, Pradip B.; Chatterjee, Subhashis N.; Arankalle, Vidya A.; Lole, Kavita S.			Analysis of Antiviral Response in Human Epithelial Cells Infected with Hepatitis E Virus	PLOS ONE			English	Article							PATTERN-RECOGNITION RECEPTORS; INNATE IMMUNE RECEPTORS; CYTOKINE PRODUCTION; UBIQUITIN LIGASE; HEPATOMA-CELLS; ORF3 PROTEIN; C VIRUS; EXPRESSION; HEV; PATHWAYS	Hepatitis E virus (HEV) is a major cause of enterically transmitted acute hepatitis in developing nations and occurs in sporadic and epidemic forms. The disease may become severe with high mortality (20%) among pregnant women. Due to lack of efficient cell culture system and small animal model, early molecular events of HEV infection are not yet known. In the present study, human lung epithelial cells, A549, were infected with HEV to monitor expression levels of genes/proteins in antiviral pathways. Both live and UV inactivated virus elicited robust induction of inflammatory cytokines/chemokines such as IL-6, IL-8, TNF-alpha, and RANTES within 12 h of infection. Cells exposed to soluble capsid protein showed no induction suggesting the capsid structure and not the protein being detected as the pathogen pattern by cells. A delayed upregulation of type I interferon genes only by the live virus at 48 h post HEV infection indicated the need of virus replication. However, absence of secreted interferons till 96 h suggested possible involvement of post-transcriptional regulation of type I IFN expression. HEV infected cells showed activation of both NF-kappa B and IRF3 transcription factors when seen at protein levels; however, reporter gene assays showed predominant expression via NF-kB promoter as compared to IRF3 promoter. Knockdown experiments done using siRNAs showed involvement of MyD88 and TRIF adaptors in generating antiviral response thus indicating role of TLR2, TLR4 and TLR3 in sensing viral molecules. MAVS knockdown surprisingly enhanced only proinflammatory cytokines and not type I IFNs. This suggested that HEV not only down-regulates RIG-I helicase like receptor mediated IFN induction but also employs MAVS in curtailing host inflammatory response. Our findings uncover an early cellular response in HEV infection and associated molecular mechanisms suggesting the potential role of inflammatory response triggered by HEV infection in host immune response and pathogenesis.	[Devhare, Pradip B.; Chatterjee, Subhashis N.; Arankalle, Vidya A.; Lole, Kavita S.] Natl Inst Virol, Hepatitis Div, Pune, Maharashtra, India	Indian Council of Medical Research (ICMR); ICMR - National Institute of Virology (NIV)	Lole, KS (corresponding author), Natl Inst Virol, Hepatitis Div, Microbial Containment Complex, Pune, Maharashtra, India.	lolekavita37@yahoo.com		Arankalle, Vidya/0000-0002-9940-3437; Devhare, Pradip/0000-0002-6546-3407	National Institute of Virology, Indian Council of Medical Research (ICMR), Pune, India	National Institute of Virology, Indian Council of Medical Research (ICMR), Pune, India	This study was funded by the National Institute of Virology, Indian Council of Medical Research (ICMR), Pune, India. P. Devhare is the recipient of an ICMR senior research fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal R, 2011, HEPATOLOGY, V54, P2218, DOI 10.1002/hep.24674; Ahmad I, 2011, VIRUS RES, V161, P47, DOI 10.1016/j.virusres.2011.02.011; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Arankalle VA, 2009, VACCINE, V27, P1032, DOI 10.1016/j.vaccine.2008.11.097; Chatterjee SN, 2012, J CLIN MICROBIOL, V50, P1467, DOI 10.1128/JCM.06717-11; Deshmukh TM, 2007, VACCINE, V25, P4350, DOI 10.1016/j.vaccine.2007.03.040; Dong C, 2012, HEPATOLOGY, V55, P1324, DOI 10.1002/hep.25530; Emerson SU, 2006, J VIROL, V80, P10457, DOI 10.1128/JVI.00892-06; Emerson SU, 2010, J VIROL, V84, P9059, DOI 10.1128/JVI.00593-10; Gack MU, 2007, NATURE, V446, P916, DOI 10.1038/nature05732; Goffic RL, 2010, J IMMUNOL, V185, P4812; Goffic RL, 2007, J IMMUNOL, V178, P3368; Graff J, 2008, J VIROL, V82, P1185, DOI 10.1128/JVI.01219-07; Ishii KJ, 2008, CELL HOST MICROBE, V3, P352, DOI 10.1016/j.chom.2008.05.003; Jensen S, 2012, J VIROL, V86, P2900, DOI 10.1128/JVI.05738-11; Julkunen I, 2001, CYTOKINE GROWTH F R, V12, P171, DOI 10.1016/S1359-6101(00)00026-5; Karpe YA, 2011, J GEN VIROL, V92, P2088, DOI 10.1099/vir.0.033738-0; Kawagoe T, 2008, NAT IMMUNOL, V9, P684, DOI 10.1038/ni.1606; Keskinen P, 1999, VIROLOGY, V263, P364, DOI 10.1006/viro.1999.9983; Lee MS, 2007, ANNU REV BIOCHEM, V76, P447, DOI 10.1146/annurev.biochem.76.060605.122847; Li K, 2005, J BIOL CHEM, V280, P16739, DOI 10.1074/jbc.M414139200; McInerney GM, 2009, J INNATE IMMUN, V1, P599, DOI 10.1159/000235861; Mogensen TH, 2001, MICROBIOL MOL BIOL R, V65, P131, DOI 10.1128/MMBR.65.1.131-150.2001; Prabhu SB, 2011, J VIRAL HEPATITIS, V18, P587, DOI 10.1111/j.1365-2893.2010.01338.x; Randall RE, 2008, J GEN VIROL, V89, P1, DOI 10.1099/vir.0.83391-0; Rehman S, 2008, VIROLOGY, V370, P77, DOI 10.1016/j.virol.2007.07.036; Shimizu Y, 2001, HEPATOLOGY, V34, P311, DOI 10.1053/jhep.2001.26631; Siren J, 2006, MICROBES INFECT, V8, P2013, DOI 10.1016/j.micinf.2006.02.028; Soo HM, 2002, VIROLOGY, V303, P253, DOI 10.1006/viro.2002.1617; Srivastava R, 2008, J VIRAL HEPATITIS, V15, P910, DOI 10.1111/j.1365-2893.2008.01036.x; Takahashi M, 2010, J CLIN MICROBIOL, V48, P1112, DOI 10.1128/JCM.02002-09; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; TAM AW, 1991, VIROLOGY, V185, P120, DOI 10.1016/0042-6822(91)90760-9; Thompson MR, 2011, VIRUSES-BASEL, V3, P920, DOI 10.3390/v3060920; Tissari J, 2005, J IMMUNOL, V174, P4289, DOI 10.4049/jimmunol.174.7.4289; Triantafilou K, 2004, J VIROL, V78, P11313, DOI 10.1128/JVI.78.20.11313-11320.2004; Tripathy AS, 2012, EUR J CLIN MICROBIOL, V31, P179, DOI 10.1007/s10096-011-1291-1; Tripathy AS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031822; Wertz IE, 2004, NATURE, V430, P694, DOI 10.1038/nature02794; Yokota SI, 2010, MEDIAT INFLAMM, P1; Yu C, 2010, J VIROL, V84, P11264, DOI 10.1128/JVI.01205-10; Zafrullah M, 1997, J VIROL, V71, P9045, DOI 10.1128/JVI.71.12.9045-9053.1997	42	54	58	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2013	8	5							e63793	10.1371/journal.pone.0063793	http://dx.doi.org/10.1371/journal.pone.0063793			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	155HD	23671700	Green Published, gold, Green Submitted			2022-12-27	WOS:000319737700060
J	Ireland, KB; Hardy, GES; Kriticos, DJ				Ireland, Kylie B.; Hardy, Giles E. St J.; Kriticos, Darren J.			Combining Inferential and Deductive Approaches to Estimate the Potential Geographical Range of the Invasive Plant Pathogen, Phytophthora ramorum	PLOS ONE			English	Article							SUDDEN OAK DEATH; 3 CLONAL LINEAGES; TREE MORTALITY; IN-VITRO; FOREST; RISK; CALIFORNIA; TEMPERATURE; DISEASE; SUSCEPTIBILITY	Phytophthora ramorum, an invasive plant pathogen of unknown origin, causes considerable and widespread damage in plant industries and natural ecosystems of the USA and Europe. Estimating the potential geographical range of P. ramorum has been complicated by a lack of biological and geographical data with which to calibrate climatic models. Previous attempts to do so, using either invaded range data or surrogate species approaches, have delivered varying results. A simulation model was developed using CLIMEX to estimate the global climate suitability patterns for establishment of P. ramorum. Growth requirements and stress response parameters were derived from ecophysiological laboratory observations and site-level transmission and disease factors related to climate data in the field. Geographical distribution data from the USA (California and Oregon) and Norway were reserved from model-fitting and used to validate the models. The model suggests that the invasion of P. ramorum in both North America and Europe is still in its infancy and that it is presently occupying a small fraction of its potential range. Phytophthora ramorum appears to be climatically suited to large areas of Africa, Australasia and South America, where it could cause biodiversity and economic losses in plant industries and natural ecosystems with susceptible hosts if introduced.	[Ireland, Kylie B.; Hardy, Giles E. St J.; Kriticos, Darren J.] Cooperat Res Ctr Natl Plant Biosecur, Canberra, ACT, Australia; [Ireland, Kylie B.; Hardy, Giles E. St J.] Murdoch Univ, Sch Vet & Life Sci, Ctr Phytophthora Sci & Management, Perth, WA, Australia; [Kriticos, Darren J.] CSIRO, Ecosyst Sci, Canberra, ACT, Australia	Murdoch University; Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Kriticos, DJ (corresponding author), Cooperat Res Ctr Natl Plant Biosecur, Canberra, ACT, Australia.	Darren.Kriticos@csiro.au	Ireland, Kylie/L-8014-2019; Kriticos, Darren J/A-4170-2008; Hardy, Giles/B-2432-2013	Ireland, Kylie/0000-0002-2337-3227; Kriticos, Darren J/0000-0003-2599-8105; Hardy, Giles/0000-0001-7419-5064	Australian Government's Cooperative Research Centres Program; Cooperative Research Centre for National Plant Biosecurity; Australian Government Department of Sustainability, Environment, Water, Population and Communities; School of Biological Sciences at Murdoch University	Australian Government's Cooperative Research Centres Program(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme); Cooperative Research Centre for National Plant Biosecurity(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme); Australian Government Department of Sustainability, Environment, Water, Population and Communities(Australian Government); School of Biological Sciences at Murdoch University	The authors would like to acknowledge the support of the Australian Government's Cooperative Research Centres Program and the Cooperative Research Centre for National Plant Biosecurity in particular. We also acknowledge the financial support of the Australian Government Department of Sustainability, Environment, Water, Population and Communities and the School of Biological Sciences at Murdoch University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to thank A. Kanaskie, R. Meentemeyer, T. Rafoss, A. Rytkonen and T. Vaclavik for assistance with obtaining point location data for P. ramorum. Thanks also to N. Brouwers for assistance with ArcGIS and my PhD supervisors Daniel Huberli, Bernard Dell and Ian Smith for valuable editorial support. The authors would like to acknowledge the support of the Cooperative Research Centre for National Plant Biosecurity, especially for supporting key collaborative opportunities. We would also like to acknowledge the efforts of three anonymous reviewers and thank them for their valuable feedback.	Brasier C, 2003, MYCOL RES, V107, P258, DOI 10.1017/S0953756203227660; Brasier C, 2012, SUDD OAK DEATH 5 SCI; Brasier C, 2006, PROGR RES PHYTOPHTHO, P166; Brasier CM, 2008, PLANT PATHOL, V57, P792, DOI 10.1111/j.1365-3059.2008.01886.x; Brasier CM, 2010, PLANT PATHOL, V59, P595, DOI 10.1111/j.1365-3059.2010.02278.x; Brasier C. M., 1994, Bulletin OEPP, V24, P221, DOI 10.1111/j.1365-2338.1994.tb01063.x; Brasier C, 2010, NATURE, V466, P824, DOI 10.1038/466824a; Browning M, 2008, MYCOLOGIA, V100, P236, DOI 10.3852/mycologia.100.2.236; COMTF, 2010, CAL OAK MORT TASK FO; COMTF, 2011, CAL OAK MORT TASK FO; Davidson J. M., 2002, General Technical Report - Pacific Southwest Research Station, USDA Forest Service, P741; Davidson JM, 2011, PHYTOPATHOLOGY, V101, P492, DOI 10.1094/PHYTO-03-10-0064; Davidson JM, 2005, PHYTOPATHOLOGY, V95, P587, DOI 10.1094/PHYTO-95-0587; Dehnen-Schmutz K, 2010, SCI HORTIC-AMSTERDAM, V125, P1, DOI 10.1016/j.scienta.2010.02.017; Elliott M, 2011, FOREST PATHOL, V41, P7, DOI 10.1111/j.1439-0329.2009.00627.x; Englander L, 2006, MYCOLOGIA, V98, P365, DOI 10.3852/mycologia.98.3.365; FAO, 2006, INT STAND PHYT MEAS, P1; Fichtner EJ, 2007, PHYTOPATHOLOGY, V97, P1366, DOI 10.1094/PHYTO-97-10-1366; Fichtner EJ, 2009, PHYTOPATHOLOGY, V99, P608, DOI 10.1094/PHYTO-99-5-0608; Forestry Commission, 2011, PHYT RAM LARCH TREES; Fowler G., 2006, General Technical Report - Pacific Southwest Research Station, USDA Forest Service, P329; Goheen E. M., 2006, General Technical Report - Pacific Southwest Research Station, USDA Forest Service, P113; Goss EM, 2009, MOL ECOL, V18, P1161, DOI 10.1111/j.1365-294X.2009.04089.x; Grunwald NJ, 2009, PHYTOPATHOLOGY, V99, P792, DOI 10.1094/PHYTO-99-7-0792; Guo QH, 2005, ECOL MODEL, V182, P75, DOI 10.1016/j.ecolmodel.2004.07.012; Guo QH, 2007, GISCI REMOTE SENS, V44, P24, DOI 10.2747/1548-1603.44.1.24; Hansen EM, 2008, CAN J FOREST RES, V38, P1133, DOI 10.1139/X07-217; Hardham AR, 2005, MOL PLANT PATHOL, V6, P589, DOI 10.1111/J.1364-3703.2005.00308.X; Huberli D, 2008, AUSTRALAS PLANT PATH, V37, P615, DOI 10.1071/AP08064; Ireland KB, 2012, FOREST PATHOL, V42, P305, DOI 10.1111/j.1439-0329.2011.00755.x; Ireland KB, 2012, PLANT PATHOL, V61, P234, DOI 10.1111/j.1365-3059.2011.02513.x; Ivors K, 2006, MOL ECOL, V15, P1493, DOI 10.1111/j.1365-294X.2006.02864.x; Kanaskie A., 2008, General Technical Report - Pacific Southwest Research Station, USDA Forest Service, P15; Kelly M, 2002, PHOTOGRAMM ENG REM S, V68, P1001; Kliejunas JT, 2010, PSWGTR234 US DEP AGR; Kluza DA, 2007, PLANT PATHOL, V56, P580, DOI 10.1111/j.1365-3059.2007.01602.x; Kriticos DJ, 2003, BIOL INVASIONS, V5, P147, DOI 10.1023/A:1026193424587; Kriticos DJ, 2012, METHODS ECOL EVOL, V3, P53, DOI 10.1111/j.2041-210X.2011.00134.x; Kriticos DJ, 2010, ECOGRAPHY, V33, P115, DOI 10.1111/j.1600-0587.2009.06042.x; Kriticos DJ, 2005, WEED RES, V45, P246, DOI 10.1111/j.1365-3180.2005.00458.x; Magarey RD, 2007, PLANT DIS, V91, P336, DOI 10.1094/PDIS-91-4-0336; Maloney PE, 2005, J ECOL, V93, P899, DOI 10.1111/j.1365-2745.2005.01031.x; McKenney D, 2003, ENVIRON MONIT ASSESS, V88, P445, DOI 10.1023/A:1025502030803; Meentemeyer R, 2004, FOREST ECOL MANAG, V200, P195, DOI 10.1016/j.foreco.2004.06.021; Meentemeyer RK, 2008, BIOL INVASIONS, V10, P1243, DOI 10.1007/s10530-007-9199-5; Meentemeyer RK, 2011, ECOSPHERE, V2, DOI 10.1890/ES10-00192.1; Pinkard EA, 2010, ECOL MODEL, V221, P2828, DOI 10.1016/j.ecolmodel.2010.08.017; Rizzo DM, 2005, ANNU REV PHYTOPATHOL, V43, P309, DOI 10.1146/annurev.phyto.42.040803.140418; Rizzo DM, 2003, FRONT ECOL ENVIRON, V1, P197, DOI 10.1890/1540-9295(2003)001[0197:SODECA]2.0.CO;2; Rizzo DM, 2002, PLANT DIS, V86, P205, DOI 10.1094/PDIS.2002.86.3.205; Sakai AK, 2001, ANNU REV ECOL SYST, V32, P305, DOI 10.1146/annurev.ecolsys.32.081501.114037; Sansford C. E., 2009, REPORT RISK ENTRY ES; Scherm H, 1999, AGR SYST, V59, P301, DOI 10.1016/S0308-521X(99)00011-6; Sundheim L., 2009, PEST RISK ASSESSMENT; Sutherst R W, 2007, CLIMEX VERSION 3 USE; Sutherst R. W., 2004, CLIMEX V2 USERS GUID; Sutherst RW, 2003, J BIOGEOGR, V30, P805, DOI 10.1046/j.1365-2699.2003.00861.x; SUTHERST RW, 1985, AGR ECOSYST ENVIRON, V13, P281, DOI 10.1016/0167-8809(85)90016-7; Swiecki TJ, 2007, PHYTOSPHERE RES; Tjosvold SA, 2008, PLANT DIS, V92, P1566, DOI 10.1094/PDIS-92-11-1566; Tjosvold SA, 2009, PLANT DIS, V93, P371, DOI 10.1094/PDIS-93-4-0371; Tooley PW, 2008, PLANT DIS, V92, P431, DOI 10.1094/PDIS-92-3-0431; Tooley PW, 2007, PLANT DIS, V91, P435, DOI 10.1094/PDIS-91-4-0435; Tooley PW, 2009, PHYTOPATHOLOGY, V99, P1045, DOI 10.1094/PHYTO-99-9-1045; Tooley PW, 2009, PLANT DIS, V93, P249, DOI 10.1094/PDIS-93-3-0249; Tsopelas P, 2011, PLANT DIS, V95, P223, DOI 10.1094/PDIS-08-10-0607; Turner J, 2008, MANAGEMENT CONTAINME; Turner J, 2005, PHYTOPHTHORA RAMORUM; USDA, 2004, USDA PUBL; Vaclavik T, 2010, FOREST ECOL MANAG, V260, P1026, DOI 10.1016/j.foreco.2010.06.026; Vaclavik T, 2009, ECOL MODEL, V220, P3248, DOI 10.1016/j.ecolmodel.2009.08.013; VANNINI A, 2009, PHYTOPHTHORAS FOREST, P54; Venette RC, 2006, FOREST ECOL MANAG, V231, P18, DOI 10.1016/j.foreco.2006.04.036; Watt MS, 2009, FOREST ECOL MANAG, V257, P1505, DOI 10.1016/j.foreco.2008.12.026; Webber J, 2009, PHYTOPHTHORA RAMORUM; Webber J. F., 2010, New Disease Reports, V22, P19, DOI 10.5197/j.2044-0588.2010.022.019; Webber J.F., 2004, MYCOLOGICAL RES, V108, P1110, DOI [10.1017/S0953756204221244, DOI 10.1017/S0953756204221244]; Werres S, 2005, MYCOL RES, V109, P860, DOI 10.1017/S0953756205003369; Werres S, 2001, MYCOL RES, V105, P1155, DOI 10.1016/S0953-7562(08)61986-3; Yonow T, 2004, PHYTOPATHOLOGY, V94, P805, DOI 10.1094/PHYTO.2004.94.8.805	80	22	23	0	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e63508	10.1371/journal.pone.0063508	http://dx.doi.org/10.1371/journal.pone.0063508			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667628	gold, Green Published			2022-12-27	WOS:000319654700153
J	Nogales, M; Gonzalez-Castro, A; Marrero, P; Bonnaud, E; Traveset, A				Nogales, Manuel; Gonzalez-Castro, Aaron; Marrero, Patricia; Bonnaud, Elsa; Traveset, Anna			Contrasting Selective Pressures on Seed Traits of Two Congeneric Species by Their Main Native Guilds of Dispersers on Islands	PLOS ONE			English	Article							GALLOTIA-GALLOTI LACERTIDAE; FRUGIVOROUS BIRDS; FLESHY FRUITS; XERIC HABITAT; GERMINATION; CONSTRAINTS; RUBIACEAE; PASSAGE; PATTERNS; LIZARDS	Many fleshy-fruited plants from the Mediterranean and Macaronesian islands are dispersed through endozoochory. In mainland Mediterranean areas, reciprocal adaptations have been found between plants and animals, although evidence is scarce. On small isolated oceanic islands, such reciprocal adaptations might well be more prevalent due to intrinsic island traits. Here we evaluate the existence of selective pressures exerted by two different disperser guilds (lizards and birds) on two seed traits (seed coat thickness and seed germination pattern) of two congeneric species present on Mediterranean and Macaronesian islands. In the continental Balearic Islands, Rubia peregrina has evolved mostly with birds, although frugivorous lizards are present in some of these islands and are known to eventually consume its fruits. By contrast, R. fruticosa, endemic to the Macaronesian archipelago, has evolved mostly interacting with lizards and only recently with birds. We hypothesized that R. fruticosa would be especially adapted to saurochory, with thicker seed coats and higher germination proportion, whereas R. peregrina would be more adapted to ornithocory, with thinner seed coats and showing a lower germination percentage after being ingested by lizards. Captivity experiments of seed ingestions by natural and non-natural dispersers (i.e., frugivores that have not evolved with those plants) were conducted. Results suggest that dispersers did not exert any strong enough selective pressure to induce changes in germination patterns. We attribute this to the fact that the Rubiaceae is an ancestral family in the Mediterranean (both on continent and islands) and thus probably interacted with lizards in the past. Lastly, although we hold that the seed coat structure of R. fruticosa is probably associated with its evolutionary success after a long interaction with insular lizards, our findings support the idea that the relationship between endozoochorous plants and the guild of dispersers with whom they evolved is rather unspecific.	[Nogales, Manuel; Gonzalez-Castro, Aaron; Marrero, Patricia; Bonnaud, Elsa] CSIC, Inst Prod Nat & Agrobiol, Isl Ecol & Evolut Res Grp, San Cristobal la Laguna, Canary Islands, Spain; [Marrero, Patricia] Univ E Anglia, Sch Biol Sci, Norwich NR4 7TJ, Norfolk, England; [Bonnaud, Elsa] Univ Paris 11, Unite Ecol Systemat & Evolut, Equipe Ecol Populat & Communautes, Paris, France; [Traveset, Anna] Univ Illes Balears, CSIC, Lab Int Cambio Global, Inst Meditarrani Estudis Avancats, Esporles, Balearic Island, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Productos Naturales y Agrobiologia (IPNA); University of East Anglia; UDICE-French Research Universities; Universite Paris Saclay; Consejo Superior de Investigaciones Cientificas (CSIC); Universitat de les Illes Balears	Gonzalez-Castro, A (corresponding author), CSIC, Inst Prod Nat & Agrobiol, Isl Ecol & Evolut Res Grp, San Cristobal la Laguna, Canary Islands, Spain.	agcastro@ipna.csic.es	Nogales, Manuel/I-9831-2014; González-Castro, Aarón/K-3290-2016; Marrero, Patricia/B-8394-2014; Traveset, Anna V/D-7802-2011	Nogales, Manuel/0000-0002-5327-3104; González-Castro, Aarón/0000-0002-5311-1017; MARRERO, PATRICIA/0000-0002-8156-8006	Spanish National Research Council; Spanish Ministry of Education; Ministry of Education and Science of the Spanish Government [CGL2007-61165/BOS, CGL2010-18759/BOS]; European Union	Spanish National Research Council; Spanish Ministry of Education(Spanish Government); Ministry of Education and Science of the Spanish Government(Spanish Government); European Union(European Commission)	A. Gonzalez-Castro (JAE-pre) and E. Bonnaud (JAE-doc) were funded by two grants from the Spanish National Research Council. P. Marrero has a postdoctoral fellowship from the Spanish Ministry of Education. This paper is framed within projects CGL2007-61165/BOS and CGL2010-18759/BOS financed by the Ministry of Education and Science of the Spanish Government and partially funded by the European Union. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcover A., 1981, QUIMERES PASSAT ELS; [Anonymous], 2001, ANIM BEHAV, V61, P271, DOI [10.1006/anbe.2000.1652, 10.1016/S0003-3472(15)00461-3]; Baskin C.C, 2001, SEEDS ECOLOGY BIOGEO; Bover P, 2008, QUATERN INT, V182, P135, DOI 10.1016/j.quaint.2007.06.039; BREMER B, 1992, BIOL J LINN SOC, V47, P79, DOI 10.1111/j.1095-8312.1992.tb00657.x; Brokaw NLV, 1986, FRUGIVORE SEED DISPE, P323; Cardinali A., 2006, PHYTOCHEM ADV RES, V661, P23; Illera JC, 2012, QUATERNARY SCI REV, V50, P14, DOI 10.1016/j.quascirev.2012.07.013; Cox SC, 2010, MOL PHYLOGENET EVOL, V56, P747, DOI 10.1016/j.ympev.2010.03.020; Dennis A.J., 2007, SEED DISPERSAL THEOR; Eriksson O, 2000, OIKOS, V156, P47; Fleming T. H., 1993, FRUGIVORY SEED DISPE; Gonzalez-Castro A, 2012, J BIOGEOGR, V39, P1938, DOI 10.1111/j.1365-2699.2012.02693.x; Gutterman Y., 1993, SEED GERMINATION DES; Herrera C.M., 1986, VERTEBRATE DISPERSED, P5, DOI DOI 10.1007/978-94-009-4812-9_2; Herrera C.M., 2001, ECOSISTEMAS MEDITERR, P125; Herrera Carlos M., 2002, P185; HERRERA CM, 1995, ANNU REV ECOL SYST, V26, P705, DOI 10.1146/annurev.es.26.110195.003421; HERRERA CM, 1984, ECOLOGY, V65, P609, DOI 10.2307/1941423; Herrera CM, 1998, ECOL MONOGR, V68, P511, DOI 10.1890/0012-9615(1998)068[0511:LTDOMF]2.0.CO;2; HERRERA CM, 1985, OIKOS, V44, P132, DOI 10.2307/3544054; HERRERA CM, 1984, ECOL MONOGR, V54, P1, DOI 10.2307/1942454; HOWE HF, 1984, AM NAT, V123, P764, DOI 10.1086/284238; HOWE HF, 1977, ECOLOGY, V58, P539, DOI 10.2307/1939003; HOWE HF, 1977, AM NAT, V111, P817, DOI 10.1086/283216; JANZEN DH, 1982, SCIENCE, V215, P19, DOI 10.1126/science.215.4528.19; JOHNSON RA, 1985, ECOLOGY, V66, P819, DOI 10.2307/1940543; JORDANO P, 1995, AM NAT, V145, P163, DOI 10.1086/285735; JORDANO P, 1981, IBIS, V123, P502, DOI 10.1111/j.1474-919X.1981.tb04055.x; JORDANO P, 1994, OIKOS, V71, P479, DOI 10.2307/3545836; Levey D.J., 2002, SEED DISPERSAL FRUGI, Vfirst; LIEBERMAN M, 1986, Journal of Tropical Ecology, V2, P113; Lopez-Darias M, 2008, J ARID ENVIRON, V72, P926, DOI 10.1016/j.jaridenv.2007.12.006; MANEN JF, 1994, PLANT SYST EVOL, V190, P195, DOI 10.1007/BF00986193; McKey D., 1975, COEVOLUTION ANIMALS, P151; Meyer GA, 1998, AM MIDL NAT, V140, P129, DOI 10.1674/0003-0031(1998)140[0129:IOSPBF]2.0.CO;2; Nogales M, 1995, ACTA OECOL, V16, P585; Nogales M, 2005, FUNCT ECOL, V19, P429, DOI 10.1111/j.0269-8463.2005.00975.x; Nogales M, 2001, J BIOGEOGR, V28, P1137, DOI 10.1046/j.1365-2699.2001.00622.x; Nogales M, 1999, ECOSCIENCE, V6, P56, DOI 10.1080/11956860.1999.11952193; Nogales M, 2009, FLORA, V204, P543, DOI 10.1016/j.flora.2008.07.006; Oliverio M, 2000, J BIOGEOGR, V27, P1403, DOI 10.1046/j.1365-2699.2000.00517.x; Perez-Tris J, 2004, EVOLUTION, V58, P1819, DOI 10.1554/03-731; Pijl van der L., 1972, PRINCIPLES DISPERSAL; Pulido F, 2008, J BIOGEOGR, V35, P1425, DOI 10.1111/j.1365-2699.2008.01898.x; R Development Core Team, 2012, R LANG ENV STAT COMP; RICK CM, 1961, EVOLUTION, V15, P407, DOI 10.2307/2406309; Ridley H., 1930, J ECOL, DOI DOI 10.2307/2255951; Robertson AW, 2006, FUNCT ECOL, V20, P58, DOI 10.1111/j.1365-2435.2005.01057.x; Rodriguez A, 2008, J HERPETOL, V42, P213, DOI 10.1670/07-0752.1; Rodriguez-Perez J, 2005, FUNCT ECOL, V19, P699, DOI 10.1111/j.0269-8463.2005.00971.x; Rumeu B, 2011, PLANT ECOL, V212, P911, DOI 10.1007/s11258-010-9875-x; Saez E, 1993, HERPETOL REV, V26, P1212; Samuels IA, 2005, FUNCT ECOL, V19, P365, DOI 10.1111/j.1365-2435.2005.00973.x; Schupp E. W., 2007, Seed dispersal: theory and its application in a changing world, P445, DOI 10.1079/9781845931650.0445; Schupp EW, 2010, NEW PHYTOL, V188, P333, DOI 10.1111/j.1469-8137.2010.03402.x; SNOW DW, 1971, IBIS, V113, P194, DOI 10.1111/j.1474-919X.1971.tb05144.x; SORENSEN AE, 1984, J ANIM ECOL, V53, P545, DOI 10.2307/4533; Traveset A, 2005, CONSERV BIOL, V19, P421, DOI 10.1111/j.1523-1739.2005.00019.x; TRAVESET A, 1995, ACTA OECOL, V16, P171; Traveset A, 2001, FUNCT ECOL, V15, P669, DOI 10.1046/j.0269-8463.2001.00561.x; Traveset A, 2008, ECOLOGY, V89, P95, DOI 10.1890/07-0094.1; Traveset Anna, 1998, Perspectives in Plant Ecology Evolution and Systematics, V1, P151, DOI 10.1078/1433-8319-00057; Tsou CH, 2002, BOT BULL ACAD SINICA, V43, P37; Valido A, 2003, J HERPETOL, V37, P741, DOI 10.1670/15-02AN; Valido A, 2011, J EVOLUTION BIOL, V24, P751, DOI 10.1111/j.1420-9101.2010.02206.x; Valido A, 2003, AMPHIBIA-REPTILIA, V24, P331, DOI 10.1163/156853803322440790; VALIDO A, 1994, OIKOS, V70, P403, DOI 10.2307/3545778; Valido A., 1999, ECOLOGIA DISPERSION; Verdu M, 2005, ECOLOGY, V86, P1385, DOI 10.1890/04-1647; Voelker G, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-163; WHEELWRIGHT NT, 1982, AM NAT, V119, P402, DOI 10.1086/283918; WILLSON MF, 1990, CONDOR, V92, P545, DOI 10.2307/1368671	73	5	5	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e63266	10.1371/journal.pone.0063266	http://dx.doi.org/10.1371/journal.pone.0063266			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667598	Green Published, gold, Green Submitted			2022-12-27	WOS:000319654700128
J	Gentry, M; Meyer, P				Gentry, Matthew; Meyer, Peter			An 11bp Region with Stem Formation Potential Is Essential for de novo DNA Methylation of the RPS Element	PLOS ONE			English	Article							SIRNA ACCUMULATION; ARABIDOPSIS; HETEROCHROMATIN; MAINTENANCE; ARGONAUTE4; NUCLEATION	The initiation of DNA methylation in Arabidopsis is controlled by the RNA-directed DNA methylation (RdDM) pathway that uses 24nt siRNAs to recruit de novo methyltransferase DRM2 to the target site. We previously described the REPETITIVE PETUNIA SEQUENCE (RPS) fragment that acts as a hot spot for de novo methylation, for which it requires the cooperative activity of all three methyltransferases MET1, CMT3 and DRM2, but not the RdDM pathway. RPS contains two identical 11nt elements in inverted orientation, interrupted by a 18nt spacer, which resembles the features of a stemloop structure. The analysis of deletion/substitution derivatives of this region showed that deletion of one 11nt element RPS is sufficient to eliminate de novo methylation of RPS. In addition, deletion of a 10nt region directly adjacent to one of the 11nt elements, significantly reduced de novo methylation. When both 11nt regions were replaced by two 11nt elements with altered DNA sequence but unchanged inverted repeat homology, DNA methylation was not affected, indicating that de novo methylation was not targeted to a specific DNA sequence element. These data suggest that de novo DNA methylation is attracted by a secondary structure to which the two 11nt elements contribute, and that the adjacent 10nt region influences the stability of this structure. This resembles the recognition of structural features by DNA methyltransferases in animals and suggests that similar mechanisms exist in plants.	[Gentry, Matthew; Meyer, Peter] Univ Leeds, Ctr Plant Sci, Leeds, W Yorkshire, England	University of Leeds	Meyer, P (corresponding author), Univ Leeds, Ctr Plant Sci, Leeds, W Yorkshire, England.	p.meyer@leeds.ac.uk	Gentry, Matthew/L-1675-2017	Gentry, Matthew/0000-0002-8476-589X	BBSRC Departmental Training Grant	BBSRC Departmental Training Grant(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	MG was supported by a BBSRC Departmental Training Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BESTOR T, 1987, NUCLEIC ACIDS RES, V15, P3835, DOI 10.1093/nar/15.9.3835; Bestor TH, 1996, NAT GENET, V12, P363, DOI 10.1038/ng0496-363; Chan SWL, 2004, SCIENCE, V303, P1336, DOI 10.1126/science.1095989; Clark Jarrod, 2008, Cancer Genomics & Proteomics, V5, P241; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Cokus SJ, 2008, NATURE, V452, P215, DOI 10.1038/nature06745; Freitag M, 2004, SCIENCE, V304, P1939, DOI 10.1126/science.1099709; Gendrel AV, 2002, SCIENCE, V297, P1871, DOI 10.1126/science.1074950; Goll MG, 2005, ANNU REV BIOCHEM, V74, P481, DOI 10.1146/annurev.biochem.74.010904.153721; Guieysse AL, 1997, J MOL BIOL, V267, P289, DOI 10.1006/jmbi.1997.0884; Hall IM, 2002, SCIENCE, V297, P2232, DOI 10.1126/science.1076466; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Hellens R, 2000, TRENDS PLANT SCI, V5, P446, DOI 10.1016/S1360-1385(00)01740-4; Herbert A, 1999, GENETICA, V106, P37, DOI 10.1023/A:1003768526018; Hetzl J, 2007, PLANT J, V51, P526, DOI 10.1111/j.1365-313X.2007.03152.x; HORWITZ MSZ, 1988, SCIENCE, V241, P703, DOI 10.1126/science.2456617; Jia ST, 2004, SCIENCE, V304, P1971, DOI 10.1126/science.1099035; Lewis ZA, 2008, GENOME RES; Muller A, 2002, PLANT MOL BIOL, V48, P383, DOI 10.1023/A:1014091131490; Shlyakhtenko LS, 2000, J MOL BIOL, V296, P1169, DOI 10.1006/jmbi.2000.3542; Singh A, 2008, PLANT J, V56, P814, DOI 10.1111/j.1365-313X.2008.03640.x; Slotkin RK, 2007, NAT REV GENET, V8, P272, DOI 10.1038/nrg2072; Tamaru H, 2003, MOL CELL BIOL, V23, P2379, DOI 10.1128/MCB.23.7.2379-2394.2003; Volpe TA, 2002, SCIENCE, V297, P1833, DOI 10.1126/science.1074973; Yamada T, 2005, MOL CELL, V20, P173, DOI 10.1016/j.molcel.2005.10.002; Yoder JA, 1997, J MOL BIOL, V270, P385, DOI 10.1006/jmbi.1997.1125; Zhang XY, 2006, CELL, V126, P1189, DOI 10.1016/j.cell.2006.08.003; Zheng XW, 2007, EMBO J, V26, P1691, DOI 10.1038/sj.emboj.7601603; Zilberman D, 2003, SCIENCE, V299, P716, DOI 10.1126/science.1079695; Zilberman D, 2004, CURR BIOL, V14, P1214, DOI 10.1016/j.cub.2004.06.055; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	31	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2013	8	5							e63652	10.1371/journal.pone.0063652	http://dx.doi.org/10.1371/journal.pone.0063652			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	177QL	23671690	Green Published, gold			2022-12-27	WOS:000321390200055
J	Oliveira, PD; Michel, RC; McBride, AJA; Moreira, AS; Lomba, RFT; Vendruscolo, CT				Oliveira, Patricia D.; Michel, Ricardo C.; McBride, Alan J. A.; Moreira, Angelita S.; Lomba, Rosana F. T.; Vendruscolo, Claire T.			Concentration Regimes of Biopolymers Xanthan, Tara, and Clairana, Comparing Dynamic Light Scattering and Distribution of Relaxation Time	PLOS ONE			English	Article							GUM SOLUTIONS; VISCOELASTIC PROPERTIES; POLYMER-SOLUTIONS; DILUTE-SOLUTIONS; GUAR GUM; POLYSACCHARIDE; BEHAVIOR; FLOW; MACROMOLECULES; REPTATION	The aim of this work was to evaluate the utilization of analysis of the distribution of relaxation time (DRT) using a dynamic light back-scattering technique as alternative method for the determination of the concentration regimes in aqueous solutions of biopolymers (xanthan, clairana and tara gums) by an analysis of the overlap (c*) and aggregation (c**) concentrations. The diffusion coefficients were obtained over a range of concentrations for each biopolymer using two methods. The first method analysed the behaviour of the diffusion coefficient as a function of the concentration of the gum solution. This method is based on the analysis of the diffusion coefficient versus the concentration curve. Using the slope of the curves, it was possible to determine the c* and c** for xanthan and tara gum. However, it was not possible to determine the concentration regimes for clairana using this method. The second method was based on an analysis of the DRTs, which showed different numbers of relaxation modes. It was observed that the concentrations at which the number of modes changed corresponded to the c* and c**. Thus, the DRT technique provided an alternative method for the determination of the critical concentrations of biopolymers.	[Oliveira, Patricia D.; McBride, Alan J. A.; Vendruscolo, Claire T.] Univ Fed Pelotas, Technol Dev Ctr, Pelotas, RS, Brazil; [Michel, Ricardo C.] Univ Fed Rio de Janeiro, Eloisa Mano Macromol Inst, Rio De Janeiro, Brazil; [Moreira, Angelita S.; Vendruscolo, Claire T.] Univ Fed Pelotas, Chem Pharmaceut & Food Sci Ctr, Pelotas, RS, Brazil; [Lomba, Rosana F. T.] Well Engn Technol Res & Dev Ctr, Petrobras, RS, Brazil	Universidade Federal de Pelotas; Universidade Federal do Rio de Janeiro; Universidade Federal de Pelotas	Oliveira, PD (corresponding author), Univ Fed Pelotas, Technol Dev Ctr, Pelotas, RS, Brazil.	bilicadiaz@yahoo.com.br	Vendruscolo, Claire Tondo/AAN-2723-2020; McBride, Alan/D-4106-2012; Diaz, Patrícia Silva/L-9364-2017; da S. Moreira, Angelita/L-8545-2017	Vendruscolo, Claire Tondo/0000-0003-0357-5988; McBride, Alan/0000-0001-9682-540X; Diaz, Patrícia Silva/0000-0001-9601-296X; da S. Moreira, Angelita/0000-0001-8711-6521; Cunha Michel, Ricardo/0000-0002-7207-0441				Andrade CT, 1999, INT J BIOL MACROMOL, V26, P181, DOI 10.1016/S0141-8130(99)00075-6; Antunes A, 2000, REV BRASILEIRA AGROC, V6, P123; Berne B., 2000, DYNAMIC LIGHT SCATTE, P384; Borges C. D., 2004, Ciencia e Tecnologia de Alimentos, V24, P327, DOI 10.1590/S0101-20612004000300004; Burke MD, 2000, MACROMOLECULES, V33, P7500, DOI 10.1021/ma000786l; COVIELLO T, 1986, MACROMOLECULES, V19, P2826, DOI 10.1021/ma00165a027; COVIELLO T, 1987, MACROMOLECULES, V20, P1102, DOI 10.1021/ma00171a038; CUVELIER G, 1986, CARBOHYD POLYM, V6, P321, DOI 10.1016/0144-8617(86)90023-8; de Gennes P., 1979, SCALING CONCEPTS POL, P324; DEGENNES PG, 1971, J CHEM PHYS, V55, P572, DOI 10.1063/1.1675789; DEGENNES PG, 1976, MACROMOLECULES, V9, P594, DOI 10.1021/ma60052a012; DINTZIS FR, 1970, CARBOHYD RES, V13, P257, DOI 10.1016/S0008-6215(00)80832-0; Doi M., 1988, THEORY POLYM DYNAMIC; Esquenet C, 2002, MACROMOLECULES, V35, P3708, DOI 10.1021/ma012047q; Food Standards Code Australia New Zealand, 2005, APPL A546 TAR GUM FO, P1; HAYNES WC, 1955, APPL MICROBIOL, V3, P361, DOI 10.1128/AEM.3.6.361-368.1955; KANG KS, 1977, EXTRACELLULAR MICROB, P220; Laguna MTR, 2003, J CHEM PHYS, V119, P1148, DOI 10.1063/1.1579674; LAPASIN R, 1995, RHEOLOGY IND POLYSAC, P620; Launay B, 1997, CARBOHYD POLYM, V34, P385, DOI 10.1016/S0144-8617(97)00104-5; MEYER EL, 1993, MACROMOLECULES, V26, P504, DOI 10.1021/ma00055a016; MILAS M, 1990, MACROMOLECULES, V23, P2506, DOI 10.1021/ma00211a018; Moreira A. N., 2005, Brazilian Journal of Food Technology, V8, P135; Moreira A. S., 1998, REV BRASILEIRA AGROC, V4, P222; Moreira Ângela Nunes, 2003, Food Sci. Technol (Campinas), V23, P300, DOI 10.1590/S0101-20612003000200034; Moreira AS, 2001, FOOD HYDROCOLLOID, V15, P469, DOI 10.1016/S0268-005X(01)00092-3; Morris Edwin R., 1995, V67, P517; Muro MA, 1989, PRESERVACAO MICRORGA, P65; Nash W, 2002, INT J BIOL MACROMOL, V30, P269, DOI 10.1016/S0141-8130(02)00041-7; Padilha FF, 1998, REV BRAS AGROCIENCIA, V4, P231; Picout DR, 2001, BIOMACROMOLECULES, V2, P1301, DOI 10.1021/bm010118n; Pinto EP, 2002, REV BRASILEIRA AGROC, V8, P247; Rodd AB, 2001, MACROMOLECULES, V34, P3339, DOI 10.1021/ma001706g; Rodd AB, 2000, CARBOHYD POLYM, V42, P159, DOI 10.1016/S0144-8617(99)00156-3; Scamparini A, 1997, INT J BIOL MACROMOL, V21, P115, DOI 10.1016/S0141-8130(97)00050-0; Scamparini A, 2001, PROCESSO PRODUCAO PO; Sittikijyothin W, 2005, CARBOHYD POLYM, V59, P339, DOI 10.1016/j.carbpol.2004.10.005; SOUTHWICK JG, 1980, CARBOHYD RES, V84, P287, DOI 10.1016/S0008-6215(00)85558-5; SOUTHWICK JG, 1981, MACROMOLECULES, V14, P1728, DOI 10.1021/ma50007a022; TINLAND B, 1990, MACROMOLECULES, V23, P596, DOI 10.1021/ma00204a036; Vendruscolo CT, 2006, PROCESS PREPARING XA; YING QC, 1987, MACROMOLECULES, V20, P362, DOI 10.1021/ma00168a023	42	15	16	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2013	8	5							e62713	10.1371/journal.pone.0062713	http://dx.doi.org/10.1371/journal.pone.0062713			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	177QL	23671627	Green Submitted, Green Published, gold			2022-12-27	WOS:000321390200035
J	Ramadanovic, B; Vasarhelyi, K; Nadaf, A; Wittenberg, RW; Montaner, JSG; Wood, E; Rutherford, AR				Ramadanovic, Bojan; Vasarhelyi, Krisztina; Nadaf, Ali; Wittenberg, Ralf W.; Montaner, Julio S. G.; Wood, Evan; Rutherford, Alexander R.			Changing Risk Behaviours and the HIV Epidemic: A Mathematical Analysis in the Context of Treatment as Prevention	PLOS ONE			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; INJECTION-DRUG USERS; SEXUAL RISK; POSITIVE MEN; TREATMENT OPTIMISM; TRANSMISSION RISK; HOMOSEXUAL-MEN; VIRAL LOAD; IMPACT; INFECTION	Background: Expanding access to highly active antiretroviral therapy (HAART) has become an important approach to HIV prevention in recent years. Previous studies suggest that concomitant changes in risk behaviours may either help or hinder programs that use a Treatment as Prevention strategy. Analysis: We consider HIV-related risk behaviour as a social contagion in a deterministic compartmental model, which treats risk behaviour and HIV infection as linked processes, where acquiring risk behaviour is a prerequisite for contracting HIV. The equilibrium behaviour of the model is analysed to determine epidemic outcomes under conditions of expanding HAART coverage along with risk behaviours that change with HAART coverage. We determined the potential impact of changes in risk behaviour on the outcomes of Treatment as Prevention strategies. Model results show that HIV incidence and prevalence decline only above threshold levels of HAART coverage, which depends strongly on risk behaviour parameter values. Expanding HAART coverage with simultaneous reduction in risk behaviour act synergistically to accelerate the drop in HIV incidence and prevalence. Above the thresholds, additional HAART coverage is always sufficient to reverse the impact of HAART optimism on incidence and prevalence. Applying the model to an HIV epidemic in Vancouver, Canada, showed no evidence of HAART optimism in that setting. Conclusions: Our results suggest that Treatment as Prevention has significant potential for controlling the HIV epidemic once HAART coverage reaches a threshold. Furthermore, expanding HAART coverage combined with interventions targeting risk behaviours amplify the preventive impact, potentially driving the HIV epidemic to elimination.	[Ramadanovic, Bojan; Nadaf, Ali; Rutherford, Alexander R.] Simon Fraser Univ, IRMACS Ctr, Burnaby, BC V5A 1S6, Canada; [Vasarhelyi, Krisztina; Montaner, Julio S. G.; Wood, Evan] British Columbia Ctr Excellence HIV AIDS, Vancouver, BC, Canada; [Vasarhelyi, Krisztina] Simon Fraser Univ, Fac Hlth Sci, Burnaby, BC V5A 1S6, Canada; [Nadaf, Ali; Wittenberg, Ralf W.; Rutherford, Alexander R.] Simon Fraser Univ, Dept Math, Burnaby, BC V5A 1S6, Canada; [Montaner, Julio S. G.; Wood, Evan] Univ British Columbia, Fac Med, Dept Med, Div Aids, Vancouver, BC, Canada	Simon Fraser University; B.C. Centre for Excellence in HIV/AIDS; Simon Fraser University; Simon Fraser University; University of British Columbia	Rutherford, AR (corresponding author), Simon Fraser Univ, IRMACS Ctr, Burnaby, BC V5A 1S6, Canada.	sandyr@irmacs.sfu.ca			Canadian Institute of Health Research [103129]	Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by Canadian Institute of Health Research (http://www.cihr-irsc.gc.ca/e/193.html) grant number: 103129. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam B, 2011, J INT AIDS SOC S2, V14, P52; Attia S, 2009, AIDS, V23, P1397, DOI 10.1097/QAD.0b013e32832b7dca; Auld MC, 2002, J HLTH EC, V22, P361; Bacaer N, 2008, J MATH BIOL, V57, P557, DOI 10.1007/s00285-008-0177-z; Bauer AL, 2008, MATH MODEL NAT PHENO, V3, P229, DOI 10.1051/mmnp:2008051; BC-CDC, 2010, TECHNICAL REPORT; Bezemer D, 2008, AIDS, V22, P1071, DOI 10.1097/QAD.0b013e3282fd167c; Bezemer D, 2010, EPIDEMICS-NETH, V2, P66, DOI 10.1016/j.epidem.2010.04.001; Bhunu CP, 2009, B MATH BIOL, V71, P1745, DOI 10.1007/s11538-009-9423-9; Blower SM, 2000, SCIENCE, V287, P650, DOI 10.1126/science.287.5453.650; Blyuss KB, 2005, APPL MATH COMPUT, V160, P177, DOI 10.1016/j.amc.2003.10.033; Bouhnik AD, 2002, J EPIDEMIOL COMMUN H, V56, P349, DOI 10.1136/jech.56.5.349; Bunnell R, 2006, AIDS, V20, P85, DOI 10.1097/01.aids.0000196566.40702.28; Cassell MM, 2006, BMJ-BRIT MED J, V332, P605, DOI 10.1136/bmj.332.7541.605; Chowell-Puente D, 2007, MATH THEORETICAL BIO, VMTBI-04-08M; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Couzin J, 2009, SCIENCE, V323, P454, DOI [10.1126/science.323.5913.454, 10.1126/science.323.5913.456]; Crepaz N, 2004, JAMA-J AM MED ASSOC, V292, P224, DOI 10.1001/jama.292.2.224; Dangerfield BC, 2001, SYST DYNAM REV, V17, P119, DOI 10.1002/sdr.211; Das M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011068; De Cock KM, 2009, B WORLD HEALTH ORGAN, V87, P488, DOI 10.2471/BLT.09.067330; Dieffenbach CW, 2009, JAMA-J AM MED ASSOC, V301, P2380, DOI 10.1001/jama.2009.828; Do AN, 2001, AIDS, V15, P1149, DOI 10.1097/00002030-200106150-00010; Dodds JP, 2000, BRIT MED J, V320, P1510, DOI 10.1136/bmj.320.7248.1510; Gill VS, 2010, CLIN INFECT DIS, V50, P98, DOI 10.1086/648729; Granich RM, 2009, LANCET, V373, P48, DOI 10.1016/S0140-6736(08)61697-9; Gray RH, 2003, AIDS, V17, P1941, DOI 10.1097/00002030-200309050-00013; Halkitis PN, 2004, AIDS EDUC PREV, V16, P448, DOI 10.1521/aeap.16.5.448.48739; Hosseinipour M, 2002, CLIN INFECT DIS, V34, P1391, DOI 10.1086/340403; Huebner DM, 2004, JAIDS-J ACQ IMM DEF, V37, P1514, DOI 10.1097/01.qai.0000127027.55052.22; Huebner DM, 2001, ANN BEHAV MED, V23, P304, DOI 10.1207/S15324796ABM2304_10; Joseph HA, 2010, AIDS CARE, V22, P29, DOI 10.1080/09540120903012627; Kalichman SC, 2006, J BEHAV MED, V29, P401, DOI 10.1007/s10865-006-9066-3; KAULT DA, 1992, MATH COMPUT MODEL, V16, P3, DOI 10.1016/0895-7177(92)90101-P; Kerr T, 2010, AM J PUBLIC HEALTH, V100, P1449, DOI 10.2105/AJPH.2009.178467; Kirschner D, 1999, THEOR POPUL BIOL, V55, P94, DOI 10.1006/tpbi.1998.1382; Law MG, 2001, AIDS, V15, P1287, DOI 10.1097/00002030-200107060-00011; Li JQ, 2008, ROCKY MT J MATH, V38, P1457, DOI 10.1216/RMJ-2008-38-5-1457; Lindenburg CEA, 2006, AIDS, V20, P1771, DOI 10.1097/01.aids.0000242824.59377.53; Long EF, 2009, OPER RES, V56, P1366; Lou J, 2009, BMC PUBLIC HEALTH, V75, P213; Marshall BDL, 2010, AIDS, V24, P2271, DOI 10.1097/QAD.0b013e32833dd101; MASSAD E, 1993, MATH COMPUT MODEL, V17, P7, DOI 10.1016/0895-7177(93)90013-O; Miller M, 2000, AIDS, V14, pF33, DOI 10.1097/00002030-200003100-00001; Montaner JSG, 2006, LANCET, V368, P531, DOI 10.1016/S0140-6736(06)69162-9; Montaner JSG, 2010, LANCET, V376, P532, DOI 10.1016/S0140-6736(10)60936-1; Murphy EL, 2001, ANN INTERN MED, V135, P17, DOI 10.7326/0003-4819-135-1-200107030-00005; Mushayabasa S, 2011, BIOSYSTEMS, V103, P27, DOI 10.1016/j.biosystems.2010.09.008; Nguyen VK, 2011, AIDS, V25, P291, DOI 10.1097/QAD.0b013e3283402c3e; Ostrow DE, 2002, AIDS, V16, P775, DOI 10.1097/00002030-200203290-00013; Palella FJ, 2006, JAIDS-J ACQ IMM DEF, V43, P27, DOI 10.1097/01.qai.0000233310.90484.16; Pinkerton SD, 2008, AIDS BEHAV, V12, P677, DOI 10.1007/s10461-007-9329-1; Quinn TC, 2000, NEW ENGL J MED, V342, P921, DOI 10.1056/NEJM200003303421303; Raboud JM, 2003, J URBAN HEALTH, V80, P302, DOI 10.1093/jurban/jtg033; Remien RH, 2005, AIDS BEHAV, V9, P167, DOI 10.1007/s10461-005-3898-7; Roeger LIW, 2009, MATH BIOSCI ENG, V6, P815, DOI 10.3934/mbe.2009.6.815; Salomon JA, 2008, AIDS, V22, pS149, DOI 10.1097/01.aids.0000327636.82542.87; Sarna A, 2008, INT J STD AIDS, V19, P85, DOI 10.1258/ijsa.2007.007097; Scheer S, 2001, LANCET, V357, P432, DOI 10.1016/S0140-6736(00)04007-1; Scherer CW, 2003, RISK ANAL, V23, P261, DOI 10.1111/1539-6924.00306; Schwarcz S, 2007, AM J PUBLIC HEALTH, V97, P1067, DOI 10.2105/AJPH.2005.072249; Sharomi O, 2008, MATH BIOSCI ENG, V5, P145; Smit C, 2006, ADDICTION, V101, P433, DOI 10.1111/j.1360-0443.2006.01339.x; Smith KP, 2008, ANNU REV SOCIOL, V34, P405, DOI 10.1146/annurev.soc.34.040507.134601; Sorathiya A, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S1-S67; Stephenson JM, 2003, SEX TRANSM INFECT, V79, P7, DOI 10.1136/sti.79.1.7; Stolte IG, 2004, AIDS, V18, P1943, DOI 10.1097/00002030-200409240-00010; Strathdee Steffanie A, 2010, Curr HIV/AIDS Rep, V7, P99, DOI 10.1007/s11904-010-0043-7; Sullivan PS, 2007, AIDS BEHAV, V11, P123, DOI 10.1007/s10461-006-9100-z; Truong HHM, 2006, SEX TRANSM INFECT, V82, P461, DOI 10.1136/sti.2006.019950; UNAIDS, 2011, TECHNICAL REPORT; Vanable PA, 2000, HEALTH PSYCHOL, V19, P134, DOI 10.1037//0278-6133.19.2.134; Velasco-Hernandez JX, 2002, LANCET INFECT DIS, V2, P487, DOI 10.1016/S1473-3099(02)00346-8; Venkatesh KK, 2011, AIDS, V25, P1939, DOI 10.1097/QAD.0b013e32834b4ced; Williams B, 2011, J INT AIDS SOC, V14, P56; Wood E, 2000, AIDS, V14, P1229, DOI 10.1097/00002030-200006160-00021; Wood E, 2009, TECHNICAL REPORT; Wood E, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1649	78	6	6	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2013	8	5							e62321	10.1371/journal.pone.0062321	http://dx.doi.org/10.1371/journal.pone.0062321			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	177QL	23671592	Green Submitted, Green Published, gold			2022-12-27	WOS:000321390200019
J	Siddique, HR; Parray, A; Tarapore, RS; Wang, L; Mukhtar, H; Karnes, RJ; Deng, YB; Konety, BR; Saleem, M				Siddique, Hifzur Rahman; Parray, Aijaz; Tarapore, Rohinton S.; Wang, Lei; Mukhtar, Hasan; Karnes, R. Jeffery; Deng, Yibin; Konety, Badrinath R.; Saleem, Mohammad			BMI1 Polycomb Group Protein Acts as a Master Switch for Growth and Death of Tumor Cells: Regulates TCF4-Transcriptional Factor-Induced BCL2 Signaling	PLOS ONE			English	Article							PROSTATE-CANCER CELLS; ANDROGEN RECEPTOR; IN-VITRO; RECURRENCE; DOCETAXEL; EXPRESSION; PATHWAYS; PROGRESSION; RESISTANCE; INHIBITORS	For advanced prostate cancer (CaP), the progression of tumors to the state of chemoresistance and paucity of knowledge about the mechanism of chemoresistance are major stumbling blocks in the management of this disease. Here, we provide compelling evidence that BMI1 polycomb group protein and a stem cell factor plays a crucial role in determining the fate of tumors vis-a-vis chemotherapy. We show that progressive increase in the levels of BMI1 occurs during the progression of CaP disease in humans. We show that BMI1-rich tumor cells are non-responsive to chemotherapy whereas BMI1-silenced tumor cells are responsive to therapy. By employing microarray, ChIP, immunoblot and Luciferase reporter assays, we identified a unique mechanism through which BMI1 rescues tumor cells from chemotherapy. We found that BMI1 regulates (i) activity of TCF4 transcriptional factor and (ii) binding of TCF4 to the promoter region of anti-apoptotic BCL2 gene. Notably, an increased TCF4 occupancy on BCL2 gene was observed in prostatic tissues exhibiting high BMI1 levels. Using tumor cells other than CaP, we also showed that regulation of TCF4-mediated BCL2 by BMI1 is universal. It is noteworthy that forced expression of BMI1 was observed to drive normal cells to hyperproliferative mode. We show that targeting BMI1 improves the outcome of docetaxel therapy in animal models bearing chemoresistant prostatic tumors. We suggest that BMI1 could be exploited as a potential molecular target for therapeutics to treat chemoresistant tumors.	[Siddique, Hifzur Rahman; Parray, Aijaz; Saleem, Mohammad] Univ Minnesota, Hormel Inst, Dept Mol Chemoprevent & Therapeut, Austin, MN 55912 USA; [Tarapore, Rohinton S.; Mukhtar, Hasan] Univ Wisconsin, Dept Dermatol, Madison, WI USA; [Wang, Lei; Deng, Yibin] Univ Minnesota, Hormel Inst, Dept Cell Death & Canc Genet, Austin, MN 55912 USA; [Karnes, R. Jeffery] Mayo Clin & Mayo Fdn, Mayo Med Sch, Dept Urol, Rochester, MN 55905 USA; [Karnes, R. Jeffery] Mayo Clin, Rochester, MN USA; [Konety, Badrinath R.; Saleem, Mohammad] Univ Minnesota, Dept Urol, Minneapolis, MN USA; [Saleem, Mohammad] Univ Minnesota, Dept Lab Med Pathol, Minneapolis, MN USA	University of Minnesota System; University of Wisconsin System; University of Wisconsin Madison; University of Minnesota System; Mayo Clinic; Mayo Clinic; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Saleem, M (corresponding author), Univ Minnesota, Hormel Inst, Dept Mol Chemoprevent & Therapeut, 801 16th Ave NE, Austin, MN 55912 USA.	msbhat@umn.edu	Saleem, Mohammad/GVS-9221-2022; Siddique, Hifzur R/H-4049-2019	Saleem, Mohammad/0000-0002-7422-7967; Siddique, Hifzur R/0000-0001-8736-0487; Deng, Yibin/0000-0001-5711-3565	Department of Defense CDMRP [W81XWH-08-1-0605]; NATIONAL CANCER INSTITUTE [P30CA014520] Funding Source: NIH RePORTER	Department of Defense CDMRP(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the Department of Defense CDMRP grant W81XWH-08-1-0605 to MS. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bigelow RLH, 2004, J BIOL CHEM, V279, P1197, DOI 10.1074/jbc.M310589200; Brunelle JK, 2009, J CELL SCI, V122, P437, DOI 10.1242/jcs.031682; Casimiro M, 2007, CANCER RES, V67, P4364, DOI 10.1158/0008-5472.CAN-06-1898; Catalona WJ, 1998, J UROLOGY, V160, P2428, DOI 10.1016/S0022-5347(01)62204-3; Chen KG, 2012, CLIN CANCER RES, V18, P1863, DOI 10.1158/1078-0432.CCR-11-1590; Crea F, 2011, INT J CANCER, V128, P1946, DOI 10.1002/ijc.25522; Cui HJ, 2007, AM J PATHOL, V170, P1370, DOI 10.2353/ajpath.2007.060754; Glinsky GV, 2005, J CLIN INVEST, V115, P1503, DOI 10.1172/JCI23412; Han M, 2003, J UROLOGY, V169, P517, DOI 10.1016/S0022-5347(05)63946-8; Hegde GV, 2008, MOL CANCER THER, V7, P1450, DOI 10.1158/1535-7163.MCT-07-2118; Huber GF, 2011, CANCER-AM CANCER SOC, V117, P4659, DOI 10.1002/cncr.26100; Jacobs JJL, 1999, GENE DEV, V13, P2678, DOI 10.1101/gad.13.20.2678; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kang MK, 2007, BRIT J CANCER, V96, P126, DOI 10.1038/sj.bjc.6603529; Kang MH, 2009, CLIN CANCER RES, V15, P1126, DOI 10.1158/1078-0432.CCR-08-0144; Kanwar SS, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-212; Klein KA, 1997, NAT MED, V3, P402, DOI 10.1038/nm0497-402; Kotb AF, 2011, PROSTATE CANCER, V2011, DOI 10.1155/2011/485189; Liu SL, 2006, CANCER RES, V66, P6063, DOI 10.1158/0008-5472.CAN-06-0054; Mackler NJ, 2005, NAT CLIN PRACT UROL, V2, P92, DOI 10.1038/ncpuro0099; Mahindroo N, 2009, J MED CHEM, V52, P3829, DOI 10.1021/jm801420y; Mahon KL, 2011, ENDOCR-RELAT CANCER, V18, pR103, DOI 10.1530/ERC-10-0343; O'Neill AJ, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-126; Parray A, 2012, BIOL-TARGETS THER, V6, P267, DOI 10.2147/BTT.S23954; Petrylak Daniel P, 2007, Rev Urol, V9 Suppl 2, pS3; Pound CR, 1999, JAMA-J AM MED ASSOC, V281, P1591, DOI 10.1001/jama.281.17.1591; Rohrs S, 2009, CELL BIOL INT, V33, P501, DOI 10.1016/j.cellbi.2009.01.016; Ross RW, 2008, CANCER-AM CANCER SOC, V112, P521, DOI 10.1002/cncr.23195; Saleem M, 2006, CANCER EPIDEM BIOMAR, V15, P217, DOI 10.1158/1055-9965.EPI-05-0737; Sanchez C, 2011, PROSTATE, V71, P1810, DOI 10.1002/pros.21398; Schug Jonathan, 2008, Curr Protoc Bioinformatics, VChapter 2, DOI 10.1002/0471250953.bi0206s21; Siddique HR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052993; Siddique HR, 2012, CURR DRUG TARGETS, V13, P1907; Siddique HR, 2012, INT J CANCER, V131, P1720, DOI 10.1002/ijc.27409; Siddique HR, 2012, STEM CELLS, V30, P372, DOI 10.1002/stem.1035; Siddique HR, 2011, CLIN CANCER RES, V17, P5379, DOI 10.1158/1078-0432.CCR-11-0916; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Song LB, 2009, J CLIN INVEST, V119, P3626, DOI 10.1172/JCI39374; Straten PT, 2010, ONCOTARGET, V1, P239; Wang EF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017918; Zhang LL, 2012, J CANCER RES CLIN, V138, P675, DOI 10.1007/s00432-011-1146-2	42	20	24	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2013	8	5							e60664	10.1371/journal.pone.0060664	http://dx.doi.org/10.1371/journal.pone.0060664			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	177QL	23671559	Green Published, Green Submitted, gold			2022-12-27	WOS:000321390200002
J	Orr, MG; Thrush, R; Plaut, DC				Orr, Mark G.; Thrush, Roxanne; Plaut, David C.			The Theory of Reasoned Action as Parallel Constraint Satisfaction: Towards a Dynamic Computational Model of Health Behavior	PLOS ONE			English	Article							LARGE SOCIAL NETWORK; PLANNED BEHAVIOR; ATTITUDES; PERSONALITY; REPRESENTATION; INTENTIONS; EMERGENCE; BELIEFS; SYSTEM	The reasoned action approach, although ubiquitous in health behavior theory (e. g., Theory of Reasoned Action/Planned Behavior), does not adequately address two key dynamical aspects of health behavior: learning and the effect of immediate social context (i.e., social influence). To remedy this, we put forth a computational implementation of the Theory of Reasoned Action (TRA) using artificial-neural networks. Our model re-conceptualized behavioral intention as arising from a dynamic constraint satisfaction mechanism among a set of beliefs. In two simulations, we show that constraint satisfaction can simultaneously incorporate the effects of past experience (via learning) with the effects of immediate social context to yield behavioral intention, i.e., intention is dynamically constructed from both an individual's pre-existing belief structure and the beliefs of others in the individual's social context. In a third simulation, we illustrate the predictive ability of the model with respect to empirically derived behavioral intention. As the first known computational model of health behavior, it represents a significant advance in theory towards understanding the dynamics of health behavior. Furthermore, our approach may inform the development of population-level agent-based models of health behavior that aim to incorporate psychological theory into models of population dynamics.	[Orr, Mark G.; Thrush, Roxanne] Columbia Univ, Dept Epidemiol, New York, NY 10027 USA; [Plaut, David C.] Carnegie Mellon Univ, Dept Psychol, Pittsburgh, PA 15213 USA	Columbia University; Carnegie Mellon University	Orr, MG (corresponding author), Columbia Univ, Dept Epidemiol, New York, NY 10027 USA.	Mo2259@columbia.edu			U.S. National Institutes of Health [1R21HD067570-01]; Mailman School of Public Health, Columbia University; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R21HD067570] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mailman School of Public Health, Columbia University; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by the U.S. National Institutes of Health, Grant 1R21HD067570-01 awarded to Mark G. Orr, David C. Plaut and Peter Bearman. Furthermore, this work was partially supported by an Epidemiology Merit Fellowship from the Mailman School of Public Health, Columbia University, to Mark G. Orr. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AJZEN I, 1991, ORGAN BEHAV HUM DEC, V50, P179, DOI 10.1016/0749-5978(91)90020-T; Albarracin D, 2001, PSYCHOL BULL, V127, P142, DOI 10.1037//0033-2909.127.1.142; Armitage CJ, 2001, BRIT J SOC PSYCHOL, V40, P471, DOI 10.1348/014466601164939; Bearman PS, 2004, AM J PUBLIC HEALTH, V94, P89, DOI 10.2105/AJPH.94.1.89; Bleakley A, 2011, HEALTH EDUC BEHAV, V38, P530, DOI 10.1177/1090198110385775; Christakis NA, 2008, NEW ENGL J MED, V358, P2249, DOI 10.1056/NEJMsa0706154; Christakis NA, 2007, NEW ENGL J MED, V357, P370, DOI 10.1056/NEJMsa066082; Conrey FR, 2007, SOC COGNITION, V25, P718, DOI 10.1521/soco.2007.25.5.718; Downs DS, 2005, PSYCHOL SPORT EXERC, V6, P1, DOI 10.1016/j.psychsport.2003.08.001; FEATHER NT, 1959, PSYCHOL REV, V66, P150, DOI 10.1037/h0045692; Fishbein M, 2000, AIDS CARE, V12, P273, DOI 10.1080/09540120050042918; Fishbein M., 1975, BELIEF ATTITUDE INTE; Fishbein M., 2010, PREDICTING CHANGING, DOI 10.4324/9780203838020; French DP, 2005, J APPL SOC PSYCHOL, V35, P1824, DOI 10.1111/j.1559-1816.2005.tb02197.x; Galea S, 2009, INT J DRUG POLICY, V20, P209, DOI 10.1016/j.drugpo.2008.08.005; Gawronski B, 2006, PSYCHOL BULL, V132, P692, DOI 10.1037/0033-2909.132.5.692; Gillmore MR, 2002, J MARRIAGE FAM, V64, P885, DOI 10.1111/j.1741-3737.2002.00885.x; Hardeman W, 2002, PSYCHOL HEALTH, V17, P123, DOI 10.1080/08870440290013644a; Hill AL, 2010, P ROY SOC B-BIOL SCI, V277, P3827, DOI 10.1098/rspb.2010.1217; LATANE B, 1994, BEHAV SCI, V39, P1, DOI 10.1002/bs.3830390102; MCCLELLAND JL, 1985, J EXP PSYCHOL GEN, V114, P159, DOI 10.1037/0096-3445.114.2.159; MISCHEL W, 1995, PSYCHOL REV, V102, P246, DOI 10.1037/0033-295X.102.2.246; Monroe BM, 2008, PSYCHOL REV, V115, P733, DOI 10.1037/0033-295X.115.3.733; MONTANO DE, 1991, SOC SCI MED, V32, P733, DOI 10.1016/0277-9536(91)90153-4; Morrison DM, 1998, J RES ADOLESCENCE, V8, P69, DOI 10.1207/s15327795jra0801_4; Nowak A, 2005, DEV REV, V25, P351, DOI 10.1016/j.dr.2005.10.004; Nowak A, 2002, ADVANCES IN PERSONALITY SCIENCE, P292; Orr MG, 2011, RES HUM DEV, V8, P48, DOI 10.1080/15427609.2011.549702; Read S J, 1997, Pers Soc Psychol Rev, V1, P26, DOI 10.1207/s15327957pspr0101_3; Read SJ, 1998, CONNECTIONIST MODELS OF SOCIAL REASONING AND SOCIAL BEHAVIOR, P27; Read SJ, 2010, PSYCHOL REV, V117, P61, DOI 10.1037/a0018131; Sheeran P, 1999, J APPL SOC PSYCHOL, V29, P1624, DOI 10.1111/j.1559-1816.1999.tb02045.x; Shoda Y, 2002, PERS SOC PSYCHOL REV, V6, P316, DOI 10.1207/S15327957PSPR0604_06; Smith KP, 2008, ANNU REV SOCIOL, V34, P405, DOI 10.1146/annurev.soc.34.040507.134601; Thomas M., 2008, CAMBRIDGE HDB COMPUT; Trafimow D, 1996, J APPL SOC PSYCHOL, V26, P2167, DOI 10.1111/j.1559-1816.1996.tb01794.x; Ueno K, 2005, SOC SCI RES, V34, P484, DOI 10.1016/j.ssresearch.2004.03.002; VanderWeele TJ, 2011, SOCIOL METHOD RES, V40, P240, DOI 10.1177/0049124111404821	38	28	28	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2013	8	5							e62490	10.1371/journal.pone.0062490	http://dx.doi.org/10.1371/journal.pone.0062490			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	175AS	23671603	Green Published, Green Submitted, gold			2022-12-27	WOS:000321202100009
J	Kandasamy, K; Bezavada, L; Escue, RB; Parthasarathi, K				Kandasamy, Kathirvel; Bezavada, Lavanya; Escue, Rachel B.; Parthasarathi, Kaushik			Lipopolysaccharide Induces Endoplasmic Store Ca2+-Dependent Inflammatory Responses in Lung Microvessels	PLOS ONE			English	Article							NF-KAPPA-B; INDUCED CYTOKINE PRODUCTION; ENDOTHELIAL-CELLS; PROINFLAMMATORY RESPONSES; CALCIUM OSCILLATION; SIGNALING PATHWAY; GENE-EXPRESSION; ACTIVATION; RECEPTOR; PROTEIN	The pulmonary microvasculature plays a critical role in endotoxin-induced acute lung injury. However, the relevant signaling remain unclear. Specifically the role of endothelial Ca2+ in the induction of endotoxin-mediated responses in lung microvessels remains undefined. Toward elucidating this, we used the isolated blood-perfused rat lung preparation. We loaded microvessels with the Ca2+ indicator, Fura 2 AM and then determined Ca2+ responses to infusions of lipopolysaccharide (LPS) into the microvessels. LPS induced a more than two-fold increase in the amplitude of cytosolic Ca2+ oscillations. Inhibiting inositol 1,4,5 trisphosphate receptors on endoplasmic reticulum (ER) Ca2+ stores with Xestospongin C (XeC), blocked the LPS-induced increase in the Ca2+ oscillation amplitude. However, XeC did not affect entry of external Ca2+ via plasma membrane Ca2+ channels in lung microvascular endothelial cells. This suggested that LPS augmented the oscillations via release of Ca2+ from ER stores. In addition, XeC also blocked LPS-mediated activation and nuclear translocation of nuclear factor-kappa B in lung microvessels. Further, inhibiting ER Ca2+ release blunted increases in intercellular adhesion molecule-1 expression and retention of naive leukocytes in LPS-treated microvessels. Taken together, the data suggest that LPS-mediated Ca2+ release from ER stores underlies nuclear factor-kappa B activation and downstream inflammatory signaling in lung microvessels. Thus, we show for the first time a role for inositol 1,4,5 trisphosphate-mediated ER Ca2+ release in the induction of LPS responses in pulmonary microvascular endothelium. Mechanisms that blunt this signaling may mitigate endotoxin-induced morbidity.	[Kandasamy, Kathirvel; Bezavada, Lavanya; Escue, Rachel B.; Parthasarathi, Kaushik] Univ Tennessee, Ctr Hlth Sci, Dept Physiol, Memphis, TN 38163 USA; [Parthasarathi, Kaushik] Univ Tennessee, Ctr Hlth Sci, Dept Orthoped Surg & Biomed Engn, Memphis, TN 38163 USA	University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center	Parthasarathi, K (corresponding author), Univ Tennessee, Ctr Hlth Sci, Dept Physiol, Memphis, TN 38163 USA.	kparthas@uthsc.edu		Kandasamy, Kathirvel/0000-0002-4966-4604; Helms, Rachel/0000-0001-5027-7153; Bezavada, Lavanya/0000-0001-8434-3323	National Heart, Lung, and Blood Institute, National Institutes of Health [HL75503]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL075503] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was funded by the National Heart, Lung, and Blood Institute, National Institutes of Health, grant number HL75503. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi T, 1997, HEPATOLOGY, V26, P295, DOI 10.1002/hep.510260207; Antonsson A, 2003, MOL CELL BIOL, V23, P1418, DOI 10.1128/MCB.23.4.1418-1427.2003; Aul R, 2012, BRIT J CLIN PHARMACO, V74, P1023, DOI 10.1111/j.1365-2125.2012.04287.x; BADER MF, 1994, GLIA, V11, P336, DOI 10.1002/glia.440110406; Beck A, 2008, J PHYSIOL-LONDON, V586, P427, DOI 10.1113/jphysiol.2007.145151; Berendji-Grun D, 2001, MOL MED, V7, P748, DOI 10.1007/BF03401964; BERRIDGE MJ, 1993, NATURE, V361, P315, DOI 10.1038/361315a0; Chin ER, 2005, J APPL PHYSIOL, V99, P414, DOI 10.1152/japplphysiol.00015.2005; Dauphinee SM, 2006, LAB INVEST, V86, P9, DOI 10.1038/labinvest.3700366; Guo F, 2012, CYTOKINE, V57, P417, DOI 10.1016/j.cyto.2011.12.009; Hoffmann A, 2003, J NEUROSCI, V23, P4410; Hu QH, 2002, BIOCHEM BIOPH RES CO, V292, P325, DOI 10.1006/bbrc.2002.6675; Hughes K, 2001, J BIOL CHEM, V276, P36008, DOI 10.1074/jbc.M106125200; Ichimura H, 2003, J CLIN INVEST, V111, P691, DOI 10.1172/JCI200317271; Inoue R, 2009, CIRC RES, V104, P1399, DOI 10.1161/CIRCRESAHA.108.193227; Islam MN, 2012, NAT MED, V18, P759, DOI 10.1038/nm.2736; Johnson JD, 2002, P NATL ACAD SCI USA, V99, P14566, DOI 10.1073/pnas.222099799; Kandasamy K, 2012, MICROVASC RES, V83, P323, DOI 10.1016/j.mvr.2012.01.006; Karpurapu M, 2011, BLOOD, V118, P5255, DOI 10.1182/blood-2011-03-341123; Kayama H, 2008, J BIOL CHEM, V283, P12468, DOI 10.1074/jbc.M709965200; Kiefmann R, 2009, AM J PHYSIOL-LUNG C, V296, pL901, DOI 10.1152/ajplung.90549.2008; Kojima S, 2000, BLOOD, V95, P1309; Lai DZ, 2009, P NATL ACAD SCI USA, V106, P1169, DOI 10.1073/pnas.0811274106; Lawson C, 1999, J IMMUNOL, V162, P2990; Lowry MAR, 1999, DEV COMP IMMUNOL, V23, P253, DOI 10.1016/S0145-305X(99)00004-X; Lu ZY, 2012, ARTERIOSCL THROM VAS, V32, P1696, DOI 10.1161/ATVBAHA.112.251181; Maloney E, 2009, ARTERIOSCL THROM VAS, V29, P1370, DOI 10.1161/ATVBAHA.109.188813; May MJ, 2000, SCIENCE, V289, P1550, DOI 10.1126/science.289.5484.1550; Meffert MK, 2003, NAT NEUROSCI, V6, P1072, DOI 10.1038/nn1110; Otterson MF, 2012, LIFE SCI, V91, P771, DOI 10.1016/j.lfs.2012.08.018; Parthasarathi K, 2002, J IMMUNOL, V169, P7078, DOI 10.4049/jimmunol.169.12.7078; Parthasarathi K, 2006, J CLIN INVEST, V116, P2193, DOI 10.1172/JCI26605; Rahman A, 2000, AM J PHYSIOL-CELL PH, V279, pC906, DOI 10.1152/ajpcell.2000.279.4.C906; Rahman A, 2002, CIRC RES, V91, P398, DOI 10.1161/01.RES.0000033520.95242.A2; Ramirez-Carrozzi VR, 2006, GENE DEV, V20, P282, DOI 10.1101/gad.1383206; Saccani S, 2001, J EXP MED, V193, P1351, DOI 10.1084/jem.193.12.1351; Scharbrodt W, 2009, J CEREBR BLOOD F MET, V29, P57, DOI 10.1038/jcbfm.2008.87; SCHUMANN MA, 1993, J BIOL CHEM, V268, P2134; Segura BJ, 2005, MOL BRAIN RES, V133, P325, DOI 10.1016/j.molbrainres.2004.10.016; Shinji H, 1997, J IMMUNOL, V158, P1370; Song YX, 2013, EUR J PHARMACOL, V705, P49, DOI 10.1016/j.ejphar.2013.02.008; Stevens Troy, 2011, Proc Am Thorac Soc, V8, P453, DOI 10.1513/pats.201101-004MW; Tauseef M, 2012, J EXP MED, V209, P1953, DOI 10.1084/jem.20111355; Thompson PW, 2002, J IMMUNOL, V169, P1007, DOI 10.4049/jimmunol.169.2.1007; Thor D, 2012, VASCUL PHARM, V53, P230; Tullai JW, 2007, J BIOL CHEM, V282, P23981, DOI 10.1074/jbc.M702044200; Valdes JA, 2007, AM J PHYSIOL-CELL PH, V292, pC1960, DOI 10.1152/ajpcell.00320.2006; Wang Q, 2005, AM J PHYSIOL-LUNG C, V288, pL359, DOI 10.1152/ajplung.00292.2004; Wehrhahn J, 2010, J IMMUNOL, V184, P2386, DOI 10.4049/jimmunol.0902474; Wildner O, 1992, Exp Dermatol, V1, P191, DOI 10.1111/j.1600-0625.1992.tb00188.x; Wurster AL, 2011, MOL IMMUNOL, V48, P2178, DOI 10.1016/j.molimm.2011.07.016; Xie YC, 1997, J LEUKOCYTE BIOL, V61, P745, DOI 10.1002/jlb.61.6.745; Yamashiro K, 2010, BIOCHEM BIOPH RES CO, V398, P284, DOI 10.1016/j.bbrc.2010.06.082; Zhou XY, 2006, J BIOL CHEM, V281, P31337, DOI 10.1074/jbc.M602739200	54	29	30	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2013	8	5							e63465	10.1371/journal.pone.0063465	http://dx.doi.org/10.1371/journal.pone.0063465			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	143FO	23675486	Green Published, gold, Green Submitted			2022-12-27	WOS:000318852400041
J	Lonsdale, CL; Taba, B; Queralto, N; Lukaszewski, RA; Martino, RA; Rhodes, PA; Lim, SH				Lonsdale, Claire L.; Taba, Brian; Queralto, Nuria; Lukaszewski, Roman A.; Martino, Raymond A.; Rhodes, Paul A.; Lim, Sung H.			The Use of Colorimetric Sensor Arrays to Discriminate between Pathogenic Bacteria	PLOS ONE			English	Article							VOLATILE ORGANIC-COMPOUNDS; IN-HOSPITAL ENVIRONMENT; ELECTRONIC NOSE; STAPHYLOCOCCUS-AUREUS; MASS-SPECTROMETRY; IDENTIFICATION; CLASSIFICATION; MICROORGANISMS; METABOLITES; PSEUDOMONAS	A colorimetric sensor array is a high-dimensional chemical sensor that is cheap, compact, disposable, robust, and easy to operate, making it a good candidate technology to detect pathogenic bacteria, especially potential bioterrorism agents like Yersinia pestis and Bacillus anthracis which feature on the Center for Disease Control and Prevention's list of potential biothreats. Here, a colorimetric sensor array was used to continuously monitor the volatile metabolites released by bacteria in solid media culture in an Advisory Committee on Dangerous Pathogen Containment Level 3 laboratory. At inoculum concentrations as low as 8 colony-forming units per plate, 4 different bacterial species were identified with 100% accuracy using logistic regression to classify the kinetic profile of sensor responses to culture headspace gas. The sensor array was able to further discriminate between different strains of the same species, including 5 strains of Yersinia pestis and Bacillus anthracis. These preliminary results suggest that disposable colorimetric sensor arrays can be an effective, low-cost tool to identify pathogenic bacteria.	[Lonsdale, Claire L.; Lukaszewski, Roman A.] Def Sci & Technol Lab, Salisbury, Wilts, England; [Taba, Brian; Queralto, Nuria; Martino, Raymond A.; Rhodes, Paul A.; Lim, Sung H.] Specif Technol, Mountain View, CA USA	Defence Science & Technology Laboratory	Lonsdale, CL (corresponding author), Def Sci & Technol Lab, Salisbury, Wilts, England.	cllonsdale@mail.dstl.gov.uk; slim@isensesystems.com			UK Ministry of Defence and Specific Technologies	UK Ministry of Defence and Specific Technologies	This work was supported by the UK Ministry of Defence and Specific Technologies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Carey JR, 2011, J AM CHEM SOC, V133, P7571, DOI 10.1021/ja201634d; Centers for Disease Control and Prevention, BIOT AG DIS; Demirev PA, 2008, ANNU REV ANAL CHEM, V1, P71, DOI 10.1146/annurev.anchem.1.031207.112838; Dorai-Raj S., 2009, BINOM BINOMIAL CONFI; Dutta R, 2005, SENSOR ACTUAT B-CHEM, V109, P355, DOI 10.1016/j.snb.2005.01.013; Dutta R, 2006, SENSOR ACTUAT B-CHEM, V120, P156, DOI 10.1016/j.snb.2006.02.013; Elgaali H, 2002, J BASIC MICROB, V42, P373, DOI 10.1002/1521-4028(200212)42:6<373::AID-JOBM373>3.0.CO;2-4; Enserink M, 2001, SCIENCE, V294, P1266, DOI 10.1126/science.294.5545.1266; Feng LA, 2010, ANAL CHEM, V82, P9433, DOI 10.1021/ac1020886; Filipiak W, 2012, MICROBIOL-SGM, V158, P3044, DOI 10.1099/mic.0.062687-0; Filipiak W, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-113; Gardner JW, 1998, MEAS SCI TECHNOL, V9, P120, DOI 10.1088/0957-0233/9/1/016; Gibson TD, 1997, SENSOR ACTUAT B-CHEM, V44, P413, DOI 10.1016/S0925-4005(97)00235-9; Holmberg M, 1998, BIOTECHNOL TECH, V12, P319, DOI 10.1023/A:1008862617082; Horsmon J. R., 2008, CHARACTERIZATION VOL; Inglesby TV, 2002, JAMA-J AM MED ASSOC, V288, P1849; Janzen MC, 2006, ANAL CHEM, V78, P3591, DOI 10.1021/ac052111s; Kai M, 2009, APPL MICROBIOL BIOT, V81, P1001, DOI 10.1007/s00253-008-1760-3; Karasinski J, 2005, ANAL CHEM, V77, P7941, DOI 10.1021/ac0512150; Koo CK, 2011, CHEM COMMUN, V47, P11435, DOI 10.1039/c1cc14871k; Lim SH, 2009, NAT CHEM, V1, P562, DOI [10.1038/NCHEM.360, 10.1038/nchem.360]; McEntegart CM, 2000, SENSOR ACTUAT B-CHEM, V70, P170, DOI 10.1016/S0925-4005(00)00561-X; Meyer D., 2012, E1071 MISC FUNCTIONS; Moens M, 2006, LETT APPL MICROBIOL, V42, P121, DOI 10.1111/j.1472-765X.2005.01822.x; Oliphant TE, 2007, COMPUT SCI ENG, V9, P10, DOI 10.1109/MCSE.2007.58; Peterson P, 2009, INT J COMPUT SCI ENG, V4, P296, DOI 10.1504/IJCSE.2009.029165; Pile JC, 1998, ARCH INTERN MED, V158, P429, DOI 10.1001/archinte.158.5.429; R Development Core Team, 2012, R LANG ENV STAT COMP; Rao SS, 2010, J MICROBIOL METH, V82, P1, DOI 10.1016/j.mimet.2010.04.005; Rossi V, 1995, J MICROBIOL METH, V24, P183, DOI 10.1016/0167-7012(95)00069-0; Schulz S, 2007, NAT PROD REP, V24, P814, DOI 10.1039/b507392h; Scotter JM, 2006, J MICROBIOL METH, V65, P628, DOI 10.1016/j.mimet.2005.09.016; Setkus A, 2008, SENSOR ACTUAT B-CHEM, V130, P351, DOI 10.1016/j.snb.2007.09.048; Song LN, 2005, EMERG INFECT DIS, V11, P1629; Suslick BA, 2010, ANAL CHEM, V82, P2067, DOI 10.1021/ac902823w; US National Institutes of Health, IMAGEJ; Wang TS, 2004, INT J MASS SPECTROM, V233, P245, DOI 10.1016/j.ijms.2003.12.024; ZECHMAN JM, 1986, J CHROMATOGR, V377, P49, DOI 10.1016/S0378-4347(00)80760-4; Zhu JJ, 2010, J CLIN MICROBIOL, V48, P4426, DOI 10.1128/JCM.00392-10	39	37	38	4	93	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2013	8	5							e62726	10.1371/journal.pone.0062726	http://dx.doi.org/10.1371/journal.pone.0062726			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	155HD	23671629	Green Published, Green Submitted, gold			2022-12-27	WOS:000319737700019
J	Massillon, G; Cueva-Procel, D; Diaz-Aguirre, P; Rodriguez-Ponce, M; Herrera-Martinez, F				Massillon-JL, Guerda; Cueva-Procel, Diego; Diaz-Aguirre, Porfirio; Rodriguez-Ponce, Miguel; Herrera-Martinez, Flor			Dosimetry for Small Fields in Stereotactic Radiosurgery Using Gafchromic MD-V2-55 Film, TLD-100 and Alanine Dosimeters	PLOS ONE			English	Article							OUTPUT FACTORS; PHOTON	This work investigated the suitability of passive dosimeters for reference dosimetry in small fields with acceptable accuracy. Absorbed dose to water rate was determined in nine small radiation fields with diameters between 4 and 35 mm in a Leksell Gamma Knife (LGK) and a modified linear accelerator (linac) for stereotactic radiosurgery treatments. Measurements were made using Gafchromic film (MD-V2-55), alanine and thermoluminescent (TLD-100) dosimeters and compared with conventional dosimetry systems. Detectors were calibrated in terms of absorbed dose to water in Co-60 gamma-ray and 6 MV x-ray reference (10x10 cm(2)) fields using an ionization chamber calibrated at a standards laboratory. Absorbed dose to water rate computed with MD-V2-55 was higher than that obtained with the others dosimeters, possibly due to a smaller volume averaging effect. Ratio between the dose-rates determined with each dosimeter and those obtained with the film was evaluated for both treatment modalities. For the LGK, the ratio decreased as the dosimeter size increased and remained constant for collimator diameters larger than 8 mm. The same behaviour was observed for the linac and the ratio increased with field size, independent of the dosimeter used. These behaviours could be explained as an averaging volume effect due to dose gradient and lack of electronic equilibrium. Evaluation of the output factors for the LGK collimators indicated that, even when agreement was observed between Monte Carlo simulation and measurements with different dosimeters, this does not warrant that the absorbed dose to water rate in the field was properly known and thus, investigation of the reference dosimetry should be an important issue. These results indicated that alanine dosimeter provides a high degree of accuracy but cannot be used in fields smaller than 20 mm diameter. Gafchromic film can be considered as a suitable methodology for reference dosimetry. TLD dosimeters are not appropriate in fields smaller than 10 mm diameters.	[Massillon-JL, Guerda; Cueva-Procel, Diego] Univ Nacl Autonoma Mexico, Inst Fis, Mexico City 04510, DF, Mexico; [Cueva-Procel, Diego] Conclina CA Hosp Metropolitano, Quito, Ecuador; [Diaz-Aguirre, Porfirio] Hosp San Javier, Guadalajara, Jalisco, Mexico; [Rodriguez-Ponce, Miguel; Herrera-Martinez, Flor] Inst Nacl Cancerol, Mexico City, DF, Mexico	Universidad Nacional Autonoma de Mexico; Instituto Nacional de Cancerologia (INCAN)	Massillon, G (corresponding author), Univ Nacl Autonoma Mexico, Inst Fis, Mexico City 04510, DF, Mexico.	massillon@fisica.unam.mx		Massillon-JL, Guerda/0000-0002-9784-4394	"DGAPA-UNAM'': Direccion General de Asuntos del Personal Academico; Universidad Nacional Autonoma de Mexico; Conacyt [127409]; DGAPA-UNAM [IN105813]	"DGAPA-UNAM'': Direccion General de Asuntos del Personal Academico; Universidad Nacional Autonoma de Mexico(Universidad Nacional Autonoma de Mexico); Conacyt(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); DGAPA-UNAM(Universidad Nacional Autonoma de Mexico)	This work was supported by "DGAPA-UNAM'': Direccion General de Asuntos del Personal Academico, Universidad Nacional Autonoma de Mexico, Conacyt grant 127409. The authors also included another grant number IN105813 from DGAPA-UNAM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfonso R, 2008, MED PHYS, V35, P5179, DOI 10.1118/1.3005481; Almond PR, 1999, MED PHYS, V26, P1847, DOI 10.1118/1.598691; [Anonymous], 1983, MED PHYS, V10, P741; ANSI/NCSL, 1997, Z54021997 ANSINCSL; Crop F, 2009, PHYS MED BIOL, V54, P2951, DOI 10.1088/0031-9155/54/9/024; Das IJ, 2000, J RADIOSURG, V3, P177, DOI DOI 10.1023/A:1009594509115; Das IJ, 2008, MED PHYS, V35, P206, DOI 10.1118/1.2815356; Fan J, 2009, MED PHYS, V36, P5292, DOI 10.1118/1.3232217; Heydarian M, 1996, PHYS MED BIOL, V41, P93, DOI 10.1088/0031-9155/41/1/008; IAEA, 2005, IAEA TECHN REP SER, V277; Mack A, 2002, MED PHYS, V29, P2080, DOI 10.1118/1.1501138; Massillon-JL G, 2006, J PHYS D APPL PHYS, V39, P262, DOI 10.1088/0022-3727/39/2/005; Massillon G, 2010, AIP CONF PROC, V1310, P23, DOI 10.1063/1.3531600; Massillon-JL G, 2010, PHYS MED BIOL, V55, P5437, DOI 10.1088/0031-9155/55/18/011; Massillon-JL G, 2010, APPL RADIAT ISOTOPES, V68, P144, DOI 10.1016/j.apradiso.2009.08.016; Massillon-JL G, 2008, MED PHYS, V35, P2920; Mitch M G, 2009, CLIN DOSIMETRY MEASU; NIST, 2012, CAL IRR CUST SUPPL D; Novotny J, 2009, MED PHYS, V36, P2612, DOI 10.1118/1.3181873; Novotny J, 2009, MED PHYS, V36, P1768, DOI 10.1118/1.3113904; Sanchez-Doblado F, 2007, PHYS MEDICA, V23, P58, DOI 10.1016/j.ejmp.2007.03.002; Sauer OA, 2007, MED PHYS, V34, P1983, DOI 10.1118/1.2734383; Taylor BN, 1994, 1297 NATL I STAND TE	23	20	20	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2013	8	5							e63418	10.1371/journal.pone.0063418	http://dx.doi.org/10.1371/journal.pone.0063418			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	155HD	23671677	Green Submitted, gold, Green Published			2022-12-27	WOS:000319737700051
J	Meyer, FRL; Grausgruber, H; Binter, C; Mair, GE; Guelly, C; Vogl, C; Steinborn, R				Meyer, Florian R. L.; Grausgruber, Heinrich; Binter, Claudia; Mair, Georg E.; Guelly, Christian; Vogl, Claus; Steinborn, Ralf			Cross-Platform Microarray Meta-Analysis for the Mouse Jejunum Selects Novel Reference Genes with Highly Uniform Levels of Expression	PLOS ONE			English	Article							REAL-TIME PCR; HOUSEKEEPING GENES; RT-PCR; DATA REPOSITORY; NORMALIZATION; IDENTIFICATION; VALIDATION; TOOL; TRANSCRIPTOME; ARABIDOPSIS	Reference genes (RGs) with uniform expression are used for normalization of reverse transcription quantitative PCR (RT-qPCR) data. Their optimization for a specific biological context, e. g. a specific tissue, has been increasingly considered. In this article, we compare RGs identified by expression data meta-analysis restricted to the context tissue, the jejunum of Mus musculus domesticus, i) to traditional RGs, ii) to expressed interspersed repeated DNA elements, and iii) to RGs identified by meta-analysis of expression data from diverse tissues and conditions. To select the set of candidate RGs, we developed a novel protocol for the cross-platform meta-analysis of microarray data. The expression stability of twenty-four putative RGs was analysed by RT-qPCR in at least 14 jejunum samples of the mouse strains C57Bl/6N, CD1, and OF1. Across strains, the levels of expression of the novel RGs Plekha7, Zfx, and Ube2v1 as well as of Oaz1 varied less than two-fold irrespective of genotype, sex or their combination. The gene set consisting of Plekha7 and Oaz1 showed superior expression stability analysed with the tool RefFinder. The novel RGs are functionally diverse. This facilitates expression studies over a wide range of conditions. The highly uniform expression of the optimized RGs in the jejunum points towards their involvement in tightly regulated pathways in this tissue. We also applied our novel protocol of cross-microarray platform meta-analysis to the identification of RGs in the duodenum, the ileum and the entire small intestine. The selection of RGs with improved expression stability in a specific biological context can reduce the number of RGs for the normalization step of RT-qPCR expression analysis, thus reducing the number of samples and experimental costs.	[Meyer, Florian R. L.; Mair, Georg E.; Steinborn, Ralf] Univ Vet Med, VetCore, Genom Core Facil, Vienna, Austria; [Meyer, Florian R. L.] Univ Vet Med, Inst Anat Histol & Embryol, Vienna, Austria; [Grausgruber, Heinrich] Univ Nat Resources & Life Sci, Dept Crop Sci, Tulln, Austria; [Binter, Claudia] Univ Vet Med, Inst Anim Nutr & Funct Plant Cpds, Vienna, Austria; [Guelly, Christian] Med Univ Graz, Med Res Ctr, Graz, Austria; [Vogl, Claus] Univ Vet Med, Inst Anim Breeding & Genet, Vienna, Austria	University of Veterinary Medicine Vienna; University of Veterinary Medicine Vienna; University of Natural Resources & Life Sciences, Vienna; University of Veterinary Medicine Vienna; Medical University of Graz; University of Veterinary Medicine Vienna	Steinborn, R (corresponding author), Univ Vet Med, VetCore, Genom Core Facil, Vienna, Austria.	Ralf.Steinborn@vetmeduni.ac.at	Grausgruber, Heinrich/D-9776-2019	Grausgruber, Heinrich/0000-0003-4790-0922	Austrian Science Fund (FWF) [P23336]; Austrian Science Fund (FWF) [P 23336] Funding Source: researchfish	Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	Microarray expression data was funded by the Austrian Ministry of Health (www.bmg.gv.at). FM was supported in part by the Austrian Science Fund (FWF; project P23336). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Akilesh S, 2003, GENOME RES, V13, P1719, DOI 10.1101/gr.533003; Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Axtner Jan, 2009, BMC Res Notes, V2, P264, DOI 10.1186/1756-0500-2-264; Bargaje R, 2010, RNA, V16, P16, DOI 10.1261/rna.1688110; Barrett T, 2009, NUCLEIC ACIDS RES, V37, pD885, DOI 10.1093/nar/gkn764; Bisognin A, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-201; Bustin SA, 2005, J MOL ENDOCRINOL, V34, P597, DOI 10.1677/jme.1.01755; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Cailotto C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005650; Chapin Robert E., 1997, Environmental Health Perspectives, V105, P199, DOI 10.2307/3433407; Chari R, 2010, BMC MED GENOMICS, V3, DOI 10.1186/1755-8794-3-32; Chen DL, 2011, J CELL PHYSIOL, V226, P2469, DOI 10.1002/jcp.22725; Cheng WC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017347; Churchill G, 2004, NAT GENET, V36, P1133, DOI 10.1038/ng1104-1133; Coker JS, 2003, BIOTECHNIQUES, V35, P740, DOI 10.2144/03354st04; Czechowski T, 2005, PLANT PHYSIOL, V139, P5, DOI 10.1104/pp.105.063743; de Jonge HJM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000898; De Santis C, 2010, MAR BIOTECHNOL NY; Du D, 2010, MOL BIOL REP, V37, P1867, DOI 10.1007/s11033-009-9622-3; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Exposito-Rodriguez M, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-131; Feil R, 2006, MUTAT RES, V600, P57; Ferguson BS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015208; Galiveti CR, 2010, RNA, V16, P450, DOI 10.1261/rna.1755810; Germain RN, 2001, SCIENCE, V293, P240, DOI 10.1126/science.1062946; GRUBBS FE, 1950, ANN MATH STAT, V21, P27, DOI 10.1214/aoms/1177729885; Haller F, 2004, ANAL BIOCHEM, V335, P1, DOI 10.1016/j.ab.2004.08.024; Hannibal J, 2001, J NEUROSCI, V21, P4883, DOI 10.1523/JNEUROSCI.21-13-04883.2001; Hindson BJ, 2011, ANAL CHEM, V83, P8604, DOI 10.1021/ac202028g; Hruz Tomas, 2008, Advances in Bioinformatics, V2008, P420747, DOI 10.1155/2008/420747; Hruz T, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-156; Hu PZ, 2006, INFORM SYST FRONT, V8, P9, DOI 10.1007/s10796-005-6099-z; Huggett J, 2005, GENES IMMUN, V6, P279, DOI 10.1038/sj.gene.6364190; Jin P, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-55; Kapetis D, 2012, BIOTECHNIQUES, V53, P33, DOI 10.2144/0000113889; Karaghiosoff M, 2003, NAT IMMUNOL, V4, P471, DOI 10.1038/ni910; Khanlou KM, 2012, PLANTA, V236, P1381, DOI 10.1007/s00425-012-1682-2; Konishi T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003555; Kosir R, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-60; Kwon MJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006162; Lefever S, 2009, NUCLEIC ACIDS RES, V37, pD942, DOI 10.1093/nar/gkn777; Marshall OJ, 2004, BIOINFORMATICS, V20, P2471, DOI 10.1093/bioinformatics/bth254; Marullo M, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-1-r9; McGlincy NJ, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-6-r54; Mehta R, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-39; Pang W, 2008, ENDOCRINOLOGY, V149, P42; Parkinson H, 2009, NUCLEIC ACIDS RES, V37, pD868, DOI 10.1093/nar/gkn889; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Pradervand S, 2009, RNA, V15, P493, DOI 10.1261/rna.1295509; Richard H, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq041; Rieu I, 2008, PLANT J, V53, P488, DOI 10.1111/j.1365-313X.2007.03356.x; Roberts A, 2007, MAMM GENOME, V18, P473, DOI 10.1007/s00335-007-9045-1; Silver N, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-33; Sinicropi D, 2007, BIOMEMS BIOMEDICAL N, VII, P540; Spandidos A, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-633; Speed T, 2003, STAT ANAL GENE EXPRE, P224; Storch KF, 2002, NATURE, V417, P78, DOI 10.1038/nature744; Tai HH, 2009, PLANT MOL BIOL REP, V27, P315, DOI 10.1007/s11105-009-0089-0; Tseng GC, 2012, NUCLEIC ACIDS RES, V40, P3785, DOI 10.1093/nar/gkr1265; Upton GJG, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-613; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Warde-Farley D, 2010, NUCLEIC ACIDS RES, V38, pW214, DOI 10.1093/nar/gkq537; Waxman S, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-243; Xia XQ, 2009, BIOINFORMATICS, V25, P2425, DOI 10.1093/bioinformatics/btp430; Yalcin B, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001085; Yan H, 2002, NAT GENET, V30, P25, DOI 10.1038/ng799; Zhu XY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044405; Zsori KS, 2013, INT J MOL SCI, V14, P3456, DOI 10.3390/ijms14023456	68	11	11	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2013	8	5							e63125	10.1371/journal.pone.0063125	http://dx.doi.org/10.1371/journal.pone.0063125			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	155HD	23671661	Green Published, gold, Green Submitted			2022-12-27	WOS:000319737700040
J	Muller, R; Jenny, A; Stanley, P				Mueller, Reto; Jenny, Andreas; Stanley, Pamela			The EGF Repeat-Specific O-GlcNAc-Transferase Eogt Interacts with Notch Signaling and Pyrimidine Metabolism Pathways in Drosophila	PLOS ONE			English	Article							LINKED-N-ACETYLGLUCOSAMINE; CELL-ADHESION; WING MUTANTS; MUTATIONS; GLYCOSYLTRANSFERASE; MELANOGASTER; DOMAIN; RUDIMENTARY; EXPRESSION; DUMPY	The O-GlcNAc transferase Eogt modifies EGF repeats in proteins that transit the secretory pathway, including Dumpy and Notch. In this paper, we show that the Notch ligands Delta and Serrate are also substrates of Eogt, that mutation of a putative UDP-GlcNAc binding DXD motif greatly reduces enzyme activity, and that Eogt and the cytoplasmic O-GlcNAc transferase Ogt have distinct substrates in Drosophila larvae. Loss of Eogt is larval lethal and disrupts Dumpy functions, but does not obviously perturb Notch signaling. To identify novel genetic interactions with eogt, we investigated dominant modification of wing blister formation caused by knock-down of eogt. Unexpectedly, heterozygosity for several members of the canonical Notch signaling pathway suppressed wing blister formation. And importantly, extensive genetic interactions with mutants in pyrimidine metabolism were identified. Removal of pyrimidine synthesis alleles suppressed wing blister formation, while removal of uracil catabolism alleles was synthetic lethal with eogt knock-down. Therefore, Eogt may regulate protein functions by O-GlcNAc modification of their EGF repeats, and cellular metabolism by affecting pyrimidine synthesis and catabolism. We propose that eogt knock-down in the wing leads to metabolic and signaling perturbations that increase cytosolic uracil levels, thereby causing wing blister formation.	[Mueller, Reto; Stanley, Pamela] Albert Einstein Coll Med, Dept Cell Biol, New York, NY USA; [Jenny, Andreas] Albert Einstein Coll Med, Dept Dev & Mol Biol, New York, NY USA; [Jenny, Andreas] Albert Einstein Coll Med, Dept Genet, New York, NY USA	Yeshiva University; Yeshiva University; Yeshiva University	Jenny, A (corresponding author), Albert Einstein Coll Med, Dept Dev & Mol Biol, New York, NY USA.	andreas.jenny@einstein.yu.edu; pamela.stanley@einstein.yu.edu		Stanley, Pamela/0000-0001-5704-3747	NCI [RO1 CA036434]; NIGMS [RO1 GM088202]; Cancer Center of the Albert Einstein College of Medicine (NCI) [PO1 13330]; NATIONAL CANCER INSTITUTE [R01CA036434] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM088202] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Cancer Center of the Albert Einstein College of Medicine (NCI); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NCI grant RO1 CA036434 (to P.S.), NIGMS grant RO1 GM088202 (to A.J.), and the Cancer Center of the Albert Einstein College of Medicine (NCI grant PO1 13330). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acar M, 2008, CELL, V132, P247, DOI 10.1016/j.cell.2007.12.016; Alfaro JF, 2012, P NATL ACAD SCI USA, V109, P7280, DOI 10.1073/pnas.1200425109; BLASS DH, 1980, MOL GEN GENET, V178, P437, DOI 10.1007/BF00270496; Bokel C, 2005, J CELL SCI, V118, P633, DOI 10.1242/jcs.01619; Borycz J, 2012, J EXP BIOL, V215, P1399, DOI 10.1242/jeb.060699; BRAND AH, 1993, DEVELOPMENT, V118, P401; Breton C, 1998, J BIOCHEM, V123, P1000; Bruckner K, 2000, NATURE, V406, P411, DOI 10.1038/35019075; Butkinaree C, 2010, BBA-GEN SUBJECTS, V1800, P96, DOI 10.1016/j.bbagen.2009.07.018; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; CAREY FG, 1960, BIOCHIM BIOPHYS ACTA, V41, P178, DOI 10.1016/0006-3002(60)90395-4; Carmon A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012319; Carmon A, 2010, FLY, V4, P117, DOI 10.4161/fly.4.2.11953; CAVENER DR, 1987, NUCLEIC ACIDS RES, V15, P1353, DOI 10.1093/nar/15.4.1353; CLYNES MM, 1976, J INSECT PHYSIOL, V22, P1709, DOI 10.1016/0022-1910(76)90064-0; Comer FI, 2001, ANAL BIOCHEM, V293, P169, DOI 10.1006/abio.2001.5132; DECELIS JF, 1994, GENETICS, V136, P183; FAUSTOSTERLING A, 1977, BIOCHEM GENET, V15, P803, DOI 10.1007/BF00484105; Gambetta MC, 2009, SCIENCE, V325, P93, DOI 10.1126/science.1169727; Groth AC, 2004, GENETICS, V166, P1775, DOI 10.1534/genetics.166.4.1775; Halfon MS, 2002, GENESIS, V34, P135, DOI 10.1002/gene.10136; Hanover JA, 2012, NAT REV MOL CELL BIO, V13, P312, DOI 10.1038/nrm3334; Hart GW, 2007, NATURE, V446, P1017, DOI 10.1038/nature05815; HARTLEY DA, 1987, EMBO J, V6, P3407, DOI 10.1002/j.1460-2075.1987.tb02664.x; Hassed SJ, 2012, AM J HUM GENET, V91, P391, DOI 10.1016/j.ajhg.2012.07.005; Herranz H, 2006, EMBO REP, V7, P297, DOI 10.1038/sj.embor.7400617; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Hutterer A, 2005, EMBO REP, V6, P836, DOI 10.1038/sj.embor.7400500; Irvine KD, 1999, CURR OPIN GENET DEV, V9, P434, DOI 10.1016/S0959-437X(99)80066-5; Ise H, 2010, GLYCOBIOLOGY, V20, P843, DOI 10.1093/glycob/cwq039; KELLEY MR, 1987, CELL, V51, P539, DOI 10.1016/0092-8674(87)90123-1; KJAER T, 1987, HEREDITAS, V107, P213; Kopan R, 1999, Sci STKE, V1999, pPE1, DOI 10.1126/stke.1999.9.pe1; Leonardi J, 2011, DEVELOPMENT, V138, P3569, DOI 10.1242/dev.068361; Li YX, 2003, DEVELOPMENT, V130, P2829, DOI 10.1242/dev.00498; Mahoney MB, 2006, GENETICS, V172, P2309, DOI 10.1534/genetics.104.035170; Martin D, 1999, J CELL BIOL, V145, P191, DOI 10.1083/jcb.145.1.191; Matsuura A, 2008, J BIOL CHEM, V283, P35486, DOI 10.1074/jbc.M806202200; Meyer V, 1998, MOL CELL BIOL, V18, P1835, DOI 10.1128/MCB.18.4.1835; Moloney DJ, 2000, NATURE, V406, P369, DOI 10.1038/35019000; Morris DH, 2012, GENETICS, V191, P1227, DOI 10.1534/genetics.112.141101; Muller R, 2009, GLYCOBIOLOGY, V19, P1337; Okajima T, 2002, CELL, V111, P893, DOI 10.1016/S0092-8674(02)01114-5; Phillips AM, 2005, GENE, V351, P131, DOI 10.1016/j.gene.2005.03.013; PISKUR J, 1993, MOL GEN GENET, V241, P335, DOI 10.1007/BF00284686; Prout M, 1997, GENETICS, V146, P275; Ramakrishnan B, 2004, CURR OPIN STRUC BIOL, V14, P593, DOI 10.1016/j.sbi.2004.09.006; Rawls JM, 2006, GENETICS, V172, P1665, DOI 10.1534/genetics.105.052753; Reed BH, 2004, CURR BIOL, V14, P372, DOI 10.1016/j.cub.2004.02.029; RIZKI RM, 1965, SCIENCE, V150, P222, DOI 10.1126/science.150.3693.222; Sakaidani Y, 2012, BIOCHEM BIOPH RES CO, V419, P14, DOI 10.1016/j.bbrc.2012.01.098; Sakaidani Y, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1591; Shaheen R, 2013, AM J HUM GE IN PRESS; Simmons AJ, 1999, J MOL BIOL, V287, P277, DOI 10.1006/jmbi.1999.2618; Smyk A, 2006, FEBS J, V273, P4728, DOI 10.1111/j.1742-4658.2006.05477.x; Stanley P, 2010, CURR TOP DEV BIOL, V92, P131, DOI 10.1016/S0070-2153(10)92004-8; STROMAN P, 1974, HEREDITAS, V78, P157; STROMAN P, 1973, HEREDITAS, V73, P239; TEPASS U, 1990, CELL, V61, P787, DOI 10.1016/0092-8674(90)90189-L; Thierry-Mieg D, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-s1-s12; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; THORIG GEW, 1987, BIOCHEM GENET, V25, P7, DOI 10.1007/BF00498948; Tsubota SI, 2011, FLY AUSTIN, V5; Varki A., 2009, ESSENTIALS GLYCOBIOL; Waddington CH, 1940, J GENET, V41, P75, DOI 10.1007/BF02982977; Walsh EP, 1998, GENETICS, V150, P791; Wilkin MB, 2000, CURR BIOL, V10, P559, DOI 10.1016/S0960-9822(00)00482-6; WODARZ A, 1995, CELL, V82, P67, DOI 10.1016/0092-8674(95)90053-5; WOJCIK E, 1994, GENETICS, V138, P1163	69	46	47	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2013	8	5							e62835	10.1371/journal.pone.0062835	http://dx.doi.org/10.1371/journal.pone.0062835			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	155HD	23671640	Green Submitted, gold, Green Published			2022-12-27	WOS:000319737700025
J	Bjork, P; Kallberg, E; Wellmar, U; Riva, M; Olsson, A; He, ZF; Torngren, M; Liberg, D; Ivars, F; Leanderson, T				Bjork, Per; Kallberg, Eva; Wellmar, Ulf; Riva, Matteo; Olsson, Anders; He, Zhifei; Torngren, Marie; Liberg, David; Ivars, Fredrik; Leanderson, Tomas			Common Interactions between S100A4 and S100A9 Defined by a Novel Chemical Probe	PLOS ONE			English	Article							ANTI-ANGIOGENIC AGENT; PROSTATE-CANCER; TASQUINIMOD ABR-215050; METASTATIC PHENOTYPE; AUTOIMMUNE-DISEASE; MYELOID CELLS; PROTEIN; EXPRESSION; BINDING; CHEMOATTRACTANTS	S100A4 and S100A9 proteins have been described as playing roles in the control of tumor growth and metastasis. We show here that a chemical probe, oxyclozanide (OX), selected for inhibiting the interaction between S100A9 and the receptor for advanced glycation end-products (RAGE) interacts with both S100A9 and S100A4. Furthermore, we show that S100A9 and S100A4 interact with RAGE and TLR4; interactions that can be inhibited by OX. Hence, S100A4 and S100A9 display similar functional elements despite their primary sequence diversity. This was further confirmed by showing that S100A4 and S100A9 dimerize both in vitro and in vivo. All of these interactions required levels of Zn++ that are found in the extracellular space but not intracellularly. Interestingly, S100A4 and S100A9 are expressed by distinct CD11b(+) subpopulations both in healthy animals and in animals with either inflammatory disease or tumor burden. The functions of S100A9 and S100A4 described in this paper, including heterodimerization, may therefore reflect S100A9 and S100A4 that are released into the extra-cellular milieu.	[Kallberg, Eva; Riva, Matteo; He, Zhifei; Ivars, Fredrik; Leanderson, Tomas] Lund Univ, Immunol Grp, Lund, Sweden; [Bjork, Per; Wellmar, Ulf; Olsson, Anders; Torngren, Marie; Liberg, David] Act Biotech AB, Lund, Sweden	Lund University	Leanderson, T (corresponding author), Lund Univ, Immunol Grp, Lund, Sweden.	tomas.leanderson@med.lu.se		Riva, Matteo/0000-0003-2697-6717	Swedish Cancer Society; Kocks Foundation; Osterlund foundation; Active Biotech AB	Swedish Cancer Society(Swedish Cancer Society); Kocks Foundation; Osterlund foundation; Active Biotech AB	This work was supported by grants from the Swedish Cancer Society, Kocks Foundation and the Osterlund foundation. The funders had no role in study design, data collection, decision to publish, or preparation of the manuscript.; UW, DL, AO, PB and MT are full time employees of Active Biotech AB that develops S100A9 binding molecules for commercial development. TL is a part time employee of Active Biotech AB. FI receives a research grant from Active Biotech AB. There are no further patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.	Ambartsumian N, 2001, ONCOGENE, V20, P4685, DOI 10.1038/sj.onc.1204636; Apetoh L, 2007, NAT MED, V13, P1050, DOI 10.1038/nm1622; Bjork P, 2009, PLOS BIOL, V7, P800, DOI 10.1371/journal.pbio.1000097; Boye K, 2010, EUR J CANCER, V46, P2919, DOI 10.1016/j.ejca.2010.07.013; Cheng PY, 2008, J EXP MED, V205, P2235, DOI 10.1084/jem.20080132; DAVIES BR, 1993, ONCOGENE, V8, P999; Foell D, 2004, ARTHRITIS RHEUM-US, V50, P3762, DOI 10.1002/art.20631; Foell D, 2007, J LEUKOCYTE BIOL, V81, P28, DOI 10.1189/jlb.0306170; Gabrilovich DI, 2012, NAT REV IMMUNOL, V12, P253, DOI 10.1038/nri3175; Garrett SC, 2006, J BIOL CHEM, V281, P677, DOI 10.1074/jbc.R500017200; Gebhardt C, 2008, J EXP MED, V205, P275, DOI 10.1084/jem.20070679; Heizmann CW, 2002, FRONT BIOSCI-LANDMRK, V7, pD1356, DOI 10.2741/heizmann; Hermani A, 2005, CLIN CANCER RES, V11, P5146, DOI 10.1158/1078-0432.CCR-05-0352; Hiratsuka S, 2006, NAT CELL BIOL, V8, P1369, DOI 10.1038/ncb1507; Isaacs JT, 2006, PROSTATE, V66, P1768, DOI 10.1002/pros.20509; Itou H, 2002, J MOL BIOL, V316, P265, DOI 10.1006/jmbi.2001.5340; Jennbacken K, 2012, PROSTATE, V72, P913, DOI 10.1002/pros.21495; Jin YL, 2010, CANCER RES, V70, P2516, DOI 10.1158/0008-5472.CAN-09-3950; Kallberg E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034207; Kriajevska M, 2000, BBA-MOL CELL RES, V1498, P252, DOI 10.1016/S0167-4889(00)00100-2; Lominadze G, 2005, J IMMUNOL, V174, P7257, DOI 10.4049/jimmunol.174.11.7257; Maelandsmo GM, 1996, CANCER RES, V56, P5490; Maelandsmo GM, 2009, TUMOR BIOL, V30, P15, DOI 10.1159/000199447; Manitz MP, 2003, MOL CELL BIOL, V23, P1034, DOI 10.1128/MCB.23.3.1034-1043.2003; Marenholz I, 2004, BIOCHEM BIOPH RES CO, V322, P1111, DOI 10.1016/j.bbrc.2004.07.096; Miranda KJ, J BIOL CHEM, V285, P31517; Olsson A, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-107; Riva M, 2012, IMMUNOLOGY, V137, P172, DOI 10.1111/j.1365-2567.2012.03619.x; Roth J, 2003, TRENDS IMMUNOL, V24, P155, DOI 10.1016/S1471-4906(03)00062-0; Rudland PS, 2000, CANCER RES, V60, P1595; Xie R, 2009, LAB INVEST, V89, P937, DOI 10.1038/labinvest.2009.52; Yammani RR, 2006, ARTHRITIS RHEUM-US, V54, P2901, DOI 10.1002/art.22042	32	26	26	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2013	8	5							e63012	10.1371/journal.pone.0063012	http://dx.doi.org/10.1371/journal.pone.0063012			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145YI	23667563	Green Published, gold, Green Submitted			2022-12-27	WOS:000319055600052
J	Ekins, S; Reynolds, RC; Franzblau, SG; Wan, BJ; Freundlich, JS; Bunin, BA				Ekins, Sean; Reynolds, Robert C.; Franzblau, Scott G.; Wan, Baojie; Freundlich, Joel S.; Bunin, Barry A.			Enhancing Hit Identification in Mycobacterium tuberculosis Drug Discovery Using Validated Dual-Event Bayesian Models	PLOS ONE			English	Article							HIGH-THROUGHPUT SCREEN; IN-VIVO ACTIVITIES; KINASE INHIBITORS; LIBRARY; ANALOGS; PA-824; PHARMACOLOGY; RESISTANCE; PREDICTION; SCAFFOLDS	High-throughput screening (HTS) in whole cells is widely pursued to find compounds active against Mycobacterium tuberculosis (Mtb) for further development towards new tuberculosis (TB) drugs. Hit rates from these screens, usually conducted at 10 to 25 mu M concentrations, typically range from less than 1% to the low single digits. New approaches to increase the efficiency of hit identification are urgently needed to learn from past screening data. The pharmaceutical industry has for many years taken advantage of computational approaches to optimize compound libraries for in vitro testing, a practice not fully embraced by academic laboratories in the search for new TB drugs. Adapting these proven approaches, we have recently built and validated Bayesian machine learning models for predicting compounds with activity against Mtb based on publicly available large-scale HTS data from the Tuberculosis Antimicrobial Acquisition Coordinating Facility. We now demonstrate the largest prospective validation to date in which we computationally screened 82,403 molecules with these Bayesian models, assayed a total of 550 molecules in vitro, and identified 124 actives against Mtb. Individual hit rates for the different datasets varied from 15-28%. We have identified several FDA approved and late stage clinical candidate kinase inhibitors with activity against Mtb which may represent starting points for further optimization. The computational models developed herein and the commercially available molecules derived from them are now available to any group pursuing Mtb drug discovery.	[Ekins, Sean; Bunin, Barry A.] Collaborat Drug Discovery, Burlingame, CA USA; [Ekins, Sean] Collaborat Chem, Fuquay Varina, NC USA; [Reynolds, Robert C.] So Res Inst, Birmingham, AL 35255 USA; [Freundlich, Joel S.] Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Physiol & Pharmacol, Newark, NJ 07103 USA; [Franzblau, Scott G.; Wan, Baojie] Univ Illinois, Inst TB Res, Chicago, IL USA; [Freundlich, Joel S.] Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Med, Ctr Emerging & Reemerging Pathogens, Newark, NJ 07103 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Rutgers State University New Brunswick; Rutgers State University Medical Center	Ekins, S (corresponding author), Collaborat Drug Discovery, Burlingame, CA USA.	ekinssean@yahoo.com		Franzblau, Scott/0000-0002-8698-0243	Bill and Melinda Gates Foundation [49852]; National Library of Medicine [R43 LM011152-01]; American Reinvestment and Recovery Act [1RC1AI086677-01]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [RC1AI086677] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [R43LM011152] Funding Source: NIH RePORTER	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); National Library of Medicine(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); American Reinvestment and Recovery Act; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	The CDD TB has been developed thanks to funding from the Bill and Melinda Gates Foundation (Grant#49852 "Collaborative drug discovery for TB through a novel database of SAR data optimized to promote data archiving and sharing''). The project described was supported by Award Number R43 LM011152-01 "Biocomputation across distributed private datasets to enhance drug discovery'' from the National Library of Medicine. RCR and SGF acknowledge the American Reinvestment and Recovery Act Grant 1RC1AI086677-01 (National Institutes of Health (NIH), National Institute of Allergy and Infectious Diseases (NIAID)) - "Targeting MDR-TB.'' The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alber T, 2009, CURR OPIN STRUC BIOL, V19, P650, DOI 10.1016/j.sbi.2009.10.017; Ananthan S, 2009, TUBERCULOSIS, V89, P334, DOI 10.1016/j.tube.2009.05.008; Andries K, 2005, SCIENCE, V307, P223, DOI 10.1126/science.1106753; ASHTEKAR DR, 1993, ANTIMICROB AGENTS CH, V37, P183, DOI 10.1128/AAC.37.2.183; Balganesh TS, 2008, TRENDS PHARMACOL SCI, V29, P576, DOI 10.1016/j.tips.2008.08.001; Ballell L, 2005, ANTIMICROB AGENTS CH, V49, P2153, DOI 10.1128/AAC.49.6.2153-2163.2005; Ballester PJ, 2012, J R SOC INTERFACE; Barry CE, 2000, BIOCHEM PHARMACOL, V59, P221, DOI 10.1016/S0006-2952(99)00253-1; Bean J, 2007, P NATL ACAD SCI USA, V104, P20932, DOI 10.1073/pnas.0710370104; Bender A, 2007, CHEMMEDCHEM, V2, P861, DOI 10.1002/cmdc.200700026; Blaser A, 2012, J MED CHEM, V55, P312, DOI 10.1021/jm2012276; Bruns H, 2012, J IMMUNOL, V189, P4069, DOI 10.4049/jimmunol.1201538; Cavazos A, 2012, J MOL BIOL, V422, P488, DOI 10.1016/j.jmb.2012.06.011; Chapman TM, 2012, BIOORG MED CHEM LETT, V22, P3349, DOI 10.1016/j.bmcl.2012.02.107; Cho SH, 2007, ANTIMICROB AGENTS CH, V51, P1380, DOI 10.1128/AAC.00055-06; Cho Y, 2008, J MED CHEM, V51, P5984, DOI 10.1021/jm800328v; Collins LA, 1997, ANTIMICROB AGENTS CH, V41, P1004, DOI 10.1128/AAC.41.5.1004; Dalton T, 2012, LANCET, V380, P1406, DOI 10.1016/S0140-6736(12)60734-X; Ekins S, 2007, BRIT J PHARMACOL, V152, P9, DOI 10.1038/sj.bjp.0707305; Ekins S, 2010, MOL BIOSYST, V6, P2316, DOI 10.1039/c0mb00104j; Ekins S, 2013, CHEM BIOL, V20, P370, DOI 10.1016/j.chembiol.2013.01.011; Ekins S, 2011, PHARM RES-DORDR, V28, P1785, DOI 10.1007/s11095-011-0486-6; Ekins S, 2011, PHARM RES-DORDR, V28, P1859, DOI 10.1007/s11095-011-0413-x; Ekins S, 2011, DRUG DISCOV TODAY, V16, P298, DOI 10.1016/j.drudis.2011.02.016; Ekins S, 2011, TRENDS MICROBIOL, V19, P65, DOI 10.1016/j.tim.2010.10.005; Ekins S, 2010, MOL BIOSYST, V6, P840, DOI 10.1039/b917766c; Falzari K, 2005, ANTIMICROB AGENTS CH, V49, P1447, DOI 10.1128/AAC.49.4.1447-1454.2005; Feng BY, 2007, J MED CHEM, V50, P2385, DOI 10.1021/jm061317y; Garcia-Garcia A, 2005, J BIOMOL SCREEN, V10, P206, DOI 10.1177/1087057104273486; Gold B, 2012, P NATL ACAD SCI USA, V109, P16004, DOI 10.1073/pnas.1214188109; Hassan M, 2006, MOL DIVERS, V10, P283, DOI 10.1007/s11030-006-9041-5; Hohman M, 2009, DRUG DISCOV TODAY, V14, P261, DOI 10.1016/j.drudis.2008.11.015; Jones DR, 2007, DRUG METAB DISPOS, V35, P1466, DOI 10.1124/dmd.106.014613; Kaneko T, 2011, FUTURE MED CHEM, V3, P1373, DOI [10.4155/fmc.11.115, 10.4155/FMC.11.115]; Kinnings SL, 2011, J CHEM INF MODEL, V51, P408, DOI 10.1021/ci100369f; Klon AE, 2006, J CHEM INF MODEL, V46, P1945, DOI 10.1021/ci0601315; Koul A, 2004, NAT REV MICROBIOL, V2, P189, DOI 10.1038/nrmicro840; Koul A, 2011, NATURE, V469, P483, DOI 10.1038/nature09657; Lopez AD, 2006, ANN TROP MED PARASIT, V100, P481, DOI 10.1179/136485906X97417; Macarron R, 2011, NAT REV DRUG DISCOV, V10, P188, DOI 10.1038/nrd3368; Maddry JA, 2009, TUBERCULOSIS, V89, P354, DOI 10.1016/j.tube.2009.07.006; Magnet S, 2010, TUBERCULOSIS, V90, P354, DOI 10.1016/j.tube.2010.09.001; Maiga M, 2012, J INFECT DIS, V205, P1705, DOI 10.1093/infdis/jis269; Mak PA, 2012, ACS CHEM BIOL, V7, P1190, DOI 10.1021/cb2004884; McGovern SL, 2003, J MED CHEM, V46, P1478, DOI 10.1021/jm020427b; Miller K, 2012, BIOMED COMPUT REV SU, P20; Napier RJ, 2011, CELL HOST MICROBE, V10, P475, DOI 10.1016/j.chom.2011.09.010; Oprea TI, 2001, J CHEM INF COMP SCI, V41, P1308, DOI 10.1021/ci010366a; Palmer BD, 2010, J MED CHEM, V53, P282, DOI 10.1021/jm901207n; Prathipati P, 2008, J CHEM INF MODEL, V48, P2362, DOI 10.1021/ci800143n; Qian F, 2009, CANCER RES, V69, P8009, DOI 10.1158/0008-5472.CAN-08-4889; Reynolds RC, 2012, TUBERCULOSIS, V92, P72, DOI 10.1016/j.tube.2011.05.005; Rogers D, 2005, J BIOMOL SCREEN, V10, P682, DOI 10.1177/1087057105281365; Sarker M, 2012, PHARM RES-DORDR, V29, P2115, DOI 10.1007/s11095-012-0741-5; Scior T, 2012, J CHEM INF MODEL, V52, P867, DOI 10.1021/ci200528d; Singh N, 2012, J CHEM INF MODEL, V52, P2559, DOI 10.1021/ci300336v; Planche AS, 2009, MOL DIVERS, V13, P445, DOI 10.1007/s11030-009-9129-9; Stanley SA, 2012, ACS CHEM BIOL, V7, P1377, DOI 10.1021/cb300151m; Stover CK, 2000, NATURE, V405, P962, DOI 10.1038/35016103; Teo M, 2012, ONKOLOGIE, V35, P514, DOI 10.1159/000341829; Thompson AM, 2011, J MED CHEM, V54, P6563, DOI 10.1021/jm200377r; Thompson AM, 2009, J MED CHEM, V52, P637, DOI 10.1021/jm801087e; Voelker R, 2013, JAMA-J AM MED ASSOC, V309, P430, DOI 10.1001/jama.2013.94; Walsh CT, 2009, P NATL ACAD SCI USA, V106, P1689, DOI 10.1073/pnas.0813405106; Ying Z, 2005, ANNU REV PHARMACOL, V45, P529, DOI 10.1146/annurev.pharmtox.45.120403.100120; You WK, 2011, CANCER RES, V71, P4758, DOI 10.1158/0008-5472.CAN-10-2527	67	38	41	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e63240	10.1371/journal.pone.0063240	http://dx.doi.org/10.1371/journal.pone.0063240			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667592	Green Published, Green Submitted, gold			2022-12-27	WOS:000319654700122
J	Herder, V; Hansmann, F; Wohlsein, P; Peters, M; Varela, M; Palmarini, M; Baumgartner, W				Herder, Vanessa; Hansmann, Florian; Wohlsein, Peter; Peters, Martin; Varela, Mariana; Palmarini, Massimo; Baumgaertner, Wolfgang			Immunophenotyping of Inflammatory Cells Associated with Schmallenberg Virus Infection of the Central Nervous System of Ruminants	PLOS ONE			English	Article							AKABANE VIRUS; CONGENITAL-ABNORMALITIES; DIARRHEA VIRUS; TRANSPLACENTAL INFECTION; VIRAL-INFECTION; OVINE FETUSES; CATTLE; DISEASE; LESIONS; MODEL	Schmallenberg virus (SBV) is a recently discovered Bunyavirus associated mainly with abortions, stillbirths and malformations of the skeletal and central nervous system (CNS) in newborn ruminants. In this study, a detailed immunophenotyping of the inflammatory cells of the CNS of affected animals was carried out in order to increase our understanding of SBV pathogenesis. A total of 82 SBV-polymerase chain reaction (PCR) positive neonatal ruminants (46 sheep lambs, 34 calves and 2 goat kids) were investigated for the presence of inflammation in the brain and spinal cord. The study focused on 15 out of 82 animals (18.3%) showing inflammation in the CNS. All 15 neonates displayed lymphohistiocytic meningoencephalomyelitis affecting most frequently the mesencephalon and the parietal and temporal lobes. The majority of infiltrating cells were CD3-positive T cells, followed by CD79 alpha-positive B cells and CD68-positive microglia/macrophages. Malformations like por- and hydranencephaly, frequently found in the temporal lobe, showed associated demyelination and axonal loss. SBV antigen was detected in 37 out of 82 (45.1%) neonatal brains by immunohistochemistry. In particular, SBV antigen was found in 93.3% (14 out of 15 ruminants) and 32.8% (22 out of 67 ruminants) of animals with and without encephalitis, respectively. Highest amounts of virus-protein expression levels were found in the temporal lobe. Our findings suggest that: (i) different brain regions display differential susceptibility to SBV infection; (ii) inflammatory cells in the CNS are found only in a minority of virus infected animals; (iii) malformations occur in association with and without inflammation in the CNS; and (iv) viral antigen is strongly associated with the presence of inflammation in naturally infected animals. Further studies are required to explore the cell tropism and pathogenesis of SBV infection in ruminants.	[Herder, Vanessa; Hansmann, Florian; Wohlsein, Peter; Baumgaertner, Wolfgang] Univ Vet Med, Dept Pathol, Hannover, Lower Saxony, Germany; [Peters, Martin] Staatl Vet Untersuchungsamt, Arnsberg, North Rhine Wes, Germany; [Varela, Mariana; Palmarini, Massimo] Univ Glasgow, MRC Ctr Virus Res, Inst Infect Immun & Inflammat, Coll Med Vet & Life Sci, Glasgow, Lanark, Scotland; [Baumgaertner, Wolfgang] Ctr Syst Neurosci, Hannover, Germany	University of Veterinary Medicine Hannover, Foundation; University of Glasgow	Baumgartner, W (corresponding author), Univ Vet Med, Dept Pathol, Hannover, Lower Saxony, Germany.	wolfgang.baumgaertner@tiho-hannover.de	Herder, Vanessa/AAG-6647-2020	Hansmann, Florian/0000-0001-6064-7728; Palmarini, Massimo/0000-0001-7007-4070; Herder, Vanessa/0000-0003-4814-1382	Medical Research Council [G0801822] Funding Source: Medline; MRC [G0801822] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Ali H, 2012, TRANSBOUND EMERG DIS, V59, P11, DOI 10.1111/j.1865-1682.2011.01240.x; [Anonymous], 2012, VET REC, V171, P140, DOI 10.1136/vr.e5373; [Anonymous], 2012, Vet Rec, V170, P660; Beer M, 2013, EPIDEMIOL INFECT, V141, P1, DOI 10.1017/S0950268812002245; BINKHORST GJ, 1983, VET QUART, V5, P145, DOI 10.1080/01652176.1983.9693889; BOLLO E, 1986, ACTA NEUROPATHOL, V72, P69, DOI 10.1007/BF00687949; Burck H, 1982, HISTOLOGISCHE TECHNI, P136; De Regge N, 2012, TRANSBOUND EMERG DIS, V59, P471, DOI 10.1111/tbed.12000; EDWARDS JF, 1989, VET PATHOL, V26, P33, DOI 10.1177/030098588902600106; Elbers ARW, 2013, EMERG INFECT DIS, V19, P106, DOI 10.3201/eid1901.121054; Elbers ARW, 2012, EMERG INFECT DIS, V18, P1065, DOI 10.3201/eid1807.120323; FERNANDEZ A, 1989, VET PATHOL, V26, P26, DOI 10.1177/030098588902600105; Garigliany MM, 2012, ANTIVIR RES, V95, P82, DOI 10.1016/j.antiviral.2012.05.014; Garten L, 2007, J CHILD NEUROL, V22, P645, DOI 10.1177/0883073807302618; Goller KV, 2012, EMERG INFECT DIS, V18, P1644, DOI 10.3201/eid1810.120835; Hahn K, 2013, EMERG INFECT DIS, V19, P154, DOI 10.3201/eid1901.120764; Harding B, 1997, GREENFIELDS NEUROPAT, P397; Herder V, 2012, VET PATHOL, V49, P588, DOI 10.1177/0300985812447831; Herder V, 2012, J NEUROIMMUNOL, V244, P84, DOI 10.1016/j.jneuroim.2012.01.010; HEWICKERTRAUTWEIN M, 1994, ACTA NEUROPATHOL, V87, P385; HEWICKERTRAUTWEIN M, 1995, J VET MED B, V42, P65, DOI 10.1111/j.1439-0450.1995.tb00684.x; Hoffmann AR, 2012, J VIROL, V86, P4793, DOI 10.1128/JVI.06858-11; Hoffmann B, 2012, EMERG INFECT DIS, V18, P469, DOI 10.3201/eid1803.111905; Hoper D, 2012, DT TIERARZTEBLATT, V4, P500; Huang CC, 2003, VET MICROBIOL, V94, P1, DOI 10.1016/S0378-1135(03)00062-2; Kamata H, 2009, J COMP PATHOL, V140, P187, DOI 10.1016/j.jcpa.2008.12.001; KIRKLAND PD, 1988, VET REC, V122, P582, DOI 10.1136/vr.122.24.582; Kitani H, 2000, VET MICROBIOL, V73, P269, DOI 10.1016/S0378-1135(00)00158-9; KONNO S, 1982, VET PATHOL, V19, P246, DOI 10.1177/030098588201900304; KONNO S, 1982, VET PATHOL, V19, P267, DOI 10.1177/030098588201900305; Kono R, 2008, BMC VET RES, V4, DOI 10.1186/1746-6148-4-20; Kreutzer M, 2012, BRAIN PATHOL, V22, P454, DOI 10.1111/j.1750-3639.2011.00541.x; Kupferschmidt K, 2012, SCIENCE, V335, P1028, DOI 10.1126/science.335.6072.1028; Maclachlan NJ, 2009, J COMP PATHOL, V141, P1, DOI 10.1016/j.jcpa.2009.04.003; Meroc E, 2013, TRANSBOUND EMERG DIS, V60, P4, DOI 10.1111/tbed.12042; Otter A, 2009, VET REC, V164, P771, DOI 10.1136/vr.164.25.771; PARSONSON IM, 1988, J COMP PATHOL, V99, P215, DOI 10.1016/0021-9975(88)90073-4; PARSONSON IM, 1981, VET MICROBIOL, V6, P209, DOI 10.1016/0378-1135(81)90014-6; PLANT JW, 1983, AUST VET J, V60, P137, DOI 10.1111/j.1751-0813.1983.tb05926.x; Rasmussen LD, 2012, EMERG INFECT DIS, V18, P1204, DOI 10.3201/eid1807.120385; Seehusen F, 2010, BRAIN PATHOL, V20, P551, DOI 10.1111/j.1750-3639.2009.00332.x; Summers BA., 1995, VET NEUROPATHOLOGY, P68; Tarlinton R, 2012, VET J, V194, P10, DOI 10.1016/j.tvjl.2012.08.017; Tizard I, 2013, VET IMMUNOLOGY INTRO, V9th, P225; Tsunoda I, 2002, SPRINGER SEMIN IMMUN, V24, P105, DOI 10.1007/s00281-002-0105-z; Varela M, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003133; Vercauteren G, 2008, TRANSBOUND EMERG DIS, V55, P293, DOI 10.1111/j.1865-1682.2008.01034.x; WOHRMANN T, 1992, J VET MED B, V39, P599, DOI 10.1111/j.1439-0450.1992.tb01211.x; Zachary J, 2007, NERVOUS SYSTEM, P833	49	20	25	4	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e62939	10.1371/journal.pone.0062939	http://dx.doi.org/10.1371/journal.pone.0062939			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667545	Green Accepted, gold, Green Published, Green Submitted			2022-12-27	WOS:000319654700084
J	Hirooka, Y; Akiba, M; Ichihara, Y; Masuya, H; Takahata, Y; Suda, T; Yada, Y; Yamamoto, S; Kubono, T				Hirooka, Yuuri; Akiba, Mitsuteru; Ichihara, Yu; Masuya, Hayato; Takahata, Yoshihiro; Suda, Tomohisa; Yada, Yutaka; Yamamoto, Shigehiro; Kubono, Takanori			A Novel Approach of Preventing Japanese Cedar Pollen Dispersal That Is the Cause of Japanese Cedar Pollinosis (JCP) Using Pollen-Specific Fungal Infection	PLOS ONE			English	Article							EXPRESSED SEQUENCE TAGS; CRY-J-I; CRYPTOMERIA-JAPONICA; BIOLOGICAL-CONTROL; MAJOR ALLERGEN; GENES	In Japan, Japanese cedar pollen dispersal is one of the major causes of pollinosis. Sydowia japonica is an ascomycetous fungus that grows exclusively on the male strobili of Japanese cedar, suggesting a possible mechanism for controlling pollen dispersal. To evaluate this possibility, eleven isolates of S. japonica were collected from around Japan and used as an inoculum to male strobili of Japanese cedar. The treatment demonstrated that the fungus infected only the pollen and prevented pollen dispersal. The fungus did not cause any additional symptoms to other parts of Japanese cedar, such as needles, stems, and buds. All S. japonica isolates collected around Japan could serve to control pollen dispersal. Periodic observation of the fungal pathogenesis with stereomicroscope and scanning electron microscope showed that hyphal fragments and conidia of S. japonica germinated on the surface of male strobili, and the germ tube entered pollen sacs through opening microsporophylls. Within the pollen sacs, the hyphae penetrated pollen gradually, such that all pollen was infected by the fungus by approximately one month before the pollen dispersal season. The infected pollen was destroyed due to the fungal infection and was never released. Our data suggests a novel approach of preventing pollen dispersal using pollen-specific fungal infection.	[Hirooka, Yuuri; Akiba, Mitsuteru; Masuya, Hayato; Kubono, Takanori] Forestry & Forest Prod Res Inst, Dept Forest Microbiol, Tsukuba, Ibaraki 305, Japan; [Ichihara, Yu] Forestry & Forest Prod Res Inst, Tohoku Res Ctr, Morioka, Iwate, Japan; [Takahata, Yoshihiro] Forestry & Forest Prod Res Inst, Kyushu Res Ctr, Kumamoto, Japan; [Suda, Tomohisa] Fukushima Prefectural Forestry Res Ctr, Koriyama, Fukushima, Japan; [Yada, Yutaka] Ishikawa Forest Expt Stn, Haku San, Ishikawa, Japan; [Yamamoto, Shigehiro] Forestry & Forest Prod Res Ctr, Shizuoka Prefectural Res Inst Agr & Forestry, Hamamatsu, Shizuoka, Japan	Forestry & Forest Products Research Institute - Japan; Forestry & Forest Products Research Institute - Japan; Forestry & Forest Products Research Institute - Japan	Hirooka, Y (corresponding author), Forestry & Forest Prod Res Inst, Dept Forest Microbiol, Tsukuba, Ibaraki 305, Japan.	yuurihirooka@gmail.com	Masuya, Hayato/AAN-8998-2021		MAFF practical technology development project [22023]	MAFF practical technology development project	The authors' study was supported by the MAFF practical technology development project grant No. 22023 "Development on the scattering prevention of cedar and cypress pollen by using fungi''. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS PB, 1990, ANNU REV PHYTOPATHOL, V28, P59, DOI 10.1146/annurev.py.28.090190.000423; Baba K, 2008, PROG MED, V28, P2001; Bateman R., 2001, Fungi as biocontrol agents: progress, problems and potential, P289, DOI 10.1079/9780851993560.0289; Bills GF, 2004, STUD MYCOL, P149; Bills GF, 1999, MYCOL RES, V103, P179, DOI 10.1017/S095375629800687X; Butt T. M., 2001, Fungi as biocontrol agents: progress, problems and potential, P377, DOI 10.1079/9780851993560.0377; Cook R. J., 1983, The nature and practice of biological control of plant pathogens.; DAY RW, 1989, ECOL MONOGR, V59, P433, DOI 10.2307/1943075; Deacon J. W., 1991, Biocontrol Science and Technology, V1, P5, DOI 10.1080/09583159109355181; Elad Y, 1996, EUR J PLANT PATHOL, V102, P719, DOI 10.1007/BF01877146; FAO, 2007, STAT WORLDS FOR 2007; Farr D. F., 2012, FUNGAL DATABASES SYS; Fukui M, 2001, PLANT CELL PHYSIOL, V42, P566, DOI 10.1093/pcp/pce069; Futamura N, 2007, INT ARCH ALLERGY IMM, V143, P59, DOI 10.1159/000098225; Futamura N, 2006, TREE PHYSIOL, V26, P1517, DOI 10.1093/treephys/26.12.1517; Futamura N, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-383; Gorbushina AA, 2008, STUD MYCOL, P91, DOI 10.3114/sim.2008.61.09; Hashizume H., 1992, Research Bulletin of the Tottori University Forests, V21, P51; Hayashi Y, 1951, B GOVT FOREST EXPT S, V48, P1; Hirooka Y, 2012, MYCOLOGICAL IN PRESS; Honma Tamaki, 2003, Biol Sci Space, V17, P48, DOI 10.2187/bss.17.48; Ishii K, 2011, PLANT BIOTECHNOL-NAR, V28, P103, DOI 10.5511/plantbiotechnology.10.0906a; Ito K., 1952, Bulletin of the Government Forest Experiment Station = Ringyo Shikenjo kenkyu hokoku, P79; Kaneko Y, 2005, INT ARCH ALLERGY IMM, V136, P365, DOI 10.1159/000084256; Kasai M, 1917, J PLANT PROT, V4, P23; Kobayashi T., 1970, Transactions of the Mycological Society of Japan, V11, P57; Koshio K., 2011, Journal of the Japanese Forest Society, V93, P43, DOI 10.4005/jjfs.93.43; Koshio K, 2000, J FOR RES, V5, P77; Magan N., 2001, Fungi as biocontrol agents: progress, problems and potential, P239, DOI 10.1079/9780851993560.0239; Onofri S, 2007, ADV SPACE RES, V40, P1657, DOI 10.1016/j.asr.2007.06.004; PALMER FE, 1990, NEW PHYTOL, V116, P613, DOI 10.1111/j.1469-8137.1990.tb00546.x; Samuels GJ, 1991, MYCOL PAP, V164, P1; Statistic Department Minister's Secretariat Ministry of Agriculture Forestry and Fisheries, 2005, 79 STAT YB MIN AGR F, P378; Sterflinger K, 1998, ANTON LEEUW INT J G, V74, P271, DOI 10.1023/A:1001753131034; SUTTON JC, 1993, ANNU REV PHYTOPATHOL, V31, P473, DOI 10.1146/annurev.py.31.090193.002353; Taira H., 1993, Journal of the Japanese Forestry Society, V75, P377; TANIAI M, 1993, MOL IMMUNOL, V30, P183; TANIGUCHI Y, 1995, ALLERGY, V50, P90, DOI 10.1111/j.1398-9995.1995.tb02489.x; TODA R, 1974, New Zealand Journal of Forestry Science, V4, P410; Tsubomura M, 2008, COMB P INT PLANT PRO, V58, P421; Tsuneda A, 2004, MYCOLOGIA, V96, P1128, DOI 10.2307/3762094; Ueuma H, 2009, J FOREST RES-JPN, V14, P123, DOI 10.1007/s10310-009-0114-z; YASUEDA H, 1983, J ALLERGY CLIN IMMUN, V71, P77, DOI 10.1016/0091-6749(83)90550-X	43	5	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e62875	10.1371/journal.pone.0062875	http://dx.doi.org/10.1371/journal.pone.0062875			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667533	Green Submitted, gold, Green Published			2022-12-27	WOS:000319654700072
J	Hu, RZ; Wallace, J; Dahlem, TJ; Grunwald, DJ; O'Connell, RM				Hu, Ruozhen; Wallace, Jared; Dahlem, Timothy J.; Grunwald, David Jonah; O'Connell, Ryan M.			Targeting Human MicroRNA Genes Using Engineered Tal-Effector Nucleases (TALENs)	PLOS ONE			English	Article							SYSTEM; EXPRESSION; ROLES	MicroRNAs (miRNAs) have quickly emerged as important regulators of mammalian physiology owing to their precise control over the expression of critical protein coding genes. Despite significant progress in our understanding of how miRNAs function in mice, there remains a fundamental need to be able to target and edit miRNA genes in the human genome. Here, we report a novel approach to disrupting human miRNA genes ex vivo using engineered TAL-effector (TALE) proteins to function as nucleases (TALENs) that specifically target and disrupt human miRNA genes. We demonstrate that functional TALEN pairs can be designed to enable disruption of miRNA seed regions, or removal of entire hairpin sequences, and use this approach to successfully target several physiologically relevant human miRNAs including miR-155*, miR-155, miR-146a and miR-125b. This technology will allow for a substantially improved capacity to study the regulation and function of miRNAs in human cells, and could be developed into a strategic means by which miRNAs can be targeted therapeutically during human disease.	[Hu, Ruozhen; Wallace, Jared; O'Connell, Ryan M.] Univ Utah, Dept Pathol, Salt Lake City, UT 84112 USA; [Dahlem, Timothy J.; Grunwald, David Jonah] Univ Utah, Dept Human Genet, Salt Lake City, UT USA	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	O'Connell, RM (corresponding author), Univ Utah, Dept Pathol, Salt Lake City, UT 84112 USA.	ryan.oconnell@path.utah.edu			University of Utah Research Foundation; National Institutes of Health [1R21HD073847-01]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R21HD073847] Funding Source: NIH RePORTER	University of Utah Research Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by the University of Utah Research Foundation (R.M.O. and D.J.G.) and National Institutes of Health 1R21HD073847-01 (D.J.G.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bedell VM, 2012, NATURE, V491, P114, DOI 10.1038/nature11537; Bogdanove AJ, 2011, SCIENCE, V333, P1843, DOI 10.1126/science.1204094; Cermak T, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr218; Dahlem TJ, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002861; Doyon Y, 2011, NAT METHODS, V8, P74, DOI 10.1038/NMETH.1539; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Filipowicz W, 2011, PROG DRUG RES, V67, P221, DOI 10.1007/978-3-7643-8989-5_11; Holkers M, 2012, NUCL ACIDS RES; Hu RZ, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4131; Jazdzewski K, 2008, P NATL ACAD SCI USA, V105, P7269, DOI 10.1073/pnas.0802682105; Mallanna SK, 2010, DEV BIOL, V344, P16, DOI 10.1016/j.ydbio.2010.05.014; Meza-Sosa KF, 2012, J NEUROSCI RES, V90, P1, DOI 10.1002/jnr.22701; Miller JC, 2011, NAT BIOTECHNOL, V29, P143, DOI 10.1038/nbt.1755; O'Connell RM, 2010, NAT REV IMMUNOL, V10, P111, DOI 10.1038/nri2708; Ono K, 2011, FEBS J, V278, P1619, DOI 10.1111/j.1742-4658.2011.08090.x; Paraboschi EM, 2011, INT J MOL SCI, V12, P8695, DOI 10.3390/ijms12128695; Szczepek M, 2007, NAT BIOTECHNOL, V25, P786, DOI 10.1038/nbt1317	17	27	31	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e63074	10.1371/journal.pone.0063074	http://dx.doi.org/10.1371/journal.pone.0063074			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667577	Green Published, gold			2022-12-27	WOS:000319654700109
J	Klimova, L; Lachova, J; Machon, O; Sedlacek, R; Kozmik, Z				Klimova, Lucie; Lachova, Jitka; Machon, Ondrej; Sedlacek, Radislav; Kozmik, Zbynek			Generation of mRx-Cre Transgenic Mouse Line for Efficient Conditional Gene Deletion in Early Retinal Progenitors	PLOS ONE			English	Article							HOMEOBOX GENE; EYE DEVELOPMENT; EXPRESSION; MORPHOGENESIS; MUTATIONS; LENS; PAX6; TOOL; RAX	During mouse eye development, all retinal cell types are generated from the population of retina-committed progenitors originating from the neuroepithelium of the optic vesicle. Conditional gene inactivation provides an efficient tool for studying the genetic basis of the developing retina; however, the number of retina-specific Cre lines is limited. Here we report generation of the mRx-Cre BAC transgenic mouse line in which the expression of Cre recombinase is controlled by regulatory sequences of the mouse Rx gene, one of the earliest determinants of retinal development. When mRx-Cre transgenic mice were crossbred with the ROSA26R or ROSA26R-EYFP reporter lines, the Cre activity was observed in the optic sulcus from embryonic day 8.5 onwards and later in all progenitors residing in the neuroepithelium of the optic cup. Our results suggest that mRx-Cre provides a unique tool for functional genetic studies in very early stages of retinal development. Moreover, since eye organogenesis is dependent on the inductive signals between the optic vesicle and head surface ectoderm, the inductive ability of the optic vesicle can be analyzed using mRx-Cre transgenic mice.	[Klimova, Lucie; Lachova, Jitka; Machon, Ondrej; Sedlacek, Radislav; Kozmik, Zbynek] Acad Sci Czech Republ, Inst Mol Genet, Prague, Czech Republic; [Klimova, Lucie] Charles Univ Prague, Dept Genet & Microbiol, Fac Sci, Prague, Czech Republic	Czech Academy of Sciences; Institute of Molecular Genetics of the Czech Academy of Sciences; Charles University Prague	Kozmik, Z (corresponding author), Acad Sci Czech Republ, Inst Mol Genet, Prague, Czech Republic.	kozmik@img.cas.cz	Sedlacek, Radislav/G-4408-2014; Kozmik, Zbynek/G-3581-2014; Machon, Ondrej/G-3587-2014; Kozmik, Zbynek/I-8807-2014	Kozmik, Zbynek/0000-0002-5850-2105	Grant Agency of the Czech Republic [P305/11/2198]; Grant Agency of Charles University in Prague [GAUK 43-251054]; Czech Ministry of Education Grant [LK11214, LM2011032]; GACR [P305/10/2143]; Operational Program Research and Development for Innovations by Ministry of School and Education, Czech Republic [CZ.1.05/1.1.00/02.0109]	Grant Agency of the Czech Republic(Grant Agency of the Czech Republic); Grant Agency of Charles University in Prague; Czech Ministry of Education Grant; GACR(Grant Agency of the Czech Republic); Operational Program Research and Development for Innovations by Ministry of School and Education, Czech Republic	This study was supported by the Grant Agency of the Czech Republic (P305/11/2198), Grant Agency of Charles University in Prague (GAUK 43-251054), Czech Ministry of Education Grant LK11214, by LM2011032 and CZ.1.05/1.1.00/02.0109 (Operational Program Research and Development for Innovations by Ministry of School and Education, Czech Republic), and by GACR (P305/10/2143) to RS, and by IMG institutional support RVO68378050. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailey TJ, 2004, INT J DEV BIOL, V48, P761, DOI 10.1387/ijdb.041878tb; Casarosa S, 1997, MECH DEVELOP, V61, P187, DOI 10.1016/S0925-4773(96)00640-5; Chow RL, 2001, ANNU REV CELL DEV BI, V17, P255, DOI 10.1146/annurev.cellbio.17.1.255; Fuhrmann S, 2010, CURR TOP DEV BIOL, V93, P61, DOI [10.1016/B978-0-12-385044-7.00003-5, 10.1016/S0070-2153(10)93003-2]; Furukawa T, 1997, P NATL ACAD SCI USA, V94, P3088, DOI 10.1073/pnas.94.7.3088; Furuta Y, 2000, GENESIS, V26, P130, DOI 10.1002/(SICI)1526-968X(200002)26:2<130::AID-GENE9>3.0.CO;2-I; Graw J, 2010, CURR TOP DEV BIOL, V90, P343, DOI 10.1016/S0070-2153(10)90010-0; GU H, 1994, SCIENCE, V265, P103, DOI 10.1126/science.8016642; HILL RE, 1991, NATURE, V354, P522, DOI 10.1038/354522a0; HOGAN BLM, 1986, J EMBRYOL EXP MORPH, V97, P95; Kreslova J, 2007, GENESIS, V45, P157, DOI 10.1002/dvg.20277; Lakowski J, 2007, DEV BIOL, V307, P498, DOI 10.1016/j.ydbio.2007.04.015; Lee EC, 2001, GENOMICS, V73, P56, DOI 10.1006/geno.2000.6451; Loosli F, 2003, EMBO REP, V4, P894, DOI 10.1038/sj.embor.embor919; Loosli F, 2001, DEVELOPMENT, V128, P4035; Marquardt T, 2001, CELL, V105, P43, DOI 10.1016/S0092-8674(01)00295-1; Mathers PH, 1997, NATURE, V387, P603, DOI 10.1038/42475; Rowan S, 2004, DEV BIOL, V271, P388, DOI 10.1016/j.ydbio.2004.03.039; Sato S, 2007, GENESIS, V45, P502, DOI 10.1002/dvg.20318; Shaham O, 2012, PROG RETIN EYE RES, V31, P351, DOI 10.1016/j.preteyeres.2012.04.002; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Swindell EC, 2006, GENESIS, V44, P361, DOI 10.1002/dvg.20225; Voronina VA, 2004, HUM MOL GENET, V13, P315, DOI 10.1093/hmg/ddh025	24	26	26	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e63029	10.1371/journal.pone.0063029	http://dx.doi.org/10.1371/journal.pone.0063029			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667567	gold, Green Submitted, Green Published			2022-12-27	WOS:000319654700099
J	Monteiro, DCF; Kamdoum, WVP; Paci, E				Monteiro, Diana C. F.; Kamdoum, Wilfride V. Petnga; Paci, Emanuele			Growth Kinetics of Bacterial Pili from Pairwise Pilin Association Rates	PLOS ONE			English	Article							DONOR-STRAND EXCHANGE; SUBUNIT SPECIFICITY; MOLECULAR-DYNAMICS; FIMBRIAE; ADHESIN	Bacterial pilogenesis is a remarkable example of biological non-templated self-assembly where a small number of different building blocks are arranged in a specific order resulting in a macroscopic hair-like fiber containing up to thousands copies of protein subunits. A number of advanced experimental techniques have been used to understand pilus growth. While details such as the conformation of the protein building blocks before and after the elementary polymerization step have enhanced our understanding of this mechanism, such information does not explain the high efficiency of this growth process. In this study, we focused on the growth of the Escherichia coli P-pilus, which is formed by the assembly of six subunits, structurally similar incomplete Ig-like domains. These subunits undergo polymerization through fold complementation by the donation of a beta-sheet strand in a specific conserved order. All pairwise rates of association of the individual subunits with the corresponding beta-sheet donor strand peptides have been previously determined through non-covalent mass-spectrometry. Here we use computational simulations to determine donor-strand exchange rates and subunit concentrations necessary to warrant the growth of pili showing similar lengths and subunit orders to those observed in vivo. Our findings confirm that additional factors must be involved in the modulation of the donor-strand exchange rate and/or pilin subunit concentration at the usher must be important for the precise ordering and rapid polymerization rates observed in vivo.	[Monteiro, Diana C. F.; Kamdoum, Wilfride V. Petnga; Paci, Emanuele] Univ Leeds, Astbury Ctr Struct Mol Biol, Leeds, W Yorkshire, England	University of Leeds	Paci, E (corresponding author), Univ Leeds, Astbury Ctr Struct Mol Biol, Leeds, W Yorkshire, England.	e.paci@leeds.ac.uk	Paci, Emanuele/B-1893-2010; Monteiro, Diana/G-1834-2011	Paci, Emanuele/0000-0002-4891-2768; Monteiro, Diana/0000-0002-6318-7306	Wellcome Trust [096686/Z/11/Z]	Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by a Wellcome Trust PhD studentship (to DCFM) [096686/Z/11/Z]. http://www.wellcome.ac.uk/The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Anderson GG, 2008, CURR TOP MICROBIOL, V322, P85; Barnhart MM, 2003, J BACTERIOL, V185, P2723, DOI 10.1128/JB.185.9.2723-2730.2003; BULLITT E, 1995, NATURE, V373, P164, DOI 10.1038/373164a0; Choudhury D, 1999, SCIENCE, V285, P1061, DOI 10.1126/science.285.5430.1061; DODSON KW, 1993, P NATL ACAD SCI USA, V90, P3670, DOI 10.1073/pnas.90.8.3670; Duncan MJ, 2005, J BIOL CHEM, V280, P37707, DOI 10.1074/jbc.M501249200; EDEN CS, 1978, INFECT IMMUN, V21, P229; JACOBDUBUISSON F, 1994, J BIOL CHEM, V269, P12447; JACOBDUBUISSON F, 1993, EMBO J, V12, P837, DOI 10.1002/j.1460-2075.1993.tb05724.x; Jass J, 2004, BIOPHYS J, V87, P4271, DOI 10.1529/biophysj.104.044867; Lee YM, 2007, J BACTERIOL, V189, P5276, DOI 10.1128/JB.01648-06; Leney AC, 2011, J AM SOC MASS SPECTR, V22, P1214, DOI 10.1007/s13361-011-0146-4; Morrissey B, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.015289; Nishiyama M, 2008, SCIENCE, V320, P376, DOI 10.1126/science.1154994; Phan G, 2011, NATURE, V474, P49, DOI 10.1038/nature10109; Remaut H, 2006, MOL CELL, V22, P831, DOI 10.1016/j.molcel.2006.05.033; ROBERTS JA, 1994, P NATL ACAD SCI USA, V91, P11889, DOI 10.1073/pnas.91.25.11889; Rose RJ, 2008, P NATL ACAD SCI USA, V105, P12873, DOI 10.1073/pnas.0802177105; Rose RJ, 2008, J MOL BIOL, V375, P908, DOI 10.1016/j.jmb.2007.10.077; Sauer FG, 1999, SCIENCE, V285, P1058, DOI 10.1126/science.285.5430.1058; Saulino ET, 1998, EMBO J, V17, P2177, DOI 10.1093/emboj/17.8.2177; Verger D, 2008, STRUCTURE, V16, P1724, DOI 10.1016/j.str.2008.08.012; Vitagliano L, 2007, J MOL BIOL, V367, P935, DOI 10.1016/j.jmb.2007.01.034; Vitagliano L, 2009, J PEPT SCI, V15, P192, DOI 10.1002/psc.1084; Waksman G, 2009, NAT REV MICROBIOL, V7, P765, DOI 10.1038/nrmicro2220	25	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e63065	10.1371/journal.pone.0063065	http://dx.doi.org/10.1371/journal.pone.0063065			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667575	Green Published, Green Submitted, gold			2022-12-27	WOS:000319654700107
J	Moodley, D; Reddy, L; Mahungo, W; Masha, R				Moodley, Dhayendre; Reddy, Leanne; Mahungo, Wisani; Masha, Rebotile			Factors Associated with Coverage of Cotrimoxazole Prophylaxis in HIV-Exposed Children in South Africa	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; RANDOMIZED CONTROLLED-TRIAL; PMTCT PROGRAM; DOUBLE-BLIND; TRANSMISSION; COHORT; PREVENTION; NEVIRAPINE; INFECTION; EFFICACY	Background: The World Health Organisation and the Joint United Nations Programme in 2006 reaffirmed the earlier recommendation of 2000 that all HIV-exposed infants in resource-poor countries should commence cotrimoxazole (CTX) prophylaxis at 6-weeks of life. CTX prophylaxis should be continued until the child is confirmed HIV-uninfected and there is no further exposure to breastmilk transmission. We determined CTX coverage and explored factors associated with CTX administration in HIV-exposed infants at a primary health clinic in South Africa. Methods: In a cross-sectional study of HIV-exposed infants 6-18 months of age attending a child immunisation clinic, data from the current visit and previous visits related to CTX prophylaxis, feeding practice and infant HIV testing were extracted from the child's immunisation record. Further information related to the administration of CTX prophylaxis was obtained from an interview with the child's mother. Results: One-third (33.0%) HIV-exposed infants had not initiated CTX at all and breastfed infants were more likely to have commenced CTX prophylaxis as compared to their non-breastfed counterparts (78.7% vs 63.4%) (p = 0.008). Availability of infant's HIV status was strongly associated with continuation or discontinuation of CTX after 6 months of age or after breastfeeding cessation. Maternal self-reports indicated that only 52.5% (95%CI 47.5-57.5) understood the reason for CTX prophylaxis, 126 (47%) did not dose during weekends; 55 (21%) dosed their infants 3 times a day and 70 (26%) dosed their infants twice daily. Conclusion: A third of HIV-exposed children attending a primary health care facility in this South African setting did not receive CTX prophylaxis. Not commencing CTX prophylaxis was strongly associated with infants not breastfeeding and unnecessary continued exposure to CTX in this paediatric population was due to limited availability of early infant diagnosis. Attendance at immunization clinics can be seen as missed opportunities for early infant diagnosis of HIV and related care.	[Moodley, Dhayendre; Reddy, Leanne; Mahungo, Wisani; Masha, Rebotile] Univ KwaZulu Natal, Nelson R Mandela Sch Med, Dept Obstet & Gynaecol, Womens Hlth & HIV Res Unit, Durban, South Africa	University of Kwazulu Natal	Moodley, D (corresponding author), Univ KwaZulu Natal, Nelson R Mandela Sch Med, Dept Obstet & Gynaecol, Womens Hlth & HIV Res Unit, Durban, South Africa.	moodleyd1@ukzn.ac.za	Moodley, Dhayendre/U-6802-2019					[Anonymous], 2009, HIV INF FEED REV PRI; Bobat R, 1996, PEDIATR INFECT DIS J, V15, P604, DOI 10.1097/00006454-199607000-00009; Chintu C, 2004, LANCET, V364, P1865, DOI 10.1016/S0140-6736(04)17442-4; Coovadia HM, 2012, LANCET, V379, P221, DOI 10.1016/S0140-6736(11)61653-X; Coutsoudis A, 2001, AIDS, V15, P379, DOI 10.1097/00002030-200102160-00011; Department of Health, 2010, NAT ANT SENT HIV SYP; Doherty T, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-406; Gill CJ, 2008, B WORLD HEALTH ORGAN, V86, P929, DOI 10.2471/BLT.07.049668; Goga A, 2011, ROM IT 6 INT AIDS SO; Graham SM, 2002, LANCET, V360, P1966, DOI 10.1016/S0140-6736(02)11921-0; Horwood C, 2010, TROP MED INT HEALTH, V15, P992, DOI 10.1111/j.1365-3156.2010.02576.x; le Roux DM, 2011, PEDIATR INFECT DIS J, V30, P904, DOI 10.1097/INF.0b013e318220a68b; Moodley D, 2003, J INFECT DIS, V187, P725, DOI 10.1086/367898; National Department of Health, 2010, CLIN GUID PREV MOTH; National Department of Health, 2011, S AFR J CLIN NUTR, V24, P214; National Department of Health, 2008, POL GUID IMPL PMTCT; Taha TE, 2011, CLIN INFECT DIS, V53, P388, DOI 10.1093/cid/cir413; *UNAIDS UNICEF WHO, 2007, CHILDR AIDS STOCKT R; UNAIDS UNICEF WHO, 2010, 5 UNAIDS UNICEF WHO; WHO/UNAIDS/UNICEF, 2004, JOINT WHO UNAIDS UNI; Wiktor SZ, 1999, LANCET, V353, P1469, DOI 10.1016/S0140-6736(99)03465-0; World Health Organisation Joint United Nations Programme on HIV/AIDS and United Nations Children Fund, 2010, UN ACC SCAL PRIOR HI, P88; World Health Organization, 2021, ANT DRUGS TREAT PREG	23	8	8	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e63273	10.1371/journal.pone.0063273	http://dx.doi.org/10.1371/journal.pone.0063273			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667599	gold, Green Published, Green Submitted			2022-12-27	WOS:000319654700129
J	Nassuato, C; Boender, GJ; Eble, PL; Alborali, L; Bellini, S; Hagenaars, TJ				Nassuato, Claudia; Boender, Gert Jan; Eble, Phaedra L.; Alborali, Loris; Bellini, Silvia; Hagenaars, Thomas J.			Spatial Transmission of Swine Vesicular Disease Virus in the 2006-2007 Epidemic in Lombardy	PLOS ONE			English	Article								In 2006 and 2007 pig farming in the region of Lombardy, in the north of Italy, was struck by an epidemic of Swine Vesicular Disease virus (SVDV). In fact this epidemic could be viewed as consisting of two sub-epidemics, as the reported outbreaks occurred in two separate time periods. These periods differed in terms of the provinces or municipalities that were affected and also in terms of the timing of implementation of movement restrictions. Here we use a simple mathematical model to analyse the epidemic data, quantifying between-farm transmission probability as a function of between-farm distance. The results show that the distance dependence of between-farm transmission differs between the two periods. In the first period transmission over relatively long distances occurred with higher probability than in the second period, reflecting the effect of movement restrictions in the second period. In the second period however, more intensive transmission occurred over relatively short distances. Our model analysis explains this in terms of the relatively high density of pig farms in the area most affected in this period, which exceeds a critical farm density for between-farm transmission. This latter result supports the rationale for the additional control measure taken in 2007 of pre-emptively culling farms in that area.	[Nassuato, Claudia; Alborali, Loris; Bellini, Silvia] IZSLER, Brescia, Italy; [Boender, Gert Jan; Eble, Phaedra L.; Hagenaars, Thomas J.] Cent Vet Inst Wageningen UR CVI, Lelystad, Netherlands	IZS Lombardia e Emilia; Wageningen University & Research	Hagenaars, TJ (corresponding author), Cent Vet Inst Wageningen UR CVI, Lelystad, Netherlands.	thomas.hagenaars@wur.nl	; Alborali, Giovanni Loris/J-2174-2018	Eble, Phaedra/0000-0003-0229-4068; Alborali, Giovanni Loris/0000-0002-4693-6395	EU Network of Excellence, EPIZONE [FOOD - CT 2006-016236]; Dutch Ministry of Economic Affairs [WOT-01-003-011, KB-08-006-006]	EU Network of Excellence, EPIZONE; Dutch Ministry of Economic Affairs(Ministry of Economic Affairs, Netherlands)	This work was supported by the EU Network of Excellence, EPIZONE (Contract No. FOOD - CT 2006-016236), and by the Dutch Ministry of Economic Affairs (project codes WOT-01-003-011 and KB-08-006-006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bellini S, 2010, REV SCI TECH OIE, V29, P639, DOI 10.20506/rst.29.3.2006; Boender GJ, 2007, PLOS COMPUT BIOL, V3, P704, DOI 10.1371/journal.pcbi.0030071; Boender GJ, 2010, EPIDEMICS-NETH, V2, P36, DOI 10.1016/j.epidem.2010.03.001; BROCCHI E, 1995, J VIROL METHODS, V52, P155, DOI 10.1016/0166-0934(94)00158-D; de Koeijer AA, 2011, VET RES, V42, DOI 10.1186/1297-9716-42-53; Dorigatti I, 2010, Epidemics, V2, P29, DOI 10.1016/j.epidem.2010.01.002; EFSA Panel on Animal Health and Welfare, 2012, EFSA J, V10, P2631; R Core Team, 2012, R LANG ENV STAT COMP; Wolfram Research Inc., 2010, MATHEMATICA	9	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e62878	10.1371/journal.pone.0062878	http://dx.doi.org/10.1371/journal.pone.0062878			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667534	Green Published, gold, Green Submitted			2022-12-27	WOS:000319654700073
J	Yamaoka, M; Asami, S; Funaki, N; Kimura, S; Liao, YJ; Fukuda, T; Yamashita, M				Yamaoka, Miki; Asami, Shun-suke; Funaki, Nayuta; Kimura, Sho; Liao Yingjie; Fukuda, Takeshi; Yamashita, Makoto			Preparation of Organic Light-Emitting Diode Using Coal Tar Pitch, a Low-Cost Material, for Printable Devices	PLOS ONE			English	Article							GRAPHENE OXIDE; FLUORESCENCE; FRACTIONATION; SPECTROSCOPY; SOLUBILITY; SPECTRA	We have identified coal tar pitch, a very cheap organic material made from coal during the iron-making process, as a source from which could be obtained emissive molecules for organic light-emitting diodes. Coal tar pitch was separated by simple dissolution in organic solvent, and subsequent separation by preparative thin-layer chromatography was used to obtain emissive organic molecules. The retardation factor of preparative thin-layer chromatography played a major role in deciding the emission characteristics of the solution as photoluminescence spectra and emission-excitation matrix spectra could be controlled by modifying the solution preparation method. In addition, the device characteristics could be improved by modifying the solution preparation method. Two rounds of preparative thin-layer chromatography separation could improve the luminance of organic light-emitting diodes with coal tar pitch, indicating that less polar components are favorable for enhancing the luminance and device performance. By appropriate choice of the solvent, the photoluminescence peak wavelength of separated coal tar pitch could be shifted from 429 nm (cyclohexane) to 550 nm (chloroform), and consequently, the optical properties of the coal tar pitch solution could be easily tuned. Hence, the use of such multicomponent materials is advantageous for fine-tuning the net properties at a low cost. Furthermore, an indium tin oxide/poly(3,4-ethylenedioxythiophene): poly(styrenesulfonate)/coal tar pitch/LiF/Al system, in which the emissive layer was formed by spin-coating a tetrahydrofuran solution of coal tar pitch on the substrate, showed a luminance of 176 cd/m(2). In addition, the emission spectrum of coal tar pitch was narrowed after the preparative thin-layer chromatography process by removing the excess emissive molecules.	[Yamaoka, Miki; Funaki, Nayuta; Kimura, Sho; Liao Yingjie; Fukuda, Takeshi] Saitama Univ, Dept Funct Mat Sci, Fac Engn, Saitama 3388570, Japan; [Asami, Shun-suke; Yamashita, Makoto] Chuo Univ, Dept Appl Chem, Fac Sci & Engn, Bunkyo Ku, Tokyo, Japan	Saitama University; Chuo University	Fukuda, T (corresponding author), Saitama Univ, Dept Funct Mat Sci, Fac Engn, Saitama 3388570, Japan.	fukuda@fms.saitama-u.ac.jp; makoto@oec.chem.chuo-u.ac.jp	Liao, Yingjie/L-8678-2013; Yamashita, Makoto/E-4607-2010; Fukuda, Takeshi/G-8647-2011	Yamashita, Makoto/0000-0002-3665-5311; 	Ministry of Education, Culture, Sports, Science, and Technology [23656507]	Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This research was supported by a Grant-in-Aid for Scientific Research (23656507 to M. Yamashita) from Ministry of Education, Culture, Sports, Science, and Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADACHI C, 1988, JPN J APPL PHYS 2, V27, pL269, DOI 10.1143/JJAP.27.L269; Alcaniz-Monge J, 2001, FUEL, V80, P41, DOI 10.1016/S0016-2361(00)00057-0; Bachilo SM, 2002, SCIENCE, V298, P2361, DOI 10.1126/science.1078727; Baldo MA, 1998, NATURE, V395, P151, DOI 10.1038/25954; BURROUGHES JH, 1990, NATURE, V347, P539, DOI 10.1038/347539a0; Chien CT, 2012, ANGEW CHEM INT EDIT, V51, P6662, DOI 10.1002/anie.201200474; Commodo M, 2012, ENERG FUEL, V26, P2191, DOI 10.1021/ef300049g; DRAKE JAG, 1978, FUEL, V57, P663, DOI 10.1016/0016-2361(78)90017-0; Eda G, 2010, ADV MATER, V22, P505, DOI 10.1002/adma.200901996; Englert JM, 2011, NAT CHEM, V3, P279, DOI [10.1038/NCHEM.1010, 10.1038/nchem.1010]; FEI YQ, 1990, FUEL, V69, P261, DOI 10.1016/0016-2361(90)90186-T; Gan ZX, 2011, NANO LETT, V11, P3951, DOI 10.1021/nl202240s; Geim AK, 2007, NAT MATER, V6, P183, DOI 10.1038/nmat1849; Geim AK, 2009, SCIENCE, V324, P1530, DOI 10.1126/science.1158877; Gokus T, 2009, ACS NANO, V3, P3963, DOI 10.1021/nn9012753; GRANDA M, 1990, FUEL, V69, P702, DOI 10.1016/0016-2361(90)90032-L; GRANDA M, 1993, FUEL, V72, P19, DOI 10.1016/0016-2361(93)90370-H; GUILLEN MD, 1992, FUEL, V71, P295, DOI 10.1016/0016-2361(92)90077-2; Hagestuen ED, 1999, TALANTA, V49, P547, DOI 10.1016/S0039-9140(99)00040-5; HEROD AA, 1995, J CHROMATOGR A, V708, P143, DOI 10.1016/0021-9673(95)00356-R; John HS, 1984, FUEL, V63, P1187; KALLMANN H, 1960, J CHEM PHYS, V32, P300, DOI 10.1063/1.1700925; KALLMANN H, 1960, NATURE, V186, P31, DOI 10.1038/186031a0; Lazaro MJ, 1999, FUEL, V78, P795, DOI 10.1016/S0016-2361(98)00201-4; Lee HW, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1545; Lu J, 2009, ACS NANO, V3, P2367, DOI 10.1021/nn900546b; Luo ZT, 2009, APPL PHYS LETT, V94, DOI 10.1063/1.3098358; Mathews JP, 2012, FUEL, V96, P1, DOI 10.1016/j.fuel.2011.11.025; Mei QS, 2010, CHEM COMMUN, V46, P7319, DOI 10.1039/c0cc02374d; Milian M, 2005, RAPID COMMUN MASS SP, V19, P1867, DOI 10.1002/rcm.1997; Patra D, 2003, APPL SPECTROSC REV, V38, P155, DOI 10.1081/ASR-120021166; Subrahmanyam KS, 2010, SOLID STATE COMMUN, V150, P1774, DOI 10.1016/j.ssc.2010.07.017; Sun XM, 2008, NANO RES, V1, P203, DOI 10.1007/s12274-008-8021-8; TANG CW, 1987, APPL PHYS LETT, V51, P913, DOI 10.1063/1.98799; White KL, 1999, IND ENG CHEM RES, V38, P3360, DOI 10.1021/ie990119k; ZANDER M, 1993, FUEL, V72, P1281, DOI 10.1016/0016-2361(93)90126-M	36	6	6	2	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e62903	10.1371/journal.pone.0062903	http://dx.doi.org/10.1371/journal.pone.0062903			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667539	Green Published, Green Submitted			2022-12-27	WOS:000319654700078
J	Chen, C; Wang, JC; Shi, Q; Zhou, W; Zhang, XM; Zhang, J; Tian, C; Gao, C; Dong, XP				Chen, Cao; Wang, Ji-Chun; Shi, Qi; Zhou, Wei; Zhang, Xiao-Mei; Zhang, Jin; Tian, Chan; Gao, Chen; Dong, Xiao-Ping			Analyses of the Survival Time and the Influencing Factors of Chinese Patients with Prion Diseases Based on the Surveillance Data from 2008-2011	PLOS ONE			English	Article							CREUTZFELDT-JAKOB-DISEASE; MEDICAL RISK-FACTORS; POLYMORPHISM; ASSOCIATION; VARIANT; CJD; FREQUENCY; MUTATIONS; DEMENTIA; SPECTRUM	Background: Prion diseases are kinds of progressive, incurable neurodegenerative disorders. So far, survival time of the patients with these diseases in China is unclear. Methods: Based upon the surveillance data from Chinese Creutzfeldt-Jakob disease (CJD) surveillance network from January 2008 to December 2011, a retrospective follow-up survey was performed. The survival times of Chinese patients with prion diseases and the possible influencing factors were analyzed. Results: Median survival time of 121 deceased patients was 7.1 months, while those for sporadic CJD (sCJD), familial CJD (fCJD) and fatal familial insomnia (FFI) cases were 6.1, 3.1 and 8.2 months, respectively. 74.0% of sCJD patients, 100% of fCJD cases and 91.7% FFI cases died within one year. The general socio-demographic factors, abnormalities in clinical examinations, clinical manifestations, and social factors did not significantly influence the survival times of Chinese prion patients. Conclusions: Survival time of Chinese patients with prion diseases was comparable with that of many Western countries, but obviously shorter than that of Japan. Patients with acute onset and rapid progression had significantly short survival times.	[Chen, Cao; Shi, Qi; Zhou, Wei; Zhang, Xiao-Mei; Zhang, Jin; Tian, Chan; Gao, Chen; Dong, Xiao-Ping] Chinese Ctr Dis Control & Prevent, Natl Inst Viral Dis Control & Prevent, State Key Lab Infect Dis Prevent & Control, Beijing, Peoples R China; [Wang, Ji-Chun] Chinese Ctr Dis Control & Prevent, Div Sci & Technol, Beijing, Peoples R China; [Dong, Xiao-Ping] Chinese Acad Sci, Inst Microbiol, Key Lab Pathogen Microbiol & Immunol, Beijing, Peoples R China	Chinese Center for Disease Control & Prevention; National Institute for Viral Disease Control & Prevention, Chinese Center for Disease Control & Prevention; Chinese Center for Disease Control & Prevention; Chinese Academy of Sciences; Institute of Microbiology, CAS	Dong, XP (corresponding author), Chinese Ctr Dis Control & Prevent, Natl Inst Viral Dis Control & Prevent, State Key Lab Infect Dis Prevent & Control, Beijing, Peoples R China.	dongxp238@sina.com	Chen, Cao/CAF-1246-2022	Chen, Cao/0000-0002-5193-9283	China Mega-Project for Infectious Disease [2011ZX10004-101, 2012 ZX10004215]; Young Scholar Scientific Research Foundation of China CDC [2012A102]; State Key Laboratory for Infectious Disease Prevention and Control (SKLID) [2012SKLID102, 2011SKLID211]; Chinese National Natural Science Foundation [81100980, 81101302, 31100117]	China Mega-Project for Infectious Disease; Young Scholar Scientific Research Foundation of China CDC; State Key Laboratory for Infectious Disease Prevention and Control (SKLID); Chinese National Natural Science Foundation(National Natural Science Foundation of China (NSFC))	This work was supported by China Mega-Project for Infectious Disease (2011ZX10004-101, 2012 ZX10004215), Young Scholar Scientific Research Foundation of China CDC (2012A102), State Key Laboratory for Infectious Disease Prevention and Control (SKLID) Development Grant (2012SKLID102, 2011SKLID211) and Chinese National Natural Science Foundation Grant (81100980, 81101302 and 31100117). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahantes JC, 2007, EUR J EPIDEMIOL, V22, P457, DOI 10.1007/s10654-007-9146-x; Almer G, 1999, BRAIN, V122, P5, DOI 10.1093/brain/122.1.5; Bratosiewicz-Wasik J, 2012, PRION, V6, P413, DOI 10.4161/pri.21773; BUDKA H, 1995, BRAIN PATHOL, V5, P459, DOI 10.1111/j.1750-3639.1995.tb00625.x; Collins S, 1999, LANCET, V353, P693, DOI 10.1016/S0140-6736(98)08138-0; Collins SJ, 2006, BRAIN, V129, P2278, DOI 10.1093/brain/awl159; DAVANIPOUR Z, 1985, NEUROLOGY, V35, P1483, DOI 10.1212/WNL.35.10.1483; Finckh U, 2000, ANN NY ACAD SCI, V920, P100; Gao C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024231; Golanska E, 2004, NEUROLOGY, V62, P313, DOI 10.1212/01.WNL.0000103290.74549.DC; HARRIESJONES R, 1988, J NEUROL NEUROSUR PS, V51, P1113, DOI 10.1136/jnnp.51.9.1113; Heinemann U, 2007, BRAIN, V130, P1350, DOI 10.1093/brain/awm063; Jeong BH, 2008, EUR J NEUROL, V15, P846, DOI 10.1111/j.1468-1331.2008.02203.x; KONDO K, 1982, ANN NEUROL, V11, P377, DOI 10.1002/ana.410110410; Kovacs GG, 2005, HUM GENET, V118, P166, DOI 10.1007/s00439-005-0020-1; Kovacs GG, 2002, J NEUROL, V249, P1567, DOI 10.1007/s00415-002-0896-9; Krasnianski A, 2009, NEUROBIOL AGING, V30, P615, DOI 10.1016/j.neurobiolaging.2007.07.014; Li XH, 2005, ANN NEUROL, V58, P858, DOI 10.1002/ana.20646; Lin SH, 2003, CHIN J NEUROIMMUNOL, V10, P4; Lundberg PO, 1998, J NEUROL NEUROSUR PS, V65, P836, DOI 10.1136/jnnp.65.6.836; Mead S, 2001, AM J HUM GENET, V69, P1225, DOI 10.1086/324710; Nagoshi K, 2011, J EPIDEMIOL, V21, P255, DOI 10.2188/jea.JE20100085; Nakamura Y, 2000, J Epidemiol, V10, P399; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Roeber S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002147; van Duijn CM, 1998, LANCET, V351, P1081, DOI 10.1016/S0140-6736(97)09468-3; Vollmert C, 2006, J MED GENET, V43, DOI 10.1136/jmg.2006.040931; WHO, 2003, WHO COMM DIS SURV RE; Wieser HG, 2006, CLIN NEUROPHYSIOL, V117, P935, DOI 10.1016/j.clinph.2005.12.007; Will RG, 2003, BRIT MED BULL, V66, P255, DOI 10.1093/bmb/66.1.255; Will RG, 1996, LANCET, V347, P921, DOI 10.1016/S0140-6736(96)91412-9; WILL RG, 1982, J NEUROL NEUROSUR PS, V45, P235, DOI 10.1136/jnnp.45.3.235; Zerr I, 2000, J CLIN EPIDEMIOL, V53, P747, DOI 10.1016/S0895-4356(99)00207-3; Zerr I, 2009, BRAIN, V231, P10	34	10	16	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2013	8	5							e62553	10.1371/journal.pone.0062553	http://dx.doi.org/10.1371/journal.pone.0062553			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	177QL	23671608	Green Published, Green Submitted, gold			2022-12-27	WOS:000321390200028
J	Funamizu, A; Kanzaki, R; Takahashi, H				Funamizu, Akihiro; Kanzaki, Ryohei; Takahashi, Hirokazu			Pre-Attentive, Context-Specific Representation of Fear Memory in the Auditory Cortex of Rat	PLOS ONE			English	Article							SPECTROTEMPORAL RECEPTIVE-FIELDS; CORTICAL MAP REORGANIZATION; DEPENDENT NEURONAL-ACTIVITY; MEDIAL PREFRONTAL CORTEX; COMBINED TONE; PLASTICITY; NOISE; HIPPOCAMPAL; SENSITIVITY; RESPONSES	Neural representation in the auditory cortex is rapidly modulated by both top-down attention and bottom-up stimulus properties, in order to improve perception in a given context. Learning-induced, pre-attentive, map plasticity has been also studied in the anesthetized cortex; however, little attention has been paid to rapid, context-dependent modulation. We hypothesize that context-specific learning leads to pre-attentively modulated, multiplex representation in the auditory cortex. Here, we investigate map plasticity in the auditory cortices of anesthetized rats conditioned in a context-dependent manner, such that a conditioned stimulus (CS) of a 20-kHz tone and an unconditioned stimulus (US) of a mild electrical shock were associated only under a noisy auditory context, but not in silence. After the conditioning, although no distinct plasticity was found in the tonotopic map, tone-evoked responses were more noise-resistive than pre-conditioning. Yet, the conditioned group showed a reduced spread of activation to each tone with noise, but not with silence, associated with a sharpening of frequency tuning. The encoding accuracy index of neurons showed that conditioning deteriorated the accuracy of tone-frequency representations in noisy condition at off-CS regions, but not at CS regions, suggesting that arbitrary tones around the frequency of the CS were more likely perceived as the CS in a specific context, where CS was associated with US. These results together demonstrate that learning-induced plasticity in the auditory cortex occurs in a context-dependent manner.	[Funamizu, Akihiro] JSPS, Chiyoda Ku, Tokyo, Japan; [Funamizu, Akihiro] Okinawa Inst Sci & Technol, Neural Computat Unit, Okinawa, Japan; [Funamizu, Akihiro; Kanzaki, Ryohei; Takahashi, Hirokazu] Univ Tokyo, Grad Sch Informat Sci & Technol, Bunkyo Ku, Tokyo, Japan; [Kanzaki, Ryohei; Takahashi, Hirokazu] Univ Tokyo, Res Ctr Adv Sci & Technol, Meguro Ku, Tokyo, Japan; [Takahashi, Hirokazu] JST, PRESTO, Kawaguchi, Saitama, Japan	Japan Society for the Promotion of Science; Okinawa Institute of Science & Technology Graduate University; University of Tokyo; University of Tokyo; Japan Science & Technology Agency (JST)	Takahashi, H (corresponding author), Univ Tokyo, Grad Sch Informat Sci & Technol, Bunkyo Ku, Tokyo, Japan.	takahashi@i.u-tokyo.ac.jp	Funamizu, Akihiro/N-1502-2014	Funamizu, Akihiro/0000-0001-8085-1048	KAKENHI [23135507]; SCOPE [121803022]; Grants-in-Aid for Scientific Research [11J08760] Funding Source: KAKEN	KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); SCOPE; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was partially supported by KAKENHI (23135507) and SCOPE (121803022). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABELES M, 1982, J NEUROSCI METH, V5, P317, DOI 10.1016/0165-0270(82)90002-4; Ahrens MB, 2008, J NEUROSCI, V28, P1929, DOI 10.1523/JNEUROSCI.3377-07.2008; Amenedo E, 2000, EUR J NEUROSCI, V12, P2570, DOI 10.1046/j.1460-9568.2000.00114.x; Antunes R, 2010, J NEUROSCI, V30, P9782, DOI 10.1523/JNEUROSCI.1037-10.2010; Atiani S, 2009, NEURON, V61, P467, DOI 10.1016/j.neuron.2008.12.027; Bar-Yosef O, 2007, FRONT COMPUT NEUROSC, V1, DOI [10.3389/neuro.10/003.2007, 10.3389/neuro.10.003.2007]; Berlau KM, 2008, NEUROBIOL LEARN MEM, V89, P153, DOI 10.1016/j.nlm.2007.07.004; Bieszczad KM, 2012, EUR J NEUROSCI, V35, P598, DOI 10.1111/j.1460-9568.2011.07974.x; Binder JR, 2004, NAT NEUROSCI, V7, P295, DOI 10.1038/nn1198; Bishop C. M, 2006, PATTERN RECOGNITION; Blake DT, 2002, J NEUROPHYSIOL, V88, P3409, DOI 10.1152/jn.00233.2002; Blake DT, 2002, P NATL ACAD SCI USA, V99, P10114, DOI 10.1073/pnas.092278099; Brosch M, 2005, J NEUROSCI, V25, P6797, DOI 10.1523/JNEUROSCI.1571-05.2005; Brown M, 2004, CEREB CORTEX, V14, P952, DOI 10.1093/cercor/bhh056; Buonomano DV, 2009, NAT REV NEUROSCI, V10, P113, DOI 10.1038/nrn2558; Burwell RD, 1998, J COMP NEUROL, V398, P179, DOI 10.1002/(SICI)1096-9861(19980824)398:2<179::AID-CNE3>3.0.CO;2-Y; CAMPEAU S, 1995, J NEUROSCI, V15, P2312, DOI 10.1523/JNEUROSCI.15-03-02312.1995; Carandini M, 2012, NAT REV NEUROSCI, V13, P51, DOI 10.1038/nrn3136; Corcoran KA, 2007, J NEUROSCI, V27, P840, DOI 10.1523/JNEUROSCI.5327-06.2007; David SV, 2009, J NEUROSCI, V29, P3374, DOI 10.1523/JNEUROSCI.5249-08.2009; Doron NN, 2002, J COMP NEUROL, V453, P345, DOI 10.1002/cne.10412; Eggermont JJ, 2011, HEARING RES, V271, P123, DOI 10.1016/j.heares.2010.01.014; Ego-Stengel V, 2001, J NEUROPHYSIOL, V86, P422, DOI 10.1152/jn.2001.86.1.422; Ehret G, 2000, HEARING RES, V141, P107, DOI 10.1016/S0378-5955(99)00213-0; Elhilali M, 2004, J NEUROSCI, V24, P1159, DOI 10.1523/JNEUROSCI.3825-03.2004; Ernst SMA, 2010, NEUROIMAGE, V49, P835, DOI 10.1016/j.neuroimage.2009.07.014; Freeman JH, 1996, J NEUROSCI, V16, P1538; Fritz J, 2003, NAT NEUROSCI, V6, P1216, DOI 10.1038/nn1141; Fritz JB, 2007, CURR OPIN NEUROBIOL, V17, P437, DOI 10.1016/j.conb.2007.07.011; Funamizu A, 2011, NEURAL NETWORKS, V24, P321, DOI 10.1016/j.neunet.2010.12.010; Ganguly K, 2011, NAT NEUROSCI, V14, P662, DOI 10.1038/nn.2797; GEISLER CD, 1980, HEARING RES, V3, P317; Gerlai R, 1998, BEHAV BRAIN RES, V95, P191, DOI 10.1016/S0166-4328(97)00144-7; Gilbert CD, 2007, NEURON, V54, P677, DOI 10.1016/j.neuron.2007.05.019; Gourevitch B, 2009, CEREB CORTEX, V19, P1448, DOI 10.1093/cercor/bhn184; Hirata A, 2006, J NEUROSCI, V26, P4426, DOI 10.1523/JNEUROSCI.5298-05.2006; Hirata A, 2010, J NEUROPHYSIOL, V103, P1147, DOI 10.1152/jn.00955.2009; HIRSH R, 1974, BEHAV BIOL, V12, P421, DOI 10.1016/S0091-6773(74)92231-7; Hobin JA, 2003, J NEUROSCI, V23, P8410; Holland PC, 1999, CURR OPIN NEUROBIOL, V9, P195, DOI 10.1016/S0959-4388(99)80027-0; HORIKAWA J, 1988, P JPN ACAD B-PHYS, V64, P260, DOI 10.2183/pjab.64.260; Hwang JH, 2007, AUDIOL NEURO-OTOL, V12, P285, DOI 10.1159/000103209; Itskov PM, 2012, J NEUROPHYSIOL, V107, P1822, DOI 10.1152/jn.00404.2011; Jakkamsetti V, 2012, J NEUROPHYSIOL, V107, P1457, DOI 10.1152/jn.01057.2010; Kalatsky VA, 2005, P NATL ACAD SCI USA, V102, P13325, DOI 10.1073/pnas.0505592102; Kalisch R, 2006, J NEUROSCI, V26, P9503, DOI 10.1523/JNEUROSCI.2021-06.2006; KIANG NYS, 1974, J ACOUST SOC AM, V55, P620, DOI 10.1121/1.1914572; Kilgard MP, 1998, SCIENCE, V279, P1714, DOI 10.1126/science.279.5357.1714; Knudsen EI, 1998, SCIENCE, V279, P1531, DOI 10.1126/science.279.5356.1531; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; Lee CC, 2011, NAT NEUROSCI, V14, P108, DOI 10.1038/nn.2713; Liang K, 2008, NEUROBIOL LEARN MEM, V90, P138, DOI 10.1016/j.nlm.2008.02.006; Ma XF, 2009, J NEUROSCI, V29, P4888, DOI 10.1523/JNEUROSCI.0167-09.2009; Mante V, 2005, NAT NEUROSCI, V8, P1690, DOI 10.1038/nn1556; Maren S, 2007, LEARN MEMORY, V14, P318, DOI 10.1101/lm.477007; Marguet SL, 2011, J NEUROSCI, V31, P6414, DOI 10.1523/JNEUROSCI.5773-10.2011; McDonald RJ, 2007, EXP BRAIN RES, V177, P509, DOI 10.1007/s00221-006-0699-9; Mesgarani N, 2012, NATURE, V485, P233, DOI 10.1038/nature11020; Moita MAP, 2003, NEURON, V37, P485, DOI 10.1016/S0896-6273(03)00033-3; Montague PR, 2004, NATURE, V431, P760, DOI 10.1038/nature03015; Noudoost B, 2011, NATURE, V474, P372, DOI 10.1038/nature09995; O'Reilly RC, 2001, PSYCHOL REV, V108, P311, DOI 10.1037//0033-295X.108.2.311; Ohl FW, 2005, CURR OPIN NEUROBIOL, V15, P470, DOI 10.1016/j.conb.2005.07.002; Ohl FW, 1996, EUR J NEUROSCI, V8, P1001, DOI 10.1111/j.1460-9568.1996.tb01587.x; PHILLIPS DP, 1992, CEREB CORTEX, V2, P134, DOI 10.1093/cercor/2.2.134; PHILLIPS DP, 1986, J ACOUST SOC AM, V80, P177, DOI 10.1121/1.394178; PHILLIPS DP, 1985, HEARING RES, V19, P253, DOI 10.1016/0378-5955(85)90145-5; PHILLIPS DP, 1985, HEARING RES, V18, P87, DOI 10.1016/0378-5955(85)90112-1; PHILLIPS DP, 1990, BEHAV BRAIN RES, V37, P197, DOI 10.1016/0166-4328(90)90132-X; PHILLIPS RG, 1992, BEHAV NEUROSCI, V106, P274, DOI 10.1037/0735-7044.106.2.274; Pienkowski M, 2011, NEUROSCI BIOBEHAV R, V35, P2117, DOI 10.1016/j.neubiorev.2011.02.002; Polley DB, 2007, J NEUROPHYSIOL, V97, P3621, DOI 10.1152/jn.01298.2006; Polley DB, 2006, J NEUROSCI, V26, P4970, DOI 10.1523/JNEUROSCI.3771-05.2006; Quirk GJ, 1997, NEURON, V19, P613, DOI 10.1016/S0896-6273(00)80375-X; Rabinowitz NC, 2011, NEURON, V70, P1178, DOI 10.1016/j.neuron.2011.04.030; RECANZONE GH, 1993, J NEUROSCI, V13, P87; Recanzone GH, 2000, J NEUROPHYSIOL, V83, P2315, DOI 10.1152/jn.2000.83.4.2315; Reed A, 2011, NEURON, V70, P121, DOI 10.1016/j.neuron.2011.02.038; Renvall H, 2012, CEREB CORTEX, V22, P132, DOI 10.1093/cercor/bhr095; Rodgers KM, 2008, CEREB CORTEX, V18, P2941, DOI 10.1093/cercor/bhn054; ROMANSKI LM, 1993, CEREB CORTEX, V3, P515, DOI 10.1093/cercor/3.6.515; ROMANSKI LM, 1992, J NEUROSCI, V12, P4501; Rutkowski RG, 2005, P NATL ACAD SCI USA, V102, P13664, DOI 10.1073/pnas.0506838102; Rutkowski RG, 2003, HEARING RES, V181, P116, DOI 10.1016/S0378-5955(03)00182-5; Sacco T, 2010, SCIENCE, V329, P649, DOI 10.1126/science.1183165; SAKURAI Y, 1994, J NEUROSCI, V14, P2606; Sakurai Y, 1996, J NEUROSCI, V16, P2809; Scheich H, 1998, EUR J NEUROSCI, V10, P803, DOI 10.1046/j.1460-9568.1998.00086.x; Shetake JA, 2011, EUR J NEUROSCI, V34, P1823, DOI 10.1111/j.1460-9568.2011.07887.x; Shulz DE, 2000, NATURE, V403, P549, DOI 10.1038/35000586; Takahashi H, 2011, NEUROSCIENCE, V199, P243, DOI 10.1016/j.neuroscience.2011.09.046; Takahashi H, 2010, BIOSYSTEMS, V101, P37, DOI 10.1016/j.biosystems.2010.04.003; Vertes RP, 2006, NEUROSCIENCE, V142, P1, DOI 10.1016/j.neuroscience.2006.06.027; Wang XQ, 2007, HEARING RES, V229, P81, DOI 10.1016/j.heares.2007.01.019; Weinberger NM, 2004, NAT REV NEUROSCI, V5, P279, DOI 10.1038/nrn1366; Weinberger NM, 2007, LEARN MEMORY, V14, P1, DOI 10.1101/lm.421807; Winer JA, 2006, HEARING RES, V212, P1, DOI 10.1016/j.heares.2005.06.014; Yokota R, 2012, NEUROSCIENCE, V223, P377, DOI 10.1016/j.neuroscience.2012.07.051	99	18	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2013	8	5							e63655	10.1371/journal.pone.0063655	http://dx.doi.org/10.1371/journal.pone.0063655			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	177QL	23671691	Green Submitted, gold, Green Published			2022-12-27	WOS:000321390200056
J	Krishnan, K; Duncan, MJ				Krishnan, Karthik; Duncan, Margaret J.			Role of Sodium in the RprY-Dependent Stress Response in Porphyromonas gingivalis	PLOS ONE			English	Article							BACTEROIDES-FRAGILIS; ESCHERICHIA-COLI; EPITHELIAL-CELLS; OXIDATIVE STRESS; GENE-EXPRESSION; POLYHYDROXYALKANOATES; IDENTIFICATION; PERIODONTITIS; PROTEIN; OPERON	Porphyromonas gingivalis is a Gram-negative oral anaerobe which is strongly associated with periodontal disease. Environmental changes in the gingival sulcus trigger the growth of P. gingivalis and a concurrent shift from periodontal health to disease. Bacteria adjust their physiology in response to environmental changes and gene regulation by two-component phospho-relay systems is one mechanism by which such adjustments are effected. In P. gingivalis RprY is an orphan response regulator and previously we showed that the RprY regulon included genes associated with oxidative stress and sodium metabolism. The goals of the present study were to identify environmental signals that induce rprY and clarify the role of the regulator in the stress response. In Escherichia coli an RprY-LacZ fusion protein was induced in sodium-depleted medium and a P. gingivalis rprY mutant was unable to grow in similar medium. By several approaches we established that sodium depletion induced up-regulation of genes involved in oxidative stress. In addition, we demonstrated that RprY interacted directly with the promoters of several molecular chaperones. Further, both genetic and transcription data suggest that the regulator acts as a repressor. We conclude that RprY is one of the regulators that controls stress responses in P. gingivalis, possibly by acting as a repressor since an rprY mutant showed a superstress reponse in sodium-depleted medium which we propose inhibited growth.	[Krishnan, Karthik; Duncan, Margaret J.] Forsyth Inst, Dept Microbiol, Cambridge, MA USA; [Krishnan, Karthik] Harvard Univ, Sch Dent Med, Dept Oral Med Infect & Immun, Boston, MA 02115 USA	Harvard University; Forsyth Institute; Harvard University; Harvard School of Dental Medicine	Duncan, MJ (corresponding author), Forsyth Inst, Dept Microbiol, Cambridge, MA USA.	mduncan@forsyth.org			National Institutes of Health [R01-DE015931]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE015931] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by National Institutes of Health grant R01-DE015931 (MJD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams SB, 2012, OSTEOARTHR CARTILAGE, V20, P64, DOI 10.1016/j.joca.2011.10.010; An D, 2010, P NATL ACAD SCI U S1, V1, P4666; Ayub ND, 2009, EXTREMOPHILES, V13, P59, DOI 10.1007/s00792-008-0197-z; Bacic MK, 2007, PLASMID, V58, P23, DOI 10.1016/j.plasmid.2006.11.005; Bernhardt TG, 2004, MOL MICROBIOL, V52, P1255, DOI 10.1111/j.1365-2958.2004.04063.x; Bostanci N, 2012, FEMS MICROBIOL LETT, V333, P1, DOI 10.1111/j.1574-6968.2012.02579.x; Colombo AV, 2007, J PERIODONTAL RES, V42, P236, DOI 10.1111/j.1600-0765.2006.00938.x; Deuerling E, 1999, NATURE, V400, P693, DOI 10.1038/23301; Diaz PI, 2006, J BACTERIOL, V188, P2454, DOI 10.1128/JB.188.7.2454-2462.2006; Duran-Pinedo AE, 2007, MOL MICROBIOL, V64, P1061, DOI 10.1111/j.1365-2958.2007.05717.x; FLETCHER HM, 1995, INFECT IMMUN, V63, P1521, DOI 10.1128/IAI.63.4.1521-1528.1995; Gardner RG, 1996, APPL ENVIRON MICROB, V62, P196, DOI 10.1128/AEM.62.1.196-202.1996; Guisbert E, 2008, MICROBIOL MOL BIOL R, V72, P545, DOI 10.1128/MMBR.00007-08; Hase CC, 2001, MICROBIOL MOL BIOL R, V65, P353, DOI 10.1128/MMBR.65.3.353-370.2001; Henry LG, 2012, FUTURE MICROBIOL, V7, P497, DOI [10.2217/FMB.12.17, 10.2217/fmb.12.17]; Hoefer P, 2010, FRONT BIOSCI-LANDMRK, V15, P93, DOI 10.2741/3609; Hoffmann A, 2010, BBA-MOL CELL RES, V1803, P650, DOI 10.1016/j.bbamcr.2010.01.017; Holt SC, 2005, PERIODONTOL 2000, V38, P72, DOI 10.1111/j.1600-0757.2005.00113.x; HORTON RM, 1990, BIOTECHNIQUES, V8, P528; Hosogi Y, 2005, INFECT IMMUN, V73, P2327, DOI 10.1128/IAI.73.4.2327-2335.2005; Kim DY, 2007, J MICROBIOL, V45, P87; Kolenbrander PE, 2010, NAT REV MICROBIOL, V8, P471, DOI 10.1038/nrmicro2381; Lamont RJ, 1998, MICROBIOL MOL BIOL R, V62, P1244, DOI 10.1128/MMBR.62.4.1244-1263.1998; Lawton KA, 2008, PHARMACOGENOMICS, V9, P383, DOI 10.2217/14622416.9.4.383; Lewis JP, 2012, INFECT IMMUN, V80, P3319, DOI 10.1128/IAI.00561-12; Lewis JP, 2009, MICROBIOL-SGM, V155, P3758, DOI 10.1099/mic.0.027953-0; Liaqat I, 2008, CURR MICROBIOL, V57, P340, DOI 10.1007/s00284-008-9200-2; Meuric V, 2010, FUTURE MICROBIOL, V5, P717, DOI 10.2217/FMB.10.32; Miller J.H., 1992, SHORT COURSE BACTERI, P150; Narberhaus F, 1999, MOL MICROBIOL, V31, P1, DOI 10.1046/j.1365-2958.1999.01166.x; Nichols FC, 2004, J LIPID RES, V45, P2317, DOI 10.1194/jlr.M400278-JLR200; Ohara N, 2006, MICROBIOL-SGM, V152, P955, DOI 10.1099/mic.0.28537-0; RASMUSSEN BA, 1993, MOL MICROBIOL, V7, P765, DOI 10.1111/j.1365-2958.1993.tb01167.x; Rudney JD, 2006, ARCH ORAL BIOL, V51, P291, DOI 10.1016/j.archoralbio.2005.09.003; SIMONS RW, 1987, GENE, V53, P85, DOI 10.1016/0378-1119(87)90095-3; SMITH CJ, 1990, PLASMID, V24, P100, DOI 10.1016/0147-619X(90)90012-2; Smyth GK, 2005, BIOINFORMATICS, V21, P2067, DOI 10.1093/bioinformatics/bti270; Smyth GK, 2003, METHODS, V31, P265, DOI 10.1016/S1046-2023(03)00155-5; Spence C, 2006, J BACTERIOL, V188, P4663, DOI 10.1128/JB.00125-06; Sund CJ, 2008, MOL MICROBIOL, V67, P129, DOI 10.1111/j.1365-2958.2007.06031.x; Thorgersen MP, 2009, MICROBIOL-SGM, V155, P295, DOI 10.1099/mic.0.020727-0; Tomoyasu T, 1998, MOL MICROBIOL, V30, P567, DOI 10.1046/j.1365-2958.1998.01090.x; Ximenez-Fyvie LA, 2000, J CLIN PERIODONTOL, V27, P648, DOI 10.1034/j.1600-051x.2000.027009648.x; Yanamandra SS, 2012, MOL ORAL MICROBIOL, V27, P202, DOI 10.1111/j.2041-1014.2012.00643.x; ZUBER U, 1994, J BACTERIOL, V176, P1359, DOI 10.1128/jb.176.5.1359-1363.1994	45	12	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2013	8	5							e63180	10.1371/journal.pone.0063180	http://dx.doi.org/10.1371/journal.pone.0063180			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	177QL	23671672	gold, Green Published, Green Submitted			2022-12-27	WOS:000321390200045
J	Lu, YH; Soong, TD; Elemento, O				Lu, Yuheng; Soong, T. David; Elemento, Olivier			A Novel Approach for Characterizing Microsatellite Instability in Cancer Cells	PLOS ONE			English	Article							DNA MISMATCH REPAIR; PROSTATE-CANCER; COLORECTAL-CANCER; GENE-EXPRESSION; TRANSCRIPTOME; MUTATIONS; LINES; MECHANISMS; LEUKEMIA; DEFECTS	Microsatellite instability (MSI) is characterized by the expansion or contraction of DNA repeat tracts as a consequence of DNA mismatch repair deficiency (MMRD). Accurate detection of MSI in cancer cells is important since MSI is associated with several cancer subtypes and can help inform therapeutic decisions. Although experimental assays have been developed to detect MSI, they typically depend on a small number of known microsatellite loci or mismatch repair genes and have limited reliability. Here, we report a novel genome-wide approach for MSI detection based on the global detection of insertions and deletions (indels) in microsatellites found in expressed genes. Our large-scale analyses of 20 cancer cell lines and 123 normal individuals revealed striking indel features associated with MSI: there is a significant increase of short microsatellite deletions in MSI samples compared to microsatellite stable (MSS) ones, suggesting a mechanistic bias of repair efficiency between insertions and deletions in normal human cells. By incorporating this observation into our MSI scoring metric, we show that our approach can correctly distinguish between MSI and MSS cancer cell lines. Moreover, when we applied this approach to primal tumor samples, our metric is also well consistent with diagnosed MSI status. Thus, our study offers new insight into DNA mismatch repair system, and also provides a novel MSI diagnosis method for clinical oncology with better reliability.	[Lu, Yuheng; Soong, T. David; Elemento, Olivier] Cornell Univ, Dept Physiol & Biophys, Weill Cornell Med Coll, New York, NY 10021 USA; [Soong, T. David; Elemento, Olivier] Cornell Univ, Inst Computat Biomed, Weill Cornell Med Coll, New York, NY 10021 USA	Cornell University; Cornell University	Elemento, O (corresponding author), Cornell Univ, Dept Physiol & Biophys, Weill Cornell Med Coll, New York, NY 10021 USA.	ole2001@med.cornell.edu			National Science Foundation (NSF) [1054964]; Direct For Biological Sciences [1054964] Funding Source: National Science Foundation	National Science Foundation (NSF)(National Science Foundation (NSF)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	OE would like to acknowledge receipt of National Science Foundation (NSF) Career Grant 1054964. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albers CA, 2011, GENOME RES, V21, P961, DOI 10.1101/gr.112326.110; Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; Berger MF, 2010, GENOME RES, V20, P413, DOI 10.1101/gr.103697.109; Boland CR, 1998, CANCER RES, V58, P5248; BOYER JC, 1995, CANCER RES, V55, P6063; Chen Y, 2001, CANCER RES, V61, P4112; de la Chapelle A, 2003, NEW ENGL J MED, V349, P209, DOI 10.1056/NEJMp038099; Dietmaier W, 1997, CANCER RES, V57, P4749; Edgren H, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-1-r6; Faulkner RD, 2004, BRIT J HAEMATOL, V124, P160, DOI 10.1046/j.1365-2141.2003.04750.x; Griffith M, 2010, NAT METHODS, V7, P843, DOI [10.1038/NMETH.1503, 10.1038/nmeth.1503]; Jiang YW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040332; Koeppel M, 2011, NUCLEIC ACIDS RES, V39, P6069, DOI 10.1093/nar/gkr028; Laghi L, 2012, CLIN CANCER RES, V18, P3142, DOI 10.1158/1078-0432.CCR-12-0175; Lee S, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkq1015; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Matheson EC, 2003, CARCINOGENESIS, V24, P31, DOI 10.1093/carcin/24.1.31; Montgomery SB, 2010, NATURE, V464, P773, DOI 10.1038/nature08903; Pickrell JK, 2010, NATURE, V464, P768, DOI 10.1038/nature08872; Prensner JR, 2011, NAT BIOTECHNOL, V29, P742, DOI 10.1038/nbt.1914; Rajadhyaksha AM, 2010, AM J HUM GENET, V87, P643, DOI 10.1016/j.ajhg.2010.10.013; Sam LT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017305; Seitz S, 2003, GENE CHROMOSOME CANC, V37, P29, DOI 10.1002/gcc.10196; Seshagiri S, 2012, NATURE, V488, P660, DOI 10.1038/nature11282; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Sia EA, 1997, MOL CELL BIOL, V17, P2851, DOI 10.1128/MCB.17.5.2851; Sinicrope FA, 2012, CLIN CANCER RES, V18, P1506, DOI 10.1158/1078-0432.CCR-11-1469; Sun XD, 2006, PROSTATE, V66, P660, DOI 10.1002/pros.20390; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; van der Heijden MS, 2006, BMC GENET, V7, DOI 10.1186/1471-2156-7-3; Verstrepen KJ, 2005, NAT GENET, V37, P986, DOI 10.1038/ng1618; Wacker SA, 2012, NAT CHEM BIOL, V8, P235, DOI [10.1038/NCHEMBIO.779, 10.1038/nchembio.779]; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Yeh CC, 2001, BIOCHEM BIOPH RES CO, V285, P409, DOI 10.1006/bbrc.2001.5187	34	35	39	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2013	8	5							e63056	10.1371/journal.pone.0063056	http://dx.doi.org/10.1371/journal.pone.0063056			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	177QL	23671654	Green Published, gold, Green Submitted			2022-12-27	WOS:000321390200041
J	Nolte, A; Funk, NW; Mukunda, L; Gawalek, P; Werckenthin, A; Hansson, BS; Wicher, D; Stengl, M				Nolte, Andreas; Funk, Nico W.; Mukunda, Latha; Gawalek, Petra; Werckenthin, Achim; Hansson, Bill S.; Wicher, Dieter; Stengl, Monika			In situ Tip-Recordings Found No Evidence for an Orco-Based Ionotropic Mechanism of Pheromone-Transduction in Manduca sexta	PLOS ONE			English	Article							DROSOPHILA ODORANT RECEPTORS; SENSITIVE TRICHOID SENSILLA; OLFACTORY RECEPTOR; MEMBRANE TOPOLOGY; EXPRESSION; IDENTIFICATION; PROTEINS; NEURONS; FAMILY; MOTH	The mechanisms of insect odor transduction are still controversial. Insect odorant receptors (ORs) are 7TM receptors with inverted membrane topology. They colocalize with a conserved coreceptor (Orco) with chaperone and ion channel function. Some studies suggest that insects employ exclusively ionotropic odor transduction via OR-Orco heteromers. Other studies provide evidence for different metabotropic odor transduction cascades, which employ second messenger-gated ion channel families for odor transduction. The hawkmoth Manduca sexta is an established model organism for studies of insect olfaction, also due to the availability of the hawkmoth-specific pheromone blend with its main component bombykal. Previous patch-clamp studies on primary cell cultures of M. sexta olfactory receptor neurons provided evidence for a pheromone-dependent activation of a phospholipase C beta. Pheromone application elicited a sequence of one rapid, apparently IP3-dependent, transient and two slower Ca2+-dependent inward currents. It remains unknown whether additionally an ionotropic pheromone-transduction mechanism is employed. If indeed an OR-Orco ion channel complex underlies an ionotropic mechanism, then Orco agonist-dependent opening of the OR-Orco channel pore should add up to pheromone-dependent opening of the pore. Here, in tip-recordings from intact pheromone-sensitive sensilla, perfusion with the Orco agonist VUAA1 did not increase pheromone-responses within the first 1000 ms. However, VUAA1 increased spontaneous activity of olfactory receptor neurons Zeitgebertime-and dose-dependently. We conclude that we find no evidence for an Orco-dependent ionotropic pheromone transduction cascade in M. sexta. Instead, in M. sexta Orco appears to be a slower, second messenger-dependent pacemaker channel which affects kinetics and threshold of pheromone-detection via changes of intracellular Ca2+ baseline concentrations.	[Nolte, Andreas; Funk, Nico W.; Gawalek, Petra; Werckenthin, Achim] Univ Kassel, Dept Anim Physiol, D-34125 Kassel, Germany; [Mukunda, Latha; Hansson, Bill S.; Wicher, Dieter; Stengl, Monika] Max Planck Inst Chem Ecol, Dept Evolutionary Neuroethol, Jena, Germany	Universitat Kassel; Max Planck Society	Stengl, M (corresponding author), Max Planck Inst Chem Ecol, Dept Evolutionary Neuroethol, Jena, Germany.	stengl@uni-kassel.de	Hansson, Bill S/G-2774-2013	Hansson, Bill S/0000-0002-4811-1223	Max Planck Society; DFG [STE 531/20-1, STE 531/20-2, HA 5871/2-1, WI 1422/3-2]	Max Planck Society(Max Planck SocietyFoundation CELLEX); DFG(German Research Foundation (DFG))	This study was supported by the Max Planck Society (L.M., B.S.H., D.W.) and DFG grants STE 531/20-1, -2, HA 5871/2-1 and WI 1422/3-2. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altner H., 1980, International Review of Cytology, V67, P69, DOI 10.1016/S0074-7696(08)62427-4; Benton R, 2006, PLOS BIOL, V4, P240, DOI 10.1371/journal.pbio.0040020; Benton R, 2007, NATURE, V450, P289, DOI 10.1038/nature06328; Bohbot JD, 2012, NEUROPHARMACOLOGY, V62, P2086, DOI 10.1016/j.neuropharm.2012.01.004; Chen SS, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0050456, 10.1371/journal.pone.0036784, 10.1371/journal.pone.0049275, 10.1371/journal.pone.0045763]; Clyne PJ, 1999, NEURON, V22, P327, DOI 10.1016/S0896-6273(00)81093-4; Deng Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018605; Dolzer J, 2003, J EXP BIOL, V206, P1575, DOI 10.1242/jeb.00302; Elmore T, 2003, J NEUROSCI, V23, P9906; Flecke C, 2006, J EXP BIOL, V209, P3898, DOI 10.1242/jeb.02432; Flecke C, 2010, J EXP BIOL, V213, P842, DOI 10.1242/jeb.032839; Flecke C, 2009, J COMP PHYSIOL A, V195, P529, DOI 10.1007/s00359-009-0429-4; Forstner M, 2008, CHEM SENSES, V33, P291, DOI 10.1093/chemse/bjm087; Gao Q, 1999, GENOMICS, V60, P31, DOI 10.1006/geno.1999.5894; German PF, 2013, INSECT BIOCHEM MOLEC, V43, P138, DOI 10.1016/j.ibmb.2012.11.002; Grosse-Wilde E, 2011, P NATL ACAD SCI USA, V108, P7449, DOI 10.1073/pnas.1017963108; Grosse-Wilde E, 2010, FRONT CELL NEUROSCI, V4, DOI 10.3389/fncel.2010.00022; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Hallem EA, 2006, CELL, V125, P143, DOI 10.1016/j.cell.2006.01.050; Hill CA, 2002, SCIENCE, V298, P176, DOI 10.1126/science.1076196; Jin X, 2008, P NATL ACAD SCI USA, V105, P10996, DOI 10.1073/pnas.0803309105; Jones PL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030304; Jones PL, 2011, P NATL ACAD SCI USA, V108, P8821, DOI 10.1073/pnas.1102425108; Jones WD, 2005, CURR BIOL, V15, pR119, DOI 10.1016/j.cub.2005.02.007; Jordan MD, 2009, CHEM SENSES, V34, P383, DOI 10.1093/chemse/bjp010; Krieger J, 2003, J COMP PHYSIOL A, V189, P519, DOI 10.1007/s00359-003-0427-x; Krieger J, 2002, EUR J NEUROSCI, V16, P619, DOI 10.1046/j.1460-9568.2002.02109.x; Larsson MC, 2004, NEURON, V43, P703, DOI 10.1016/j.neuron.2004.08.019; Lundin C, 2007, FEBS LETT, V581, P5601, DOI 10.1016/j.febslet.2007.11.007; Malpel S, 2008, INSECT MOL BIOL, V17, P587, DOI 10.1111/j.1365-2583.2008.00830.x; Melo ACA, 2004, CHEM SENSES, V29, P403, DOI 10.1093/chemse/bjh041; Nakagawa T, 2009, CURR OPIN NEUROBIOL, V19, P284, DOI 10.1016/j.conb.2009.07.015; Nakagawa T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032372; Neuhaus EM, 2005, NAT NEUROSCI, V8, P15, DOI 10.1038/nn1371; Nichols AS, 2011, CHEM SENSES, V36, P781, DOI 10.1093/chemse/bjr053; Pask GM, 2013, CHEM SENSES; Pask GM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028774; Patch HM, 2009, CHEM SENSES, V34, P305, DOI 10.1093/chemse/bjp002; Pitts RJ, 2004, P NATL ACAD SCI USA, V101, P5058, DOI 10.1073/pnas.0308146101; Rogers ME, 1997, J BIOL CHEM, V272, P14792, DOI 10.1074/jbc.272.23.14792; Rogers ME, 2001, CELL TISSUE RES, V303, P433, DOI 10.1007/s004410000305; Rogers ME, 2001, J NEUROBIOL, V49, P47, DOI 10.1002/neu.1065; Rollecke K, 2011, CHARACTERIZATION BLO; Sargsyan V, 2011, FRONT CELL NEUROSCI, V5, DOI 10.3389/fncel.2011.00005; SASAKI M, 1984, PHYSIOL ENTOMOL, V9, P315, DOI 10.1111/j.1365-3032.1984.tb00713.x; Sato K, 2008, NATURE, V452, P1002, DOI 10.1038/nature06850; Schendzielorz T, 2012, J BIOL RHYTHM, V27, P388, DOI 10.1177/0748730412456265; Schuckel J, 2007, CELL TISSUE RES, V330, P271, DOI 10.1007/s00441-007-0471-x; Smart R, 2008, INSECT BIOCHEM MOLEC, V38, P770, DOI 10.1016/j.ibmb.2008.05.002; STENGL M, 1993, J EXP BIOL, V178, P125; STENGL M, 1992, ANNU REV PHYSIOL, V54, P665; STENGL M, 1994, J COMP PHYSIOL A, V174, P187; Stengl M, 2010, FRONT CELL NEUROSCI, V4, DOI 10.3389/fncel.2010.00133; Stocker RF, 2001, MICROSC RES TECHNIQ, V55, P284, DOI 10.1002/jemt.1178; Stortkuhl KF, 2001, P NATL ACAD SCI USA, V98, P9381, DOI 10.1073/pnas.151105698; Su CY, 2012, NATURE, V492, P66, DOI 10.1038/nature11712; Taylor RW, 2012, ACS CHEM BIOL, V7, P1647, DOI 10.1021/cb300331z; Tsitoura P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015428; Vogt RG, 2009, INSECT BIOCHEM MOLEC, V39, P448, DOI 10.1016/j.ibmb.2009.03.007; Vosshall LB, 2000, CELL, V102, P147, DOI 10.1016/S0092-8674(00)00021-0; Vosshall LB, 1999, CELL, V96, P725, DOI 10.1016/S0092-8674(00)80582-6; Vosshall LB, 2011, CHEM SENSES, V36, P497, DOI 10.1093/chemse/bjr022; Wicher D, 2008, NATURE, V452, P1007, DOI 10.1038/nature06861; Wistrand M, 2006, PROTEIN SCI, V15, P509, DOI 10.1110/ps.051745906; Yang Y, 2012, INT J BIOL SCI, V8, P159, DOI 10.7150/ijbs.8.159	65	23	23	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2013	8	5							e62648	10.1371/journal.pone.0062648	http://dx.doi.org/10.1371/journal.pone.0062648			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175AS	23671617	gold, Green Submitted, Green Published			2022-12-27	WOS:000321202100026
J	Nordgard, O; Singh, G; Solberg, S; Jorgensen, L; Halvorsen, AR; Smaaland, R; Brustugun, OT; Helland, A				Nordgard, Oddmund; Singh, Gurpartap; Solberg, Steinar; Jorgensen, Lars; Halvorsen, Ann Rita; Smaaland, Rune; Brustugun, Odd Terje; Helland, Aslaug			Novel Molecular Tumor Cell Markers in Regional Lymph Nodes and Blood Samples from Patients Undergoing Surgery for Non-Small Cell Lung Cancer	PLOS ONE			English	Article							QUANTITATIVE RT-PCR; MESSENGER-RNA; COLORECTAL-CANCER; MICROMETASTASES; EXPRESSION; SURVIVAL; TRIAL	Introduction: Recent evidence suggests that microscopic lymph node metastases and circulating tumor cells may have clinical importance in lung cancer. The purpose of this study was to identify new molecular markers for tumor cells in regional lymph nodes (LNs) and peripheral blood (PB) from patients with non-small cell lung cancer (NSCLC). Methods: Candidate markers were selected based on digital transcript profiling and previous literature. KRT19, CEACAM5, EPCAM, DSG3, SFTPA, SFTPC and SFTPB mRNA levels were initially validated by real-time reverse transcription PCR-based quantification in 16 NSCLC tumors and 22 LNs and 12 PB samples from individuals without known cancer. Five of the candidate markers were selected for secondary validation by quantification in parallel tumor biopsies, regional LNs and PB samples from 55 patients undergoing surgery for NSCLC. LN and PB marker status were compared to clinicopathological patient data. Results: All selected markers except DSG3 were present at high levels in the primary tumors and at very low or non-detectable levels in normal LNs and PB in the first round of validation, indicating a potential for detecting tumor cells in NSCLC patients. The expression profiles of KRT19, CEACAM5, DSG3, SFTPA and SFTPC mRNA were confirmed in the larger group during the secondary validation. Using the highest normal LN level of each marker as threshold, 39 (71%) of the 55 patients had elevated levels of at least one marker in regional LNs. Similarly, 26 (47%) patients had elevated levels of at least one marker in PB. A significantly higher number of patients with adenocarcinomas had positive LN status for these markers, compared with other histological types (P = 0.004). Conclusions: Several promising molecular tumor cell markers in regional LNs and PB were identified, including the new SFTPA and SFTPC mRNAs. Clinical follow-up in a larger cohort is needed to elucidate their prognostic value.	[Nordgard, Oddmund; Singh, Gurpartap; Smaaland, Rune; Brustugun, Odd Terje; Helland, Aslaug] Stavanger Univ Hosp, Dept Hematol & Oncol, Stavanger, Norway; [Solberg, Steinar; Jorgensen, Lars] Univ Oslo, Rikshosp, Oslo Univ Hosp, Dept Cardiothorac Surg, N-0027 Oslo, Norway; [Halvorsen, Ann Rita; Brustugun, Odd Terje; Helland, Aslaug] Norwegian Radium Hosp, Oslo Univ Hosp, Dept Genet, Oslo, Norway; [Brustugun, Odd Terje; Helland, Aslaug] Norwegian Radium Hosp, Oslo Univ Hosp, Dept Oncol, Oslo, Norway	Stavanger University Hospital; University of Oslo; National Hospital Norway; University of Oslo; University of Oslo	Nordgard, O (corresponding author), Stavanger Univ Hosp, Dept Hematol & Oncol, Stavanger, Norway.	nood@sus.no	Smaaland, Rune/AAH-2149-2021; Helland, Åslaug/H-3910-2015; Nordgard, Oddmund/AAJ-1029-2020	Helland, Åslaug/0000-0002-5520-0275; Nordgard, Oddmund/0000-0002-5847-6752	South-Eastern Norway Regional Health Authority; Folke Hermansen Fund	South-Eastern Norway Regional Health Authority; Folke Hermansen Fund	This work was supported by 1) South-Eastern Norway Regional Health Authority and 2) Folke Hermansen Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bednarz-Knoll N, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2940; Benlloch S, 2009, ANN ONCOL, V20, P91, DOI 10.1093/annonc/mdn538; Cancer Registry of Norway, 2012, CANC INC MORT SURV P; Edge S, 2010, AJCC CANC STAGING MA; Effenberger KE, 2007, CANCER TREAT RES, P167; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Heinrich S, 2006, CURR MED CHEM, V13, P3239, DOI 10.2174/092986706778773112; Hou JM, 2012, J CLIN ONCOL, V30, P525, DOI 10.1200/JCO.2010.33.3716; Jolliffe I., 2005, SPRINGERLINK PRINCIP, DOI 10.1007/b98835; Krebs MG, 2011, J CLIN ONCOL, V29, P1556, DOI 10.1200/JCO.2010.28.7045; Kubuschok B, 1999, J CLIN ONCOL, V17, P19, DOI 10.1200/JCO.1999.17.1.19; Lardinois D, 2006, EUR J CARDIO-THORAC, V30, P787, DOI 10.1016/j.ejcts.2006.08.008; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lucci A, 2012, LANCET ONCOL, V13, P688, DOI 10.1016/S1470-2045(12)70209-7; Nordgard O, 2012, ANN SURG ONCOL, V19, P3719, DOI 10.1245/s10434-012-2454-8; Nordgard O, 2009, ANN SURG, V249, P602, DOI 10.1097/SLA.0b013e31819ec923; Ohlsson L, 2006, BRIT J CANCER, V95, P218, DOI 10.1038/sj.bjc.6603206; Perez-Gil J, 2010, PHYSIOLOGY, V25, P132, DOI 10.1152/physiol.00006.2010; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Punnoose EA, 2012, CLIN CANCER RES, V18, P2391, DOI 10.1158/1078-0432.CCR-11-3148; Qiu Y, 2010, JPN J CLIN ONCOL, V40, P146, DOI 10.1093/jjco/hyp144; Rhim AD, 2012, CELL, V148, P349, DOI 10.1016/j.cell.2011.11.025; Rusch VW, 2011, J CLIN ONCOL, V29, P4313, DOI 10.1200/JCO.2011.35.2500; Saintigny P, 2005, INT J CANCER, V115, P777, DOI 10.1002/ijc.20942; Tjensvoll K, 2013, INT J CANC IN PRESS; Venables WN., 2002, MODERN APPL STAT S 4; Xi LQ, 2006, CLIN CANCER RES, V12, P2484, DOI 10.1158/1078-0432.CCR-05-2037; Xi LQ, 2006, CLIN CHEM, V52, P520, DOI 10.1373/clinchem.2005.062844; Yu M, 2013, SCIENCE, V339, P580, DOI 10.1126/science.1228522	29	12	13	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2013	8	5							e62153	10.1371/journal.pone.0062153	http://dx.doi.org/10.1371/journal.pone.0062153			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175AS	23671585	Green Submitted, Green Published, gold			2022-12-27	WOS:000321202100007
J	Huang, WH; Yu, MC; Huang, JY; Lai, PC				Huang, Wen-Hung; Yu, Mei-Ching; Huang, Jeng-Yi; Lai, Ping-Chin			Impact of Hepatitis C Virus Infection on Bone Mineral Density in Renal Transplant Recipients	PLOS ONE			English	Article							NECROSIS-FACTOR RECEPTOR; VITAMIN-D; LIVER-DISEASE; OSTEOCLAST DIFFERENTIATION; SECONDARY HYPERPARATHYROIDISM; OSTEOPROTEGERIN LIGAND; PARATHYROID-HORMONE; DENDRITIC-CELL; OSTEOPOROSIS; FRACTURES	Background: The average prevalence of hepatitis C virus (HCV) infection in renal transplant recipients is 10%. Studies of these patients with HCV infection usually focuses on long-term graft survival and patient survival. Studies of the correlation between HCV infection and bone mineral density (BMD) in renal transplant patients are limited. The aim of this study was to investigate whether HCV infection is a risk factor for BMD change during a short follow-up period. Methods: Seventy-six renal transplant recipients underwent 2 separate dual-energy X-ray absorptiometry (DXA) scans during a mean period of 14 months. Fifteen patients were HCV infection. First bone mineral density (BMD) at the lumbar spine, hip, and femoral neck was determined using dual-energy X-ray absorptiometry (DXA) between September 2008 and March 2009. After that, 34 patients took alendronate sodium 70 mg per week. Subgroups risk factors analysis was also performed into with or without alendronate. Immunosuppressive agents, bisphosphonates, patient characteristics, and biochemical factors were analyzed to identify associations with BMD. Results: After 14 months, in 76 patients, BMD of the lumbar spine had significantly increased (from 0.9 g/cm(2) to 0.92 g/cm(2), p < 0.001), whereas BMD of the hip and femoral neck had not. Multiple linear regression analysis showed that HCV infection was negatively associated with BMD change in the lumbar spine (beta: -0.247, 95% CI, -0.035 to -0.002; p = 0.028). Moreover, in subgroup analysis, among 42 patients without alendronate, multiple linear regression analysis showed HCV infection was a risk factor for adverse BMD change of the lumbar spine (beta: -0.371, 95% CI, -0.043 to -0.003; p = 0.023). Conclusion: HCV infection in renal transplant recipients was a negative risk factor for BMD change in the lumbar spine. Moreover, alendronate may be able to reverse the negative effect of HCV infection on bone in renal transplant recipients.	[Huang, Wen-Hung; Huang, Jeng-Yi; Lai, Ping-Chin] Chang Gung Mem Hosp, Dept Nephrol, Linkou, Taiwan; [Yu, Mei-Ching] Chang Gung Childrens Hosp, Dept Paediat Nephrol, Linkou, Taiwan; [Huang, Wen-Hung; Yu, Mei-Ching; Huang, Jeng-Yi; Lai, Ping-Chin] Chang Gung Univ, Coll Med, Tao Yuan, Taiwan	Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung University	Lai, PC (corresponding author), Chang Gung Mem Hosp, Dept Nephrol, Linkou, Taiwan.	williammaxima@gmail.com	huang, wen/GXW-0661-2022					Alimonti JB, 2003, J GEN VIROL, V84, P1649, DOI 10.1099/vir.0.19110-0; Anderson DM, 1997, NATURE, V390, P175, DOI 10.1038/36593; Arase Y, 2010, J MED VIROL, V82, P390, DOI 10.1002/jmv.21691; Aroldi A, 1997, TRANSPLANTATION, V63, P380, DOI 10.1097/00007890-199702150-00009; Arteh J, 2010, DIGEST DIS SCI, V55, P2624, DOI 10.1007/s10620-009-1069-9; Barone A, 2007, J AM GERIATR SOC, V55, P752, DOI 10.1111/j.1532-5415.2007.01161.x; Bruchfeld A, 2004, TRANSPLANTATION, V78, P745, DOI 10.1097/01.TP.0000131948.29742.24; Carey EJ, 2003, LIVER TRANSPLANT, V9, P1166, DOI 10.1053/jlts.2003.50242; Collin F, 2009, AIDS, V23, P1021, DOI 10.1097/QAD.0b013e3283292195; Deane A, 2007, BMC MUSCULOSKEL DIS, V8, DOI 10.1186/1471-2474-8-3; Dunstan CR, 2000, ENDOCRINOLOGIST, V10, P18, DOI 10.1097/00019616-200010010-00005; El-Maouche D, 2011, J HEPATOL, V55, P770, DOI 10.1016/j.jhep.2011.01.035; Fabrega E, 2005, LIVER INT, V25, P305, DOI 10.1111/j.1478-3231.2005.01073.x; Fabrizi F, 2006, ALIMENT PHARM THER, V24, P1413, DOI 10.1111/j.1365-2036.2006.03151.x; Fabrizi F, 2005, AM J TRANSPLANT, V5, P1452, DOI 10.1111/j.1600-6143.2005.00864.x; Fabrizi F, 2002, HEPATOLOGY, V36, P3, DOI 10.1053/jhep.2002.34613; George J, 2009, WORLD J GASTROENTERO, V15, P3516, DOI 10.3748/wjg.15.3516; Gutierrez JA, 2011, SEMIN LIVER DIS, V31, P387, DOI 10.1055/s-0031-1297927; Hansen ABE, 2012, AIDS, V26, P285, DOI 10.1097/QAD.0b013e32834ed8a7; Hay J Eileen, 2005, Clin Liver Dis, V9, P747, DOI 10.1016/j.cld.2005.07.003; HEPNER GW, 1976, AM J DIG DIS, V21, P527, DOI 10.1007/BF01464758; Huang WH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048481; Huang WH, 2011, RENAL FAILURE, V33, P776, DOI 10.3109/0886022X.2011.599914; Hung CJ, 1996, TRANSPLANT P, V28, P1548; Kartsogiannis V, 1999, BONE, V25, P525, DOI 10.1016/S8756-3282(99)00214-8; Kodras K, 2006, EUR J CLIN INVES S75, V36; Kokado Y, 2000, TRANSPL INT S5, V13; Lacey DL, 1998, CELL, V93, P165, DOI 10.1016/S0092-8674(00)81569-X; Lips P, 2001, ENDOCR REV, V22, P477, DOI 10.1210/er.22.4.477; Liu SH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036576; Loria I, 2010, TRANSPL P, V42, P1191, DOI 10.1016/j.transproceed.2010.03.096; Mitwalli AH, 2006, NEPHRON CLIN PRACT, V102, P72, DOI 10.1159/000089090; Morales JM, 2004, NEPHROL DIAL TRAN S6, V19; Moschen AR, 2005, J HEPATOL, V43, P973, DOI 10.1016/j.jhep.2005.05.034; PERIERA BJG, 1995, TRANSPLANTATION, V60, P799, DOI 10.1097/00007890-199510270-00007; Rostami Z, 2011, HEPAT MON, V11, P247; ROTH D, 1995, AM J KIDNEY DIS, V25, P3, DOI 10.1016/0272-6386(95)90617-7; Schiefke I, 2005, WORLD J GASTROENTERO, V11, P1843, DOI 10.3748/wjg.v11.i12.1843; Sigurdsson G, 2000, OSTEOPOROSIS INT, V11, P1031, DOI 10.1007/s001980070024; Suda T, 1999, ENDOCR REV, V20, P345, DOI 10.1210/er.20.3.345; Szalay F, 2003, J HEPATOL, V38, P395, DOI 10.1016/S0168-8278(02)00435-X; van der Merwe SW, 2006, WORLD J GASTROENTERO, V12, P4504, DOI 10.3748/wjg.v12.i28.4504; von Elm E, 2007, PLOS MED, V4, P1623, DOI [10.1371/journal.pmed.0040296, 10.1371/journal.pmed.0040297]; von Muhlen DG, 2005, OSTEOPOROSIS INT, V16, P1721, DOI 10.1007/s00198-005-1910-8; Vosnides GG, 1997, KIDNEY INT, V52, P843, DOI 10.1038/ki.1997.403; Westenfeld R, 2011, NEPHROL DIAL TRANSPL, V26, P4115, DOI 10.1093/ndt/gfr214; Wong BR, 1997, J BIOL CHEM, V272, P25190, DOI 10.1074/jbc.272.40.25190; Wong BR, 1999, J LEUKOCYTE BIOL, V65, P715, DOI 10.1002/jlb.65.6.715; Yasuda H, 1998, P NATL ACAD SCI USA, V95, P3597, DOI 10.1073/pnas.95.7.3597; Young B, 2011, CLIN INFECT DIS, V52, P1061, DOI 10.1093/cid/ciq242	50	2	2	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2013	8	5							e63263	10.1371/journal.pone.0063263	http://dx.doi.org/10.1371/journal.pone.0063263			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145RZ	23675468	Green Submitted, Green Published, gold			2022-12-27	WOS:000319036100032
J	Rise, MB; Pellerud, A; Rygg, LO; Steinsbekk, A				Rise, Marit B.; Pellerud, Anneli; Rygg, Lisbeth O.; Steinsbekk, Aslak			Making and Maintaining Lifestyle Changes after Participating in Group Based Type 2 Diabetes Self-Management Educations: A Qualitative Study	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIAL; CARE MANAGEMENT; PEOPLE; METAANALYSIS; MEDICATION; BEHAVIORS; MELLITUS.; STANDARDS; EXERCISE; PROGRAM	Background: Disease management is crucial in type 2 diabetes. Diabetes self-management education aims to provide the knowledge necessary to make and maintain lifestyle changes. However, few studies have investigated the processes after such courses. The aim of this study was to investigate how participants make and maintain lifestyle changes after participating in group-based type 2 diabetes self-management education. Methods: Data was collected through qualitative semi-structured interviews with 23 patients who attended educational group programs in Central Norway. The participants were asked how they had used the advice given and what they had changed after the course. Results: Knowledge was essential for making lifestyle changes following education. Three factors affected whether lifestyle changes were implemented: obtaining new knowledge, taking responsibility, and receiving confirmation of an already healthy lifestyle. Four factors motivated individuals to maintain changes: support from others, experiencing an effect, fear of complications, and the formation of new habits. Conclusion: Knowledge was used to make and maintain changes in diet, medication and physical activity. Knowledge also acted as confirmation of an already adequate lifestyle. Knowledge led to no changes if diabetes appeared "not that scary'' or if changes appeared too time consuming. Those involved in diabetes education need to be aware of the challenges in convincing asymptomatic patients about the benefits of adherence to self-management behaviour.	[Rise, Marit B.; Pellerud, Anneli; Rygg, Lisbeth O.; Steinsbekk, Aslak] Norwegian Univ Sci & Technol, Dept Publ Hlth & Gen Practice, N-7034 Trondheim, Norway; [Rygg, Lisbeth O.] Helse Nord Trondelag Hosp Trust, Levanger, Norway	Norwegian University of Science & Technology (NTNU)	Rise, MB (corresponding author), Norwegian Univ Sci & Technol, Dept Publ Hlth & Gen Practice, N-7034 Trondheim, Norway.	marit.b.rise@ntnu.no	Steinsbekk, Aslak/E-9223-2012; Albertin, Paloma C/X-1093-2018	Steinsbekk, Aslak/0000-0001-9090-0739; Rygg, Lisbeth Ostgaard/0000-0002-8415-8715	Central Norway Health Authorities [46011600-47]	Central Norway Health Authorities	The study was funded by The Central Norway Health Authorities (grant number 46011600-47). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alm-Roijer Carin, 2004, Eur J Cardiovasc Nurs, V3, P321; Balcou-Debussche M, 2009, QUAL HEALTH RES, V19, P1100, DOI 10.1177/1049732309341642; Bandura A, 2004, HEALTH EDUC BEHAV, V31, P143, DOI 10.1177/1090198104263660; Barlow JH, 2005, J HEALTH PSYCHOL, V10, P863, DOI 10.1177/1359105305057320; Blissmer B, 2010, J HEALTH PSYCHOL, V15, P205, DOI 10.1177/1359105309345555; Burge S, 2005, FAM MED, V37, P712; Eigenmann C, 2007, OUTCOMES INDICATORS; Farmer A, 2006, DIABETIC MED, V23, P265, DOI 10.1111/j.1464-5491.2005.01778.x; Fredrickson BL, 2005, AM PSYCHOL, V60, P678, DOI 10.1037/0003-066X.60.7.678; Funnell MM, 2012, DIABETES CARE, V35, pS101, DOI 10.2337/dc12-s101; Gazmararian JA, 2009, DIABETES EDUCATOR, V35, P778, DOI 10.1177/0145721709338527; Giorgi A., 2009, DESCRIPTIVE PHENOMEN; Hibbard JH, 2010, PATIENT EDUC COUNS, V78, P377, DOI 10.1016/j.pec.2009.12.015; HISCOCK J, 2001, LISTENING DIABETES S; HORTON ES, 1988, DIABETES CARE, V11, P201, DOI 10.2337/diacare.11.2.201; Khunti K, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e2333; Kvale S, 1996, INTERVIEWS INTRO QUA; Lawton J, 2005, SOC SCI MED, V60, P1423, DOI 10.1016/j.socscimed.2004.08.013; Malpass A, 2009, PATIENT EDUC COUNS, V74, P258, DOI 10.1016/j.pec.2008.08.018; Malterud K, 2001, LANCET, V358, P483, DOI 10.1016/S0140-6736(01)05627-6; Malterud K, 2012, SCAND J PUBLIC HEALT, V40, P795, DOI 10.1177/1403494812465030; Manderson L, 2009, CHRONIC ILLN, V5, P21, DOI 10.1177/1742395309102243; Marks DF, 2008, J HEALTH PSYCHOL, V13, P977, DOI 10.1177/1359105308098002; Minet L, 2010, PATIENT EDUC COUNS, V80, P29, DOI 10.1016/j.pec.2009.09.033; Moser A, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-91; Mulcahy K, 2003, DIABETES EDUCATOR, V29, P768, DOI 10.1177/014572170302900509; MURPHY E, 1995, FAM PRACT, V12, P184, DOI 10.1093/fampra/12.2.184; Norris SL, 2002, DIABETES CARE, V25, P1159, DOI 10.2337/diacare.25.7.1159; Ockleford E, 2008, CHRONIC ILLN, V4, P28, DOI 10.1177/1742395307086673; Parry O, 2006, HEALTH EDUC RES, V21, P97, DOI 10.1093/her/cyh044; Peel E, 2004, PATIENT EDUC COUNS, V53, P269, DOI 10.1016/j.pec.2003.07.010; Peel E, 2010, BRIT J GEN PRACT, V60, P570, DOI 10.3399/bjgp10X515061; Polonsky WH, 2003, DIABETES CARE, V26, P3048, DOI 10.2337/diacare.26.11.3048; PROCHASKA JO, 1992, AM PSYCHOL, V47, P1102, DOI 10.1037/0003-066X.47.9.1102; Rygg LO, 2012, PATIENT EDUC COUNS, V86, P98, DOI 10.1016/j.pec.2011.04.008; Rygg LO, 2010, SCAND J PUBLIC HEALT, V38, P788, DOI 10.1177/1403494810382475; Shariff F, 2009, QUAL HEALTH RES, V19, P1037, DOI 10.1177/1049732309341189; Snoek FJ, 2002, INT J CLIN PRACT, P80; Steinsbekk A, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-213; Tucker M, 2002, J NUTR EDUC BEHAV, V34, pS14, DOI 10.1016/S1499-4046(06)60306-0; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047; Zimmerman GL, 2000, AM FAM PHYSICIAN, V61, P1409	42	43	44	1	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2013	8	5							e64009	10.1371/journal.pone.0064009	http://dx.doi.org/10.1371/journal.pone.0064009			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	155HD	23671705	Green Published, Green Submitted, gold			2022-12-27	WOS:000319737700063
J	Tryjanowski, P; Sparks, TH; Kuzniak, S; Czechowski, P; Jerzak, L				Tryjanowski, Piotr; Sparks, Tim H.; Kuzniak, Stanislaw; Czechowski, Pawel; Jerzak, Leszek			Bird Migration Advances More Strongly in Urban Environments	PLOS ONE			English	Article							CLIMATE-CHANGE; ARRIVAL DATES; URBANIZATION; PHENOLOGY; ECOLOGY; AREAS	Urbanization has a marked effect on the reproduction and other ecological and behavioural traits of many living organisms, including birds. In migrant birds, survival and reproductive output is influenced by the (mis) synchronization of arrival with the availability of resources. Many recent studies have shown that arrival timing is related to temperatures en-route and at destination. Because urban areas are "heat islands'', with higher temperatures that influence earlier vegetation and invertebrate development, this should favour earlier arrival of migrant birds to cities rather than to rural areas. In this paper, we analysed differences between urban and rural habitats in mean dates and trends of first arrival dates of 18 species of migratory bird species in western Poland during 1983-2010. For many individual species, and overall, mean first arrival date was significantly earlier in rural areas than in urban areas (significant for 11 species). However, the trend towards earlier first arrival dates was stronger in urban areas for 15 of the 18 species (significantly stronger in four species). Consequently, arrival dates in urban areas are fast approaching, or have now matched or passed those in rural areas. These findings suggest that recent environmental changes may have more rapidly changed the migratory habits of birds occupying urban habitats than those occupying rural habitats.	[Tryjanowski, Piotr; Sparks, Tim H.; Kuzniak, Stanislaw] Poznan Univ Life Sci, Inst Zool, Poznan, Poland; [Sparks, Tim H.] Tech Univ Munich, Fachgebiet Okoklimatol, Freising Weihenstephan, Germany; [Sparks, Tim H.] Tech Univ Munich, Inst Adv Study, Garching, Germany; [Sparks, Tim H.] Coventry Univ, Fac Engn & Comp, Coventry, W Midlands, England; [Czechowski, Pawel] State Higher Vocat Sch Sulechow, Inst Tourism & Recreat, Sulechow, Poland; [Jerzak, Leszek] Univ Zielona Gora, Fac Biol Sci, Zielona Gora, Poland	Poznan University of Life Sciences; Technical University of Munich; Technical University of Munich; Coventry University; University of Zielona Gora	Tryjanowski, P (corresponding author), Poznan Univ Life Sci, Inst Zool, Poznan, Poland.	piotr.tryjanowski@gmail.com		Sparks, Tim/0000-0003-4382-7051; Tryjanowski, Piotr/0000-0002-8358-0797	Technische Universitat Munchen - Institute for Advanced Study; German Excellence Initiative	Technische Universitat Munchen - Institute for Advanced Study; German Excellence Initiative	THS acknowledges the support of the Technische Universitat Munchen - Institute for Advanced Study, funded by the German Excellence Initiative. The analysis and data collection was partially financed by sources from the authors' universities. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banaszak-Cibicka W, 2012, J INSECT CONSERV, V16, P331, DOI 10.1007/s10841-011-9419-2; Biadun W, 2011, POL J ECOL, V59, P381; Buyantuyev A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051260; DIAMOND JM, 1986, NATURE, V324, P107, DOI 10.1038/324107a0; Draper N.R, 1998, WILEY SERIES PROBABI, Vthird; Evans KL, 2011, GLOBAL CHANGE BIOL, V17, P32, DOI 10.1111/j.1365-2486.2010.02247.x; Gilbert O.L., 1989, ECOLOGY URBAN HABITA; Grimm NB, 2008, SCIENCE, V319, P756, DOI 10.1126/science.1150195; Harvey P.H., 1991, COMP METHOD EVOLUTIO; Horak P, 1998, IBIS, V140, P205, DOI 10.1111/j.1474-919X.1998.tb04380.x; Hurlbert AH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031662; Imhoff ML, 2010, REMOTE SENS ENVIRON, V114, P504, DOI 10.1016/j.rse.2009.10.008; Jochner SC, 2012, INT J BIOMETEOROL, V56, P387, DOI 10.1007/s00484-011-0444-3; Jonzen N, 2006, SCIENCE, V312, P1959, DOI 10.1126/science.1126119; Konvicka M, 2011, EUR J ENTOMOL, V108, P219, DOI 10.14411/eje.2011.030; Lehikoinen Esa, 2010, P89; Lu PL, 2006, AGR FOREST METEOROL, V138, P120, DOI 10.1016/j.agrformet.2006.04.002; Matteson Kevin C., 2010, Urban Ecosystems, V13, P333, DOI 10.1007/s11252-010-0122-y; Mimet A, 2009, INT J BIOMETEOROL, V53, P287, DOI 10.1007/s00484-009-0214-7; Moller AP, 2008, P NATL ACAD SCI USA, V105, P16195, DOI 10.1073/pnas.0803825105; Moller AP, 2010, BEHAV ECOL, V21, P365, DOI 10.1093/beheco/arp199; Moller AP, 2009, OECOLOGIA, V159, P849, DOI 10.1007/s00442-008-1259-8; Neil Kaesha, 2006, Urban Ecosystems, V9, P243, DOI 10.1007/s11252-006-9354-2; Raupp MJ, 2010, ANNU REV ENTOMOL, V55, P19, DOI 10.1146/annurev-ento-112408-085351; Satterthwaite D, 2010, ENVIRON URBAN ASIA, V1, P1, DOI 10.1177/097542530900100102; Shochat E, 2006, TRENDS ECOL EVOL, V21, P186, DOI 10.1016/j.tree.2005.11.019; Sparks TH, 2005, GLOBAL CHANGE BIOL, V11, P22, DOI 10.1111/j.1365-2486.2004.00887.x; Tryjanowski P, 2005, J ORNITHOL, V146, P200, DOI 10.1007/s10336-005-0079-4; Visser ME, 2009, GLOBAL CHANGE BIOL, V15, P1859, DOI 10.1111/j.1365-2486.2009.01865.x; White MA, 2002, ECOSYSTEMS, V5, P260, DOI 10.1007/s10021-001-0070-8	30	53	55	6	126	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2013	8	5							e63482	10.1371/journal.pone.0063482	http://dx.doi.org/10.1371/journal.pone.0063482			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145YI	23667625	Green Submitted, Green Published, gold			2022-12-27	WOS:000319055600061
J	Yan, XH; Lyu, TJ; Jia, N; Yu, YH; Hua, KQ; Feng, WW				Yan, Xiaohui; Lyu, Tianjiao; Jia, Nan; Yu, Yinhua; Hua, Keqin; Feng, Weiwei			Huaier Aqueous Extract Inhibits Ovarian Cancer Cell Motility via the AKT/GSK3 beta/beta-Catenin Pathway	PLOS ONE			English	Article							BETA-CATENIN; CYCLIN D1; COMPONENTS; EXPRESSION; TARGET; WNT	Traditional Chinese medicine has gained popularity due to its ability to kill tumor cells. Recently, the apoptotic and anti-angiogenic effects of Trametes robiniophila murr (Huaier) have been investigated. The aim of this study was to investigate its effect on cell mobility and tumor growth in ovarian cancer. Cell viability and motility were measured using SRB, scratch and migration assays. Cell apoptosis was analysed by annexin V/PI staining. Using a reverse-phase protein array (RPPA) assay, we analyzed the levels of 153 proteins and/or phosphorylations in Huaier-treated and untreated cells. Huaier inhibited cell viability and induced both early and late apoptosis in SKOV3, SKOV3.ip1 and Hey cells in a time-and dosedependent manner. Cell invasiveness and migration were also suppressed significantly. The RPPA results showed significant differences (of at least 30%; P < 0.05) in the levels of 7 molecules in SKOV3 cells and 10 in SKOV3.ip1 cells between the untreated and treated cells. Most of the molecules identified play roles in cell proliferation, apoptosis or cell adhesion/invasion. Western blot analysis further validated that Huaier treatment resulted in decreased AKT phosphorylation, enhanced expression of total GSK3 beta, inhibition of the phosphorylation of GSK3 beta on S9, reduction of both cytoplasmic beta-catenin expression and nuclear beta-catenin translocation, and transcriptional repression of several Wnt/beta-catenin target genes (DIXDC1, LRP6, WNT5A, and cyclin D1). After knocking down GSK3 beta, beta-catenin expression could not be inhibited by Huaier. Finally, Huaier inhibited the growth of ovarian tumor xenografts in vivo. These studies indicate that Huaier inhibits tumor cell mobility in ovarian cancer via the AKT/GSK3 beta/beta-catenin signaling pathway.	[Yan, Xiaohui; Lyu, Tianjiao; Jia, Nan; Yu, Yinhua; Hua, Keqin; Feng, Weiwei] Fudan Univ, Dept Gynecol, Obstet & Gynecol Hosp, Shanghai 200433, Peoples R China; [Yan, Xiaohui; Lyu, Tianjiao; Jia, Nan; Yu, Yinhua; Hua, Keqin; Feng, Weiwei] Fudan Univ, Shanghai Key Lab Female Reprod Endocrine Related, Obstet & Gynecol Hosp, Shanghai 200433, Peoples R China; [Yu, Yinhua] Univ Texas MD Anderson Canc Ctr, Dept Expt Therapeut, Houston, TX 77030 USA	Fudan University; Fudan University; University of Texas System; UTMD Anderson Cancer Center	Hua, KQ (corresponding author), Fudan Univ, Dept Gynecol, Obstet & Gynecol Hosp, Shanghai 200433, Peoples R China.	huakeqin@126.com; jingsakura@gmail.com			National Natural Science Foundation of China [30973185]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work is supported by National Natural Science Foundation of China, grant number 30973185 (http://www.nsfc.gov.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brabletz T, 2005, NAT REV CANCER, V5, P744, DOI 10.1038/nrc1694; Burger RA, 2011, NEW ENGL J MED, V365, P2473, DOI 10.1056/NEJMoa1104390; Burkhalter RJ, 2011, J BIOL CHEM, V286, P23467, DOI 10.1074/jbc.M110.199539; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Dihlmann S, 2005, INT J CANCER, V113, P515, DOI 10.1002/ijc.20609; FRIXEN UH, 1991, J CELL BIOL, V113, P173, DOI 10.1083/jcb.113.1.173; Giles RH, 2003, BBA-REV CANCER, V1653, P1, DOI 10.1016/S0304-419X(03)00005-2; Guo Y., 1992, J CHINA PHARM U, V23, P155; Guo Y., 1993, CHIN J BIOCH PHARM, V63, P56; He Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031087; Huang T, 2001, CHIN J TUBERC RESP D, V24, P487; Li CX, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027053; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Magnuson B, 2012, BIOCHEM J, V441, P1, DOI 10.1042/BJ20110892; McCulloch M, 2006, J CLIN ONCOL, V24, P419, DOI 10.1200/JCO.2005.03.6392; McDonald SL, 2009, BRIT J CANCER, V101, P209, DOI 10.1038/sj.bjc.6605174; Nelson WJ, 2004, SCIENCE, V303, P1483, DOI 10.1126/science.1094291; Niessen CM, 2008, BBA-BIOMEMBRANES, V1778, P562, DOI 10.1016/j.bbamem.2007.12.015; Onder TT, 2008, CANCER RES, V68, P3645, DOI 10.1158/0008-5472.CAN-07-2938; Ren JZ, 2009, J HUAZHONG U SCI-MED, V29, P198, DOI 10.1007/s11596-009-0212-3; Siegel R, 2011, CA-CANCER J CLIN, V61, P212, DOI 10.3322/caac.20121; Takahashi-Yanaga F, 2008, CELL SIGNAL, V20, P581, DOI 10.1016/j.cellsig.2007.10.018; Tibes R, 2006, MOL CANCER THER, V5, P2512, DOI 10.1158/1535-7163.MCT-06-0334; Wang CY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031195; Wang L, 2009, CANCER SCI, V100, P1801, DOI 10.1111/j.1349-7006.2009.01246.x; Wang XL, 2012, ONCOL REP, V28, P1167, DOI 10.3892/or.2012.1961; Weinberg RA, 2007, BIOL CANC; Willems L, 2012, CURR ONCOL REP, V14, P129, DOI 10.1007/s11912-012-0227-y; YU DH, 1993, CANCER RES, V53, P891; Zhang N, 2010, CANCER SCI, V101, P2375, DOI 10.1111/j.1349-7006.2010.01680.x	31	55	60	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2013	8	5							e63731	10.1371/journal.pone.0063731	http://dx.doi.org/10.1371/journal.pone.0063731			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145YI	23667667	Green Published, gold, Green Submitted			2022-12-27	WOS:000319055600072
J	Liu, J; Wei, W; Kuang, H; Zhao, F; Tsien, JZ				Liu, Jun; Wei, Wei; Kuang, Hui; Zhao, Fang; Tsien, Joe Z.			Changes in Heart Rate Variability Are Associated with Expression of Short-Term and Long-Term Contextual and Cued Fear Memories	PLOS ONE			English	Article							FREELY BEHAVING RAT; CONDITIONED FEAR; NMDA RECEPTOR; HIPPOCAMPUS; MICE; RESPONSES; AMYGDALA; NEURONS; TRACES; BRAIN	Heart physiology is a highly useful indicator for measuring not only physical states, but also emotional changes in animals. Yet changes of heart rate variability during fear conditioning have not been systematically studied in mice. Here, we investigated changes in heart rate and heart rate variability in both short-term and long-term contextual and cued fear conditioning. We found that while fear conditioning could increase heart rate, the most significant change was the reduction in heart rate variability which could be further divided into two distinct stages: a highly rhythmic phase (stage-I) and a more variable phase (stage-II). We showed that the time duration of the stage-I rhythmic phase were sensitive enough to reflect the transition from short-term to long-term fear memories. Moreover, it could also detect fear extinction effect during the repeated tone recall. These results suggest that heart rate variability is a valuable physiological indicator for sensitively measuring the consolidation and expression of fear memories in mice.	[Liu, Jun; Wei, Wei] E China Normal Univ, Inst Brain Funct Genom, Minist Educ, Key Lab Brain Funct Genom, Shanghai 200062, Peoples R China; [Kuang, Hui; Zhao, Fang; Tsien, Joe Z.] Banna Biomed Res Inst, Xishuangbanna, Yunnan, Peoples R China; [Liu, Jun; Wei, Wei; Kuang, Hui; Zhao, Fang; Tsien, Joe Z.] Georgia Regents Univ, Med Coll Georgia, Brain & Behav Discovery Inst, Augusta, GA USA; [Liu, Jun; Wei, Wei; Kuang, Hui; Zhao, Fang; Tsien, Joe Z.] Georgia Regents Univ, Med Coll Georgia, Dept Neurol, Augusta, GA USA	East China Normal University; University System of Georgia; Augusta University; University System of Georgia; Augusta University	Zhao, F (corresponding author), Banna Biomed Res Inst, Xishuangbanna, Yunnan, Peoples R China.	zhaofang.magic@gmail.com; jtsien@gru.edu	Kuang, Hui/I-1006-2013	Kuang, Hui/0000-0002-7806-2864	National Institutes of Health [NS079774, AG034663-01, MH060236]; Shanghai Commission of Science and Technology [10140900500]; Yunnan Province Department of Science and Technology [2012BA009]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH060236] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS079774] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG034663] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Shanghai Commission of Science and Technology(Shanghai Science & Technology Committee); Yunnan Province Department of Science and Technology; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Grant support the National Institutes of Health (NS079774; AG034663-01; and MH060236), Shanghai Commission of Science and Technology (Grant # 10140900500), and Yunnan Province Department of Science and Technology (Grant # 2012BA009). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bangasser DA, 2006, J NEUROSCI, V26, P8702, DOI 10.1523/JNEUROSCI.1742-06.2006; BERGER TW, 1978, P NATL ACAD SCI USA, V75, P1572, DOI 10.1073/pnas.75.3.1572; BERGER TW, 1976, SCIENCE, V192, P483, DOI 10.1126/science.1257783; BERRY SD, 1978, SCIENCE, V200, P1298, DOI 10.1126/science.663612; BLANCHARD DC, 1972, J COMP PHYSIOL PSYCH, V81, P281, DOI 10.1037/h0033521; Chan PK, 2009, BMC BIOTECHNOL, V9, DOI 10.1186/1472-6750-9-11; Charlet A, 2011, PHYSIOL BEHAV, V104, P694, DOI 10.1016/j.physbeh.2011.07.004; Chen GF, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008256; Cui ZZ, 2004, NEURON, V41, P781, DOI 10.1016/S0896-6273(04)00072-8; DAVIS M, 1992, ANNU REV NEUROSCI, V15, P353, DOI 10.1146/annurev.neuro.15.1.353; DAVIS M, 1987, PSYCHOL LEARNING MEM; DISTERHOFT JF, 1986, P NATL ACAD SCI USA, V83, P2733, DOI 10.1073/pnas.83.8.2733; FANSELOW MS, 1984, TRENDS NEUROSCI, V7, P460; GABRIEL M, 1976, PHYSIOL PSYCHOL, V4, P275; Herry C, 2008, NATURE, V454, P600, DOI 10.1038/nature07166; Hurst JL, 2010, NAT METHODS, V7, P825, DOI [10.1038/nmeth.1500, 10.1038/NMETH.1500]; IWATA J, 1988, BEHAV NEUROSCI, V102, P66, DOI 10.1037/0735-7044.102.1.66; KIM JJ, 1992, BEHAV NEUROSCI, V106, P591, DOI 10.1037/0735-7044.106.4.591; Kim JJ, 2006, NEUROSCI BIOBEHAV R, V30, P188, DOI 10.1016/j.neubiorev.2005.06.005; KIM JJ, 1992, SCIENCE, V256, P675, DOI 10.1126/science.1585183; Lin LN, 2006, J NEUROSCI METH, V155, P28, DOI 10.1016/j.jneumeth.2005.12.032; Maren S, 2001, ANNU REV NEUROSCI, V24, P897, DOI 10.1146/annurev.neuro.24.1.897; McCauley Mark D, 2010, J Vis Exp, DOI 10.3791/1739; McEchron MD, 2003, J NEUROSCI, V23, P1535, DOI 10.1523/JNEUROSCI.23-04-01535.2003; OLDS J, 1972, J NEUROPHYSIOL, V35, P202, DOI 10.1152/jn.1972.35.2.202; Pennartz CMA, 2004, J NEUROSCI, V24, P6446, DOI 10.1523/JNEUROSCI.0575-04.2004; PHILLIPS RG, 1992, BEHAV NEUROSCI, V106, P274, DOI 10.1037/0735-7044.106.2.274; QUIRK GJ, 1995, NEURON, V15, P1029, DOI 10.1016/0896-6273(95)90092-6; Rampon C, 2000, NAT NEUROSCI, V3, P238, DOI 10.1038/72945; Romcy-Pereira RN, 2009, PHYSIOL BEHAV, V98, P44, DOI 10.1016/j.physbeh.2009.04.010; Seidenbecher T, 2003, SCIENCE, V301, P846, DOI 10.1126/science.1085818; Shimizu E, 2000, SCIENCE, V290, P1170, DOI 10.1126/science.290.5494.1170; Steenland HW, 2009, J NEUROSCI METH, V177, P355, DOI 10.1016/j.jneumeth.2008.10.020; Stiedl O, 2004, AUTON NEUROSCI-BASIC, V115, P15, DOI 10.1016/j.autneu.2004.07.006; Stiedl O, 1997, BEHAV NEUROSCI, V111, P703, DOI 10.1037/0735-7044.111.4.703; Thompson RE, 2005, ANNU REV PSYCHOL, V56, P1, DOI 10.1146/annurev.psych.56.091103.070239; THOMPSON RF, 1994, ANNU REV NEUROSCI, V17, P519, DOI 10.1146/annurev.neuro.17.1.519; Zhang WN, 2004, BEHAV BRAIN RES, V154, P199, DOI 10.1016/j.bbr.2004.02.016	38	12	13	3	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e63590	10.1371/journal.pone.0063590	http://dx.doi.org/10.1371/journal.pone.0063590			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667644	Green Published, Green Submitted, gold			2022-12-27	WOS:000319654700165
J	Machado, RB; Tufik, S; Suchecki, D				Machado, Ricardo Borges; Tufik, Sergio; Suchecki, Deborah			Role of Corticosterone on Sleep Homeostasis Induced by REM Sleep Deprivation in Rats	PLOS ONE			English	Article							CORTICOTROPIN-RELEASING HORMONE; POSTTRAUMATIC-STRESS-DISORDER; SLOW-WAVE ACTIVITY; PROHORMONE CONVERTASES PC1; PITUITARY-ADRENAL AXIS; CENTRAL-NERVOUS-SYSTEM; EYE-MOVEMENT SLEEP; EEG POWER SPECTRA; PARADOXICAL SLEEP; ENERGY-METABOLISM	Sleep is regulated by humoral and homeostatic processes. If on one hand chronic elevation of stress hormones impair sleep, on the other hand, rapid eye movement (REM) sleep deprivation induces elevation of glucocorticoids and time of REM sleep during the recovery period. In the present study we sought to examine whether manipulations of corticosterone levels during REM sleep deprivation would alter the subsequent sleep rebound. Adult male Wistar rats were fit with electrodes for sleep monitoring and submitted to four days of REM sleep deprivation under repeated corticosterone or metyrapone (an inhibitor of corticosterone synthesis) administration. Sleep parameters were continuously recorded throughout the sleep deprivation period and during 3 days of sleep recovery. Plasma levels of adrenocorticotropic hormone and corticosterone were also evaluated. Metyrapone treatment prevented the elevation of corticosterone plasma levels induced by REM sleep deprivation, whereas corticosterone administration to REM sleep-deprived rats resulted in lower corticosterone levels than in non-sleep deprived rats. Nonetheless, both corticosterone and metyrapone administration led to several alterations on sleep homeostasis, including reductions in the amount of non-REM and REM sleep during the recovery period, although corticosterone increased delta activity (1.0-4.0 Hz) during REM sleep deprivation. Metyrapone treatment of REM sleep-deprived rats reduced the number of REM sleep episodes. In conclusion, reduction of corticosterone levels during REM sleep deprivation resulted in impairment of sleep rebound, suggesting that physiological elevation of corticosterone levels resulting from REM sleep deprivation is necessary for plentiful recovery of sleep after this stressful event.	[Machado, Ricardo Borges; Tufik, Sergio; Suchecki, Deborah] Univ Fed Sao Paulo, Dept Psychobiol, Sao Paulo, Brazil	Universidade Federal de Sao Paulo (UNIFESP)	Machado, RB (corresponding author), Univ Fed Sao Paulo, Dept Psychobiol, Sao Paulo, Brazil.	machado.ricardoborges@gmail.com	Suchecki, Deborah/B-9790-2014; Machado, Ricardo/GXM-8198-2022; Suchecki, Deborah/B-7654-2012; Machado, Ricardo/A-2789-2012	Suchecki, Deborah/0000-0003-1697-8663; Machado, Ricardo/0000-0001-5878-554X	Associacao Fundo de Incentivo a Pesquisa (AFIP); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo-FAPESP [98/14303-3]; FAPESP [04/02213-2]; National Research Council (CNPq)	Associacao Fundo de Incentivo a Pesquisa (AFIP); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo-FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); National Research Council (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by Associacao Fundo de Incentivo a Pesquisa (AFIP) and Fundacao de Amparo a Pesquisa do Estado de Sao Paulo-FAPESP (Grant #98/14303-3). Ricardo Borges Machado was the recipient of PhD fellowship from FAPESP (04/02213-2). Deborah Suchecki and Sergio Tufik are the recipients of a scholarship from the National Research Council (CNPq). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achermann P, 2003, FRONT BIOSCI-LANDMRK, V8, pS683, DOI 10.2741/1064; Benington JH, 1999, SLEEP, V22, P1033; BENINGTON JH, 1995, PROG NEUROBIOL, V45, P347, DOI 10.1016/0301-0082(94)00057-O; BERGMANN BM, 1987, SLEEP, V10, P1; BERGMANN BM, 1987, SLEEP, V10, P523; Borbely AA, 1999, J BIOL RHYTHM, V14, P557, DOI 10.1177/074873099129000894; BORBELY AA, 1981, ELECTROEN CLIN NEURO, V51, P483, DOI 10.1016/0013-4694(81)90225-X; Bradbury MJ, 1998, AM J PHYSIOL-REG I, V275, pR555, DOI 10.1152/ajpregu.1998.275.2.R555; BRUNNER DP, 1990, ELECTROEN CLIN NEURO, V75, P492, DOI 10.1016/0013-4694(90)90136-8; Burade VS, 1996, NEUROREPORT, V8, P139, DOI 10.1097/00001756-199612200-00028; CARTWRIGHT RD, 1991, PSYCHIAT RES, V39, P199, DOI 10.1016/0165-1781(91)90088-7; Chang FC, 1998, AM J PHYSIOL-REG I, V275, pR793, DOI 10.1152/ajpregu.1998.275.3.R793; Chang FC, 2001, NEUROSCI BIOBEHAV R, V25, P445, DOI 10.1016/S0149-7634(01)00024-0; CHASTRETTE N, 1985, NEUROSCI LETT, V62, P365, DOI 10.1016/0304-3940(85)90576-2; COENEN AML, 1985, PHYSIOL BEHAV, V35, P501, DOI 10.1016/0031-9384(85)90130-1; Cui RJ, 2007, ACTA MED OKAYAMA, V61, P319; DAY R, 1992, MOL ENDOCRINOL, V6, P485, DOI 10.1210/me.6.3.485; DEMENT W, 1960, SCIENCE, V131, P1705, DOI 10.1126/science.131.3415.1705; DeSouza EB, 1995, PSYCHONEUROENDOCRINO, V20, P789, DOI 10.1016/0306-4530(95)00011-9; DESOUZA EB, 1985, J NEUROSCI, V5, P3189; DIJK DJ, 1993, BRAIN RES, V626, P190, DOI 10.1016/0006-8993(93)90579-C; Drouet JB, 2011, EUR J PHARMACOL, V652, P60, DOI 10.1016/j.ejphar.2010.10.071; EBERLY LB, 1983, PEPTIDES, V4, P837, DOI 10.1016/0196-9781(83)90077-3; EHLERS CL, 1986, NEUROENDOCRINOLOGY, V42, P467, DOI 10.1159/000124489; Endo T, 1997, PSYCHIAT RES, V66, P97, DOI 10.1016/S0165-1781(96)03029-6; FEISE G, 1977, BRAIN RES, V126, P263, DOI 10.1016/0006-8993(77)90725-9; Ferrara M, 1999, Sleep Res Online, V2, P15; Franken P, 2001, J NEUROSCI, V21, P2610, DOI 10.1523/JNEUROSCI.21-08-02610.2001; GALVAO MD, 2009, PSYCHONEUROENDOCRINO; Garcia-Borreguero D, 2000, J CLIN ENDOCR METAB, V85, P4201, DOI 10.1210/jc.85.11.4201; Gip P, 2004, AM J PHYSIOL-REG I, V286, pR1057, DOI 10.1152/ajpregu.00528.2003; GRAHNSTEDT S, 1985, BEHAV BRAIN RES, V18, P233, DOI 10.1016/0166-4328(85)90031-2; Held K, 2004, J PSYCHIATR RES, V38, P129, DOI 10.1016/S0022-3956(03)00076-1; Huntsman MM, 1999, SCIENCE, V283, P541, DOI 10.1126/science.283.5401.541; Igarreta P, 1999, LIFE SCI, V64, P2285, DOI 10.1016/S0024-3205(99)00179-4; Igaz P, 2008, CURR MED CHEM, V15, P2734, DOI 10.2174/092986708786242921; Jahn H, 2003, SLEEP, V26, P823, DOI 10.1093/sleep/26.7.823; KANT GJ, 1995, PHYSIOL BEHAV, V57, P359; LANCEL M, 1992, SLEEP, V15, P102, DOI 10.1093/sleep/15.2.102; LANCEL M, 1992, BRAIN RES, V596, P285, DOI 10.1016/0006-8993(92)91559-W; Lancel M, 2002, J PSYCHIAT RES, V36, P197, DOI 10.1016/S0022-3956(02)00009-2; Lee SN, 2007, J ENDOCRINOL, V192, P515, DOI 10.1677/JOE-06-0145; Liu XL, 2003, BRAIN RES, V991, P1, DOI 10.1016/j.brainres.2003.07.003; Ma X, 2011, TOXICOLOGY, V285, P83, DOI 10.1016/j.tox.2011.04.007; Machado RB, 2005, BEHAV BRAIN RES, V160, P356, DOI 10.1016/j.bbr.2005.01.001; Machado RB, 2004, BRAIN RES, V1004, P45, DOI 10.1016/j.brainres.2004.01.019; Machado RB, 2008, PSYCHONEUROENDOCRINO, V33, P1211, DOI 10.1016/j.psyneuen.2008.06.007; Machado RB, 2010, INT J ENDOCRINOL, V2010, DOI 10.1155/2010/326151; MAJEWSKA MD, 1985, BRAIN RES, V339, P178, DOI 10.1016/0006-8993(85)90641-9; Marinesco S, 1999, NEUROSCIENCE, V92, P921, DOI 10.1016/S0306-4522(99)00045-7; McCormick DA, 1997, ANNU REV NEUROSCI, V20, P185, DOI 10.1146/annurev.neuro.20.1.185; Mellman TA, 2002, AM J PSYCHIAT, V159, P1696, DOI 10.1176/appi.ajp.159.10.1696; MILCU SM, 1967, ELECTROEN CLIN NEURO, V22, P574; Mongrain V, 2010, SLEEP, V33, P1147, DOI 10.1093/sleep/33.9.1147; Morimoto M, 1996, NEUROSCI RES, V26, P235, DOI 10.1016/S0168-0102(96)01105-4; Morin CM, 2003, PSYCHOSOM MED, V65, P259, DOI 10.1097/01.PSY.0000030391.09558.A3; Neylan TC, 2003, NEUROPSYCHOPHARMACOL, V28, P1666, DOI 10.1038/sj.npp.1300215; Opp MR, 1997, PHYSIOL BEHAV, V63, P67, DOI 10.1016/S0031-9384(97)00390-9; Ortego J, 2002, NEUROSCI LETT, V333, P49, DOI 10.1016/S0304-3940(02)00028-9; Pawlyk AC, 2005, BIOL PSYCHIAT, V57, P268, DOI 10.1016/j.biopsych.2004.11.008; Philbert J, 2011, BEHAV BRAIN RES, V221, P149, DOI 10.1016/j.bbr.2011.02.039; RATCHESON RA, 1981, J NEUROCHEM, V36, P1952, DOI 10.1111/j.1471-4159.1981.tb10820.x; Rechtschaffen A, 1999, SLEEP, V22, P1038, DOI 10.1093/sleep/22.8.1038; Rechtschaffen A, 1999, SLEEP, V22, P11, DOI 10.1093/sleep/22.1.11; REUL JMHM, 1986, J STEROID BIOCHEM, V24, P269, DOI 10.1016/0022-4731(86)90063-4; Romanowski CPN, 2010, SLEEP, V33, P427, DOI 10.1093/sleep/33.4.427; ROSENBERG RS, 1976, PHYSIOL BEHAV, V17, P931, DOI 10.1016/0031-9384(76)90011-1; Ross RJ, 1999, BIOL PSYCHIAT, V45, P938, DOI 10.1016/S0006-3223(98)00233-9; Rotllant D, 2005, NEUROSCIENCE, V130, P427, DOI 10.1016/j.neuroscience.2004.09.007; Rotllant D, 2002, EUR J NEUROSCI, V16, P693, DOI 10.1046/j.1460-9568.2002.02120.x; Sanford LD, 2010, SLEEP, V33, P621, DOI 10.1093/sleep/33.5.621; Schwierin B, 1999, NEUROSCI LETT, V261, P61, DOI 10.1016/S0304-3940(98)01006-4; SOUSA RJ, 1989, MOL ENDOCRINOL, V3, P481, DOI 10.1210/mend-3-3-481; STERIADE M, 1993, SCIENCE, V262, P679, DOI 10.1126/science.8235588; Suchecki D, 2000, BRAIN RES, V875, P14, DOI 10.1016/S0006-8993(00)02531-2; Suchecki D, 2003, J NEUROENDOCRINOL, V15, P815, DOI 10.1046/j.1365-2826.2003.01067.x; Suchecki Deborah, 2012, Front Neurol, V3, P41, DOI 10.3389/fneur.2012.00041; Tiba PA, 2008, SLEEP, V31, P505, DOI 10.1093/sleep/31.4.505; TIMOIARIA C, 1970, PHYSIOL BEHAV, V5, P1057, DOI 10.1016/0031-9384(70)90162-9; TOBLER I, 1990, BEHAV BRAIN RES, V36, P73, DOI 10.1016/0166-4328(90)90161-7; TOBLER I, 1986, ELECTROEN CLIN NEURO, V64, P74, DOI 10.1016/0013-4694(86)90044-1; TOBLER I, 1983, NEUROSCI LETT, V35, P297, DOI 10.1016/0304-3940(83)90333-6; Vazquez-Palacios G, 2001, PHARMACOL BIOCHEM BE, V70, P305, DOI 10.1016/S0091-3057(01)00620-7; Vazquez-Palacios G, 2000, PHYSIOL BEHAV, V71, P23, DOI 10.1016/S0031-9384(00)00285-7; VONKROSIGK M, 1993, SCIENCE, V261, P361, DOI 10.1126/science.8392750; WETZEL W, 1994, PEPTIDES, V15, P237, DOI 10.1016/0196-9781(94)90008-6; Wetzel W, 1997, NEUROPEPTIDES, V31, P41, DOI 10.1016/S0143-4179(97)90018-4; Zallocchi M, 2004, CAN J PHYSIOL PHARM, V82, P422, DOI 10.1139/Y04-035	88	21	21	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e63520	10.1371/journal.pone.0063520	http://dx.doi.org/10.1371/journal.pone.0063520			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667630	Green Published, gold, Green Submitted			2022-12-27	WOS:000319654700155
J	Olsen, K; Danielsen, K; Wilsgaard, T; Sangvik, M; Sollid, JUE; Thune, I; Eggen, AE; Simonsen, GS; Furberg, AS				Olsen, Karina; Danielsen, Kjersti; Wilsgaard, Tom; Sangvik, Maria; Sollid, Johanna U. E.; Thune, Inger; Eggen, Anne E.; Simonsen, Gunnar S.; Furberg, Anne-Sofie			Obesity and Staphylococcus aureus Nasal Colonization among Women and Men in a General Population	PLOS ONE			English	Article							BODY-FAT DISTRIBUTION; BETA-DEFENSIN 3; PERINEAL CARRIAGE; SEXUAL-DIMORPHISM; SKIN; RISK; INFECTIONS; PREVALENCE; CARRIERS; TROMSO	Background: Obesity and diabetes mellitus (DM) have been linked to increased risk of infections, and Staphylococcus aureus nasal colonization is a major risk factor for developing infections with the microbe. We therefore sought to find whether body mass index (BMI) and waist circumference (WC) could be associated with S. aureus colonization independent of DM. Methodology: S. aureus colonization was assessed by nasal swab cultures among 2,169 women and 1,709 men, aged 30-87 years, in the population-based Tromso Staph and Skin Study in 2007-08. Height (cm), weight (kg), WC (cm), and glycated haemoglobin (HbA1c,%) were measured. Multivariable logistic regression analyses including information on DM, HbA1c, hormonal contraceptive use and other potential confounders were used. Results: In the female population, each 2.5 kg/m(2) increase in BMI was associated with a 7% higher odds of S. aureus nasal colonization (P = 0.01). When comparing obese and lean women aged 30-43 years, we observed that BMI >= 32.5 versus <22.5 kg/m(2) and WC >= 101 versus <80 cm was associated with a 2.60 and 2.12 times higher odds of S. aureus colonization, respectively (95% confidence intervals 1.35-4.98 and 1.17-3.85). Among men, high WC was also associated with S. aureus nasal colonization. The associations did not change significantly when the analysis was restricted to participants without signs of pre-diabetes (HbA1c <6.0%) among women and men, and to non-users of hormonal contraceptives among women. Conclusion: Our results support that obesity is a possible determinant for S. aureus nasal colonization independent of DM, in particular for premenopausal women. The role of obesity at different ages and by sex should be addressed in future prospective studies of S. aureus colonization.	[Olsen, Karina; Simonsen, Gunnar S.; Furberg, Anne-Sofie] Univ Hosp North Norway, Dept Microbiol & Infect Control, Tromso, Norway; [Olsen, Karina; Danielsen, Kjersti; Wilsgaard, Tom; Thune, Inger; Eggen, Anne E.; Furberg, Anne-Sofie] Univ Tromso, Dept Community Med, Fac Hlth Sci, Tromso, Norway; [Danielsen, Kjersti] Univ Hosp North Norway, Dept Dermatol, Tromso, Norway; [Sangvik, Maria; Sollid, Johanna U. E.; Simonsen, Gunnar S.] Univ Tromso, Fac Hlth Sci, Dept Med Biol, Res Grp Host Microbe Interact, Tromso, Norway; [Thune, Inger] Oslo Univ Hosp, Dept Oncol, Oslo, Norway	UiT The Arctic University of Tromso; University Hospital of North Norway; UiT The Arctic University of Tromso; UiT The Arctic University of Tromso; University Hospital of North Norway; UiT The Arctic University of Tromso; University of Oslo	Olsen, K (corresponding author), Univ Hosp North Norway, Dept Microbiol & Infect Control, Tromso, Norway.	karina.olsen@unn.no		Ericson, Johanna Ulrica/0000-0001-5196-4932	Research Council of Norway [191264]; Northern Norway Regional Health Authority [7150.00003, SFP877-09, SFP920-10]; Odd Berg Group Medical Research Grant	Research Council of Norway(Research Council of Norway); Northern Norway Regional Health Authority; Odd Berg Group Medical Research Grant	The study was supported by grants from the Research Council of Norway (grant number 191264), URL: http://www.forskningsradet.no/servlet/Satellite?c=Page&cid=1177315753906&p=1177315753906&pagename=ForskningsradetEngelsk%2FHovedsidemal; Northern Norway Regional Health Authority, 2009 (project number 7150.00003, grant numbers SFP877-09 and SFP920-10), URL: http://www.helse-nord.no/and the Odd Berg Group Medical Research Grant 2007. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baik I, 2000, ARCH INTERN MED, V160, P3082, DOI 10.1001/archinte.160.20.3082; Beery Theresa A, 2003, Crit Care Nurs Clin North Am, V15, P55, DOI 10.1016/S0899-5885(02)00028-X; Biswas B, 2011, AM J REPROD IMMUNOL, V65, P557, DOI 10.1111/j.1600-0897.2010.00937.x; Bode LGM, 2010, NEW ENGL J MED, V362, P9, DOI 10.1056/NEJMoa0808939; CHOBAN PS, 1995, AM SURGEON, V61, P1001; Choban PS, 1997, J AM COLL SURGEONS, V185, P593, DOI 10.1016/S1072-7515(97)00109-9; Eggen AE, 2013, SCAND J PUBLIC HEALT, V41, P65, DOI 10.1177/1403494812469851; Falagas ME, 2006, LANCET INFECT DIS, V6, P438, DOI 10.1016/S1473-3099(06)70523-0; Gorwitz RJ, 2008, J INFECT DIS, V197, P1226, DOI 10.1086/533494; Han JH, 2010, CYTOKINE, V49, P209, DOI 10.1016/j.cyto.2009.09.005; Herwaldt LA, 2004, INFECT CONT HOSP EP, V25, P481, DOI 10.1086/502426; HOEGER PH, 1992, J INFECT DIS, V165, P1064, DOI 10.1093/infdis/165.6.1064; Jacobsen BK, 2012, INT J EPIDEMIOL, V41, P961, DOI 10.1093/ije/dyr049; Kahn SE, 2006, NATURE, V444, P840, DOI 10.1038/nature05482; Kanda N, 2008, ENDOCRINOLOGY, V149, P5189, DOI 10.1210/en.2008-0343; Karlsson EA, 2010, EXP BIOL MED, V235, P1412, DOI 10.1258/ebm.2010.010227; King AE, 2003, J REPROD IMMUNOL, V59, P1, DOI 10.1016/S0165-0378(02)00083-9; KOTANI K, 1994, INT J OBESITY, V18, P207; Lamaro-Cardoso J, 2009, J CLIN MICROBIOL, V47, P3991, DOI 10.1128/JCM.01322-09; Liedtke S, 2012, OBESITY, V20, P1088, DOI 10.1038/oby.2011.383; LIPSKY BA, 1987, DIABETES CARE, V10, P483, DOI 10.2337/diacare.10.4.483; Little RR, 2011, CLIN CHEM, V57, P205, DOI 10.1373/clinchem.2010.148841; Marriott I, 2006, IMMUNOL RES, V34, P177, DOI 10.1385/IR:34:3:177; Meli R, 2004, ENDOCRINOLOGY, V145, P3115, DOI 10.1210/en.2004-0129; Myles TD, 2002, OBSTET GYNECOL, V100, P959, DOI 10.1016/S0029-7844(02)02323-2; Nathan DM, 2009, DIABETES CARE, V32, P1327, DOI 10.2337/dc09-9033; Nouwen J.L., 2004, THESIS ERASMUS U MED; Olsen K, 2012, EUR J CLIN MICROBIOL, V31, P465, DOI 10.1007/s10096-011-1331-x; Olsen K, 2012, EPIDEMIOL INFECT, P1; Pandey Shilpi, 2010, J Hum Reprod Sci, V3, P62, DOI 10.4103/0974-1208.69332; PEDERSEN SB, 1995, EUR J ENDOCRINOL, V133, P200, DOI 10.1530/eje.0.1330200; Phillips LK, 2008, CURR HYPERTENS REP, V10, P156, DOI 10.1007/s11906-008-0029-7; Pickkers P, 2004, NETH J MED, V62, P143; RIDLEY M, 1959, BRIT MED J, V1, P270, DOI 10.1136/bmj.1.5117.270; Rohrmann S, 2011, CANCER CAUSE CONTROL, V22, P1141, DOI 10.1007/s10552-011-9790-z; Sangvik M, 2011, J CLIN MICROBIOL, V49, P4213, DOI 10.1128/JCM.05290-11; Strandberg L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007605; van Belkum A, 2009, INFECT GENET EVOL, V9, P32, DOI 10.1016/j.meegid.2008.09.012; VARGA DT, 1961, J CLIN INVEST, V40, P2209, DOI 10.1172/JCI104447; von Eiff C, 2001, NEW ENGL J MED, V344, P11, DOI 10.1056/NEJM200101043440102; Wertheim HFL, 2005, LANCET INFECT DIS, V5, P751, DOI 10.1016/S1473-3099(05)70295-4; Wertheim HFL, 2005, ANTIMICROB AGENTS CH, V49, P1465, DOI 10.1128/AAC.49.4.1465-1467.2005; Wertheim HFL, 2004, LANCET, V364, P703, DOI 10.1016/S0140-6736(04)16897-9; WILLIAMS RE, 1963, BACTERIOL REV, V27, P56, DOI 10.1128/MMBR.27.1.56-71.1963; World Health Organization, 2008, WAIST CIRCUMFERENCE; World Health Organization, GLOB DAT BOD MASS IN; Zanger P, 2012, CLIN INFECT DIS, V55, P1625, DOI 10.1093/cid/cis778; Zanger P, 2011, INFECT IMMUN, V79, P2658, DOI 10.1128/IAI.00101-11; Zanger P, 2010, INFECT IMMUN, V78, P3112, DOI 10.1128/IAI.00078-10; Zeigler CC, 2012, OBESITY, V20, P157, DOI 10.1038/oby.2011.305	50	39	40	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e63716	10.1371/journal.pone.0063716	http://dx.doi.org/10.1371/journal.pone.0063716			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667661	Green Published, gold, Green Submitted			2022-12-27	WOS:000319654700179
J	Devambez, I; Agha, MA; Mitri, C; Bockaert, J; Parmentier, ML; Marion-Poll, F; Grau, Y; Soustelle, L				Devambez, Isabelle; Agha, Moutaz Ali; Mitri, Christian; Bockaert, Joel; Parmentier, Marie-Laure; Marion-Poll, Frederic; Grau, Yves; Soustelle, Laurent			G alpha o Is Required for L-Canavanine Detection in Drosophila	PLOS ONE			English	Article							METABOTROPIC GLUTAMATE RECEPTORS; CANDIDATE TASTE RECEPTORS; 2ND INTRACELLULAR LOOP; GUSTATORY RECEPTORS; MULTIPLE RECEPTORS; SUGAR PERCEPTION; UMAMI TASTE; G-PROTEINS; TRANSDUCTION; MELANOGASTER	Taste is an essential sense for the survival of most organisms. In insects, taste is particularly important as it allows to detect and avoid ingesting many plant toxins, such as L-canavanine. We previously showed that L-canavanine is toxic for Drosophila melanogaster and that flies are able to detect this toxin in the food. L-canavanine is a ligand of DmXR, a variant G-protein coupled receptor (GPCR) belonging to the metabotropic glutamate receptor subfamily that is expressed in bitter-sensitive taste neurons of Drosophila. To transduce the signal intracellularly, GPCR activate heterotrimeric G proteins constituted of alpha, beta and gamma subunits. The aim of this study was to identify which G alpha protein was required for L-canavanine detection in Drosophila. By using a pharmacological approach, we first demonstrated that DmXR has the best coupling with G alpha(o) protein subtype. Then, by using genetic, behavioral assays and electrophysiology, we found that G alpha o47A is required in bitter-sensitive taste neurons for L-canavanine sensitivity. In conclusion, our study revealed that G alpha o47A plays a crucial role in L-canavanine detection.	[Devambez, Isabelle; Bockaert, Joel; Parmentier, Marie-Laure; Grau, Yves; Soustelle, Laurent] CNRS, Inst Genom Fonctionnelle, UMR 5203, Montpellier, France; [Devambez, Isabelle; Bockaert, Joel; Parmentier, Marie-Laure; Grau, Yves; Soustelle, Laurent] INSERM, U661, Montpellier, France; [Devambez, Isabelle; Bockaert, Joel; Parmentier, Marie-Laure; Grau, Yves; Soustelle, Laurent] Univ Montpellier I, Montpellier, France; [Devambez, Isabelle; Bockaert, Joel; Parmentier, Marie-Laure; Grau, Yves; Soustelle, Laurent] Univ Montpellier 2, UMR 5203, Montpellier, France; [Agha, Moutaz Ali; Marion-Poll, Frederic] INRA, UMR 1272, F-78026 Versailles, France; [Agha, Moutaz Ali; Marion-Poll, Frederic] Univ Paris 06, UMR Physiol Insecte 1272, Versailles, France; [Agha, Moutaz Ali; Marion-Poll, Frederic] AgroParisTech, Dept Sci Vie & Sante, Paris, France; [Mitri, Christian] Inst Pasteur, CNRS, URA3012, Unite Genet & Genom Insectes Vecteurs, Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; Ecole Normale Superieure de Lyon (ENS de LYON); Universite de Montpellier; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier; INRAE; UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Sorbonne Universite; AgroParisTech; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Soustelle, L (corresponding author), CNRS, Inst Genom Fonctionnelle, UMR 5203, Montpellier, France.	Laurent.Soustelle@igf.cnrs.fr	Parmentier, Marie-Laure/N-9915-2017; Frederic, Marion-Poll/I-1358-2019	Parmentier, Marie-Laure/0000-0001-6133-3413; Frederic, Marion-Poll/0000-0001-6824-0180; Soustelle, Laurent/0000-0003-1034-2955; Mitri, Christian/0000-0003-3882-2029	French Ministry of Research and Technology; Syrian government	French Ministry of Research and Technology; Syrian government	ID was supported by a fellowship from the French Ministry of Research and Technology. MAA was funded by a grant from the Syrian government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bessis AS, 2002, P NATL ACAD SCI USA, V99, P11097, DOI 10.1073/pnas.162138699; Bredendiek N, 2011, CHEM SENSES, V36, P69, DOI 10.1093/chemse/bjq100; Cabrera-Vera TM, 2003, ENDOCR REV, V24, P765, DOI 10.1210/er.2000-0026; Cameron P, 2010, NATURE, V465, P91, DOI 10.1038/nature09011; Chen ZJ, 2010, J NEUROSCI, V30, P6247, DOI 10.1523/JNEUROSCI.0627-10.2010; Clyne PJ, 2000, SCIENCE, V287, P1830, DOI 10.1126/science.287.5459.1830; CONKLIN BR, 1993, NATURE, V363, P274, DOI 10.1038/363274a0; Conn PJ, 1997, ANNU REV PHARMACOL, V37, P205, DOI 10.1146/annurev.pharmtox.37.1.205; Dethier VG, 1976, HUNGRY FLY; Dunipace L, 2001, CURR BIOL, V11, P822, DOI 10.1016/S0960-9822(01)00258-5; Ferris J, 2006, NAT NEUROSCI, V9, P1036, DOI 10.1038/nn1738; Giannone F, 2010, J MOL ENDOCRINOL, V44, P259, DOI 10.1677/JME-09-0134; Gomeza J, 1996, J BIOL CHEM, V271, P2199, DOI 10.1074/jbc.271.4.2199; Hiroi M, 2002, ZOOL SCI, V19, P1009, DOI 10.2108/zsj.19.1009; Ishimoto H, 2005, EMBO J, V24, P3259, DOI 10.1038/sj.emboj.7600796; Jiao YC, 2008, CURR BIOL, V18, P1797, DOI 10.1016/j.cub.2008.10.009; Kain P, 2010, CHEM SENSES, V35, P663, DOI 10.1093/chemse/bjq055; Kang K, 2010, NATURE, V464, P597, DOI 10.1038/nature08848; Katanaev VL, 2005, CELL, V120, P111, DOI 10.1016/j.cell.2004.11.014; Lee Y, 2012, J NEUROSCI, V32, P1429, DOI 10.1523/JNEUROSCI.4630-11.2012; Lee Y, 2010, NEURON, V67, P555, DOI 10.1016/j.neuron.2010.07.006; Liman E. R., 2007, V179, P287; Liu L, 2003, NEURON, V39, P133, DOI 10.1016/S0896-6273(03)00394-5; MarionPoll F, 1996, ENTOMOL EXP APPL, V80, P113, DOI 10.1007/BF00194738; MarionPoll F, 1996, ENTOMOL EXP APPL, V80, P116, DOI 10.1007/BF00194739; Milligan G, 2006, BRIT J PHARMACOL, V147, pS46, DOI 10.1038/sj.bjp.0706405; Milligan G, 1996, TRENDS PHARMACOL SCI, V17, P235, DOI 10.1016/0165-6147(96)10026-2; Mitri C, 2004, J BIOL CHEM, V279, P9313, DOI 10.1074/jbc.M310878200; Mitri C, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000147; Miyamoto T, 2008, NAT NEUROSCI, V11, P874, DOI 10.1038/nn.2161; Moon SJ, 2006, CURR BIOL, V16, P1812, DOI 10.1016/j.cub.2006.07.024; Moon SJ, 2009, CURR BIOL, V19, P1623, DOI 10.1016/j.cub.2009.07.061; MOSS J, 1988, ADV ENZYMOL RAMB, V61, P303; Ouyang Q, 2009, COMP BIOCHEM PHYS A, V153, P309, DOI 10.1016/j.cbpa.2009.03.004; Parmentier ML, 2000, NEUROPHARMACOLOGY, V39, P1119, DOI 10.1016/S0028-3908(99)00204-X; PIN JP, 1995, CURR OPIN NEUROBIOL, V5, P342, DOI 10.1016/0959-4388(95)80047-6; PIN JP, 1995, BIOCHEM SOC T, V23, P91, DOI 10.1042/bst0230091; PROVOST NM, 1988, J BIOL CHEM, V263, P12070; Rosenthal GA, 2001, AMINO ACIDS, V21, P319, DOI 10.1007/s007260170017; Sato K, 2008, NATURE, V452, P1002, DOI 10.1038/nature06850; Sato K, 2011, P NATL ACAD SCI USA, V108, P11680, DOI 10.1073/pnas.1019622108; Simon SA, 2006, NAT REV NEUROSCI, V7, P890, DOI 10.1038/nrn2006; Ueno K, 2006, J NEUROSCI, V26, P6143, DOI 10.1523/JNEUROSCI.0857-06.2006; Vosshall LB, 2007, ANNU REV NEUROSCI, V30, P505, DOI 10.1146/annurev.neuro.30.051606.094306; Watanabe K, 2011, BEHAV GENET, V41, P746, DOI 10.1007/s10519-011-9461-6; Weiss LA, 2011, NEURON, V69, P258, DOI 10.1016/j.neuron.2011.01.001; Wicher D, 2008, NATURE, V452, P1007, DOI 10.1038/nature06861; Yarmolinsky DA, 2009, CELL, V139, P234, DOI 10.1016/j.cell.2009.10.001; Yasumatsu K, 2012, J PHYSIOL-LONDON, V590, P1155, DOI 10.1113/jphysiol.2011.211920; Yasumatsu K, 2009, AM J CLIN NUTR, V90, p747S, DOI 10.3945/ajcn.2009.27462J; Zhang HJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024111; Zhao GQ, 2003, CELL, V115, P255, DOI 10.1016/S0092-8674(03)00844-4	52	12	12	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2013	8	5							e63484	10.1371/journal.pone.0063484	http://dx.doi.org/10.1371/journal.pone.0063484			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	177QL	23671680	gold, Green Published, Green Submitted			2022-12-27	WOS:000321390200050
J	Fekete, T; Wilf, M; Rubin, D; Edelman, S; Malach, R; Mujica-Parodi, LR				Fekete, Tomer; Wilf, Meytal; Rubin, Denis; Edelman, Shimon; Malach, Rafael; Mujica-Parodi, Lilianne R.			Combining Classification with fMRI-Derived Complex Network Measures for Potential Neurodiagnostics	PLOS ONE			English	Article							FUNCTIONAL CONNECTIVITY; BRAIN NETWORKS; EEG; SCHIZOPHRENIA; COHERENCE; HEALTH	Complex network analysis (CNA), a subset of graph theory, is an emerging approach to the analysis of functional connectivity in the brain, allowing quantitative assessment of network properties such as functional segregation, integration, resilience, and centrality. Here, we show how a classification framework complements complex network analysis by providing an efficient and objective means of selecting the best network model characterizing given functional connectivity data. We describe a novel kernel-sum learning approach, block diagonal optimization (BDopt), which can be applied to CNA features to single out graph-theoretic characteristics and/or anatomical regions of interest underlying discrimination, while mitigating problems of multiple comparisons. As a proof of concept for the method's applicability to future neurodiagnostics, we apply BDopt classification to two resting state fMRI data sets: a trait (between-subjects) classification of patients with schizophrenia vs. controls, and a state (within-subjects) classification of wake vs. sleep, demonstrating powerful discriminant accuracy for the proposed framework.	[Fekete, Tomer; Rubin, Denis; Mujica-Parodi, Lilianne R.] SUNY Stony Brook, Dept Biomed Engn, Stony Brook, NY 11794 USA; [Wilf, Meytal; Malach, Rafael] Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel; [Edelman, Shimon] Cornell Univ, Dept Psychol, Ithaca, NY 14853 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Weizmann Institute of Science; Cornell University	Mujica-Parodi, LR (corresponding author), SUNY Stony Brook, Dept Biomed Engn, Stony Brook, NY 11794 USA.	lmujicaparodi@gmail.com		Rubin, Denis/0000-0002-0483-9458; Mujica-Parodi, Lilianne Rivka/0000-0002-3752-5519; Fekete, Tomer/0000-0003-3164-125X; Wilf, Meytal/0000-0002-4037-8505	Office of Naval Research [N000140410051]; National Science Foundation [0954643]; Div Of Chem, Bioeng, Env, & Transp Sys [0954643, 1141995] Funding Source: National Science Foundation	Office of Naval Research(Office of Naval Research); National Science Foundation(National Science Foundation (NSF)); Div Of Chem, Bioeng, Env, & Transp Sys(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG))	This research was supported by the Office of Naval Research, Grant #N000140410051 (LRMP) and the National Science Foundation, Grant #0954643 (LRMP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achard S, 2006, J NEUROSCI, V26, P63, DOI 10.1523/JNEUROSCI.3874-05.2006; Anand A, 2005, NEUROPSYCHOPHARMACOL, V30, P1334, DOI 10.1038/sj.npp.1300725; [Anonymous], NEUROIMAGE; [Anonymous], J NEUROSCIENCE METHO; Bassett DS, 2008, J NEUROSCI, V28, P9239, DOI 10.1523/JNEUROSCI.1929-08.2008; Bassett DS, 2009, CURR OPIN NEUROL, V22, P340, DOI 10.1097/WCO.0b013e32832d93dd; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Chang C.-C., 2011, ACM T INTEL SYST TEC, V2, P1, DOI [10.1145/1961189.1961199, DOI 10.1145/1961189.1961199]; Eguiluz VM, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.018102; Fan JQ, 2008, ANN STAT, V36, P2605, DOI 10.1214/07-AOS504; Fekete T, 2009, J COMPUT NEUROSCI, V27, P211, DOI 10.1007/s10827-009-0138-6; Fisher RA, 1922, J R STAT SOC, V85, P87, DOI 10.2307/2340521; FREEMAN LC, 1979, SOC NETWORKS, V1, P215, DOI 10.1016/0378-8733(78)90021-7; Friston KJ, 1995, HUM BRAIN MAPP, V3, P56, DOI 10.1002/hbm.460030106; Friston KJ, 1994, HUMAN BRAIN MAPPING, V2, P189, DOI DOI 10.1002/HBM.460020402; Humphries MD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002051; Iturria-Medina Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019071; Jeong J, 2001, CLIN NEUROPHYSIOL, V112, P827, DOI 10.1016/S1388-2457(01)00513-2; Lanckriet GRG, 2004, J MACH LEARN RES, V5, P27; Latora V, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.198701; Leung CC, 2007, PHYSICA A, V378, P591, DOI 10.1016/j.physa.2006.12.022; Liu Y, 2008, BRAIN, V131, P945, DOI 10.1093/brain/awn018; Lord A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041282; Lynall ME, 2010, J NEUROSCI, V30, P9477, DOI 10.1523/JNEUROSCI.0333-10.2010; Maldjian JA, 2003, NEUROIMAGE, V19, P1233, DOI 10.1016/S1053-8119(03)00169-1; Massimini M, 2005, SCIENCE, V309, P2228, DOI 10.1126/science.1117256; Massimini M, 2010, COGN NEUROSCI-UK, V1, P176, DOI 10.1080/17588921003731578; Murias M, 2007, BIOL PSYCHIAT, V62, P270, DOI 10.1016/j.biopsych.2006.11.012; Na SH, 2002, CLIN NEUROPHYSIOL, V113, P1954, DOI 10.1016/S1388-2457(02)00197-9; Newman MEJ, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.066133; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; Nyssen E., 1998, Advances in Pattern Recognition. Joint IAPR International Workshops SSPR'98 and SPR'98. Proceedings, P890, DOI 10.1007/BFb0033316; Power JD, 2011, NEUROIMAGE; Radulescu AR, 2008, NEUROPSYCHOBIOLOGY, V57, P206, DOI 10.1159/000151731; Rissman J, 2004, NEUROIMAGE, V23, P752, DOI 10.1016/j.neuroimage.2004.06.035; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Salomon R, 2011, J NEUROSCI, V31, P12972, DOI 10.1523/JNEUROSCI.2987-11.2011; Salvador R, 2005, CEREB CORTEX, V15, P1332, DOI 10.1093/cercor/bhi016; Siegle GJ, 2007, BIOL PSYCHIAT, V61, P198, DOI 10.1016/j.biopsych.2006.05.048; Smith SM, 2011, NEUROIMAGE, V54, P875, DOI 10.1016/j.neuroimage.2010.08.063; Spoormaker VI, 2010, J NEUROSCI, V30, P11379, DOI 10.1523/JNEUROSCI.2015-10.2010; Sun FT, 2004, NEUROIMAGE, V21, P647, DOI 10.1016/j.neuroimage.2003.09.056; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; van den Heuvel MP, 2010, J NEUROSCI, V30, P15915, DOI 10.1523/JNEUROSCI.2874-10.2010; Wang LA, 2010, J NEUROSCI, V30, P13171, DOI 10.1523/JNEUROSCI.3514-10.2010; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Zhang JR, 2011, BIOL PSYCHIAT, V70, P334, DOI 10.1016/j.biopsych.2011.05.018	47	33	33	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2013	8	5							e62867	10.1371/journal.pone.0062867	http://dx.doi.org/10.1371/journal.pone.0062867			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	177QL	23671641	Green Submitted, gold, Green Published			2022-12-27	WOS:000321390200039
J	Kristensen, NP; De Barro, PJ; Schellhorn, NA				Kristensen, Nadiah P.; De Barro, Paul J.; Schellhorn, Nancy A.			The Initial Dispersal and Spread of an Intentional Invader at Three Spatial Scales	PLOS ONE			English	Article							LONG-DISTANCE DISPERSAL; TABACI GENNADIUS HEMIPTERA; BIOLOGICAL-CONTROL AGENT; BEMISIA-TABACI; ERETMOCERUS-EREMICUS; HYMENOPTERA-APHELINIDAE; GONATOCERUS-ASHMEADI; ENCARSIA-FORMOSA; FLIGHT BEHAVIOR; INVASION	The way an invasion progresses through space is a theme of interest common to invasion ecology and biological pest control. Models and mark-release studies of arthropods have been used extensively to extend and inform invasion processes of establishment and spread. However, the extremely common single-scale approach of monitoring initial spread leads to misinterpretation of rate and mode. Using the intentional release of a novel biological control agent (a parasitic hymenoptera, Eretmocerus hayati Zolnerowich & Rose (Hymenoptera: Aphelinidae), we studied its initial dispersal and spread at three different spatial scales, the local scale (tens of metres), field scale (hundreds of metres) and landscape scale (kilometres) around the release point. We fit models to each observed spread pattern at each spatial scale. We show that E. hayati exhibits stratified dispersal; moving further, faster and by a different mechanism than would have been concluded with a single local-scale post-release sampling design. In fact, interpretation of each scale independent of other scales gave three different models of dispersal, and three different impressions of the dominant dispersal mechanisms. Our findings demonstrate that using a single-scale approach may lead to quite erroneous conclusions, hence the necessity of using a multiple-scale hierarchical sampling design for inferring spread and the dominant dispersal mechanism of either human intended or unintended invasions.	[Kristensen, Nadiah P.; De Barro, Paul J.; Schellhorn, Nancy A.] Commonwealth Sci & Ind Res Org, Brisbane, Qld, Australia	Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Schellhorn, NA (corresponding author), Commonwealth Sci & Ind Res Org, Brisbane, Qld, Australia.	nancy.schellhorn@csiro.au	Schellhorn, Nancy/B-6716-2009; De Barro, Paul J/C-1724-2008		Horticulture Australia from the vegetable industry levy; Australian Government	Horticulture Australia from the vegetable industry levy; Australian Government(Australian GovernmentCGIAR)	The project was funded by Horticulture Australia from the vegetable industry levy and matched funds from the Australian Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANTOLIN MF, 1987, OECOLOGIA, V73, P288, DOI 10.1007/BF00377520; Asplen MK, 2009, PHYSIOL ENTOMOL, V34, P350, DOI 10.1111/j.1365-3032.2009.00698.x; Bellamy DE, 2001, ECOL ENTOMOL, V26, P571, DOI 10.1046/j.1365-2311.2001.00370.x; BLACKMER JL, 1993, PHYSIOL ENTOMOL, V18, P223, DOI 10.1111/j.1365-3032.1993.tb00592.x; Blackmer JL, 2001, ENTOMOL EXP APPL, V100, P295, DOI 10.1023/A:1019278205175; BLACKMER JL, 1993, PHYSIOL ENTOMOL, V18, P336, DOI 10.1111/j.1365-3032.1993.tb00606.x; Bled F, 2011, ECOL APPL, V21, P290, DOI 10.1890/09-1877.1; Brewster CC, 1997, ENVIRON ENTOMOL, V26, P473, DOI 10.1093/ee/26.3.473; Brewster CC, 1997, ENVIRON ENTOMOL, V26, P603, DOI 10.1093/ee/26.3.603; Byrne D, 2001, 148 NCR; Chauzat MP, 2002, ANN APPL BIOL, V141, P293, DOI 10.1111/j.1744-7348.2002.tb00221.x; CHEEK S, 1994, PESTIC SCI, V42, P135, DOI 10.1002/ps.2780420211; De Barro PJ, 2009, B ENTOMOL RES, V99, P193, DOI 10.1017/S0007485308006445; De Barro PJ, 2000, AUST J ENTOMOL, V39, P259, DOI 10.1046/j.1440-6055.2000.00194.x; De Barro PJ, 2001, ENTOMOL EXP APPL, V99, P225, DOI 10.1046/j.1570-7458.2001.00821.x; Dinsdale A, 2010, ANN ENTOMOL SOC AM, V103, P196, DOI 10.1603/AN09061; Ehler LE, 1998, BIOL CONTROL, V13, P127, DOI 10.1006/bcon.1998.0649; Elzinga JA, 2007, BASIC APPL ECOL, V8, P75, DOI 10.1016/j.baae.2006.04.003; Fagan WF, 2002, ECOL LETT, V5, P148, DOI 10.1046/j.1461-0248.2002.0_285.x; Fauvergue X, 2009, POPUL ECOL, V51, P385, DOI 10.1007/s10144-009-0147-3; Ferguson CM, 1997, PROCEEDINGS OF THE FIFTIETH NEW ZEALAND PLANT PROTECTION CONFERENCE, P41, DOI 10.30843/nzpp.1997.50.11274; FREEMAN JA, 1945, J ANIM ECOL, V14, P128, DOI 10.2307/1389; Gerling D, 1998, BIOCONTROL, V43, P289, DOI 10.1023/A:1009905525300; Gilbert M, 2004, J ANIM ECOL, V73, P459, DOI 10.1111/j.0021-8790.2004.00820.x; Glick PA, 1939, DISTRIBUTION INSECTS; Godfray H. C. J., 1994, PARASITOIDS BEHAV EV, DOI 10.1515/9780691207025; Grillenberger BK, 2009, ENTOMOL EXP APPL, V132, P147, DOI 10.1111/j.1570-7458.2009.00881.x; GUNNING RV, 1995, J AUST ENTOMOL SOC, V34, P116; Hastings A, 2005, ECOL LETT, V8, P91, DOI 10.1111/j.1461-0248.2004.00687.x; Hastings A, 2000, PARASITOID POPULATION BIOLOGY, P70; Havel JE, 2006, BIOL INVASIONS, V8, P459, DOI 10.1007/s10530-005-6410-4; Hirose Y, 2009, APPL ENTOMOL ZOOL, V44, P175, DOI 10.1303/aez.2009.175; Ims Rolf A., 2001, P203; KAREIVA PM, 1983, OECOLOGIA, V57, P322, DOI 10.1007/BF00377175; Koch FH, 2012, J ECON ENTOMOL, V105, P438, DOI 10.1603/EC11270; Kot M, 1996, ECOLOGY, V77, P2027, DOI 10.2307/2265698; Kristensen N, ENV ENTOM UNPUB; LeBrun EG, 2008, BIOL INVASIONS, V10, P989, DOI 10.1007/s10530-007-9177-y; LIEBHOLD AM, 1992, J BIOGEOGR, V19, P513, DOI 10.2307/2845770; Liebhold AM, 2008, ANNU REV ENTOMOL, V53, P387, DOI 10.1146/annurev.ento.52.110405.091401; MCCLURE MS, 1990, ENVIRON ENTOMOL, V19, P36, DOI 10.1093/ee/19.1.36; Moiroux J, 2010, ECOL ENTOMOL, V35, P727, DOI 10.1111/j.1365-2311.2010.01233.x; Nathan R, 2005, DIVERS DISTRIB, V11, P125, DOI 10.1111/j.1366-9516.2005.00159.x; Nathan R, 2008, P NATL ACAD SCI USA, V105, P19052, DOI 10.1073/pnas.0800375105; Pauchard A, 2006, BIOL INVASIONS, V8, P399, DOI 10.1007/s10530-005-6419-8; PERRY JN, 1995, J ANIM ECOL, V64, P303, DOI 10.2307/5892; Perry JN, 2002, ECOSCIENCE, V9, P133, DOI 10.1080/11956860.2002.11682699; Perry JN, 1999, ECOL LETT, V2, P106, DOI 10.1046/j.1461-0248.1999.22057.x; Petit JN, 2008, BIOL CONTROL, V45, P344, DOI 10.1016/j.biocontrol.2008.01.020; Petit JN, 2009, BIOCONTROL, V54, P485, DOI 10.1007/s10526-008-9204-7; Puth LM, 2005, ECOL LETT, V8, P715, DOI 10.1111/j.1461-0248.2005.00774.x; Qiu YT, 2004, EUR J ENTOMOL, V101, P83, DOI 10.14411/eje.2004.017; Shea K, 2000, J APPL ECOL, V37, P77, DOI 10.1046/j.1365-2664.2000.00467.x; Shigesada N., 1997, BIOL INVASIONS THEOR; Simmons GS, 2000, THESIS U ARIZONA TUC; Suarez AV, 2001, P NATL ACAD SCI USA, V98, P1095, DOI 10.1073/pnas.98.3.1095; Turchin Peter, 1998; Venette RC, 2004, ANN ENTOMOL SOC AM, V97, P219, DOI 10.1603/0013-8746(2004)097[0219:ATIBSA]2.0.CO;2; Villanueva-Jimenez JA, 2012, BIOL CONTROL, V63, P333, DOI 10.1016/j.biocontrol.2012.09.002; WIENS JA, 1993, OIKOS, V66, P369, DOI 10.2307/3544931; Williamson M., 1996, BIOL INVASIONS; With KA, 2002, CONSERV BIOL, V16, P1192, DOI 10.1046/j.1523-1739.2002.01064.x; Wright MG, 2001, BIOL CONTROL, V22, P29, DOI 10.1006/bcon.2001.0948	63	14	14	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2013	8	5							e62407	10.1371/journal.pone.0062407	http://dx.doi.org/10.1371/journal.pone.0062407			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	177QL	23671595	Green Published, Green Submitted, gold			2022-12-27	WOS:000321390200022
J	Leung, ES; Auge, AA; Chilvers, BL; Moore, AB; Robertson, BC				Leung, Elaine S.; Auge, Amelie A.; Chilvers, B. Louise; Moore, Antoni B.; Robertson, Bruce C.			Foraging Behaviour of Juvenile Female New Zealand Sea Lions (Phocarctos hookeri) in Contrasting Environments	PLOS ONE			English	Article							ANTARCTIC FUR SEALS; DIVING BEHAVIOR; BODY-SIZE; EUMETOPIAS-JUBATUS; DIET; DECLINE; MANAGEMENT; ABUNDANCE; PATTERNS; SURVIVAL	Foragers can show adaptive responses to changes within their environment through morphological and behavioural plasticity. We investigated the plasticity in body size, at sea movements and diving behaviour of juvenile female New Zealand (NZ) sea lions (Phocarctos hookeri) in two contrasting environments. The NZ sea lion is one of the rarest pinnipeds in the world. Most of the species is based at the subantarctic Auckland Islands (AI; considered to be marginal foraging habitat), with a recolonizing population on the Otago Peninsula, NZ mainland (considered to be more optimal habitat). We investigated how juvenile NZ sea lions adjust their foraging behaviour in contrasting environments by deploying satellite-linked platform transmitting terminals (PTTs) and time-depth recorders (TDRs) on 2-3 year-old females at AI (2007-2010) and Otago (2009-2010). Juvenile female NZ sea lions exhibited plasticity in body size and behaviour. Otago juveniles were significantly heavier than AI juveniles. Linear mixed effects models showed that study site had the most important effect on foraging behaviour, while mass and age had little influence. AI juveniles spent more time at sea, foraged over larger areas, and dove deeper and longer than Otago juveniles. It is difficult to attribute a specific cause to the observed contrasts in foraging behaviour because these differences may be driven by disparities in habitat/prey characteristics, conspecific density levels or interseasonal variation. Nevertheless, the smaller size and increased foraging effort of AI juveniles, combined with the lower productivity in this region, support the hypothesis that AI are less optimal habitat than Otago. It is more difficult for juveniles to forage in suboptimal habitats given their restricted foraging ability and lower tolerance for food limitation compared to adults. Thus, effective management measures should consider the impacts of low resource environments, along with changes that can alter food availability such as potential resource competition with fisheries.	[Leung, Elaine S.; Auge, Amelie A.; Robertson, Bruce C.] Univ Otago, Dept Zool, POB 56, Dunedin, New Zealand; [Leung, Elaine S.; Auge, Amelie A.; Moore, Antoni B.] Univ Otago, Sch Surveying, Dunedin, New Zealand; [Chilvers, B. Louise] Aquat & Threats Unit, Dept Conservat, Wellington, New Zealand	University of Otago; University of Otago	Leung, ES (corresponding author), Univ Otago, Dept Zool, POB 56, Dunedin, New Zealand.	elaineswleung@gmail.com	Chilvers, B. Louise/AAV-1965-2021	Chilvers, B. Louise/0000-0002-7657-4217	New Zealand Department of Conservation (DOC) [1638]; DOC project Pop [2007/01]; University of Otago Zoology Department; University of Otago	New Zealand Department of Conservation (DOC); DOC project Pop; University of Otago Zoology Department; University of Otago	Data presented in this paper were collected from a long-term study funded by the New Zealand Department of Conservation (DOC) investigation no. 1638, in parallel with fieldwork undertaken for the DOC Conservation Services Program (DOC project Pop 2007/01; http://www.doc.govt.nz/conservation/marine-and-coastal/commercial-fishing/conservation-services-programme/) and through a levy principally on the quota holders of SQU6T. Funding was also provided by the University of Otago Zoology Department. E. L. and A. A. were supported by University of Otago Postgraduate Scholarships. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonzo SH, 2003, J APPL ECOL, V40, P692, DOI 10.1046/j.1365-2664.2003.00830.x; Andersen SM, 2007, ICES J MAR SCI, V64, P1235, DOI 10.1093/icesjms/fsm092; [Anonymous], 2010, R LANG ENV STAT COMP; Auge AA, 2012, NEW ZEAL J MAR FRESH, V46, P97, DOI 10.1080/00288330.2011.606326; Auge AA, 2011, MAR ECOL PROG SER, V432, P247, DOI 10.3354/meps09176; Auge AA, 2011, FORAGING ECOLOGY REC; Auge AA, 2011, CAN J ZOOL, V89, P1195, DOI 10.1139/Z11-098; Ayling T., 1982, COLLINS GUIDE SEA FI; Baker CS, 2010, NEW ZEAL J MAR FRESH, V44, P101, DOI 10.1080/00288330.2010.482970; Barton K., 2010, **DATA OBJECT**; Bojarska K, 2012, MAMMAL REV, V42, P120, DOI 10.1111/j.1365-2907.2011.00192.x; Bolnick DI, 2003, INTEGR COMP BIOL, V43, P1078; Bradford-Grieve JM, 2003, J EXP MAR BIOL ECOL, V289, P223, DOI 10.1016/S0022-0981(03)00045-5; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Childerhouse S, 1998, NEW ZEAL J ZOOL, V25, P1, DOI 10.1080/03014223.1998.9518131; Childerhouse SJ, 2010, J MAMMAL, V91, P165, DOI 10.1644/09-MAMM-A-110R.1; Chilvers BL, 2008, J ZOOL, V276, P28, DOI 10.1111/j.1469-7998.2008.00463.x; Chilvers BL, 2006, J ZOOL, V269, P233, DOI 10.1111/j.1469-7998.2006.00059.x; Chilvers BL, 2010, J MAMMAL, V91, P758, DOI 10.1644/09-MAMM-A-285.1; Chilvers BL, 2010, J AGR BIOL ENVIR ST, V15, P259, DOI 10.1007/s13253-009-0011-0; Chilvers B. Louise, 2008, Endangered Species Research, V5, P193, DOI 10.3354/esr00086; Chilvers BL, 2005, MAR ECOL PROG SER, V304, P235, DOI 10.3354/meps304235; COSTA DP, 1989, ECOLOGY, V70, P596, DOI 10.2307/1940211; Craig MP, 1999, MAR MAMMAL SCI, V15, P786, DOI 10.1111/j.1748-7692.1999.tb00843.x; Daunt F, 2007, BIOL LETTERS, V3, P371, DOI 10.1098/rsbl.2007.0157; ESRI, 2009, ARCGIS DESKT 9 3 1; Feldman GC, 2006, OCEAN COLOR WEB MODI; Finkelstein ME, 2010, ANIM CONSERV, V13, P148, DOI 10.1111/j.1469-1795.2009.00311.x; Freitas C, 2008, MAR MAMMAL SCI, V24, P315, DOI 10.1111/j.1748-7692.2007.00180.x; Gales NJ, 1999, WILDLIFE RES, V26, P35, DOI 10.1071/WR98022; Gales NJ, 1997, CAN J ZOOL, V75, P1695, DOI 10.1139/z97-796; Gales NJ, 1998, MAR MAMMAL SCI, V14, P355, DOI 10.1111/j.1748-7692.1998.tb00727.x; Geschke K, 2009, WILDLIFE RES, V36, P666, DOI 10.1071/WR09133; Guinet C, 1998, CAN J ZOOL, V76, P1418, DOI 10.1139/cjz-76-8-1418; Halsey LG, 2006, FUNCT ECOL, V20, P889, DOI 10.1111/j.1365-2435.2006.01170.x; Harcourt RG, 2002, MAR ECOL PROG SER, V227, P11, DOI 10.3354/meps227011; HEINSOHN RG, 1991, AM NAT, V137, P864, DOI 10.1086/285198; Hindell Mark A., 2010, P243; Horning M, 1997, BEHAVIOUR, V134, P1211, DOI 10.1163/156853997X00133; Irvine LG, 2000, J ZOOL, V251, P463, DOI 10.1017/S0952836900008062; Jeglinski JWE, 2012, MAR ECOL PROG SER, V453, P279, DOI 10.3354/meps09649; Jenkins KJ, 2005, CAN J ZOOL, V83, P1174, DOI 10.1139/Z05-111; Jonsen ID, 2006, J ANIM ECOL, V75, P1046, DOI 10.1111/j.1365-2656.2006.01129.x; Lalas C, 2007, RECOLONISATION OTAGO; Leung ES, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045389; Lindstrom J, 1999, TRENDS ECOL EVOL, V14, P343, DOI 10.1016/S0169-5347(99)01639-0; Luque SP., 2007, R NEWS, V7, P8, DOI DOI 10.1155/2007/92385; McCafferty DJ, 1998, MAR ECOL PROG SER, V166, P285, DOI 10.3354/meps166285; McConkey S. D., 2002, Australian Mammalogy, V24, P97; Meynier L, 2008, MAR ECOL PROG SER, V366, P271, DOI 10.3354/meps07617; Meynier L, 2010, J MAMMAL, V91, P1484, DOI 10.1644/09-MAMM-A-299.1; Meynier L, 2009, MAR MAMMAL SCI, V25, P302, DOI 10.1111/j.1748-7692.2008.00252.x; MILLAR JS, 1990, FUNCT ECOL, V4, P5, DOI 10.2307/2389646; MONAGHAN P, 1994, IBIS, V136, P214, DOI 10.1111/j.1474-919X.1994.tb01087.x; Monson DH, 2000, OIKOS, V90, P457, DOI 10.1034/j.1600-0706.2000.900304.x; Murphy RJ, 2001, NEW ZEAL J MAR FRESH, V35, P343, DOI 10.1080/00288330.2001.9517005; Nakagawa S, 2011, BEHAV ECOL SOCIOBIOL, V65, P103, DOI 10.1007/s00265-010-1044-7; Orians G.H., 1979, P155; OWENSMITH N, 1990, J ANIM ECOL, V59, P893, DOI 10.2307/5021; Paul L.J., 2000, NZ FISHES IDENTIFICA; Pettorelli N, 2005, J ANIM ECOL, V74, P972, DOI 10.1111/j.1365-2656.2005.00988.x; PICKSTON L, 1982, NEW ZEAL J SCI, V25, P19; Pinheiro J., 2010, NLME LINEAR NONLINEA, P1; Pinheiro J, 2001, MIXED EFFECTS MODELS; Quispe R, 2009, ETHOLOGY, V115, P465, DOI 10.1111/j.1439-0310.2009.01621.x; Raum-Suryan KL, 2004, MAR MAMMAL SCI, V20, P823, DOI 10.1111/j.1748-7692.2004.tb01195.x; Riet-Sapriza FG, 2012, J MAMMAL, V93, P1006, DOI 10.1644/11-MAMM-A-220.2; Rivera M., 2021, IUCN RED LIST THREAT, DOI DOI 10.2305/IUCN.UK.2020-3.RLTS.T22678711A183481909.EN; Robertson BC, 2011, MAMMAL REV, V41, P253, DOI 10.1111/j.1365-2907.2011.00186.x; RODGERS AR, 2007, HRT HOME RANGE TOOLS; Sand H, 1996, OECOLOGIA, V106, P212, DOI 10.1007/BF00328601; Schielzeth H, 2010, METHODS ECOL EVOL, V1, P103, DOI 10.1111/j.2041-210X.2010.00012.x; Spiegelhalter D., 2004, WINBUGS USER MANUAL; Staniland IJ, 2011, MAR ECOL PROG SER, V434, P183, DOI 10.3354/meps09201; Staniland IJ, 2010, MAR BIOL, V157, P2383, DOI 10.1007/s00227-010-1503-8; Tinker MT, 2008, P NATL ACAD SCI USA, V105, P560, DOI 10.1073/pnas.0709263105; Trites AW, 2003, MAMMAL REV, V33, P3, DOI 10.1046/j.1365-2907.2003.00009.x; Vincent C, 2002, MAR MAMMAL SCI, V18, P156, DOI 10.1111/j.1748-7692.2002.tb01025.x; Vlieg P, 1986, NZ J TECHNOLOGY, V9, P245; WAUTERS L, 1989, J ANIM ECOL, V58, P637, DOI 10.2307/4853; Winship AJ, 2002, MAR ECOL PROG SER, V229, P291, DOI 10.3354/meps229291; WORTON BJ, 1989, ECOLOGY, V70, P164, DOI 10.2307/1938423; [No title captured]	83	2	2	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2013	8	5							e62728	10.1371/journal.pone.0062728	http://dx.doi.org/10.1371/journal.pone.0062728			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	177QL	23671630	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000321390200036
J	Covey, DP; Juliano, SA; Garris, PA				Covey, Dan P.; Juliano, Steven A.; Garris, Paul A.			Amphetamine Elicits Opposing Actions on Readily Releasable and Reserve Pools for Dopamine	PLOS ONE			English	Article							VESICULAR MONOAMINE TRANSPORTER-2; MEDIAL FOREBRAIN-BUNDLE; RAT NUCLEUS-ACCUMBENS; FREELY MOVING RATS; EXTRACELLULAR DOPAMINE; UPTAKE INHIBITORS; CAUDATE-PUTAMEN; INVIVO VOLTAMMETRY; STIMULATED RELEASE; SYNAPTIC VESICLES	Amphetamine, a highly addictive drug with therapeutic efficacy, exerts paradoxical effects on the fundamental communication modes employed by dopamine neurons in modulating behavior. While amphetamine elevates tonic dopamine signaling by depleting vesicular stores and driving non-exocytotic release through reverse transport, this psychostimulant also activates phasic dopamine signaling by up-regulating vesicular dopamine release. We hypothesized that these seemingly incongruent effects arise from amphetamine depleting the reserve pool and enhancing the readily releasable pool. This novel hypothesis was tested using in vivo voltammetry and stimulus trains of varying duration to access different vesicular stores. We show that amphetamine actions are stimulus dependent in the dorsal striatum. Specifically, amphetamine up-regulated vesicular dopamine release elicited by a short-duration train, which interrogates the readily releasable pool, but depleted release elicited by a long-duration train, which interrogates the reserve pool. These opposing actions of vesicular dopamine release were associated with concurrent increases in tonic and phasic dopamine responses. A link between vesicular depletion and tonic signaling was supported by results obtained for amphetamine in the ventral striatum and cocaine in both striatal sub-regions, which demonstrated augmented vesicular release and phasic signals only. We submit that amphetamine differentially targeting dopamine stores reconciles the paradoxical activation of tonic and phasic dopamine signaling. Overall, these results further highlight the unique and region-distinct cellular mechanisms of amphetamine and may have important implications for its addictive and therapeutic properties.	[Covey, Dan P.; Juliano, Steven A.; Garris, Paul A.] Illinois State Univ, Sch Biol Sci, Normal, IL 61761 USA	Illinois State University	Garris, PA (corresponding author), Illinois State Univ, Sch Biol Sci, Normal, IL 61761 USA.	pagarri@ilstu.edu	Covey, Dan/Y-6333-2019	Juliano, Steven/0000-0002-6178-4553	National Science Foundation [DBI-0754615]; National Institutes of Health (NIH) [DA 021770]; Weigel grant through Phi Sigma at Illinois State University; NATIONAL INSTITUTE ON DRUG ABUSE [R03DA021770] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Weigel grant through Phi Sigma at Illinois State University; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by National Science Foundation DBI-0754615 (http://www.nsf.gov/) and National Institutes of Health (NIH) DA 021770 (http://www.nih.gov/). DPC was also supported through a Weigel grant through Phi Sigma at Illinois State University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson BB, 1998, BRAIN RES, V788, P294, DOI 10.1016/S0006-8993(98)00040-7; Aragona BJ, 2008, J NEUROSCI, V28, P8821, DOI 10.1523/JNEUROSCI.2225-08.2008; Avelar AJ, 2013, J NEUROCHEM IN PRESS; Bales JW, 2009, NEUROSCI BIOBEHAV R, V33, P981, DOI 10.1016/j.neubiorev.2009.03.011; BENWELL MEM, 1993, PSYCHOPHARMACOLOGY, V112, P467, DOI 10.1007/BF02244896; Borland LM, 2005, J NEUROSCI METH, V146, P149, DOI 10.1016/j.jneumeth.2005.02.002; BOWYER JF, 1987, J PHARMACOL EXP THER, V240, P177; CARBONI E, 1989, NEUROSCIENCE, V28, P653, DOI 10.1016/0306-4522(89)90012-2; CASS WA, 1992, J NEUROCHEM, V59, P259, DOI 10.1111/j.1471-4159.1992.tb08899.x; Cheer JF, 2005, P NATL ACAD SCI USA, V102, P19150, DOI 10.1073/pnas.0509607102; Cheer JF, 2007, J NEUROSCI, V27, P791, DOI 10.1523/JNEUROSCI.4152-06.2007; CHEN GY, 1995, BRAIN RES, V701, P167, DOI 10.1016/0006-8993(95)00989-9; Daberkow DP, 2013, J NEUROSCI, V33, P452, DOI 10.1523/JNEUROSCI.2136-12.2013; DICHIARA G, 1988, P NATL ACAD SCI USA, V85, P5274; DUGAST C, 1994, NEUROSCIENCE, V62, P647, DOI 10.1016/0306-4522(94)90466-9; Everitt BJ, 2005, NAT NEUROSCI, V8, P1481, DOI 10.1038/nn1579; EWING AG, 1983, SCIENCE, V221, P169, DOI 10.1126/science.6857277; Fleckenstein AE, 2007, ANNU REV PHARMACOL, V47, P681, DOI 10.1146/annurev.pharmtox.47.120505.105140; Fleckenstein AE, 2009, NEUROPHARMACOLOGY, V56, P133, DOI 10.1016/j.neuropharm.2008.07.002; Floor E, 1996, NEUROSCI LETT, V215, P53, DOI 10.1016/S0304-3940(96)12963-3; Hermans A, 2008, ANAL CHEM, V80, P4040, DOI 10.1021/ac800108j; Hondebrink L, 2009, J NEUROCHEM, V111, P624, DOI 10.1111/j.1471-4159.2009.06357.x; Howell LL, 2008, BIOCHEM PHARMACOL, V75, P196, DOI 10.1016/j.bcp.2007.08.003; Hyman SE, 2006, ANNU REV NEUROSCI, V29, P565, DOI 10.1146/annurev.neuro.29.051605.113009; Ingram SL, 2002, NAT NEUROSCI, V5, P971, DOI 10.1038/nn920; John CE, 2007, NEUROPHARMACOLOGY, V52, P1596, DOI 10.1016/j.neuropharm.2007.03.004; Jones SR, 1998, J NEUROSCI, V18, P1979; JONES SR, 1995, J PHARMACOL EXP THER, V274, P396; Keithley RB, 2011, ACS CHEM NEUROSCI, V2, P514, DOI 10.1021/cn200035u; KELLAND MD, 1990, SYNAPSE, V6, P207, DOI 10.1002/syn.890060213; Kile BM, 2010, J NEUROSCI, V30, P9762, DOI 10.1523/JNEUROSCI.2071-09.2010; Koulchitsky S, 2012, NEUROPSYCHOPHARMACOL, V37, P1559, DOI 10.1038/npp.2011.339; KUCZENSKI R, 1975, NEUROPHARMACOLOGY, V14, P1, DOI 10.1016/0028-3908(75)90060-X; KUCZENSKI R, 1991, J NEUROSCI, V11, P2703; Kuczenski R, 1997, J PHARMACOL EXP THER, V282, P591; KUHR WG, 1985, J PHARMACOL EXP THER, V232, P388; KUHR WG, 1986, J NEUROSCI, V6, P974; KUHR WG, 1987, BRAIN RES, V418, P122, DOI 10.1016/0006-8993(87)90968-1; Lee TH, 2001, SYNAPSE, V41, P301, DOI 10.1002/syn.1087; LEW R, 1992, BRAIN RES, V584, P266, DOI 10.1016/0006-8993(92)90905-O; MARSHALL JF, 1990, NEUROSCIENCE, V37, P11, DOI 10.1016/0306-4522(90)90187-9; MAY LJ, 1988, J NEUROCHEM, V51, P1060, DOI 10.1111/j.1471-4159.1988.tb03069.x; MICHAEL AC, 1987, BRAIN RES, V421, P325, DOI 10.1016/0006-8993(87)91302-3; MICHAEL AC, 1987, NEUROSCI LETT, V76, P81, DOI 10.1016/0304-3940(87)90196-0; Michael D, 1998, ANAL CHEM, V70; Montague PR, 2004, J NEUROSCI, V24, P1754, DOI 10.1523/JNEUROSCI.4279-03.2004; Mosharov EV, 2003, J NEUROSCI, V23, P5835; Mundorf ML, 1999, J NEUROCHEM, V73, P2397, DOI 10.1046/j.1471-4159.1999.0732397.x; NOMIKOS GG, 1990, SYNAPSE, V6, P106, DOI 10.1002/syn.890060113; Oleson EB, 2009, NEUROSCI LETT, V467, P144, DOI 10.1016/j.neulet.2009.10.025; Owesson-White CA, 2012, J NEUROCHEM, V121, P252, DOI 10.1111/j.1471-4159.2012.07677.x; Paladini CA, 2001, NAT NEUROSCI, V4, P275, DOI 10.1038/85124; Patel J, 2003, J NEUROCHEM, V85, P898, DOI 10.1046/j.1471-4159.2003.01732.x; Paxinos G., 1986, RAT BRAIN STEREOTAXI, V2nd; Ramsson ES, 2011, J NEUROCHEM, V119, P1162, DOI 10.1111/j.1471-4159.2011.07407.x; Ramsson ES, 2011, J NEUROCHEM, V117, P937, DOI 10.1111/j.1471-4159.2011.07258.x; Riddle EL, 2007, EUR J PHARMACOL, V571, P25, DOI 10.1016/j.ejphar.2007.05.044; Rizzoli SO, 2005, NAT REV NEUROSCI, V6, P57, DOI 10.1038/nrn1583; Robinson DL, 2008, CHEM REV, V108, P2554, DOI 10.1021/cr068081q; Robinson DL, 2009, ALCOHOL CLIN EXP RES, V33, P1187, DOI 10.1111/j.1530-0277.2009.00942.x; Schmitz Y, 2001, J NEUROSCI, V21, P5916, DOI 10.1523/JNEUROSCI.21-16-05916.2001; Schultz W, 2007, ANNU REV NEUROSCI, V30, P259, DOI 10.1146/annurev.neuro.28.061604.135722; Scorza MC, 1997, BIOCHEM PHARMACOL, V54, P1361, DOI 10.1016/S0006-2952(97)00405-X; Shi WX, 2000, J NEUROSCI, V20, P3504, DOI 10.1523/JNEUROSCI.20-09-03504.2000; Sitte HH, 1998, J NEUROCHEM, V71, P1289; STAMFORD JA, 1986, NEUROSCI LETT, V69, P70, DOI 10.1016/0304-3940(86)90416-7; Stuber GD, 2005, NEUROPSYCHOPHARMACOL, V30, P853, DOI 10.1038/sj.npp.1300619; SULZER D, 1995, J NEUROSCI, V15, P4102; Sulzer D, 2011, NEURON, V69, P628, DOI 10.1016/j.neuron.2011.02.010; Venton BJ, 2006, J NEUROSCI, V26, P3206, DOI 10.1523/JNEUROSCI.4901-04.2006; Venton BJ, 2003, J NEUROCHEM, V87, P1284, DOI 10.1046/j.1471-4159.2003.02109.x; Volkow ND, 2011, P NATL ACAD SCI USA, V108, P15037, DOI 10.1073/pnas.1010654108; Volz TJ, 2007, J PHARMACOL EXP THER, V323, P738, DOI 10.1124/jpet.107.126888; WESTERINK BHC, 1987, N-S ARCH PHARMACOL, V336, P502, DOI 10.1007/BF00169306; Wiecki TV, 2010, PROG BRAIN RES, V183, P275, DOI 10.1016/S0079-6123(10)83014-6; Wightman RM, 2007, EUR J NEUROSCI, V26, P2046, DOI 10.1111/j.1460-9568.2007.05772.x; WIGHTMAN RM, 1988, NEUROSCIENCE, V25, P513, DOI 10.1016/0306-4522(88)90255-2; Wu Q, 2001, J NEUROSCI METH, V112, P119, DOI 10.1016/S0165-0270(01)00459-9; Wu Q, 2001, J NEUROSCI, V21, P6338, DOI 10.1523/JNEUROSCI.21-16-06338.2001; Yavich L, 2000, BRAIN RES, V870, P73, DOI 10.1016/S0006-8993(00)02403-3	80	30	30	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2013	8	5							e60763	10.1371/journal.pone.0060763	http://dx.doi.org/10.1371/journal.pone.0060763			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175AS	23671560	Green Published, Green Submitted, gold			2022-12-27	WOS:000321202100001
J	Dutta, S; Dattagupta, JK; Biswas, S				Dutta, Sruti; Dattagupta, Jiban Kanti; Biswas, Sampa			Enhancement of Proteolytic Activity of a Thermostable Papain-Like Protease by Structure-Based Rational Design	PLOS ONE			English	Article							PLANT CYSTEINE PROTEASE; SUBSTRATE-SPECIFICITY; TROPICAL PLANT; SITE	Ervatamins (A, B and C) are papain-like cysteine proteases from the plant Ervatamia coronaria. Among Ervatamins, Ervatamin-C is a thermostable protease, but it shows lower catalytic efficiency. In contrast, Ervatamin-A which has a high amino acid sequence identity (similar to 90%) and structural homology (C alpha rmsd 0.4 angstrom) with Ervatamin-C, has much higher catalytic efficiency (similar to 57 times). From the structural comparison of Ervatamin-A and -C, two residues Thr32 and Tyr67 in the catalytic cleft of Ervatamin-A have been identified whose contributions for higher activity of Ervatamin-A are established in our earlier studies. In this study, these two residues have been introduced in Ervatamin-C by site directed mutagenesis to enhance the catalytic efficiency of the thermostable protease. Two single mutants (S32T and A67Y) and one double mutant (S32T/A67Y) of Ervatamin-C have been generated and characterized. All the three mutants show similar to 8 times higher catalytic efficiency (k(cat)/K-m) than the wild-type. The thermostability of all the three mutant enzymes remained unchanged. The double mutant does not achieve the catalytic efficiency of the template enzyme Ervatamin-A. By modeling the structure of the double mutant and probing the role of active site residues by docking a substrate, the mechanistic insights of higher activity of the mutant protease have been addressed. The in-silico study demonstrates that the residues beyond the catalytic cleft also influence the substrate binding and positioning of the substrate at the catalytic centre, thus controlling the catalytic efficiency of an enzyme.	[Dutta, Sruti; Dattagupta, Jiban Kanti; Biswas, Sampa] Saha Inst Nucl Phys, Crystallog & Mol Biol Div, Kolkata, India	Saha Institute of Nuclear Physics	Biswas, S (corresponding author), Saha Inst Nucl Phys, Crystallog & Mol Biol Div, Kolkata, India.	sampa.biswas@saha.ac.in			Department of Atomic Energy (DAE); Council of Scientific and Industrial Research (CSIR) [21/0653/06/EMR-II]; Department of Biotechnology (DBT), Govt. of India [BT/PR13895/BRB/10/789/2010]	Department of Atomic Energy (DAE)(Department of Atomic Energy (DAE)); Council of Scientific and Industrial Research (CSIR)(Council of Scientific & Industrial Research (CSIR) - India); Department of Biotechnology (DBT), Govt. of India(Department of Biotechnology (DBT) India)	In addition to institute funding from Department of Atomic Energy (DAE), this work was supported by Council of Scientific and Industrial Research (CSIR), (21/0653/06/EMR-II) and Department of Biotechnology (DBT) (BT/PR13895/BRB/10/789/2010), Govt. of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker PJ, 2012, BIOMACROMOLECULES, V13, P947, DOI 10.1021/bm201862z; Barrett A. J., 1998, HDB PROTEOLYTIC ENZY; Behnke JM, 2008, PARASITE VECTOR, V1, DOI 10.1186/1756-3305-1-29; BLOW DM, 1974, ISRAEL J CHEM, V12, P483; Cheng YS, 2012, APPL MICROBIOL BIOT, V95, P661, DOI 10.1007/s00253-011-3791-4; Choudhury D, 2010, PROTEIN ENG DES SEL, V23, P457, DOI 10.1093/protein/gzq016; Dardenne LE, 2003, PROTEINS, V52, P236, DOI 10.1002/prot.10368; Dutta S, 2011, FEBS J, V278, P3012, DOI 10.1111/j.1742-4658.2011.08221.x; Dutta S, 2010, PROCESS BIOCHEM, V45, P1307, DOI 10.1016/j.procbio.2010.04.020; Gao DQ, 2009, MOL PHARMACOL, V75, P318, DOI 10.1124/mol.108.049486; Ghosh R, 2008, FEBS J, V275, P421, DOI 10.1111/j.1742-4658.2007.06211.x; Ghosh R, 2007, BIOCHEM BIOPH RES CO, V362, P965, DOI 10.1016/j.bbrc.2007.08.098; Grudkowska M, 2004, ACTA BIOCHIM POL, V51, P609; Hu W, 2012, BIOCHIMIE, V94, P656, DOI 10.1016/j.biochi.2011.09.018; Huang X, 2011, ORG BIOMOL CHEM, V9, P4138, DOI 10.1039/c0ob00972e; MOLE JE, 1973, BIOCHEMISTRY-US, V12, P816, DOI 10.1021/bi00729a005; Reddy SY, 2002, J AM CHEM SOC, V124, P12979, DOI 10.1021/ja020918l; SCHECHTER I, 1967, BIOCHEM BIOPH RES CO, V27, P157, DOI 10.1016/S0006-291X(67)80055-X; Sundd M, 1998, BIOSCI BIOTECH BIOCH, V62, P1947, DOI 10.1271/bbb.62.1947; Thakurta PG, 2004, BIOCHEMISTRY-US, V43, P1532, DOI 10.1021/bi0357659; Tuck SA, 2012, INT J CHRONIC OBSTR, V7, P21, DOI 10.2147/COPD.S27312; Turk D, 1998, BIOL CHEM, V379, P137, DOI 10.1515/bchm.1998.379.2.137; Turner P, 2007, MICROB CELL FACT, V6, DOI 10.1186/1475-2859-6-9	23	3	3	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2013	8	5							e62619	10.1371/journal.pone.0062619	http://dx.doi.org/10.1371/journal.pone.0062619			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175AS	23671614	Green Submitted, Green Published, gold			2022-12-27	WOS:000321202100021
J	Shu, CC; Lee, P; Lin, JW; Huang, CT; Chang, YC; Yu, CJ; Wang, HC				Shu, Chin-Chung; Lee, Peilin; Lin, Jou-Wei; Huang, Chun-Ta; Chang, Yeun-Chung; Yu, Chong-Jen; Wang, Hao-Chien			The Use of Sub-Mental Ultrasonography for Identifying Patients with Severe Obstructive Sleep Apnea	PLOS ONE			English	Article							UPPER AIRWAY; METABOLIC SYNDROME; CHINESE; RISK; POLYSOMNOGRAPHY; INFLAMMATION; POPULATION; ULTRASOUND; PHARYNX; OSA	Objective: This study aimed to explore the association between obstructive sleep apnea (OSA) severity and pharyngeal parameters using sub-mental ultrasonography (US), and investigate the accuracy of US for identifying severe OSA patients. Methods: One hundred and five consecutive referrals for suspected OSA were enrolled. The diameters of the retro-glossal (RG) and retro-palatal (RP) regions were measured via sub-mental US upon expiration during tidal breathing, forced inspiration, and Muller maneuver (MM). Independent factors associated with severe OSA identified from two-thirds of randomly-selected patients (model-development group) were used to construct a model for predicting severe OSA. The accuracy of the model was validated in the remaining one-third of patients (validation group). Results: Fifty severe OSA patients, 30 with mild-moderate OSA, and 25 without OSA were enrolled. Compared to non-OSA and mild-moderate OSA patients, those with severe OSA had narrower RP diameter in all three maneuvers. Using the prediction model constructed with changes of RP diameters at MM and neck circumference, the independent predictors of severe OSA in the model-development group had 100% sensitivity and 65% specificity. Conclusion: Sub-mental US can accurately discriminate the severity of OSA and be used to identify patients with severe OSA.	[Shu, Chin-Chung; Huang, Chun-Ta] Natl Taiwan Univ Hosp, Dept Traumatol, Taipei, Taiwan; [Shu, Chin-Chung; Lee, Peilin; Huang, Chun-Ta; Yu, Chong-Jen; Wang, Hao-Chien] Natl Taiwan Univ, Sch Med, Coll Med, Taipei 10764, Taiwan; [Lee, Peilin; Yu, Chong-Jen; Wang, Hao-Chien] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan; [Lee, Peilin; Yu, Chong-Jen] Natl Taiwan Univ Hosp, Ctr Sleep Disorder, Taipei, Taiwan; [Lin, Jou-Wei] Natl Taiwan Univ Hosp, Dept Internal Med, Yun Lin Branch, Yunlin Cty, Taiwan; [Chang, Yeun-Chung] Natl Taiwan Univ Hosp, Dept Med Imaging, Taipei, Taiwan	National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital	Wang, HC (corresponding author), Natl Taiwan Univ, Sch Med, Coll Med, Taipei 10764, Taiwan.	haochienwang@gmail.com	Lee, Pei-Lin/L-5564-2019	Lee, Pei-Lin/0000-0002-6883-9502; Wang, Hao-Chien/0000-0002-7528-7494; HUANG, CHUN-TA/0000-0002-5234-4986; CHANG, YEUN-CHUNG/0000-0001-9984-5713; Yu, Chong-Jen/0000-0001-5664-9392; SHU, CHIN-CHUNG/0000-0003-0311-5148				Abrishami A, 2010, CAN J ANAESTH, V57, P423, DOI 10.1007/s12630-010-9280-x; [Anonymous], 1998, RECOMMENDATIONS CRIT; Chen NH, 2002, LARYNGOSCOPE, V112, P721, DOI 10.1097/00005537-200204000-00023; Ciscar MA, 2001, EUR RESPIR J, V17, P79, DOI 10.1183/09031936.01.17100790; Coughlin SR, 2007, EUR RESPIR J, V29, P720, DOI 10.1183/09031936.00043306; Ding LW, 2006, EUR RESPIR J, V27, P384, DOI 10.1183/09031936.06.00029605; Gold AR, 2008, SLEEP MED, V9, P675, DOI 10.1016/j.sleep.2007.08.013; Gozal D, 2008, AM J RESP CRIT CARE, V177, P1142, DOI 10.1164/rccm.200711-1670OC; Grundy SM, 2004, CIRCULATION, V109, P433, DOI 10.1161/01.CIR.0000111245.75752.C6; Gurubhagavatula I, 2001, AM J RESP CRIT CARE, V164, P1904, DOI 10.1164/ajrccm.164.10.2103039; Jager L, 1998, AM J NEURORADIOL, V19, P1205; Kushida CA, 2005, SLEEP, V28, P499, DOI 10.1093/sleep/28.4.499; Lahav Y, 2009, ANN OTO RHINOL LARYN, V118, P179, DOI 10.1177/000348940911800304; Lee PL, 2009, CHEST, V135, P537, DOI 10.1378/chest.08-1664; Lin JW, 2009, DIABETES CARE, V32, P2294, DOI 10.2337/dc09-0694; Liu KH, 2007, SLEEP, V30, P1503, DOI 10.1093/sleep/30.11.1503; Liu YH, 2000, AM J ORTHOD DENTOFAC, V117, P479, DOI 10.1016/S0889-5406(00)70169-7; Magalang UJ, 2003, CHEST, V124, P1694, DOI 10.1378/chest.124.5.1694; McNicholas WT, 2007, EUR RESPIR J, V29, P156, DOI 10.1183/09031936.00027406; Ritter CT, 1999, LARYNGOSCOPE, V109, P954, DOI 10.1097/00005537-199906000-00022; Ryan S, 2007, THORAX, V62, P509, DOI 10.1136/thx.2006.066720; Segal Y, 2008, SLEEP BREATH, V12, P311, DOI 10.1007/s11325-008-0191-9; Siegel H, 2000, NEUROLOGY, V54, P1872, DOI 10.1212/WNL.54.9.1872; Stuck BA, 2008, SLEEP MED REV, V12, P411, DOI 10.1016/j.smrv.2007.08.009; Tasali Esra, 2008, Proc Am Thorac Soc, V5, P207, DOI 10.1513/pats.200708-139MG; Thakkar K, 2007, OTOLARYNG CLIN N AM, V40, P785, DOI 10.1016/j.otc.2007.04.005; YOUNG T, 1993, NEW ENGL J MED, V328, P1230, DOI 10.1056/NEJM199304293281704	27	29	30	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2013	8	5							e62848	10.1371/journal.pone.0062848	http://dx.doi.org/10.1371/journal.pone.0062848			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	143FO	23675433	gold, Green Published, Green Submitted			2022-12-27	WOS:000318852400015
J	Gupta, P; Goel, R; Pathak, S; Srivastava, A; Singh, SP; Sangwan, RS; Asif, MH; Trivedi, PK				Gupta, Parul; Goel, Ridhi; Pathak, Sumya; Srivastava, Apeksha; Singh, Surya Pratap; Sangwan, Rajender Singh; Asif, Mehar Hasan; Trivedi, Prabodh Kumar			De Novo Assembly, Functional Annotation and Comparative Analysis of Withania somnifera Leaf and Root Transcriptomes to Identify Putative Genes Involved in the Withanolides Biosynthesis	PLOS ONE			English	Article							EXPRESSED SEQUENCE TAGS; STEROIDAL LACTONES; MEDICINAL-PLANT; GLYCOSYLTRANSFERASES; CYTOCHROME-P450; REPEATS; GINSENG; CLONING; STRESS; BARLEY	Withania somnifera is one of the most valuable medicinal plants used in Ayurvedic and other indigenous medicine systems due to bioactive molecules known as withanolides. As genomic information regarding this plant is very limited, little information is available about biosynthesis of withanolides. To facilitate the basic understanding about the withanolide biosynthesis pathways, we performed transcriptome sequencing for Withania leaf (101L) and root (101R) which specifically synthesize withaferin A and withanolide A, respectively. Pyrosequencing yielded 8,34,068 and 7,21,755 reads which got assembled into 89,548 and 1,14,814 unique sequences from 101L and 101R, respectively. A total of 47,885 (101L) and 54,123 (101R) could be annotated using TAIR10, NR, tomato and potato databases. Gene Ontology and KEGG analyses provided a detailed view of all the enzymes involved in withanolide backbone synthesis. Our analysis identified members of cytochrome P450, glycosyltransferase and methyltransferase gene families with unique presence or differential expression in leaf and root and might be involved in synthesis of tissue-specific withanolides. We also detected simple sequence repeats (SSRs) in transcriptome data for use in future genetic studies. Comprehensive sequence resource developed for Withania, in this study, will help to elucidate biosynthetic pathway for tissue-specific synthesis of secondary plant products in non-model plant organisms as well as will be helpful in developing strategies for enhanced biosynthesis of withanolides through biotechnological approaches.	[Gupta, Parul; Goel, Ridhi; Pathak, Sumya; Srivastava, Apeksha; Asif, Mehar Hasan; Trivedi, Prabodh Kumar] CSIR, Natl Bot Res Inst, Lucknow, Uttar Pradesh, India; [Sangwan, Rajender Singh] CSIR, Cent Inst Med & Aromat Plants, Lucknow, Uttar Pradesh, India; [Singh, Surya Pratap] Banaras Hindu Univ, Fac Sci, Dept Biochem, Varanasi 221005, Uttar Pradesh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - National Botanical Research Institute (NBRI); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Institute of Medicinal & Aromatic Plants (CIMAP); Banaras Hindu University (BHU)	Trivedi, PK (corresponding author), CSIR, Natl Bot Res Inst, Rana Pratap Marg, Lucknow, Uttar Pradesh, India.	prabodht@hotmail.com		Singh, Surya/0000-0001-5668-1712	Council of Scientific and Industrial Research, New Delhi, Govt. of India under; New Millennium Indian Technology Leadership Initiative (NMITLI) scheme	Council of Scientific and Industrial Research, New Delhi, Govt. of India under; New Millennium Indian Technology Leadership Initiative (NMITLI) scheme	The authors are thankful to the Council of Scientific and Industrial Research, New Delhi, Govt. of India, for providing the financial support to carry out this work under New Millennium Indian Technology Leadership Initiative (NMITLI) scheme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhtar N, 2013, PROTOPLASMA, V250, P613, DOI 10.1007/s00709-012-0450-2; Alam N, 2012, PHYTOCHEM REV, V11, P97, DOI 10.1007/s11101-011-9221-5; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bharti SK, 2011, MAGN RESON CHEM, V49, P659, DOI 10.1002/mrc.2817; Bowles D, 2006, ANNU REV PLANT BIOL, V57, P567, DOI 10.1146/annurev.arplant.57.032905.105429; Cardle L, 2000, GENETICS, V156, P847; Chaturvedi P, 2012, MOL BIOL REP, V39, P9755, DOI 10.1007/s11033-012-1841-3; Chaurasiya ND, 2012, PLANT CELL REP, V31, P1889, DOI 10.1007/s00299-012-1302-4; Chaurasiya ND, 2009, FITOTERAPIA, V80, P496, DOI 10.1016/j.fitote.2009.06.012; Coon MJ, 2005, ANNU REV PHARMACOL, V45, P1, DOI 10.1146/annurev.pharmtox.45.120403.100030; Der JP, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-99; Desgagne-Penix I, 2012, PLANT MOL BIOL, V79, P295, DOI 10.1007/s11103-012-9913-2; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Grover A, 2012, J BIOMOL STRUCT DYN, V29, P651, DOI 10.1080/07391102.2012.10507408; Gupta P, 2013, PROTOPLASMA, V250, P285, DOI 10.1007/s00709-012-0410-x; Gupta P, 2011, PLANT GROWTH REGUL, V65, P93, DOI 10.1007/s10725-011-9578-x; Hatlestad GJ, 2012, NAT GENET, V44, P816, DOI 10.1038/ng.2297; Kaileh M, 2007, J ETHNOPHARMACOL, V113, P510, DOI 10.1016/j.jep.2007.07.008; Kantety RV, 2002, PLANT MOL BIOL, V48, P501, DOI 10.1023/A:1014875206165; Kota R, 2001, HEREDITAS, V135, P145, DOI 10.1111/j.1601-5223.2001.00145.x; Kushwaha S, 2012, PARASITE IMMUNOL, V34, P199, DOI 10.1111/j.1365-3024.2012.01352.x; Lairson LL, 2008, ANNU REV BIOCHEM, V77, P521, DOI 10.1146/annurev.biochem.76.061005.092322; Li Y, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-268; Madina BR, 2007, BBA-PROTEINS PROTEOM, V1774, P1199, DOI 10.1016/j.bbapap.2007.06.015; Mansour HH, 2012, ECOTOX ENVIRON SAFE, V80, P14, DOI 10.1016/j.ecoenv.2012.02.003; Meyer E, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-219; Mirjalili MH, 2009, MOLECULES, V14, P2373, DOI 10.3390/molecules14072373; Mizutani M, 2010, ANNU REV PLANT BIOL, V61, P291, DOI 10.1146/annurev-arplant-042809-112305; Morant M, 2003, CURR OPIN BIOTECH, V14, P151, DOI 10.1016/S0958-1669(03)00024-7; Moriya Y, 2007, NUCLEIC ACIDS RES, V35, pW182, DOI 10.1093/nar/gkm321; Murthy M. R. Ven, 2010, Central Nervous System Agents in Medicinal Chemistry, V10, P238; Parchman TL, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-180; Parkinson John, 2009, V533, P1, DOI 10.1007/978-1-60327-136-3_1; Prakash J, 2001, PHYTOTHER RES, V15, P240, DOI 10.1002/ptr.779; Sangwan RS, 2008, PHYSIOL PLANTARUM, V133, P278, DOI 10.1111/j.1399-3054.2008.01076.x; Sehgal N, 2012, P NATL ACAD SCI USA, V109, P3510, DOI 10.1073/pnas.1112209109; Senthil K, 2010, MOL BIOL REP, V37, P893, DOI 10.1007/s11033-009-9696-y; Sharma LK, 2007, ARCH BIOCHEM BIOPHYS, V460, P48, DOI 10.1016/j.abb.2007.01.024; Sidhu OP, 2011, PHYTOCHEM ANALYSIS, V22, P492, DOI 10.1002/pca.1307; Standeven R, 1998, EUR J HERBAL MED, V4, P17; Stekel DJ, 2000, GENOME RES, V10, P2055, DOI 10.1101/gr.GR-1325RR; Sun C, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-262; Varshney RK, 2005, TRENDS BIOTECHNOL, V23, P48, DOI 10.1016/j.tibtech.2004.11.005; Vera JC, 2008, MOL ECOL, V17, P1636, DOI 10.1111/j.1365-294X.2008.03666.x; Wang W, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-465; Zeng SH, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-94	46	62	64	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2013	8	5							e62714	10.1371/journal.pone.0062714	http://dx.doi.org/10.1371/journal.pone.0062714			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145YI	23667511	Green Published, Green Submitted, gold			2022-12-27	WOS:000319055600040
J	Wu, LL; Feng, Z; Cui, SY; Hou, K; Tang, L; Zhou, JH; Cai, GY; Xie, YS; Hong, Q; Fu, B; Chen, XM				Wu, Lingling; Feng, Zhe; Cui, Shaoyuan; Hou, Kai; Tang, Li; Zhou, Jianhui; Cai, Guangyan; Xie, Yuansheng; Hong, Quan; Fu, Bo; Chen, Xiangmei			Rapamycin Upregulates Autophagy by Inhibiting the mTOR-ULK1 Pathway, Resulting in Reduced Podocyte Injury	PLOS ONE			English	Article							MTORC1 ACTIVATION; MAMMALIAN TARGET; DIFFERENTIATION; CYTOSKELETON; BIOLOGY	The podocyte functions as a glomerular filtration barrier. Autophagy of postmitotic cells is an important protective mechanism that is essential for maintaining the homeostasis of podocytes. Exploring an in vivo rat model of passive Heymann nephritis and an in vitro model of puromycin amino nucleotide (PAN)-cultured podocytes, we examined the specific mechanisms underlying changing autophagy levels and podocyte injury. In the passive Heymann nephritis model rats, the mammalian target-of-rapamycin (mTOR) levels were upregulated in injured podocytes while autophagy was inhibited. In PAN-treated podocytes, mTOR lowered the level of autophagy through the mTOR-ULK1 pathway resulting in damaged podocytes. Rapamycin treatment of these cells reduced podocyte injury by raising the levels of autophagy. These in vivo and in vitro experiments demonstrate that podocyte injury is associated with changes in autophagy levels, and that rapamycin can reduce podocyte injury by increasing autophagy levels via inhibition of the mTOR-ULK1 pathway. These results provide an important theoretical basis for future treatment of diseases involving podocyte injury.	[Wu, Lingling; Feng, Zhe; Cui, Shaoyuan; Hou, Kai; Tang, Li; Zhou, Jianhui; Cai, Guangyan; Xie, Yuansheng; Hong, Quan; Fu, Bo; Chen, Xiangmei] Peoples Liberat Army Gen Hosp, Dept Nephrol, State Key Lab Kidney Dis, Beijing, Peoples R China; [Wu, Lingling; Feng, Zhe; Cui, Shaoyuan; Hou, Kai; Tang, Li; Zhou, Jianhui; Cai, Guangyan; Xie, Yuansheng; Hong, Quan; Fu, Bo; Chen, Xiangmei] Mil Med Postgrad Coll, Beijing, Peoples R China; [Wu, Lingling] Nankai Univ, Coll Med, Tianjin 300071, Peoples R China	Chinese People's Liberation Army General Hospital; Nankai University	Feng, Z (corresponding author), Peoples Liberat Army Gen Hosp, Dept Nephrol, State Key Lab Kidney Dis, Beijing, Peoples R China.	zhezhe_4025@126.com; xmchen301@126.com	hou, kai/GWU-6579-2022; Wu, Ling/GZN-2235-2022		Programs of the National Natural Science Foundation of China [30800521, 81102673]; National Basic Research Program of China [2011CB944000, 2012CB530800]	Programs of the National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China)	This work was supported by grants from Programs of the National Natural Science Foundation of China (30800521, 81102673) and the National Basic Research Program of China (2011CB944000, 2012CB530800). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asanuma K, 2003, FASEB J, V17, P1165, DOI 10.1096/fj.02-0580fje; Ballou Lisa M, 2008, J Chem Biol, V1, P27, DOI 10.1007/s12154-008-0003-5; Barisoni L, 2003, AM J NEPHROL, V23, P353, DOI 10.1159/000072917; Chan EY, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.284pe51; Choi JW, 1996, SCIENCE, V273, P239, DOI 10.1126/science.273.5272.239; Hartleben B, 2010, J CLIN INVEST, V120, P1084, DOI 10.1172/JCI39492; Hosokawa N, 2009, MOL BIOL CELL, V20, P1981, DOI 10.1091/mbc.E08-12-1248; Huber TB, 2011, KIDNEY INT, V79, P502, DOI 10.1038/ki.2010.457; Inoki K, 2012, CURR OPIN NEPHROL HY, V21, P251, DOI 10.1097/MNH.0b013e3283520f38; Inoki K, 2011, J CLIN INVEST, V121, P2181, DOI 10.1172/JCI44771; Ito N, 2011, LAB INVEST, V91, P1584, DOI 10.1038/labinvest.2011.135; Jung CH, 2009, MOL BIOL CELL, V20, P1992, DOI 10.1091/mbc.E08-12-1249; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kim J, 2011, NAT CELL BIOL, V13, P132, DOI 10.1038/ncb2152; Klionsky DJ, 2005, J CELL SCI, V118, P7, DOI 10.1242/jcs.01620; Kundu M, 2011, ANTIOXID REDOX SIGN, V14, P1953, DOI 10.1089/ars.2010.3809; Lee EJ, 2011, AUTOPHAGY, V7, P689, DOI 10.4161/auto.7.7.15450; Lee JHW, 2009, J HYDRO-ENVIRON RES, V3, P1, DOI 10.1016/j.jher.2009.05.002; Levine B, 2005, J CLIN INVEST, V115, P2679, DOI 10.1172/JCI26390; Lieberthal W, 2012, AM J PHYSIOL-RENAL, V303, pF1, DOI 10.1152/ajprenal.00014.2012; Lieberthal W, 2009, J AM SOC NEPHROL, V20, P2493, DOI 10.1681/ASN.2008111186; Mehrpour M, 2010, CELL RES, V20, P748, DOI 10.1038/cr.2010.82; Mizushima N, 2010, CURR OPIN CELL BIOL, V22, P132, DOI 10.1016/j.ceb.2009.12.004; Mundel P, 2002, J AM SOC NEPHROL, V13, P3005, DOI 10.1097/01.ASN.0000039661.06947.FD; Mundel P, 1997, EXP CELL RES, V236, P248, DOI 10.1006/excr.1997.3739; Ravikumar B, 2010, PHYSIOL REV, V90, P1383, DOI 10.1152/physrev.00030.2009; Perez JCR, 2011, NEFROLOGIA, V31, P251, DOI 10.3265/Nefrologia.pre2011.Apr.10947; SALANT DJ, 1988, METHODS ENZYMOL, V162, P421; Sarbassov DD, 2005, CURR OPIN CELL BIOL, V17, P596, DOI 10.1016/j.ceb.2005.09.009; SUCCAR L, 2011, ROLE MAMMALIAN TARGE, P184; Tanaka Y, 2012, EXP DIABETES RES, DOI 10.1155/2012/628978; Vollenbroker B, 2009, AM J PHYSIOL-RENAL, V296, pF418, DOI 10.1152/ajprenal.90319.2008; Wang LM, 2008, KIDNEY BLOOD PRESS R, V31, P111, DOI 10.1159/000121531; Weide T, 2011, CELL TISSUE RES, V343, P467, DOI 10.1007/s00441-010-1115-0; Wen DH, 2011, AM J NEPHROL, V34, P423, DOI 10.1159/000331701; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025	36	84	97	2	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2013	8	5							e63799	10.1371/journal.pone.0063799	http://dx.doi.org/10.1371/journal.pone.0063799			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145YI	23667674	gold, Green Submitted, Green Published			2022-12-27	WOS:000319055600075
J	Esterlechner, J; Reichert, N; Iltzsche, F; Krause, M; Finkernagel, F; Gaubatz, S				Esterlechner, Jasmina; Reichert, Nina; Iltzsche, Fabian; Krause, Michael; Finkernagel, Florian; Gaubatz, Stefan			LIN9, a Subunit of the DREAM Complex, Regulates Mitotic Gene Expression and Proliferation of Embryonic Stem Cells	PLOS ONE			English	Article							B-MYB; SELF-RENEWAL; MOUSE EMBRYOS; G(2)/M GENES; PROTEIN; CYCLE; TRANSCRIPTION; MICE; DIFFERENTIATION; IDENTIFICATION	The DREAM complex plays an important role in regulation of gene expression during the cell cycle. We have previously shown that the DREAM subunit LIN9 is required for early embryonic development and for the maintenance of the inner cell mass in vitro. In this study we examined the effect of knocking down LIN9 on ESCs. We demonstrate that depletion of LIN9 alters the cell cycle distribution of ESCs and results in an accumulation of cells in G2 and M and in an increase of polyploid cells. Genome-wide expression studies showed that the depletion of LIN9 results in downregulation of mitotic genes and in upregulation of differentiation-specific genes. ChIP-on chip experiments showed that mitotic genes are direct targets of LIN9 while lineage specific markers are regulated indirectly. Importantly, depletion of LIN9 does not alter the expression of pluripotency markers SOX2, OCT4 and Nanog and LIN9 depleted ESCs retain alkaline phosphatase activity. We conclude that LIN9 is essential for proliferation and genome stability of ESCs by activating genes with important functions in mitosis and cytokinesis.	[Esterlechner, Jasmina; Reichert, Nina; Iltzsche, Fabian; Gaubatz, Stefan] Univ Wurzburg, Theodor Boveri Inst, Bioctr, D-97070 Wurzburg, Germany; [Krause, Michael; Finkernagel, Florian] Univ Marburg, Inst Mol Biol & Tumor Res IMT, Marburg, Germany	University of Wurzburg; Philipps University Marburg	Gaubatz, S (corresponding author), Univ Wurzburg, Theodor Boveri Inst, Bioctr, D-97070 Wurzburg, Germany.	stefan.gaubatz@biozentrum.uni-wuerzburg.de		Gaubatz, Stefan/0000-0001-8751-4191	DFG: (Deutsche Forschungsgemeinschaft) [575/5-2, TR17 B1]	DFG: (Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG))	This work was supported by grants from the DFG: (Deutsche Forschungsgemeinschaft) (575/5-2 and TR17 B1) towards SG; URL: http://www.dfg.de/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAIN G, 1995, DEV BIOL, V168, P342, DOI 10.1006/dbio.1995.1085; Brandeis M, 1998, P NATL ACAD SCI USA, V95, P4344, DOI 10.1073/pnas.95.8.4344; Cutts SM, 1999, HUM MOL GENET, V8, P1145, DOI 10.1093/hmg/8.7.1145; Driegen S, 2005, TRANSGENIC RES, V14, P477, DOI 10.1007/s11248-005-7220-2; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; He SH, 2009, ANNU REV CELL DEV BI, V25, P377, DOI 10.1146/annurev.cellbio.042308.113248; HOOPER M, 1987, NATURE, V326, P292, DOI 10.1038/326292a0; Howman EV, 2000, P NATL ACAD SCI USA, V97, P1148, DOI 10.1073/pnas.97.3.1148; Kalitsis P, 2000, GENE DEV, V14, P2277, DOI 10.1101/gad.827500; Kim J, 2009, NAT PROTOC, V4, P506, DOI 10.1038/nprot.2009.23; Kleinschmidt MA, 2008, NUCLEIC ACIDS RES, V36, P3202, DOI 10.1093/nar/gkn166; Knight AS, 2009, ONCOGENE, V28, P1737, DOI 10.1038/onc.2009.22; Korenjak M, 2004, CELL, V119, P181, DOI 10.1016/j.cell.2004.09.034; Lange C, 2010, CELL CYCLE, V9, P1893, DOI 10.4161/cc.9.10.11598; Lewis PW, 2004, GENE DEV, V18, P2929, DOI 10.1101/gad.1255204; Li VC, 2012, P NATL ACAD SCI USA, V109, P12550, DOI 10.1073/pnas.1206740109; Litovchick L, 2007, MOL CELL, V26, P539, DOI 10.1016/j.molcel.2007.04.015; Lorvellec M, 2010, STEM CELLS, V28, P1751, DOI 10.1002/stem.496; Lu LY, 2008, MOL CELL BIOL, V28, P6870, DOI 10.1128/MCB.00392-08; Minato Y, 2007, GENE, V403, P89, DOI 10.1016/j.gene.2007.08.011; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; Orford KW, 2008, NAT REV GENET, V9, P115, DOI 10.1038/nrg2269; Osterloh L, 2007, EMBO J, V26, P144, DOI 10.1038/sj.emboj.7601478; Pilkinton M, 2007, J BIOL CHEM, V282, P168, DOI 10.1074/jbc.M609924200; Reichert N, 2010, MOL CELL BIOL, V30, P2896, DOI 10.1128/MCB.00028-10; Schmit F, 2007, CELL CYCLE, V6, P1903, DOI 10.4161/cc.6.15.4512; Singh AM, 2009, CELL STEM CELL, V5, P141, DOI 10.1016/j.stem.2009.07.003; SNOW MHL, 1978, J EMBRYOL EXP MORPH, V47, P39; Stead E, 2002, ONCOGENE, V21, P8320, DOI 10.1038/sj.onc.1206015; Tanaka Y, 1999, J BIOL CHEM, V274, P28067, DOI 10.1074/jbc.274.40.28067; Tarasov KV, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002478; Tavner F, 2007, ONCOGENE, V26, P2727, DOI 10.1038/sj.onc.1210087; Weaver BAA, 2003, J CELL BIOL, V162, P551, DOI 10.1083/jcb.200303167; White J, 2005, MOL BIOL CELL, V16, P2018, DOI 10.1091/mbc.e04-12-1056; White J, 2005, STEM CELL REV, V1, P131, DOI 10.1385/SCR:1:2:131; Woo AJ, 2008, MOL CELL BIOL, V28, P2675, DOI 10.1128/MCB.01945-07; Yoshikawa T, 2006, GENE EXPR PATTERNS, V6, P213, DOI 10.1016/j.modgep.2005.06.003; Young RA, 2011, CELL, V144, P940, DOI 10.1016/j.cell.2011.01.032; Zhan M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042350	39	13	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e62882	10.1371/journal.pone.0062882	http://dx.doi.org/10.1371/journal.pone.0062882			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667535	Green Published, Green Submitted, gold			2022-12-27	WOS:000319654700074
J	Haddad, NF; Teodoro, AJ; de Oliveira, FL; Soares, N; de Mattos, RM; Hecht, F; Dezonne, RS; Vairo, L; Goldenberg, RCD; Gomes, FCA; de Carvalho, DP; Gadelha, MR; Nasciutti, LE; Miranda-Alves, L				Haddad, Natalia F.; Teodoro, Anderson J.; de Oliveira, Felipe Leite; Soares, Nathalia; de Mattos, Romulo Medina; Hecht, Fabio; Dezonne, Romulo Sperduto; Vairo, Leandro; dos Santos Goldenberg, Regina Coeli; Alcantara Gomes, Flavia Carvalho; de Carvalho, Denise Pires; Gadelha, Monica R.; Nasciutti, Luiz Eurico; Miranda-Alves, Leandro			Lycopene and Beta-Carotene Induce Growth Inhibition and Proapoptotic Effects on ACTH-Secreting Pituitary Adenoma Cells	PLOS ONE			English	Article							GAP JUNCTIONAL COMMUNICATION; COLON ADENOCARCINOMA CELLS; HEPATIC STELLATE CELLS; PROSTATE-CANCER CELLS; RETINOIC ACID; CYCLE ARREST; DOWN-REGULATION; TUMOR-CELLS; IN-VITRO; SOMATOSTATIN RECEPTORS	Pituitary adenomas comprise approximately 10-15% of intracranial tumors and result in morbidity associated with altered hormonal patterns, therapy and compression of adjacent sella turcica structures. The use of functional foods containing carotenoids contributes to reduce the risk of chronic diseases such as cancer and vascular disorders. In this study, we evaluated the influence of different concentrations of beta-carotene and lycopene on cell viability, colony formation, cell cycle, apoptosis, hormone secretion, intercellular communication and expression of connexin 43, Skp2 and p27(kip1) in ACTH-secreting pituitary adenoma cells, the AtT20 cells, incubated for 48 and 96 h with these carotenoids. We observed a decrease in cell viability caused by the lycopene and beta-carotene treatments; in these conditions, the clonogenic ability of the cells was also significantly decreased. Cell cycle analysis revealed that beta-carotene induced an increase of the cells in S and G2/M phases; furthermore, lycopene increased the proportion of these cells in G0/G1 while decreasing the S and G2/M phases. Also, carotenoids induced apoptosis after 96 h. Lycopene and beta-carotene decreased the secretion of ACTH in AtT20 cells in a dose-dependent manner. Carotenoids blocked the gap junction intercellular communication. In addition, the treatments increased the expression of phosphorylated connexin43. Finally, we also demonstrate decreased expression of S-phase kinase-associated protein 2 (Skp2) and increased expression of p27(kip1) in carotenoid-treated cells. These results show that lycopene and beta-carotene were able to negatively modulate events related to the malignant phenotype of AtT20 cells, through a mechanism that could involve changes in the expression of connexin 43, Skp2 and p27(kip1); and suggest that these compounds might provide a novel pharmacological approach to the treatment of Cushing's disease.	[Haddad, Natalia F.; Teodoro, Anderson J.; de Oliveira, Felipe Leite; Soares, Nathalia; de Mattos, Romulo Medina; Dezonne, Romulo Sperduto; Alcantara Gomes, Flavia Carvalho; Nasciutti, Luiz Eurico; Miranda-Alves, Leandro] Univ Fed Rio de Janeiro, Inst Ciencias Biomed, BR-21941 Rio De Janeiro, Brazil; [Haddad, Natalia F.; Hecht, Fabio; de Carvalho, Denise Pires; Gadelha, Monica R.] Univ Fed Rio de Janeiro, Serv Endocrinol, Hosp Univ Clementino Fraga Filho, BR-21941 Rio De Janeiro, Brazil; [Vairo, Leandro; dos Santos Goldenberg, Regina Coeli] Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, BR-21941 Rio De Janeiro, Brazil; [Teodoro, Anderson J.] Univ Estado Rio de Janeiro, Programa Nutr & Alimentos, Rio De Janeiro, Brazil	Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Universidade do Estado do Rio de Janeiro	Miranda-Alves, L (corresponding author), Univ Fed Rio de Janeiro, Inst Ciencias Biomed, BR-21941 Rio De Janeiro, Brazil.	lmiranda@ufrj.br	Dezonne, Romulo Sperdudo/ABB-4292-2021; Gomes, Flavia/AAX-6354-2021; Oliveira, Felipe L/H-9902-2012; Goldenberg, Regina/ABI-2609-2020; Vairo, Leandro/J-9938-2013; Carvalho, Denise P/H-6306-2012; Teodoro, Anderson Junger/F-9608-2015; Hecht, Fabio/R-9004-2017; Gomes, Flavia/C-5383-2013; Miranda-Alves, Leandro/D-9932-2014	Goldenberg, Regina/0000-0002-0886-9603; Carvalho, Denise P/0000-0001-6933-6424; Teodoro, Anderson Junger/0000-0002-0949-9528; Hecht, Fabio/0000-0001-9110-2587; Gomes, Flavia/0000-0003-2966-0638; Dezonne, Romulo/0000-0002-5838-0881; Miranda-Alves, Leandro/0000-0001-7832-8717	Conselho Nacional de Desenvolvimento Cientifico (CNPq); Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)	Conselho Nacional de Desenvolvimento Cientifico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ))	This work was supported by Conselho Nacional de Desenvolvimento Cientifico (CNPq) and Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Wadei HAN, 2009, INT J ONCOL, V34, P1093, DOI 10.3892/ijo_00000236; Bangaru MLY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009893; Ben-Dor A, 2001, ARCH BIOCHEM BIOPHYS, V391, P295, DOI 10.1006/abbi.2001.2412; Bertram JS, 2004, BIOCHEM SOC T, V32, P985, DOI 10.1042/BST0320985; BUONASSISI V, 1962, P NATL ACAD SCI USA, V48, P1184, DOI 10.1073/pnas.48.7.1184; Chalabi N, 2007, J HISTOCHEM CYTOCHEM, V55, P877, DOI 10.1369/jhc.7A7185.2007; Daly AF, 2007, HORM RES, V68, P195, DOI 10.1159/000110624; Dbouk HA, 2009, CELL COMMUN SIGNAL, V7, DOI 10.1186/1478-811X-7-4; Florio T, 2008, FRONT BIOSCI-LANDMRK, V13, P822, DOI 10.2741/2722; Fornelli F, 2007, TOXICOL IN VITRO, V21, P217, DOI 10.1016/j.tiv.2006.09.024; FURTH J, 1953, P SOC EXP BIOL MED, V84, P253; Giacomini D, 2006, ENDOCRINOLOGY, V147, P247, DOI 10.1210/en.2005-0958; He WW, 2012, CANCER BIOTHER RADIO, V27, P399, DOI 10.1089/cbr.2010.0802; Hix LA, 2004, CANCER LETT, V211, P25, DOI 10.1016/j.canlet.2004.01.036; Hix LM, 2004, REDOX REP, V9, P181, DOI 10.1179/135100004225005967; Hofland LJ, 2010, NEUROENDOCRINOLOGY, V92, P11, DOI 10.1159/000314296; Huang HC, 2011, J AGR FOOD CHEM, V59, P6765, DOI 10.1021/jf201096v; Hwang ES, 2004, J MED FOOD, V7, P284, DOI 10.1089/1096620041938614; Ishida E, 2011, ENDOCR J, V58, P287, DOI 10.1507/endocrj.K10E-158; Jang SH, 2009, ANN NY ACAD SCI, V1171, P156, DOI 10.1111/j.1749-6632.2009.04711.x; Kanemitsu MY, 1998, CELL GROWTH DIFFER, V9, P13; Kelkel M, 2011, FREE RADICAL RES, V45, P925, DOI 10.3109/10715762.2011.564168; Kiec-Wilk B, 2011, NUTR CANCER, V63, P1053, DOI 10.1080/01635581.2011.596644; KLEIN SB, 1992, J CELL PHYSIOL, V151, P326, DOI 10.1002/jcp.1041510214; Kotake-Nara E, 2001, J NUTR, V131, P3303, DOI 10.1093/jn/131.12.3303; Labeur M, 2006, FRONT HORM RES, V35, P169, DOI 10.1159/000094325; Labeur M, 2009, REV ENDOCR METAB DIS, V10, P103, DOI 10.1007/s11154-008-9080-6; Lampe PD, 1998, J CELL SCI, V111, P833; Leithe E, 2010, TOXICOL APPL PHARM, V247, P10, DOI 10.1016/j.taap.2010.05.006; Libe R, 2012, NEW ENGL J MED, V366, P2134, DOI 10.1056/NEJMc1204078; Liu NA, 2011, P NATL ACAD SCI USA, V108, P8414, DOI 10.1073/pnas.1018091108; Long AC, 2010, CURR EYE RES, V35, P670, DOI 10.3109/02713681003770746; Lu MD, 2012, MED ONCOL, V29, P3409, DOI 10.1007/s12032-012-0275-z; Marquez-Rosado L, 2012, BBA-BIOMEMBRANES, V1818, P1985, DOI 10.1016/j.bbamem.2011.07.028; Martucci RB, 2004, J CELL BIOCHEM, V92, P414, DOI 10.1002/jcb.20073; Miller M, 2008, ENDOCRINOLOGY, V149, P4158, DOI 10.1210/en.2007-1760; Moennikes O, 2003, CARCINOGENESIS, V24, P1561, DOI 10.1093/carcin/bgg099; Nahum A, 2001, ONCOGENE, V20, P3428, DOI 10.1038/sj.onc.1204452; Nahum A, 2006, EUR J NUTR, V45, P275, DOI 10.1007/s00394-006-0595-x; Neggers SJ, 2011, HORM RES PAEDIAT, V76, P102, DOI 10.1159/000329189; Palozza P, 2002, CARCINOGENESIS, V23, P11, DOI 10.1093/carcin/23.1.11; Palozza P, 2007, BRIT J NUTR, V98, P789, DOI 10.1017/S0007114507746883; Palozza P, 2010, CARCINOGENESIS, V31, P1813, DOI 10.1093/carcin/bgq157; Palozza P, 2009, BRIT J NUTR, V102, P207, DOI 10.1017/S0007114508169902; Pan SY, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-372; Pivonello R, 2004, J CLIN ENDOCR METAB, V89, P4493, DOI 10.1210/jc.2003-031746; RUCH RJ, 1987, TOXICOL APPL PHARM, V87, P111, DOI 10.1016/0041-008X(87)90089-5; Sakagami Y, 2010, YAKUGAKU ZASSHI, V130, P1445, DOI 10.1248/yakushi.130.1445; Sathyapalan T, 2012, EXPERT REV ANTICANC, V12, P669, DOI [10.1586/ERA.12.27, 10.1586/era.12.27]; Schaaf C, 2009, ENDOCR-RELAT CANCER, V16, P1339, DOI 10.1677/ERC-09-0129; Schaaf C, 2010, NEUROENDOCRINOLOGY, V91, P200, DOI 10.1159/000287236; Stahl W, 1998, INT J VITAM NUTR RES, V68, P354; Sun SH, 2012, EUR J PHARMACOL, V690, P22, DOI 10.1016/j.ejphar.2012.05.036; Talvas J, 2010, AM J CLIN NUTR, V91, P1716, DOI 10.3945/ajcn.2009.28666; Tang FY, 2008, MOL NUTR FOOD RES, V52, P646, DOI 10.1002/mnfr.200700272; Tani Y, 2011, ENDOCR J, V58, P297, DOI 10.1507/endocrj.K10E-389; Teodoro AJ, 2009, EUR J NUTR, V48, P261, DOI 10.1007/s00394-009-0001-6; Teodoro AJ, 2012, CANCER CELL INT, V12, DOI 10.1186/1475-2867-12-36; Theodoropoulou M, 2010, FRONT HORM RES, V38, P158, DOI 10.1159/000318506; VINDELOV LL, 1977, VIRCHOWS ARCH B, V24, P227; Vinken M, 2012, BBA-BIOMEMBRANES, V1818, P2002, DOI 10.1016/j.bbamem.2011.06.011; Vogt TM, 2002, AM J EPIDEMIOL, V155, P1023, DOI 10.1093/aje/155.11.1023; Yang CM, 2011, MOL NUTR FOOD RES, V55, P606, DOI 10.1002/mnfr.201000308; Yang ZF, 2008, INT J VITAM NUTR RES, V78, P105, DOI 10.1024/0300-9831.78.3.105	64	27	27	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e62773	10.1371/journal.pone.0062773	http://dx.doi.org/10.1371/journal.pone.0062773			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667519	gold, Green Published, Green Submitted			2022-12-27	WOS:000319654700062
J	Johnstone, VPA; Yan, EB; Alwis, DS; Rajan, R				Johnstone, Victoria Philippa Anne; Yan, Edwin Bingbing; Alwis, Dasuni Sathsara; Rajan, Ramesh			Cortical Hypoexcitation Defines Neuronal Responses in the Immediate Aftermath of Traumatic Brain Injury	PLOS ONE			English	Article							RAT BARREL CORTEX; FLUID-PERCUSSION INJURY; SPREADING DEPRESSION; INTRATHECAL BACLOFEN; PYRAMIDAL NEURONS; POSTTRAUMATIC EPILEPSY; SOMATOSENSORY CORTEX; RECEPTOR AGONISTS; WHISKER VIBRATION; HIPPOCAMPAL CA1	Traumatic brain injury (TBI) from a blow to the head is often associated with complex patterns of brain abnormalities that accompany deficits in cognitive and motor function. Previously we reported that a long-term consequence of TBI, induced with a closed-head injury method modelling human car and sporting accidents, is neuronal hyper-excitation in the rat sensory barrel cortex that receives tactile input from the face whiskers. Hyper-excitation occurred only in supra-granular layers and was stronger to complex than simple stimuli. We now examine changes in the immediate aftermath of TBI induced with same injury method. At 24 hours post-trauma significant sensorimotor deficits were observed and characterisation of the cortical population neuronal responses at that time revealed a depth-dependent suppression of neuronal responses, with reduced responses from supragranular layers through to input layer IV, but not in infragranular layers. In addition, increased spontaneous firing rate was recorded in cortical layers IV and V. We postulate that this early post-injury suppression of cortical processing of sensory input accounts for immediate post-trauma sensory morbidity and sets into train events that resolve into long-term cortical hyper-excitability in upper sensory cortex layers that may account for long-term sensory hyper-sensitivity in humans with TBI.	[Johnstone, Victoria Philippa Anne; Yan, Edwin Bingbing; Alwis, Dasuni Sathsara; Rajan, Ramesh] Monash Univ, Dept Physiol, Monash, Vic, Australia	Monash University	Rajan, R (corresponding author), Monash Univ, Dept Physiol, Monash, Vic, Australia.	ramesh.rajan@monash.edu	Johnstone, Victoria/B-5083-2015; rajan, ramesh/L-4842-2019	Johnstone, Victoria/0000-0001-9885-3607; Rajan, Ramesh/0000-0001-9862-0520	National Health & Medical Research Council of Australia [APP1029311]	National Health & Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	This study was funded by the National Health & Medical Research Council of Australia (grant no. APP1029311). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abelson-Mitchell N, 2008, J CLIN NURS, V17, P46, DOI 10.1111/j.1365-2702.2007.01941.x; Akasu T, 2002, NEUROSCI LETT, V329, P305, DOI 10.1016/S0304-3940(02)00707-3; Alloway KD, 2008, CEREB CORTEX, V18, P979, DOI 10.1093/cercor/bhm138; Alwis DS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052169; Ansari MA, 2008, FREE RADICAL BIO MED, V45, P443, DOI 10.1016/j.freeradbiomed.2008.04.038; Arabzadeh E, 2004, J NEUROSCI, V24, P6011, DOI 10.1523/JNEUROSCI.1389-04.2004; Arabzadeh E, 2003, J NEUROSCI, V23, P9146; BOHNEN N, 1991, J NEUROL, V238, P443, DOI 10.1007/BF00314651; BOHNEN N, 1992, J NEUROL NEUROSUR PS, V55, P222, DOI 10.1136/jnnp.55.3.222; BRANDS D.W.A., 2002, PREDICTING BRAIN MEC; Brecht M, 2002, J PHYSIOL-LONDON, V543, P49, DOI 10.1113/jphysiol.2002.018465; Bruno RM, 2006, SCIENCE, V312, P1622, DOI 10.1126/science.1124593; Church AJ, 2005, J NEUROTRAUM, V22, P277, DOI 10.1089/neu.2005.22.277; Clarkson AN, 2010, NATURE, V468, P305, DOI 10.1038/nature09511; Cohen AS, 2007, PROG BRAIN RES, V161, P143, DOI 10.1016/S0079-6123(06)61010-8; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; D'Ambrosio R, 1999, J NEUROSCI, V19, P8152; de Kock CPJ, 2007, J PHYSIOL-LONDON, V581, P139, DOI 10.1113/jphysiol.2006.124321; DIETRICH WD, 1994, J NEUROTRAUM, V11, P629, DOI 10.1089/neu.1994.11.629; Ding MC, 2011, J NEUROSCI, V31, P14085, DOI 10.1523/JNEUROSCI.3572-11.2011; Dischinger PC, 1998, ACCIDENT ANAL PREV, V30, P831, DOI 10.1016/S0001-4575(98)00036-0; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; Feldmeyer D, 2005, J NEUROSCI, V25, P3423, DOI 10.1523/JNEUROSCI.5227-04.2005; Feldmeyer D, 2012, FRONT NEUROANAT, V6, DOI 10.3389/fnana.2012.00024; Francisco GE, 2007, BRAIN INJURY, V21, P335, DOI 10.1080/02699050701311018; Fraser PA, 2011, FREE RADICAL BIO MED, V51, P967, DOI 10.1016/j.freeradbiomed.2011.06.003; Fujioka H, 2004, STROKE, V35, pE346, DOI 10.1161/01.STR.0000130990.28734.9c; Fukuda K, 1996, J NEUROTRAUM, V13, P255, DOI 10.1089/neu.1996.13.255; GLOBUS MYT, 1995, J NEUROCHEM, V65, P1704; Golarai G, 2001, J NEUROSCI, V21, P8523, DOI 10.1523/JNEUROSCI.21-21-08523.2001; Griesemer D, 2007, J NEUROTRAUM, V24, P1823, DOI 10.1089/neu.2006.0237; Hall KD, 2010, BRAIN RES, V1323, P161, DOI 10.1016/j.brainres.2010.01.067; Hartmann MJ, 2003, J NEUROSCI, V23, P6510; Hellewell SC, 2010, J NEUROTRAUM, V27, P1997, DOI 10.1089/neu.2009.1245; Helmy A, 2011, PROG NEUROBIOL, V95, P352, DOI 10.1016/j.pneurobio.2011.09.003; Hendricks S, 2012, J SPORT SCI, V30, P1215, DOI 10.1080/02640414.2012.707328; HERNANDEZCACERES J, 1987, BRAIN RES, V437, P360, DOI 10.1016/0006-8993(87)91652-0; HICKS RR, 1993, J NEUROTRAUM, V10, P405, DOI 10.1089/neu.1993.10.405; Hooks BM, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000572; Hunt RF, 2011, J NEUROSCI, V31, P6880, DOI 10.1523/JNEUROSCI.0032-11.2011; JENSEN KF, 1987, J NEUROSCI, V7, P3529; Kao T, 2011, J NEUROPHYSIOL, V106, P2662, DOI 10.1152/jn.01017.2010; KELLER A, 1985, BRAIN RES, V343, P159, DOI 10.1016/0006-8993(85)91171-0; Kharatishvili I, 2006, NEUROSCIENCE, V140, P685, DOI 10.1016/j.neuroscience.2006.03.012; Kleiven S, 2007, STAPP CAR CRASH JO, V51, P81; Koerner C, 2004, NEUROSCI LETT, V361, P21, DOI 10.1016/j.neulet.2003.12.074; KORALEK KA, 1988, BRAIN RES, V463, P346, DOI 10.1016/0006-8993(88)90408-8; Lamy M, 2013, MED BIOL ENG COMPUT, V51, P353, DOI 10.1007/s11517-012-1004-7; Larsen DD, 2006, J COMP NEUROL, V494, P398, DOI 10.1002/cne.20754; Lauritzen M, 2011, J CEREBR BLOOD F MET, V31, P17, DOI 10.1038/jcbfm.2010.191; Learoyd AE, 2012, BEHAV BRAIN RES, V226, P197, DOI 10.1016/j.bbr.2011.09.016; Lei ZG, 2012, J NEUROTRAUM, V29, P235, DOI 10.1089/neu.2010.1537; Levchakov A, 2006, J NEUROTRAUM, V23, P1570, DOI 10.1089/neu.2006.23.1570; Lew HL, 2004, AM J PHYS MED REHAB, V83, P428, DOI 10.1097/00002060-200406000-00004; Li HF, 2002, J NEUROPHYSIOL, V88, P2, DOI 10.1152/jn.00507.2001; Li Y, 2011, J NEUROTRAUM, V28, P1767, DOI 10.1089/neu.2010.1687; LOWENSTEIN DH, 1992, J NEUROSCI, V12, P4846; Lubke J, 2003, CEREB CORTEX, V13, P1051, DOI 10.1093/cercor/13.10.1051; Manns ID, 2004, J PHYSIOL-LONDON, V556, P601, DOI 10.1113/jphysiol.2003.053132; Maravall M, 2007, PLOS BIOL, V5, P323, DOI 10.1371/journal.pbio.0050019; Marino S, 2007, J NEUROL NEUROSUR PS, V78, P501, DOI 10.1136/jnnp.2006.099796; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; McNamara KCS, 2010, J NEUROTRAUM, V27, P695, DOI 10.1089/neu.2009.1237; Meyer HS, 2010, CEREB CORTEX, V20, P2287, DOI 10.1093/cercor/bhq069; Meythaler JM, 1999, ARCH PHYS MED REHAB, V80, P13, DOI 10.1016/S0003-9993(99)90301-5; Mulders WHAM, 2009, NEUROSCIENCE, V164, P733, DOI 10.1016/j.neuroscience.2009.08.036; Nance ML, 2006, ANN SURG, V243, P121, DOI 10.1097/01.sla.0000193838.11102.56; NELLGARD B, 1992, ACTA PHYSIOL SCAND, V146, P497, DOI 10.1111/j.1748-1716.1992.tb09451.x; NEUMANNHAEFELIN T, 1995, NEUROSCI LETT, V193, P101, DOI 10.1016/0304-3940(95)11677-O; Oberlaender M, 2012, CEREB CORTEX, V22, P2375, DOI 10.1093/cercor/bhr317; Pavlov I, 2011, NEUROSCIENCE, V194, P208, DOI 10.1016/j.neuroscience.2011.07.074; Petersen CCH, 2007, NEURON, V56, P339, DOI 10.1016/j.neuron.2007.09.017; Pinto DJ, 2000, J NEUROPHYSIOL, V83, P1158, DOI 10.1152/jn.2000.83.3.1158; Piot-Grosjean O, 2001, NEUROBIOL DIS, V8, P1082, DOI 10.1006/nbdi.2001.0450; Rajan R, 2007, EUR J NEUROSCI, V25, P2383, DOI 10.1111/j.1460-9568.2007.05481.x; Rajan R, 2006, J NEUROSCI METH, V157, P103, DOI 10.1016/j.jneumeth.2006.04.008; Reinert M, 2000, Neurosurg Focus, V8, pe10; RIBAK CE, 1982, CAN J PHYSIOL PHARM, V60, P864, DOI 10.1139/y82-122; Ritt JT, 2008, NEURON, V57, P599, DOI 10.1016/j.neuron.2007.12.024; Rosenfeld JV, 2012, LANCET, V380, P1088, DOI 10.1016/S0140-6736(12)60864-2; Salin P, 1995, J NEUROSCI, V15, P8234; Sanders MJ, 2001, BRAIN RES, V904, P141, DOI 10.1016/S0006-8993(01)02424-6; Sarno S, 2003, BRAIN INJURY, V17, P413, DOI 10.1080/0269905031000070161; Schiene K, 1996, J CEREBR BLOOD F MET, V16, P906, DOI 10.1097/00004647-199609000-00014; Schubert D, 2006, CEREB CORTEX, V16, P223, DOI 10.1093/cercor/bhi100; Shimizu T, 2002, BRAIN, V125, P1896, DOI 10.1093/brain/awf183; Shojo H, 2010, NEUROSCIENCE, V171, P1273, DOI 10.1016/j.neuroscience.2010.10.018; Signoretti S, 2010, MOL CELL BIOCHEM, V333, P269, DOI 10.1007/s11010-009-0228-9; SMITH ML, 1984, ACTA NEUROPATHOL, V64, P319, DOI 10.1007/BF00690397; Somjen GG, 2001, PHYSIOL REV, V81, P1065, DOI 10.1152/physrev.2001.81.3.1065; Staiger JF, 2004, CEREB CORTEX, V14, P690, DOI 10.1093/cercor/bhh029; Takano T, 2007, NAT NEUROSCI, V10, P754, DOI 10.1038/nn1902; Turner MS, 2003, ACT NEUR S, V87, P81; Tuttolomondo A, 2009, CURR TOP MED CHEM, V9, P1317, DOI 10.2174/156802609789869646; WADDELL PA, 1984, ACTA NEUROL SCAND, V69, P270, DOI 10.1111/j.1600-0404.1984.tb07812.x; Wilson SM, 2012, NEUROSCIENCE, V210, P451, DOI 10.1016/j.neuroscience.2012.02.038; Wood DP, 2005, P I MECH ENG D-J AUT, V219, P183, DOI 10.1243/095440705X6703; Xu J, 2008, NEUROPHARMACOLOGY, V54, P1029, DOI 10.1016/j.neuropharm.2008.01.014; Yan EB, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-147; Yan WY, 2011, COMPUT METHOD BIOMEC, V14, P1049, DOI 10.1080/10255842.2010.506435; Yang L, 2010, J NEUROTRAUM, V27, P1541, DOI 10.1089/neu.2009.1244; Ydenius A, 2010, TRAFFIC INJ PREV, V11, P526, DOI 10.1080/15389588.2010.492053; Yi JH, 2006, NEUROCHEM INT, V48, P394, DOI 10.1016/j.neuint.2005.12.001; Zhao H, 2010, INT J CRASHWORTHINES, V15, P313, DOI 10.1080/13588260903335290; Zhou C, 2008, J NEUROSCI RES, V86, P2973, DOI 10.1002/jnr.21728	105	35	35	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e63454	10.1371/journal.pone.0063454	http://dx.doi.org/10.1371/journal.pone.0063454			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667624	Green Published, Green Submitted, gold			2022-12-27	WOS:000319654700150
J	Li, Q; Wang, YR; Zhang, Y; Li, W; Zhu, J; Zheng, Y; Chen, JJ; Zhao, LY; Zhou, ZY; Liu, YJ; Wang, W; Tian, J				Li, Qiang; Wang, Yarong; Zhang, Yi; Li, Wei; Zhu, Jia; Zheng, Ying; Chen, Jiajie; Zhao, Liyan; Zhou, Zhenyu; Liu, Yijun; Wang, Wei; Tian, Jie			Assessing Cue-Induced Brain Response as a Function of Abstinence Duration in Heroin-Dependent Individuals: An Event-Related fMRI Study	PLOS ONE			English	Article							MEDIAL FRONTAL-CORTEX; NEURAL RESPONSES; MOTOR IMAGERY; SMOKING CUES; ADDICTION; WITHDRAWAL; TIME; ORGANIZATION; CONSUMPTION; DYSFUNCTION	The brain activity induced by heroin-related cues may play a role in the maintenance of heroin dependence. Whether the reinforcement or processing biases construct an everlasting feature of heroin addiction remains to be resolved. We used an event-related fMRI paradigm to measure brain activation in response to heroin cue-related pictures versus neutral pictures as the control condition in heroin-dependent patients undergoing short-term and long-term abstinence. The self-reported craving scores were significantly increased after cue exposure in the short-term abstinent patients (t = 3.000, P = 0.008), but no increase was found in the long-term abstinent patients (t = 1.510, P = 0.149). However, no significant differences in cue-induced craving changes were found between the two groups (t = 1.193, P = 0.850). Comparing between the long-term abstinence and short-term abstinence groups, significant decreases in brain activation were detected in the bilateral anterior cingulated cortex, left medial prefrontal cortex, caudate, middle occipital gyrus, inferior parietal lobule and right precuneus. Among all of the heroin dependent patients, the abstinence duration was negatively correlated with brain activation in the left medial prefrontal cortex and left inferior parietal lobule. These findings suggest that long-term abstinence may be useful for heroin-dependent patients to diminish their saliency value of heroin-related cues and possibly lower the relapse vulnerability to some extent.	[Li, Qiang; Wang, Yarong; Li, Wei; Zhu, Jia; Zheng, Ying; Chen, Jiajie; Wang, Wei; Tian, Jie] Fourth Mil Med Univ, Dept Radiol, Tangdu Hosp, Xian 710032, Peoples R China; [Zhang, Yi; Tian, Jie] Xidian Univ, Life Sci Res Ctr, Sch Life Sci & Technol, Xian, Peoples R China; [Zhao, Liyan] Peking Univ, Natl Inst Drug Dependence, Beijing 100871, Peoples R China; [Liu, Yijun] Univ Florida, Dept Psychiat, McKnight Brain Inst, Gainesville, FL 32611 USA; [Zhou, Zhenyu; Liu, Yijun] Peking Univ, Coll Engn, Beijing 100871, Peoples R China; [Tian, Jie] Chinese Acad Sci, Inst Automat, Beijing, Peoples R China	Air Force Military Medical University; Xidian University; Peking University; State University System of Florida; University of Florida; Peking University; Chinese Academy of Sciences; Institute of Automation, CAS	Wang, W (corresponding author), Fourth Mil Med Univ, Dept Radiol, Tangdu Hosp, Xian 710032, Peoples R China.	m_d_Wang@hotmail.com; tian@ieee.org	Tian, Jie/H-1190-2011; Zhang, Yi/J-7496-2017; Zhang, Yi/M-9408-2013	Tian, Jie/0000-0003-0498-0432; Zhang, Yi/0000-0003-0859-9735; Zhang, Yi/0000-0001-6657-403X	National Natural Science Foundation of China [81201081, 81071142, 81071143, 60901064]; Development Project of Science and Technology of Shaanxi Province [2008K12-02, 2009K01-65, 2010K16-03-01, 2010K16-03-02]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Development Project of Science and Technology of Shaanxi Province	This work was supported by grants from the National Natural Science Foundation of China (Nos. 81201081, 81071142, 81071143 and 60901064) and the Development Project of Science and Technology of Shaanxi Province (Nos. 2008K12-02, 2009K01-65, 2010K16-03-01 and 2010K16-03-02). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baler RD, 2006, TRENDS MOL MED, V12, P559, DOI 10.1016/j.molmed.2006.10.005; Bush G, 2000, TRENDS COGN SCI, V4, P215, DOI 10.1016/S1364-6613(00)01483-2; Due DL, 2002, AM J PSYCHIAT, V159, P954, DOI 10.1176/appi.ajp.159.6.954; Filbey FM, 2009, P NATL ACAD SCI USA, V106, P13016, DOI 10.1073/pnas.0903863106; Fogassi L, 2005, SCIENCE, V308, P662, DOI 10.1126/science.1106138; Franklin TR, 2007, NEUROPSYCHOPHARMACOL, V32, P2301, DOI 10.1038/sj.npp.1301371; Fu LP, 2008, NEUROSCI LETT, V438, P322, DOI 10.1016/j.neulet.2008.04.033; Garavan H, 2000, AM J PSYCHIAT, V157, P1789, DOI 10.1176/appi.ajp.157.11.1789; Goldstein RZ, 2011, NAT REV NEUROSCI, V12, P652, DOI 10.1038/nrn3119; Grimm JW, 2001, NATURE, V412, P141, DOI 10.1038/35084134; Hahn B, 2007, J NEUROSCI, V27, P3477, DOI 10.1523/JNEUROSCI.5129-06.2007; Haruno M, 2004, J NEUROSCI, V24, P1660, DOI 10.1523/JNEUROSCI.3417-03.2004; Hser YI, 2007, EVAL PROGRAM PLANN, V30, P187, DOI 10.1016/j.evalprogplan.2006.10.008; Kalivas PW, 2005, AM J PSYCHIAT, V162, P1403, DOI 10.1176/appi.ajp.162.8.1403; Kiefer F, 2006, ADDICTION, V101, P1215, DOI 10.1111/j.1360-0443.2006.01541.x; Langleben DD, 2008, AM J PSYCHIAT, V165, P390, DOI 10.1176/appi.ajp.2007.07010070; Li CSR, 2008, NEUROSCI BIOBEHAV R, V32, P581, DOI 10.1016/j.neubiorev.2007.10.003; Li Q, 2012, BRAIN RES, V1469, P63, DOI 10.1016/j.brainres.2012.06.024; Liu JX, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023098; Lou MW, 2012, SUBST USE MISUSE, V47, P631, DOI 10.3109/10826084.2011.646381; Lu L, 2004, NEUROPHARMACOLOGY, V47, P214, DOI 10.1016/j.neuropharm.2004.06.027; Majdandzic J, 2007, NEUROIMAGE, V37, P589, DOI 10.1016/j.neuroimage.2007.04.071; Malouin F, 2003, HUM BRAIN MAPP, V19, P47, DOI 10.1002/hbm.10103; Mintzer MZ, 2002, DRUG ALCOHOL DEPEN, V67, P41, DOI 10.1016/S0376-8716(02)00013-3; Ogiso T, 2000, NEUROREPORT, V11, P1345, DOI 10.1097/00001756-200004270-00039; Rushworth MFS, 2007, CURR OPIN NEUROBIOL, V17, P220, DOI 10.1016/j.conb.2007.03.001; Rushworth MFS, 2004, TRENDS COGN SCI, V8, P410, DOI 10.1016/j.tics.2004.07.009; Sell LA, 2000, DRUG ALCOHOL DEPEN, V60, P207, DOI 10.1016/S0376-8716(99)00158-1; Shalev U, 2001, PSYCHOPHARMACOLOGY, V156, P98, DOI 10.1007/s002130100748; Sinha R, 2006, ARCH GEN PSYCHIAT, V63, P324, DOI 10.1001/archpsyc.63.3.324; Tang YL, 2006, ADDICTION, V101, P657, DOI 10.1111/j.1360-0443.2006.01367.x; Volkow ND, 2011, P NATL ACAD SCI USA, V108, P15037, DOI 10.1073/pnas.1010654108; Wang W, 2011, AM J DRUG ALCOHOL AB, V37, P123, DOI 10.3109/00952990.2010.543997; Wang Z, 2007, J NEUROSCI, V27, P14035, DOI 10.1523/JNEUROSCI.2966-07.2007; Weerts EM, 2006, ALCOHOL CLIN EXP RES, V30, P2026, DOI 10.1111/j.1530-0277.2006.00249.x; Yang Z, 2009, HUM BRAIN MAPP, V30, P766, DOI 10.1002/hbm.20542; Zijlstra F, 2009, DRUG ALCOHOL DEPEN, V99, P183, DOI 10.1016/j.drugalcdep.2008.07.012	37	27	33	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e62911	10.1371/journal.pone.0062911	http://dx.doi.org/10.1371/journal.pone.0062911			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667541	Green Submitted, Green Published, gold			2022-12-27	WOS:000319654700080
J	Otjacques, E; Binsfeld, M; Rocks, N; Blacher, S; Vanderkerken, K; Noel, A; Beguin, Y; Cataldo, D; Caers, J				Otjacques, Eleonore; Binsfeld, Marilene; Rocks, Natacha; Blacher, Silvia; Vanderkerken, Karin; Noel, Agnes; Beguin, Yves; Cataldo, Didier; Caers, Jo			Mithramycin Exerts an Anti-Myeloma Effect and Displays Anti-Angiogenic Effects through Up-Regulation of Anti-Angiogenic Factors	PLOS ONE			English	Article							BONE-MARROW ANGIOGENESIS; TUMOR-NECROSIS-FACTOR; MULTIPLE-MYELOMA; IN-VIVO; COMBINATORIAL BIOSYNTHESIS; PANCREATIC-CANCER; SP1 BINDING; CELLS; INHIBITION; ANTITUMOR	Mithramycin (MTM), a cytotoxic compound, is currently being investigated for its anti-angiogenic activity that seems to be mediated through an inhibition of the transcription factor SP1. In this study we evaluated its anti-myeloma effects in the syngenic 5TGM1 model in vitro as well as in vivo. In vitro, MTM inhibited DNA synthesis of 5TGM1 cells with an IC50 of 400 nM and induced an arrest in cell cycle progression at the G1/S transition point. Western-blot revealed an up-regulation of p53, p21 and p27 and an inhibition of c-Myc, while SP1 remained unaffected. In rat aortic ring assays, a strong anti-angiogenic effect was seen, which could be explained by a decrease of VEGF production and an up-regulation of anti-angiogenic proteins such as IP10 after MTM treatment. The administration of MTM to mice injected with 5TGM1 decreased 5TGM1 cell invasion into bone marrow and myeloma neovascularisation. These data suggest that MTM displays anti-myeloma and anti-angiogenic effects that are not mediated by an inhibition of SP1 but rather through c-Myc inhibition and p53 activation.	[Otjacques, Eleonore; Binsfeld, Marilene; Beguin, Yves; Caers, Jo] Univ Liege, Hematol Lab, Grp Interdisciplinaire Genoprote Appl GIGA Res, Liege, Belgium; [Otjacques, Eleonore; Rocks, Natacha; Blacher, Silvia; Noel, Agnes; Cataldo, Didier] Univ Liege, Lab Tumour & Dev Biol, Grp Interdisciplinaire Genoprote Appl GIGA Res, Liege, Belgium; [Vanderkerken, Karin] Vrije Univ Brussel, Dept Hematol & Immunol, Myeloma Ctr Brussels, Brussels, Belgium	University of Liege; University of Liege; Vrije Universiteit Brussel	Caers, J (corresponding author), Univ Liege, Hematol Lab, Grp Interdisciplinaire Genoprote Appl GIGA Res, Liege, Belgium.	jo.caers@chu.ulg.ac.be	Cataldo, Didier/GPG-3453-2022; Vanderkerken, Karin/I-3513-2013; Binsfeld, Marilene/AAG-9121-2020	Cataldo, Didier/0000-0002-3079-7941; Noel, Agnes/0000-0002-7670-6179; Caers, Jo/0000-0002-3175-1195; Vanderkerken, Karin/0000-0002-2137-7179	Belgian Foundation Against Cancer; Fonds de la Recherche Scientifique Medicale; Fonds National de la Recherche Scientifique (Belgium); Fonds speciaux de la Recherche (University of Liege); DGO6 from the "Region Wallonne" (Belgium); Interuniversity Attraction Poles Program - Belgian Science Policy IUAP program (Brussels, Belgium) [7/30]	Belgian Foundation Against Cancer; Fonds de la Recherche Scientifique Medicale(Fonds de la Recherche Scientifique - FNRS); Fonds National de la Recherche Scientifique (Belgium)(Fonds de la Recherche Scientifique - FNRS); Fonds speciaux de la Recherche (University of Liege)(University of Liege); DGO6 from the "Region Wallonne" (Belgium); Interuniversity Attraction Poles Program - Belgian Science Policy IUAP program (Brussels, Belgium)	The study was in part supported by funds from the Belgian Foundation Against Cancer, the Fonds de la Recherche Scientifique Medicale, the Fonds National de la Recherche Scientifique (Belgium), the Fonds speciaux de la Recherche (University of Liege), the DGO6 from the "Region Wallonne" (Belgium), and the Interuniversity Attraction Poles Program - Belgian Science Policy IUAP program 7/30 (Brussels, Belgium). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguayo A, 2000, BLOOD, V96, P2240, DOI 10.1182/blood.V96.6.2240.h8002240_2240_2245; Ahn SY, 2004, AM J PATHOL, V164, P1663, DOI 10.1016/S0002-9440(10)63725-X; Anderson KC, 2011, ANNU REV PATHOL-MECH, V6, P249, DOI 10.1146/annurev-pathol-011110-130249; ANGIOLILLO AL, 1995, J EXP MED, V182, P155, DOI 10.1084/jem.182.1.155; Anthony ET, 2009, CLIN EXP DERMATOL, V34, P409, DOI 10.1111/j.1365-2230.2008.02901.x; Barcelo F, 2010, BIOCHEMISTRY-US, V49, P10543, DOI 10.1021/bi101398s; Bergsagel PL, 2005, BLOOD, V106, P296, DOI 10.1182/blood-2005-01-0034; Blacher Silvia, 2001, Angiogenesis, V4, P133, DOI 10.1023/A:1012251229631; BLUME SW, 1991, J CLIN INVEST, V88, P1613, DOI 10.1172/JCI115474; Caers J, 2008, BRIT J CANCER, V98, P1966, DOI 10.1038/sj.bjc.6604388; Caers J, 2008, EUR J HAEMATOL, V81, P329, DOI 10.1111/j.1600-0609.2008.01127.x; Chesi M, 2011, HEMATOL-AM SOC HEMAT, P344, DOI 10.1182/asheducation-2011.1.344; Coluccia AML, 2008, BLOOD, V112, P1346, DOI 10.1182/blood-2007-10-116590; Deshpande A, 2005, ONCOGENE, V24, P2909, DOI 10.1038/sj.onc.1208618; Detry B, 2012, BLOOD, V119, P5048, DOI 10.1182/blood-2011-12-400267; Ely S, 2005, CANCER RES, V65, P11345, DOI 10.1158/0008-5472.CAN-05-2159; Farnebo M, 2010, BIOCHEM BIOPH RES CO, V396, P85, DOI 10.1016/j.bbrc.2010.02.152; Fulciniti M, 2011, CLIN CANCER RES, V17, P6500, DOI 10.1158/1078-0432.CCR-11-1036; Gao Y, 2011, CANCER RES, V71, P5182, DOI 10.1158/0008-5472.CAN-10-2016; Garrett IR, 1997, BONE, V20, P515, DOI 10.1016/S8756-3282(97)00056-2; Gerlo S, 2008, CELL SIGNAL, V20, P1489, DOI 10.1016/j.cellsig.2008.04.004; GREEN L, 1984, CANCER TREAT REP, V68, P1379; Hose D, 2009, BLOOD, V114, P128, DOI 10.1182/blood-2008-10-184226; Jia ZL, 2007, CANCER RES, V67, P4878, DOI 10.1158/0008-5472.CAN-06-3494; Koutsodontis G, 2004, ONCOGENE, V23, P9190, DOI 10.1038/sj.onc.1208141; Lombo F, 2006, APPL MICROBIOL BIOT, V73, P1, DOI 10.1007/s00253-006-0511-6; Malek A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035130; Masson Veronique, 2002, Biological Procedures Online, V4, P24, DOI 10.1251/bpo30; Ohgami T, 2010, CANCER SCI, V101, P1387, DOI 10.1111/j.1349-7006.2010.01543.x; Otjacques E, 2011, INT J HEMATOL, V94, P505, DOI 10.1007/s12185-011-0963-z; Oyajobi BO, 2007, MOL CANCER THER, V6, P1701, DOI 10.1158/1535-7163.MCT-07-0121; Patten SG, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-683; Ping DS, 2000, J BIOL CHEM, V275, P1708, DOI 10.1074/jbc.275.3.1708; Presta M, 2002, LEUKEMIA, V16, P1490, DOI 10.1038/sj.leu.2402646; Previdi S, 2010, GYNECOL ONCOL, V118, P182, DOI 10.1016/j.ygyno.2010.03.020; RADL J, 1979, J IMMUNOL, V122, P609; RADL J, 1988, AM J PATHOL, V132, P593; Rajkumar SV, 2002, CLIN CANCER RES, V8, P2210; Remsing LL, 2003, J AM CHEM SOC, V125, P5745, DOI 10.1021/ja034162h; Rocks N, 2008, CANCER RES, V68, P9541, DOI 10.1158/0008-5472.CAN-08-0548; Safe S, 2005, EUR J CANCER, V41, P2438, DOI 10.1016/j.ejca.2005.08.006; SNYDER RC, 1991, BIOCHEMISTRY-US, V30, P4290, DOI 10.1021/bi00231a027; Spurrell JCL, 2005, AM J PHYSIOL-LUNG C, V289, pL85, DOI 10.1152/ajplung.00397.2004; VACCA A, 1994, BRIT J HAEMATOL, V87, P503, DOI 10.1111/j.1365-2141.1994.tb08304.x; Van Valckenborgh E, 2002, BRIT J CANCER, V86, P796, DOI 10.1038/sj.bjc.6600137; Wang LW, 2008, INT J ONCOL, V33, P161; Yuan P, 2007, CANCER-AM CANCER SOC, V110, P2682, DOI 10.1002/cncr.23092	47	16	16	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e62818	10.1371/journal.pone.0062818	http://dx.doi.org/10.1371/journal.pone.0062818			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667526	Green Published, gold, Green Submitted			2022-12-27	WOS:000319654700066
J	Takasugi, N; Sasaki, T; Ebinuma, I; Osawa, S; Isshiki, H; Takeo, K; Tomita, T; Iwatsubo, T				Takasugi, Nobumasa; Sasaki, Tomoki; Ebinuma, Ihori; Osawa, Satoko; Isshiki, Hayato; Takeo, Koji; Tomita, Taisuke; Iwatsubo, Takeshi			FTY720/Fingolimod, a Sphingosine Analogue, Reduces Amyloid-beta Production in Neurons	PLOS ONE			English	Article							EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; IMMUNOMODULATORY DRUG FTY720; GAMMA-SECRETASE ACTIVITY; MULTIPLE-SCLEROSIS; ALZHEIMERS-DISEASE; T-CELLS; A-BETA; PROTEIN; SPHINGOSINE-1-PHOSPHATE; PRESENILIN	Sphingosine-1-phosphate (S1P) is a pluripotent lipophilic mediator working as a ligand for G-protein coupled S1P receptors (S1PR), which is currently highlighted as a therapeutic target for autoimmune diseases including relapsing forms of multiple sclerosis. Sphingosine related compounds, FTY720 and KRP203 known as S1PR modulators, are phosphorylated by sphingosine kinase 2 (SphK2) to yield the active metabolites FTY720-P and KRP203-P, which work as functional antagonists for S1PRs. Here we report that FTY720 and KRP203 decreased production of Amyloid-beta peptide (A beta), a pathogenic proteins causative for Alzheimer disease (AD), in cultured neuronal cells. Pharmacological analyses suggested that the mechanism of FTY720-mediated A beta decrease in cells was independent of known downstream signaling pathways of S1PRs. Unexpectedly, 6-days treatment of APP transgenic mice with FTY720 resulted in a decrease in A beta 40, but an increase in A beta 42 levels in brains. These results suggest that S1PR modulators are novel type of regulators for A beta metabolisms that are active in vitro and in vivo.	[Takasugi, Nobumasa; Sasaki, Tomoki; Ebinuma, Ihori; Osawa, Satoko; Takeo, Koji; Tomita, Taisuke; Iwatsubo, Takeshi] Univ Tokyo, Grad Sch Pharmaceut Sci, Dept Neuropathol & Neurosci, Tokyo, Japan; [Takasugi, Nobumasa; Isshiki, Hayato; Iwatsubo, Takeshi] Univ Tokyo, Grad Sch Med, Dept Neuropathol, Tokyo, Japan; [Takasugi, Nobumasa; Isshiki, Hayato; Tomita, Taisuke; Iwatsubo, Takeshi] Univ Tokyo, Japan Sci & Technol Agcy, Core Res Evolut Sci & Technol, Tokyo, Japan	University of Tokyo; University of Tokyo; Japan Science & Technology Agency (JST); University of Tokyo	Tomita, T (corresponding author), Univ Tokyo, Grad Sch Pharmaceut Sci, Dept Neuropathol & Neurosci, Tokyo, Japan.	taisuke@mol.f.u-tokyo.ac.jp	Tomita, Taisuke/L-5427-2015	Tomita, Taisuke/0000-0002-0075-5943; TAKASUGI, NOBUMASA/0000-0002-6059-2082	Japan Society for the Promotion of Science (JSPS); Ministry of Education, Culture, Sports, Science & Technology in Japan; Ministry of Health, Labor and Welfare of Japan (Comprehensive Research on Aging and Health); Core Research for Evolutional Science and Technology of JST	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science & Technology in Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labor and Welfare of Japan (Comprehensive Research on Aging and Health)(Ministry of Health, Labour and Welfare, Japan); Core Research for Evolutional Science and Technology of JST	This work is supported in part by Grants-in-Aid for Young Scientists (S) (for T.T.) and (B) (for N.T.) from Japan Society for the Promotion of Science (JSPS), by the Grant-in-Aid for Scientific Research on Innovative Areas (Brain Environment) from the Ministry of Education, Culture, Sports, Science & Technology in Japan (for T.T.), by the Ministry of Health, Labor and Welfare of Japan (Comprehensive Research on Aging and Health) (for T.T.), by Core Research for Evolutional Science and Technology of JST (for T.T., T.I.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aktas O, 2010, NAT REV NEUROL, V6, P373, DOI 10.1038/nrneurol.2010.76; Becuwe M, 2012, BIOCHEM RES INT, V2012, DOI 10.1155/2012/242764; Brinkmann V, 2010, NAT REV DRUG DISCOV, V9, P883, DOI 10.1038/nrd3248; Choi JW, 2011, P NATL ACAD SCI USA, V108, P751, DOI 10.1073/pnas.1014154108; Cutler RG, 2004, P NATL ACAD SCI USA, V101, P2070, DOI 10.1073/pnas.0305799101; De Strooper B, 2010, NAT REV NEUROL, V6, P99, DOI 10.1038/nrneurol.2009.218; Don AS, 2007, J BIOL CHEM, V282, P15833, DOI 10.1074/jbc.M609124200; Foster CA, 2007, J PHARMACOL EXP THER, V323, P469, DOI 10.1124/jpet.107.127183; Fujino M, 2003, J PHARMACOL EXP THER, V305, P70, DOI 10.1124/jpet.102.045658; Fukumoto H, 1999, NEUROREPORT, V10, P2965, DOI 10.1097/00001756-199909290-00017; Gomez-Raja J, 2012, EUKARYOT CELL, V11, P683, DOI 10.1128/EC.05211-11; Grimm MOW, 2012, EXP BRAIN RES, V217, P365, DOI 10.1007/s00221-011-2975-6; Han XL, 2002, J NEUROCHEM, V82, P809, DOI 10.1046/j.1471-4159.2002.00997.x; Haughey NJ, 2010, BBA-MOL CELL BIOL L, V1801, P878, DOI 10.1016/j.bbalip.2010.05.003; He XX, 2010, NEUROBIOL AGING, V31, P398, DOI 10.1016/j.neurobiolaging.2008.05.010; Hognauer K, 2008, CHEMMEDCHEM, V3, P1027, DOI 10.1002/cmdc.200800037; Holmes O, 2012, BIOCHEMISTRY-US, V51, P3565, DOI 10.1021/bi300303g; Imamura Y, 2009, J AM CHEM SOC, V131, P7353, DOI 10.1021/ja9001458; Iwata H, 2001, J BIOL CHEM, V276, P21678, DOI 10.1074/jbc.M007989200; IWATSUBO T, 1994, NEURON, V13, P45, DOI 10.1016/0896-6273(94)90458-8; Kalvodova L, 2005, J BIOL CHEM, V280, P36815, DOI 10.1074/jbc.M504484200; Kan T, 2003, CHEM COMMUN, P2244, DOI 10.1039/b306970b; Kaneider NC, 2004, FASEB J, V18, P1309, DOI 10.1096/fj.03-1050fje; Kaneko T, 2006, BIOCHEM BIOPH RES CO, V345, P85, DOI 10.1016/j.bbrc.2006.04.067; Karlstrom H, 2002, J BIOL CHEM, V277, P6763, DOI 10.1074/jbc.C100649200; Kopan R, 1996, P NATL ACAD SCI USA, V93, P1683, DOI 10.1073/pnas.93.4.1683; Lee MJ, 1996, J BIOL CHEM, V271, P11272, DOI 10.1074/jbc.271.19.11272; Lieven CJ, 2012, INVEST OPHTH VIS SCI, V53, P3990, DOI 10.1167/iovs.11-9321; Liu X, 2012, CELL RES; Merhi A, 2012, MOL CELL BIOL, V32, P4510, DOI 10.1128/MCB.00463-12; Miron VE, 2008, ANN NEUROL, V63, P61, DOI 10.1002/ana.21227; Mullershausen F, 2007, J NEUROCHEM, V102, P1151, DOI 10.1111/j.1471-4159.2007.04629.x; Ni YX, 2006, NAT MED, V12, P1390, DOI 10.1038/nm1485; Osawa S, 2008, J BIOL CHEM, V283, P19283, DOI 10.1074/jbc.M705954200; Osenkowski P, 2008, J BIOL CHEM, V283, P22529, DOI 10.1074/jbc.M801925200; Qi-Takahara Y, 2005, J NEUROSCI, V25, P436, DOI 10.1523/JNEUROSCI.1575-04.2005; Shichita T, 2009, NAT MED, V15, P946, DOI 10.1038/nm.1999; Suzuki K, 2012, NEURON, V76, P410, DOI 10.1016/j.neuron.2012.10.003; Takabe K, 2008, PHARMACOL REV, V60, P181, DOI 10.1124/pr.107.07113; Takasugi N, 2003, NATURE, V422, P438, DOI 10.1038/nature01506; Takasugi N, 2011, J NEUROSCI, V31, P6850, DOI 10.1523/JNEUROSCI.6467-10.2011; Tanaka S, 2007, J BIOL CHEM, V282, P10506, DOI 10.1074/jbc.M700911200; Thathiah A, 2012, NAT MED; Thathiah A, 2009, SCIENCE, V323, P946, DOI 10.1126/science.1160649; Tomita T, 1999, J NEUROSCI, V19, P10627, DOI 10.1523/JNEUROSCI.19-24-10627.1999; Tomita T, 1997, P NATL ACAD SCI USA, V94, P2025, DOI 10.1073/pnas.94.5.2025; Tomita T, 2009, EXPERT REV NEUROTHER, V9, P661, DOI [10.1586/ern.09.24, 10.1586/ERN.09.24]; Vassar R, 2009, J NEUROSCI, V29, P12787, DOI 10.1523/JNEUROSCI.3657-09.2009; Vetrivel KS, 2010, BBA-MOL CELL BIOL L, V1801, P860, DOI 10.1016/j.bbalip.2010.03.007; Wei SH, 2005, NAT IMMUNOL, V6, P1228, DOI 10.1038/ni1269; Yamada K, 2009, J NEUROSCI, V29, P11393, DOI 10.1523/JNEUROSCI.2021-09.2009; Zemann B, 2006, BLOOD, V107, P1454, DOI 10.1182/blood-2005-07-2628	52	65	74	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e64050	10.1371/journal.pone.0064050	http://dx.doi.org/10.1371/journal.pone.0064050			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667698	Green Published, gold, Green Submitted			2022-12-27	WOS:000319654700201
J	Villabona-Arenas, CJ; Mondini, A; Bosch, I; Schimitt, D; Calzavara-Silva, CE; Zanotto, PMD; Nogueira, ML				Villabona-Arenas, Christian Julian; Mondini, Adriano; Bosch, Irene; Schimitt, Diane; Calzavara-Silva, Carlos E.; Zanotto, Paolo M. de A.; Nogueira, Mauricio L.			Dengue Virus Type 3 Adaptive Changes during Epidemics in Sao Jose de Rio Preto, Brazil, 2006-2007	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; POSITIVE SELECTION; PHYLOGENETIC ANALYSIS; MOLECULAR EPIDEMIOLOGY; DE-JANEIRO; EVOLUTION; VACCINE; DYNAMICS; SITES; TRANSMISSION	Global dengue virus spread in tropical and sub-tropical regions has become a major international public health concern. It is evident that DENV genetic diversity plays a significant role in the immunopathology of the disease and that the identification of polymorphisms associated with adaptive responses is important for vaccine development. The investigation of naturally occurring genomic variants may play an important role in the comprehension of different adaptive strategies used by these mutants to evade the human immune system. In order to elucidate this role we sequenced the complete polyprotein-coding region of thirty-three DENV-3 isolates to characterize variants circulating under high endemicity in the city of Sao Jose de Rio Preto, Brazil, during the onset of the 2006-07 epidemic. By inferring the evolutionary history on a local-scale and estimating rates of synonymous (dS) and nonsynonimous (dN) substitutions, we have documented at least two different introductions of DENV-3 into the city and detected 10 polymorphic codon sites under significant positive selection (dN/dS > 1) and 8 under significant purifying selection (dN/dS < 1). We found several polymorphic amino acid coding sites in the envelope (15), NS1 (17), NS2A ( 11), and NS5 (24) genes, which suggests that these genes may be experiencing relatively recent adaptive changes. Furthermore, some polymorphisms correlated with changes in the immunogenicity of several epitopes. Our study highlights the existence of significant and informative DENV variability at the spatio-temporal scale of an urban outbreak.	[Villabona-Arenas, Christian Julian; Zanotto, Paolo M. de A.] Univ Sao Paulo, Inst Ciencias Biomed, Dept Microbiol, LEMB, BR-05508 Sao Paulo, Brazil; [Mondini, Adriano] Univ Estadual Paulista Julio de Mesquita Filho Ar, Fac Ciencias Farmaceut, Dept Ciencias Biol, Lab Saude Publ, Sao Paulo, Brazil; [Bosch, Irene] MIT, Div Hlth Sci & Technol, Cambridge, MA 02139 USA; [Schimitt, Diane] Tufts Univ, Dept Infect Dis & Global Hlth, Cummings Sch Vet Med, North Grafton, MA USA; [Calzavara-Silva, Carlos E.] Fundacao Oswaldo Cruz Fiocruz, Ctr Pesquisas Rene Rachou CPqRR, LICM, Belo Horizonte, MG, Brazil; [Nogueira, Mauricio L.] Fac Med Sao Jose do Rio Preto, Lab Pesquisas Virol, Sao Jose Do Rio Preto, SP, Brazil	Universidade de Sao Paulo; Massachusetts Institute of Technology (MIT); Tufts University; Fundacao Oswaldo Cruz; Universidade de Sao Paulo; Faculdade de Medicina de Sao Jose do Rio Preto (FAMERP)	Nogueira, ML (corresponding author), Fac Med Sao Jose do Rio Preto, Lab Pesquisas Virol, Sao Jose Do Rio Preto, SP, Brazil.	mnogueira@famerp.br	de A. Zanotto, Paolo M./B-9286-2019; Nogueira, Mauricio L/B-7599-2012; Mondini, Adriano/AAB-4358-2020; Mondini, Adriano/F-7446-2012; Calzavara-Silva, Carlos/ABF-2829-2021	de A. Zanotto, Paolo M./0000-0002-8167-0625; Nogueira, Mauricio L/0000-0003-1102-2419; Mondini, Adriano/0000-0002-5557-9721; Mondini, Adriano/0000-0002-5557-9721; Calzavara-Silva, Carlos/0000-0002-1406-6401; Villabona Arenas, Christian Julian/0000-0001-9928-3968	CNPq-PQ; INCT - Dengue; FAPESP [2011/17071-2, 10/19059-7, 2012/11733-6, 2011/10458-9]; PRONEX-Dengue (CNPq)	CNPq-PQ(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); INCT - Dengue; FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); PRONEX-Dengue (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	CJVA holds a FAPESP scholarship (2011/17071-2); PMAZ and MLN hold a CNPq-PQ scholarship, AM holds an INCT - Dengue scholarship. This work was funded by FAPESP process number 10/19059-7 (PMAZ), by INCT-Dengue and PRONEX-Dengue (CNPq to MLN) and FAPESP Grants # 2012/11733-6 and 2011/10458-9 to MLN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1989, NEUTRAL THEORY MOL E; Aquino VH, 2006, AM J TROP MED HYG, V75, P710, DOI 10.4269/ajtmh.2006.75.710; Aquino VH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007299; Araujo JMG, 2009, INFECT GENET EVOL, V9, P716, DOI 10.1016/j.meegid.2008.10.005; Beaute J, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-521; Bennett SN, 2006, J GEN VIROL, V87, P885, DOI 10.1099/vir.0.81309-0; Bennett SN, 2003, MOL BIOL EVOL, V20, P1650, DOI 10.1093/molbev/msg182; Casali Clarisse Guimarães, 2004, Rev. Soc. Bras. Med. Trop., V37, P296, DOI 10.1590/S0037-86822004000400002; Castaneda-Orjuela Carlos, 2012, Value Health Reg Issues, V1, P123, DOI 10.1016/j.vhri.2012.09.014; Chen RB, 2008, J MOL EVOL, V66, P655, DOI 10.1007/s00239-008-9119-z; Costa RL, 2012, INFECT GENET EVOL, V12, P309, DOI 10.1016/j.meegid.2011.12.011; Danecek P, 2010, J MOL BIOL, V396, P550, DOI 10.1016/j.jmb.2009.11.070; dos Santos FB, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-387; Drummond A, 2005, MOL BIOL; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Ferguson NM, 1999, PHILOS T R SOC B, V354, P757, DOI 10.1098/rstb.1999.0428; Figueiredo LB, 2008, EMERG INFECT DIS, V14, P314, DOI 10.3201/eid1402.070278; Garg P, 2008, T ROY SOC TROP MED H, V102, P570, DOI 10.1016/j.trstmh.2008.02.015; Gubler DJ, 1998, CLIN MICROBIOL REV, V11, P480, DOI 10.1128/CMR.11.3.480; Guy B, 2008, COMP IMMUNOL MICROB, V31, P239, DOI 10.1016/j.cimid.2007.07.011; Guzman M, 2010, NATURE REV; Guzman MG, 2012, INT J INFECT DIS, V16, pE198, DOI 10.1016/j.ijid.2011.09.026; Halasa YA, 2012, AM J TROP MED HYG, V86, P745, DOI 10.4269/ajtmh.2012.11-0784; Halstead SB, 2012, LANCET, V380, P1535, DOI 10.1016/S0140-6736(12)61510-4; Harris E, 2012, NAT MED, V18, P1622, DOI 10.1038/nm.2997; Holmes EC, 2003, J VIROL, V77, P11296, DOI 10.1128/JVI.77.20.11296-11298.2003; Villabona-Arenas CJ, 2009, TROP MED INT HEALTH, V14, P1241, DOI 10.1111/j.1365-3156.2009.02339.x; Khan AM, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000272; King CC, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-63; Kochel T, 2008, MOL EPIDEMIOLOGY DEN; Kyle JL, 2008, ANNU REV MICROBIOL, V62, P71, DOI 10.1146/annurev.micro.62.081307.163005; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; San Martin JL, 2010, AM J TROP MED HYG, V82, P128, DOI 10.4269/ajtmh.2010.09-0346; Luz PM, 2009, TROP MED INT HEALTH, V14, P237, DOI 10.1111/j.1365-3156.2008.02203.x; Maddison D. R., 2005, MACCLADE 4 08A ANAL, DOI [DOI 10.1046/J.1420-9101.1996.9020153.X, DOI 10.1007/s13592-012-0141-1]; Mondini A, 2005, REV SAUDE PUBL, V39, P444, DOI 10.1590/S0034-89102005000300016; Mondini A, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000448; Nei M., 1987, MOL EVOLUTIONARY GEN; Nogueira RMR, 2001, MEM I OSWALDO CRUZ, V96, P925, DOI 10.1590/S0074-02762001000700007; Pond SLK, 2005, MOL BIOL EVOL, V22, P1208, DOI 10.1093/molbev/msi105; Pond SLK, 2005, BIOINFORMATICS, V21, P2531, DOI 10.1093/bioinformatics/bti320; Pond SLK, 2005, BIOINFORMATICS, V21, P676, DOI 10.1093/bioinformatics/bti079; Raghwani J, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002064; RICOHESSE R, 1990, VIROLOGY, V174, P479, DOI 10.1016/0042-6822(90)90102-W; Rodpothong P, 2012, VIRUS GENES, V44, P408, DOI 10.1007/s11262-011-0709-2; Rodriguez F, 1990, J THEORETICAL BIOL; Ross H, 2002, J VIROLOGY; Barrero PR, 2008, VIRUS RES, V135, P83, DOI 10.1016/j.virusres.2008.02.013; Sabchareon A, 2012, LANCET, V380, P1559, DOI 10.1016/S0140-6736(12)61428-7; Saude SdVe, 2008, INFORME EPIDEMIOLOGI; Saude SdVe, 2007, INFORME DPIDEMIOLOGI; Schmidt DJ, 2011, INFECT GENET EVOL, V11, P2011, DOI 10.1016/j.meegid.2011.09.010; Shepard DS, 2011, AM J TROP MED HYG, V84, P200, DOI 10.4269/ajtmh.2011.10-0503; Sheridan I, 2004, J VIROL, V78, P3447, DOI 10.1128/JVI.78.7.3447-3454.2004; Simmons CP, 2012, NEW ENGL J MED, V366, P1423, DOI 10.1056/NEJMra1110265; Suzuki Y, 2008, GENE, V427, P111, DOI 10.1016/j.gene.2008.09.012; TAJIMA F, 1989, GENETICS, V123, P585; Twiddy SS, 2002, VIROLOGY, V298, P63, DOI 10.1006/viro.2002.1447; Twiddy SS, 2002, J GEN VIROL, V83, P1679, DOI 10.1099/0022-1317-83-7-1679; Usme-Ciro J, 2008, VIROL J, V10, P1; Uzcategui NY, 2003, J GEN VIROL, V84, P1569, DOI 10.1099/vir.0.18807-0; Villabona-Arenas CJ, 2011, IEEE AER C, P1, DOI DOI 10.1109/AERO.2011.5747269; Zanotto PMAGEA, 2002, MOL EPIDEMIOLOGY EVO; Zanotto PMD, 1999, GENETICS, V153, P1077; Zanotto PMD, 1996, P NATL ACAD SCI USA, V93, P548, DOI 10.1073/pnas.93.2.548; Zanotto PMD, 1996, J VIROL, V70, P6083, DOI 10.1128/JVI.70.9.6083-6096.1996	70	9	9	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e63496	10.1371/journal.pone.0063496	http://dx.doi.org/10.1371/journal.pone.0063496			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667626	Green Published, gold, Green Submitted			2022-12-27	WOS:000319654700151
J	Bauer, MHA; Kuhnt, D; Barbieri, S; Klein, J; Becker, A; Freisleben, B; Hahn, HK; Nimsky, C				Bauer, Miriam H. A.; Kuhnt, Daniela; Barbieri, Sebastiano; Klein, Jan; Becker, Andreas; Freisleben, Bernd; Hahn, Horst K.; Nimsky, Christopher			Reconstruction of White Matter Tracts via Repeated Deterministic Streamline Tracking - Initial Experience	PLOS ONE			English	Article							NEURONAL FIBER PATHWAYS; DIFFUSION-TENSOR; GLIOBLASTOMA-MULTIFORME; DTI SEGMENTATION; THALAMIC NUCLEI; WILD BOOTSTRAP; GLIOMA REMOVAL; TRACTOGRAPHY; BRAIN; MRI	Diffusion Tensor Imaging (DTI) and fiber tractography are established methods to reconstruct major white matter tracts in the human brain in-vivo. Particularly in the context of neurosurgical procedures, reliable information about the course of fiber bundles is important to minimize postoperative deficits while maximizing the tumor resection volume. Since routinely used deterministic streamline tractography approaches often underestimate the spatial extent of white matter tracts, a novel approach to improve fiber segmentation is presented here, considering clinical time constraints. Therefore, fiber tracking visualization is enhanced with statistical information from multiple tracking applications to determine uncertainty in reconstruction based on clinical DTI data. After initial deterministic fiber tracking and centerline calculation, new seed regions are generated along the result's midline. Tracking is applied to all new seed regions afterwards, varying in number and applied offset. The number of fibers passing each voxel is computed to model different levels of fiber bundle membership. Experimental results using an artificial data set of an anatomical software phantom are presented, using the Dice Similarity Coefficient (DSC) as a measure of segmentation quality. Different parameter combinations were classified to be superior to others providing significantly improved results with DSCs of 81.02%+/- 4.12%, 81.32%+/- 4.22% and 80.99%+/- 3.81% for different levels of added noise in comparison to the deterministic fiber tracking procedure using the two-ROI approach with average DSCs of 65.08%+/- 5.31%, 64.73%+/- 6.02% and 65.91%+/- 6.42%. Whole brain tractography based on the seed volume generated by the calculated seeds delivers average DSCs of 67.12%+/- 0.86%, 75.10%+/- 0.28% and 72.91%+/- 0.15%, original whole brain tractography delivers DSCs of 67.16%, 75.03% and 75.54%, using initial ROIs as combined include regions, which is clearly improved by the repeated fiber tractography method.	[Bauer, Miriam H. A.; Kuhnt, Daniela; Becker, Andreas; Nimsky, Christopher] Univ Marburg, Dept Neurosurg, Marburg, Germany; [Bauer, Miriam H. A.; Freisleben, Bernd] Univ Marburg, Dept Math & Comp Sci, Marburg, Germany; [Bauer, Miriam H. A.] St Annes Univ Hosp Brno, Int Clin Res Ctr, Brno, Czech Republic; [Barbieri, Sebastiano; Klein, Jan; Hahn, Horst K.] Fraunhofer MEVIS Inst Med Image Comp, Bremen, Germany	Philipps University Marburg; Philipps University Marburg; St Anne's University Hospital Brno (FNUSA-ICRC)	Bauer, MHA (corresponding author), Univ Marburg, Dept Neurosurg, Marburg, Germany.	bauermi@med.uni-marburg.de	Nimsky, Christopher/E-3702-2014	Nimsky, Christopher/0000-0002-8216-9410; Freisleben, Bernd/0000-0002-7205-8389; Bopp, Miriam H. A./0000-0003-1574-7572; Klein, Jan/0000-0001-9421-3549	German Research Foundation [DFG NI 568/3-1, DFG PE 199/21-1]; von Behring-Rontgen-Foundation [58-0044]; European Regional Development Fund-Project FNUSA-ICRC [CZ.1.05/1.1.00/02.0123]	German Research Foundation(German Research Foundation (DFG)); von Behring-Rontgen-Foundation; European Regional Development Fund-Project FNUSA-ICRC	This project was funded in part by the German Research Foundation (DFG NI 568/3-1 and DFG PE 199/21-1), the von Behring-Rontgen-Foundation (Project 58-0044) and the European Regional Development Fund-Project FNUSA-ICRC (No. CZ.1.05/1.1.00/02.0123). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aganj I, 2011, MED IMAGE ANAL, V15, P414, DOI 10.1016/j.media.2011.01.003; Arsigny V, 2006, MAGN RESON MED, V56, P411, DOI 10.1002/mrm.20965; Awate SP, 2007, IEEE T MED IMAGING, V26, P1525, DOI 10.1109/TMI.2007.907301; Barbieri S, 2010, JOINT ANN M ISMRM ES, P1672; Barbieri S., 2010, P SPIE, V7623; Barbieri S, 2012, NEUROIMAGE, V60, P1025, DOI 10.1016/j.neuroimage.2012.01.076; Basser PJ, 2000, MAGNET RESON MED, V44, P625, DOI 10.1002/1522-2594(200010)44:4<625::AID-MRM17>3.0.CO;2-O; BASSER PJ, 1994, BIOPHYS J, V66, P259, DOI 10.1016/S0006-3495(94)80775-1; BASSER PJ, 1994, J MAGN RESON SER B, V103, P247, DOI 10.1006/jmrb.1994.1037; Basser PJ., 1998, P 6 ANN M ISMRM, P1226; Bauer MHA, 2011, INT J COMPUT ASS RAD, V6, P1, DOI 10.1007/s11548-010-0423-x; Behrens TEJ, 2007, NEUROIMAGE, V34, P144, DOI 10.1016/j.neuroimage.2006.09.018; Behrens TEJ, 2003, NAT NEUROSCI, V6, P750, DOI 10.1038/nn1075; Behrens TEJ, 2003, MAGN RESON MED, V50, P1077, DOI 10.1002/mrm.10609; Beppu T, 2003, J NEURO-ONCOL, V63, P109, DOI 10.1023/A:1023977520909; Black PM, 1997, NEUROSURGERY, V41, P831, DOI 10.1097/00006123-199710000-00013; Bohinski RJ, 2001, NEUROSURGERY, V48, P731, DOI 10.1227/00006123-200104000-00007; Brun A, 2004, LECT NOTES COMPUT SC, V3216, P368; Clark CA, 2003, NEUROIMAGE, V20, P1601, DOI 10.1016/j.neuroimage.2003.07.022; Collins DL, 1998, IEEE T MED IMAGING, V17, P463, DOI 10.1109/42.712135; Conturo TE, 1999, P NATL ACAD SCI USA, V96, P10422, DOI 10.1073/pnas.96.18.10422; Descoteaux M, 2009, THESIS NICE SOPHIA A; Descoteaux M, 2009, IEEE T MED IMAGING, V28, P269, DOI 10.1109/TMI.2008.2004424; Ding ZH, 2003, MAGNET RESON MED, V49, P716, DOI 10.1002/mrm.10415; Ding ZH, 2001, IEEE VISUAL, P453, DOI 10.1109/VISUAL.2001.964549; Fletcher PT, 2007, SIGNAL PROCESS, V87, P250, DOI 10.1016/j.sigpro.2005.12.018; Friman O, 2006, IEEE T MED IMAGING, V25, P965, DOI 10.1109/TMI.2006.877093; Hahn HK, 2006, ACTA NEUROCHIR SUPPL, V98, P33; Hall WA, 2000, NEUROSURGERY, V46, P632, DOI 10.1097/00006123-200003000-00022; Hatiboglu MA, 2009, NEUROSURGERY, V64, P1073, DOI 10.1227/01.NEU.0000345647.58219.07; Hattingen E, 2009, NEUROSURG REV, V32, P445, DOI 10.1007/s10143-009-0197-1; Jbabdi S, 2007, NEUROIMAGE, V37, P116, DOI 10.1016/j.neuroimage.2007.04.039; Jbabdi S, 2008, INT J BIOMED IMAGING, V2008, DOI 10.1155/2008/320195; Jenkinson M, 2012, NEUROIMAGE, V62, P782, DOI 10.1016/j.neuroimage.2011.09.015; Jonasson L, 2007, SIGNAL PROCESS, V87, P309, DOI 10.1016/j.sigpro.2005.12.017; Jones D., 1998, 6 ANN M INT SOC MAGN, P531; Jones DK, 2008, IEEE T MED IMAGING, V27, P1268, DOI 10.1109/TMI.2008.922191; Jones DK, 2005, MAGNET RESON MED, V53, P1143, DOI 10.1002/mrm.20466; Kinoshita M, 2005, NEUROIMAGE, V25, P424, DOI 10.1016/j.neuroimage.2004.07.076; Klein J, 2007, AUTOMATIC QUANTIFICA, P272; Koch M, 2001, NEUROIMAGE, V13, pS176; Kreher BW, 2008, MAGN RESON MED, V60, P953, DOI 10.1002/mrm.21749; Kreher BW, 2007, JOINT ANN M ISMRM ES, P1554; Kuhnt D, 2011, NEUROSURGERY; Kuhnt D, 2013, NEUROSURGERY, V72, pA165, DOI 10.1227/NEU.0b013e318270d9fb; Kuhnt D, 2011, NEUROSURGERY, V69, P852, DOI 10.1227/NEU.0b013e318225ea6b; Lacroix M, 2001, J NEUROSURG, V95, P190, DOI 10.3171/jns.2001.95.2.0190; Lamborn KR, 2004, NEURO-ONCOLOGY, V6, P227, DOI 10.1215/S1152851703000620; Laws ER, 2003, ACT NEUR S, V85, P47; Lazar M, 2003, HUM BRAIN MAPP, V18, P306, DOI 10.1002/hbm.10102; Le Bihan D, 2001, J MAGN RESON IMAGING, V13, P534, DOI 10.1002/jmri.1076; Le Bihan D, 2002, NMR BIOMED, V15, P431, DOI 10.1002/nbm.798; Lenglet C, 2005, LECT NOTES COMPUT SC, V3565, P591; Lin JJ, 2008, EPILEPSY RES, V82, P162, DOI 10.1016/j.eplepsyres.2008.07.020; Melonakos J, 2007, LECT NOTES COMPUT SC, V4791, P36; Merhof D, 2005, PROC SPIE, V5744, P165, DOI 10.1117/12.594621; Merhof D, 2010, FIBER SELECTION DIFF, P147; Merhof D, 2006, LECT NOTES COMPUT SC, V4191, P225; Merhof D, 2009, STEREOT FUNCT NEUROS, V87, P50, DOI 10.1159/000195720; Michailovich O, 2011, IEEE T MED IMAGING, V30, P1100, DOI 10.1109/TMI.2011.2142189; Michailovich O, 2010, LECT NOTES COMPUT SC, V6361, P607; Mori S, 1999, ANN NEUROL, V45, P265, DOI 10.1002/1531-8249(199902)45:2<265::AID-ANA21>3.0.CO;2-3; Mori S, 2002, NMR BIOMED, V15, P468, DOI 10.1002/nbm.781; Mori S, 2007, INTRO DIFFUSION TENS; Nimsky C, 2004, NEUROSURGERY, V55, P358, DOI 10.1227/01.NEU.0000129694.64671.91; Nimsky C, 2005, ACAD RADIOL, V12, P1065, DOI 10.1016/j.acra.2005.05.020; Nimsky C, 2004, RADIOLOGY, V233, P67, DOI 10.1148/radiol.2331031352; Nimsky C, 2006, INT J COMPUT ASS RAD, V1, P13, DOI 10.1007/s11548-006-0003-2; Nimsky C, 2006, NEUROIMAGE, V30, P1219, DOI 10.1016/j.neuroimage.2005.11.001; PAJEVIC S, 1999, 7 ANN M ISMRM, P1790; Parker GJM, 2002, IEEE T MED IMAGING, V21, P505, DOI 10.1109/TMI.2002.1009386; Parker GJM, 2003, J MAGN RESON IMAGING, V18, P242, DOI 10.1002/jmri.10350; Pennec X, 2006, INT J COMPUT VISION, V66, P41, DOI 10.1007/s11263-005-3222-z; Poupon C, 2000, NEUROIMAGE, V12, P184, DOI 10.1006/nimg.2000.0607; Reisert M, 2011, NEUROIMAGE, V54, P955, DOI 10.1016/j.neuroimage.2010.09.016; Schneider JP, 2005, NEURORADIOLOGY, V47, P489, DOI 10.1007/s00234-005-1397-1; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Stieltjes B, 2001, NEUROIMAGE, V14, P723, DOI 10.1006/nimg.2001.0861; Tuch DS, 2004, MAGN RESON MED, V52, P1358, DOI 10.1002/mrm.20279; VECHT CJ, 1990, J NEUROL NEUROSUR PS, V53, P466, DOI 10.1136/jnnp.53.6.466; Vernooij MW, 2007, NEUROIMAGE, V35, P1064, DOI 10.1016/j.neuroimage.2006.12.041; Wang ZZ, 2005, IEEE T MED IMAGING, V24, P1267, DOI 10.1109/TMI.2005.854516; Wang ZZ, 2004, LECT NOTES COMPUT SC, V2034, P304; Weiler F, 2009, 2 WORKSH SOFTW ASS M, P1485; Weinstein D., 1999, Proceedings Visualization '99 (Cat. No.99CB37067), P249, DOI 10.1109/VISUAL.1999.809894; Whitcher B, 2005, 13 ANN M INT SOC MAG, P1333; Whitcher B, 2008, HUM BRAIN MAPP, V29, P346, DOI 10.1002/hbm.20395; Wiegell MR, 2003, NEUROIMAGE, V19, P391, DOI 10.1016/S1053-8119(03)00044-2; Witwer BP, 2002, J NEUROSURG, V97, P568, DOI 10.3171/jns.2002.97.3.0568; Woolrich MW, 2009, NEUROIMAGE, V45, pS173, DOI 10.1016/j.neuroimage.2008.10.055; Yamada K, 2003, RADIOLOGY, V227, P295, DOI 10.1148/radiol.2271020313; Zhukov L, 2003, J ELECTRON IMAGING, V12, P125, DOI 10.1117/1.1527628; Ziyan U, 2006, LECT NOTES COMPUT SC, V4191, P807; Zou KH, 2004, ACAD RADIOL, V11, P178, DOI 10.1016/S1076-6332(03)00671-8	94	6	6	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2013	8	5							e63082	10.1371/journal.pone.0063082	http://dx.doi.org/10.1371/journal.pone.0063082			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	177QL	23671656	Green Submitted, Green Published, gold			2022-12-27	WOS:000321390200042
J	Brem, FMR; Parris, MJ; Padgett-Flohr, GE				Brem, Forrest M. R.; Parris, Matthew J.; Padgett-Flohr, Gretchen E.			Re-Isolating Batrachochytrium dendrobatidis from an Amphibian Host Increases Pathogenicity in a Subsequent Exposure	PLOS ONE			English	Article							FROG-KILLING FUNGUS; CHYTRID PATHOGEN; TEMPERATURE; CHYTRIDIOMYCOSIS; ANTIBIOTICS; BEAUVERIA; VIRULENCE; ANURANS; DISEASE	Controlled exposure experiments can be very informative, however, they are based on the assumption that pathogens maintained on artificial media under long-term storage retain the infective and pathogenic properties of the reproducing pathogen as it occurs in a host. We observed that JEL284, an in vitro cultured and maintained isolate of Batrachochytrium dendrobatidis (Bd), was becoming less infectious with successive uses. We hypothesized that passing an isolate propagated on artificial media through an amphibian host would make the isolate more infectious and pathogenic in subsequent exposures. To test our hypothesis, we used two discreet steps, a reisolation step (step 1) and a comparative exposure step (step 2). In step 1, we exposed eastern spadefoot toads, Scaphiopus holbrooki, to JEL284 and JEL197, another isolate that had been maintained in vitro for over six years. We then re-isolated JEL284 only from a successful infection and named this new isolate JEL284(FMBa). JEL197 did not infect any amphibians and, thus, did not proceed to step 2. In step 2, we compared infectivity and pathogenicity (mortality and survival time) of JEL284 and JEL284(FMBa) by exposing 54 naive S. holbrooki to three treatments (JEL284, JEL284(FMBa), and negative control) with 18 individuals per group. We found that JEL284(FMBa) caused higher mortality and decreased survival time in infected individuals when compared to JEL284 and negative controls. Thus, our data show that pathogenicity of Bd can decrease when cultured successively in media only and can be partially restored by passage through an amphibian host. Therefore, we have demonstrated that pathogenicity shifts can occur rapidly in this pathogen. Given the potential for shifts in pathogenicity demonstrated here, we suspect Bd to have similar potential in natural populations. We suggest that, when possible, the use of freshly isolated or cryopreserved Bd would improve the quality of controlled exposure experiments using this pathogen.	[Brem, Forrest M. R.; Parris, Matthew J.] Univ Memphis, Dept Biol Sci, Memphis, TN 38152 USA; [Padgett-Flohr, Gretchen E.] So Illinois Univ, Dept Zool, Carbondale, IL 62901 USA	University of Memphis; Southern Illinois University System; Southern Illinois University	Brem, FMR (corresponding author), Univ Memphis, Dept Biol Sci, Memphis, TN 38152 USA.	fbrem@memphis.edu			Chester Zoo/North England Zoological Society	Chester Zoo/North England Zoological Society	Funding was provided by a conservation grant from the Chester Zoo/North England Zoological Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altizer S, 2003, TRENDS ECOL EVOL, V18, P589, DOI 10.1016/j.tree.2003.08.013; Baer CF, 2007, NAT REV GENET, V8, P619, DOI 10.1038/nrg2158; Berger L, 2005, DIS AQUAT ORGAN, V68, P47, DOI 10.3354/dao068047; Berger L, 2004, AUST VET J, V82, P434, DOI 10.1111/j.1751-0813.2004.tb11137.x; Butt TM, 2006, ECOLOGICAL SOC APPRO, V2, DOI [10.1007/978-1-4020-4401-4_10, DOI 10.1007/978-1-4020-4401-4_]; Davidson EW, 2003, COPEIA, P601, DOI 10.1643/CP-02-120R1; DEBONO M, 1994, ANNU REV MICROBIOL, V48, P471, DOI 10.1146/annurev.mi.48.100194.002351; Farrer RA, 2011, P NATL ACAD SCI USA, V108, P18732, DOI 10.1073/pnas.1111915108; Feller G, 2003, NAT REV MICROBIOL, V1, P200, DOI 10.1038/nrmicro773; Fernandes EKK, 2008, J INVERTEBR PATHOL, V98, P69, DOI 10.1016/j.jip.2007.10.011; Fisher MC, 2009, MOL ECOL, V18, P415, DOI 10.1111/j.1365-294X.2008.04041.x; Gahl MK, 2012, CONSERV BIOL, V26, P135, DOI 10.1111/j.1523-1739.2011.01801.x; Gilbert MA, 2001, J PARASITOL, V87, P101, DOI 10.1645/0022-3395(2001)087[0101:PIOMCT]2.0.CO;2; Idnurm A, 2007, SEX FUNGI MOL DETERM; Inglis GD, 1996, BIOL CONTROL, V7, P131, DOI 10.1006/bcon.1996.0076; James TY, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000458; Longcore JE, 1999, MYCOLOGIA, V91, P219, DOI 10.2307/3761366; MCDONOUGH ES, 1960, J LAB CLIN MED, V55, P116; Morehouse EA, 2003, MOL ECOL, V12, P395, DOI 10.1046/j.1365-294X.2003.01732.x; Morgan JAT, 2007, P NATL ACAD SCI USA, V104, P13845, DOI 10.1073/pnas.0701838104; Padgett-Flohr GE, 2011, HERPETOL CONSERV BIO, V6, P99; Parris MJ, 2004, ECOLOGY, V85, P3385, DOI 10.1890/04-0383; Piotrowski JS, 2004, MYCOLOGIA, V96, P9, DOI 10.2307/3761981; Rosenblum EB, 2008, P NATL ACAD SCI USA, V105, P17034, DOI 10.1073/pnas.0804173105; Savage AE, 2011, P NATL ACAD SCI USA, V108, P16705, DOI 10.1073/pnas.1106893108; Scully LR, 2005, CAN J MICROBIOL, V51, P185, DOI 10.1139/W04-124; Searle CL, 2011, CONSERV BIOL, V25, P965, DOI 10.1111/j.1523-1739.2011.01708.x; Tupper Todd A., 2011, Herpetological Review, V42, P62; Velo-Anton G, 2012, BIOL CONSERV, V146, P213, DOI 10.1016/j.biocon.2011.12.003; Venesky MD, 2009, ECOHEALTH, V6, P565, DOI 10.1007/s10393-009-0272-7; Venesky MD, 2010, J PARASITOL, V96, P552, DOI 10.1645/GE-2353.1; Voyles J, 2012, ECOL EVOL, V2, P2241, DOI 10.1002/ece3.334; Voyles J, 2011, FUNGAL ECOL, V4, P196, DOI [10.1016/j.funeco.2010.12.003, 10.1016/j.funeco.2010.12.00]; Voyles J, 2009, SCIENCE, V326, P582, DOI 10.1126/science.1176765; Woodhams DC, 2003, DIS AQUAT ORGAN, V55, P65, DOI 10.3354/dao055065	35	17	18	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2013	8	5							e61260	10.1371/journal.pone.0061260	http://dx.doi.org/10.1371/journal.pone.0061260			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	177QL	23671564	Green Published, Green Submitted, gold			2022-12-27	WOS:000321390200004
J	Kosulin, K; Hoffmann, F; Clauditz, TS; Wilczak, W; Dobner, T				Kosulin, Karin; Hoffmann, Franziska; Clauditz, Till Sebastian; Wilczak, Waldemar; Dobner, Thomas			Presence of Adenovirus Species C in Infiltrating Lymphocytes of Human Sarcoma	PLOS ONE			English	Article							CELL-TRANSFORMATION; HUMAN TONSIL; T-CELLS; IN-VIVO; DNA; SEQUENCES; CANCER; EXPRESSION; PATIENT; PROTEIN	Human adenoviruses are known to persist in T-lymphocytes of tonsils, adenoids and intestinal tract. The oncogenic potential of different adenovirus types has been widely studied in rodents, in which adenovirus inoculation can induce multiple tumors such as undifferentiated sarcomas, adenocarcinomas and neuroectodermal tumors. However, the oncogenic potential of this virus has never been proven in human subjects. Using a highly sensitive broad-spectrum qRT-PCR, we have screened a set of different human sarcomas including leiomyosarcoma, liposarcoma and gastro intestinal stroma tumors. Primers binding the viral oncogene E1A and the capsid-coding gene Hexon were used to detect the presence of adenovirus DNA in tumor samples. We found that 18% of the tested leiomyosarcomas and 35% of the liposarcomas were positive for the presence of adenovirus DNA, being species C types the most frequently detected adenoviruses. However, only in one sample of the gastro intestinal stroma tumors the virus DNA could be detected. The occurrence of adenovirus in the tumor sections was confirmed by subsequent fluorescence in-situ-hybridization analysis and co-staining with the transcription factor Bcl11b gives evidence for the presence of the virus in infiltrating T-lymphocytes within the tumors. Together these data underline, for the first time, the persistence of adenovirus in T-lymphocytes infiltrated in muscular and fatty tissue tumor samples. If an impaired immune system leads to the viral persistence and reactivation of the virus is involved in additional diseases needs further investigation.	[Kosulin, Karin; Hoffmann, Franziska; Dobner, Thomas] Heinrich Pette Inst, Leibniz Inst Expt Virol, Dept Mol Virol, Hamburg, Germany; [Clauditz, Till Sebastian; Wilczak, Waldemar] Univ Med Ctr Hamburg Eppendorf, Dept Pathol, Hamburg, Germany	Heinrich Pette Institute; University of Hamburg; University Medical Center Hamburg-Eppendorf	Dobner, T (corresponding author), Heinrich Pette Inst, Leibniz Inst Expt Virol, Dept Mol Virol, Hamburg, Germany.	thomas.dobner@hpi.uni-hamburg.de	Kosulin, Karin/AAB-2471-2019	Kosulin, Karin/0000-0001-7397-9692	Wilhelm-Sander-Stiftung [2007.109.1]; Stiftung fur neurovirale Erkrankungen (NVE), Hamburg, Germany; Freie und Hansestadt Hamburg; Bundesministerium fur Gesundheit (BMG)	Wilhelm-Sander-Stiftung; Stiftung fur neurovirale Erkrankungen (NVE), Hamburg, Germany; Freie und Hansestadt Hamburg; Bundesministerium fur Gesundheit (BMG)	This work was supported by the the Wilhelm-Sander-Stiftung (Grant #2007.109.1) and the Stiftung fur neurovirale Erkrankungen (NVE), Hamburg, Germany and by the Freie und Hansestadt Hamburg and the Bundesministerium fur Gesundheit (BMG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albu DI, 2010, METHODS MOL BIOL, V647, P377, DOI 10.1007/978-1-60761-738-9_23; Atkinson RL, 2010, INT J PEDIATR OBES, V5, P157, DOI 10.3109/17477160903111789; Ducimetiere F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020294; Ebner K, 2005, J CLIN MICROBIOL, V43, P3049, DOI 10.1128/JCM.43.7.3049-3053.2005; Endter C, 2004, CURR TOP MICROBIOL, V273, P163; Fallaux FJ, 1996, HUM GENE THER, V7, P215, DOI 10.1089/hum.1996.7.2-215; Fernandez-Soria V, 2002, ONCOL REP, V9, P897; Ferrari R, 2008, SCIENCE, V321, P1086, DOI 10.1126/science.1155546; Garnett CT, 2009, J VIROL, V83, P2417, DOI 10.1128/JVI.02392-08; Garnett CT, 2002, J VIROL, V76, P10608, DOI 10.1128/JVI.76.21.10608-10616.2002; Glaunsinger BA, 2001, EMBO J, V20, P5578, DOI 10.1093/emboj/20.20.5578; GRAHAM FL, 1984, J CELL PHYSIOL, P151; GRAHAM FL, 1977, J GEN VIROL, V36, P59, DOI 10.1099/0022-1317-36-1-59; GREEN M, 1979, P NATL ACAD SCI USA, V76, P6606, DOI 10.1073/pnas.76.12.6606; Groitl Peter, 2007, Methods Mol Med, V130, P29; Gutierrez A, 2011, P NATL ACAD SCI USA, V108, P16386, DOI 10.1073/pnas.1106127108; Hartl B, 2008, ONCOGENE, V27, P3673, DOI 10.1038/sj.onc.1211039; HAWLEYNELSON P, 1989, EMBO J, V8, P3905, DOI 10.1002/j.1460-2075.1989.tb08570.x; Hogg JC, 2001, AM J RESP CRIT CARE, V164, pS71, DOI 10.1164/ajrccm.164.supplement_2.2106063; Hohlweg U, 2004, CURR TOP MICROBIOL, V273, P215; Honkaniemi E, 2010, BRIT J CANCER, V102, P796, DOI 10.1038/sj.bjc.6605581; JAVIER R, 1991, J VIROL, V65, P3192, DOI 10.1128/JVI.65.6.3192-3202.1991; Jones MS, 2007, J VIROL, V81, P5978, DOI 10.1128/JVI.02650-06; JONSSON N, 1977, CANCER, V39, P2513, DOI 10.1002/1097-0142(197706)39:6<2513::AID-CNCR2820390631>3.0.CO;2-7; Kaneko H, 2011, BRIT J OPHTHALMOL, V95, P32, DOI 10.1136/bjo.2009.178772; Konig M, 2002, BRIT J HAEMATOL, V116, P758, DOI 10.1046/j.0007-1048.2002.03340.x; Kosulin K, 2007, J VIROL, V81, P7629, DOI 10.1128/JVI.00355-07; Kuwano K, 1997, EUR RESPIR J, V10, P1445, DOI 10.1183/09031936.97.10071445; Kuwano K, 1997, J CANCER RES CLIN, V123, P377, DOI 10.1007/BF01240120; Lion T, 2003, BLOOD, V102, P1114, DOI 10.1182/blood-2002-07-2152; Lion T, 2010, LEUKEMIA, V24, P706, DOI 10.1038/leu.2010.4; Madisch I, 2006, J MED VIROL, V78, P1210, DOI 10.1002/jmv.20683; MAJOR FJ, 1993, CANCER-AM CANCER SOC, V71, P1702, DOI 10.1002/cncr.2820710440; McNees AL, 2004, J VIROL, V78, P6955, DOI 10.1128/JVI.78.13.6955-6966.2004; Mende Y, 2004, VIRUS RES, V104, P81, DOI 10.1016/j.virusres.2004.02.039; Nevels M, 1997, P NATL ACAD SCI USA, V94, P1206, DOI 10.1073/pnas.94.4.1206; Nevels M, 2001, J VIROL, V75, P3089, DOI 10.1128/JVI.75.7.3089-3094.2001; POIESZ BJ, 1980, P NATL ACAD SCI-BIOL, V77, P7415, DOI 10.1073/pnas.77.12.7415; Roy S, 2011, PLOS ONE; Roy S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024859; Segerman A, 2006, VIROLOGY, V349, P96, DOI 10.1016/j.virol.2005.12.044; Sengupta S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018091; Seto D, 2011, J VIROL, V85, P5701, DOI 10.1128/JVI.00354-11; Solovei I, 2010, METHODS MOL BIOL, V659, P117, DOI 10.1007/978-1-60761-789-1_8; Szmuness W, 1978, Prog Med Virol, V24, P40; Tatsis N, 2007, BLOOD, V110, P1916, DOI 10.1182/blood-2007-02-062117; TRENTIN JJ, 1962, SCIENCE, V137, P835, DOI 10.1126/science.137.3533.835; Watzinger F, 2004, J CLIN MICROBIOL, V42, P5189, DOI 10.1128/JCM.42.11.5189-5198.2004; Whigham LD, 2006, AM J PHYSIOL-REG I, V290, pR190, DOI 10.1152/ajpregu.00479.2005; Wold W.S.M., 2007, FIELDS VIROLOGY, V7th, P2395	50	9	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2013	8	5							e63646	10.1371/journal.pone.0063646	http://dx.doi.org/10.1371/journal.pone.0063646			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	177QL	23671688	Green Published, gold, Green Submitted			2022-12-27	WOS:000321390200054
J	Sekonyela, R; Palmer, JM; Bok, JW; Jain, S; Berthier, E; Forseth, R; Schroeder, F; Keller, NP				Sekonyela, Relebohile; Palmer, Jonathan M.; Bok, Jin-Woo; Jain, Sachin; Berthier, Erwin; Forseth, Ry; Schroeder, Frank; Keller, Nancy P.			RsmA Regulates Aspergillus fumigatus Gliotoxin Cluster Metabolites Including Cyclo(L-Phe-L-Ser), a Potential New Diagnostic Marker for Invasive Aspergillosis	PLOS ONE			English	Article							OXIDATIVE STRESS-RESPONSE; SECONDARY METABOLISM; TRANSCRIPTIONAL REGULATOR; VIRULENCE FACTOR; GENE; LAEA; CONTRIBUTES; GROWTH; GLIP; DIFFERENTIATION	Dimeric basic leucine zipper (bZIP) proteins are conserved transcriptional enhancers found in all eukaryotes. A recently reported and novel function for bZIPs is association of these proteins with secondary metabolite production in filamentous fungi. In particular a Yap-like bZIP termed RsmA (restorer of secondary metabolism A) was identified in Aspergillus nidulans that positively regulates the carcinogen sterigmatocystin. To assess for conserved function for RsmA, we examined a role of this protein in secondary metabolism in the pathogen A. fumigatus. RsmA was found to positively regulate gliotoxin where overexpression (OE) of rsmA led to 2-100 fold increases of twelve gli cluster metabolites in culture medium including the newly identified gli metabolite cyclo(L-Phe-L-Ser). Lungs from both wild type and OErsmA infected mice contained gliotoxin (2.3 fold higher in OErsmA treatment) as well as the gliotoxin precursor cyclo(L-Phe-L-Ser) (3.2 fold higher in OErsmA treatment). The data here presents a conserved role for RsmA in secondary metabolite cluster activation and suggests cyclo(L-Phe-L-Ser) may serve as an alternative marker for diagnosis of invasive aspergillosis.	[Sekonyela, Relebohile; Jain, Sachin; Keller, Nancy P.] Univ Wisconsin, Dept Bacteriol, Madison, WI 53706 USA; [Palmer, Jonathan M.; Bok, Jin-Woo; Berthier, Erwin; Keller, Nancy P.] Univ Wisconsin, Dept Med Microbiol & Immunol, Madison, WI 53706 USA; [Forseth, Ry; Schroeder, Frank] Cornell Univ, Boyce Thompson Inst, Ithaca, NY USA; [Forseth, Ry; Schroeder, Frank] Cornell Univ, Dept Chem & Chem Biol, Ithaca, NY USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Cornell University; Boyce Thompson Institute for Plant Research; Cornell University	Keller, NP (corresponding author), Univ Wisconsin, Dept Bacteriol, Madison, WI 53706 USA.	npkeller@wisc.edu	Bok, Jin Woo/F-7140-2010; Palmer, Jonathan/A-3890-2009; Keller, Nancy P./ABC-5911-2021	Berthier, Erwin/0000-0002-4421-9034; Schroeder, Frank/0000-0002-4420-0237; Palmer, Jonathan/0000-0003-0929-3658	National Institutes of Health (NIH) [R01 Al065728-01, GM008500]; DuPont Young Professor Award; American Asthma Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008500] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DuPont Young Professor Award; American Asthma Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported in part by National Institutes of Health (NIH) (R01 Al065728-01 to NPK and GM008500 to RRF), a DuPont Young Professor Award (to FCS) and a grant from the American Asthma Foundation to NPK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaike S, 2009, EUKARYOT CELL, V8, P1051, DOI 10.1128/EC.00088-09; Asano Y, 2007, BIOSCI BIOTECH BIOCH, V71, P1800, DOI 10.1271/bbb.70133; Berthier E, 2010, INTEGR BIOL-UK, V2, P630, DOI 10.1039/c0ib00030b; Bok JW, 2006, INFECT IMMUN, V74, P6761, DOI 10.1128/IAI.00780-06; Bok JW, 2005, EUKARYOT CELL, V4, P1574, DOI 10.1128/EC.4.9.1574-1582.2005; Bok JW, 2004, EUKARYOT CELL, V3, P527, DOI 10.1128/EC.3.2.527-535.2004; Butchko RAE, 2012, FUNGAL GENET BIOL, V49, P602, DOI 10.1016/j.fgb.2012.06.003; Calvo AM, 2004, APPL ENVIRON MICROB, V70, P4733, DOI 10.1128/AEM.70.8.4733-4739.2004; Carberry S, 2012, FUNGAL GENET BIOL, V49, P302, DOI 10.1016/j.fgb.2012.02.003; Cramer RA, 2006, EUKARYOT CELL, V5, P972, DOI 10.1128/EC.00049-06; Dagenais TRT, 2009, CLIN MICROBIOL REV, V22, P447, DOI 10.1128/CMR.00055-08; Domingo MP, 2012, DIAGN MICR INFEC DIS, V73, P57, DOI 10.1016/j.diagmicrobio.2012.01.012; Fernandes M, 1998, MOL MICROBIOL, V28, P1355, DOI 10.1046/j.1365-2958.1998.00907.x; Forseth RR, 2011, J AM CHEM SOC, V133, P9678, DOI 10.1021/ja2029987; Hoffmeister D, 2007, NAT PROD REP, V24, P393, DOI 10.1039/b603084j; Kupfahl C, 2006, MOL MICROBIOL, V62, P292, DOI 10.1111/j.1365-2958.2006.05373.x; Latge JP, 2001, TRENDS MICROBIOL, V9, P382, DOI 10.1016/S0966-842X(01)02104-7; Lessing F, 2007, EUKARYOT CELL, V6, P2290, DOI 10.1128/EC.00267-07; Lewis RE, 2005, J CLIN MICROBIOL, V43, P6120, DOI 10.1128/JCM.43.12.6120-6122.2005; McDonald T, 2005, MOL PLANT MICROBE IN, V18, P539, DOI 10.1094/MPMI-18-0539; Murayama T, 1996, EUR RESPIR J, V9, P293, DOI 10.1183/09031936.96.09020293; Pahl HL, 1996, J EXP MED, V183, P1829, DOI 10.1084/jem.183.4.1829; Palmer JM, 2008, EUKARYOT CELL, V7, P2052, DOI 10.1128/EC.00224-08; Puri A, 2010, BIOMED CHROMATOGR, V24, P887, DOI 10.1002/bmc.1382; Qiao JJ, 2008, MED MYCOL, V46, P773, DOI 10.1080/13693780802054215; Ramirez-Ortiz ZG, 2011, CELL HOST MICROBE, V9, P415, DOI 10.1016/j.chom.2011.04.007; Reverberi M, 2007, FOOD ADDIT CONTAM A, V24, P1070, DOI 10.1080/02652030701553244; Reverberi M, 2012, APPL MICROBIOL BIOT, V95, P1293, DOI 10.1007/s00253-012-3985-4; Roze LV, 2011, J BIOL CHEM, V286, P35137, DOI 10.1074/jbc.M111.253468; Sambrook J., 2001, MOL CLONING LAB MANU; Scharf DH, 2010, J AM CHEM SOC, V132, P10136, DOI 10.1021/ja103262m; Schrettl M, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000952; Shaaban MI, 2010, EUKARYOT CELL, V9, P1816, DOI 10.1128/EC.00189-10; Shah D T, 1998, Infect Dis Obstet Gynecol, V6, P168, DOI 10.1155/S1064744998000349; Shi LN, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-11; Shimizu K, 2001, GENETICS, V157, P591; Speth C, 2011, MOL IMMUNOL, V48, P2122, DOI 10.1016/j.molimm.2011.07.005; Spikes S, 2008, J INFECT DIS, V197, P479, DOI 10.1086/525044; Stanzani M, 2005, BLOOD, V105, P2258, DOI 10.1182/blood-2004-09-3421; Sugui JA, 2007, EUKARYOT CELL, V6, P1552, DOI 10.1128/EC.00140-07; Sugui JA, 2007, EUKARYOT CELL, V6, P1562, DOI 10.1128/EC.00141-07; Szewczyk E, 2006, NAT PROTOC, V1, P3111, DOI 10.1038/nprot.2006.405; Temme N, 2012, MOL PLANT PATHOL, V13, P704, DOI 10.1111/j.1364-3703.2011.00778.x; Wagner D, 2010, EUKARYOT CELL, V9, P1588, DOI 10.1128/EC.00146-10; Wiemann P, 2010, MOL MICROBIOL, V77, P972, DOI 10.1111/j.1365-2958.2010.07263.x; WOLOSHUK CP, 1994, APPL ENVIRON MICROB, V60, P2408, DOI 10.1128/AEM.60.7.2408-2414.1994; Wu DL, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002542; Xue T, 2004, ARCH MICROBIOL, V182, P346, DOI 10.1007/s00203-004-0707-z; Yin WB, 2013, MICROBIOL-SGM, V159, P77, DOI 10.1099/mic.0.063370-0; Yin WB, 2012, MOL MICROBIOL, V83, P1024, DOI 10.1111/j.1365-2958.2012.07986.x; Yu JH, 2004, FUNGAL GENET BIOL, V41, P973, DOI 10.1016/j.fgb.2004.08.001	51	32	34	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2013	8	5							e62591	10.1371/journal.pone.0062591	http://dx.doi.org/10.1371/journal.pone.0062591			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	177QL	23671611	Green Published, gold, Green Submitted			2022-12-27	WOS:000321390200029
J	Valente, F; Costa, C; Silva, A				Valente, Frederico; Costa, Carlos; Silva, Augusto			Dicoogle, a Pacs Featuring Profiled Content Based Image Retrieval	PLOS ONE			English	Article							DICOM; DISTANCE	Content-based image retrieval (CBIR) has been heralded as a mechanism to cope with the increasingly larger volumes of information present in medical imaging repositories. However, generic, extensible CBIR frameworks that work natively with Picture Archive and Communication Systems (PACS) are scarce. In this article we propose a methodology for parametric CBIR based on similarity profiles. The architecture and implementation of a profiled CBIR system, based on query by example, atop Dicoogle, an open-source, full-fletched PACS is also presented and discussed. In this solution, CBIR profiles allow the specification of both a distance function to be applied and the feature set that must be present for that function to operate. The presented framework provides the basis for a CBIR expansion mechanism and the solution developed integrates with DICOM based PACS networks where it provides CBIR functionality in a seamless manner.	[Valente, Frederico; Costa, Carlos; Silva, Augusto] Univ Aveiro, IEETA, P-3800 Aveiro, Portugal	Universidade de Aveiro	Valente, F (corresponding author), Univ Aveiro, IEETA, P-3800 Aveiro, Portugal.	fmvalente@ua.pt	Costa, Carlos A/A-4693-2012	Costa, Carlos A/0000-0002-2707-5331; Silva, Augusto/0000-0003-3786-2889	"Fundacao para a Ciencia e Tecnologia" (FCT) [PTDC/EIA-EIA/104428/2008]	"Fundacao para a Ciencia e Tecnologia" (FCT)(Portuguese Foundation for Science and TechnologyEuropean Commission)	This work has received funding from "Fundacao para a Ciencia e Tecnologia" (FCT) under grant agreement PTDC/EIA-EIA/104428/2008. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akgul CB, 2011, J DIGIT IMAGING, V24, P208, DOI 10.1007/s10278-010-9290-9; [Anonymous], 2008, PREP DIS TACKL TER E; [Anonymous], 2011, DIG IM COMM MED DI 1; [Anonymous], 2011, DIG IM COMM MED DI 7; Beebe C, 2006, BRIDGING SEMANTIC GA; Caicedo JC, 2009, LECT NOTES ARTIF INT, V5651, P126, DOI 10.1007/978-3-642-02976-9_17; Chang H, 2007, IMAGE VISION COMPUT, V25, P695, DOI 10.1016/j.imavis.2006.05.013; Chavez E, 2001, ACM COMPUT SURV, V33, P273, DOI 10.1145/502807.502808; Chia-Chi Teng, 2010, 2010 IEEE International Conference on Software Engineering and Service Sciences (ICSESS 2010), P431, DOI 10.1109/ICSESS.2010.5552343; Comaniciu D, 2003, IEEE T PATTERN ANAL, V25, P564, DOI 10.1109/TPAMI.2003.1195991; Costa C, 2011, J DIGIT IMAGING, V24, P848, DOI 10.1007/s10278-010-9347-9; Costa C, 2007, STUD COMPUT INTELL, V65, P79; Costa C, 2009, INT J COMPUT ASS RAD, V4, P71, DOI 10.1007/s11548-008-0269-7; Datta R, 2008, ACM COMPUT SURV, V40, DOI 10.1145/1348246.1348248; El-Naqa I, 2004, IEEE T MED IMAGING, V23, P1233, DOI 10.1109/TMI.2004.834601; Farman AG, 2005, J DIGIT IMAGING, V18, P23, DOI 10.1007/s10278-004-1029-z; Fischer B, 2008, SPIE C SERIES, V6919; Guyon I., 2006, STUDIES FUZZINESS SO; HAFNER J, 1995, IEEE T PATTERN ANAL, V17, P729, DOI 10.1109/34.391417; Hjaltason GR, 2003, ACM T DATABASE SYST, V28, P517, DOI 10.1145/958942.958948; Huang HK, 2010, PACS IMAGING INFORM; Lux M, 2008, P 16 ACM INT C MULT, DOI [DOI 10.1145/1459359.1459577, 10.1145/1459359.1459577]; Ly Q., 2007, P 23 INT C VER LARG, P950; McCandless M, 2010, MANNING PUBS CO SERI; Mehta Kamal, 2012, INT J COMPUTER APPL, V48, P12; Muller H, 2007, 2007 IEEE INTERNATIONAL CONFERENCE ON MULTIMEDIA AND EXPO, VOLS 1-5, P683; Oosterwijk H, 2005, DICOM BASICS; Quellec G, 2010, MED IMAGE ANAL, V14, P227, DOI 10.1016/j.media.2009.11.004; Rubin GD, 2000, EUR J RADIOL, V36, P74, DOI 10.1016/S0720-048X(00)00270-9; Rubner Y, 2000, INT J COMPUT VISION, V40, P99, DOI 10.1023/A:1026543900054; Rui Y, 1998, CIRCUITS SYSTEMS VID, V8; Santos M, 2011, COMM COM INF SC, V221, P254; Schindler U, 2008, COMPUT GEOSCI-UK, V34, P1947, DOI 10.1016/j.cageo.2008.02.023; Siegle RL, 1998, ACAD RADIOL, V5, P148, DOI 10.1016/S1076-6332(98)80277-8; Soffa David J, 2004, J Am Coll Radiol, V1, P212, DOI 10.1016/j.jacr.2003.12.017; Vossberg M, 2008, IEEE T INF TECHNOL B, V12, P145, DOI 10.1109/TITB.2007.905862; Warnock MJ, 2007, J DIGIT IMAGING, V20, P125, DOI 10.1007/s10278-007-9064-1; Wei LY, 2006, IEEE IMAGE PROC, P2517, DOI 10.1109/ICIP.2006.312805; Yang CT, 2010, FUTURE GENER COMP SY, V26, P1127, DOI 10.1016/j.future.2010.05.013; Zezula P, 2010, ADV DATABASE SYSTEMS; Zwonitzer R, 2007, COMPUT METH PROG BIO, V87, P181, DOI 10.1016/j.cmpb.2007.05.010	41	28	28	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2013	8	5							e61888	10.1371/journal.pone.0061888	http://dx.doi.org/10.1371/journal.pone.0061888			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	177QL	23671578	gold, Green Published, Green Submitted			2022-12-27	WOS:000321390200011
J	Barros, S; Mencia, N; Rodriguez, L; Oleaga, C; Santos, C; Noe, V; Ciudad, CJ				Barros, Susana; Mencia, Nuria; Rodriguez, Laura; Oleaga, Carlota; Santos, Conceicao; Noe, Veronique; Ciudad, Carlos J.			The Redox State of Cytochrome C Modulates Resistance to Methotrexate in Human MCF7 Breast Cancer Cells	PLOS ONE			English	Article							GLUTATHIONE-S-TRANSFERASE; ANTICANCER DRUG-RESISTANCE; DIHYDROFOLATE-REDUCTASE; INDUCED APOPTOSIS; DEPENDENT ENZYMES; MECHANISM; RELEASE; MITOCHONDRIA; CARDIOLIPIN; LEUKEMIA	Background: Methotrexate is a chemotherapeutic agent used to treat a variety of cancers. However, the occurrence of resistance limits its effectiveness. Cytochrome c in its reduced state is less capable of triggering the apoptotic cascade. Thus, we set up to study the relationship among redox state of cytochrome c, apoptosis and the development of resistance to methotrexate in MCF7 human breast cancer cells. Results: Cell incubation with cytochrome c-reducing agents, such as tetramethylphenylenediamine, ascorbate or reduced glutathione, decreased the mortality and apoptosis triggered by methotrexate. Conversely, depletion of glutathione increased the apoptotic action of methotrexate, showing an involvement of cytochrome c redox state in methotrexate-induced apoptosis. Methotrexate-resistant MCF7 cells showed increased levels of endogenous reduced glutathione and a higher capability to reduce exogenous cytochrome c. Using functional genomics we detected the overexpression of GSTM1 and GSTM4 in methotrexate-resistant MCF7 breast cancer cells, and determined that methotrexate was susceptible of glutathionylation by GSTs. The inhibition of these GSTM isoforms caused an increase in methotrexate cytotoxicity in sensitive and resistant cells. Conclusions: We conclude that overexpression of specific GSTMs, GSTM1 and GSTM4, together with increased endogenous reduced glutathione levels help to maintain a more reduced state of cytochrome c which, in turn, would decrease apoptosis, thus contributing to methotrexate resistance in human MCF7 breast cancer cells.	[Barros, Susana; Mencia, Nuria; Rodriguez, Laura; Oleaga, Carlota; Noe, Veronique; Ciudad, Carlos J.] Univ Barcelona, Dept Biochem & Mol Biol, Sch Pharm, Barcelona, Spain; [Barros, Susana; Santos, Conceicao] Univ Aveiro, Dept Biol, CESAM, P-3800 Aveiro, Portugal	University of Barcelona; Universidade de Aveiro	Ciudad, CJ (corresponding author), Univ Barcelona, Dept Biochem & Mol Biol, Sch Pharm, Barcelona, Spain.	cciudad@ub.edu	Santos, Conceição/ABE-6172-2020; Noe, Veronique/K-3615-2014; Santos, Conceição LV/A-8651-2008; santos, conceição/GQQ-7378-2022; Ciudad, Carlos J./D-7917-2014; Oleaga, Carlota/N-9276-2019	Santos, Conceição/0000-0003-4129-6381; Noe, Veronique/0000-0001-7937-8038; Santos, Conceição LV/0000-0003-4129-6381; Ciudad, Carlos J./0000-0002-7855-392X; Oleaga, Carlota/0000-0002-2146-9671; MENCIA TRINCHANT, Nuria/0000-0003-1376-8708	"Plan Nacional de Investigacion Cientifica" (Spain) [SAF2011-23582]	"Plan Nacional de Investigacion Cientifica" (Spain)	The work was supported by grant SAF2011-23582 from "Plan Nacional de Investigacion Cientifica" (Spain). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdellatif Y, 2007, CELL CALCIUM, V41, P429, DOI 10.1016/j.ceca.2006.08.004; Adler V, 1999, EMBO J, V18, P1321, DOI 10.1093/emboj/18.5.1321; ALT FW, 1978, J BIOL CHEM, V253, P1357; Armstrong RN, 1997, CHEM RES TOXICOL, V10, P2, DOI 10.1021/tx960072x; AUPETIT B, 1986, BIOCHIM BIOPHYS ACTA, V884, P270, DOI 10.1016/0304-4165(86)90173-X; Belikova NA, 2006, BIOCHEMISTRY-US, V45, P4998, DOI 10.1021/bi0525573; BLAKLEY RL, 1984, BIOCHEMISTRY-US, V23, P2377, DOI 10.1021/bi00306a009; Borutaite V, 2007, J BIOL CHEM, V282, P31124, DOI 10.1074/jbc.M700322200; Bracht K, 2006, ANTI-CANCER DRUG, V17, P41, DOI 10.1097/01.cad.0000190280.60005.05; Brown GC, 2008, BBA-BIOENERGETICS, V1777, P877, DOI 10.1016/j.bbabio.2008.03.024; CHEN G, 1994, BIOCHEM PHARMACOL, V47, P1079, DOI 10.1016/0006-2952(94)90420-0; Cho SG, 2001, J BIOL CHEM, V276, P12749, DOI 10.1074/jbc.M005561200; Chu E, 1996, STEM CELLS, V14, P41, DOI 10.1002/stem.140041; Circu ML, 2008, FREE RADICAL RES, V42, P689, DOI 10.1080/10715760802317663; de Almagro MC, 2011, HUM GENE THER, V22, P451, DOI 10.1089/hum.2010.102; de Almagro MC, 2011, BIOCHEM PHARMACOL, V81, P60, DOI 10.1016/j.bcp.2010.09.008; de Almagro MC, 2009, J BIOL CHEM, V284, P11579, DOI 10.1074/jbc.M900981200; Deng HT, 2006, BIOCHEM BIOPH RES CO, V342, P73, DOI 10.1016/j.bbrc.2006.01.108; Estrela JM, 2006, CRIT REV CL LAB SCI, V43, P143, DOI 10.1080/10408360500523878; EVERSE J, 1979, BIOCHEMISTRY-US, V18, P2668, DOI 10.1021/bi00579a037; Fan MY, 2001, DRUG RESIST UPDATE, V4, P253, DOI 10.1054/drup.2001.0214; Ghibelli L, 1999, FASEB J, V13, P2031, DOI 10.1096/fasebj.13.14.2031; Gorlick R, 1997, BLOOD, V89, P1013, DOI 10.1182/blood.V89.3.1013; HABER DA, 1981, J BIOL CHEM, V256, P9501; HABIG WH, 1974, J BIOL CHEM, V249, P7130; Han I, 2011, PROTEOMICS, V11, P352, DOI 10.1002/pmic.201000475; Hancock JT, 2003, ANN NY ACAD SCI, V1010, P446, DOI 10.1196/annals.1299.081; Hancock JT, 2001, FREE RADICAL BIO MED, V31, P697, DOI 10.1016/S0891-5849(01)00646-3; Hayes JD, 1999, FREE RADICAL RES, V31, P273, DOI 10.1080/10715769900300851; Hayes JD, 2005, ANNU REV PHARMACOL, V45, P51, DOI 10.1146/annurev.pharmtox.45.120403.095857; Hayes JD, 1995, CRIT REV BIOCHEM MOL, V30, P445, DOI 10.3109/10409239509083491; Hosono N, 2010, CANCER SCI, V101, P767, DOI 10.1111/j.1349-7006.2009.01432.x; Huang CC, 2005, APOPTOSIS, V10, P895, DOI 10.1007/s10495-005-2947-z; Ip SW, 2008, IN VIVO, V22, P237; JOLIVET J, 1983, NEW ENGL J MED, V309, P1094, DOI 10.1056/NEJM198311033091805; Jordan J, 2002, BRIT J PHARMACOL, V137, P993, DOI 10.1038/sj.bjp.0704953; Kagan VE, 2005, NAT CHEM BIOL, V1, P223, DOI 10.1038/nchembio727; Kuznetsov AV, 2004, AM J PHYSIOL-HEART C, V286, pH1633, DOI 10.1152/ajpheart.00701.2003; Li M, 2008, PROTEIN PEPTIDE LETT, V15, P200; Li TS, 2009, CANCER CHEMOTH PHARM, V63, P873, DOI 10.1007/s00280-008-0809-4; Liani E, 2003, INT J CANCER, V103, P587, DOI 10.1002/ijc.10829; Luo W, 2009, ONCOGENE, V28, P4126, DOI 10.1038/onc.2009.262; McLellan LI, 1999, DRUG RESIST UPDATE, V2, P153, DOI 10.1054/drup.1999.0083; Mencia N, 2011, BIOCHEM PHARMACOL, V82, P1572, DOI 10.1016/j.bcp.2011.08.009; Mencia N, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-250; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Moyer AM, 2010, CANCER EPIDEM BIOMAR, V19, P811, DOI 10.1158/1055-9965.EPI-09-0871; Nishimura G, 2001, FEBS LETT, V505, P399, DOI 10.1016/S0014-5793(01)02859-9; NOE V, 1995, ANAL BIOCHEM, V224, P600, DOI 10.1006/abio.1995.1093; Ott M, 2007, CELL DEATH DIFFER, V14, P1243, DOI 10.1038/sj.cdd.4402135; Pasello M, 2011, ANAL CELL PATHOL, V34, P131, DOI [10.1155/2011/414985, 10.3233/ACP-2011-012]; PERRY RR, 1993, CANCER, V72, P783, DOI 10.1002/1097-0142(19930801)72:3<783::AID-CNCR2820720325>3.0.CO;2-U; Ripple MO, 2010, APOPTOSIS, V15, P563, DOI 10.1007/s10495-010-0455-2; SARTI P, 1992, ARCH BIOCHEM BIOPHYS, V299, P8, DOI 10.1016/0003-9861(92)90237-Q; SARTI P, 1992, BIOCHEM J, V284, P123, DOI 10.1042/bj2840123; Selga E, 2008, BIOCHEM PHARMACOL, V75, P414, DOI 10.1016/j.bcp.2007.08.034; Selga E, 2009, GENOME MED, V1, DOI 10.1186/gm83; Selga E, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-35; Silva AM, 2012, METHODS MOL BIOL, V810, P7, DOI 10.1007/978-1-61779-382-0_2; SIROTNAK FM, 1981, CANCER RES, V41, P4447; Suto D, 2005, BIOCHEM J, V392, P399, DOI 10.1042/BJ20050580; Tang SC, 2011, CANCER-AM CANCER SOC, V117, P3209, DOI 10.1002/cncr.25875; TEW KD, 1994, CANCER RES, V54, P4313; TEW KD, 2012, ANTIOXID REDOX SIGNA; Townsend DM, 2003, ONCOGENE, V22, P7369, DOI 10.1038/sj.onc.1206940; Vaughn AE, 2008, NAT CELL BIOL, V10, P1477, DOI 10.1038/ncb1807; Wang CH, 2011, J MED CHEM, V54, P8574, DOI 10.1021/jm201131n	67	16	16	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2013	8	5							e63276	10.1371/journal.pone.0063276	http://dx.doi.org/10.1371/journal.pone.0063276			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145RZ	23675469	Green Published, gold			2022-12-27	WOS:000319036100033
J	Gao, TY; He, BS; Pan, YQ; Li, R; Xu, YQ; Chen, LP; Nie, ZL; Gu, L; Wang, SK				Gao, Tianyi; He, Bangshun; Pan, Yuqin; Li, Rui; Xu, Yeqiong; Chen, Liping; Nie, Zhenling; Gu, Ling; Wang, Shukui			The Association of Retinoic Acid Receptor Beta2(RAR beta 2) Methylation Status and Prostate Cancer Risk: A Systematic Review and Meta-Analysis	PLOS ONE			English	Article							PROMOTER METHYLATION; MOLECULAR-DETECTION; GENE; BETA; EXPRESSION; HYPERMETHYLATION; PROGRESSION; CARCINOMA; PATTERNS; DISEASE	The retinoic acid receptor beta2(RAR beta 2) is a type of nuclear receptor that is activated by both all-trans retinoic acid and 9-cis retinoic acid, which has been shown to function as a tumor suppressor gene in different types of human tumors. Previous reports demonstrated that the frequency of RAR beta 2 methylation was significantly higher in prostate cancer patients compared with controls, but the relationship between RAR beta 2 promoter methylation and pathological stage or Gleason score of prostate cancer remained controversial. Therefore, a meta-analysis of published studies investigating the effects of RAR beta 2 methylation status in prostate cancer occurrence and association with both pathological stage and Gleason score in prostate cancer was performed in the study. A total of 12 eligible studies involving 777 cases and 404 controls were included in the pooled analyses. Under the random-effects model, the pooled OR of RAR beta 2 methylation in prostate cancer patients, compared to non-cancer controls, was 17.62 with 95%CI = 6.30-49.28. The pooled OR with the fixed-effects model of pathological stage in RASSF1A methylated patients, compared to unmethylated patients, was 0.67 (95%CI = 0.40-1.09) and the pooled OR of low-GS in RAR beta 2 methylated patients by the random-effect model, compared to high-GS RAR beta 2 methylated patients, was 0.54 (95% CI = 0.28-1.04). This study showed that RAR beta 2 might be a potential biomarker in prostate cancer prevention and diagnosis. The detection of RAR beta 2 methylation in urine or serum is a potential non-invasive diagnostic tool in prostate cancer. The present findings also require confirmation through adequately designed prospective studies.	[Gao, Tianyi; He, Bangshun; Pan, Yuqin; Li, Rui; Xu, Yeqiong; Chen, Liping; Nie, Zhenling; Gu, Ling; Wang, Shukui] Nanjing Med Univ, Nanjing Hosp 1, Cent Lab, Nanjing, Jiangsu, Peoples R China; [Li, Rui; Chen, Liping; Gu, Ling] Nanjing Normal Univ, Dept Life Sci, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University; Nanjing Normal University	Wang, SK (corresponding author), Nanjing Med Univ, Nanjing Hosp 1, Cent Lab, Nanjing, Jiangsu, Peoples R China.	sk_wang@njmu.edu.cn			National Natural Science Foundation of China [NSFC:C0606]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China (http://www.nsfc.gov.cn/Portal0/default152.htm) NSFC:C0606. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLENBY G, 1993, P NATL ACAD SCI USA, V90, P30, DOI 10.1073/pnas.90.1.30; Baden J, 2009, J UROLOGY, V182, P1186, DOI 10.1016/j.juro.2009.05.003; Bastian PJ, 2007, EUR UROL, V51, P665, DOI 10.1016/j.eururo.2006.08.008; Catalona WJ, 1997, JAMA-J AM MED ASSOC, V277, P1452, DOI 10.1001/jama.277.18.1452; Chambon P, 1996, FASEB J, V10, P940, DOI 10.1096/fasebj.10.9.8801176; Chung LWK, 2005, J UROLOGY, V173, P10, DOI 10.1097/01.ju.0000141582.15218.10; Collin SM, 2008, LANCET ONCOL, V9, P445, DOI 10.1016/S1470-2045(08)70104-9; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Dumache R, 2012, CHIRURGIA-BUCHAREST, V107, P780; Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Esteller M, 2002, CANCER RES, V62, P5902; FROMMER M, 1992, P NATL ACAD SCI USA, V89, P1827, DOI 10.1073/pnas.89.5.1827; Fuks F, 2003, NUCLEIC ACIDS RES, V31, P2305, DOI 10.1093/nar/gkg332; GARDINERGARDEN M, 1987, J MOL BIOL, V196, P261, DOI 10.1016/0022-2836(87)90689-9; GIGUERE V, 1994, ENDOCR REV, V15, P61, DOI 10.1210/er.15.1.61; Greenlee RT, 2000, CA-CANCER J CLIN, V50, P7, DOI 10.3322/canjclin.50.1.7; Han M, 2001, UROL CLIN N AM, V28, P555, DOI 10.1016/S0094-0143(05)70163-4; Handoll HH, 2006, ARCH PHYS MED REHAB, V87, P875, DOI 10.1016/j.apmr.2006.04.006; Hanson JA, 2006, JNCI-J NATL CANCER I, V98, P255, DOI 10.1093/jnci/djj051; Henrique R, 2006, MOL CANCER RES, V4, P1, DOI 10.1158/1541-7786.MCR-05-0113; Henrique R, 2004, EUR UROL, V46, P660, DOI 10.1016/j.eururo.2004.06.014; Herman JG, 2003, NEW ENGL J MED, V349, P2042, DOI 10.1056/NEJMra023075; Hoque MO, 2005, J CLIN ONCOL, V23, P6569, DOI 10.1200/JCO.2005.07.009; HOULE B, 1993, P NATL ACAD SCI USA, V90, P985, DOI 10.1073/pnas.90.3.985; Jeronimo C, 2004, CLIN CANCER RES, V10, P4010, DOI 10.1158/1078-0432.CCR-03-0643; Karray-Chouayekh S, 2000, JNCI-J NATL CANCER I, V92, P826; MANTEL N, 1959, J NATL CANCER I, V22, P719; Maruyama R, 2002, CLIN CANCER RES, V8, P514; Mian BM, 2002, UROLOGY, V60, P836, DOI 10.1016/S0090-4295(02)01950-7; Moinpour CM, 1998, J NATL CANCER I, V90, P1537, DOI 10.1093/jnci/90.20.1537; Nakayama T, 2001, LAB INVEST, V81, P1049, DOI 10.1038/labinvest.3780316; ROMAN SD, 1992, CANCER RES, V52, P2236; Roupret M, 2007, CLIN CANCER RES, V13, P1720, DOI 10.1158/1078-0432.CCR-06-2467; Sabichi AL, 1998, J NATL CANCER I, V90, P597, DOI 10.1093/jnci/90.8.597; SEEWALDT VL, 1995, CELL GROWTH DIFFER, V6, P1077; Sirchia SM, 2002, CANCER RES, V62, P2455; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; SWISSHELM K, 1994, CELL GROWTH DIFFER, V5, P133; Toulouse A, 1996, BBA-GENE STRUCT EXPR, V1309, P1, DOI 10.1016/S0167-4781(96)00126-1; Virmani AK, 2000, J NATL CANCER I, V92, P1303, DOI 10.1093/jnci/92.16.1303; Woodson K, 2004, PROSTATE, V60, P25, DOI 10.1002/pros.20013; Woodson K, 2004, CANCER LETT, V205, P181, DOI 10.1016/j.canlet.2003.11.027; Yamanaka M, 2003, INT J CANCER, V106, P382, DOI 10.1002/ijc.11227; Yates DR, 2006, ONCOGENE, V25, P1984, DOI 10.1038/sj.onc.1209209; Zagars GK, 1997, CANCER, V79, P1370, DOI 10.1002/(SICI)1097-0142(19970401)79:7<1370::AID-CNCR15>3.0.CO;2-X; Zhang JM, 2004, ONCOGENE, V23, P2241, DOI 10.1038/sj.onc.1207328	47	12	15	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2013	8	5							e62950	10.1371/journal.pone.0062950	http://dx.doi.org/10.1371/journal.pone.0062950			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145RZ	23675444	Green Published, gold, Green Submitted			2022-12-27	WOS:000319036100025
J	Khan, P; Drobic, B; Perez-Cadahia, B; Healy, S; He, SH; Davie, JR				Khan, Protiti; Drobic, Bojan; Perez-Cadahia, Beatriz; Healy, Shannon; He, Shihua; Davie, James R.			Mitogen- and Stress-Activated Protein Kinases 1 and 2 Are Required for Maximal Trefoil Factor 1 Induction	PLOS ONE			English	Article							BREAST-CANCER CELLS; ESTROGEN-RECEPTOR-ALPHA; HISTONE H3; INDUCED PHOSPHORYLATION; NUCLEOSOMAL RESPONSE; GENE-EXPRESSION; PS2 GENE; MSK1; CHROMATIN; PROMOTER	Mitogen- and stress-activated protein kinases 1 and 2 (MSK1 and MSK2), activated downstream of the ERK- and p38-mitogen-activated protein kinase pathways are involved in cell survival, proliferation and differentiation. Following mitogenic or stress stimuli, they mediate the nucleosomal response, which includes phosphorylation of histone H3 at serine 10 (H3S10ph) coupled with transcriptional activation of immediate-early genes. While MSK1 and MSK2 are closely related, their relative roles may vary with cellular context and/or stimuli. However, our knowledge of MSK2 recruitment to immediate-early genes is limited, as research has primarily focused on MSK1. Here, we demonstrate that both MSK1 and MSK2, regulate the phorbol ester 12-O-tetradecanoylphorbol-13-acetate induced expression of the breast cancer marker gene, trefoil factor 1 (TFF1), by phosphorylating H3S10 at its 59 regulatory regions. The MSK-mediated phosphorylation of H3S10 promotes the recruitment of 14-3-3 isoforms and BRG1, the ATPase subunit of the BAF/PBAF remodeling complex, to the enhancer and upstream promoter elements of TFF1. The recruited chromatin remodeling activity leads to the RNA polymerase II carboxy-terminal domain phosphorylation at the TFF1 promoter, initiating TFF1 expression in MCF-7 breast cancer cells. Moreover, we show that MSK1 or MSK2 is recruited to TFF1 regulatory regions, but as components of different multiprotein complexes.	[Khan, Protiti; Drobic, Bojan; Perez-Cadahia, Beatriz; Healy, Shannon; He, Shihua; Davie, James R.] Univ Manitoba, Manitoba Inst Child Hlth, Winnipeg, MB, Canada	University of Manitoba	Davie, JR (corresponding author), Univ Manitoba, Manitoba Inst Child Hlth, Winnipeg, MB, Canada.	davie@cc.umanitoba.ca		Davie, James/0000-0002-0420-6888	Canadian Cancer Society [2010 700323]; Canadian Breast Cancer Foundation; Canadian Institute of Health Research [MOP-9186]; Canada Research Chair; UMGF/CancerCare Manitoba Studentship Award; Canadian Cancer Society Research Institute Terry Fox Foundation studentship; Manitoba Health Research Council	Canadian Cancer Society(Canadian Cancer Society (CCS)); Canadian Breast Cancer Foundation(Canadian Cancer Society (CCS)); Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); Canada Research Chair(Natural Resources CanadaCanadian Forest ServiceCanada Research Chairs); UMGF/CancerCare Manitoba Studentship Award; Canadian Cancer Society Research Institute Terry Fox Foundation studentship; Manitoba Health Research Council	This work was supported with funding from Canadian Cancer Society [2010 700323] (http://www.cancer.ca/), a Canadian Breast Cancer Foundation (http://www.cbcf.org/), and a Canadian Institute of Health Research [MOP-9186] (http://www.cihr-irsc.gc.ca/) to J.R.D., a Canada Research Chair (http://www.chairs-chaires.gc.ca/home-accueil-eng.aspx) to J.R.D., a UMGF/CancerCare Manitoba (http://www.cancercare.mb.ca/home/) Studentship Award to P. K., a Canadian Cancer Society Research Institute Terry Fox Foundation studentship to B. D., and Manitoba Health Research Council (http://mhrc.mb.ca/) Fellowships to B. P-C and S. H. The authors acknowledge the strong support of the Manitoba Institute of Child Health and CancerCare Manitoba Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amiry N, 2009, ENDOCRINOLOGY, V150, P4473, DOI 10.1210/en.2009-0066; Ananieva O, 2008, NAT IMMUNOL, V9, P1028, DOI 10.1038/ni.1644; ANGEL P, 1988, CELL, V55, P875, DOI 10.1016/0092-8674(88)90143-2; Arthur JSC, 2008, FRONT BIOSCI-LANDMRK, V13, P5866, DOI 10.2741/3122; Berglund L, 2008, MOL CELL PROTEOMICS, V7, P2019, DOI 10.1074/mcp.R800013-MCP200; Bougen NM, 2013, CANCER LETT, V332, P19, DOI 10.1016/j.canlet.2012.12.012; Brami-Cherrier K, 2005, J NEUROSCI, V25, P11444, DOI 10.1523/JNEUROSCI.1711-05.2005; Carroll JS, 2005, CELL, V122, P33, DOI 10.1016/j.cell.2005.05.008; Chandramohan Y, 2008, EUR J NEUROSCI, V27, P2701, DOI 10.1111/j.1460-9568.2008.06230.x; Chang S, 2011, CANCER INVEST, V29, P240, DOI 10.3109/07357907.2010.550594; Chwang WB, 2007, J NEUROSCI, V27, P12732, DOI 10.1523/JNEUROSCI.2522-07.2007; Clapier CR, 2009, ANNU REV BIOCHEM, V78, P273, DOI 10.1146/annurev.biochem.77.062706.153223; Corte MD, 2006, BREAST CANCER RES TR, V96, P63, DOI 10.1007/s10549-005-9041-7; Darragh J, 2005, BIOCHEM J, V390, P749, DOI 10.1042/BJ20050196; Drobic B, 2010, NUCLEIC ACIDS RES, V38, P3196, DOI 10.1093/nar/gkq030; Espino PS, 2006, CANCER RES, V66, P4610, DOI 10.1158/0008-5472.CAN-05-4251; Euskirchen GM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002008; Giamarchi C, 1999, ONCOGENE, V18, P533, DOI 10.1038/sj.onc.1202317; He SH, 2005, MOL BIOL CELL, V16, P4073, DOI 10.1091/mbc.e05-05-0388; Healy S, 2012, BIOCHEM CELL BIOL, V90, P39, DOI [10.1139/o11-092, 10.1139/O11-092]; Hsu YL, 2012, ONCOGENE; Jacks KA, 2010, J BIOL CHEM, V285, P1661, DOI 10.1074/jbc.M109.083808; Kim J, 2000, J STEROID BIOCHEM, V74, P157, DOI 10.1016/S0960-0760(00)00119-9; Kim SI, 2009, NUCLEIC ACIDS RES, V37, P6019, DOI 10.1093/nar/gkp677; Lacroix M, 2006, ENDOCR-RELAT CANCER, V13, P1033, DOI 10.1677/ERC-06-0001; Li L, 2008, J CELL BIOCHEM, V105, P365, DOI 10.1002/jcb.21832; MacDonald N, 2005, MOL CELL, V20, P199, DOI 10.1016/j.molcel.2005.08.032; McCoy CE, 2005, BIOCHEM J, V387, P507, DOI 10.1042/BJ20041501; Mccoy CE, 2007, BIOCHEM J, V402, P491, DOI 10.1042/BJ20061183; Metivier R, 2003, CELL, V115, P751, DOI 10.1016/S0092-8674(03)00934-6; NUNEZ AM, 1989, EMBO J, V8, P823, DOI 10.1002/j.1460-2075.1989.tb03443.x; Perez-Cadahia B, 2011, J BIOL CHEM, V286, P42, DOI 10.1074/jbc.M110.156687; Prest SJ, 2002, FASEB J, V16, P592, DOI 10.1096/fj.01-0498fje; Rodrigues S, 2003, FASEB J, V17, P7, DOI 10.1096/fj.02-0201com; Rodrigues S, 2003, ONCOGENE, V22, P4488, DOI 10.1038/sj.onc.1206685; Roze E, 2008, FASEB J, V22, P1083, DOI 10.1096/fj.07-9814; Sewack GF, 1997, J BIOL CHEM, V272, P31118, DOI 10.1074/jbc.272.49.31118; Soloaga A, 2003, EMBO J, V22, P2788, DOI 10.1093/emboj/cdg273; Taube JH, 2010, P NATL ACAD SCI USA, V107, P15449, DOI 10.1073/pnas.1004900107; Thomson S, 1999, EMBO J, V18, P4779, DOI 10.1093/emboj/18.17.4779; Vermeulen L, 2009, TRENDS BIOCHEM SCI, V34, P311, DOI 10.1016/j.tibs.2009.02.007; Vicent GP, 2008, J STEROID BIOCHEM, V109, P344, DOI 10.1016/j.jsbmb.2008.03.015; Vicent GP, 2006, MOL CELL, V24, P367, DOI 10.1016/j.molcel.2006.10.011; WALTER W, 2008, MOL CELL BIOL; Wiggin GR, 2002, MOL CELL BIOL, V22, P2871, DOI 10.1128/MCB.22.8.2871-2881.2002; Winter S, 2008, EMBO J, V27, P88, DOI 10.1038/sj.emboj.7601954; Yuen HF, 2011, J PATHOL, V224, P78, DOI 10.1002/path.2859	47	12	14	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2013	8	5							e63189	10.1371/journal.pone.0063189	http://dx.doi.org/10.1371/journal.pone.0063189			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145RZ	23675462	Green Submitted, Green Published, gold			2022-12-27	WOS:000319036100030
J	Wang, Y; Du, HX; Xia, MR; Ren, L; Xu, M; Xie, T; Gong, GL; Xu, NY; Yang, HZ; He, Y				Wang, Yu; Du, Haixiao; Xia, Mingrui; Ren, Ling; Xu, Mo; Xie, Teng; Gong, Gaolang; Xu, Ningyi; Yang, Huazhong; He, Yong			A Hybrid CPU-GPU Accelerated Framework for Fast Mapping of High-Resolution Human Brain Connectome	PLOS ONE			English	Article							GRAPH-THEORETICAL ANALYSIS; SMALL-WORLD; FUNCTIONAL CONNECTIVITY; CORTICAL NETWORKS; MODULAR ORGANIZATION; ANATOMICAL NETWORKS; ARCHITECTURE; PARCELLATION; STABILITY; PATTERNS	Recently, a combination of non-invasive neuroimaging techniques and graph theoretical approaches has provided a unique opportunity for understanding the patterns of the structural and functional connectivity of the human brain (referred to as the human brain connectome). Currently, there is a very large amount of brain imaging data that have been collected, and there are very high requirements for the computational capabilities that are used in high-resolution connectome research. In this paper, we propose a hybrid CPU-GPU framework to accelerate the computation of the human brain connectome. We applied this framework to a publicly available resting-state functional MRI dataset from 197 participants. For each subject, we first computed Pearson's Correlation coefficient between any pairs of the time series of gray-matter voxels, and then we constructed unweighted undirected brain networks with 58 k nodes and a sparsity range from 0.02% to 0.17%. Next, graphic properties of the functional brain networks were quantified, analyzed and compared with those of 15 corresponding random networks. With our proposed accelerating framework, the above process for each network cost 80 similar to 150 minutes, depending on the network sparsity. Further analyses revealed that high-resolution functional brain networks have efficient small-world properties, significant modular structure, a power law degree distribution and highly connected nodes in the medial frontal and parietal cortical regions. These results are largely compatible with previous human brain network studies. Taken together, our proposed framework can substantially enhance the applicability and efficacy of high-resolution (voxel-based) brain network analysis, and have the potential to accelerate the mapping of the human brain connectome in normal and disease states.	[Wang, Yu; Du, Haixiao; Ren, Ling; Xu, Mo; Yang, Huazhong] Tsinghua Univ, Dept Elect Engn, Beijing 100084, Peoples R China; [Xia, Mingrui; Xie, Teng; Gong, Gaolang; He, Yong] Beijing Normal Univ, State Key Lab Cognit Neurosci & Learning, Beijing 100875, Peoples R China; [Xu, Ningyi] Microsoft Res Asia, Beijing, Peoples R China	Tsinghua University; Beijing Normal University; Microsoft; Microsoft Research Asia	He, Y (corresponding author), Beijing Normal Univ, State Key Lab Cognit Neurosci & Learning, Beijing 100875, Peoples R China.	yong.he@bnu.edu.cn	He, Yong/C-2161-2009; WANG, Yu/B-7985-2011; Xia, Mingrui/J-3267-2019; He, Yong/Q-5756-2018; , Teng/AAC-1774-2022	WANG, Yu/0000-0001-6108-5157; Xia, Mingrui/0000-0003-4615-9132; , Teng/0000-0002-3708-5189; He, Yong/0000-0002-7039-2850	Microsoft Research Asia, National Basic Research Program of China (973) [2013CB531004]; Beijing Natural Science Foundation [Z111107067311036]; Natural Science Foundation of China [81030028]; National Science Fund for Distinguished Young Scholars [81225012]	Microsoft Research Asia, National Basic Research Program of China (973); Beijing Natural Science Foundation(Beijing Natural Science Foundation); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science Fund for Distinguished Young Scholars(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars)	This work was supported by the Microsoft Research Asia, National Basic Research Program of China (973) (Grant No. 2013CB531004), Beijing Natural Science Foundation (Grant No. Z111107067311036), Natural Science Foundation of China (Grant No. 81030028) and National Science Fund for Distinguished Young Scholars (Grant No. 81225012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achard S, 2006, J NEUROSCI, V26, P63, DOI 10.1523/JNEUROSCI.3874-05.2006; Achard S, 2007, PLOS COMPUT BIOL, V3, P174, DOI 10.1371/journal.pcbi.0030017; Amunts K, 2005, ANAT EMBRYOL, V210, P343, DOI 10.1007/s00429-005-0025-5; Bassett DS, 2008, J NEUROSCI, V28, P9239, DOI 10.1523/JNEUROSCI.1929-08.2008; Behrens TEJ, 2003, MAGN RESON MED, V50, P1077, DOI 10.1002/mrm.10609; Bell M G H, 1997, Q APPL MATH, P17, DOI 10.1090/qam/102435; Brodmann K, 1909, VERGLEICHENDE LOKALI; Buckner RL, 2009, J NEUROSCI, V29, P1860, DOI 10.1523/JNEUROSCI.5062-08.2009; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Cecchi GA, 2007, BMC CELL BIOL, V8, DOI 10.1186/1471-2121-8-S1-S5; Chen ZJ, 2011, NEUROIMAGE, V56, P235, DOI 10.1016/j.neuroimage.2011.01.010; D'Alberto P, 2007, ALGORITHMICA, V47, P203, DOI 10.1007/s00453-006-1224-z; Dijkstra E.W, 1959, NUMER MATH, V1, P269, DOI DOI 10.1007/BF01386390; Dosenbach NUF, 2010, SCIENCE, V329, P1358, DOI 10.1126/science.1194144; Eguiluz VM, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.018102; Fair DA, 2008, P NATL ACAD SCI USA, V105, P4028, DOI 10.1073/pnas.0800376105; Fair DA, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000381; FLOYD RW, 1962, COMMUN ACM, V5, P345, DOI 10.1145/367766.368168; Gong GL, 2009, CEREB CORTEX, V19, P524, DOI 10.1093/cercor/bhn102; Guye M, 2010, MAGN RESON MATER PHY, V23, P409, DOI 10.1007/s10334-010-0205-z; Hagmann P, 2010, P NATL ACAD SCI USA, V107, P19067, DOI 10.1073/pnas.1009073107; Hagmann P, 2008, PLOS BIOL, V6, P1479, DOI 10.1371/journal.pbio.0060159; Hagmann P, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000597; Hayasaka S, 2010, NEUROIMAGE, V50, P499, DOI 10.1016/j.neuroimage.2009.12.051; He Y, 2008, J NEUROSCI, V28, P4756, DOI 10.1523/JNEUROSCI.0141-08.2008; He Y, 2007, CEREB CORTEX, V17, P2407, DOI 10.1093/cercor/bhl149; He Y, 2010, CURR OPIN NEUROL, V23, P341, DOI 10.1097/WCO.0b013e32833aa567; He Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005226; Jarrell TA, 2012, SCIENCE, V337, P437, DOI 10.1126/science.1221762; JOHNSON DB, 1977, J ACM, V24, P1, DOI 10.1145/321992.321993; Kotter R, 2003, NEURAL NETWORKS, V16, P1261, DOI 10.1016/j.neunet.2003.06.002; Liu Y, 2008, BRAIN, V131, P945, DOI 10.1093/brain/awn018; Lo CY, 2010, J NEUROSCI, V30, P16876, DOI 10.1523/JNEUROSCI.4136-10.2010; Margulies DS, 2009, P NATL ACAD SCI USA, V106, P20069, DOI 10.1073/pnas.0905314106; Maslov S, 2002, SCIENCE, V296, P910, DOI 10.1126/science.1065103; Matsumoto K, 2011, BLOCKED ALL PAIRS SH, P145; Meunier D, 2009, NEUROIMAGE, V44, P715, DOI 10.1016/j.neuroimage.2008.09.062; Mohsen A., 1978, Proceedings of the 8th European Microwave Conference, P433; Nath R, 2010, INT J HIGH PERFORM C, V24, P511, DOI 10.1177/1094342010385729; Nelson SM, 2010, NEURON, V67, P156, DOI 10.1016/j.neuron.2010.05.025; Newman MEJ, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.036104; Newman MEJ, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.066133; Owens JD, 2007, COMPUT GRAPH FORUM, V26, P80, DOI 10.1111/j.1467-8659.2007.01012.x; Pons P, 2005, LECT NOTES COMPUT SC, V3733, P284; Power JD, 2011, NEURON, V72, P665, DOI 10.1016/j.neuron.2011.09.006; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Rixner S, 1998, BANDWIDTH EFFICIENT, P3; RODGERS JL, 1988, AM STAT, V42, P59, DOI 10.2307/2685263; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Salvador R, 2005, CEREB CORTEX, V15, P1332, DOI 10.1093/cercor/bhi016; Sanz-Arigita EJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013788; Schwarz AJ, 2011, NEUROIMAGE, V55, P1132, DOI 10.1016/j.neuroimage.2010.12.047; Sporns O, 2000, CEREB CORTEX, V10, P127, DOI 10.1093/cercor/10.2.127; Sporns O, 2005, PLOS COMPUT BIOL, V1, P245, DOI 10.1371/journal.pcbi.0010042; Sporns O, 2011, ANN NY ACAD SCI, V1224, P109, DOI 10.1111/j.1749-6632.2010.05888.x; Stam CJ, 2010, J NEUROL SCI, V289, P128, DOI 10.1016/j.jns.2009.08.028; Supekar K, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000100; Tomasi D, 2010, P NATL ACAD SCI USA, V107, P9885, DOI 10.1073/pnas.1001414107; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Valencia M, 2009, CHAOS, V19, DOI 10.1063/1.3129783; van den Heuvel MP, 2008, NEUROIMAGE, V43, P528, DOI 10.1016/j.neuroimage.2008.08.010; van den Heuvel MP, 2011, J NEUROSCI, V31, P15775, DOI 10.1523/JNEUROSCI.3539-11.2011; van den Heuvel MP, 2009, J NEUROSCI, V29, P7619, DOI 10.1523/JNEUROSCI.1443-09.2009; Venkatamaran G, 2003, ACM J EXPT ALGORITHM, V8; Wang JH, 2009, HUM BRAIN MAPP, V30, P1511, DOI 10.1002/hbm.20623; WARSHALL S, 1962, J ACM, V9, P11, DOI 10.1145/321105.321107; Wen W, 2011, J NEUROSCI, V31, P1204, DOI 10.1523/JNEUROSCI.4085-10.2011; Wu D, 2010, P 2010 IEEE 16 INT C; Wu K, 2012, HUM BRAIN MAPP, V33, P552, DOI 10.1002/hbm.21232; Xia MR, 2011, BRAIN CONNECT, V1, P349, DOI 10.1089/brain.2011.0062; Yan CG, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00013; Yap PT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024678; Yuan K, 2010, NEUROSCI LETT, V477, P37, DOI 10.1016/j.neulet.2010.04.032; Zalesky A, 2011, BIOL PSYCHIAT, V69, P80, DOI 10.1016/j.biopsych.2010.08.022; Zalesky A, 2010, NEUROIMAGE, V50, P970, DOI 10.1016/j.neuroimage.2009.12.027; Zhang JR, 2011, BIOL PSYCHIAT, V70, P334, DOI 10.1016/j.biopsych.2011.05.018; Zhu CY, 2011, CLIN NEUROPHYSIOL, V122, P278, DOI 10.1016/j.clinph.2010.06.016; Zuo XN, 2012, CEREB CORTEX, V22, P1862, DOI 10.1093/cercor/bhr269; Zuo XN, 2011, NETWORK CENTRALITY H	79	210	211	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2013	8	5							e62789	10.1371/journal.pone.0062789	http://dx.doi.org/10.1371/journal.pone.0062789			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	143FO	23675425	Green Published, Green Submitted, gold			2022-12-27	WOS:000318852400010
J	Fujimura, T; Okanoya, K				Fujimura, Tomomi; Okanoya, Kazuo			Event-Related Potentials Elicited by Pre-Attentive Emotional Changes in Temporal Context	PLOS ONE			English	Article							VISUAL MISMATCH NEGATIVITY; FACIAL EXPRESSIONS; ERP; REGULARITIES; MOTIVATION; STIMULI; HUMANS; MEMORY; WORDS; FMRI	The ability to detect emotional change in the environment is essential for adaptive behavior. The current study investigated whether event-related potentials (ERPs) can reflect emotional change in a visual sequence. To assess pre-attentive processing, we examined visual mismatch negativity (vMMN): the negative potentials elicited by a deviant (infrequent) stimulus embedded in a sequence of standard (frequent) stimuli. Participants in two experiments pre-attentively viewed visual sequences of Japanese kanji with different emotional connotations while ERPs were recorded. The visual sequence in Experiment 1 consisted of neutral standards and two types of emotional deviants with a strong and weak intensity. Although the results indicated that strongly emotional deviants elicited more occipital negativity than neutral standards, it was unclear whether these negativities were derived from emotional deviation in the sequence or from the emotional significance of the deviants themselves. In Experiment 2, the two identical emotional deviants were presented against different emotional standards. One type of deviants was emotionally incongruent with the standard and the other type of deviants was emotionally congruent with the standard. The results indicated that occipital negativities elicited by deviants resulted from perceptual changes in a visual sequence at a latency of 100-200 ms and from emotional changes at latencies of 200-260 ms. Contrary to the results of the ERP experiment, reaction times to deviants showed no effect of emotional context; negative stimuli were consistently detected more rapidly than were positive stimuli. Taken together, the results suggest that brain signals can reflect emotional change in a temporal context.	[Fujimura, Tomomi; Okanoya, Kazuo] Japan Sci & Technol Agcy, Exploratory Res Adv Technol ERATO, Okanoya Emot Informat Project, Wako, Saitama, Japan; [Fujimura, Tomomi; Okanoya, Kazuo] RIKEN, Brain Sci Inst, Emot Informat Joint Res Lab, Wako, Saitama, Japan; [Okanoya, Kazuo] Univ Tokyo, Grad Sch Arts & Sci, Dept Life Sci, Meguro Ku, Tokyo, Japan	Japan Science & Technology Agency (JST); RIKEN; University of Tokyo	Okanoya, K (corresponding author), Japan Sci & Technol Agcy, Exploratory Res Adv Technol ERATO, Okanoya Emot Informat Project, Wako, Saitama, Japan.	cokanoya@mail.ecc.u-tokyo.ac.jp	Fujimura, Tomomi/N-6040-2016	Fujimura, Tomomi/0000-0002-4506-4337	Japan Science and Technology Agency, Exploratory Research for Advanced Technology, Okanoya Emotional Information Project; Grants-in-Aid for Scientific Research [24730639] Funding Source: KAKEN	Japan Science and Technology Agency, Exploratory Research for Advanced Technology, Okanoya Emotional Information Project; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work is supported by funding from the Japan Science and Technology Agency, Exploratory Research for Advanced Technology, Okanoya Emotional Information Project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Astikainen P, 2009, BEHAV BRAIN FUNCT, V5, DOI 10.1186/1744-9081-5-30; Berti S, 2001, COGNITIVE BRAIN RES, V10, P265, DOI 10.1016/S0926-6410(00)00044-6; Bradley MM, 2001, EMOTION, V1, P276, DOI 10.1037//1528-3542.1.3.276; CACIOPPO JT, 1994, J PERS SOC PSYCHOL, V67, P115, DOI 10.1037/0022-3514.67.1.115; Cuthbert BN, 2000, BIOL PSYCHOL, V52, P95, DOI 10.1016/S0301-0511(99)00044-7; Czigler I, 2004, NEUROSCI LETT, V364, P149, DOI 10.1016/j.neulet.2004.04.048; Czigler I, 2002, PSYCHOPHYSIOLOGY, V39, P869, DOI 10.1111/1469-8986.3960869; CZIGLER I, 1992, PSYCHOPHYSIOLOGY, V29, P471, DOI 10.1111/j.1469-8986.1992.tb01722.x; Czigler I, 2007, J PSYCHOPHYSIOL, V21, P224, DOI 10.1027/0269-8803.21.34.224; Gainotti G, 2012, NEUROPSYCHOLOGIA, V50, P205, DOI 10.1016/j.neuropsychologia.2011.12.005; Herbert C, 2008, PSYCHOPHYSIOLOGY, V45, P487, DOI 10.1111/j.1469-8986.2007.00638.x; Hirata M, 2007, NEUROIMAGE, V35, P420, DOI 10.1016/j.neuroimage.2006.11.025; Inaba M, 2005, INT J PSYCHOPHYSIOL, V57, P165, DOI 10.1016/j.ijpsycho.2005.01.002; Kimura M, 2012, CEREB CORTEX, V22, P1774, DOI 10.1093/cercor/bhr244; Kimura M, 2011, NEUROREPORT, V22, P669, DOI 10.1097/WNR.0b013e32834973ba; Kimura M, 2010, BRAIN RES, V1317, P165, DOI 10.1016/j.brainres.2009.12.076; Kissler J, 2007, PSYCHOL SCI, V18, P475, DOI 10.1111/j.1467-9280.2007.01924.x; Kissler J, 2009, BIOL PSYCHOL, V80, P75, DOI 10.1016/j.biopsycho.2008.03.004; Lang PJ, 1998, BIOL PSYCHIAT, V44, P1248, DOI 10.1016/S0006-3223(98)00275-3; Monk CS, 2003, NEUROIMAGE, V20, P420, DOI 10.1016/S1053-8119(03)00355-0; Morris JS, 1998, NATURE, V393, P467, DOI 10.1038/30976; Naatanen R, 1999, PSYCHOL BULL, V125, P826, DOI 10.1037/0033-2909.125.6.826; Ogawa T, 2004, JPN PSYCHOL RES, V46, P20, DOI 10.1111/j.1468-5884.2004.00233.x; Olofsson JK, 2008, BIOL PSYCHOL, V77, P247, DOI 10.1016/j.biopsycho.2007.11.006; Pazo-Alvarez P, 2003, BIOL PSYCHOL, V63, P199, DOI 10.1016/S0301-0511(03)00049-8; Sakaki M, 2012, COGN AFFECT BEHAV NE, V12, P115, DOI 10.3758/s13415-011-0062-x; Schacht A, 2009, COGN AFFECT BEHAV NE, V9, P28, DOI 10.3758/CABN.9.1.28; Schupp HT, 2006, PROG BRAIN RES, V156, P31, DOI 10.1016/S0079-6123(06)56002-9; Schupp HT, 2004, PSYCHOPHYSIOLOGY, V41, P441, DOI 10.1111/j.1469-8986.2004.00174.x; Schupp HT, 2003, PSYCHOL SCI, V14, P7, DOI 10.1111/1467-9280.01411; Scott GG, 2009, BIOL PSYCHOL, V80, P95, DOI 10.1016/j.biopsycho.2008.03.010; Simpson JR, 2000, J COGNITIVE NEUROSCI, V12, P157, DOI 10.1162/089892900564019; Stefanics G, 2012, NEUROIMAGE, V59, P3042, DOI 10.1016/j.neuroimage.2011.10.041; TIITINEN H, 1994, NATURE, V372, P90, DOI 10.1038/372090a0; Urakawa T, 2010, PSYCHOPHYSIOLOGY, V47, P905, DOI 10.1111/j.1469-8986.2010.00987.x; Waugh CE, 2011, EMOTION, V11, P1059, DOI 10.1037/a0021786; Wei JH, 2002, BRAIN RES BULL, V57, P221, DOI 10.1016/S0361-9230(01)00742-0; Yucel G, 2007, NEUROIMAGE, V34, P1245, DOI 10.1016/j.neuroimage.2006.08.050; Zhao L, 2006, NEUROSCI LETT, V410, P126, DOI 10.1016/j.neulet.2006.09.081	39	10	11	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2013	8	5							e63703	10.1371/journal.pone.0063703	http://dx.doi.org/10.1371/journal.pone.0063703			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	155HD	23671693	Green Published, gold, Green Submitted			2022-12-27	WOS:000319737700056
J	Kaipparettu, BA; Ma, YW; Park, JH; Lee, TL; Zhang, YQ; Yotnda, P; Creighton, CJ; Chan, WY; Wong, LJC				Kaipparettu, Benny Abraham; Ma, Yewei; Park, Jun Hyoung; Lee, Tin-Lap; Zhang, Yiqun; Yotnda, Patricia; Creighton, Chad J.; Chan, Wai-Yee; Wong, Lee-Jun C.			Crosstalk from Non-Cancerous Mitochondria Can Inhibit Tumor Properties of Metastatic Cells by Suppressing Oncogenic Pathways	PLOS ONE			English	Article							VITAMIN-E ANALOGS; DNA MUTATIONS; PATHOGENIC MUTATIONS; CANCER; APOPTOSIS; MTDNA; DEPLETION; DEATH	Mitochondrial-nucleus cross talks and mitochondrial retrograde regulation can play a significant role in cellular properties. Transmitochondrial cybrid systems (cybrids) are an excellent tool to study specific effects of altered mitochondria under a defined nuclear background. The majority of the studies using the cybrid model focused on the significance of specific mitochondrial DNA variations in mitochondrial function or tumor properties. However, most of these variants are benign polymorphisms without known functional significance. From an objective of rectifying mitochondrial defects in cancer cells and to establish mitochondria as a potential anticancer drug target, understanding the role of functional mitochondria in reversing oncogenic properties under a cancer nuclear background is very important. Here we analyzed the potential reversal of oncogenic properties of a highly metastatic cell line with the introduction of non-cancerous mitochondria. Cybrids were established by fusing the mitochondria DNA depleted 143B TK- rho 0 cells from an aggressive osteosarcoma cell line with mitochondria from benign breast epithelial cell line MCF10A, moderately metastatic breast cancer cell line MDA-MB-468 and 143B cells. In spite of the uniform cancerous nuclear background, as observed with the mitochondria donor cells, cybrids with benign mitochondria showed high mitochondrial functional properties including increased ATP synthesis, oxygen consumption and respiratory chain activities compared to cybrids with cancerous mitochondria. Interestingly, benign mitochondria could reverse different oncogenic characteristics of 143B TK- cell including cell proliferation, viability under hypoxic condition, anti-apoptotic properties, resistance to anti-cancer drug, invasion, and colony formation in soft agar, and in vivo tumor growth in nude mice. Microarray analysis suggested that several oncogenic pathways observed in cybrids with cancer mitochondria are inhibited in cybrids with non-cancerous mitochondria. These results suggest the critical oncogenic regulation by mitochondrial-nuclear cross talk and highlights rectifying mitochondrial functional properties as a promising target in cancer therapy.	[Kaipparettu, Benny Abraham; Ma, Yewei; Park, Jun Hyoung; Wong, Lee-Jun C.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Kaipparettu, Benny Abraham; Zhang, Yiqun; Creighton, Chad J.] Baylor Coll Med, Dan L Duncan Canc Ctr, Houston, TX 77030 USA; [Lee, Tin-Lap; Chan, Wai-Yee] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Sect Dev Gen, NIH, Bethesda, MD USA; [Lee, Tin-Lap; Chan, Wai-Yee] Chinese Univ Hong Kong, Sch Biomed Sci, Fac Med, Hong Kong, Hong Kong, Peoples R China; [Yotnda, Patricia] Baylor Coll Med, Ctr Gene Therapy, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Chinese University of Hong Kong; Baylor College of Medicine	Kaipparettu, BA (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA.	kaippare@bcm.edu; ljwong@bcm.edu	Lee, Tin-Lap/W-6595-2019; Lee, Tin-Lap/A-7853-2009; Zhang, YiQun/HCI-2427-2022; Chan, Wai Yee/R-7442-2018	Lee, Tin-Lap/0000-0002-6654-0988; Lee, Tin-Lap/0000-0002-6654-0988; Chan, Wai Yee/0000-0002-9714-0936; Kaipparettu, Benny/0000-0003-3444-4307	DOD [W81XWH-11-1-0292]; National Institutes of Health/National Cancer Institute (NIH/NCI) [U54-CA149196]; DLD Cancer Center Pilot Project; NIH/NCI grant [R01 CA-100023]; NATIONAL CANCER INSTITUTE [R01CA100023, U54CA149196] Funding Source: NIH RePORTER	DOD(United States Department of Defense); National Institutes of Health/National Cancer Institute (NIH/NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); DLD Cancer Center Pilot Project; NIH/NCI grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was partially supported by DOD (W81XWH-11-1-0292), National Institutes of Health/National Cancer Institute (NIH/NCI) (U54-CA149196 Pilot Project) and DLD Cancer Center Pilot Project to B. Kaipparettu and NIH/NCI (R01 CA-100023) grant to L. Wong. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANKARCRONA M, 1995, NEURON, V15, P961, DOI 10.1016/0896-6273(95)90186-8; Augenlicht LH, 2001, NAT GENET, V28, P104, DOI 10.1038/88800; Bayona-Bafaluy MP, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng100; Berridge MV, 1996, J IMMUNOL, V156, P4092; Biasutto L, 2010, MITOCHONDRION, V10, P670, DOI 10.1016/j.mito.2010.06.004; Chen X, 2010, NEUROSCIENCE, V165, P705, DOI 10.1016/j.neuroscience.2009.11.007; Chonghaile TN, 2011, SCIENCE, V334, P1129, DOI 10.1126/science.1206727; Creighton CJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001816; Dasgupta S, 2008, CANCER RES, V68, P700, DOI 10.1158/0008-5472.CAN-07-5532; Davids MS, 2012, J CLIN ONCOL, V30, P3127, DOI 10.1200/JCO.2011.37.0981; Dimmock D, 2010, CLIN CHEM, V56, P1119, DOI 10.1373/clinchem.2009.141549; Dong LF, 2007, CANCER RES, V67, P11906, DOI 10.1158/0008-5472.CAN-07-3034; Garber K, 2006, SCIENCE, V312, P1158, DOI 10.1126/science.312.5777.1158; Gatenby RA, 2004, NAT REV CANCER, V4, P891, DOI 10.1038/nrc1478; Ghelli A, 2003, J BIOL CHEM, V278, P4145, DOI 10.1074/jbc.M210285200; Ishikawa K, 2008, SCIENCE, V320, P661, DOI 10.1126/science.1156906; Kaipparettu BA, 2010, ANN NY ACAD SCI, V1201, P137, DOI 10.1111/j.1749-6632.2010.05621.x; KING MP, 1989, SCIENCE, V246, P500, DOI 10.1126/science.2814477; Kirches E, 2001, INT J CANCER, V93, P534, DOI 10.1002/ijc.1375; Kulawiec M, 2009, J HUM GENET, V54, P647, DOI 10.1038/jhg.2009.89; Liu VWS, 2001, CANCER RES, V61, P5998; Ma YW, 2010, BBA-BIOENERGETICS, V1797, P29, DOI 10.1016/j.bbabio.2009.07.008; McLennan HR, 2000, J BIOENERG BIOMEMBR, V32, P153, DOI 10.1023/A:1005507913372; Minocherhomji S, 2012, EPIGENETICS-US, V7, P326, DOI 10.4161/epi.19547; Modica-Napolitano JS, 2007, CURR MOL MED, V7, P121, DOI 10.2174/156652407779940495; Neuzil J, 2007, J BIOENERG BIOMEMBR, V39, P65, DOI 10.1007/s10863-006-9060-z; Neuzil J, 2013, MITOCHONDRION, V13, P199, DOI 10.1016/j.mito.2012.07.112; Ohta H, 2009, BRIT J CANCER, V100, P389, DOI 10.1038/sj.bjc.6604846; Petros JA, 2005, P NATL ACAD SCI USA, V102, P719, DOI 10.1073/pnas.0408894102; Shidara Y, 2005, CANCER RES, V65, P1655, DOI 10.1158/0008-5472.CAN-04-2012; Shock LS, 2011, P NATL ACAD SCI USA, V108, P3630, DOI 10.1073/pnas.1012311108; Tan DJ, 2003, GENE CHROMOSOME CANC, V37, P186, DOI 10.1002/gcc.10217; Tan DJ, 2002, CANCER RES, V62, P972; Tu YF, 2011, BBA-BIOENERGETICS, V1807, P1125, DOI 10.1016/j.bbabio.2011.04.015; Venegas V, 2011, CURR PROTOC HUM GENE, V19; Vithayathil SA, 2012, METHODS MOL BIOL, V837, P219, DOI 10.1007/978-1-61779-504-6_15; Wang J, 2009, MOL GENET METAB, V96, P59, DOI 10.1016/j.ymgme.2008.10.006; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Ware SM, 2009, J MED GENET, V46, P308, DOI 10.1136/jmg.2008.063149; Yamazaki H, 2008, ONCOL REP, V19, P1545; Yen HC, 2005, ANN NY ACAD SCI, V1042, P516, DOI 10.1196/annals.1338.047; Zhang JM, 2009, AM J RESP CELL MOL, V40, P135, DOI 10.1165/rcmb.2007-0277OC	42	64	65	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2013	8	5							e61747	10.1371/journal.pone.0061747	http://dx.doi.org/10.1371/journal.pone.0061747			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	155HD	23671572	Green Submitted, gold, Green Published			2022-12-27	WOS:000319737700005
J	Gaugue, I; Oberto, J; Putzer, H; Plumbridge, J				Gaugue, Isabelle; Oberto, Jacques; Putzer, Harald; Plumbridge, Jacqueline			The Use of Amino Sugars by Bacillus subtilis: Presence of a Unique Operon for the Catabolism of Glucosamine	PLOS ONE			English	Article							ESCHERICHIA-COLI K-12; PHOSPHOTRANSFERASE SYSTEM; N-ACETYLGLUCOSAMINE; N-ACETYLGLUCOSAMINE-6-PHOSPHATE DEACETYLASE; GLUCOSAMINE-6-PHOSPHATE DEAMINASE; 6-PHOSPHATE DEAMINASE; METABOLISM; EXPRESSION; GENE; GENOME	B. subtilis grows more rapidly using the amino sugar glucosamine as carbon source, than with N-acetylglucosamine. Genes for the transport and metabolism of N-acetylglucosamine (nagP and nagAB) are found in all the sequenced Bacilli (except Anoxybacillus flavithermus). In B. subtilis there is an additional operon (gamAP) encoding second copies of genes for the transport and catabolism of glucosamine. We have developed a method to make multiple deletion mutations in B. subtilis employing an excisable spectinomycin resistance cassette. Using this method we have analysed the contribution of the different genes of the nag and gam operons for their role in utilization of glucosamine and N-acetylglucosamine. Faster growth on glucosamine is due to the presence of the gamAP operon, which is strongly induced by glucosamine. Although the gamA and nagB genes encode isozymes of GlcN6P deaminase, catabolism of N-acetylglucosamine relies mostly upon the gamA gene product. The genes for use of N-acetylglucosamine, nagAB and nagP, are repressed by YvoA (NagR), a GntR family regulator, whose gene is part of the nagAB yvoA(nagR) operon. The gamAP operon is repressed by YbgA, another GntR family repressor, whose gene is expressed divergently from gamAP. The nagAB yvoA synton is found throughout the Bacilli and most firmicutes. On the other hand the ybgA-gamAP synton, which includes the ybgB gene for a small protein of unknown provenance, is only found in B. subtilis (and a few very close relatives). The origin of ybgBA-gamAP grouping is unknown but synteny analysis suggests lateral transfer from an unidentified donor. The presence of gamAP has enabled B. subtilis to efficiently use glucosamine as carbon source.	[Gaugue, Isabelle; Putzer, Harald; Plumbridge, Jacqueline] Univ Diderot, Sorbonne Paris Cite, Inst Biol Phys Chim, CNRS UPR9073, Paris, France; [Oberto, Jacques] Univ Paris 11, Inst Genet & Microbiol, CNRS UMR8621, F-91405 Orsay, France	UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Saclay	Plumbridge, J (corresponding author), Univ Diderot, Sorbonne Paris Cite, Inst Biol Phys Chim, CNRS UPR9073, Paris, France.	Jackie.Plumbridge@ibpc.fr	Putzer, Harald/GRY-6203-2022	Isabelle, Gaugue/0000-0001-6618-3899	CNRS; Universite Paris 7 Denis Diderot; GRONAG [ANR-09-BLAN-0399]	CNRS(Centre National de la Recherche Scientifique (CNRS)); Universite Paris 7 Denis Diderot; GRONAG	This work was supported by funds from the CNRS, Universite Paris 7 Denis Diderot and ANR-09-BLAN-0399 (GRONAG)(http://www.agence-nationale-recherche.fr/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alice AF, 2003, MICROBIOL-SGM, V149, P1687, DOI 10.1099/mic.0.26231-0; Alvarez-Anorve LI, 2009, J BACTERIOL, V191, P6401, DOI 10.1128/JB.00633-09; Alvarez-Anorve LI, 2005, J BACTERIOL, V187, P2974, DOI 10.1128/JB.187.9.2974-2982.2005; BATES CJ, 1965, BIOCHEM J, V96, P147, DOI 10.1042/bj0960147; BATES CJ, 1965, BIOCHEM J, V96, P155, DOI 10.1042/bj0960155; Bechhofer DH, 2008, METHOD ENZYMOL, V447, P259, DOI 10.1016/S0076-6879(08)02214-3; Bertram R, 2011, J BACTERIOL, V193, P3525, DOI 10.1128/JB.00264-11; Borriss R, 2011, INT J SYST EVOL MICR, V61, P1786, DOI 10.1099/ijs.0.023267-0; Bryksin AV, 2010, BIOTECHNIQUES, V48, P463, DOI 10.2144/000113418; CALCAGNO M, 1984, BIOCHIM BIOPHYS ACTA, V787, P165, DOI 10.1016/0167-4838(84)90076-1; Cao M, 2003, J BACTERIOL, V185, P4883, DOI 10.1128/JB.185.16.4883-4890.2003; Cho EK, 2011, BMB REP, V44, P193, DOI 10.5483/BMBRep.2011.44.3.193; CHOMCZYNSKI P, 1992, ANAL BIOCHEM, V201, P134, DOI 10.1016/0003-2697(92)90185-A; CLARKE JS, 1962, BIOCHEM J, V84, P185, DOI 10.1042/bj0840185; COMB DG, 1958, J BIOL CHEM, V232, P807; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; de Goes KCGP, 2012, J MICROBIOL BIOTECHN, V22, P437, DOI 10.4014/jmb.1109.09007; Despalins A, 2011, BIOINFORMATICS, V27, P2905, DOI 10.1093/bioinformatics/btr473; Deutscher J, 2006, MICROBIOL MOL BIOL R, V70, P939, DOI 10.1128/MMBR.00024-06; Earl AM, 2012, J BACTERIOL, V194, P2378, DOI 10.1128/JB.05675-11; Ferreira FM, 2006, J MOL BIOL, V359, P308, DOI 10.1016/j.jmb.2006.03.024; GueroutFleury AM, 1995, GENE, V167, P335, DOI 10.1016/0378-1119(95)00652-4; Hall RS, 2007, BIOCHEMISTRY-US, V46, P7942, DOI 10.1021/bi700543x; Hanson KG, 2002, MICROBIOL-SGM, V148, P1805, DOI 10.1099/00221287-148-6-1805; Harwood C., 1990, MOL BIOL METHODS BAC, P1; Herskovitz MA, 2000, MOL MICROBIOL, V38, P1027, DOI 10.1046/j.1365-2958.2000.02185.x; HEUSTERSPREUTE M, 1985, GENE, V39, P299, DOI 10.1016/0378-1119(85)90327-0; Horjales E, 1999, STRUCTURE, V7, P527, DOI 10.1016/S0969-2126(99)80069-0; Lerat E, 2003, PLOS BIOL, V1, P101, DOI 10.1371/journal.pbio.0000019; LERECLUS D, 1989, FEMS MICROBIOL LETT, V60, P211, DOI 10.1016/0378-1097(89)90511-9; Markowitz VM, 2009, BIOINFORMATICS, V25, P2271, DOI 10.1093/bioinformatics/btp393; MARTINVERSTRAETE I, 1990, J MOL BIOL, V214, P657, DOI 10.1016/0022-2836(90)90284-S; NEIDHARDT FC, 1974, J BACTERIOL, V119, P736, DOI 10.1128/JB.119.3.736-747.1974; Nicolas P, 2012, SCIENCE, V335, P1103, DOI 10.1126/science.1206848; Oberto J, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-4; Oliva G, 1995, STRUCTURE, V3, P1323, DOI 10.1016/S0969-2126(01)00270-2; Pennetier C, 2008, MOL MICROBIOL, V67, P364, DOI 10.1111/j.1365-2958.2007.06041.x; PLUMBRIDGE JA, 1993, J BACTERIOL, V175, P4951, DOI 10.1128/JB.175.16.4951-4956.1993; Postma P. W., 1996, ESCHERICHIA COLI SAL, V1, P1149; Reizer J, 1999, MICROBIOL-UK, V145, P3419, DOI 10.1099/00221287-145-12-3419; Resch M, 2010, NUCLEIC ACIDS RES, V38, P2485, DOI 10.1093/nar/gkp1191; Rigali S, 2008, EMBO REP, V9, P670, DOI 10.1038/embor.2008.83; Sampson MN, 1998, MICROBIOL-SGM, V144, P2189, DOI 10.1099/00221287-144-8-2189; Souza JM, 1997, ARCH BIOCHEM BIOPHYS, V340, P338, DOI 10.1006/abbi.1997.9780; STRAGIER P, 1988, CELL, V52, P697, DOI 10.1016/0092-8674(88)90407-2; Stulke J, 1997, MOL MICROBIOL, V25, P65, DOI 10.1046/j.1365-2958.1997.4351797.x; Tremblay LW, 2006, BIOCHEMISTRY-US, V45, P1183, DOI 10.1021/bi051842j; Tsigos I, 2000, TRENDS BIOTECHNOL, V18, P305, DOI 10.1016/S0167-7799(00)01462-1; Tyson GW, 2004, NATURE, V428, P37, DOI 10.1038/nature02340; UZAN M, 1988, P NATL ACAD SCI USA, V85, P8895, DOI 10.1073/pnas.85.23.8895; Vincent F, 2005, J BIOL CHEM, V280, P19649, DOI 10.1074/jbc.M502131200; Vincent F, 2004, J BIOL CHEM, V279, P2809, DOI 10.1074/jbc.M310165200; Vlamakis H, 2013, NAT REV MICROBIOL, V11, P157, DOI 10.1038/nrmicro2960; VOGLER AP, 1989, MOL GEN GENET, V219, P97, DOI 10.1007/BF00261163; Wang SL, 2006, CARBOHYD RES, V341, P2507, DOI 10.1016/j.carres.2006.06.027; WHITE RJ, 1968, BIOCHEM J, V106, P847, DOI 10.1042/bj1060847	56	30	30	3	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2013	8	5							e63025	10.1371/journal.pone.0063025	http://dx.doi.org/10.1371/journal.pone.0063025			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145YI	23667565	Green Published, gold, Green Submitted			2022-12-27	WOS:000319055600054
J	Ribeiro, WS; Mari, JD; Quintana, MI; Dewey, ME; Evans-Lacko, S; Vilete, LMP; Figueira, I; Bressan, RA; de Mello, MF; Prince, M; Ferri, CP; Coutinho, ESF; Andreoli, SB				Ribeiro, Wagner Silva; Mari, Jair de Jesus; Quintana, Maria Ines; Dewey, Michael E.; Evans-Lacko, Sara; Pereira Vilete, Liliane Maria; Figueira, Ivan; Bressan, Rodrigo Affonseca; de Mello, Marcelo Feijo; Prince, Martin; Ferri, Cleusa P.; Freire Coutinho, Evandro Silva; Andreoli, Sergio Baxter			The Impact of Epidemic Violence on the Prevalence of Psychiatric Disorders in Sao Paulo and Rio de Janeiro, Brazil	PLOS ONE			English	Article							POSTTRAUMATIC-STRESS-DISORDER; ICD-10 MENTAL-DISORDERS; DSM-IV; 12-MONTH PREVALENCE; LIFETIME PREVALENCE; TRAUMA; DEPRESSION; GENDER; MEXICO; MORBIDITY	Background: Violence and other traumatic events, as well as psychiatric disorders are frequent in developing countries, but there are few population studies to show the actual impact of traumatic events in the psychiatric morbidity in low and middle-income countries (LMIC). Aims: To study the relationship between traumatic events and prevalence of mental disorders in Sao Paulo and Rio de Janeiro, Brazil. Methods: Cross-sectional survey carried out in 2007-2008 with a probabilistic representative sample of 15- to 75-year-old residents in Sao Paulo and Rio de Janeiro, Brazil, using the Composite International Diagnostic Interview. Results: The sample comprised 3744 interviews. Nearly 90% of participants faced lifetime traumatic events. Lifetime prevalence of any disorders was 44% in Sao Paulo and 42.1% in Rio de Janeiro. One-year estimates were 32.5% and 31.2%. One-year prevalence of traumatic events was higher in Rio de Janeiro than Sao Paulo (35.1 vs. 21.7; p<0.001). Participants from Rio de Janeiro were less likely to have alcohol dependence (OR = 0.55; p = 0.027), depression (OR = 0.6; p = 0.006) generalized anxiety (OR = 0.59; p = 0.021) and post-traumatic stress disorder (OR = 0.62; p = 0.027). Traumatic events correlated with all diagnoses -e.g. assaultive violence with alcohol dependence (OR = 5.7; p<0.001) and with depression (OR = 1.7; p = 0.001). Conclusion: Our findings show that psychiatric disorders and traumatic events, especially violence, are extremely common in Sao Paulo and Rio de Janeiro, supporting the idea that neuropsychiatric disorders and external causes have become a major public health priority, as they are amongst the leading causes of burden of disease in low and middle-income countries. The comparison between the two cities regarding patterns of violence and psychiatric morbidity suggests that environmental factors may buffer the negative impacts of traumatic events. Identifying such factors might guide the implementation of interventions to improve mental health and quality of life in LMIC urban centers.	[Ribeiro, Wagner Silva; Mari, Jair de Jesus; Quintana, Maria Ines; Bressan, Rodrigo Affonseca; de Mello, Marcelo Feijo; Andreoli, Sergio Baxter] Univ Fed Sao Paulo, Dept Psiquiatria, Sao Paulo, Brazil; [Ribeiro, Wagner Silva; Mari, Jair de Jesus; Dewey, Michael E.; Evans-Lacko, Sara; Prince, Martin; Ferri, Cleusa P.] Kings Coll London, Hlth Serv & Populat Res Dept, Inst Psychiat, London WC2R 2LS, England; [Pereira Vilete, Liliane Maria; Freire Coutinho, Evandro Silva] Fundacao Oswaldo Cruz, Escola Nacl Saude Publ, Rio De Janeiro, Brazil; [Figueira, Ivan] Univ Fed Rio de Janeiro, Inst Psiquiatria, Rio De Janeiro, Brazil	Universidade Federal de Sao Paulo (UNIFESP); University of London; King's College London; Fundacao Oswaldo Cruz; Universidade Federal do Rio de Janeiro	Ribeiro, WS (corresponding author), Univ Fed Sao Paulo, Dept Psiquiatria, Sao Paulo, Brazil.	wagner.ribeiro@me.com	Evans-Lacko, Sara/A-8768-2011; Ribeiro, Wagner Silva/O-2927-2018; de Jesus Mari, Jair/A-7309-2008; Andreoli, Sergio Baxter/D-9568-2012; Ferri, Cleusa Pinheiro/B-2922-2010; Prince, Martin J/A-9170-2010; Bressan, Rodrigo A/E-9178-2010; Andreoli, Sergio Baxter/M-7112-2019; Evans-Lacko, Sara/F-8489-2014; Dewey, Michael E/E-2049-2010; Quintana, Maria Ines/F-6320-2012	Evans-Lacko, Sara/0000-0003-4691-2630; Ribeiro, Wagner Silva/0000-0001-6735-3861; de Jesus Mari, Jair/0000-0002-5403-0112; Andreoli, Sergio Baxter/0000-0002-1976-0881; Ferri, Cleusa Pinheiro/0000-0002-1815-7685; Prince, Martin J/0000-0003-1379-7146; Bressan, Rodrigo A/0000-0002-0868-4449; Andreoli, Sergio Baxter/0000-0002-1976-0881; Evans-Lacko, Sara/0000-0003-4691-2630; Dewey, Michael E/0000-0002-7522-3677; Coutinho, Evandro/0000-0002-4649-7353; Quintana, Maria Ines/0000-0002-3808-8189	State of Sao Paulo Research Foundation - FAPESP [2004/15039-0]; National Research and Technology Development Council - CNPq [420122/2005-2]; CNPQ [141467/2007-0]; Brazilian Coordination for Improvement of Faculty Personnel - CAPES [Proc.4516/07-9]	State of Sao Paulo Research Foundation - FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); National Research and Technology Development Council - CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CNPQ(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Brazilian Coordination for Improvement of Faculty Personnel - CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This study was supported by the State of Sao Paulo Research Foundation -FAPESP (www.fapesp.br) through the grant 2004/15039-0, and the National Research and Technology Development Council - CNPq (www.cnpq.br) through the grant 420122/2005-2. Wagner Ribeiro received a doctorate scholarship from CNPQ (141467/2007-0) and a one-year scholarship from the Brazilian Coordination for Improvement of Faculty Personnel - CAPES (www.capes.gov.br), Proc.4516/07-9, for a one-year training at the Institute of Psychiatry - King's College London. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida N, 1997, BRIT J PSYCHIAT, V171, P524, DOI 10.1192/bjp.171.6.524; Alonso J, 2004, ACTA PSYCHIAT SCAND, V109, P21; Andrade L, 2002, SOC PSYCH PSYCH EPID, V37, P316, DOI 10.1007/s00127-002-0551-x; Andrade LH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031879; [Anonymous], 2000, Bull World Health Organ, V78, P413; Baker CK, 2005, SOC PSYCH PSYCH EPID, V40, P519, DOI 10.1007/s00127-005-0921-2; Breslau N, 2004, PSYCHOL MED, V34, P889, DOI 10.1017/S0033291703001612; Breslau N, 2008, ARCH GEN PSYCHIAT, V65, P431, DOI 10.1001/archpsyc.65.4.431; Bressan RA, 2009, BMC PSYCHIATRY, V9, DOI 10.1186/1471-244X-9-30; Cardia N, 2003, HLTH HUMAN RIGHTS, V6, P2; Central Intelligence Agency, 2011, WORLD FACTB COUNTR C; de Vries S, 2003, ENVIRON PLANN A, V35, P1717, DOI 10.1068/a35111; Eaton NR, 2012, J ABNORM PSYCHOL, V121, P282, DOI 10.1037/a0024780; [IBGE Instituto Brasileiro de Geografia e Estatistica], 2010, CENS 2010 POP BRAS 1; IBGE-INSTITUTO BRASILEIRO DE GEOGRAFIA E ESTATISTICA, 2009, SINT IND SOC AN COND; Icaza MEMM, 2005, SALUD PUBLICA MEXICO, V47, P8, DOI 10.1590/S0036-36342005000100004; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593; KESSLER RC, 1994, ARCH GEN PSYCHIAT, V51, P8; KISH L, 1949, J AM STAT ASSOC, V44, P380, DOI 10.2307/2280236; Krueger RF, 1999, ARCH GEN PSYCHIAT, V56, P921, DOI 10.1001/archpsyc.56.10.921; Ludermir AB, 2008, SOC SCI MED, V66, P1008, DOI 10.1016/j.socscimed.2007.10.021; de Souza MDM, 2007, HEALTH AFFAIR, V26, P575, DOI 10.1377/hlthaff.26.2.575; MCFARLANE AC, 1989, BRIT J PSYCHIAT, V154, P221, DOI 10.1192/bjp.154.2.221; Medina-Mora ME, 2007, BRIT J PSYCHIAT, V190, P521, DOI 10.1192/bjp.bp.106.025841; Medina-Mora ME, 2005, PSYCHOL MED, V35, P1773, DOI 10.1017/S0033291705005672; Mello MF, 2009, BMC PSYCHIATRY, V9, DOI 10.1186/1471-244X-9-28; Norris FH, 2003, J ABNORM PSYCHOL, V112, P646, DOI 10.1037/0021-843X.112.4.646; Omran AR, 2005, MILBANK Q, V83, P731, DOI 10.1111/j.1468-0009.2005.00398.x; Pedersen D, 2008, SOC SCI MED, V67, P205, DOI 10.1016/j.socscimed.2008.03.040; Post RM, 1998, BIOL PSYCHIAT, V44, P193, DOI 10.1016/S0006-3223(98)00144-9; Quintana MI, 2007, REV BRAS PSIQUIATR, V29, P18, DOI 10.1590/S1516-44462007000100007; Reichenheim ME, 2011, LANCET, V377, P1962, DOI 10.1016/S0140-6736(11)60053-6; Ribeiro WS, 2009, REV BRAS PSIQUIATR, V31, P549; Roberts B, 2008, BMC PSYCHIATRY, V8, DOI 10.1186/1471-244X-8-38; Rubio-Stipec M, 1991, Acta Psiquiatr Psicol Am Lat, V37, P191; Schmidt MI, 2011, LANCET, V377, P1949, DOI 10.1016/S0140-6736(11)60135-9; Schraedley PK, 2002, J HEALTH SOC BEHAV, V43, P307, DOI 10.2307/3090206; Schramm Joyce Mendes de Andrade, 2004, Ciênc. saúde coletiva, V9, P897, DOI 10.1590/S1413-81232004000400011; Seedat S, 2009, ARCH GEN PSYCHIAT, V66, P785, DOI 10.1001/archgenpsychiatry.2009.36; Slade T, 2006, PSYCHOL MED, V36, P1593, DOI 10.1017/S0033291706008452; Suliman S, 2009, COMPR PSYCHIAT, V50, P121, DOI 10.1016/j.comppsych.2008.06.006; United Nations Development Programme, 2010, HUM DEV REP 2010 205; Vicente B, 2006, AM J PSYCHIAT, V163, P1362, DOI 10.1176/appi.ajp.163.8.1362; Waiselfisz JJ, 2011, MAPA VILENCIA 2011 J; *WHO, 1997, COMP INT DIAGN INT V; World Bank, 2010, GDP RANK; Zlotnick C, 2006, PSYCHOL MED, V36, P1523, DOI 10.1017/S0033291706008282	47	80	81	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2013	8	5							e63545	10.1371/journal.pone.0063545	http://dx.doi.org/10.1371/journal.pone.0063545			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	145YI	23667636	Green Submitted, Green Published, gold			2022-12-27	WOS:000319055600063
J	Usatyuk, PV; Burns, M; Mohan, V; Pendyala, S; He, DH; Ebenezer, DL; Harijith, A; Fu, PF; Huang, LS; Bear, JE; Garcia, JGN; Natarajan, V				Usatyuk, Peter V.; Burns, Michael; Mohan, Vijay; Pendyala, Srikanth; He, Donghong; Ebenezer, David L.; Harijith, Anantha; Fu, Panfeng; Huang, Long Shuang; Bear, James E.; Garcia, Joe G. N.; Natarajan, Viswanathan			Coronin 1B Regulates S1P-Induced Human Lung Endothelial Cell Chemotaxis: Role of PLD2, Protein Kinase C and Rac1 Signal Transduction	PLOS ONE			English	Article							STRESS FIBER FORMATION; BRONCHIAL EPITHELIAL-CELLS; PHOSPHOLIPASE-D ACTIVITY; ACTIN-BINDING-PROTEIN; SPHINGOSINE 1-PHOSPHATE; PHOSPHATIDIC-ACID; NUCLEOTIDE EXCHANGE; INTRACELLULAR TRAFFICKING; INTERLEUKIN-8 SECRETION; NADPH OXIDASE	Coronins are a highly conserved family of actin binding proteins that regulate actin-dependent processes such as cell motility and endocytosis. We found that treatment of human pulmonary artery endothelial cells (HPAECs) with the bioactive lipid, sphingosine-1-phosphate (S1P) rapidly stimulates coronin 1B translocation to lamellipodia at the cell leading edge, which is required for S1P-induced chemotaxis. Further, S1P-induced chemotaxis of HPAECs was attenuated by pretreatment with small interfering RNA (siRNA) targeting coronin 1B (similar to 36%), PLD2 (similar to 45%) or Rac1 (similar to 50%) compared to scrambled siRNA controls. Down regulation PLD2 expression by siRNA also attenuated S1P-induced coronin 1B translocation to the leading edge of the cell periphery while PLD1 silencing had no effect. Also, S1P-induced coronin 1B redistribution to cell periphery and chemotaxis was attenuated by inhibition of Rac1 and over-expression of dominant negative PKC delta, epsilon and zeta isoforms in HPAECs. These results demonstrate that S1P activation of PLD2, PKC and Rac1 is part of the signaling cascade that regulates coronin 1B translocation to the cell periphery and the ensuing cell chemotaxis.	[Usatyuk, Peter V.; Burns, Michael; Mohan, Vijay; Pendyala, Srikanth; He, Donghong; Ebenezer, David L.; Fu, Panfeng; Huang, Long Shuang; Garcia, Joe G. N.; Natarajan, Viswanathan] Univ Illinois, Inst Personalized Resp Med, Chicago, IL 60680 USA; [Usatyuk, Peter V.; Mohan, Vijay; Pendyala, Srikanth; He, Donghong; Ebenezer, David L.; Fu, Panfeng; Huang, Long Shuang; Natarajan, Viswanathan] Univ Illinois, Dept Pharmacol, Chicago, IL USA; [Harijith, Anantha] Univ Illinois, Dept Pediat, Chicago, IL USA; [Bear, James E.] Univ N Carolina, Dept Cell & Dev Biol, Chapel Hill, NC USA; [Garcia, Joe G. N.; Natarajan, Viswanathan] Univ Illinois, Dept Med, Chicago, IL USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of North Carolina; University of North Carolina Chapel Hill; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Natarajan, V (corresponding author), Univ Illinois, Inst Personalized Resp Med, Chicago, IL 60680 USA.	visnatar@uic.edu	Harijith, Anantha/AAA-5708-2021; Fu, Panfeng/F-7345-2015; Huang, Longshuang/H-9553-2016	Fu, Panfeng/0000-0001-8813-9258; 	National Institutes of Health [P01 HL 98050]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL058064, P01HL098050] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health grant P01 HL 98050 to VN. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Amiri A, 2007, MOL CANCER RES, V5, P933, DOI 10.1158/1541-7786.MCR-06-0362; Argraves Kelley M, 2010, World J Biol Chem, V1, P291, DOI 10.4331/wjbc.v1.i10.291; Berdyshev EV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016571; Brieher WM, 2006, J CELL BIOL, V175, P315, DOI 10.1083/jcb.200603149; Cai L, 2005, J BIOL CHEM, V280, P31913, DOI 10.1074/jbc.M504146200; Cai L, 2008, CELL, V134, P828, DOI 10.1016/j.cell.2008.06.054; Chen Q, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2003257; Clarke M, 2006, MOL BIOL CELL, V17, P4866, DOI 10.1091/mbc.E06-04-0365; Cockcroft S, 2009, BBA-MOL CELL BIOL L, V1791, P905, DOI 10.1016/j.bbalip.2009.03.007; Cummings R, 2002, MOL CELL BIOCHEM, V234, P99, DOI 10.1023/A:1015944828973; Cummings RJ, 2002, J BIOL CHEM, V277, P30227, DOI 10.1074/jbc.M111078200; DEHOSTOS EL, 1991, EMBO J, V10, P4097, DOI 10.1002/j.1460-2075.1991.tb04986.x; DEHOSTOS EL, 1993, J CELL BIOL, V120, P163, DOI 10.1083/jcb.120.1.163; Desire L, 2005, J BIOL CHEM, V280, P37516, DOI 10.1074/jbc.M507913200; Du GW, 2004, MOL BIOL CELL, V15, P1024, DOI 10.1091/mbc.E03-09-0673; English D, 2000, FASEB J, V14, P2255, DOI 10.1096/fj.00-0134com; Erickson RW, 1999, J BIOL CHEM, V274, P22243, DOI 10.1074/jbc.274.32.22243; Estrada R, 2008, J BIOL CHEM, V283, P30363, DOI 10.1074/jbc.M804392200; Foger N, 2006, SCIENCE, V313, P839, DOI 10.1126/science.1130563; Freyberg Z, 2001, MOL BIOL CELL, V12, P943, DOI 10.1091/mbc.12.4.943; Gao Y, 2004, P NATL ACAD SCI USA, V101, P7618, DOI 10.1073/pnas.0307512101; GERISCH G, 1995, CURR BIOL, V5, P1280, DOI 10.1016/S0960-9822(95)00254-5; Gil Pilar Rivera, 2010, Cytoskeleton (Hoboken), V67, P773, DOI 10.1002/cm.20486; Gorshkova I, 2008, J BIOL CHEM, V283, P11794, DOI 10.1074/jbc.M800250200; Hammad SM, 2010, J LIPID RES, V51, P3074, DOI 10.1194/jlr.D008532; Harrington EO, 1997, J BIOL CHEM, V272, P7390, DOI 10.1074/jbc.272.11.7390; Hashimoto M, 2008, AM J RESP CELL MOL, V39, P356, DOI 10.1165/rcmb.2006-0427OC; Hashimoto Y, 2008, BBA-MOL CELL RES, V1783, P153, DOI 10.1016/j.bbamcr.2007.08.011; Hilpela P, 2004, CURR TOP MICROBIOL, V282, P117; Hirai T, 2003, J BIOCHEM, V133, P1, DOI 10.1093/jb/mvg017; Hotulainen P, 2005, MOL BIOL CELL, V16, P649, DOI 10.1091/mbc.E04-07-0555; Humphries CL, 2002, J CELL BIOL, V159, P993, DOI 10.1083/jcb.200206113; Iglesias PA, 2008, CURR OPIN CELL BIOL, V20, P35, DOI 10.1016/j.ceb.2007.11.011; Jarquin-Pardo M, 2007, J CELL BIOCHEM, V100, P112, DOI 10.1002/jcb.21027; Jenkins GM, 2005, CELL MOL LIFE SCI, V62, P2305, DOI 10.1007/s00018-005-5195-z; Jeon H, 2011, CELL SIGNAL, V23, P1320, DOI 10.1016/j.cellsig.2011.03.014; Jones DR, 2000, FEBS LETT, V476, P160, DOI 10.1016/S0014-5793(00)01702-6; Kam Y, 2001, MOL CELL BIOL, V21, P4055, DOI 10.1128/MCB.21.12.4055-4066.2001; Knapek K, 2010, MOL CELL BIOL, V30, P4492, DOI 10.1128/MCB.00229-10; Koh E, 2007, CELL SIGNAL, V19, P1328, DOI 10.1016/j.cellsig.2007.01.005; Komati H, 2005, MOL BIOL CELL, V16, P1232, DOI 10.1091/mbc.E04-06-0459; Kueh HY, 2008, J CELL BIOL, V182, P341, DOI 10.1083/jcb.200801027; Lauffenburger DA, 1996, CELL, V84, P359, DOI 10.1016/S0092-8674(00)81280-5; Lee JF, 2006, J BIOL CHEM, V281, P29190, DOI 10.1074/jbc.M604310200; Lee MJ, 1999, CELL, V99, P301, DOI 10.1016/S0092-8674(00)81661-X; Li Z, 2005, PROSTAG OTH LIPID M, V76, P95, DOI 10.1016/j.prostaglandins.2005.02.002; LIMATOLA C, 1994, BIOCHEM J, V304, P1001, DOI 10.1042/bj3041001; Liscovitch M, 1996, J LIPID MEDIAT CELL, V14, P215, DOI 10.1016/0929-7855(96)00528-7; Mahankali M, 2011, P NATL ACAD SCI USA, V108, P19617, DOI 10.1073/pnas.1114692108; MANIAK M, 1995, CELL, V83, P915, DOI 10.1016/0092-8674(95)90207-4; Mao YS, 2007, PFLUG ARCH EUR J PHY, V455, P5, DOI 10.1007/s00424-007-0286-3; Min J, MOL PHARM, V80, P760; Mishima M, 1999, J CELL SCI, V112, P2833; Morris AJ, 2007, BIOCHEM SOC SYMP, V74, P247, DOI 10.1042/BSS2007c20; Natarajan V, 1996, CHEM PHYS LIPIDS, V80, P103, DOI 10.1016/0009-3084(96)02548-0; NATARAJAN V, 1994, AM J RESP CELL MOL, V11, P221, DOI 10.1165/ajrcmb.11.2.8049083; Okamoto H, 2000, THROMB RES, V99, P259, DOI 10.1016/S0049-3848(00)00251-6; Oubaha M, 2012, BLOOD, V120, P3371, DOI 10.1182/blood-2012-03-419721; Paik JH, 2001, J BIOL CHEM, V276, P11830, DOI 10.1074/jbc.M009422200; Parri M, 2010, CELL COMMUN SIGNAL, V8, DOI 10.1186/1478-811X-8-23; Pfaendtner J, 2010, P NATL ACAD SCI USA, V107, P7299, DOI 10.1073/pnas.0911675107; Pilquil C, 2006, J BIOL CHEM, V281, P38418, DOI 10.1074/jbc.M601670200; Porcelli AM, 2002, CELL SIGNAL, V14, P75, DOI 10.1016/S0898-6568(01)00222-4; Regier DS, 2000, J BIOL CHEM, V275, P28406, DOI 10.1074/jbc.M004703200; SADAHIRA Y, 1992, P NATL ACAD SCI USA, V89, P9686, DOI 10.1073/pnas.89.20.9686; Sauer B, 2004, J BIOL CHEM, V279, P38471, DOI 10.1074/jbc.M313557200; Snider AJ, 2010, AM J PHYSIOL-CELL PH, V298, pC163, DOI 10.1152/ajpcell.00001.2009; Spiering D, 2011, CELL ADHES MIGR, V5, P170, DOI 10.4161/cam.5.2.14403; Sun XG, 2012, AM J RESP CELL MOL, V47, P628, DOI 10.1165/rcmb.2012-0048OC; Takuwa Y, 2008, BBA-MOL CELL BIOL L, V1781, P483, DOI 10.1016/j.bbalip.2008.04.003; TILNEY LG, 1981, J CELL BIOL, V90, P485, DOI 10.1083/jcb.90.2.485; Usatyuk PV, 2009, J BIOL CHEM, V284, P15339, DOI 10.1074/jbc.M109.005439; Usatyuk PV KS, 2012, PULM CIRCUL IN PRESS; Van Brocklyn JR, 2003, CANCER LETT, V199, P53, DOI 10.1016/S0304-3835(03)00334-3; Venkataraman K, 2008, CIRC RES, V102, P669, DOI 10.1161/CIRCRESAHA.107.165845; Wang L, 2008, HISTOCHEM CELL BIOL, V129, P579, DOI 10.1007/s00418-008-0389-8; Wang LX, 2002, BIOCHEM J, V367, P751, DOI 10.1042/BJ20020586; Wegener J, 2000, EXP CELL RES, V259, P158, DOI 10.1006/excr.2000.4919; Williams HC, 2012, CIRC RES, V111, P56, DOI 10.1161/CIRCRESAHA.111.255745; Williams Michael J, 2012, Small GTPases, V3, P1, DOI 10.4161/sgtp.20335; Wu M, 2010, TOXICOL LETT, V196, P168, DOI 10.1016/j.toxlet.2010.04.014; Ruiz-Loredo AY, 2011, J CELL PHYSIOL, V226, P414, DOI 10.1002/jcp.22347; Zeiller C, 2009, BBA-MOL CELL RES, V1793, P1236, DOI 10.1016/j.bbamcr.2009.04.001; Zheng Y, 2006, J BIOL CHEM, V281, P15862, DOI 10.1074/jbc.M600660200	84	16	17	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2013	8	5							e63007	10.1371/journal.pone.0063007	http://dx.doi.org/10.1371/journal.pone.0063007			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145YI	23667561	gold, Green Published, Green Submitted			2022-12-27	WOS:000319055600051
J	Jessopp, M; Cronin, M; Hart, T				Jessopp, Mark; Cronin, Michelle; Hart, Tom			Habitat-Mediated Dive Behavior in Free-Ranging Grey Seals	PLOS ONE			English	Article							FORAGING BEHAVIOR; DIET; TRACKING; PREY; ASSOCIATIONS; ACCURACY; GPS	Understanding the links between foraging behaviour and habitat use of key species is essential to addressing fundamental questions about trophic interactions and ecosystem functioning. Eight female grey seals (Halichoerus grypus) were equipped with time-depth recorders linked to Fastloc GPS tags following the annual moult in southwest Ireland. Individual dives were coupled with environmental correlates to investigate the habitat use and dive behaviour of free-ranging seals. Dives were characterised as either pelagic, benthic, or shallow (where errors in location and charted water depth made differentiating between pelagic and benthic dives unreliable). Sixty-nine percent of dives occurring in water >50 m were benthic. Pelagic dives were more common at night than during the day. Seals performed more pelagic dives over fine sediments (mud/sand), and more benthic dives when foraging over more three-dimensionally complex rock substrates. We used Markov chain analysis to determine the probability of transiting between dive states. A low probability of repeat pelagic dives suggests that pelagic prey were encountered en route to the seabed. This approach could be applied to make more accurate predictions of habitat use in data-poor areas, and investigate contentious issues such as resource overlap and competition between top predators and fisheries, essential for the effective conservation of these key marine species.	[Jessopp, Mark; Cronin, Michelle] Natl Univ Ireland Univ Coll Cork, Coastal & Marine Res Ctr, Environm Res Inst, Cork, Ireland; [Hart, Tom] Univ Oxford, Dept Zool, Oxford OX1 3PS, England	University College Cork; University of Oxford	Jessopp, M (corresponding author), Natl Univ Ireland Univ Coll Cork, Coastal & Marine Res Ctr, Environm Res Inst, Cork, Ireland.	mjessopp@gmail.com	Jessopp, Mark/AAI-4786-2020	Jessopp, Mark/0000-0002-2692-3730	Beaufort Marine Research Award; Strategy for Science Technology and Innovation; Marine Institute; Marine Research Sub-Programme of the National Development Plan; Higher Education Authority Ireland [PTRLI4]	Beaufort Marine Research Award; Strategy for Science Technology and Innovation; Marine Institute; Marine Research Sub-Programme of the National Development Plan; Higher Education Authority Ireland	MJ and MC were supported by a Beaufort Marine Research Award carried out under the Sea Change Strategy and the Strategy for Science Technology and Innovation (2006-2013), with the support of the Marine Institute, funded under the Marine Research Sub-Programme of the National Development Plan 2007-2013, and Higher Education Authority Ireland PTRLI4 funding mechanism. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson TJ, 2009, J EXP MAR BIOL ECOL, V379, P34, DOI 10.1016/j.jembe.2009.07.033; Arnould JPY, 2007, AQUAT CONSERV, V17, pS53, DOI 10.1002/aqc.908; Austin D, 2006, J ANIM ECOL, V75, P408, DOI 10.1111/j.1365-2656.2006.01057.x; Beck CA, 2007, J ANIM ECOL, V76, P490, DOI 10.1111/j.1365-2656.2007.01215.x; Boelens RGV, 1999, IRELANDS MARINE COAS; Bowen WD, 2006, CONSERV BIOL SER, P63, DOI 10.1017/CBO9780511541964.006; BOYD IL, 1994, J ANIM ECOL, V63, P703, DOI 10.2307/5235; Bradshaw CJA, 2004, ICES J MAR SCI, V61, P1014, DOI 10.1016/j.icesjms.2004.07.012; Brown SL, 2012, J MAR BIOL ASSOC UK, V92, P1711, DOI 10.1017/S0025315411002050; Burns JM, 2008, DEEP-SEA RES PT II, V55, P500, DOI 10.1016/j.dsr2.2007.11.012; Chittaro PM, 2004, CORAL REEFS, V23, P235, DOI 10.1007/s00338-004-0376-z; Costa DP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008677; Cronin M, 2013, MAR BIOL, V160, P531, DOI 10.1007/s00227-012-2109-0; Cronin MA, 2012, BIOL CONSERV, V150, P136, DOI 10.1016/j.biocon.2012.02.013; Cronin MA, 2011, MAR POLICY, V35, P748, DOI 10.1016/j.marpol.2011.01.006; Gosch M, 2010, THESIS U COLL CORK C; Hays GC, 2001, ANIM BEHAV, V61, P1035, DOI 10.1006/anbe.2001.1685; Hazel J, 2009, J EXP MAR BIOL ECOL, V374, P58, DOI 10.1016/j.jembe.2009.04.009; Hooker SK, 2007, DEEP-SEA RES PT II, V54, P177, DOI 10.1016/j.dsr2.2007.01.001; Hooker SK, 2002, MAR MAMMAL SCI, V18, P680, DOI 10.1111/j.1748-7692.2002.tb01066.x; Jaud T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047444; Kamenos NA, 2004, ICES J MAR SCI, V61, P422, DOI 10.1016/j.icesjms.2004.02.004; Lea MA, 2003, ICES J MAR SCI, V60, P990, DOI 10.1016/S1054-3139(03)00101-2; McConnell BJ, 1999, J APPL ECOL, V36, P573, DOI 10.1046/j.1365-2664.1999.00429.x; MCCONNELL BJ, 1992, ANTARCT SCI, V4, P393, DOI 10.1017/S0954102092000580; Parrish FA, 2000, MAR MAMMAL SCI, V16, P392, DOI 10.1111/j.1748-7692.2000.tb00932.x; Ridoux V, 2007, J MAR BIOL ASSOC UK, V87, P255, DOI 10.1017/S002531540705463X; Ryan PG, 2004, MAR BIOL, V145, P215, DOI 10.1007/s00227-004-1328-4; Simmons SE, 2007, MAR ECOL PROG SER, V346, P265, DOI 10.3354/meps07014; Tollit DJ, 1998, J ZOOL, V244, P209, DOI 10.1111/j.1469-7998.1998.tb00026.x; Viviant M, 2010, POLAR BIOL, V33, P713, DOI 10.1007/s00300-009-0750-y; Williams A, 2001, MAR FRESHWATER RES, V52, P513, DOI 10.1071/MF00017; Wilson RP, 2012, MAR ECOL PROG SER, V451, P245, DOI 10.3354/meps09608; WILSON RP, 1993, MAR ECOL PROG SER, V94, P101	34	24	24	0	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e63720	10.1371/journal.pone.0063720	http://dx.doi.org/10.1371/journal.pone.0063720			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667663	Green Published, gold, Green Submitted			2022-12-27	WOS:000319654700180
J	Krishnan, M; Kannan, TR; Baseman, JB				Krishnan, Manickam; Kannan, T. R.; Baseman, Joel B.			Mycoplasma pneumoniae CARDS Toxin Is Internalized via Clathrin-Mediated Endocytosis	PLOS ONE			English	Article							SHIGA TOXIN; PULMONARY INFLAMMATION; DIPHTHERIA-TOXIN; BINDING-PROTEIN; ORGAN-CULTURE; MURINE MODEL; COATED PITS; CELLS; INFECTION; MECHANISMS	Bacterial toxins possess specific mechanisms of binding and uptake by mammalian cells. Mycoplasma pneumoniae CARDS (Community Acquired Respiratory Distress Syndrome) toxin is a 68 kDa protein, which demonstrates high binding affinity to human surfactant protein-A and exhibits specific biological activities including mono-ADP ribosylation and vacuolization. These properties lead to inflammatory processes in the airway and a range of cytopathologies including ciliostasis, loss of tissue integrity and injury, and cell death. However, the process by which CARDS toxin enters target cells is unknown. In this study, we show that CARDS toxin binds to mammalian cell surfaces and is internalized rapidly in a dose and time-dependent manner using a clathrin-mediated pathway, as indicated by inhibition of toxin internalization by monodansylcadaverine but not by methyl-beta-cyclodextrin or filipin. Furthermore, the internalization of CARDS toxin was markedly inhibited in clathrin-depleted cells.	[Krishnan, Manickam; Kannan, T. R.; Baseman, Joel B.] Univ Texas Hlth Sci Ctr San Antonio, Dept Microbiol & Immunol, San Antonio, TX 78229 USA	University of Texas System; University of Texas Health San Antonio	Baseman, JB (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Microbiol & Immunol, San Antonio, TX 78229 USA.	baseman@uthscsa.edu			National Institute of Allergy and Infectious Diseases [U19AI070412]; Kleberg Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI070412] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Kleberg Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funding was provided by an award number U19AI070412 from the National Institute of Allergy and Infectious Diseases and The Kleberg Foundation. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of Allergy and Infectious Diseases or the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baseman JB, 1997, EMERG INFECT DIS, V3, P21, DOI 10.3201/eid0301.970103; Brodsky FM, 2001, ANNU REV CELL DEV BI, V17, P517, DOI 10.1146/annurev.cellbio.17.1.517; COHEN G, 1967, ANN NY ACAD SCI, V143, P85, DOI 10.1111/j.1749-6632.1967.tb27648.x; COLLIER AM, 1971, P SOC EXP BIOL MED, V136, P569, DOI 10.3181/00379727-136-35313; DIDSBURY JR, 1983, MOL CELL BIOL, V3, P1283, DOI 10.1128/MCB.3.7.1283; Doherty GJ, 2009, ANNU REV BIOCHEM, V78, P857, DOI 10.1146/annurev.biochem.78.081307.110540; GIL JC, 1993, ANN ALLERGY, V70, P23; Hardy RD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007562; Hardy RD, 2002, INFECT IMMUN, V70, P649, DOI 10.1128/IAI.70.2.649-654.2002; Hardy RD, 2001, INFECT IMMUN, V69, P3869, DOI 10.1128/IAI.69.6.3869-3876.2001; Hinrichsen L, 2003, J BIOL CHEM, V278, P45160, DOI 10.1074/jbc.M307290200; Horiguchi H, 2006, COMPREHENSIVE SOURCE, P106; HU PC, 1975, INFECT IMMUN, V11, P704, DOI 10.1128/IAI.11.4.704-710.1975; Johannes L, 2002, TRAFFIC, V3, P443, DOI 10.1034/j.1600-0854.2002.30701.x; Johnson C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022877; Kannan TR, 2011, J INFECT DIS, V204, P1596, DOI 10.1093/infdis/jir557; Kannan TR, 2010, MOL MICROBIOL, V76, P1127, DOI 10.1111/j.1365-2958.2010.07092.x; Kannan TR, 2006, P NATL ACAD SCI USA, V103, P6724, DOI 10.1073/pnas.0510644103; Kannan TR, 2005, INFECT IMMUN, V73, P2828, DOI 10.1128/IAI.73.5.2828-2834.2005; KRUEGER KM, 1995, CLIN MICROBIOL REV, V8, P34, DOI 10.1128/CMR.8.1.34; Lauvrak SU, 2004, J CELL SCI, V117, P2321, DOI 10.1242/jcs.01081; MIDDLEBROOK JL, 1984, MICROBIOL REV, V48, P199, DOI 10.1128/MMBR.48.3.199-221.1984; MORRIS RE, 1983, INFECT IMMUN, V40, P806, DOI 10.1128/IAI.40.2.806-811.1983; MOYA M, 1985, J CELL BIOL, V101, P548, DOI 10.1083/jcb.101.2.548; Muir MT, 2011, CHEST, V139, P305, DOI 10.1378/chest.10-1222; MURPHY GF, 1980, VIRCHOWS ARCH A, V389, P93, DOI 10.1007/BF00428670; Navarro-Garcia F, 2007, MICROBIOL-SGM, V153, P2828, DOI 10.1099/mic.0.2007/007088-0; Nisar N, 2007, POSTGRAD MED J, V83, P100, DOI 10.1136/pgmj.2006.049023; Owen DJ, 2004, ANNU REV CELL DEV BI, V20, P153, DOI 10.1146/annurev.cellbio.20.010403.104543; Papatheodorou P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010673; Peters J, 2011, CHEST, V140, P401, DOI 10.1378/chest.11-0221; Rappoport J, 2004, TRAFFIC, V5, P327, DOI 10.1111/j.1600-0854.2004.00187.x; Romer W, 2007, NATURE, V450, P670, DOI 10.1038/nature05996; ROGEL A, 1992, J BIOL CHEM, V267, P22599; Sanchez-Vargas FM, 2008, CLIN MICROBIOL INFEC, V14, P105, DOI 10.1111/j.1469-0691.2007.01834.x; Sandvig K, 2002, ANNU REV CELL DEV BI, V18, P1, DOI 10.1146/annurev.cellbio.18.011502.142107; SANDVIG K, 1989, J CELL BIOL, V108, P1331, DOI 10.1083/jcb.108.4.1331; Sandvig K, 2002, HISTOCHEM CELL BIOL, V117, P131, DOI 10.1007/s00418-001-0346-2; Sandvig K, 2011, CURR OPIN CELL BIOL, V23, P413, DOI 10.1016/j.ceb.2011.03.007; SEGGEV JS, 1986, ANN ALLERGY, V57, P263; Torgersen ML, 2001, J CELL SCI, V114, P3737; Torgersen ML, 2005, FEBS J, V272, P4103, DOI 10.1111/j.1742-4658.2005.04835.x; Waites KB, 2004, CLIN MICROBIOL REV, V17, P697, DOI 10.1128/CMR.17.4.697-728.2004	43	27	31	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e62706	10.1371/journal.pone.0062706	http://dx.doi.org/10.1371/journal.pone.0062706			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667510	Green Published, gold, Green Submitted			2022-12-27	WOS:000319654700057
J	MacKinnon, CD; Allen, DP; Shiratori, T; Rogers, MW				MacKinnon, Colum D.; Allen, David P.; Shiratori, Takako; Rogers, Mark W.			Early and Unintentional Release of Planned Motor Actions during Motor Cortical Preparation	PLOS ONE			English	Article							MOVEMENT-RELATED POTENTIALS; SIMPLE REACTION-TIME; ACOUSTIC STARTLE; PREMOTOR CORTEX; PREDICTABILITY; INITIATION; DIRECTION; HUMANS; ONSET	Voluntary movements are often preceded by a movement-related potential beginning as much as two seconds prior to the onset of movement. In light of evidence that motor actions can be prepared and initiated in less than 200 ms, the function of this early activity has remained enigmatic. We hypothesized that the movement-related potential reflects the state of preparation of the planned movement. This was tested by delivering a startling acoustic stimulus during the preparation phase of a load-release task. The cue to release the load was presented either 3.5 seconds after a warning cue (PREDICT condition) or randomly between 4-12 seconds (REACT condition). Electroencephalographic, electromyographic and limb and load kinematic signals were recorded. In a subset of trials, a startle stimulus was delivered at -1500, -1000, -500, -250, -100 or 0 ms before the release cue. A contingent-negative variation (CNV) waveform, with a late phase of slowrising negativity beginning an average of 1459 ms prior to movement, was observed for the PREDICT condition but not the REACT condition. For both conditions, the startle stimulus frequently evoked the early and unintentional release of the loadrelease sequence. The incidence of release was significantly (p<0.001) correlated with the late phase of the CNV for the PREDICT condition but not the REACT condition. For the REACT condition, the incidence of movement release was subjectspecific, constant across the preparation interval, and uncorrelated with cortical activity. The onset of movement release by the startle stimulus was significantly shorter (p<0.001) for the PREDICT compared to the REACT condition. These findings provide evidence that the late phase of the CNV reflects cortical activity mediating the progressive preparation and storage of the forthcoming movement and that during this phase an intense sensory stimulus can evoke early and unintentional release of the planned action.	[MacKinnon, Colum D.; Allen, David P.; Shiratori, Takako] Univ Minnesota, Dept Neurol, Minneapolis, MN 55455 USA; [MacKinnon, Colum D.] Northwestern Univ, Feinberg Sch Med, Dept Phys Therapy & Human Movement Sci, Chicago, IL 60611 USA; [Rogers, Mark W.] Univ Maryland, Sch Med, Dept Neurol, Dept Phys Therapy & Rehabil Sci, Baltimore, MD 21201 USA; [Rogers, Mark W.] Univ Maryland, Sch Med, Dept Anat & Neurobiol, Dept Phys Therapy & Rehabil Sci, Baltimore, MD 21201 USA	University of Minnesota System; University of Minnesota Twin Cities; Northwestern University; Feinberg School of Medicine; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	MacKinnon, CD (corresponding author), Univ Minnesota, Dept Neurol, Minneapolis, MN 55455 USA.	cmackinn@umn.edu		Shiratori, Takako/0000-0001-7916-2499	National Institutes of Health [RO1 NS054199]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS070264, R01NS054199] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Funding provided by National Institutes of Health Grant RO1 NS054199. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alibiglou L, 2012, J PHYSIOL-LONDON, V590, DOI 10.1113/jphysiol.2011.219592; Brass M, 2008, NEUROSCIENTIST, V14, P319, DOI 10.1177/1073858408317417; Carlsen AN, 2004, EXP BRAIN RES, V159, P301, DOI 10.1007/s00221-004-1924-z; Carlsen AN, 2010, BRAIN RES, V1322, P38, DOI 10.1016/j.brainres.2010.01.076; Churchland MM, 2010, NEURON, V68, P387, DOI 10.1016/j.neuron.2010.09.015; Churchland MM, 2006, NEURON, V52, P1085, DOI 10.1016/j.neuron.2006.10.034; Cisek P, 2005, NEURON, V45, P801, DOI 10.1016/j.neuron.2005.01.027; Colebatch JG, 2007, MOVEMENT DISORD, V22, P601, DOI 10.1002/mds.21323; Confais J, 2012, J NEUROSCI, V32, P15359, DOI 10.1523/JNEUROSCI.1768-12.2012; Cui RQ, 2009, EXP BRAIN RES, V194, P477, DOI 10.1007/s00221-009-1725-5; CUNNINGTON R, 1995, BRAIN, V118, P935, DOI 10.1093/brain/118.4.935; DEECKE L, 1976, BIOL CYBERN, V23, P99, DOI 10.1007/BF00336013; Diggle P, 1990, TIME SERIES BIOSTATI; Duque J, 2010, J NEUROSCI, V30, P3793, DOI 10.1523/JNEUROSCI.5722-09.2010; Duque J, 2009, CEREB CORTEX, V19, P2013, DOI 10.1093/cercor/bhn230; Floeter MK, 1999, NEUROLOGY, V53, P664, DOI 10.1212/WNL.53.4.664; Gilbertson T, 2005, J NEUROSCI, V25, P7771, DOI 10.1523/JNEUROSCI.1762-05.2005; Hallett M, 2007, CLIN NEUROPHYSIOL, V118, P1179, DOI 10.1016/j.clinph.2007.03.019; Hanes DP, 1996, SCIENCE, V274, P427, DOI 10.1126/science.274.5286.427; Hodges PW, 1996, ELECTROMYOGR MOTOR C, V101, P511, DOI 10.1016/S0013-4694(96)95190-5; HUGON M, 1982, PFLUG ARCH EUR J PHY, V393, P292, DOI 10.1007/BF00581412; Jankelowitz SK, 2002, EXP BRAIN RES, V147, P98, DOI 10.1007/s00221-002-1220-8; Jenkins IH, 2000, BRAIN, V123, P1216, DOI 10.1093/brain/123.6.1216; Jenkinson N, 2011, TRENDS NEUROSCI, V34, P611, DOI 10.1016/j.tins.2011.09.003; KLEMMER ET, 1956, J EXP PSYCHOL, V51, P179, DOI 10.1037/h0042317; KORNHUBE.HH, 1965, PFLUG ARCH GES PHYS, V284, P1, DOI 10.1007/BF00412364; LIBET B, 1983, BRAIN, V106, P623, DOI 10.1093/brain/106.3.623; MacKinnon CD, 2007, J NEUROPHYSIOL, V97, P4368, DOI 10.1152/jn.01136.2006; MCADAM DW, 1969, PSYCHOPHYSIOLOGY, V5, P349, DOI 10.1111/j.1469-8986.1969.tb02833.x; NIEMI P, 1981, PERCEPT MOTOR SKILL, V53, P615, DOI 10.2466/pms.1981.53.2.615; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Pfurtscheller G, 1999, CLIN NEUROPHYSIOL, V110, P1842, DOI 10.1016/S1388-2457(99)00141-8; Prochazka A, 2000, EXP BRAIN RES, V130, P417, DOI 10.1007/s002219900250; Rektor I, 2002, CLIN NEUROPHYSIOL, V113, P1998, DOI 10.1016/S1388-2457(02)00286-9; RIEHLE A, 1993, BEHAV BRAIN RES, V53, P35, DOI 10.1016/S0166-4328(05)80264-5; Shibasaki H, 2006, CLIN NEUROPHYSIOL, V117, P2341, DOI 10.1016/j.clinph.2006.04.025; TANJI J, 1976, J NEUROPHYSIOL, V39, P1062, DOI 10.1152/jn.1976.39.5.1062; Valls-Sole J, 1999, J PHYSIOL-LONDON, V516, P931, DOI 10.1111/j.1469-7793.1999.0931u.x; Valls-Sole J, 2008, EXP BRAIN RES, V187, P497, DOI 10.1007/s00221-008-1402-0; VALLSSOLE J, 1995, NEUROSCI LETT, V195, P97, DOI 10.1016/0304-3940(94)11790-P; WALTER WG, 1964, NATURE, V203, P380, DOI 10.1038/203380a0	41	20	20	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e63417	10.1371/journal.pone.0063417	http://dx.doi.org/10.1371/journal.pone.0063417			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667613	Green Published, gold, Green Submitted			2022-12-27	WOS:000319654700141
J	Panagopoulos, I; Micci, F; Thorsen, J; Haugom, L; Buechner, J; Kerndrup, G; Tierens, A; Zeller, B; Heim, S				Panagopoulos, Ioannis; Micci, Francesca; Thorsen, Jim; Haugom, Lisbeth; Buechner, Jochen; Kerndrup, Gitte; Tierens, Anne; Zeller, Bernward; Heim, Sverre			Fusion of ZMYND8 and RELA Genes in Acute Erythroid Leukemia	PLOS ONE			English	Article							NF-KAPPA-B; ACUTE MYELOGENOUS LEUKEMIA; MYELODYSPLASTIC SYNDROME; DNA-BINDING; IDENTIFICATION; CLASSIFICATION; CHILDHOOD; CANCER	Acute erythroid leukemia was diagnosed in a 4-month-old boy. Cytogenetic analysis of bone marrow (BM) cells showed a t(11; 20)(p11; q11) translocation. RNA extracted from the BM was sequenced and analyzed for fusion transcripts using the software FusionMap. A ZMYND8-RELA fusion was ranked first. RT-PCR and direct sequencing verified the presence of an in frame ZMYND8-RELA chimeric transcript. Fluorescence in situ hybridization showed that the ZMYND8-RELA was located on the p12 band of der(11); therefore a cytogenetically invisible pericentric inversion in chromosome 11 must have taken place besides the translocation. The putative ZMYND8-RELA fusion protein contains the Zinc-PHD finger domain, a bromodomain, a PWWP domain, a MYND type of zinc finger of ZMYND8, and the entire RELA protein, indicating that it might act leukemogenically by influencing several cellular processes including the NF-kappa-B pathway.	[Panagopoulos, Ioannis; Micci, Francesca; Thorsen, Jim; Haugom, Lisbeth; Heim, Sverre] Oslo Univ Hosp, Norwegian Radium Hosp, Inst Med Informat, Sect Canc Cytogenet, Oslo, Norway; [Panagopoulos, Ioannis; Micci, Francesca; Thorsen, Jim; Haugom, Lisbeth; Heim, Sverre] Univ Oslo, Fac Med, Ctr Canc Biomed, Oslo, Norway; [Buechner, Jochen] Univ Hosp North Norway, Dept Pediat, Tromso, Norway; [Buechner, Jochen; Zeller, Bernward] Oslo Univ Hosp, Dept Pediat, Oslo, Norway; [Kerndrup, Gitte] Vejle Hosp, Dept Pathol, Vejle, Denmark; [Tierens, Anne] Oslo Univ Hosp, Norwegian Radium Hosp, Dept Pathol, Oslo, Norway; [Heim, Sverre] Univ Oslo, Fac Med, Oslo, Norway	University of Oslo; University of Oslo; UiT The Arctic University of Tromso; University Hospital of North Norway; University of Oslo; University of Southern Denmark; Lillebaelt Hospital; University of Oslo; University of Oslo	Panagopoulos, I (corresponding author), Oslo Univ Hosp, Norwegian Radium Hosp, Inst Med Informat, Sect Canc Cytogenet, Oslo, Norway.	ioannis.panagopoulos@rr-research.no		tierens, anne/0000-0002-5350-8313; Buechner, Jochen/0000-0001-5848-4501; Panagopoulos, Ioannis/0000-0003-2159-5341	Norwegian Cancer Society; South-Eastern Norway Regional Health Authority	Norwegian Cancer Society(Norwegian Cancer Society); South-Eastern Norway Regional Health Authority	The study was supported by grants from the Norwegian Cancer Society and the South-Eastern Norway Regional Health Authority. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahamsson J, 2011, J CLIN ONCOL, V29, P310, DOI 10.1200/JCO.2010.30.6829; Barnard DR, 2007, PEDIATR BLOOD CANCER, V49, P17, DOI 10.1002/pbc.20951; Baumgartner B, 2002, LEUKEMIA, V16, P2062, DOI 10.1038/sj.leu.2402641; Brunning RD, 2008, WHO CLASSIFICATION T, P130; DiDonato JA, 2012, IMMUNOL REV, V246, P379, DOI 10.1111/j.1600-065X.2012.01099.x; Emerenciano M, 2007, BRAZ J MED BIOL RES, V40, P749, DOI 10.1590/S0100-879X2007000600002; Fossey SC, 2000, MAMM GENOME, V11, P919, DOI 10.1007/s003350010174; Ge HY, 2011, BIOINFORMATICS, V27, P1922, DOI 10.1093/bioinformatics/btr310; Guzman ML, 2001, BLOOD, V98, P2301, DOI 10.1182/blood.V98.8.2301; Hasserjian RP, 2010, BLOOD, V115, P1985, DOI 10.1182/blood-2009-09-243964; Henter JI, 2007, PEDIATR BLOOD CANCER, V48, P124, DOI 10.1002/pbc.21039; Karin M, 2002, NAT REV CANCER, V2, P301, DOI 10.1038/nrc780; Kasyan A, 2010, MODERN PATHOL, V23, P1113, DOI 10.1038/modpathol.2010.96; Micci F, 2011, LEUKEMIA, V25, P1510, DOI 10.1038/leu.2011.100; Micci F, 2012, LEUKEMIA IN PRESS; Mitelman F, 2009, CANC CYTOGENETICS; NOLAN GP, 1991, CELL, V64, P961, DOI 10.1016/0092-8674(91)90320-X; Reikvam Hakon, 2009, Critical Reviews in Oncogenesis, V15, P1; Strahm B, 2011, LEUKEMIA, V25, P455, DOI 10.1038/leu.2010.297; Trecca D, 1997, ONCOGENE, V14, P791, DOI 10.1038/sj.onc.1200895	20	31	31	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e63663	10.1371/journal.pone.0063663	http://dx.doi.org/10.1371/journal.pone.0063663			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667654	Green Submitted, gold, Green Published			2022-12-27	WOS:000319654700174
J	Shean, K; Streicher, E; Pieterson, E; Symons, G; Smit, RV; Theron, G; Lehloenya, R; Padanilam, X; Wilcox, P; Victor, TC; van Helden, P; Groubusch, M; Warren, R; Badri, M; Dheda, K				Shean, Karen; Streicher, Elizabeth; Pieterson, Elize; Symons, Greg; Smit, Richard van Zyl; Theron, Grant; Lehloenya, Rannakoe; Padanilam, Xavier; Wilcox, Paul; Victor, Tommie C.; van Helden, Paul; Groubusch, Martin; Warren, Robin; Badri, Motasim; Dheda, Keertan			Drug-Associated Adverse Events and Their Relationship with Outcomes in Patients Receiving Treatment for Extensively Drug-Resistant Tuberculosis in South Africa	PLOS ONE			English	Article							MULTIDRUG-RESISTANT; MYCOBACTERIUM-TUBERCULOSIS; EPIDEMIOLOGY; THERAPY; HIV	Background: Treatment-related outcomes in patients with extensively drug-resistant tuberculosis (XDR-TB) are poor. However, data about the type, frequency and severity of presumed drug-associated adverse events (AEs) and their association with treatment-related outcomes in patients with XDR-TB are scarce. Methods: Case records of 115 South-African XDR-TB patients were retrospectively reviewed by a trained researcher. AEs were estimated and graded according to severity [grade 0 = none; grade 1-2 = mild to moderate; and grade 3-5 = severe (drug stopped, life-threatening or death)]. Findings: 161 AEs were experienced by 67/115(58%) patients: 23/67(34%) required modification of treatment, the offending drug was discontinued in 19/67(28%), reactions were life-threatening in 2/67(3.0%), and 6/67(9.0%) died. similar to 50% of the patients were still on treatment at the time of data capture. Sputum culture-conversion was less likely in those with severe (grade 3-5) vs. grade 0-2 AEs [2/27(7%) vs. 24/88(27%); p = 0.02]. The type, frequency and severity of AEs was similar in HIV-infected and uninfected patients. Capreomycin, which was empirically administered in most cases, was withdrawn in 14/104(14%) patients, implicated in (14/34) 41% of the total drug withdrawals, and was associated with all 6 deaths in the severe AE group (renal failure in five patients and hypokalemia in one patient). Conclusion: Drug-associated AEs occur commonly with XDR-TB treatment, are often severe, frequently interrupt therapy, and negatively impact on culture conversion outcomes. These preliminary data inform on the need for standardised strategies (including pre-treatment counselling, early detection, monitoring, and follow-up) and less toxic drugs to optimally manage patients with XDR-TB.	[Shean, Karen; Pieterson, Elize; Symons, Greg; Smit, Richard van Zyl; Theron, Grant; Lehloenya, Rannakoe; Wilcox, Paul; Badri, Motasim; Dheda, Keertan] Univ Cape Town, Div Pulmonol, Lung Infect & Immun Unit, ZA-7925 Cape Town, South Africa; [Shean, Karen; Pieterson, Elize; Symons, Greg; Smit, Richard van Zyl; Theron, Grant; Lehloenya, Rannakoe; Wilcox, Paul; Badri, Motasim; Dheda, Keertan] Univ Cape Town, Dept Med, UCT Lung Inst, ZA-7925 Cape Town, South Africa; [Dheda, Keertan] Univ Cape Town, Inst Infect Dis & Mol Med, ZA-7925 Cape Town, South Africa; [Dheda, Keertan] UCL, Sch Med, Dept Infect, London W1N 8AA, England; [Padanilam, Xavier; Groubusch, Martin] Sizwe Trop Dis Hosp, Johannesburg, South Africa; [Groubusch, Martin] Univ Witwatersrand, Natl Hlth Lab Serv, Johannesburg, South Africa; [Groubusch, Martin] Univ Witwatersrand, Div Clin Microbiol & Infect Dis, Johannesburg, South Africa; [Padanilam, Xavier; Groubusch, Martin] Univ Witwatersrand, Dept Med, Fac Hlth Sci, Div Infect Dis, ZA-2001 Johannesburg, South Africa; [Streicher, Elizabeth; Victor, Tommie C.; van Helden, Paul; Warren, Robin] Univ Stellenbosch, MRC Ctr Mol & Cellular Biol, DST NRF Ctr Excellence Biomed TB Res, ZA-7600 Stellenbosch, South Africa; [Groubusch, Martin] Univ Amsterdam, Dept Infect Dis, Ctr Trop Med & Travel Med, Div Internal Med,Amsterdam Med Ctr, Amsterdam, Netherlands; [Badri, Motasim] King Saud Bin Abdulaziz Univ Hlth Sci, Coll Med, Riyadh, Saudi Arabia	University of Cape Town; University of Cape Town; University of Cape Town; University of London; University College London; UCL Medical School; National Health Laboratory Service; University of Witwatersrand; University of Witwatersrand; University of Witwatersrand; National Research Foundation - South Africa; Stellenbosch University; University of Amsterdam; Academic Medical Center Amsterdam; King Saud Bin Abdulaziz University for Health Sciences	Dheda, K (corresponding author), Univ Cape Town, Div Pulmonol, Lung Infect & Immun Unit, ZA-7925 Cape Town, South Africa.	keertan.dheda@uct.ac.za	Streicher, Elizabeth/O-9597-2019; Streicher, Elizabeth M/I-7780-2018; Theron, Grant/ABB-1167-2020; Lehloenya, Rannakoe J/C-5672-2012; Badri, Motasim/E-1141-2013	Streicher, Elizabeth/0000-0003-3901-1981; Streicher, Elizabeth M/0000-0003-3901-1981; Theron, Grant/0000-0002-9216-2415; van Zyl-Smit, Richard/0000-0002-4115-5362; Lehloenya, Rannakoe J/0000-0002-1281-1789; Warren, Robin/0000-0001-5741-7358; Badri, Motasim/0000-0002-5268-6492	South Africa MRC Fellowship; EU [FW7 TB Susgent]; EDCTP European and Developing Countries Clinical Trails Partnership	South Africa MRC Fellowship; EU(European Commission); EDCTP European and Developing Countries Clinical Trails Partnership	KD is supported by a South Africa MRC Fellowship, the EU (FW7 TB Susgent) and the EDCTP European and Developing Countries Clinical Trails Partnership. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Desouza GA, MOL CELL PROTEOMICS; Dheda K, 2010, INFECT DIS IN PRESS; Dheda K, 2010, INFECT DIS CLIN N AM, V24, P705, DOI 10.1016/j.idc.2010.05.001; Dheda K, 2010, LANCET, V375, P1798, DOI 10.1016/S0140-6736(10)60492-8; Furin JJ, 2001, INT J TUBERC LUNG D, V5, P648; Javadi MR, 2007, PHARMACOEPIDEM DR S, V16, P1104, DOI 10.1002/pds.1468; Kamerbeek J, 1997, J CLIN MICROBIOL, V35, P907, DOI 10.1128/JCM.35.4.907-914.1997; Lawn SD, 2012, CLIN INFECT DIS; Marks DJB, 2009, INT J STD AIDS, V20, P339, DOI 10.1258/ijsa.2008.008361; Marra F, 2007, INT J TUBERC LUNG D, V11, P868; Migliori GB, 2008, EUR RESPIR J, V31, P1155, DOI 10.1183/09031936.00028708; Mitnick CD, 2008, NEW ENGL J MED, V359, P563, DOI 10.1056/NEJMoa0800106; Nathanson E, 2004, INT J TUBERC LUNG D, V8, P1382; O'Donnell MR, 2009, INT J TUBERC LUNG D, V13, P855; Shean KP, 2008, INT J TUBERC LUNG D, V12, P1182; Shin SS, 2007, INT J TUBERC LUNG D, V11, P1314; Shin SY, 2004, CHEST, V125, P974, DOI 10.1378/chest.125.3.974; Streicher EM, 2007, J CLIN MICROBIOL, V45, P237, DOI 10.1128/JCM.01429-06; Torun T, 2005, INT J TUBERC LUNG D, V9, P1373; Warren R, 2006, J CLIN MICROBIOL, V44, P254, DOI 10.1128/JCM.44.1.254-256.2006; Yee D, 2003, AM J RESP CRIT CARE, V167, P1472, DOI 10.1164/rccm.200206-626OC	21	69	71	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e63057	10.1371/journal.pone.0063057	http://dx.doi.org/10.1371/journal.pone.0063057			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667572	Green Published, gold, Green Submitted			2022-12-27	WOS:000319654700104
J	Toppozini, L; Dies, H; Deamer, DW; Rheinstadter, MC				Toppozini, Laura; Dies, Hannah; Deamer, David W.; Rheinstaedter, Maikel C.			Adenosine Monophosphate Forms Ordered Arrays in Multilamellar Lipid Matrices: Insights into Assembly of Nucleic Acid for Primitive Life	PLOS ONE			English	Article							CRYSTAL-STRUCTURE; POLYMERIZATION; MEMBRANES; MACROMOLECULES; ENCAPSULATION; TEMPLATE; MEDIA	A fundamental question of biology is how nucleic acids first assembled and then were incorporated into the earliest forms of cellular life 4 billion years ago. The polymerization of nucleotides is a condensation reaction in which phosphodiester bonds are formed. This reaction cannot occur in aqueous solutions, but guided polymerization in an anhydrous lipid environment could promote a non-enzymatic condensation reaction in which oligomers of single stranded nucleic acids are synthesized. We used X-ray scattering to investigate 5'-adenosine monophosphate (AMP) molecules captured in a multilamellar phospholipid matrix composed of dimyristoylphosphatidylcholine. Bragg peaks corresponding to the lateral organization of the confined AMP molecules were observed. Instead of forming a random array, the AMP molecules are highly entangled, with the phosphate and ribose groups in close proximity. This structure may facilitate polymerization of the nucleotides into RNA-like polymers.	[Toppozini, Laura; Dies, Hannah; Rheinstaedter, Maikel C.] McMaster Univ, Dept Phys & Astron, Hamilton, ON L8S 4M1, Canada; [Toppozini, Laura; Rheinstaedter, Maikel C.] McMaster Univ, Origins Inst, Hamilton, ON L8S 4M1, Canada; [Deamer, David W.] Univ Calif Santa Cruz, Dept Biomol Engn, Santa Cruz, CA 95064 USA; [Rheinstaedter, Maikel C.] Natl Res Council Canada, Chalk River Labs, Canadian Neutron Beam Ctr, Chalk River, ON, Canada	McMaster University; McMaster University; University of California System; University of California Santa Cruz; Atomic Energy of Canada Limited; National Research Council Canada	Toppozini, L (corresponding author), McMaster Univ, Dept Phys & Astron, Hamilton, ON L8S 4M1, Canada.	toppozl@mcmaster.ca; deamer@soe.ucsc.edu; rheinstadter@mcmaster.ca	Rheinstadter, Maikel C/D-5322-2009; Bacon, Hannah/AAQ-9604-2021	Rheinstadter, Maikel C/0000-0002-0558-7475; Bacon, Hannah/0000-0002-2772-141X	Natural Sciences and Engineering Research Council of Canada (NSERC); National Research Council Canada (NRC); Canada Foundation for Innovation (CFI); Ontario Ministry of Economic Development and Innovation; NSERC-Undergraduate Student Research Award; Early Researcher Award of the Province of Ontario; QEII scholarship through the Origins Institute at McMaster; Lonsdale Research Award	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); National Research Council Canada (NRC); Canada Foundation for Innovation (CFI)(Canada Foundation for Innovation); Ontario Ministry of Economic Development and Innovation; NSERC-Undergraduate Student Research Award(Natural Sciences and Engineering Research Council of Canada (NSERC)); Early Researcher Award of the Province of Ontario; QEII scholarship through the Origins Institute at McMaster; Lonsdale Research Award	This research was funded by the Natural Sciences and Engineering Research Council of Canada (NSERC), the National Research Council Canada (NRC), the Canada Foundation for Innovation (CFI) and the Ontario Ministry of Economic Development and Innovation. H.D. is the recipient of an NSERC-Undergraduate Student Research Award, M.C.R. is the recipient of an Early Researcher Award of the Province of Ontario. L.T. is supported through a QEII scholarship through the Origins Institute at McMaster. D.W.D. is the recipient of the Lonsdale Research Award that supports research on the origin of life. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARRALL EM, 1979, J MACROMOL SCI R M C, VC17, P137; Barrett MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034357; BARTELL LS, 1970, INORG CHEM, V9, P1903, DOI 10.1021/ic50090a021; BLUMSTEIN A, 1971, MOL CRYST LIQ CRYST, V12, P215, DOI 10.1080/15421407108082774; de Groot BL, 2002, BIOPHYS J, V82, P2934, DOI 10.1016/S0006-3495(02)75634-8; de Meyer FJM, 2010, J PHYS CHEM B, V114, P10451, DOI 10.1021/jp103903s; Deamer D, 2012, CHEM SOC REV, V41, P5375, DOI 10.1039/c2cs35042d; DEAMER DW, 1982, J MOL EVOL, V18, P203, DOI 10.1007/BF01733047; KRAUT J, 1963, ACTA CRYSTALLOGR, V16, P79, DOI 10.1107/S0365110X63000207; Kuruma Y, 2009, BBA-BIOMEMBRANES, V1788, P567, DOI 10.1016/j.bbamem.2008.10.017; LOHRMANN R, 1973, NATURE, V244, P418, DOI 10.1038/244418a0; MABREY S, 1976, P NATL ACAD SCI USA, V73, P3862, DOI 10.1073/pnas.73.11.3862; Malathi R, 2001, J BIOMOL STRUCT DYN, V18, P709, DOI 10.1080/07391102.2001.10506701; Mansy SS, 2008, NATURE, V454, P122, DOI 10.1038/nature07018; Mills TT, 2008, BIOPHYS J, V95, P669, DOI 10.1529/biophysj.107.127845; Mulkidjanian AY, 2012, P NATL ACAD SCI USA, V109, pE821, DOI 10.1073/pnas.1117774109; NEIDLE S, 1976, ACTA CRYSTALLOGR B, V32, P1850, DOI 10.1107/S0567740876006511; Nomura K, 2011, J PHYS CHEM B, V115, P14991, DOI 10.1021/jp208958a; Oliynyk V, 2007, BBA-BIOMEMBRANES, V1768, P236, DOI 10.1016/j.bbamem.2006.10.007; Radler JO, 1997, SCIENCE, V275, P810, DOI 10.1126/science.275.5301.810; Rajamani S, 2008, ORIGINS LIFE EVOL B, V38, P57, DOI 10.1007/s11084-007-9113-2; Richter R, 2003, BIOPHYS J, V85, P3035, DOI 10.1016/S0006-3495(03)74722-5; SHEW RL, 1985, BIOCHIM BIOPHYS ACTA, V816, P1, DOI 10.1016/0005-2736(85)90386-4; Szostak JW, 2001, NATURE, V409, P387, DOI 10.1038/35053176; TIDSWELL IM, 1990, PHYS REV B, V41, P1111, DOI 10.1103/PhysRevB.41.1111; Tristram-Nagle S, 2002, BIOPHYS J, V83, P3324, DOI 10.1016/S0006-3495(02)75333-2; USHER DA, 1976, SCIENCE, V192, P53, DOI 10.1126/science.1257755; VERLANDER MS, 1973, J MOL EVOL, V2, P303, DOI 10.1007/BF01654098; WATTS TH, 1984, P NATL ACAD SCI-BIOL, V81, P7564, DOI 10.1073/pnas.81.23.7564	29	34	42	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e62810	10.1371/journal.pone.0062810	http://dx.doi.org/10.1371/journal.pone.0062810			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667523	Green Submitted, Green Published, gold			2022-12-27	WOS:000319654700064
J	Zhang, X; Zhang, ZY; Wang, QL; Chen, P; Chen, GP; Zhou, RY				Zhang, Xin; Zhang, Zhiyong; Wang, Qinglian; Chen, Peng; Chen, Guoping; Zhou, Ruiyang			Effects of Rootstocks on Cryotolerance and Overwintering Survivorship of Genic Male Sterile Lines in Upland Cotton (Gossypium hirsutum L.)	PLOS ONE			English	Article							PERENNIAL COTTON; FROST DAMAGE; YIELD; HETEROSIS; RESPONSES; RECOVERY; TISSUES; HYBRIDS; LEAVES	Grafting desirable scion on stress-tolerant rootstocks provides an opportunity to improve the cryotolerance of scion. Genic male sterile (GMS) lines of plant could be used as sterile line and maintainer in breeding, and they have the conspicuous characteristics that the fertility of which is easy to regain but hard to maintain by sexual reproduction. In order to maintain the fertility of GMS cotton by means of its perennial growth on the basis of frostless winters in Nanning, Guangxi autonomous region, GMS line A4 was grafted onto 7 cryotolerant rootstocks (F118, F697, F098, F112, F113, P098 and P113), and the cryotolerance and the overwintering survivorship of scions were investigated. In consequence, when compared with control (self-grafted A4), the relative conductivity of the grafted plants in shoot bark was reduced (8.80%), the content of soluble sugar, soluble protein and free proline were higher, 25.00, 1.55, 3.46%, respectively; the overwintering survival rate and the height of regeneration bud under field condition of grafted plants were higher, 10.44, 15.75%, respectively; the order of the grafted plants based on the average subordinate function value of overwintering survivorship was A4/F113>A4/F118>A4/F098>A4/F697>A4/F112>A4/P098>A4/P113>A4/A4(CK); the correlation analyses indicated that the physiological parameters of cryotolerance could be used for forecasting the overwintering survivorship, and the relative conductivity could be chosen as the first physiological parameter for forecasting cryotolerance or overwintering survivorship. The results indicate that the cryotolerance and the overwintering survivorship of GMS cotton could be improved by grafting, and F113 appeared to be a valuable rootstock.	[Zhang, Xin; Chen, Peng; Chen, Guoping; Zhou, Ruiyang] Guangxi Univ, Coll Agron, Nanning 530004, Guangxi, Peoples R China; [Zhang, Xin; Zhang, Zhiyong; Wang, Qinglian] Henan Inst Sci & Technol, Cotton Res Inst, Xinxiang, Henan, Peoples R China	Guangxi University; Chinese Academy of Agricultural Sciences; Institute of Cotton Research, CAAS; Henan Institute of Science & Technology	Zhou, RY (corresponding author), Guangxi Univ, Coll Agron, Nanning 530004, Guangxi, Peoples R China.	ruiyangzhou@yahoo.com.cn	Zhang, Xin/ABI-7149-2020		State Science and Technology Support Project [2006BAD01A05-xz02]; Innovation Project of Guangxi Postgraduate Education of China [2008105930901D015]	State Science and Technology Support Project; Innovation Project of Guangxi Postgraduate Education of China	This project is partially supported by the State Science and Technology Support Project (2006BAD01A05-xz02) and the Innovation Project of Guangxi Postgraduate Education (2008105930901D015) of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn SJ, 1999, SCI HORTIC-AMSTERDAM, V81, P397, DOI 10.1016/S0304-4238(99)00042-4; BATES LS, 1973, PLANT SOIL, V39, P205, DOI 10.1007/BF00018060; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chen CY, 2007, J HERED, V98, P1; [陈国平 Chen Guoping], 2010, [西北农业学报, Acat Agriculturae Boreali-Occidentalis Sinica], V19, P53; Chen ZH, 2005, EUPHYTICA, V144, P353, DOI 10.1007/s10681-005-8188-y; Choudhary B., 2013, BT COTTON INDIA COUN; DEANS JD, 1995, FORESTRY, V68, P25, DOI 10.1093/forestry/68.1.25; DESOUZA JG, 1987, J EXP BOT, V38, P1211, DOI 10.1093/jxb/38.7.1211; DESOUZA NA, 1993, PESQUI AGROPECU BRAS, V28, P797; Dionisio-Sese ML, 1998, PLANT SCI, V135, P1, DOI 10.1016/S0168-9452(98)00025-9; Dong HH, 2008, J EXP BOT, V59, P1295, DOI 10.1093/jxb/ern035; Dong J, 2006, EUPHYTICA, V151, P71, DOI 10.1007/s10681-006-9129-0; Galanopoulou-Sendouca S, 1999, EUR J AGRON, V11, P53, DOI 10.1016/S1161-0301(99)00018-0; Hao JunJie, 2010, Scientia Agricultura Sinica, V43, P3974; HEARN AB, 1980, OUTLOOK AGR, V10, P159, DOI 10.1177/003072708001000402; Jin SX, 2006, PLANT CELL TISS ORG, V85, P181, DOI 10.1007/s11240-005-9068-9; Li B, 2012, J PLANT PHYSIOL, V169, P327, DOI 10.1016/j.jplph.2011.10.009; Li JianYong, 2008, Agricultural Sciences in China, V7, P570, DOI 10.1016/S1671-2927(08)60054-1; Luo JH, 1999, PLANT CELL TISS ORG, V57, P211, DOI 10.1023/A:1006393009094; Malcolm P, 2007, SCI HORTIC-AMSTERDAM, V112, P58, DOI 10.1016/j.scienta.2006.12.003; MCCLURE MA, 1974, J NEMATOL, V6, P17; MURRAY MB, 1989, NEW PHYTOL, V113, P307, DOI 10.1111/j.1469-8137.1989.tb02408.x; Nunes MES, 2003, CROP SCI, V43, P1349, DOI 10.2135/cropsci2003.1349; Srivastava HK, 2000, CURR SCI INDIA, V79, P176; STEPONKUS PL, 1984, ANNU REV PLANT PHYS, V35, P543, DOI 10.1146/annurev.pp.35.060184.002551; Venema JH, 2008, ENVIRON EXP BOT, V63, P359, DOI 10.1016/j.envexpbot.2007.12.015; Verslues PE, 2006, PLANT J, V45, P523, DOI 10.1111/j.1365-313X.2005.02593.x; Wang X, 2007, J PLANT PHYSIOL, V164, P1062, DOI 10.1016/j.jplph.2006.06.003; Wen B, 2009, PROTOPLASMA, V236, P29, DOI 10.1007/s00709-009-0044-9; WILNER J., 1960, CANADIAN JOUR PLANT SCI, V40, P630; Xia XT, 2000, MEAS SCI TECHNOL, V11, P430, DOI 10.1088/0957-0233/11/4/314; YAMAKAWA K, 1982, JARQ-JPN AGR RES Q, V15, P175; Zhang JL, 2009, SCI HORTIC-AMSTERDAM, V122, P125, DOI 10.1016/j.scienta.2009.04.002; Zhang T., 1999, HETEROSIS HYBRID SEE, P149; Zhang Xin, 2009, Journal of Tropical and Subtropical Botany, V17, P489; Zhang X, 2012, J INTEGR AGR, V11, P537, DOI 10.1016/S2095-3119(12)60040-9; Zhang Xin, 2010, Guangxi Zhiwu / Guihaia, V30, P391	38	6	6	2	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e63534	10.1371/journal.pone.0063534	http://dx.doi.org/10.1371/journal.pone.0063534			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667634	Green Submitted, Green Published, gold			2022-12-27	WOS:000319654700158
J	Dong, HM; Guo, H; Xie, LX; Wang, G; Zhong, XY; Khoury, T; Tan, DF; Zhang, H				Dong, Hongmei; Guo, Hong; Xie, Liangxi; Wang, Geng; Zhong, Xueyun; Khoury, Thaer; Tan, Dongfeng; Zhang, Hao			The Metastasis-Associated Gene MTA3, a Component of the Mi-2/NuRD Transcriptional Repression Complex, Predicts Prognosis of Gastroesophageal Junction Adenocarcinoma	PLOS ONE			English	Article							LYMPH-NODE INVOLVEMENT; E-CADHERIN EXPRESSION; GASTRIC-CANCER; BREAST-CANCER; SNAIL; FAMILY; PROGRESSION; CARCINOMAS; ESOPHAGEAL; SURVIVAL	Gastroesophageal junction (GEJ) adenocarcinoma carries a poor prognosis that is largely attributable to early and frequent metastasis. The acquisition of metastatic potential in cancer involves epithelial-to-mesenchymal transition (EMT). The metastasis-associated gene MTA3, a novel component of the Mi-2/NuRD transcriptional repression complex, was identified as master regulator of EMT through inhibition of Snail to increase E-cadherin expression in breast cancer. Here, we evaluated the expression pattern of the components of MTA3 pathway and the corresponding prognostic significance in GEJ adenocarcinoma. MTA3 expression was decreased at both protein and mRNA levels in tumor tissues compared to the non-tumorous and lowed MTA3 levels were noted in tumor cell lines with stronger metastatic potential. Immunohistochemical analysis of a cohort of 128 cases exhibited that patients with lower expression of MTA3 had poorer outcomes. Combined misexpression of MTA3, Snail and E-cadherin had stronger correlation with malignant properties. Collectively, results suggest that the MTA3-regulated EMT pathway is altered to favor EMT and, therefore, disease progression and that MTA3 expression was an independent prognostic factor in patients with GEJ adenocarcinoma.	[Dong, Hongmei; Zhang, Hao] Shantou Univ, Coll Med, Affiliated Canc Hosp, Dept Integrat Oncol, Shantou, Peoples R China; [Zhang, Hao] Shantou Univ, Coll Med, Affiliated Canc Hosp, Tumor Tissue Bank, Shantou, Peoples R China; [Guo, Hong; Xie, Liangxi] Shantou Univ, Coll Med, Affiliated Canc Hosp, Dept Radiat Oncol, Shantou, Peoples R China; [Wang, Geng] Shantou Univ, Coll Med, Affiliated Canc Hosp, Dept Thorac Surg, Shantou, Peoples R China; [Dong, Hongmei; Zhang, Hao] Shantou Univ, Coll Med, Canc Res Ctr, Shantou, Peoples R China; [Zhong, Xueyun] Jinan Univ, Coll Med, Dept Pathol, Guangzhou, Guangdong, Peoples R China; [Khoury, Thaer] Roswell Pk Canc Inst, Dept Pathol, Buffalo, NY 14263 USA; [Tan, Dongfeng] Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA	Shantou University; Shantou University; Shantou University; Shantou University; Shantou University; Jinan University; Roswell Park Cancer Institute; University of Texas System; UTMD Anderson Cancer Center	Zhang, H (corresponding author), Shantou Univ, Coll Med, Affiliated Canc Hosp, Dept Integrat Oncol, Shantou, Peoples R China.	haozhang@stu.edu.cn			National Natural Science Foundation of China [30973508, 81071736, 81171994]; The University of Texas MD Anderson Cancer Center; Cancer Center Support Grant from the National Institutes of Health [CA016672]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); The University of Texas MD Anderson Cancer Center; Cancer Center Support Grant from the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work is supported in part by National Natural Science Foundation of China grants 30973508 (HZ), 81071736 (HZ), and 81171994 (LX); The University of Texas MD Anderson Cancer Center is supported in part by a Cancer Center Support Grant (CA016672) from the National Institutes of Health. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bain GH, 2010, ONCOLOGIST, V15, P270, DOI 10.1634/theoncologist.2009-0293; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Bruning A, 2010, HISTOL HISTOPATHOL, V25, P1447, DOI 10.14670/HH-25.1447; Bruning A, 2009, HISTOCHEM CELL BIOL, V132, P33, DOI 10.1007/s00418-009-0595-z; Chan AOO, 2006, WORLD J GASTROENTERO, V12, P199, DOI 10.3748/wjg.v12.i2.199; Chen X, 2003, MOL BIOL CELL, V14, P3208, DOI 10.1091/mbc.E02-12-0833; Dannenmann C, 2008, CANCER BIOL THER, V7, P1462, DOI 10.4161/cbt.7.9.6427; Fearon ER, 2003, CANCER CELL, V3, P307, DOI 10.1016/S1535-6108(03)00087-4; Fujita N, 2004, CELL, V119, P75, DOI 10.1016/j.cell.2004.09.014; Fujita N, 2003, CELL, V113, P207, DOI 10.1016/S0092-8674(03)00234-4; Gu Y, 2006, CANCER-AM CANCER SOC, V106, P1017, DOI 10.1002/cncr.21693; Gulmann C, 2003, APPL IMMUNOHISTO M M, V11, P230; He HY, 2012, CANCER SCI, V103, P1296, DOI 10.1111/j.1349-7006.2012.02295.x; Hosokawa Y, 2012, ANN SURG ONCOL, V19, P677, DOI 10.1245/s10434-011-1983-x; Kim SM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015074; Lagarde SM, 2007, ANN SURG ONCOL, V14, P977, DOI 10.1245/s10434-006-9262-y; Lagarde SM, 2006, AM J SURG PATHOL, V30, P171, DOI 10.1097/01.pas.0000189182.92815.12; Li X, 2009, BLOOD, V114, P5464, DOI 10.1182/blood-2009-06-227777; Maeda H, 2008, J AM COLL SURGEONS, V206, P306, DOI 10.1016/j.jamcollsurg.2007.06.306; Manavathi B, 2007, J BIOL CHEM, V282, P1529, DOI 10.1074/jbc.R600029200; Menges M, 2009, J CANCER RES CLIN, V135, P29, DOI 10.1007/s00432-008-0425-z; Moehler M, 2008, WORLD J GASTROENTERO, V14, P3773, DOI 10.3748/wjg.14.3773; Mylonas I, 2012, HISTOPATHOLOGY, V60, P665, DOI 10.1111/j.1365-2559.2011.04103.x; Nakamura M, 2012, AM SURGEON, V78, P567; Natsugoe S, 2007, ONCOL REP, V17, P517; Pedrazzani C, 2007, J THORAC CARDIOV SUR, V134, P378, DOI 10.1016/j.jtcvs.2007.03.034; Rosivatz E, 2006, VIRCHOWS ARCH, V448, P277, DOI 10.1007/s00428-005-0118-9; Rosivatz E, 2002, AM J PATHOL, V161, P1881, DOI 10.1016/S0002-9440(10)64464-1; Singh RR, 2007, J MAMMARY GLAND BIOL, V12, P115, DOI 10.1007/s10911-007-9043-7; Sobin LH, 2010, CANCER-AM CANCER SOC, V116, P5336, DOI 10.1002/cncr.25537; Stanculescu D, 2011, ROM J MORPHOL EMBRYO, V52, P1107; Uchikado Y, 2011, GASTRIC CANCER, V14, P41, DOI 10.1007/s10120-011-0004-x; Zhang H, 2006, CLIN CANCER RES, V12, P1479, DOI 10.1158/1078-0432.CCR-05-1519; Zhang H, 2006, GENE DEV, V20, P2943, DOI 10.1101/gad.1461706	34	21	23	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2013	8	5							e62986	10.1371/journal.pone.0062986	http://dx.doi.org/10.1371/journal.pone.0062986			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175AS	23671646	gold, Green Published, Green Submitted			2022-12-27	WOS:000321202100049
J	Ou, HY; Wang, CY; Yang, YC; Chen, MF; Chang, CJ				Ou, Horng-Yih; Wang, Chih-Yuan; Yang, Yi-Ching; Chen, Ming-Fong; Chang, Chih-Jen			The Association between Nonalcoholic Fatty Pancreas Disease and Diabetes	PLOS ONE			English	Article							LIVER-DISEASE; METABOLIC SYNDROME; RISK-FACTORS; ALANINE AMINOTRANSFERASE; INSULIN-RESISTANCE; ABDOMINAL OBESITY; ACCUMULATION; STEATOSIS; PATHOGENESIS; INDEXES	Background: Fatty infiltration of the pancreas has been shown to interfere with insulin secretion. Both insulin sensitivity and secretion are important in the pathogenesis of diabetes and prediabetes. However, the relationship between diabetes, prediabetes, and fatty pancreas remains unknown. We aim to investigate the relationships that fatty pancreas and nonalcoholic fatty liver disease (NAFLD) have with prediabetes and diabetes in a Chinese population. Patients and Methods: This was a cross-sectional study. A total of 7,464 subjects were recruited. NAFLD and fatty pancreas were assessed by sonography. Clinico-metabolic parameters were compared among subjects with normoglycemia, prediabetes, and diabetes. Multinomial logistic regression was used to evaluate the relationship between fatty pancreas and NAFLD and diabetes or prediabetes with adjustment for cardiometabolic risk factors. Results: With an increase in glycemia, a significantly greater proportion of subjects had NAFLD and fatty pancreas (test for trend p<0.05). Similar trends were also found for hypertension, general and central obesity, low-HDL cholesterol, and hypertriglyceridemia. In the logistic regression analysis, age, hypertension, male gender, hypertriglyceridemia, and central obesity were significantly associated with prediabetes and diabetes. Furthermore, the ORs of prediabetes and diabetes for NAFLD were 1.798 (95% CI 1.544-2.094) and 2.578 (95% CI 2.024-3.284), respectively. In addition, fatty pancreas was independently related to diabetes (OR, 1.379; 95% CI, 1.047-1.816) and prediabetes (OR, 1.222; 95% CI, 1.002-1.491) in male subjects. Conclusions: Both NAFLD and fatty pancreas were associated with diabetes independent of age, gender, adiposity, and other cardiometabolic risk factors. Fatty pancreas was also related to prediabetes in males.	[Ou, Horng-Yih] Natl Cheng Kung Univ, Coll Med, Natl Cheng Kung Univ Hosp, Dept Internal Med, Tainan 70101, Taiwan; [Wang, Chih-Yuan; Chen, Ming-Fong] Natl Taiwan Univ, Coll Med, Dept Internal Med, Natl Taiwan Univ Hosp, Taipei, Taiwan; [Yang, Yi-Ching; Chang, Chih-Jen] Natl Cheng Kung Univ, Coll Med, Natl Cheng Kung Univ Hosp, Dept Family Med, Tainan 70101, Taiwan	National Cheng Kung University; National Cheng Kung University Hospital; National Taiwan University; National Taiwan University Hospital; National Cheng Kung University; National Cheng Kung University Hospital	Chen, MF (corresponding author), Natl Taiwan Univ, Coll Med, Dept Internal Med, Natl Taiwan Univ Hosp, Taipei, Taiwan.	mfchen@ntu.edu.tw; em75210@email.ncku.edu.tw	Chen, Ming/GVU-8412-2022; Yang, Yi-Ching/C-7033-2014	Yang, Yi-Ching/0000-0003-1391-8040; WANG, CHIH-YUAN/0000-0002-6742-3935				Adams LA, 2005, J HEPATOL, V42, P132, DOI 10.1016/j.jhep.2004.09.012; Al-Haddad M, 2009, PANCREAS, V38, P672, DOI 10.1097/MPA.0b013e3181a9d5af; ALZAID A, 1993, DIABETIC MED, V10, P759, DOI 10.1111/j.1464-5491.1993.tb00160.x; American Diabetes Association, 2010, DIABETES CARE S, V1, pS62; Balkau B, 2010, BMC GASTROENTEROL, V10, DOI 10.1186/1471-230X-10-56; Cornier MA, 2008, ENDOCR REV, V29, P777, DOI 10.1210/er.2008-0024; Coutinho T, 2011, J AM COLL CARDIOL, V57, P1877, DOI 10.1016/j.jacc.2010.11.058; Despres JP, 2006, NATURE, V444, P881, DOI 10.1038/nature05488; Fernandes-Santos C, 2009, PANCREAS, V38, pE80, DOI 10.1097/MPA.0b013e3181987d9d; Finucane MM, 2011, LANCET, V377, P557, DOI 10.1016/S0140-6736(10)62037-5; Fraser A, 2009, DIABETES CARE, V32, P741, DOI 10.2337/dc08-1870; Fraulob JC, 2010, J CLIN BIOCHEM NUTR, V46, P212, DOI 10.3164/jcbn.09-83; Gaujoux S, 2010, SURGERY, V148, P15, DOI 10.1016/j.surg.2009.12.005; Goossens GH, 2008, PHYSIOL BEHAV, V94, P206, DOI 10.1016/j.physbeh.2007.10.010; Hannukainen JC, 2011, J HEPATOL, V54, P545, DOI 10.1016/j.jhep.2010.07.029; Heni M, 2010, DIABETES-METAB RES, V26, P200, DOI 10.1002/dmrr.1073; Kahn SE, 2001, J CLIN ENDOCR METAB, V86, P4047, DOI 10.1210/jc.86.9.4047; Kharroubi I, 2004, ENDOCRINOLOGY, V145, P5087, DOI 10.1210/en.2004-0478; Kim HJ, 2004, ARCH INTERN MED, V164, P2169, DOI 10.1001/archinte.164.19.2169; Kotronen A, 2008, ARTERIOSCL THROM VAS, V28, P27, DOI 10.1161/ATVBAHA.107.147538; Kotronen A, 2007, J CLIN ENDOCR METAB, V92, P3490, DOI 10.1210/jc.2007-0482; Le KA, 2011, DIABETES CARE, V34, P485, DOI 10.2337/dc10-0760; Lee CMY, 2008, J CLIN EPIDEMIOL, V61, P646, DOI 10.1016/j.jclinepi.2007.08.012; Lee JS, 2009, WORLD J GASTROENTERO, V15, P1869, DOI 10.3748/wjg.15.1869; LEE Y, 1994, P NATL ACAD SCI USA, V91, P10878, DOI 10.1073/pnas.91.23.10878; Lonardo A, 2006, J HEPATOL, V44, P1196, DOI 10.1016/j.jhep.2006.03.005; Loria P, 2013, HEPATOL RES, V43, P51, DOI 10.1111/j.1872-034X.2012.01031.x; MARKS WM, 1980, RADIOLOGY, V137, P475, DOI 10.1148/radiology.137.2.7433680; Mathur Abhishek, 2007, HPB (Oxford), V9, P312, DOI 10.1080/13651820701504157; Mathur A, 2007, ANN SURG, V246, P1058, DOI 10.1097/SLA.0b013e31814a6906; Mathur A, 2009, J AM COLL SURGEONS, V208, P989, DOI 10.1016/j.jamcollsurg.2008.12.026; Nannipieri M, 2005, DIABETES CARE, V28, P1757, DOI 10.2337/diacare.28.7.1757; Pitt Henry A, 2007, HPB (Oxford), V9, P92, DOI 10.1080/13651820701286177; Porepa L, 2010, CAN MED ASSOC J, V182, pE526, DOI 10.1503/cmaj.092144; Rasmussen BB, 2002, J CLIN INVEST, V110, P1687, DOI 10.1172/JCI200215715; Rossi AP, 2011, OBESITY, V19, P1747, DOI 10.1038/oby.2011.114; Ruckert IM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022932; Schwenzer NF, 2008, INVEST RADIOL, V43, P330, DOI 10.1097/RLI.0b013e31816a88c6; Sepe PS, 2011, GASTROINTEST ENDOSC, V73, P987, DOI 10.1016/j.gie.2011.01.015; Seppala-Lindroos A, 2002, J CLIN ENDOCR METAB, V87, P3023, DOI 10.1210/jc.87.7.3023; Shimabukuro M, 1998, J BIOL CHEM, V273, P32487, DOI 10.1074/jbc.273.49.32487; Smits MM, 2011, NAT REV GASTRO HEPAT, V8, P169, DOI 10.1038/nrgastro.2011.4; Stefan N, 2008, ENDOCR REV, V29, P939, DOI 10.1210/er.2008-0009; Suzuki A, 2005, HEPATOLOGY, V41, P64, DOI 10.1002/hep.20543; Targher G, 2005, DIABETES, V54, P3541, DOI 10.2337/diabetes.54.12.3541; Tseng CH, 2010, ATHEROSCLEROSIS, V210, P585, DOI 10.1016/j.atherosclerosis.2009.12.015; Tushuizen ME, 2007, DIABETES CARE, V30, P2916, DOI 10.2337/dc07-0326; Utzschneider KM, 2006, J CLIN ENDOCR METAB, V91, P4753, DOI 10.1210/jc.2006-0587; van der Zijl NJ, 2011, J CLIN ENDOCR METAB, V96, P459, DOI 10.1210/jc.2010-1722; van Geenen EJM, 2010, PANCREAS, V39, P1185, DOI 10.1097/MPA.0b013e3181f6fce2; van Raalte DH, 2010, CURR OPIN CLIN NUTR, V13, P478, DOI 10.1097/MCO.0b013e32833aa1ef; Vanni E, 2010, DIGEST LIVER DIS, V42, P320, DOI 10.1016/j.dld.2010.01.016; Vozarova B, 2002, DIABETES, V51, P1889, DOI 10.2337/diabetes.51.6.1889; Zhang XL, 2008, PANCREAS, V37, pE31, DOI 10.1097/MPA.0b013e3181744b50	54	98	105	3	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2013	8	5							e62561	10.1371/journal.pone.0062561	http://dx.doi.org/10.1371/journal.pone.0062561			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175AS	23671610	Green Published, Green Submitted, gold			2022-12-27	WOS:000321202100016
J	Dickin, SK; Schuster-Wallace, CJ; Elliott, SJ				Dickin, Sarah K.; Schuster-Wallace, Corinne J.; Elliott, Susan J.			Developing a Vulnerability Mapping Methodology: Applying the Water-Associated Disease Index to Dengue in Malaysia	PLOS ONE			English	Article							AEDES-AEGYPTI DIPTERA; CLIMATE-CHANGE; TRANSMISSION DYNAMICS; CONCEPTUAL-FRAMEWORK; HABITAT SEGREGATION; ADAPTIVE CAPACITY; HUMAN HEALTH; FEVER; VECTOR; URBAN	The Water-associated Disease Index (WADI) was developed to identify and visualize vulnerability to different water-associated diseases by integrating a range of social and biophysical determinants in map format. In this study vulnerability is used to encompass conditions of exposure, susceptibility, and differential coping capacity to a water-associated health hazard. By assessing these conditions, the tool is designed to provide stakeholders with an integrated and long-term understanding of subnational vulnerabilities to water-associated disease and contribute to intervention strategies to reduce the burden of illness. The objective of this paper is to describe and validate the WADI tool by applying it to dengue. A systemic ecohealth framework that considers links between people, the environment and health was applied to identify secondary datasets, populating the index with components including climate conditions, land cover, education status and water use practices. Data were aggregated to create composite indicators of exposure and of susceptibility in a Geographic Information System (GIS). These indicators were weighted by their contribution to dengue vulnerability, and the output consisted of an overall index visualized in map format. The WADI was validated in this Malaysia case study, demonstrating a significant association with dengue rates at a sub-national level, and illustrating a range of factors that drive vulnerability to the disease within the country. The index output indicated high vulnerability to dengue in urban areas, especially in the capital Kuala Lumpur and surrounding region. However, in other regions, vulnerability to dengue varied throughout the year due to the influence of seasonal climate conditions, such as monsoon patterns. The WADI tool complements early warning models for water-associated disease by providing upstream information for planning prevention and control approaches, which increasingly require a comprehensive and geographically broad understanding of vulnerability for implementation.	[Dickin, Sarah K.; Schuster-Wallace, Corinne J.] McMaster Univ, Sch Geog & Earth Sci, Hamilton, ON, Canada; [Dickin, Sarah K.; Schuster-Wallace, Corinne J.] United Nations Univ Inst Water Environm & Hlth, Hamilton, ON, Canada; [Elliott, Susan J.] Univ Waterloo, Fac Appl Hlth Sci, Waterloo, ON N2L 3G1, Canada	McMaster University; University of Waterloo	Dickin, SK (corresponding author), McMaster Univ, Sch Geog & Earth Sci, Hamilton, ON, Canada.	dickinsk@mcmaster.ca	Dickin, Sarah K/AAJ-1083-2020; Schuster-Wallace, Corinne J/ABE-9445-2020	Schuster-Wallace, Corinne J/0000-0003-0187-0326; Dickin, Sarah K/0000-0003-0437-3755	Social Sciences and Humanities Research Council of Canada	Social Sciences and Humanities Research Council of Canada(Social Sciences and Humanities Research Council of Canada (SSHRC))	This work was carried out with the support of the International Development Research Centre (IDRC) (CoPEH-Can research award). SKD is supported by the Social Sciences and Humanities Research Council of Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adger WN, 2006, GLOBAL ENVIRON CHANG, V16, P268, DOI 10.1016/j.gloenvcha.2006.02.006; [Anonymous], MILL DEV GOALS REP 2; [Anonymous], 2003, MAKING DIFFERENCE IN; Arcari P, 2007, SINGAPORE J TROP GEO, V28, P251, DOI 10.1111/j.1467-9493.2007.00300.x; Ballenger-Browning KK, 2009, TROP MED INT HEALTH, V14, P1542, DOI 10.1111/j.1365-3156.2009.02396.x; Barnett J, 2008, ANN ASSOC AM GEOGR, V98, P102, DOI 10.1080/00045600701734315; Barrera R, 2006, J MED ENTOMOL, V43, P484, DOI 10.1603/0022-2585(2006)43[484:EFIAAD]2.0.CO;2; Batterman S, 2009, ENVIRON HEALTH PERSP, V117, P1023, DOI 10.1289/ehp.0800423; Birkmann J., 2007, Environmental Hazards, V7, P20, DOI 10.1016/j.envhaz.2007.04.002; Birkmann J., 2006, MEASURING VULNERABIL, P55; Bohringer C, 2007, ECOL ECON, V63, P1, DOI 10.1016/j.ecolecon.2007.03.008; Brady OJ, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001760; Braga C, 2010, ACTA TROP, V113, P234, DOI 10.1016/j.actatropica.2009.10.021; Braks MAH, 2003, J MED ENTOMOL, V40, P785, DOI 10.1603/0022-2585-40.6.785; Brocklehurst C, 2010, B WORLD HEALTH ORGAN, V88, P482, DOI 10.2471/BLT.10.080077; Brooks N, 2005, GLOBAL ENVIRON CHANG, V15, P151, DOI 10.1016/j.gloenvcha.2004.12.006; Bunch MJ, 2011, ECOL SOC, V16; Burattini MN, 2008, EPIDEMIOL INFECT, V136, P309, DOI 10.1017/S0950268807008667; Burt FJ, 2011, LANCET, V379, P18; Camara FP, 2009, REV SOC BRAS MED TRO, V42, P137, DOI 10.1590/S0037-86822009000200008; Canyon DV, 1999, J INSECT PHYSIOL, V45, P959, DOI 10.1016/S0022-1910(99)00085-2; Caprara A, 2009, CAD SAUDE PUBLICA, V25, pS125, DOI 10.1590/S0102-311X2009001300012; Chadee DD, 2007, ANN TROP MED PARASIT, V101, P69, DOI 10.1179/136485907X157059; Chadee DD, 2005, TROP MED INT HEALTH, V10, P748, DOI 10.1111/j.1365-3156.2005.01449.x; Chen SC, 2012, SCI TOTAL ENVIRON, V431, P385, DOI 10.1016/j.scitotenv.2012.05.012; Clements ACA, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000431; Cole DC, 1998, SCI TOTAL ENVIRON, V224, P201, DOI 10.1016/S0048-9697(98)00350-7; Cox J, 2007, AM J TROP MED HYG, V76, P820, DOI 10.4269/ajtmh.2007.76.820; Cutter S.L., 2009, FINAL REPORT OXFAM A, V5, P1; Cutter SL, 2000, ANN ASSOC AM GEOGR, V90, P713, DOI 10.1111/0004-5608.00219; Depradine CA, 2004, INT J ENVIRON HEAL R, V14, P429, DOI 10.1080/09603120400012868; DURBIN J, 1951, BIOMETRIKA, V38, P159, DOI 10.1093/biomet/38.1-2.159; Eakin H, 2008, GLOBAL ENVIRON CHANG, V18, P112, DOI 10.1016/j.gloenvcha.2007.09.001; Ebi KL, 2006, ENVIRON HEALTH PERSP, V114, P1930, DOI 10.1289/ehp.8430; Edward Parham Paul, 2009, ENV HLTH PERSPECT, V118, P620, DOI DOI 10.1289/EHP.0901256; Eisenberg JNS, 2007, ENVIRON HEALTH PERSP, V115, P1216, DOI 10.1289/ehp.9806; Fekete A, 2009, NAT HAZARD EARTH SYS, V9, P393, DOI 10.5194/nhess-9-393-2009; Field C.B., 2014, SPEC REP GLOB WARM 1, DOI 10.1017/cbo9780511976988.002; FOCKS DA, 1995, AM J TROP MED HYG, V53, P489, DOI 10.4269/ajtmh.1995.53.489; Focks DA, 2000, AM J TROP MED HYG, V62, P11, DOI 10.4269/ajtmh.2000.62.11; Focks DA, 2006, SCI WORK GROUP M DEN, P92; Fussel HM, 2007, GLOBAL ENVIRON CHANG, V17, P155, DOI 10.1016/j.gloenvcha.2006.05.002; Gamble J, 2000, CLIN SCI, V98, P211, DOI 10.1042/CS19990296; Garriga RG, 2010, J ENVIRON ENG-ASCE, V136, P1287, DOI 10.1061/(ASCE)EE.1943-7870.0000255; Gubler DJ, 1998, CLIN MICROBIOL REV, V11, P480, DOI 10.1128/CMR.11.3.480; Gubler Duane J., 2002, Trends in Microbiology, V10, P100, DOI 10.1016/S0966-842X(01)02288-0; Guzman Maria G., 2002, International Journal of Infectious Diseases, V6, P118, DOI 10.1016/S1201-9712(02)90072-X; Hahn MB, 2009, GLOBAL ENVIRON CHANG, V19, P74, DOI 10.1016/j.gloenvcha.2008.11.002; Hales S, 1999, ENVIRON HEALTH PERSP, V107, P99, DOI 10.2307/3434364; Halstead SB, 2006, REV PANAM SALUD PUBL, V20, P407, DOI 10.1590/S1020-49892006001100007; Hammond SN, 2005, AM J TROP MED HYG, V73, P1063; Hardoy J, 2009, ENVIRON URBAN, V21, P203, DOI 10.1177/0956247809103019; Hii YL, 2009, GLOBAL HEALTH ACTION, V2, P124, DOI 10.3402/gha.v2i0.2036; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hinkel J, 2011, GLOBAL ENVIRON CHANG, V21, P198, DOI 10.1016/j.gloenvcha.2010.08.002; Hopp MJ, 2001, CLIMATIC CHANGE, V48, P441, DOI 10.1023/A:1010717502442; Hurlimann E, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001404; Jain A, 2010, FEMS IMMUNOL MED MIC, V59, P119, DOI 10.1111/j.1574-695X.2010.00670.x; Johansson MA, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000382; Jury MR, 2008, INT J ENVIRON HEAL R, V18, P323, DOI 10.1080/09603120701849836; Keating J, 2001, SOC SCI MED, V53, P1587, DOI 10.1016/S0277-9536(00)00443-3; Khun S, 2007, PLOS NEGLECT TROP D, V1, DOI 10.1371/journal.pntd.0000143; Kittinger JN, 2009, ECOHEALTH, V6, P601, DOI 10.1007/s10393-010-0285-2; Lankao PR, 2011, CURR OPIN ENV SUST, V3, P142, DOI 10.1016/j.cosust.2010.12.016; Lian CW, 2006, TROP BIOMED, V23, P85; Liang S, 2006, B WORLD HEALTH ORGAN, V84, P139, DOI 10.2471/BLT.05.025031; San Martin JL, 2010, AM J TROP MED HYG, V82, P128, DOI 10.4269/ajtmh.2010.09-0346; Malaysian Ministry of Health, 2010, DENG SIT MAL; Mendis K, 2009, TROP MED INT HEALTH, V14, P802, DOI 10.1111/j.1365-3156.2009.02287.x; Metzger MJ, 2006, AGR ECOSYST ENVIRON, V114, P69, DOI 10.1016/j.agee.2005.11.025; Michalos A., 2011, CANADIAN INDEX WELLB; Miettinen J, 2012, REMOTE SENS LETT, V3, P11, DOI 10.1080/01431161.2010.526971; Nagao Y, 2008, EPIDEMIOL INFECT, V136, P843, DOI 10.1017/S0950268807008990; Naiman RJ, 2011, ECOL RES, V26, P865, DOI 10.1007/s11284-010-0693-3; Nardo M., 2005, EUR COM ISPRA, V15, P19; Niemeijer D, 2008, ECOL INDIC, V8, P14, DOI 10.1016/j.ecolind.2006.11.012; Okogun GRA, 2003, ANN AGR ENV MED, V10, P217; Ooi EE, 2001, LANCET, V357, P685, DOI 10.1016/S0140-6736(00)04137-4; Ooi EE, 2009, FUTURE VIROL, V4, P571, DOI 10.2217/FVL.09.55; Patz JA, 2008, MED CLIN N AM, V92, P1473, DOI 10.1016/j.mcna.2008.07.007; Pena R, 2000, AM J PUBLIC HEALTH, V90, P64, DOI 10.2105/AJPH.90.1.64; Peterson AT, 2005, T ROY SOC TROP MED H, V99, P647, DOI 10.1016/j.trstmh.2005.02.004; Poveda G., 1999, P 10 S GLOB CHANG ST, P173; Pruss-Ustun A., 2008, SAFER WATER BETTER H; Racloz V, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001648; Ravallion, 2010, POLICY RES WORKING P; Reid CE, 2009, ENVIRON HEALTH PERSP, V117, P1730, DOI 10.1289/ehp.0900683; Reiter P, 2003, EMERG INFECT DIS, V9, P86; Ricketts TC, 2005, NURS OUTLOOK, V53, P274, DOI 10.1016/j.outlook.2005.06.007; Rodhain Francois, 1997, P45; Rozilawati H, 2007, TROP BIOMED, V24, P83; Schmidt WP, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001082; Schmidtlein MC, 2008, RISK ANAL, V28, P1099, DOI 10.1111/j.1539-6924.2008.01072.x; Schroter D, 2005, SCIENCE, V310, P1333, DOI 10.1126/science.1115233; Shah SA, 2011, EPIDEMIOLOGY, V22, pS144, DOI 10.1097/01.ede.0000392114.75536.dc; Socheat D, 2004, DENGUE B, V28, pS8; Srinivasan R., 2007, Dengue Bulletin, V31, P174; Strickman D, 2002, AM J TROP MED HYG, V67, P247, DOI 10.4269/ajtmh.2002.67.247; Sullivan C, 2002, WORLD DEV, V30, P1195, DOI 10.1016/S0305-750X(02)00035-9; Sullivan CA, 2007, WATER RESOUR MANAG, V21, P111, DOI 10.1007/s11269-006-9044-0; Summers LH, 1992, WORLD BANK WORKING P; Tate E, 2012, NAT HAZARDS, V63, P325, DOI 10.1007/s11069-012-0152-2; Thai KTD, 2011, EXP BIOL MED, V236, P944, DOI 10.1258/ebm.2011.010402; Thiboutot MM, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000623; Tran HP, 2010, INT HEALTH, V2, P136, DOI 10.1016/j.inhe.2009.12.007; Tsuzuki A, 2009, ACTA TROP, V111, P325, DOI 10.1016/j.actatropica.2009.05.010; Tun-Lin W, 2000, MED VET ENTOMOL, V14, P31, DOI 10.1046/j.1365-2915.2000.00207.x; UNDP, 2011, AFR AD PROGR DISC PA; United Nations, 2011, MILL DEV GOALS 2010; United Nations Development Programme, 2009, HUM DEV REP 2007 200; Utarini A, 2003, SOC SCI MED, V56, P701, DOI 10.1016/S0277-9536(02)00066-7; Vos T, 2012, LANCET, V380, P2163, DOI 10.1016/S0140-6736(12)61729-2; Waddington H., 2009, WATER SANITATION HYG; Waltner-Toews D, 2001, CAD SAUDE PUBLICA, V17, pS07; Watt S, 2011, CURR OPIN ENV SUST, V3, P491, DOI 10.1016/j.cosust.2011.10.008; Webb JC, 2010, CAN J PUBLIC HEALTH, V101, P439, DOI 10.1007/BF03403959; Wilder-Smith A, 2011, MED HYPOTHESES, V76, P861, DOI 10.1016/j.mehy.2011.02.037; World Health Organization, 2012, DENG SEV DENG; Wu PC, 2007, ACTA TROP, V103, P50, DOI 10.1016/j.actatropica.2007.05.014; Yusuf AA, 2009, EC ENV PROGRAM SE AS	120	48	48	0	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2013	8	5							e63584	10.1371/journal.pone.0063584	http://dx.doi.org/10.1371/journal.pone.0063584			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	145YI	23667642	gold, Green Published, Green Submitted			2022-12-27	WOS:000319055600064
J	Khazaei, H; Street, K; Bari, A; Mackay, M; Stoddard, FL				Khazaei, Hamid; Street, Kenneth; Bari, Abdallah; Mackay, Michael; Stoddard, Frederick L.			The FIGS (Focused Identification of Germplasm Strategy) Approach Identifies Traits Related to Drought Adaptation in Vicia faba Genetic Resources	PLOS ONE			English	Article							WATER-USE EFFICIENCY; CORE COLLECTIONS; PREDICTIVE ASSOCIATION; SAMPLING STRATEGY; RANDOM FORESTS; WHEAT; RESISTANCE; CLASSIFICATION; DIVERSITY; STRESS	Efficient methods to explore plant agro-biodiversity for climate change adaptive traits are urgently required. The focused identification of germplasm strategy (FIGS) is one such approach. FIGS works on the premise that germplasm is likely to reflect the selection pressures of the environment in which it developed. Environmental parameters describing plant germplasm collection sites are used as selection criteria to improve the probability of uncovering useful variation. This study was designed to test the effectiveness of FIGS to search a large faba bean (Vicia faba L.) collection for traits related to drought adaptation. Two sets of faba bean accessions were created, one from moisture-limited environments, and the other from wetter sites. The two sets were grown under well watered conditions and leaf morpho-physiological traits related to plant water use were measured. Machine-learning algorithms split the accessions into two groups based on the evaluation data and the groups created by this process were compared to the original climate-based FIGS sets. The sets defined by trait data were in almost perfect agreement to the FIGS sets, demonstrating that ecotypic differentiation driven by moisture availability has occurred within the faba bean genepool. Leaflet and canopy temperature as well as relative water content contributed more than other traits to the discrimination between sets, indicating that their utility as drought-tolerance selection criteria for faba bean germplasm. This study supports the assertion that FIGS could be an effective tool to enhance the discovery of new genes for abiotic stress adaptation.	[Khazaei, Hamid; Stoddard, Frederick L.] Univ Helsinki, Dept Agr Sci, Helsinki, Finland; [Street, Kenneth; Bari, Abdallah] Int Ctr Agr Res Dry Areas, Aleppo, Syria; [Mackay, Michael] Univ Queensland, Queensland Alliance Agr & Food Innovat, St Lucia, Qld, Australia	University of Helsinki; CGIAR; International Center for Agricultural Research in the Dry Areas (ICARDA); University of Queensland	Khazaei, H (corresponding author), Univ Helsinki, Dept Agr Sci, Helsinki, Finland.	hamid.khazaei@helsinki.fi	Khazaei, Hamid/E-8195-2018; Stoddard, Frederick/E-6436-2015	Khazaei, Hamid/0000-0002-5202-8764; Stoddard, Frederick/0000-0002-8097-5750	CIMO (Centre for International Mobility); Emil Aaltonen Foundation (Emil Aaltosen Saatio) fellowship; University of Helsinki and Legume Futures [KBBE 2009-1-2-01, 245216]	CIMO (Centre for International Mobility); Emil Aaltonen Foundation (Emil Aaltosen Saatio) fellowship; University of Helsinki and Legume Futures	HK was supported by CIMO (Centre for International Mobility) and is currently supported by Emil Aaltonen Foundation (Emil Aaltosen Saatio) fellowship. The project was also supported by the University of Helsinki and Legume Futures (KBBE 2009-1-2-01, contract 245216 CP-FP 'Legume Futures: Legume supported cropping systems for Europe'). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avola G, 2008, J PLANT PHYSIOL, V165, P796, DOI 10.1016/j.jplph.2007.09.004; Bari A, 2012, GENET RESOUR CROP EV, V59, P1465, DOI 10.1007/s10722-011-9775-5; Barnabas B, 2008, PLANT CELL ENVIRON, V31, P11, DOI 10.1111/j.1365-3040.2007.01727.x; Barros V, 2012, MANAGING THE RISKS OF EXTREME EVENTS AND DISASTERS TO ADVANCE CLIMATE CHANGE ADAPTATION, pIX; BARRS HD, 1962, AUST J BIOL SCI, V15, P413, DOI 10.1071/BI9620413; Bartish GI, 2000, AGR FOOD SCI FINLAND, V9, P279, DOI 10.23986/afsci.5669; Bhullar NK, 2009, P NATL ACAD SCI USA, V106, P9519, DOI 10.1073/pnas.0904152106; Blum A, 2009, FIELD CROP RES, V112, P119, DOI 10.1016/j.fcr.2009.03.009; Blum A, 2011, FUNCT PLANT BIOL, V38, P753, DOI 10.1071/FP11101; Blum A, 2011, PLANT BREEDING FOR WATER-LIMITED ENVIRONMENTS, P11, DOI 10.1007/978-1-4419-7491-4_2; Bouchabke O, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001705; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Brown A. H. D., 1989, The use of plant genetic resources., P136; Brown A. H. D., 1999, Core collections for today and tomorrow., P1; BROWN AHD, 1989, GENOME, V31, P818, DOI 10.1139/g89-144; CASLER MD, 1995, CROP SCI, V35, P1169, DOI 10.2135/cropsci1995.0011183X003500040043x; Crepon K, 2010, FIELD CROP RES, V115, P329, DOI 10.1016/j.fcr.2009.09.016; CUBERO JI, 1974, THEOR APPL GENET, V45, P47, DOI 10.1007/BF00283475; Cutler DR, 2007, ECOLOGY, V88, P2783, DOI 10.1890/07-0539.1; Dimitriadou E, 2010, R LIB E1071; Drake JM, 2006, J APPL ECOL, V43, P424, DOI 10.1111/j.1365-2664.2006.01141.x; Duc G, 1997, FIELD CROP RES, V53, P99, DOI 10.1016/S0378-4290(97)00025-7; Duc G, 2011, CROP ADAPTATION TO CLIMATE CHANGE, P269; Dwivedi SL, 2008, PL BRED RE, V30, P179; El Bouhssini M, 2011, PLANT BREEDING, V130, P96, DOI 10.1111/j.1439-0523.2010.01814.x; El Bouhssini M, 2009, GENET RESOUR CROP EV, V56, P1065, DOI 10.1007/s10722-009-9427-1; Endresen DTF, 2011, CROP SCI, V51, P2036, DOI 10.2135/cropsci2010.12.0717; Endresen DTF, 2010, CROP SCI, V50, P2418, DOI 10.2135/cropsci2010.03.0174; EPPERSON BK, 1990, GENETICS, V124, P757; Fan JW, 2012, CROP SCI, V52, P2341, DOI 10.2135/cropsci2011.11.0603; FAO, 2010, 2 FAO; Fawcett T, 2006, PATTERN RECOGN LETT, V27, P861, DOI 10.1016/j.patrec.2005.10.010; Fischer RA, 1998, CROP SCI, V38, P1467, DOI 10.2135/cropsci1998.0011183X003800060011x; Frankel O. H., 1984, Genetic manipulation: impact on man and society., P161; Freeman EA, 2008, ECOL MODEL, V217, P48, DOI 10.1016/j.ecolmodel.2008.05.015; Fu YB, 2005, THEOR APPL GENET, V111, P530, DOI 10.1007/s00122-005-2044-2; Furman Bonnie J., 2006, Plant Genetic Resources Characterization and Utilization, V4, P2, DOI 10.1079/PGR200599; Gepts P, 2006, CROP SCI, V46, P2278, DOI 10.2135/cropsci2006.03.0169gas; Gollin D, 2000, AM J AGR ECON, V82, P812, DOI 10.1111/0002-9092.00083; Guerin GR, 2012, BIOL LETTERS, V8, P882, DOI 10.1098/rsbl.2012.0458; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hodgkin T., 1995, CORE COLLECTIONS PLA; HOLBROOK CC, 1993, CROP SCI, V33, P859, DOI 10.2135/cropsci1993.0011183X003300040044x; Hothorn T, 2006, J COMPUT GRAPH STAT, V15, P651, DOI 10.1198/106186006X133933; Hu J, 2000, THEOR APPL GENET, V101, P264, DOI 10.1007/s001220051478; Karatzoglou A., 2006, J STAT SOFTW, V15, P1, DOI [10.18637/jss.v015.i09, DOI 10.18637/JSS.V015.I09]; Kaur N, 2008, EUR J PLANT PATHOL, V121, P387, DOI 10.1007/s10658-007-9252-3; Khan HR, 2010, FIELD CROP RES, V115, P279, DOI 10.1016/j.fcr.2009.09.003; Khan HUR, 2007, PLANT SOIL, V292, P205, DOI 10.1007/s11104-007-9217-5; Kuhn M, 2008, J STAT SOFTW, V28, P1, DOI 10.18637/jss.v028.i05; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Liknes GC, 2009, FOR INV AN FIA S 200; Lumpkin TA, 2010, MOLECULAR PLANT BREEDING, P151, DOI 10.1079/9781845933920.0151; Mackay M., 2005, Czech Journal of Genetics and Plant Breeding, V41, P335; Mackay M. C., 1995, P199; Mackay M.C., 2004, P 11 WHEAT BREED ASS, P138; MACKAY MC, 1990, WHEAT GENETIC RESOURCES : MEETING DIVERSE NEEDS, P21; Malosetti M, 2001, GENET RESOUR CROP EV, V48, P381, DOI 10.1023/A:1012003611371; Masi CEA, 1998, J AGR SCI, V131, P259, DOI 10.1017/S0021859698005826; Mba C., 2012, AGR FOOD SECURITY, V1, P7, DOI DOI 10.1186/2048-7010-1-7; McKhann HI, 2004, PLANT J, V38, P193, DOI 10.1111/j.1365-313X.2004.02034.x; Muratova V.S., 1931, B APPL BOT GENET P S, V50, P1; Mut Z, 2010, BULG J AGRIC SCI, V16, P459; Ortiz R, 1998, THEOR APPL GENET, V96, P475, DOI 10.1007/s001220050764; Parra-Quijano M., 2012, Genetic Resources and Crop Evolution, V59, P205, DOI 10.1007/s10722-011-9676-7; Peleg Z, 2005, PLANT CELL ENVIRON, V28, P176, DOI 10.1111/j.1365-3040.2005.01259.x; Pessoa-Filho M, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-127; Polignano G. B., 2001, Plant Genetic Resources Newsletter, P33; Prasad AM, 2006, ECOSYSTEMS, V9, P181, DOI 10.1007/s10021-005-0054-1; R Development Core Team, 2012, R LANG ENV STAT COMP; SPIETH PT, 1979, AM NAT, V113, P247, DOI 10.1086/283383; Steinberg D, 2009, CART CLASSIFICATION; Strobl C, 2009, PSYCHOL METHODS, V14, P323, DOI 10.1037/a0016973; Swets JA, 2000, SCI AM, V283, P82, DOI 10.1038/scientificamerican1000-82; Therneau TM, 1997, 61 MAYO CLIN SECT BI; Tirelli T, 2009, ECOL INFORM, V4, P234, DOI 10.1016/j.ecoinf.2009.07.003; Tohme J, 1996, CROP SCI, V36, P1375, DOI 10.2135/cropsci1996.0011183X003600050048x; Upadhyaya HD, 2001, THEOR APPL GENET, V102, P1292, DOI 10.1007/s00122-001-0556-y; Vavilov N. I., 1926, B APPL BOT GEN PB, V14, P1; WANG H, 1993, CAN J PLANT SCI, V73, P671, DOI 10.4141/cjps93-088; WU L, 1975, HEREDITY, V34, P165, DOI 10.1038/hdy.1975.21; Xu F, 2009, PROG NAT SCI-MATER, V19, P1789, DOI 10.1016/j.pnsc.2009.10.001	82	83	85	2	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2013	8	5							e63107	10.1371/journal.pone.0063107	http://dx.doi.org/10.1371/journal.pone.0063107			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145YI	23667581	gold, Green Published			2022-12-27	WOS:000319055600055
J	Duong, CPM; Westwood, JA; Yong, CSM; Murphy, A; Devaud, C; John, LB; Darcy, PK; Kershaw, MH				Duong, Connie P. M.; Westwood, Jennifer A.; Yong, Carmen S. M.; Murphy, Amanda; Devaud, Christel; John, Liza B.; Darcy, Phillip K.; Kershaw, Michael H.			Engineering T Cell Function Using Chimeric Antigen Receptors Identified Using a DNA Library Approach	PLOS ONE			English	Article							CD28 COSTIMULATION; TUMOR; ACTIVATION; LYMPHOCYTES; EXPRESSION; IMMUNOGLOBULIN; RECOGNITION; DOMAINS; COMPLEX	Genetic engineering of cellular function holds much promise for the treatment of a variety of diseases including gene deficiencies and cancer. However, engineering the full complement of cellular functions can be a daunting genetic exercise since many molecular triggers need to be activated to achieve complete function. In the case of T cells, genes encoding chimeric antigen receptors (CARs) covalently linking antibodies to cytoplasmic signaling domains can trigger some, but not all, cellular functions against cancer cells. To date, relatively few CAR formats have been investigated using a candidate molecule approach, in which rationally chosen molecules were trialed one by one. Therefore, to expedite this arduous process we developed an innovative screening method to screen many thousands of CAR formats to identify genes able to enhance the anticancer ability of T cells. We used a directional in-frame library of randomly assembled signaling domains in a CAR specific for the tumor associated antigen erbB2. Several new and original CARs were identified, one of which had an enhanced ability to lyse cancer cells and inhibit tumor growth in mice. This study highlights novel technology that could be used to screen a variety of molecules for their capacity to induce diverse functions in cells.	[Duong, Connie P. M.; Westwood, Jennifer A.; Yong, Carmen S. M.; Murphy, Amanda; Devaud, Christel; John, Liza B.; Darcy, Phillip K.; Kershaw, Michael H.] Univ Melbourne, Canc Immunol Res Program, Sir Peter MacCallum Dept Oncol, Parkville, Vic 3052, Australia; [Duong, Connie P. M.] Univ Melbourne, Dept Pathol, Parkville, Vic 3052, Australia; [Darcy, Phillip K.; Kershaw, Michael H.] Monash Univ, Dept Immunol, Prahran, Vic, Australia	Peter Maccallum Cancer Center; University of Melbourne; University of Melbourne; Monash University	Kershaw, MH (corresponding author), Univ Melbourne, Canc Immunol Res Program, Sir Peter MacCallum Dept Oncol, Parkville, Vic 3052, Australia.	michael.kershaw@petermac.org	Devaud, Christel'/W-8141-2019	Devaud, Christel'/0000-0003-3511-3219; Kershaw, Michael/0000-0002-2697-487X; Darcy, Phillip/0000-0002-5303-9561; Duong, Connie/0000-0002-9067-8557	National Health and Medical Research Council of Australia [1006188]	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	Funding was provided by the National Health and Medical Research Council of Australia, grant number 1006188 (www.nhmrc.gov.au/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso-Camino V, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007174; BESTWICK RK, 1988, P NATL ACAD SCI USA, V85, P5404, DOI 10.1073/pnas.85.15.5404; Bridgeman JS, 2010, CURR GENE THER, V10, P77; Carpenito C, 2009, P NATL ACAD SCI USA, V106, P3360, DOI 10.1073/pnas.0813101106; ESHHAR Z, 1993, P NATL ACAD SCI USA, V90, P720, DOI 10.1073/pnas.90.2.720; Friedmann-Morvinski D, 2005, BLOOD, V105, P3087, DOI 10.1182/blood-2004-09-3737; Gilham DE, 2002, J IMMUNOTHER, V25, P139, DOI 10.1097/00002371-200203000-00002; Haynes NM, 2002, BLOOD, V100, P3155, DOI 10.1182/blood-2002-04-1041; Lam JS, 1996, HUM GENE THER, V7, P1415, DOI 10.1089/hum.1996.7.12-1415; Lo ASY, 2010, CLIN CANCER RES, V16, P2769, DOI 10.1158/1078-0432.CCR-10-0043; Ma QZ, 2004, CANCER GENE THER, V11, P297, DOI 10.1038/sj.cgt.7700685; Maher J, 2002, NAT BIOTECHNOL, V20, P70, DOI 10.1038/nbt0102-70; Marin V, 2007, EXP HEMATOL, V35, P1388, DOI 10.1016/j.exphem.2007.05.018; Marzo AL, 1999, CANCER RES, V59, P1071; Moeller M, 2004, CANCER GENE THER, V11, P371, DOI 10.1038/sj.cgt.7700710; Monks CRF, 1998, NATURE, V395, P82, DOI 10.1038/25764; Morgan RA, 2012, HUM GENE THER; Padhan K, 2010, IMMUNOLOGY, V129, P322, DOI 10.1111/j.1365-2567.2009.03241.x; Savoldo B, 2011, J CLIN INVEST, V121, P1822, DOI 10.1172/JCI46110; SHILONI E, 1993, CANCER IMMUNOL IMMUN, V37, P286, DOI 10.1007/BF01518450; Song DG, 2012, BLOOD, V119, P696, DOI 10.1182/blood-2011-03-344275; Torikai H, 2012, BLOOD, V119, P5697, DOI 10.1182/blood-2012-01-405365; VITIELLO A, 1991, J EXP MED, V173, P1007, DOI 10.1084/jem.173.4.1007; Wilkie S, 2008, J IMMUNOL, V180, P4901, DOI 10.4049/jimmunol.180.7.4901; Wu J, 1999, SCIENCE, V285, P730, DOI 10.1126/science.285.5428.730; Zhong XS, 2010, MOL THER, V18, P413, DOI 10.1038/mt.2009.210	26	36	37	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e63037	10.1371/journal.pone.0063037	http://dx.doi.org/10.1371/journal.pone.0063037			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667569	Green Published, gold			2022-12-27	WOS:000319654700101
J	Egger, C; Cannet, C; Gerard, C; Jarman, E; Jarai, G; Feige, A; Suply, T; Micard, A; Dunbar, A; Tigani, B; Beckmann, N				Egger, Christine; Cannet, Catherine; Gerard, Christelle; Jarman, Elizabeth; Jarai, Gabor; Feige, Agnes; Suply, Thomas; Micard, Arthur; Dunbar, Andrew; Tigani, Bruno; Beckmann, Nicolau			Administration of Bleomycin via the Oropharyngeal Aspiration Route Leads to Sustained Lung Fibrosis in Mice and Rats as Quantified by UTE-MRI and Histology	PLOS ONE			English	Article							INDUCED PULMONARY-FIBROSIS; DIGITAL IMAGE-ANALYSIS; POLARIZED-LIGHT MICROSCOPY; FIBRILLAR COLLAGEN CONTENT; DIASTOLIC FUNCTION ROLE; QUANTITATIVE ASSESSMENT; SUBEPITHELIAL FIBROSIS; NONINVASIVE ASSESSMENT; ANTINEOPLASTIC AGENTS; FIBROTIC LESIONS	Pulmonary fibrosis can be experimentally induced in small rodents by bleomycin. The antibiotic is usually administered via the intratracheal or intranasal routes. In the present study, we investigated the oropharyngeal aspiration of bleomycin as an alternative route for the induction of lung fibrosis in rats and mice. The development of lung injury was followed in vivo by ultrashort echo time magnetic resonance imaging (UTE-MRI) and by post- mortem analyses (histology of collagen, hydroxyproline determination, and qRT-PCR). In C57BL/6 mice, oropharyngeal aspiration of bleomycin led to more prominent lung fibrosis as compared to intranasal administration. Consequently, the oropharyngeal aspiration route allowed a dose reduction of bleomycin and, therewith, a model refinement. Moreover, the distribution of collagen after oropharyngeal aspiration of bleomycin was more homogenous than after intranasal administration: for the oropharyngeal aspiration route, fibrotic areas appeared all over the lung lobes, while for the intranasal route fibrotic lesions appeared mainly around the largest superior airways. Thus, oropharyngeal aspiration of bleomycin induced morphological changes that were more comparable to the human disease than the intranasal administration route did. Oropharyngeal aspiration of bleomycin led to a homogeneous fibrotic injury also in rat lungs. The present data suggest oropharyngeal aspiration of bleomycin as a less invasive means to induce homogeneous and sustained fibrosis in the lungs of mice and rats.	[Egger, Christine; Cannet, Catherine; Gerard, Christelle; Micard, Arthur; Dunbar, Andrew; Tigani, Bruno; Beckmann, Nicolau] Novartis Inst BioMed Res, Global Imaging Grp, Basel, Switzerland; [Egger, Christine] Univ Basel, Bioctr, CH-4056 Basel, Switzerland; [Jarman, Elizabeth; Jarai, Gabor] Novartis Inst BioMed Res, Dept Resp Dis, Horsham, W Sussex, England; [Feige, Agnes; Suply, Thomas] Novartis Inst BioMed Res, Dev & Mol Pathways Dept, Basel, Switzerland	Novartis; University of Basel; Novartis; Novartis	Beckmann, N (corresponding author), Novartis Inst BioMed Res, Global Imaging Grp, Basel, Switzerland.	nicolau.beckmann@novartis.com	Beckmann, Nicolau/H-7616-2019		Novartis Pharma AG	Novartis Pharma AG	Novartis Pharma AG, is the funder of this study. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials, as detailed online in the guide for authors.	Adachi K, 2010, J TOXICOL SCI, V35, P503, DOI 10.2131/jts.35.503; Andrade GB, 1997, EUR J HISTOCHEM, V41, P203; AUSTYN JM, 1981, EUR J IMMUNOL, V11, P805, DOI 10.1002/eji.1830111013; Babin AL, 2012, MAGN RESON MED, V67, P499, DOI 10.1002/mrm.23009; Babin AL, 2011, J MAGN RESON IMAGING, V33, P603, DOI 10.1002/jmri.22476; Ble FX, 2008, RADIOLOGY, V248, P834, DOI 10.1148/radiol.2482071452; BOSANQUET AG, 1986, CANCER CHEMOTH PHARM, V17, P1, DOI 10.1007/BF00299858; Bradshaw AD, 2010, AM J PHYSIOL-HEART C, V298, pH614, DOI 10.1152/ajpheart.00474.2009; Bradshaw AD, 2009, CIRCULATION, V119, P269, DOI 10.1161/CIRCULATIONAHA.108.773424; BREWSTER CEP, 1990, AM J RESP CELL MOL, V3, P507, DOI 10.1165/ajrcmb/3.5.507; Chua F, 2005, AM J RESP CELL MOL, V33, P9, DOI 10.1165/rcmb.2005-0062TR; Corbel M, 2001, J PATHOL, V193, P538, DOI 10.1002/path.826; De Vooght V, 2009, TOXICOLOGY, V259, P84, DOI 10.1016/j.tox.2009.02.007; Degryse AL, 2010, AM J PHYSIOL-LUNG C, V299, pL442, DOI 10.1152/ajplung.00026.2010; Encarnacion MMD, 2004, AM J TRANSPLANT, V4, P248, DOI 10.1046/j.1600-6143.2003.00311.x; England KA, 2011, AM J PHYSIOL-LUNG C, V301, pL519, DOI 10.1152/ajplung.00383.2009; Farris AB, 2011, J AM SOC NEPHROL, V22, P176, DOI 10.1681/ASN.2009091005; Foster WM, 2001, J APPL PHYSIOL, V90, P1111, DOI 10.1152/jappl.2001.90.3.1111; Galli GG, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002711; Gold LI, 2006, J INVEST DERM SYMP P, V11, P57, DOI 10.1038/sj.jidsymp.5650011; Gong LK, 2005, J ETHNOPHARMACOL, V96, P537, DOI 10.1016/j.jep.2004.09.046; Gong LK, 2004, BIOL PHARM BULL, V27, P634, DOI 10.1248/bpb.27.634; Gross TJ, 2001, NEW ENGL J MED, V345, P517, DOI 10.1056/NEJMra003200; HAY J, 1991, ARCH TOXICOL, V65, P81, DOI 10.1007/BF02034932; Holgate ST, 2000, J ALLERGY CLIN IMMUN, V105, P193, DOI 10.1016/S0091-6749(00)90066-6; Iwasawa T, 2012, EUR J RADIO IN PRESS, DOI [10.1016/j.ejrad.2012.02.014, DOI 10.1016/J.EJRAD.2012.02.014)]; Izbicki G, 2002, INT J EXP PATHOL, V83, P111, DOI 10.1046/j.1365-2613.2002.00220.x; Jeffery PK, 2001, AM J RESP CRIT CARE, V164, pS28, DOI 10.1164/ajrccm.164.supplement_2.2106061; Katzenstein ALA, 1998, AM J RESP CRIT CARE, V157, P1301, DOI 10.1164/ajrccm.157.4.9707039; Lakatos HF, 2006, EXP LUNG RES, V32, P181, DOI 10.1080/01902140600817465; LAZENBY AJ, 1990, AM REV RESPIR DIS, V142, P206, DOI 10.1164/ajrccm/142.1.206; MONTES GS, 1991, MEM I OSWALDO CRUZ, V86, P1; Moon JCC, 2004, J AM COLL CARDIOL, V43, P2260, DOI 10.1016/j.jacc.2004.03.035; Moore BB, 2008, AM J PHYSIOL-LUNG C, V294, pL152, DOI 10.1152/ajplung.00313.2007; Morgan DL, 2008, TOXICOL SCI, V103, P169, DOI 10.1093/toxsci/kfn016; MORRIS L, 1991, DEVELOPMENT, V112, P517; Nart P, 2004, J COMP PATHOL, V130, P235, DOI 10.1016/j.jcpa.2003.11.002; Ophof R, 2004, WOUND REPAIR REGEN, V12, P528, DOI 10.1111/j.1067-1927.2004.012505.x; PICKERING JG, 1991, AM J PATHOL, V138, P1225; Rao GVS, 2003, J TOXICOL ENV HEAL A, V66, P1441, DOI 10.1080/15287390306417; ROCHE WR, 1989, LANCET, V1, P520; ROSSI GA, 1987, AM REV RESPIR DIS, V135, P448; SCHRIER DJ, 1983, AM REV RESPIR DIS, V127, P63, DOI 10.1164/arrd.1983.127.1.63; SHAPIRO SD, 1992, J BIOL CHEM, V267, P4664; SHAPIRO SD, 1993, J BIOL CHEM, V268, P23824; SNIDER GL, 1978, AM REV RESPIR DIS, V117, P1099; Southam DS, 2002, AM J PHYSIOL-LUNG C, V282, pL833, DOI 10.1152/ajplung.00173.2001; Takahashi M, 2010, J MAGN RESON IMAGING, V32, P326, DOI 10.1002/jmri.22267; Takemasa A, 2012, EUR RESPIR J, V40, P1475, DOI 10.1183/09031936.00127011; THRALL RS, 1979, AM J PATHOL, V95, P117; UEDA Y, 1983, ANTIMICROB AGENTS CH, V23, P374, DOI 10.1128/AAC.23.3.374; van Echteld CJA, 2011, J PHARMACOL EXP THER, V337, P335, DOI 10.1124/jpet.110.172635; WHITTAKER P, 1994, BASIC RES CARDIOL, V89, P397, DOI 10.1007/BF00788278; Zhang H, 2006, J BIOMED MATER RES A, V76A, P120, DOI 10.1002/jbm.a.30491; Zurek M, 2012, MAGN RESON MED, V68, P898, DOI 10.1002/mrm.23281	55	69	71	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e63432	10.1371/journal.pone.0063432	http://dx.doi.org/10.1371/journal.pone.0063432			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667616	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000319654700143
J	Gonsalves, L; Law, B; Webb, C; Monamy, V				Gonsalves, Leroy; Law, Brad; Webb, Cameron; Monamy, Vaughan			Foraging Ranges of Insectivorous Bats Shift Relative to Changes in Mosquito Abundance	PLOS ONE			English	Article							AUSTRALIA; FOREST; INSECTS; BEETLE; VESPERTILIONIDAE; FRAGMENTATION; CHIROPTERA; PATTERNS; DENSITY; ECOLOGY	The need to develop effective management strategies for insectivorous bat populations requires an understanding of factors influencing habitat use. Availability of pest prey, such as mosquitoes is likely to be one such factor. To assess whether this is the case, we radio-tracked Vespadelus vulturnus Thomas (little forest bat), a predator of Aedes vigilax Skuse (saltmarsh mosquito), in saltmarsh and adjacent coastal swamp forest during periods of high and low Ae. vigilax abundance. When mosquito abundance in structurally-open saltmarsh was similar to the more cluttered coastal swamp forest, use of saltmarsh by V. vulturnus was disproportionately greater than its availability, with saltmarsh selected preferentially for foraging. However, at times of low Ae. vigilax abundance in saltmarsh, use of saltmarsh by V. vulturnus was reduced and all habitats were used in proportion to availability in the study area. This is the first radio-tracking study to demonstrate a shift in foraging range by an insectivorous bat species correlated with fluctuations in the distribution and abundance of a particular prey resource. The shift in foraging range by V. vulturnus, corresponding with a spatio-temporal variation in abundance of Ae. vigilax highlights the importance of mosquitoes as a dietary item. Broadscale pest control of Ae. vigilax may have ecological implications for the diet and habitat use of V. vulturnus. An adaptive management approach is proposed, whereby careful monitoring of insectivorous bat populations is recommended before and after any application of broadscale mosquito control measures. We also suggest a precautionary approach is taken such that broadscale control of mosquitoes avoids the lactation period of bats, a time when their energetic demands are greatest and when there is reduced risk of contracting mosquito-borne diseases transmitted by Ae. vigilax.	[Gonsalves, Leroy; Monamy, Vaughan] Australian Catholic Univ, Sch Arts & Sci, Sydney, NSW 2059, Australia; [Law, Brad] Forest Sci Ctr, Dept Primary Ind, Beecroft, NSW, Australia; [Webb, Cameron] Westmead Hosp, Dept Med Entomol, Wentworthville, NSW, Australia; [Webb, Cameron] Univ Sydney, Wentworthville, NSW, Australia	Australian Catholic University; University of Sydney; University of Sydney	Gonsalves, L (corresponding author), Australian Catholic Univ, Sch Arts & Sci, Sydney, NSW 2059, Australia.	leroy.gonsalves@acu.edu.au		Webb, Cameron/0000-0003-1029-5140; Law, Bradley/0000-0002-3991-3865	New South Wales Environmental Trust	New South Wales Environmental Trust	Funding for this research was provided by the New South Wales Environmental Trust (http://www.environment.nsw.gov.au/grants/envtrust.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam P, 2009, AUSTRALIAN SALTMARSH ECOLOGY, P1; Adams MD, 2009, FOREST ECOL MANAG, V258, P2090, DOI 10.1016/j.foreco.2009.08.002; AEBISCHER NJ, 1993, ECOLOGY, V74, P1313, DOI 10.2307/1940062; Aguirre LF, 2003, FUNCT ECOL, V17, P201, DOI 10.1046/j.1365-2435.2003.00721.x; ALDRIDGE HDJN, 1988, J MAMMAL, V69, P379, DOI 10.2307/1381393; Belbase S., 2005, THESIS AUSTR CATHOLI; BELL GP, 1982, BEHAV ECOL SOCIOBIOL, V10, P217, DOI 10.1007/BF00299688; Bell SAJ, 2010, NATURAL VEGETATION G; Brigham RM, 1997, CAN J ZOOL, V75, P131, DOI 10.1139/z97-017; Campbell S, 2000, THESIS U MELBOURNE M; Chen XL, 2004, J ARID ENVIRON, V56, P559, DOI 10.1016/S0140-1963(03)00079-X; Churchill S., 2009, AUSTR BATS; De Little SC, 2009, ENVIRON ENTOMOL, V38, P1013, DOI 10.1603/022.038.0408; DEFOLIART G, 1992, CROP PROT, V11, P395, DOI 10.1016/0261-2194(92)90020-6; Driscoll DA, 2005, CONSERV BIOL, V19, P182, DOI 10.1111/j.1523-1739.2005.00586.x; FENTON MB, 1990, CAN J ZOOL, V68, P411, DOI 10.1139/z90-061; FOSTER WA, 1995, ANNU REV ENTOMOL, V40, P443, DOI 10.1146/annurev.en.40.010195.002303; Fukui D, 2006, J ANIM ECOL, V75, P1252, DOI 10.1111/j.1365-2656.2006.01146.x; GERELL R, 1993, BIOL CONSERV, V65, P153, DOI 10.1016/0006-3207(93)90444-6; Gonsalves L, 2012, THESIS AUSTR CATHOLI; Gonsalves Leroy, 2012, Pacific Conservation Biology, V18, P282; Gonsalves L, 2013, WILDLIFE RES, V40, P10, DOI 10.1071/WR12148; Griffin D. R., 1960, Animal Behaviour, V8, P141, DOI 10.1016/0003-3472(60)90022-1; Herr A, 1998, THESIS C STURT U THU; Hoye, 2002, PILOT SURVEY MICROCH; Hutson A, 2001, MICROCHIROPTERAN BAT; Irmler U, 2002, BIODIVERS CONSERV, V11, P1129, DOI 10.1023/A:1016018021533; KLEIN BC, 1989, ECOLOGY, V70, P1715, DOI 10.2307/1938106; Kokkinn MJ, 2009, MED VET ENTOMOL, V23, P85, DOI 10.1111/j.1365-2915.2008.00787.x; Laegdsgaard P., 2004, WETLANDS, V22, P29; Lamb S, 2009, THESIS AUSTR CATHOLI; Law B, 2002, J APPL ECOL, V39, P605, DOI 10.1046/j.1365-2664.2002.00739.x; Law BS, 2000, AUSTRAL ECOL, V25, P352, DOI 10.1046/j.1442-9993.2000.01046.x; LUNNEY D, 1988, Australian Mammalogy, V11, P167; Major RE, 2003, BIOL CONSERV, V113, P35, DOI 10.1016/S0006-3207(02)00347-6; Pavey CR, 2001, BIOTROPICA, V33, P670, DOI 10.1646/0006-3606(2001)033[0670:DBOTFB]2.0.CO;2; Payne R, 2006, MICROBAT SMALL MAMMA; Poulin B, 2010, J APPL ECOL, V47, P884, DOI 10.1111/j.1365-2664.2010.01821.x; Rainho A, 2010, J APPL ECOL, V47, P850, DOI 10.1111/j.1365-2664.2010.01820.x; Rodgers A. R., 2005, HRT HOME RANGE TOOLS; Rohe D.L., 1979, Bulletin of the Society of Vector Ecologists, V4, P24; Russell R. C., 1995, Review of Medical and Veterinary Entomology, V83, P141; Russell RC, 1998, INT J PARASITOL, V28, P955, DOI 10.1016/S0020-7519(98)00053-8; RUSSELL RC, 1996, COLOUR PHOTO ATLAS M; Russell TL, 2008, AUST J ENTOMOL, V47, P232, DOI 10.1111/j.1440-6055.2008.00642.x; Rydell J., 1990, Bats (Austin), V8, P8; Saintilan N, 1999, GLOBAL ECOL BIOGEOGR, V8, P117, DOI 10.1046/j.1365-2699.1999.00133.x; Schnitzler HU, 1998, ECHOLOCATING BATS SE, P183; SPEAKMAN JR, 1991, MAMMAL REV, V21, P123, DOI 10.1111/j.1365-2907.1991.tb00114.x; STUDIER EH, 1973, COMP BIOCHEM PHYSIOL, V44, P467, DOI 10.1016/0300-9629(73)90499-4; Webb C, 2002, THESIS U SYDNEY SYDN; Webb CE, 2011, ANN REPORT MOSQUITO; WYATT TD, 1988, ECOL ENTOMOL, V13, P453, DOI 10.1111/j.1365-2311.1988.tb00378.x	53	34	35	1	93	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e64081	10.1371/journal.pone.0064081	http://dx.doi.org/10.1371/journal.pone.0064081			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667699	Green Submitted, Green Published, gold			2022-12-27	WOS:000319654700202
J	Muhumuza, S; Olsen, A; Katahoire, A; Nuwaha, F				Muhumuza, Simon; Olsen, Annette; Katahoire, Anne; Nuwaha, Fred			Uptake of Preventive Treatment for Intestinal Schistosomiasis among School Children in Jinja District, Uganda: A Cross Sectional Study	PLOS ONE			English	Article							NEGLECTED TROPICAL DISEASES; SOIL-TRANSMITTED HELMINTHS; PRAZIQUANTEL; INFECTION; EFFICACY; MANSONI; IMPACT; INTERVENTIONS; CHEMOTHERAPY; MANAGEMENT	Background: In Uganda, the current national health sector strategic and investment plan underscores schistosomiasis as one of the diseases targeted for elimination by the year 2015. However, uptake of treatment among school children is unknown but suspected to be low. We estimated the uptake and predictors of preventive treatment with praziquantel. Methods: In a cross sectional study carried out in Jinja district of Uganda, a random sample of 1,010 children in 12 primary schools was questioned about their uptake of praziquantel, knowledge and perceptions about schistosomiasis, support for taking preventive treatment and the dangers of taking praziquantel. The prevalence and mean intensity of infection with Schistosoma mansoni were determined. Results: Self reported uptake of praziquantel at last mass treatment was 28.2% (95% confidence interval (CI): 22.9%-33.6%). Overall prevalence and mean intensity of S. mansoni infection was 35% (95% CI: 25.4%-37.9%) and 116.1 eggs per gram (epg) of stool (95% CI: 98.3-137.1) respectively. Uptake of praziquantel was more likely if a child was from a school with high prevalence of infection, had knowledge about schistosomiasis transmission and prevention, and reported teachers' support to take praziquantel. Of the 285 children who took praziquantel, 142 (49.8%) developed side effects. Of the 725 children who did not take the drug, 522 (72.0%) reported fear of side effects as a major reason for non-uptake. Conclusions: Uptake of praziquantel in this population is very low. Fear of side effects of praziquantel, lack of knowledge about schistosomiasis transmission and prevention and lack of teacher support are some of the major factors associated with low uptake.	[Muhumuza, Simon; Katahoire, Anne] Makerere Univ, Sch Med, Child Hlth & Dev Ctr, Kampala, Uganda; [Olsen, Annette] Univ Copenhagen, Fac Hlth & Med Sci, Sect Parasitol Hlth & Dev, Copenhagen, Denmark; [Nuwaha, Fred] Makerere Univ, Sch Publ Hlth, Kampala, Uganda	Makerere University; University of Copenhagen; Makerere University	Muhumuza, S (corresponding author), Makerere Univ, Sch Med, Child Hlth & Dev Ctr, Kampala, Uganda.	simonmhmz@yahoo.com		Olsen, Annette/0000-0001-9352-621X	DANIDA	DANIDA	DANIDA: The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen T, 2012, LANCET, V379, P1097, DOI 10.1016/S0140-6736(12)60159-7; Brooker S, 2001, TROP MED INT HEALTH, V6, P1075, DOI 10.1046/j.1365-3156.2001.00806.x; Chitsulo L, 2000, ACTA TROP, V77, P41, DOI 10.1016/S0001-706X(00)00122-4; DFID, 2012, UK PROT 140 MILL NEG; Engels D, 2002, ACTA TROP, V82, P139, DOI 10.1016/S0001-706X(02)00045-1; Fleming FM, 2009, PARASITOLOGY, V136, P1759, DOI 10.1017/S0031182009990709; Frenzel K, 1999, AM J TROP MED HYG, V60, P927, DOI 10.4269/ajtmh.1999.60.927; Glinz D, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000754; Gryseels B, 2006, LANCET, V368, P1106, DOI 10.1016/S0140-6736(06)69440-3; Guyatt HL, 2001, B WORLD HEALTH ORGAN, V79, P695; Hatz CF, 1998, AM J TROP MED HYG, V59, P775, DOI 10.4269/ajtmh.1998.59.775; Hotez P.J., 2006, HELMINTH INFECT SOIL; Jukes MCH, 2002, TROP MED INT HEALTH, V7, P104, DOI 10.1046/j.1365-3156.2002.00843.x; Kabatereine NB, 2007, B WORLD HEALTH ORGAN, V85, P91, DOI 10.2471/BLT.06.030353; Kabatereine NB, 2003, T ROY SOC TROP MED H, V97, P599, DOI 10.1016/S0035-9203(03)80044-5; Kabatereine NB, 2004, TROP MED INT HEALTH, V9, P372, DOI 10.1046/j.1365-3156.2003.01176.x; Katz N, 1972, Rev Inst Med Trop Sao Paulo, V14, P397; Khairy A. A. M., 1995, Eastern Mediterranean Health Journal, V1, P215; Kironde Samson, 2002, Afr Health Sci, V2, P16; Krug EG, 2002, LANCET, V360, P1083, DOI 10.1016/S0140-6736(02)11133-0; Lansdown R, 2002, HEALTH EDUC RES, V17, P425, DOI 10.1093/her/17.4.425; M.O.H, 2010, HLTH SECT STRAT INV; Mafe MA, 2005, ACTA TROP, V93, P181, DOI 10.1016/j.actatropica.2004.11.004; Magnussen P, 2001, T ROY SOC TROP MED H, V95, P58, DOI 10.1016/S0035-9203(01)90333-5; Montresor A., 1998, WORLD HLTH ORG; Montresor A, 2011, T ROY SOC TROP MED H, V105, P361, DOI 10.1016/j.trstmh.2011.04.003; Muhumuza S, 2009, TROP MED INT HEALTH, V14, P612, DOI 10.1111/j.1365-3156.2009.02273.x; N'Goran EK, 2003, ANN TROP MED PARASIT, V97, P37, DOI 10.1179/000349803125002553; Nsungwa-Sabiiti J, 2004, TROP MED INT HEALTH, V9, P1191, DOI 10.1111/j.1365-3156.2004.01319.x; Nuwaha F, 1997, E AFR MED J, V74, P690; Parker M, 2012, J BIOSOC SCI, V27, P1; Parker M, 2008, J BIOSOC SCI, V40, P161, DOI 10.1017/S0021932007002301; Parker M, 2011, HEALTH RES POLICY SY, V9, DOI 10.1186/1478-4505-9-3; Savioli L, 2009, PARASITOLOGY, V136, P1677, DOI 10.1017/S0031182009991181; Schall V, 2001, MEM I OSWALDO CRUZ, V96, P35, DOI 10.1590/S0074-02762001000900005; Sousa-Figueiredo JC, 2010, INT HEALTH, V2, P103, DOI 10.1016/j.inhe.2010.02.003; Utzinger J, 2003, ANTIMICROB AGENTS CH, V47, P1487, DOI 10.1128/AAC.47.5.1487-1495.2003; World Health Organization, 2002, PREV CONTR SCHIST SO; Yuan LP, 2005, ACTA TROP, V96, P248, DOI 10.1016/j.actatropica.2005.07.019	39	39	39	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e63438	10.1371/journal.pone.0063438	http://dx.doi.org/10.1371/journal.pone.0063438			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	154EP	23667617	gold, Green Published, Green Submitted			2022-12-27	WOS:000319654700144
J	Wang, S; Hou, WG; Dong, HL; Jiang, HC; Huang, LQ; Wu, G; Zhang, CL; Song, ZQ; Zhang, Y; Ren, HL; Zhang, J; Zhang, L				Wang, Shang; Hou, Weiguo; Dong, Hailiang; Jiang, Hongchen; Huang, Liuqin; Wu, Geng; Zhang, Chuanlun; Song, Zhaoqi; Zhang, Yong; Ren, Huilei; Zhang, Jing; Zhang, Li			Control of Temperature on Microbial Community Structure in Hot Springs of the Tibetan Plateau	PLOS ONE			English	Article							YELLOWSTONE-NATIONAL-PARK; 16S RIBOSOMAL-RNA; MOLECULAR CHARACTERIZATION; SPECIES COMPOSITION; GENOME SEQUENCE; SP-NOV.; DIVERSITY; BACTERIA; HYDROGEN; MATS	The Tibetan Plateau in Northwest China hosts a number of hot springs that represent a biodiversity hotspot for thermophiles, yet their diversity and relationship to environmental conditions are poorly explored in these habitats. In this study we investigated microbial diversity and community composition in 13 Tibetan hot springs with a wide range of temperatures (22.1-75 degrees C) and other geochemical conditions by using the 16S rRNA gene pyrosequencing approach. Bacteria (10(8)-10(11) copy/g; 42 bacterial phyla) in Tibetan hot springs were more abundant and far more diverse than Archaea (10(7)-10(10) copy/g; 5 archaeal phyla). The dominant bacterial phyla systematically varied with temperature. Moderate temperatures (75-66 degrees C) favored Aquificae, GAL35, and novel Bacteria, whereas low temperatures (60-22.1 degrees C) selected for Deinococcus-Thermus, Cyanobacteria, and Chloroflexi. The relative abundance of Aquificae was correlated positively with temperature, but the abundances of Deinococcus-Thermus, Cyanobacteria, and Chloroflexi were negatively correlated with temperature. Cyanobacteria and Chloroflexi were abundant in Tibetan hot springs and their abundances were positively correlated at low temperatures (55-43 degrees C) but negatively correlated at moderate temperatures (75-55 degrees C). These correlation patterns suggest a complex physiological relationship between these two phyla. Most archaeal sequences were related to Crenarchaeota with only a few related to Euryarchaeota and Thaumarchaeota. Despite the fact that microbial composition in Tibetan hot springs was strongly shaped by temperature, microbial diversity (richness, evenness and Shannon diversity) was not significantly correlated with temperature change. The results of this study expand our current understanding of microbial ecology in Tibetan hot springs and provide a basis for a global comparison.	[Wang, Shang; Hou, Weiguo; Dong, Hailiang; Huang, Liuqin; Zhang, Yong; Ren, Huilei] China Univ Geosci, State Key Lab Biogeol & Environm Geol, Beijing, Peoples R China; [Wang, Shang; Hou, Weiguo; Dong, Hailiang; Huang, Liuqin; Zhang, Yong; Ren, Huilei] China Univ Geosci, Sch Earth Sci & Resources, Beijing, Peoples R China; [Dong, Hailiang; Zhang, Jing; Zhang, Li] Miami Univ, Dept Geol & Environm Earth Sci, Oxford, OH 45056 USA; [Jiang, Hongchen; Wu, Geng] China Univ Geosci, State Key Lab Biogeol & Environm Geol, Wuhan 430074, Peoples R China; [Zhang, Chuanlun] Tongji Univ, State Key Lab Marine Geol, Sch Ocean Earth Sci, Shanghai 200092, Peoples R China; [Zhang, Chuanlun] Univ Georgia, Dept Marine Sci, Athens, GA 30602 USA; [Song, Zhaoqi] Yunnan Univ, Lab Conservat & Utilizat Bioresources, Yunnan Inst Microbiol, Kunming, Peoples R China	China University of Geosciences; China University of Geosciences; University System of Ohio; Miami University; China University of Geosciences; Tongji University; University System of Georgia; University of Georgia; Yunnan University	Dong, HL (corresponding author), China Univ Geosci, State Key Lab Biogeol & Environm Geol, Beijing, Peoples R China.	dongh@cugb.edu.cn; hongchen.jiang@gmail.com	Wu, Geng/G-9740-2018; hou, wei/GWM-4800-2022; Jiang, Hongchen/I-5838-2016; Jiang, Hongchen/Y-9471-2018; WU, Geng/F-8840-2010	Jiang, Hongchen/0000-0003-1271-7028; WU, Geng/0000-0002-7259-1044; Dong, Hailiang/0000-0002-7468-1350	National Natural Science Foundation grants of China [41030211, 41002123, 40972211]; Key Project of International Cooperation of China Ministry of Science & Technology (MOST) [2013DFA31980]; Scientific Research Funds for the 1000 "Talents'' Program Plan from China University of Geosciences-Beijing; Tongji University; National Science Foundation [OISE-0968421, DBI REU 1005223, ETBC-1024614]; Program for New Century Excellent Talents in University [NCET-12-0954]	National Natural Science Foundation grants of China(National Natural Science Foundation of China (NSFC)); Key Project of International Cooperation of China Ministry of Science & Technology (MOST); Scientific Research Funds for the 1000 "Talents'' Program Plan from China University of Geosciences-Beijing; Tongji University; National Science Foundation(National Science Foundation (NSF)); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET))	This work was supported by the National Natural Science Foundation grants of China (41030211, 41002123 and 40972211), the Key Project of International Cooperation of China Ministry of Science & Technology (MOST) (No. 2013DFA31980), the Scientific Research Funds for the 1000 "Talents'' Program Plan from China University of Geosciences-Beijing (H.D.) and Tongji University (C.Z.), and National Science Foundation grants (OISE-0968421, DBI REU 1005223, and ETBC-1024614), and the Program for New Century Excellent Talents in University (NCET-12-0954). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; [Anonymous], 2010, R LANG ENV STAT COMP; Baker GC, 2003, J MICROBIOL METH, V55, P541, DOI 10.1016/j.mimet.2003.08.009; Belkova NL, 2007, MICROBIOL RES, V162, P99, DOI 10.1016/j.micres.2006.01.006; Blank CE, 2002, APPL ENVIRON MICROB, V68, P5123, DOI 10.1128/AEM.68.10.5123-5135.2002; Bonch-Osmolovskaya EA, 1999, MICROBIOLOGY+, V68, P343; Boomer SM, 2009, APPL ENVIRON MICROB, V75, P2464, DOI 10.1128/AEM.01802-08; Caporaso JG, 2010, BIOINFORMATICS, V26, P266, DOI 10.1093/bioinformatics/btp636; CLARKE KR, 1993, MAR ECOL PROG SER, V92, P205, DOI 10.3354/meps092205; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; Cole JK, 2012, ISME J, DOI [10.1038/ismej.2012.1157, DOI 10.1038/ISMEJ.2012.1157]; Costa KC, 2009, EXTREMOPHILES, V13, P447, DOI 10.1007/s00792-009-0230-x; Cox A, 2011, CHEM GEOL, V280, P344, DOI 10.1016/j.chemgeo.2010.11.022; Dodsworth JA, 2011, ENVIRON MICROBIOL, V13, P2371, DOI 10.1111/j.1462-2920.2011.02508.x; Eberl D.D., 2003, 0378 US GEOL SURV, P47; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Everroad RC, 2012, MICROBES ENVIRON, V27, P374, DOI 10.1264/jsme2.ME11350; Finke N, 2013, ENVIRON MICROBIOL, V15, P1532, DOI 10.1111/1462-2920.12032; Gadd GM, 2010, MICROBIOL-SGM, V156, P609, DOI 10.1099/mic.0.037143-0; Gumerov VM, 2011, MICROBIOLOGY+, V80, P244, DOI 10.1134/S002626171102007X; Haas BJ, 2011, GENOME RES, V21, P494, DOI 10.1101/gr.112730.110; Hall JR, 2008, APPL ENVIRON MICROB, V74, P4910, DOI 10.1128/AEM.00233-08; Hanada S., 2003, MICROBES ENVIRON, V18, P51, DOI [10.1264/jsme2.18.51, DOI 10.1264/JSME2.18.51]; Hjorleifsdottir S, 2001, MICROBIAL ECOL, V42, P117; Hobel CFV, 2005, APPL ENVIRON MICROB, V71, P2771, DOI 10.1128/AEM.71.5.2771-2776.2005; Hou WG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053350; Huang QY, 2011, EXTREMOPHILES, V15, P549, DOI 10.1007/s00792-011-0386-z; Jiang HC, 2010, APPL ENVIRON MICROB, V76, P4538, DOI 10.1128/AEM.00143-10; Kanokratana P, 2004, J BASIC MICROB, V44, P430, DOI 10.1002/jobm.200410388; Klatt CG, 2007, ENVIRON MICROBIOL, V9, P2067, DOI 10.1111/j.1462-2920.2007.01323.x; Kubo K, 2011, SYST APPL MICROBIOL, V34, P293, DOI 10.1016/j.syapm.2010.12.002; Kunin V, 2010, ENVIRON MICROBIOL, V12, P118, DOI 10.1111/j.1462-2920.2009.02051.x; Kuznetsov BB, 2011, J BACTERIOL, V193, P321, DOI 10.1128/JB.00931-10; Lalonde SV, 2005, GEOBIOLOGY, V3, P41, DOI 10.1111/j.1472-4669.2005.00042.x; Lane D.J., 1991, NUCL ACID TECH BACT, P115, DOI DOI 10.1007/S00227-012-2133-0; Lau CY, 2008, GEOBIOLOGY, V6, P136, DOI 10.1111/j.1472-4669.2007.00124.x; Lau MCY, 2009, EXTREMOPHILES, V13, P139, DOI 10.1007/s00792-008-0205-3; Lebedeva EV, 2011, FEMS MICROBIOL ECOL, V75, P195, DOI 10.1111/j.1574-6941.2010.01006.x; Liu ZF, 2011, ISME J, V5, P1279, DOI 10.1038/ismej.2011.37; Lozupone C, 2011, ISME J, V5, P169, DOI 10.1038/ismej.2010.133; Meyer-Dombard DR, 2005, GEOBIOLOGY, V3, P211, DOI 10.1111/j.1472-4669.2005.00052.x; Miller SR, 2009, APPL ENVIRON MICROB, V75, P4565, DOI 10.1128/AEM.02792-08; MUYZER G, 1993, APPL ENVIRON MICROB, V59, P695, DOI 10.1128/AEM.59.3.695-700.1993; Nakagawa T, 2003, APPL ENVIRON MICROB, V69, P7044, DOI 10.1128/AEM.69.12.7044-7057.2003; Nakagawa T, 2002, J GEN APPL MICROBIOL, V48, P211, DOI 10.2323/jgam.48.211; Nobre MF, 1996, INT J SYST BACTERIOL, V46, P604, DOI 10.1099/00207713-46-2-604; Nubel U, 2001, APPL ENVIRON MICROB, V67, P4365, DOI 10.1128/AEM.67.9.4365-4371.2001; Nubel U, 1997, APPL ENVIRON MICROB, V63, P3327; Ochsenreiter T, 2003, ENVIRON MICROBIOL, V5, P787, DOI 10.1046/j.1462-2920.2003.00476.x; Osburn MR, 2011, GEOCHIM COSMOCHIM AC, V75, P4830, DOI 10.1016/j.gca.2011.05.038; Otaki H, 2012, MICROBES ENVIRON, V27, P293, DOI 10.1264/jsme2.ME11348; Pearson A, 2008, APPL ENVIRON MICROB, V74, P3523, DOI 10.1128/AEM.02450-07; Purcell D, 2007, FEMS MICROBIOL ECOL, V60, P456, DOI 10.1111/j.1574-6941.2007.00302.x; Reysenbach A.L., 2005, GEOTHERMAL BIOL GEOC, P129; Reysenbach AL, 2009, J BACTERIOL, V191, P1992, DOI 10.1128/JB.01645-08; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Schloss PD, 2004, MICROBIOL MOL BIOL R, V68, P686, DOI 10.1128/MMBR.68.4.686-691.2004; Skirnisdottir S, 2000, APPL ENVIRON MICROB, V66, P2835, DOI 10.1128/AEM.66.7.2835-2841.2000; Sompong U, 2005, FEMS MICROBIOL ECOL, V52, P365, DOI 10.1016/j.femsec.2004.12.007; Spear JR, 2005, P NATL ACAD SCI USA, V102, P2555, DOI 10.1073/pnas.0409574102; Spear JR, 2005, GEOTHERMAL BIOL GEOC, P113; STRAUSS G, 1993, EUR J BIOCHEM, V215, P633, DOI 10.1111/j.1432-1033.1993.tb18074.x; Takai K, 2003, INT J SYST EVOL MICR, V53, P1947, DOI 10.1099/ijs.0.02773-0; Tang KH, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-334; Tobler DJ, 2011, EXTREMOPHILES, V15, P473, DOI 10.1007/s00792-011-0378-z; Tringe SG, 2008, CURR OPIN MICROBIOL, V11, P442, DOI 10.1016/j.mib.2008.09.011; van der Meer MTJ, 2000, ENVIRON MICROBIOL, V2, P428, DOI 10.1046/j.1462-2920.2000.00124.x; Vick TJ, 2010, GEOBIOLOGY, V8, P140, DOI 10.1111/j.1472-4669.2009.00228.x; Ward DM, 1998, MICROBIOL MOL BIOL R, V62, P1353, DOI 10.1128/MMBR.62.4.1353-1370.1998; Ward DM, 1987, ECOLOGY MICROBIAL CO, P179; Wittebolle L, 2009, NATURE, V458, P623, DOI 10.1038/nature07840; Yamada T, 2006, INT J SYST EVOL MICR, V56, P1331, DOI 10.1099/ijs.0.64169-0; Yamada T, 2009, MICROBES ENVIRON, V24, P205, DOI 10.1264/jsme2.ME09151S; Yim LC, 2006, FEMS MICROBIOL ECOL, V57, P80, DOI 10.1111/j.1574-6941.2006.00104.x; Zhang CL, 2008, APPL ENVIRON MICROB, V74, P6417, DOI 10.1128/AEM.00843-08; Zhao P, 2002, ACTA PETROL SIN, V18, P539; [No title captured]	77	99	107	2	88	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e62901	10.1371/journal.pone.0062901	http://dx.doi.org/10.1371/journal.pone.0062901			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667538	gold, Green Published, Green Submitted			2022-12-27	WOS:000319654700077
J	Gu, WJ; Wang, XF; Zhai, CY; Zhou, T; Xie, XY				Gu, Wanjun; Wang, Xiaofei; Zhai, Chuanying; Zhou, Tong; Xie, Xueying			Biological Basis of miRNA Action when Their Targets Are Located in Human Protein Coding Region	PLOS ONE			English	Article							RNA SECONDARY STRUCTURE; SYNONYMOUS CODON USAGE; MICRORNA TARGETS; TRANSLATION EFFICIENCY; ARABIDOPSIS-THALIANA; SPLICING ENHANCERS; MESSENGER-RNAS; EVOLUTION; SELECTION; SITES	Recent analyses have revealed many functional microRNA (miRNA) targets in mammalian protein coding regions. But, the mechanisms that ensure miRNA function when their target sites are located in protein coding regions of mammalian mRNA transcripts are largely unknown. In this paper, we investigate some potential biological factors, such as target site accessibility and local translation efficiency. We computationally analyze these two factors using experimentally identified miRNA targets in human protein coding region. We find site accessibility is significantly increased in miRNA target region to facilitate miRNA binding. At the mean time, local translation efficiency is also selectively decreased near miRNA target region. GC-poor codons are preferred in the flank region of miRNA target sites to ease the access of miRNA targets. Within-genome analysis shows substantial variations of site accessibility and local translation efficiency among different miRNA targets in the genome. Further analyses suggest target gene's GC content and conservation level could explain some of the differences in site accessibility. On the other hand, target gene's functional importance and conservation level can affect local translation efficiency near miRNA target region. We hence propose both site accessibility and local translation efficiency are important in miRNA action when miRNA target sites are located in mammalian protein coding regions.	[Gu, Wanjun; Wang, Xiaofei; Zhai, Chuanying; Xie, Xueying] Southeast Univ, Res Ctr Learning Sci, Nanjing, Jiangsu, Peoples R China; [Zhou, Tong] Univ Illinois, Inst Personalized Resp Med, Chicago, IL USA; [Zhou, Tong] Univ Illinois, Dept Med, Sect Pulm Crit Care Sleep & Allergy, Chicago, IL USA	Southeast University - China; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Gu, WJ (corresponding author), Southeast Univ, Res Ctr Learning Sci, Nanjing, Jiangsu, Peoples R China.	wanjungu@gmail.com; tongzhou@uic.edu; xxying.rcls@seu.edu.cn	Gu, Wanjun/P-5389-2019	Gu, Wanjun/0000-0003-4501-0539	National Basic Research Program of China [2012CB316501]; National High Technology Research and Development Program of China [2012AA020401]; National Natural Science Foundation of China [30900836, 61171143, 61001175]; Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry, China	National Basic Research Program of China(National Basic Research Program of China); National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry, China(Scientific Research Foundation for the Returned Overseas Chinese ScholarsMinistry of Education, China)	This work was supported by grants from the National Basic Research Program of China (2012CB316501), the National High Technology Research and Development Program of China (2012AA020401), the National Natural Science Foundation of China (30900836, 61171143 and 61001175), and a Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry, China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akashi H, 1998, CURR OPIN GENET DEV, V8, P688, DOI 10.1016/S0959-437X(98)80038-5; Axtell MJ, 2008, TRENDS PLANT SCI, V13, P343, DOI 10.1016/j.tplants.2008.03.009; Axtell MJ, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-4-221; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Brest P, 2011, NAT GENET, V43, P242, DOI 10.1038/ng.762; Brodersen P, 2009, NAT REV MOL CELL BIO, V10, P141, DOI 10.1038/nrm2619; Chamary JV, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-9-r75; Chamary JV, 2005, TRENDS GENET, V21, P256, DOI 10.1016/j.tig.2005.03.001; Chamary JV, 2006, NAT REV GENET, V7, P98, DOI 10.1038/nrg1770; Chan PP, 2009, NUCLEIC ACIDS RES, V37, pD93, DOI 10.1093/nar/gkn787; Chi SW, 2009, NATURE, V460, P479, DOI 10.1038/nature08170; Cuperus JT, 2011, PLANT CELL, V23, P431, DOI 10.1105/tpc.110.082784; dos Reis M, 2004, NUCLEIC ACIDS RES, V32, P5036, DOI 10.1093/nar/gkh834; Duret L, 2002, CURR OPIN GENET DEV, V12, P640, DOI 10.1016/S0959-437X(02)00353-2; Ehrenreich IM, 2008, PLANT SIGNAL BEHAV, V3, P829, DOI 10.4161/psb.3.10.5914; Fahlgren N, 2010, PLANT CELL, V22, P1074, DOI 10.1105/tpc.110.073999; Fang Z, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018067; Forman JJ, 2010, CELL CYCLE, V9, P1533, DOI 10.4161/cc.9.8.11202; Forman JJ, 2008, P NATL ACAD SCI USA, V105, P14879, DOI 10.1073/pnas.0803230105; Fujita PA, 2011, NUCLEIC ACIDS RES, V39, pD876, DOI 10.1093/nar/gkq963; Gu S, 2009, NAT STRUCT MOL BIOL, V16, P144, DOI 10.1038/nsmb.1552; Gu WJ, 2012, EVOL BIOINFORM, V8, P565, DOI 10.4137/EBO.S10362; Gu WJ, 2012, MOL BIOL EVOL, V29, P3037, DOI 10.1093/molbev/mss109; Gu WJ, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000664; Hafner M, 2010, CELL, V141, P129, DOI 10.1016/j.cell.2010.03.009; Hausser J, 2009, GENOME RES, V19, P2009, DOI 10.1101/gr.091181.109; Hofacker IL, 2003, NUCLEIC ACIDS RES, V31, P3429, DOI 10.1093/nar/gkg599; Hurst LD, 2006, J MOL EVOL, V63, P174, DOI 10.1007/s00239-005-0273-2; Hurst LD, 2011, NATURE, V471, P582, DOI 10.1038/471582a; IKEMURA T, 1985, MOL BIOL EVOL, V2, P13; Itzkovitz S, 2010, GENOME RES, V20, P1582, DOI 10.1101/gr.105072.110; Kersey PJ, 2010, NUCLEIC ACIDS RES, V38, pD563, DOI 10.1093/nar/gkp871; Kertesz M, 2007, NAT GENET, V39, P1278, DOI 10.1038/ng2135; Komar AA, 1999, FEBS LETT, V462, P387, DOI 10.1016/S0014-5793(99)01566-5; Kudla G, 2009, SCIENCE, V324, P255, DOI 10.1126/science.1170160; Lin HR, 2011, P NATL ACAD SCI USA, V108, P5148, DOI 10.1073/pnas.1102033108; Lin MF, 2011, GENOME RES, V21, P1916, DOI 10.1101/gr.108753.110; Lindblad-Toh K, 2011, NATURE, V478, P476, DOI 10.1038/nature10530; Lu M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003420; Morton BR, 2007, MOL BIOL EVOL, V24, P122, DOI 10.1093/molbev/msl139; Parmley JL, 2006, MOL BIOL EVOL, V23, P301, DOI 10.1093/molbev/msj035; Reczko M, 2012, BIOINFORMATICS, V28, P771, DOI 10.1093/bioinformatics/bts043; Richter AS, 2010, BIOINFORMATICS, V26, P1, DOI 10.1093/bioinformatics/btp609; Rigoutsos I, 2009, CANCER RES, V69, P3245, DOI 10.1158/0008-5472.CAN-09-0352; Ruepp A, 2010, NUCLEIC ACIDS RES, V38, pD497, DOI 10.1093/nar/gkp914; Saunders MA, 2007, P NATL ACAD SCI USA, V104, P3300, DOI 10.1073/pnas.0611347104; Schnall-Levin M, 2011, GENOME RES, V21, P1395, DOI 10.1101/gr.121210.111; Schnall-Levin M, 2010, P NATL ACAD SCI USA, V107, P15751, DOI 10.1073/pnas.1006172107; Seffens W, 1999, NUCLEIC ACIDS RES, V27, P1578, DOI 10.1093/nar/27.7.1578; Stoletzki N, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-224; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Tay Y, 2008, NATURE, V455, P1124, DOI 10.1038/nature07299; Thanaraj TA, 1996, PROTEIN SCI, V5, P1594, DOI 10.1002/pro.5560050814; Tuller T, 2010, P NATL ACAD SCI USA, V107, P3645, DOI 10.1073/pnas.0909910107; Vinogradov AE, 2003, NUCLEIC ACIDS RES, V31, P1838, DOI 10.1093/nar/gkg296; Waldman YY, 2010, NUCLEIC ACIDS RES, V38, P2964, DOI 10.1093/nar/gkq009; Warnecke T, 2007, MOL BIOL EVOL, V24, P2755, DOI 10.1093/molbev/msm210; Warnecke T, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000250; Wilke CO, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002296; WRIGHT F, 1990, GENE, V87, P23, DOI 10.1016/0378-1119(90)90491-9; Ying XM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022705; Zhao Y, 2005, NATURE, V436, P214, DOI 10.1038/nature03817; Zhou T, 2009, MOL BIOL EVOL, V26, P1571, DOI 10.1093/molbev/msp070	63	20	20	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2013	8	5							e63403	10.1371/journal.pone.0063403	http://dx.doi.org/10.1371/journal.pone.0063403			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	177QL	23671676	gold, Green Published, Green Submitted			2022-12-27	WOS:000321390200047
J	John-Baptiste, AA; Wu, W; Rochon, P; Anderson, GM; Bell, CM				John-Baptiste, Ava A.; Wu, Wei; Rochon, Paula; Anderson, Geoffrey M.; Bell, Chaim M.			A Systematic Review and Methodological Evaluation of Published Cost-Effectiveness Analyses of Aromatase Inhibitors versus Tamoxifen in Early Stage Breast Cancer	PLOS ONE			English	Article							INITIAL ADJUVANT THERAPY; COMPLETED TREATMENT ANALYSIS; POSTMENOPAUSAL WOMEN; HORMONE THERAPIES; UTILITY ANALYSES; ATAC ARIMIDEX; ANASTROZOLE; LETROZOLE; CARE; METAANALYSIS	Background: A key priority in developing policies for providing affordable cancer care is measuring the value for money of new therapies using cost-effectiveness analyses (CEAs). For CEA to be useful it should focus on relevant outcomes and include thorough investigation of uncertainty. Randomized controlled trials (RCTs) of five years of aromatase inhibitors (AI) versus five years of tamoxifen in the treatment of post-menopausal women with early stage breast cancer, show benefit of AI in terms of disease free survival (DFS) but not overall survival (OS) and indicate higher risk of fracture with AI. Policy-relevant CEA of AI versus tamoxifen should focus on OS and include analysis of uncertainty over key assumptions. Methods: We conducted a systematic review of published CEAs comparing an AI to tamoxifen. We searched Ovid MEDLINE, EMBASE, PsychINFO, and the Cochrane Database of Systematic Reviews without language restrictions. We selected CEAs with outcomes expressed as cost per life year or cost per quality adjusted life year (QALY). We assessed quality using the Neumann checklist. Using structured forms two abstractors collected descriptive information, sources of data, baseline assumptions on effectiveness and adverse events, and recorded approaches to assessing parameter uncertainty, methodological uncertainty, and structural uncertainty. Results: We identified 1,622 citations and 18 studies met inclusion criteria. All CE estimates assumed a survival benefit for aromatase inhibitors. Twelve studies performed sensitivity analysis on the risk of adverse events and 7 assumed no additional mortality risk with any adverse event. Sub-group analysis was limited; 6 studies examined older women, 2 examined women with low recurrence risk, and 1 examined women with multiple comorbidities. Conclusion: Published CEAs comparing AIs to tamoxifen assumed an OS benefit though none has been shown in RCTs, leading to an overestimate of the cost-effectiveness of AIs. Results of these CEA analyses may be suboptimal for guiding policy.	[John-Baptiste, Ava A.; Wu, Wei; Rochon, Paula; Anderson, Geoffrey M.] Womens Coll Hosp, Womens Coll Res Inst, Toronto, ON, Canada; [John-Baptiste, Ava A.] St Michaels Hosp, Keenan Res Ctr, Li Ka Shing Knowledge Inst, Toronto, ON M5B 1W8, Canada; [John-Baptiste, Ava A.] Canc Care Ontario, Pharmacoecon Res Unit, Toronto, ON, Canada; [John-Baptiste, Ava A.] Canadian Ctr Appl Res Canc Control, Toronto, ON, Canada; [John-Baptiste, Ava A.; Rochon, Paula; Anderson, Geoffrey M.; Bell, Chaim M.] Inst Clin Evaluat Sci, Toronto, ON, Canada; [Rochon, Paula; Anderson, Geoffrey M.; Bell, Chaim M.] Univ Toronto, Fac Med, Inst Hlth Policy Management & Evaluat, Toronto, ON, Canada; [Bell, Chaim M.] Mt Sinai Hosp, Dept Med, Toronto, ON M5G 1X5, Canada	University of Toronto; University Toronto Affiliates; Womens College Hospital; University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto; Cancer Care Ontario; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute	John-Baptiste, AA (corresponding author), Womens Coll Hosp, Womens Coll Res Inst, Toronto, ON, Canada.	ava.john-baptiste@wchospital.ca	Bell, Chaim/C-4611-2015; Rochon, Paula A/J-2918-2016	Bell, Chaim/0000-0002-3778-9469; Rochon, Paula A/0000-0002-5973-4151; Wu, Wei/0000-0002-9633-4122; John-Baptiste, Ava/0000-0001-6108-1105	Canadian Institutes of Health Research (CIHR) Institute of Nutrition, Metabolism and Diabetes [OTG-88591]; Cancer Care Ontario; Ontario Institute for Cancer Research; Ministry of Health and Long-Term Care; Ministry of Economic Development and Innovatio; Canadian Institutes of Health Research; Canadian Institutes of Health Research/Canadian Patient Safety Institute Chair in Patient Safety and Continuity of Care	Canadian Institutes of Health Research (CIHR) Institute of Nutrition, Metabolism and Diabetes(Canadian Institutes of Health Research (CIHR)); Cancer Care Ontario; Ontario Institute for Cancer Research; Ministry of Health and Long-Term Care(Ministry of Health and Long-Term Care, Ontario); Ministry of Economic Development and Innovatio; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Institutes of Health Research/Canadian Patient Safety Institute Chair in Patient Safety and Continuity of Care	This work was supported by a Team Grant [Grant number OTG-88591] from the Canadian Institutes of Health Research (CIHR) Institute of Nutrition, Metabolism and Diabetes (http://www.cihr-irsc.gc.ca/e/13521.html), Cancer Care Ontario (https://www.cancercare.on.ca), and the Ontario Institute for Cancer Research (http://oicr.on.ca) (through funding provided by the Ministry of Health and Long-Term Care - http://www.health.gov.on.ca/en/- and the Ministry of Economic Development and Innovation - http://www.ontariocanada.com/ontcan/1medt/en/home_en.jsp - of the Government of Ontario). Ava John-Baptiste was supported by a postdoctoral fellowship from the Canadian Institutes of Health Research -http://www.cihr-irsc.gc.ca/e/193.html (through funding provided by the Ministry of Health and Long-Term Care). Chaim Bell is supported by a Canadian Institutes of Health Research/Canadian Patient Safety Institute Chair in Patient Safety and Continuity of Care (http://www.patientsafetyinstitute.ca/English/research/PatientSafetyPartnershipProjects/patientSafetyResearchChair/Pages/default.aspx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe O, 2005, LANCET, V365, P1687, DOI 10.1016/s0140-6736(05)66544-0; Amir E, 2011, JNCI-J NATL CANCER I, V103, P1299, DOI 10.1093/jnci/djr242; Annemans L, 2008, PHARMACOECONOMICS, V26, P409, DOI 10.2165/00019053-200826050-00005; Bell CM, 2006, BMJ-BRIT MED J, V332, P699, DOI 10.1136/bmj.38737.607558.80; Briggs AH, 1999, BRIT MED J, V319, P635, DOI 10.1136/bmj.319.7210.635; Briggs AH, 2012, MED DECIS MAKING, V32, P722, DOI 10.1177/0272989X12458348; Bureau of Labor Statistics: United States Department of Labor, 2010, CPI ALL URB CONS CPI; Chauhan D, 2007, INT J TECHNOL ASSESS, V23, P96, DOI 10.1017/S0266462307051628; Coates AS, 2007, J CLIN ONCOL, V25, P486, DOI 10.1200/JCO.2006.08.8617; Coyle D, 2001, PHARMACOECONOMICS, V19, P565, DOI 10.2165/00019053-200119050-00010; Cuzick J, 2010, LANCET ONCOL, V11, P1135, DOI 10.1016/S1470-2045(10)70257-6; Delea TE, 2008, BREAST CANCER RES TR, V108, P375, DOI 10.1007/s10549-007-9607-7; Delea TE, 2007, CLIN BREAST CANCER, V7, P608, DOI 10.3816/CBC.2007.n.018; Dowsett M, 2010, J CLIN ONCOL, V28, P509, DOI 10.1200/JCO.2009.23.1274; Drummond MF., 2005, METHODS EC EVALUATIO, P55; Fonseca M, 2009, REV ASSOC MED BRAS, V55, P410, DOI 10.1590/S0104-42302009000400015; Gamboa O, 2010, BIOMEDICA, V30, P46, DOI 10.7705/biomedica.v30i1.152; Garattini L, 2010, INT J TECHNOL ASSESS, V26, P330, DOI 10.1017/S0266462310000322; Gil J M, 2006, Clin Transl Oncol, V8, P339, DOI 10.1007/s12094-006-0180-z; Ginnelly L, 2005, APPL HEALTH ECON HEA, V4, P37, DOI 10.2165/00148365-200504010-00006; Greenberg D, 2010, JNCI-J NATL CANCER I, V102, P82, DOI 10.1093/jnci/djp472; Haentjens P, 2010, ANN INTERN MED, V152, P380, DOI 10.7326/0003-4819-152-6-201003160-00008; Hillner BE, 2004, CANCER-AM CANCER SOC, V101, P1311, DOI 10.1002/cncr.20492; Hind D, 2007, Health Technol Assess, V11, piii; Howell A, 2005, LANCET, V365, P60, DOI 10.1016/s0140-6736(04)17666-6; International Bank for Reconstruction and Development/The World Bank, 2008, GLOB PURCH POW PAR R; Jain R, 2011, PHARMACOECONOMICS, V29, P297, DOI 10.2165/11584630-000000000-00000; Jang S, 2010, BREAST CANCER RES TR, V121, P273, DOI 10.1007/s10549-010-0870-7; Jassem J, 2008, ANTI-CANCER DRUG, V19, pS3, DOI 10.1097/01.cad.0000277608.23376.bc; John-Baptiste A, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c5350; John-Baptiste AA, 2011, CAN MED ASSOC J, V183, pE307, DOI 10.1503/cmaj.110384; Jonat W, 2006, LANCET ONCOL, V7, P991, DOI 10.1016/S1470-2045(06)70948-2; Karnon J, 2008, EUR J HEALTH ECON, V9, P171, DOI 10.1007/s10198-007-0058-1; LAUPACIS A, 1992, CAN MED ASSOC J, V146, P473; Lazzaro, 2007, PHARMACOECONOMICS IT, V9, P31, DOI [10.1007/ BF03320568, DOI 10.1007/BF03320568]; Lee HJ, 2010, J BREAST CANCER, V13, P286, DOI 10.4048/jbc.2010.13.3.286; Locker GY, 2007, BREAST CANCER RES TR, V106, P229, DOI 10.1007/s10549-006-9483-6; Lux MP, 2010, ONKOLOGIE, V33, P155, DOI 10.1159/000286233; Mansel R, 2007, BRIT J CANCER, V97, P152, DOI 10.1038/sj.bjc.6603804; Moeremans K, 2006, Int J Gynecol Cancer, V16 Suppl 2, P576, DOI 10.1111/j.1525-1438.2006.00699.x; Mouridsen H, 2009, NEW ENGL J MED, V361, P766, DOI 10.1056/NEJMoa0810818; Neumann PJ, 2000, ANNU REV PUBL HEALTH, V21, P587, DOI 10.1146/annurev.publhealth.21.1.587; Neumann PJ, 2000, ANN INTERN MED, V132, P964, DOI 10.7326/0003-4819-132-12-200006200-00007; Neuner JM, 2011, OSTEOPOROSIS INT, V22, P2847, DOI 10.1007/s00198-010-1493-x; Pezo RC, 2011, J CLIN ONCOL, V29, DOI 10.1200/jco.2011.29.15_suppl.e13037; Polyzos NP, 2011, CAN MED ASSOC J, V183, pE337, DOI 10.1503/cmaj.101506; Rabaglio M, 2009, ANN ONCOL, V20, P1489, DOI 10.1093/annonc/mdp033; Roberts M, 2012, MED DECIS MAKING, V32, P678, DOI [10.1177/0272989X12454941, 10.1016/j.jval.2012.06.016]; Rocchi A, 2006, SUPPORT CARE CANCER, V14, P917, DOI 10.1007/s00520-006-0035-8; Sasse AD, 2009, REV ASSOC MED BRAS, V55, P535, DOI 10.1590/S0104-42302009000500015; Sculpher M, 2008, PHARMACOECONOMICS, V26, P799, DOI 10.2165/00019053-200826090-00009; Seruga B, 2010, J CLIN ONCOL, V28, pE346, DOI 10.1200/JCO.2010.28.3564; Seruga B, 2009, J CLIN ONCOL, V27, P840, DOI 10.1200/JCO.2008.19.5594; Shiroiwa T, 2010, HEALTH ECON, V19, P422, DOI 10.1002/hec.1481; Skedgel C, 2007, BREAST, V16, P252, DOI 10.1016/j.breast.2006.12.002; Skedgel C, 2007, BREAST CANCER RES TR, V101, P325, DOI 10.1007/s10549-006-9299-4; Smith TJ, 2011, NEW ENGL J MED, V364, P2060, DOI 10.1056/NEJMsb1013826; Sroczynski G, 2010, J VIRAL HEPATITIS, V17, P34, DOI 10.1111/j.1365-2893.2009.01147.x; Sroczynski G, 2009, EUR J PUBLIC HEALTH, V19, P245, DOI 10.1093/eurpub/ckp001; Sullivan R, 2011, LANCET ONCOL, V12, P933, DOI 10.1016/S1470-2045(11)70141-3; The World Bank, 2005, INT COMP PROGR; TORRANCE GW, 1987, J CHRON DIS, V40, P593, DOI 10.1016/0021-9681(87)90019-1; Williams N, 2008, LANCET ONCOL, V9, P45, DOI 10.1016/S1470-2045(07)70385-6	63	14	16	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2013	8	5							e62614	10.1371/journal.pone.0062614	http://dx.doi.org/10.1371/journal.pone.0062614			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	177QL	23671612	Green Published, gold, Green Submitted			2022-12-27	WOS:000321390200030
J	Triep, M; Hess, D; Chaves, H; Brucker, C; Balmert, A; Westhoff, G; Bleckmann, H				Triep, Michael; Hess, David; Chaves, Humberto; Bruecker, Christoph; Balmert, Alexander; Westhoff, Guido; Bleckmann, Horst			3D Flow in the Venom Channel of a Spitting Cobra: Do the Ridges in the Fangs Act as Fluid Guide Vanes?	PLOS ONE			English	Article							NAJA-NIGRICOLLIS; SERPENTES; ELAPIDAE; SEQUENCES; BEHAVIOR	The spitting cobra Naja pallida can eject its venom towards an offender from a distance of up to two meters. The aim of this study was to understand the mechanisms responsible for the relatively large distance covered by the venom jet although the venom channel is only of micro-scale. Therefore, we analysed factors that influence secondary flow and pressure drop in the venom channel, which include the physical-chemical properties of venom liquid and the morphology of the venom channel. The cobra venom showed shear-reducing properties and the venom channel had paired ridges that span from the last third of the channel to its distal end, terminating laterally and in close proximity to the discharge orifice. To analyze the functional significance of these ridges we generated a numerical and an experimental model of the venom channel. Computational fluid dynamics (CFD) and Particle-Image Velocimetry (PIV) revealed that the paired interior ridges shape the flow structure upstream of the sharp 90 degrees bend at the distal end. The occurrence of secondary flow structures resembling Dean-type vortical structures in the venom channel can be observed, which induce additional pressure loss. Comparing a venom channel featuring ridges with an identical channel featuring no ridges, one can observe a reduction of pressure loss of about 30%. Therefore it is concluded that the function of the ridges is similar to guide vanes used by engineers to reduce pressure loss in curved flow channels.	[Triep, Michael; Hess, David; Chaves, Humberto; Bruecker, Christoph] TU Bergakad Freiberg, Inst Mech & Fluiddynam, Freiberg, Germany; [Balmert, Alexander; Westhoff, Guido; Bleckmann, Horst] Univ Bonn, Inst Zool, Bonn, Germany	Technical University Freiberg; University of Bonn	Triep, M (corresponding author), TU Bergakad Freiberg, Inst Mech & Fluiddynam, Freiberg, Germany.	Michael.Triep@imfd.tu-freiberg.de	Chaves, Humberto/A-9707-2012	Chaves, Humberto/0000-0002-8709-8834; Bruecker, Christoph/0000-0001-5834-3020	Deutsche Forschungsgemeinschaft [BR 1494/16-1, BL 242/17-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This study was supported by Deutsche Forschungsgemeinschaft (BR 1494/16-1 and BL 242/17-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balmert A, 2010, P 103 ANN M DTSCH ZO; Berthe R. A., 2011, THESIS RHEINISCHE FR; Berthe RA, 2009, J COMP PHYSIOL A, V195, P753, DOI 10.1007/s00359-009-0451-6; Bird R., 2006, WILEY INT EDITION; Bogert Charles Mitchill, 1943, BULL AMER MUS NAT HIST, V81, P285; Cascardi J, 1999, TOXICON, V37, P1271, DOI 10.1016/S0041-0101(98)00264-5; Dean WR, 1927, LONDON EDINBURGH DUB, V7, P208; Greene H.W., 1988, Biology of Reptilia, V16, P1; Haynes, 2004, P 15 AUSTR FLUID MEC; HORTON CW, 1948, COPEIA, P23; LEVY Y, 1990, AIAA J, V28, P1347, DOI 10.2514/3.25224; Prandtl L, 1957, FUHRER DURCH STROMUN; RASMUSSEN S, 1995, J ZOOL, V237, P27, DOI 10.1111/j.1469-7998.1995.tb02743.x; Slowinski JB, 1997, MOL PHYLOGENET EVOL, V8, P349, DOI 10.1006/mpev.1997.0434; WARRELL DA, 1976, AM J TROP MED HYG, V25, P525, DOI 10.4269/ajtmh.1976.25.525; Westhoff G, 2005, J COMP PHYSIOL A, V191, P873, DOI 10.1007/s00359-005-0010-8; WUSTER W, 1992, HERPETOLOGICA, V48, P424; Wuster W, 2007, MOL PHYLOGENET EVOL, V45, P437, DOI 10.1016/j.ympev.2007.07.021; Young BA, 2004, J EXP BIOL, V207, P3483, DOI 10.1242/jeb.01170; Young BA, 2001, ANAT REC, V264, P415, DOI 10.1002/ar.10015; Young BA, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.198103; Young BA, 2009, PHYSIOL BIOCHEM ZOOL, V82, P80, DOI 10.1086/595589; Zug G. R., 2001, HERPETOLOGY INTRO BI, P630	23	7	8	2	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2013	8	5							e61548	10.1371/journal.pone.0061548	http://dx.doi.org/10.1371/journal.pone.0061548			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	177QL	23671569	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000321390200008
J	Zeng, V; Ewen-Campen, B; Horch, HW; Roth, S; Mito, T; Extavour, CG				Zeng, Victor; Ewen-Campen, Ben; Horch, Hadley W.; Roth, Siegfried; Mito, Taro; Extavour, Cassandra G.			Developmental Gene Discovery in a Hemimetabolous Insect: De Novo Assembly and Annotation of a Transcriptome for the Cricket Gryllus bimaculatus	PLOS ONE			English	Article							PERIPHERAL NERVOUS-SYSTEM; RECENT IMPROVEMENTS; PROXIMODISTAL AXIS; SIGNALING PATHWAY; SPECIATION GENES; GENOME SEQUENCES; PROTEIN FAMILIES; LEG REGENERATION; PEA APHID; DATABASE	Most genomic resources available for insects represent the Holometabola, which are insects that undergo complete metamorphosis like beetles and flies. In contrast, the Hemimetabola (direct developing insects), representing the basal branches of the insect tree, have very few genomic resources. We have therefore created a large and publicly available transcriptome for the hemimetabolous insect Gryllus bimaculatus (cricket), a well-developed laboratory model organism whose potential for functional genetic experiments is currently limited by the absence of genomic resources. cDNA was prepared using mRNA obtained from adult ovaries containing all stages of oogenesis, and from embryo samples on each day of embryogenesis. Using 454 Titanium pyrosequencing, we sequenced over four million raw reads, and assembled them into 21,512 isotigs (predicted transcripts) and 120,805 singletons with an average coverage per base pair of 51.3. We annotated the transcriptome manually for over 400 conserved genes involved in embryonic patterning, gametogenesis, and signaling pathways. BLAST comparison of the transcriptome against the NCBI non-redundant protein database (nr) identified significant similarity to nr sequences for 55.5% of transcriptome sequences, and suggested that the transcriptome may contain 19,874 unique transcripts. For predicted transcripts without significant similarity to known sequences, we assessed their similarity to other orthopteran sequences, and determined that these transcripts contain recognizable protein domains, largely of unknown function. We created a searchable, web-based database to allow public access to all raw, assembled and annotated data. This database is to our knowledge the largest de novo assembled and annotated transcriptome resource available for any hemimetabolous insect. We therefore anticipate that these data will contribute significantly to more effective and higher-throughput deployment of molecular analysis tools in Gryllus.	[Zeng, Victor; Ewen-Campen, Ben; Extavour, Cassandra G.] Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA; [Horch, Hadley W.] Bowdoin Coll, Dept Biol, Brunswick, ME 04011 USA; [Horch, Hadley W.] Bowdoin Coll, Dept Neurosci, Brunswick, ME 04011 USA; [Roth, Siegfried] Univ Cologne, Cologne Bioctr, Inst Dev Biol, D-50931 Cologne, Germany; [Mito, Taro] Univ Tokushima, Grad Sch, Inst Sci & Technol, Dept Life Syst, Tokushima 770, Japan	Harvard University; Bowdoin College; Bowdoin College; University of Cologne; Tokushima University	Extavour, CG (corresponding author), Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA.	extavour@oeb.harvard.edu	Roth, Siegfried/E-8241-2010; Extavour, Cassandra G/I-4567-2012	Roth, Siegfried/0000-0001-5772-3558; Extavour, Cassandra G/0000-0003-2922-5855; Ewen-Campen, Ben/0000-0002-4326-3033	Harvard Stem Cell Institute [SG-0057-10-00]; Ellison Medical Foundation [AG-NS-07010-10]; National Science Foundation (NSF) [IOS-0817678]; Bowdoin College; DFG Collaborative Research Centre 680; JSPS KAKENHI [22124003/22370080/23687033]	Harvard Stem Cell Institute; Ellison Medical Foundation(Lawrence Ellison Foundation); National Science Foundation (NSF)(National Science Foundation (NSF)); Bowdoin College; DFG Collaborative Research Centre 680; JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was partially supported by Harvard Stem Cell Institute Seed Grant SG-0057-10-00, Ellison Medical Foundation New Scholar Award AG-NS-07010-10, and National Science Foundation (NSF) Grant IOS-0817678 to CE, an NSF Predoctoral Fellowship to BEC, a Fletcher Family award from Bowdoin College to HH, DFG Collaborative Research Centre 680 funds to SR, and JSPS KAKENHI 22124003/22370080/23687033 to TM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; Andres JA, 2008, P ROY SOC B-BIOL SCI, V275, P1975, DOI 10.1098/rspb.2008.0423; Attwood TK, 2003, NUCLEIC ACIDS RES, V31, P400, DOI 10.1093/nar/gkg030; Attwood TK, 2012, DATABASE 2012; Badisco L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017274; Bando T, 2013, DEVELOPMENT, V140, P959, DOI 10.1242/dev.084590; Bando T, 2011, DEV DYNAM, V240, P1440, DOI 10.1002/dvdy.22647; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Bru C, 2005, NUCLEIC ACIDS RES, V33, pD212, DOI 10.1093/nar/gki034; Buning J., 1994, INSECT OVARY ULTRAST, Vfirst; Bussiere LF, 2006, EVOLUTION, V60, P792, DOI 10.1554/05-378.1; Ceccato P, 2007, INT J PEST MANAGE, V53, P7, DOI 10.1080/09670870600968826; Chen F, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000383; Chen SL, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0008613, 10.1371/journal.pone.0015633]; Danbara Y, 2010, J INSECT PHYSIOL, V56, P1738, DOI 10.1016/j.jinsphys.2010.07.002; Danley PD, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-109; Ellison CK, 2011, J EVOLUTION BIOL, V24, P1110, DOI 10.1111/j.1420-9101.2011.02244.x; Ewen-Campen B, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-61; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; Fedorka KM, 2004, NATURE, V429, P65, DOI 10.1038/nature02492; Feuillet C, 2011, TRENDS PLANT SCI, V16, P77, DOI 10.1016/j.tplants.2010.10.005; Gough J, 2001, J MOL BIOL, V313, P903, DOI 10.1006/jmbi.2001.5080; Gregory TR, 2005, NAT REV GENET, V6, P699, DOI 10.1038/nrg1674; Grimaldi David, 2005, pi; Haft DH, 2003, NUCLEIC ACIDS RES, V31, P371, DOI 10.1093/nar/gkg128; Hanrahan SJ, 2011, CHROMOSOME RES, V19, P809, DOI 10.1007/s10577-011-9231-6; Holt RA, 2002, SCIENCE, V298, P129, DOI 10.1126/science.1076181; Howard DJ, 2002, AM NAT, V159, pS8, DOI 10.1086/338369; Huber F, 1989, INSECT ENDOCRINOLOGY, P13; Huebner E, 2007, COMP BIOCHEM PHYS A, V148, pS130, DOI 10.1016/j.cbpa.2007.06.325; Hulo N, 2004, NUCLEIC ACIDS RES, V32, pD134, DOI 10.1093/nar/gkh044; Ingham PW, 2011, NAT REV GENET, V12, P393, DOI 10.1038/nrg2984; Inoue Y, 2002, MECH DEVELOP, V110, P245, DOI 10.1016/S0925-4773(01)00584-6; Iseli C, 1999, Proc Int Conf Intell Syst Mol Biol, P138; Jaroszewski L, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000205; Kainz F, 2009, CELL COMMUNICATION P; Kainz F, 2011, DEVELOPMENT, V138, P5015, DOI 10.1242/dev.073395; Kanehisa M, 2010, NUCLEIC ACIDS RES, V38, pD355, DOI 10.1093/nar/gkp896; Kang L, 2004, P NATL ACAD SCI USA, V101, P17611, DOI 10.1073/pnas.0407753101; Kirkness EF, 2010, P NATL ACAD SCI USA, V107, P12168, DOI 10.1073/pnas.1003379107; Kitisin Krit, 2007, Sci STKE, V2007, pcm1, DOI 10.1126/stke.3992007cm1; Kopan R, 2009, CELL, V137, P216, DOI 10.1016/j.cell.2009.03.045; Kumar S, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-571; Letunic I, 2002, NUCLEIC ACIDS RES, V30, P242, DOI 10.1093/nar/30.1.242; Lin GW, 2009, MECH DEVELOP, V126, pS252, DOI 10.1016/j.mod.2009.06.661; Liu DM, 2010, GENETICS, V184, P1025, DOI 10.1534/genetics.110.114017; Lomer CJ, 2001, ANNU REV ENTOMOL, V46, P667, DOI 10.1146/annurev.ento.46.1.667; Lu HL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028051; Lynch JA, 2010, CURR BIOL, V20, P1042, DOI 10.1016/j.cub.2010.04.023; Ma C, 2012, MOL ECOLOGY; Ma ZY, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-11; Maroja LS, 2008, HEREDITY, V101, P435, DOI 10.1038/hdy.2008.75; Megy K, 2012, NUCLEIC ACIDS RES, V40, pD729, DOI 10.1093/nar/gkr1089; MEIER T, 1991, DEVELOPMENT, V112, P241; MEIER T, 1991, J COMP NEUROL, V305, P201, DOI 10.1002/cne.903050204; MEIER T, 1990, J NEUROBIOL, V21, P592, DOI 10.1002/neu.480210407; Mi HY, 2005, NUCLEIC ACIDS RES, V33, pD284, DOI 10.1093/nar/gki078; Mito T, 2002, MECH DEVELOP, V114, P27, DOI 10.1016/S0925-4773(02)00052-7; Mito T, 2007, DEV BIOL, V303, P202, DOI 10.1016/j.ydbio.2006.11.003; Mito T, 2011, DEVELOPMENT, V138, P3823, DOI 10.1242/dev.060681; Miyawaki K, 2004, MECH DEVELOP, V121, P119, DOI 10.1016/j.mod.2004.01.002; Myers EW, 2000, SCIENCE, V287, P2196, DOI 10.1126/science.287.5461.2196; Nakamura T, 2008, CELL MOL LIFE SCI, V65, P64, DOI 10.1007/s00018-007-7432-0; Nakamura T, 2008, DEV BIOL, V319, P46, DOI 10.1016/j.ydbio.2008.04.002; Nakamura T, 2010, CURR BIOL, V20, P1641, DOI 10.1016/j.cub.2010.07.044; NOLTE DJ, 1963, NATURE, V200, P660, DOI 10.1038/200660a0; Nusse R, 2012, EMBO J, V31, P2670, DOI 10.1038/emboj.2012.146; O'Neil ST, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-310; Pearl FMG, 2000, NUCLEIC ACIDS RES, V28, P277, DOI 10.1093/nar/28.1.277; Pfreundt U, 2010, NUCLEIC ACIDS RES, V38, pD443, DOI 10.1093/nar/gkp910; Richards S, 2008, NATURE, V452, P949, DOI 10.1038/nature06784; Richards S, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000313; Roche, 2011, 454 SEQ SYST SOFTW C; Schatz MC, 2010, GENOME RES, V20, P1165, DOI 10.1101/gr.101360.109; Schindler C, 2007, J BIOL CHEM, V282, P20059, DOI 10.1074/jbc.R700016200; Shaul YD, 2007, BBA-MOL CELL RES, V1773, P1213, DOI 10.1016/j.bbamcr.2006.10.005; Shaw KL, 2007, MOL ECOL, V16, P2879, DOI 10.1111/j.1365-294X.2007.03321.x; Shaw KL, 2009, P NATL ACAD SCI USA, V106, P9737, DOI 10.1073/pnas.0900229106; Shigenobu S, 2010, INSECT MOL BIOL, V19, P47, DOI 10.1111/j.1365-2583.2009.00944.x; Sonnhammer E L, 1998, Proc Int Conf Intell Syst Mol Biol, V6, P175; Takagi A, 2012, DEV GROWTH DIFFER, V54, P227, DOI 10.1111/j.1440-169X.2011.01325.x; Takahashi T, 2009, J NEUROSCI METH, V179, P9, DOI 10.1016/j.jneumeth.2009.01.002; Tomioka K, 2012, J COMP PHYSIOL B, V182, P729, DOI 10.1007/s00360-012-0651-1; Tomioka K, 2010, CELL MOL LIFE SCI, V67, P1397, DOI 10.1007/s00018-009-0232-y; Tordjmann T, 2011, CLIN RES HEPATOLOGY; Watanabe T, 2012, NATURE COMM IN PRESS; WELCH BL, 1947, BIOMETRIKA, V34, P28, DOI 10.2307/2332510; Wheeler DL, 2007, NUCLEIC ACIDS RES, V35, pD5, DOI 10.1093/nar/gkl1031; Wu CH, 2004, NUCLEIC ACIDS RES, V32, pD112, DOI 10.1093/nar/gkh097; Yandell M, 2006, PLOS COMPUT BIOL, V2, P113, DOI 10.1371/journal.pcbi.0020015; Zdobnov EM, 2001, BIOINFORMATICS, V17, P847, DOI 10.1093/bioinformatics/17.9.847; Zdobnov EM, 2007, TRENDS GENET, V23, P16, DOI 10.1016/j.tig.2006.10.004; Zeng V, 2012, DATABASE-OXFORD, DOI 10.1093/database/bas048; Zeng V, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-581; Zera AJ, 2006, COMP BIOCHEM PHYS A, V144, P365, DOI 10.1016/j.cbpa.2005.11.026	98	37	39	4	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2013	8	5							e61479	10.1371/journal.pone.0061479	http://dx.doi.org/10.1371/journal.pone.0061479			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	177QL	23671567	Green Submitted, gold, Green Published			2022-12-27	WOS:000321390200007
J	Holcombe, A; Howorko, A; Powell, RA; Schalomon, M; Hamilton, TJ				Holcombe, Adam; Howorko, Adam; Powell, Russell A.; Schalomon, Melike; Hamilton, Trevor J.			Reversed Scototaxis during Withdrawal after Daily-Moderate, but Not Weekly-Binge, Administration of Ethanol in Zebrafish	PLOS ONE			English	Article							EXCESSIVE ALCOHOL-DRINKING; LIGHT/DARK PREFERENCE TEST; BEHAVIOR GENETIC MODEL; DANIO-RERIO; EXPOSURE; ANXIETY; SYSTEM; FISH; INJECTIONS; ADDICTION	Alcohol abuse can lead to severe psychological and physiological damage. Little is known, however, about the relative impact of a small, daily dose of alcohol (daily-moderate schedule) versus a large, once per week dose (weekly-binge schedule). In this study, we examined the effect of each of these schedules on behavioural measures of anxiety in zebrafish (Danio rerio). Adult wild-type zebrafish were administered either 0.2% ethanol on a daily-moderate schedule or 1.4% ethanol on a weekly-binge schedule for a period of 21 days, and then tested for scototaxis (preference for darkness) during withdrawal. Compared to a control group with no alcohol exposure, the daily-moderate group spent significantly more time on the light side of the arena (indicative of decreased anxiety) on day two of withdrawal, but not day 9 of withdrawal. The weekly-binge group was not significantly different from the control group on either day of withdrawal and showed no preference for either the light or dark zones. Our results indicate that even a small dose of alcohol on a daily basis can cause significant, though reversible, changes in behaviour.	[Holcombe, Adam; Howorko, Adam; Powell, Russell A.; Schalomon, Melike; Hamilton, Trevor J.] Grant MacEwan Univ, Dept Psychol, Edmonton, AB, Canada		Hamilton, TJ (corresponding author), Grant MacEwan Univ, Dept Psychol, Edmonton, AB, Canada.	hamiltont9@macewan.ca			Grant MacEwan University; MacEwan Research Office	Grant MacEwan University; MacEwan Research Office	Funding was provided internally by Grant MacEwan University and the MacEwan Research Office. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amatruda JF, 2002, CANCER CELL, V1, P229, DOI 10.1016/S1535-6108(02)00052-1; Bardag-Gorce F, 2009, ALCOHOL CLIN EXP RES, V33, P684, DOI 10.1111/j.1530-0277.2008.00885.x; Bell RL, 2006, ADDICT BIOL, V11, P270, DOI 10.1111/j.1369-1600.2005.00029.x; Bencan Z, 2009, PHARMACOL BIOCHEM BE, V94, P75, DOI 10.1016/j.pbb.2009.07.009; Blaser RE, 2011, PHYSIOL BEHAV, V104, P831, DOI 10.1016/j.physbeh.2011.07.029; Blaser RE, 2010, BEHAV BRAIN RES, V208, P56, DOI 10.1016/j.bbr.2009.11.009; Cachat J, 2010, BEHAV BRAIN RES, V208, P371, DOI 10.1016/j.bbr.2009.12.004; Chakraborty C, 2009, CURR DRUG METAB, V10, P116, DOI 10.2174/138920009787522197; Champagne DL, 2010, BEHAV BRAIN RES, V214, P332, DOI 10.1016/j.bbr.2010.06.001; Chiva-Blanch G, 2013, ALCOHOL ALCOHOLISM, V48, P270, DOI 10.1093/alcalc/agt007; Crews FT, 2009, PHARMACOL BIOCHEM BE, V93, P237, DOI 10.1016/j.pbb.2009.04.018; Dlugos CA, 2003, PHARMACOL BIOCHEM BE, V74, P471, DOI 10.1016/S0091-3057(02)01026-2; Domjan M., 2010, PRINCIPLES LEARNING; Egan RJ, 2009, BEHAV BRAIN RES, V205, P38, DOI 10.1016/j.bbr.2009.06.022; Gebauer DL, 2011, PHARMACOL BIOCHEM BE, V99, P480, DOI 10.1016/j.pbb.2011.04.021; George O, 2012, P NATL ACAD SCI USA, V109, P18156, DOI 10.1073/pnas.1116523109; Gerlai R, 2000, PHARMACOL BIOCHEM BE, V67, P773, DOI 10.1016/S0091-3057(00)00422-6; Gerlai R, 2003, BEHAV GENET, V33, P461, DOI 10.1023/A:1025762314250; Gerlai R, 2009, GENES BRAIN BEHAV, V8, P586, DOI 10.1111/j.1601-183X.2009.00488.x; Gerlai R, 2006, PHARMACOL BIOCHEM BE, V85, P752, DOI 10.1016/j.pbb.2006.11.010; Harper C, 2007, HUM EXP TOXICOL, V26, P251, DOI 10.1177/0960327107070499; Hayton SJ, 2012, ALCOHOL CLIN EXP RES, V36, P594, DOI 10.1111/j.1530-0277.2011.01668.x; Hoeppner BB, 2012, J STUD ALCOHOL DRUGS, V73, P613, DOI 10.15288/jsad.2012.73.613; Holmes A, 2012, NAT NEUROSCI, V15, P1359, DOI 10.1038/nn.3204; Kily LJM, 2008, J EXP BIOL, V211, P1623, DOI 10.1242/jeb.014399; Klee EW, 2012, HUM GENET, V131, P977, DOI 10.1007/s00439-011-1128-0; Kroener S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037541; Langheinrich U, 2003, BIOESSAYS, V25, P904, DOI 10.1002/bies.10326; Le AD, 1999, NEUROPSYCHOPHARMACOL, V21, P435, DOI 10.1016/S0893-133X(99)00024-X; LEBLANC AE, 1969, J PHARMACOL EXP THER, V168, P244; Liu S, 2011, ANNU REV PATHOL-MECH, V6, P71, DOI 10.1146/annurev-pathol-011110-130330; Mathur P, 2011, BEHAV BRAIN RES, V219, P234, DOI 10.1016/j.bbr.2011.01.019; Mathur P, 2011, BEHAV BRAIN RES, V217, P128, DOI 10.1016/j.bbr.2010.10.015; Maximino C, 2011, PROG NEURO-PSYCHOPH, V35, P624, DOI 10.1016/j.pnpbp.2011.01.006; Maximino C, 2010, NAT PROTOC, V5, P209, DOI 10.1038/nprot.2009.225; Miller NY, 2011, REV NEUROSCIENCE, V22, P17, DOI 10.1515/RNS.2011.004; Ninkovic J, 2006, METHODS, V39, P262, DOI 10.1016/j.ymeth.2005.12.007; Pham J, 2009, J NEUROSCI METH, V178, P323, DOI 10.1016/j.jneumeth.2008.12.021; Qin LY, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-130; Renninger SL, 2011, NEUROGENETICS, V12, P97, DOI 10.1007/s10048-011-0273-x; Sackerman James, 2010, Int J Comp Psychol, V23, P43; Santoriello C, 2012, J CLIN INVEST, V122, P2337, DOI 10.1172/JCI60434; Serra EL, 1999, BRAZ J MED BIOL RES, V32, P1551, DOI 10.1590/S0100-879X1999001200016; Silvers JM, 2003, ALCOHOL CLIN EXP RES, V27, P1606, DOI 10.1097/01.ALC.0000090141.66526.22; Spence R, 2008, BIOL REV, V83, P13, DOI 10.1111/j.1469-185X.2007.00030.x; Steenbergen PJ, 2011, BEHAV BRAIN RES, V222, P15, DOI 10.1016/j.bbr.2011.03.025; Tierney KB, 2011, BBA-MOL BASIS DIS, V1812, P381, DOI 10.1016/j.bbadis.2010.10.011; Ward RJ, 2009, ALCOHOL ALCOHOLISM, V44, P128, DOI 10.1093/alcalc/agn100; Wen XJ, 2012, PREV CHRONIC DIS, V9, DOI 10.5888/pcd9.110204; World Health Organization, 2011, GLOB STAT REP ALC HL	50	32	32	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2013	8	5							e63319	10.1371/journal.pone.0063319	http://dx.doi.org/10.1371/journal.pone.0063319			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145RZ	23675478	Green Published, gold, Green Submitted			2022-12-27	WOS:000319036100038
J	Guo, X; Zhang, ZZ; Zhang, F; Tao, YL; An, P; Wu, Q; Wang, CY; Knutson, MD; Wang, FD				Guo, Xin; Zhang, Zhuzhen; Zhang, Fan; Tao, Yunlong; An, Peng; Wu, Qian; Wang, Chia-Yu; Knutson, Mitchell D.; Wang, Fudi			Fine-Mapping and Genetic Analysis of the Loci Affecting Hepatic Iron Overload in Mice	PLOS ONE			English	Article							V-ATPASE; METABOLISM; EXPRESSION; HOMEOSTASIS; PARAMETERS; TRANSPORT; FERRITIN; DELIVERY; CELLS; MON1A	The liver, as the major organ for iron storage and production of hepcidin, plays pivotal roles in maintaining mammalian iron homeostasis. A previous study showed that Quantitative Trait Loci (QTLs) on chromosome 7 (Chr7) and 16 (Chr16) may control hepatic non-heme iron overload in an F2 intercross derived from C57BL/6J (B6) and SWR/J (SWR) mice. In this study, we aimed to validate the existence of these loci and identify the genes responsible for the phenotypic variations by generating congenic mice carrying SWR chromosome segments expanding these QTLs (D7Mit68-D7Mit71 and D16Mit125-D16Mit185, respectively). We excluded involvement of Chr7 based on the lack of iron accumulation in congenic mice. In contrast, liver iron accumulation was observed in Chr16 congenic mice. Through use of a series of subcongenic murine lines the interval on Chr16 was further fine-mapped to a 0.8 Mb segment spanning 11 genes. We found that the mRNA expression pattern in the liver remained unchanged for all 11 genes tested. Most importantly, we detected 4 missense mutations in 3 candidate genes including Sidt1 (P172R), Spice1(R708S), Boc (Q1051R) and Boc (S450-insertion in B6 allele) in the liver of SWR homozygous congenic mice. To further delineate potential modifier gene(s), we reconstituted seven candidate genes, Sidt1, Boc, Zdhhc23, Gramd1c, Atp6v1a, Naa50 and Gtpbp8, in mouse liver through hydrodynamic transfection. However, we were unable to detect significant changes in liver iron levels upon reconstitution of these candidate genes. Taken together, our work provides strong genetic evidence of the existence of iron modifiers on Chr16. Moreover, we were able to delineate the phenotypically responsible region to a 0.8 Mb region containing 11 coding genes, 3 of which harbor missense mutations, using a series of congenic mice.	[Guo, Xin; Zhang, Zhuzhen; Zhang, Fan; Tao, Yunlong; An, Peng; Wu, Qian] Chinese Acad Sci, Shanghai Key Lab Pediat Gastroenterol & Nutr, Key Lab Nutr & Metab, Inst Nutr Sci,Shanghai Inst Biol Sci,Grad Sch, Shanghai, Peoples R China; [Guo, Xin; Zhang, Zhuzhen; Zhang, Fan; Tao, Yunlong; An, Peng; Wu, Qian; Wang, Fudi] Zhejiang Univ, Collaborat Innovat Ctr Diag & Treatment Infect Di, Sch Publ Hlth, Dept Nutr,Inst Nutr & Food Safety, Hangzhou 310003, Zhejiang, Peoples R China; [Wang, Chia-Yu; Knutson, Mitchell D.] Univ Florida, Dept Food Sci & Human Nutr, Gainesville, FL 32611 USA	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Collaborative Innovation Center for Diagnosis & Treatment of Infectious Diseases; Zhejiang University; State University System of Florida; University of Florida	Wang, FD (corresponding author), Zhejiang Univ, Collaborat Innovat Ctr Diag & Treatment Infect Di, Sch Publ Hlth, Dept Nutr,Inst Nutr & Food Safety, Hangzhou 310003, Zhejiang, Peoples R China.	fwang@zju.edu.cn	Tao, Yunlong/I-8328-2019; Wang, Fudi/L-7888-2018; Wang, Chia-Yu/ABF-1758-2020; An, Peng/GWZ-9176-2022	Tao, Yunlong/0000-0003-0377-7133; Wang, Fudi/0000-0001-8730-0003; Wang, Chia-Yu/0000-0003-3679-6453; An, Peng/0000-0002-0421-0035; Zhang, Zhuzhen/0000-0001-6787-3920; Wu, Qian/0000-0003-3934-0128	Ministry of Science and Technology of China (973 Program) [2009CB941404, 2011CB966200, 2012BAD33B05]; National Natural Science Foundation of China [31225013, 31030039, 10979071, 30970665]; Science & Technology Commission of Shanghai Municipality [10JC1416800]	Ministry of Science and Technology of China (973 Program)(Ministry of Science and Technology, ChinaNational Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science & Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM))	This work was supported by the research grants from the Ministry of Science and Technology of China (973 Program) (grant numbers 2009CB941404, 2011CB966200, 2012BAD33B05); The National Natural Science Foundation of China (grant numbers 31225013, 31030039, 10979071, 30970665); Science & Technology Commission of Shanghai Municipality grant (grant number 10JC1416800). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitman TJ, 1999, NAT GENET, V21, P76, DOI 10.1038/5013; Ajioka RS, 2007, BLOOD CELL MOL DIS, V39, P199, DOI 10.1016/j.bcmd.2007.03.007; Allen BL, 2011, DEV CELL, V20, P775, DOI 10.1016/j.devcel.2011.04.018; Andrews NC, 2008, BLOOD, V112, P219, DOI 10.1182/blood-2007-12-077388; Andrews NC, 2007, ANNU REV PHYSIOL, V69, P69, DOI 10.1146/annurev.physiol.69.031905.164337; Andrews NC, 2000, NAT REV GENET, V1, P208, DOI 10.1038/35042073; Baravalle G, 2005, CELL TISSUE RES, V320, P99, DOI 10.1007/s00441-004-1060-x; Bartnikas TB, 2012, MAMM GENOME, V23, P356, DOI 10.1007/s00335-012-9393-3; Bell JB, 2007, NAT PROTOC, V2, P3153, DOI 10.1038/nprot.2007.471; Bensaid M, 2004, GASTROENTEROLOGY, V126, P1400, DOI 10.1053/j.gastro.2004.01.021; Bothwell, 1980, METHODS HEMATOLOGY, V1, P90; De Domenico I, 2008, NAT REV MOL CELL BIO, V9, P72, DOI 10.1038/nrm2295; Doerks T, 2000, TRENDS BIOCHEM SCI, V25, P483, DOI 10.1016/S0968-0004(00)01664-9; Evjenth R, 2009, J BIOL CHEM, V284, P31122, DOI 10.1074/jbc.M109.001347; Feinberg EH, 2003, SCIENCE, V301, P1545, DOI 10.1126/science.1087117; Ganz T, 2003, BLOOD, V102, P783, DOI 10.1182/blood-2003-03-0672; Gao L, 2012, ACTA VIROL, V56, P25, DOI 10.4149/av_2012_01_25; Glazier AM, 2002, SCIENCE, V298, P2345, DOI 10.1126/science.1076641; Gorman N, 1999, BIOCHEM PHARMACOL, V58, P375, DOI 10.1016/S0006-2952(99)00088-X; Grant GR, 2006, HEPATOLOGY, V44, P174, DOI 10.1002/hep.21233; Gunshin H, 1997, NATURE, V388, P482, DOI 10.1038/41343; Hintze KJ, 2007, J BIOL CHEM, V282, P34365, DOI 10.1074/jbc.M700254200; Horng JL, 2007, AM J PHYSIOL-REG I, V292, pR2068, DOI 10.1152/ajpregu.00578.2006; Jones BC, 2007, AM J PHYSIOL-REG I, V293, pR116, DOI 10.1152/ajpregu.00608.2006; Lafourcade C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002758; Liuzzi JP, 2006, P NATL ACAD SCI USA, V103, P13612, DOI 10.1073/pnas.0606424103; Mackenzie, 1999, BIOMEMBRANE TRANSPOR, P327; McCreedy RA, 2009, NUTR REV, V67, P607, DOI 10.1111/j.1753-4887.2009.00233.x; McLachlan S, 2011, PHYSIOL GENOMICS, V43, P136, DOI 10.1152/physiolgenomics.00025.2010; Nieland TJF, 2004, TRAFFIC, V5, P478, DOI 10.1111/j.1398-9219.2004.00193.x; Okada A, 2006, NATURE, V444, P369, DOI 10.1038/nature05246; Paine A, 2010, BIOCHEM PHARMACOL, V80, P1895, DOI 10.1016/j.bcp.2010.07.014; Pei JM, 2011, BIOL DIRECT, V6, DOI 10.1186/1745-6150-6-37; Poss KD, 1997, P NATL ACAD SCI USA, V94, P10919, DOI 10.1073/pnas.94.20.10919; Pratt AJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033607; Ryter SW, 2006, PHYSIOL REV, V86, P583, DOI 10.1152/physrev.00011.2005; Shipston MJ, 2011, J BIOL CHEM, V286, P8709, DOI 10.1074/jbc.R110.210005; Smith AG, 1997, BLOOD, V89, P1045, DOI 10.1182/blood.V89.3.1045; Stam LF, 1996, GENETICS, V144, P1559; Straud S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011629; Tian LJ, 2012, J BIOL CHEM, V287, P14718, DOI 10.1074/jbc.M111.335547; Vanoaica L, 2010, CELL METAB, V12, P273, DOI 10.1016/j.cmet.2010.08.003; Wang FD, 2007, NAT GENET, V39, P1025, DOI 10.1038/ng2059; Whitlock EP, 2006, ANN INTERN MED, V145, P209, DOI 10.7326/0003-4819-145-3-200608010-00009; Winston WM, 2002, SCIENCE, V295, P2456, DOI 10.1126/science.1068836; Wolfrum C, 2007, NAT BIOTECHNOL, V25, P1149, DOI 10.1038/nbt1339; Zhang Z, 2012, HEPATOLOGY; Zhang ZZ, 2011, BLOOD, V118, P1912, DOI 10.1182/blood-2011-01-330324	48	2	2	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2013	8	5							e63280	10.1371/journal.pone.0063280	http://dx.doi.org/10.1371/journal.pone.0063280			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	143FO	23675470	gold, Green Published, Green Submitted			2022-12-27	WOS:000318852400033
J	Main, H; Radenkovic, J; Jin, SB; Lendahl, U; Andersson, ER				Main, Heather; Radenkovic, Jelena; Jin, Shao-bo; Lendahl, Urban; Andersson, Emma R.			Notch Signaling Maintains Neural Rosette Polarity	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; AMYLOID PRECURSOR PROTEIN; CENTRAL-NERVOUS-SYSTEM; RADIAL GLIAL IDENTITY; BINDING PROTEIN; TUBE CLOSURE; SELF-RENEWAL; APICAL CONSTRICTION; ASYMMETRIC DIVISION; VERTEBRATE EMBRYO	Formation of the metazoan body plan requires a complex interplay of morphological changes and patterning, and central to these processes is the establishment of apical/basal cell polarity. In the developing nervous system, apical/basal cell polarity is essential for neural tube closure and maintenance of the neural stem cell population. In this report we explore how a signaling pathway important for nervous system development, Notch signaling, impacts on apical/basal cell polarity in neural differentiation. CSL-/- mouse embryos, which are devoid of canonical Notch signaling, demonstrated a neural tube phenotype consistent with cell polarity and convergent extension defects, including deficiencies in the restricted expression of apical polarity markers in the neuroepithelium. CSL-/- mouse embryonic stem (ES) cells, cultured at low density, behaved as wild-type in the establishment of neural progenitors and apical specification, though progression through rosette formation, an in vitro correlate of neurulation, required CSL for correct maintenance of rosette structure and regulation of neuronal differentiation. Similarly, acute pharmacological inhibition of Notch signaling led to the breakdown of neural rosettes and accelerated neuronal differentiation. In addition to functional Notch signaling, rosette integrity was found to require actin polymerization and Rho kinase (ROCK) activity. Disruption of rosettes through inhibition of actin polymerization or ROCK activity, however, had no effect on neuronal differentiation, indicating that rosette maintenance is not a prerequisite for normal neuronal differentiation. In conclusion, our data indicate that Notch signaling plays a role not only in differentiation, but also in organization and maintenance of polarity during development of the early nervous system.	[Main, Heather; Radenkovic, Jelena; Jin, Shao-bo; Lendahl, Urban; Andersson, Emma R.] Karolinska Inst, Dept Cell & Mol Biol, Stockholm, Sweden	Karolinska Institutet	Main, H (corresponding author), Karolinska Inst, Dept Cell & Mol Biol, Stockholm, Sweden.	h.main@physics.usyd.edu.au; emma.andersson@ki.se	Andersson, Emma R/J-4236-2012; Andersson, Emma/AAB-8532-2019	Andersson, Emma R/0000-0002-8608-625X; Andersson, Emma/0000-0002-8608-625X; Lendahl, Urban/0000-0001-9543-8141	Karolinska Institutet KID; Swedish Cancer Society; Swedish Research Council (DBRM); Swedish Research Council (Strategic Research Initiative in Stem Cells and Regenerative Medicine); EC project EuroSyStem; EC project NotchIT; Karolinska Institutet; Knut och Alice Wallenbergs Stiftelse (WIRM)	Karolinska Institutet KID; Swedish Cancer Society(Swedish Cancer Society); Swedish Research Council (DBRM)(Swedish Research Council); Swedish Research Council (Strategic Research Initiative in Stem Cells and Regenerative Medicine)(Swedish Research Council); EC project EuroSyStem; EC project NotchIT; Karolinska Institutet(Karolinska Institutet); Knut och Alice Wallenbergs Stiftelse (WIRM)(Knut & Alice Wallenberg Foundation)	This work was financially supported by Karolinska Institutet KID funding (HM), the Swedish Cancer Society, the Swedish Research Council (DBRM; the Strategic Research Initiative in Stem Cells and Regenerative Medicine), the EC projects EuroSyStem and NotchIT, Karolinska Institutet and Knut och Alice Wallenbergs Stiftelse (WIRM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abranches E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006286; Andersson ER, 2011, DEVELOPMENT, V138, P3593, DOI 10.1242/dev.063610; Anthony TE, 2005, GENE DEV, V19, P1028, DOI 10.1101/gad.1302105; ARTAVANISTSAKONAS S, 1983, P NATL ACAD SCI-BIOL, V80, P1977, DOI 10.1073/pnas.80.7.1977; Barsi JC, 2005, MECH DEVELOP, V122, P1106, DOI 10.1016/j.mod.2005.06.005; Boroviak T, 2010, STEM CELLS; Bultje RS, 2009, NEURON, V63, P189, DOI 10.1016/j.neuron.2009.07.004; Chen YC, 2012, J NEUROSCI RES, V90, P1382, DOI 10.1002/jnr.23030; CONLON RA, 1995, DEVELOPMENT, V121, P1533; Conti L, 2005, PLOS BIOL, V3, P1594, DOI 10.1371/journal.pbio.0030283; Copp AJ, 2003, NAT REV GENET, V4, P784, DOI 10.1038/nrg1181; Corbeil D, 2010, FEBS LETT, V584, P1659, DOI 10.1016/j.febslet.2010.01.050; Costa MR, 2008, DEVELOPMENT, V135, P11, DOI 10.1242/dev.009951; De Marco P, 2011, BIOFACTORS; De-Regil LM, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007950.pub2; Del Bene F, 2008, CELL, V134, P1055, DOI 10.1016/j.cell.2008.07.017; DESMOND ME, 1986, J EMBRYOL EXP MORPH, V97, P25; Doudney K, 2005, AM J MED GENET C, V135C, P42, DOI 10.1002/ajmg.c.30052; Dovey HF, 2001, J NEUROCHEM, V76, P173, DOI 10.1046/j.1471-4159.2001.00012.x; Dunwoodie SL, 2002, DEVELOPMENT, V129, P1795; Egger B, 2011, FLY, V5, P237, DOI 10.4161/fly.5.3.15640; Ehebauer M, 2006, SCIENCE, V314, P1414, DOI 10.1126/science.1134042; Elkabetz Y, 2008, GENE DEV, V22, P152, DOI 10.1101/gad.1616208; Fietz SA, 2011, CURR OPIN NEUROBIOL, V21, P23, DOI 10.1016/j.conb.2010.10.002; FRISEN J, 1995, J CELL BIOL, V131, P453, DOI 10.1083/jcb.131.2.453; Gaiano N, 2000, NEURON, V26, P395, DOI 10.1016/S0896-6273(00)81172-1; Geling A, 2002, EMBO REP, V3, P688, DOI 10.1093/embo-reports/kvf124; Guruharsha KG, 2012, NAT REV GENET, V13, P654, DOI 10.1038/nrg3272; Guzman-Ayala M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004268; Hamblet NS, 2002, DEVELOPMENT, V129, P5827, DOI 10.1242/dev.00164; Han H, 2002, INT IMMUNOL, V14, P637, DOI 10.1093/intimm/dxf030; Hatakeyama J, 2004, DEVELOPMENT, V131, P5539, DOI 10.1242/dev.01436; Herreman A, 1999, P NATL ACAD SCI USA, V96, P11872, DOI 10.1073/pnas.96.21.11872; Hildebrand JD, 1999, CELL, V99, P485, DOI 10.1016/S0092-8674(00)81537-8; Huppert SS, 2000, NATURE, V405, P966, DOI 10.1038/35016111; Ishiuchi T, 2011, NAT CELL BIOL, V13, P860, DOI 10.1038/ncb2274; Jolly LA, 2009, MOL BIOL CELL, V20, P2015, DOI 10.1091/mbc.E08-06-0596; Kiernan AE, 2001, P NATL ACAD SCI USA, V98, P3873, DOI 10.1073/pnas.071496998; Kinoshita N, 2008, MOL BIOL CELL, V19, P2289, DOI 10.1091/mbc.E07-12-1286; Kobayashi NR, 2010, MOL PSYCHIATR, V15, P672, DOI 10.1038/mp.2009.131; LEE H, 1985, TERATOLOGY, V31, P119, DOI 10.1002/tera.1420310114; Lee JD, 2007, DEVELOPMENT, V134, P2007, DOI 10.1242/dev.000885; Letizia A, 2011, J CELL SCI, V124, P240, DOI 10.1242/jcs.073601; Li T, 2003, J NEUROSCI, V23, P3272; Liu HA, 2010, J CLIN BIOCHEM NUTR, V47, P174, DOI 10.3164/jcbn.10-47; Lowell S, 2006, PLOS BIOL, V4, P805, DOI 10.1371/journal.pbio.0040121; Main H, 2010, EXP CELL RES, V316, P1610, DOI 10.1016/j.yexcr.2009.12.012; Malicki J, 1999, DEVELOPMENT, V126, P1235; Marthiens V, 2009, EMBO REP, V10, P515, DOI 10.1038/embor.2009.36; Micchelli CA, 2002, FASEB J, V16, P79, DOI 10.1096/fj.02-0394fje; Mitchell KJ, 2011, CURR OPIN NEUROBIOL, V21, P197, DOI 10.1016/j.conb.2010.08.009; Nemir M, 2006, CIRC RES, V98, P1471, DOI 10.1161/01.RES.0000226497.52052.2a; Nishimura T, 2012, CELL, V149, P1084, DOI 10.1016/j.cell.2012.04.021; Ohata S, 2011, NEURON, V69, P215, DOI 10.1016/j.neuron.2010.12.026; OKA C, 1995, DEVELOPMENT, V121, P3291; Omori Y, 2006, CURR BIOL, V16, P945, DOI 10.1016/j.cub.2006.03.058; Ossipova O, 2009, DEV CELL, V17, P222, DOI 10.1016/j.devcel.2009.06.010; Pierfelice T, 2011, NEURON, V69, P840, DOI 10.1016/j.neuron.2011.02.031; Roebroek AJM, 1998, DEVELOPMENT, V125, P4863; Sathananthan AH, 2011, MICROSC MICROANAL, V17, P520, DOI 10.1017/S1431927611000584; Schroeder T, 2000, EMBO J, V19, P2558, DOI 10.1093/emboj/19.11.2558; Schroeder T, 2003, P NATL ACAD SCI USA, V100, P4018, DOI 10.1073/pnas.0438008100; Schroeder T, 2006, MECH DEVELOP, V123, P570, DOI 10.1016/j.mod.2006.05.002; Shi SL, 2003, P NATL ACAD SCI USA, V100, P5234, DOI 10.1073/pnas.0831126100; Smith CA, 2007, EMBO J, V26, P468, DOI 10.1038/sj.emboj.7601495; Takenobu H, 2011, ONCOGENE, V30, P97, DOI 10.1038/onc.2010.383; Torban E, 2004, J BIOL CHEM, V279, P52703, DOI 10.1074/jbc.M408675200; Tropepe V, 2001, NEURON, V30, P65, DOI 10.1016/S0896-6273(01)00263-X; Uchida N, 2000, P NATL ACAD SCI USA, V97, P14720, DOI 10.1073/pnas.97.26.14720; Wilson PG, 2006, STEM CELL REV, V2, P67, DOI 10.1385/SCR:2:1:67; Woo SM, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-97; Yamaguchi TP, 1999, DEVELOPMENT, V126, P1211; Ybot-Gonzalez P, 1999, DEV DYNAM, V215, P273, DOI 10.1002/(SICI)1097-0177(199907)215:3<273::AID-AJA9>3.0.CO;2-H; Ybot-Gonzalez P, 2007, DEVELOPMENT, V134, P789, DOI 10.1242/dev.000380; Ying QL, 2003, METHOD ENZYMOL, V365, P327; Yoon KJ, 2004, J NEUROSCI, V24, P9497, DOI 10.1523/JNEUROSCI.0993-04.2004; Zecchini V, 1999, CURR BIOL, V9, P460, DOI 10.1016/S0960-9822(99)80211-5; Zhang XM, 2008, J NUTR SCI VITAMINOL, V54, P353, DOI 10.3177/jnsv.54.353; Zhang XM, 2012, NUTR NEUROSCI, V15, P55, DOI 10.1179/1476830511Y.0000000025	79	21	22	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2013	8	5							e62959	10.1371/journal.pone.0062959	http://dx.doi.org/10.1371/journal.pone.0062959			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	143FO	23675446	Green Published, Green Submitted, gold			2022-12-27	WOS:000318852400016
J	Xu, D; Zheng, H; Yu, WM; Qu, CK				Xu, Dan; Zheng, Hong; Yu, Wen-Mei; Qu, Cheng-Kui			Activating Mutations in Protein Tyrosine Phosphatase Ptpn11 (Shp2) Enhance Reactive Oxygen Species Production That Contributes to Myeloproliferative Disorder	PLOS ONE			English	Article							OF-FUNCTION MUTATION; GROWTH-FACTOR RECEPTOR; HEMATOPOIETIC STEM; MOUSE MODEL; LEUKEMIA; BINDING; GENE; MITOCHONDRIA; CHECKPOINT; DISTINCT	Gain of function (GOF) mutations in protein tyrosine phosphatase Ptpn11 have been identified in childhood leukemias, and these mutations are sufficient to drive the development of myeloproliferative disorder and malignant leukemias in mice. However, the molecular mechanisms by which Ptpn11 mutations induce these malignancies are not completely understood. Here we report that Ptpn11 GOF mutations cause cytokine hypersensitivity in hematopoietic cells partly by enhancing the production of reactive oxygen species (ROS). GOF mutations D61G or E76K in Ptpn11 increased ROS levels in myeloid progenitors but not in hematopoietic stem cells. Increased ROS enhanced cellular responses to cytokines by promoting cytokine signaling. Treatment with an antioxidant partially corrected cytokine hypersensitivity in Ptpn11 mutant progenitors. Further analyses demonstrated that Ptpn11 mutations increased mitochondrial aerobic metabolism by interacting with a novel substrate in the mitochondria. This study provides new insights into the pathogenic effects of GOF mutations of Ptpn11 and implies that antioxidants may have a therapeutic benefit for the leukemic patients with these mutations.	[Xu, Dan; Zheng, Hong; Yu, Wen-Mei; Qu, Cheng-Kui] Case Western Reserve Univ, Dept Med, Ctr Stem Cell & Regenerat Med, Div Hematol & Oncol,Case Comprehens Canc Ctr, Cleveland, OH 44106 USA	Case Western Reserve University	Qu, CK (corresponding author), Case Western Reserve Univ, Dept Med, Ctr Stem Cell & Regenerat Med, Div Hematol & Oncol,Case Comprehens Canc Ctr, Cleveland, OH 44106 USA.	cxq6@case.edu			National Institutes of Health [HL068212, DK092722]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL068212] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK092722] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the National Institutes of Health grants HL068212 and DK092722 (to C. K. Q.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agazie YM, 2003, J BIOL CHEM, V278, P13952, DOI 10.1074/jbc.M210670200; Arachiche A, 2008, J BIOL CHEM, V283, P24406, DOI 10.1074/jbc.M709217200; Araki T, 2004, NAT MED, V10, P849, DOI 10.1038/nm1084; Araki T, 2009, P NATL ACAD SCI USA, V106, P4736, DOI 10.1073/pnas.0810053106; Barford D, 1998, STRUCTURE, V6, P249, DOI 10.1016/S0969-2126(98)00027-6; BENNETT AM, 1994, P NATL ACAD SCI USA, V91, P7335, DOI 10.1073/pnas.91.15.7335; Bentires-Alj M, 2004, CANCER RES, V64, P8816, DOI 10.1158/0008-5472.CAN-04-1923; Birnbaum RA, 2000, MOL CELL, V5, P189, DOI 10.1016/S1097-2765(00)80415-3; Carcamo JM, 2002, BLOOD, V99, P3205, DOI 10.1182/blood.V99.9.3205; Chan G, 2008, CANCER METAST REV, V27, P179, DOI 10.1007/s10555-008-9126-y; Chan G, 2011, BLOOD, V117, P4253, DOI 10.1182/blood-2010-11-319517; Chan G, 2009, BLOOD, V113, P4414, DOI 10.1182/blood-2008-10-182626; Chan RJ, 2005, BLOOD, V105, P3737, DOI 10.1182/blood-2004-10-4002; Chughtai N, 2002, J BIOL CHEM, V277, P31107, DOI 10.1074/jbc.M200156200; Eck MJ, 1996, NATURE, V379, P277, DOI 10.1038/379277a0; Fragale A, 2004, HUM MUTAT, V23, P267, DOI 10.1002/humu.20005; Gu HH, 1997, J BIOL CHEM, V272, P16421, DOI 10.1074/jbc.272.26.16421; Hof P, 1998, CELL, V92, P441, DOI 10.1016/S0092-8674(00)80938-1; Jakob S, 2008, J BIOL CHEM, V283, P33155, DOI 10.1074/jbc.M805138200; Keilhack H, 2005, J BIOL CHEM, V280, P30984, DOI 10.1074/jbc.M504699200; Kontaridis MI, 2006, J BIOL CHEM, V281, P6785, DOI 10.1074/jbc.M513068200; Lee I, 2010, BBA-MOL BASIS DIS, V1802, P275, DOI 10.1016/j.bbadis.2009.10.005; LI W, 1994, MOL CELL BIOL, V14, P509, DOI 10.1128/MCB.14.1.509; Loh ML, 2004, LEUKEMIA, V18, P1831, DOI 10.1038/sj.leu.2403492; Loh ML, 2004, BLOOD, V103, P2325, DOI 10.1182/blood-2003-09-3287; Mohi MG, 2005, CANCER CELL, V7, P179, DOI 10.1016/j.ccr.2005.01.010; Norddahl GL, 2011, CELL STEM CELL, V8, P499, DOI 10.1016/j.stem.2011.03.009; Qu CK, 2001, BLOOD, V97, P911, DOI 10.1182/blood.V97.4.911; Qu CK, 1998, MOL CELL BIOL, V18, P6075, DOI 10.1128/MCB.18.10.6075; Qu CK, 1997, MOL CELL BIOL, V17, P5499, DOI 10.1128/MCB.17.9.5499; Salvi M, 2004, CELL MOL LIFE SCI, V61, P2393, DOI 10.1007/s00018-004-4211-z; Sattler M, 1999, BLOOD, V93, P2928; Shen JH, 2011, MOL CELL BIOL, V31, P4902, DOI 10.1128/MCB.05629-11; Simsek T, 2010, CELL STEM CELL, V7, P380, DOI 10.1016/j.stem.2010.07.011; Tartaglia M, 2004, BLOOD, V104, P307, DOI 10.1182/blood-2003-11-3876; Tartaglia M, 2001, NAT GENET, V29, P465, DOI 10.1038/ng772; Tartaglia M, 2003, NAT GENET, V34, P148, DOI 10.1038/ng1156; Tonks NK, 2006, NAT REV MOL CELL BIO, V7, P833, DOI 10.1038/nrm2039; Wu TR, 2002, J BIOL CHEM, V22, P22; Xu D, 2008, FRONT BIOSCI-LANDMRK, V13, P4925, DOI 10.2741/3051; Xu D, 2011, J EXP MED, V208, P1977, DOI 10.1084/jem.20110450; Xu D, 2010, BLOOD, V116, P3611, DOI 10.1182/blood-2010-01-265652; Yu WM, 2006, J BIOL CHEM, V281, P5426, DOI 10.1074/jbc.M507622200; Yu WM, 2003, ONCOGENE, V22, P5995, DOI 10.1038/sj.onc.1206846; Yuan LP, 2003, J BIOL CHEM, V278, P42812, DOI 10.1074/jbc.M305075200; Yuan LP, 2003, J BIOL CHEM, V278, P15208, DOI 10.1074/jbc.M211327200; Zhu HH, 2011, BLOOD, V117, P5350, DOI 10.1182/blood-2011-01-333476	47	26	26	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2013	8	5							e63152	10.1371/journal.pone.0063152	http://dx.doi.org/10.1371/journal.pone.0063152			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	143FO	23675459	Green Published, Green Submitted, gold			2022-12-27	WOS:000318852400027
J	Li, YK; Li, CG				Li, Yuke; Li, Chunguang			Synergies between Intrinsic and Synaptic Plasticity Based on Information Theoretic Learning	PLOS ONE			English	Article							NONLINEAR ADAPTIVE PREDICTION; EXCITABILITY; NEURONS; ALGORITHM	In experimental and theoretical neuroscience, synaptic plasticity has dominated the area of neural plasticity for a very long time. Recently, neuronal intrinsic plasticity (IP) has become a hot topic in this area. IP is sometimes thought to be an information-maximization mechanism. However, it is still unclear how IP affects the performance of artificial neural networks in supervised learning applications. From an information-theoretical perspective, the error-entropy minimization (MEE) algorithm has newly been proposed as an efficient training method. In this study, we propose a synergistic learning algorithm combining the MEE algorithm as the synaptic plasticity rule and an information-maximization algorithm as the intrinsic plasticity rule. We consider both feedforward and recurrent neural networks and study the interactions between intrinsic and synaptic plasticity. Simulations indicate that the intrinsic plasticity rule can improve the performance of artificial neural networks trained by the MEE algorithm.	Zhejiang Univ, Dept Informat Sci & Elect Engn, Hangzhou 310027, Zhejiang, Peoples R China	Zhejiang University	Li, CG (corresponding author), Zhejiang Univ, Dept Informat Sci & Elect Engn, Hangzhou 310027, Zhejiang, Peoples R China.	cgli@zju.edu.cn	Li, Yuke/P-2327-2016; Li, Chunguang/F-1458-2016	Li, Chunguang/0000-0003-3147-1553	National Natural Science Foundation of China [61171153, 61101045]; Foundation for the Author of National Excellent Doctoral Dissertation of PR China; Scientific Research Foundation for the Returned Overseas Chinese Scholars; Zhejiang Provincial Natural Science Foundation of China [LR12F01001]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Foundation for the Author of National Excellent Doctoral Dissertation of PR China(Foundation for the Author of National Excellent Doctoral Dissertation of China); Scientific Research Foundation for the Returned Overseas Chinese Scholars(Scientific Research Foundation for the Returned Overseas Chinese Scholars); Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province)	This work was supported by the National Natural Science Foundation of China (Grant Nos. 61171153 and 61101045), the Foundation for the Author of National Excellent Doctoral Dissertation of PR China, the Scientific Research Foundation for the Returned Overseas Chinese Scholars, and Zhejiang Provincial Natural Science Foundation of China (Grant No. LR12F01001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baddeley R, 1997, P ROY SOC B-BIOL SCI, V264, P1775, DOI 10.1098/rspb.1997.0246; Baltersee J, 1998, IEEE T SIGNAL PROCES, V46, P2207, DOI 10.1109/78.705435; BELL AJ, 1995, NEURAL COMPUT, V7, P1129, DOI 10.1162/neco.1995.7.6.1129; Cudmore RH, 2004, J NEUROPHYSIOL, V92, P341, DOI 10.1152/jn.01059.2003; Daoudal G, 2003, LEARN MEMORY, V10, P456, DOI 10.1101/lm.64103; Desai NS, 1999, NAT NEUROSCI, V2, P515, DOI 10.1038/9165; Erdogmus D, 2002, IEEE T SIGNAL PROCES, V50, P1780, DOI 10.1109/TSP.2002.1011217; Erdogmus D, 2000, P ICA HELS FINL; Glass L, 1998, CLOCK CHAOS; HAYKIN S, 1995, IEEE T SIGNAL PROCES, V43, P526, DOI 10.1109/78.348134; LAUGHLIN S, 1981, Z NATURFORSCH C, V36, P910; Lazar A, 2009, FRONT COMPUT NEUROSC, V3, DOI 10.3389/neuro.10.023.2009; Li CG, 2013, IEEE T AUTON MENT DE, V5, P62, DOI 10.1109/TAMD.2012.2211101; Li CG, 2011, IEEE T AUTON MENT DE, V3, P277, DOI 10.1109/TAMD.2011.2159379; Mandic DP, 1999, IEEE T NEURAL NETWOR, V10, P1435, DOI 10.1109/72.809088; Marder E, 1996, P NATL ACAD SCI USA, V93, P13481, DOI 10.1073/pnas.93.24.13481; Mozzachiodi R, 2010, TRENDS NEUROSCI, V33, P17, DOI 10.1016/j.tins.2009.10.001; Neumann K, 2011, LECT NOTES COMPUT SC, V6791, P339, DOI 10.1007/978-3-642-21735-7_42; PARZEN E, 1962, ANN MATH STAT, V33, P1065, DOI 10.1214/aoms/1177704472; Principe JC, 1999, NEURAL ADAPTIVE SYST; Schrauwen B, 2008, NEUROCOMPUTING, V71, P1159, DOI 10.1016/j.neucom.2007.12.020; Steil JJ, 2007, NEURAL NETWORKS, V20, P353, DOI 10.1016/j.neunet.2007.04.011; Stemmler M, 1999, NAT NEUROSCI, V2, P521, DOI 10.1038/9173; Triesch J, 2005, LECT NOTES COMPUT SC, V3696, P65, DOI 10.1007/11550822_11; Triesch J, 2007, NEURAL COMPUT, V19, P885, DOI 10.1162/neco.2007.19.4.885; Watt A. J., 2010, FRONT SYNAPTIC NEURO, V2; Williams R.J., 1995, BACKPROPAGATION THEO, V1, P433; Williams RJ, 1989, NEURAL COMPUT, V1, P270, DOI 10.1162/neco.1989.1.2.270; Zhang M, 2004, J NEUROBIOL, V61, P277, DOI 10.1002/neu.20045; Zhang W, 2003, NAT REV NEUROSCI, V4, P885, DOI 10.1038/nrn1248	31	8	8	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2013	8	5							e62894	10.1371/journal.pone.0062894	http://dx.doi.org/10.1371/journal.pone.0062894			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	155HD	23671642	gold, Green Submitted, Green Published			2022-12-27	WOS:000319737700026
J	Tworzydlo, W; Kisiel, E; Bilinski, SM				Tworzydlo, Waclaw; Kisiel, Elzbieta; Bilinski, Szczepan M.			Embryos of the Viviparous Dermapteran, Arixenia esau Develop Sequentially in Two Compartments: Terminal Ovarian Follicles and the Uterus	PLOS ONE			English	Article							OOGENESIS; EVOLUTION; COCKROACH; DIPTERA; MILK	Three main reproductive strategies have been described among insects: most common oviparity, ovoviviparity and viviparity. In the latter strategy, the embryonic development takes place within the body of the mother which provides gas exchange and nutrients for embryos. Here we present the results of histological and EM analyses of the female reproductive system of the viviparous earwig, Arixenia esau, focusing on all the modifications related to the viviparity. We show that in the studied species the embryonic development consists of two "physiological phases" that take place in two clearly disparate compartments, i.e. the terminal ovarian follicle and the uterus. In both compartments the embryos are associated with synthetically active epithelial cells. We suggest that these cells are involved in the nourishment of the embryo. Our results indicate that viviparity in arixeniids is more complex than previously considered. We propose the new term "pseudoplacento-uterotrophic viviparity" for this unique two-phase reproductive strategy.	[Tworzydlo, Waclaw; Kisiel, Elzbieta; Bilinski, Szczepan M.] Jagiellonian Univ, Inst Zool, Dept Dev Biol & Morphol Invertebrates, PL-30060 Krakow, Poland	Jagiellonian University	Tworzydlo, W (corresponding author), Jagiellonian Univ, Inst Zool, Dept Dev Biol & Morphol Invertebrates, PL-30060 Krakow, Poland.	w.tworzydlo@uj.edu.pl	Tworzydlo, Waclaw/AAJ-1343-2020	Tworzydlo, Waclaw/0000-0003-1481-1050	National Science Center (NCN) in Krakow, Poland [2011/01/D/NZ4/00137]	National Science Center (NCN) in Krakow, Poland	Financial support for this study was received by WT from National Science Center (NCN) in Krakow, Poland (project: 2011/01/D/NZ4/00137). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDREWS RM, 1994, PHYSIOL ZOOL, V67, P1006, DOI 10.1086/physzool.67.4.30163876; Attardo GM, 2008, J INSECT PHYSIOL, V54, P1236, DOI 10.1016/j.jinsphys.2008.06.008; Attardo GM, 2006, J INSECT PHYSIOL, V52, P1128, DOI 10.1016/j.jinsphys.2006.07.007; Bermingham J, 2009, PHYSIOL ENTOMOL, V34, P103, DOI 10.1111/j.1365-3032.2008.00669.x; Bilinski SM, 1996, HISTOCHEM J, V28, P651, DOI 10.1007/BF02331386; Buning J, 1998, INT J INSECT MORPHOL, V27, P3, DOI 10.1016/S0020-7322(97)00028-7; Buning J., 1994, INSECT OVARY ULTRAST, Vfirst; Haas F, 2001, EUR J ENTOMOL, V98, P445, DOI 10.14411/eje.2001.065; Hagan HR., 1951, EMBRYOLOGY VIVIPAROU; Herter K, 1943, Z MORPHOLOGIE OKOLOG, V40, P158, DOI DOI 10.1007/BF00421680; Holbrook GL, 2004, P NATL ACAD SCI USA, V101, P5595, DOI 10.1073/pnas.0400209101; HOWELL WM, 1980, EXPERIENTIA, V36, P1014, DOI 10.1007/BF01953855; JUNQUERA P, 1984, ROUX ARCH DEV BIOL, V193, P197, DOI 10.1007/BF01260339; Kathirithamby J., 1992, Frustula Entomologica, V13, P1; Kocarek P, 2009, TROP ZOOL, V22, P237; Kunkel J.G., 1985, P83; Margaritis L.H., 1985, P153; Meier R, 1999, BIOL REV, V74, P199, DOI 10.1017/S0006323199005320; NAKATA S, 1974, PAC INSECTS, V16, P307; Ochs RL, 1998, METHOD CELL BIOL, V53, P303; Pellegrini A, 2011, TISSUE CELL, V43, P1, DOI 10.1016/j.tice.2010.10.005; POPHAM EJ, 1985, Z ZOOL SYST EVOL, V23, P199; Ramon, 1903, TRAB LAB INVEST BIOL, V2, P129; Retnakaran A., 1985, P231; Sabri A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018847; SCHUPBACH PM, 1983, INT J INSECT MORPHOL, V12, P211, DOI 10.1016/0020-7322(83)90018-1; SOUSA M, 1987, CAN J ZOOL, V65, P2607, DOI 10.1139/z87-395; SOUSA M, 1988, INT J INVER REP DEV, V13, P1; Thompson SW, 1966, SELECTED HISTOCHEMIC; TOBE SS, 1973, TISSUE CELL, V5, P633, DOI 10.1016/S0040-8166(73)80050-3; TOBE SS, 1978, ANNU REV ENTOMOL, V23, P283, DOI 10.1146/annurev.en.23.010178.001435; Tworzydlo W, 2005, GENESIS, V43, P49, DOI 10.1002/gene.20155; Tworzydlo W, 2013, ZOOL ANZ, V252, P410, DOI 10.1016/j.jcz.2012.11.002; Tworzydlo W, 2010, ARTHROPOD STRUCT DEV, V39, P360, DOI 10.1016/j.asd.2010.05.004; Wheeler DE, 2003, ENCY INSECTS, P991; Williford A, 2004, EVOL DEV, V6, P67, DOI 10.1111/j.1525-142X.2004.04012.x; Youngsteadt E, 2005, J INSECT PHYSIOL, V51, P803, DOI 10.1016/j.jinsphys.2005.03.008	37	17	17	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2013	8	5							e64087	10.1371/journal.pone.0064087	http://dx.doi.org/10.1371/journal.pone.0064087			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145YI	23667700	Green Published, gold, Green Submitted			2022-12-27	WOS:000319055600085
J	Chakraborty, P; Kulkarni, S; Rajan, R; Sainis, K				Chakraborty, Pampi; Kulkarni, Savita; Rajan, Ramakrishna; Sainis, Krishna			Drug Resistant Clinical Isolates of Mycobacterium tuberculosis from Different Genotypes Exhibit Differential Host Responses in THP-1 Cells	PLOS ONE			English	Article							BEIJING FAMILY STRAINS; HUMAN MACROPHAGES; IN-VITRO; MURINE MACROPHAGES; TNF-ALPHA; VIRULENT; APOPTOSIS; INDUCTION; GROWTH; COMPLEX	Mycobacterium tuberculosis (MTB) persistently infects and survives within the host macrophages. Substantial genotypic variation exists among MTB strains which correlate with their interactions with the host. The present study was designed to establish a correlation, if any, between infection and induction of innate immune response by genetically diverse drug resistant MTB isolates from India. For this purpose, three clinical isolates from ancient and modern lineages, along with H37Ra and H37Rv were evaluated for intracellular growth, phagocytic index, induction of proinflammatory cytokines and apoptosis following infection in THP-1 cell line. A wide variation in the induction of cytokines was revealed subsequent to infection with different strains. EAI-5 strain from ancient lineage 1, induced higher proinflammatory responses, higher apoptosis and moderate intracellular growth compared to other strains, in contrast, for Beijing strain of modern lineage 2, all three parameters were lowest among the clinical isolates. Further, the responses induced by LAM-6 from modern lineage 4 were at a moderate level, similar to the laboratory strain H37Rv which also belongs to lineage 4. Thus, these profiles were specific to their respective lineages and/or genotypes and independent of their drug resistance status. Further, a positive correlation, among TNF-alpha, IL-1 beta, IL-6 and IL-12 induced in infected THP-1 cells was demonstrated. In addition, induction of all pro-inflammatory cytokines correlated well with the host cell apoptosis. A positive correlation was observed between phagocytic index in the category of '>10 bacilli/cell' and induction of apoptosis, only for virulent strains, indicating that initial accumulation of MTB strains inside the host cell may be an important determining factor for different innate responses.	[Chakraborty, Pampi; Kulkarni, Savita; Rajan, Ramakrishna; Sainis, Krishna] Bhabha Atom Res Ctr, Radiat Med Ctr, Biomed Grp, Bombay 400085, Maharashtra, India	Bhabha Atomic Research Center (BARC)	Kulkarni, S (corresponding author), Bhabha Atom Res Ctr, Radiat Med Ctr, Biomed Grp, Bombay 400085, Maharashtra, India.	savita.kulkarni1@gmail.com			Bhabha Atomic Research Centre which is part of Department of Atomic Energy (DAE), Government of India; Homi Bhabha National Institute, Mumbai	Bhabha Atomic Research Centre which is part of Department of Atomic Energy (DAE), Government of India; Homi Bhabha National Institute, Mumbai	This was funded by the authors' own department, Bhabha Atomic Research Centre which is part of Department of Atomic Energy (DAE), Government of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We acknowledge Homi Bhabha National Institute, Mumbai for providing Research Fellowship to Mrs Pampi Chakraborty. We are grateful to Mr. Mukti Kanta Ray for his support for radiorespirometry measurements for this study.	Almeida D, 2005, CLIN INFECT DIS, V40, P881, DOI 10.1086/427940; [Anonymous], 2012, WHO TUB GLOB FACTSH; Bifani PJ, 2002, TRENDS MICROBIOL, V10, P45, DOI 10.1016/S0966-842X(01)02277-6; Boeuf P, 2005, BMC IMMUNOL, V6, DOI 10.1186/1471-2172-6-5; Bosio CM, 2000, J IMMUNOL, V164, P6417, DOI 10.4049/jimmunol.164.12.6417; Brosch R, 2002, P NATL ACAD SCI USA, V99, P3684, DOI 10.1073/pnas.052548299; Brudey K, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-23; Chacon-Salinas R, 2005, CLIN EXP IMMUNOL, V140, P443, DOI 10.1111/j.1365-2249.2005.02797.x; Ciaramella A, 2002, J INFECT DIS, V186, P1277, DOI 10.1086/344645; Comas I, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000600; Cooper AM, 2008, IMMUNOL REV, V226, P191, DOI 10.1111/j.1600-065X.2008.00702.x; Domenech P, 2009, MICROBIOL-SGM, V155, P3532, DOI 10.1099/mic.0.029199-0; Duan L, 2001, J IMMUNOL, V166, P7469, DOI 10.4049/jimmunol.166.12.7469; Freeman S, 2006, J INTERF CYTOK RES, V26, P27, DOI 10.1089/jir.2006.26.27; GANATRA RD, 1980, J NUCL MED, V21, P480; Hoal-Van Helden EG, 2001, CELL BIOL INT, V25, P83, DOI 10.1006/cbir.2000.0680; Honore-Bouakline S, 2003, J CLIN MICROBIOL, V41, P2323, DOI 10.1128/JCM.41.6.2323-2329.2003; Ignatova A, 2006, J MED MICROBIOL, V55, P1413, DOI 10.1099/jmm.0.46575-0; Keane J, 2000, J IMMUNOL, V164, P2016, DOI 10.4049/jimmunol.164.4.2016; Kulkarni S, 2005, RES MICROBIOL, V156, P588, DOI 10.1016/j.resmic.2005.01.005; LAMBRECHT RS, 1988, APPL ENVIRON MICROB, V54, P910, DOI 10.1128/AEM.54.4.910-916.1988; Lan NTN, 2003, EMERG INFECT DIS, V9, P1633, DOI 10.3201/eid0912.030169; Lasunskaia E, 2010, MICROBES INFECT, V12, P467, DOI 10.1016/j.micinf.2010.02.008; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lopez B, 2003, CLIN EXP IMMUNOL, V133, P30, DOI 10.1046/j.1365-2249.2003.02171.x; Manca C, 2004, INFECT IMMUN, V72, P5511, DOI 10.1128/IAI.72.9.5511-5514.2004; Manca C, 1999, J IMMUNOL, V162, P6740; Marquina-Castillo B, 2009, IMMUNOLOGY, V128, P123, DOI 10.1111/j.1365-2567.2008.03004.x; Narayanan S, 2008, INFECT GENET EVOL, V8, P474, DOI 10.1016/j.meegid.2007.09.007; Lazzarini LCO, 2008, J CLIN MICROBIOL, V46, P2175, DOI 10.1128/JCM.00065-08; Park JS, 2006, J LEUKOCYTE BIOL, V79, P80, DOI 10.1189/jlb.0505250; Parwati I, 2010, LANCET INFECT DIS, V10, P103, DOI 10.1016/S1473-3099(09)70330-5; Pitchappan RM, 1997, J BIOSCIENCE, V22, P47, DOI 10.1007/BF02703617; Portevin D, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001307; Pravica V, 2000, HUM IMMUNOL, V61, P863, DOI 10.1016/S0198-8859(00)00167-1; Rajavelu P, 2007, MICROBIOL IMMUNOL, V51, P201, DOI 10.1111/j.1348-0421.2007.tb03902.x; Rojas M, 1999, J IMMUNOL, V162, P6122; Russell DG, 2007, NAT REV MICROBIOL, V5, P39, DOI 10.1038/nrmicro1538; Sarkar R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043170; SCHLESINGER LS, 1993, J IMMUNOL, V150, P2920; Silver RF, 1998, INFECT IMMUN, V66, P1190, DOI 10.1128/IAI.66.3.1190-1199.1998; Sinsimer D, 2008, INFECT IMMUN, V76, P3027, DOI 10.1128/IAI.01663-07; Sohn H, 2009, SCAND J IMMUNOL, V69, P43, DOI 10.1111/j.1365-3083.2008.02188.x; Supply P, 2001, J CLIN MICROBIOL, V39, P3563, DOI 10.1128/JCM.39.10.3563-3571.2001; Tanveer M, 2009, T ROY SOC TROP MED H, V103, P581, DOI 10.1016/j.trstmh.2009.03.014; Theus SA, 2005, J INFECT DIS, V191, P453, DOI 10.1086/425936; Thuong NTT, 2007, GENES IMMUN, V8, P422, DOI 10.1038/sj.gene.6364405; Torrelles JB, 2008, J BIOL CHEM, V283, P31417, DOI 10.1074/jbc.M806350200; Tripathy NK, 2004, CLIN EXP IMMUNOL, V138, P369, DOI 10.1111/j.1365-2249.2004.02613.x; van der Spuy GD, 2009, TUBERCULOSIS, V89, P120, DOI 10.1016/j.tube.2008.09.003; VANEMBDEN JDA, 1993, J CLIN MICROBIOL, V31, P406, DOI 10.1128/JCM.31.2.406-409.1993; von Groll A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010191; Weniger T, 2010, NUCLEIC ACIDS RES, V38, pW326, DOI 10.1093/nar/gkq351; Wolf AJ, 2007, J IMMUNOL, V179, P2509, DOI 10.4049/jimmunol.179.4.2509; Zhang M, 1998, INFECT IMMUN, V66, P794, DOI 10.1128/IAI.66.2.794-799.1998	55	19	20	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e62966	10.1371/journal.pone.0062966	http://dx.doi.org/10.1371/journal.pone.0062966			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667550	Green Submitted, gold, Green Published			2022-12-27	WOS:000319654700088
J	Chen, HL; Zhang, ZP				Chen, Hailin; Zhang, Zuping			A Semi-Supervised Method for Drug-Target Interaction Prediction with Consistency in Networks	PLOS ONE			English	Article							DIVERSITY-ORIENTED SYNTHESIS; PHARMACOLOGY; INTEGRATION; MODEL	Computational prediction of interactions between drugs and their target proteins is of great importance for drug discovery and design. The difficulties of developing computational methods for the prediction of such potential interactions lie in the rarity of known drug-protein interactions and no experimentally verified negative drug-target interaction sample. Furthermore, target proteins need also to be predicted for some new drugs without any known target interaction information. In this paper, a semi-supervised learning method NetCBP is presented to address this problem by using labeled and unlabeled interaction information. Assuming coherent interactions between the drugs ranked by their relevance to a query drug, and the target proteins ranked by their relevance to the hidden target proteins of the query drug, we formulate a learning framework maximizing the rank coherence with respect to the known drug-target interactions. When applied to four classes of important drug-target interaction networks, our method improves previous methods in terms of cross-validation and some strongly predicted interactions are confirmed by the publicly accessible drug target databases, which indicates the usefulness of our method. Finally, a comprehensive prediction of drug-target interactions enables us to suggest many new potential drug-target interactions for further studies.	[Chen, Hailin; Zhang, Zuping] Cent S Univ, Sch Informat Sci & Engn, Changsha, Hunan, Peoples R China; [Chen, Hailin] Hunan Univ Humanities Sci & Technol, Dept Comp Sci & Technol, Loudi, Peoples R China	Central South University; Hunan University Of Humanities, Science & Technology	Zhang, ZP (corresponding author), Cent S Univ, Sch Informat Sci & Engn, Changsha, Hunan, Peoples R China.	zpzhang@mail.csu.edu.cn		Chen, Hailin/0000-0002-5119-4517	National Natural Science Foundation of China [60970095, 61003124, M1121008]; Research Fund for the Doctoral Program of Higher Education of China [20120162110077]; National High Technology Research and Development Program of China (863 Program) [2012AA011205]; Program for New Century Excellent Talents in University [NCET-12-0547]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Research Fund for the Doctoral Program of Higher Education of China(Research Fund for the Doctoral Program of Higher Education of China (RFDP)Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET))	This research was supported by the National Natural Science Foundation of China (Grants 60970095, 61003124 and M1121008), Research Fund for the Doctoral Program of Higher Education of China (Grant no. 20120162110077), the National High Technology Research and Development Program of China (863 Program, no. 2012AA011205), and the Program for New Century Excellent Talents in University (NCET-12-0547). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburn TT, 2004, NAT REV DRUG DISCOV, V3, P673, DOI 10.1038/nrd1468; Bleakley K, 2009, BIOINFORMATICS, V25, P2397, DOI 10.1093/bioinformatics/btp433; Chen X, 2012, MOL BIOSYST, V8, P1970, DOI 10.1039/c2mb00002d; Cheng AC, 2007, NAT BIOTECHNOL, V25, P71, DOI 10.1038/nbt1273; Cheng FX, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002503; Deroo BJ, 2006, J CLIN INVEST, V116, P561, DOI 10.1172/JCI27987; Gaulton A, 2012, NUCLEIC ACIDS RES, V40, pD1100, DOI 10.1093/nar/gkr777; Gonen M, 2012, BIOINFORMATICS, V28, P2304, DOI 10.1093/bioinformatics/bts360; Haggarty SJ, 2003, CHEM BIOL, V10, P383, DOI 10.1016/S1074-5521(03)00095-4; Hattori M, 2003, J AM CHEM SOC, V125, P11853, DOI 10.1021/ja036030u; Hecker N, 2012, NUCLEIC ACIDS RES, V40, pD1113, DOI 10.1093/nar/gkr912; Hopkins AL, 2008, NAT CHEM BIOL, V4, P682, DOI 10.1038/nchembio.118; Hwang TH, 2011, BIOINFORMATICS, V27, P2692, DOI 10.1093/bioinformatics/btr463; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Kanehisa M, 2006, NUCLEIC ACIDS RES, V34, pD354, DOI 10.1093/nar/gkj102; Keiser MJ, 2007, NAT BIOTECHNOL, V25, P197, DOI 10.1038/nbt1284; Knox C, 2011, NUCLEIC ACIDS RES, V39, pD1035, DOI 10.1093/nar/gkq1126; Kuruvilla FG, 2002, NATURE, V416, P653, DOI 10.1038/416653a; SMITH TF, 1981, J MOL BIOL, V147, P195, DOI 10.1016/0022-2836(81)90087-5; Stettner M, 2007, MOL CANCER THER, V6, P2626, DOI 10.1158/1535-7163.MCT-07-0197; Tiihonen J, 2009, LANCET, V374, P620, DOI 10.1016/S0140-6736(09)60742-X; Xia Z, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-S2-S6; Xie L, 2012, ANNU REV PHARMACOL, V52, P361, DOI 10.1146/annurev-pharmtox-010611-134630; Yamanishi Y, 2008, BIOINFORMATICS, V24, pI232, DOI 10.1093/bioinformatics/btn162; Yamanishi Y, 2010, BIOINFORMATICS, V26, pi246, DOI 10.1093/bioinformatics/btq176; Zhou DY, 2004, ADV NEUR IN, V16, P321; Zhu SF, 2005, BIOINFORMATICS, V21, P245, DOI 10.1093/bioinformatics/bti1141	27	95	96	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e62975	10.1371/journal.pone.0062975	http://dx.doi.org/10.1371/journal.pone.0062975			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667553	gold, Green Published, Green Submitted			2022-12-27	WOS:000319654700091
J	Damsker, JM; Dillingham, BC; Rose, MC; Balsley, MA; Heier, CR; Watson, AM; Stemmy, EJ; Jurjus, RA; Huynh, T; Tatem, K; Uaesoontrachoon, K; Berry, DM; Benton, AS; Freishtat, RJ; Hoffman, EP; McCall, JM; Gordish-Dressman, H; Constant, SL; Reeves, EKM; Nagaraju, K				Damsker, Jesse M.; Dillingham, Blythe C.; Rose, Mary C.; Balsley, Molly A.; Heier, Christopher R.; Watson, Alan M.; Stemmy, Erik J.; Jurjus, Roslyn A.; Huynh, Tony; Tatem, Kathleen; Uaesoontrachoon, Kitipong; Berry, Dana M.; Benton, Angela S.; Freishtat, Robert J.; Hoffman, Eric P.; McCall, John M.; Gordish-Dressman, Heather; Constant, Stephanie L.; Reeves, Erica K. M.; Nagaraju, Kanneboyina			VBP15, a Glucocorticoid Analogue, Is Effective at Reducing Allergic Lung Inflammation in Mice	PLOS ONE			English	Article							INHALED CORTICOSTEROIDS; PROMOTER ACTIVITY; DNA-BINDING; MAST-CELLS; ASTHMA; RECEPTOR; MECHANISMS; EPITHELIUM; RESPONSES; INTERLEUKIN-10	Asthma is a chronic inflammatory condition of the lower respiratory tract associated with airway hyperreactivity and mucus obstruction in which a majority of cases are due to an allergic response to environmental allergens. Glucocorticoids such as prednisone have been standard treatment for many inflammatory diseases for the past 60 years. However, despite their effectiveness, long-term treatment is often limited by adverse side effects believed to be caused by glucocorticoid receptor-mediated gene transcription. This has led to the pursuit of compounds that retain the anti-inflammatory properties yet lack the adverse side effects associated with traditional glucocorticoids. We have developed a novel series of steroidal analogues (VBP compounds) that have been previously shown to maintain anti-inflammatory properties such as NFkB-inhibition without inducing glucocorticoid receptor-mediated gene transcription. This study was undertaken to determine the effectiveness of the lead compound, VBP15, in a mouse model of allergic lung inflammation. We show that VBP15 is as effective as the traditional glucocorticoid, prednisolone, at reducing three major hallmarks of lung inflammation-NFkB activity, leukocyte degranulation, and pro-inflammatory cytokine release from human bronchial epithelial cells obtained from patients with asthma. Moreover, we found that VBP15 is capable of reducing inflammation of the lung in vivo to an extent similar to that of prednisone. We found that prednisolone-but not VBP15 shortens the tibia in mice upon a 5 week treatment regimen suggesting effective dissociation of side effects from efficacy. These findings suggest that VBP15 may represent a potent and safer alternative to traditional glucocorticoids in the treatment of asthma and other inflammatory diseases.	[Damsker, Jesse M.; Dillingham, Blythe C.; Hoffman, Eric P.; McCall, John M.; Reeves, Erica K. M.; Nagaraju, Kanneboyina] ReveraGen BioPharma, Rockville, MD USA; [Dillingham, Blythe C.; Rose, Mary C.; Heier, Christopher R.; Watson, Alan M.; Huynh, Tony; Tatem, Kathleen; Uaesoontrachoon, Kitipong; Berry, Dana M.; Benton, Angela S.; Freishtat, Robert J.; Hoffman, Eric P.; Gordish-Dressman, Heather; Nagaraju, Kanneboyina] Childrens Natl Med Ctr, Med Genet Res Ctr, Washington, DC 20010 USA; [Rose, Mary C.; Freishtat, Robert J.; Hoffman, Eric P.; Gordish-Dressman, Heather; Nagaraju, Kanneboyina] Childrens Natl Med Ctr, Dept Integrat Syst Biol, Washington, DC 20010 USA; [Rose, Mary C.; Freishtat, Robert J.; Hoffman, Eric P.; Gordish-Dressman, Heather; Nagaraju, Kanneboyina] George Washington Univ, Sch Med & Hlth Sci, Washington, DC 20052 USA; [Balsley, Molly A.; Stemmy, Erik J.; Jurjus, Roslyn A.; Constant, Stephanie L.] George Washington Univ, Med Ctr, Dept Microbiol Immunol & Trop Med, Washington, DC 20037 USA; [Huynh, Tony] Endocrine Res Unit, Canberra, ACT, Australia; [Huynh, Tony] Australian Natl Univ, Sch Med, Canberra Hosp, Canberra, ACT 0200, Australia; [McCall, John M.] PharMac LLC, Boca Grande, FL USA	Children's National Health System; Children's National Health System; George Washington University; George Washington University; Australian National University; Canberra Hospital	Damsker, JM (corresponding author), ReveraGen BioPharma, Rockville, MD USA.	Jesse.Damsker@reveragen.com	Huynh, Tony/AAU-9811-2020; Nagaraju, Kanneboyina/AAV-7684-2021; Huynh, Tony/J-6783-2014; Nagaraju, Kanneboyina/ABA-6525-2021; Jurjus, Rosalyn A./AAG-7853-2020	Huynh, Tony/0000-0002-7909-3670; Huynh, Tony/0000-0002-7909-3670; Heier, Christopher/0000-0001-7914-2068; Hoffman, Eric/0000-0001-6470-5139; Jurjus, Rosalyn A./0000-0003-3912-8020; Freishtat, Robert/0000-0002-7411-2342; Dillingham, Blythe/0000-0001-9183-7057	NIH [1R41HL104939-01B, 1K26RR032082, 1P50AR060836-01, 1U54HD071601, 2R24HD050846-06, R01 HL033152-25]; DOD [W81XWH-11-1-0330, W81XWH-11-1-0782, W81XWH-10-1-0659, W81XWH-11-1-0809, W81XWH-09-1-0599]; MDA; Parent Project Muscular Dystrophy (PPMD); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R24HD050846, U54HD071601] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [K26RR032082] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL033152, R41HL104939] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P50AR060836] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [K26OD011171] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DOD(United States Department of Defense); MDA(Muscular Dystrophy Association); Parent Project Muscular Dystrophy (PPMD); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Supported in part by grants from the NIH (1R41HL104939-01B; 1K26RR032082; 1P50AR060836-01; 1U54HD071601; 2R24HD050846-06, R01 HL033152-25), DOD grants (W81XWH-11-1-0330; W81XWH-11-1-0782; W81XWH-10-1-0659; W81XWH-11-1-0809; W81XWH-09-1-0599) a translational research grant from MDA, pilot grant from Parent Project Muscular Dystrophy (PPMD), and a contribution from the Clark Family Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adcock IM, 2008, LANCET, V372, P1073, DOI 10.1016/S0140-6736(08)61449-X; Akinbami Lara J, 2011, Natl Health Stat Report, P1; Balsley MA, 2010, J IMMUNOL, V185, P7663, DOI 10.4049/jimmunol.1001707; Baudy AR, 2012, J PHARMACOL EXP THER, V343, P225, DOI 10.1124/jpet.112.194340; Baudy AR, 2009, INT IMMUNOPHARMACOL, V9, P1209, DOI 10.1016/j.intimp.2009.07.001; Busse W, 1999, AM J RESP CRIT CARE, V160, P1035, DOI 10.1164/ajrccm.160.3.9902064; Busse W, 2004, AM J RESP CRIT CARE, V170, P683, DOI 10.1164/rccm.200311-1539WS; Campbell JD, 2009, J EXP MED, V206, P1535, DOI 10.1084/jem.20082901; Castro-Rodriguez JA, 2013, CURR OPIN PULM MED, V19, P54, DOI 10.1097/MCP.0b013e32835b1165; CHROUSOS GA, 1993, JAMA-J AM MED ASSOC, V269, P2110, DOI 10.1001/jama.269.16.2110; Coghlan MJ, 2003, CURR TOP MED CHEM, V3, P1617, DOI 10.2174/1568026033451718; Cohn L, 2004, ANNU REV IMMUNOL, V22, P789, DOI 10.1146/annurev.immunol.22.012703.104716; Davies DE, 2002, INT J BIOCHEM CELL B, V34, P1520, DOI 10.1016/S1357-2725(02)00048-1; De Bosscher K, 2010, J STEROID BIOCHEM, V120, P96, DOI 10.1016/j.jsbmb.2010.02.027; Dougherty RH, 2009, CLIN EXP ALLERGY, V39, P193, DOI 10.1111/j.1365-2222.2008.03157.x; Epps D.E., 1997, ANTIOXIDANTS HLTH DI, P95; Eskdale J, 1997, IMMUNOGENETICS, V46, P120, DOI 10.1007/s002510050250; FREISHTAT RJ, 2011, AM J RESP CELL MOL B; Freishtat RJ, 2010, J INVEST MED, V58, P19, DOI 10.2310/JIM.0b013e3181b91654; GALLI SJ, 1995, ALLERGY, V50, P851, DOI 10.1111/j.1398-9995.1995.tb02490.x; Garbe E, 1997, JAMA-J AM MED ASSOC, V277, P722, DOI 10.1001/jama.277.9.722; Gessner A, 2005, J IMMUNOL, V174, P1063, DOI 10.4049/jimmunol.174.2.1063; Grunig G, 1998, SCIENCE, V282, P2261, DOI 10.1126/science.282.5397.2261; Gwinn WM, 2006, J IMMUNOL, V177, P4870, DOI 10.4049/jimmunol.177.7.4870; Hackett TL, 2011, AM J RESP CELL MOL, V45, P1090, DOI 10.1165/rcmb.2011-0031OC; Herrlich P, 2001, ONCOGENE, V20, P2465, DOI 10.1038/sj.onc.1204388; Hillier SG, 2007, J ENDOCRINOL, V195, P1, DOI 10.1677/JOE-07-0309; Hinz M, 2002, J EXP MED, V196, P605, DOI 10.1084/jem.20020062; Holgate ST, 1999, CLIN EXP ALLERGY, V29, P90, DOI 10.1046/j.1365-2222.1999.00016.x; HOLGATE ST, 1988, ALLERGY, V43, P22, DOI 10.1111/j.1398-9995.1988.tb05044.x; ITO T, 1979, JPN CIRC J, V43, P1043, DOI 10.1253/jcj.43.1043; John M, 1998, AM J RESP CRIT CARE, V157, P256, DOI 10.1164/ajrccm.157.1.9703079; Kabra S. K., 2003, Indian Journal of Pediatrics, V70, P63, DOI 10.1007/BF02722747; Kelly HW, 2012, NEW ENGL J MED, V367, P904, DOI 10.1056/NEJMoa1203229; Kicic A, 2006, AM J RESP CRIT CARE, V174, P1110, DOI 10.1164/rccm.200603-392OC; King EM, 2009, J BIOL CHEM, V284, P26803, DOI 10.1074/jbc.M109.028381; KUBE D, 1995, CYTOKINE, V7, P1, DOI 10.1006/cyto.1995.1001; Larche M, 2003, J ALLERGY CLIN IMMUN, V111, P450, DOI 10.1067/mai.2003.169; Larj Michael J, 2004, Chest, V126, p138S, DOI 10.1378/chest.126.2_suppl_1.138S; Liu L, 2005, INFLAMM RES, V54, P37, DOI 10.1007/s00011-004-1320-y; Manzur AY, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003725.pub3; Mayr SI, 2002, J IMMUNOL, V169, P2061, DOI 10.4049/jimmunol.169.4.2061; Mcmillan SJ, 2004, CLIN EXP ALLERGY, V34, P497, DOI 10.1111/j.1365-2222.2004.01895.x; Moriuchi H, 1997, J IMMUNOL, V158, P3483; National Asthma Education and Prevention Program, 2007, J Allergy Clin Immunol, V120, pS94; Newton R, 2007, MOL PHARMACOL, V72, P799, DOI 10.1124/mol.107.038794; Reeves EKM, 2013, BIOORGAN MED CHEM, V21, P2241, DOI 10.1016/j.bmc.2013.02.009; Rehman Q, 2003, MED PEDIATR ONCOL, V41, P212, DOI 10.1002/mpo.10339; Reichardt HM, 1998, CELL, V93, P531, DOI 10.1016/S0092-8674(00)81183-6; Reichardt HM, 2001, EMBO J, V20, P7168, DOI 10.1093/emboj/20.24.7168; Renzi PM, 1999, CAN MED ASSOC J, V160, P217; Rhen T, 2005, NEW ENGL J MED, V353, P1711, DOI 10.1056/NEJMra050541; Rissmiller RW, 2004, CHEST, V125, P1590, DOI 10.1378/chest.125.4.1590; ROBINSON DS, 1992, NEW ENGL J MED, V326, P298, DOI 10.1056/NEJM199201303260504; Sharek PJ, 2000, PEDIATRICS, V106, DOI 10.1542/peds.106.1.e8; Stahn C, 2007, MOL CELL ENDOCRINOL, V275, P71, DOI 10.1016/j.mce.2007.05.019; TRUSS M, 1993, ENDOCR REV, V14, P459, DOI 10.1210/er.14.4.459; Tuckermann Jan, 2010, Mol Endocrinol, V24, P1311, DOI 10.1210/me.2010-0083; vanderBurg B, 1997, TRENDS ENDOCRIN MET, V8, P152, DOI 10.1016/S1043-2760(97)00006-4; Wills-Karp M, 1999, ANNU REV IMMUNOL, V17, P255, DOI 10.1146/annurev.immunol.17.1.255; Wills-Karp M, 1998, SCIENCE, V282, P2258, DOI 10.1126/science.282.5397.2258; Wordinger RJ, 1999, PROG RETIN EYE RES, V18, P629, DOI 10.1016/S1350-9462(98)00035-4; Ying S, 1996, EUR J IMMUNOL, V26, P70, DOI 10.1002/eji.1830260111; Zhou J, 2008, ALLERGY, V63, P1177, DOI 10.1111/j.1398-9995.2008.01725.x	64	18	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e63871	10.1371/journal.pone.0063871	http://dx.doi.org/10.1371/journal.pone.0063871			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667681	Green Submitted, gold, Green Published			2022-12-27	WOS:000319654700191
J	Guimond, DM; Cam, NR; Hirve, N; Duan, W; Lambris, JD; Croft, M; Tsoukas, CD				Guimond, David M.; Cam, Nicholas R.; Hirve, Nupura; Duan, Wei; Lambris, John D.; Croft, Michael; Tsoukas, Constantine D.			Regulation of Immune Responsiveness In Vivo by Disrupting an Early T-Cell Signaling Event Using a Cell-Permeable Peptide	PLOS ONE			English	Article							TH2 EFFECTOR FUNCTION; TYROSINE KINASE; AIRWAY HYPERRESPONSIVENESS; ALLERGIC-ASTHMA; MICE LACKING; ITK; FAMILY; ACTIVATION; DIFFERENTIATION; INFLAMMATION	The inducible T cell kinase (ITK) regulates type 2 (Th2) cytokines that provide defense against certain parasitic and bacterial infections and are involved in the pathogenesis of lung inflammation such as allergic asthma. Activation of ITK requires the interaction of its SH3 domain with the poly-proline region of its signaling partner, the SH2 domain containing leukocyte phosphoprotein of 76 kilodaltons (SLP-76). The specific disruption of the ITK-SH3/SLP-76 poly-proline interaction in vitro by a cell-permeable competitive inhibitor peptide (R9-QQP) interferes with the activation of ITK and the transduction of its cellular functions in T lymphocytes. In the present investigation, we assessed the effects of R9-QQP treatment on the induction of an in vivo immune response as represented by lung inflammation in a murine model of allergic asthma. We found that mice treated with R9-QQP and sensitized and challenged with the surrogate allergen ovalbumin (OVA) display significant inhibition of lung inflammation in a peptide-specific manner. Thus, parameters of the allergic response, such as airway hyper-responsiveness, suppression of inflammatory cell infiltration, reduction of bronchial mucus accumulation, and production of relevant cytokines from draining lymph nodes were significantly suppressed. These findings represent the first demonstration of the biological significance of the interaction between ITK and SLP-76 in the induction of an immune response in a whole animal model and specifically underscore the significance of the ITK-SH3 domain interaction with the poly-proline region of SLP-76 in the development of an inflammatory response. Furthermore, the experimental approach of intracellular peptide-mediated inhibition might be applicable to the study of other important intracellular interactions thus providing a paradigm for dissecting signal transduction pathways.	[Guimond, David M.; Cam, Nicholas R.; Hirve, Nupura; Tsoukas, Constantine D.] San Diego State Univ, Dept Biol, San Diego, CA 92182 USA; [Guimond, David M.; Cam, Nicholas R.; Hirve, Nupura; Tsoukas, Constantine D.] San Diego State Univ, Ctr Microbial Sci, San Diego, CA 92182 USA; [Duan, Wei; Croft, Michael] La Jolla Inst Allergy & Immunol, Div Immune Regulat, San Diego, CA USA; [Lambris, John D.] Univ Penn, Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA	California State University System; San Diego State University; California State University System; San Diego State University; La Jolla Institute for Immunology; University of Pennsylvania	Tsoukas, CD (corresponding author), San Diego State Univ, Dept Biol, San Diego, CA 92182 USA.	ctsoukas@mail.sdsu.edu	Lambris, John/Q-5633-2018	Lambris, John/0000-0002-9370-5776	National Institutes of Health [AI082321, AI060687, AI070535, CA91837]; NATIONAL CANCER INSTITUTE [R01CA091837] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI082321, U19AI070535, R01AI060687] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grants from the National Institutes of Health (http://www.niaid.nih.gov and http://www.cancer.gov) to CDT (AI082321), JDL (AI060687), and MC (AI070535 and CA91837). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreotti AH, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a002287; Au-Yeung BB, 2006, J IMMUNOL, V176, P3895, DOI 10.4049/jimmunol.176.7.3895; Bochner BS, 2005, J ALLERGY CLIN IMMUN, V115, P953, DOI 10.1016/j.jaci.2005.02.032; Bogin Y, 2007, P NATL ACAD SCI USA, V104, P6638, DOI 10.1073/pnas.0609771104; Bunnell SC, 2000, J BIOL CHEM, V275, P2219, DOI 10.1074/jbc.275.3.2219; Burton OT, 2011, IMMUNOL REV, V242, P128, DOI 10.1111/j.1600-065X.2011.01024.x; Ferrara TJ, 2006, J ALLERGY CLIN IMMUN, V117, P780, DOI 10.1016/j.jaci.2005.12.1330; Fowell DJ, 2009, CYTOKINE, V46, P1, DOI 10.1016/j.cyto.2008.12.023; Fowell DJ, 1999, IMMUNITY, V11, P399, DOI 10.1016/S1074-7613(00)80115-6; Grasis JA, 2003, J IMMUNOL, V170, P3971, DOI 10.4049/jimmunol.170.8.3971; Grasis Juris A, 2011, J Signal Transduct, V2011, P297868, DOI 10.1155/2011/297868; Grasis JA, 2010, MOL CELL BIOL, V30, P3596, DOI 10.1128/MCB.01657-09; Hamelmann E, 1999, ALLERGY, V54, P297, DOI 10.1034/j.1398-9995.1999.00085.x; Hogan SP, 2008, CLIN EXP ALLERGY, V38, P709, DOI 10.1111/j.1365-2222.2008.02958.x; Holgate ST, 2008, NAT REV IMMUNOL, V8, P218, DOI 10.1038/nri2262; Jordan MS, 2008, IMMUNITY, V28, P359, DOI 10.1016/j.immuni.2008.01.010; Kim HY, 2010, NAT IMMUNOL, V11, P577, DOI 10.1038/ni.1892; Labno CM, 2003, CURR BIOL, V13, P1619, DOI 10.1016/j.cub.2003.08.005; Matsushita M, 2001, J NEUROSCI, V21, P6000, DOI 10.1523/JNEUROSCI.21-16-06000.2001; Miller AT, 2004, IMMUNITY, V21, P67, DOI 10.1016/j.immuni.2004.06.009; Mueller C, 2003, J IMMUNOL, V170, P5056, DOI 10.4049/jimmunol.170.10.5056; Noguchi H, 2004, NAT MED, V10, P305, DOI 10.1038/nm994; Rothbard JB, 2000, NAT MED, V6, P1253, DOI 10.1038/81359; Schaeffer EM, 2001, NAT IMMUNOL, V2, P1183, DOI 10.1038/ni734; Stevens WW, 2007, J IMMUNOL METHODS, V327, P63, DOI 10.1016/j.jim.2007.07.011; Su YW, 1999, EUR J IMMUNOL, V29, P3702, DOI 10.1002/(SICI)1521-4141(199911)29:11<3702::AID-IMMU3702>3.0.CO;2-R; Takesono A, 2004, CURR BIOL, V14, P917, DOI 10.1016/j.cub.2004.04.011; Williams CMM, 2012, TOXICOL PATHOL, V40, P205, DOI 10.1177/0192623311430694; Yang WC, 2000, IMMUNITY, V12, P373, DOI 10.1016/S1074-7613(00)80189-2	29	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e63645	10.1371/journal.pone.0063645	http://dx.doi.org/10.1371/journal.pone.0063645			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667652	Green Published, gold			2022-12-27	WOS:000319654700173
J	Rasche, L; Duell, J; Morgner, C; Chatterjee, M; Hensel, F; Rosenwald, A; Einsele, H; Topp, MS; Brandlein, S				Rasche, Leo; Duell, Johannes; Morgner, Charlotte; Chatterjee, Manik; Hensel, Frank; Rosenwald, Andreas; Einsele, Hermann; Topp, Max S.; Braendlein, Stephanie			The Natural Human IgM Antibody PAT-SM6 Induces Apoptosis in Primary Human Multiple Myeloma Cells by Targeting Heat Shock Protein GRP78	PLOS ONE			English	Article							MONOCLONAL-ANTIBODY; CLINICAL-TRIAL; STRESS INDUCTION; PROSTATE-CANCER; EXPRESSION; SURVIVAL; THERAPY; CYTOTOXICITY; CHAPERONE; ACTIVATION	In contrast to other haematological malignancies, targeted immunotherapy has not entered standard treatment regimens for de novo or relapsed multiple myeloma (MM) yet. While a number of IgG-formatted monoclonal antibodies are currently being evaluated in clinical trials in MM, our study aimed to investigate whether the fully human IgM monoclonal antibody PAT-SM6 that targets a tumour-specific variant of the heat shock protein GRP78 might be an attractive candidate for future immunotherapeutic approaches. We here show that GRP78 is stably and consistently expressed on the surface on tumour cells from patients with de novo, but also relapsed MM and that binding of PAT-SM6 to MM cells can specifically exert cytotoxic effects on malignant plasma cells, whereas non-malignant cells are not targeted. We demonstrate that the induction of apoptosis and, to a lesser extent, complement dependent cytotoxicity is the main mode of action of PAT-SM6, whereas antibody dependent cellular cytotoxicity does not appear to contribute to the cytotoxic properties of this antibody. Given the favourable safety profile of PAT-SM6 in monkeys, but also in a recent phase I trial in patients with malignant melanoma, our results form the basis for a planned phase I study in patients with relapsed MM.	[Rasche, Leo; Duell, Johannes; Einsele, Hermann; Topp, Max S.] Univ Hosp Wurzburg, Dept Internal Med 2, Wurzburg, Germany; [Morgner, Charlotte; Rosenwald, Andreas; Braendlein, Stephanie] Univ Wurzburg, Inst Pathol, Wurzburg, Germany; [Chatterjee, Manik] Comprehens Canc Ctr Mainfranken, Wurzburg, Germany; [Hensel, Frank] Patrys GmbH, Wurzburg, Germany	University of Wurzburg; University of Wurzburg; University of Wurzburg	Brandlein, S (corresponding author), Univ Wurzburg, Inst Pathol, Josef Schneider Str 2, Wurzburg, Germany.	stephanie.braendlein@uni-wuerzburg.de			IZKF Wuerzburg Erstantragstellerprogramm [Z-3/15]; Deutsche Forschungsgemeinschaft (DFG) [KFO 216]; Patrys Ltd, Australia	IZKF Wuerzburg Erstantragstellerprogramm; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Patrys Ltd, Australia	LR was supported by IZKF Wuerzburg Erstantragstellerprogramm (Projekt Z-3/15) and the Deutsche Forschungsgemeinschaft (DFG) (KFO 216). This work was supported by research funding from Patrys Ltd, Australia, a company currently conducting clinical trials of PAT-SM6 as a potential anti-cancer treatment. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson KC, 2011, HEMATOL-AM SOC HEMAT, P184, DOI 10.1182/asheducation-2011.1.184; Arap MA, 2004, CANCER CELL, V6, P275, DOI 10.1016/j.ccr.2004.08.018; Brandlein S, 2003, CANCER RES, V63, P7995; Brandlein S, 2007, MOL CANCER THER, V6, P326, DOI 10.1158/1535-7163.MCT-06-0399; Brocke-Heidrich K, 2004, BLOOD, V103, P242, DOI 10.1182/blood-2003-04-1048; Chanan-Khan AA, 2010, J CLIN ONCOL, V28, P2612, DOI 10.1200/JCO.2009.25.4250; Chatterjee M, 2007, BLOOD, V109, P720, DOI 10.1182/blood-2006-05-024372; Daneshmand S, 2007, HUM PATHOL, V38, P1547, DOI 10.1016/j.humpath.2007.03.014; Davenport EL, 2007, BLOOD, V110, P2641, DOI 10.1182/blood-2006-11-053728; de Weers M, 2011, J IMMUNOL, V186, P1840, DOI 10.4049/jimmunol.1003032; Derkx B, 1999, CLIN INFECT DIS, V28, P770, DOI 10.1086/515184; Feldman DE, 2005, MOL CANCER RES, V3, P597, DOI 10.1158/1541-7786.MCR-05-0221; Gerritsen AF, 2010, J IMMUNOL METHODS, V352, P140, DOI 10.1016/j.jim.2009.10.009; Gonzalez-Gronow M, 2006, CANCER RES, V66, P11424, DOI 10.1158/0008-5472.CAN-06-1721; Hendershot LM, 2004, MT SINAI J MED, V71, P289; Irie RF, 2004, CANCER IMMUNOL IMMUN, V53, P110, DOI 10.1007/s00262-003-0436-1; Kumar SK, 2008, BLOOD, V111, P2516, DOI 10.1182/blood-2007-10-116129; Lee AS, 2007, CANCER RES, V67, P3496, DOI 10.1158/0008-5472.CAN-07-0325; Lee AS, 2001, TRENDS BIOCHEM SCI, V26, P504, DOI 10.1016/S0968-0004(01)01908-9; Li JZ, 2006, CURR MOL MED, V6, P45, DOI 10.2174/156652406775574523; MacMillan ML, 2007, BLOOD, V109, P2657, DOI 10.1182/blood-2006-08-013995; MASHIMA T, 1995, BIOCHEM BIOPH RES CO, V209, P907, DOI 10.1006/bbrc.1995.1584; Misra UK, 2004, CELL SIGNAL, V16, P929, DOI 10.1016/j.cellsig.2004.01.003; Mitsiades CS, 2006, BLOOD, V107, P1092, DOI 10.1182/blood-2005-03-1158; Mossner E, 2010, BLOOD, V115, P4393, DOI 10.1182/blood-2009-06-225979; MORDOH J, 1995, J IMMUNOTHER, V17, P151, DOI 10.1097/00002371-199504000-00004; Palumbo A, 2011, NEW ENGL J MED, V364, P1046, DOI 10.1056/NEJMra1011442; Pohle T, 2004, CANCER RES, V64, P3900, DOI 10.1158/0008-5472.CAN-03-3149; PRICOP L, 1993, J IMMUNOL, V151, P3018; RANDALL TD, 1992, P NATL ACAD SCI USA, V89, P962, DOI 10.1073/pnas.89.3.962; Rauschert N, 2008, LAB INVEST, V88, P375, DOI 10.1038/labinvest.2008.2; Richardson PG, 2011, BRIT J HAEMATOL, V154, P745, DOI 10.1111/j.1365-2141.2011.08790.x; Sawada R, 2011, CLIN CANCER RES, V17, P1024, DOI 10.1158/1078-0432.CCR-10-2640; Stuhmer T, 2010, BRIT J HAEMATOL, V149, P529, DOI 10.1111/j.1365-2141.2010.08126.x; Tai YT, 2008, BLOOD, V112, P1329, DOI 10.1182/blood-2007-08-107292; Tchoudakova A, 2009, MABS, V1, P163, DOI 10.4161/mabs.1.2.7945; Valasek CCJ, 2011, BIOPROCESS INT, V9, P28; van de Donk NWCJ, 2012, LEUKEMIA, V26, P199, DOI 10.1038/leu.2011.214; Weiner LM, 2009, LANCET, V373, P1033, DOI 10.1016/S0140-6736(09)60251-8; Yang J, 2011, AM J BLOOD RES, V1, P22; Zhang Y, 2010, J BIOL CHEM, V285, P15065, DOI 10.1074/jbc.M109.087445	41	47	47	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e63414	10.1371/journal.pone.0063414	http://dx.doi.org/10.1371/journal.pone.0063414			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667612	Green Published, gold, Green Submitted			2022-12-27	WOS:000319654700140
J	Richardson, TG; Thomas, EC; Sessions, RB; Lawlor, DA; Tavare, JM; Day, INM				Richardson, Tom G.; Thomas, Elaine C.; Sessions, Richard B.; Lawlor, Debbie A.; Tavare, Jeremy M.; Day, Ian N. M.			Structural and Population-Based Evaluations of TBC1D1 p.Arg125Trp	PLOS ONE			English	Article							TRANSMISSION DISEQUILIBRIUM TEST; BODY-MASS INDEX; LINKAGE DISEQUILIBRIUM; TRANSMISSION/DISEQUILIBRIUM TEST; STRUCTURE PREDICTION; PROTEIN-STRUCTURE; GASTRIC BYPASS; SEVERE OBESITY; I-TASSER; INSULIN	Obesity is now a leading cause of preventable death in the industrialised world. Understanding its genetic influences can enhance insight into molecular pathogenesis and potential therapeutic targets. A non-synonymous polymorphism (rs35859249, p.Arg125Trp) in the N-terminal TBC1D1 phosphotyrosine-binding (PTB) domain has shown a replicated association with familial obesity in women. We investigated these findings in the Avon Longitudinal Study of Parents and Children (ALSPAC), a large European birth cohort of mothers and offspring, and by generating a predicted model of the structure of this domain. Structural prediction involved the use of three separate algorithms; Robetta, HHpred/MODELLER and I-TASSER. We used the transmission disequilibrium test (TDT) to investigate familial association in the ALSPAC study cohort (N = 2,292 mother-offspring pairs). Linear regression models were used to examine the association of genotype with mean measurements of adiposity (Body Mass Index (BMI), waist circumference and Dual-energy X-ray absorptiometry (DXA) assessed fat mass), and logistic regression was used to examine the association with odds of obesity. Modelling showed that the R125W mutation occurs in a location of the TBC1D1 PTB domain that is predicted to have a function in a putative protein: protein interaction. We did not detect an association between R125W and BMI (mean per allele difference 0.27 kg/m(2) (95% Confidence Interval: 0.00, 0.53) P = 0.05) or obesity (odds ratio 1.01 (95% Confidence Interval: 0.77, 1.31, P = 0.96) in offspring after adjusting for multiple comparisons. Furthermore, there was no evidence to suggest that there was familial association between R125W and obesity (chi(2) = 0.06, P = 0.80). Our analysis suggests that R125W in TBC1D1 plays a role in the binding of an effector protein, but we find no evidence that the R125W variant is related to mean BMI or odds of obesity in a general population sample.	[Richardson, Tom G.; Day, Ian N. M.] Univ Bristol, Bristol Genet Epidemiol Labs, Sch Social & Community Med, Bristol, Avon, England; [Thomas, Elaine C.; Sessions, Richard B.; Tavare, Jeremy M.] Univ Bristol, Sch Biochem, Bristol, Avon, England; [Lawlor, Debbie A.; Day, Ian N. M.] Univ Bristol, MRC Ctr Causal Anal Translat Epidemiol CAiTE, Sch Social & Community Med, Bristol, Avon, England	University of Bristol; University of Bristol; University of Bristol	Richardson, TG (corresponding author), Univ Bristol, Bristol Genet Epidemiol Labs, Sch Social & Community Med, Oakfield House, Bristol, Avon, England.	Tom.G.Richardson@bristol.ac.uk		Richardson, Tom/0000-0002-7918-2040; Lawlor, Debbie A/0000-0002-6793-2262; Sessions, Richard/0000-0003-0320-0895; Thomas, Elaine/0000-0002-9435-3653	British Heart Foundation [PG/10/008]; Wellcome Trust [092731]; MRC [MC_UU_12013/5] Funding Source: UKRI; British Heart Foundation [PG/10/008/28186] Funding Source: researchfish; Medical Research Council [1170461, MC_UU_12013/5, G9815508] Funding Source: researchfish	British Heart Foundation(British Heart Foundation); Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the British Heart Foundation (Ref: PG/10/008). The UK Medical Research Council and the Wellcome Trust (Grant ref: 092731) and the University of Bristol provide core support for ALSPAC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. TR is a UK MRC PhD student.	Adams TD, 2005, CONTEMP CLIN TRIALS, V26, P534, DOI 10.1016/j.cct.2005.05.003; An D, 2010, DIABETES, V59, P1358, DOI 10.2337/db09-1266; Balding DJ, 2007, HDB STAT GENETICS, V1, P1271; Bonferroni C.E, 1936, PUBBL R 1 SUPER SCI, V8, P3; Chadt A, 2008, NAT GENET, V40, P1354, DOI 10.1038/ng.244; Chen SA, 2008, BIOCHEM J, V409, P449, DOI 10.1042/BJ20071114; Cole C, 2008, NUCLEIC ACIDS RES, V36, pW197, DOI 10.1093/nar/gkn238; Cole TJ, 2000, BMJ-BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240; CURTIS D, 1995, AM J HUM GENET, V56, P811; DiNitto JP, 2006, BBA-MOL CELL BIOL L, V1761, P850, DOI 10.1016/j.bbalip.2006.04.008; Dudbridge F, 2000, AM J HUM GENET, V66, P2009, DOI 10.1086/302915; Finn RD, 2010, NUCLEIC ACIDS RES, V38, pD211, DOI 10.1093/nar/gkp985; Forman-Kay JD, 1999, CURR OPIN STRUC BIOL, V9, P690, DOI 10.1016/S0959-440X(99)00031-7; Fraser A, 2013, INT J EPIDEMIOL, V42, P97, DOI 10.1093/ije/dys066; Golding J, 2001, PAEDIATR PERINAT EP, V15, P74; Gordon D, 2004, EUR J HUM GENET, V12, P752, DOI 10.1038/sj.ejhg.5201219; Kim DE, 2004, NUCLEIC ACIDS RES, V32, pW526, DOI 10.1093/nar/gkh468; Koumanov F, 2011, J BIOL CHEM, V286, P16574, DOI 10.1074/jbc.M111.226092; LASKOWSKI RA, 1993, J MOL BIOL, V231, P1049, DOI 10.1006/jmbi.1993.1351; LILLIEFORS HW, 1967, J AM STAT ASSOC, V62, P399, DOI 10.2307/2283970; Loos RJF, 2003, J INTERN MED, V254, P401, DOI 10.1046/j.1365-2796.2003.01242.x; Meyre D, 2008, HUM MOL GENET, V17, P1798, DOI 10.1093/hmg/ddn070; Morton NE, 1998, P NATL ACAD SCI USA, V95, P11389, DOI 10.1073/pnas.95.19.11389; Pehmoller C, 2009, AM J PHYSIOL-ENDOC M, V297, pE665, DOI 10.1152/ajpendo.00115.2009; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Risch N, 1998, GENOME RES, V8, P1273, DOI 10.1101/gr.8.12.1273; Roach WG, 2007, BIOCHEM J, V403, P353, DOI 10.1042/BJ20061798; Rodriguez S, 2009, AM J EPIDEMIOL, V169, P505, DOI 10.1093/aje/kwn359; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Rubin CJ, 2010, NATURE, V464, P587, DOI 10.1038/nature08832; SALI A, 1995, PROTEINS, V23, P318, DOI 10.1002/prot.340230306; Sebastiani P, 2004, GENETICS, V168, P2329, DOI 10.1534/genetics.103.025841; Smith EM, 2006, GENOMICS, V88, P407, DOI 10.1016/j.ygeno.2006.04.004; SMITH SC, 1995, OBES SURG, V5, P314, DOI 10.1381/096089295765557700; Soding J, 2005, BIOINFORMATICS, V21, P951, DOI 10.1093/bioinformatics/bti125; SPIELMAN RS, 1993, AM J HUM GENET, V52, P506; Stone S, 2002, AM J HUM GENET, V70, P1459, DOI 10.1086/340670; Stone S, 2006, HUM MOL GENET, V15, P2709, DOI 10.1093/hmg/ddl204; STUNKARD AJ, 1986, JAMA-J AM MED ASSOC, V256, P51, DOI 10.1001/jama.256.1.51; STUNKARD AJ, 1990, NEW ENGL J MED, V322, P1483, DOI 10.1056/NEJM199005243222102; Sun FZ, 1999, AM J EPIDEMIOL, V150, P97; Taylor EB, 2008, J BIOL CHEM, V283, P9787, DOI 10.1074/jbc.M708839200; Thusberg J, 2011, HUM MUTAT, V32, P358, DOI 10.1002/humu.21445; WILLIAMS RR, 1988, AM J PUBLIC HEALTH, V78, P1283, DOI 10.2105/AJPH.78.10.1283; Wormser D, 2011, LANCET, V377, P1085, DOI 10.1016/S0140-6736(11)60105-0; Zhang Y, 2007, PROTEINS, V69, P108, DOI 10.1002/prot.21702; Zhou MM, 1996, NAT STRUCT BIOL, V3, P388, DOI 10.1038/nsb0496-388	47	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e63897	10.1371/journal.pone.0063897	http://dx.doi.org/10.1371/journal.pone.0063897			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667688	Green Published, Green Submitted, gold			2022-12-27	WOS:000319654700194
J	Shen, ML; Zhou, TT; Xie, WB; Ling, T; Zhu, QY; Zong, L; Lyu, GL; Gao, QQ; Zhang, FX; Tao, W				Shen, Meili; Zhou, Tingting; Xie, Wenbing; Ling, Te; Zhu, Qiaoyun; Zong, Le; Lyu, Guoliang; Gao, Qianqian; Zhang, Feixiong; Tao, Wei			The Chromatin Remodeling Factor CSB Recruits Histone Acetyltransferase PCAF to rRNA Gene Promoters in Active State for Transcription Initiation	PLOS ONE			English	Article							POLYMERASE-I TRANSCRIPTION; GROUP-B PROTEIN; COCKAYNE-SYNDROME; COUPLING FACTOR; DNA-DAMAGE; REPAIR; COMPLEX; ACETYLATION; BROMODOMAIN; BINDING	The promoters of poised rRNA genes (rDNA) are marked by both euchromatic and heterochromatic histone modifications and are associated with two transcription factors, UBF and SL1 that nucleate transcription complex formation. Active rRNA genes contain only euchromatic histone modifications and are loaded with all components of transcriptional initiation complex including RNA polymerase I. Coupled with histone acetylation and RNA polymerase I targeting, poised promoters can be converted to active ones by ATP-dependent chromatin remodeling factor CSB for initiation of rDNA transcription. However, it is not clear how dynamic histone modifications induce the assembly of polymerase I transcription initiation complex to active promoters during such conversion. Here we show that a complex consisting of CSB, RNA polymerase I and histone acetyltransferase PCAF is present at the rDNA promoters in active state. CSB is required for the association of PCAF with rDNA, which induces acetylation of histone H4 and histone H3K9. Overexpression of CSB promotes the association of PCAF with rDNA. Knockdown of PCAF leads to decreased levels of H4ac and H3K9ac at rDNA promoters, prevents the association of RNA polymerase I and inhibits pre-rRNA synthesis. The results demonstrate that CSB recruits PCAF to rDNA, which allows histone acetylation that is required for the assembly of polymerase I transcription initiation complex during the transition from poised to active state of rRNA genes, suggesting that CSB and PCAF play cooperative roles to establish the active state of rRNA genes by histone acetylation.	[Shen, Meili; Zhou, Tingting; Xie, Wenbing; Ling, Te; Zhu, Qiaoyun; Zong, Le; Lyu, Guoliang; Gao, Qianqian; Tao, Wei] Peking Univ, Key Lab Cell Proliferat & Differentiat, Natl Key Lab Prot Engn & Plant Gene Engn, Coll Life Sci, Beijing 100871, Peoples R China; [Ling, Te; Zhang, Feixiong] Capital Normal Univ, Coll Life Sci, Beijing, Peoples R China	Peking University; Capital Normal University	Tao, W (corresponding author), Peking Univ, Key Lab Cell Proliferat & Differentiat, Natl Key Lab Prot Engn & Plant Gene Engn, Coll Life Sci, Beijing 100871, Peoples R China.	weitao@pku.edu.cn	tao, wei/GXN-4445-2022; Xie, Wenbing/J-7962-2014; Xie, Wenbing/AAD-5987-2019	Xie, Wenbing/0000-0003-2546-2415; Xie, Wenbing/0000-0003-2546-2415; Ling, Te/0000-0002-0315-2662	National Natural Science Foundation of China (NSFC) [30871377, 31171255, 30971453, 91219101, 31071116]; National Basic Research Program of China (973 Program) [2013CB530700]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China (973 Program)(National Basic Research Program of China)	Work in WT lab was supported by the National Natural Science Foundation of China (NSFC, grant #30871377, 31171255, 30971453, 91219101 and 31071116) and the National Basic Research Program of China (973 Program, Grant No. 2013CB530700. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Awad S, 2008, ANN NY ACAD SCI, V1138, P366, DOI 10.1196/annals.1414.038; Bradsher J, 2002, MOL CELL, V10, P819, DOI 10.1016/S1097-2765(02)00678-0; Carrozza MJ, 2003, TRENDS GENET, V19, P321, DOI 10.1016/S0168-9525(03)00115-X; Chen DY, 2004, P NATL ACAD SCI USA, V101, P15106, DOI 10.1073/pnas.0404767101; Citterio E, 2000, MOL CELL BIOL, V20, P7643, DOI 10.1128/MCB.20.20.7643-7653.2000; Dey A, 2003, P NATL ACAD SCI USA, V100, P8758, DOI 10.1073/pnas.1433065100; Grummt I, 2003, GENE DEV, V17, P1691, DOI 10.1101/gad.1098503R; Hirschler-Laszkiewicz I, 2001, NUCLEIC ACIDS RES, V29, P4114, DOI 10.1093/nar/29.20.4114; Inari A, 2004, J BIOL CHEM, V279, P30830, DOI 10.1074/jbc.M402403200; Korzus E, 1998, SCIENCE, V279, P703, DOI 10.1126/science.279.5351.703; Laine JP, 2006, TRENDS GENET, V22, P430, DOI 10.1016/j.tig.2006.06.006; Liu L, 1999, MOL CELL BIOL, V19, P1202; McStay B, 2008, ANNU REV CELL DEV BI, V24, P131, DOI 10.1146/annurev.cellbio.24.110707.175259; Moss T, 2004, CURR OPIN GENET DEV, V14, P210, DOI 10.1016/j.gde.2004.02.005; Mujtaba S, 2002, MOL CELL, V9, P575, DOI 10.1016/S1097-2765(02)00483-5; Muth V, 2001, EMBO J, V20, P1353, DOI 10.1093/emboj/20.6.1353; Newman JC, 2006, P NATL ACAD SCI USA, V103, P9613, DOI 10.1073/pnas.0510909103; Pazin MJ, 1997, CELL, V88, P737, DOI 10.1016/S0092-8674(00)81918-2; Roth SY, 2001, ANNU REV BIOCHEM, V70, P81, DOI 10.1146/annurev.biochem.70.1.81; Russell J, 2006, BIOCHEM SOC SYMP, V73, P203; Santoro R, 2001, MOL CELL, V8, P719, DOI 10.1016/S1097-2765(01)00317-3; Selby CP, 1997, P NATL ACAD SCI USA, V94, P11205, DOI 10.1073/pnas.94.21.11205; Shahbazian MD, 2007, ANNU REV BIOCHEM, V76, P75, DOI 10.1146/annurev.biochem.76.052705.162114; Tantin D, 1997, MOL CELL BIOL, V17, P6803, DOI 10.1128/MCB.17.12.6803; VENEMA J, 1990, P NATL ACAD SCI USA, V87, P4707, DOI 10.1073/pnas.87.12.4707; VetteseDadey M, 1996, EMBO J, V15, P2508, DOI 10.1002/j.1460-2075.1996.tb00608.x; Vintermist A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019184; Wang ZB, 2009, CELL, V138, P1019, DOI 10.1016/j.cell.2009.06.049; Xie WB, 2012, P NATL ACAD SCI USA, V109, P8161, DOI 10.1073/pnas.1201262109; Yu AD, 2000, MOL CELL, V5, P801, DOI 10.1016/S1097-2765(00)80320-2; Yuan XJ, 2007, MOL CELL, V27, P585, DOI 10.1016/j.molcel.2007.06.021; Zhou YG, 2002, EMBO J, V21, P4632, DOI 10.1093/emboj/cdf460	32	12	12	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e62668	10.1371/journal.pone.0062668	http://dx.doi.org/10.1371/journal.pone.0062668			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667505	gold, Green Published, Green Submitted			2022-12-27	WOS:000319654700053
J	Thompson, RC; Vardinogiannis, I; Gilmore, TD				Thompson, Ryan C.; Vardinogiannis, Iosif; Gilmore, Thomas D.			The Sensitivity of Diffuse Large B-Cell Lymphoma Cell Lines to Histone Deacetylase Inhibitor-Induced Apoptosis Is Modulated by BCL-2 Family Protein Activity	PLOS ONE			English	Article							SUBEROYLANILIDE HYDROXAMIC ACID; NF-KAPPA-B; BH3 MIMETIC ABT-737; IN-VITRO; REVERSIBLE ACETYLATION; FRAMESHIFT MUTATIONS; EXPRESSION; MCL-1; GENE; VORINOSTAT	Background: Diffuse large B-cell lymphoma (DLBCL) is a genetically heterogeneous disease and this variation can often be used to explain the response of individual patients to chemotherapy. One cancer therapeutic approach currently in clinical trials uses histone deacetylase inhibitors (HDACi's) as monotherapy or in combination with other agents. Methodology/Principal Findings: We have used a variety of cell-based and molecular/biochemical assays to show that two pan-HDAC inhibitors, trichostatin A and vorinostat, induce apoptosis in seven of eight human DLBCL cell lines. Consistent with previous reports implicating the BCL-2 family in regulating HDACi-induced apoptosis, ectopic over-expression of anti-apoptotic proteins BCL-2 and BCL-XL or pro-apoptotic protein BIM in these cell lines conferred further resistance or sensitivity, respectively, to HDACi treatment. Additionally, BCL-2 family antgonist ABT-737 increased the sensitivity of several DLBCL cell lines to vorinostat-induced apoptosis, including one cell line (SUDHL6) that is resistant to vorinostat alone. Moreover, two variants of the HDACi-sensitive SUDHL4 cell line that have decreased sensitivity to vorinostat showed up-regulation of BCL-2 family anti-apoptotic proteins such as BCL-XL and MCL-1, as well as decreased sensitivity to ABT-737. These results suggest that the regulation and overall balance of anti- to pro-apoptotic BCL-2 family protein expression is important in defining the sensitivity of DLBCL to HDACi-induced apoptosis. However, the sensitivity of DLBCL cell lines to HDACi treatment does not correlate with expression of any individual BCL-2 family member. Conclusions/Significance: These studies indicate that the sensitivity of DLBCL to treatment with HDACi's is dependent on the complex regulation of BCL-2 family members and that BCL-2 antagonists may enhance the response of a subset of DLBCL patients to HDACi treatment.	[Thompson, Ryan C.; Vardinogiannis, Iosif; Gilmore, Thomas D.] Boston Univ, Dept Biol, Boston, MA 02215 USA	Boston University	Gilmore, TD (corresponding author), Boston Univ, Dept Biol, 5 Cummington St, Boston, MA 02215 USA.	gilmore@bu.edu			NIH grant [CA047763]; ARRA supplement [CA047763-21S3]; NHLBI Hematology Training Grant [T32 HL007501]; NATIONAL CANCER INSTITUTE [R29CA047763, R01CA047763] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007501] Funding Source: NIH RePORTER	NIH grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ARRA supplement; NHLBI Hematology Training Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This research was supported by NIH grant CA047763 and ARRA supplement CA047763-21S3 (both to T.D.G.). R.C.T. was partially supported by NHLBI Hematology Training Grant T32 HL007501. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; Allaman-Pillet N, 2011, OPHTHALMIC IN PRESS; Bhattacharya S, 2005, BIOCHEM J, V392, P335, DOI 10.1042/BJ20050465; Bodo J, 2011, APOPTOSIS, V16, P914, DOI 10.1007/s10495-011-0617-x; Bolden JE, 2006, NAT REV DRUG DISCOV, V5, P769, DOI 10.1038/nrd2133; Brimmell M, 1998, ONCOGENE, V16, P1803, DOI 10.1038/sj.onc.1201704; Chen CL, 2000, MOL CELL BIOL, V20, P2687, DOI 10.1128/MCB.20.8.2687-2695.2000; Chen LF, 2001, SCIENCE, V293, P1653, DOI 10.1126/science.1062374; Chen LF, 2002, EMBO J, V21, P6539, DOI 10.1093/emboj/cdf660; Chen S, 2007, CANCER RES, V67, P782, DOI 10.1158/0008-5472.CAN-06-3964; Chen SW, 2009, J ELECTRON MATER, V38, P1, DOI 10.1007/s11664-008-0572-7; Chen Zu-jin, 2011, Zhonghua Zhong Liu Za Zhi, V33, P891; Chin M, 2009, ONCOGENE, V28, P2100, DOI 10.1038/onc.2009.74; Cotto M, 2010, CLIN TRANSL ONCOL, V12, P401, DOI 10.1007/s12094-010-0527-3; Crump M, 2008, ANN ONCOL, V19, P964, DOI 10.1093/annonc/mdn031; Dalgard CL, 2008, CLIN CANCER RES, V14, P3113, DOI 10.1158/1078-0432.CCR-07-4836; Dasmahapatra G, 2010, BLOOD, V115, P4478, DOI 10.1182/blood-2009-12-257261; Davis RE, 2001, J EXP MED, V194, P1861, DOI 10.1084/jem.194.12.1861; Debien E, 2011, CLIN EPIGENETICS, V2, P369, DOI 10.1007/s13148-011-0035-5; Ding BB, 2008, BLOOD, V111, P1515, DOI 10.1182/blood-2007-04-087734; Faber AC, 2011, CANCER DISCOV, V1, P352, DOI 10.1158/2159-8290.CD-11-0106; Faber AC, 2009, P NATL ACAD SCI USA, V106, P19503, DOI 10.1073/pnas.0905056106; Fang H, 2011, CLIN CANCER RES, V17, P7093, DOI 10.1158/1078-0432.CCR-11-0578; Fantin VR, 2008, CANCER RES, V68, P3785, DOI 10.1158/0008-5472.CAN-07-6091; Fitzgerald DJ, 2011, LEUKEMIA LYMPHOMA, V52, P79, DOI 10.3109/10428194.2011.569961; Garbati MR, 2011, CANCER LETT, V302, P76, DOI 10.1016/j.canlet.2010.12.018; Gilmore TD, 2003, VIROLOGY, V316, P9, DOI 10.1016/S0042-6822(03)00562-2; Gupta M, 2012, LEUKEMIA, V26, P1356, DOI 10.1038/leu.2011.340; Henderson C, 2003, J BIOL CHEM, V278, P12579, DOI 10.1074/jbc.M213093200; Hrzenjak A, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-49; Hunt KE, 2008, ARCH PATHOL LAB MED, V132, P118, DOI 10.1043/1543-2165(2008)132[118:DLBL]2.0.CO;2; Ishitsuka K, 2012, CANCER LETT, V317, P218, DOI 10.1016/j.canlet.2011.11.030; Jing H, 2011, GENE DEV, V25, P2137, DOI 10.1101/gad.17620611; Lenz G, 2008, NEW ENGL J MED, V359, P2313, DOI 10.1056/NEJMoa0802885; Leonard JP, 2008, SEMIN HEMATOL, V45, pS11, DOI 10.1053/j.seminhematol.2008.07.004; Longe HO, 2009, INT J CANCER, V124, P473, DOI 10.1002/ijc.23946; Mestre-Escorihuela C, 2007, BLOOD, V109, P271, DOI 10.1182/blood-2006-06-026500; Mohammad RM, 2007, CLIN CANCER RES, V13, P2226, DOI 10.1158/1078-0432.CCR-06-1574; Moore VD, 2007, J CLIN INVEST, V117, P112, DOI 10.1172/JCI28281; Morales AA, 2011, BLOOD, V118, P1329, DOI 10.1182/blood-2011-01-327197; Morales JC, 2010, CANCER LETT, V297, P91, DOI 10.1016/j.canlet.2010.04.029; Nusinzon I, 2003, P NATL ACAD SCI USA, V100, P14742, DOI 10.1073/pnas.2433987100; O'Connor OA, 2006, J CLIN ONCOL, V24, P166, DOI 10.1200/JCO.2005.01.9679; Oltersdorf T, 2005, NATURE, V435, P677, DOI 10.1038/nature03579; Paoluzzi L, 2008, BLOOD, V112, P2906, DOI 10.1182/blood-2007-12-130781; Pasqualucci L, 2011, NATURE, V471, P189, DOI 10.1038/nature09730; Pitts TM, 2009, MOL CANCER THER, V8, P342, DOI 10.1158/1535-7163.MCT-08-0534; Rampino N, 1997, SCIENCE, V275, P967, DOI 10.1126/science.275.5302.967; Ribble D, 2005, BMC BIOTECHNOL, V5, DOI 10.1186/1472-6750-5-12; Risberg K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024012; Rosenwald A, 2002, NEW ENGL J MED, V346, P1937, DOI 10.1056/NEJMoa012914; Sakajiri S, 2005, EXP HEMATOL, V33, P53, DOI 10.1016/j.exphem.2004.09.008; Sevilla L, 2001, HISTOL HISTOPATHOL, V16, P595, DOI 10.14670/HH-16.595; Shamas-Din A, 2011, BBA-MOL CELL RES, V1813, P508, DOI 10.1016/j.bbamcr.2010.11.024; Strasser A, 2011, EMBO J, V30, P3667, DOI 10.1038/emboj.2011.307; Sturm I, 2006, CELL DEATH DIFFER, V13, P619, DOI 10.1038/sj.cdd.4401782; Thompson RC, 2011, J BIOL CHEM, V286, P1675, DOI 10.1074/jbc.M110.177063; Tsutsui M, 2010, INT J LAB HEMATOL, V32, P419, DOI 10.1111/j.1751-553X.2009.01204.x; van Delft MF, 2006, CANCER CELL, V10, P389, DOI 10.1016/j.ccr.2006.08.027; Walensky LD, 2011, TRENDS BIOCHEM SCI, V36, P642, DOI 10.1016/j.tibs.2011.08.009; Wenzel SS, 2012, LEUKEMIA; Whitecross KF, 2009, BLOOD, V113, P1982, DOI 10.1182/blood-2008-05-156851; Wiegmans AP, 2011, CANCER RES, V71, P3603, DOI 10.1158/0008-5472.CAN-10-3289; Wright G, 2003, P NATL ACAD SCI USA, V100, P9991, DOI 10.1073/pnas.1732008100; Yarkoni S, 1996, J NATL CANCER I, V88, P973, DOI 10.1093/jnci/88.14.973; Yecies D, 2010, BLOOD, V115, P3304, DOI 10.1182/blood-2009-07-233304; Yeo AT, 2012, CANCER LETT, V318, P53, DOI 10.1016/j.canlet.2011.11.035; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308; Yuan ZL, 2005, SCIENCE, V307, P269, DOI 10.1126/science.1105166; Zhao Y, 2005, P NATL ACAD SCI USA, V102, P16090, DOI 10.1073/pnas.0505585102	70	27	28	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e62822	10.1371/journal.pone.0062822	http://dx.doi.org/10.1371/journal.pone.0062822			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667527	Green Published, gold			2022-12-27	WOS:000319654700067
J	Bocharova, N; Treu, G; Czirjak, GA; Krone, O; Stefanski, V; Wibbelt, G; Unnsteinsdottir, ER; Hersteinsson, P; Schares, G; Doronina, L; Goltsman, M; Greenwood, AD				Bocharova, Natalia; Treu, Gabriele; Czirjak, Gabor Arpad; Krone, Oliver; Stefanski, Volker; Wibbelt, Gudrun; Unnsteinsdottir, Ester Rut; Hersteinsson, Pall; Schares, Gereon; Doronina, Lilia; Goltsman, Mikhail; Greenwood, Alex D.			Correlates between Feeding Ecology and Mercury Levels in Historical and Modern Arctic Foxes (Vulpes lagopus)	PLOS ONE			English	Article							ALOPEX-LAGOPUS; URSUS-MARITIMUS; HAIR; DIET; CONTAMINANTS; GREENLAND; SEABIRDS; ELEMENTS; METALS; RATIOS	Changes in concentration of pollutants and pathogen distribution can vary among ecotypes (e.g. marine versus terrestrial food resources). This may have important implications for the animals that reside within them. We examined 1) canid pathogen presence in an endangered arctic fox (Vulpes lagopus) population and 2) relative total mercury (THg) level as a function of ecotype ('coastal' or 'inland') for arctic foxes to test whether the presence of pathogens or heavy metal concentration correlate with population health. The Bering Sea populations on Bering and Mednyi Islands were compared to Icelandic arctic fox populations with respect to inland and coastal ecotypes. Serological and DNA based pathogen screening techniques were used to examine arctic foxes for pathogens. THg was measured by atomic absorption spectrometry from hair samples of historical and modern collected arctic foxes and samples from their prey species (hair and internal organs). Presence of pathogens did not correlate with population decline from Mednyi Island. However, THg concentration correlated strongly with ecotype and was reflected in the THg concentrations detected in available food sources in each ecotype. The highest concentration of THg was found in ecotypes where foxes depended on marine vertebrates for food. Exclusively inland ecotypes had low THg concentrations. The results suggest that absolute exposure to heavy metals may be less important than the feeding ecology and feeding opportunities of top predators such as arctic foxes which may in turn influence population health and stability. A higher risk to wildlife of heavy metal exposure correlates with feeding strategies that rely primarily on a marine based diet.	[Bocharova, Natalia; Doronina, Lilia; Goltsman, Mikhail] Moscow MV Lomonosov State Univ, Fac Biol, Dept Vertebrate Zool, Moscow, Russia; [Treu, Gabriele; Czirjak, Gabor Arpad; Krone, Oliver; Wibbelt, Gudrun; Greenwood, Alex D.] Leibniz Inst Zoo & Wildlife Res, Dept Wildlife Dis, Berlin, Germany; [Stefanski, Volker] Univ Hohenheim, Stuttgart, Germany; [Unnsteinsdottir, Ester Rut; Hersteinsson, Pall] Univ Iceland, Dept Life & Environm Sci, Reykjavik, Iceland; [Schares, Gereon] Fed Res Inst Anim Hlth, Friedrich Loeffler Inst, Inst Epidemiol, Wusterhausen, Germany	Lomonosov Moscow State University; Leibniz Institut fur Zoo und Wildtierforschung; University Hohenheim; University of Iceland; Friedrich Loeffler Institute	Greenwood, AD (corresponding author), Leibniz Inst Zoo & Wildlife Res, Dept Wildlife Dis, Berlin, Germany.	greenwood@izw-berlin.de	Greenwood, Alex/GWU-8292-2022; Czirják, Gábor Árpád/F-5440-2011; Schares, Gereon R.M./F-9850-2019	Czirják, Gábor Árpád/0000-0001-9488-0069; Schares, Gereon R.M./0000-0002-3217-289X	Deutscher Akademischer Austauschdienst - DAAD; Russian Foundation of Basic Research	Deutscher Akademischer Austauschdienst - DAAD(Deutscher Akademischer Austausch Dienst (DAAD)); Russian Foundation of Basic Research(Russian Foundation for Basic Research (RFBR))	Natalia A. Bocharova was funded in part by the Deutscher Akademischer Austauschdienst - DAAD. Research on Mednyi Island is funded by a grant from Russian Foundation of Basic Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abolitis AS, 1987, EFFICIENT UTILIZATIO, P144; AMAP, 2011, ASS 2011 MERC ARCT A; AMAP, 2005, AMAP ASS 2002 HEAV M; AMAP, 2004, AMAP ASS 2002 PRES O; Audet Alexandra M., 2002, Mammalian Species, V713, P1, DOI 10.1644/1545-1410(2002)713<0001:AL>2.0.CO;2; Bank MS, 2006, BIOL CONSERV, V130, P230, DOI 10.1016/j.biocon.2005.12.033; Bernhard M., 1984, CHANGING METAL CYCLE, P143; BORN EW, 1991, POLAR RES, V9, P113, DOI 10.1111/j.1751-8369.1991.tb00607.x; Braestrup F. W., 1941, Meddelelser om Gronland, V131, P1; Buckman AH, 2004, ENVIRON POLLUT, V128, P327, DOI 10.1016/j.envpol.2003.09.017; Campbell LM, 2005, SCI TOTAL ENVIRON, V351, P247, DOI 10.1016/j.scitotenv.2005.02.043; Castellini JM, 2012, ECOHEALTH, V9, P267, DOI 10.1007/s10393-012-0784-4; Dalerum F, 2000, ARCTIC, V53, P1; Das K, 2008, ENVIRON HEALTH-GLOB, V7, DOI 10.1186/1476-069X-7-52; Dietz C, 2013, SCI TOTAL ENVIRON, V443, P775, DOI [10.1016/j.scitotenv.2012.11.046, DOI 10.1016/J.SCIT0TENV.2012.11.046]; Dietz R, 2009, SCI TOTAL ENVIRON, V407, P6120, DOI 10.1016/j.scitotenv.2009.08.036; Egeland GM, 2009, ENVIRON RES, V109, P281, DOI 10.1016/j.envres.2008.11.004; Elliott JE, 2005, ENVIRON TOXICOL CHEM, V24, P3099, DOI 10.1897/04-474R.1; Fitzgerald WF, 2005, ENVIRON SCI TECHNOL, V39, P557, DOI 10.1021/es049128x; Fuglei E, 2007, ENVIRON POLLUT, V146, P128, DOI 10.1016/j.envpol.2006.06.036; GEPTNER VG, 1967, MAMMALS USSR 1; Goltsman M., 1996, Oryx, V30, P251; Goltsman ME, 2011, BIOL BULL+, V38, P709, DOI 10.1134/S1062359010151014; Hersteinsson P, 1996, J ZOOL, V240, P457, DOI 10.1111/j.1469-7998.1996.tb05298.x; Hersteinsson P, 2007, POLAR BIOL, V30, P1047, DOI 10.1007/s00300-007-0264-4; Ikemoto T, 2004, ENVIRON POLLUT, V127, P83, DOI 10.1016/S0269-7491(03)00251-3; Il'ina ED, 1950, FUR FARMING ISLANDS; Kim EY, 1996, ARCH ENVIRON CON TOX, V30, P259; Klobes U, 1998, INT J ENVIRON AN CH, V69, P67, DOI 10.1080/03067319808032575; Lindberg SE, 2002, ENVIRON SCI TECHNOL, V36, P1245, DOI 10.1021/es0111941; Morton J, 2002, ANAL CHIM ACTA, V455, P23, DOI 10.1016/S0003-2670(01)01578-1; Naumov N.P., 1981, P31; NODA K, 1995, ENVIRON POLLUT, V90, P51, DOI 10.1016/0269-7491(94)00089-V; Outridge PM, 2008, ENVIRON CHEM, V5, P89, DOI 10.1071/EN08002; Pagh S, 2008, POLAR RES, V27, P44, DOI 10.1111/j.1751-8369.2008.00042.x; Sanger G.A., 1987, P229; Sonne C, 2010, ENVIRON INT, V36, P461, DOI 10.1016/j.envint.2010.03.002; Stern GA, 2012, SCI TOTAL ENVIRON, V414, P22, DOI 10.1016/j.scitotenv.2011.10.039; Unnsteinsdottir ER, 2009, J ZOOL, V277, P232, DOI 10.1111/j.1469-7998.2008.00532.x; Whittaker R. J., 2007, ISLAND BIOGEOGRAPHY; Wikelski M, 2004, ECOL SOC, V9; Wyatt KB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003602; Zagrebel'nyi SV, 2000, ZOOL ZH, V79, P595; Zalkin VI, 1944, ZOOL J MOSCOW, V28	44	40	40	1	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2013	8	5							e60879	10.1371/journal.pone.0060879	http://dx.doi.org/10.1371/journal.pone.0060879			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	177QL	23671561	Green Submitted, Green Published, gold			2022-12-27	WOS:000321390200003
J	Frosig, C; Jensen, TE; Jeppesen, J; Pehmoller, C; Treebak, JT; Maarbjerg, SJ; Kristensen, JM; Sylow, L; Alsted, TJ; Schjerling, P; Kiens, B; Wojtaszewski, JFP; Richter, EA				Frosig, Christian; Jensen, Thomas E.; Jeppesen, Jacob; Pehmoller, Christian; Treebak, Jonas T.; Maarbjerg, Stine J.; Kristensen, Jonas M.; Sylow, Lykke; Alsted, Thomas J.; Schjerling, Peter; Kiens, Bente; Wojtaszewski, Jorgen F. P.; Richter, Erik A.			AMPK and Insulin Action - Responses to Ageing and High Fat Diet	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; ACETYL-COA CARBOXYLASE; SKELETAL-MUSCLE; GLUCOSE-TRANSPORT; RESISTANCE; EXERCISE; SENSITIVITY; HOMEOSTASIS; MICE; METABOLISM	The 5'-AMP-activated protein kinase (AMPK) is considered "a metabolic master-switch" in skeletal muscle reducing ATP-consuming processes whilst stimulating ATP regeneration. Within recent years, AMPK has also been proposed as a potential target to attenuate insulin resistance, although the exact role of AMPK is not well understood. Here we hypothesized that mice lacking alpha 2AMPK activity in muscle would be more susceptible to develop insulin resistance associated with ageing alone or in combination with high fat diet. Young (similar to 4 month) or old (similar to 18 month) wild type and muscle specific alpha 2AMPK kinase-dead mice on chow diet as well as old mice on 17 weeks of high fat diet were studied for whole body glucose homeostasis (OGTT, ITT and HOMA-IR), insulin signaling and insulin-stimulated glucose uptake in muscle. We demonstrate that high fat diet in old mice results in impaired glucose homeostasis and insulin stimulated glucose uptake in both the soleus and extensor digitorum longus muscle, coinciding with reduced insulin signaling at the level of Akt (pSer473 and pThr308), TBC1D1 (pThr590) and TBC1D4 (pThr642). In contrast to our hypothesis, the impact of ageing and high fat diet on insulin action was not worsened in mice lacking functional alpha 2AMPK in muscle. It is concluded that alpha 2AMPK deficiency in mouse skeletal muscle does not cause muscle insulin resistance in young and old mice and does not exacerbate obesity-induced insulin resistance in old mice suggesting that decreased alpha 2AMPK activity does not increase susceptibility for insulin resistance in skeletal muscle.	[Frosig, Christian; Jensen, Thomas E.; Jeppesen, Jacob; Pehmoller, Christian; Treebak, Jonas T.; Maarbjerg, Stine J.; Kristensen, Jonas M.; Sylow, Lykke; Alsted, Thomas J.; Kiens, Bente; Wojtaszewski, Jorgen F. P.; Richter, Erik A.] Univ Copenhagen, August Krogh Inst, Dept Nutr Exercise & Sports, Sect Mol Physiol, DK-2100 Copenhagen, Denmark; [Schjerling, Peter] Univ Copenhagen, Bispebjerg Hosp, Dept Orthoped Surg M, Inst Sports Med, Copenhagen, Denmark; [Schjerling, Peter] Univ Copenhagen, Fac Hlth Sci, Ctr Hlth Aging, Copenhagen, Denmark	University of Copenhagen; University of Copenhagen; Bispebjerg Hospital; University of Copenhagen	Frosig, C (corresponding author), Univ Copenhagen, August Krogh Inst, Dept Nutr Exercise & Sports, Sect Mol Physiol, DK-2100 Copenhagen, Denmark.	cfrosig@ifi.ku.dk	Wojtaszewski, Jørgen FP/P-6583-2014; Richter, Erik A./Y-8131-2019; Schjerling, Peter/F-6194-2011; Treebak, Jonas Thue/B-4521-2017; Frøsig, Christian/A-3750-2015; Jensen, Thomas/E-1215-2015; Sylow, Lykke/C-8997-2015; Kristensen, Jonas/A-3249-2017; Kiens, Bente/B-1375-2015	Wojtaszewski, Jørgen FP/0000-0001-9785-6830; Richter, Erik A./0000-0002-6850-3056; Schjerling, Peter/0000-0001-7138-3211; Treebak, Jonas Thue/0000-0003-1488-7012; Frøsig, Christian/0000-0001-9302-9328; Jensen, Thomas/0000-0001-6139-8268; Pehmoller, Christian/0000-0001-7102-7727; Sylow, Lykke/0000-0003-0905-5932; Kristensen, Jonas/0000-0002-8296-975X; wojtaszewski, jorgen/0000-0001-8185-3408; Kiens, Bente/0000-0001-5705-5625	Lundbaek Foundation, Denmark; Danish Medical Research Council, Denmark; Danish Agency of Science, Technology and Innovation; Danish Ministry of Food, Agriculture and Fisheries; Novo Nordisk Foundation; Danish Diabetes Association; Danish Ministry of Science, Technology and Innovation; Danish Agency for Science, Technology and Innovation; Alfred Benzon Foundation; Nordea Foundation	Lundbaek Foundation, Denmark; Danish Medical Research Council, Denmark(Danish Medical Research Council); Danish Agency of Science, Technology and Innovation; Danish Ministry of Food, Agriculture and Fisheries; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Danish Diabetes Association; Danish Ministry of Science, Technology and Innovation; Danish Agency for Science, Technology and Innovation; Alfred Benzon Foundation; Nordea Foundation	This work was supported by grants from the Lundbaek Foundation, Denmark, The Danish Medical Research Council, Denmark, The Danish Agency of Science, Technology and Innovation, The Danish Ministry of Food, Agriculture and Fisheries, The Novo Nordisk Foundation, and the Danish Diabetes Association. The Molecular Physiology group, Department of Nutrition, Exercise and Sports is part of the August Krogh Centre and the UNIversal Kit Project: Food, Fitness & Pharma for Health and Disease, supported by the Danish Ministry of Science, Technology and Innovation. TEJ and JTT were supported by a postdoctoral fellowship from The Danish Agency for Science, Technology and Innovation. JJ was supported by a research fellowship from The Alfred Benzon Foundation. PS was supported by the Nordea Foundation (Healthy Aging Grant). The Novo Nordisk Foundation Center for Basic Metabolic Research is an independent Research Center, based at the University of Copenhagen, Denmark and partially funded by an unconditional donation from the Novo Nordisk Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrikopoulos S, 2008, AM J PHYSIOL-ENDOC M, V295, pE1323, DOI 10.1152/ajpendo.90617.2008; Broome CS, 2006, FASEB J, V20, P1549, DOI 10.1096/fj.05-4935fje; Bruce CR, 2009, DIABETES, V58, P550, DOI 10.2337/db08-1078; Cartee GD, 2007, APPL PHYSIOL NUTR ME, V32, P557, DOI 10.1139/H07-026; Chen SA, 2008, BIOCHEM J, V409, P449, DOI 10.1042/BJ20071114; Chen SA, 2011, CELL METAB, V13, P68, DOI 10.1016/j.cmet.2010.12.005; Choi CS, 2007, P NATL ACAD SCI USA, V104, P16480, DOI 10.1073/pnas.0706794104; DAVIES SP, 1990, EUR J BIOCHEM, V187, P183, DOI 10.1111/j.1432-1033.1990.tb15293.x; DEFRONZO RA, 1981, DIABETES, V30, P1000, DOI 10.2337/diab.30.12.1000; Du KY, 2003, SCIENCE, V300, P1574, DOI 10.1126/science.1079817; Escriva F, 1997, ENDOCRINOLOGY, V138, P49, DOI 10.1210/en.138.1.49; Fujii N, 2005, J BIOL CHEM, V280, P39033, DOI 10.1074/jbc.M504208200; Fujii N, 2008, DIABETES, V57, P2958, DOI 10.2337/db07-1187; Fujii N, 2007, DIABETES RES CLIN PR, V77, pS92, DOI 10.1016/j.diabres.2007.01.040; Gabriely I, 2002, DIABETES, V51, P2951, DOI 10.2337/diabetes.51.10.2951; Gupte AA, 2008, J APPL PHYSIOL, V105, P839, DOI 10.1152/japplphysiol.00148.2008; Hardie DG, 2011, GENE DEV, V25, P1895, DOI 10.1101/gad.17420111; Hardie DG, 2004, REV ENDOCR METAB DIS, V5, P119, DOI 10.1023/B:REMD.0000021433.63915.bb; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Hu CC, 2004, OBES RES, V12, P1264, DOI 10.1038/oby.2004.160; Jorgensen SB, 2009, DIABETOLOGIA, V52, P2395, DOI 10.1007/s00125-009-1483-8; Koh HJ, 2006, MOL CELL BIOL, V26, P8217, DOI 10.1128/MCB.00979-06; Lauritzen HPMM, 2008, DIABETES, V57, P13, DOI 10.2337/db07-0516; Maarbjerg SJ, 2009, AM J PHYSIOL-ENDOC M, V297, pE924, DOI 10.1152/ajpendo.90653.2008; Manetta J, 2001, METABOLISM, V50, P349, DOI 10.1053/meta.2001.20205; Matos A, 2010, ACTA PHYSIOL, V198, P61, DOI 10.1111/j.1748-1716.2009.02031.x; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Merrill GF, 1997, AM J PHYSIOL-ENDOC M, V273, pE1107, DOI 10.1152/ajpendo.1997.273.6.E1107; Morino K, 2008, DIABETES, V57, P2644, DOI 10.2337/db06-0454; Mu J, 2001, MOL CELL, V7, P1085, DOI 10.1016/S1097-2765(01)00251-9; Mu J, 2003, BIOCHEM SOC T, V31, P236, DOI 10.1042/bst0310236; Perreault M, 2001, NAT MED, V7, P1138, DOI 10.1038/nm1001-1138; Richter EA, 2009, BIOCHEM J, V418, P261, DOI 10.1042/BJ20082055; Sakamoto K, 2008, AM J PHYSIOL-ENDOC M, V295, pE29, DOI 10.1152/ajpendo.90331.2008; Savage DB, 2007, PHYSIOL REV, V87, P507, DOI 10.1152/physrev.00024.2006; Standaert ML, 2004, J BIOL CHEM, V279, P24929, DOI 10.1074/jbc.M402440200; Treebak JT, 2008, INT J OBESITY, V32, pS13, DOI 10.1038/ijo.2008.117; Turdi S, 2011, J MOL CELL CARDIOL, V50, P712, DOI 10.1016/j.yjmcc.2010.12.007; Vind BF, 2012, DIABETOLOGIA, V55, P1435, DOI 10.1007/s00125-012-2482-8; Zierath JB, 1997, DIABETES, V46, P215, DOI 10.2337/diabetes.46.2.215	40	22	22	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2013	8	5							e62338	10.1371/journal.pone.0062338	http://dx.doi.org/10.1371/journal.pone.0062338			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	177QL	23671593	Green Submitted, Green Published, gold			2022-12-27	WOS:000321390200020
J	Liu, Y; Guo, YB; An, S; Kuang, YY; He, X; Ma, HJ; Li, JF; Lv, J; Zhang, N; Jiang, C				Liu, Yang; Guo, Yubo; An, Sai; Kuang, Yuyang; He, Xi; Ma, Haojun; Li, Jianfeng; Lv, Jing; Zhang, Ning; Jiang, Chen			Targeting Caspase-3 as Dual Therapeutic Benefits by RNAi Facilitating Brain-Targeted Nanoparticles in a Rat Model of Parkinson's Disease	PLOS ONE			English	Article							ACTIVATION; MICROGLIA; APOPTOSIS; SYSTEM; DEATH	The activation of caspase-3 is an important hallmark in Parkinson's disease. It could induce neuron death by apoptosis and microglia activation by inflammation. As a result, inhibition the activation of caspase-3 would exert synergistic dual effect in brain in order to prevent the progress of Parkinson's disease. Silencing caspase-3 genes by RNA interference could inhibit the activation of caspase-3. We developed a brain-targeted gene delivery system based on non-viral gene vector, dendrigraft poly-L-lysines. A rabies virus glycoprotein peptide with 29 amino-acid linked to dendrigraft poly-L-lysines could render gene vectors the ability to get across the blood brain barrier by specific receptor mediated transcytosis. The resultant brain-targeted vector was complexed with caspase-3 short hairpin RNA coding plasmid DNA, yielding nanoparticles. In vivo imaging analysis indicated the targeted nanoparticles could accumulate in brain more efficiently than non-targeted ones. A multiple dosing regimen by weekly intravenous administration of the nanoparticles could reduce activated casapse-3 levels, significantly improve locomotor activity and rescue dopaminergic neuronal loss and in Parkinson's disease rats' brain. These results indicated the rabies virus glycoprotein peptide modified brain-targeted nanoparticles were promising gene delivery system for RNA interference to achieve anti-apoptotic and anti-inflammation synergistic therapeutic effects by down-regulation the expression and activation of caspase-3.	[Liu, Yang; Guo, Yubo; An, Sai; Kuang, Yuyang; He, Xi; Ma, Haojun; Li, Jianfeng; Jiang, Chen] Fudan Univ, Minist Educ, Key Lab Smart Drug Delivery, Shanghai 200433, Peoples R China; [Liu, Yang; Guo, Yubo; An, Sai; Kuang, Yuyang; He, Xi; Ma, Haojun; Li, Jianfeng; Jiang, Chen] Fudan Univ, Sch Pharm, PLA, Shanghai 200433, Peoples R China; [Lv, Jing; Zhang, Ning] Caliper, Dept Life Sci & Technol, Alameda, CA USA	Fudan University; Fudan University	Jiang, C (corresponding author), Fudan Univ, Minist Educ, Key Lab Smart Drug Delivery, Shanghai 200433, Peoples R China.	jiangchen@shmu.edu.cn	An, Sai/N-3596-2017		National Natural Foundation of China [30973652]; Program for New Century Excellent Talents in University;  [20110071110048]	National Natural Foundation of China(National Natural Science Foundation of China (NSFC)); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); 	This work was supported by the grant from National Natural Foundation of China (30973652), Program for New Century Excellent Talents in University and Funding for doctoral discipline in high education university (20110071110048). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azzouz M, 2002, J NEUROSCI, V22, P10302; Bashkatova V, 2004, EXP NEUROL, V186, P235, DOI 10.1016/j.expneurol.2003.12.005; Betarbet R, 2000, NAT NEUROSCI, V3, P1301, DOI 10.1038/81834; Bjorklund A, 2010, PROG BRAIN RES, V184, P237, DOI 10.1016/S0079-6123(10)84013-0; Burguillos MA, 2011, NATURE, V472, P319, DOI 10.1038/nature09788; Burke RE, 2010, PROG BRAIN RES, V183, P79, DOI 10.1016/S0079-6123(10)83005-5; Carvey PM, 2006, CELL TRANSPLANT, V15, P239, DOI 10.3727/000000006783981990; Cottet H, 2007, BIOMACROMOLECULES, V8, P3235, DOI 10.1021/bm070268j; Denyer R, 2012, PARKINSONS DIS-US, V2012, DOI 10.1155/2012/757305; Fahn S, 2006, J NEURAL TRANSM-SUPP, P1; Gao Y, 2011, BIOMATERIALS, V32, P1738, DOI 10.1016/j.biomaterials.2010.11.001; Hartmann A, 2000, P NATL ACAD SCI USA, V97, P2875, DOI 10.1073/pnas.040556597; Huang RQ, 2010, J NEUROL SCI, V290, P123, DOI 10.1016/j.jns.2009.09.032; Kirik D, 1998, EXP NEUROL, V152, P259, DOI 10.1006/exnr.1998.6848; Kumar P, 2007, NATURE, V448, P39, DOI 10.1038/nature05901; Liu Y, 2012, J CONTROL RELEASE, V163, P203, DOI 10.1016/j.jconrel.2012.09.001; Lo Bianco C, 2002, P NATL ACAD SCI USA, V99, P10813, DOI 10.1073/pnas.152339799; Lou JN, 1998, EUR J IMMUNOL, V28, P3989, DOI 10.1002/(SICI)1521-4141(199812)28:12&lt;3989::AID-IMMU3989&gt;3.0.CO;2-X; Lu XF, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-46; Mattson MP, 2000, NAT REV MOL CELL BIO, V1, P120, DOI 10.1038/35040009; Ravenstijn PGM, 2012, FLUIDS BARRIERS CNS, V9, DOI 10.1186/2045-8118-9-4; Sherer TB, 2003, NEUROSCI LETT, V341, P87, DOI 10.1016/S0304-3940(03)00172-1; Sherer TB, 2002, NEUROSCIENTIST, V8, P192, DOI 10.1177/1073858402008003004; Sherer TB, 2002, J NEUROSCI, V22, P7006; Tsogas I, 2007, BIOMACROMOLECULES, V8, P3263, DOI 10.1021/bm700668w; Wood MJA, 2003, HUM MOL GENET, V12, pR279, DOI 10.1093/hmg/ddg275; Yuan JY, 2000, NATURE, V407, P802, DOI 10.1038/35037739; Zhao XW, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0046302, 10.1371/journal.pone.0029935]	28	43	44	1	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2013	8	5							e62905	10.1371/journal.pone.0062905	http://dx.doi.org/10.1371/journal.pone.0062905			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145RZ	23675438	Green Published, Green Submitted, gold			2022-12-27	WOS:000319036100019
J	Lu, SG; Le, S; Tan, YL; Zhu, JM; Li, M; Rao, XC; Zou, LY; Li, S; Wang, J; Jin, XL; Huang, GT; Zhang, L; Zhao, X; Hu, FQ				Lu, Shuguang; Le, Shuai; Tan, Yinling; Zhu, Junmin; Li, Ming; Rao, Xiancai; Zou, Lingyun; Li, Shu; Wang, Jing; Jin, Xiaolin; Huang, Guangtao; Zhang, Lin; Zhao, Xia; Hu, Fuquan			Genomic and Proteomic Analyses of the Terminally Redundant Genome of the Pseudomonas aeruginosa Phage PaP1: Establishment of Genus PaP1-Like Phages	PLOS ONE			English	Article							COMPLETE NUCLEOTIDE-SEQUENCE; BACTERIOPHAGE; DATABASE; THERAPY; GENES; DNA; RESEMBLES; COREGENES; TOOL	We isolated and characterized a new Pseudomonas aeruginosa myovirus named PaP1. The morphology of this phage was visualized by electron microscopy and its genome sequence and ends were determined. Finally, genomic and proteomic analyses were performed. PaP1 has an icosahedral head with an apex diameter of 68-70 nm and a contractile tail with a length of 138-140 nm. The PaP1 genome is a linear dsDNA molecule containing 91,715 base pairs (bp) with a G+C content of 49.36% and 12 tRNA genes. A strategy to identify the genome ends of PaP1 was designed. The genome has a 1190 bp terminal redundancy. PaP1 has 157 open reading frames (ORFs). Of these, 143 proteins are homologs of known proteins, but only 38 could be functionally identified. Sodium dodecyl sulfate-polyacrylamide gel electrophoresis and high-performance liquid chromatography-mass spectrometry allowed identification of 12 ORFs as structural protein coding genes within the PaP1 genome. Comparative genomic analysis indicated that the Pseudomonas aeruginosa phage PaP1, JG004, PAK_P1 and vB_PaeM_C2-10_Ab1 share great similarity. Besides their similar biological characteristics, the phages contain 123 core genes and have very close phylogenetic relationships, which distinguish them from other known phage genera. We therefore propose that these four phages be classified as PaP1-like phages, a new phage genus of Myoviridae that infects Pseudomonas aeruginosa.	[Lu, Shuguang; Le, Shuai; Tan, Yinling; Zhu, Junmin; Li, Ming; Rao, Xiancai; Zou, Lingyun; Li, Shu; Wang, Jing; Jin, Xiaolin; Huang, Guangtao; Zhang, Lin; Zhao, Xia; Hu, Fuquan] Third Mil Med Univ, Coll Basic Med Sci, Dept Microbiol, Chongqing, Peoples R China	Army Medical University	Hu, FQ (corresponding author), Third Mil Med Univ, Coll Basic Med Sci, Dept Microbiol, Chongqing, Peoples R China.	hufuquan2009@yahoo.cn	Rao, Xiancai/F-3033-2012	Rao, Xiancai/0000-0002-9905-760X; Le, Shuai/0000-0003-3748-5454	National Natural Science Foundation of China [31070153]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants 31070153 from the National Natural Science Foundation of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abedon S, 2011, ADV APPL MICROBIOL, V77, P1, DOI 10.1016/B978-0-12-387044-5.00001-7; Ackermann HW, 2012, ARCH VIROL, V157, P1843, DOI 10.1007/s00705-012-1383-y; Alemayehu D, 2012, MBIO, V3, DOI 10.1128/mBio.00029-12; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bamford DH, 2005, CURR OPIN STRUC BIOL, V15, P655, DOI 10.1016/j.sbi.2005.10.012; Besemer J, 1999, NUCLEIC ACIDS RES, V27, P3911, DOI 10.1093/nar/27.19.3911; Bonomo RA, 2006, CLIN INFECT DIS, V43, pS49, DOI 10.1086/504477; BOWDEN DW, 1985, J BIOL CHEM, V260, P6999; BRAVO A, 1990, NUCLEIC ACIDS RES, V18, P2881, DOI 10.1093/nar/18.10.2881; Carver T, 2009, BIOINFORMATICS, V25, P119, DOI 10.1093/bioinformatics/btn578; Carver T, 2008, BIOINFORMATICS, V24, P2672, DOI 10.1093/bioinformatics/btn529; Casas V, 2007, METHOD ENZYMOL, V421, P259, DOI 10.1016/S0076-6879(06)21020-6; Casjens S, 1992, SEMINARS VIROLOGY, V3, P383; Ceyssens PJ, 2008, VIROLOGY, V377, P233, DOI 10.1016/j.virol.2008.04.038; Ceyssens PJ, 2010, FUTURE MICROBIOL, V5, P1041, DOI 10.2217/FMB.10.66; Ceyssens PJ, 2009, ENVIRON MICROBIOL, V11, P2874, DOI 10.1111/j.1462-2920.2009.02030.x; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Ciprandi G, 2008, INT IMMUNOPHARMACOL, V8, P1622, DOI 10.1016/j.intimp.2008.07.007; d'Herelle F, 1917, CR HEBD ACAD SCI, V165, P373; de la Bastide Melissa, 2007, Curr Protoc Bioinformatics, VChapter 11, DOI 10.1002/0471250953.bi1104s17; Debarbieux L, 2008, MED MALADIES INFECT, V38, P421, DOI 10.1016/j.medmal.2008.06.014; Debarbieux L, 2010, J INFECT DIS, V201, P1096, DOI 10.1086/651135; Diard M, 2010, J BACTERIOL, V192, P4885, DOI 10.1128/JB.00804-10; Eyer L, 2007, PROTEOMICS, V7, P64, DOI 10.1002/pmic.200600280; Garbe J, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-301; Garbe J, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-102; Govind R, 2006, J BACTERIOL, V188, P2568, DOI 10.1128/JB.188.7.2568-2577.2006; Grigoriev A, 1999, VIRUS RES, V60, P1, DOI 10.1016/S0168-1702(98)00139-7; Hendrix RW, 2003, CURR OPIN MICROBIOL, V6, P506, DOI 10.1016/j.mib.2003.09.004; Hendrix RW, 1999, P NATL ACAD SCI USA, V96, P2192, DOI 10.1073/pnas.96.5.2192; Hertveldt K, 2005, J MOL BIOL, V354, P536, DOI 10.1016/j.jmb.2005.08.075; JUST W, 1990, J GEN VIROL, V71, P2157, DOI 10.1099/0022-1317-71-9-2157; Keppel F, 1988, STRATEGIES BACTERIOP, P145; Kimelman A, 2012, GENOME RES, V22, P802, DOI 10.1101/gr.133850.111; Klumpp J, 2008, J BACTERIOL, V190, P5753, DOI 10.1128/JB.00461-08; Krumsiek J, 2007, BIOINFORMATICS, V23, P1026, DOI 10.1093/bioinformatics/btm039; Kwan T, 2006, J BACTERIOL, V188, P1184, DOI 10.1128/JB.188.3.1184-1187.2006; Lima-Mendez G, 2007, VIROLOGY, V365, P241, DOI 10.1016/j.virol.2007.03.047; Mahadevan Padmanabhan, 2009, International Journal of Computational Biology and Drug Design, V2, P100; Manoharadas S, 2009, J BIOTECHNOL, V139, P118, DOI 10.1016/j.jbiotec.2008.09.003; Mesyanzhinov VV, 2002, J MOL BIOL, V317, P1, DOI 10.1006/jmbi.2001.5396; Moak M, 2004, MOL MICROBIOL, V51, P1169, DOI 10.1046/j.1365-2958.2003.03894.x; Monod C, 1997, J MOL BIOL, V267, P237, DOI 10.1006/jmbi.1996.0867; Morello E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016963; Nakayama K, 1999, MOL MICROBIOL, V31, P399, DOI 10.1046/j.1365-2958.1999.01158.x; Pajunen MI, 2001, J BACTERIOL, V183, P1928, DOI 10.1128/JB.183.6.1928-1937.2001; Reese MG, 2001, COMPUT CHEM, V26, P51, DOI 10.1016/S0097-8485(01)00099-7; Rosseel T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041967; Sambrook J., 2001, MOL CLONING LAB MANU; Schattner P, 2005, NUCLEIC ACIDS RES, V33, pW686, DOI 10.1093/nar/gki366; Skurnik M, 2006, INT J MED MICROBIOL, V296, P5, DOI 10.1016/j.ijmm.2005.09.002; Som A, 2009, MOL PHYLOGENET EVOL, V52, P846, DOI 10.1016/j.ympev.2009.05.025; Stewart CR, 1998, VIROLOGY, V246, P329, DOI 10.1006/viro.1998.9197; Sun WZ, 2010, AFR J MICROBIOL RES, V4, P933; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tan YL, 2007, CELL MICROBIOL, V9, P479, DOI 10.1111/j.1462-5822.2006.00804.x; Twort A, 1993, FOCUS OUT STEP BIOGR, Vxi; Uchiyama J, 2012, ARCH VIROL, V157, P733, DOI 10.1007/s00705-011-1210-x; Welker M, 2007, J MASS SPECTROM, V42, P1062, DOI 10.1002/jms.1237; Wheeler DL, 2003, NUCLEIC ACIDS RES, V31, P28, DOI 10.1093/nar/gkg033; Williams EA, 2009, MOL ECOL, V18, P4434, DOI 10.1111/j.1365-294X.2009.04371.x; Wu HY, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-54; WU R, 1971, J MOL BIOL, V57, P491, DOI 10.1016/0022-2836(71)90105-7; Zafar N, 2002, BMC BIOINFORMATICS, V3, DOI 10.1186/1471-2105-3-12; Zhang YZ, 2007, J VIROL, V81, P7662, DOI 10.1128/JVI.00186-07; Zheng ZL, 2011, NAT PROTOC, V6, P1367, DOI 10.1038/nprot.2011.369	66	50	61	2	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2013	8	5							e62933	10.1371/journal.pone.0062933	http://dx.doi.org/10.1371/journal.pone.0062933			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145RZ	23675441	Green Submitted, gold, Green Published			2022-12-27	WOS:000319036100022
J	Minato, Y; Fassio, SR; Hase, CC				Minato, Yusuke; Fassio, Sara R.; Haese, Claudia C.			Malonate Inhibits Virulence Gene Expression in Vibrio cholerae	PLOS ONE			English	Article							CARBON METABOLISM; TOXR REGULON; PROTEIN; COLONIZATION; ACTIVATION; SEQUENCE; ACETATE; CASCADE; APHA	We previously found that inhibition of the TCA cycle, either through mutations or chemical inhibition, increased toxT transcription in Vibrio cholerae. In this study, we found that the addition of malonate, an inhibitor of succinate dehydrogenase (SDH), decreased toxT transcription in V. cholerae, an observation inconsistent with the previous pattern observed. Unlike another SDH inhibitor, 2-thenoyltrifluoroacetone (TTFA), which increased toxT transcription and slightly inhibited V. cholerae growth, malonate inhibited toxT transcription in both the wild-type strain and TCA cycle mutants, suggesting malonate-mediated inhibition of virulence gene expression is independent to TCA cycle activity. Addition of malonate also inhibited ctxB and tcpA expressions but did not affect aphA, aphB, tcpP and toxR expressions. Malonate inhibited cholera toxin (CT) production in both V. cholerae classical biotype strains O395N1 and CA401, and El Tor biotype strain, N16961. Consistent with previous reports, we confirmed that these strains of V. cholerae did not utilize malonate as a primary carbon source. However, we found that the addition of malonate to the growth medium stimulated V. cholerae growth. All together, these results suggest that metabolizing malonate as a nutrient source negatively affects virulence gene expression in V. cholerae.	[Minato, Yusuke; Haese, Claudia C.] Oregon State Univ, Coll Vet Med, Dept Biomed Sci, Corvallis, OR 97331 USA; [Fassio, Sara R.; Haese, Claudia C.] Oregon State Univ, Dept Microbiol, Coll Sci, Corvallis, OR 97331 USA	Oregon State University; Oregon State University	Hase, CC (corresponding author), Oregon State Univ, Coll Vet Med, Dept Biomed Sci, Corvallis, OR 97331 USA.	hasec@science.oregonstate.edu	Minato, Yusuke/B-9510-2018	Minato, Yusuke/0000-0002-0888-8564	National Institutes of Health [AI-063121-02]; Medical Research Foundation (MRF) from OHSU Foundation; Undergraduate Research, Innovation, Scholarship & Creativity fund; OSU Howard Hughes Medical Institute Summer Undergraduate Research Program	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Research Foundation (MRF) from OHSU Foundation; Undergraduate Research, Innovation, Scholarship & Creativity fund; OSU Howard Hughes Medical Institute Summer Undergraduate Research Program	This research was supported by grants from the National Institutes of Health to C. C. H. (AI-063121-02) and by the Medical Research Foundation (MRF) from OHSU Foundation. S. R. F. was partially supported by the Undergraduate Research, Innovation, Scholarship & Creativity fund and the OSU Howard Hughes Medical Institute Summer Undergraduate Research Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barquera B, 2002, BIOCHEMISTRY-US, V41, P3781, DOI 10.1021/bi011873o; Bergey DH, 1984, BERGEYS MANUAL SYSTE; Bogard RW, 2012, MBIO, V3, DOI 10.1128/mBio.00236-12; BROWN TDK, 1977, J GEN MICROBIOL, V102, P327, DOI 10.1099/00221287-102-2-327; CHIANG SL, 1995, MOL MICROBIOL, V17, P1133, DOI 10.1111/j.1365-2958.1995.mmi_17061133.x; Davies BW, 2012, CELL, V149, P358, DOI 10.1016/j.cell.2012.01.053; Dimroth P, 1997, MOL MICROBIOL, V25, P3, DOI 10.1046/j.1365-2958.1997.4611824.x; DIRITA VJ, 1991, P NATL ACAD SCI USA, V88, P5403, DOI 10.1073/pnas.88.12.5403; Eisenreich W, 2010, NAT REV MICROBIOL, V8, P401, DOI 10.1038/nrmicro2351; GARDEL CL, 1994, METHOD ENZYMOL, V235, P517; Hase CC, 1999, P NATL ACAD SCI USA, V96, P3183, DOI 10.1073/pnas.96.6.3183; Hase CC, 1998, P NATL ACAD SCI USA, V95, P730, DOI 10.1073/pnas.95.2.730; HERRINGTON DA, 1988, J EXP MED, V168, P1487, DOI 10.1084/jem.168.4.1487; Hoenke S, 1997, EUR J BIOCHEM, V246, P530, DOI 10.1111/j.1432-1033.1997.00530.x; IWANAGA M, 1987, J CLIN MICROBIOL, V25, P2314, DOI 10.1128/JCM.25.12.2314-2316.1987; IWANAGA M, 1985, J CLIN MICROBIOL, V22, P405, DOI 10.1128/JCM.22.3.405-408.1985; Kim YS, 2002, J BIOCHEM MOL BIOL, V35, P443; Kovacikova G, 1999, J BACTERIOL, V181, P4250, DOI 10.1128/JB.181.14.4250-4256.1999; Lee KM, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.394932; Matson JS, 2007, INFECT IMMUN, V75, P5542, DOI 10.1128/IAI.01094-07; Minato Y, 2013, MICROBIOLOG IN PRESS; Minato Y, 2011, J BACTERIOL, V193, P5850, DOI 10.1128/JB.05222-11; Patra T, 2012, J BACTERIOL, V194, P3377, DOI 10.1128/JB.06379-11; PETERSON KM, 1988, INFECT IMMUN, V56, P2822, DOI 10.1128/IAI.56.11.2822-2829.1988; Poncet S, 2009, CONTRIB MICROBIOL, V16, P88, DOI 10.1159/000219374; Ray S, 2011, INFECT IMMUN, V79, P258, DOI 10.1128/IAI.00663-10; ROSE IA, 1954, J BIOL CHEM, V211, P737; SCHNEIDER DR, 1978, J INFECT DIS, V138, P143, DOI 10.1093/infdis/138.2.143; SHAW CE, 1990, INFECT IMMUN, V58, P3042, DOI 10.1128/IAI.58.9.3042-3049.1990; Skorupski K, 1999, MOL MICROBIOL, V31, P763, DOI 10.1046/j.1365-2958.1999.01215.x; Somerville GA, 2009, MICROBIOL MOL BIOL R, V73, P233, DOI 10.1128/MMBR.00005-09; TAYLOR RK, 1987, P NATL ACAD SCI USA, V84, P2833, DOI 10.1073/pnas.84.9.2833; Vanden Broeck D, 2007, INT J BIOCHEM CELL B, V39, P1771, DOI 10.1016/j.biocel.2007.07.005; Wolfe AJ, 2005, MICROBIOL MOL BIOL R, V69, P12, DOI 10.1128/MMBR.69.1.12-50.2005; Wolfe AJ, 2010, CURR OPIN MICROBIOL, V13, P204, DOI 10.1016/j.mib.2010.01.002	35	7	9	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2013	8	5							e63336	10.1371/journal.pone.0063336	http://dx.doi.org/10.1371/journal.pone.0063336			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145RZ	23675480	gold, Green Submitted, Green Published			2022-12-27	WOS:000319036100039
J	Freeman, EE; Roy-Gagnon, MH; Samson, E; Haddad, S; Aubin, MJ; Vela, C; Zunzunegui, MV				Freeman, Ellen E.; Roy-Gagnon, Marie-Helene; Samson, Elodie; Haddad, Slim; Aubin, Marie-Josee; Vela, Claudia; Zunzunegui, Maria Victoria			The Global Burden of Visual Difficulty in Low, Middle, and High Income Countries	PLOS ONE			English	Article							EYE CARE UTILIZATION; IMPAIRMENT; RISK; CATARACT; PREVALENCE; HEALTH; IMPACT	Purpose: Using a world-wide, population-based dataset of adults, we sought to determine the frequency of far visual difficulty and its associated risk factors. Methods: The World Health Survey (WHS) was conducted in 70 countries throughout the world in 2003 using a random, multi-stage, stratified, cluster sampling design of adults ages 18 years and older. Far vision was assessed by asking "In the last 30 days, how much difficulty did you have in seeing and recognizing a person you know across the road (i.e. from a distance of about 20 meters)?". Responses included none, mild, moderate, severe, or extreme/unable. The income status of countries was estimated using gross national income per capita data from 2003 from the World Bank. Prevalence and regression estimates were adjusted to account for the complex sample design. Results: 21% of adults reported any visual difficulty. The rate varied by the income status of the country with the percentage who had any visual difficulty being 24%, 23%, and 13% in low, middle, and high income countries, respectively. Five percent of people reported severe or extreme visual difficulty with rates in low, middle, and high income countries of 6%, 5%, and 2% respectively. Risk factors for visual difficulty included older age, female sex, poorer socioeconomic status, little to no formal education, and diabetes (P<0.05). Conclusions: One out of five adults in the WHS reported some degree of far visual difficulty. Given the importance of vision to living an independent life, better access to quality eye care services and life course factors affecting vision health (e. g. repeated eye infections, diet lacking vitamin A) must receive adequate attention and resources, especially in low and middle income countries.	[Freeman, Ellen E.; Aubin, Marie-Josee] Univ Montreal, Dept Ophthalmol, Montreal, PQ, Canada; [Freeman, Ellen E.; Roy-Gagnon, Marie-Helene; Samson, Elodie; Aubin, Marie-Josee; Vela, Claudia] Hop Maison Neuve Rosemont, Ctr Rech, Montreal, PQ H1T 2M4, Canada; [Haddad, Slim; Zunzunegui, Maria Victoria] Ctr Hosp Univ Montreal, Ctr Rech, Montreal, PQ, Canada	Universite de Montreal; Universite de Montreal; Universite de Montreal	Freeman, EE (corresponding author), Univ Montreal, Dept Ophthalmol, Montreal, PQ, Canada.	eefreeman@gmail.com	Aubin, Marie-Josée/AAI-9745-2020	Roy-Gagnon, Marie-Helene/0000-0001-8747-0846; Freeman, Ellen/0000-0002-1403-8427; Zunzunegui, Maria-Victoria/0000-0003-0827-2804	CIHR [MOP 106533]; Department of Ophthalmology at Universite de Montreal	CIHR(Canadian Institutes of Health Research (CIHR)); Department of Ophthalmology at Universite de Montreal	This work was supported by CIHR grant MOP 106533 and funds from the Department of Ophthalmology at Universite de Montreal. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad OB, 2001, AGE STANDARDIZATION, V31, P10; Bank W, 2003, GNI PER CAPITA; Cho EY, 2004, ARCH OPHTHALMOL-CHIC, V122, P883, DOI 10.1001/archopht.122.6.883; Christen WG, 2005, AM J CLIN NUTR, V81, P1417; Cockburn N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030718; Coffeng LE, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002032; Eusebio C, 2007, BRIT J OPHTHALMOL, V91, P1588, DOI 10.1136/bjo.2007.119123; Filmer D, 2001, DEMOGRAPHY, V38, P115, DOI 10.2307/3088292; Freeman EE, 2007, OPHTHALMOLOGY; Freeman EE, 2010, OPHTHAL EPIDEMIOL, V17, P301, DOI 10.3109/09286586.2010.508354; Glover SJ, 2012, BRIT J OPHTHALMOL, V96, P156, DOI 10.1136/bjo.2010.196071; Guthold R, 2008, AM J PREV MED, V34, P486, DOI 10.1016/j.amepre.2008.02.013; Hosseinpoor AR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042843; Jacques PF, 2001, ARCH OPHTHALMOL-CHIC, V119, P1009, DOI 10.1001/archopht.119.7.1009; Janz NK, 2001, OPHTHALMOLOGY, V108, P887, DOI 10.1016/S0161-6420(00)00624-2; Klein B E, 1999, Ophthalmic Epidemiol, V6, P49; Lamoureux EL, 2011, CURR OPIN OPHTHALMOL, V22, P19, DOI 10.1097/ICU.0b013e3283414284; Loerbroks A, 2012, INT J EPIDEMIOL, V41, P1436, DOI 10.1093/ije/dys123; Mangione CM, 1998, ARCH OPHTHALMOL-CHIC, V116, P227; Mechakra-Tahiri SD, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-598; Moussavi S, 2007, LANCET, V370, P851, DOI 10.1016/S0140-6736(07)61415-9; Ojofeitimi E. O., 1999, Nutrition and Health (Bicester), V13, P61; Orr P, 1999, OPHTHALMOLOGY, V106, P904, DOI 10.1016/S0161-6420(99)00508-4; Pascolini D, 2012, BRIT J OPHTHALMOL, V96, P614, DOI 10.1136/bjophthalmol-2011-300539; Resnikoff S, 2004, B WORLD HEALTH ORGAN, V82, P844; Resnikoff S, 2008, B WORLD HEALTH ORGAN, V86, P63, DOI 10.2471/BLT.07.041210; Roba AA, 2011, J EPIDEMIOL COMMUN H, V65, P626, DOI 10.1136/jech.2009.094763; Schaumberg DA, 2000, MED CARE, V38, P638, DOI 10.1097/00005650-200006000-00005; Shankar AV, 1996, AM J CLIN NUTR, V64, P242, DOI 10.1093/ajcn/64.2.242; Sherwin JC, 2012, T ROY SOC TROP MED H, V106, P205, DOI 10.1016/j.trstmh.2012.01.004; UNDP, 2009, HUM DEV REP; Vela C, 2012, BMC OPHTHALMOL, V12, DOI 10.1186/1471-2415-12-5; Woldeyes Alemayehu, 2008, Ethiop Med J, V46, P211; World Health Organization, 2009, WORLD HLTH SURV	34	64	64	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2013	8	5							e63315	10.1371/journal.pone.0063315	http://dx.doi.org/10.1371/journal.pone.0063315			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	143FO	23675477	gold, Green Submitted, Green Published			2022-12-27	WOS:000318852400036
J	Maiti, GP; Mondal, P; Mukherjee, N; Ghosh, A; Ghosh, S; Dey, S; Chakrabarty, J; Roy, A; Biswas, J; Roychoudhury, S; Panda, CK				Maiti, Guru Prasad; Mondal, Pinaki; Mukherjee, Nupur; Ghosh, Amlan; Ghosh, Susmita; Dey, Sanjib; Chakrabarty, Jayanta; Roy, Anup; Biswas, Jaydip; Roychoudhury, Susanta; Panda, Chinmay Kumar			Overexpression of EGFR in Head and Neck Squamous Cell Carcinoma Is Associated with Inactivation of SH3GL2 and CDC25A Genes	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; COPY NUMBER; LOCI; METHYLATION; EXPRESSION; DELETIONS; LESIONS; HPV	The aim of this study is to understand the mechanism of EGFR overexpression in head and neck squamous cell carcinoma (HNSCC). For this reason, expression/mutation of EGFR were analyzed in 30 dysplastic head and neck lesions and 148 HNSCC samples of Indian patients along with 3 HNSCC cell lines. In addition, deletion/methylation/mutation/expression of SH3GL2 (associated with EGFR degradation) and CDC25A (associated with dephosphorylation of EGFR) were analyzed in the same set of samples. Our study revealed high frequency of EGFR overexpression (66-84%), low frequency of gene amplification (10-32.5%) and absence of functional mutation in the dysplastic lesions and HNSCC samples. No correlation was found between protein overexpression and mRNA expression/gene amplification status of EGFR. On the other hand, frequent alterations (deletion/methylation) of SH3GL2 (63-77%) and CDC25A (37-64%) were seen in the dysplastic and HNSCC samples. Two novel single nucleotide polymorphism (SNPs) were found in the promoter region of SH3GL2. Reduced expression of these genes showed concordance with their alterations. Overexpression of EGFR and p-EGFR were significantly associated with reduced expression and alterations of SH3GL2 and CDC25A respectively. In-vitro demethylation experiment by 5-aza-2'-deoxycytidine (5-aza-dC) showed upregulation of SH3GL2 and CDC25A and downregulation of EGFR expression in Hep2 cell line. Poor patient outcome was predicted in the cases with alterations of SH3GL2 and CDC25A in presence of human papilloma virus (HPV) infection. Also, low SH3GL2 and high EGFR expression was a predictor of poor patient survival. Thus, our data suggests that overexpression of EGFR due to its reduced degradation and dephosphorylation is needed for development of HNSCC.	[Maiti, Guru Prasad; Mukherjee, Nupur; Ghosh, Amlan; Ghosh, Susmita; Panda, Chinmay Kumar] Chittaranjan Natl Canc Inst, Dept Oncogene Regulat, Kolkata, India; [Mondal, Pinaki; Dey, Sanjib; Roychoudhury, Susanta] CSIR, Indian Inst Chem Biol, Canc Biol & Inflammatory Disorder Div, Kolkata, India; [Ghosh, Amlan] Presidency Univ, Dept Zool, Kolkata, India; [Ghosh, Susmita] Johns Hopkins Sch Med, Dept Pathol, Baltimore, MD USA; [Chakrabarty, Jayanta; Biswas, Jaydip] Chittaranjan Natl Canc Inst, Dept Surg Oncol, Kolkata, India; [Roy, Anup] North Bengal Med Coll, Darjeeling, W Bengal, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Biology (IICB); Presidency University, Kolkata; Johns Hopkins University; Johns Hopkins Medicine	Panda, CK (corresponding author), Chittaranjan Natl Canc Inst, Dept Oncogene Regulat, Kolkata, India.	ckpanda.cnci@gmail.com	Maiti, Prasad/M-7729-2014; Mondal, Pinaki/AAB-8998-2022; Roychoudhury, Susanta/AAD-7946-2021	Maiti, Prasad/0000-0003-1936-363X; 	Department of Biotechnology, Government of India [BT/PR/5524/Med/14/649/2004]; Council for Scientific and Industrial Research-Project, Government of India [IAP-001]; CSIR-SRF Fellowship [09/30 (0053)2k9-EMR-I]	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); Council for Scientific and Industrial Research-Project, Government of India; CSIR-SRF Fellowship(Council of Scientific & Industrial Research (CSIR) - India)	Financial support for this work was provided by grants from Department of Biotechnology, (BT/PR/5524/Med/14/649/2004), Government of India, to Dr. CK Panda and Dr. S Roychoudhury, Council for Scientific and Industrial Research-Project (IAP-001), Government of India to Dr. S Roychoudhury and CSIR-SRF Fellowship (grant no. 09/30 (0053)2k9-EMR-I) to Mr. GP Maiti. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhattacharya N, 2009, J ORAL PATHOL MED, V38, P759, DOI 10.1111/j.1600-0714.2009.00781.x; Chau NG, 2011, HEAD NECK ONCOL, V3, DOI 10.1186/1758-3284-3-11; Choi SH, 2007, ONCOGENE, V26, P1567, DOI 10.1038/sj.onc.1209957; Chung CH, 2006, J CLIN ONCOL, V24, P4170, DOI 10.1200/JCO.2006.07.2587; Dasgupta S, 2002, ORAL ONCOL, V38, P6, DOI 10.1016/S1368-8375(00)00131-7; Dasgupta S, 2013, J MOL MED, V91, P381, DOI 10.1007/s00109-012-0955-3; Dikic I, 2003, BIOCHEM SOC T, V31, P1178; Farrell WE, 1997, CANCER RES, V57, P2703; Ghosh A, 2009, J PATHOL, V217, P408, DOI 10.1002/path.2464; Ghosh S, 2008, DEUT VIER LIT GEIST, V82, P3; Ghosh S, 2009, HUM GENET, V125, P189, DOI 10.1007/s00439-008-0610-9; Giordani L, 2002, CANCER GENET CYTOGEN, V135, P42, DOI 10.1016/S0165-4608(01)00640-9; Herman JG, 1996, P NATL ACAD SCI USA, V93, P9821, DOI 10.1073/pnas.93.18.9821; Leemans CR, 2011, NAT REV CANCER, V11, P9, DOI 10.1038/nrc2982; Mitra S, 2010, GENE CHROMOSOME CANC, V49, P155, DOI 10.1002/gcc.20726; Nath S, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.160671; Perez-Ordonez B, 2006, J CLIN PATHOL, V59, P445, DOI 10.1136/jcp.2003.007641; Perrone F, 2006, CLIN CANCER RES, V12, P6643, DOI 10.1158/1078-0432.CCR-06-1759; Potter N, 2008, NEOPLASIA, V10, P757, DOI 10.1593/neo.07914; Ray D, 2008, CANCER RES, V68, P1251, DOI 10.1158/0008-5472.CAN-07-5983; Shang C, 2007, CHINESE MED J-PEKING, V120, P385, DOI 10.1097/00029330-200703010-00007; Shang C, 2010, MED SCI MONITOR, V16, pBR168; Sinha S, 2008, ANN SURG ONCOL, V15, P1070, DOI 10.1245/s10434-007-9790-0; Tripathi A, 2003, INT J GYNECOL CANCER, V13, P472, DOI 10.1046/j.1525-1438.2003.13330.x; Wang ZQ, 2002, J BIOL CHEM, V277, P19470, DOI 10.1074/jbc.M201097200; Xu YR, 2010, MOL BIOL CELL, V21, P29, DOI 10.1091/mbc.E09-08-0710; Zhang BY, 2005, ONCOGENE, V24, P2585, DOI 10.1038/sj.onc.1208453	27	54	56	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2013	8	5							e63440	10.1371/journal.pone.0063440	http://dx.doi.org/10.1371/journal.pone.0063440			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	143FO	23675485	Green Published, Green Submitted, gold			2022-12-27	WOS:000318852400040
J	Waisberg, M; Lin, CK; Huang, CY; Pena, M; Orandle, M; Bolland, S; Pierce, SK				Waisberg, Michael; Lin, Christina K.; Huang, Chiung-Yu; Pena, Mirna; Orandle, Marlene; Bolland, Silvia; Pierce, Susan K.			The Impact of Genetic Susceptibility to Systemic Lupus Erythematosus on Placental Malaria in Mice	PLOS ONE			English	Article							FALCIPARUM-MALARIA; CEREBRAL MALARIA; PROGNOSTIC-SIGNIFICANCE; CLINICAL-IMPLICATIONS; AUTOIMMUNE DISEASE; THROMBOCYTOPENIA; INFECTION; POPULATIONS; PROTECTION; COMPLEMENT	Severe malaria, including cerebral malaria (CM) and placental malaria (PM), have been recognized to have many of the features of uncontrolled inflammation. We recently showed that in mice genetic susceptibility to the lethal inflammatory autoimmune disease, systemic lupus erythematosus (SLE), conferred resistance to CM. Protection appeared to be mediated by immune mechanisms that allowed SLE-prone mice, prior to the onset of overt SLE symptoms, to better control their inflammatory response to Plasmodium infection. Here we extend these findings to ask does SLE susceptibility have 1) a cost to reproductive fitness and/or 2) an effect on PM in mice? The rates of conception for WT and SLE susceptible (SLEs) mice were similar as were the number and viability of fetuses in pregnant WT and SLEs mice indicating that SLE susceptibility does not have a reproductive cost. We found that Plasmodium chabaudi AS (Pc) infection disrupted early stages of pregnancy before the placenta was completely formed resulting in massive decidual necrosis 8 days after conception. Pc-infected pregnant SLEs mice had significantly more fetuses (similar to 1.8 fold) but SLE did not significantly affect fetal viability in infected animals. This was despite the fact that Pc-infected pregnant SLEs mice had more severe symptoms of malaria as compared to Pc-infected pregnant WT mice. Thus, although SLE susceptibility was not protective in PM in mice it also did not have a negative impact on reproductive fitness.	[Waisberg, Michael; Lin, Christina K.; Pena, Mirna; Bolland, Silvia; Pierce, Susan K.] NIAID, Immunogenet Lab, NIH, Rockville, MD 20852 USA; [Huang, Chiung-Yu] NIAID, Biostat Res Branch, NIH, Rockville, MD USA; [Orandle, Marlene] NIAID, Comparat Med Branch, NIH, Rockville, MD USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Waisberg, M (corresponding author), NIAID, Immunogenet Lab, NIH, Rockville, MD 20852 USA.	waisberg@gmail.com		Lin, Christina/0000-0001-9728-6591	National Institute of Allergy and Infectious Diseases, National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001064, ZIGAI001047, ZIAAI000912] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported by the Intramural Research Program of the National Institute of Allergy and Infectious Diseases, National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bae SC, 1998, ARTHRITIS RHEUM-US, V41, P2091, DOI 10.1002/1529-0131(199812)41:12<2091::AID-ART2>3.3.CO;2-4; Bolland S, 2002, J EXP MED, V195, P1167, DOI 10.1084/jem.20020165; Brabin BJ, 2004, PLACENTA, V25, P359, DOI 10.1016/j.placenta.2003.10.019; BURROWS RF, 1993, NEW ENGL J MED, V329, P1463, DOI 10.1056/NEJM199311113292005; BUTCHER GA, 1990, PARASITOL TODAY, V6, P259, DOI 10.1016/0169-4758(90)90186-8; Crocker I, 1999, CLIN DIAGN LAB IMMUN, V6, P587, DOI 10.1128/CDLI.6.4.587-593.1999; Francischetti IMB, 2008, MICROCIRCULATION, V15, P81, DOI 10.1080/10739680701451516; Gerardin P, 2002, AM J TROP MED HYG, V66, P686, DOI 10.4269/ajtmh.2002.66.686; GREENWOO.BM, 1968, LANCET, V2, P380; Greenwood B, 2001, LANCET, V358, P1182, DOI 10.1016/S0140-6736(01)06281-X; GREENWOOD BM, 1970, T ROY SOC TROP MED H, V64, P7; Guyatt HL, 2004, CLIN MICROBIOL REV, V17, P760, DOI 10.1128/CMR.17.4.760-769.2004; HENTATI B, 1994, EUR J IMMUNOL, V24, P8, DOI 10.1002/eji.1830240103; Jallouli M, 2012, LUPUS, V21, P682, DOI 10.1177/0961203312438630; Joos C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009871; Lee SW, 2012, MOD RHEUMATOL; Molokhia M, 2006, LUPUS, V15, P827, DOI 10.1177/0961203306070007; Mullick A, 2004, INFECT IMMUN, V72, P5868, DOI 10.1128/IAI.72.10.5868-5876.2004; Patel SN, 2008, J EXP MED, V205, P1133, DOI 10.1084/jem.20072248; PHANUPHAK P, 1985, CLIN EXP IMMUNOL, V59, P571; Poovassery J, 2006, INFECT IMMUN, V74, P2839, DOI 10.1128/IAI.74.5.2839-2848.2006; REST JR, 1982, T ROY SOC TROP MED H, V76, P410, DOI 10.1016/0035-9203(82)90203-6; Sturfelt G, 2005, RHEUMATOLOGY, V44, P1227, DOI 10.1093/rheumatology/keh719; Umbers AJ, 2011, TRENDS PARASITOL, V27, P168, DOI 10.1016/j.pt.2011.01.007; Waisberg M, 2011, P NATL ACAD SCI USA, V108, P1122, DOI 10.1073/pnas.1017996108; Willcocks LC, 2010, P NATL ACAD SCI USA, V107, P7881, DOI 10.1073/pnas.0915133107; Wu SA, 2013, LUPUS, V22, P279, DOI 10.1177/0961203312474704; Ziakas PD, 2005, ANN RHEUM DIS, V64, P1366, DOI 10.1136/ard.2004.033100	28	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2013	8	5							e62820	10.1371/journal.pone.0062820	http://dx.doi.org/10.1371/journal.pone.0062820			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	143FO	23675429	Green Submitted, gold, Green Published			2022-12-27	WOS:000318852400012
J	Xia, LG; Zhang, ML; Chang, Q; Wang, LZ; Zeng, DL; Zhang, XL; Zhang, ZY; Jiang, XQ				Xia, Lunguo; Zhang, Maolin; Chang, Qing; Wang, Lizhen; Zeng, Deliang; Zhang, Xiuli; Zhang, Zhiyuan; Jiang, Xinquan			Enhanced Dentin-Like Mineralized Tissue Formation by AdShh-Transfected Human Dental Pulp Cells and Porous Calcium Phosphate Cement	PLOS ONE			English	Article							MARROW STROMAL CELLS; MESENCHYMAL STEM-CELLS; OSTEOGENIC DIFFERENTIATION; TOOTH DEVELOPMENT; MATRIX PROTEIN-1; ENGINEERED BONE; GENE-THERAPY; HEDGEHOG; PROLIFERATION; SCAFFOLD	The aim of the present study was to investigate the effect of Sonic hedgehog (Shh) on human dental pulp cells (hDPCs) and the potential of complexes with Shh gene modified hDPCs and porous calcium phosphate cement (CPC) for mineralized tissue formation. hDPCs were cultured and transfected with adenoviral mediated human Shh gene (AdShh). Overexpression of Shh and cell proliferation was tested by real-time PCR analysis, western blotting analysis, and MTT analysis, respectively. The odontoblastic differentiation was assessed by alkaline phosphatase (ALP) activity and real-time PCR analysis on markers of Patched-1 (Ptc-1), Smoothened (Smo), Gli 1, Gli 2, Gli 3, osteocalcin (OCN), dentin matrix protein-1 (DMP-1), and dentin sialophosphoprotein (DSPP). Finally, AdShh-transfected hDPCs were combined with porous CPC and placed subcutaneously in nude mice for 8 and 12 weeks, while AdEGFP-transfected and untransfected hDPCs were treated as control groups. Results indicated that Shh could promote proliferation and odontoblastic differentiation of hDPCs, while Shh/Gli 1 signaling pathway played a key role in this process. Importantly, more mineralized tissue formation was observed in combination with AdShh transfected hDPCs and porous CPC, moreover, the mineralized tissue exhibited dentin-like features such as structures similar to dentin-pulp complex and the positive staining for DSPP protein similar to the tooth tissue. These results suggested that the constructs with AdShh-transfected hDPCs and porous CPC might be a better alternative for dental tissue regeneration.	[Xia, Lunguo; Zhang, Maolin; Zhang, Zhiyuan] Shanghai Jiao Tong Univ, Dept Oral & Maxillofacial Surg, Shanghai Peoples Hosp 9, Sch Med, Shanghai 200030, Peoples R China; [Xia, Lunguo; Zhang, Maolin; Chang, Qing; Zeng, Deliang; Zhang, Xiuli; Zhang, Zhiyuan; Jiang, Xinquan] Shanghai Jiao Tong Univ, Oral Bioengn Lab, Shanghai Peoples Hosp 9, Shanghai Res Inst Stomatol,Sch Med, Shanghai 200030, Peoples R China; [Zeng, Deliang; Jiang, Xinquan] Shanghai Jiao Tong Univ, Dept Prosthodont, Shanghai Peoples Hosp 9, Sch Med, Shanghai 200030, Peoples R China; [Wang, Lizhen] Shanghai Jiao Tong Univ, Dept Oral Pathol, Shanghai Peoples Hosp 9, Sch Med, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University	Zhang, ZY (corresponding author), Shanghai Jiao Tong Univ, Dept Oral & Maxillofacial Surg, Shanghai Peoples Hosp 9, Sch Med, Shanghai 200030, Peoples R China.	zhzhy@omschina.org.cn; xinquanj@yahoo.cn	zhang, zhiyuan/GRS-2141-2022		National Basic Research Program of China (973 Program) [2012CB933600(4)]; National Natural Science Foundation of China [30973342, 81170939]; Science and Technology Commission of Shanghai Municipality [12 nm0501600, 10ZR1418100]; Biomedical Engineering Cross Research Foundation of Shanghai Jiao Tong University School [YG2012MS29]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM)); Biomedical Engineering Cross Research Foundation of Shanghai Jiao Tong University School	This work was supported by National Basic Research Program of China (973 Program, 2012CB933600(4)), National Natural Science Foundation of China (30973342, 81170939), Science and Technology Commission of Shanghai Municipality (12 nm0501600, 10ZR1418100), and Biomedical Engineering Cross Research Foundation of Shanghai Jiao Tong University School (YG2012MS29). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alliot-Licht B, 2005, CELL TISSUE RES, V321, P391, DOI 10.1007/s00441-005-1115-7; Alsanea R, 2011, J ENDODONT, V37, P1092, DOI 10.1016/j.joen.2011.05.019; Cai JQ, 2012, CELL BIOL INT, V36, P349, DOI 10.1042/CBI20110284; Cobourne MT, 2004, DEVELOPMENT, V131, P2875, DOI 10.1242/dev.01163; Dassule HR, 2000, DEVELOPMENT, V127, P4775; DICKENSVENZ SH, 1994, DENT MATER, V10, P100, DOI 10.1016/0109-5641(94)90048-5; Feng JQ, 1998, J BIOL CHEM, V273, P9457, DOI 10.1074/jbc.273.16.9457; Gronthos S, 2000, P NATL ACAD SCI USA, V97, P13625, DOI 10.1073/pnas.240309797; Jackman WR, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-119; James AW, 2010, TISSUE ENG PT A, V16, P2605, DOI [10.1089/ten.tea.2010.0048, 10.1089/ten.TEA.2010.0048]; Janebodin K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027526; Jiang X, 2006, INT J ORAL MAX SURG, V35, P1133, DOI 10.1016/j.ijom.2006.07.005; Jiang XQ, 2009, BIOMATERIALS, V30, P4522, DOI 10.1016/j.biomaterials.2009.05.021; Kang R, 2000, CLIN ORTHOP RELAT R, P324; LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529; Lee SK, 2010, J ENDODONT, V36, P1537, DOI 10.1016/j.joen.2010.04.027; Li Y, 2011, Adv Dent Res, V23, P280, DOI 10.1177/0022034511405387; Liu QH, 2008, BIOMATERIALS, V29, P4792, DOI 10.1016/j.biomaterials.2008.08.039; Lopez-Cazaux S, 2006, EUR CELLS MATER, V11, P35, DOI 10.22203/eCM.v011a05; Lu KG, 2012, CELL BIOL INT, V36, P119, DOI 10.1042/CBI20100848; Lye KW, 2009, TISSUE ENG PART B-RE, V15, P485, DOI 10.1089/ten.TEB.2009.0139; MacDougall M, 1996, CONNECT TISSUE RES, V35, P267, DOI 10.3109/03008209609029200; Martinez C, 2011, J DENT RES, V90, P483, DOI 10.1177/0022034510391797; Nakashima M, 2005, J ENDODONT, V31, P711, DOI 10.1097/01.don.0000164138.49923.e5; Nakatomi M, 2006, J DENT RES, V85, P427, DOI 10.1177/154405910608500506; Neumann CJ, 2005, CELL CYCLE, V4, P1139, DOI 10.4161/cc.4.9.1999; Reiser J, 2005, EXPERT OPIN BIOL TH, V5, P1571, DOI 10.1517/14712598.5.12.1571; Spinella-Jaegle S, 2001, J CELL SCI, V114, P2085; Stagg J, 2004, HUM GENE THER, V15, P597, DOI 10.1089/104303404323142042; Stitzel J, 2006, BIOMATERIALS, V27, P1088, DOI 10.1016/j.biomaterials.2005.07.048; Takahashi S, 2007, BIOCHEM BIOPH RES CO, V353, P405, DOI 10.1016/j.bbrc.2006.12.053; Tonomura A, 2007, CONNECT TISSUE RES, V48, P229, DOI 10.1080/03008200701507909; Wang J, 2011, BIOMATERIALS, V32, P7822, DOI 10.1016/j.biomaterials.2011.04.034; Xia LU, 2011, CELLS TISSUES ORGANS, V194, P481, DOI 10.1159/000323918; Xia LG, 2011, CALCIFIED TISSUE INT, V89, P53, DOI 10.1007/s00223-011-9493-1; Yang B, 2012, BIOMATERIALS, V33, P2449, DOI 10.1016/j.biomaterials.2011.11.074; Yang X, 2009, J DENT RES, V88, P1020, DOI 10.1177/0022034509346258; Zhang L, 2008, J MOL HISTOL, V39, P87, DOI 10.1007/s10735-007-9132-3; Zhang YD, 2005, CELL RES, V15, P301, DOI 10.1038/sj.cr.7290299; Zou DR, 2012, TISSUE ENG PT A, V18, P1464, DOI [10.1089/ten.tea.2011.0501, 10.1089/ten.TEA.2011.0501]	40	10	10	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2013	8	5							e62645	10.1371/journal.pone.0062645	http://dx.doi.org/10.1371/journal.pone.0062645			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	143FO	23675415	Green Published, Green Submitted, gold			2022-12-27	WOS:000318852400007
J	Cordones, I; Gomez, CM; Escudero, M				Cordones, Isabel; Gomez, Carlos M.; Escudero, Miguel			Cortical Dynamics during the Preparation of Antisaccadic and Prosaccadic Eye Movements in Humans in a Gap Paradigm	PLOS ONE			English	Article							EVENT-RELATED POTENTIALS; SUPERIOR COLLICULUS; WORKING-MEMORY; ANTERIOR CINGULATE; EPISODIC RETRIEVAL; EXPRESS SACCADES; BLIND SEPARATION; FIXATION POINT; REACTION-TIMES; ANTI-SACCADES	To compare the cortical dynamics of different oculomotor tasks, EEG and eye movements were recorded in 21 volunteers. Using a comprehensive approach, subjects were asked to perform saccadic tasks, which included a saccadic eye movement to a peripheral target (prosaccadic), a movement to the opposite side (antisaccadic), or maintain the gaze fixed (no-go). In mixed trials, prosaccadic, antisaccadic and no-go tasks were indicated by a color square (S1) present for 1900-2500 ms (instructive period). S1 disappeared for 370 ms (gap) and a black dot at 8 deg at right or left indicated the beginning of the task. Reaction times, amplitude of eye movements and number of errors were greatest in antisaccadic tasks, suggesting a greater difficulty. The EEG showed a contingent negativity variation (CNV) that increased progressively along the instructive period and suddenly during the gap: higher in antisaccadic, followed by prosaccadic and no-go tasks. Principal component analysis (PCA) disentangled fronto-central and occipital CNV-related and fronto-central gap-related components. The instructive period was characterized by fronto-central and occipital beta desynchronization (ERD) higher in antisaccadic than in no-go and parieto-occipital alpha synchronization higher in no-go than in antisaccadic tasks. During the gap, parieto-occipital beta and alpha ERD were higher in antisaccadic compared to no-go. The gap was further characterized by a fronto-central increase of inter-trial coherence in theta: highest during antisaccadic, followed by prosaccadic and no-go tasks. This phase locking in theta was also accompanied by theta ERS, which was significantly higher in antisaccadic than in the other two tasks. In PCA of spectral power two main components had dynamics similar to those extracted from voltage data, suggesting cross-frequency coupling. These results suggest that the more difficult saccadic tasks are associated with top-down control mediated by frontal cortex, while simpler tasks rely more on bottom-up control mediated by posterior cortices.	[Cordones, Isabel; Escudero, Miguel] Univ Seville, Fac Biol, Dept Fisiol, Neurosci & Behav Grp, Seville, Spain; [Gomez, Carlos M.] Univ Seville, Fac Psicol, Dept Psicol Expt, Human Psychobiol Lab, Seville, Spain	University of Sevilla; University of Sevilla	Escudero, M (corresponding author), Univ Seville, Fac Biol, Dept Fisiol, Neurosci & Behav Grp, Seville, Spain.	mescudero@us.es	Escudero, Miguel/E-6335-2010; Cordones, Isabel/L-3284-2017; Gómez, Carlos/C-6461-2011	Escudero, Miguel/0000-0002-0075-8802; Cordones, Isabel/0000-0003-3049-2731; Gómez, Carlos/0000-0001-6399-5066	Consejeria de Innovacion, Ciencia y Empresa of the Junta de Andalucia [P07-CVI-02717, P09-CVI-4712]; Ministerio de Ciencia e Innovacion, Spain [MCYT-BFU2008-04537, SAF2009-10560]; European Union	Consejeria de Innovacion, Ciencia y Empresa of the Junta de Andalucia(Junta de Andalucia); Ministerio de Ciencia e Innovacion, Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); European Union(European Commission)	research was supported by grants P07-CVI-02717 and P09-CVI-4712 from the Consejeria de Innovacion, Ciencia y Empresa of the Junta de Andalucia, and the MCYT-BFU2008-04537 and SAF2009-10560 from the Ministerio de Ciencia e Innovacion, Spain and co-financed by FEDER founds from the European Union. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agam Y, 2010, NEUROIMAGE, V52, P336, DOI 10.1016/j.neuroimage.2010.04.010; BELL AJ, 1995, NEURAL COMPUT, V7, P1129, DOI 10.1162/neco.1995.7.6.1129; Benjamini Y, 2001, ANN STAT, V29, P1165; Botvinick MM, 2001, PSYCHOL REV, V108, P624, DOI 10.1037//0033-295X.108.3.624; Brown MRG, 2007, J NEUROPHYSIOL, V98, P1751, DOI 10.1152/jn.00460.2007; Brown MRG, 2006, NEUROIMAGE, V33, P644, DOI 10.1016/j.neuroimage.2006.07.002; Brunia CHM, 2001, INT J PSYCHOPHYSIOL, V43, P59, DOI 10.1016/S0167-8760(01)00179-9; Cherkasova MV, 2002, EXP BRAIN RES, V144, P528, DOI 10.1007/s00221-002-1075-z; Connolly JD, 2002, NAT NEUROSCI, V5, P1345, DOI 10.1038/nn969; Curtis CE, 2003, J COGNITIVE NEUROSCI, V15, P409, DOI 10.1162/089892903321593126; Deiber MP, 2007, J COGNITIVE NEUROSCI, V19, P158, DOI 10.1162/jocn.2007.19.1.158; Delinte A, 2002, NEUROSCI RES, V42, P21, DOI 10.1016/S0168-0102(01)00300-5; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; DeSouza JFX, 2003, J NEUROPHYSIOL, V89, P1016, DOI 10.1152/jn.00562.2002; Dorris MC, 1997, J NEUROSCI, V17, P8566; Engbert R, 2003, VISION RES, V43, P1035, DOI 10.1016/S0042-6989(03)00084-1; Everling S, 1999, J NEUROSCI, V19, P2740; Everling S, 1998, EXP BRAIN RES, V118, P27, DOI 10.1007/s002210050252; Everling S, 1996, EXP BRAIN RES, V111, P139; Everling S, 1997, ELECTROEN CLIN NEURO, V102, P356, DOI 10.1016/S0013-4694(96)96569-4; Fairclough SH, 2005, INT J PSYCHOPHYSIOL, V56, P171, DOI 10.1016/j.ijpsycho.2004.11.003; FISCHER B, 1987, NEUROPSYCHOLOGIA, V25, P73, DOI 10.1016/0028-3932(87)90044-3; FISCHER B, 1993, EXP BRAIN RES, V92, P528; Flores AB, 2009, BRAIN COGNITION, V71, P129, DOI 10.1016/j.bandc.2009.04.011; Ford KA, 2005, J NEUROPHYSIOL, V94, P429, DOI 10.1152/jn.00471.2004; Funderud I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048504; Gomez C, 1998, BIOL PSYCHOL, V47, P77, DOI 10.1016/S0301-0511(97)00022-7; GOMEZ C, 1994, PERG S NEUR, P109; GOMEZ C, 1995, NEUROSCI LETT, V186, P107, DOI 10.1016/0304-3940(95)11296-9; Gomez C, 1996, INT J PSYCHOPHYSIOL, V23, P91, DOI 10.1016/0167-8760(96)00034-7; Gomez CM, 2006, BRAIN RES, V1107, P151, DOI 10.1016/j.brainres.2006.06.019; Gorsuch R., 1983, FACTOR ANAL; HALLETT PE, 1978, VISION RES, V18, P1279, DOI 10.1016/0042-6989(78)90218-3; Hari R, 1997, INT J PSYCHOPHYSIOL, V26, P51, DOI 10.1016/S0167-8760(97)00755-1; Irving EL, 2009, BRAIN RES, V1255, P67, DOI 10.1016/j.brainres.2008.12.006; Johnston K, 2007, NEURON, V53, P453, DOI 10.1016/j.neuron.2006.12.023; KINGSTONE A, 1993, PERCEPT PSYCHOPHYS, V54, P260, DOI 10.3758/BF03211762; Klein C, 2000, EXP BRAIN RES, V135, P141, DOI 10.1007/s002210000506; Klein C, 2000, BIOL PSYCHIAT, V47, P978, DOI 10.1016/S0006-3223(00)00234-1; KLEIN RM, 1995, PERCEPT PSYCHOPHYS, V57, P573, DOI 10.3758/BF03213082; Klimesch W, 2006, CEREB CORTEX, V16, P280, DOI 10.1093/cercor/bhi107; KLIMESCH W, 1994, ELECTROEN CLIN NEURO, V91, P428, DOI 10.1016/0013-4694(94)90164-3; Klimesch W, 1996, NEUROREPORT, V7, P1235, DOI 10.1097/00001756-199605170-00002; Klimesch W, 2001, COGNITIVE BRAIN RES, V12, P33, DOI 10.1016/S0926-6410(01)00024-6; Klimesch W, 2001, NEUROSCI LETT, V302, P49, DOI 10.1016/S0304-3940(01)01656-1; Lakatos P, 2008, SCIENCE, V320, P110, DOI 10.1126/science.1154735; Makeig S, 2002, SCIENCE, V295, P690, DOI 10.1126/science.1066168; Makeig S, 1996, COGNITIVE BRAIN RES, V4, P15, DOI 10.1016/0926-6410(95)00042-9; Makeig S, 1997, P NATL ACAD SCI USA, V94, P10979, DOI 10.1073/pnas.94.20.10979; MAKEIG S, 1993, ELECTROEN CLIN NEURO, V86, P283, DOI 10.1016/0013-4694(93)90110-H; May PJ, 2006, PROG BRAIN RES, V151, P321, DOI 10.1016/S0079-6123(05)51011-2; Missonnier P, 2006, J NEURAL TRANSM, V113, P1477, DOI 10.1007/s00702-005-0443-9; Munoz DP, 2004, NAT REV NEUROSCI, V5, P218, DOI 10.1038/nrn1345; Pare M, 1996, J NEUROPHYSIOL, V76, P3666, DOI 10.1152/jn.1996.76.6.3666; PFURTSCHELLER G, 1977, ELECTROEN CLIN NEURO, V42, P817, DOI 10.1016/0013-4694(77)90235-8; PFURTSCHELLER G, 1992, J CLIN NEUROPHYSIOL, V9, P120, DOI 10.1097/00004691-199201000-00013; Pfurtscheller G, 1999, CLIN NEUROPHYSIOL, V110, P1842, DOI 10.1016/S1388-2457(99)00141-8; PIERROTDESEILLIGNY C, 1991, J NEUROL NEUROSUR PS, V54, P1106, DOI 10.1136/jnnp.54.12.1106; REUTERLORENZ PA, 1991, PERCEPT PSYCHOPHYS, V49, P167, DOI 10.3758/BF03205036; ROBERTS RJ, 1994, J EXP PSYCHOL GEN, V123, P374, DOI 10.1037/0096-3445.123.4.374; SASLOW MG, 1967, J OPT SOC AM, V57, P1030, DOI 10.1364/JOSA.57.001030; Sauseng P, 2010, NEUROSCI BIOBEHAV R, V34, P1015, DOI 10.1016/j.neubiorev.2009.12.006; Spantekow A, 1999, EXP BRAIN RES, V127, P291, DOI 10.1007/s002210050798; Sparks D, 2000, VISION RES, V40, P2763, DOI 10.1016/S0042-6989(00)00133-4; TallonBaudry C, 1996, J NEUROSCI, V16, P4240; Weerts T C, 1973, Biol Psychol, V1, P1, DOI 10.1016/0301-0511(73)90010-0	66	16	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2013	8	5							e63751	10.1371/journal.pone.0063751	http://dx.doi.org/10.1371/journal.pone.0063751			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	155HD	23671699	Green Submitted, Green Published, gold			2022-12-27	WOS:000319737700059
J	Laird, RM; Wolf, BJ; Princiotta, MF; Hayes, SM				Laird, Renee M.; Wolf, Benjamin J.; Princiotta, Michael F.; Hayes, Sandra M.			gamma delta T Cells Acquire Effector Fates in the Thymus and Differentiate into Cytokine-Producing Effectors in a Listeria Model of Infection Independently of CD28 Costimulation	PLOS ONE			English	Article							MONOCYTOGENES INFECTION; THYMOCYTE DEVELOPMENT; B7-CD28 INTERACTION; INTERFERON-GAMMA; GLUCOSE-UPTAKE; ALPHA-BETA; PRE-T; EXPRESSION; LYMPHOCYTES; ACTIVATION	Both antigen recognition and CD28 costimulation are required for the activation of naive alpha beta T cells and their subsequent differentiation into cytokine-producing or cytotoxic effectors. Notably, this two-signal paradigm holds true for all alpha beta T cell subsets, regardless of whether they acquire their effector function in the periphery or the thymus. Because of contradictory results, however, it remains unresolved as to whether CD28 costimulation is necessary for gamma delta T cell activation and differentiation. Given that gamma delta T cells have been recently shown to acquire their effector fates in the thymus, it is conceivable that the contradictory results may be explained, in part, by a differential requirement for CD28 costimulation in the development or differentiation of each gamma delta T cell effector subset. To test this, we examined the role of CD28 in gamma delta T cell effector fate determination and function. We report that, although IFN gamma-producing gamma delta T (gamma delta-IFN gamma) cells express higher levels of CD28 than IL-17-producing gamma delta T (gamma delta-17) cells, CD28-deficiency had no effect on the thymic development of either subset. Also, following Listeria infection, we found that the expansion and differentiation of gamma delta-17 and gamma delta-IFN gamma effectors were comparable between CD28(+/+) and CD28(-/-) mice. To understand why CD28 costimulation is dispensable for gamma delta T cell activation and differentiation, we assessed glucose uptake and utilization by gamma delta T cells, as CD28 costimulation is known to promote glycolysis in alpha beta T cells. Importantly, we found that gamma delta T cells express higher surface levels of glucose transporters than alpha beta T cells and, when activated, exhibit effector functions over a broader range of glucose concentrations than activated alpha beta T cells. Together, these data not only demonstrate an enhanced glucose metabolism in gamma delta T cells but also provide an explanation for why gamma delta T cells are less dependent on CD28 costimulation than alpha beta T cells.	[Laird, Renee M.; Wolf, Benjamin J.; Princiotta, Michael F.; Hayes, Sandra M.] SUNY Upstate Med Univ, Dept Microbiol & Immunol, Syracuse, NY 13210 USA	State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center	Hayes, SM (corresponding author), SUNY Upstate Med Univ, Dept Microbiol & Immunol, Syracuse, NY 13210 USA.	HayesSa@upstate.edu			American Heart Association [0835319N]; National Institutes of Health [R21 AI090516-01, R56 AI091908]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI090516, R56AI091908] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Supported by grants from American Heart Association (0835319N) and National Institutes of Health (R21 AI090516-01 and R56 AI091908). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acuto O, 2003, NAT REV IMMUNOL, V3, P939, DOI 10.1038/nri1248; Agosti V, 2004, J EXP MED, V199, P867, DOI 10.1084/jem.20031983; Asano M, 1996, J EXP MED, V184, P387, DOI 10.1084/jem.184.2.387; Awasthi A, 2009, J IMMUNOL, V182, P5904, DOI 10.4049/jimmunol.0900732; Aydintug MK, 2008, MOL IMMUNOL, V45, P3253, DOI 10.1016/j.molimm.2008.02.031; Bautista JL, 2009, NAT IMMUNOL, V10, P610, DOI 10.1038/ni.1739; Benlagha K, 2005, J EXP MED, V202, P485, DOI 10.1084/jem.20050456; Benlagha K, 2002, SCIENCE, V296, P553, DOI 10.1126/science.1069017; BOISE LH, 1995, IMMUNITY, V3, P87, DOI 10.1016/1074-7613(95)90161-2; Brzoza KL, 2004, J IMMUNOL, V173, P2641, DOI 10.4049/jimmunol.173.4.2641; Butte MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040032; ELASED K, 1994, INFECT IMMUN, V62, P5157, DOI 10.1128/IAI.62.11.5157-5160.1994; Frauwirth KA, 2002, IMMUNITY, V16, P769, DOI 10.1016/S1074-7613(02)00323-0; Fu YC, 2004, BLOOD CELL MOL DIS, V32, P182, DOI 10.1016/j.bcmd.2003.09.002; Ganguly A, 2007, AM J PHYSIOL-ENDOC M, V292, pE1241, DOI 10.1152/ajpendo.00344.2006; Haas J, 2009, NATION, V289, P6; Hamada S, 2008, J IMMUNOL, V181, P3456, DOI 10.4049/jimmunol.181.5.3456; Hamada S, 2008, IMMUNOLOGY, V125, P170, DOI 10.1111/j.1365-2567.2008.02841.x; HARDING FA, 1992, NATURE, V356, P607, DOI 10.1038/356607a0; Hayes SM, 2005, IMMUNITY, V22, P583, DOI 10.1016/j.immuni.2005.03.014; Hayes SM, 2002, IMMUNITY, V16, P827, DOI 10.1016/S1074-7613(02)00320-5; Huang JX, 2005, J IMMUNOL, V175, P4858, DOI 10.4049/jimmunol.175.8.4858; Jacobs SR, 2008, J IMMUNOL, V180, P4476, DOI 10.4049/jimmunol.180.7.4476; JENKINS MK, 1991, J IMMUNOL, V147, P2461; Jensen KDC, 2008, IMMUNITY, V29, P90, DOI 10.1016/j.immuni.2008.04.022; Kang JS, 1998, IMMUNITY, V8, P713, DOI 10.1016/S1074-7613(00)80576-2; Laird RM, 2010, J IMMUNOL, V185, P6518, DOI 10.4049/jimmunol.1002766; Laird RM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008899; Li C, 1999, INFECT IMMUN, V67, P4435, DOI 10.1128/IAI.67.9.4435-4442.1999; Lind EF, 2001, J EXP MED, V194, P127, DOI 10.1084/jem.194.2.127; LINDSTEN T, 1989, SCIENCE, V244, P339, DOI 10.1126/science.2540528; Maratou E, 2007, EUR J CLIN INVEST, V37, P282, DOI 10.1111/j.1365-2362.2007.01786.x; Marko AJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015425; Martin B, 2009, IMMUNITY, V31, P321, DOI 10.1016/j.immuni.2009.06.020; Meeks KD, 2009, J IMMUNOL, V183, P8026, DOI 10.4049/jimmunol.0901588; Miller J, 2009, IMMUNOL RES, V45, P159, DOI 10.1007/s12026-009-8097-6; Mittrucker HW, 2001, J IMMUNOL, V167, P5620, DOI 10.4049/jimmunol.167.10.5620; Park K, 2010, EMBO J, V29, P2329, DOI 10.1038/emboj.2010.113; Pellicci DG, 2002, J EXP MED, V195, P835, DOI 10.1084/jem.20011544; PESCHON JJ, 1994, J EXP MED, V180, P1955, DOI 10.1084/jem.180.5.1955; Rathmell JC, 2000, MOL CELL, V6, P683, DOI 10.1016/S1097-2765(00)00066-6; Ribot JC, 2012, J IMMUNOL, V189, P1202, DOI 10.4049/jimmunol.1200268; Ribot JC, 2009, NAT IMMUNOL, V10, P427, DOI 10.1038/ni.1717; Shah DK, 2004, J IMMUNOL, V172, P2296, DOI 10.4049/jimmunol.172.4.2296; Shedlock DJ, 2003, J IMMUNOL, V170, P2053, DOI 10.4049/jimmunol.170.4.2053; Silva-Santos B, 2005, SCIENCE, V307, P925, DOI 10.1126/science.1103978; SIM GK, 1995, J IMMUNOL, V154, P5821; Simpson IA, 2008, AM J PHYSIOL-ENDOC M, V295, pE242, DOI 10.1152/ajpendo.90388.2008; Sutton CE, 2009, IMMUNITY, V31, P331, DOI 10.1016/j.immuni.2009.08.001; Tai XG, 2005, NAT IMMUNOL, V6, P152, DOI 10.1038/ni1160; TAN P, 1993, J EXP MED, V177, P165, DOI 10.1084/jem.177.1.165; Teague TK, 2010, INT IMMUNOL, V22, P387, DOI 10.1093/intimm/dxq020; Telford W, 2005, CYTOM PART A, V68A, P36, DOI 10.1002/cyto.a.20182; vonFreedenJeffry U, 1997, IMMUNITY, V7, P147, DOI 10.1016/S1074-7613(00)80517-8; WILDER MS, 1967, J BACTERIOL, V93, P538, DOI 10.1128/JB.93.2.538-543.1967; Williams JA, 2005, J IMMUNOL, V175, P4199, DOI 10.4049/jimmunol.175.7.4199; Williams JA, 2008, J IMMUNOL, V181, P907, DOI 10.4049/jimmunol.181.2.907; Wofford JA, 2008, BLOOD, V111, P2101, DOI 10.1182/blood-2007-06-096297; Wolf BJ, 2011, MOL IMMUNOL, V48, P463, DOI 10.1016/j.molimm.2010.10.002; Wolf BJ, 2013, J IMMUNOL; Xu S, 2010, J IMMUNOL, V185, P5879, DOI 10.4049/jimmunol.1001763; Yu Q, 2003, J EXP MED, V197, P475, DOI 10.1084/jem.20021765; Zheng XC, 2004, J IMMUNOL, V173, P2253, DOI 10.4049/jimmunol.173.4.2253; Zheng XC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002703	64	14	14	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2013	8	5							e63178	10.1371/journal.pone.0063178	http://dx.doi.org/10.1371/journal.pone.0063178			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	155HD	23671671	Green Submitted, Green Published, gold			2022-12-27	WOS:000319737700049
J	Barbizan, R; Castro, MV; Rodrigues, AC; Barraviera, B; Ferreira, RS; Oliveira, ALR				Barbizan, Roberta; Castro, Mateus V.; Rodrigues, Antonio C.; Barraviera, Benedito; Ferreira, Rui S.; Oliveira, Alexandre L. R.			Motor Recovery and Synaptic Preservation after Ventral Root Avulsion and Repair with a Fibrin Sealant Derived from Snake Venom	PLOS ONE			English	Article							CROTALUS-DURISSUS-TERRIFICUS; SPINAL-CORD IMPLANTATION; REDUCES MOTONEURON DEATH; FOCAL CEREBRAL-ISCHEMIA; BRACHIAL-PLEXUS INJURY; BLOOD-BRAIN-BARRIER; CNS SCAR TISSUE; FUNCTIONAL RECOVERY; ADULT-RAT; REGENERATION	Background: Ventral root avulsion is an experimental model of proximal axonal injury at the central/peripheral nervous system interface that results in paralysis and poor clinical outcome after restorative surgery. Root reimplantation may decrease neuronal degeneration in such cases. We describe the use of a snake venom-derived fibrin sealant during surgical reconnection of avulsed roots at the spinal cord surface. The present work investigates the effects of this fibrin sealant on functional recovery, neuronal survival, synaptic plasticity, and glial reaction in the spinal motoneuron microenvironment after ventral root reimplantation. Methodology/Principal Findings: Female Lewis rats (7 weeks old) were subjected to VRA and root replantation. The animals were divided into two groups: 1) avulsion only and 2) replanted roots with fibrin sealant derived from snake venom. Post-surgical motor performance was evaluated using the CatWalk system twice a week for 12 weeks. The rats were sacrificed 12 weeks after surgery, and their lumbar intumescences were processed for motoneuron counting and immunohistochemistry (GFAP, Iba-1 and synaptophysin antisera). Array based qRT-PCR was used to evaluate gene regulation of several neurotrophic factors and receptors as well as inflammatory related molecules. The results indicated that the root reimplantation with fibrin sealant enhanced motor recovery, preserved the synaptic covering of the motoneurons and improved neuronal survival. The replanted group did not show significant changes in microglial response compared to VRA-only. However, the astroglial reaction was significantly reduced in this group. Conclusions/Significance: In conclusion, the present data suggest that the repair of avulsed roots with snake venom fibrin glue at the exact point of detachment results in neuroprotection and preservation of the synaptic network at the microenvironment of the lesioned motoneurons. Also such procedure reduced the astroglial reaction and increased mRNA levels to neurotrophins and anti-inflammatory cytokines that may in turn, contribute to improving recovery of motor function.	[Barbizan, Roberta; Castro, Mateus V.; Oliveira, Alexandre L. R.] Univ Estadual Campinas, UNICAMP, Dept Struct & Funct Biol, Lab Nerve Regenerat, Campinas, SP, Brazil; [Rodrigues, Antonio C.] FOB USP, Bauru, Brazil; [Barraviera, Benedito; Ferreira, Rui S.] CEVAP Unesp, Botucatu, SP, Brazil	Universidade Estadual de Campinas	Oliveira, ALR (corresponding author), Univ Estadual Campinas, UNICAMP, Dept Struct & Funct Biol, Lab Nerve Regenerat, Campinas, SP, Brazil.	alroliv@unicamp.br	Oliveira, Alexandre L. R./C-4436-2012; Ferreira, Rui Seabra/R-5920-2019; Oliveira, Alexandre/AAI-6815-2020; Barraviera, Benedito/C-6511-2012; Ferreira, Rui Seabra/D-1285-2012; Castro, Mateus Vidigal de/CAA-2167-2022; Rodrigues, Antonio/G-6851-2012; Ferreira, Rui/D-1285-2012	Oliveira, Alexandre L. R./0000-0003-4224-4575; Ferreira, Rui Seabra/0000-0001-6952-0512; Oliveira, Alexandre/0000-0003-4224-4575; Barraviera, Benedito/0000-0002-9855-5594; Ferreira, Rui Seabra/0000-0001-6952-0512; Castro, Mateus Vidigal de/0000-0002-8895-652X; Ferreira, Rui/0000-0003-1856-2792	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo - FAPESP [2010/0986-5, 2013/06574-9, 2010/00729-2]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq [563582/2010-3]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior CAPES (AUX-PE Toxinology) [1219/2011, 23038.000823/2011-21]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo - FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior CAPES (AUX-PE Toxinology)	The present work was supported by grants from: Fundacao de Amparo a Pesquisa do Estado de Sao Paulo - FAPESP (2010/0986-5, 2013/06574-9), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq (563582/2010-3) and Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior CAPES (AUX-PE Toxinology 1219/2011, 23038.000823/2011-21). RSF is a CNPq DTI fellow researcher (310207/2011-8). ALRO is a CNPq fellow researcher (300789/2009-2). RB was supported by a scholarship from Fundacao de Amparo a Pesquisa do Estado de Sao Paulo - FAPESP (2010/00729-2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABERCROMBIE M, 1946, J ANAT, V80, P37; Aldskogius H, 1999, J NEUROSCI RES, V58, P33, DOI 10.1002/(SICI)1097-4547(19991001)58:1<33::AID-JNR5>3.3.CO;2-D; ALEXANDER G, 1988, TOXICON, V26, P953, DOI 10.1016/0041-0101(88)90260-7; Arvanian VL, 2001, EUR J NEUROSCI, V14, P1800, DOI 10.1046/j.0953-816x.2001.01811.x; Asher R A, 2001, Prog Brain Res, V132, P611; BAIN JR, 1989, PLAST RECONSTR SURG, V83, P129, DOI 10.1097/00006534-198901000-00024; Barrabin H, 1978, TOXINS ANIMALS PLANT, P133; Barros LC, 2009, J TOXICOL ENV HEAL B, V12, P553, DOI 10.1080/10937400903442514; Bigbee AJ, 2007, EXP NEUROL, V204, P273, DOI 10.1016/j.expneurol.2006.11.003; Bitar-Alatorre WE, 2011, NEUROSCI LETT, V491, P18, DOI 10.1016/j.neulet.2010.12.062; Brannstrom T, 1998, EXP BRAIN RES, V118, P1, DOI 10.1007/s002210050249; CARLSTEDT T, 1986, ACTA PHYSIOL SCAND, V128, P645, DOI 10.1111/j.1748-1716.1986.tb08024.x; Carlstedt T, 2008, RESTOR NEUROL NEUROS, V26, P225; Carlstedt T, 2009, NEUROSURG CLIN N AM, V20, P39, DOI 10.1016/j.nec.2008.07.020; CARLSTEDT TP, 1993, J NEUROL NEUROSUR PS, V56, P649, DOI 10.1136/jnnp.56.6.649; Colton CA, 2009, J NEUROIMMUNE PHARM, V4, P399, DOI 10.1007/s11481-009-9164-4; CULLHEIM S, 1989, NEUROSCIENCE, V29, P725, DOI 10.1016/0306-4522(89)90144-9; Cullheim S, 2007, BRAIN RES REV, V55, P89, DOI 10.1016/j.brainresrev.2007.03.012; de Vries J, 2002, SURG NEUROL, V57, P415, DOI 10.1016/S0090-3019(02)00736-X; DELGADOGARCIA JM, 1988, NEUROSCIENCE, V24, P143, DOI 10.1016/0306-4522(88)90319-3; Eggers R, 2010, EXP NEUROL, V223, P207, DOI 10.1016/j.expneurol.2009.07.021; Freria CM, 2011, SYNAPSE, V66, P128; FRISEN J, 1993, INT J DEV NEUROSCI, V11, P461, DOI 10.1016/0736-5748(93)90020-E; Gasparini Andréa Licre Pessina, 2007, Acta ortop. bras., V15, P285, DOI 10.1590/S1413-78522007000500011; Gordon T, 2003, J PERIPHER NERV SYST, V8, P236, DOI 10.1111/j.1085-9489.2003.03029.x; Griffiths MR, 2009, J NEUROPATH EXP NEUR, V68, P217, DOI 10.1097/NEN.0b013e3181996688; Hallin RG, 1999, EXP BRAIN RES, V124, P304, DOI 10.1007/s002210050627; Havton LA, 2009, CURR OPIN NEUROL, V22, P570, DOI 10.1097/WCO.0b013e328331b63f; Hoke A, 1996, PROG BRAIN RES, V108, P149, DOI 10.1016/S0079-6123(08)62538-8; Hoke A, 2006, NAT CLIN PRACT NEURO, V2, P448, DOI 10.1038/ncpneuro0262; Kachramanoglou C, 2013, NEUROREHAB NEURAL RE, V27, P118, DOI 10.1177/1545968312457825; Kalmar B, 2002, EXP NEUROL, V176, P87, DOI 10.1006/exnr.2002.7945; Kawano H, 2012, CELL TISSUE RES, V349, P169, DOI 10.1007/s00441-012-1336-5; Kigerl KA, 2009, J NEUROSCI, V29, P13435, DOI 10.1523/JNEUROSCI.3257-09.2009; Kishino A, 1997, EXP NEUROL, V144, P273, DOI 10.1006/exnr.1996.6367; KOLIATSOS VE, 1994, J COMP NEUROL, V342, P35, DOI 10.1002/cne.903420105; Kreutzberg GW, 1996, TRENDS NEUROSCI, V19, P312, DOI 10.1016/0166-2236(96)10049-7; KUNO M, 1970, J PHYSIOL-LONDON, V210, P823, DOI 10.1113/jphysiol.1970.sp009244; Loddick SA, 1998, J CEREBR BLOOD F MET, V18, P176, DOI 10.1097/00004647-199802000-00008; LOWERY OH, 1951, J BIOL CHEM, V193, P265; Marland FS, 1977, CHEM BIOL TROMBIN, P71; MOLANDER C, 1985, J COMP NEUROL, V237, P476, DOI 10.1002/cne.902370405; NOVIKOV L, 1995, NEUROSCI LETT, V200, P45, DOI 10.1016/0304-3940(95)12078-I; Ohlsson M, 2006, EXP BRAIN RES, V170, P52, DOI 10.1007/s00221-005-0188-6; Oliet SHR, 2001, SCIENCE, V292, P923, DOI 10.1126/science.1059162; Oliveira ALR, 2000, NEUROSCI LETT, V293, P131, DOI 10.1016/S0304-3940(00)01506-8; Oliveira ALR, 2004, P NATL ACAD SCI USA, V101, P17843, DOI 10.1073/pnas.0408154101; Penas C, 2011, J NEUROTRAUM, V28, P831, DOI 10.1089/neu.2010.1674; Penas C, 2009, J NEUROTRAUM, V26, P763, DOI [10.1089/neu.2008.0661, 10.1089/neu.2008-0661]; Piehl F, 1999, J NEUROIMMUNOL, V101, P87, DOI 10.1016/S0165-5728(99)00136-8; Pinter S, 2010, J NEUROTRAUM, V27, P2273, DOI 10.1089/neu.2010.1445; PURVES D, 1975, J PHYSIOL-LONDON, V252, P429, DOI 10.1113/jphysiol.1975.sp011151; RISLING M, 1993, BRAIN RES BULL, V30, P405, DOI 10.1016/0361-9230(93)90272-D; RISLING M, 1989, BRAIN RES, V494, P13, DOI 10.1016/0006-8993(89)90138-8; SENDTNER M, 1991, J CELL SCI, P103; Shimazawa M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015307; SJOGREN A, 1991, BRAIN RES, V559, P276, DOI 10.1016/0006-8993(91)90012-K; TAKATA M, 1983, NEUROSCIENCE, V10, P23, DOI 10.1016/0306-4522(83)90077-5; Terzis JK, 2001, WORLD J SURG, V25, P1049, DOI 10.1007/s00268-001-0058-8; Tom VJ, 2004, J NEUROSCI, V24, P6531, DOI 10.1523/JNEUROSCI.0994-04.2004; TOULMOND S, 1992, NEUROSCI LETT, V144, P49, DOI 10.1016/0304-3940(92)90713-H; Unoki M, 2003, INT J ONCOL, V22, P1217; Wang DD, 2008, PROG NEUROBIOL, V86, P342, DOI 10.1016/j.pneurobio.2008.09.015; Wu JC, 2009, J NEUROSURG, V110, P775, DOI 10.3171/2008.8.JNS08328; WU WT, 1993, NEUROSCI LETT, V153, P121, DOI 10.1016/0304-3940(93)90303-3; Yang K, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-S4-S8; Zhang ZH, 2008, NEUROSCI LETT, V444, P227, DOI 10.1016/j.neulet.2008.08.049	67	49	49	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e63260	10.1371/journal.pone.0063260	http://dx.doi.org/10.1371/journal.pone.0063260			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667596	gold, Green Submitted, Green Published			2022-12-27	WOS:000319654700126
J	Berndt, B; Haverkampf, S; Reith, G; Keil, S; Niggemann, B; Zanker, KS; Dittmar, T				Berndt, Benjamin; Haverkampf, Sonja; Reith, Georg; Keil, Silvia; Niggemann, Bernd; Zaenker, Kurt S.; Dittmar, Thomas			Fusion of CCL21 Non-Migratory Active Breast Epithelial and Breast Cancer Cells Give Rise to CCL21 Migratory Active Tumor Hybrid Cell Lines	PLOS ONE			English	Article							CHEMOKINE RECEPTOR CCR7; LYMPH-NODE METASTASIS; TUMORIGENIC HYBRIDS; HEMATOPOIETIC STEM; LIGANDS; ACTIVATION; CXCR4; MACROPHAGES; CHEMOTAXIS; EXPRESSION	The biological phenomenon of cell fusion has been linked to tumor progression because several data provided evidence that fusion of tumor cells and normal cells gave rise to hybrid cell lines exhibiting novel properties, such as increased metastatogenic capacity and an enhanced drug resistance. Here we investigated M13HS hybrid cell lines, derived from spontaneous fusion events between M13SV1-EGFP-Neo breast epithelial cells exhibiting stem cell characteristics and HS578T-Hyg breast cancer cells, concerning CCL21/CCR7 signaling. Western Blot analysis showed that all cell lines varied in their CCR7 expression levels as well as differed in the induction and kinetics of CCR7 specific signal transduction cascades. Flow cytometry-based calcium measurements revealed that a CCL21 induced calcium influx was solely detected in M13HS hybrid cell lines. Cell migration demonstrated that only M13HS hybrid cell lines, but not parental derivatives, responded to CCL21 stimulation with an increased migratory activity. Knockdown of CCR7 expression by siRNA completely abrogated the CCL21 induced migration of hybrid cell lines indicating the necessity of CCL21/CCR7 signaling. Because the CCL21/CCR7 axis has been linked to metastatic spreading of breast cancer to lymph nodes we conclude from our data that cell fusion could be a mechanism explaining the origin of metastatic cancer (hybrid) cells.	[Berndt, Benjamin; Haverkampf, Sonja; Reith, Georg; Keil, Silvia; Niggemann, Bernd; Zaenker, Kurt S.; Dittmar, Thomas] Univ Witten Herdecke, Inst Immunol, Ctr Biomed Educ & Res ZBAF, Witten, Germany	Witten Herdecke University	Dittmar, T (corresponding author), Univ Witten Herdecke, Inst Immunol, Ctr Biomed Educ & Res ZBAF, Witten, Germany.	thomas.dittmar@uni-wh.de	Dittmar, Thomas/T-6679-2019; Dittmar, Thomas/X-3691-2019		Verein zur Forderung der Krebsforschung e.V., Berlin, Germany; Westermann-Westdorp-Foundation, Essen, Germany; Fritz-Bender-Foundation, Munich, Germany	Verein zur Forderung der Krebsforschung e.V., Berlin, Germany; Westermann-Westdorp-Foundation, Essen, Germany; Fritz-Bender-Foundation, Munich, Germany	This work was supported by the Verein zur Forderung der Krebsforschung e.V., Berlin, Germany, the Westermann-Westdorp-Foundation, Essen, Germany and the Fritz-Bender-Foundation, Munich, Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aichel O., 1911, ZELLVERSCHMELZUNG QU; Andersen TL, 2007, J PATHOL, V211, P10, DOI 10.1002/path.2078; Balz LM, 2012, J PATHOL, V227, P234, DOI 10.1002/path.3991; Bardi G, 2001, EUR J IMMUNOL, V31, P3291, DOI 10.1002/1521-4141(200111)31:11<3291::AID-IMMU3291>3.0.CO;2-Z; Berndt Benjamin, 2013, Critical Reviews in Oncogenesis, V18, P97; Borroni EM, 2008, IMMUNOL INVEST, V37, P483, DOI 10.1080/08820130802191318; Britschgi MR, 2010, EUR J IMMUNOL, V40, P1266, DOI 10.1002/eji.200939921; Busund LTR, 2002, INT J CANCER, V100, P407, DOI 10.1002/ijc.10502; Busund LTR, 2002, INT J CANCER, V98, P573, DOI 10.1002/ijc.10249; Cabioglu N, 2005, CLIN CANCER RES, V11, P5686, DOI 10.1158/1078-0432.CCR-05-0014; Castedo M, 2004, ONCOGENE, V23, P2825, DOI 10.1038/sj.onc.1207528; Chakraborty AK, 2001, GENE, V275, P103, DOI 10.1016/S0378-1119(01)00647-3; Chakraborty AK, 2000, CANCER RES, V60, P2512; Chang CC, 2001, RADIAT RES, V155, P201, DOI 10.1667/0033-7587(2001)155[0201:AHBECT]2.0.CO;2; Comerford I, 2007, BIOESSAYS, V29, P237, DOI 10.1002/bies.20537; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Cunningham HD, 2010, TRANSL ONCOL, V3, P354, DOI 10.1593/tlo.10178; Davies PS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006530; Dittma T, 2008, CLIN EXP METASTAS, V25, P11, DOI 10.1007/s10585-007-9095-5; Dittmar T, 2000, ANTISENSE NUCLEIC A, V10, P401, DOI 10.1089/oli.1.2000.10.401; Dittmar T, 2012, CURRENT MOL IN PRESS; Dittmar T, 2011, CELL FUSION HLTH DIS, P1; Dittmar T, 2011, CLIN EXP METASTAS, V28, P75, DOI 10.1007/s10585-010-9359-3; Dittmar T, 2009, MED HYPOTHESES, V73, P542, DOI 10.1016/j.mehy.2009.05.044; Duelli D, 2003, CANCER CELL, V3, P445, DOI 10.1016/S1535-6108(03)00114-4; DVORAK HF, 1986, NEW ENGL J MED, V315, P1650; Forster R, 2008, NAT REV IMMUNOL, V8, P362, DOI 10.1038/nri2297; Gergely L, 1997, CLIN DIAGN LAB IMMUN, V4, P70, DOI 10.1128/CDLI.4.1.70-74.1997; Goldenberg DM, 2012, INT J CANCER, V131, P49, DOI 10.1002/ijc.26327; GOLDENBERG DM, 1974, NATURE, V250, P649, DOI 10.1038/250649a0; GOLDENBERG DM, 1971, CANCER RES, V31, P1148; Gollmer K, 2009, BLOOD, V114, P580, DOI 10.1182/blood-2009-01-200923; Gunn MD, 1998, P NATL ACAD SCI USA, V95, P258, DOI 10.1073/pnas.95.1.258; Haessler U, 2011, P NATL ACAD SCI USA, V108, P5614, DOI 10.1073/pnas.1014920108; Heyder C, 2005, CLIN EXP METASTAS, V22, P99, DOI 10.1007/s10585-005-4335-z; Jacob A, 2002, J BIOL CHEM, V277, P23420, DOI 10.1074/jbc.M202485200; Jacobsen BM, 2006, CANCER RES, V66, P8274, DOI 10.1158/0008-5472.CAN-06-1456; Kassmer SH, 2008, BIOL CHEM, V389, P863, DOI 10.1515/BC.2008.099; Kochetkova M, 2009, CELL DEATH DIFFER, V16, P664, DOI 10.1038/cdd.2008.190; Kohout TA, 2004, J BIOL CHEM, V279, P23214, DOI 10.1074/jbc.M402125200; Kollet O, 2002, BLOOD, V100, P2778, DOI 10.1182/blood-2002-02-0564; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LARIZZA L, 1984, CANCER METAST REV, V3, P193, DOI 10.1007/BF00048385; Li J, 2011, DIGEST LIVER DIS, V43, P40, DOI 10.1016/j.dld.2010.05.013; Liu YX, 2010, J EXP CLIN CANC RES, V29, DOI 10.1186/1756-9966-29-16; LopezIlasaca M, 1997, SCIENCE, V275, P394, DOI 10.1126/science.275.5298.394; Lu X, 2009, CANCER RES, V69, P8536, DOI 10.1158/0008-5472.CAN-09-2159; Lu X, 2009, P NATL ACAD SCI USA, V106, P9385, DOI 10.1073/pnas.0900108106; Luo C, 1998, EXP CELL RES, V243, P282, DOI 10.1006/excr.1998.4170; Mekler L B, 1971, Vestn Akad Med Nauk SSSR, V26, P75; Mekler L B, 1971, Vestn Akad Med Nauk SSSR, V26, P80; MILLER FR, 1989, CANCER RES, V49, P4316; MILLER FR, 1988, J CELL BIOCHEM, V36, P129, DOI 10.1002/jcb.240360204; Nagler C, 2011, CANCER CELL INT, V11, DOI 10.1186/1475-2867-11-21; Ozel C, 2012, CELL COMMUN SIGNAL, V10, DOI 10.1186/1478-811X-10-10; Otero C, 2006, J IMMUNOL, V177, P2314, DOI 10.4049/jimmunol.177.4.2314; Parris GE, 2005, MED HYPOTHESES, V64, P1011, DOI 10.1016/j.mehy.2004.11.012; Pawelek JM, 2008, NAT REV CANCER, V8, P377, DOI 10.1038/nrc2371; Powell AE, 2011, CANCER RES, V71, P1497, DOI 10.1158/0008-5472.CAN-10-3223; Rachkovsky M, 1998, CLIN EXP METASTAS, V16, P299; Rachkovsky M, 1999, CELL GROWTH DIFFER, V10, P517; Rappa G, 2012, AM J PATHOL, V180, P2504, DOI 10.1016/j.ajpath.2012.02.020; Redondo-Munoz J, 2008, BLOOD, V111, P383, DOI 10.1182/blood-2007-08-107300; Sanchez-Sanchez N, 2006, J IMMUNOL, V176, P5153, DOI 10.4049/jimmunol.176.9.5153; Seidel J, 2007, STEM CELLS DEV, V16, P827, DOI 10.1089/scd.2007.0004; Silvestris F, 2011, ADV EXP MED BIOL, V714, P113, DOI 10.1007/978-94-007-0782-5_5; Sullivan SK, 1999, BIOCHEM BIOPH RES CO, V263, P685, DOI 10.1006/bbrc.1999.1442; Townson JR, 2002, EUR J IMMUNOL, V32, P1230, DOI 10.1002/1521-4141(200205)32:5<1230::AID-IMMU1230>3.0.CO;2-L; vonWillebrand M, 1996, EUR J BIOCHEM, V235, P828; WAKELING WF, 1994, CELL BIOL INT, V18, P207, DOI 10.1006/cbir.1994.1063; Wang J, 2005, ONCOGENE, V24, P5897, DOI 10.1038/sj.onc.1208740; Wang RX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042653; Wennstrom S, 1999, MOL CELL BIOL, V19, P4279; Wiley HE, 2001, J NATL CANCER I, V93, P1638, DOI 10.1093/jnci/93.21.1638; Willimann K, 1998, EUR J IMMUNOL, V28, P2025, DOI 10.1002/(SICI)1521-4141(199806)28:06<2025::AID-IMMU2025>3.0.CO;2-C; Yang JY, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-388; Zidar DA, 2009, P NATL ACAD SCI USA, V106, P9649, DOI 10.1073/pnas.0904361106; Zmajkovicova K, 2013, MOL CELL, DOI DOI 10.1016/J.M0LCEL.2013.1001.1037	78	27	28	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e63711	10.1371/journal.pone.0063711	http://dx.doi.org/10.1371/journal.pone.0063711			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667660	Green Published, gold, Green Submitted			2022-12-27	WOS:000319654700178
J	Xue, HH; Qian, JH; Wang, LW; Yuan, XJ; Chen, Y; Wu, WL; Chen, Y; Sun, K				Xue, Haihong; Qian, Jihong; Wang, Lianwen; Yuan, Xiaojun; Chen, Yi; Wu, Weilan; Chen, Yan; Sun, Kun			3C3R Modified PBL Pediatric Teaching of Chinese Medical Students	PLOS ONE			English	Article							CURRICULA	A Content, Context, Connection and Researching, Reasoning, Reflecting (3C3R) model is a conceptual framework for problem-based learning (PBL) problem design. We introduced the 3C3R-PBL method into a pediatric teaching plan, and evaluated its effectiveness and feasibility. The 3C3R model was applied in a pediatric problem design teaching plan "why the lips turn purple when a baby is crying''. All students were assigned either into a traditional PBL course or into a 9-step 3C3R model PBL course (3C3R-PBL). The performance outcomes of both groups were compared. For the PBL group, the proportion of students scoring >= 4 for content, context, and problem design connection, was 90.8%, 80.3%, and 64.5% respectively, while for tutors, it was 71.4%, 71.4%, and 28.6%; for researching, reasoning, and reflecting, the proportion of students scoring >= 4 was 81.6%, 55.3%, and 40.8%, while for tutors, it was 71.4%, 100%, and 57.1%. The learning difficulty was not considered high with only 31.6% of students and 42.9% of tutors rating the task as difficult. For the 3C3R-PBL group, the proportion of students scoring content, context, and connection, >= 4 was 100%, 98.4%, and 90.5%, while for tutors it was 100%, 100%, 83.3%; for researching, reasoning, and reflecting, the proportion of students scoring >= 4 was 95.2%, 88.9%, and 76.2%, while for tutors it was 100% for all 3 R components. Students and tutors were convinced by the content, case context, research process and reasoning process of both teaching plans, while scores for connection and reflecting were significantly improved when the PBL plan was amended by a 3C3R model (p<0.05) and the case learning difficulty was statistically increased (p<0.05). The 3C3R model, evaluated for the first time in China, was helpful for effective and reliable problem design in a pediatric PBL teaching plan for Chinese students.	[Xue, Haihong; Qian, Jihong; Wang, Lianwen; Yuan, Xiaojun; Chen, Yi; Wu, Weilan; Chen, Yan; Sun, Kun] Shanghai Jiao Tong Univ, Dept Pediat, Xinhua Hosp, Sch Med, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University	Sun, K (corresponding author), Shanghai Jiao Tong Univ, Dept Pediat, Xinhua Hosp, Sch Med, Shanghai 200030, Peoples R China.	dr_sunkun@163.com			4th Undergraduate Education Highland; Undergraduate Education, School of Medicine, Shanghai Jiaotong University	4th Undergraduate Education Highland; Undergraduate Education, School of Medicine, Shanghai Jiaotong University	This work was supported by the Project of the 4th Undergraduate Education Highland. The funder participated in study design, decision to publish and preparation of the manuscript. This work was also supported by a research fund for Undergraduate Education, School of Medicine, Shanghai Jiaotong University. The funder participated in study design, data analysis, decision to publish, and preparation of the manuscript.	Alghasham AA, 2012, MED TEACH, V34, pS14, DOI 10.3109/0142159X.2012.656744; Barrows H., 1980, PROBLEM BASED LEARNI; Benedict N, 2010, AM J PHARM EDUC, V74, DOI 10.5688/aj7408143; Bransford J. D, 1999, PEOPLE LEARN BRAIN M; Donovan M. S., 2005, STUDENTS LEARN SCI C; Farnsworth C. C., 1994, P 35 ADCIS C, V2, P137; Gingerich A, 2012, J INTERPROF CARE, V26, P69, DOI 10.3109/13561820.2011.613494; Hung W, 2006, INTERDISCIPLINARY J, V1; Hung W., 2008, HDB RES ED COMMUNICA, P485, DOI DOI 10.1007/978-1-4419-1428-6_; Hung W, 2011, ETR&D-EDUC TECH RES, V59, P529, DOI 10.1007/s11423-011-9198-1; Hung WE, 2009, EDUC RES REV-NETH, V4, P118, DOI 10.1016/j.edurev.2008.12.001; Khan H, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000632; Kirschner PA, 2006, EDUC PSYCHOL-US, V41, P75, DOI 10.1207/s15326985ep4102_1; Malik AS, 2012, MED TEACH, V34, P198, DOI 10.3109/0142159X.2011.588741; McGrath Colman, 2006, J Dent Educ, V70, P387; Okubo Y, 2012, TOHOKU J EXP MED, V227, P23, DOI 10.1620/tjem.227.23; Onyon C, 2012, CLIN TEACH, V9, P22, DOI 10.1111/j.1743-498X.2011.00501.x; Price Kerfoot B, 2005, MED EDUC, V39, P380, DOI 10.1111/j.1365-2929.2005.02105.x; Romero RM, 2010, AM J PHARM EDUC, V74, DOI 10.5688/aj740466; Salinitri FD, 2012, AM J PHARM EDUC, V76, DOI 10.5688/ajpe76344; Sockalingam N, 2011, HIGH EDUC, V62, P1, DOI 10.1007/s10734-010-9361-3; Strohfeldt K, 2010, AM J PHARM EDUC, V74, DOI 10.5688/aj7409173; Tian JH, 2012, MED TEACH, V34, P341, DOI 10.3109/0142159X.2011.531169; Torp L., 2002, PROBLEMS POSSIBILITI, V2nd; Wang G, 2008, J DENT EDUC, V72, P610	25	2	2	3	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e63412	10.1371/journal.pone.0063412	http://dx.doi.org/10.1371/journal.pone.0063412			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667610	Green Published, gold, Green Submitted			2022-12-27	WOS:000319654700138
J	Lou, QF; He, YH; Cheng, CY; Zhang, ZH; Li, J; Huang, SW; Chen, JF				Lou, Qunfeng; He, Yuhua; Cheng, Chunyan; Zhang, Zhonghua; Li, Ji; Huang, Sanwen; Chen, Jinfeng			Integration of High-Resolution Physical and Genetic Map Reveals Differential Recombination Frequency between Chromosomes and the Genome Assembling Quality in Cucumber	PLOS ONE			English	Article							IN-SITU HYBRIDIZATION; CYTOGENETIC MAP; SATIVUS L.; RICE; PACHYTENE; FISH; DNA; REARRANGEMENTS; CONSTRUCTION; CENTROMERE	Cucumber is an important model crop and the first species sequenced in Cucurbitaceae family. Compared to the fast increasing genetic and genomics resources, the molecular cytogenetic researches in cucumber are still very limited, which results in directly the shortage of relation between plenty of physical sequences or genetic data and chromosome structure. We mapped twenty-three fosmids anchored by SSR markers from LG-3, the longest linkage group, and LG-4, the shortest linkage group on pachytene chromosomes 3 and 4, using uorescence in situ hybridization (FISH). Integrated molecular cytogenetic maps of chromosomes 3 and 4 were constructed. Except for three SSR markers located on heterochromatin region, the cytological order of markers was concordant with those on the linkage maps. Distinct structural differences between chromosomes 3 and 4 were revealed by the high resolution pachytene chromosomes. The extreme difference of genetic length between LG-3 and LG-4 was mainly attributed to the difference of overall recombination frequency. The significant differentiation of heterochromatin contents in chromosomes 3 and 4 might have a direct correlation with recombination frequency. Meanwhile, the uneven distribution of recombination frequency along chromosome 4 was observed, and recombination frequency of the long arm was nearly 3.5 times higher than that of the short arm. The severe suppression of recombination was exhibited in centromeric and heterochromatin domains of chromosome 4. Whereas a close correlation between the gene density and recombination frequency was observed in chromosome 4, no significant correlation was observed between them along chromosome 3. The comparison between cytogenetic and sequence maps revealed a large gap on the pericentromeric heterochromatin region of sequence map of chromosome 4. These results showed that integrated molecular cytogenetic maps can provide important information for the study of genetic and genomics in cucumber.	[Lou, Qunfeng; He, Yuhua; Cheng, Chunyan; Li, Ji; Chen, Jinfeng] Nanjing Agr Univ, State Key Lab Crop Genet & Germplasm Enhancement, Nanjing, Jiangsu, Peoples R China; [Zhang, Zhonghua; Huang, Sanwen] Chinese Acad Agr Sci, Inst Vegetables & Flowers, Beijing 100193, Peoples R China	Nanjing Agricultural University; Chinese Academy of Agricultural Sciences; Institute of Vegetables & Flowers, CAAS	Chen, JF (corresponding author), Nanjing Agr Univ, State Key Lab Crop Genet & Germplasm Enhancement, Nanjing, Jiangsu, Peoples R China.	jfchen@njau.edu.cn	Huang, Sanwen/ABE-9053-2020	Huang, Sanwen/0000-0002-8547-5309; zhang, zhonghua/0000-0002-1034-227X	National Basic Research Program of China (973 Program) [2012CB113900]; '863' Programs [2012AA100102]; National Natural Science Foundation of China [U1178307];  [31272174]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); '863' Programs(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 	This research was partially supported by National Basic Research Program of China (973 Program) (2012CB113900); the '863' Programs (2012AA100102); the Program 31272174, and U1178307 from the National Natural Science Foundation of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arumuganathan K, 1991, PLANT MOL BIOL REP, V9, P208, DOI DOI 10.1007/BF02672069; Chen J, 2003, THEOR APPL GENET, V106, P688, DOI 10.1007/s00122-002-1118-7; Cheng ZK, 2001, GENETICS, V157, P1749; Cheng ZK, 2002, CHROMOSOME RES, V10, P379, DOI 10.1023/A:1016849618707; de Jong JH, 1999, TRENDS PLANT SCI, V4, P258; Findley SD, 2010, GENETICS, V185, P727, DOI 10.1534/genetics.109.113753; FLAVELL RB, 1974, BIOCHEM GENET, V12, P257, DOI 10.1007/BF00485947; Guo SG, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-384; Han YH, 2008, CYTOGENET GENOME RES, V122, P80, DOI 10.1159/000151320; Han YH, 2011, BMC GENET, V12, DOI 10.1186/1471-2156-12-18; Havey MJ, 1997, J HERED, V88, P232, DOI 10.1093/oxfordjournals.jhered.a023094; Huang SW, 2009, NAT GENET, V41, P1275, DOI 10.1038/ng.475; Iovene M, 2008, GENETICS, V180, P1307, DOI 10.1534/genetics.108.093179; JEFFREY C, 1980, BOT J LINN SOC, V81, P233, DOI 10.1111/j.1095-8339.1980.tb01676.x; Jiang JM, 2006, GENOME, V49, P1057, DOI 10.1139/G06-076; Kim JS, 2005, GENETICS, V169, P955, DOI 10.1534/genetics.104.026765; Kim JS, 2005, GENETICS, V171, P1963, DOI 10.1534/genetics.105.048215; Kulikova O, 2001, PLANT J, V27, P49, DOI 10.1046/j.1365-313x.2001.01057.x; Kunzel G, 2000, GENETICS, V154, P397; Lou QF, 2010, CHROMOSOMA, V119, P435, DOI 10.1007/s00412-010-0269-6; Ohmido N, 2010, CHROMOSOME RES, V18, P287, DOI 10.1007/s10577-009-9103-5; Ren Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005795; ROBERTS PA, 1965, NATURE, V205, P725, DOI 10.1038/205725b0; Tang XM, 2008, GENETICS, V180, P1319, DOI 10.1534/genetics.108.093211; Treangen TJ, 2012, NAT REV GENET, V13, P36, DOI 10.1038/nrg3117; Wai CM, 2012, CHROMOSOME RES, V20, P753, DOI 10.1007/s10577-012-9312-1; Wang CJR, 2006, PLANT CELL, V18, P529, DOI 10.1105/tpc.105.037838; Woycicki R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022728; Yan HH, 2005, PLANT CELL, V17, P3227, DOI 10.1105/tpc.105.037945; Yang LM, 2012, PLANT J, V71, P895, DOI 10.1111/j.1365-313X.2012.05017.x; Zhang WW, 2012, THEOR APPL GENET, V124, P249, DOI 10.1007/s00122-011-1701-x	31	24	28	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2013	8	5							e62676	10.1371/journal.pone.0062676	http://dx.doi.org/10.1371/journal.pone.0062676			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	177QL	23671621	Green Published, Green Submitted, gold			2022-12-27	WOS:000321390200033
J	Saaristo, M; Tomkins, P; Allinson, M; Allinson, G; Wong, BBM				Saaristo, Minna; Tomkins, Patrick; Allinson, Mayumi; Allinson, Graeme; Wong, Bob B. M.			An Androgenic Agricultural Contaminant Impairs Female Reproductive Behaviour in a Freshwater Fish	PLOS ONE			English	Article							MOSQUITOFISH GAMBUSIA-HOLBROOKI; GROWTH PROMOTER 17-BETA-TRENBOLONE; TRENBOLONE ACETATE; SEXUAL SELECTION; MATE CHOICE; 17-ALPHA-ETHINYL ESTRADIOL; POMATOSCHISTUS-MINUTUS; WESTERN MOSQUITOFISH; EASTERN MOSQUITOFISH; AGGRESSIVE-BEHAVIOR	Endocrine disrupting chemicals (EDCs) are a large group of environmental pollutants that can interfere with the endocrine system function of organisms at very low levels. One compound of great concern is trenbolone, which is widely used as a growth promoter in the cattle industry in many parts of the world. The aim of this study was to test how short-term (21-day) exposure to an environmentally relevant concentration of 17 beta-trenbolone (measured concentration 6 ng/L) affects reproductive behaviour and fin morphology in the eastern mosquitofish (Gambusia holbrooki). The mosquitofish is a sexually dimorphic livebearer with males inseminating females using their modified anal fin, the gonopodium, as an intromittent organ. Although the species has a coercive mating system, females are able to exert some control over the success of male mating attempts by selectively associating with, or avoiding, certain males over others. We found that females exposed to trenbolone approached males less and spent more time swimming away from males than non-exposed (control) females. By contrast, we found no difference in the behaviour of exposed and non-exposed males. Furthermore, exposure did not affect the anal fin morphology of males or females. This is the first study to demonstrate that exposure to an androgenic EDC can impair female (but not male) behaviour. Our study illustrates how anthropogenic contaminants can have sex-specific effects, and highlights the need to examine the behavioural responses of environmental contaminants in both sexes.	[Saaristo, Minna; Tomkins, Patrick; Wong, Bob B. M.] Monash Univ, Sch Biol Sci, Melbourne, Vic 3004, Australia; [Allinson, Mayumi; Allinson, Graeme] Univ Melbourne, CAPIM, Inst Bio21, Melbourne, Vic, Australia; [Allinson, Graeme] DPI, DPI Queenscliff, Melbourne, Vic, Australia	Monash University; University of Melbourne	Saaristo, M (corresponding author), Monash Univ, Sch Biol Sci, Melbourne, Vic 3004, Australia.	minna.saaristo@monash.edu		Wong, Bob/0000-0001-9352-6500; Allinson, Mayumi/0000-0001-9424-4599	Finnish Academy; Australian Research Council; Monash University; Centre for Aquatic Pollution, Identification and Management (CAPIM); Victorian Science Agenda Investment Fund; Melbourne Water, Department of Primary Industries (Victoria); Environment Protection Authority (Victoria)	Finnish Academy(Academy of Finland); Australian Research Council(Australian Research Council); Monash University(Monash University); Centre for Aquatic Pollution, Identification and Management (CAPIM); Victorian Science Agenda Investment Fund; Melbourne Water, Department of Primary Industries (Victoria); Environment Protection Authority (Victoria)	This work was supported by the Finnish Academy, the Australian Research Council, Monash University and The Centre for Aquatic Pollution, Identification and Management (CAPIM). CAPIM is funded by The Victorian Science Agenda Investment Fund managed by the Department of Business and Innovation (DBI) (www.innovation.vic.gov.au) with partner funding contributed from Melbourne Water, Department of Primary Industries (Victoria), and Environment Protection Authority (Victoria). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angus RA, 2001, GEN COMP ENDOCR, V123, P222, DOI 10.1006/gcen.2001.7669; Ankley GT, 2003, ENVIRON TOXICOL CHEM, V22, P1350, DOI [10.1897/1551-5028(2003)022&lt;1350:EOTAGP&gt;2.0.CO;2, 10.1002/etc.5620220623]; Bangsgaard K, 2006, AQUAT TOXICOL, V80, P23, DOI 10.1016/j.aquatox.2006.07.009; Bartelt-Hunt SL, 2012, ENVIRON SCI TECHNOL, V46, P1352, DOI 10.1021/es202680q; Batty J, 1999, ARCH ENVIRON CON TOX, V36, P301, DOI 10.1007/s002449900475; BISAZZA A, 1995, ETHOL ECOL EVOL, V7, P169, DOI 10.1080/08927014.1995.9522963; Bisazza A, 1996, J FISH BIOL, V48, P726, DOI 10.1111/j.1095-8649.1996.tb01468.x; Bisazza A, 2001, BEHAV ECOL, V12, P59, DOI 10.1093/oxfordjournals.beheco.a000379; BORTONE SA, 1994, BIOSCIENCE, V44, P165, DOI 10.2307/1312253; Brockmeier EK, 2013, AQUAT TOXICOL, V128, P163, DOI 10.1016/j.aquatox.2012.12.007; Buchanan KL, 2012, BEHAVIOURAL RESPONSES TO A CHANGING WORLD: MECHANISMS AND CONSEQUENCES, P32; Colman JR, 2009, AQUAT TOXICOL, V91, P346, DOI 10.1016/j.aquatox.2008.12.001; Constantz G.D., 1989, P33; Cunha FEA, 2006, J FISH BIOL, V69, P1504, DOI 10.1111/j.1095-8649.2006.01213.x; Dosen LD, 2004, BEHAV ECOL SOCIOBIOL, V55, P266, DOI 10.1007/s00265-003-0710-4; Doyle CJ, 2005, ECOTOX ENVIRON SAFE, V61, P392, DOI 10.1016/j.ecoenv.2004.10.012; Doyle CJ, 2002, ECOTOX ENVIRON SAFE, V61, P392; Dreze V, 2000, ECOTOXICOLOGY, V9, P93, DOI 10.1023/A:1008976431227; Durhan EJ, 2006, ENVIRON HEALTH PERSP, V114, P65, DOI 10.1289/ehp.8055; Gall HE, 2011, ENVIRON SCI TECHNOL, V45, P8755, DOI 10.1021/es2011435; GUILLETTE LJ, 1994, ENVIRON HEALTH PERSP, V102, P680, DOI 10.2307/3432198; HAYNES JL, 1995, J FISH BIOL, V46, P1026, DOI 10.1111/j.1095-8649.1995.tb01407.x; HERBST AL, 1971, NEW ENGL J MED, V284, P878, DOI 10.1056/NEJM197104222841604; HOWELL WM, 1980, COPEIA, P676; Jensen KM, 2006, ENVIRON SCI TECHNOL, V40, P3112, DOI 10.1021/es052174s; Jobling S, 1998, ENVIRON SCI TECHNOL, V32, P2498, DOI 10.1021/es9710870; Kahn AT, 2010, BIOL LETTERS, V6, P55, DOI 10.1098/rsbl.2009.0637; Larsen MG, 2010, ENVIRON TOXICOL CHEM, V29, P1828, DOI 10.1002/etc.214; Lephart ED, 1996, BRAIN RES REV, V22, P1; Leusch FDL, 2006, ARCH ENVIRON CON TOX, V50, P562, DOI 10.1007/s00244-005-1040-5; Lundholm CE, 1997, COMP BIOCHEM PHYS C, V118, P113, DOI 10.1016/S0742-8413(97)00105-9; Majewski AR, 2002, WATER QUAL RES J CAN, V37, P697, DOI 10.2166/wqrj.2002.047; MARTIN RG, 1975, COPEIA, P445, DOI 10.2307/1443641; Martinovic D, 2007, ENVIRON TOXICOL CHEM, V26, P271, DOI 10.1897/06-065R.1; Maunder RJ, 2007, BIOL REPROD, V77, P999, DOI 10.1095/biolreprod.107.062240; MCPEEK MA, 1992, BEHAV ECOL, V3, P1, DOI 10.1093/beheco/3.1.1; Mills LJ, 2005, SCI TOTAL ENVIRON, V343, P1, DOI 10.1016/j.scitotenv.2004.12.070; Morthorst JE, 2010, AQUAT TOXICOL, V98, P336, DOI 10.1016/j.aquatox.2010.03.008; Orlando EF, 2007, AQUAT TOXICOL, V84, P399, DOI 10.1016/j.aquatox.2007.06.018; Pelletier F, 2012, BEHAVIOURAL RESPONSES TO A CHANGING WORLD: MECHANISMS AND CONSEQUENCES, P159; Pyke GH, 2005, REV FISH BIOL FISHER, V15, P339, DOI 10.1007/s11160-006-6394-x; Quinn MJ, 2007, CHEMOSPHERE, V66, P1191, DOI 10.1016/j.chemosphere.2006.07.085; Saaristo M, 2010, AQUAT TOXICOL, V97, P285, DOI 10.1016/j.aquatox.2009.12.015; Saaristo M, 2010, CHEMOSPHERE, V79, P541, DOI 10.1016/j.chemosphere.2010.02.019; Saaristo M, 2009, HORM BEHAV, V56, P315, DOI 10.1016/j.yhbeh.2009.06.010; Saaristo M, 2009, HORM BEHAV, V55, P530, DOI 10.1016/j.yhbeh.2009.01.006; Schiffer B, 2001, ENVIRON HEALTH PERSP, V109, P1145, DOI 10.2307/3454862; Schlupp I, 1997, BEHAV ECOL, V8, P104, DOI 10.1093/beheco/8.1.104; Sone K, 2005, GEN COMP ENDOCR, V143, P151, DOI 10.1016/j.ygcen.2005.03.007; Swan SH, 2000, APMIS, V108, P793, DOI 10.1111/j.1600-0463.2000.tb00001.x; Toft G, 2004, AQUAT TOXICOL, V70, P213, DOI 10.1016/j.aquatox.2004.09.002; Turner CL, 1942, J EXP ZOOL, V91, P167, DOI 10.1002/jez.1400910205; Wierman ME, 2007, ADV PHYSIOL EDUC, V31, P26, DOI 10.1152/advan.00086.2006; Wong BBM, 2006, AM NAT, V167, P136, DOI 10.1086/498278; Wong BBM, 2005, BEHAV ECOL, V16, P818, DOI 10.1093/beheco/ari058; Wong BBM, 2009, BEHAV ECOL, V20, P278, DOI 10.1093/beheco/arp010; Yarrow JF, 2010, STEROIDS, V75, P377, DOI 10.1016/j.steroids.2010.01.019; Zala SM, 2004, ANIM BEHAV, V68, P649, DOI 10.1016/j.anbehav.2004.01.005	58	33	33	1	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2013	8	5							e62782	10.1371/journal.pone.0062782	http://dx.doi.org/10.1371/journal.pone.0062782			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175AS	23671634	Green Published, gold			2022-12-27	WOS:000321202100040
J	Chen, YW; Xu, ZH; Baksh, ANH; Wang, JK; Chen, CY; Swanson, R; Olson, ST; Kataoka, H; Johnson, MD; Lin, CY				Chen, Ya-Wen; Xu, Zhenghong; Baksh, Adrienne N. H.; Wang, Jehng-Kang; Chen, Chiu-Yuan; Swanson, Richard; Olson, Steve T.; Kataoka, Hiroaki; Johnson, Michael D.; Lin, Chen-Yong			Antithrombin Regulates Matriptase Activity Involved in Plasmin Generation, Syndecan Shedding, and HGF Activation in Keratinocytes	PLOS ONE			English	Article							HEPATOCYTE GROWTH-FACTOR; SERINE-PROTEASE MATRIPTASE; EPIDERMAL BARRIER FUNCTION; MAMMARY EPITHELIAL-CELLS; HEPARIN-BINDING; PROTEOLYTIC CASCADE; ZYMOGEN ACTIVATION; CANCER-CELLS; HUMAN-MILK; INHIBITOR	Matriptase, a membrane-associated serine protease, plays an essential role in epidermal barrier function through activation of the glycosylphosphatidylinositol (GPI)-anchored serine protease prostasin. The matriptase-prostasin proteolytic cascade is tightly regulated by hepatocyte growth factor activator inhibitor (HAI)-1 such that matriptase autoactivation and prostasin activation occur simultaneously and are followed immediately by the inhibition of both enzymes by HAI-1. However, the mechanisms whereby matriptase acts on extracellular substrates remain elusive. Here we report that some active matriptase can escape HAI-1 inhibition by being rapidly shed from the cell surface. In the pericellular environment, shed active matriptase is able to activate hepatocyte growth factor (HGF), accelerate plasminogen activation, and shed syndecan 1. The amount of active matriptase shed is inversely correlated with the amount of antithrombin (AT) bound to the surface of the keratinocytes. Binding of AT to the surface of keratinocytes is dependent on a functional heparin binding site, Lys-125, and that the N-glycosylation site Asn-135 be unglycosylated. This suggests that beta-AT, and not alpha-AT, is responsible for regulation of pericellular matriptase activity in keratinocytes. Keratinocytes appear to rely on AT to regulate the level of pericellular active matriptase much more than breast and prostate epithelial cells in which AT regulation of matriptase activity occurs at much lower levels than keratinocytes. These results suggest that keratinocytes employ two distinct serine protease inhibitors to control the activation and processing of two different sets of matriptase substrates leading to different biological events: 1) HAI-1 for prostasin activation/inhibition, and 2) AT for the pericellular proteolysis involved in HGF activation, accelerating plasminogen activation, and shedding of syndecans.	[Chen, Ya-Wen; Xu, Zhenghong; Lin, Chen-Yong] Univ Maryland, Greenebaum Canc Ctr, Baltimore, MD 21201 USA; [Chen, Ya-Wen] Univ Maryland, Grad Program Life Sci, Baltimore, MD 21201 USA; [Baksh, Adrienne N. H.] Univ Illinois, Dept Med, Chicago, IL USA; [Wang, Jehng-Kang] Natl Def Med Ctr, Dept Biochem, Taipei 10764, Taiwan; [Chen, Chiu-Yuan] Nanhua Univ, Grad Inst Nat Healing Sci, Chiayi, Taiwan; [Swanson, Richard; Olson, Steve T.] Univ Illinois, Ctr Mol Biol Oral Dis, Chicago, IL USA; [Kataoka, Hiroaki] Miyazaki Univ, Fac Med, Dept Pathol, Miyazaki, Japan; [Johnson, Michael D.; Lin, Chen-Yong] Georgetown Univ, Lombardi Canc Ctr, Washington, DC USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; National Defense Medical Center; Nanhua University; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Miyazaki; Georgetown University	Lin, CY (corresponding author), Univ Maryland, Greenebaum Canc Ctr, Baltimore, MD 21201 USA.	lincy@georgetown.edu		Chen, Ya-Wen/0000-0003-2382-8444; johnson, Michael/0000-0001-6260-7586	National Institutes of Health (NIH) [R01-CA-123223]; Maryland Cigarette Restitution Fund Program; NATIONAL CANCER INSTITUTE [R01CA123223] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000101] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL039888] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Maryland Cigarette Restitution Fund Program; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health (NIH) Grants R01-CA-123223 (MDJ and CL), and the Maryland Cigarette Restitution Fund Program (CL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arocas V, 2001, J BIOL CHEM, V276, P43809, DOI 10.1074/jbc.M105294200; Benaud C, 2002, J BIOL CHEM, V277, P10539, DOI 10.1074/jbc.M109064200; Benaud C, 2001, EUR J BIOCHEM, V268, P1439, DOI 10.1046/j.1432-1327.2001.02016.x; Blasi F, 2002, NAT REV MOL CELL BIO, V3, P932, DOI 10.1038/nrm977; Carney TJ, 2007, DEVELOPMENT, V134, P3461, DOI 10.1242/dev.004556; Chen CJ, 2011, AM J PHYSIOL-CELL PH, V300, pC406, DOI 10.1152/ajpcell.00403.2010; Chen YW, 2010, J BIOL CHEM, V285, P31755, DOI 10.1074/jbc.M110.150367; Chou FP, 2011, AM J PHYSIOL-CELL PH, V301, pC1093, DOI 10.1152/ajpcell.00122.2011; Ding K, 2005, J CELL BIOL, V171, P729, DOI 10.1083/jcb.200508010; ECKERT RL, 1989, PHYSIOL REV, V69, P1316, DOI 10.1152/physrev.1989.69.4.1316; ELIAS PM, 1987, J INVEST DERMATOL, V88, P459, DOI 10.1111/1523-1747.ep12469885; Friis S, 2011, J BIOL CHEM, V286, P5793, DOI 10.1074/jbc.M110.186874; Green KA, 2008, J INVEST DERMATOL, V128, P2092, DOI 10.1038/jid.2008.54; Kainulainen V, 1998, J BIOL CHEM, V273, P11563, DOI 10.1074/jbc.273.19.11563; Kataoka H, 2000, J BIOL CHEM, V275, P40453, DOI 10.1074/jbc.M006412200; Kilpatrick LM, 2006, BLOOD, V108, P2616, DOI 10.1182/blood-2006-02-001073; Kirchhofer D, 2003, J BIOL CHEM, V278, P36341, DOI 10.1074/jbc.M304643200; Lee MS, 2005, AM J PHYSIOL-CELL PH, V288, pC932, DOI 10.1152/ajpcell.00497.2004; Lee SL, 2000, J BIOL CHEM, V275, P36720, DOI 10.1074/jbc.M007802200; Leyvraz C, 2005, J CELL BIOL, V170, P487, DOI 10.1083/jcb.200501038; Li Q, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016483; Lin CY, 1999, J BIOL CHEM, V274, P18237, DOI 10.1074/jbc.274.26.18237; Lin CY, 1997, J BIOL CHEM, V272, P9147; List K, 2002, ONCOGENE, V21, P3765, DOI 10.1038/sj.onc.1205502; List K, 2007, J CELL PHYSIOL, V213, P237, DOI 10.1002/jcp.21115; Lund LR, 2006, EMBO J, V25, P2686, DOI 10.1038/sj.emboj.7601173; Manon-Jensen T, 2010, FEBS J, V277, P3876, DOI 10.1111/j.1742-4658.2010.07798.x; Myerburg MM, 2008, AM J PHYSIOL-LUNG C, V294, pL932, DOI 10.1152/ajplung.00437.2007; Nagaike K, 2008, AM J PATHOL, V173, P1464, DOI 10.2353/ajpath.2008.071142; Netzel-Arnett S, 2006, J BIOL CHEM, V281, P32941, DOI 10.1074/jbc.C600208200; Oberst MD, 2005, AM J PHYSIOL-CELL PH, V289, pC462, DOI 10.1152/ajpcell.00076.2005; Oberst MD, 2003, J BIOL CHEM, V278, P26773, DOI 10.1074/jbc.M304282200; Opal SM, 2002, CRIT CARE MED, V30, pS325, DOI 10.1097/00003246-200205001-00024; Ovaere P, 2009, TRENDS BIOCHEM SCI, V34, P453, DOI 10.1016/j.tibs.2009.08.001; PETERSON CB, 1985, J BIOL CHEM, V260, P610; Romer J, 1996, NAT MED, V2, P287, DOI 10.1038/nm0396-287; Satomi S, 2001, BIOCHEM BIOPH RES CO, V287, P995, DOI 10.1006/bbrc.2001.5686; Schedin-Weiss S, 2002, BIOCHEMISTRY-US, V41, P12369, DOI 10.1021/bi020406j; Schedin-Weiss S, 2002, BIOCHEMISTRY-US, V41, P4779, DOI 10.1021/bi012163l; STAMPFER MR, 1985, P NATL ACAD SCI USA, V82, P2394, DOI 10.1073/pnas.82.8.2394; Subramanian SV, 1997, J BIOL CHEM, V272, P14713, DOI 10.1074/jbc.272.23.14713; Swedenborg J, 1998, BLOOD COAGUL FIBRIN, V9, pS7; Szabo R, 2011, ONCOGENE, V30, P2003, DOI 10.1038/onc.2010.586; Szabo R, 2009, AM J PATHOL, V174, P2015, DOI 10.2353/ajpath.2009.090053; Takeuchi T, 2000, J BIOL CHEM, V275, P26333, DOI 10.1074/jbc.M002941200; Tseng IC, 2008, AM J PHYSIOL-CELL PH, V295, pC423, DOI 10.1152/ajpcell.00164.2008; Tseng IC, 2010, J BIOL CHEM, V285, P3261, DOI 10.1074/jbc.M109.055640; Wang JK, 2009, AM J PHYSIOL-CELL PH, V297, pC459, DOI 10.1152/ajpcell.00201.2009; Xu H, 2012, AM J PHYSIOL-CELL PH, V302, pC453, DOI 10.1152/ajpcell.00344.2011; Zeeuwen PLJM, 2004, EUR J CELL BIOL, V83, P761, DOI 10.1078/0171-9335-00388	50	15	16	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2013	8	5							e62826	10.1371/journal.pone.0062826	http://dx.doi.org/10.1371/journal.pone.0062826			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145RZ	23675430	Green Published, gold, Green Submitted			2022-12-27	WOS:000319036100014
J	Aliyu, G; El-Kamary, SS; Abimiku, A; Brown, C; Tracy, K; Hungerford, L; Blattner, W				Aliyu, Gambo; El-Kamary, Samer S.; Abimiku, Alash'le; Brown, Clayton; Tracy, Kathleen; Hungerford, Laura; Blattner, William			Prevalence of Non-Tuberculous Mycobacterial Infections among Tuberculosis Suspects in Nigeria	PLOS ONE			English	Article							DIRECT ASSAY; COMPLEX; DISEASE; AFRICA; SILICA; IDENTIFICATION; MACROPHAGES; MENINGITIS; SPECIMENS; BACILLI	Background: Nigeria is ranked in the top five countries for tuberculosis deaths worldwide. This study investigated the mycobacterial agents associated with presumptive clinical pulmonary tuberculosis (TB) in Nigeria and evaluated the pattern and frequency of mycobacterial infections over twelve calendar months period. Methods: Sputum samples from 1,603 consecutive new cases with presumptive diagnosis of TB were collected from August 2010 to July 2011. All sputum samples were incubated for detection of mycobacterial growth and those with positive acid fast bacilli (AFB) growth were tested to detect mycobacterium tuberculosis (MTB) complex and characterized to differentiate between MTB complex species. Cultures suggestive of Non-tuberculous mycobacterial infections (NTM) were sub-cultured and characterized. Results: Of the 1,603 patients screened, 444 (28%) culture-positive cases of pulmonary tuberculosis were identified. Of these, 375 (85%) were due to strains of MTB complex (354 cases of M. tuberculosis, 20 M. africanum and one case of M. bovis) and 69 (15%) were due to infection with NTM. In contrast to the MTB complex cases, the NTM cases were more likely to have been diagnosed during the calendar months of the Harmattan dust season (OR = 2.34, 1.28-4.29; p = 0.01), and aged older than 35 years (OR = 2.77, 1.52-5.02, p = 0.0007), but less likely to have AFB identified on their sputum smear (OR = 0.06, 0.02-0.14, p<0.0001). Among those with NTM infection, cases 35 years or younger were more likely to have co-infection with HIV (3.76, 1.72-8.22; p = 0.0009) compared to those older than 35 years. Interpretation: The high proportion of younger patients with clinical pulmonary TB due to NTM and co-infection with HIV and the likely role of the seasonal dust exposure in the occurrence of the disease, present novel public health challenges for prevention and treatment.	[Aliyu, Gambo; Abimiku, Alash'le; Blattner, William] Univ Maryland, Sch Med, Inst Human Virol, Baltimore, MD 21201 USA; [El-Kamary, Samer S.; Brown, Clayton; Tracy, Kathleen; Hungerford, Laura; Blattner, William] Univ Maryland, Sch Med, Dept Epidemiol & Publ Hlth, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Aliyu, G (corresponding author), Univ Maryland, Sch Med, Inst Human Virol, Baltimore, MD 21201 USA.	algambo@yahoo.com			Fogarty AIDS International Training and Research Program [D43TW001041]; FOGARTY INTERNATIONAL CENTER [D43TW001041] Funding Source: NIH RePORTER	Fogarty AIDS International Training and Research Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	This study was supported by the Fogarty AIDS International Training and Research Program (Grant no: D43TW001041. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addo Kk, 2007, Ghana Med J, V41, P52; Agliari E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055017; Amorim A, 2010, SCAND J INFECT DIS, V42, P626, DOI 10.3109/00365541003754485; ANJORIN FI, 1984, T ROY SOC TROP MED H, V78, P577, DOI 10.1016/0035-9203(84)90209-8; Bonard D, 2004, AIDS, V18, P1961, DOI 10.1097/00002030-200409240-00015; Buijtels PCAM, 2010, CLIN MICROBIOL INFEC, V16, P1142, DOI 10.1111/j.1469-0691.2009.03072.x; Buijtels PCAM, 2005, J CLIN MICROBIOL, V43, P6020, DOI 10.1128/JCM.43.12.6020-6026.2005; Cadmus S, 2006, J CLIN MICROBIOL, V44, P29, DOI 10.1128/JCM.44.1.29-34.2006; Corbett EL, 2000, AIDS, V14, P2759, DOI 10.1097/00002030-200012010-00016; Crump JA, 2009, EMERG INFECT DIS, V15, P53, DOI 10.3201/eid1501.081093; ELLIS RC, 1993, J CLIN PATHOL, V46, P559, DOI 10.1136/jcp.46.6.559; GHIO AJ, 1990, LANCET, V336, P967, DOI 10.1016/0140-6736(90)92421-D; Gomgnimbou MK, 2012, EMERG INFECT DIS, V18, P117, DOI 10.3201/eid1801.110275; Gopinath K, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000615; Griffith DE, 2007, AM J RESP CRIT CARE, V175, P367, DOI 10.1164/rccm.200604-571ST; Hamilton RF, 2008, FREE RADICAL BIO MED, V44, P1246, DOI 10.1016/j.freeradbiomed.2007.12.027; Hooja Saroj, 2011, Indian J Tuberc, V58, P72; Kiraz N, 2010, J MED MICROBIOL, V59, P930, DOI 10.1099/jmm.0.013490-0; LAWANDE RV, 1984, ANN ALLERGY, V52, P47; Marlowe EM, 2011, J CLIN MICROBIOL, V49, P1621, DOI 10.1128/JCM.02214-10; Marras TK, 2002, CLIN CHEST MED, V23, P553, DOI 10.1016/S0272-5231(02)00019-9; Mohapatra H, 2010, J ENVIRON BIOL, V31, P953; Monkongdee P, 2009, AM J RESP CRIT CARE, V180, P903, DOI 10.1164/rccm.200905-0692OC; Niobe-Eyangoh SN, 2003, J CLIN MICROBIOL, V41, P2547, DOI 10.1128/JCM.41.6.2547-2553.2003; Park HH, 2009, AM J IND MED, V52, P901, DOI 10.1002/ajim.20767; Pasula R, 2009, J IMMUNOL, V182, P7102, DOI 10.4049/jimmunol.0803642; Pokam Benjamin Thumamo, 2012, Tuberc Res Treat, V2012, P301056, DOI 10.1155/2012/301056; Rees D, 2007, INT J TUBERC LUNG D, V11, P474; Roberts L, 2008, SCIENCE, V320, P1710, DOI 10.1126/science.320.5884.1710; Rodrigues C, 2009, INDIAN J MED MICROBI, V27, P217, DOI 10.4103/0255-0857.53203; Sakatani M, 1999, Kekkaku, V74, P377; Seagar AL, 2008, J MED MICROBIOL, V57, P605, DOI 10.1099/jmm.0.47484-0; Singh S, 2007, JPN J INFECT DIS, V60, P14; Somoskovi A, 2008, J CLIN MICROBIOL, V46, P1854, DOI 10.1128/JCM.00105-07; Sultan B, 2005, PLOS MED, V2, P43, DOI 10.1371/journal.pmed.0020006; Tiwari Rajnarayan R, 2007, Indian J Occup Environ Med, V11, P61, DOI 10.4103/0019-5278.34530; Traore B, 2012, INT J TUBERCULOSIS L; Van Deun A, 2008, INT J TUBERC LUNG D, V12, P108; Weinstein JP, 2010, CHEMOSPHERE, V78, P980, DOI 10.1016/j.chemosphere.2009.12.022; ZYKOV MP, 1967, B WORLD HEALTH ORGAN, V37, P947; ZYKOV MP, 1967, B WORLD HEALTH ORGAN, V37, P927	41	60	65	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2013	8	5							e63170	10.1371/journal.pone.0063170	http://dx.doi.org/10.1371/journal.pone.0063170			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	155HD	23671669	Green Published, gold, Green Submitted			2022-12-27	WOS:000319737700047
J	Anderson, M; Amin, S; Luise, F; Zeef, L; Bobola, N				Anderson, Megan; Amin, Shilu; Luise, Fabiana; Zeef, Leo; Bobola, Nicoletta			Differential Distribution of the Ca (2+) Regulator Pcp4 in the Branchial Arches Is Regulated by Hoxa2	PLOS ONE			English	Article							HOMEOTIC TRANSFORMATION; GENE; PEP-19; DISRUPTION; EXPRESSION; SIX2; BODY	Branchial arches are externally visible tissue bands in the head region of all vertebrate embryos. Although initially formed from similar components, each arch will give rise to different head and neck structures. In a screen designed to characterize the molecular control of branchial arch identity in mouse, we identified Pcp4 as a second branchial arch-specific molecular signature. We further show that the transcription factor Hoxa2 binds to Pcp4 chromatin and regulates Pcp4 expression in the second arch. Hoxa2 is also sufficient to induce Pcp4 expression in anterior first arch cells, which are Pcp4-negative.	[Anderson, Megan] Univ Manchester, Manchester Acad Hlth Sci Ctr, Fac Med & Human Sci, Manchester, Lancs, England; [Amin, Shilu; Luise, Fabiana; Bobola, Nicoletta] Univ Manchester, Sch Dent, Fac Med & Human Sci, Manchester Acad Hlth Sci Ctr, Manchester, Lancs, England; [Zeef, Leo] Univ Manchester, Fac Life Sci, Manchester, Lancs, England; [Bobola, Nicoletta] Univ Manchester, Manchester Acad Hlth Sci Ctr, Fac Med & Human Sci, Ctr Endocrinol & Diabet,Inst Human Dev, Manchester, Lancs, England	University of Manchester; University of Manchester; University of Manchester; University of Manchester	Bobola, N (corresponding author), Univ Manchester, Sch Dent, Fac Med & Human Sci, Manchester Acad Hlth Sci Ctr, Manchester, Lancs, England.	Nicoletta.Bobola@manchester.ac.uk			Biotechnology and Biological Sciences Research Council [BB/H018123/2]; Biotechnology and Biological Sciences Research Council [1085991, BB/E017355/1] Funding Source: researchfish; BBSRC [BB/E017355/1, BB/H018123/2] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the Biotechnology and Biological Sciences Research Council BB/H018123/2 to N.B and facilitated by the Manchester Biomedical Research Centre. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abzhanov A, 2006, NATURE, V442, P563, DOI 10.1038/nature04843; Baltzinger M, 2005, DEV DYNAM, V234, P858, DOI 10.1002/dvdy.20567; Barrow JR, 1999, DEVELOPMENT, V126, P5011; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Depew MJ, 2002, SCIENCE, V298, P381, DOI 10.1126/science.1075703; Donaldson IJ, 2012, NUCLEIC ACIDS RES, V40, P3990, DOI 10.1093/nar/gkr1240; Erhardt JA, 2000, NEUROREPORT, V11, P3719, DOI 10.1097/00001756-200011270-00026; GENDRONMAGUIRE M, 1993, CELL, V75, P1317, DOI 10.1016/0092-8674(93)90619-2; Harashima S, 2011, J NEUROSCI RES, V89, P1519, DOI 10.1002/jnr.22688; Jacobson AC, 2009, MOL IMMUNOL, V46, P1488, DOI 10.1016/j.molimm.2008.12.030; Johanson RA, 2000, J NEUROSCI, V20, P2860; Kameda Y, 2003, CELL TISSUE RES, V311, P343, DOI 10.1007/s00441-002-0681-1; Kameda Y, 2002, DEV BIOL, V247, P197, DOI 10.1006/dbio.2002.0689; Kanzler B, 1998, DEVELOPMENT, V125, P2587; Kirilenko P, 2011, MOL CELL BIOL, V31, P1301, DOI 10.1128/MCB.00705-10; Kleerekoper QK, 2009, J BIOL CHEM, V284, P7455, DOI 10.1074/jbc.M808067200; Kutejova E, 2005, DEVELOPMENT, V132, P469, DOI 10.1242/dev.01536; Kutejova E, 2008, DEVELOPMENT, V135, P1463, DOI 10.1242/dev.017624; Mallo M, 1997, DEV BIOL, V184, P175, DOI 10.1006/dbio.1997.8519; Manley NR, 1997, DEV BIOL, V192, P274, DOI 10.1006/dbio.1997.8765; Ovcharenko I, 2004, NUCLEIC ACIDS RES, V32, pW280, DOI 10.1093/nar/gkh355; Pearson JC, 2005, NAT REV GENET, V6, P893, DOI 10.1038/nrg1726; Putkey JA, 2008, J BIOL CHEM, V283, P1401, DOI 10.1074/jbc.M703831200; RIJLI FM, 1993, CELL, V75, P1333, DOI 10.1016/0092-8674(93)90620-6; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Thomas S, 2003, GENE EXPR PATTERNS, V3, P93, DOI 10.1016/S1567-133X(02)00100-X; Wei P, 2011, MOL CELL BIOL, V31, P2838, DOI 10.1128/MCB.05208-11; Xiao JG, 2008, MOL CELL BIOCHEM, V309, P143, DOI 10.1007/s11010-007-9652-x	29	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2013	8	5							e63160	10.1371/journal.pone.0063160	http://dx.doi.org/10.1371/journal.pone.0063160			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	155HD	23671666	Green Submitted, gold, Green Published			2022-12-27	WOS:000319737700044
J	Bay, LK; Guerecheau, A; Andreakis, N; Ulstrup, KE; Matz, MV				Bay, Line K.; Guerecheau, Aurelie; Andreakis, Nikos; Ulstrup, Karin E.; Matz, Mikhail V.			Gene Expression Signatures of Energetic Acclimatisation in the Reef Building Coral Acropora millepora	PLOS ONE			English	Article							THERMAL-STRESS; CLIMATE-CHANGE; ENVIRONMENTAL-STRESS; CARBONIC-ANHYDRASE; PROTEIN EXPRESSION; LIPID-CONTENT; PHOTOSYNTHESIS; SYMBIODINIUM; RESILIENCE; PLASTICITY	Background: Understanding the mechanisms by which natural populations cope with environmental stress is paramount to predict their persistence in the face of escalating anthropogenic impacts. Reef-building corals are increasingly exposed to local and global stressors that alter nutritional status causing reduced fitness and mortality, however, these responses can vary considerably across species and populations. Methodology/Principal Findings: We compare the expression of 22 coral host genes in individuals from an inshore and an offshore reef location using quantitative Reverse Transcription-PCR (qRT-PCR) over the course of 26 days following translocation into a shaded, filtered seawater environment. Declines in lipid content and PSII activity of the algal endosymbionts (Symbiodinium ITS-1 type C2) over the course of the experiment indicated that heterotrophic uptake and photosynthesis were limited, creating nutritional deprivation conditions. Regulation of coral host genes involved in metabolism, CO2 transport and oxidative stress could be detected already after five days, whereas PSII activity took twice as long to respond. Opposing expression trajectories of Tgl, which releases fatty acids from the triacylglycerol storage, and Dgat1, which catalyses the formation of triglycerides, indicate that the decline in lipid content can be attributed, at least in part, by mobilisation of triacylglycerol stores. Corals from the inshore location had initially higher lipid content and showed consistently elevated expression levels of two genes involved in metabolism (aldehyde dehydrogenase) and calcification (carbonic anhydrase). Conclusions/Significance: Coral host gene expression adjusts rapidly upon change in nutritional conditions, and therefore can serve as an early signature of imminent coral stress. Consistent gene expression differences between populations indicate that corals acclimatize and/or adapt to local environments. Our results set the stage for analysis of these processes in natural coral populations, to better understand the responses of coral communities to global climate change and to develop more efficient management strategies.	[Bay, Line K.; Guerecheau, Aurelie; Andreakis, Nikos] Australian Inst Marine Sci, Climate Change & Ocean Acidificat Team, Townsville, Qld 4810, Australia; [Ulstrup, Karin E.] Univ Copenhagen, Dept Biol, Helsingor, Denmark; [Matz, Mikhail V.] Univ Texas Austin, Integrat Biol Sect, Austin, TX 78712 USA	Australian Institute of Marine Science; University of Copenhagen; University of Texas System; University of Texas Austin	Bay, LK (corresponding author), Australian Inst Marine Sci, Climate Change & Ocean Acidificat Team, PMB 3, Townsville, Qld 4810, Australia.	l.bay@aims.gov.au	Andreakis, Nikos/A-4010-2010; Matz, Mikhail V/K-4392-2017	Andreakis, Nikos/0000-0001-7120-4279; Matz, Mikhail V/0000-0001-5453-9819; Bay, Line/0000-0002-9760-2977	Marine and Tropical Sciences Research Facility; ARC Centre of Excellence for Coral Reef Studies; Australian Institute of Marine Science	Marine and Tropical Sciences Research Facility; ARC Centre of Excellence for Coral Reef Studies(Australian Research Council); Australian Institute of Marine Science	Funding was provided by the Marine and Tropical Sciences Research Facility, the ARC Centre of Excellence for Coral Reef Studies and the Australian Institute of Marine Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainsworth TD, 2008, J EXP MAR BIOL ECOL, V364, P63, DOI 10.1016/j.jembe.2008.06.032; Allemand D, 2011, CORAL REEFS: AN ECOSYSTEM IN TRANSITION, P119, DOI 10.1007/978-94-007-0114-4_9; Anthony KRN, 2009, FUNCT ECOL, V23, P539, DOI 10.1111/j.1365-2435.2008.01531.x; Anthony KRN, 2003, OECOLOGIA, V134, P23, DOI 10.1007/s00442-002-1095-1; Anthony KRN, 2000, J EXP MAR BIOL ECOL, V252, P221, DOI 10.1016/S0022-0981(00)00237-9; Baird AH, 2009, TRENDS ECOL EVOL, V24, P16, DOI 10.1016/j.tree.2008.09.005; Barrientos A, 2002, GENE, V286, P53, DOI 10.1016/S0378-1119(01)00803-4; Barshis DJ, 2010, MOL ECOL, V19, P1705, DOI 10.1111/j.1365-294X.2010.04574.x; Barshis DJ, 2013, P NATL ACAD SCI USA, V110, P1387, DOI 10.1073/pnas.1210224110; Bates D, 2005, R NEWS, V5, P4; Bay LK, 2009, MAR GENOM, V2, P119, DOI 10.1016/j.margen.2009.07.004; Bay LK, 2009, MOL ECOL, V18, P3062, DOI 10.1111/j.1365-294X.2009.04257.x; Benjamini Y, 2001, ANN STAT, V29, P1165; Berkelmans R, 2006, P ROY SOC B-BIOL SCI, V273, P2305, DOI 10.1098/rspb.2006.3567; Blasi F, 2002, NAT REV MOL CELL BIO, V3, P932, DOI 10.1038/nrm977; Brown BE, 2011, CORAL REEFS: AN ECOSYSTEM IN TRANSITION, P421, DOI 10.1007/978-94-007-0114-4_24; Bruno JF, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000711; Cantin NE, 2009, CORAL REEFS, V28, P405, DOI 10.1007/s00338-009-0478-8; Carpenter KE, 2008, SCIENCE, V321, P560, DOI 10.1126/science.1159196; Carr HS, 2003, ACCOUNTS CHEM RES, V36, P309, DOI 10.1021/ar0200807; Castilho PC, 2009, MOL ECOL, V18, P2092, DOI 10.1111/j.1365-294X.2009.04174.x; Cnaan A, 1997, STAT MED, V16, P2349, DOI 10.1002/(SICI)1097-0258(19971030)16:20<2349::AID-SIM667>3.0.CO;2-E; Coles SL, 2003, ADV MAR BIOL, V46, P183, DOI 10.1016/S0065-2881(03)46004-5; Connolly SR, 2012, CORAL REEFS, V31, P951, DOI 10.1007/s00338-012-0925-9; Cooper TF, 2011, ESTUARINE COASTAL SH, V83, P186; Cooper TF, 2007, ESTUAR COAST SHELF S, V74, P458, DOI 10.1016/j.ecss.2007.05.020; Cooper TF, 2011, P ROY SOC B-BIOL SCI, V278, P1840, DOI 10.1098/rspb.2010.2321; Cossins A, 2006, J EXP BIOL, V209, P2328, DOI 10.1242/jeb.02256; Csaszar NBM, 2009, MAR ECOL PROG SER, V392, P93, DOI 10.3354/meps08194; Dalziel AC, 2009, MOL ECOL, V18, P4997, DOI 10.1111/j.1365-294X.2009.04427.x; De'ath G, 2012, P NATL ACAD SCI USA, V109, P17995, DOI 10.1073/pnas.1208909109; Desalvo MK, 2008, MOL ECOL, V17, P3952, DOI 10.1111/j.1365-294X.2008.03879.x; DeSalvo MK, 2010, MAR ECOL PROG SER, V402, P97, DOI 10.3354/meps08372; Donner SD, 2005, GLOBAL CHANGE BIOL, V11, P2251, DOI 10.1111/j.1365-2486.2005.01073.x; Drew JE, 2011, J MOL DIAGN, V13, P233, DOI 10.1016/j.jmoldx.2010.10.001; Dunn SR, 2004, CELL DEATH DIFFER, V11, P1213, DOI 10.1038/sj.cdd.4401484; Edge SE, 2008, J EXP MAR BIOL ECOL, V355, P114, DOI 10.1016/j.jembe.2007.12.004; Edge SE, 2005, MAR POLLUT BULL, V51, P507, DOI 10.1016/j.marpolbul.2005.07.007; Edmunds PJ, 2008, MAR ECOL PROG SER, V361, P307, DOI 10.3354/meps07556; Ferrier-Pages C, 2011, CORAL REEFS: AN ECOSYSTEM IN TRANSITION, P215, DOI 10.1007/978-94-007-0114-4_15; Fitt WK, 2009, J EXP MAR BIOL ECOL, V373, P102, DOI 10.1016/j.jembe.2009.03.011; Foret S, 2007, CORAL REEFS, V26, P475, DOI 10.1007/s00338-007-0206-1; Furla P, 2000, AM J PHYSIOL-REG I, V278, pR870, DOI 10.1152/ajpregu.2000.278.4.R870; Ganot P, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002187; Gardner TA, 2003, SCIENCE, V301, P958, DOI 10.1126/science.1086050; Geel C, 1997, PHOTOSYNTH RES, V51, P61, DOI 10.1023/A:1005779112140; Grasso LC, 2011, DEV BIOL, V353, P411, DOI 10.1016/j.ydbio.2011.02.010; Grasso LC, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-540; Grottoli AG, 2006, NATURE, V440, P1186, DOI 10.1038/nature04565; Grottoli AG, 2004, MAR BIOL, V145, P621, DOI 10.1007/s00227-004-1337-3; Hadfield JD, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i02; Hansen MM, 2012, MOL ECOL, V21, P1311, DOI 10.1111/j.1365-294X.2011.05463.x; HARLAND AD, 1992, MAR BIOL, V112, P253, DOI 10.1007/BF00702469; Hennige SJ, 2009, CORAL REEFS, V28, P179, DOI 10.1007/s00338-008-0444-x; Hill R, 2004, MAR BIOL, V144, P633, DOI 10.1007/s00227-003-1226-1; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; Hofmann GE, 2010, ANNU REV PHYSIOL, V72, P127, DOI 10.1146/annurev-physiol-021909-135900; Hoogenboom M, 2010, CORAL REEFS, V29, P21, DOI 10.1007/s00338-009-0558-9; Hoogenboom M, 2010, J EXP BIOL, V213, P2399, DOI 10.1242/jeb.040147; Houlbreque F, 2003, J EXP MAR BIOL ECOL, V296, P145, DOI 10.1016/S0022-0981(03)00259-4; Houlbreque F, 2009, BIOL REV, V84, P1, DOI 10.1111/j.1469-185X.2008.00058.x; Howells EJ, 2012, NAT CLIM CHANGE, V2, P116, DOI 10.1038/NCLIMATE1330; Huey R.B., 1996, Society for Experimental Biology Seminar Series, V59, P205; Hughes TP, 2003, SCIENCE, V301, P929, DOI 10.1126/science.1085046; Imagawa S, 2004, COMP BIOCHEM PHYS B, V137, P11, DOI 10.1016/j.cbpc.2003.09.011; Jackson JBC, 2008, P NATL ACAD SCI USA, V105, P11458, DOI 10.1073/pnas.0802812105; Kenkel CD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026914; Knowlton N, 2001, P NATL ACAD SCI USA, V98, P5419, DOI 10.1073/pnas.091092998; Kortschak RD, 2003, CURR BIOL, V13, P2190, DOI 10.1016/j.cub.2003.11.030; Krueger Charlene, 2004, Biol Res Nurs, V6, P151, DOI 10.1177/1099800404267682; Kvennefors ECE, 2008, DEV COMP IMMUNOL, V32, P1582, DOI 10.1016/j.dci.2008.05.010; Leuzinger S, 2012, MAR BIOL, V159, P177, DOI 10.1007/s00227-011-1797-1; Lu P, 2007, NAT BIOTECHNOL, V25, P117, DOI 10.1038/nbt1270; MALY IP, 1988, HISTOCHEMISTRY, V88, P387; Meyer E, 2011, MOL ECOL, V20, P3599, DOI 10.1111/j.1365-294X.2011.05205.x; Meyer E, 2009, MAR ECOL PROG SER, V392, P81, DOI 10.3354/meps08208; Middlebrook R, 2008, J EXP BIOL, V211, P1050, DOI 10.1242/jeb.013284; Middlebrook R, 2010, J EXP BIOL, V213, P1026, DOI 10.1242/jeb.031633; Miller DJ, 2007, GENOME BIOL, P8; Morgan MB, 2005, MAR POLLUT BULL, V51, P524, DOI 10.1016/j.marpolbul.2005.09.023; Narum SR, 2006, CONSERV GENET, V7, P783, DOI 10.1007/s10592-005-9056-y; Newman JRS, 2006, NATURE, V441, P840, DOI 10.1038/nature04785; Oliver TA, 2011, CORAL REEFS, V30, P429, DOI 10.1007/s00338-011-0721-y; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Pigliucci M, 2005, TRENDS ECOL EVOL, V20, P481, DOI 10.1016/j.tree.2005.06.001; PIGLIUCCI M, 1993, TRENDS ECOL EVOL, V8, P379, DOI 10.1016/0169-5347(93)90225-E; PLATT T, 1980, J MAR RES, V38, P687; Putnam HM, 2010, INVERTEBR BIOL, V129, P199, DOI 10.1111/j.1744-7410.2010.00199.x; R Development Core Team, 2012, R LANG ENV STAT COMP; Rai AJ, 2009, ANAL BIOANAL CHEM, V393, P1505, DOI 10.1007/s00216-008-2436-7; Ralph PJ, 2005, AQUAT BOT, V82, P222, DOI 10.1016/j.aquabot.2005.02.006; Ranz JM, 2006, TRENDS ECOL EVOL, V21, P29, DOI 10.1016/j.tree.2005.09.002; Reyes-Bermudez A, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-178; Rocker MM, 2012, THERMAL STRESS RELAT; Rodrigues LJ, 2007, LIMNOL OCEANOGR, V52, P1874, DOI 10.4319/lo.2007.52.5.1874; Rowan R, 1997, NATURE, V388, P265, DOI 10.1038/40843; Schrader M, 2006, BBA-MOL CELL RES, V1763, P1755, DOI 10.1016/j.bbamcr.2006.09.006; Schreiber U, 2004, ADV PHOTO RESPIRAT, V19, P279; Schwarz JA, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-435; Smith HW, 2010, NAT REV MOL CELL BIO, V11, P23, DOI 10.1038/nrm2821; Smith-Keune C, 2006, CORAL REEFS, V25, P493, DOI 10.1007/s00338-006-0129-2; Souter P, 2011, MOL ECOL RESOUR, V11, P328, DOI 10.1111/j.1755-0998.2010.02923.x; Tambutte S, 2011, J EXP MAR BIOL ECOL, V408, P58, DOI 10.1016/j.jembe.2011.07.026; Tocher DR, 2003, REV FISH SCI, V11, P107, DOI 10.1080/713610925; Toller WW, 2001, BIOL BULL, V201, P348, DOI 10.2307/1543613; Tomanek L, 2011, ANNU REV MAR SCI, V3, P373, DOI 10.1146/annurev-marine-120709-142729; Ulstrup KE, 2006, MAR BIOL, V149, P1325, DOI 10.1007/s00227-006-0286-4; Ulstrup KE, 2006, MAR ECOL PROG SER, V314, P135, DOI 10.3354/meps314135; Unuma T, 2003, J EXP BIOL, V206, P365, DOI 10.1242/jeb.00102; Van Oppen MJH, 2006, MOL ECOL, V15, P3863, DOI 10.1111/j.1365-294X.2006.03026.x; van Oppen MJH, 2011, MOL ECOL, V20, P4899, DOI 10.1111/j.1365-294X.2011.05328.x; van Oppen MJH, 2001, P ROY SOC B-BIOL SCI, V268, P1759, DOI 10.1098/rspb.2001.1733; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vidal-Dupiol Jeremie, 2009, BMC Physiology, V9, P14, DOI 10.1186/1472-6793-9-14; Voolstra CR, 2009, MOL ECOL, V18, P1823, DOI 10.1111/j.1365-294X.2009.04167.x; Voolstra CR, 2011, PLOS ONE, V6; Webster N, 2013, MOL ECOL, V22, P1854, DOI 10.1111/mec.12213; WEIS VM, 1989, MAR BIOL, V100, P195, DOI 10.1007/BF00391958; WEIS VM, 1993, J EXP MAR BIOL ECOL, V174, P209, DOI 10.1016/0022-0981(93)90018-J; WEIS VM, 1991, BIOL BULL, V180, P496, DOI 10.2307/1542351; West J, 2003, COMMENTARY, V115, P17; Yamashiro H, 2005, FISHERIES SCI, V71, P448, DOI 10.1111/j.1444-2906.2005.00983.x; YOUNG SD, 1973, INT J BIOCHEM, V4, P339, DOI 10.1016/0020-711X(73)90056-6; Yuyama I, 2011, MAR BIOTECHNOL, V13, P32, DOI 10.1007/s10126-010-9265-3	124	19	19	1	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2013	8	5							e61736	10.1371/journal.pone.0061736	http://dx.doi.org/10.1371/journal.pone.0061736			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	155HD	23671571	Green Submitted, Green Published, gold			2022-12-27	WOS:000319737700004
J	Kandiah, V; Shepelyansky, DL				Kandiah, Vivek; Shepelyansky, Dima L.			Google Matrix Analysis of DNA Sequences	PLOS ONE			English	Article								For DNA sequences of various species we construct the Google matrix G of Markov transitions between nearby words composed of several letters. The statistical distribution of matrix elements of this matrix is shown to be described by a power law with the exponent being close to those of outgoing links in such scale-free networks as the World Wide Web (WWW). At the same time the sum of ingoing matrix elements is characterized by the exponent being significantly larger than those typical for WWW networks. This results in a slow algebraic decay of the PageRank probability determined by the distribution of ingoing elements. The spectrum of G is characterized by a large gap leading to a rapid relaxation process on the DNA sequence networks. We introduce the PageRank proximity correlator between different species which determines their statistical similarity from the view point of Markov chains. The properties of other eigenstates of the Google matrix are also discussed. Our results establish scale-free features of DNA sequence networks showing their similarities and distinctions with the WWW and linguistic networks.	[Kandiah, Vivek; Shepelyansky, Dima L.] Univ Toulouse, UPS, Lab Phys Theor CNRS, IRSAMC, Toulouse, France	Universite de Toulouse; Universite Toulouse III - Paul Sabatier	Shepelyansky, DL (corresponding author), Univ Toulouse, UPS, Lab Phys Theor CNRS, IRSAMC, Toulouse, France.	dima@irsamc.ups-tlse.fr	Shepelyansky, Dima L/G-6050-2016	Shepelyansky, Dima L/0000-0002-2752-0765	EC FET Open project "New tools and algorithms for directed network analysis" (NADINE) [288956]; France-Armenia collaboration grant CNRS/SCS [24943 (IE-017)]; CNRS - Region Midi-Pyrenees grant	EC FET Open project "New tools and algorithms for directed network analysis" (NADINE); France-Armenia collaboration grant CNRS/SCS; CNRS - Region Midi-Pyrenees grant(Region Occitanie)	This research is supported in part by the EC FET Open project "New tools and algorithms for directed network analysis" (NADINE No. 288956); the France-Armenia collaboration grant CNRS/SCS No. 24943 (IE-017) on "Classical and quantum chaos"; VK is supported by CNRS - Region Midi-Pyrenees grant. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BRENDEL V, 1986, J BIOMOL STRUCT DYN, V4, P11, DOI 10.1080/07391102.1986.10507643; Brin M., 2002, INTRO DYNAMICAL SYST; Brin S, 1998, COMPUT NETWORKS ISDN, V30, P107, DOI 10.1016/S0169-7552(98)00110-X; Burden CJ, 2012, STAT APPL GENET MOL, V11, DOI 10.2202/1544-6115.1724; Cancho RFI, 2001, P ROY SOC B-BIOL SCI, V268, P2261, DOI 10.1098/rspb.2001.1800; Dai Q, 2008, BIOINFORMATICS, V24, P2296, DOI 10.1093/bioinformatics/btn436; Donato D, 2004, EUR PHYS J B, V38, P239, DOI 10.1140/epjb/e2004-00056-6; Dorogovtsev SN, 2001, P ROY SOC B-BIOL SCI, V268, P2603, DOI 10.1098/rspb.2001.1824; Ermann L, 2012, J PHYS A-MATH THEOR, V45, DOI 10.1088/1751-8113/45/27/275101; Ermann L, 2012, PHYSICA D, V241, P514, DOI 10.1016/j.physd.2011.11.012; Ermann L, 2012, ARXIV12121068CSIR; Fortunato S, 2010, PHYS REP, V486, P75, DOI 10.1016/j.physrep.2009.11.002; Frahm KM, 2012, EUR PHYS J B, V85, DOI 10.1140/epjb/e2012-30599-6; Frahm KM, 2012, PHYS REV E, V85, DOI 10.1103/PhysRevE.85.016214; Frahm KM, 2011, J PHYS A-MATH THEOR, V44, DOI 10.1088/1751-8113/44/46/465101; Frahm KM, 2010, EUR PHYS J B, V76, P57, DOI 10.1140/epjb/e2010-00190-6; Frenkel ZM, 2009, J THEOR BIOL, V260, P438, DOI 10.1016/j.jtbi.2009.07.004; Froyland G, 2009, PHYSICA D, V238, P1507, DOI 10.1016/j.physd.2009.03.002; Giraud O, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.026107; Halpern D, 2007, PLOS GENET, V3, P1614, DOI 10.1371/journal.pgen.0030153; Langville A., 2006, GOOGLES PAGERANK SCI; MANTEGNA RN, 1995, PHYS REV E, V52, P2939, DOI 10.1103/PhysRevE.52.2939; Markov A., 1906, IZVESTIYA FIZIKOMATE, V2, P135; Pandurangan G, 2006, INTERNET MATH, V3, P1, DOI 10.1080/15427951.2006.10129114; Popov O, 1996, BIOSYSTEMS, V38, P65, DOI 10.1016/0303-2647(95)01568-X; Reinert G, 2009, J COMPUT BIOL, V16, P1615, DOI 10.1089/cmb.2009.0198; ROBIN S, 2005, DNA WORDS MODELS; Shepelyansky DL, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.036213; Ulam S. M., 1960, INTERSCIENCE TRACS P, V8, P73; Zhirov AO, 2010, EUR PHYS J B, V77, P523, DOI 10.1140/epjb/e2010-10500-7; Zipf G. K., 1949, HUMAN BEHAV PRINCIPL	31	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2013	8	5							e61519	10.1371/journal.pone.0061519	http://dx.doi.org/10.1371/journal.pone.0061519			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	155HD	23671568	Green Submitted, gold, Green Published			2022-12-27	WOS:000319737700003
J	Lee, WH; Wee, JH; Kim, DK; Rhee, CS; Lee, CH; Ahn, S; Lee, JH; Cho, YS; Lee, KH; Kim, KS; Kim, SW; Lee, A; Kim, JW				Lee, Woo Hyun; Wee, Jee Hye; Kim, Dong-Kyu; Rhee, Chae-Seo; Lee, Chul Hee; Ahn, Soyeon; Lee, Ju Hyun; Cho, Yang-Sun; Lee, Kun Hee; Kim, Kyung Soo; Kim, Si Whan; Lee, Ari; Kim, Jeong-Whun			Prevalence of Subjective Olfactory Dysfunction and Its Risk Factors: Korean National Health and Nutrition Examination Survey	PLOS ONE			English	Article							SMELL IDENTIFICATION; ADULT-POPULATION; MITRAL CELLS; AGE; SENSITIVITY; IMPAIRMENT; SMOKING; BULB	Background: Population-based studies for olfactory dysfunction are lacking. The aim of this study is to evaluate the prevalence of subjective olfactory dysfunction and its risk factors in the Korean general population. Methods: The data were obtained from the 2009 Korea National Health and Nutrition Examination Survey (KNHANES), which was a cross-sectional survey of non-institutionalized population all around the country (n = 10,533). All interviewees underwent medical interviews, physical examinations, endoscopic examination and blood/urine tests. Whether sense of smell has been normal or abnormal during the last 3 months was asked. Complete olfaction data were obtained from 7,306 participants and the participants were divided into normosmic and hyposmic group. Multivariate logistic regression analyses were performed to identify its risk factors. Results: The weighted prevalence of subjective olfactory dysfunction was 4.5%. Its increased prevalence was significantly associated with the increasing age for both men and women. In the multivariate analyses, low income (adjusted odds ratio [OR] = 1.43, 95% Confidence Interval [CI] = 1.01-2.03), habitual exposure to air pollutants (adjusted OR = 2.18, CI = 1.33-3.55), a history of hepatitis B (adjusted OR = 3.10, CI = 1.25-7.68), rhinitis (adjusted OR = 1.78, CI = 1.26-2.51) and chronic sinusitis (adjusted OR = 14.55, CI = 10.06-21.05) were risk factors of olfactory dysfunction. Conclusion: Our population-based study showed that olfactory dysfunction was quite prevalent and several risk factors were associated with impaired sense of smell. Given its prevalence, further researches for its prevention and management are required.	[Lee, Woo Hyun; Wee, Jee Hye; Kim, Dong-Kyu; Rhee, Chae-Seo; Lee, Chul Hee; Kim, Jeong-Whun] Seoul Natl Univ, Bundang Hosp, Dept Otorhinolaryngol, Songnam, South Korea; [Lee, Woo Hyun; Wee, Jee Hye; Kim, Dong-Kyu; Rhee, Chae-Seo; Lee, Chul Hee; Kim, Jeong-Whun] Seoul Natl Univ, Coll Med, Seoul, South Korea; [Ahn, Soyeon; Lee, Ju Hyun] Seoul Natl Univ, Bundang Hosp, Med Res Collaborating Ctr, Songnam, South Korea; [Cho, Yang-Sun] Sungkyunkwan Univ, Sch Med, Dept Otorhinolaryngol Head & Neck Surg, Seoul, South Korea; [Lee, Kun Hee] Kyung Hee Univ, Sch Med, Dept Otorhinolaryngol Head & Neck Surg, Seoul, South Korea; [Kim, Kyung Soo] Yonsei Univ, Coll Med, Dept Otorhinolaryngol Head & Neck Surg, Seoul 120749, South Korea; [Kim, Si Whan] Hallym Univ, Coll Med, Dept Otorhinolaryngol Head & Neck Surg, Anyang, South Korea; [Lee, Ari] Korea Ctr Dis Control & Prevent, Div Chron Dis Surveillance, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Sungkyunkwan University (SKKU); Kyung Hee University; Yonsei University; Yonsei University Health System; Hallym University; Korea Centers for Disease Control & Prevention (KCDC)	Kim, JW (corresponding author), Seoul Natl Univ, Bundang Hosp, Dept Otorhinolaryngol, Songnam, South Korea.	kimemail@snu.ac.kr	Lee, Kun Hee/AAH-9967-2020; Cho, Yang Sun/F-4611-2014	Lee, Kun Hee/0000-0002-5380-3726; 				Amoore J. E., 1986, TOXICOLOGY NASAL PAS; BHATNAGAR KP, 1987, ANAT REC, V218, P73, DOI 10.1002/ar.1092180112; Bramerson A, 2004, LARYNGOSCOPE, V114, P733; Doty RL, 1995, CHEM SENSES, V20, P645, DOI 10.1093/chemse/20.6.645; Doty RL., 2003, HDB OLFACTION GUSTAT, V2nd; Gobba F, 2006, INT ARCH OCC ENV HEA, V79, P322, DOI 10.1007/s00420-005-0043-x; HENKIN RI, 1971, LANCET, V1, P823; Hoffman HJ, 1998, ANN NY ACAD SCI, V855, P716, DOI 10.1111/j.1749-6632.1998.tb10650.x; HUBERT HB, 1980, SCIENCE, V208, P607, DOI 10.1126/science.7189296; Jernigan TL, 2001, NEUROBIOL AGING, V22, P581, DOI 10.1016/S0197-4580(01)00217-2; Jones N, 1998, J LARYNGOL OTOL, V112, P11, DOI 10.1017/S0022215100139829; JOYNER RE, 1964, ARCHIV OTOLARYNGOL, V80, P576; Lafreniere D, 2009, OTOLARYNG CLIN N AM, V42, P123, DOI 10.1016/j.otc.2008.09.001; Landis BN, 2004, LARYNGOSCOPE, V114, P1764, DOI 10.1097/00005537-200410000-00017; Meisami E, 1998, ANN NY ACAD SCI, V855, P708, DOI 10.1111/j.1749-6632.1998.tb10649.x; Murphy C, 2002, JAMA-J AM MED ASSOC, V288, P2307, DOI 10.1001/jama.288.18.2307; NAKASHIMA T, 1984, ARCH OTOLARYNGOL, V110, P641; Nordin S, 2004, ACTA OTO-LARYNGOL, V124, P1171, DOI 10.1080/00016480410017468; Schubert CR, 2012, CHEM SENSES, V37, P325, DOI 10.1093/chemse/bjr102; SHIP JA, 1993, J GERONTOL, V48, pM26, DOI 10.1093/geronj/48.1.M26; Ship JA, 1996, J GERONTOL A-BIOL, V51, pM86, DOI 10.1093/gerona/51A.2.M86; Temmel AFP, 2005, WIEN KLIN WOCHENSCHR, V117, P26, DOI 10.1007/s00508-004-0303-x; Van Toller S, 1999, CHEM SENSES, V24, P705, DOI 10.1093/chemse/24.6.705; VENSTROM D, 1968, J FOOD SCI, V33, P264, DOI 10.1111/j.1365-2621.1968.tb01364.x; WEINSTOCK RS, 1993, PHYSIOL BEHAV, V53, P17, DOI 10.1016/0031-9384(93)90005-Z	25	60	60	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2013	8	5							e62725	10.1371/journal.pone.0062725	http://dx.doi.org/10.1371/journal.pone.0062725			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	155HD	23671628	Green Published, gold, Green Submitted			2022-12-27	WOS:000319737700018
J	Werner, MU; Petersen, KL; Rowbotham, MC; Dahl, JB				Werner, Mads U.; Petersen, Karin L.; Rowbotham, Michael C.; Dahl, Jorgen B.			Healthy Volunteers Can Be Phenotyped Using Cutaneous Sensitization Pain Models	PLOS ONE			English	Article							HEAT-CAPSAICIN SENSITIZATION; ACUTE INFLAMMATORY PAIN; HYPERALGESIA; GABAPENTIN; ANALGESIA; AGREEMENT; MORPHINE; TWIN	Background: Human experimental pain models leading to development of secondary hyperalgesia are used to estimate efficacy of analgesics and antihyperalgesics. The ability to develop an area of secondary hyperalgesia varies substantially between subjects, but little is known about the agreement following repeated measurements. The aim of this study was to determine if the areas of secondary hyperalgesia were consistently robust to be useful for phenotyping subjects, based on their pattern of sensitization by the heat pain models. Methods: We performed post-hoc analyses of 10 completed healthy volunteer studies (n = 342 [409 repeated measurements]). Three different models were used to induce secondary hyperalgesia to monofilament stimulation: the heat/capsaicin sensitization (H/C), the brief thermal sensitization (BTS), and the burn injury (BI) models. Three studies included both the H/C and BTS models. Results: Within-subject compared to between-subject variability was low, and there was substantial strength of agreement between repeated induction-sessions in most studies. The intraclass correlation coefficient (ICC) improved little with repeated testing beyond two sessions. There was good agreement in categorizing subjects into 'small area' (1st quartile [<25%]) and 'large area' (4th quartile [>75%]) responders: 56-76% of subjects consistently fell into same 'small-area' or 'large-area' category on two consecutive study days. There was moderate to substantial agreement between the areas of secondary hyperalgesia induced on the same day using the H/C (forearm) and BTS (thigh) models. Conclusion: Secondary hyperalgesia induced by experimental heat pain models seem a consistent measure of sensitization in pharmacodynamic and physiological research. The analysis indicates that healthy volunteers can be phenotyped based on their pattern of sensitization by the heat [and heat plus capsaicin] pain models.	[Werner, Mads U.] Copenhagen Univ Hosp, Rigshosp, Ctr Multidisciplinary Pain, Neurosci Ctr, Copenhagen, Denmark; [Petersen, Karin L.; Rowbotham, Michael C.] Calif Pacific Med Ctr, Res Inst, San Francisco, CA USA; [Dahl, Jorgen B.] Rigshosp, Copenhagen Univ Hosp, Ctr Head & Orthopaed, Dept Anaesthesia, DK-2100 Copenhagen, Denmark	Rigshospitalet; University of Copenhagen; California Pacific Medical Center; California Pacific Medical Center Research Institute; Rigshospitalet; University of Copenhagen	Werner, MU (corresponding author), Copenhagen Univ Hosp, Rigshosp, Ctr Multidisciplinary Pain, Neurosci Ctr, Copenhagen, Denmark.	mads.u.werner@gmail.com	Rowbotham, Michael/AAA-3606-2019	Werner, Mads/0000-0003-1540-8845	Schwab Gift Fund at University of California, San Francisco (UCSF); Neuropathic Pain Research Gift Fund at California Pacific Medical Center Research Institute (CPMCRI)	Schwab Gift Fund at University of California, San Francisco (UCSF); Neuropathic Pain Research Gift Fund at California Pacific Medical Center Research Institute (CPMCRI)	Support was provided from institutional and departmental sources at Copenhagen University Hospital, from the Schwab Gift Fund at University of California, San Francisco (UCSF), and the Neuropathic Pain Research Gift Fund at California Pacific Medical Center Research Institute (CPMCRI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angst MS, 2012, PAIN, V153, P1397, DOI 10.1016/j.pain.2012.02.022; Armitage P, 2002, STAT METHODS MED RES, P648; Bland JM, 1999, STAT METHODS MED RES, V8, P135, DOI 10.1191/096228099673819272; Dirks J, 2000, ANESTH ANALG, V91, P967, DOI 10.1097/00000539-200010000-00037; Dirks J, 2003, J PAIN, V4, P122, DOI 10.1054/jpai.2003.10; Dirks J, 2002, ANESTHESIOLOGY, V97, P102, DOI 10.1097/00000542-200207000-00015; Dirks J, 2001, REGION ANESTH PAIN M, V26, P414, DOI 10.1097/00115550-200109000-00005; Frymoyer AR, 2007, J PAIN, V8, P19, DOI 10.1016/j.jpain.2006.05.010; Geber C, 2011, PAIN, V152, P548, DOI 10.1016/j.pain.2010.11.013; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Martinez V, 2012, PAIN, V153, P1478, DOI 10.1016/j.pain.2012.04.004; Mikkelsen S, 2001, BRIT J ANAESTH, V86, P871, DOI 10.1093/bja/86.6.871; Norbury TA, 2007, BRAIN, V130, P3041, DOI 10.1093/brain/awm233; Pedersen JL, 1998, PAIN, V74, P139, DOI 10.1016/S0304-3959(97)00160-7; Petersen KL, 2008, PAIN, V137, P395, DOI 10.1016/j.pain.2007.09.019; Petersen KL, 2001, ANESTHESIOLOGY, V94, P15, DOI 10.1097/00000542-200101000-00008; Pfau DB, 2011, PAIN, V152, P1532, DOI 10.1016/j.pain.2011.02.037; Ravn Pernille, 2012, J Pain Res, V5, P313, DOI 10.2147/JPR.S33925; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; Werner MU, 2004, ANESTHESIOLOGY, V100, P115, DOI 10.1097/00000542-200401000-00020; Werner MU, REG ANESTH PAIN MED, V26, P322; Woolf CJ, 2011, PAIN, V152, pS2, DOI 10.1016/j.pain.2010.09.030	22	33	33	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2013	8	5							e62733	10.1371/journal.pone.0062733	http://dx.doi.org/10.1371/journal.pone.0062733			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	155HD	23671631	Green Published, Green Submitted, gold			2022-12-27	WOS:000319737700020
J	Wu, Y; You, HH; Ma, P; Li, L; Yuan, Y; Li, JQ; Ye, X; Liu, XD; Yao, HC; Chen, RC; Lai, KF; Yang, X				Wu, Yang; You, Huihui; Ma, Ping; Li, Li; Yuan, Ye; Li, Jinquan; Ye, Xin; Liu, Xudong; Yao, Hanchao; Chen, Ruchong; Lai, Kefang; Yang, Xu			Role of Transient Receptor Potential Ion Channels and Evoked Levels of Neuropeptides in a Formaldehyde-Induced Model of Asthma in Balb/c Mice	PLOS ONE			English	Article							SUBSTANCE-P; NEUROGENIC INFLAMMATION; AIRWAY HYPERRESPONSIVENESS; IGE ANTIBODIES; TRP CHANNELS; CELLS; PAIN; MACROPHAGES; MECHANISMS; EXPRESSION	Objective: Asthma is a complex pulmonary inflammatory disease characterized by the hyper-responsiveness, remodeling and inflammation of airways. Formaldehyde is a common indoor air pollutant that can cause asthma in people experiencing long-term exposure. The irritant effect and adjuvant effect are the two possible pathways of formaldehyde promoted asthma. Methodology/Principal Findings: To explore the neural mechanisms and adjuvant effect of formaldehyde, 48 Balb/c mice in six experimental groups were exposed to (a) vehicle control; (b) ovalbumin; (c) formaldehyde (3.0 mg/m(3)); (d) ovalbumin+formaldehyde (3.0 mg/m(3)); (e) ovalbumin+formaldehyde (3.0 mg/m(3))+HC-030031 (transient receptor potential ankyrin 1 antagonist); (f) ovalbumin+formaldehyde (3.0 mg/m(3))+capsazepine (transient receptor potential vanilloid 1 antagonist). Experiments were conducted after 4 weeks of combined exposure and 1-week challenge with aerosolized ovalbumin. Airway hyper-responsiveness, pulmonary tissue damage, eosinophil infiltration, and increased levels of interleukin-4, interleukin-6, interleukin-1 beta, immunoglobulin E, substance P and calcitonin gene-related peptide in lung tissues were found in the ovalbumin+formaldehyde (3.0 mg/m(3)) group compared with the values seen in ovalbumin -only immunized mice. Except for interleukin-1 beta levels, other changes in the levels of biomarker could be inhibited by HC-030031 and capsazepine. Conclusions/Significance: Formaldehyde might be a key risk factor for the rise in asthma cases. Transient receptor potential ion channels and neuropeptides have important roles in formaldehyde promoted-asthma.	[Wu, Yang; You, Huihui; Ma, Ping; Li, Li; Yuan, Ye; Li, Jinquan; Ye, Xin; Liu, Xudong; Yao, Hanchao; Yang, Xu] Cent China Normal Univ, Sect Environm Biomed, Hubei Key Lab Genet Regulat & Integrat Biol, Coll Life Sci, Wuhan, Peoples R China; [Wu, Yang; Chen, Ruchong] Guangzhou Med Univ, Guangzhou Inst Resp Dis, State Key Lab Resp Dis, Guangzhou, Guangdong, Peoples R China; [Ma, Ping] Hubei Univ Sci & Technol, Coll Basic Med Sci, Xianning, Peoples R China	Central China Normal University; Guangzhou Medical University; State Key Laboratory of Respiratory Disease; Hubei University of Science & Technology	Lai, KF (corresponding author), Guangzhou Med Univ, Guangzhou Inst Resp Dis, State Key Lab Resp Dis, Guangzhou, Guangdong, Peoples R China.	klai@163.com; yangxu@mail.ccnu.edu.cn		li, jinquan/0000-0003-0498-5399	National Natural Science Foundation of China [51136002, 51076079]; State Key Laboratory of Respiratory Disease of China [2007DA780154F0906]; China Key Technologies RD Program [2012BAJ02B03]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); State Key Laboratory of Respiratory Disease of China; China Key Technologies RD Program	This work was funded by the National Natural Science Foundation of China (51136002 and 51076079), the Open Project of State Key Laboratory of Respiratory Disease of China (2007DA780154F0906), and the China Key Technologies R&D Program (No. 2012BAJ02B03). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2006, IARC MON EV CARC RIS, V88, P196; Apgar JM, 1998, J MICROSC-OXFORD, V191, P20; ATSDR (Agenct for Toxic Disease SUbstances Registry), 2010, TOX PROF FORM, P4; BANGLE R, 1954, J HISTOCHEM CYTOCHEM, V2, P62, DOI 10.1177/2.1.62; Barnes PJ, 2001, RESP PHYSIOL, V125, P145, DOI 10.1016/S0034-5687(00)00210-3; Bateman ED, 2008, EUR RESPIR J, V31, P143, DOI 10.1183/09031936.00138707; Bautista DM, 2013, ANNU REV PHYSIOL, V75, P181, DOI 10.1146/annurev-physiol-030212-183811; Bautista DM, 2005, P NATL ACAD SCI USA, V102, P12248, DOI 10.1073/pnas.0505356102; Belvisi MG, 2002, CURR OPIN PHARMACOL, V2, P211, DOI 10.1016/S1471-4892(02)00145-5; Bessac BF, 2008, PHYSIOLOGY, V23, P360, DOI 10.1152/physiol.00026.2008; Biro T, 1998, BLOOD, V91, P1332, DOI 10.1182/blood.V91.4.1332; Busse WW, 2001, NEW ENGL J MED, V344, P350, DOI 10.1056/NEJM200102013440507; Caceres AI, 2009, P NATL ACAD SCI USA, V106, P9099, DOI 10.1073/pnas.0900591106; Capuron L, 2011, PHARMACOL THERAPEUT, V130, P226, DOI 10.1016/j.pharmthera.2011.01.014; Carlsten C, 2012, CURR OPIN ALLERGY CL, V12, P455, DOI 10.1097/ACI.0b013e328357cc55; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Dakhama A, 2005, AM J PHYSIOL-LUNG C, V288, pL761, DOI 10.1152/ajplung.00143.2004; de Vries A, 2006, CLIN EXP ALLERGY, V36, P1192, DOI 10.1111/j.1365-2222.2006.02549.x; Drazen JM, 1999, ANNU REV PHYSIOL, V61, P593, DOI 10.1146/annurev.physiol.61.1.593; Ezratty V, 2007, ENVIRON HEALTH PERSP, V115, P210, DOI 10.1289/ehp.9414; Fahy John V, 2009, Proc Am Thorac Soc, V6, P256, DOI 10.1513/pats.200808-087RM; Geppetti P, 2008, BJU INT, V101, P2, DOI 10.1111/j.1464-410X.2008.07493.x; Germonpre PR, 1999, EUR RESPIR J, V14, P776, DOI 10.1034/j.1399-3003.1999.14d08.x; Giovanna P, 2009, INFLAMM ALLERGY DRUG, V8, P176; Grant J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031697; Hamid Q, 2009, ANNU REV PHYSIOL, V71, P489, DOI 10.1146/annurev.physiol.010908.163200; Han B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017236; Han Y, 2012, NEUROSCI BULL, V28, P165, DOI 10.1007/s12264-012-1211-0; Ho WZ, 1997, J IMMUNOL, V159, P5654; Joos GF, 2000, ALLERGY, V55, P321, DOI 10.1034/j.1398-9995.2000.00112.x; Jordt SE, 2004, NATURE, V427, P260, DOI 10.1038/nature02282; Jung WW, 2007, ENVIRON TOXICOL PHAR, V24, P174, DOI 10.1016/j.etap.2007.05.001; KRAMPS JA, 1989, CLIN EXP ALLERGY, V19, P509, DOI 10.1111/j.1365-2222.1989.tb02425.x; Larson SD, 2004, AM J PHYSIOL-LUNG C, V287, pL286, DOI 10.1152/ajplung.00369.2003; Lee LY, 2001, RESP PHYSIOL, V125, P47, DOI 10.1016/S0034-5687(00)00204-8; Leikauf GD, 2002, ENVIRON HEALTH PERSP, V110, P505, DOI 10.1289/ehp.02110s4505; LIDEN S, 1993, ALLERGY, V48, P525, DOI 10.1111/j.1398-9995.1993.tb01109.x; Liu DD, 2011, J IMMUNOTOXICOL, V8, P305, DOI 10.3109/1547691X.2011.600738; Locksley RM, 2010, CELL, V140, P777, DOI 10.1016/j.cell.2010.03.004; Lu Z, 2008, INDOOR AIR, V18, P77, DOI 10.1111/j.1600-0668.2008.00524.x; Lu ZS, 2005, FRONT BIOSCI-LANDMRK, V10, P2527, DOI 10.2741/1717; McAlexander MA, 2011, ADV EXP MED BIOL, V704, P969, DOI 10.1007/978-94-007-0265-3_50; McGwin G, 2010, ENVIRON HEALTH PERSP, V118, P313, DOI 10.1289/ehp.0901143; McNamara CR, 2007, P NATL ACAD SCI USA, V104, P13525, DOI 10.1073/pnas.0705924104; Mendell MJ, 2007, INDOOR AIR, V17, P259, DOI 10.1111/j.1600-0668.2007.00478.x; Mostafa GA, 2009, EGYPT J PEDIATR ALLE, V7, P45; Nambu Aya, 2010, Allergology International, V59, P125, DOI 10.2332/allergolint.10-RAI-0190; Nassini R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042454; Nilius B, 2007, PHYSIOL REV, V87, P165, DOI 10.1152/physrev.00021.2006; O'Connor TM, 2004, J CELL PHYSIOL, V201, P167, DOI 10.1002/jcp.20061; Qiao Y, 2009, INHAL TOXICOL, V21, P1200, DOI 10.3109/08958370902806159; Ramalho R, 2013, ALLERGY, V68, P48, DOI 10.1111/all.12052; Richardson JD, 2002, J PHARMACOL EXP THER, V302, P839, DOI 10.1124/jpet.102.032797; Rumchev KB, 2002, EUR RESPIR J, V20, P403, DOI 10.1183/09031936.02.00245002; Sadakane Kaori, 2002, Journal of Environmental Pathology Toxicology and Oncology, V21, P267; Salthammer T, 2010, CHEM REV, V110, P2536, DOI 10.1021/cr800399g; Schmiedeberg L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004636; Singer K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057929; Sousa AR, 1996, AM J RESP CRIT CARE, V154, P1061, DOI 10.1164/ajrccm.154.4.8887608; Tang XJ, 2009, ENVIRON INT, V35, P1210, DOI 10.1016/j.envint.2009.06.002; Tano JYK, 2012, CHANNELS, V6, P141, DOI 10.4161/chan.20292; TARKOWSKI M, 1995, INT ARCH ALLERGY IMM, V106, P422, DOI 10.1159/000236876; Tong ZQ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010234; Tracey KJ, 2009, NAT REV IMMUNOL, V9, P418, DOI 10.1038/nri2566; Undem Bradley J, 2002, Curr Allergy Asthma Rep, V2, P159, DOI 10.1007/s11882-002-0011-4; Yates AB, 2005, ATOPY ASTHMA ENCY LI, P1; Zhang D, 2012, PHYSIOL RES, V61, P113, DOI 10.33549/physiolres.932053	67	30	36	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2013	8	5							e62827	10.1371/journal.pone.0062827	http://dx.doi.org/10.1371/journal.pone.0062827			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	155HD	23671638	gold, Green Published, Green Submitted			2022-12-27	WOS:000319737700023
J	Yu, XF; Lu, CL; Liu, H; Rao, SX; Cai, JR; Liu, SP; Kriegel, AJ; Greene, AS; Liang, MY; Ding, XQ				Yu, Xiaofang; Lu, Chunlai; Liu, Hong; Rao, Shengxiang; Cai, Jieru; Liu, Shaopeng; Kriegel, Alison J.; Greene, Andrew S.; Liang, Minyu; Ding, Xiaoqiang			Hypoxic Preconditioning with Cobalt of Bone Marrow Mesenchymal Stem Cells Improves Cell Migration and Enhances Therapy for Treatment of Ischemic Acute Kidney Injury	PLOS ONE			English	Article							ACUTE-RENAL-FAILURE; INDUCIBLE FACTOR; CXCR4 EXPRESSION; STROMAL CELLS; INDUCTION; DIFFERENTIATION; CHEMOKINE; INHIBITION; PROTECTION; RECOVERY	Mesenchymal stem cell (MSC) administration is known to enhance the recovery of the kidney following injury. Here we tested the potential of hypoxic-preconditioned-MSC transplantation to enhance the efficacy of cell therapy on acute kidney injury (AKI) by improving MSC migration to the injured kidney. Cobalt was used as hypoxia mimetic preconditioning (HMP). MSC were subjected to HMP through 24 h culture in 200 mu mol/L cobalt. Compared to normoxia cultured MSC (NP-MSC), HMP significantly increased the expression of HIF-1 alpha and CXCR4 in MSC and enhanced the migration of MSC in vitro. This effect was lost when MSC were treated with siRNA targeting HIF-1 alpha or CXCR4 antagonist. SPIO labeled MSC were administered to rats with I/R injury followed immediately by magnetic resonance imaging. Imaging clearly showed that HMP-MSC exhibited greater migration and a longer retention time in the ischemic kidney than NP-MSC. Histological evaluation showed more HMP-MSC in the glomerular capillaries of ischemic kidneys than in the kidneys receiving NP-MSC. Occasional tubules showed iron labeling in the HMP group, while no tubules had iron labeling in NP group, indicating the possibility of tubular transdifferentiation after HMP. These results were also confirmed by fluorescence microscopy study using CM-DiI labeling. The increased recruitment of HMP-MSC was associated with reduced kidney injury and enhanced functional recovery. This effect was also related to the increased paracrine action by HMP-MSC. Thus we suggest that by enhancing MSC migration and prolonging kidney retention, hypoxic preconditioning of MSC may be a useful approach for developing AKI cell therapy.	[Yu, Xiaofang; Cai, Jieru; Liu, Shaopeng; Ding, Xiaoqiang] Fudan Univ, Dept Nephrol, Zhongshan Hosp, Shanghai Med Coll, Shanghai 200433, Peoples R China; [Lu, Chunlai] Fudan Univ, Dept Thorac Surg, Zhongshan Hosp, Shanghai Med Coll, Shanghai 200433, Peoples R China; [Liu, Hong] TCM, Hangzhou Hosp, Dept Nephrol, Hangzhou, Zhejiang, Peoples R China; [Rao, Shengxiang] Fudan Univ, Dept Radiol, Zhongshan Hosp, Shanghai Med Coll, Shanghai 200433, Peoples R China; [Kriegel, Alison J.; Greene, Andrew S.; Liang, Minyu] Med Coll Wisconsin, Dept Physiol, Milwaukee, WI 53226 USA	Fudan University; Fudan University; Fudan University; Medical College of Wisconsin	Yu, XF (corresponding author), Fudan Univ, Dept Nephrol, Zhongshan Hosp, Shanghai Med Coll, Shanghai 200433, Peoples R China.	yu.xiaofang@zs-hospital.sh.cn; ding.xiaoqiang@zs-hospital.sh.cn	Rao, Sheng-Xiang/I-8612-2019; Greene, Andrew S/B-9696-2015; Liang, Mingyu/A-2331-2008; Rao, Sheng-Xiang/AGL-7232-2022	Rao, Sheng-Xiang/0000-0001-7722-8327; Rao, Sheng-Xiang/0000-0001-7722-8327; Greene, Andrew/0000-0002-3191-2112	National Natural Science Funds of China [81000307, 81100524]; Major Project of Technology Committee in Shanghai of China [12DJ1400200]	National Natural Science Funds of China(National Natural Science Foundation of China (NSFC)); Major Project of Technology Committee in Shanghai of China	This study was supported by grants from National Natural Science Funds of China (Nos. 81000307 and 81100524) and the Major Project of Technology Committee in Shanghai of China (No. 12DJ1400200). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmadbeigi N, 2010, CELL BIOL INT, V34, P687, DOI 10.1042/CBI20090415; Bellomo R, 2004, CRIT CARE, V8, pR204, DOI 10.1186/cc2872; Bussolati B, 2008, AM J NEPHROL, V28, P813, DOI 10.1159/000137681; Ceradini DJ, 2004, NAT MED, V10, P858, DOI 10.1038/nm1075; Chacko SM, 2010, AM J PHYSIOL-CELL PH, V299, pC1562, DOI 10.1152/ajpcell.00221.2010; Chamberlain G, 2007, STEM CELLS, V25, P2739, DOI 10.1634/stemcells.2007-0197; Das R, 2010, TISSUE ENG PART B-RE, V16, P159, DOI 10.1089/ten.TEB.2009.0296; Demirjian SG, 2011, CONTRIB NEPHROL, V174, P242, DOI 10.1159/000329402; El Sabbahy M, 2011, WIRES SYST BIOL MED, V3, P606, DOI 10.1002/wsbm.133; Fang Y, 2010, BLOOD PURIFICAT, V30, P120, DOI 10.1159/000319972; GOLDBERG MA, 1988, SCIENCE, V242, P1412, DOI 10.1126/science.2849206; Grayson WL, 2007, BIOCHEM BIOPH RES CO, V358, P948, DOI 10.1016/j.bbrc.2007.05.054; Hagiwara M, 2008, HUM GENE THER, V19, P807, DOI [10.1089/hum.2008.016, 10.1089/hgt.2008.016]; Hara Y, 2011, TRANSPL INT, V24, P1112, DOI 10.1111/j.1432-2277.2011.01328.x; Harrison JS, 2002, BLOOD, V99, P394, DOI 10.1182/blood.V99.1.394; Harting MT, 2008, CYTOTHERAPY, V10, P243, DOI 10.1080/14653240801950000; Hashimoto O, 2011, PATHOBIOLOGY, V78, P181, DOI 10.1159/000325538; Hauger O, 2006, RADIOLOGY, V238, P200, DOI 10.1148/radiol.2381041668; Honczarenko M, 2006, STEM CELLS, V24, P1030, DOI 10.1634/stemcells.2005-0319; Horiguchi H, 2004, TOXICOL LETT, V151, P459, DOI 10.1016/j.toxlet.2004.03.018; Ishikawa T, 2009, ONCOL REP, V21, P707, DOI 10.3892/or_00000275; Ittrich H, 2007, J MAGN RESON IMAGING, V25, P1179, DOI 10.1002/jmri.20925; Jiang HT, 2011, J SURG RES, V168, P127, DOI 10.1016/j.jss.2009.07.035; Jiang SH, 2007, CELL BIOCHEM FUNCT, V25, P335, DOI 10.1002/cbf.1395; Kim KS, 2006, J IMMUNOL, V177, P7211, DOI 10.4049/jimmunol.177.10.7211; Lange C, 2005, KIDNEY INT, V68, P1613, DOI 10.1111/j.1523-1755.2005.00573.x; Le Blanc K, 2003, CYTOTHERAPY, V5, P485, DOI 10.1080/14653240310003611; Liu HB, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0034608, 10.1371/journal.pone.0050785]; Liu HB, 2010, BIOCHEM BIOPH RES CO, V401, P509, DOI 10.1016/j.bbrc.2010.09.076; Liu KD, 2008, CRIT CARE MED, V36, pS187, DOI 10.1097/CCM.0b013e318168ca4a; Lotan D, 2008, PEDIATR NEPHROL, V23, P71, DOI 10.1007/s00467-007-0648-2; Matsumoto M, 2003, J AM SOC NEPHROL, V14, P1825, DOI 10.1097/01.ASN.0000074239.22357.06; Moll NM, 2010, EXPERT REV HEMATOL, V3, P315, DOI 10.1586/EHM.10.16; Nervi B, 2006, J CELL BIOCHEM, V99, P690, DOI 10.1002/jcb.21043; Ohtomo S, 2008, NEPHROL DIAL TRANSPL, V23, P1166, DOI 10.1093/ndt/gfm715; Pacary E, 2006, J CELL SCI, V119, P2667, DOI 10.1242/jcs.03004; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Sagrinati C, 2008, TRENDS MOL MED, V14, P277, DOI 10.1016/j.molmed.2008.05.005; Salnikow K, 2004, J BIOL CHEM, V279, P40337, DOI 10.1074/jbc.M403057200; Schioppa T, 2003, J EXP MED, V198, P1391, DOI 10.1084/jem.20030267; Semedo P, 2007, TRANSPL P, V39, P421, DOI 10.1016/j.transproceed.2007.01.036; Song YR, 2010, NEPHROL DIAL TRANSPL, V25, P77, DOI 10.1093/ndt/gfp454; Sun JH, 2008, SWISS MED WKLY, V138, P404, DOI 2008/27/smw-12000; Tanaka T, 2005, KIDNEY INT, V68, P2714, DOI 10.1111/j.1523-1755.2005.00742.x; Tanaka T, 2005, LAB INVEST, V85, P1292, DOI 10.1038/labinvest.3700328; Tang YL, 2009, CIRC RES, V104, P1209, DOI 10.1161/CIRCRESAHA.109.197723; Togel F, 2005, AM J PHYSIOL-RENAL, V289, pF31, DOI 10.1152/ajprenal.00007.2005; Togel F, 2005, KIDNEY INT, V67, P1772, DOI 10.1111/j.1523-1755.2005.00275.x; Togel F, 2007, AM J PHYSIOL-RENAL, V292, pF1626, DOI 10.1152/ajprenal.00339.2006; Wang XB, 2008, BIOCHEM BIOPH RES CO, V371, P283, DOI 10.1016/j.bbrc.2008.04.055; Wang Y, 2008, BRAIN RES, V1195, P104, DOI 10.1016/j.brainres.2007.11.068	51	51	56	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2013	8	5							e62703	10.1371/journal.pone.0062703	http://dx.doi.org/10.1371/journal.pone.0062703			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	155HD	23671625	Green Published, gold, Green Submitted			2022-12-27	WOS:000319737700017
J	Wang, W; Liu, ZH; Qu, P; Zhou, ZD; Zeng, YG; Fan, J; Liu, Y; Guo, YF; Qiu, JX				Wang, Wei; Liu, Zhihong; Qu, Ping; Zhou, Zhengdong; Zeng, Yigang; Fan, Jie; Liu, Yong; Guo, Yifeng; Qiu, Jianxin			Knockdown of Regulator of Cullins-1 (ROC1) Expression Induces Bladder Cancer Cell Cycle Arrest at the G2 Phase and Senescence	PLOS ONE			English	Article							NEDD8-ACTIVATING ENZYME; CHECKPOINTS; INHIBITOR	Regulator of Cullins-1 (ROC1) is a key subunit in the Cullin-RING ligase (CRL) protein complex. Overexpression of ROC1 protein is associated with tumor progression and poor prognosis of non-muscle invasive bladder transitional cell carcinoma (NMIBC). This study was designed to assess the effects of ROC1 knockdown in bladder cancer cells and to determine the potential mechanisms involved. A total of 112 bladder cancer tissue specimens were recruited for immunohistochemical analyses of ROC1 overexpression. Bladder cancer cell lines were used to knockdown ROC1 expression using ROC1 siRNA. Our data showed that ROC1 knockdown remarkably inhibited bladder cancer cell growth, arrested cells at the G2 phase of the cell cycle, and induced the p53-dependent cell senescence. Molecularly, G2 arrest was associated with upregulation of p21, p27, cyclin B1, and Cdc2 proteins. ROC1 knockdown induced-senescence functioned through p53/p21 pathway. Knockdown of p21 expression partially rescued ROC1 knockdown-induced growth inhibition in cancer cells. Furthermore, nude mouse xenograft analyses confirmed these in vitro data. In conclusion, data from the current study indicate that ROC1 plays an essential role in bladder cancer progression and could serve as a novel anticancer target for bladder transitional cell carcinoma (BTCC).	[Wang, Wei; Liu, Zhihong; Zeng, Yigang; Fan, Jie; Liu, Yong; Guo, Yifeng; Qiu, Jianxin] Shanghai Jiao Tong Univ, Sch Med, Shanghai Peoples Hosp 1, Dept Urol, Shanghai 200030, Peoples R China; [Wang, Wei; Qu, Ping; Zhou, Zhengdong] Nantong Univ, Yancheng Peoples Hosp 1, Affiliated Hosp 4, Dept Urol, Nantong, Jiangsu, Peoples R China	Shanghai Jiao Tong University; Nantong University	Qiu, JX (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Shanghai Peoples Hosp 1, Dept Urol, Shanghai 200030, Peoples R China.	jasonqiu@sjtu.edu.cn	Qiu, Jason/B-3502-2012	Qiu, Jason/0000-0003-1067-3199	Shanghai Academic Leaders' Program of the Health System [XBR2011038]	Shanghai Academic Leaders' Program of the Health System	This work was supported by Shanghai Academic Leaders' Program of the Health System (No. XBR2011038). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Campisi J, 2005, CELL, V120, P513, DOI 10.1016/j.cell.2005.02.003; Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233; Gabrielli B, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00009; Jacobs BL, 2010, CA-CANCER J CLIN, V60, P244, DOI 10.3322/caac.20077; Jia LJ, 2011, J BIOL CHEM, V286, P3379, DOI 10.1074/jbc.M110.188425; Jia LJ, 2009, CANCER RES, V69, P4974, DOI 10.1158/0008-5472.CAN-08-4671; Kaufman DS, 2009, LANCET, V374, P239, DOI 10.1016/S0140-6736(09)60491-8; Lee CT, 2001, CLIN CANCER RES, V7, P210; Lin DI, 2006, MOL CELL, V24, P355, DOI 10.1016/j.molcel.2006.09.007; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Malumbres M, 2005, TRENDS BIOCHEM SCI, V30, P630, DOI 10.1016/j.tibs.2005.09.005; Malumbres M, 2009, NAT REV CANCER, V9, P153, DOI 10.1038/nrc2602; Milhollen MA, 2010, BLOOD, V116, P1515, DOI 10.1182/blood-2010-03-272567; Mitra AP, 2007, WORLD J UROL, V25, P563, DOI 10.1007/s00345-007-0197-0; Mitra AP, 2009, ANNU REV PATHOL-MECH, V4, P251, DOI 10.1146/annurev.pathol.4.110807.092230; Nai G, 2011, PATHOL RES PRACT, V207, P174, DOI 10.1016/j.prp.2011.01.001; Nakayama KI, 2006, NAT REV CANCER, V6, P369, DOI 10.1038/nrc1881; Pan H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048799; Petroski MD, 2005, NAT REV MOL CELL BIO, V6, P9, DOI 10.1038/nrm1547; Prasad SM, 2011, NAT REV UROL, V8, P631, DOI 10.1038/nrurol.2011.144; Schauble S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042150; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Soucy TA, 2009, NATURE, V458, P732, DOI 10.1038/nature07884; Tan M, 2009, P NATL ACAD SCI USA, V106, P6203, DOI 10.1073/pnas.0812425106; Xu B, 2001, MOL CELL BIOL, V21, P3445, DOI 10.1128/MCB.21.10.3445-3450.2001; Yang D, 2013, CELL DEATH DIFFER, V20, P235, DOI 10.1038/cdd.2012.113; Yang D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034079	27	18	19	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2013	8	5							e62734	10.1371/journal.pone.0062734	http://dx.doi.org/10.1371/journal.pone.0062734			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145YI	23667514	Green Published, gold, Green Submitted			2022-12-27	WOS:000319055600042
J	Yang, C; Yang, WH; Chen, SS; Ma, BF; Li, B; Lu, T; Qu, TY; Klein, RL; Zhao, LR; Duan, WM				Yang, Chun; Yang, Wei-Hua; Chen, Sha-Sha; Ma, Bao-Feng; Li, Bin; Lu, Tao; Qu, Ting-Yu; Klein, Ronald L.; Zhao, Li-Ru; Duan, Wei-Ming			Pre-immunization with an Intramuscular Injection of AAV9-Human Erythropoietin Vectors Reduces the Vector-Mediated Transduction following Re-Administration in Rat Brain	PLOS ONE			English	Article							ADENOASSOCIATED VIRUS VECTORS; GENE-TRANSFER; PARKINSONS-DISEASE; TRANSGENE EXPRESSION; VIRAL VECTORS; NEUTRALIZING ANTIBODIES; DOPAMINERGIC-NEURONS; CEREBRAL-ISCHEMIA; IMMUNE-RESPONSES; PRIMATE MODEL	We have recently demonstrated that adeno-associated virus serotype 9 (AAV9)-mediated human erythropoietin (hEPO) gene delivery into the brain protects dopaminergic (DA) neurons in the substantia nigra in a rat model of Parkinson's disease. In the present study, we examined whether pre-exposure to AAV9-hEPO vectors with an intramuscular or intrastriatal injection would reduce AAV9-mediated hEPO transduction in rat brain. We first characterized transgene expression and immune responses against AAV9-hEPO vectors in rat striatum at 4 days, 3 weeks and 6 months, and with doses ranging from 10(11) to 10(13) viral genomes. To sensitize immune system, rats received an injection of AAV9-hEPO into either the muscle or the left striatum, and then sequentially an injection of AAV9-hEPO into the right striatum 3 weeks later. We observed that transgene expression exhibited in a time course and dose dependent manner, and inflammatory and immune responses displayed in a time course manner. Intramuscular, but not intrastriatal injections of AAV9-hEPO resulted in reduced levels of hEPO transduction and increased levels of the major histocompatibility complex (MHC) class I and class II antigen expression in the striatum following AAV9-hEPO re-administration. There were infiltration of the cluster of differentiation 4 (CD4)-and CD8-lymphacytes, and accumulation of activated microglial cells and astrocytes in the virally injected striatum. In addition, the sera from the rats with intramuscular injections of AAV9-hEPO contained greater levels of antibodies against both AAV9 capsid protein and hEPO protein than the other treatment groups. hEPO gene expression was negatively correlated with the levels of circulating antibodies against AAV9 capsid protein. Intramuscular and intrastriatal readministration of AAV9-hEPO led to increased numbers of red blood cells in peripheral blood. Our results suggest that preimmunization with an intramuscular injection can lead to the reduction of transgene expression in the striatal readministration.	[Yang, Chun; Yang, Wei-Hua; Chen, Sha-Sha; Lu, Tao; Duan, Wei-Ming] Capital Med Univ, Dept Anat, Beijing, Peoples R China; [Ma, Bao-Feng] Louisiana State Univ Hlth Sci Ctr, Dept Cellular Biol & Anat, Shreveport, LA USA; [Li, Bin] Louisiana State Univ Hlth Sci Ctr, Dept Neurol, Shreveport, LA USA; [Qu, Ting-Yu] Univ Illinois, Coll Med, Dept Psychiat, Chicago, IL USA; [Klein, Ronald L.] Louisiana State Univ Hlth Sci Ctr, Dept Pharmacol Toxicol & Neurosci, Shreveport, LA USA; [Zhao, Li-Ru] SUNY Upstate Med Univ, Dept Neurosurg, Syracuse, NY 13210 USA	Capital Medical University; Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport; Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center	Duan, WM (corresponding author), Capital Med Univ, Dept Anat, Beijing, Peoples R China.	duanwm08@yahoo.com	qu, tingyu/AGX-7752-2022; qu, tingyu/AHA-0840-2022		Chinese Ministry of Science and Technology [2011CB504100]; Beijing Natural Science Foundation [11120087, 7112011]	Chinese Ministry of Science and Technology(Ministry of Science and Technology, China); Beijing Natural Science Foundation(Beijing Natural Science Foundation)	This work was supported by grants from the Chinese Ministry of Science and Technology (2011CB504100, to WMD), Beijing Natural Science Foundation (11120087, to WMD; 7112011, to WMD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bankiewicz KS, 2006, MOL THER, V14, P564, DOI 10.1016/j.ymthe.2006.05.005; Boutin S, 2010, HUM GENE THER, V21, P704, DOI 10.1089/hum.2009.182; Brockstedt DG, 1999, CLIN IMMUNOL, V92, P67, DOI 10.1006/clim.1999.4724; Broekman MLD, 2006, NEUROSCIENCE, V138, P501, DOI 10.1016/j.neuroscience.2005.11.057; Calcedo R, 2009, J INFECT DIS, V199, P381, DOI 10.1086/595830; Cearley CN, 2006, MOL THER, V13, P528, DOI 10.1016/j.ymthe.2005.11.015; Ciesielska A, 2012, MOL THER; Digicaylioglu M, 2001, NATURE, V412, P641, DOI 10.1038/35088074; Duan WM, 1997, NEUROSCIENCE, V77, P599, DOI 10.1016/S0306-4522(96)00470-8; DUAN WM, 1995, NEUROSCIENCE, V64, P629, DOI 10.1016/0306-4522(94)00416-3; DUAN WM, 1995, EXP BRAIN RES, V104, P227; DUAN WM, 1993, NEUROSCIENCE, V57, P261, DOI 10.1016/0306-4522(93)90061-J; Duan WM, 1997, EXP NEUROL, V148, P334, DOI 10.1006/exnr.1997.6656; Foust KD, 2009, NAT BIOTECHNOL, V27, P59, DOI 10.1038/nbt.1515; Ge Y, 2001, BLOOD, V97, P3733, DOI 10.1182/blood.V97.12.3733; Halbert CL, 2000, J VIROL, V74, P1524, DOI 10.1128/JVI.74.3.1524-1532.2000; Kaplitt MG, 2007, LANCET, V369, P2097, DOI 10.1016/S0140-6736(07)60982-9; Klein RL, 2006, MOL THER, V13, P517, DOI 10.1016/j.ymthe.2005.10.008; Klein RL, 2008, EUR J NEUROSCI, V27, P1615, DOI 10.1111/j.1460-9568.2008.06161.x; Klein RL, 2008, MOL THER, V16, P89, DOI 10.1038/sj.mt.6300331; Klein RL, 2010, NEUROBIOL AGING, V31, P2091, DOI 10.1016/j.neurobiolaging.2008.12.002; Li CW, 2007, J VIROL, V81, P7540, DOI 10.1128/JVI.00529-07; Li H, 2007, MOL THER, V15, P792, DOI 10.1038/sj.mt.6300090; Liu RQ, 2006, J NEUROCHEM, V96, P1101, DOI 10.1111/j.1471-4159.2005.03597.x; Lo WD, 1999, HUM GENE THER, V10, P201, DOI 10.1089/10430349950018995; Lowenstein PR, 2007, CURR GENE THER, V7, P347, DOI 10.2174/156652307782151498; Mandel RJ, 2006, MOL THER, V13, P463, DOI 10.1016/j.ymthe.2005.11.009; Manning WC, 1998, HUM GENE THER, V9, P477, DOI 10.1089/hum.1998.9.4-477; Mastakov MY, 2002, J VIROL, V76, P8446, DOI 10.1128/JVI.76.16.8446-8454.2002; McIntosh JH, 2012, GENE THER, V19, P78, DOI 10.1038/gt.2011.64; Mingozzi F, 2007, BLOOD, V110, P2334, DOI 10.1182/blood-2007-03-080093; Mingozzi F, 2007, NAT MED, V13, P419, DOI 10.1038/nm1549; Muramatsu SI, 2002, HUM GENE THER, V13, P345, DOI 10.1089/10430340252792486; Peden CS, 2009, MOL THER, V17, P524, DOI 10.1038/mt.2008.284; Peden CS, 2004, J VIROL, V78, P6344, DOI 10.1128/JVI.78.12.6344-6359.2004; Petry H, 2008, GENE THER, V15, P54, DOI 10.1038/sj.gt.3303037; Rapti K, 2012, MOL THER, V20, P73, DOI 10.1038/mt.2011.177; Reimsnider S, 2007, MOL THER, V15, P1504, DOI 10.1038/sj.mt.6300227; Sanftner LM, 2004, MOL THER, V9, P403, DOI 10.1016/j.ymthe.2003.12.005; Signore AP, 2006, J NEUROCHEM, V96, P428, DOI 10.1111/j.1471-4159.2005.03587.x; Siren AL, 2001, P NATL ACAD SCI USA, V98, P4044, DOI 10.1073/pnas.051606598; Veron P, 2012, J IMMUNOL, V188, P6418, DOI 10.4049/jimmunol.1200620; Villa P, 2003, J EXP MED, V198, P971, DOI 10.1084/jem.20021067; Wang DB, 2010, MOL THER, V18, P2064, DOI 10.1038/mt.2010.191; WEST MJ, 1991, ANAT RECORD, V231, P482, DOI 10.1002/ar.1092310411; Xiao WD, 2000, MOL THER, V1, P323, DOI 10.1006/mthe.2000.0045; Xue YQ, 2007, NEUROSCIENCE, V146, P1245, DOI 10.1016/j.neuroscience.2007.02.004; Xue YQ, 2010, GENE THER, V17, P83, DOI 10.1038/gt.2009.113; Zaiss AK, 2008, GENE THER, V15, P808, DOI 10.1038/gt.2008.54	49	7	7	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2013	8	5							e63876	10.1371/journal.pone.0063876	http://dx.doi.org/10.1371/journal.pone.0063876			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145YI	23667683	Green Published, Green Submitted, gold			2022-12-27	WOS:000319055600078
J	Pedersen, J; Jensen, TB; Carlsen, THR; Schonning, K; Christensen, PB; Laursen, AL; Krarup, H; Bukh, J; Weis, N				Pedersen, Jannie; Jensen, Tanja B.; Carlsen, Thomas H. R.; Schonning, Kristian; Christensen, Peer Brehm; Laursen, Alex Lund; Krarup, Henrik; Bukh, Jens; Weis, Nina			Neutralizing Antibodies in Patients with Chronic Hepatitis C, Genotype 1, against a Panel of Genotype 1 Culture Viruses: Lack of Correlation to Treatment Outcome	PLOS ONE			English	Article							ALPHA-2B PLUS RIBAVIRIN; HYPERVARIABLE REGION-1; ANTIVIRAL TREATMENT; IMMUNE-RESPONSES; INFECTION; PEGINTERFERON; TELAPREVIR; INTERFERON; CLEARANCE; TRANSMISSION	The correlation of neutralizing antibodies to treatment outcome in patients with chronic hepatitis C virus (HCV) infection has not been established. The aim of this study was to determine whether neutralizing antibodies could be used as an outcome predictor in patients with chronic HCV, genotype 1, infection treated with pegylated interferon-alpha and ribavirin. Thirty-nine patients with chronic hepatitis C, genotype 1a or 1b, with either sustained virologic response (n = 23) or non-sustained virologic response (n = 16) were enrolled. Samples taken prior to treatment were tested for their ability to neutralize 6 different HCV genotype 1 cell culture recombinants (1a: H77/JFH1, TN/JFH1, DH6/JFH1; 1b: J4/JFH1, DH1/JFH1, DH5/JFH1). The results were expressed as the highest dilution yielding 50% neutralization (NAb(50)-titer). We observed no genotype or subtype specific differences in NAb(50)-titers between patients with chronic HCV infection with and without sustained virologic response when tested against any of the included culture viruses. However, NAb(50)-titers varied significantly with a mean reciprocal NAb(50)-titer of 800 (range: 100-6400) against DH6/JFH1 compared to a mean NAb(50)-titer of 50 (range: <50-400) against all other included isolates. Subsequent studies demonstrated that the efficient neutralization of DH6/JFH1 could be linked to engineered adaptive mutations in the envelope-2 protein. In analysis of envelope 1 and 2 sequences of HCV, recovered from a subset of patients, we observed no apparent link between relatedness of patient sequences with culture viruses used and the corresponding neutralization results. In conclusion, pre-treatment levels of neutralizing antibodies against HCV genotype 1 isolates could not predict treatment outcome in patients with chronic HCV infection. High neutralization susceptibility of DH6/JFH1 could be correlated with adaptive envelope mutations previously highlighted as important for neutralization. Our study emphasizes the importance of using multiple culture viruses for neutralization studies and contributes to the current knowledge about neutralizing epitopes, important for future therapeutic- and vaccine-studies.	[Pedersen, Jannie; Weis, Nina] Copenhagen Univ Hosp, Dept Infect Dis, Hvidovre, Denmark; [Pedersen, Jannie; Jensen, Tanja B.; Carlsen, Thomas H. R.; Bukh, Jens] Copenhagen Univ Hosp, Copenhagen Hepatitis Program CO HEP C, Dept Infect Dis, Hvidovre, Denmark; [Pedersen, Jannie; Jensen, Tanja B.; Carlsen, Thomas H. R.; Bukh, Jens] Copenhagen Univ Hosp, Clin Res Ctr, Hvidovre, Denmark; [Schonning, Kristian] Copenhagen Univ Hosp, Dept Clin Microbiol, Hvidovre, Denmark; [Christensen, Peer Brehm] Odense Univ Hosp, Dept Infect Dis, DK-5000 Odense, Denmark; [Laursen, Alex Lund] Aarhus Univ Hosp, Dept Infect Dis, Skejby, Denmark; [Krarup, Henrik] Aalborg Univ Hosp, Dept Clin Biochem, Aalborg, Denmark; [Weis, Nina] Univ Copenhagen, Fac Hlth & Med Sci, Copenhagen, Denmark; [Pedersen, Jannie; Jensen, Tanja B.; Carlsen, Thomas H. R.; Bukh, Jens] Univ Copenhagen, Dept Int Hlth Immunol & Microbiol, Fac Hlth & Med Sci, Copenhagen, Denmark	University of Copenhagen; University of Copenhagen; University of Copenhagen; University of Copenhagen; University of Southern Denmark; Odense University Hospital; Aarhus University; Aalborg University; Aalborg University Hospital; University of Copenhagen; University of Copenhagen	Bukh, J (corresponding author), Copenhagen Univ Hosp, Copenhagen Hepatitis Program CO HEP C, Dept Infect Dis, Hvidovre, Denmark.	jbukh@sund.ku.dk; ninaweis@dadlnet.dk	Weis, Nina/GLT-4232-2022; Christensen, Peer B./B-8042-2015	Christensen, Peer Brehm/0000-0003-1394-058X; Weis, Nina/0000-0002-3133-2724; Laursen, Alex Lund/0000-0002-1206-156X; Pedersen, Jannie/0000-0003-2822-3014; Bukh, Jens/0000-0002-7815-4806; Krarup, Henrik/0000-0001-5294-2428	A.P. Moller Foundation for the Advancement of Medical Science; Danish Agency for Science Technology and Innovation; Capital Region of Denmarks Research Foundation; Lundbeck Foundation; Danish Cancer Society; Novo Nordisk Foundation; Danish Medical Research Council; Faculty of Health Science, University of Copenhagen; Novo Nordisk Fonden [NNF12OC0002037] Funding Source: researchfish	A.P. Moller Foundation for the Advancement of Medical Science; Danish Agency for Science Technology and Innovation; Capital Region of Denmarks Research Foundation; Lundbeck Foundation(Lundbeckfonden); Danish Cancer Society(Danish Cancer Society); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Faculty of Health Science, University of Copenhagen; Novo Nordisk Fonden(Novo Nordisk Foundation)	The A.P. Moller Foundation for the Advancement of Medical Science (grant support to NW), the Danish Agency for Science Technology and Innovation (NW, JP); The Capital Region of Denmarks Research Foundation (JB), the Lundbeck Foundation (JB), the Danish Cancer Society (JB), the Novo Nordisk Foundation (JB), The Danish Medical Research Council (JB), and Ph.D stipends from the Faculty of Health Science, University of Copenhagen (THRC, TBJ) supported the study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Askarieh G, 2010, HEPATOLOGY, V51, P1523, DOI 10.1002/hep.23509; Bartosch B, 2005, J VIROL, V79, P8217, DOI 10.1128/JVI.79.13.8217-8229.2005; Boo I, 2007, J CLIN VIROL, V39, P288, DOI 10.1016/j.jcv.2007.04.019; Christensen PB, 2007, SCAND J INFECT DIS, V39, P245, DOI 10.1080/00365540600978864; Clausen LN, 2011, J VIRAL HEPATITIS, V18, pe66, DOI 10.1111/j.1365-2893.2010.01392.x; Corbet S, 2003, J CLIN MICROBIOL, V41, P1091, DOI 10.1128/JCM.41.3.1091-1100.2003; Darling JM, 2011, HEPATOLOGY, V53, P14, DOI 10.1002/hep.24056; Davis GL, 2003, HEPATOLOGY, V38, P645, DOI 10.1053/jhep.2003.50364; Farci P, 1999, J INFECT DIS, V179, P1007, DOI 10.1086/314653; Fofana I, 2012, GASTROENTEROLOGY, V143, P223, DOI 10.1053/j.gastro.2012.04.006; Freeman AJ, 2001, HEPATOLOGY, V34, P809, DOI 10.1053/jhep.2001.27831; Gerotto M, 2001, BLOOD, V98, P2657, DOI 10.1182/blood.V98.9.2657; Giang E, 2012, P NATL ACAD SCI USA, V109, P6205, DOI 10.1073/pnas.1114927109; Gottwein JM, 2007, GASTROENTEROLOGY, V133, P1614, DOI 10.1053/j.gastro.2007.08.005; Gottwein JM, 2010, J VIROL, V84, P5277, DOI 10.1128/JVI.02667-09; Gottwein JM, 2009, HEPATOLOGY, V49, P364, DOI 10.1002/hep.22673; Hansen N, 2009, J VIRAL HEPATITIS, V16, P659, DOI 10.1111/j.1365-2893.2009.01126.x; Hansen N, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-177; Helle F, 2007, J VIROL, V81, P8101, DOI 10.1128/JVI.00127-07; HOHNE M, 1994, ARCH VIROL, V137, P25, DOI 10.1007/BF01311170; Jacobson IM, 2011, NEW ENGL J MED, V364, P2405, DOI 10.1056/NEJMoa1012912; Jensen TB, 2008, J INFECT DIS, V198, P1756, DOI 10.1086/593021; Keck ZY, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002653; Keck Z, 2013, J VIROL, V87, P37, DOI 10.1128/JVI.01941-12; Kolykhalov AA, 1997, SCIENCE, V277, P570, DOI 10.1126/science.277.5325.570; Kong L, 2012, P NATL ACAD SCI USA, V109, P9499, DOI 10.1073/pnas.1202924109; Kumada H, 2012, J HEPATOL, V56, P78, DOI 10.1016/j.jhep.2011.07.016; Lavanchy D, 2009, LIVER INT, V29, P74, DOI 10.1111/j.1478-3231.2008.01934.x; Law M, 2008, NAT MED, V14, P25, DOI 10.1038/nm1698; Lechner F, 2000, J EXP MED, V191, P1499, DOI 10.1084/jem.191.9.1499; Lindenbach BD, 2005, SCIENCE, V309, P623, DOI 10.1126/science.1114016; Liu L, 2010, J VIROL, V84, P5067, DOI 10.1128/JVI.02265-09; Logvinoff C, 2004, P NATL ACAD SCI USA, V101, P10149, DOI 10.1073/pnas.0403519101; Manns MP, 2001, LANCET, V358, P958, DOI 10.1016/S0140-6736(01)06102-5; Meuleman P, 2011, HEPATOLOGY, V53, P755, DOI 10.1002/hep.24171; Meunier JC, 2005, P NATL ACAD SCI USA, V102, P4560, DOI 10.1073/pnas.0501275102; Missale G, 1996, J CLIN INVEST, V98, P706, DOI 10.1172/JCI118842; Pestka JM, 2007, P NATL ACAD SCI USA, V104, P6025, DOI 10.1073/pnas.0607026104; Pietschmann T, 2006, P NATL ACAD SCI USA, V103, P7408, DOI 10.1073/pnas.0504877103; Poordad F, 2011, NEW ENGL J MED, V364, P1195, DOI 10.1056/NEJMoa1010494; Prentoe J, 2011, J VIROL, V85, P2224, DOI 10.1128/JVI.01594-10; Raghuraman S, 2012, J INFECT DIS, V205, P763, DOI 10.1093/infdis/jir835; Ramirez S, 2010, J GEN VIROL, V91, P1183, DOI 10.1099/vir.0.018929-0; Rehermann B, 2009, J CLIN INVEST, V119, P1745, DOI 10.1172/JCI39133; Salmeron J, 2006, DIGEST DIS SCI, V51, P960, DOI 10.1007/s10620-006-9347-2; Sasayama Mikiko, 2010, Kobe J Med Sci, V56, pE60; Scheel TKH, 2008, P NATL ACAD SCI USA, V105, P997, DOI 10.1073/pnas.0711044105; Scheel TKH, 2011, J VIROL, V85, P2891, DOI 10.1128/JVI.01605-10; Sherman KE, 2011, NEW ENGL J MED, V365, P1014, DOI 10.1056/NEJMoa1014463; Von Hahn T, 2007, GASTROENTEROLOGY, V132, P667, DOI 10.1053/j.gastro.2006.12.008; Wakita T, 2005, NAT MED, V11, P791, DOI 10.1038/nm1268; Yi MK, 2007, J VIROL, V81, P629, DOI 10.1128/JVI.01890-06; Zeuzem S, 2004, GASTROENTEROLOGY, V127, P1724, DOI 10.1053/j.gastro.2004.09.050; Zhang P, 2009, P NATL ACAD SCI USA, V106, P7537, DOI 10.1073/pnas.0902749106	54	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e62674	10.1371/journal.pone.0062674	http://dx.doi.org/10.1371/journal.pone.0062674			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667506	Green Published, Green Submitted, gold			2022-12-27	WOS:000319654700054
J	Ranghini, E; Mora, CF; Edgar, D; Kenny, SE; Murray, P; Wilm, B				Ranghini, Egon; Mora, Cristina Fuente; Edgar, David; Kenny, Simon E.; Murray, Patricia; Wilm, Bettina			Stem Cells Derived from Neonatal Mouse Kidney Generate Functional Proximal Tubule-Like Cells and Integrate into Developing Nephrons In Vitro	PLOS ONE			English	Article							PROGENITOR CELLS; METANEPHRIC MESENCHYME; ADULT KIDNEY; DIFFERENTIATION; REGENERATION; REPAIR; IDENTIFICATION; MICE	We have recently shown that kidney-derived stem cells (KSCs) isolated from the mouse newborn kidney differentiate into a range of kidney-specific cell types. However, the functionality and integration capacity of these mouse KSCs remain unknown. Therefore, the main objectives of this study were (1) to determine if proximal tubule-like cells, generated in vitro from KSCs, displayed absorptive function typical of proximal tubule cells in vivo, and (2) to establish whether the ability of KSCs to integrate into developing nephrons was comparable with that of metanephric mesenchyme (MM), a transient population of progenitor cells that gives rise to the nephrons during kidney organogenesis. We found that proximal tubule-like cells generated in vitro from mouse KSCs displayed megalin-dependent absorptive function. Subsequently, we used a chimeric kidney rudiment culture system to show that the KSCs could generate proximal tubule cells and podocytes that were appropriately located within the developing nephrons. Finally, we compared the ability of KSCs to integrate into developing kidneys ex vivo with that of metanephric mesenchyme cells. We found that KSCs integrated into nascent nephrons to a similar extent as metanephric mesenchyme cells while both were excluded from ureteric bud branches. Our analysis of the behavior of the two cell types shows that some, but not all KSC characteristics are similar to those of the MM.	[Ranghini, Egon; Mora, Cristina Fuente; Edgar, David; Murray, Patricia; Wilm, Bettina] Univ Liverpool, Inst Translat Med, Fac Hlth & Life Sci, Liverpool L69 3BX, Merseyside, England; [Kenny, Simon E.] Alder Hey Childrens NHS Trust, Dept Paediat Surg & Urol, Liverpool, Merseyside, England	University of Liverpool; Alder Hey Children's NHS Foundation Trust	Murray, P (corresponding author), Univ Liverpool, Inst Translat Med, Fac Hlth & Life Sci, Liverpool L69 3BX, Merseyside, England.	p.a.murray@liv.ac.uk; bwilm@liv.ac.uk	Wilm, Bettina/V-8621-2018	Wilm, Bettina/0000-0002-9245-993X; Murray, Patricia/0000-0003-1316-148X; Kenny, Simon/0000-0002-5917-8554	Biotechnology and Biological Sciences Research Council (BBSRC); Medical Research Council (MRC); Alder Hey Children's Kidney Fund [10991]; KIDSTEM European Union Framework Programme 6 Research Training Network Grant; Medical Research Council [G0700654B, G0802548] Funding Source: researchfish; MRC [G0802548] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Alder Hey Children's Kidney Fund; KIDSTEM European Union Framework Programme 6 Research Training Network Grant; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Funding was provided by (1) Biotechnology and Biological Sciences Research Council (BBSRC); (2) Medical Research Council (MRC); (3) Alder Hey Children's Kidney Fund 10991; and (4) KIDSTEM European Union Framework Programme 6 Research Training Network Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angelotti ML, 2012, STEM CELLS, V30, P1714, DOI 10.1002/stem.1130; Barak H, 2012, DEV CELL, V22, P1191, DOI 10.1016/j.devcel.2012.04.018; Bussolati B, 2005, AM J PATHOL, V166, P545, DOI 10.1016/S0002-9440(10)62276-6; CARROLL TJ, 2003, KIDNEY NORMAL DEV CO, P343; DAVIES JA, 1995, DEV BIOL, V167, P50, DOI 10.1006/dbio.1995.1006; Dickinson H, 2005, AM J PHYSIOL-RENAL, V289, pF273, DOI 10.1152/ajprenal.00400.2004; Diep CQ, 2011, NATURE, V470, P95, DOI 10.1038/nature09669; Donovan MJ, 1999, DEV GENET, V24, P252, DOI 10.1002/(SICI)1520-6408(1999)24:3/4<252::AID-DVG8>3.0.CO;2-K; Dressler GR, 2006, ANNU REV CELL DEV BI, V22, P509, DOI 10.1146/annurev.cellbio.22.010305.104340; Dressler GR, 2009, ORGANOGENESIS, V5, P73, DOI 10.4161/org.5.2.8930; Dudley AT, 1999, GENE DEV, V13, P1601, DOI 10.1101/gad.13.12.1601; Hartman HA, 2007, DEV BIOL, V310, P379, DOI 10.1016/j.ydbio.2007.08.021; Humphreys BD, 2008, CELL STEM CELL, V2, P284, DOI 10.1016/j.stem.2008.01.014; Humphreys BD, 2011, P NATL ACAD SCI USA, V108, P9226, DOI 10.1073/pnas.1100629108; Itaranta P, 2002, GENESIS, V32, P259, DOI 10.1002/gene.10079; Kim D, 2005, J AM SOC NEPHROL, V16, P3527, DOI 10.1681/ASN.2005050544; Kispert A, 1998, DEVELOPMENT, V125, P4225; Kuure S, 2007, J AM SOC NEPHROL, V18, P1130, DOI 10.1681/ASN.2006111206; Kuzma-Kuzniarska M, 2012, DIFFERENTIATION, V83, P128, DOI 10.1016/j.diff.2011.11.004; Lee PT, 2010, STEM CELLS, V28, P573, DOI 10.1002/stem.310; Leheste JR, 1999, AM J PATHOL, V155, P1361, DOI 10.1016/S0002-9440(10)65238-8; Lindgren D, 2011, AM J PATHOL, V178, P828, DOI 10.1016/j.ajpath.2010.10.026; Lusis M, 2010, STEM CELL RES, V5, P23, DOI 10.1016/j.scr.2010.03.003; Maeshima A, 2006, J AM SOC NEPHROL, V17, P188, DOI 10.1681/ASN.2005040370; Mora CF, 2012, STEM CELLS DEV, V21, P296, DOI 10.1089/scd.2010.0470; Mundel P, 1997, J CELL BIOL, V139, P193, DOI 10.1083/jcb.139.1.193; Nielsen R, 2010, PEDIATR NEPHROL, V25, P813, DOI 10.1007/s00467-009-1381-9; Oliver JA, 2004, J CLIN INVEST, V114, P795, DOI 10.1172/JCI200420921; Osafune K, 2006, DEVELOPMENT, V133, P151, DOI 10.1242/dev.02174; Pleniceanu O, 2010, STEM CELLS, V28, P1649, DOI 10.1002/stem.486; Rak-Raszewska A, 2012, ORGANOGENESIS, V8, P125, DOI 10.4161/org.22597; Rak-Raszewska A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032650; Reimschuessel R, 2002, ILAR J, V42, P285; Ronconi E, 2009, J AM SOC NEPHROL, V20, P322, DOI 10.1681/ASN.2008070709; Sagrinati C, 2006, J AM SOC NEPHROL, V17, P2443, DOI 10.1681/ASN.2006010089; Sallustio F, 2013, KIDNEY INT, V83, P392, DOI 10.1038/ki.2012.413; Saxen L., 1987, ORGANOGENESIS KIDNEY; Siegel N, 2010, HUM MOL GENET, V19, P3320, DOI 10.1093/hmg/ddq236; Slack JMW, 2008, SCIENCE, V322, P1498, DOI 10.1126/science.1162782; Smeets B, 2013, J PATHOL, V229, P645, DOI 10.1002/path.4125; Torres M, 1995, DEVELOPMENT, V121, P4057; Unbekandt M, 2010, KIDNEY INT, V77, P407, DOI 10.1038/ki.2009.482; Vize P.D., 2003, KIDNEY NORMAL DEV CO; Ward HH, 2011, BBA-MOL BASIS DIS, V1812, P1344, DOI 10.1016/j.bbadis.2011.01.010; Zhai XY, 2000, KIDNEY INT, V58, P1523, DOI 10.1046/j.1523-1755.2000.00314.x; Zhou WB, 2010, AM J PHYSIOL-RENAL, V299, pF1040, DOI 10.1152/ajprenal.00394.2010	46	16	16	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e62953	10.1371/journal.pone.0062953	http://dx.doi.org/10.1371/journal.pone.0062953			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667549	Green Published, Green Submitted, gold			2022-12-27	WOS:000319654700087
J	Thouin, A; Griffiths, PG; Hudson, G; Chinnery, PF; Yu-Wai-Man, P				Thouin, Anais; Griffiths, Philip G.; Hudson, Gavin; Chinnery, Patrick F.; Yu-Wai-Man, Patrick			Raised Intraocular Pressure as a Potential Risk Factor for Visual Loss in Leber Hereditary Optic Neuropathy	PLOS ONE			English	Article							MITOCHONDRIAL DYSFUNCTION; MTDNA MUTATIONS; CELL-DEATH; GLAUCOMA; INVOLVEMENT; RELEASE; DISEASE; QUALITY; VIRUS; MODEL	Leber Hereditary Optic Neuropathy (LHON) is an important cause of inherited mitochondrial blindness among young adults. The majority of patients carry one of three mitochondrial DNA (mtDNA) point mutations: m. 3460G>A, m. 11778G> A and m. 14484T>C, all of which affect critical complex I subunits of the mitochondrial respiratory chain. LHON is characterised by marked incomplete penetrance, clearly implying that the mtDNA mutation is insufficient on its own to trigger retinal ganglion cell dysfunction and visual loss. In this case series of three affected patients harbouring the m. 11778G>A mutation, we provide evidence suggesting that raised intraocular pressure could be a risk factor triggering visual loss in atrisk LHON carriers.	[Thouin, Anais; Chinnery, Patrick F.] Royal Victoria Infirm, Dept Neurol, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England; [Thouin, Anais] Newcastle Univ, Inst Neurosci, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Griffiths, Philip G.; Yu-Wai-Man, Patrick] Royal Victoria Infirm, Dept Ophthalmol, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England; [Hudson, Gavin; Chinnery, Patrick F.; Yu-Wai-Man, Patrick] Newcastle Univ, Inst Med Genet, Wellcome Trust Ctr Mitochondrial Res, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England	Newcastle University - UK; Newcastle University - UK; Newcastle University - UK; Newcastle University - UK	Yu-Wai-Man, P (corresponding author), Royal Victoria Infirm, Dept Ophthalmol, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England.	Patrick.Yu-Wai-Man@ncl.ac.uk	Hudson, Gavin/E-7117-2017	Chinnery, Patrick/0000-0002-7065-6617; Hudson, Gavin/0000-0001-7210-2733	Medical Research Council (MRC, UK); Wellcome Trust; MRC [G0701386, MR/K000608/1, G1002570] Funding Source: UKRI; Medical Research Council [G0701386, MR/K000608/1, G1002570] Funding Source: researchfish; National Institute for Health Research [NF-SI-0509-10011] Funding Source: researchfish	Medical Research Council (MRC, UK)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	This work was supported by the Medical Research Council (MRC, UK) and the Wellcome Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almasieh M, 2012, PROG RETIN EYE RES, V31, P152, DOI 10.1016/j.preteyeres.2011.11.002; BORRUAT FX, 1994, KLIN MONATSBL AUGENH, V204, P400, DOI 10.1055/s-2008-1035568; Burr JM, 2012, HEALTH TECHNOL ASSES, V16, P1, DOI 10.3310/hta16290; Burr J, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004399.pub3; Carelli V, 2007, ENVIRON HEALTH PERSP, V115, P113, DOI 10.1289/ehp.9245; Carelli V, 2009, BBA-BIOENERGETICS, V1787, P518, DOI 10.1016/j.bbabio.2009.02.024; Dandekar SS, 2002, EUR J OPHTHALMOL, V12, P537, DOI 10.1177/112067210201200615; De Marinis M, 2001, J NEUROL, V248, P818, DOI 10.1007/s004150170103; Edwards TL, 2007, NEURO-OPHTHALMOLOGY, V31, P87, DOI 10.1080/01658100701501125; Fraser JA, 2010, SURV OPHTHALMOL, V55, P299, DOI 10.1016/j.survophthal.2009.10.002; Ju WK, 2008, INVEST OPHTH VIS SCI, V49, P4903, DOI 10.1167/iovs.07-1661; Ju WK, 2009, MOL VIS, V15, P120; Kirkman MA, 2009, BRAIN, V132, P2317, DOI 10.1093/brain/awp158; Kirkman MA, 2009, INVEST OPHTH VIS SCI, V50, P3112, DOI 10.1167/iovs.08-3166; Klopstock T, 2011, BRAIN, V134, P2677, DOI 10.1093/brain/awr170; Lascaratos G, 2012, MITOCHONDRION, V12, P202, DOI 10.1016/j.mito.2011.11.004; Lin CS, 2012, P NATL ACAD SCI USA, V109, P20065, DOI 10.1073/pnas.1217113109; Mackey DA, 2003, EYE, V17, P312, DOI 10.1038/sj.eye.6700362; Mackey DA, 1996, AM J HUM GENET, V59, P481; Man PYW, 2003, AM J HUM GENET, V72, P333, DOI 10.1016/j.ajhg.2016.05.015; Nagai A, 2005, JPN J OPHTHALMOL, V49, P65, DOI 10.1007/s10384-004-0140-5; Nikoskelainen EK, 1996, OPHTHALMOLOGY, V103, P504; Nucci C, 2013, INT OPHTHALMOL, V33, P75, DOI 10.1007/s10792-012-9623-4; Ou Y, 2011, OPHTHALMOLOGY, V118, P1017, DOI 10.1016/j.ophtha.2011.03.038; Pan BX, 2012, INVEST OPHTH VIS SCI, V53, P7608, DOI 10.1167/iovs.12-10452; Rahman ML, 2010, INVEST OPHTH VIS SCI, V51, P2512, DOI 10.1167/iovs.09-4270; Redmill B, 2001, EYE, V15, P544, DOI 10.1038/eye.2001.172; Sadun A A, 2000, Trans Am Ophthalmol Soc, V98, P223; Sadun A.A., 2000, T AM OPHTHAL SOC, V98, P232; Seo JH, 2010, CLIN EXP OPHTHALMOL, V38, P363, DOI 10.1111/j.1442-9071.2010.02240.x; Sugisaka E, 2007, CLIN EXP OPHTHALMOL, V35, P868, DOI 10.1111/j.1442-9071.2007.01628.x; Yu H, 2012, P NATL ACAD SCI USA, V109, pE1238, DOI 10.1073/pnas.1119577109; Yu-Wai-Man P, 2012, INVEST OPHTH VIS SCI, V53, P2438, DOI 10.1167/iovs.12-9815; Yu-Wai-Man P, 2011, PROG RETIN EYE RES, V30, P81, DOI 10.1016/j.preteyeres.2010.11.002	34	21	21	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e63446	10.1371/journal.pone.0063446	http://dx.doi.org/10.1371/journal.pone.0063446			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667621	Green Published, gold, Green Submitted			2022-12-27	WOS:000319654700147
J	Estalrrich, A; Rosas, A				Estalrrich, Almudena; Rosas, Antonio			Handedness in Neandertals from the El Sidron (Asturias, Spain): Evidence from Instrumental Striations with Ontogenetic Inferences	PLOS ONE			English	Article							HUMAN ANTERIOR TEETH; MODERN HUMANS; CUTMARKS; MIDDLE; (ASTURIAS; ATAPUERCA; WEAR; HOMO; SIMA	The developed cognitive capabilities for Homo sapiens seems to be the result of a specialized and lateralized brain, and as a result of this, humans display the highest degree of manual specialization or handedness among the primates. Studies regarding its emergence and distribution within the genus Homo show that handedness is present very early. The mode in which it was articulated and spread across the different species during the course of human evolution could provide information about our own cognitive capacities. Here we report the manual laterality attributed to eleven 49,000 old Neandertal individuals from El Sidron cave (Spain), through the study of instrumental or cultural striations on the anterior dentition. Our results show a predominant pattern addressed to right-handers. These results fit within the modern human handedness distribution pattern and provide indirect evidence for behavior and brain lateralization on Neandertals. They support the early establishment of handedness in our genus. Moreover, the individual identified as Juvenile 1 (6-8 years old at death), displays the same striation pattern as the adult Neandertals from the sample, and thereby the ontogenic development of manual laterality in that Neandertal population seems to be similar to that of living modern humans.	[Estalrrich, Almudena; Rosas, Antonio] Museo Nacl Ciencias Nat MNCN CSIC, PaleoAnthropol Grp, Dept Paleobiol, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Museo Nacional de Ciencias Naturales (MNCN)	Estalrrich, A (corresponding author), Museo Nacl Ciencias Nat MNCN CSIC, PaleoAnthropol Grp, Dept Paleobiol, Madrid, Spain.	aestalrrich@mncn.csic.es	Rosas, Antonio/D-9742-2016; Estalrrich, Almudena/ABF-1891-2020	Rosas, Antonio/0000-0002-5829-9952; Estalrrich, Almudena/0000-0003-2295-5396	Spanish Ministerio de Economia y Competitividad [CGL2009-09013, CGL2012-36682, BES-2010-033914]	Spanish Ministerio de Economia y Competitividad(Spanish Government)	This research is funded by the Spanish Ministerio de Economia y Competitividad (Projects CGL2009-09013 and CGL2012-36682). El Sidron site is being excavated with the support of the Consejeria de Cultura of the Asturias Autonomous Government. A. E. has the benefit of a predoctoral FPI fellowship of the Spanish Ministerio de Economia y Competitividad (BES-2010-033914) (http://www.mineco.gob.es/portal/site/mineco/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams DM, 2012, J R SOC INTERFACE, V9, P2718, DOI 10.1098/rsif.2012.0211; [Anonymous], 1994, HUMAN EVOLUTION, DOI DOI 10.1007/BF02437262; ARENSBURG B, 1989, NATURE, V338, P758, DOI 10.1038/338758a0; Bargallo A, 2013, TARR LAT C SPAIN; Bax JS, 1999, INT J OSTEOARCHAEOL, V9, P189, DOI 10.1002/(SICI)1099-1212(199905/06)9:3<189::AID-OA474>3.0.CO;2-N; Brace CL, 1975, CURR ANTHROPOL, V16, P809; BROMAGE TG, 1987, SCANNING MICROSCOPY, V1, P607; BROMAGE TG, 1984, AM J PHYS ANTHROPOL, V65, P359, DOI 10.1002/ajpa.1330650404; Cashmore L, 2008, J ANTHROPOL SCI, V86, P7; DECASTRO JMB, 1988, J HUM EVOL, V17, P403, DOI 10.1016/0047-2484(88)90029-2; DELUMLEY MA, 1973, ET QUATERN, V2, P311; Faurie C, 2005, CURR ANTHROPOL, V46, P142, DOI 10.1086/427101; Fennell E.B., 1986, EXPT TECHNIQUES HUMA, P15; Fox CL, 1997, INT J OSTEOARCHAEOL, V7, P133, DOI 10.1002/(SICI)1099-1212(199703)7:2<133::AID-OA326>3.0.CO;2-4; Frayer DW, 2012, LATERALITY, V17, P51, DOI 10.1080/1357650X.2010.529451; Frayer DW, 2010, J ANTHROPOL SCI, V88, P113; Green TJ, 1998, AM ANTIQUITY, V63, P437, DOI 10.2307/2694629; Hillson SW, 2010, J HUM EVOL, V59, P493, DOI 10.1016/j.jhevol.2010.06.004; Holloway R. L., 2009, ENCY NEUROSCIENCE, P1326; Krause J, 2007, CURR BIOL, V17, P1908, DOI 10.1016/j.cub.2007.10.008; Lalueza-Fox C., 1992, INT J OSTEOARCHAEOL, V2, P155, DOI DOI 10.1002/0A.1390020207; Lalueza-Fox C, 2011, P NATL ACAD SCI USA, V108, P250, DOI 10.1073/pnas.1011553108; Lozano M, 2008, J HUM EVOL, V55, P713, DOI 10.1016/j.jhevol.2008.04.007; Lozano M, 2009, EVOL HUM BEHAV, V30, P369, DOI 10.1016/j.evolhumbehav.2009.03.001; Lozano-Ruiz M, 2004, J ARCHAEOL SCI, V31, P1127, DOI 10.1016/j.jas.2004.02.005; Lucaks HR, 1988, AM J PHYS ANTHROPOL, V76, P377; Martin H, 1923, HOMME FOSSILE QUINA; Martinez-Maza C, 2011, BIOL LETTERS, V7, P593, DOI 10.1098/rsbl.2010.1188; Molnar P, 2008, AM J PHYS ANTHROPOL, V136, P423, DOI 10.1002/ajpa.20824; Nelson EL, 2013, INFANT BEHAV DEV, V36, P181, DOI 10.1016/j.infbeh.2013.01.009; Olle A., 2003, THESIS U ROVIRA VIRG; Pena-Melian A, 2011, ANAT REC, V294, P1370, DOI 10.1002/ar.21427; Pickering TR, 2008, J ARCHAEOL SCI, V35, P310, DOI 10.1016/j.jas.2007.03.012; Prieto J.L., 2005, MONOGRAFIAS MUSEO AL, V20, P397; Radovcic J, 1988, KRAPINA HOMINIDS ILU; Rasband W.S, 1997, IMAGE J IMAGE PROCES; Rosas A, 2006, P NATL ACAD SCI USA, V103, P19266, DOI 10.1073/pnas.0609662104; Rosas A, 2012, ANTHROPOLOGIE, V116, P57, DOI 10.1016/j.anthro.2011.12.003; Sacrey LAR, 2013, DEV PSYCHOBIOL, V55, P902, DOI 10.1002/dev.21083; SHIPMAN P, 1983, J ANTHROPOL ARCHAEOL, V2, P57, DOI 10.1016/0278-4165(83)90008-9; Steele J, 2005, STONE KNAPPING NECES, P217; Torres T., 2010, ARCHAEOMETRY, V52, P680; TRINKAUS E, 1994, AM J PHYS ANTHROPOL, V93, P1, DOI 10.1002/ajpa.1330930102; Trinkaus E, 1983, SHANIDAR NEADERTALS; Uomini NT, 2011, VERTEBR PALEOBIOL PA, P139, DOI 10.1007/978-94-007-0415-2_14; Volpato V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043949; Wood RE, 2013, ARCHAEOMETRY, V55, P148, DOI 10.1111/j.1475-4754.2012.00671.x	47	39	39	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2013	8	5							e62797	10.1371/journal.pone.0062797	http://dx.doi.org/10.1371/journal.pone.0062797			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	177QL	23671635	Green Published, gold, Green Submitted			2022-12-27	WOS:000321390200038
J	Ning, J; Wang, MX; Li, CL; Sun, S				Ning, Juan; Wang, Minxiao; Li, Chaolun; Sun, Song			Transcriptome Sequencing and De Novo Analysis of the Copepod Calanus sinicus Using 454 GS FLX	PLOS ONE			English	Article							GENE-EXPRESSION; YELLOW SEA; EGG-PRODUCTION; RNA-SEQ; DIAPAUSE; FINMARCHICUS; REPRODUCTION; ANNOTATION; DROSOPHILA; DISCOVERY	Background: Despite their species abundance and primary economic importance, genomic information about copepods is still limited. In particular, genomic resources are lacking for the copepod Calanus sinicus, which is a dominant species in the coastal waters of East Asia. In this study, we performed de novo transcriptome sequencing to produce a large number of expressed sequence tags for the copepod C. sinicus. Results: Copepodid larvae and adults were used as the basic material for transcriptome sequencing. Using 454 pyrosequencing, a total of 1,470,799 reads were obtained, which were assembled into 56,809 high quality expressed sequence tags. Based on their sequence similarity to known proteins, about 14,000 different genes were identified, including members of all major conserved signaling pathways. Transcripts that were putatively involved with growth, lipid metabolism, molting, and diapause were also identified among these genes. Differentially expressed genes related to several processes were found in C. sinicus copepodid larvae and adults. We detected 284,154 single nucleotide polymorphisms (SNPs) that provide a resource for gene function studies. Conclusion: Our data provide the most comprehensive transcriptome resource available for C. sinicus. This resource allowed us to identify genes associated with primary physiological processes and SNPs in coding regions, which facilitated the quantitative analysis of differential gene expression. These data should provide foundation for future genetic and genomic studies of this and related species.	[Ning, Juan; Wang, Minxiao; Li, Chaolun; Sun, Song] Chinese Acad Sci, Inst Oceanol, Key Lab Marine Ecol & Environm Sci, Qingdao, Peoples R China; [Ning, Juan] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China; [Sun, Song] Chinese Ecosyst Res Network, Jiaozhou Bay Marine Ecosyst Res Stn, Qingdao, Peoples R China	Chinese Academy of Sciences; Institute of Oceanology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Li, CL (corresponding author), Chinese Acad Sci, Inst Oceanol, Key Lab Marine Ecol & Environm Sci, Qingdao, Peoples R China.	lcl@qdio.ac.cn; sunsong@qido.ac.cn	Li, Chao/GSM-8117-2022	Li, Chao/0000-0001-6110-6210; Li, Chaolun/0000-0003-1890-0587; Minxiao, Wang/0000-0002-6567-3295	National Key Basic Research Program of China [2011CB403604]; National Natural Science Foundation of China [41076099]; National Marine Public Welfare Project of China [201005018]	National Key Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Marine Public Welfare Project of China	This research was supported by special funds from National Key Basic Research Program of China (2011CB403604), National Natural Science Foundation of China (41076099), and National Marine Public Welfare Project of China (201005018). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aruda AM, 2011, J INSECT PHYSIOL, V57, P665, DOI 10.1016/j.jinsphys.2011.03.007; Barreto FS, 2011, MOL ECOL, V20, P560, DOI 10.1111/j.1365-294X.2010.04963.x; Beaugrand G, 2003, NATURE, V426, P661, DOI 10.1038/nature02164; Bi H., 2001, ACTA ECOL SIN, V21, P177; Brockman W, 2008, GENOME RES, V18, P763, DOI 10.1101/gr.070227.107; Bron JE, 2011, FRONT ZOOL, V8, DOI 10.1186/1742-9994-8-22; Chen, 1964, OCEANOL LIMNOL SIN, V6, P272; Chen ZZ, 2005, PROG BIOCHEM BIOPHYS, V32, P187; Colbourne JK, 2011, SCIENCE, V331, P555, DOI 10.1126/science.1197761; Collins LJ, 2008, GENOME INFORM SER, V21, P3; Denlinger DL, 2002, ANNU REV ENTOMOL, V47, P93, DOI 10.1146/annurev.ento.47.091201.145137; Dubrovsky EB, 2005, TRENDS ENDOCRIN MET, V16, P6, DOI 10.1016/j.tem.2004.11.003; Eichner C, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-126; Emrich SJ, 2007, GENOME RES, V17, P69, DOI 10.1101/gr.5145806; Ewen-Campen B, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-61; Frangoulis C, 2005, ADV MAR BIOL, V47, P253; Fraser BA, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-202; Gregory R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017418; Harrison PM, 1996, BBA-BIOENERGETICS, V1275, P161, DOI 10.1016/0005-2728(96)00022-9; Helvig C, 2004, P NATL ACAD SCI USA, V101, P4024, DOI 10.1073/pnas.0306980101; HENRICH VC, 1993, DEV GENET, V14, P369, DOI 10.1002/dvg.1020140506; Hou R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021560; Hudson ME, 2008, MOL ECOL RESOUR, V8, P3, DOI 10.1111/j.1471-8286.2007.02019.x; Hulsemann Kuni, 1994, Invertebrate Taxonomy, V8, P1461, DOI 10.1071/IT9941461; HUMES AG, 1994, HYDROBIOLOGIA, V293, P1, DOI 10.1007/BF00229916; Irigoien X, 2004, J PLANKTON RES, V26, P259, DOI 10.1093/plankt/fbh030; Jakobsson A, 2006, PROG LIPID RES, V45, P237, DOI 10.1016/j.plipres.2006.01.004; Kanehisa M, 2010, NUCLEIC ACIDS RES, V38, pD355, DOI 10.1093/nar/gkp896; Kang Hyung-Ku, 2011, Ocean Science Journal, V46, P133, DOI 10.1007/s12601-011-0012-0; Kidokoro K, 2006, J INSECT PHYSIOL, V52, P473, DOI 10.1016/j.jinsphys.2006.01.001; Li TR, 2000, DEVELOPMENT, V127, P2897; Liu Qing-Ming, 2010, Chinese Bulletin of Entomology, V47, P247; MacRae TH, 2010, CELL MOL LIFE SCI, V67, P2405, DOI 10.1007/s00018-010-0311-0; Marguerat S, 2010, CELL MOL LIFE SCI, V67, P569, DOI 10.1007/s00018-009-0180-6; Meyer E, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-219; Morozova O, 2009, ANNU REV GENOM HUM G, V10, P135, DOI 10.1146/annurev-genom-082908-145957; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; O'Neil ST, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-310; Parchman TL, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-180; Pierceall WE, 1999, MOL CELL ENDOCRINOL, V150, P73, DOI 10.1016/S0303-7207(99)00022-2; Pu XM, 2004, J PLANKTON RES, V26, P1059, DOI 10.1093/plankt/fbh101; REIF DW, 1992, FREE RADICAL BIO MED, V12, P417, DOI 10.1016/0891-5849(92)90091-T; Richardson AJ, 2008, ICES J MAR SCI, V65, P279, DOI 10.1093/icesjms/fsn028; Riddiford LM, 2008, J INSECT PHYSIOL, V54, P895, DOI 10.1016/j.jinsphys.2008.01.014; Rothberg JM, 2008, NAT BIOTECHNOL, V26, P1117, DOI 10.1038/nbt1485; Sun Song, 2005, GLOBEC International Newsletter, V11, P34; Tarrant AM, 2008, MAR ECOL PROG SER, V355, P193, DOI 10.3354/meps07207; Tillman JA, 1999, INSECT BIOCHEM MOLEC, V29, P481, DOI 10.1016/S0965-1748(99)00016-8; Uye S, 2000, ICES J MAR SCI, V57, P1850, DOI 10.1006/jmsc.2000.0965; Vannini L, 2010, ARCH INSECT BIOCHEM, V75, P92, DOI 10.1002/arch.20382; Vera JC, 2008, MOL ECOL, V17, P1636, DOI 10.1111/j.1365-294X.2008.03666.x; Vos MJ, 2008, BIOCHEMISTRY-US, V47, P7001, DOI 10.1021/bi800639z; Wang LK, 2010, BIOINFORMATICS, V26, P136, DOI 10.1093/bioinformatics/btp612; Wang M, 2010, THESIS CHINESE ACAD; Wang MX, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-73; Wang S. W., 2009, THESIS CHINESE ACAD; Wang SW, 2009, MAR ECOL PROG SER, V379, P123, DOI 10.3354/meps07902; Zeng V, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-581; Zhang WC, 2009, HYDROBIOLOGIA, V636, P257, DOI 10.1007/s10750-009-9955-x	59	42	43	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2013	8	5							e63741	10.1371/journal.pone.0063741	http://dx.doi.org/10.1371/journal.pone.0063741			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	177QL	23671698	Green Published, Green Submitted, gold			2022-12-27	WOS:000321390200060
J	Suter, LG; Paltiel, AD; Rome, BN; Solomon, DH; Thornhill, TS; Abrams, SK; Katz, JN; Losina, E				Suter, Lisa G.; Paltiel, A. David; Rome, Benjamin N.; Solomon, Daniel H.; Thornhill, Thomas S.; Abrams, Stanley K.; Katz, Jeffrey N.; Losina, Elena			Placing a Price on Medical Device Innovation: The Example of Total Knee Arthroplasty	PLOS ONE			English	Article							CROSS-LINKED POLYETHYLENE; SURGEON PROCEDURE VOLUME; TOTAL HIP-ARTHROPLASTY; QUALITY-OF-LIFE; COST-EFFECTIVENESS; PATIENT OUTCOMES; TOTAL JOINT; REPLACEMENT; WEAR; ASSOCIATION	Background: Total knee arthroplasty (TKA) is common, effective, and cost-effective. Innovative implants promising reduced long-term failure at increased cost are under continual development. We sought to define the implant cost and performance thresholds under which innovative TKA implants are cost-effective. Methods: We performed a cost-effectiveness analysis using a validated, published computer simulation model of knee osteoarthritis. Model inputs were derived using published literature, Medicare claims, and National Health and Nutrition Examination Survey data. We compared projected TKA implant survival, quality-adjusted life expectancy (QALE), lifetime costs, and cost-effectiveness (incremental cost-effectiveness ratios or ICERs) of standard versus innovative TKA implants. We assumed innovative implants offered 5-70% decreased long-term TKA failure rates at costs 20-400% increased above standard implants. We examined the impact of patient age, comorbidity, and potential increases in short-term failure on innovative implant cost-effectiveness. Results: Implants offering >= 50% decrease in long-term TKA failure at <= 50% increased cost offered ICERs, <$100,000 regardless of age or baseline comorbidity. An implant offering a 20% decrease in long-term failure at 50% increased cost provided ICERs <$150,000 per QALY gained only among healthy 50-59-year-olds. Increasing short-term failure, consistent with recent device failures, reduced cost-effectiveness across all groups. Increasing the baseline likelihood of long-term TKA failure among younger, healthier and more active individuals further enhanced innovative implant cost-effectiveness among younger patients. Conclusions: Innovative implants must decrease actual TKA failure, not just radiographic wear, by 50-55% or more over standard implants to be broadly cost-effective. Comorbidity and remaining life span significantly affect innovative implant cost-effectiveness and should be considered in the development, approval and implementation of novel technologies, particularly in orthopedics. Model-based evaluations such as this offer valuable, unique insights for evaluating technological innovation in medical devices.	[Suter, Lisa G.] Yale Univ, Sch Med, Dept Med, New Haven, CT 06510 USA; [Suter, Lisa G.] VA Connecticut Healthcare Syst, Dept Med, West Haven, CT USA; [Paltiel, A. David] Yale Univ, Sch Publ Hlth, Dept Hlth Policy & Management, New Haven, CT 06510 USA; [Rome, Benjamin N.; Abrams, Stanley K.; Katz, Jeffrey N.; Losina, Elena] Brigham & Womens Hosp, Dept Orthoped Surg, Orthoped & Arthrit Ctr Outcomes Res, Boston, MA 02115 USA; [Solomon, Daniel H.; Katz, Jeffrey N.; Losina, Elena] Brigham & Womens Hosp, Dept Med, Clin Sci Sect, Div Rheumatol Immunol & Allergy, Boston, MA 02115 USA; [Solomon, Daniel H.; Thornhill, Thomas S.; Katz, Jeffrey N.; Losina, Elena] Harvard Univ, Sch Med, Boston, MA USA; [Thornhill, Thomas S.; Katz, Jeffrey N.; Losina, Elena] Brigham & Womens Hosp, Dept Orthoped Surg, Boston, MA 02115 USA; [Katz, Jeffrey N.] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Losina, Elena] Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA USA	Yale University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Connecticut Healthcare System; Yale University; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard T.H. Chan School of Public Health; Boston University	Suter, LG (corresponding author), Yale Univ, Sch Med, Dept Med, New Haven, CT 06510 USA.	lisa.suter@yale.edu		Paltiel, A. David/0000-0002-4861-3290; Rome, Benjamin/0000-0001-5776-3293; Losina, ELENA/0000-0002-3424-0892	United States National Institutes of Health (NIH)/NIAMS [R01 AR053112]; NIH [K23 AR054095-01]; Arthritis Foundation; VA Connecticut Healthcare System; Centers for Medicare & Medicaid Services, an agency of the U.S. Department of Health and Human Services; NIH/NIAMS [K24 AR057827, R01AR064320]; Orthopedic and Education Research Foundation (OREF); Orthopedic Medical Grants Administration (OMeGA); DePuy;  [HHSM-500-2008-0025I/HHSM-500-T0001];  [000005]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P60AR047782, K24AR057827, R01AR053112, R01AR064320, K23AR054095] Funding Source: NIH RePORTER	United States National Institutes of Health (NIH)/NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Arthritis Foundation; VA Connecticut Healthcare System(US Department of Veterans Affairs); Centers for Medicare & Medicaid Services, an agency of the U.S. Department of Health and Human Services; NIH/NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Orthopedic and Education Research Foundation (OREF); Orthopedic Medical Grants Administration (OMeGA); DePuy; ; ; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported in part by United States National Institutes of Health (NIH)/NIAMS R01 AR053112. Dr. Suter was supported by an NIH K23 AR054095-01 Mentored Career Development Award and an Arthritis Foundation Arthritis Investigator Award and is currently supported in part by the VA Connecticut Healthcare System and by Contract Number HHSM-500-2008-0025I/HHSM-500-T0001, Modification No. 000005, entitled "Measure & Instrument Development and Support (MIDS)-Development and Re-evaluation of the CMS Hospital Outcomes and Efficiency Measures,'' funded by the Centers for Medicare & Medicaid Services, an agency of the U.S. Department of Health and Human Services. Dr. Losina is supported in part by NIH/NIAMS K24 AR057827 and R01AR064320 and Drs. Losina, Katz and Solomon by NIH/NIAMS P60 AR47782. Dr. Thornhill currently receives support from the Orthopedic and Education Research Foundation (OREF) and the Orthopedic Medical Grants Administration (OMeGA), as well as consulting fees and royalties from DePuy, and he owns stock in Conformis SAB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anand Rajan, 2011, J Bone Joint Surg Am, V93 Suppl 3, P51, DOI 10.2106/JBJS.K.00867; [Anonymous], 2010, SEARCH 510 K PREM NO; [Anonymous], 2009, HOSP MAT MANAGEMENT, V34, P9; [Anonymous], 1 KNEE TEST 30 SIM Y; [Anonymous], 2008, RED BOOK PHARM FUND; Bozic KJ, 2006, J BONE JOINT SURG AM, V88A, P706, DOI 10.2106/JBJS.E.00614; CALLAHAN CM, 1994, JAMA-J AM MED ASSOC, V271, P1349, DOI 10.1001/jama.271.17.1349; Centers for Disease Control and Prevention (CDC), 2006, 2005 2006 NAT HLTH N; Centers for Disease Control and Prevention (CDC), 2008, 2007 2008 NAT HLTH N; Centers for Medicare & Medicaid Services [CMS], 2008, PHYS FEE SCHED SEARC; Challoner DR, 2011, NEW ENGL J MED, V365, P977, DOI 10.1056/NEJMp1109150; Crowninshield RD, 2006, CLIN ORTHOP RELAT R, P266, DOI 10.1097/01.blo.0000188066.01833.4f; Curfman GD, 2011, NEW ENGL J MED, V365, P975, DOI 10.1056/NEJMp1109094; Fisman DN, 2001, CLIN INFECT DIS, V32, P419, DOI 10.1086/318502; Freeman JV, 2011, ANN INTERN MED, V154, P1, DOI 10.7326/0003-4819-154-1-201101040-00289; Frost & Sullivan, 2005, US AS MARK ORTH JOIN; Gandhi R, 2009, J BONE JOINT SURG BR, V91B, P889, DOI 10.1302/0301-620X.91B7.21702; Glyn-Jones S, 2008, J BONE JOINT SURG BR, V90B, P556, DOI 10.1302/0301-620X.90B5.20545; Glyn-Jones S, 2008, J ARTHROPLASTY, V23, P337, DOI 10.1016/j.arth.2006.12.117; Gold MR, 1996, COST EFFECTIVENESS H; Hawker G, 1998, J BONE JOINT SURG AM, V80A, P163, DOI 10.2106/00004623-199802000-00003; Healthcare Cost and Utilization Project (HCUP), 2008, NAT INP SAMPL NIS; Healy WL, 2007, CLIN ORTHOP RELAT R, P57, DOI 10.1097/BLO.0b013e31803372e0; Heck DA, 1998, CLIN ORTHOP RELAT R, P93, DOI 10.1097/00003086-199811000-00015; Heisel C, 2004, J BONE JOINT SURG AM, V86A, P748, DOI 10.2106/00004623-200404000-00012; Holt HL, 2011, OSTEOARTHR CARTILAGE, V19, P44, DOI 10.1016/j.joca.2010.10.009; Institute of Medicine (IOM), 2011, MED DEV PUBL HLTH FD; International Monetary Fund, 2009, WORLD EC OUTL DAT; Kalisvaart MM, 2012, J BONE JOINT SURG AM, V94A, P481, DOI 10.2106/JBJS.K.00315; Katz JN, 2007, ARTHRITIS RHEUM, V56, P568, DOI 10.1002/art.22333; Katz JN, 2004, J BONE JOINT SURG AM, V86A, P1909, DOI 10.2106/00004623-200409000-00008; Kurtz SM., 2004, UHMWPE HDB, V1; Kurtz SM, 2009, CLIN ORTHOP RELAT R, V467, P2606, DOI 10.1007/s11999-009-0834-6; Lee D W, 2001, Value Health, V4, P329, DOI 10.1046/j.1524-4733.2001.44012.x; Losina E, 2012, J BONE JOINT SURG AM, V94A, P201, DOI [10.2106/JBJS.J.01958, 10.2106/JBJS.K.00009, 10.2106/JBJS.J.101958]; Losina E, 2011, ANN INTERN MED, V154, P217, DOI 10.7326/0003-4819-154-4-201102150-00001; Losina E, 2009, ARCH INTERN MED, V169, P1113, DOI 10.1001/archinternmed.2009.136; Luo R, 2012, J ARTHROPLASTY; Martell JM, 2003, J ARTHROPLASTY, V18, P55, DOI 10.1016/S0883-5403(03)00341-3; McEwen HMJ, 2005, J BIOMECH, V38, P357, DOI 10.1016/j.jbiomech.2004.02.015; McKinsey Global Institute, 2008, ACC COST US HLTH CAR; MD Buyline Inc, 2008, IMP CONS ORTH JOINT; Melnikow J, 2008, MED CARE, V46, P946, DOI 10.1097/MLR.0b013e318179250f; Mendenhall Stan, 2004, OR Manager, V20, P32; Mundy A, 2009, WALL STREET J; Muratoglu OK, 2004, J ARTHROPLASTY, V19, P887, DOI 10.1016/j.arth.2004.03.019; Muratoglu OK, 2003, J BONE JOINT SURG AM, V85A, P7, DOI 10.2106/00004623-200300001-00003; Muratoglu OK, 2002, CLIN ORTHOP RELAT R, P89, DOI 10.1097/01.blo.0000036526.46246.6c; Muratoglu OK, 2007, J ARTHROPLASTY, V22, P435, DOI 10.1016/j.arth.2006.07.014; Park JW, 2011, J BONE JOINT SURG BR, V93B, P1479, DOI 10.1302/0301-620X.93B11.27507; Paxton EW, 2010, J BONE JOINT SURG AM, V92A, P117, DOI 10.2106/JBJS.J.00807; Reichmann WM, 2009, ARTHRIT RHEUM-ARTHR, V61, P1046, DOI 10.1002/art.24839; Rinfret S, 2005, CIRCULATION, V111, P165, DOI 10.1161/01.CIR.0000151810.69732.41; Robinson JC, 2012, J BONE JOINT SURG AM; Skinner J, 2006, J BONE JOINT SURG AM, V88A, P2159, DOI 10.2106/JBJS.E.00271; Smith AJ, 2012, LANCET, V379, P1199, DOI 10.1016/S0140-6736(12)60353-5; Suter LG, 2011, NEW ENGL J MED, V365, P1464, DOI 10.1056/NEJMp1109285; Taylor DCA, 2009, EUR J HEALTH ECON, V10, P255, DOI 10.1007/s10198-008-0126-1; Teeny SM, 2003, J ARTHROPLASTY, V18, P954, DOI 10.1016/j.arth.2003.09.001; Weaver M, 2001, ARCH INTERN MED, V161, P111, DOI 10.1001/archinte.161.1.111; World Health Organization, CHOOSING INT AR COST; World Health Organization, 2001, MACR HLTH INV HLTH E; Wylde V, 2008, J BONE JOINT SURG BR, V90B, P1172, DOI 10.1302/0301-620X.90B9.21031; Zuckerman DM, 2011, ARCH INTERN MED, V171, P1006, DOI 10.1001/archinternmed.2011.30	64	42	42	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2013	8	5							e62709	10.1371/journal.pone.0062709	http://dx.doi.org/10.1371/journal.pone.0062709			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	177QL	23671626	Green Published, Green Submitted, gold			2022-12-27	WOS:000321390200034
J	Kalb, A; von Haefen, C; Sifringer, M; Tegethoff, A; Paeschke, N; Kostova, M; Feldheiser, A; Spies, CD				Kalb, Alexander; von Haefen, Clarissa; Sifringer, Marco; Tegethoff, Annalena; Paeschke, Nadine; Kostova, Mariya; Feldheiser, Aarne; Spies, Claudia D.			Acetylcholinesterase Inhibitors Reduce Neuroinflammation and -Degeneration in the Cortex and Hippocampus of a Surgery Stress Rat Model	PLOS ONE			English	Article							POSTOPERATIVE COGNITIVE DYSFUNCTION; CHOLINERGIC ANTIINFLAMMATORY PATHWAY; ELDERLY-PATIENTS; NONCARDIAC SURGERY; SYSTEMIC INFLAMMATION; PERIPHERAL INFECTION; MEMORY CONSOLIDATION; ALZHEIMERS-DISEASE; IMPROVES SURVIVAL; DENTATE GYRUS	Exogenous stress like tissue damage and pathogen invasion during surgical trauma could lead to a peripheral inflammatory response and induce neuroinflammation, which can result in postoperative cognitive dysfunction (POCD). The cholinergic anti-inflammatory pathway is a neurohumoral mechanism that plays a prominent role by suppressing the inflammatory response. Treatments with acetylcholinesterase inhibitors enhance cholinergic transmission and may therefore act as a potential approach to prevent neuroinflammation. In the presence or absence of acetylcholinesterase inhibitors, adult Wistar rats underwent surgery alone or were additionally treated with lipopolysaccharide (LPS). Physostigmine, which can overcome the blood-brain barrier or neostigmine acting only peripheral, served as acetylcholinesterase inhibitors. The expression of pro- and anti-inflammatory cytokines in the cortex, hippocampus, spleen and plasma was measured after 1 h, 24 h, 3 d and 7 d using Real-Time PCR, western blot analysis or cytometric bead array (CBA). Fluoro-Jade B staining of brain slices was employed to elucidate neurodegeneration. The activity of acetylcholinesterase was estimated using a spectrofluorometric method. Surgery accompanied by LPS-treatment led to increased IL-1beta gene and protein upregulation in the cortex and hippocampus but was significantly reduced by physostigmine and neostigmine. Furthermore, surgery in combination with LPS-treatment caused increased protein expression of IL-1, TNF-alpha and IL-10 in the spleen and plasma. Physostigmine and neostigmine significantly decreased the protein expression of IL-1 and TNF-alpha. Neuronal degeneration and the activity of acetylcholinesterase were elevated after surgery with LPS-treatment and reduced by physostigmine and neostigmine. Along with LPS-treatment, acetylcholinesterase inhibitors reduce the pro-inflammatory response as well as neurodegeneration after surgery in the cortex and hippocampus. This combination may represent a tool to break the pathogenesis of POCD.	[Spies, Claudia D.] Univ Med Berlin, Charite, Campus Charite Mitte, Dept Anesthesiol & Intens Care Med, Berlin, Germany; Univ Med Berlin, Charite, Campus Virchow Klinikum, Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Spies, CD (corresponding author), Univ Med Berlin, Charite, Campus Charite Mitte, Dept Anesthesiol & Intens Care Med, Berlin, Germany.	claudia.spies@charite.de	Feldheiser, Aarne/AAH-1503-2019; Feldheiser, Aarne/GRS-9593-2022	Feldheiser, Aarne/0000-0002-0014-8879; Spies, Claudia/0000-0002-1062-0495				Abildstrom H, 2000, ACTA ANAESTH SCAND, V44, P1246, DOI 10.1034/j.1399-6576.2000.441010.x; Ancelin ML, 2001, BRIT J PSYCHIAT, V178, P360, DOI 10.1192/bjp.178.4.360; Andersson U, 2012, J EXP MED, V209, P1057, DOI 10.1084/jem.20120571; Andersson U, 2012, ANNU REV IMMUNOL, V30, P313, DOI 10.1146/annurev-immunol-020711-075015; Barrientos RM, 2006, NEUROBIOL AGING, V27, P723, DOI 10.1016/j.neurobiolaging.2005.03.010; Barrientos RM, 2002, BEHAV BRAIN RES, V134, P291, DOI 10.1016/S0166-4328(02)00043-8; Barrientos RM, 2012, J NEUROSCI, V32, P14641, DOI 10.1523/JNEUROSCI.2173-12.2012; Barrientos RM, 2009, BRAIN BEHAV IMMUN, V23, P46, DOI 10.1016/j.bbi.2008.07.002; Bernik TR, 2002, J EXP MED, V195, P781, DOI 10.1084/jem.20011714; Borovikova LV, 2000, NATURE, V405, P458, DOI 10.1038/35013070; Cao XZ, 2010, PROG NEURO-PSYCHOPH, V34, P1426, DOI 10.1016/j.pnpbp.2010.07.027; Caza N, 2008, PROG BRAIN RES, V169, P409, DOI 10.1016/S0079-6123(07)00026-X; Cibelli M, 2010, ANN NEUROL, V68, P360, DOI 10.1002/ana.22082; Cooke SF, 2006, BRAIN, V129, P1659, DOI 10.1093/brain/awl082; Fidalgo AR, 2011, NEUROSCIENCE, V190, P194, DOI 10.1016/j.neuroscience.2011.05.073; Fidalgo AR, 2011, NEUROSCI LETT, V498, P63, DOI 10.1016/j.neulet.2011.04.063; Fong HK, 2006, ANESTH ANALG, V102, P1255, DOI 10.1213/01.ane.0000198602.29716.53; Hofer S, 2008, CRIT CARE MED, V36, P404, DOI 10.1097/01.CCM.0B013E31816208B3; Huston JM, 2012, SURG INFECT, V13, P187, DOI 10.1089/sur.2012.126; Kelly A, 2003, J BIOL CHEM, V278, P19453, DOI 10.1074/jbc.M301938200; Li Q, 2011, LIFE SCI, V89, P395, DOI 10.1016/j.lfs.2011.07.008; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lynch AM, 2004, J NEUROCHEM, V88, P635, DOI 10.1046/j.1471-4159.2003.02157.x; Lynch AM, 2002, EUR J NEUROSCI, V15, P1779, DOI 10.1046/j.1460-9568.2002.02012.x; MARCANTONIO ER, 1994, JAMA-J AM MED ASSOC, V272, P1518, DOI 10.1001/jama.272.19.1518; Moller JT, 1998, LANCET, V351, P857, DOI 10.1016/S0140-6736(97)07382-0; Monk TG, 2008, ANESTHESIOLOGY, V108, P18, DOI 10.1097/01.anes.0000296071.19434.1e; Muller SV, 2004, Z GERONTOL GERIATR, V37, P475, DOI 10.1007/s00391-004-0212-7; Newman S, 2007, ANESTHESIOLOGY, V106, P572, DOI 10.1097/00000542-200703000-00023; O'Donnell E, 2000, EUR J NEUROSCI, V12, P345, DOI 10.1046/j.1460-9568.2000.00900.x; Olofsson PS, 2012, IMMUNOL REV, V248, P188, DOI 10.1111/j.1600-065X.2012.01138.x; Parrish WR, 2008, MOL MED, V14, P567, DOI 10.2119/2008-00079.Parrish; Patel HC, 2003, ANN NY ACAD SCI, V992, P39, DOI 10.1111/j.1749-6632.2003.tb03136.x; Pavlov VA, 2006, BIOCHEM SOC T, V34, P1037, DOI 10.1042/BST0341037; Pavlov VA, 2007, CRIT CARE MED, V35, P1139, DOI 10.1097/01.CCM.0000259381.56526.96; Pavlov VA, 2009, BRAIN BEHAV IMMUN, V23, P41, DOI 10.1016/j.bbi.2008.06.011; Pohanka M, 2012, EXPERT OPIN THER PAT, V22, P871, DOI 10.1517/13543776.2012.701620; Radtke FM, 2012, J INT MED RES, V40, P612, DOI 10.1177/147323001204000223; Rosas-Ballina M, 2009, J INTERN MED, V265, P663, DOI 10.1111/j.1365-2796.2009.02098.x; Rosas-Ballina M, 2011, SCIENCE, V334, P98, DOI 10.1126/science.1209985; Rothwell NJ, 2000, TRENDS NEUROSCI, V23, P618, DOI 10.1016/S0166-2236(00)01661-1; Singh A, 2010, CURR OPIN ANESTHESIO, V23, P449, DOI 10.1097/ACO.0b013e328339ef22; Small DH, 1996, NEUROCHEM INT, V28, P453, DOI 10.1016/0197-0186(95)00099-2; Steinmetz J, 2009, ANESTHESIOLOGY, V110, P548, DOI 10.1097/ALN.0b013e318195b569; Terrando N, 2010, CRIT CARE, V14, DOI 10.1186/cc9019; Toiber D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003108; Tracey KJ, 2010, NAT IMMUNOL, V11, P561, DOI 10.1038/ni0710-561; Tracey KJ, 2009, NAT REV IMMUNOL, V9, P418, DOI 10.1038/nri2566; Tyagi E, 2010, NEUROCHEM INT, V56, P135, DOI 10.1016/j.neuint.2009.09.011; van Munster BC, 2009, BMC NEUROL, V9, DOI 10.1186/1471-2377-9-21; Vereker E, 2001, EUR J NEUROSCI, V14, P1809, DOI 10.1046/j.0953-816x.2001.01809.x; Wan YJ, 2007, ANESTHESIOLOGY, V106, P436, DOI 10.1097/00000542-200703000-00007; Wang H, 2003, NATURE, V421, P384, DOI 10.1038/nature01339; WANG P, 1995, J BIOL CHEM, V270, P9558, DOI 10.1074/jbc.270.16.9558; Wilson CJ, 2002, J AM GERIATR SOC, V50, P2041, DOI 10.1046/j.1532-5415.2002.50619.x; Young S, 2010, BIOORG MED CHEM LETT, V20, P2987, DOI 10.1016/j.bmcl.2010.02.102; Zhang XJ, 2012, FRONT MOL NEUROSCI, V5, DOI 10.3389/fnmol.2012.00040; Zimmerman G, 2006, CELL TISSUE RES, V326, P655, DOI 10.1007/s00441-006-0239-8	58	63	71	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2013	8	5							e62679	10.1371/journal.pone.0062679	http://dx.doi.org/10.1371/journal.pone.0062679			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175AS	23671623	gold, Green Submitted, Green Published			2022-12-27	WOS:000321202100032
J	Farhana, L; Dawson, MI; Murshed, F; Das, JK; Rishi, AK; Fontana, JA				Farhana, Lulu; Dawson, Marcia I.; Murshed, Farhan; Das, Jayanta K.; Rishi, Arun K.; Fontana, Joseph A.			Upregulation of miR-150*and miR-630 Induces Apoptosis in Pancreatic Cancer Cells by Targeting IGF-1R	PLOS ONE			English	Article							EXPRESSION PROFILES; TUMOR-SUPPRESSOR; MICRORNAS; GROWTH; MIR-150; PROLIFERATION; MOLECULES; PATHWAYS	MicroRNAs have been implicated in many critical cellular processes including apoptosis. We have previously found that apoptosis in pancreatic cancer cells was induced by adamantyl retinoid-related (ARR) molecule 3-Cl-AHPC. Here we report that 3-Cl-AHPC-dependent apoptosis involves regulating a number of microRNAs including miR-150* and miR-630. 3-Cl-AHPC stimulated miR-150* expression and caused decreased expression of c-Myb and IGF-1R in the pancreatic cancer cells. 3-Cl-AHPC-mediated reduction of c-Myb resulted in diminished binding of c-Myb with IGF-1R and Bcl-2 promoters, thereby causing repression of their transcription and protein expression. Over-expression of miR-150* also resulted in diminished levels of c-Myb and Bcl-2 proteins. Furthermore, the addition of the miRNA inhibitor 2'-O-methylated miR-150 blocked 3-Cl-AHPC-mediated increase in miR-150* levels and abrogated loss of c-Myb protein. Knockdown of c-Myb in PANC-1 cells resulted in enhanced apoptosis both in the presence or absence of 3-Cl-AHPC confirming the anti-apoptotic property of c-Myb. Overexpression of miR-630 also induced apoptosis in the pancreatic cancer cells and inhibited target protein IGF-1R mRNA and protein expression. Together these results implicate key roles for miR-150* and miR-630 and their targeting of IGF-1R to promote apoptosis in pancreatic cancer cells.	[Farhana, Lulu; Das, Jayanta K.; Rishi, Arun K.; Fontana, Joseph A.] Wayne Sate Univ, Dept Oncol, Detroit, MI USA; [Farhana, Lulu; Murshed, Farhan; Das, Jayanta K.; Rishi, Arun K.; Fontana, Joseph A.] John D Dingell VA Med Ctr, Detroit, MI USA; [Farhana, Lulu; Das, Jayanta K.; Rishi, Arun K.; Fontana, Joseph A.] Wayne State Univ, Detroit, MI USA; [Farhana, Lulu; Rishi, Arun K.; Fontana, Joseph A.] Karmanos Canc Inst, Detroit, MI USA; [Dawson, Marcia I.] Sanford Burnham Med Res Inst, La Jolla, CA USA	Wayne State University; Barbara Ann Karmanos Cancer Institute; Sanford Burnham Prebys Medical Discovery Institute	Fontana, JA (corresponding author), Wayne Sate Univ, Dept Oncol, Detroit, MI USA.	Joseph.Fontana@va.gov	DAS, JAYANTA/E-2596-2015	DAS, JAYANTA/0000-0002-2840-1645; Fontana, Joseph/0000-0003-3829-3358	Veterans Affairs Merit Review Grant; National Cancer Institute (NCI)	Veterans Affairs Merit Review Grant(US Department of Veterans Affairs); National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by Veterans Affairs Merit Review Grant (JAF, MID) and National Cancer Institute (NCI) grants (JAF, MID). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal S, 2011, CRIT REV THER DRUG, V28, P293, DOI 10.1615/CritRevTherDrugCarrierSyst.v28.i4.10; Ambros V, 2003, CELL, V113, P673, DOI 10.1016/S0092-8674(03)00428-8; Andrews GA, 2004, HEAD NECK-J SCI SPEC, V26, P870, DOI 10.1002/hed.20029; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bauer TW, 2006, MOL CANCER THER, V5, P1676, DOI 10.1158/1535-7163.MCT-05-0175; Beverly LJ, 2012, J CELL BIOCHEM, V113, P3, DOI 10.1002/jcb.23335; Bhardwaj Arun, 2010, Mol Cell Pharmacol, V2, P213; Bhayani MK, 2012, MUTAT RES-FUND MOL M, V731, P14, DOI 10.1016/j.mrfmmm.2011.10.014; Dawson MI, 2010, MINI-REV MED CHEM, V10, P455, DOI 10.2174/138955710791384045; Farhana L, 2007, CANCER RES, V67, P318, DOI 10.1158/0008-5472.CAN-06-2164; Farhana L, 2012, J ONCOL, V2012, DOI 10.1155/2012/796729; Fujita H, 2011, INT J ONCOL, V38, P629, DOI 10.3892/ijo.2011.908; Galluzzi L, 2010, CANCER RES, V70, P1793, DOI 10.1158/0008-5472.CAN-09-3112; Haldar Subrata, 2011, Mol Cell Pharmacol, V3, P135; Iorio MV, 2007, CANCER RES, V67, P8699, DOI 10.1158/0008-5472.CAN-07-1936; Jia CY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027008; Kota SK, 2010, DRUG DISCOV TODAY, V15, P733, DOI 10.1016/j.drudis.2010.07.003; Kumar MS, 2007, NAT GENET, V39, P673, DOI 10.1038/ng2003; Kunej T, 2011, MUTAT RES-FUND MOL M, V717, P77, DOI 10.1016/j.mrfmmm.2011.03.008; Lang G, 2005, ONCOGENE, V24, P1375, DOI 10.1038/sj.onc.1208301; Lee YS, 2009, ANNU REV PATHOL-MECH, V4, P199, DOI 10.1146/annurev.pathol.4.110807.092222; Li YW, 2009, CANCER RES, V69, P6704, DOI 10.1158/0008-5472.CAN-09-1298; Lin MS, 2011, ONCOL REP, V25, P739, DOI 10.3892/or.2010.1112; Liu LX, 2012, FEBS J, V279, P3800, DOI 10.1111/j.1742-4658.2012.08741.x; McDermott AM, 2011, PHARM RES-DORDR, V28, P3016, DOI 10.1007/s11095-011-0550-2; Moser C, 2008, EUR J CANCER, V44, P1577, DOI 10.1016/j.ejca.2008.04.003; Mott JL, 2009, HEPATOLOGY, V50, P630, DOI 10.1002/hep.23010; Nana-Sinkam SP, 2011, MOL ONCOL, V5, P483, DOI 10.1016/j.molonc.2011.10.003; Park JY, 2011, WORLD J GASTROENTERO, V17, P817, DOI 10.3748/wjg.v17.i7.817; Saito Y, 2006, CANCER CELL, V9, P435, DOI 10.1016/j.ccr.2006.04.020; Srivastava SK, 2011, CARCINOGENESIS, V32, P1832, DOI 10.1093/carcin/bgr223; Sun M, 2008, MOL CANCER THER, V7, P464, DOI 10.1158/1535-7163.MCT-07-2272; Tsang WP, 2010, J NUTR BIOCHEM, V21, P140, DOI 10.1016/j.jnutbio.2008.12.003; Wang M, 2008, J PATHOL, V215, P13, DOI 10.1002/path.2333; Watanabe A, 2011, LEUKEMIA, V25, P1324, DOI 10.1038/leu.2011.81; Wu Q, 2010, BIOCHEM BIOPH RES CO, V392, P340, DOI 10.1016/j.bbrc.2009.12.182; Xiao CC, 2007, CELL, V131, P146, DOI 10.1016/j.cell.2007.07.021; Zhang J, 2012, INT J ONCOL, V40, P747, DOI 10.3892/ijo.2011.1242; Zhang YX, 2002, BLOOD, V100, P2917, DOI 10.1182/blood.V100.8.2917	39	77	80	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2013	8	5							e61015	10.1371/journal.pone.0061015	http://dx.doi.org/10.1371/journal.pone.0061015			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	143FO	23675407	Green Published, gold, Green Submitted			2022-12-27	WOS:000318852400003
J	Gu, SH; Hsieh, YC; Young, SC; Lin, PL				Gu, Shi-Hong; Hsieh, Yun-Chin; Young, Shun-Chieh; Lin, Pei-Ling			Involvement of Phosphorylation of Adenosine 5 '-Monophosphate-Activated Protein Kinase in PTTH-Stimulated Ecdysteroidogenesis in Prothoracic Glands of the Silkworm, Bombyx mori	PLOS ONE			English	Article							HORMONE STIMULATION; MOLECULAR-CLONING; MAMMALIAN TARGET; CELL-GROWTH; CYCLIC-AMP; ACTIVATION; EXPRESSION; RAPAMYCIN; RECEPTOR; CALCIUM	In this study, we investigated inhibition of the phosphorylation of adenosine 5'-monophosphate-activated protein kinase (AMPK) by prothoracicotropic hormone (PTTH) in prothoracic glands of the silkworm, Bombyx mori. We found that treatment with PTTH in vitro inhibited AMPK phosphorylation in time- and dose-dependent manners, as seen on Western blots of glandular lysates probed with antibody directed against AMPK alpha phosphorylated at Thr172. Moreover, in vitro inhibition of AMPK phosphorylation by PTTH was also verified by in vivo experiments: injection of PTTH into day 7 last instar larvae greatly inhibited glandular AMPK phosphorylation. PTTH-inhibited AMPK phosphorylation appeared to be partially reversed by treatment with LY294002, indicating involvement of phosphatidylinositol 3-kinase (PI3K) signaling. A chemical activator of AMPK (5-aminoimidazole-4-carboxamide-1-b=beta-d-ribofuranoside, AICAR) increased both basal and PTTH-inhibited AMPK phosphorylation. Treatment with AICAR also inhibited PTTH-stimulated ecdysteroidogenesis of prothoracic glands. The mechanism underlying inhibition of PTTH-stimulated ecdysteroidogenesis by AICAR was further investigated by determining the phosphorylation of eIF4E-binding protein (4E-BP) and p70 ribosomal protein S6 kinase (S6K), two known downstream signaling targets of the target of rapamycin complex 1 (TORC1). Upon treatment with AICAR, decreases in PTTH-stimulated phosphorylation of 4E-BP and S6K were detected. In addition, treatment with AICAR did not affect PTTH-stimulated extracellular signal-regulated kinase (ERK) phosphorylation, indicating that AMPK phosphorylation is not upstream signaling for ERK phosphorylation. Examination of gene expression levels of AMPK alpha, beta, and gamma by quantitative real-time PCR (qRT-PCR) showed that PTTH did not affect AMPK transcription. From these results, it is assumed that inhibition of AMPK phosphorylation, which lies upstream of PTTH-stimulated TOR signaling, may play a role in PTTH stimulation of ecdysteroidogenesis.	[Gu, Shi-Hong; Hsieh, Yun-Chin; Young, Shun-Chieh; Lin, Pei-Ling] Natl Museum Nat Sci, Dept Zool, Taichung, Taiwan		Gu, SH (corresponding author), Natl Museum Nat Sci, Dept Zool, Taichung, Taiwan.	gu330@mail.nmns.edu.tw			National Science Council, Taipei, Taiwan [NSC99-2628-B-178-002-MY3, NSC100-2313-B-001-MY3]	National Science Council, Taipei, Taiwan(Ministry of Science and Technology, Taiwan)	This study was supported by the National Science Council, Taipei, Taiwan (NSC99-2628-B-178-002-MY3 and NSC100-2313-B-001-MY3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bolster DR, 2002, J BIOL CHEM, V277, P23977, DOI 10.1074/jbc.C200171200; Carling D, 2004, TRENDS BIOCHEM SCI, V29, P18, DOI 10.1016/j.tibs.2003.11.005; CORTON JM, 1995, EUR J BIOCHEM, V229, P558, DOI 10.1111/j.1432-1033.1995.0558k.x; Fellner SK, 2005, INSECT BIOCHEM MOLEC, V35, P263, DOI 10.1016/j.ibmb.2004.11.006; Gilbert LI, 2002, ANNU REV ENTOMOL, V47, P883, DOI 10.1146/annurev.ento.47.091201.145302; Gu SH, 1998, INSECT BIOCHEM MOLEC, V28, P861, DOI 10.1016/S0965-1748(98)00074-5; Gu SH, 1996, MOL CELL ENDOCRINOL, V120, P99, DOI 10.1016/0303-7207(96)03821-X; Gu SH, 2012, INSECT BIOCHEM MOLEC, V42, P296, DOI 10.1016/j.ibmb.2011.12.010; Gu SH, 2011, INSECT BIOCHEM MOLEC, V41, P197, DOI 10.1016/j.ibmb.2010.12.004; Gu SH, 2010, J INSECT PHYSIOL, V56, P93, DOI 10.1016/j.jinsphys.2009.09.008; Gu SH, 2009, INSECT BIOCHEM MOLEC, V39, P171, DOI 10.1016/j.ibmb.2008.10.012; Hahn-Windgassen A, 2005, J BIOL CHEM, V280, P32081, DOI 10.1074/jbc.M502876200; Hardie DG, 2011, GENE DEV, V25, P1895, DOI 10.1101/gad.17420111; Hawley SA, 1996, J BIOL CHEM, V271, P27879, DOI 10.1074/jbc.271.44.27879; Horman S, 2006, J BIOL CHEM, V281, P5335, DOI 10.1074/jbc.M506850200; Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2; Johnson EC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012799; Kahn BB, 2005, CELL METAB, V1, P15, DOI 10.1016/j.cmet.2004.12.003; KAWAKAMI A, 1990, SCIENCE, V247, P1333, DOI 10.1126/science.2315701; Kovacic S, 2003, J BIOL CHEM, V278, P39422, DOI 10.1074/jbc.M305371200; Lee JH, 2007, NATURE, V447, P1017, DOI 10.1038/nature05828; Lim CT, 2010, J MOL ENDOCRINOL, V44, P87, DOI 10.1677/JME-09-0063; Lin JL, 2007, J INSECT PHYSIOL, V53, P622, DOI 10.1016/j.jinsphys.2007.03.004; Marchal E, 2010, PEPTIDES, V31, P506, DOI 10.1016/j.peptides.2009.08.020; Mihaylova MM, 2011, NAT CELL BIOL, V13, P1016, DOI 10.1038/ncb2329; Ning JY, 2011, ENDOCRINOLOGY, V152, P3143, DOI 10.1210/en.2011-0155; NOGUTI T, 1995, FEBS LETT, V376, P251, DOI 10.1016/0014-5793(95)01296-8; OREILLY DR, 1995, INSECT BIOCHEM MOLEC, V25, P475, DOI 10.1016/0965-1748(94)00087-F; Pan DA, 2002, BIOCHEM J, V367, P179, DOI 10.1042/BJ20020703; Rewitz KF, 2009, SCIENCE, V326, P1403, DOI 10.1126/science.1176450; Rewitz KF, 2009, INSECT BIOCHEM MOLEC, V39, P475, DOI 10.1016/j.ibmb.2009.04.005; Rybczynski R, 2001, MOL CELL ENDOCRINOL, V184, P1, DOI 10.1016/S0303-7207(01)00664-5; Rybczynski R, 2006, MOL CELL ENDOCRINOL, V251, P78, DOI 10.1016/j.mce.2006.02.015; Smith W, 2003, INSECT BIOCHEM MOLEC, V33, P1317, DOI 10.1016/j.ibmb.2003.06.003; SMITH WA, 1984, MOL CELL ENDOCRINOL, V37, P285, DOI 10.1016/0303-7207(84)90098-4; SMITH WA, 1985, MOL CELL ENDOCRINOL, V39, P71, DOI 10.1016/0303-7207(85)90093-0; Smith WA, 2012, INSECT ENDOCRINOLOGY, P1, DOI [10.1016/B978-0-12-384749-2.10001-9, DOI 10.1016/B978-0-12-384749-2.10001-9]; SONG QS, 1995, INSECT BIOCHEM MOLEC, V25, P591, DOI 10.1016/0965-1748(94)00100-V; SONG QS, 1994, DEV GENET, V15, P332, DOI 10.1002/dvg.1020150404; Song QS, 1997, J BIOL CHEM, V272, P4429, DOI 10.1074/jbc.272.7.4429; Steinberg GR, 2009, PHYSIOL REV, V89, P1025, DOI 10.1152/physrev.00011.2008; TAKEDA S, 1986, Bulletin of the Sericultural Experiment Station (Tokyo), V30, P361; Tohyama D, 2010, BIOCHEM BIOPH RES CO, V394, P112, DOI 10.1016/j.bbrc.2010.02.126; Tosca L, 2007, BIOL REPROD, V76, P368, DOI 10.1095/biolreprod.106.055749; Young SC, 2012, J INSECT PHYSIOL, V58, P102, DOI 10.1016/j.jinsphys.2011.10.005; ZHUO S, 1993, J BIOL CHEM, V268, P17754	46	10	10	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2013	8	5							e63102	10.1371/journal.pone.0063102	http://dx.doi.org/10.1371/journal.pone.0063102			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	155HD	23671658	Green Published, gold, Green Submitted			2022-12-27	WOS:000319737700038
J	Wang, H; Zhang, XW; Zhang, J; He, QF; Hu, RY; Wang, LX; Su, DT; Xiao, YY; Pan, J; Ye, Z				Wang, Hao; Zhang, Xinwei; Zhang, Jie; He, Qingfang; Hu, Ruying; Wang, Lixin; Su, Danting; Xiao, Yuanyuan; Pan, Jin; Ye, Zhen			Factors Associated with Prevalence, Awareness, Treatment and Control of Hypertension among Adults in Southern China: A Community-Based, Cross-Sectional Survey	PLOS ONE			English	Article							RISK-FACTORS; BLOOD-PRESSURE; URBAN ADULTS; POPULATION; PREHYPERTENSION; MANAGEMENT; HEALTH; NETHERLANDS; GUIDELINES; AMSTERDAM	The aim of this study was to investigate factors associated with prevalence, awareness, treatment and control of hypertension in southern China. A cross-sectional, population-based survey was conducted in 180 villages across 15 counties in southern China from July to November 2010. Totally, 17437 persons completed all of the questionnaires, measurement examination and blood specimen collection. Adjusted rate of hypertension was 22.59% (95%CI: 22.52%-22.66%), for men 23.36% (95%CI: 23.25%-23.47%) and for women 21.77% (95%CI: 21.68%-21.86%). Multivariate logistic regression showed that old age, education attainment, alcohol use, diabetes, obesity, high TC and high TG were associated with hypertension. Among the hypertensive individuals, 54.33% were aware of their hypertension, and 46.34% were currently taking antihypertensive medication, but only 18.26% had their blood pressure controlled. Among all the hypertensive subjects, awareness was more common in those who were female, living in the urban, old age, low education attainment, diabetes, overweight, obese, Low HDL-C. Among the subjects aware of their diagnosis of hypertension, medication treatment was more common in those living in the urban, old age, nonsmoker and diabetes. Among the individuals who receiving medication treatment, controlled hypertension were less common in those living in the urban, young age, low education attainment, overweight and obese. Despite high rate of hypertension, awareness, treatment and control of hypertension still need to be strengthened.	[Wang, Hao; Zhang, Xinwei; Zhang, Jie; He, Qingfang; Hu, Ruying; Wang, Lixin; Su, Danting; Xiao, Yuanyuan; Pan, Jin] Zhejiang Prov Ctr Dis Control & Prevent, Dept Chron Noncommunicable Dis Control & Prevent, Hangzhou, Zhejiang, Peoples R China; [Ye, Zhen] Hlth Bur Zhejiang Prov, Gen Off, Hangzhou, Zhejiang, Peoples R China	Zhejiang Provincial Center for Disease Control & Prevention	Ye, Z (corresponding author), Hlth Bur Zhejiang Prov, Gen Off, Hangzhou, Zhejiang, Peoples R China.	yz1668@sina.com.cn	su, dan/GYJ-1940-2022		grand science and technology projects of Zhejiang province [2011C12032-1]	grand science and technology projects of Zhejiang province	The study is supported by grand science and technology projects of Zhejiang province (project number 2011C12032-1) (http://www.zjkjt.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afridi I, 2003, J HYPERTENS, V21, P1983, DOI 10.1097/01.hjh.0000084751-37215.d2; Agyemang C, 2006, J HUM HYPERTENS, V20, P874, DOI 10.1038/sj.jhh.1002073; Agyemang C, 2006, J HUM HYPERTENS, V20, P67, DOI 10.1038/sj.jhh.1001923; Agyemang C, 2005, J HYPERTENS, V23, P1971, DOI 10.1097/01.hjh.0000186835.63996.d4; Ashraf MS, 2006, CURR HYPERTENS REP, V8, P368, DOI 10.1007/s11906-006-0080-1; Barengo NC, 2009, J HUM HYPERTENS, V23, P808, DOI 10.1038/jhh.2009.30; Cai L, 2012, CLIN EXP HYPERTENS, V34, P45, DOI 10.3109/10641963.2011.618206; Chalmers J, 1999, CLIN EXP HYPERTENS, V21, P1009; Chen R, 2003, J HUM HYPERTENS, V17, P751, DOI 10.1038/sj.jhh.1001612; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Choi KM, 2006, J HYPERTENS, V24, P1515, DOI 10.1097/01.hjh.0000239286.02389.0f; Erem C, 2009, J PUBLIC HEALTH-UK, V31, P47, DOI 10.1093/pubmed/fdn078; He J, 2005, NEW ENGL J MED, V353, P1124, DOI 10.1056/NEJMsa050467; He J, 2002, ARCH INTERN MED, V162, P1051, DOI 10.1001/archinte.162.9.1051; Huang JP, 2011, KIDNEY BLOOD PRESS R, V34, P69, DOI 10.1159/000323164; Joshi V, 2007, ASIA-PAC J PUBLIC HE, V19, P3, DOI 10.1177/10105395070190020201; Kanazawa M, 2005, WORLD REV NUTR DIET, V94, P1, DOI 10.1159/000088200; Kearney PM, 2005, LANCET, V365, P217, DOI 10.1016/S0140-6736(05)70151-3; Ko-Ko-Zaw, 2011, ASIA-PAC J PUBLIC HE, V23, P496, DOI 10.1177/1010539509349147; Liu LB, 2007, J ENVIRON SCI, V19, P1, DOI 10.1016/S1001-0742(07)60001-1; Liu ZQ, 2009, AM J HYPERTENS, V22, P929, DOI 10.1038/ajh.2009.134; Manzoli L, 2012, J HYPERTENS, V30, P1955, DOI 10.1097/HJH.0b013e3283577b20; Meisinger C, 2006, J HYPERTENS, V24, P293, DOI 10.1097/01.hjh.0000200508.10324.8e; Meng XJ, 2011, J HYPERTENS, V29, P1303, DOI 10.1097/HJH.0b013e328347f79e; Muntner P, 2004, HYPERTENSION, V43, P578, DOI 10.1161/01.HYP.0000116302.08484.14; Pereira M, 2009, J HYPERTENS, V27, P963, DOI 10.1097/HJH.0b013e3283282f65; Prince MJ, 2012, J HYPERTENS, V30, P177, DOI 10.1097/HJH.0b013e32834d9eda; Tian S, 2011, HYPERTENS RES, V34, P1087, DOI 10.1038/hr.2011.99; Ulasi II, 2011, INT J HYPERTENS, V2011, DOI 10.4061/2011/869675; Vigna-Taglianti F, 2009, J EPIDEMIOL COMMUN H, V63, P722, DOI 10.1136/jech.2008.081513; Williams B, 2004, J HUM HYPERTENS, V18, P139, DOI 10.1038/sj.jhh.1001683; Wu YF, 2008, CIRCULATION, V118, P2679, DOI 10.1161/CIRCULATIONAHA.108.788166; Wu Y, 2009, J HYPERTENS, V27, P190, DOI 10.1097/HJH.0b013e328317c8c3; Wyatt SB, 2008, HYPERTENSION, V51, P650, DOI 10.1161/HYPERTENSIONAHA.107.100081; Yang JM, 2010, HYPERTENS RES, V33, P331, DOI 10.1038/hr.2009.235; Yoon S, 2010, HYPERTENSION, V56, pE65; Zhao LC, 2004, HYPERTENSION, V43, P1332, DOI 10.1161/01.HYP.0000128243.06502.bc	37	53	63	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2013	8	5							e62469	10.1371/journal.pone.0062469	http://dx.doi.org/10.1371/journal.pone.0062469			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	155HD	23671599	Green Submitted, Green Published, gold			2022-12-27	WOS:000319737700012
J	Marschollek, M				Marschollek, Michael			A Semi-Quantitative Method to Denote Generic Physical Activity Phenotypes from Long-Term Accelerometer Data - The ATLAS Index	PLOS ONE			English	Article							WEEKEND WARRIOR; PATTERNS; RISK	Background: Physical activity is inversely correlated to morbidity and mortality risk. Large cohort studies use wearable accelerometer devices to measure physical activity objectively, providing data potentially relevant to identify different activity patterns and to correlate these to health-related outcome measures. A method to compute relevant characteristics of such data not only with regard to duration and intensity, but also to regularity of activity events, is necessary. The aims of this paper are to propose a new method - the ATLAS index (Activity Types from Long-term Accelerometric Sensor data) - to derive generic measures for distinguishing different characteristic activity phenotypes from accelerometer data, to propose a comprehensive graphical representation, and to conduct a proof- of-concept with long-term measurements from different devices and cohorts. Methods: The ATLAS index consists of the three dimensions regularity (reg), duration (dur) and intensity (int) of relevant activity events identified in long-term accelerometer data. It can be regarded as a 3D vector and represented in a 3D cube graph. 12 exemplary data sets of three different cohort studies with 99,467 minutes of data were chosen for concept validation. Results: Five archetypical activity types are proposed along with their dimensional characteristics (insufficiently active: low reg, int and dur; busy bee: low dur and int, high reg; cardio-active: medium reg, int and dur, endurance athlete: high reg, int and dur; and weekend warrior: high int and dur, low reg). The data sets are displayed in one common graph, indicating characteristic differences in activity patterns. Conclusion: The ATLAS index incorporates the relevant regularity dimension apart from the widely-used measures of duration and intensity. Along with the 3D representation, it allows to compare different activity types in cohort study populations, both visually and computationally using vector distance measures. Further research is necessary to validate the ATLAS index in order to find normative values and group centroids.	Peter L Reichertz Inst Med Informat, Hanover Med Sch, Hannover, Germany	Hannover Medical School	Marschollek, M (corresponding author), Peter L Reichertz Inst Med Informat, Hanover Med Sch, Hannover, Germany.	Michael.Marschollek@plri.de			project "Open Access Publizieren''; Deutsche Forschungsgemeinschaft (DFG)	project "Open Access Publizieren''; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This publication is supported by the project "Open Access Publizieren'' by the Deutsche Forschungsgemeinschaft (DFG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bouten CVC, 1997, IEEE T BIO-MED ENG, V44, P136, DOI 10.1109/10.554760; Haskell WL, 2007, MED SCI SPORT EXER, V39, P1423, DOI [10.1249/mss.0b013e3180616b27, 10.1161/CIRCULATIONAHA.107.185649]; Kruger J, 2007, MED SCI SPORT EXER, V39, P796, DOI 10.1249/mss.0b013e318031faac; Kwak L, 2011, SCAND J WORK ENV HEA, V37, P6, DOI 10.5271/sjweh.3085; Lee IM, 2004, AM J EPIDEMIOL, V160, P636, DOI 10.1093/aje/kwh274; Marschollek M, 2011, METHOD INFORM MED, V50, P420, DOI 10.3414/ME10-01-0040; Marschollek M, 2007, MULTIMODAL HOME MONI; Mathie M., 2003, MONITORING INTERPRET; Mathie MJ, 2004, PHYSIOL MEAS, V25, pR1, DOI 10.1088/0967-3334/25/2/R01; Metzger JS, 2008, MED SCI SPORT EXER, V40, P630, DOI 10.1249/MSS.0b013e3181620ebc; Nelson ME, 2007, MED SCI SPORT EXER, V39, P1435, DOI [10.1249/mss.0b013e3180616aa2, 10.1161/CIRCULATIONAHA.107.185650]; Patnode CD, 2011, J PHYS ACT HEALTH, V8, P457, DOI 10.1123/jpah.8.4.457; Sattelmair J, 2011, CIRCULATION, V124, P789, DOI 10.1161/CIRCULATIONAHA.110.010710; Tudor-Locke C, 2010, INT J BEHAV NUTR PHY, V7, DOI 10.1186/1479-5868-7-60; Westerterp KR, 2001, NATURE, V410, P539, DOI 10.1038/35069142; WHO, 2010, SCREENING DONATED BLOOD FOR TRANSFUSION: TRANSMISSIBLE INFECTIONS, P1; Woodcock J, 2011, INT J EPIDEMIOL, V40, P121, DOI 10.1093/ije/dyq104	17	19	19	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2013	8	5							e63522	10.1371/journal.pone.0063522	http://dx.doi.org/10.1371/journal.pone.0063522			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145YI	23667631	Green Submitted, Green Published, gold			2022-12-27	WOS:000319055600062
J	Ding, C; Li, L; Su, YC; Xiang, RL; Cong, X; Yu, HK; Li, SL; Wu, LL; Yu, GY				Ding, Chong; Li, Li; Su, Yun-Chao; Xiang, Ruo-Lan; Cong, Xin; Yu, Hong-Kui; Li, Sheng-Lin; Wu, Li-Ling; Yu, Guang-Yan			Adiponectin Increases Secretion of Rat Submandibular Gland via Adiponectin Receptors-Mediated AMPK Signaling	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; TIGHT JUNCTION; EPITHELIAL-CELLS; EXPRESSION; SALIVARY; ASSOCIATION; HYPOADIPONECTINEMIA; PERMEABILITY; BARRIER	Adiponectin and adiponectin receptors (AdipoR1/2) are expressed in various tissues and are involved in the regulation of multiple functions such as energy metabolism and inflammatory responses. However, the effect of adiponectin and AdipoRs in submandibular glands has not been fully evaluated. In the present study, we found that mRNA and protein of both adiponectin and AdipoR1/2 were expressed in rat submandibular glands and in the SMG-C6 cell line, as evidenced by RT-PCR and Western blot analysis. Immunofluorescence staining showed that adiponectin was diffused in the cytoplasm, while AdipoR1/2 was concentrated in the membrane of acinar cells. Saliva flow was significantly increased by full length adiponectin (fAd) or globular adiponectin (gAd) perfusion in isolated rat submandibular glands. 5-Aminoimidazole-4carboxamide- 1-4-ribofuranoside (AICAR), an adenosine monophosphate activated protein kinase (AMPK) activator, also increased saliva secretion. fAd, gAd, and AICAR all increased the average width of apical tight junctions in perfused submandibular glands, and decreased transepithelial electrical resistance (TER) in SMG-C6 cells, suggesting that adiponectin promoted secretion by modulating paracellular permeability. fAd and gAd increased p-AMPK levels, while AraA, an AMPK antagonist, abolished fAd- and gAd-induced changes in secretion, tight junction ultrastructure, and TER. Moreover, both AdipoR1 and AdipoR2 were required for fAd- or gAd-induced p-AMPK and TER responses, suggesting from their inhibition following AdipoR1 or AdipoR2 knockdown, and co-knockdown of AdipoRs by RNA interference. Our results suggest that adiponectin functions as a promoter of salivary secretion in rat submandibular glands via activation of AdipoRs, AMPK, and paracellular permeability.	[Ding, Chong; Li, Sheng-Lin] Peking Univ, Sch & Hosp Stomatol, Ctr Salivary Gland Dis, Beijing 100871, Peoples R China; [Ding, Chong; Li, Sheng-Lin] Peking Univ, Sch & Hosp Stomatol, Ctr Lab, Beijing 100871, Peoples R China; [Li, Li; Su, Yun-Chao; Xiang, Ruo-Lan; Cong, Xin; Wu, Li-Ling] Peking Univ, Hlth Sci Ctr, Dept Physiol & Pathophysiol, Beijing 100871, Peoples R China; [Li, Li; Su, Yun-Chao; Xiang, Ruo-Lan; Cong, Xin; Wu, Li-Ling] Minist Educ, Key Lab Mol Cardiovasc Sci, Beijing, Peoples R China; [Yu, Hong-Kui; Yu, Guang-Yan] Peking Univ, Sch & Hosp Stomatol, Dept Oral & Maxillofacial Surg, Beijing 100871, Peoples R China	Peking University; Peking University; Peking University; Peking University	Wu, LL (corresponding author), Peking Univ, Hlth Sci Ctr, Dept Physiol & Pathophysiol, Beijing 100871, Peoples R China.	pathophy@bjmu.edu.cn; gyyu@263.net	Xiang, Ruo-Lan/T-6845-2019		National Natural Science Foundation of China [30973316, 81070847, 81271161]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by grants from the National Natural Science Foundation of China (Nos. 30973316, 81070847, and 81271161). (Website:http://www.nsfc.gov.cn.) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERBERG EK, 1993, PHARMACEUT RES, V10, P857, DOI 10.1023/A:1018909210879; BAUM BJ, 1993, ANN NY ACAD SCI, V694, P17; Berner HS, 2004, BONE, V35, P842, DOI 10.1016/j.bone.2004.06.008; Bjursell M, 2007, DIABETES, V56, P583, DOI 10.2337/db06-1432; Civitarese AE, 2004, DIABETOLOGIA, V47, P816, DOI 10.1007/s00125-004-1359-x; Cong X, 2012, LAB INVEST, V92, P753, DOI 10.1038/labinvest.2012.12; Corbetta S, 2005, J CLIN ENDOCR METAB, V90, P2397, DOI 10.1210/jc.2004-1553; Dadson Keith, 2011, Front Endocrinol (Lausanne), V2, P62, DOI 10.3389/fendo.2011.00062; Ding C, 2011, J PROTEOME RES, V10, P2206, DOI 10.1021/pr100965q; Garrett JR, 1999, NEURAL MECH SALIVARY; Groschl M, 2001, J CLIN ENDOCR METAB, V86, P5234, DOI 10.1210/jc.86.11.5234; Guo ZX, 2007, METABOLISM, V56, P1363, DOI 10.1016/j.metabol.2007.05.005; Guo ZX, 2011, J PHARM PHARMACOL, V63, P87, DOI 10.1111/j.2042-7158.2010.01157.x; Hug C, 2004, P NATL ACAD SCI USA, V101, P10308, DOI 10.1073/pnas.0403382101; Kadowaki T, 2005, ENDOCR REV, V26, P439, DOI 10.1210/er.2005-0005; Katsiougiannis S, 2006, ARTHRITIS RHEUM, V54, P2295, DOI 10.1002/art.21944; Katsiougiannis S, 2010, ARTHRITIS RHEUM-US, V62, P414, DOI 10.1002/art.27239; Kawedia JD, 2008, J PHARMACOL EXP THER, V326, P829, DOI 10.1124/jpet.107.135798; Kraus D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030716; Kumada M, 2003, ARTERIOSCL THROM VAS, V23, P85, DOI 10.1161/01.ATV.0000048856.22331.50; Li YM, 2006, LIFE SCI, V79, P2091, DOI 10.1016/j.lfs.2006.07.017; Ma TH, 1999, J BIOL CHEM, V274, P20071, DOI 10.1074/jbc.274.29.20071; Mamali I, 2012, PEPTIDES, V33, P120, DOI 10.1016/j.peptides.2011.11.007; Matsuzaki T, 1999, CELL TISSUE RES, V295, P513, DOI 10.1007/s004410051257; Mitic LL, 1998, ANNU REV PHYSIOL, V60, P121, DOI 10.1146/annurev.physiol.60.1.121; Mizumachi-Kubono M, 2012, ARCH ORAL BIOL, V57, P877, DOI 10.1016/j.archoralbio.2012.02.006; Nighot PK, 2010, AM J PHYSIOL-GASTR L, V299, pG449, DOI 10.1152/ajpgi.00520.2009; Ogawa Y, 2003, PROG HISTOCHEM CYTO, V38, P343, DOI 10.1016/S0079-6336(03)80001-3; Peng LY, 2009, J NUTR, V139, P1619, DOI 10.3945/jn.109.104638; Pineiro R, 2005, FEBS LETT, V579, P5163, DOI 10.1016/j.febslet.2005.07.098; Pischon T, 2004, JAMA-J AM MED ASSOC, V291, P1730, DOI 10.1001/jama.291.14.1730; Quissell D O, 1997, In Vitro Cell Dev Biol Anim, V33, P164; Saito Y, 2007, AM J PHYSIOL-HEART C, V293, pH3490, DOI 10.1152/ajpheart.00310.2007; SCHERER PE, 1995, J BIOL CHEM, V270, P26746, DOI 10.1074/jbc.270.45.26746; Shibata R, 2004, NAT MED, V10, P1384, DOI 10.1038/nm1137; Shibata R, 2005, NAT MED, V11, P1096, DOI 10.1038/nm1295; Shibata R, 2007, J MOL CELL CARDIOL, V42, P1065, DOI 10.1016/j.yjmcc.2007.03.808; Staiger K, 2005, J CLIN ENDOCR METAB, V90, P6707, DOI 10.1210/jc.2005-0467; Thundyil J, 2011, BRIT J PHARMACOL, V165, P313; Toda M, 2007, ACTA DIABETOL, V44, P20, DOI 10.1007/s00592-007-0236-8; Tsukita S, 2001, NAT REV MOL CELL BIO, V2, P285, DOI 10.1038/35067088; Turner JR, 1997, AM J PHYSIOL-CELL PH, V273, pC1378, DOI 10.1152/ajpcell.1997.273.4.C1378; Waki H, 2005, ENDOCRINOLOGY, V146, P790, DOI 10.1210/en.2004-1096; Weyer C, 2001, J CLIN ENDOCR METAB, V86, P1930, DOI 10.1210/jc.86.5.1930; Yamauchi T, 2008, INT J OBESITY, V32, pS13, DOI 10.1038/ijo.2008.233; Yamauchi T, 2003, NATURE, V423, P762, DOI 10.1038/nature01705; Yamauchi T, 2002, NAT MED, V8, P1288, DOI 10.1038/nm788; Zhang L, 2006, P NATL ACAD SCI USA, V103, P17272, DOI 10.1073/pnas.0608531103; Zheng B, 2007, P NATL ACAD SCI USA, V104, P819, DOI 10.1073/pnas.0610157104; Zhou YH, 2005, GENE EXPR PATTERNS, V5, P711, DOI 10.1016/j.modgep.2005.02.002	50	21	24	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e63878	10.1371/journal.pone.0063878	http://dx.doi.org/10.1371/journal.pone.0063878			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667684	gold, Green Published, Green Submitted			2022-12-27	WOS:000319654700193
J	Giannini, C; Kloss, A; Gohlke, S; Mishto, M; Nicholson, TP; Sheppard, PW; Kloetzel, PM; Dahlmann, B				Giannini, Carolin; Kloss, Alexander; Gohlke, Sabrina; Mishto, Michele; Nicholson, Thomas P.; Sheppard, Paul W.; Kloetzel, Peter-Michael; Dahlmann, Burkhardt			Poly-Ub-Substrate-Degradative Activity of 26S Proteasome Is Not Impaired in the Aging Rat Brain	PLOS ONE			English	Article							OXIDATIVE STRESS; 20S PROTEASOME; PROTEOLYTIC ACTIVITY; TISSUE DISTRIBUTION; INTERFERON-GAMMA; SKELETAL-MUSCLE; IMMUNOPROTEASOME; PROTEINS; AGE; DISEASES	Proteostasis is critical for the maintenance of life. In neuronal cells an imbalance between protein synthesis and degradation is thought to be involved in the pathogenesis of neurodegenerative diseases during aging. Partly, this seems to be due to a decrease in the activity of the ubiquitin-proteasome system, wherein the 20S/26S proteasome complexes catalyse the proteolytic step. We have characterised 20S and 26S proteasomes from cerebrum, cerebellum and hippocampus of 3 weeks old (young) and 24 month old (aged) rats. Our data reveal that the absolute amount of the proteasome is not dfferent between both age groups. Within the majority of standard proteasomes in brain the minute amounts of immuno-subunits are slightly increased in aged rat brain. While this goes along with a decrease in the activities of 20S and 26S proteasomes to hydrolyse synthetic fluorogenic tripeptide substrates from young to aged rats, the capacity of 26S proteasomes for degradation of poly-Ub-model substrates and its activation by poly-Ub-substrates is not impaired or even slightly increased in brain of aged rats. We conclude that these alterations in proteasome properties are important for maintaining proteostasis in the brain during an uncomplicated aging process.	[Giannini, Carolin; Kloss, Alexander; Gohlke, Sabrina; Mishto, Michele; Kloetzel, Peter-Michael; Dahlmann, Burkhardt] Charite, Inst Biochem, D-13353 Berlin, Germany; [Nicholson, Thomas P.; Sheppard, Paul W.] Enzo Life Sci UK Ltd, Exeter, Devon, England	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Dahlmann, B (corresponding author), Charite, Inst Biochem, D-13353 Berlin, Germany.	burkhardt.dahlmann@charite.de	mishto, michele/A-5592-2010	mishto, michele/0000-0003-3042-2792	Sonnenfeld-Stiftung, Berlin; Berliner Krebsgesellschaft [KOFF201102]; excellence cluster NeuroCure; Deutsche Forschunsgemeinschaft [SFB TRR 34]; EU [LSHC-CT-2005-018683]	Sonnenfeld-Stiftung, Berlin; Berliner Krebsgesellschaft; excellence cluster NeuroCure; Deutsche Forschunsgemeinschaft(German Research Foundation (DFG)); EU(European Commission)	C.G. was supported by a PhD studentship from the Sonnenfeld-Stiftung, Berlin. M. M. was supported by Berliner Krebsgesellschaft (KOFF201102). P.-M.K. was supported by the excellence cluster NeuroCure and the Deutsche Forschunsgemeinschaft (SFB TRR 34). P.W.S. and T.P.N. were supported by the EU Network of Excellence 'Role of ubiquitin and ubiquitin-like modifiers in cellular recognition (RUBICON)' Project number LSHC-CT-2005-018683. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Akaishi T, 1996, BIOCHEM MOL BIOL INT, V39, P1017; AZARYAN A, 1989, NEUROCHEM RES, V14, P995, DOI 10.1007/BF00965934; Bech-Otschir D, 2009, NAT STRUCT MOL BIOL, V16, P219, DOI 10.1038/nsmb.1547; Bedford L, 2010, TRENDS CELL BIOL, V20, P391, DOI 10.1016/j.tcb.2010.03.007; Bellavista E, 2013, CURR PHARM DESIGN, V19, P702, DOI 10.2174/138161213804581927; Chondrogianni N, 2005, EXP GERONTOL, V40, P931, DOI 10.1016/j.exger.2005.09.004; Cook C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005888; Cooper HJ, 2004, ANAL CHEM, V76, P6982, DOI 10.1021/ac0401063; DAHLMANN B, 1995, BIOCHEM J, V309, P195, DOI 10.1042/bj3090195; Dahlmann B, 2000, J MOL BIOL, V303, P643, DOI 10.1006/jmbi.2000.4185; Dasuri K, 2009, MECH AGEING DEV, V130, P777, DOI 10.1016/j.mad.2009.10.003; Ding QX, 2006, ANTIOXID REDOX SIGN, V8, P163, DOI 10.1089/ars.2006.8.163; Dudek EJ, 2005, FASEB J, V19, P1707, DOI 10.1096/fj.05-4049fje; El Mohsen MMA, 2005, BIOCHEM BIOPH RES CO, V336, P386, DOI 10.1016/j.bbrc.2005.07.201; Ferrington DA, 2005, FASEB J, V19, P664, DOI 10.1096/fj.04-2578fje; Franceschi C, 2007, MECH AGEING DEV, V128, P92, DOI 10.1016/j.mad.2006.11.016; Gallastegui N, 2010, TRENDS BIOCHEM SCI, V35, P634, DOI 10.1016/j.tibs.2010.05.005; Gavilan MP, 2009, J NEUROCHEM, V108, P260, DOI 10.1111/j.1471-4159.2008.05762.x; Gillardon F, 2007, J NEUROCHEM, V101, P1483, DOI 10.1111/j.1471-4159.2006.04438.x; Huber EM, 2012, CELL, V148, P727, DOI 10.1016/j.cell.2011.12.030; KAMAKURA K, 1988, J NEUROSCI RES, V20, P473, DOI 10.1002/jnr.490200410; Keller JN, 2000, NEUROSCIENCE, V98, P149, DOI 10.1016/S0306-4522(00)00067-1; Keller JN, 2000, MECH AGEING DEV, V113, P61, DOI 10.1016/S0047-6374(99)00101-3; Kimura Y, 2000, J BIOL CHEM, V275, P4635, DOI 10.1074/jbc.275.7.4635; Kremer M, 2010, J IMMUNOL, V185, P5549, DOI 10.4049/jimmunol.1001517; KUEHN L, 1986, Ciencia Biologica Molecular and Cellular Biology, V11, P107; Li XH, 2009, BIOCHEM J, V421, P397, DOI 10.1042/BJ20090528; Martinez-Vicente M, 2005, EXP GERONTOL, V40, P622, DOI 10.1016/j.exger.2005.07.005; Medicherla B, 2008, J CELL BIOL, V182, P663, DOI 10.1083/jcb.200803022; Mishto M, 2006, NEUROBIOL AGING, V27, P54, DOI 10.1016/j.neurobiolaging.2004.12.004; Mishto M, 2010, BIOCHEM RES TRENDS, P225; Mishto M, 2011, BIOCHEM BIOPH RES CO, V408, P65, DOI 10.1016/j.bbrc.2011.03.117; Mouton PR, 2002, BRAIN RES, V956, P30, DOI 10.1016/S0006-8993(02)03475-3; Noda C, 2000, BIOCHEM BIOPH RES CO, V277, P348, DOI 10.1006/bbrc.2000.3676; Opitz E, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002233; Piccinini M, 2000, MOL BRAIN RES, V76, P103, DOI 10.1016/S0169-328X(99)00337-X; Piccinini M, 2003, J NEUROIMMUNOL, V135, P135, DOI 10.1016/S0165-5728(02)00439-3; Pintado C, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-87; Ponnappan S, 2013, MECH AGEING DEV; Rechsteiner M, 2005, TRENDS CELL BIOL, V15, P27, DOI 10.1016/j.tcb.2004.11.003; Rodriguez KA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035890; Schmidt F, 2006, PROTEOMICS, V6, P4622, DOI 10.1002/pmic.200500920; Seifert U, 2010, CELL, V142, P613, DOI 10.1016/j.cell.2010.07.036; Shringarpure R, 2003, J BIOL CHEM, V278, P311, DOI 10.1074/jbc.M206279200; Stohwasser R, 2000, GLIA, V29, P355, DOI 10.1002/(SICI)1098-1136(20000215)29:4<355::AID-GLIA6>3.0.CO;2-4; Tai H. C., 2010, FRONT MOL NEUROSCI, V3, P1; TANAKA K, 1986, J BIOL CHEM, V261, P5197; Tonoki A, 2009, MOL CELL BIOL, V29, P1095, DOI 10.1128/MCB.01227-08; Vernace VA, 2007, FASEB J, V21, P2672, DOI 10.1096/fj.06-6751com; Vigouroux S, 2003, J NEUROCHEM, V84, P392, DOI 10.1046/j.1471-4159.2003.01534.x; WEEKE B, 1973, SCAND J IMMUNOL, V2, P37, DOI 10.1111/j.1365-3083.1973.tb03777.x; Wehren A, 1996, BIOL CHEM, V377, P497; Zeng BY, 2005, MECH AGEING DEV, V126, P760, DOI 10.1016/j.mad.2005.01.008	54	22	22	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e64042	10.1371/journal.pone.0064042	http://dx.doi.org/10.1371/journal.pone.0064042			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667697	Green Submitted, gold, Green Published			2022-12-27	WOS:000319654700200
J	Gramatzki, D; Herrmann, C; Happold, C; Becker, KA; Gulbins, E; Weller, M; Tabatabai, G				Gramatzki, Dorothee; Herrmann, Caroline; Happold, Caroline; Becker, Katrin Anne; Gulbins, Erich; Weller, Michael; Tabatabai, Ghazaleh			Glioma Cell Death Induced by Irradiation or Alkylating Agent Chemotherapy Is Independent of the Intrinsic Ceramide Pathway	PLOS ONE			English	Article							RADIATION-INDUCED APOPTOSIS; CENTRAL-NERVOUS-SYSTEM; HUMAN COLON-CANCER; GLUCOSYLCERAMIDE SYNTHASE; ACID SPHINGOMYELINASE; ADJUVANT TEMOZOLOMIDE; MULTIDRUG-RESISTANCE; GLIOBLASTOMA CELLS; BREAST-CARCINOMA; MALIGNANT GLIOMA	Background/Aims: Resistance to genotoxic therapy is a characteristic feature of glioma cells. Acid sphingomyelinase (ASM) hydrolyzes sphingomyelin to ceramide and glucosylceramide synthase (GCS) catalyzes ceramide metabolism. Increased ceramide levels have been suggested to enhance chemotherapy-induced death of cancer cells. Methods: Microarray and clinical data for ASM and GCS in astrocytomas WHO grade II-IV were acquired from the Rembrandt database. Moreover, the glioblastoma database of the Cancer Genome Atlas network (TCGA) was used for survival data of glioblastoma patients. For in vitro studies, increases in ceramide levels were achieved either by ASM overexpression or by the GCS inhibitor DL-threo-1-phenyl-2-palmitoylamino-3-morpholino-1-propanol (PPMP) in human glioma cell lines. Combinations of alkylating chemotherapy or irradiation and ASM overexpression, PPMP or exogenous ceramide were applied in parental cells. The anti-glioma effects were investigated by assessing proliferation, metabolic activity, viability and clonogenicity. Finally, viability and clonogenicity were assessed in temozolomide (TMZ)-resistant cells upon treatment with PPMP, exogenous ceramide, alkylating chemotherapy, irradiation or their combinations. Results: Interrogations from the Rembrandt and TCGA database showed a better survival of glioblastoma patients with low expression of ASM or GCS. ASM overexpression or PPMP treatment alone led to ceramide accumulation but did not enhance the anti-glioma activity of alkylating chemotherapy or irradiation. PPMP or exogenous ceramide induced acute cytotoxicity in glioblastoma cells. Combined treatments with chemotherapy or irradiation led to additive, but not synergistic effects. Finally, no synergy was found when TMZ-resistant cells were treated with exogenous ceramide or PPMP alone or in combination with TMZ or irradiation. Conclusion: Modulation of intrinsic glioma cell ceramide levels by ASM overexpression or GCS inhibition does not enhance the anti-glioma activity of alkylating chemotherapy or irradiation.	[Gramatzki, Dorothee; Happold, Caroline; Weller, Michael; Tabatabai, Ghazaleh] Univ Zurich Hosp, Dept Neurol, Lab Mol Neurooncol, CH-8091 Zurich, Switzerland; [Herrmann, Caroline] Univ Hosp Tuebingen, Dept Preclin Imaging & Radiopharm, Tubingen, Germany; [Becker, Katrin Anne; Gulbins, Erich] Univ Duisburg Essen, Dept Mol Biol, Essen, Germany; [Weller, Michael; Tabatabai, Ghazaleh] Univ Zurich, Neurosci Ctr Zurich, Zurich, Switzerland; [Weller, Michael; Tabatabai, Ghazaleh] Swiss Fed Inst Technol, Zurich, Switzerland	University of Zurich; University Zurich Hospital; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; University of Duisburg Essen; University of Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich	Tabatabai, G (corresponding author), Univ Zurich Hosp, Dept Neurol, Lab Mol Neurooncol, CH-8091 Zurich, Switzerland.	ghazaleh.tabatabai@usz.ch	Gulbins, Erich/L-6989-2014; Tabatabai, Ghazaleh/A-6365-2015	Gulbins, Erich/0000-0002-3117-1342; Tabatabai, Ghazaleh/0000-0003-3702-923X; Tabatabai, Ghazaleh/0000-0002-3542-8782; Weller, Michael/0000-0002-1748-174X	German Research Council (DFG) [SFB773]; NCCR Neural Plasticity and Repair	German Research Council (DFG)(German Research Foundation (DFG)); NCCR Neural Plasticity and Repair(Swiss National Science Foundation (SNSF))	This study was funded by the German Research Council (DFG, SFB773) and by the NCCR Neural Plasticity and Repair. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basu S, 2004, GLYCOCONJUGATE J, V20, P563; Becker KA, 2010, AM J RESP CELL MOL, V42, P716, DOI 10.1165/rcmb.2009-0174OC; Boyle PJ, 2006, GLYCOCONJUGATE J, V23, P175, DOI 10.1007/s10719-006-7923-5; Brada M, 2010, J CLIN ONCOL, V28, P4601, DOI 10.1200/JCO.2009.27.1932; Brenner B, 1998, CELL DEATH DIFFER, V5, P29, DOI 10.1038/sj.cdd.4400307; Chatterjee M, 2001, MOL CARCINOGEN, V30, P47, DOI 10.1002/1098-2744(200101)30:1<47::AID-MC1012>3.0.CO;2-3; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; CIFONE MG, 1994, J EXP MED, V180, P1547, DOI 10.1084/jem.180.4.1547; Demaison C, 2002, HUM GENE THER, V13, P803, DOI 10.1089/10430340252898984; Dumitru CA, 2009, J CELL PHYSIOL, V221, P688, DOI 10.1002/jcp.21907; Eberhardt O, 2000, J NEUROSCI, V20, P9126; FERLINZ K, 1994, BIOCHEM J, V301, P855, DOI 10.1042/bj3010855; Garcia-Barros M, 2004, CANCER RES, V64, P8285, DOI 10.1158/0008-5472.CAN-04-2715; Giussani P, 2012, CANCER INVEST, V30, P27, DOI 10.3109/07357907.2011.629379; Gloeckner H, 2001, J IMMUNOL METHODS, V252, P131, DOI 10.1016/S0022-1759(01)00347-7; Gouaze V, 2004, MOL CANCER THER, V3, P633; Grammatikos G, 2007, ANTIOXID REDOX SIGN, V9, P1449, DOI 10.1089/ars.2007.1673; Grassme H, 2007, PROG LIPID RES, V46, P161, DOI 10.1016/j.plipres.2007.03.002; GRECO WR, 1995, PHARMACOL REV, V47, P331; Gulbins E, 2002, BBA-MOL CELL BIOL L, V1585, P139, DOI 10.1016/S1388-1981(02)00334-7; GULBINS E, 1995, IMMUNITY, V2, P341, DOI 10.1016/1074-7613(95)90142-6; Happold C, 2012, J NEUROCHEM, V122, P444, DOI 10.1111/j.1471-4159.2012.07781.x; Hara S, 2004, CELL DEATH DIFFER, V11, P853, DOI 10.1038/sj.cdd.4401428; Hermisson M, 2006, J NEUROCHEM, V96, P766, DOI 10.1111/j.1471-4159.2005.03583.x; Hsiao LL, 2001, PHYSIOL GENOMICS, V7, P97, DOI 10.1152/physiolgenomics.00040.2001; Johnson DR, 2012, CANCER-AM CANCER SOC, V118, P5608, DOI 10.1002/cncr.27590; Lacour S, 2004, CANCER RES, V64, P3593, DOI 10.1158/0008-5472.CAN-03-2787; Liu YY, 2011, INT J ONCOL, V39, P425, DOI 10.3892/ijo.2011.1052; Liu YY, 1999, J BIOL CHEM, V274, P1140, DOI 10.1074/jbc.274.2.1140; Liu YY, 2001, FASEB J, V15, P719, DOI 10.1096/fj.00-0223com; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; Lovat PE, 2004, JNCI-J NATL CANCER I, V96, P1288, DOI 10.1093/jnci/djh254; Madhavan S, 2009, MOL CANCER RES, V7, P157, DOI 10.1158/1541-7786.MCR-08-0435; Maurer BJ, 2000, JNCI-J NATL CANCER I, V92, P1897, DOI 10.1093/jnci/92.23.1897; Maurer BJ, 1999, JNCI-J NATL CANCER I, V91, P1138, DOI 10.1093/jnci/91.13.1138; Ogretmen B, 2004, NAT REV CANCER, V4, P604, DOI 10.1038/nrc1411; Pena LA, 2000, CANCER RES, V60, P321; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Preusser M, 2011, ANN NEUROL, V70, P9, DOI 10.1002/ana.22425; Prinetti A, 2006, BIOCHEM J, V395, P311, DOI 10.1042/BJ20051184; Riboni L, 2002, GLIA, V39, P105, DOI 10.1002/glia.10087; Roth W, 2000, BRAIN PATHOL, V10, P223, DOI 10.1111/j.1750-3639.2000.tb00256.x; Rylova SN, 1998, BIOCHEMISTRY-MOSCOW+, V63, P1057; Sanchenkov A, 2001, JNCI-J NATL CANCER I, V93, P347, DOI 10.1093/jnci/93.5.347; Santana P, 1996, CELL, V86, P189, DOI 10.1016/S0092-8674(00)80091-4; SCHUTZE S, 1992, CELL, V71, P765, DOI 10.1016/0092-8674(92)90553-O; Selzner M, 2001, CANCER RES, V61, P1233; Shayman JA, 2000, METHOD ENZYMOL, V311, P373; Smith EL, 2008, FASEB J, V22, P3419, DOI 10.1096/fj.08-108043; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Stupp R, 2009, LANCET ONCOL, V10, P459, DOI 10.1016/S1470-2045(09)70025-7; Tabatabai G, 2007, ANN NEUROL, V61, P153, DOI 10.1002/ana.21057; Tabatabai G, 2010, INT J ONCOL, V36, P1409, DOI 10.3892/ijo_00000626; Tepper AD, 2000, J BIOL CHEM, V275, P34810, DOI 10.1074/jbc.M005142200; van den Bent MJ, 2009, J CLIN ONCOL, V27, P1268, DOI 10.1200/JCO.2008.17.5984; Veldman RJ, 2003, FASEB J, V17, P1144, DOI 10.1096/fj.02-1053fje; Wagenknecht B, 2001, CELL DEATH DIFFER, V8, P595, DOI 10.1038/sj.cdd.4400848; Weller M, 2013, NEURO-ONCOLOGY, V15, P4, DOI 10.1093/neuonc/nos273; Wick A, 2004, J NEUROCHEM, V91, P1067, DOI 10.1111/j.1471-4159.2004.02774.x; Xie P, 2008, LEUKEMIA RES, V32, P475, DOI 10.1016/j.leukres.2007.07.006	60	12	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e63527	10.1371/journal.pone.0063527	http://dx.doi.org/10.1371/journal.pone.0063527			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667632	Green Submitted, Green Accepted, Green Published, gold			2022-12-27	WOS:000319654700156
J	Komeilipoor, N; Pizzolato, F; Daffertshofer, A; Cesari, P				Komeilipoor, Naeem; Pizzolato, Fabio; Daffertshofer, Andreas; Cesari, Paola			Excitability of Motor Cortices as a Function of Emotional Sounds	PLOS ONE			English	Article							TRANSCRANIAL MAGNETIC STIMULATION; SELF-INDUCED SADNESS; HEMISPHERIC-ASYMMETRY; AUTOMATIC EVALUATION; CORTEX EXCITABILITY; BRAIN ACTIVITY; EAR ASYMMETRY; BLOOD-FLOW; PERCEPTION; LATERALIZATION	We used transcranial magnetic stimulation (TMS) to clarify how non-verbal emotionally-characterized sounds modulate the excitability of the corticospinal motor tract (CST). While subjects were listening to sounds (monaurally and binaurally), single TMS pulses were delivered to either left or right primary motor cortex (M1), and electromyographic activities were recorded from the contralateral abductor pollicis brevis muscle. We found a significant increase in CST excitability in response to unpleasant as compared to neutral sounds. The increased excitability was lateralized as a function of stimulus valence: Unpleasant stimuli resulted in a significantly higher facilitation of motor potentials evoked in the left hemisphere, while pleasant stimuli yielded a greater CST excitability in the right one. Furthermore, TMS induced higher motor evoked potentials when listening to unpleasant sounds with the left than with the right ear. Taken together, our findings provide compelling evidence for an asymmetric modulation of CST excitability as a function of emotional sounds along with ear laterality.	[Komeilipoor, Naeem; Pizzolato, Fabio; Cesari, Paola] Univ Verona, Dept Neurol Neuropsychol Morphol & Movement Sci, I-37100 Verona, Italy; [Komeilipoor, Naeem; Daffertshofer, Andreas] Univ Amsterdam, Vrije Univ, MOVE Res Inst, Amsterdam, Netherlands	University of Verona; University of Amsterdam; Vrije Universiteit Amsterdam	Cesari, P (corresponding author), Univ Verona, Dept Neurol Neuropsychol Morphol & Movement Sci, I-37100 Verona, Italy.	paola.cesari@univr.it		Cesari, Paola/0000-0002-1705-6065; Daffertshofer, Andreas/0000-0001-9107-3552	Netherlands Organisation for Scientific Research (NWO) [400-08-127]	Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	AD received financial support from the Netherlands Organisation for Scientific Research (NWO grant #400-08-127).	Adolphs R, 2000, J NEUROSCI, V20, P2683; Adolphs R, 1996, J NEUROSCI, V16, P7678; Adolphs R, 2001, J COGNITIVE NEUROSCI, V13, P232, DOI 10.1162/089892901564289; AHERN GL, 1985, NEUROPSYCHOLOGIA, V23, P745, DOI 10.1016/0028-3932(85)90081-8; Amunts K, 1996, NEUROIMAGE, V4, P216, DOI 10.1006/nimg.1996.0073; Baumert A, 2011, COGN AFFECT BEHAV NE, V11, P404, DOI 10.3758/s13415-011-0044-z; Baumgartner T, 2007, NEUROREPORT, V18, P261, DOI 10.1097/WNR.0b013e328012272e; BEST CT, 1994, J EXP PSYCHOL HUMAN, V20, P751, DOI 10.1037/0096-1523.20.4.751; Bloom JS, 2005, NEUROPSYCHOL REV, V15, P59, DOI 10.1007/s11065-005-6252-y; BOROD JC, 1992, J CONSULT CLIN PSYCH, V60, P339, DOI 10.1037/0022-006X.60.3.339; Borod JC, 1998, NEUROPSYCHOLOGY, V12, P446, DOI 10.1037/0894-4105.12.3.446; BOWERS D, 1985, BRAIN COGNITION, V4, P258, DOI 10.1016/0278-2626(85)90020-X; Bradley MM, 1999, INT AFFECTIVE DIGITI; BRYDEN MP, 1963, J EXP PSYCHOL, V65, P103, DOI 10.1037/h0042773; BUCK R, 1980, CORTEX, V16, P351, DOI 10.1016/S0010-9452(80)80037-2; CARMON A, 1973, ACTA PSYCHOL, V37, P351, DOI 10.1016/0001-6918(73)90002-4; Chen M, 1999, PERS SOC PSYCHOL B, V25, P215, DOI 10.1177/0146167299025002007; Coelho CM, 2010, NEUROSCI LETT, V481, P135, DOI 10.1016/j.neulet.2010.03.027; Coombes SA, 2006, NEUROSCI LETT, V396, P192, DOI 10.1016/j.neulet.2005.11.048; Coombes SA, 2005, J MOTOR BEHAV, V37, P425, DOI 10.3200/JMBR.37.6.425-436; Coombes SA, 2007, EMOTION, V7, P275, DOI 10.1037/1528-3542.7.2.275; Coombes SA, 2009, COGN AFFECT BEHAV NE, V9, P380, DOI 10.3758/CABN.9.4.380; Damasio AR, 2000, NAT NEUROSCI, V3, P1049, DOI 10.1038/79871; Darwin C., 2002, EXPRESSION EMOTIONS; DAVIDSON RJ, 1982, SCIENCE, V218, P1235, DOI 10.1126/science.7146906; DAVIDSON RJ, 1990, J PERS SOC PSYCHOL, V58, P330, DOI 10.1037/0022-3514.58.2.330; de Gelder B, 2004, P NATL ACAD SCI USA, V101, P16701, DOI 10.1073/pnas.0407042101; Duckworth KL, 2002, PSYCHOL SCI, V13, P513, DOI 10.1111/1467-9280.00490; EKMAN P, 1993, PSYCHOL SCI, V4, P342, DOI 10.1111/j.1467-9280.1993.tb00576.x; Facchinetti LD, 2006, NEUROSCI LETT, V410, P52, DOI 10.1016/j.neulet.2006.09.063; Frijda NH, 1987, STUDIES EMOTION SOCI; Gagnon L, 2000, BRAIN COGNITION, V43, P206; Gainotti G, 2012, NEUROPSYCHOLOGIA, V50, P205, DOI 10.1016/j.neuropsychologia.2011.12.005; George MS, 1996, BIOL PSYCHIAT, V40, P859, DOI 10.1016/0006-3223(95)00572-2; GORELICK PB, 1987, J NEUROL NEUROSUR PS, V50, P553, DOI 10.1136/jnnp.50.5.553; Goycoolea M, 2005, ACTA OTO-LARYNGOL, V125, P513, DOI 10.1080/00016480510026250; Grezes J, 2007, NEUROIMAGE, V35, P959, DOI 10.1016/j.neuroimage.2006.11.030; HAGGARD MP, 1971, Q J EXP PSYCHOL, V23, P168, DOI 10.1080/14640747108400237; Hajcak G, 2007, PSYCHOPHYSIOLOGY, V44, P91, DOI 10.1111/j.1469-8986.2006.00487.x; Harciarek M, 2009, J CLIN EXP NEUROPSYC, V31, P322, DOI 10.1080/13803390802119930; Hellige, 1993, PERSPECTIVES COGNITI; Hillman CH, 2004, BIOL PSYCHOL, V66, P51, DOI 10.1016/j.biopsycho.2003.07.005; HIRSCHMAN RS, 1982, CORTEX, V18, P569, DOI 10.1016/S0010-9452(82)80054-3; Huang YX, 2006, NEUROSCI LETT, V398, P91, DOI 10.1016/j.neulet.2005.12.074; KALLMAN HJ, 1977, NEUROPSYCHOLOGIA, V15, P833, DOI 10.1016/0028-3932(77)90017-3; KALLMAN HJ, 1975, PERCEPT PSYCHOPHYS, V17, P368, DOI 10.3758/BF03199348; Ketter TA, 1996, ARCH GEN PSYCHIAT, V53, P59; KIMURA D, 1961, CAN J PSYCHOLOGY, V15, P166, DOI 10.1037/h0083219; Kimura D., 1967, CORTEX, V3, P163, DOI DOI 10.1016/S0010-9452(67)80010-8; KING FL, 1972, CAN J PSYCHOLOGY, V26, P111, DOI 10.1037/h0082420; KOIKE KJ, 1994, OTOLARYNG HEAD NECK, V111, P625, DOI 10.1016/S0194-5998(94)70531-3; Lane RD, 1997, AM J PSYCHIAT, V154, P926; Lane RD, 1997, NEUROPSYCHOLOGIA, V35, P1437, DOI 10.1016/S0028-3932(97)00070-5; Lee Gregory P, 2004, Cogn Behav Neurol, V17, P9, DOI 10.1097/00146965-200403000-00002; Ley R G, 1982, Brain Cogn, V1, P3, DOI 10.1016/0278-2626(82)90002-1; Lezak M.D., 2012, NEUROPSYCHOLOGICAL A; MAHONEY AM, 1987, BRAIN COGNITION, V6, P216, DOI 10.1016/0278-2626(87)90122-9; Mandal MK, 1999, J NERV MENT DIS, V187, P603, DOI 10.1097/00005053-199910000-00003; Mills C.K., 1912, T COLLEGE PHYSICIANS, V34, P381; Onal-Hartmann C, 2012, PSYCHOL RES-PSYCH FO, V76, P311, DOI 10.1007/s00426-011-0337-4; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Oliveri M, 2003, EXP BRAIN RES, V149, P214, DOI 10.1007/s00221-002-1346-8; PANTEV C, 1986, AUDIOLOGY, V25, P54; PARTIOT A, 1995, NEUROREPORT, V6, P1397, DOI 10.1097/00001756-199507100-00009; REITE M, 1981, ELECTROEN CLIN NEURO, V51, P388, DOI 10.1016/0013-4694(81)90102-4; REUTERLORENZ P, 1981, NEUROPSYCHOLOGIA, V19, P609, DOI 10.1016/0028-3932(81)90030-0; Rodway P, 2007, BRAIN COGNITION, V63, P31, DOI 10.1016/j.bandc.2006.07.008; ROSSINI PM, 1994, ELECTROEN CLIN NEURO, V91, P79, DOI 10.1016/0013-4694(94)90029-9; Rotteveel M, 2004, EMOTION, V4, P156, DOI 10.1037/1528-3542.4.2.156; SACKEIM HA, 1982, ARCH NEUROL-CHICAGO, V39, P210, DOI 10.1001/archneur.1982.00510160016003; SAFER MA, 1977, J EXP PSYCHOL HUMAN, V3, P75, DOI 10.1037/0096-1523.3.1.75; Scheffler K, 1998, CEREB CORTEX, V8, P156, DOI 10.1093/cercor/8.2.156; Schneider F, 1995, PSYCHIAT RES-NEUROIM, V61, P265, DOI 10.1016/0925-4927(95)02678-Q; Schutter DJLG, 2008, PSYCHOPHYSIOLOGY, V45, P345, DOI 10.1111/j.1469-8986.2007.00635.x; SILBERMAN EK, 1986, BRAIN COGNITION, V5, P322, DOI 10.1016/0278-2626(86)90035-7; Stach B, 2008, CLIN AUDIOLOGY INTRO; Stins JF, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-83; Tormos JM, 1997, NEUROLOGY, V49, P487, DOI 10.1212/WNL.49.2.487; van Loon AM, 2010, COGN AFFECT BEHAV NE, V10, P174, DOI 10.3758/CABN.10.2.174; Voyer D, 2009, NEUROPSYCHOLOGIA, V47, P23, DOI 10.1016/j.neuropsychologia.2008.08.022; Wager TD, 2003, NEUROIMAGE, V19, P513, DOI 10.1016/S1053-8119(03)00078-8; Waldstein SR, 2000, BIOL PSYCHOL, V55, P3, DOI 10.1016/S0301-0511(00)00065-X	82	14	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e63060	10.1371/journal.pone.0063060	http://dx.doi.org/10.1371/journal.pone.0063060			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	154EP	23667574	Green Submitted, Green Published, gold			2022-12-27	WOS:000319654700106
J	Marano, RJ; Tickner, J; Redmond, SL				Marano, Robert J.; Tickner, Jennifer; Redmond, Sharon L.			Prolactin Expression in the Cochlea of Aged BALB/c Mice Is Gender Biased and Correlates to Loss of Bone Mineral Density and Hearing Loss	PLOS ONE			English	Article							KAPPA-B LIGAND/OSTEOPROTEGERIN; RECEPTOR ACTIVATOR; INNER-EAR; GENE; ESTROGEN; BRAIN; PROMOTER; IDENTIFICATION; SCHIZOPHRENIA; PRESBYCUSIS	Prolactin is a versatile hormone with over 300 known functions and predominantly expressed in the pituitary. However, its expression has additionally been found in a number of extrapituitary organs. Recently, we described the expression of prolactin in the inner ear of mice, where it was correlated to age. Previous research has shown prolactin to be linked to abnormal bone metabolism and hearing loss due to changes in morphology of the bony otic capsule. Here we further investigated the relationship between prolactin, hearing loss and cochlea bone metabolism. BALB/c mice were tested for hearing using ABR at 6 and 12 months of age. Bone mineral density of the cochlea was evaluated using microCT scanning. Prolactin expression was calculated using quantitative real time PCR. Expression of the key regulators of bone metabolism, osteoprotegerin and receptor activator of nuclear factor-kappaB ligand were also determined. We found that prolactin expression was exclusive to the female mice. This also correlated to a greater threshold shift in hearing for the females between 6 and 12 months of age. Analyses of the cochlea also show that the bone mineral density was lower in females compared to males. However, no gender differences in expression of osteoprotegerin or receptor activator of nuclear factor-kappaB ligand could be found. Further analysis of cochlea histological sections revealed larger ostocyte lacunae in the females. These results provide a possible mechanism for an age related hearing loss sub-type that is associated with gender and provides clues as to how this gender bias in hearing loss develops. In addition, it has the potential to lead to treatment for this specific type of hearing loss.	[Marano, Robert J.; Redmond, Sharon L.] Ear Sci Inst Australia, Subiaco, WA, Australia; [Marano, Robert J.; Redmond, Sharon L.] Univ Western Australia, Ear Sci Ctr, Sch Surg, Nedlands, WA 6009, Australia; [Tickner, Jennifer] Univ Western Australia, Sch Pathol & Lab Med, QEII Med Ctr, Nedlands, WA 6009, Australia	Ear Science Institute Australia; University of Western Australia; University of Western Australia	Marano, RJ (corresponding author), Ear Sci Inst Australia, Subiaco, WA, Australia.	rob.marano@earscience.org.au	Tickner, Jennifer/H-5965-2014; Marano, Robert/A-3552-2015	Tickner, Jennifer/0000-0002-5020-0671; Marano, Robert/0000-0001-9565-3167	Garnet Passe and Rodney Williams Memorial Foundation; Ear Science Institute Australia; HEARing Cooperative Research Centre (CRC); Australian Government's Cooperative Research Centres Program; Victorian State Government's Operational Infrastructure Support Program; Australian Government's National Health and Medical Research Council's (NHMRC) Independent Research Institutes Infrastructure Support Scheme (IRIISS); University, State and Commonwealth Governments	Garnet Passe and Rodney Williams Memorial Foundation; Ear Science Institute Australia; HEARing Cooperative Research Centre (CRC); Australian Government's Cooperative Research Centres Program(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme); Victorian State Government's Operational Infrastructure Support Program; Australian Government's National Health and Medical Research Council's (NHMRC) Independent Research Institutes Infrastructure Support Scheme (IRIISS)(National Health and Medical Research Council (NHMRC) of Australia); University, State and Commonwealth Governments	This work was primarily supported by the Garnet Passe and Rodney Williams Memorial Foundation Project Grant (Grant # 2008) and Fellowship Award program and the Ear Science Institute Australia. Further support was provided by the HEARing Cooperative Research Centre (CRC), established and supported under the Australian Government's Cooperative Research Centres Program; the Victorian State Government's Operational Infrastructure Support Program and the Australian Government's National Health and Medical Research Council's (NHMRC) Independent Research Institutes Infrastructure Support Scheme (IRIISS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to thank Dr Rachel Burt, Dr Marina Carpinelli and Ms Anne Cooray from the Murdoch Children's Research Institute and the Walter and Eliza Hall Institute of Medical Research, Parkville 3052 VIC, Australia for their assistance in obtaining the ABR data. The authors also wish to acknowledge the facilities, scientific and technical assistance of the Australian Microscopy & Microanalysis Research Facility at the Centre for Microscopy, Characterisation and Analysis, The University of Western Australia, a facility funded by the University, State and Commonwealth Governments.	Abraham G, 2003, AM J PSYCHIAT, V160, P1618, DOI 10.1176/appi.ajp.160.9.1618; Adamson AD, 2008, ENDOCRINOLOGY, V149, P687, DOI 10.1210/en.2007-1066; Atkins GJ, 2012, OSTEOPOROSIS INT, V23, P2067, DOI 10.1007/s00198-012-1915-z; Ben-Jonathan N, 2008, ENDOCR REV, V29, P1, DOI 10.1210/er.2007-0017; BenJonathan N, 1996, ENDOCR REV, V17, P639, DOI 10.1210/er.17.6.639; BERWAER M, 1994, MOL ENDOCRINOL, V8, P635, DOI 10.1210/me.8.5.635; Bole-Feysot C, 1998, ENDOCR REV, V19, P225, DOI 10.1210/edrv.19.3.0334; Brandebourg T, 2007, DIABETES OBES METAB, V9, P464, DOI 10.1111/j.1463-1326.2006.00671.x; Carpinelli MR, 2011, HEARING RES, V275, P105, DOI 10.1016/j.heares.2010.12.009; Charoenphandhu N, 2008, CAN J PHYSIOL PHARM, V86, P240, DOI [10.1139/Y08-037, 10.1139/y08-037]; Colao A, 2000, CLIN ENDOCRINOL, V52, P319, DOI 10.1046/j.1365-2265.2000.00902.x; Duan RQ, 2008, MOL CELL ENDOCRINOL, V281, P9, DOI 10.1016/j.mce.2007.10.004; Egli M, 2010, REPRODUCTION, V140, P643, DOI 10.1530/REP-10-0033; EMANUELE NV, 1992, MOL ENDOCRINOL, V6, P35, DOI 10.1210/me.6.1.35; Fetoni AR, 2011, EXP GERONTOL, V46, P413, DOI 10.1016/j.exger.2010.12.003; Freeman ME, 2000, PHYSIOL REV, V80, P1523, DOI 10.1152/physrev.2000.80.4.1523; Horiguchi K, 2007, J REPROD DEVELOP, V53, P515, DOI 10.1262/jrd.18119; Horner KC, 2007, AM J PHYSIOL-ENDOC M, V293, pE1224, DOI 10.1152/ajpendo.00279.2007; Johnson KR, 1997, HEARING RES, V114, P83, DOI 10.1016/S0378-5955(97)00155-X; Johnson KR, 2000, GENOMICS, V70, P171, DOI 10.1006/geno.2000.6377; Liu XZ, 2007, J PATHOL, V211, P188, DOI 10.1002/path.2102; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Marano RJ, 2012, AGING CLIN EXP RES, V24, P603, DOI 10.3275/8590; Meaney AM, 2003, J PSYCHOPHARMACOL, V17, P455, DOI 10.1177/0269881103174011; Misra M, 2004, J CLIN PSYCHIAT, V65, P1607, DOI 10.4088/JCP.v65n1205; Nelson EG, 2006, LARYNGOSCOPE, V116, P1, DOI 10.1097/01.mlg.0000236089.44566.62; Ohlemiller KK, 2009, BRAIN RES, V1277, P70, DOI 10.1016/j.brainres.2009.02.079; Qing H, 2009, INT J ORAL SCI, V1, P59, DOI 10.4248/ijos.09019; Ramesh R, 2000, CELL TISSUE RES, V299, P371, DOI 10.1007/s004410050035; Riddle O, 1933, AM J PHYSIOL, V105, P191, DOI 10.1152/ajplegacy.1933.105.1.191; Roselli CE, 2008, NEUROENDOCRINOLOGY, V87, P206, DOI 10.1159/000114643; Seriwatanachai D, 2008, CELL BIOL INT, V32, P1126, DOI 10.1016/j.cellbi.2008.04.026; Seriwatanachai D, 2008, BONE, V42, P535, DOI 10.1016/j.bone.2007.11.008; Sharashenidze N, 2007, Georgian Med News, P14; Simonoska R, 2009, J ENDOCRINOL, V201, P397, DOI 10.1677/JOE-09-0060; Stenberg AE, 2001, HEARING RES, V157, P87, DOI 10.1016/S0378-5955(01)00280-5; Torner L, 2004, EUR J NEUROSCI, V19, P1601, DOI 10.1111/j.1460-9568.2004.03264.x; Willott JF, 1998, HEARING RES, V115, P162, DOI 10.1016/S0378-5955(97)00189-5	38	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e63952	10.1371/journal.pone.0063952	http://dx.doi.org/10.1371/journal.pone.0063952			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667691	Green Published, gold, Green Submitted			2022-12-27	WOS:000319654700196
J	Peng, ZK; Liu, N; Huang, DM; Duan, CJ; Li, YJ; Tang, XW; Mei, WH; Zhu, F; Tang, FQ				Peng, Zhengke; Liu, Na; Huang, Damao; Duan, Chaojun; Li, Yuejin; Tang, Xiaowei; Mei, Wenhua; Zhu, Feng; Tang, Faqing			N,N '-Dinitrosopiperazine-Mediated Heat-Shock Protein 70-2 Expression Is Involved in Metastasis of Nasopharyngeal Carcinoma	PLOS ONE			English	Article							CERVICAL-CARCINOMA; GENE-EXPRESSION; HSP70 FAMILY; CELL GROWTH; SALTED FISH; ANTIGEN 9; CANCER; SUSCEPTIBILITY; IDENTIFICATION; CHAPERONES	N,N'-Dinitrosopiperazine (DNP) is invovled in nasopharyngeal carcinoma (NPC) development and metastasis, and it shows organ specificity to the nasopharyngeal epithelium. Herein, we demonstrate that DNP induces heat-shock protein (HSP) 70-2 expression in NPC cells (6-10B) at a non-cytotoxic concentration. DNP induced HSP70-2 expression in a dose- and time-dependent manner, but showed no effect on other HSP70 family members. Furthermore, DNP also increased HSP70-2 RNA transcription through directly binding to the hypoxia-responsive elements (HRE) and heat shock elements (HSE) located in the HSP70-2 promoter. DNP-mediated HSP70-2 expression might act through enhancing the transcription of HSP70-2 RNA. Importantly, DNP induced motility and invasion of 6-10B cells dose- and time-dependently, and DNP-mediated NPC metastasis was confirmed in nude mice, which showed high HSP70-2 expression in the metastatic tumor tissue. However, the motility and invasion of NPC cells that were stably transfected using short interfering RNA against HSP70-2 could not effectively induce DNP. These results indicate that DNP induces HSP70-2 expression through increasing HSP70-2 transcription, increases the motility and invasion of cells, and promotes NPC tumor metastasis. Therefore, DNP mediated HSP70-2 expression may be an important factor of NPC-high metastasis.	[Peng, Zhengke; Li, Yuejin; Mei, Wenhua; Tang, Faqing] Jinan Univ, Med Res Ctr, Zhuhai Hosp, Zhuhai Peoples Hosp, Zhuhai, Peoples R China; [Peng, Zhengke; Li, Yuejin; Mei, Wenhua; Tang, Faqing] Jinan Univ, Clin Lab, Zhuhai Hosp, Zhuhai Peoples Hosp, Zhuhai, Peoples R China; [Liu, Na; Huang, Damao; Duan, Chaojun; Tang, Faqing] Cent S Univ, Med Res Ctr, Xiangya Hosp, Changsha, Hunan, Peoples R China; [Liu, Na; Huang, Damao; Duan, Chaojun; Tang, Faqing] Cent S Univ, Clin Lab, Xiangya Hosp, Changsha, Hunan, Peoples R China; [Tang, Xiaowei] Cent S Univ, Changsha, Hunan, Peoples R China; [Zhu, Feng] Univ Minnesota, Hormel Inst, Austin, MN 55912 USA	Jinan University; Jinan University; Central South University; Central South University; Central South University; University of Minnesota System	Tang, FQ (corresponding author), Jinan Univ, Med Res Ctr, Zhuhai Hosp, Zhuhai Peoples Hosp, Zhuhai, Peoples R China.	tangfaqing33@hotmail.com	LI, Yue/GRS-8071-2022		National Natural Science Foundation of China [81071718, 81000881, 30973400]; Fundamental Research Funds for the Central Universities [21611612]; Foundation of State Key Laboratory of Oncology in South China [HN2011-04]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Foundation of State Key Laboratory of Oncology in South China	This work was in part supported by the National Natural Science Foundation of China (81071718,81000881 and 30973400), Fundamental Research Funds for the Central Universities (21611612), and Foundation of State Key Laboratory of Oncology in South China (HN2011-04). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank National Natural Science Foundation of China (81071718, 81000881 and 30973400), Fundamental Research Funds for the Central Universities (21611612), and Foundation of State Key Laboratory of Oncology in South China (HN2011-04) for support.	Al-Sarraf M, 1998, J CLIN ONCOL, V16, P1310, DOI 10.1200/JCO.1998.16.4.1310; Armstrong RW, 1998, INT J CANCER, V77, P228, DOI 10.1002/(SICI)1097-0215(19980717)77:2&lt;228::AID-IJC11&gt;3.0.CO;2-7; Attiga FA, 2000, CANCER RES, V60, P4629; BARTSCH H, 1992, PHARMACOGENETICS, V2, P272, DOI 10.1097/00008571-199212000-00005; BONNYCASTLE LLC, 1994, GENOMICS, V23, P85, DOI 10.1006/geno.1994.1462; Chen Kai, 2008, Ai Zheng, V27, P650; Chen Z C, 1991, IARC Sci Publ, P434; Chew MMS, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-574; Chua DTT, 1998, INT J RADIAT ONCOL, V41, P379, DOI 10.1016/S0360-3016(98)00063-7; Daugaard M, 2005, CELL CYCLE, V4, P877, DOI 10.4161/cc.4.7.1838; Dix DJ, 1996, P NATL ACAD SCI USA, V93, P3264, DOI 10.1073/pnas.93.8.3264; Gallicchio L, 2006, INT J CANCER, V119, P1125, DOI 10.1002/ijc.21946; Garg M, 2010, CANCER-AM CANCER SOC, V116, P3785, DOI 10.1002/cncr.25218; Garg M, 2010, EUR J CANCER, V46, P207, DOI 10.1016/j.ejca.2009.10.020; Garg M, 2009, CANCER-AM CANCER SOC, V115, P2671, DOI 10.1002/cncr.24293; Henderson B E, 1978, IARC Sci Publ, P251; HUANG SC, 1985, INT J RADIAT ONCOL, V11, P1789, DOI 10.1016/0360-3016(85)90033-1; Huang WJ, 2009, INT J CANCER, V124, P298, DOI 10.1002/ijc.23906; Jalbout M, 2003, CANCER LETT, V193, P75, DOI 10.1016/S0304-3835(02)00697-3; Kang S, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-136; Kanojia D, 2009, CANCER EPIDEM BIOMAR, V18, P630, DOI 10.1158/1055-9965.EPI-08-0629; Kong QL, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000940; Krone PH, 2003, SEMIN CELL DEV BIOL, V14, P267, DOI 10.1016/j.semcdb.2003.09.018; Lamitina T, 2012, VIRULENCE, V3, P238, DOI 10.4161/viru.20794; Leung TW, 2005, HEAD NECK-J SCI SPEC, V27, P555, DOI 10.1002/hed.20189; Maugeri N, 2010, HUM MOL GENET, V19, P4939, DOI 10.1093/hmg/ddq418; Mayer MP, 2005, CELL MOL LIFE SCI, V62, P670, DOI 10.1007/s00018-004-4464-6; Meschler JP, 1999, PHARMACOL BIOCHEM BE, V62, P473, DOI 10.1016/S0091-3057(98)00195-6; Mitani N, 2001, CANCER LETT, V165, P35, DOI 10.1016/S0304-3835(00)00710-2; Muir C, 1987, IARC SCI PUBL, V5, P1; Rohde M, 2005, GENE DEV, V19, P570, DOI 10.1101/gad.305405; ROSARIO MO, 1992, DEV BIOL, V150, P1, DOI 10.1016/0012-1606(92)90002-X; Son WY, 2000, FERTIL STERIL, V73, P1138, DOI 10.1016/S0015-0282(00)00496-9; Song HM, 2010, J PLANT PHYSIOL, V167, P1172, DOI 10.1016/j.jplph.2010.03.016; Tahara T, 2009, ANTICANCER RES, V29, P3453; Tang FQ, 2009, CANCER SCI, V100, P216, DOI 10.1111/j.1349-7006.2008.01028.x; Tang FQ, 2011, J BIOL CHEM, V286, P36956, DOI 10.1074/jbc.M111.259234; Tang FQ, 2009, J BIOL CHEM, V284, P27456, DOI 10.1074/jbc.M109.033795; Tavaria M, 1996, CELL STRESS CHAPERON, V1, P23, DOI 10.1379/1466-1268(1996)001<0023:AHSGTT>2.3.CO;2; Tian DF, 2009, J ZHEJIANG UNIV-SC B, V10, P172, DOI 10.1631/jzus.B0820186; Wadhwa R, 2002, CELL STRESS CHAPERON, V7, P309, DOI 10.1379/1466-1268(2002)007<0309:AHFCMM>2.0.CO;2; Wang YZ, 2010, CLIN CHEM LAB MED, V48, P1657, DOI 10.1515/CCLM.2010.304; Yang XY, 2005, CELL ONCOL, V27, P215; Young JC, 2004, NAT REV MOL CELL BIO, V5, P781, DOI 10.1038/nrm1492; Young P, 2008, J GEN VIROL, V89, P866, DOI 10.1099/vir.0.83414-0; YU MC, 1989, INT J CANCER, V43, P1077, DOI 10.1002/ijc.2910430621; YU MC, 1986, CANCER RES, V46, P956; Yuan JM, 2000, INT J CANCER, V85, P358, DOI 10.1002/(SICI)1097-0215(20000201)85:3&lt;358::AID-IJC11&gt;3.0.CO;2-E; Zhu DH, 1997, DEVELOPMENT, V124, P3007; Zou J, 2000, J Radiat Res, V41 Suppl, P53	50	7	7	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e62908	10.1371/journal.pone.0062908	http://dx.doi.org/10.1371/journal.pone.0062908			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667540	Green Published, gold, Green Submitted			2022-12-27	WOS:000319654700079
J	Tovar, C; Arnillas, CA; Cuesta, F; Buytaert, W				Tovar, Carolina; Alberto Arnillas, Carlos; Cuesta, Francisco; Buytaert, Wouter			Diverging Responses of Tropical Andean Biomes under Future Climate Conditions	PLOS ONE			English	Article							LAND-USE CHANGE; CHANGE IMPACTS; SPECIES DISTRIBUTIONS; ICE-AGE; BIODIVERSITY; CONSERVATION; FOREST; VEGETATION; MIGRATION; PATTERNS	Observations and projections for mountain regions show a strong tendency towards upslope displacement of their biomes under future climate conditions. Because of their climatic and topographic heterogeneity, a more complex response is expected for biodiversity hotspots such as tropical mountain regions. This study analyzes potential changes in the distribution of biomes in the Tropical Andes and identifies target areas for conservation. Biome distribution models were developed using logistic regressions. These models were then coupled to an ensemble of 8 global climate models to project future distribution of the Andean biomes and their uncertainties. We analysed projected changes in extent and elevational range and identified regions most prone to change. Our results show a heterogeneous response to climate change. Although the wetter biomes exhibit an upslope displacement of both the upper and the lower boundaries as expected, most dry biomes tend to show downslope expansion. Despite important losses being projected for several biomes, projections suggest that between 74.8% and 83.1% of the current total Tropical Andes will remain stable, depending on the emission scenario and time horizon. Between 3.3% and 7.6% of the study area is projected to change, mostly towards an increase in vertical structure. For the remaining area (13.1%-17.4%), there is no agreement between model projections. These results challenge the common believe that climate change will lead to an upslope displacement of biome boundaries in mountain regions. Instead, our models project diverging responses, including downslope expansion and large areas projected to remain stable. Lastly, a significant part of the area expected to change is already affected by land use changes, which has important implications for management. This, and the inclusion of a comprehensive uncertainty analysis, will help to inform conservation strategies in the Tropical Andes, and to guide similar assessments for other tropical mountains.	[Tovar, Carolina; Alberto Arnillas, Carlos] Univ Nacl Agr La Molina, Ctr Datos Conservac, Lima, Peru; [Tovar, Carolina] Univ Oxford, Dept Zool, Biodivers Inst, Long Term Ecol Lab, Oxford OX1 3PS, England; [Cuesta, Francisco] Consorcio Desarrollo Sostenible Ecorreg Andina, Quito, Ecuador; [Buytaert, Wouter] Univ London Imperial Coll Sci Technol & Med, London, England; [Buytaert, Wouter] Univ London Imperial Coll Sci Technol & Med, Grantham Inst Climate Change, London, England	University Nacional Agraria La Molina; University of Oxford; Imperial College London; Imperial College London	Tovar, C (corresponding author), Univ Nacl Agr La Molina, Ctr Datos Conservac, Lima, Peru.	ctovar@lamolina.edu.pe	Buytaert, Wouter/AFU-2595-2022; Buytaert, Wouter/D-9912-2011; Tovar, Carolina/AAT-7070-2020	Buytaert, Wouter/0000-0001-6994-4454; Buytaert, Wouter/0000-0001-6994-4454; Tovar, Carolina/0000-0002-8256-9174; Cuesta, Francisco/0000-0002-5150-073X	World Bank; Andean Regional Program of the Spanish Agency for International Cooperation and Development	World Bank(The World Bank India); Andean Regional Program of the Spanish Agency for International Cooperation and Development	The Project was funded by the World Bank, and the Andean Regional Program of the Spanish Agency for International Cooperation and Development. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araujo MB, 2011, ECOL LETT, V14, P484, DOI 10.1111/j.1461-0248.2011.01610.x; Armenteras D, 2003, BIOL CONSERV, V113, P245, DOI 10.1016/S0006-3207(02)00359-2; Bader MY, 2007, PLANT ECOL, V191, P33, DOI 10.1007/s11258-006-9212-6; Barry S, 2006, J APPL ECOL, V43, P413, DOI 10.1111/j.1365-2664.2006.01136.x; Beaumont LJ, 2011, P NATL ACAD SCI USA, V108, P2306, DOI 10.1073/pnas.1007217108; Bush MB, 2010, GLOBAL CHANGE BIOL, V16, P3223, DOI 10.1111/j.1365-2486.2010.02203.x; Bush MB, 2005, J QUATERNARY SCI, V20, P703, DOI 10.1002/jqs.983; Bush MB, 2002, GLOBAL ECOL BIOGEOGR, V11, P463, DOI 10.1046/j.1466-822X.2002.00305.x; Bush MB, 2004, SCIENCE, V303, P827, DOI 10.1126/science.1090795; Buytaert W, 2012, WATER RESOUR RES, V48, DOI 10.1029/2011WR011755; Buytaert W, 2011, GLOBAL ECOL BIOGEOGR, V20, P19, DOI 10.1111/j.1466-8238.2010.00585.x; Buytaert W, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2008GL037048; Crimmins SM, 2011, SCIENCE, V331, P324, DOI 10.1126/science.1199040; de Chazal J, 2009, GLOBAL ENVIRON CHANG, V19, P306, DOI 10.1016/j.gloenvcha.2008.09.007; Di Pasquale G, 2008, PALAEOGEOGR PALAEOCL, V259, P17, DOI 10.1016/j.palaeo.2006.12.016; Dirnbock T, 2003, J BIOGEOGR, V30, P401, DOI 10.1046/j.1365-2699.2003.00839.x; Dulhoste R, 2010, THESIS U LOS ANDES; Etter A, 2006, AGR ECOSYST ENVIRON, V114, P369, DOI 10.1016/j.agee.2005.11.013; Farr TG, 2007, REV GEOPHYS, V45, DOI 10.1029/2005RG000183; Feeley KJ, 2011, J BIOGEOGR, V38, P783, DOI 10.1111/j.1365-2699.2010.02444.x; Feeley KJ, 2010, GLOBAL CHANGE BIOL, V16, P3215, DOI 10.1111/j.1365-2486.2010.02197.x; Fitzpatrick MC, 2009, BIODIVERS CONSERV, V18, P2255, DOI 10.1007/s10531-009-9584-8; Gonzalez P, 2010, GLOBAL ECOL BIOGEOGR, V19, P755, DOI 10.1111/j.1466-8238.2010.00558.x; GRABHERR G, 1994, NATURE, V369, P448, DOI 10.1038/369448a0; Harrison PA, 2006, ENVIRON SCI POLICY, V9, P116, DOI 10.1016/j.envsci.2005.11.003; HESS CG, 1990, MT RES DEV, V10, P333, DOI 10.2307/3673495; Higgins PAT, 2007, GLOBAL ECOL BIOGEOGR, V16, P197, DOI 10.1111/j.1466-8238.2006.00278.x; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hillyer R, 2010, GLOBAL CHANGE BIOL, V16, P3205, DOI 10.1111/j.1365-2486.2010.02268.x; Hoffmann AA, 2011, NATURE, V470, P479, DOI 10.1038/nature09670; Hooghiemstra H, 2004, PHILOS T ROY SOC B, V359, P173, DOI 10.1098/rstb.2003.1420; Jetz W, 2007, PLOS BIOL, V5, P1211, DOI 10.1371/journal.pbio.0050157; Josse C, 2009, ECOBONA INTERCOOPERA; Jump AS, 2005, ECOL LETT, V8, P1010, DOI 10.1111/j.1461-0248.2005.00796.x; Killeen TJ, 2007, J BIOGEOGR, V34, P1357, DOI 10.1111/j.1365-2699.2006.01682.x; Kullman L, 2002, J ECOL, V90, P68, DOI 10.1046/j.0022-0477.2001.00630.x; Lenoir J, 2008, SCIENCE, V320, P1768, DOI 10.1126/science.1156831; Lloyd AH, 2003, ECOSCIENCE, V10, P176, DOI 10.1080/11956860.2003.11682765; Loarie SR, 2009, NATURE, V462, P1052, DOI 10.1038/nature08649; Lopez RP, 2006, BIODIVERS CONSERV, V15, P2163, DOI 10.1007/s10531-004-6898-4; Malcolm JR, 2002, J BIOGEOGR, V29, P835, DOI 10.1046/j.1365-2699.2002.00702.x; Malcolm JR, 2006, CONSERV BIOL, V20, P538, DOI 10.1111/j.1523-1739.2006.00364.x; Maraun D, 2010, REV GEOPHYS, V48, DOI 10.1029/2009RG000314; Meehl GA, 2007, B AM METEOROL SOC, V88, P1383, DOI 10.1175/BAMS-88-9-1383; Midgley GF, 2003, BIOL CONSERV, V112, P87, DOI 10.1016/S0006-3207(02)00414-7; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Ni J, 2000, MT RES DEV, V20, P80, DOI 10.1659/0276-4741(2000)020[0080:ASOBOT]2.0.CO;2; Nunez CI, 1999, J VEG SCI, V10, P357, DOI 10.2307/3237064; Olson DM, 2001, BIOSCIENCE, V51, P933, DOI 10.1641/0006-3568(2001)051[0933:TEOTWA]2.0.CO;2; Opdam P, 2004, BIOL CONSERV, V117, P285, DOI 10.1016/j.biocon.2003.12.008; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Pauli H, 2007, GLOBAL CHANGE BIOL, V13, P147, DOI 10.1111/j.1365-2486.2006.01282.x; Penuelas J, 2003, GLOBAL CHANGE BIOL, V9, P131, DOI 10.1046/j.1365-2486.2003.00566.x; Rivas-Martinez S., 1999, ITINERA GEOBOT, V12, P5; Roman-Cuesta RM, 2011, FOREST ECOL MANAG, V261, P1987, DOI 10.1016/j.foreco.2011.02.025; Sanz-Elorza M, 2003, ANN BOT-LONDON, V92, P273, DOI 10.1093/aob/mcg130; Thuiller W, 2008, PERSPECT PLANT ECOL, V9, P137, DOI 10.1016/j.ppees.2007.09.004; Tovar C, 2013, LANDSCAPE URBAN PLAN, V112, P40, DOI 10.1016/j.landurbplan.2012.12.003; United Nations, 2006, STAT YB LAT AM CAR; Urrutia R, 2009, J GEOPHYS RES-ATMOS, V114, DOI 10.1029/2008JD011021; Valencia BG, 2010, J BIOGEOGR, V37, P1637, DOI 10.1111/j.1365-2699.2010.02318.x; Vuille M, 2008, EARTH-SCI REV, V89, P79, DOI 10.1016/j.earscirev.2008.04.002; Young B, 2011, CLIMATE CHANGE BIODI, P170; Zapata-Caldas E, 2012, POTENCIALES IMPACTOS; Zelazowski P, 2011, PHILOS T R SOC A, V369, P137, DOI 10.1098/rsta.2010.0238	65	58	62	1	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e63634	10.1371/journal.pone.0063634	http://dx.doi.org/10.1371/journal.pone.0063634			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667651	gold, Green Submitted, Green Published			2022-12-27	WOS:000319654700172
J	Haug, I; Setaro, S; Suarez, JP				Haug, Ingeborg; Setaro, Sabrina; Pablo Suarez, Juan			Reforestation Sites Show Similar and Nested AMF Communities to an Adjacent Pristine Forest in a Tropical Mountain Area of South Ecuador	PLOS ONE			English	Article							ARBUSCULAR MYCORRHIZAL FUNGI; ABANDONED PASTURES; NETWORK STRUCTURE; GLOBAL DIVERSITY; SPECIES-RICH; ROOTS; SOIL; BIODIVERSITY; ARCHITECTURE; DISTURBANCE	Arbuscular mycorrhizae are important for growth and survival of tropical trees. We studied the community of arbuscular mycorrhizal fungi in a tropical mountain rain forest and in neighbouring reforestation plots in the area of Reserva Biologica San Francisco (South Ecuador). The arbuscular mycorrhizal fungi were analysed with molecular methods sequencing part of the 18 S rDNA. The sequences were classified as Operational Taxonomic Units (OTUs). We found high fungal species richness with OTUs belonging to Glomerales, Diversisporales and Archaeosporales. Despite intensive sampling, the rarefaction curves are still unsaturated for the pristine forest and the reforestation plots. The communities consisted of few frequent and many rare species. No specific interactions are recognizable. The plant individuals are associated with one to ten arbuscular mycorrhizal fungi and mostly with one to four. The fungal compositions associated with single plant individuals show a great variability and variety within one plant species. Planted and naturally occurring plants show high similarities in their fungal communities. Pristine forest and reforestation plots showed similar richness, similar diversity and a significantly nested structure of plant-AMF community. The results indicate that small-scale fragmentation presently found in this area has not destroyed the natural AMF community, at least yet. Thus, the regeneration potential of natural forest vegetation at the tested sites is not inhibited by a lack of appropriate mycobionts.	[Haug, Ingeborg] Univ Tubingen, Inst Evolut & Ecol, Tubingen, Germany; [Setaro, Sabrina] Wake Forest Univ, Dept Biol, Winston Salem, NC 27109 USA; [Pablo Suarez, Juan] Univ Tecn Particular Loja, Dept Ciencias Nat, Loja, Ecuador	Eberhard Karls University of Tubingen; Wake Forest University; Universidad Tecnica Particular de Loja	Haug, I (corresponding author), Univ Tubingen, Inst Evolut & Ecol, Tubingen, Germany.	ingeborg.haug@uni-tuebingen.de	Suárez, Juan Pablo/D-1839-2009; Suárez, Juan Pablo/AHB-9751-2022	Suárez, Juan Pablo/0000-0002-9453-5545; Suárez, Juan Pablo/0000-0002-9453-5545	DFG (Research Unit 816) [HA2029/2-1]; Tuebingen University; Deutsche Forschungsgemeinschaft	DFG (Research Unit 816); Tuebingen University; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	The study was funded by DFG (Research Unit 816, HA2029/2-1). We acknowledge support by Open Access Publishing Fund of Tuebingen University and Deutsche Forschungsgemeinschaft. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre NM, 2007, SILVICULTURAL DISTRI; Alguacil MM, 2012, SOIL BIOL BIOCHEM, V49, P132, DOI 10.1016/j.soilbio.2012.02.024; Almeida-Neto M, 2008, OIKOS, V117, P1227, DOI 10.1111/j.0030-1299.2008.16644.x; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bascompte J, 2010, SCIENCE, V329, P765, DOI 10.1126/science.1194255; Bastolla U, 2009, NATURE, V458, P1018, DOI 10.1038/nature07950; Batagelj V, 2004, MATH VIS, P77; Blaskowski J, 2008, MYCOTAXON, V106, P247; Bluethgen Nico, 2006, BMC Ecology, V6, P9, DOI 10.1186/1472-6785-6-9; Brehm G, 2005, J BIOGEOGR, V32, P1621, DOI 10.1111/j.1365-2699.2005.01304.x; Brummitt N, 2003, CONSERV BIOL, V17, P1442, DOI 10.1046/j.1523-1739.2003.02344.x; Cesaro P, 2008, APPL ENVIRON MICROB, V74, P5776, DOI 10.1128/AEM.00719-08; Chagnon PL, 2012, NEW PHYTOL, V194, P307, DOI 10.1111/j.1469-8137.2011.04044.x; Chao A, 2005, ECOL LETT, V8, P148, DOI 10.1111/j.1461-0248.2004.00707.x; Chao A, 2006, BIOMETRICS, V62, P361, DOI 10.1111/j.1541-0420.2005.00489.x; Colwell RK, 2012, J PLANT ECOL, V5, P3, DOI 10.1093/jpe/rtr044; Davison J, 2011, FEMS MICROBIOL ECOL, V78, P103, DOI 10.1111/j.1574-6941.2011.01103.x; Alguacil MD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034887; Dormann C.F., 2008, R NEWS, V8, P8; Dumbrell AJ, 2010, J ECOL, V98, P419, DOI 10.1111/j.1365-2745.2009.01622.x; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Fitter AH, 2005, J ECOL, V93, P231, DOI 10.1111/j.0022-0477.2005.00990.x; Fortuna MA, 2006, ECOL LETT, V9, P278, DOI 10.1111/j.1461-0248.2005.00868.x; Fortuna MA, 2010, J ANIM ECOL, V79, P811, DOI 10.1111/j.1365-2656.2010.01688.x; Goker M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006319; GRACE C, 1991, MYCOL RES, V95, P1160, DOI 10.1016/S0953-7562(09)80005-1; Gunter S, 2009, FOREST ECOL MANAG, V258, P81, DOI 10.1016/j.foreco.2009.03.042; Guimaraes PR, 2006, ENVIRON MODELL SOFTW, V21, P1512, DOI 10.1016/j.envsoft.2006.04.002; Guimera R, 2005, NATURE, V433, P895, DOI 10.1038/nature03288; Haug I, 2010, TROP ECOL, V51, P125; HOMEIER J, 2007, ECOTROPICAL MONOGRAP, V4, P15; Homeier J, 2010, BIOTROPICA, V42, P140, DOI 10.1111/j.1744-7429.2009.00547.x; Huber T, 2004, BIOINFORMATICS, V20, P2317, DOI 10.1093/bioinformatics/bth226; Husband R, 2002, MOL ECOL, V11, P2669, DOI 10.1046/j.1365-294X.2002.01647.x; Husband R, 2002, FEMS MICROBIOL ECOL, V42, P131, DOI 10.1111/j.1574-6941.2002.tb01002.x; Jacquemyn H, 2011, NEW PHYTOL, V192, P518, DOI 10.1111/j.1469-8137.2011.03796.x; Joppa LN, 2010, EVOL ECOL RES, V12, P35; Jost Lou, 2011, P66; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; Kiers ET, 2011, SCIENCE, V333, P880, DOI 10.1126/science.1208473; Kivlin SN, 2011, SOIL BIOL BIOCHEM, V43, P2294, DOI 10.1016/j.soilbio.2011.07.012; Kottke I., 2013, ECOSYSTEM SERVICES B, P187, DOI DOI 10.1007/978-3-642-38137-9_14; Kottke I, 2008, BASIC APPL ECOL, V9, P13, DOI 10.1016/j.baae.2007.03.007; Kruger M, 2012, NEW PHYTOL, V193, P970, DOI 10.1111/j.1469-8137.2011.03962.x; Kuptz D, 2010, TREES-STRUCT FUNCT, V24, P117, DOI 10.1007/s00468-009-0385-1; Lee J, 2008, FEMS MICROBIOL ECOL, V65, P339, DOI 10.1111/j.1574-6941.2008.00531.x; Lekberg Y, 2012, J ECOL, V100, P151, DOI 10.1111/j.1365-2745.2011.01894.x; Liu YJ, 2011, FEMS MICROBIOL ECOL, V78, P355, DOI 10.1111/j.1574-6941.2011.01163.x; Martos F, 2012, MOL ECOL, V21, P5098, DOI 10.1111/j.1365-294X.2012.05692.x; Medan D, 2007, J THEOR BIOL, V246, P510, DOI 10.1016/j.jtbi.2006.12.033; Memmott J, 2004, P ROY SOC B-BIOL SCI, V271, P2605, DOI 10.1098/rspb.2004.2909; Meskens C, 2011, ECOL ENTOMOL, V36, P480, DOI 10.1111/j.1365-2311.2011.01294.x; Montesinos-Navarro A, 2012, NEW PHYTOL, V194, P536, DOI 10.1111/j.1469-8137.2011.04045.x; Moora M, 2011, J BIOGEOGR, V38, P1305, DOI 10.1111/j.1365-2699.2011.02478.x; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Opik M, 2009, NEW PHYTOL, V184, P424, DOI 10.1111/j.1469-8137.2009.02920.x; Opik M, 2012, NEW PHYTOL, V194, P304, DOI 10.1111/j.1469-8137.2012.04121.x; Opik M, 2008, NEW PHYTOL, V179, P867, DOI 10.1111/j.1469-8137.2008.02515.x; Opik M, 2006, J ECOL, V94, P778, DOI 10.1111/j.1365-2745.2006.01136.x; Palomeque X, 2012, NATURAL SUCCESSION T; Mello MAR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017395; Schnoor TK, 2011, MYCORRHIZA, V21, P211, DOI 10.1007/s00572-010-0325-3; Swofford DL, 2002, PAUP 4 0B10 PHYLOGEN; Sykorova Z, 2007, MYCORRHIZA, V18, P1, DOI 10.1007/s00572-007-0147-0; Thompson J. N., 2005, INTERSPEC INTERACT; Weber M., 2008, V198, P431; White TJ, 1990, AMPLIFICATION DIRECT, V18, P315; Wirsel SGR, 2004, FEMS MICROBIOL ECOL, V48, P129, DOI 10.1016/j.femsec.2004.01.006	68	16	16	0	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2013	8	5							e63524	10.1371/journal.pone.0063524	http://dx.doi.org/10.1371/journal.pone.0063524			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	177QL	23671682	Green Published, gold, Green Submitted			2022-12-27	WOS:000321390200051
J	McDowell, SC; Akmakjian, G; Sladek, C; Mendoza-Cozatl, D; Morrissey, JB; Saini, N; Mittler, R; Baxter, I; Salt, DE; Ward, JM; Schroeder, JI; Guerinot, ML; Harper, JF				McDowell, Stephen C.; Akmakjian, Garo; Sladek, Chris; Mendoza-Cozatl, David; Morrissey, Joe B.; Saini, Nick; Mittler, Ron; Baxter, Ivan; Salt, David E.; Ward, John M.; Schroeder, Julian I.; Guerinot, Mary Lou; Harper, Jeffrey F.			Elemental Concentrations in the Seed of Mutants and Natural Variants of Arabidopsis thaliana Grown under Varying Soil Conditions	PLOS ONE			English	Article							CAP-BINDING-PROTEIN; QUANTITATIVE TRAIT LOCI; NUCLEOTIDE-GATED CHANNEL; SIGNAL-TRANSDUCTION; FUNCTIONAL-CHARACTERIZATION; SACCHAROMYCES-CEREVISIAE; MINERAL CONCENTRATIONS; PLANT DEVELOPMENT; GENETIC-ANALYSIS; SALT TOLERANCE	The concentrations of mineral nutrients in seeds are critical to both the life cycle of plants as well as human nutrition. These concentrations are strongly influenced by soil conditions, as shown here by quantifying the concentration of 14 elements in seeds from Arabidopsis thaliana plants grown under four different soil conditions: standard, or modified with NaCl, heavy metals, or alkali. Each of the modified soils resulted in a unique change to the seed ionome (the mineral nutrient content of the seeds). To help identify the genetic networks regulating the seed ionome, changes in elemental concentrations were evaluated using mutants corresponding to 760 genes as well as 10 naturally occurring accessions. The frequency of ionomic phenotypes supports an estimate that as much as 11% of the A. thaliana genome encodes proteins of functional relevance to ion homeostasis in seeds. A subset of mutants were analyzed with two independent alleles, providing five examples of genes important for regulation of the seed ionome: SOS2, ABH1, CCC, At3g14280 and CNGC2. In a comparison of nine different accessions to a Col-0 reference, eight accessions were observed to have reproducible differences in elemental concentrations, seven of which were dependent on specific soil conditions. These results indicate that the A. thaliana seed ionome is distinct from the vegetative ionome, and that elemental analysis is a sensitive approach to identify genes controlling ion homeostasis, including those that regulate gene expression, phospho-regulation, and ion transport.	[McDowell, Stephen C.; Sladek, Chris; Saini, Nick; Harper, Jeffrey F.] Univ Nevada, Dept Biochem & Mol Biol, Reno, NV 89557 USA; [Akmakjian, Garo; Mendoza-Cozatl, David; Schroeder, Julian I.] Univ Calif San Diego, Div Biol Sci, San Diego, CA 92103 USA; [Morrissey, Joe B.; Guerinot, Mary Lou] Dartmouth Coll, Dept Biol Sci, Hanover, NH 03755 USA; [Salt, David E.] Univ Aberdeen, Inst Biol & Environm Sci, Aberdeen, Scotland; [Ward, John M.] Univ Minnesota, Dept Plant Biol, St Paul, MN USA; [Mittler, Ron] Univ N Texas, Dept Biol Sci, Denton, TX 76203 USA; [Baxter, Ivan] ARS, USDA, Plant Genet Res Unit, Donald Danforth Plant Sci Ctr, St Louis, MO USA	Nevada System of Higher Education (NSHE); University of Nevada Reno; University of California System; University of California San Diego; Dartmouth College; University of Aberdeen; University of Minnesota System; University of Minnesota Twin Cities; University of North Texas System; University of North Texas Denton; Donald Danforth Plant Science Center; United States Department of Agriculture (USDA)	Harper, JF (corresponding author), Univ Nevada, Dept Biochem & Mol Biol, Reno, NV 89557 USA.	jfharper@unr.edu	Baxter, Ivan R/A-1052-2009; Mittler, Ron/ABE-6496-2020	Baxter, Ivan R/0000-0001-6680-1722; Ward, John/0000-0001-8185-0434; Schroeder, Julian/0000-0002-3283-5972; Mendoza Cozatl, David/0000-0002-9616-0791	National Science Foundation [DBI-0077378]; National Institutes of Health [1RO1 GM070813-01, P42 ES010337]; Department of Energy [DE-FG03-94ER20152, DE-FG02-03ER15449]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P42ES010337] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078536, R01GM070813] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Energy(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The seed ionome mutant screen was supported by a grant from the National Science Foundation (http://www.nsf.gov, DBI-0077378) to MLG/JFH/JIS/JW. Grants to JFH from the National Institutes of Health (http://www.nih.gov, 1RO1 GM070813-01) and the Department of Energy (http://www.energy.gov, DE-FG03-94ER20152) supported genetic studies on CNGCs/ACAs, and ALAs, respectively. Grants to JIS from the Department of Energy (http://www.energy.gov, DE-FG02-03ER15449) and the National Institutes of Health (http://www.nih.gov, P42 ES010337) in part supported sos mutant analysis and metal accession analysis. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali R, 2007, PLANT CELL, V19, P1081, DOI 10.1105/tpc.106.045096; Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; Balatsos NAA, 2006, J BIOL CHEM, V281, P4517, DOI 10.1074/jbc.M508590200; Baxter I, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000004; Baxter I, 2007, PLANT PHYSIOL, V143, P600, DOI 10.1104/pp.106.092528; Baxter I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035121; Baxter I, 2012, SCIENCE, V336, P1661, DOI 10.1126/science.1219992; Baxter I, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001193; Baxter I, 2010, BRIEF FUNCT GENOMICS, V9, P149, DOI 10.1093/bfgp/elp055; Baxter I, 2009, CURR OPIN PLANT BIOL, V12, P381, DOI 10.1016/j.pbi.2009.05.002; Baxter IR, 2008, P NATL ACAD SCI USA, V105, P12081, DOI 10.1073/pnas.0804175105; Bentsink L, 2003, THEOR APPL GENET, V106, P1234, DOI 10.1007/s00122-002-1177-9; Buescher E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011081; Bush MS, 2009, PLANT J, V59, P400, DOI 10.1111/j.1365-313X.2009.03882.x; Chan CWM, 2003, PLANT PHYSIOL, V132, P728, DOI 10.1104/pp.102.019216; Chen XM, 2008, DEV CELL, V14, P811, DOI 10.1016/j.devcel.2008.05.012; Chen Z, 2009, NEW PHYTOL, V181, P795, DOI 10.1111/j.1469-8137.2008.02730.x; Clough SJ, 2000, P NATL ACAD SCI USA, V97, P9323, DOI 10.1073/pnas.150005697; Colmenero-Flores JM, 2007, PLANT J, V50, P278, DOI 10.1111/j.1365-313X.2007.03048.x; Conn SJ, 2012, NEW PHYTOL, V193, P859, DOI 10.1111/j.1469-8137.2011.03977.x; Danku JMC, 2009, J ANAL ATOM SPECTROM, V24, P103, DOI 10.1039/b803529f; Eide DJ, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-9-r77; Ernst WHO, 2000, ENVIRON EXP BOT, V43, P55, DOI 10.1016/S0098-8472(99)00048-9; Frietsch S, 2007, P NATL ACAD SCI USA, V104, P14531, DOI 10.1073/pnas.0701781104; Ghandilyan A, 2009, NEW PHYTOL, V184, P180, DOI 10.1111/j.1469-8137.2009.02953.x; Ghandilyan A, 2009, J EXP BOT, V60, P1409, DOI 10.1093/jxb/erp084; Gobert A, 2006, J EXP BOT, V57, P791, DOI 10.1093/jxb/erj064; Gollery M, 2007, TRENDS PLANT SCI, V12, P492, DOI 10.1016/j.tplants.2007.08.018; Gollery M, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-7-r57; Gregory BD, 2008, DEV CELL, V14, P854, DOI 10.1016/j.devcel.2008.04.005; Grennan AK, 2006, PLANT PHYSIOL, V141, P1164, DOI 10.1104/pp.104.900198; Guo KM, 2010, PHYSIOL PLANTARUM, V139, P303, DOI 10.1111/j.1399-3054.2010.01366.x; HAMM J, 1990, CELL, V63, P109, DOI 10.1016/0092-8674(90)90292-M; Hoekenga OA, 2003, PLANT PHYSIOL, V132, P936, DOI 10.1104/pp.103.023085; Huang GT, 2012, MOL BIOL REP, V39, P969, DOI 10.1007/s11033-011-0823-1; Hugouvieux V, 2001, CELL, V106, P477, DOI 10.1016/S0092-8674(01)00460-3; Hugouvieux V, 2002, PLANT PHYSIOL, V130, P1276, DOI 10.1104/pp.009480; IZAURRALDE E, 1992, J CELL BIOL, V118, P1287, DOI 10.1083/jcb.118.6.1287; Kim S, 2008, PLANT CELL PHYSIOL, V49, P1634, DOI 10.1093/pcp/pcn146; Kobayashi Y, 2002, PLANT CELL PHYSIOL, V43, P1526, DOI 10.1093/pcp/pcf174; Kong XQ, 2011, PLANT MOL BIOL, V75, P567, DOI 10.1007/s11103-011-9744-6; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Krysan PJ, 1996, P NATL ACAD SCI USA, V93, P8145, DOI 10.1073/pnas.93.15.8145; Kuhn JM, 2008, CURR TOP MICROBIOL, V326, P139; Lahner B, 2003, NAT BIOTECHNOL, V21, P1215, DOI 10.1038/nbt865; Laubinger S, 2008, P NATL ACAD SCI USA, V105, P8795, DOI 10.1073/pnas.0802493105; Leng Q, 1999, PLANT PHYSIOL, V121, P753, DOI 10.1104/pp.121.3.753; Leng Q, 2002, PLANT PHYSIOL, V128, P400, DOI 10.1104/pp.010832; Liu JP, 2000, P NATL ACAD SCI USA, V97, P3730, DOI 10.1073/pnas.060034197; Loudet O, 2007, NAT GENET, V39, P896, DOI 10.1038/ng2050; Ma W, 2006, PLANT PHYSIOL BIOCH, V44, P494, DOI 10.1016/j.plaphy.2006.08.007; Mahajan S, 2008, ARCH BIOCHEM BIOPHYS, V471, P146, DOI 10.1016/j.abb.2008.01.010; Marschner H., 1995, MINERAL NUTR HIGHER, V2nd ed.; Maser P, 2001, PLANT PHYSIOL, V126, P1646, DOI 10.1104/pp.126.4.1646; Maser P, 2002, FEBS LETT, V531, P157, DOI 10.1016/S0014-5793(02)03488-9; Morrissey J, 2009, PLANT CELL, V21, P3326, DOI 10.1105/tpc.109.069401; Munns R, 2012, NAT BIOTECHNOL, V30, P360, DOI 10.1038/nbt.2120; Nordborg M, 2005, PLOS BIOL, V3, P1289, DOI 10.1371/journal.pbio.0030196; Payne KA, 2004, NEW PHYTOL, V162, P535, DOI 10.1111/j.1469-8137.2004.01026.x; Prinzenberg AE, 2010, PLANT PHYSIOL, V154, P1361, DOI 10.1104/pp.110.161398; Qiu QS, 2004, J BIOL CHEM, V279, P207, DOI 10.1074/jbc.M307982200; Qiu QS, 2002, P NATL ACAD SCI USA, V99, P8436, DOI 10.1073/pnas.122224699; Quintero FJ, 2002, P NATL ACAD SCI USA, V99, P9061, DOI 10.1073/pnas.132092099; Raczynska KD, 2010, NUCLEIC ACIDS RES, V38, P265, DOI 10.1093/nar/gkp869; Rus A, 2006, PLOS GENET, V2, P1964, DOI 10.1371/journal.pgen.0020210; Russell JM, 2000, PHYSIOL REV, V80, P211, DOI 10.1152/physrev.2000.80.1.211; Salt DE, 2008, ANNU REV PLANT BIOL, V59, P709, DOI 10.1146/annurev.arplant.59.032607.092942; Salt DE, 2004, PLANT PHYSIOL, V136, P2451, DOI 10.1104/pp.104.047753; Sanchez-Rodriguez E, 2010, PLANT SOIL, V335, P339, DOI 10.1007/s11104-010-0422-2; Sessions A, 2002, PLANT CELL, V14, P2985, DOI 10.1105/tpc.004630; Shi HZ, 2000, P NATL ACAD SCI USA, V97, P6896, DOI 10.1073/pnas.120170197; Shi HZ, 2002, PLANT CELL, V14, P465, DOI 10.1105/tpc.010371; Soric R, 2011, MAYDICA, V56, P323; SUNDARESAN V, 1995, GENE DEV, V9, P1797, DOI 10.1101/gad.9.14.1797; Tian H, 2010, PLANT CELL, V22, P3963, DOI 10.1105/tpc.110.080010; Tissier AF, 1999, PLANT CELL, V11, P1841, DOI 10.1105/tpc.11.10.1841; Vreugdenhil D, 2004, PLANT CELL ENVIRON, V27, P828, DOI 10.1111/j.1365-3040.2004.01189.x; Woody ST, 2007, J PLANT RES, V120, P157, DOI 10.1007/s10265-006-0048-x; Zhu JK, 2003, CURR OPIN PLANT BIOL, V6, P441, DOI 10.1016/S1369-5266(03)00085-2; Zhu JK, 1998, PLANT CELL, V10, P1181, DOI 10.1105/tpc.10.7.1181	81	14	15	1	78	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2013	8	5							e63014	10.1371/journal.pone.0063014	http://dx.doi.org/10.1371/journal.pone.0063014			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	177QL	23671651	Green Submitted, Green Published, gold			2022-12-27	WOS:000321390200040
J	Willis, L; Graham, TA; Alarcon, T; Alison, MR; Tomlinson, IPM; Page, KM				Willis, Lisa; Graham, Trevor A.; Alarcon, Tomas; Alison, Malcolm R.; Tomlinson, Ian P. M.; Page, Karen M.			What Can Be Learnt about Disease Progression in Breast Cancer Dormancy from Relapse Data?	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; CIRCULATING TUMOR-CELLS; ANGIOGENIC SWITCH; REGRESSION; RECURRENCE; MECHANISMS; PROPOSAL; SURGERY; GROWTH; MODEL	Breast cancer patients have an anomalously high rate of relapse many years-up to 25 years-after apparently curative surgery removed the primary tumour. Disease progression during the intervening years between resection and relapse is poorly understood. There is evidence that the disease persists as dangerous, tiny metastases that remain at a growth restricted, clinically undetectable size until a transforming event restarts growth. This is the starting point for our study, where patients who have metastases that are all tiny and growth-restricted are said to have cancer dormancy. Can long-term follow-up relapse data from breast cancer patients be used to extract knowledge about the progression of the undetected disease? Here, we evaluate whether this is the case by introducing and analysing four simple mathematical models of cancer dormancy. These models extend the common assumption that a random transforming event, such as a mutation, can restart growth of a tiny, growth-restricted metastasis; thereafter, cancer dormancy progresses to detectable metastasis. We find that physiopathological details, such as the number of random transforming events that metastases must undergo to escape from growth restriction, cannot be extracted from relapse data. This result is unsurprising. However, the same analysis suggested a natural question that does have a surprising answer: why are interesting trends in long-term relapse data not more commonly observed? Further, our models indicate that (a) therapies which induce growth restriction among metastases but do not prevent increases in metastases' tumourigenicity may introduce a time post-surgery when more patients are prone to relapse; and (b), if a number of facts about disease progression are first established, how relapse data might be used to estimate clinically relevant variables, such as the likely numbers of undetected growth-restricted metastases. This work is a necessary, early step in building a quantitative mechanistic understanding of cancer dormancy.	[Willis, Lisa; Graham, Trevor A.; Page, Karen M.] UCL, Ctr Math & Phys Life Sci & Expt Biol, London, England; [Willis, Lisa] Univ Cambridge, Sainsbury Lab, Cambridge, England; [Graham, Trevor A.] Univ Calif San Francisco, Dept Surg, Ctr Evolut & Canc, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA USA; [Alarcon, Tomas] Ctr Recerca Matemat, Barcelona, Spain; [Alison, Malcolm R.] Barts & London Queen Marys Sch Med & Dent, Barts Canc Inst, Ctr Tumour Biol, London, England; [Tomlinson, Ian P. M.] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England; [Page, Karen M.] UCL, Dept Math, London, England	University of London; University College London; University of Cambridge; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; Centre de Recerca Matematica (CRM); University of London; Queen Mary University London; University of Oxford; Wellcome Centre for Human Genetics; University of London; University College London	Willis, L (corresponding author), UCL, Ctr Math & Phys Life Sci & Expt Biol, London, England.	lw464@cam.ac.uk	Alison, Malcolm/H-6961-2019; Alarcon, Tomas/AAW-2908-2021; Alarcon, Tomas/D-9083-2013	Alarcon, Tomas/0000-0002-8566-3676; Alarcon, Tomas/0000-0002-8566-3676; Graham, Trevor/0000-0001-9582-1597	British Engineering and Physical Sciences Research Council; Engineering and Physical Sciences Research Council United Kingdom; National Institute for Mathematical and Biological Synthesis, Knoxville, Tennessee; Direct For Biological Sciences [1300426] Funding Source: National Science Foundation	British Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council United Kingdom(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); National Institute for Mathematical and Biological Synthesis, Knoxville, Tennessee; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by the British Engineering and Physical Sciences Research Council. LW was supported by an Engineering and Physical Sciences Research Council United Kingdom studentship. KMP gratefully acknowledges the support of a Leverhulme Research Fellowship and a sabbatical fellowship at the National Institute for Mathematical and Biological Synthesis, Knoxville, Tennessee. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe O, 2005, LANCET, V365, P1687, DOI 10.1016/s0140-6736(05)66544-0; Aguirre-Ghiso JA, 2007, NAT REV CANCER, V7, P834, DOI 10.1038/nrc2256; Almog N, 2009, CANCER RES, V69, P836, DOI 10.1158/0008-5472.CAN-08-2590; [Anonymous], GRAPHCLICK VERS 3 0; ARMITAGE P, 1954, BRIT J CANCER, V8, P1, DOI 10.1038/bjc.1954.1; Bos SD, 1996, SCAND J UROL NEPHROL, V30, P489, DOI 10.3109/00365599609182329; Bouck N, 1996, ADV CANCER RES, V69, P135, DOI 10.1016/S0065-230X(08)60862-3; Chambers AF, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2197; Chia SK, 2004, J CLIN ONCOL, V22, P1630, DOI 10.1200/JCO.2004.09.070; Demicheli R, 1998, BREAST CANCER RES TR, V51, P133, DOI 10.1023/A:1005887422022; Demicheli R, 2001, SEMIN CANCER BIOL, V11, P297, DOI 10.1006/scbi.2001.0385; Demicheli R, 1997, ANN ONCOL, V8, P1075, DOI 10.1023/A:1008263116022; Folkman J, 2006, ANNU REV MED, V57, P1, DOI 10.1146/annurev.med.57.121304.131306; GIMBRONE MA, 1972, J EXP MED, V136, P261, DOI 10.1084/jem.136.2.261; Hanahan D, 1996, CELL, V86, P353, DOI 10.1016/S0092-8674(00)80108-7; HOLMGREN L, 1995, NAT MED, V1, P149, DOI 10.1038/nm0295-149; Hornsby C, 2007, LANCET ONCOL, V8, P1030, DOI 10.1016/S1470-2045(07)70343-1; Hudis CA, 2007, J CLIN ONCOL, V25, P2127, DOI 10.1200/JCO.2006.10.3523; Karnoub AE, 2007, NATURE, V449, P557, DOI 10.1038/nature06188; Karrison TG, 1999, JNCI-J NATL CANCER I, V91, P80, DOI 10.1093/jnci/91.1.80; Koebel CM, 2007, NATURE, V450, P903, DOI 10.1038/nature06309; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; MELTZER A, 1990, J SURG ONCOL, V43, P181, DOI 10.1002/jso.2930430312; Meng SD, 2004, CLIN CANCER RES, V10, P8152, DOI 10.1158/1078-0432.CCR-04-1110; Naumov GN, 2006, JNCI-J NATL CANCER I, V98, P316, DOI 10.1093/jnci/djj068; Naumov GN, 2001, SEMIN CANCER BIOL, V11, P271, DOI 10.1006/scbi.2001.0382; Nussenbaum F, 2010, J ONCOL, V2010, DOI 10.1155/2010/132641; OGIHARA Y, 1994, CANCER, V74, P2798, DOI 10.1002/1097-0142(19941115)74:10<2798::AID-CNCR2820741009>3.0.CO;2-2; OReilly MS, 1996, NAT MED, V2, P689, DOI 10.1038/nm0696-689; Paterlini-Brechot P, 2007, CANCER LETT, V253, P180, DOI 10.1016/j.canlet.2006.12.014; Radisky DC, 2008, CELL STEM CELL, V2, P511, DOI 10.1016/j.stem.2008.05.007; Rayson D, 1997, CANCER, V79, P605; Retsky MW, 2008, APMIS, V116, P730, DOI 10.1111/j.1600-0463.2008.00990.x; Retsky MW, 1997, BREAST CANCER RES TR, V45, P193, DOI 10.1023/A:1005849301420; Saphner T, 1996, J CLIN ONCOL, V14, P2738, DOI 10.1200/JCO.1996.14.10.2738; Uhra JW, 2011, P NATL ACAD SCI USA, V108, P12396, DOI 10.1073/pnas.1106613108; WEINHOLD KJ, 1977, NATURE, V270, P59, DOI 10.1038/270059a0; Willis L, 2010, CANCER RES, V70, P4310, DOI 10.1158/0008-5472.CAN-09-3144; Yin WJ, 2009, BREAST CANCER RES TR, V114, P527, DOI 10.1007/s10549-008-0022-5	39	10	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2013	8	5							e62320	10.1371/journal.pone.0062320	http://dx.doi.org/10.1371/journal.pone.0062320			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	177QL	23671591	Green Published, Green Submitted, gold			2022-12-27	WOS:000321390200018
J	Malm, M; Kronqvist, N; Lindberg, H; Gudmundsdotter, L; Bass, T; Frejd, FY; Hoiden-Guthenberg, I; Varasteh, Z; Orlova, A; Tolmachev, V; Stahl, S; Lofblom, J				Malm, Magdalena; Kronqvist, Nina; Lindberg, Hanna; Gudmundsdotter, Lindvi; Bass, Tarek; Frejd, Fredrik Y.; Hoiden-Guthenberg, Ingmarie; Varasteh, Zohreh; Orlova, Anna; Tolmachev, Vladimir; Stahl, Stefan; Lofblom, John			Inhibiting HER3-Mediated Tumor Cell Growth with Affibody Molecules Engineered to Low Picomolar Affinity by Position-Directed Error-Prone PCR-Like Diversification	PLOS ONE			English	Article							STAPHYLOCOCCAL SURFACE DISPLAY; BREAST-CANCER CELLS; TYROSINE KINASE; HER2 EXPRESSION; IN-VITRO; ERBB3; EGFR; RECEPTOR; PROTEIN; PROLIFERATION	The HER3 receptor is implicated in the progression of various cancers as well as in resistance to several currently used drugs, and is hence a potential target for development of new therapies. We have previously generated Affibody molecules that inhibit heregulin-induced signaling of the HER3 pathways. The aim of this study was to improve the affinity of the binders to hopefully increase receptor inhibition efficacy and enable a high receptor-mediated uptake in tumors. We explored a novel strategy for affinity maturation of Affibody molecules that is based on alanine scanning followed by design of library diversification to mimic the result from an error-prone PCR reaction, but with full control over mutated positions and thus less biases. Using bacterial surface display and flow-cytometric sorting of the maturation library, the affinity for HER3 was improved more than 30-fold down to 21 PM. The affinity is among the higher that has been reported for Affibody molecules and we believe that the maturation strategy should be generally applicable for improvement of affinity proteins. The new binders also demonstrated an improved thermal stability as well as complete refolding after denaturation. Moreover, inhibition of ligand-induced proliferation of HER3-positive breast cancer cells was improved more than two orders of magnitude compared to the previously best-performing clone. Radiolabeled Affibody molecules showed specific targeting of a number of HER3-positive cell lines in vitro as well as targeting of HER3 in in vivo mouse models and represent promising candidates for future development of targeted therapies and diagnostics.	[Malm, Magdalena; Kronqvist, Nina; Lindberg, Hanna; Bass, Tarek; Stahl, Stefan; Lofblom, John] KTH Royal Inst Technol, Sch Biotechnol, Div Prot Technol, Stockholm, Sweden; [Gudmundsdotter, Lindvi; Frejd, Fredrik Y.; Hoiden-Guthenberg, Ingmarie] Affibody AB, Stockholm, Sweden; [Varasteh, Zohreh; Orlova, Anna] Uppsala Univ, Dept Med Chem, Preclin PET Platform, Uppsala, Sweden; [Frejd, Fredrik Y.; Tolmachev, Vladimir] Uppsala Univ, Unit Biomed Radiat Sci, Uppsala, Sweden	Royal Institute of Technology; Uppsala University; Uppsala University	Stahl, S (corresponding author), KTH Royal Inst Technol, Sch Biotechnol, Div Prot Technol, Stockholm, Sweden.	stefans@biotech.kth.se	Kronqvist, Nina/M-6920-2015; Orlova, Anna/S-9692-2019; Tolmachev, Vladimir/T-3722-2017; Tolmachev, Vladimir/U-3107-2019; Kronqvist, Nina/M-6927-2015	Orlova, Anna/0000-0001-6120-2683; Tolmachev, Vladimir/0000-0002-6122-1734; Tolmachev, Vladimir/0000-0002-6122-1734; Lofblom, John/0000-0001-9423-0541; Malm, Magdalena/0000-0003-1763-9073	Swedish Foundation for Strategic Research (SSF); Swedish Research Council (VR); Swedish Cancer Society (Cancerfonden); Affinomics (EU-collaborative Project); ProNova excellence center for protein technology (VINNOVA - Swedish Governmental Agency for Innovation Systems)	Swedish Foundation for Strategic Research (SSF)(Swedish Foundation for Strategic Research); Swedish Research Council (VR)(Swedish Research Council); Swedish Cancer Society (Cancerfonden)(Swedish Cancer Society); Affinomics (EU-collaborative Project); ProNova excellence center for protein technology (VINNOVA - Swedish Governmental Agency for Innovation Systems)	This work was supported by the Swedish Foundation for Strategic Research (SSF), Swedish Research Council (VR), Swedish Cancer Society (Cancerfonden), Affinomics (EU-collaborative Project) and the ProNova excellence center for protein technology (VINNOVA - Swedish Governmental Agency for Innovation Systems). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar Z, 1999, ONCOGENE, V18, P6050, DOI 10.1038/sj.onc.1202993; Aurisicchio L, 2012, ONCOTARGET, V3, P744, DOI 10.18632/oncotarget.550; Baselga J, 2009, NAT REV CANCER, V9, P463, DOI 10.1038/nrc2656; Baum RP, 2010, J NUCL MED, V51, P892, DOI 10.2967/jnumed.109.073239; BREEMAN WAP, 1995, J NUCL MED, V36, P623; Citri A, 2003, EXP CELL RES, V284, P54, DOI 10.1016/S0014-4827(02)00101-5; DEJONG M, 1995, EUR J NUCL MED, V22, P608, DOI 10.1007/BF01254561; Ekerljung L, 2012, BIOCONJUGATE CHEM, V23, P1802, DOI 10.1021/bc3000645; Feldwisch J, 2010, J MOL BIOL, V398, P232, DOI 10.1016/j.jmb.2010.03.002; Friedman M, 2009, BIOTECHNOL APPL BIOC, V54, P121, DOI 10.1042/BA20090096; Frogne T, 2009, BREAST CANCER RES TR, V114, P263, DOI 10.1007/s10549-008-0011-8; Garrett JT, 2011, P NATL ACAD SCI USA, V108, P5021, DOI 10.1073/pnas.1016140108; Gostring L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040023; GUY PM, 1994, P NATL ACAD SCI USA, V91, P8132, DOI 10.1073/pnas.91.17.8132; Hofland LJ, 2003, J NUCL MED, V44, P1315; Holbro T, 2003, P NATL ACAD SCI USA, V100, P8933, DOI 10.1073/pnas.1537685100; Jonsson A, 2008, PROTEIN ENG DES SEL, V21, P515, DOI 10.1093/protein/gzn028; Jura N, 2009, P NATL ACAD SCI USA, V106, P21608, DOI 10.1073/pnas.0912101106; Kong A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002881; Kronqvist N, 2008, PROTEIN ENG DES SEL, V21, P247, DOI 10.1093/protein/gzm090; Kronqvist N, 2011, PROTEIN ENG DES SEL, V24, P385, DOI 10.1093/protein/gzq118; LaFleur DW, 2013, MABS-AUSTIN, V5, P208, DOI 10.4161/mabs.23043; Liu BL, 2007, INT J CANCER, V120, P1874, DOI 10.1002/ijc.22423; Lofblom J, 2007, J APPL MICROBIOL, V102, P736, DOI 10.1111/j.1365-2672.2006.03127.x; Lofblom J, 2005, FEMS MICROBIOL LETT, V248, P189, DOI 10.1016/j.femsle.2005.05.040; Lofblom J, 2010, FEBS LETT, V584, P2670, DOI 10.1016/j.febslet.2010.04.014; Orlova A, 2006, J NUCL MED, V47, P512; Robinson MK, 2008, BRIT J CANCER, V99, P1415, DOI 10.1038/sj.bjc.6604700; Schmidt MM, 2009, MOL CANCER THER, V8, P2861, DOI 10.1158/1535-7163.MCT-09-0195; Sergina NV, 2007, NATURE, V445, P437, DOI 10.1038/nature05474; Sheng Q, 2010, CANCER CELL, V17, P298, DOI 10.1016/j.ccr.2009.12.047; Sierke SL, 1997, BIOCHEM J, V322, P757, DOI 10.1042/bj3220757; Tolmachev V, 2006, J NUCL MED, V47, P846; Tolmachev V, 2004, CANCER BIOTHER RADIO, V19, P491, DOI 10.1089/1084978041979616; Tolmachev V, 2012, J NUCL MED, V53, P953, DOI 10.2967/jnumed.111.101527; Tolmachev V, 2012, J NUCL MED, V53, P90, DOI 10.2967/jnumed.111.090829; Tolmachev V, 2010, LANCET ONCOL, V11, P992, DOI 10.1016/S1470-2045(10)70088-7; Tolmachev V, 2010, EUR J NUCL MED MOL I, V37, P613, DOI 10.1007/s00259-009-1283-x; Waibel R, 1999, NAT BIOTECHNOL, V17, P897, DOI 10.1038/12890	39	51	51	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2013	8	5							e62791	10.1371/journal.pone.0062791	http://dx.doi.org/10.1371/journal.pone.0062791			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	143FO	23675426	Green Submitted, Green Published, gold			2022-12-27	WOS:000318852400011
J	Fernandes, AM; Herlofsen, SR; Karlsen, TA; Kuchler, AM; Floisand, Y; Brinchmann, JE				Fernandes, Amilton M.; Herlofsen, Sarah R.; Karlsen, Tommy A.; Kuchler, Axel M.; Floisand, Yngvar; Brinchmann, Jan E.			Similar Properties of Chondrocytes from Osteoarthritis Joints and Mesenchymal Stem Cells from Healthy Donors for Tissue Engineering of Articular Cartilage	PLOS ONE			English	Article							ANTERIOR CRUCIATE LIGAMENT; X COLLAGEN; BONE-MARROW; KNEE; DEFECTS; DIFFERENTIATION; EXPRESSION; PROTEIN; GROWTH; REPAIR	Lesions of hyaline cartilage do not heal spontaneously, and represent a therapeutic challenge. In vitro engineering of articular cartilage using cells and biomaterials may prove to be the best solution. Patients with osteoarthritis (OA) may require tissue engineered cartilage therapy. Chondrocytes obtained from OA joints are thought to be involved in the disease process, and thus to be of insufficient quality to be used for repair strategies. Bone marrow (BM) derived mesenchymal stem cells (MSCs) from healthy donors may represent an alternative cell source. We have isolated chondrocytes from OA joints, performed cell culture expansion and tissue engineering of cartilage using a disc-shaped alginate scaffold and chondrogenic differentiation medium. We performed real-time reverse transcriptase quantitative PCR and fluorescence immunohistochemistry to evaluate mRNA and protein expression for a range of molecules involved in chondrogenesis and OA pathogenesis. Results were compared with those obtained by using BM-MSCs in an identical tissue engineering strategy. Finally the two populations were compared using genome-wide mRNA arrays. At three weeks of chondrogenic differentiation we found high and similar levels of hyaline cartilage-specific type II collagen and fibrocartilage-specific type I collagen mRNA and protein in discs containing OA and BM-MSC derived chondrocytes. Aggrecan, the dominant proteoglycan in hyaline cartilage, was more abundantly distributed in the OA chondrocyte extracellular matrix. OA chondrocytes expressed higher mRNA levels also of other hyaline extracellular matrix components. Surprisingly BM-MSC derived chondrocytes expressed higher mRNA levels of OA markers such as COL10A1, SSP1 (osteopontin), ALPL, BMP2, VEGFA, PTGES, IHH, and WNT genes, but lower levels of MMP3 and S100A4. Based on the results presented here, OA chondrocytes may be suitable for tissue engineering of articular cartilage.	[Fernandes, Amilton M.; Herlofsen, Sarah R.; Karlsen, Tommy A.; Kuchler, Axel M.; Brinchmann, Jan E.] Univ Oslo, Norwegian Ctr Stem Cell Res, Oslo, Norway; [Fernandes, Amilton M.; Herlofsen, Sarah R.; Karlsen, Tommy A.; Kuchler, Axel M.; Brinchmann, Jan E.] Univ Oslo, Rikshosp, Oslo Univ Hosp, Inst Immunol, N-0027 Oslo, Norway; [Floisand, Yngvar] Univ Oslo, Rikshosp, Oslo Univ Hosp, Dept Hematol, N-0027 Oslo, Norway	University of Oslo; University of Oslo; National Hospital Norway; University of Oslo; National Hospital Norway	Brinchmann, JE (corresponding author), Univ Oslo, Norwegian Ctr Stem Cell Res, Oslo, Norway.	jan.brinchmann@rr-research.no			South-Eastern Norway Regional Health Authority; Research Council of Norway; Gidske and Peter Jacob Sorensens Foundation for the Promotion of Science	South-Eastern Norway Regional Health Authority; Research Council of Norway(Research Council of Norway); Gidske and Peter Jacob Sorensens Foundation for the Promotion of Science	This work was supported by a grant from South-Eastern Norway Regional Health Authority, Storforsk and Stamceller grants from the Research Council of Norway and the Gidske and Peter Jacob Sorensens Foundation for the Promotion of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed TAE, 2010, TISSUE ENG PART B-RE, V16, P305, DOI [10.1089/ten.teb.2009.0590, 10.1089/ten.TEB.2009.0590]; Aroen A, 2004, AM J SPORT MED, V32, P211, DOI 10.1177/0363546503259345; Aspden RM, 2008, RHEUMATOLOGY, V47, P1452, DOI 10.1093/rheumatology/ken199; Ballock RT, 2003, J BONE JOINT SURG AM, V85A, P715, DOI 10.2106/00004623-200304000-00021; BENYA PD, 1982, CELL, V30, P215, DOI 10.1016/0092-8674(82)90027-7; Berardini TZ, 2010, NUCLEIC ACIDS RES, V38, pD331, DOI 10.1093/nar/gkp1018; Boeuf S, 2010, STEM CELL RES THER, V1, DOI 10.1186/scrt31; Breitling R, 2004, FEBS LETT, V573, P83, DOI 10.1016/j.febslet.2004.07.055; BRITTBERG M, 1994, NEW ENGL J MED, V331, P889, DOI 10.1056/NEJM199410063311401; Chu CR, 2010, TISSUE ENG PART B-RE, V16, P105, DOI [10.1089/ten.teb.2009.0452, 10.1089/ten.TEB.2009.0452]; Corr M, 2008, NAT CLIN PRACT RHEUM, V4, P550, DOI 10.1038/ncprheum0904; Crofford LJ, 2001, GASTROENTEROL CLIN N, V30, P863, DOI 10.1016/S0889-8553(05)70217-X; Curl WW, 1997, ARTHROSCOPY, V13, P456, DOI 10.1016/S0749-8063(97)90124-9; Dieppe PA, 2005, LANCET, V365, P965, DOI 10.1016/S0140-6736(05)71086-2; Drissi Hicham, 2005, Molecular Aspects of Medicine, V26, P169, DOI 10.1016/j.mam.2005.01.003; Dysvik B, 2001, BIOINFORMATICS, V17, P369, DOI 10.1093/bioinformatics/17.4.369; Goldring MB, 2011, CURR OPIN RHEUMATOL, V23, P471, DOI 10.1097/BOR.0b013e328349c2b1; Goldring MB, 2006, J CELL BIOCHEM, V97, P33, DOI 10.1002/jcb.20652; Gomoll AH, 2010, J BONE JOINT SURG AM, V92A, P2470; Grigolo B, 2005, J BONE JOINT SURG AM, V87A, P46, DOI 10.2106/JBJS.C.01685; Grigolo B, 2009, TISSUE ENG PART C-ME, V15, P647, DOI [10.1089/ten.tec.2008.0569, 10.1089/ten.TEC.2008.0569]; Herlofsen SR, 2011, TISSUE ENG PT A, V17, P1003, DOI [10.1089/ten.TEA.2010.0499, 10.1089/ten.tea.2010.0499]; Hjelle K, 2002, ARTHROSCOPY, V18, P730, DOI 10.1053/jars.2002.32839; Jakobsen RB, 2010, KNEE SURG SPORT TR A, V18, P1407, DOI 10.1007/s00167-009-1017-4; Karlsen TA, 2011, TISSUE ENG PART C-ME, V17, P219, DOI [10.1089/ten.tec.2010.0200, 10.1089/ten.TEC.2010.0200]; Karlsson C, 2007, J ORTHOP RES, V25, P152, DOI 10.1002/jor.20287; KIELTY CM, 1985, BIOCHEM J, V227, P545, DOI 10.1042/bj2270545; Knutsen G, 2007, J BONE JOINT SURG AM, V89A, P2105, DOI 10.2106/JBJS.G.00003; KRISTIANSEN A, 2007, EUR BIOPHARM REV SPR, P34; Lin AC, 2009, NAT MED, V15, P1421, DOI 10.1038/nm.2055; Lohmander LS, 2004, ARTHRITIS RHEUM-US, V50, P3145, DOI 10.1002/art.20589; Mackie EJ, 2011, J ENDOCRINOL, V211, P109, DOI 10.1530/JOE-11-0048; Marlovits S, 2006, EUR J RADIOL, V57, P24, DOI 10.1016/j.ejrad.2005.08.009; Matricali GA, 2010, ACTA ORTHOP BELG, V76, P669; Melvik J-E, 2006, US Patent, Patent No. [2006/0159823 A1, 20060159823]; Mueller-Rath R, 2007, BIO-MED MATER ENG, V17, P357; Oslejskova L, 2008, ANN RHEUM DIS, V67, P1499, DOI 10.1136/ard.2007.079905; Pitsillides AA, 2011, NAT REV RHEUMATOL, V7, P654, DOI 10.1038/nrrheum.2011.129; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Pullig O, 2000, MATRIX BIOL, V19, P245, DOI 10.1016/S0945-053X(00)00068-8; Roos H, 1995, OSTEOARTHR CARTILAGE, V3, P261, DOI 10.1016/S1063-4584(05)80017-2; Salem HK, 2010, STEM CELLS, V28, P585, DOI 10.1002/stem.269; SCHMID TM, 1990, ANN NY ACAD SCI, V580, P64, DOI 10.1111/j.1749-6632.1990.tb17918.x; SCHMID TM, 1985, J CELL BIOL, V100, P598, DOI 10.1083/jcb.100.2.598; SCHMID TM, 1990, DEV BIOL, V138, P53, DOI 10.1016/0012-1606(90)90176-J; Schu S, 2011, J CELL MOL MED; Shahdadfar A, 2008, TISSUE ENG PT A, V14, P1999, DOI 10.1089/ten.tea.2007.0344; Shen G, 2005, Orthod Craniofac Res, V8, P11, DOI 10.1111/j.1601-6343.2004.00308.x; Tchetina EV, 2005, J RHEUMATOL, V32, P876; Uccelli A, 2008, NAT REV IMMUNOL, V8, P726, DOI 10.1038/nri2395; van der Kraan PM, 2012, OSTEOARTHR CARTILAGE, V20, P223, DOI 10.1016/j.joca.2011.12.003; Vasiliadis HS, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003323.pub3; Widuchowski W, 2007, KNEE, V14, P177, DOI 10.1016/j.knee.2007.02.001	53	32	35	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2013	8	5							e62994	10.1371/journal.pone.0062994	http://dx.doi.org/10.1371/journal.pone.0062994			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	155HD	23671648	gold, Green Published, Green Submitted			2022-12-27	WOS:000319737700031
J	Kumar, A; Lo Nigro, A; Gysemans, C; Cai, Q; Esguerra, C; Nelson-Holte, M; Heremans, Y; Jimenez-Gonzalez, M; Porciuncula, A; Mathieu, C; Binas, B; Heimberg, H; Prosper, F; Hering, B; Verfaillie, CM; Barajas, M				Kumar, Anujith; Lo Nigro, Antonio; Gysemans, Conny; Cai, Qing; Esguerra, Camila; Nelson-Holte, Molly; Heremans, Yves; Jimenez-Gonzalez, Maria; Porciuncula, Angelo; Mathieu, Chantal; Binas, Bert; Heimberg, Harry; Prosper, Felipe; Hering, Bernhard; Verfaillie, Catherine M.; Barajas, Miguel			Reversal of Hyperglycemia by Insulin-Secreting Rat Bone Marrow- and Blastocyst-Derived Hypoblast Stem Cell-Like Cells	PLOS ONE			English	Article							PANCREATIC BETA-CELLS; PROGENITOR CELLS; MOUSE PANCREAS; IN-VIVO; DIFFERENTIATION; ENDODERM; GENE; EXPRESSION; CULTURE; LIVER	beta-cell replacement may efficiently cure type 1 diabetic (T1D) patients whose insulin-secreting beta-cells have been selectively destroyed by autoantigen-reactive T cells. To generate insulin-secreting cells we used two cell sources: rat multipotent adult progenitor cells (rMAPC) and the highly similar rat extra-embryonic endoderm precursor (rXEN-P) cells isolated under rMAPC conditions from blastocysts (rHypoSC). rMAPC/rHypoSC were sequentially committed to definitive endoderm, pancreatic endoderm, and beta-cell like cells. On day 21, 20% of rMAPC/rHypoSC progeny expressed Pdx1 and C-peptide. rMAPCr/HypoSC progeny secreted C-peptide under the stimulus of insulin agonist carbachol, and was inhibited by the L-type voltage-dependent calcium channel blocker nifedipine. When rMAPC or rHypoSC differentiated d21 progeny were grafted under the kidney capsule of streptozotocin-induced diabetic nude mice, hyperglycemia reversed after 4 weeks in 6/10 rMAPC-and 5/10 rHypoSC-transplanted mice. Hyperglycemia recurred within 24 hours of graft removal and the histological analysis of the retrieved grafts revealed presence of Pdx1-, Nkx6.1- and C-peptide-positive cells. The ability of both rMAPC and HypoSC to differentiate to functional beta-cell like cells may serve to gain insight into signals that govern beta-cell differentiation and aid in developing culture systems to commit other (pluripotent) stem cells to clinically useful beta-cells for cell therapy of T1D.	[Kumar, Anujith; Lo Nigro, Antonio; Cai, Qing; Esguerra, Camila; Nelson-Holte, Molly; Verfaillie, Catherine M.] Katholieke Univ Leuven, Stamcel Inst Leuven, Louvain, Belgium; [Gysemans, Conny; Mathieu, Chantal] Katholieke Univ Leuven, Lab Expt Med & Endocrinol, Louvain, Belgium; [Heremans, Yves; Verfaillie, Catherine M.; Barajas, Miguel] Univ Minnesota, Stem Cell Inst, Minneapolis, MN USA; [Heremans, Yves; Heimberg, Harry] Vrije Univ Brussel, Diabet Res Ctr, Brussels, Belgium; [Jimenez-Gonzalez, Maria; Porciuncula, Angelo; Prosper, Felipe; Barajas, Miguel] Univ Navarra, Univ Navarra Clin, E-31080 Pamplona, Spain; [Jimenez-Gonzalez, Maria; Porciuncula, Angelo; Prosper, Felipe; Barajas, Miguel] Univ Navarra, Fdn Appl Med Res, Div Oncol, E-31080 Pamplona, Spain; [Binas, Bert] Hanyang Univ, Coll Sci & Technol, Div Mol & Life Sci, Ansan, South Korea; [Hering, Bernhard] Univ Minnesota, Diabet Inst Immunol & Transplantat, Minneapolis, MN USA; [Kumar, Anujith] Manipal Inst Regenerat Med, Bangalore, Karnataka, India	KU Leuven; KU Leuven; University of Minnesota System; University of Minnesota Twin Cities; Vrije Universiteit Brussel; University of Navarra; University of Navarra; Hanyang University; University of Minnesota System; University of Minnesota Twin Cities; Manipal Academy of Higher Education (MAHE)	Verfaillie, CM (corresponding author), Katholieke Univ Leuven, Stamcel Inst Leuven, Louvain, Belgium.	catherine.verfaillie@med.kuleuven.be; mbarajas@unav.es	mathieu, chantal/ABD-5505-2021; Esguerra, Camila/N-6159-2015; Prosper, Felipe/H-6859-2017; Esguerra, Camila/D-7657-2014; Barajas, Miguel/AAG-8408-2019; Verfaillie, Catherine/H-5148-2013	mathieu, chantal/0000-0002-4055-5233; Esguerra, Camila/0000-0002-2271-8094; Prosper, Felipe/0000-0001-6115-8790; Esguerra, Camila/0000-0001-7891-1427; Barajas, Miguel/0000-0003-4004-1432; gysemans, conny/0000-0003-3559-6089; Heimberg, Harry/0000-0003-1954-7375; Lo Nigro, Antonio/0000-0003-0137-4525; , ANUJITH/0000-0002-9889-1985; Verfaillie, Catherine/0000-0001-7564-4079	NIH [U19 DK61244]; UCSF/Minnesota Center grant from JDRF; Odysseus grant from FWO [G.0667.07]; K.U.Leuven [IUAPVII-07, EF/05/011, PF/10/019, GOA/11/012]; FWO [G.0601.07]; European Community's Health Seventh Framework Programme [241447]; Fundacion Mutua Madrilena and Caja de Ahorros de Navarra; Instituto de Salud Carlos III [FIS PS09/01250, ISCIII-RETIC RD12/0019/0031]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U19DK061244] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UCSF/Minnesota Center grant from JDRF; Odysseus grant from FWO(FWO); K.U.Leuven(KU Leuven); FWO(FWO); European Community's Health Seventh Framework Programme; Fundacion Mutua Madrilena and Caja de Ahorros de Navarra; Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by NIH award U19 DK61244; a UCSF/Minnesota Center grant from JDRF; the G.0667.07 Odysseus grant from FWO; IUAPVII-07, EF/05/011, PF/10/019 and GOA/11/012 funding from the K.U.Leuven to CMV, the FWO grant G.0601.07 to CMV, CG and CM. CG is supported by the European Community's Health Seventh Framework Programme (FP7/2009-2014 under grant agreement 241447 with acronym NAIMIT) and the K.U.Leuven. This work was also supported by the Fundacion Mutua Madrilena and Caja de Ahorros de Navarra, and grants from Instituto de Salud Carlos III (FIS PS09/01250 and ISCIII-RETIC RD12/0019/0031) to FP and MB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguayo-Mazzucato C, 2011, DIABETOLOGIA, V54, P583, DOI 10.1007/s00125-010-2026-z; Baharvand H, 2006, DEV GROWTH DIFFER, V48, P323, DOI 10.1111/j.1440-169x.2006.00867.x; BLACK MA, 1994, CELL SIGNAL, V6, P897, DOI 10.1016/0898-6568(94)90022-1; Collombat P, 2009, CELL, V138, P449, DOI 10.1016/j.cell.2009.05.035; D'Amour KA, 2006, NAT BIOTECHNOL, V24, P1392, DOI 10.1038/nbt1259; Debeb BG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007216; Dichmann DS, 2006, DEV DYNAM, V235, P3016, DOI 10.1002/dvdy.20953; Harmon EB, 2004, DEVELOPMENT, V131, P6163, DOI 10.1242/dev.01535; Hebrok M, 1998, GENE DEV, V12, P1705, DOI 10.1101/gad.12.11.1705; HIRIART M, 1993, MOL CELL ENDOCRINOL, V93, P63, DOI 10.1016/0303-7207(93)90140-F; Huotari MA, 2002, ENDOCRINOLOGY, V143, P4437, DOI 10.1210/en.2002-220382; Jacquemin P, 2000, MOL CELL BIOL, V20, P4445, DOI 10.1128/MCB.20.12.4445-4454.2000; Jacquemin P, 2003, DEV BIOL, V258, P105, DOI 10.1016/S0012-1606(03)00115-5; Jiang W, 2007, CELL RES, V17, P333, DOI 10.1038/cr.2007.28; Jung JN, 1999, SCIENCE, V284, P1998, DOI 10.1126/science.284.5422.1998; Kataoka K, 2002, J BIOL CHEM, V277, P49903, DOI 10.1074/jbc.M206796200; Kojima H, 2003, NAT MED, V9, P596, DOI 10.1038/nm867; Kroon E, 2008, NAT BIOTECHNOL, V26, P443, DOI 10.1038/nbt1393; Kwon GS, 2008, DEV CELL, V15, P509, DOI 10.1016/j.devcel.2008.07.017; Nigro A, 2012, J MOL CELL BIOL, V4, P423, DOI 10.1093/jmcb/mjs046; Matveyenko AV, 2010, AM J PHYSIOL-ENDOC M, V299, pE713, DOI 10.1152/ajpendo.00279.2010; Mfopou JK, 2010, GASTROENTEROLOGY, V138, P2233, DOI 10.1053/j.gastro.2010.02.056; Movassat J, 2002, J CLIN ENDOCR METAB, V87, P4775, DOI 10.1210/jc.2002-020137; Roelandt P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012101; Sancho-Bru P, 2011, J HEPATOL, V54, P98, DOI 10.1016/j.jhep.2010.06.014; Sander M, 2000, DEVELOPMENT, V127, P5533; Serafimidis I, 2008, STEM CELLS, V26, P3, DOI 10.1634/stemcells.2007-0194; Shapiro AMJ, 2006, NEW ENGL J MED, V355, P1318, DOI 10.1056/NEJMoa061267; Shi Y, 2005, STEM CELLS, V23, P656, DOI 10.1634/stemcells.2004-0241; SMITH DE, 1992, DEVELOPMENT, V116, P555; Smith SB, 1999, MOL CELL BIOL, V19, P8272; Subramanian K, 2010, METHODS MOL BIOL, V636, P55, DOI 10.1007/978-1-60761-691-7_4; Tada S, 2005, DEVELOPMENT, V132, P4363, DOI 10.1242/dev.02005; Ulloa-Montoya F, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-r163; Xu XB, 2008, CELL, V132, P197, DOI 10.1016/j.cell.2007.12.015; Yamaguchi TP, 2001, CURR BIOL, V11, pR713, DOI 10.1016/S0960-9822(01)00417-1; Yechoor V, 2009, DEV CELL, V16, P358, DOI 10.1016/j.devcel.2009.01.012	37	3	3	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2013	8	5							e63491	10.1371/journal.pone.0063491	http://dx.doi.org/10.1371/journal.pone.0063491			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	155HD	23671681	gold, Green Published			2022-12-27	WOS:000319737700052
J	Byun, SH; Ma, SH; Jun, JK; Jung, KW; Park, B				Byun, Sang-Ho; Ma, Seung Hyun; Jun, Jae Kwan; Jung, Kyu-Won; Park, Boyoung			Screening for Diabetic Retinopathy and Nephropathy in Patients with Diabetes: A Nationwide Survey in Korea	PLOS ONE			English	Article							QUALITY-OF-CARE; DIRECT MEDICAL COSTS; UNITED-STATES; GLOBAL PREVALENCE; EYE EXAMINATIONS; COMPLICATIONS; POPULATION; HEALTH; RISK; DISPARITIES	This study was performed to identify factors associated with screening for diabetic retinopathy and nephropathy. Data from the Korean National Health and Nutrition Examination Survey between 2007 and 2009 were analyzed. Of 24,871 participants, 1,288 patients diagnosed with diabetes at >= 30 years of age were included. 36.3% received screening for diabetic retinopathy, and 40.5% received screening for diabetic nephropathy during the previous year. Patients living in rural areas, those with less education, those who had not received education about diabetes care, and those who did not receive medical care for diabetes were screened less often for retinopathy or nephropathy. Patients with poorer self-reported health status were screened more often. Occupation, smoking status, and diabetes duration were associated with retinopathy screening. Lower family income was associated with decreased nephropathy screening. Receiving education about diabetes care and receiving medical care for diabetes were significant factors in patients with a shorter duration of diabetes ( the significant odds ratio [OR] of not receiving education varied between 0.27 and 0.51, and that of not receiving medical care varied between 0.34 and 0.42). Sociodemographic factors and health-related factors as well as education and medical care influenced screening for diabetic complications among those with a longer duration of diabetes ( for retinopathy and nephropathy, the significant OR of living in a rural area varied between 0.56 and 0.61; for retinopathy, the significant OR of current smokers was 0.55, and the p-trend of subjective health status was <0.001; for nephropathy, the significant OR of a monthly household income of <3000 dollars was 0.61 and the p-trends of education and subjective health status were 0.030 and 0.007, respectively). Efforts to decrease sociodemographic disparities should be combined with education about diabetes care to increase the screening, especially for those with a longer duration of diabetes.	[Byun, Sang-Ho; Ma, Seung Hyun] Seoul Natl Univ, Coll Med, Dept Prevent Med, Seoul, South Korea; [Jun, Jae Kwan; Jung, Kyu-Won; Park, Boyoung] Natl Canc Ctr, Natl Canc Control Inst, Goyang Si, Gyeonggi Do, South Korea	Seoul National University (SNU); National Cancer Center - Korea (NCC)	Park, B (corresponding author), Natl Canc Ctr, Natl Canc Control Inst, Goyang Si, Gyeonggi Do, South Korea.	hayejine@ncc.re.kr			National Cancer Center of Korea [1310230]	National Cancer Center of Korea	This study was supported by a Grant-in-Aid for Cancer Research and Control from the National Cancer Center of Korea (#1310230. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler AI, 2003, KIDNEY INT, V63, P225, DOI 10.1046/j.1523-1755.2003.00712.x; Amer Diabet Assoc, 2013, DIABETES CARE, V36, P1033, DOI 10.2337/dc12-2625; [Anonymous], 2012, DIABETES CARE S1, V35, pS4, DOI DOI 10.2337/DC12-S004; Brown AF, 2005, DIABETES CARE, V28, P2864, DOI 10.2337/diacare.28.12.2864; Choi YJ, 2009, DIABETES CARE, V32, P2016, DOI 10.2337/dc08-2228; Cutler DM, 2010, J HEALTH ECON, V29, P1, DOI 10.1016/j.jhealeco.2009.10.003; Dervan E, 2008, IRISH J MED SCI, V177, P303, DOI 10.1007/s11845-008-0192-5; Do YK, 2011, INT J QUAL HEALTH C, V23, P397, DOI 10.1093/intqhc/mzr035; Fioretto P, 2006, J AM SOC NEPHROL, V17, pS86, DOI 10.1681/ASN.2005121343; Fowles JB, 1999, INT J QUAL HEALTH C, V11, P407, DOI 10.1093/intqhc/11.5.407; Girach A, 2006, INT J CLIN PRACT, V60, P1471, DOI 10.1111/j.1742-1241.2006.01175.x; Kim TH, 2012, J KOREAN MED SCI, V27, P876, DOI 10.3346/jkms.2012.27.8.876; Lee YH, 2012, DIABETES CARE, V35, P1723, DOI 10.2337/dc11-2347; Lim H, 2012, DIABETES CARE, V35, P2028, DOI 10.2337/dc11-1841; Mangione CM, 2006, ANN INTERN MED, V145, P107, DOI 10.7326/0003-4819-145-2-200607180-00008; Moon Sangho, 2007, World Health Popul, V9, P95; Muller A, 2006, OPTOMETRY VISION SCI, V83, P96, DOI 10.1097/01.opx.0000200678.77515.2e; O'Brien JA, 2003, BMC HEALTH SERV RES, V3, DOI 10.1186/1472-6963-3-7; O'Brien JA, 2003, CLIN THER, V25, P1017, DOI 10.1016/S0149-2918(03)80122-4; Onakpoya OH, 2010, EUR J INTERN MED, V21, P176, DOI 10.1016/j.ejim.2010.01.009; Ramsey Fred, 2008, Morbidity and Mortality Weekly Report, V57, P1; Rossing K, 2004, KIDNEY INT, V66, P1596, DOI 10.1111/j.1523-1755.2004.00925.x; Saaddine JB, 2006, ANN INTERN MED, V144, P465, DOI 10.7326/0003-4819-144-7-200604040-00005; Saadine JB, 2008, RETINA-J RET VIT DIS, V28, P195, DOI 10.1097/IAE.0b013e318115169a; Si DM, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-169; Sundling V, 2008, BMC HEALTH SERV RES, V8, DOI [10.1186/1472-6963-8-38, 10.1186/1472-6963-8-159]; Tapp RJ, 2004, DIABETES CARE, V27, P688, DOI 10.2337/diacare.27.3.688; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047; Williams R, 2002, DIABETOLOGIA, V45, pS13, DOI 10.1007/s00125-002-0859-9; Yau JWY, 2012, DIABETES CARE, V35, P556, DOI 10.2337/dc11-1909; Yoon JY, 2012, J KOREAN MED SCI, V27, P512, DOI 10.3346/jkms.2012.27.5.512; 신광훈, 2009, [Journal of The Korean Ophthalmological Society, 대한안과학회지], V50, P1319	32	27	27	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2013	8	5							e62991	10.1371/journal.pone.0062991	http://dx.doi.org/10.1371/journal.pone.0062991			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	145YI	23667557	Green Submitted, Green Published, gold			2022-12-27	WOS:000319055600049
J	Cao, WF; Zhang, B; Ding, F; Zhang, WR; Sun, BC; Liu, ZH				Cao, Wenfeng; Zhang, Bin; Ding, Fang; Zhang, Weiran; Sun, Baocun; Liu, Zhihua			Expression of SLP-2 Was Associated with Invasion of Esophageal Squamous Cell Carcinoma	PLOS ONE			English	Article							STOMATIN-LIKE PROTEIN-2; BREAST-CANCER; PROGNOSTIC-FACTOR; GROWTH; OVEREXPRESSION; PROGRESSION; ACTIVATION; MICROARRAY; KINASE; GENES	Introduction: Stomatin-like protein 2 (SLP-2), a member of the Stomatin superfamily, has been identified as an oncogenic-related protein and found to be up-regulated in multi-cancers. Nonetheless, the expression pattern and regulation of SLP-2 in human esophageal squamous cell carcinoma (ESCC) remain unexplored. Methods: Immunohistochemistry and immunofluorescence staining analysis were performed to show SLP-2 expression and location. RNAi method was used to inhibit specific protein expression. Transwell assay was done to investigate cells invasive capability. RT-PCR and Western blot analysis were used to detect mRNA and protein expression levels. Results: Immunohistochemical analysis showed that up-regulation of SLP-2 was found in invasive front compared with cancer central tissue in ESCC. Inhibition of SLP-2 by SLP-2 siRNA can decrease ESCC cells invasive capability through MMP-2 dependent manner. Up-regulation of SLP-2 was effectively abrogated by the ERK1/2 inhibitors either PD98059 or U0126, but no effect was showed by the treatment of AKT inhibitors either LY294002 or MK-2206. So the regulation of SLP-2 was involved in activation of the MAPK/ERK pathway. Conclusions: We found that PMA/EGF could induce the up-regulated expression of SLP-2 probably through activating ERK signalling. The current study suggests that SLP-2 may represent an important molecular hallmark that is clinically relevant to the invasion of ESCC.	[Cao, Wenfeng; Sun, Baocun] Tianjin Med Univ Canc Inst & Hosp, Dept Pathol, Key Lab Canc Prevent & Therapy, Tianjin, Peoples R China; [Cao, Wenfeng; Ding, Fang; Liu, Zhihua] Chinese Acad Med Sci, Inst Canc, State Key Lab Mol Oncol, Beijing 100021, Peoples R China; [Cao, Wenfeng; Ding, Fang; Liu, Zhihua] Peking Union Med Coll, Beijing 100021, Peoples R China; [Zhang, Bin; Zhang, Weiran] Tianjin Med Univ Canc Inst & Hosp, Dept Breast Canc, State Key Lab Breast Canc Res, Tianjin, Peoples R China	Tianjin Medical University; Chinese Academy of Medical Sciences - Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Tianjin Medical University	Sun, BC (corresponding author), Tianjin Med Univ Canc Inst & Hosp, Dept Pathol, Key Lab Canc Prevent & Therapy, Tianjin, Peoples R China.	baocunsun@eyou.com; liuzh@cicams.ac.cn			Subject of Science and Technology Development Fund of Tianjin Education Commission [20060108]; Tianjin Municipal Science and Technology Commission Research Fund [10JCYBJC14100]; Tianjin Medical University Cancer Hospital Research Funds	Subject of Science and Technology Development Fund of Tianjin Education Commission; Tianjin Municipal Science and Technology Commission Research Fund; Tianjin Medical University Cancer Hospital Research Funds	This work was partially supported by the grant: Subject of Science and Technology Development Fund of Tianjin Education Commission (20060108), Tianjin Municipal Science and Technology Commission Research Fund (10JCYBJC14100), Tianjin Medical University Cancer Hospital Research Funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adeyinka A, 2002, CLIN CANCER RES, V8, P1747; Albanell J, 2001, CANCER RES, V61, P6500; Brown M, 2010, HISTOPATHOLOGY, V56, P893, DOI 10.1111/j.1365-2559.2010.03559.x; Cao WF, 2007, HUM PATHOL, V38, P747, DOI 10.1016/j.humpath.2006.11.004; Cao WF, 2007, AM J CLIN PATHOL, V128, P430, DOI 10.1309/C6X54HRB580EP2NQ; Cao WF, 2011, PATHOLOGY, V43, P713, DOI 10.1097/PAT.0b013e32834c34ed; Fidler IJ, 2003, NAT REV CANCER, V3, P453, DOI 10.1038/nrc1098; Groblewska M, 2012, FOLIA HISTOCHEM CYTO, V50, P12, DOI [10.5603/FHC.2012.0002, 10.2478/18691]; Ljuslinder I, 2011, INT J CANCER, V128, P2031, DOI 10.1002/ijc.25559; Lu JY, 2001, INT J CANCER, V91, P288, DOI 10.1002/1097-0215(200002)9999:9999<::AID-IJC1063>3.0.CO;2-S; Luo AP, 2004, ONCOGENE, V23, P1291, DOI 10.1038/sj.onc.1207218; Mandell JW, 1998, AM J PATHOL, V153, P1411, DOI 10.1016/S0002-9440(10)65728-8; Oberst MD, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-189; Ohike N, 2010, AM J SURG PATHOL, V34, P1417, DOI 10.1097/PAS.0b013e3181f0b05a; Owczarek CM, 2001, CYTOGENET CELL GENET, V92, P196, DOI 10.1159/000056902; Segal E, 2005, NAT GENET, V37, pS38, DOI 10.1038/ng1561; SHIMADA Y, 1992, CANCER, V69, P277, DOI 10.1002/1097-0142(19920115)69:2<277::AID-CNCR2820690202>3.0.CO;2-C; Tasioudi KE, 2012, PATHOL RES PRACT, V208, P398, DOI 10.1016/j.prp.2012.05.009; Wang YJ, 2000, J BIOL CHEM, V275, P8062, DOI 10.1074/jbc.275.11.8062; Wang YQ, 2009, CANCER BIOL THER, V8, P1658, DOI 10.4161/cbt.8.17.9283; Zhang J, 2005, J PATHOL, V207, P402, DOI 10.1002/path.1846; Zhang Li-Yong, 2005, Ai Zheng, V24, P155; Zhang LY, 2006, CLIN CANCER RES, V12, P1639, DOI 10.1158/1078-0432.CCR-05-1858; Zhang LY, 2004, WORLD CHIN J DIGESTO, V12, P1517; Zhi HY, 2003, INT J CANCER, V106, P327, DOI 10.1002/ijc.11225	25	17	20	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2013	8	5							e63890	10.1371/journal.pone.0063890	http://dx.doi.org/10.1371/journal.pone.0063890			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145YI	23667687	gold, Green Submitted, Green Published			2022-12-27	WOS:000319055600081
J	Cook, S; Leon, DA; Kiryanov, N; Ploubidis, GB; De Stavola, BL				Cook, Sarah; Leon, David A.; Kiryanov, Nikolay; Ploubidis, George B.; De Stavola, Bianca L.			Alcohol-Related Dysfunction in Working-Age Men in Izhevsk, Russia: An Application of Structural Equation Models to Study the Association with Education	PLOS ONE			English	Article							MORTALITY; DRINKING; HANGOVER; CONSUMPTION; POPULATION; PATTERNS; TRENDS; COHORT; ADULTS; LEVEL	Background: Acute alcohol-related dysfunctional behaviours, such as hangover, are predictive of poor health and mortality. Although much is known about the association of education with alcohol consumption, little is known about its association with these dysfunctional behaviours. Methods: The study population was 1,705 male drinkers aged 25-54 years resident in the city of Izhevsk, Russia who participated in a cross-sectional survey (2003-6). Structural equation modelling was used to examine the relationships between education, beverage and non-beverage alcohol intake, drinking patterns, and acute alcohol-related dysfunction score among these drinkers. Results: Dysfunction was related to all other drinking variables, with the strongest predictors being spirit intake, non-beverage alcohol consumption and drinking patterns. There was a strong relationship between education and acute dysfunction which was not explained by adjusting for alcohol intake and drinking patterns (mean adjusted dysfunction score 0.35 SD (95% CI 0.10, 0.61) lower in men with higher versus secondary education). Conclusions: Although by definition one or more aspects of alcohol consumption should explain the educational differences in alcohol-related dysfunction, detailed information on drinking only partly accounted for the observed patterns. Thus beyond their intrinsic interest, these results illustrate the challenges in constructing statistical models that convincingly identify the pathways that link educational differences to health-related outcomes.	[Cook, Sarah; Leon, David A.; Ploubidis, George B.; De Stavola, Bianca L.] London Sch Hyg & Trop Med, London WC1, England; [Kiryanov, Nikolay] Izhevsk State Med Acad, Izhevsk, Russia	University of London; London School of Hygiene & Tropical Medicine	Cook, S (corresponding author), London Sch Hyg & Trop Med, London WC1, England.	sarah.cook@lshtm.ac.uk	Leon, David A/G-2195-2010; Ploubidis, George B/G-9531-2011	Leon, David A/0000-0001-9747-1762; Ploubidis, George B/0000-0002-8198-5790; De Stavola, Bianca Lucia/0000-0001-7853-0528; Cook, Sarah/0000-0003-1250-2967	Wellcome Trust [067232, 078557]	Wellcome Trust(Wellcome TrustEuropean Commission)	The Izhevsk Family Study was funded by the Wellcome Trust (grant numbers 067232 and 078557). S.C. received a UK Medical Research Council PhD Studentship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ames GM, 1997, J STUD ALCOHOL, V58, P37, DOI 10.15288/jsa.1997.58.37; Bessudnov A, 2012, EUR J PUBLIC HEALTH, V22, P332, DOI 10.1093/eurpub/ckr130; Bobak M, 2004, J EPIDEMIOL COMMUN H, V58, P238, DOI 10.1136/jech.2003.011825; Bobrova N, 2009, SUBST USE MISUSE, V44, P1821, DOI 10.3109/10826080802490717; Carlson P, 1998, EUR J PUBLIC HEALTH, V8, P280, DOI 10.1093/eurpub/8.4.280; Cook S, 2011, ALCOHOL ALCOHOLISM, V46, P702, DOI 10.1093/alcalc/agr076; Gil A, 2009, ALCOHOL CLIN EXP RES, V33, P79, DOI 10.1111/j.1530-0277.2008.00813.x; Hills, 1993, STAT MODELS EPIDEMIO; Kline RB, 2005, PRINCIPLES PRACTICE; Leon DA, 2007, LANCET, V369, P2001, DOI 10.1016/S0140-6736(07)60941-6; Leon DA, 2009, ADDICTION, V104, P1630, DOI 10.1111/j.1360-0443.2009.02655.x; Malyutina S, 2004, ALCOHOL ALCOHOLISM, V39, P64, DOI 10.1093/alcalc/agh022; Midanik LT, 1999, ADDICTION, V94, P887, DOI 10.1046/j.1360-0443.1999.94688711.x; Murphy M, 2006, AM J PUBLIC HEALTH, V96, P1293, DOI 10.2105/AJPH.2004.056929; Muthen B., 2010, MPLUS USERS GUIDE; Nemtsov AV, 2002, ADDICTION, V97, P1413, DOI 10.1046/j.1360-0443.2002.00262.x; Nicholson A, 2005, B WORLD HEALTH ORGAN, V83, P812; Paljarvi T, 2011, ADDICTION; Paljarvi T, 2011, ALCOHOL ALCOHOLISM, V46, P607, DOI 10.1093/alcalc/agr072; POIKOLAINEN K, 1983, INT J EPIDEMIOL, V12, P151, DOI 10.1093/ije/12.2.151; Popova S, 2007, ALCOHOL ALCOHOLISM, V42, P465, DOI 10.1093/alcalc/agl124; Prat G, 2009, HUM PSYCHOPHARM CLIN, V24, P259, DOI 10.1002/hup.1023; Pridemore WA, 2010, EUROPEAN J PUBLIC HL; Rohsenow DJ, 2010, ALCOHOL CLIN EXP RES, V34, P509, DOI 10.1111/j.1530-0277.2009.01116.x; Shkolnikov VM, 1998, SOC SCI MED, V47, P357, DOI 10.1016/S0277-9536(98)00096-3; StataCorp, 2021, STATA STAT SOFTWARE; Stephens R, 2008, ALCOHOL ALCOHOLISM, V43, P163, DOI 10.1093/alcalc/agm160; Streiner DL, 2006, CAN J PSYCHIAT, V51, P317, DOI 10.1177/070674370605100507; Tabachnik BG, 2013, USING MULTIVARIATE S, V6th; Tomkins S, 2007, ADDICTION, V102, P544, DOI 10.1111/j.1360-0443.2006.01693.x; Verster JC, 2008, ALCOHOL ALCOHOLISM, V43, P124, DOI 10.1093/alcalc/agm163; Wiese JG, 2000, ANN INTERN MED, V132, P897, DOI 10.7326/0003-4819-132-11-200006060-00008; World Health Organization, 2011, GLOB STAT REP ALC HL; Zaridze D, 2009, INT J EPIDEMIOL, V38, P143, DOI 10.1093/ije/dyn160; Zaridze D, 2009, LANCET, V373, P2201, DOI 10.1016/S0140-6736(09)61034-5	35	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2013	8	5							e63792	10.1371/journal.pone.0063792	http://dx.doi.org/10.1371/journal.pone.0063792			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	145YI	23667673	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000319055600074
J	Crociara, P; Parolisi, R; Conte, D; Fumagalli, M; Bonfanti, L				Crociara, Paola; Parolisi, Roberta; Conte, Daniele; Fumagalli, Marta; Bonfanti, Luca			Cellular and Molecular Characterization of Multipolar Map5-Expressing Cells: A Subset of Newly Generated, Stage-Specific Parenchymal Cells in the Mammalian Central Nervous System	PLOS ONE			English	Article							MICROTUBULE-ASSOCIATED PROTEIN; NEURAL STEM-CELLS; ADULT-RAT BRAIN; SPINAL-CORD; NG2 CELLS; NEUROFIBRILLARY TANGLES; STRUCTURAL PLASTICITY; NG2-EXPRESSING CELLS; MAP1B EXPRESSION; PROGENITOR CELLS	Although extremely interesting in adult neuro-glio-genesis and promising as an endogenous source for repair, parenchymal progenitors remain largely obscure in their identity and physiology, due to a scarce availability of stage-specific markers. What appears difficult is the distinction between real cell populations and various differentiation stages of the same population. Here we focused on a subset of multipolar, polydendrocyte-like cells (mMap5 cells) expressing the microtubule associated protein 5 (Map5), which is known to be present in most neurons. We characterized the morphology, phenotype, regional distribution, proliferative dynamics, and stage-specific marker expression of these cells in the rabbit and mouse CNS, also assessing their existence in other mammalian species. mMap5 cells were never found to co-express the Ng2 antigen. They appear to be a population of glial cells sharing features but also differences with Ng2+progenitor cells. We show that mMap5 cells are newly generated, postmitotic parenchymal elements of the oligodendroglial lineage, thus being a stage-specific population of polydendrocytes. Finally, we report that the number of mMap5 cells, although reduced within the brain of adult/old animals, can increase in neurodegenerative and traumatic conditions.	[Crociara, Paola; Parolisi, Roberta; Conte, Daniele; Bonfanti, Luca] Univ Turin, Neurosci Inst Cavalieri Ottolenghi, Turin, Italy; [Crociara, Paola; Parolisi, Roberta; Conte, Daniele; Bonfanti, Luca] Univ Turin, Dept Vet Sci, Turin, Italy; [Conte, Daniele] Univ Turin, Ctr Mol Biotechnol, Turin, Italy; [Fumagalli, Marta] Univ Milan, Dept Pharmacol Sci, Milan, Italy	University of Turin; University of Turin; University of Turin; University of Milan	Bonfanti, L (corresponding author), Univ Turin, Neurosci Inst Cavalieri Ottolenghi, Turin, Italy.	luca.bonfanti@unito.it	Bonfanti, Luca/AAW-2997-2021; Crociara, Paola/N-4862-2019; Fumagalli, Marta/AEP-4117-2022	Crociara, Paola/0000-0001-7446-1609; Fumagalli, Marta/0000-0002-0158-842X; Parolisi, Roberta/0000-0002-1948-7766	Compagnia di San Paolo [NEUROTRANSPLANT 2008.2192]; Universita di Torino, Regione Piemonte	Compagnia di San Paolo(Compagnia di San Paolo); Universita di Torino, Regione Piemonte	Funding provided by Compagnia di San Paolo (NEUROTRANSPLANT 2008.2192), Universita di Torino, Regione Piemonte. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen E, 2005, NATURE, V438, P224, DOI 10.1038/nature04256; Baumann N, 2001, PHYSIOL REV, V81, P871, DOI 10.1152/physrev.2001.81.2.871; BLACK MM, 1994, J NEUROSCI, V14, P857; BLOOM GS, 1985, P NATL ACAD SCI USA, V82, P5404, DOI 10.1073/pnas.82.16.5404; Boda E, 2011, GLIA, V59, P1958, DOI 10.1002/glia.21237; Bonfanti L, 2007, PROG NEUROBIOL, V83, P24, DOI 10.1016/j.pneurobio.2006.11.002; Bonfanti L, 2011, EUR J NEUROSCI, V34, P930, DOI 10.1111/j.1460-9568.2011.07832.x; Bonfanti L, 2011, THESCIENTIFICWORLDJO, V11, P1270, DOI 10.1100/tsw.2011.113; Bradl M, 2010, ACTA NEUROPATHOL, V119, P37, DOI 10.1007/s00401-009-0601-5; Butt AM, 2005, J ANAT, V207, P695, DOI 10.1111/j.1469-7580.2005.00458.x; CALVERT R, 1985, EMBO J, V4, P1171, DOI 10.1002/j.1460-2075.1985.tb03756.x; Chauhan N, 1997, NEUROCHEM RES, V22, P713, DOI 10.1023/A:1027306227402; Chen Y, 2009, NAT NEUROSCI, V12, P1398, DOI 10.1038/nn.2410; Cheng AW, 1999, DEV BRAIN RES, V113, P107, DOI 10.1016/S0165-3806(99)00006-1; Ciana P, 2006, EMBO J, V25, P4615, DOI 10.1038/sj.emboj.7601341; Coffee RL, 2012, HUM MOL GENET, V21, P900, DOI 10.1093/hmg/ddr527; Dawson MRL, 2003, MOL CELL NEUROSCI, V24, P476, DOI 10.1016/S1044-7431(03)00210-0; Emery B, 2010, SCIENCE, V330, P779, DOI 10.1126/science.1190927; FISCHER I, 1990, J NEUROSCI RES, V27, P112, DOI 10.1002/jnr.490270117; Frohlich N, 2011, J ANAT, V219, P18, DOI 10.1111/j.1469-7580.2011.01392.x; Fumagalli M, 2011, J BIOL CHEM, V286, P10593, DOI 10.1074/jbc.M110.162867; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; Gonzalez-Billault C, 2001, MOL BIOL CELL, V12, P2087, DOI 10.1091/mbc.12.7.2087; GREENE LA, 1983, J CELL BIOL, V96, P76, DOI 10.1083/jcb.96.1.76; HASEGAWA M, 1990, NEURON, V4, P909, DOI 10.1016/0896-6273(90)90144-5; Ihrie RA, 2011, NEURON, V70, P674, DOI 10.1016/j.neuron.2011.05.004; Kawakami SI, 2003, CELL MOL NEUROBIOL, V23, P887, DOI 10.1023/B:CEMN.0000005317.79634.27; Kee N, 2002, J NEUROSCI METH, V115, P97, DOI 10.1016/S0165-0270(02)00007-9; Keirstead HS, 1998, GLIA, V22, P161, DOI 10.1002/(SICI)1098-1136(199802)22:2<161::AID-GLIA7>3.3.CO;2-Z; Kozorovitskiy Y, 2003, J CLIN EXP NEUROPSYC, V25, P721, DOI 10.1076/jcen.25.5.721.14580; Kriegstein A, 2009, ANNU REV NEUROSCI, V32, P149, DOI 10.1146/annurev.neuro.051508.135600; Kukley M, 2010, J NEUROSCI, V30, P8320, DOI 10.1523/JNEUROSCI.0854-10.2010; Lecca D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003579; Ligon KL, 2006, GLIA, V54, P1, DOI 10.1002/glia.20273; Lu R, 2004, P NATL ACAD SCI USA, V101, P15201, DOI 10.1073/pnas.0404995101; Luzzati F, 2006, J NEUROSCI, V26, P609, DOI 10.1523/JNEUROSCI.4371-05.2006; Lytle JM, 2009, GLIA, V57, P270, DOI 10.1002/glia.20755; Ma D, 2000, NEUROSCIENCE, V99, P157, DOI 10.1016/S0306-4522(00)00141-X; Ma D, 1997, J NEUROSCI RES, V49, P319, DOI 10.1002/(SICI)1097-4547(19970801)49:3<319::AID-JNR7>3.0.CO;2-F; Ma DL, 1999, BRAIN RES, V823, P141, DOI 10.1016/S0006-8993(99)01148-8; Majewska B, 2000, INT J DEV NEUROSCI, V18, P113, DOI 10.1016/S0736-5748(99)00070-2; Mansfield SG, 1991, J NEUROCYTOL, V21, P1007; Nishiyama A, 1996, J NEUROSCI RES, V43, P299, DOI 10.1002/(SICI)1097-4547(19960201)43:3<299::AID-JNR5>3.0.CO;2-E; Nishiyama A, 2007, NEUROSCIENTIST, V13, P62, DOI 10.1177/1073858406295586; Nishiyama A, 2009, NAT REV NEUROSCI, V10, P9, DOI 10.1038/nrn2495; Nothias F, 1996, J COMP NEUROL, V368, P317, DOI 10.1002/(SICI)1096-9861(19960506)368:3<317::AID-CNE1>3.0.CO;2-8; Ohyu J, 1997, BRAIN DEV-JPN, V19, P541, DOI 10.1016/S0387-7604(97)00075-2; Oudega M, 1995, J ANAT, V187, P723; Pevny LH, 2010, INT J BIOCHEM CELL B, V42, P421, DOI 10.1016/j.biocel.2009.08.018; Polito A, 2005, J ANAT, V207, P707, DOI 10.1111/j.1469-7580.2005.00454.x; Ponti G, 2006, DEV BIOL, V294, P168, DOI 10.1016/j.ydbio.2006.02.037; Ponti G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002366; Radde R, 2006, EMBO REP, V7, P940, DOI 10.1038/sj.embor.7400784; RamonCueto A, 1997, NEUROSCIENCE, V77, P485, DOI 10.1016/S0306-4522(96)00437-X; Richardson WD, 2011, NEURON, V70, P661, DOI 10.1016/j.neuron.2011.05.013; RIEDERER B, 1986, J NEUROCYTOL, V15, P763, DOI 10.1007/BF01625193; Riederer BM, 2007, BRAIN RES BULL, V71, P541, DOI 10.1016/j.brainresbull.2006.11.012; RIEDERER BM, 1995, J NEUROCYTOL, V24, P45, DOI 10.1007/BF01370159; Robel S, 2011, NAT REV NEUROSCI, V12, P88, DOI 10.1038/nrn2978; Rudrabhatla P, 2011, FASEB J, V25, P3896, DOI 10.1096/fj.11-181297; SCHOENFELD TA, 1989, J NEUROSCI, V9, P1712; Simon C, 2011, GLIA, V59, P869, DOI 10.1002/glia.21156; Soares S, 1998, J COMP NEUROL, V396, P193; Soares S, 2007, EUR J NEUROSCI, V26, P1446, DOI 10.1111/j.1460-9568.2007.05794.x; STALLCUP WB, 1981, DEV BIOL, V83, P154, DOI 10.1016/S0012-1606(81)80018-8; Stolt CC, 2010, INT J BIOCHEM CELL B, V42, P437, DOI 10.1016/j.biocel.2009.07.014; Trotter J, 2010, BRAIN RES REV, V63, P72, DOI 10.1016/j.brainresrev.2009.12.006; TUCKER RP, 1989, NEURON, V2, P1245, DOI 10.1016/0896-6273(89)90309-7; TUCKER RP, 1990, BRAIN RES REV, V15, P101, DOI 10.1016/0165-0173(90)90013-E; Ulfig N, 2000, NEUROSCI RES, V38, P397, DOI 10.1016/S0168-0102(00)00189-9; ULLOA L, 1994, GLIA, V10, P266, DOI 10.1002/glia.440100405; Velez-Fort M, 2009, GLIA, V57, P1104, DOI 10.1002/glia.20834; VIERECK C, 1989, J NEUROSCI, V9, P3547; VOUYIOUKLIS DA, 1993, J NEUROSCI RES, V35, P257, DOI 10.1002/jnr.490350305; Vouyiouklis DA, 1995, J NEUROSCI RES, V42, P803, DOI 10.1002/jnr.490420609; Watanabe M, 2006, J NEUROSCI RES, V84, P525, DOI 10.1002/jnr.20950; Wu HY, 2001, MOL CELL NEUROSCI, V17, P292, DOI 10.1006/mcne.2000.0941; Zhao LX, 2006, MOL BIOL CELL, V17, P4179, DOI 10.1091/mbc.E06-04-0355	78	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e63258	10.1371/journal.pone.0063258	http://dx.doi.org/10.1371/journal.pone.0063258			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667595	Green Submitted, Green Published, gold			2022-12-27	WOS:000319654700125
J	Mughal, N; Coppotelli, G; Callegari, S; Gastaldello, S; Masucci, MG				Mughal, Nouman; Coppotelli, Giuseppe; Callegari, Simone; Gastaldello, Stefano; Masucci, Maria G.			Interaction of Gamma-Herpesvirus Genome Maintenance Proteins with Cellular Chromatin	PLOS ONE			English	Article							EPSTEIN-BARR-VIRUS; SARCOMA-ASSOCIATED HERPESVIRUS; NUCLEAR ANTIGEN 1; KAPOSIS-SARCOMA; DNA-SEQUENCES; PROTEASOMAL DEGRADATION; METAPHASE CHROMOSOMES; GENE-EXPRESSION; ENCODED LANA; VIRAL GENOME	The capacity of gamma-herpesviruses to establish lifelong infections is dependent on the expression of genome maintenance proteins (GMPs) that tether the viral episomes to cellular chromatin and allow their persistence in latently infected proliferating cells. Here we have characterized the chromatin interaction of GMPs encoded by viruses belonging to the genera Lymphocryptovirus (LCV) and Rhadinovirus (RHV). We found that, in addition to a similar diffuse nuclear localization and comparable detergent resistant interaction with chromatin in transfected cells, all GMPs shared the capacity to promote the decondensation of heterochromatin in the A03-1 reporter cell line. They differed, however, in their mobility measured by fluorescence recovery after photobleaching (FRAP), and in the capacity to recruit accessory molecules required for the chromatin remodeling function. While the AT-hook containing GMPs of LCVs were highly mobile, a great variability was observed among GMPs encoded by RHV, ranging from virtually immobile to significantly reduced mobility compared to LCV GMPs. Only the RHV GMPs recruited the bromo- and extra terminal domain (BET) proteins BRD2 and BRD4 to the site of chromatin remodeling. These findings suggest that differences in the mode of interaction with cellular chromatin may underlie different strategies adopted by these viruses for reprogramming of the host cells during latency.	[Mughal, Nouman; Coppotelli, Giuseppe; Callegari, Simone; Gastaldello, Stefano; Masucci, Maria G.] Karolinska Inst, Dept Cell & Mol Biol, Stockholm, Sweden	Karolinska Institutet	Masucci, MG (corresponding author), Karolinska Inst, Dept Cell & Mol Biol, Stockholm, Sweden.	maria.masucci@ki.se	Coppotelli, Giuliano/P-5558-2014; Gastaldello, Stefano/AAM-6768-2020; Gastaldello, Stefano/AAD-3788-2020; Masucci, Maria/AAC-6666-2019	Gastaldello, Stefano/0000-0001-7369-8452; Masucci, Maria/0000-0002-5541-2809	Kasrolisnka Institutet; Swedish research Council; Swedish Cancer Research Foundation	Kasrolisnka Institutet; Swedish research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Research Foundation	Funding provided by Kasrolisnka Institutet, Swedish research Council, Swedish Cancer Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	BAER R, 1984, NATURE, V310, P207, DOI 10.1038/310207a0; Barbera AJ, 2006, SCIENCE, V311, P856, DOI 10.1126/science.1120541; Belkina AC, 2012, NAT REV CANCER, V12, P465, DOI 10.1038/nrc3256; Blake N, 2010, J GEN VIROL, V91, P829, DOI 10.1099/vir.0.018242-0; Burnside KL, 2006, VIROLOGY, V354, P103, DOI 10.1016/j.virol.2006.06.022; Canaan A, 2009, P NATL ACAD SCI USA, V106, P22421, DOI 10.1073/pnas.0911676106; Cesarman E, 2011, CANCER LETT, V305, P163, DOI 10.1016/j.canlet.2011.03.003; Cleynen I, 2008, INT J ONCOL, V32, P289; Coppotelli G, 2013, NUCL ACIDS IN PRESS; Coppotelli G, 2011, J BIOL CHEM, V286, P19565, DOI 10.1074/jbc.M111.224782; Dresang LR, 2009, J VIROL, V83, P2930, DOI 10.1128/JVI.01974-08; FALK K, 1995, J GEN VIROL, V76, P779, DOI 10.1099/0022-1317-76-4-779; Feeney KM, 2009, P ROY SOC B-BIOL SCI, V276, P1535, DOI 10.1098/rspb.2008.1642; Hirai H, 2010, INT J DEV BIOL, V54, P1589, DOI 10.1387/ijdb.103194hh; Jourdan N, 2012, J VIROL, V86, P5314, DOI 10.1128/JVI.06303-11; Katano H, 1999, AM J PATHOL, V155, P47, DOI 10.1016/S0002-9440(10)65097-3; Krithivas A, 2002, J VIROL, V76, P11596, DOI 10.1128/JVI.76.22.11596-11604.2002; Lu F, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-262; Marechal V, 1999, J VIROL, V73, P4385, DOI 10.1128/JVI.73.5.4385-4392.1999; Mcwilliam H, 2009, NUCLEIC ACIDS RES, V37, pW6, DOI 10.1093/nar/gkp302; Moore PS, 1996, J VIROL, V70, P549, DOI 10.1128/JVI.70.1.549-558.1996; Ottinger M, 2006, J VIROL, V80, P10772, DOI 10.1128/JVI.00804-06; Phair RD, 2004, METHOD ENZYMOL, V375, P393; Reeves R, 2010, BBA-GENE REGUL MECH, V1799, P3, DOI 10.1016/j.bbagrm.2009.09.001; Ren J, 2009, CELL RES, V19, P271, DOI 10.1038/cr.2009.6; Robinett CC, 1996, J CELL BIOL, V135, P1685, DOI 10.1083/jcb.135.6.1685; Sears J, 2004, J VIROL, V78, P11487, DOI 10.1128/JVI.78.21.11487-11505.2004; Sharipo A, 2001, FEBS LETT, V499, P137, DOI 10.1016/S0014-5793(01)02542-X; Shinohara H, 2002, J VIROL, V76, P12917, DOI 10.1128/JVI.76.24.12917-12924.2002; Shire K, 1999, J VIROL, V73, P2587, DOI 10.1128/JVI.73.4.2587-2595.1999; Si HX, 2008, J VIROL, V82, P6734, DOI 10.1128/JVI.00342-08; Smeenk G, 2010, J CELL BIOL, V190, P741, DOI 10.1083/jcb.201001048; Sompallae R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012052; Soutoglou E, 2002, SCIENCE, V295, P1901, DOI 10.1126/science.1068356; Stuber G, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-28; Tumbar T, 1999, J CELL BIOL, V145, P1341, DOI 10.1083/jcb.145.7.1341; Verma SC, 2003, J VIROL, V77, P12494, DOI 10.1128/JVI.77.23.12494-12506.2003; Virgin HW, 1997, J VIROL, V71, P5894, DOI 10.1128/JVI.71.8.5894-5904.1997; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Weidner-Glunde M, 2010, FRONT BIOSCI-LANDMRK, V15, P537, DOI 10.2741/3632; Woodard C, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002972; Yates JL, 1996, VIROLOGY, V222, P1, DOI 10.1006/viro.1996.0392; Zaret KS, 2011, GENE DEV, V25, P2227, DOI 10.1101/gad.176826.111	43	3	3	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e62783	10.1371/journal.pone.0062783	http://dx.doi.org/10.1371/journal.pone.0062783			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667520	Green Published, gold, Green Submitted			2022-12-27	WOS:000319654700063
J	Nishioka, M; Imaizumi, A; Ando, T; Tochikubo, O				Nishioka, Manabu; Imaizumi, Akira; Ando, Toshihiko; Tochikubo, Osamu			The Overnight Effect of Dietary Energy Balance on Postprandial Plasma Free Amino Acid (PFAA) Profiles in Japanese Adult Men	PLOS ONE			English	Article							DIURNAL-VARIATIONS; LUNG-CANCER; PROTEIN; METABOLISM; INGESTION; DIAGNOSIS; RESPONSES; REAGENTS; CASEIN; MUSCLE	The plasma free amino acid (PFAA) profile is affected by various nutritional conditions, such as the dietary energy balance. Regarding the clinical use of PFAA profiling, it is of concern that differences in food ingestion patterns may generate systematic errors in a plasma amino acid profile and constitute a confounding factor in assessment. In this study, the overnight impact of the dietary energy balance on the postprandial plasma amino acid profile was investigated to elucidate in particular the effects of high protein meals typical in Japanese cuisine. We conducted diet-controlled, crossover trials in eleven healthy male volunteers aged 40-61 y. They consumed either a normal meal (meal N) or high protein meal (meal H) at dinner. Forearm venous blood was collected, and plasma amino acid concentrations were measured before dinner and the next morning. We found that a high protein meal in the evening that contained 40% energy would significantly increase the PFAA concentration the next morning, even more than 12 hours after the meal. Among amino acids, the most significant difference was observed in the branched-chain amino acids (BCAAs) and in some urea-cycle related compounds. If the subject consumed the high protein diet at dinner, the PFAA profile after overnight fasting might be still affected by the meal even 12 hours after the meal, suggesting that the PFAA profile does not reflect the subject's health condition, but rather the acute effect of high protein ingestion.	[Nishioka, Manabu] Comfort Med Fdn, Liberty Sq Clin, Kawasaki, Kanagawa, Japan; [Imaizumi, Akira] Ajinomoto Co Inc, Inst Innovat, Kawasaki, Kanagawa, Japan; [Ando, Toshihiko] Ajinomoto Co Inc, Dept AminoIndex, Tokyo, Japan; [Tochikubo, Osamu] Kanagawa Hlth Serv Assoc, Yokohama, Kanagawa, Japan	Ajinomoto Co Inc; Ajinomoto Co Inc	Imaizumi, A (corresponding author), Ajinomoto Co Inc, Inst Innovat, Kawasaki, Kanagawa, Japan.	akira_imaizumi@ajinomoto.com		Imaizumi, Akira/0000-0002-8615-1007	Ministry of Education, Culture, Sports, Science and Technology of Japan [17390195]; Ajinomoto, CO., Inc.	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ajinomoto, CO., Inc.	This work has been supported by a Grant-in-Aid for Scientific Research on Basic Research B (No. 17390195) from the Ministry of Education, Culture, Sports, Science and Technology of Japan (http://kaken.nii.ac.jp/d/p/17390195.ja.html). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Ajinomoto, CO., Inc. did have a role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have read the journal's policy and have the following conflicts. Akira Imaizumi and Toshihiko Ando are employees of Ajinomoto, CO., Inc. Osamu Tochikubo received a research grant from Ajinomoto, CO., Inc. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	ASHLEY DV, 1982, AM J CLIN NUTR, V36, P143, DOI 10.1093/ajcn/36.1.143; Boirie Y, 1997, P NATL ACAD SCI USA, V94, P14930, DOI 10.1073/pnas.94.26.14930; Bossola M, 2009, J RENAL NUTR, V19, P2, DOI 10.1053/j.jrn.2008.10.003; Cheng SS, 2012, CIRCULATION, V125, P2222, DOI 10.1161/CIRCULATIONAHA.111.067827; FERNSTROM JD, 1979, AM J CLIN NUTR, V32, P1912, DOI 10.1093/ajcn/32.9.1912; FERNSTROM JD, 1979, AM J CLIN NUTR, V32, P1923, DOI 10.1093/ajcn/32.9.1923; FISCHER JE, 1975, SURGERY, V78, P276; Fischer K, 2002, PHYSIOL BEHAV, V75, P411, DOI 10.1016/S0031-9384(01)00676-X; GARIBOTTO G, 1993, NEPHRON, V64, P216, DOI 10.1159/000187317; HEBER D, 1985, CANCER, V55, P225, DOI 10.1002/1097-0142(19850101)55:1+<225::AID-CNCR2820551304>3.0.CO;2-7; Hisamatsu T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031131; KERN KA, 1988, JPEN-PARENTER ENTER, V12, P286, DOI 10.1177/0148607188012003286; Lacroix M, 2006, AM J CLIN NUTR, V84, P1070, DOI 10.1093/ajcn/84.5.1070; Maeda J, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-690; Magnusson M, 2012, EUR HEART J; MARRS TC, 1975, BRIT J NUTR, V34, P259, DOI 10.1017/S000711457500030X; Miyagi Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024143; MORRISON WL, 1988, EUR J CLIN INVEST, V18, P648, DOI 10.1111/j.1365-2362.1988.tb01282.x; Nakamura M, 1998, P YAMANASHI MED COL, V15, P35; NASSET ES, 1979, J NUTR, V109, P621, DOI 10.1093/jn/109.4.621; Noguchi Y, 2006, AM J CLIN NUTR, V83, p513S; Noguchi Y, 2008, PHYSIOL GENOMICS, V34, P315, DOI 10.1152/physiolgenomics.00007.2008; OKAMOTO N, 2011, NINGEN DOCK, V26, P454; Polge A, 1997, AGE AGEING, V26, P457, DOI 10.1093/ageing/26.6.457; Proenza AM, 2003, J NUTR BIOCHEM, V14, P133, DOI 10.1016/S0955-2863(02)00225-5; Riggio O, 1989, Recenti Prog Med, V80, P591; Shikata N, 2007, AMINO ACIDS, V33, P113, DOI 10.1007/s00726-006-0412-0; Shimbo K, 2010, BIOMED CHROMATOGR, V24, P683, DOI 10.1002/bmc.1346; Shimbo K, 2009, ANAL CHEM, V81, P5172, DOI 10.1021/ac900470w; Shimbo K, 2009, RAPID COMMUN MASS SP, V23, P1483, DOI 10.1002/rcm.4026; TORRES N, 1995, J NUTR, V125, P1884, DOI 10.1093/jn/125.7.1884; Tremblay F, 2007, ANNU REV NUTR, V27, P293, DOI 10.1146/annurev.nutr.25.050304.092545; Tsai PJ, 2000, J FORMOS MED ASSOC, V99, P151; van Loon LJC, 2000, AM J CLIN NUTR, V72, P96; Velazquez A, 2000, ARCH MED RES, V31, P145, DOI 10.1016/S0188-4409(00)00053-9; Vissers YLJ, 2005, AM J CLIN NUTR, V81, P1142; Volpi E, 2001, JAMA-J AM MED ASSOC, V286, P1206, DOI 10.1001/jama.286.10.1206; Wang TJ, 2011, NAT MED, V17, P448, DOI 10.1038/nm.2307; Yamakado M, 2012, CLIN OBES, V2, P29, DOI 10.1111/j.1758-8111.2012.00039.x; Zhang QW, 2006, HEPATOL RES, V34, P170, DOI 10.1016/j.hepres.2005.12.006	40	19	20	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e62929	10.1371/journal.pone.0062929	http://dx.doi.org/10.1371/journal.pone.0062929			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667542	Green Published, gold, Green Submitted			2022-12-27	WOS:000319654700081
J	Wang, Q; Wagner, RT; Cooney, AJ				Wang, Qin; Wagner, Ryan T.; Cooney, Austin J.			Regulatable In Vivo Biotinylation Expression System in Mouse Embryonic Stem Cells	PLOS ONE			English	Article							KRUPPEL-LIKE FACTOR-4; NANOG GENE-EXPRESSION; SELF-RENEWAL; TRANSCRIPTIONAL NETWORK; SIGNALING PATHWAYS; ES CELLS; DIFFERENTIATION; PLURIPOTENCY; KLF4; STATE	Embryonic stem (ES) cells have several unique attributes, the two most important of which are they can differentiate into all cell types in the body and they can proliferate indefinitely. To study the regulation of these phenomena, we developed a regulatable in vivo biotinylation expression system in mouse ES cells. The E. coli biotin ligase gene BirA, whose protein product can biotinylate a 15-aa peptide sequence, called the AviTag, was cloned downstream of an IRES. The primary vector containing the doxycycline controlled transactivator gene tTA and IRES-BirA was knocked into the ROSA26 locus by homologous recombination. The secondary vector containing the AviTag tagged hKlf4 gene was exchanged into the ROSA26 locus using Cre recombinase. Western blot analysis showed that the doxycycline induced BirA protein can biotinylate the doxycycline induced AviTag tagged hKlf4 protein. The induction of hKlf4 repressed cell growth in the presence or absence of LIF. Chromatin immunoprecipitation assays using streptavidin beads showed that the AviTag tagged hKlf4 protein could enrich the Nanog enhancer. Our results suggested that the regulatable biotinylation system is promising for the gene function studies in mouse ES cells.	[Wang, Qin; Wagner, Ryan T.; Cooney, Austin J.] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA	Baylor College of Medicine	Cooney, AJ (corresponding author), Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA.	acooney@bcm.edu			National Institute of General Medical Sciences [P01GM081627]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM081627] Funding Source: NIH RePORTER	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by a grant to A.J.C. from the National Institute of General Medical Sciences (P01GM081627). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bourillot PY, 2009, STEM CELLS, V27, P1760, DOI 10.1002/stem.110; Bruce SJ, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-365; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; de Boer E, 2003, P NATL ACAD SCI USA, V100, P7480, DOI 10.1073/pnas.1332608100; Feng B, 2009, NAT CELL BIOL, V11, P197, DOI 10.1038/ncb1827; Ghaleb AM, 2005, CELL RES, V15, P92, DOI 10.1038/sj.cr.7290271; Gu PL, 2005, MOL CELL BIOL, V25, P8507, DOI 10.1128/MCB.25.19.8507-8519.2005; Gu PL, 2005, MOL CELL BIOL, V25, P3492, DOI 10.1128/MCB.25.9.3492-3505.2005; Guo G, 2009, DEVELOPMENT, V136, P1063, DOI 10.1242/dev.030957; Hall J, 2009, CELL STEM CELL, V5, P597, DOI 10.1016/j.stem.2009.11.003; Hanna J, 2010, P NATL ACAD SCI USA, V107, P9222, DOI 10.1073/pnas.1004584107; Jiang JM, 2008, NAT CELL BIOL, V10, P353, DOI 10.1038/ncb1698; Kim JW, 2008, CELL, V132, P1049, DOI 10.1016/j.cell.2008.02.039; Kopp JL, 2008, STEM CELLS, V26, P903, DOI 10.1634/stemcells.2007-0951; Li Y, 2005, BLOOD, V105, P635, DOI 10.1182/blood-2004-07-2681; Lu R, 2011, J BIOL CHEM, V286, P8425, DOI 10.1074/jbc.M110.202150; Masui S, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni043; McConnell BB, 2007, BIOESSAYS, V29, P549, DOI 10.1002/bies.20581; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Niwa H, 2007, DEVELOPMENT, V134, P635, DOI 10.1242/dev.02787; Niwa H, 2009, NATURE, V460, P118, DOI 10.1038/nature08113; NUSSLEINVOLHARD C, 1980, NATURE, V287, P795, DOI 10.1038/287795a0; Parisi S, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-128; Rowland BD, 2005, NAT CELL BIOL, V7, P1074, DOI 10.1038/ncb1314; Schulz H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006804; Segre JA, 1999, NAT GENET, V22, P356, DOI 10.1038/11926; Shields JM, 1996, J BIOL CHEM, V271, P20009, DOI 10.1074/jbc.271.33.20009; SMITH AG, 1988, NATURE, V336, P688, DOI 10.1038/336688a0; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; van den Berg DLC, 2008, MOL CELL BIOL, V28, P5986, DOI 10.1128/MCB.00301-08; Wagner RT, 2010, STEM CELLS, V28, P1794, DOI 10.1002/stem.502; Whitney EM, 2006, GENE EXPRESSION, V13, P85, DOI 10.3727/000000006783991908; Young RA, 2011, CELL, V144, P940, DOI 10.1016/j.cell.2011.01.032; Zhang PL, 2010, J BIOL CHEM, V285, P9180, DOI 10.1074/jbc.M109.077958	34	4	4	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e63532	10.1371/journal.pone.0063532	http://dx.doi.org/10.1371/journal.pone.0063532			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667633	Green Published, gold, Green Submitted			2022-12-27	WOS:000319654700157
J	Wang, YN; Gao, D; Chen, Z; Li, SF; Gao, CM; Cao, DL; Liu, F; Liu, HX; Jiang, Y				Wang, Yini; Gao, Dan; Chen, Zhe; Li, Shangfu; Gao, Chunmei; Cao, Deliang; Liu, Feng; Liu, Hongxia; Jiang, Yuyang			Acridone Derivative 8a Induces Oxidative Stress-Mediated Apoptosis in CCRF-CEM Leukemia Cells: Application of Metabolomics in Mechanistic Studies of Antitumor Agents	PLOS ONE			English	Article							CANCER-CELLS; REVEALS; LINES; METABONOMICS; METABOLISM; ALKALOIDS; RESPONSES; TOXICITY; LIGANDS; ACID	A new acridone derivative, 2-aminoacetamido-10-(3, 5-dimethoxy)-benzyl-9(10H)-acridone hydrochloride (named 8a) synthesized in our lab shows potent antitumor activity, but the mechanism of action remains unclear. Herein, we report the use of an UPLC/Q-TOF MS metabolomic approach to study the effects of three compounds with structures optimized step-by-step, 9(10H)-acridone (A), 10-(3,5-dimethoxy)benzyl-9(10H)-acridone (I), and 8a, on CCRF-CEM leukemia cells and to shed new light on the probable antitumor mechanism of 8a. Acquired data were processed by principal component analysis (PCA) and orthogonal partial least squares discriminant analysis (OPLS-DA) to identify potential biomarkers. Comparing 8a-treated CCRF-CEM leukemia cells with vehicle control (DMSO), 23 distinct metabolites involved in five metabolic pathways were identified. Metabolites from glutathione (GSH) and glycerophospholipid metabolism were investigated in detail, and results showed that GSH level and the reduced/oxidized glutathione (GSH/GSSG) ratio were significantly decreased in 8a-treated cells, while L-cysteinyl-glycine (L-Cys-Gly) and glutamate were greatly increased. In glycerophospholipid metabolism, cell membrane components phosphatidylcholines (PCs) were decreased in 8a-treated cells, while the oxidative products lysophosphatidylcholines (LPCs) were significantly increased. We further found that in 8a-treated cells, the reactive oxygen species (ROS) and lipid peroxidation product malondialdehyde (MDA) were notably increased, accompanied with decrease of mitochondrial transmembrane potential, release of cytochrome C and activation of caspase-3. Taken together our results suggest that the acridone derivative 8a induces oxidative stress-mediated apoptosis in CCRF-CEM leukemia cells. The UPLC/Q-TOF MS based metabolomic approach provides novel insights into the mechanistic studies of antitumor drugs from a point distinct from traditional biological investigations.	[Wang, Yini] Tsinghua Univ, Dept Chem, Beijing 100084, Peoples R China; [Wang, Yini; Gao, Dan; Liu, Hongxia] Key Lab Tumor Metabol Shenzhen, Shenzhen, Peoples R China; [Gao, Dan; Chen, Zhe; Li, Shangfu; Gao, Chunmei; Cao, Deliang; Liu, Feng; Liu, Hongxia; Jiang, Yuyang] Tsinghua Univ, Grad Sch Shenzhen, State Key Lab Breeding Base Shenzhen Key Lab Chem, Shenzhen 518057, Peoples R China; [Jiang, Yuyang] Tsinghua Univ, Sch Med, Beijing 100084, Peoples R China	Tsinghua University; Tsinghua University; University Town of Shenzhen; Tsinghua Shenzhen International Graduate School; Tsinghua University	Liu, HX (corresponding author), Key Lab Tumor Metabol Shenzhen, Shenzhen, Peoples R China.	liuhx@sz.tsinghua.edu.cn; jiangyy@sz.tsinghua.edu.cn			Chinese National Natural Science Foundation of China [21172129, 20902053]; China Postdoctoral Science Foundation [2012M510407]; China Ministry of Science and Technology [2012ZX09506001-010]; International S&T Cooperation Program of China [2011DFA30620]	Chinese National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); China Ministry of Science and Technology(Ministry of Science and Technology, China); International S&T Cooperation Program of China	The research work was supported in part by the Chinese National Natural Science Foundation of China (Nos. 21172129), a finance supported by Chinese National Natural Science Foundation of China (20902053), China Postdoctoral Science Foundation (number 2012M510407), China Ministry of Science and Technology under Contract (number 2012ZX09506001-010), and International S&T Cooperation Program of China (number 2011DFA30620). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baguley BC, 2003, CURR MED CHEM, V10, P2643, DOI 10.2174/0929867033456332; Blaise BJ, 2007, P NATL ACAD SCI USA, V104, P19808, DOI 10.1073/pnas.0707393104; Bundy JG, 2006, CANCER RES, V66, P7606, DOI 10.1158/0008-5472.CAN-05-2999; Bylesjo M, 2006, J CHEMOMETR, V20, P341, DOI 10.1002/cem.1006; Cai S, 2009, BIOMED CHROMATOGR, V23, P782, DOI 10.1002/bmc.1185; Catala A, 2009, CHEM PHYS LIPIDS, V157, P1, DOI 10.1016/j.chemphyslip.2008.09.004; Cholewinski G, 2011, PHARMACOL REP, V63, P305, DOI 10.1016/S1734-1140(11)70499-6; Chukaew A, 2008, PHYTOCHEMISTRY, V69, P2616, DOI 10.1016/j.phytochem.2008.08.007; Cuenca F, 2009, BIOORG MED CHEM LETT, V19, P5109, DOI 10.1016/j.bmcl.2009.07.033; Dietmair S, 2010, ANAL BIOCHEM, V404, P155, DOI 10.1016/j.ab.2010.04.031; Dunn WB, 2007, METABOLOMICS, V3, P413, DOI 10.1007/s11306-007-0063-5; Fernandez-Calienes A, 2011, BIOMED PHARMACOTHER, V65, P210, DOI 10.1016/j.biopha.2011.04.001; Gao CM, 2008, BIOORGAN MED CHEM, V16, P8670, DOI 10.1016/j.bmc.2008.07.086; Gao CM, 2012, TETRAHEDRON, V68, P7920, DOI 10.1016/j.tet.2012.07.016; Gao CM, 2010, BIOORGAN MED CHEM, V18, P7507, DOI 10.1016/j.bmc.2010.08.058; Giustarini D, 2003, FREE RADICAL BIO MED, V35, P1365, DOI 10.1016/j.freeradbiomed.2003.08.013; Griffin Julian L, 2004, Drug Discov Today Technol, V1, P285, DOI 10.1016/j.ddtec.2004.10.011; Indran IR, 2011, CANCER RES, V71, P266, DOI 10.1158/0008-5472.CAN-10-1588; Jain M, 2012, SCIENCE, V336, P1040, DOI 10.1126/science.1218595; Jin S, 2010, ANN ONCOL, V21, P263, DOI 10.1093/annonc/mdp499; Koba M, 2011, MED CHEM RES, V20, P1385, DOI 10.1007/s00044-010-9487-y; Kuiper HA, 2003, CURR OPIN BIOTECH, V14, P238, DOI 10.1016/S0958-1669(03)00021-1; Li SF, 2011, J CHROMATOGR B, V879, P2369, DOI 10.1016/j.jchromb.2011.06.018; Lin SH, 2010, TALANTA, V83, P262, DOI 10.1016/j.talanta.2010.09.019; Lin SH, 2010, RAPID COMMUN MASS SP, V24, P1312, DOI 10.1002/rcm.4516; Michael JP, 2005, NAT PROD REP, V22, P627, DOI 10.1039/b413750g; Minotti G, 2004, PHARMACOL REV, V56, P185, DOI 10.1124/pr.56.2.6; Moolenaar SH, 2003, ANN CLIN BIOCHEM, V40, P16, DOI 10.1258/000456303321016132; Nicholson JK, 1999, XENOBIOTICA, V29, P1181, DOI 10.1080/004982599238047; Nicholson JK, 2002, NAT REV DRUG DISCOV, V1, P153, DOI 10.1038/nrd728; Prasad VVSR, 2011, EUR J PHARM SCI, V43, P217, DOI 10.1016/j.ejps.2011.04.010; Raj L, 2011, NATURE, V475, P231, DOI 10.1038/nature10167; Raza A, 2012, INVEST NEW DRUG, V30, P1443, DOI 10.1007/s10637-011-9720-7; Roseghini R, 2009, PLANTA MED, V75, P488, DOI 10.1055/s-0029-1185316; Salimon J, 2010, ARAB J CHEM, V3, P205, DOI 10.1016/j.arabjc.2010.06.001; SCHOLZ RW, 1989, ANN NY ACAD SCI, V570, P514; Sellick CA, 2010, METABOLOMICS, V6, P427, DOI 10.1007/s11306-010-0216-9; Spencer SL, 2011, CELL, V144, P926, DOI 10.1016/j.cell.2011.03.002; Stankiewicz-Drogon A, 2010, J MED CHEM, V53, P3117, DOI 10.1021/jm901741p; Su TL, 2005, PLANTA MED, V71, P28, DOI 10.1055/s-2005-837747; Tiziani S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004251; Valdes Ayme Fernandez-Calienes, 2011, Open Med Chem J, V5, P11, DOI 10.2174/1874104501105010011; Wang C, 2009, J BIOL CHEM, V284, P26742, DOI 10.1074/jbc.M109.022897; Wang MX, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015441; Want EJ, 2010, NAT PROTOC, V5, P1005, DOI 10.1038/nprot.2010.50; Wishart DS, 2008, TRENDS FOOD SCI TECH, V19, P482, DOI 10.1016/j.tifs.2008.03.003; Wright MM, 2004, BIOCHEM CELL BIOL, V82, P18, DOI 10.1139/o03-092; Yan C, 2011, EXP TOXICOL PATHOL, V63, P413, DOI 10.1016/j.etp.2010.02.018; Yan RL, 2007, INT J CANCER, V121, P2301, DOI 10.1002/ijc.22933	49	10	11	1	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e63572	10.1371/journal.pone.0063572	http://dx.doi.org/10.1371/journal.pone.0063572			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667640	Green Published, Green Submitted, gold			2022-12-27	WOS:000319654700163
J	Wen, MS; Wang, CY; Lin, SL; Hung, KC				Wen, Ming-Shien; Wang, Chao-Yung; Lin, Shuei-Liong; Hung, Kuo-Chun			Decrease in Irisin in Patients with Chronic Kidney Disease	PLOS ONE			English	Article							RESTING ENERGY-EXPENDITURE; CHRONIC-RENAL-FAILURE; HDL-CHOLESTEROL; ENDURANCE EXERCISE; INSULIN-RESISTANCE; RISK-FACTORS; METABOLISM	Patients with chronic kidney disease have abnormal energy expenditure and metabolism. The mechanisms underlying altered energy expenditure in uremia are unknown and remain to be elucidated. Irisin is a peroxisome proliferator-activated receptor gamma coactivator 1-alpha-dependent myokine, and it increases energy expenditure in the absence of changes in food intake or activity. We hypothesize that chronic kidney disease patients have altered irisin levels. We measured resting irisin levels in 38 patients with stage 5 chronic kidney disease and in 19 age-and sex-matched normal subjects. Plasma irisin levels were significantly decreased in chronic kidney disease patients (58.59%; 95% CI 47.9%-69.2%, p<0.0001). The decrease in irisin levels was inversely correlated with the levels of blood urea nitrogen and creatinine. Further association analysis revealed that irisin level is independently associated with high-density lipoprotein cholesterol level. Our results suggest that chronic kidney disease patients have lower than normal irisin levels at rest. Furthermore, irisin may play a major role in affecting high-density lipoprotein cholesterol levels and abnormal energy expenditure in chronic kidney disease patients.	[Wen, Ming-Shien; Wang, Chao-Yung; Hung, Kuo-Chun] Chang Gung Mem Hosp, Dept Cardiol, Tao Yuan, Taiwan; [Wen, Ming-Shien; Wang, Chao-Yung; Hung, Kuo-Chun] Chang Gung Univ, Coll Med, Tao Yuan, Taiwan; [Lin, Shuei-Liong] Natl Taiwan Univ Hosp, Div Renal, Dept Med, Taipei, Taiwan; [Lin, Shuei-Liong] Natl Taiwan Univ, Coll Med, Grad Inst Physiol, Taipei 10764, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; National Taiwan University; National Taiwan University Hospital; National Taiwan University	Wen, MS (corresponding author), Chang Gung Mem Hosp, Dept Cardiol, Tao Yuan, Taiwan.	ocean.laboratory@me.com	Lin, Shuei-Liong/AGR-2002-2022; Wang, Chao-Yung/ABA-6757-2021	Lin, Shuei-Liong/0000-0002-1041-5571; Wang, Chao-Yung/0000-0003-1546-7298	National Health Research Institute [NHRI-EX100-9925SC]; National Science Council [101-2314-B-182A-009, 101-2314-B-182A- 098-MY3, 101-2321-B-002-060]; Chang Gung Memorial Hospital [CMRPG3B1641, CMRPG 371953, CMRPG3A1072]; Mrs. Hsiu-Chin Lee Kidney Research Foundation; National Research Program for Biopharmaceuticals [PMRPG3B0091]	National Health Research Institute(National Health Research Institutes - Taiwan); National Science Council(Ministry of Science and Technology, Taiwan); Chang Gung Memorial Hospital(Chang Gung Memorial Hospital); Mrs. Hsiu-Chin Lee Kidney Research Foundation; National Research Program for Biopharmaceuticals	CYW received support from National Health Research Institute (NHRI-EX100-9925SC), National Science Council (101-2314-B-182A-009, 101-2314-B-182A- 098-MY3), and Chang Gung Memorial Hospital (CMRPG3B1641). KCH received support from Chang Gung Memorial Hospital (CMRPG 371953). LSL received support from the National Science Council (101-2321-B-002-060) and Mrs. Hsiu-Chin Lee Kidney Research Foundation. MSW received support from National Research Program for Biopharmaceuticals (PMRPG3B0091) and Chang Gung Memorial Hospital (CMRPG3A1072). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avesani CM, 2011, J RENAL NUTR, V21, P27, DOI 10.1053/j.jrn.2010.10.013; Avesani CM, 2004, NEPHROL DIAL TRANSPL, V19, P3091, DOI 10.1093/ndt/gfh547; Badimon L, 2012, ANN NY ACAD SCI, V1254, P18, DOI 10.1111/j.1749-6632.2012.06480.x; Barreto FC, 2009, CLIN J AM SOC NEPHRO, V4, P1551, DOI 10.2215/CJN.03980609; Bostrom P, 2012, NATURE, V481, P463, DOI 10.1038/nature10777; Brenner Ingrid, 2008, CANNT J, V18, P36; Chen J, 2003, J AM SOC NEPHROL, V14, P469, DOI 10.1097/01.ASN.0000046029.53933.09; Chyu KY, 2011, CURR ATHEROSCLER REP, V13, P405, DOI 10.1007/s11883-011-0189-9; Couillard C, 2001, ARTERIOSCL THROM VAS, V21, P1226, DOI 10.1161/hq0701.092137; Degoma EM, 2011, NAT REV CARDIOL, V8, P266, DOI 10.1038/nrcardio.2010.200; DURSTINE JL, 1983, METABOLISM, V32, P993, DOI 10.1016/0026-0495(83)90141-5; Holzer M, 2011, J AM SOC NEPHROL, V22, P1631, DOI 10.1681/ASN.2010111144; Huh JY, 2012, METAB CLIN EXP, DOI [10.1016/j.metabol.2012.09.002, DOI 10.1016/J.METAB0L.2012.09.002]; Kamimura MA, 2007, EUR J CLIN NUTR, V61, P362, DOI 10.1038/sj.ejcn.1602516; Kamimura MA, 2011, NEPHROL DIAL TRANSPL, V26, P544, DOI 10.1093/ndt/gfq452; Kelly DP, 2012, SCIENCE, V336, P42, DOI 10.1126/science.1221688; Kobayashi S, 2005, AM J KIDNEY DIS, V45, P275, DOI 10.1053/j.ajkd.2004.09.034; Kuhlmann U, 2001, J RENAL NUTR, V11, P202, DOI 10.1053/jren.2001.26981; Lekawanvijit S, 2012, CIRC RES, V111, P1470, DOI 10.1161/CIRCRESAHA.112.278457; Lekawanvijit S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041281; Levey AS, 2012, LANCET, V379, P165, DOI 10.1016/S0140-6736(11)60178-5; Matsuki N, 1999, FREE RADICAL RES, V31, P1, DOI 10.1080/10715769900300551; Panesar A, 2003, CLIN NEPHROL, V59, P360; Sacks FM, 2000, CIRCULATION, V102, P1893, DOI 10.1161/01.CIR.102.16.1893; SCHNEEWEISS B, 1990, AM J CLIN NUTR, V52, P596, DOI 10.1093/ajcn/52.4.596; Stengel B, 2010, J NEPHROL, V23, P253; Thompson PD, 2001, ARTERIOSCL THROM VAS, V21, P1097, DOI 10.1161/hq0701.092147; Verma A, 2007, J AM COLL CARDIOL, V50, P1238, DOI 10.1016/j.jacc.2007.06.018; Villarroya F, 2012, CELL METAB, V15, P277, DOI 10.1016/j.cmet.2012.02.010; Wang AYM, 2011, J RENAL NUTR, V21, P31, DOI 10.1053/j.jrn.2010.10.018; ZURLO F, 1990, J CLIN INVEST, V86, P1423, DOI 10.1172/JCI114857	31	135	143	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e64025	10.1371/journal.pone.0064025	http://dx.doi.org/10.1371/journal.pone.0064025			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667695	gold, Green Submitted, Green Published			2022-12-27	WOS:000319654700199
J	Macchia, A; Romero, M; D'Ettorre, A; Tognoni, G; Mariani, J				Macchia, Alejandro; Romero, Marilena; D'Ettorre, Antonio; Tognoni, Gianni; Mariani, Javier			Exploratory Analysis on the Use of Statins with or without n-3 PUFA and Major Events in Patients Discharged for Acute Myocardial Infarction: An Observational Retrospective Study	PLOS ONE			English	Article							POLYUNSATURATED FATTY-ACIDS; CHRONIC HEART-FAILURE; DOUBLE-BLIND; EICOSAPENTAENOIC ACID; FISH-OIL; OMEGA-3-FATTY-ACIDS; PREVENTION; MORTALITY; EFFICACY; HEALTH	Background: Combined treatment (CT) with statins and polyunsaturated fatty acids (n-3 PUFA) resulted in a reduction of death and major cardiovascular events when administered after a myocardial infarction (MI). However, recent data suggests that CT may be ineffective because patients are currently treated aggressively and the risk may not be further decreased. We aimed to study the prevalence and the results on major outcomes with CT among patients discharged with a MI in Italy. Methodology/Principal findings: Retrospective cohort study that used linked hospital discharge, prescription databases and vital statistics containing information on 14,704 patients who were discharged for MI between 1/2003 and 12/2003 in 117 hospitals in Italy. All analyses were time-dependent and adjusted for major confounders. Sensibility and paired matched analysis were conducted to further verify main results. A total of 11,532 (78.4%) filled a prescription for a statin. Of these, 4302 (37.3%) were on CT. There were 45,528 patients/years of follow-up. As compared with statins alone, CT was associated with an adjusted higher survival rate (HR = 0.59 [0.52-0.66], p < 0.001), survival free of atrial fibrillation (HR = 0.78 [0.71-0.86], p < 0.001) and survival free of new heart failure development (HR = 0.81 [0.74-0.88], p < 0.001), but not with re-infarction (HR = 0.94 [0.86-1.02], p < 0.127). Clinically this means that between 2 to 3 fewer events for each 100 patients/year were obtained in the group under CT. Conclusions/Significance: Among a representative sample of patients discharged with MI in Italy, we observed clinically significant synergism between the effects of statins and n-3 PUFA for most cardiovascular outcomes, including all cause mortality.	[Macchia, Alejandro; Romero, Marilena; D'Ettorre, Antonio; Tognoni, Gianni] Consorzio Mario Negri Sud, Lab Pharmacoepidemiol, Chieti, Italy; [Macchia, Alejandro; Mariani, Javier] GESICA Grp Estudio Invest Clin Argentina Fdn, Buenos Aires, DF, Argentina	Consorzio Mario Negri Sud	Mariani, J (corresponding author), GESICA Grp Estudio Invest Clin Argentina Fdn, Buenos Aires, DF, Argentina.	ja_mariani@hotmail.com	Mariani, Javier/P-9144-2018; Macchia, Alejandro/AAV-9665-2020; D'Ettorre, Antonio/ABG-2375-2020	Macchia, Alejandro/0000-0002-5424-5009; D'Ettorre, Antonio/0000-0002-5880-4234				Austin PC, 2005, STAT MED, V24, P1563, DOI 10.1002/sim.2053; Ayanian JZ, 1999, EUR HEART J, V20, P1689, DOI 10.1053/euhj.1999.1823; Biondi-Zoccai G, 2011, CONTEMP CLIN TRIALS, V32, P731, DOI 10.1016/j.cct.2011.05.006; Bosch J, 2012, NEW ENGL J MED, V367, P309, DOI 10.1056/NEJMoa1203859; BYAR DP, 1991, STAT MED, V10, P663, DOI 10.1002/sim.4780100417; Collett D, 1994, MODELLING SURVIVAL D; COX DR, 1972, J R STAT SOC B, V34, P187; Davidson MH, 2007, CLIN THER, V29, P1354, DOI 10.1016/j.clinthera.2007.07.018; Duda MK, 2009, CARDIOVASC RES, V81, P319, DOI 10.1093/cvr/cvn310; Galan P, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c6273; Harris WS, 2009, J NUTR, V139, p804S, DOI 10.3945/jn.108.101329; Kalbfleisch R.L, 2011, STAT ANAL FAILURE TI; Kromhout D, 2011, DIABETES CARE, V34, P2515, DOI 10.2337/dc11-0896; Kromhout D, 2010, NEW ENGL J MED, V363, P2015, DOI 10.1056/NEJMoa1003603; Kwak SM, 2012, ARCH INTERN MED, V172, P686, DOI 10.1001/archinternmed.2012.262; Leaf A, 2005, CIRCULATION, V112, P2762, DOI 10.1161/CIRCULATIONAHA.105.549527; Leon H, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a2931; Maki KC, 2008, AM J CARDIOL, V102, P429, DOI 10.1016/j.amjcard.2008.03.078; Marchioli R, 2002, CIRCULATION, V105, P1897, DOI 10.1161/01.CIR.0000014682.14181.F2; Monte S, 2006, EUR HEART J, V27, P2217, DOI 10.1093/eurheartj/ehl208; Mozaffarian D, 2006, JAMA-J AM MED ASSOC, V296, P1885, DOI 10.1001/jama.296.15.1885; Rauch B, 2010, CIRCULATION, V122, P2152, DOI 10.1161/CIRCULATIONAHA.110.948562; Tavazzi L, 2008, LANCET, V372, P1223, DOI 10.1016/S0140-6736(08)61239-8; Teng LL, 2010, J INT MED RES, V38, P940, DOI 10.1177/147323001003800320; Therneau T.M., 2000, MODELING SURVIVAL DA; Valagussa F, 1999, LANCET, V354, P447, DOI 10.1016/S0140-6736(99)07072-5; WHO Collaborating Centre for Drug Statistics Methodology, 2003, ATC IND DDDS; Yamagishi K, 2008, J AM COLL CARDIOL, V52, P988, DOI 10.1016/j.jacc.2008.06.018; Yokoyama M, 2007, LANCET, V369, P1090, DOI 10.1016/S0140-6736(07)60527-3	29	14	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2013	8	5							e62772	10.1371/journal.pone.0062772	http://dx.doi.org/10.1371/journal.pone.0062772			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	177QL	23671633	gold, Green Published, Green Submitted			2022-12-27	WOS:000321390200037
J	Yamasaki, K; Kawanami, T; Yatera, K; Fukuda, K; Noguchi, S; Nagata, S; Nishida, C; Kido, T; Ishimoto, H; Taniguchi, H; Mukae, H				Yamasaki, Kei; Kawanami, Toshinori; Yatera, Kazuhiro; Fukuda, Kazumasa; Noguchi, Shingo; Nagata, Shuya; Nishida, Chinatsu; Kido, Takashi; Ishimoto, Hiroshi; Taniguchi, Hatsumi; Mukae, Hiroshi			Significance of Anaerobes and Oral Bacteria in Community-Acquired Pneumonia	PLOS ONE			English	Article							FIBEROPTIC BRONCHOSCOPY; BRONCHOALVEOLAR LAVAGE; PULMONARY INFECTIONS; SEQUENCE-ANALYSIS; ETIOLOGY; ADULTS; MICROBIOME; GUIDELINES; MANAGEMENT; DIAGNOSIS	Background: Molecular biological modalities with better detection rates have been applied to identify the bacteria causing infectious diseases. Approximately 10-48% of bacterial pathogens causing community-acquired pneumonia are not identified using conventional cultivation methods. This study evaluated the bacteriological causes of community-acquired pneumonia using a cultivation-independent clone library analysis of the 16S ribosomal RNA gene of bronchoalveolar lavage specimens, and compared the results with those of conventional cultivation methods. Methods: Patients with community-acquired pneumonia were enrolled based on their clinical and radiological findings. Bronchoalveolar lavage specimens were collected from pulmonary pathological lesions using bronchoscopy and evaluated by both a culture-independent molecular method and conventional cultivation methods. For the culture-independent molecular method, approximately 600 base pairs of 16S ribosomal RNA genes were amplified using polymerase chain reaction with universal primers, followed by the construction of clone libraries. The nucleotide sequences of 96 clones randomly chosen for each specimen were determined, and bacterial homology was searched. Conventional cultivation methods, including anaerobic cultures, were also performed using the same specimens. Results: In addition to known common pathogens of community-acquired pneumonia [Streptococcus pneumoniae (18.8%), Haemophilus influenzae (18.8%), Mycoplasma pneumoniae (17.2%)], molecular analysis of specimens from 64 patients with community-acquired pneumonia showed relatively higher rates of anaerobes (15.6%) and oral bacteria (15.6%) than previous reports. Conclusion: Our findings suggest that anaerobes and oral bacteria are more frequently detected in patients with community-acquired pneumonia than previously believed. It is possible that these bacteria may play more important roles in community-acquired pneumonia.	[Yamasaki, Kei; Kawanami, Toshinori; Yatera, Kazuhiro; Noguchi, Shingo; Nagata, Shuya; Nishida, Chinatsu; Kido, Takashi; Ishimoto, Hiroshi; Mukae, Hiroshi] Univ Occupat & Environm Hlth, Dept Resp Med, Kitakyushu, Fukuoka 807, Japan; [Fukuda, Kazumasa; Taniguchi, Hatsumi] Univ Occupat & Environm Hlth, Dept Microbiol, Kitakyushu, Fukuoka 807, Japan	University of Occupational & Environmental Health - Japan; University of Occupational & Environmental Health - Japan	Mukae, H (corresponding author), Univ Occupat & Environm Hlth, Dept Resp Med, Kitakyushu, Fukuoka 807, Japan.	hmukae@med.uoeh-u.ac.jp	千夏, 西田/GRJ-3050-2022	Ishimoto, Hiroshi/0000-0002-4374-2894	University of Occupational and Environmental Health, Japan; Ministry of Education, Science, Sports and Culture [23591173]	University of Occupational and Environmental Health, Japan(University of Occupational & Environmental Health - Japan); Ministry of Education, Science, Sports and Culture(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was partially supported by a High Altitude Research Grant from the University of Occupational and Environmental Health, Japan, and was partially supported by a Ministry of Education, Science, Sports and Culture Grant-in-Aid for Scientific Research (C), 23591173, 2011. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2005, AM J RESP CRIT CARE, V171, P388, DOI 10.1164/rccm.200405-644ST; Bousbia S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032486; Charlson ES, 2011, AM J RESP CRIT CARE, V184, P957, DOI 10.1164/rccm.201104-0655OC; Cilloniz C, 2011, THORAX, V66, P340, DOI 10.1136/thx.2010.143982; Drancourt M, 2000, J CLIN MICROBIOL, V38, P3623, DOI 10.1128/JCM.38.10.3623-3630.2000; Erb-Downward JR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016384; Fine MJ, 1997, NEW ENGL J MED, V336, P243, DOI 10.1056/NEJM199701233360402; Friend JAR, 2001, THORAX, V56, P1, DOI 10.1136/thorax.56.1.1; Han MK, 2012, THORAX, V67, P456, DOI 10.1136/thoraxjnl-2011-201183; Harris JK, 2007, P NATL ACAD SCI USA, V104, P20529, DOI 10.1073/pnas.0709804104; Ishida Tadashi, 2004, Journal of Infection and Chemotherapy, V10, P359, DOI 10.1007/s10156-004-0351-1; JIMENEZ P, 1993, CHEST, V103, P1023, DOI 10.1378/chest.103.4.1023; Johansson N, 2010, CLIN INFECT DIS, V50, P202, DOI 10.1086/648678; Kawanami T, 2011, TOHOKU J EXP MED, V225, P65, DOI 10.1620/tjem.225.65; Kawanami T, 2011, CHEST, V139, P600, DOI 10.1378/chest.10-0460; Kawanami T, 2009, J CLIN MICROBIOL, V47, P496, DOI 10.1128/JCM.01429-08; Lambotte O, 2002, CHEST, V122, P1389, DOI 10.1378/chest.122.4.1389; Lane D.J., 1991, NUCL ACID TECH BACT, P115, DOI DOI 10.1007/S00227-012-2133-0; Lim WS, 2001, THORAX, V56, P296, DOI 10.1136/thorax.56.4.296; Mandell LA, 2007, CLIN INFECT DIS, V44, pS27, DOI 10.1086/511159; MARRIE TJ, 1993, CLIN INVEST MED, V16, P38; Marston BJ, 1997, ARCH INTERN MED, V157, P1709, DOI 10.1001/archinte.157.15.1709; Ministry of Health Labour and Welfare of Japan, SUMM VIT STAT TRENDS; Miyashita N, 2005, J MED MICROBIOL, V54, P395, DOI 10.1099/jmm.0.45920-0; National Center for Health Statistics, HLTH US 2011 CHARTB; Park DR, 2001, J INFECT DIS, V184, P268, DOI 10.1086/322040; Ruiz M, 1999, AM J RESP CRIT CARE, V160, P397, DOI 10.1164/ajrccm.160.2.9808045; Saito Atsushi, 2006, Journal of Infection and Chemotherapy, V12, P63, DOI 10.1007/s10156-005-0425-8; Shinzato T, 1995, CLIN INFECT DIS, V21, pS238, DOI 10.1093/clind/21.Supplement_3.S238; Sze MA, 2012, AM J RESP CRIT CARE, V185, P1073, DOI 10.1164/rccm.201111-2075OC; WIMBERLEY N, 1979, AM REV RESPIR DIS, V119, P337; WIMBERLEY NW, 1982, CHEST, V81, P556, DOI 10.1378/chest.81.5.556	32	80	84	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2013	8	5							e63103	10.1371/journal.pone.0063103	http://dx.doi.org/10.1371/journal.pone.0063103			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	177QL	23671659	Green Published, Green Submitted, gold			2022-12-27	WOS:000321390200043
J	Lu, JY; Chen, MY; Ren, XR; Wang, JB; Lyerly, HK; Barak, L; Chen, W				Lu, Jiuyi; Chen, Minyong; Ren, Xiu-Rong; Wang, Jiangbo; Lyerly, H. Kim; Barak, Larry; Chen, Wei			Regulation of Hedgehog Signaling by Myc-Interacting Zinc Finger Protein 1, Miz1	PLOS ONE			English	Article							PRIMARY CILIUM; PATHWAY; EXPRESSION; MEDULLOBLASTOMA; ACTIVATION; GLI; LOCALIZATION; ASSOCIATION; MECHANISMS; REPRESSION	Smoothened (Smo) mediated Hedgehog (Hh) signaling plays an essential role in regulating embryonic development and postnatal tissue homeostasis. Aberrant activation of the Hh pathway contributes to the formation and progression of various cancers. In vertebrates, however, key regulatory mechanisms responsible for transducing signals from Smo to the nucleus remain to be delineated. Here, we report the identification of Myc-interacting Zinc finger protein 1 (Miz1) as a Smo and Gli2 binding protein that positively regulates Hh signaling. Overexpression of Miz1 increases Gli luciferase reporter activity, whereas knockdown of endogenous Miz1 has the opposite effect. Activation of Smo induces translocation of Miz1 to the primary cilia together with Smo and Gli2. Furthermore, Miz1 is localized to the nucleus upon Hh activation in a Smo-dependent manner, and loss of Miz1 prevents the nuclear translocation of Gli2. More importantly, silencing Miz1 expression inhibits cell proliferation in vitro and the growth of Hh-driven medulloblastoma tumors allografted in SCID mice. Taken together, these results identify Miz1 as a novel regulator in the Hh pathway that plays an important role in mediating Smo-dependent oncogenic signaling.	[Lu, Jiuyi; Chen, Minyong; Ren, Xiu-Rong; Wang, Jiangbo; Chen, Wei] Duke Univ, Dept Med, Durham, NC 27708 USA; [Lyerly, H. Kim] Duke Univ, Dept Surg, Durham, NC USA; [Barak, Larry] Duke Univ, Dept Cell Biol, Durham, NC USA	Duke University; Duke University; Duke University	Chen, W (corresponding author), Duke Univ, Dept Med, Durham, NC 27708 USA.	w.chen@duke.edu	Lyerly, Herbert K/B-6528-2014; Lyerly, Herbert Kim/AAX-4925-2020	Lyerly, Herbert K/0000-0002-0063-4770; Lyerly, Herbert Kim/0000-0002-0063-4770; Chen, Wei/0000-0002-9934-4000	Clinical Oncology Research Center Development Grant [5K12-CA100639-08]; National Institutes of Health Grant [5R01CA113656-03, 1U01-DA022950]; Fred and Alice Stanback; NATIONAL CANCER INSTITUTE [R01CA113656, K12CA100639] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [U01DA022950] Funding Source: NIH RePORTER	Clinical Oncology Research Center Development Grant; National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fred and Alice Stanback; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This project was supported in part by a Clinical Oncology Research Center Development Grant 5K12-CA100639-08 (to MC), National Institutes of Health Grant 5R01CA113656-03 (to WC), National Institutes of Health Grant 1U01-DA022950 (to LSB), and Fred and Alice Stanback (HKL). WC is a V Foundation Scholar and an American Cancer Society Scholar. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adhikary S, 2003, MOL CELL BIOL, V23, P7648, DOI 10.1128/MCB.23.21.7648-7657.2003; Berman DM, 2002, SCIENCE, V297, P1559, DOI 10.1126/science.1073733; Chen Y, 2011, J BIOL CHEM, V286, P13502, DOI 10.1074/jbc.M110.217604; Corbit KC, 2005, NATURE, V437, P1018, DOI 10.1038/nature04117; Dahmane N, 1997, NATURE, V389, P876, DOI 10.1038/39918; Gilbertson RJ, 2008, ANNU REV PATHOL-MECH, V3, P341, DOI 10.1146/annurev.pathmechdis.3.121806.151518; Goetz SC, 2010, NAT REV GENET, V11, P331, DOI 10.1038/nrg2774; Goodrich LV, 1997, SCIENCE, V277, P1109, DOI 10.1126/science.277.5329.1109; Huangfu D, 2006, DEVELOPMENT, V133, P3, DOI 10.1242/dev.02169; Huangfu DW, 2003, NATURE, V426, P83, DOI 10.1038/nature02061; Humke EW, 2010, GENE DEV, V24, P670, DOI 10.1101/gad.1902910; Jiang J, 2008, DEV CELL, V15, P801, DOI 10.1016/j.devcel.2008.11.010; Kim J, 2009, P NATL ACAD SCI USA, V106, P21666, DOI 10.1073/pnas.0912180106; Kovacs JJ, 2008, SCIENCE, V320, P1777, DOI 10.1126/science.1157983; May SR, 2005, DEV BIOL, V287, P378, DOI 10.1016/j.ydbio.2005.08.050; Miao L, 2010, ONCOGENE, V29, P711, DOI 10.1038/onc.2009.372; NUSSLEINVOLHARD C, 1980, NATURE, V287, P795, DOI 10.1038/287795a0; Patel JH, 2007, J BIOL CHEM, V282, P5, DOI 10.1074/jbc.M609138200; Peukert K, 1997, EMBO J, V16, P5672, DOI 10.1093/emboj/16.18.5672; Rohatgi R, 2007, SCIENCE, V317, P372, DOI 10.1126/science.1139740; Sakurai T, 2004, J BIOL CHEM, V279, P15505, DOI 10.1074/jbc.M310437200; Scales SJ, 2009, TRENDS PHARMACOL SCI, V30, P303, DOI 10.1016/j.tips.2009.03.007; Seoane J, 2001, NAT CELL BIOL, V3, P400, DOI 10.1038/35070086; Sinha S, 2006, NAT CHEM BIOL, V2, P29, DOI 10.1038/nchembio753; Staller P, 2001, NAT CELL BIOL, V3, P392, DOI 10.1038/35070076; Taipale J, 2002, NATURE, V418, P892, DOI 10.1038/nature00989; Tukachinsky H, 2010, J CELL BIOL, V191, P415, DOI 10.1083/jcb.201004108; Varjosalo M, 2008, GENE DEV, V22, P2454, DOI 10.1101/gad.1693608; Wang JB, 2010, P NATL ACAD SCI USA, V107, P9323, DOI 10.1073/pnas.0910712107; Wanzel M, 2003, TRENDS CELL BIOL, V13, P146, DOI 10.1016/S0962-8924(03)00003-5; Wen XH, 2010, MOL CELL BIOL, V30, P1910, DOI 10.1128/MCB.01089-09; Wu SQ, 2003, ONCOGENE, V22, P351, DOI 10.1038/sj.onc.1206145; Zhao NX, 2004, J CELL BIOCHEM, V92, P65, DOI 10.1002/jcb.20025; Ziegelbauer J, 2004, P NATL ACAD SCI USA, V101, P458, DOI 10.1073/pnas.0307562100	34	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2013	8	5							e63353	10.1371/journal.pone.0063353	http://dx.doi.org/10.1371/journal.pone.0063353			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175AS	23671675	Green Published, gold, Green Submitted			2022-12-27	WOS:000321202100064
J	Choi, EJ; Kim, YH; Choe, SW; Tak, YG; Garrido-Martin, EM; Chang, M; Lee, YJ; Oh, SP				Choi, Eun-Jung; Kim, Yong Hwan; Choe, Se-woon; Tak, Yu Gyoung; Garrido-Martin, Eva M.; Chang, Myron; Lee, Young Jae; Oh, S. Paul			Enhanced Responses to Angiogenic Cues Underlie the Pathogenesis of Hereditary Hemorrhagic Telangiectasia 2	PLOS ONE			English	Article							RECEPTOR-LIKE KINASE-1; ENDOTHELIAL-CELL PROLIFERATION; GROWTH-FACTOR-BETA; TGF-BETA; SIGNAL-TRANSDUCTION; REGULATORY REGION; TUMOR-GROWTH; I RECEPTORS; 1 ALK1; ACTIVIN	Hereditary Hemorrhagic Telangiectasia (HHT) is a genetic vascular disease in which arteriovenous malformations (AVMs) manifest in skin and multiple visceral organs. HHT is caused by heterozygous mutations in endoglin (ENG), activin receptor-like kinase 1 (ALK1), or SMAD4. ALK1 regulates angiogenesis, but the precise function of ALK1 in endothelial cells (ECs) remains elusive. Since most blood vessels of HHT patients do not produce pathological vascular lesions, ALK1 heterozygous ECs may be normal unless additional genetic or environmental stresses are imposed. To investigate the cellular and biochemical phenotypes of Alk1-null versus Alk1-heterozygous ECs, we have generated pulmonary EC lines in which a genotype switch from the Alk1-conditional allele (Alk1(2f)) to the Alk1-null allele (Alk1(1f)) can be induced by tamoxifen treatment. Alk1-null (1 f/1 f) ECs displayed increased migratory properties in vitro in response to bFGF compared with Alk1-het (2 f/1 f) ECs. The 1 f/1 f-ECs formed a denser and more persistent tubular network as compared with their parental 2 f/1 f-ECs. Interestingly, the response to BMP-9 on SMAD1/5 phosphorylation was impaired in both 2 f/1 f- and 1 f/1 f-ECs at a comparable manner, suggesting that other factors in addition to SMADs may play a crucial role for enhanced angiogenic activity in 1 f/1 f-ECs. We also demonstrated in vivo that Alk1-deficient ECs exhibited high migratory and invasive properties. Taken together, these data suggest that enhanced responses to angiogenic cues in ALK1-deficient ECs underlie the pathogenesis of HHT2.	[Choi, Eun-Jung; Kim, Yong Hwan; Choe, Se-woon; Garrido-Martin, Eva M.; Lee, Young Jae; Oh, S. Paul] Univ Florida, Coll Med, Dept Physiol & Funct Genom, Gainesville, FL 32611 USA; [Tak, Yu Gyoung; Lee, Young Jae; Oh, S. Paul] Gachon Univ, World Class Univ Program, Lee Gil Ya Canc & Diabet Inst, Inchon, South Korea; [Chang, Myron] Univ Florida, Dept Biostat, Gainesville, FL USA	State University System of Florida; University of Florida; Gachon University; State University System of Florida; University of Florida	Oh, SP (corresponding author), Univ Florida, Coll Med, Dept Physiol & Funct Genom, Gainesville, FL 32611 USA.	ohp@ufl.edu	Garrido Martín, Eva María/HHM-3287-2022; Kim, Yong Hwan/AAL-8113-2021; Martin, Eva Maria Garrido/A-9497-2017	Garrido Martín, Eva María/0000-0002-8094-2668; Kim, Yong Hwan/0000-0003-1244-4269; Martin, Eva Maria Garrido/0000-0002-8094-2668; Choe, Se-woon/0000-0002-7298-4147; Lee, Young Jae/0000-0002-3841-1994	National Heart, Lung, and Blood Institute [HL64024]; American Heart Association; World Class University (WCU by Korean Ministry of Education, Science and Technology); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL064024] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); American Heart Association(American Heart Association); World Class University (WCU by Korean Ministry of Education, Science and Technology); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Heart, Lung, and Blood Institute (HL64024) to S.P.O., American Heart Association predoctoral fellowship to Y. H. K., American Heart Association postdoctoral fellowship to E. M. G. M., and in part by World Class University (WCU by Korean Ministry of Education, Science and Technology) to S.P.O. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdalla SA, 2000, HUM MOL GENET, V9, P1227, DOI 10.1093/hmg/9.8.1227; Bayrak-Toydemir P, 2006, AM J MED GENET A, V140A, P2155, DOI 10.1002/ajmg.a.31450; Bourdeau A, 2000, AM J PATHOL, V156, P911, DOI 10.1016/S0002-9440(10)64960-7; Brown MA, 2005, J BIOL CHEM, V280, P25111, DOI 10.1074/jbc.M503328200; Chang H, 2001, MOL CELL ENDOCRINOL, V180, P39, DOI 10.1016/S0303-7207(01)00513-5; Chen YG, 1999, J BIOL CHEM, V274, P3672, DOI 10.1074/jbc.274.6.3672; Cole SG, 2005, J MED GENET, V42, P577, DOI 10.1136/jmg.2004.028712; Corti P, 2011, DEVELOPMENT, V138, P1573, DOI 10.1242/dev.060467; Cunha SI, 2010, J EXP MED, V207, P85, DOI 10.1084/jem.20091309; Dakeishi M, 2002, HUM MUTAT, V19, P140, DOI 10.1002/humu.10026; David L, 2008, CIRC RES, V102, P914, DOI 10.1161/CIRCRESAHA.107.165530; David L, 2007, J CELL PHYSIOL, V213, P484, DOI 10.1002/jcp.21126; David L, 2007, BLOOD, V109, P1953, DOI 10.1182/blood-2006-07-034124; David L, 2009, CYTOKINE GROWTH F R, V20, P203, DOI 10.1016/j.cytogfr.2009.05.001; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Gallione CJ, 2004, LANCET, V363, P852, DOI 10.1016/S0140-6736(04)15732-2; Goumans MJ, 2002, EMBO J, V21, P1743, DOI 10.1093/emboj/21.7.1743; Goumans MJ, 2003, MOL CELL, V12, P817, DOI 10.1016/S1097-2765(03)00386-1; Goumans MJ, 2003, TRENDS CARDIOVAS MED, V13, P301, DOI 10.1016/S1050-1738(03)00142-7; Guo X, 2009, CELL RES, V19, P71, DOI 10.1038/cr.2008.302; Hao Q, 2010, STROKE, V41, pE264; Hong KH, 2008, CIRCULATION, V118, P722, DOI 10.1161/CIRCULATIONAHA.107.736801; Johnson DW, 1996, NAT GENET, V13, P189, DOI 10.1038/ng0696-189; Kim JH, 2012, ANGIOGENESIS, V15, P497, DOI 10.1007/s10456-012-9277-x; Kjeldsen AD, 1999, J INTERN MED, V245, P31, DOI 10.1046/j.1365-2796.1999.00398.x; Korchynskyi O, 2002, J BIOL CHEM, V277, P4883, DOI 10.1074/jbc.M111023200; Lamouille S, 2002, BLOOD, V100, P4495, DOI 10.1182/blood.V100.13.4495; Larrivee B, 2012, DEV CELL, V22, P489, DOI 10.1016/j.devcel.2012.02.005; Lebrin F, 2004, EMBO J, V23, P4018, DOI 10.1038/sj.emboj.7600386; Lednicky JA, 1997, J GEN VIROL, V78, P1697, DOI 10.1099/0022-1317-78-7-1697; Lee NY, 2012, MOL BIOL CELL, V23, P2412, DOI 10.1091/mbc.E11-12-0993; Lux A, 1999, J BIOL CHEM, V274, P9984, DOI 10.1074/jbc.274.15.9984; Mahmoud M, 2010, CIRC RES, V106, P1425, DOI 10.1161/CIRCRESAHA.109.211037; Mallet C, 2006, STEM CELLS, V24, P2120, DOI 10.1634/stemcells.2005-0494; Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753; MCALLISTER KA, 1994, NAT GENET, V8, P345, DOI 10.1038/ng1294-345; Mitchell D, 2010, MOL CANCER THER, V9, P379, DOI 10.1158/1535-7163.MCT-09-0650; Oh SP, 2000, P NATL ACAD SCI USA, V97, P2626, DOI 10.1073/pnas.97.6.2626; Park SO, 2008, BLOOD, V111, P633, DOI 10.1182/blood-2007-08-107359; Park SO, 2009, J CLIN INVEST, V119, P3487, DOI 10.1172/JCI39482; PASSANITI A, 1992, LAB INVEST, V67, P519; Pece-Barbara N, 1999, HUM MOL GENET, V8, P2171, DOI 10.1093/hmg/8.12.2171; Piek E, 1999, FASEB J, V13, P2105, DOI 10.1096/fasebj.13.15.2105; Ray BN, 2010, CARCINOGENESIS, V31, P435, DOI 10.1093/carcin/bgp327; Ricard N, 2012, BLOOD, V119, P6162, DOI 10.1182/blood-2012-01-407593; Roman BL, 2002, DEVELOPMENT, V129, P3009; Scharpfenecker M, 2007, J CELL SCI, V120, P964, DOI 10.1242/jcs.002949; Seki T, 2004, CIRC RES, V94, pE72, DOI 10.1161/01.RES.0000127048.81744.31; Seki T, 2003, CIRC RES, V93, P682, DOI 10.1161/01.RES.0000095246.40391.3B; Shao ES, 2009, BLOOD, V114, P2197, DOI 10.1182/blood-2009-01-199166; Shovlin CL, 2000, AM J MED GENET, V91, P66, DOI 10.1002/(SICI)1096-8628(20000306)91:1<66::AID-AJMG12>3.0.CO;2-P; Staton CA, 2004, INT J EXP PATHOL, V85, P233, DOI 10.1111/j.0959-9673.2004.00396.x; Stewart AR, 1998, J NEUROVIROL, V4, P182; Suzuki Y, 2010, J CELL SCI, V123, P1684, DOI 10.1242/jcs.061556; TENDIJKE P, 1994, SCIENCE, V264, P101, DOI 10.1126/science.8140412; van Meeteren LA, 2012, J BIOL CHEM, V287, P18551, DOI 10.1074/jbc.M111.338103; Vogt J, 2011, CELL SIGNAL, V23, P1831, DOI 10.1016/j.cellsig.2011.06.019; Walker EJ, 2011, ANN NEUROL, V69, P954, DOI 10.1002/ana.22348; Yu PB, 2008, NAT MED, V14, P1363, DOI 10.1038/nm.1888; Zhang YE, 2009, CELL RES, V19, P128, DOI 10.1038/cr.2008.328	60	21	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2013	8	5							e63138	10.1371/journal.pone.0063138	http://dx.doi.org/10.1371/journal.pone.0063138			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	143FO	23675457	Green Published, gold, Green Submitted			2022-12-27	WOS:000318852400025
J	Gomez-Morales, MA; Ludovisi, A; Amati, M; Pozio, E				Gomez-Morales, Maria Angeles; Ludovisi, Alessandra; Amati, Marco; Pozio, Edoardo			Validation of an Excretory/Secretory Antigen Based-Elisa for the Diagnosis of Opisthorchis felineus Infection in Humans from Low Trematode Endemic Areas	PLOS ONE			English	Article							LINKED-IMMUNOSORBENT-ASSAY; VIVERRINI INFECTION; ANTIBODY-RESPONSES; SERUM; URINE	Since opisthorchiasis does not show pathognomonic signs or symptoms, physicians can have serious problems to make a differential diagnosis of this infection in non endemic areas, in particular when there is a simultaneous occurrence with other seasonal infections. Moreover, symptomatic infections due to O. felineus can last a few weeks and then the signs and symptoms disappear, but the worms survive in the bile ducts for years causing hepatobiliary diseases including hepatomegaly, cholangitis, fibrosis of the periportal system, cholecystitis, and gallstones. Consequently, an early diagnosis prevents chronicity and loss of working days. The detection of specific antibodies has been considered as a complementary tool to the fecal examination to establish the definitive diagnosis of this infection and for the follow up. Therefore the aim of this work was the development and validation of an enzyme-linked immunosorbent assay (ELISA) using excretory/secretory antigens (ESA) from O. felineus adult worms to detect anti-Opisthorchis IgG in human sera. A total of 370 human sera were tested: 144 sera from persons with a confirmed diagnosis of opisthorchiasis, 110 sera from healthy Italian people, and 116 sera from people with other parasitic or non-parasitic infections. Results were analyzed by receiver-operator characteristic (ROC) curve analysis. The accuracy of the test, calculated by the area under curve (AUC), yielded a 0.999 value, indicating the high performance of the test. The sensitivity was 100% (95% CI: 97.40% to 100%) and no false-negative sera were detected; the specificity was 99.09% (95% CI: 95.02% to 99.83%). The validated ELISA shows a good performance in terms of sensitivity, repeatability and reproducibility, and it is suitable to detect anti-Opisthorchis IgG in human sera for diagnostic purposes and for the follow up to assess the efficacy of drug treatment.	[Gomez-Morales, Maria Angeles; Ludovisi, Alessandra; Amati, Marco; Pozio, Edoardo] Ist Super Sanita, Dept Infect Parasit & Immunomediated Dis, I-00161 Rome, Italy	Istituto Superiore di Sanita (ISS)	Gomez-Morales, MA (corresponding author), Ist Super Sanita, Dept Infect Parasit & Immunomediated Dis, Viale Regina Elena 299, I-00161 Rome, Italy.	mariaangeles.gomezmorales@iss.it	DE LOS ANGELES GOMEZ MORALES, MARIA/O-2283-2015	DE LOS ANGELES GOMEZ MORALES, MARIA/0000-0001-9116-4948	European Commission, contract DG SANCO/EURLP	European Commission, contract DG SANCO/EURLP(European Commission)	This work was supported by the European Commission, contract DG SANCO/EURLP 2012. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAI PS, 1995, INT J PARASITOL, V25, P971, DOI 10.1016/0020-7519(94)00212-7; AMORNPUNT S, 1991, INT J PARASITOL, V21, P421, DOI 10.1016/0020-7519(91)90099-S; [Anonymous], OFF J L, V276, P3379; Armignacco O, 2008, EMERG INFECT DIS, V14, P1902, DOI 10.3201/eid1412.080782; Armignacco O, 2013, AM J TROP MED HYG, V88, P364, DOI 10.4269/ajtmh.2012.12-0280; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Crotti, 2007, MICROBIOLOGIA MED, V42, P36, DOI 10.4081/MM.2007.2896; ELKINS DB, 1991, PARASITOLOGY, V102, P283, DOI 10.1017/S0031182000062600; Glupov V V, 1997, Med Parazitol (Mosk), P17; HASWELLELKINS MR, 1991, CLIN EXP IMMUNOL, V84, P213, DOI 10.1111/j.1365-2249.1991.tb08151.x; Hewitson JP, 2009, MOL BIOCHEM PARASIT, V167, P1, DOI 10.1016/j.molbiopara.2009.04.008; Johansen MV, 2010, ADV PARASIT, V73, P171, DOI 10.1016/S0065-308X(10)73007-4; Keiser J, 2009, CLIN MICROBIOL REV, V22, P466, DOI 10.1128/CMR.00012-09; Kim YJ, 2010, J CLIN MICROBIOL, V48, P2365, DOI 10.1128/JCM.02506-09; Klebanovskaia IA, 1985, MED PARAZITOL MOSK, V54, P25; KLEBANOVSKAYA I A, 1981, Meditsinskaya Parazitologiya i Parazitarnye Bolezni, V50, P20; Kotelkin A. T., 2001, Vestnik Rossiiskoi Akademii Meditsinskikh Nauk, P34; Kotelkin A T, 1997, Med Parazitol (Mosk), P12; Meniavtseva T A, 1996, Med Parazitol (Mosk), P41; Mordvinov VA, 2012, PARASITOL INT, V61, P25, DOI 10.1016/j.parint.2011.07.021; Perroncito E, 1901, PARASSITI UOMO ANIMA; POOPYRUCHPONG N, 1990, ASIAN PAC J ALLERGY, V8, P27; Pozio E, 2013, ACTA TROP, V126, P54, DOI 10.1016/j.actatropica.2013.01.005; Rivolta S., 1884, GIORNALE ANATOMIA FI, VXVI, P20; Sawangsoda P, 2012, PARASITOL INT, V61, P196, DOI 10.1016/j.parint.2011.06.009; Sergeant ESG, 2012, EPITOOLS EPIDEMIOLOG; SIRISINHA S, 1995, AM J TROP MED HYG, V52, P521, DOI 10.4269/ajtmh.1995.52.521; Sirisinha S, 1991, Southeast Asian J Trop Med Public Health, V22 Suppl, P179; Sirisinha Stitaya, 1992, Southeast Asian Journal of Tropical Medicine and Public Health, V23, P489; SITHITHAWORN P, 1991, T ROY SOC TROP MED H, V85, P765, DOI 10.1016/0035-9203(91)90449-9; Sripa B, 2000, PARASITE IMMUNOL, V22, P139, DOI 10.1046/j.1365-3024.2000.00286.x; Sripa B, 2007, PLOS MED, V4, P1148, DOI 10.1371/journal.pmed.0040201; Sripa B, 2011, ACTA TROP, V120, pS158, DOI 10.1016/j.actatropica.2010.07.006; Sripa B, 2011, LANCET INFECT DIS, V11, P77, DOI 10.1016/S1473-3099(10)70289-9; Sripa J, 2012, PARASITOL INT, V61, P191, DOI 10.1016/j.parint.2011.05.009; SRIVATANAKUL P, 1985, Southeast Asian Journal of Tropical Medicine and Public Health, V16, P234; Tesana S, 2007, ANN TROP MED PARASIT, V101, P585, DOI 10.1179/136485907X229068; Traverso A, 2012, EUR J CLIN MICROBIOL, V31, P1089, DOI 10.1007/s10096-011-1411-y; Upatham ES, 2003, ACTA TROP, V88, P171, DOI 10.1016/j.actatropica.2003.01.001; WONGRATANACHEEWIN S, 1988, AM J TROP MED HYG, V38, P356, DOI 10.4269/ajtmh.1988.38.356; Wongratanacheewin S, 2003, ACTA TROP, V88, P195, DOI 10.1016/j.actatropica.2003.02.002; Wongsaroj T, 2001, ASIAN PAC J ALLERGY, V19, P245; Yossepowitch O, 2004, EMERG INFECT DIS, V10, P2122, DOI 10.3201/eid1012.040410; ZWEIG MH, 1993, CLIN CHEM, V39, P561	44	13	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2013	8	5							e62267	10.1371/journal.pone.0062267	http://dx.doi.org/10.1371/journal.pone.0062267			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	155HD	23671589	Green Published, gold, Green Submitted			2022-12-27	WOS:000319737700009
J	Lenart, A; Dudkiewicz, M; Grynberg, M; Pawlowski, K				Lenart, Anna; Dudkiewicz, Malgorzata; Grynberg, Marcin; Pawlowski, Krzysztof			CLCAs - A Family of Metalloproteases of Intriguing Phylogenetic Distribution and with Cases of Substituted Catalytic Sites	PLOS ONE			English	Article							HORIZONTAL GENE-TRANSFER; MATRIX METALLOPROTEINASES; PROTEIN; DOMAIN; SEQUENCE; PROTEASES; CLEAVAGE; REVEALS; CHANNEL; DATABASE	The zinc-dependent metalloproteases with His-Glu-x-x-His (HExxH) active site motif, zincins, are a broad group of proteins involved in many metabolic and regulatory functions, and found in all forms of life. Human genome contains more than 100 genes encoding proteins with known zincin-like domains. A survey of all proteins containing the HExxH motif shows that approximately 52% of HExxH occurrences fall within known protein structural domains (as defined in the Pfam database). Domain families with majority of members possessing a conserved HExxH motif include, not surprisingly, many known and putative metalloproteases. Furthermore, several HExxH-containing protein domains thus identified can be confidently predicted to be putative peptidases of zincin fold. Thus, we predict zincin-like fold for eight uncharacterised Pfam families. Besides the domains with the HExxH motif strictly conserved, and those with sporadic occurrences, intermediate families are identified that contain some members with a conserved HExxH motif, but also many homologues with substitutions at the conserved positions. Such substitutions can be evolutionarily conserved and non-random, yet functional roles of these inactive zincins are not known. The CLCAs are a novel zincin-like protease family with many cases of substituted active sites. We show that this allegedly metazoan family has a number of bacterial and archaeal members. An extremely patchy phylogenetic distribution of CLCAs in prokaryotes and their conserved protein domain composition strongly suggests an evolutionary scenario of horizontal gene transfer (HGT) from multicellular eukaryotes to bacteria, providing an example of eukaryote-derived xenologues in bacterial genomes. Additionally, in a protein family identified here as closely homologous to CLCA, the CLCA_X (CLCA-like) family, a number of proteins is found in phages and plasmids, supporting the HGT scenario.	[Lenart, Anna; Pawlowski, Krzysztof] Polish Acad Sci, Dept Cellular & Mol Neurobiol, Nencki Inst Expt Biol, Warsaw, Poland; [Dudkiewicz, Malgorzata; Pawlowski, Krzysztof] Warsaw Univ Life Sci, Fac Agr & Biol, Warsaw, Poland; [Grynberg, Marcin] Polish Acad Sci, Inst Biochem & Biophys, Dept Genet, Warsaw, Poland	Polish Academy of Sciences; Nencki Institute of Experimental Biology of the Polish Academy of Sciences; Warsaw University of Life Sciences; Polish Academy of Sciences; Institute of Biochemistry & Biophysics - Polish Academy of Sciences	Pawlowski, K (corresponding author), Polish Acad Sci, Dept Cellular & Mol Neurobiol, Nencki Inst Expt Biol, Warsaw, Poland.	krzysztof_pawlowski@sggw.pl	Pawłowski, Krzysztof/C-2949-2013; Dudkiewicz, Małgorzata/AAG-4553-2020	Pawłowski, Krzysztof/0000-0002-5367-0935; Grynberg, Marcin/0000-0003-1887-7209; Dudkiewicz, Malgorzata/0000-0003-4432-2530	Ministry of of Science and Higher Education, Republic of Poland [N N301 3165 33]	Ministry of of Science and Higher Education, Republic of Poland	AL, MD, MG and KP were supported by the grant N N301 3165 33 from the Ministry of of Science and Higher Education, Republic of Poland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alva V, 2010, PROTEIN SCI, V19, P124, DOI 10.1002/pro.297; Anderson MT, 2011, MBIO, V2, DOI 10.1128/mBio.00005-11; Andreeva A, 2008, NUCLEIC ACIDS RES, V36, pD419, DOI 10.1093/nar/gkm993; Bateman A, 2003, TRENDS BIOCHEM SCI, V28, P234, DOI 10.1016/S0968-0004(03)00061-6; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Bateman A, 2010, ACTA CRYSTALLOGR F, V66, P1148, DOI 10.1107/S1744309110001685; Blanchard H, 2011, BIOCHIMIE, V93, P87, DOI 10.1016/j.biochi.2010.03.002; BODE W, 1993, FEBS LETT, V331, P134, DOI 10.1016/0014-5793(93)80312-I; Bothe MK, 2012, MOL CELLS, V33, P251, DOI 10.1007/s10059-012-2217-1; Bothe M, 2011, MOL CELLS, V32, P535, DOI 10.1007/s10059-011-0158-8; Brown CK, 2001, P NATL ACAD SCI USA, V98, P3127, DOI 10.1073/pnas.051633198; Cai W, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-33; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Cerda-Costa N, 2011, MOL MICROBIOL, V79, P119, DOI 10.1111/j.1365-2958.2010.07434.x; CHOTHIA C, 1986, EMBO J, V5, P823, DOI 10.1002/j.1460-2075.1986.tb04288.x; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Cudic M, 2009, CURR PROTEIN PEPT SC, V10, P297, DOI 10.2174/138920309788922207; Dayhoff M. O., 1978, ATLAS PROTEIN SEQ S3, P345; Dudkiewicz M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032138; Eggermont Jan, 2004, Proc Am Thorac Soc, V1, P22, DOI 10.1513/pats.2306010; Frickey T, 2004, BIOINFORMATICS, V20, P3702, DOI 10.1093/bioinformatics/bth444; Gattiker Alexandre, 2002, Appl Bioinformatics, V1, P107; Goulas T, 2011, P NATL ACAD SCI USA, V108, P1856, DOI 10.1073/pnas.1012173108; HARTLEY BS, 1960, ANNU REV BIOCHEM, V29, P45, DOI 10.1146/annurev.bi.29.070160.000401; HOOPER NM, 1994, FEBS LETT, V354, P1, DOI 10.1016/0014-5793(94)01079-X; Hotopp JCD, 2007, SCIENCE, V317, P1753, DOI 10.1126/science.1142490; Iwashita H, 2012, RESP RES, V13, DOI 10.1186/1465-9921-13-55; Jaroszewski L, 2005, NUCLEIC ACIDS RES, V33, pW284, DOI 10.1093/nar/gki418; Jaroszewski L, 2011, NUCLEIC ACIDS RES, V39, pW38, DOI 10.1093/nar/gkr441; Jaroszewski L, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000205; Joint Center for Structural Genomics, 2010, CRYST STRUCT MET BAC; Keeling PJ, 2009, CURR OPIN GENET DEV, V19, P613, DOI 10.1016/j.gde.2009.10.001; KNIGHT CG, 1995, BIOCHEM J, V308, P145, DOI 10.1042/bj3080145; Kondo N, 2002, P NATL ACAD SCI USA, V99, P14280, DOI 10.1073/pnas.222228199; Kong Lesheng, 2008, BMC Bioinformatics, V9 Suppl 1, pS22, DOI 10.1186/1471-2105-9-S1-S22; Koonin EV, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00119; Koonin EV, 2001, ANNU REV MICROBIOL, V55, P709, DOI 10.1146/annurev.micro.55.1.709; Kosowska K, 2002, J BIOL CHEM, V277, P11987, DOI 10.1074/jbc.M110883200; Lattka E, 2010, CURR OPIN LIPIDOL, V21, P64, DOI 10.1097/MOL.0b013e3283327ca8; Leplae R, 2010, NUCLEIC ACIDS RES, V38, pD57, DOI 10.1093/nar/gkp938; Letunic I, 2011, NUCLEIC ACIDS RES, V39, pW475, DOI [10.1093/nar/gkr931, 10.1093/nar/gkr201]; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Liu HQ, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-276; Lobocka MB, 2004, J BACTERIOL, V186, P7032, DOI 10.1128/JB.186.21.7032-7068.2004; Loewen ME, 2005, PHYSIOL REV, V85, P1061, DOI 10.1152/physrev.00016.2004; MATTHEWS BW, 1988, ACCOUNTS CHEM RES, V21, P333, DOI 10.1021/ar00153a003; MCKERROW JH, 1987, J BIOL CHEM, V262, P5943; Morais DADL, 2011, NUCLEIC ACIDS RES, V39, pD427, DOI 10.1093/nar/gkq1130; Mundhenk L, 2012, AM J RESP CELL MOL, V47, P87, DOI 10.1165/rcmb.2010-0508OC; Nakjang S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030287; NEURATH H, 1976, P NATL ACAD SCI USA, V73, P3825, DOI 10.1073/pnas.73.11.3825; Nishimura H, 2001, DEV BIOL, V233, P204, DOI 10.1006/dbio.2001.0166; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Ochman H, 2000, NATURE, V405, P299, DOI 10.1038/35012500; Oh JS, 2009, MOL CELLS, V28, P441, DOI 10.1007/s10059-009-0140-x; Page-McCaw A, 2007, NAT REV MOL CELL BIO, V8, P221, DOI 10.1038/nrm2125; Patel AC, 2009, ANNU REV PHYSIOL, V71, P425, DOI 10.1146/annurev.physiol.010908.163253; Pauli BU, 2000, CLIN EXP PHARMACOL P, V27, P901, DOI 10.1046/j.1440-1681.2000.03358.x; Pawlowski K, 2006, PROTEINS, V63, P424, DOI 10.1002/prot.20887; Pawlowski K, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-590; Podell S, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-419; Poole AM, 2009, RES MICROBIOL, V160, P473, DOI 10.1016/j.resmic.2009.07.009; RAWLINGS ND, 1993, BIOCHEM J, V290, P205, DOI 10.1042/bj2900205; Rawlings ND, 2012, NUCLEIC ACIDS RES, V40, pD343, DOI [10.1093/nar/gkr987, 10.1093/nar/gkt953]; Rychlewski L, 2000, PROTEIN SCI, V9, P232, DOI 10.1110/ps.9.2.232; Sadreyev RI, 2009, CURR OPIN STRUC BIOL, V19, P321, DOI 10.1016/j.sbi.2009.04.009; Soding J, 2005, BIOINFORMATICS, V21, P951, DOI 10.1093/bioinformatics/bti125; Soding J, 2006, NUCLEIC ACIDS RES, V34, pW374, DOI 10.1093/nar/gkl195; Steuber H, 2010, CURR TOP MED CHEM, V10, P323, DOI 10.2174/156802610790725470; Tallant C, 2010, BBA-MOL CELL RES, V1803, P20, DOI 10.1016/j.bbamcr.2009.04.003; Tanikawa C, 2012, NEOPLASIA, V14, P141, DOI 10.1593/neo.111700; Turk B, 2007, FEBS LETT, V581, P2761, DOI 10.1016/j.febslet.2007.05.038; Turk B, 2006, NAT REV DRUG DISCOV, V5, P785, DOI 10.1038/nrd2092; Turk B, 2012, EMBO J, V31, P1630, DOI 10.1038/emboj.2012.42; Walia V, 2012, ONCOGENE, V31, P2237, DOI 10.1038/onc.2011.392; Winpenny John P., 2009, Inflammation & Allergy Drug Targets, V8, P146; Gomis-Ruth FX, 2009, J BIOL CHEM, V284, P15353, DOI 10.1074/jbc.R800069200; Xu QP, 2012, J BACTERIOL, V194, P2987, DOI 10.1128/JB.00038-12; Yurtsever Z, 2012, J BIOL CHEM, V287, P42138, DOI 10.1074/jbc.M112.410282	79	14	14	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2013	8	5							e62272	10.1371/journal.pone.0062272	http://dx.doi.org/10.1371/journal.pone.0062272			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	155HD	23671590	Green Submitted, Green Published, gold			2022-12-27	WOS:000319737700010
J	Rillich, J; Stevenson, PA; Pflueger, HJ				Rillich, Jan; Stevenson, Paul A.; Pflueger, Hans-Joachim			Flight and Walking in Locusts-Cholinergic Co-Activation, Temporal Coupling and Its Modulation by Biogenic Amines	PLOS ONE			English	Article							CENTRAL PATTERN GENERATOR; CENTRAL NERVOUS CONTROL; MOTOR PATTERN; BIFUNCTIONAL MUSCLES; RHYTHMIC PATTERNS; THORACIC GANGLIA; NEURAL-CONTROL; DUM NEURONS; OCTOPAMINE; BEHAVIOR	Walking and flying in locusts are exemplary rhythmical behaviors generated by central pattern generators (CPG) that are tuned in intact animals by phasic sensory inputs. Although these two behaviors are mutually exclusive and controlled by independent CPGs, leg movements during flight can be coupled to the flight rhythm. To investigate potential central coupling between the underlying CPGs, we used the muscarinic agonist pilocarpine and the amines octopamine and tyramine to initiate fictive flight and walking in deafferented locust preparations. Our data illustrate that fictive walking is readily evoked by comparatively lower concentrations of pilocarpine, whereas higher concentrations are required to elicit fictive flight. Interestingly, fictive flight did not suppress fictive walking so that the two patterns were produced simultaneously. Frequently, leg motor units were temporally coupled to the flight rhythm, so that each spike in a step cycle volley occurred synchronously with wing motor units firing at flight rhythm frequency. Similarly, tyramine also induced fictive walking and flight, but mostly without any coupling between the two rhythms. Octopamine in contrast readily evoked fictive flight but generally failed to elicit fictive walking. Despite this, numerous leg motor units were recruited, whereby each was temporarily coupled to the flight rhythm. Our results support the notion that the CPGs for walking and flight are largely independent, but that coupling can be entrained by aminergic modulation. We speculate that octopamine biases the whole motor machinery of a locust to flight whereas tyramine primarily promotes walking.	[Rillich, Jan; Pflueger, Hans-Joachim] Free Univ Berlin, Inst Neurobiol, Berlin, Germany; [Stevenson, Paul A.] Univ Leipzig, Inst Biol, D-04109 Leipzig, Germany	Free University of Berlin; Leipzig University	Rillich, J (corresponding author), Free Univ Berlin, Inst Neurobiol, Berlin, Germany.	jan.rillich@fu-berlin.de	Stevenson, Paul A/A-2048-2010		Deutsche Forschungsgemeinschaft - Forschergruppe [FOR 1363 Pf 128/30-1]	Deutsche Forschungsgemeinschaft - Forschergruppe(German Research Foundation (DFG))	Funded by Deutsche Forschungsgemeinschaft - Forschergruppe: Biogenic amines in insects: coordination of physiological processes and behaviour FOR 1363 Pf 128/30-1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ausborn J, 2007, J NEUROSCI, V27, P9319, DOI 10.1523/JNEUROSCI.0907-07.2007; Ayali A, 2010, J INSECT PHYSIOL, V56, P834, DOI 10.1016/j.jinsphys.2010.03.015; Baudoux S, 1998, J NEUROPHYSIOL, V79, P361, DOI 10.1152/jn.1998.79.1.361; Braunig P, 2001, ADV INSECT PHYSIOL, V28, P185, DOI 10.1016/S0065-2806(01)28011-4; Brembs B, 2007, J NEUROSCI, V27, P11122, DOI 10.1523/JNEUROSCI.2704-07.2007; Buschges A, 2011, CURR BIOL, V21, pR513, DOI 10.1016/j.cub.2011.05.029; Buhl E, 2008, J EXP BIOL, V211, P2346, DOI 10.1242/jeb.017384; BURROWS M, 1975, J EXP BIOL, V63, P735; BUSCHGES A, 1995, J EXP BIOL, V198, P435; Campbell JI, 1961, R F P ZOOL SOC LOND, V137, P403; CLAASSEN DE, 1986, J NEUROBIOL, V17, P1, DOI 10.1002/neu.480170102; Duch C, 1999, J COMP PHYSIOL A, V184, P489, DOI 10.1007/s003590050349; DUCH C, 1995, J EXP BIOL, V198, P1963; DUGARD JJ, 1967, J INSECT PHYSIOL, V13, P1055, DOI 10.1016/0022-1910(67)90107-2; EVANS PD, 1981, J PHYSIOL-LONDON, V318, P99; Evans Peter D., 2005, Invertebrate Neuroscience, V5, P111, DOI 10.1007/s10158-005-0001-z; Heinrich R, 2002, MICROSC RES TECHNIQ, V56, P292, DOI 10.1002/jemt.10033; Heinrich R, 2001, J COMP PHYSIOL A, V187, P155, DOI 10.1007/s003590100188; HENNIG RM, 1990, J COMP PHYSIOL A, V167, P617; Homberg U, 2013, J COMP NEUR IN PRESS; Hustert R, 2012, J PHYSL IN PRESS; Johnson BR, 2011, J NEUROPHYSIOL, V105, P293, DOI 10.1152/jn.00809.2010; Johnston Rebecca M., 2002, Invertebrate Neuroscience, V4, P175, DOI 10.1007/s10158-002-0019-4; KINNAMON SC, 1984, J NEUROBIOL, V15, P283, DOI 10.1002/neu.480150405; Kononenko NL, 2009, J COMP NEUROL, V512, P433, DOI 10.1002/cne.21911; Lange AB, 2009, GEN COMP ENDOCR, V162, P18, DOI 10.1016/j.ygcen.2008.05.021; Libersat F, 2004, BIOSCIENCE, V54, P17, DOI 10.1641/0006-3568(2004)054[0017:MATOOB]2.0.CO;2; LOREZ M, 1995, J EXP BIOL, V198, P869; Marder E, 2007, ANNU REV PHYSIOL, V69, P291, DOI 10.1146/annurev.physiol.69.031905.161516; Marder E, 2012, NEURON, V76, P1, DOI 10.1016/j.neuron.2012.09.010; Miles GB, 2011, PHYSIOLOGY, V26, P393, DOI 10.1152/physiol.00013.2011; MOHL B, 1993, J COMP PHYSIOL A, V172, P325, DOI 10.1007/BF00216614; Monastirioti M, 1996, J NEUROSCI, V16, P3900; Morris OT, 1999, J EXP BIOL, V202, P3555; Nusbaum MP, 2002, NATURE, V417, P343, DOI 10.1038/417343a; ORCHARD I, 1993, ANNU REV ENTOMOL, V38, P227, DOI 10.1146/annurev.en.38.010193.001303; Paripovic I, 1996, PHYSIOL ENTOMOL, V21, P223, DOI 10.1111/j.1365-3032.1996.tb00859.x; RAMIREZ JM, 1991, J NEUROPHYSIOL, V66, P1522, DOI 10.1152/jn.1991.66.5.1522; Ramirez JM, 1998, J NEUROPHYSIOL, V80, P3137, DOI 10.1152/jn.1998.80.6.3137; RAMIREZ JM, 1988, J NEUROBIOL, V19, P257, DOI 10.1002/neu.480190307; RAMIREZ JM, 1991, BRAIN RES, V549, P332, DOI 10.1016/0006-8993(91)90477-D; Rand D, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00288; Rast GF, 1997, J EXP BIOL, V200, P2197; Roeder T, 1998, EUR J PHARMACOL, V349, P171, DOI 10.1016/S0014-2999(98)00192-7; Roeder T, 2003, ARCH INSECT BIOCHEM, V54, P1, DOI 10.1002/arch.10102; Roeder T, 2005, ANNU REV ENTOMOL, V50, P447, DOI 10.1146/annurev.ento.50.071803.130404; RONACHER B, 1988, J COMP PHYSIOL A, V163, P749, DOI 10.1007/BF00604052; Rosenberg LA, 2007, J EXP BIOL, V210, P4411, DOI 10.1242/jeb.010488; ROWELL CHF, 1991, TISSUE CELL, V23, P75, DOI 10.1016/0040-8166(91)90068-5; RYCKEBUSCH S, 1993, J NEUROPHYSIOL, V69, P1583, DOI 10.1152/jn.1993.69.5.1583; Sachs L, 1992, ANGEW STAT, V7; Sadaf S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046405; Scheiner R, 2006, CURR NEUROPHARMACOL, V4, P259, DOI 10.2174/157015906778520791; SCHOFIELD PK, 1984, J EXP BIOL, V109, P333; Schoneich S, 2012, BRAIN BEHAV, V2, P707, DOI 10.1002/brb3.89; SIMPSON SJ, 2013, OXFORD HDB IN PRESS; SNODGRASS R. E., 1929, SMITHSONIAN MISCELLANEOUS COLLECTIONS, V82, P1; SOMBATI S, 1984, J NEUROBIOL, V15, P481, DOI 10.1002/neu.480150607; STEVENSON PA, 1988, J COMP PHYSIOL A, V162, P247, DOI 10.1007/BF00606089; Stevenson PA, 2005, J NEUROSCI, V25, P1431, DOI 10.1523/JNEUROSCI.4258-04.2005; STEVENSON PA, 1995, COMP BIOCHEM PHYS A, V110, P203, DOI 10.1016/0300-9629(94)00152-J; Stevenson PA, 1997, J COMP PHYSIOL A, V180, P91, DOI 10.1007/s003590050030; STEVENSON PA, 1987, J COMP PHYSIOL A, V161, P115, DOI 10.1007/BF00609460; Stevenson PA, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00118; THOMPSON KJ, 1986, J EXP BIOL, V122, P413; Verlinden H, 2010, J INSECT PHYSIOL, V56, P854, DOI 10.1016/j.jinsphys.2010.05.018; Vierk R, 2009, J COMP PHYSIOL A, V195, P265, DOI 10.1007/s00359-008-0404-5; Vierk R, 2010, J COMP PHYSIOL A, V196, P37, DOI 10.1007/s00359-009-0490-z; Weisel Eichler A., 1996, J COMP PHYSIOL A, V179, P103; WEISFOGH T, 1956, PHILOS T ROY SOC B, V239, P459, DOI 10.1098/rstb.1956.0008; WILSON DM, 1961, J EXP BIOL, V38, P471; WILSON DM, 1962, J EXP BIOL, V39, P669; Zilberstein Y, 2002, J EXP BIOL, V205, P2833	73	24	25	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2013	8	5							e62899	10.1371/journal.pone.0062899	http://dx.doi.org/10.1371/journal.pone.0062899			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	155HD	23671643	Green Published, Green Submitted, gold			2022-12-27	WOS:000319737700027
J	Stegger, JG; Schmidt, EB; Berentzen, TL; Tjonneland, A; Vogel, U; Rimm, E; Sorensen, TIA; Overvad, K; Jensen, MK				Stegger, Jakob Gerhard; Schmidt, Erik Berg; Berentzen, Tina Landsvig; Tjonneland, Anne; Vogel, Ulla; Rimm, Eric; Sorensen, Thorkild I. A.; Overvad, Kim; Jensen, Majken K.			Interaction between Obesity and the NFKB1-94ins/delATTG Promoter Polymorphism in Relation to Incident Acute Coronary Syndrome: A Follow Up Study in Three Independent Cohorts	PLOS ONE			English	Article							FACTOR-KAPPA-B; HEART-DISEASE; MYOCARDIAL-INFARCTION; ALCOHOL-CONSUMPTION; ADIPOSE-TISSUE; BODY-FAT; RISK; HEALTH; CHOLESTEROL; MEN	Introduction: The NF-kappa B transcription factor family regulates several genes encoding pro-inflammatory and anti-inflammatory proteins in adipose tissues and in atherosclerotic plaques. The deletion variant allele of the NFKB1 - 94ins/delATTG promoter polymorphism leads to lower transcript levels of the p50 subunit, and the variant allele has been associated with the risk of several inflammatory diseases as well as coronary heart disease where inflammation is important in the pathogenesis. The objective of this study was to explore the potential interaction between the NFKB1-94ins/delATTG promoter polymorphism and general, abdominal, and gluteofemoral obesity in relation to the risk of incident acute coronary syndrome (ACS) in three large independent cohorts. Methods and Results: The analyses were conducted in the Danish prospective study Diet, Cancer and Health and the two US based cohorts; Nurses' Health Study and Health Professionals Follow-up Study. We conducted sex stratified analyses that included 1202 male and 708 female cases of incident ACS. We observed a positive association for general and abdominal obesity with risk of incident ACS, independent of genotype in both genders. Gluteofemoral obesity was negatively associated with ACS risk in women independent of genotype, whereas there was no clear association for men. We calculated the relative excess risk due to interaction (RERI) and observed a statistically significant excess risk among men jointly exposed to general or abdominal obesity and the variant allele of the NFKB1-94ATTG polymorphism, whereas there was a tendency towards sub-additivity for gluteofemoral obesity. The excess risks in all analyses were, however, small and could not clearly be demonstrated in women. Conclusion: The variant allele of the NFKB1-94ins/delATTG promoter polymorphism did not substantially modify the association between obesity and incident ACS.	[Stegger, Jakob Gerhard; Schmidt, Erik Berg; Overvad, Kim; Jensen, Majken K.] Aarhus Univ Hosp, Aalborg Hosp, Cardiovasc Res Ctr, Dept Cardiol, Aalborg, Denmark; [Stegger, Jakob Gerhard] Aalborg Univ Hosp, Dept Anesthesiol, Aalborg, Denmark; [Berentzen, Tina Landsvig; Sorensen, Thorkild I. A.] Copenhagen Univ Hosp, Inst Prevent Med, Copenhagen, Denmark; [Tjonneland, Anne] Danish Canc Soc, Inst Canc Epidemiol, Copenhagen, Denmark; [Vogel, Ulla] Natl Res Ctr Working Environm, Copenhagen, Denmark; [Rimm, Eric; Jensen, Majken K.] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; [Rimm, Eric; Jensen, Majken K.] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Rimm, Eric] Brigham & Womens Hosp, Dept Med, Channing Div Network Med, Boston, MA 02115 USA; [Rimm, Eric] Harvard Univ, Sch Med, Boston, MA USA; [Sorensen, Thorkild I. A.] Univ Copenhagen, Fac Med & Hlth Sci, Sect Metab Genet, Novo Nordisk Fdn,Ctr Basic Metab Res, Copenhagen, Denmark; [Overvad, Kim] Aarhus Univ, Dept Publ Hlth, Epidemiol Sect, Aarhus, Denmark	Aalborg University; Aalborg University Hospital; Aarhus University; Aalborg University; Aalborg University Hospital; University of Copenhagen; Danish Cancer Society; National Research Centre for the Working Environment; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Novo Nordisk Foundation; University of Copenhagen; Aarhus University	Stegger, JG (corresponding author), Aarhus Univ Hosp, Aalborg Hosp, Cardiovasc Res Ctr, Dept Cardiol, Aalborg, Denmark.	Jakob.stegger@rn.dk	Vogel, Ulla/ABC-2212-2020; Vogel, Ulla B/I-5048-2012	Vogel, Ulla/0000-0001-6807-1524; Vogel, Ulla B/0000-0001-6807-1524; Overvad, Kim/0000-0001-6429-7921; Jensen, Majken Karoline/0000-0003-4729-7545; Tjonneland, Anne/0000-0003-4385-2097; Schmidt, Erik Berg/0000-0002-0623-5666	Danish Cancer Society; Danish Heart Foundation [08-10-R68-A2176-B994-22514, 09-4-R72-A2346-22544]; Danish Obesity Research Centre (DanORC); Gene-diet Interactions in Obesity (GENDINOB); Hepatic and Adipose Tissue and Functions in the Metabolic Syndrome (HEPADIP); National Institutes of Health, Bethesda, MD [CA55075, HL35464, HL34594, CA87969]; NATIONAL CANCER INSTITUTE [P01CA087969] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL034594, R01HL035464] Funding Source: NIH RePORTER	Danish Cancer Society(Danish Cancer Society); Danish Heart Foundation; Danish Obesity Research Centre (DanORC); Gene-diet Interactions in Obesity (GENDINOB); Hepatic and Adipose Tissue and Functions in the Metabolic Syndrome (HEPADIP); National Institutes of Health, Bethesda, MD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The authors would like to thank the Danish Cancer Society for the funding of the Diet, Cancer and Health study. The present study was funded by the Danish Heart Foundation (08-10-R68-A2176-B994-22514 and 09-4-R72-A2346-22544) as well as the Danish Obesity Research Centre (DanORC), Gene-diet Interactions in Obesity (GENDINOB), and the Hepatic and Adipose Tissue and Functions in the Metabolic Syndrome (HEPADIP). The HPFS and NHS were funded by grants from the National Institutes of Health, Bethesda, MD (CA55075, HL35464, HL34594, CA87969). The authors would like to thank Hardeep Ranu and Pati Soule from the DF/HCC Genotyping Core for genotyping. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen TF, 1999, DAN MED BULL, V46, P263; Bogers RP, 2007, ARCH INTERN MED, V167, P1720, DOI 10.1001/archinte.167.16.1720; Canoy D, 2008, CURR OPIN CARDIOL, V23, P591, DOI 10.1097/HCO.0b013e328313133a; Cao SJ, 2006, J BIOL CHEM, V281, P26041, DOI 10.1074/jbc.M602222200; Colditz GA, 1997, J WOMENS HEALTH, V6, P49, DOI 10.1089/jwh.1997.6.49; de Winther MPJ, 2005, ARTERIOSCL THROM VAS, V25, P904, DOI 10.1161/01.ATV.0000160340.72641.87; Hajer GR, 2008, EUR HEART J, V29, P2959, DOI 10.1093/eurheartj/ehn387; HOSMER DW, 1992, EPIDEMIOLOGY, V3, P452, DOI 10.1097/00001648-199209000-00012; Jensen MK, 2008, EUR HEART J, V29, P104, DOI 10.1093/eurheartj/ehm517; Jensen MK, 2009, EUR HEART J, V30, P1584, DOI 10.1093/eurheartj/ehp145; Joensen AM, 2009, J CLIN EPIDEMIOL, V62, P188, DOI 10.1016/j.jclinepi.2008.03.005; KALBFLEISCH JD, 1988, STAT MED, V7, P149, DOI 10.1002/sim.4780070116; Karban AS, 2004, HUM MOL GENET, V13, P35, DOI 10.1093/hmg/ddh008; Kershaw EE, 2004, J CLIN ENDOCR METAB, V89, P2548, DOI 10.1210/jc.2004-0395; Korn EL, 1997, AM J EPIDEMIOL, V145, P72; Liou YJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033598; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Pereira SG, 2008, INT J BIOCHEM CELL B, V40, P1425, DOI 10.1016/j.biocel.2007.05.004; Ridker Paul M., 2003, Cardiology Clinics, V21, P315, DOI 10.1016/S0733-8651(03)00079-1; Rimm E B, 1990, Epidemiology, V1, P466, DOI 10.1097/00001648-199011000-00009; RIMM EB, 1992, AM J EPIDEMIOL, V135, P1114, DOI 10.1093/oxfordjournals.aje.a116211; RIMM EB, 1991, LANCET, V338, P464, DOI 10.1016/0140-6736(91)90542-W; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Rothman K., 1998, MODERN EPIDEMIOLOGY; Stegger JG, 2011, INT J OBESITY, V35, P1433, DOI 10.1038/ijo.2010.278; Tjonneland A, 2007, SCAND J PUBLIC HEALT, V35, P432, DOI 10.1080/14034940601047986; Van der Heiden K, 2010, CLIN SCI, V118, P593, DOI 10.1042/CS20090557; Vogel U, 2011, ATHEROSCLEROSIS, V219, P200, DOI 10.1016/j.atherosclerosis.2011.06.018; Vogel U, 2010, ATHEROSCLEROSIS, V209, P155, DOI 10.1016/j.atherosclerosis.2009.08.036; Vogel U, 2009, BMC MED GENET, V10, DOI 10.1186/1471-2350-10-52; Yusuf S, 2004, LANCET, V364, P937, DOI 10.1016/S0140-6736(04)17018-9	31	11	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2013	8	5							e63004	10.1371/journal.pone.0063004	http://dx.doi.org/10.1371/journal.pone.0063004			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	155HD	23671649	gold, Green Published, Green Submitted			2022-12-27	WOS:000319737700032
J	Bola, M; Gall, C; Sabel, BA				Bola, Michal; Gall, Carolin; Sabel, Bernhard A.			The Second Face of Blindness: Processing Speed Deficits in the Intact Visual Field after Pre- and Post-Chiasmatic Lesions	PLOS ONE			English	Article							VISION RESTORATION THERAPY; STRIATE CORTEX LESIONS; QUALITY-OF-LIFE; CORTICAL ACTIVATION; RETINAL LESIONS; OPTIC NEURITIS; FUNCTIONAL CONNECTIVITY; MACULAR DEGENERATION; HEMIANOPIC PATIENTS; HOMONYMOUS HEMIANOPIA	Purpose: Damage along the visual pathway results in a visual field defect (scotoma), which retinotopically corresponds to the damaged neural tissue. Other parts of the visual field, processed by the uninjured tissue, are considered to be intact. However, perceptual deficits have been observed in the "intact'' visual field, but these functional impairments are poorly understood. We now studied temporal processing deficits in the intact visual field of patients with either pre- or post-chiasmatic lesions to better understand the functional consequences of partial blindness. Methods: Patients with pre- (n = 53) or post-chiasmatic lesions (n = 98) were tested with high resolution perimetry - a method used to map visual fields with supra-threshold light stimuli. Reaction time of detections in the intact visual field was then analyzed as an indicator of processing speed and correlated with features of the visual field defect. Results: Patients from both groups exhibited processing speed deficits in their presumably "intact'' field as indicated by comparison to a normative sample. Further, in both groups processing speed was found to be a function of two factors. Firstly, a spatially restricted (retinotopic) influence of the scotoma was seen in longer reaction times when stimuli were presented in intact field sectors close to the defect. Secondly, patients with larger scotomata had on average longer reaction times in their intact field indicating a more general (non-retinotopic) influence of the scotoma. Conclusions: Processing speed deficits in the "intact'' visual field of patients with visual system damage demonstrate that visual system lesions have more widespread consequences on perception than previously thought. Because dysfunctions of the seeing field are expected to contribute to subjective vision, including visual tests of the presumed "intact'' field may help to better understand vision loss and to improve methods of vision restoration and rehabilitation.	[Bola, Michal; Gall, Carolin; Sabel, Bernhard A.] Univ Magdeburg, Fac Med, Inst Med Psychol, D-39106 Magdeburg, Germany	Otto von Guericke University	Sabel, BA (corresponding author), Univ Magdeburg, Fac Med, Inst Med Psychol, D-39106 Magdeburg, Germany.	bernhard.sabel@med.ovgu.de	Sabel, Bernhard A./E-6579-2013	Sabel, Bernhard/0000-0002-4472-5543; Bola, Michal/0000-0002-4609-8029	Otto-von-Guericke University of Magdeburg	Otto-von-Guericke University of Magdeburg	The study was funded by the Otto-von-Guericke University of Magdeburg. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arckens L, 2000, J COMP NEUROL, V425, P531, DOI 10.1002/1096-9861(20001002)425:4<531::AID-CNE5>3.0.CO;2-J; Azzopardi P, 2003, NEUROPSYCHOLOGIA, V41, P1738, DOI 10.1016/S0028-3932(03)00176-3; Baker CI, 2005, J NEUROSCI, V25, P614, DOI 10.1523/JNEUROSCI.3476-04.2005; BARTON JJS, 1994, NEUROLOGY, V44, P273, DOI 10.1212/WNL.44.2.273; Bocci T, 2011, NEUROSCIENCE, V187, P43, DOI 10.1016/j.neuroscience.2011.04.050; Bridge H, 2008, BRAIN, V131, P1433, DOI 10.1093/brain/awn063; Calford MB, 2000, J PHYSIOL-LONDON, V524, P587, DOI 10.1111/j.1469-7793.2000.t01-1-00587.x; Carter AR, 2012, NEUROREHAB NEURAL RE, V26, P7, DOI 10.1177/1545968311411054; Cavezian C, 2010, CORTEX, V46, P1123, DOI 10.1016/j.cortex.2009.08.013; Cowey A, 2010, EXP BRAIN RES, V200, P3, DOI 10.1007/s00221-009-1914-2; Dai H, 2013, HUM BRAIN MAPP, V34, P2455, DOI 10.1002/hbm.22079; Danziger S, 1997, CONSCIOUS COGN, V6, P291, DOI 10.1006/ccog.1997.0312; de Haan EHF, 2011, TRENDS COGN SCI, V15, P460, DOI 10.1016/j.tics.2011.08.005; Dilks DD, 2007, J NEUROSCI, V27, P9585, DOI 10.1523/JNEUROSCI.2650-07.2007; Dilks DD, 2009, J NEUROSCI, V29, P2768, DOI 10.1523/JNEUROSCI.5258-08.2009; Eysel UT, 1999, CEREB CORTEX, V9, P101, DOI 10.1093/cercor/9.2.101; Fink GR, 2000, ANN NEUROL, V47, P440; Gall C, 2011, BRAIN STIMUL, V4, P175, DOI 10.1016/j.brs.2011.07.003; Gall C, 2008, RESTOR NEUROL NEUROS, V26, P341; Gall C, 2009, INVEST OPHTH VIS SCI, V50, P2765, DOI 10.1167/iovs.08-2519; Geng JJ, 2006, J NEUROPHYSIOL, V96, P2601, DOI 10.1152/jn.01245.2005; GILBERT CD, 1992, NATURE, V356, P150, DOI 10.1038/356150a0; Goebel R, 2001, VISION RES, V41, P1459, DOI 10.1016/S0042-6989(01)00069-4; Grefkes C, 2008, ANN NEUROL, V63, P236, DOI 10.1002/ana.21228; He BJ, 2007, NEURON, V53, P905, DOI 10.1016/j.neuron.2007.02.013; HESS RF, 1989, BRAIN, V112, P871, DOI 10.1093/brain/112.4.871; Kasten E, 1998, NAT MED, V4, P1083, DOI 10.1038/2079; Kollias SS, 1998, J NEUROSURG, V89, P780, DOI 10.3171/jns.1998.89.5.0780; Korsholm K, 2007, BRAIN, V130, P1244, DOI 10.1093/brain/awm045; Nelles G, 2007, NEUROSCI LETT, V426, P34, DOI 10.1016/j.neulet.2007.08.028; Nelles G, 2007, J NEUROL, V254, P1244, DOI 10.1007/s00415-007-0511-1; Nowomiejska K, 2010, ACTA OPHTHALMOL, V88, P65, DOI 10.1111/j.1755-3768.2008.01407.x; Nurminen L, 2009, J NEUROPHYSIOL, V102, P2900, DOI 10.1152/jn.00201.2009; Palagina G, 2009, P NATL ACAD SCI USA, V106, P8743, DOI 10.1073/pnas.0900068106; Pambakian ALM, 2000, J NEUROL NEUROSUR PS, V69, P751, DOI 10.1136/jnnp.69.6.751; Paramei GV, 2008, BEHAV BRAIN RES, V188, P109, DOI 10.1016/j.bbr.2007.10.025; Perez C, 2013, BRAIN TOPOGR, V26, P264, DOI 10.1007/s10548-012-0244-z; Plow EB, 2012, NEUROREHABIL NEURAL; Plow EB, 2011, PM&R, V9, P825; Plow EB, 2009, EXPERT REV MED DEVIC, V6, P291, DOI [10.1586/erd.09.8, 10.1586/ERD.09.8]; Poggel DA, 2004, NEUROLOGY, V63, P2069, DOI 10.1212/01.WNL.0000145773.26378.E5; Poggel DA, 2012, ATTEN PERCEPT PSYCHO, V74, P1114, DOI 10.3758/s13414-012-0278-z; Poggel DA, 2011, BRAIN RES, V1368, P196, DOI 10.1016/j.brainres.2010.10.065; POPPEL E, 1973, NATURE, V243, P295, DOI 10.1038/243295a0; Putnam MC, 2010, J COGNITIVE NEUROSCI, V22, P1662, DOI 10.1162/jocn.2009.21290; Qiu AQ, 2006, NEUROIMAGE, V31, P125, DOI 10.1016/j.neuroimage.2005.11.049; Raz N, 2011, NEUROLOGY, V76, P2103, DOI 10.1212/WNL.0b013e31821f4602; Raz N, 2012, ANN NEUROL, V71, P531, DOI 10.1002/ana.22692; Rizzo M, 1996, BRAIN, V119, P951, DOI 10.1093/brain/119.3.951; Rousselet GA, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00119; Roux FE, 2001, J NEUROL NEUROSUR PS, V71, P505, DOI 10.1136/jnnp.71.4.505; Sabel BA, 2004, RESTOR NEUROL NEUROS, V22, P399; Sabel BA, 2011, RESTOR NEUROL NEUROS, V29, P493, DOI 10.3233/RNN-2011-0624; Sabel BA, 2011, PROG BRAIN RES, V192, P199, DOI 10.1016/B978-0-444-53355-5.00013-0; Saenz M, 2010, NEUROIMAGE, V52, P1224, DOI 10.1016/j.neuroimage.2010.05.060; Schadow J, 2009, NEUROPSYCHOLOGIA, V47, P556, DOI 10.1016/j.neuropsychologia.2008.10.012; Schoenfeld MA, 2002, ANN NEUROL, V52, P814, DOI 10.1002/ana.10394; Schumacher EH, 2008, RESTOR NEUROL NEUROS, V26, P391; Silvanto J, 2007, NEUROPSYCHOLOGIA, V45, P3346, DOI 10.1016/j.neuropsychologia.2007.06.008; Silvanto J, 2009, EXP BRAIN RES, V193, P645, DOI 10.1007/s00221-009-1712-x; Stoerig P, 1996, TRENDS NEUROSCI, V19, P401, DOI 10.1016/S0166-2236(96)10051-5; Toosy AT, 2005, ANN NEUROL, V57, P622, DOI 10.1002/ana.20448; Vanni S, 2001, NEUROREPORT, V12, P861, DOI 10.1097/00001756-200103260-00047; Waleszczyk WJ, 2003, EUR J NEUROSCI, V17, P2351, DOI 10.1046/j.1460-9568.2003.02674.x; Wandell BA, 2009, NAT REV NEUROSCI, V10, P873, DOI 10.1038/nrn2741; WEISKRANTZ L, 1974, BRAIN, V97, P709, DOI 10.1093/brain/97.1.709; Wust S, 2002, J COGNITIVE NEUROSCI, V14, P243, DOI 10.1162/089892902317236876; Young JM, 2002, J PHYSIOL-LONDON, V541, P601, DOI 10.1113/jphysiol.2001.016212; ZIHL J, 1995, NEUROPSYCHOLOGIA, V33, P287, DOI 10.1016/0028-3932(94)00119-A	69	26	26	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2013	8	5							e63700	10.1371/journal.pone.0063700	http://dx.doi.org/10.1371/journal.pone.0063700			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	145YI	23667657	Green Published, gold			2022-12-27	WOS:000319055600068
J	Gou, SM; Cui, PF; Li, XS; Shi, PF; Liu, T; Wang, CY				Gou, Shanmiao; Cui, Pengfei; Li, Xiangsheng; Shi, Pengfei; Liu, Tao; Wang, Chunyou			Low Concentrations of Metformin Selectively Inhibit CD133(+) Cell Proliferation in Pancreatic Cancer and Have Anticancer Action	PLOS ONE			English	Article							STEM-CELLS; SOLID TUMORS; GROWTH; MTOR; RISK; CHEMOTHERAPY; METAANALYSIS; ACTIVATION; THERAPIES; VIABILITY	Pancreatic cancer is the fourth leading cause of cancer related deaths in the United States. The prognosis remains dismal with little advance in treatment. Metformin is a drug widely used for the treatment of type II diabetes. Recent epidemiologic data revealed that oral administration of metformin is associated with a reduced risk of pancreatic cancer, suggesting its potential as a novel drug for this disease. Many studies have demonstrated the in vitro anticancer action of metformin, but the typically used concentrations were much higher than the in vivo plasma and tissue concentrations achieved with recommended therapeutic doses of metformin, and low concentrations of metformin had little effect on the proliferation of pancreatic cancer cells. We examined the effect of low concentrations of metformin on different subpopulations of pancreatic cancer cells and found that these selectively inhibited the proliferation of CD133(+) but not CD24(+) CD44(+)ESA(+) cells. We also examined the effect of low concentrations of metformin on cell invasion and in vivo tumor formation, demonstrating in vitro and in vivo anticancer action. Metformin was associated with a reduction of phospho-Erk and phospho-mTOR independent of Akt and AMPK phosphorylation. CD133(+) pancreatic cancer cells are considered to be cancer stem cells that contribute to recurrence, metastasis and resistance to adjuvant therapies in pancreatic cancer. Our results provide a basis for combination of metformin with current therapies to improve the prognosis of this disease.	[Gou, Shanmiao; Cui, Pengfei; Li, Xiangsheng; Shi, Pengfei; Liu, Tao; Wang, Chunyou] HUST, Union Hosp, Dept Gen Surg, Pancreat Dis Inst, Wuhan, Peoples R China	Huazhong University of Science & Technology	Gou, SM (corresponding author), HUST, Union Hosp, Dept Gen Surg, Pancreat Dis Inst, Wuhan, Peoples R China.	gousm@163.com; chunyouwang52@126.com			National Natural Science Foundation of China [81001064]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was funded by National Natural Science Foundation of China (No. 81001064) (Website: http://www.nsfc.gov.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ailles LE, 2007, CURR OPIN BIOTECH, V18, P460, DOI 10.1016/j.copbio.2007.10.007; Andriulli A, 2012, ANN SURG ONCOL, V19, P1644, DOI 10.1245/s10434-011-2110-8; Bao B, 2012, CANCER PREV RES, V5, P355, DOI 10.1158/1940-6207.CAPR-11-0299; Barnhart BC, 2007, CANCER METAST REV, V26, P261, DOI 10.1007/s10555-007-9053-3; Ben Sahra I, 2011, CANCER RES, V71, P4366, DOI 10.1158/0008-5472.CAN-10-1769; Carriere A, 2011, J BIOL CHEM, V286, P567, DOI 10.1074/jbc.M110.159046; Currie CJ, 2009, DIABETOLOGIA, V52, P1766, DOI 10.1007/s00125-009-1440-6; Dancey J, 2010, NAT REV CLIN ONCOL, V7, P209, DOI 10.1038/nrclinonc.2010.21; Davis JL, 2012, PANCREAS, V41, P678, DOI 10.1097/MPA.0b013e318249955a; Del Barco S, 2011, ONCOTARGET, V2, P896, DOI 10.18632/oncotarget.387; Ding Q, 2012, HUM CELL, V25, P1, DOI 10.1007/s13577-011-0037-9; Dragovich Tomislav, 2012, Clin Adv Hematol Oncol, V10, P344; Evans JMM, 2005, BMJ-BRIT MED J, V330, P1304, DOI 10.1136/bmj.38415.708634.F7; Grotenhuis BA, 2012, J SURG ONCOL, V106, P209, DOI 10.1002/jso.23069; Guertin DA, 2007, CANCER CELL, V12, P9, DOI 10.1016/j.ccr.2007.05.008; Hermann PC, 2007, CELL STEM CELL, V1, P313, DOI 10.1016/j.stem.2007.06.002; Hyun S, 2009, CELL, V139, P1096, DOI 10.1016/j.cell.2009.11.020; Ibanez L, 2006, J CLIN ENDOCR METAB, V91, P2888, DOI 10.1210/jc.2006-0336; JUNIEN JL, 1979, ARCH INT PHARMACOD T, V241, P165; Kirpichnikov D, 2002, ANN INTERN MED, V137, P25, DOI 10.7326/0003-4819-137-1-200207020-00009; Kisfalvi K, 2009, CANCER RES, V69, P6539, DOI 10.1158/0008-5472.CAN-09-0418; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Li CW, 2009, METHODS MOL BIOL, V568, P161, DOI 10.1007/978-1-59745-280-9_10; Li DH, 2009, GASTROENTEROLOGY, V137, P482, DOI 10.1053/j.gastro.2009.04.013; Lord JM, 2003, BRIT MED J, V327, P951, DOI 10.1136/bmj.327.7421.951; Marchesini G, 2001, LANCET, V358, P893, DOI 10.1016/S0140-6736(01)06042-1; McCubrey JA, 2010, ADV ENZYME REGUL, V50, P285, DOI 10.1016/j.advenzreg.2009.10.016; Nentwich MF, 2012, ANTICANCER RES, V32, P1999; Poruk KE, 2013, ANN SURG, V257, P17, DOI 10.1097/SLA.0b013e31825ffbfb; Rocha GZ, 2011, CLIN CANCER RES, V17, P3993, DOI 10.1158/1078-0432.CCR-10-2243; Schneider MB, 2001, GASTROENTEROLOGY, V120, P1263, DOI 10.1053/gast.2001.23258; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Soares HP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057289; Tomic T, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.86; Visvader JE, 2008, NAT REV CANCER, V8, P755, DOI 10.1038/nrc2499; Wang CY, 2008, J GASTROINTEST SURG, V12, P2183, DOI 10.1007/s11605-008-0621-9; Wang LW, 2008, WORLD J GASTROENTERO, V14, P7192, DOI 10.3748/wjg.14.7192; Wurth R, 2013, CELL CYCLE, V12, P145, DOI 10.4161/cc.23050; Zakikhani M, 2006, CANCER RES, V66, P10269, DOI 10.1158/0008-5472.CAN-06-1500; Zhou JB, 2007, P NATL ACAD SCI USA, V104, P16158, DOI 10.1073/pnas.0702596104	40	78	86	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2013	8	5							e63969	10.1371/journal.pone.0063969	http://dx.doi.org/10.1371/journal.pone.0063969			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145YI	23667692	Green Published, Green Submitted, gold			2022-12-27	WOS:000319055600083
J	Yao, S; Cheng, MG; Zhang, Q; Wasik, M; Kelsh, R; Winkler, C				Yao, Sheng; Cheng, Mangeng; Zhang, Qian; Wasik, Mariusz; Kelsh, Robert; Winkler, Christoph			Anaplastic Lymphoma Kinase Is Required for Neurogenesis in the Developing Central Nervous System of Zebrafish	PLOS ONE			English	Article							RECEPTOR TYROSINE KINASE; MAMMALIAN ACHAETE-SCUTE; NON-HODGKINS-LYMPHOMA; NEUROBLASTOMA PREDISPOSITION; DROSOPHILA-MELANOGASTER; ACTIVATING MUTATIONS; THERAPEUTIC TARGET; ATONAL HOMOLOGS; ALK KINASE; GENE	Anaplastic Lymphoma Kinase (ALK) was initially discovered as an oncogene in human lymphoma and other cancers, including neuroblastoma. However, little is known about the physiological function of ALK. We identified the alk ortholog in zebrafish (Danio rerio) and found that it is highly expressed in the developing central nervous system (CNS). Heat-shock inducible transgenic zebrafish lines were generated to over-express alk during early neurogenesis. Its ectopic expression resulted in activation of the MEK/ERK pathway, increased cell proliferation, and aberrant neurogenesis leading to mis-positioning of differentiated neurons. Thus, overexpressed alk is capable of promoting cell proliferation in the nervous system, similar to the situation in ALK-related cancers. Next, we used Morpholino mediated gene knock-down and a pharmacological inhibitor to interfere with expression and function of endogenous Alk. Alk inhibition did not affect neuron progenitor formation but severely compromised neuronal differentiation and neuron survival in the CNS. These data indicate that tightly controlled alk expression is critical for the balance between neural progenitor proliferation, differentiation and survival during embryonic neurogenesis.	[Yao, Sheng; Winkler, Christoph] Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore; [Yao, Sheng; Winkler, Christoph] Natl Univ Singapore, Ctr BioImaging Sci, Singapore 117548, Singapore; [Cheng, Mangeng] Merck Res Lab, In Vitro Pharmacol, Boston, MA USA; [Zhang, Qian; Wasik, Mariusz] Univ Penn, Dept Pathol & Lab Med, Philadelphia, PA USA; [Kelsh, Robert] Univ Bath, Dept Biol & Biochem, Ctr Regenerat Med, Dev Biol Programme, Bath BA2 7AY, Avon, England	National University of Singapore; National University of Singapore; Merck & Company; University of Pennsylvania; University of Bath	Winkler, C (corresponding author), Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore.	dbswcw@nus.edu.sg	Winkler, Christoph/G-4822-2012; Kelsh, Robert/B-6445-2008	Winkler, Christoph/0000-0003-4688-6241; Kelsh, Robert/0000-0002-9381-0066	Singapore Ministry of Education-Academic Research Fund grant [R-154-000-478-112]; United Kingdom Medical Research Council (MRC) grant [G0400806]; National Cancer Institute (NCI) [R01-CA96856]; MRC [G0400806] Funding Source: UKRI; NATIONAL CANCER INSTITUTE [R01CA096856] Funding Source: NIH RePORTER; Medical Research Council [G0400806] Funding Source: researchfish	Singapore Ministry of Education-Academic Research Fund grant; United Kingdom Medical Research Council (MRC) grant; National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This project was supported by a Singapore Ministry of Education-Academic Research Fund grant (R-154-000-478-112) to CW, an United Kingdom Medical Research Council (MRC) grant (G0400806) to RK, and a grant from the National Cancer Institute (NCI) R01-CA96856 to MW. SY is a National University of Singapore -Department of Biological Sciences graduate scholar. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bajoghli B, 2004, DEV BIOL, V271, P416, DOI 10.1016/j.ydbio.2004.04.006; BENZLEMOINE E, 1988, BLOOD, V72, P1045; Berry T, 2012, CANCER CELL, V22, P117, DOI 10.1016/j.ccr.2012.06.001; Bertrand N, 2002, NAT REV NEUROSCI, V3, P517, DOI 10.1038/nrn874; Chen YY, 2008, NATURE, V455, P971, DOI 10.1038/nature07399; Cheng MG, 2012, MOL CANCER THER, V11, P670, DOI 10.1158/1535-7163.MCT-11-0776; Chiarle R, 2008, NAT REV CANCER, V8, P11, DOI 10.1038/nrc2291; Cooper MS, 2005, DEV DYNAM, V232, P359, DOI 10.1002/dvdy.20252; Degoutin J, 2009, EUR J NEUROSCI, V29, P275, DOI 10.1111/j.1460-9568.2008.06593.x; Di Paolo D, 2011, MOL THER, V19, P2201, DOI 10.1038/mt.2011.142; Diez del Corral R, 2001, NAT REV NEUROSCI, V2, P835; Dirks WG, 2002, INT J CANCER, V100, P49, DOI 10.1002/ijc.10435; DOLBEARE F, 1995, HISTOCHEM J, V27, P339; Dong ZQ, 2012, NEURON, V74, P65, DOI 10.1016/j.neuron.2012.01.031; Englund C, 2003, NATURE, V425, P512, DOI 10.1038/nature01950; FISCHER P, 1988, BLOOD, V72, P234; George RE, 2008, NATURE, V455, P975, DOI 10.1038/nature07397; Godinho Leanne, 2011, Cold Spring Harb Protoc, V2011, P877, DOI 10.1101/pdb.prot5646; Grandel H, 2006, DEV BIOL, V295, P263, DOI 10.1016/j.ydbio.2006.03.040; Hurley SP, 2006, J COMP NEUROL, V495, P202, DOI 10.1002/cne.20887; Iwahara T, 1997, ONCOGENE, V14, P439, DOI 10.1038/sj.onc.1200849; Janoueix-Lerosey I, 2008, NATURE, V455, P967, DOI 10.1038/nature07398; Kageyama R, 2005, EXP CELL RES, V306, P343, DOI 10.1016/j.yexcr.2005.03.015; Kageyama R, 2008, DEV GROWTH DIFFER, V50, pS97, DOI 10.1111/j.1440-169X.2008.00993.x; Kim CH, 1996, NEUROSCI LETT, V216, P109, DOI 10.1016/0304-3940(96)13021-4; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Langheinrich U, 2002, CURR BIOL, V12, P2023, DOI 10.1016/S0960-9822(02)01319-2; Lee HH, 2003, NATURE, V425, P507, DOI 10.1038/nature01916; Liedtke D, 2008, DEV DYNAM, V237, P62, DOI 10.1002/dvdy.21384; Link V, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-1; Lo LC, 2002, DEVELOPMENT, V129, P1553; Loeb-Hennard C, 2005, GENE EXPR PATTERNS, V5, P341, DOI 10.1016/j.modgep.2004.10.003; Lopes SS, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000026; Loren CE, 2003, EMBO REP, V4, P781, DOI 10.1038/sj.embor.embor897; Loren CE, 2001, GENES CELLS, V6, P531, DOI 10.1046/j.1365-2443.2001.00440.x; Lyons DA, 2003, DEVELOPMENT, V130, P3427, DOI 10.1242/dev.00569; Maris JM, 2007, LANCET, V369, P2106, DOI 10.1016/S0140-6736(07)60983-0; Morris SW, 1997, ONCOGENE, V14, P2175, DOI 10.1038/sj.onc.1201062; Mosse YP, 2008, NATURE, V455, P930, DOI 10.1038/nature07261; Musgrove EA, 2011, NAT REV CANCER, V11, P558, DOI 10.1038/nrc3090; Ott GR, 2010, ACS MED CHEM LETT, V1, P493, DOI 10.1021/ml100158s; Palmer RH, 2009, BIOCHEM J, V420, P345, DOI 10.1042/BJ20090387; Park HC, 2000, NEUROSCI LETT, V279, P81, DOI 10.1016/S0304-3940(99)00940-4; Pasini A, 2001, MECH DEVELOP, V100, P317, DOI 10.1016/S0925-4773(00)00538-4; Perez-Pinera P, 2007, J BIOL CHEM, V282, P28683, DOI 10.1074/jbc.M704505200; Pogoda HM, 2006, DEVELOPMENT, V133, P1079, DOI 10.1242/dev.02296; Reiff T, 2011, DEVELOPMENT, V138, P4699, DOI 10.1242/dev.072157; Robu ME, 2007, PLOS GENET, V3, P787, DOI 10.1371/journal.pgen.0030078; Roll JD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031733; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; SHIOTA M, 1995, BLOOD, V86, P1954, DOI 10.1182/blood.V86.5.1954.bloodjournal8651954; Soda M, 2007, NATURE, V448, P561, DOI 10.1038/nature05945; Thermes V, 2002, MECH DEVELOP, V118, P91, DOI 10.1016/S0925-4773(02)00218-6; To TT, 2012, DEVELOPMENT, V139, P141, DOI 10.1242/dev.071035; Tomita K, 2000, EMBO J, V19, P5460, DOI 10.1093/emboj/19.20.5460; Vernersson E, 2006, GENE EXPR PATTERNS, V6, P448, DOI 10.1016/j.modgep.2005.11.006; Weiss A, 1998, CELL, V94, P277, DOI 10.1016/S0092-8674(00)81469-5; Yi SH, 2008, MOL THER, V16, P1873, DOI 10.1038/mt.2008.189; Zhu SZ, 2012, CANCER CELL, V21, P362, DOI 10.1016/j.ccr.2012.02.010	59	41	42	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2013	8	5							e63757	10.1371/journal.pone.0063757	http://dx.doi.org/10.1371/journal.pone.0063757			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145YI	23667670	Green Published, gold			2022-12-27	WOS:000319055600073
J	Cox, JL; Wilder, PJ; Gilmore, JM; Wuebben, EL; Washburn, MP; Rizzino, A				Cox, Jesse L.; Wilder, Phillip J.; Gilmore, Joshua M.; Wuebben, Erin L.; Washburn, Michael P.; Rizzino, Angie			The SOX2-Interactome in Brain Cancer Cells Identifies the Requirement of MSI2 and USP9X for the Growth of Brain Tumor Cells	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; TRANSFORMING GROWTH-FACTOR-BETA-2 GENE; AGGRESSIVE MYELOID-LEUKEMIA; FAM DEUBIQUITYLATING ENZYME; PROTEIN-INTERACTION NETWORK; GLIOBLASTOMA-MULTIFORME; HUMAN MEDULLOBLASTOMAS; INITIATING CELLS; BETA-CATENIN; IN-VITRO	Medulloblastomas and glioblastomas, the most common primary brain tumors in children and adults, respectively, are extremely difficult to treat. Efforts to identify novel proteins essential for the growth of these tumors may help to further our understanding of the biology of these tumors, as well as, identify targets for future therapies. The recent identification of multiple transcription factor-centric protein interaction landscapes in embryonic stem cells has identified numerous understudied proteins that are essential for the self-renewal of these stem cells. To identify novel proteins essential for the fate of brain tumor cells, we examined the protein interaction network of the transcription factor, SOX2, in medulloblastoma cells. For this purpose, Multidimensional Protein Identification Technology (MudPIT) identified >280 SOX2-associated proteins in the medulloblastoma cell line DAOY. To begin to understand the roles of SOX2-associated proteins in brain cancer, we focused on two SOX2-associated proteins, Musashi 2 (MSI2) and Ubiquitin Specific Protease 9x (USP9X). Recent studies have implicated MSI2, a putative RNA binding protein, and USP9X, a deubiquitinating enzyme, in several cancers, but not brain tumors. We demonstrate that knockdown of MSI2 significantly reduces the growth of DAOY cells as well as U87 and U118 glioblastoma cells. We also demonstrate that the knockdown of USP9X in DAOY, U87 and U118 brain tumor cells strongly reduces their growth. Together, our studies identify a large set of SOX2-associated proteins in DAOY medulloblastoma cells and identify two proteins, MSI2 and USP9X, that warrant further investigation to determine whether they are potential therapeutic targets for brain cancer.	[Cox, Jesse L.; Wilder, Phillip J.; Wuebben, Erin L.; Rizzino, Angie] Univ Nebraska Med Ctr, Eppley Inst Res Canc & Allied Dis, Omaha, NE USA; [Gilmore, Joshua M.; Washburn, Michael P.] Stowers Inst Med Res, Kansas City, MO USA; [Gilmore, Joshua M.; Washburn, Michael P.] Univ Kansas, Med Ctr, Dept Pathol & Lab Med, Kansas City, KS 66103 USA	University of Nebraska System; University of Nebraska Medical Center; Stowers Institute for Medical Research; University of Kansas; University of Kansas Medical Center	Rizzino, A (corresponding author), Univ Nebraska Med Ctr, Eppley Inst Res Canc & Allied Dis, Omaha, NE USA.	arizzino@unmc.edu		Washburn, Michael/0000-0001-7568-2585	Nebraska Department of Health [2011-29, 2012-33]; NCI training grant [CA009476]; Stowers Institute for Medical Research; NATIONAL CANCER INSTITUTE [T32CA009476] Funding Source: NIH RePORTER	Nebraska Department of Health; NCI training grant; Stowers Institute for Medical Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was funded by grants from the Nebraska Department of Health (2011-29, 2012-33). EW was supported in part by an NCI training grant (CA009476). JMG and MPW were supported by the Stowers Institute for Medical Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdouh M, 2009, J NEUROSCI, V29, P8884, DOI 10.1523/JNEUROSCI.0968-09.2009; Abreu RD, 2009, J BIOL CHEM, V284, P12125, DOI 10.1074/jbc.M809605200; Al-Hakim AK, 2008, BIOCHEM J, V411, P249, DOI 10.1042/BJ20080067; Cheng X, 2008, DEVELOPMENT, V135, P3447, DOI 10.1242/dev.025916; Cho YJ, 2011, J CLIN ONCOL, V29, P1424, DOI 10.1200/JCO.2010.28.5148; Connolly EC, 2012, INT J BIOL SCI, V8, P964, DOI 10.7150/ijbs.4564; Cox JL, 2011, J CELL SCI, V124, P2654, DOI 10.1242/jcs.083238; Cox JL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015486; Di Marcotullio L, 2006, NAT CELL BIOL, V8, P1415, DOI 10.1038/ncb1510; Ding JJ, 2012, CELL RES, V22, P155, DOI 10.1038/cr.2011.179; Dupont S, 2009, CELL, V136, P123, DOI 10.1016/j.cell.2008.10.051; Eichhorn PJA, 2012, NAT MED, V18, P429, DOI 10.1038/nm.2619; Elias JE, 2005, NAT METHODS, V2, P667, DOI 10.1038/NMETH785; Euskirchen P, 2011, EXP CELL RES, V317, P2864, DOI 10.1016/j.yexcr.2011.09.002; Fang XF, 2011, PROTEOMICS, V11, P921, DOI 10.1002/pmic.201000419; Festa M, 2011, AM J PATHOL, V178, P2504, DOI 10.1016/j.ajpath.2011.02.002; Gangemi RMR, 2009, STEM CELLS, V27, P40, DOI 10.1634/stemcells.2008-0493; Gao ZH, 2012, J BIOL CHEM, V287, P11384, DOI 10.1074/jbc.M111.320143; Griner LN, 2010, CANCER BIOL THER, V10, P979, DOI 10.4161/cbt.10.10.14010; Huang Q, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-304; Imai T, 2001, MOL CELL BIOL, V21, P3888, DOI 10.1128/MCB.21.12.3888-3900.2001; Ito T, 2010, NATURE, V466, P765, DOI 10.1038/nature09171; Katoh M, 2006, INT J MOL MED, V18, P517; KELLY D, 1995, MOL REPROD DEV, V40, P135, DOI 10.1002/mrd.1080400202; Kharas MG, 2010, NAT MED, V16, P903, DOI 10.1038/nm.2187; Kingsley-Kallesen M, 2001, IN VITRO CELL DEV-AN, V37, P684; Krex D, 2007, BRAIN, V130, P2596, DOI 10.1093/brain/awm204; Leung C, 2004, NATURE, V428, P337, DOI 10.1038/nature02385; Liang J, 2008, NAT CELL BIOL, V10, P731, DOI 10.1038/ncb1736; Mallanna SK, 2012, J CELL PHYSIOL, V227, P27, DOI 10.1002/jcp.22721; Mallanna SK, 2010, STEM CELLS, V28, P1715, DOI 10.1002/stem.494; Mouchantaf R, 2006, J BIOL CHEM, V281, P38738, DOI 10.1074/jbc.M605959200; Murray RZ, 2004, MOL BIOL CELL, V15, P1591, DOI 10.1091/mbc.E03-08-0630; Muto J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033431; Nagai H, 2009, MOL CELL, V36, P805, DOI 10.1016/j.molcel.2009.10.016; Nathan JA, 2008, TRAFFIC, V9, P1130, DOI 10.1111/j.1600-0854.2008.00747.x; Pantaleon M, 2001, MECH DEVELOP, V109, P151, DOI 10.1016/S0925-4773(01)00551-2; Pardo M, 2010, CELL STEM CELL, V6, P382, DOI 10.1016/j.stem.2010.03.004; Perek D, 1998, CHILD NERV SYST, V14, P582, DOI 10.1007/s003810050276; Perez-Mancera PA, 2012, NATURE, V486, P266, DOI 10.1038/nature11114; Ringer L, 2011, CANCER BIOL THER, V12, P818, DOI 10.4161/cbt.12.9.17682; Rizzino A., 2013, STEM CELL IN PRESS; Robinson G, 2012, NATURE, V488, P43, DOI 10.1038/nature11213; Sanchez-Diaz PC, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-280; Schwickart M, 2010, NATURE, V463, P103, DOI 10.1038/nature08646; Shi DD, 2010, CANCER BIOL THER, V10, P737, DOI 10.4161/cbt.10.8.13417; Sutter R, 2010, ONCOGENE, V29, P1845, DOI 10.1038/onc.2009.472; Taya S, 1999, GENES CELLS, V4, P757, DOI 10.1046/j.1365-2443.1999.00297.x; Taylor MD, 2012, ACTA NEUROPATHOL, V123, P465, DOI 10.1007/s00401-011-0922-z; Theard D, 2010, EMBO J, V29, P1499, DOI 10.1038/emboj.2010.46; Thompson MC, 2006, J CLIN ONCOL, V24, P1924, DOI 10.1200/JCO.2005.04.4974; van den Berg DLC, 2010, CELL STEM CELL, V6, P369, DOI 10.1016/j.stem.2010.02.014; Wang JL, 2006, NATURE, V444, P364, DOI 10.1038/nature05284; Wiebe MS, 2007, CELL HOST MICROBE, V1, P187, DOI 10.1016/j.chom.2007.03.007; Wuebben EL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034827; Zhang Y, 2010, ANAL CHEM, V82, P2272, DOI 10.1021/ac9023999	56	80	85	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e62857	10.1371/journal.pone.0062857	http://dx.doi.org/10.1371/journal.pone.0062857			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667531	gold, Green Submitted, Green Published			2022-12-27	WOS:000319654700070
J	De La Fuente, L; Parker, JK; Oliver, JE; Granger, S; Brannen, PM; van Santen, E; Cobine, PA				De La Fuente, Leonardo; Parker, Jennifer K.; Oliver, Jonathan E.; Granger, Shea; Brannen, Phillip M.; van Santen, Edzard; Cobine, Paul A.			The Bacterial Pathogen Xylella fastidiosa Affects the Leaf Ionome of Plant Hosts during Infection	PLOS ONE			English	Article							PHONY PEACH DISEASE; VITIS-VINIFERA CV; PIERCES-DISEASE; NUTRITIONAL IMMUNITY; BIOFILM FORMATION; WATER-STRESS; CALCIUM; GRAPEVINE; CITRUS; SYMPTOMS	Xylella fastidiosa is a plant pathogenic bacterium that lives inside the host xylem vessels, where it forms biofilm believed to be responsible for disrupting the passage of water and nutrients. Here, Nicotiana tabacum was infected with X. fastidiosa, and the spatial and temporal changes in the whole-leaf ionome (i.e. the mineral and trace element composition) were measured as the host plant transitioned from healthy to diseased physiological status. The elemental composition of leaves was used as an indicator of the physiological changes in the host at a specific time and relative position during plant development. Bacterial infection was found to cause significant increases in concentrations of calcium prior to the appearance of symptoms and decreases in concentrations of phosphorous after symptoms appeared. Field-collected leaves from multiple varieties of grape, blueberry, and pecan plants grown in different locations over a four-year period in the Southeastern US showed the same alterations in Ca and P. This descriptive ionomics approach characterizes the existence of a mineral element-based response to X. fastidiosa using a model system suitable for further manipulation to uncover additional details of the role of mineral elements during plant-pathogen interactions. This is the first report on the dynamics of changes in the ionome of the host plant throughout the process of infection by a pathogen.	[De La Fuente, Leonardo; Parker, Jennifer K.; Oliver, Jonathan E.] Auburn Univ, Dept Entomol & Plant Pathol, Auburn, AL 36849 USA; [Granger, Shea; Cobine, Paul A.] Auburn Univ, Dept Biol Sci, Auburn, AL 36849 USA; [Brannen, Phillip M.] Univ Georgia, Dept Plant Pathol, Athens, GA 30602 USA; [van Santen, Edzard] Auburn Univ, Dept Agron & Soils, Auburn, AL 36849 USA	Auburn University System; Auburn University; Auburn University System; Auburn University; University System of Georgia; University of Georgia; Auburn University System; Auburn University	De La Fuente, L (corresponding author), Auburn Univ, Dept Entomol & Plant Pathol, Auburn, AL 36849 USA.	lzd0005@auburn.edu	van Santen, Edzard/AAH-5979-2020; Parker, Jennifer/A-3273-2012; Cobine, Paul/AAH-6619-2020; Cobine, Paul A/G-3107-2011; Parker, Jennifer K/AGX-7067-2022; De La Fuente, Leonardo/A-2012-2013	Parker, Jennifer/0000-0002-4382-0741; Cobine, Paul/0000-0001-6012-0985; Cobine, Paul A/0000-0001-6012-0985; Parker, Jennifer K/0000-0002-4382-0741; De La Fuente, Leonardo/0000-0002-0027-4840; Oliver, Jonathan/0000-0003-2692-5055	Agriculture and Food Research Initiative Competitive Grants Program from the USDA National Institute of Food and Agriculture [2010-65108-20633]; Alabama Agricultural Experiment Station Hatch Grant Program	Agriculture and Food Research Initiative Competitive Grants Program from the USDA National Institute of Food and Agriculture; Alabama Agricultural Experiment Station Hatch Grant Program	This project was supported by Agriculture and Food Research Initiative Competitive Grants Program grant no. 2010-65108-20633 from the USDA National Institute of Food and Agriculture and the Alabama Agricultural Experiment Station Hatch Grant Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSEN PC, 1989, PHYSIOL PLANTARUM, V75, P63, DOI 10.1111/j.1399-3054.1989.tb02064.x; ANDERSEN PC, 1987, PHYSIOL MOL PLANT P, V31, P25, DOI 10.1016/0885-5765(87)90004-X; Andersen PC, 2007, FEMS MICROBIOL LETT, V274, P210, DOI 10.1111/j.1574-6968.2007.00827.x; Barker A. V., 2007, HDB PLANT NUTR; Barker A.V., 2007, HDB PLANT NUTR, V2nd ed., P3; Baxter IR, 2008, P NATL ACAD SCI USA, V105, P12081, DOI 10.1073/pnas.0804175105; BENGTSSON B, 1982, PHYSIOL PLANTARUM, V54, P107, DOI 10.1111/j.1399-3054.1982.tb06311.x; Chang CJ, 2009, HORTSCIENCE, V44, P413, DOI 10.21273/HORTSCI.44.2.413; Chatterjee S, 2008, ANNU REV PHYTOPATHOL, V46, P243, DOI 10.1146/annurev.phyto.45.062806.094342; Choat B, 2009, PHYSIOL PLANTARUM, V136, P384, DOI 10.1111/j.1399-3054.2009.01231.x; Choi H-K, 2013, MOL PLANT MICROBE IN; CLARKSON DT, 1984, PLANT CELL ENVIRON, V7, P449, DOI 10.1111/j.1365-3040.1984.tb01435.x; Cobine PA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054936; Cruz LF, 2012, APPL ENVIRON MICROB, V78, P1321, DOI 10.1128/AEM.06501-11; Dandekar AM, 2012, P NATL ACAD SCI USA, V109, P3721, DOI 10.1073/pnas.1116027109; Datnoff LE., 2007, MINERAL NUTR PLANT D; DAVIS MJ, 1981, CURR MICROBIOL, V6, P309, DOI 10.1007/BF01566883; DOYLE JJ, 1987, TAXON, V36, P715, DOI 10.2307/1221122; EVERT DR, 1981, J AM SOC HORTIC SCI, V106, P780; Finney LA, 2003, SCIENCE, V300, P931, DOI 10.1126/science.1085049; Francis M, 2008, PLANT DIS, V92, P14, DOI 10.1094/PDIS-92-1-0014; Francis M, 2006, EUR J PLANT PATHOL, V115, P203, DOI 10.1007/s10658-006-9009-4; Fritschi FB, 2008, PLANT DIS, V92, P276, DOI 10.1094/PDIS-92-2-0276; Gomes MMA, 2003, PLANT GROWTH REGUL, V39, P263, DOI 10.1023/A:1022854405898; GOODWIN PH, 1988, PHYSIOL MOL PLANT P, V32, P17, DOI 10.1016/S0885-5765(88)80003-1; GOODWIN PH, 1988, PHYSIOL MOL PLANT P, V32, P1, DOI 10.1016/S0885-5765(88)80002-X; Habermann G, 2003, SCI HORTIC-AMSTERDAM, V98, P233, DOI 10.1016/S0304-4238(02)00228-5; Hansch R, 2009, CURR OPIN PLANT BIOL, V12, P259, DOI 10.1016/j.pbi.2009.05.006; Hirschi KD, 2003, TRENDS BIOTECHNOL, V21, P520, DOI 10.1016/j.tibtech.2003.09.013; Hood MI, 2012, NAT REV MICROBIOL, V10, P525, DOI 10.1038/nrmicro2836; HOPKINS DL, 1989, ANNU REV PHYTOPATHOL, V27, P271, DOI 10.1146/annurev.py.27.090189.001415; Hopkins DL, 2002, PLANT DIS, V86, P1056, DOI 10.1094/PDIS.2002.86.10.1056; Huber DM, 2007, LANDBAUFORSCH VOLK, V57, P313; Krivanek AF, 2005, PHYTOPATHOLOGY, V95, P36, DOI 10.1094/PHYTO-95-0036; Kudla J, 2010, PLANT CELL, V22, P541, DOI 10.1105/tpc.109.072686; Lahner B, 2003, NAT BIOTECHNOL, V21, P1215, DOI 10.1038/nbt865; Lecourieux D, 2006, NEW PHYTOL, V171, P249, DOI 10.1111/j.1469-8137.2006.01777.x; Leite B, 2002, BRAZ J MED BIOL RES, V35, P645, DOI 10.1590/S0100-879X2002000600003; Maathuis FJM, 2009, CURR OPIN PLANT BIOL, V12, P250, DOI 10.1016/j.pbi.2009.04.003; MARSCHNER H, 1995, MINERAL NUTR HIGHER, V15; MINSAVAGE GV, 1994, PHYTOPATHOLOGY, V84, P456, DOI 10.1094/Phyto-84-456; Musetti R, 2012, MOL PLANT MICROBE IN; Pilbeam DJ, 2007, HDB PLANT NUTR, P121; Purcell AH, 1996, ANNU REV PHYTOPATHOL, V34, P131, DOI 10.1146/annurev.phyto.34.1.131; Purcino RP, 2007, J EXP BOT, V58, P2733, DOI 10.1093/jxb/erm138; Reuter DJ., 1997, PLANT ANAL INTERPRET, P241, DOI 10.1071/9780643101265; Salt DE, 2008, ANNU REV PLANT BIOL, V59, P709, DOI 10.1146/annurev.arplant.59.032607.092942; Sanchez C., 2007, HDB PLANT NUTR, P51; Silva-Stenico ME, 2009, BRAZ J BIOL, V69, P859, DOI 10.1590/S1519-69842009000400013; Thorne ET, 2006, AM J ENOL VITICULT, V57, P1; Van Sluys MA, 2003, J BACTERIOL, V185, P1018, DOI 10.1128/JB.185.3.1018-1026.2003; Van Sluys MA, 2002, ANNU REV PHYTOPATHOL, V40, P169, DOI 10.1146/annurev.phyto.40.030402.090559; Wallis CM, 2012, PHYTOPATHOLOGY, V102, P816, DOI 10.1094/PHYTO-04-12-0074-R; WEINBERG ED, 1975, JAMA-J AM MED ASSOC, V231, P39, DOI 10.1001/jama.231.1.39; Williams L, 2009, CURR OPIN PLANT BIOL, V12, P247, DOI 10.1016/j.pbi.2009.05.009; Zaini PA, 2008, J BACTERIOL, V190, P2368, DOI 10.1128/JB.01495-07; Zhou T, 2012, DALTON T, V41, P6371, DOI 10.1039/c2dt12159j	57	51	52	1	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e62945	10.1371/journal.pone.0062945	http://dx.doi.org/10.1371/journal.pone.0062945			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667547	gold, Green Submitted, Green Published			2022-12-27	WOS:000319654700085
J	Hernandez, L; Terradas, M; Martin, M; Feijoo, P; Soler, D; Tusell, L; Genesca, A				Hernandez, Laia; Terradas, Mariona; Martin, Marta; Feijoo, Purificacion; Soler, David; Tusell, Laura; Genesca, Anna			Increased Mammogram-Induced DNA Damage in Mammary Epithelial Cells Aged In Vitro	PLOS ONE			English	Article							CANCER-MORTALITY; BREAST-CANCER; IONIZING-RADIATION; TELOMERE DYSFUNCTION; GENOMIC INSTABILITY; HISTONE H2AX; EXPOSURE; RISKS; REPAIR; WORKERS	Concerned about the risks of mammography screening in the adult population, we analyzed the ability of human mammary epithelial cells to cope with mammogram-induced DNA damage. Our study shows that an X-ray dose of 20 mGy, which is the standard dose received by the breast surface per two-view mammogram X-ray exploration, induces increased frequencies of DNA double-strand breaks to in vitro aged-but not to young-human mammary epithelial cells. We provide evidence that aged epithelial breast cells are more radiosensitive than younger ones. Our studies point to an inefficient damage response of aged cells to low-dose radiation, this being due to both delayed and incomplete mobilization of repair proteins to DNA strand breaks. This inefficient damage response is translated into an important delay in double-strand break disappearance and consequent accumulation of unrepaired DNA breaks. The result of this is a significant increase in micronuclei frequency in the in vitro aged mammary epithelial cells exposed to doses equivalent to a single mammogram X-ray exploration. Since our experiments were carried out in primary epithelial cell cultures in which cells age at the same time as they undergo replication-dependent telomere shortening, we needed to determine the contribution of these two factors to their phenotype. In this paper, we report that the exogenous expression of human telomerase retrotranscriptase in late population doubling epithelial cells does not rescue its delayed repair phenotype. Therefore, retarded DNA break repair is a direct consequence of cellular aging itself, rather than a consequence of the presence of dysfunctional telomeres. Our findings of long-lasting double strand breaks and incomplete DNA break repair in the in vitro aged epithelial cells are in line with the increased carcinogenic risks of radiation exposures at older ages revealed by epidemiologic studies.	[Hernandez, Laia; Terradas, Mariona; Martin, Marta; Feijoo, Purificacion; Soler, David; Tusell, Laura; Genesca, Anna] Univ Autonoma Barcelona, Dept Cell Biol Physiol & Immunol, Bellaterra, Spain	Autonomous University of Barcelona	Genesca, A (corresponding author), Univ Autonoma Barcelona, Dept Cell Biol Physiol & Immunol, Bellaterra, Spain.	anna.genesca@uab.es	Martín Flix, Marta/J-4325-2017; Terradas, Mariona/K-5775-2017; Genesca, Anna/J-4195-2017; Tusell, Laura/H-8699-2017	Martín Flix, Marta/0000-0001-7849-3616; Terradas, Mariona/0000-0001-7813-1172; Genesca, Anna/0000-0002-0509-956X; Tusell, Laura/0000-0002-2848-345X	Consejo de Seguridad Nuclear [CSN 2012-0001]; EURATOM [GA 323216]; Instituto de Salud Carlos III [RD06/0020/1020]; Generalitat de Catalunya [2009SGR-282]	Consejo de Seguridad Nuclear; EURATOM; Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Generalitat de Catalunya(Generalitat de Catalunya)	This work was funded by grants from Consejo de Seguridad Nuclear (CSN 2012-0001) and EURATOM (Dark. Risk GA 323216). AG laboratory is supported by Instituto de Salud Carlos III (RD06/0020/1020) and Generalitat de Catalunya (2009SGR-282). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Autier P, 2011, ANN ONCOL, V22, P1726, DOI 10.1093/annonc/mdq633; Brenner DJ, 2003, P NATL ACAD SCI USA, V100, P13761, DOI 10.1073/pnas.2235592100; Campisi J, 2005, CELL, V120, P513, DOI 10.1016/j.cell.2005.02.003; Costes SV, 2010, MUTAT RES-REV MUTAT, V704, P78, DOI 10.1016/j.mrrev.2009.12.006; D'Angelo MA, 2009, CELL, V136, P284, DOI 10.1016/j.cell.2008.11.037; Esserman L, 2009, JAMA-J AM MED ASSOC, V302, P1685, DOI 10.1001/jama.2009.1498; FitzGerald JE, 2009, BIOCHEM SOC T, V37, P897, DOI 10.1042/BST0370897; Hong Z, 2007, J CELL PHYSIOL, V210, P567, DOI 10.1002/jcp.20919; Howe GR, 1996, RADIAT RES, V145, P694, DOI 10.2307/3579360; KNEALE GW, 1995, OCCUP ENVIRON MED, V52, P515, DOI 10.1136/oem.52.8.515; Kreiling JA, 2011, AGING CELL, V10, P292, DOI 10.1111/j.1474-9726.2010.00666.x; Krishnan V, 2011, AGING-US, V3, P943, DOI 10.18632/aging.100399; Lobrich M, 2007, NAT REV CANCER, V7, P861, DOI 10.1038/nrc2248; Ma HY, 2008, BREAST CANCER RES TR, V109, P77, DOI 10.1007/s10549-007-9625-5; MacPhail SH, 2003, RADIAT RES, V159, P759, DOI 10.1667/RR3003; Mao ZY, 2012, P NATL ACAD SCI USA, V109, P11800, DOI 10.1073/pnas.1200583109; Martin M, 2005, CANCER RES, V65, P10223, DOI 10.1158/0008-5472.CAN-05-0932; Martin M, 2003, INT J RADIAT BIOL, V79, P203, DOI 10.1080/0955300031000089601; Mullenders L, 2009, NAT REV CANCER, V9, P596, DOI 10.1038/nrc2677; Richardson DB, 1999, ENVIRON HEALTH PERSP, V107, P649, DOI 10.2307/3434457; Ritz B, 1999, EPIDEMIOLOGY, V10, P531, DOI 10.1097/00001648-199909000-00012; Rogakou EP, 1999, J CELL BIOL, V146, P905, DOI 10.1083/jcb.146.5.905; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Romanov SR, 2001, NATURE, V409, P633, DOI 10.1038/35054579; Ronckers CM, 2010, RADIAT RES, V174, P83, DOI 10.1667/RR2022.1; Rothkamm K, 2003, P NATL ACAD SCI USA, V100, P5057, DOI 10.1073/pnas.0830918100; Rothkamm K, 2001, CANCER RES, V61, P3886; Sedelnikova OA, 2004, NAT CELL BIOL, V6, P168, DOI 10.1038/ncb1095; Sedelnikova OA, 2008, AGING CELL, V7, P89, DOI 10.1111/j.1474-9726.2007.00354.x; Seluanov A, 2004, P NATL ACAD SCI USA, V101, P7624, DOI 10.1073/pnas.0400726101; Seluanov A, 2007, DNA REPAIR, V6, P1740, DOI 10.1016/j.dnarep.2007.06.010; Shuryak I, 2010, JNCI-J NATL CANCER I, V102, P1628, DOI 10.1093/jnci/djq346; Soler D, 2005, GENE CHROMOSOME CANC, V44, P339, DOI 10.1002/gcc.20244; Soler D, 2009, AGING CELL, V8, P414, DOI 10.1111/j.1474-9726.2009.00488.x; Terradas M, 2012, MUTAT RES-FUND MOL M, V729, P35, DOI 10.1016/j.mrfmmm.2011.09.003; Wing S, 2005, OCCUP ENVIRON MED, V62, P465, DOI 10.1136/oem.2005.019760	36	24	26	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e63052	10.1371/journal.pone.0063052	http://dx.doi.org/10.1371/journal.pone.0063052			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667571	Green Submitted, Green Published, gold			2022-12-27	WOS:000319654700103
J	Hogg, K; Blair, JD; McFadden, DE; von Dadelszen, P; Robinson, WP				Hogg, Kirsten; Blair, John D.; McFadden, Deborah E.; von Dadelszen, Peter; Robinson, Wendy P.			Early Onset Pre-Eclampsia Is Associated with Altered DNA Methylation of Cortisol-Signalling and Steroidogenic Genes in the Placenta	PLOS ONE			English	Article							CORTICOTROPIN-RELEASING HORMONE; 11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE-2; BETA-HYDROXYSTEROID DEHYDROGENASE; INTRAUTERINE GROWTH RESTRICTION; GLUCOCORTICOID-RECEPTOR; MESSENGER-RNA; HUMAN-FETAL; EPIGENETIC REGULATION; REDUCED EXPRESSION; MATERNAL PLASMA	Placental cortisol is inactivated in normotensive pregnancies, but is frequently present in pre-eclampsia associated placentae. Since glucocorticoids are strongly associated with the programming of long-term health, we assessed DNA methylation of genes involved in cortisol signalling and bioavailability, and hormonal signalling in the placenta of normotensive and hypertensive pregnancies. Candidate genes/CpG sites were selected through analysis of Illumina Infinium HumanMethylation450 BeadChip array data on control (n = 19) and early onset pre-eclampsia (EOPET; n = 19) placental samples. DNA methylation was further quantified by bisulfite pyrosequencing in a larger cohort of control (n = 111) cases, in addition to EOPET (n = 19), late onset pre-eclampsia (LOPET; n = 18) and normotensive intrauterine growth restriction (nIUGR; n = 13) cases. DNA methylation (percentage points) was increased at CpG sites within genes encoding the glucocorticoid receptor (NR3C1 exon 1D promoter; +8.46%; P<0.01) and corticotropin releasing hormone (CRH) binding protein (CRHBP intron 3; +9.14%; P<0.05), and decreased within CRH (5' UTR; -4.30%; P = 0.11) in EOPET-associated placentae, but not in LOPET nor nIUGR cases, compared to controls. Differential DNA methylation was not observed among groups at the 11 beta-hydroxysteroid dehydrogenase type 2 (HSD11B2) gene promoter. Significant hypomethylation was observed in pre-eclampsia but not nIUGR placentae for steroidogenic genes, including CYP11A1 (exon1; EOPET; -9.66%; P<0.00001, and LOPET; -5.77%; P<0.001), 3 beta-hydroxy-delta-5-steroid dehydrogenase type 1 (HSD3B1 exon 2; EOPET; -12.49%; P<0.00001, and LOPET; -6.88%; P<0.001), TEA domain family member 3 (TEAD3 intron 1; EOPET; -12.56%; P<0.00001) and CYP19 (placental-specific exon 1.1 promoter; EOPET; -10.62%, P<0.0001). These data represent dysregulation of the placental epigenome in pre-eclampsia related to genes involved in maintaining the hormonal environment during pregnancy and highlights particular susceptibility in the early onset syndrome.	[Hogg, Kirsten; Blair, John D.; Robinson, Wendy P.] Univ British Columbia, Dept Med Genet, Vancouver, BC, Canada; [McFadden, Deborah E.] Univ British Columbia, Dept Pathol, Vancouver, BC, Canada; [von Dadelszen, Peter] Univ British Columbia, Dept Obstet & Gynaecol, Vancouver, BC V5Z 1M9, Canada; [Hogg, Kirsten; Blair, John D.; McFadden, Deborah E.; von Dadelszen, Peter; Robinson, Wendy P.] Child & Family Res Inst, Vancouver, BC, Canada	University of British Columbia; University of British Columbia; University of British Columbia; Child & Family Research Institute	Robinson, WP (corresponding author), Univ British Columbia, Dept Med Genet, Vancouver, BC, Canada.	wrobinson@cfri.ca	Robinson, Wendy P/I-9590-2014; Robinson, Wendy/AAB-6420-2020; von Dadelszen, Peter/AAP-7480-2021	Robinson, Wendy P/0000-0002-2010-6174; Robinson, Wendy/0000-0002-2010-6174; McFadden, Deborah/0000-0002-0629-3436; von Dadelszen, Peter/0000-0003-4136-3070	Child & Family Research Institute (CFRI); CIHR grant [FRN-119402]; CFRI	Child & Family Research Institute (CFRI); CIHR grant(Canadian Institutes of Health Research (CIHR)); CFRI	KH is funded through a post-doctoral fellowship granted by the Child & Family Research Institute (CFRI), and work related to this study was funded through a CIHR grant (FRN-119402) to WPR. PvD and WPR receive salary support from the CFRI. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alikhani-Koopaei R, 2004, J CLIN INVEST, V114, P1146, DOI 10.1172/JCI200421647; Aufdenblatten M, 2009, PEDIATR RES, V65, P198, DOI 10.1203/PDR.0b013e31818d6c24; Avila L, 2010, PLACENTA, V31, P1070, DOI 10.1016/j.placenta.2010.09.011; Beaudoin C, 1997, J ENDOCRINOL, V154, P379, DOI 10.1677/joe.0.1540379; Ben-Zimra M, 2002, MOL ENDOCRINOL, V16, P1864, DOI 10.1210/me.2002-0056; Beshay VE, 2007, SEMIN REPROD MED, V25, P14, DOI 10.1055/s-2006-956772; Bourque DK, 2010, PLACENTA, V31, P197, DOI 10.1016/j.placenta.2009.12.003; Bromer C, 2013, DEV PSYCHOBIOL, V55, P673, DOI 10.1002/dev.21061; Bulun SE, 2004, SEMIN REPROD MED, V22, P5; Cao-Lei L, 2011, HUM GENET, V129, P533, DOI 10.1007/s00439-011-0949-1; Demura M, 2008, MOL CELL ENDOCRINOL, V283, P127, DOI 10.1016/j.mce.2007.12.003; Du P, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-587; Dy J, 2008, PLACENTA, V29, P193, DOI 10.1016/j.placenta.2007.10.010; EDWARDS CRW, 1993, LANCET, V341, P355, DOI 10.1016/0140-6736(93)90148-A; Egbor M, 2006, BJOG-INT J OBSTET GY, V113, P580, DOI 10.1111/j.1471-0528.2006.00882.x; Filiberto AC, 2011, EPIGENETICS-US, V6, P566, DOI 10.4161/epi.6.5.15236; Florio P, 2004, J CLIN ENDOCR METAB, V89, P4673, DOI 10.1210/jc.2004-0186; Galbiati S, 2010, CLIN CHEM LAB MED, V48, P791, DOI 10.1515/CCLM.2010.160; Gangestad SW, 2012, BIOL REV, V87, P856, DOI 10.1111/j.1469-185X.2012.00226.x; Goland RS, 1995, REPROD FERT DEVELOP, V7, P1227, DOI 10.1071/RD9951227; GOLAND RS, 1993, J CLIN ENDOCR METAB, V77, P1174, DOI 10.1210/jc.77.5.1174; GOLAND RS, 1994, AM J OBSTET GYNECOL, V171, P1287, DOI 10.1016/0002-9378(94)90149-X; GOLAND RS, 1995, PLACENTA, V16, P375, DOI 10.1016/0143-4004(95)90095-0; Goswami D, 2006, PLACENTA, V27, P56, DOI 10.1016/j.placenta.2004.11.007; Harris A, 2011, HORM BEHAV, V59, P279, DOI 10.1016/j.yhbeh.2010.06.007; HERMANN R, 1991, FEBS LETT, V281, P191, DOI 10.1016/0014-5793(91)80391-F; Hogg K, 2012, CLIN PHARMACOL THER, V92, P716, DOI 10.1038/clpt.2012.141; Hogg K, 2013, MOL CELL ENDOCRINOL, V367, P64, DOI 10.1016/j.mce.2012.12.018; HOLLENBERG SM, 1985, NATURE, V318, P635, DOI 10.1038/318635a0; Holmes MC, 2006, J NEUROSCI, V26, P3840, DOI 10.1523/JNEUROSCI.4464-05.2006; Jacquemin P, 1997, J BIOL CHEM, V272, P12928, DOI 10.1074/jbc.272.20.12928; Jiang XY, 2012, FASEB J, V26, P3563, DOI 10.1096/fj.12-207894; Johnson RF, 2008, J CLIN ENDOCR METAB, V93, P4887, DOI 10.1210/jc.2008-1077; JONES SA, 1989, J CLIN ENDOCR METAB, V68, P825, DOI 10.1210/jcem-68-4-825; Karteris E, 2003, J CLIN ENDOCR METAB, V88, P363, DOI 10.1210/jc.2002-020375; KHONG TY, 1986, BRIT J OBSTET GYNAEC, V93, P1049, DOI 10.1111/j.1471-0528.1986.tb07830.x; Khulan B, 2012, BEST PRACT RES CL EN, V26, P689, DOI 10.1016/j.beem.2012.03.007; King BR, 2001, PEPTIDES, V22, P1939, DOI 10.1016/S0196-9781(01)00485-5; Knower KC, 2010, MOL CELL ENDOCRINOL, V321, P123, DOI 10.1016/j.mce.2010.02.035; Kramer MS, 2001, PEDIATRICS, V108, DOI 10.1542/peds.108.2.e35; Lee KJ, 2010, PLACENTA, V31, P698, DOI 10.1016/j.placenta.2010.05.006; Lewis G, 2003, BRIT MED BULL, V67, P27, DOI 10.1093/bmb/ldg009; Lindsay RS, 1996, HYPERTENSION, V27, P1200, DOI 10.1161/01.HYP.27.6.1200; Lindsay RS, 1996, DIABETOLOGIA, V39, P1299, DOI 10.1007/s001250050573; Magee LA, 2008, J OBSTET GYNAECOL CA, V30, pS1, DOI 10.1016/S1701-2163(16)32776-1; Maksimovic J, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-6-r44; Marsit CJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033794; Mayor-Lynn K, 2011, REPROD SCI, V18, P46, DOI 10.1177/1933719110374115; McGowan PO, 2009, NAT NEUROSCI, V12, P342, DOI 10.1038/nn.2270; McTernan CL, 2001, J CLIN ENDOCR METAB, V86, P4979, DOI 10.1210/jc.86.10.4979; Mendelson CR, 2007, J STEROID BIOCHEM, V106, P62, DOI 10.1016/j.jsbmb.2007.05.001; Michael AE, 2008, HUM REPROD UPDATE, V14, P497, DOI 10.1093/humupd/dmn021; Mikeska T, 2011, METHODS MOL BIOL, V791, P33, DOI 10.1007/978-1-61779-316-5_4; Moldenhauer JS, 2003, AM J OBSTET GYNECOL, V189, P1173, DOI 10.1067/S0002-9378(03)00576-3; Mulligan CJ, 2012, EPIGENETICS-US, V7, P853, DOI 10.4161/epi.21180; MUNCK A, 1984, ENDOCR REV, V5, P25, DOI 10.1210/edrv-5-1-25; Ng EKO, 2003, CLIN CHEM, V49, P727, DOI 10.1373/49.5.727; Non AL, 2012, PLACENTA, V33, P183, DOI 10.1016/j.placenta.2011.12.013; Oberlander TF, 2008, EPIGENETICS-US, V3, P97, DOI 10.4161/epi.3.2.6034; Pena CJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039791; Peng LH, 2004, MOL ENDOCRINOL, V18, P2049, DOI 10.1210/me.2004-0028; Perroud N, 2011, TRANSL PSYCHIAT, V1, DOI 10.1038/tp.2011.60; PLOTSKY PM, 1993, MOL BRAIN RES, V18, P195, DOI 10.1016/0169-328X(93)90189-V; Price EM, 2013, EPIGENETICS IN PRESS; Radtke KM, 2011, TRANSL PSYCHIAT, V1, DOI 10.1038/tp.2011.21; RILEY SC, 1991, J CLIN ENDOCR METAB, V72, P1001, DOI 10.1210/jcem-72-5-1001; Roberts JM, 2004, AM J OBSTET GYNECOL, V190, P1177, DOI 10.1016/j.ajog.2004.04.001; ROBINSON BG, 1988, P NATL ACAD SCI USA, V85, P5244, DOI 10.1073/pnas.85.14.5244; Rolfo A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013288; Rots NY, 1996, J NEUROENDOCRINOL, V8, P501, DOI 10.1046/j.1365-2826.1996.04843.x; Schoof E, 2001, J CLIN ENDOCR METAB, V86, P1313, DOI 10.1210/jc.86.3.1313; Shams M, 1998, HUM REPROD, V13, P799, DOI 10.1093/humrep/13.4.799; Shenker N, 2012, BRIT J CANCER, V106, P248, DOI 10.1038/bjc.2011.550; Sirianni R, 2005, J CLIN ENDOCR METAB, V90, P279, DOI 10.1210/jc.2004-0865; Strauss JF, 1996, BIOL REPROD, V54, P303, DOI 10.1095/biolreprod54.2.303; Takahashi LK, 1998, PSYCHONEUROENDOCRINO, V23, P571; Tamimi R, 2003, CANCER EPIDEM BIOMAR, V12, P647; Tuckey RC, 2004, ENDOCRINOLOGY, V145, P1700, DOI 10.1210/en.2003-1034; Turner JD, 2005, J MOL ENDOCRINOL, V35, P283, DOI 10.1677/jme.1.01822; Turner JD, 2008, NUCLEIC ACIDS RES, V36, P7207, DOI 10.1093/nar/gkn897; van der Merwe JL, 2010, HYPERTENS PREGNANCY, V29, P457, DOI 10.3109/10641950903572282; VINCE GS, 1995, BRIT J OBSTET GYNAEC, V102, P20, DOI 10.1111/j.1471-0528.1995.tb09020.x; von Dadelszen P, 2003, HYPERTENS PREGNANCY, V22, P143, DOI 10.1081/PRG-120021060; WALSH SW, 1988, OBSTET GYNECOL, V71, P222; Watari H, 1997, P NATL ACAD SCI USA, V94, P8462, DOI 10.1073/pnas.94.16.8462; Waterland RA, 2007, ANNU REV NUTR, V27, P363, DOI 10.1146/annurev.nutr.27.061406.093705; Weaver ICG, 2007, J NEUROSCI, V27, P1756, DOI 10.1523/JNEUROSCI.4164-06.2007; Weaver ICG, 2004, NAT NEUROSCI, V7, P847, DOI 10.1038/nn1276; Welberg LAM, 2000, EUR J NEUROSCI, V12, P1047, DOI 10.1046/j.1460-9568.2000.00958.x; Welberg LAM, 2001, J NEUROENDOCRINOL, V13, P113, DOI 10.1046/j.1365-2826.2001.00601.x; Wyrwoll CS, 2012, PLACENTA, V33, P220, DOI 10.1016/j.placenta.2011.12.017; Yang RF, 2006, J MOL ENDOCRINOL, V37, P533, DOI 10.1677/jme.1.02119; You XJ, 2006, BIOL REPROD, V74, P1067, DOI 10.1095/biolreprod.105.049361; Yuen RKC, 2010, EUR J HUM GENET, V18, P1006, DOI 10.1038/ejhg.2010.63; Yuen RKC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007389	95	83	88	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e62969	10.1371/journal.pone.0062969	http://dx.doi.org/10.1371/journal.pone.0062969			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667551	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000319654700089
J	Kim, JY; Ji, SY; Goo, YK; Na, BK; Pyo, HJ; Lee, HN; Lee, J; Kim, NH; von Seidlein, L; Cheng, Q; Cho, SH; Lee, WJ				Kim, Jung-Yeon; Ji, So-Young; Goo, Youn-Kyoung; Na, Byoung-Kuk; Pyo, Hyo-Joo; Lee, Han-Na; Lee, Juyoung; Kim, Nam Hee; von Seidlein, Lorenz; Cheng, Qin; Cho, Shin-Hyung; Lee, Won-Ja			Comparison of Rapid Diagnostic Tests for the Detection of Plasmodium vivax Malaria in South Korea	PLOS ONE			English	Article							ACCURACY; FALCIPARUM; FIELD	South Korea is one of many countries with endemic Plasmodium vivax malaria. Here we report the evaluation of four rapid diagnostic tests (RDTs) for diagnosis of this disease. A total of 253 subjects were enrolled in the study. The sensitivities, specificities and agreement frequencies were estimated by comparing the four RDTs against the standard of nested-PCR and microscopic examination. The CareStart (TM) and SD Bioline had higher test sensitivities (99.4 and 98.8%, respectively) compared with the NanoSign and Asan Easy tests (93.0 and 94.7%, respectively). The CareStart (TM) and SD Bioline tests could detect P. vivax in samples with parasite densities <150/mu l, which was a slightly better performance than the other two RDTs. The quantitative accuracy of the four RDTs was also estimated by comparing results with P. vivax counts from blood samples. Lower test price would result in increased use of these RDTs in the field. The results of this study contribute valuable information that will aid in the selection of a diagnostic method for the detection of malaria.	[Kim, Jung-Yeon; Ji, So-Young; Goo, Youn-Kyoung; Pyo, Hyo-Joo; Lee, Han-Na; Cho, Shin-Hyung; Lee, Won-Ja] Korea CDC, Natl Inst Hlth, Div Malaria & Parasit Dis, Osong, South Korea; [Goo, Youn-Kyoung] Kyungpook Natl Univ, Sch Med, Dept Parasitol & Trop Med, Taegu, South Korea; [Na, Byoung-Kuk] Gyeongsang Natl Univ, Sch Med, Dept Parasitol, Jinju, South Korea; [Na, Byoung-Kuk] Gyeongsang Natl Univ, Sch Med, Inst Hlth Sci, Jinju, South Korea; [Lee, Juyoung; Kim, Nam Hee] Korea CDC, Natl Inst Hlth, Ctr Genome Sci, Div Struct & Funct Genom, Osong, South Korea; [von Seidlein, Lorenz] Menzies Sch Hlth Res, Global Hlth Div, Casuarina, NT, Australia; [Cheng, Qin] Australian Army Malaria Inst, Brisbane, Qld, Australia	Korea Centers for Disease Control & Prevention (KCDC); Korea National Institute of Health (KNIH); Kyungpook National University; Gyeongsang National University; Gyeongsang National University; Korea Centers for Disease Control & Prevention (KCDC); Korea National Institute of Health (KNIH); Korea CDC Center for Genome Science; Charles Darwin University; Menzies School of Health Research; QIMR Berghofer Medical Research Institute	Lee, WJ (corresponding author), Korea CDC, Natl Inst Hlth, Div Malaria & Parasit Dis, Osong, South Korea.	wonja@nih.go.kr	Cheng, Qin/AAO-2198-2020	Cheng, Qin/0000-0001-7776-4437	Asia Pacific Migration and Environment Network (APMEN) [107-05]; intramural fund of Korea NIH [4837-302-210-13]	Asia Pacific Migration and Environment Network (APMEN); intramural fund of Korea NIH	This study was supported by extramural fund by the Asia Pacific Migration and Environment Network (APMEN) (project number 107-05) and intramural fund of Korea NIH (4837-302-210-13). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, MAL RAP DIAGN TEST P; [Anonymous], 2012, MAL RAP DIAGN TEST P; Ashton RA, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-297; Bates I, 2004, MALARIA J, V3, DOI 10.1186/1475-2875-3-38; Bossuyt PM, 2003, ANN INTERN MED, V138, P40, DOI 10.7326/0003-4819-138-1-200301070-00010; BRUCECHWATT LJ, 1987, LANCET, V2, P1509; Cho D, 2001, PARASITOL RES, V87, P445, DOI 10.1007/s004360000360; Coleman RE, 2002, AM J TROP MED HYG, V67, P141, DOI 10.4269/ajtmh.2002.67.141; Kim KH, 2011, TROP MED INT HEALTH, V16, P1427, DOI 10.1111/j.1365-3156.2011.02846.x; Kim SH, 2008, TROP MED INT HEALTH, V13, P1495, DOI 10.1111/j.1365-3156.2008.02163.x; Korea Center for Diseases Prevention and Control, 2011, NAT GUID MAL CONTR P; Mackinnon A, 2000, COMPUT BIOL MED, V30, P127, DOI 10.1016/S0010-4825(00)00006-8; Marx A, 2005, ANN INTERN MED, V142, P836, DOI 10.7326/0003-4819-142-10-200505170-00009; Mendis K, 2001, AM J TROP MED HYG, V64, P97, DOI 10.4269/ajtmh.2001.64.97; Moody A, 2002, CLIN MICROBIOL REV, V15, P66, DOI 10.1128/CMR.15.1.66-78.2002; Ochola LB, 2006, LANCET INFECT DIS, V6, P582, DOI 10.1016/S1473-3099(06)70579-5; Park Tae Sung, 2006, Korean J Lab Med, V26, P241, DOI 10.3343/kjlm.2006.26.4.241; SNOUNOU G, 1993, MOL BIOCHEM PARASIT, V58, P283, DOI 10.1016/0166-6851(93)90050-8	18	10	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e64353	10.1371/journal.pone.0064353	http://dx.doi.org/10.1371/journal.pone.0064353			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667710	gold, Green Published, Green Submitted			2022-12-27	WOS:000319654700208
J	Sentoku, A; Ezaki, Y				Sentoku, Asuka; Ezaki, Yoichi			Intrinsic Constraints on Sympodial Growth Morphologies of Azooxanthellate Scleractinian Coral Dendrophyllia	PLOS ONE			English	Article							BUDDING MODE; PLASTICITY; REGULARITY; MADRACIS; COLONIES; POLARITY	Background: Asexual increase occurs in virtually all colonial organisms. However, little is known about the intrinsic mechanisms that control asexual reproduction and the resultant morphologies of colonies. Scleractinian corals, both symbiotic (zoaxanthellate) and non-symbiotic (azooxanthellate) corals are known to form elaborate colonies. To better understand the growth mechanisms that control species-specific type of colony in azooxanthellate dendrophyllid scleractinian corals, we have studied details of the budding pattern in the sympodial colonies of Dendrophyllia boschmai and Dendrophyllia cribrosa. Principal Findings: Budding exhibits the following regularities: (1) the two directive septa of offset corallites are oriented almost perpendicular to the growth direction of parent corallites; (2) offsets generally occur in either of the lateral primary septa that occur on one side of a corallite; the individuals thus show a definite polarity with respect to the directive septa, and only when branching dichotomously offsets occur in both primary septa; (3) the lateral corallites grow more-or-less diagonally upwards; and (4) the regularities and polarities are maintained throughout growth. Given these regularities, D. boschmai grows in a zigzag fashion by alternately budding on the right and left sites. In contrast, D. cribrosa grows helically by budding at a particular site. Conclusions/Significance: The strict constraints on budding regularities and shifts in budding sites observed in the sympodial growth forms of corals greatly affect resulting morphologies in azooxanthellate coral colonies. A precise understanding of these intrinsic constraints leads to a fundamental comprehension of colony-forming mechanisms in modular organisms.	[Sentoku, Asuka; Ezaki, Yoichi] Osaka City Univ, Grad Sch Sci, Dept Geosci, Osaka 558, Japan	Osaka Metropolitan University	Sentoku, A (corresponding author), Osaka City Univ, Grad Sch Sci, Dept Geosci, Osaka 558, Japan.	sentoku@sci.osaka-cu.ac.jp			Scientific Research Fund of the Japan Society for the Promotion of Science [24340130, 25610151]	Scientific Research Fund of the Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by grants (24340130 and 25610151) from the Scientific Research Fund of the Japan Society for the Promotion of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bruno JF, 1997, ECOLOGY, V78, P2177, DOI 10.2307/2265954; Cairns Stephen D., 2001, Smithsonian Contributions to Zoology, V615, P1; Cairns Stephen D., 1994, SMITHSONIAN CONTRIBU, V557, P1, DOI DOI 10.5479/SI.00810282.557.I; DAUGET JM, 1991, MAR BIOL, V111, P157, DOI 10.1007/BF01986357; Ezaki Y, 2004, PALAEONTOLOGY, V47, P1075, DOI 10.1111/j.0031-0239.2004.00401.x; Filatov MV, 2010, P ROY SOC B-BIOL SCI, V277, P3555, DOI 10.1098/rspb.2010.0957; GRAUS R R, 1982, Smithsonian Contributions to the Marine Sciences, P441; Jackson JBC, 1979, MORPHOLOGICAL, V11, P499; Kaandorp JA, 2001, VIRTUAL LAB, P1; Lasker HR, 2003, BIOL BULL-US, V205, P319, DOI 10.2307/1543295; Muko S, 2000, B MAR SCI, V66, P225; Rinkevich B, 2002, ISRAEL J ZOOL, V48, P71, DOI 10.1560/BCPA-UM3A-MKBP-HGL2; Sentoku A, 2012, CORAL REEFS, V31, P67, DOI 10.1007/s00338-011-0808-5; Sentoku A, 2012, PALEONTOL RES, V16, P252, DOI 10.2517/1342-8144-16.3.252; Sentoku A, 2012, LETHAIA, V45, P586, DOI 10.1111/j.1502-3931.2012.00321.x; Sentoku A, 2012, LETHAIA, V45, P62, DOI 10.1111/j.1502-3931.2011.00293.x; Shaish L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004095; Todd PA, 2008, BIOL REV, V83, P315, DOI 10.1111/j.1469-185X.2008.00045.x	18	2	3	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e63790	10.1371/journal.pone.0063790	http://dx.doi.org/10.1371/journal.pone.0063790			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667672	gold, Green Published, Green Submitted			2022-12-27	WOS:000319654700186
J	Przewozniak, M; Czaplicka, I; Czerwinska, AM; Markowska-Zagrajek, A; Moraczewski, J; Streminska, W; Janczyk-Ilach, K; Ciemerych, MA; Brzoska, E				Przewozniak, Marta; Czaplicka, Iwona; Czerwinska, Areta M.; Markowska-Zagrajek, Agnieszka; Moraczewski, Jerzy; Streminska, Wladyslawa; Janczyk-Ilach, Katarzyna; Ciemerych, Maria A.; Brzoska, Edyta			Adhesion Proteins - An Impact on Skeletal Myoblast Differentiation	PLOS ONE			English	Article							MUSCLE SATELLITE CELLS; M-CADHERIN; MELTRIN-ALPHA; TERMINAL DIFFERENTIATION; FUSION; EXPRESSION; INTEGRIN; MYOGENESIS; MOLECULES; ADAM12	Formation of mammalian skeletal muscle myofibers, that takes place during embryogenesis, muscle growth or regeneration, requires precise regulation of myoblast adhesion and fusion. There are few evidences showing that adhesion proteins play important role in both processes. To follow the function of these molecules in myoblast differentiation we analysed integrin alpha3, integrin beta1, ADAM12, CD9, CD81, M-cadherin, and VCAM-1 during muscle regeneration. We showed that increase in the expression of these proteins accompanies myoblast fusion and myotube formation in vivo. We also showed that during myoblast fusion in vitro integrin alpha3 associates with integrin beta1 and ADAM12, and also CD9 and CD81, but not with M-cadherin or VCAM-1. Moreover, we documented that experimental modification in the expression of integrin alpha3 lead to the modification of myoblast fusion in vitro. Underexpression of integrin alpha3 decreased myoblasts' ability to fuse. This phenomenon was not related to the modifications in the expression of other adhesion proteins, i.e. integrin beta1, CD9, CD81, ADAM12, M-cadherin, or VCAM-1. Apparently, aberrant expression only of one partner of multiprotein adhesion complexes necessary for myoblast fusion, in this case integrin alpha3, prevents its proper function. Summarizing, we demonstrated the importance of analysed adhesion proteins in myoblast fusion both in vivo and in vitro.	[Przewozniak, Marta; Czaplicka, Iwona; Czerwinska, Areta M.; Markowska-Zagrajek, Agnieszka; Moraczewski, Jerzy; Streminska, Wladyslawa; Janczyk-Ilach, Katarzyna; Ciemerych, Maria A.; Brzoska, Edyta] Univ Warsaw, Fac Biol, Dept Cytol, Warsaw, Poland	University of Warsaw	Brzoska, E (corresponding author), Univ Warsaw, Fac Biol, Dept Cytol, Warsaw, Poland.	edbrzoska@biol.uw.edu.pl	Czerwinska, Areta/ABC-1239-2020; Gawor, Marta/AAC-4561-2021	Gawor, Marta/0000-0001-6757-9668; Czerwinska, Areta M./0000-0002-0862-4542; Brzoska, Edyta/0000-0002-7886-0436; Ciemerych, Maria A./0000-0003-0387-4179	Polish Ministry of Science and Higher Education [2P04C11230, N N301 422438]	Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland)	This research was supported by Polish Ministry of Science and Higher Education grant number 2P04C11230 and N N301 422438. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe E, 1999, CALCIFIED TISSUE INT, V64, P508, DOI 10.1007/s002239900641; Abmayr SM, 2012, DEVELOPMENT, V139, P641, DOI 10.1242/dev.068353; BASSAGLIA Y, 1995, J MUSCLE RES CELL M, V16, P420, DOI 10.1007/BF00114507; Beauchamp JR, 2000, J CELL BIOL, V151, P1221, DOI 10.1083/jcb.151.6.1221; Berditchevski F, 1996, MOL BIOL CELL, V7, P193, DOI 10.1091/mbc.7.2.193; Berditchevski F, 2001, J CELL SCI, V114, P4143; Biressi S, 2007, DEV BIOL, V308, P281, DOI 10.1016/j.ydbio.2007.06.006; Biressi S, 2010, SEMIN CELL DEV BIOL, V21, P845, DOI 10.1016/j.semcdb.2010.09.003; BISCHOFF R, 1975, ANAT REC, V182, P215, DOI 10.1002/ar.1091820207; Blanco-Bose WE, 2001, EXP CELL RES, V265, P212, DOI 10.1006/excr.2001.5191; Bornemann A, 2000, J MUSCLE RES CELL M, V21, P475, DOI 10.1023/A:1005657607591; Brzoska E, 2006, DIFFERENTIATION, V74, P105, DOI 10.1111/j.1432-0436.2005.00059.x; Buckingham M, 2007, CR BIOL, V330, P530, DOI 10.1016/j.crvi.2007.03.015; CIFUENTESDIAZ C, 1995, MECH DEVELOP, V50, P85, DOI 10.1016/0925-4773(94)00327-J; Cornelison DDW, 2001, DEV BIOL, V239, P79, DOI 10.1006/dbio.2001.0416; DENNY-BROWN D, 1955, Am J Phys Med, V34, P210; Galliano MF, 2000, J BIOL CHEM, V275, P13933, DOI 10.1074/jbc.275.18.13933; Gullberg D, 2003, NATURE, V424, P138, DOI 10.1038/424138a; Gullberg Donald, 1998, Frontiers in Bioscience, V3, pD1039; Horsley V, 2004, CELLS TISSUES ORGANS, V176, P67, DOI 10.1159/000075028; IRINTCHEV A, 1994, DEV DYNAM, V199, P326, DOI 10.1002/aja.1001990407; Kassar-Duchossoy L, 2005, GENE DEV, V19, P1426, DOI 10.1101/gad.345505; Kaufmann U, 1999, J CELL SCI, V112, P55; Kreidberg JA, 2000, CURR OPIN CELL BIOL, V12, P548, DOI 10.1016/S0955-0674(00)00130-7; Kurisaki T, 2003, MOL CELL BIOL, V23, P55, DOI 10.1128/MCB.23.1.55-61.2003; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lafuste P, 2005, MOL BIOL CELL, V16, P861, DOI 10.1091/mbc.e04-03-0226; Maitra N, 2000, CARDIOVASC RES, V47, P715, DOI 10.1016/S0008-6363(00)00140-1; Marino M, 2011, GENE THER, V18, P109, DOI 10.1038/gt.2010.124; MCDONALD KA, 1995, J CELL SCI, V108, P2573; MEGE RM, 1992, J CELL SCI, V103, P897; Moraczewski J, 1988, Monogr Dev Biol, V21, P78; Nowak SJ, 2009, J CELL SCI, V122, P3282, DOI 10.1242/jcs.047597; Pavlath GK, 2010, EXP CELL RES, V316, P3067, DOI 10.1016/j.yexcr.2010.05.025; POULIOT Y, 1994, DEV DYNAM, V200, P305, DOI 10.1002/aja.1002000405; Quach NL, 2009, MOL BIOL CELL, V20, P3422, DOI 10.1091/mbc.E09-02-0175; ROSEN GD, 1992, CELL, V69, P1107, DOI 10.1016/0092-8674(92)90633-N; Rosenberg P, 1997, DEV BIOL, V187, P55, DOI 10.1006/dbio.1997.8602; Schwander M, 2003, DEV CELL, V4, P673, DOI 10.1016/S1534-5807(03)00118-7; Tachibana I, 1999, J CELL BIOL, V146, P893, DOI 10.1083/jcb.146.4.893; Takemura T, 1999, KIDNEY INT, V55, P71, DOI 10.1046/j.1523-1755.1999.00259.x; Tidball JG, 2005, AM J PHYSIOL-REG I, V288, pR345, DOI 10.1152/ajpregu.00454.2004; Verca MSB, 2001, MOL CELL NEUROSCI, V17, P303, DOI 10.1006/mcne.2000.0942; Wrobel E, 2007, EUR J CELL BIOL, V86, P99, DOI 10.1016/j.ejcb.2006.11.004; YAGAMIHIROMASA T, 1995, NATURE, V377, P652, DOI 10.1038/377652a0; Yang JT, 1996, J CELL BIOL, V135, P829, DOI 10.1083/jcb.135.3.829; Zammit PS, 2013, J CELL SCI, V8; Zhao ZF, 2004, EXP CELL RES, V298, P28, DOI 10.1016/j.yexcr.2004.04.005	48	30	31	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2013	8	5							e61760	10.1371/journal.pone.0061760	http://dx.doi.org/10.1371/journal.pone.0061760			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	177QL	23671573	Green Published, gold, Green Submitted			2022-12-27	WOS:000321390200010
J	Dean, A; Mungall, W; McKinnell, C; Sharpe, RM				Dean, Afshan; Mungall, William; McKinnell, Chris; Sharpe, Richard M.			Prostaglandins, Masculinization and Its Disorders: Effects of Fetal Exposure of the Rat to the Cyclooxygenase Inhibitor- Indomethacin	PLOS ONE			English	Article							PROGRAMMING WINDOW; REPRODUCTIVE DEVELOPMENT; CRYPTORCHIDISM; PHTHALATE; TESTOSTERONE; PREGNANCY; INDUCTION; RUPTURE; RISK; ACID	Recent studies have established that masculinization of the male reproductive tract is programmed by androgens in a critical fetal 'masculinization programming window' (MPW). What is peculiar to androgen action during this period is, however, unknown. Studies from 20 years ago in mice implicated prostaglandin (PG)-mediation of androgen-induced masculinization, but this has never been followed up. We therefore investigated if PGs might mediate androgen effects in the MPW by exposing pregnant rats to indomethacin (which blocks PG production by inhibiting cyclooxygenase activity) during this period and then examining if androgen production or action (masculinization) was affected. Pregnant rats were treated with indomethacin (0.8 mg/kg/day; e15.5-e18.5) to encompass the MPW. Indomethacin exposure decreased fetal bodyweight (e21.5), testis weight (e21.5) and testicular PGE(2) (e17.5, e21.5), but had no effect on intratesticular testosterone (ITT; e17.5) or anogenital index (AGI; e21.5). Postnatally, AGI, testis weight and blood testosterone were unaffected by indomethacin exposure and no cryptorchidism or hypospadias occurred. Penis length was normal in indomethacin-exposed animals at Pnd25 but was reduced by 26% (p<0.001) in adulthood, an effect that is unexplained. Our results demonstrate that indomethacin can effectively decrease intra-testicular PGE(2) level. However, the resulting male phenotype does not support a role for PGs in mediating androgen-induced masculinization during the MPW in rats. The contrast with previous mouse studies is unexplained but may reflect a species difference.	[Dean, Afshan; Mungall, William; McKinnell, Chris; Sharpe, Richard M.] Univ Edinburgh, Queens Med Res Inst, MRC Ctr Reprod Hlth, Edinburgh, Midlothian, Scotland	University of Edinburgh	Sharpe, RM (corresponding author), Univ Edinburgh, Queens Med Res Inst, MRC Ctr Reprod Hlth, Edinburgh, Midlothian, Scotland.	r.sharpe@ed.ac.uk	Sharpe, Richard/D-2725-2013	Sharpe, Richard/0000-0003-1686-8085	UK Medical Research Council [G1100358]; European Union [FP7-ENV-2007-1-212844]; MRC [G1100358, G1002033] Funding Source: UKRI; Medical Research Council [G1100358, G1002033] Funding Source: researchfish	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Union(European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported in part by grant G1100358 from the UK Medical Research Council and by grant FP7-ENV-2007-1-212844 from the European Union. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amann R. P., 2006, Animal Reproduction, V3, P108; Amateau SK, 2004, NAT NEUROSCI, V7, P643, DOI 10.1038/nn1254; ARMSTRONG DT, 1981, J REPROD FERTIL, V62, P283; Berkowitz GS, 1996, PAEDIATR PERINAT EP, V10, P39, DOI 10.1111/j.1365-3016.1996.tb00024.x; Dean A, 2012, INT J ANDROL, V35, P330, DOI 10.1111/j.1365-2605.2011.01236.x; Drake AJ, 2009, ENDOCRINOLOGY, V150, P5055, DOI 10.1210/en.2009-0700; Eisenberg ML, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018973; Gaytan F, 2002, BIOL REPROD, V67, P1140, DOI 10.1095/biolreprod67.4.1140; Graham Garry G, 2005, Am J Ther, V12, P46, DOI 10.1097/00045391-200501000-00008; GUPTA C, 1986, P NATL ACAD SCI USA, V83, P4346, DOI 10.1073/pnas.83.12.4346; GUPTA C, 1989, ENDOCRINOLOGY, V124, P129, DOI 10.1210/endo-124-1-129; Hannah ME, 1996, NEW ENGL J MED, V334, P1005, DOI 10.1056/NEJM199604183341601; Hsieh Michael H, 2008, Curr Urol Rep, V9, P137; Jensen MS, 2010, EPIDEMIOLOGY, V21, P779, DOI 10.1097/EDE.0b013e3181f20bed; Kristensen D, 2010, HUMAN REPROD, V0, P1; Kristensen DM, 2012, INT J ANDROL, V35, P377, DOI 10.1111/j.1365-2605.2012.01282.x; MacLeod DJ, 2010, INT J ANDROL, V33, P279, DOI 10.1111/j.1365-2605.2009.01005.x; Mylchreest E, 2000, TOXICOL SCI, V55, P143, DOI 10.1093/toxsci/55.1.143; OATES JA, 1988, NEW ENGL J MED, V319, P689, DOI 10.1056/NEJM198809153191106; Parks LG, 2000, TOXICOL SCI, V58, P339, DOI 10.1093/toxsci/58.2.339; Sharpe Richard M, 2008, Fertil Steril, V89, pe33, DOI 10.1016/j.fertnstert.2007.12.026; Skakkebaek NE, 2001, HUM REPROD, V16, P972, DOI 10.1093/humrep/16.5.972; Skakkebek NE, 2007, INT J ANDROL, V30, P198, DOI 10.1111/j.1365-2605.2007.00776.x; Snijder CA, 2012, HUM REPROD, V27, P1191, DOI 10.1093/humrep/der474; Swan SH, 2005, ENVIRON HEALTH PERSP, V113, P1056, DOI 10.1289/ehp.8100; Thankamony A, 2009, ENVIRON HEALTH PERSP, V117, P1786, DOI 10.1289/ehp.0900881; van den Driesche S, 2011, INT J ANDROL, V34, pE578, DOI 10.1111/j.1365-2605.2011.01175.x; van den Driesche S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037064; Welsh M, 2008, J CLIN INVEST, V118, P1479, DOI 10.1172/JCI34241; Welsh M, 2010, INT J ANDROL, V33, pE144, DOI 10.1111/j.1365-2605.2009.00978.x	30	23	24	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2013	8	5							e62556	10.1371/journal.pone.0062556	http://dx.doi.org/10.1371/journal.pone.0062556			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175AS	23671609	gold, Green Published, Green Accepted, Green Submitted			2022-12-27	WOS:000321202100015
J	Grellety, E; Luquero, FJ; Mambula, C; Adamu, HH; Elder, G; Porten, K				Grellety, Emmanuel; Luquero, Francisco J.; Mambula, Christopher; Adamu, Hassana H.; Elder, Greg; Porten, Klaudia			Observational Bias during Nutrition Surveillance: Results of a Mixed Longitudinal and Cross-Sectional Data Collection System in Northern Nigeria	PLOS ONE			English	Article								Background: The Sahel is subject to seasonal hungry periods with increasing rates of malnutrition. In Northern Nigeria, there is no surveillance system and surveys are rare. The objectives were to analyse possible observational bias in a sentinel surveillance system using repeated mixed longitudinal/cross-sectional data and estimate the extent of seasonal variation. Methods: Thirty clusters were randomly selected using probability proportional to size (PPS) sampling from Kazaure Local Government Area, Jigawa State. In each cluster, all the children aged 6-59 months within 20 randomly selected households had their mid-upper arm circumference measured and were tested for oedema. The surveys were repeated every 2 or 4 weeks. At each survey round, three of the clusters were randomly selected to be replaced by three new clusters chosen at random by PPS. The seasonal variation of acute malnutrition was assessed using cyclical regression. The effect of repeated visits to the same cluster was examined using general linear mixed effects models adjusted for the seasonal change. Results: There was a significant seasonal fluctuation of Global Acute Malnutrition (GAM) with a peak in October. With each repeat survey of a cluster, the prevalence of GAM decreased by 1.6% (95% CI: 0.4 to 2.7; p = 0.012) relative to the prevalence observed during the previous visit after adjusting for seasonal change. Conclusions: Northern Nigeria has a seasonal variation in the prevalence of acute malnutrition. Repeated surveys in the same cluster-village, even if different children are selected, lead to a progressive improvement of the nutritional status of that village. Sentinel site surveillance of nutritional status is prone to observational bias, with the sentinel site progressively deviating from that of the community it is presumed to represent.	[Grellety, Emmanuel; Luquero, Francisco J.; Porten, Klaudia] Epictr, Paris, France; [Mambula, Christopher; Elder, Greg] Medecins Sans Frontieres, Paris, France	Doctors Without Borders	Grellety, E (corresponding author), Epictr, Paris, France.	Emmanuel.GRELLETY@epicentre.msf.org		Grellety Bosviel, Emmanuel/0000-0001-9736-414X	Medecins Sans Frontieres (MSF)	Medecins Sans Frontieres (MSF)	This study was funded by Medecins Sans Frontieres (MSF). MSF reviewed the final study protocol, contributed to the conception of the study, the interpretation of the data and preparation of the manuscript.	Beghin Ivan, 2002, Sante, V12, P112; Bilukha O, 2012, FOOD NUTR BULL, V33, P169, DOI 10.1177/156482651203300211; Central Intelligence Agency (United States), AFR NIG WORLD FACTB; Erhardt J, 2011, SOFTWARE EMERGENCY N; Famine Early Warning Systems Network (FEWS Net), NIG SEAS CAL CRIT EV; Grellety E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044549; Leo R, 2012, NIGERIA MALNUTRITION; Levy PS, 2008, SAMPLING POPULATIONS, V4th; McKinney P, 2011, NUTR INFORM SURVEILL; Naumova EN, 2007, STAT IND TECHNOL, P437, DOI 10.1007/978-0-8176-4542-7_28; Nnyepi M, 2011, J PUBLIC HEALTH POL, V32, P281, DOI 10.1057/jphp.2011.32; R Development Core Team, R LANG ENV STAT COMP; Rabe-Hesketh S., 2008, MULTILEVEL LONGITUDI; Regional Technical Working Group Nairobi, 2010, Food Nutr Bull, V31, pS272; SACKETT DL, 1979, J CHRON DIS, V32, P51, DOI 10.1016/0021-9681(79)90012-2; Standardized Monitoring Assessment of Relief Transitions (SMART), 2006, MEAS MORT NUTR STAT; Stolwijk AM, 1999, J EPIDEMIOL COMMUN H, V53, P235, DOI 10.1136/jech.53.4.235; Tulane University School of Public Health and Tropical Medicine and the United Nations Children's Fund, 2007, NUTR INF PROJ HORN A; Vogel L, 2010, CAN MED ASSOC J, V182, pE555, DOI 10.1503/cmaj.109-3315; World Medical Association, 2001, B WORLD HEALTH ORGAN, V79, P373, DOI DOI 10.1111/DDG.13528	20	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2013	8	5							e62767	10.1371/journal.pone.0062767	http://dx.doi.org/10.1371/journal.pone.0062767			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175AS	23671632	Green Published, gold, Green Submitted			2022-12-27	WOS:000321202100037
J	Wu, CK; Huang, YT; Lin, HH; Yang, CY; Lien, YC; Lee, JK; Huang, JW; Hung, KY				Wu, Cho-Kai; Huang, Yin-Tsen; Lin, Heng-Hsu; Yang, Chung-Yi; Lien, Yu-Chung; Lee, Jen-Kuang; Huang, Jenq-Wen; Hung, Kuan-Yu			Dissecting the Mechanisms of Left Ventricular Diastolic Dysfunction and Inflammation in Peritoneal Dialysis Patients	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; SYSTEM GENE POLYMORPHISMS; CHRONIC KIDNEY-DISEASE; STAGE RENAL-DISEASE; HEART-FAILURE; EJECTION FRACTION; CYTOKINES; THERAPY; MICE; ECHOCARDIOGRAPHY	Objective: Patients with symptoms of heart failure and preserved left ventricular (LV) systolic function are commonly encountered in clinical practice especially in peritoneal dialysis (PD) patients. We hypothesized that adiposity might influence LV diastolic function through systemic inflammation in this specific group. Methods: We designed a cross-sectional study in 173 prevalent PD patients. LV diastolic dysfunction was diagnosed by echocardiography. PD patient without LV diastolic dysfunction served as the control group. Serum inflammatory biomarkers were examined including tissue necrosis factor-alpha (TNF-alpha) and interleukin-6 (IL-6). The location and amount of adipose tissue were assessed by computerized tomography (CT) at the level of the fourth lumbar vertebra. Results: Subjects with LV diastolic dysfunction had higher levels of the pro-inflammation cytokines and more visceral and peritoneal fat (all P<0.001) than control subjects. A significant correlation was found between visceral adipose tissue and pro-inflammatory cytokines (r = 0.70; P<0.001). Multivariable regression analysis found that the relationship between visceral adipose tissue and LV diastolic dysfunction became insignificant when either TNF-alpha or IL-6 were introduced into the model, although TNF-alpha and IL-6 were both significantly associated with LV diastolic dysfunction even after adjusting for visceral fat (OR = 1.51; 95% CI = 1.09-2.02; P = 0.033 and OR = 1.62; 95% CI = 1.09-1.82; P = 0.031, respectively). Conclusions: Larger amounts of adipose tissue were associated with higher serum pro-inflammatory levels in PD patients, which might be related to the development of LV diastolic dysfunction. Modulating inflammatory reactions in PD patients can be a useful therapeutic approach for managing LV diastolic dysfunction.	[Wu, Cho-Kai] Natl Taiwan Univ, Div Cardiol, Dept Internal Med, Coll Med & Hosp, Taipei 10764, Taiwan; [Wu, Cho-Kai] Natl Taiwan Univ, Coll Med, Grad Inst Clin Med, Taipei 10764, Taiwan; [Huang, Yin-Tsen] Far Eastern Mem Hosp, Dept Family Med, New Taipei City, Taiwan; [Huang, Yin-Tsen] Far Eastern Mem Hosp, Hlth Management Ctr, New Taipei City, Taiwan; [Lin, Heng-Hsu] Far Eastern Mem Hosp, Dept Internal Med, Div Cardiol, New Taipei City, Taiwan; [Yang, Chung-Yi] Natl Taiwan Univ, Coll Med & Hosp, Dept Med Imaging, Taipei 10764, Taiwan; [Lien, Yu-Chung; Huang, Jenq-Wen; Hung, Kuan-Yu] Natl Taiwan Univ, Div Nephrol, Dept Internal Med, Coll Med & Hosp, Taipei 10764, Taiwan; [Lee, Jen-Kuang] Natl Taiwan Univ Hosp, Dept Lab Med, Taipei, Taiwan; [Lee, Jen-Kuang] Far Eastern Mem Hosp, Dept Clin Pathol, New Taipei City, Taiwan; [Lee, Jen-Kuang] Natl Taiwan Univ, Grad Inst Biomed Elect & Bioinformat, Taipei 10764, Taiwan	National Taiwan University; National Taiwan University; Far Eastern Memorial Hospital; Far Eastern Memorial Hospital; Far Eastern Memorial Hospital; National Taiwan University; National Taiwan University; National Taiwan University; National Taiwan University Hospital; Far Eastern Memorial Hospital; National Taiwan University	Lee, JK (corresponding author), Natl Taiwan Univ Hosp, Dept Lab Med, Taipei, Taiwan.	b85401104@gmail.com; 007378@ntuh.gov.tw	; Stefanadis, Christodoulos/ABH-2232-2020	HUANG, JENQ-WEN/0000-0001-8011-2317; Stefanadis, Christodoulos/0000-0001-5974-6454; HUNG, KUAN-YU/0000-0003-3472-5512; WU, CHO-KAI/0000-0002-3867-150X	Far Eastern Memorial Hospital [FEMH-2012-C-046, FEMH-2012-C-048, FEMH-2012-C-051, FEMH-2012-C-007]	Far Eastern Memorial Hospital	The authors have financial supports from the research grants of Far Eastern Memorial Hospital number: FEMH-2012-C-046, FEMH-2012-C-048, FEMH-2012-C-051, FEMH-2012-C-007. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arici M, 2001, KIDNEY INT, V59, P407, DOI 10.1046/j.1523-1755.2001.059002407.x; Bajraktari G, 2009, CROAT MED J, V50, P543, DOI 10.3325/cmj.2009.50.543; Bryant D, 1998, CIRCULATION, V97, P1375, DOI 10.1161/01.CIR.97.14.1375; de Mattos AM, 2013, INFLAMMAINFLAMM 0116; Deswal A, 2001, CIRCULATION, V103, P2055; Ernanuela M, 2007, BIOMED PHARMACOTHER, V61, P360, DOI 10.1016/j.biopha.2007.03.002; Fellstrom BC, 2009, NEW ENGL J MED, V360, P1395, DOI 10.1056/NEJMoa0810177; FINKEL MS, 1992, SCIENCE, V257, P387, DOI 10.1126/science.1631560; Gaasch WH, 2004, ANNU REV MED, V55, P373, DOI 10.1146/annurev.med.55.091902.104417; Gniuli D, 2010, INT J OBESITY, V34, P1726, DOI 10.1038/ijo.2010.99; Hillebrand JJG, 2010, OBESITY, V18, P848, DOI 10.1038/oby.2009.341; HIROTA H, 1995, P NATL ACAD SCI USA, V92, P4862, DOI 10.1073/pnas.92.11.4862; Ikonomidis I, 2010, SHOCK, V33, P141, DOI 10.1097/SHK.0b013e3181ad31f8; Kapadia SR, 2000, J AM COLL CARDIOL, V36, P208, DOI 10.1016/S0735-1097(00)00721-X; Lee JK, 2012, NUTR METAB CARDIOVAS, V22, P974, DOI 10.1016/j.numecd.2011.01.001; Lester SJ, 2008, J AM COLL CARDIOL, V51, P679, DOI 10.1016/j.jacc.2007.09.061; London GM, 2003, SEMIN DIALYSIS, V16, P85, DOI 10.1046/j.1525-139X.2003.16023.x; Nagueh SF, 2001, CIRCULATION, V103, P1844; Nagueh SF, 2009, EUR J ECHOCARDIOGR, V10, P165, DOI 10.1093/ejechocard/jep007; Oberg BP, 2004, KIDNEY INT, V65, P1009, DOI 10.1111/j.1523-1755.2004.00465.x; OGSTON D, 1964, LANCET, V2, P1205; Panagiotakos DB, 2005, ATHEROSCLEROSIS, V183, P308, DOI 10.1016/j.atherosclerosis.2005.03.010; Paraskevas KI, 2008, INT UROL NEPHROL, V40, P165, DOI 10.1007/s11255-007-9307-6; Prabhu SD, 2004, CIRC RES, V95, P1140, DOI 10.1161/01.RES.0000150734.79804.92; SAHN DJ, 1978, CIRCULATION, V58, P1072, DOI 10.1161/01.CIR.58.6.1072; Saiki A, 2005, INT J OBESITY, V29, P1115, DOI 10.1038/sj.ijo.0803009; SOLERTE SB, 1989, INT J OBESITY, V13, P203; Stenvinkel P, 2006, NEPHROLOGY, V11, P36, DOI 10.1111/j.1440-1797.2006.00541.x; Wu CK, 2008, EUR J CLIN INVEST, V38, P789, DOI 10.1111/j.1365-2362.2008.02017.x; Wu CK, 2012, OBESITY, V20, P730, DOI 10.1038/oby.2011.30; Wu CK, 2011, CRIT CARE MED, V39, P984, DOI 10.1097/CCM.0b013e31820a91b9; Wu CK, 2009, ATHEROSCLEROSIS, V205, P497, DOI 10.1016/j.atherosclerosis.2008.12.033; Wu CK, 2009, J HYPERTENS, V27, P502, DOI 10.1097/HJH.0b013e32831fda3a	33	12	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2013	8	5							e62722	10.1371/journal.pone.0062722	http://dx.doi.org/10.1371/journal.pone.0062722			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145RZ	23675418	Green Published, gold, Green Submitted			2022-12-27	WOS:000319036100007
J	Krieg, E; Albeck, S; Weissman, H; Shimoni, E; Rybtchinski, B				Krieg, Elisha; Albeck, Shira; Weissman, Haim; Shimoni, Eyal; Rybtchinski, Boris			Separation, Immobilization, and Biocatalytic Utilization of Proteins by a Supramolecular Membrane	PLOS ONE			English	Article							TEMPERATURE ELECTRON-MICROSCOPY; PERYLENE BISIMIDE DYES; BLOCK-COPOLYMER; POLYSACCHARIDE ULTRASTRUCTURES; WATER; BINDING; ENZYME; HYDROGELS; ULTRAFILTRATION; NANOFILTRATION	Membrane separation of biomolecules and their application in biocatalysis is becoming increasingly important for biotechnology, demanding the development of new biocompatible materials with novel properties. In the present study, an entirely noncovalent water-based material is used as a membrane for size-selective separation, immobilization, and biocatalytic utilization of proteins. The membrane shows stable performance under physiological conditions, allowing filtration of protein mixtures with a 150 kDa molecular weight cutoff (similar to 8 nm hydrodynamic diameter cutoff). Due to the biocompatibility of the membrane, filtered proteins stay functionally active and retained proteins can be partially recovered. Upon filtration, large enzymes become immobilized within the membrane. They exhibit stable activity when subjected to a constant flux of substrates for prolonged periods of time, which can be used to carry out heterogeneous biocatalysis. The noncovalent membrane material can be easily disassembled, purified, reassembled, and reused, showing reproducible performance after recycling. The robustness, recyclability, versatility, and biocompatibility of the supramolecular membrane may open new avenues for manipulating biological systems.	[Krieg, Elisha; Weissman, Haim; Rybtchinski, Boris] Weizmann Inst Sci, Dept Organ Chem, IL-76100 Rehovot, Israel; [Albeck, Shira] Weizmann Inst Sci, ISPC, IL-76100 Rehovot, Israel; [Shimoni, Eyal] Weizmann Inst Sci, Dept Chem Res Support, IL-76100 Rehovot, Israel	Weizmann Institute of Science; Weizmann Institute of Science; Weizmann Institute of Science	Rybtchinski, B (corresponding author), Weizmann Inst Sci, Dept Organ Chem, IL-76100 Rehovot, Israel.	boris.rybtchinski@weizmann.ac.il	Krieg, Elisha/J-4591-2014	Krieg, Elisha/0000-0002-2989-9879	Israel Science Foundation; Minerva Foundation; Gerhardt M.J. Schmidt Minerva Center for Supramolecular Architectures; Helen and Martin Kimmel Center for Molecular Design; Yeda Sela Center for Basic Research	Israel Science Foundation(Israel Science Foundation); Minerva Foundation; Gerhardt M.J. Schmidt Minerva Center for Supramolecular Architectures; Helen and Martin Kimmel Center for Molecular Design; Yeda Sela Center for Basic Research	This work was supported by grants from the Israel Science Foundation, the Minerva Foundation, the Gerhardt M.J. Schmidt Minerva Center for Supramolecular Architectures, the Helen and Martin Kimmel Center for Molecular Design, and the Yeda Sela Center for Basic Research. E. K. acknowledges the Minerva PhD fellowship. B. R. holds the Abraham and Jennie Fialkow Career Development Chair. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aida T, 2012, SCIENCE, V335, P813, DOI 10.1126/science.1205962; As Illanes, 2008, ENZYME BIOCATALYSIS; Baker R. W., 2004, MEMBRANE TECHNOLOGY, DOI DOI 10.1002/0470020393; Ball P, 2008, CHEM REV, V108, P74, DOI 10.1021/cr068037a; Beginn U, 2000, ADV MATER, V12, P510, DOI 10.1002/(SICI)1521-4095(200004)12:7<510::AID-ADMA510>3.3.CO;2-V; Beginn U, 1998, ADV MATER, V10, P1391, DOI 10.1002/(SICI)1521-4095(199811)10:16<1391::AID-ADMA1391>3.0.CO;2-0; Benfer S, 2004, ADV ENG MATER, V6, P495, DOI 10.1002/adem.200400577; Bernstein HJ, 2000, TRENDS BIOCHEM SCI, V25, P453, DOI 10.1016/S0968-0004(00)01606-6; Bhattacharjee S, 2006, J MEMBRANE SCI, V275, P141, DOI 10.1016/j.memsci.2005.09.013; BLOKZIJL W, 1993, ANGEW CHEM INT EDIT, V32, P1545, DOI 10.1002/anie.199315451; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brady D, 2009, BIOTECHNOL LETT, V31, P1639, DOI 10.1007/s10529-009-0076-4; Cao LQ, 2000, ORG LETT, V2, P1361, DOI 10.1021/ol005593x; Capito RM, 2008, SCIENCE, V319, P1812, DOI 10.1126/science.1154586; Chandler D, 2005, NATURE, V437, P640, DOI 10.1038/nature04162; Chen ZJ, 2009, CHEM SOC REV, V38, P564, DOI 10.1039/b809359h; Corbin PS, 1998, J AM CHEM SOC, V120, P9710, DOI 10.1021/ja981884d; Cordier P, 2008, NATURE, V451, P977, DOI 10.1038/nature06669; Dalsin JL, 2005, LANGMUIR, V21, P640, DOI 10.1021/la048626g; Dankers PYW, 2007, B CHEM SOC JPN, V80, P2047, DOI 10.1246/bcsj.80.2047; Dankers PYW, 2010, MACROMOL BIOSCI, V10, P1345, DOI 10.1002/mabi.201000146; Fenske T, 2012, CHEM-EUR J, V18, P738, DOI 10.1002/chem.201102435; Gibb BC, 2011, ISR J CHEM, V51, P798, DOI 10.1002/ijch.201100058; Gorl D, 2012, ANGEW CHEM INT EDIT, V51, P6328, DOI 10.1002/anie.201108690; Huang Z, 2011, NAT COMMUN, V2, DOI [10.1038/ncomms1465, 10.1038/ncomms1545]; Joerger AC, 2000, BIOCHEMISTRY-US, V39, P6033, DOI 10.1021/bi9927686; Kane RS, 2003, LANGMUIR, V19, P2388, DOI 10.1021/la020737x; Keller K, 2001, TRENDS BIOTECHNOL, V19, P438, DOI 10.1016/S0167-7799(01)01803-0; Khersonsky O, 2011, J MOL BIOL, V407, P391, DOI 10.1016/j.jmb.2011.01.041; Kingshott P, 2002, BIOMATERIALS, V23, P2043, DOI 10.1016/S0142-9612(01)00334-9; Krieg E, 2011, CHEM-EUR J, V17, P9016, DOI 10.1002/chem.201100809; Krieg E, 2011, NAT NANOTECHNOL, V6, P141, DOI [10.1038/nnano.2010.274, 10.1038/NNANO.2010.274]; Krieg E, 2009, J AM CHEM SOC, V131, P14365, DOI 10.1021/ja903938g; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; LEHN JM, 1993, SCIENCE, V260, P1762, DOI 10.1126/science.8511582; Lightfoot EN, 2004, BIOTECHNOL BIOENG, V87, P259, DOI 10.1002/bit.20111; Lim YB, 2008, J MATER CHEM, V18, P2909, DOI 10.1039/b802639d; Lo Nostro P, 2006, BIOPHYS CHEM, V124, P208, DOI 10.1016/j.bpc.2006.04.004; Lu JR, 2005, IND ENG CHEM RES, V44, P7610, DOI 10.1021/ie049042c; Lu YY, 2007, CHEM MATER, V19, P3194, DOI 10.1021/cm070200a; Matzelle T, 2008, ACTA MICROSC, V17, P45; Maurus R, 2003, BIOCHEMISTRY-US, V42, P5555, DOI 10.1021/bi020622s; Menger FM, 2002, J AM CHEM SOC, V124, P12408, DOI 10.1021/ja021025w; Nguyen NT, 2001, BIOCHEMISTRY-US, V40, P13177, DOI 10.1021/bi010408o; Nunes SP, 2011, ACS NANO, V5, P3516, DOI 10.1021/nn200484v; Onda M, 1996, J FERMENT BIOENG, V82, P502, DOI 10.1016/S0922-338X(97)86992-9; Oshovsky GV, 2007, ANGEW CHEM INT EDIT, V46, P2366, DOI 10.1002/anie.200602815; Peeva PD, 2012, IND ENG CHEM RES, V51, P7231, DOI 10.1021/ie202893e; Peinemann KV, 2007, NAT MATER, V6, P992, DOI 10.1038/nmat2038; Percec V, 2010, SCIENCE, V328, P1009, DOI 10.1126/science.1185547; Phillip WA, 2010, ACS APPL MATER INTER, V2, P847, DOI 10.1021/am900882t; Prins LJ, 2001, ANGEW CHEM INT EDIT, V40, P2382, DOI 10.1002/1521-3773(20010702)40:13<2382::AID-ANIE2382>3.0.CO;2-G; Rothlisberger D, 2008, NATURE, V453, P190, DOI 10.1038/nature06879; Rybtchinski B, 2011, ACS NANO, V5, P6791, DOI 10.1021/nn2025397; Ryu JH, 2008, CHEM COMMUN, P1043, DOI 10.1039/b713737k; Saxena A, 2009, ADV COLLOID INTERFAC, V145, P1, DOI 10.1016/j.cis.2008.07.004; SAYLE RA, 1995, TRENDS BIOCHEM SCI, V20, P374, DOI 10.1016/S0968-0004(00)89080-5; Schmuck C, 2003, J AM CHEM SOC, V125, P452, DOI 10.1021/ja028485+; Serp D, 2002, BIOTECHNOL BIOENG, V79, P253, DOI 10.1002/bit.10287; Serp D, 2002, BIOTECHNOL BIOENG, V79, P243, DOI 10.1002/bit.10286; Shah RN, 2010, P NATL ACAD SCI USA, V107, P3293, DOI 10.1073/pnas.0906501107; Sheldon RA, 2007, ADV SYNTH CATAL, V349, P1289, DOI 10.1002/adsc.200700082; Sijbesma RP, 1997, SCIENCE, V278, P1601, DOI 10.1126/science.278.5343.1601; Spahn Cynthia, 2008, Recent Patents on Engineering, V2, P195, DOI 10.2174/187221208786306333; SRERE PA, 1963, ACTA CHEM SCAND, V17, P129, DOI 10.3891/acta.chem.scand.17s-0129; Stoddart JF, 2009, NAT CHEM, V1, P14, DOI 10.1038/nchem.142; Stupp SI, 2010, NANO LETT, V10, P4783, DOI 10.1021/nl103567y; Stupp SI, 1997, SCIENCE, V276, P384, DOI 10.1126/science.276.5311.384; Tidhar Y, 2011, CHEM-EUR J, V17, P6068, DOI 10.1002/chem.201003419; Tokarev I, 2009, ADV MATER, V21, P241, DOI 10.1002/adma.200801408; Torres-Salas P, 2011, ADV MATER, V23, P5275, DOI 10.1002/adma.201101821; Tran DN, 2011, ACS CATAL, V1, P956, DOI 10.1021/cs200124a; Tyagi P, 2012, ANGEW CHEM INT EDIT, V51, P7166, DOI 10.1002/anie.201201686; Uehara H, 2009, ACS NANO, V3, P924, DOI 10.1021/nn8008728; Ulbricht M, 2006, POLYMER, V47, P2217, DOI 10.1016/j.polymer.2006.01.084; van Reis R, 2001, CURR OPIN BIOTECH, V12, P208, DOI 10.1016/S0958-1669(00)00201-9; van Reis R, 2007, J MEMBRANE SCI, V297, P16, DOI 10.1016/j.memsci.2007.02.045; Vandezande P, 2008, CHEM SOC REV, V37, P365, DOI 10.1039/b610848m; Wang Q, 2010, NATURE, V463, P339, DOI 10.1038/nature08693; WHITESIDES GM, 1991, SCIENCE, V254, P1312, DOI 10.1126/science.1962191; Wurthner F, 2004, CHEM COMMUN, P1564, DOI 10.1039/b401630k; Yang Q, 2011, J MATER CHEM, V21, P2783, DOI 10.1039/c0jm02234a; Yang SY, 2010, ACS NANO, V4, P3817, DOI 10.1021/nn100464u; Zhang SG, 2002, BIOTECHNOL ADV, V20, P321, DOI 10.1016/S0734-9750(02)00026-5	84	15	15	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2013	8	5							e63188	10.1371/journal.pone.0063188	http://dx.doi.org/10.1371/journal.pone.0063188			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	143FO	23675461	Green Published, gold, Green Submitted			2022-12-27	WOS:000318852400028
J	Darias, MJ; Andree, KB; Boglino, A; Fernandez, I; Estevez, A; Gisbert, E				Darias, Maria J.; Andree, Karl B.; Boglino, Anais; Fernandez, Ignacio; Estevez, Alicia; Gisbert, Enric			Coordinated Regulation of Chromatophore Differentiation and Melanogenesis during the Ontogeny of Skin Pigmentation of Solea senegalensis (Kaup, 1858)	PLOS ONE			English	Article							HALIBUT HIPPOGLOSSUS-HIPPOGLOSSUS; FLOUNDER PARALICHTHYS-OLIVACEUS; AGOUTI-SIGNALING PROTEIN; ZEBRAFISH NEURAL CREST; JAPANESE FLOUNDER; C-KIT; TRANSCRIPTION FACTOR; MELANOCORTIN SYSTEM; MICROARRAY ANALYSIS; ARTEMIA ENRICHMENT	Abnormal pigmentation of Senegalese sole has been described as one problem facing the full exploitation of its commercial production. To improve our understanding of flatfish pigmentation of this commercially important species we have evaluated eleven genes related to two different processes of pigmentation: melanophore differentiation, and melanin production. The temporal distribution of gene expression peaks corresponds well with changes in pigmentation patterns and the intensity of skin melanization. Several gene ratios were also examined to put in perspective possible genetic markers for the different stages of normal pigmentation development. Further, the phenotypic changes that occur during morphogenesis correspond well with the main transitions in gene expression that occur. Given the dramatic phenotypic alterations which flatfish undergo, including the asymmetric coloration that occurs between the ocular and the blind side, and the synchrony of the two processes of morphogenesis and pigmentation ontogenesis, these species constitute an interesting model for the study of pigmentation. In this study we present a first approximation towards explaining the genetic mechanisms for regulating pigmentation ontogeny in Senegalese sole, Solea senegalensis.	[Darias, Maria J.; Andree, Karl B.; Boglino, Anais; Estevez, Alicia; Gisbert, Enric] Inst Recerca & Tecnol Agroalimentaries, Ctr St Carles de la Rapita, Unitat Cultius Expt, San Carlos de la Rapita, Catalonia, Spain; [Fernandez, Ignacio] Univ Algarve, Ctr Ciencias Mar, Evolutionary & Dev Gene Express Dept, Faro, Portugal	IRTA; Universidade do Algarve	Darias, MJ (corresponding author), Inst Rech Dev, Inst Sci Evolut Montpellier, Dept Conservat & Domesticat, UMR226, Montpellier, Herault, France.	maria.darias@ird.fr	Gisbert, Enric/B-3654-2011; Gisbert, Enric/I-7224-2019; Fernandez, Ignacio/B-1527-2017; Darias, Maria J./D-5715-2012; Estevez, Alicia/AAE-1471-2021; Andree, Karl/L-7465-2014	Gisbert, Enric/0000-0002-7457-8468; Gisbert, Enric/0000-0002-7457-8468; Fernandez, Ignacio/0000-0002-8088-7902; Darias, Maria J./0000-0003-1954-6284; Estevez, Alicia/0000-0002-7776-0521; Andree, Karl/0000-0001-6564-0015; Estevez, Alicia/0000-0002-3690-0532	Ministry of Science and Innovation (MICIIN) of the Spanish Government [AGL2008-03897-C04-01/ACU]; European Community [FP7/2007-2013-222719-LIFECYCLE]; Spanish Government	Ministry of Science and Innovation (MICIIN) of the Spanish Government; European Community(European Commission); Spanish Government(Spanish GovernmentEuropean Commission)	This research was partially funded by the Ministry of Science and Innovation (MICIIN) of the Spanish Government (project AGL2008-03897-C04-01/ACU) and by the European Community's Seventh Framework program (FP7/2007-2013-222719-LIFECYCLE). I. F. and M.J.D. were supported by a pre-doctoral fellowship and a post-doctoral contract "Juan de la Cierva'' of the Spanish Government, respectively. The funders had no role in industry design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexeev V, 2006, J INVEST DERMATOL, V126, P1102, DOI 10.1038/sj.jid.5700125; [Anonymous], 2002, GEN CLUST TREE VIEW; Bertolotto C, 1998, J CELL BIOL, V142, P827, DOI 10.1083/jcb.142.3.827; Boglino A, 2012, AQUACULTURE, V324, P290, DOI 10.1016/j.aquaculture.2011.11.018; Bolker JA, 2000, J FISH BIOL, V56, P1029, DOI 10.1111/j.1095-8649.2000.tb02121.x; Braasch I, 2009, PIGM CELL MELANOMA R, V22, P839, DOI 10.1111/j.1755-148X.2009.00614.x; Brenner Michaela, 2008, Drug Discov Today Dis Mech, V5, pe189, DOI 10.1016/j.ddmec.2008.02.001; BURCHILL SA, 1993, J ENDOCRINOL, V137, P189, DOI 10.1677/joe.0.1370189; Burton D, 2008, J FISH BIOL, V73, P639, DOI 10.1111/j.1095-8649.2008.01960.x; Burton D, 2002, MICROSC RES TECHNIQ, V58, P481, DOI 10.1002/jemt.10166; Burton D, 2010, REV FISH BIOL FISHER, V20, P31, DOI 10.1007/s11160-009-9119-0; Camacho-Hubner A, 2002, GENE, V285, P59, DOI 10.1016/S0378-1119(02)00411-0; Campinho MA, 2012, CELL TISSUE RES, V350, P333, DOI 10.1007/s00441-012-1473-x; Canavate JP, 2006, AQUACULTURE, V258, P368, DOI 10.1016/j.aquaculture.2006.04.009; Carlson JA, 2007, DERMATOL CLIN, V25, P541, DOI 10.1016/j.det.2007.06.005; Cerda-Reverter JM, 2003, ENDOCRINOLOGY, V144, P2336, DOI 10.1210/en.2002-0213; Cerda-Reverter JM, 2005, ENDOCRINOLOGY, V146, P1597, DOI 10.1210/en.2004-1346; Couldridge VCK, 2002, BEHAV ECOL, V13, P59, DOI 10.1093/beheco/13.1.59; Cunningham J. T., 1893, PHILOS T R SOC B, V184, P765; Curran K, 2010, DEV BIOL, V344, P107, DOI 10.1016/j.ydbio.2010.04.023; Darias MJ, 2008, MAR BIOTECHNOL, V10, P416, DOI 10.1007/s10126-007-9078-1; Dorsky RI, 2000, GENE DEV, V14, P158; Estevez A, 1995, AQUACULT NUTR, V1, P159, DOI 10.1111/j.1365-2095.1995.tb00040.x; Fu YS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022957; Fujii R, 2000, PIGM CELL RES, V13, P300, DOI 10.1034/j.1600-0749.2000.130502.x; Fukamachi S, 2004, P NATL ACAD SCI USA, V101, P10661, DOI 10.1073/pnas.0401278101; Fukamachi S, 2009, GENE, V442, P81, DOI 10.1016/j.gene.2009.04.010; Gantz I, 2003, AM J PHYSIOL-ENDOC M, V284, pE468, DOI 10.1152/ajpendo.00434.2002; Geffen AJ, 2007, J SEA RES, V58, P35, DOI 10.1016/j.seares.2007.02.004; Ginger RS, 2008, J BIOL CHEM, V283, P5486, DOI 10.1074/jbc.M707521200; Gross JB, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000326; Guillot R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048526; Guo XL, 2010, PIGM CELL MELANOMA R, V23, P252, DOI 10.1111/j.1755-148X.2010.00677.x; Haffter P, 1996, DEVELOPMENT, V123, P1; Hallsson JH, 2004, GENETICS, V167, P233, DOI 10.1534/genetics.167.1.233; Hamre K, 2007, AQUACULT NUTR, V13, P65, DOI 10.1111/j.1365-2095.2007.00467.x; Hamre K, 2008, AQUACULTURE, V277, P101, DOI 10.1016/j.aquaculture.2008.02.020; Hathaway Jessica Diann, 2011, Open Cancer J, V4, P1; Healey EG, 1999, J FISH BIOL, V55, P937; Hoekstra HE, 2006, SCIENCE, V313, P101, DOI 10.1126/science.1126121; Hoshino T, 2010, J BIOL CHEM, V285, P13254, DOI 10.1074/jbc.M110.103051; HUNT G, 1995, J INVEST DERMATOL, V104, P83, DOI 10.1111/1523-1747.ep12613565; INAGAKI H, 1994, GENE, V150, P319, DOI 10.1016/0378-1119(94)90445-6; Ito S, 2008, PHOTOCHEM PHOTOBIOL, V84, P582, DOI 10.1111/j.1751-1097.2007.00238.x; Jaattela M, 1998, EMBO J, V17, P6124, DOI 10.1093/emboj/17.21.6124; JOHNSON SL, 1995, DEV BIOL, V167, P27, DOI 10.1006/dbio.1995.1004; Kanazawa Akio, 1993, Journal of the World Aquaculture Society, V24, P162, DOI 10.1111/j.1749-7345.1993.tb00005.x; Kelsh RN, 1996, DEVELOPMENT, V123, P369; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; Klovins J, 2004, MOL BIOL EVOL, V21, P563, DOI 10.1093/molbev/msh050; KOBAYASHI T, 1994, EMBO J, V13, P5818, DOI 10.1002/j.1460-2075.1994.tb06925.x; Kubic JD, 2008, PIGM CELL MELANOMA R, V21, P627, DOI 10.1111/j.1755-148X.2008.00514.x; Kuntz A., 1918, Bulletin of the Bureau of Fisheries Washington, V35; Lamason RL, 2005, SCIENCE, V310, P1782, DOI 10.1126/science.1116238; Larribere L, 2005, GENE DEV, V19, P1980, DOI 10.1101/gad.335905; Lasker R., 1984, MARINE FISH LARVAE M, P33; Le Pape E, 2009, P NATL ACAD SCI USA, V106, P1802, DOI 10.1073/pnas.0806753106; Levy C, 2011, TRANSCR-AUSTIN, V2, P19, DOI 10.4161/trns.2.1.13650; Lin JY, 2007, NATURE, V445, P843, DOI 10.1038/nature05660; Lister JA, 1999, DEVELOPMENT, V126, P3757; LUO D, 1995, MELANOMA RES, V5, P303, DOI 10.1097/00008390-199510000-00002; Mast SO, 1914, B US BUR FISH, V34, P177; MATSUMOTO J, 1992, PIGM CELL RES, P275; Minchin JEN, 2008, DEV BIOL, V317, P508, DOI 10.1016/j.ydbio.2008.02.058; Nadeau N, 2008, GENETICS, V178, P777, DOI 10.1534/genetics.107.077073; Nakamasu A, 2009, P NATL ACAD SCI USA, V106, P8429, DOI 10.1073/pnas.0808622106; Nakamura M, 2010, FISHERIES SCI, V76, P243, DOI 10.1007/s12562-009-0209-7; Olivares C, 2001, BIOCHEM J, V354, P131, DOI 10.1042/0264-6021:3540131; Parichy DM, 1999, DEVELOPMENT, V126, P3425; Parichy DM, 2001, DEV GENES EVOL, V211, P319, DOI 10.1007/s004270100155; Parichy DM, 2003, DEVELOPMENT, V130, P817, DOI 10.1242/dev.00307; Parra G, 2001, J EXP BIOL, V204, P2175; Patton EE, 2010, PIGM CELL MELANOMA R, V23, P314, DOI 10.1111/j.1755-148X.2010.00693.x; Pederzoli A, 2003, PIGM CELL RES, V16, P50, DOI 10.1034/j.1600-0749.2003.00013.x; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Power DM, 2008, REV FISH SCI, V16, P95, DOI 10.1080/10641260802325377; Prota G, 1995, Fortschr Chem Org Naturst, V64, P93; Puebla O, 2007, P ROY SOC B-BIOL SCI, V274, P1265, DOI 10.1098/rspb.2006.0435; RANDALL JOHN E., 1960, BULL MAR SCI GULF AND CARIBBEAN, V10, P444; RANDWEAVER M, 1992, J ENDOCRINOL, V133, P393, DOI 10.1677/joe.0.1330393; Rawls JF, 2000, DEVELOPMENT, V127, P3715; ROBERTS RJ, 1972, J FISH BIOL, V4, P87, DOI 10.1111/j.1095-8649.1972.tb05656.x; Sarasquete C, 1996, HISTOL HISTOPATHOL, V11, P881; SCHIOTH HB, 1995, EUR J PHARM-MOLEC PH, V288, P311, DOI 10.1016/0922-4106(95)90043-8; SEIKAI T, 1987, PIGM CELL RES, V1, P143, DOI 10.1111/j.1600-0749.1987.tb00405.x; Seikai Tadahisa, 1994, Journal of the World Aquaculture Society, V25, P78, DOI 10.1111/j.1749-7345.1994.tb00807.x; Sumner FB, 1911, J EXP ZOOL, V11, P409; Sviderskaya EV, 2001, DEV DYNAM, V221, P373, DOI 10.1002/dvdy.1153; Villalta M, 2005, AQUACULTURE, V249, P353, DOI 10.1016/j.aquaculture.2005.03.037; Villalta M, 2005, AQUACULTURE, V245, P193, DOI 10.1016/j.aquaculture.2004.11.035; Vogel P, 2008, VET PATHOL, V45, P264, DOI 10.1354/vp.45-2-264; Yamada T, 2010, DEV DYNAM, V239, P3147, DOI 10.1002/dvdy.22440; Yamashita M, 2008, J EXP BIOL, V211, P1874, DOI 10.1242/jeb.012690; Yamashita Y, 2010, EXP DERMATOL, V19, pE340, DOI 10.1111/j.1600-0625.2009.01061.x; Zhu Y, 1997, GEN COMP ENDOCR, V105, P127, DOI 10.1006/gcen.1996.6810; Zhu Y, 1996, GEN COMP ENDOCR, V101, P21, DOI 10.1016/S0016-6480(96)90191-4	96	24	27	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2013	8	5							e63005	10.1371/journal.pone.0063005	http://dx.doi.org/10.1371/journal.pone.0063005			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	155HD	23671650	Green Submitted, Green Published, gold			2022-12-27	WOS:000319737700033
J	Pereira, F; Niu, XZ; deMello, AJ				Pereira, Fiona; Niu, Xize; deMello, Andrew J.			A Nano LC-MALDI Mass Spectrometry Droplet Interface for the Analysis of Complex Protein Samples	PLOS ONE			English	Article							LIQUID-CHROMATOGRAPHY; MS; MICROFLUIDICS; PROTEOMICS; PEPTIDES; ONLINE; FLOW	The integration of matrix-assisted laser desorption ionization (MALDI) mass spectrometry with an upstream analytical separations (such as liquid chromatography and electrophoresis) has opened up new opportunities for the automated investigation of complex protein and peptide mixtures. The ability to efficiently analyze complex proteomic mixtures in this manner is primarily determined by the ability to preserve spatial discrimination of sample components as they leave the separation column. Current interfacing methods are problematic in this respect since minimum fraction volumes are limited to several microliters. Herein we show for the first time an LC-MALDI interface based on the formation, processing and destruction of a segmented flow. The interface consists of a droplet-generator to fractionate LC effluent into nL-volume droplets and a deposition probe that transfers the sample (and MALDI matrix) onto a conventional MALDI-MS target. The efficacy of the method is demonstrated through the analysis of Trypsin digests of both BSA and Cytochrome C, with a 50% enhancement in analytical performance when compared to conventional interface technology.	[Pereira, Fiona; deMello, Andrew J.] Swiss Fed Inst Technol, Dept Chem & Appl Biosci, Inst Chem & Bioengn, Zurich, Switzerland; [Niu, Xize] Univ Southampton, Southampton, Hants, England; [Niu, Xize] Univ Southampton, Inst Life Sci, Southampton, Hants, England	Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Southampton; University of Southampton	deMello, AJ (corresponding author), Swiss Fed Inst Technol, Dept Chem & Appl Biosci, Inst Chem & Bioengn, Zurich, Switzerland.	andrew.demello@chem.ethz.ch	Niu, Xize/D-4627-2013		University of Southampton; Swiss Federal Institute of Technology, ETH Zurich	University of Southampton; Swiss Federal Institute of Technology, ETH Zurich(ETH Zurich)	XN acknowledges an Annual Adventure in Research Grant from the University of Southampton. AdM and FP gratefully acknowledge financial support from the Swiss Federal Institute of Technology, ETH Zurich. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beavis R C, 1989, Rapid Commun Mass Spectrom, V3, P233, DOI 10.1002/rcm.1290030708; BIEMANN K, 1992, ANNU REV BIOCHEM, V61, P977, DOI 10.1146/annurev.bi.61.070192.004553; Cohen SL, 1996, ANAL CHEM, V68, P31, DOI 10.1021/ac9507956; Dutta D, 2006, MICROFLUID NANOFLUID, V2, P275, DOI 10.1007/s10404-005-0070-7; Edgar JS, 2009, ANGEW CHEM INT EDIT, V48, P2719, DOI 10.1002/anie.200805396; Fidalgo LM, 2009, ANGEW CHEM INT EDIT, V48, P3665, DOI 10.1002/anie.200806103; Hatakeyama T, 2006, J AM CHEM SOC, V128, P2518, DOI 10.1021/ja057720w; HILLENKAMP F, 1991, ANAL CHEM, V63, pA1193; KARAS M, 1988, ANAL CHEM, V60, P2299, DOI 10.1021/ac00171a028; Kelly RT, 2009, ANGEW CHEM INT EDIT, V48, P6832, DOI 10.1002/anie.200902501; Lazar IM, 2006, MASS SPECTROM REV, V25, P573, DOI 10.1002/mas.20081; Lee J, 2009, J MASS SPECTROM, V44, P579, DOI 10.1002/jms.1585; Li Q, 2010, ANAL CHEM, V82, P5260, DOI 10.1021/ac100669z; Lim CK, 2002, BIOL PHARM BULL, V25, P547, DOI 10.1248/bpb.25.547; Metzger J, 2009, CRIT REV CL LAB SCI, V46, P129, DOI 10.1080/10408360902805261; Mirgorodskaya E, 2005, PROTEOMICS, V5, P399, DOI 10.1002/pmic.200400984; Niu XZ, 2009, CHEM COMMUN, P6159, DOI 10.1039/b918100h; Ogilvie IRG, 2011, ANAL CHEM, V83, P4814, DOI 10.1021/ac200463y; Pereira F, 2011, CHROMATOGRAPHY TODAY, V4, P12; Pes O, 2010, J CHROMATOGR A, V1217, P3966, DOI 10.1016/j.chroma.2010.02.058; Ro KW, 2006, J CHROMATOGR A, V1111, P40, DOI 10.1016/j.chroma.2006.01.105; Smyth WF, 2004, ELECTROPHORESIS, V25, P1413, DOI 10.1002/elps.200305850; Srisa-Art M, 2008, ANAL CHEM, V80, P7063, DOI 10.1021/ac801199k; Zhang BY, 2004, ANAL CHEM, V76, P992, DOI 10.1021/ac034934s; Zhang X, 2004, J AM SOC MASS SPECTR, V15, P1471, DOI 10.1016/j.jasms.2004.06.016; Zhu Y, 2010, ANAL CHEM, V82, P8361, DOI 10.1021/ac101902c	26	24	25	1	70	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2013	8	5							e63087	10.1371/journal.pone.0063087	http://dx.doi.org/10.1371/journal.pone.0063087			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	155HD	23671657	gold, Green Accepted, Green Published, Green Submitted			2022-12-27	WOS:000319737700037
J	Westengen, OT; Jeppson, S; Guarino, L				Westengen, Ola T.; Jeppson, Simon; Guarino, Luigi			Global Ex-Situ Crop Diversity Conservation and the Svalbard Global Seed Vault: Assessing the Current Status	PLOS ONE			English	Article							PLANT GENETIC-RESOURCES; SECURITY; FOOD	Ex-situ conservation of crop diversity is a global concern, and the development of an efficient and sustainable conservation system is a historic priority recognized in international law and policy. We assess the completeness of the safety duplication collection in the Svalbard Global Seed Vault with respect to data on the world's ex-situ collections as reported by the Food and Agriculture Organization of the United Nations. Currently, 774,601 samples are deposited at Svalbard by 53 genebanks. We estimate that more than one third of the globally distinct accessions of 156 crop genera stored in genebanks as orthodox seeds are conserved in the Seed Vault. The numbers of safety duplicates of Triticum (wheat), Sorghum (sorghum), Pennisetum (pearl millet), Eleusine (finger millet), Cicer (chickpea) and Lens (lentil) exceed 50% of the estimated numbers of distinct accessions in global ex-situ collections. The number of accessions conserved globally generally reflects importance for food production, but there are significant gaps in the safety collection at Svalbard in some genera of high importance for food security in tropical countries, such as Amaranthus (amaranth), Chenopodium (quinoa), Eragrostis (teff) and Abelmoschus (okra). In the 29 food-crop genera with the largest number of accessions stored globally, an average of 5.5 out of the ten largest collections is already represented in the Seed Vault collection or is covered by existing deposit agreements. The high coverage of ITPGRFA Annex 1 crops and of those crops for which there is a CGIAR mandate in the current Seed Vault collection indicates that existence of international policies and institutions are important determinants for accessions to be safety duplicated at Svalbard. As a back-up site for the global conservation system, the Seed Vault plays not only a practical but also a symbolic role for enhanced integration and cooperation for conservation of crop diversity.	[Westengen, Ola T.; Jeppson, Simon] Nord Genet Resource Ctr NordGen, Alnarp, Sweden; [Westengen, Ola T.] Univ Oslo, Ctr Dev & Environm, Oslo, Norway; [Guarino, Luigi] Global Crop Divers Trust, Bonn, Germany	University of Oslo	Westengen, OT (corresponding author), Nord Genet Resource Ctr NordGen, Alnarp, Sweden.	ola.westengen@nordgen.org	jeppson, simon/R-2099-2019	jeppson, simon/0000-0003-1083-2022				CGRFA, 2012, CGRFAWGPGR612INF6 GL; CGRFA, 2007, 11 REG SESS COMM GEN; Darwin Charles, 2007, VARIATION ANIMALS PL, V1; Engels JMM, 2003, IPGRI HDB GENEBANKS, V6; Esquinas-Alcazar J, 2005, NAT REV GENET, V6, P946, DOI 10.1038/nrg1729; FAO, 2012, REV GEN STA IN PRESS; FAO, 2013, WORLD INF EARL WARN; FAO, 2010, 2 FAO; FAO-MAF, 2022, SANL STEPP CONS STRA; Food and Agriculture Organization of the United Nations (FAO), 1998, STAT WORLDS PLANT GE; Fowler C, 2004, ANNU REV ENV RESOUR, V29, P143, DOI 10.1146/annurev.energy.29.062403.102203; Fowler C., 2004, STUDY ASSESS FEASIBI; Fowler C, 2008, BIOSCIENCE, V58, P190, DOI 10.1641/B580302; Frankel O.H, 1987, DIVERSITY, V3, P25; Frankel OH., 1970, GENETIC RESOURCES PL; FRANKEL OH, 1975, CROP GENETIC RESOURC; Frison E, 1994, IPGRI HDB GENEBANKS, P107; GCDT, 2013, SVALB GLOB SEED VAUL; GeneSys, 2013, BIOV; Gepts P, 2006, CROP SCI, V46, P2278, DOI 10.2135/cropsci2006.03.0169gas; Harlan Jack R., 1995, LIVING FIELDS OUR AG; ITPGRFA, 2009, INT TREAT PLANT GEN; Khoury C, 2010, GENET RESOUR CROP EV, V57, P625, DOI 10.1007/s10722-010-9534-z; Kilian B, 2012, BRIEF FUNCT GENOMICS, V11, P38, DOI 10.1093/bfgp/elr046; Koo B, SAVING SEEDS EC CONS; Myers N, 1997, BIODIVERSITYS GENETI, p[255, 255]; NMAF GCDT NordGen, 2007, AGR ROYAL NORW MIN A; NMFA NordGen, 2012, STAND AGR DEP NORW M; Pistorius Robin, 1997, SCI PLANTS POLITICS; PRESCOTTALLEN R, 1990, CONSERV BIOL, V4, P365, DOI 10.1111/j.1523-1739.1990.tb00310.x; Qvenild M, 2008, DEV PRACT, V18, P110, DOI 10.1080/09614520701778934; Royal Botanical Gardens KEW, 2008, SEED INF DAT SID VER; Simmonds NW, 1997, POTATO RES, V40, P191, DOI 10.1007/BF02358245; The Government of the United Kingdom, 2006, AN WELF ACT 2006; van Hintum T, 2010, PLANT GENET RESOUR-C, V8, P182, DOI 10.1017/S1479262110000158; VANHINTUM TJL, 1995, GENET RESOUR CROP EV, V42, P135, DOI 10.1007/BF02539517; Vavilov NJ., 1992, ORIGIN GEOGRAPHY CUL	37	49	52	3	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2013	8	5							e64146	10.1371/journal.pone.0064146	http://dx.doi.org/10.1371/journal.pone.0064146			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	155HD	23671707	Green Published, gold, Green Submitted			2022-12-27	WOS:000319737700065
J	Passilongo, D; Reby, D; Carranza, J; Apollonio, M				Passilongo, Daniela; Reby, David; Carranza, Juan; Apollonio, Marco			Roaring High and Low: Composition and Possible Functions of the Iberian Stag's Vocal Repertoire	PLOS ONE			English	Article							SOURCE-FILTER THEORY; RED DEER; BODY-SIZE; GEOGRAPHICAL VARIATION; FALLOW BUCKS; TRACT LENGTH; BEHAVIOR; COMMUNICATION; VOCALIZATIONS; ACOUSTICS	We provide a detailed description of the rutting vocalisations of free-ranging male Iberian deer (Cervus elaphus hispanicus, Hilzheimer 1909), a geographically isolated and morphologically differentiated subspecies of red deer Cervus elaphus. We combine spectrographic examinations, spectral analyses and automated classifications to identify different call types, and compare the composition of the vocal repertoire with that of other red deer subspecies. Iberian stags give bouts of roars (and more rarely, short series of barks) that are typically composed of two different types of calls. Long Common Roars are mostly given at the beginning or at the end of the bout, and are characterised by a high fundamental frequency (F0) resulting in poorly defined formant frequencies but a relatively high amplitude. In contrast, Short Common Roars are typically given in the middle or at the end of the bout, and are characterised by a lower F0 resulting in relatively well defined vocal tract resonances, but low amplitude. While we did not identify entirely Harsh Roars (as described in the Scottish red deer subspecies (Cervus elaphus scoticus)), a small percentage of Long Common Roars contained segments of deterministic chaos. We suggest that the evolution of two clearly distinct types of Common Roars may reflect divergent selection pressures favouring either vocal efficiency in high pitched roars or the communication of body size in low-pitched, high spectral density roars highlighting vocal tract resonances. The clear divergence of the Iberian red deer vocal repertoire from those of other documented European red deer populations reinforces the status of this geographical variant as a distinct subspecies.	[Passilongo, Daniela; Apollonio, Marco] Univ Sassari, Dept Sci Nat & Environm Resources, I-07100 Sassari, Italy; [Reby, David] Univ Sussex, Sch Psychol, Brighton, E Sussex, England; [Carranza, Juan] Univ Cordoba, Ungulate Res Unit, Game & Fish Res Ctr, Cordoba, Spain	University of Sassari; University of Sussex; Universidad de Cordoba	Passilongo, D (corresponding author), Univ Sassari, Dept Sci Nat & Environm Resources, I-07100 Sassari, Italy.	dpassilongo@uniss.it	Carranza, Juan/E-4472-2010; Passilongo, Daniela/F-2282-2018	Passilongo, Daniela/0000-0003-0005-0852; Reby, David/0000-0001-9261-1711; Carranza, Juan/0000-0002-0368-7173	University of Sassari; Italian Ministry of University and Research	University of Sassari; Italian Ministry of University and Research(Ministry of Education, Universities and Research (MIUR))	DP was supported by the University of Sassari and the Italian Ministry of University and Research with a PhD grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boersma Paul, 2002, GLOT INT, V5, P341; Briefer E, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-35; Brumm H, 2009, ADV STUD BEHAV, V40, P1, DOI 10.1016/S0065-3454(09)40001-9; Campbell P, 2010, EVOLUTION, V64, P1955, DOI 10.1111/j.1558-5646.2010.00962.x; Cap H, 2008, CLADISTICS, V24, P917, DOI 10.1111/j.1096-0031.2008.00223.x; CARRANZA J, 1990, ANIM BEHAV, V40, P79, DOI 10.1016/S0003-3472(05)80667-0; CARRANZA J, 1991, APPL ANIM BEHAV SCI, V30, P363, DOI 10.1016/0168-1591(91)90141-J; Carranza J, 1999, BEHAV ECOL, V10, P525, DOI 10.1093/beheco/10.5.525; CARRANZA J, 1995, ANIM BEHAV, V50, P445, DOI 10.1006/anbe.1995.0258; Carranza J, 1996, ETHOLOGY, V102, P793; Carranza J., 2004, ENCICLOPEDIA VIRTUAL; Charlton BD, 2008, ETHOLOGY, V114, P1023, DOI 10.1111/j.1439-0310.2008.01539.x; Charlton BD, 2007, ANIM BEHAV, V74, P707, DOI 10.1016/j.anbehav.2006.09.021; Charlton BD, 2007, BIOL LETTERS, V3, P382, DOI 10.1098/rsbl.2007.0244; Charlton BD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045420; Charlton BD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021066; Charlton BD, 2009, ANIM BEHAV, V78, P893, DOI 10.1016/j.anbehav.2009.06.029; CLARIDGE MF, 1993, BIOL J LINN SOC, V48, P267, DOI 10.1111/j.1095-8312.1993.tb00891.x; Clutton-Brock TH., 1982, RED DEER BEHAV ECOLO; CLUTTONBROCK TH, 1979, BEHAVIOUR, V69, P145, DOI 10.1163/156853979X00449; DAVIES NB, 1979, ANIM BEHAV, V27, P1253, DOI 10.1016/0003-3472(79)90070-8; Ey E, 2007, PRIMATES, V48, P253, DOI 10.1007/s10329-006-0033-y; Fallow PM, 2010, ANIM BEHAV, V79, P411, DOI 10.1016/j.anbehav.2009.11.018; Fant G., 1960, ACOUSTIC THEORY SPEE; Fitch WT, 1997, J ACOUST SOC AM, V102, P1213, DOI 10.1121/1.421048; Fitch WT, 2001, P ROY SOC B-BIOL SCI, V268, P1669, DOI 10.1098/rspb.2001.1704; FORREST TG, 1994, AM ZOOL, V34, P644; Frey R, 2012, J ANAT, V220, P271, DOI 10.1111/j.1469-7580.2011.01467.x; Gamba M, 2012, J ETHOL, V30, P191, DOI 10.1007/s10164-011-0291-z; Geist V., 1998, DEER WORLD THEIR EVO; HUNTER ML, 1979, J ANIM ECOL, V48, P759, DOI 10.2307/4194; Kidjo N, 2008, BIOACOUSTICS, V18, P159, DOI 10.1080/09524622.2008.9753598; LASS NJ, 1978, J ACOUST SOC AM, V63, P1218, DOI 10.1121/1.381808; Ludt CJ, 2004, MOL PHYLOGENET EVOL, V31, P1064, DOI 10.1016/j.ympev.2003.10.003; Marshall AJ, 1999, ANIM BEHAV, V58, P825, DOI 10.1006/anbe.1999.1219; MCCOMB KE, 1991, ANIM BEHAV, V41, P79, DOI 10.1016/S0003-3472(05)80504-4; McCracken KG, 1997, P NATL ACAD SCI USA, V94, P3833, DOI 10.1073/pnas.94.8.3833; McElligott AG, 1999, ANIM BEHAV, V58, P1095, DOI 10.1006/anbe.1999.1237; Mendelson TC, 2005, NATURE, V433, P375, DOI 10.1038/433375a; MORTON ES, 1977, AM NAT, V111, P855, DOI 10.1086/283219; MORTON ES, 1975, AM NAT, V109, P17, DOI 10.1086/282971; Owren MJ, 1997, J ACOUST SOC AM, V101, P2951, DOI 10.1121/1.418523; Patten MA, 2004, EVOLUTION, V58, P2144; Peters Gustav, 1999, Journal of Mammalian Evolution, V6, P129, DOI 10.1023/A:1020620121416; Prohl H, 2006, EVOLUTION, V60, P1669; R Core Development Team, 2011, R LANG ENV STAT COMP; Reby D, 1998, J ZOOL, V245, P79, DOI 10.1017/S0952836998005093; Reby D, 2005, P ROY SOC B-BIOL SCI, V272, P941, DOI 10.1098/rspb.2004.2954; Reby D, 2003, ADV STUD BEHAV, V33, P231, DOI 10.1016/S0065-3454(03)33005-0; Reby D, 2003, ANIM BEHAV, V65, P519, DOI 10.1006/anbe.2003.2078; Reby D, 2006, J ACOUST SOC AM, V120, P4080, DOI 10.1121/1.2358006; Reby D, 2012, ANIM COGN, V15, P265, DOI 10.1007/s10071-011-0451-0; Reby D, 2010, P ROY SOC B-BIOL SCI, V277, P2747, DOI 10.1098/rspb.2010.0467; Rendall D, 2005, J ACOUST SOC AM, V117, P944, DOI 10.1121/1.1848011; Rendall D, 1998, J ACOUST SOC AM, V103, P602, DOI 10.1121/1.421104; Riede T, 1999, J EXP BIOL, V202, P2859; ROUSSEEUW PJ, 1987, J COMPUT APPL MATH, V20, P53, DOI 10.1016/0377-0427(87)90125-7; RYALLS JH, 1982, J ACOUST SOC AM, V72, P1631, DOI 10.1121/1.388499; RYAN MJ, 1990, EVOLUTION, V44, P1869, DOI 10.1111/j.1558-5646.1990.tb05256.x; Semple S, 2000, P ROY SOC B-BIOL SCI, V267, P707, DOI 10.1098/rspb.2000.1060; Soltis J, 2005, ANIM BEHAV, V70, P589, DOI 10.1016/j.anbehav.2004.11.016; Taylor AM, 2010, J ZOOL, V280, P221, DOI 10.1111/j.1469-7998.2009.00661.x; Templeton CN, 2005, SCIENCE, V308, P1934, DOI 10.1126/science.1108841; Titze IR, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000897; Titze IR, 1994, PRINCIPLES VOICE PRO; Vannoni E, 2007, ETHOLOGY, V113, P223, DOI 10.1111/j.1439-0310.2006.01323.x; Vannoni E, 2009, ANIM BEHAV, V78, P3, DOI 10.1016/j.anbehav.2009.03.015; Vannoni E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003113; Volodin I, 2013, ACTA ETHOL, V16, P57, DOI 10.1007/s10211-012-0133-1; Wyman MT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023296; Yu X, 2011, ETHOL ECOL EVOL, V23, P211, DOI 10.1080/03949370.2011.566581	71	23	24	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2013	8	5							e63841	10.1371/journal.pone.0063841	http://dx.doi.org/10.1371/journal.pone.0063841			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145YI	23667678	Green Submitted, gold, Green Published			2022-12-27	WOS:000319055600077
J	Khademi, M; Dring, AM; Gilthorpe, JD; Wuolikainen, A; Al Nimer, F; Harris, RA; Andersson, M; Brundin, L; Piehl, F; Olsson, T; Svenningsson, A				Khademi, Mohsen; Dring, Ann M.; Gilthorpe, Jonathan D.; Wuolikainen, Anna; Al Nimer, Faiez; Harris, Robert A.; Andersson, Magnus; Brundin, Lou; Piehl, Fredrik; Olsson, Tomas; Svenningsson, Anders			Intense Inflammation and Nerve Damage in Early Multiple Sclerosis Subsides at Older Age: A Reflection by Cerebrospinal Fluid Biomarkers	PLOS ONE			English	Article							SECONDARY PROGRESSIVE MS; AUTOIMMUNE-DISEASES; PROGNOSTIC MARKER; NATURAL-HISTORY; INTERFERON-BETA; AXONAL DAMAGE; DOUBLE-BLIND; ACTIVE MS; B-CELLS; OSTEOPONTIN	Inflammatory mediators have crucial roles in leukocyte recruitment and subsequent central nervous system (CNS) neuroinflammation. The extent of neuronal injury and axonal loss are associated with the degree of CNS inflammation and determine physical disability in multiple sclerosis (MS). The aim of this study was to explore possible associations between a panel of selected cerebrospinal fluid biomarkers and robust clinical and demographic parameters in a large cohort of patients with MS and controls (n = 1066) using data-driven multivariate analysis. Levels of matrix metalloproteinase 9 (MMP9), chemokine (C-X-C motif) ligand 13 (CXCL13), osteopontin (OPN) and neurofilament-light chain (NFL) were measured by ELISA in 548 subjects comprising different MS subtypes (relapsing-remitting, secondary progressive and primary progressive), clinically isolated syndrome and persons with other neurological diseases with or without signs of inflammation/infection. Principal component analyses and orthogonal partial least squares methods were used for unsupervised and supervised interrogation of the data. Models were validated using data from a further 518 subjects in which one or more of the four selected markers were measured. There was a significant association between increased patient age and lower levels of CXCL13, MMP9 and NFL. CXCL13 levels correlated well with MMP9 in the younger age groups, but less so in older patients, and after approximately 54 years of age the levels of CXCL13 and MMP9 were consistently low. CXCL13 and MMP9 levels also correlated well with both NFL and OPN in younger patients. We demonstrate a strong effect of age on both inflammatory and neurodegenerative biomarkers in a large cohort of MS patients. The findings support an early use of adequate immunomodulatory disease modifying drugs, especially in younger patients, and may provide a biological explanation for the relative inefficacy of such treatments in older patients at later disease stages.	[Khademi, Mohsen; Al Nimer, Faiez; Harris, Robert A.; Brundin, Lou; Piehl, Fredrik; Olsson, Tomas] Karolinska Inst, Dept Clin Neurosci, Neuroimmunol Unit, Stockholm, Sweden; [Dring, Ann M.; Gilthorpe, Jonathan D.; Svenningsson, Anders] Umea Univ, Dept Pharmacol & Clin Neurosci, Umea, Sweden; [Wuolikainen, Anna] Umea Univ, Dept Chem, Umea, Sweden; [Al Nimer, Faiez; Andersson, Magnus; Brundin, Lou; Piehl, Fredrik; Olsson, Tomas] Karolinska Univ Hosp, Dept Neurol, Stockholm, Sweden	Karolinska Institutet; Umea University; Umea University; Karolinska Institutet; Karolinska University Hospital	Olsson, T (corresponding author), Karolinska Inst, Dept Clin Neurosci, Neuroimmunol Unit, Stockholm, Sweden.	Tomas.Olsson@ki.se	Nimer, Faiez Al/ABB-9465-2020; Harris, Robert A./I-6234-2019	Harris, Robert A./0000-0003-4990-509X; Svenningsson, Anders/0000-0003-0663-2220; Wuolikainen, Anna/0000-0003-0838-5526; Khademi, Mohsen/0000-0003-0801-1444; Al Nimer, Faiez/0000-0003-0937-5995; Brundin, Lou/0000-0003-4408-7817; Gilthorpe, Jonathan/0000-0002-6884-4774; Olsson, Tomas/0000-0002-2938-1877	BayerScheringPharma; BiogenIdec; MerckSerono; SanofiAventis; BayerSchering; Novartis; BiogenIdec Sweden AB; Genzyme; Amirall; Genzyme/SanofiAventis	BayerScheringPharma(Bayer AG); BiogenIdec(Biogen); MerckSerono(Merck & Company); SanofiAventis(Sanofi-Aventis); BayerSchering(Bayer AG); Novartis(Novartis); BiogenIdec Sweden AB; Genzyme(Sanofi-AventisGenzyme Corporation); Amirall; Genzyme/SanofiAventis	AS has received travel support and/or lecture honoraria from BiogenIdec, MerckSerono, Genzyme/SanofiAventis, and Baxter, and he has received unconditional research grants from BayerScheringPharma and BiogenIdec. TO has received personal compensation for consultancy or lecture fees from BiogenIdec, MerckSerono, SanofiAventis, BayerSchering and Novartis. BiogenIdec Sweden AB provided an unrestricted grant for this study. LB has recieved teaching and consultation fees from BiogenIdec, SanofiAventis, Novartis, Genzyme and Amirall. MK, AD, JG, AW, FA, RH, MA and FP have no conflicts to declare. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.; AS has received travel support and/or lecture honoraria from BiogenIdec, MerckSerono, Genzyme/SanofiAventis, and Baxter, and he has received unconditional research grants from BayerScheringPharma and BiogenIdec. TO has received personal compensation for consultancy or lecture fees from BiogenIdec, MerckSerono, SanofiAventis, BayerSchering and Novartis. BiogenIdec Sweden AB provided an unrestricted grant for this study. LB has recieved teaching and consultation fees from BiogenIdec, SanofiAventis, Novartis, Genzyme and Amirall. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Bielekova B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048370; Bornsen L., 2012, MULTIPLE SCLEROSIS; Bornsen L, 2011, MULT SCLER J, V17, P32, DOI 10.1177/1352458510382247; Brettschneider J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011986; BRUCK W, 1995, ANN NEUROL, V38, P788, DOI 10.1002/ana.410380514; Buchanan RJ, 2009, NEUROREHABILITATION, V25, P271, DOI 10.3233/NRE-2009-0525; Chabas D, 2001, SCIENCE, V294, P1731, DOI 10.1126/science.1062960; Clinical Trial of Recombinant Interferon-beta-la in MS (SPECTRIMS) Study Group, 2004, NEUROLOGY, V63, P1768; Compston A, 2002, LANCET, V359, P1221, DOI 10.1016/S0140-6736(02)08220-X; Compston A, 2008, LANCET, V372, P1502, DOI 10.1016/S0140-6736(08)61620-7; Confavreux C, 2006, BRAIN, V129, P606, DOI 10.1093/brain/awl007; Confavreux C, 2006, BRAIN, V129, P595, DOI 10.1093/brain/awh714; Danilov AI, 2003, J NEUROIMMUNOL, V136, P112, DOI 10.1016/S0165-5728(02)00464-2; De Stefano N, 2001, ARCH NEUROL-CHICAGO, V58, P65, DOI 10.1001/archneur.58.1.65; Deryck O, 2006, J NEUROL, V253, P720, DOI 10.1007/s00415-006-0095-1; Ferguson B, 1997, BRAIN, V120, P393, DOI 10.1093/brain/120.3.393; Franceschi C, 2000, VACCINE, V18, P1717, DOI 10.1016/S0264-410X(99)00513-7; Frischer JM, 2009, BRAIN, V132, P1175, DOI 10.1093/brain/awp070; GIJBELS K, 1992, J NEUROIMMUNOL, V41, P29, DOI 10.1016/0165-5728(92)90192-N; Gunnarsson M, 2011, ANN NEUROL, V69, P83, DOI 10.1002/ana.22247; Harris VK, 2009, MOL DIAGN THER, V13, P225, DOI 10.2165/11313470-000000000-00000; Hawker K, 2009, ANN NEUROL, V66, P460, DOI 10.1002/ana.21867; Iacobaeus E, 2009, MULT SCLER J, V15, P28, DOI 10.1177/1352458508096870; Khademi M, 2009, EUR J NEUROL, V16, P528, DOI 10.1111/j.1468-1331.2009.02532.x; Khademi M, 2011, MULT SCLER J, V17, P335, DOI 10.1177/1352458510389102; Kieseier BC, 1999, NEUROLOGY, V53, P20, DOI 10.1212/WNL.53.1.20; Kipp M, 2012, CNS NEUROL DISORD-DR, V11, P506, DOI 10.2174/187152712801661248; Koch M, 2007, J NEUROL SCI, V255, P35, DOI 10.1016/j.jns.2007.01.067; Kornek B, 1999, BRAIN PATHOL, V9, P651; Kremenchutzky M, 1999, BRAIN, V122, P1941, DOI 10.1093/brain/122.10.1941; Krumbholz M, 2006, BRAIN, V129, P200, DOI 10.1093/brain/awh680; Kuenz B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002559; Leppert D, 1998, BRAIN, V121, P2327, DOI 10.1093/brain/121.12.2327; Linton PJ, 2005, IMMUNOL REV, V205, P207, DOI 10.1111/j.0105-2896.2005.00266.x; Lycke JN, 1998, J NEUROL NEUROSUR PS, V64, P402, DOI 10.1136/jnnp.64.3.402; Mazzali M, 2002, QJM-INT J MED, V95, P3, DOI 10.1093/qjmed/95.1.3; McDonald WI, 2001, ANN NEUROL, V50, P121, DOI 10.1002/ana.1032; Meinl E, 2008, J NEUROL SCI; MILLER RA, 1991, INT REV CYTOL, V124, P187; Norgren N, 2004, NEUROLOGY, V63, P1586, DOI 10.1212/01.WNL.0000142988.49341.D1; Panitch H, 2004, NEUROLOGY, V63, P1788; Ram M, 2006, J CLIN IMMUNOL, V26, P299, DOI 10.1007/s10875-006-9022-6; Ransohoff RM, 2003, NAT REV IMMUNOL, V3, P569, DOI 10.1038/nri1130; Ratchford JN, 2013, NEUROLOGY, V80, P47, DOI 10.1212/WNL.0b013e31827b1a1c; Salzer J, 2010, MULT SCLER J, V16, P287, DOI 10.1177/1352458509359725; Sellebjerg F, 2009, NEUROLOGY, V73, P2003, DOI 10.1212/WNL.0b013e3181c5b457; Sellebjerg F, 2003, BRAIN RES BULL, V61, P347, DOI 10.1016/S0361-9230(03)00097-2; Sorensen TL, 2002, J NEUROIMMUNOL, V122, P125, DOI 10.1016/S0165-5728(01)00453-2; Tektonidou MG, 2011, NAT REV RHEUMATOL, V7, P708, DOI 10.1038/nrrheum.2011.157; Tortorella C, 2005, J NEUROL SCI, V239, P95, DOI 10.1016/j.jns.2005.08.006; Trapp BD, 2008, ANNU REV NEUROSCI, V31, P247, DOI 10.1146/annurev.neuro.30.051606.094313; Tremlett H, 2008, J NEUROL NEUROSUR PS, V79, P1368, DOI 10.1136/jnnp.2008.145805; Tremlett H, 2006, NEUROLOGY, V66, P172, DOI 10.1212/01.wnl.0000194259.90286.fe; Trojano M, 2002, ANN NEUROL, V51, P475, DOI 10.1002/ana.10147; Trygg J, 2002, J CHEMOMETR, V16, P119, DOI 10.1002/cem.695; Tutuncu M, 2012, MULT SCLE; Wang KX, 2008, CYTOKINE GROWTH F R, V19, P333, DOI 10.1016/j.cytogfr.2008.08.001; WOLD S, 1987, CHEMOMETR INTELL LAB, V2, P37, DOI 10.1016/0169-7439(87)80084-9; Wolinsky JS, 2007, ANN NEUROL, V61, P14, DOI 10.1002/ana.21079	59	55	55	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e63172	10.1371/journal.pone.0063172	http://dx.doi.org/10.1371/journal.pone.0063172			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667585	Green Submitted, Green Published, gold			2022-12-27	WOS:000319654700115
J	Pages, JF; Gera, A; Romero, J; Farina, S; Garcia-Rubies, A; Hereu, B; Alcoverro, T				Pages, Jordi F.; Gera, Alessandro; Romero, Javier; Farina, Simone; Garcia-Rubies, Antoni; Hereu, Bernat; Alcoverro, Teresa			The Mediterranean Benthic Herbivores Show Diverse Responses to Extreme Storm Disturbances	PLOS ONE			English	Article							URCHIN PARACENTROTUS-LIVIDUS; SEA-URCHINS; SARPA-SALPA; HYDRODYNAMIC-FORCES; COMMUNITY STRUCTURE; ALGAL ASSEMBLAGES; PHASE-SHIFTS; HABITAT USE; PATTERNS; RESILIENCE	Catastrophic storms have been observed to be one of the major elements in shaping the standing structure of marine benthic ecosystems. Yet, little is known about the effect of catastrophic storms on ecosystem processes. Specifically, herbivory is the main control mechanism of macrophyte communities in the Mediterranean, with two main key herbivores: the sea urchin Paracentrotus lividus and the fish Sarpa salpa. Consequently, the effects of extreme storm events on these two herbivores (at the population level and on their behaviour) may be critical for the functioning of the ecosystem. With the aim of filling this gap, we took advantage of two parallel studies that were conducted before, during and after an unexpected catastrophic storm event. Specifically, fish and sea urchin abundance were assessed before and after the storm in monitored fixed areas (one site for sea urchin assessment and 3 sites for fish visual transects). Additionally, we investigated the behavioural response to the disturbance of S. salpa fishes that had been tagged with acoustic transmitters. Given their low mobility, sea urchins were severely affected by the storm (ca. 50% losses) with higher losses in those patches with a higher density of sea urchins. This may be due to a limited availability of refuges within each patch. In contrast, fish abundance was not affected, as fish were able to move to protected areas (i.e. deeper) as a result of the high mobility of this species. Our results highlight that catastrophic storms differentially affect the two dominant macroherbivores of rocky macroalgal and seagrass systems due to differences in mobility and escaping strategies. This study emphasises that under catastrophic disturbances, the presence of different responses among the key herbivores of the system may be critical for the maintenance of the herbivory function.	[Pages, Jordi F.; Gera, Alessandro; Farina, Simone; Garcia-Rubies, Antoni; Alcoverro, Teresa] Ctr Estudis Avancats Blanes CEAB CSIC, Blanes, Spain; [Romero, Javier; Hereu, Bernat] Univ Barcelona, Fac Biol, Dept Ecol, Barcelona, Spain; [Alcoverro, Teresa] Nat Conservat Fdn, Mysore, Karnataka, India	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centre d'Estudis Avancats de Blanes (CEAB); University of Barcelona	Pages, JF (corresponding author), Ctr Estudis Avancats Blanes CEAB CSIC, Blanes, Spain.	jpages@ceab.csic.es	Farina, Simone/ABF-4876-2021; Hereu, Bernat/K-9150-2015; Romero, Javier/A-8905-2013; Alcoverro, Teresa/J-9258-2012; Pagès, Jordi F/E-7107-2013; Farina, Simone/AAB-9308-2021	Hereu, Bernat/0000-0001-6247-7638; Romero, Javier/0000-0002-2772-8486; Alcoverro, Teresa/0000-0002-3910-9594; Pagès, Jordi F/0000-0001-9346-8312; Farina, Simone/0000-0003-0169-8044; Garcia-Rubies, Antoni/0000-0002-4824-9337	Spanish Ministry of Science and Innovation [CTM2010-22273-C02-01, CTM2010-22273-C02-02]; Spanish Ministry of Education [AP2008-01601]; Spanish National Research Council [JAEPre_08_00466]	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Spanish Ministry of Education(Spanish Government); Spanish National Research Council	This research has been funded by the Spanish Ministry of Science and Innovation (projects CTM2010-22273-C02-01 and 02). The Spanish Ministry of Education supported JP (scholarship AP2008-01601) and the Spanish National Research Council supported AG (scholarship JAEPre_08_00466). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abecasis D, 2012, J APPL ICHTHYOL, V28, P126, DOI 10.1111/j.1439-0426.2011.01795.x; Alcoverro T, 2012, 200430E599 CEABCSIC, P147; Bellwood DR, 2006, P ROY SOC B-BIOL SCI, V273, P101, DOI 10.1098/rspb.2005.3276; BORTONE S A, 1976, Florida Scientist, V39, P245; Calenge C, 2006, ECOL MODEL, V197, P516, DOI 10.1016/j.ecolmodel.2006.03.017; Coma R, 2012, ASSESSMENT ECOLOGICA, P67; CYR H, 1993, NATURE, V361, P148, DOI 10.1038/361148a0; DANCE C, 1987, MAR ECOL-P S Z N I, V8, P131, DOI 10.1111/j.1439-0485.1987.tb00179.x; DAYTON PK, 1992, ECOL MONOGR, V62, P421, DOI 10.2307/2937118; Denny M, 1996, J EXP BIOL, V199, P717; DENNY MW, 1985, ECOL MONOGR, V55, P69, DOI 10.2307/1942526; DENNY MW, 1994, J EXP BIOL, V194, P97; EBELING AW, 1985, MAR BIOL, V84, P287, DOI 10.1007/BF00392498; Elmqvist T, 2003, FRONT ECOL ENVIRON, V1, P488, DOI 10.2307/3868116; ESTES JA, 1974, SCIENCE, V185, P1058, DOI 10.1126/science.185.4156.1058; Farina S, 2009, MAR ECOL PROG SER, V377, P131, DOI 10.3354/meps07692; Fulton CJ, 2001, MAR BIOL, V139, P25; Garcia-Rubies A, 2012, ASSESSMENT ECOLOGICA, P201; Guidetti P, 2006, ECOL APPL, V16, P963, DOI 10.1890/1051-0761(2006)016[0963:MRRLPI]2.0.CO;2; HARROLD C, 1985, ECOLOGY, V66, P1160, DOI 10.2307/1939168; Heck KL, 2006, J EXP MAR BIOL ECOL, V330, P420, DOI 10.1016/j.jembe.2005.12.044; Hereu B, 2005, MAR ECOL-EVOL PERSP, V26, P54, DOI 10.1111/j.1439-0485.2005.00038.x; Hereu B, 2004, THESIS U BARCELONA B; Hereu B, 2012, 200430E599 CEABCSIC, P123; Hereu B, 2012, ASSESSMENT ECOLOGICA, P55; Hereu B, 2010, CARTOGRAFIA BIONOMIC; Hereu B, 2011, CARTOGRAFIA BIONOMIC; Hereu B, 2006, MAR ECOL PROG SER, V313, P95, DOI 10.3354/meps313095; Hereu B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036901; Hooper DU, 2005, ECOL MONOGR, V75, P3, DOI 10.1890/04-0922; Hughes TP, 2007, CURR BIOL, V17, P360, DOI 10.1016/j.cub.2006.12.049; HUGHES TP, 1994, SCIENCE, V265, P1547, DOI 10.1126/science.265.5178.1547; Jadot C, 2006, ICES J MAR SCI, V63, P128, DOI 10.1016/j.icesjms.2005.06.010; Jadot C, 2003, OCEANOL ACTA, V26, P497, DOI 10.1016/S0399-1784(03)00044-6; Kaufman L.S., 1983, Coral Reefs, V2, P43, DOI 10.1007/BF00304731; Koch EW, 2006, SEAGRASSES: BIOLOGY, ECOLOGY AND CONSERVATION, P193; LASSIG BR, 1983, ENVIRON BIOL FISH, V9, P55, DOI 10.1007/BF00001058; LETOURNEUR Y, 1993, ENVIRON BIOL FISH, V37, P109, DOI 10.1007/BF00000586; MARBA N, 1995, J ECOL, V83, P381, DOI 10.2307/2261592; Mateo MA, 2012, ASSESSMENT ECOLOGICA; Navarro L, 2011, ESTUAR COAST SHELF S, V95, P52, DOI 10.1016/j.ecss.2011.08.002; Nystrom M, 2006, AMBIO, V35, P30, DOI 10.1639/0044-7447(2006)035[0030:RARDOF]2.0.CO;2; Pages JF, 2012, FUNCT ECOL, V26, P1015, DOI 10.1111/j.1365-2435.2012.02038.x; Palacin C, 1998, J SEA RES, V39, P281, DOI 10.1016/S1385-1101(97)00061-0; Palacin C, 1997, CAH BIOL MAR, V38, P267; Peterson G, 1998, ECOSYSTEMS, V1, P6, DOI 10.1007/s100219900002; Poore AGB, 2012, ECOL LETT, V15, P912, DOI 10.1111/j.1461-0248.2012.01804.x; Prado P, 2007, MAR ECOL PROG SER, V340, P63, DOI 10.3354/meps340063; Prado P, 2009, ESTUAR COAST SHELF S, V85, P472, DOI 10.1016/j.ecss.2009.09.012; RDevelopmentCoreTeam, 2012, R LANG ENV STAT COMP; Sanchez-Vidal A, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0030395, 10.1371/journal.pone.0043943]; Siddon CE, 2003, MAR ECOL PROG SER, V261, P99, DOI 10.3354/meps261099; Sousa WP, 2001, MARINE COMMUNITY ECOLOGY, P85; SOUSA WP, 1980, OECOLOGIA, V45, P72, DOI 10.1007/BF00346709; Tomas F, 2005, MAR ECOL PROG SER, V301, P95, DOI 10.3354/meps301095; Trussell GC, 1997, MAR ECOL PROG SER, V151, P73, DOI 10.3354/meps151073; Venables WN., 2002, MODERN APPL STAT S 4; Verges A, 2009, MAR ECOL PROG SER, V375, P1, DOI 10.3354/meps07778; Walsh W.J., 1983, Coral Reefs, V2, P49, DOI 10.1007/BF00304732; Winfree R, 2009, P R SOC B, V276, P229, DOI 10.1098/rspb.2008.0709; Zuur Alain F., 2009, P1	61	12	12	0	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e62719	10.1371/journal.pone.0062719	http://dx.doi.org/10.1371/journal.pone.0062719			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667512	Green Published, Green Submitted, gold			2022-12-27	WOS:000319654700058
J	Peabody, JW; Strand, V; Shimkhada, R; Lee, R; Chernoff, D				Peabody, John W.; Strand, Vibeke; Shimkhada, Riti; Lee, Rachel; Chernoff, David			Impact of Rheumatoid Arthritis Disease Activity Test on Clinical Practice	PLOS ONE			English	Article							HEALTH-CARE-SYSTEM; AMERICAN-COLLEGE; RECOMMENDATIONS; QUALITY; VALIDATION; VIGNETTES; PERFORMANCE; MANAGEMENT; DIAGNOSIS; CRITERIA	Background: Variability exists in the assessment of disease activity in rheumatoid arthritis (RA) patients that may affect quality of care. Objectives: To measure the impact on quality of care of a Multi-Biomarker Disease Activity (MBDA) test that quantitatively assesses RA disease activity. Methods: Board-certified rheumatologists without prior experience with the MBDA test (N = 81) were randomized into an intervention or control group as part of a longitudinal randomized-control study. All physicians were asked to care for three simulated RA patients, using Clinical Performance and Value (CPV (TM)) vignettes, in a before and after design. CPV (TM) vignettes have been validated to assess the quality of clinical practice and identify variation in care. The vignettes covered all domains of a regular patient visit; scores were determined as a percentage of explicit predefined criteria completed. Three vignettes, representing typical RA cases, were administered each round. In the first round, no physician received information about the MBDA test. In the second round, only physicians in the intervention group were given educational materials about the test and hypothetical test results for each of the simulated patients. The outcome measures were the overall quality of care, disease assessment and treatment. Results: The overall quality scores in the intervention group improved by 3 percent (p = 0.02) post-intervention compared with baseline, versus no change in the control group. The greatest benefit in the intervention group was to the quality of disease activity assessment and treatment decisions, which improved by 12 percent (p<0.01) compared with no significant change in the control group. The intervention was associated with more appropriate use of biologic and/or combination DMARDs in the co-morbidity case type (p<0.01). Conclusions: Based on these results, use of the MBDA test improved the assessment and treatment decisions for simulated cases of RA and may prove useful for rheumatologists in clinical practice.	[Peabody, John W.] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; [Peabody, John W.] Univ Calif San Francisco, Dept Med, San Francisco, CA USA; [Peabody, John W.; Shimkhada, Riti; Lee, Rachel] QURE Healthcare, San Rafael, CA USA; [Strand, Vibeke] Stanford Univ, Div Immunol Rheumatol, Stanford, CA 94305 USA; [Shimkhada, Riti] Univ Calif Los Angeles, Dept Hlth Policy & Management, Los Angeles, CA USA; [Chernoff, David] Crescendo Biosci, San Francisco, CA USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Stanford University; University of California System; University of California Los Angeles	Peabody, JW (corresponding author), Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA.	jpeabody@qurehealthcare.com	Shimkhada, Riti/N-7823-2016	Shimkhada, Riti/0000-0002-5177-4853	Crescendo Bioscience, Inc., South San Francisco, California; Crescendo Biosciences; Crescendo; Crescendo Bioscience, Inc.	Crescendo Bioscience, Inc., South San Francisco, California; Crescendo Biosciences; Crescendo(European Commission); Crescendo Bioscience, Inc.	Funding for this study was provided by Crescendo Bioscience, Inc., South San Francisco, California (http://www.crescendobio.com/). The funders were informed and contributed to study design, had no role in data collection or analysis, and agreed to the decision to publish and contributed to preparation of the manuscript.; VS and DC are paid consultants of Crescendo Biosciences. QURE Healthcare was contracted by Crescendo to conduct this study and analysis. Crescendo Bioscience, Inc. was the commercial funder. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Aletaha D, 2010, ARTHRITIS RHEUM-US, V62, P2569, DOI 10.1002/art.27584; Anderson J, 2012, ARTHRIT CARE RES, V64, P640, DOI 10.1002/acr.21649; Bakker MF, 2012, ANN RHEUM DIS, V71, P1692, DOI 10.1136/annrheumdis-2011-200963; Beresniak A, 2007, J RHEUMATOL, V34, P2193; Butcher Lola, 2009, Manag Care, V18, P30; Bykerk VP, 2011, J RHEUMATOL, V39, P1555; Curtis JR, 2012, ARTHRIT CARE RES, V64, P1794, DOI 10.1002/acr.21767; Dresselhaus TR, 2004, J GEN INTERN MED, V19, P1013, DOI 10.1007/s11606-004-0003-2; Eastman PS, 2012, J PHARMACEUT BIOMED, V70, P415, DOI 10.1016/j.jpba.2012.06.003; Farheen K, 2011, J MANAG CARE PHARM, V17, pS09; Fox MG, 2012, JCR-J CLIN RHEUMATOL, V18, P15, DOI 10.1097/RHU.0b013e31823e5ab3; Fuster V, 2001, Circulation, V104, P2118; Graf J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006242; Jiang YL, 2001, RADIOLOGY, V220, P787, DOI 10.1148/radiol.220001257; Lacaille D, 2005, ARTHRIT RHEUM-ARTHR, V53, P241, DOI 10.1002/art.21077; Luce BR, 2009, ANN INTERN MED, V151, P206, DOI 10.7326/0003-4819-151-3-200908040-00126; MacLean CH, 2000, JAMA-J AM MED ASSOC, V284, P984, DOI 10.1001/jama.284.8.984; Majithia V, 2007, AM J MED, V120, P936, DOI 10.1016/j.amjmed.2007.04.005; Masri KR, 2012, J RHEUMATOL, V39, P1139, DOI 10.3899/jrheum.111543; Panella M, 2003, INT J QUAL HEALTH C, V15, P509, DOI 10.1093/intqhc/mzg057; Peabody JW, 2007, HEALTH POLICY PLANN, V22, P294, DOI 10.1093/heapol/czm020; Peabody JW, 2000, JAMA-J AM MED ASSOC, V283, P1715, DOI 10.1001/jama.283.13.1715; Peabody JW, 2004, ANN INTERN MED, V141, P771, DOI 10.7326/0003-4819-141-10-200411160-00008; Peabody JW, 2012, ISPOR 17 ANN INT M W; Sacks JJ, 2010, ARTHRIT CARE RES, V62, P460, DOI 10.1002/acr.20041; Singh JA, 2012, ARTHRIT CARE RES, V64, P625, DOI 10.1002/acr.21641; Smolen JS, 2010, ANN RHEUM DIS, V69, P964, DOI 10.1136/ard.2009.126532; Smolen JS, 2010, ANN RHEUM DIS, V69, P631, DOI 10.1136/ard.2009.123919; Solon O, 2009, HEALTH POLICY PLANN, V24, P167, DOI 10.1093/heapol/czp003; Studenic P, 2012, ARTHRITIS RHEUM-US, V64, P2814, DOI 10.1002/art.34543; van der Helm-van Mil AH, 2012, RHEUMATOLOG IN PRESS; Wennberg DE, 1998, ANN INTERN MED, V128, P866, DOI 10.7326/0003-4819-128-10-199805150-00012; Wolfe F, 2009, J RHEUMATOL, V36, P1568, DOI 10.3899/jrheum.090386; Zhao XY, 2012, J IMMUNOL METHODS, V378, P72, DOI 10.1016/j.jim.2012.02.007	34	16	16	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e63215	10.1371/journal.pone.0063215	http://dx.doi.org/10.1371/journal.pone.0063215			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	154EP	23667587	gold, Green Published, Green Submitted			2022-12-27	WOS:000319654700117
J	Song, YP; Ma, KF; Ci, D; Zhang, ZY; Zhang, DQ				Song, Yuepeng; Ma, Kaifeng; Ci, Dong; Zhang, Zhiyi; Zhang, Deqiang			Sexual Dimorphism Floral MicroRNA Profiling and Target Gene Expression in Andromonoecious Poplar (Populus tomentosa)	PLOS ONE			English	Article							STRESS-RESPONSIVE MICRORNAS; BLACK-COTTONWOOD; DNA METHYLATION; FLOWERING TIME; SMALL RNAS; ARABIDOPSIS; APETALA2; FAMILY; AUXIN; IDENTIFICATION	Although the molecular basis of poplar sex-specific flower development remains largely unknown, increasing evidence indicates an essential role for microRNAs (miRNAs). The specific miRNA types and precise miRNA expression patterns in dioecious plant flower development remain unclear. Here, we used andromonoecious poplar, an exceptional model system, to eliminate the confounding effects of genetic background of dioecious plants. This system, combined with high-throughput sequencing and computational analysis, allowed us to characterize sex-specific miRNAomes from female and male flowers. Comparative miRNAome analysis combined with quantitative real-time PCR revealed the expression patterns of 27 miRNAs in poplar flower and showed that the targets of these miRNAs are involved in flower organogenesis, Ca2+ transport, phytohormone synthesis and metabolism, and DNA methylation. This paper describes a complex regulatory network consisting of these miRNAs expressed in sex-specific flower development in a dioecious plant. The conserved and novel miRNA locations were annotated in the Populus trichocarpa genome. Among these, miRNA Pto-F70 and 4 targets are located in the sex-determination regions of chromosome XIX. Furthermore, two novel miRNAs, Pto-F47 and Pto-F68, were shown for the first time to be regulatory factors in phytohormone interactions. To our knowledge, this report is the first systematic investigation of sex-specific flower-related miRNAs and their targets in poplar, and it deepens our understanding of the important regulatory functions of miRNAs in female and male flower development in this dioecious plant.	[Song, Yuepeng; Ma, Kaifeng; Ci, Dong; Zhang, Zhiyi; Zhang, Deqiang] Beijing Forestry Univ, Natl Engn Lab Tree Breeding, Coll Biol Sci & Technol, Beijing, Peoples R China; [Song, Yuepeng; Ma, Kaifeng; Ci, Dong; Zhang, Zhiyi; Zhang, Deqiang] Beijing Forestry Univ, Key Lab Genet & Breeding Forest Trees & Ornamenta, Coll Biol Sci & Technol, Beijing, Peoples R China	Beijing Forestry University; Beijing Forestry University	Zhang, DQ (corresponding author), Beijing Forestry Univ, Natl Engn Lab Tree Breeding, Coll Biol Sci & Technol, Beijing, Peoples R China.	DeqiangZhang@bjfu.edu.cn	Song, Yuepeng/T-8731-2019		Introduction of Foreign Advanced Agricultural Science and Technology into China [2009-4-22]; Project of the National Natural Science Foundation of China [31170622, 30872042]; Specific Programs in Graduate Science and Technology Innovation of Beijing Forestry University [BLYJ201202]	Introduction of Foreign Advanced Agricultural Science and Technology into China; Project of the National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Specific Programs in Graduate Science and Technology Innovation of Beijing Forestry University	This work was supported by the Introduction of Foreign Advanced Agricultural Science and Technology into China (No. 2009-4-22), the Project of the National Natural Science Foundation of China (No. 31170622, 30872042), and the Specific Programs in Graduate Science and Technology Innovation of Beijing Forestry University (No.BLYJ201202). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen E, 2005, CELL, V121, P207, DOI 10.1016/j.cell.2005.04.004; An XM, 2011, PLANT CELL REP, V30, P89, DOI 10.1007/s00299-010-0947-0; Aukerman MJ, 2003, PLANT CELL, V15, P2730, DOI 10.1105/tpc.016238; Baker CC, 2005, CURR BIOL, V15, P303, DOI 10.1016/j.cub.2005.02.017; Barakat Abdelali, 2007, BMC Genomics, V8, P481, DOI 10.1186/1471-2164-8-481; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Benson DA, 2011, NUCLEIC ACIDS RES, V39, pD32, DOI [10.1093/nar/gkw1070, 10.1093/nar/gks1195, 10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkx1094, 10.1093/nar/gkn723, 10.1093/nar/gkp1024, 10.1093/nar/gkr1202]; BOES TK, 1994, AM J BOT, V81, P562, DOI 10.2307/2445730; Brzeski J, 2003, J BIOL CHEM, V278, P823, DOI 10.1074/jbc.M209260200; Cerdan PD, 2003, NATURE, V423, P881, DOI 10.1038/nature01636; Chang S. J., 1993, Plant Molecular Biology Reporter, V11, P113, DOI 10.1007/BF02670468; Chen XM, 2004, SCIENCE, V303, P2022, DOI 10.1126/science.1088060; Chen XM, 2010, PLANT J, V61, P941, DOI 10.1111/j.1365-313X.2009.04089.x; Cheng SH, 2002, PLANT PHYSIOL, V129, P469, DOI 10.1104/pp.005645; Chuck G, 2007, NAT GENET, V39, P1517, DOI 10.1038/ng.2007.20; Fahlgren N, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000219; Finnegan EJ, 1998, ANNU REV PLANT PHYS, V49, P223, DOI 10.1146/annurev.arplant.49.1.223; Fu XD, 2003, NATURE, V421, P740, DOI 10.1038/nature01387; Gao ZH, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-371; Gaudet M, 2008, TREE GENET GENOMES, V4, P25, DOI 10.1007/s11295-007-0085-1; German MA, 2008, NAT BIOTECHNOL, V26, P941, DOI 10.1038/nbt1417; Griffiths S, 2003, PLANT PHYSIOL, V131, P1855, DOI 10.1104/pp.102.016188; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Hepworth SR, 2006, PLANTA, V223, P769, DOI 10.1007/s00425-005-0138-3; Ji LZ, 2011, PURE APPL MATH Q, V7, P1, DOI 10.1371/journal.pgen.1001358; Jones-Rhoades MW, 2006, ANNU REV PLANT BIOL, V57, P19, DOI 10.1146/annurev.arplant.57.032905.105218; Klevebring D, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-620; Kuno N, 2003, PLANT CELL, V15, P2476, DOI 10.1105/tpc.014217; Ledger Susan, 2001, Plant Journal, V26, P15, DOI 10.1046/j.1365-313x.2001.01003.x; Li RQ, 2008, BIOINFORMATICS, V24, P713, DOI 10.1093/bioinformatics/btn025; Lippman Z, 2004, NATURE, V431, P364, DOI 10.1038/nature02875; Llave C, 2002, SCIENCE, V297, P2053, DOI 10.1126/science.1076311; Lu C, 2005, SCIENCE, V309, P1567, DOI 10.1126/science.1114112; Lu SF, 2005, PLANT CELL, V17, P2186, DOI 10.1105/tpc.105.033456; Lu SF, 2008, PLANT J, V55, P131, DOI 10.1111/j.1365-313X.2008.03497.x; Mathews DH, 1999, J MOL BIOL, V288, P911, DOI 10.1006/jmbi.1999.2700; Meyers BC, 2008, PLANT CELL, V20, P3186, DOI 10.1105/tpc.108.064311; Nag A, 2010, CURR TOP DEV BIOL, V91, P349, DOI 10.1016/S0070-2153(10)91012-0; Nag R, 2005, PLANT MOL BIOL, V59, P821, DOI 10.1007/s11103-005-1387-z; Navarro L, 2006, SCIENCE, V312, P436, DOI 10.1126/science.1126088; Okamuro JK, 1997, P NATL ACAD SCI USA, V94, P7076, DOI 10.1073/pnas.94.13.7076; Pakull B, 2009, TREE GENET GENOMES, V5, P505, DOI 10.1007/s11295-009-0204-2; Pantaleo V, 2010, PLANT J, V62, P960, DOI [10.1111/j.1365-313X.2010.04208.x, 10.1111/j.0960-7412.2010.04208.x]; Paolucci I, 2010, TREE GENET GENOMES, V6, P863, DOI 10.1007/s11295-010-0297-7; Rajagopalan R, 2006, GENE DEV, V20, P3407, DOI 10.1101/gad.1476406; Reinhart BJ, 2002, GENE DEV, V16, P1616, DOI 10.1101/gad.1004402; Riechmann JL, 1998, BIOL CHEM, V379, P633; Rottmann WH, 2000, PLANT J, V22, P235, DOI 10.1046/j.1365-313x.2000.00734.x; Schmid M, 2003, DEVELOPMENT, V130, P6001, DOI 10.1242/dev.00842; Schwab R, 2005, DEV CELL, V8, P517, DOI 10.1016/j.devcel.2005.01.018; Sheppard LA, 2000, PLANT PHYSIOL, V124, P627, DOI 10.1104/pp.124.2.627; Shi R, 2005, BIOTECHNIQUES, V39, P519, DOI 10.2144/000112010; Song YP, 2012, PLANT CELL REP, V31, P1393, DOI 10.1007/s00299-012-1255-7; Stepanova AN, 2007, PLANT CELL, V19, P2169, DOI 10.1105/tpc.107.052068; Sun YH, 2012, PLANT MOL BIOL, V80, P37, DOI 10.1007/s11103-011-9864-z; Tuskan GA, 2004, PLANT BIOLOGY, V6, P2, DOI 10.1055/s-2003-44715; Tuskan GA, 2012, TREE GENET GENOMES, V8, P559, DOI 10.1007/s11295-012-0495-6; Wang ZM, 2012, MOL PLANT, V5, P889, DOI 10.1093/mp/ssr094; WEIGEL D, 1995, PLANT CELL, V7, P388, DOI 10.1105/tpc.7.4.388; Wu G, 2009, CELL, V138, P750, DOI 10.1016/j.cell.2009.06.031; Xiong LM, 2001, PLANT CELL, V13, P2063, DOI 10.1105/tpc.13.9.2063; Yin T, 2008, GENOME RES, V18, P422, DOI 10.1101/gr.7076308; Zhao CZ, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-3; Zluvova J, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-208	64	31	36	1	71	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e62681	10.1371/journal.pone.0062681	http://dx.doi.org/10.1371/journal.pone.0062681			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667507	Green Published, Green Submitted, gold			2022-12-27	WOS:000319654700055
J	Autore, F; Pfuhl, M; Quan, XP; Williams, A; Roberts, RG; Shanahan, CM; Fraternali, F				Autore, Flavia; Pfuhl, Mark; Quan, Xueping; Williams, Aisling; Roberts, Roland G.; Shanahan, Catherine M.; Fraternali, Franca			Large-Scale Modelling of the Divergent Spectrin Repeats in Nesprins: Giant Modular Proteins	PLOS ONE			English	Article							DREIFUSS MUSCULAR-DYSTROPHY; ALPHA-ACTININ ROD; NUCLEAR-ENVELOPE; ERYTHROID SPECTRIN; CRYSTAL-STRUCTURE; EVOLUTIONARY CONSERVATION; SEQUENCE ALIGNMENTS; MOLECULAR-DYNAMICS; LAMIN A/C; NESPRIN-1-ALPHA	Nesprin-1 and nesprin-2 are nuclear envelope (NE) proteins characterized by a common structure of an SR (spectrin repeat) rod domain and a C-terminal transmembrane KASH [Klarsicht-ANC-Syne-homology] domain and display N-terminal actin-binding CH (calponin homology) domains. Mutations in these proteins have been described in Emery-Dreifuss muscular dystrophy and attributed to disruptions of interactions at the NE with nesprins binding partners, lamin A/C and emerin. Evolutionary analysis of the rod domains of the nesprins has shown that they are almost entirely composed of unbroken SR-like structures. We present a bioinformatical approach to accurate definition of the boundaries of each SR by comparison with canonical SR structures, allowing for a large-scale homology modelling of the 74 nesprin-1 and 56 nesprin-2 SRs. The exposed and evolutionary conserved residues identify important pbs for protein-protein interactions that can guide tailored binding experiments. Most importantly, the bioinformatics analyses and the 3D models have been central to the design of selected constructs for protein expression. 1D NMR and CD spectra have been performed of the expressed SRs, showing a folded, stable, high content a-helical structure, typical of SRs. Molecular Dynamics simulations have been performed to study the structural and elastic properties of consecutive SRs, revealing insights in the mechanical properties adopted by these modules in the cell.	[Autore, Flavia; Pfuhl, Mark; Quan, Xueping; Williams, Aisling; Fraternali, Franca] Kings Coll London, Sch Phys Sci & Engn, Randall Div Cell & Mol Biophys, London WC2R 2LS, England; [Autore, Flavia; Williams, Aisling; Shanahan, Catherine M.] Kings Coll London, Div Cardiovasc Med, BHF Ctr Res Excellence, London WC2R 2LS, England; [Roberts, Roland G.] Kings Coll London, Guys Hosp, Div Med & Mol Genet, London WC2R 2LS, England; [Fraternali, Franca] Thomas Young Ctr Theory & Simulat Mat, London, England	University of London; King's College London; University of London; King's College London; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London	Fraternali, F (corresponding author), Kings Coll London, Sch Phys Sci & Engn, Randall Div Cell & Mol Biophys, London WC2R 2LS, England.	franca.fraternali@kcl.ac.uk	Fraternali, Franca/C-8912-2009; Fraternali, Franca/D-4410-2011	Fraternali, Franca/0000-0002-3143-6574; Pfuhl, Mark/0000-0001-9592-6639; Shanahan, Catherine/0000-0002-8352-8171; Roberts, Roland/0000-0001-6636-1579	BHF Centre of Excellence; Leverhulme Trust [F/07040/AL]; British Heart Foundation [NH/12/2/29427, RG/11/14/29056] Funding Source: researchfish	BHF Centre of Excellence; Leverhulme Trust(Leverhulme Trust); British Heart Foundation(British Heart Foundation)	This work was supported the BHF Centre of Excellence. FF is funded by the Leverhulme Trust (grant No. F/07040/AL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; AMADEI A, 1993, PROTEINS, V17, P412, DOI 10.1002/prot.340170408; Amann KJ, 1999, J BIOL CHEM, V274, P35375, DOI 10.1074/jbc.274.50.35375; An XL, 2006, BIOCHEMISTRY-US, V45, P13670, DOI 10.1021/bi061368x; An XL, 2006, J BIOL CHEM, V281, P10527, DOI 10.1074/jbc.M513725200; Apel ED, 2000, J BIOL CHEM, V275, P31986, DOI 10.1074/jbc.M004775200; Ashkenazy H, 2010, NUCLEIC ACIDS RES, V38, pW529, DOI 10.1093/nar/gkq399; Berendsen H. J. C., 1981, INTERMOLECULAR FORCE, P331, DOI [10.1007/978-94-015-7658-1_21, DOI 10.1007/978-94-015-7658-1_21, 10.1007/978-94-015-7658, DOI 10.1007/978-94-015-7658]; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Bhasin N, 2005, J MOL BIOL, V352, P795, DOI 10.1016/j.jmb.2005.07.064; Broderick MJF, 2005, ADV PROTEIN CHEM, V70, P203, DOI 10.1016/S0065-3233(04)70007-8; Cavallo L, 2003, NUCLEIC ACIDS RES, V31, P3364, DOI 10.1093/nar/gkg601; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Darden T, 1999, STRUCT FOLD DES, V7, pR55, DOI 10.1016/S0969-2126(99)80033-1; Davis L, 2009, J BIOL CHEM, V284, P6982, DOI 10.1074/jbc.M809245200; Djinovic-Carugo K, 2002, FEBS LETT, V513, P119, DOI 10.1016/S0014-5793(01)03304-X; Djinovic-Carugo K, 1999, CELL, V98, P537, DOI 10.1016/S0092-8674(00)81981-9; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; Eisenberg D, 1997, METHOD ENZYMOL, V277, P396, DOI 10.1016/S0076-6879(97)77022-8; Finn RD, 2008, NUCLEIC ACIDS RES, V36, pD281, DOI 10.1093/nar/gkm960; Fogl C, 2011, PROTEINS; Fraternali F, 2002, NUCLEIC ACIDS RES, V30, P2950, DOI 10.1093/nar/gkf373; Golji J, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000389; Grum VL, 1999, CELL, V98, P523, DOI 10.1016/S0092-8674(00)81980-7; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Ipsaro JJ, 2010, BLOOD, V115, P4843, DOI 10.1182/blood-2010-01-261396; Jerschow A, 1997, J MAGN RESON, V125, P372, DOI 10.1006/jmre.1997.1123; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kowalski K, 2004, J BIOMOL NMR, V29, P533, DOI 10.1023/B:JNMR.0000034342.20537.01; Kusunoki H, 2004, J MOL BIOL, V344, P495, DOI 10.1016/j.jmb.2004.09.019; Kusunoki H, 2004, STRUCTURE, V12, P645, DOI 10.1016/j.str.2004.02.022; Landau M, 2005, NUCLEIC ACIDS RES, V33, pW299, DOI 10.1093/nar/gki370; Libotte T, 2005, MOL BIOL CELL, V16, P3411, DOI 10.1091/mbc.E04-11-1009; Liu J, 2004, J MOL BIOL, V338, P115, DOI 10.1016/j.jmb.2004.02.034; Lupyan D, 2005, BIOINFORMATICS, V21, P3255, DOI 10.1093/bioinformatics/bti527; MacDonald RI, 2004, P NATL ACAD SCI USA, V101, P1502, DOI 10.1073/pnas.0308059100; Mirijanian DT, 2007, J MOL BIOL, V365, P523, DOI 10.1016/j.jmb.2006.10.003; Mislow JMK, 2002, FEBS LETT, V525, P135, DOI 10.1016/S0014-5793(02)03105-8; Mislow JMK, 2002, J CELL SCI, V115, P61; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159; O'Sullivan O, 2004, J MOL BIOL, V340, P385, DOI 10.1016/j.jmb.2004.04.058; Oostenbrink C, 2004, J COMPUT CHEM, V25, P1656, DOI 10.1002/jcc.20090; Ortiz V, 2005, J MOL BIOL, V349, P638, DOI 10.1016/j.jmb.2005.03.086; Padmakumar VC, 2004, EXP CELL RES, V295, P330, DOI 10.1016/j.yexcr.2004.01.014; Pare GC, 2005, EXP CELL RES, V303, P388, DOI 10.1016/j.yexcr.2004.10.009; Park S, 2003, J BIOL CHEM, V278, P21837, DOI 10.1074/jbc.M300617200; Pascual J, 1996, FEBS LETT, V383, P201, DOI 10.1016/0014-5793(96)00251-7; Pascual J, 1997, J MOL BIOL, V273, P740, DOI 10.1006/jmbi.1997.1344; PIOTTO M, 1992, J BIOMOL NMR, V2, P661, DOI 10.1007/BF02192855; Rajgor D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040098; Rost B, 1999, PROTEIN ENG, V12, P85, DOI 10.1093/protein/12.2.85; Rybakova IN, 2006, J BIOL CHEM, V281, P9996, DOI 10.1074/jbc.M513121200; Rybakova IN, 2005, J BIOL CHEM, V280, P23018, DOI 10.1074/jbc.M502530200; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Schneider M, 2004, PLANT PHYSIOL BIOCH, V42, P1013, DOI 10.1016/j.plaphy.2004.10.009; Schroder S, 2011, BIOCHEM J, V435, P651, DOI 10.1042/BJ20101810; Simpson JG, 2008, BIOCHEM SOC T, V36, P1359, DOI 10.1042/BST0361359; Stabach PR, 2009, BLOOD, V113, P5377, DOI 10.1182/blood-2008-10-184291; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Vishwanatha KS, 2012, BIOCHEMISTRY-US, V51, P5663, DOI 10.1021/bi300583s; Vorobiev S.M., 2008, NE STRUCT GENOMICS C; Warren Derek T., 2005, Expert Reviews in Molecular Medicine, V7, P1, DOI 10.1017/S1462399405009294; Warren DT, 2010, J BIOL CHEM, V285, P1311, DOI 10.1074/jbc.M109.032557; Wheeler MA, 2007, EXP CELL RES, V313, P2845, DOI 10.1016/j.yexcr.2007.03.025; Wheeler MA, 2008, BIOCHEM SOC T, V36, P1354, DOI 10.1042/BST0361354; Wiederstein M, 2007, NUCLEIC ACIDS RES, V35, pW407, DOI 10.1093/nar/gkm290; YAN Y, 1993, SCIENCE, V262, P2027, DOI 10.1126/science.8266097; Ylanne J, 2001, STRUCTURE, V9, P597, DOI 10.1016/S0969-2126(01)00619-0; Zhang QP, 2007, HUM MOL GENET, V16, P2816, DOI 10.1093/hmg/ddm238; Zhang QP, 2005, J CELL SCI, V118, P673, DOI 10.1242/jcs.01642; Zhang QP, 2001, J CELL SCI, V114, P4485	72	29	31	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2013	8	5							e63633	10.1371/journal.pone.0063633	http://dx.doi.org/10.1371/journal.pone.0063633			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	177QL	23671687	Green Submitted, gold, Green Published			2022-12-27	WOS:000321390200053
J	Martin, E; Caubit, X; Airik, R; Vola, C; Fatmi, A; Kispert, A; Fasano, L				Martin, Elise; Caubit, Xavier; Airik, Rannar; Vola, Christine; Fatmi, Ahmed; Kispert, Andreas; Fasano, Laurent			TSHZ3 and SOX9 Regulate the Timing of Smooth Muscle Cell Differentiation in the Ureter by Reducing Myocardin Activity (Publication with Expression of Concern. See vol. 14, 2019)	PLOS ONE			English	Article; Publication with Expression of Concern							EXPRESSION; TEASHIRT; KIDNEY; GENES; PROTEINS; COFACTOR; TBX18	Smooth muscle cells are of key importance for the proper functioning of different visceral organs including those of the urogenital system. In the mouse ureter, the two transcriptional regulators TSHZ3 and SOX9 are independently required for initiation of smooth muscle differentiation from uncommitted mesenchymal precursor cells. However, it has remained unclear whether TSHZ3 and SOX9 act independently or as part of a larger regulatory network. Here, we set out to characterize the molecular function of TSHZ3 in the differentiation of the ureteric mesenchyme. Using a yeast-two-hybrid screen, we identified SOX9 as an interacting protein. We show that TSHZ3 also binds to the master regulator of the smooth muscle program, MYOCD, and displaces it from the coregulator SRF, thereby disrupting the activation of smooth muscle specific genes. We found that the initiation of the expression of smooth muscle specific genes in MYOCD-positive ureteric mesenchyme coincides with the down regulation of Sox9 expression, identifying SOX9 as a possible negative regulator of smooth muscle cell differentiation. To test this hypothesis, we prolonged the expression of Sox9 in the ureteric mesenchyme in vivo. We found that Sox9 does not affect Myocd expression but significantly reduces the expression of MYOCD/SRF-dependent smooth muscle genes, suggesting that down-regulation of Sox9 is a prerequisite for MYOCD activity. We propose that the dynamic expression of Sox9 and the interaction between TSHZ3, SOX9 and MYOCD provide a mechanism that regulates the pace of progression of the myogenic program in the ureter.	[Martin, Elise; Caubit, Xavier; Vola, Christine; Fatmi, Ahmed; Fasano, Laurent] Aix Marseille Univ, CNRS, IBDM UMR7288, Marseille, France; [Airik, Rannar; Kispert, Andreas] Hannover Med Sch, Inst Mol Biol, D-30623 Hannover, Germany	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite; Hannover Medical School	Fasano, L (corresponding author), Aix Marseille Univ, CNRS, IBDM UMR7288, Marseille, France.	laurent.fasano@univ-amu.fr	Fasano, Laurent/AAH-1688-2022; Airik, Rannar/AAS-7810-2021; Fasano, Laurent/AFL-9580-2022	Fasano, Laurent/0000-0003-2307-8428; Airik, Rannar/0000-0002-7055-6325; Fasano, Laurent/0000-0003-2307-8428	Centre National de la Recherche Scientifique (CNRS); Association Francaise contre les Myopathies (AFM) [12545, 13013]; Agence Nationale de la Recherche (ANR) [ANR-09-GENO-027-01]; Deutsche Forschungsgemeinschaft (German Research Council) [DFG Ki728/7-1]; Agence Nationale de la Recherche [ANR-10-INSB-04-01]	Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Association Francaise contre les Myopathies (AFM)(Association Francaise contre les Myopathies); Agence Nationale de la Recherche (ANR)(French National Research Agency (ANR)); Deutsche Forschungsgemeinschaft (German Research Council)(German Research Foundation (DFG)); Agence Nationale de la Recherche(French National Research Agency (ANR))	Research in the laboratory of LF was supported by the Centre National de la Recherche Scientifique (CNRS) with additional funding from the Association Francaise contre les Myopathies (AFM, grants 12545, 13013) and the Agence Nationale de la Recherche (ANR, grant ANR-09-GENO-027-01). Work in the laboratory of AK was supported by a grant (DFG Ki728/7-1) from the Deutsche Forschungsgemeinschaft (German Research Council). E. Martin was a fellow of the AFM. Part of this work was performed using France-BioImaging infrastructure supported by the Agence Nationale de la Recherche (ANR-10-INSB-04-01, call "Investissements d'Avenir"). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Airik R, 2006, J CLIN INVEST, V116, P663, DOI 10.1172/JCI26027; Airik R, 2010, HUM MOL GENET, V19, P4918, DOI 10.1093/hmg/ddq426; Brenner-Anantharam A, 2007, DEVELOPMENT, V134, P1967, DOI 10.1242/dev.004234; Cain JE, 2008, DIFFERENTIATION, V76, P831, DOI 10.1111/j.1432-0436.2008.00265.x; Carroll TJ, 2005, DEV CELL, V9, P283, DOI 10.1016/j.devcel.2005.05.016; Caubit X, 2005, J COMP NEUROL, V486, P76, DOI 10.1002/cne.20500; Caubit X, 2008, DEVELOPMENT, V135, P3301, DOI 10.1242/dev.022442; Chen JY, 2002, J MOL CELL CARDIOL, V34, P1345, DOI 10.1006/jmcc.2002.2086; Creemers EE, 2006, DEVELOPMENT, V133, P4245, DOI 10.1242/dev.02610; DELLAGNOLA CA, 1990, Z KINDERCHIR, V45, P286; Du KL, 2003, MOL CELL BIOL, V23, P2425, DOI 10.1128/MCB.23.7.2425-2437.2003; Faralli H, 2011, J BIOL CHEM, V286, P23498, DOI 10.1074/jbc.M110.206003; Gallet A, 2000, DEVELOPMENT, V127, P5509; GUNN TR, 1995, AM J OBSTET GYNECOL, V172, P479, DOI 10.1016/0002-9378(95)90560-X; Hirschi KK, 1998, J CELL BIOL, V141, P805, DOI 10.1083/jcb.141.3.805; Huang JH, 2008, J CLIN INVEST, V118, P515, DOI [10.1172/JC133304, 10.1172/JCI33304]; Ismaili K, 2006, J PEDIATR-US, V148, P222, DOI 10.1016/j.jpeds.2005.09.037; Iwanaga Y, 2006, J MOL CELL CARDIOL, V41, P798, DOI 10.1016/j.yjmcc.2006.07.004; Kajiwara Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005071; Karsenty G, 2008, ANNU REV GENOM HUM G, V9, P183, DOI 10.1146/annurev.genom.9.081307.164437; Li SJ, 2003, P NATL ACAD SCI USA, V100, P9366, DOI 10.1073/pnas.1233635100; Liu ZP, 2005, DEV CELL, V9, P261, DOI 10.1016/j.devcel.2005.05.017; Lye CM, 2010, J AM SOC NEPHROL, V21, P24, DOI 10.1681/ASN.2008111206; MCHUGH KM, 1995, DEV DYNAM, V204, P278, DOI 10.1002/aja.1002040306; Michos O, 2007, DEVELOPMENT, V134, P2397, DOI 10.1242/dev.02861; Miyazaki Y, 2000, J CLIN INVEST, V105, P863, DOI 10.1172/JCI8256; Nie XG, 2010, DEVELOPMENT, V137, P755, DOI 10.1242/dev.045757; Onai T, 2007, EMBO J, V26, P2350, DOI 10.1038/sj.emboj.7601684; Raatikainen-Ahokas A, 2000, DEV DYNAM, V217, P146, DOI 10.1002/(SICI)1097-0177(200002)217:2<146::AID-DVDY2>3.3.CO;2-9; Reginensi A, 2011, HUM MOL GENET, V20, P1143, DOI 10.1093/hmg/ddq558; Schmidt K, 2003, J BIOL CHEM, V278, P29769, DOI 10.1074/jbc.M301539200; Taghli-Lamallem O, 2007, DEV BIOL, V307, P142, DOI 10.1016/j.ydbio.2007.04.028; Wang DZ, 2002, P NATL ACAD SCI USA, V99, P14855, DOI 10.1073/pnas.222561499; Wang DZ, 2001, CELL, V105, P851, DOI 10.1016/S0092-8674(01)00404-4; Wang GJ, 2009, J UROLOGY, V181, P401, DOI 10.1016/j.juro.2008.08.117; Wang ZG, 2003, P NATL ACAD SCI USA, V100, P7129, DOI 10.1073/pnas.1232341100; Wang ZG, 2004, NATURE, V428, P185, DOI 10.1038/nature02382; Yu J, 2002, DEVELOPMENT, V129, P5301; Zacharias William J, 2011, Dev Biol, V355, P152, DOI 10.1016/j.ydbio.2011.04.025; Zhang PL, 2000, PEDIATR NEPHROL, V14, P820, DOI 10.1007/s004679900240; Zhou JL, 2005, J BIOL CHEM, V280, P10861, DOI 10.1074/jbc.M411586200	41	13	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2013	8	5							e63721	10.1371/journal.pone.0063721	http://dx.doi.org/10.1371/journal.pone.0063721			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	177QL	23671695	gold, Green Published, Green Submitted			2022-12-27	WOS:000321390200058
J	Vos, M; te Beek, TAH; van Driel, MA; Huynen, MA; Eyre-Walker, A; van Passel, MWJ				Vos, Michiel; te Beek, Tim A. H.; van Driel, Marc A.; Huynen, Martijn A.; Eyre-Walker, Adam; van Passel, Mark W. J.			ODoSE: A Webserver for Genome-Wide Calculation of Adaptive Divergence in Prokaryotes	PLOS ONE			English	Article							POSITIVE SELECTION; EVOLUTION; RECOMBINATION; DROSOPHILA	Quantifying patterns of adaptive divergence between taxa is a major goal in the comparative and evolutionary study of prokaryote genomes. When applied appropriately, the McDonald-Kreitman (MK) test is a powerful test of selection based on the relative frequency of non-synonymous and synonymous substitutions between species compared to non-synonymous and synonymous polymorphisms within species. The webserver ODoSE (Ortholog Direction of Selection Engine) allows the calculation of a novel extension of the MK test, the Direction of Selection (DoS) statistic, as well as the calculation of a weighted-average Neutrality Index (NI) statistic for the entire core genome, allowing for systematic analysis of the evolutionary forces shaping core genome divergence in prokaryotes. ODoSE is hosted in a Galaxy environment, which makes it easy to use and amenable to customization and is freely available at www.odose.nl.	[Vos, Michiel] Univ Exeter, Sch Med, European Ctr Environm & Human Hlth, Truro, England; [te Beek, Tim A. H.; van Driel, Marc A.] Netherlands Bioinformat Ctr, Nijmegen, Netherlands; [te Beek, Tim A. H.; Huynen, Martijn A.] Radboud Univ Nijmegen, Med Ctr, Ctr Mol & Biomol Informat, NL-6525 ED Nijmegen, Netherlands; [Eyre-Walker, Adam] Univ Sussex, Sch Life Sci, Ctr Study Evolut, Brighton, E Sussex, England; [van Passel, Mark W. J.] Wageningen Univ, NL-6700 AP Wageningen, Netherlands	University of Exeter; Radboud University Nijmegen; University of Sussex; Wageningen University & Research	Vos, M (corresponding author), Univ Exeter, Sch Med, European Ctr Environm & Human Hlth, Truro, England.	michiel.vos@pcmd.ac.uk; mark.vanpassel@wur.nl	Eyre-Walker, Adam/G-6216-2011; Huynen, Martijn A/A-1530-2014; Huijnen, M.A./H-8051-2014	Eyre-Walker, Adam/0000-0001-5527-8729; Huynen, Martijn A/0000-0001-6189-5491; 	Netherlands Organization for Scientific Research (NWO) via a VENI grant; BioAssist/BRS programme of the Netherlands Bioinformatics Centre; Netherlands Genomics Initiative; NWO; European Regional Development Fund; European Social Fund Convergence Programme for Cornwall; Isles of Scilly	Netherlands Organization for Scientific Research (NWO) via a VENI grant(Netherlands Organization for Scientific Research (NWO)); BioAssist/BRS programme of the Netherlands Bioinformatics Centre; Netherlands Genomics Initiative; NWO(Netherlands Organization for Scientific Research (NWO)); European Regional Development Fund(European Commission); European Social Fund Convergence Programme for Cornwall; Isles of Scilly	MWJvP is funded by the Netherlands Organization for Scientific Research (NWO) via a VENI grant. TtB and MAvD are funded by the BioAssist/BRS programme of the Netherlands Bioinformatics Centre, which is supported by the Netherlands Genomics Initiative. This work is part of the programme of BiG Grid, the Dutch e-Science Grid, which is financially supported by the NWO. MV is supported by investment from the European Regional Development Fund and the European Social Fund Convergence Programme for Cornwall and the Isles of Scilly to the European Centre for the Environment and Human Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bruen TC, 2006, GENETICS, V172, P2665, DOI 10.1534/genetics.105.048975; Charlesworth J, 2006, MOL BIOL EVOL, V23, P1348, DOI 10.1093/molbev/msk025; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Eyre-Walker A, 2006, TRENDS ECOL EVOL, V21, P569, DOI 10.1016/j.tree.2006.06.015; Eyre-Walker A, 2009, MOL BIOL EVOL, V26, P2097, DOI 10.1093/molbev/msp119; Giardine B, 2005, GENOME RES, V15, P1451, DOI 10.1101/gr.4086505; Hughes AL, 2008, MOL BIOL EVOL, V25, P2199, DOI 10.1093/molbev/msn166; Joseph B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018441; Lefebure T, 2010, GENOME BIOL EVOL, V2, P646, DOI 10.1093/gbe/evq048; Lefebure T, 2009, GENOME RES, V19, P1224, DOI 10.1101/gr.089250.108; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; MCDONALD JH, 1991, NATURE, V351, P652, DOI 10.1038/351652a0; Presgraves DC, 2005, CURR BIOL, V15, P1651, DOI 10.1016/j.cub.2005.07.065; Rand DM, 1996, MOL BIOL EVOL, V13, P735, DOI 10.1093/oxfordjournals.molbev.a025634; Shapiro BJ, 2009, ISME J, V3, P1180, DOI 10.1038/ismej.2009.51; Shapiro BJ, 2008, PLOS GENET, V4, DOI [10.1371/journal.pgen.0040023.eor, 10.1371/journal.pgen.0040023]; Soyer Y, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-264; Stoletzki N, 2011, MOL BIOL EVOL, V28, P63, DOI 10.1093/molbev/msq249; van Passel MWJ, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000059; Vos M, 2011, TRENDS MICROBIOL, V19, P1, DOI 10.1016/j.tim.2010.10.003; Xu ZF, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-203; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088	22	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2013	8	5							e62447	10.1371/journal.pone.0062447	http://dx.doi.org/10.1371/journal.pone.0062447			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	177QL	23671597	Green Published, Green Submitted, gold			2022-12-27	WOS:000321390200023
J	Bily, J; Grycova, L; Holendova, B; Jirku, M; Janouskova, H; Bousova, K; Teisinger, J				Bily, Jan; Grycova, Lenka; Holendova, Blanka; Jirku, Michaela; Janouskova, Hana; Bousova, Kristyna; Teisinger, Jan			Characterization of the S100A1 Protein Binding Site on TRPC6 C-Terminus	PLOS ONE			English	Article							3-DIMENSIONAL SOLUTION STRUCTURE; RYANODINE RECEPTOR; SKELETAL-MUSCLE; CALMODULIN; CHANNELS; ASSOCIATION; EXPRESSION; COMPLEX; FAMILY; TRPV6	The transient receptor potential (TRP) protein superfamily consists of seven major groups, among them the "canonical TRP'' family. The TRPC proteins are calcium-permeable nonselective cation channels activated after the emptying of intracellular calcium stores and appear to be gated by various types of messengers. The TRPC6 channel has been shown to be expressed in various tissues and cells, where it modulates the calcium level in response to external signals. Calcium binding proteins such as Calmodulin or the family of S100A proteins are regulators of TRPC channels. Here we characterized the overlapping integrative binding site for S100A1 at the C-tail of TRPC6, which is also able to accomodate various ligands such as Calmodulin and phosphatidyl-inositol-(4,5)-bisphosphate. Several positively charged amino acid residues (Arg852, Lys856, Lys859, Arg860 and Arg864) were determined by fluorescence anisotropy measurements for their participation in the calcium-dependent binding of S100A1 to the C terminus of TRPC6. The triple mutation Arg852/Lys859/Arg860 exhibited significant disruption of the binding of S100A1 to TRPC6. This indicates a unique involvement of these three basic residues in the integrative overlapping binding site for S100A1 on the C tail of TRPC6.	[Bily, Jan; Grycova, Lenka; Holendova, Blanka; Jirku, Michaela; Janouskova, Hana; Bousova, Kristyna; Teisinger, Jan] Acad Sci Czech Republic, Inst Physiol, Dept Prot Struct, Prague, Czech Republic	Czech Academy of Sciences; Institute of Physiology of the Czech Academy of Sciences	Teisinger, J (corresponding author), Acad Sci Czech Republic, Inst Physiol, Dept Prot Struct, Prague, Czech Republic.	teisingr@biomed.cas.cz	Bousova, Kristyna/AAT-8543-2020; Teisinger, Jan/B-7122-2012; Grycova, Lenka/B-7118-2012; Holendova, Blanka/A-7170-2016; Vodičková, Michaela/O-8121-2017	Bousova, Kristyna/0000-0001-9030-3811; Grycova, Lenka/0000-0002-6476-3627; Holendova, Blanka/0000-0002-3904-8189; Vodičková, Michaela/0000-0002-0163-1432	Grant Agency of the Czech Republic [301/10/1159, P205/10/P308]; Institute of Physiology (RVO) [67985823]; Institute of Microbiology, Academy of Sciences of the Czech Republic (RVO) [61388971]	Grant Agency of the Czech Republic(Grant Agency of the Czech Republic); Institute of Physiology (RVO); Institute of Microbiology, Academy of Sciences of the Czech Republic (RVO)	This work was supported by grant 301/10/1159 of the Grant Agency of the Czech Republic, grant P205/10/P308 of the Grant Agency of the Czech Republic and from institutional project of the Institute of Physiology (RVO: 67985823) and institutional project of the Institute of Microbiology, Academy of Sciences of the Czech Republic (RVO: 61388971). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Borthwick LA, 2008, CELL CALCIUM, V44, P147, DOI 10.1016/j.ceca.2007.11.001; Clapham DE, 2001, NAT REV NEUROSCI, V2, P387, DOI 10.1038/35077544; Friedlova E, 2010, NEUROCHEM INT, V56, P363, DOI 10.1016/j.neuint.2009.11.009; Grycova L, 2008, BIOCHEM BIOPH RES CO, V375, P680, DOI 10.1016/j.bbrc.2008.08.094; Holakovska B, 2012, J BIOL CHEM, V287, P16645, DOI 10.1074/jbc.M112.350686; Holakovska B, 2011, AMINO ACIDS, V40, P741, DOI 10.1007/s00726-010-0712-2; JOHNSON JD, 1978, J BIOL CHEM, V253, P6451; KINCAID RL, 1982, J BIOL CHEM, V257, P638; Kwon Y, 2007, MOL CELL, V25, P491, DOI 10.1016/j.molcel.2007.01.021; Minke B, 2006, CELL CALCIUM, V40, P261, DOI 10.1016/j.ceca.2006.05.002; Nilius B, 2007, PHYSIOL REV, V87, P165, DOI 10.1152/physrev.00021.2006; Pedersen SF, 2005, CELL CALCIUM, V38, P233, DOI 10.1016/j.ceca.2005.06.028; Prochazkova K, 2005, J BIOL CHEM, V280, P3251, DOI 10.1074/jbc.M411232200; Ramsey IS, 2006, ANNU REV PHYSIOL, V68, P619, DOI 10.1146/annurev.physiol.68.040204.100431; Rustandi RR, 2002, BIOCHEMISTRY-US, V41, P788, DOI 10.1021/bi0118308; Santamaria-Kisiel L, 2006, BIOCHEM J, V396, P201, DOI 10.1042/BJ20060195; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Treves S, 1997, BIOCHEMISTRY-US, V36, P11496, DOI 10.1021/bi970160w; Van de Graaf SFJ, 2003, EMBO J, V22, P1478, DOI 10.1093/emboj/cdg162; Wright NT, 2008, J BIOL CHEM, V283, P26676, DOI 10.1074/jbc.M804432200; Wright Nathan T, 2009, Curr Chem Biol, V3, P138; Wright NT, 2005, J MOL BIOL, V353, P410, DOI 10.1016/j.jmb.2005.08.027; Zhu MX, 2005, PFLUG ARCH EUR J PHY, V451, P105, DOI 10.1007/s00424-005-1427-1; Zimmer DB, 2005, CELL MOL BIOL, V51, P201, DOI 10.1170/T620; ZIMMER DB, 1995, J NEUROCHEM, V64, P2727	25	12	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2013	8	5							e62677	10.1371/journal.pone.0062677	http://dx.doi.org/10.1371/journal.pone.0062677			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175AS	23671622	Green Submitted, gold, Green Published			2022-12-27	WOS:000321202100031
J	Saitoh, M; Shirakihara, T; Fukasawa, A; Horiguchi, K; Sakamoto, K; Sugiya, H; Beppu, H; Fujita, Y; Morita, I; Miyazono, K; Miyazawa, K				Saitoh, Masao; Shirakihara, Takuya; Fukasawa, Akira; Horiguchi, Kana; Sakamoto, Kei; Sugiya, Hiroshi; Beppu, Hideyuki; Fujita, Yasuyuki; Morita, Ikuo; Miyazono, Kohei; Miyazawa, Keiji			Basolateral BMP Signaling in Polarized Epithelial Cells	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; PRIMARY PULMONARY-HYPERTENSION; MESENCHYMAL TRANSITION; MDCK CELLS; RECEPTOR; CANCER; TIGHT; ORGANIZATION; TRAFFICKING; COMPLEXES	Bone morphogenetic proteins (BMPs) regulate various biological processes, mostly mediated by cells of mesenchymal origin. However, the roles of BMPs in epithelial cells are poorly understood. Here, we demonstrate that, in polarized epithelial cells, BMP signals are transmitted from BMP receptor complexes exclusively localized at the basolateral surface of the cell membrane. In addition, basolateral stimulation with BMP increased expression of components of tight junctions and enhanced the transepithelial resistance (TER), counteracting reduction of TER by treatment with TGF-beta or an anti-tumor drug. We conclude that BMPs maintain epithelial polarity via intracellular signaling from basolaterally localized BMP receptors.	[Saitoh, Masao; Fukasawa, Akira; Miyazawa, Keiji] Univ Yamanashi, Interdisciplinary Grad Sch Med & Engn, Dept Biochem, Chuo, Yamanashi, Japan; [Shirakihara, Takuya] Natl Canc Ctr, Div Metastasis & Invas Signaling, Chuo Ku, Tokyo, Japan; [Saitoh, Masao; Shirakihara, Takuya; Horiguchi, Kana; Miyazono, Kohei] Univ Tokyo, Dept Mol Pathol, Grad Sch Med, Bunkyo Ku, Tokyo, Japan; [Sakamoto, Kei] Tokyo Med & Dent Univ, Sect Oral Pathol, Int Res Ctr Mol Sci Tooth & Bone Dis, Grad Sch Med & Dent Sci,Bunkyo Ku, Tokyo, Japan; [Sugiya, Hiroshi] Nihon Univ, Coll Bioresource Sci, Vet Biochem Lab, Fujisawa, Kanagawa, Japan; [Beppu, Hideyuki] Toyama Univ, Dept Clin Lab & Mol Pathol, Grad Sch Med & Pharmaceut Sci Res, Toyama 930, Japan; [Fujita, Yasuyuki] Hokkaido Univ, Inst Med Genet, Div Mol Oncol, Sapporo, Hokkaido, Japan; [Saitoh, Masao; Morita, Ikuo] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Int Res Ctr Mol Sci Tooth & Bone Dis, Dept Cellular Physiol Chem, Tokyo, Japan; [Saitoh, Masao; Morita, Ikuo] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Int Res Ctr Mol Sci Tooth & Bone Dis, Global Ctr Excellence GCOE Program, Tokyo, Japan	University of Yamanashi; National Cancer Center - Japan; University of Tokyo; Tokyo Medical & Dental University (TMDU); Nihon University; University of Toyama; Hokkaido University; Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU)	Saitoh, M (corresponding author), Univ Yamanashi, Interdisciplinary Grad Sch Med & Engn, Dept Biochem, Chuo, Yamanashi, Japan.	msaitoh-ind@umin.ac.jp	MIYAZAWA, KEIJI/I-9713-2014	Shirakihara, Takuya/0000-0002-6222-0143	KAKENHI; Global Center of Excellence (GCOE) Program (International Research Center for Molecular Science in Tooth and Bone Diseases); Japan Society for the Promotion of Science; Grants-in-Aid for Scientific Research [22112002, 22390059] Funding Source: KAKEN	KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Global Center of Excellence (GCOE) Program (International Research Center for Molecular Science in Tooth and Bone Diseases); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by KAKENHI (Grants-in-Aid for Scientific Research), the Global Center of Excellence (GCOE) Program (International Research Center for Molecular Science in Tooth and Bone Diseases), and the Core-to-Core program "Cooperative International Framework in TGF-beta Family Signaling" from the Japan Society for the Promotion of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beppu H, 1997, BIOCHEM BIOPH RES CO, V235, P499, DOI 10.1006/bbrc.1997.6816; Daly AC, 2008, MOL CELL BIOL, V28, P6889, DOI 10.1128/MCB.01192-08; Folsch H, 1999, CELL, V99, P189, DOI 10.1016/S0092-8674(00)81650-5; Folsch H, 2005, TRENDS CELL BIOL, V15, P222, DOI 10.1016/j.tcb.2005.02.006; Furuse M, 2001, J CELL BIOL, V153, P263, DOI 10.1083/jcb.153.2.263; Gonzalez A, 2009, FEBS LETT, V583, P3784, DOI 10.1016/j.febslet.2009.10.050; Goumans MJ, 2003, MOL CELL, V12, P817, DOI 10.1016/S1097-2765(03)00386-1; Gravotta D, 2012, DEV CELL, V22, P811, DOI 10.1016/j.devcel.2012.02.004; Hardwick JC, 2008, NAT REV CANCER, V8, P806, DOI 10.1038/nrc2467; HOBERT M, 1995, J CELL PHYSIOL, V162, P434, DOI 10.1002/jcp.1041620316; Hogan C, 2009, NAT CELL BIOL, V11, P460, DOI 10.1038/ncb1853; Horiguchi K, 2009, J BIOL CHEM, V284, P245, DOI 10.1074/jbc.M804777200; Kallioniemi A, 2012, CANCER GENET-NY, V205, P267, DOI 10.1016/j.cancergen.2012.05.009; Katsuno Y, 2008, ONCOGENE, V27, P6322, DOI 10.1038/onc.2008.232; Keita AV, 2012, ANN NY ACAD SCI, V1258, P125, DOI 10.1111/j.1749-6632.2012.06502.x; Ludwig T, 2004, KIDNEY INT, V66, P196, DOI 10.1111/j.1523-1755.2004.00720.x; Machado RD, 2001, AM J HUM GENET, V68, P92, DOI 10.1086/316947; Miyazono K, 2005, CYTOKINE GROWTH F R, V16, P251, DOI 10.1016/j.cytogfr.2005.01.009; Miyazono K, 2010, J BIOCHEM, V147, P35, DOI 10.1093/jb/mvp148; Murphy SJ, 2007, MOL BIOL CELL, V18, P3788, DOI 10.1091/mbc.E06-10-0930; Nishihara A, 2002, MOL BIOL CELL, V13, P3055, DOI 10.1091/mbc.E02-02-0063; Ohno H, 1999, FEBS LETT, V449, P215, DOI 10.1016/S0014-5793(99)00432-9; Peinado H, 2003, J BIOL CHEM, V278, P21113, DOI 10.1074/jbc.M211304200; Rodriguez-Boulan E, 2005, NAT REV MOL CELL BIO, V6, P233, DOI 10.1038/nrm1593; Saitoh M, 2012, J BIOCHEM, V151, P563, DOI 10.1093/jb/mvs040; Shirakihara T, 2011, EMBO J, V30, P783, DOI 10.1038/emboj.2010.351; Simmen T, 2002, NAT CELL BIOL, V4, P154, DOI 10.1038/ncb745; Sountoulidis A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041460; STUART RO, 1994, J CELL PHYSIOL, V159, P423, DOI 10.1002/jcp.1041590306; Takahashi D, 2011, GASTROENTEROLOGY, V141, P621, DOI 10.1053/j.gastro.2011.04.056; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Tsukita S, 2001, NAT REV MOL CELL BIO, V2, P285, DOI 10.1038/35067088; Xia Y, 2010, J AM SOC NEPHROL, V21, P666, DOI 10.1681/ASN.2009050511; Yakovich AJ, 2010, J CELL PHYSIOL, V224, P398, DOI 10.1002/jcp.22135; Zeisberg M, 2001, AM J PATHOL, V159, P1313, DOI 10.1016/S0002-9440(10)62518-7; Zeisberg M, 2003, NAT MED, V9, P964, DOI 10.1038/nm888	36	16	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2013	8	5							e62659	10.1371/journal.pone.0062659	http://dx.doi.org/10.1371/journal.pone.0062659			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145RZ	23675417	Green Published, Green Submitted, gold			2022-12-27	WOS:000319036100006
J	Liu, S; Fan, JW; Wang, XL; Gong, ZJ; Wang, SY; Huang, L; Xing, TH; Li, T; Peng, ZH; Sun, X				Liu, Shuang; Fan, Junwei; Wang, Xiaoliang; Gong, Zijun; Wang, Shuyun; Huang, Li; Xing, Tonghai; Li, Tao; Peng, Zhihai; Sun, Xing			Intraoperative Cryoprecipitate Transfusion and Its Association with the Incidence of Biliary Complications after Liver Transplantation-A Retrospective Cohort Study	PLOS ONE			English	Article							FRESH-FROZEN PLASMA; CARDIAC DEATH DONORS; ACUTE LUNG INJURY; T-TUBE; TRACT COMPLICATIONS; SINGLE-CENTER; RISK-FACTORS; PLATELET; MICROPARTICLES; TRIAL	Background: Cryoprecipitate is largely used for acquired hypofibrinogenemia in the setting of massive hemorrhage in liver transplantation (LT). However, the influence of intraoperative cryoprecipitate transfusion on biliary complications (BC) after LT has not been studied in detail. Study Design and Methods: In a series of 356 adult patients who received their first LT, the causes of BC were retrospectively studied by multivariate logistic regression analysis. The clinical relationship between intraoperative cryoprecipitate transfusion and BC occurrence was studied through a retrospective cohort study in patients. All patients received follow-ups for one year, and, during the follow-up period, the time of BC occurrence and liver biopsies were recorded. Results: Intraoperative cryoprecipitate transfusion (RR=3.46, 95% CI [1.72-6.97], P<0.001), cold ischemia time >8 h (RR=4.24, 95% CI [2.28-7.92], P<0.01), and high-level Child-Pugh (RR=1.71, 95% CI [1.11-2.63], P=0.014) are independent risk factors to predict BC after LT according to time-to-event analysis. One year BC-free survival probability of patients received intraoperative cryoprecipitate transfusions was significantly lower when compared to the group that received no cryoprecipitate(P<0.001). Moreover, BC patients in the cryoprecipitate transfusion group owned different liver pathological feature, pathological micro-thrombus formation and cholestasis were seen more often (41.4% vs 0%, 62.1% vs 12.5%, respectively) than no cryoprecipitate transfusion group. Conclusion: These findings suggested that intraoperative cryoprecipitate transfusion was associated with BC after LT. The mechanism of BC occurrence might involve micro-thrombus formation and immune rejection.	[Liu, Shuang; Fan, Junwei; Wang, Xiaoliang; Gong, Zijun; Wang, Shuyun; Huang, Li; Xing, Tonghai; Li, Tao; Peng, Zhihai; Sun, Xing] Shanghai Jiao Tong Univ, Dept Gen Surg, Shanghai Peoples Hosp 1, Sch Med, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University	Peng, ZH (corresponding author), Shanghai Jiao Tong Univ, Dept Gen Surg, Shanghai Peoples Hosp 1, Sch Med, Shanghai 200030, Peoples R China.	shzhihaipeng@hotmail.com; xingsun@hotmail.com			National Natural Science Foundation of China [81170445]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work is supported by the National Natural Science Foundation of China (81170445). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alport EC, 2008, TRANSFUSION, V48, P2122, DOI 10.1111/j.1537-2995.2008.01826.x; Amador A, 2005, TRANSPL P, V37, P1129, DOI 10.1016/j.transproceed.2005.01.015; [Anonymous], 2007, BRIT J HAEMATOL, V136, P514, DOI 10.1111/j.1365-2141.2006.06451.x; [Anonymous], 1994, JAMA, V271, P777; Atwal T, 2012, J CLIN EXP HEPATOL, V2, P81, DOI 10.1016/S0973-6883(12)60085-1; Ben Qian Y, 2004, ARCH SURG-CHICAGO, V139, P1101, DOI 10.1001/archsurg.139.10.1101; Benson AB, 2011, LIVER TRANSPLANT, V17, P149, DOI 10.1002/lt.22212; Biro E, 2005, J THROMB HAEMOST, V3, P2754, DOI 10.1111/j.1538-7836.2005.01646.x; Boin IFSF, 2008, TRANSPL P, V40, P789, DOI 10.1016/j.transproceed.2008.02.058; Busquets J, 2007, J GASTROINTEST SURG, V11, P458, DOI 10.1007/s11605-007-0116-0; Callum JL, 2009, TRANSFUS MED REV, V23, P177, DOI 10.1016/j.tmrv.2009.03.001; Chan EY, 2008, LIVER TRANSPLANT, V14, P604, DOI 10.1002/lt.21361; Chang TI, 2011, J FORMOS MED ASSOC, V110, P183, DOI 10.1016/S0929-6646(11)60029-6; de Boer MT, 2008, ANESTH ANALG, V106, P32, DOI 10.1213/01.ane.0000289638.26666.ed; de Vera ME, 2009, AM J TRANSPLANT, V9, P773, DOI 10.1111/j.1600-6143.2009.02560.x; Dorobantu B, 2010, HEPATO-GASTROENTEROL, V57, P932; Fenger-Eriksen C, 2008, BRIT J ANAESTH, V101, P769, DOI 10.1093/bja/aen270; Foley DP, 2011, ANN SURG, V253, P817, DOI 10.1097/SLA.0b013e3182104784; Fujita S, 2007, TRANSPLANTATION, V84, P1631, DOI 10.1097/01.tp.0000295983.55088.96; Fusai G, 2006, LIVER TRANSPLANT, V12, P1626, DOI 10.1002/lt.20870; Gantxegi A, 2011, TRANSPL P, V43, P745, DOI 10.1016/j.transproceed.2011.01.102; GEORGE JN, 1986, BLOOD, V68, P307; Halme L, 2003, TRANSPLANTATION, V75, P1853, DOI 10.1097/01.TP.0000064620.08328.E5; Heidenhain C, 2010, TRANSPL INT, V23, P14, DOI 10.1111/j.1432-2277.2009.00947.x; Kelly D, 2004, LANCET, V364, P1054, DOI 10.1016/S0140-6736(04)17060-8; Levi M, 2009, BRIT J HAEMATOL, V145, P24, DOI [10.1111/j.1365-2141.2008.07445.x, 10.1111/j.1365-2141.2009.07600.x]; Lim JK, 2011, J CLIN GASTROENTEROL, V45, P914, DOI [10.1097/MCG. 0b013e31822cf4a5, DOI 10.1097/MCG.1090B, 10.1097/MCG.1090b 1013e31822cf31824a31825]; Nieuwland R, 1997, CIRCULATION, V96, P3534; Nishida S, 2002, ARCH SURG-CHICAGO, V137, P1279, DOI 10.1001/archsurg.137.11.1279; Pereboom ITA, 2009, ANESTH ANALG, V108, P1083, DOI 10.1213/ane.0b013e3181948a59; Perrakis A, 2010, TRANSPL P, V42, P4154, DOI 10.1016/j.transproceed.2010.09.045; POOL JG, 1964, NATURE, V203, P312, DOI 10.1038/203312a0; Scatton O, 2001, ANN SURG, V233, P432, DOI 10.1097/00000658-200103000-00019; Schofield WN, 2003, MED J AUSTRALIA, V178, P117, DOI 10.5694/j.1326-5377.2003.tb05101.x; Sinauridze EI, 2007, THROMB HAEMOSTASIS, V97, P425, DOI 10.1160/TH06-06-0313; Sorensen B, 2010, BRIT J HAEMATOL, V149, P834, DOI 10.1111/j.1365-2141.2010.08208.x; Sotiropoulos GC, 2009, TRANSPLANTATION, V87, P1672, DOI 10.1097/TP.0b013e3181a5cf3f; Sparrow RL, 2011, METHODS MOL BIOL, V728, P259, DOI 10.1007/978-1-61779-068-3_17; Sprague DL, 2008, BLOOD, V111, P5028, DOI 10.1182/blood-2007-06-097410; Tripodi A, 2011, NEW ENGL J MED, V365, P147, DOI 10.1056/NEJMra1011170; Welling TH, 2008, LIVER TRANSPLANT, V14, P73, DOI 10.1002/lt.21354; Wojcicki M, 2008, DIGEST SURG, V25, P245, DOI 10.1159/000144653	42	19	22	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2013	8	5							e60727	10.1371/journal.pone.0060727	http://dx.doi.org/10.1371/journal.pone.0060727			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	143FO	23675406	gold, Green Published, Green Submitted			2022-12-27	WOS:000318852400002
J	Snijder, PM; de Boer, RA; Bos, EM; van den Born, JC; Ruifrok, WPT; Vreeswijk-Baudoin, I; van Dijk, MCRF; Hillebrands, JL; Leuvenink, HGD; van Goor, H				Snijder, Pauline M.; de Boer, Rudolf A.; Bos, Eelke M.; van den Born, Joost C.; Ruifrok, Willem-Peter T.; Vreeswijk-Baudoin, Inge; van Dijk, Marcory C. R. F.; Hillebrands, Jan-Luuk; Leuvenink, Henri G. D.; van Goor, Harry			Gaseous Hydrogen Sulfide Protects against Myocardial Ischemia-Reperfusion Injury in Mice Partially Independent from Hypometabolism	PLOS ONE			English	Article							ANIMATION-LIKE STATE; OXIDATIVE STRESS; ISCHEMIA/REPERFUSION INJURY; IMPROVES SURVIVAL; HEART-FAILURE; RAT MODEL; H2S; INFARCTION; MECHANISMS; CARDIOPROTECTION	Background: Ischemia-reperfusion injury (IRI) is a major cause of cardiac damage following various pathological processes. Gaseous hydrogen sulfide (H2S) is protective during IRI by inducing a hypometabolic state in mice which is associated with anti-apoptotic, anti-inflammatory and antioxidant properties. We investigated whether gaseous H2S administration is protective in cardiac IRI and whether non-hypometabolic concentrations of H2S have similar protective properties. Methods: Male C57BL/6 mice received a 0, 10, or 100 ppm H2S-N-2 mixture starting 30 minutes prior to ischemia until 5 minutes pre-reperfusion. IRI was inflicted by temporary ligation of the left coronary artery for 30 minutes. High-resolution respirometry equipment was used to assess CO2-production and blood pressure was measured using internal transmitters. The effects of H2S were assessed by histological and molecular analysis. Results: Treatment with 100 ppm H2S decreased CO2-production by 72%, blood pressure by 14% and heart rate by 25%, while treatment with 10 ppm H2S had no effects. At day 1 of reperfusion 10 ppm H2S showed no effect on necrosis, while treatment with 100 ppm H2S reduced necrosis by 62% (p<0.05). Seven days post-reperfusion, both 10 ppm (p<0.01) and 100 ppm (p<0.05) H2S showed a reduction in fibrosis compared to IRI animals. Both 10 ppm and 100 ppm H2S reduced granulocyte-influx by 43% (p<0.05) and 60% (p<0.001), respectively. At 7 days post-reperfusion both 10 and 100 ppm H2S reduced expression of fibronectin by 63% (p<0.05) and 67% (p<0.01) and ANP by 84% and 63% (p<0.05), respectively. Conclusions: Gaseous administration of H2S is protective when administered during a cardiac ischemic insult. Although hypometabolism is restricted to small animals, we now showed that low non-hypometabolic concentrations of H2S also have protective properties in IRI. Since IRI is a frequent cause of myocardial damage during percutaneous coronary intervention and cardiac transplantation, H2S treatment might lead to novel therapeutical modalities.	[Snijder, Pauline M.; Bos, Eelke M.; van den Born, Joost C.; van Dijk, Marcory C. R. F.; Hillebrands, Jan-Luuk; van Goor, Harry] Univ Groningen, Univ Med Ctr Groningen, Dept Pathol & Med Biol, Groningen, Netherlands; [Snijder, Pauline M.; Bos, Eelke M.; Leuvenink, Henri G. D.] Univ Groningen, Univ Med Ctr Groningen, Dept Surg, Groningen, Netherlands; [de Boer, Rudolf A.; Ruifrok, Willem-Peter T.; Vreeswijk-Baudoin, Inge] Univ Groningen, Univ Med Ctr Groningen, Dept Cardiol, Groningen, Netherlands	University of Groningen; University of Groningen; University of Groningen	Snijder, PM (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Pathol & Med Biol, Groningen, Netherlands.	p.m.snijder@umcg.nl	van+Goor, Harry/AAS-7712-2020; de Boer, Rudolf/ABE-9879-2020; van den Born, Joost C./H-3740-2018	van Goor, Harry/0000-0002-6670-1577; Hillebrands, Jan-Luuk/0000-0003-3135-3274; Leuvenink, Henri/0000-0001-5036-2999; Bos, Eelke/0000-0003-3647-6740; van den Born, Joost/0000-0003-2637-4046	J.K. de Cock Foundation; Dutch Organization for Health Research and Development (ZonMW) [40-00506-98-9021]	J.K. de Cock Foundation; Dutch Organization for Health Research and Development (ZonMW)(Netherlands Organization for Health Research and Development)	This study was financially supported by a grant from the J.K. de Cock Foundation. Microscopic imaging was performed at the UMCG Imaging Center (UMIC), which is supported by the Dutch Organization for Health Research and Development (ZonMW grant 40-00506-98-9021). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali MY, 2006, BRIT J PHARMACOL, V149, P625, DOI 10.1038/sj.bjp.0706906; Aminzadeh MA, 2012, NEPHROL DIAL TRANSPL, V27, P498, DOI 10.1093/ndt/gfr560; Baxter GF, 2002, BASIC RES CARDIOL, V97, P268, DOI 10.1007/s00395-002-0366-7; Blackstone E, 2005, SCIENCE, V308, P518, DOI 10.1126/science.1108581; Blackstone E, 2007, SHOCK, V27, P370, DOI 10.1097/SHK.0b013e31802e27a0; Bos EM, 2012, TRANSPL INT, V25, P897, DOI 10.1111/j.1432-2277.2012.01514.x; Bos EM, 2009, J AM SOC NEPHROL, V20, P1901, DOI 10.1681/ASN.2008121269; Bracht H, 2012, CRIT CARE MED, V40, P2157, DOI 10.1097/CCM.0b013e31824e6b30; Calvert JW, 2010, CIRCULATION, V122, P11, DOI 10.1161/CIRCULATIONAHA.109.920991; Chen Q, 2006, J PHARMACOL EXP THER, V319, P1405, DOI 10.1124/jpet.106.110262; Damman J, 2011, NEPHROL DIAL TRANSPL, V26, P2345, DOI 10.1093/ndt/gfq717; Dawe GS, 2008, NEUROSCIENCE, V152, P169, DOI 10.1016/j.neuroscience.2007.12.008; De Silva TM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028393; Elrod JW, 2007, P NATL ACAD SCI USA, V104, P15560, DOI 10.1073/pnas.0705891104; Fiorucci S, 2005, GASTROENTEROLOGY, V129, P1210, DOI 10.1053/j.gastro.2005.07.060; Fu ZF, 2008, LIFE SCI, V82, P1196, DOI 10.1016/j.lfs.2008.04.005; Fukui T, 2001, BIOCHEM BIOPH RES CO, V281, P1200, DOI 10.1006/bbrc.2001.4493; Haouzi P, 2008, RESP PHYSIOL NEUROBI, V160, P109, DOI 10.1016/j.resp.2007.09.001; Hausenloy DJ, 2012, CARDIOVASC RES, V94, P253, DOI 10.1093/cvr/cvs131; HILL BC, 1984, BIOCHEM J, V224, P591, DOI 10.1042/bj2240591; Hishikari K, 2009, CARDIOVASC RES, V81, P123, DOI 10.1093/cvr/cvn254; Hori M, 2009, CARDIOVASC RES, V81, P457, DOI 10.1093/cvr/cvn335; Hu LF, 2007, J NEUROCHEM, V100, P1121, DOI 10.1111/j.1471-4159.2006.04283.x; Ichihara S, 2002, CIRCULATION, V106, P2244, DOI 10.1161/01.CIR.0000033826.52681.37; Jha S, 2008, AM J PHYSIOL-HEART C, V295, pH801, DOI 10.1152/ajpheart.00377.2008; Johansen D, 2006, BASIC RES CARDIOL, V101, P53, DOI 10.1007/s00395-005-0569-9; Kida K, 2011, ANTIOXID REDOX SIGN, V15, P343, DOI 10.1089/ars.2010.3671; Kimura H, 2011, AMINO ACIDS, V41, P113, DOI 10.1007/s00726-010-0510-x; Kimura Y, 2004, FASEB J, V18, P1165, DOI 10.1096/fj.04-1815fje; Kimura Y, 2010, ANTIOXID REDOX SIGN, V12, P1, DOI 10.1089/ars.2008.2282; Kleinschnitz C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000479; Kohn C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041951; Lavu M, 2011, CLIN SCI, V120, P219, DOI 10.1042/CS20100462; Li J, 2008, PEDIATR CRIT CARE ME, V9, P110, DOI 10.1097/01.PCC.0000298639.08519.0C; Li XH, 2005, CIRC J, V69, P1418, DOI 10.1253/circj.69.1418; Liu H, 2009, J PHARM PHARMACOL, V61, P207, DOI 10.1211/jpp/61.02.0010; Ma LX, 2012, AM J PHYSIOL-HEART C, V302, pH2341, DOI 10.1152/ajpheart.01126.2011; Minamishima S, 2009, CIRCULATION, V120, P888, DOI 10.1161/CIRCULATIONAHA.108.833491; Mitsuhashi H, 2005, SHOCK, V24, P529, DOI 10.1097/01.shk.0000183393.83272.de; Morrison ML, 2008, J TRAUMA, V65, P183, DOI 10.1097/TA.0b013e3181507579; Ojha N, 2008, AM J PHYSIOL-HEART C, V294, pH2435, DOI 10.1152/ajpheart.01190.2007; Olson KR, 2011, AM J PHYSIOL-REG I, V301, pR297, DOI 10.1152/ajpregu.00045.2011; Qipshidze N, 2012, INT J BIOL SCI, V8, P430, DOI 10.7150/ijbs.3632; Simon F, 2008, SHOCK, V30, P359, DOI 10.1097/SHK.0b013e3181674185; Sivarajah A, 2009, SHOCK, V31, P267, DOI 10.1097/SHK.0b013e318180ff89; Szabo C, 2007, NAT REV DRUG DISCOV, V6, P917, DOI 10.1038/nrd2425; Szabo G, 2011, NITRIC OXIDE-BIOL CH, V25, P201, DOI 10.1016/j.niox.2010.11.001; Tokuda K, 2012, ANTIOXID REDOX SIGN, V17, P11, DOI 10.1089/ars.2011.4363; Ufnal M, 2008, ACTA NEUROBIOL EXP, V68, P382; Volpato GP, 2008, ANESTHESIOLOGY, V108, P659, DOI 10.1097/ALN.0b013e318167af0d; Wang XL, 2011, BIOSCIENCE REP, V31, P87, DOI 10.1042/BSR20100003; Wu N, 2010, J BIOL CHEM, V285, P18225, DOI 10.1074/jbc.M110.132142; Yan H, 2004, BIOCHEM BIOPH RES CO, V313, P22, DOI 10.1016/j.bbrc.2003.11.081; Yang GD, 2008, SCIENCE, V322, P587, DOI 10.1126/science.1162667; Yellon DM, 2007, NEW ENGL J MED, V357, P1121, DOI 10.1056/NEJMra071667; Zhang HL, 2008, IMMUNOPHARM IMMUNOT, V30, P631, DOI [10.1080/08923970802278045, 10.1080/08923970802278045 ]; Zhao WM, 2001, EMBO J, V20, P6008, DOI 10.1093/emboj/20.21.6008	57	48	48	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2013	8	5							e63291	10.1371/journal.pone.0063291	http://dx.doi.org/10.1371/journal.pone.0063291			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	143FO	23675473	Green Submitted, gold, Green Published			2022-12-27	WOS:000318852400035
J	Heffernan, JB; Watts, DL; Cohen, MJ				Heffernan, James B.; Watts, Danielle L.; Cohen, Matthew J.			Discharge Competence and Pattern Formation in Peatlands: A Meta-Ecosystem Model of the Everglades Ridge-Slough Landscape	PLOS ONE			English	Article							EARLY WARNING SIGNAL; REGIME SHIFTS; WATER-FLOW; ECOHYDROLOGICAL FEEDBACKS; SPATIAL HETEROGENEITY; SEDIMENT TRANSPORT; POSITIVE FEEDBACKS; SLOWING-DOWN; VEGETATION; DYNAMICS	Regular landscape patterning arises from spatially-dependent feedbacks, and can undergo catastrophic loss in response to changing landscape drivers. The central Everglades (Florida, USA) historically exhibited regular, linear, flow-parallel orientation of high-elevation sawgrass ridges and low-elevation sloughs that has degraded due to hydrologic modification. In this study, we use a meta-ecosystem approach to model a mechanism for the establishment, persistence, and loss of this landscape. The discharge competence (or self-organizing canal) hypothesis assumes non-linear relationships between peat accretion and water depth, and describes flow-dependent feedbacks of microtopography on water depth. Closed-form model solutions demonstrate that 1) this mechanism can produce spontaneous divergence of local elevation; 2) divergent and homogenous states can exhibit global bi-stability; and 3) feedbacks that produce divergence act anisotropically. Thus, discharge competence and non-linear peat accretion dynamics may explain the establishment, persistence, and loss of landscape pattern, even in the absence of other spatial feedbacks. Our model provides specific, testable predictions that may allow discrimination between the self-organizing canal hypotheses and competing explanations. The potential for global bi-stability suggested by our model suggests that hydrologic restoration may not re-initiate spontaneous pattern establishment, particularly where distinct soil elevation modes have been lost. As a result, we recommend that management efforts should prioritize maintenance of historic hydroperiods in areas of conserved pattern over restoration of hydrologic regimes in degraded regions. This study illustrates the value of simple meta-ecosystem models for investigation of spatial processes.	[Heffernan, James B.] Duke Univ, Nicholas Sch Environm, Durham, NC 27708 USA; [Watts, Danielle L.] Univ Florida, Sch Nat Resources & Environm, Gainesville, FL USA; [Cohen, Matthew J.] Univ Florida, Sch Forest Resources & Conservat, Gainesville, FL 32611 USA	Duke University; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Heffernan, JB (corresponding author), Duke Univ, Nicholas Sch Environm, Durham, NC 27708 USA.	james.heffernan@duke.edu	Heffernan, James/D-1261-2010	Heffernan, James/0000-0001-7641-9949; Watts, Danielle/0000-0002-8648-2412	South Florida Water Management District; Army Corps of Engineers	South Florida Water Management District; Army Corps of Engineers(United States Department of DefenseUnited States Army)	This work has been supported by the South Florida Water Management District and the Army Corps of Engineers, but the conclusions presented here do not represent the position of any US Federal or State agency. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bader MY, 2008, ARCT ANTARCT ALP RES, V40, P269, DOI 10.1657/1523-0430(07-024)[BADER]2.0.CO;2; Barbier N, 2006, J ECOL, V94, P537, DOI 10.1111/j.1365-2745.2006.01126.x; Belyea LR, 2007, HYDROL PROCESS, V21, P675, DOI 10.1002/hyp.6275; Belyea LR, 2006, ECOL MONOGR, V76, P299, DOI 10.1890/0012-9615(2006)076[0299:BTLTPB]2.0.CO;2; Bernhardt CE, 2009, ECOL APPL, V19, P1723, DOI 10.1890/08-0779.1; Bruland GL, 2006, SOIL SCI SOC AM J, V70, P1662, DOI 10.2136/sssaj2005.0134; Carpenter SR, 2008, ECOL LETT, V11, P128, DOI 10.1111/j.1461-0248.2007.01131.x; Cheng YW, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2010GL046091; Childers DL, 2003, J ENVIRON QUAL, V32, P344, DOI 10.2134/jeq2003.0344; Cohen MJ, 2011, CRIT REV ENV SCI TEC, V41, P395, DOI 10.1080/10643389.2010.531224; CRAFT CB, 1995, WETLANDS, V15, P258, DOI 10.1007/BF03160706; CRAFT CB, 1993, ECOL APPL, V3, P446, DOI 10.2307/1941914; D'Odorico P, 2006, J GEOPHYS RES-BIOGEO, V111, DOI 10.1029/2006JG000176; D'Odorico P, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL027499; D'Odorico P, 2011, ECOSYSTEMS, V14, P298, DOI 10.1007/s10021-011-9412-3; D'Odorico P, 2007, J GEOPHYS RES-BIOGEO, V112, DOI 10.1029/2006JG000379; Dakos V, 2008, P NATL ACAD SCI USA, V105, P14308, DOI 10.1073/pnas.0802430105; Dakos V, 2011, AM NAT, V177, pE153, DOI 10.1086/659945; Dakos V, 2010, THEOR ECOL-NETH, V3, P163, DOI 10.1007/s12080-009-0060-6; Eppinga MB, 2009, PLANT ECOL, V200, P53, DOI 10.1007/s11258-007-9309-6; Eppinga MB, 2008, ECOSYSTEMS, V11, P520, DOI 10.1007/s10021-008-9138-z; Eppinga MB, 2010, ECOLOGY, V91, P2344, DOI 10.1890/09-1313.1; Eppinga MB, 2009, AM NAT, V173, P803, DOI 10.1086/598487; Ewe SML, 2006, HYDROBIOLOGIA, V569, P459, DOI 10.1007/s10750-006-0149-5; Foti R, 2012, P NATL ACAD SCI USA, V109, P19596, DOI 10.1073/pnas.1218056109; Gaucherel C, 2011, J ECOSYSTEM ECOGRAPH, V1, P2; Givnish TJ, 2008, GLOBAL ECOL BIOGEOGR, V17, P384, DOI 10.1111/j.1466-8238.2007.00371.x; Gravel D, 2010, AM NAT, V176, P289, DOI 10.1086/655426; Gravel D, 2010, ECOLOGY, V91, P2172, DOI 10.1890/09-0843.1; Guttal V, 2008, ECOL LETT, V11, P450, DOI 10.1111/j.1461-0248.2008.01160.x; Guttal V, 2009, THEOR ECOL-NETH, V2, P3, DOI 10.1007/s12080-008-0033-1; Hagerthey SE, 2008, ECOL MONOGR, V78, P547, DOI 10.1890/07-0538.1; Harvey JW, 2009, WATER RESOUR RES, V45, DOI 10.1029/2008WR007129; Hua DY, 2007, CHINESE PHYS LETT, V24, P3586; Ives AR, 1998, ECOSYSTEMS, V1, P35, DOI 10.1007/s100219900004; Jenerette GD, 2012, ECOHYDROLOGY, V5, P184, DOI 10.1002/eco.217; Jordan F, 1997, WETLANDS, V17, P275, DOI 10.1007/BF03161415; Kaplan DA, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL052754; Kefi S, 2007, THEOR POPUL BIOL, V71, P367, DOI 10.1016/j.tpb.2006.09.003; Kefi S, 2011, ECOL LETT, V14, P29, DOI 10.1111/j.1461-0248.2010.01553.x; Lago ME, 2010, ADV WATER RESOUR, V33, P1268, DOI 10.1016/j.advwatres.2010.07.009; Larsen L, 2011, CRIT REV ENV SCI TEC, V41, P344, DOI 10.1080/10643389.2010.531219; Larsen LG, 2007, ECOL MONOGR, V77, P591, DOI 10.1890/06-1267.1; Larsen LG, 2011, GEOMORPHOLOGY, V126, P279, DOI 10.1016/j.geomorph.2010.03.015; Larsen LG, 2010, AM NAT, V176, pE66, DOI 10.1086/655215; Larsen LG, 2009, ECOL ENG, V35, P1773, DOI 10.1016/j.ecoleng.2009.09.002; Larsen LG, 2009, WATER RESOURCES RES, V45; LIGHT SS, 1997, EVERGLADES ECOSYSTEM, P47; Lockwood JL, 2003, FRONT ECOL ENVIRON, V1, P462, DOI 10.1890/1540-9295(2003)001[0462:SOTWTI]2.0.CO;2; Loreau M, 2003, ECOL LETT, V6, P673, DOI 10.1046/j.1461-0248.2003.00483.x; Loreau M, 2004, AM NAT, V163, P606, DOI 10.1086/382600; Ludwig JA, 2005, ECOLOGY, V86, P288, DOI 10.1890/03-0569; Ludwig JA, 2000, ECOSYSTEMS, V3, P84, DOI 10.1007/s100210000012; Mauchamp A, 2001, ECOL STU AN, V149, P146; McVoy CWS, 2011, LANDSCAPES HYDROLOGY, P576; Min JH, 2010, J HYDROL, V390, P1, DOI 10.1016/j.jhydrol.2010.06.023; Moreno-de las Heras M, 2011, ECOL APPL, V21, P2793, DOI 10.1890/10-2113.1; Morris PJ, 2011, J ECOL, V99, P1190, DOI 10.1111/j.1365-2745.2011.01842.x; Nungesser MK, 2011, WETL ECOL MANAG, V19, P475, DOI 10.1007/s11273-011-9229-z; Nungesser MK, 2003, ECOL MODEL, V165, P175, DOI 10.1016/S0304-3800(03)00067-X; Ogden JC, 2005, WETLANDS, V25, P810, DOI 10.1672/0277-5212(2005)025[0810:ERASCE]2.0.CO;2; Qualls RG, 2003, BIOGEOCHEMISTRY, V62, P197, DOI 10.1023/A:1021150503664; Ridolfi L, 2008, ECOL SOC, V13; Rietkerk M, 2004, AM NAT, V163, P699, DOI 10.1086/383065; Rietkerk M, 2004, SCIENCE, V305, P1926, DOI 10.1126/science.1101867; Rietkerk M, 2002, AM NAT, V160, P524, DOI 10.1086/342078; Rietkerk M, 2008, TRENDS ECOL EVOL, V23, P169, DOI 10.1016/j.tree.2007.10.013; Ross MS, 2003, WETL ECOL MANAG, V11, P291, DOI 10.1023/B:WETL.0000005541.30283.11; Ross MS, 2006, HYDROBIOLOGIA, V569, P37, DOI 10.1007/s10750-006-0121-4; Ross MS, 2011, ECOSYSTEMS, V14, P632, DOI 10.1007/s10021-011-9433-y; Scheffer M, 2009, NATURE, V461, P53, DOI 10.1038/nature08227; Science Coordinating Team, 2003, ROL FLOW EV RIDG SLO; SFWMD and USACE, 1999, CENTR SO FLOR FLOOD; SFWMD and USACE, 2012, DECOMP DEC WAT CONV; Silliman BR, 2005, SCIENCE, V310, P1803, DOI 10.1126/science.1118229; Slocum MG, 2007, NAT AREA J, V27, P41, DOI 10.3375/0885-8608(2007)27[41:DNAAFR]2.0.CO;2; Suding KN, 2009, TRENDS ECOL EVOL, V24, P271, DOI 10.1016/j.tree.2008.11.012; Suding KN, 2004, TRENDS ECOL EVOL, V19, P46, DOI 10.1016/j.tree.2003.10.005; Sullivan PL, 2011, HYDROGEOL J, V19, P367, DOI 10.1007/s10040-010-0691-0; Tongway DJ, 2001, ECOL STU AN, V149, P20; Troxler TG, 2009, AQUAT BOT, V91, P157, DOI 10.1016/j.aquabot.2009.04.003; Vaithiyanathan P, 1998, J ENVIRON QUAL, V27, P1439, DOI 10.2134/jeq1998.00472425002700060021x; van de Koppel J, 2005, AM NAT, V165, pE66; van de Koppel J, 2002, AM NAT, V159, P209, DOI 10.1086/324791; van Nes EH, 2005, ECOLOGY, V86, P1797, DOI 10.1890/04-0550; Wang X, 2011, BIOGEOCHEMISTRY, V104, P133, DOI 10.1007/s10533-010-9492-8; Watts DL, 2010, ECOSYSTEMS, V13, P813, DOI 10.1007/s10021-010-9356-z; Weerman EJ, 2010, AM NAT, V176, pE15, DOI 10.1086/652991; Wetzel PR, 2011, CRIT REV ENV SCI TEC, V41, P670, DOI 10.1080/10643389.2010.530908; Wu YG, 2006, ECOL COMPLEX, V3, P183, DOI 10.1016/j.ecocom.2005.12.002; Zweig CL, 2009, ECOLOGY, V90, P1900, DOI 10.1890/08-1392.1; Zweig CL, 2008, WETLANDS, V28, P1086, DOI 10.1672/08-96.1	92	21	22	0	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2013	8	5							e64174	10.1371/journal.pone.0064174	http://dx.doi.org/10.1371/journal.pone.0064174			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	155HD	23671708	Green Published, gold, Green Submitted			2022-12-27	WOS:000319737700066
J	Jones, J; Estirado, A; Redondo, C; Martinez, S				Jones, Jonathan; Estirado, Alicia; Redondo, Carolina; Martinez, Salvador			Stem Cells from Wildtype and Friedreich's Ataxia Mice Present Similar Neuroprotective Properties in Dorsal Root Ganglia Cells	PLOS ONE			English	Article							OXIDATIVE STRESS; REPEAT EXPANSION; MITOCHONDRIAL DYSFUNCTION; ANTIOXIDANT TREATMENT; IDEBENONE TREATMENT; EPIGENETIC CHANGES; FRATAXIN; GENE; PATHOLOGY	Many neurodegenerative disorders share a common susceptibility to oxidative stress, including Alzheimer's, Parkinson Disease, Huntington Disease and Friedreich's ataxia. In a previous work, we proved that stem cell-conditioned medium increased the survival of cells isolated from Friedreich's ataxia patients, when submitted to oxidative stress. The aim of the present work is to confirm this same effect in dorsal root ganglia cells isolated from YG8 mice, a mouse model of Friedreich's ataxia. In this disorder, the neurons of the dorsal root ganglia are the first to degenerate. Also, in this work we cultured mesenchymal stem cells isolated from YG8 mice, in order to compare them with their wildtype counterpart. To this end, dorsal root ganglia primary cultures isolated from YG8 mice were exposed to oxidative stress and cultured with conditioned medium from either wildtype or YG8 stem cells. As a result, the conditioned medium increased the survival of the dorsal root ganglia cells. This coincided with an increase in oxidative stress-related markers and frataxin expression levels. BDNF, NT3 and NT4 trophic factors were detected in the conditioned medium of both wild-type and YG8 stem cells, all which bind to the various neuronal cell types present in the dorsal root ganglia. No differences were observed in the stem cells isolated from wildtype and YG8 mice. The results presented confirm the possibility that autologous stem cell transplantation may be a viable therapeutic approach in protecting dorsal root ganglia neurons of Friedreich's ataxia patients.	[Jones, Jonathan; Estirado, Alicia; Redondo, Carolina; Martinez, Salvador] UMH, Neurosci Inst, Dept Expt Embryol, CSIC, Alicante, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); Universidad Miguel Hernandez de Elche	Jones, J (corresponding author), UMH, Neurosci Inst, Dept Expt Embryol, CSIC, Alicante, Spain.	jon@umh.es	Estirado, Alicia/L-8295-2014; Mratinez, Salvador/L-4896-2014	Estirado, Alicia/0000-0003-2191-5819; Mratinez, Salvador/0000-0002-9320-4103; Martinez, Salvador/0000-0002-2910-8926	FARA (Friedreich's Ataxia Research Alliance); ASOGAF (Friedreich's Ataxia association of Granada); Science and Innovation Ministry [MICINN BFU2010-27326]; GVA Prometeo grant [2009/028]; Tercel [RD06/0010/0023, RD06/0010/24]; MEC-CONSOLIDER [CSD2007-00023]; Cinco P menos Foundation; EUCOMM; Fundacion Diogenes-Elche city government; Walk on Project; MAPFRE Foundation	FARA (Friedreich's Ataxia Research Alliance); ASOGAF (Friedreich's Ataxia association of Granada); Science and Innovation Ministry; GVA Prometeo grant; Tercel; MEC-CONSOLIDER(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Cinco P menos Foundation; EUCOMM; Fundacion Diogenes-Elche city government; Walk on Project; MAPFRE Foundation	This work was supported by FARA (Friedreich's Ataxia Research Alliance), ASOGAF (Friedreich's Ataxia association of Granada), Science and Innovation Ministry (MICINN BFU2010-27326), GVA Prometeo grant 2009/028, Tercel (RD06/0010/0023 & RD06/0010/24), MEC-CONSOLIDER CSD2007-00023, Cinco P menos Foundation, EUCOMM, Fundacion Diogenes-Elche city government, Walk on Project, and MAPFRE Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Mahdawi S, 2004, GENOMICS, V84, P301, DOI 10.1016/j.ygeno.2004.04.003; Al-Mahdawi S, 2008, HUM MOL GENET, V17, P735, DOI 10.1093/hmg/ddm346; Al-Mahdawi S, 2006, GENOMICS, V88, P580, DOI 10.1016/j.ygeno.2006.06.015; Bueno C, 2012, CELL TRANSPLANTATION; Buyse G, 2003, NEUROLOGY, V60, P1679, DOI 10.1212/01.WNL.0000068549.52812.0F; Calabrese V, 2005, J NEUROL SCI, V233, P145, DOI 10.1016/j.jns.2005.03.012; Campuzano V, 1996, SCIENCE, V271, P1423, DOI 10.1126/science.271.5254.1423; Campuzano V, 1997, HUM MOL GENET, V6, P1771, DOI 10.1093/hmg/6.11.1771; Cooper JM, 2003, BIOFACTORS, V18, P163, DOI 10.1002/biof.5520180219; De Biase I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007914; Dusek P, 2012, NEUROBIOL DIS, V46, P1, DOI 10.1016/j.nbd.2011.12.054; ERNFORS P, 1994, CELL, V77, P503, DOI 10.1016/0092-8674(94)90213-5; Gordon DM, 1999, HUM MOL GENET, V8, P2255, DOI 10.1093/hmg/8.12.2255; Greene E, 2007, NUCLEIC ACIDS RES, V35, P3383, DOI 10.1093/nar/gkm271; Hart PE, 2005, ARCH NEUROL-CHICAGO, V62, P621, DOI 10.1001/archneur.62.4.621; Hausse AO, 2002, HEART, V87, P346, DOI 10.1136/heart.87.4.346; Herman D, 2006, NAT CHEM BIOL, V2, P551, DOI 10.1038/nchembio815; Jessen KR, 2005, NAT REV NEUROSCI, V6, P671, DOI 10.1038/nrn1746; Jones J, 2012, STEM CELLS DEV, V21, P2817, DOI 10.1089/scd.2012.0029; Jones J, 2010, NEUROBIOL DIS, V40, P415, DOI 10.1016/j.nbd.2010.07.001; Koeppen AH, 2011, J NEUROL SCI, V303, P1, DOI 10.1016/j.jns.2011.01.010; Koeppen AH, 2009, ACTA NEUROPATHOL, V118, P763, DOI 10.1007/s00401-009-0589-x; Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292; Lodi R, 2001, ANN NEUROL, V49, P590; Mariotti C, 2003, NEUROLOGY, V60, P1676, DOI 10.1212/01.WNL.0000055872.50364.FC; Marmolino D, 2011, BRAIN RES REV, V67, P311, DOI 10.1016/j.brainresrev.2011.04.001; Meng H, 2007, BRAIN RES, V1160, P47, DOI 10.1016/j.brainres.2007.05.048; Muller FL, 2007, FREE RADICAL BIO MED, V43, P477, DOI 10.1016/j.freeradbiomed.2007.03.034; Pandolfo M, 2009, J NEUROL, V256, P3, DOI 10.1007/s00415-009-1002-3; Rustin P, 1999, LANCET, V354, P477, DOI 10.1016/S0140-6736(99)01341-0; Saveliev A, 2003, NATURE, V422, P909, DOI 10.1038/nature01596; Sayre LM, 2008, CHEM RES TOXICOL, V21, P172, DOI 10.1021/tx700210j; Schulz JB, 2000, NEUROLOGY, V55, P1719, DOI 10.1212/WNL.55.11.1719; Schulz JB, 2009, NAT REV NEUROL, V5, P222, DOI 10.1038/nrneurol.2009.26; Sparaco M, 2009, J NEUROL SCI, V287, P111, DOI 10.1016/j.jns.2009.08.052; Terenghi G, 1999, J ANAT, V194, P1, DOI 10.1046/j.1469-7580.1999.19410001.x; Viana F, 2002, NAT NEUROSCI, V5, P254, DOI 10.1038/nn809	37	11	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2013	8	5							e62807	10.1371/journal.pone.0062807	http://dx.doi.org/10.1371/journal.pone.0062807			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	155HD	23671637	Green Published, gold, Green Submitted			2022-12-27	WOS:000319737700022
J	Kiadaliri, AA; Gerdtham, UG; Nilsson, P; Eliasson, B; Gudbjornsdottir, S; Carlsson, KS				Kiadaliri, Aliasghar Ahmad; Gerdtham, Ulf-G.; Nilsson, Peter; Eliasson, Bjorn; Gudbjornsdottir, Soffia; Carlsson, Katarina Steen			Towards Renewed Health Economic Simulation of Type 2 Diabetes: Risk Equations for First and Second Cardiovascular Events from Swedish Register Data	PLOS ONE			English	Article							COST-EFFECTIVENESS; GLYCEMIC CONTROL; MODEL; DISEASE; VALIDATION; PREDICTION; MELLITUS; OUTCOMES; SCORE; PIOGLITAZONE	Objective: Predicting the risk of future events is an essential part of health economic simulation models. In pursuit of this goal, the current study aims to predict the risk of developing first and second acute myocardial infarction, heart failure, non-acute ischaemic heart disease, and stroke after diagnosis in patients with type 2 diabetes, using data from the Swedish National Diabetes Register. Material and Methods: Register data on 29,034 patients with type 2 diabetes were analysed over five years of follow up (baseline 2003). To develop and validate the risk equations, the sample was randomly divided into training (75%) and test (25%) subsamples. The Weibull proportional hazard model was used to estimate the coefficients of the risk equations, and these were validated in both the training and the test samples. Results: In total, 4,547 first and 2,418 second events were observed during the five years of follow up. Experiencing a first event substantially elevated the risk of subsequent events. There were heterogeneities in the effects of covariates within as well as between events; for example, while for females the hazard ratio of having a first acute myocardial infarction was 0.79 (0.70-0.90), the hazard ratio of a second was 1.21 (0.98-1.48). The hazards of second events decreased as the time since first events elapsed. The equations showed adequate calibration and discrimination (C statistics range: 0.70-0.84 in test samples). Conclusion: The accuracy of health economic simulation models of type 2 diabetes can be improved by ensuring that they account for the heterogeneous effects of covariates on the risk of first and second cardiovascular events. Thus it is important to extend such models by including risk equations for second cardiovascular events.	[Kiadaliri, Aliasghar Ahmad; Gerdtham, Ulf-G.; Carlsson, Katarina Steen] Lund Univ, Malmo Univ Hosp, Div Hlth Econ, Dept Clin Sci, Malmo, Sweden; [Kiadaliri, Aliasghar Ahmad; Gerdtham, Ulf-G.; Carlsson, Katarina Steen] Lund Univ, Inst Econ Res, Lund, Sweden; [Kiadaliri, Aliasghar Ahmad] Univ Tehran Med Sci, Dept Hlth Management & Econ, Sch Publ Hlth, Tehran, Iran; [Gerdtham, Ulf-G.] Lund Univ, Dept Econ, Lund, Sweden; [Nilsson, Peter] Lund Univ, Malmo Univ Hosp, Dept Clin Sci, Malmo, Sweden; [Eliasson, Bjorn; Gudbjornsdottir, Soffia] Univ Gothenburg, Sahlgrenska Univ Hosp, Dept Med, Gothenburg, Sweden	Lund University; Skane University Hospital; Lund University; Tehran University of Medical Sciences; Lund University; Lund University; Skane University Hospital; Sahlgrenska University Hospital; University of Gothenburg	Kiadaliri, AA (corresponding author), Lund Univ, Malmo Univ Hosp, Div Hlth Econ, Dept Clin Sci, Malmo, Sweden.	aliasghar.ahmad_kiadaliri@med.lu.se	Gerdtham, Ulf-Göran/I-6766-2018; Kiadaliri, Ali/E-8685-2017; Eliasson, Bjorn/H-5783-2016	Gerdtham, Ulf-Göran/0000-0002-0647-7817; Kiadaliri, Ali/0000-0002-4254-9099; Venkatasubramanian, Siddharth/0000-0002-5860-0768; Steen Carlsson, Katarina/0000-0002-2325-5634; Eliasson, Bjorn/0000-0003-2569-4160	Health Ministry of Iran; Novo Nordisk Ltd; FAS [dnr. 2006-1660]; Government Grant for Clinical Research (ALF); Skane Region	Health Ministry of Iran; Novo Nordisk Ltd(Novo Nordisk); FAS; Government Grant for Clinical Research (ALF); Skane Region	A.A.K. received funds from the Health Ministry of Iran to perform this research as a part of his PhD thesis. An unrestricted educational grant from Novo Nordisk Ltd is gratefully acknowledged. The Health Economics Programme (HEP) at Lund University receives core funding from FAS (dnr. 2006-1660), a Government Grant for Clinical Research (ALF) and the Skane Region (Ulf-G. Gerdtham). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brown JB, 2000, DIABETES RES CLIN PR, V50, pS15, DOI 10.1016/S0168-8227(00)00215-1; Caro JJ, 2000, CLIN THER, V22, P116, DOI 10.1016/S0149-2918(00)87983-7; Caro JJ, 2003, CAN J DIABETES, V27, P33; Cederholm J, 2008, DIABETES CARE, V31, P2038, DOI 10.2337/dc08-0662; Clarke PM, 2004, DIABETOLOGIA, V47, P1747, DOI 10.1007/s00125-004-1527-z; D'Agostino RB, 2004, HDB STAT SURVIVAL ME, V23; Donnan PT, 2006, DIABETES CARE, V29, P1231, DOI 10.2337/dc05-1911; Eastman RC, 1997, DIABETES CARE, V20, P725, DOI 10.2337/diacare.20.5.725; Ekstrom N, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001076; Elley CR, 2010, DIABETES CARE, V33, P1347, DOI 10.2337/dc09-1444; Erdmann E, 2007, J AM COLL CARDIOL, V49, P1772, DOI 10.1016/j.jacc.2006.12.048; Giorda CB, 2008, DIABETES CARE, V31, P2154, DOI 10.2337/dc08-1013; Glynn RJ, 1996, BMJ-BRIT MED J, V312, P364; Gould W., 1993, STATA TECHNICAL B, P13; Gronnesby J K, 1996, Lifetime Data Anal, V2, P315, DOI 10.1007/BF00127305; Gudbjornsdottir S, 2009, DIABETIC MED, V26, P53, DOI 10.1111/j.1464-5491.2008.02633.x; Gudbjornsdottir S, 2003, DIABETES CARE, V26, P1270, DOI 10.2337/diacare.26.4.1270; Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4; Hayes AJ, 2011, DIABETOLOGIA, V54, pS8; Hoelzel W, 2004, CLIN CHEM, V50, P166, DOI 10.1373/clinchem.2003.024802; Hosmer D. W., 1999, APPL SURVIVAL ANAL; Juutilainen A, 2008, DIABETES CARE, V31, P714, DOI 10.2337/dc07-2124; Kahn R, 2004, DIABETES CARE, V27, P2262; KANNEL WB, 1979, CIRCULATION, V59, P8, DOI 10.1161/01.CIR.59.1.8; Kothari V, 2002, STROKE, V33, P1776, DOI 10.1161/01.STR.0000020091.07144.C7; Mueller E, 2006, DIABETES TECHNOL THE, V8, P219, DOI 10.1089/dia.2006.8.219; Palmer AJ, 2000, SCHWEIZ MED WSCHR, V130, P1034; Palmer AJ, 2004, CURR MED RES OPIN, V20, pS5, DOI 10.1185/030079904X1980; Palmer AJ, 2007, DIABETES CARE, V30, P1638, DOI 10.2337/dc07-9919; PRENTICE RL, 1981, BIOMETRIKA, V68, P373, DOI 10.1093/biomet/68.2.373; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; StataCorp, 2011, STAT STAT SOFTW REL, P173; Sukor JA, 2012, PHYSIOL MEAS, V33, P465, DOI 10.1088/0967-3334/33/3/465; Tarride JE, 2010, PHARMACOECONOMICS, V28, P255, DOI 10.2165/11531590-000000000-00000; Tilden DP, 2007, PHARMACOECONOMICS, V25, P39, DOI 10.2165/00019053-200725010-00005; TURNER RC, 1991, DIABETOLOGIA, V34, P877; van Dieren S, 2012, HEART, V98, P360, DOI 10.1136/heartjnl-2011-300734; Ward Alexandra J, 2004, Cost Eff Resour Alloc, V2, P2, DOI 10.1186/1478-7547-2-2; Yang XL, 2008, CARDIOVASC DIABETOL, V7, DOI 10.1186/1475-2840-7-9; Yeo WW, 2001, DIABETIC MED, V18, P341, DOI 10.1046/j.1464-5491.2001.00510.x; Zethelius B, 2011, DIABETES RES CLIN PR, V93, P276, DOI 10.1016/j.diabres.2011.05.037	41	19	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2013	8	5							e62650	10.1371/journal.pone.0062650	http://dx.doi.org/10.1371/journal.pone.0062650			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	155HD	23671618	Green Published, Green Submitted, gold			2022-12-27	WOS:000319737700016
J	Ryu, JS; Kang, SJ; Koo, HS				Ryu, Jin-Sun; Kang, Sang Jo; Koo, Hyeon-Sook			The 53BP1 Homolog in C. elegans Influences DNA Repair and Promotes Apoptosis in Response to Ionizing Radiation	PLOS ONE			English	Article							PROGRAMMED CELL-DEATH; DOUBLE-STRAND BREAKS; DAMAGE-RESPONSE; HISTONE-H4 LYSINE-20; CHECKPOINT PATHWAY; TUMOR-SUPPRESSOR; PROTEIN; METHYLATION; SITES; MDC1	53BP1 contributes to activation of the G2/M checkpoint downstream of ATM and MDC1 in response to ionizing radiation and promotes nonhomologous end-joining (NHEJ) in mammalian cells. In order to determine whether the cellular activities of 53BP1 are conserved in the model organism C. elegans, we analyzed the function of its homolog, HSR-9 in response to DNA damage. Deletion or Mos1-insertion in hsr-9 did not affect the sensitivity of worms to double strand DNA breaks (DSBs), as reflected in embryonic survival and larval development. Nevertheless, the hsr-9 mutations, as well as a lig-4 deletion, reversed the hypersensitivity of rad-54-deficient worms to DSBs. In addition, oocyte chromosomal aberrations, which were increased by rad-54 knockdown in response to DSBs, were also reduced by the hsr-9 mutations. The hsr-9 mutations did not prevent the cell cycle arrest induced by DSBs in mitotically proliferating germ cells. However, they attenuated apoptosis induced by DSBs, but not when CEP-1 (a p53 ortholog) was absent, suggesting that HSR-9 functions in the same pathway as CEP-1. We concluded that the 53BP1 homolog in C. elegans is not directly involved in cell cycle arrest in response to DSBs, but that it promotes apoptosis and also a form of NHEJ that occurs only when rad-54 is deficient.	[Ryu, Jin-Sun; Kang, Sang Jo; Koo, Hyeon-Sook] Yonsei Univ, Coll Life Sci & Biotechnol, Dept Biochem, Seoul 120749, South Korea	Yonsei University	Koo, HS (corresponding author), Yonsei Univ, Coll Life Sci & Biotechnol, Dept Biochem, Seoul 120749, South Korea.	kooh@yonsei.ac.kr	Ryu, Jin-Sun/AAW-8104-2021; Ryu, Jin-Sun/T-7900-2017	Ryu, Jin-Sun/0000-0002-9644-1526; Ryu, Jin-Sun/0000-0002-9644-1526; Koo, Hyeon-Sook/0000-0002-5712-3875	Nuclear Research & Development Program [2010-0017583]; National Research Foundation of Korea (NRF); Korean government (MEST) [2012-029610]; NIH Office of Research Infrastructure Programs [P40 OD010440]	Nuclear Research & Development Program; National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Korean government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government); NIH Office of Research Infrastructure Programs(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the Nuclear Research & Development Program (grant code: 2010-0017583) and a National Research Foundation of Korea (NRF) grant funded by the Korean government (MEST) (No. 2012-029610) to HSK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; C. elegans N2, hsr-9(ok759), atm-1(gk186), brd-1(gk297), lig-4(ok716), cep-1(lg12501), and brc-1(tm1145) were provided by the C. elegans Genetics Center (St. Paul, MN), which is funded by NIH Office of Research Infrastructure Programs (P40 OD010440). The hsr-9(ttTi14815) in UMS3421 was provided by Drs. Laurent Segalat (Universite Claude Bernard Lyon 1, France) and Maite Carre-Pierrat (Plateforme "Biologie de Caenorhabditis elegans", France). We thank Mi So Park (Yonsei Univ.) for assistance with rad-54 experiments.	Adamo A, 2010, MOL CELL, V39, P25, DOI 10.1016/j.molcel.2010.06.026; Anderson L, 2001, MOL CELL BIOL, V21, P1719, DOI 10.1128/MCB.21.5.1719-1729.2001; Botuyan MV, 2006, CELL, V127, P1361, DOI 10.1016/j.cell.2006.10.043; Boulton SJ, 2002, SCIENCE, V295, P127, DOI 10.1126/science.1065986; Boulton SJ, 2004, CURR BIOL, V14, P33, DOI 10.1016/j.cub.2003.11.029; Bunting SF, 2010, CELL, V141, P243, DOI 10.1016/j.cell.2010.03.012; Cao L, 2009, MOL CELL, V35, P534, DOI 10.1016/j.molcel.2009.06.037; Ceballos SJ, 2011, BBA-GENE REGUL MECH, V1809, P509, DOI 10.1016/j.bbagrm.2011.06.006; Clejan I, 2006, GENETICS, V173, P1301, DOI 10.1534/genetics.106.058628; Conradt B, 1998, CELL, V93, P519, DOI 10.1016/S0092-8674(00)81182-4; Craig AL, 2012, METHOD CELL BIOL, V107, P321, DOI 10.1016/B978-0-12-394620-1.00011-4; Crittenden SL, 2006, MOL BIOL CELL, V17, P3051, DOI 10.1091/mbc.E06-03-0170; Derry WB, 2001, SCIENCE, V294, P591, DOI 10.1126/science.1065486; Difilippantonio S, 2008, NATURE, V456, P529, DOI 10.1038/nature07476; Dimitrova N, 2008, NATURE, V456, P524, DOI 10.1038/nature07433; DiTullio RA, 2002, NAT CELL BIOL, V4, P998, DOI 10.1038/ncb892; Eliezer Y, 2009, J BIOL CHEM, V284, P426, DOI 10.1074/jbc.M807375200; Fernandez-Capetillo O, 2002, NAT CELL BIOL, V4, P993, DOI 10.1038/ncb884; Garcia-Muse T, 2005, EMBO J, V24, P4345, DOI 10.1038/sj.emboj.7600896; Gartner A, 2000, MOL CELL, V5, P435, DOI 10.1016/S1097-2765(00)80438-4; Greeson NT, 2008, J BIOL CHEM, V283, P33168, DOI 10.1074/jbc.M806857200; Gumienny TL, 1999, DEVELOPMENT, V126, P1011; Hayashi M, 2007, PLOS GENET, V3, P2068, DOI 10.1371/journal.pgen.0030191; Higashitani A, 2000, FEBS LETT, V485, P35, DOI 10.1016/S0014-5793(00)02178-5; Hofmann ER, 2002, CURR BIOL, V12, P1908, DOI 10.1016/S0960-9822(02)01262-9; Huen MSY, 2007, CELL, V131, P901, DOI 10.1016/j.cell.2007.09.041; Huyen Y, 2004, NATURE, V432, P406, DOI 10.1038/nature03114; IWABUCHI K, 1994, P NATL ACAD SCI USA, V91, P6098, DOI 10.1073/pnas.91.13.6098; Jowsey P, 2007, DNA REPAIR, V6, P1536, DOI 10.1016/j.dnarep.2007.04.011; Lazzaro F, 2008, EMBO J, V27, P1502, DOI 10.1038/emboj.2008.81; Lee JH, 2010, EMBO J, V29, P574, DOI 10.1038/emboj.2009.372; Lee SJ, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000801; MacQueen AJ, 2001, GENE DEV, V15, P1674, DOI 10.1101/gad.902601; Mailand N, 2007, CELL, V131, P887, DOI 10.1016/j.cell.2007.09.040; Manis JP, 2004, NAT IMMUNOL, V5, P481, DOI 10.1038/ni1067; Mazina OM, 2012, J BIOL CHEM, V287, P11820, DOI 10.1074/jbc.M112.341347; Minter-Dykhouse K, 2008, J CELL BIOL, V181, P727, DOI 10.1083/jcb.200801083; Moser SC, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000451; Nimonkar AV, 2012, J BIOL CHEM, V287, P28727, DOI 10.1074/jbc.M112.373290; Oda H, 2010, MOL CELL, V40, P364, DOI 10.1016/j.molcel.2010.10.011; Pei HD, 2011, NATURE, V470, P124, DOI 10.1038/nature09658; Penkner A, 2007, EMBO J, V26, P5071, DOI 10.1038/sj.emboj.7601916; Rappold I, 2001, J CELL BIOL, V153, P613, DOI 10.1083/jcb.153.3.613; Sanders SL, 2004, CELL, V119, P603, DOI 10.1016/j.cell.2004.11.009; Schumacher B, 2001, CURR BIOL, V11, P1722, DOI 10.1016/S0960-9822(01)00534-6; Shibata A, 2010, MOL CELL BIOL, V30, P3371, DOI 10.1128/MCB.01644-09; Stergiou L, 2004, CELL DEATH DIFFER, V11, P21, DOI 10.1038/sj.cdd.4401340; Stergiou L, 2011, CELL DEATH DIFFER, V18, P897, DOI 10.1038/cdd.2010.158; Wang B, 2002, SCIENCE, V298, P1435, DOI 10.1126/science.1076182; Ward IM, 2003, MOL CELL BIOL, V23, P2556, DOI 10.1128/MCB.23.7.2556-2563.2003; Ward IM, 2004, J CELL BIOL, V165, P459, DOI 10.1083/jcb.200403021; Wu JX, 2009, J BIOL CHEM, V284, P18078, DOI 10.1074/jbc.M109.002527; Wysocki R, 2005, MOL CELL BIOL, V25, P8430, DOI 10.1128/MCB.25.19.8430-8443.2005; Xie AY, 2007, MOL CELL, V28, P1045, DOI 10.1016/j.molcel.2007.12.005; Yang HB, 2008, J BIOL CHEM, V283, P12085, DOI 10.1074/jbc.M707974200; Zgheib O, 2009, MOL CELL BIOL, V29, P1050, DOI 10.1128/MCB.01011-08	56	13	20	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2013	8	5							e64028	10.1371/journal.pone.0064028	http://dx.doi.org/10.1371/journal.pone.0064028			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145YI	23667696	Green Submitted, Green Published, gold			2022-12-27	WOS:000319055600084
J	Calzolari, M; Bonilauri, P; Bellini, R; Albieri, A; Defilippo, F; Tamba, M; Tassinari, M; Gelati, A; Cordioli, P; Angelini, P; Dottori, M				Calzolari, Mattia; Bonilauri, Paolo; Bellini, Romeo; Albieri, Alessandro; Defilippo, Francesco; Tamba, Marco; Tassinari, Massimo; Gelati, Antonio; Cordioli, Paolo; Angelini, Paola; Dottori, Michele			Usutu Virus Persistence and West Nile Virus Inactivity in the Emilia-Romagna Region (Italy) in 2011	PLOS ONE			English	Article							CULEX-PIPIENS-PIPIENS; HOST FEEDING PATTERNS; NEW-YORK-CITY; VERTICAL TRANSMISSION; PCR ASSAY; MOSQUITOS; DIPTERA; CULICIDAE; FLAVIVIRUSES; EMERGENCE	Background: The circulation of West Nile virus and Usutu virus was detected in the Emilia-Romagna region in 2008 and 2009. To evaluate the extent of circulation of both viruses, environmental surveillance, based on bird and mosquito testing, was conducted in 2008 and gradually improved over the years. Methods: In February-March 2009-2011, 5,993 hibernating mosquitoes were manually sampled, out of which 80.1% were Culex pipiens; none tested positive for the viruses. From 2008 to 2011, 946,213 mosquitoes, sampled between May and October, were tested; 86.5% were Cx. pipiens. West Nile virus was detected in 32 Cx. pipiens pools, and Usutu virus was detected in 229 mosquito pools (217 Cx. pipiens, 10 Aedes albopictus, one Anopheles maculipennis s.l., and one Aedes caspius). From 2009 to 2011, of 4,546 birds collected, 42 tested positive for West Nile virus and 48 for Usutu virus. West Nile virus and Usutu virus showed different patterns of activity during the 2008-2011 surveillance period. West Nile virus was detected in 2008, 2009, and 2010, but not in 2011. Usutu virus, however, was continuously active throughout 2009, 2010, and 2011. Conclusions: The data strongly suggest that both viruses overwinter in the surveyed area rather than being continually reintroduced every season. The lack of hibernating mosquitoes testing positive for the viruses and the presence of positive birds sampled early in the season support the hypothesis that the viruses overwinter in birds rather than in mosquitoes. Herd immunity in key bird species could explain the decline of West Nile virus observed in 2011, while the persistence of Usutu virus may be explained by not yet identified reservoirs. Reported results are comparable with a peri-Mediterranean circulation of the West Nile virus lineage 1 related strain, which became undetectable in the environment after two to three years of obvious circulation.	[Calzolari, Mattia; Bonilauri, Paolo; Defilippo, Francesco; Tamba, Marco; Cordioli, Paolo; Dottori, Michele] Ist Zooprofilatt Sperimentale Lombardia & Emilia, Brescia, Italy; [Bellini, Romeo; Albieri, Alessandro] Ctr Agr Ambiente G Nicoli CAA, Crevalcore, Italy; [Tassinari, Massimo; Gelati, Antonio] Serv Vet Azienda USL Ferrara, Ferrara, Italy; [Angelini, Paola] DG Sanita & Polit Sociali, Bologna, Regione Emilia, Italy	IZS Lombardia e Emilia	Calzolari, M (corresponding author), Ist Zooprofilatt Sperimentale Lombardia & Emilia, Brescia, Italy.	mattia.calzolari@izsler.it	Calzolari, Mattia/AAB-9487-2019; Tamba, Marco/J-5495-2016; dottori, michele/AAB-3815-2019	Calzolari, Mattia/0000-0001-7489-2556; Tamba, Marco/0000-0002-5878-4595; defilippo, francesco/0000-0002-1898-0997; Bonilauri, Paolo/0000-0002-2625-7993; Dottori, Michele/0000-0002-9975-0367	Regione Emilia-Romagna; Italian Ministry of Health [PRC2009004, PRC2008005]; Regional project on insect borne diseases [COMM07001]	Regione Emilia-Romagna(Regione Emilia Romagna); Italian Ministry of Health(Ministry of Health, Italy); Regional project on insect borne diseases	The Regione Emilia-Romagna (www.regione.emilia-romagna.it/) had partially funded this work to IZSLER (www.izsler.it) and CAA (www.caa.it) by the Regional project on insect borne diseases (COMM07001). Funds were also obtained by the IZSLER projects: "West Nile virus overwintering mechanisms in Emilia-Romagna region" (PRC2009004) and "Field evaluation of monitoring techniques of some arthropod vectors for their mapping" (PRC2008005) financed by the Italian Ministry of Health (http://www.salute.gov.it/). No other external funding was utilized for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson JF, 2008, J MED ENTOMOL, V45, P445, DOI 10.1603/0022-2585(2008)45[445:EIPFHA]2.0.CO;2; Anderson JF, 2012, AM J TROP MED HYG, V86, P134, DOI 10.4269/ajtmh.2012.11-0473; Andreadis TG, 2010, J AM MOSQUITO CONTR, V26, P257, DOI 10.2987/10-6004.1; Angelini P, 2010, EUROSURVEILLANCE, V15, P11; BAQAR S, 1993, AM J TROP MED HYG, V48, P757, DOI 10.4269/ajtmh.1993.48.757; Becker N, 2010, MOSQUITOES AND THEIR CONTROL, SECOND EDITION, P3, DOI 10.1007/978-3-540-92874-4_1; Bellini R., 2002, 68 ANN M AM MOSQ CON; BirdLife International, 2004, BIRDS EUR POP EST TR; Bonds MH, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001456; Bugbee LM, 2004, J AM MOSQUITO CONTR, V20, P326; CALISHER CH, 1989, J GEN VIROL, V70, P37, DOI 10.1099/0022-1317-70-1-37; Calzolari M., 2011, Giornale Italiano di Medicina Tropicale, V16, P57; Calzolari M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038058; Calzolari M, 2012, J GEN VIROL, V93, P1215, DOI 10.1099/vir.0.040485-0; Calzolari M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014324; Calzolari M, 2010, VECTOR-BORNE ZOONOT, V10, P875, DOI 10.1089/vbz.2009.0176; Dohm DJ, 2002, J MED ENTOMOL, V39, P640, DOI 10.1603/0022-2585-39.4.640; Farajollahi A, 2005, J MED ENTOMOL, V42, P490, DOI 10.1603/0022-2585(2005)042[0490:DOWNVR]2.0.CO;2; Fornasari L, 2010, AVOCETTA, V34, P1; Fornasari Lorenzo, 2002, Avocetta, V26, P59; Gingrich JB, 2005, J AM MOSQUITO CONTR, V21, P194, DOI 10.2987/8756-971X(2005)21[194:HPOSWN]2.0.CO;2; Goddard LB, 2003, J MED ENTOMOL, V40, P743, DOI 10.1603/0022-2585-40.6.743; Hamer GL, 2008, VECTOR-BORNE ZOONOT, V8, P57, DOI 10.1089/vbz.2007.0123; Hubalek Z, 1999, EMERG INFECT DIS, V5, P643, DOI 10.3201/eid0505.990505; Hubalek Z, 2000, VIRAL IMMUNOL, V13, P415, DOI 10.1089/vim.2000.13.415; IGARASHI A, 1978, J GEN VIROL, V40, P531, DOI 10.1099/0022-1317-40-3-531; JAENSON TGT, 1987, MED VET ENTOMOL, V1, P151, DOI 10.1111/j.1365-2915.1987.tb00336.x; Keesing F, 2010, NATURE, V468, P647, DOI 10.1038/nature09575; Komar N, 2003, EMERG INFECT DIS, V9, P311, DOI 10.3201/eid0903.020628; Kramer LD, 2008, ANNU REV ENTOMOL, V53, P61, DOI 10.1146/annurev.ento.53.103106.093258; Kuno G, 2005, CLIN MICROBIOL REV, V18, P608, DOI 10.1128/CMR.18.4.608-637.2005; Kuno G, 1998, J VIROL, V72, P73, DOI 10.1128/JVI.72.1.73-83.1998; Kwan JL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034127; Lanciotti RS, 2000, J CLIN MICROBIOL, V38, P4066, DOI 10.1128/JCM.38.11.4066-4071.2000; Macini P, 2008, EURO SURVEILL, V13; Manarolla G, 2010, VET MICROBIOL, V141, P159, DOI 10.1016/j.vetmic.2009.07.036; Mannelli A, 2012, INVENTORY AVAILABLE; Meister T, 2008, VET MICROBIOL, V127, P237, DOI 10.1016/j.vetmic.2007.08.023; MITCHELL CJ, 1989, J MED ENTOMOL, V26, P318, DOI 10.1093/jmedent/26.4.318; Molaei G, 2006, EMERG INFECT DIS, V12, P468, DOI 10.3201/eid1203.051004; Murray K, 2010, J INFECT DIS, V201, P2, DOI 10.1086/648731; Nasci RS, 2001, EMERG INFECT DIS, V7, P742; Nemeth N, 2009, ARCH VIROL, V154, P783, DOI 10.1007/s00705-009-0369-x; Nemeth NM, 2008, AM J TROP MED HYG, V79, P283, DOI 10.4269/ajtmh.2008.79.283; Nemeth NM, 2009, AM J TROP MED HYG, V80, P864, DOI 10.4269/ajtmh.2009.80.864; ODA T, 1976, TROPENMED PARASITOL, V27, P101; Pfeffer M, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-35; Phillips RA, 2006, J AM MOSQUITO CONTR, V22, P561, DOI 10.2987/8756-971X(2006)22[561:FCELFN]2.0.CO;2; Ravasini M, 1995, AVIFAUNA NIDIFICANTE; Reisen WK, 2006, J MED ENTOMOL, V43, P344, DOI 10.1603/0022-2585(2006)043[0344:OOWNVI]2.0.CO;2; Reiter P, 2010, EUROSURVEILLANCE, V15, P4; Rossi P, 2010, CENSIMENTO AVIFAUNA; Rossini G, 2011, EMERG INFECT DIS, V17, P903, DOI 10.3201/eid1705.101569; Savage HM, 2004, J AM MOSQUITO CONTR, V20, P208; Scaramozzino N, 2001, J CLIN MICROBIOL, V39, P1922, DOI 10.1128/JCM.39.5.1922-1927.2001; Schaffner E., 2001, MOSQUITOES EUROPE; SERVICE MW, 1971, B ENTOMOL RES, V60, P653, DOI 10.1017/S0007485300042401; Severini Francesco, 2009, Fragmenta Entomologica, V41, P213; SLAFF ME, 1977, MOSQ NEWS, V37, P11; Spina F, 2008, ATLANTA MIGRAZIONE U; Stojanovich CJ, 1997, MOSQUITOES ITALIAN B; Sutherland GL, 2007, J AM MOSQUITO CONTR, V23, P389, DOI 10.2987/5630.1; Tamba M, 2011, VECTOR-BORNE ZOONOT, V11, P551, DOI 10.1089/vbz.2010.0055; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tang YL, 2006, J CLIN VIROL, V36, P177, DOI 10.1016/j.jcv.2006.02.008; Tesh RB, 2005, J INFECT DIS, V192, P287, DOI 10.1086/431153; Turell MJ, 2001, J MED ENTOMOL, V38, P130, DOI 10.1603/0022-2585-38.2.130; Unlu I, 2010, J VECTOR ECOL, V35, P95, DOI 10.1111/j.1948-7134.2010.00034.x; Vazquez A, 2011, EUROSURVEILLANCE, V16, P22; Weissenbock H, 2002, EMERG INFECT DIS, V8, P652, DOI 10.3201/eid0807.020094; Weissenbock H, 2007, ECOL CONT VECTOR-BOR, V1, P153	71	44	45	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e63978	10.1371/journal.pone.0063978	http://dx.doi.org/10.1371/journal.pone.0063978			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667694	gold, Green Published, Green Submitted			2022-12-27	WOS:000319654700198
J	Feizi, A; Osterlund, T; Petranovic, D; Bordel, S; Nielsen, J				Feizi, Amir; Osterlund, Tobias; Petranovic, Dina; Bordel, Sergio; Nielsen, Jens			Genome-Scale Modeling of the Protein Secretory Machinery in Yeast	PLOS ONE			English	Article							BIOSYNTHESIS; PATHWAY; PYROPHOSPHORYLASE; TRANSLOCATION; TRAFFICKING; INFORMATION; EUKARYOTES; MECHANISMS; EXPRESSION; PHENOTYPE	The protein secretory machinery in Eukarya is involved in post-translational modification (PTMs) and sorting of the secretory and many transmembrane proteins. While the secretory machinery has been well-studied using classic reductionist approaches, a holistic view of its complex nature is lacking. Here, we present the first genome-scale model for the yeast secretory machinery which captures the knowledge generated through more than 50 years of research. The model is based on the concept of a Protein Specific Information Matrix (PSIM: characterized by seven PTMs features). An algorithm was developed which mimics secretory machinery and assigns each secretory protein to a particular secretory class that determines the set of PTMs and transport steps specific to each protein. Protein abundances were integrated with the model in order to gain system level estimation of the metabolic demands associated with the processing of each specific protein as well as a quantitative estimation of the activity of each component of the secretory machinery.	[Feizi, Amir; Osterlund, Tobias; Petranovic, Dina; Bordel, Sergio; Nielsen, Jens] Chalmers Univ Technol, Novo Nordisk Fdn Ctr Biosustainabil, S-41296 Gothenburg, Sweden; [Nielsen, Jens] Tech Univ Denmark, Novo Nordisk Fdn Ctr Biosustainabil, Horsholm, Denmark	Chalmers University of Technology; Technical University of Denmark; Technical University of Denmark	Nielsen, J (corresponding author), Chalmers Univ Technol, Novo Nordisk Fdn Ctr Biosustainabil, S-41296 Gothenburg, Sweden.	nielsenj@chalmers.se	Bordel, Sergio/A-3325-2017; Nielsen, Jens/Q-1347-2017	Bordel, Sergio/0000-0001-6162-6478; Petranovic, Dina/0000-0001-8724-3942; Nielsen, Jens/0000-0002-9955-6003	Novo Nordisk Foundation; European Research Council (ERC) [247013]; Novo Nordisk Fonden [NNF10CC1016517] Funding Source: researchfish	Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); European Research Council (ERC)(European Research Council (ERC)European Commission); Novo Nordisk Fonden(Novo Nordisk Foundation)	Novo Nordisk Foundation and the European Research Council (ERC grant no. 247013) provided the funding for this project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babst M, 1998, EMBO J, V17, P2982, DOI 10.1093/emboj/17.11.2982; BENNETT MK, 1993, P NATL ACAD SCI USA, V90, P2559, DOI 10.1073/pnas.90.7.2559; Bharadwaj P, 2010, FEMS YEAST RES, V10, P961, DOI 10.1111/j.1567-1364.2010.00658.x; Boyle EI, 2004, BIOINFORMATICS, V20, P3710, DOI 10.1093/bioinformatics/bth456; Chavrier P, 1999, CURR OPIN CELL BIOL, V11, P466, DOI 10.1016/S0955-0674(99)80067-2; Cherry JM, 1998, NUCLEIC ACIDS RES, V26, P73, DOI 10.1093/nar/26.1.73; Dacks JB, 2007, J CELL SCI, V120, P2977, DOI 10.1242/jcs.013250; DARAN JM, 1995, EUR J BIOCHEM, V233, P520, DOI 10.1111/j.1432-1033.1995.520_2.x; de Groot PWJ, 2001, COMP FUNCT GENOM, V2, P124, DOI 10.1002/cfg.85; Dempski RE, 2002, CURR OPIN CHEM BIOL, V6, P844, DOI 10.1016/S1367-5931(02)00390-3; Ding Y, 2012, TRENDS PLANT SCI, V17, P606, DOI 10.1016/j.tplants.2012.06.004; Engling A, 2002, J CELL SCI, V115, P3619, DOI 10.1242/jcs.00036; Ferreira T, 2002, J BIOL CHEM, V277, P21027, DOI 10.1074/jbc.M112281200; Freeze HH, 2006, NAT REV GENET, V7, P537, DOI 10.1038/nrg1894; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Gupta R, 1999, NUCLEIC ACIDS RES, V27, P370, DOI 10.1093/nar/27.1.370; HANSEN W, 1986, CELL, V45, P397, DOI 10.1016/0092-8674(86)90325-9; Hashimoto H, 1997, J BIOL CHEM, V272, P16308, DOI 10.1074/jbc.272.26.16308; Horton AC, 2004, NAT CELL BIOL, V6, P585, DOI 10.1038/ncb0704-585; Hou J, 2012, FEMS YEAST RES; Idiris A, 2010, APPL MICROBIOL BIOT, V86, P403, DOI 10.1007/s00253-010-2447-0; Karr JR, 2012, CELL, V150, P389, DOI 10.1016/j.cell.2012.05.044; KLIONSKY DJ, 1989, EMBO J, V8, P2241, DOI 10.1002/j.1460-2075.1989.tb08348.x; Lee TY, 2006, NUCLEIC ACIDS RES, V34, pD622, DOI 10.1093/nar/gkj083; Lewis NE, 2012, NAT REV MICROBIOL, V10, P291, DOI 10.1038/nrmicro2737; Lipke PN, 1998, J BACTERIOL, V180, P3735, DOI 10.1128/JB.180.15.3735-3740.1998; Magrane M, 2011, UNIPROT KNOWLEDGEBAS; Matlack KES, 1999, CELL, V97, P553, DOI 10.1016/S0092-8674(00)80767-9; McCracken AA, 1996, J CELL BIOL, V132, P291, DOI 10.1083/jcb.132.3.291; Mercado G, 2013, TRENDS MOL MED; Milewski S, 2006, YEAST, V23, P1, DOI 10.1002/yea.1337; Nickel W, 2011, UNCONVENTIONAL SECRE; Nickel W, 2009, NAT REV MOL CELL BIO, V10, P148, DOI 10.1038/nrm2617; Nielsen J, 2013, BIOENGINEERED, V4, P207, DOI 10.4161/bioe.22856; Nombela C, 2006, TRENDS MICROBIOL, V14, P15, DOI 10.1016/j.tim.2005.11.009; NOVICK P, 1981, CELL, V25, P461, DOI 10.1016/0092-8674(81)90064-7; OGG SC, 1992, MOL BIOL CELL, V3, P895, DOI 10.1091/mbc.3.8.895; Orlean P., 1997, MOL CELLULAR BIOL YE, V21, P229; PARODI AJ, 1979, J BIOL CHEM, V254, P51; Payne T, 2008, APPL ENVIRON MICROB, V74, P7759, DOI 10.1128/AEM.01178-08; Reynaud EG, 2002, EMBO REP, V3, P828, DOI 10.1093/embo-reports/kvf185; Robinson AS, 1996, J BIOL CHEM, V271, P10017, DOI 10.1074/jbc.271.17.10017; Rocha Isabel, 2008, V416, P409, DOI 10.1007/978-1-59745-321-9_29; Schekman R, 2010, MOL BIOL CELL, V21, P3781, DOI 10.1091/mbc.E10-05-0416; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shao SC, 2011, ANNU REV CELL DEV BI, V27, P25, DOI 10.1146/annurev-cellbio-092910-154125; Shelikoff M, 1996, BIOTECHNOL BIOENG, V50, P73, DOI 10.1002/(SICI)1097-0290(19960405)50:1<73::AID-BIT9>3.0.CO;2-Z; SIMONS JF, 1995, J CELL BIOL, V130, P41, DOI 10.1083/jcb.130.1.41; Smits GJ, 2001, MICROBIOL-SGM, V147, P781, DOI 10.1099/00221287-147-4-781; Steel GJ, 2004, SCIENCE, V303, P98, DOI 10.1126/science.1092287; Stephanopoulos G., 1998, METAB ENG; Tenreiro S, 2010, FEMS YEAST RES, V10, P970, DOI 10.1111/j.1567-1364.2010.00649.x; Thiele I, 2010, NAT PROTOC, V5, P93, DOI 10.1038/nprot.2009.203; Thiele I, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000312; Tu BP, 2004, J CELL BIOL, V164, P341, DOI 10.1083/jcb.200311055; Tu BP, 2002, MOL CELL, V10, P983, DOI 10.1016/S1097-2765(02)00696-2; VALLS LA, 1990, J CELL BIOL, V111, P361, DOI 10.1083/jcb.111.2.361; Varki A, 2011, COLD SPRING HARBOR P, V3; Wilkinson B, 2004, BBA-PROTEINS PROTEOM, V1699, P35, DOI 10.1016/j.bbapap.2004.02.017; Winklhofer KF, 2006, HANDB EXP PHARM, V172, P221; Ye Y, 2001, MIGRATION, V276, P7327; Zanetti G, 2012, NAT CELL BIOL, V14, P20, DOI 10.1038/ncb2390; ZHOURAVLEVA G, 1995, EMBO J, V14, P4065, DOI 10.1002/j.1460-2075.1995.tb00078.x	63	50	52	4	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e63284	10.1371/journal.pone.0063284	http://dx.doi.org/10.1371/journal.pone.0063284			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667601	gold, Green Published, Green Submitted			2022-12-27	WOS:000319654700131
J	Lin, YW; Li, AL; Grasso, V; Battaglia, D; Crino, A; Colombo, C; Barbetti, F; Nichols, CG				Lin, Yu-Wen; Li, Anlong; Grasso, Valeria; Battaglia, Domenica; Crino, Antonino; Colombo, Carlo; Barbetti, Fabrizio; Nichols, Colin G.			Functional Characterization of a Novel KCNJ11 in Frame Mutation-Deletion Associated with Infancy-Onset Diabetes and a Mild Form of Intermediate DEND: A Battle between K-ATP Gain of Channel Activity and Loss of Channel Expression	PLOS ONE			English	Article							ACTIVATING MUTATIONS; NEUROLOGICAL FEATURES; POTASSIUM CHANNELS; KIR6.2 MUTATIONS; INSULIN; REGION	ATP-sensitive potassium (K-ATP) channels are widely distributed in various tissues and cell types where they couple cell metabolism to cell excitability. Gain of channel function (GOF) mutations in the genes encoding Kir6.2 (KCNJ11) or the associated regulatory ssulfonylurea receptor 1 subunit (ABCC8), cause developmental delay, epilepsy and neonatal diabetes (DEND) due to suppressed cell excitability in pancreatic beta-cells and neurons. The objective of this study was to determine the molecular basis of infancy-onset diabetes and a mild form of intermediate DEND, resulting from a novel KCNJ11 in frame mutation plus deletion. The naturally occurring Kir6.2 mutation plus deletion (Ser225Thr, Pro226_Pro232del) as well as the isolated S225T mutation or isolated del226-232 deletion were coexpressed with SUR1 in COS cells in homozygous or heterozygous states. The protein expression and gating effects of the resulting channels were assessed biochemically and electrophysiologically. For both the deletion and point mutations, simulated heterozygous expression resulted in overall increased conductance in intact cells in basal conditions and rightward shifted ATP dose-response curves in excised patches, due to increased intrinsic open probability. Interestingly, homomeric channels for the combined deletion/mutation, or for the deletion alone, showed dramatically reduced channel expression at the cell membrane, which would underlie a reduced function in vivo. These results demonstrate that both the mis-sense mutation and the deleted region in the Kir6.2 subunit are important for control of the intrinsic channel gating and suggest that the clinical presentation could be affected by the competition between loss-of-function by reduced trafficking and enhanced channel gating.	[Lin, Yu-Wen; Li, Anlong; Nichols, Colin G.] Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA; [Lin, Yu-Wen; Li, Anlong; Nichols, Colin G.] Washington Univ, Sch Med, Ctr Invest Membrane Excitabil Dis, St Louis, MO 63110 USA; [Grasso, Valeria; Colombo, Carlo; Barbetti, Fabrizio] Univ Roma Tor Vergata, Lab Mendelian Diabet, Bambino Gesu Childrens Hosp, Res Inst, Rome, Italy; [Battaglia, Domenica] Sacro Cuore Catholic Univ, Dept Pediat, Child Neurol Unit, Rome, Italy; [Crino, Antonino] Bambino Gesu Pediat Hosp, Res Inst, Dept Endocrinol, Autoimmune Endocrine Dis Unit, Rome, Italy; [Barbetti, Fabrizio] Univ Roma Tor Vergata, Dept Internal Med, Rome, Italy	Washington University (WUSTL); Washington University (WUSTL); IRCCS Bambino Gesu; University of Rome Tor Vergata; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; IRCCS Bambino Gesu; University of Rome Tor Vergata	Nichols, CG (corresponding author), Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA.	cnichols@wustl.edu	Barbetti, Fabrizio/AAK-9106-2021; BATTAGLIA, DOMENICA IMMACOLATA/AAA-5951-2019; Barbetti, Fabrizio/I-7351-2018	Barbetti, Fabrizio/0000-0003-4687-980X; Barbetti, Fabrizio/0000-0003-4687-980X; Crino, Antonino/0000-0003-3548-7114; BATTAGLIA, Domenica Immacolata/0000-0003-0491-4021	grant Fondazione Roma' Molecular mechanisms in the pathogenesis of type 2 diabetes mellitus and its cardiovascular complications'; NIH [DK69445]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK069445, P30DK020579] Funding Source: NIH RePORTER	grant Fondazione Roma' Molecular mechanisms in the pathogenesis of type 2 diabetes mellitus and its cardiovascular complications'; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by the grant Fondazione Roma' Molecular mechanisms in the pathogenesis of type 2 diabetes mellitus and its cardiovascular complications' (to FB) and NIH grant DK69445 (to CGN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar-Bryan L, 1999, ENDOCR REV, V20, P101, DOI 10.1210/er.20.2.101; Battaglia D, 2012, PEDIAT DIAB IN PRESS; Codner E, 2005, DIABETES CARE, V28, P758, DOI 10.2337/diacare.28.3.758; Edghill EL, 2010, REV ENDOCR METAB DIS, V11, P193, DOI 10.1007/s11154-010-9149-x; Enkvetchakul D, 2000, BIOPHYS J, V78, P2334, DOI 10.1016/S0006-3495(00)76779-8; Flanagan SE, 2006, DIABETOLOGIA, V49, P1190, DOI 10.1007/s00125-006-0246-z; FLANAGAN SE, 2008, HUM MUTAT; Girard CAJ, 2006, PFLUG ARCH EUR J PHY, V453, P323, DOI 10.1007/s00424-006-0112-3; Gloyn AL, 2004, NEW ENGL J MED, V350, P1838, DOI 10.1056/NEJMoa032922; Gloyn AL, 2006, EUR J HUM GENET, V14, P824, DOI 10.1038/sj.ejhg.5201629; Kline CF, 2009, P NATL ACAD SCI USA, V106, P16669, DOI 10.1073/pnas.0907138106; Koster JC, 2008, BIOPHYS J, V95, P4689, DOI 10.1529/biophysj.108.138685; Li JD, 2010, J BIOL CHEM, V285, P28723, DOI 10.1074/jbc.M110.147868; Loechner KJ, 2011, DIABETES, V60, P209, DOI 10.2337/db10-0731; Masia R, 2007, DIABETES, V56, P1357, DOI 10.2337/db06-1746; Nichols CG, 1997, ANNU REV PHYSIOL, V59, P171, DOI 10.1146/annurev.physiol.59.1.171; Nichols CG, 2006, NATURE, V440, P470, DOI 10.1038/nature04711; Pearson ER, 2006, NEW ENGL J MED, V355, P467, DOI 10.1056/NEJMoa061759; Proks P, 2004, P NATL ACAD SCI USA, V101, P17539, DOI 10.1073/pnas.0404756101; Tao X, 2009, SCIENCE, V326, P1668, DOI 10.1126/science.1180310	20	9	10	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e63758	10.1371/journal.pone.0063758	http://dx.doi.org/10.1371/journal.pone.0063758			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667671	gold, Green Published, Green Submitted			2022-12-27	WOS:000319654700185
J	Sarafian, TA; Ryan, CM; Souda, P; Masliah, E; Kar, UK; Vinters, HV; Mathern, GW; Faull, KF; Whitelegge, JP; Watson, JB				Sarafian, Theodore A.; Ryan, Christopher M.; Souda, Puneet; Masliah, Eliezer; Kar, Upendra K.; Vinters, Harry V.; Mathern, Gary W.; Faull, Kym F.; Whitelegge, Julian P.; Watson, Joseph B.			Impairment of Mitochondria in Adult Mouse Brain Overexpressing Predominantly Full-Length, N-Terminally Acetylated Human alpha-Synuclein	PLOS ONE			English	Article							PARKINSONS-DISEASE; COMPLEX-I; POSTTRANSLATIONAL MODIFICATIONS; MICE; AGGREGATION; PLASTICITY; PROTEINS; MODEL; PHOSPHORYLATION; ACCUMULATION	While most forms of Parkinson's Disease (PD) are sporadic in nature, a small percentage of PD have genetic causes as first described for dominant, single base pair changes as well as duplication and triplication in the alpha-synuclein gene. The alpha-synuclein gene encodes a 140 amino acid residue protein that interacts with a variety of organelles including synaptic vesicles, lysosomes, endoplasmic reticulum/Golgi vesicles and, reported more recently, mitochondria. Here we examined the structural and functional interactions of human alpha-synuclein with brain mitochondria obtained from an early, pre-manifest mouse model for PD over-expressing human alpha-synuclein (ASOTg). The membrane potential in ASOTg brain mitochondria was decreased relative to wildtype (WT) mitochondria, while reactive oxygen species (ROS) were elevated in ASOTg brain mitochondria. No selective interaction of human alpha-synuclein with mitochondrial electron transport complexes cl-cV was detected. Monomeric human alpha-synuclein plus carboxyl terminally truncated forms were the predominant isoforms detected in ASOTg brain mitochondria by 2-dimensional PAGE (Native/SDS) and immunoblotting. Oligomers or fibrils were not detected with amyloid conformational antibodies. Mass spectrometry of human alpha-synuclein in both ASOTg brain mitochondria and homogenates from surgically resected human cortex demonstrated that the protein was full-length and postranslationally modified by N-terminal acetylation. Overall the study showed that accumulation of full-length, N-terminally acetylated human alpha-synuclein was sufficient to disrupt brain mitochondrial function in adult mice.	[Sarafian, Theodore A.; Ryan, Christopher M.; Souda, Puneet; Kar, Upendra K.; Mathern, Gary W.; Faull, Kym F.; Whitelegge, Julian P.; Watson, Joseph B.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Psychiat & Biobehav Sci, Los Angeles, CA 90095 USA; [Masliah, Eliezer] Univ Calif San Diego, Sch Med, Dept Neurosci, La Jolla, CA 92093 USA; [Vinters, Harry V.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA; [Mathern, Gary W.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurosurg, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California San Diego; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Watson, JB (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Psychiat & Biobehav Sci, Los Angeles, CA 90095 USA.	jwatson@mednet.ucla.edu	Kar, Upendra K/H-5250-2012; Mathern, Gary W./J-2483-2016	Kar, Upendra K/0000-0003-4065-0860; 	Center for Gene Environment Studies in Parkinson's Disease (CGEP) at UCLA [NIH U54 ES016732]; UCLA Academic Senate's Committee on Research; NIH [AG18440, AG022074]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK063491] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P01ES016732] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS049134] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG018440, P01AG022074, P50AG005131, R37AG018440] Funding Source: NIH RePORTER	Center for Gene Environment Studies in Parkinson's Disease (CGEP) at UCLA; UCLA Academic Senate's Committee on Research; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The project was supported by a Pilot Grant (JBW) from the Center for Gene Environment Studies in Parkinson's Disease (CGEP) at UCLA (NIH U54 ES016732), a Faculty Research Grant (JBW) from the UCLA Academic Senate's Committee on Research, and NIH AG18440 and AG022074 grants (EM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson JP, 2006, J BIOL CHEM, V281, P29739, DOI 10.1074/jbc.M600933200; Banerjee K, 2010, FEBS LETT, V584, P1571, DOI 10.1016/j.febslet.2010.03.012; Bartels T, 2011, NATURE, V477, P107, DOI 10.1038/nature10324; Bayir H, 2009, J BIOL CHEM, V284, P15951, DOI 10.1074/jbc.M900418200; Blumcke I, 2011, EPILEPSIA, V52, P158, DOI 10.1111/j.1528-1167.2010.02777.x; Braak H, 2003, NEUROBIOL AGING, V24, P197, DOI 10.1016/S0197-4580(02)00065-9; Bueler H, 2009, EXP NEUROL, V218, P235, DOI 10.1016/j.expneurol.2009.03.006; Burre J, 2012, J NEUROSCI, V32, P15227, DOI 10.1523/JNEUROSCI.3545-12.2012; Cabin DE, 2002, J NEUROSCI, V22, P8797; Cannon JR, 2009, NEUROBIOL DIS, V34, P279, DOI 10.1016/j.nbd.2009.01.016; Chandra S, 2005, CELL, V123, P383, DOI 10.1016/j.cell.2005.09.028; Chang JW, 2012, J NEUROSCI METH, V211, P289, DOI 10.1016/j.jneumeth.2012.09.005; Chang JW, 1997, J NEUROPATH EXP NEUR, V56, P1105, DOI 10.1097/00005072-199710000-00004; Chinta SJ, 2010, NEUROSCI LETT, V486, P235, DOI 10.1016/j.neulet.2010.09.061; Clayton DF, 1998, TRENDS NEUROSCI, V21, P249, DOI 10.1016/S0166-2236(97)01213-7; Cummings DM, 2012, J NEUROPHYSIOL, V107, P677, DOI 10.1152/jn.00762.2011; Dauer W, 2003, NEURON, V39, P889, DOI 10.1016/S0896-6273(03)00568-3; Davidson WS, 1998, J BIOL CHEM, V273, P9443, DOI 10.1074/jbc.273.16.9443; Devi L, 2008, J BIOL CHEM, V283, P9089, DOI 10.1074/jbc.M710012200; Dudkina NV, 2010, BBA-BIOENERGETICS, V1797, P664, DOI 10.1016/j.bbabio.2009.12.013; Ellis CE, 2005, MOL CELL BIOL, V25, P10190, DOI 10.1128/MCB.25.22.10190-10201.2005; Fauvet B, 2012, J BIOL CHEM, V287, P15345, DOI 10.1074/jbc.M111.318949; Fernagut PO, 2007, SYNAPSE, V61, P991, DOI 10.1002/syn.20456; Fleming SM, 2006, NEUROSCIENCE, V142, P1245, DOI 10.1016/j.neuroscience.2006.07.005; Fleming SM, 2008, EUR J NEUROSCI, V28, P247, DOI 10.1111/j.1460-9568.2008.06346.x; Fleming SM, 2004, J NEUROSCI, V24, P9434, DOI 10.1523/JNEUROSCI.3080-04.2004; Giasson BI, 2002, NEURON, V34, P521, DOI 10.1016/S0896-6273(02)00682-7; Gitler AD, 2008, P NATL ACAD SCI USA, V105, P145, DOI 10.1073/pnas.0710685105; Graham J M, 1993, Methods Mol Biol, V19, P29; Gundersen CB, 2010, BRAIN RES, V1332, P1, DOI 10.1016/j.brainres.2010.03.044; Hsu LJ, 2000, AM J PATHOL, V157, P401, DOI 10.1016/S0002-9440(10)64553-1; Johnson MW, 1997, J NEUROSCI METH, V77, P151, DOI 10.1016/S0165-0270(97)00120-9; Kang LJ, 2012, PROTEIN SCI, V21, P911, DOI 10.1002/pro.2088; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Klucken J, 2004, J BIOL CHEM, V279, P25497, DOI 10.1074/jbc.M400255200; Kubo S, 2005, J BIOL CHEM, V280, P31664, DOI 10.1074/jbc.M504894200; Laganowsky A, 2012, SCIENCE, V335, P1228, DOI 10.1126/science.1213151; Lam HA, 2011, J NEUROSCI RES, V89, P1091, DOI 10.1002/jnr.22611; Larsen KE, 2006, J NEUROSCI, V26, P11915, DOI 10.1523/JNEUROSCI.3821-06.2006; Lee KW, 2011, J NEUROSCI, V31, P6963, DOI 10.1523/JNEUROSCI.6513-10.2011; Lee MK, 2002, P NATL ACAD SCI USA, V99, P8968, DOI 10.1073/pnas.132197599; Li WX, 2005, P NATL ACAD SCI USA, V102, P2162, DOI 10.1073/pnas.0406976102; Liu GW, 2009, NEUROSCI LETT, V454, P187, DOI 10.1016/j.neulet.2009.02.056; Loeb V, 2010, J BIOL CHEM, V285, P7334, DOI 10.1074/jbc.M109.061051; Manning-Bog AB, 2003, J NEUROSCI, V23, P3095; Maroteaux L, 1991, BRAIN RES MOL BRAIN, V11, P35; Martin I, 2011, ANNU REV GENOM HUM G, V12, P301, DOI 10.1146/annurev-genom-082410-101440; Martin LJ, 2006, J NEUROSCI, V26, P41, DOI 10.1523/JNEUROSCI.4308-05.2006; McLean JR, 2012, MOL CELL NEUROSCI, V49, P230, DOI 10.1016/j.mcn.2011.11.006; Muntane G, 2012, NEUROSCIENCE, V200, P106, DOI 10.1016/j.neuroscience.2011.10.042; Nakamura K, 2011, J BIOL CHEM, V286, P20710, DOI 10.1074/jbc.M110.213538; Nakamura K, 2008, J NEUROSCI, V28, P12305, DOI 10.1523/JNEUROSCI.3088-08.2008; Nemani VM, 2010, NEURON, V65, P66, DOI 10.1016/j.neuron.2009.12.023; Oueslati A, 2010, PROG BRAIN RES, V183, P115, DOI 10.1016/S0079-6123(10)83007-9; Paisan-Ruiz C, 2004, NEURON, V44, P595, DOI 10.1016/j.neuron.2004.10.023; Rahimi F, 2008, CURR ALZHEIMER RES, V5, P319, DOI 10.2174/156720508784533358; Rockenstein E, 2002, J NEUROSCI RES, V68, P568, DOI 10.1002/jnr.10231; Ryan CM, 2010, MOL CELL PROTEOMICS, V9, P791, DOI 10.1074/mcp.M900516-MCP200; Ryan CM, 2010, J AM SOC MASS SPECTR, V21, P908, DOI 10.1016/j.jasms.2010.01.025; Sarafian TA, 2006, AM J PHYSIOL-LUNG C, V290, pL1202, DOI 10.1152/ajplung.00371.2005; Sarafian TA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009532; Sasse J., 1991, CURRENT PROTOCOLS MO, V2; SCHAPIRA AHV, 1990, J NEUROCHEM, V54, P823, DOI 10.1111/j.1471-4159.1990.tb02325.x; Shaw BF, 2008, J BIOL CHEM, V283, P8340, DOI 10.1074/jbc.M707751200; Steiner JA, 2011, CELL DEATH DIFFER, V18, P1425, DOI 10.1038/cdd.2011.53; Trancikova A, 2012, ANTIOXID REDOX SIGN, V16, P896, DOI 10.1089/ars.2011.4200; Trexler AJ, 2012, PROTEIN SCI, V21, P601, DOI 10.1002/pro.2056; Ullman O, 2011, J AM CHEM SOC, V133, P19536, DOI 10.1021/ja208657z; Velde CV, 2008, P NATL ACAD SCI USA, V105, P4022, DOI 10.1073/pnas.0712209105; Wang W, 2011, P NATL ACAD SCI USA, V108, P17797, DOI 10.1073/pnas.1113260108; Watson JB, 2006, J NEUROSCI RES, V84, P1564, DOI 10.1002/jnr.21040; Watson JB, 2009, NEUROSCIENCE, V159, P501, DOI 10.1016/j.neuroscience.2009.01.021; Whitelegge JP, 2007, INT J MASS SPECTROM, V268, P190, DOI 10.1016/j.ijms.2007.08.008; Whitellegge JP, 2009, COMPR ANAL CHEM, V52; Wu N, 2010, J NEUROSCI RES, V88, P1764, DOI 10.1002/jnr.22327; Xie J, 2007, FEBS LETT, V581, P3545, DOI 10.1016/j.febslet.2007.06.052; Zeevalk GD, 2008, BIOMED PHARMACOTHER, V62, P236, DOI 10.1016/j.biopha.2008.01.017; Zhu YG, 2011, INT J BIOCHEM CELL B, V43, P732, DOI 10.1016/j.biocel.2011.01.014; Zigoneanu IG, 2012, BBA-BIOMEMBRANES, V1818, P512, DOI 10.1016/j.bbamem.2011.11.024	79	31	34	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e63557	10.1371/journal.pone.0063557	http://dx.doi.org/10.1371/journal.pone.0063557			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667637	Green Published, gold			2022-12-27	WOS:000319654700160
J	Stumhofer, JS; Silver, JS; Hunter, CA				Stumhofer, Jason S.; Silver, Jonathan S.; Hunter, Christopher A.			IL-21 Is Required for Optimal Antibody Production and T Cell Responses during Chronic Toxoplasma gondii Infection	PLOS ONE			English	Article							FOLLICULAR-HELPER-CELLS; CHRONIC VIRAL-INFECTION; ARYL-HYDROCARBON RECEPTOR; GERMINAL CENTER RESPONSES; B-CELLS; C-MAF; DIFFERENTIATION; INTERLEUKIN-21; GENERATION; AUTOIMMUNITY	Previous studies have indicated that Il21r(-/-) mice chronically infected with Toxoplasma gondii display a defect in serum IgG; however, the basis for this antibody defect was not defined and questions remain about the role of IL-21 in promoting the production of IL-10, which is required to limit infection-induced pathology during toxoplasmosis. Therefore, Il21(-/-) mice were challenged with T. gondii to determine whether IL-21 impacts the parasite-specific CD8(+) T cell response, its contribution to thymus-dependent antibody production after infection, and balance between protective and pathogenic responses. Whereas IL-21 has been implicated in the differentiation of IL-10 producing CD4(+) T cells no immune-mediated pathology was evident in Il21(-/-) mice during the acute response, nor was there a defect in the development of this population in chronically infected Il21(-/-) mice. However, Il21(-/-) mice displayed a defect in IgG production after infection that correlated with a decrease in GC B cell numbers, the CD4(+) and CD8(+) T cell numbers in the brain were reduced over the course of the chronic infection leading to a decrease in total IFN-gamma production and an increase in parasite numbers associated with susceptibility to toxoplasmic encephalitis. Together, these results identify a key role for IL-21 in shaping the humoral and cellular response to T. gondii, but indicate that IL-21 has a limited role in regulating immunopathology.	[Stumhofer, Jason S.] Univ Arkansas Med Sci, Dept Microbiol & Immunol, Little Rock, AR 72205 USA; [Silver, Jonathan S.; Hunter, Christopher A.] Univ Penn, Dept Pathobiol, Sch Vet Med, Philadelphia, PA 19104 USA	University of Arkansas System; University of Arkansas Medical Sciences; University of Pennsylvania	Stumhofer, JS (corresponding author), Univ Arkansas Med Sci, Dept Microbiol & Immunol, Little Rock, AR 72205 USA.	jstumhofer@uams.edu			Commonwealth of Pennsylvania; NIH [AI071302, AI084882, R21-AI090179, 1 P20 GM103625, AI007532]; Arkansas Biosciences Institute; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007532, R01AI071302, R21AI090179] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103625] Funding Source: NIH RePORTER	Commonwealth of Pennsylvania; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Arkansas Biosciences Institute; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Commonwealth of Pennsylvania, the Arkansas Biosciences Institute, NIH grants AI071302 and AI084882 (C.A.H.), R21-AI090179 and 1 P20 GM103625 (J.S. Stumhofer), T32 Training Grant AI007532 (J.S. Silver). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allard EL, 2007, EUR J IMMUNOL, V37, P3069, DOI 10.1002/eji.200637017; Apetoh L, 2010, NAT IMMUNOL, V11, P854, DOI 10.1038/ni.1912; Bessa J, 2010, J IMMUNOL, V184, P4615, DOI 10.4049/jimmunol.0903949; CROTTY S, 2011, ANN REV IMMUNOL; Crotty S, 2010, NAT IMMUNOL, V11, P114, DOI 10.1038/ni.1837; Dienz O, 2009, J EXP MED, V206, P69, DOI 10.1084/jem.20081571; Elsaesser H, 2009, SCIENCE, V324, P1569, DOI 10.1126/science.1174182; Eto D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017739; Ferrari-Lacraz S, 2008, INT IMMUNOL, V20, P1009, DOI 10.1093/intimm/dxn059; Frohlich A, 2009, SCIENCE, V324, P1576, DOI 10.1126/science.1172815; GAZZINELLI R, 1992, J IMMUNOL, V149, P175; Goenka R, 2011, J IMMUNOL, V187, P1091, DOI 10.4049/jimmunol.1100853; Johnson LL, 2002, INFECT IMMUN, V70, P185, DOI 10.1128/IAI.70.1.185-191.2002; Jordan KA, 2010, EXP PARASITOL, V126, P318, DOI 10.1016/j.exppara.2010.05.008; Jordan KA, 2009, INFECT IMMUN, V77, P3894, DOI 10.1128/IAI.00024-09; Kang H, 2000, J IMMUNOL, V164, P2629, DOI 10.4049/jimmunol.164.5.2629; Korn T, 2007, NATURE, V448, P484, DOI 10.1038/nature05970; Linterman MA, 2010, J EXP MED, V207, P353, DOI 10.1084/jem.20091738; Novy P, 2011, J IMMUNOL, V186, P2729, DOI 10.4049/jimmunol.1003009; Nurieva R, 2007, NATURE, V448, P480, DOI 10.1038/nature05969; Nurieva RI, 2008, IMMUNITY, V29, P138, DOI 10.1016/j.immuni.2008.05.009; Ozaki K, 2002, SCIENCE, V298, P1630, DOI 10.1126/science.1077002; Poholek AC, 2010, J IMMUNOL, V185, P313, DOI 10.4049/jimmunol.0904023; Pot C, 2009, J IMMUNOL, V183, P797, DOI 10.4049/jimmunol.0901233; Sayles PC, 2000, INFECT IMMUN, V68, P1026, DOI 10.1128/IAI.68.3.1026-1033.2000; SHARMA SD, 1983, J IMMUNOL, V131, P977; Spolski R, 2008, CURR OPIN IMMUNOL, V20, P295, DOI 10.1016/j.coi.2008.02.004; Spolski R, 2008, ANNU REV IMMUNOL, V26, P57, DOI 10.1146/annurev.immunol.26.021607.090316; Spolski R, 2010, INT IMMUNOL, V22, P7, DOI 10.1093/intimm/dxp112; Spolski R, 2009, J IMMUNOL, V182, P2859, DOI 10.4049/jimmunol.0802978; Stumhofer JS, 2006, NAT IMMUNOL, V7, P937, DOI 10.1038/ni1376; Stumhofer JS, 2007, NAT IMMUNOL; Veldhoen M, 2009, J EXP MED, V206, P43, DOI 10.1084/jem.20081438; Villarino AV, 2006, J IMMUNOL, V176, P237, DOI 10.4049/jimmunol.176.1.237; Vogelzang A, 2008, IMMUNITY, V29, P127, DOI 10.1016/j.immuni.2008.06.001; Williams LD, 2011, J VIROL, V85, P2316, DOI 10.1128/JVI.01476-10; Wilson EH, 2005, J NEUROIMMUNOL, V165, P63, DOI 10.1016/j.jneuroim.2005.04.018; Yi JS, 2009, SCIENCE, V324, P1572, DOI 10.1126/science.1175194; Zhou LA, 2007, NAT IMMUNOL, V8, P967, DOI 10.1038/ni1488; Zotos D, 2010, J EXP MED, V207, P365, DOI 10.1084/jem.20091777	40	20	22	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e62889	10.1371/journal.pone.0062889	http://dx.doi.org/10.1371/journal.pone.0062889			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667536	gold, Green Published, Green Submitted			2022-12-27	WOS:000319654700075
J	Doyle, VP; Oudemans, PV; Rehner, SA; Litt, A				Doyle, Vinson P.; Oudemans, Peter V.; Rehner, Stephen A.; Litt, Amy			Habitat and Host Indicate Lineage Identity in Colletotrichum gloeosporioides s.l. from Wild and Agricultural Landscapes in North America	PLOS ONE			English	Article							PHYLOGENETIC SPECIES RECOGNITION; CRANBERRY FRUIT ROT; MOLECULAR CHARACTERIZATION; ECOLOGICAL SPECIATION; GENEALOGICAL APPROACH; PATHOGENICITY; ANTHRACNOSE; COMPLEX; SPP.; CONCORDANCE	Understanding the factors that drive the evolution of pathogenic fungi is central to revealing the mechanisms of virulence and host preference, as well as developing effective disease control measures. Prerequisite to these pursuits is the accurate delimitation of species boundaries. Colletotrichum gloeosporioides s.l. is a species complex of plant pathogens and endophytic fungi for which reliable species recognition has only recently become possible through a multi-locus phylogenetic approach. By adopting an intensive regional sampling strategy encompassing multiple hosts within and beyond agricultural zones associated with cranberry (Vaccinium macrocarpon Aiton), we have integrated North America strains of Colletotrichum gloeosporioides s.l. from these habitats into a broader phylogenetic framework. We delimit species on the basis of genealogical concordance phylogenetic species recognition (GCPSR) and quantitatively assess the monophyly of delimited species at each of four nuclear loci and in the combined data set with the genealogical sorting index (gsi). Our analysis resolved two principal lineages within the species complex. Strains isolated from cranberry and sympatric host plants are distributed across both of these lineages and belong to seven distinct species or terminal clades. Strains isolated from V. macrocarpon in commercial cranberry beds belong to four species, three of which are described here as new. Another species, C. rhexiae Ellis & Everh., is epitypified. Intensive regional sampling has revealed a combination of factors, including the host species from which a strain has been isolated, the host organ of origin, and the habitat of the host species, as useful indicators of species identity in the sampled regions. We have identified three broadly distributed temperate species, C. fructivorum, C. rhexiae, and C. nupharicola, that could be useful for understanding the microevolutionary forces that may lead to species divergence in this important complex of endophytes and plant pathogens.	[Doyle, Vinson P.; Litt, Amy] New York Bot Garden, Bronx, NY 10458 USA; [Doyle, Vinson P.] CUNY, Grad Ctr, New York, NY USA; [Oudemans, Peter V.] Rutgers State Univ, Philip E Marucci Ctr Blueberry & Cranberry Res &, Chatsworth, NJ USA; [Rehner, Stephen A.] ARS, Systemat Mycol & Microbiol Lab, USDA, Beltsville, MD USA	New York Botanical Garden; City University of New York (CUNY) System; Rutgers State University New Brunswick; United States Department of Agriculture (USDA)	Doyle, VP (corresponding author), New York Bot Garden, Bronx, NY 10458 USA.	vinsonpdoyle@gmail.com		Oudemans, Peter/0000-0001-7564-0641; Doyle, Vinson/0000-0002-2350-782X	National Science Foundation [DBI 0749751, DEB 1011120]; Torrey Botanical Society; New York Botanical Garden	National Science Foundation(National Science Foundation (NSF)); Torrey Botanical Society; New York Botanical Garden	Financial support from the National Science Foundation [www.nsf.gov] (DBI 0749751 and DEB 1011120 - Doctoral Dissertation Improvement Grant), the Torrey Botanical Society Graduate Research Fellowship [www.torreybotanical.org], and The New York Botanical Garden [www.nybg.org] helped to fund this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Adaskaveg JE, 2000, COLLETOTRICHUM, P317; AGOSTINI JP, 1994, PHYTOPATHOLOGY, V84, P420, DOI 10.1094/Phyto-84-420; Ane C, 2007, MOL BIOL EVOL, V24, P412; [Anonymous], 1894, P ACAD NAT SCI PHILA; Bailey J. A., 1992, COLLETOTRICHUM BIOL; Bazinet AL, 2009, GENEALOGICALSORTING; BILLS G F, 1992, Sydowia, V44, P1; BRASIER CM, 1995, CAN J BOT, V73, pS1213, DOI 10.1139/b95-381; Cannon PF, 2008, MYCOTAXON, V104, P189; Chakraborty S, 2002, PHYTOPATHOLOGY, V92, P553, DOI 10.1094/PHYTO.2002.92.5.553; CHILTON SJP, 1945, AM J BOT, V32, P549, DOI 10.2307/2437685; Colon-Garay J, 2002, J AGR U PUERTO RICO, V86, P55; Crouch JA, 2006, PHYTOPATHOLOGY, V96, P46, DOI 10.1094/PHYTO-96-0046; Crouch JA, 2009, MYCOLOGIA, V101, P648, DOI 10.3852/08-231; Crouch JA, 2009, MOL ECOL, V18, P123, DOI 10.1111/j.1365-294X.2008.04008.x; Cummings MP, 2008, EVOLUTION, V62, P2411, DOI 10.1111/j.1558-5646.2008.00442.x; Dettman JR, 2003, EVOLUTION, V57, P2703, DOI 10.1554/03-073; Du MZ, 2005, MYCOLOGIA, V97, P641, DOI 10.3852/mycologia.97.3.641; EDGERTON CW, 1945, AM J BOT, V32, P115, DOI 10.2307/2437529; Edgerton CW, 1914, AM J BOT, V1, P244, DOI 10.2307/2435256; Freeman S, 1996, APPL ENVIRON MICROB, V62, P1014, DOI 10.1128/AEM.62.3.1014-1020.1996; Giraud T, 2010, TRENDS ECOL EVOL, V25, P387, DOI 10.1016/j.tree.2010.03.006; Gladieux P, 2011, MOL ECOL, V20, P4521, DOI 10.1111/j.1365-294X.2011.05288.x; Goloboff P, 2008, CLADISTICS, V24, P91; Gonzalez E, 2006, PHYTOPATHOLOGY, V96, P982, DOI 10.1094/PHYTO-96-0982; Halsted B, 1889, SOME FUNGUS DIS CRAN, P1; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Hyde KD, 2009, FUNGAL DIVERS, V39, P1; Hyde KD, 2009, FUNGAL DIVERS, V39, P147; Johnson DA, 1997, MYCOL RES, V101, P641, DOI 10.1017/S0953756296003115; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; Katoh K, 2008, BRIEF BIOINFORM, V9, P286, DOI 10.1093/bib/bbn013; Kaufmann PJ, 1996, PLANT DIS, V80, P1289, DOI 10.1094/PD-80-1289; Larget BR, 2010, BIOINFORMATICS, V26, P2910, DOI 10.1093/bioinformatics/btq539; Latunde-Dada AO, 2001, MOL PLANT PATHOL, V2, P187, DOI 10.1046/j.1464-6722.2001.00069.x; Legard DE, 2000, COLLETOTRICHUM, P292; Lu GZ, 2004, MYCOL RES, V108, P53, DOI 10.1017/S0953756203008906; MacKenzie SJ, 2007, PHYTOPATHOLOGY, V97, P1130, DOI 10.1094/PHYTO-97-9-1130; MacKenzie S.J., 2005, POPULATION STRUCTURE; Miller M.A., 2010, P GAT COMP ENV WORKS; Morris CE, 2009, PLOS PATHOG, V5, P1; Nirenberg HI, 1976, MITT BIOL BUNDESANST, V169, P1, DOI DOI 10.1002/JPLN.19771400220; Nylander J. A. A., 2004, MRMODELTEST V2; ODonnell K, 1997, MOL PHYLOGENET EVOL, V7, P103, DOI 10.1006/mpev.1996.0376; Olatinwo RO, 2003, PLANT DIS, V87, P550, DOI 10.1094/PDIS.2003.87.5.550; Oudemans PV, 1998, PLANT DIS, V82, P1176, DOI 10.1094/PDIS.1998.82.11.1176; Photita W, 2005, FUNGAL DIVERS, V18, P117; Phoulivong S, 2010, MYCOTAXON, V114, P247, DOI 10.5248/114.247; Phoulivong S, 2010, FUNGAL DIVERS, V44, P33, DOI 10.1007/s13225-010-0046-0; Polashock JJ, 2009, PLANT PATHOL, V58, P1116, DOI 10.1111/j.1365-3059.2009.02120.x; Prihastuti H, 2009, FUNGAL DIVERS, V39, P89; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Rambaut A, 2007, TRACER V 1 4; Rasband W., 2006, IMAGEJ; Rodriguez-Saona C, 2011, J EXP BOT, V62, P2633, DOI 10.1093/jxb/erq466; Rojas EI, 2010, MYCOLOGIA, V102, P1318, DOI 10.3852/09-244; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Seifert KA, 2009, MOL ECOL RESOUR, V9, P83, DOI 10.1111/j.1755-0998.2009.02635.x; Shear CL, 1907, BOT GAZ, V43, P0259, DOI 10.1086/329172; SHEAR CL, 1907, B TORREY BOT CLUB, V34, P305, DOI DOI 10.2307/2479158; Shear CL, 1907, CRANBERRY DIS; Silva DN, 2012, MOL ECOL, V21, P2655, DOI 10.1111/j.1365-294X.2012.05557.x; Silva DN, 2012, MYCOLOGIA, V104, P396, DOI 10.3852/11-145; SIMMONDS J. H., 1965, QUEENSLAND J AGR ANIM SCI, V22, P437; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Stiles C. M., 1997, Phytopathology, V87, pS94; Stiles CM, 1999, PHYTOPATHOLOGY, V89, P218, DOI 10.1094/PHYTO.1999.89.3.218; Sukumaran J, 2010, BIOINFORMATICS, V26, P1569, DOI 10.1093/bioinformatics/btq228; SUTTON B, 1992, CL LIB APPL, P1; Taylor JW, 2000, FUNGAL GENET BIOL, V31, P21, DOI 10.1006/fgbi.2000.1228; Than PP, 2008, FUNGAL DIVERS, V28, P97; Vorsa N, 2005, J AM SOC HORTIC SCI, V130, P711, DOI 10.21273/JASHS.130.5.711; Vorsa N, 1994, BREEDING AM CRANBERR; Weir BS, 2012, STUD MYCOL, P115, DOI 10.3114/sim0011; WHEELER HE, 1952, AM J BOT, V39, P110, DOI 10.2307/2438177; White TJ., 1990, PCR PROTOCOLS GUIDE, P315; Wikee S, 2011, FUNGAL DIVERS, V46, P171, DOI 10.1007/s13225-010-0049-x; Yang YL, 2009, FUNGAL DIVERS, V39, P123; Yang YL, 2012, TROP PLANT PATHOL, V37, P165, DOI 10.1590/S1982-56762012000300001; Zhu P, 1999, GENETIC DIVERSITY SY; [No title captured], DOI DOI 10.1371/J0URNAL.P0NE.0090910	83	75	80	2	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2013	8	5							e62394	10.1371/journal.pone.0062394	http://dx.doi.org/10.1371/journal.pone.0062394			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	177QL	23671594	Green Published, gold, Green Submitted			2022-12-27	WOS:000321390200021
J	Dzhafarov, EN; Kujala, JV				Dzhafarov, Ehtibar N.; Kujala, Janne V.			All-Possible-Couplings Approach to Measuring Probabilistic Context	PLOS ONE			English	Article							HIDDEN-VARIABLES; QUANTUM; EINSTEIN; ROSEN; SELECTIVITY; INEQUALITY; VIOLATION; TESTS	From behavioral sciences to biology to quantum mechanics, one encounters situations where (i) a system outputs several random variables in response to several inputs, (ii) for each of these responses only some of the inputs may "directly" influence them, but (iii) other inputs provide a "context" for this response by influencing its probabilistic relations to other responses. These contextual influences are very different, say, in classical kinetic theory and in the entanglement paradigm of quantum mechanics, which are traditionally interpreted as representing different forms of physical determinism. One can mathematically construct systems with other types of contextuality, whether or not empirically realizable: those that form special cases of the classical type, those that fall between the classical and quantum ones, and those that violate the quantum type. We show how one can quantify and classify all logically possible contextual influences by studying various sets of probabilistic couplings, i.e., sets of joint distributions imposed on random outputs recorded at different (mutually incompatible) values of inputs.	[Dzhafarov, Ehtibar N.] Purdue Univ, Dept Psychol Sci, W Lafayette, IN 47907 USA; [Kujala, Janne V.] Univ Jyvaskyla, Dept Math Informat Technol, Jyvaskyla, Finland	Purdue University System; Purdue University; Purdue University West Lafayette Campus; University of Jyvaskyla	Dzhafarov, EN (corresponding author), Purdue Univ, Dept Psychol Sci, W Lafayette, IN 47907 USA.	ehtibar@purdue.edu			NSF [SES-1155956]; Direct For Social, Behav & Economic Scie [1155956] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); Direct For Social, Behav & Economic Scie(National Science Foundation (NSF)NSF - Directorate for Social, Behavioral & Economic Sciences (SBE))	This work is supported by NSF grant SES-1155956 (www.nsf.gov). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding has been received for this study.	ASPECT A, 1982, PHYS REV LETT, V49, P91, DOI 10.1103/PhysRevLett.49.91; ASPECT A, 1981, PHYS REV LETT, V47, P460, DOI 10.1103/PhysRevLett.47.460; Basoalto RM, 2003, J PHYS A-MATH GEN, V36, P7411, DOI 10.1088/0305-4470/36/26/312; Bell J. S., 1964, PHYSICS, V1, P195, DOI [10.1103/Physics-PhysiqueFizika.1.195, DOI 10.1103/PHYSICSPHYSIQUEFIZIKA.1.195]; BELL JS, 1966, REV MOD PHYS, V38, P447, DOI 10.1103/RevModPhys.38.447; BOHM D, 1957, PHYS REV, V108, P1070, DOI 10.1103/PhysRev.108.1070; Cabello A, 2005, PHYS REV A, V72, P1; Cereceda JL, 2000, FOUND PHYS LETT, V13, P427, DOI 10.1023/A:1007828731477; CIRELSON BS, 1980, LETT MATH PHYS, V4, P93, DOI 10.1007/BF00417500; CLAUSER JF, 1969, PHYS REV LETT, V23, P880, DOI 10.1103/PhysRevLett.23.880; CLAUSER JF, 1974, PHYS REV D, V10, P526, DOI 10.1103/PhysRevD.10.526; Dzhafarov Ehtibar N., 2012, Quantum Interaction. 6th International Symposium, QI 2012. Revised Selected Papers, P184, DOI 10.1007/978-3-642-35659-9_17; Dzhafarov EN, 2012, J MATH PSYCHOL, V56, P54, DOI 10.1016/j.jmp.2011.12.003; Dzhafarov EN, 2010, FRONT PSYCHOL, V1, DOI 10.3389/fpsyg.2010.00151; Dzhafarov EN, 2004, J MATH PSYCHOL, V48, P51, DOI [10.1016/j.jmp.2003.12.003, 10.1016/j.jmp.2003.11.003]; Dzhafarov EN, 2003, PSYCHOMETRIKA, V68, P7, DOI 10.1007/BF02296650; Dzhafarov EN, P AM MATH S IN PRESS; FINE A, 1982, J MATH PHYS, V23, P1306, DOI 10.1063/1.525514; FINE A, 1982, PHYS REV LETT, V48, P291, DOI 10.1103/PhysRevLett.48.291; Khrennikov A, 2008, THEOR MATH PHYS+, V157, P1448, DOI 10.1007/s11232-008-0119-3; Khrennikov A, 2009, FUND THEOR PHYS, V160, P3, DOI 10.1007/978-1-4020-9593-1_1; Kujala JV, 2008, J MATH PSYCHOL, V52, P128, DOI 10.1016/j.jmp.2008.01.008; LANDAU LJ, 1987, PHYS LETT A, V120, P54, DOI 10.1016/0375-9601(87)90075-2; Laudisa F, 1997, PHILOS SCI, V64, P478, DOI 10.1086/392562; Pitowsky I., 1989, LECT NOTES PHYS, V321; Schweickert R, 2010, J MATH PSYCHOL, V54, P405, DOI 10.1016/j.jmp.2010.06.004; Sternberg S, 1969, ACTA PSYCHOL, V30, P276, DOI 10.1016/0001-6918(69)90055-9; SUPPES P, 1981, SYNTHESE, V48, P191, DOI 10.1007/BF01063886; Suppes P., 2002, CSLI LECT N; Thorisson Hermann, 2000, PROB APPL S; TOWNSEND JT, 1989, J MATH PSYCHOL, V33, P309, DOI 10.1016/0022-2496(89)90012-6; TOWNSEND JT, 1984, J MATH PSYCHOL, V28, P363, DOI 10.1016/0022-2496(84)90007-5	33	28	28	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2013	8	5							e61712	10.1371/journal.pone.0061712	http://dx.doi.org/10.1371/journal.pone.0061712			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	177QL	23671570	Green Published, Green Submitted, gold			2022-12-27	WOS:000321390200009
J	Peterman, WE; Semlitsch, RD				Peterman, William E.; Semlitsch, Raymond D.			Fine-Scale Habitat Associations of a Terrestrial Salamander: The Role of Environmental Gradients and Implications for Population Dynamics	PLOS ONE			English	Article							ESTIMATING SITE OCCUPANCY; GREAT SMOKY MOUNTAINS; PLETHODON-CINEREUS; IMPERFECT DETECTION; DETECTION PROBABILITIES; VEGETATION ANALYSIS; LANDSCAPE-SCALE; ABUNDANCE; MOISTURE; MODELS	Environmental gradients are instrumental in shaping the distribution and local abundance of species because at the most fundamental level, an organism's performance is constrained by the environment it inhabits. In topographically complex landscapes, slope, aspect, and vegetative cover interact to affect solar exposure, creating temperature-moisture gradients and unique microclimates. The significance of the interaction of abiotic gradients and biotic factors such as competition, movement, or physiology has long been recognized, but the scale at which these factors vary on the landscape has generally precluded their inclusion in spatial abundance models. We used fine-scale spatial data relating to surface-soil moisture, temperature, and canopy cover to describe the spatial distribution of abundance of a terrestrial salamander, Plethodon albagula, across the landscape. Abundance was greatest in dense-canopy ravine habitats with high moisture and low solar exposure, resulting in a patchy distribution of abundance. We hypothesize that these patterns reflect the physiological constraints of Plethodontid salamanders. Furthermore, demographic cohorts were not uniformly distributed among occupied plots on the landscape. The probability of gravid female occurrence was nearly uniform among occupied plots, but juveniles were much more likely to occur on plots with lower surface temperatures. The disconnect between reproductive effort and recruitment suggests that survival differs across the landscape and that local population dynamics vary spatially. Our study demonstrates a connection between abundance, fine-scale environmental gradients, and population dynamics, providing a foundation for future research concerning movement, population connectivity, and physiology.	[Peterman, William E.; Semlitsch, Raymond D.] Univ Missouri, Div Biol Sci, Columbia, MO 65211 USA	University of Missouri System; University of Missouri Columbia	Peterman, WE (corresponding author), Univ Missouri, Div Biol Sci, Columbia, MO 65211 USA.	bill.peterman@gmail.com	Peterman, William/H-7809-2013	Peterman, William/0000-0001-5229-9268; Semlitsch, Raymond/0000-0002-7999-5762	University of Missouri Research Board [CB000402]; Trans World Airline Scholarship; DoD Strategic Environmental Research and Development Program [RC2155]	University of Missouri Research Board; Trans World Airline Scholarship; DoD Strategic Environmental Research and Development Program	Support was provided by the University of Missouri Research Board (number CB000402), Trans World Airline Scholarship, and DoD Strategic Environmental Research and Development Program (http://www.serdp.org/; grant RC2155). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Funding from these sources does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	ADOLPH SC, 1990, ECOLOGY, V71, P315, DOI 10.2307/1940271; Albrecht MA, 2009, J ECOL, V97, P1037, DOI 10.1111/j.1365-2745.2009.01527.x; ANDREWARTHA HG, 1954, DISTRIBUTION ABUNDAN; [Anonymous], 2010, SALAMANDERS US CANAD; Antvogel H, 2001, ECOGRAPHY, V24, P470, DOI 10.1034/j.1600-0587.2001.d01-203.x; Bailey LL, 2004, J HERPETOL, V38, P370, DOI 10.1670/194-03A; Bailey LL, 2004, ECOL APPL, V14, P692, DOI 10.1890/03-5012; BARRY RG, 1992, MT RES DEV, V12, P71, DOI 10.2307/3673749; BAUR B, 1995, ECOGRAPHY, V18, P123, DOI 10.1111/j.1600-0587.1995.tb00332.x; Bennie J, 2008, ECOL MODEL, V216, P47, DOI 10.1016/j.ecolmodel.2008.04.010; BOBKA MS, 1981, COPEIA, P417; Brown JH, 2004, ECOLOGY, V85, P1771, DOI 10.1890/03-9000; BROWN JH, 1984, AM NAT, V124, P255, DOI 10.1086/284267; Cabe PR, 2007, HEREDITY, V98, P53, DOI 10.1038/sj.hdy.6800905; Chapman SS, 2002, ECOREGIONS IOWA MISS; Chen JQ, 1999, BIOSCIENCE, V49, P288, DOI 10.2307/1313612; Cushman Samuel A., 2013, Diversity-Basel, V5, P51; Daniel RE, 2012, ATLAS MISSOURI AMPHI; Deng YX, 2007, REMOTE SENS ENVIRON, V111, P122, DOI 10.1016/j.rse.2007.03.016; Dodd CK, 2004, HERPETOLOGICA, V60, P468, DOI 10.1655/03-60; Elith J, 2009, ANNU REV ECOL EVOL S, V40, P677, DOI 10.1146/annurev.ecolsys.110308.120159; FEDER ME, 1985, BIOL REV, V60, P1, DOI 10.1111/j.1469-185X.1985.tb00416.x; FEDER ME, 1983, HERPETOLOGICA, V39, P291; FRASER DF, 1976, ECOLOGY, V57, P459, DOI 10.2307/1936431; Fridley JD, 2009, J APPL METEOROL CLIM, V48, P1033, DOI 10.1175/2008JAMC2084.1; Gelman A, 1996, STAT SINICA, V6, P733; Gelman A., 2004, BAYESIAN DATA ANAL; Gifford ME, 2012, ECOGRAPHY, V35, P193, DOI 10.1111/j.1600-0587.2011.06866.x; Gillette Jennifer R., 2001, Herpetological Review, V32, P233; Graae BJ, 2011, OECOLOGIA, V166, P565, DOI 10.1007/s00442-010-1878-8; Grover MC, 1998, J HERPETOL, V32, P489, DOI 10.2307/1565202; Hairston N. G., 1987, COMMUNITY ECOLOGY SA; HALL CAS, 1992, OIKOS, V65, P377, DOI 10.2307/3545553; HARRISON S, 1994, OECOLOGIA, V99, P27, DOI 10.1007/BF00317080; HEATWOLE H, 1962, ECOLOGY, V43, P460, DOI 10.2307/1933374; Highton R, 1989, GEOGRAPHIC PROTEIN V, P1; Hutchinson TF, 1999, PLANT ECOL, V144, P177, DOI 10.1023/A:1009804020976; Hyde EJ, 2001, J WILDLIFE MANAGE, V65, P624, DOI 10.2307/3803013; Ihaka R., 1996, J COMPUT GRAPH STAT, V5, P299, DOI [DOI 10.1080/10618600.1996.10474713, 10.2307/1390807]; Indermaur L, 2009, AM NAT, V173, P60, DOI 10.1086/593355; Jenness J., 2006, TOPOGRAPHIC POSITION; Jorgensen CB, 1997, BIOL REV, V72, P153, DOI 10.1017/S0006323196004963; Kappes H, 2005, J MOLLUS STUD, V71, P85, DOI 10.1093/mollus/eyi011; KEEN WH, 1979, J HERPETOL, V13, P461, DOI 10.2307/1563483; KEEN WH, 1984, COPEIA, P684; Kery M, 2012, BAYESIAN POPULATION ANALYSIS USING WINBUGS: A HIERARCHICAL PERSPECTIVE, P1; Kery M, 2008, COMMUNITY ECOL, V9, P207, DOI 10.1556/ComEc.9.2008.2.10; Kery M., 2010, INTRO WINBUGS ECOLOG; Kery M, 2010, J ANIM ECOL, V79, P453, DOI 10.1111/j.1365-2656.2009.01632.x; Kery M, 2009, J APPL ECOL, V46, P1163, DOI 10.1111/j.1365-2664.2009.01724.x; Kery M, 2009, ENVIRON ECOL STAT SE, V3, P639, DOI 10.1007/978-0-387-78151-8_28; KLEEBERGER SR, 1982, COPEIA, P409, DOI 10.2307/1444622; Liebgold EB, 2011, MOL ECOL, V20, P249, DOI 10.1111/j.1365-294X.2010.04946.x; Lloyd P, 1998, AUK, V115, P404; Lookingbill T, 2004, LANDSCAPE ECOL, V19, P417, DOI 10.1023/B:LAND.0000030451.29571.8b; Lookingbill TR, 2003, AGR FOREST METEOROL, V114, P141, DOI 10.1016/S0168-1923(02)00196-X; Mackenzie DI, 2009, ECOLOGY, V90, P823, DOI 10.1890/08-0141.1; MacKenzie DI, 2005, AUST NZ J STAT, V47, P65, DOI 10.1111/j.1467-842X.2005.00372.x; MacKenzie DI, 2002, ECOLOGY, V83, P2248, DOI 10.1890/0012-9658(2002)083[2248:ESORWD]2.0.CO;2; Marsh DM, 2008, CONSERV GENET, V9, P603, DOI 10.1007/s10592-007-9377-0; MENGE BA, 1987, AM NAT, V130, P730, DOI 10.1086/284741; Oliver T, 2010, ECOL LETT, V13, P473, DOI 10.1111/j.1461-0248.2010.01441.x; Pabijan M, 2012, J EVOLUTION BIOL, V25, P2310, DOI 10.1111/j.1420-9101.2012.02613.x; Pattison RR, 2009, OECOLOGIA, V158, P591, DOI 10.1007/s00442-008-1187-7; Pellet J, 2005, BIOL CONSERV, V123, P27, DOI 10.1016/j.biocon.2004.10.005; PETRANKA JW, 1993, CONSERV BIOL, V7, P363, DOI 10.1046/j.1523-1739.1993.07020363.x; Pierce KB, 2005, LANDSCAPE ECOL, V20, P137, DOI 10.1007/s10980-004-1296-6; Royle J. A., 2004, Animal Biodiversity and Conservation, V27, P375; Royle J.A., 2008, HEIRARCHICAL MODELIN; Royle JA, 2007, ECOL MONOGR, V77, P465, DOI 10.1890/06-0912.1; Royle JA, 2004, BIOMETRICS, V60, P108, DOI 10.1111/j.0006-341X.2004.00142.x; Scherrer D, 2011, J BIOGEOGR, V38, P406, DOI 10.1111/j.1365-2699.2010.02407.x; Semlitsch RD, 2008, ECOL APPL, V18, P283, DOI 10.1890/07-0853.1; SEMLITSCH RD, 1980, HERPETOLOGICA, V36, P6; Spiegelhalter D., 2003, WINBUGS USER MANUAL; SPOTILA JR, 1972, ECOL MONOGR, V42, P95, DOI 10.2307/1942232; SPOTILA JR, 1976, COMP BIOCHEM PHYS A, V55, P407, DOI 10.1016/0300-9629(76)90069-4; Sturtz S, 2005, J STAT SOFTW, V12, P1, DOI 10.18637/jss.v012.i03; Suggitt AJ, 2011, OIKOS, V120, P1, DOI 10.1111/j.1600-0706.2010.18270.x; Theobold D.M., 2007, LCAP V 1 0 LANDSCAPE; TRACY CR, 1976, ECOL MONOGR, V46, P293, DOI 10.2307/1942256; Trauth S.E., 2004, AMPHIBIANS REPTILES; TUCKER CJ, 1979, REMOTE SENS ENVIRON, V8, P127, DOI 10.1016/0034-4257(79)90013-0; Tyre AJ, 2003, ECOL APPL, V13, P1790, DOI 10.1890/02-5078; Wachob DG, 1996, CONDOR, V98, P114, DOI 10.2307/1369514; WEISS SB, 1988, ECOLOGY, V69, P1486, DOI 10.2307/1941646; WHITTAKER RH, 1956, ECOL MONOGR, V26, P1, DOI 10.2307/1943577	87	82	83	0	71	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2013	8	5							e62184	10.1371/journal.pone.0062184	http://dx.doi.org/10.1371/journal.pone.0062184			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	177QL	23671586	Green Published, Green Submitted, gold			2022-12-27	WOS:000321390200015
J	Walsh, AD; Bimber, BN; Das, A; Piaskowski, SM; Rakasz, EG; Bean, AT; Mudd, PA; Ericsen, AJ; Wilson, NA; Hughes, AL; O'Connor, DH; Maness, NJ				Walsh, Andrew D.; Bimber, Benjamin N.; Das, Arpita; Piaskowski, Shari M.; Rakasz, Eva G.; Bean, Alexander T.; Mudd, Philip A.; Ericsen, Adam J.; Wilson, Nancy A.; Hughes, Austin L.; O'Connor, David H.; Maness, Nicholas J.			Acute Phase CD8+T Lymphocytes against Alternate Reading Frame Epitopes Select for Rapid Viral Escape during SIV Infection	PLOS ONE			English	Article							SIMIAN IMMUNODEFICIENCY VIRUS; T-CELL RESPONSES; CRYPTIC EPITOPES; RHESUS MACAQUES; IN-VIVO; AIDS; REPLICATION; SIVMAC239; MUTATIONS; SUBSTITUTIONS	CD8+ T Lymphocytes (CTL) can control AIDS virus replication. However, natural selection favoring viral variants that escape CTL recognition is a common feature of both simian immunodeficiency virus (SIV) infection of macaques and HIV infection of humans. Emerging data indicate that CTL directed against alternate reading frame (ARF)-derived epitopes (a.k.a. cryptic epitopes) are important components of the total virus-specific response in SIV and HIV infection but the contributions of these responses during the critical first several weeks of infection have not been determined. We used a focused deep sequencing approach to examine acute phase viral evolution in response to CTL targeting two polypeptides encoded by ARFs of SIVmac239 in SIV-infected rhesus macaques. We report high magnitude CTL responses as early as three weeks post-infection against epitopes within both ARFs, which both overlap the 5' end of the env gene. Further, mutations accumulated in the epitopes by three to four weeks post infection consistent with viral escape. Interestingly, these mutations largely maintained the primary amino acid sequence of the overlapping Envelope protein. Our data show that high frequency CTL target cryptic epitopes and exert selective pressure on SIV during the acute phase, underscoring the importance of these unique immune responses.	[Walsh, Andrew D.; Bean, Alexander T.; Mudd, Philip A.; Ericsen, Adam J.; Wilson, Nancy A.; O'Connor, David H.] Univ Wisconsin, Dept Pathol & Lab Med, Madison, WI USA; [Bimber, Benjamin N.] Oregon Hlth & Sci Univ, Oregon Natl Primate Res Ctr, Beaverton, OR USA; [Das, Arpita; Maness, Nicholas J.] Tulane Natl Primate Res Ctr, Div Microbiol, Covington, LA USA; [Piaskowski, Shari M.; Rakasz, Eva G.; O'Connor, David H.] Univ Wisconsin, Wisconsin Natl Primate Res Ctr, Madison, WI USA; [Mudd, Philip A.] Univ Wisconsin, Med Scientist Training Program, Madison, WI USA; [Hughes, Austin L.] Univ S Carolina, Dept Biol Sci, Columbia, SC 29208 USA; [Maness, Nicholas J.] Tulane Univ, Sch Med, Dept Microbiol & Immunol, New Orleans, LA 70112 USA	University of Wisconsin System; University of Wisconsin Madison; Oregon Health & Science University; Oregon National Primate Research Center; Tulane University; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of South Carolina; University of South Carolina System; University of South Carolina Columbia; Tulane University	Maness, NJ (corresponding author), Tulane Natl Primate Res Ctr, Div Microbiol, Covington, LA USA.	nmaness@tulane.edu	Rakasz, Eva G/H-9197-2019; Ericsen, Adam/AAW-1187-2020	Ericsen, Adam/0000-0003-4176-8270; Mudd, Philip/0000-0002-3860-5473; Bimber, Benjamin/0000-0001-8092-3080; o'connor, david/0000-0003-2139-470X	Foundation for AIDS Research (amfAR) [108340-51-RKVA]; National Center for Research Resources (NCRR), a component of the National Institutes of Health (NIH) [P51 RR000167]; NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR000167] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI078985] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008692] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011106] Funding Source: NIH RePORTER	Foundation for AIDS Research (amfAR); National Center for Research Resources (NCRR), a component of the National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was funded in part by a grant from the Foundation for AIDS Research (amfAR) to NJM: 108340-51-RKVA. This work was also made possible in part by grant number P51 RR000167 from the National Center for Research Resources (NCRR), a component of the National Institutes of Health (NIH), to the Wisconsin National Primate Research Center, University of Wisconsin-Madison. This publication's contents are solely the responsibility of the authors and do not necessarily represent the official views of the NCRR or NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen TM, 2005, J VIROL, V79, P13239, DOI 10.1128/JVI.79.21.13239-13249.2005; Bansal A, 2010, J EXP MED, V207, P51, DOI 10.1084/jem.20092060; Becker EA, 2012, GENOME BIOL EVOL, V4, P457, DOI 10.1093/gbe/evs029; Berger CT, 2010, J EXP MED, V207, P61, DOI 10.1084/jem.20091808; Bimber BN, 2010, J VIROL, V84, P12087, DOI 10.1128/JVI.01378-10; Bimber BN, 2009, J VIROL, V83, P8247, DOI 10.1128/JVI.00897-09; Burwitz BJ, 2011, J VIROL, V85, P13088, DOI 10.1128/JVI.05650-11; Cardinaud S, 2004, J EXP MED, V199, P1053, DOI 10.1084/jem.20031869; Cardinaud S, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002049; Carrington M, 2003, ANNU REV MED, V54, P535, DOI 10.1146/annurev.med.54.101601.152346; Champiat S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039311; Cline AN, 2005, J MED PRIMATOL, V34, P303; Fischer W, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012303; Friedrich TC, 2004, NAT MED, V10, P275, DOI 10.1038/nm998; Friedrich TC, 2004, J VIROL, V78, P2581, DOI 10.1128/JVI.78.5.2581-2585.2004; Friedrich TC, 2007, J VIROL, V81, P3465, DOI 10.1128/JVI.02392-06; Garrison KE, 2009, CLIN VACCINE IMMUNOL, V16, P1369, DOI 10.1128/CVI.00410-08; Goonetilleke N, 2009, J EXP MED; Goulder PJR, 1997, NAT MED, V3, P212, DOI 10.1038/nm0297-212; Henn MR, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002529; Ho O, 2006, J IMMUNOL, V176, P2470, DOI 10.4049/jimmunol.176.4.2470; Kelleher AD, 2001, J EXP MED, V193, P375, DOI 10.1084/jem.193.3.375; LAHM HW, 1985, J CHROMATOGR, V326, P357, DOI 10.1016/S0021-9673(01)87461-6; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Loffredo JT, 2007, J VIROL, V81, P8827, DOI 10.1128/JVI.00895-07; Maness NJ, 2007, J EXP MED, V204, P2505, DOI 10.1084/jem.20071261; Maness NJ, 2010, J VIROL, V84, P11569, DOI 10.1128/JVI.01419-10; Maness NJ, 2009, J VIROL, V83, P10280, DOI 10.1128/JVI.00138-09; Matano T, 1998, J VIROL, V72, P164, DOI 10.1128/JVI.72.1.164-169.1998; Migueles SA, 2000, P NATL ACAD SCI USA, V97, P2709, DOI 10.1073/pnas.050567397; Moreland AJ, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-295; Mudd PA, 2011, J VIROL, V85, P12804, DOI 10.1128/JVI.05841-11; NEI M, 1986, MOL BIOL EVOL, V3, P418; Nelson EK, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-71; O'Connor DH, 2002, NAT MED, V8, P493, DOI 10.1038/nm0502-493; O'Connor DH, 2004, J VIROL, V78, P14012, DOI 10.1128/JVI.78.24.14012-14022.2004; Schmitz JE, 1999, SCIENCE, V283, P857, DOI 10.1126/science.283.5403.857; Stajich JE, 2002, GENOME RES, V12, P1611, DOI 10.1101/gr.361602; Starck SR, 2011, CELL MOL LIFE SCI, V68, P1471, DOI 10.1007/s00018-011-0655-0; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Wilson NA, 2006, J VIROL, V80, P5875, DOI 10.1128/JVI.00171-06; Yant LJ, 2006, J VIROL, V80, P5074, DOI 10.1128/JVI.80.10.5074-5077.2006	43	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2013	8	5							e61383	10.1371/journal.pone.0061383	http://dx.doi.org/10.1371/journal.pone.0061383			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	177QL	23671565	Green Published, gold, Green Submitted			2022-12-27	WOS:000321390200005
J	Cao, M; Wang, P; Sun, CH; He, W; Wang, FJ				Cao, Min; Wang, Pei; Sun, Chunhong; He, Wen; Wang, Fengjun			Amelioration of IFN-gamma and TNF-alpha-Induced Intestinal Epithelial Barrier Dysfunction by Berberine via Suppression of MLCK-MLC Phosphorylation Signaling Pathway	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; TIGHT JUNCTION PERMEABILITY; INTERFERON-GAMMA; INFLAMMATORY RESPONSES; INDUCED INCREASE; IN-VITRO; KINASE; EXPRESSION; HIF-1-ALPHA; COLITIS	Intestinal barrier dysfunction occurs in many intestinal diseases, in which proinflammatory cytokines play critical roles. However, researchers are still on the way to defining the underlying mechanisms and to evaluate therapeutic strategies for restoring intestinal barrier function. Berberine, a drug that has clinically been used to treat gastroenteritis and diarrhea for thousands of years, has been shown to protect barrier function in both endothelial and epithelial cells, but the mechanisms are completely unknown. In this study, we investigate the protective actions of berberine on barrier function and the underlying mechanisms in Caco-2 monolayers challenged with IFN-gamma and TNF-alpha. Caco-2 monolayers were treated without or with simultaneous IFN-gamma and TNF-alpha in the absence or presence of berberine. Both transepithelial electrical resistance (TER) and paracellular permeability were measured to evaluate barrier function. The expression and distribution of tight junction proteins ZO-1, occluding, and claudin-1 were respectively analyzed by immunoblot or immunofluorescence. The expressions of phosphorylated myosin light chain (pMLC), MLC kinase (MLCK) and hypoxia-inducible factor-1 alpha (HIF-1 alpha) were determined by immunoblot. The translocation of NF-kappa B p65 to nuclei was analyzed by immunofluorescence and immunoblot, respectively. The results showed that berberine significantly attenuated TER decrease and paracellular permeability increase in Caco-2 monolayers treated with IFN-gamma and TNF-alpha. Berberine also dramatically alleviated IFN-gamma and TNF-alpha-induced morphological alteration of tight junction proteins ZO-1, occluding, and claudin-1. The increase of both MLC phosphorylation and MLCK protein expression induced by IFN-gamma and TNF-alpha was significantly inhibited by berberine treatment. Additionally, berberine suppressed the activation of HIF-1 alpha, but not NF-kappa B. Taken together, it is suggested that berberine attenuates IFN-gamma and TNF-alpha-induced intestinal epithelial barrier dysfunction by inhibiting the signaling pathway of MLCK-dependent MLC phosphorylation mediated by HIF-1 alpha.	[Cao, Min; Wang, Pei; Sun, Chunhong; He, Wen; Wang, Fengjun] Third Mil Med Univ, Southwest Hosp, Inst Burn Res, State Key Lab Trauma Burns & Combined Injury, Chongqing, Peoples R China	Army Medical University	Wang, FJ (corresponding author), Third Mil Med Univ, Southwest Hosp, Inst Burn Res, State Key Lab Trauma Burns & Combined Injury, Chongqing, Peoples R China.	wangfj@tmmu.edu.cn	Wang, Fengjun/A-4114-2009		National Natural Science Foundation of China [81070290]; State Key Laboratory of Trauma, Burns and Combined Injury [SKLZZ200818]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); State Key Laboratory of Trauma, Burns and Combined Injury	This work was supported by the National Natural Science Foundation of China (81070290), and the project from State Key Laboratory of Trauma, Burns and Combined Injury (SKLZZ200818). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Sadi R, 2008, J IMMUNOL, V180, P5653, DOI 10.4049/jimmunol.180.8.5653; Amasheh M, 2010, J CELL SCI, V123, P4145, DOI 10.1242/jcs.070896; Amasheh M, 2009, SCAND J GASTROENTERO, V44, P1226, DOI 10.1080/00365520903131973; Beaurepaire C, 2009, J INTERF CYTOK RES, V29, P133, DOI 10.1089/jir.2008.0057; Boberek JM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013745; Chen CL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034946; Clayburgh DR, 2004, LAB INVEST, V84, P282, DOI 10.1038/labinvest.3700050; Cramer T, 2003, CELL, V112, P645, DOI 10.1016/S0092-8674(03)00154-5; Cui HS, 2007, JPN J OPHTHALMOL, V51, P64, DOI 10.1007/s10384-006-0395-0; Enk R, 2007, J ETHNOPHARMACOL, V109, P170, DOI 10.1016/j.jep.2006.07.013; Feinman R, 2010, AM J PHYSIOL-GASTR L, V299, pG833, DOI 10.1152/ajpgi.00065.2010; Frede S, 2007, METHOD ENZYMOL, V435, P405, DOI 10.1016/S0076-6879(07)35021-0; Graham WV, 2006, J BIOL CHEM, V281, P26205, DOI 10.1074/jbc.M602164200; Gu LL, 2011, J INFECT DIS, V203, P1602, DOI 10.1093/infdis/jir147; Gu LL, 2009, FITOTERAPIA, V80, P241, DOI 10.1016/j.fitote.2009.02.005; Hamsa TP, 2012, DRUG CHEM TOXICOL, V35, P57, DOI 10.3109/01480545.2011.589437; Hong T, 2012, IMMUNOPHARM IMMUNOT, V34, P391, DOI 10.3109/08923973.2011.609887; Irvine EJ, 2000, GASTROENTEROLOGY, V119, P1740, DOI 10.1053/gast.2000.20231; Kannan KB, 2011, AM J PHYSIOL-GASTR L, V300, pG853, DOI 10.1152/ajpgi.00459.2010; Kuo CL, 2004, CANCER LETT, V203, P127, DOI 10.1016/j.canlet.2003.09.002; Lee IA, 2010, EUR J PHARMACOL, V648, P162, DOI 10.1016/j.ejphar.2010.08.046; Li QR, 2008, CLIN IMMUNOL, V126, P67, DOI 10.1016/j.clim.2007.08.017; Lin SK, 2004, MOL PHARMACOL, V66, P612; Liu H, 2012, CELL PHYSIOL BIOCHEM, V29, P799, DOI 10.1159/000188076; Liu H, 2011, CYTOKINE, V56, P581, DOI 10.1016/j.cyto.2011.08.023; Ma TY, 2005, AM J PHYSIOL-GASTR L, V288, pG422, DOI 10.1152/ajpgi.00412.2004; Ma TY, 2004, AM J PHYSIOL-GASTR L, V286, pG367, DOI 10.1152/ajpgi.00173.2003; Ma XM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013489; Martinez C, 2012, GUT LIVER, V6, P305, DOI 10.5009/gnl.2012.6.3.305; McGuckin MA, 2009, INFLAMM BOWEL DIS, V15, P100, DOI 10.1002/ibd.20539; Ning L, 2010, EUR J PHARM SCI, V40, P1, DOI 10.1016/j.ejps.2010.02.001; Park J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031512; Qi HB, 2011, CELL PHYSIOL BIOCHEM, V27, P251, DOI 10.1159/000327951; Rosen MJ, 2011, INFLAMM BOWEL DIS, V17, P2224, DOI 10.1002/ibd.21628; Rosenberger P, 2007, FASEB J, V21, P2613, DOI 10.1096/fj.06-8004com; Saha P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018467; Salim SY, 2011, INFLAMM BOWEL DIS, V17, P362, DOI 10.1002/ibd.21403; Scharte M, 2003, AM J PHYSIOL-GASTR L, V284, pG373, DOI 10.1152/ajpgi.00076.2002; Schwarz BT, 2007, GASTROENTEROLOGY, V132, P2383, DOI 10.1053/j.gastro.2007.02.052; Shen L, 2011, ANNU REV PHYSIOL, V73, P283, DOI 10.1146/annurev-physiol-012110-142150; Su LP, 2009, GASTROENTEROLOGY, V136, P551, DOI 10.1053/j.gastro.2008.10.081; Sumbayev VV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034259; Suzuki T, 2013, CELL MOL LIFE SCI, V70, P631, DOI 10.1007/s00018-012-1070-x; Suzuki T, 2011, J BIOL CHEM, V286, P31263, DOI 10.1074/jbc.M111.238147; Tan Wen, 2011, Int J Nanomedicine, V6, P1773, DOI 10.2147/IJN.S22683; Turner JR, 2009, NAT REV IMMUNOL, V9, P799, DOI 10.1038/nri2653; Wang FJ, 2006, GASTROENTEROLOGY, V131, P1153, DOI 10.1053/j.gastro.2006.08.022; Wang FJ, 2005, AM J PATHOL, V166, P409, DOI 10.1016/S0002-9440(10)62264-X; Weber CR, 2012, ANN NY ACAD SCI, V1257, P77, DOI 10.1111/j.1749-6632.2012.06528.x; Weber CR, 2010, J BIOL CHEM, V285, P12037, DOI 10.1074/jbc.M109.064808; WYATT J, 1993, LANCET, V341, P1437, DOI 10.1016/0140-6736(93)90882-H; Yan F, 2012, AM J PHYSIOL-GASTR L, V302, pG504, DOI 10.1152/ajpgi.00312.2011; Yan JQ, 2012, CELL MOL LIFE SCI, V69, P115, DOI 10.1007/s00018-011-0731-5; Ye D, 2008, J CELL MOL MED, V12, P1331, DOI 10.1111/j.1582-4934.2008.00302.x; Yeh WL, 2007, MOL PHARMACOL, V72, P440, DOI 10.1124/mol.107.036418; Zhou HY, 2000, J PHARMACOL EXP THER, V294, P822	56	156	173	3	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2013	8	5							e61944	10.1371/journal.pone.0061944	http://dx.doi.org/10.1371/journal.pone.0061944			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175AS	23671580	Green Submitted, gold, Green Published			2022-12-27	WOS:000321202100003
J	Pillow, JW; Shlens, J; Chichilnisky, EJ; Simoncelli, EP				Pillow, Jonathan W.; Shlens, Jonathon; Chichilnisky, E. J.; Simoncelli, Eero P.			A Model-Based Spike Sorting Algorithm for Removing Correlation Artifacts in Multi-Neuron Recordings	PLOS ONE			English	Article							CHAIN MONTE-CARLO; FIRING PATTERNS; CLASSIFICATION; IDENTIFICATION; SEPARATION; TETRODES	We examine the problem of estimating the spike trains of multiple neurons from voltage traces recorded on one or more extracellular electrodes. Traditional spike-sorting methods rely on thresholding or clustering of recorded signals to identify spikes. While these methods can detect a large fraction of the spikes from a recording, they generally fail to identify synchronous or near-synchronous spikes: cases in which multiple spikes overlap. Here we investigate the geometry of failures in traditional sorting algorithms, and document the prevalence of such errors in multi-electrode recordings from primate retina. We then develop a method for multi-neuron spike sorting using a model that explicitly accounts for the superposition of spike waveforms. We model the recorded voltage traces as a linear combination of spike waveforms plus a stochastic background component of correlated Gaussian noise. Combining this measurement model with a Bernoulli prior over binary spike trains yields a posterior distribution for spikes given the recorded data. We introduce a greedy algorithm to maximize this posterior that we call "binary pursuit". The algorithm allows modest variability in spike waveforms and recovers spike times with higher precision than the voltage sampling rate. This method substantially corrects cross-correlation artifacts that arise with conventional methods, and substantially outperforms clustering methods on both real and simulated data. Finally, we develop diagnostic tools that can be used to assess errors in spike sorting in the absence of ground truth.	[Pillow, Jonathan W.] Univ Texas Austin, Dept Psychol, Ctr Perceptual Syst, Austin, TX 78712 USA; [Pillow, Jonathan W.] Univ Texas Austin, Neurobiol Sect, Austin, TX 78712 USA; [Shlens, Jonathon; Chichilnisky, E. J.] Salk Inst Biol Studies, La Jolla, CA USA; [Simoncelli, Eero P.] NYU, Howard Hughes Med Inst, New York, NY USA; [Simoncelli, Eero P.] NYU, Ctr Neural Sci, New York, NY 10003 USA; [Simoncelli, Eero P.] NYU, Courant Inst, New York, NY USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; Salk Institute; Howard Hughes Medical Institute; New York University; New York University; New York University	Pillow, JW (corresponding author), Univ Texas Austin, Dept Psychol, Ctr Perceptual Syst, Austin, TX 78712 USA.	pillow@mail.utexas.edu		Pillow, Jonathan/0000-0002-3638-8831; Simoncelli, Eero/0000-0002-1206-527X; Chichilnisky, E.J./0000-0002-5613-0248	Royal Society Society USA/Canada Research Fellowship; Center for Perceptual Systems; Sloan Research Fellowship; Miller Institute for Basic Research in Science; National Eye Institute (NEI) [EY018003]; National Institutes of Health (NIH) [EY017736]; Howard Hughes Medical Institute; NATIONAL EYE INSTITUTE [R01EY018003, R01EY017736] Funding Source: NIH RePORTER	Royal Society Society USA/Canada Research Fellowship; Center for Perceptual Systems; Sloan Research Fellowship(Alfred P. Sloan Foundation); Miller Institute for Basic Research in Science; National Eye Institute (NEI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by: Royal Society Society USA/Canada Research Fellowship (JWP) (http://royalsociety.org/grants/); Center for Perceptual Systems, startup funding (JP) (http://www.utexas.edu/cola/centers/cps/); Sloan Research Fellowship (JWP) (http://www.sloan.org/); Miller Institute for Basic Research in Science (JS) (http://millerinstitute.berkeley.edu/); National Eye Institute (NEI) grant EY018003 (EJC, EPS); National Institutes of Health (NIH) Grant EY017736 (EJC); and Howard Hughes Medical Institute (EPS) (http://www.hhmi.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, P ADV NEURAL PROCESS; Bar-Gad I, 2001, J NEUROSCI METH, V107, P1, DOI 10.1016/S0165-0270(01)00339-9; Blanche TJ, 2005, J NEUROPHYSIOL, V93, P2987, DOI 10.1152/jn.01023.2004; Brown EN, 2004, NAT NEUROSCI, V7, P456, DOI 10.1038/nn1228; Calabrese A, 2010, J NEUROSCIENCE METHO; Calabrese A, 2011, J NEUROSCI METH, V196, P159, DOI 10.1016/j.jneumeth.2010.12.002; Delescluse M, 2006, J NEUROSCI METH, V150, P16, DOI 10.1016/j.jneumeth.2005.05.023; DeVries SH, 1999, J NEUROPHYSIOL, V81, P908, DOI 10.1152/jn.1999.81.2.908; Field GD, 2007, ANNU REV NEUROSCI, V30, P1, DOI 10.1146/annurev.neuro.30.051606.094252; Gasthaus J, 2009, ADV NEURAL INFORM PR, P497; Ge D, 2011, IEEE T NEUR SYS REH, V19, P249, DOI 10.1109/TNSRE.2011.2112780; Gelman A., 2004, BAYESIAN DATA ANAL; GERSTEIN GL, 1964, SCIENCE, V143, P1325, DOI 10.1126/science.143.3612.1325; Gerwinn S, 2010, FRONTIERS COMPUTATIO; Gray CM, 1995, J NEUROSCI METH, V63, P43, DOI 10.1016/0165-0270(95)00085-2; Green D. M., 1974, SIGNAL DETECTION THE; Green DM, 1966, SIGNAL DETECTION THE; Greschner M, 2011, J PHYSIOL-LONDON, V589, P75, DOI 10.1113/jphysiol.2010.193888; Harris KD, 2000, J NEUROPHYSIOL, V84, P401, DOI 10.1152/jn.2000.84.1.401; Hastie T., 2009, UNSUPERVISED LEARNIN; Herbst JA, 2008, J NEUROSCI METH, V174, P126, DOI 10.1016/j.jneumeth.2008.06.011; Johnston D, 1994, FDN CELLULAR NEUROPH; Kohavi J., 1994, P 11 INT C MACH LEAR, P121, DOI [DOI 10.1016/B978-1-55860-335-6.50023-4, 10.1016/B978-1-55860-335-6.50023-4]; Lewicki MS, 1998, NETWORK-COMP NEURAL, V9, pR53, DOI 10.1088/0954-898X/9/4/001; LEWICKI MS, 1994, NEURAL COMPUT, V6, P1005, DOI 10.1162/neco.1994.6.5.1005; Litke AM, 2004, IEEE T NUCL SCI, V51, P1434, DOI 10.1109/TNS.2004.832706; Luczak A, 2005, J NEUROSCI METH, V144, P53, DOI 10.1016/j.jneumeth.2004.10.009; MACKAY DJC, 1992, NEURAL COMPUT, V4, P590, DOI 10.1162/neco.1992.4.4.590; Marre O, 2012, J NEUROSCI, V32, P14859, DOI 10.1523/JNEUROSCI.0723-12.2012; MASTRONARDE DN, 1989, TRENDS NEUROSCI, V12, P75, DOI 10.1016/0166-2236(89)90140-9; McGill KC, 2002, IEEE T BIO-MED ENG, V49, P640, DOI 10.1109/TBME.2002.1010847; MEISTER M, 1994, J NEUROSCI METH, V51, P95, DOI 10.1016/0165-0270(94)90030-2; Nguyen DP, 2003, NETWORK-COMP NEURAL, V14, P61, DOI 10.1088/0954-898X/14/1/304; Obeid I, 2004, IEEE T BIO-MED ENG, V51, P905, DOI 10.1109/TBME.2004.826683; Pazienti A, 2006, J COMPUT NEUROSCI, V21, P329, DOI 10.1007/s10827-006-8899-7; Petrusca D, 2007, J NEUROSCI, V27, P11019, DOI 10.1523/JNEUROSCI.2836-07.2007; Pillow JW, 2008, NATURE, V454, P995, DOI 10.1038/nature07140; Plexon, 2006, PLEX US GUID VERS 2; Pouzat C, 2004, J NEUROPHYSIOL, V91, P2910, DOI 10.1152/jn.00227.2003; Pouzat C, 2002, J NEUROSCI METH, V122, P43, DOI 10.1016/S0165-0270(02)00276-5; Prentice JS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019884; Quiroga Quian Rodrigo, 2004, NEURAL COMPUTATION; Rebrik SP, 1999, NEUROCOMPUTING, V26-7, P1033, DOI 10.1016/S0925-2312(99)00101-0; RODIECK RW, 1967, J NEUROPHYSIOL, V30, P1043, DOI 10.1152/jn.1967.30.5.1043; Rutishauser U, 2006, J NEUROSCI METH, V154, P204, DOI 10.1016/j.jneumeth.2005.12.033; Sahani Bickel, 2006, THESIS UCL; Sahani M, 1999, THESIS CAL TECH; Sahani M, 1998, ADV NEURAL INFORM PR, V10; SCHMIDT EM, 1984, J NEUROSCI METH, V12, P95, DOI 10.1016/0165-0270(84)90009-8; Schnitzer MJ, 2003, NEURON, V37, P499, DOI 10.1016/S0896-6273(03)00004-7; Segev R, 2004, NAT NEUROSCI, V7, P1155, DOI 10.1038/nn1323; Shlens J, 2006, J NEUROSCI, V26, P8254, DOI 10.1523/JNEUROSCI.1282-06.2006; Shlens J, 2009, J NEUROSCI, V29, P5022, DOI 10.1523/JNEUROSCI.5187-08.2009; Shlens J, 2008, CURR OPIN NEUROBIOL, V18, P396, DOI 10.1016/j.conb.2008.09.010; Shoham S, 2003, J NEUROSCI METH, V127, P111, DOI 10.1016/S0165-0270(03)00120-1; Stevenson IH, 2009, IEEE T NEUR SYS REH, V17, P203, DOI 10.1109/TNSRE.2008.2010471; Takahashi S, 2003, J NEUROPHYSIOL, V89, P2245, DOI 10.1152/jn.00827.2002; Takekawa T, 2010, EUR J NEUROSCI, V31, P263, DOI 10.1111/j.1460-9568.2009.07068.x; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Trong PK, 2008, NAT NEUROSCI, V11, P1343, DOI 10.1038/nn.2199; TURIN GL, 1960, IRE T INFORM THEOR, V6, P311, DOI 10.1109/TIT.1960.1057571; Ventura V, 2009, NEURAL COMPUT, V21, P2466, DOI 10.1162/neco.2009.12-07-669; Ventura V, 2009, P NATL ACAD SCI USA, V106, P6921, DOI 10.1073/pnas.0901771106; Wood F, 2008, J NEUROSCI METH, V173, P1, DOI 10.1016/j.jneumeth.2008.04.030; Zhang PM, 2004, J NEUROSCI METH, V135, P55, DOI 10.1016/j.jneumeth.2003.12.001	65	79	80	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2013	8	5							e62123	10.1371/journal.pone.0062123	http://dx.doi.org/10.1371/journal.pone.0062123			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175AS	23671583	Green Published, gold, Green Submitted			2022-12-27	WOS:000321202100006
J	Wong, TT; Tesfamichael, A; Collodi, P				Wong, Ten-Tsao; Tesfamichael, Abraham; Collodi, Paul			Production of Zebrafish Offspring from Cultured Female Germline Stem Cells	PLOS ONE			English	Article							LONG-TERM PROLIFERATION; RAINBOW-TROUT; IN-VITRO; GROWTH-FACTORS; SELF-RENEWAL; LINE; EXPRESSION; PIWI; GENES; SPERM	Zebrafish female germline stem cell (FGSC) cultures were generated from a transgenic line of fish that expresses Neo and DsRed under the control of the germ cell specific promoter, ziwi [Tg(ziwi:neo); Tg(ziwi:DsRed)]. Homogeneous FGSC cultures were established by G418 selection and continued to express ziwi for more than 6 weeks along with the germ cell markers nanos3, dnd, dazl and vasa. A key component of the cell culture system was the use of a feeder cell line that was initiated from ovaries of a transgenic line of fish [Tg(gsdf:neo)] that expresses Neo controlled by the zebrafish gonadal soma derived factor (gsdf) promoter. The feeder cell line was selected in G418 and engineered to express zebrafish leukemia inhibitory factor (Lif), basic fibroblast growth factor (Fgf2) and glial-cell-line derived neurotrophic factor (Gdnf). These factors were shown to significantly enhance FGSC growth, survival and germline competency in culture. Results from cell transplantation experiments revealed that the cultured FGSCs were able to successfully colonize the gonad of sterile recipient fish and generate functional gametes. Up to 20% of surviving recipient fish that were injected with the cultured FGSCs were fertile and generated multiple batches of normal offspring for at least 6 months. The FGSC cultures will provide an in vitro system for studies of zebrafish germ cell growth and differentiation and their high frequency of germline transmission following transplantation could form the basis of a stem cell-mediated strategy for gene transfer and manipulation of the zebrafish genome.	[Wong, Ten-Tsao; Tesfamichael, Abraham; Collodi, Paul] Purdue Univ, Dept Anim Sci, W Lafayette, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus	Wong, TT (corresponding author), Purdue Univ, Dept Anim Sci, W Lafayette, IN 47907 USA.	Wong20@purdue.edu	Wong, Ten-Tsao/J-7524-2017	Wong, Ten-Tsao/0000-0001-5573-9767	National Institutes of Health [NIH R01GM069384, R01GM069384-7S1]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069384] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the grants (NIH R01GM069384 and R01GM069384-7S1) from the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Briggs JP, 2002, AM J PHYSIOL-REG I, V282, pR3, DOI 10.1152/ajpregu.00589.2001; Cox DN, 1998, GENE DEV, V12, P3715, DOI 10.1101/gad.12.23.3715; Cox DN, 2000, DEVELOPMENT, V127, P503; Dranow DB, 2013, DEV BIOL IN PRESS; Draper BW, 2007, DEV BIOL, V305, P589, DOI 10.1016/j.ydbio.2007.03.007; Driever W, 1996, DEVELOPMENT, V123, P37; Durcova-Hills G, 2006, STEM CELLS, V24, P1441, DOI 10.1634/stemcells.2005-0424; Eisen JS, 1996, CELL, V87, P969, DOI 10.1016/S0092-8674(00)81792-4; Gautier A, 2011, BIOL REPROD, V85, P1240, DOI 10.1095/biolreprod.111.091892; Haffter P, 1996, DEVELOPMENT, V123, P1; Hofmann MC, 2005, DEV BIOL, V279, P114, DOI 10.1016/j.ydbio.2004.12.006; Hong YH, 2004, P NATL ACAD SCI USA, V101, P8011, DOI 10.1073/pnas.0308668101; Houwing S, 2007, CELL, V129, P69, DOI 10.1016/j.cell.2007.03.026; Kanatsu-Shinohara M, 2003, BIOL REPROD, V69, P612, DOI 10.1095/biolreprod.103.017012; Kanatsu-Shinohara M, 2007, BIOL REPROD, V76, P55, DOI 10.1095/biolreprod.106.055863; Kawakami K, 2005, DEV DYNAM, V234, P244, DOI 10.1002/dvdy.20516; Kawasaki T, 2012, GENES CELLS, V17, P316, DOI 10.1111/j.1365-2443.2012.01589.x; Knaut H, 2000, J CELL BIOL, V149, P875, DOI 10.1083/jcb.149.4.875; Kubota H, 2004, P NATL ACAD SCI USA, V101, P16489, DOI 10.1073/pnas.0407063101; Kurita K, 2004, P NATL ACAD SCI USA, V101, P1263, DOI 10.1073/pnas.0304265101; Leu DH, 2010, DEV DYNAM, V239, P2714, DOI 10.1002/dvdy.22404; MATSUI Y, 1992, CELL, V70, P841, DOI 10.1016/0092-8674(92)90317-6; McMillan DB, 2007, OVARIAN FOLLICLES FI, P67; Meng XJ, 2000, SCIENCE, V287, P1489, DOI 10.1126/science.287.5457.1489; Nakamura S, 2010, SCIENCE, V328, P1561, DOI 10.1126/science.1185473; RESNICK JL, 1992, NATURE, V359, P550, DOI 10.1038/359550a0; Saito T, 2008, BIOL REPROD, V78, P159, DOI 10.1095/biolreprod.107.060038; Sakai N, 2002, DEVELOPMENT, V129, P3359; Sawatari E, 2007, DEV BIOL, V301, P266, DOI 10.1016/j.ydbio.2006.10.001; Shibata Y, 2010, GENE EXPR PATTERNS, V10, P283, DOI 10.1016/j.gep.2010.06.005; Shikina S, 2010, BIOL REPROD, V83, P268, DOI 10.1095/biolreprod.109.082123; Slanchev K, 2005, P NATL ACAD SCI USA, V102, P4074, DOI 10.1073/pnas.0407475102; Tadokoro Y, 2002, MECH DEVELOP, V113, P29, DOI 10.1016/S0925-4773(02)00004-7; Tan CH, 2002, MECH DEVELOP, V119, pS221, DOI 10.1016/S0925-4773(03)00120-5; Villefranc JA, 2007, DEV DYNAM, V236, P3077, DOI 10.1002/dvdy.21354; Westerfield M, 2000, ZEBRAFISH BOOK GUIDE; Wong TT, 2013, BIOCHEM BIOPH RES CO, V430, P347, DOI 10.1016/j.bbrc.2012.11.014; Wong TT, 2011, BIOL REPROD, V84, P1190, DOI 10.1095/biolreprod.110.088427; Wong TT, 2004, ENDOCRINOLOGY, V145, P5210, DOI 10.1210/en.2004-0558; Yomogida K, 2003, BIOL REPROD, V69, P1303, DOI 10.1095/biolreprod.103.015958; Yoshizaki G, 2010, DEVELOPMENT, V137, P1227, DOI 10.1242/dev.044982; Zon LI, 1999, GENOME RES, V9, P99; Zon LI, 2005, NAT REV DRUG DISCOV, V4, P35, DOI 10.1038/nrd1606; Zou K, 2009, NAT CELL BIOL, V11, P631, DOI 10.1038/ncb1869	44	17	21	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2013	8	5							e62660	10.1371/journal.pone.0062660	http://dx.doi.org/10.1371/journal.pone.0062660			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175AS	23671620	Green Published, Green Submitted, gold			2022-12-27	WOS:000321202100029
J	Patra, P; Klumpp, S				Patra, Pintu; Klumpp, Stefan			Population Dynamics of Bacterial Persistence	PLOS ONE			English	Article							ESCHERICHIA-COLI K-12; FLUCTUATING ENVIRONMENTS; GENE-EXPRESSION; AFFECTS FREQUENCY; MUREIN SYNTHESIS; GROWTH; BISTABILITY; INHIBITION; TOLERANCE; CELLS	Persistence is a prime example of phenotypic heterogeneity, where a microbial population splits into two distinct subpopulations with different growth and survival properties as a result of reversible phenotype switching. Specifically, persister cells grow more slowly than normal cells under unstressed growth conditions, but survive longer under stress conditions such as the treatment with bactericidal antibiotics. We analyze the population dynamics of such a population for several typical experimental scenarios, namely a constant environment, shifts between growth and stress conditions, and periodically switching environments. We use an approximation scheme that allows us to map the dynamics to a logistic equation for the subpopulation ratio and derive explicit analytical expressions for observable quantities that can be used to extract underlying dynamic parameters from experimental data. Our results provide a theoretical underpinning for the study of phenotypic switching, in particular for organisms where detailed mechanistic knowledge is scarce.	[Patra, Pintu; Klumpp, Stefan] Max Planck Inst Colloids & Interfaces, Potsdam, Germany	Max Planck Society	Patra, P (corresponding author), Max Planck Inst Colloids & Interfaces, Sci Pk Golm, Potsdam, Germany.	pintu.patra@mpikg.mpg.de	Klumpp, Stefan/AAC-3936-2019; Patra, Pintu/AAF-2635-2019; Klumpp, Stefan/C-2966-2008	Klumpp, Stefan/0000-0003-0584-2146; Klumpp, Stefan/0000-0003-0584-2146; Patra, Pintu/0000-0002-2275-3738				Balaban NQ, 2004, SCIENCE, V305, P1622, DOI 10.1126/science.1099390; Bigger JW, 1944, LANCET, V2, P497; Cataudella I, 2012, NUCL ACIDS RES; Dhar N, 2007, CURR OPIN MICROBIOL, V10, P30, DOI 10.1016/j.mib.2006.12.007; Dorr T, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000317; Dorr T, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000760; Dubnau D, 2006, MOL MICROBIOL, V61, P564, DOI 10.1111/j.1365-2958.2006.05249.x; Klumpp S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020403; Klumpp S, 2009, CELL, V139, P1366, DOI 10.1016/j.cell.2009.12.001; Korch SB, 2003, MOL MICROBIOL, V50, P1199, DOI 10.1046/j.1365-2958.2003.03779.x; Kussell E, 2005, GENETICS, V169, P1807, DOI 10.1534/genetics.104.035352; Kussell E, 2005, SCIENCE, V309, P2075, DOI 10.1126/science.1114383; Lachmann M, 1996, J THEOR BIOL, V181, P1, DOI 10.1006/jtbi.1996.0109; Lechner S, 2012, J MOL MICROB BIOTECH, V22, P381, DOI 10.1159/000346073; Levin BR, 2006, NAT REV MICROBIOL, V4, P556, DOI 10.1038/nrmicro1445; Lewis K, 2007, NAT REV MICROBIOL, V5, P48, DOI 10.1038/nrmicro1557; Lou CB, 2008, J THEOR BIOL, V255, P205, DOI 10.1016/j.jtbi.2008.07.035; Maisonneuve E, 2011, P NATL ACAD SCI USA, V108, P13206, DOI 10.1073/pnas.1100186108; MOYED HS, 1986, J BACTERIOL, V166, P399, DOI 10.1128/jb.166.2.399-403.1986; MOYED HS, 1983, J BACTERIOL, V155, P768, DOI 10.1128/JB.155.2.768-775.1983; Neidhardt FC, 1990, PHYSL BACTERIAL CELL; Pearl S, 2008, PLOS BIOL, V6, P957, DOI 10.1371/journal.pbio.0060120; Rotem E, 2010, P NATL ACAD SCI USA, V107, P12541, DOI 10.1073/pnas.1004333107; Scott M, 2010, SCIENCE, V330, P1099, DOI 10.1126/science.1192588; Shah D, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-53; Smits WK, 2006, NAT REV MICROBIOL, V4, P259, DOI 10.1038/nrmicro1381; Stewart GR, 2003, NAT REV MICROBIOL, V1, P97, DOI 10.1038/nrmicro749; Tan C, 2009, NAT CHEM BIOL, V5, P842, DOI 10.1038/nchembio.218; Thattai M, 2004, GENETICS, V167, P523, DOI 10.1534/genetics.167.1.523; Wylie CS, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001108	30	43	46	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2013	8	5							e62814	10.1371/journal.pone.0062814	http://dx.doi.org/10.1371/journal.pone.0062814			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145RZ	23675428	Green Published, Green Submitted, gold			2022-12-27	WOS:000319036100013
J	Sawant, SN; Selvaraj, V; Prabhawathi, V; Doble, M				Sawant, Shilpa N.; Selvaraj, Veerapandian; Prabhawathi, Veluchamy; Doble, Mukesh			Antibiofilm Properties of Silver and Gold Incorporated PU, PCLm, PC and PMMA Nanocomposites under Two Shear Conditions	PLOS ONE			English	Article							ESCHERICHIA-COLI; BACTERIAL ADHESION; ZINC-OXIDE; ANTIBACTERIAL; SURFACE; NANOPARTICLES; BIOFILM; PARTICLES	Silver and gold nanoparticles (of average size similar to 20-27 nm) were incorporated in PU (Polyurethane), PCLm (Polycaprolactam), PC (polycarbonate) and PMMA (Polymethylmethaacrylate) by swelling and casting methods under ambient conditions. In the latter method the nanoparticle would be present not only on the surface, but also inside the polymer. These nanoparticles were prepared initially by using a cosolvent, THF. PU and PCLm were dissolved and swollen with THF. PC and PMMA were dissolved in CHCl3 and here the cosolvent, THF, acted as an intermediate between water and CHCl3. FTIR indicated that the interaction between the polymer and the nanoparticle was through the functional group in the polymer. The formation of E. coli biofilm on these nanocomposites under low (in a Drip flow biofilm reactor) and high shear (in a Shaker) conditions indicated that the biofilm growth was higher (twice) in the former than in the latter (ratio of shear force = 15). A positive correlation between the contact angle (of the virgin surface) and the number of colonies, carbohydrate and protein attached on it were observed. Ag nanocomposites exhibited better antibiofilm properties than Au. Bacterial attachment was highest on PC and least on PU nanocomposite. Casting method appeared to be better than swelling method in reducing the attachment (by a factor of 2). Composites reduced growth of organisms by six orders of magnitude, and protein and carbohydrate by 2-5 times. This study indicates that these nanocomposites may be suitable for implant applications.	[Sawant, Shilpa N.] Bhabha Atom Res Ctr, Div Chem, Mumbai 400085, Maharashtra, India; [Selvaraj, Veerapandian; Prabhawathi, Veluchamy; Doble, Mukesh] Indian Inst Technol, Dept Biotechnol, Chennai 600036, Tamil Nadu, India	Bhabha Atomic Research Center (BARC); Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Madras	Doble, M (corresponding author), Indian Inst Technol, Dept Biotechnol, Chennai 600036, Tamil Nadu, India.	genprabha@yahoo.co.in		Veluchamy, Prabhawathi/0000-0002-9703-5714; Doble, Mukeshd/0000-0002-4335-0698; Sawant, Shilpa/0000-0003-2835-4575				Balazs AC, 2006, SCIENCE, V314, P1107, DOI 10.1126/science.1130557; Boks NP, 2008, MICROBIOL-SGM, V154, P3122, DOI 10.1099/mic.0.2008/018622-0; Bollinger RR, 2003, IMMUNOLOGY, V109, P580; Corcione CE, 2009, THERMOCHIM ACTA, V485, P43, DOI 10.1016/j.tca.2008.12.009; Cunningham AB, 2008, BIOFILMS HYPER TXB V; Di Maio E, 2004, POLYMER, V45, P8893, DOI 10.1016/j.polymer.2004.10.037; Feng QL, 2000, J BIOMED MATER RES, V52, P662, DOI 10.1002/1097-4636(20001215)52:4<662::AID-JBM10>3.0.CO;2-3; Hernandez-Sierra JF, 2008, NANOMED-NANOTECHNOL, V4, P237, DOI 10.1016/j.nano.2008.04.005; Goeres DM, 2009, NAT PROTOC, V4, P783, DOI 10.1038/nprot.2009.59; Gomez-Suarez C, 2001, APPL ENVIRON MICROB, V67, P2531, DOI 10.1128/AEM.67.6.2531-2537.2001; Gubin SP, 2002, COLLOID SURFACE A, V202, P155, DOI 10.1016/S0927-7757(01)01074-3; Gupta A, 1998, NAT BIOTECHNOL, V16, P888, DOI 10.1038/nbt1098-888; Hanisch C, 2008, J PHYS CONF SER, V100, DOI 10.1088/1742-6596/100/5/052043; Hetrick EM, 2007, BIOMATERIALS, V28, P1948, DOI 10.1016/j.biomaterials.2007.01.006; Huang JL, 2007, NANOTECHNOLOGY, V18, DOI 10.1088/0957-4484/18/10/105104; Jung R, 2008, POLYMER, V49, P2071, DOI 10.1016/j.polymer.2008.02.045; Kannan P, 2008, NANOTECHNOLOGY, V19, DOI 10.1088/0957-4484/19/8/085602; Katoch S., 2011, DIFFUS FUNDAM, V15, P28; Katsikogianni MG, 2010, ACTA BIOMATER, V6, P1107, DOI 10.1016/j.actbio.2009.08.006; Khandwekar AP, 2011, J BIOMATER APPL, V26, P227, DOI 10.1177/0885328210367442; Khandwekar AP, 2011, J MATER SCI-MATER M, V22, P1231, DOI 10.1007/s10856-011-4285-8; Khandwekar AP, 2009, J MATER SCI-MATER M, V20, P1115, DOI 10.1007/s10856-008-3655-3; Kraft CN, 2000, J BIOMED MATER RES, V49, P192, DOI 10.1002/(SICI)1097-4636(200002)49:2<192::AID-JBM6>3.3.CO;2-3; Lansdown A B G, 2002, J Wound Care, V11, P125; Li SH, 2010, NANO REV EXP, V1, DOI 10.3402/nano.v1i0.5214; Maiti P, 2002, CHEM MATER, V14, P4654, DOI 10.1021/cm020391b; Maki DG, 2001, EMERG INFECT DIS, V7, P342, DOI 10.3201/eid0702.010240; Meinders JM, 1995, J COLLOID INTERF SCI, V176, P329, DOI 10.1006/jcis.1995.9960; Nair B, 2002, CRYST GROWTH DES, V2, P293, DOI 10.1021/cg0255164; Nandakumar V, 2013, POLYM J, V45, P137, DOI 10.1038/pj.2012.130; Pal A, 2009, MATER CHEM PHYS, V114, P530, DOI 10.1016/j.matchemphys.2008.11.056; Pattanayak A, 2005, POLYMER, V46, P3394, DOI 10.1016/j.polymer.2005.03.021; Pavia DL., 2001, INTRO SPECTROSCOPY; Pavithra D, 2008, BIOMED MATER, V3, DOI 10.1088/1748-6041/3/3/034003; Prabhakar PK, 2011, COLLOID SURFACE B, V86, P146, DOI 10.1016/j.colsurfb.2011.03.033; Rapoport L, 2004, ADV ENG MATER, V6, P44, DOI 10.1002/adem.200300512; Reisner A, 2003, MOL MICROBIOL, V48, P933, DOI 10.1046/j.1365-2958.2003.03490.x; Roach P, 2007, J MATER SCI-MATER M, V18, P1263, DOI 10.1007/s10856-006-0064-3; Sanchez-Soto M, 2009, EUR POLYM J, V45, P341, DOI 10.1016/j.eurpolymj.2008.10.026; Sivakumar PM, 2010, COLLOID SURFACE B, V81, P439, DOI 10.1016/j.colsurfb.2010.07.037; Sivakumar PM, 2010, CARBOHYD POLYM, V79, P717, DOI 10.1016/j.carbpol.2009.09.027; Sivakumar PM, 2012, CARBOHYD POLYM, V87, P353, DOI 10.1016/j.carbpol.2011.07.061; Styan K, 2007, KEY ENG MATER, V342-343, P757, DOI 10.4028/www.scientific.net/KEM.342-343.757; Styan KE, 2008, J BIOMED MATER RES A, V86A, P571, DOI 10.1002/jbm.a.31667; Sudhakar M, 2007, INT BIODETER BIODEGR, V60, P144, DOI 10.1016/j.ibiod.2007.02.002; Tang EJ, 2006, POWDER TECHNOL, V161, P209, DOI 10.1016/j.powtec.2005.10.007; Van Houdt R, 2005, RES MICROBIOL, V156, P626, DOI 10.1016/j.resmic.2005.02.005; Veeraapandian S, 2012, J BIOMED NANOTECHNOL, V8, P140, DOI 10.1166/jbn.2012.1356; Veluchamy P, 2011, J AGR FOOD CHEM, V59, P10869, DOI 10.1021/jf201124v; Wang XY, 2007, CARBOHYD POLYM, V69, P41, DOI 10.1016/j.carbpol.2006.08.025; Wang ZX, 2009, COORDIN CHEM REV, V253, P1607, DOI 10.1016/j.ccr.2009.01.005; Yeo SY, 2003, POLYM INT, V52, P1053, DOI 10.1002/pi.1215; Yu JG, 2006, J MOL CATAL A-CHEM, V246, P176, DOI 10.1016/j.molcata.2005.10.034; Zhou N.L., 2007, CURR APPL PHYS, V7, P58, DOI [10.1016/j.cap.2006.11.016, DOI 10.1016/J.CAP.2006.11.016]	54	48	49	0	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2013	8	5							e63311	10.1371/journal.pone.0063311	http://dx.doi.org/10.1371/journal.pone.0063311			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145RZ	23675476	gold, Green Submitted, Green Published			2022-12-27	WOS:000319036100037
J	Yang, N; Xie, W; Yang, X; Wang, SL; Wu, QJ; Li, RM; Pan, HP; Liu, BM; Shi, XB; Fang, Y; Xu, BY; Zhou, XG; Zhang, YJ				Yang, Nina; Xie, Wen; Yang, Xin; Wang, Shaoli; Wu, Qingjun; Li, Rumei; Pan, Huipeng; Liu, Baiming; Shi, Xiaobin; Fang, Yong; Xu, Baoyun; Zhou, Xuguo; Zhang, Youjun			Transcriptomic and Proteomic Responses of Sweetpotato Whitefly, Bemisia tabaci, to Thiamethoxam	PLOS ONE			English	Article							CYTOCHROME-C-OXIDASE; GLUTATHIONE-S-TRANSFERASE; INSECTICIDE-RESISTANCE; DROSOPHILA-MELANOGASTER; GENE-EXPRESSION; BROWN PLANTHOPPER; MULTIGENE FAMILY; MESSENGER-RNA; B-BIOTYPE; MECHANISMS	Background: The sweetpotato whitefly, Bemisia tabaci (Hemiptera: Aleyrodidae), is one of the most widely distributed agricultural pests. Although it has developed resistance to many registered insecticides including the neonicotinoid insecticide thiamethoxam, the mechanisms that regulate the resistance are poorly understood. To understand the molecular basis of thiamethoxam resistance, "omics" analyses were carried out to examine differences between resistant and susceptible B. tabaci at both transcriptional and translational levels. Results: A total of 1,338 mRNAs and 52 proteins were differentially expressed between resistant and susceptible B. tabaci. Among them, 11 transcripts had concurrent transcription and translation profiles. KEGG analysis mapped 318 and 35 differentially expressed genes and proteins, respectively, to 160 and 59 pathways (p<0.05). Thiamethoxam treatment activated metabolic pathways (e.g., drug metabolism), in which 118 transcripts were putatively linked to insecticide resistance, including up-regulated glutathione-S-transferase, UDP glucuronosyltransferase, glucosyl/glucuronosyl transferase, and cytochrome P450. Gene Ontology analysis placed these genes and proteins into protein complex, metabolic process, cellular process, signaling, and response to stimulus categories. Quantitative real-time PCR analysis validated "omics" response, and suggested a highly overexpressed P450, CYP6CX1, as a candidate molecular basis for the mechanistic study of thiamethoxam resistance in whiteflies. Finally, enzymatic activity assays showed elevated detoxification activities in the resistant B. tabaci. Conclusions: This study demonstrates the applicability of high-throughput omics tools for identifying molecular candidates related to thiamethoxam resistance in an agricultural important insect pest. In addition, transcriptomic and proteomic analyses provide a solid foundation for future functional investigations into the complex molecular mechanisms governing the neonicotinoid resistance in whiteflies.	[Yang, Nina; Xie, Wen; Yang, Xin; Wang, Shaoli; Wu, Qingjun; Li, Rumei; Pan, Huipeng; Liu, Baiming; Shi, Xiaobin; Fang, Yong; Xu, Baoyun; Zhang, Youjun] Chinese Acad Agr Sci, Dept Plant Protect, Inst Vegetables & Flowers, Beijing 100193, Peoples R China; [Zhou, Xuguo] Univ Kentucky, Dept Entomol, Lexington, KY 40546 USA	Chinese Academy of Agricultural Sciences; Institute of Vegetables & Flowers, CAAS; University of Kentucky	Zhou, XG (corresponding author), Univ Kentucky, Dept Entomol, Lexington, KY 40546 USA.	xuguozhou@uky.edu; zhangyoujun@caas.cn	Yang, Xin/AAG-5375-2020; Zhang, Youjun/AAY-7948-2020	Zhang, Youjun/0000-0003-3508-6695	National Basic Research Program of China [2013CB127602]; National Technology Support Program [2012BAD19B06]; Beijing Key Laboratory for Pest Control and Sustainable Cultivation of Vegetables, P.R. China	National Basic Research Program of China(National Basic Research Program of China); National Technology Support Program; Beijing Key Laboratory for Pest Control and Sustainable Cultivation of Vegetables, P.R. China	This research was supported by the National Basic Research Program of China (2013CB127602), National Technology Support Program (2012BAD19B06) and Beijing Key Laboratory for Pest Control and Sustainable Cultivation of Vegetables, P.R. China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn SJ, 2012, INSECT BIOCHEM MOLEC, V42, P133, DOI 10.1016/j.ibmb.2011.11.006; Alemany C, 2000, BBA-MOL CELL RES, V1495, P319, DOI 10.1016/S0167-4889(99)00159-7; Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Bolognani F, 2008, J NEUROSCI RES, V86, P481, DOI 10.1002/jnr.21473; CAPALDI RA, 1990, ANNU REV BIOCHEM, V59, P569, DOI 10.1146/annurev.bi.59.070190.003033; Carolan JC, 2011, J PROTEOME RES, V10, P1505, DOI 10.1021/pr100881q; Chaudhuri J, 1997, J BIOL CHEM, V272, P7883, DOI 10.1074/jbc.272.12.7883; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Daborn PJ, 2002, SCIENCE, V297, P2253, DOI 10.1126/science.1074170; De Barro P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025579; De Barro PJ, 2011, ANNU REV ENTOMOL, V56, P1, DOI 10.1146/annurev-ento-112408-085504; Dinsdale A, 2010, ANN ENTOMOL SOC AM, V103, P196, DOI 10.1603/AN09061; Elbert A, 2000, PEST MANAG SCI, V56, P60, DOI 10.1002/(SICI)1526-4998(200001)56:1<60::AID-PS88>3.0.CO;2-K; Emamzadeh R, 2010, ENZYME MICROB TECH, V47, P159, DOI 10.1016/j.enzmictec.2010.05.008; Feng JX, 2012, BIOINFORMATICS, V28, P2782, DOI 10.1093/bioinformatics/bts515; Feng YT, 2009, J APPL ENTOMOL, V133, P466, DOI 10.1111/j.1439-0418.2009.01383.x; Feng YT, 2010, PEST MANAG SCI, V66, P313, DOI 10.1002/ps.1877; Feyereisen R, 1995, TOXICOL LETT, V82-3, P83, DOI 10.1016/0378-4274(95)03470-6; Greenamyre JT, 1999, BIOCHEM SOC SYMP, V66, P85, DOI 10.1042/bss0660085; Hand SC, 2008, J EXP BIOL, V211, P1829, DOI 10.1242/jeb.000299; Hemingway J, 2000, INSECT BIOCHEM MOLEC, V30, P1009, DOI 10.1016/S0965-1748(00)00079-5; Hogenhout SA, 2008, ANNU REV PHYTOPATHOL, V46, P327, DOI 10.1146/annurev.phyto.022508.092135; Horowitz AR, 2004, J ECON ENTOMOL, V97, P2051, DOI 10.1603/0022-0493-97.6.2051; Huang FF, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-563; HUNDLE BS, 1992, P NATL ACAD SCI USA, V89, P9321, DOI 10.1073/pnas.89.19.9321; James DG, 2002, J ECON ENTOMOL, V95, P729, DOI 10.1603/0022-0493-95.4.729; Joussen N, 2010, CHEM BIODIVERS, V7, P722, DOI 10.1002/cbdv.200900020; Karunker I, 2008, INSECT BIOCHEM MOLEC, V38, P634, DOI 10.1016/j.ibmb.2008.03.008; Kislinger T, 2006, CELL, V125, P173, DOI 10.1016/j.cell.2006.01.044; Kokoszka JE, 2004, NATURE, V427, P461, DOI 10.1038/nature02229; Kostaropoulos I, 2001, INSECT BIOCHEM MOLEC, V31, P313, DOI 10.1016/S0965-1748(00)00123-5; Lee JS, 2002, BIOCHEM BIOPH RES CO, V291, P158, DOI 10.1006/bbrc.2002.6398; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Li XC, 2007, ANNU REV ENTOMOL, V52, P231, DOI 10.1146/annurev.ento.51.110104.151104; Liu B., 2011, PLOS ONE, V6, P1, DOI [10.1371/journal.pone.0025794, DOI 10.1371/JOURNAL.PONE.0025794]; Liu N, 1998, INSECT BIOCHEM MOLEC, V28, P531, DOI 10.1016/S0965-1748(98)00039-3; Liu SS, 2007, SCIENCE, V318, P1769, DOI 10.1126/science.1149887; Liu ZW, 2005, P NATL ACAD SCI USA, V102, P8420, DOI 10.1073/pnas.0502901102; Low WY, 2007, GENETICS, V177, P1363, DOI 10.1534/genetics.107.075838; Lumjuan N, 2005, INSECT BIOCHEM MOLEC, V35, P861, DOI 10.1016/j.ibmb.2005.03.008; Luo Chen, 2002, Acta Entomologica Sinica, V45, P759; Luque T, 2002, INSECT BIOCHEM MOLEC, V32, P1597, DOI 10.1016/S0965-1748(02)00080-2; Markussen MDK, 2010, PESTIC BIOCHEM PHYS, V98, P50, DOI 10.1016/j.pestbp.2010.04.012; Miley MJ, 2007, J MOL BIOL, V369, P498, DOI 10.1016/j.jmb.2007.03.066; Misra JR, 2011, GENE DEV, V25, P1796, DOI 10.1101/gad.17280911; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Muller P, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000286; Nie L, 2006, BIOCHEM BIOPH RES CO, V339, P603, DOI 10.1016/j.bbrc.2005.11.055; Oakeshott JG, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-1-202; Ono M, 1999, INSECT BIOCHEM MOLEC, V29, P1065, DOI 10.1016/S0965-1748(99)00082-X; Pereira C, 1998, PARASITOLOGY, V117, P63, DOI 10.1017/S003118209800273X; Perry T, 2011, INSECT BIOCHEM MOLEC, V41, P411, DOI 10.1016/j.ibmb.2011.03.003; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Popesku JT, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012338; Pridgeon JW, 2009, J MED ENTOMOL, V46, P810, DOI 10.1603/033.046.0411; Pridgeon JW, 2003, INSECT BIOCHEM MOLEC, V33, P1043, DOI 10.1016/S0965-1748(03)00120-6; Puinean AM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000999; Qiu BL, 2009, INSECT SCI, V16, P237, DOI 10.1111/j.1744-7917.2009.01253.x; Ranson H, 2002, SCIENCE, V298, P179, DOI 10.1126/science.1076781; Rauch N, 2003, ARCH INSECT BIOCHEM, V54, P165, DOI 10.1002/arch.10114; Rausell C, 1997, ARCH INSECT BIOCHEM, V34, P347, DOI 10.1002/(SICI)1520-6327(1997)34:3<347::AID-ARCH8>3.0.CO;2-R; Roditakis E, 2009, PEST MANAG SCI, V65, P313, DOI 10.1002/ps.1690; Samokyszyn VM, 2000, J BIOL CHEM, V275, P6908, DOI 10.1074/jbc.275.10.6908; Scott JG, 1999, INSECT BIOCHEM MOLEC, V29, P757, DOI 10.1016/S0965-1748(99)00038-7; Small GJ, 2000, INSECT MOL BIOL, V9, P647, DOI 10.1046/j.1365-2583.2000.00229.x; Stansly P.A., 2010, BEMISIA BIONOMICS MA, DOI DOI 10.1007/978-90-481-2460-2; Stumpf N, 2002, PESTIC BIOCHEM PHYS, V72, P111, DOI 10.1006/pest.2001.2583; Syvanen M, 1996, J MOL EVOL, V43, P236, DOI 10.1007/PL00006082; Tijet N, 2001, GENE, V262, P189, DOI 10.1016/S0378-1119(00)00533-3; Tomizawa M, 2005, ANNU REV PHARMACOL, V45, P247, DOI 10.1146/annurev.pharmtox.45.120403.095930; Tomizawa M, 2003, ANNU REV ENTOMOL, V48, P339, DOI 10.1146/annurev.ento.48.091801.112731; Tournier C, 2000, SCIENCE, V288, P870, DOI 10.1126/science.288.5467.870; Vontas JG, 2002, BIOCHEM J, V362, P329, DOI 10.1042/bj3620329; Wang XW, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-400; Wang ZY, 2010, PEST MANAG SCI, V66, P1360, DOI 10.1002/ps.2023; Wang ZY, 2009, PEST MANAG SCI, V65, P1189, DOI 10.1002/ps.1808; Wondji CS, 2009, GENOME RES, V19, P452, DOI 10.1101/gr.087916.108; Xie W, 2012, PLOS ONE, DOI [10.1371/journal.-pone.0035181, DOI 10.1371/J0URNAL.-P0NE.0035181]; Xie W, 2012, J INSECT SCI, V12, DOI 10.1673/031.012.4601; ZHOU Y, 1949, ENTOMOL SINICA, V3, P1; Zhu F, 2010, P NATL ACAD SCI USA, V107, P8557, DOI 10.1073/pnas.1000059107; Zhuang HM, 2011, INSECT SCI, V18, P484, DOI 10.1111/j.1744-7917.2010.01380.x	83	55	62	2	88	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2013	8	5							e61820	10.1371/journal.pone.0061820	http://dx.doi.org/10.1371/journal.pone.0061820			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	155HD	23671574	gold, Green Published, Green Submitted			2022-12-27	WOS:000319737700006
J	Persichetti, A; Sciuto, R; Rea, S; Basciani, S; Lubrano, C; Mariani, S; Ulisse, S; Nofroni, I; Maini, CL; Gnessi, L				Persichetti, Agnese; Sciuto, Rosa; Rea, Sandra; Basciani, Sabrina; Lubrano, Carla; Mariani, Stefania; Ulisse, Salvatore; Nofroni, Italo; Maini, Carlo Ludovico; Gnessi, Lucio			Prevalence, Mass, and Glucose-Uptake Activity of F-18-FDG-Detected Brown Adipose Tissue in Humans Living in a Temperate Zone of Italy	PLOS ONE			English	Article							RECEPTOR GENE-EXPRESSION; FDG UPTAKE; OUTDOOR TEMPERATURE; FAT; SEX; MECHANISMS; AGE	Background: The F-18-fluorodeoxyglucose (F-18-FDG)-detected brown adipose tissue (BAT), is enhanced by cold stimulus and modulated by other factors that still have to be disentangled. We investigated the prevalence, mass, and glucose-uptake activity of F-18-FDG-detected BAT in a population of adults living in the temperate climatic zone of the Rome area. Methods and Findings: We retrospectively analyzed 6454 patients who underwent F-18-FDG positron emission tomography/computed tomography (PET/CT) examinations. We found F-18-FDG BAT in 217 of the 6454 patients (3.36%). Some of them underwent more than one scan and the positive scans were 278 among 8004 (3.47%). The prevalence of patients with at least one positive scan was lower in men (1.77%; 56 of 3161) compared with women (4.88%; 161 of 3293). The BAT positive patients were most frequently younger, thinner and with lower plasma glucose levels compared with BAT negative patients. The amount of BAT in the defined region of interest, the activity of BAT and the number of positive sites of active BAT were similar in both sexes. The prevalence of patients with F-18-FDG positive PET/CT was highest in December-February, lower in March-May and September-November, and lowest in June-August and was positively correlated with night length and negatively correlated with ambient temperature. Changes in day length and variations of temperature, associated with the prevalence of positive BAT patients. Among the patients who had multiple scans, outdoor temperature was significantly lower and day length was shorter on the occasion when BAT was detected. Conclusions: This study identifies day length, outdoor temperature, age, sex, BMI, and plasma glucose levels as major determinants of the prevalence, mass, and activity of 18F-FDG-detected BAT.	[Persichetti, Agnese; Basciani, Sabrina; Lubrano, Carla; Mariani, Stefania; Ulisse, Salvatore; Gnessi, Lucio] Univ Roma La Sapienza, Dept Expt Med, Sect Med Pathophysiol Food Sci & Endocrinol, I-00185 Rome, Italy; [Sciuto, Rosa; Rea, Sandra; Maini, Carlo Ludovico] Regina Elena Inst Canc Res, Dept Nucl Med, Rome, Italy; [Nofroni, Italo] Univ Roma La Sapienza, Dept Publ Hlth & Infect Dis Med Stat & Biometry, I-00185 Rome, Italy	Sapienza University Rome; IRCCS Istituti Fisioterapici Ospitalieri (IFO); IRCCS Regina Elena; Sapienza University Rome	Gnessi, L (corresponding author), Univ Roma La Sapienza, Dept Expt Med, Sect Med Pathophysiol Food Sci & Endocrinol, I-00185 Rome, Italy.	lucio.gnessi@uniroma1.it	Ulisse, Salvatore/H-5362-2019; Rea, Sandra/ABA-6207-2020; Gnessi, Lucio/K-8025-2016	Ulisse, Salvatore/0000-0002-7573-0759; Rea, Sandra/0000-0002-4336-7406; Gnessi, Lucio/0000-0001-8217-2372	Sapienza University of Rome, Italy	Sapienza University of Rome, Italy	This study was funded by the Sapienza University of Rome, Italy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akkas BE, 2011, REV ESP MED NUCL, V30, P14, DOI 10.1016/j.remn.2010.05.006; Au-Yong ITH, 2009, DIABETES, V58, P2583, DOI 10.2337/db09-0833; Bartness TJ, 2007, PHYSIOL BEHAV, V91, P343, DOI 10.1016/j.physbeh.2007.04.002; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Cohade C, 2003, J NUCL MED, V44, P1267; Cypess AM, 2009, NEW ENGL J MED, V360, P1509, DOI 10.1056/NEJMoa0810780; Demas GE, 2003, AM J PHYSIOL-REG I, V285, pR873, DOI 10.1152/ajpregu.00209.2003; Fain JN, 2010, METABOLISM, V59, P1379, DOI 10.1016/j.metabol.2009.12.027; Hany TF, 2002, EUR J NUCL MED MOL I, V29, P1393, DOI 10.1007/s00259-002-0902-6; HELDMAIER G, 1981, J COMP PHYSIOL, V142, P429, DOI 10.1007/BF00688972; Huang YC, 2012, SCI WORLD J, P1, DOI 10.1100/2012/793039; Huang YC, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-238; Johnston JD, 2004, J ENDOCRINOL, V180, P351, DOI 10.1677/joe.0.1800351; Kim S, 2008, EUR J NUCL MED MOL I, V35, P984, DOI 10.1007/s00259-007-0670-4; Klingenspor M, 1996, FEBS LETT, V399, P290, DOI 10.1016/S0014-5793(96)01343-9; Lacobellis G, 2008, HORM METAB RES, V40, P442, DOI 10.1055/s-2008-1062724; Lichtenbelt WDV, 2009, NEW ENGL J MED, V360, P1500, DOI 10.1056/NEJMoa0808718; Ling C, 2000, ENDOCRINOLOGY, V141, P3564, DOI 10.1210/en.141.10.3564; Lubrano C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047059; Mariani S, 2013, INT J CARDIOL, V167, P2244, DOI 10.1016/j.ijcard.2012.06.011; Nedergaard J, 2007, AM J PHYSIOL-ENDOC M, V293, pE444, DOI 10.1152/ajpendo.00691.2006; Ouellet V, 2011, J CLIN ENDOCR METAB, V96, P192, DOI 10.1210/jc.2010-0989; Pfannenberg C, 2010, DIABETES, V59, P1789, DOI 10.2337/db10-0004; Quarta C, 2012, J MOL ENDOCRINOL, V49, pR1, DOI 10.1530/JME-12-0043; Sacks HS, 2009, J CLIN ENDOCR METAB, V94, P3611, DOI 10.1210/jc.2009-0571; Saito M, 2009, DIABETES, V58, P1526, DOI 10.2337/db09-0530; Symonds ME, 1998, J NEUROENDOCRINOL, V10, P885; Symonds Michael E., 2011, Frontiers in Genetics, V2, P24, DOI 10.3389/fgene.2011.00024; Tam CS, 2012, CIRCULATION, V125, P2782, DOI 10.1161/CIRCULATIONAHA.111.042929; Tan DX, 2011, OBES REV, V12, P167, DOI 10.1111/j.1467-789X.2010.00756.x; Truong MT, 2004, AM J ROENTGENOL, V183, P1127, DOI 10.2214/ajr.183.4.1831127; Viengchareun S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001535; Virtanen KA, 2009, NEW ENGL J MED, V360, P1518, DOI 10.1056/NEJMoa0808949; Wehr TA, 1998, HORM RES, V49, P118, DOI 10.1159/000023157; Weil ZM, 2009, P NATL ACAD SCI USA, V106, P4525, DOI 10.1073/pnas.0810973106; Yeung HWD, 2003, J NUCL MED, V44, P1789; Zingaretti MC, 2009, FASEB J, V23, P3113, DOI 10.1096/fj.09-133546	37	49	49	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2013	8	5							e63391	10.1371/journal.pone.0063391	http://dx.doi.org/10.1371/journal.pone.0063391			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145YI	23667608	Green Submitted, Green Published, gold			2022-12-27	WOS:000319055600058
J	Kosaka, J; Morimatsu, H; Takahashi, T; Shimizu, H; Kawanishi, S; Omori, E; Endo, Y; Tamaki, N; Morita, M; Morita, K				Kosaka, Junko; Morimatsu, Hiroshi; Takahashi, Toru; Shimizu, Hiroko; Kawanishi, Susumu; Omori, Emiko; Endo, Yasumasa; Tamaki, Naofumi; Morita, Manabu; Morita, Kiyoshi			Effects of Biliverdin Administration on Acute Lung Injury Induced by Hemorrhagic Shock and Resuscitation in Rats	PLOS ONE			English	Article							MULTIPLE ORGAN FAILURE; RESPIRATORY-DISTRESS-SYNDROME; DECREASED PROGRESSION; REPERFUSION INJURY; HEME OXYGENASE-1; OXIDATIVE DAMAGE; PROTECTS; MODEL; INFLAMMATION; DYSFUNCTION	Hemorrhagic shock and resuscitation induces pulmonary inflammation that leads to acute lung injury. Biliverdin, a metabolite of heme catabolism, has been shown to have potent cytoprotective, anti-inflammatory, and anti-oxidant effects. This study aimed to examine the effects of intravenous biliverdin administration on lung injury induced by hemorrhagic shock and resuscitation in rats. Biliverdin or vehicle was administered to the rats 1 h before sham or hemorrhagic shock-inducing surgery. The sham-operated rats underwent all surgical procedures except bleeding. To induce hemorrhagic shock, rats were bled to achieve a mean arterial pressure of 30 mmHg that was maintained for 60 min, followed by resuscitation with shed blood. Histopathological changes in the lungs were evaluated by histopathological scoring analysis. Inflammatory gene expression was determined by Northern blot analysis, and oxidative DNA damage was assessed by measuring 8-hydroxy-2' deoxyguanosine levels in the lungs. Hemorrhagic shock and resuscitation resulted in prominent histopathological damage, including congestion, edema, cellular infiltration, and hemorrhage. Biliverdin administration prior to hemorrhagic shock and resuscitation significantly ameliorated these lung injuries as judged by histopathological improvement. After hemorrhagic shock and resuscitation, inflammatory gene expression of tumor necrosis factor-alpha and inducible nitric oxide synthase were increased by 18- and 8-fold, respectively. Inflammatory gene expression significantly decreased when biliverdin was administered prior to hemorrhagic shock and resuscitation. Moreover, after hemorrhagic shock and resuscitation, lung 8-hydroxy-2' deoxyguanosine levels in mitochondrial DNA expressed in the pulmonary interstitium increased by 1.5-fold. Biliverdin administration prior to hemorrhagic shock and resuscitation decreased mitochondrial 8-hydroxy-2' deoxyguanosine levels to almost the same level as that in the control animals. We also confirmed that biliverdin administration after hemorrhagic shock and resuscitation had protective effects on lung injury. Our findings suggest that biliverdin has a protective role, at least in part, against hemorrhagic shock and resuscitation-induced lung injury through anti-inflammatory and anti-oxidant mechanisms.	[Kosaka, Junko; Morimatsu, Hiroshi; Takahashi, Toru; Shimizu, Hiroko; Kawanishi, Susumu; Omori, Emiko; Morita, Kiyoshi] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Anesthesiol & Resuscitol, Okayama, Japan; [Takahashi, Toru] Okayama Prefectural Univ, Fac Hlth & Welf Sci, Okayama, Japan; [Endo, Yasumasa; Morita, Manabu] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Prevent Dent, Okayama, Japan; [Tamaki, Naofumi] Univ Tokushima, Grad Sch, Dept Prevent Dent, Inst Hlth Biosci, Tokushima 770, Japan	Okayama University; Okayama Prefectural University; Okayama University; Tokushima University	Morimatsu, H (corresponding author), Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Anesthesiol & Resuscitol, Okayama, Japan.	morima-h@md.okayama-u.ac.jp	Morimatsu, Hiroshi/B-2236-2011	Morimatsu, Hiroshi/0000-0002-6744-0508	Grants-in-Aid for Scientific Research [24592735] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		Anaya-Prado R, 2002, J SURG RES, V105, P248, DOI 10.1006/jsre.2002.6385; Baek JH, 2012, J CLIN INVEST, V122, P1444, DOI 10.1172/JCI59770; Baranano DE, 2002, P NATL ACAD SCI USA, V99, P16093, DOI 10.1073/pnas.252626999; BRADLEY PP, 1982, J INVEST DERMATOL, V78, P206, DOI 10.1111/1523-1747.ep12506462; Ciesla DJ, 2006, SURGERY, V140, P640, DOI 10.1016/j.surg.2006.06.015; Ciesla DJ, 2005, SURGERY, V138, P749, DOI 10.1016/j.surg.2005.07.020; Deguchi K, 2008, BRAIN RES, V1188, P1, DOI 10.1016/j.brainres.2007.07.104; Dennery PA, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00115; Dewar D, 2009, INJURY, V40, P912, DOI 10.1016/j.injury.2009.05.024; Fondevila C, 2004, HEPATOLOGY, V40, P1333, DOI 10.1002/hep.20480; Franklin GA, 2006, SURGERY, V140, P647; Jansen T, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00030; Jiang HC, 2007, SURGERY, V141, P32, DOI 10.1016/j.surg.2006.03.024; Kanagawa F, 2010, J TRAUMA, V69, P185, DOI 10.1097/TA.0b013e3181bbd516; Kasai H, 2002, FREE RADICAL BIO MED, V33, P450, DOI 10.1016/S0891-5849(02)00818-3; Maeshima K, 2005, BIOCHEM PHARMACOL, V69, P1667, DOI 10.1016/j.bcp.2005.03.007; Malangoni MA, 2005, SURGERY, V138, P757; Murakami K, 2002, SHOCK, V18, P236, DOI 10.1097/00024382-200209000-00006; Nakao A, 2004, GASTROENTEROLOGY, V127, P595, DOI 10.1053/j.gastro.2004.05.059; Nicholson SE, 2011, J TRAUMA, V70, P466, DOI 10.1097/TA.0b013e3182032584; Rushing GD, 2008, ANN SURG, V247, P929, DOI 10.1097/SLA.0b013e31816757f7; Sarady-Andrews JK, 2005, AM J PHYSIOL-LUNG C, V289, pL1131, DOI 10.1152/ajplung.00458.2004; STEPHENS KE, 1988, AM REV RESPIR DIS, V137, P1364, DOI 10.1164/ajrccm/137.6.1364; STOCKER R, 1987, SCIENCE, V235, P1043, DOI 10.1126/science.3029864; Tomofuji T, 2006, FEBS LETT, V580, P3601, DOI 10.1016/j.febslet.2006.05.041; Tomofuji T, 2011, BIOMED RES-TOKYO, V32, P343, DOI 10.2220/biomedres.32.343; Uehara K, 2005, CRIT CARE MED, V33, P381, DOI 10.1097/01.CCM.0000153407.14237.7F; Umeda K, 2009, SHOCK, V31, P40, DOI 10.1097/SHK.0b013e318177823a; Yamashita K, 2004, FASEB J, V18, P765, DOI 10.1096/fj.03-0839fje; Zegdi R, 2003, SHOCK, V20, P569, DOI 10.1097/01.shk.0000094765.36694.92	30	34	37	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e63606	10.1371/journal.pone.0063606	http://dx.doi.org/10.1371/journal.pone.0063606			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667646	Green Published, Green Submitted, gold			2022-12-27	WOS:000319654700167
J	Moody, EK; Sabo, JL				Moody, Eric K.; Sabo, John L.			Crayfish Impact Desert River Ecosystem Function and Litter-Dwelling Invertebrate Communities through Association with Novel Detrital Resources	PLOS ONE			English	Article							RIPARIAN VEGETATION; LONG-TERM; PACIFASTACUS-LENIUSCULUS; TAMARIX-RAMOSISSIMA; SIGNAL CRAYFISH; COLORADO RIVER; LEAF-LITTER; STREAM; FLOW; DIVERSITY	Shifts in plant species distributions due to global change are increasing the availability of novel resources in a variety of ecosystems worldwide. In semiarid riparian areas, hydric pioneer tree species are being replaced by drought-tolerant plant species as water availability decreases. Additionally, introduced omnivorous crayfish, which feed upon primary producers, allochthonous detritus, and benthic invertebrates, can impact communities at multiple levels through both direct and indirect effects mediated by drought-tolerant plants. We tested the impact of both virile crayfish (Orconectes virilis) and litter type on benthic invertebrates and the effect of crayfish on detrital resources across a gradient of riparian vegetation drought-tolerance using field cages with leaf litter bags in the San Pedro River in Southeastern Arizona. Virile crayfish increased breakdown rate of novel drought-tolerant saltcedar (Tamarix ramosissima), but did not impact breakdown of drought-tolerant seepwillow (Baccharis salicifolia) or hydric Fremont cottonwood (Populus fremontii) and Gooding's willow (Salix goodingii). Effects on invertebrate diversity were observed at the litter bag scale, but no effects were found at the cage scale. Crayfish decreased alpha diversity of colonizing macroinvertebrates, but did not affect beta diversity. In contrast, the drought-tolerant litter treatment decreased beta diversity relative to hydric litter. As drought-tolerant species become more abundant in riparian zones, their litter will become a larger component of the organic matter budget of desert streams which may serve to homogenize the litter-dwelling community and support elevated populations of virile crayfish. Through impacts at multiple trophic levels, crayfish have a significant effect on desert stream ecosystems.	[Moody, Eric K.; Sabo, John L.] Arizona State Univ, Sch Life Sci, Tempe, AZ 85287 USA	Arizona State University; Arizona State University-Tempe	Moody, EK (corresponding author), Arizona State Univ, Sch Life Sci, Tempe, AZ 85287 USA.	eric.k.moody@asu.edu			Arizona Water Association	Arizona Water Association	Funding for the study was provided by a scholarship from the Arizona Water Association (www.azwater.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailey JK, 2001, WETLANDS, V21, P442, DOI 10.1672/0277-5212(2001)021[0442:SCNABO]2.0.CO;2; Ball BA, 2010, BIOSCIENCE, V60, P590, DOI 10.1525/bio.2010.60.8.5; Bates D., 2011, PACKAGE LME4 LINEAR; Bobeldyk AM, 2010, CRUSTACEANA, V83, P641, DOI 10.1163/001121610X491031; Bogan MT, 2011, FRESHWATER BIOL, V56, P2070, DOI 10.1111/j.1365-2427.2011.02638.x; Bondar CA, 2009, J N AM BENTHOL SOC, V28, P294, DOI 10.1899/08-092.1; Carlisle DM, 2011, FRONT ECOL ENVIRON, V9, P264, DOI 10.1890/100053; Chao A, 2003, ENVIRON ECOL STAT, V10, P429, DOI 10.1023/A:1026096204727; Charlebois PM, 1996, J N AM BENTHOL SOC, V15, P551, DOI 10.2307/1467806; Clarke KR, 2006, J EXP MAR BIOL ECOL, V330, P55, DOI 10.1016/j.jembe.2005.12.017; CREED RP, 1994, ECOLOGY, V75, P2091, DOI 10.2307/1941613; Ermgassen PSEZ, 2011, HYDROBIOLOGIA, V658, P303, DOI 10.1007/s10750-010-0500-8; FISHER SG, 1973, ECOL MONOGR, V43, P421, DOI 10.2307/1942301; FISHER SG, 1981, SOUTHWEST NAT, V26, P31, DOI 10.2307/3671326; FLECKER AS, 1992, ECOLOGY, V73, P927, DOI 10.2307/1940169; Fox J., 2019, R COMPANION APPL REG, V.; Frost PJ, 2002, J MANAGE INQUIRY, V11, P21, DOI 10.1177/1056492602111007; Going BM, 2008, BIOL INVASIONS, V10, P1041, DOI 10.1007/s10530-007-9182-1; Hauer F. R., 2006, METHODS STREAM ECOLO; Helms KR, 2002, ECOLOGY, V83, P2425, DOI 10.1890/0012-9658(2002)083[2425:WAOTIA]2.0.CO;2; Henseler J., 2010, HDB PARTIAL LEAST SQ, P713, DOI DOI 10.1007/978-3-540-32827-8_31; Hladyz S, 2009, FRESHWATER BIOL, V54, P957, DOI 10.1111/j.1365-2427.2008.02138.x; Hobbs RJ, 2006, GLOBAL ECOL BIOGEOGR, V15, P1, DOI 10.1111/j.1466-822x.2006.00212.x; Horton JL, 2001, PLANT CELL ENVIRON, V24, P293, DOI 10.1046/j.1365-3040.2001.00681.x; HURYN AD, 1987, FRESHWATER BIOL, V18, P277, DOI 10.1111/j.1365-2427.1987.tb01314.x; Kennedy TA, 2005, ECOL APPL, V15, P2072, DOI 10.1890/04-1533; Kennedy TA, 2004, FRESHWATER BIOL, V49, P65, DOI 10.1046/j.1365-2426.2003.01166.x; Kominoski JS, 2007, ECOLOGY, V88, P1167, DOI 10.1890/06-0674; Lennon JJ, 2001, J ANIM ECOL, V70, P966, DOI 10.1046/j.0021-8790.2001.00563.x; Ludlam JP, 2009, J N AM BENTHOL SOC, V28, P371, DOI 10.1899/08-149.1; Lytle DA, 2004, TRENDS ECOL EVOL, V19, P94, DOI 10.1016/j.tree.2003.10.002; Maechler M., 2011, SFSMISC UTILITIES SE; Martinez PJ, 2012, AQUAT INVASIONS, V7, P219, DOI 10.3391/ai.2012.7.2.008; McCarthy JM, 2006, FRESHWATER BIOL, V51, P224, DOI 10.1111/j.1365-2427.2005.01485.x; McCune B., 2002, ANAL ECOLOGICAL COMM, DOI 10.1016/S0022-0981(03)00091-1; Moline AB, 2008, FRESHWATER BIOL, V53, P1012, DOI 10.1111/j.1365-2427.2008.01960.x; Moody E. K., 2012, SW NAT, V57, P343; Oksanen J., 2015, VEGAN COMMUNITY ECOL, V22-1, P1; Olden JD, 2009, AQUAT ECOL, V43, P1073, DOI 10.1007/s10452-009-9244-9; Paine RT, 1998, ECOSYSTEMS, V1, P535, DOI 10.1007/s100219900049; Parkyn SM, 1997, NEW ZEAL J MAR FRESH, V31, P685, DOI 10.1080/00288330.1997.9516798; Pintor LM, 2006, BIOL CONSERV, V130, P584, DOI 10.1016/j.biocon.2006.01.021; Pomeroy KE, 2000, HYDROBIOLOGIA, V434, P193, DOI 10.1023/A:1004081309986; Sabo JL, 2008, ECOL MONOGR, V78, P19, DOI 10.1890/06-1340.1; Sabo JL, 2010, P NATL ACAD SCI USA, V107, P21263, DOI 10.1073/pnas.1009734108; Sabo JL, 2010, SCIENCE, V330, P965, DOI 10.1126/science.1196005; Sanchez G., 2012, PLSPM PARTIAL LEAST; Schade JD, 1997, J N AM BENTHOL SOC, V16, P612, DOI 10.2307/1468148; Schade JD, 2006, ECOSYSTEMS, V9, P740, DOI 10.1007/s10021-006-0159-1; Seager R, 2007, SCIENCE, V316, P1181, DOI 10.1126/science.1139601; SEEGRIST DW, 1972, T AM FISH SOC, V101, P478, DOI 10.1577/1548-8659(1972)101<478:EOFOTI>2.0.CO;2; Serrat-Capdevila A, 2007, J HYDROL, V347, P48, DOI 10.1016/j.jhydrol.2007.08.028; Sponseller RA, 2010, GLOBAL CHANGE BIOL, V16, P2891, DOI 10.1111/j.1365-2486.2010.02200.x; STANLEY EH, 1994, AM MIDL NAT, V131, P288, DOI 10.2307/2426255; Stromberg JC, 2010, RIVER RES APPL, V26, P712, DOI 10.1002/rra.1272; Stromberg JC, 2005, RIVER RES APPL, V21, P925, DOI 10.1002/rra.858; Turner DS, 2011, ENVIRON MANAGE, V47, P497, DOI 10.1007/s00267-010-9607-y; Usio N, 2000, OECOLOGIA, V124, P608, DOI 10.1007/s004420000422; Usio N, 2007, BIOL CONSERV, V134, P517, DOI 10.1016/j.biocon.2006.09.002; Vandersande MW, 2001, J ARID ENVIRON, V49, P147, DOI 10.1006/jare.2001.0839; VITOUSEK PM, 1994, ECOLOGY, V75, P1861, DOI 10.2307/1941591; Wallace JB, 1997, SCIENCE, V277, P102, DOI 10.1126/science.277.5322.102; Walther GR, 2009, TRENDS ECOL EVOL, V24, P686, DOI 10.1016/j.tree.2009.06.008; Wilson KA, 2004, CAN J FISH AQUAT SCI, V61, P2255, DOI [10.1139/f04-170, 10.1139/F04-170]	64	18	18	1	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e63274	10.1371/journal.pone.0063274	http://dx.doi.org/10.1371/journal.pone.0063274			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667600	Green Submitted, Green Published, gold			2022-12-27	WOS:000319654700130
J	Na, YR; Yoon, YN; Son, DI; Seok, SH				Na, Yi-Rang; Yoon, Yi-Na; Son, Da-In; Seok, Seung-Hyeok			Cyclooxygenase-2 Inhibition Blocks M2 Macrophage Differentiation and Suppresses Metastasis in Murine Breast Cancer Model	PLOS ONE			English	Article							TUMOR-ASSOCIATED MACROPHAGES; ACTIVATED MACROPHAGES; STIMULATING FACTOR; MYELOID CELLS; POLARIZATION; PROGRESSION; LYMPHANGIOGENESIS; MICROENVIRONMENT; INFLAMMATION; EXPRESSION	Tumor cells are often associated with abundant macrophages that resemble the alternatively activated M2 subset. Tumor-associated macrophages (TAMs) inhibit anti-tumor immune responses and promote metastasis. Cyclooxygenase-2 (COX-2) inhibition is known to prevent breast cancer metastasis. This study hypothesized that COX-2 inhibition affects TAM characteristics potentially relevant to tumor cell metastasis. We found that the specific COX-2 inhibitor, etodolac, inhibited human M2 macrophage differentiation, as determined by decreased CD14 and CD163 expressions and increased TNF alpha production. Several key metastasis-related mediators, such as vascular endothelial growth factor-A, vascular endothelial growth factor-C, and matrix metalloproteinase-9, were inhibited in the presence of etodolac as compared to untreated M2 macrophages. Murine bone marrow derived M2 macrophages also showed enhanced surface MHCII IA/IE and CD80, CD86 expressions together with enhanced TNF alpha expressions with etodolac treatment during differentiation. Using a BALB/c breast cancer model, we found that etodolac significantly reduced lung metastasis, possibly due to macrophages expressing increased IA/IE and TNF alpha, but decreased M2 macrophage-related genes expressions (Ym1, TGF beta). In conclusion, COX-2 inhibition caused loss of the M2 macrophage characteristics of TAMs and may assist prevention of breast cancer metastasis.	[Seok, Seung-Hyeok] Seoul Natl Univ, Coll Med, Dept Microbiol & Immunol, Seoul, South Korea; Seoul Natl Univ, Coll Med, Inst Endem Dis, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU)	Seok, SH (corresponding author), Seoul Natl Univ, Coll Med, Dept Microbiol & Immunol, Seoul, South Korea.	lamseok@snu.ac.kr	Seok, Seung Hyeok/J-3279-2012	Seok, Seung Hyeok/0000-0002-4315-0688	Ministry of Education, Science and Technology, Korea [2012-0004090]; Seoul National University Hospital Research Fund [04-2010-0240]	Ministry of Education, Science and Technology, Korea(Ministry of Education, Science & Technology (MEST), Republic of Korea); Seoul National University Hospital Research Fund	This work was funded both by the Ministry of Education, Science and Technology, Korea (2012-0004090), and supported by the Seoul National University Hospital Research Fund (04-2010-0240). The funders only financially supported this study and had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achen MG, 2006, INT J CANCER, V119, P1755, DOI 10.1002/ijc.21899; Alitalo K, 2005, NATURE, V438, P946, DOI 10.1038/nature04480; Almand B, 2001, J IMMUNOL, V166, P678, DOI 10.4049/jimmunol.166.1.678; Beatty GL, 2011, SCIENCE, V331, P1612, DOI 10.1126/science.1198443; Bingle L, 2002, J PATHOL, V196, P254, DOI 10.1002/path.1027; Borrello IM, 2009, BLOOD, V114, P1736, DOI 10.1182/blood-2009-02-205278; Dannenberg AJ, 2001, LANCET ONCOL, V2, P544, DOI 10.1016/S1470-2045(01)00488-0; DeNardo D, 2010, CANCER METAST REV, V29, P309, DOI 10.1007/s10555-010-9223-6; DeNardo DG, 2009, CANCER CELL, V16, P91, DOI 10.1016/j.ccr.2009.06.018; Ghassabeh GH, 2006, BLOOD, V108, P575, DOI 10.1182/blood-2005-04-1485; Gilroy DW, 1999, NAT MED, V5, P698, DOI 10.1038/9550; Gocheva V, 2010, GENE DEV, V24, P241, DOI 10.1101/gad.1874010; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Guiet R, 2011, J IMMUNOL, V187, P3806, DOI 10.4049/jimmunol.1101245; Hallam S, 2009, J PATHOL, V219, P143, DOI 10.1002/path.2602; Herlong JL, 2006, IMMUNOL LETT, V102, P121, DOI 10.1016/j.imlet.2005.10.004; Iwata C, 2007, CANCER RES, V67, P10181, DOI 10.1158/0008-5472.CAN-07-2366; Joyce JA, 2009, NAT REV CANCER, V9, P239, DOI 10.1038/nrc2618; Kim EH, 2006, BIOCHEM PHARMACOL, V72, P1516, DOI 10.1016/j.bcp.2006.07.030; Kozin SV, 2010, CANCER RES, V70, P5679, DOI 10.1158/0008-5472.CAN-09-4446; Leidi M, 2009, J IMMUNOL, V182, P4415, DOI 10.4049/jimmunol.0713732; Lewis CE, 2006, CANCER RES, V66, P605, DOI 10.1158/0008-5472.CAN-05-4005; Lin EY, 2001, J EXP MED, V193, P727, DOI 10.1084/jem.193.6.727; Mantovani A, 2005, IMMUNITY, V23, P344, DOI 10.1016/j.immuni.2005.10.001; Mantovani A, 2002, TRENDS IMMUNOL, V23, P549, DOI 10.1016/S1471-4906(02)02302-5; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Mantovani A, 2010, CURR OPIN IMMUNOL, V22, P231, DOI 10.1016/j.coi.2010.01.009; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; Martinez FO, 2008, FRONT BIOSCI-LANDMRK, V13, P453, DOI 10.2741/2692; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; Meng YR, 2010, CANCER RES, V70, P1534, DOI 10.1158/0008-5472.CAN-09-2995; Murdoch C, 2007, J IMMUNOL, V178, P7405, DOI 10.4049/jimmunol.178.11.7405; Nakanishi Y, 2011, CARCINOGENESIS, V32, P1333, DOI 10.1093/carcin/bgr128; Pollard JW, 2008, J LEUKOCYTE BIOL, V84, P623, DOI 10.1189/jlb.1107762; Pollard JW, 2004, NAT REV CANCER, V4, P71, DOI 10.1038/nrc1256; Qian BZ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006562; Raes G, 2002, J LEUKOCYTE BIOL, V71, P597; Sica A, 2008, SEMIN CANCER BIOL, V18, P349, DOI 10.1016/j.semcancer.2008.03.004; Sinha P, 2007, J IMMUNOL, V179, P977, DOI 10.4049/jimmunol.179.2.977; Sinha P, 2007, CANCER RES, V67, P4507, DOI 10.1158/0008-5472.CAN-06-4174; Solinas G, 2010, J IMMUNOL, V185, P642, DOI 10.4049/jimmunol.1000413; Talmadge JE, 2007, CANCER METAST REV, V26, P373, DOI 10.1007/s10555-007-9072-0; Thun MJ, 2002, JNCI-J NATL CANCER I, V94, P252, DOI 10.1093/jnci/94.4.252; Tsujii M, 1998, CELL, V93, P705, DOI 10.1016/S0092-8674(00)81433-6; Wang DZ, 2005, GASTROENTEROLOGY, V128, P1445, DOI 10.1053/j.gastro.2004.09.080; Zhang WJ, 2011, J IMMUNOL, V187, P1764, DOI 10.4049/jimmunol.1002315	47	114	122	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e63451	10.1371/journal.pone.0063451	http://dx.doi.org/10.1371/journal.pone.0063451			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667623	Green Published, gold, Green Submitted			2022-12-27	WOS:000319654700149
J	Saliasi, E; Geerligs, L; Lorist, MM; Maurits, NM				Saliasi, Emi; Geerligs, Linda; Lorist, Monicque M.; Maurits, Natasha M.			The Relationship between P3 Amplitude and Working Memory Performance Differs in Young and Older Adults	PLOS ONE			English	Article							AGE-RELATED-CHANGES; BRAIN ACTIVITY; COGNITIVE NEUROSCIENCE; ACTIVATION; INFORMATION; NOVELTY	While some elderly show deteriorations in cognitive performance, others achieve performance levels comparable to young adults. To examine whether age-related changes in brain activity varied with working memory performance efficiency, we recorded electroencephalography (EEG) from young and older healthy adults during performance on an n-back task with two loads (0- and 1-back) and two versions (identity and integrated). Young adults showed a typical P3 amplitude pattern with a parietal-maximum. Compared to young adults, the P3 amplitude of older adults was characterized by frontal hyperactivity coupled with posterior hypoactivity. Moreover, P3 amplitude in young and older adults varied with working memory performance efficiency. Among young adults, more efficient performance correlated with a larger P3 amplitude at parietal sites. In contrast, a higher P3 amplitude at midline electrode sites in older adults correlated with less efficient performance. Particularly, the enhanced frontal midline EEG activity in older adults during working memory performance seems to reflect inefficient use of neural resources due to frontal lobe dysfunction.	[Saliasi, Emi; Maurits, Natasha M.] Univ Groningen, Univ Med Ctr Groningen, Dept Neurol, Groningen, Netherlands; [Geerligs, Linda; Lorist, Monicque M.] Univ Groningen, Dept Expt Psychol, Groningen, Netherlands; [Saliasi, Emi; Geerligs, Linda; Lorist, Monicque M.; Maurits, Natasha M.] Univ Groningen, Univ Med Ctr Groningen, BCN Neuroimaging Ctr, Groningen, Netherlands	University of Groningen; University of Groningen; University of Groningen	Saliasi, E (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Neurol, Groningen, Netherlands.	e.saliasi@umcg.nl	Geerligs, Linda/D-5212-2013	Geerligs, Linda/0000-0002-1624-8380; Maurits, Natasha/0000-0001-6231-7044; Saliasi, Emi/0000-0003-1009-6010; Lorist, Monicque M./0000-0002-7361-093X				Baayen RH, 2008, J MEM LANG, V59, P390, DOI 10.1016/j.jml.2007.12.005; Baddeley A, 2003, NAT REV NEUROSCI, V4, P829, DOI 10.1038/nrn1201; Cabeza R, 2004, CEREB CORTEX, V14, P364, DOI 10.1093/cercor/bhg133; Cabeza R, 1997, J NEUROSCI, V17, P391; Cabeza R, 2002, NEUROIMAGE, V17, P1394, DOI 10.1006/nimg.2002.1280; Cabeza R, 2002, PSYCHOL AGING, V17, P85, DOI 10.1037//0882-7974.17.1.85; Cona G, 2012, NEUROPSYCHOLOGIA, V50, P2692, DOI 10.1016/j.neuropsychologia.2012.07.033; Daffner KR, 2011, J COGNITIVE NEUROSCI, V23, P1298, DOI 10.1162/jocn.2010.21540; Davis SW, 2008, CEREB CORTEX, V18, P1201, DOI 10.1093/cercor/bhm155; DONCHIN E, 1981, PSYCHOPHYSIOLOGY, V18, P493, DOI 10.1111/j.1469-8986.1981.tb01815.x; Fabiani M, 1998, PSYCHOPHYSIOLOGY, V35, P698, DOI 10.1017/S0048577298970780; FABIANI M, 1995, PSYCHOPHYSIOLOGY, V32, P579, DOI 10.1111/j.1469-8986.1995.tb01234.x; Fjell AM, 2001, BRAIN TOPOGR, V14, P25, DOI 10.1023/A:1012563605837; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Friedman D, 2001, NEUROSCI BIOBEHAV R, V25, P355, DOI 10.1016/S0149-7634(01)00019-7; Friedman D, 2003, J CLIN EXP NEUROPSYC, V25, P702, DOI 10.1076/jcen.25.5.702.14578; Gajewski PD, 2011, NEUROBIOL AGING, V32, DOI 10.1016/j.neurobiolaging.2011.06.010; Grady C, 2012, NAT REV NEUROSCI, V13, P491, DOI 10.1038/nrn3256; Grady CL, 2008, ANN NY ACAD SCI, V1124, P127, DOI 10.1196/annals.1440.009; GRADY CL, 1994, J NEUROSCI, V14, P1450, DOI 10.1523/JNEUROSCI.14-03-01450.1994; Grady CL, 2000, BIOL PSYCHOL, V54, P259, DOI 10.1016/S0301-0511(00)00059-4; GRADY CL, 1995, SCIENCE, V269, P218, DOI 10.1126/science.7618082; GRATTON G, 1989, PSYCHOPHYSIOLOGY, V26, P222, DOI 10.1111/j.1469-8986.1989.tb03160.x; Jonides J, 2000, J COGNITIVE NEUROSCI, V12, P188, DOI 10.1162/089892900561823; Kok A, 2001, PSYCHOPHYSIOLOGY, V38, P557, DOI 10.1017/S0048577201990559; Lezak M.D., 1995, NEUROPSYCHOLOGICAL A; Logan JM, 2002, NEURON, V33, P827, DOI 10.1016/S0896-6273(02)00612-8; Mattay VS, 2006, NEUROSCI LETT, V392, P32, DOI 10.1016/j.neulet.2005.09.025; Missonnier P, 2004, J NEURAL TRANSM, V111, P1141, DOI 10.1007/s00702-004-0159-2; Mitchell KJ, 2000, COGNITIVE BRAIN RES, V10, P197, DOI 10.1016/S0926-6410(00)00029-X; Nagel IE, 2009, P NATL ACAD SCI USA, V106, P22552, DOI 10.1073/pnas.0908238106; Newman AJ, 2012, J COGNITIVE NEUROSCI, V24, P1205, DOI 10.1162/jocn_a_00143; Nieuwenhuis S, 2005, PSYCHOL BULL, V131, P510, DOI 10.1037/0033-2909.131.4.510; O'Connell RG, 2012, NEUROBIOL AGING, V33, P2448, DOI 10.1016/j.neurobiolaging.2011.12.021; Park DC, 2009, ANNU REV PSYCHOL, V60, P173, DOI 10.1146/annurev.psych.59.103006.093656; Pinheiro J, 2001, MIXED EFFECTS MODELS; POLICH J, 1995, BIOL PSYCHOL, V41, P103, DOI 10.1016/0301-0511(95)05130-9; Polich J, 2007, CLIN NEUROPHYSIOL, V118, P2128, DOI 10.1016/j.clinph.2007.04.019; Reuter-Lorenz PA, 2000, J COGNITIVE NEUROSCI, V12, P174, DOI 10.1162/089892900561814; Salthouse TA, 1996, PSYCHOL REV, V103, P403, DOI 10.1037/0033-295X.103.3.403; Sandrini M, 2008, NEUROPSYCHOLOGIA, V46, P2056, DOI 10.1016/j.neuropsychologia.2008.02.003; Schmand B., 1992, NEDERLANDSE LEESTEST; Schneider-Garces NJ, 2010, J COGNITIVE NEUROSCI, V22, P655, DOI 10.1162/jocn.2009.21230; Segalowitz SJ, 2001, COGNITIVE BRAIN RES, V12, P451, DOI 10.1016/S0926-6410(01)00082-9; Soltani Maryam, 2000, Critical Reviews in Neurobiology, V14, P199; Turner GR, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.06.005; Uterwijk J., 2001, WAIS 3 NEDERLANDSTAL; van Rijn H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051134; Velanova K, 2007, CEREB CORTEX, V17, P1033, DOI 10.1093/cercor/bhl013; Wierda SM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015024; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	51	59	61	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e63701	10.1371/journal.pone.0063701	http://dx.doi.org/10.1371/journal.pone.0063701			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	154EP	23667658	Green Published, gold, Green Submitted			2022-12-27	WOS:000319654700176
J	Song, D; Cho, WK; Park, SH; Jo, Y; Kim, KH				Song, Dami; Cho, Won Kyong; Park, Sang-Ho; Jo, Yeonhwa; Kim, Kook-Hyung			Evolution of and Horizontal Gene Transfer in the Endornavirus Genus	PLOS ONE			English	Article							UDP-GLUCOSESTEROL GLUCOSYLTRANSFERASE; DIATOM THALASSIOSIRA-PSEUDONANA; VEIN-CLEARING VIRUS; DOUBLE-STRANDED-RNA; MOLECULAR CHARACTERIZATION; FUNCTIONAL EXPRESSION; PLANT PARARETROVIRUS; GENOME; MUTATIONS; SEQUENCES	The transfer of genetic information between unrelated species is referred to as horizontal gene transfer. Previous studies have demonstrated that both retroviral and non-retroviral sequences have been integrated into eukaryotic genomes. Recently, we identified many non-retroviral sequences in plant genomes. In this study, we investigated the evolutionary origin and gene transfer of domains present in endornaviruses which are double-stranded RNA viruses. Using the available sequences for endornaviruses, we found that Bell pepper endornavirus-like sequences homologous to the glycosyltransferase 28 domain are present in plants, fungi, and bacteria. The phylogenetic analysis revealed the glycosyltransferase 28 domain of Bell pepper endornavirus may have originated from bacteria. In addition, two domains of Oryza sativa endornavirus, a glycosyltransferase sugar-binding domain and a capsular polysaccharide synthesis protein, also exhibited high similarity to those of bacteria. We found evidence that at least four independent horizontal gene transfer events for the glycosyltransferase 28 domain have occurred among plants, fungi, and bacteria. The glycosyltransferase sugar-binding domains of two proteobacteria may have been horizontally transferred to the genome of Thalassiosira pseudonana. Our study is the first to show that three glycome-related viral genes in the genus Endornavirus have been acquired from marine bacteria by horizontal gene transfer.	[Song, Dami; Cho, Won Kyong; Park, Sang-Ho; Jo, Yeonhwa; Kim, Kook-Hyung] Seoul Natl Univ, Coll Agr & Life Sci, Inst Agr & Life Sci, Dept Agr Biotechnol,Plant Genom & Breeding Inst, Seoul, South Korea	Seoul National University (SNU)	Kim, KH (corresponding author), Seoul Natl Univ, Coll Agr & Life Sci, Inst Agr & Life Sci, Dept Agr Biotechnol,Plant Genom & Breeding Inst, Seoul, South Korea.	kookkim@snu.ac.kr	Cho, Won Kyong/I-5098-2012	Cho, Won Kyong/0000-0002-8416-5173	National Research Foundation of Korea (NRF); Korea government (MEST) [2011-0010027]; Next-Generation BioGreen 21 Program through the Rural Development Administration [PJ00798402]; Vegetable Breeding Research Center through the Agriculture Research Center program from the Ministry for Food, Agriculture, Forestry and Fisheries [710001-03]	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Korea government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government); Next-Generation BioGreen 21 Program through the Rural Development Administration; Vegetable Breeding Research Center through the Agriculture Research Center program from the Ministry for Food, Agriculture, Forestry and Fisheries	This research was supported in part by grants from the National Research Foundation of Korea (NRF) grant funded by the Korea government (MEST) (No. 2011-0010027), the Next-Generation BioGreen 21 Program (No. PJ00798402) through the Rural Development Administration, and the Vegetable Breeding Research Center (No. 710001-03) through the Agriculture Research Center program from the Ministry for Food, Agriculture, Forestry and Fisheries. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; Alverson AJ, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-125; Anisimova M, 2006, SYST BIOL, V55, P539, DOI 10.1080/10635150600755453; Armbrust EV, 2004, SCIENCE, V306, P79, DOI 10.1126/science.1101156; BENVENISTE RE, 1974, NATURE, V252, P456, DOI 10.1038/252456a0; Boeke J. D., 1997, P343; Bratlie MS, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-1; Cebulla CM, 2000, TRANSPLANTATION, V69, P1202, DOI 10.1097/00007890-200003270-00027; Chan CX, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029138; Chiba S, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002146; Dallot S, 2001, ARCH VIROL, V146, P2179, DOI 10.1007/s007050170028; DeBolt S, 2009, PLANT PHYSIOL, V151, P78, DOI 10.1104/pp.109.140582; Desbiez C, 2011, INFECT GENET EVOL, V11, P812, DOI 10.1016/j.meegid.2011.02.020; Dolja VV, 2006, VIRUS RES, V117, P38, DOI 10.1016/j.virusres.2006.02.002; Edwards K, 2009, PLANT BIOTECHNOL J, V7, P1, DOI 10.1111/j.1467-7652.2008.00392.x; Finn RD, 2010, NUCLEIC ACIDS RES, V38, pD211, DOI 10.1093/nar/gkp985; FUKUHARA T, 1993, PLANT MOL BIOL, V21, P1121, DOI 10.1007/BF00023608; Gibbs MJ, 2000, J GEN VIROL, V81, P227, DOI 10.1099/0022-1317-81-1-227; Gilbert C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000495; Goodstein DM, 2012, NUCLEIC ACIDS RES, V40, pD1178, DOI 10.1093/nar/gkr944; Hiraiwa N, 2003, BLOOD, V101, P3615, DOI 10.1182/blood-2002-07-2301; Holmes EC, 2011, CELL HOST MICROBE, V10, P368, DOI 10.1016/j.chom.2011.09.002; Hordijk W, 2005, BIOINFORMATICS, V21, P4338, DOI 10.1093/bioinformatics/bti713; Horie M, 2010, NATURE, V463, P84, DOI 10.1038/nature08695; Horiuchi H, 2004, VIRUS GENES, V29, P365, DOI 10.1007/s11262-004-7441-0; Jain R, 1999, P NATL ACAD SCI USA, V96, P3801, DOI 10.1073/pnas.96.7.3801; Jiang SM, 2001, INFECT IMMUN, V69, P1244, DOI 10.1128/IAI.69.3.1244-1255.2001; Katzourakis A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001191; Keeling PJ, 2008, NAT REV GENET, V9, P605, DOI 10.1038/nrg2386; King A.M.Q., 2011, VIRUS TAXONOMY, V1st ed; Koonin EV, 2001, ANNU REV MICROBIOL, V55, P709, DOI 10.1146/annurev.micro.55.1.709; Linder-Basso D, 2005, VIROLOGY, V337, P192, DOI 10.1016/j.virol.2005.03.038; Liu HQ, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-91; Lockhart BE, 2000, J GEN VIROL, V81, P1579, DOI 10.1099/0022-1317-81-6-1579; Makarenkov U, 2001, BIOINFORMATICS, V17, P664, DOI 10.1093/bioinformatics/17.7.664; Markine-Goriaynoff N, 2004, J GEN VIROL, V85, P2741, DOI 10.1099/vir.0.80320-0; Mbanzibwa DR, 2009, J VIROL, V83, P6934, DOI 10.1128/JVI.00537-09; MENGINLECREULX D, 1991, J BACTERIOL, V173, P4625, DOI 10.1128/jb.173.15.4625-4636.1991; Monier A, 2009, GENOME RES, V19, P1441, DOI 10.1101/gr.091686.109; Okada R, 2011, J GEN VIROL, V92, P2664, DOI 10.1099/vir.0.034686-0; Potocka A, 2008, ACTA BIOCHIM POL, V55, P127, DOI 10.18388/abp.2008_3105; RichertPoggeler KR, 1997, VIROLOGY, V236, P137, DOI 10.1006/viro.1997.8712; Roossinck MJ, 2011, J GEN VIROL, V92, P2674, DOI 10.1099/vir.0.034702-0; Roossinck MJ, 2010, PHILOS T R SOC B, V365, P1899, DOI 10.1098/rstb.2010.0057; Rosewich UL, 2000, ANNU REV PHYTOPATHOL, V38, P325, DOI 10.1146/annurev.phyto.38.1.325; Staginnus C, 2006, TRENDS PLANT SCI, V11, P485, DOI 10.1016/j.tplants.2006.08.008; Thomas CM, 2005, NAT REV MICROBIOL, V3, P711, DOI 10.1038/nrmicro1234; Warnecke D, 1999, J BIOL CHEM, V274, P13048, DOI 10.1074/jbc.274.19.13048; Warnecke DC, 1997, PLANT MOL BIOL, V35, P597, DOI 10.1023/A:1005806119807; Wiggins CAR, 1998, P NATL ACAD SCI USA, V95, P7945, DOI 10.1073/pnas.95.14.7945; Xie J, 2006, J GEN VIROL, V87, P241, DOI 10.1099/vir.0.81522-0; Yaegashi H, 2012, VIRUS RES, V165, P143, DOI 10.1016/j.virusres.2012.02.008	52	21	21	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e64270	10.1371/journal.pone.0064270	http://dx.doi.org/10.1371/journal.pone.0064270			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667703	Green Published, gold, Green Submitted			2022-12-27	WOS:000319654700205
J	Hale, JD; Davies, G; Fairbrass, AJ; Matthews, TJ; Rogers, CDF; Sadler, JP				Hale, James D.; Davies, Gemma; Fairbrass, Alison J.; Matthews, Thomas J.; Rogers, Christopher D. F.; Sadler, Jon P.			Mapping Lightscapes: Spatial Patterning of Artificial Lighting in an Urban Landscape	PLOS ONE			English	Article							GRADIENT ANALYSIS; AERIAL SURVEY; DARK SIDE; NIGHT-SKY; POLLUTION; URBANIZATION; POPULATION; EMISSIONS; ECOLOGY	Artificial lighting is strongly associated with urbanisation and is increasing in its extent, brightness and spectral range. Changes in urban lighting have both positive and negative effects on city performance, yet little is known about how its character and magnitude vary across the urban landscape. A major barrier to related research, planning and governance has been the lack of lighting data at the city extent, particularly at a fine spatial resolution. Our aims were therefore to capture such data using aerial night photography and to undertake a case study of urban lighting. We present the finest scale multi-spectral lighting dataset available for an entire city and explore how lighting metrics vary with built density and land-use. We found positive relationships between artificial lighting indicators and built density at coarse spatial scales, whilst at a local level lighting varied with land-use. Manufacturing and housing are the primary land-use zones responsible for the city's brightly lit areas, yet manufacturing sites are relatively rare within the city. Our data suggests that efforts to address light pollution should broaden their focus from residential street lighting to include security lighting within manufacturing areas.	[Hale, James D.; Sadler, Jon P.] Univ Birmingham, Sch Geog Earth & Environm Sci, Birmingham, W Midlands, England; [Davies, Gemma] Univ Lancaster, Lancaster Environm Ctr, Lancaster, Lancs, England; [Fairbrass, Alison J.] UCL, Ctr Urban Sustainabil & Resilience, London, England; [Matthews, Thomas J.] Univ Oxford, Sch Geog & Environm, Oxford, Oxon, England; [Rogers, Christopher D. F.] Univ Birmingham, Sch Civil Engn, Birmingham B15 2TT, W Midlands, England	University of Birmingham; Lancaster University; University of London; University College London; University of Oxford; University of Birmingham	Hale, JD (corresponding author), Univ Birmingham, Sch Geog Earth & Environm Sci, Birmingham, W Midlands, England.	j.hale@bham.ac.uk	Fairbrass, Alison/K-6563-2016; Rogers, Christopher/AAE-2395-2020	Fairbrass, Alison/0000-0002-4907-9683; Rogers, Christopher/0000-0002-1693-1999; Davies, Gemma/0000-0002-7420-2479; Matthews, Thomas/0000-0002-7624-244X; Sadler, Jonathan/0000-0003-0443-4458; Hale, James/0000-0001-9662-1853	Urban Futures (SUE2) program [EP/E0216030]; EPSRC [EP/I035129/1, EP/J017698/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/J017698/1, EP/I035129/1] Funding Source: researchfish; Natural Environment Research Council [ceh010010] Funding Source: researchfish	Urban Futures (SUE2) program; EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This research was undertaken as part of the Urban Futures (SUE2) program (EP/E0216030) (grant holder JPS) (http://www.epsrc.ac.uk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti M, 2005, INT REGIONAL SCI REV, V28, P168, DOI 10.1177/0160017605275160; Andersson E, 2006, ECOL SOC, V11; Andersson E, 2009, LANDSCAPE ECOL, V24, P1331, DOI 10.1007/s10980-009-9385-1; [Anonymous], 2010, WORLD URB PROSP 2009; Antrop M, 2000, LANDSCAPE ECOL, V15, P257, DOI 10.1023/A:1008151109252; Aubrecht C, 2010, LIGHTING GOVERNANCE; Barducci A, 2003, APPL OPTICS, V42, P4349, DOI 10.1364/AO.42.004349; Bolund P, 1999, ECOL ECON, V29, P293, DOI 10.1016/S0921-8009(99)00013-0; Bruce-White C., 2011, REV IMPACT ARTIFICIA; Cadenasso ML, 2007, FRONT ECOL ENVIRON, V5, P80, DOI 10.1890/1540-9295(2007)5[80:SHIUER]2.0.CO;2; Cervero R, 2001, URBAN STUD, V38, P1651, DOI 10.1080/00420980120084804; Cinzano P, 2001, MON NOT R ASTRON SOC, V328, P689, DOI 10.1046/j.1365-8711.2001.04882.x; Cinzano P, 2006, 26 IAU GEN ASS; Dallimer M, 2011, BIOL LETTERS, V7, P763, DOI 10.1098/rsbl.2011.0025; Davies TW, 2012, BIOL LETT; Doll C, 2008, THEMATIC GUIDE NIGHT; Dunn R, 1995, PREPARATORY WORK LAN; Elvidge CD, 2007, INT J REMOTE SENS, V28, P2645, DOI 10.1080/01431160600981525; Elvidge CD, 1997, INT J REMOTE SENS, V18, P1373, DOI 10.1080/014311697218485; Elvidge CD, 1997, GLOBAL CHANGE BIOL, V3, P387, DOI 10.1046/j.1365-2486.1997.00115.x; Elvidge CD, 2010, SENSORS-BASEL, V10, P3961, DOI 10.3390/s100403961; Falchi F, 2011, J ENVIRON MANAGE, V92, P2714, DOI 10.1016/j.jenvman.2011.06.029; Farrington DP, 2002, JUSTICE Q, V19, P313, DOI 10.1080/07418820200095261; Flanders Government, ORD FLEM GOV 1 JUN 1; Foster RG, 2005, NAT REV NEUROSCI, V6, P407, DOI 10.1038/nrn1670; Fuller RA, 2009, BIOL LETTERS, V5, P352, DOI 10.1098/rsbl.2009.0010; Gallaway T, 2010, ECOL ECON, V69, P658, DOI 10.1016/j.ecolecon.2009.10.003; Glaeser E, 2011, SCIENCE, V333, P592, DOI 10.1126/science.1209264; Grimm NB, 2008, SCIENCE, V319, P756, DOI 10.1126/science.1150195; Hahs AK, 2006, LANDSCAPE URBAN PLAN, V78, P435, DOI 10.1016/j.landurbplan.2005.12.005; Holker F, 2010, ECOL SOC, V15; ILE, 2005, GUID NOT RED OBSTR L; Imhoff ML, 1997, REMOTE SENS ENVIRON, V61, P361; Kruse F. A., 2011, IDENTIFYING MAPPING, P1, DOI [10.1109/AERO.2011.5747396, DOI 10.1109/AERO.2011.5747396]; Kuechly HU, 2012, REMOTE SENS ENVIRON, V126, P39, DOI 10.1016/j.rse.2012.08.008; Kyba CCM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017307; Levin N, 2012, REMOTE SENS ENVIRON, V119, P1, DOI 10.1016/j.rse.2011.12.005; Longcore T, 2004, FRONT ECOL ENVIRON, V2, P191, DOI 10.2307/3868314; Luginbuhl CB, 2009, PUBL ASTRON SOC PAC, V121, P185, DOI 10.1086/597625; Lyytimaki J, 2012, LAND USE POLICY, V29, P598, DOI 10.1016/j.landusepol.2011.10.002; Massey P, 2000, PUBL ASTRON SOC PAC, V112, P566, DOI 10.1086/316552; McDonnell MJ, 2008, LANDSCAPE ECOL, V23, P1143, DOI 10.1007/s10980-008-9253-4; MCDONNELL MJ, 1990, ECOLOGY, V71, P1232, DOI 10.2307/1938259; Mizon B., 2002, LIGHT POLLUTION RESP; Navara KJ, 2007, J PINEAL RES, V43, P215, DOI 10.1111/j.1600-079X.2007.00473.x; Neuman M, 2005, J PLAN EDUC RES, V25, P11, DOI 10.1177/0739456X04270466; Pimputkar S, 2009, NAT PHOTONICS, V3, P179, DOI 10.1038/nphoton.2009.32; RCEP, 2007, URB ENV ORYAL COMM E; Royal Commission on Environmental Pollution (RCEP), 2009, ART LIGHT ENV ROYAL; Small C, 2005, REMOTE SENS ENVIRON, V96, P277, DOI 10.1016/j.rse.2005.02.002; Smith M, 2009, NATURE, V457, P27, DOI 10.1038/457027a; Stevens RG, 2009, INT J EPIDEMIOL, V38, P963, DOI 10.1093/ije/dyp178; Sutton P, 2001, INT J REMOTE SENS, V22, P3061, DOI 10.1080/01431160010007015; Sutton P. C., 2007, URBAN REMOTE SENSING, P291; Taylor M.M., 2006, JPL, V8, P1114; Wanvik PO, 2009, ACCIDENT ANAL PREV, V41, P123, DOI 10.1016/j.aap.2008.10.003; Weng Q., 2007, URBAN REMOTE SENSING, P71; Williams K, 1999, LAND USE POLICY, V16, P167, DOI 10.1016/S0264-8377(99)00010-1; Wu JG, 2011, ECOL COMPLEX, V8, P1, DOI 10.1016/j.ecocom.2010.03.002; Zhang LQ, 2004, LANDSCAPE URBAN PLAN, V69, P1, DOI 10.1016/j.landurbplan.2003.08.006	60	81	83	5	87	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2013	8	5							e61460	10.1371/journal.pone.0061460	http://dx.doi.org/10.1371/journal.pone.0061460			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	177QL	23671566	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000321390200006
J	Lecarpentier, E; Tsatsaris, V; Goffinet, F; Cabrol, D; Sibai, B; Haddad, B				Lecarpentier, Edouard; Tsatsaris, Vassilis; Goffinet, Francois; Cabrol, Dominique; Sibai, Baha; Haddad, Bassam			Risk Factors of Superimposed Preeclampsia in Women with Essential Chronic Hypertension Treated before Pregnancy	PLOS ONE			English	Article							BLOOD-PRESSURE; UNITED-STATES; FETAL-GROWTH; OUTCOMES	Objective: To determine risk factors of superimposed preeclampsia in women with essential chronic hypertension receiving antihypertensive therapy prior to conception. Methods: A retrospective study of 211 patients that analyzed risk factors of superimposed preeclampsia at first prenatal visit. Variables with a p < .1 at univariate analysis were included in a logistic regression analysis. P < .05 was considered as significant. Results: Superimposed preeclampsia occurred in 49 (23.2%) women. In logistic regression analysis, previous preeclampsia [OR: 4.05 (1.61-10.16)], and mean arterial blood pressure of 95 mmHg or higher [OR: 4.60 (1.94-10.93)] were associated with increased risk of superimposed preeclampsia. When both variables were present, sensitivity, specificity, positive predictive value, negative predictive value, and likelihood ratio for superimposed preeclampsia were 43%, 94%, 70%, 85%, and 7.71 (95% CI: 3.20-18.57), respectively. Conclusion: In essential chronic hypertensive women, previous preeclampsia and mean arterial blood pressure of 95 mmHg or higher are associated with increased risks of superimposed preeclampsia.	[Lecarpentier, Edouard; Haddad, Bassam] Univ Paris 12, CHI Creteil, Creteil, France; [Tsatsaris, Vassilis; Goffinet, Francois; Cabrol, Dominique] Univ Paris 05, AP HP Cochin Port Royal, Paris, France; [Sibai, Baha] Univ Cincinnati, Cincinnati, OH USA; [Tsatsaris, Vassilis; Goffinet, Francois; Cabrol, Dominique; Haddad, Bassam] PREMUP Fdn, Paris, France; [Haddad, Bassam] CRC CHI Creteil, Creteil, France	Universite Paris-Est-Creteil-Val-de-Marne (UPEC); CHI Creteil; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; University System of Ohio; University of Cincinnati; UDICE-French Research Universities; Universite Paris Cite	Haddad, B (corresponding author), Univ Paris 12, CHI Creteil, Creteil, France.	bhaddad@chicreteil.fr	Haddad, Bassam/Q-7767-2018; Lecarpentier, Edouard/Q-4557-2018	GOFFINET, Francois/0000-0001-9643-0299				Abalos E, 2007, COCHRANE DB SYST REV, V24; Alexander GR, 1996, OBSTET GYNECOL, V87, P163, DOI 10.1016/0029-7844(95)00386-X; Askie LM, 2007, LANCET, V369, P1791, DOI 10.1016/S0140-6736(07)60712-0; Bujold E, 2010, OBSTET GYNECOL, V116, P402, DOI 10.1097/AOG.0b013e3181e9322a; Caritis S, 1998, NEW ENGL J MED, V338, P701, DOI 10.1056/NEJM199803123381101; Chappell LC, 2008, HYPERTENSION, V51, P1002, DOI 10.1161/HYPERTENSIONAHA.107.107565; Duckitt K, 2005, BRIT MED J, V330, P565, DOI 10.1136/bmj.38380.674340.E0; Elkadry E, 2003, AM J OBSTET GYNECOL, V189, P195, DOI 10.1067/mob.2003.371; Giannubilo SR, 2006, EUR J OBSTET GYN R B, V126, P63, DOI 10.1016/j.ejogrb.2005.06.042; McCowan LME, 1996, BRIT J OBSTET GYNAEC, V103, P123, DOI 10.1111/j.1471-0528.1996.tb09662.x; REY E, 1994, AM J OBSTET GYNECOL, V171, P410, DOI 10.1016/0002-9378(94)90276-3; SAFTLAS AF, 1990, AM J OBSTET GYNECOL, V163, P460, DOI 10.1016/0002-9378(90)91176-D; Sibai BM, 2011, AM J OBSTET GYNECOL, V204, DOI 10.1016/j.ajog.2010.11.027; Sibai BM, 2004, OBSTET GYNECOL, V103, P981, DOI 10.1097/01.AOG.0000126245.35811.2a; Sibai BM, 1998, NEW ENGL J MED, V339, P667, DOI 10.1056/NEJM199809033391004; Sibai BM, 2002, OBSTET GYNECOL, V100, P369, DOI 10.1016/S0029-7844(02)02128-2; Vernay M, 2012, J HYPERTENS, V30, P1920, DOI 10.1097/HJH.0b013e328356c59f; von Dadelszen P, 2000, LANCET, V355, P87, DOI 10.1016/S0140-6736(98)08049-0	18	29	34	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2013	8	5							e62140	10.1371/journal.pone.0062140	http://dx.doi.org/10.1371/journal.pone.0062140			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	177QL	23671584	Green Published, gold, Green Submitted			2022-12-27	WOS:000321390200014
J	Wu, DL; Zhang, R; Zhao, R; Chen, G; Cai, Y; Jin, JJ				Wu, Donglu; Zhang, Rui; Zhao, Rui; Chen, Guang; Cai, Yong; Jin, Jingji			A Novel Function of Novobiocin: Disrupting the Interaction of HIF 1 alpha and p300/CBP through Direct Binding to the HIF1 alpha C-Terminal Activation Domain	PLOS ONE			English	Article							CARBONIC-ANHYDRASE-IX; RENAL-CELL CARCINOMA; STRUCTURAL BASIS; HYPOXIA; EXPRESSION; PROTEIN; CANCER; PROGNOSIS; INHIBITION; DIAGNOSIS	Hypoxia-inducible factor 1 alpha (HIF1 alpha) is an important cellular survival protein under hypoxic conditions, regulating the cellular response to low oxygen tension via recruitment of a transcriptional co-activator, p300/CBP.p300/CBP induces expression of multiple genes involved in cell survival, proliferation, angiogenesis, and tumor development. Thus, a strategy to inhibit hypoxic responses in tumors may be to target the protein-protein interaction between HIF1 alpha and p300/CBP. Here, we document, for the first time, that the aminocoumarin antibiotic, novobiocin, directly blocks the protein-protein interaction between the HIF1 alpha C-terminal activation domain (CTAD) and the cysteine-histidine rich (CH1) region of p300/CBP. Also, novobiocin down-regulated HIF1 alpha-controlled gene expression, specifically CA9, which is related to tumorigenesis. In a monolayer cell culture, novobiocin inhibited cell proliferation and colony formation in the MCF-7 human breast adenocarcinoma cell line and the A549 human lung cancer cell line. Rescue experiments revealed that the recombinant CTAD fragment of HIF1 alpha partially reversed novobiocin's inhibitory effects on cell proliferation and colony formation in MCF-7 cells. These findings suggest a novel mechanism of action for novobiocin which has the potential for innovative therapeutic use in tumor treatment.	[Wu, Donglu; Zhang, Rui; Zhao, Rui; Cai, Yong; Jin, Jingji] Jilin Univ, Coll Life Sci, Changchun 130023, Jilin, Peoples R China; [Wu, Donglu; Zhang, Rui; Zhao, Rui] Jilin Univ, Grad Sch, Changchun 130023, Jilin, Peoples R China; [Chen, Guang] Jilin Univ, Clin Hosp 1, Changchun 130023, Jilin, Peoples R China; [Cai, Yong; Jin, Jingji] Jilin Univ, Coll Life Sci, Natl Engn Lab AIDS Vaccine, Changchun 130023, Jilin, Peoples R China	Jilin University; Jilin University; Jilin University; Jilin University	Cai, Y (corresponding author), Jilin Univ, Coll Life Sci, Changchun 130023, Jilin, Peoples R China.	caiyong62@jlu.edu.cn; jjjin@jlu.edu.cn		Zhao, Shane/0000-0002-2137-5536	National Natural Science Foundation of China [31070668, 31071131]; Research Fund for the Doctoral Program of Colleges and Universities [20110061110020]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Research Fund for the Doctoral Program of Colleges and Universities	This work was supported in part by National Natural Science Foundation of China (31070668 JJ and 31071131 YC) and Research Fund for the Doctoral Program of Colleges and Universities (20110061110020 JJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Akagi T, 2003, P NATL ACAD SCI USA, V100, P13567, DOI 10.1073/pnas.1834876100; Alqawi O, 2006, PROSTATE CANCER P D, V9, P126, DOI 10.1038/sj.pcan.4500852; Brandt GEL, 2009, CURR TOP MED CHEM, V9, P1447, DOI 10.2174/156802609789895683; Dames SA, 2002, P NATL ACAD SCI USA, V99, P5271, DOI 10.1073/pnas.082121399; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Dorai T, 2005, EUR J CANCER, V41, P2935, DOI 10.1016/j.ejca.2005.09.011; EASTMAN A, 1987, PHARMACOL THERAPEUT, V34, P155, DOI 10.1016/0163-7258(87)90009-X; Freedman SJ, 2002, P NATL ACAD SCI USA, V99, P5367, DOI 10.1073/pnas.082117899; Ho V, 2010, ENVIRON MOL MUTAGEN, V51, P552, DOI 10.1002/em.20573; Hofr C, 2001, J BIOL CHEM, V276, P9655, DOI 10.1074/jbc.M010205200; Hussain SA, 2007, BRIT J CANCER, V96, P104, DOI 10.1038/sj.bjc.6603530; Ivan M, 2002, P NATL ACAD SCI USA, V99, P13459, DOI 10.1073/pnas.192342099; Jubb AM, 2009, BRIT J CANCER, V101, P1749, DOI 10.1038/sj.bjc.6605368; Kim BR, 2012, CELL SIGNAL, V24, P1406, DOI 10.1016/j.cellsig.2012.03.002; Klatte T, 2009, CANCER-AM CANCER SOC, V115, P1448, DOI 10.1002/cncr.24163; Kung AL, 2004, CANCER CELL, V6, P33, DOI 10.1016/j.ccr.2004.06.009; Kung AL, 2000, NAT MED, V6, P1335, DOI 10.1038/82146; Kushal S, 2011, BIOPOLYMERS, V95, P8, DOI 10.1002/bip.21550; Kusuma BR, 2011, BIOORG MED CHEM LETT, V21, P7170, DOI 10.1016/j.bmcl.2011.09.073; Leibovich BC, 2007, J CLIN ONCOL, V25, P4757, DOI 10.1200/JCO.2007.12.1087; Liao SY, 1997, CANCER RES, V57, P2827; Luo XG, 2010, IUBMB LIFE, V62, P194, DOI 10.1002/iub.288; Marcu MG, 2000, JNCI-J NATL CANCER I, V92, P242, DOI 10.1093/jnci/92.3.242; Marcu MG, 2000, J BIOL CHEM, V275, P37181, DOI 10.1074/jbc.M003701200; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; Mooring SR, 2011, SCI CHINA CHEM, V54, P24, DOI 10.1007/s11426-010-4187-5; Newton AL, 2000, J BIOL CHEM, V275, P15128, DOI 10.1074/jbc.M910396199; Ratcliffe PJ, 1998, J EXP BIOL, V201, P1153; Ruan K, 2009, J CELL BIOCHEM, V107, P1053, DOI 10.1002/jcb.22214; Schwab LP, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3087; Seeber LMS, 2011, CRIT REV ONCOL HEMAT, V78, P173, DOI 10.1016/j.critrevonc.2010.05.003; SEMENZA GL, 1992, MOL CELL BIOL, V12, P5447, DOI 10.1128/MCB.12.12.5447; Stillebroer AB, 2010, EUR UROL, V58, P75, DOI 10.1016/j.eururo.2010.03.015; Swinson DEB, 2003, J CLIN ONCOL, V21, P473, DOI 10.1200/JCO.2003.11.132; Tostain J, 2010, EUR J CANCER, V46, P3141, DOI 10.1016/j.ejca.2010.07.020; Wan J, 2011, J EXP CLIN CANC RES, V30, DOI 10.1186/1756-9966-30-77; Yeo EJ, 2006, BLOOD, V107, P916, DOI 10.1182/blood-2005-06-2564	37	17	19	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2013	8	5							e62014	10.1371/journal.pone.0062014	http://dx.doi.org/10.1371/journal.pone.0062014			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	177QL	23671581	gold, Green Published, Green Submitted			2022-12-27	WOS:000321390200013
J	Fernandez, LP; Lopez-Marquez, A; Martinez, AM; Gomez-Lopez, G; Santisteban, P				Fernandez, Lara P.; Lopez-Marquez, Aristides; Martinez, Angel M.; Gomez-Lopez, Gonzalo; Santisteban, Pilar			New Insights into FoxE1 Functions: Identification of Direct FoxE1 Targets in Thyroid Cells	PLOS ONE			English	Article							SODIUM/IODIDE SYMPORTER GENE; PAIRED-DOMAIN TRANSCRIPTION; FACTOR PAX8; FACTOR-I; THYROPEROXIDASE PROMOTER; HORMONAL-REGULATION; GENOMIC DATA; FACTOR TTF-2; EXPRESSION; DIFFERENTIATION	Background: FoxE1 is a thyroid-specific forkhead transcription factor essential for thyroid gland development, as well as for the maintenance of the thyroid differentiated state in adults. FoxE1 recognizes and binds to a short DNA sequence present in thyroglobulin (Tg) and thyroperoxidase (Tpo) promoters, but FoxE1 binding to regulatory regions other than Tg and Tpo promoters remains almost unexplored. Improving knowledge of the regulatory functions of FoxE1 is necessary to clarify its role in endocrine syndromes and cancer susceptibility. Methodology/Principal Finding: In order to further investigate downstream FoxE1 targets, we performed a genome-wide expression screening after knocking-down FoxE1 and obtained new insights into FoxE1 transcriptional networks in thyroid follicular cells. After validation, we confirmed Adamts9, Cdh1, Duox2 and S100a4 as upregulated genes and Casp4, Creld2, Dusp5, Etv5, Hsp5a, Nr4a2 and Tm4sf1 as downregulated genes when FoxE1 was silenced. In promoter regions of putative FoxE1-regulated genes and also in the promoters of the classical thyroid genes Nis, Pax8 and Titf1, we performed an in silico search of the FoxE1 binding motif that was in close proximity to the NF1/CTF binding sequence, as previously described for other forkhead factors. Using chromatin immunoprecipitation we detected specific in vivo FoxE1 binding to novel regulatory regions in two relevant thyroid genes, Nis and Duox2. Moreover, we demonstrated simultaneous binding of FoxE1 and NF1/CTF to the Nis upstream enhancer region, as well as a clear functional activation of the Nis promoter by both transcription factors. Conclusions/Significance: In search for potential downstream mediators of FoxE1 function in thyroid cells, we identified two novel direct FoxE1 target genes. To our knowledge, this is the first evidence regarding the implication of Nis and Duox2 in executing the transcriptional program triggered by FoxE1. Furthermore, this study points out the important role of FoxE1 in the regulation of a large number of genes in thyroid cells.	[Fernandez, Lara P.; Lopez-Marquez, Aristides; Martinez, Angel M.; Santisteban, Pilar] CSIC, Inst Invest Biomed Alberto Sols, Madrid, Spain; [Fernandez, Lara P.; Lopez-Marquez, Aristides; Martinez, Angel M.; Santisteban, Pilar] Univ Autonoma Madrid CSIC UAM, Madrid, Spain; [Martinez, Angel M.; Gomez-Lopez, Gonzalo] Spanish Natl Canc Res Ctr CNIO, Bioinformat Unit, Struct Biol Program, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas Alberto Sols (IIBM); Consejo Superior de Investigaciones Cientificas (CSIC); Centro Nacional de Investigaciones Oncologicas (CNIO)	Santisteban, P (corresponding author), CSIC, Inst Invest Biomed Alberto Sols, Madrid, Spain.	psantisteban@iib.uam.es	Gomez-Lopez, Gonzalo/D-9123-2016; Lopez-Marquez, Aristides/N-8788-2015; Alvarez, Lara Paula Fernandez/ABF-3692-2020; Álvarez, Lara Fernández/Z-4685-2019; López-Márquez, Arístides/AAN-9814-2021; López-Márquez, Arístides/AAA-6500-2021; Santisteban, Pilar/E-7829-2016	Gomez-Lopez, Gonzalo/0000-0002-4146-0551; López-Márquez, Arístides/0000-0002-0124-3261; López-Márquez, Arístides/0000-0002-0124-3261; Santisteban, Pilar/0000-0002-2758-796X; Fernandez Alvarez, Lara Paula/0000-0001-8830-6300; Martinez Montes, Angel Mario/0000-0003-1461-4516	Direccion General de Proyectos de Investigacion [BFU-2010-16025]; FIS, Instituto de Salud Carlos III [RD06/0020/0060, RD12/0036/0030]; Comunidad de Madrid (Spain) [S2011/BMD-2328 TIRONET]; Juan de la Cierva programme of the Spanish Government	Direccion General de Proyectos de Investigacion; FIS, Instituto de Salud Carlos III(Instituto de Salud Carlos III); Comunidad de Madrid (Spain)(Comunidad de Madrid); Juan de la Cierva programme of the Spanish Government	This work was supported by Grants BFU-2010-16025 from the Direccion General de Proyectos de Investigacion; RD06/0020/0060 and RD12/0036/0030 from FIS, Instituto de Salud Carlos III; and S2011/BMD-2328 TIRONET project from the Comunidad de Madrid (Spain). LP Fernandez holds a postdoctoral grant of the Juan de la Cierva programme of the Spanish Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Shahrour F, 2007, NUCLEIC ACIDS RES, V35, pW91, DOI 10.1093/nar/gkm260; AZABLANC P, 1993, MOL ENDOCRINOL, V7, P1297, DOI 10.1210/me.7.10.1297; BAMFORTH JS, 1989, J MED GENET, V26, P49, DOI 10.1136/jmg.26.1.49; BJORKMAN U, 1981, J ULTRA MOL STRUCT R, V74, P105, DOI 10.1016/S0022-5320(81)80113-X; BJORKMAN U, 1984, ENDOCRINOLOGY, V115, P392; BRABANT G, 1995, ENDOCRINOLOGY, V136, P3113, DOI 10.1210/en.136.7.3113; Brune K, 2008, CANCER EPIDEM BIOMAR, V17, P3536, DOI 10.1158/1055-9965.EPI-08-0630; Bullock M, 2012, J CLIN ENDOCR METAB, V97, pE1814, DOI 10.1210/jc.2012-1456; Carlsson P, 2002, DEV BIOL, V250, P1, DOI 10.1006/dbio.2002.0780; Christophe-Hobertus C, 2007, MOL CELL ENDOCRINOL, V264, P157, DOI 10.1016/j.mce.2006.11.005; Clifton-Bligh RJ, 1998, NAT GENET, V19, P399, DOI 10.1038/1294; Costamagna E, 2004, J BIOL CHEM, V279, P3439, DOI 10.1074/jbc.M307138200; Cuesta I, 2007, MOL CELL BIOL, V27, P7302, DOI 10.1128/MCB.00758-07; D'Andrea B, 2006, MOL ENDOCRINOL, V20, P1810, DOI 10.1210/me.2005-0463; Damante G, 2001, PROG NUCLEIC ACID RE, V66, P307; De Felice M, 2004, ENDOCR REV, V25, P722, DOI 10.1210/er.2003-0028; De Felice M, 1998, NAT GENET, V19, P395, DOI 10.1038/1289; De la Vieja A, 2007, J BIOL CHEM, V282, P25290, DOI 10.1074/jbc.M700147200; Dupuy C, 2000, BIOCHEM BIOPH RES CO, V277, P287, DOI 10.1006/bbrc.2000.3671; Dupuy C, 1999, J BIOL CHEM, V274, P37265, DOI 10.1074/jbc.274.52.37265; FRANCISLANG H, 1992, MOL CELL BIOL, V12, P576, DOI 10.1128/MCB.12.2.576; FUSCO A, 1987, MOL CELL BIOL, V7, P3365, DOI 10.1128/MCB.7.9.3365; Garcia B, 2002, MOL ENDOCRINOL, V16, P342, DOI 10.1210/me.16.2.342; Gudmundsson J, 2009, NAT GENET, V41, P460, DOI 10.1038/ng.339; Hishinuma A, 2004, MOL CELL ENDOCRINOL, V221, P33, DOI 10.1016/j.mce.2004.04.003; JACKSON DA, 1993, MOL CELL BIOL, V13, P2401, DOI 10.1128/MCB.13.4.2401; Landa I, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000637; Lee HS, 2010, STEM CELLS, V28, P501, DOI 10.1002/stem.294; Li W, 2010, ENDOCR-RELAT CANCER, V17, P383, DOI 10.1677/ERC-09-0156; Maijenburg MW, 2012, STEM CELLS DEV, V21, P228, DOI 10.1089/scd.2011.0076; Medina DL, 2000, EUR J ENDOCRINOL, V143, P161, DOI 10.1530/eje.0.1430161; Medina I, 2010, NUCLEIC ACIDS RES, V38, pW210, DOI 10.1093/nar/gkq388; Moreno JC, 2002, NEW ENGL J MED, V347, P95, DOI 10.1056/NEJMoa012752; Myatt SS, 2007, NAT REV CANCER, V7, P847, DOI 10.1038/nrc2223; NEBL G, 1995, CELL MOL BIOL RES, V41, P85; Ohno M, 1999, MOL CELL BIOL, V19, P2051; Ortiz L, 1999, J BIOL CHEM, V274, P15213, DOI 10.1074/jbc.274.21.15213; Ortiz L, 1997, J BIOL CHEM, V272, P23334, DOI 10.1074/jbc.272.37.23334; Park E, 2012, BIOCHEM BIOPH RES CO, V421, P532, DOI 10.1016/j.bbrc.2012.04.039; Perrone L, 2000, BIOCHEM BIOPH RES CO, V275, P203, DOI 10.1006/bbrc.2000.3232; PIERROU S, 1994, EMBO J, V13, P5002, DOI 10.1002/j.1460-2075.1994.tb06827.x; Ruiz-Llorente S, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-147; SANTISTEBAN P, 1992, MOL ENDOCRINOL, V6, P1310, DOI 10.1210/me.6.8.1310; Venza I, 2010, BRIT J DERMATOL, V162, P1093, DOI 10.1111/j.1365-2133.2009.09560.x; Venza I, 2010, BRIT J DERMATOL, V162, P681, DOI 10.1111/j.1365-2133.2009.09557.x; Venza I, 2011, HUM MOL GENET, V20, P1016, DOI 10.1093/hmg/ddq547; Vigone Maria Cristina, 2005, Hum Mutat, V26, P395; Wang B, 2003, J BIOL CHEM, V278, P24259, DOI 10.1074/jbc.M207174200; YAP AS, 1995, ENDOCRINOLOGY, V136, P4672, DOI 10.1210/en.136.10.4672; Zannini M, 1997, EMBO J, V16, P3185, DOI 10.1093/emboj/16.11.3185; Zaret KS, 2011, GENE DEV, V25, P2227, DOI 10.1101/gad.176826.111	51	31	31	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2013	8	5							e62849	10.1371/journal.pone.0062849	http://dx.doi.org/10.1371/journal.pone.0062849			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145RZ	23675434	gold, Green Published, Green Submitted			2022-12-27	WOS:000319036100015
J	Ramos-Fernandez, G; Aguilar, SES; Schaffner, CM; Vick, LG; Aureli, F				Ramos-Fernandez, Gabriel; Smith Aguilar, Sandra E.; Schaffner, Colleen M.; Vick, Laura G.; Aureli, Filippo			Site Fidelity in Space Use by Spider Monkeys (Ateles geoffroyi) in the Yucatan Peninsula, Mexico	PLOS ONE			English	Article							HOME-RANGE SIZE; NATIONAL-PARK; HABITAT USE; CORE AREAS; FOREST; PATTERNS; BEHAVIOR; QUALITY; DETERMINANTS; MOVEMENTS	Animal home ranges may vary little in their size and location in the short term but nevertheless show more variability in the long term. We evaluated the degree of site fidelity of two groups of spider monkeys (Ateles geoffroyi) over a 10- and 13-year period, respectively, in the northeastern Yucatan peninsula, Mexico. We used the Local Convex Hull method to estimate yearly home ranges and core areas (defined as the 60% probability contour) for the two groups. Home ranges varied from 7.7 to 49.6 ha and core areas varied from 3.1 to 9.2 ha. We evaluated the degree of site fidelity by quantifying the number of years in which different areas were used as either home ranges or core areas. Large tracts were used only as home ranges and only for a few years, whereas small areas were used as either core area or home range for the duration of the study. The sum of the yearly core areas coincided partially with the yearly home ranges, indicating that home ranges contain areas used intermittently. Home ranges, and especially core areas, contained a higher proportion of mature forest than the larger study site as a whole. Across years and only in one group, the size of core areas was positively correlated with the proportion of adult males in the group, while the size of home ranges was positively correlated with both the proportion of males and the number of tree species included in the diet. Our findings suggest that spider monkey home ranges are the result of a combination of long-term site fidelity and year-to-year use variation to enable exploration of new resources.	[Ramos-Fernandez, Gabriel; Smith Aguilar, Sandra E.] Inst Politecn Nacl, Ctr Interdisciplinario Invest El Desarrollo Integ, Unidad Oaxaca, Xoxocotlan, Oaxaca, Mexico; [Schaffner, Colleen M.; Aureli, Filippo] Univ Veracruzana, Inst Neuroetol, Xalapa 91000, Veracruz, Mexico; [Schaffner, Colleen M.] Univ Chester, Dept Psychol, Chester, Cheshire, England; [Vick, Laura G.] William Peace Univ, Dept Anthropol, Raleigh, NC USA; [Aureli, Filippo] Liverpool John Moores Univ, Sch Nat Sci & Psychol, Res Ctr Evolutionary Anthropol & Palaeoecol, Liverpool L3 5UX, Merseyside, England	Instituto Politecnico Nacional - Mexico; Universidad Veracruzana; University of Chester; Liverpool John Moores University	Ramos-Fernandez, G (corresponding author), Inst Politecn Nacl, Ctr Interdisciplinario Invest El Desarrollo Integ, Unidad Oaxaca, Xoxocotlan, Oaxaca, Mexico.	ramosfer@alumni.upenn.edu	Ramos-Fernandez, Gabriel/F-9798-2015; Ramos-Fernandez, Gabriel/GQR-1310-2022; Smith-Aguilar, Sandra Elizabeth/AAR-2926-2021	Ramos-Fernandez, Gabriel/0000-0001-7175-3905; Ramos-Fernandez, Gabriel/0000-0001-7175-3905; Smith-Aguilar, Sandra Elizabeth/0000-0003-2209-5496; Aureli, Filippo/0000-0002-0671-013X	Consejo Nacional de Ciencia y Tecnologia (CONACYT) [J51278, 157656]; Wenner-Gren Foundation; North of England Zoological Society; British Academy; National Geographic Society; University of Chester; Instituto Politecnico Nacional; William Peace University; Laboratorio Ecotono (INIBIOMA-CONICET); Laboratorio Ecotono (Universidad Nacional del Comahue)	Consejo Nacional de Ciencia y Tecnologia (CONACYT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Wenner-Gren Foundation; North of England Zoological Society; British Academy; National Geographic Society(National Geographic Society); University of Chester; Instituto Politecnico Nacional; William Peace University; Laboratorio Ecotono (INIBIOMA-CONICET); Laboratorio Ecotono (Universidad Nacional del Comahue)	We are grateful to the Consejo Nacional de Ciencia y Tecnologia (CONACYT; grants J51278 and 157656), The Wenner-Gren Foundation, The North of England Zoological Society, The British Academy, The National Geographic Society, The University of Chester, Instituto Politecnico Nacional, William Peace University and Laboratorio Ecotono (INIBIOMA-CONICET and Universidad Nacional del Comahue) for their financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asensio N, 2012, J ZOOL, V287, P250, DOI 10.1111/j.1469-7998.2012.00911.x; Asensio N, 2012, PRIMATES, V53, P147, DOI 10.1007/s10329-011-0288-9; Blake S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003546; Borger L, 2008, ECOL LETT, V11, P637, DOI 10.1111/j.1461-0248.2008.01182.x; BOLLINGER EK, 1989, AUK, V106, P584; Borger L, 2006, J ANIM ECOL, V75, P1393, DOI 10.1111/j.1365-2656.2006.01164.x; Borger L, 2006, AM NAT, V168, P471, DOI 10.1086/507883; Burt W. H., 1943, J MAMMAL, V24, P346, DOI DOI 10.2307/1374834; Cairns MA, 2003, FOREST ECOL MANAG, V186, P125, DOI 10.1016/S0378-1127(03)00229-9; Challeger A, 1998, UTILIZACION CONSERVA; Comision Nacional del Agua, 2005, PATR MENS PREC TEMP; Connor EF, 2000, ECOLOGY, V81, P734, DOI 10.2307/177373; Creel S., 2002, AFRICAN WILD DOG BEH; De Solla SR, 1999, J ANIM ECOL, V68, P221, DOI 10.1046/j.1365-2656.1999.00279.x; Deutsch CJ, 2003, WILDLIFE MONOGR, P1; ESRI, 2007, ARCGIS 9 2; Garcia-Frapolli E, 2007, LANDSCAPE URBAN PLAN, V83, P137, DOI 10.1016/j.landurbplan.2007.03.007; Getz WM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000207; Getz WM, 2004, ECOGRAPHY, V27, P489, DOI 10.1111/j.0906-7590.2004.03835.x; Hanski IK, 2000, J MAMMAL, V81, P798, DOI 10.1644/1545-1542(2000)081<0798:HRSMAN>2.3.CO;2; Janmaat KRL, 2009, INT J PRIMATOL, V30, P443, DOI 10.1007/s10764-009-9352-3; Janson C, 2000, ON THE MOVE: HOW AND WHY ANIMALS TRAVEL IN GROUPS, P165; Janson CH, 2007, ANIM COGN, V10, P357, DOI 10.1007/s10071-007-0080-9; Jetz W, 2004, SCIENCE, V306, P266, DOI 10.1126/science.1102138; Kie JG, 2010, PHILOS T R SOC B, V365, P2221, DOI 10.1098/rstb.2010.0093; Laver PN, 2008, J WILDLIFE MANAGE, V72, P290, DOI 10.2193/2005-589; Lurz PWW, 1997, ANIM BEHAV, V54, P427, DOI 10.1006/anbe.1996.0486; McLoughlin PD, 2000, EVOL ECOL, V14, P39, DOI 10.1023/A:1011019031766; Michalski F, 2005, BIOL CONSERV, V124, P383, DOI 10.1016/j.biocon.2005.01.045; Ortega YK, 2006, OECOLOGIA, V149, P340, DOI 10.1007/s00442-006-0438-8; Peres CA, 2001, CONSERV BIOL, V15, P1490, DOI 10.1046/j.1523-1739.2001.01089.x; Powell RA, 2000, METH C CONS, P65; R Core Team, 2012, R LANG ENV STAT COMP; Radespiel U, 2003, AM J PRIMATOL, V59, P139, DOI 10.1002/ajp.10071; Ramos-Fernandez G, 2005, INT J PRIMATOL, V26, P1077, DOI 10.1007/s10764-005-6459-z; Ramos-Fernandez G, 2004, BEHAV ECOL SOCIOBIOL, V55, P223, DOI 10.1007/s00265-003-0700-6; Ramos-Fernandez G, 2003, PRIMATES IN FRAGMENTS: ECOLOGY AND CONSERVATION, P191; Ramos-Fernandez G, 2001, PATTERNS ASS FEEDING; Ramos-Fernandez Gabriel, 2003, Neotropical Primates, V11, P155; Schaffner CM, 2012, INT J PRIMATOL, V33, P922, DOI 10.1007/s10764-012-9621-4; Spehar SN, 2010, AM J PRIMATOL, V72, P129, DOI 10.1002/ajp.20763; Suarez SA, 2006, INT J PRIMATOL, V27, P411, DOI 10.1007/s10764-006-9023-6; Switzer PV, 1997, ANIM BEHAV, V53, P865, DOI 10.1006/anbe.1996.0352; SYMINGTON MM, 1990, INT J PRIMATOL, V11, P47, DOI 10.1007/BF02193695; SYMINGTON MM, 1988, AM J PRIMATOL, V15, P45, DOI 10.1002/ajp.1350150106; Symonds MRE, 2011, BEHAV ECOL SOCIOBIOL, V65, P13, DOI 10.1007/s00265-010-1037-6; Topping DT, 2006, MAR ECOL PROG SER, V326, P257, DOI 10.3354/meps326257; Valero A, 2007, ANIM COGN, V10, P305, DOI 10.1007/s10071-006-0066-z; van Beest FM, 2011, J ANIM ECOL, V80, P771, DOI 10.1111/j.1365-2656.2011.01829.x; Van Moorter B, 2009, OIKOS, V118, P641, DOI 10.1111/j.1600-0706.2008.17003.x; Wallace RB, 2006, AM J PRIMATOL, V68, P313, DOI 10.1002/ajp.20227; Wallace RB, 2008, AM J PRIMATOL, V70, P271, DOI 10.1002/ajp.20484; Wallace RB, 2008, CAM S BIO EVOL ANTHR, V55, P138; Wartmann FM, 2010, PRIMATES, V51, P119, DOI 10.1007/s10329-009-0186-6; Watts DP, 1998, INT J PRIMATOL, V19, P651, DOI 10.1023/A:1020324909101; Wayne Getz lab, 2005, LOCOH ARCGIS TOOLB; WORTON BJ, 1995, J WILDLIFE MANAGE, V59, P794, DOI 10.2307/3801959; WORTON BJ, 1987, ECOL MODEL, V38, P277, DOI 10.1016/0304-3800(87)90101-3	58	34	34	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2013	8	5							e62813	10.1371/journal.pone.0062813	http://dx.doi.org/10.1371/journal.pone.0062813			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145RZ	23675427	gold, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000319036100012
J	Skalova, H; Jarosik, V; Dvorackova, S; Pysek, P				Skalova, Hana; Jarosik, Vojtech; Dvorackova, Sarka; Pysek, Petr			Effect of Intra- and Interspecific Competition on the Performance of Native and Invasive Species of Impatiens under Varying Levels of Shade and Moisture	PLOS ONE			English	Article							ALIEN PLANTS; PHENOTYPIC PLASTICITY; TRAITS; EVOLUTION; DIVERSITY; FRAMEWORK; DYNAMICS; HABITAT; GLANDULIFERA; COMMUNITIES	Many alien plants are thought to be invasive because of unique traits and greater phenotypic plasticity relative to resident species. However, many studies of invasive species are unable to quantify the importance of particular traits and phenotypic plasticity in conferring invasive behavior because traits used in comparative studies are often measured in a single environment and by using plants from a single population. To obtain a deeper insight into the role of environmental factors, local differences and competition in plant invasions, we compared species of Impatiens (Balsaminaceae) of different origin and invasion status that occur in central Europe: native I. noli-tangere and three alien species (highly invasive I. glandulifera, less invasive I. parviflora and potentially invasive I. capensis). In two experiments we harvested late-stage reproductive plants to estimate performance. The first experiment quantified how populations differed in performance under varying light and moisture levels in the absence of competition. The second experiment quantified performance across these environments in the presence of intra-and inter-specific competition. The highly invasive I. glandulifera was the strongest competitor, was the tallest and produced the greatest biomass. Small size and high plasticity were characteristic for I. parviflora. This species appeared to be the second strongest competitor, especially under low soil moisture. The performance of I. capensis was within the range of the other Impatiens species studied, but sometimes limited by alien competitors. Our results suggest that invasion success within the genus Impatiens depends on the ability to grow large under a range of environmental conditions, including competition. The invasive species also exhibited greater phenotypic plasticity across environmental conditions than the native species. Finally, the decreased performance of the native I. noli-tangere in competition with other species studied indicates that this species may be possibly excluded from its sites by invading congeners.	[Skalova, Hana; Jarosik, Vojtech; Dvorackova, Sarka; Pysek, Petr] Acad Sci Czech Republ, Inst Bot, CS-25243 Pruhonice, Czech Republic; [Jarosik, Vojtech; Pysek, Petr] Charles Univ Prague, Dept Ecol, Prague, Czech Republic	Czech Academy of Sciences; Institute of Botany of the Czech Academy of Sciences; Charles University Prague	Skalova, H (corresponding author), Acad Sci Czech Republ, Inst Bot, CS-25243 Pruhonice, Czech Republic.	hana.skalova@ibot.cas.cz	Pysek, Petr/B-1957-2012; Skalova, Hana/H-1627-2014	Skalova, Hana/0000-0002-1252-2952	Academy of Sciences of the Czech Republic;  [GACR 206/07/0668];  [206/09/0563];  [RVO 67985939]	Academy of Sciences of the Czech Republic(Czech Academy of Sciences); ; ; 	The work was supported by grants GACR 206/07/0668 and 206/09/0563, long-term research development project no. RVO 67985939. Petr Pysek acknowledges the support of a Praemium Academiae award from the Academy of Sciences of the Czech Republic. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamowski W., 2008, Plant invasions: human perception, ecological impacts and management, P57; Alexander JM, 2010, J BIOGEOGR, V37, P1951, DOI 10.1111/j.1365-2699.2010.02335.x; Baker H. G., 1965, The genetics of colonizing species., P147; BEERLING DJ, 1993, J ECOL, V81, P367, DOI 10.2307/2261507; Bimova K, 2004, J VEG SCI, V15, P495, DOI 10.1111/j.1654-1103.2004.tb02288.x; Blackburn TM, 2011, TRENDS ECOL EVOL, V26, P333, DOI 10.1016/j.tree.2011.03.023; Blumenthal D, 2009, P NATL ACAD SCI USA, V106, P7899, DOI 10.1073/pnas.0812607106; Burns JH, 2006, BIOL INVASIONS, V8, P797, DOI 10.1007/s10530-005-3838-5; Burns JH, 2004, DIVERS DISTRIB, V10, P387, DOI 10.1111/j.1366-9516.2004.00105.x; Chytry M, 2008, J APPL ECOL, V45, P448, DOI 10.1111/j.1365-2664.2007.01398.x; COOMBE DE, 1956, J ECOL, V44, P701, DOI 10.2307/2256857; Crawley M.J., 1993, GLIM ECOLOGISTS; Crawley M. J, 2002, STAT COMPUTING INTRO; Daehler CC, 2003, ANNU REV ECOL EVOL S, V34, P183, DOI 10.1146/annurev.ecolsys.34.011802.132403; Davidson AM, 2011, ECOL LETT, V14, P419, DOI 10.1111/j.1461-0248.2011.01596.x; Davis MA, 2000, J ECOL, V88, P528, DOI 10.1046/j.1365-2745.2000.00473.x; Dayan T, 2005, ECOL LETT, V8, P875, DOI 10.1111/j.1461-0248.2005.00791.x; Diggle P., 2002, ANAL LONGITUDINAL DA, DOI DOI 10.2307/2983303; Foxcroft LC, 2007, CONSERV BIOL, V21, P412, DOI 10.1111/j.1523-1739.2007.00673.x; Foxcroft LC, 2011, CONSERV BIOL, V25, P400, DOI 10.1111/j.1523-1739.2010.01617.x; Franks PJ, 1999, PLANT CELL ENVIRON, V22, P1337, DOI 10.1046/j.1365-3040.1999.00494.x; Funk JL, 2008, J ECOL, V96, P1162, DOI 10.1111/j.1365-2745.2008.01435.x; Grotkopp E, 2002, AM NAT, V159, P396, DOI 10.1086/338995; Grotkopp E, 2007, AM J BOT, V94, P526, DOI 10.3732/ajb.94.4.526; Hatcher PE, 2003, J ECOL, V91, P147, DOI 10.1046/j.1365-2745.2003.00741.x; Hejda M, 2009, GLOBAL ECOL BIOGEOGR, V18, P372, DOI 10.1111/j.1466-8238.2009.00445.x; Hejda M, 2009, J ECOL, V97, P393, DOI 10.1111/j.1365-2745.2009.01480.x; Kartesz JT, 1999, SYNTHESIS N AM FLORA; Keller SR, 2008, ECOL LETT, V11, P852, DOI 10.1111/j.1461-0248.2008.01188.x; Kubesova M, 2010, PRESLIA, V82, P81; Lambdon PW, 2008, PRESLIA, V80, P101; Leicht-Young SA, 2007, OECOLOGIA, V154, P273, DOI 10.1007/s00442-007-0839-3; LHOTSKA MARIE, 1966, PRESLIA [PRAHA], V38, P376; Mack RN, 2000, ECOL APPL, V10, P689, DOI 10.1890/1051-0761(2000)010[0689:BICEGC]2.0.CO;2; Malikova L., 2010, Ecohydrology and Hydrobiology, V10, P81, DOI 10.2478/v10104-009-0050-8; Mangla S, 2011, PLANT ECOL, V212, P531, DOI 10.1007/s11258-011-9909-z; Molina-Montenegro MA, 2012, BIOL INVASIONS, V14, P21, DOI 10.1007/s10530-011-0055-2; Monty A, 2009, OECOLOGIA, V159, P305, DOI 10.1007/s00442-008-1228-2; Monty A, 2010, OIKOS, V119, P1563, DOI 10.1111/j.1600-0706.2010.17769.x; Moravcova L, 2010, PRESLIA, V82, P365; MORGAN DC, 1979, PLANTA, V145, P253, DOI 10.1007/BF00454449; Palacio-Lopez K, 2011, OIKOS, V120, P1393, DOI 10.1111/j.1600-0706.2010.19114.x; Pathikonda S, 2009, CONSERV BIOL, V23, P164, DOI 10.1111/j.1523-1739.2008.01073.x; Perglova I, 2009, PRESLIA, V81, P357; Pigliucci M, 2005, TRENDS ECOL EVOL, V20, P481, DOI 10.1016/j.tree.2005.06.001; Powell KI, 2009, INT J PLANT SCI, V170, P918, DOI 10.1086/600140; Prentis PJ, 2008, TRENDS PLANT SCI, V13, P288, DOI 10.1016/j.tplants.2008.03.004; PYSEK P, 1995, BIOL CONSERV, V74, P41, DOI 10.1016/0006-3207(95)00013-T; PYSEK P, 1993, J BIOGEOGR, V20, P413, DOI 10.2307/2845589; Pysek P, 2004, TAXON, V53, P131, DOI 10.2307/4135498; Pysek Petr, 2007, V193, P97; Pysek P, 2012, PRESLIA, V84, P575; Pysek P, 2012, PRESLIA, V84, P155; Pysek P, 2012, GLOBAL CHANGE BIOL, V18, P1725, DOI 10.1111/j.1365-2486.2011.02636.x; Pysek P, 2010, GLOBAL ECOL BIOGEOGR, V19, P317, DOI 10.1111/j.1466-8238.2009.00514.x; R Development Core Team R, 2009, R LANG ENV STAT COMP; Reinhart KO, 2006, ECOL APPL, V16, P1821, DOI 10.1890/1051-0761(2006)016[1821:ITQEIS]2.0.CO;2; Rejmanek M, 1996, ECOLOGY, V77, P1655, DOI 10.2307/2265768; Rejmanek M., 2005, VEGETATION ECOLOGY, DOI DOI 10.1002/9781118452592.CH13; Richards CL, 2006, ECOL LETT, V9, P981, DOI 10.1111/j.1461-0248.2006.00950.x; RICHARDSON D M, 1989, South African Forestry Journal, P1; Richardson DM, 2007, DIVERS DISTRIB, V13, P126, DOI 10.1111/j.1366-9516.2006.00314.x; Richardson David M., 2000, Diversity and Distributions, V6, P93, DOI 10.1046/j.1472-4642.2000.00083.x; Sakai AK, 2001, ANNU REV ECOL SYST, V32, P305, DOI 10.1146/annurev.ecolsys.32.081501.114037; Seastedt TR, 2011, ANNU REV ECOL EVOL S, V42, P133, DOI 10.1146/annurev-ecolsys-102710-145057; Shea K, 2002, TRENDS ECOL EVOL, V17, P170, DOI 10.1016/S0169-5347(02)02495-3; Skalova H, 2012, ANN BOT-LONDON, V110, P1429, DOI 10.1093/aob/mcr316; Skalova H, 2011, PERSPECT PLANT ECOL, V13, P173, DOI 10.1016/j.ppees.2011.03.005; Slavik B., 1997, KVETENA CESKE REPUBL, V5, P234; Sokal RR, 1995, BIOMETRY; Tilman D., 1982, Monographs in Population Biology, pi; van Kleunen M, 2010, ECOL LETT, V13, P947, DOI 10.1111/j.1461-0248.2010.01503.x; van Kleunen M, 2010, ECOL LETT, V13, P235, DOI 10.1111/j.1461-0248.2009.01418.x; Verbeke G, 2000, LINEAR MIXED MODELS; Vila M, 2004, OIKOS, V105, P229, DOI 10.1111/j.0030-1299.2004.12682.x; Vinton MA, 2006, ECOSYSTEMS, V9, P967, DOI 10.1007/s10021-005-0107-5; Vitousek PM, 1996, AM SCI, V84, P468; Williams JL, 2008, OECOLOGIA, V157, P239, DOI 10.1007/s00442-008-1075-1; Winter M, 2009, P NATL ACAD SCI USA, V106, P21721, DOI 10.1073/pnas.0907088106; Zuur Alain F., 2009, P1	80	52	54	9	177	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2013	8	5							e62842	10.1371/journal.pone.0062842	http://dx.doi.org/10.1371/journal.pone.0062842			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	143FO	23675432	Green Published, gold			2022-12-27	WOS:000318852400014
J	Aiyegbo, MS; Sapparapu, G; Spiller, BW; Eli, IM; Dewight, RW; Kim, R; Lee, DE; Liu, T; Li, S; Woods, VL; Nannemann, DP; Meiler, J; Stewart, PL; Crowe, JE				Aiyegbo, Mohammed S.; Sapparapu, Gopal; Spiller, Benjamin W.; Eli, Ilyas M.; Williams, Dewight R.; Kim, Robert; Lee, David E.; Liu, Tong; Li, Sheng; Woods, Virgil L., Jr.; Nannemann, David P.; Meiler, Jens; Stewart, Phoebe L.; Crowe, James E., Jr.			Human Rotavirus VP6-Specific Antibodies Mediate Intracellular Neutralization by Binding to a Quaternary Structure in the Transcriptional Pore	PLOS ONE			English	Article							VIRUS-LIKE PARTICLES; 3-DIMENSIONAL STRUCTURE; CRYOELECTRON MICROSCOPY; PROTECTIVE IMMUNITY; MASS-SPECTROMETRY; PROTEIN-STRUCTURE; YOUNG-CHILDREN; CRYO-EM; B-CELLS; VISUALIZATION	Several live attenuated rotavirus (RV) vaccines have been licensed, but the mechanisms of protective immunity are still poorly understood. The most frequent human B cell response is directed to the internal protein VP6 on the surface of double-layered particles, which is normally exposed only in the intracellular environment. Here, we show that the canonical VP6 antibodies secreted by humans bind to such particles and inhibit viral transcription. Polymeric IgA RV antibodies mediated an inhibitory effect against virus replication inside cells during IgA transcytosis. We defined the recognition site on VP6 as a quaternary epitope containing a high density of charged residues. RV human mAbs appear to bind to a negatively-charged patch on the surface of the Type I channel in the transcriptionally active particle, and they sterically block the channel. This unique mucosal mechanism of viral neutralization, which is not apparent from conventional immunoassays, may contribute significantly to human immunity to RV.	[Aiyegbo, Mohammed S.; Spiller, Benjamin W.; Eli, Ilyas M.; Crowe, James E., Jr.] Vanderbilt Univ Sch Med, Dept Pathol Microbiol & Immunol, Nashville, TN 37203 USA; [Sapparapu, Gopal; Crowe, James E., Jr.] Vanderbilt Univ Sch Med, Dept Pediat, Nashville, TN USA; [Williams, Dewight R.; Kim, Robert; Stewart, Phoebe L.] Vanderbilt Univ Sch Med, Dept Mol Physiol & Biophys, Nashville, TN USA; [Sapparapu, Gopal; Crowe, James E., Jr.] Vanderbilt Univ Sch Med, Vanderbilt Vaccine Ctr, Nashville, TN USA; [Nannemann, David P.; Meiler, Jens] Vanderbilt Univ, Dept Chem, Nashville, TN USA; [Lee, David E.; Liu, Tong; Li, Sheng; Woods, Virgil L., Jr.] Univ Calif San Diego, Sch Med, La Jolla, CA 92093 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; University of California System; University of California San Diego	Crowe, JE (corresponding author), Vanderbilt Univ Sch Med, Dept Pathol Microbiol & Immunol, Nashville, TN 37203 USA.	james.crowe@vanderbilt.edu	Crowe, James/B-5549-2009	Crowe, James/0000-0002-0049-1079; Sapparapu, Gopal/0000-0001-9670-1757; Lee, David/0000-0001-7232-0968; Meiler, Jens/0000-0001-8945-193X; Nannemann, David/0000-0002-4946-3263	National Institutes of Health (NIH) [R21 AI083574, R21 AI092268, U01 AI078407-03S2]; Vanderbilt Digestive Disease Research Center [DK058404]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI083574, R21AI092268, U01AI078407] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK058404] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Vanderbilt Digestive Disease Research Center; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health (NIH) grants R21 AI083574, R21 AI092268, and U01 AI078407-03S2. The Genome Sciences Resource was supported by the Vanderbilt Digestive Disease Research Center (DK058404). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Aoki ST, 2009, SCIENCE, V324, P1444, DOI 10.1126/science.1170481; Brunger AT, 1997, STRUCTURE, V5, P325, DOI 10.1016/S0969-2126(97)00190-1; Brunger AT, 1997, METHOD ENZYMOL, V277, P366, DOI 10.1016/S0076-6879(97)77021-6; Burns JW, 1996, SCIENCE, V272, P104, DOI 10.1126/science.272.5258.104; Chen JZ, 2009, P NATL ACAD SCI USA, V106, P10644, DOI 10.1073/pnas.0904024106; Chen SC, 1997, VACCINE, V15, P899; COHEN J, 1979, ARCH VIROL, V60, P177, DOI 10.1007/BF01317489; Corthesy B, 2006, J VIROL, V80, P10692, DOI 10.1128/JVI.00927-06; Diprose JM, 2001, EMBO J, V20, P7229, DOI 10.1093/emboj/20.24.7229; Durocher Y, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.2.e9; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Estes M.K., 2001, FIELDS VIROLOGY, V2., P1747; Estes MK, 2007, FIELDS VIROLOGY, V2, P1918; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Feng NG, 2002, J CLIN INVEST, V109, P1203, DOI 10.1172/JCI200214397; Fleishman SJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020161; Herrmann JE, 1996, J INFECT DIS, V174, pS93, DOI 10.1093/infdis/174.Supplement_1.S93; Hsu S, 2009, BIOCHEMISTRY-US, V48, P9891, DOI 10.1021/bi9008853; Johnson JE, 2000, CURR OPIN STRUC BIOL, V10, P229, DOI 10.1016/S0959-440X(00)00073-7; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P133, DOI 10.1107/S0907444909047374; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kallewaard NL, 2008, J IMMUNOL, V180, P3980, DOI 10.4049/jimmunol.180.6.3980; Kapikian A. Z, 2001, NOVART FDN SYMP, V238, P171; Kapikian AZ, 2001, NOVART FDN SYMP, V238, P153; Kaufmann B, 2006, P NATL ACAD SCI USA, V103, P12400, DOI 10.1073/pnas.0603488103; Lawton JA, 1999, P NATL ACAD SCI USA, V96, P5428, DOI 10.1073/pnas.96.10.5428; Lawton JA, 1997, NAT STRUCT BIOL, V4, P118, DOI 10.1038/nsb0297-118; Li S, 2011, J BIOL CHEM, V286, P17889, DOI 10.1074/jbc.M111.224535; Libersou S, 2008, J VIROL, V82, P2844, DOI 10.1128/JVI.02268-07; Lu WYD, 2012, PROTEIN SCI, V21, P178, DOI 10.1002/pro.2000; LUDERT JE, 1986, J GEN VIROL, V67, P1721, DOI 10.1099/0022-1317-67-8-1721; McKinney Brett A, 2007, Immunome Res, V3, P8, DOI 10.1186/1745-7580-3-8; McLean GR, 2002, J IMMUNOL, V169, P1379, DOI 10.4049/jimmunol.169.3.1379; McLean GR, 2000, MOL IMMUNOL, V37, P837, DOI 10.1016/S0161-5890(00)00101-2; OFFIT PA, 1986, J VIROL, V57, P46, DOI 10.1128/JVI.57.1.46-49.1986; OFFIT PA, 1986, J VIROL, V57, P376, DOI 10.1128/JVI.57.1.376-378.1986; ONeal CM, 1997, J VIROL, V71, P8707, DOI 10.1128/JVI.71.11.8707-8717.1997; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; Prasad BVV, 1996, NATURE, V382, P471, DOI 10.1038/382471a0; PRASAD BVV, 1988, J MOL BIOL, V199, P269, DOI 10.1016/0022-2836(88)90313-0; ROSETO A, 1979, VIROLOGY, V98, P471, DOI 10.1016/0042-6822(79)90571-3; Sauter NK, 2004, J APPL CRYSTALLOGR, V37, P399, DOI 10.1107/S0021889804005874; Schwarz BA, 2002, J VIROL METHODS, V105, P277, DOI 10.1016/S0166-0934(02)00118-0; SHAW AL, 1993, CELL, V74, P693, DOI 10.1016/0092-8674(93)90516-S; Stewart PL, 1997, EMBO J, V16, P1189, DOI 10.1093/emboj/16.6.1189; Thouvenin E, 2001, J MOL BIOL, V307, P161, DOI 10.1006/jmbi.2000.4479; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Weitkamp JH, 2006, HUM IMMUNOL, V67, P33, DOI 10.1016/j.humimm.2006.02.024; Weitkamp JH, 2005, HUM IMMUNOL, V66, P666, DOI 10.1016/j.humimm.2005.02.008; Weitkamp JH, 2005, J IMMUNOL, V174, P3454, DOI 10.4049/jimmunol.174.6.3454; Weitkamp JH, 2003, J IMMUNOL, V171, P4680, DOI 10.4049/jimmunol.171.9.4680; Winter G, 2010, J APPL CRYSTALLOGR, V43, P186, DOI 10.1107/S0021889809045701; Wolbank S, 2003, J VIROL, V77, P4095, DOI 10.1128/JVI.77.7.4095-4103.2003; YEAGER M, 1994, EMBO J, V13, P1011, DOI 10.1002/j.1460-2075.1994.tb06349.x; YEAGER M, 1990, J CELL BIOL, V110, P2133, DOI 10.1083/jcb.110.6.2133; Zhang X, 2008, P NATL ACAD SCI USA, V105, P1867, DOI 10.1073/pnas.0711623105; ZHANG ZQ, 1993, PROTEIN SCI, V2, P522	59	43	46	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2013	8	5							e61101	10.1371/journal.pone.0061101	http://dx.doi.org/10.1371/journal.pone.0061101			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	155HD	23671563	Green Submitted, Green Published, gold			2022-12-27	WOS:000319737700002
J	Burgstaller, G; Oehrle, B; Koch, I; Lindner, M; Eickelberg, O				Burgstaller, Gerald; Oehrle, Bettina; Koch, Ina; Lindner, Michael; Eickelberg, Oliver			Multiplex Profiling of Cellular Invasion in 3D Cell Culture Models	PLOS ONE			English	Article							EPIDERMAL-GROWTH-FACTOR; FIBROBLAST MIGRATION; EXTRACELLULAR-MATRIX; MORPHOLOGY; EXPRESSION; ADHESIONS	To-date, most invasion or migration assays use a modified Boyden chamber-like design to assess migration as single-cell or scratch assays on coated or uncoated planar plastic surfaces. Here, we describe a 96-well microplate-based, high-content, three-dimensional cell culture assay capable of assessing invasion dynamics and molecular signatures thereof. On applying our invasion assay, we were able to demonstrate significant effects on the invasion capacity of fibroblast cell lines, as well as primary lung fibroblasts. Administration of epidermal growth factor resulted in a substantial increase of cellular invasion, thus making this technique suitable for high-throughput pharmacological screening of novel compounds regulating invasive and migratory pathways of primary cells. Our assay also correlates cellular invasiveness to molecular events. Thus, we argue of having developed a powerful and versatile toolbox for an extensive profiling of invasive cells in a 96-well format. This will have a major impact on research in disease areas like fibrosis, metastatic cancers, or chronic inflammatory states.	[Burgstaller, Gerald; Oehrle, Bettina; Eickelberg, Oliver] Univ Munich, Univ Hosp, Comprehens Pneumol Ctr, Munich, Germany; [Burgstaller, Gerald; Oehrle, Bettina; Eickelberg, Oliver] Helmholtz Zentrum Munchen, Munich, Germany; [Koch, Ina; Lindner, Michael] Asklepios Clin Munich Gauting, Comprehens Pneumol Ctr, Asklepios Biobank Lung Dis, Ctr Thorac Surg, Munich, Germany	University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health	Burgstaller, G (corresponding author), Univ Munich, Univ Hosp, Comprehens Pneumol Ctr, Munich, Germany.	gerald.burgstaller@helmholtz-muenchen.de; oliver.eickelberg@helmholtz-muenchen.de	lindner, michael/AAO-8653-2020; Burgstaller, Gerald/M-6753-2019	lindner, michael/0000-0002-2106-0286; 	Helmholtz Association	Helmholtz Association(Helmholtz Association)	The study was funded by the Helmholtz Association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Artym Vira V, 2010, Curr Protoc Cell Biol, VChapter 10, DOI 10.1002/0471143030.cb1018s48; Birgersdotter A, 2005, SEMIN CANCER BIOL, V15, P405, DOI 10.1016/j.semcancer.2005.06.009; Booth AJ, 2012, AM J RESP CRIT CARE; Cukierman E, 2002, CURR OPIN CELL BIOL, V14, P633, DOI 10.1016/S0955-0674(02)00364-2; Cukierman E, 2001, SCIENCE, V294, P1708, DOI 10.1126/science.1064829; Fraley SI, 2010, NAT CELL BIOL, V12, P598, DOI 10.1038/ncb2062; Freytag J, 2010, J INVEST DERMATOL, V130, P2179, DOI 10.1038/jid.2010.106; Friedl P, 1998, MICROSC RES TECHNIQ, V43, P369, DOI 10.1002/(SICI)1097-0029(19981201)43:5<369::AID-JEMT3>3.0.CO;2-6; Friedl P, 2012, NAT CELL BIOL, V14, P777, DOI 10.1038/ncb2548; Gobin AS, 2003, BIOTECHNOL PROGR, V19, P1781, DOI 10.1021/bp0341390; Griffith LG, 2006, NAT REV MOL CELL BIO, V7, P211, DOI 10.1038/nrm1858; Hakkinen KM, 2011, TISSUE ENG PT A, V17, P713, DOI 10.1089/ten.TEA.2010.0273; Hinz B, 2007, AM J PATHOL, V170, P1807, DOI 10.2353/ajpath.2007.070112; Hulkower Keren I, 2011, Pharmaceutics, V3, P107, DOI 10.3390/pharmaceutics3010107; Klingberg F, 2012, J PATHOL; Kramer N, 2012, MUTAT RES; Lu ZM, 2001, MOL CELL BIOL, V21, P4016, DOI 10.1128/MCB.21.12.4016-4031.2001; Rhee S, 2009, EXP MOL MED, V41, P858, DOI 10.3858/emm.2009.41.12.096; Sharova LV, 2009, DNA RES, V16, P45, DOI 10.1093/dnares/dsn030; Vasaturo A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052251; Ware MF, 1998, J CELL SCI, V111, P2423; Westermarck J, 1999, FASEB J, V13, P781, DOI 10.1096/fasebj.13.8.781; Wight TN, 2011, AM J PHYSIOL-GASTR L, V301, pG950, DOI 10.1152/ajpgi.00132.2011; Wilson R., 2012, MOL CELL PROTEOMICS, V11.1, DOI DOI 10.1074/MCP.M111.014159	24	28	29	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2013	8	5							e63121	10.1371/journal.pone.0063121	http://dx.doi.org/10.1371/journal.pone.0063121			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	155HD	23671660	gold, Green Submitted, Green Published			2022-12-27	WOS:000319737700039
J	Jacewicz, A; Izumi, A; Brunner, K; Schnell, R; Schneider, G				Jacewicz, Agata; Izumi, Atsushi; Brunner, Katharina; Schnell, Robert; Schneider, Gunter			Structural Insights into the UbiD Protein Family from the Crystal Structure of PA0254 from Pseudomonas aeruginosa	PLOS ONE			English	Article							ESCHERICHIA-COLI; UBIQUINONE BIOSYNTHESIS; MOLECULAR REPLACEMENT; COENZYME-Q; DECARBOXYLASE; CONSERVATION; SEQUENCE; ROLES	The 3-polyprenyl-4-hydroxybenzoate decarboxylase (UbiD) catalyzes the conversion of 3-polyprenyl-4-hydroxybenzoate to 2-polyprenylphenol in the biosynthesis of ubiquinone. Pseudomonas aeruginosa contains two genes (PA0254 and PA5237) that are related in sequence to putative UbiD enzymes. A bioinformatics analysis suggests that the UbiD sequence family can be divided into two subclasses, with PA5237 and PA0254 belonging to different branches of this family. The three-dimensional structure of PA0254 has been determined using single wavelength anomalous diffraction and molecular replacement in two different crystal forms to resolutions of 1.95 and 2.3 angstrom, respectively. The subunit of PA0254 consists of three domains, an N-terminal alpha/beta domain, a split beta-barrel with a similar fold of a family of flavin reductases and a C-terminal alpha/beta domain with a topology characteristic for the UbiD protein family. The middle domain contains a metal binding site adjacent to a large open cleft that may represent the active site. The two protein ligands binding a magnesium ion, His188 and Glu229, invariant in the PA0254 subclass, are also conserved in a corresponding metal site found in one of the FMN binding proteins from the split beta-barrel fold family. PA0254 forms, in contrast to the hexameric UbiD from E. coli and P. aeruginosa, a homo-dimer. Insertion of four residues in a loop region in the PA0254 type enzymes results in structural differences that are incompatible with hexamer assembly.	[Jacewicz, Agata; Izumi, Atsushi; Brunner, Katharina; Schnell, Robert; Schneider, Gunter] Karolinska Inst, Dept Med Biochem & Biophys, Stockholm, Sweden	Karolinska Institutet	Schnell, R (corresponding author), Karolinska Inst, Dept Med Biochem & Biophys, Stockholm, Sweden.	Robert.schnell@ki.se; gunter.schneider@ki.se		SCHNELL, ROBERT/0000-0001-7530-3629; Schneider, Gunter/0000-0003-0622-5713	European Commission through the 7th Framework program [HEALTH-F3-2008-223461]; Swedish Research Council	European Commission through the 7th Framework program; Swedish Research Council(Swedish Research CouncilEuropean Commission)	This work was supported by the European Commission through the 7th Framework program (grant agreement HEALTH-F3-2008-223461), and the Swedish Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Ashkenazy H, 2010, NUCLEIC ACIDS RES, V38, pW529, DOI 10.1093/nar/gkq399; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Bentinger M, 2010, BIOCHEM BIOPH RES CO, V396, P74, DOI 10.1016/j.bbrc.2010.02.147; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Christendat D, 2000, NAT STRUCT BIOL, V7, P903; COLLINS MD, 1981, MICROBIOL REV, V45, P316, DOI 10.1128/MMBR.45.2.316-354.1981; Doublie S, 1997, METHOD ENZYMOL, V276, P523, DOI 10.1016/S0076-6879(97)76075-0; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Gulmezian M, 2007, ARCH BIOCHEM BIOPHYS, V467, P144, DOI 10.1016/j.abb.2007.08.009; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Jacobs MA, 2003, P NATL ACAD SCI USA, V100, P14339, DOI 10.1073/pnas.2036282100; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kim SH, 2008, INFECT IMMUN, V76, P4152, DOI 10.1128/IAI.01637-07; Kopec J, 2011, ACTA CRYSTALLOGR F, V67, P1184, DOI 10.1107/S174430911102923X; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Langridge GC, 2009, GENOME RES, V19, P2308, DOI 10.1101/gr.097097.109; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; LEPPIK RA, 1976, BIOCHIM BIOPHYS ACTA, V436, P800, DOI 10.1016/0005-2736(76)90407-7; Meganathan R, 2001, FEMS MICROBIOL LETT, V203, P131, DOI 10.1016/S0378-1097(01)00330-5; Moynie L, 2013, ACTA CRYSTALLOGR F, V69, P25, DOI 10.1107/S1744309112044739; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nishihara K, 1998, APPL ENVIRON MICROB, V64, P1694; Rangarajan ES, 2004, PROTEIN SCI, V13, P3006, DOI 10.1110/ps.04953004; Salama NR, 2004, J BACTERIOL, V186, P7926, DOI 10.1128/JB.186.23.7926-7935.2004; Soballe B, 1999, MICROBIOL-SGM, V145, P1817, DOI 10.1099/13500872-145-8-1817; Stein N, 2008, J APPL CRYSTALLOGR, V41, P641, DOI 10.1107/S0021889808006985; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749	31	24	24	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2013	8	5							e63161	10.1371/journal.pone.0063161	http://dx.doi.org/10.1371/journal.pone.0063161			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	155HD	23671667	Green Published, Green Submitted, gold			2022-12-27	WOS:000319737700045
J	Riera, M; Burguera, D; Garcia-Fernandez, J; Gonzalez-Duarte, R				Riera, Marina; Burguera, Demian; Garcia-Fernandez, Jordi; Gonzalez-Duarte, Roser			CERKL Knockdown Causes Retinal Degeneration in Zebrafish	PLOS ONE			English	Article							CERAMIDE KINASE-LIKE; RECESSIVE RETINITIS-PIGMENTOSA; NUCLEAR-LOCALIZATION SIGNAL; CONE-ROD DYSTROPHY; EMBRYONIC-DEVELOPMENT; CELL-PROLIFERATION; ANALYSIS REVEALS; ANIMAL-MODELS; GENE; MUTATIONS	The human CERKL gene is responsible for common and severe forms of retinal dystrophies. Despite intense in vitro studies at the molecular and cellular level and in vivo analyses of the retina of murine knockout models, CERKL function remains unknown. In this study, we aimed to approach the developmental and functional features of cerkl in Danio rerio within an Evo-Devo framework. We show that gene expression increases from early developmental stages until the formation of the retina in the optic cup. Unlike the high mRNA-CERKL isoform multiplicity shown in mammals, the moderate transcriptional complexity in fish facilitates phenotypic studies derived from gene silencing. Moreover, of relevance to pathogenicity, teleost CERKL shares the two main human protein isoforms. Morpholino injection has been used to generate a cerkl knockdown zebrafish model. The morphant phenotype results in abnormal eye development with lamination defects, failure to develop photoreceptor outer segments, increased apoptosis of retinal cells and small eyes. Our data support that zebrafish Cerkl does not interfere with proliferation and neural differentiation during early developmental stages but is relevant for survival and protection of the retinal tissue. Overall, we propose that this zebrafish model is a powerful tool to unveil CERKL contribution to human retinal degeneration.	[Riera, Marina; Burguera, Demian; Garcia-Fernandez, Jordi; Gonzalez-Duarte, Roser] Univ Barcelona, Fac Biol, Dept Genet, Barcelona, Spain; [Riera, Marina; Burguera, Demian; Garcia-Fernandez, Jordi; Gonzalez-Duarte, Roser] Univ Barcelona, Inst Biomed IBUB, Barcelona, Spain; [Riera, Marina; Gonzalez-Duarte, Roser] Inst Salud Carlos III, CIBERER, Barcelona, Spain	University of Barcelona; University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Instituto de Salud Carlos III	Gonzalez-Duarte, R (corresponding author), Univ Barcelona, Fac Biol, Dept Genet, Barcelona, Spain.	rgonzalez@ub.edu	Garcia-Fernandez, Jordi/B-3839-2013	Garcia-Fernandez, Jordi/0000-0001-5677-5970; Burguera, Demian/0000-0001-8627-1634	Ministerio de Ciencia e Innovacion [SAF2009-08079, BFU2011-23291]; Generalitat de Catalunya [SGR2009-1427]; CIBERER [U718]; Retina Asturias; ICREA Academia Prize (Generalitat de Catalunya); ONCE	Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Generalitat de Catalunya(Generalitat de Catalunya); CIBERER; Retina Asturias; ICREA Academia Prize (Generalitat de Catalunya)(ICREA); ONCE	This study was supported by grants SAF2009-08079 (Ministerio de Ciencia e Innovacion), SGR2009-1427 (Generalitat de Catalunya), CIBERER (U718), Retina Asturias and ONCE to RGD, and BFU2011-23291 (Ministerio de Ciencia e Innovacion) and ICREA Academia Prize (Generalitat de Catalunya) to JGF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aleman TS, 2009, INVEST OPHTH VIS SCI, V50, P5944, DOI 10.1167/iovs.09-3982; Ali M, 2008, MOL VIS, V14, P1960; Auslender N, 2007, INVEST OPHTH VIS SCI, V48, P5431, DOI 10.1167/iovs.07-0736; Avila-Fernandez A, 2008, INVEST OPHTH VIS SCI, V49, P2709, DOI 10.1167/iovs.07-0865; Barbosa-Morais NL, 2012, SCIENCE, V338, P1587, DOI 10.1126/science.1230612; Berger W, 2010, PROG RETIN EYE RES, V29, P335, DOI 10.1016/j.preteyeres.2010.03.004; Bornancin FR, 2005, BBA-MOL CELL BIOL L, V1687, P31, DOI 10.1016/j.bbalip.2004.11.012; Brockerhoff SE, 2011, CELL MOL LIFE SCI, V68, P651, DOI 10.1007/s00018-010-0563-8; Carre A, 2004, BIOCHEM BIOPH RES CO, V324, P1215, DOI 10.1016/j.bbrc.2004.09.181; Chakarova CF, 2011, HUM MOL GENET, V20, P975, DOI 10.1093/hmg/ddq543; den Hollander AI, 2010, J CLIN INVEST, V120, P3042, DOI 10.1172/JCI42258; Dowling J. E., 1987, RETINA APPROACHABLE; Dyer MA, 2001, J NEUROSCI, V21, P4259, DOI 10.1523/JNEUROSCI.21-12-04259.2001; Ellis JD, 2012, MOL CELL, V46, P884, DOI 10.1016/j.molcel.2012.05.037; Fadool JM, 2008, PROG RETIN EYE RES, V27, P89, DOI 10.1016/j.preteyeres.2007.08.002; Garanto A, 2013, EXPT EYE RE IN PRESS; Garanto A, 2012, BBA-MOL BASIS DIS, V1822, P1258, DOI 10.1016/j.bbadis.2012.04.004; Garanto A, 2011, INVEST OPHTH VIS SCI, V52, P5202, DOI 10.1167/iovs.10-7101; Gestri G, 2012, DEV NEUROBIOL, V72, P302, DOI 10.1002/dneu.20919; Gracheva EO, 2011, NATURE, V476, P88, DOI 10.1038/nature10245; Graf C, 2008, BIOCHEM BIOPH RES CO, V373, P159, DOI 10.1016/j.bbrc.2008.06.002; Haider NB, 2001, HUM MOL GENET, V10, P1619, DOI 10.1093/hmg/10.16.1619; Inagaki Y, 2006, BIOCHEM BIOPH RES CO, V343, P982, DOI 10.1016/j.bbrc.2006.03.056; Kay JN, 2005, DEVELOPMENT, V132, P2573, DOI 10.1242/dev.01831; Labbe RM, 2012, STEM CELLS, V30, P1734, DOI 10.1002/stem.1144; Lakowski J, 2007, DEV BIOL, V307, P498, DOI 10.1016/j.ydbio.2007.04.015; Li Z, 2000, DEV DYNAM, V219, P391, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1063>3.0.CO;2-G; Lieschke GJ, 2007, NAT REV GENET, V8, P353, DOI 10.1038/nrg2091; Littink KW, 2010, INVEST OPHTH VIS SCI, V51, P5943, DOI 10.1167/iovs.10-5797; Luo J, 2012, NEURAL DEV, V7, DOI 10.1186/1749-8104-7-33; Mandal NA, 2013, EXP EYE RES, V106, P24, DOI 10.1016/j.exer.2012.10.014; Maurer CM, 2011, REV NEUROSCIENCE, V22, P5, DOI 10.1515/RNS.2011.003; Melamud E, 2009, NUCLEIC ACIDS RES, V37, P4862, DOI 10.1093/nar/gkp444; Melamud E, 2009, NUCLEIC ACIDS RES, V37, P4873, DOI 10.1093/nar/gkp471; Merkin J, 2012, SCIENCE, V338, P1593, DOI 10.1126/science.1228186; Morris AC, 2011, BIRTH DEFECTS RES C, V93, P215, DOI 10.1002/bdrc.20211; Nevet MJ, 2012, INVEST OPHTH VIS SCI, V53, P4565, DOI 10.1167/iovs.12-9770; Nishida A, 2003, NAT NEUROSCI, V6, P1255, DOI 10.1038/nn1155; Pauli A, 2012, GENOME RES, V22, P577, DOI 10.1101/gr.133009.111; Pomares E, 2007, HUM MUTAT, V28, P511, DOI 10.1002/humu.20479; Rivas MA, 2009, HISTOL HISTOPATHOL, V24, P1295, DOI 10.14670/HH-24.1295; Rodriguez-Mari A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001034; Scott GR, 2012, P NATL ACAD SCI USA, V109, P14247, DOI 10.1073/pnas.1205012109; Shu XH, 2011, INVEST OPHTH VIS SCI, V52, P2960, DOI 10.1167/iovs.10-6800; Shu XH, 2010, HUM MOL GENET, V19, P657, DOI 10.1093/hmg/ddp533; Sugiura M, 2002, J BIOL CHEM, V277, P23294, DOI 10.1074/jbc.M201535200; Tang ZH, 2009, ARCH OPHTHALMOL-CHIC, V127, P1077, DOI 10.1001/archophthalmol.2009.207; Thisse C, 2008, NAT PROTOC, V3, P59, DOI 10.1038/nprot.2007.514; Tuson M, 2004, AM J HUM GENET, V74, P128, DOI 10.1086/381055; Tuson M, 2009, MOL VIS, V15, P168; Ulitsky I, 2012, GENOME RES, V22, P2054, DOI 10.1101/gr.139733.112; Vekslin S, 2010, MOL VIS, V16, P2539; Veleri S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034389; Wang SW, 2001, GENE DEV, V15, P24, DOI 10.1101/gad.855301; Wittkopp N, 2009, MOL CELL BIOL, V29, P3517, DOI 10.1128/MCB.00177-09; Yan YL, 2002, DEVELOPMENT, V129, P5065; Yang DH, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-319	57	19	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2013	8	5							e64048	10.1371/journal.pone.0064048	http://dx.doi.org/10.1371/journal.pone.0064048			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	155HD	23671706	Green Submitted, gold, Green Published			2022-12-27	WOS:000319737700064
J	Huang, JW; Xu, XR; Weng, QY; Hong, HR; Guo, ZN; He, SZ; Niu, JJ				Huang, Jianwei; Xu, Xuerong; Weng, Qinyun; Hong, Huarong; Guo, Zhinan; He, Shuizhen; Niu, Jianjun			Serial Foodborne Norovirus Outbreaks Associated with Multiple Genotypes	PLOS ONE			English	Article							ACUTE GASTROENTERITIS; UNITED-STATES; VIRUS	Noroviruses (NoV) have been recognized as an important pathogen associated with acute gastroenteritis worldwide during the past three decades. In the spring of 2012, a series of foodborne outbreaks in tourist groups were reported to Xiamen Center for Disease Control and Prevention, Xiamen, Fujian province, China. Among a total of 268 tourists in 7 groups, the prevalence rate of acute gastroenteritis was 16.0% (43/268). Twenty-three feces or anal swabs were collected for laboratory tests of causative agents, no bacterial pathogen was identified, while 22 of them were positive for NoV RNA. In addition, thirteen NoV fragments were recovered from positive specimens and sequenced, belonging to five genotypes such as GI.3, GI.4, GII.4, GII.6, and GII.14, respectively. However, NoV fragments obtained from locally infected patients showed distinct genotypes. Therefore, epidemiological investigation and laboratory analyses demonstrated that the serial foodborne NoV outbreaks in tourists were co-infection of multiple genotypes induced acute gastroenteritis linked to a restaurant.	[Huang, Jianwei; Xu, Xuerong; Weng, Qinyun; Hong, Huarong; Guo, Zhinan; He, Shuizhen; Niu, Jianjun] Xiamen Ctr Dis Control & Prevent, Xiamen, Fujian Province, Peoples R China		Niu, JJ (corresponding author), Xiamen Ctr Dis Control & Prevent, Xiamen, Fujian Province, Peoples R China.	fjxmhjw@hotmail.com		Niu, Jianjun/0000-0003-1960-654X	Priority Discipline Construction Project, Xiamen Meciacal Centers; Xiamen municipal Bureau of Science Technology [350222007707]	Priority Discipline Construction Project, Xiamen Meciacal Centers; Xiamen municipal Bureau of Science Technology	This study was supported by the following grants: 1) Priority Discipline Construction Project, Xiamen Meciacal Centers; 2) Planned Instruction Projects in 2007, Xiamen municipal Bureau of Science & Technology (No. 350222007707). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blanton LH, 2006, J INFECT DIS, V193, P413, DOI 10.1086/499315; Bull RA, 2011, TRENDS MICROBIOL, V19, P233, DOI 10.1016/j.tim.2011.01.002; China National Center for Food Safety Risk Assessment, 2012, MAN FOODB PATH SURV, P253; Gilgen M, 1997, INT J FOOD MICROBIOL, V37, P189, DOI 10.1016/S0168-1605(97)00075-5; Glass RI, 2009, NEW ENGL J MED, V361, P1776, DOI 10.1056/NEJMra0804575; Green K. Y., 2007, FIELDS VIROLOGY, V1, P949; Guo L, 2009, J CLIN VIROL, V44, P94, DOI 10.1016/j.jcv.2008.10.002; Harris JP, 2010, J HOSP INFECT, V74, P1, DOI 10.1016/j.jhin.2009.07.025; [贾宁 Jia Ning], 2012, [中华医院感染学杂志, Chinese Journal of Nosocomiology], V22, P536; Jin M, 2008, J MED VIROL, V80, P1997, DOI 10.1002/jmv.21308; Kageyama T, 2004, J CLIN MICROBIOL, V42, P2988, DOI 10.1128/JCM.42.7.2988-2995.2004; Kapikian AZ, 1990, VIROLOGY, P671; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lindesmith L, 2003, NAT MED, V9, P548, DOI 10.1038/nm860; Nishida T, 2003, APPL ENVIRON MICROB, V69, P5782, DOI 10.1128/AEM.69.10.5782-5786.2003; Patel MM, 2009, J CLIN VIROL, V44, P1, DOI 10.1016/j.jcv.2008.10.009; Siebenga JJ, 2007, EMERG INFECT DIS, V13, P144; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Vinje J, 2000, ARCH VIROL, V145, P223, DOI 10.1007/s007050050020; Widdowson MA, 2005, EMERG INFECT DIS, V11, P95, DOI 10.3201/eid1101.040426; Workowski Kimberly A, 2010, MMWR Recomm Rep, V59, P1; Zeng M, 2012, J MED VIROL, V84, P145, DOI 10.1002/jmv.22248; Zheng HN, 2008, CHIN J ZOONOSES, V26, P259	23	10	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2013	8	5							e63327	10.1371/journal.pone.0063327	http://dx.doi.org/10.1371/journal.pone.0063327			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145YI	23667602	gold, Green Published, Green Submitted			2022-12-27	WOS:000319055600057
J	Muhly, TB; Hebblewhite, M; Paton, D; Pitt, JA; Boyce, MS; Musiani, M				Muhly, Tyler B.; Hebblewhite, Mark; Paton, Dale; Pitt, Justin A.; Boyce, Mark S.; Musiani, Marco			Humans Strengthen Bottom-Up Effects and Weaken Trophic Cascades in a Terrestrial Food Web	PLOS ONE			English	Article							RESOURCE SELECTION FUNCTIONS; HABITAT SELECTION; CONSEQUENCES; WOLVES; CONSERVATION; PREDATION; RESPONSES; DENSITY; IMPACT; RANGE	Ongoing debate about whether food webs are primarily regulated by predators or by primary plant productivity, cast as top-down and bottom-up effects, respectively, may becoming superfluous. Given that most of the world's ecosystems are human dominated we broadened this dichotomy by considering human effects in a terrestrial food-web. We studied a multiple human-use landscape in southwest Alberta, Canada, as opposed to protected areas where previous terrestrial food-web studies have been conducted. We used structural equation models (SEMs) to assess the strength and direction of relationships between the density and distribution of: (1) humans, measured using a density index; (2) wolves (Canis lupus), elk (Cervus elpahus) and domestic cattle (Bos taurus), measured using resource selection functions, and; (3) forage quality, quantity and utilization (measured at vegetation sampling plots). Relationships were evaluated by taking advantage of temporal and spatial variation in human density, including day versus night, and two landscapes with the highest and lowest human density in the study area. Here we show that forage-mediated effects of humans had primacy over predator-mediated effects in the food web. In our parsimonious SEM, occurrence of humans was most correlated with occurrence of forage (beta = 0.637, p < 0.0001). Elk and cattle distribution were correlated with forage (elk day: beta = 0.400, p < 0.0001; elk night: beta = 0.369, p < 0.0001; cattle day: beta = 0.403, p < 0.0001; cattle, night: beta = 0.436, p < 0.0001), and the distribution of elk or cattle and wolves were positively correlated during daytime (elk: beta = 0.293, p < 0.0001, cattle: beta = 0.303, p < 0.0001) and night-time (elk: beta = 0.460, p < 0.0001, cattle: beta = 0.482, p < 0.0001). Our results contrast with research conducted in protected areas that suggested human effects in the food web are primarily predator-mediated. Instead, human influence on vegetation may strengthen bottom-up predominance and weaken top-down trophic cascades in ecosystems. We suggest that human influences on ecosystems may usurp top-down and bottom-up effects.	[Muhly, Tyler B.; Paton, Dale; Musiani, Marco] Univ Calgary, Fac Environm Design, Calgary, AB T2N 1N4, Canada; [Muhly, Tyler B.] Alberta Innovates Technol Futures, Ecosyst Management, Vegreville, AB, Canada; [Hebblewhite, Mark] Univ Montana, Dept Ecosyst & Conservat Sci, Missoula, MT 59812 USA; [Pitt, Justin A.; Boyce, Mark S.] Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada	University of Calgary; Alberta Innovates; University of Montana System; University of Montana; University of Alberta	Muhly, TB (corresponding author), Univ Calgary, Fac Environm Design, Calgary, AB T2N 1N4, Canada.	tyler.muhly@albertainnovates.ca	hebblewhite, mark/G-6164-2013; Boyce, Mark S/A-2620-2014; Musiani, Marco/ABB-9387-2021; Hebblewhite, Mark/AAI-8101-2020	Boyce, Mark S/0000-0001-5811-325X; Musiani, Marco/0000-0002-6097-5841; Hebblewhite, Mark/0000-0001-5382-1361	Natural Science and Engineering Research Council (NSERC) of Canada; Shell Canada; Institute for Sustainable Energy; Environment and Economy; Canadian Wildlife Federation; Glaholt Scholarship; Parks Canada; Alberta Beef Producers; Alberta Conservation Association; Alberta Tourism; Parks and Recreation; Alberta Sustainable Resource Development; Alberta Community Development; Calgary Zoo; Alberta Ecotrust; Alberta Ingenuity; University of Calgary; University of Alberta; Safari Club International	Natural Science and Engineering Research Council (NSERC) of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Shell Canada; Institute for Sustainable Energy; Environment and Economy; Canadian Wildlife Federation; Glaholt Scholarship; Parks Canada; Alberta Beef Producers; Alberta Conservation Association; Alberta Tourism; Parks and Recreation; Alberta Sustainable Resource Development; Alberta Community Development; Calgary Zoo; Alberta Ecotrust; Alberta Ingenuity; University of Calgary; University of Alberta(University of Alberta); Safari Club International	The authors' group's research on human impacts on wildlife species was funded by a substantial ($1.7 million) grant from the Natural Science and Engineering Research Council (NSERC) of Canada. The authors thank the following for their important financial contributions to this work: the Natural Science and Engineering Research Council of Canada, Shell Canada, the Institute for Sustainable Energy, Environment and Economy, the Canadian Wildlife Federation, the Glaholt Scholarship, Parks Canada, Alberta Beef Producers, Alberta Conservation Association, Alberta Tourism, Parks and Recreation, Alberta Sustainable Resource Development, Alberta Community Development, the Calgary Zoo, Alberta Ecotrust, Alberta Ingenuity, the University of Calgary, the University of Alberta, and Safari Club International. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2002, CAUSE CORRELATION BI; Apps CD, 2004, J WILDLIFE MANAGE, V68, P138, DOI 10.2193/0022-541X(2004)068[0138:EGBDAA]2.0.CO;2; Barnosky AD, 2004, SCIENCE, V306, P70, DOI 10.1126/science.1101476; Bork EW, 1999, J RANGE MANAGE, V52, P151, DOI 10.2307/4003509; Boyce MS, 2002, ECOL MODEL, V157, P281, DOI 10.1016/S0304-3800(02)00200-4; Boyce MS, 1999, CARNIVORES IN ECOSYSTEMS: THE YELLOWSTONE EXPERIENCE, P265; Darimont CT, 2009, P NATL ACAD SCI USA, V106, P952, DOI 10.1073/pnas.0809235106; Estes JA, 2011, SCIENCE, V333, P301, DOI 10.1126/science.1205106; Fieberg J, 2010, PHILOS T R SOC B, V365, P2233, DOI 10.1098/rstb.2010.0079; Foley JA, 2005, SCIENCE, V309, P570, DOI 10.1126/science.1111772; Grace JB., 2015, STRUCTURAL EQUATION; Hebblewhite M, 2005, ECOLOGY, V86, P2135, DOI 10.1890/04-1269; Hebblewhite M, 2008, J APPL ECOL, V45, P834, DOI 10.1111/j.1365-2664.2008.01466.x; IRVING BD, 1995, J RANGE MANAGE, V48, P358, DOI 10.2307/4002489; Johnson CJ, 2006, J WILDLIFE MANAGE, V70, P347, DOI 10.2193/0022-541X(2006)70[347:RSFBOU]2.0.CO;2; Joreskog K., 2005, LISREL 8 72; Kelloway E. K., 1998, USING LISREL STRUCTU; KREBS CJ, 1995, SCIENCE, V269, P1112, DOI 10.1126/science.269.5227.1112; Lele SR, 2009, J WILDLIFE MANAGE, V73, P122, DOI 10.2193/2007-535; Manly B.F.J., 2002, RESOURCE SELECTION A; McDermid GJ, 2009, FOREST ECOL MANAG, V257, P2262, DOI 10.1016/j.foreco.2009.03.005; Melis C, 2009, GLOBAL ECOL BIOGEOGR, V18, P724, DOI 10.1111/j.1466-8238.2009.00480.x; Muhly TB, 2010, OIKOS, V119, P1243, DOI 10.1111/j.1600-0706.2009.18350.x; Musiani M, 2003, CONSERV BIOL, V17, P1538, DOI 10.1111/j.1523-1739.2003.00063.x; Paine RT, 1980, J ANIM ECOL, V49, P666, DOI DOI 10.2307/4220; Pettorelli N, 2005, TRENDS ECOL EVOL, V20, P503, DOI 10.1016/j.tree.2005.05.011; Polis GA, 1999, OIKOS, V86, P3, DOI 10.2307/3546565; Ripple WJ, 2001, BIOL CONSERV, V102, P227, DOI 10.1016/S0006-3207(01)00107-0; Sawyer H, 2006, J WILDLIFE MANAGE, V70, P396, DOI 10.2193/0022-541X(2006)70[396:WHSOMD]2.0.CO;2; SCHULTZ RD, 1978, J WILDLIFE MANAGE, V42, P91, DOI 10.2307/3800694; Seaman DE, 1996, ECOLOGY, V77, P2075, DOI 10.2307/2265701; Sinclair ARE, 2000, SCIENCE, V289, P1875; Smith BD, 2007, SCIENCE, V315, P1797, DOI 10.1126/science.1137740; StataCorp LP, 2009, STATA SE 10 1 WIND; Stolzenburg W, 2008, CONSERVATION MAGAZIN; Vitousek PM, 1997, ECOL APPL, V7, P737, DOI 10.2307/2269431	36	57	57	2	71	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2013	8	5							e64311	10.1371/journal.pone.0064311	http://dx.doi.org/10.1371/journal.pone.0064311			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145YI	23667705	Green Published, Green Submitted, gold			2022-12-27	WOS:000319055600087
J	Wang, MP; Ho, SY; Lo, WS; Lam, TH				Wang, Man Ping; Ho, Sai Yin; Lo, Wing Sze; Lam, Tai Hing			Secondhand Smoke Exposure and Health Services Use among Adolescent Current Smokers	PLOS ONE			English	Article							ENVIRONMENTAL TOBACCO-SMOKE; MEDICAL-CARE UTILIZATION; NICOTINE DEPENDENCE; CHILDREN; PATTERNS; DISEASE; BURDEN; FAMILY; HOME	Background: To investigate the associations of secondhand smoke (SHS) exposure with medical consultation and hospitalisation among adolescents in Hong Kong. Methods: A total of 35827 secondary 1 (US grade 7) to secondary 5 students from 85 randomly selected schools completed an anonymous questionnaire on smoking, SHS at home, SHS outside home, medical consultation in the past 14 days, hospitalisation in the past 12 months, and socio-demographic characteristics. Current smoking was defined as any smoking in the past 30 days. SHS exposure was classified as none (reference), 1-4 and 5-7 days/week. Logistic regression yielded adjusted odds ratios (AORs) for medical consultation and hospitalisation in relation to SHS exposure at home and outside home in current smokers. Analyses were also done among never-smokers for comparison. Results: Among all students, 15.9% had medical consultation and 5.2% had been hospitalised. Any SHS exposure at home was associated with AORs (95% CI) for medical consultation and hospitalisation of 1.69 (1.14-2.51) and 2.85 (1.47-5.52) in current smokers, and 1.03 (0.91-1.15) and 1.25 (1.02-1.54) in never-smokers, respectively, (P < 0.01 for interaction between smoking status and SHS exposure at home). SHS exposure outside home was generally not associated with medical consultation and hospitalisation in smokers and never-smokers. Conclusions: SHS exposure at home was associated with health services use among adolescent current smokers. Adolescent smokers should be aware of the harm of SHS in addition to that from their own smoking. The evidence helps health care professionals to advise adolescent smokers to avoid SHS exposure and stop smoking.	[Wang, Man Ping; Ho, Sai Yin; Lo, Wing Sze; Lam, Tai Hing] Univ Hong Kong, Sch Publ Hlth, Pokfulam, Hong Kong, Peoples R China	University of Hong Kong	Ho, SY (corresponding author), Univ Hong Kong, Sch Publ Hlth, Pokfulam, Hong Kong, Peoples R China.	syho@hku.hk	; Lam, Tai Hing/C-4317-2009; Ho, Daniel Sai Yin/C-4307-2009	Wang, Man Ping/0000-0003-4000-2388; Lam, Tai Hing/0000-0002-2033-9971; Ho, Daniel Sai Yin/0000-0001-9485-0273	Hong Kong Council on Smoking and Health; Department of Health	Hong Kong Council on Smoking and Health; Department of Health	Funding from Hong Kong Council on Smoking and Health, and Department of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Census and Statistics Department, 1997, DOCT CONC HONG KONG; [Census and Statistics Department Social Survey Section Census and Statistics Department], 2003, THEM HOUS SURV REP; Crombie IK, 2001, THORAX, V56, P9, DOI 10.1136/thorax.56.1.9; Department of Health, 2011, HONG KONG FACTS; Hill SC, 2008, TOB CONTROL, V17, P32, DOI 10.1136/tc.2007.020990; Ho SY, 2010, TOB CONTROL, V19, P129, DOI 10.1136/tc.2009.032003; Ho SY, 2010, J PEDIATR-US, V157, P1012, DOI 10.1016/j.jpeds.2010.06.013; Ho SY, 2011, SCH BASED SMOK UNPUB; Kobus K, 2003, ADDICTION, V98, P37, DOI 10.1046/j.1360-0443.98.s1.4.x; Lai HK, 2009, PEDIATRICS, V124, P1306, DOI 10.1542/peds.2009-0669; Lam TH, 2005, TOB CONTROL, V14, P307, DOI 10.1136/tc.2005.011775; Lam TH, 2001, PEDIATRICS, V107, part. no., DOI 10.1542/peds.107.6.e91; Lau JTF, 2000, J ADOLESCENT HEALTH, V27, P443, DOI 10.1016/S1054-139X(99)00075-0; Lee A, 2001, PUBLIC HEALTH, V115, P30; Leung GM, 2004, ARCH PEDIAT ADOL MED, V158, P687, DOI 10.1001/archpedi.158.7.687; O'Callaghan FV, 2006, ADDICTION, V101, P282, DOI 10.1111/j.1360-0443.2006.01323.x; Oberg M, 2011, LANCET, V377, P139, DOI 10.1016/S0140-6736(10)61388-8; Okoli CTC, 2008, PUBLIC HEALTH NURS, V25, P46, DOI 10.1111/j.1525-1446.2008.00679.x; Piccardo MT, 2010, ENVIRON HEALTH-GLOB, V9, DOI 10.1186/1476-069X-9-5; U. S. Department of Health and Human Services, 2007, CHILDR SEC SMOK EXP; VOGT TM, 1984, AM J PUBLIC HEALTH, V74, P30, DOI 10.2105/AJPH.74.1.30; Wang MP, 2013, NICOTINE TOB RES, V15, P185, DOI 10.1093/ntr/nts109; Wang MP, 2012, NICOTINE TOB RES, V14, P682, DOI 10.1093/ntr/ntr266; Wang MP, 2012, ADDICT BEHAV, V37, P743, DOI 10.1016/j.addbeh.2012.02.016; Warren CW, 2006, TOB CONTROL, V15, pII4, DOI 10.1136/tc.2006.015685; Warren CW, 2006, LANCET, V367, P749, DOI 10.1016/S0140-6736(06)68192-0; Wilson-Frederick SM, 2011, ADDICT BEHAV, V36, P412, DOI 10.1016/j.addbeh.2010.12.005; World Health Organization, 2001, GLOB CONS AD HLTH SE; Yach D, 2002, TOB CONTROL, V11, P252, DOI 10.1136/tc.11.3.252	29	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2013	8	5							e64322	10.1371/journal.pone.0064322	http://dx.doi.org/10.1371/journal.pone.0064322			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	145YI	23667706	Green Published, gold, Green Submitted			2022-12-27	WOS:000319055600088
J	Wuerger, S				Wuerger, Sophie			Colour Constancy Across the Life Span: Evidence for Compensatory Mechanisms	PLOS ONE			English	Article							OPPONENT-PROCESS ADDITIVITY; CHROMATIC MECHANISMS; NEURAL BASIS; UNIQUE HUES; VISION; DISCRIMINATION	It is well known that the peripheral visual system declines with age: the yellowing of the lens causes a selective reduction of short-wavelength light and sensitivity losses occur in the cone receptor mechanisms. At the same time, our subjective experience of colour does not change with age. The main purpose of this large-scale study (n = 185) covering a wide age range of colour-normal observers (18-75 years of age) was to assess the extent to which the human visual system is able to compensate for the changes in the optical media and at which level of processing this compensation is likely to occur. We report two main results: (1) Supra-threshold parafoveal colour perception remains largely unaffected by the age-related changes in the optical media (yellowing of the lens) whereas our ability to discriminate between small colour differences is compromised with an increase in age. (2) Significant changes in colour appearance are only found for unique green settings under daylight viewing condition which is consistent with the idea that the yellow-blue mechanism is most affected by an increase in age due to selective attenuation of short-wavelength light. The data on the invariance of hue perception, in conjunction with the age-related decline in chromatic sensitivity, provides evidence for compensatory mechanisms that enable colour-normal human observers a large degree of colour constancy across the life span. These compensatory mechanisms are likely to originate at cortical sites.	Univ Liverpool, Dept Psychol Sci, Inst Psychol Hlth & Soc, Liverpool L69 3BX, Merseyside, England	University of Liverpool	Wuerger, S (corresponding author), Univ Liverpool, Dept Psychol Sci, Inst Psychol Hlth & Soc, Liverpool L69 3BX, Merseyside, England.	s.m.wuerger@liverpool.ac.uk	Wuerger, Sophie/AAZ-1212-2020	Wuerger, Sophie/0000-0003-0080-5813	Wellcome Trust [GR/080205]; Spanish research project, Spanish Ministry of Science [TIN2008-04998]	Wellcome Trust(Wellcome TrustEuropean Commission); Spanish research project, Spanish Ministry of Science	The equipment has been supported by the Wellcome Trust (GR/080205). The data collection was supported by a Spanish research project, Spanish Ministry of Science (TIN2008-04998.) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARBUR JL, 1994, P ROY SOC B-BIOL SCI, V258, P327, DOI 10.1098/rspb.1994.0181; Bompas A, 2013, J VISION, V13, DOI 10.1167/13.1.19; Delahunt PB, 2004, VISUAL NEUROSCI, V21, P301, DOI 10.1017/S0952523804213025; DERRINGTON AM, 1984, J PHYSIOL-LONDON, V357, P241, DOI 10.1113/jphysiol.1984.sp015499; DeValois RL, 1997, VISION RES, V37, P885, DOI 10.1016/S0042-6989(96)00234-9; Gegenfurtner KR, 1997, J NEUROPHYSIOL, V77, P1906, DOI 10.1152/jn.1997.77.4.1906; HELMHOLTZ H, 2000, TREATISE PHYSL OPTIC; Hering E., 1964, OUTLINES THEORY LIGH; Hurlbert A, 2003, CURR BIOL, V13, pR270, DOI 10.1016/S0960-9822(03)00198-2; JAMESON D, 1955, J OPT SOC AM, V45, P546, DOI 10.1364/JOSA.45.000546; KNOBLAUCH K, 1987, APPL OPTICS, V26, P1441, DOI 10.1364/AO.26.001441; LARIMER J, 1975, VISION RES, V15, P723, DOI 10.1016/0042-6989(75)90291-6; LARIMER J, 1974, VISION RES, V14, P1127, DOI 10.1016/0042-6989(74)90209-0; MACLEOD DIA, 1979, J OPT SOC AM, V69, P1183, DOI 10.1364/JOSA.69.001183; Mateus C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055348; Mollon JD, 2009, CURR BIOL, V19, pR441, DOI 10.1016/j.cub.2009.05.008; MOLLON JD, 1982, ANNU REV PSYCHOL, V33, P41, DOI 10.1146/annurev.ps.33.020182.000353; Neitz J, 2002, NEURON, V35, P783, DOI 10.1016/S0896-6273(02)00818-8; Okajima K, 2001, OPT REV, V8, P64, DOI 10.1007/s10043-001-0064-y; Paramei GV, 2012, J OPT SOC AM A, V29, pA290, DOI 10.1364/JOSAA.29.00A290; Peters A., 2007, EFFECTS NORMAL AGING; POKORNY J, 1987, APPL OPTICS, V26, P1437, DOI 10.1364/AO.26.001437; REGAN BC, 1994, VISION RES, V34, P1279, DOI 10.1016/0042-6989(94)90203-8; SCHEFRIN BE, 1990, J OPT SOC AM A, V7, P305, DOI 10.1364/JOSAA.7.000305; Stockman A, 2000, VISION RES, V40, P1711, DOI 10.1016/S0042-6989(00)00021-3; Stoughton CM, 2008, CURR BIOL, V18, pR698, DOI 10.1016/j.cub.2008.06.018; VALBERG A, 1971, VISION RES, V11, P157, DOI 10.1016/0042-6989(71)90231-8; Webster MA, 2000, J OPT SOC AM A, V17, P1545, DOI 10.1364/JOSAA.17.001545; Webster MA, 2000, J OPT SOC AM A, V17, P1535, DOI 10.1364/JOSAA.17.001535; Webster MA, 2002, J OPT SOC AM A, V19, P1951, DOI 10.1364/JOSAA.19.001951; Webster MA, 2010, P ROY SOC B-BIOL SCI, V277, P1817, DOI 10.1098/rspb.2009.1832; Werner A, 2010, VISION RES, V50, P1641, DOI 10.1016/j.visres.2010.05.004; Werner JS, 1996, PROG RETIN EYE RES, V15, P621, DOI 10.1016/1350-9462(96)00001-8; Wuerger SM, 2005, VISION RES, V45, P3210, DOI 10.1016/j.visres.2005.06.016; Wyszecki G., 2000, COLOR SCI CONCEPTS M, V2nd ed., P117	35	31	32	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2013	8	5							e63921	10.1371/journal.pone.0063921	http://dx.doi.org/10.1371/journal.pone.0063921			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145YI	23667689	Green Published, Green Submitted, gold			2022-12-27	WOS:000319055600082
J	Umemura, M; Koyama, Y; Takeda, I; Hagiwara, H; Ikegami, T; Koike, H; Machida, M				Umemura, Myco; Koyama, Yoshinori; Takeda, Itaru; Hagiwara, Hiroko; Ikegami, Tsutomu; Koike, Hideaki; Machida, Masayuki			Fine De Novo Sequencing of a Fungal Genome Using only SOLiD Short Read Data: Verification on Aspergillus oryzae RIB40	PLOS ONE			English	Article							CORYNEBACTERIUM-PSEUDOTUBERCULOSIS I19; GENE-CLUSTER; BIOSYNTHESIS; PARALLEL	The development of next-generation sequencing (NGS) technologies has dramatically increased the throughput, speed, and efficiency of genome sequencing. The short read data generated from NGS platforms, such as SOLiD and Illumina, are quite useful for mapping analysis. However, the SOLiD read data with lengths of,60 bp have been considered to be too short for de novo genome sequencing. Here, to investigate whether de novo sequencing of fungal genomes is possible using only SOLiD short read sequence data, we performed de novo assembly of the Aspergillus oryzae RIB40 genome using only SOLiD read data of 50 bp generated from mate-paired libraries with 2.8- or 1.9-kb insert sizes. The assembled scaffolds showed an N50 value of 1.6 Mb, a 22-fold increase than those obtained using only SOLiD short read in other published reports. In addition, almost 99% of the reference genome was accurately aligned by the assembled scaffold fragments in long lengths. The sequences of secondary metabolite biosynthetic genes and clusters, whose products are of considerable interest in fungal studies due to their potential medicinal, agricultural, and cosmetic properties, were also highly reconstructed in the assembled scaffolds. Based on these findings, we concluded that de novo genome sequencing using only SOLiD short reads is feasible and practical for molecular biological study of fungi. We also investigated the effect of filtering low quality data, library insert size, and k-mer size on the assembly performance, and recommend for the assembly use of mild filtered read data where the N50 was not so degraded and the library has an insert size of similar to 2.0 kb, and k-mer size 33.	[Umemura, Myco; Machida, Masayuki] Natl Inst Adv Ind Sci & Technol, Bioprod Res Inst, Sapporo, Hokkaido, Japan; [Koyama, Yoshinori; Takeda, Itaru; Hagiwara, Hiroko; Koike, Hideaki] Natl Inst Adv Ind Sci & Technol, Bioprod Res Inst, Tsukuba, Ibaraki, Japan; [Takeda, Itaru; Machida, Masayuki] Tokyo Univ Agr & Technol, Dept Biotechnol & Life Sci, Koganei, Tokyo, Japan; [Ikegami, Tsutomu] Natl Inst Adv Ind Sci & Technol, Informat Technol Res Inst, Tsukuba, Ibaraki, Japan	National Institute of Advanced Industrial Science & Technology (AIST); National Institute of Advanced Industrial Science & Technology (AIST); Tokyo University of Agriculture & Technology; National Institute of Advanced Industrial Science & Technology (AIST)	Koike, H (corresponding author), Natl Inst Adv Ind Sci & Technol, Bioprod Res Inst, Tsukuba, Ibaraki, Japan.	hi-koike@aist.go.jp	IKEGAMI, TSUTOMU/N-3452-2016; Umemura, Maiko/M-4092-2018	IKEGAMI, TSUTOMU/0000-0003-2977-6390; Umemura, Maiko/0000-0001-8730-1380				ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Brown DW, 1996, P NATL ACAD SCI USA, V93, P1418, DOI 10.1073/pnas.93.4.1418; Cane DE, 1999, CHEM BIOL, V6, pR319, DOI 10.1016/S1074-5521(00)80001-0; Cerdeira LT, 2011, J MICROBIOL METH, V86, P218, DOI 10.1016/j.mimet.2011.05.008; Cunningham C, 2010, J GEN VIROL, V91, P605, DOI 10.1099/vir.0.015891-0; den Bakker HC, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-688; DiGuistini S, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-9-r94; Earl D, 2011, GENOME RES, V21, P2224, DOI 10.1101/gr.126599.111; Farrer RA, 2009, FEMS MICROBIOL LETT, V291, P103, DOI 10.1111/j.1574-6968.2008.01441.x; Frith MC, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq010; Frith MC, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-80; Georgianna DR, 2010, MOL PLANT PATHOL, V11, P213, DOI 10.1111/j.1364-3703.2009.00594.x; Georgianna DR, 2009, FUNGAL GENET BIOL, V46, P113, DOI 10.1016/j.fgb.2008.10.011; Ghosh W, 2011, J BACTERIOL, V193, P5553, DOI 10.1128/JB.05781-11; Gnerre S, 2011, P NATL ACAD SCI USA, V108, P1513, DOI 10.1073/pnas.1017351108; Haridas S, 2011, J MICROBIOL METH, V86, P368, DOI 10.1016/j.mimet.2011.06.019; Kielbasa SM, 2011, GENOME RES, V21, P487, DOI 10.1101/gr.113985.110; Kiyota T, 2011, J BIOSCI BIOENG, V111, P512, DOI 10.1016/j.jbiosc.2010.12.022; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; Kusumoto K, 2000, CURR GENET, V37, P104, DOI 10.1007/s002940050016; Lee SW, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-197; Li RQ, 2010, NATURE, V463, P311, DOI 10.1038/nature08696; Lin Y, 2011, BIOINFORMATICS, V27, P2031, DOI 10.1093/bioinformatics/btr319; MacCallum I, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-10-r103; Machida M, 2005, NATURE, V438, P1157, DOI 10.1038/nature04300; Marroni F, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00133; Nowrousian M, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000891; Palmer JM, 2010, CURR OPIN MICROBIOL, V13, P431, DOI 10.1016/j.mib.2010.04.008; Chaparro PJP, 2011, J MICROBIOL METH, V87, P208, DOI 10.1016/j.mimet.2011.08.003; Rumble SM, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000386; Sanchez JF, 2012, NAT PROD REP, V29, P351, DOI 10.1039/c2np00084a; Schwarzer D, 2003, NAT PROD REP, V20, P275, DOI 10.1039/b111145k; Silva A, 2011, J BACTERIOL, V193, P323, DOI 10.1128/JB.01211-10; Spanu PD, 2010, SCIENCE, V330, P1543, DOI 10.1126/science.1194573; States D J, 1994, J Comput Biol, V1, P39; Staunton J, 2001, NAT PROD REP, V18, P380, DOI 10.1039/a909079g; Terabayashi Y, 2010, FUNGAL GENET BIOL, V47, P953, DOI 10.1016/j.fgb.2010.08.014; Tominaga M, 2006, APPL ENVIRON MICROB, V72, P484, DOI 10.1128/AEM.72.1.484-490.2006; Umemura M, 2012, DNA RES, V19, P375, DOI 10.1093/dnares/dss019; Watson AJ, 1999, APPL ENVIRON MICROB, V65, P307; Yin WB, 2011, J MICROBIOL, V49, P329, DOI 10.1007/s12275-011-1009-1; Yu JJ, 2004, APPL ENVIRON MICROB, V70, P1253, DOI 10.1128/AEM.70.3.1253-1262.2004; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	43	14	14	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e63673	10.1371/journal.pone.0063673	http://dx.doi.org/10.1371/journal.pone.0063673			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667655	Green Published, gold, Green Submitted			2022-12-27	WOS:000319654700175
J	Verheyen, S; Storms, G				Verheyen, Steven; Storms, Gert			A Mixture Approach to Vagueness and Ambiguity	PLOS ONE			English	Article							MODELING INDIVIDUAL-DIFFERENCES; TREE EXPERTS; RASCH MODEL; CATEGORIZATION; CONTEXT; CLASSIFICATION; RESPONSES; MEMORY; NORMS	When asked to indicate which items from a set of candidates belong to a particular natural language category inter-individual differences occur: Individuals disagree which items should be considered category members. The premise of this paper is that these inter-individual differences in semantic categorization reflect both ambiguity and vagueness. Categorization differences are said to be due to ambiguity when individuals employ different criteria for categorization. For instance, individuals may disagree whether hiking or darts is the better example of sports because they emphasize respectively whether an activity is strenuous and whether rules apply. Categorization differences are said to be due to vagueness when individuals employ different cut-offs for separating members from non-members. For instance, the decision to include hiking in the sports category or not, may hinge on how strenuous different individuals require sports to be. This claim is supported by the application of a mixture model to categorization data for eight natural language categories. The mixture model can identify latent groups of categorizers who regard different items likely category members (i.e., ambiguity) with categorizers within each of the groups differing in their propensity to provide membership responses (i.e., vagueness). The identified subgroups are shown to emphasize different sets of category attributes when making their categorization decisions.	[Verheyen, Steven; Storms, Gert] Univ Louvain, Fac Psychol & Educ Sci, Louvain, Belgium		Verheyen, S (corresponding author), Univ Louvain, Fac Psychol & Educ Sci, Louvain, Belgium.	steven.verheyen@ppw.kuleuven.be	verheyen, steven/AFL-4133-2022	verheyen, steven/0000-0002-6778-6744; Storms, Gert/0000-0002-4100-8725	Research Foundation-Flanders	Research Foundation-Flanders(FWO)	This work was supported by the Research Foundation-Flanders (www.fwo.be) in the form of a postdoctoral fellowship awarded to the first author. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON RC, 1975, COGNITIVE PSYCHOL, V7, P167, DOI 10.1016/0010-0285(75)90008-0; BARSALOU LW, 1982, MEM COGNITION, V10, P82, DOI 10.3758/BF03197629; Barsalou LW, 1984, CONSTRUCTING REPRESE; Berlin B., 1969, BASIC COLOR TERMS TH; Black M., 1990, International Journal of General Systems, V17, P107, DOI 10.1080/03081079008935103; Bonnefon JF, 2008, Q J EXP PSYCHOL, V61, P809, DOI 10.1080/17470210701434573; BRAISBY N, 1993, IRISH J PSYCHOL, V14, P426, DOI 10.1080/03033910.1993.10557948; Braisby NR, 2005, COMPOSITIONALITY MEA, VII, P179; CARABINE B, 1991, J CHILD LANG, V18, P355, DOI 10.1017/S0305000900011107; Caramazza A., 1976, SEMANTICS THEORY APP, P181; Craig S, 2012, Q J EXP PSYCHOL, V65, P439, DOI 10.1080/17470218.2011.608854; Cruse D, 2001, AXIOMATHES, V12, P35; Cruse D. A., 2000, POLYSEMY THEORETICAL, P30; Dale R, 2007, MEM COGNITION, V35, P15, DOI 10.3758/BF03195938; De Deyne S, 2008, BEHAV RES METHODS, V40, P1030, DOI 10.3758/BRM.40.4.1030; Everitt B.S., 2001, APPL MULTIVARIATE DA, V2, P48, DOI DOI 10.1002/9781118887486.CH3; Fine K., 1975, SYNTHESE, P265, DOI DOI 10.1007/BF00485047; FODOR JA, 1980, COGNITION, V8, P263, DOI 10.1016/0010-0277(80)90008-6; Gibbs R.W., 1994, J SEMANT, V11, P231, DOI [DOI 10.1093/JOS/11.4.231, 10.1093/jos/11.4.231]; Gorfein DS, 2008, BEHAV RES METHODS, V40, P522, DOI 10.3758/BRM.40.2.522; GORFEIN DS, 1982, MEM COGNITION, V10, P503, DOI 10.3758/BF03197654; Griffiths TL, 2007, PSYCHOL REV, V114, P211, DOI 10.1037/0033-295X.114.2.211; HAMPTON JA, 1979, J VERB LEARN VERB BE, V18, P441, DOI 10.1016/S0022-5371(79)90246-9; Hampton JA, 2007, COGNITIVE SCI, V31, P355, DOI 10.1080/15326900701326402; Hampton JA, 2006, MEM COGNITION, V34, P1431, DOI 10.3758/BF03195908; Hampton James A, 1995, J MEM LANG, V34, P686, DOI 10.1006/jmla.1995.1031; Hampton JA, 2006, PSYCHOL LEARN MOTIV, V46, P79, DOI 10.1016/S0079-7421(06)46003-5; Hampton James A, 1998, COGNITION, V65, P137, DOI 10.1016/S0010-0277(97)00042-5; Johansen MK, 2002, COGNITIVE PSYCHOL, V45, P482, DOI 10.1016/S0010-0285(02)00505-4; Keefe, 2000, THEORIES VAGUENESS; Klein DE, 2002, J MEM LANG, V47, P548, DOI 10.1016/S0749-596X(02)00020-7; Klein DE, 2001, J MEM LANG, V45, P259, DOI 10.1006/jmla.2001.2779; Kooij JG, 1971, AMBIGUITY NATURLA LA; Kruschke J. K., 2011, DOING BAYESIAN DATA; LAKOFF G, 1970, LINGUIST INQ, V1, P357; Lakoff G, 1973, J PHILOS LOGIC, V2, P458, DOI DOI 10.1007/BF00262952; Lakoff George, 1987, WOMEN FIRE, DOI DOI 10.7208/CHICAGO/9780226471013.001.0001; Lee MD, 2005, PSYCHON B REV, V12, P605, DOI 10.3758/BF03196751; Lee MD, 2010, COGNITION IN FLUX, P387; Li FM, 2009, APPL PSYCH MEAS, V33, P353, DOI 10.1177/0146621608326422; Little DR, 2009, J EXP PSYCHOL HUMAN, V35, P530, DOI 10.1037/0096-1523.35.2.530; Lunn DJ, 2000, STAT COMPUT, V10, P325, DOI 10.1023/A:1008929526011; Lynch EB, 2000, MEM COGNITION, V28, P41, DOI 10.3758/BF03211575; MACHINA KF, 1976, J PHILOS LOGIC, V5, P47; MALT BC, 1982, MEM COGNITION, V10, P69, DOI 10.3758/BF03197627; MARTIN RC, 1980, J EXP PSYCHOL GEN, V109, P320, DOI 10.1037/0096-3445.109.3.320; MCCLOSKEY ME, 1978, MEM COGNITION, V6, P462, DOI 10.3758/BF03197480; McLachlan G., 2000, WILEY SER PROB STAT; MEDIN DL, 1989, AM PSYCHOL, V44, P1469, DOI 10.1037/0003-066X.44.12.1469; Medin DL, 1997, COGNITIVE PSYCHOL, V32, P49, DOI 10.1006/cogp.1997.0645; MERVIS CB, 1981, ANNU REV PSYCHOL, V32, P89, DOI 10.1146/annurev.ps.32.020181.000513; Meyer JP, 2010, APPL PSYCH MEAS, V34, P521, DOI 10.1177/0146621609355451; MISLEVY RJ, 1990, PSYCHOMETRIKA, V55, P195, DOI 10.1007/BF02295283; NOSOFSKY RM, 1994, PSYCHOL REV, V101, P53, DOI 10.1037/0033-295X.101.1.53; PALMERI TJ, 1995, J EXP PSYCHOL LEARN, V21, P548, DOI 10.1037/0278-7393.21.3.548; Plummer M., 2003, P 3 INT WORKSH DISTR; ROSCH E, 1975, COGNITIVE PSYCHOL, V7, P573, DOI 10.1016/0010-0285(75)90024-9; Rosch E., 1978, COGNITION CATEGORIZA, P27, DOI DOI 10.1037/0012-1649.16.5.391; Ross BH, 1996, J EXP PSYCHOL LEARN, V22, P1249, DOI 10.1037/0278-7393.22.5.1249; Ross BH, 1999, J EXP PSYCHOL LEARN, V25, P743, DOI 10.1037/0278-7393.25.3.743; Ross BH, 1999, COGNITIVE PSYCHOL, V38, P495, DOI 10.1006/cogp.1998.0712; ROST J, 1990, APPL PSYCH MEAS, V14, P271, DOI 10.1177/014662169001400305; SADLER DD, 1993, J EXP PSYCHOL LEARN, V19, P128, DOI 10.1037/0278-7393.19.1.128; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Schyns PG, 1997, J EXP PSYCHOL LEARN, V23, P681, DOI 10.1037/0278-7393.23.3.681; Shapiro S., 2006, VAGUENESS CONTEXT; Smith JD, 1997, J EXP PSYCHOL LEARN, V23, P659, DOI 10.1037/0278-7393.23.3.659; Thomas RD, 1998, J EXP PSYCHOL LEARN, V24, P119, DOI 10.1037/0278-7393.24.1.119; TWILLEY LC, 1994, MEM COGNITION, V22, P111, DOI 10.3758/BF03202766; van Deemter K., 2010, NOT EXACTLY PRAISE V; Vandekerckhove J, 2010, ACTA PSYCHOL, V133, P269, DOI 10.1016/j.actpsy.2009.10.009; Vanpaemel W., 2007, P 29 ANN C COGN SCI, P1599; Verheyen S., 2008, P 30 ANN C COGN SCI, P751; Verheyen S, 2007, PSYCHOL BELG, V47, P219, DOI 10.5334/pb-47-4-219; Verheyen S, 2011, J EXP PSYCHOL LEARN, V37, P1515, DOI 10.1037/a0024431; Verheyen S, 2010, ACTA PSYCHOL, V135, P216, DOI 10.1016/j.actpsy.2010.07.002; von Eckardt B, 1993, WHAT IS COGNITIVE SC; Wilson E.O., 1975, P1; Yang LX, 2003, J EXP PSYCHOL LEARN, V29, P663, DOI 10.1037/0278-7393.29.4.663; Zeigenfuse MD, 2009, P 31 ANN C COGN SCI, P1412	80	9	9	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e63507	10.1371/journal.pone.0063507	http://dx.doi.org/10.1371/journal.pone.0063507			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	154EP	23667627	Green Published, gold, Green Submitted			2022-12-27	WOS:000319654700152
J	Wang, JN; Fulford, T; Shao, Q; Javelle, A; Yang, HY; Zhu, WL; Merrick, M				Wang, Jinan; Fulford, Tim; Shao, Qiang; Javelle, Arnaud; Yang, Huaiyu; Zhu, Weiliang; Merrick, Mike			Ammonium Transport Proteins with Changes in One of the Conserved Pore Histidines Have Different Performance in Ammonia and Methylamine Conduction	PLOS ONE			English	Article							MOLECULAR-DYNAMICS SIMULATIONS; AMTB-GLNK COMPLEX; ESCHERICHIA-COLI; CHANNEL AMTB; NITROSOMONAS-EUROPAEA; FUNCTIONAL-CHARACTERIZATION; CORYNEBACTERIUM-GLUTAMICUM; SACCHAROMYCES-CEREVISIAE; DEPROTONATION MECHANISM; CRYSTAL-STRUCTURE	Two conserved histidine residues are located near the mid-point of the conduction channel of ammonium transport proteins. The role of these histidines in ammonia and methylamine transport was evaluated by using a combination of in vivo studies, molecular dynamics (MD) simulation, and potential of mean force (PMF) calculations. Our in vivo results showed that a single change of either of the conserved histidines to alanine leads to the failure to transport methylamine but still facilitates good growth on ammonia, whereas double histidine variants completely lose their ability to transport both methylamine and ammonia. Molecular dynamics simulations indicated the molecular basis of the in vivo observations. They clearly showed that a single histidine variant (H168A or H318A) of AmtB confines the rather hydrophobic methylamine more strongly than ammonia around the mutated sites, resulting in dysfunction in conducting the former but not the latter molecule. PMF calculations further revealed that the single histidine variants form a potential energy well of up to 6 kcal/mol for methylamine, impairing conduction of this substrate. Unlike the single histidine variants, the double histidine variant, H168A/H318A, of AmtB was found to lose its unidirectional property of transporting both ammonia and methylamine. This could be attributed to a greatly increased frequency of opening of the entrance gate formed by F215 and F107, in this variant compared to wild-type, with a resultant lowering of the energy barrier for substrate to return to the periplasm.	[Wang, Jinan; Shao, Qiang; Yang, Huaiyu; Zhu, Weiliang] Chinese Acad Sci, Shanghai Inst Mat Med, CAS Key Lab Receptor Res, Drug Discovery & Design Ctr, Shanghai 200031, Peoples R China; [Fulford, Tim; Javelle, Arnaud; Merrick, Mike] John Innes Ctr, Dept Mol Microbiol, Norwich, Norfolk, England	Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center	Zhu, WL (corresponding author), Chinese Acad Sci, Shanghai Inst Mat Med, CAS Key Lab Receptor Res, Drug Discovery & Design Ctr, Shanghai 200031, Peoples R China.	wlzhu@mail.shcnc.ac.cn; mike.merrick@jic.ac.uk	Shao, Qiang/O-4528-2019	Shao, Qiang/0000-0001-6460-3095	Biotechnology and Biological Sciences Research Council - BBSRC; BBSRC Committee Studentship; Ministry of Science and Technology [2010DFB73280, 2012AA01A305, 2012CB910403]; National Natural Science Foundation [21021063]; Computer Network Information Center (CNIC); Chinese Academy of Sciences (CAS); Shanghai Supercomputing Center (SCC)	Biotechnology and Biological Sciences Research Council - BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC Committee Studentship(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Computer Network Information Center (CNIC); Chinese Academy of Sciences (CAS)(Chinese Academy of Sciences); Shanghai Supercomputing Center (SCC)	This research was supported by the Biotechnology and Biological Sciences Research Council - BBSRC (M.M. and A.J.), a BBSRC Committee Studentship (T.F.)(http://www.jic.ac.uk), the Ministry of Science and Technology (2010DFB73280, 2012AA01A305 & 2012CB910403, W.Z.) (http://www.most.gov.cn), and National Natural Science Foundation (21021063, W.Z.)(http://www.nsfc.gov.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Computation resources were supported by Computer Network Information Center (CNIC), Chinese Academy of Sciences (CAS) and Shanghai Supercomputing Center (SCC).	Akgun U, 2011, P NATL ACAD SCI USA, V108, P3970, DOI 10.1073/pnas.1007240108; Andrade SLA, 2005, P NATL ACAD SCI USA, V102, P14994, DOI 10.1073/pnas.0506254102; BENNAIM A, 1984, J CHEM PHYS, V81, P2016, DOI 10.1063/1.447824; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Bjelkmar P, 2010, J CHEM THEORY COMPUT, V6, P459, DOI 10.1021/ct900549r; Boeckstaens M, 2008, J BIOL CHEM, V283, P21362, DOI 10.1074/jbc.M801467200; Bostick DL, 2007, PLOS COMPUT BIOL, V3, P231, DOI 10.1371/journal.pcbi.0030022; Bostick DL, 2007, BIOPHYS J, V92, pL103, DOI 10.1529/biophysj.107.109165; Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420; Cao Z, 2007, ANGEW CHEM INT EDIT, V46, P6811, DOI 10.1002/anie.200701348; Cherif-Zahar B, 2007, J BACTERIOL, V189, P9090, DOI 10.1128/JB.01089-07; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Fong RN, 2007, P NATL ACAD SCI USA, V104, P18706, DOI 10.1073/pnas.0709267104; Gruswitz F, 2007, P NATL ACAD SCI USA, V104, P42, DOI 10.1073/pnas.0609796104; Gruswitz F, 2010, P NATL ACAD SCI USA, V107, P9638, DOI 10.1073/pnas.1003587107; Hall JA, 2011, P NATL ACAD SCI USA, V108, P13270, DOI 10.1073/pnas.1108451108; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; HOOVER WG, 1985, PHYS REV A, V31, P1695, DOI 10.1103/PhysRevA.31.1695; Hub JS, 2010, J CHEM THEORY COMPUT, V6, P3713, DOI 10.1021/ct100494z; Hub JS, 2010, J AM CHEM SOC, V132, P13251, DOI 10.1021/ja102133x; Ishikita H, 2007, J AM CHEM SOC, V129, P1210, DOI 10.1021/ja066208n; Javelle A, 2005, BIOCHEM J, V390, P215, DOI 10.1042/BJ20042094; Javelle A, 2004, J BIOL CHEM, V279, P8530, DOI 10.1074/jbc.M312399200; Javelle A, 2008, P NATL ACAD SCI USA, V105, P5040, DOI 10.1073/pnas.0711742105; Javelle A, 2007, J STRUCT BIOL, V158, P472, DOI 10.1016/j.jsb.2007.01.004; Javelle A, 2006, J BIOL CHEM, V281, P39492, DOI 10.1074/jbc.M608325200; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Khademi S, 2004, SCIENCE, V305, P1587, DOI 10.1126/science.1101952; KLEINER D, 1985, FEMS MICROBIOL LETT, V32, P87, DOI 10.1016/0378-1097(85)90059-X; KUMAR S, 1992, J COMPUT CHEM, V13, P1011, DOI 10.1002/jcc.540130812; Lamoureux G, 2010, TRANSFUS CLIN BIOL, V17, P168, DOI 10.1016/j.tracli.2010.06.004; Lamoureux G, 2007, BIOPHYS J, V92, pL82, DOI 10.1529/biophysj.106.102756; Le Van Kim C, 2006, BLOOD REV, V20, P93, DOI 10.1016/j.blre.2005.04.002; Li X, 2007, P NATL ACAD SCI USA, V104, P19279, DOI 10.1073/pnas.0709710104; Lin YC, 2009, J PHYS CHEM B, V113, P4922, DOI 10.1021/jp810651m; Lin YC, 2006, J AM CHEM SOC, V128, P10876, DOI 10.1021/ja0631549; Liu YM, 2006, J PHYS CHEM A, V110, P1375, DOI 10.1021/jp054261c; Ludewig U, 2006, TRANSFUS CLIN BIOL, V13, P111, DOI 10.1016/j.tracli.2006.02.012; Ludewig U, 2003, J BIOL CHEM, V278, P45603, DOI 10.1074/jbc.M307424200; Lupo D, 2007, P NATL ACAD SCI USA, V104, P19303, DOI 10.1073/pnas.0706563104; Mackerell AD, 2004, J COMPUT CHEM, V25, P1400, DOI 10.1002/jcc.20065; Marini AM, 2000, NAT GENET, V26, P341, DOI 10.1038/81656; Marini AM, 1997, MOL CELL BIOL, V17, P4282, DOI 10.1128/MCB.17.8.4282; Mayer M, 2006, PLANT BIOLOGY, V8, P522, DOI 10.1055/s-2006-923877; Mayer M, 2006, J GEN PHYSIOL, V127, P133, DOI 10.1085/jgp.200509369; Meier-Wagner J, 2001, MICROBIOL-UK, V147, P135, DOI 10.1099/00221287-147-1-135; MERRICK MJ, 1995, MICROBIOL REV, V59, P604, DOI 10.1128/MMBR.59.4.604-622.1995; NINNEMANN O, 1994, EMBO J, V13, P3464, DOI 10.1002/j.1460-2075.1994.tb06652.x; NOSE S, 1984, MOL PHYS, V52, P255, DOI 10.1080/00268978400101201; Nygaard TP, 2006, BIOPHYS J, V91, P4401, DOI 10.1529/biophysj.106.089714; Nygaard TP, 2010, J PHYS CHEM B, V114, P11859, DOI 10.1021/jp102338h; PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693; Planelles G, 2007, NEPHRON PHYSIOL, V105, P11, DOI 10.1159/000096979; RENTSCH D, 1995, FEBS LETT, V370, P264, DOI 10.1016/0014-5793(95)00853-2; Rutherford JC, 2008, MOL BIOL CELL, V19, P3028, DOI 10.1091/mbc.E08-01-0033; Siewe RM, 1996, J BIOL CHEM, V271, P5398, DOI 10.1074/jbc.271.10.5398; Sohlenkamp C, 2002, PLANT PHYSIOL, V130, P1788, DOI 10.1104/pp.008599; Soupene E, 1998, P NATL ACAD SCI USA, V95, P7030, DOI 10.1073/pnas.95.12.7030; Soupene E, 2002, J BACTERIOL, V184, P3396, DOI 10.1128/JB.184.12.3396-3400.2002; Soupene E, 2002, P NATL ACAD SCI USA, V99, P3926, DOI 10.1073/pnas.062043799; Thomas G, 2000, TRENDS GENET, V16, P11, DOI 10.1016/S0168-9525(99)01887-9; Tremblay PL, 2008, J BACTERIOL, V190, P1588, DOI 10.1128/JB.01643-07; von Wiren N, 2000, CURR OPIN PLANT BIOL, V3, P254, DOI 10.1016/S1369-5266(00)00073-X; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; Wang JN, 2010, J PHYS CHEM B, V114, P15172, DOI 10.1021/jp104508k; Wang SH, 2012, J AM CHEM SOC, V134, P10419, DOI 10.1021/ja300129x; Yang HY, 2007, BIOPHYS J, V92, P877, DOI 10.1529/biophysj.106.090191; Zheng L, 2004, P NATL ACAD SCI USA, V101, P17090, DOI 10.1073/pnas.0406475101; Zoete V, 2011, J COMPUT CHEM, V32, P2359, DOI 10.1002/jcc.21816	70	17	17	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e62745	10.1371/journal.pone.0062745	http://dx.doi.org/10.1371/journal.pone.0062745			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667517	Green Accepted, Green Published, gold			2022-12-27	WOS:000319654700061
J	White, AM; Zipkin, EF; Manley, PN; Schlesinger, MD				White, Angela M.; Zipkin, Elise F.; Manley, Patricia N.; Schlesinger, Matthew D.			Conservation of Avian Diversity in the Sierra Nevada: Moving beyond a Single-Species Management Focus	PLOS ONE			English	Article							RESTORATION TREATMENTS; BIRD COMMUNITIES; FOREST STRUCTURE; FIRE SEVERITY; BIODIVERSITY; RICHNESS; IMPACTS; DISTURBANCE; CALIFORNIA; MODELS	Background: As a result of past practices, many of the dry coniferous forests of the western United States contain dense, even-aged stands with uncharacteristically high levels of litter and downed woody debris. These changes to the forest have received considerable attention as they elevate concerns regarding the outcome of wildland fire. However, attempts to reduce biomass through fuel reduction (i.e., thinning of trees) are often opposed by public interest groups whose objectives include maintaining habitat for species of concern such as the spotted owl, Strix occidentalis, the northern goshawk, Accipiter gentilis, and the Pacific fisher, Martes pennanti. Whether protection of these upper-trophic level species confers adequate conservation of avian forest diversity is unknown. Methodology and Principal Findings: We use a multi-species occurrence model to estimate the habitat associations of 47 avian species detected at 742 sampling locations within an 880-km(2) area in the Sierra Nevada. Our approach, which accounts for variations in detectability of species, estimates occurrence probabilities of all species in a community by linking species occurrence models into one hierarchical community model, thus improving inferences on all species, especially those that are rare or observed infrequently. We address how the avian community is influenced by covariates related to canopy cover, tree size and shrub cover while accounting for the impacts of abiotic variables known to affect species distributions. Conclusions and Significance: Environmental parameters estimated through our approach emphasize the importance of within and between stand-level heterogeneity in meeting biodiversity objectives and suggests that many avian species would increase under more open canopy habitat conditions than those favored by umbrella species of high conservation concern. Our results suggest that a more integrated approach that emphasizes maintaining a diversity of habitats across environmental gradients and minimizing urbanization may have a greater benefit to ecosystem functioning then a single-species management focus.	[White, Angela M.; Schlesinger, Matthew D.] US Forest Serv, Conservat Biodivers Grp, Pacific Southwest Res Stn, USDA, Davis, CA USA; [Zipkin, Elise F.] USGS Patuxent Wildlife Res Ctr, Laurel, MD USA; [Zipkin, Elise F.] Univ Maryland, Dept Biol, College Pk, MD 20742 USA; [Manley, Patricia N.] US Forest Serv, Conservat Biodivers Grp, Pacific Southwest Res Stn, USDA, Hilo, HI USA; [Schlesinger, Matthew D.] Univ Calif Davis, Dept Environm Sci & Policy, Davis, CA 95616 USA; [Schlesinger, Matthew D.] Univ Calif Davis, Grad Grp Ecol, Davis, CA 95616 USA; [Schlesinger, Matthew D.] New York Nat Heritage Program, Albany, NY USA	United States Department of Agriculture (USDA); United States Forest Service; United States Department of the Interior; United States Geological Survey; University System of Maryland; University of Maryland College Park; United States Department of Agriculture (USDA); United States Forest Service; University of California System; University of California Davis; University of California System; University of California Davis	White, AM (corresponding author), US Forest Serv, Conservat Biodivers Grp, Pacific Southwest Res Stn, USDA, Davis, CA USA.	angelawhite@fs.fed.us	White, Angela/I-6436-2019; White, Angela M/N-7088-2013	White, Angela/0000-0001-7499-7390; White, Angela M/0000-0001-7499-7390; Zipkin, Elise/0000-0003-4155-6139	U.S. Forest Service Lake Tahoe Basin Management Unit; U.S. Forest Service Pacific Southwest Research Station; Sierra Nevada Public Lands Management Act	U.S. Forest Service Lake Tahoe Basin Management Unit(United States Department of Agriculture (USDA)United States Forest Service); U.S. Forest Service Pacific Southwest Research Station(United States Department of Agriculture (USDA)United States Forest Service); Sierra Nevada Public Lands Management Act	Funding was provided by U.S. Forest Service Lake Tahoe Basin Management Unit, U.S. Forest Service Pacific Southwest Research Station, and the Sierra Nevada Public Lands Management Act. The funders had no rule in study design, data collection and analysis decision to publish, or preparation of the manuscript.	Aerts Raf, 2011, BMC Ecology, V11, P29, DOI 10.1186/1472-6785-11-29; Agee JK, 2005, FOREST ECOL MANAG, V211, P83, DOI 10.1016/j.foreco.2005.01.034; Anderson MK, 2005, TENDING THE WILD: NATIVE AMERICAN KNOWLEDGE AND THE MANAGEMENT OF CALIFORNIA'S NATURAL RESOURCES, P1; Barbour M, 2002, J VEG SCI, V13, P461, DOI 10.1111/j.1654-1103.2002.tb02073.x; Beaty RM, 2007, J VEG SCI, V18, P879, DOI 10.1111/j.1654-1103.2007.tb02604.x; Benton TG, 2003, TRENDS ECOL EVOL, V18, P182, DOI 10.1016/S0169-5347(03)00011-9; Buckland ST, 2006, AUK, V123, P345, DOI 10.1642/0004-8038(2006)123[345:PSFSRM]2.0.CO;2; Bunker D.E., 2009, BIODIVERSITY ECOSYST; Caro T. M, 2010, CONSERVATION PROXY I; CDFG (California Department of Fish and Game), 2000, CAL WILDL HAB REL PR; Collins BM, 2010, J FOREST, V108, P24; Daily GC, 1997, NATURES SERVICES SOC, DOI DOI 10.12987/9780300188479-039; Daly C, 2002, CLIM RES, V22, P99, DOI 10.3354/cr022099; Dobrowski SZ, 2006, ECOL MODEL, V192, P126, DOI 10.1016/j.ecolmodel.2005.09.006; Dorazio RM, 2006, ECOLOGY, V87, P842, DOI 10.1890/0012-9658(2006)87[842:ESRAAB]2.0.CO;2; Dorazio RM, 2005, J AM STAT ASSOC, V100, P389, DOI 10.1198/016214505000000015; Ehrlich A.H., 1981, EXTINCTION; ERDELEN M, 1984, OECOLOGIA, V61, P277, DOI 10.1007/BF00396773; Ferraro PJ, 2006, PLOS BIOL, V4, P482, DOI 10.1371/journal.pbio.0040105; Fischer J, 2004, J APPL ECOL, V41, P32, DOI 10.1111/j.1365-2664.2004.00869.x; Folke C, 1996, ECOL APPL, V6, P1018, DOI 10.2307/2269584; Gelman A., 2007, DATA ANAL USING REGR; Gill F. B., 1995, ORNITHOLOGY; Gutierrez R.J., 1996, Studies in Avian Biology, V17, P2; Hessburg PF, 2005, FOREST ECOL MANAG, V211, P117, DOI 10.1016/j.foreco.2005.02.016; Hessburg PF, 2003, FOREST ECOL MANAG, V178, P23, DOI 10.1016/S0378-1127(03)00052-5; Hirt PW., 1996, CONSPIRACY OPTIMISM; Huntzinger M, 2003, BIOL CONSERV, V113, P1, DOI 10.1016/S0006-3207(02)00356-7; Johnson DH, 2008, J WILDLIFE MANAGE, V72, P857, DOI 10.2193/2007-294; Kalies EL, 2010, FOREST ECOL MANAG, V259, P333, DOI 10.1016/j.foreco.2009.10.024; Keeley JE, 2003, ECOL APPL, V13, P1355, DOI 10.1890/02-5002; Kery M., 2010, INTRO WINBUGS ECOLOG; Kie JG, 1996, J RANGE MANAGE, V49, P482, DOI 10.2307/4002286; Kittel Timothy G. F., 1998, Madrono, V45, P75; LANDRES PB, 1988, CONSERV BIOL, V2, P316, DOI 10.1111/j.1523-1739.1988.tb00195.x; Lindenmayer D, 2008, ECOL LETT, V11, P78, DOI 10.1111/j.1461-0248.2007.01114.x; Lindenmayer DB, 2002, CONSERV BIOL, V16, P338, DOI 10.1046/j.1523-1739.2002.00450.x; LINDSTROM S, 2000, LAKE TAHOE WATERSHED; Long JN, 2000, J FOREST, V98, P25; Lydersen J, 2012, ECOSYSTEMS, P1; Mac Nally R, 2002, ECOL APPL, V12, P900, DOI 10.1890/1051-0761(2002)012[0900:HWDEBP]2.0.CO;2; MacKenzie DI, 2002, ECOLOGY, V83, P3532; Manley PN, 2009, LANDSCAPE URBAN PLAN, V89, P28, DOI 10.1016/j.landurbplan.2008.09.005; Manley PN, 2005, J WILDLIFE MANAGE, V69, P950, DOI 10.2193/0022-541X(2005)069[0950:AFEOAP]2.0.CO;2; Margules CR, 2000, NATURE, V405, P243, DOI 10.1038/35012251; Matlock RB, 2006, BIODIVERS CONSERV, V15, P2987, DOI 10.1007/s10531-005-4873-3; Mayer K.E., 1988, GUIDE WILDLIFE HABIT; McKelvey KS, 1996, 37 U CAL WILDL RES C, V37, P1033; Miller JD, 2009, ECOSYSTEMS, V12, P16, DOI 10.1007/s10021-008-9201-9; Noon BR, 2009, MODELS FOR PLANNING WILDLIFE CONSERVATION IN LARGE LANDSCAPES, P51, DOI 10.1016/B978-0-12-373631-4.00003-4; Noon BR, 1996, ANNU REV ECOL SYST, V27, P135, DOI 10.1146/annurev.ecolsys.27.1.135; North M, 2005, PLANT ECOL, V177, P13, DOI 10.1007/s11258-005-2270-3; North M, 2009, GEN TECHNICAL REPORT; North M., 2012, PSWGTR237 USDA FOR S; North M, 2007, CAN J FOREST RES, V37, P331, DOI 10.1139/X06-236; Ozaki K, 2006, CONSERV BIOL, V20, P1507, DOI 10.1111/j.1523-1739.2006.00444.x; Pulliam HR, 2000, ECOL LETT, V3, P349, DOI 10.1046/j.1461-0248.2000.00143.x; Purcell Kathryn L., 2005, Studies in Avian Biology, V30, P33; Purcell KL, 2009, FOREST ECOL MANAG, V258, P2696, DOI 10.1016/j.foreco.2009.09.041; Ralph CJ, 1993, HDB FIELD METHODS MO; Roberge JM, 2004, CONSERV BIOL, V18, P76, DOI 10.1111/j.1523-1739.2004.00450.x; Russell RE, 2009, ECOL APPL, V19, P1253, DOI 10.1890/08-0910.1; Schlesinger MD, 2008, ECOLOGY, V89, P2302, DOI 10.1890/07-0256.1; Schluter D., 1993, SPECIES DIVERSITY EC; Sergio F, 2008, ANNU REV ECOL EVOL S, V39, P1, DOI 10.1146/annurev.ecolsys.39.110707.173545; Shrader-Frechette KS, 1993, METHOD ECOLOGY STRAT; Siegel RB, 2010, BIRD MONITORING PROT; Skinner CN, 1996, SIERRA NEVADA ECOSYS, V2, P1041; Stephens SL, 2012, BIOSCIENCE, V62, P549, DOI 10.1525/bio.2012.62.6.6; Stephens SL, 2009, ECOL APPL, V19, P305, DOI 10.1890/07-1755.1; Stephens Scott L., 2000, Madrono, V47, P43; Stephens SL, 2005, FOREST ECOL MANAG, V215, P21, DOI 10.1016/j.foreco.2005.03.070; Stephens SL, 2005, ECOL APPL, V15, P532, DOI 10.1890/04-0545; Taki H, 2010, FOREST ECOL MANAG, V259, P607, DOI 10.1016/j.foreco.2009.11.019; Tilman D, 1999, ECOLOGY, V80, P1455, DOI 10.1890/0012-9658(1999)080[1455:TECOCI]2.0.CO;2; Tscharntke T, 2005, ECOL LETT, V8, P857, DOI 10.1111/j.1461-0248.2005.00782.x; USDA, 2004, SIERR NEV FOR PLAN A; Verschuyl JP, 2008, ECOL APPL, V18, P1155, DOI 10.1890/07-0839.1; Waltz AEM, 2004, RESTOR ECOL, V12, P85, DOI 10.1111/j.1061-2971.2004.00262.x; Yi H, 2005, ENVIRON ENTOMOL, V34, P1071, DOI 10.1603/0046-225X(2005)034[1071:ROGATD]2.0.CO;2; Zielinski WJ, 2004, J WILDLIFE MANAGE, V68, P475, DOI 10.2193/0022-541X(2004)068[0475:RHSBFI]2.0.CO;2; Zipkin EF, 2012, ECOL APPL, V22, P1962, DOI 10.1890/11-1936.1; Zipkin EF, 2010, BIOL CONSERV, V143, P479, DOI 10.1016/j.biocon.2009.11.016; Zipkin EF, 2009, J APPL ECOL, V46, P815, DOI 10.1111/j.1365-2664.2009.01664.x	84	29	31	1	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e63088	10.1371/journal.pone.0063088	http://dx.doi.org/10.1371/journal.pone.0063088			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667579	Green Published, gold			2022-12-27	WOS:000319654700111
J	Zheng, CX; Chen, LJ; Chen, XP; He, XB; Yang, JW; Shi, Y; Zhou, NM				Zheng, Congxia; Chen, Linjie; Chen, Xiaopan; He, Xiaobai; Yang, Jingwen; Shi, Ying; Zhou, Naiming			The Second Intracellular Loop of the Human Cannabinoid CB2 Receptor Governs G Protein Coupling in Coordination with the Carboxyl Terminal Domain	PLOS ONE			English	Article							CRYSTAL-STRUCTURE; AMINO-ACID; FUNCTIONAL EXPRESSION; SIGNAL-TRANSDUCTION; PROSTAGLANDIN EP2; KEY ROLE; ACTIVATION; CELLS; PHARMACOLOGY; STIMULATION	The major effects of cannabinoids and endocannabinoids are mediated via two G protein-coupled receptors, CB1 and CB2, elucidation of the mechanism and structural determinants of the CB2 receptor coupling with G proteins will have a significant impact on drug discovery. In the present study, we systematically investigated the role of the intracellular loops in the interaction of the CB2 receptor with G proteins using chimeric receptors alongside the characterization of cAMP accumulation and ERK1/2 phosphorylation. We provided evidence that ICL2 was significantly involved in G protein coupling in coordination with the C-terminal end. Moreover, a single alanine substitution of the Pro-139 in the CB2 receptor that corresponds to Leu-222 in the CB1 receptor resulted in a moderate impairment in the inhibition of cAMP accumulation, whereas mutants P139F, P139M and P139L were able to couple to the G(s) protein in a CRE-driven luciferase assay. With the ERK activation experiments, we further found that P139L has the ability to activate ERK through both G(i)- and G(s)-mediated pathways. Our findings defined an essential role of the second intracellular loop of the CB2 receptor in coordination with the C-terminal tail in G protein coupling and receptor activation.	[Zheng, Congxia; Chen, Linjie; Chen, Xiaopan; He, Xiaobai; Shi, Ying; Zhou, Naiming] Zhejiang Univ, Coll Life Sci, Inst Biochem, Hangzhou 310003, Zhejiang, Peoples R China; [Yang, Jingwen] Zhejiang Univ, Coll Anim Sci, Inst Sericulture & Apiculture, Hangzhou 310003, Zhejiang, Peoples R China; [Zheng, Congxia] Zhejiang Int Studies Univ, Sch Art, Hangzhou, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University; Zhejiang International Studies University	Zhou, NM (corresponding author), Zhejiang Univ, Coll Life Sci, Inst Biochem, Hangzhou 310003, Zhejiang, Peoples R China.	znm2000@yahoo.com	Zhou, Naiming/AHC-1121-2022	Chen, Xiaopan/0000-0003-4289-7541	Ministry of Science and Technology [2012CB910402, 2012AA020303-05]; National Natural Science Foundation of China [30871292]	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the Ministry of Science and Technology [Grants 2012CB910402 and 2012AA020303-05], and the National Natural Science Foundation of China (30871292). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams IB, 1996, ADDICTION, V91, P1585, DOI 10.1111/j.1360-0443.1996.tb02264.x; ARORA KK, 1995, J BIOL CHEM, V270, P22820, DOI 10.1074/jbc.270.39.22820; Bab I, 2008, BRIT J PHARMACOL, V153, P182, DOI 10.1038/sj.bjp.0707593; Berg KA, 2008, J PHARMACOL EXP THER, V324, P1084, DOI 10.1124/jpet.107.131524; BLIN N, 1995, J BIOL CHEM, V270, P17741, DOI 10.1074/jbc.270.30.17741; Borner C, 2009, J BIOL CHEM, V284, P35450, DOI 10.1074/jbc.M109.006338; Bonhaus DW, 1998, J PHARMACOL EXP THER, V287, P884; Bouaboula M, 1996, EUR J BIOCHEM, V237, P704, DOI 10.1111/j.1432-1033.1996.0704p.x; Burstein ES, 1998, J BIOL CHEM, V273, P24322, DOI 10.1074/jbc.273.38.24322; Chen LJ, 2010, ANAL BIOCHEM, V407, P180, DOI 10.1016/j.ab.2010.08.018; Chen Z, 2001, CHEM REV, V101, P2449, DOI 10.1021/cr000241p; Demuth DG, 2006, LIFE SCI, V78, P549, DOI 10.1016/j.lfs.2005.05.055; Felder CC, 1998, J PHARMACOL EXP THER, V284, P291; FELDER CC, 1995, MOL PHARMACOL, V48, P443; Fernandez LM, 1997, MOL CELL ENDOCRINOL, V128, P161, DOI 10.1016/S0303-7207(97)04035-5; Gaborik Z, 2003, ENDOCRINOLOGY, V144, P2220, DOI 10.1210/en.2002-0135; Gershengorn MC, 2001, ENDOCRINOLOGY, V142, P2, DOI 10.1210/en.142.1.2; Guindon J, 2008, BRIT J PHARMACOL, V153, P319, DOI 10.1038/sj.bjp.0707531; HERKENHAM M, 1990, P NATL ACAD SCI USA, V87, P1932, DOI 10.1073/pnas.87.5.1932; Howlett AC, 2002, PHARMACOL REV, V54, P161, DOI 10.1124/pr.54.2.161; Jarrahian A, 2004, J PHARMACOL EXP THER, V308, P880, DOI 10.1124/jpet.103.057620; Kobayashi Y, 2001, J BIOCHEM-TOKYO, V129, P665, DOI 10.1093/oxfordjournals.jbchem.a002904; Koehler JA, 2005, MOL ENDOCRINOL, V19, P459, DOI 10.1210/me.2004-0196; Lambert D M, 2001, J Pharm Belg, V56, P111; Maccarrone M, 2008, BRIT J PHARMACOL, V153, P189, DOI 10.1038/sj.bjp.0707444; Marion S, 2006, J BIOL CHEM, V281, P2932, DOI 10.1074/jbc.M508074200; MATSUDA LA, 1990, NATURE, V346, P561, DOI 10.1038/346561a0; MORO O, 1993, J BIOL CHEM, V268, P22273; MUNRO S, 1993, NATURE, V365, P61, DOI 10.1038/365061a0; Onaivi ES, 2006, ANN NY ACAD SCI, V1074, P514, DOI 10.1196/annals.1369.052; Pal-Ghosh R, 2003, ARCH BIOCHEM BIOPHYS, V415, P54, DOI 10.1016/S0003-9861(03)00217-0; Ramanjaneya M, 2009, J ENDOCRINOL, V202, P249, DOI 10.1677/JOE-08-0536; Rasmussen SGF, 2007, NATURE, V450, P383, DOI 10.1038/nature06325; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Sanchez MG, 2003, CELL SIGNAL, V15, P851, DOI 10.1016/S0898-6568(03)00036-6; Scheerer P, 2008, NATURE, V455, P497, DOI 10.1038/nature07330; SEAMON KB, 1981, P NATL ACAD SCI-BIOL, V78, P3363, DOI 10.1073/pnas.78.6.3363; STRADER CD, 1994, ANNU REV BIOCHEM, V63, P101, DOI 10.1146/annurev.bi.63.070194.000533; Sugimoto Y, 2004, J BIOL CHEM, V279, P11016, DOI 10.1074/jbc.M307404200; Viscomi MT, 2009, J NEUROSCI, V29, P4564, DOI 10.1523/JNEUROSCI.0786-09.2009; Wacker JL, 2008, J BIOL CHEM, V283, P31068, DOI 10.1074/jbc.M805251200; Warne T, 2008, NATURE, V454, P486, DOI 10.1038/nature07101; Werry TD, 2005, TRENDS ENDOCRIN MET, V16, P26, DOI 10.1016/j.tem.2004.11.008; Wess J, 1998, PHARMACOL THERAPEUT, V80, P231, DOI 10.1016/S0163-7258(98)00030-8; Zoratti C, 2003, BRIT J PHARMACOL, V140, P1351, DOI 10.1038/sj.bjp.0705529	45	21	21	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e63262	10.1371/journal.pone.0063262	http://dx.doi.org/10.1371/journal.pone.0063262			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667597	Green Published, gold, Green Submitted			2022-12-27	WOS:000319654700127
J	Borgaro, JG; Benner, N; Zhu, ZY				Borgaro, Janine G.; Benner, Nicole; Zhu, Zhenyu			Fidelity Index Determination of DNA Methyltransferases	PLOS ONE			English	Article							HAEIII METHYLTRANSFERASE; SINGLE-MOLECULE; METHYLATION; RECOGNITION; ENZYMES; SITES	DNA methylation is the most frequent form of epigenetic modification in the cell, which involves gene regulation in eukaryotes and protection against restriction enzymes in prokaryotes. Even though many methyltransferases exclusively modify their cognate sites, there have been reports of those that exhibit promiscuity. Previous experimental approaches used to characterize these methyltransferases do not provide the exact concentration at which off-target methylation occurs. Here, we present the first reported fidelity index (FI) for a number of DNA methyltransferases. We define the FI as the ratio of the highest amount of methyltransferase that exhibits no star activity (off-target effects) to the lowest amount that exhibits complete modification of the cognate site. Of the methyltransferases assayed, M. MspI and M. AluI exhibited the highest fidelity of >= 250 and >= 500, respectively, and do not show star activity even at very high concentrations. In contrast, M. HaeIII, M.EcoKDam and M. BamHI have the lowest fidelity of 4, 4 and 2, respectively, and exhibit star activity at concentrations close to complete methylation of the cognate site. The fidelity indexes provide vital information on the usage of methyltransferases and are especially important in applications where site specific methylation is required.	[Borgaro, Janine G.; Benner, Nicole; Zhu, Zhenyu] New England Biolabs Inc, Ipswich, MA USA	New England Biolabs	Zhu, ZY (corresponding author), New England Biolabs Inc, Ipswich, MA USA.	zhuz@neb.com			New England Biolabs	New England Biolabs	New England Biolabs is the funder. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. However, the methylases studied in this paper are the current products of New England Biolabs.	Bandaru B, 1996, J BIOL CHEM, V271, P7851, DOI 10.1074/jbc.271.13.7851; BERKNER KL, 1978, NUCLEIC ACIDS RES, V5, P435, DOI 10.1093/nar/5.2.435; Casadesus J, 2006, MICROBIOL MOL BIOL R, V70, P830, DOI 10.1128/MMBR.00016-06; Clark TA, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gkr1146; Cohen HM, 2004, PROTEIN ENG DES SEL, V17, P3, DOI 10.1093/protein/gzh001; Cohen HM, 2002, NUCLEIC ACIDS RES, V30, P3880, DOI 10.1093/nar/gkf507; DUBEY AK, 1992, NUCLEIC ACIDS RES, V20, P3167, DOI 10.1093/nar/20.12.3167; Fang G, 2012, NAT BIOTECHNOL, V30, P1232, DOI 10.1038/nbt.2432; Fuks F, 2005, CURR OPIN GENET DEV, V15, P490, DOI 10.1016/j.gde.2005.08.002; KUMAR S, 1994, NUCLEIC ACIDS RES, V22, P1, DOI 10.1093/nar/22.1.1; MALONE T, 1995, J MOL BIOL, V253, P618, DOI 10.1006/jmbi.1995.0577; NARDONE G, 1984, J BIOL CHEM, V259, P357; Okamoto I, 2004, SCIENCE, V303, P644, DOI 10.1126/science.1092727; RAZIN A, 1994, CELL, V77, P473, DOI 10.1016/0092-8674(94)90208-9; Roberts RJ, 2001, NUCLEIC ACIDS RES, V29, P268, DOI 10.1093/nar/29.1.268; Rockah-Shmuel L, 2012, NUCLEIC ACIDS RES, V40, P11627, DOI 10.1093/nar/gks944; RUBIN RA, 1977, J BIOL CHEM, V252, P7265; TAYLOR JD, 1990, BIOCHEMISTRY-US, V29, P10727, DOI 10.1021/bi00500a003; Wei H, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn182; WOODBURY CP, 1980, J BIOL CHEM, V255, P1526; Youngblood B, 2006, BIOCHEMISTRY-US, V45, P15563, DOI 10.1021/bi061414t	21	8	8	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2013	8	5							e63866	10.1371/journal.pone.0063866	http://dx.doi.org/10.1371/journal.pone.0063866			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	177QL	23671703	gold, Green Submitted, Green Published			2022-12-27	WOS:000321390200062
J	Suzuki, E; Kashima, S; Kawachi, I; Subramanian, SV				Suzuki, Etsuji; Kashima, Saori; Kawachi, Ichiro; Subramanian, S. V.			Social and Geographical Inequalities in Suicide in Japan from 1975 through 2005: A Census-Based Longitudinal Analysis	PLOS ONE			English	Article							CAUSE-SPECIFIC MORTALITY; MIDDLE-AGED MEN; ALCOHOL-CONSUMPTION; OCCUPATIONAL GROUPS; COMPLETED SUICIDE; ECONOMIC-CRISIS; SOUTH-KOREA; HEALTH; RATES; POPULATION	Background: Despite advances in our understanding of the countercyclical association between economic contraction and suicide, less is known about the levels of and changes in inequalities in suicide. The authors examined social and geographical inequalities in suicide in Japan from 1975 through 2005. Methods: Based on quinquennial vital statistics and census data, the authors analyzed the entire population aged 25-64 years. The total number of suicides was 75,840 men and 30,487 women. For each sex, the authors estimated odds ratios (ORs) and 95% credible intervals (CIs) for suicide using multilevel logistic regression models with "cells'' (cross-tabulated by age and occupation) at level 1, seven different years at level 2, and 47 prefectures at level 3. Prefecture-level variance was used as an estimate of geographical inequalities in suicide. Results: Adjusting for age and time-trends, the lowest odds for suicide was observed among production process and related workers (the reference group) in both sexes. The highest OR for men was 2.52 (95% CI: 2.43, 2.61) among service workers, whereas the highest OR for women was 9.24 (95% CI: 7.03, 12.13) among security workers. The degree of occupational inequalities increased among men with a striking change in the pattern. Among women, we observed a steady decline in suicide risk across all occupations, except for administrative and managerial workers and transport and communication workers. After adjusting for individual age, occupation, and time-trends, prefecture-specific ORs ranged from 0.76 (Nara Prefecture) to 1.36 (Akita Prefecture) for men and from 0.79 (Kanagawa Prefecture) to 1.22 (Akita Prefecture) for women. Geographical inequalities have increased primarily among men since 1995. Conclusions: The present findings demonstrate a striking temporal change in the pattern of social inequalities in suicide among men. Further, geographical inequalities in suicide have considerably increased across 47 prefectures, primarily among men, since 1995.	[Suzuki, Etsuji] Okayama Univ, Dept Epidemiol, Grad Sch Med Dent & Pharmaceut Sci, Okayama, Japan; [Kashima, Saori] Hiroshima Univ, Inst Biomed & Hlth Sci, Dept Publ Hlth & Hlth Policy, Hiroshima, Japan; [Kawachi, Ichiro; Subramanian, S. V.] Harvard Univ, Sch Publ Hlth, Dept Social & Behav Sci, Boston, MA 02115 USA	Okayama University; Hiroshima University; Harvard University; Harvard T.H. Chan School of Public Health	Suzuki, E (corresponding author), Okayama Univ, Dept Epidemiol, Grad Sch Med Dent & Pharmaceut Sci, Okayama, Japan.	etsuji-s@cc.okayama-u.ac.jp	Kashima, Saori/B-4524-2010; Suzuki, Etsuji/B-2342-2011	Kashima, Saori/0000-0002-3401-8191; Suzuki, Etsuji/0000-0002-1290-5793	Ministry of Education, Culture, Sports, Science and Technology, Japan; Robert Wood Johnson Investigator Award in Health Policy Research; National Institutes of Health [NHLBI K25 HL081275]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K25HL081275] Funding Source: NIH RePORTER	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Robert Wood Johnson Investigator Award in Health Policy Research; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	A part of this research was supported by a Grant-in-Aid for Scientific Research, Ministry of Education, Culture, Sports, Science and Technology, Japan. Dr. S. V. Subramanian was supported by a Robert Wood Johnson Investigator Award in Health Policy Research and by a career development award from the National Institutes of Health (NHLBI K25 HL081275). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ager E, 2007, PSYCHOL MED, V37, P1131, DOI 10.1017/S0033291707000487; Akechi T, 2006, BRIT J PSYCHIAT, V188, P231, DOI 10.1192/bjp.188.3.231; Browne WJ, 2012, MCMC ESTIMATION MLWI; Catalano R, 2011, ANNU REV PUBL HEALTH, V32, P431, DOI 10.1146/annurev-publhealth-031210-101146; Chang SS, 2009, SOC SCI MED, V68, P1322, DOI 10.1016/j.socscimed.2009.01.010; Chen YY, 2012, EPIDEMIOL REV, V34, P129, DOI 10.1093/epirev/mxr025; Cherpitel CJ, 2004, ALCOHOL CLIN EXP RES, V28, p18S, DOI 10.1097/01.ALC.0000127411.61634.14; Dejong TM, 2010, J AFFECT DISORDERS, V124, P90, DOI 10.1016/j.jad.2009.10.020; Fleischmann, 2008, SUICIDE SUICIDE PREV, P7; Fukuda Y, 2005, INT J EPIDEMIOL, V34, P100, DOI 10.1093/ije/dyh283; Fushimi M, 2006, PSYCHIAT CLIN NEUROS, V60, P289, DOI 10.1111/j.1440-1819.2006.01504.x; Granados JAT, 2008, DEMOGRAPHY, V45, P323, DOI 10.1353/dem.0.0008; Green MJ, 2011, PSYCHOL MED, V41, P565, DOI 10.1017/S0033291710000851; Gunnell D, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b1891; Hasegawa T, 2001, CHALLENGING INEQUITI, P90; Hawton K, 2011, J AFFECT DISORDERS, V134, P320, DOI 10.1016/j.jad.2011.05.044; Hawton K, 2009, LANCET, V373, P1372, DOI 10.1016/S0140-6736(09)60372-X; Hughes JR, 2008, DRUG ALCOHOL DEPEN, V98, P169, DOI 10.1016/j.drugalcdep.2008.06.003; Ikeda N, 2011, LANCET, V378, P1094, DOI 10.1016/S0140-6736(11)61055-6; Iwasaki M, 2005, ANN EPIDEMIOL, V15, P286, DOI 10.1016/j.annepidem.2004.08.011; Kagamimori S, 2004, IND HEALTH, V42, P328, DOI 10.2486/indhealth.42.328; Kim SY, 2011, CRISIS, V32, P5, DOI 10.1027/0227-5910/a000046; Kondo N, 2010, J EPIDEMIOL COMMUN H, V64, P649, DOI 10.1136/jech.2009.090787; Koo J, 2008, CONTEMP ECON POLICY, V26, P162, DOI 10.1111/j.1465-7287.2007.00042.x; Krieger N, 2010, AM J IND MED, V53, P104, DOI 10.1002/ajim.20759; Landsbergis PA, 2010, AM J IND MED, V53, P95, DOI 10.1002/ajim.20766; Li ZY, 2011, SOC SCI MED, V72, P608, DOI 10.1016/j.socscimed.2010.11.008; Maris RW, 2002, LANCET, V360, P319, DOI 10.1016/S0140-6736(02)09556-9; Matsubayashi T, 2011, SOC SCI MED, V73, P1395, DOI 10.1016/j.socscimed.2011.08.022; Ministry of Health Labor and Welfare, OUTL VIT STAT JAP; Ministry of Health Labour and Welfare, OV REP VIT STAT FY 2; Ministry of Internal Affairs and Communication, JAP STAND OCC CLASS; Ministry of Internal Affairs and Communications, POP CENS; Motohashi Y, 2012, LANCET, V379, P1282, DOI 10.1016/S0140-6736(11)61130-6; Mustard CA, 2010, CAN J PSYCHIAT, V55, P369, DOI 10.1177/070674371005500606; Nakao Mutsuhiro, 2008, Environmental Health and Preventive Medicine, V13, P313, DOI 10.1007/s12199-008-0048-7; Nakaya N, 2007, ALCOHOL, V41, P503, DOI 10.1016/j.alcohol.2007.08.001; Niedhammer I, 2011, EUR J EPIDEMIOL, V26, P1, DOI 10.1007/s10654-010-9506-9; Nock MK, 2008, EPIDEMIOL REV, V30, P133, DOI 10.1093/epirev/mxn002; Otsu A, 2004, SOC SCI MED, V58, P1137, DOI 10.1016/S0277-9536(03)00285-5; Pompili M, 2010, INT J ENV RES PUB HE, V7, P1392, DOI 10.3390/ijerph7041392; Poudel-Tandukar K, 2011, J PSYCHIATR RES, V45, P1545, DOI 10.1016/j.jpsychires.2011.07.009; Poudel-Tandukar K, 2011, J AFFECT DISORDERS, V131, P113, DOI 10.1016/j.jad.2010.11.027; Rasbash J., 2012, MLWIN VERSION 2 25; Raudenbush SW, 2002, HIERARCHICAL LINEAR; Riva M, 2011, INT J PUBLIC HEALTH, V56, P3, DOI 10.1007/s00038-010-0220-x; Shiho Y, 2005, CRISIS, V26, P12, DOI 10.1027/0227-5910.26.1.12; Skegg K, 2010, AUST NZ J PSYCHIAT, V44, P429, DOI 10.3109/00048670903487191; Stack S, 2001, SOC SCI QUART, V82, P384, DOI 10.1111/0038-4941.00030; Stansfeld SA, 2013, PSYCHOL MED, V43, P961, DOI 10.1017/S0033291712001821; Subramanian SV, 2001, ENVIRON PLANN A, V33, P399, DOI 10.1068/a3357; Subramanian SV, 2007, MACROSOCIAL DETERMIN, P301, DOI DOI 10.1007/978-0-387-70812-6_15; Suzuki E, 2009, J EPIDEMIOL COMMUN H, V63, P692, DOI 10.1136/jech.2008.082453; Suzuki E, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2011-000425; Suzuki E, 2012, AM J EPIDEMIOL, V175, P567, DOI 10.1093/aje/kwr333; Suzuki E, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-489; Suzuki E, 2010, SOC SCI MED, V70, P1367, DOI 10.1016/j.socscimed.2010.01.014; Tollefsen IM, 2012, BMC PSYCHIATRY, V12, DOI 10.1186/1471-244X-12-9; Wada K, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e1191; World Health Organization, SUIC PREV SUPRE; Yamasaki A, 2005, PSYCHOL REP, V96, P337; Yoshimasu Kouichi, 2008, Environmental Health and Preventive Medicine, V13, P243, DOI 10.1007/s12199-008-0037-x	62	18	18	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2013	8	5							e63443	10.1371/journal.pone.0063443	http://dx.doi.org/10.1371/journal.pone.0063443			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	177QL	23671679	Green Submitted, Green Published, gold			2022-12-27	WOS:000321390200049
J	Nilmeier, JP; Kirshner, DA; Wong, SE; Lightstone, FC				Nilmeier, Jerome P.; Kirshner, Daniel A.; Wong, Sergio E.; Lightstone, Felice C.			Rapid Catalytic Template Searching as an Enzyme Function Prediction Procedure	PLOS ONE			English	Article							PROTEIN FUNCTION PREDICTION; COMBINATORIAL EXTENSION CE; 3D COORDINATE TEMPLATES; LIGAND-BINDING-SITES; STRUCTURAL CLASSIFICATION; DIVERGENT EVOLUTION; FUNCTION INFERENCE; GENE ONTOLOGY; CLUSTAL-W; SEQUENCE	We present an enzyme protein function identification algorithm, Catalytic Site Identification (CatSId), based on identification of catalytic residues. The method is optimized for highly accurate template identification across a diverse template library and is also very efficient in regards to time and scalability of comparisons. The algorithm matches three-dimensional residue arrangements in a query protein to a library of manually annotated, catalytic residues - The Catalytic Site Atlas (CSA). Two main processes are involved. The first process is a rapid protein-to-template matching algorithm that scales quadratically with target protein size and linearly with template size. The second process incorporates a number of physical descriptors, including binding site predictions, in a logistic scoring procedure to re-score matches found in Process 1. This approach shows very good performance overall, with a Receiver-Operator-Characteristic Area Under Curve (AUC) of 0.971 for the training set evaluated. The procedure is able to process cofactors, ions, nonstandard residues, and point substitutions for residues and ions in a robust and integrated fashion. Sites with only two critical (catalytic) residues are challenging cases, resulting in AUCs of 0.9411 and 0.5413 for the training and test sets, respectively. The remaining sites show excellent performance with AUCs greater than 0.90 for both the training and test data on templates of size greater than two critical (catalytic) residues. The procedure has considerable promise for larger scale searches.	[Nilmeier, Jerome P.; Kirshner, Daniel A.; Wong, Sergio E.; Lightstone, Felice C.] Lawrence Livermore Natl Lab, Biosci & Biotechnol Div, Phys & Life Sci Directorate, Livermore, CA USA	United States Department of Energy (DOE); Lawrence Livermore National Laboratory	Lightstone, FC (corresponding author), Lawrence Livermore Natl Lab, Biosci & Biotechnol Div, Phys & Life Sci Directorate, Livermore, CA USA.	lightstone1@llnl.gov			Defense Threat Reduction Agency (DTRA) [B094679I]; LDRD [12-SI-004]; U.S. Department of Energy by Lawrence Livermore National Laboratory [DE-AC52-07NA27344]	Defense Threat Reduction Agency (DTRA)(United States Department of DefenseDefense Threat Reduction Agency); LDRD; U.S. Department of Energy by Lawrence Livermore National Laboratory(United States Department of Energy (DOE))	The authors gratefully acknowledge the Defense Threat Reduction Agency (DTRA) for supporting this work (grant B094679I). A portion of this work was also funded by LDRD 12-SI-004. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work performed under the auspices of the U.S. Department of Energy by Lawrence Livermore National Laboratory under Contract DE-AC52-07NA27344. Release Number LLNL-POST-564184.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Arakaki AK, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-107; ARTYMIUK PJ, 1994, J MOL BIOL, V243, P327, DOI 10.1006/jmbi.1994.1657; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Ausiello G, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-S4-S5; BAIROCH A, 1994, NUCLEIC ACIDS RES, V22, P3626, DOI 10.1093/nar/22.17.3626; Barker JA, 2003, BIOINFORMATICS, V19, P1644, DOI 10.1093/bioinformatics/btg226; Brakoulias A, 2004, PROTEINS, V56, P250, DOI 10.1002/prot.20123; Brylinski M, 2008, P NATL ACAD SCI USA, V105, P129, DOI 10.1073/pnas.0707684105; Chen BY, 2007, J COMPUT BIOL, V14, P791, DOI 10.1089/cmb.2007.R017; Coutsias EA, 2004, J COMPUT CHEM, V25, P1849, DOI 10.1002/jcc.20110; Friedberg I, 2006, BRIEF BIOINFORM, V7, P225, DOI 10.1093/bib/bbl004; Friedman J., 2001, ELEMENTS STAT LEARNI, DOI 10.1007/978-0-387-21606-5; Galperin MY, 1998, GENOME RES, V8, P779, DOI 10.1101/gr.8.8.779; Gerlt JA, 2001, ANNU REV BIOCHEM, V70, P209, DOI 10.1146/annurev.biochem.70.1.209; Gerlt JA, 2011, BIOCHEMISTRY; Gerlt JA, 2012, J BIOL CHEM, V287, P29, DOI 10.1074/jbc.R111.240945; Glanville JG, 2007, NUCLEIC ACIDS RES, V35, pW27, DOI 10.1093/nar/gkm325; Gold ND, 2006, J MOL BIOL, V355, P1112, DOI 10.1016/j.jmb.2005.11.044; Gold ND, 2006, NUCLEIC ACIDS RES, V34, pD231, DOI 10.1093/nar/gkj062; Halgren TA, 2009, J CHEM INF MODEL, V49, P377, DOI 10.1021/ci800324m; Halgren T, 2007, CHEM BIOL DRUG DES, V69, P146, DOI 10.1111/j.1747-0285.2007.00483.x; Harris MA, 2004, NUCLEIC ACIDS RES, V32, pD258, DOI 10.1093/nar/gkh036; HENIKOFF S, 1992, P NATL ACAD SCI USA, V89, P10915, DOI 10.1073/pnas.89.22.10915; Holliday GL, 2007, NUCLEIC ACIDS RES, V35, pD515, DOI 10.1093/nar/gkl774; Jambon M, 2003, PROTEINS, V52, P137, DOI 10.1002/prot.10339; Kalyanaraman C, 2008, STRUCTURE, V16, P1668, DOI 10.1016/j.str.2008.08.015; Kinjo Akira R, 2007, Biophysics (Nagoya-shi), V3, P75, DOI 10.2142/biophysics.3.75; Kinoshita K, 2003, PROTEIN SCI, V12, P1589, DOI 10.1110/ps.0368703; Kleywegt GJ, 1999, J MOL BIOL, V285, P1887, DOI 10.1006/jmbi.1998.2393; KLEYWEGT GJ, 1989, J MAGN RESON, V85, P186, DOI 10.1016/0022-2364(89)90335-1; Kleywegt GJ, 1997, METHOD ENZYMOL, V277, P525, DOI 10.1016/S0076-6879(97)77029-0; Krishnamurthy N, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-9-r83; KROGH A, 1994, J MOL BIOL, V235, P1501, DOI 10.1006/jmbi.1994.1104; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Laskowski RA, 2005, NUCLEIC ACIDS RES, V33, pW89, DOI 10.1093/nar/gki414; Liang MP, 2003, NUCLEIC ACIDS RES, V31, P3324, DOI 10.1093/nar/gkg553; Lichtarge O, 1996, J MOL BIOL, V257, P342, DOI 10.1006/jmbi.1996.0167; Liu P, 2010, J COMPUT CHEM, V31, P1561, DOI 10.1002/jcc.21439; Marti-Renom MA, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-S4-S4; Meng EC, 2004, PROTEINS, V55, P962, DOI 10.1002/prot.20099; MITCHELL EM, 1990, J MOL BIOL, V212, P151, DOI 10.1016/0022-2836(90)90312-A; Moll M, 2008, LABELHASH FLEXIBLE E; Moll M, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-555; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159; Nosrati GR, 2012, PROTEIN SCI, V21, P697, DOI 10.1002/pro.2055; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; Orengo C A, 2003, Methods Biochem Anal, V44, P249; Pegg S, 2005, REPRESENTING STRUCTU, P358; Pegg SCH, 2006, BIOCHEMISTRY-US, V45, P2545, DOI 10.1021/bi052101l; Polacco BJ, 2006, BIOINFORMATICS, V22, P723, DOI 10.1093/bioinformatics/btk038; Porter CT, 2004, NUCLEIC ACIDS RES, V32, pD129, DOI 10.1093/nar/gkh028; Ren JY, 2010, NUCLEIC ACIDS RES, V38, pW441, DOI 10.1093/nar/gkq400; Rothlisberger D, 2008, NATURE, V453, P190, DOI 10.1038/nature06879; Russell RB, 1998, J MOL BIOL, V279, P1211, DOI 10.1006/jmbi.1998.1844; Sankararaman S, 2008, BIOINFORMATICS, V24, P2445, DOI 10.1093/bioinformatics/btn474; Sankararaman S, 2010, BIOINFORMATICS, V26, P617, DOI 10.1093/bioinformatics/btq008; Schmitt S, 2002, J MOL BIOL, V323, P387, DOI 10.1016/S0022-2836(02)00811-2; Shindyalov IN, 1998, PROTEIN ENG, V11, P739, DOI 10.1093/protein/11.9.739; Shindyalov IN, 2001, NUCLEIC ACIDS RES, V29, P228, DOI 10.1093/nar/29.1.228; Shulman-Peleg A, 2004, J MOL BIOL, V339, P607, DOI 10.1016/j.jmb.2004.04.012; Sjolander K, 1996, COMPUT APPL BIOSCI, V12, P327; Skolnick J, 2009, BRIEF BIOINFORM, V10, P378, DOI 10.1093/bib/bbp017; Song L, 2007, NAT CHEM BIOL, V3, P486, DOI 10.1038/nchembio.2007.11; Spriggs RV, 2003, J CHEM INF COMP SCI, V43, P412, DOI 10.1021/ci0255984; Stark A, 2003, NUCLEIC ACIDS RES, V31, P3341, DOI 10.1093/nar/gkg506; Styczynski MP, 2008, NAT BIOTECHNOL, V26, P274, DOI 10.1038/nbt0308-274; Team R, 2010, R LANG ENV STAT COMP; Theobald DL, 2005, ACTA CRYSTALLOGR A, V61, P478, DOI 10.1107/S0108767305015266; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tian WD, 2004, NUCLEIC ACIDS RES, V32, P6226, DOI 10.1093/nar/gkh956; Tian WD, 2003, J MOL BIOL, V333, P863, DOI 10.1016/j.jmb.2003.08.057; Torrance JW, 2005, J MOL BIOL, V347, P565, DOI 10.1016/j.jmb.2005.01.044; Tseng YY, 2009, J MOL BIOL, V387, P451, DOI 10.1016/j.jmb.2008.12.072; Tseng YY, 2006, MOL BIOL EVOL, V23, P421, DOI 10.1093/molbev/msj048; ULLMANN JR, 1976, J ACM, V23, P31, DOI 10.1145/321921.321925; Wallace AC, 1996, PROTEIN SCI, V5, P1001; Wallace AC, 1997, PROTEIN SCI, V6, P2308; Webb E. C., 1992, ENZYME NOMENCLATURE; Whisstock JC, 2003, Q REV BIOPHYS, V36, P307, DOI 10.1017/S0033583503003901; Wolfson HJ, 1997, IEEE COMPUT SCI ENG, V4, P10, DOI 10.1109/99.641604; Xie L, 2008, P NATL ACAD SCI USA, V105, P5441, DOI 10.1073/pnas.0704422105; Xie L, 2009, BIOINFORMATICS, V25, pI305, DOI 10.1093/bioinformatics/btp220; Yang LW, 2005, STRUCTURE, V13, P893, DOI 10.1016/j.str.2005.03.015; Zemla A, 2003, NUCLEIC ACIDS RES, V31, P3370, DOI 10.1093/nar/gkg571	85	25	25	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2013	8	5							e62535	10.1371/journal.pone.0062535	http://dx.doi.org/10.1371/journal.pone.0062535			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	143FO	23675414	Green Submitted, Green Published, gold			2022-12-27	WOS:000318852400006
J	Bos, J; Duverger, Y; Thouvenot, B; Chiaruttini, C; Branlant, C; Springer, M; Charpentier, B; Barras, F				Bos, Julia; Duverger, Yohann; Thouvenot, Benoit; Chiaruttini, Claude; Branlant, Christiane; Springer, Mathias; Charpentier, Bruno; Barras, Frederic			The sRNA RyhB Regulates the Synthesis of the Escherichia coli Methionine Sulfoxide Reductase MsrB but Not MsrA	PLOS ONE			English	Article							MESSENGER-RNA; ANTIOXIDANT DEFENSE; OXIDATIVE STRESS; BINDING-SITE; PROTEIN; EXPRESSION; OPERON; REPAIR; HFQ; TRANSLATION	Controlling iron homeostasis is crucial for all aerobically grown living cells that are exposed to oxidative damage by reactive oxygen species (ROS), as free iron increases the production of ROS. Methionine sulfoxide reductases (Msr) are key enzymes in repairing ROS-mediated damage to proteins, as they reduce oxidized methionine (MetSO) residues to methionine. E. coli synthesizes two Msr, A and B, which exhibit substrate diastereospecificity. The bacterial iron-responsive small RNA (sRNA) RyhB controls iron metabolism by modulating intracellular iron usage. We show in this paper that RyhB is a direct regulator of the msrB gene that encodes the MsrB enzyme. RyhB down-regulates msrB transcripts along with Hfq and RNaseE proteins since mutations in the ryhB, fur, hfq, or RNaseE-encoded genes resulted in iron-insensitive expression of msrB. Our results show that RyhB binds to two sequences within the short 5'UTR of msrB mRNA as identified by reverse transcriptase and RNase and lead (II) protection assays. Toeprinting analysis shows that RyhB pairing to msrB mRNA prevents efficient ribosome binding and thereby inhibits translation initiation. In vivo site directed-mutagenesis experiments in the msrB 5'UTR region indicate that both RyhB-pairing sites are required to decrease msrB expression. Thus, this study suggests a novel mechanism of translational regulation where a same sRNA can basepair to two different locations within the same mRNA species. In contrast, expression of msrA is not influenced by changes in iron levels.	[Bos, Julia; Duverger, Yohann; Barras, Frederic] Aix Marseille Univ, CNRS, Chim Bacterienne Lab, Inst Microbiol Mediterranee,UMR, Marseille, France; [Thouvenot, Benoit; Branlant, Christiane; Charpentier, Bruno] Univ Lorraine, CNRS, UMR, Vandoeuvre Les Nancy, France; [Chiaruttini, Claude; Springer, Mathias] Univ Paris 07, CNRS, Inst Biol Physicochim, Unite Propre Rech, Paris, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); Universite de Lorraine; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite	Barras, F (corresponding author), Aix Marseille Univ, CNRS, Chim Bacterienne Lab, Inst Microbiol Mediterranee,UMR, Marseille, France.	barras@imm.cnrs.fr		Barras, Frederic/0000-0003-3458-2574; Bos, Julia/0000-0002-4947-4675; Branlant, Christiane/0000-0003-4728-5499; CHARPENTIER, Bruno/0000-0003-2955-2987	Centre National de la Recherche Scientifique; French National Research Agency and Aix-Marseille University	Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); French National Research Agency and Aix-Marseille University(French National Research Agency (ANR))	This work was made possible by grants from the Centre National de la Recherche Scientifique, the French National Research Agency and Aix-Marseille University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript."	Afonyushkin T, 2005, NUCLEIC ACIDS RES, V33, P1678, DOI 10.1093/nar/gki313; Balbontin R, 2010, MOL MICROBIOL, V78, P380, DOI 10.1111/j.1365-2958.2010.07342.x; Boschi-Muller S, 2005, BBA-PROTEINS PROTEOM, V1703, P231, DOI 10.1016/j.bbapap.2004.09.016; Boschi-Muller S, 2008, ARCH BIOCHEM BIOPHYS, V474, P266, DOI 10.1016/j.abb.2008.02.007; Bouvier M, 2008, MOL CELL, V32, P827, DOI 10.1016/j.molcel.2008.10.027; Brosnan JT, 2006, J NUTR, V136, p1636S, DOI 10.1093/jn/136.6.1636S; Cornelis P, 2011, METALLOMICS, V3, P540, DOI 10.1039/c1mt00022e; Denkel LA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026974; Desnoyers G, 2009, EMBO J, V28, P1551, DOI 10.1038/emboj.2009.116; Dhandayuthapani S, 2001, J BACTERIOL, V183, P5645, DOI 10.1128/JB.183.19.5645-5650.2001; Douglas T, 2004, J BACTERIOL, V186, P3590, DOI 10.1128/JB.186.11.3590-3598.2004; El Hassouni M, 1999, P NATL ACAD SCI USA, V96, P887, DOI 10.1073/pnas.96.3.887; Ezraty B, 2005, BBA-PROTEINS PROTEOM, V1703, P221, DOI 10.1016/j.bbapap.2004.08.017; Ezraty B, 2005, J BACTERIOL, V187, P231, DOI 10.1128/JB.187.1.231-237.2005; Ezraty B, 2004, EMBO J, V23, P1868, DOI 10.1038/sj.emboj.7600172; Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687; Geissmann TA, 2004, EMBO J, V23, P396, DOI 10.1038/sj.emboj.7600058; Grimaud R, 2001, J BIOL CHEM, V276, P48915, DOI 10.1074/jbc.M105509200; Haentjens-Sitri J, 2008, J MOL BIOL, V375, P612, DOI 10.1016/j.jmb.2007.10.058; Hansel A, 2005, BBA-PROTEINS PROTEOM, V1703, P239, DOI 10.1016/j.bbapap.2004.09.010; Hansel A, 2003, REDOX REP, V8, P384, DOI 10.1179/135100003225003429; HUTTENHOFER A, 1994, EMBO J, V13, P3892, DOI 10.1002/j.1460-2075.1994.tb06700.x; Koc A, 2007, ANN NY ACAD SCI, V1100, P383, DOI 10.1196/annals.1395.042; Luo S, 2009, FASEB J, V23, P464, DOI 10.1096/fj.08-118414; Maisonneuve E, 2008, J BACTERIOL, V190, P6070, DOI 10.1128/JB.00736-08; Maisonneuve E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007269; MAKHNO VI, 1988, MOL BIOL+, V22, P528; Masse E, 2002, P NATL ACAD SCI USA, V99, P4620, DOI 10.1073/pnas.032066599; Masse E, 2005, J BACTERIOL, V187, P6962, DOI 10.1128/JB.187.20.6962-6971.2005; Masse E, 2003, GENE DEV, V17, P2374, DOI 10.1101/gad.1127103; Masse E, 2007, CURR OPIN MICROBIOL, V10, P140, DOI 10.1016/j.mib.2007.03.013; Moll I, 2003, RNA, V9, P1308, DOI 10.1261/rna.5850703; Morita T, 2005, GENE DEV, V19, P2176, DOI 10.1101/gad.1330405; Morita T, 2004, MOL MICROBIOL, V54, P1063, DOI 10.1111/j.1365-2958.2004.04329.x; Moskovitz J, 2005, CURR PHARM DESIGN, V11, P1451, DOI 10.2174/1381612053507846; Moskovitz J, 1997, P NATL ACAD SCI USA, V94, P9585, DOI 10.1073/pnas.94.18.9585; Moskovitz J, 2001, P NATL ACAD SCI USA, V98, P12920, DOI 10.1073/pnas.231472998; Moskovitz J, 2010, ANTIOXID REDOX SIGN, V12, P405, DOI 10.1089/ars.2009.2809; Olry A, 2005, PROTEIN SCI, V14, P2828, DOI 10.1110/ps.051711105; Papenfort K, 2010, P NATL ACAD SCI USA, V107, P20435, DOI 10.1073/pnas.1009784107; PLUMBRIDGE J, 1989, MOL GEN GENET, V216, P113, DOI 10.1007/BF00332238; POWELL BS, 1994, NUCLEIC ACIDS RES, V22, P5765, DOI 10.1093/nar/22.25.5765; Prevost K, 2007, MOL MICROBIOL, V64, P1260, DOI 10.1111/j.1365-2958.2007.05733.x; Prevost K, 2011, GENE DEV, V25, P385, DOI 10.1101/gad.2001711; Rice JB, 2012, P NATL ACAD SCI USA, V109, pE2691, DOI 10.1073/pnas.1207927109; Rouhier N, 2006, PHOTOSYNTH RES, V89, P247, DOI 10.1007/s11120-006-9097-1; Ruan H, 2002, P NATL ACAD SCI USA, V99, P2748, DOI 10.1073/pnas.032671199; Sharma CM, 2007, GENE DEV, V21, P2804, DOI 10.1101/gad.447207; Sharov VS, 1999, FEBS LETT, V455, P247, DOI 10.1016/S0014-5793(99)00888-1; Sharov VS, 2000, FREE RADICAL BIO MED, V29, P986, DOI 10.1016/S0891-5849(00)00400-7; SIMONS RW, 1987, GENE, V53, P85, DOI 10.1016/0378-1119(87)90095-3; Singh VK, 2003, MICROBIOL-SGM, V149, P2739, DOI 10.1099/mic.0.26442-0; Skaar EP, 2002, P NATL ACAD SCI USA, V99, P10108, DOI 10.1073/pnas.152334799; Wizemann TM, 1996, P NATL ACAD SCI USA, V93, P7985, DOI 10.1073/pnas.93.15.7985; You CH, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-128; Zhang XH, 2008, BIOL REV, V83, P249, DOI 10.1111/j.1469-185X.2008.00042.x; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	57	18	21	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2013	8	5							e63647	10.1371/journal.pone.0063647	http://dx.doi.org/10.1371/journal.pone.0063647			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	155HD	23671689	Green Submitted, Green Published, gold			2022-12-27	WOS:000319737700055
J	Cousins, S; Kaski, D; Cutfield, N; Seemungal, B; Golding, JF; Gresty, M; Glasauer, S; Bronstein, AM				Cousins, Sian; Kaski, Diego; Cutfield, Nicholas; Seemungal, Barry; Golding, John F.; Gresty, Michael; Glasauer, Stefan; Bronstein, Adolfo M.			Vestibular Perception following Acute Unilateral Vestibular Lesions	PLOS ONE			English	Article							SELF-MOTION PERCEPTION; QUALITATIVELY DIFFERENT MECHANISMS; EARTH-VERTICAL AXIS; VESTIBULOOCULAR REFLEX; NEURONAL-ACTIVITY; VELOCITY STORAGE; STIMULATION; THRESHOLDS; ROTATION; HABITUATION	Little is known about the vestibulo-perceptual (VP) system, particularly after a unilateral vestibular lesion. We investigated vestibulo-ocular (VO) and VP function in 25 patients with vestibular neuritis (VN) acutely (2 days after onset) and after compensation (recovery phase, 10 weeks). Since the effect of VN on reflex and perceptual function may differ at threshold and supra-threshold acceleration levels, we used two stimulus intensities, acceleration steps of 0.5 degrees/s(2) and velocity steps of 90 degrees/s (acceleration 180 degrees/s(2)). We hypothesised that the vestibular lesion or the compensatory processes could dissociate VO and VP function, particularly if the acute vertiginous sensation interferes with the perceptual tasks. Both in acute and recovery phases, VO and VP thresholds increased, particularly during ipsilesional rotations. In signal detection theory this indicates that signals from the healthy and affected side are still fused, but result in asymmetric thresholds due to a lesion-induced bias. The normal pattern whereby VP thresholds are higher than VO thresholds was preserved, indicating that any 'perceptual noise' added by the vertigo does not disrupt the cognitive decision-making processes inherent to the perceptual task. Overall, the parallel findings in VO and VP thresholds imply little or no additional cortical processing and suggest that vestibular thresholds essentially reflect the sensitivity of the fused peripheral receptors. In contrast, a significant VO-VP dissociation for supra-threshold stimuli was found. Acutely, time constants and duration of the VO and VP responses were reduced - asymmetrically for VO, as expected, but surprisingly symmetrical for perception. At recovery, VP responses normalised but VO responses remained shortened and asymmetric. Thus, unlike threshold data, supra-threshold responses show considerable VO-VP dissociation indicative of additional, higher-order processing of vestibular signals. We provide evidence of perceptual processes (ultimately cortical) participating in vestibular compensation, suppressing asymmetry acutely in unilateral vestibular lesions.	[Cousins, Sian; Kaski, Diego; Seemungal, Barry; Gresty, Michael; Bronstein, Adolfo M.] Univ London Imperial Coll Sci Technol & Med, Charing Cross Hosp, Neurootol Unit, Div Brain Sci, London, England; [Cutfield, Nicholas] Univ Otago, Dunedin Hosp, Dunedin, New Zealand; [Golding, John F.] Univ Westminster, Dept Psychol, London W1R 8AL, England; [Glasauer, Stefan] Univ Munich, Sensorimotor Res & German Vertigo Ctr, Munich, Germany	Imperial College London; Dunedin Public Hospital; University of Otago; University of Westminster; University of Munich	Bronstein, AM (corresponding author), Univ London Imperial Coll Sci Technol & Med, Charing Cross Hosp, Neurootol Unit, Div Brain Sci, London, England.	a.bronstein@imperial.ac.uk	Kaski, Diego/GQY-5716-2022; Glasauer, Stefan/A-5898-2008	Glasauer, Stefan/0000-0002-4313-6210; Seemungal, Barry/0000-0002-6578-0904; Kaski, Diego/0000-0002-0591-646X	Medical Research Council [07/Q0406/48]; Academy of Medical Sciences (AMS) [AMS-CSF3-Seemungal] Funding Source: researchfish; Medical Research Council [MR/J004685/1, G0600183] Funding Source: researchfish; MRC [MR/J004685/1, G0600183] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Academy of Medical Sciences (AMS)(Academy of Medical Sciences (AMS)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The study is funded by the Medical Research Council (www.mrc.ac.uk), study reference 07/Q0406/48. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BALOH RW, 1984, ANN NEUROL, V16, P222, DOI 10.1002/ana.410160209; Benson AJ, 1990, PERCEPTION CONTROL S; Bertolini G, 2011, J NEUROPHYSIOL, V105, P209, DOI 10.1152/jn.00154.2010; Bertolini G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036763; BRANTBERG K, 1990, AM J OTOLARYNG, V11, P345, DOI 10.1016/0196-0709(90)90066-5; Bronstein AM, 2008, NEUROREPORT, V19, P691, DOI 10.1097/WNR.0b013e3282fbf9f6; Clement G, 2008, EXP BRAIN RES, V190, P307, DOI 10.1007/s00221-008-1471-0; COATS AC, 1966, ANN OTO RHINOL LARYN, V75, P1135, DOI 10.1177/000348946607500423; Cutfield NJ, 2011, ANN NY ACAD SCI, V1233, P256, DOI 10.1111/j.1749-6632.2011.06159.x; Dieterich M, 2008, BRAIN, V131, P2538, DOI 10.1093/brain/awn042; Ernst MO, 2002, NATURE, V415, P429, DOI 10.1038/415429a; GOLDBERG JM, 1971, J NEUROPHYSIOL, V34, P635, DOI 10.1152/jn.1971.34.4.635; Grabherr L, 2008, EXP BRAIN RES, V186, P677, DOI 10.1007/s00221-008-1350-8; Graham BP, 2001, EXP BRAIN RES, V137, P387, DOI 10.1007/s002210100677; Green DM, 1966, SIGNAL DETECTION THE; Grunfeld EA, 2003, NEUROLOGY, V60, P1993, DOI 10.1212/01.WNL.0000067992.17185.60; GUEDRY FE, 1964, J APPL PHYSIOL, V19, P1005, DOI 10.1152/jappl.1964.19.5.1005; Guedry FE, 1965, CONTRIBUTIONS SENSOR, P93; Guldin WO, 1998, TRENDS NEUROSCI, V21, P254, DOI 10.1016/S0166-2236(97)01211-3; Haburcakova C, 2011, J NEUROPHYSIOLOGY; Haburcakova C, 2012, J NEUROPHYSIOL, V107, P973, DOI 10.1152/jn.00451.2011; Helmchen C, 2009, ANN NY ACAD SCI, V1164, P104, DOI 10.1111/j.1749-6632.2008.03745.x; Kahane P, 2003, ANN NEUROL, V54, P615, DOI 10.1002/ana.10726; Kandel E., 2000, PRINCIPLES NEURAL SC; Karmali F, 2012, J NEUROPHYSIOL, V108, P390, DOI 10.1152/jn.00883.2011; Klingner CM, 2013, BEHAV BRAIN RES, V236, P194, DOI 10.1016/j.bbr.2012.08.049; Leigh R. J., 2006, NEUROLOGY EYE MOVEME; Lopez C, 2012, NEUROSCIENCE, V212, P159, DOI 10.1016/j.neuroscience.2012.03.028; MacNeilage PR, 2008, J NEUROPHYSIOL, V100, P2981, DOI 10.1152/jn.90677.2008; Magnusson M, 1989, Acta Otolaryngol Suppl, V468, P329; Mallery RM, 2010, EXP BRAIN RES, V204, P11, DOI 10.1007/s00221-010-2288-1; Meng H, 2007, J NEUROSCI, V27, P13590, DOI 10.1523/JNEUROSCI.3931-07.2007; Merfeld DM, 2011, EXP BRAIN RES, V210, P389, DOI 10.1007/s00221-011-2557-7; Merfeld DM, 2005, J NEUROPHYSIOL, V94, P186, DOI 10.1152/jn.00904.2004; Merfeld DM, 2005, J NEUROPHYSIOL, V94, P199, DOI 10.1152/jn.00905.2004; MILLER EF, 1975, PERCEPT PSYCHOPHYS, V17, P329, DOI 10.3758/BF03203219; Okada T, 1999, BRAIN, V122, P1293, DOI 10.1093/brain/122.7.1293; Palermo A, 2011, EXP BRAIN RES, V212, P101, DOI 10.1007/s00221-011-2701-4; Pettorossi VE, 2013, J PHYSIOL-LONDON, V591, P1907, DOI 10.1113/jphysiol.2012.241182; Schmid-Priscoveanu A, 2001, JARO-J ASSOC RES OTO, V2, P72, DOI 10.1007/s101620010060; Seemungal BM, 2007, J NEUROPHYSIOL, V97, P4341, DOI 10.1152/jn.01321.2006; Seemungal Barry M, 2011, Front Neurol, V2, P2, DOI 10.3389/fneur.2011.00002; Seemungal BM, 2004, J VESTIBUL RES-EQUIL, V14, P461; Shaikh AG, 2013, CEREBELLUM, V12, P97, DOI 10.1007/s12311-012-0401-7; SHIMAZU H, 1966, J NEUROPHYSIOL, V29, P467, DOI 10.1152/jn.1966.29.3.467; Sinha N, 2008, PROG BRAIN RES, V171, P277, DOI 10.1016/S0079-6123(08)00639-0; SMITH PF, 1988, BRAIN RES, V444, P295, DOI 10.1016/0006-8993(88)90938-9; Viaud-Delmon I, 1999, COGNITIVE BRAIN RES, V7, P507, DOI 10.1016/S0926-6410(98)00052-4; WAESPE W, 1977, EXP BRAIN RES, V27, P523; Wickens Thomas D., 2002, ELEMENTARY SIGNAL DE; Zhang Z, 2011, FRONT AGING NEUROSCI, V3, DOI 10.3389/fnagi.2011.00018; Zwergal A, 2009, ANN NY ACAD SCI, V1164, P51, DOI 10.1111/j.1749-6632.2009.04461.x	52	63	64	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2013	8	5							e61862	10.1371/journal.pone.0061862	http://dx.doi.org/10.1371/journal.pone.0061862			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	155HD	23671577	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000319737700008
J	Oyarzun, DA; Lopez-Caamal, F; Garcia, MR; Middleton, RH; Weisse, AY				Oyarzun, Diego A.; Lopez-Caamal, Fernando; Garcia, Miriam R.; Middleton, Richard H.; Weisse, Andrea Y.			Cumulative Signal Transmission in Nonlinear Reaction-Diffusion Networks	PLOS ONE			English	Article							SYSTEMS; OSCILLATIONS; COMPUTATION; MODELS	Quantifying signal transmission in biochemical systems is key to uncover the mechanisms that cells use to control their responses to environmental stimuli. In this work we use the time-integral of chemical species as a measure of a network's ability to cumulatively transmit signals encoded in spatiotemporal concentrations. We identify a class of nonlinear reaction-diffusion networks in which the time-integrals of some species can be computed analytically. The derived time-integrals do not require knowledge of the solution of the reaction-diffusion equation, and we provide a simple graphical test to check if a given network belongs to the proposed class. The formulae for the time-integrals reveal how the kinetic parameters shape signal transmission in a network under spatiotemporal stimuli. We use these to show that a canonical complex-formation mechanism behaves as a spatial low-pass filter, the bandwidth of which is inversely proportional to the diffusion length of the ligand.	[Oyarzun, Diego A.] Univ London Imperial Coll Sci Technol & Med, Ctr Synthet Biol & Innovat, Dept Bioengn, London, England; [Lopez-Caamal, Fernando; Garcia, Miriam R.] Natl Univ Ireland, Hamilton Inst, Maynooth, Kildare, Ireland; [Middleton, Richard H.] Univ Newcastle, Ctr Complex Dynam Syst & Control, Newcastle, NSW 2300, Australia; [Weisse, Andrea Y.] Univ Edinburgh, SynthSys Synthet & Syst Biol, Edinburgh, Midlothian, Scotland	Imperial College London; Maynooth University; University of Newcastle; University of Edinburgh	Oyarzun, DA (corresponding author), Univ London Imperial Coll Sci Technol & Med, Ctr Synthet Biol & Innovat, Dept Bioengn, London, England.	d.oyarzun@imperial.ac.uk	García, Miriam/HGD-0780-2022; García, Míriam R./D-7185-2012; Middleton, Richard H/A-2950-2013	García, Míriam R./0000-0001-9538-6388; Middleton, Richard H/0000-0001-9885-8803; Oyarzun, Diego/0000-0002-0381-5278; Lopez-Caamal, Fernando/0000-0003-2861-7013	Engineering and Physical Sciences Research Council (EPSRC) through the Centre for Synthetic Biology and Innovation	Engineering and Physical Sciences Research Council (EPSRC) through the Centre for Synthetic Biology and Innovation	DAO is funded by Engineering and Physical Sciences Research Council (EPSRC) through the Centre for Synthetic Biology and Innovation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Becker V, 2010, SCIENCE, V328, P1404, DOI 10.1126/science.1184913; Britton N., 1986, REACTION DIFFUSION E; Buchler NE, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.30; CASTEN RG, 1977, SIAM J APPL MATH, V33, P353, DOI 10.1137/0133023; Chan G, 2008, TRENDS BIOTECHNOL, V26, P382, DOI 10.1016/j.tibtech.2008.03.011; Chandra FA, 2011, SCIENCE, V333, P187, DOI 10.1126/science.1200705; Cottrell D, 2012, P NATL ACAD SCI USA, V109, P9699, DOI 10.1073/pnas.1201103109; Craciun G, 2006, SIAM J APPL MATH, V66, P1321, DOI 10.1137/050634177; Grima R, 2008, ESSAYS BIOCHEM, V45, P41, DOI 10.1042/BSE0450041; Heinrich R, 2002, MOL CELL, V9, P957, DOI 10.1016/S1097-2765(02)00528-2; Kholodenko BN, 2010, NAT REV MOL CELL BIO, V11, P414, DOI 10.1038/nrm2901; Krippendorff BF, 2012, J PHARMACOKINET PHAR, V39, P125, DOI 10.1007/s10928-012-9243-7; Lathi, 2009, SIGNAL PROCESSING LI; Lebiedz D, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.208301; Lopez-Caamal F, 2012, IEEE DECIS CONTR P, P1047, DOI 10.1109/CDC.2012.6426397; Schenk CP, 1997, PHYS REV LETT, V78, P3781, DOI 10.1103/PhysRevLett.78.3781; Shankaran H, 2007, PLOS COMPUT BIOL, V3, P986, DOI 10.1371/journal.pcbi.0030101; Sick S, 2006, SCIENCE, V314, P1447, DOI 10.1126/science.1130088; SNEYD J, 2009, MATH PHYSL CELLULAR, V1; Sontag ED, 2006, AUTOMATICA, V42, P1987, DOI 10.1016/j.automatica.2006.06.011; TURING AM, 1952, PHILOS T ROY SOC B, V237, P37, DOI 10.1098/rstb.1952.0012; Vilas C, 2008, PHYSICA D, V237, P2353, DOI 10.1016/j.physd.2008.02.019; WAGNER J, 1994, BIOPHYS J, V67, P447, DOI 10.1016/S0006-3495(94)80500-4	23	2	2	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2013	8	5							e62834	10.1371/journal.pone.0062834	http://dx.doi.org/10.1371/journal.pone.0062834			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145YI	23667528	gold, Green Published, Green Submitted			2022-12-27	WOS:000319055600047
J	Soderstrom, L; Perez-Vicente, R; Juarez, S; Merlo, J				Soderstrom, Lovisa; Perez-Vicente, Raquel; Juarez, Sol; Merlo, Juan			Questioning the Causal Link between Maternal Smoking during Pregnancy and Offspring Use of Psychotropic Medication: A Sibling Design Analysis	PLOS ONE			English	Article							RISK-FACTOR; EXTERNALIZING PROBLEMS; HYPERKINETIC DISORDER; PATERNAL SMOKING; PRENATAL SMOKING; EXPOSURE; SYMPTOMS; CHILDREN; WOMEN; ADHD	A recent population-based, longitudinal study from Finland observed a dose-response association between smoking during pregnancy (SDP) and use of psychotropic medications in exposed children and young adults. However, this association may be confounded by unmeasured familial characteristics related to both SDP and offspring mental health. Consequently, we aim to investigate the effect of SDP by means of a sibling design that to some extent allows controlling for unknown environmental and genetic confounders. Using the Swedish Medical Birth Register (1987-1993), which was linked to the Swedish Prescribed Drugs Register (July 2005-December 2008), we investigated 579,543 children and among them 39, 007 were discordant for use of psychotropic medication and 4,021 siblings discordant for both use of psychotropic medication and for smoking exposure. Replicating the Finnish study using traditional logistic regression methods we found an association between exposure to >= 10 cigarettes per day during pregnancy and psychotropic drug use (odds ratio = 1.61, 95% confidence interval 1.56, 1.66). Similar in size to the association reported from Finland (odds ratio = 1.63; 95% confidence interval 1.53, 1.74). However, in the adjusted sibling analysis using conditional logistic regression, the association was considerably reduced (odds ratio 1.22; 95% confidence interval 1.08, 1.38). Preventing smoking is of major public health importance. However, SDP per se appears to have less influence on offspring psychotropic drug use than previously suggested.	[Soderstrom, Lovisa; Perez-Vicente, Raquel; Juarez, Sol; Merlo, Juan] Lund Univ, Fac Med, Dept Clin Sci, Unit Social Epidemiol, Malmo, Sweden; [Juarez, Sol] Lund Univ, Ctr Econ Demog, Malmo, Sweden	Lund University; Lund University	Merlo, J (corresponding author), Lund Univ, Fac Med, Dept Clin Sci, Unit Social Epidemiol, Malmo, Sweden.	juan.merlo@med.lu.se	Merlo, Juan/E-2136-2011	Merlo, Juan/0000-0001-8379-9708; Juarez, Sol Pia/0000-0001-9086-7588	Centre for Economic Demography at Lund University	Centre for Economic Demography at Lund University	This work was supported by the Centre for Economic Demography at Lund University http://www.ed.lu.se/EN/AboutCED/default.asp. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Sahab B, 2010, BMC PREGNANCY CHILDB, V10, DOI 10.1186/1471-2393-10-24; [Anonymous], 2002, FACTS MOTH CHILDB NE; Ashford J, 2008, J AM ACAD CHILD PSY, V47, P779, DOI 10.1097/CHI.0b013e318172eefb; CNATTINGIUS S, 1990, SCAND J SOC MED, V18, P143, DOI 10.1177/140349489001800209; D'Onofrio BM, 2011, PSYCHOL MED, P1; D'Onofrio BM, 2008, DEV PSYCHOPATHOL, V20, P139, DOI 10.1017/S0954579408000072; D'Onofrio BM, 2010, ARCH GEN PSYCHIAT, V67, P529, DOI 10.1001/archgenpsychiatry.2010.33; D'Onofrio BM, 2010, CHILD DEV, V81, P80, DOI 10.1111/j.1467-8624.2009.01382.x; Ekblad M, 2011, AM J EPIDEMIOL, V174, P681, DOI 10.1093/aje/kwr150; Ep C, 2003, SWEDISH MED BIRTH RE; Fergusson DM, 1998, ARCH GEN PSYCHIAT, V55, P721, DOI 10.1001/archpsyc.55.8.721; Frisell T, 2012, EPIDEMIOLOGY, V23, P713, DOI 10.1097/EDE.0b013e31825fa230; Knopik VS, 2009, DEV NEUROPSYCHOL, V34, P1, DOI 10.1080/87565640802564366; Lahey BB, 2010, CURR DIR PSYCHOL SCI, V19, P319, DOI 10.1177/0963721410383977; Langley K, 2012, AM J EPIDEMIOL, V176, P261, DOI 10.1093/aje/kwr510; Lavigne JV, 2011, J PEDIATR PSYCHOL, V36, P10, DOI 10.1093/jpepsy/jsq044; Lawlor DA, 2009, FAMILY MATTERS DESIG; Lindblad F, 2010, NICOTINE TOB RES, V12, P408, DOI 10.1093/ntr/ntq017; Lindqvist R, 2002, ACTA OBSTET GYN SCAN, V81, P240; Linnet KM, 2005, PEDIATRICS, V116, P462, DOI 10.1542/peds.2004-2054; Maxson PJ, 2012, ADDICT BEHAV, V37, P153, DOI 10.1016/j.addbeh.2011.08.011; Merlo J, 2012, SOCIAL SCI IN PRESS; Merlo J, 2010, INT J EPIDEMIOL, V39, P936; Milberger S, 1996, AM J PSYCHIAT, V153, P1138; Nomura Y, 2010, J NERV MENT DIS, V198, P672, DOI 10.1097/NMD.0b013e3181ef3489; Obel C, 2011, INT J EPIDEMIOL, V40, P338, DOI 10.1093/ije/dyq185; Ramsay MC, 2000, NEUROPSYCHOL REV, V10, P1, DOI 10.1023/A:1009065713389; Thapar A, 2009, BRIT J PSYCHIAT, V195, P100, DOI 10.1192/bjp.bp.109.062828; Wettermark B, 2007, PHARMACOEPIDEM DR S, V16, P726, DOI 10.1002/pds.1294	29	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2013	8	5							e63420	10.1371/journal.pone.0063420	http://dx.doi.org/10.1371/journal.pone.0063420			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	145YI	23667614	Green Submitted, Green Published, gold			2022-12-27	WOS:000319055600059
J	Canestrelli, D; Zampiglia, M; Nascetti, G				Canestrelli, Daniele; Zampiglia, Mauro; Nascetti, Giuseppe			Widespread Occurrence of Batrachochytrium dendrobatidis in Contemporary and Historical Samples of the Endangered Bombina pachypus along the Italian Peninsula	PLOS ONE			English	Article							EMERGING INFECTIOUS-DISEASES; GENETIC DIVERSITY; POPULATION DECLINES; AMPHIBIAN CHYTRIDIOMYCOSIS; EPIDEMIC DISEASE; GLOBAL DECLINE; PATHOGEN; FROG; TEMPERATURE; EMERGENCE	Batrachochytrium dendrobatidis is considered a main driver of the worldwide declines and extinctions of amphibian populations. Nonetheless, fundamental questions about its epidemiology, including whether it acts mainly as a "lone killer'' or in conjunction with other factors, remain largely open. In this paper we analysed contemporary and historical samples of the endangered Apennine yellow-bellied toad (Bombina pachypus) along the Italian peninsula, in order to assess the presence of the pathogen and its spreading dynamics. Once common throughout its range, B. pachypus started to decline after the mid-1990s in the northern and central regions, whereas no declines have been observed so far in the southern region. We show that Batrachochytrium dendrobatidis is currently widespread along the entire peninsula, and that this was already so at least as early as the late 1970s, that is, well before the beginning of the observed declines. This temporal mismatch between pathogen occurrence and host decline, as well as the spatial pattern of the declines, suggests that the pathogen has not acted as a "lone killer'', but in conjunction with other factors. Among the potentially interacting factors, we identified two as the most probable, genetic diversity of host populations and recent climate changes. We discuss the plausibility of this scenario and its implications on the conservation of B. pachypus populations.	[Canestrelli, Daniele; Zampiglia, Mauro; Nascetti, Giuseppe] Univ Tuscia, Dipartimento Sci Ecol & Biol, Viterbo, Italy	Tuscia University	Canestrelli, D (corresponding author), Univ Tuscia, Dipartimento Sci Ecol & Biol, Viterbo, Italy.	canestrelli@unitus.it	Canestrelli, Daniele/N-1724-2015; Nascetti, Giuseppe/AAA-6396-2020	Canestrelli, Daniele/0000-0001-9351-4972; Nascetti, Giuseppe/0000-0002-1159-8103; Zampiglia, Mauro/0000-0003-2542-2552	Agenzia Regionale dei Parchi (ARP) Lazio; Italian Ministry of Environment	Agenzia Regionale dei Parchi (ARP) Lazio; Italian Ministry of Environment	This work was funded by the Agenzia Regionale dei Parchi (ARP) Lazio and the Italian Ministry of Environment. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acevedo-Whitehouse K, 2003, NATURE, V422, P35, DOI 10.1038/422035a; Andreone F, 2009, IUCN 2012 IUCN RED L; Annis SL, 2004, J WILDLIFE DIS, V40, P420, DOI 10.7589/0090-3558-40.3.420; Barbieri F., 2004, B ZOOL, V71, P83, DOI DOI 10.1080/11250003.2004.95; Beebee TJC, 2005, BIOL CONSERV, V125, P271, DOI 10.1016/j.biocon.2005.04.009; Berger L, 1998, P NATL ACAD SCI USA, V95, P9031, DOI 10.1073/pnas.95.15.9031; Blaustein AR, 2011, ANN NY ACAD SCI, V1223, P108, DOI 10.1111/j.1749-6632.2010.05909.x; Blaustein Andrew R., 2010, Diversity, V2, P281; Blaustein AR, 2002, ECOL LETT, V5, P597, DOI 10.1046/j.1461-0248.2002.00352.x; Bodinof CM, 2011, DIS AQUAT ORGAN, V96, P1, DOI 10.3354/dao02380; Bosch J, 2007, P ROY SOC B-BIOL SCI, V274, P253, DOI 10.1098/rspb.2006.3713; Boyle DG, 2004, DIS AQUAT ORGAN, V60, P141, DOI 10.3354/dao060141; Brunetti M, 2004, GLOBAL PLANET CHANGE, V40, P141, DOI 10.1016/S0921-8181(03)00104-8; Canestrelli D, 2008, MOL ECOL, V17, P3856, DOI 10.1111/j.1365-294X.2008.03870.x; Canestrelli D, 2006, MOL ECOL, V15, P3741, DOI 10.1111/j.1365-294X.2006.03055.x; Canestrelli D, 2012, BIOL J LINN SOC, V105, P42, DOI 10.1111/j.1095-8312.2011.01767.x; Canestrelli D, 2010, MOL ECOL, V19, P5432, DOI 10.1111/j.1365-294X.2010.04900.x; Cheng TL, 2011, P NATL ACAD SCI USA, V108, P9502, DOI 10.1073/pnas.1105538108; Collins JP, 2003, DIVERS DISTRIB, V9, P89, DOI 10.1046/j.1472-4642.2003.00012.x; Daszak P, 1999, EMERG INFECT DIS, V5, P735, DOI 10.3201/eid0506.990601; Daszak P, 2003, DIVERS DISTRIB, V9, P141, DOI 10.1046/j.1472-4642.2003.00016.x; Di Rosa I, 2007, NATURE, V447, pE4, DOI 10.1038/nature05941; Farrer RA, 2011, P NATL ACAD SCI USA, V108, P18732, DOI 10.1073/pnas.1111915108; Federici S., 2009, HERPETOLOGY NOTES, V1, P33; Ficetola GF, 2011, ACTA HERPETOL, V6, P297; Fisher Matthew C., 2007, Fungal Biology Reviews, V21, P2, DOI 10.1016/j.fbr.2007.02.002; Fisher MC, 2009, ANNU REV MICROBIOL, V63, P291, DOI 10.1146/annurev.micro.091208.073435; Frankham R, 2005, BIOL CONSERV, V126, P131, DOI 10.1016/j.biocon.2005.05.002; Garner TWJ, 2006, BIOL LETTERS, V2, P455, DOI 10.1098/rsbl.2006.0494; Goka K, 2009, MOL ECOL, V18, P4757, DOI 10.1111/j.1365-294X.2009.04384.x; Harvell CD, 2002, SCIENCE, V296, P2158, DOI 10.1126/science.1063699; Hughes WOH, 2004, EVOLUTION, V58, P1251, DOI 10.1111/j.0014-3820.2004.tb01704.x; Hyatt AD, 2007, DIS AQUAT ORGAN, V73, P175, DOI 10.3354/dao073175; James TY, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000458; Kilpatrick AM, 2010, TRENDS ECOL EVOL, V25, P109, DOI 10.1016/j.tree.2009.07.011; Laurance WF, 1996, CONSERV BIOL, V10, P406, DOI 10.1046/j.1523-1739.1996.10020406.x; Lips KR, 2008, PLOS BIOL, V6, P441, DOI 10.1371/journal.pbio.0060072; Lips KR, 1999, CONSERV BIOL, V13, P117, DOI 10.1046/j.1523-1739.1999.97185.x; Longcore JE, 1999, MYCOLOGIA, V91, P219, DOI 10.2307/3761366; Luquet E, 2012, EVOLUTION, V66, P1942, DOI 10.1111/j.1558-5646.2011.01570.x; McCallum H, 2005, CONSERV BIOL, V19, P1421, DOI 10.1111/j.1523-1739.2005.00217.x; Morehouse EA, 2003, MOL ECOL, V12, P395, DOI 10.1046/j.1365-294X.2003.01732.x; Morgan JAT, 2007, P NATL ACAD SCI USA, V104, P13845, DOI 10.1073/pnas.0701838104; Ouellet M, 2005, CONSERV BIOL, V19, P1431, DOI 10.1111/j.1523-1739.2005.00108.x; Pearman PB, 2005, ECOL LETT, V8, P401, DOI 10.1111/j.1461-0248.2005.00735.x; Pessier AP, 1999, J VET DIAGN INVEST, V11, P194, DOI 10.1177/104063879901100219; Phillips BL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052502; Pounds JA, 2006, NATURE, V439, P161, DOI 10.1038/nature04246; Pounds JA, 2009, NATURE, V462, P38; Pounds JA, 2008, NAT REP CLIM CHANG, P57, DOI DOI 10.1038/CLIMATE.2008.37; Rachowicz LJ, 2005, CONSERV BIOL, V19, P1441, DOI 10.1111/j.1523-1739.2005.00255.x; Raffel TR, 2013, NAT CLIM CHANGE, V3, P146, DOI [10.1038/nclimate1659, 10.1038/NCLIMATE1659]; Rohr JR, 2010, P NATL ACAD SCI USA, V107, P8269, DOI 10.1073/pnas.0912883107; Simoncelli Francesca, 2005, EcoHealth, V2, P307, DOI 10.1007/s10393-005-8337-8; Skerratt LF, 2007, ECOHEALTH, V4, P125, DOI 10.1007/s10393-007-0093-5; Soto-Azat C, 2010, DIVERS DISTRIB, V16, P126, DOI 10.1111/j.1472-4642.2009.00618.x; Spielman D, 2004, CONSERV GENET, V5, P439, DOI 10.1023/B:COGE.0000041030.76598.cd; Spielman D, 2004, P NATL ACAD SCI USA, V101, P15261, DOI 10.1073/pnas.0403809101; Stagni G, 2004, ITAL J ZOOL, V71, P151, DOI 10.1080/11250000409356625; Toreti A, 2008, INT J CLIMATOL, V28, P733, DOI 10.1002/joc.1576; Velo-Anton G, 2012, BIOL CONSERV, V146, P213, DOI 10.1016/j.biocon.2011.12.003; Vredenburg VT, 2010, P NATL ACAD SCI USA, V107, P9689, DOI 10.1073/pnas.0914111107; Walker SF, 2010, ECOL LETT, V13, P372, DOI 10.1111/j.1461-0248.2009.01434.x; Weldon C, 2004, EMERG INFECT DIS, V10, P2100, DOI 10.3201/eid1012.030804	64	21	20	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e63349	10.1371/journal.pone.0063349	http://dx.doi.org/10.1371/journal.pone.0063349			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667603	Green Submitted, gold, Green Published			2022-12-27	WOS:000319654700132
J	Henson, TM; Cory, W; Rutter, MT				Henson, Tessa M.; Cory, Wendy; Rutter, Matthew T.			Extensive Variation in Cadmium Tolerance and Accumulation among Populations of Chamaecrista fasciculata	PLOS ONE			English	Article							THLASPI-CAERULESCENS; HEAVY-METALS; GENETIC-VARIATION; EXTRAFLORAL NECTAR; ZINC ACCUMULATION; HYPERACCUMULATION; HONEY; SOIL; PHYTOREMEDIATION; METALLOIDS	Plant populations may vary substantially in their tolerance for and accumulation of heavy metals, and assessment of this variability is important when selecting species to use in restoration or phytoremediation projects. We examined the population variation in cadmium tolerance and accumulation in a leguminous pioneer species native to the eastern United States, the partridge pea (Chamaecrista fasciculata). We assayed growth, reproduction and patterns of cadmium accumulation in six populations of C. fasciculata grown on a range of cadmium-contaminated soils. In general, C. fasciculata exhibited tolerance in low to moderate soil cadmium concentrations. Both tolerance and accumulation patterns varied across populations. C. fasciculata exhibited many characteristics of a hyperaccumulator species, with high cadmium uptake in shoots and roots. However, cadmium was excluded from extrafloral nectar. As a legume with tolerance for moderate cadmium contamination, C. fasciculata has potential for phytoremediation. However, our findings also indicate the importance of considering the effects of genetic variation on plant performance when screening plant populations for utilization in remediation and restoration activities. Also, there is potential for cadmium contamination to affect other species through contamination of leaves, fruits, flowers, pollen and root nodules.	[Henson, Tessa M.; Rutter, Matthew T.] Coll Charleston, Dept Biol, Charleston, SC 29424 USA; [Cory, Wendy] Coll Charleston, Dept Chem & Biochem, Charleston, SC 29401 USA	College of Charleston; College of Charleston	Rutter, MT (corresponding author), Coll Charleston, Dept Biol, Charleston, SC 29424 USA.	rutterm@cofc.edu			College of Charleston	College of Charleston	This study was supported by funding from the College of Charleston. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams SV, 2012, OCCUP ENVIRON MED, V69, P153, DOI 10.1136/oemed-2011-100111; Adriano D. C., 1986, Trace elements in the terrestrial environment.; Agrawal AA, 1998, OIKOS, V83, P227, DOI 10.2307/3546834; Assuncao AGL, 2003, NEW PHYTOL, V159, P411, DOI 10.1046/j.1469-8137.2003.00819.x; Assuncao AGL, 2003, NEW PHYTOL, V159, P383, DOI 10.1046/j.1469-8137.2003.00758.x; ATSDR (Agency for Toxic Substances and Disease Registry), 1997, TOX PROF CADM UPD; BALSBERG AM, 1982, OIKOS, V38, P91, DOI 10.2307/3544570; Belimov AA, 2007, ACTA PHYSIOL PLANT, V29, P473, DOI 10.1007/s11738-007-0057-y; Bert V, 2000, NEW PHYTOL, V146, P225, DOI 10.1046/j.1469-8137.2000.00634.x; Best EPH, 2007, TR0711 ERDC US ARM; Bogdanov S, 2007, J APICULT RES, V46, P269, DOI 10.1080/00218839.2007.11101407; Bolan NS, 2011, ADV AGRON, V112, P145, DOI 10.1016/B978-0-12-385538-1.00004-4; Bosiacki M, 2008, ACTA SCI POL-HORTORU, V7, P21; Broadley MR, 2001, NEW PHYTOL, V152, P9, DOI 10.1046/j.0028-646x.2001.00238.x; BROWN SL, 1994, J ENVIRON QUAL, V23, P1151, DOI 10.2134/jeq1994.00472425002300060004x; Chen H, 2001, CHEMOSPHERE, V45, P21, DOI 10.1016/S0045-6535(01)00031-5; Chen WM, 2008, J HAZARD MATER, V151, P364, DOI 10.1016/j.jhazmat.2007.05.082; Cobbett C, 2003, NEW PHYTOL, V159, P289, DOI 10.1046/j.1469-8137.2003.00832.x; Dierkes C, 1999, WATER SCI TECHNOL, V39, P201, DOI 10.1016/S0273-1223(99)00024-4; Escarre J, 2000, NEW PHYTOL, V145, P429, DOI 10.1046/j.1469-8137.2000.00599.x; Etterson JR, 2004, EVOLUTION, V58, P1459, DOI 10.1111/j.0014-3820.2004.tb01727.x; Feist LJ, 2001, NEW PHYTOL, V149, P61, DOI 10.1046/j.1469-8137.2001.00004.x; GUREVITCH J, 2006, ECOLOGY PLANTS; Ji PH, 2011, ENVIRON POLLUT, V159, P762, DOI 10.1016/j.envpol.2010.11.029; Kearns C. A., 1993, TECHNIQUES POLLINATI; KOPTUR S, 1994, BIOTROPICA, V26, P276, DOI 10.2307/2388848; Lin ZQ, 2007, DEV ENVIRONM SCI, V5, P487, DOI 10.1016/S1474-8177(07)05022-X; Liu ZL, 2009, J HAZARD MATER, V169, P170, DOI 10.1016/j.jhazmat.2009.03.090; Lombi E, 2000, NEW PHYTOL, V145, P11, DOI 10.1046/j.1469-8137.2000.00560.x; Macnair MR, 2002, NEW PHYTOL, V155, P59, DOI 10.1046/j.1469-8137.2002.00445.x; Macnair MR, 1999, P ROY SOC B-BIOL SCI, V266, P2175, DOI 10.1098/rspb.1999.0905; MACNAIR MR, 1993, NEW PHYTOL, V124, P541, DOI 10.1111/j.1469-8137.1993.tb03846.x; Mahieu S, 2011, PLANT SOIL, V342, P405, DOI 10.1007/s11104-010-0705-7; Manier N, 2009, J ENVIRON QUAL, V38, P685, DOI 10.2134/jeq2008.0013; Marschner H., 1995, MARSCHNERS MINERAL N, DOI DOI 10.1016/B978-0-12-473542-2.X5000-7; McGrath SP, 2002, ADV AGRON, V75, P1, DOI 10.1016/S0065-2113(02)75002-5; Meers E, 2006, ENVIRON MONIT ASSESS, V120, P243, DOI 10.1007/s10661-005-9059-7; Meerts P, 1997, PLANT ECOL, V133, P221, DOI 10.1023/A:1009717619579; Mogren CL, 2010, ENTOMOL EXP APPL, V135, P1, DOI 10.1111/j.1570-7458.2010.00967.x; Molitor M, 2005, NEW PHYTOL, V165, P503, DOI 10.1111/j.1469-8137.2004.01240.x; Morris JB, 2012, GENET RESOUR CROP EV, V59, P1577, DOI 10.1007/s10722-012-9881-z; Page A.L., 1987, LEAD MERCURY CADMIUM, P119; Pohl P, 2009, TRAC-TREND ANAL CHEM, V28, P117, DOI 10.1016/j.trac.2008.09.015; Pollard AJ, 2002, CRIT REV PLANT SCI, V21, P539, DOI 10.1080/0735-260291044359; Robinson BH, 2000, PLANT SOIL, V227, P301, DOI 10.1023/A:1026515007319; Roman A, 2010, POL J ENVIRON STUD, V19, P663; Roosens N, 2003, PLANT CELL ENVIRON, V26, P1657, DOI 10.1046/j.1365-3040.2003.01084.x; Rutter MT, 2005, EVOL ECOL RES, V7, P407; Rutter MT, 2004, EVOLUTION, V58, P2657, DOI 10.1111/j.0014-3820.2004.tb01619.x; Sahinler N, 2009, ASIAN J CHEM, V21, P1887; Shamsi IH, 2008, BIOL PLANTARUM, V52, P165, DOI 10.1007/s10535-008-0036-1; Singer SR, 2009, PLANT PHYSIOL, V151, P1041, DOI 10.1104/pp.109.144774; SMITH LL, 1990, ECOLOGY, V71, P107, DOI 10.2307/1940251; Stolt P, 2006, J AGRON CROP SCI, V192, P201, DOI 10.1111/j.1439-037X.2006.00202.x; Sun YB, 2009, J HAZARD MATER, V161, P808, DOI 10.1016/j.jhazmat.2008.04.030; USDA, 2013, USDA NAT RES CONS SE; Walker DJ, 2007, WATER AIR SOIL POLL, V184, P335, DOI 10.1007/s11270-007-9422-0; WILKINS DA, 1978, NEW PHYTOL, V80, P623, DOI 10.1111/j.1469-8137.1978.tb01595.x; Wu FY, 2009, ENVIRON POLLUT, V157, P2394, DOI 10.1016/j.envpol.2009.03.022; Wu FZ, 2010, J HAZARD MATER, V177, P268, DOI 10.1016/j.jhazmat.2009.12.028; Xiong ZT, 2001, ECOTOX ENVIRON SAFE, V48, P51, DOI 10.1006/eesa.2000.2002; Yazgan S, 2006, DEUT LEBENSM-RUNDSCH, V102, P192; Zacchini M, 2009, WATER AIR SOIL POLL, V197, P23, DOI 10.1007/s11270-008-9788-7; Zha HG, 2004, NEW PHYTOL, V163, P299, DOI 10.1111/j.1469-8137.2004.01113.x; Zhu Y, 2007, J AGR FOOD CHEM, V55, P1045, DOI 10.1021/jf062971p; Zorrig W, 2010, J PLANT PHYSIOL, V167, P1239, DOI 10.1016/j.jplph.2010.04.012; Zuur Alain F., 2009, P1	67	20	21	5	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e63200	10.1371/journal.pone.0063200	http://dx.doi.org/10.1371/journal.pone.0063200			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667586	Green Published, Green Submitted, gold			2022-12-27	WOS:000319654700116
J	Schmidt, FM; Kratzsch, J; Gertz, HJ; Tittmann, M; Jahn, I; Pietsch, UC; Kaisers, UX; Thiery, J; Hegerl, U; Schoknecht, P				Schmidt, Frank M.; Kratzsch, Juergen; Gertz, Hermann-Josef; Tittmann, Mandy; Jahn, Ina; Pietsch, Uta-Carolin; Kaisers, Udo X.; Thiery, Joachim; Hegerl, Ulrich; Schoenknecht, Peter			Cerebrospinal Fluid Melanin-Concentrating Hormone (MCH) and Hypocretin-1 (HCRT-1, Orexin-A) in Alzheimer's Disease	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; SLEEP-WAKE CYCLE; MEMORY CONSOLIDATION; HEALTHY CONTROLS; MESSENGER-RNA; DEMENTIA; NEURONS; RAT; MICE; AGE	Ancillary to decline in cognitive abilities, patients with Alzheimer's disease (AD) frequently suffer from behavioural and psychological symptoms of dementia (BPSD). Hypothalamic polypeptides such as melanin-concentrating hormone (MCH) and hypocretin-1 (HCRT-1, orexin-A) are promoters of sleep-wake regulation and energy homeostasis and are found to impact on cognitive performance. To investigate the role of MCH and HCRT-1 in AD, cerebrospinal fluid (CSF) levels were measured in 33 patients with AD and 33 healthy subjects (HS) using a fluorescence immunoassay (FIA). A significant main effect of diagnosis (F(1,62) = 8.490, p<0.01) on MCH levels was found between AD (93.76 +/- 13.47 pg/mL) and HS (84.65 +/- 11.40 pg/mL). MCH correlated with T-tau (r = 0.47; p<0.01) and P-tau (r = 0.404; p<0.05) in the AD but not in the HS. CSF-MCH correlated negatively with MMSE scores in the AD (r = -0.362, p<0.05) and was increased in more severely affected patients (MMSE <= 20) compared to HS (p<0.001) and BPSD-positive patients compared to HS (p<0.05). In CSF-HCRT-1, a significant main effect of sex (F(1,31) = 4.400, p<0.05) with elevated levels in females (90.93 +/- 17.37 pg/mL vs. 82.73 +/- 15.39 pg/mL) was found whereas diagnosis and the sex*diagnosis interaction were not significant. Elevated levels of MCH in patients suffering from AD and correlation with Tau and severity of cognitive impairment point towards an impact of MCH in AD. Gender differences of CSF-HCRT-1 controversially portend a previously reported gender dependence of HCRT-1-regulation. Histochemical and actigraphic explorations are warranted to further elucidate alterations of hypothalamic transmitter regulation in AD.	[Schmidt, Frank M.; Gertz, Hermann-Josef; Tittmann, Mandy; Jahn, Ina; Hegerl, Ulrich; Schoenknecht, Peter] Univ Hosp Leipzig, Dept Psychiat & Psychotherapy, Leipzig, Germany; [Kratzsch, Juergen; Thiery, Joachim] Univ Hosp Leipzig, Inst Lab Med Clin Chem & Mol Diagnost, Leipzig, Germany; [Pietsch, Uta-Carolin; Kaisers, Udo X.] Univ Hosp Leipzig, Dept Anesthesiol & Intens Care Med, Leipzig, Germany	Leipzig University; Leipzig University; Leipzig University	Schmidt, FM (corresponding author), Univ Hosp Leipzig, Dept Psychiat & Psychotherapy, Leipzig, Germany.	frank.schmidt2@medizin.uni-leipzig.de		Hegerl, Ulrich/0000-0002-3039-7470				Adamantidis A, 2005, EUR J NEUROSCI, V21, P2837, DOI 10.1111/j.1460-9568.2005.04100.x; Adamantidis A, 2009, PEPTIDES, V30, P2066, DOI 10.1016/j.peptides.2009.06.024; Arrigoni E, 2010, ACTA PHYSIOL, V198, P223, DOI 10.1111/j.1748-1716.2009.02036.x; Baumann CR, 2006, J NEUROL, V253, P1232, DOI 10.1007/s00415-006-0146-7; Bayer L, 2005, NEUROSCIENCE, V130, P807, DOI 10.1016/j.neuroscience.2004.10.032; Burkart M, 1998, NERVENARZT, V69, P983, DOI 10.1007/s001150050373; Cecon E, 2011, RECENT PATENTS ENDOC, V5, P91, DOI 10.2174/187221411799015381; Chung SJ, 2011, J MOL NEUROSCI, V43, P115, DOI 10.1007/s12031-010-9411-4; Clinton LK, 2007, NEUROBIOL DIS, V28, P76, DOI 10.1016/j.nbd.2007.06.013; Delazer M, 2011, NEUROPSYCHOLOGY, V25, P477, DOI 10.1037/a0022357; Dubois B, 2010, LANCET NEUROL, V9, P1118, DOI 10.1016/S1474-4422(10)70223-4; Ellenbogen JM, 2006, CURR OPIN NEUROBIOL, V16, P716, DOI 10.1016/j.conb.2006.10.006; Fernandez M, 2010, BMC NEUROL, V10, DOI 10.1186/1471-2377-10-87; Fetzner S, 2004, ARCH CLIN NEUROPSYCH, V19, P918; First M. B., 1997, STRUCTURED CLIN INTE; Friedman LF, 2007, NEUROLOGY, V68, P793, DOI 10.1212/01.wnl.0000256731.57544.f9; Fronczek R, 2012, NEUROBIOL AGING, V33, P1642, DOI 10.1016/j.neurobiolaging.2011.03.014; Gao S, 1998, ARCH GEN PSYCHIAT, V55, P809, DOI 10.1001/archpsyc.55.9.809; Gerashchenko D, 2003, EXP NEUROL, V184, P1010, DOI 10.1016/S0014-4886(03)00388-1; Gozzi A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016406; Guyon A, 2009, PEPTIDES, V30, P2031, DOI 10.1016/j.peptides.2009.05.028; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; Hassani OK, 2009, P NATL ACAD SCI USA, V106, P2418, DOI 10.1073/pnas.0811400106; Hervieu GJ, 2000, EUR J NEUROSCI, V12, P1194, DOI 10.1046/j.1460-9568.2000.00008.x; Jack CR, 2010, LANCET NEUROL, V9, P119, DOI 10.1016/S1474-4422(09)70299-6; Johren O, 2002, PEPTIDES, V23, P1177, DOI 10.1016/S0196-9781(02)00052-9; Kang JE, 2009, SCIENCE, V326, P1005, DOI 10.1126/science.1180962; Kessler BA, 2011, NEUROSCIENCE, V178, P82, DOI 10.1016/j.neuroscience.2011.01.031; Lambe EK, 2005, J NEUROSCI, V25, P5225, DOI 10.1523/JNEUROSCI.0719-05.2005; Lessig S, 2010, NEUROREPORT, V21, P756, DOI 10.1097/WNR.0b013e32833bfb7c; McCurry S. M., 1985, CURR TREAT OPTION NE, V5, P261; MCDUFF T, 1985, NEUROLOGY, V35, P123, DOI 10.1212/WNL.35.1.123; Millan MJ, 2008, INT J NEUROPSYCHOPH, V11, P1105, DOI 10.1017/S1461145708008894; Monzon ME, 1999, PEPTIDES, V20, P1517, DOI 10.1016/S0196-9781(99)00164-3; MORRIS JC, 1989, NEUROLOGY, V39, P1159, DOI 10.1212/wnl.43.12.2457; MUNGAS D, 1991, GERIATRICS, V46, P54; Naumann A, 2003, BEHAV NEUROL, V14, P89, DOI 10.1155/2003/323060; OGOMORI K, 1989, AM J PATHOL, V134, P243; Peyron C, 2009, PEPTIDES, V30, P2052, DOI 10.1016/j.peptides.2009.07.022; Raggi A, 2011, NEUROSCI BIOBEHAV R, V35, P1144, DOI 10.1016/j.neubiorev.2010.12.001; Rolls A, 2011, P NATL ACAD SCI USA, V108, P13305, DOI 10.1073/pnas.1015633108; RUSSELL EW, 1982, PERCEPT MOTOR SKILL, V54, P971, DOI 10.2466/pms.1982.54.3.971; Sakamaki R, 2005, INT J MOL MED, V15, P1033; Salomon RM, 2003, BIOL PSYCHIAT, V54, P96, DOI 10.1016/S0006-3223(02)01740-7; Saper CB, 2010, NEURON, V68, P1023, DOI 10.1016/j.neuron.2010.11.032; Schmidt FM, 2011, PSYCHIAT RES, V190, P240, DOI 10.1016/j.psychres.2011.06.004; Shimada M, 1998, NATURE, V396, P670, DOI 10.1038/25341; Shulman KI, 2000, INT J GERIATR PSYCH, V15, P548, DOI 10.1002/1099-1166(200006)15:6<548::AID-GPS242>3.0.CO;2-U; Silva A, 2008, BRAZ J MED BIOL RES, V41, P1067, DOI 10.1590/S0100-879X2008001200005; Silveyra P, 2009, REGUL PEPTIDES, V158, P121, DOI 10.1016/j.regpep.2009.08.002; SIMPSON J, 1988, NEUROPATH APPL NEURO, V14, P381, DOI 10.1111/j.1365-2990.1988.tb01140.x; Slats D, 2012, CURR ALZHEIMER RES, V9, P1119, DOI 10.2174/156720512804142840; Smith DG, 2006, NEUROPSYCHOPHARMACOL, V31, P1135, DOI 10.1038/sj.npp.1300913; Stanley EM, 2012, SYNAPSE, V66, P445, DOI 10.1002/syn.21533; van den Pol AN, 2004, NEURON, V42, P635, DOI 10.1016/S0896-6273(04)00251-X; Varas M, 2002, PEPTIDES, V23, P151, DOI 10.1016/S0196-9781(01)00591-5; Verret L, 2003, BMC NEUROSCI, V4, DOI 10.1186/1471-2202-4-19; Wang G, 2011, TRENDS NEUROSCI, V34, P452, DOI 10.1016/j.tins.2011.07.005; Wennstrom M, 2012, J ALZHEIMERS DIS, V29, P125, DOI [10.3233/JAD-2011-111655, 10.3233/JAD-2012-111655]	59	50	54	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e63136	10.1371/journal.pone.0063136	http://dx.doi.org/10.1371/journal.pone.0063136			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667582	Green Published, Green Submitted, gold			2022-12-27	WOS:000319654700113
J	Downer, EJ; Jones, RS; McDonald, CL; Greco, E; Brennan, S; Connor, TJ; Robertson, IH; Lynch, MA				Downer, Eric J.; Jones, Raasay S.; McDonald, Claire L.; Greco, Eleonora; Brennan, Sabina; Connor, Thomas J.; Robertson, Ian H.; Lynch, Marina A.			Identifying Early Inflammatory Changes in Monocyte-Derived Macrophages from a Population with IQ-Discrepant Episodic Memory	PLOS ONE			English	Article							BLOOD MONONUCLEAR-CELLS; AMYLOID BETA-PROTEIN; ALZHEIMERS-DISEASE; SIGNAL-TRANSDUCTION; CYTOKINE PRODUCTION; MOUSE MODEL; HUMAN BRAIN; RECEPTOR 2; MICROGLIA; ACTIVATION	Background: Cells of the innate immune system including monocytes and macrophages are the first line of defence against infections and are critical regulators of the inflammatory response. These cells express toll-like receptors (TLRs), innate immune receptors which govern tailored inflammatory gene expression patterns. Monocytes, which produce pro-inflammatory mediators, are readily recruited to the central nervous system (CNS) in neurodegenerative diseases. Methods: This study explored the expression of receptors (CD11b, TLR2 and TLR4) on circulating monocyte-derived macrophages (MDMs) and peripheral blood mononuclear cells (PBMCs) isolated from healthy elderly adults who we classified as either IQ memory-consistent (high-performing, HP) or IQ memory-discrepant (low-performing, LP). Results: The expression of CD11b, TLR4 and TLR2 was increased in MDMs from the LP group when compared to HP cohort. MDMs from both groups responded robustly to treatment with the TLR4 activator, lipopolysaccharide (LPS), in terms of cytokine production. Significantly, MDMs from the LP group displayed hypersensitivity to LPS exposure. Interpretation: Overall these findings define differential receptor expression and cytokine profiles that occur in MDMs derived from a cohort of IQ memory-discrepant individuals. These changes are indicative of inflammation and may be involved in the prodromal processes leading to the development of neurodegenerative disease.	[Downer, Eric J.; Jones, Raasay S.; McDonald, Claire L.; Greco, Eleonora; Brennan, Sabina; Connor, Thomas J.; Robertson, Ian H.; Lynch, Marina A.] Trinity Coll Dublin, Inst Neurosci, Dublin, Ireland; [Downer, Eric J.; Jones, Raasay S.; McDonald, Claire L.; Connor, Thomas J.; Lynch, Marina A.] Trinity Coll Dublin, Dept Physiol, Dublin, Ireland; [Robertson, Ian H.] Trinity Coll Dublin, Sch Psychol, Dublin, Ireland	Trinity College Dublin; Trinity College Dublin; Trinity College Dublin	Downer, EJ (corresponding author), Natl Univ Ireland Univ Coll Cork, Dept Anat & Neurosci, Cork, Ireland.	edowner@ucc.ie		McDonald, Claire/0000-0002-0583-742X; Downer, Eric/0000-0002-6012-2291; Lynch, Marina/0000-0002-4631-0499; Robertson, Ian H/0000-0001-8637-561X	Science Foundation Ireland; Health Research Board Ireland; Trinity College Institute of Neuroscience Research Consortium on Neurodegeneration	Science Foundation Ireland(Science Foundation IrelandEuropean Commission); Health Research Board Ireland; Trinity College Institute of Neuroscience Research Consortium on Neurodegeneration	This project was jointly funded by Science Foundation Ireland, Health Research Board Ireland, and Trinity College Institute of Neuroscience Research Consortium on Neurodegeneration. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Allman D, 2005, IMMUNOL REV, V205, P18, DOI 10.1111/j.0105-2896.2005.00269.x; Andreani G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008246; Biju KC, 2010, MOL THER, V18, P1536, DOI 10.1038/mt.2010.107; CLARK JA, 1994, MECH AGEING DEV, V77, P127, DOI 10.1016/0047-6374(94)90020-5; Cribbs DH, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-179; Dalmau I, 2003, J COMP NEUROL, V458, P144, DOI 10.1002/cne.10572; DeCarli C, 2003, LANCET NEUROL, V2, P15, DOI 10.1016/S1474-4422(03)00262-X; Delpedro AD, 1998, J INTERF CYTOK RES, V18, P429, DOI 10.1089/jir.1998.18.429; El Khoury J, 2007, NAT MED, V13, P432, DOI 10.1038/nm1555; Fulop T, 2004, AGING CELL, V3, P217, DOI 10.1111/j.1474-9728.2004.00110.x; Gallagher JJ, 2012, J ALZHEIMERS DIS, V28, P147, DOI 10.3233/JAD-2011-110614; Geissmann F, 2010, SCIENCE, V327, P656, DOI 10.1126/science.1178331; Good DW, 2012, J BIOL CHEM, V287, P20208, DOI 10.1074/jbc.M111.336255; Graber DJ, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-8; Hearps AC, 2012, AGING CELL; Hendriks JJA, 2005, BRAIN RES REV, V48, P185, DOI 10.1016/j.brainresrev.2004.12.008; Hochstrasser T, 2010, EXP GERONTOL, V45, P70, DOI 10.1016/j.exger.2009.10.005; Kaplin A, 2009, INT PSYCHOGERIATR, V21, P413, DOI 10.1017/S1041610208008107; Kent LM, 2009, J PHARMACOL EXP THER, V328, P458, DOI 10.1124/jpet.108.142950; Lunnon K, 2012, J ALZHEIMERS DIS, V30, P685, DOI 10.3233/JAD-2012-111592; Mariani E, 2002, EXP GERONTOL, V37, P219, DOI 10.1016/S0531-5565(01)00187-5; Mattsson N, 2009, JAMA-J AM MED ASSOC, V302, P385, DOI 10.1001/jama.2009.1064; MAZZONE A, 1995, HAEMATOLOGICA, V80, P161; McGeer PL, 1996, NEUROLOGY, V47, P425, DOI 10.1212/WNL.47.2.425; Michaud JP, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-5; Mildner A, 2008, J IMMUNOL, V181, P2713, DOI 10.4049/jimmunol.181.4.2713; Mildner A, 2009, BRAIN, V132, P2487, DOI 10.1093/brain/awp144; Moreira AP, 2011, J INTERF CYTOK RES, V31, P485, DOI 10.1089/jir.2011.0027; Muzio M, 2000, J IMMUNOL, V164, P5998, DOI 10.4049/jimmunol.164.11.5998; Naert G, 2012, MOL MED, V18, P297, DOI 10.2119/molmed.2011.00306; Nelson HE., 1982, NATL ADULT READING T; Ojo B, 2011, EXP NEUROL, V232, P318, DOI 10.1016/j.expneurol.2011.09.025; Orme J, 2012, DISCOV MED, V13, P151; Paresce DM, 1996, NEURON, V17, P553, DOI 10.1016/S0896-6273(00)80187-7; PERLMUTTER LS, 1992, J NEUROSCI RES, V33, P549, DOI 10.1002/jnr.490330407; Perry VH, 2007, NAT REV IMMUNOL, V7, P161, DOI 10.1038/nri2015; Poussin C, 1998, J BIOL CHEM, V273, P20285, DOI 10.1074/jbc.273.32.20285; Qiu WQ, 1997, J BIOL CHEM, V272, P6641, DOI 10.1074/jbc.272.10.6641; Rami L, 2012, INT J GERIATR PSYCH, V27, P127, DOI 10.1002/gps.2696; Reed-Geaghan EG, 2010, J NEUROSCI, V30, P15369, DOI 10.1523/JNEUROSCI.2637-10.2010; Reed-Geaghan EG, 2009, J NEUROSCI, V29, P11982, DOI 10.1523/JNEUROSCI.3158-09.2009; Rowan AG, 2008, J IMMUNOL, V181, P4485, DOI 10.4049/jimmunol.181.7.4485; Schilling E, 2012, INNATE IMMUN-LONDON, V18, P518, DOI 10.1177/1753425911423853; Sebastian C, 2005, IMMUNOBIOLOGY, V210, P121, DOI 10.1016/j.imbio.2005.05.006; Shi C, 2011, NAT REV IMMUNOL, V11, P762, DOI 10.1038/nri3070; Simard AR, 2006, NEURON, V49, P489, DOI 10.1016/j.neuron.2006.01.022; Simard AR, 2004, FASEB J, V18, P998, DOI 10.1096/fj.04-1517fje; Smythies LE, 2010, AM J PHYSIOL-CELL PH, V298, pC1538, DOI 10.1152/ajpcell.00467.2009; SPRINGER TA, 1990, NATURE, V346, P425, DOI 10.1038/346425a0; Stalder AK, 2005, J NEUROSCI, V25, P11125, DOI 10.1523/JNEUROSCI.2545-05.2005; Templeton SP, 2008, BRAIN PATHOL, V18, P40, DOI 10.1111/j.1750-3639.2007.00098.x; van Duin D, 2007, J IMMUNOL, V178, P970, DOI 10.4049/jimmunol.178.2.970; Verreck FAW, 2004, P NATL ACAD SCI USA, V101, P4560, DOI 10.1073/pnas.0400983101; Vezzani A, 2011, BRAIN BEHAV IMMUN; Vollmar P, 2010, J IMMUNOL, V185, P6338, DOI 10.4049/jimmunol.1001765; Wahle T, 2006, J NEUROSCI, V26, P12838, DOI 10.1523/JNEUROSCI.1982-06.2006; Wang LZ, 2011, NEUROSCI LETT, V489, P164, DOI 10.1016/j.neulet.2010.12.008; Wechsler D, 1998, WMS 3 UK ADM SCORING; Wehrhahn J, 2010, J IMMUNOL, V184, P2386, DOI 10.4049/jimmunol.0902474; Wei W, 2010, MOL IMMUNOL, V47, P2475, DOI 10.1016/j.molimm.2010.06.004; Weng NP, 2006, IMMUNITY, V24, P495, DOI 10.1016/j.immuni.2006.05.001; Wilcock Donna M, 2012, Int J Alzheimers Dis, V2012, P495243, DOI 10.1155/2012/495243; Xie L, 2012, J NEUROIMMUNE PHARM, V7, P231, DOI 10.1007/s11481-011-9322-3; Zhang W, 2012, J NEUROL SCI, V315, P67, DOI 10.1016/j.jns.2011.11.032	65	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2013	8	5							e63194	10.1371/journal.pone.0063194	http://dx.doi.org/10.1371/journal.pone.0063194			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	177QL	23671673	Green Submitted, Green Published, gold			2022-12-27	WOS:000321390200046
J	Postlethwaite, CM; Dennis, TE				Postlethwaite, Claire M.; Dennis, Todd E.			Effects of Temporal Resolution on an Inferential Model of Animal Movement	PLOS ONE			English	Article							GPS COLLAR PERFORMANCE; STATE-SPACE MODELS; TRICHOSURUS-VULPECULA; SATELLITE TELEMETRY; LOCATION ERROR; SAMPLING RATE; RANDOM-WALKS; TRACKING; BEHAVIOR; ECOLOGY	Recently, there has been much interest in describing the behaviour of animals by fitting various movement models to tracking data. Despite this interest, little is known about how the temporal 'grain' of movement trajectories affects the outputs of such models, and how behaviours classified at one timescale may differ from those classified at other scales. Here, we present a study in which random-walk state-space models were fit both to nightly geospatial lifelines of common brushtail possums (Trichosurus vulpecula) and synthetic trajectories parameterised from empirical observations. Observed trajectories recorded by GPS collars at 5-min intervals were sub-sampled at periods varying between 10 and 60 min, to approximate the effect of collecting data at lower sampling frequencies. Markov-Chain Monte-Carlo fitting techniques, using information about movement rates and turning angles between sequential fixes, were employed using a Bayesian framework to assign distinct behavioural states to individual location estimates. We found that in trajectories with higher temporal granularities behaviours could be clearly differentiated into 'slow-area-restricted' and 'fast-transiting' states, but for trajectories with longer inter-fix intervals this distinction was markedly less obvious. Specifically, turning-angle distributions varied from being highly peaked around either 00 or 1800 at fine temporal scales, to being uniform across all angles at low sampling intervals. Our results highlight the difficulty of comparing model results amongst tracking-data sets that vary substantially in temporal grain, and demonstrate the importance of matching the observed temporal resolution of tracking devices to the timescales of behaviours of interest, otherwise inter-individual comparisons of inferred behaviours may be invalid, or important biological information may be obscured.	[Postlethwaite, Claire M.] Univ Auckland, Dept Math, Auckland, New Zealand; [Dennis, Todd E.] Univ Auckland, Sch Biol Sci, Auckland 1, New Zealand	University of Auckland; University of Auckland	Postlethwaite, CM (corresponding author), Univ Auckland, Dept Math, Auckland, New Zealand.	c.postlethwaite@math.auckland.ac.nz	Postlethwaite, Claire M/D-4696-2009	Postlethwaite, Claire M/0000-0003-0654-6736	Nga Pae o te Maramatanga [08-RF1-22]; School of Biological Sciences at the University of Auckland; Department of Mathematics at the University of Auckland	Nga Pae o te Maramatanga; School of Biological Sciences at the University of Auckland; Department of Mathematics at the University of Auckland	The authors gratefully acknowledge the financial support by Nga Pae o te Maramatanga (08-RF1-22 to T.E.D.) and the School of Biological Sciences and the Department of Mathematics at the University of Auckland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Austin D, 2003, MAR MAMMAL SCI, V19, P371, DOI 10.1111/j.1748-7692.2003.tb01115.x; Benhamou S, 2004, J THEOR BIOL, V229, P209, DOI 10.1016/j.jtbi.2004.03.016; BOVET P, 1988, J THEOR BIOL, V131, P419, DOI 10.1016/S0022-5193(88)80038-9; Brooks C, 2008, J WILDLIFE MANAGE, V72, P527, DOI 10.2193/2007-061; Codling EA, 2005, J THEOR BIOL, V233, P573, DOI 10.1016/j.jtbi.2004.11.008; Cooke SJ, 2004, TRENDS ECOL EVOL, V19, P334, DOI 10.1016/j.tree.2004.04.003; COWAN PE, 1989, AUST WILDLIFE RES, V16, P63; D'Eon RG, 2005, J APPL ECOL, V42, P383, DOI 10.1111/j.1365-2664.2005.01010.x; D'Eon RG, 2002, WILDLIFE SOC B, V30, P430; Dennis T.E., 2010, Wildlife Biology in Practice, V6, P14; Di Orio AP, 2003, WILDLIFE SOC B, V31, P372; Egevang C, 2010, P NATL ACAD SCI USA, V107, P2078, DOI 10.1073/pnas.0909493107; Girard I, 2006, J WILDLIFE MANAGE, V70, P1249, DOI 10.2193/0022-541X(2006)70[1249:BNOLWN]2.0.CO;2; Herbert PA, 1999, AUST J ZOOL, V47, P579, DOI 10.1071/ZO99035; Holden C, 2006, SCIENCE, V313, P779, DOI 10.1126/science.313.5788.779; Horne JS, 2007, ECOLOGY, V88, P2354, DOI 10.1890/06-0957.1; Jonsen ID, 2005, ECOLOGY, V86, P2874, DOI 10.1890/04-1852; Jonsen ID, 2003, ECOLOGY, V84, P3055, DOI 10.1890/02-0670; KEATING KA, 1991, J WILDLIFE MANAGE, V55, P160, DOI 10.2307/3809254; Lewis JS, 2007, J APPL ECOL, V44, P663, DOI 10.1111/j.1365-2664.2007.01286.x; Lunn DJ, 2000, STAT COMPUT, V10, P325, DOI 10.1023/A:1008929526011; MacLennan D.G., 1984, P155; Mattisson J, 2010, J WILDLIFE MANAGE, V74, P557, DOI 10.2193/2009-157; Mills KJ, 2006, WILDLIFE SOC B, V34, P1463, DOI 10.2193/0091-7648(2006)34[1463:EOVSFO]2.0.CO;2; Moen R, 1996, J WILDLIFE MANAGE, V60, P659, DOI 10.2307/3802085; Morales JM, 2004, ECOLOGY, V85, P2436, DOI 10.1890/03-0269; Nathan R, 2008, P NATL ACAD SCI USA, V105, P19052, DOI 10.1073/pnas.0800375105; Patterson TA, 2008, TRENDS ECOL EVOL, V23, P87, DOI 10.1016/j.tree.2007.10.009; Patterson TA, 2009, J ANIM ECOL, V78, P1113, DOI 10.1111/j.1365-2656.2009.01583.x; Ryan PG, 2004, MAR BIOL, V145, P215, DOI 10.1007/s00227-004-1328-4; Schick RS, 2008, ECOL LETT, V11, P1338, DOI 10.1111/j.1461-0248.2008.01249.x; Shaffer SA, 2005, MAR BIOL, V147, P833, DOI 10.1007/s00227-005-1631-8; Stephens M, 2000, J ROY STAT SOC B, V62, P795, DOI 10.1111/1467-9868.00265; Ward GD, 1978, P NATL ZOOLOGICAL PA, V1, P267	34	25	25	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2013	8	5							e57640	10.1371/journal.pone.0057640	http://dx.doi.org/10.1371/journal.pone.0057640			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	177QL	23671558	Green Published, gold, Green Submitted			2022-12-27	WOS:000321390200001
J	Talamini, LM; Bringmann, LF; de Boer, M; Hofman, WF				Talamini, Lucia M.; Bringmann, Laura F.; de Boer, Marieke; Hofman, Winni F.			Sleeping Worries Away or Worrying Away Sleep? Physiological Evidence on Sleep-Emotion Interactions	PLOS ONE			English	Article							SLOW-WAVE SLEEP; POSTTRAUMATIC-STRESS-DISORDER; EYE-MOVEMENT SLEEP; REM-SLEEP; DECLARATIVE MEMORY; DEPRIVATION; DEPRESSION; ADAPTATION; INSOMNIA; CONSOLIDATION	Recent findings suggest that sleep might serve a role in emotional coping. However, most findings are based on subjective reports of sleep quality, while the relation with underlying sleep physiology is still largely unknown. In this study, the impact of an emotionally distressing experience on the EEG correlates of sleep was assessed. In addition, the association between sleep physiological parameters and the extent of emotional attenuation over sleep was determined. The experimental set up involved presentation of an emotionally neutral or distressing film fragment in the evening, followed by polysomnographic registration of undisturbed, whole-night sleep and assessment of emotional reactivity to film cues on the next evening. We found that emotional distress induced mild sleep deterioration, but also an increase in the proportion of slow wave sleep (SWS) and altered patterning of rapid eye movement (REM) sleep. Indeed, while REM sleep occurrence normally increases over the course of the night, emotional distress flattened this distribution and correlated with an increased number of REM periods. While sleep deterioration was negatively associated to emotional attenuation over sleep, the SWS response was positively related to such attenuation and may form part of a compensatory response to the stressor. Interestingly, trait-like SWS characteristics also correlated positively with the extent of emotion attenuation over sleep. The combined results provide strong evidence for an intimate reciprocal relation between sleep physiology and emotional processing. Moreover, individual differences in subjects' emotional and sleep responses suggest there may be a coupling of certain emotion and sleep traits into distinct emotional sleep types.	[Talamini, Lucia M.; Bringmann, Laura F.; de Boer, Marieke; Hofman, Winni F.] Univ Amsterdam, Dept Psychol, Amsterdam, Netherlands; [Talamini, Lucia M.; de Boer, Marieke; Hofman, Winni F.] Univ Amsterdam, Cognit Sci Ctr Amsterdam, Amsterdam, Netherlands	University of Amsterdam; University of Amsterdam	Talamini, LM (corresponding author), Univ Amsterdam, Dept Psychol, Amsterdam, Netherlands.	L.M.Talamini@uva.nl			NWO (Netherlands Organisation for Scientific Research) [452-08-013]	NWO (Netherlands Organisation for Scientific Research)(Netherlands Organization for Scientific Research (NWO))	This work was funded by NWO (Netherlands Organisation for Scientific Research) grant 452-08-013 (www.nwo.nl). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babson KA, 2010, J ANXIETY DISORD, V24, P1, DOI 10.1016/j.janxdis.2009.08.002; BAEKELAND F, 1968, PSYCHOPHYSIOLOGY, V4, P436; Baldwin DC, 2004, SLEEP, V27, P217, DOI 10.1093/sleep/27.2.217; Borbely A A, 1982, Hum Neurobiol, V1, P195; BRUNNER DP, 1990, ELECTROEN CLIN NEURO, V75, P492, DOI 10.1016/0013-4694(90)90136-8; Burnham KP, 2004, SOCIOL METHOD RES, V33, P261, DOI 10.1177/0049124104268644; Buysse DJ, 2008, SLEEP, V31, P473, DOI 10.1093/sleep/31.4.473; CARTWRIGHT RD, 1991, AM J PSYCHIAT, V148, P1530; Cluydts R, 1980, Waking Sleeping, V4, P199; COHEN DB, 1975, J ABNORM PSYCHOL, V84, P91, DOI 10.1037/h0076938; Cox R, 2012, LEARN MEMORY, V19, P264, DOI 10.1101/lm.026252.112; DEDIANA IPF, 1976, SLEEP RES, V5, P101; DEKONINCK JM, 1975, J ABNORM PSYCHOL, V84, P250, DOI 10.1037/h0076648; Deliens G., 2012, CORTEX, DOI 10.1016/j.cortex.2012.11.014; Dijk DJ, 2010, WORLD J BIOL PSYCHIA, V11, P22, DOI 10.3109/15622971003637645; Dinges DF, 1997, SLEEP, V20, P267; Ellenbogen JM, 2006, CURR BIOL, V16, P1290, DOI 10.1016/j.cub.2006.05.024; Franzen PL, 2009, BIOL PSYCHOL, V80, P300, DOI 10.1016/j.biopsycho.2008.10.010; Germain A, 2003, PSYCHOSOM MED, V65, P857, DOI 10.1097/01.PSY.0000079376.87711.B0; GREENBERG R, 1972, PSYCHOSOM MED, V34, P257, DOI 10.1097/00006842-197205000-00007; Groch S, 2013, NEUROBIOL LEARN MEM, V99, P1, DOI 10.1016/j.nlm.2012.10.006; Gujar N, 2011, J NEUROSCI, V31, P4466, DOI 10.1523/JNEUROSCI.3220-10.2011; Haack M, 2005, PAIN, V119, P56, DOI 10.1016/j.pain.2005.09.011; HODDES E, 1973, PSYCHOPHYSIOLOGY, V10, P431, DOI 10.1111/j.1469-8986.1973.tb00801.x; HOLM S, 1979, SCAND J STAT, V6, P65; Hu P, 2006, PSYCHOL SCI, V17, P891, DOI 10.1111/j.1467-9280.2006.01799.x; Huber R, 2004, NATURE, V430, P78, DOI 10.1038/nature02663; Keklund G, 1997, J SLEEP RES, V6, P217, DOI 10.1111/j.1365-2869.1997.00217.x; Kim Eui-Joong, 2007, Behav Sleep Med, V5, P256; Kothe M, 2001, DREAMING, V11, P43, DOI 10.1023/A:1009468517557; KOULACK D, 1985, SLEEP, V8, P244, DOI 10.1093/sleep/8.3.244; Lara-Carrasco J, 2009, J SLEEP RES, V18, P178, DOI 10.1111/j.1365-2869.2008.00709.x; LAUER C, 1987, PSYCHOPHYSIOLOGY, V24, P263, DOI 10.1111/j.1469-8986.1987.tb00293.x; Manber R, 2008, SLEEP, V31, P489, DOI 10.1093/sleep/31.4.489; Marshall L, 2006, NATURE, V444, P610, DOI 10.1038/nature05278; Marshall L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016905; Meerlo P, 2001, PHYSIOL BEHAV, V73, P331, DOI 10.1016/S0031-9384(01)00451-6; Meerlo P, 2001, BRAIN RES, V907, P84, DOI 10.1016/S0006-8993(01)02603-8; Meerlo P, 1997, NEUROSCI LETT, V225, P41, DOI 10.1016/S0304-3940(97)00180-8; Mellman TA, 2002, AM J PSYCHIAT, V159, P1696, DOI 10.1176/appi.ajp.159.10.1696; Molle M, 2004, P NATL ACAD SCI USA, V101, P13963, DOI 10.1073/pnas.0402820101; Nielsen T, 2007, NEW SCI DREAMING, P253; Pace-Schott EF, 2011, NEUROBIOL LEARN MEM, V95, P24, DOI 10.1016/j.nlm.2010.10.006; Payne JD, 2008, PSYCHOL SCI, V19, P781, DOI 10.1111/j.1467-9280.2008.02157.x; Peigneux P, 2004, NEURON, V44, P535, DOI 10.1016/j.neuron.2004.10.007; Peyrache A, 2009, NAT NEUROSCI, V12, P919, DOI 10.1038/nn.2337; Pigeon WR, 2008, SLEEP, V31, P481, DOI 10.1093/sleep/31.4.481; Pilcher JJ, 1996, SLEEP, V19, P318, DOI 10.1093/sleep/19.4.318; RECHTSCHAFFEN A, 1968, PUBLICATION NIH, V204; Rosales-Lagarde A, 2012, FRONT BEHAV NEUROSCI, V6, DOI 10.3389/fnbeh.2012.00025; Skaggs WE, 1996, SCIENCE, V271, P1870, DOI 10.1126/science.271.5257.1870; Spoormaker VI, 2008, SLEEP MED REV, V12, P169, DOI 10.1016/j.smrv.2007.08.008; Staner L, 2010, SLEEP MED REV, V14, P35, DOI 10.1016/j.smrv.2009.09.003; Sterpenich V, 2009, J NEUROSCI, V29, P5143, DOI 10.1523/JNEUROSCI.0561-09.2009; Stickgold R, 2001, SCIENCE, V294, P1052, DOI 10.1126/science.1063530; Talamini LM, 2008, LEARN MEMORY, V15, P233, DOI 10.1101/lm.771608; Tsuno N, 2005, J CLIN PSYCHIAT, V66, P1254, DOI 10.4088/JCP.v66n1008; Van der Ark L.A., 2003, HANDLEIDING VERANTWO; van der Helm E, 2011, CURR BIOL, V21, P2029, DOI 10.1016/j.cub.2011.10.052; Visser P, 1979, SLEEP RES, P135; Wagner U, 2001, LEARN MEMORY, V8, P112, DOI 10.1101/lm.36801; Wagner U, 2004, NATURE, V427, P352, DOI 10.1038/nature02223; Wagner U, 2006, BIOL PSYCHIAT, V60, P788, DOI 10.1016/j.biopsych.2006.03.061; Walker MP, 2009, PSYCHOL BULL, V135, P731, DOI 10.1037/a0016570; Yoo SS, 2007, CURR BIOL, V17, pR877, DOI 10.1016/j.cub.2007.08.007; Zohar D, 2005, SLEEP, V28, P47, DOI 10.1093/sleep/28.1.47; [No title captured]	67	46	46	2	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2013	8	5							e62480	10.1371/journal.pone.0062480	http://dx.doi.org/10.1371/journal.pone.0062480			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	147KY	23671601	Green Published, gold, Green Submitted			2022-12-27	WOS:000319167000049
J	Kazak, L; Reyes, A; He, JY; Wood, SR; Brea-Calvo, G; Holen, TT; Holt, IJ				Kazak, Lawrence; Reyes, Aurelio; He, Jiuya; Wood, Stuart R.; Brea-Calvo, Gloria; Holen, Torgeir T.; Holt, Ian J.			A Cryptic Targeting Signal Creates a Mitochondrial FEN1 Isoform with Tailed R-Loop Binding Properties	PLOS ONE			English	Article							FLAP ENDONUCLEASE-1; CELL MITOCHONDRIA; GENOME STABILITY; SORTING SIGNALS; DNA-REPLICATION; LAGGING-STRAND; RNA-POLYMERASE; DAMAGE REPAIR; PROTEINS; TRANSCRIPTION	A growing number of DNA transacting proteins is found in the nucleus and in mitochondria, including the DNA repair and replication protein Flap endonuclease 1, FEN1. Here we show a truncated FEN1 isoform is generated by alternative translation initiation, exposing a mitochondrial targeting signal. The shortened form of FEN1, which we term FENMIT, localizes to mitochondria, based on import into isolated organelles, immunocytochemistry and subcellular fractionation. In vitro FENMIT binds to flap structures containing a 59 RNA flap, and prefers such substrates to single-stranded RNA. FENMIT can also bind to R-loops, and to a lesser extent to D-loops. Exposing human cells to ethidium bromide results in the generation of RNA/DNA hybrids near the origin of mitochondrial DNA replication. FENMIT is recruited to the DNA under these conditions, and is released by RNase treatment. Moreover, high levels of recombinant FENMIT expression inhibit mtDNA replication, following ethidium bromide treatment. These findings suggest FENMIT interacts with RNA/DNA hybrids in mitochondrial DNA, such as those found at the origin of replication.	[Kazak, Lawrence; Reyes, Aurelio; He, Jiuya; Wood, Stuart R.; Brea-Calvo, Gloria] Wellcome Trust Res Labs, Mitochondrial Biol Unit, MRC, Cambridge, England; [Holen, Torgeir T.] Univ Oslo, Inst Basic Med Sci, Oslo, Norway; [Holt, Ian J.] Natl Inst Med Res, MRC, London NW7 1AA, England	Wellcome Trust Sanger Institute; University of Oslo; MRC National Institute for Medical Research	Holt, IJ (corresponding author), Natl Inst Med Res, MRC, Mill Hill, London NW7 1AA, England.	iholt@nimr.mrc.ac.uk	Brea-Calvo, Gloria/N-4728-2014	Brea-Calvo, Gloria/0000-0001-5536-6868; holt, ian/0000-0001-5468-0193	UK Medical Research Council; Cambridge University Commonwealth Trust Fellowship; Medical Research Council [MC_UP_1202/14, MC_U105663140] Funding Source: researchfish; MRC [MC_UP_1202/14, MC_U105663140] Funding Source: UKRI	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cambridge University Commonwealth Trust Fellowship; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The study was funded by the UK Medical Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Elizabeth Ing-Simmons for help with experiments using recombinant FEN1, and our colleagues and collaborators for their support and advice, in particular Drs Jaakko Pohjoismaki and Johannes Spelbrink. The TWINKLE and TFAM antibodies were kind gifts of Dr. Anu Suomalainen and Dr. Rudolph Wiesner, respectively. LK was the recipient of a Cambridge University Commonwealth Trust Fellowship.	Aguilera A, 2012, MOL CELL, V46, P115, DOI 10.1016/j.molcel.2012.04.009; ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; Bannai H, 2002, BIOINFORMATICS, V18, P298, DOI 10.1093/bioinformatics/18.2.298; Bazykin GA, 2011, NUCLEIC ACIDS RES, V39, P567, DOI 10.1093/nar/gkq806; BOGUSLAWSKI SJ, 1986, J IMMUNOL METHODS, V89, P123, DOI 10.1016/0022-1759(86)90040-2; BREEN GAM, 1980, J CELL BIOL, V86, P723, DOI 10.1083/jcb.86.3.723; CARRE D, 1978, BIOCHEMISTRY-US, V17, P3263, DOI 10.1021/bi00609a014; Chacinska A, 2009, CELL, V138, P628, DOI 10.1016/j.cell.2009.08.005; CHANG DD, 1985, P NATL ACAD SCI USA, V82, P351, DOI 10.1073/pnas.82.2.351; Claros MG, 1996, EUR J BIOCHEM, V241, P779, DOI 10.1111/j.1432-1033.1996.00779.x; CURRAN J, 1988, EMBO J, V7, P245, DOI 10.1002/j.1460-2075.1988.tb02806.x; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; Gloor JW, 2010, J BIOL CHEM, V285, P34922, DOI 10.1074/jbc.M110.165902; Guo ZG, 2008, MOL CELL BIOL, V28, P4310, DOI 10.1128/MCB.00200-08; He J, 2012, NUCLEIC ACIDS RES, V40, P6109, DOI 10.1093/nar/gks266; Holt IJ, 2009, TRENDS BIOCHEM SCI, V34, P358, DOI 10.1016/j.tibs.2009.03.007; Holt IJ, 2000, CELL, V100, P515, DOI 10.1016/S0092-8674(00)80688-1; Kaiser MW, 1999, J BIOL CHEM, V274, P21387, DOI 10.1074/jbc.274.30.21387; Kalifa L, 2009, DNA REPAIR, V8, P1242, DOI 10.1016/j.dnarep.2009.07.008; Kazak L, 2013, NUCLEIC ACIDS RES, V41, P2354, DOI 10.1093/nar/gks1347; Kazak L, 2012, NAT REV MOL CELL BIO, V13, P659, DOI 10.1038/nrm3439; KOZAK M, 1987, J MOL BIOL, V196, P947, DOI 10.1016/0022-2836(87)90418-9; Kozak M, 2002, GENE, V299, P1, DOI 10.1016/S0378-1119(02)01056-9; Lakshmipathy U, 1999, MOL CELL BIOL, V19, P3869; Larsen E, 2003, MOL CELL BIOL, V23, P5346, DOI 10.1128/MCB.23.15.5346-5353.2003; Liu P, 2008, MOL CELL BIOL, V28, P4975, DOI 10.1128/MCB.00457-08; Liu R, 2006, NUCLEIC ACIDS RES, V34, P1772, DOI 10.1093/nar/gkl106; Maniura-Weber K, 2004, NUCLEIC ACIDS RES, V32, P6015, DOI 10.1093/nar/gkh921; Moe SE, 2008, J NEUROSCI METH, V171, P233, DOI 10.1016/j.jneumeth.2008.03.012; Mootha VK, 2003, CELL, V115, P629, DOI 10.1016/S0092-8674(03)00926-7; Nakai K, 1999, TRENDS BIOCHEM SCI, V24, P34, DOI 10.1016/S0968-0004(98)01336-X; Pohjoismaki JLO, 2010, J MOL BIOL, V397, P1144, DOI 10.1016/j.jmb.2010.02.029; PRATS AC, 1989, J MOL BIOL, V205, P363, DOI 10.1016/0022-2836(89)90347-1; Reyes A, 2011, NUCLEIC ACIDS RES, V39, P5098, DOI 10.1093/nar/gkr052; Ropp PA, 1996, GENOMICS, V36, P449, DOI 10.1006/geno.1996.0490; Sharma NK, 2012, NUCLEIC ACIDS RES, V40, P712, DOI 10.1093/nar/gkr758; Shen BH, 2005, BIOESSAYS, V27, P717, DOI 10.1002/bies.20255; Small I, 2004, PROTEOMICS, V4, P1581, DOI 10.1002/pmic.200300776; Suzuki Y, 2010, MOL CELL BIOL, V30, P5123, DOI 10.1128/MCB.00619-10; Tann AW, 2011, J BIOL CHEM, V286, P31975, DOI 10.1074/jbc.M110.215715; Tiranti V, 1997, HUM MOL GENET, V6, P615, DOI 10.1093/hmg/6.4.615; Tsutakawa SE, 2011, CELL, V145, P198, DOI 10.1016/j.cell.2011.03.004; Vaseva AV, 2009, BBA-BIOENERGETICS, V1787, P414, DOI 10.1016/j.bbabio.2008.10.005; Wanrooij PH, 2010, P NATL ACAD SCI USA, V107, P16072, DOI 10.1073/pnas.1006026107; WARING MJ, 1964, BIOCHIM BIOPHYS ACTA, V87, P358, DOI 10.1016/0926-6550(64)90238-5; Yasukawa T, 2005, MOL CELL, V18, P651, DOI 10.1016/j.molcel.2005.05.002; Yasukawa T, 2006, EMBO J, V25, P5358, DOI 10.1038/sj.emboj.7601392; Zheng L, 2007, NAT MED, V13, P812, DOI 10.1038/nm1599; Zhou JQ, 2000, SCIENCE, V289, P771, DOI 10.1126/science.289.5480.771	49	30	31	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2013	8	5							e62340	10.1371/journal.pone.0062340	http://dx.doi.org/10.1371/journal.pone.0062340			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145RZ	23675412	Green Submitted, gold, Green Published			2022-12-27	WOS:000319036100003
J	Shen, BZ; Yu, Y; Chen, H; Cao, X; Lao, XZ; Fang, YL; Shi, Y; Chen, J; Zheng, H				Shen, Bingzheng; Yu, Yan; Chen, Hui; Cao, Xin; Lao, Xingzhen; Fang, Yongliang; Shi, Yun; Chen, Jiao; Zheng, Heng			Inhibitor Discovery of Full-Length New Delhi Metallo-beta-Lactamase-1 (NDM-1)	PLOS ONE			English	Article							METALLO-BETA-LACTAMASE; STANDARD NUMBERING SCHEME; ESCHERICHIA-COLI; EMERGENCE; DENSITY; IMP-1; RESISTANCE; MEROPENEM; MECHANISM; ENERGY	New Delhi metallo-beta-lactmase-1 (NDM-1) has recently attracted extensive attention for its biological activities to catalyze the hydrolysis of almost all of beta-lactam antibiotics. To study the catalytic property of NDM-1, the steady-kinetic parameters of NDM-1 toward several kinds of b-lactam antibiotics have been detected. It could effectively hydrolyze most beta-lactams (k(cat)/K-m ratios between 0.03 to 1.28 mu mol(-1).s(-1)), except aztreonam. We also found that thiophene-carboxylic acid derivatives could inhibit NDM-1 and have shown synergistic antibacterial activity in combination with meropenem. Flexible docking and quantum mechanics (QM) study revealed electrostatic interactions between the sulfur atom of thiophene-carboxylic acid derivatives and the zinc ion of NDM-1, along with hydrogen bond between inhibitor and His189 of NDM-1. The interaction models proposed here can be used in rational design of NDM-1 inhibitors.	[Shen, Bingzheng; Fang, Yongliang; Zheng, Heng] Chinese Acad Sci, State Key Lab Soil & Sustainable Agr, Inst Soil Sci, Nanjing, Jiangsu, Peoples R China; [Shen, Bingzheng; Chen, Hui; Lao, Xingzhen; Fang, Yongliang; Shi, Yun; Chen, Jiao; Zheng, Heng] China Pharmaceut Univ, Dept Pharmaceut Bioinformat, Nanjing, Jiangsu, Peoples R China; [Yu, Yan] Huazhong Univ Sci & Technol, Dept Gastroenterol & Hepatol, Tongji Hosp, Tongji Med Coll, Wuhan 430074, Hubei, Peoples R China; [Cao, Xin] Chinese Acad Sci, Shanghai Inst Organ Chem, State Key Lab Bioorgan & Nat Prod Chem, Shanghai 200032, Peoples R China; [Shen, Bingzheng] Wuhan Univ, Dept Pharm, Renmin Hosp, Wuhan 430072, Hubei, Peoples R China	Chinese Academy of Sciences; Institute of Soil Science, CAS; China Pharmaceutical University; Huazhong University of Science & Technology; Chinese Academy of Sciences; Shanghai Institute of Organic Chemistry, CAS; Wuhan University	Zheng, H (corresponding author), Chinese Acad Sci, State Key Lab Soil & Sustainable Agr, Inst Soil Sci, Nanjing, Jiangsu, Peoples R China.	zhengh18@hotmail.com	CHEN, JIAO/GZA-5784-2022; Cao, Xin/L-7110-2019; Shi, Yun/AAG-3890-2020; chen, JJ/HGB-6029-2022	Cao, Xin/0000-0003-1722-023X; Shi, Yun/0000-0003-3365-4679; 	State Key Laboratory of Soil and Sustainable Agriculture, Institute of Soil Science, Chinese Academy of Sciences [Y052010040]; Fundamental Research Funds for the Central Universities of China [JKZ2009007]	State Key Laboratory of Soil and Sustainable Agriculture, Institute of Soil Science, Chinese Academy of Sciences(Chinese Academy of Sciences); Fundamental Research Funds for the Central Universities of China(Fundamental Research Funds for the Central Universities)	This work was supported by the Open Project Program of State Key Laboratory of Soil and Sustainable Agriculture, Institute of Soil Science, Chinese Academy of Sciences (No. Y052010040) and the Fundamental Research Funds for the Central Universities of China (No. JKZ2009007). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMBLER RP, 1980, PHILOS T R SOC B, V289, P321, DOI 10.1098/rstb.1980.0049; [Anonymous], 2009, DISC STUD VERS 2 5 U; BECKE AD, 1988, J CHEM PHYS, V88, P2547, DOI 10.1063/1.454033; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; Clinical and Laboratory Standards Institute, 2010, M100S20 CLSI; Cornaglia G, 2011, LANCET INFECT DIS, V11, P381, DOI 10.1016/S1473-3099(11)70056-1; Galleni M, 2001, ANTIMICROB AGENTS CH, V45, P660, DOI 10.1128/AAC.45.3.660-663.2001; Garau G, 2004, ANTIMICROB AGENTS CH, V48, P2347, DOI 10.1128/AAC.48.7.2347-2349.2004; Guo Y, 2011, PROTEIN CELL, V2, P384, DOI 10.1007/s13238-011-1055-9; Hammond GG, 1999, FEMS MICROBIOL LETT, V179, P289, DOI 10.1111/j.1574-6968.1999.tb08740.x; Hao QR, 2013, J PEPT SCI, V19, P173, DOI 10.1002/psc.2488; HOHENBERG P, 1964, PHYS REV B, V136, pB864, DOI 10.1103/PhysRevB.7.1912; Jamal W, 2012, INT J ANTIMICROB AG, V39, P183, DOI 10.1016/j.ijantimicag.2011.10.002; Kim Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024621; Koska J, 2008, J CHEM INF MODEL, V48, P1965, DOI 10.1021/ci800081s; Kumarasamy KK, 2010, LANCET INFECT DIS, V10, P597, DOI 10.1016/S1473-3099(10)70143-2; Laraki N, 1999, ANTIMICROB AGENTS CH, V43, P902, DOI 10.1128/AAC.43.4.902; LEE CT, 1988, PHYS REV B, V37, P785, DOI 10.1103/PhysRevB.37.785; LEVY M, 1979, P NATL ACAD SCI USA, V76, P6062, DOI 10.1073/pnas.76.12.6062; Menikarachchi LC, 2010, CURR TOP MED CHEM, V10, P46, DOI 10.2174/156802610790232297; Moellering RC, 2010, NEW ENGL J MED, V363, P2377, DOI 10.1056/NEJMp1011715; Moloughney JG, 2005, FEMS MICROBIOL LETT, V243, P65, DOI 10.1016/j.femsle.2004.11.042; Poirel L, 2010, ANTIMICROB AGENTS CH, V54, P4914, DOI 10.1128/AAC.00878-10; Riley KE, 2007, J CHEM THEORY COMPUT, V3, P407, DOI 10.1021/ct600185a; Rolain JM, 2010, CLIN MICROBIOL INFEC, V16, P1699, DOI 10.1111/j.1469-0691.2010.03385.x; Shen B, 2012, Faming Zhuanli Shenqing, Patent No. [CN102304108A, 102304108]; Sherwood P, 2003, J MOL STRUC-THEOCHEM, V632, P1, DOI 10.1016/S0166-1280(03)00285-9; Teague SJ, 2003, NAT REV DRUG DISCOV, V2, P527, DOI 10.1038/nrd1129; Thomas PA, 2011, CURR CLIN PATHOL, P1, DOI 10.1007/978-1-60327-154-7_1; Ververs TFT, 2000, CRIT CARE MED, V28, P3412, DOI 10.1097/00003246-200010000-00006; Wachino J, 2011, ANTIMICROB AGENTS CH, V55, P5143, DOI 10.1128/AAC.05045-11; Williamson DA, 2012, INT J ANTIMICROB AG, V39, P529, DOI 10.1016/j.ijantimicag.2012.02.017; Yang H, 2012, BIOCHEMISTRY-US, V51, P3839, DOI 10.1021/bi300056y; Yong D, 2009, ANTIMICROB AGENTS CH, V53, P5046, DOI 10.1128/AAC.00774-09; Zhang HM, 2011, FASEB J, V25, P2574, DOI 10.1096/fj.11-184036	35	32	38	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2013	8	5							e62955	10.1371/journal.pone.0062955	http://dx.doi.org/10.1371/journal.pone.0062955			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145RZ	23675445	Green Published, gold, Green Submitted			2022-12-27	WOS:000319036100026
J	Riddle, RC; Diegel, CR; Leslie, JM; Van Koevering, KK; Faugere, MC; Clemens, TL; Williams, BO				Riddle, Ryan C.; Diegel, Cassandra R.; Leslie, Julie M.; Van Koevering, Kyle K.; Faugere, Marie-Claude; Clemens, Thomas L.; Williams, Bart O.			Lrp5 and Lrp6 Exert Overlapping Functions in Osteoblasts during Postnatal Bone Acquisition	PLOS ONE			English	Article							RECEPTOR-RELATED PROTEIN-5; BETA-CATENIN; DENSITY; MUTATION; GENE; MICE; MASS; MOUSE; CLONING; MEMBER	The canonical Wnt signaling pathway is critical for skeletal development and maintenance, but the precise roles of the individual Wnt co-receptors, Lrp5 and Lrp6, that enable Wnt signals to be transmitted in osteoblasts remain controversial. In these studies, we used Cre-loxP recombination, in which Cre-expression is driven by the human osteocalcin promoter, to determine the individual contributions of Lrp5 and Lrp6 in postnatal bone acquisition and osteoblast function. Mice selectively lacking either Lrp5 or Lrp6 in mature osteoblasts were born at the expected Mendelian frequency but demonstrated significant reductions in whole-body bone mineral density. Bone architecture measured by microCT revealed that Lrp6 mutant mice failed to accumulate normal amounts of trabecular bone. By contrast, Lrp5 mutants had normal trabecular bone volume at 8 weeks of age, but with age, these mice also exhibited trabecular bone loss. Both mutants also exhibited significant alterations in cortical bone structure. In vitro differentiation was impaired in both Lrp5 and Lrp6 null osteoblasts as indexed by alkaline phosphatase and Alizarin red staining, but the defect was more pronounced in Lrp6 mutant cells. Mice lacking both Wnt co-receptors developed severe osteopenia similar to that observed previously in mice lacking beta-catenin in osteoblasts. Likewise, calvarial cells doubly deficient for Lrp5 and Lrp6 failed to form osteoblasts when cultured in osteogenic media, but instead attained a chondrocyte-like phenotype. These results indicate that expression of both Lrp5 and Lrp6 are required within mature osteoblasts for normal postnatal bone development.	[Riddle, Ryan C.; Leslie, Julie M.; Clemens, Thomas L.] Johns Hopkins Univ, Sch Med, Dept Orthopaed Surg, Baltimore, MD 21218 USA; [Riddle, Ryan C.; Clemens, Thomas L.] Vet Adm Med Ctr, Baltimore, MD 21218 USA; [Diegel, Cassandra R.; Van Koevering, Kyle K.; Williams, Bart O.] Van Andel Res Inst, Ctr Skeletal Dis & Tumor Metastasis, Grand Rapids, MI USA; [Diegel, Cassandra R.; Van Koevering, Kyle K.; Williams, Bart O.] Van Andel Res Inst, Lab Cell Signaling & Carcinogenesis, Grand Rapids, MI USA; [Faugere, Marie-Claude] Univ Kentucky, Dept Med, Lexington, KY 40506 USA	Johns Hopkins University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Van Andel Institute; Van Andel Institute; University of Kentucky	Riddle, RC (corresponding author), Johns Hopkins Univ, Sch Med, Dept Orthopaed Surg, Baltimore, MD 21218 USA.	rriddle1@jhmi.org; bart.williams@vai.org	Williams, Bart/A-3539-2013	Williams, Bart/0000-0002-5261-5301; Diegel, Cassandra/0000-0002-6526-9372	National Institutes of Health [AR053293, AR04910]; Van Andel Research Institute; Veterans Administration; Genentech; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR053293] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK079637] Funding Source: NIH RePORTER; Veterans Affairs [IK2BX001284] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Van Andel Research Institute; Veterans Administration(US Department of Veterans Affairs); Genentech(Roche HoldingGenentech); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported by grants from the National Institutes of Health (B.O.W. AR053293, T.L.C AR04910) and Van Andel Research Institute. R. C. R is the recipient of a Career Development Award from the Veterans Administration. T. L. C. is the recipient of a Research Career Scientist Award from the Veterans Administration.; While there are no direct competing interests associated with this study, BOW did receive support for other indirectly related studies from Genentech. Bart O. Williams is a PLOS ONE Editorial Board member. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Babij P, 2003, J BONE MINER RES, V18, P960, DOI 10.1359/jbmr.2003.18.6.960; Bouxsein ML, 2010, J BONE MINER RES, V25, P1468, DOI 10.1002/jbmr.141; Boyden LM, 2002, NEW ENGL J MED, V346, P1513, DOI 10.1056/NEJMoa013444; Brault V, 2001, DEVELOPMENT, V128, P1253; Brown SD, 1998, BIOCHEM BIOPH RES CO, V248, P879, DOI 10.1006/bbrc.1998.9061; Chen D, 1999, GENOMICS, V55, P314, DOI 10.1006/geno.1998.5688; Cui YJ, 2011, NAT MED, V17, P684, DOI 10.1038/nm.2388; Figueroa DJ, 2000, J HISTOCHEM CYTOCHEM, V48, P1357, DOI 10.1177/002215540004801006; Frost M, 2010, J BONE MINER RES, V25, P673, DOI 10.1002/jbmr.44; Fujino T, 2003, P NATL ACAD SCI USA, V100, P229, DOI 10.1073/pnas.0133792100; Glass DA, 2005, DEV CELL, V8, P751, DOI 10.1016/j.devcel.2005.02.017; Gong YQ, 2001, CELL, V107, P513, DOI 10.1016/S0092-8674(01)00571-2; He X, 2004, DEVELOPMENT, V131, P1663, DOI 10.1242/dev.01117; Hey PJ, 1998, GENE, V216, P103, DOI 10.1016/S0378-1119(98)00311-4; Hill TP, 2005, DEV CELL, V8, P727, DOI 10.1016/j.devcel.2005.02.013; Holmen SL, 2004, J BONE MINER RES, V19, P2033, DOI 10.1359/JBMR.040907; Holmen SL, 2005, J BIOL CHEM, V280, P21162, DOI 10.1074/jbc.M501900200; Holmen SL, 2002, J BIOL CHEM, V277, P34727, DOI 10.1074/jbc.M204989200; Joeng KS, 2011, DEV BIOL, V359, P222, DOI 10.1016/j.ydbio.2011.08.020; Kato M, 2002, J CELL BIOL, V157, P303, DOI 10.1083/jcb.200201089; Kelly OG, 2004, DEVELOPMENT, V131, P2803, DOI 10.1242/dev.01137; Kim DH, 1998, J BIOCHEM-TOKYO, V124, P1072, DOI 10.1093/oxfordjournals.jbchem.a022223; Kokubu C, 2004, DEVELOPMENT, V131, P5469, DOI 10.1242/dev.01405; Kubota T, 2008, J BONE MINER RES, V23, P1661, DOI 10.1359/JBMR.080512; Little RD, 2002, AM J HUM GENET, V70, P11, DOI 10.1086/338450; Mani A, 2007, SCIENCE, V315, P1278, DOI 10.1126/science.1136370; Moon RT, 2004, NAT REV GENET, V5, P689, DOI 10.1038/nrg1427; PARFITT AM, 1987, J BONE MINER RES, V2, P595, DOI 10.1002/jbmr.5650020617; Pinson KI, 2000, NATURE, V407, P535, DOI 10.1038/35035124; Robinson JA, 2006, J BIOL CHEM, V281, P31720, DOI 10.1074/jbc.M602308200; Sawakami K, 2006, J BIOL CHEM, V281, P23698, DOI 10.1074/jbc.M601000200; Tamai K, 2000, NATURE, V407, P530, DOI 10.1038/35035117; Wan M, 2008, GENE DEV, V22, P2968, DOI 10.1101/gad.1702708; Yadav VK, 2010, CALCIFIED TISSUE INT, V86, P382, DOI 10.1007/s00223-010-9350-7; Yadav VK, 2008, CELL, V135, P825, DOI 10.1016/j.cell.2008.09.059; Zhang M, 2002, J BIOL CHEM, V277, P44005, DOI 10.1074/jbc.M208265200; Zhong ZD, 2012, J CELL BIOCHEM, V113, P31, DOI 10.1002/jcb.23324	37	80	89	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2013	8	5							e63323	10.1371/journal.pone.0063323	http://dx.doi.org/10.1371/journal.pone.0063323			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	143FO	23675479	Green Submitted, Green Published, gold			2022-12-27	WOS:000318852400037
J	Sweeting, B; Brown, E; Khan, MQ; Chakrabartty, A; Pai, EF				Sweeting, Braden; Brown, Eric; Khan, M. Qasim; Chakrabartty, Avijit; Pai, Emil F.			N-Terminal Helix-Cap in alpha-Helix 2 Modulates beta-State Misfolding in Rabbit and Hamster Prion Proteins	PLOS ONE			English	Article							NMR STRUCTURE; SCRAPIE; PRP; STABILITY; RESIDUES; SUSCEPTIBILITY; CONFORMATION; RESISTANCE; CONVERSION; INFECTION	Susceptibility of a particular species to prion disease is affected by small differences in the sequence of PrP and correlates with the propensity of its PrP to assume the beta-state. A helix-cap motif in the beta 2-alpha 2-loop of native a-helical rabbit PrP, a resistant species, contains sequence differences that influence intra-and interspecies transmission. To determine the effect the helix-cap motif on beta-state refolding propensity, we mutated S170N, S174N, and S170N/ S174N of the rabbit PrP helix-cap to resemble that of hamster PrP and conversely, N170S, N174S, and N170S/ N174S of hamster PrP to resemble the helix-cap of rabbit PrP. High-resolution crystal structures (1.45-1.6 angstrom) revealed that these mutations ablate hydrogen-bonding interactions within the helix-cap motif in rabbit PrPC. They also alter the beta-state-misfolding propensity of PrP; the serine mutations in hamster PrP decrease the propensity up to 35%, whereas the asparagine mutations in rabbit PrP increase it up to 42%. Rapid dilution of rabbit and hamster into beta-state buffer conditions causes quick conversion to beta-state monomers. Kinetic monitoring using size-exclusion chromatography showed that the monomer population decreases exponentially mirrored by an increase in an octameric species. The monomer-octamer transition rates are faster for hamster than for rabbit PrP. The N170S/N174S mutant of hamster PrP has a smaller octamer component at the endpoint compared to the wild-type, whereas the kinetics of octamer formation in mutant and wild-type rabbit PrP are comparable. These findings demonstrate that the sequence of the beta 2-alpha 2 helix-cap affects refolding to the beta-state and subsequently, may influence susceptibility to prion disease.	[Sweeting, Braden; Brown, Eric; Chakrabartty, Avijit; Pai, Emil F.] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada; [Sweeting, Braden; Khan, M. Qasim; Chakrabartty, Avijit; Pai, Emil F.] Ontario Canc Inst, Campbell Family Canc Res Inst, Toronto, ON M4X 1K9, Canada; [Khan, M. Qasim; Chakrabartty, Avijit; Pai, Emil F.] Univ Toronto, Dept Biochem, Toronto, ON, Canada; [Pai, Emil F.] Univ Toronto, Dept Mol Genet, Toronto, ON, Canada	University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University of Toronto	Pai, EF (corresponding author), Univ Toronto, Dept Med Biophys, Toronto, ON, Canada.	pai@hera.med.utoronto.ca	Pai, Emil/R-8908-2019	Pai, Emil/0000-0002-1162-7242; Chakrabartty, Avi/0000-0001-7002-8381	PrioNet Canada; CIHR; Canada Research Chairs program; Ontario Ministry of Health and Long Term Care; Natural Sciences and Engineering Research Council of Canada; National Research Council Canada; Canadian Institutes of Health Research; Province of Saskatchewan; Western Economic Diversification Canada; University of Saskatchewan	PrioNet Canada; CIHR(Canadian Institutes of Health Research (CIHR)); Canada Research Chairs program(Canada Research Chairs); Ontario Ministry of Health and Long Term Care(Ministry of Health and Long-Term Care, Ontario); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); National Research Council Canada; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Province of Saskatchewan; Western Economic Diversification Canada; University of Saskatchewan	This research was supported by grants from PrioNet Canada (A. C. and E. F. P.), the CIHR Strategic Training Program in Protein Folding and Interaction Dynamics (M. Q. K. and B. S.), and the Canada Research Chairs program (E. F. P.). This study was supported in part by the Ontario Ministry of Health and Long Term Care. The views expressed do not necessarily reflect those of the OMOHLTC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We gratefully acknowledge the help we received from the staff of the Canadian Macromolecular Crystallography Facility. Parts of the research described in this paper was performed at the Canadian Light Source, which is supported by the Natural Sciences and Engineering Research Council of Canada, the National Research Council Canada, the Canadian Institutes of Health Research, the Province of Saskatchewan, Western Economic Diversification Canada, and the University of Saskatchewan.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Aguzzi A, 2004, CELL, V116, P313, DOI 10.1016/S0092-8674(03)01031-6; Baskakov IV, 2002, J BIOL CHEM, V277, P21140, DOI 10.1074/jbc.M111402200; Baskakov IV, 2001, J BIOL CHEM, V276, P19687, DOI 10.1074/jbc.C100180200; BESSEN RA, 1994, J VIROL, V68, P7859, DOI 10.1128/JVI.68.12.7859-7868.1994; Chianini F, 2012, P NATL ACAD SCI USA, V109, P5080, DOI 10.1073/pnas.1120076109; Christen B, 2008, J MOL BIOL, V383, P306, DOI 10.1016/j.jmb.2008.08.045; Donne DG, 1997, P NATL ACAD SCI USA, V94, P13452, DOI 10.1073/pnas.94.25.13452; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Garcia FL, 2000, P NATL ACAD SCI USA, V97, P8334, DOI 10.1073/pnas.97.15.8334; GIBBS CJ, 1973, SCIENCE, V182, P67, DOI 10.1126/science.182.4107.67; Gossert AD, 2005, P NATL ACAD SCI USA, V102, P646, DOI 10.1073/pnas.0409008102; Hornemann S, 1998, P NATL ACAD SCI USA, V95, P6010, DOI 10.1073/pnas.95.11.6010; Jackson GS, 1999, SCIENCE, V283, P1935, DOI 10.1126/science.283.5409.1935; Julien O, 2009, PROTEIN SCI, V18, P2172, DOI 10.1002/pro.231; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kaneko K, 1997, P NATL ACAD SCI USA, V94, P10069, DOI 10.1073/pnas.94.19.10069; Khan MQ, 2010, P NATL ACAD SCI USA, V107, P19808, DOI 10.1073/pnas.1005267107; KIMBERLIN RH, 1977, J GEN VIROL, V34, P295, DOI 10.1099/0022-1317-34-2-295; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Legname G, 2004, SCIENCE, V305, P673, DOI 10.1126/science.1100195; Loftus B, 1997, GENE, V184, P215, DOI 10.1016/S0378-1119(96)00598-7; Lysek DA, 2005, P NATL ACAD SCI USA, V102, P640, DOI 10.1073/pnas.0408937102; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Moore Jo, 2011, BMC Res Notes, V4, P501, DOI 10.1186/1756-0500-4-501; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Nisbet RM, 2010, J VIROL, V84, P6678, DOI 10.1128/JVI.02709-09; Nonno R, 2006, PLOS PATHOG, V2, P112, DOI 10.1371/journal.ppat.0020012; Novitskaya V, 2006, J BIOL CHEM, V281, P13828, DOI 10.1074/jbc.M511174200; Piening N, 2006, J BIOL CHEM, V281, P9373, DOI 10.1074/jbc.M512239200; PRESTA LG, 1988, SCIENCE, V240, P1632, DOI 10.1126/science.2837824; PRIOLA SA, 1994, J VIROL, V68, P4873, DOI 10.1128/JVI.68.8.4873-4878.1994; PRUSINER SB, 1990, CELL, V63, P673, DOI 10.1016/0092-8674(90)90134-Z; Raymond GJ, 2012, J VIROLOGY; Riek R, 1997, FEBS LETT, V413, P282, DOI 10.1016/S0014-5793(97)00920-4; Riek R, 1996, NATURE, V382, P180, DOI 10.1038/382180a0; Sandberg MK, 2011, NATURE, V470, P540, DOI 10.1038/nature09768; Sigurdson CJ, 2009, P NATL ACAD SCI USA, V106, P304, DOI 10.1073/pnas.0810680105; Swietnicki W, 1997, J BIOL CHEM, V272, P27517, DOI 10.1074/jbc.272.44.27517; Vorberg I, 2003, J VIROL, V77, P2003, DOI 10.1128/JVI.77.3.2003-2009.2003; Wang F, 2010, SCIENCE, V327, P1132, DOI 10.1126/science.1183748; Wen Y, 2010, J BIOL CHEM, V285, P31682, DOI 10.1074/jbc.M110.118844; Zahn R, 2000, P NATL ACAD SCI USA, V97, P145, DOI 10.1073/pnas.97.1.145; Zahn R, 1997, FEBS LETT, V417, P400, DOI 10.1016/S0014-5793(97)01330-6; Zhang JP, 2011, J THEOR BIOL, V269, P88, DOI 10.1016/j.jtbi.2010.10.020; Zhang JP, 2010, J THEOR BIOL, V264, P119, DOI 10.1016/j.jtbi.2010.01.024	46	14	14	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2013	8	5							e63047	10.1371/journal.pone.0063047	http://dx.doi.org/10.1371/journal.pone.0063047			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	143FO	23675452	Green Published, Green Submitted, gold			2022-12-27	WOS:000318852400021
J	Dai, XF; Lu, DD; Guan, WB; Xia, P; Wang, HX; He, PX; Zhang, DS				Dai, Xinfeng; Lu, Douding; Guan, Weibing; Xia, Ping; Wang, Hongxia; He, Piaoxia; Zhang, Dongsheng			The Correlation between Prorocentrum donghaiense Blooms and the Taiwan Warm Current in the East China Sea - Evidence for the "Pelagic Seed Bank'' Hypothesis	PLOS ONE			English	Article							COCHLODINIUM-POLYKRIKOIDES; NITRATE; WATERS; LU	During the last two decades, large-scale high biomass algal blooms of the dinoflagellate Prorocentrum donghaiense Lu have occurred frequently in the East China Sea (ECS). The role of increasing nutrient concentrations in driving those blooms is well-established, but the source population that initiates them is poorly understood. We hypothesized that the front of Taiwan Warm Current (TWC) may serve as a 'seed bank' that initiates P. donghaiense blooms in the ECS, as the physiochemical conditions in the TWC are suitable for the growth of P. donghaiense. In order to test this hypothesis, two surveys at different spatio-temporal scales were conducted in 2010 and 2011. We found a strong correlation in space and time between the abundance of P. donghaiense and the TWC. The spatial extent of the P. donghaiense bloom coincided with the TWC front in both 2010 and 2011. During the early development of the blooms, P. donghaiense concentration was highest at the TWC front, and then the bloom mass shifted inshore over the course of our 2011 survey. The TWC also moved inshore, albeit after the appearance of P. donghaiense. Overall, these results support our hypothesis that P. donghaiense blooms develop from the population at the TWC front in the ECS, suggesting the role of the ocean current front as a seed bank to dinoflagellate blooms.	[Dai, Xinfeng; Lu, Douding; Guan, Weibing; Xia, Ping; Wang, Hongxia; He, Piaoxia; Zhang, Dongsheng] SOA, Inst Oceanog 2, State Key Lab Satellite Ocean Environm Dynam, Hangzhou, Zhejiang, Peoples R China	State Oceanic Administration	Lu, DD (corresponding author), SOA, Inst Oceanog 2, Hangzhou, Zhejiang, Peoples R China.	ludd21@126.com			CEOHAB-II National 973 Program [2010CB428702, 2010CB428704]; National Science Foundation [41176141]; scientific research fund of the Second Institute of Oceanography, SOA [SZ1040]; Foundation of Key Laboratory of Integrated Marine Monitoring and Applied Technologies for Harmful Algal Blooms, SOA [MATHAB20100310]; Zhejiang Provincial Natural Science Foundation [Y5110185]	CEOHAB-II National 973 Program(National Basic Research Program of China); National Science Foundation(National Science Foundation (NSF)); scientific research fund of the Second Institute of Oceanography, SOA; Foundation of Key Laboratory of Integrated Marine Monitoring and Applied Technologies for Harmful Algal Blooms, SOA; Zhejiang Provincial Natural Science Foundation(Natural Science Foundation of Zhejiang Province)	This study was supported by CEOHAB-II National 973 Program (2010CB428702; 2010CB428704), National Science Foundation (41176141), Grant from the scientific research fund of the Second Institute of Oceanography, SOA (SZ1040), Foundation of Key Laboratory of Integrated Marine Monitoring and Applied Technologies for Harmful Algal Blooms, SOA (MATHAB20100310) and Zhejiang Provincial Natural Science Foundation (Y5110185). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], [No title captured]; CHEN CTA, 1995, CONT SHELF RES, V15, P19, DOI 10.1016/0278-4343(93)E0001-O; Chen D.X., 1992, MARINE ATLAS BOHAI S, P13; Gentien P, 2008, GLOBAL ECOLOGY OCEAN; Jiao NZ, 2002, AQUAT MICROB ECOL, V30, P37; [经志友 JING Zhiyou], 2007, [河海大学学报. 自然科学版, Journal of Hohai University. Natural Sciences], V35, P464; Joyce LB, 2005, HARMFUL ALGAE, V4, P309, DOI 10.1016/j.hal.2004.08.001; Kremp A, 2001, MAR ECOL PROG SER, V216, P57, DOI 10.3354/meps216057; Lasker R., 1978, NATO Conference Series IV Marine Sciences, V3, P329; Lee DK, 2008, HARMFUL ALGAE, V7, P318, DOI 10.1016/j.hal.2007.12.014; Li J, 2010, HARMFUL ALGAE, V9, P531, DOI 10.1016/j.hal.2010.03.007; Li Y, 2011, HARMFUL ALGAE, V10, P426, DOI 10.1016/j.hal.2010.08.002; Lu D, 2008, P 12 INT C HARMF AL, P132; Lu D, 2001, DONGHAI MARINE SCI, V19, P11; Lu DD, 2005, HARMFUL ALGAE, V4, P493, DOI 10.1016/j.hal.2004.08.015; Luo Y. Y., 1998, T OCEANOLOGY LIMNOLO, V3, P1; Luo Y.Y., 1998, J OCEAN U, V28, P536, DOI [10.1088/0256-307X/15/3/016, DOI 10.1088/0256-307X/15/3/016]; Naimie CE, 2001, CONT SHELF RES, V21, P667; PACKARD TT, 1978, J MAR RES, V36, P59; Park GH, 2005, LIMNOL OCEANOGR, V50, P578, DOI 10.4319/lo.2005.50.2.0578; Qiao FL, 2006, J GEOPHYS RES-OCEANS, V111, DOI 10.1029/2005JC003264; Smayda Theodore J., 2002, Harmful Algae, V1, P95, DOI 10.1016/S1568-9883(02)00010-0; Wang H., 2011, J MARINE SCI, V29, P42; Wong GTF, 1998, ESTUAR COAST SHELF S, V46, P411, DOI 10.1006/ecss.1997.0287; Xia Wenjuan, 2011, Journal of Ocean University of China, V10, P135, DOI 10.1007/s11802-011-1732-6; Xu N, 2010, HARMFUL ALGAE, V9, P13, DOI 10.1016/j.hal.2009.06.002; Zhou MJ, 2008, CONT SHELF RES, V28, P1483, DOI 10.1016/j.csr.2007.02.009; Zhou Mingjiang, 2003, Yingyong Shengtai Xuebao, V14, P1031; Zhu D, 2008, ACTA OCEANOL SIN, V31, P31; Zhu MY, 2009, ACTA OCEANOL SIN, V28, P72	30	24	32	2	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2013	8	5							e64188	10.1371/journal.pone.0064188	http://dx.doi.org/10.1371/journal.pone.0064188			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	155HD	23671709	gold, Green Published, Green Submitted			2022-12-27	WOS:000319737700067
J	Smidt, M; Battig, P; Verhaegh, SJC; Niebisch, A; Hanner, M; Selak, S; Schuler, W; Morfeldt, E; Hellberg, C; Nagy, E; Lundberg, U; Hays, JP; Meinke, A; Henriques-Normark, B				Smidt, Margarita; Battig, Patrick; Verhaegh, Suzanne J. C.; Niebisch, Axel; Hanner, Markus; Selak, Sanja; Schueler, Wolfgang; Morfeldt, Eva; Hellberg, Christel; Nagy, Eszter; Lundberg, Urban; Hays, John P.; Meinke, Andreas; Henriques-Normark, Birgitta			Comprehensive Antigen Screening Identifies Moraxella catarrhalis Proteins That Induce Protection in a Mouse Pulmonary Clearance Model	PLOS ONE			English	Article							OUTER-MEMBRANE PROTEIN; BRANHAMELLA-CATARRHALIS; CYTOCHROME-C; VACCINE DEVELOPMENT; IMMUNE-RESPONSE; M. CATARRHALIS; USPA2 PROTEIN; BINDING; RECEPTOR; IMMUNIZATION	Moraxella catarrhalis is one of the three most common causative bacterial pathogens of otitis media, however no effective vaccine against M. catarrhalis has been developed so far. To identify M. catarrhalis vaccine candidate antigens, we used carefully selected sera from children with otitis media and healthy individuals to screen small-fragment genomic libraries that are expressed to display frame-selected peptides on a bacterial cell surface. This ANTIGENome technology led to the identification of 214 antigens, 23 of which were selected by in vitro or in vivo studies for additional characterization. Eight of the 23 candidates were tested in a Moraxella mouse pulmonary clearance model, and 3 of these antigens induced significantly faster bacterial clearance compared to adjuvant or to the previously characterized antigen OmpCD. The most significant protection data were obtained with the antigen MCR_1416 (Msp22), which was further investigated for its biological function by in vitro studies suggesting that Msp22 is a heme binding protein. This study comprises one of the most exhaustive studies to identify potential vaccine candidate antigens against the bacterial pathogen M. catarrhalis.	[Smidt, Margarita; Niebisch, Axel; Hanner, Markus; Selak, Sanja; Schueler, Wolfgang; Nagy, Eszter; Lundberg, Urban; Meinke, Andreas] Intercell AG, Vienna, Austria; [Battig, Patrick; Morfeldt, Eva; Hellberg, Christel; Henriques-Normark, Birgitta] Karolinska Inst, Dept Microbiol Tumor & Cell Biol, Stockholm, Sweden; [Verhaegh, Suzanne J. C.; Hays, John P.] Erasmus MC, Dept Med Microbiol & Infect Dis, Rotterdam, Netherlands	Intercell; Karolinska Institutet; Erasmus University Rotterdam; Erasmus MC	Meinke, A (corresponding author), Intercell AG, Campus Vienna Bioctr 3, Vienna, Austria.	ameinke@intercell.com	Hays, J/I-9007-2017	Hays, J/0000-0001-9183-4497	EU-project OMVac [LSHB-CT-2006-037653]; DG research within the 6th Framework Programme	EU-project OMVac; DG research within the 6th Framework Programme	This work was supported by the EU-project OMVac (LSHB-CT-2006-037653) granted by DG research within the 6th Framework Programme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aebi C, 1998, INFECT IMMUN, V66, P540, DOI 10.1128/IAI.66.2.540-548.1998; Aebi C, 1996, INFECT IMMUN, V64, P2024, DOI 10.1128/IAI.64.6.2024-2030.1996; Aebi C, 1998, INFECT IMMUN, V66, P3113, DOI 10.1128/IAI.66.7.3113-3119.1998; Afonina G, 2006, INFECT IMMUN, V74, P2224, DOI 10.1128/IAI.74.4.2224-2232.2006; Attia AS, 2005, INFECT IMMUN, V73, P2400, DOI 10.1128/IAI.73.4.2400-2410.2005; Balder R, 2009, INFECT IMMUN, V77, P4597, DOI 10.1128/IAI.00212-09; Becker PD, 2007, INFECT IMMUN, V75, P1778, DOI 10.1128/IAI.01081-06; Bijlsma JJE, 2007, APPL ENVIRON MICROB, V73, P1514, DOI 10.1128/AEM.01900-06; Bingham-Ramos LK, 2008, INFECT IMMUN, V76, P1105, DOI 10.1128/IAI.01430-07; Bonnah RA, 1999, INFECT IMMUN, V67, P1517, DOI 10.1128/IAI.67.3.1517-1520.1999; Caroppi P, 2009, CURR MED CHEM, V16, P4058, DOI 10.2174/092986709789378206; CATLIN BW, 1990, CLIN MICROBIOL REV, V3, P293, DOI 10.1128/CMR.3.4.293-320.1990; Chauhan D, 1997, J BIOL CHEM, V272, P29995, DOI 10.1074/jbc.272.48.29995; Chen DX, 1996, INFECT IMMUN, V64, P1900, DOI 10.1128/IAI.64.6.1900-1905.1996; Chen DX, 1999, INFECT IMMUN, V67, P1310, DOI 10.1128/IAI.67.3.1310-1316.1999; CHRISTENSEN JJ, 1994, FEMS MICROBIOL LETT, V119, P155; Cripps AW, 2006, EXPERT REV VACCINES, V5, P517, DOI 10.1586/14760584.5.4.517; Enright MC, 1997, J MED MICROBIOL, V46, P360, DOI 10.1099/00222615-46-5-360; Etz H, 2001, J BACTERIOL, V183, P6924, DOI 10.1128/JB.183.23.6924-6935.2001; FADEN H, 1992, INFECT IMMUN, V60, P3824, DOI 10.1128/IAI.60.9.3824-3829.1992; Feissner R, 2003, ANAL BIOCHEM, V315, P90, DOI 10.1016/S0003-2697(02)00658-9; Ferguson AD, 2004, CELL, V116, P15, DOI 10.1016/S0092-8674(03)01030-4; Ferguson AD, 2002, BBA-BIOMEMBRANES, V1565, P318, DOI 10.1016/S0005-2736(02)00578-3; Forsgren A, 2004, J INFECT DIS, V190, P352, DOI 10.1086/422155; Forsgren A, 2003, INFECT IMMUN, V71, P3302, DOI 10.1128/IAI.71.6.3302-3309.2003; Fritzer A, 2010, INFECT IMMUN, V78, P4051, DOI 10.1128/IAI.00295-10; Furano K, 2005, MICROBIOL-SGM, V151, P1151, DOI 10.1099/mic.0.27820-0; Furano K, 2004, INFECT IMMUN, V72, P6426, DOI 10.1128/IAI.72.11.6426-6432.2004; Garmory HS, 2004, INFECT IMMUN, V72, P6757, DOI 10.1128/IAI.72.12.6757-6763.2004; Hays JP, 2005, PLASMID, V53, P263, DOI 10.1016/j.plasmid.2004.11.003; Hoiczyk E, 2000, EMBO J, V19, P5989, DOI 10.1093/emboj/19.22.5989; Huttemann M, 2011, MITOCHONDRION, V11, P369, DOI 10.1016/j.mito.2011.01.010; JOHNSON MA, 1981, J CLIN MICROBIOL, V13, P1066, DOI 10.1128/JCM.13.6.1066-1069.1981; Lafontaine ER, 2000, J BACTERIOL, V182, P1364, DOI 10.1128/JB.182.5.1364-1373.2000; Liu DF, 2007, INFECT IMMUN, V75, P2818, DOI 10.1128/IAI.00074-07; Liu XS, 1996, CELL, V86, P147, DOI 10.1016/S0092-8674(00)80085-9; Locher KP, 1998, CELL, V95, P771, DOI 10.1016/S0092-8674(00)81700-6; Malmvall B E, 1984, Lakartidningen, V81, P3931; Mathers KE, 1997, FEMS IMMUNOL MED MIC, V19, P231, DOI 10.1016/S0928-8244(97)00088-6; Mawas F, 2009, EXPERT REV VACCINES, V8, P77, DOI 10.1586/14760584.8.1.77; Meier PS, 2003, INFECT IMMUN, V71, P6793, DOI 10.1128/IAI.71.12.6793-6798.2003; Meinke A, 2005, VACCINE, V23, P2035, DOI 10.1016/j.vaccine.2005.01.005; Meinke A, 2004, CURR OPIN MICROBIOL, V7, P314, DOI 10.1016/j.mib.2004.04.008; Meinke A, 2009, VACCINE, V27, P3251, DOI 10.1016/j.vaccine.2009.01.066; Mollenkvist A, 2003, J BACTERIOL, V185, P2285, DOI 10.1128/JB.185.7.2285-2295.2003; Murphy ER, 2002, INFECT IMMUN, V70, P5390, DOI 10.1128/IAI.70.10.5390-5403.2002; Murphy TF, 1998, THORAX, V53, P124, DOI 10.1136/thx.53.2.124; Murphy TF, 2005, VACCINE, V23, P2696, DOI 10.1016/j.vaccine.2004.12.014; Murphy TF, 1998, J INFECT DIS, V178, P1667, DOI 10.1086/314501; Murphy TF, 2005, EXPERT REV VACCINES, V4, P843, DOI 10.1586/14760584.4.6.843; Murphy TF, 2009, EXPERT REV VACCINES, V8, P655, DOI [10.1586/erv.09.28, 10.1586/ERV.09.28]; Murphy TF, 2009, CLIN INFECT DIS, V49, P124, DOI 10.1086/599375; NICOTRA B, 1986, ARCH INTERN MED, V146, P890, DOI 10.1001/archinte.146.5.890; OTTO BR, 1992, CRIT REV MICROBIOL, V18, P217, DOI 10.3109/10408419209114559; Pearson MM, 2002, INFECT IMMUN, V70, P4523, DOI 10.1128/IAI.70.8.4523-4533.2002; Rovers MM, 2004, LANCET, V363, P465, DOI 10.1016/S0140-6736(04)15495-0; Ruckdeschel EA, 2008, INFECT IMMUN, V76, P1599, DOI 10.1128/IAI.01253-07; Ruckdeschel EA, 2009, VACCINE, V27, P7065, DOI 10.1016/j.vaccine.2009.09.062; Sabirov A, 2008, VACCINE, V26, P1501, DOI 10.1016/j.vaccine.2008.01.029; Schaar V, 2011, CELL MICROBIOL, V13, P432, DOI 10.1111/j.1462-5822.2010.01546.x; Schellack C, 2006, VACCINE, V24, P5461, DOI 10.1016/j.vaccine.2006.03.071; SHANN F, 1986, AUST NZ J MED, V16, P718, DOI 10.1111/j.1445-5994.1986.tb00026.x; Tauseef I, 2011, MICROBIOL-SGM, V157, P1446, DOI 10.1099/mic.0.046946-0; Thony-Meyer L, 2000, BBA-BIOENERGETICS, V1459, P316, DOI 10.1016/S0005-2728(00)00167-5; UNHANAND M, 1992, J INFECT DIS, V165, P644, DOI 10.1093/infdis/165.4.644; Verhaegh SJC, 2011, VACCINE, V29, P5603, DOI 10.1016/j.vaccine.2011.06.019; Vidakovics MLAP, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000724; WATERS MJ, 1985, AUST NZ J MED, V15, P579; Yang M, 2011, INFECT IMMUN, V79, P846, DOI 10.1128/IAI.00314-10; Yu RH, 1999, INFECT IMMUN, V67, P3793, DOI 10.1128/IAI.67.8.3793-3799.1999	70	19	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2013	8	5							e64422	10.1371/journal.pone.0064422	http://dx.doi.org/10.1371/journal.pone.0064422			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	155HD	23671716	Green Published, Green Submitted, gold			2022-12-27	WOS:000319737700074
J	Yen, FL; Tsai, MH; Yang, CM; Liang, CJ; Lin, CC; Chiang, YC; Lee, HC; Ko, HH; Lee, CW				Yen, Feng-Lin; Tsai, Ming-Horng; Yang, Chuen-Mao; Liang, Chan-Jung; Lin, Chun-Ching; Chiang, Yao-Chang; Lee, Hui-Chun; Ko, Horng-Huey; Lee, Chiang-Wen			Curcumin Nanoparticles Ameliorate ICAM-1 Expression in TNF-alpha-Treated Lung Epithelial Cells through p47 (phox) and MAPKs/AP-1 Pathways	PLOS ONE			English	Article							NF-KAPPA-B; ADHESION MOLECULES; ENDOTHELIAL-CELLS; KINASE-ACTIVITY; ACTIVATION; INFLAMMATION; INHIBITION; AKT; PHOSPHORYLATION; INVOLVEMENT	Upregulation of intercellular adhesion molecule-1 (ICAM-1) involves adhesions between both circulating and resident leukocytes and the human lung epithelial cells during lung inflammatory reactions. We have previously demonstrated that curcumin-loaded polyvinylpyrrolidone nanoparticles (CURN) improve the anti-inflammatory and anti-oxidative properties of curcumin in hepatocytes. In this study, we focused on the effects of CURN on the expression of ICAM-1 in TNF-alpha-treated lung epithelial cells and compared these to the effects of curcumin water preparation (CURH). TNF-alpha induced ICAM-1 expression, ROS production, and cell-cell adhesion were significantly attenuated by the pretreatment with antioxidants (DPI, APO, or NAC) and CURN, but not by CURH, as revealed by western blot analysis, RT-PCR, promoter assay, and ROS detection and adhesion assay. In addition, treatment of TNF-alpha-treated cells with CURN and antioxidants also resulted in an inhibition of activation of p47 phox and phosphorylation of MAPKs, as compared to that using CURH. Our findings also suggest that phosphorylation of MAPKs may eventually lead to the activation of transcription factors. We also observed that the effects of TNF-alpha treatment for 30 min, which includes a significant increase in the binding activity of AP-1 and phosphorylation of c-jun and c-fos genes, were reduced by CURN treatment. In vivo studies have revealed that CURN improved the antiinflammation activities of CURH in the lung epithelial cells of TNF-a-treated mice. Our results indicate that curcumin-loaded polyvinylpyrrolidone nanoparticles may potentially serve as an anti-inflammatory drug for the treatment of respiratory diseases.	[Yen, Feng-Lin; Ko, Horng-Huey] Kaohsiung Med Univ, Coll Pharm, Dept Fragrance & Cosmet Sci, Kaohsiung, Taiwan; [Tsai, Ming-Horng] Chang Gung Mem Hosp, Dept Pediat, Div Neonatol & Pediat Hematol Oncol, Yunlin, Taiwan; [Yang, Chuen-Mao] Chang Gung Univ, Dept Physiol & Pharmacol, Tao Yuan, Taiwan; [Liang, Chan-Jung] Natl Taiwan Univ, Coll Med, Dept Anat & Cell Biol, Taipei 10764, Taiwan; [Lin, Chun-Ching] Kaohsiung Med Univ, Coll Pharm, Grad Inst Nat Prod, Kaohsiung, Taiwan; [Lin, Chun-Ching] Kaohsiung Med Univ, Coll Pharm, Sch Pharm, Kaohsiung, Taiwan; [Chiang, Yao-Chang] China Med Univ Hosp, Ctr Drug Abuse & Addict, Taichung, Taiwan; [Chiang, Yao-Chang] China Med Univ, Taichung, Taiwan; [Lee, Hui-Chun; Lee, Chiang-Wen] Chang Gung Inst Technol, Dept Nursing, Div Basic Med Sci, Chiayi, Taiwan; [Lee, Hui-Chun; Lee, Chiang-Wen] Chang Gung Inst Technol, Chron Dis & Hlth Promot Res Ctr, Chiayi, Taiwan	Kaohsiung Medical University; Chang Gung Memorial Hospital; Chang Gung University; National Taiwan University; Kaohsiung Medical University; Kaohsiung Medical University; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; Chang Gung University of Science & Technology; Chang Gung University of Science & Technology	Lee, CW (corresponding author), Chang Gung Inst Technol, Dept Nursing, Div Basic Med Sci, Chiayi, Taiwan.	cwlee@gw.cgust.edu.tw		Yang, Chuen-Mao/0000-0002-3208-5438; Chiang, Yao-Chang/0000-0002-7619-1902	National Science Council, Taiwan [NSC99-2313-B-255-001-MY3]; Chang Gung Medical Research Foundation, Taiwan [CMRPF6A0081]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); Chang Gung Medical Research Foundation, Taiwan	This work was supported by NSC99-2313-B-255-001-MY3 from National Science Council, Taiwan; CMRPF6A0081 from Chang Gung Medical Research Foundation, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of manuscript.	Al Ghouleh I, 2011, FREE RADICAL BIO MED, V51, P1271, DOI 10.1016/j.freeradbiomed.2011.06.011; Bhawana, 2011, J AGR FOOD CHEM, V59, P2056, DOI 10.1021/jf104402t; Brightling CE, 2012, CLIN EXP ALLERGY, V42, P638, DOI 10.1111/j.1365-2222.2011.03917.x; Brown DI, 2009, FREE RADICAL BIO MED, V47, P1239, DOI 10.1016/j.freeradbiomed.2009.07.023; Carnesecchi S, 2011, ANTIOXID REDOX SIGN, V15, P607, DOI 10.1089/ars.2010.3829; Carnesecchi S, 2009, AM J RESP CRIT CARE, V180, P972, DOI 10.1164/rccm.200902-0296OC; Chen CC, 2006, CURR PHARM DESIGN, V12, P3497, DOI 10.2174/138161206778343028; Chi PL, 2012, ARTHRITIS RHEUM, V63, P2905; Chiarugi P, 2005, FREE RADICAL RES, V39, P353, DOI 10.1080/10715760400027987; Decramer M, 2012, LANCET, V379, P1341, DOI 10.1016/S0140-6736(11)60968-9; Glauert HP, 2010, MOL NUTR FOOD RES, V54, P875, DOI 10.1002/mnfr.200900482; Golias C, 2011, CELL COMMUN ADHES, V18, P19, DOI 10.3109/15419061.2011.606381; Gong L, 2012, MOL MED REP, V5, P935, DOI 10.3892/mmr.2012.760; Griendling KK, 2000, ARTERIOSCL THROM VAS, V20, P2175, DOI 10.1161/01.ATV.20.10.2175; Hsieh HL, 2010, ANTIOXID REDOX SIGN, V13, P1829, DOI 10.1089/ars.2009.2957; Huang QR, 2010, J FOOD SCI, V75, pR50, DOI 10.1111/j.1750-3841.2009.01457.x; Huang WC, 2003, J BIOL CHEM, V278, P9944, DOI 10.1074/jbc.M208521200; Jang JH, 2012, INT J MOL MED, V30, P1357, DOI 10.3892/ijmm.2012.1158; Kakkar V, 2011, MOL NUTR FOOD RES, V55, P495, DOI 10.1002/mnfr.201000310; Kumar S, 2007, BIOCHEM PHARMACOL, V73, P1602, DOI 10.1016/j.bcp.2007.01.015; Lee CW, 2008, MOL PHARMACOL, V73, P1454, DOI 10.1124/mol.107.038091; Lee IT, 2013, J NUTR BIOCHEM, V24, P124, DOI 10.1016/j.jnutbio.2012.03.009; Lee IT, 2009, AM J PATHOL, V175, P519, DOI 10.2353/ajpath.2009.090016; Liang CJ, 2011, FREE RADICAL BIO MED, V51, P1337, DOI 10.1016/j.freeradbiomed.2011.06.023; Lin CC, 2007, J CELL PHYSIOL, V211, P771, DOI 10.1002/jcp.20987; Lin FS, 2005, J CELL PHYSIOL, V202, P464, DOI 10.1002/jcp.20142; Mathew A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032616; Mladenka P, 2010, FREE RADICAL BIO MED, V49, P963, DOI 10.1016/j.freeradbiomed.2010.06.010; Oh JH, 2010, INT IMMUNOPHARMACOL, V10, P572, DOI 10.1016/j.intimp.2010.02.004; Pendyala S, 2010, RESP PHYSIOL NEUROBI, V174, P265, DOI 10.1016/j.resp.2010.09.016; Ray PD, 2012, CELL SIGNAL, V24, P981, DOI 10.1016/j.cellsig.2012.01.008; Recio MC, 2012, CURR MED CHEM, V19, P2088; Rosanna D, 2012, CURR PHARM DESIGN, V18, P3889, DOI 10.2174/138161212802083716; Sareila O, 2011, ANTIOXID REDOX SIGN, V15, P2197, DOI 10.1089/ars.2010.3635; Schaffer M, 2011, CURR OPIN CLIN NUTR, V14, P588, DOI 10.1097/MCO.0b013e32834bfe94; Seldon MP, 2007, J IMMUNOL, V179, P7840, DOI 10.4049/jimmunol.179.11.7840; Song HY, 2011, FREE RADICAL BIO MED, V50, P576, DOI 10.1016/j.freeradbiomed.2010.12.019; Takemura Y, 2010, AM J PHYSIOL-LUNG C, V298, pL509, DOI 10.1152/ajplung.00230.2009; Thannickal VJ, 2000, AM J PHYSIOL-LUNG C, V279, pL1005; Tsai YM, 2011, INT J PHARMACEUT, V416, P331, DOI 10.1016/j.ijpharm.2011.06.030; Yallapu MM, 2012, DRUG DISCOV TODAY, V17, P71, DOI 10.1016/j.drudis.2011.09.009; Yang CM, 2010, J CELL PHYSIOL, V224, P516, DOI 10.1002/jcp.22153; Yen FL, 2010, J AGR FOOD CHEM, V58, P7376, DOI 10.1021/jf100135h; Ying BW, 2009, MOL BIOL REP, V36, P1825, DOI 10.1007/s11033-008-9386-1; Zhang GX, 2007, CARDIOVASC RES, V76, P204, DOI 10.1016/j.cardiores.2007.07.014	45	30	31	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2013	8	5							e63845	10.1371/journal.pone.0063845	http://dx.doi.org/10.1371/journal.pone.0063845			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	155HD	23671702	Green Published, gold, Green Submitted			2022-12-27	WOS:000319737700061
J	Poudel, R; Stanley, JL; Rueda-Clausen, CF; Andersson, IJ; Sibley, CP; Davidge, ST; Baker, PN				Poudel, Rajan; Stanley, Joanna L.; Rueda-Clausen, Christian F.; Andersson, Irene J.; Sibley, Colin P.; Davidge, Sandra T.; Baker, Philip N.			Effects of Resveratrol in Pregnancy Using Murine Models with Reduced Blood Supply to the Uterus	PLOS ONE			English	Article							FETAL-GROWTH; NITRIC-OXIDE; CARDIOVASCULAR FUNCTION; TRANS-RESVERATROL; UTERINE ARTERIES; KNOCKOUT MOUSE; DOPPLER FLOW; PREECLAMPSIA; SYNTHASE; MICE	Preeclampsia (PE) and fetal growth restriction (FGR) contribute significantly to fetal and maternal morbidity and mortality. Although the causes of PE and FGR are not fully understood, both conditions are known to be associated with impaired uterine artery blood flow. Resveratrol, a polyphenol found in a number of plants, has been shown to induce relaxation of uterine arteries in vitro as well as improve many pathological conditions associated with PE and FGR. We hypothesized that treatment of endothelial nitric oxide synthase knockout mice (eNOS(-/-)) and catechol-O-methyltransferase knockout mice (COMT-/-) with resveratrol during pregnancy would improve uterine artery blood flow and therefore ameliorate the PE-like phenotype and FGR in these murine models. Pregnant C57BL/6J, eNOS(-/-) and COMT-/- mice received either resveratrol supplemented diet (4 g/kg diet) or control diet between gestational day (GD) 0.5 and GD 18.5. Resveratrol supplementation significantly increased uterine artery blood flow velocity and fetal weight in COMT-/- but not in eNOS(-/-) mice. There were no effects of resveratrol on litter size and placental weight among the groups. In conclusion, resveratrol increased uterine artery blood flow velocity and fetal weight in COMT-/- mice, suggesting potential as a therapeutic strategy for PE and FGR.	[Poudel, Rajan; Stanley, Joanna L.; Rueda-Clausen, Christian F.; Andersson, Irene J.; Davidge, Sandra T.; Baker, Philip N.] Univ Alberta, Edmonton, AB, Canada; [Sibley, Colin P.] Univ Manchester, Maternal & Fetal Hlth Res Ctr, Manchester M13 9PL, Lancs, England; [Sibley, Colin P.] Cent Manchester Univ Hosp NHS Fdn Trust, Manchester, Lancs, England; [Poudel, Rajan; Stanley, Joanna L.; Rueda-Clausen, Christian F.; Andersson, Irene J.; Davidge, Sandra T.] Women & Childrens Hlth Res Inst, Edmonton, AB, Canada; [Stanley, Joanna L.; Baker, Philip N.] Univ Auckland, Liggins Inst, Auckland 1, New Zealand	University of Alberta; University of Manchester; University of Manchester; University of Auckland	Stanley, JL (corresponding author), Univ Alberta, Edmonton, AB, Canada.	jlstanle@ualberta.ca	Rueda-Clausen, Christian/S-2428-2019	Rueda-Clausen, Christian/0000-0002-4077-6159; Davidge, Sandra/0000-0002-5559-4905; Stanley, Joanna/0000-0001-6364-3415; Baker, Philip/0000-0002-4592-6427	Medical Research Council Programme Grant (United Kingdom); Medical Research Council [G0802770] Funding Source: researchfish; MRC [G0802770] Funding Source: UKRI	Medical Research Council Programme Grant (United Kingdom); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This study was funded by a Medical Research Council Programme Grant (United Kingdom) awarded to PNB and CPS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aardema MW, 2001, PLACENTA, V22, P405, DOI 10.1053/plac.2001.0676; BARKER DJP, 1992, BRIT J OBSTET GYNAEC, V99, P275, DOI 10.1111/j.1471-0528.1992.tb13719.x; CAMPBELL S, 1983, LANCET, V1, P675; Chan V, 2011, CURR PHARM BIOTECHNO, V12, P429, DOI 10.2174/138920111794480552; Cnossen JS, 2008, CAN MED ASSOC J, V178, P701, DOI 10.1503/cmaj.070430; Das S, 2005, VASC PHARMACOL, V42, P281, DOI 10.1016/j.vph.2005.02.013; Dolinsky VW, 2011, DIABETES, V60, P2274, DOI 10.2337/db11-0374; Juan ME, 2012, PHARMACOL RES, V65, P584, DOI 10.1016/j.phrs.2012.03.010; Facchinetti F, 2011, J MATERN-FETAL NEO M, V24, P407, DOI 10.3109/14767058.2010.496880; Gagnon R, 2003, EUR J OBSTET GYN R B, V110, pS99, DOI 10.1016/S0301-2115(03)00179-9; HANRETTY KP, 1989, BRIT MED J, V299, P1205, DOI 10.1136/bmj.299.6709.1205; Harrington K, 1996, ULTRASOUND OBST GYN, V7, P182, DOI 10.1046/j.1469-0705.1996.07030182.x; Hefler LA, 2001, AM J PHYSIOL-REG I, V280, pR174, DOI 10.1152/ajpregu.2001.280.1.R174; Holthoff JH, 2012, KIDNEY INT, V81, P370, DOI 10.1038/ki.2011.347; Kanasaki K, 2008, NATURE, V453, P1117, DOI 10.1038/nature06951; Kennedy DO, 2010, AM J CLIN NUTR, V91, P1590, DOI 10.3945/ajcn.2009.28641; Khan KS, 2006, LANCET, V367, P1066, DOI 10.1016/S0140-6736(06)68397-9; KHONG TY, 1986, BRIT J OBSTET GYNAEC, V93, P1049, DOI 10.1111/j.1471-0528.1986.tb07830.x; Kulandavelu S, 2006, HYPERTENSION, V47, P1175, DOI 10.1161/01.HYP.0000218440.71846.db; Kulandavelu S, 2012, HYPERTENSION, V60, P231, DOI 10.1161/HYPERTENSIONAHA.111.187559; Kusinski LC, 2012, AM J PHYSIOL-REG I, V303, pR86, DOI 10.1152/ajpregu.00600.2011; Lagouge M, 2006, CELL, V127, P1109, DOI 10.1016/j.cell.2006.11.013; Lelfert WR, 2008, NUTR RES, V28, P842, DOI 10.1016/j.nutres.2008.09.001; Lewis G, 2007, 7 CEMACH, P114; Moore RJ, 2000, PLACENTA, V21, P726, DOI 10.1053/plac.2000.0567; Moraloglu O, 2011, J MATERN-FETAL NEO M, P1; Naderali EK, 2000, CLIN SCI, V98, P537, DOI 10.1042/CS19990303; Nihei T, 2001, LIFE SCI, V68, P2845, DOI 10.1016/S0024-3205(01)01061-X; Patel KR, 2011, ANN NY ACAD SCI, V1215, P161, DOI 10.1111/j.1749-6632.2010.05853.x; Rivera L, 2009, BIOCHEM PHARMACOL, V77, P1053, DOI 10.1016/j.bcp.2008.11.027; Shesely EG, 2001, AM J OBSTET GYNECOL, V185, P1198, DOI 10.1067/mob.2001.118142; Sibai B, 2005, LANCET, V365, P785, DOI 10.1016/S0140-6736(05)71003-5; Singh CK, 2011, MOL NUTR FOOD RES, V55, P1186, DOI 10.1002/mnfr.201000457; Smith GN, 2009, AM J OBSTET GYNECOL, V200, DOI 10.1016/j.ajog.2008.06.035; Stanley JL, 2012, HYPERTENSION, V59, P1021, DOI 10.1161/HYPERTENSIONAHA.111.186270; Stanley JL, 2012, BIOL REPROD, V87, DOI 10.1095/biolreprod.111.096198; Wang Zhi-rong, 2011, Zhonghua Xin Xue Guan Bing Za Zhi, V39, P946; Whitesall SE, 2004, AM J PHYSIOL-HEART C, V286, pH2408, DOI 10.1152/ajpheart.01089.2003; Williams LD, 2009, FOOD CHEM TOXICOL, V47, P2170, DOI 10.1016/j.fct.2009.06.002	39	56	57	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2013	8	5							e64401	10.1371/journal.pone.0064401	http://dx.doi.org/10.1371/journal.pone.0064401			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145YI	23667712	Green Published, Green Submitted, gold			2022-12-27	WOS:000319055600092
J	Aida, J; Yokoyama, A; Shimomura, N; Nakamura, K; Ishikawa, N; Terai, M; Poon, S; Matsuura, M; Fujiwara, M; Sawabe, M; Arai, T; Takubo, K				Aida, Junko; Yokoyama, Akira; Shimomura, Naotaka; Nakamura, Ken-ichi; Ishikawa, Naoshi; Terai, Masanori; Poon, Steven; Matsuura, Masaaki; Fujiwara, Mutsunori; Sawabe, Motoji; Arai, Tomio; Takubo, Kaiyo			Telomere Shortening in the Esophagus of Japanese Alcoholics: Relationships with Chromoendoscopic Findings, ALDH2 and ADH1B Genotypes and Smoking History	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; ALDEHYDE DEHYDROGENASE GENOTYPES; IODINE-UNSTAINED LESIONS; P53 PROTEIN ACCUMULATION; Q-FISH ANALYSIS; IN-SITU; CANCER; MEN; ASSOCIATION; LENGTH	Chromoendoscopy with Lugol iodine staining provides important information on the development of squamous cell carcinoma (SCC). In particular, distinct iodine-unstained lesions (DIULs) larger than 10 mm show a high prevalence in high-grade intraepithelial neoplasia. It has also been reported that inactive ALDH2*1/*2 and less-active ADH1B*1/*1, and smoking, are risk factors for esophageal SCC. We previously examined telomere shortening in the esophageal epithelium of alcoholics, and suggested a high prevalence of chromosomal instability in such individuals. In the present study, we attempted to analyze telomere lengths in 52 DIULs with reference to both their size and multiplicity, ALDH2 and ADH1B genotypes, and smoking history. Patients with DIULs <10 mm (n = 42) had significantly longer telomeres than those with DIULs >= 10 mm (n = 10, p = 0.008). No significant differences in telomere length were recognized between the ALDH2 and ADH1B genotypes (ALDH2 active/inactive = 35/17, ADH1B active/inactive = 32/20; p = 0.563, 0.784, respectively) or among four groups of patients divided according to smoking history (never-, ex-, light, and heavy smokers = 3, 6, 21, and 22 patients, respectively; p = 0.956). Patients without multiple DIULs (n = 17) had significantly longer telomeres than patients with multiple DIULs (n = 35, p = 0.040). It is suggested that alcoholism reduces telomere length in the esophagus, irrespective of genotype or smoking habit. Telomere shortening may not generate cancer directly, but may create conditions under which SCC can develop more easily, depending on subsequent exposure to carcinogens.	[Aida, Junko; Shimomura, Naotaka; Nakamura, Ken-ichi; Ishikawa, Naoshi; Terai, Masanori; Takubo, Kaiyo] Tokyo Metropolitan Inst Gerontol, Res Team Geriatr Pathol, Tokyo, Japan; [Yokoyama, Akira] Natl Hosp Org, Kurihama Med & Addict Ctr, Clin Res Unit, Yokosuka, Kanagawa, Japan; [Poon, Steven] British Columbia Canc Res Ctr, Terry Fox Lab, Vancouver, BC V5Z 1L3, Canada; [Matsuura, Masaaki] Japanese Fdn Canc Res, Inst Canc, Dept Canc Genom, Tokyo 170, Japan; [Fujiwara, Mutsunori] Japanese Red Cross Med Ctr, Dept Pathol, Tokyo, Japan; [Sawabe, Motoji] Tokyo Med & Dent Univ, Dept Moleculogenet Sci, Div Biomed Lab Sci, Grad Sch Hlth Care Sci, Tokyo, Japan; [Sawabe, Motoji; Arai, Tomio] Tokyo Metropolitan Geriatr Hosp, Dept Pathol, Tokyo 173, Japan	Tokyo Metropolitan Institute of Gerontology; British Columbia Cancer Agency; Japanese Foundation for Cancer Research; Japanese Red Cross Medical Center; University of Tokyo; Tokyo Medical & Dental University (TMDU); Tokyo Metropolitan Institute of Gerontology	Aida, J (corresponding author), Tokyo Metropolitan Inst Gerontol, Res Team Geriatr Pathol, Tokyo, Japan.	aidajs@tmig.or.jp	Aida, Junko/Q-5697-2019	Aida, Junko/0000-0003-4923-5540	JSPS (Japan Society for the Promotion of Science) [21390109, 20590378, 23590440, 20590389, 1n3 22590343]	JSPS (Japan Society for the Promotion of Science)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This study was supported by JSPS (Japan Society for the Promotion of Science) KAKENHI 21390109, 20590378, 23590440, 20590389, 1n3 22590343 (http://www.jsps.go.jp/english/index.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. But they took the role of purchase and maintenance of the equipments for FISH and FISH analysis, purchase instruments and reagents for FISH, and version up of telomere analysis application.	Aida J, 2008, EXP GERONTOL, V43, P833, DOI 10.1016/j.exger.2008.06.001; Aida J, 2007, HUM PATHOL, V38, P1192, DOI 10.1016/j.humpath.2006.11.023; Aida J, 2012, J ORAL PATHOL MED, V41, P372, DOI 10.1111/j.1600-0714.2011.01120.x; Aida J, 2011, J PATHOL, V223, P410, DOI 10.1002/path.2817; Aida J, 2010, EUR J CANCER, V46, P430, DOI 10.1016/j.ejca.2009.10.018; American Psychiatric Association, 1994, DIAGN STAT MAN MENT; Asakage T, 2007, CARCINOGENESIS, V28, P865, DOI 10.1093/carcin/bgl206; Baan R, 2009, LANCET ONCOL, V10, P1143, DOI 10.1016/S1470-2045(09)70358-4; BERGLUND M, 1984, ACTA PSYCHIAT SCAND, V70, P407, DOI 10.1111/j.1600-0447.1984.tb01228.x; Blackburn EH, 2001, CELL, V106, P661, DOI 10.1016/S0092-8674(01)00492-5; de Lange T, 2005, GENE DEV, V19, P2100, DOI 10.1101/gad.1346005; DePinho RA, 2000, NATURE, V408, P248, DOI 10.1038/35041694; HIGUCHI S, 1994, LANCET, V343, P741, DOI 10.1016/S0140-6736(94)91629-2; Kurabayashi R, 2008, HUM PATHOL, V39, P1647, DOI 10.1016/j.humpath.2008.04.005; Londono-Vallejo JA, 2008, BIOCHIMIE, V90, P73, DOI 10.1016/j.biochi.2007.07.009; Ma HX, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020466; Montgomery E, 2010, WHO CLASSIFICATION T, P18; Muto M, 2000, GUT, V47, P256, DOI 10.1136/gut.47.2.256; Muto M, 2005, CARCINOGENESIS, V26, P1008, DOI 10.1093/carcin/bgi035; O'Sullivan JN, 2004, CYTOM PART A, V58A, P120, DOI 10.1002/cyto.a.20006; OHASHI M, 1980, EXP GERONTOL, V15, P121, DOI 10.1016/0531-5565(80)90083-2; Pavanello S, 2011, INT J CANCER, V129, P983, DOI 10.1002/ijc.25999; Poschl G, 2004, ALCOHOL ALCOHOLISM, V39, P155, DOI 10.1093/alcalc/agh057; Sanada Y, 2012, WORLD J SURG, V36, P908, DOI 10.1007/s00268-012-1453-z; SCHMIDT W, 1972, Q J STUD ALCOHOL, V33, P171; Shiraishi H, 2009, SCAND J GASTROENTERO, V44, P538, DOI 10.1080/00365520902718705; Takubo K, 2007, HISTOPATHOLOGY, V51, P733, DOI 10.1111/j.1365-2559.2007.02766.x; Takubo K, 1999, AGE, V22, P95, DOI 10.1007/s11357-999-0011-6; Takubo K, 2002, EXP GERONTOL, V37, P523, DOI 10.1016/S0531-5565(01)00218-2; Takubo K, 2007, PATHOLOGY ESOPHAGUS, P182; Takubo K, 2010, J PATHOL, V221, P201, DOI 10.1002/path.2704; Turkyilmaz A, 2009, DIS ESOPHAGUS, V22, P211, DOI 10.1111/j.1442-2050.2008.00890.x; Wentzensen IM, 2011, CANCER EPIDEM BIOMAR, V20, P1238, DOI 10.1158/1055-9965.EPI-11-0005; Yokoyama A, 2001, CARCINOGENESIS, V22, P433, DOI 10.1093/carcin/22.3.433; Yokoyama A, 2007, CANCER LETT, V247, P243, DOI 10.1016/j.canlet.2006.05.004; Yokoyama A, 2012, INT J CANCER, V130, P2949, DOI 10.1002/ijc.26296; Yokoyama A, 2011, CANCER LETT, V308, P112, DOI 10.1016/j.canlet.2011.04.020	37	10	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e63860	10.1371/journal.pone.0063860	http://dx.doi.org/10.1371/journal.pone.0063860			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667679	Green Published, gold, Green Submitted			2022-12-27	WOS:000319654700189
J	Cheng, JJ; Yin, Y; Wu, HW; Zhang, Q; Hua, J; Hua, XL; Xu, JR				Cheng, Jiejun; Yin, Yan; Wu, Huawei; Zhang, Qing; Hua, Jia; Hua, Xiaolan; Xu, Jianrong			Optimal Monochromatic Energy Levels in Spectral CT Pulmonary Angiography for the Evaluation of Pulmonary Embolism	PLOS ONE			English	Article							COMPUTED-TOMOGRAPHY; LUNG PERFUSION; IMAGE QUALITY; DIAGNOSIS	Background: The aim of this study was to determine the optimal monochromatic spectral CT pulmonary angiography (sCTPA) levels to obtain the highest image quality and diagnostic confidence for pulmonary embolism detection. Methods: The Institutional Review Board of the Shanghai Jiao Tong University School of Medicine approved this study, and written informed consent was obtained from all participating patients. Seventy-two patients with pulmonary embolism were scanned with spectral CT mode in the arterial phase. One hundred and one sets of virtual monochromatic spectral (VMS) images were generated ranging from 40 keV to 140 keV. Image noise, clot diameter and clot to artery contrast-to-noise ratio (CNR) from seven sets of VMS images at selected monochromatic levels in sCTPA were measured and compared. Subjective image quality and diagnostic confidence for these images were also assessed and compared. Data were analyzed by paired t test and Wilcoxon rank sum test. Results: The lowest noise and the highest image quality score for the VMS images were obtained at 65 keV. The VMS images at 65 keV also had the second highest CNR value behind that of 50 keV VMS images. There was no difference in the mean noise and CNR between the 65 keV and 70 keV VMS images. The apparent clot diameter correlated with the keV levels. Conclusions: The optimal energy level for detecting pulmonary embolism using dual-energy spectral CT pulmonary angiography was 65-70 keV. Virtual monochromatic spectral images at approximately 65-70 keV yielded the lowest image noise, high CNR and highest diagnostic confidence for the detection of pulmonary embolism.	[Cheng, Jiejun; Yin, Yan; Wu, Huawei; Zhang, Qing; Hua, Jia; Hua, Xiaolan; Xu, Jianrong] Shanghai Jiao Tong Univ, Renji Hosp, Dept Radiol, Sch Med, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University	Wu, HW (corresponding author), Shanghai Jiao Tong Univ, Renji Hosp, Dept Radiol, Sch Med, Shanghai 200030, Peoples R China.	huawei_wu@yahoo.com.cn; xujianr@gmail.com			Shanghai Municipal Health Bureau [20120176]; key discipline project of Renji hospital, Shanghai Jiao Tong University School of Medicine [RJ4101309]	Shanghai Municipal Health Bureau; key discipline project of Renji hospital, Shanghai Jiao Tong University School of Medicine	This work was supported in part by research project of the Shanghai Municipal Health Bureau (20120176) and key discipline project of Renji hospital, Shanghai Jiao Tong University School of Medicine (RJ4101309). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ferda J, 2011, EUR J RADIOL, V77, P287, DOI 10.1016/j.ejrad.2009.08.005; Fink C, 2008, ROFO-FORTSCHR RONTG, V180, P879, DOI 10.1055/s-2008-1027724; Gorgos A, 2009, J COMPUT ASSIST TOMO, V33, P981, DOI 10.1097/RCT.0b013e3181a5cd0f; Gotway MB, 2000, J COMPUT ASSIST TOMO, V24, P267, DOI 10.1097/00004728-200003000-00016; Kang MJ, 2010, RADIOGRAPHICS, V30, P685, DOI 10.1148/rg.303095101; Krissak R, 2010, INVEST RADIOL, V45, P341, DOI 10.1097/RLI.0b013e3181dfda37; Lin XZ, 2011, J COMPUT ASSIST TOMO, V35, P294, DOI 10.1097/RCT.0b013e3182058d5c; Matsumoto K, 2011, RADIOLOGY, V259, P257, DOI 10.1148/radiol.11100978; Maturen KE, 2012, J COMPUT ASSIST TOMO, V36, P83, DOI 10.1097/RCT.0b013e31824258cb; Pontana F, 2008, ACAD RADIOL, V15, P1494, DOI 10.1016/j.acra.2008.05.018; Ragni MV, 2009, CURR OPIN PULM MED, V15, P430, DOI 10.1097/MCP.0b013e32832d860d; Renard B, 2011, EUR J RADIOL, V79, P467, DOI 10.1016/j.ejrad.2010.04.018; Sangwaiya MJ, 2010, J COMPUT ASSIST TOMO, V34, P46, DOI 10.1097/RCT.0b013e3181aac7ec; Schoepf UJ, 2004, RADIOLOGY, V230, P329, DOI 10.1148/radiol.2302021489; Stein PD, 2006, NEW ENGL J MED, V354, P2317, DOI 10.1056/NEJMoa052367; Sueyoshi E, 2011, EUR J RADIOL, V80, pE505, DOI 10.1016/j.ejrad.2010.10.011; Thieme SF, 2008, EUR J RADIOL, V68, P369, DOI 10.1016/j.ejrad.2008.07.031; Torbicki A, 2008, EUR HEART J, V29, P2276, DOI 10.1093/eurheartj/ehn310; Wu HW, 2012, INVEST RADIOL, V47, P85, DOI 10.1097/RLI.0b013e31823441a1; Yamada Y, 2012, INVEST RADIOL, V47, P292, DOI 10.1097/RLI.0b013e318240a874; Yuan R, 2012, RADIOLOGY, V262, P290, DOI 10.1148/radiol.11110648; Zhang LJ, 2009, RADIOLOGY, V252, P61, DOI 10.1148/radiol.2521081682; Zhao LQ, 2012, EUR J RADIOL, V81, P1677, DOI 10.1016/j.ejrad.2011.02.063	23	42	47	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e63140	10.1371/journal.pone.0063140	http://dx.doi.org/10.1371/journal.pone.0063140			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667583	Green Published, Green Submitted, gold			2022-12-27	WOS:000319654700114
J	Kim, KH; Kim, SH; Min, YK; Yang, HM; Lee, JB; Lee, MS				Kim, Kook Hwan; Kim, Seong Hun; Min, Young-Ki; Yang, Hun-Mo; Lee, Jeong-Beom; Lee, Myung-Shik			Acute Exercise Induces FGF21 Expression in Mice and in Healthy Humans	PLOS ONE			English	Article							FIBROBLAST GROWTH FACTOR-21; HUMAN SKELETAL-MUSCLE; PPAR-ALPHA; METABOLIC REGULATOR; HEPATIC STEATOSIS; ACTIVATION; OBESITY; FIBROBLAST-GROWTH-FACTOR-21; INDUCTION; FGF-21	Fibroblast growth factor 21 (FGF21) plays an important role in the regulation of energy homeostasis during starvation and has an excellent therapeutic potential for the treatment of type 2 diabetes in rodents and monkeys. Acute exercise affects glucose and lipid metabolism by increasing glucose uptake and lipolysis. However, it is not known whether acute exercise affects FGF21 expression. Here, we showed that serum FGF21 level is increased in mice after a single bout of acute exercise, and that this is accompanied by increased serum levels of free fatty acid, glycerol and ketone body. FGF21 gene expression was induced in the liver but not in skeletal muscle and white adipose tissue of mice after acute exercise, and further, the gene expression levels of hepatic peroxisome proliferator-activated receptor alpha (PPAR alpha) and activating transcription factor 4 (ATF4) were also increased. In addition, we observed increased FGF21 level in serum of healthy male volunteers performing a treadmill run at 50 or 80% VO(2)max. These results suggest that FGF21 may also be associated with exercise-induced lipolysis in addition to increased catecholamines and reduced insulin.	[Kim, Kook Hwan; Lee, Myung-Shik] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Med, Seoul, South Korea; [Kim, Kook Hwan; Kim, Seong Hun; Lee, Myung-Shik] Sungkyunkwan Univ, Sch Med, Samsung Adv Inst Hlth Sci & Technol, Seoul, South Korea; [Min, Young-Ki; Yang, Hun-Mo; Lee, Jeong-Beom] Soonchunhyang Univ, Dept Physiol, Coll Med, Cheonan, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Soonchunhyang University	Lee, JB (corresponding author), Soonchunhyang Univ, Dept Physiol, Coll Med, 366-1 Ssang Yong Dong, Cheonan, South Korea.	leejb@sch.ac.kr; mslee0923@skku.edu	Lee, Myung Shik/C-9606-2011	Kim, Kook Hwan/0000-0003-2702-9156	Global Research Laboratory Grant of the National Research Foundation of Korea [K21004000003-12A0500-00310]; Bio & Medical Technology Development Program grant from the Ministry of Education, Science & Technology, Korea [20120006344]; Samsung Biomedical Research Institute [SP1-B2-051-2]; Korea Healthcare Technology R&D Project, Ministry for Health, Welfare & Family Affairs, Korea [A084065-1222-0000300]	Global Research Laboratory Grant of the National Research Foundation of Korea(National Research Foundation of Korea); Bio & Medical Technology Development Program grant from the Ministry of Education, Science & Technology, Korea; Samsung Biomedical Research Institute(Samsung); Korea Healthcare Technology R&D Project, Ministry for Health, Welfare & Family Affairs, Korea	This study was supported by the Global Research Laboratory Grant of the National Research Foundation of Korea (K21004000003-12A0500-00310) and the Bio & Medical Technology Development Program grant from the Ministry of Education, Science & Technology, Korea (20120006344). M-SL is the recipient of the Samsung Biomedical Research Institute Grant (SP1-B2-051-2) and the Korea Healthcare Technology R&D Project, Ministry for Health, Welfare & Family Affairs, Korea (A084065-1222-0000300). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badman MK, 2007, CELL METAB, V5, P426, DOI 10.1016/j.cmet.2007.05.002; Broholm C, 2008, J PHYSIOL-LONDON, V586, P2195, DOI 10.1113/jphysiol.2007.149781; Cho H, 2013, BMC SYST BIOL, V7, DOI 10.1186/1752-0509-7-9; Coskun T, 2008, ENDOCRINOLOGY, V149, P6018, DOI 10.1210/en.2008-0816; Cuevas-Ramos D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038022; Cuevas-Ramos D, 2010, EUR J ENDOCRINOL, V163, P469, DOI 10.1530/EJE-10-0454; DRENTH JPH, 1995, J APPL PHYSIOL, V79, P1497, DOI 10.1152/jappl.1995.79.5.1497; Galman C, 2008, CELL METAB, V8, P169, DOI 10.1016/j.cmet.2008.06.014; Hai T, 2010, GENE EXPRESSION, V15, P1, DOI 10.3727/105221610X12819686555015; Hojman P, 2009, DIABETES, V58, P2797, DOI 10.2337/db09-0713; Inagaki T, 2007, CELL METAB, V5, P415, DOI 10.1016/j.cmet.2007.05.003; Izumiya Y, 2008, FEBS LETT, V582, P3805, DOI 10.1016/j.febslet.2008.10.021; Kharitonenkov A, 2005, J CLIN INVEST, V115, P1627, DOI 10.1172/JCI23606; Kharitonenkov A, 2007, ENDOCRINOLOGY, V148, P774, DOI 10.1210/en.2006-1168; Kim KH, 2007, GASTROENTEROLOGY, V132, P1955, DOI 10.1053/j.gastro.2007.03.039; Kim KH, 2013, NAT MED, V19, P83, DOI 10.1038/nm.3014; Krey G, 1997, MOL ENDOCRINOL, V11, P779, DOI 10.1210/me.11.6.779; De Sousa-Coelho AL, 2012, BIOCHEM J, V443, P165, DOI 10.1042/BJ20111748; Matthews VB, 2009, DIABETOLOGIA, V52, P1409, DOI 10.1007/s00125-009-1364-1; MEAD WF, 1979, J FAM PRACTICE, V9, P479; Nielsen AR, 2007, J PHYSIOL-LONDON, V584, P305, DOI 10.1113/jphysiol.2007.139618; Nishimura T, 2000, BBA-GENE STRUCT EXPR, V1492, P203, DOI 10.1016/S0167-4781(00)00067-1; Pedersen BK, 2012, NAT REV ENDOCRINOL, V8, P457, DOI 10.1038/nrendo.2012.49; Qiu SH, 2012, DIABETES METAB J, V36, P1, DOI 10.4093/dmj.2012.36.1.1; Wente W, 2006, DIABETES, V55, P2470, DOI 10.2337/db05-1435; Xu J, 2009, DIABETES, V58, P250, DOI 10.2337/db08-0392; Zhang X, 2008, DIABETES, V57, P1246, DOI 10.2337/db07-1476	27	186	196	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e63517	10.1371/journal.pone.0063517	http://dx.doi.org/10.1371/journal.pone.0063517			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667629	Green Published, Green Submitted, gold			2022-12-27	WOS:000319654700154
J	Klint, JK; Senff, S; Saez, NJ; Seshadri, R; Lau, HY; Bende, NS; Undheim, EAB; Rash, LD; Mobli, M; King, GF				Klint, Julie K.; Senff, Sebastian; Saez, Natalie J.; Seshadri, Radha; Lau, Ho Yee; Bende, Niraj S.; Undheim, Eivind A. B.; Rash, Lachlan D.; Mobli, Mehdi; King, Glenn F.			Production of Recombinant Disulfide-Rich Venom Peptides for Structural and Functional Analysis via Expression in the Periplasm of E. coli	PLOS ONE			English	Article							MACROMOLECULAR NMR-SPECTROSCOPY; SODIUM-CHANNEL INHIBITOR; SINGLE-STEP PURIFICATION; MALTOSE-BINDING PROTEIN; HIGH-LEVEL EXPRESSION; ESCHERICHIA-COLI; INSECTICIDAL PEPTIDES; FUSION PROTEINS; AFFINITY PURIFICATION; CAPSAICIN RECEPTOR	Disulfide-rich peptides are the dominant component of most animal venoms. These peptides have received much attention as leads for the development of novel therapeutic agents and bioinsecticides because they target a wide range of neuronal receptors and ion channels with a high degree of potency and selectivity. In addition, their rigid disulfide framework makes them particularly well suited for addressing the crucial issue of in vivo stability. Structural and functional characterization of these peptides necessitates the development of a robust, reliable expression system that maintains their native disulfide framework. The bacterium Escherichia coli has long been used for economical production of recombinant proteins. However, the expression of functional disulfide-rich proteins in the reducing environment of the E. coli cytoplasm presents a significant challenge. Thus, we present here an optimised protocol for the expression of disulfide-rich venom peptides in the periplasm of E. coli, which is where the endogenous machinery for production of disulfide-bonds is located. The parameters that have been investigated include choice of media, induction conditions, lysis methods, methods of fusion protein and peptide purification, and sample preparation for NMR studies. After each section a recommendation is made for conditions to use. We demonstrate the use of this method for the production of venom peptides ranging in size from 2 to 8 kDa and containing 2-6 disulfide bonds.	[Klint, Julie K.; Senff, Sebastian; Saez, Natalie J.; Seshadri, Radha; Lau, Ho Yee; Bende, Niraj S.; Undheim, Eivind A. B.; Rash, Lachlan D.; Mobli, Mehdi; King, Glenn F.] Univ Queensland, Inst Mol Biosci, St Lucia, Qld, Australia	University of Queensland	Mobli, M (corresponding author), Univ Queensland, Inst Mol Biosci, St Lucia, Qld, Australia.	m.mobli@uq.edu.au; glenn.king@imb.uq.edu.au	Rash, Lachlan D/A-3858-2010; Klint, Julie/M-5458-2013; Mobli, Mehdi/O-7244-2014; SAEZ, Natalie/I-9620-2014; King, Glenn F/J-5059-2012	Rash, Lachlan D/0000-0003-3616-0279; Klint, Julie/0000-0001-7586-8216; Mobli, Mehdi/0000-0003-2420-4262; SAEZ, Natalie/0000-0002-1664-325X; King, Glenn F/0000-0002-2308-2200; Undheim, Eivind/0000-0002-8667-3999; Lau, Carus/0000-0002-4363-181X; Senff, Sebastian/0000-0001-9665-9376	Australian National Health and Medical Research Council [APP1044414]; Australian Research Council [FT100100027]; NHMRC [APP1044414, APP1012338, APP1034958]; ARC [DP1095728, DP110103129, LP110100509]	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); ARC(Australian Research Council)	Australian National Health and Medical Research Council (APP1044414) and Australian Research Council (FT100100027). NHMRC Project Grants APP1012338 and APP1034958 and Research Fellowship APP1044414 to GFK, as well as ARC Discovery Grants DP1095728 and DP110103129 and ARC Linkage Grant LP110100509. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitken A, 2002, PROTEIN PROTOCOLS HD, P3, DOI [10.1385/1-59259-169-8:3., DOI 10.1385/1-59259-169-8:3]; ANGLISTER J, 1993, J BIOMOL NMR, V3, P121; Annis I, 1997, METHOD ENZYMOL, V289, P198; Baneyx F, 2004, NAT BIOTECHNOL, V22, P1399, DOI 10.1038/nbt1029; BASSFORD PJ, 1990, J BIOENERG BIOMEMBR, V22, P401, DOI 10.1007/BF00763175; Bell PA, 2001, MOL BIOL PROBLEM SOL, P461; Bende N, 2013, BICOH PHARM IN PRESS; Berrow NS, 2006, ACTA CRYSTALLOGR D, V62, P1218, DOI 10.1107/S0907444906031337; Berthold DA, 2012, 15 CAMBR IS LAB; Bieri M, 2011, FEBS J, V278, P704, DOI 10.1111/j.1742-4658.2011.08005.x; Bohlen CJ, 2010, CELL, V141, P834, DOI 10.1016/j.cell.2010.03.052; Bosmans F, 2006, MOL PHARMACOL, V69, P419, DOI 10.1124/mol.105.015941; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BREMER H, 1975, J THEOR BIOL, V53, P115, DOI 10.1016/0022-5193(75)90106-X; Bulaj G, 2001, BIOCHEMISTRY-US, V40, P13201, DOI 10.1021/bi010683a; Cabrita LD, 2006, BMC BIOTECHNOL, V6, DOI 10.1186/1472-6750-6-12; CHESSHYRE JA, 1989, APPL MICROBIOL BIOT, V31, P158, DOI 10.1007/BF00262455; Choi JH, 2004, APPL MICROBIOL BIOT, V64, P625, DOI 10.1007/s00253-004-1559-9; Choi SJ, 2004, FEBS LETT, V572, P109, DOI 10.1016/j.febslet.2004.07.019; CORDEIRO MD, 1993, TOXICON, V31, P35, DOI 10.1016/0041-0101(93)90354-L; CORDINGLEY MG, 1990, J BIOL CHEM, V265, P9062; Davis GD, 1999, BIOTECHNOL BIOENG, V65, P382, DOI 10.1002/(SICI)1097-0290(19991120)65:4<382::AID-BIT2>3.3.CO;2-9; De Marco V, 2004, BIOCHEM BIOPH RES CO, V322, P766, DOI 10.1016/j.bbrc.2004.07.189; Desjardins P., 2009, CURR PROTOC PROTEIN, V55, P10; DIGUAN C, 1988, GENE, V67, P21, DOI 10.1016/0378-1119(88)90004-2; DINGLEY AJ, 1995, J BIOMOL NMR, V6, P321; Dutertre S, 2007, EMBO J, V26, P3858, DOI 10.1038/sj.emboj.7601785; Dyson MR, 2004, BMC BIOTECHNOL, V4, DOI 10.1186/1472-6750-4-32; Ebbinghaus J, 2004, TOXICON, V43, P923, DOI 10.1016/j.toxicon.2003.12.012; Einhauer A, 2001, J BIOCHEM BIOPH METH, V49, P455, DOI 10.1016/S0165-022X(01)00213-5; Fang L, 2007, PROTEIN EXPRES PURIF, V51, P102, DOI 10.1016/j.pep.2006.07.003; FORSBERG G, 1992, J PROTEIN CHEM, V11, P201, DOI 10.1007/BF01025226; Gaberc-Porekar V, 2001, J BIOCHEM BIOPH METH, V49, P335, DOI 10.1016/S0165-022X(01)00207-X; Gaberc-Porekar V, 2005, CHEM ENG TECHNOL, V28, P1306, DOI 10.1002/ceat.200500167; Goldberg Stanley, 2008, V424, P3, DOI 10.1007/978-1-60327-064-9_1; Golovanov AP, 2004, J AM CHEM SOC, V126, P8933, DOI 10.1021/ja049297h; GUAN KL, 1991, ANAL BIOCHEM, V192, P262, DOI 10.1016/0003-2697(91)90534-Z; Hardy MC, 2012, PEST CONTROLLING AGE; Heras B, 2009, NAT REV MICROBIOL, V7, P215, DOI 10.1038/nrmicro2087; Jansson M, 1996, J BIOMOL NMR, V7, P131; Jenny RJ, 2003, PROTEIN EXPRES PURIF, V31, P1, DOI 10.1016/S1046-5928(03)00168-2; Jensen JE, 2009, TOXICON, V54, P56, DOI 10.1016/j.toxicon.2009.03.014; JOCELYN PC, 1967, EUR J BIOCHEM, V2, P327, DOI 10.1111/j.1432-1033.1967.tb00142.x; Johnson JH, 1998, ARCH INSECT BIOCHEM, V38, P19, DOI 10.1002/(SICI)1520-6327(1998)38:1&lt;19::AID-ARCH3&gt;3.0.CO;2-Q; Jung HJ, 2005, BIOCHEMISTRY-US, V44, P6015, DOI 10.1021/bi0477034; Kainosho M, 1997, NAT STRUCT BIOL, V4, P858; Kapust RB, 1999, PROTEIN SCI, V8, P1668, DOI 10.1110/ps.8.8.1668; Kapust RB, 2002, BIOCHEM BIOPH RES CO, V294, P949, DOI 10.1016/S0006-291X(02)00574-0; Kelly AE, 2002, J AM CHEM SOC, V124, P12013, DOI 10.1021/ja026121b; KIEFHABER T, 1991, BIO-TECHNOL, V9, P825, DOI 10.1038/nbt0991-825; King GF, 2010, COMPREHENSIVE NATURAL PRODUCTS II: CHEMISTRY AND BIOLOGY, VOL 9: MODERN METHODS IN NATURAL PRODUCTS CHEMISTRY, P279; King GF, 2013, ANNU REV ENTOMOL, V58, P475, DOI 10.1146/annurev-ento-120811-153650; King GF, 2011, EXPERT OPIN BIOL TH, V11, P1469, DOI 10.1517/14712598.2011.621940; KRAPCHO KJ, 1995, INSECT BIOCHEM MOLEC, V25, P991, DOI 10.1016/0965-1748(95)00029-U; Kurz M, 2006, PROTEIN EXPRES PURIF, V50, P68, DOI 10.1016/j.pep.2006.05.006; Kwan AH, 2011, FEBS J, V278, P687, DOI 10.1111/j.1742-4658.2011.08004.x; Lewis RJ, 2003, NAT REV DRUG DISCOV, V2, P790, DOI 10.1038/nrd1197; Li DL, 2003, FEBS LETT, V555, P616, DOI 10.1016/S0014-5793(03)01303-6; Lipkin A, 2002, TOXICON, V40, P125, DOI 10.1016/S0041-0101(01)00181-7; Listwan Pawel, 2010, Journal of Structural and Functional Genomics, V11, P41, DOI 10.1007/s10969-009-9077-8; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Maertens B, 2010, PROTEIN SCI, V19, P1312, DOI 10.1002/pro.408; Maertens C, 2006, MOL PHARMACOL, V70, P405, DOI 10.1124/mol.106.022970; MAINA CV, 1988, GENE, V74, P365, DOI 10.1016/0378-1119(88)90170-9; Majerle A, 2000, J BIOMOL NMR, V18, P145, DOI 10.1023/A:1008362401928; Makrides SC, 1996, MICROBIOL REV, V60, P512, DOI 10.1128/MMBR.60.3.512-538.1996; Marley J, 2001, J BIOMOL NMR, V20, P71, DOI 10.1023/A:1011254402785; MERTENS N, 1995, BIO-TECHNOL, V13, P175, DOI 10.1038/nbt0295-175; Middleton RE, 2002, BIOCHEMISTRY-US, V41, P14734, DOI 10.1021/bi026546a; Mobli M, 2009, ANGEW CHEM INT EDIT, V48, P9312, DOI 10.1002/anie.200905206; Morales RAV, 2010, CHEMBIOCHEM, V11, P1882, DOI 10.1002/cbic.201000330; NEU HC, 1965, J BIOL CHEM, V240, P3685; Nijeholt JALA, 2012, PHILOS T R SOC B, V367, P1016, DOI 10.1098/rstb.2011.0201; OTTING G, 1993, BIOCHEMISTRY-US, V32, P3571, DOI 10.1021/bi00065a008; OZOLS J, 1990, METHOD ENZYMOL, V182, P587; QIAGEN, 2003, QIAEXPRESSIONIST HDB; QUISTAD GB, 1994, J BIOL CHEM, V269, P11098; REILLY D, 1994, J BIOMOL NMR, V4, P459; Riggs P, 2001, CURRENT PROTOCOLS MO; Robosky LC, 2007, ANAL BIOANAL CHEM, V387, P529, DOI 10.1007/s00216-006-0982-4; Robson SA, 2006, P NATL ACAD SCI USA, V103, P6700, DOI 10.1073/pnas.0601397103; Rudolph R, 1996, FASEB J, V10, P49, DOI 10.1096/fasebj.10.1.8566547; Rutherfurd SM, 2011, CURRENT PROTOCOLS PR; Saez NJ, 2011, MOL PHARMACOL, V80, P796, DOI 10.1124/mol.111.072207; Salinas G, 2011, BIOTECHNOL J, V6, P686, DOI 10.1002/biot.201000335; Schaefer SA, 2013, J MOL BIOL, V425, P222, DOI 10.1016/j.jmb.2012.11.011; Schafer FQ, 2001, FREE RADICAL BIO MED, V30, P1191, DOI 10.1016/S0891-5849(01)00480-4; SCHATZ PJ, 1993, BIO-TECHNOL, V11, P1138, DOI 10.1038/nbt1093-1138; SCHEIN CH, 1990, BIO-TECHNOL, V8, P308, DOI 10.1038/nbt0490-308; SCHMIDT TGM, 1994, J CHROMATOGR A, V676, P337, DOI 10.1016/0021-9673(94)80434-6; Schmidt TGM, 2007, NAT PROTOC, V2, P1528, DOI 10.1038/nprot.2007.209; Siemens J, 2006, NATURE, V444, P208, DOI 10.1038/nature05285; Sivashanmugam A, 2009, PROTEIN SCI, V18, P936, DOI 10.1002/pro.102; SKINNER WS, 1992, TOXICON, V30, P1043, DOI 10.1016/0041-0101(92)90049-B; SMITH DB, 1988, GENE, V67, P31, DOI 10.1016/0378-1119(88)90005-4; Sollod BL, 2005, PEPTIDES, V26, P131, DOI 10.1016/j.peptides.2004.07.016; STOFKOHAHN RE, 1992, FEBS LETT, V302, P274, DOI 10.1016/0014-5793(92)80458-S; Tyler RC, 2005, PROTEIN EXPRES PURIF, V40, P268, DOI 10.1016/j.pep.2004.12.024; Tytgat J, 2001, FEBS LETT, V491, P217, DOI 10.1016/S0014-5793(01)02201-3; Vetter I, 2011, AMINO ACIDS, V40, P15, DOI 10.1007/s00726-010-0516-4; Walewska A, 2009, ANGEW CHEM INT EDIT, V48, P2221, DOI 10.1002/anie.200806085; WALKER PA, 1994, BIO-TECHNOL, V12, P601, DOI 10.1038/nbt0694-601; Waugh DS, 2011, PROTEIN EXPRES PURIF, V80, P283, DOI 10.1016/j.pep.2011.08.005; Waugh DS, 2005, TRENDS BIOTECHNOL, V23, P316, DOI 10.1016/j.tibtech.2005.03.012; Waugh DS, 2010, TEV PROTEASE FAQ; Xiao XC, 2003, EUR J PHARMACOL, V477, P1, DOI 10.1016/S0014-2999(03)02190-3; Xiao YC, 2003, TOXICON, V41, P643, DOI 10.1016/S0041-0101(02)00280-5; Yang S, 2012, MOL CELL PROTEOMICS, V11, P640, DOI 10.1074/mcp.M112.018853; Young CL, 2012, BIOTECHNOL J, V7, P620, DOI 10.1002/biot.201100155; Zhang YB, 2004, PROTEIN EXPRES PURIF, V36, P207, DOI 10.1016/j.pep.2004.04.020; Zheng CF, 1997, GENE, V186, P55, DOI 10.1016/S0378-1119(96)00680-4	111	117	122	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e63865	10.1371/journal.pone.0063865	http://dx.doi.org/10.1371/journal.pone.0063865			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667680	gold, Green Published			2022-12-27	WOS:000319654700190
J	Omranian, N; Klie, S; Mueller-Roeber, B; Nikoloski, Z				Omranian, Nooshin; Klie, Sebastian; Mueller-Roeber, Bernd; Nikoloski, Zoran			Network-Based Segmentation of Biological Multivariate Time Series	PLOS ONE			English	Article							JOINT SEGMENTATION; CENTRALITY; CYCLE; MODELS	Molecular phenotyping technologies (e.g., transcriptomics, proteomics, and metabolomics) offer the possibility to simultaneously obtain multivariate time series (MTS) data from different levels of information processing and metabolic conversions in biological systems. As a result, MTS data capture the dynamics of biochemical processes and components whose couplings may involve different scales and exhibit temporal changes. Therefore, it is important to develop methods for determining the time segments in MTS data, which may correspond to critical biochemical events reflected in the coupling of the system's components. Here we provide a novel network-based formalization of the MTS segmentation problem based on temporal dependencies and the covariance structure of the data. We demonstrate that the problem of partitioning MTS data into k segments to maximize a distance function, operating on polynomially computable network properties, often used in analysis of biological network, can be efficiently solved. To enable biological interpretation, we also propose a breakpoint-penalty (BP-penalty) formulation for determining MTS segmentation which combines a distance function with the number/length of segments. Our empirical analyses of synthetic benchmark data as well as time-resolved transcriptomics data from the metabolic and cell cycles of Saccharomyces cerevisiae demonstrate that the proposed method accurately infers the phases in the temporal compartmentalization of biological processes. In addition, through comparison on the same data sets, we show that the results from the proposed formalization of the MTS segmentation problem match biological knowledge and provide more rigorous statistical support in comparison to the contending state-of-the-art methods.	[Omranian, Nooshin; Mueller-Roeber, Bernd] Univ Potsdam, Inst Biochem & Biol, Potsdam, Germany; [Omranian, Nooshin; Nikoloski, Zoran] Max Planck Inst Mol Plant Physiol, Syst Biol & Math Modeling Grp, Potsdam, Germany; [Klie, Sebastian] Max Planck Inst Mol Plant Physiol, Genes & Small Mol Grp, Potsdam, Germany	University of Potsdam; Max Planck Society; Max Planck Society	Nikoloski, Z (corresponding author), Max Planck Inst Mol Plant Physiol, Syst Biol & Math Modeling Grp, Potsdam, Germany.	nikoloski@mpimp-golm.mpg.de	Mueller-Roeber, Bernd/Z-4052-2019; omranian, nooshin/F-1233-2011	omranian, nooshin/0000-0001-5548-4338; Nikoloski, Zoran/0000-0003-2671-6763				Abonyi J, 2005, FUZZY SET SYST, V149, P39, DOI 10.1016/j.fss.2004.07.008; Albert R, 2005, J CELL SCI, V118, P4947, DOI 10.1242/jcs.02714; Batal L, 2009, P 22 INT FLOR ART IN, P344; BELLMAN R, 1969, J AM STAT ASSOC, V64, P1079; Brockwell P., 1996, INTRO TIME SERIES FO; Dobigeon N, 2007, IEEE T SIGNAL PROCES, V55, P414, DOI 10.1109/TSP.2006.885768; Duchene F, 2007, ARTIF INTELL MED, V39, P25, DOI 10.1016/j.artmed.2006.07.004; Fearnhead P, 2006, STAT COMPUT, V16, P203, DOI 10.1007/s11222-006-8450-8; Fisher J, 2007, NAT BIOTECHNOL, V25, P1239, DOI 10.1038/nbt1356; FREEMAN LC, 1979, SOC NETWORKS, V1, P215, DOI 10.1016/0378-8733(78)90021-7; FREEMAN LC, 1977, SOCIOMETRY, V40, P35, DOI 10.2307/3033543; GIONIS A, 2003, P 7 ANN INT C COMP M, V3, P123; Graves D, 2009, PROCEEDINGS OF THE JOINT 2009 INTERNATIONAL FUZZY SYSTEMS ASSOCIATION WORLD CONGRESS AND 2009 EUROPEAN SOCIETY OF FUZZY LOGIC AND TECHNOLOGY CONFERENCE, P1108; Guha GKS01b] Sudipto, 2001, P 33 ANN ACM S THEOR, P471, DOI DOI 10.1145/380752.380841; Hahn M. W., 2004, MOL BIOL EVOL, V22, P7; Jeong H, 2001, NATURE, V411, P41, DOI 10.1038/35075138; Joy MP, 2005, J BIOMED BIOTECHNOL, P96, DOI 10.1155/JBB.2005.96; KAHN AB, 1962, COMMUN ACM, V5, P558, DOI 10.1145/368996.369025; KEOGH E, 2003, DATA MINING TIME SER, P1, DOI DOI 10.1142/97898125654020001; Kleinberg J., 2005, ALGORITHM DESIGN; Koschutzki D, 2008, GENE REGUL SYST BIO, V2, P193, DOI 10.4137/GRSB.S702; Kruglyak S, 2001, J COMPUT BIOL, V8, P463, DOI 10.1089/106652701753216486; Manimaran P, 2009, MOL BIOSYST, V5, P1936, DOI [10.1039/b905264j, 10.1039/B905264j]; Picard F, 2011, COMPUT STAT DATA AN, V55, P1160, DOI 10.1016/j.csda.2010.09.015; Ramakrishnan N, 2010, P NATL ACAD SCI USA, V107, P12511, DOI 10.1073/pnas.1006283107; Ramoni M, 2002, MACH LEARN, V47, P91, DOI 10.1023/A:1013635829250; Shapira M, 2004, MOL BIOL CELL, V15, P5659, DOI 10.1091/mbc.E04-04-0340; Spellman PT, 1998, MOL BIOL CELL, V9, P3273, DOI 10.1091/mbc.9.12.3273; Steuer R, 2003, BIOCHEM SOC T, V31, P1476; Sweetlove LJ, 2008, BIOCHEM J, V409, P27, DOI 10.1042/BJ20071115; Tadepalli S, 2008, WODES' 08: PROCEEDINGS OF THE 9TH INTERNATIONAL WORKSHOP ON DISCRETE EVENT SYSTEMS, P406, DOI 10.1109/WODES.2008.4605980; TERZI E, 2006, SDM; Tu BP, 2005, SCIENCE, V310, P1152, DOI 10.1126/science.1120499; Tucker A, 2001, INT J INTELL SYST, V16, P621, DOI 10.1002/int.1027; Xuan X., 2007, P 24 INT C MACH LEAR, P1055, DOI DOI 10.1145/1273496.1273629; Yang KY, 2007, INFORM COMPUT, V205, P65, DOI 10.1016/j.ic.2006.08.004; Yin J., 2005, AAAI, P28	38	4	4	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e62974	10.1371/journal.pone.0062974	http://dx.doi.org/10.1371/journal.pone.0062974			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667552	Green Published, Green Submitted, gold			2022-12-27	WOS:000319654700090
J	Sevilla-Reyes, EE; Chavaro-Perez, DA; Piten-Isidro, E; Gutierrez-Gonzalez, LH; Santos-Mendoza, T				Sevilla-Reyes, Edgar E.; Chavaro-Perez, David A.; Piten-Isidro, Elvira; Gutierrez-Gonzalez, Luis H.; Santos-Mendoza, Teresa			Protein Clustering and RNA Phylogenetic Reconstruction of the Influenza a Virus NS1 Protein Allow an Update in Classification and Identification of Motif Conservation	PLOS ONE			English	Article							NONSTRUCTURAL PROTEIN-1; CD-HIT; RIG-I; NEURAMINIDASE; REPLICATION; EXPRESSION; PHILOSOPHY; PROGRAM; TARGET; GENES	The non-structural protein 1 (NS1) of influenza A virus (IAV), coded by its third most diverse gene, interacts with multiple molecules within infected cells. NS1 is involved in host immune response regulation and is a potential contributor to the virus host range. Early phylogenetic analyses using 50 sequences led to the classification of NS1 gene variants into groups (alleles) A and B. We reanalyzed NS1 diversity using 14,716 complete NS IAV sequences, downloaded from public databases, without host bias. Removal of sequence redundancy and further structured clustering at 96.8% amino acid similarity produced 415 clusters that enhanced our capability to detect distinct subgroups and lineages, which were assigned a numerical nomenclature. Maximum likelihood phylogenetic reconstruction using RNA sequences indicated the previously identified deep branching separating group A from group B, with five distinct subgroups within A as well as two and five lineages within the A4 and A5 subgroups, respectively. Our classification model proposes that sequence patterns in thirteen amino acid positions are sufficient to fit >99.9% of all currently available NS1 sequences into the A subgroups/lineages or the B group. This classification reduces host and virus bias through the prioritization of NS1 RNA phylogenetics over host or virus phenetics. We found significant sequence conservation within the subgroups and lineages with characteristic patterns of functional motifs, such as the differential binding of CPSF30 and crk/crkL or the availability of a C-terminal PDZ-binding motif. To understand selection pressures and evolution acting on NS1, it is necessary to organize the available data. This updated classification may help to clarify and organize the study of NS1 interactions and pathogenic differences and allow the drawing of further functional inferences on sequences in each group, subgroup and lineage rather than on a strain-by-strain basis.	[Sevilla-Reyes, Edgar E.; Chavaro-Perez, David A.; Piten-Isidro, Elvira] Inst Nacl Enfermedades Resp Ismael Cosio Villegas, Dept Invest Enfermedades Infecciosas, Mexico City, DF, Mexico; [Gutierrez-Gonzalez, Luis H.] Inst Nacl Enfermedades Resp Ismael Cosio Villegas, Dept Virol & Micol, Mexico City, DF, Mexico; [Santos-Mendoza, Teresa] Inst Nacl Enfermedades Resp Ismael Cosio Villegas, Dept Inmunol, Mexico City, DF, Mexico		Sevilla-Reyes, EE (corresponding author), Inst Nacl Enfermedades Resp Ismael Cosio Villegas, Dept Invest Enfermedades Infecciosas, Mexico City, DF, Mexico.	edgar.sevilla@gmail.com; tesalonster@gmail.com	Sevilla, Edgar/AAS-3300-2021; Santos-Mendoza, Teresa/AAK-8528-2021	Sevilla, Edgar/0000-0002-7047-0222; Santos-Mendoza, Teresa/0000-0003-1015-5631; Gutierrez-Gonzalez, Luis Horacio/0000-0003-0708-0448	Consejo Nacional de Ciencia y Tecnologia [CB2010-155382]; Instituto De Ciencia Y Tecnologia Del Distrito Federal [PIFUTP09-281]	Consejo Nacional de Ciencia y Tecnologia(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Instituto De Ciencia Y Tecnologia Del Distrito Federal	Project supported by Consejo Nacional de Ciencia y Tecnologia grant CB2010-155382 and Instituto De Ciencia Y Tecnologia Del Distrito Federal grant PIFUTP09-281. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aragon T, 2000, MOL CELL BIOL, V20, P6259, DOI 10.1128/MCB.20.17.6259-6268.2000; Bao YM, 2008, J VIROL, V82, P596, DOI 10.1128/JVI.02005-07; BELLETT A. J. D., 1967, J VIROL, V1, P245; Boni MF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010434; Centers for Disease Control and Prevention (CDC), 2011, MMWR Morb Mortal Wkly Rep, V60, P1615; Chen GW, 2006, EMERG INFECT DIS, V12, P1353, DOI 10.3201/eid1209.060276; Chen RB, 2006, MOL BIOL EVOL, V23, P2336, DOI 10.1093/molbev/msl102; Chen RB, 2010, J MOL EVOL, V70, P98, DOI 10.1007/s00239-009-9312-8; COWAN ST, 1955, J GEN MICROBIOL, V12, P314, DOI 10.1099/00221287-12-2-314; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Dugan VG, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000076; Dundon WG, 2012, VIRUS GENES, V44, P363, DOI 10.1007/s11262-012-0714-0; Dundon WG, 2009, VIRUSES-BASEL, V1, P1057, DOI 10.3390/v1031057; Fouchier RAM, 2005, J VIROL, V79, P2814, DOI 10.1128/JVI.79.5.2814-2822.2005; Garten RJ, 2009, SCIENCE, V325, P197, DOI 10.1126/science.1176225; Guo Z, 2007, AM J RESP CELL MOL, V36, P263, DOI 10.1165/rcmb.2006-0283RC; Hale BG, 2008, J GEN VIROL, V89, P2359, DOI 10.1099/vir.0.2008/004606-0; Hale BG, 2010, J VIROL, V84, P6909, DOI 10.1128/JVI.00081-10; Heikkinen LS, 2008, J BIOL CHEM, V283, P5719, DOI 10.1074/jbc.M707195200; Huang Y, 2010, BIOINFORMATICS, V26, P680, DOI 10.1093/bioinformatics/btq003; Igarashi M, 2008, VIROLOGY, V376, P323, DOI 10.1016/j.virol.2008.03.036; Imai M, 2012, NATURE, V486, P420, DOI 10.1038/nature10831; Jackson D, 2008, P NATL ACAD SCI USA, V105, P4381, DOI 10.1073/pnas.0800482105; Kainov DE, 2011, J BIOL CHEM, V286, P7239, DOI 10.1074/jbc.M110.203489; Katoh K, 2008, BRIEF BIOINFORM, V9, P286, DOI 10.1093/bib/bbn013; Kobasa D, 1997, J VIROL, V71, P6706, DOI 10.1128/JVI.71.9.6706-6713.1997; Kochs G, 2007, J VIROL, V81, P7011, DOI 10.1128/JVI.02581-06; Lazarevic V, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-523; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; LUDWIG S, 1991, VIROLOGY, V183, P566, DOI 10.1016/0042-6822(91)90985-K; Martin DP, 2010, BIOINFORMATICS, V26, P2462, DOI 10.1093/bioinformatics/btq467; Min JY, 2007, VIROLOGY, V363, P236, DOI 10.1016/j.virol.2007.01.038; Miotto O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009025; Munir M, 2011, J GEN VIROL, V92, P2111, DOI 10.1099/vir.0.031716-0; NELSON GJ, 1971, SYST ZOOL, V20, P373, DOI 10.2307/2412351; Noronha JM, 2012, J VIROL, V86, P5857, DOI 10.1128/JVI.06901-11; Obenauer JC, 2006, SCIENCE, V311, P1576, DOI 10.1126/science.1121586; Opitz B, 2007, CELL MICROBIOL, V9, P930, DOI 10.1111/j.1462-5822.2006.00841.x; Pal S, 2010, J VIROL METHODS, V163, P498, DOI 10.1016/j.jviromet.2009.11.010; Pichlmair A, 2006, SCIENCE, V314, P997, DOI 10.1126/science.1132998; Russell CA, 2012, SCIENCE, V336, P1541, DOI 10.1126/science.1222526; Smith GJD, 2012, INFLUENZA OTHER RESP, V6, P1, DOI 10.1111/j.1750-2659.2011.00298.x; Smith GJD, 2009, NATURE, V459, P1122, DOI 10.1038/nature08182; Soubies SM, 2010, J VIROL, V84, P6733, DOI 10.1128/JVI.02427-09; Squires RB, 2012, INFLUENZA OTHER RESP, V6, P404, DOI 10.1111/j.1750-2659.2011.00331.x; Suzek BE, 2007, BIOINFORMATICS, V23, P1282, DOI 10.1093/bioinformatics/btm098; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tong SX, 2012, P NATL ACAD SCI USA, V109, P4269, DOI 10.1073/pnas.1116200109; TREANOR JJ, 1989, VIROLOGY, V171, P1, DOI 10.1016/0042-6822(89)90504-7; Twu KY, 2007, J VIROL, V81, P8112, DOI 10.1128/JVI.00006-07; VANREGENMORTEL MHV, 1991, ARCH VIROL, V120, P313, DOI 10.1007/BF01310487; VANREGENMORTEL MHV, 1989, ARCH VIROL, V104, P1, DOI 10.1007/BF01313804; WEBSTER RG, 1992, MICROBIOL REV, V56, P152, DOI 10.1128/MMBR.56.1.152-179.1992; Xu K, 2011, J VIROL, V85, P1086, DOI 10.1128/JVI.00877-10	54	8	8	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e63098	10.1371/journal.pone.0063098	http://dx.doi.org/10.1371/journal.pone.0063098			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667580	Green Published, Green Submitted, gold			2022-12-27	WOS:000319654700112
J	Wang, S; Hou, R; Bao, ZM; Du, HX; He, Y; Su, HL; Zhang, YY; Fu, XT; Jiao, WQ; Li, Y; Zhang, LL; Wang, S; Hu, XL				Wang, Shan; Hou, Rui; Bao, Zhenmin; Du, Huixia; He, Yan; Su, Hailin; Zhang, Yueyue; Fu, Xiaoteng; Jiao, Wenqian; Li, Yan; Zhang, Lingling; Wang, Shi; Hu, Xiaoli			Transcriptome Sequencing of Zhikong Scallop (Chlamys farreri) and Comparative Transcriptomic Yesso Scallop (Patinopecten yessoensis)	PLOS ONE			English	Article							IMMUNE-RESPONSE; GENE; ANNOTATION; EXPRESSION; TOOL; CONSTRUCTION; DIVERGENCE; SELECTION; BLAST2GO; JONES	Background: Bivalves play an important role in the ecosystems they inhabit and represent an important food source all over the world. So far limited genetic research has focused on this group of animals largely due to the lack of sufficient genetic or genomic resources. Here, we performed de novo transcriptome sequencing to produce the most comprehensive expressed sequence tag resource for Zhikong scallop (Chlamys farreri), and conducted the first transcriptome comparison for scallops. Results: In a single 454 sequencing run, 1,033,636 reads were produced and then assembled into 26,165 contigs. These contigs were then clustered into 24,437 isotigs and further grouped into 20,056 isogroups. About 47% of the isogroups showed significant matches to known proteins based on sequence similarity. Transcripts putatively involved in growth, reproduction and stress/immune-response were identified through Gene ontology (GO) and KEGG pathway analyses. Transcriptome comparison with Yesso scallop (Patinopecten yessoensis) revealed similar patterns of GO representation. Moreover, 38 putative fast-evolving genes were identified through analyzing the orthologous gene pairs between the two scallop species. More than 46,000 single nucleotide polymorphisms (SNPs) and 350 simple sequence repeats (SSRs) were also detected. Conclusion: Our study provides the most comprehensive transcriptomic resource currently available for C. farreri. Based on this resource, we performed the first large-scale transcriptome comparison between the two scallop species, C. farreri and P. yessoensis, and identified a number of putative fast-evolving genes, which may play an important role in scallop speciation and/or local adaptation. A large set of single nucleotide polymorphisms and simple sequence repeats were identified, which are ready for downstream marker development. This transcriptomic resource should lay an important foundation for future genetic or genomic studies on C. farreri.	[Wang, Shan; Hou, Rui; Bao, Zhenmin; Du, Huixia; He, Yan; Su, Hailin; Zhang, Yueyue; Fu, Xiaoteng; Jiao, Wenqian; Li, Yan; Zhang, Lingling; Wang, Shi; Hu, Xiaoli] Ocean Univ China, Coll Marine Life Sci, Minist Educ, Key Lab Marine Genet & Breeding MGB, Qingdao, Peoples R China	Ocean University of China	Wang, S (corresponding author), Ocean Univ China, Coll Marine Life Sci, Minist Educ, Key Lab Marine Genet & Breeding MGB, Qingdao, Peoples R China.	swang@ouc.edu.cn; hxl707@ouc.edu.cn	Su, Hailin/D-1352-2017; zhang, lingling/HDM-2189-2022	Su, Hailin/0000-0002-0284-2071; 	National Basic Research Program of China [973 Program] [2010CB126406]; National Natural Science Foundation of China [31172384, 30972239]; National High Technology Research and Development Program of China [2012AA092204, 2012AA10405, 2012AA10402, 2012AA10401]; Open Project Program of the Key Laboratory of Marine Bio-resources Sustainable Utilization; SCSIO; CAS; China Ministry of Education	National Basic Research Program of China [973 Program](National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); Open Project Program of the Key Laboratory of Marine Bio-resources Sustainable Utilization; SCSIO; CAS(Chinese Academy of Sciences); China Ministry of Education(Ministry of Education, China)	This work was supported by National Basic Research Program of China [973 Program, 2010CB126406], National Natural Science Foundation of China [31172384, 30972239], National High Technology Research and Development Program of China [2012AA092204, 2012AA10405, 2012AA10402, 2012AA10401], Open Project Program of the Key Laboratory of Marine Bio-resources Sustainable Utilization, SCSIO, CAS and Scholarship award for Excellent Doctoral Student granted by China Ministry of Education. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agelopoulou B, 2004, BBA-GENE STRUCT EXPR, V1676, P12, DOI 10.1016/j.bbaexp.2003.10.004; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Baldo L, 2011, GENOME BIOL EVOL, V3, P443, DOI 10.1093/gbe/evr047; Barakat A, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-51; Bettencourt R, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-559; Bieler R, 2006, ZOOL J LINN SOC-LOND, V148, P223, DOI 10.1111/j.1096-3642.2006.00255.x; Brand Andrew R., 2006, Developments in Aquaculture and Fisheries Science, V35, P651; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Conesa Ana, 2008, Int J Plant Genomics, V2008, P619832, DOI 10.1155/2008/619832; Cox DN, 2000, DEVELOPMENT, V127, P503; Craft JA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008875; Du HX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033311; Durban J, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-259; Gotz S, 2008, NUCLEIC ACIDS RES, V36, P3420, DOI 10.1093/nar/gkn176; Hou R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021560; Hu XL, 2006, AQUAC RES, V37, P1187, DOI 10.1111/j.1365-2109.2006.01546.x; Hu XL, 2010, GENES GENET SYST, V85, P207, DOI 10.1266/ggs.85.207; Huan P, 2012, MAR BIOTECHNOL, V14, P69, DOI 10.1007/s10126-011-9389-0; Jiang GD, 2011, CONSERV GENET RESOUR, V3, P659, DOI 10.1007/s12686-011-9427-2; Joubert C, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-613; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; KAUTSKY MP, 1970, J BIOL CHEM, V245, P1978; Kinoshita S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021238; Kofler R, 2007, BIOINFORMATICS, V23, P1683, DOI 10.1093/bioinformatics/btm157; Kukekova AV, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-482; Li FM, 2011, DEV COMP IMMUNOL, V35, P62, DOI 10.1016/j.dci.2010.08.009; Marracci S, 2007, DEV GENES EVOL, V217, P395, DOI 10.1007/s00427-007-0143-6; Meyer E, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-219; Milan M, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-234; Overbeek R, 1999, P NATL ACAD SCI USA, V96, P2896, DOI 10.1073/pnas.96.6.2896; PAUSE A, 1992, EMBO J, V11, P2643, DOI 10.1002/j.1460-2075.1992.tb05330.x; Raz E, 2000, GENOME BIOL, V1, P1, DOI [10.1186/gb-2000-1-3-reviews1017, DOI 10.1186/GB-2000-1-3-REVIEWS1017]; Rismani-Yazdi H, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-148; Saavedra C, 2006, AQUACULTURE, V256, P1, DOI 10.1016/j.aquaculture.2006.02.023; Shi XD, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0037054, 10.1371/journal.pone.0030828]; Shi XW, 2012, DEV COMP IMMUNOL, V37, P270, DOI 10.1016/j.dci.2012.03.008; SPIETH J, 1991, J MOL EVOL, V32, P429, DOI 10.1007/BF02101283; Tiffin P, 2002, J MOL EVOL, V54, P746, DOI 10.1007/s0023901-0074-1; Vera JC, 2008, MOL ECOL, V17, P1636, DOI 10.1111/j.1365-294X.2008.03666.x; WALLER TR, 1991, SCALLOPS BIOL ECOLOG, P1; Wang S, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r126; Wang XW, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-458; Wang XW, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-400; Wang XJ, 2012, CONSERV GENET RESOUR, V4, P747, DOI 10.1007/s12686-012-9636-3; Wang YP, 2007, MAR BIOTECHNOL, V9, P500, DOI 10.1007/s10126-007-9011-7; Yang ZH, 2000, MOL BIOL EVOL, V17, P32, DOI 10.1093/oxfordjournals.molbev.a026236; Zhan A, 2009, ANIM GENET, V40, P821, DOI 10.1111/j.1365-2052.2009.01920.x; Zhang Zhang, 2006, Genomics Proteomics & Bioinformatics, V4, P259, DOI 10.1016/S1672-0229(07)60007-2; Zhou Z, 2012, FISH SHELLFISH IMMUN, V33, P375, DOI 10.1016/j.fsi.2012.05.022; Zhou Z, 2011, FISH SHELLFISH IMMUN, V31, P1065, DOI 10.1016/j.fsi.2011.09.009; Zhou Z, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018596	51	47	48	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e63927	10.1371/journal.pone.0063927	http://dx.doi.org/10.1371/journal.pone.0063927			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667690	Green Submitted, Green Published, gold			2022-12-27	WOS:000319654700195
J	Cole, S; Richardson, R; McNally, GP				Cole, Sindy; Richardson, Rick; McNally, Gavan P.			Ventral Hippocampal Kappa Opioid Receptors Mediate the Renewal of Fear following Extinction in the Rat	PLOS ONE			English	Article							INACTIVATION DISRUPTS; NOR-BINALTORPHIMINE; PREFRONTAL CORTEX; AMYGDALA; DORSAL; ACQUISITION; PROJECTIONS; ANTAGONISTS; EXPRESSION; STRESS	The hippocampus is part of a neural network which regulates the renewal of fear following extinction. Both the ventral (VH) and dorsal (DH) hippocampus have been shown to be necessary for renewal, however the critical receptors and neurotransmitters mediating these contributions are poorly understood. One candidate mechanism is the kappa opioid receptor (KOR) system, which has been implicated in fear learning and anxiety. Here we examined the effect of the KOR antagonist norbinaltorphamine hydrochloride (norBNI), infused into either the VH or DH, on the renewal of extinguished fear. We found that an infusion of norBNI into the VH significantly reduced the relapse of fear on test compared to that seen in saline controls (Experiment 1), while similar infusions of norBNI into the DH had no effect on renewal (Experiment 2). These findings show that hippocampal KORs are involved in fear renewal and also identify a dissociation in the contribution of VH and DH KORs to the expression of renewed fear.	[Cole, Sindy; Richardson, Rick; McNally, Gavan P.] Univ New S Wales, Sch Psychol, Sydney, NSW, Australia	University of New South Wales Sydney	McNally, GP (corresponding author), Univ New S Wales, Sch Psychol, Sydney, NSW, Australia.	g.mcnally@unsw.edu.au		McNally, Gavan/0000-0001-9061-6463; Richardson, Rick/0000-0003-1833-9777	Australian Research Council [DP0880854]	Australian Research Council(Australian Research Council)	This work was supported by an Australian Research Council award to Rick Richardson and Gavan P. McNally (DP0880854) (http://www.arc.gov.au/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bilkei-Gorzo A, 2012, J NEUROSCI, V32, P9335, DOI 10.1523/JNEUROSCI.1034-12.2012; Bird K. D., 2004, ANAL VARIANCE VIA CO; BOUTON ME, 1979, LEARN MOTIV, V10, P445, DOI 10.1016/0023-9690(79)90057-2; Burgos-Robles A, 2009, J NEUROSCI, V29, P8474, DOI 10.1523/JNEUROSCI.0378-09.2009; Cenquizca LA, 2007, BRAIN RES REV, V56, P1, DOI 10.1016/j.brainresrev.2007.05.002; Cole S, 2011, LEARN MEMORY, V18, P88, DOI 10.1101/lm.2049511; Corcoran KA, 2005, J NEUROSCI, V25, P8978, DOI 10.1523/JNEUROSCI.2246-05.2005; Corcoran KA, 2001, J NEUROSCI, V21, P1720, DOI 10.1523/JNEUROSCI.21-05-01720.2001; Drake CT, 2007, PROG BRAIN RES, V163, P245, DOI 10.1016/S0079-6123(07)63015-5; Fanselow MS, 2010, NEURON, V65, P7, DOI 10.1016/j.neuron.2009.11.031; FANSELOW MS, 1991, PEPTIDES, V12, P1033, DOI 10.1016/0196-9781(91)90056-U; Fanselow MS, 2000, BEHAV BRAIN RES, V110, P73, DOI 10.1016/S0166-4328(99)00186-2; Grillon C, 2007, NEUROPSYCHOPHARMACOL, V32, P225, DOI 10.1038/sj.npp.1301204; Halasy K, 2000, J CHEM NEUROANAT, V19, P233, DOI 10.1016/S0891-0618(00)00068-5; HENKE PG, 1990, BRAIN RES BULL, V25, P691, DOI 10.1016/0361-9230(90)90044-Z; Herry C, 2008, NATURE, V454, P600, DOI 10.1038/nature07166; Hobin JA, 2006, HIPPOCAMPUS, V16, P174, DOI 10.1002/hipo.20144; HORAN P, 1992, J PHARMACOL EXP THER, V260, P1237; Ishikawa A, 2006, J NEUROPHYSIOL, V96, P2134, DOI 10.1152/jn.00069.2006; Ji JZ, 2005, LEARN MEMORY, V12, P270, DOI 10.1101/lm.91705; Kanoski SE, 2013, BIOL PSYCHIAT, V73, P915, DOI 10.1016/j.biopsych.2012.07.002; Kishi T, 2000, J COMP NEUROL, V419, P205, DOI 10.1002/(SICI)1096-9861(20000403)419:2<205::AID-CNE5>3.0.CO;2-0; Kjelstrup KG, 2002, P NATL ACAD SCI USA, V99, P10825, DOI 10.1073/pnas.152112399; Knapska E, 2009, LEARN MEMORY, V16, P486, DOI 10.1101/lm.1463909; Knoll AT, 2007, J PHARMACOL EXP THER, V323, P838, DOI 10.1124/jpet.107.127415; Knoll AT, 2010, BRAIN RES, V1314, P56, DOI 10.1016/j.brainres.2009.09.074; Lemos JC, 2011, RECEPT SER, P265, DOI 10.1007/978-1-60761-993-2_11; Mague SD, 2003, J PHARMACOL EXP THER, V305, P323, DOI 10.1124/jpet.102.046433; Maren S, 2004, BEHAV NEUROSCI, V118, P97, DOI 10.1037/0735-7044.118.1.97; Maren S, 2011, NEURON, V70, P830, DOI 10.1016/j.neuron.2011.04.023; MOSER MB, 1995, P NATL ACAD SCI USA, V92, P9697, DOI 10.1073/pnas.92.21.9697; NEUMAIER JF, 1988, J PHARMACOL EXP THER, V244, P564; Orsini CA, 2011, J NEUROSCI, V31, P17269, DOI 10.1523/JNEUROSCI.4095-11.2011; Paxinos G., 2007, RAT BRAIN STEREOTAXI, V6th ed.; Pitkanen A, 2000, ANN NY ACAD SCI, V911, P369; Quirk GJ, 2008, NEUROPSYCHOPHARMACOL, V33, P56, DOI 10.1038/sj.npp.1301555; Rescorla RA, 2001, HANDBOOK OF CONTEMPORARY LEARNING THEORIES, P119; Shirayama Y, 2004, J NEUROCHEM, V90, P1258, DOI 10.1111/j.1471-4159.2004.02589.x; Sierra-Mercado D, 2011, NEUROPSYCHOPHARMACOL, V36, P529, DOI 10.1038/npp.2010.184; TEMPEL A, 1987, P NATL ACAD SCI USA, V84, P4308, DOI 10.1073/pnas.84.12.4308; Zhang H, 2007, EUR J PHARMACOL, V570, P89, DOI 10.1016/j.ejphar.2007.05.045; ZUKIN RS, 1988, P NATL ACAD SCI USA, V85, P4061, DOI 10.1073/pnas.85.11.4061	42	10	10	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2013	8	5							e58701	10.1371/journal.pone.0058701	http://dx.doi.org/10.1371/journal.pone.0058701			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	143FO	23675405	Green Published, gold, Green Submitted			2022-12-27	WOS:000318852400001
J	Dos Santos, HG; Abia, D; Janowski, R; Mortuza, G; Bertero, MG; Boutin, M; Guarin, N; Mendez-Giraldez, R; Nunez, A; Pedrero, JG; Redondo, P; Sanz, M; Speroni, S; Teichert, F; Bruix, M; Carazo, JM; Gonzalez, C; Reina, J; Valpuesta, JM; Vernos, I; Zabala, JC; Montoya, G; Coll, M; Bastolla, U; Serrano, L				Dos Santos, Helena G.; Abia, David; Janowski, Robert; Mortuza, Gulnahar; Bertero, Michela G.; Boutin, Mailys; Guarin, Nayibe; Mendez-Giraldez, Raul; Nunez, Alfonso; Pedrero, Juan G.; Redondo, Pilar; Sanz, Maria; Speroni, Silvia; Teichert, Florian; Bruix, Marta; Carazo, Jose M.; Gonzalez, Cayetano; Reina, Jose; Valpuesta, Jose M.; Vernos, Isabelle; Zabala, Juan C.; Montoya, Guillermo; Coll, Miquel; Bastolla, Ugo; Serrano, Luis			Structure and Non-Structure of Centrosomal Proteins	PLOS ONE			English	Article							FUNCTIONAL-ANALYSIS; PREDICTION; DATABASE; DISORDER; SEQUENCE; TOOL; RECOGNITION; COMPLEXITY; NETWORKS; BINDING	Here we perform a large-scale study of the structural properties and the expression of proteins that constitute the human Centrosome. Centrosomal proteins tend to be larger than generic human proteins (control set), since their genes contain in average more exons (20.3 versus 14.6). They are rich in predicted disordered regions, which cover 57% of their length, compared to 39% in the general human proteome. They also contain several regions that are dually predicted to be disordered and coiled-coil at the same time: 55 proteins (15%) contain disordered and coiled-coil fragments that cover more than 20% of their length. Helices prevail over strands in regions homologous to known structures (47% predicted helical residues against 17% predicted as strands), and even more in the whole centrosomal proteome (52% against 7%), while for control human proteins 34.5% of the residues are predicted as helical and 12.8% are predicted as strands. This difference is mainly due to residues predicted as disordered and helical (30% in centrosomal and 9.4% in control proteins), which may correspond to alpha-helix forming molecular recognition features (alpha-MoRFs). We performed expression assays for 120 full-length centrosomal proteins and 72 domain constructs that we have predicted to be globular. These full-length proteins are often insoluble: Only 39 out of 120 expressed proteins (32%) and 19 out of 72 domains (26%) were soluble. We built or retrieved structural models for 277 out of 361 human proteins whose centrosomal localization has been experimentally verified. We could not find any suitable structural template with more than 20% sequence identity for 84 centrosomal proteins (23%), for which around 74% of the residues are predicted to be disordered or coiled-coils. The three-dimensional models that we built are available at http://ub.cbm.uam.es/centrosome/models/index.php.	[Dos Santos, Helena G.; Abia, David; Mendez-Giraldez, Raul; Nunez, Alfonso; Teichert, Florian; Bastolla, Ugo] CSIC UAM, CBMSO, Madrid, Spain; [Janowski, Robert; Boutin, Mailys; Guarin, Nayibe; Coll, Miquel] IBMB, Barcelona, Spain; [Janowski, Robert; Boutin, Mailys; Guarin, Nayibe; Gonzalez, Cayetano; Reina, Jose; Coll, Miquel] Inst Res Biomed IRB Barcelona, Barcelona, Spain; [Mortuza, Gulnahar; Pedrero, Juan G.; Redondo, Pilar; Montoya, Guillermo] CNIO, Madrid, Spain; [Bertero, Michela G.; Sanz, Maria; Speroni, Silvia; Vernos, Isabelle; Serrano, Luis] CRG, Barcelona, Spain; [Bruix, Marta] CSIC, IQFR, Madrid, Spain; [Carazo, Jose M.; Valpuesta, Jose M.] CSIC, CNB, Madrid, Spain; [Reina, Jose] ICREA, Barcelona, Spain; [Zabala, Juan C.] Univ Cantabria, IFIMAV, E-39005 Santander, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Biologia Molecular de Barcelona (IBMB); Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona; Centro Nacional de Investigaciones Oncologicas (CNIO); Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Quimica Fisica Rocasolano (IQFR); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); ICREA; Universidad de Cantabria	Bastolla, U (corresponding author), CSIC UAM, CBMSO, Madrid, Spain.	ubastolla@cbm.uam.es; luis.serrano@crg.eu	Gonzalez, Cayetano/K-3933-2019; Bastolla, Ugo/H-6330-2015; Zabala, Juan Carlos/K-5163-2014; Garcia, Jose Maria Carazo/E-9234-2016; Redondo, Pilar/L-7612-2014; Valpuesta, Jose M/AAA-6002-2019; Valpuesta, José M/T-1977-2017; Serrano, Luis/B-3355-2013; Bruix, Marta/H-4161-2011; Gonzalez, Cayetano/K-3055-2019; Coll, Miquel/L-5999-2014; Vernos, Isabelle/C-1687-2015	Bastolla, Ugo/0000-0001-9342-4678; Zabala, Juan Carlos/0000-0003-2679-5473; Garcia, Jose Maria Carazo/0000-0003-0788-8447; Redondo, Pilar/0000-0002-6723-0818; Valpuesta, José M/0000-0001-7468-8053; Serrano, Luis/0000-0002-5276-1392; Bruix, Marta/0000-0002-0096-3558; Gonzalez, Cayetano/0000-0002-5259-3608; Coll, Miquel/0000-0003-4471-8674; Vernos, Isabelle/0000-0003-1469-9214; Reina, Jose/0000-0003-3789-4514; Bertero, Michela/0000-0002-2012-6706; Speroni, Silvia/0000-0001-5501-087X; Janowski, Robert/0000-0002-9940-2143; Abia, David/0000-0003-0401-7590	Spanish Ministry of Science [CSD2006-00023]; Madrid Community [S2010/BMD-2305]; ICREA Funding Source: Custom	Spanish Ministry of Science(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Madrid Community; ICREA(ICREA)	The authors gratefully acknowledge financial support from the Spanish Ministry of Science, grant CSD2006-00023, and from the Madrid Community, grant S2010/BMD-2305. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Andersen JS, 2003, NATURE, V426, P570, DOI 10.1038/nature02166; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bastolla U, 2001, PROTEINS, V44, P79, DOI 10.1002/prot.1075; Berrow NS, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm047; Bettencourt-Dias M, 2007, NAT REV MOL CELL BIO, V8, P451, DOI 10.1038/nrm2180; Bond J, 2006, CURR OPIN CELL BIOL, V18, P95, DOI 10.1016/j.ceb.2005.11.004; Boveri T, 1914, CELL SCI, V121, P1; Buchan DWA, 2010, NUCLEIC ACIDS RES, V38, pW563, DOI 10.1093/nar/gkq427; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Cline MS, 2007, NAT PROTOC, V2, P2366, DOI 10.1038/nprot.2007.324; Dolinsky TJ, 2007, NUCLEIC ACIDS RES, V35, pW522, DOI 10.1093/nar/gkm276; Dosztanyi Z, 2005, BIOINFORMATICS, V21, P3433, DOI 10.1093/bioinformatics/bti541; Durbin R., 1998, BIOL SEQUENCE ANAL P; Eswar Narayanan, 2008, V426, P145, DOI 10.1007/978-1-60327-058-8_8; Flicek P, 2008, NUCLEIC ACIDS RES, V36, pD707, DOI 10.1093/nar/gkm988; Garcia-Mayoral MF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025912; Follis AV, 2008, CHEM BIOL, V15, P1149, DOI 10.1016/j.chembiol.2008.09.011; Gerdes JM, 2009, CELL, V137, P32, DOI 10.1016/j.cell.2009.03.023; Gruber M, 2006, J STRUCT BIOL, V155, P140, DOI 10.1016/j.jsb.2006.03.009; Hatch E, 2010, COLD SH Q B, V75, P425, DOI 10.1101/sqb.2010.75.054; Hermjakob H, 2004, NUCLEIC ACIDS RES, V32, pD452, DOI 10.1093/nar/gkh052; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Jakobsen L, 2011, EMBO J, V30, P1520, DOI 10.1038/emboj.2011.63; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Letunic I., 2010, NUCL AC RES, V40, pD302; Linding R, 2003, STRUCTURE, V11, P1453, DOI 10.1016/j.str.2003.10.002; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; Lupas AN, 2005, ADV PROTEIN CHEM, V70, P37, DOI 10.1016/S0065-3233(04)70003-0; Marshall WF, 2009, CURR OPIN CELL BIOL, V21, P14, DOI 10.1016/j.ceb.2009.01.008; Mishra GR, 2006, NUCLEIC ACIDS RES, V34, pD411, DOI 10.1093/nar/gkj141; Muller H, 2010, EMBO J, V29, P3344, DOI 10.1038/emboj.2010.210; Newman M., 2010, NETWORKS INTRO, DOI [10.1162/artl_r_00062, 10.1093/acprof:oso/9780199206650.001.0001, DOI 10.1093/ACPROF:OSO/9780199206650.001.0001]; Nido GS, 2012, MOL BIOSYST, V8, P353, DOI 10.1039/c1mb05199g; Nigg EA, 2009, CELL, V139, P663, DOI 10.1016/j.cell.2009.10.036; Nogales-Cadenas R, 2009, NUCLEIC ACIDS RES, V37, pD175, DOI 10.1093/nar/gkn815; Oldfield CJ, 2005, BIOCHEMISTRY-US, V44, P12454, DOI 10.1021/bi050736e; Ou Y, 2004, CELL MOTIL CYTOSKEL, V57, P1, DOI 10.1002/cm.10154; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Prasad TSK, 2009, NUCLEIC ACIDS RES, V37, pD767, DOI 10.1093/nar/gkn892; Prilusky J, 2005, BIOINFORMATICS, V21, P3435, DOI 10.1093/bioinformatics/bti537; Remmert M, 2012, NAT METHODS, V9, P173, DOI [10.1038/NMETH.1818, 10.1038/nmeth.1818]; Ren J, 2010, NUCLEIC ACIDS RES, V38, pD155, DOI 10.1093/nar/gkp784; Romero P, 1999, FEBS LETT, V462, P363, DOI 10.1016/S0014-5793(99)01557-4; Shen MY, 2006, PROTEIN SCI, V15, P2507, DOI 10.1110/ps.062416606; Sirota FL, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-S1-S15; Stark C, 2006, NUCLEIC ACIDS RES, V34, pD535, DOI 10.1093/nar/gkj109; Teichert F, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-251; The evolution of the Protein Data Bank, 2011, NATURE STRUCTURAL MO, V18, P1310; Uversky VN, 2010, BBA-PROTEINS PROTEOM, V1804, P1231, DOI 10.1016/j.bbapap.2010.01.017; Ward JJ, 2004, J MOL BIOL, V337, P635, DOI 10.1016/j.jmb.2004.02.002; Xenarios I, 2000, NUCLEIC ACIDS RES, V28, P289, DOI 10.1093/nar/28.1.289; Zanzoni A, 2002, FEBS LETT, V513, P135, DOI 10.1016/S0014-5793(01)03293-8	55	15	15	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2013	8	5							e62633	10.1371/journal.pone.0062633	http://dx.doi.org/10.1371/journal.pone.0062633			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	155HD	23671615	Green Published, gold			2022-12-27	WOS:000319737700015
J	Rockett, RJ; Sloots, TP; Bowes, S; O'Neill, N; Ye, SF; Robson, J; Whiley, DM; Lambert, SB; Wang, D; Nissen, MD; Bialasiewicz, S				Rockett, Rebecca J.; Sloots, Theo P.; Bowes, Sharleen; O'Neill, Nicholas; Ye, Suifang; Robson, Jenny; Whiley, David M.; Lambert, Stephen B.; Wang, David; Nissen, Michael D.; Bialasiewicz, Seweryn			Detection of Novel Polyomaviruses, TSPyV, HPyV6, HPyV7, HPyV9 and MWPyV in Feces, Urine, Blood, Respiratory Swabs and Cerebrospinal Fluid	PLOS ONE			English	Article							MERKEL CELL POLYOMAVIRUS; TRANSCRIPTASE-PCR ASSAY; REAL-TIME PCR; BK VIRUS; KI POLYOMAVIRUSES; DNA-SEQUENCES; JC VIRUS; WU; TRACT; CHILDREN	Eight novel human polyomaviruses have been discovered since 2007. Prevalence rates and tissue tropism for the most recent members HPyV 6, 7, 9, TSPyV and MWPyV are largely unknown. We used real-time PCR to determine the presence of HPyV 6, 7, 9, TSPyV and MWPyV in feces (n = 263), urine (n = 189), blood (n = 161), respiratory swabs (n = 1385) and cerebrospinal fluid (n = 171) from both healthy control children and children and adults undergoing diagnostic testing. Whole genome sequencing was able to be performed on 9 MWPyV positive specimens. Novel polyomaviruses were only detected in respiratory swabs and feces, with no detections of HPyV 9 in any sample type. MWPyV was found to be the most prevalent novel polyomavirus, being detected in 18 (1.5%) respiratory specimens from symptomatic patients, 16 (9.8%) respiratory sample from healthy control children, 11 (5.9%) fecal specimens from patient suffering gastrointestinal illness, and in 13 (15.3%) of feces from healthy control children. MWPyV was found only in respiratory and fecal specimens from children, the oldest being 9 years old. HPyV 6, 7, 9 and TSPyV were also detected in respiratory specimens and fecal specimens at low prevalence (<1.3%). The majority of these detections were found in immunocompromised patients. Our findings suggest that MWPyV can result in a subclinical infection, persistent or intermittent shedding, particularly in young children. The other novel polyomaviruses were also found in respiratory and fecal specimens, but at lower prevalence and most commonly in immunocompromised individuals.	[Rockett, Rebecca J.; Sloots, Theo P.; Bowes, Sharleen; O'Neill, Nicholas; Ye, Suifang; Whiley, David M.; Lambert, Stephen B.; Nissen, Michael D.; Bialasiewicz, Seweryn] Univ Queensland, Queensland Childrens Med Res Inst, Queensland Paediat Infect Dis Lab, Brisbane, Qld, Australia; [Robson, Jenny] Sullivan Nicolaides Pathol, Dept Microbiol, Brisbane, Qld, Australia; [Lambert, Stephen B.] Queensland Hlth, Communicable Dis Branch, Immunisat Program, Herston, Qld, Australia; [Wang, David] Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA; [Wang, David] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO USA; [Nissen, Michael D.] Pathol Queensland Cent Lab, Div Microbiol, Herston, Qld, Australia	University of Queensland; Queensland Health; Washington University (WUSTL); Washington University (WUSTL)	Rockett, RJ (corresponding author), Univ Queensland, Queensland Childrens Med Res Inst, Queensland Paediat Infect Dis Lab, Brisbane, Qld, Australia.	r.rockett@uq.edu.au	Whiley, David M/E-8955-2011; Bialasiewicz, Seweryn/F-1414-2010; Nissen, Michael D/M-6823-2013; Lambert, Stephen/N-7819-2019	Whiley, David M/0000-0001-5969-3161; Bialasiewicz, Seweryn/0000-0001-9474-6943; Nissen, Michael D/0000-0003-1686-3313; Lambert, Stephen/0000-0002-2709-193X	Queensland Children's Medical Research Institute [10298]; Children's Health foundation, Queensland [50006]; Woolworths	Queensland Children's Medical Research Institute; Children's Health foundation, Queensland; Woolworths	Funding is generously supplied by the Queensland Children's Medical Research Institute (PhD Scholarship 10298) and program grant #50006 from Children's Health foundation, Queensland and Woolworths. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abedi Kiasari B, 2011, J MED VIROL, V83, P2220, DOI [10.1002/jmv, DOI 10.1002/JMV]; Allander T, 2007, J VIROL, V81, P4130, DOI 10.1128/JVI.00028-07; Antonsson A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039842; Arden KE, 2006, J MED VIROL, V78, P1232, DOI 10.1002/jmv.20689; Babakir-Mina M, 2011, NEW MICROBIOL, V34, P1; Babakir-Mina M, 2009, J CLIN VIROL, V46, P75, DOI 10.1016/j.jcv.2009.06.009; Babakir-Mina M, 2009, J MED VIROL, V81, P1668, DOI 10.1002/jmv.21559; Barzon L, 2009, J CLIN VIROL, V45, P370, DOI 10.1016/j.jcv.2009.05.026; Bialasiewicz S, 2009, SEX TRANSM INFECT, V85, P102, DOI 10.1136/sti.2008.032607; Bialasiewicz S, 2009, EMERG INFECT DIS, V15, P492, DOI 10.3201/eid1503.081067; Bialasiewicz S, 2009, J CLIN VIROL, V45, P249, DOI 10.1016/j.jcv.2009.05.002; Bialasiewicza S, 2007, J CLIN VIROL, V40, P15, DOI 10.1016/j.jcv.2007.07.001; Bofill-Mas S, 2001, J VIROL, V75, P10290, DOI 10.1128/JVI.75.21.10290-10299.2001; Bogdanovic G, 2004, J CLIN MICROBIOL, V42, P5394, DOI 10.1128/JCM.42.11.5394-5396.2004; Buck CB, 2012, J VIROL, V86, P10887, DOI 10.1128/JVI.01690-12; Champeau W, 2011, DETECTION MERKEL CEL, V1439, P1435, DOI [10.1002/jmv, DOI 10.1002/JMV]; CHESTERS PM, 1983, J INFECT DIS, V147, P676, DOI 10.1093/infdis/147.4.676; Csoma E, 2011, J MED VIROL, V83, P1275, DOI 10.1002/jmv.22083; Doerries K, 2006, ADV EXP MED BIOL, V577, P102; Feng HC, 2008, SCIENCE, V319, P1096, DOI 10.1126/science.1152586; Foulongne V, 2010, BRIT J DERMATOL, V162, P59, DOI 10.1111/j.1365-2133.2009.09381.x; GARDNER SD, 1971, LANCET, V1, P1253; Gaynor AM, 2007, PLOS PATHOG, V3, P595, DOI 10.1371/journal.ppat.0030064; GOUDSMIT J, 1982, J MED VIROL, V10, P91, DOI 10.1002/jmv.1890100203; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; HERITAGE J, 1981, J MED VIROL, V8, P143, DOI 10.1002/jmv.1890080208; Hirsch HH, 2002, AM J TRANSPLANT, V2, P25, DOI 10.1034/j.1600-6143.2002.020106.x; Kumar S, 2008, BRIEF BIOINFORM, V9, P299, DOI 10.1093/bib/bbn017; Lu XY, 2008, J CLIN MICROBIOL, V46, P533, DOI 10.1128/JCM.01739-07; Mackay IM, 2007, REAL TIME PCR MICROB, P2679; Maertzdorf J, 2004, J CLIN MICROBIOL, V42, P981, DOI 10.1128/JCM.42.3.981-986.2004; Mourez T, 2009, EMERG INFECT DIS, V15, P107, DOI [10.3201/eid1501.080758, 10.3201/1501.080758]; Neske F, 2009, J CLIN VIROL, V44, P115, DOI 10.1016/j.jcv.2008.12.004; PADGETT BL, 1971, LANCET, V1, P1257; Rao S, 2011, J CLIN VIROL, V52, P28, DOI 10.1016/j.jcv.2011.05.024; Schowalter RM, 2010, CELL HOST MICROBE, V7, P509, DOI 10.1016/j.chom.2010.05.006; Scuda N, 2011, J VIROL, V85, P4586, DOI 10.1128/JVI.02602-10; Shishido-Hara Y, 2010, ACTA NEUROPATHOL, V120, P403, DOI 10.1007/s00401-010-0694-x; Siebrasse EA, 2012, J VIROLOGY; Siebrasse EA, 2012, EMERG INFECT DIS, V18, P1676, DOI 10.3201/eid1810.120359; Stoner GL, 2000, MICROBES INFECT, V2, P1905, DOI 10.1016/S1286-4579(00)01339-3; Syrmis MW, 2004, J MOL DIAGN, V6, P125, DOI 10.1016/S1525-1578(10)60500-4; Tolstov YL, 2011, EMERG INFECT DIS, V17, P1371, DOI 10.3201/eid1708.110079; Wang CYT, 2012, J CLIN VIROL, V54, P83, DOI 10.1016/j.jcv.2012.01.013; Yu GX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049449; Zhong S, 2009, J GEN VIROL, V90, P144, DOI 10.1099/vir.0.83611-0; [No title captured]	47	44	44	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2013	8	5							e62764	10.1371/journal.pone.0062764	http://dx.doi.org/10.1371/journal.pone.0062764			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145YI	23667518	Green Submitted, Green Published, gold			2022-12-27	WOS:000319055600043
J	Bermudez, O; Hennen, E; Koch, I; Lindner, M; Eickelberg, O				Bermudez, Olga; Hennen, Elisabeth; Koch, Ina; Lindner, Michael; Eickelberg, Oliver			Gli1 Mediates Lung Cancer Cell Proliferation and Sonic Hedgehog-Dependent Mesenchymal Cell Activation	PLOS ONE			English	Article							IDIOPATHIC-PULMONARY-FIBROSIS; GROWTH-FACTOR-BETA; SIGNALING PATHWAY; MITOCHONDRIAL METABOLISM; TUMOR MICROENVIRONMENT; BREAST-CANCER; IN-VIVO; CARCINOGENESIS; ANGIOGENESIS; EXPRESSION	Non-Small-Cell-Lung-Cancer (NSCLC) represents approximately 85% of all lung cancers and remains poorly understood. While signaling pathways operative during organ development, including Sonic Hedgehog (Shh) and associated Gli transcription factors (Gli1-3), have recently been found to be reactivated in NSCLC, their functional role remains unclear. Here, we hypothesized that Shh/Gli1-3 could mediate NSCLC autonomous proliferation and epithelial/stromal signaling in the tumoral tissue. In this context, we have investigated the activity of Shh/Gli1-3 signaling in NSCLC in both, cancer and stromal cells. We report here that inhibition of Shh signaling induces a significant decrease in the proliferation of NSCLC cells. This effect is mediated by Gli1 and Gli2, but not Gli3, through regulation of cyclin D1 and cyclin D2 expression. While exogenous Shh was unable to induce signaling in either A549 lung adenocarcinoma or H520 lung squamous carcinoma cells, both cells were found to secrete Shh ligand, which induced fibroblast proliferation, survival, migration, invasion, and collagen synthesis. Furthermore, Shh secreted by NSCLC mediates the production of proangiogenic and metastatic factors in lung fibroblasts. Our results thus provide evidence that Shh plays an important role in mediating epithelial/mesenchymal crosstalk in NSCLC. While autonomous Gli activity controls NSCLC proliferation, increased Shh expression by NSCLC is associated with fibroblast activation in tumor-associated stroma. Our study highlights the relevance of studying stromal-associated cells in the context of NSCLC regarding new prognosis and therapeutic options.	[Bermudez, Olga; Hennen, Elisabeth; Eickelberg, Oliver] Univ Munich, Comprehens Pneumol Ctr, Univ Hosp, Munich, Germany; [Bermudez, Olga; Hennen, Elisabeth; Eickelberg, Oliver] Helmholtz Zentrum Munchen, Munich, Germany; [Koch, Ina; Lindner, Michael] Asklepios Clin Munich Gauting, Comprehens Pneumol Ctr, Ctr Thorac Surg, Asklepios Biobank Lung Dis, Gauting, Germany; [Koch, Ina; Lindner, Michael] Univ Munich, Gauting, Germany	University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munich	Eickelberg, O (corresponding author), Univ Munich, Comprehens Pneumol Ctr, Univ Hosp, Munich, Germany.	oliver.eickelberg@helmholtz-muenchen.de	lindner, michael/AAO-8653-2020	lindner, michael/0000-0002-2106-0286	Helmholtz Association	Helmholtz Association(Helmholtz Association)	This study was supported by the Helmholtz Association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai CYB, 2001, DEVELOPMENT, V128, P5161; Beachy PA, 2010, GENE DEV, V24, P2001, DOI 10.1101/gad.1951710; Bray F, 2013, INT J CANCER, V132, P1133, DOI 10.1002/ijc.27711; Brentnall TA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030219; Castello-Cros R, 2011, CELL CYCLE, V10, P2021, DOI 10.4161/cc.10.12.16002; Chen WW, 2011, P NATL ACAD SCI USA, V108, P9589, DOI 10.1073/pnas.1017945108; Chi SM, 2006, CANCER LETT, V244, P53, DOI 10.1016/j.canlet.2005.11.036; Chinchilla P, 2010, CELL CYCLE, V9, P570, DOI 10.4161/cc.9.3.10591; Cigna N, 2012, AM J PATHOL, V181, P2126, DOI 10.1016/j.ajpath.2012.08.019; Coussens LM, 2000, CELL, V103, P481, DOI 10.1016/S0092-8674(00)00139-2; Dennler S, 2007, CANCER RES, V67, P6981, DOI 10.1158/0008-5472.CAN-07-0491; Dennler S, 2009, J BIOL CHEM, V284, P31523, DOI 10.1074/jbc.M109.059964; Fan QP, 2010, J BIOL CHEM, V285, P36570, DOI 10.1074/jbc.C110.164442; Franco OE, 2011, CANCER RES, V71, P1272, DOI 10.1158/0008-5472.CAN-10-3142; Giraudo E, 2004, J CLIN INVEST, V114, P623, DOI 10.1172/JCI200422087; Hruz Tomas, 2008, Advances in Bioinformatics, V2008, P420747, DOI 10.1155/2008/420747; Johnson RW, 2011, CANCER RES, V71, P822, DOI 10.1158/0008-5472.CAN-10-2993; Kinzel D, 2010, DEV CELL, V19, P66, DOI 10.1016/j.devcel.2010.06.005; Levental KR, 2009, CELL, V139, P891, DOI 10.1016/j.cell.2009.10.027; Li GH, 2013, MED ONCOL, V30, DOI 10.1007/s12032-012-0437-z; Li Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052093; Loewen GM, 2005, BMC CANCER, V5, DOI 10.1186/1471-2407-5-145; Low WC, 2008, DEV BIOL, V321, P188, DOI 10.1016/j.ydbio.2008.06.014; Bolanos AL, 2012, AM J PHYSIOL-LUNG C, V303, pL978, DOI 10.1152/ajplung.00184.2012; Meyers-Needham M, 2012, MOL CANCER THER, V11, P1092, DOI 10.1158/1535-7163.MCT-11-0705; Migneco G, 2010, CELL CYCLE, V9, P2412, DOI 10.4161/cc.9.12.11989; Moran CM, 2012, DEV DYNAM, V241, P1034, DOI 10.1002/dvdy.23795; Moreno-Barriuso N, 2006, DEV DYNAM, V235, P2040, DOI 10.1002/dvdy.20842; Motoyama J, 1998, NAT GENET, V20, P54, DOI 10.1038/1711; Nolan-Stevaux O, 2009, GENE DEV, V23, P24, DOI 10.1101/gad.1753809; O'Toole SA, 2011, CANCER RES, V71, P4002, DOI 10.1158/0008-5472.CAN-10-3738; Pan Y, 2006, MOL CELL BIOL, V26, P3365, DOI 10.1128/MCB.26.9.3365-3377.2006; Park KS, 2011, NAT MED, V17, P1504, DOI 10.1038/nm.2473; Pu X, 2012, CLIN CANCER RES, V18, P5983, DOI 10.1158/1078-0432.CCR-12-0774; Salem AF, 2012, CELL CYCLE, V11, P2545, DOI 10.4161/cc.20920; Seton-Rogers S, 2011, NAT REV CANCER, V11, P831, DOI 10.1038/nrc3176; Shin JE, 2011, MOL CELLS, V31, P181, DOI 10.1007/s10059-011-0020-z; Slusarz A, 2010, CANCER RES, V70, P3382, DOI 10.1158/0008-5472.CAN-09-3012; Stecca B, 2010, J MOL CELL BIOL, V2, P84, DOI 10.1093/jmcb/mjp052; Stewart GA, 2003, J PATHOL, V199, P488, DOI 10.1002/path.1295; Taipale J, 2001, NATURE, V411, P349, DOI 10.1038/35077219; Trimboli AJ, 2009, NATURE, V461, P1084, DOI 10.1038/nature08486; van Kempen LCL, 2002, CANCER CELL, V2, P251, DOI 10.1016/S1535-6108(02)00157-5; Varjosalo M, 2008, GENE DEV, V22, P2454, DOI 10.1101/gad.1693608; Wallace JA, 2011, CANCER RES, V71, P1203, DOI 10.1158/0008-5472.CAN-10-3263; Wang CB, 2010, DEVELOPMENT, V137, P2001, DOI 10.1242/dev.052126; Watkins DN, 2003, NATURE, V422, P313, DOI 10.1038/nature01493; Wysoczynski M, 2007, CANCER RES, V67, P2131, DOI 10.1158/0008-5472.CAN-06-1021; Yamazaki M, 2008, CANCER SCI, V99, P1131, DOI 10.1111/j.1349-7006.2008.00795.x; Yoo YA, 2011, CANCER RES, V71, P7061, DOI 10.1158/0008-5472.CAN-11-1338; Yoon JW, 2002, J BIOL CHEM, V277, P5548, DOI 10.1074/jbc.M105708200; Yuan Z, 2007, ONCOGENE, V26, P1046, DOI 10.1038/sj.onc.1209860; Zhang XM, 2009, BREAST CANCER RES TR, V115, P505, DOI 10.1007/s10549-008-0093-3	53	73	76	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e63226	10.1371/journal.pone.0063226	http://dx.doi.org/10.1371/journal.pone.0063226			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667589	Green Submitted, Green Published, gold			2022-12-27	WOS:000319654700119
J	Das, DS; Wadhwa, N; Kunj, N; Sarda, K; Pradhan, BS; Majumdar, SS				Das, Deepika Sharma; Wadhwa, Neerja; Kunj, Neetu; Sarda, Kanchan; Pradhan, Bhola Shankar; Majumdar, Subeer S.			Dickkopf Homolog 3 (DKK3) Plays a Crucial Role Upstream of WNT/beta-CATENIN Signaling for Sertoli Cell Mediated Regulation of Spermatogenesis	PLOS ONE			English	Article							MESSENGER-RNA; GENE; FSH; HORMONE; SECRETION; DIFFERENTIATION; PROLIFERATION; REPLACEMENT; INFERTILITY; ACTIVATION	Testicular Sertoli cells (Sc) are main somatic component of seminiferous tubules that govern the differentiation of germ cells (Gc) and provide them physical support. Sc are the target of follicle stimulating hormone (FSH) and testosterone (T) which are known to regulate spermatogenesis. FSH and T levels in human and sub-human male primates remain high during infancy (4-6 months post birth), similar to those during puberty. Subsequently, juvenile phase is marked with low levels of these hormones. In spite of prolonged hormonal exposure, spermatogenesis is not discerned during infancy unlike that during puberty. Situation during infancy is similar to certain idiopathic male infertility, where prolonged hormone supplementation fails to initiate spermatogenesis. In our quest to determine non hormonal causes of idiopathic infertility which may reside within the Sc, we investigated the association between spermatogenesis and Sc specific gene(s) expressed differentially during puberty and infancy. Although products of several genes may be necessary for quantitatively normal spermatogenesis, one needs to investigate their roles one by one. Differential display and real time PCR analysis revealed higher expression of a known tumor suppressor, Dickkopf homolog 3 (DKK3), by pubertal monkey Sc as compared to infant Sc. To evaluate role of DKK3 in spermatogenesis, we generated DKK3 knock down mice (DKDM) using shRNA construct targeted to DKK3. In testis of adult DKDM, expression of DKK3 mRNA and protein were significantly (p<0.05) low and was associated with elevated WNT-4/beta-CATENIN activity. Elevated beta-CATENIN activity is known to restrict Sc maturation. Abundant expression of infant Sc marker, Mullerian inhibiting substance (MIS), in the testes of adult DKDM confirmed lack of Sc maturation in DKDM. Gc differentiation and fertility was severely compromised in DKDM. This is the first report of role of DKK3 in the testis and DKK3 mediated regulation of spermatogenesis via WNT-4/beta-CATENIN modulation.	[Das, Deepika Sharma; Sarda, Kanchan; Pradhan, Bhola Shankar; Majumdar, Subeer S.] Natl Inst Immunol, Div Cellular Endocrinol, New Delhi 110067, India; [Wadhwa, Neerja; Kunj, Neetu; Majumdar, Subeer S.] Natl Inst Immunol, Div Embryo Biotechnol, New Delhi 110067, India	Department of Biotechnology (DBT) India; National Institute of Immunology (NII); Department of Biotechnology (DBT) India; National Institute of Immunology (NII)	Majumdar, SS (corresponding author), Natl Inst Immunol, Div Cellular Endocrinol, Aruna Asaf Ali Marg, New Delhi 110067, India.	subeer@nii.ac.in		PRADHAN, BHOLA/0000-0002-6346-2523; Majumdar, Subeer/0000-0003-1724-7483	Department of Biotechnology [BT/PR11313/AAQ/01/376/2008]; Indian Council of Medical Research [5/10/FR/8/2010-RHN]; National Institute of Immunology, India	Department of Biotechnology; Indian Council of Medical Research(Indian Council of Medical Research (ICMR)); National Institute of Immunology, India	This study was supported by a grant from Department of Biotechnology (Grant number BT/PR11313/AAQ/01/376/2008 SSM), grant from Indian Council of Medical Research (Grant number 5/10/FR/8/2010-RHN to SSM) and National Institute of Immunology, India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel MH, 2009, J MOL ENDOCRINOL, V42, P291, DOI 10.1677/JME-08-0107; Bandapalli OR, 2009, J PATHOL, V218, P370, DOI 10.1002/path.2539; Barrantes ID, 2006, MOL CELL BIOL, V26, P2317, DOI 10.1128/MCB.26.6.2317-2326.2006; BEHRINGER RR, 1990, NATURE, V345, P167, DOI 10.1038/345167a0; Bhattacharya I, 2012, AM J PHYSIOL-ENDOC M, V303, pE886, DOI 10.1152/ajpendo.00293.2012; Boyer A, 2008, BIOL REPROD, V79, P475, DOI 10.1095/biolreprod.108.068627; Boyer A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029764; Chang H, 2008, DEVELOPMENT, V135, P1875, DOI 10.1242/dev.018572; Devi YS, 2006, J CLIN ENDOCR METAB, V91, P1062, DOI 10.1210/jc.2005-2072; Dhup S, 2008, NAT METHODS, V5, P601, DOI 10.1038/nmeth.1225; Diep DB, 2004, DEV BRAIN RES, V153, P261, DOI 10.1016/j.devbrainres.2004.09.008; Glinka A, 1998, NATURE, V391, P357, DOI 10.1038/34848; Golestaneh N, 2009, REPRODUCTION, V138, P151, DOI 10.1530/REP-08-0510; Gossen M, 2002, ANNU REV GENET, V36, P153, DOI 10.1146/annurev.genet.36.041002.120114; Grima J, 1997, J BIOL CHEM, V272, P6499, DOI 10.1074/jbc.272.10.6499; Griswold MD, 1998, SEMIN CELL DEV BIOL, V9, P411, DOI 10.1006/scdb.1998.0203; Hogan B, 1994, MANIPULATING MOUSE E; Ikawa M, 2002, P NATL ACAD SCI USA, V99, P7524, DOI 10.1073/pnas.072207299; Krupnik VE, 1999, GENE, V238, P301, DOI 10.1016/S0378-1119(99)00365-0; Kunath T, 2003, NAT BIOTECHNOL, V21, P559, DOI 10.1038/nbt813; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lee EJ, 2009, INT J CANCER, V124, P287, DOI 10.1002/ijc.23913; LIANG P, 1992, SCIENCE, V257, P967, DOI 10.1126/science.1354393; Lo KC, 2004, FERTIL STERIL, V82, pS22, DOI 10.1016/j.fertnstert.2004.07.062; Majumdar SS, 1998, BIOL REPROD, V58, P633, DOI 10.1095/biolreprod58.3.633; MAJUMDAR SS, 1995, ENDOCRINOLOGY, V136, P1969, DOI 10.1210/en.136.5.1969; Majumdar SS, 2012, PROG BIOPHYS MOL BIO, V27, P2515; Majumdar SS, 2012, HUM REPROD, V27, P2515, DOI 10.1093/humrep/des184; Mao BY, 2001, NATURE, V411, P321, DOI 10.1038/35077108; Matzuk MM, 2008, NAT MED, V14, P1197, DOI 10.1038/nm.f.1895; Meng XJ, 2000, SCIENCE, V287, P1489, DOI 10.1126/science.287.5457.1489; MULLER SR, 1990, DNA CELL BIOL, V9, P221, DOI 10.1089/dna.1990.9.221; Nakanishi Y, 2004, BIOL PHARM BULL, V27, P13, DOI 10.1248/bpb.27.13; Niehrs C, 2006, ONCOGENE, V25, P7469, DOI 10.1038/sj.onc.1210054; Okabe S, 1996, MECH DEVELOP, V59, P89, DOI 10.1016/0925-4773(96)00572-2; ORTH JM, 1988, ENDOCRINOLOGY, V122, P787, DOI 10.1210/endo-122-3-787; Plant TM, 2005, ANN NY ACAD SCI, V1061, P149, DOI 10.1196/annals.1336.016; Plant TM, 2006, KNOBIL AND NEILL'S PHYSIOLOGY OF REPRODUCTION, VOLS 1 AND 2, 3RD EDITON, P2177; Racine C, 1998, P NATL ACAD SCI USA, V95, P594, DOI 10.1073/pnas.95.2.594; SCHAISON G, 1993, J CLIN ENDOCR METAB, V77, P1545, DOI 10.1210/jc.77.6.1545; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Sharpe RM, 2003, REPRODUCTION, V125, P769, DOI 10.1530/rep.0.1250769; SKINNER MK, 1982, BIOL REPROD, V27, P211, DOI 10.1095/biolreprod27.1.211; Tanimoto R, 2007, INT J MOL MED, V19, P363; Tanwar PS, 2010, BIOL REPROD, V82, P422, DOI 10.1095/biolreprod.109.079335; Veeck J, 2012, BBA-REV CANCER, V1825, P18, DOI 10.1016/j.bbcan.2011.09.003; Walker WH, 2005, REPRODUCTION, V130, P15, DOI 10.1530/rep.1.00358; WELSH MJ, 1975, ENDOCRINOLOGY, V96, P618, DOI 10.1210/endo-96-3-618; Xia HB, 2002, NAT BIOTECHNOL, V20, P1006, DOI 10.1038/nbt739	49	31	34	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e63603	10.1371/journal.pone.0063603	http://dx.doi.org/10.1371/journal.pone.0063603			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667645	Green Published, gold, Green Submitted			2022-12-27	WOS:000319654700166
J	Gong, L; Chen, Y; Hu, Z; Hu, MY				Gong, Liang; Chen, Yong; Hu, Zhen; Hu, Meiying			Testing Insecticidal Activity of Novel Chemically Synthesized siRNA against Plutella xylostella under Laboratory and Field Conditions	PLOS ONE			English	Article							RNA INTERFERENCE; DIAMONDBACK MOTH; ACETYLCHOLINESTERASE GENE; LEPIDOPTERA PLUTELLIDAE; LARVAL GROWTH; RESISTANCE; CHITOSAN; MANAGEMENT; TRIBOLIUM; L.	Background: Over the last 60 years, synthetic chemical pesticides have served as a main tactic in the field of crop protection, but their availability is now declining as a result of the development of insect resistance. Therefore, alternative pest management agents are needed. However, the demonstration of RNAi gene silencing in insects and its successful usage in disrupting the expression of vital genes opened a door to the development of a variety of novel, environmentally sound approaches for insect pest management. Methodology/Principal Findings: Six small interfering RNAs (siRNAs) were chemically synthesized and modified according to the cDNA sequence of P. xylostella acetylcholine esterase genes AChE1 and AChE2. All of them were formulated and used in insecticide activity screening against P. xylostella. Bioassay data suggested that Si-ace1_003 and Si-ace2_001 at a concentration of 3 mu g cm(-2) displayed the best insecticidal activity with 73.7% and 89.0%, mortality, respectively. Additional bioassays were used to obtain the acute lethal concentrations of LC50 and LC90 for Si-ace2_001, which were 53.66 mu g/ml and 759.71 mu g/ml, respectively. Quantitative Real-time PCR was used to confirm silencing and detected that the transcript levels of P. xylostella AChE2 (PxAChE2) were reduced by 5.7-fold compared to the control group. Consequently, AChE activity was also reduced by 1.7-fold. Finally, effects of the siRNAs on treated plants of Brassica oleracea and Brassica alboglabra were investigated with different siRNA doses. Our results showed that Si-ace2_001 had no negative effects on plant morphology, color and growth of vein under our experimental conditions. Conclusions: The most important finding of this study is the discovery that chemically synthesized and modified siRNA corresponding to P. xylostella AChE genes cause significant mortality of the insect both under laboratory and field conditions, which provides a novel strategy to control P. xylostella and to develop bio-pesticides based on the RNA interference technology.	[Gong, Liang; Chen, Yong; Hu, Zhen; Hu, Meiying] South China Agr Univ, Key Lab Pesticide & Chem Biol, Coll Nat Resources & Environm, Guangzhou, Guangdong, Peoples R China	South China Agricultural University	Hu, MY (corresponding author), South China Agr Univ, Key Lab Pesticide & Chem Biol, Coll Nat Resources & Environm, Guangzhou, Guangdong, Peoples R China.	humy@scau.edu.cn			National Nature Science Foundation, People's Republic of China [31171870]	National Nature Science Foundation, People's Republic of China(National Natural Science Foundation of China (NSFC))	We thank the National Nature Science Foundation, People's Republic of China for funding this work under grant no. 31171870. The authors also thank the Guangdong Province guided program of university industry cooperation (2010B090400138). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABBOTT WS, 1925, J ECON ENTOMOL, V18, P256; Badawy MEI, 2012, PLANT PROTECT SCI, V48, P131, DOI 10.17221/67/2010-PPS; BOESE Q, 2003, TARGETS, V2, P93; Boller EF, 2006, WORKING DOCUMENT SEL; Bolognesi R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047534; Burand JP, 2013, J INVERTEBR PATHOL, V112, pS68, DOI 10.1016/j.jip.2012.07.012; Chandler D, 2011, PHILOS T R SOC B, V366, P1987, DOI 10.1098/rstb.2010.0390; Chen ZZ, 2001, INSECT BIOCHEM MOLEC, V31, P805, DOI 10.1016/S0965-1748(00)00186-7; ELLMAN GL, 1961, BIOCHEM PHARMACOL, V7, P88, DOI 10.1016/0006-2952(61)90145-9; Endersby NM, 2011, B ENTOMOL RES, V101, P393, DOI 10.1017/S0007485310000684; Fire AZ, 2007, ANGEW CHEM INT EDIT, V46, P6967, DOI 10.1002/anie.200701979; Furlong MJ, 2013, ANNU REV ENTOMOL, V58, P517, DOI 10.1146/annurev-ento-120811-153605; Gary DJ, 2007, J CONTROL RELEASE, V121, P64, DOI 10.1016/j.jconrel.2007.05.021; Gong L, 2012, B ENTOMOL RES, V102, P600, DOI 10.1017/S0007485312000168; Gong LA, 2011, PEST MANAG SCI, V67, P514, DOI 10.1002/ps.2086; Grzywacz D, 2010, CROP PROT, V29, P68, DOI 10.1016/j.cropro.2009.08.009; Helle W, 1985, TOXICOLOGICAL METHOD, P183; Hsu JC, 2008, INSECT BIOCHEM MOLEC, V38, P146, DOI 10.1016/j.ibmb.2007.10.002; Huang Z, 2009, GENE THER, V16, P1271, DOI 10.1038/gt.2009.76; Hui XM, 2011, INSECT MOL BIOL, V20, P507, DOI 10.1111/j.1365-2583.2011.01081.x; Huvenne H, 2010, J INSECT PHYSIOL, V56, P227, DOI 10.1016/j.jinsphys.2009.10.004; Jiang XJ, 2009, BIOCHEM BIOPH RES CO, V378, P269, DOI 10.1016/j.bbrc.2008.11.046; Jinek M, 2009, NATURE, V457, P405, DOI 10.1038/nature07755; Kakani EG, 2013, B ENTOMOL RES, V103, P36, DOI 10.1017/S0007485312000478; Kao CH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034969; Khalaf SA., 2004, INT J AGRIC BIOL, V6, P1033; Kumar M, 2009, J INSECT PHYSIOL, V55, P273, DOI 10.1016/j.jinsphys.2008.12.005; LASOTA JA, 1991, ANNU REV ENTOMOL, V36, P91, DOI 10.1146/annurev.en.36.010191.000515; Lee DW, 2007, BIOCHEM BIOPH RES CO, V353, P591, DOI 10.1016/j.bbrc.2006.12.088; Lee DW, 2006, BBA-GEN SUBJECTS, V1760, P125, DOI 10.1016/j.bbagen.2005.10.009; Li XX, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017788; Linden JC, 2000, AGRO FOOD IND HI TEC, V11, P32; Liu H, 2004, INT J FOOD MICROBIOL, V95, P147, DOI 10.1016/j.ijfoodmicro.2004.01.022; Liu XX, 2012, J ECON ENTOMOL, V105, P354, DOI 10.1603/EC11299; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu YH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032288; Lu YH, 2012, SCI REP-UK, V2, DOI 10.1038/srep00288; Mao JJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048718; Marrone PG, 1999, OUTLOOK AGR, V28, P149, DOI 10.5367/000000099101292917; Pang YP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004349; Rabea EI, 2005, PEST MANAG SCI, V61, P951, DOI 10.1002/ps.1085; Revuelta L, 2009, INSECT BIOCHEM MOLEC, V39, P913, DOI 10.1016/j.ibmb.2009.11.001; Santos VC, 2011, NEOTROP ENTOMOL, V40, P264, DOI 10.1590/S1519-566X2011000200017; Silva AX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036366; TALEKAR NS, 1993, ANNU REV ENTOMOL, V38, P275, DOI 10.1146/annurev.en.38.010193.001423; TAYLOR P, 1994, ANNU REV PHARMACOL, V34, P281, DOI 10.1146/annurev.pa.34.040194.001433; Temeyer KB, 2007, DNA SEQUENCE, V18, P85, DOI 10.1080/10425170601060558; Teng XL, 2012, J INSECT SCI, V12, DOI 10.1673/031.012.6001; Terenius O, 2011, J INSECT PHYSIOL, V57, P231, DOI 10.1016/j.jinsphys.2010.11.006; Thacker JRM., 2002, INTRO ARTHROPOD PEST; Tomoyasu Y, 2004, DEV GENES EVOL, V214, P575, DOI 10.1007/s00427-004-0434-0; Tomoyasu Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-1-r10; Weill M, 2002, P ROY SOC B-BIOL SCI, V269, P2007, DOI 10.1098/rspb.2002.2122; Whangbo JS, 2008, TRENDS GENET, V24, P297, DOI 10.1016/j.tig.2008.03.007; Wuriyanghan H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027736; Zhang M, 2003, J BIOACT COMPAT POL, V18, P391, DOI 10.1177/0883911503039019; Zhang PJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047861; Zhang X, 2010, INSECT MOL BIOL, V19, P683, DOI 10.1111/j.1365-2583.2010.01029.x; Zhao JZ, 2006, J ECON ENTOMOL, V99, P176, DOI 10.1603/0022-0493(2006)099[0176:MODMLP]2.0.CO;2; Zhou LJ, 2011, CROP PROT, V30, P272, DOI 10.1016/j.cropro.2010.10.006; Zhu JQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038572	61	40	49	1	78	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e62990	10.1371/journal.pone.0062990	http://dx.doi.org/10.1371/journal.pone.0062990			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667556	Green Published, gold, Green Submitted			2022-12-27	WOS:000319654700094
J	Lobato, NS; Filgueira, FP; Prakash, R; Giachini, FR; Ergul, A; Carvalho, MHC; Webb, RC; Tostes, RC; Fortes, ZB				Lobato, Nubia S.; Filgueira, Fernando P.; Prakash, Roshini; Giachini, Fernanda R.; Ergul, Adviye; Carvalho, Maria Helena C.; Webb, R. Clinton; Tostes, Rita C.; Fortes, Zuleica B.			Reduced Endothelium-Dependent Relaxation to Anandamide in Mesenteric Arteries from Young Obese Zucker Rats	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; SENSITIVE SENSORY NERVES; NITRIC-OXIDE SYNTHASE; ENDOCANNABINOID SYSTEM; CANNABINOID RECEPTORS; CORONARY-ARTERY; ENDOGENOUS CANNABINOIDS; CARDIOMETABOLIC RISK; VANILLOID RECEPTORS; RESISTANCE VESSELS	Impaired vascular function, manifested by an altered ability of the endothelium to release endothelium-derived relaxing factors and endothelium-derived contracting factors, is consistently reported in obesity. Considering that the endothelium plays a major role in the relaxant response to the cannabinoid agonist anandamide, the present study tested the hypothesis that vascular relaxation to anandamide is decreased in obese rats. Mechanisms contributing to decreased anandamideinduced vasodilation were determined. Resistance mesenteric arteries from young obese Zucker rats (OZRs) and their lean counterparts (LZRs) were used. Vascular reactivity was evaluated in a myograph for isometric tension recording. Protein expression and localization were analyzed by Western blotting and immunofluorescence, respectively. Vasorelaxation to anandamide, acetylcholine, and sodium nitroprusside, as well as to CB1, CB2, and TRPV1 agonists was decreased in endothelium-intact mesenteric arteries from OZRs. Incubation with an AMP-dependent protein kinase (AMPK) activator or a fatty acid amide hydrolase inhibitor restored anandamide-induced vascular relaxation in OZRs. CB1 and CB2 receptors protein expression was decreased in arteries from OZRs. Incubation of mesenteric arteries with anandamide evoked endothelial nitric oxide synthase (eNOS), AMPK and acetyl CoA carboxylase phosphorylation in LZRs, whereas it decreased phosphorylation of these proteins in OZRs. In conclusion, obesity decreases anandamide-induced relaxation in resistance arteries. Decreased cannabinoid receptors expression, increased anandamide degradation, decreased AMPK/eNOS activity as well as impairment of the response mediated by TRPV1 activation seem to contribute to reduce responses to cannabinoid agonists in obesity.	[Lobato, Nubia S.; Filgueira, Fernando P.] Univ Fed Goias, Dept Biol Sci, Jatai, Go, Brazil; [Lobato, Nubia S.; Filgueira, Fernando P.; Prakash, Roshini; Giachini, Fernanda R.; Ergul, Adviye; Webb, R. Clinton] Georgia Hlth Sci Univ, Dept Physiol, Augusta, GA USA; [Lobato, Nubia S.; Filgueira, Fernando P.; Carvalho, Maria Helena C.; Fortes, Zuleica B.] Univ Sao Paulo, Inst Biomed Sci, Dept Pharmacol, Sao Paulo, Brazil; [Tostes, Rita C.] Univ Sao Paulo, Dept Pharmacol, Sch Med Ribeirao Preto, BR-14049 Ribeirao Preto, SP, Brazil	Universidade Federal de Goias; University System of Georgia; Augusta University; Universidade de Sao Paulo; Universidade de Sao Paulo	Fortes, ZB (corresponding author), Univ Sao Paulo, Inst Biomed Sci, Dept Pharmacol, Sao Paulo, Brazil.	zbfortes@icb.usp.br	Giachini, Fernanda R/J-7958-2012; Carvalho, Maria Helena C/C-8539-2013; Filgueira, Fernando/C-5668-2013; Tostes, Rita C/C-1025-2012	Giachini, Fernanda R/0000-0003-2688-7204; Filgueira, Fernando/0000-0001-8910-1796; Tostes, Rita C/0000-0002-9446-0707; Prakash, Roshini/0000-0003-4309-3078	National Institutes of Health [HL71138, HL74167]; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP); INCT Obesity and Diabetes; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) Brazil; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL071138, P01HL074167] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); INCT Obesity and Diabetes; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by grants from the National Institutes of Health (HL71138 and HL74167), Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP), INCT Obesity and Diabetes and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) Brazil. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Batkai S, 2004, CIRCULATION, V110, P1996, DOI 10.1161/01.CIR.0000143230.23252.D2; BEVAN S, 1992, BRIT J PHARMACOL, V107, P544, DOI 10.1111/j.1476-5381.1992.tb12781.x; Bluher M, 2006, DIABETES, V55, P3053, DOI 10.2337/db06-0812; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Chen Z, 2009, CIRC RES, V104, P496, DOI 10.1161/CIRCRESAHA.108.187567; Chen ZP, 1999, FEBS LETT, V443, P285, DOI 10.1016/S0014-5793(98)01705-0; Cota D, 2003, J CLIN INVEST, V112, P423, DOI 10.1172/JCI17725; Cote M, 2007, INT J OBESITY, V31, P692, DOI 10.1038/sj.ijo.0803539; Cravatt BF, 1996, NATURE, V384, P83, DOI 10.1038/384083a0; Deutsch DG, 1997, J CLIN INVEST, V100, P1538, DOI 10.1172/JCI119677; Di Marzo V, 2008, NAT REV DRUG DISCOV, V7, P438, DOI 10.1038/nrd2553; DRAY A, 1990, NEUROSCI LETT, V110, P52, DOI 10.1016/0304-3940(90)90786-9; Echahidi N, 2007, CIRCULATION, V116, pI213, DOI 10.1161/CIRCULATIONAHA.106.681304; Engeli S, 2005, DIABETES, V54, P2838, DOI 10.2337/diabetes.54.10.2838; Flegal KM, 2002, JAMA-J AM MED ASSOC, V288, P1723, DOI 10.1001/jama.288.14.1723; Gardiner SM, 2009, BRIT J PHARMACOL, V158, P1143, DOI 10.1111/j.1476-5381.2009.00363.x; Gaskari SA, 2005, BRIT J PHARMACOL, V146, P315, DOI 10.1038/sj.bjp.0706331; Goirand F, 2007, J PHYSIOL-LONDON, V581, P1163, DOI 10.1113/jphysiol.2007.132589; Gokce N, 2003, J AM COLL CARDIOL, V41, P1769, DOI 10.1016/S0735-1097(03)00333-4; Grainger J, 2001, BRIT J PHARMACOL, V134, P1003, DOI 10.1038/sj.bjp.0704340; Gunthorpe MJ, 2002, TRENDS PHARMACOL SCI, V23, P183, DOI 10.1016/S0165-6147(02)01999-5; Herradon E, 2007, BRIT J PHARMACOL, V152, P699, DOI 10.1038/sj.bjp.0707404; Hill JO, 2006, ENDOCR REV, V27, P750, DOI 10.1210/er.2006-0032; Hillard CJ, 2000, J PHARMACOL EXP THER, V294, P27; HOLZER P, 1991, PHARMACOL REV, V43, P143; Jiang SX, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000641; Kaczocha M, 2009, P NATL ACAD SCI USA, V106, P6375, DOI 10.1073/pnas.0901515106; Kadoi Y, 2005, CRIT CARE MED, V33, P2629, DOI 10.1097/01.CCM.0000187010.14426.CC; KAWASAKI H, 1988, NATURE, V335, P164, DOI 10.1038/335164a0; Kola B, 2005, J BIOL CHEM, V280, P25196, DOI 10.1074/jbc.C500175200; Kotsis V, 2010, HYPERTENS RES, V33, P386, DOI 10.1038/hr.2010.9; Lerman A, 2005, CIRCULATION, V111, P363, DOI 10.1161/01.CIR.0000153339.27064.14; Liu J, 2008, NEUROPHARMACOLOGY, V54, P1, DOI 10.1016/j.neuropharm.2007.05.020; Lobato NS, 2011, NUTR METAB CARDIOVAS, V21, P808, DOI 10.1016/j.numecd.2010.02.006; Lopez-Miranda V, 2008, CURR VASC PHARMACOL, V6, P335, DOI 10.2174/157016108785909706; Mackie K, 2006, AAPS J, V8, pE298, DOI 10.1007/BF02854900; Matias I, 2008, MOL CELL ENDOCRINOL, V286, pS66, DOI 10.1016/j.mce.2008.01.026; Mitchell GF, 2004, HYPERTENSION, V44, P134, DOI 10.1161/01.HYP.0000137305.77635.68; MONCADA S, 1991, P NATL ACAD SCI USA, V88, P2166, DOI 10.1073/pnas.88.6.2166; Mukhopadhyay P, 2007, J AM COLL CARDIOL, V50, P528, DOI 10.1016/j.jacc.2007.03.057; MULVANY MJ, 1977, CIRC RES, V41, P19, DOI 10.1161/01.RES.41.1.19; O'Sullivan SE, 2004, BRIT J PHARMACOL, V142, P435, DOI 10.1038/sj.bjp.0705810; Pratt PF, 1998, AM J PHYSIOL-HEART C, V274, pH375, DOI 10.1152/ajpheart.1998.274.1.H375; Ralevic V, 2000, BRIT J PHARMACOL, V130, P1483, DOI 10.1038/sj.bjp.0703456; Randall MD, 2004, BRIT J PHARMACOL, V142, P20, DOI 10.1038/sj.bjp.0705725; Rayment SJ, 2007, FASEB J, V21, P577, DOI 10.1096/fj.06-7050com; Sarzani R, 2008, J NEUROENDOCRINOL, V20, P58, DOI 10.1111/j.1365-2826.2008.01677.x; Scotland RS, 2004, CIRC RES, V95, P1027, DOI 10.1161/01.RES.0000148633.93110.24; Shaul PW, 2002, ANNU REV PHYSIOL, V64, P749, DOI 10.1146/annurev.physiol.64.081501.155952; Stapleton Phoebe A, 2008, Pathophysiology, V15, P79, DOI 10.1016/j.pathophys.2008.04.007; Stepp DW, 2007, AM J PHYSIOL-HEART C, V293, pH2537, DOI 10.1152/ajpheart.01081.2006; Subramanian R, 2003, EUR J PHARMACOL, V477, P143, DOI 10.1016/j.ejphar.2003.08.003; Szmitko PE, 2008, ATHEROSCLEROSIS, V199, P248, DOI 10.1016/j.atherosclerosis.2008.03.011; Varga K, 1998, FASEB J, V12, P1035, DOI 10.1096/fasebj.12.11.1035; Wagner JA, 2001, J AM COLL CARDIOL, V38, P2048, DOI 10.1016/S0735-1097(01)01671-0; Wagner JA, 1997, NATURE, V390, P518, DOI 10.1038/37371; Wagner JA, 1999, HYPERTENSION, V33, P429, DOI 10.1161/01.HYP.33.1.429; Wheal AJ, 2007, BRIT J PHARMACOL, V152, P717, DOI 10.1038/sj.bjp.0707410; ZUCKER LM, 1972, ENDOCRINOLOGY, V90, P1320, DOI 10.1210/endo-90-5-1320; Zygmunt PM, 1999, NATURE, V400, P452, DOI 10.1038/22761; Zygmunt PM, 2002, J NEUROSCI, V22, P4720, DOI 10.1523/JNEUROSCI.22-11-04720.2002	61	27	27	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e63449	10.1371/journal.pone.0063449	http://dx.doi.org/10.1371/journal.pone.0063449			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667622	gold, Green Submitted, Green Published			2022-12-27	WOS:000319654700148
J	Ke, F; He, LB; Zhang, QY				Ke, Fei; He, Li-Bo; Zhang, Qi-Ya			Nonstructural Protein NS80 Is Crucial in Recruiting Viral Components to Form Aquareoviral Factories	PLOS ONE			English	Article							RANA-GRYLIO VIRUS; GRASS CARP REOVIRUS; MU-NS; SIGMA-NS; FUNCTIONAL DOMAINS; GENUS AQUAREOVIRUS; INCLUSIONS; IDENTIFICATION; ASSOCIATIONS; REPLICATION	Background: Replication and assembly of vertebrate reoviruses occur in specific intracellular compartments known as viral factories. Recently, NS88 and NS80, the nonstructural proteins from aquareoviruses, have been proposed to share common traits with mu NS from orthoreoviruses, which are involved in the formation of viral factories. Methodology/Principal Findings: In this study, the NS80 characteristics and its interactions with other viral components were investigated. We observed that the NS80 structure ensured its self-aggregation and selective recruitment of viral proteins to viral factories like structures (VFLS). The minimum amino acids (aa) of NS80 required for VFLS formation included 193 aa at the C-terminal. However, this truncated protein only contained one aa coil and located in the nucleus. Its N-terminal residual regions, aa 1-55 and aa 55-85, were required for recruiting viral nonstructural protein NS38 and structural protein VP3, respectively. A conserved N-terminal region of NS38, which was responsible for the interaction with NS80, was also identified. Moreover, the minimal region of C-terminal residues, aa 506-742 (Delta 505), required for NS80 self-aggregation in the cytoplasm, and aa 550-742 (Delta 549), which are sufficient for recruiting viral structure proteins VP1, VP2, and VP4 were also identified. Conclusions/Significance: The present study shows detailed interactions between NS80 and NS38 or other viral proteins. Sequence and structure characteristics of NS80 ensures its self-aggregation to form VFLS (either in the cytoplasm or nucleus) and recruitment of viral structural or nonstructural proteins.	[Ke, Fei; He, Li-Bo; Zhang, Qi-Ya] Chinese Acad Sci, Inst Hydrobiol, State Key Lab Freshwater Ecol & Biotechnol, Wuhan, Peoples R China	Chinese Academy of Sciences; Institute of Hydrobiology, CAS	Zhang, QY (corresponding author), Chinese Acad Sci, Inst Hydrobiol, State Key Lab Freshwater Ecol & Biotechnol, Wuhan, Peoples R China.	zhangqy@ihb.ac.cn			National Major Basic Research Program [2009CB118704, 2010CB126303]; National Natural Science Foundation of China [30871938, 31072239]; Knowledge Innovation Program of the Chinese Academy of Sciences [KSCX2-EW-Z-3]; Project of State Key Laboratory of Freshwater Ecology and Biotechnology [2011FBZ12, 2013FB13]	National Major Basic Research Program(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Knowledge Innovation Program of the Chinese Academy of Sciences(Chinese Academy of SciencesKnowledge Innovation Program of the Chinese Academy of Sciences); Project of State Key Laboratory of Freshwater Ecology and Biotechnology	This work is supported by grants from the National Major Basic Research Program (2009CB118704, 2010CB126303), the National Natural Science Foundation of China (30871938, 31072239), the Knowledge Innovation Program of the Chinese Academy of Sciences (KSCX2-EW-Z-3) and the Project of State Key Laboratory of Freshwater Ecology and Biotechnology (2011FBZ12, 2013FB13). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Attoui H, 2002, J GEN VIROL, V83, P1941, DOI 10.1099/0022-1317-83-8-1941; Attoui H., 2011, VIRUS TAXONOMY, P541; Becker MM, 2003, J VIROL, V77, P5948, DOI 10.1128/JVI.77.10.5948-5963.2003; Becker MM, 2001, J VIROL, V75, P1459, DOI 10.1128/JVI.75.3.1459-1475.2001; Brandariz-Nunez A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013785; Brandariz-Nunez A, 2010, J VIROL, V84, P4289, DOI 10.1128/JVI.02534-09; Broering TJ, 2005, J VIROL, V79, P6194, DOI 10.1128/JVI.79.10.6194-6206.2005; Broering TJ, 2004, J VIROL, V78, P1882, DOI 10.1128/JVI.78.4.1882-1892.2004; Broering TJ, 2002, J VIROL, V76, P8285, DOI 10.1128/JVI.76.16.8285-8297.2002; Busch LK, 2011, J GEN VIROL, V92, P2566, DOI 10.1099/vir.0.036459-0; Cai L, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-168; Danthi P, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000248; Du CS, 2004, VIRUS RES, V101, P119, DOI 10.1016/j.virusres.2003.12.034; Fang Q, 2000, BIOCHEM BIOPH RES CO, V274, P762, DOI 10.1006/bbrc.2000.3215; Gao EB, 2012, J VIROL, V86, P236, DOI 10.1128/JVI.06282-11; Gui JF, 2012, CHINESE SCI BULL, V57, P1751, DOI 10.1007/s11434-012-5213-0; Huang XH, 2006, J VIROL METHODS, V133, P117, DOI 10.1016/j.jviromet.2005.10.029; Huang XH, 2007, MICRON, V38, P599, DOI 10.1016/j.micron.2006.10.001; Huang YH, 2007, APOPTOSIS, V12, P1569, DOI 10.1007/s10495-007-0089-1; Ivanovic T, 2008, EMBO J, V27, P1289, DOI 10.1038/emboj.2008.60; Ivanovic T, 2011, TRAFFIC, V12, P1179, DOI 10.1111/j.1600-0854.2011.01233.x; Kaufer S, 2012, J VIROL, V86, P1079, DOI 10.1128/JVI.02662-10; Ke F, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-323; Ke F, 2009, MOL BIOL REP, V36, P1651, DOI 10.1007/s11033-008-9365-6; Kim YS, 2009, FISH SHELLFISH IMMUN, V27, P336, DOI 10.1016/j.fsi.2009.06.006; Kim YS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010308; Kirchner E, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000235; Kobayashi T, 2009, J VIROL, V83, P2892, DOI 10.1128/JVI.01495-08; KOZAK M, 1991, J BIOL CHEM, V266, P19867; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; McCutcheon AM, 1999, VIROLOGY, V264, P16, DOI 10.1006/viro.1999.9990; Miller CL, 2007, MOL CELL PROTEOMICS, V6, P1027, DOI 10.1074/mcp.M700056-MCP200; Miller CL, 2010, J VIROL, V84, P867, DOI 10.1128/JVI.01571-09; Miller CL, 2003, J VIROL, V77, P4566, DOI 10.1128/JVI.77.8.4566-4576.2003; Novoa RR, 2005, BIOL CELL, V97, P147, DOI 10.1042/BC20040058; Schmitz AM, 2009, NAT METHODS, V6, P500, DOI 10.1038/nmeth.1337; Tao YJ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000943; Tao YZ, 2002, CELL, V111, P733, DOI 10.1016/S0092-8674(02)01110-8; Touris-Otero F, 2004, VIROLOGY, V319, P94, DOI 10.1016/j.virol.2003.10.034; Trask SD, 2012, NAT REV MICROBIOL, V10, P165, DOI 10.1038/nrmicro2673; WIENER JR, 1989, VIROLOGY, V169, P293, DOI 10.1016/0042-6822(89)90154-2; Yan XD, 2011, J VIROL, V85, P7483, DOI 10.1128/JVI.00729-11; Zhang Q.Y., 2003, HIGH TECHNOL LETT, V9, P7; Zhang QY, 2000, DIS AQUAT ORGAN, V42, P1, DOI 10.3354/dao042001; Zhang QY, 2004, J VIROL, V78, P6982, DOI 10.1128/JVI.78.13.6982-6994.2004; Zhang QY, 2003, DIS AQUAT ORGAN, V57, P27, DOI 10.3354/dao057027; Zhang QY, 2001, DIS AQUAT ORGAN, V48, P27, DOI 10.3354/dao048027; Zhang QY, 2012, ATLAS AQUATIC VIRUSE; Zhang X, 2010, CELL, V141, P472, DOI 10.1016/j.cell.2010.03.041; Zhao Z, 2008, J GEN VIROL, V89, P1866, DOI 10.1099/vir.0.2008/000810-0; Zhao Z, 2008, VIROLOGY, V372, P118, DOI 10.1016/j.virol.2007.10.028; Zhu R, 2008, J VIROL, V82, P6889, DOI 10.1128/JVI.02385-07; Zurney J, 2009, J VIROL, V83, P2178, DOI 10.1128/JVI.01787-08	54	16	20	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2013	8	5							e63737	10.1371/journal.pone.0063737	http://dx.doi.org/10.1371/journal.pone.0063737			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	177QL	23671697	gold, Green Submitted, Green Published			2022-12-27	WOS:000321390200059
J	Vollmers, J; Voget, S; Dietrich, S; Gollnow, K; Smits, M; Meyer, K; Brinkhoff, T; Simon, M; Daniel, R				Vollmers, John; Voget, Sonja; Dietrich, Sascha; Gollnow, Kathleen; Smits, Maike; Meyer, Katja; Brinkhoff, Thorsten; Simon, Meinhard; Daniel, Rolf			Poles Apart: Arctic and Antarctic Octadecabacter strains Share High Genome Plasticity and a New Type of Xanthorhodopsin	PLOS ONE			English	Article							GAS VACUOLATE BACTERIA; SEA-ICE; PROTON PUMP; SALINIBACTER-RUBER; MARINE-BACTERIA; SP-NOV; CYANOPHYCIN SYNTHETASE; ACINETOBACTER-SP; GENE-TRANSFER; FOREIGN DNA	The genus Octadecabacter is a member of the ubiquitous marine Roseobacter clade. The two described species of this genus, Octadecabacter arcticus and Octadecabacter antarcticus, are psychrophilic and display a bipolar distribution. Here we provide the manually annotated and finished genome sequences of the type strains O. arcticus 238 and O. antarcticus 307, isolated from sea ice of the Arctic and Antarctic, respectively. Both genomes exhibit a high genome plasticity caused by an unusually high density and diversity of transposable elements. This could explain the discrepancy between the low genome synteny and high 16S rRNA gene sequence similarity between both strains. Numerous characteristic features were identified in the Octadecabacter genomes, which show indications of horizontal gene transfer and may represent specific adaptations to the habitats of the strains. These include a gene cluster encoding the synthesis and degradation of cyanophycin in O. arcticus 238, which is absent in O. antarcticus 307 and unique among the Roseobacter clade. Furthermore, genes representing a new subgroup of xanthorhodopsins as an adaptation to icy environments are present in both Octadecabacter strains. This new xanthorhodopsin subgroup differs from the previously characterized xanthorhodopsins of Salinibacter ruber and Gloeobacter violaceus in phylogeny, biogeography and the potential to bind 4-keto-carotenoids. Biochemical characterization of the Octadecabacter xanthorhodopsins revealed that they function as light-driven proton pumps.	[Vollmers, John; Voget, Sonja; Dietrich, Sascha; Gollnow, Kathleen; Smits, Maike; Meyer, Katja; Daniel, Rolf] Univ Gottingen, Inst Microbiol & Genet, Dept Genom & Appl Microbiol, D-37073 Gottingen, Germany; [Vollmers, John; Voget, Sonja; Dietrich, Sascha; Gollnow, Kathleen; Smits, Maike; Meyer, Katja; Daniel, Rolf] Univ Gottingen, Inst Microbiol & Genet, Gottingen Genom Lab, D-37073 Gottingen, Germany; [Brinkhoff, Thorsten; Simon, Meinhard] Carl von Ossietzky Univ Oldenburg, Inst Chem & Biol Marine Environm, D-26111 Oldenburg, Germany	University of Gottingen; University of Gottingen; Carl von Ossietzky Universitat Oldenburg	Daniel, R (corresponding author), Univ Gottingen, Inst Microbiol & Genet, Dept Genom & Appl Microbiol, D-37073 Gottingen, Germany.	rdaniel@gwdg.de	Daniel, Rolf/AAQ-5933-2021; Vollmers, John/H-1075-2019	Daniel, Rolf/0000-0002-8646-7925; Vollmers, John/0000-0001-5980-5178	Niedersachsisches VW-Vorab, Germany [ZN2235]; Collaborative Research Center Roseobacter [TRR 51]; Deutsche Forschungsgemeinschaft, Germany; Marine Microbiology Initiative of the Moore Foundation, USA	Niedersachsisches VW-Vorab, Germany; Collaborative Research Center Roseobacter; Deutsche Forschungsgemeinschaft, Germany(German Research Foundation (DFG)); Marine Microbiology Initiative of the Moore Foundation, USA	This study was supported by the Niedersachsisches VW-Vorab "Comparative and functional genome analysis of representative members of the Roseobacter clade'' (ZN2235), Germany, the Collaborative Research Center Roseobacter (TRR 51) funded by Deutsche Forschungsgemeinschaft, Germany, and the Marine Microbiology Initiative of the Moore Foundation, USA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adekambi T, 2004, INT J SYST EVOL MICR, V54, P2095, DOI 10.1099/ijs.0.63094-0; Altenhoff AM, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000262; Ariya PA, 2004, TELLUS B, V56, P397, DOI 10.1111/j.1600-0889.2004.00118.x; Armstrong GA, 1997, ANNU REV MICROBIOL, V51, P629, DOI 10.1146/annurev.micro.51.1.629; Ayub ND, 2004, CURR MICROBIOL, V49, P170, DOI 10.1007/s00284-004-4254-2; Balashov SP, 2010, BIOCHEMISTRY-US, V49, P9792, DOI 10.1021/bi1014166; Balashov SP, 2005, SCIENCE, V309, P2061, DOI 10.1126/science.1118046; Balashov SP, 2000, BBA-BIOENERGETICS, V1460, P75, DOI 10.1016/S0005-2728(00)00131-6; Beja O, 2000, SCIENCE, V289, P1902, DOI 10.1126/science.289.5486.1902; Berg H, 2000, EUR J BIOCHEM, V267, P5561, DOI 10.1046/j.1432-1327.2000.01622.x; Biers EJ, 2008, APPL ENVIRON MICROB, V74, P2933, DOI 10.1128/AEM.02129-07; Bowers Karen J, 2009, Saline Syst, V5, P9, DOI 10.1186/1746-1448-5-9; Bowman JP, 1998, INT J SYST BACTERIOL, V48, P1171, DOI 10.1099/00207713-48-4-1171; Brinkhoff T, 2008, ARCH MICROBIOL, V189, P531, DOI 10.1007/s00203-008-0353-y; Brinkmeyer R, 2003, APPL ENVIRON MICROB, V69, P6610, DOI 10.1128/AEM.69.11.6610-6619.2003; Brown LS, 2004, PHOTOCH PHOTOBIO SCI, V3, P555, DOI 10.1039/b315527g; Buchan A, 2005, APPL ENVIRON MICROB, V71, P5665, DOI 10.1128/AEM.71.10.5665-5677.2005; Collins RE, 2011, POLAR BIOL, V34, P1831, DOI 10.1007/s00300-011-1008-z; Collins RE, 2011, POLAR BIOL, V34, P1819, DOI 10.1007/s00300-011-1041-y; de Vries J, 2002, P NATL ACAD SCI USA, V99, P2094, DOI 10.1073/pnas.042263399; Delcher AL, 2007, BIOINFORMATICS, V23, P673, DOI 10.1093/bioinformatics/btm009; DeLong EF, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000359; Dinsdale EA, 2008, NATURE, V452, P629, DOI 10.1038/nature06810; Ebinghaus R, 2002, ENVIRON SCI TECHNOL, V36, P1238, DOI 10.1021/es015710z; Fernandes N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027387; FRANZMANN PD, 1987, AUST J MAR FRESH RES, V38, P409; Fuser G, 2007, MACROMOL BIOSCI, V7, P278, DOI 10.1002/mabi.200600207; Fuhrman JA, 2008, NAT REV MICROBIOL, V6, P488, DOI 10.1038/nrmicro1893; Gilbert JA, 2009, ENVIRON MICROBIOL, V11, P111, DOI 10.1111/j.1462-2920.2008.01745.x; Gomez-Consarnau L, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000358; GOSINK JJ, 1995, APPL ENVIRON MICROB, V61, P3486, DOI 10.1128/AEM.61.9.3486-3489.1995; Gosink JJ, 1997, SYST APPL MICROBIOL, V20, P356, DOI 10.1016/S0723-2020(97)80003-3; Gray YHM, 2000, TRENDS GENET, V16, P461, DOI 10.1016/S0168-9525(00)02104-1; Havig JR, 2011, J GEOPHYS RES-BIOGEO, V116, DOI 10.1029/2010JG001415; Hewson I, 2009, LIMNOL OCEANOGR, V54, P1981, DOI 10.4319/lo.2009.54.6.1981; Hulsen T, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-4-r31; Imasheva ES, 2009, BIOCHEMISTRY-US, V48, P10948, DOI 10.1021/bi901552x; Kalhoefer D, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-324; Kamennaya NA, 2011, APPL ENVIRON MICROB, V77, P291, DOI 10.1128/AEM.01272-10; Kan JJ, 2011, ISME J, V5, P1784, DOI 10.1038/ismej.2011.56; Krehenbrink M, 2002, ARCH MICROBIOL, V177, P371, DOI 10.1007/s00203-001-0396-9; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; Kyndt JA, 2004, BIOCHEMISTRY-US, V43, P1809, DOI 10.1021/bi035789f; Langille MGI, 2009, BIOINFORMATICS, V25, P664, DOI 10.1093/bioinformatics/btp030; Lanyi JK, 2008, BBA-BIOENERGETICS, V1777, P684, DOI 10.1016/j.bbabio.2008.05.005; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lauro FM, 2011, ISME J, V5, P879, DOI 10.1038/ismej.2010.185; Ludwig W, 2004, NUCLEIC ACIDS RES, V32, P1363, DOI 10.1093/nar/gkh293; Luecke H, 2008, P NATL ACAD SCI USA, V105, P16561, DOI 10.1073/pnas.0807162105; Luo H., 2011, ENVIRON MICROBIOL, V14, P41; Lutnaes BF, 2002, J NAT PROD, V65, P1340, DOI 10.1021/np020125c; Markowitz VM, 2012, NUCLEIC ACIDS RES, V40, pD115, DOI 10.1093/nar/gkr1044; Martinez A, 2010, ENVIRON MICROBIOL, V12, P222, DOI 10.1111/j.1462-2920.2009.02062.x; McCarren J, 2007, ENVIRON MICROBIOL, V9, P846, DOI 10.1111/j.1462-2920.2006.01203.x; Methe BA, 2005, P NATL ACAD SCI USA, V102, P10913, DOI 10.1073/pnas.0504766102; Mock T, 2005, ENVIRON MICROBIOL, V7, P605, DOI 10.1111/j.1462-2920.2005.00781.x; Moller AK, 2011, FEMS MICROBIOL ECOL, V75, P390, DOI 10.1111/j.1574-6941.2010.01016.x; Mongodin EF, 2005, P NATL ACAD SCI USA, V102, P18147, DOI 10.1073/pnas.0509073102; NEEDLEMAN SB, 1970, J MOL BIOL, V48, P443, DOI 10.1016/0022-2836(70)90057-4; Newton RJ, 2010, ISME J, V4, P784, DOI 10.1038/ismej.2009.150; Offner S, 2000, J BACTERIOL, V182, P4328, DOI 10.1128/JB.182.15.4328-4336.2000; Ortega-Retuerta E, 2012, POLAR BIOL, V35, P785, DOI 10.1007/s00300-011-1109-8; Osborn AM, 1997, FEMS MICROBIOL REV, V19, P239, DOI 10.1111/j.1574-6976.1997.tb00300.x; Overbeek R, 2003, NUCLEIC ACIDS RES, V31, P164, DOI 10.1093/nar/gkg148; Palys T, 2000, INT J SYST EVOL MICR, V50, P1021, DOI 10.1099/00207713-50-3-1021; Palys T, 1997, INT J SYST BACTERIOL, V47, P1145, DOI 10.1099/00207713-47-4-1145; Petrosino JF, 2006, J BACTERIOL, V188, P6977, DOI 10.1128/JB.00506-06; Poulain AJ, 2007, APPL ENVIRON MICROB, V73, P2230, DOI 10.1128/AEM.02701-06; Prudhomme M, 2002, P NATL ACAD SCI USA, V99, P2100, DOI 10.1073/pnas.032262999; Qian D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018300; Rankin L. M., 1999, POLARFORSCHUNG, V66, P33; Rich VI, 2011, ENVIRON MICROBIOL, V13, P116, DOI 10.1111/j.1462-2920.2010.02314.x; Richter M, 2009, P NATL ACAD SCI USA, V106, P19126, DOI 10.1073/pnas.0906412106; RIPPKA R, 1974, ARCH MICROBIOL, V100, P419, DOI 10.1007/BF00446333; Rusch DB, 2007, PLOS BIOL, V5, P398, DOI 10.1371/journal.pbio.0050077; Sabehi G, 2005, PLOS BIOL, V3, P1409, DOI 10.1371/journal.pbio.0030273; Sangar V, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-294; Scanlan DJ, 2009, MICROBIOL MOL BIOL R, V73, P249, DOI 10.1128/MMBR.00035-08; SEVERIN J, 1992, J GEN MICROBIOL, V138, P1629, DOI 10.1099/00221287-138-8-1629; Sharma AK, 2009, ISME J, V3, P726, DOI 10.1038/ismej.2009.13; Siguier P, 2006, NUCLEIC ACIDS RES, V34, pD32, DOI 10.1093/nar/gkj014; Siguier P, 2006, CURR OPIN MICROBIOL, V9, P526, DOI 10.1016/j.mib.2006.08.005; Simon C, 2009, APPL ENVIRON MICROB, V75, P7519, DOI 10.1128/AEM.00946-09; Slamovits CH, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1188; Soria-Carrasco V, 2007, SYST APPL MICROBIOL, V30, P171, DOI 10.1016/j.syapm.2006.07.001; Sorokin DY, 2002, INT J SYST EVOL MICR, V52, P657, DOI 10.1099/00207713-52-2-657; Spudich JL, 2000, ANNU REV CELL DEV BI, V16, P365, DOI 10.1146/annurev.cellbio.16.1.365; Staden R, 1996, MOL BIOTECHNOL, V5, P233, DOI 10.1007/BF02900361; Staley JT, 1999, ANNU REV MICROBIOL, V53, P189, DOI 10.1146/annurev.micro.53.1.189; Tech Maike, 2003, In Silico Biology, V3, P441; Thole S, 2012, ISME J, V6, P2229, DOI 10.1038/ismej.2012.62; Thomas CM, 2005, NAT REV MICROBIOL, V3, P711, DOI 10.1038/nrmicro1234; Thomas DN, 2002, SCIENCE, V295, P641, DOI 10.1126/science.1063391; Thomas T, 2010, ISME J, V4, P1557, DOI 10.1038/ismej.2010.74; Thompson FL, 2005, APPL ENVIRON MICROB, V71, P5107, DOI 10.1128/AEM.71.9.5107-5115.2005; Varin T, 2010, LIMNOL OCEANOGR, V55, P1901, DOI 10.4319/lo.2010.55.5.1901; Wagner-Dobler I, 2006, ANNU REV MICROBIOL, V60, P255, DOI 10.1146/annurev.micro.60.080805.142115; Wallden K, 2010, CELL MICROBIOL, V12, P1203, DOI 10.1111/j.1462-5822.2010.01499.x; WAYNE LG, 1987, INT J SYST BACTERIOL, V37, P463, DOI 10.1099/00207713-37-4-463; Yau S, 2011, P NATL ACAD SCI USA, V108, P6163, DOI 10.1073/pnas.1018221108; Yoon JH, 2007, INT J SYST EVOL MICR, V57, P856, DOI 10.1099/ijs.0.64779-0; Zdobnov EM, 2001, BIOINFORMATICS, V17, P847, DOI 10.1093/bioinformatics/17.9.847; Zhang DC, 2008, INT J SYST EVOL MICR, V58, P1384, DOI 10.1099/ijs.0.65708-0; Zobell CE, 1941, J MAR RES, V4, P42	104	77	80	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2013	8	5							e63422	10.1371/journal.pone.0063422	http://dx.doi.org/10.1371/journal.pone.0063422			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	177QL	23671678	Green Submitted, Green Published, gold			2022-12-27	WOS:000321390200048
J	Vujovic, P; Stamenkovic, S; Jasnic, N; Lakic, I; Djurasevic, SF; Cvijic, G; Djordjevic, J				Vujovic, Predrag; Stamenkovic, Stefan; Jasnic, Nebojsa; Lakic, Iva; Djurasevic, Sinisa F.; Cvijic, Gordana; Djordjevic, Jelena			Fasting Induced Cytoplasmic Fto expression in Some Neurons of Rat Hypothalamus	PLOS ONE			English	Article							FOOD-INTAKE; GENE-EXPRESSION; OBESITY GENE; FAT MASS; DEPRIVATION; METHYLATION; TRANSPORT; VARIANT; ACID; BODY	Fat mass and obesity associated protein (Fto) is a nucleic acid demethylase, with a preference for thymine or uracil, according to the recent structural data. This fact suggests that methylated single-stranded RNA, rather than DNA, may be the primary Fto substrate. Fto is abundantly expressed in all hypothalamic sites governing feeding behavior. Considering that selective modulation of Fto levels in the hypothalamus can influence food intake, we set out to investigate the effect of 48 h fasting on the Fto expression in lateral hypothalamic area, paraventricular, ventromedial and arcuate nucleus, the regulatory centres of energy homeostasis. We have demonstrated that 48 h fasting causes not only an increase in the overall hypothalamic levels of both Fto mRNA and protein, but also alters Fto intracellular distribution. This switch happens in some neurons of paraventricular and ventromedial nucleus, as well as lateral hypothalamic area, resulting in the majority of the enzyme being localized outside the cell nuclei. Interestingly, the change in the Fto intracellular localization was not observed in neurons of arcuate nucleus, suggesting that fasting did not universally affect Fto in all of the hypothalmic sites involved in energy homeostasis regulation. Both Fto mRNA and catechol-O-methyltransferaze mRNA were upregulated in the identical time-dependent manner in fasting animals. This fact, combined with the knowledge of the Fto substrate preference, may provide further insight into monoamine metabolism in the state of disturbed energy homeostasis.	[Vujovic, Predrag; Jasnic, Nebojsa; Lakic, Iva; Djurasevic, Sinisa F.; Cvijic, Gordana; Djordjevic, Jelena] Univ Belgrade, Fac Biol, Inst Physiol & Biochem, Belgrade, Serbia; [Stamenkovic, Stefan] Univ Belgrade, Fac Biol, Ctr Laser Microscopy, Belgrade, Serbia	University of Belgrade; University of Belgrade	Vujovic, P (corresponding author), Univ Belgrade, Fac Biol, Inst Physiol & Biochem, Belgrade, Serbia.	predragv@bio.bg.ac.rs	Djurasevic, Sinisa/G-4064-2016; Djordjevic, Jelena/HIK-1329-2022	Djurasevic, Sinisa/0000-0003-4406-8376; Djordjevic, Jelena/0000-0002-6510-1027; Jasnic, Nebojsa/0000-0003-0333-333X; Vujovic, Predrag/0000-0002-9444-4758; Stamenkovic, Stefan/0000-0002-3443-9156	Serbian Ministry of Education, Science and Technological Development Grant [173023]	Serbian Ministry of Education, Science and Technological Development Grant	The experimental work was funded by the Serbian Ministry of Education, Science and Technological Development Grant No 173023. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	CHEREL Y, 1991, CLIN SCI, V81, P611, DOI 10.1042/cs0810611; Fetissov SO, 2000, NEUROSCIENCE, V101, P657, DOI 10.1016/S0306-4522(00)00374-2; Fischer J, 2009, NATURE, V458, P894, DOI 10.1038/nature07848; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Fredriksson R, 2008, ENDOCRINOLOGY, V149, P2062, DOI 10.1210/en.2007-1457; Gerken T, 2007, SCIENCE, V318, P1469, DOI 10.1126/science.1151710; GLICK SD, 1973, RES COMMUN CHEM PATH, V6, P775; Han ZF, 2010, NATURE, V464, P1205, DOI 10.1038/nature08921; Haupt A, 2009, EXP CLIN ENDOCR DIAB, V117, P194, DOI 10.1055/s-0028-1087176; Jans DA, 1996, PHYSIOL REV, V76, P651, DOI 10.1152/physrev.1996.76.3.651; Larder R, 2011, TRENDS ENDOCRIN MET, V22, P53, DOI 10.1016/j.tem.2010.11.001; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Micura R, 2001, NUCLEIC ACIDS RES, V29, P3997, DOI 10.1093/nar/29.19.3997; NEGRE D, 1989, P NATL ACAD SCI USA, V86, P4902, DOI 10.1073/pnas.86.13.4902; Olszewski PK, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-129; Otis KO, 2006, CURR OPIN NEUROBIOL, V16, P329, DOI 10.1016/j.conb.2006.05.001; Qi L, 2008, DIABETES, V57, P3145, DOI 10.2337/db08-0006; Ramos EJB, 2005, NUTRITION, V21, P269, DOI 10.1016/j.nut.2004.06.021; Sanchez-Pulido Luis, 2007, BMC Biochemistry, V8, P23, DOI 10.1186/1471-2091-8-23; Scuteri A, 2007, PLOS GENET, V3, P1200, DOI 10.1371/journal.pgen.0030115; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Stratigopoulos G, 2008, AM J PHYSIOL-REG I, V294, pR1185, DOI 10.1152/ajpregu.00839.2007; Tung YCL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008771	23	31	31	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2013	8	5							e63694	10.1371/journal.pone.0063694	http://dx.doi.org/10.1371/journal.pone.0063694			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	177QL	23671692	Green Submitted, gold, Green Published			2022-12-27	WOS:000321390200057
J	Pearson, SH; Avery, HW; Kilham, SS; Velinsky, DJ; Spotila, JR				Pearson, Steven H.; Avery, Harold W.; Kilham, Susan S.; Velinsky, David J.; Spotila, James R.			Stable Isotopes of C and N Reveal Habitat Dependent Dietary Overlap between Native and Introduced Turtles Pseudemys rubriventris and Trachemys scripta	PLOS ONE			English	Article							FRESH-WATER TURTLES; COMPETITION; FOOD; CONSERVATION; NITROGEN; DISCRIMINATION; FRAGMENTATION; TEMPERATURE; COEXISTENCE; DISTURBANCE	Habitat degradation and species introductions are two of the leading causes of species declines on a global scale. Invasive species negatively impact native species through predation and competition for limited resources. The impacts of invasive species may be increased in habitats where habitat degradation is higher due to reductions of prey abundance and distribution. Using stable isotope analyses and extensive measurements of resource availability we determined how resource availability impacts the long term carbon and nitrogen assimilation of the invasive red-eared slider turtle (Trachemys scripta elegans) and a native, threatened species, the red-bellied turtle (Pseudemys rubriventris) at two different freshwater wetland complexes in Pennsylvania, USA. At a larger wetland complex with greater vegetative species richness and diversity, our stable isotope analyses showed dietary niche partitioning between species, whereas analyses from a smaller wetland complex with lower vegetative species richness and diversity showed significant dietary niche overlap. Determining the potential for competition between these two turtle species is important to understanding the ecological impacts of red-eared slider turtles in wetland habitats. In smaller wetlands with increased potential for competition between native turtles and invasive red-eared slider turtles we expect that when shared resources become limited, red-eared slider turtles will negatively impact native turtle species leading to long term population declines. Protection of intact wetland complexes and the reduction of introduced species populations are paramount to preserving populations of native species.	[Pearson, Steven H.; Kilham, Susan S.; Velinsky, David J.; Spotila, James R.] Drexel Univ, Dept Biodivers Earth & Environm Sci, Philadelphia, PA 19104 USA; [Avery, Harold W.] Drexel Univ, Dept Biol, Philadelphia, PA 19104 USA	Drexel University; Drexel University	Pearson, SH (corresponding author), Drexel Univ, Dept Biodivers Earth & Environm Sci, Philadelphia, PA 19104 USA.	shp36@drexel.edu	Pearson, Steven/X-8726-2019	Pearson, Steven/0000-0001-5098-9476	PA Fish and Boat Commission SWG Project [T-38]; DuPont Clear into the Future Student Fellowship; Betz Chair of Environmental Science at Drexel University	PA Fish and Boat Commission SWG Project; DuPont Clear into the Future Student Fellowship; Betz Chair of Environmental Science at Drexel University	Funding for this research has come from three sources: PA Fish and Boat Commission SWG Project T-38, DuPont Clear into the Future Student Fellowship to Steven Pearson, The Betz Chair of Environmental Science at Drexel University. The funders at the PA Fish and Boat Commission and at DuPont Clear into the Future had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The Betz Chair of Environmental Science at Drexel University was involved in study design, data analysis, and preparation of the manuscript.	Alves-Stanley CD, 2010, MAR ECOL PROG SER, V402, P255, DOI 10.3354/meps08450; Amarasekare P, 2002, P ROY SOC B-BIOL SCI, V269, P2541, DOI 10.1098/rspb.2002.2181; Amarasekare P, 2004, AM NAT, V164, P310, DOI 10.1086/422858; AVERY HW, 1993, PHYSIOL ZOOL, V66, P902, DOI 10.1086/physzool.66.6.30163746; AVERY HW, 1984, COPEIA, P209, DOI 10.2307/1445055; Avery HW, 2006, FINAL REPORT RED BEL; Baum JK, 2009, J ANIM ECOL, V78, P699, DOI 10.1111/j.1365-2656.2009.01531.x; Bellgraph BJ, 2008, T AM FISH SOC, V137, P790, DOI 10.1577/T07-102.1; Beyer HL, 2004, HAWTHS ANAL TOOLS AR; Bluthgen N, 2003, OECOLOGIA, V137, P426, DOI 10.1007/s00442-003-1347-8; Bulte G, 2008, FRESHWATER BIOL, V53, P497, DOI 10.1111/j.1365-2427.2007.01915.x; Cadi A, 2004, BIODIVERS CONSERV, V13, P2511, DOI 10.1023/B:BIOC.0000048451.07820.9c; Cadotte MW, 2007, ECOLOGY, V88, P823, DOI 10.1890/06-1117; CHAIKOFF IL, 1946, J BIOL CHEM, V166, P683; Cherel Y, 2005, PHYSIOL BIOCHEM ZOOL, V78, P106, DOI 10.1086/425202; CONGDON JD, 1985, HERPETOLOGICA, V41, P194; CONGDON JD, 1993, CONSERV BIOL, V7, P826, DOI 10.1046/j.1523-1739.1993.740826.x; CREE A, 1995, CONSERV BIOL, V9, P373, DOI 10.1046/j.1523-1739.1995.9020373.x; DANTONIO CM, 1992, ANNU REV ECOL SYST, V23, P63, DOI 10.1146/annurev.es.23.110192.000431; Ernst C.H., 1994, TURTLES US CANADA; Ervin GN, 2007, WETLANDS, V27, P620, DOI 10.1672/0277-5212(2007)27[620:AESOTF]2.0.CO;2; Fahrig L, 2003, ANNU REV ECOL EVOL S, V34, P487, DOI 10.1146/annurev.ecolsys.34.011802.132419; Fry B., 2006, STABLE ISOTOPE ECOLO; Gibbons J.W., 1990, P124; GRAHAM TE, 1971, COPEIA, P353; HANSEN RM, 1976, J RANGE MANAGE, V29, P347, DOI 10.2307/3897105; Heppell SS, 1998, COPEIA, P367, DOI 10.2307/1447430; Kamler JF, 2007, SOUTHWEST NAT, V52, P504, DOI 10.1894/0038-4909(2007)52[504:DOSFVV]2.0.CO;2; Kemp SJ, 2008, MAR ECOL PROG SER, V371, P233, DOI 10.3354/meps07641; Kilham SS, 2009, INT VER THEOR ANGEW, V30, P749; Krebs C.J., 1999, ECOLOGICAL METHODOLO; Litzgus JD, 2008, COPEIA, P86, DOI 10.1643/CH-07-093; Luiselli L, 2004, HERPETOL J, V14, P57; Luiselli L, 2006, J TROP ECOL, V22, P695, DOI 10.1017/S0266467406003634; Mack RN, 2000, ECOL APPL, V10, P689, DOI 10.1890/1051-0761(2000)010[0689:BICEGC]2.0.CO;2; McCutchan J. H., 2001, SIL P, V27, P1922, DOI [10.1080/03680770.1998.11902437, DOI 10.1080/03680770.1998.11902437]; Miranda NAF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031897; Paoletti G, 2007, EMU, V107, P52, DOI 10.1071/MU05042; Parmenter R.R., 1990, P257; PETERSON BJ, 1987, ANNU REV ECOL SYST, V18, P293, DOI 10.1146/annurev.es.18.110187.001453; POLIS GA, 1987, ECOLOGY, V68, P332, DOI 10.2307/1939264; Polo-Cavia N, 2010, BIOL INVASIONS, V12, P2141, DOI 10.1007/s10530-009-9615-0; Post DM, 2007, OECOLOGIA, V152, P179, DOI 10.1007/s00442-006-0630-x; Post DM, 2002, ECOLOGY, V83, P703, DOI 10.2307/3071875; R Development Core Team, 2011, R LANG ENV STAT COMP; Reich KJ, 2007, BIOL LETTERS, V3, P712, DOI 10.1098/rsbl.2007.0394; Rodda GH, 1997, BIOSCIENCE, V47, P565, DOI 10.2307/1313163; ROWE JW, 1992, J HERPETOL, V26, P111, DOI 10.2307/1565040; SCHOENER TW, 1983, AM NAT, V122, P240, DOI 10.1086/284133; SEASTEDT TR, 1991, OECOLOGIA, V87, P72, DOI 10.1007/BF00323782; Seminoff JA, 2007, COPEIA, P534, DOI 10.1643/0045-8511(2007)2007[534:SCANID]2.0.CO;2; Shenko AN, 2012, INTEGR ZOOL, V7, P16, DOI [10.1111/j.1749-4877.2012.00272.x, 10.1111/j.1749-4877.2011.00274.x]; SIBLY RM, 1994, FUNCT ECOL, V8, P486, DOI 10.2307/2390073; Steiniger S, 2009, ECOL INFORM, V4, P183, DOI 10.1016/j.ecoinf.2009.07.004; Swihart RK, 2003, DIVERS DISTRIB, V9, P1, DOI 10.1046/j.1472-4642.2003.00158.x; TILMAN D, 1981, ECOLOGY, V62, P802, DOI 10.2307/1937747; Titus John E., 1993, Lake and Reservoir Management, V7, P155; Vanderklift MA, 2003, OECOLOGIA, V136, P169, DOI 10.1007/s00442-003-1270-z; Wallace BP, 2009, J EXP MAR BIOL ECOL, V373, P50, DOI 10.1016/j.jembe.2009.03.006; Wilcove DS, 1998, BIOSCIENCE, V48, P607, DOI 10.2307/1313420	60	11	11	1	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2013	8	5							e62891	10.1371/journal.pone.0062891	http://dx.doi.org/10.1371/journal.pone.0062891			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145RZ	23675437	gold, Green Published, Green Submitted			2022-12-27	WOS:000319036100018
J	Szeto, CC; Kwan, BCH; Chow, KM; Leung, CB; Li, PKT				Szeto, Cheuk-Chun; Kwan, Bonnie Ching-Ha; Chow, Kai-Ming; Leung, Chi-Bon; Li, Philip Kam-Tao			The Safety and Short-Term Efficacy of Aliskiren in the Treatment of Immunoglobulin A Nephropathy - A Randomized Cross-Over Study	PLOS ONE			English	Article							DIRECT RENIN INHIBITION; CARDIORENAL END-POINTS; IGA NEPHROPATHY; OXFORD CLASSIFICATION; NORMOTENSIVE PATIENTS; DOUBLE-BLIND; TRIAL; LOSARTAN; RATIONALE; OUTCOMES	Background: Laboratory research and previous study suggest that aliskiren, a direct renin inhibitor, has anti-proteinuric effects. We conducted a randomized crossover study to evaluate the anti-proteinuric effect of aliskiren in patients with immunoglobulin A (IgA) nephropathy. Methods: We studied 22 patients with biopsy-proven IgA nephropathy and persistent proteinuria despite angiotensin converting enzyme (ACE) inhibitor or angiotensin receptor blocker (ARB). Patients were randomized to either oral aliskiren 300 mg/day or placebo for 16 weeks and then crossed over to the other treatment arm after a washout period. Proteinuria, estimated glomerular filtration rate (eGFR), blood pressure, and serum potassium were monitored. Results: After aliskiren treatment, there was a significant reduction in proteinuria in 4 weeks (1.76 +/- 0.95 to 1.03 +/- 0.69 g:g-Cr, p<0.0001), which remained at a low level throughout the treatment period. There was a significant difference in proteinuria between the aliskiren and placebo groups from 4 to 16 weeks after treatment (p<0.01 for all comparisons). After aliskiren treatment, there were modest but statistically significant reductions in eGFR (57.2 +/- 29.1 to 54.8 +/- 29.3 ml/min/1.73 m(2), p=0.013) and diastolic blood pressure (72.6 +/- 12.3 to 66.2 +/- 11.2 mmHg, p<0.0001). None of the patient developed severe hyperkalemia (serum potassium >= 6.0 mmol/l) during the study period. Conclusions: Aliskiren has anti-proteinuric effect in patients with IgA nephropathy and persistent proteinuria despite ACE inhibitor or ARB. Further studies are needed to confirm the renal protecting effect of direct renin inhibition in chronic proteinuric kidney diseases.	[Szeto, Cheuk-Chun; Kwan, Bonnie Ching-Ha; Chow, Kai-Ming; Leung, Chi-Bon; Li, Philip Kam-Tao] Chinese Univ Hong Kong, Prince Wales Hosp, Dept Med & Therapeut, Shatin, Hong Kong, Peoples R China	Chinese University of Hong Kong; Prince of Wales Hospital	Szeto, CC (corresponding author), Chinese Univ Hong Kong, Prince Wales Hosp, Dept Med & Therapeut, Shatin, Hong Kong, Peoples R China.	ccszeto@cuhk.edu.hk	Szeto, Cheuk Chun/N-4954-2015; Kwan, Bonnie/N-3463-2015; Li, Philip K. T./D-4051-2017; Ming, Chow Kai/Y-5568-2019	Szeto, Cheuk Chun/0000-0002-8898-8505; Kwan, Bonnie/0000-0001-6742-8480; Ming, Chow Kai/0000-0001-5310-5197	Novartis Pharmaceuticals (Hong Kong) Limited; Chinese University of Hong Kong [6901031]	Novartis Pharmaceuticals (Hong Kong) Limited; Chinese University of Hong Kong(Chinese University of Hong Kong)	The study was supported in part by Novartis Pharmaceuticals (Hong Kong) Limited, and the Chinese University of Hong Kong research accounts 6901031. The study medications, including placebo, were prepared and packed by Novartis Pharmaceuticals. The funding sources had no influence on data analysis or preparation of this manuscript. All authors have nothing else to disclose.	Angeli F, 2012, EXPERT OPIN DRUG SAF, V11, P659, DOI 10.1517/14740338.2012.696608; Cattran DC, 2009, KIDNEY INT, V76, P534, DOI 10.1038/ki.2009.243; DAMICO G, 1987, Q J MED, V64, P709; Fisher NDL, 2005, J AM SOC NEPHROL, V16, P592, DOI 10.1681/ASN.2004100874; Fung JWH, 2003, AM J CARDIOL, V92, P406, DOI 10.1016/S0002-9149(03)00658-1; Gheorghiade M, 2011, EUR J HEART FAIL, V13, P100, DOI 10.1093/eurjhf/hfq209; Gradman AH, 2005, CIRCULATION, V111, P1012, DOI 10.1161/01.CIR.0000156466.02908.ED; Haas M, 1997, AM J KIDNEY DIS, V29, P829, DOI 10.1016/S0272-6386(97)90456-X; Krum H, 2011, EUR J HEART FAIL, V13, P107, DOI 10.1093/eurjhf/hfq212; Leung WYS, 2004, NEPHROL DIAL TRANSPL, V19, P2519, DOI 10.1093/ndt/gfh408; Li PKT, 2006, AM J KIDNEY DIS, V47, P751, DOI 10.1053/j.ajkd.2006.01.017; Li PKT, 2002, NEPHROL DIAL TRANSPL, V17, P64, DOI 10.1093/ndt/17.1.64; Li SY, 2012, BMC NEPHROL, V13, DOI 10.1186/1471-2369-13-89; Lizakowski S, 2012, AM J HYPERTENS, V25, P636, DOI 10.1038/ajh.2012.14; Ma YC, 2006, J AM SOC NEPHROL, V17, P2937, DOI 10.1681/ASN.2006040368; MASCHIO G, 1994, NEPHROL DIAL TRANSPL, V9, P265; Moist L, 2012, ANN INTERN MED, V156, DOI 10.7326/0003-4819-156-12-201206190-02009; Parving HH, 2008, NEW ENGL J MED, V358, P2433, DOI 10.1056/NEJMoa0708379; Parving HH, 2012, NEW ENGL J MED, V367, P2204, DOI 10.1056/NEJMoa1208799; Parving HH, 2012, J RENIN-ANGIO-ALDO S, V13, P387, DOI 10.1177/1470320311434818; Perico N, 1998, J AM SOC NEPHROL, V9, P2308; Persson F, 2008, KIDNEY INT, V73, P1419, DOI 10.1038/ki.2008.68; Persson F, 2011, CLIN J AM SOC NEPHRO, V6, P1025, DOI 10.2215/CJN.07590810; Persson F, 2010, DIABETES CARE, V33, P2304, DOI 10.2337/dc10-0833; Roberts ISD, 2009, KIDNEY INT, V76, P546, DOI 10.1038/ki.2009.168; Ruggenenti P, 2000, AM J KIDNEY DIS, V35, P1155, DOI 10.1016/S0272-6386(00)70054-0; Russo D, 1999, AM J KIDNEY DIS, V33, P851, DOI 10.1016/S0272-6386(99)70416-6; Staessen JA, 2006, LANCET, V368, P1449, DOI 10.1016/S0140-6736(06)69442-7; Stanton A, 2003, HYPERTENSION, V42, P1137, DOI 10.1161/01.HYP.0000101688.17370.87; Tang SCW, 2012, NEPHROL DIAL TRANSPL, V27, P613, DOI 10.1093/ndt/gfr349; To KF, 2000, AM J KIDNEY DIS, V35, P392, DOI 10.1016/S0272-6386(00)70191-0; van Paassen P, 2000, NEPHROL DIAL TRANSPL, V15, P637, DOI 10.1093/ndt/15.5.637; Yusuf S, 2008, NEW ENGL J MED, V358, P1547, DOI 10.1056/NEJMoa0801317	33	15	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2013	8	5							e62736	10.1371/journal.pone.0062736	http://dx.doi.org/10.1371/journal.pone.0062736			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	143FO	23675422	Green Submitted, Green Published, gold			2022-12-27	WOS:000318852400009
J	Todoroff, J; Lemaire, MM; Fillee, C; Jurion, F; Renauld, JC; Huygen, K; Vanbever, R				Todoroff, Julie; Lemaire, Muriel M.; Fillee, Catherine; Jurion, Fabienne; Renauld, Jean-Christophe; Huygen, Kris; Vanbever, Rita			Mucosal and Systemic Immune Responses to Mycobacterium tuberculosis Antigen 85A following Its Co-Delivery with CpG, MPLA or LTB to the Lungs in Mice	PLOS ONE			English	Article							MONOPHOSPHORYL-LIPID-A; PROTECTIVE EFFICACY; INFLUENZA VACCINE; ADJUVANT; IMMUNIZATION; IMMUNOGENICITY; ENTEROTOXIN; MECHANISMS; INFECTION; DEFENSE	Pulmonary vaccination is a promising route for immunization against tuberculosis because the lung is the natural site of infection with Mycobacterium tuberculosis. Yet, adjuvants with a suitable safety profile need to be found to enhance mucosal immunity to recombinant antigens. The aim of this study was to evaluate the immunogenicity, the safety and the protective efficacy of a subunit vaccine composed of the immunodominant mycolyl-transferase antigen 85A (Ag85A) and one of three powerful mucosal adjuvants: the oligodeoxynucleotide containing unmethylated cytosine-phosphate-guanine motifs (CpG), the monophosphoryl lipid A of Salmonella minnesota (MPLA) or the B subunit of heat-labile enterotoxin of Escherichia coli (LTB). BALB/c mice were vaccinated in the deep lungs. Our results showed that lung administration of these adjuvants could specifically induce different types of T cell immunity. Both CpG and MPLA induced a Th-1 type immune response with significant antigen-specific IFN-gamma production by spleen mononuclear cells in vitro and a tendency of increased IFN-gamma in the lungs. Moreover, MPLA triggered a Th-17 response reflected by high IL-17A levels in the spleen and lungs. By contrast, LTB promoted a Th-2 biased immune response, with a production of IL-5 but not IFN-gamma by spleen mononuclear cells in vitro. CpG did not induce inflammation in the lungs while LTB and MPLA showed a transient inflammation including a neutrophil influx one day after pulmonary administration. Pulmonary vaccination with Ag85A without or with MPLA or LTB tended to decrease bacterial counts in the spleen and lungs following a virulent challenge with M. tuberculosis H37Rv. In conclusion, CpG and MPLA were found to be potential adjuvants for pulmonary vaccination against tuberculosis, providing Th-1 and Th-17 immune responses and a good safety profile.	[Todoroff, Julie; Vanbever, Rita] Catholic Univ Louvain, Louvain Drug Res Inst, Pharmaceut & Drug Delivery Grp, B-1200 Brussels, Belgium; [Lemaire, Muriel M.; Renauld, Jean-Christophe] Catholic Univ Louvain, de Duve Inst, Expt Med Unit, B-1200 Brussels, Belgium; [Lemaire, Muriel M.; Jurion, Fabienne; Renauld, Jean-Christophe] Ludwig Inst Canc Res, Brussels Branch, Brussels, Belgium; [Fillee, Catherine] Clin Univ St Luc, Dept Biol Clin, B-1200 Brussels, Belgium; [Huygen, Kris] Sci Inst Publ Hlth, Serv Immunol, Brussels, Belgium	Universite Catholique Louvain; Universite Catholique Louvain; Ludwig Institute for Cancer Research; Universite Catholique Louvain; Cliniques Universitaires Saint-Luc	Vanbever, R (corresponding author), Catholic Univ Louvain, Louvain Drug Res Inst, Pharmaceut & Drug Delivery Grp, B-1200 Brussels, Belgium.	rita.vanbever@uclouvain.be	; Renauld, Jean-Christophe/B-7268-2012	Huygen, Kris/0000-0001-7808-0512; Renauld, Jean-Christophe/0000-0003-1736-2131	Fonds de la Recherche Scientifique Medicale, Belgium [3.4530.09 FNRS]; Fonds National de la Recherche Scientifique (FNRS, Belgium); FWO-Vlaanderen [G.0063.09N]	Fonds de la Recherche Scientifique Medicale, Belgium(Fonds de la Recherche Scientifique - FNRS); Fonds National de la Recherche Scientifique (FNRS, Belgium)(Fonds de la Recherche Scientifique - FNRS); FWO-Vlaanderen(FWO)	The work was supported by the Fonds de la Recherche Scientifique Medicale (grant number 3.4530.09 FNRS, Belgium; www1.frs-fnrs.be) and by the Fonds National de la Recherche Scientifique (FNRS, Belgium). The work was also partially supported by grant G.0063.09N of FWO-Vlaanderen. Rita Vanbever is Senior research associate of the FNRS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baldridge JR, 2000, VACCINE, V18, P2416, DOI 10.1016/S0264-410X(99)00572-1; Banaiee N, 2006, J IMMUNOL, V176, P3019, DOI 10.4049/jimmunol.176.5.3019; Barry M, 2007, EXPERT OPIN BIOL TH, V7, P1731, DOI 10.1517/14712598.7.11.1731; Boom WH, 1996, INFECT AGENT DIS, V5, P73; Casella CR, 2008, CELL MOL LIFE SCI, V65, P3231, DOI 10.1007/s00018-008-8228-6; Cooper AM, 2012, CURR OPIN IMMUNOL, V24, P431, DOI 10.1016/j.coi.2012.04.008; D'Souza S, 2003, INFECT IMMUN, V71, P483; da Hora VP, 2011, VACCINE, V29, P1538, DOI 10.1016/j.vaccine.2010.11.091; Dietrich J, 2006, J IMMUNOL, V177, P6353, DOI 10.4049/jimmunol.177.9.6353; Drent M, 1996, EUR RESPIR J, V9, P1736, DOI 10.1183/09031936.96.09081736; Elamin AA, 2009, J MICROBIOL METH, V79, P358, DOI 10.1016/j.mimet.2009.10.010; Fingerut E, 2006, VET IMMUNOL IMMUNOP, V112, P253, DOI 10.1016/j.vetimm.2006.03.005; Fischer G, 2010, WORLD J MICROB BIOT, V26, P489, DOI 10.1007/s11274-009-0195-z; Garcia-Contreras L, 2008, P NATL ACAD SCI USA, V105, P4656, DOI 10.1073/pnas.0800043105; Gartner T, 2007, IMMUNOL LETT, V111, P26, DOI 10.1016/j.imlet.2007.04.010; Goonetilleke NP, 2003, J IMMUNOL, V171, P1602, DOI 10.4049/jimmunol.171.3.1602; GRUBHOFER N, 1995, IMMUNOL LETT, V44, P19, DOI 10.1016/0165-2478(94)00188-W; Holt PG, 2008, NAT REV IMMUNOL, V8, P142, DOI 10.1038/nri2236; Jeyanathan M, 2008, J IMMUNOL, V181, P5618, DOI 10.4049/jimmunol.181.8.5618; Krieg AM, 2000, VACCINE, V19, P618, DOI 10.1016/S0264-410X(00)00249-8; Krieg AM, 2006, NAT REV DRUG DISCOV, V5, P471, DOI 10.1038/nrd2059; Lemaire MM, 2011, J IMMUNOL, V187, P3530, DOI 10.4049/jimmunol.1101720; Lewis DJM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006999; Lu DM, 2007, EXPERT REV VACCINES, V6, P213, DOI 10.1586/14760584.6.2.213; Mata-Haro V, 2007, SCIENCE, V316, P1628, DOI 10.1126/science.1138963; Minne A, 2007, IMMUNOLOGY, V122, P316, DOI 10.1111/j.1365-2567.2007.02641.x; Nicod LP, 1999, RESPIRATION, V66, P2, DOI 10.1159/000029329; Ottenhoff THM, 2012, TRENDS MICROBIOL, V20, P419, DOI 10.1016/j.tim.2012.06.002; ROCHE PW, 1995, TRENDS MICROBIOL, V3, P397, DOI 10.1016/S0966-842X(00)88986-6; Romano M, 2006, IMMUNOLOGY, V118, P321, DOI 10.1111/j.1365-2567.2006.02373.x; Romano M, 2012, EXPERT OPIN BIOL TH, V12, P1601, DOI 10.1517/14712598.2012.721768; Santosuosso M, 2005, J IMMUNOL, V174, P7986, DOI 10.4049/jimmunol.174.12.7986; Santosuosso M, 2007, J IMMUNOL, V178, P2387, DOI 10.4049/jimmunol.178.4.2387; Scriba TJ, 2011, J INFECT DIS, V203, P1832, DOI 10.1093/infdis/jir195; Snewin VA, 1999, INFECT IMMUN, V67, P4586, DOI 10.1128/IAI.67.9.4586-4593.1999; Stephenson I, 2006, J VIROL, V80, P4962, DOI 10.1128/JVI.80.10.4962-4970.2006; Stop TB Partnership, 2009, TUB VACC CAND; Sundaramurthy V, 2007, MICROBES INFECT, V9, P1671, DOI 10.1016/j.micinf.2007.09.007; Todoroff J, 2013, EUR J PHARM BIOPHARM, V84, P40, DOI 10.1016/j.ejpb.2012.11.020; Wang J, 2004, J IMMUNOL, V173, P6357, DOI 10.4049/jimmunol.173.10.6357; WHO, 2006, STOP TB STRAT	41	28	31	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2013	8	5							e63344	10.1371/journal.pone.0063344	http://dx.doi.org/10.1371/journal.pone.0063344			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	143FO	23675482	Green Submitted, Green Published, gold			2022-12-27	WOS:000318852400038
J	Agarwal, JJ; Zhu, Y; Zhang, QY; Mongin, AA; Hough, LB				Agarwal, Jay J.; Zhu, Yi; Zhang, Qing-Yu; Mongin, Alexander A.; Hough, Lindsay B.			TRAM-34, a Putatively Selective Blocker of Intermediate-Conductance, Calcium-Activated Potassium Channels, Inhibits Cytochrome P450 Activity	PLOS ONE			English	Article							CA2+-ACTIVATED K+ CHANNEL; KCNN4 CHANNELS; SECRETION; PROLIFERATION; KCNN4/KCA3.1; CONTRIBUTES; PROTECTION; STRATEGY; K(CA)3.1	TRAM-34, a clotrimazole analog characterized as a potent and selective inhibitor of intermediate-conductance, calcium-activated K+ (IKCa) channels, has been used extensively in vitro and in vivo to study the biological roles of these channels. The major advantage of TRAM-34 over clotrimazole is the reported lack of inhibition of the former drug on cytochrome P450 (CYP) activity. CYPs, a large family of heme-containing oxidases, play essential roles in endogenous signaling and metabolic pathways, as well as in xenobiotic metabolism. However, previously published work has only characterized the effects of TRAM-34 on a single CYP isoform. To test the hypothesis that TRAM-34 may inhibit some CYP isoforms, the effects of this compound were presently studied on the activities of four rat and five human CYP isoforms. TRAM-34 inhibited recombinant rat CYP2B1, CYP2C6 and CYP2C11 and human CYP2B6, CYP2C19 and CYP3A4 with IC50 values ranging from 0.9 mu M to 12.6 mu M, but had no inhibitory effects (up to 80 mu M) on recombinant rat CYP1A2, human CYP1A2, or human CYP19A1. TRAM-34 also had both stimulatory and inhibitory effects on human CYP3A4 activity, depending on the substrate used. These results show that low micromolar concentrations of TRAM-34 can inhibit several rat and human CYP isoforms, and suggest caution in the use of high concentrations of this drug as a selective IKCa channel blocker. In addition, in vivo use of TRAM-34 could lead to CYP-related drug-drug interactions.	[Agarwal, Jay J.; Mongin, Alexander A.; Hough, Lindsay B.] Albany Med Coll, Ctr Neuropharmacol & Neurosci, Albany, NY 12208 USA; [Zhu, Yi; Zhang, Qing-Yu] SUNY Albany, Wadsworth Ctr, New York State Dept Hlth, Albany, NY 12222 USA; [Zhu, Yi; Zhang, Qing-Yu] SUNY Albany, Sch Publ Hlth, Albany, NY USA	Albany Medical College; State University of New York (SUNY) System; State University of New York (SUNY) Albany; Wadsworth Center; State University of New York (SUNY) System; State University of New York (SUNY) Albany	Hough, LB (corresponding author), Albany Med Coll, Ctr Neuropharmacol & Neurosci, Albany, NY 12208 USA.	houghl@mail.amc.edu	Mongin, Alexander A./A-5526-2008	Mongin, Alexander A./0000-0002-2501-3778	National Institute on Drug Abuse [DA027835]; National Institute of Neurological Disorders and Stroke [NS061953]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS061953] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA027835] Funding Source: NIH RePORTER	National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by grants from the National Institute on Drug Abuse (DA027835 to LBH) and the National Institute of Neurological Disorders and Stroke (NS061953 to AAM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdullaev IF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012304; Basalingappa KM, 2011, AM J PHYSIOL-GASTR L, V301, pG905, DOI 10.1152/ajpgi.00558.2010; Begenisich T, 2004, J BIOL CHEM, V279, P47681, DOI 10.1074/jbc.M409627200; Bouhy D, 2011, J NEUROSCI, V31, P16298, DOI 10.1523/JNEUROSCI.0047-11.2011; Chia Elizabeth, 2011, BMC Pharmacology, V11, P10, DOI 10.1186/1471-2210-11-10; Crankshaw DL, 2009, P BRIT PHARM SOC, V7; Crespi CL, 1997, ANAL BIOCHEM, V248, P188, DOI 10.1006/abio.1997.2145; Cruse G, 2006, THORAX, V61, P880, DOI 10.1136/thx.2006.060319; DEFRANCESCHI L, 1994, J CLIN INVEST, V93, P1670, DOI 10.1172/JCI117149; Gaete PS, 2012, FREE RADICAL BIO MED, V52, P860, DOI 10.1016/j.freeradbiomed.2011.11.036; Grgic I, 2009, TRANSPL P, V41, P2601, DOI 10.1016/j.transproceed.2009.06.025; Henderson GL, 1999, LIFE SCI, V65, pPL209, DOI 10.1016/S0024-3205(99)00407-5; Itoh T, 2012, BRIT J PHARMACOL, V167, P682, DOI 10.1111/j.1476-5381.2012.02038.x; Kaushal V, 2007, J NEUROSCI, V27, P234, DOI 10.1523/JNEUROSCI.3593-06.2007; Kohler R, 2003, CIRCULATION, V108, P1119, DOI 10.1161/01.CIR.0000086464.04719.DD; Kumar NSN, 2010, AM J PHYSIOL-GASTR L, V299, pG707, DOI 10.1152/ajpgi.00101.2010; Lin JH, 1998, CLIN PHARMACOKINET, V35, P361, DOI 10.2165/00003088-199835050-00003; Mene P, 2010, NEPHROL DIAL TRANSPL, V25, P353, DOI 10.1093/ndt/gfp634; Millership JE, 2011, AM J PHYSIOL-CELL PH, V300, pC792, DOI 10.1152/ajpcell.00274.2010; Nelson David R., 2009, Human Genomics, V4, P59; Ortiz de Montellano P. R., 2005, CYTOCHROME P450 STRU; Quast SA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039290; Reich EP, 2005, EUR J IMMUNOL, V35, P1027, DOI 10.1002/eji.200425954; Roy JW, 2010, BRIT J PHARMACOL, V159, P650, DOI 10.1111/j.1476-5381.2009.00557.x; Schilling T, 2004, EUR J NEUROSCI, V19, P1469, DOI 10.1111/j.1460-9568.2004.03265.x; Schilling T, 2007, PFLUG ARCH EUR J PHY, V454, P559, DOI 10.1007/s00424-007-0232-4; Schmidt J, 2010, CELL RES, V20, P1224, DOI 10.1038/cr.2010.121; Sciaccaluga M, 2010, AM J PHYSIOL-CELL PH, V299, pC175, DOI 10.1152/ajpcell.00344.2009; Singh SK, 2012, AM J PHYSIOL-CELL PH, V302, pC1353, DOI 10.1152/ajpcell.00216.2011; Stresser DM, 2000, DRUG METAB DISPOS, V28, P1440; Suzuki S, 2000, EUR J DRUG METAB PH, V25, P121, DOI 10.1007/BF03190078; Toyama K, 2008, J CLIN INVEST, V118, P3025, DOI 10.1172/JCI30836; Ueng YF, 1997, BIOCHEMISTRY-US, V36, P370, DOI 10.1021/bi962359z; VanAlstine MA, 2011, DRUG METAB DISPOS, V39, P1221, DOI 10.1124/dmd.110.037424; Wang BX, 2010, FASEB J, V24, P4078, DOI 10.1096/fj.09-153841; Wang ZH, 2007, ONCOGENE, V26, P5107, DOI 10.1038/sj.onc.1210308; Wulff H, 2000, P NATL ACAD SCI USA, V97, P8151, DOI 10.1073/pnas.97.14.8151; Wulff Heike, 2010, Expert Rev Clin Pharmacol, V3, P385, DOI 10.1586/ecp.10.11; Yano JK, 2006, J MED CHEM, V49, P6987, DOI 10.1021/jm060519r; Zhang WJ, 2002, DRUG METAB DISPOS, V30, P314, DOI 10.1124/dmd.30.3.314; Zhu Y, 2011, DRUG METAB DISPOS, V39, P939, DOI 10.1124/dmd.110.037861	41	19	19	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e63028	10.1371/journal.pone.0063028	http://dx.doi.org/10.1371/journal.pone.0063028			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667566	Green Published, Green Submitted, gold			2022-12-27	WOS:000319654700098
J	Dusetzina, SB; Mack, CD; Sturmer, T				Dusetzina, Stacie B.; Mack, Christina D.; Stuermer, Til			Propensity Score Estimation to Address Calendar Time-Specific Channeling in Comparative Effectiveness Research of Second Generation Antipsychotics	PLOS ONE			English	Article							TRENDS; RISK	Background: Channeling occurs when a medication and its potential comparators are selectively prescribed based on differences in underlying patient characteristics. Drug safety advisories can provide new information regarding the relative safety or effectiveness of a drug product which might increase selective prescribing. In particular, when reported adverse effects vary among drugs within a therapeutic class, clinicians may channel patients toward or away from a drug based on the patient's underlying risk for an adverse outcome. If channeling is not identified and appropriately managed it might lead to confounding in observational comparative effectiveness studies. Objective: To demonstrate channeling among new users of second generation antipsychotics following a Food and Drug Administration safety advisory and to evaluate the impact of channeling on cardiovascular risk estimates over time. Data Source: Florida Medicaid data from 2001-2006. Study Design: Retrospective cohort of adults initiating second generation antipsychotics. We used propensity scores to match olanzapine initiators with other second generation antipsychotic initiators. To evaluate channeling away from olanzapine following an FDA safety advisory, we estimated calendar time-specific propensity scores. We compare the performance of these calendar time-specific propensity scores with conventionally-estimated propensity scores on estimates of cardiovascular risk. Principal Findings: Increased channeling away from olanzapine was evident for some, but not all, cardiovascular risk factors and corresponded with the timing of the FDA advisory. Covariate balance was optimized within period and across all periods when using the calendar time-specific propensity score. Hazard ratio estimates for cardiovascular outcomes did not differ across models (Conventional PS: 0.97, 95% CI: 0.81-3.18 versus calendar time-specific PS: 0.93, 95% CI: 0.77-3.04). Conclusions: Changes in channeling over time was evident for several covariates but had limited impact on cardiovascular risk estimates, possibly due to unmeasured confounding. Although calendar time-specific propensity scores appear to improve covariate balance, the impact on comparative effectiveness results is limited in this setting.	[Dusetzina, Stacie B.] Univ N Carolina, Sch Med, Div Gen Med & Clin Epidemiol, Chapel Hill, NC 27515 USA; [Dusetzina, Stacie B.] Univ N Carolina, Gillings Sch Global Publ Hlth, Dept Hlth Policy & Management, Chapel Hill, NC USA; [Dusetzina, Stacie B.] Univ N Carolina, Cecil G Sheps Ctr Hlth Serv Res, Chapel Hill, NC USA; [Mack, Christina D.; Stuermer, Til] Univ N Carolina, Dept Epidemiol, Gillings Sch Global Publ Hlth, Chapel Hill, NC USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Dusetzina, SB (corresponding author), Univ N Carolina, Sch Med, Div Gen Med & Clin Epidemiol, Chapel Hill, NC 27515 USA.	Dusetzina@unc.edu	Stürmer, Til/AAB-5459-2022; Dusetzina, Stacie B/J-6682-2019	Dusetzina, Stacie B/0000-0002-3907-9196	Agency for Healthcare Research and Quality [RO1 HS0189960]; NIMH; Harvard Medical School, Department of Health Care Policy [T32MH019733-17]; Christina D. Mack: Fellowship; Merck; NIH [R01 AG023178]; National Institute on Aging at the NIH [AG023178, R01 AG018833]; UNC-DEcIDE center from AHRQ; Center for Pharmacoepidemiology; Department of Epidemiology; UNC; GSK; Sanofi; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH019733] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG018833, R01AG023178] Funding Source: NIH RePORTER	Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Harvard Medical School, Department of Health Care Policy; Christina D. Mack: Fellowship; Merck(Merck & Company); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute on Aging at the NIH; UNC-DEcIDE center from AHRQ; Center for Pharmacoepidemiology; Department of Epidemiology; UNC; GSK(GlaxoSmithKline); Sanofi; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the Agency for Healthcare Research and Quality (RO1 HS0189960). The funding sources had no role in the design and conduct of the study; collection, management, analysis, or interpretation of the data; and preparation, review, or approval of the manuscript for publication.; The authors have read the journal's policy and have the following conflicts: Stacie B. Dusetzina: Received funding through a Ruth L. Kirschstein-National Service Research Award Post-Doctoral Traineeship sponsored by NIMH and Harvard Medical School, Department of Health Care Policy, Grant No. T32MH019733-17. The funding sources had no role in the design and conduct of the study; collection, management, analysis, or interpretation of the data; and preparation, review, or approval of the manuscript for publication. Dr. Dusetzina has no conflicts of interest. Christina D. Mack: Fellowship, Merck; NIH grant R01 AG023178; Consultant to Roche and AHRQ through Outcome, A Quintiles Company. No perceived conflicts of interest. Til Sturmer: R01 AG023178, R01 AG018833 from the National Institute on Aging at the NIH; UNC-DEcIDE center from AHRQ; salary support from Center for Pharmacoepidemiology, Department of Epidemiology, UNC, and unrestricted research and other grants from pharmaceutical companies (GSK, Merck, Sanofi) to UNC. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Amer Diabet Assoc, 2004, DIABETES CARE, V27, P596, DOI 10.2337/diacare.27.2.596; Amiel JM, 2008, CURR OPIN PSYCHIATR, V21, P613, DOI 10.1097/YCO.0b013e328314b74b; Anand G, 2003, WALL STREET J; Austin PC, 2009, STAT MED, V28, P3083, DOI 10.1002/sim.3697; Brookhart MA, 2006, AM J EPIDEMIOL, V163, P1149, DOI 10.1093/aje/kwj149; Center for Medicare and Medicaid Services, 2007, MED AN EXTR CHARTB; CHARLSON M, 1994, J CLIN EPIDEMIOL, V47, P1245, DOI 10.1016/0895-4356(94)90129-5; Constantine R, 2008, PSYCHIAT SERV, V59, P1162, DOI 10.1176/appi.ps.59.10.1162; Donohue JM, 2009, HEALTH AFFAIR, V28, P746, DOI 10.1377/hlthaff.28.3.746; Dusetzina SB, 2012, PHARMACOEPIDEM DR S, V21, P1251, DOI 10.1002/pds.3272; Ellis AR, 2013, PHARMACOEPIDEM DR S, V22, P138, DOI 10.1002/pds.3396; F.D.A, 2004, FDA SAFETY NEWS; F.D.A, 2004, MEDWATCH SAF INF GEO; F.D.A, 2005, MEDWATCH SAF INF AT; Frank RG, 2009, HEALTH AFFAIR, V28, P649, DOI 10.1377/hlthaff.28.3.649; Goode E, 2003, NEW YORK TIMES; Hughes MD, 2007, NEW ENGL J MED, V356, P1705, DOI 10.1056/NEJMp078038; Koro CE, 2002, ARCH GEN PSYCHIAT, V59, P1021, DOI 10.1001/archpsyc.59.11.1021; Lieberman JA, 2005, NEW ENGL J MED, V353, P1209, DOI 10.1056/NEJMoa051688; Mack CD, 2013, PHARMACOEPIDEM DR S, V22, P810, DOI 10.1002/pds.3386; Morrato EH, 2010, ARCH GEN PSYCHIAT, V67, P17, DOI 10.1001/archgenpsychiatry.2009.179; Parsons L, 2001, REDUCING BIAS PROPEN; PETRI H, 1991, STAT MED, V10, P577, DOI 10.1002/sim.4780100409; Signorovitch J, 2011, J CLIN PSYCHIAT, V72, P787, DOI 10.4088/JCP.09m05868yel; Sox HC, 2009, ANN INTERN MED, V151, P203, DOI 10.7326/0003-4819-151-3-200908040-00125	25	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e63973	10.1371/journal.pone.0063973	http://dx.doi.org/10.1371/journal.pone.0063973			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667693	Green Submitted, Green Published, gold			2022-12-27	WOS:000319654700197
J	Jia, CC; Wang, TT; Liu, W; Fu, BS; Hua, X; Wang, GY; Li, TJ; Li, X; Wu, XY; Tai, Y; Zhou, J; Chen, GH; Zhang, Q				Jia, Chang-Chang; Wang, Tian-Tian; Liu, Wei; Fu, Bin-Sheng; Hua, XueFeng; Wang, Guo-Ying; Li, Tuan-Jie; Li, Xing; Wu, Xiang-Yuan; Tai, Yan; Zhou, Jie; Chen, Gui-Hua; Zhang, Qi			Cancer-Associated Fibroblasts from Hepatocellular Carcinoma Promote Malignant Cell Proliferation by HGF Secretion	PLOS ONE			English	Article							HEPATOCYTE GROWTH-FACTOR; TUMOR-GROWTH; MESENCHYMAL TRANSITION; STROMAL FIBROBLASTS; PROGRESSION; BREAST; ACTIVATION; MICROENVIRONMENT; PATHWAYS; MODEL	Cancer-associated fibroblasts (CAFs) are reported to support tumorigenesis by stimulating angiogenesis, cancer cell proliferation, and invasion in most solid tumors. However, the roles of CAFs in the liver cancer microenvironment have not been thoroughly studied. In our previous study, we successfully isolated CAFs from hepatocellular carcinoma (HCC) (H-CAFs) and proved that H-CAFs suppressed the activation of NK cells and thereby created favorable conditions for HCC progression. In our present study, we found that the proliferation of MHCC97L and Hep3B cells was significantly promoted by treatment with conditioned medium from H-CAFs. Pathological analysis also revealed that H-CAFs increased the proportion of Ki-67 (+) malignant cells and prevented them from undergoing necrosis. Moreover, the concentration of hepatocyte growth factor (HGF) cytokine in the conditioned medium of H-CAFs was higher than conditioned medium from normal skin fibroblasts (NSFs). Anti-HGF significantly reduced the proliferation-promoting capability of H-CAFs. In addition, we found that the abundance of H-CAFs correlated positively with tumor size. These results indicate that H-CAFs are an important factor for promoting the growth of HCC in vitro and in vivo, and that HGF plays a key role in HCC proliferation induced by H-CAFs.	[Jia, Chang-Chang; Fu, Bin-Sheng; Hua, XueFeng; Wang, Guo-Ying; Li, Tuan-Jie; Tai, Yan; Chen, Gui-Hua] Sun Yat Sen Univ, Affiliated Hosp 3, Dept Hepat Surg, Guangzhou 510275, Guangdong, Peoples R China; [Jia, Chang-Chang; Wang, Tian-Tian; Liu, Wei; Hua, XueFeng; Wang, Guo-Ying; Li, Tuan-Jie; Tai, Yan; Chen, Gui-Hua; Zhang, Qi] Guangdong Prov Key Lab Liver Dis Res, Guangzhou, Guangdong, Peoples R China; [Wang, Tian-Tian; Li, Xing; Wu, Xiang-Yuan] Sun Yat Sen Univ, Affiliated Hosp 3, Dept Med Oncol, Guangzhou 510275, Guangdong, Peoples R China; [Zhang, Qi] Sun Yat Sen Univ, Affiliated Hosp 3, Cell Gene Therapy Translat Med Res Ctr, Guangzhou 510275, Guangdong, Peoples R China; [Zhou, Jie] Southern Med Univ, Dept Hepatobiliary Surg, Nanfang Hosp, Guangzhou, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University; Southern Medical University - China	Zhou, J (corresponding author), Southern Med Univ, Dept Hepatobiliary Surg, Nanfang Hosp, Guangzhou, Guangdong, Peoples R China.	zhoujie01@medmail.com.cn; keekee77@126.com	LI, TUANJIE/S-3903-2018	LI, TUANJIE/0000-0002-5540-6345	State 973 National Basic Research Program of China [2009CB522404]; National Natural Science Foundation of China [NSFC-30972914, 81000936, 81172036, 81170451, 81170452]; 985 Project [82000-3281901]; Fundamental Research Funds for the Central Universities [10ykpy05]; State Key Projects on Infection Diseases of China [2012ZX10002016-023, 2012ZX10002010-001-007]; National Natural Science Foundation of Guangdong Province [10151008901000208]; Key project of Medical Science in Sun Yat-sen University [10YKJC03]	State 973 National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 985 Project(Jilin UniversityXiamen University); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); State Key Projects on Infection Diseases of China; National Natural Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province); Key project of Medical Science in Sun Yat-sen University	This work was supported by: State 973 National Basic Research Program of China (2009CB522404), National Natural Science Foundation of China (NSFC-30972914, 81000936, 81172036, 81170451, 81170452), 985 Project (82000-3281901), Fundamental Research Funds for the Central Universities (10ykpy05), State Key Projects on Infection Diseases of China (2012ZX10002016-023, 2012ZX10002010-001-007), National Natural Science Foundation of Guangdong Province (10151008901000208) as well as Key project of Medical Science in Sun Yat-sen University (10YKJC03). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amann T, 2009, CANCER SCI, V100, P646, DOI 10.1111/j.1349-7006.2009.01087.x; Bhowmick NA, 2004, NATURE, V432, P332, DOI 10.1038/nature03096; Dong G, 2001, CANCER RES, V61, P5911; Erez N, 2010, CANCER CELL, V17, P135, DOI 10.1016/j.ccr.2009.12.041; Fu L, 2011, GUT, V60, P1635, DOI 10.1136/gut.2011.241638; Giulianelli S, 2008, INT J CANCER, V123, P2518, DOI 10.1002/ijc.23802; Gonda TA, 2010, SEMIN CELL DEV BIOL, V21, P2, DOI 10.1016/j.semcdb.2009.10.001; Haviv I, 2009, CELL CYCLE, V8, P589, DOI 10.4161/cc.8.4.7669; Hawsawi NM, 2008, CANCER RES, V68, P2717, DOI 10.1158/0008-5472.CAN-08-0192; Hwang RF, 2008, CANCER RES, V68, P918, DOI 10.1158/0008-5472.CAN-07-5714; Jiang WG, 2005, CRIT REV ONCOL HEMAT, V53, P35, DOI 10.1016/j.critrevonc.2004.09.004; Kalluri R, 2006, NAT REV CANCER, V6, P392, DOI 10.1038/nrc1877; Koukourakis MI, 2006, CANCER RES, V66, P632, DOI 10.1158/0008-5472.CAN-05-3260; Li Q, 2011, AM J PATHOL, V179, P1483, DOI 10.1016/j.ajpath.2011.05.060; Li TJ, 2012, CANCER LETT, V318, P154, DOI 10.1016/j.canlet.2011.12.020; Liao D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007965; Mazzocca A, 2011, HEPATOLOGY, V54, P920, DOI 10.1002/hep.24485; Ostman A, 2009, CURR OPIN GENET DEV, V19, P67, DOI 10.1016/j.gde.2009.01.003; Orimo A, 2005, CELL, V121, P335, DOI 10.1016/j.cell.2005.02.034; Paland N, 2009, MOL CANCER RES, V7, P1212, DOI 10.1158/1541-7786.MCR-09-0073; Pietras K, 2010, EXP CELL RES, V316, P1324, DOI 10.1016/j.yexcr.2010.02.045; Rasanen K, 2010, EXP CELL RES, V316, P2713, DOI 10.1016/j.yexcr.2010.04.032; Saito RA, 2010, CANCER RES, V70, P2644, DOI 10.1158/0008-5472.CAN-09-3644; Sonnenberg M, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-364; Spaeth EL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004992; Sun R, 2012, ONCOL LETT, V3, P1124, DOI 10.3892/ol.2012.613; Tsukada Y, 2001, J BIOL CHEM, V276, P40968, DOI 10.1074/jbc.M010890200; Vered M, 2010, INT J CANCER, V127, P1356, DOI 10.1002/ijc.25358; Xing F, 2010, FRONT BIOSCI-LANDMRK, V15, P166, DOI 10.2741/3613; Yan XL, 2012, BREAST CANCER RES TR, V132, P153, DOI 10.1007/s10549-011-1577-0; Yuen MF, 2009, J HEPATOL, V50, P80, DOI 10.1016/j.jhep.2008.07.023; Zeisberg EM, 2007, CANCER RES, V67, P10123, DOI 10.1158/0008-5472.CAN-07-3127	32	104	110	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e63243	10.1371/journal.pone.0063243	http://dx.doi.org/10.1371/journal.pone.0063243			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667593	gold, Green Published, Green Submitted			2022-12-27	WOS:000319654700123
J	Menke, J; Weber, J; Broz, K; Kistler, HC				Menke, Jon; Weber, Jakob; Broz, Karen; Kistler, H. Corby			Cellular Development Associated with Induced Mycotoxin Synthesis in the Filamentous Fungus Fusarium graminearum	PLOS ONE			English	Article							SUBCELLULAR-LOCALIZATION; PENICILLIN BIOSYNTHESIS; ASPERGILLUS-PARASITICUS; FUNCTIONAL EXPRESSION; GENE; ACTIN; DYNAMICS; REVEALS; ACCUMULATION; CHRYSOGENUM	Several species of the filamentous fungus Fusarium colonize plants and produce toxic small molecules that contaminate agricultural products, rendering them unsuitable for consumption. Among the most destructive of these species is F. graminearum, which causes disease in wheat and barley and often infests the grain with harmful trichothecene mycotoxins. Synthesis of these secondary metabolites is induced during plant infection or in culture in response to chemical signals. Our results show that trichothecene biosynthesis involves a complex developmental process that includes dynamic changes in cell morphology and the biogenesis of novel subcellular structures. Two cytochrome P-450 oxygenases (Tri4p and Tri1p) involved in early and late steps in trichothecene biosynthesis were tagged with fluorescent proteins and shown to co-localize to vesicles we provisionally call "toxisomes.'' Toxisomes, the inferred site of trichothecene biosynthesis, dynamically interact with motile vesicles containing a predicted major facilitator superfamily protein (Tri12p) previously implicated in trichothecene export and tolerance. The immediate isoprenoid precursor of trichothecenes is the primary metabolite farnesyl pyrophosphate. Changes occur in the cellular localization of the isoprenoid biosynthetic enzyme HMG CoA reductase when cultures non-induced for trichothecene biosynthesis are transferred to trichothecene biosynthesis inducing medium. Initially localized in the cellular endomembrane system, HMG CoA reductase, upon induction of trichothecene biosynthesis, increasingly is targeted to toxisomes. Metabolic pathways of primary and secondary metabolism thus may be coordinated and co-localized under conditions when trichothecene biosynthesis occurs.	[Menke, Jon; Weber, Jakob; Kistler, H. Corby] Univ Minnesota, Dept Plant Pathol, St Paul, MN 55108 USA; [Weber, Jakob] Univ Hamburg, Hamburg, Germany; [Broz, Karen; Kistler, H. Corby] ARS, USDA, Cereal Dis Lab, St Paul, MN USA	University of Minnesota System; University of Minnesota Twin Cities; University of Hamburg; United States Department of Agriculture (USDA)	Kistler, HC (corresponding author), Univ Minnesota, Dept Plant Pathol, St Paul, MN 55108 USA.	hckist@umn.edu	Kistler, Harold/AAC-1645-2019	Kistler, Harold/0000-0001-5312-6297; Broz, Karen/0000-0001-7928-7216	United States Department of Agriculture, Agriculture and Food Research Initiative, National Institute of Food and Agriculture [2010-65108-20642]; United States Wheat and Barley Scab Initiative [FY09-KI-016, FY08-KI-118, FY07-KI-12]	United States Department of Agriculture, Agriculture and Food Research Initiative, National Institute of Food and Agriculture; United States Wheat and Barley Scab Initiative	This work was funded by the United States Department of Agriculture, Agriculture and Food Research Initiative, National Institute of Food and Agriculture award number 2010-65108-20642, as well as the United States Wheat and Barley Scab Initiative awards FY09-KI-016, FY08-KI-118 and FY07-KI-12. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albermann S, 2013, APPL MICROBIOL BIOT, V97, P2979, DOI 10.1007/s00253-012-4377-5; Alexander NJ, 2009, TOXIN REV, V28, P198, DOI 10.1080/15569540903092142; Alexander NJ, 1999, MOL GEN GENET, V261, P977, DOI 10.1007/s004380051046; Bennett JW, 2003, CLIN MICROBIOL REV, V16, P497, DOI 10.1128/CMR.16.3.497-516.2003; Berepiki A, 2011, NAT REV MICROBIOL, V9, P876, DOI 10.1038/nrmicro2666; Chanda A, 2010, EUKARYOT CELL, V9, P1724, DOI 10.1128/EC.00118-10; Chanda A, 2009, P NATL ACAD SCI USA, V106, P19533, DOI 10.1073/pnas.0907416106; Coleman JJ, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000486; Cuomo CA, 2007, SCIENCE, V317, P1400, DOI 10.1126/science.1143708; Gaffoor I, 2005, EUKARYOT CELL, V4, P1926, DOI 10.1128/EC.4.11.1926-1933.2005; Gardiner DM, 2009, FUNGAL GENET BIOL, V46, P604, DOI 10.1016/j.fgb.2009.04.004; Goswami RS, 2005, PHYTOPATHOLOGY, V95, P1397, DOI 10.1094/PHYTO-95-1397; Hoffmeister D, 2007, NAT PROD REP, V24, P393, DOI 10.1039/b603084j; Honda S, 2009, GENETICS, V182, P11, DOI 10.1534/genetics.108.098707; Hong SY, 2008, APPL ENVIRON MICROB, V74, P6385, DOI 10.1128/AEM.01185-08; Hong SY, 2009, MYCOL RES, V113, P591, DOI 10.1016/j.mycres.2009.01.013; Lee LW, 2004, ARCH MICROBIOL, V181, P204, DOI 10.1007/s00203-003-0643-3; LENDENFELD T, 1993, J BIOL CHEM, V268, P665; Maggio-Hall LA, 2005, MOL PLANT MICROBE IN, V18, P783, DOI 10.1094/MPMI-18-0783; McCormick SP, 2006, CAN J MICROBIOL, V52, P220, DOI 10.1139/W05-124; McCormick SP, 2004, APPL ENVIRON MICROB, V70, P2044, DOI 10.1128/AEM.70.4.2044-2051.2004; McCormick SP, 2006, CAN J MICROBIOL, V52, P636, DOI 10.1139/W06-011; McLaughlin JE, 2009, P NATL ACAD SCI USA, V106, P21883, DOI 10.1073/pnas.0909777106; Meijer WH, 2010, APPL ENVIRON MICROB, V76, P5702, DOI 10.1128/AEM.02327-09; Menke J, 2012, MOL PLANT MICROBE IN, V25, P1408, DOI 10.1094/MPMI-04-12-0081-R; Morton WM, 2000, NAT CELL BIOL, V2, P376, DOI 10.1038/35014075; MULLER WH, 1992, BIOCHIM BIOPHYS ACTA, V1116, P210, DOI 10.1016/0304-4165(92)90118-E; Nierman WC, 2005, NATURE, V438, P1151, DOI 10.1038/nature04332; Pestka JJ, 2005, J TOXICOL ENV HEAL B, V8, P39, DOI 10.1080/10937400590889458; Riedl J, 2008, NAT METHODS, V5, P605, DOI 10.1038/nmeth.1220; Rosewich UL, 1998, PHYTOPATHOLOGY, V88, P1087, DOI 10.1094/PHYTO.1998.88.10.1087; Roze LV, 2011, FUNGAL GENET BIOL, V48, P35, DOI 10.1016/j.fgb.2010.05.006; Seong K, 2006, FUNGAL GENET BIOL, V43, P34, DOI 10.1016/j.fgb.2005.10.002; Seong KY, 2009, MOL MICROBIOL, V72, P354, DOI 10.1111/j.1365-2958.2009.06649.x; Sprote P, 2009, EUKARYOT CELL, V8, P421, DOI 10.1128/EC.00374-08; Stadler M, 2008, MYCOL RES, V112, P127, DOI 10.1016/j.mycres.2007.12.002; Szewczyk E, 2006, NAT PROTOC, V1, P3111, DOI 10.1038/nprot.2006.405; Teijeira F, 2009, BIOCHEM J, V418, P113, DOI 10.1042/BJ20081180; Yang HC, 2002, P NATL ACAD SCI USA, V99, P751, DOI 10.1073/pnas.022462899	39	70	75	2	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e63077	10.1371/journal.pone.0063077	http://dx.doi.org/10.1371/journal.pone.0063077			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667578	Green Published, gold, Green Submitted			2022-12-27	WOS:000319654700110
J	Michely, S; Gaillardin, C; Nicaud, JM; Neuveglise, C				Michely, Stephanie; Gaillardin, Claude; Nicaud, Jean-Marc; Neuveglise, Cecile			Comparative Physiology of Oleaginous Species from the Yarrowia Clade	PLOS ONE			English	Article							DEFORMANS ZACH LANGERON; LIPID-ACCUMULATION; CANDIDA-DEFORMANS; SP-NOV.; LIPOLYTICA STRAINS; YEAST; LIPASE; ACID; IDENTIFICATION; PURIFICATION	Yarrowia lipolytica is a genetically tractable yeast species that has become an attractive model for analyses of lipid metabolism, due to its oleaginous nature. We investigated the regulation and evolution of lipid metabolism in non-Saccharomycetaceae yeasts, by carrying out a comparative physiological analysis of eight species recently assigned to the Yarrowia clade: Candida alimentaria, Y. deformans, C. galli, C. hispaniensis, C. hollandica, C. oslonensis, C. phangngensis and Y. yakushimensis. We compared the abilities of type strains of these species to grow on 31 non hydrophobic (sugars and other carbohydrate compounds) and 13 hydrophobic (triglycerides, alkanes and free fatty acids) carbon sources. Limited phenotypic diversity was observed in terms of the range of substrates used and, in the case of short-chain fatty acids, their toxicity. We assessed the oleaginous nature of these species, by evaluating their ability to store and to synthesize lipids. The mean lipid content of cells grown on oleic acid differed considerably between species, ranging from 30% of cell dry weight in C. oslonensis to 67% in C. hispaniensis. Lipid synthesis in cells grown on glucose resulted in the accumulation of C18:1 (n-9) as the major compound in most species, except for C. alimentaria and Y. yakushimensis, which accumulated principally C18:2(n-6), and C. hispaniensis, which accumulated both C16:0 and C18:1(n-9). Thus, all species of the clade were oleaginous, but they presented specific patterns of growth, lipid synthesis and storage, and therefore constitute good models for the comparative analysis of lipid metabolism in this basal yeast clade.	[Michely, Stephanie; Neuveglise, Cecile] INRA, UMR 1319 Micalis, Jouy En Josas, France; [Gaillardin, Claude] AgroParisTech, Micalis, Jouy En Josas, France; [Nicaud, Jean-Marc] CNRS, Micalis, Jouy En Josas, France	AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay; AgroParisTech; UDICE-French Research Universities; Universite Paris Saclay; AgroParisTech; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Neuveglise, C (corresponding author), INRA, UMR 1319 Micalis, Jouy En Josas, France.	Cecile.Neuveglise@grignon.inra.fr	NICAUD, Jean-marc/ABA-9076-2021; Nicaud, jean marc/G-4204-2016	Nicaud, jean marc/0000-0002-6679-972X; Neuveglise, Cecile/0000-0001-5017-7830	French Minister of Research via the ABIES doctoral school; Institut National de la Recherche Agronomique (INRA); SAS PIVERT, in the frame of the French Institute of Excellence in the field of Low-Carbon Energies (IEED) P.I.V.E.R.T selected as an Investment for the Future ("Investissements d'Avenir")	French Minister of Research via the ABIES doctoral school; Institut National de la Recherche Agronomique (INRA); SAS PIVERT, in the frame of the French Institute of Excellence in the field of Low-Carbon Energies (IEED) P.I.V.E.R.T selected as an Investment for the Future ("Investissements d'Avenir")(French National Research Agency (ANR))	SM has a PhD fellowship funded by the French Minister of Research via the ABIES doctoral school. This work was supported in part by the Institut National de la Recherche Agronomique (INRA) and additionally by the SAS PIVERT, in the frame of the French Institute of Excellence in the field of Low-Carbon Energies (IEED) P.I.V.E.R.T (www.institut-pivert.com) selected as an Investment for the Future ("Investissements d'Avenir"). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguileta G, 2008, SYST BIOL, V57, P613, DOI 10.1080/10635150802306527; BARNETT JA, 2000, YEASTS CHARACTERISTI; Barth G, 1996, NONCONVENTIONAL YEAS, P313, DOI [DOI 10.1007/978-3-642-79856-6_10, 10.1007/978-3-642-79856-6_10]; Beopoulos A, 2008, APPL ENVIRON MICROB, V74, P7779, DOI 10.1128/AEM.01412-08; Beopoulos A, 2009, BIOCHIMIE, V91, P692, DOI 10.1016/j.biochi.2009.02.004; Bigey F, 2003, YEAST, V20, P233, DOI 10.1002/yea.958; Bonfield JK, 1995, NUCLEIC ACIDS RES, V23, P4992, DOI 10.1093/nar/23.24.4992; BOUTUR O, 1995, J BIOTECHNOL, V42, P23, DOI 10.1016/0168-1656(95)00060-4; BROWSE J, 1986, ANAL BIOCHEM, V152, P141, DOI 10.1016/0003-2697(86)90132-6; Chi ZY, 2011, APPL BIOCHEM BIOTECH, V165, P442, DOI 10.1007/s12010-011-9263-6; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Fickers P, 2011, BIOTECHNOL ADV, V29, P632, DOI 10.1016/j.biotechadv.2011.04.005; Fillaudeau L, 2009, 8 WORLD C CHEM ENG W; Groenewald M, 2013, ANTON LEEUW INT J G, P1; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; HOFFMAN CS, 1987, GENE, V57, P267, DOI 10.1016/0378-1119(87)90131-4; Hong SP, 2012, YEAST, V29, P59, DOI 10.1002/yea.1917; KLUG MJ, 1967, J BACTERIOL, V93, P1847, DOI 10.1128/JB.93.6.1847-1852.1967; Knutsen AK, 2007, INT J SYST EVOL MICR, V57, P2426, DOI 10.1099/ijs.0.65200-0; Kurtzman CP, 2011, YEASTS: A TAXONOMIC STUDY, VOLS 1-3, 5TH EDITION, P87, DOI 10.1016/B978-0-444-52149-1.00007-0; Kurtzman CP, 2011, YEASTS: A TAXONOMIC STUDY, VOLS 1-3, 5TH EDITION, P927, DOI 10.1016/B978-0-444-52149-1.00082-3; Kurtzman CP, 2005, ANTON LEEUW INT J G, V88, P121, DOI 10.1007/s10482-005-2495-0; Lachance MA, 2011, YEASTS: A TAXONOMIC STUDY, VOLS 1-3, 5TH EDITION, P511, DOI 10.1016/B978-0-444-52149-1.00041-0; Limtong S, 2008, INT J SYST EVOL MICR, V58, P515, DOI 10.1099/ijs.0.65506-0; Luo YS, 2002, ARCH BIOCHEM BIOPHYS, V407, P32, DOI 10.1016/S0003-9861(02)00466-6; Luo YS, 2000, ARCH BIOCHEM BIOPHYS, V384, P1, DOI 10.1006/abbi.2000.2079; Mauersberger S, 1991, ALKANE METABOLISM OV, P59; Mlickova K, 2004, APPL ENVIRON MICROB, V70, P3918, DOI 10.1128/AEM.70.7.3918-3924.2004; MUDERHWA JM, 1985, J AM OIL CHEM SOC, V62, P1031, DOI 10.1007/BF02935709; Nicaud JM, 2012, YEAST, V29, P409, DOI 10.1002/yea.2921; NYNS EJ, 1968, A VAN LEEUW J MICROB, V34, P197, DOI 10.1007/BF02046431; Papanikolaou S, 2002, BIORESOURCE TECHNOL, V82, P43, DOI 10.1016/S0960-8524(01)00149-3; Papanikolaou S, 2002, APPL MICROBIOL BIOT, V58, P308, DOI 10.1007/s00253-001-0897-0; Papanikolaou S, 2002, J APPL MICROBIOL, V92, P737, DOI 10.1046/j.1365-2672.2002.01577.x; Papanikolaou S, 2009, EUR J LIPID SCI TECH, V111, P1221, DOI 10.1002/ejlt.200900055; Peter G, 2004, ANTON LEEUW INT J G, V86, P105, DOI 10.1023/B:ANTO.0000036117.03847.bd; Pignede G, 2000, J BACTERIOL, V182, P2802, DOI 10.1128/JB.182.10.2802-2810.2000; PONCET S, 1965, ANTON VAN LEE J M S, V31, P433, DOI 10.1007/BF02045922; Prasitchoke P, 2007, GENE, V391, P16, DOI 10.1016/j.gene.2006.11.013; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; RATLEDGE C, 1991, ACTA BIOTECHNOL, V11, P429, DOI 10.1002/abio.370110506; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tylicki A, 2012, MYCOSES, V55, pe106, DOI 10.1111/j.1439-0507.2011.02152.x; Wang HJ, 1999, CELL BIOCHEM BIOPHYS, V31, P165, DOI 10.1007/BF02738170	44	32	36	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e63356	10.1371/journal.pone.0063356	http://dx.doi.org/10.1371/journal.pone.0063356			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667605	Green Published, gold, Green Submitted			2022-12-27	WOS:000319654700134
J	Sakaki, M; Murayama, K				Sakaki, Michiko; Murayama, Kou			Automatic Ability Attribution after Failure: A Dual Process View of Achievement Attribution	PLOS ONE			English	Article							CAUSAL ATTRIBUTIONS; COLLEGE-STUDENTS; SELF-ESTEEM; SUCCESS; MOTIVATION; INFORMATION; IMPROVEMENT	Causal attribution has been one of the most influential frameworks in the literature of achievement motivation, but previous studies considered achievement attribution as relatively deliberate and effortful processes. In the current study, we tested the hypothesis that people automatically attribute their achievement failure to their ability, but reduce the ability attribution in a controlled manner. To address this hypothesis, we measured participants' causal attribution belief for their task failure either under the cognitive load (load condition) or with full attention (no-load condition). Across two studies, participants attributed task performance to their ability more in the load than in the no-load condition. The increased ability attribution under cognitive load further affected intrinsic motivation. These results indicate that cognitive resources available after feedback play crucial roles in determining causal attribution belief, as well as achievement motivations.	[Sakaki, Michiko] Univ So Calif, Davis Sch Gerontol, Los Angeles, CA 90089 USA; [Murayama, Kou] Univ Calif Los Angeles, Dept Psychol, Los Angeles, CA 90024 USA	University of Southern California; University of California System; University of California Los Angeles	Sakaki, M (corresponding author), Univ So Calif, Davis Sch Gerontol, Los Angeles, CA 90089 USA.	msakaki@usc.edu		Murayama, Kou/0000-0003-2902-9600	Ministry of Education, Culture, Science, Sports, and Technology	Ministry of Education, Culture, Science, Sports, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This research was supported by the Grant in Aid of Scientific Research for a JSPS Research Fellow, from the Ministry of Education, Culture, Science, Sports, and Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAMSON LY, 1978, J ABNORM PSYCHOL, V87, P49, DOI 10.1037/0021-843X.87.1.49; Baumeister R.F., 2001, REV GEN PSYCHOL, V5, P323, DOI [10.1037//1089-2680.5.4.323, DOI 10.1037//1089-2680.5.4.323, https://doi.org/10.1037/1089-2680.5.4.323, DOI 10.1037/1089-2680.5.4.323]; Campbell W. K., 1999, REV GEN PSYCHOL, V3, P23, DOI DOI 10.1037/1089-2680.3.1.23; Chen S, 1999, DUAL-PROCESS THEORIES IN SOCIAL PSYCHOLOGY, P73; Cohen GL, 2009, SCIENCE, V324, P400, DOI 10.1126/science.1170769; Crocker J, 2004, PSYCHOL BULL, V130, P392, DOI 10.1037/0033-2909.130.3.392; Deci EL, 1999, PSYCHOL BULL, V125, P627, DOI 10.1037/0033-2909.125.6.627; Dodgson PG, 1998, J PERS SOC PSYCHOL, V75, P178, DOI 10.1037/0022-3514.75.1.178; Duval TS, 2002, J PERS SOC PSYCHOL, V82, P49, DOI 10.1037//0022-3514.82.1.49; DWECK CS, 1995, PSYCHOL INQ, V6, P267, DOI 10.1207/s15327965pli0604_1; Elliot A.J., 2005, HDB COMPETENCE MOTIV; FRIEZE IH, 1976, J RES PERS, V10, P293, DOI 10.1016/0092-6566(76)90019-2; Gilbert DT, 1996, J PERS SOC PSYCHOL, V70, P678, DOI 10.1037/0022-3514.70.4.678; Hareli S, 2000, MOTIV EMOTION, V24, P215, DOI 10.1023/A:1005666212320; Heimpel SA, 2002, J PERS SOC PSYCHOL, V82, P128, DOI 10.1037//0022-3514.82.1.128; Lench HC, 2008, J EXP SOC PSYCHOL, V44, P631, DOI 10.1016/j.jesp.2007.02.011; MacKinnon DP, 2007, BEHAV RES METHODS, V39, P384, DOI 10.3758/BF03193007; MCFARLAND C, 1982, J PERS SOC PSYCHOL, V43, P937, DOI 10.1037/0022-3514.43.5.937; Mezulis AH, 2004, PSYCHOL BULL, V130, P711, DOI 10.1037/0033-2909.130.5.711; Nasu M, 1990, JAPANESE J ED PSYCHO, V38, P17; NICHOLLS JG, 1979, AM PSYCHOL, V34, P1071, DOI 10.1037/0003-066X.34.11.1071; Olejnik S, 2003, PSYCHOL METHODS, V8, P434, DOI 10.1037/1082-989X.8.4.434; PAULHUS DL, 1987, J PERS SOC PSYCHOL, V52, P245, DOI 10.1037/0022-3514.52.2.245; Perry RP, 2008, EUR J PSYCHOL EDUC, V23, P459, DOI 10.1007/BF03172753; PERRY RP, 1990, J EDUC PSYCHOL, V82, P262, DOI 10.1037/0022-0663.82.2.262; PERRY RP, 1989, J EDUC PSYCHOL, V81, P164; Plaks JE, 2007, J PERS SOC PSYCHOL, V93, P667, DOI 10.1037/0022-3514.93.4.667; Podsakoff PM, 2003, J APPL PSYCHOL, V88, P879, DOI 10.1037/0021-9010.88.5.879; Przybylski AK, 2012, PSYCHOL SCI, V23, P69, DOI 10.1177/0956797611418676; Sakaki M, 2007, J PERS, V75, P421, DOI 10.1111/j.1467-6494.2007.00444.x; Sakurai S., 1985, TSUKUBA PSYCHOL RES, V7, P43; Sedikides C, 1997, ADV EXP SOC PSYCHOL, V29, P209, DOI 10.1016/S0065-2601(08)60018-0; Sedikides C, 2008, PERSPECT PSYCHOL SCI, V3, P102, DOI 10.1111/j.1745-6916.2008.00068.x; SWEENEY PD, 1986, J PERS SOC PSYCHOL, V50, P974, DOI 10.1037/0022-3514.50.5.974; TROPE Y, 1982, J PERS SOC PSYCHOL, V42, P637, DOI 10.1037/0022-3514.42.4.637; Tukey JW, 1977, EXPLORATORY DATA ANA; WEINER B, 1985, PSYCHOL REV, V92, P548, DOI 10.1037/0033-295X.92.4.548; WEINER B, 1970, J PERS SOC PSYCHOL, V15, P1, DOI 10.1037/h0029211	38	1	2	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e63066	10.1371/journal.pone.0063066	http://dx.doi.org/10.1371/journal.pone.0063066			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	154EP	23667576	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000319654700108
J	Saraheimo, S; Hepojoki, J; Nurmi, V; Lahtinen, A; Hemmila, I; Vaheri, A; Vapalahti, O; Hedman, K				Saraheimo, Satu; Hepojoki, Jussi; Nurmi, Visa; Lahtinen, Anne; Hemmila, Ilkka; Vaheri, Antti; Vapalahti, Olli; Hedman, Klaus			Time-Resolved FRET-Based Approach for Antibody Detection - A New Serodiagnostic Concept	PLOS ONE			English	Article							RESONANCE ENERGY-TRANSFER; PROBING MOLECULAR-INTERACTIONS; ASSAY	Forster resonance energy transfer (FRET) is a phenomenon widely utilized in biomedical research of macromolecular interactions. In FRET energy is transferred between two fluorophores, the donor and the acceptor. Herein we describe a novel approach utilizing time-resolved FRET (TR-FRET) for the detection of antibodies not only in a solution-phase homogenous assay but also in single- and two-step solid-phase assays. Our method is based on the principle that the Y-shaped immunoglobulin G molecule is able to simultaneously bind two identical antigen molecules. Hence, if a specific IgG is mixed with donor- and acceptor-labeled antigens, the binding of antigens can be measured by TR-FRET. Using donor- and acceptor-labeled streptavidins (SAs) in conjunction with a polyclonal and a monoclonal anti-SA antibody we demonstrate that this approach is fully functional. In addition we characterize the immune complexes responsible for the TR-FRET signal using density gradient ultracentrifugation and solid-phase immunoassays. The homogenous TR-FRET assay described provides a rapid and robust tool for antibody detection, with a wide potential in medical diagnostics.	[Saraheimo, Satu; Hepojoki, Jussi; Nurmi, Visa; Lahtinen, Anne; Vaheri, Antti; Vapalahti, Olli; Hedman, Klaus] Univ Helsinki, Dept Virol, Infect Biol Res Program, Haartman Inst, Helsinki, Finland; [Hemmila, Ilkka] BN Prod & Serv, Finland Lab Div, Turku, Finland; [Vaheri, Antti; Vapalahti, Olli; Hedman, Klaus] Univ Helsinki, Cent Hosp, Lab Div, Helsinki, Finland; [Vapalahti, Olli] Univ Helsinki, Dept Vet Biosci, Helsinki, Finland	University of Helsinki; University of Helsinki; Helsinki University Central Hospital; University of Helsinki	Saraheimo, S (corresponding author), Univ Helsinki, Dept Virol, Infect Biol Res Program, Haartman Inst, Helsinki, Finland.	satu.saraheimo@helsinki.fi; klaus.hedman@helsinki.fi	Vaheri, Antti/AAV-1523-2020; Hedman, Klaus/D-5379-2009; Hepojoki, Jussi/W-4667-2017	Hepojoki, Jussi/0000-0001-5699-214X; Nurmi, Visa/0000-0001-8052-5592; Vapalahti, Olli/0000-0003-2270-6824; Hepojoki, Satu/0000-0002-0696-1879; Hedman, Klaus/0000-0003-1779-7960	Magnus Ehrnrooth Foundation; Finnish Funding Agency for Technology and Innovation (TEKES) [40140/11]; Foundation for Finnish Inventions; Sigrid Juselius Foundation	Magnus Ehrnrooth Foundation; Finnish Funding Agency for Technology and Innovation (TEKES)(Finnish Funding Agency for Technology & Innovation (TEKES)); Foundation for Finnish Inventions; Sigrid Juselius Foundation(Sigrid Juselius Foundation)	Magnus Ehrnrooth Foundation, the Finnish Funding Agency for Technology and Innovation (TEKES, grant number 40140/11), The Foundation for Finnish Inventions, and Sigrid Juselius Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bazin H, 2001, SPECTROCHIM ACTA A, V57, P2197, DOI 10.1016/S1386-1425(01)00493-0; Blomberg K, 1999, CLIN CHEM, V45, P855; Bongini L, 2004, P NATL ACAD SCI USA, V101, P6466, DOI 10.1073/pnas.0400119101; Clegg Robert M., 1995, Current Opinion in Biotechnology, V6, P103, DOI 10.1016/0958-1669(95)80016-6; DIAMANDIS EP, 1988, CLIN BIOCHEM, V21, P139, DOI 10.1016/S0009-9120(88)80104-8; EKINS RP, 1985, PURE APPL CHEM, V57, P473, DOI 10.1351/pac198557030473; EVANGELISTA RA, 1988, CLIN BIOCHEM, V21, P173, DOI 10.1016/0009-9120(88)90006-9; FORSTER T, 1948, ANN PHYS-BERLIN, V2, P55, DOI 10.1002/andp.19484370105; HEMMILA I, 1988, SCAND J CLIN LAB INV, V48, P389, DOI 10.3109/00365518809085747; Hepojoki J, 2010, J VIROL, V84, P227, DOI 10.1128/JVI.00481-09; Hildebrandt N, 2007, J BIOMED BIOTECHNOL, DOI 10.1155/2007/79169; Hu LA, 2008, ASSAY DRUG DEV TECHN, V6, P543, DOI 10.1089/adt.2008.152; Huiskonen JT, 2010, J VIROL, V84, P4889, DOI 10.1128/JVI.00057-10; Kenworthy AK, 2001, METHODS, V24, P289, DOI 10.1006/meth.2001.1189; Kolb J. M., 1996, J BIOMOL SCREENING, V1, P203; Kramer HEA, 2011, CHEMPHYSCHEM, V12, P555, DOI 10.1002/cphc.201000733; Liu LZ, 2008, ANAL CHEM, V80, P7735, DOI 10.1021/ac801106w; Loura LMS, 2011, FRONT PHYSIOL, V2, DOI 10.3389/fphys.2011.00082; MATHIS G, 1995, CLIN CHEM, V41, P1391; MCEWEN CR, 1967, ANAL BIOCHEM, V20, P114, DOI 10.1016/0003-2697(67)90271-0; MORRISON LE, 1988, ANAL BIOCHEM, V174, P101, DOI 10.1016/0003-2697(88)90524-6; Roux KH, 1997, J IMMUNOL, V159, P3372; Sahoo H, 2011, J PHOTOCH PHOTOBIO C, V12, P20, DOI 10.1016/j.jphotochemrev.2011.05.001; Saphire EO, 2002, J MOL BIOL, V319, P9, DOI 10.1016/S0022-2836(02)00244-9; Stenroos K, 1998, CYTOKINE, V10, P495, DOI 10.1006/cyto.1997.0321; WU PG, 1994, ANAL BIOCHEM, V218, P1, DOI 10.1006/abio.1994.1134	26	18	20	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e62739	10.1371/journal.pone.0062739	http://dx.doi.org/10.1371/journal.pone.0062739			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667515	gold, Green Published, Green Submitted			2022-12-27	WOS:000319654700059
J	Serre, MC; El Arnaout, T; Brooks, MA; Durand, D; Lisboa, J; Lazar, N; Raynal, B; van Tilbeurgh, H; Quevillon-Cheruel, S				Serre, Marie-Claude; El Arnaout, Toufic; Brooks, Mark A.; Durand, Dominique; Lisboa, Johnny; Lazar, Noureddine; Raynal, Bertrand; van Tilbeurgh, Herman; Quevillon-Cheruel, Sophie			The Carboxy-Terminal alpha N Helix of the Archaeal XerA Tyrosine Recombinase Is a Molecular Switch to Control Site-Specific Recombination	PLOS ONE			English	Article							DNA CLEAVAGE; CRYSTAL-STRUCTURE; CATALYTIC DOMAIN; ACTIVE-SITE; INTEGRASE; FLP; SCATTERING; MECHANISM; ULTRACENTRIFUGATION; MACROMOLECULES	Tyrosine recombinases are conserved in the three kingdoms of life. Here we present the first crystal structure of a full-length archaeal tyrosine recombinase, XerA from Pyrococcus abyssi, at 3.0 angstrom resolution. In the absence of DNA substrate XerA crystallizes as a dimer where each monomer displays a tertiary structure similar to that of DNA-bound Tyr-recombinases. Active sites are assembled in the absence of dif except for the catalytic Tyr, which is extruded and located equidistant from each active site within the dimer. Using XerA active site mutants we demonstrate that XerA follows the classical cis-cleavage reaction, suggesting rearrangements of the C-terminal domain upon DNA binding. Surprisingly, XerA C-terminal aN helices dock in cis in a groove that, in bacterial tyrosine recombinases, accommodates in trans aN helices of neighbour monomers in the Holliday junction intermediates. Deletion of the XerA C-terminal aN helix does not impair cleavage of suicide substrates but prevents recombination catalysis. We propose that the enzymatic cycle of XerA involves the switch of the aN helix from cis to trans packing, leading to (i) repositioning of the catalytic Tyr in the active site in cis and (ii) dimer stabilisation via aN contacts in trans between monomers.	[Serre, Marie-Claude] Univ Paris 11, Inst Genet & Microbiol, F-91405 Orsay, France; [El Arnaout, Toufic; Brooks, Mark A.; Durand, Dominique; Lisboa, Johnny; Lazar, Noureddine; van Tilbeurgh, Herman; Quevillon-Cheruel, Sophie] Univ Paris 11, Inst Biochim & Biophys Mol & Cellulaire, Orsay, France; [Serre, Marie-Claude; Durand, Dominique; Quevillon-Cheruel, Sophie] CNRS, F-91405 Orsay, France; [Raynal, Bertrand] Inst Pasteur, Dept Biol Struct & Chim, Paris, France	UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Serre, MC (corresponding author), Univ Paris 11, Inst Genet & Microbiol, F-91405 Orsay, France.	marie-claude.serre@igmors.u-psud.fr; sophie.quevillon-cheruel@u-psud.fr	Lisboa, Johnny/V-9696-2019; Serre, Marie-Claude/B-4159-2008	Lisboa, Johnny/0000-0001-7329-8993; SERRE, Marie-Claude/0000-0002-7899-9833; Brooks, Mark/0000-0003-2614-6115; El Arnaout, Toufic/0000-0003-2570-9668	Centre National de la Recherche Scientifique; University Paris-Sud [UMR8619, UMR8621]	Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); University Paris-Sud	This work was supported by funds from the Centre National de la Recherche Scientifique and the University Paris-Sud (UMR8619 and UMR8621). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afonine PV, 2007, ACTA CRYSTALLOGR D, V63, P1194, DOI 10.1107/S0907444907046148; Aihara H, 2003, MOL CELL, V12, P187, DOI 10.1016/S1097-2765(03)00268-5; Aihara H, 2007, MOL CELL, V27, P901, DOI 10.1016/j.molcel.2007.07.026; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bricogne G, 2003, ACTA CRYSTALLOGR D, V59, P2023, DOI 10.1107/S0907444903017694; Brookes E, 2010, EUR BIOPHYS J BIOPHY, V39, P423, DOI 10.1007/s00249-009-0418-0; Brunger AT, 2007, NAT PROTOC, V2, P2728, DOI 10.1038/nprot.2007.406; CHEN JW, 1992, CELL, V69, P647, DOI 10.1016/0092-8674(92)90228-5; Chen Y, 2000, MOL CELL, V6, P885, DOI 10.1016/S1097-2765(05)00088-2; Cheng CH, 1998, CELL, V92, P841, DOI 10.1016/S0092-8674(00)81411-7; Conway AB, 2003, J MOL BIOL, V326, P425, DOI 10.1016/S0022-2836(02)01370-0; Cortez D, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001166; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; de la Torre JG, 2000, BIOPHYS J, V78, P719, DOI 10.1016/S0006-3495(00)76630-6; Duggin IG, 2011, EMBO J, V30, P145, DOI 10.1038/emboj.2010.301; Eilers BJ, 2012, J VIROL, V86, P8309, DOI 10.1128/JVI.00547-12; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ghosh K, 2007, J BIOL CHEM, V282, P24004, DOI 10.1074/jbc.M703283200; Gibb B, 2010, NUCLEIC ACIDS RES, V38, P5817, DOI 10.1093/nar/gkq384; Gopaul DN, 1998, EMBO J, V17, P4175, DOI 10.1093/emboj/17.14.4175; Grindley NDF, 2006, ANNU REV BIOCHEM, V75, P567, DOI 10.1146/annurev.biochem.73.011303.073908; Guo F, 1997, NATURE, V389, P40, DOI 10.1038/37925; Hickman AB, 1997, CELL, V89, P227, DOI 10.1016/S0092-8674(00)80202-0; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Jayaram M, 1997, SCIENCE, V276, P49, DOI 10.1126/science.276.5309.49; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kamadurai HB, 2008, ACTA CRYSTALLOGR F, V64, P470, DOI 10.1107/S174430910801381X; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kwon HJ, 1997, SCIENCE, V276, P126, DOI 10.1126/science.276.5309.126; Lesterlin C, 2004, MOL MICROBIOL, V54, P1151, DOI 10.1111/j.1365-2958.2004.04356.x; Letzelter C, 2004, J BIOL CHEM, V279, P28936, DOI 10.1074/jbc.M403971200; MacDonald D, 2006, NATURE, V440, P1157, DOI 10.1038/nature04643; Maupetit J, 2006, NUCLEIC ACIDS RES, V34, pW147, DOI 10.1093/nar/gkl289; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; MUSKHELISHVILI G, 1993, MOL GEN GENET, V237, P334, DOI 10.1007/BF00279436; NUNESDUBY SE, 1989, CELL, V59, P197, DOI 10.1016/0092-8674(89)90881-7; Patel A, 2006, J BIOL CHEM, V281, P6030, DOI 10.1074/jbc.M512332200; Petoukhov MV, 2005, BIOPHYS J, V89, P1237, DOI 10.1529/biophysj.105.064154; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Schuck P, 2003, ANAL BIOCHEM, V320, P104, DOI 10.1016/S0003-2697(03)00289-6; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Serre MC, 2002, J BIOL CHEM, V277, P16758, DOI 10.1074/jbc.M200707200; SERRE MC, 1992, J MOL BIOL, V225, P621, DOI 10.1016/0022-2836(92)90390-6; Sherratt DJ, 2004, PHILOS T R SOC B, V359, P61, DOI 10.1098/rstb.2003.1365; Spiers AJ, 1999, MOL MICROBIOL, V32, P1031, DOI 10.1046/j.1365-2958.1999.01418.x; Subramanya HS, 1997, EMBO J, V16, P5178, DOI 10.1093/emboj/16.17.5178; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; Svergun DI, 2001, BIOPHYS J, V80, P2946, DOI 10.1016/S0006-3495(01)76260-1; Van Duyne G.D., 2002, MOBILE DNA, VII, P93; Zhan ZY, 2012, ACTA CRYSTALLOGR D, V68, P659, DOI 10.1107/S0907444912007202	52	14	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e63010	10.1371/journal.pone.0063010	http://dx.doi.org/10.1371/journal.pone.0063010			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667562	Green Submitted, Green Published, gold			2022-12-27	WOS:000319654700097
J	Singh, P; Sharma, L; Kulothungan, SR; Adkar, BV; Prajapati, RS; Ali, PSS; Krishnan, B; Varadarajan, R				Singh, Pranveer; Sharma, Likhesh; Kulothungan, S. Rajendra; Adkar, Bharat V.; Prajapati, Ravindra Singh; Ali, P. Shaik Syed; Krishnan, Beena; Varadarajan, Raghavan			Effect of Signal Peptide on Stability and Folding of Escherichia coli Thioredoxin	PLOS ONE			English	Article							MALTOSE-BINDING PROTEIN; IMMUNOGLOBULIN LIGHT-CHAINS; MULTIVARIATE DATA-ANALYSIS; AMINO-ACID-SEQUENCE; CONFORMATIONAL TRANSITIONS; GUANIDINE-HYDROCHLORIDE; CHAPERONE SECB; EXPORT; TRANSLOCATION; MEMBRANE	The signal peptide plays a key role in targeting and membrane insertion of secretory and membrane proteins in both prokaryotes and eukaryotes. In E. coli, recombinant proteins can be targeted to the periplasmic space by fusing naturally occurring signal sequences to their N-terminus. The model protein thioredoxin was fused at its N-terminus with malE and pelB signal sequences. While WT and the pelB fusion are soluble when expressed, the malE fusion was targeted to inclusion bodies and was refolded in vitro to yield a monomeric product with identical secondary structure to WT thioredoxin. The purified recombinant proteins were studied with respect to their thermodynamic stability, aggregation propensity and activity, and compared with wild type thioredoxin, without a signal sequence. The presence of signal sequences leads to thermodynamic destabilization, reduces the activity and increases the aggregation propensity, with malE having much larger effects than pelB. These studies show that besides acting as address labels, signal sequences can modulate protein stability and aggregation in a sequence dependent manner.	[Singh, Pranveer; Sharma, Likhesh; Kulothungan, S. Rajendra; Adkar, Bharat V.; Prajapati, Ravindra Singh; Ali, P. Shaik Syed; Krishnan, Beena; Varadarajan, Raghavan] Indian Inst Sci, Mol Biophys Unit, Bangalore 560012, Karnataka, India; [Varadarajan, Raghavan] Jawaharlal NehruCtr Adv Sci Res, Chem Biol Unit, Bangalore, Karnataka, India	Indian Institute of Science (IISC) - Bangalore; Department of Science & Technology (India); Jawaharlal Nehru Center for Advanced Scientific Research (JNCASR)	Varadarajan, R (corresponding author), Indian Inst Sci, Mol Biophys Unit, Bangalore 560012, Karnataka, India.	varadar@mbu.iisc.ernet.in	Adkar, Bharat Vighnahar/AAP-2634-2021	Adkar, Bharat Vighnahar/0000-0002-9168-051X	Department of Biotechnology and Department of Science and Technology, Government of India; University Grant Commission, India	Department of Biotechnology and Department of Science and Technology, Government of India; University Grant Commission, India(University Grants Commission, India)	This work was funded by grants from Department of Biotechnology and Department of Science and Technology, Government of India. P.S. was supported by the DS Kothari post doctoral fellowship of University Grant Commission, India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGASHE VR, 1995, BIOCHEMISTRY-US, V34, P3286, DOI 10.1021/bi00010a019; Beena K, 2004, BIOCHEMISTRY-US, V43, P3608, DOI 10.1021/bi0360509; BLOBEL G, 1975, J CELL BIOL, V67, P835, DOI 10.1083/jcb.67.3.835; Chakrabarti A, 1999, PROTEIN SCI, V8, P2455; Chakraborty K, 2005, BIOCHEMISTRY-US, V44, P14638, DOI 10.1021/bi050921s; Conchillo-Sole O, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-65; Cristobal S, 1999, EMBO J, V18, P2982, DOI 10.1093/emboj/18.11.2982; Das M, 2007, J MOL BIOL, V372, P1278, DOI 10.1016/j.jmb.2007.07.033; Debarbieux L, 1998, P NATL ACAD SCI USA, V95, P10751, DOI 10.1073/pnas.95.18.10751; DeLisa MP, 2003, P NATL ACAD SCI USA, V100, P6115, DOI 10.1073/pnas.0937838100; Du Plessis DJF, 2011, BBA-BIOMEMBRANES, V1808, P851, DOI 10.1016/j.bbamem.2010.08.016; Edman M, 1999, PROTEINS, V35, P195, DOI 10.1002/(SICI)1097-0134(19990501)35:2<195::AID-PROT6>3.3.CO;2-G; EKLUND H, 1991, PROTEINS, V11, P13, DOI 10.1002/prot.340110103; Fekkes P, 1999, MICROBIOL MOL BIOL R, V63, P161, DOI 10.1128/MMBR.63.1.161-173.1999; Francetic O, 1996, J BACTERIOL, V178, P5954, DOI 10.1128/jb.178.20.5954-5959.1996; Ganesh C, 1997, BIOCHEMISTRY-US, V36, P5020, DOI 10.1021/bi961967b; Ghoshal AK, 1999, BIOCHEM J, V339, P721, DOI 10.1042/0264-6021:3390721; HARDY SJS, 1991, SCIENCE, V251, P439, DOI 10.1126/science.1989077; HARTL FU, 1990, CELL, V63, P269, DOI 10.1016/0092-8674(90)90160-G; HOFFSCHUTE HK, 1994, J BIOL CHEM, V269, P12833; HOLMGREN A, 1972, J BIOL CHEM, V247, P1992; HOLMGREN A, 1968, EUR J BIOCHEM, V6, P475, DOI 10.1111/j.1432-1033.1968.tb00470.x; HOLMGREN A, 1979, J BIOL CHEM, V254, P9627; Huber D, 2005, P NATL ACAD SCI USA, V102, P18872, DOI 10.1073/pnas.0509583102; Huber D, 2005, J BACTERIOL, V187, P2983, DOI 10.1128/JB.187.9.2983-2991.2005; Humphreys DP, 2000, PROTEIN EXPRES PURIF, V20, P252, DOI 10.1006/prep.2000.1286; IZARD JW, 1994, MOL MICROBIOL, V13, P765, DOI 10.1111/j.1365-2958.1994.tb00469.x; JENG MF, 1994, STRUCTURE, V2, P853, DOI 10.1016/S0969-2126(94)00086-7; JOSEFSSON LG, 1983, METHOD ENZYMOL, V97, P77; KATTI SK, 1990, J MOL BIOL, V212, P167, DOI 10.1016/0022-2836(90)90313-B; KELLEY RF, 1987, BIOCHEMISTRY-US, V26, P1406, DOI 10.1021/bi00379a029; KELLEY RF, 1984, BIOCHEMISTRY-US, V23, P5095, DOI 10.1021/bi00317a003; Krishnan B, 2009, J MOL BIOL, V385, P1243, DOI 10.1016/j.jmb.2008.10.094; Kulothungan SR, 2009, LANGMUIR, V25, P6637, DOI 10.1021/la900198h; KUSUKAWA N, 1989, EMBO J, V8, P3517, DOI 10.1002/j.1460-2075.1989.tb08517.x; LEI SP, 1987, J BACTERIOL, V169, P4379, DOI 10.1128/jb.169.9.4379-4383.1987; MILSTEIN C, 1972, NATURE-NEW BIOL, V239, P117, DOI 10.1038/newbio239117a0; Nielsen H, 1997, PROTEIN ENG, V10, P1, DOI 10.1093/protein/10.1.1; Pedone E, 2003, BIOCHEM J, V373, P875, DOI 10.1042/BJ20021747; PUGSLEY AP, 1993, MICROBIOL REV, V57, P50, DOI 10.1128/MMBR.57.1.50-108.1993; RANDALL LL, 1995, TRENDS BIOCHEM SCI, V20, P65, DOI 10.1016/S0968-0004(00)88959-8; RANDALL LL, 1986, CELL, V46, P921, DOI 10.1016/0092-8674(86)90074-7; ROBBENS J, 1995, PROTEIN EXPRES PURIF, V6, P481, DOI 10.1006/prep.1995.1064; SCHATZ PJ, 1990, ANNU REV GENET, V24, P215, DOI 10.1146/annurev.ge.24.120190.001243; Schierle CF, 2003, J BACTERIOL, V185, P5706, DOI 10.1128/JB.185.19.5706-5713.2003; Sheshadri S, 1999, PROTEIN SCI, V8, P1689, DOI 10.1110/ps.8.8.1689; SJOSTROM M, 1987, EMBO J, V6, P823, DOI 10.1002/j.1460-2075.1987.tb04825.x; Slaby I, 1996, J BIOL CHEM, V271, P3091, DOI 10.1074/jbc.271.6.3091; Steiner D, 2006, NAT BIOTECHNOL, V24, P823, DOI 10.1038/nbt1218; Stuart RA, 2000, NATURE, V406, P575, DOI 10.1038/35020668; Tartaglia GG, 2008, CHEM SOC REV, V37, P1395, DOI 10.1039/b706784b; Trovato A, 2007, PROTEIN ENG DES SEL, V20, P521, DOI 10.1093/protein/gzm042; Varadarajan R, 1996, P NATL ACAD SCI USA, V93, P13908, DOI 10.1073/pnas.93.24.13908; VONHEIJNE G, 1985, J MOL BIOL, V184, P99, DOI 10.1016/0022-2836(85)90046-4; WALTER P, 1994, ANNU REV CELL BIOL, V10, P87, DOI 10.1146/annurev.cb.10.110194.000511; Wan EWM, 1998, PROTEIN EXPRES PURIF, V14, P13, DOI 10.1006/prep.1998.0941; WILD J, 1992, GENE DEV, V6, P1165, DOI 10.1101/gad.6.7.1165; WOODY RW, 1995, METHOD ENZYMOL, V246, P34; Zalucki YM, 2011, BBA-BIOMEMBRANES, V1808, P2544, DOI 10.1016/j.bbamem.2011.06.004; Zalucki YM, 2010, BBA-BIOMEMBRANES, V1798, P1244, DOI 10.1016/j.bbamem.2010.03.010; ZIMMERMAN SB, 1993, ANNU REV BIOPH BIOM, V22, P27, DOI 10.1146/annurev.bb.22.060193.000331	61	44	48	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e63442	10.1371/journal.pone.0063442	http://dx.doi.org/10.1371/journal.pone.0063442			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667620	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000319654700146
J	Southon, A; Greenough, MA; Ganio, G; Bush, AI; Burke, R; Camakaris, J				Southon, Adam; Greenough, Mark A.; Ganio, George; Bush, Ashley I.; Burke, Richard; Camakaris, James			Presenilin Promotes Dietary Copper Uptake	PLOS ONE			English	Article							SUPEROXIDE-DISMUTASE; DROSOPHILA-MELANOGASTER; ALZHEIMERS-DISEASE; HOMEOSTASIS; ZINC; DEFICIENCY; TOXICITY; GENE; TRAFFICKING; ABSORPTION	Dietary copper is essential for multicellular organisms. Copper is redox active and required as a cofactor for enzymes such as the antioxidant Superoxide Dismutase 1 (SOD1). Copper dyshomeostasis has been implicated in Alzheimer's disease. Mutations in the presenilin genes encoding PS1 and PS2 are major causes of early-onset familial Alzheimer's disease. PS1 and PS2 are required for efficient copper uptake in mammalian systems. Here we demonstrate a conserved role for presenilin in dietary copper uptake in the fly Drosophila melanogaster. Ubiquitous RNA interference-mediated knockdown of the single Drosophila presenilin (PSN) gene is lethal. However, PSN knockdown in the midgut produces viable flies. These flies have reduced copper levels and are more tolerant to excess dietary copper. Expression of a copper-responsive EYFP construct was also lower in the midgut of these larvae, indicative of reduced dietary copper uptake. SOD activity was reduced by midgut PSN knockdown, and these flies were sensitive to the superoxide-inducing chemical paraquat. These data support presenilin being needed for dietary copper uptake in the gut and so impacting on SOD activity and tolerance to oxidative stress. These results are consistent with previous studies of mammalian presenilins, supporting a conserved role for these proteins in mediating copper uptake.	[Southon, Adam; Greenough, Mark A.; Camakaris, James] Univ Melbourne, Dept Genet, Melbourne, Vic 3010, Australia; [Greenough, Mark A.; Ganio, George; Bush, Ashley I.] Univ Melbourne, Florey Inst Neurosci & Mental Hlth, Melbourne, Vic 3010, Australia; [Burke, Richard] Monash Univ, Sch Biol Sci, Clayton, Vic 3800, Australia	University of Melbourne; Florey Institute of Neuroscience & Mental Health; University of Melbourne; Monash University	Camakaris, J (corresponding author), Univ Melbourne, Dept Genet, Melbourne, Vic 3010, Australia.	j.camakaris@unimelb.edu.au	Bush, Ashley/Y-2457-2019; Bush, Ashley I/A-1186-2007; Greenough, Mark/AAK-1615-2021	Bush, Ashley/0000-0001-8259-9069; Bush, Ashley I/0000-0001-8259-9069; Greenough, Mark/0000-0001-6767-0584; Burke, Richard/0000-0003-0086-0767	J.N. Peters Bequest postdoctoral fellowship from the University of Melbourne	J.N. Peters Bequest postdoctoral fellowship from the University of Melbourne	Adam Southon is a recipient of the J.N. Peters Bequest postdoctoral fellowship from the University of Melbourne. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arquier N, 2007, CELL METAB, V5, P83, DOI 10.1016/j.cmet.2007.01.006; Balamurugan K, 2006, BBA-MOL CELL RES, V1763, P737, DOI 10.1016/j.bbamcr.2006.05.001; Binks T, 2010, J BIOL INORG CHEM, V15, P621, DOI 10.1007/s00775-010-0629-y; Chung H, 2007, GENETICS, V175, P1071, DOI 10.1534/genetics.106.066597; Dow JAT, 2006, J INSECT PHYSIOL, V52, P365, DOI 10.1016/j.jinsphys.2005.10.007; Greenough MA, 2013, NEUROCHEM INT, V62, P540, DOI 10.1016/j.neuint.2012.08.014; Greenough MA, 2011, J BIOL CHEM, V286, P9776, DOI 10.1074/jbc.M110.163964; Hua HQ, 2011, BIOL CHEM, V392, P919, DOI 10.1515/BC.2011.084; Kirby K, 2008, J BIOL CHEM, V283, P35393, DOI 10.1074/jbc.M807131200; Li A, 2011, CURR ALZHEIMER RES, V8, P313, DOI 10.2174/156720511795563746; Li DX, 2006, AM J HUM GENET, V79, P1030, DOI 10.1086/509900; Marcus DL, 1998, EXP NEUROL, V150, P40, DOI 10.1006/exnr.1997.6750; Maynard CJ, 2006, J INORG BIOCHEM, V100, P952, DOI 10.1016/j.jinorgbio.2006.02.010; Murakami K, 2011, J BIOL CHEM, V286, P44557, DOI 10.1074/jbc.M111.279208; Naruse S, 1998, NEURON, V21, P1213, DOI 10.1016/S0896-6273(00)80637-6; Norgate M, 2006, MOL BIOL CELL, V17, P475, DOI 10.1091/mbc.E05-06-0492; Norgate M, 2007, BIOMETALS, V20, P683, DOI 10.1007/s10534-006-9075-2; Norgate M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014303; Peskin AV, 2000, CLIN CHIM ACTA, V293, P157, DOI 10.1016/S0009-8981(99)00246-6; Phillips MD, 2006, J CELL SCI, V119, P1361, DOI 10.1242/jcs.02839; Sanokawa-Akakura R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008626; Selvaraj A, 2005, GENE DEV, V19, P891, DOI 10.1101/gad.1301805; Southon A, 2004, BIOCHEM J, V383, P303, DOI 10.1042/BJ20040745; Struhl G, 1999, NATURE, V398, P522, DOI 10.1038/19091; Tuerk MJ, 2009, CURR OPIN GASTROEN, V25, P136, DOI 10.1097/MOG.0b013e328321b395; Valko M, 2005, CURR MED CHEM, V12, P1161, DOI 10.2174/0929867053764635; van den Berghe PVE, 2009, NUTR REV, V67, P658, DOI 10.1111/j.1753-4887.2009.00250.x; Vetrivel KS, 2006, MOL NEURODEGENER, V1, DOI 10.1186/1750-1326-1-4; Vontas JG, 2001, GENOME, V44, P597, DOI 10.1139/gen-44-4-597; Wang RS, 2006, P NATL ACAD SCI USA, V103, P353, DOI 10.1073/pnas.0509822102; Wang XX, 2009, FASEB J, V23, P2650, DOI 10.1096/fj.08-126649; Wolfe MS, 2009, CHEM REV, V109, P1599, DOI 10.1021/cr8004197; Wong PC, 2000, P NATL ACAD SCI USA, V97, P2886, DOI 10.1073/pnas.040461197; Yu JT, 2009, PROG NEUROBIOL, V89, P240, DOI 10.1016/j.pneurobio.2009.07.009; Zhang M, 2006, FASEB J, V20, P1176, DOI 10.1096/fj.05-5531fje; Zhang XL, 2012, J NEUROSCI, V32, P8633, DOI 10.1523/JNEUROSCI.0556-12.2012	36	21	21	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e62811	10.1371/journal.pone.0062811	http://dx.doi.org/10.1371/journal.pone.0062811			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667524	Green Published, Green Submitted, gold			2022-12-27	WOS:000319654700065
J	Basu, D; Reyes-Mugica, M; Rebbaa, A				Basu, Dipanjan; Reyes-Mugica, Miguel; Rebbaa, Abdelhadi			Histone Acetylation-Mediated Regulation of the Hippo Pathway	PLOS ONE			English	Article							CELL SELF-RENEWAL; PROMOTES APOPTOSIS; EPITHELIAL-CELLS; PROTEIN-KINASE; GROWTH-CONTROL; SIZE CONTROL; LUNG-CANCER; WNT PATHWAY; YAP; PROLIFERATION	The Hippo pathway is a signaling cascade recently found to play a key role in tumorigenesis therefore understanding the mechanisms that regulate it should open new opportunities for cancer treatment. Available data indicate that this pathway is controlled by signals from cell-cell junctions however the potential role of nuclear regulation has not yet been described. Here we set out to verify this possibility and define putative mechanism(s) by which it might occur. By using a luciferase reporter of the Hippo pathway, we measured the effects of different nuclear targeting drugs and found that chromatin-modifying agents, and to a lesser extent certain DNA damaging drugs, strongly induced activity of the reporter. This effect was not mediated by upstream core components (i.e. Mst, Lats) of the Hippo pathway, but through enhanced levels of the Hippo transducer TAZ. Investigation of the underlying mechanism led to the finding that cancer cell exposure to histone deacetylase inhibitors induced secretion of growth factors and cytokines, which in turn activate Akt and inhibit the GSK3 beta associated protein degradation complex in drug-affected as well as in their neighboring cells. Consequently, expression of EMT genes, cell migration and resistance to therapy were induced. These processes were suppressed by using pyrvinium, a recently described small molecule activator of the GSK 3 beta associated degradation complex. Overall, these findings shed light on a previously unrecognized phenomenon by which certain anti-cancer agents may paradoxically promote tumor progression by facilitating stabilization of the Hippo transducer TAZ and inducing cancer cell migration and resistance to therapy. Pharmacological targeting of the GSK3 beta associated degradation complex may thus represent a unique approach to treat cancer.	[Rebbaa, Abdelhadi] Univ Pittsburgh, Dept Pathol, Pittsburgh, PA 15260 USA; UPMC, Childrens Hosp Pittsburgh, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Rebbaa, A (corresponding author), Univ Pittsburgh, Dept Pathol, Pittsburgh, PA 15260 USA.	abr25@pitt.edu	Basu, Dipanjan/J-8043-2019; Reyes-Mugica, Miguel/C-2483-2008	Basu, Dipanjan/0000-0002-3083-2954; Reyes-Mugica, Miguel/0000-0001-5698-3702	University of Pittsburgh	University of Pittsburgh(University of Pittsburgh)	This work was supported by startup funds from the University of Pittsburgh. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alarcon C, 2009, CELL, V139, P757, DOI 10.1016/j.cell.2009.09.035; Avruch J, 2012, CELL CYCLE, V11, P1090, DOI 10.4161/cc.11.6.19453; Azzolin L, 2012, CELL, V151, P1443, DOI 10.1016/j.cell.2012.11.027; Basu D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052188; Chen HJ, 2011, DEV BIOL, V357, P370, DOI 10.1016/j.ydbio.2011.07.003; Cho HH, 2010, J CELL PHYSIOL, V223, P168, DOI 10.1002/jcp.22024; Chu F, 2008, AGING CELL, V7, P516, DOI 10.1111/j.1474-9726.2008.00403.x; Cordenonsi M, 2011, CELL, V147, P759, DOI 10.1016/j.cell.2011.09.048; de Cristofaro T, 2011, EUR J CANCER, V47, P926, DOI 10.1016/j.ejca.2010.11.008; Grusche FA, 2010, CURR BIOL, V20, pR574, DOI 10.1016/j.cub.2010.05.023; Grzeschik NA, 2010, CURR BIOL, V20, P573, DOI 10.1016/j.cub.2010.01.055; Halder G, 2011, DEVELOPMENT, V138, P9, DOI 10.1242/dev.045500; Hao YW, 2008, J BIOL CHEM, V283, P5496, DOI 10.1074/jbc.M709037200; Harvey KF, 2003, CELL, V114, P457, DOI 10.1016/S0092-8674(03)00557-9; Harvey K, 2007, NAT REV CANCER, V7, P182, DOI 10.1038/nrc2070; Harvey KF, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a011288; Huang W, 2012, J BIOL CHEM, V287, P26245, DOI 10.1074/jbc.M112.382036; Kanai F, 2000, EMBO J, V19, P6778, DOI 10.1093/emboj/19.24.6778; Konsavage Jr WM, 2012, ACTA BIOCH BIOPHYS S; Konsavage WM, 2012, J BIOL CHEM, V287, P11730, DOI 10.1074/jbc.M111.327767; Lai D, 2011, CANCER RES, V71, P2728, DOI 10.1158/0008-5472.CAN-10-2711; Lei QY, 2008, MOL CELL BIOL, V28, P2426, DOI 10.1128/MCB.01874-07; Li XJ, 2012, CARCINOGENESIS, V33, P1302, DOI 10.1093/carcin/bgs181; Lian I, 2010, GENE DEV, V24, P1106, DOI 10.1101/gad.1903310; Liu YQ, 2010, INVEST OPHTH VIS SCI, V51, P3372, DOI 10.1167/iovs.09-4321; Lyons JP, 2004, EXP CELL RES, V298, P369, DOI 10.1016/j.yexcr.2004.04.036; Mardin BR, 2010, NAT CELL BIOL, V12, P1166, DOI 10.1038/ncb2120; Martin-Belmonte F, 2012, NAT REV CANCER, V12, P23, DOI 10.1038/nrc3169; McCaffrey LM, 2011, TRENDS CELL BIOL, V21, P727, DOI 10.1016/j.tcb.2011.06.005; Miller E, 2012, CHEM BIOL, V19, P955, DOI 10.1016/j.chembiol.2012.07.005; Mirkin BL, 2005, ONCOGENE, V24, P4965, DOI 10.1038/sj.onc.1208671; Mousa SA, 2010, CANCER LETT, V289, P208, DOI 10.1016/j.canlet.2009.08.018; Oh H, 2008, DEVELOPMENT, V135, P1081, DOI 10.1242/dev.015255; Oh H, 2010, TRENDS CELL BIOL, V20, P410, DOI 10.1016/j.tcb.2010.04.005; Pazolli E, 2012, CANCER RES, V72, P2251, DOI 10.1158/0008-5472.CAN-11-3386; Prince HM, 2009, CLIN CANCER RES, V15, P3958, DOI 10.1158/1078-0432.CCR-08-2785; Rebbaa A, 2001, MOL MED, V7, P393, DOI 10.1007/BF03402185; Robinson BS, 2010, CURR BIOL, V20, P582, DOI 10.1016/j.cub.2010.03.019; Salic A, 2000, MOL CELL, V5, P523, DOI 10.1016/S1097-2765(00)80446-3; St John MAR, 1999, NAT GENET, V21, P182, DOI 10.1038/5965; Sudol Marius, 2010, Genes Cancer, V1, P1115, DOI 10.1177/1947601911401911; Thorne CA, 2010, NAT CHEM BIOL, V6, P829, DOI 10.1038/NCHEMBIO.453; Udan RS, 2003, NAT CELL BIOL, V5, P914, DOI 10.1038/ncb1050; Varelas X, 2010, DEV CELL, V19, P831, DOI 10.1016/j.devcel.2010.11.012; Varelas X, 2010, DEV CELL, V18, P579, DOI 10.1016/j.devcel.2010.03.007; Wang Y, 2010, CANCER SCI, V101, P1279, DOI 10.1111/j.1349-7006.2010.01511.x; Wu S, 2003, CELL, V114, P445, DOI 10.1016/S0092-8674(03)00549-X; XU TA, 1995, DEVELOPMENT, V121, P1053; Yu FX, 2012, CELL, V150, P780, DOI 10.1016/j.cell.2012.06.037; Zender L, 2006, CELL, V125, P1253, DOI 10.1016/j.cell.2006.05.030; Zhang CY, 2009, CANCER RES, V69, P828, DOI 10.1158/0008-5472.CAN-08-2588; Zhang JM, 2008, CANCER RES, V68, P2789, DOI 10.1158/0008-5472.CAN-07-6205; Zhao B, 2007, GENE DEV, V21, P2747, DOI 10.1101/gad.1602907; Zhao B, 2011, NAT CELL BIOL, V13, P877, DOI 10.1038/ncb2303; Zhao LM, 2010, TISSUE ENG PT A, V16, P725, DOI [10.1089/ten.tea.2009.0495, 10.1089/ten.TEA.2009.0495]; Zhou Z, 2011, ONCOGENE, V30, P2181, DOI 10.1038/onc.2010.606	56	14	14	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2013	8	5							e62478	10.1371/journal.pone.0062478	http://dx.doi.org/10.1371/journal.pone.0062478			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	177QL	23671600	Green Submitted, gold, Green Published, Green Accepted			2022-12-27	WOS:000321390200024
J	Forristal, CE; Christensen, DR; Chinnery, FE; Petruzzelli, R; Parry, KL; Sanchez-Elsner, T; Houghton, FD				Forristal, Catherine E.; Christensen, David R.; Chinnery, Fay E.; Petruzzelli, Raffaella; Parry, Kate L.; Sanchez-Elsner, Tilman; Houghton, Franchesca D.			Environmental Oxygen Tension Regulates the Energy Metabolism and Self-Renewal of Human Embryonic Stem Cells	PLOS ONE			English	Article							HYPOXIA-INDUCIBLE FACTOR-1-ALPHA; AMINO-ACID TURNOVER; GLUCOSE-TRANSPORTER; HUMAN BLASTOCYSTS; MOUSE BLASTOCYST; TARGET GENES; EXPRESSION; DIFFERENTIATION; IDENTIFICATION; TRANSCRIPTION	Energy metabolism is intrinsic to cell viability but surprisingly has been little studied in human embryonic stem cells (hESCs). The current study aims to investigate the effect of environmental O-2 tension on carbohydrate utilisation of hESCs. Highly pluripotent hESCs cultured at 5% O-2 consumed significantly more glucose, less pyruvate and produced more lactate compared to those maintained at 20% O-2. Moreover, hESCs cultured at atmospheric O-2 levels expressed significantly less OCT4, SOX2 and NANOG than those maintained at 5% O-2. To determine whether this difference in metabolism was a reflection of the pluripotent state, hESCs were cultured at 5% O-2 in the absence of FGF2 for 16 hours leading to a significant reduction in the expression of SOX2. In addition, these cells consumed less glucose and produced significantly less lactate compared to those cultured in the presence of FGF2. hESCs maintained at 5% O2 were found to consume significantly less O-2 than those cultured in the absence of FGF2, or at 20% (O)2. GLUT1 expression correlated with glucose consumption and using siRNA and chromatin immunoprecipitation was found to be directly regulated by hypoxia inducible factor (HIF)-2 alpha at 5% O-2. In conclusion, highly pluripotent cells associated with hypoxic culture consume low levels of O-2, high levels of glucose and produce large amounts of lactate, while at atmospheric conditions glucose consumption and lactate production are reduced and there is an increase in oxidative metabolism. These data suggest that environmental O-2 regulates energy metabolism and is intrinsic to the self-renewal of hESCs.	[Forristal, Catherine E.; Christensen, David R.; Chinnery, Fay E.; Petruzzelli, Raffaella; Parry, Kate L.; Sanchez-Elsner, Tilman; Houghton, Franchesca D.] Univ Southampton, Fac Med, Ctr Human Dev Stem Cells & Regenerat, Southampton SO9 5NH, Hants, England	University of Southampton	Houghton, FD (corresponding author), Univ Southampton, Fac Med, Ctr Human Dev Stem Cells & Regenerat, Southampton SO9 5NH, Hants, England.	F.D.Houghton@soton.ac.uk	Petruzzelli, Raffaella/ABH-7049-2020; , Catherine/D-9925-2019	Petruzzelli, Raffaella/0000-0003-2868-4486; , Catherine/0000-0002-6304-1286; Houghton, Franchesca/0000-0002-5167-1694; Sanchez-Elsner, Tilman/0000-0003-1915-2410; Christensen, David/0000-0003-4018-3537	Gerald Kerkut Charitable Trust; UK Medical Research Council [G0701153]; Medical Research Council [974249, G0701153] Funding Source: researchfish; MRC [G0701153] Funding Source: UKRI	Gerald Kerkut Charitable Trust; UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was funded by the Gerald Kerkut Charitable Trust (http://www.soton.ac.uk/gktrust/) and the UK Medical Research Council, grant number G0701153 (www.mrc.ac.uk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amit M, 2003, BIOL REPROD, V68, P2150, DOI 10.1095/biolreprod.102.012583; Brison DR, 2004, HUM REPROD, V19, P2319, DOI 10.1093/humrep/deh409; Chen CT, 2008, STEM CELLS, V26, P960, DOI 10.1634/stemcells.2007-0509; Cowan CA, 2004, NEW ENGL J MED, V350, P1353, DOI 10.1056/NEJMsr040330; Draper JS, 2003, ARCH MED RES, V34, P558, DOI 10.1016/j.arcmed.2003.08.006; Ezashi T, 2005, P NATL ACAD SCI USA, V102, P4783, DOI 10.1073/pnas.0501283102; FLIER JS, 1987, J CLIN INVEST, V79, P657, DOI 10.1172/JCI112864; Folmes CDL, 2011, CELL METAB, V14, P264, DOI 10.1016/j.cmet.2011.06.011; Forristal CE, 2010, REPRODUCTION, V139, P85, DOI 10.1530/REP-09-0300; Forsyth NR, 2006, CLONING STEM CELLS, V8, P16, DOI 10.1089/clo.2006.8.16; FROEHNER SC, 1988, J NEUROCYTOL, V17, P173, DOI 10.1007/BF01674204; Hayashi M, 2004, J ENDOCRINOL, V183, P145, DOI 10.1677/joe.1.05599; Henderson JK, 2002, STEM CELLS, V20, P329, DOI 10.1634/stemcells.20-4-329; HEWITSON LC, 1993, J EXP ZOOL, V267, P337, DOI 10.1002/jez.1402670310; Houghton FD, 2006, DIFFERENTIATION, V74, P11, DOI 10.1111/j.1432-0436.2006.00052.x; Houghton FD, 2002, HUM REPROD, V17, P999, DOI 10.1093/humrep/17.4.999; Hu CJ, 2003, MOL CELL BIOL, V23, P9361, DOI 10.1128/MCB.23.24.9361-9374.2003; Iyer NV, 1998, GENE DEV, V12, P149, DOI 10.1101/gad.12.2.149; KAHN BB, 1990, DIABETES CARE, V13, P548, DOI 10.2337/diacare.13.6.548; Kihira Y, 2011, INT J BIOCHEM CELL B, V43, P1602, DOI 10.1016/j.biocel.2011.07.009; Kondoh H, 2007, ANTIOXID REDOX SIGN, V9, P293, DOI 10.1089/ars.2006.1467; Lee SH, 2007, CELL PHYSIOL BIOCHEM, V19, P269, DOI 10.1159/000100646; Lofstedt T, 2007, CELL CYCLE, V6, P919, DOI 10.4161/cc.6.8.4133; Ludwig TE, 2006, NAT BIOTECHNOL, V24, P185, DOI 10.1038/nbt1177; Panopoulos AD, 2012, CELL RES, V22, P168, DOI 10.1038/cr.2011.177; Petruzzelli R, 2010, BRIT J HAEMATOL, V150, P689, DOI 10.1111/j.1365-2141.2010.08303.x; Prigione A, 2010, STEM CELLS, V28, P721, DOI 10.1002/stem.404; Ryan HE, 1998, EMBO J, V17, P3005, DOI 10.1093/emboj/17.11.3005; Sathananthan Henry, 2002, Reprod Biomed Online, V4, P56; Seagroves TN, 2001, MOL CELL BIOL, V21, P3436, DOI 10.1128/MCB.21.10.3436-3444.2001; Semenza GL, 1996, J BIOL CHEM, V271, P32529, DOI 10.1074/jbc.271.51.32529; Tay JI, 1997, HUM REPROD, V12, P2451, DOI 10.1093/humrep/12.11.2451; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Van Blerkom J, 2002, HUM REPROD, V17, P393, DOI 10.1093/humrep/17.2.393; Varum S, 2009, STEM CELL RES, V3, P142, DOI 10.1016/j.scr.2009.07.002; Varum S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020914; Weinmann AS, 2002, METHODS, V26, P37, DOI 10.1016/S1046-2023(02)00006-3; Westfall SD, 2008, STEM CELLS DEV, V17, P869, DOI 10.1089/scd.2007.0240; Wright G, 2003, J BIOL CHEM, V278, P20235, DOI 10.1074/jbc.M301391200; Xu CH, 2001, NAT BIOTECHNOL, V19, P971, DOI 10.1038/nbt1001-971; Zelzer E, 1998, EMBO J, V17, P5085, DOI 10.1093/emboj/17.17.5085	41	56	58	2	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2013	8	5							e62507	10.1371/journal.pone.0062507	http://dx.doi.org/10.1371/journal.pone.0062507			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	177QL	23671606	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000321390200026
J	Jannot, AS; Pelet, A; Henrion-Caude, A; Chaoui, A; Masse-Morel, M; Arnold, S; Sanlaville, D; Ceccherini, I; Borrego, S; Hofstra, RMW; Munnich, A; Bondurand, N; Chakravarti, A; Clerget-Darpoux, F; Amiel, J; Lyonnet, S				Jannot, Anne-Sophie; Pelet, Anna; Henrion-Caude, Alexandra; Chaoui, Asma; Masse-Morel, Marine; Arnold, Stacey; Sanlaville, Damien; Ceccherini, Isabella; Borrego, Salud; Hofstra, Robert M. W.; Munnich, Arnold; Bondurand, Nadege; Chakravarti, Aravinda; Clerget-Darpoux, Francoise; Amiel, Jeanne; Lyonnet, Stanislas			Chromosome 21 Scan in Down Syndrome Reveals DSCAM as a Predisposing Locus in Hirschsprung Disease	PLOS ONE			English	Article							CONGENITAL HEART-DEFECTS; ESTROGEN-RECEPTOR-BETA; NETRIN RECEPTOR; RET ENHANCER; GENE; MUTATION; DISEQUILIBRIUM; HYDROCEPHALUS; ASSOCIATION; EXPRESSION	Hirschsprung disease (HSCR) genetics is a paradigm for the study and understanding of multigenic disorders. Association between Down syndrome and HSCR suggests that genetic factors that predispose to HSCR map to chromosome 21. To identify these additional factors, we performed a dose-dependent association study on chromosome 21 in Down syndrome patients with HSCR. Assessing 10,895 SNPs in 26 Caucasian cases and their parents led to identify two associated SNPs (rs2837770 and rs8134673) at chromosome-wide level. Those SNPs, which were located in intron 3 of the DSCAM gene within a 19 kb-linkage disequilibrium block region were in complete association and are consistent with DSCAM expression during enteric nervous system development. We replicated the association of HSCR with this region in an independent sample of 220 non-syndromic HSCR Caucasian patients and their parents. At last, we provide the functional rationale to the involvement of DSCAM by network analysis and assessment of SOX10 regulation. Our results reveal the involvement of DSCAM as a HSCR susceptibility locus, both in Down syndrome and HSCR isolated cases. This study further ascertains the chromosome-scan dose-dependent methodology used herein as a mean to map the genetic bases of other sub-phenotypes both in Down syndrome and other aneuploidies.	[Jannot, Anne-Sophie; Pelet, Anna; Henrion-Caude, Alexandra; Masse-Morel, Marine; Munnich, Arnold; Clerget-Darpoux, Francoise; Amiel, Jeanne; Lyonnet, Stanislas] Hop Necker Enfants Malad, AP HP, INSERM, U781, Paris, France; [Jannot, Anne-Sophie; Pelet, Anna; Henrion-Caude, Alexandra; Masse-Morel, Marine; Munnich, Arnold; Clerget-Darpoux, Francoise; Amiel, Jeanne; Lyonnet, Stanislas] Univ Paris 05, Dept Genet, Fac Med, Paris, France; [Chaoui, Asma; Bondurand, Nadege] Hop Henri Mondor, INSERM, U955, F-94010 Creteil, France; [Arnold, Stacey; Chakravarti, Aravinda] Johns Hopkins Univ, Sch Med, Ctr Complex Dis Genom, McKusick Nathans Inst Genet Med, Baltimore, MD USA; [Sanlaville, Damien] HCL, Serv Genet, Bron, France; [Sanlaville, Damien] Univ Lyon 1, INSERM, CNRS, Equipe TIGER,U1028,UMRS5292, F-69365 Lyon, France; [Ceccherini, Isabella] Ist Giannina Gaslini, Lab Genet Mol, I-16148 Genoa, Italy; [Borrego, Salud] Univ Seville, CSIC, Unidad Gest Clin Genet Reprod & Med Fetal, Inst Biomed Sevilla IBIS,Hosp Univ Virgen Rocio, Seville, Spain; [Borrego, Salud] CIBER Enfermedades Raras, ISCIII, Seville, Spain; [Hofstra, Robert M. W.] Univ Rotterdam, Dept Clin Genet, ErasmusMC, Rotterdam, Netherlands	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); Johns Hopkins University; CHU Lyon; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; University of Genoa; IRCCS Istituto Giannina Gaslini; Consejo Superior de Investigaciones Cientificas (CSIC); University of Sevilla; CSIC-JA-USE - Instituto de Biomedicina de Sevilla (IBIS); Virgen del Rocio University Hospital; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Instituto de Salud Carlos III; Erasmus University Rotterdam; Erasmus MC	Lyonnet, S (corresponding author), Hop Necker Enfants Malad, AP HP, INSERM, U781, Paris, France.	stanislas.lyonnet@inserm.fr	amiel, jeanne/H-3501-2017; Bondurand, Nadege/H-4737-2017; IBIS, REPRODUCCION/P-3399-2015; IBIS, GENETICA/P-3384-2015; Ceccherini, Isabella/P-8195-2014; Lyonnet, Stanislas/H-5483-2017; amiel, jeanne/AGX-1124-2022; Sanlaville, Damien/M-4716-2014; Borrego, Salud/M-6314-2015; Caude, Alexandra A Henrion/I-2778-2016; Clerget-Darpoux, Francoise/I-4825-2017	amiel, jeanne/0000-0001-5973-4728; Bondurand, Nadege/0000-0002-1531-1544; Ceccherini, Isabella/0000-0001-8732-1955; Lyonnet, Stanislas/0000-0001-5426-9417; Sanlaville, Damien/0000-0001-9939-2849; Caude, Alexandra A Henrion/0000-0002-8170-2260; Clerget-Darpoux, Francoise/0000-0003-4816-6619; PELET, Anastella/0000-0002-8353-1725; Hofstra, Robert/0000-0001-7498-3829; Jannot, Anne-Sophie/0000-0002-8001-8539	French National Research Agency (ANR); French National Research Agency (ANR, ERare-HSCR Consortium); Fondation pour la Recherche Medicale (FRM); Fondation Jerome Lejeune; USA National Institutes of Health [R37 HD28088]; Italian Telethon [GGP04257]; Fondo de Investigacion Sanitaria. Instituto de Salud Carlos III [PI10/01290]; Consejeria de Innovacion, Ciencia y Empresa de la Junta de Andalucia [CTS-2590]; NWO Bernoulle Foundation [901-04-225]; Ubbo Emmius Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R37HD028088] Funding Source: NIH RePORTER	French National Research Agency (ANR)(French National Research Agency (ANR)); French National Research Agency (ANR, ERare-HSCR Consortium)(French National Research Agency (ANR)); Fondation pour la Recherche Medicale (FRM)(Fondation pour la Recherche Medicale); Fondation Jerome Lejeune; USA National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Italian Telethon(Fondazione Telethon); Fondo de Investigacion Sanitaria. Instituto de Salud Carlos III(Instituto de Salud Carlos III); Consejeria de Innovacion, Ciencia y Empresa de la Junta de Andalucia(Junta de Andalucia); NWO Bernoulle Foundation; Ubbo Emmius Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was funded by the French National Research Agency (ANR, grants MRARE-HirGenet to SL, EvoDevoMut Grant, and ERare-HSCR Consortium to SL, IC, and SB), the Fondation pour la Recherche Medicale (FRM) to SL and JA; Fondation Jerome Lejeune; the USA National Institutes of Health (R37 HD28088 to A. C.); the Italian Telethon (GGP04257 to IC); Fondo de Investigacion Sanitaria. Instituto de Salud Carlos III (PI10/01290) and Consejeria de Innovacion, Ciencia y Empresa de la Junta de Andalucia (CTS-2590) to S. B.; the NWO (901-04-225) Bernoulle Foundation and Ubbo Emmius Foundation to R. M. W. H. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Affymetrix, 2006, BRLMM IMPR GEN CALL; Amano K, 2009, J NEUROSCI, V29, P2984, DOI 10.1523/JNEUROSCI.3624-08.2009; Amiel J, 2008, J MED GENET, V45, P1, DOI 10.1136/jmg.2007.053959; Anderson RB, 2006, GASTROENTEROLOGY, V130, P1221, DOI 10.1053/j.gastro.2006.01.002; Arnold S, 2009, HUM MUTAT, V30, P771, DOI 10.1002/humu.20944; Bondurand N, 2000, HUM MOL GENET, V9, P1907, DOI 10.1093/hmg/9.13.1907; Bondurand N, 2001, HUM MOL GENET, V10, P2783, DOI 10.1093/hmg/10.24.2783; Britsch S, 1998, GENE DEV, V12, P1825, DOI 10.1101/gad.12.12.1825; Campbell-Thompson M, 2001, J ENDOCRINOL, V171, P65, DOI 10.1677/joe.0.1710065; Carroll JS, 2005, CELL, V122, P33, DOI 10.1016/j.cell.2005.05.008; Carvalho B, OLIGOCLASSES CLASSES; Carvalho B, PD GENOMEWIDESNP 6 P; de Pontual L, 2007, HUM MUTAT, V28, P790, DOI 10.1002/humu.20517; Emison ES, 2005, NATURE, V434, P857, DOI 10.1038/nature03467; Gabriel SB, 2002, NAT GENET, V31, P89, DOI 10.1038/ng868; Garcia-Barcelo MM, 2009, P NATL ACAD SCI USA, V106, P2694, DOI 10.1073/pnas.0809630105; Gershon Michael D, 2004, Semin Pediatr Surg, V13, P224, DOI 10.1053/j.sempedsurg.2004.10.019; Gershon MD, 2010, TRENDS NEUROSCI, V33, P446, DOI 10.1016/j.tins.2010.06.002; Heanue TA, 2006, P NATL ACAD SCI USA, V103, P6919, DOI 10.1073/pnas.0602152103; Herbarth B, 1998, P NATL ACAD SCI USA, V95, P5161, DOI 10.1073/pnas.95.9.5161; Jiang Y, 2003, DEV BIOL, V258, P364, DOI 10.1016/S0012-1606(03)00136-2; Kazeem GR, 2005, ANN HUM GENET, V69, P329, DOI 10.1046/j.1529-8817.2005.00156.x; Kerstann KF, 2004, GENET EPIDEMIOL, V27, P240, DOI 10.1002/gepi.20019; Korbel JO, 2009, P NATL ACAD SCI USA, V106, P12031, DOI 10.1073/pnas.0813248106; Lin Y, 2008, BIOINFORMATICS, V24, P2665, DOI 10.1093/bioinformatics/btn509; Liu GF, 2009, P NATL ACAD SCI USA, V106, P2951, DOI 10.1073/pnas.0811083106; Liu Y, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-S5-S4; Locke AE, 2010, GENET EPIDEMIOL, V34, P613, DOI 10.1002/gepi.20518; Luzon-Toro B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036524; Ly A, 2008, CELL, V133, P1241, DOI 10.1016/j.cell.2008.05.030; McCallion AS, 2003, COLD SPRING HARB SYM, V68, P373, DOI 10.1101/sqb.2003.68.373; Moore SW, J PEDIAT SURG, V47, P299; Nielsen DM, 1998, AM J HUM GENET, V63, P1531, DOI 10.1086/302114; Okamoto N, 2004, J HUM GENET, V49, P334, DOI 10.1007/s10038-004-0153-4; Okamoto N, 1997, J MED GENET, V34, P670, DOI 10.1136/jmg.34.8.670; Parisi MA, 2002, AM J MED GENET, V108, P51, DOI 10.1002/ajmg.10185; Peirano RI, 2000, NUCLEIC ACIDS RES, V28, P3047, DOI 10.1093/nar/28.16.3047; Peirano RI, 2000, MOL CELL BIOL, V20, P3198, DOI 10.1128/MCB.20.9.3198-3209.2000; PUFFENBERGER EG, 1994, HUM MOL GENET, V3, P1217; Southard-Smith EM, 1998, NAT GENET, V18, P60, DOI 10.1038/ng0198-60; St-Laurent V, 2005, J STEROID BIOCHEM, V94, P23, DOI 10.1016/j.jsbmb.2005.02.001; Stine ZE, HUMAN MOL GENETICS, V20, P3746; Tang CSM, 2012, HUM GENET, V131, P67, DOI 10.1007/s00439-011-1035-4; Wallace AS, 2010, NEUROBIOL DIS, V40, P622, DOI 10.1016/j.nbd.2010.08.006; Xu ZY, 2004, GENET EPIDEMIOL, V26, P125, DOI 10.1002/gepi.10302; Yamakawa K, 1998, HUM MOL GENET, V7, P227, DOI 10.1093/hmg/7.2.227	46	14	14	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2013	8	5							e62519	10.1371/journal.pone.0062519	http://dx.doi.org/10.1371/journal.pone.0062519			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	177QL	23671607	Green Submitted, Green Published, gold			2022-12-27	WOS:000321390200027
J	Nel, R; Punt, AE; Hughes, GR				Nel, Ronel; Punt, Andre E.; Hughes, George R.			Are Coastal Protected Areas Always Effective in Achieving Population Recovery for Nesting Sea Turtles?	PLOS ONE			English	Article							PELAGIC LONGLINE FISHERY; DERMOCHELYS-CORIACEA; LEATHERBACK TURTLES; CHELONIA-MYDAS; INDIAN-OCEAN; BYCATCH; PACIFIC; MANAGEMENT; ALBATROSSES; BENEFITS	Sea turtles are highly migratory and usually dispersed, but aggregate off beaches during the nesting season, rendering them vulnerable to coastal threats. Consequently, coastal Marine Protection Areas (MPAs) have been used to facilitate the recovery of turtle populations, but the effectiveness of these programs is uncertain as most have been operating for less than a single turtle generation (or<20 yr). South Africa, however, hosts one of the longest running conservation programs, protecting nesting loggerhead (Caretta caretta) and leatherback (Dermochelys coriacea) turtles since 1963 in a series of coastal MPAs. This provides a unique opportunity to evaluate the long-term effect of spatial protection on the abundance of two highly migratory turtle species with different life history characteristics. Population responses were assessed by modeling the number of nests over time in an index area (13 km) and an expanded monitoring area (53 km) with varying survey effort. Loggerhead abundance increased dramatically from similar to 250 to>1700 nests pa (index area) especially over the last decade, while leatherback abundance increased initially similar to 10 to 70 nests pa (index area), but then stabilized. Although leatherbacks have higher reproductive output per female and comparable remigration periods and hatching success to loggerheads, the leatherback population failed to expand. Our results suggest that coastal MPAs can work but do not guarantee the recovery of sea turtle populations as pressures change over time. Causes considered for the lack of population growth include factors in the MPA (expansion into unmonitored areas or incubation environment) of outside of the MPA (including carrying capacity and fishing mortality). Conservation areas for migratory species thus require careful design to account for species-specific needs, and need to be monitored to keep track of changing pressures.	[Nel, Ronel] Nelson Mandela Metropolitan Univ, Dept Zool, Port Elizabeth, South Africa; [Punt, Andre E.] Univ Washington, Sch Aquat & Fishery Sci, Seattle, WA 98195 USA; [Hughes, George R.] Retired Conservator, Howick, South Africa	Nelson Mandela University; University of Washington; University of Washington Seattle	Nel, R (corresponding author), Nelson Mandela Metropolitan Univ, Dept Zool, Port Elizabeth, South Africa.	Ronel.Nel@nmmu.ac.za		Punt, Andre/0000-0001-8489-2488	South African National Research Foundation/Thuthuka grant; Nelson Mandela Metropolitan University, Port Elizabeth	South African National Research Foundation/Thuthuka grant; Nelson Mandela Metropolitan University, Port Elizabeth	RN was funded by the South African National Research Foundation/Thuthuka grant (www.nrf.ac.za) and a Faculty Grant from Nelson Mandela Metropolitan University, Port Elizabeth. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker GB, 2002, EMU, V102, P71, DOI 10.1071/MU01036; Balazs GH, 2004, MAR BIOL, V145, P1043, DOI 10.1007/s00227-004-1387-6; Baldwin R, 2003, LOGGERHEAD SEA TURTL, P218; Beare D, 2010, NATURWISSENSCHAFTEN, V97, P797, DOI 10.1007/s00114-010-0696-5; Boonzaaier MK, 2011, THESIS N MANDELA MET, P111; Botha M, 2010, THESIS N MANDELA MET, P122; Botsford LW, 2009, REV FISH BIOL FISHER, V19, P69, DOI 10.1007/s11160-008-9092-z; Bourjea J., 2008, Western Indian Ocean Journal of Marine Science, V7, P137; Brazier W, 2012, AFR J MAR SCI, V34, P249, DOI 10.2989/1814232X.2012.709967; Carroll E, 2011, MAR ECOL PROG SER, V432, P257, DOI 10.3354/meps09145; Chaloupka M, 2001, BIOL CONSERV, V102, P235, DOI 10.1016/S0006-3207(01)00106-9; Couturier LIE, 2011, MAR FRESHWATER RES, V62, P628, DOI 10.1071/MF10148; Crawford RJM, 2007, ICES J MAR SCI, V64, P570, DOI 10.1093/icesjms/fsm009; Donlan CJ, 2010, CONSERV BIOL, V24, P1586, DOI 10.1111/j.1523-1739.2010.01541.x; Donoso M, 2010, BIOL CONSERV, V143, P2672, DOI 10.1016/j.biocon.2010.07.011; Dunn DC, 2011, FISH FISH, V12, P110, DOI 10.1111/j.1467-2979.2010.00388.x; Dutton DL, 2005, BIOL CONSERV, V126, P186, DOI 10.1016/j.biocon.2005.05.013; Fennessy ST, 2007, AFR J MAR SCI, V29, P453, DOI 10.2989/AJMS.2007.29.3.12.342; Fossette S, 2008, J EXP MAR BIOL ECOL, V356, P69, DOI 10.1016/j.jembe.2007.12.024; Gaspar P, 2012, MARINE ECOLOGY PROGR; Godley BJ, 2001, BIOL CONSERV, V97, P151, DOI 10.1016/S0006-3207(00)00107-5; Halpern BS, 2003, P ROY SOC B-BIOL SCI, V270, P1871, DOI 10.1098/rspb.2003.2405; Hays GC, 2004, TRENDS ECOL EVOL, V19, P349, DOI 10.1016/j.tree.2004.05.009; Hays GC, 2003, GLOBAL CHANGE BIOL, V9, P642, DOI 10.1046/j.1365-2486.2003.00606.x; Hilborn R, 2004, OCEAN COAST MANAGE, V47, P197, DOI 10.1016/j.ocecoaman.2004.04.001; Hinch PR, 2011, MAR POLICY, V35, P163, DOI 10.1016/j.marpol.2010.09.002; Hughes G.R., 1975, Lammergeyer, VNo. 22, P9; Hughes G.R., 1989, P230; Hughes G.R., 1972, Lammergeyer, V17, P40; HUGHES G. R., 1967, LAMMERGEYER, V7, P55; Hughes G.R., 1980, P288; Hughes G.R., 1967, LAMMERGEYER, V7, P5; Hughes G.R., 1974, SEA TURTLES S E AFRI; Hughes George R., 1996, Chelonian Conservation and Biology, V2, P153; Humber F, 2011, ANIM CONSERV, V14, P175, DOI 10.1111/j.1469-1795.2010.00413.x; Ismar SMH, 2011, WILSON J ORNITHOL, V123, P121, DOI 10.1676/10-072.1; Jensen OP, 2010, PROG OCEANOGR, V86, P176, DOI 10.1016/j.pocean.2010.04.020; Jorgensen SJ, 2010, P ROY SOC B-BIOL SCI, V277, P679, DOI 10.1098/rspb.2009.1155; Koldewey HJ, 2010, MAR POLLUT BULL, V60, P1906, DOI 10.1016/j.marpolbul.2010.10.002; Lauret-Stepler M., 2007, Endangered Species Research, V3, P217, DOI 10.3354/esr003217; Lewison RL, 2007, CONSERV BIOL, V21, P79, DOI 10.1111/j.1523-1739.2006.00592.x; Louzao M, 2011, J APPL ECOL, V48, P121, DOI 10.1111/j.1365-2664.2010.01910.x; Luschi P, 2006, S AFR J SCI, V102, P51; Luschi P, 2003, P ROY SOC B-BIOL SCI, V270, pS129, DOI 10.1098/rsbl.2003.0036; Lynam CP, 2006, CURR BIOL, V16, pR492, DOI 10.1016/j.cub.2006.06.018; Mackley EK, 2010, MAR ECOL PROG SER, V406, P291, DOI 10.3354/meps08532; MAXWELL JA, 1988, S AFR J ZOOL, V23, P342; McAllister HJ, 1965, LAMMERGEYER, V3, P12; McClellan CM, 2009, ECOL APPL, V19, P1660, DOI 10.1890/08-1091.1; Micheli F, 2004, ECOL APPL, V14, P1709, DOI 10.1890/03-5260; Mortimer J.A., 1985, Oryx, V19, P146; Mortimer J. A., 2000, MARINE COASTAL PROTE, P327; Nada M, 2011, ORYX, V45, P143, DOI 10.1017/S0030605310001286; Nel DC, 2002, POLAR BIOL, V25, P81, DOI 10.1007/s003000100315; Nel R, 2010, SEA TURTLES KWAZULU; Okkonen SR, 2011, REMOTE SENS ENVIRON, V115, P2168, DOI 10.1016/j.rse.2011.04.024; Peckham SH, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001041; Perrault JR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031841; Petersen SL, 2009, AFR J MAR SCI, V31, P87, DOI 10.2989/AJMS.2009.31.1.8.779; Piatt JF, 2006, DEEP-SEA RES PT II, V53, P387, DOI 10.1016/j.dsr2.2006.01.008; Pike DA, 2008, BIOL LETTERS, V4, P704, DOI 10.1098/rsbl.2008.0359; Plug I, 2004, S AFR J SCI, V100, P151; Rakotonirina Berthin, 1994, Oryx, V28, P51; Spotila JR, 2000, NATURE, V405, P529, DOI 10.1038/35014729; Steckenreuter A, 2010, CHELONIAN CONSERV BI, V9, P123, DOI 10.2744/CCB-0763.1; Stewart K, 2011, ECOL APPL, V21, P263, DOI 10.1890/09-1838.1; Thorson JT, 2012, J APPL ECOL, V49, P601, DOI 10.1111/j.1365-2664.2012.02143.x; Tomillo PS, 2008, CONSERV BIOL, V22, P1216, DOI 10.1111/j.1523-1739.2008.00987.x; Tomillo PS, 2009, MAR BIOL, V156, P2021, DOI 10.1007/s00227-009-1234-x; Tuck GN, 2001, J APPL ECOL, V38, P1182, DOI 10.1046/j.0021-8901.2001.00661.x; Van Houtan KS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019043; Videira EJS, 2011, ANN REP 2010 11 AICM; Wakefield ED, 2011, ECOL MONOGR, V81, P141, DOI 10.1890/09-0763.1; Walker Ryan C.J., 2005, Western Indian Ocean Journal of Marine Science, V4, P219; Wallace BP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024510; Wallace BP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015465; Witt MJ, 2009, BIOL CONSERV, V142, P1719, DOI 10.1016/j.biocon.2009.03.009; Wood S, 2017, GEN ADDITIVE MODELS, DOI 10.1201/9781315370279; WOOD VE, 1986, BIOL CONSERV, V37, P321, DOI 10.1016/0006-3207(86)90076-5; Zbinden Judith A., 2007, Endangered Species Research, V3, P305, DOI 10.3354/esr00058	80	44	45	0	76	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2013	8	5							e63525	10.1371/journal.pone.0063525	http://dx.doi.org/10.1371/journal.pone.0063525			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175AS	23671683	gold, Green Submitted, Green Published			2022-12-27	WOS:000321202100071
J	Du, X; Zhu, YJ; Song, Y; Li, TM; Luo, T; Sun, G; Yang, CG; Cao, CM; Lu, Y; Li, M				Du, Xin; Zhu, Yuanjun; Song, Yan; Li, Tianming; Luo, Tao; Sun, Gang; Yang, Chongguang; Cao, Cuiming; Lu, Yuan; Li, Min			Molecular Analysis of Staphylococcus epidermidis Strains Isolated from Community and Hospital Environments in China	PLOS ONE			English	Article							CATABOLIC MOBILE ELEMENT; COAGULASE-NEGATIVE STAPHYLOCOCCI; ACME-ARCA GENE; METHICILLIN-RESISTANT; ANTIMICROBIAL RESISTANCE; BIOFILM FORMATION; AUREUS; SEQUENCE; MEC; INFECTIONS	Background: Staphylococcus epidermidis is a common cause of nosocomial infections worldwide. This study analyzed the differences in genetic endowment and clonal lineages with pathogenesis and resistance traits of S. epidermidis isolates collected from community and hospital environments (patients and healthcare staff) of the same ecological niche, time period, and geographical location in China. Methodology/Principal Findings: Molecular epidemiology and population analysis showed that nasal colonization rates of S. epidermidis in the community of Shanghai area of China and in healthcare personnel were 44.8% (methicillin-resistant S. epidermidis, MRSE: 17.2%) and 61.3% (MRSE: 30.0%), respectively. 86.7% of clinical isolates were MRSE. Among the strains studied, 44 sequence types (STs) were identified with 91.7% belonging to clonal complex 2 (CC2). Only 40.8% isolates from patients were also found in healthy individuals. MRSE-ST2-SCCmecIII was the predominant clone in clinical isolates, almost resistant to all antibiotics tested. Biofilm-related genes IS256 and icaA were detected in majority of the predominant clinical MRSE-ST2 clone with a 40.5% biofilm-positive rate. No ST2 isolate was found in community setting. We found a high prevalence of arginine catabolic mobile element (ACME) (74.1%). The prevalence of ACME-arc and ACME-opp3 clusters was 71.6% and 32.4%, respectively. Methicillin-sensitive S. epidermidis (MSSE) isolates harbored more ACME (83.3%) than MRSE isolates (67.7%), and there was no association between ACME and SCCmec types. An association was found between low-level ACME presence and invasive infections. Conclusions/Significance: We observed a high level of diversity within S. epidermidis in this study, with CC2 as the dominant clonal complex in both community and hospital settings. Only 40.8% of the isolates from patients were also found in healthy individuals. Contrary to that biofilm formation and multiple antibiotic resistance were associated closely with pathogenicity of S. epidermidis, ACME was more likely to be an indicator for colonization rather than a virulence factor.	[Du, Xin; Zhu, Yuanjun; Song, Yan; Li, Tianming; Lu, Yuan; Li, Min] Fudan Univ, Shanghai Med Coll, Huashan Hosp, Dept Lab Med, Shanghai 200433, Peoples R China; [Luo, Tao; Sun, Gang; Yang, Chongguang] Fudan Univ, Key Lab Med Mol Virol, Inst Biomed Sci, Shanghai 200433, Peoples R China; [Luo, Tao; Sun, Gang; Yang, Chongguang] Fudan Univ, Inst Med Microbiol, Shanghai 200433, Peoples R China; [Cao, Cuiming] Shandong Univ, Jinan Cent Hosp, Dept Lab Med, Jinan 250100, Shandong, Peoples R China	Fudan University; Fudan University; Fudan University; Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong University	Lu, Y (corresponding author), Fudan Univ, Shanghai Med Coll, Huashan Hosp, Dept Lab Med, Shanghai 200433, Peoples R China.	yuanlu@hsh.stn.sh.cn; ruth_limin124@yahoo.com	Du, Xin/ABD-4327-2022; Yang, Chongguang/N-3298-2016; Du, Xin/AAG-4635-2022; Yang, Chongguang/S-9117-2019; , 罗涛/AHA-1191-2022	Du, Xin/0000-0002-6907-3609; Yang, Chongguang/0000-0001-8109-4974; Du, Xin/0000-0002-6907-3609; Yang, Chongguang/0000-0001-8109-4974; 	National Natural Science Foundation of China [30900026, 81171623, 812111033]; Outstanding Young Talent Plan of Shanghai [2011039]; Ming Dao Plan of Fudan University [MDJH2012016]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Outstanding Young Talent Plan of Shanghai; Ming Dao Plan of Fudan University	This study was supported by a grant from the National Natural Science Foundation of China (grants 30900026, 81171623 and 812111033), Outstanding Young Talent Plan of Shanghai (2011039) and Ming Dao Plan of Fudan University (MDJH2012016). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbier F, 2011, J ANTIMICROB CHEMOTH, V66, P29, DOI 10.1093/jac/dkq410; Bogado I, 2002, INFECT CONT HOSP EP, V23, P447, DOI 10.1086/502083; Conlon KM, 2004, J BACTERIOL, V186, P6208, DOI 10.1128/JB.186.18.6208-6219.2004; Cuevas O, 2004, ANTIMICROB AGENTS CH, V48, P4240, DOI 10.1128/AAC.48.11.4240-4245.2004; Diep BA, 2006, LANCET, V367, P731, DOI 10.1016/S0140-6736(06)68231-7; Diep BA, 2008, J INFECT DIS, V197, P1523, DOI 10.1086/587907; Ellington MJ, 2008, J ANTIMICROB CHEMOTH, V61, P73, DOI 10.1093/jac/dkm422; Galdbart JO, 1999, J CLIN MICROBIOL, V37, P1306, DOI 10.1128/JCM.37.5.1306-1312.1999; Goering RV, 2007, J CLIN MICROBIOL, V45, P1981, DOI 10.1128/JCM.00273-07; Gotz F, 2002, MOL MICROBIOL, V43, P1367, DOI 10.1046/j.1365-2958.2002.02827.x; Granslo HN, 2010, PEDIATR RES, V68, P237, DOI [10.1203/PDR.0b013e3181eb01e0, 10.1203/00006450-201011001-00463]; Hall-Stoodley L, 2004, NAT REV MICROBIOL, V2, P95, DOI 10.1038/nrmicro821; Ito T, 2009, ANTIMICROB AGENTS CH, V53, P4961, DOI 10.1128/AAC.00579-09; Jamaluddin TZMT, 2008, J CLIN MICROBIOL, V46, P3778, DOI 10.1128/JCM.02262-07; Kondo Y, 2007, ANTIMICROB AGENTS CH, V51, P264, DOI 10.1128/AAC.00165-06; Kozitskaya S, 2005, J CLIN MICROBIOL, V43, P4751, DOI 10.1128/JCM.43.9.4751-4757.2005; Kuehnert MJ, 2006, J INFECT DIS, V193, P172, DOI 10.1086/499632; Li M, 2009, J MED MICROBIOL, V58, P456, DOI 10.1099/jmm.0.007567-0; Maki H, 1997, J BACTERIOL, V179, P6944, DOI 10.1128/jb.179.22.6944-6948.1997; Miragaia M, 2007, J BACTERIOL, V189, P2540, DOI 10.1128/JB.01484-06; Miragaia M, 2005, MICROB DRUG RESIST, V11, P83, DOI 10.1089/mdr.2005.11.83; Miragaia M, 2002, J CLIN MICROBIOL, V40, P430, DOI 10.1128/JCM.40.2.430-438.2002; Miragaia M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007722; Nikbakht M, 2008, J HOSP INFECT, V69, P46, DOI 10.1016/j.jhin.2008.01.034; Nunes APF, 2005, J HOSP INFECT, V59, P19, DOI 10.1016/j.jhin.2004.07.021; Otto M, 2009, NAT REV MICROBIOL, V7, P555, DOI 10.1038/nrmicro2182; Pi BR, 2009, J MED MICROBIOL, V58, P731, DOI 10.1099/jmm.0.007351-0; Iorio NLP, 2012, DIAGN MICR INFEC DIS, V72, P32, DOI 10.1016/j.diagmicrobio.2011.09.017; Robinson DA, 2003, ANTIMICROB AGENTS CH, V47, P3926, DOI 10.1128/AAC.47.12.3926-3934.2003; Rogers KL, 2009, INFECT DIS CLIN N AM, V23, P73, DOI 10.1016/j.idc.2008.10.001; Rolo J, 2012, J ANTIMICROB CHEMOTH, V67, P1333, DOI 10.1093/jac/dks068; Shore AC, 2011, ANTIMICROB AGENTS CH, V55, P3765, DOI 10.1128/AAC.00187-11; Silva FR, 2001, EPIDEMIOL INFECT, V127, P57, DOI 10.1017/S095026880100574X; Thomas JC, 2007, J CLIN MICROBIOL, V45, P616, DOI 10.1128/JCM.01934-06; von Eiff C, 2002, LANCET INFECT DIS, V2, P677, DOI 10.1016/S1473-3099(02)00438-3; Wang L, 2008, J INFECT DIS, V197, P1254, DOI 10.1086/586714; Widerstrom M, 2012, J CLIN MICROBIOL, V50, P2147, DOI 10.1128/JCM.06456-11; Ziebuhr W, 2006, INT J ANTIMICROB AG, V28, pS14, DOI 10.1016/j.ijantimicag.2006.05.012	38	65	67	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2013	8	5							e62742	10.1371/journal.pone.0062742	http://dx.doi.org/10.1371/journal.pone.0062742			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145RZ	23675424	Green Published, gold, Green Submitted			2022-12-27	WOS:000319036100011
J	Labrique, AB; Zaman, K; Hossain, Z; Saha, P; Yunus, M; Hossain, A; Ticehurst, J; Kmush, B; Nelson, KE				Labrique, Alain B.; Zaman, K.; Hossain, Zahid; Saha, Parimalendu; Yunus, Mohammad; Hossain, Anowar; Ticehurst, John; Kmush, Brittany; Nelson, Kenrad E.			An Exploratory Case Control Study of Risk Factors for Hepatitis E in Rural Bangladesh	PLOS ONE			English	Article							E VIRUS-INFECTION; ACUTE SPORADIC HEPATITIS; WEST KALIMANTAN BORNEO; PHYLOGENETIC ANALYSIS; VIRAL-HEPATITIS; HIGH PREVALENCE; BLOOD-DONORS; SOUTH-INDIA; TRANSMISSION; ANTIBODIES	Hepatitis E virus (HEV) is the major cause of epidemic and sporadic hepatitis globally. Outbreaks are associated with fecal contamination of drinking water, yet the environmental reservoir of HEV between epidemics remains unclear. In contrast to neighboring countries, where epidemics and sporadic disease co-occur, HEV-endemic communities in rural Bangladesh seldom report outbreaks; sporadic hepatitis E is reported from urban and rural areas of the country. Besides typical enteric risk factors, other routes for HEV infection and disease are unclear. We conducted monthly household surveillance of a southern Bangladeshi community of 23,500 people to find incident cases of acute hepatitis E over a 22 month period. An algorithm was used to capture 279 candidate cases, of which 46 were confirmed acute HEV infections. An exploratory case-control study was conducted to identify putative risk factors for disease. Nearly 70% of cases were over 15 years old. Female gender seemed protective (OR: 0.34) against hepatitis E in this conservative setting, as was the use of sanitary latrines (OR: 0.28). Socioeconomic status or animal exposures were not significant predictors of disease, although outdoor employment and recent urban travel were. Unexpectedly, recent contact with a "jaundiced" patient and a history of injection exposure in the 3 months prior to disease (OR: 15.50) were significant. Susceptible individuals from "endemic" communities share similar enteric exposure risks to those commonly associated with tourists from non-endemic countries. This study also raises the novel possibility of parenteral and person-to-person transmission of HEV in non-epidemic, sporadic disease settings.	[Labrique, Alain B.; Kmush, Brittany] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD 21205 USA; [Zaman, K.; Hossain, Zahid; Saha, Parimalendu; Yunus, Mohammad; Hossain, Anowar] Icddr B, Dhaka, Bangladesh; [Ticehurst, John] Johns Hopkins Sch Med, Dept Pathol, Baltimore, MD USA; [Labrique, Alain B.; Nelson, Kenrad E.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; International Centre for Diarrhoeal Disease Research (ICDDR); Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Labrique, AB (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD 21205 USA.	alabriqu@jhsph.edu	Kmush, Brittany L/O-5329-2019	Kmush, Brittany L/0000-0003-2143-7554; Labrique, Alain/0000-0003-2502-7819; Hossain, Mohammad Zahid/0000-0003-0511-4085; Ticehurst, John/0000-0002-7137-8495; Yunus, Mohammed/0000-0003-1116-4978	National Institutes of Health (NIH) [AI51/31/2004]	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was conducted under an R01 grant AI51/31/2004 from the National Institutes of Health (NIH). Additional support was provided in kind (HAV, HBV, HCV, and HEV antibody testing of study specimens) by the Armed Forces Research Institute of Medical Sciences (AFRIMS), a special foreign activity of the Walter Reed Army Institute of Research (WRAIR) in Bangkok, Thailand. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGGARWAL R, 1994, J HEPATOL, V21, P718, DOI 10.1016/S0168-8278(94)80229-7; Ahmed M, 2009, INDIAN J MED MICROBI, V27, P48; Arankalle VA, 2001, J VIRAL HEPATITIS, V8, P293, DOI 10.1046/j.1365-2893.2001.00279.x; ARANKALLE VA, 1995, J INFECT DIS, V171, P447, DOI 10.1093/infdis/171.2.447; Arankalle VA, 2001, J VIRAL HEPATITIS, V8, P223, DOI 10.1046/j.1365-2893.2001.00290.x; Arankalle VA, 2003, J MED VIROL, V69, P391, DOI 10.1002/jmv.10301; Arankalle VA, 1999, J VIRAL HEPATITIS, V6, P161, DOI 10.1046/j.1365-2893.1999.00141.x; Arora NK, 1996, J MED VIROL, V48, P215, DOI 10.1002/(SICI)1096-9071(199603)48:3&lt;215::AID-JMV1&gt;3.0.CO;2-B; Baylis SA, 2010, VOX SANG, V98, P479, DOI 10.1111/j.1423-0410.2009.01258.x; Boccia D, 2006, CLIN INFECT DIS, V42, P1679, DOI 10.1086/504322; Chauhan Naresh T, 2010, Indian J Community Med, V35, P294, DOI 10.4103/0970-0218.66864; Clayson ET, 1997, J INFECT DIS, V176, P763, DOI 10.1086/517296; CLAYSON ET, 1995, J INFECT DIS, V172, P927, DOI 10.1093/infdis/172.4.927; Colson P, 2010, J INFECT DIS, V202, P825, DOI 10.1086/655898; CORWIN A, 1995, T ROY SOC TROP MED H, V89, P262, DOI 10.1016/0035-9203(95)90529-4; Corwin A, 1997, AM J TROP MED HYG, V57, P62, DOI 10.4269/ajtmh.1997.57.62; Corwin AL, 1996, AM J TROP MED HYG, V54, P559, DOI 10.4269/ajtmh.1996.54.559; Corwin AL, 1999, T ROY SOC TROP MED H, V93, P255, DOI 10.1016/S0035-9203(99)90014-7; Dilawari J B, 1994, Indian J Gastroenterol, V13, P44; Echevarria JM, 2010, J CLIN VIROL; Emerson SU, 2003, REV MED VIROL, V13, P145, DOI 10.1002/rmv.384; Faveau V, 1994, MATLAB WOMEN CHILDRE; Guo QS, 2010, J CLIN MICROBIOL, V48, P317, DOI 10.1128/JCM.01466-09; Gupta R S, 1995, J Commun Dis, V27, P175; Hau CH, 1999, AM J TROP MED HYG, V60, P277, DOI 10.4269/ajtmh.1999.60.277; Health and DemographicSurveillance System-Matlab, 2006, REG HLTH DEM EV 2004; Hossain Z, 2006, 8 CAPGAN COMM C DIAR; Innis BL, 2002, CLIN DIAGN LAB IMMUN, V9, P639, DOI 10.1128/CDLI.9.3.639-648.2002; Jameel S, 1999, Expert Rev Mol Med, V1999, P1, DOI 10.1017/S1462399499001271; Khan WI, 2000, ASIAN PAC J ALLERGY, V18, P99; Labrique A, 2007, THESIS J HOPKINS U B; Labrique AB, 1999, EPIDEMIOL REV, V21, P162, DOI 10.1093/oxfordjournals.epirev.a017994; Labrique AB, 2010, EMERG INFECT, V9, P53; Labrique AB, 2010, AM J EPIDEMIOL, V172, P952, DOI 10.1093/aje/kwq225; Labrique AB, 2009, AM J TROP MED HYG, V81, P875, DOI 10.4269/ajtmh.2009.09-0352; LONGER CF, 1994, EPIDEMIOLOGY HEPATIT, P409; Lu L, 2006, REV MED VIROL, V16, P5, DOI 10.1002/rmv.482; Maine D, 1996, STUD FAMILY PLANN, V27, P179, DOI 10.2307/2137952; Malathi S, 1998, J TROP PEDIATRICS, V44, P275, DOI 10.1093/tropej/44.5.275; Mast EE, 1998, HEPATOLOGY, V27, P857, DOI 10.1002/hep.510270331; Mathur P, 2001, Indian Pediatr, V38, P461; Matlab HDSS, 2009, SR106 MATL HDSS; Matsuda H, 2003, J INFECT DIS, V188, P944, DOI 10.1086/378074; Meng XJ, 1997, P NATL ACAD SCI USA, V94, P9860, DOI 10.1073/pnas.94.18.9860; Myint KSA, 2006, T ROY SOC TROP MED H, V100, P938, DOI 10.1016/j.trstmh.2005.12.005; NAIDU S S, 1957, Indian J Med Res, V45, P71; NANDA SK, 1995, GASTROENTEROLOGY, V108, P225, DOI 10.1016/0016-5085(95)90028-4; Purcell Robert H, 2010, J Infect Dis, V202, P819, DOI 10.1086/655900; Rab MA, 1997, AM J TROP MED HYG, V57, P151, DOI 10.4269/ajtmh.1997.57.151; Seriwatana J, 2002, CLIN DIAGN LAB IMMUN, V9, P1072, DOI 10.1128/CDLI.9.5.1072-1078.2002; Sheikh A, 2002, AM J TROP MED HYG, V66, P721, DOI 10.4269/ajtmh.2002.66.721; Shrestha MP, 2007, NEW ENGL J MED, V356, P895, DOI 10.1056/NEJMoa061847; Shukla P, 2007, J VIRAL HEPATITIS, V14, P310, DOI 10.1111/j.1365-2893.2006.00815.x; Siddiqui AR, 2005, CLIN INFECT DIS, V40, P908, DOI 10.1086/428357; Singh Jagvir, 1995, Journal of Communicable Diseases, V27, P92; Somani SK, 2003, J VIRAL HEPATITIS, V10, P446, DOI 10.1046/j.1365-2893.2003.00458.x; Stoszek SK, 2006, T ROY SOC TROP MED H, V100, P95, DOI 10.1016/j.trstmh.2004.12.005; Stoszek SK, 2006, T ROY SOC TROP MED H, V100, P89, DOI 10.1016/j.trstmh.2005.05.019; Streatfield PK, 2005, HLTH DEMOGRAPHIC SUR; Tei S, 2003, LANCET, V362, P371, DOI 10.1016/S0140-6736(03)14025-1; Teshale EH, 2010, CLIN INFECT DIS, V50, P1006, DOI 10.1086/651077; TICEHURST JR, 1999, MANUAL CLIN MICROBIO, P1057; Toyoda K, 2008, J GASTROEN HEPATOL, V23, P1885, DOI 10.1111/j.1440-1746.2008.05568.x; TSAREV SA, 1994, J MED VIROL, V43, P135, DOI 10.1002/jmv.1890430207; VANGINNIKEN J, 1998, HLTH DEMOGRAPHIC SUR; Wibawa IDN, 2004, J MED VIROL, V73, P38, DOI 10.1002/jmv.20059; Wu JC, 1998, HEPATOLOGY, V27, P1415, DOI 10.1002/hep.510270532; Zhu FC, 2010, LANCET, V376, P895, DOI 10.1016/S0140-6736(10)61030-6; Zijlstra JG, 1997, LANCET, V350, P289, DOI 10.1016/S0140-6736(05)62253-2	69	26	26	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2013	8	5							e61351	10.1371/journal.pone.0061351	http://dx.doi.org/10.1371/journal.pone.0061351			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145RZ	23675410	gold, Green Published, Green Submitted			2022-12-27	WOS:000319036100001
J	Lin, YY; Jean, YH; Lee, HP; Chen, WF; Sun, YM; Su, JH; Lu, Y; Huang, SY; Hung, HC; Sung, PJ; Sheu, JH; Wen, ZH				Lin, Yen-You; Jean, Yen-Hsuan; Lee, Hsin-Pai; Chen, Wu-Fu; Sun, Yu-Min; Su, Jui-Hsin; Lu, Yi; Huang, Shi-Ying; Hung, Han-Chun; Sung, Ping-Jyun; Sheu, Jyh-Horng; Wen, Zhi-Hong			A Soft Coral-Derived Compound, 11-epi-Sinulariolide Acetate Suppresses Inflammatory Response and Bone Destruction in Adjuvant-Induced Arthritis	PLOS ONE			English	Article							COLLAGEN-INDUCED ARTHRITIS; FIBROBLAST-LIKE SYNOVIOCYTES; RHEUMATOID-ARTHRITIS; CATHEPSIN-K; ANTIINFLAMMATORY CEMBRANOIDS; OSTEOCLAST DIFFERENTIATION; SINULARIA-QUERCIFORMIS; TRANSGENIC MICE; DOWN-REGULATION; JOINT DISEASE	In recent years, a significant number of metabolites with potent anti-inflammatory properties have been discovered from marine organisms, and several of these compounds are now under clinical trials. In the present study, we isolated 11-epi-sinulariolide acetate (Ya-s11), a cembrane-type compound with anti-inflammatory effects, from the Formosa soft coral Sinularia querciformis. Preliminary screening revealed that Ya-s11 significantly inhibited the expression of the proinflammatory proteins induced nitric oxide synthase and cyclooxygenase-2 in lipopolysaccharide-stimulated murine macrophages. We also examined the therapeutic effects of Ya-s11 on adjuvant-induced arthritis (AIA) in female Lewis rats, which demonstrate features similar to human rheumatoid arthritis (RA). Animal experiments revealed that Ya-s11 (subcutaneously 9 mg/kg once every 2 days from day 7 to day 28 postimmunization) significantly inhibited AIA characteristics. Moreover, Ya-s11 also attenuated protein expression of cathepsin K, matrix metalloproteinases-9 (MMP-9), tartrate-resistant acid phosphatase (TRAP), and tumor necrosis factor-alpha (TNF-alpha) in ankle tissues of AIA-rats. Based on its attenuation of the expression of proinflammatory proteins and disease progression in AIA rats, the marine-derived compound Ya-s11 may serve as a useful therapeutic agent for the treatment of RA.	[Lin, Yen-You; Lee, Hsin-Pai; Lu, Yi; Huang, Shi-Ying; Sheu, Jyh-Horng; Wen, Zhi-Hong] Natl Sun Yat Sen Univ, Dept Marine Biotechnol & Resources, Asia Pacific Ocean Res Ctr, Kaohsiung 80424, Taiwan; [Jean, Yen-Hsuan; Lee, Hsin-Pai] Pingtung Christian Hosp, Sect Orthoped Surg, Pingtung, Taiwan; [Chen, Wu-Fu] Chang Gung Univ, Coll Med, Kaohsiung Med Ctr, Dept Neurosurg,Chang Gung Mem Hosp, Kaohsiung, Taiwan; [Sun, Yu-Min; Hung, Han-Chun] Natl Sun Yat Sen Univ, Doctoral Degree Program Marine Biotechnol, Kaohsiung 80424, Taiwan; [Su, Jui-Hsin; Sung, Ping-Jyun] Natl Dong Hwa Univ, Grad Inst Marine Biotechnol, Pingtung, Taiwan; [Su, Jui-Hsin; Sung, Ping-Jyun] Natl Museum Marine Biol & Aquarium, Taiwan Coral Res Ctr, Pingtung, Taiwan	National Sun Yat Sen University; Chang Gung Memorial Hospital; Chang Gung University; National Sun Yat Sen University; National Dong Hwa University; National Museum of Marine Biology & Aquarium	Sheu, JH (corresponding author), Natl Sun Yat Sen Univ, Dept Marine Biotechnol & Resources, Asia Pacific Ocean Res Ctr, Kaohsiung 80424, Taiwan.	sheu@mail.nsysu.edu.tw; wzh@mail.nsysu.edu.tw	Sung, Ping-Jyun/Z-4162-2019; Hung, Han-Chun/A-9347-2010; Wen, Zhi-Hong/AAG-8034-2019; Sheu, Jyh-Horng/T-9521-2017	Hung, Han-Chun/0000-0002-0013-3247; Sheu, Jyh-Horng/0000-0002-1216-5991; Huang, Shi-Ying/0000-0002-0370-1553	National Science Council, Taiwan [NSC100-2325-B-110-001, NSC99-2313-B110-003-MY03]; Pingtung Christian Hospital, Taiwan	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); Pingtung Christian Hospital, Taiwan	This work was supported, in part, by grants from the National Science Council, Taiwan (NSC100-2325-B-110-001 and NSC99-2313-B110-003-MY03), and Pingtung Christian Hospital, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal SK, 2011, J MANAGE CARE PHARM, V17, pS3, DOI 10.18553/jmcp.2011.17.s9-b.S03; Baharav E, 2004, J NUTR, V134, P1964, DOI 10.1093/jn/134.8.1964; Cascao R, 2012, AUTOIMMUN REV, V11, P856, DOI 10.1016/j.autrev.2012.02.022; Chao CH, 2011, MAR DRUGS, V9, P1955, DOI 10.3390/md9101955; Chen WF, 2012, N-S ARCH PHARMACOL, V385, P265, DOI 10.1007/s00210-011-0710-2; Cheng SY, 2010, J NAT PROD, V73, P1184, DOI 10.1021/np100185a; Choi YH, 2012, ARCH PHARM RES, V35, P801, DOI 10.1007/s12272-012-0506-z; Conway JG, 2001, J PHARMACOL EXP THER, V298, P900; Cuzzocrea S, 2005, ARTHRITIS RHEUM-US, V52, P1929, DOI 10.1002/art.21044; Firestein GS, 2003, NATURE, V423, P356, DOI 10.1038/nature01661; Fujita K, 2012, IMMUNOL LETT, V144, P1, DOI 10.1016/j.imlet.2012.02.012; Gravallese EM, 2000, ARTHRITIS RHEUM, V43, P250, DOI 10.1002/1529-0131(200002)43:2<250::AID-ANR3>3.0.CO;2-P; Hah YS, 2010, ARTHRITIS RHEUM-US, V62, P2313, DOI 10.1002/art.27545; Hamade E, 2012, MED CHEM, V8, P401, DOI 10.2174/1573406411208030401; Hofkens W, 2011, J CONTROL RELEASE, V152, P363, DOI 10.1016/j.jconrel.2011.03.001; Hou WS, 2001, AM J PATHOL, V159, P2167, DOI 10.1016/S0002-9440(10)63068-4; Huang JL, 2011, EUR J PHARMACOL, V670, P304, DOI 10.1016/j.ejphar.2011.07.045; Ishida S, 2009, IMMUNOLOGY, V128, pe315, DOI 10.1111/j.1365-2567.2008.02965.x; Jean YH, 2008, EUR J PHARMACOL, V578, P323, DOI 10.1016/j.ejphar.2007.08.048; Kamel HN, 2005, PHARM BIOL, V43, P253, DOI 10.1080/13880200590928852; Kaneko M, 2001, RHEUMATOLOGY, V40, P247, DOI 10.1093/rheumatology/40.3.247; KASHMAN Y, 1977, ISRAEL J CHEM, V16, P1; Kim KC, 2005, ARCH PHARM RES, V28, P1257, DOI 10.1007/BF02978209; Kinne RW, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2333; Klein LE, 2005, CELL CYCLE, V4, P501, DOI 10.4161/cc.4.3.1550; Li QT, 2002, NAT REV IMMUNOL, V2, P725, DOI 10.1038/nri910; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Lu Y, 2008, J NAT PROD, V71, P1754, DOI 10.1021/np8003563; Lu Y, 2011, ARCH PHARM RES, V34, P1263, DOI 10.1007/s12272-011-0804-x; Lu Y, 2010, CHEM PHARM BULL, V58, P464, DOI 10.1248/cpb.58.464; Mayer AMS, 2011, COMP BIOCHEM PHYS C, V153, P191, DOI 10.1016/j.cbpc.2010.08.008; McInnes IB, 2007, NAT REV IMMUNOL, V7, P429, DOI 10.1038/nri2094; Morko J, 2005, ARTHRITIS RHEUM-US, V52, P3713, DOI 10.1002/art.21423; Niki Y, 2001, J CLIN INVEST, V107, P1127, DOI 10.1172/JCI11530; Noguchi M, 2005, EUR J PHARMACOL, V513, P229, DOI 10.1016/j.ejphar.2005.01.058; Noss EH, 2008, IMMUNOL REV, V223, P252, DOI 10.1111/j.1600-065X.2008.00648.x; Ochi Y, 2011, BONE, V49, P1351, DOI 10.1016/j.bone.2011.09.041; Ross MH, 2005, CONNECT TISSUE, P146; SANO H, 1992, J CLIN INVEST, V89, P97, DOI 10.1172/JCI115591; SATO A, 1985, TETRAHEDRON, V41, P4303, DOI 10.1016/S0040-4020(01)97201-1; Scott DL, 2003, CLIN EXP RHEUMATOL, V21, pS20; Shin HS, 2012, BIOSCI BIOTECH BIOCH, V76, P847, DOI 10.1271/bbb.110908; Shiota N, 2010, BRIT J PHARMACOL, V159, P626, DOI 10.1111/j.1476-5381.2009.00561.x; Shiozawa S, 2011, ARCH IMMUNOL THER EX, V59, P89, DOI 10.1007/s00005-011-0116-3; Su JH, 2012, ARCH PHARM RES, V35, P779, DOI 10.1007/s12272-012-0503-2; Su JH, 2011, MAR DRUGS, V9, P944, DOI 10.3390/md9060944; Svelander L, 2009, EUR J PHARMACOL, V613, P155, DOI 10.1016/j.ejphar.2009.03.074; Takahashi D, 2009, ARTHRITIS RHEUM-US, V60, P2372, DOI 10.1002/art.24718; Tow K, 2004, LAB INVEST, V84, P1092, DOI 10.1038/labinvest.3700132; Tsuboi H, 2003, ANN RHEUM DIS, V62, P196, DOI 10.1136/ard.62.3.196; Turull A, 2000, INFLAMMATION, V24, P533, DOI 10.1023/A:1007025423232; Yamashita A, 2002, J IMMUNOL, V168, P450, DOI 10.4049/jimmunol.168.1.450; Yang CR, 2010, SHOCK, V33, P662, DOI 10.1097/SHK.0b013e3181cc0738; YOCUM DE, 1986, ARTHRITIS RHEUM, V29, P262, DOI 10.1002/art.1780290215	54	20	21	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2013	8	5							e62926	10.1371/journal.pone.0062926	http://dx.doi.org/10.1371/journal.pone.0062926			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145RZ	23675440	Green Published, Green Submitted, gold			2022-12-27	WOS:000319036100021
J	Xiao, CL; Chen, XZ; Du, YL; Li, ZF; Wei, L; Zhang, G; He, QY				Xiao, Chuan-Le; Chen, Xiao-Zhou; Du, Yang-Li; Li, Zhe-Fu; Wei, Li; Zhang, Gong; He, Qing-Yu			Dispec: A Novel Peptide Scoring Algorithm Based on Peptide Matching Discriminability	PLOS ONE			English	Article							PROTEIN IDENTIFICATION; TANDEM; PROTEOMICS; DATABASE	Identifying peptides from the fragmentation spectra is a fundamental step in mass spectrometry (MS) data processing. The significance (discriminability) of every peak varies, providing additional information for potentially enhancing the identification sensitivity and the correct match rate. However this important information was not considered in previous algorithms. Here we presented a novel method based on Peptide Matching Discriminability (PMD), in which the PMD information of every peak reflects the discriminability of candidate peptides. In addition, we developed a novel peptide scoring algorithm Dispec based on PMD, by taking three aspects of discriminability into consideration: PMD, intensity discriminability and m/z error discriminability. Compared with Mascot and Sequest, Dispec identified remarkably more peptides from three experimental datasets with the same confidence at 1% PSM-level FDR. Dispec is also robust and versatile for various datasets obtained on different instruments. The concept of discriminability enhances the peptide identification and thus may contribute largely to the proteome studies. As an open-source program, Dispec is freely available at http://bioinformatics.jnu.edu.cn/software/dispec/.	[Xiao, Chuan-Le; Zhang, Gong; He, Qing-Yu] Jinan Univ, Coll Life Sci & Technol, Guangdong Higher Educ Inst, Key Lab Funct Prot Res,Inst Life & Hlth Engn, Guangzhou, Guangdong, Peoples R China; [Chen, Xiao-Zhou; Du, Yang-Li; Wei, Li] Yunnan Univ Nationalities, Sch Math & Comp Sci, Kunming, Peoples R China; [Li, Zhe-Fu] Jinan Univ, Network & Educ Technol Ctr, Guangzhou, Guangdong, Peoples R China	Jinan University; Yunnan Minzu University; Jinan University	Zhang, G (corresponding author), Jinan Univ, Coll Life Sci & Technol, Guangdong Higher Educ Inst, Key Lab Funct Prot Res,Inst Life & Hlth Engn, Guangzhou, Guangdong, Peoples R China.	zhanggong@jnu.edu.cn; tqyhe@jnu.edu.cn	He, Qing-Yu/H-7078-2014; Zhang, Gong/Q-7419-2017	He, Qing-Yu/0000-0003-0503-9492; Zhang, Gong/0000-0003-0418-3433	National "973" Projects of China [2011CB910700]; National Natural Science Foundation of China [31200612, 20871057]; Foundation for Distinguished Young Talents in Higher Education of Guangdong, China [2012LYM_0026]; Fundamental Research Funds for the Central Universities [11610101, 21611201]; Pearl River Rising Star of Science and Technology of Guangzhou City [2011048b]; "211" Projects	National "973" Projects of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Foundation for Distinguished Young Talents in Higher Education of Guangdong, China; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Pearl River Rising Star of Science and Technology of Guangzhou City; "211" Projects	This work was collectively supported by National "973" Projects of China (2011CB910700), National Natural Science Foundation of China (31200612 and 20871057), Foundation for Distinguished Young Talents in Higher Education of Guangdong, China (2012LYM_0026), the Fundamental Research Funds for the Central Universities (11610101 and 21611201)?"211" Projects and the Pearl River Rising Star of Science and Technology of Guangzhou City (2011048b). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chi H, 2010, J PROTEOME RES, V9, P2713, DOI 10.1021/pr100182k; Colinge J, 2007, PLOS COMPUT BIOL, V3, P1151, DOI 10.1371/journal.pcbi.0030114; Cox J., 2011, J PROTEOME RES; Craig R, 2004, BIOINFORMATICS, V20, P1466, DOI 10.1093/bioinformatics/bth092; Dagda Ruben K, 2010, J Proteomics Bioinform, V3, P39; Elias JE, 2005, NAT METHODS, V2, P667, DOI 10.1038/NMETH785; Elias JE, 2007, NAT METHODS, V4, P207, DOI 10.1038/nmeth1019; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Fu Y, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.000455; Geer LY, 2004, J PROTEOME RES, V3, P958, DOI 10.1021/pr0499491; Kall L, 2008, J PROTEOME RES, V7, P29, DOI 10.1021/pr700600n; Kapp EA, 2005, PROTEOMICS, V5, P3475, DOI 10.1002/pmic.200500126; KARAS M, 1988, ANAL CHEM, V60, P2299, DOI 10.1021/ac00171a028; Klimek J, 2008, J PROTEOME RES, V7, P96, DOI 10.1021/pr070244j; Li WZ, 2011, J PROTEOME RES, V10, P1593, DOI 10.1021/pr100959y; Matthiesen R, 2007, PROTEOMICS, V7, P2815, DOI 10.1002/pmic.200700116; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Ramakrishnan SR, 2009, BIOINFORMATICS, V25, P1397, DOI 10.1093/bioinformatics/btp168; Sun XS, 2011, OMICS, V15, P477, DOI 10.1089/omi.2010.0113; Tanner S, 2005, ANAL CHEM, V77, P4626, DOI 10.1021/ac050102d; Xiao CL, 2013, J PROTEOME RES, V12, P328, DOI 10.1021/pr300781t; Yadav AK, 2011, J PROTEOME RES, V10, P2154, DOI 10.1021/pr200031z; Zhang N, 2002, PROTEOMICS, V2, P1406, DOI 10.1002/1615-9861(200210)2:10<1406::AID-PROT1406>3.0.CO;2-9	23	2	2	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2013	8	5							e62724	10.1371/journal.pone.0062724	http://dx.doi.org/10.1371/journal.pone.0062724			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145RZ	23675420	Green Published, Green Submitted, gold			2022-12-27	WOS:000319036100009
J	Ederveen, THA; Overmars, L; van Hijum, SAFT				Ederveen, Thomas H. A.; Overmars, Lex; van Hijum, Sacha A. F. T.			Reduce Manual Curation by Combining Gene Predictions from Multiple Annotation Engines, a Case Study of Start Codon Prediction	PLOS ONE			English	Article							COMPLETE GENOME SEQUENCE; TECHNOLOGIES; RESOURCE; PROGRAMS; SERVER; SET	Nowadays, prokaryotic genomes are sequenced faster than the capacity to manually curate gene annotations. Automated genome annotation engines provide users a straight-forward and complete solution for predicting ORF coordinates and function. For many labs, the use of AGEs is therefore essential to decrease the time necessary for annotating a given prokaryotic genome. However, it is not uncommon for AGEs to provide different and sometimes conflicting predictions. Combining multiple AGEs might allow for more accurate predictions. Here we analyzed the ab initio open reading frame (ORF) calling performance of different AGEs based on curated genome annotations of eight strains from different bacterial species with GC% ranging from 35-52%. We present a case study which demonstrates a novel way of comparative genome annotation, using combinations of AGEs in a pre-defined order (or path) to predict ORF start codons. The order of AGE combinations is from high to low specificity, where the specificity is based on the eight genome annotations. For each AGE combination we are able to derive a so-called projected confidence value, which is the average specificity of ORF start codon prediction based on the eight genomes. The projected confidence enables estimating likeliness of a correct prediction for a particular ORF start codon by a particular AGE combination, pinpointing ORFs notoriously difficult to predict start codons. We correctly predict start codons for 90.5+/-4.8% of the genes in a genome (based on the eight genomes) with an accuracy of 81.1+/-7.6%. Our consensus-path methodology allows a marked improvement over majority voting (9.7+/-4.4%) and with an optimal path ORF start prediction sensitivity is gained while maintaining a high specificity.	[Ederveen, Thomas H. A.; Overmars, Lex; van Hijum, Sacha A. F. T.] Radboud Univ Nijmegen, Med Ctr, Ctr Mol & Biomol Informat, NL-6525 ED Nijmegen, Netherlands; [Overmars, Lex; van Hijum, Sacha A. F. T.] Netherlands Bioinformat Ctr, Nijmegen, Netherlands; [van Hijum, Sacha A. F. T.] NIZO Food Res, Kluyver Ctr Genom Ind Fermentat, Ede, Netherlands; [van Hijum, Sacha A. F. T.] Top Inst Food & Nutr, Wageningen, Netherlands	Radboud University Nijmegen; NIZO Food Research; Top Institute Food & Nutrition	van Hijum, SAFT (corresponding author), Radboud Univ Nijmegen, Med Ctr, Ctr Mol & Biomol Informat, NL-6525 ED Nijmegen, Netherlands.	svhijum@cmbi.ru.nl	van Hijum, Sacha/F-6445-2014; Ederveen, Thomas HA/G-6294-2016	Ederveen, Thomas HA/0000-0003-0068-1275; van Hijum, Sacha/0000-0003-0741-2991	NIZO; TIFN	NIZO; TIFN	Funding for this study for SH's contribution came from both NIZO and TIFN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Bairoch A, 2007, NUCLEIC ACIDS RES, V35, pD193, DOI 10.1093/nar/gkl929; Bakke P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006291; Barbe V, 2009, MICROBIOL-SGM, V155, P1758, DOI 10.1099/mic.0.027839-0; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Benson DA, 2000, NUCLEIC ACIDS RES, V28, P15, DOI 10.1093/nar/28.1.15; Besemer J, 2005, NUCLEIC ACIDS RES, V33, pW451, DOI 10.1093/nar/gki487; Besemer J, 2001, NUCLEIC ACIDS RES, V29, P2607, DOI 10.1093/nar/29.12.2607; Bocs S, 2002, BMC BIOINFORMATICS, V3, DOI 10.1186/1471-2105-3-5; Brenner SE, 1999, TRENDS GENET, V15, P132, DOI 10.1016/S0168-9525(99)01706-0; Chaudhuri RR, 2008, NUCLEIC ACIDS RES, V36, pD543, DOI 10.1093/nar/gkm928; Chaudhuri RR, 2006, NUCLEIC ACIDS RES, V34, pD335, DOI 10.1093/nar/gkj140; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Delcher AL, 1999, NUCLEIC ACIDS RES, V27, P4636, DOI 10.1093/nar/27.23.4636; Delcher AL, 2007, BIOINFORMATICS, V23, P673, DOI 10.1093/bioinformatics/btm009; Deng W, 2003, J BACTERIOL, V185, P2330, DOI 10.1128/JB.185.7.2330-2337.2003; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; FLEISCHMANN RD, 1995, SCIENCE, V269, P496, DOI 10.1126/science.7542800; Hall N, 2007, J EXP BIOL, V210, P1518, DOI 10.1242/jeb.001370; Hemmerich C, 2010, BIOINFORMATICS, V26, P1122, DOI 10.1093/bioinformatics/btq090; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Hyatt D, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-119; Jaffe JD, 2004, GENOME RES, V14, P1447, DOI 10.1101/gr.2674004; MacLean D, 2009, NAT REV MICROBIOL, V7, P287, DOI [10.1038/nrmicro2088, 10.1038/nrmicro2122]; Meyer F, 2009, NUCLEIC ACIDS RES, V37, P6643, DOI 10.1093/nar/gkp698; Nelson KE, 2002, ENVIRON MICROBIOL, V4, P799, DOI 10.1046/j.1462-2920.2002.00366.x; Pavlovic V, 2002, BIOINFORMATICS, V18, P19, DOI 10.1093/bioinformatics/18.1.19; Pruitt KD, 2009, NUCLEIC ACIDS RES, V37, pD32, DOI 10.1093/nar/gkn721; Redenbach M, 1996, MOL MICROBIOL, V21, P77, DOI 10.1046/j.1365-2958.1996.6191336.x; Richardson EJ, 2013, BRIEF BIOINFORM, V14, P1, DOI 10.1093/bib/bbs007; Riley M, 2006, NUCLEIC ACIDS RES, V34, P1, DOI 10.1093/nar/gkj405; Shah SP, 2003, BIOINFORMATICS, V19, P1296, DOI 10.1093/bioinformatics/btg139; Siezen RJ, 2008, APPL ENVIRON MICROB, V74, P424, DOI 10.1128/AEM.01850-07; Siezen RJ, 2012, J BACTERIOL, V194, P195, DOI 10.1128/JB.06275-11; Siezen RJ, 2010, MICROB BIOTECHNOL, V3, P362, DOI 10.1111/j.1751-7915.2010.00191.x; Tatusov RL, 1997, SCIENCE, V278, P631, DOI 10.1126/science.278.5338.631; Tettelin H, 2001, SCIENCE, V293, P498, DOI 10.1126/science.1061217; Tettelin H, 2000, SCIENCE, V287, P1809, DOI 10.1126/science.287.5459.1809; Van Domselaar GH, 2005, NUCLEIC ACIDS RES, V33, pW455, DOI 10.1093/nar/gki593; Wall ME, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002284; Yada T, 2003, Pac Symp Biocomput, P375; Yok N, 2010, IEEE ENG MED BIO, P6190, DOI 10.1109/IEMBS.2010.5627744; Yok NG, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-20; Yu NY, 2011, NUCLEIC ACIDS RES, V39, pD241, DOI 10.1093/nar/gkq1093	45	11	12	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2013	8	5							e63523	10.1371/journal.pone.0063523	http://dx.doi.org/10.1371/journal.pone.0063523			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	143FO	23675487	Green Published, Green Submitted, gold			2022-12-27	WOS:000318852400042
J	Goto, K; Kumarendran, B; Mettananda, S; Gunasekara, D; Fujii, Y; Kaneko, S				Goto, Kensuke; Kumarendran, Balachandran; Mettananda, Sachith; Gunasekara, Deepa; Fujii, Yoshito; Kaneko, Satoshi			Analysis of Effects of Meteorological Factors on Dengue Incidence in Sri Lanka Using Time Series Data	PLOS ONE			English	Article							CLIMATE VARIABLES; CHOLERA; MALARIA; PLAGUE; MODELS	In tropical and subtropical regions of eastern and South-eastern Asia, dengue fever (DF) and dengue hemorrhagic fever (DHF) outbreaks occur frequently. Previous studies indicate an association between meteorological variables and dengue incidence using time series analyses. The impacts of meteorological changes can affect dengue outbreak. However, difficulties in collecting detailed time series data in developing countries have led to common use of monthly data in most previous studies. In addition, time series analyses are often limited to one area because of the difficulty in collecting meteorological and dengue incidence data in multiple areas. To gain better understanding, we examined the effects of meteorological factors on dengue incidence in three geographically distinct areas (Ratnapura, Colombo, and Anuradhapura) of Sri Lanka by time series analysis of weekly data. The weekly average maximum temperature and total rainfall and the total number of dengue cases from 2005 to 2011 (7 years) were used as time series data in this study. Subsequently, time series analyses were performed on the basis of ordinary least squares regression analysis followed by the vector autoregressive model (VAR). In conclusion, weekly average maximum temperatures and the weekly total rainfall did not significantly affect dengue incidence in three geographically different areas of Sri Lanka. However, the weekly total rainfall slightly influenced dengue incidence in the cities of Colombo and Anuradhapura.	[Goto, Kensuke; Fujii, Yoshito; Kaneko, Satoshi] Nagasaki Univ, Inst Trop Med, Dept Ecoepidemiol, Nagasaki 852, Japan; [Kumarendran, Balachandran] Univ Kelaniya, Fac Med, Dept Publ Hlth, Kelaniya, Western Provinc, Sri Lanka; [Mettananda, Sachith] Univ Kelaniya, Fac Med, Dept Paediat, Kelaniya, Western Provinc, Sri Lanka; [Gunasekara, Deepa] Univ Kelaniya, Fac Med, Dept Biochem & Clin Med, Kelaniya, Western Provinc, Sri Lanka	Nagasaki University; University Kelaniya; University Kelaniya; University Kelaniya	Goto, K (corresponding author), Nagasaki Univ, Inst Trop Med, Dept Ecoepidemiol, Nagasaki 852, Japan.	k-goto@nagasaki-u.ac.jp	Mettananda, Sachith/H-4640-2019	Mettananda, Sachith/0000-0002-0760-0418; Kaneko, Satoshi/0000-0001-9464-0911	FY2011 SATREPS Special Project Formation Investigation: Young Research Team Feasibility Studies	FY2011 SATREPS Special Project Formation Investigation: Young Research Team Feasibility Studies	This work was supported by FY2011 SATREPS Special Project Formation Investigation: Young Research Team Feasibility Studies. (http://www.jst.go.jp/ global/english/fskoubo.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akinboade OA, 2010, INT J TOUR RES, V12, P149, DOI 10.1002/jtr.743; Ari TB, 2010, AM J TROP MED HYG, V83, P624, DOI 10.4269/ajtmh.2010.09-0775; Ben Ari T, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002160; Brady OJ, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001760; Chastel C, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00070; de Magny GC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044577; de Magny GC, 2008, P NATL ACAD SCI USA, V105, P17676, DOI 10.1073/pnas.0809654105; Descloux E, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001470; Egbendewe-Mondzozo A, 2011, INT J ENV RES PUB HE, V8, P913, DOI 10.3390/ijerph8030913; Epidemiology Unit MoH Sri Lanka, 2011, SURV CAS DEF NORT DI; Epidemiology Unit MoH Sri Lanka, 2011, EP B SRI LANK, P1; Gharbi M, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-166; Haque U, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014341; Hii Y. L., 2009, GLOB HLTH ACTION, V2; Honda Y, 2009, GLOB HLTH ACTION, V2; Huang F, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-54; Ji X., 2012, ADV INFORM TECHNOLOG, V2, P268; Kanakaratne N, 2009, EMERG INFECT DIS, V15, P192, DOI 10.3201/eid1502.080926; Kularatne SAM, 2007, T ROY SOC TROP MED H, V101, P804, DOI 10.1016/j.trstmh.2007.02.021; Kumar S, 2012, ENERG ECON, V34, P215, DOI 10.1016/j.eneco.2011.03.002; Mohammed HP, 2010, J TRAVEL MED, V17, P8, DOI 10.1111/j.1708-8305.2009.00374.x; Opgen-Rhein R, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-S2-S3; Pesaran HH, 1998, ECON LETT, V58, P17, DOI 10.1016/S0165-1765(97)00214-0; Pinto E, 2011, INT J ENVIRON HEAL R, V21, P415, DOI 10.1080/09603123.2011.572279; Rajapakse Senaka, 2012, Infect Drug Resist, V5, P103, DOI 10.2147/IDR.S22613; Rasgon JL, 2011, NATURE, V476, P407, DOI 10.1038/476407a; Reller ME, 2012, EMERG INFECT DIS, V18, P256, DOI 10.3201/eid1802.110962; Tissera HA, 2011, EMERG INFECT DIS, V17, P2053, DOI 10.3201/eid1711.101893; Traerup SLM, 2011, INT J ENV RES PUB HE, V8, P4386, DOI 10.3390/ijerph8124386; Weaver SC, 2009, INFECT GENET EVOL, V9, P523, DOI 10.1016/j.meegid.2009.02.003; Weerakoon Kosala Gad, 2011, BMC Res Notes, V4, P268, DOI 10.1186/1756-0500-4-268; WHO, 2009, WHO TECH REP SER, V958, P1; WHO, 2010, COMM DIS EP PROF; Xu L, 2011, P NATL ACAD SCI USA, V108, P10214, DOI 10.1073/pnas.1019486108	34	44	44	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2013	8	5							e63717	10.1371/journal.pone.0063717	http://dx.doi.org/10.1371/journal.pone.0063717			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	155HD	23671694	Green Published, gold, Green Submitted			2022-12-27	WOS:000319737700057
J	Schanen, BC; Das, S; Reilly, CM; Warren, WL; Self, WT; Seal, S; Drake, DR				Schanen, Brian C.; Das, Soumen; Reilly, Christopher M.; Warren, William L.; Self, William T.; Seal, Sudipta; Drake, Donald R., III			Immunomodulation and T Helper TH1/TH2 Response Polarization by CeO2 and TiO2 Nanoparticles	PLOS ONE			English	Article							CERIUM OXIDE NANOPARTICLES; DENDRITIC CELL MATURATION; ANTIGEN-PRESENTING CELLS; REACTIVE OXYGEN; IN-VITRO; TITANIUM-DIOXIDE; CYTOKINE RELEASE; SURFACE; ACTIVATION; MODEL	Immunomodulation by nanoparticles, especially as related to the biochemical properties of these unique materials, has scarcely been explored. In an in vitro model of human immunity, we demonstrate two catalytic nanoparticles, TiO2 (oxidant) and CeO2 (antioxidant), have nearly opposite effects on human dendritic cells and T helper (T-H) cells. For example, whereas TiO2 nanoparticles potentiated DC maturation that led towards T(H)1-biased responses, treatment with antioxidant CeO2 nanoparticles induced APCs to secrete the anti-inflammatory cytokine, IL-10, and induce a T(H)2-dominated T cell profile. In subsequent studies, we demonstrate these results are likely explained by the disparate capacities of the nanoparticles to modulate ROS, since TiO2, but not CeO2 NPs, induced inflammatory responses through an ROS/inflammasome/IL-1 beta pathway. This novel capacity of metallic NPs to regulate innate and adaptive immunity in profoundly different directions via their ability to modulate dendritic cell function has strong implications for human health since unintentional exposure to these materials is common in modern societies.	[Schanen, Brian C.; Warren, William L.; Drake, Donald R., III] Sanofi Pasteur, Orlando, FL USA; [Schanen, Brian C.; Warren, William L.; Self, William T.] UCF Coll Med, Dept Mol Biol & Microbiol, Burnett Sch Biomed Sci, Orlando, FL USA; [Das, Soumen; Seal, Sudipta] Nanosci & Technol Ctr NSTC, Dept Mech Mat & Aerosp Engn MMAE, AMPAC, Orlando, FL USA; [Reilly, Christopher M.] Virginia Tech, Virginia Maryland Reg Coll Vet Med, Virginia Coll Osteopath Med Res, Blacksburg, VA USA	Sanofi-Aventis; State University System of Florida; University of Central Florida; Virginia Polytechnic Institute & State University	Drake, DR (corresponding author), Sanofi Pasteur, VaxDesign Campus, Orlando, FL USA.	Donald.Drake@sanofipasteur.com	Self, William/Q-4113-2019; Self, William/A-6704-2008; Seal, Sudipta/A-7698-2012	Self, William/0000-0001-9874-0194	NSF [CBET-0711239]	NSF(National Science Foundation (NSF))	This work was funded by NSF Grant CBET-0711239 (http://www.nsf.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allouni ZE, 2012, TOXICOL IN VITRO, V26, P469, DOI 10.1016/j.tiv.2012.01.019; Asati A, 2010, ACS NANO, V4, P5321, DOI 10.1021/nn100816s; Bar-Ilan O, NANOTOXICOLOGY, V0, P1; Boonstra A, 2006, J IMMUNOL, V177, P7551, DOI 10.4049/jimmunol.177.11.7551; Boscolo P, 2010, J BIOL REG HOMEOS AG, V24, P207; Bruchhausen S, 2003, J INVEST DERMATOL, V121, P1039, DOI 10.1046/j.1523-1747.2003.12510.x; Byers AM, 2009, BIOLOGICALS, V37, P148, DOI 10.1016/j.biologicals.2009.02.018; Cai X, 2012, BIOMATERIALS, V33, P8771, DOI 10.1016/j.biomaterials.2012.08.030; Chauveau C, 2005, BLOOD, V106, P1694, DOI 10.1182/blood-2005-02-0494; Churg A, 1998, AM J PHYSIOL-LUNG C, V274, pL81, DOI 10.1152/ajplung.1998.274.1.L81; Colon J, 2010, NANOMED-NANOTECHNOL, V6, P698, DOI 10.1016/j.nano.2010.01.010; Deng ZJ, 2011, NAT NANOTECHNOL, V6, P39, DOI [10.1038/nnano.2010.250, 10.1038/NNANO.2010.250]; Dhir V, 2011, J IMMUNOTOXICOL; Dhir V, 2012, J IMMUNOTOXICOL, V9, P34, DOI 10.3109/1547691X.2011.613419; Donaldson K, 1996, TOXICOL LETT, V88, P293, DOI 10.1016/0378-4274(96)03752-6; Dowding JM, 2012, CHEM COMMUN, V48, P4896, DOI 10.1039/c2cc30485f; Drake DR, 2012, DISRUPTIVE SCI TECHN, V1, P28; Duffin R, 2007, INHAL TOXICOL, V19, P849, DOI 10.1080/08958370701479323; Fan AM, 2010, J NANOSCI NANOTECHNO, V10, P8646, DOI 10.1166/jnn.2010.2493; Fialkow L, 2007, FREE RADICAL BIO MED, V42, P153, DOI 10.1016/j.freeradbiomed.2006.09.030; Finkel T, 2000, FEBS LETT, V476, P52, DOI 10.1016/S0014-5793(00)01669-0; Gaiser BK, 2012, ENVIRON TOXICOL CHEM, V31, P144, DOI 10.1002/etc.703; Gaucher D, 2008, J EXP MED, V205, P3119, DOI 10.1084/jem.20082292; Goncalves DM, 2010, TOXICOL IN VITRO, V24, P1002, DOI 10.1016/j.tiv.2009.12.007; Hanley C, 2009, NANOSCALE RES LETT, V4, P1409, DOI 10.1007/s11671-009-9413-8; Higbee RG, 2009, ATLA-ALTERN LAB ANIM, V37, P19, DOI 10.1177/026119290903701S05; Hirst SM, 2009, SMALL, V5, P2848, DOI 10.1002/smll.200901048; Karakoti AS, 2009, J AM CHEM SOC, V131, P14144, DOI 10.1021/ja9051087; Kotake Y, 2003, SHOCK, V19, P252, DOI 10.1097/00024382-200303000-00009; Lamkanfi M, 2009, J BIOL CHEM, V284, P20574, DOI 10.1074/jbc.M109.023689; Lander HM, 1996, NATURE, V381, P380, DOI 10.1038/381380a0; Laouini D, 2003, J CLIN INVEST, V112, P1058, DOI 10.1172/JCI200318246; Liu Y, 2009, BIOMATERIALS, V30, P3934, DOI 10.1016/j.biomaterials.2009.04.001; Lutsiak MEC, 2006, J PHARM PHARMACOL, V58, P739, DOI 10.1211/jpp.58.6.0004; Ma YF, 2010, IMMUNOLOGY, V130, P374, DOI 10.1111/j.1365-2567.2009.03237.x; Mayer A, 2009, TOXICOLOGY, V258, P139, DOI 10.1016/j.tox.2009.01.015; MNneil SE, 2005, J LEUKOCYTE BIOL, V78, P585, DOI 10.1189/jlb.0205074; Moore KW, 2001, ANNU REV IMMUNOL, V19, P683, DOI 10.1146/annurev.immunol.19.1.683; Moser JM, 2010, J IMMUNOL METHODS, V353, P8, DOI 10.1016/j.jim.2009.11.006; Patil S, 2007, BIOMATERIALS, V28, P4600, DOI 10.1016/j.biomaterials.2007.07.029; Paulsen M, 2011, CELL DEATH DIFFER, V18, P619, DOI 10.1038/cdd.2010.134; Rutault K, 1999, FREE RADICAL BIO MED, V26, P232, DOI 10.1016/S0891-5849(98)00194-4; Schanen BC, 2008, J IMMUNOL METHODS, V335, P53, DOI 10.1016/j.jim.2008.02.021; Schanen BC, 2011, VACCINE, V29, P3299, DOI 10.1016/j.vaccine.2011.02.019; Schanen BC, 2009, ACS NANO, V3, P2523, DOI 10.1021/nn900403h; Schroecksnadel Katharina, 2007, Drug Metab Lett, V1, P166; Shin SH, 2007, INT IMMUNOPHARMACOL, V7, P1813, DOI 10.1016/j.intimp.2007.08.025; Song HF, 2010, VACCINE, V28, P5524, DOI 10.1016/j.vaccine.2010.06.044; Stringer B, 1996, AM J RESP CELL MOL, V14, P155, DOI 10.1165/ajrcmb.14.2.8630265; Sun Q, 2012, J BIOMED MAT RES A; Tang H, 2010, NAT IMMUNOL, V11, P608, DOI 10.1038/ni.1883; Thevenot P, 2008, CURR TOP MED CHEM, V8, P270; Thevenot P, 2008, NANOMED-NANOTECHNOL, V4, P226, DOI 10.1016/j.nano.2008.04.001; Tse HM, 2004, FREE RADICAL BIO MED, V36, P233, DOI 10.1016/j.freeradbiomed.2003.10.029; Warheit David B, 2009, Inhal Toxicol, V21 Suppl 1, P61, DOI 10.1080/08958370902942640; Wason MS, 2012, NANOMEDICINE; Wittman V, 2010, IDRUGS, V13, P248; Xu MH, 1998, SUPRAMOL SCI, V5, P449, DOI 10.1016/S0968-5677(98)00048-0; Yang D, 2010, ACS NANO, V4, P1178, DOI 10.1021/nn901478z; Yang HY, 2004, J APPL POLYM SCI, V92, P3201, DOI 10.1002/app.20327; Yazdi AS, 2010, P NATL ACAD SCI USA, V107, P19449, DOI 10.1073/pnas.1008155107; Zhang AP, 2004, WORLD J GASTROENTERO, V10, P3191; Zhu ZJ, 2008, J AM CHEM SOC, V130, P14139, DOI 10.1021/ja805392f	63	62	66	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2013	8	5							e62816	10.1371/journal.pone.0062816	http://dx.doi.org/10.1371/journal.pone.0062816			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145YI	23667525	Green Published, gold, Green Submitted			2022-12-27	WOS:000319055600046
J	Ignatius, MS; Eroglu, AU; Malireddy, S; Gallagher, G; Nambiar, RM; Henion, PD				Ignatius, Myron S.; Eroglu, Arife Unal; Malireddy, Smitha; Gallagher, Glen; Nambiar, Roopa M.; Henion, Paul D.			Distinct Functional and Temporal Requirements for Zebrafish Hdac1 during Neural Crest-Derived Craniofacial and Peripheral Neuron Development	PLOS ONE			English	Article							HISTONE DEACETYLASE INHIBITORS; TRANSCRIPTION FACTOR HAND2; II COLLAGEN; NORADRENERGIC NEURONS; MOLECULAR-MECHANISMS; GENE-EXPRESSION; DORSAL-ROOT; SOX9; DIFFERENTIATION; SPECIFICATION	The regulation of gene expression is accomplished by both genetic and epigenetic means and is required for the precise control of the development of the neural crest. In hdac1(b382) mutants, craniofacial cartilage development is defective in two distinct ways. First, fewer hoxb3a, dlx2 and dlx3-expressing posterior branchial arch precursors are specified and many of those that are consequently undergo apoptosis. Second, in contrast, normal numbers of progenitors are present in the anterior mandibular and hyoid arches, but chondrocyte precursors fail to terminally differentiate. In the peripheral nervous system, there is a disruption of enteric, DRG and sympathetic neuron differentiation in hdac1(b382) mutants compared to wildtype embryos. Specifically, enteric and DRG-precursors differentiate into neurons in the anterior gut and trunk respectively, while enteric and DRG neurons are rarely present in the posterior gut and tail. Sympathetic neuron precursors are specified in hdac1(b382) mutants and they undergo generic neuronal differentiation but fail to undergo noradrenergic differentiation. Using the HDAC inhibitor TSA, we isolated enzyme activity and temporal requirements for HDAC function that reproduce hdac1(b382) defects in craniofacial and sympathetic neuron development. Our study reveals distinct functional and temporal requirements for zebrafish hdac1 during neural crest-derived craniofacial and peripheral neuron development.	[Malireddy, Smitha; Gallagher, Glen; Henion, Paul D.] Ohio State Univ, Dept Neurosci, Columbus, OH 43210 USA; [Ignatius, Myron S.; Eroglu, Arife Unal; Nambiar, Roopa M.; Henion, Paul D.] Ohio State Univ, Mol Cellular & Dev Biol Program, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Henion, PD (corresponding author), Ohio State Univ, Dept Neurosci, Columbus, OH 43210 USA.	henion.1@osu.edu			NSF [IBN0315765]; NIH [GM074505]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM074505] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NSF grant IBN0315765 and NIH grant GM074505 to P.D.H. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahringer J, 2000, TRENDS GENET, V16, P351, DOI 10.1016/S0168-9525(00)02066-7; AKIMENKO MA, 1994, J NEUROSCI, V14, P3475; ALLFREY VG, 1966, CANCER RES, V26, P2026; An M, 2002, J COMP NEUROL, V446, P267, DOI 10.1002/cne.10214; Barembaum M, 2005, SEMIN CELL DEV BIOL, V16, P642, DOI 10.1016/j.semcdb.2005.06.006; Barrallo-Gimeno A, 2004, DEVELOPMENT, V131, P1463, DOI 10.1242/dev.01033; Bell DM, 1997, NAT GENET, V16, P174, DOI 10.1038/ng0697-174; Britsch S, 2001, GENE DEV, V15, P66, DOI 10.1101/gad.186601; Carney TJ, 2006, DEVELOPMENT, V133, P4619, DOI 10.1242/dev.02668; Cornell RA, 2005, SEMIN CELL DEV BIOL, V16, P663, DOI 10.1016/j.semcdb.2005.06.009; Cunliffe VT, 2006, MECH DEVELOP, V123, P24, DOI 10.1016/j.mod.2005.10.005; Cunliffe VT, 2004, DEVELOPMENT, V131, P2983, DOI 10.1242/dev.01166; De Ruijter AJM, 2003, BIOCHEM J, V370, P737, DOI 10.1042/BJ20021321; del Barrio MG, 2002, DEVELOPMENT, V129, P1583; Dokmanovic M, 2007, MOL CANCER RES, V5, P981, DOI 10.1158/1541-7786.MCR-07-0324; Dutton KA, 2001, DEVELOPMENT, V128, P4113; EPSTEIN DJ, 1991, CELL, V67, P767, DOI 10.1016/0092-8674(91)90071-6; Etchevers HC, 2006, ADV EXP MED BIOL, V589, P213; Guo S, 1999, NEURON, V24, P555, DOI 10.1016/S0896-6273(00)81112-5; Haberland M, 2009, NAT REV GENET, V10, P32, DOI 10.1038/nrg2485; Holzschuh J, 2003, DEVELOPMENT, V130, P5741, DOI 10.1242/dev.00816; Howard MJ, 2005, DEV BIOL, V277, P271, DOI 10.1016/j.ydbio.2004.09.034; Huber K, 2006, DEV BIOL, V298, P335, DOI 10.1016/j.ydbio.2006.07.010; Hunter MP, 2002, DEV BIOL, V247, P367, DOI 10.1006/dbio.2002.0701; Ignatius MS, 2008, DEV BIOL, V313, P568, DOI 10.1016/j.ydbio.2007.10.045; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Kelsh RN, 2000, DEVELOPMENT, V127, P515; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Knapik EW, 1998, NAT GENET, V18, P338, DOI 10.1038/ng0498-338; Knapik EW, 1996, DEVELOPMENT, V123, P451; Knight RD, 2003, DEVELOPMENT, V130, P5755, DOI 10.1242/dev.00575; Knight RD, 2006, ADV EXP MED BIOL, V589, P120; Kos R, 2001, DEVELOPMENT, V128, P1467; Lagger G, 2002, EMBO J, V21, P2672, DOI 10.1093/emboj/21.11.2672; Le Douarin NM, 1999, NEURAL CREST, V2; Lefebvre V, 1997, MOL CELL BIOL, V17, P2336, DOI 10.1128/MCB.17.4.2336; Lister JA, 2006, DEV BIOL, V290, P92, DOI 10.1016/j.ydbio.2005.11.014; Lucas ME, 2006, DEVELOPMENT, V133, P4015, DOI 10.1242/dev.02574; Luo RS, 2001, DEV DYNAM, V220, P169, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1097>3.0.CO;2-1; Marks PA, 2003, CURR OPIN PHARMACOL, V3, P344, DOI 10.1016/S1471-4892(03)00084-5; Medeiros DM, 2012, DEV BIOL, V371, P121, DOI 10.1016/j.ydbio.2012.08.026; Minoux M, 2010, DEVELOPMENT, V137, P2605, DOI 10.1242/dev.040048; Minucci S, 2006, NAT REV CANCER, V6, P38, DOI 10.1038/nrc1779; Montgomery RL, 2007, GENE DEV, V21, P1790, DOI 10.1101/gad.1563807; Nambiar RM, 2004, DEV BIOL, V267, P165, DOI 10.1016/j.ydbio.2003.11.019; Nambiar RM, 2007, MECH DEVELOP, V124, P682, DOI 10.1016/j.mod.2007.07.003; Ng LJ, 1997, DEV BIOL, V183, P108, DOI 10.1006/dbio.1996.8487; O'Brien EK, 2004, DEV BIOL, V265, P246, DOI 10.1016/j.ydbio.2003.09.029; Pillai R, 2004, DEV DYNAM, V231, P647, DOI 10.1002/dvdy.20168; Piotrowski T, 2003, DEVELOPMENT, V130, P5043, DOI 10.1242/dev.00704; Richards EJ, 2002, CELL, V108, P489, DOI 10.1016/S0092-8674(02)00644-X; Roth SY, 2001, ANNU REV BIOCHEM, V70, P81, DOI 10.1146/annurev.biochem.70.1.81; Rubinstein AL, 2000, GENESIS, V26, P86, DOI 10.1002/(SICI)1526-968X(200001)26:1<86::AID-GENE11>3.0.CO;2-Q; Sasai N, 2001, DEVELOPMENT, V128, P2525; SCHILLING TF, 1994, DEVELOPMENT, V120, P483; Sefton M, 1998, DEVELOPMENT, V125, P3111; Sonnenberg-Riethmacher E, 2001, MECH DEVELOP, V109, P253, DOI 10.1016/S0925-4773(01)00547-0; Spotswood HT, 2002, J CLIN INVEST, V110, P577, DOI 10.1172/JCI200216547; Stadler JA, 2005, DEV DYNAM, V233, P883, DOI 10.1002/dvdy.20427; Steventon B, 2005, SEMIN CELL DEV BIOL, V16, P647, DOI 10.1016/j.semcdb.2005.06.001; Stewart RA, 2004, METHOD CELL BIOL, V76, P237; Stewart RA, 2006, DEV BIOL, V292, P174, DOI 10.1016/j.ydbio.2005.12.035; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; THISSE C, 1993, DEVELOPMENT, V119, P1203; Turner BM, 2007, NAT CELL BIOL, V9, P2, DOI 10.1038/ncb0107-2; VANDENBERG P, 1991, P NATL ACAD SCI USA, V88, P7640, DOI 10.1073/pnas.88.17.7640; WRIGHT E, 1995, NAT GENET, V9, P15, DOI 10.1038/ng0195-15; Xu WS, 2007, ONCOGENE, V26, P5541, DOI 10.1038/sj.onc.1210620; Yamaguchi M, 2005, DEVELOPMENT, V132, P3027, DOI 10.1242/dev.01881; YAN YL, 1995, DEV DYNAM, V203, P363, DOI 10.1002/aja.1002030308; Yan YL, 2005, DEVELOPMENT, V132, P1069, DOI 10.1242/dev.01674; Yan YL, 2002, DEVELOPMENT, V129, P5065; Yelon D, 2000, DEVELOPMENT, V127, P2573; Zhao Q, 1997, DEV DYNAM, V209, P377, DOI 10.1002/(SICI)1097-0177(199708)209:4<377::AID-AJA5>3.0.CO;2-F	74	35	35	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e63218	10.1371/journal.pone.0063218	http://dx.doi.org/10.1371/journal.pone.0063218			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667588	Green Published, Green Submitted, gold			2022-12-27	WOS:000319654700118
J	McCaughan, JA; Duffy, S; O'Hagan, T; Courtney, AE; Borrows, R; Conlon, PJ; Maxwell, AP; McKnight, AJ				McCaughan, Jennifer A.; Duffy, Seamus; O'Hagan, Thomas; Courtney, Aisling E.; Borrows, Richard; Conlon, Peter J.; Maxwell, Alexander P.; McKnight, Amy Jayne			Comprehensive Investigation of the Caveolin 2 Gene: Resequencing and Association for Kidney Transplant Outcomes	PLOS ONE			English	Article							CHRONIC ALLOGRAFT NEPHROPATHY; RENAL-TRANSPLANTATION; TISSUE FIBROSIS; UNITED-STATES; IN-VITRO; EXPRESSION; SURVIVAL; CELLS; REJECTION; GENOME	Caveolae are plasma membrane structures formed from a complex of the proteins caveolin-1 and caveolin-2. Caveolae interact with pro-inflammatory cytokines and are dysregulated in fibrotic disease. Although caveolae are present infrequently in healthy kidneys, they are abundant during kidney injury. An association has been identified between a CAV1 gene variant and long term kidney transplant survival. Chronic, gradual decline in transplant function is a persistent problem in kidney transplantation. The aetiology of this is diverse but fibrosis within the transplanted organ is the common end point. This study is the first to investigate the association of CAV2 gene variants with kidney transplant outcomes. Genomic DNA from donors and recipients of 575 kidney transplants performed in Belfast was investigated for common variation in CAV2 using a tag SNP approach. The CAV2 SNP rs13221869 was nominally significant for kidney transplant failure. Validation was sought in an independent group of kidney transplant donors and recipients from Dublin, Ireland using a second genotyping technology. Due to the unexpected absence of rs13221869 from this cohort, the CAV2 gene was resequenced. One novel SNP and a novel insertion/deletion in CAV2 were identified; rs13221869 is located in a repetitive region and was not a true variant in resequenced populations. CAV2 is a plausible candidate gene for association with kidney transplant outcomes given its proximity to CAV1 and its role in attenuating fibrosis. This study does not support an association between CAV2 variation and kidney transplant survival. Further analysis of CAV2 should be undertaken with an awareness of the sequence complexities and genetic variants highlighted by this study.	[McCaughan, Jennifer A.; Duffy, Seamus; O'Hagan, Thomas; Maxwell, Alexander P.; McKnight, Amy Jayne] Queens Univ Belfast, Nephrol Res Grp, Belfast, Antrim, North Ireland; [McCaughan, Jennifer A.; Courtney, Aisling E.; Maxwell, Alexander P.] Belfast City Hosp, Reg Nephrol Unit, Belfast BT9 7AD, Antrim, North Ireland; [Borrows, Richard] Univ Hosp Birmingham, Dept Nephrol & Transplantat, Birmingham, W Midlands, England; [Conlon, Peter J.] Beaumont Hosp, Renal Unit, Dublin Kidney Transplant Res Grp, Dublin 9, Ireland	Queens University Belfast; Belfast City Hospital; University of Birmingham	McCaughan, JA (corresponding author), Queens Univ Belfast, Nephrol Res Grp, Belfast, Antrim, North Ireland.	jamccaughan@doctors.org.uk	McKnight, Amy Jayne/ABF-4492-2020	McKnight, Amy Jayne/0000-0002-7482-709X; Maxwell, Alexander P./0000-0002-6110-7253	Kidney Research UK [TF20/2012]; Northern Ireland Kidney Research Fund; Public Health Agency [STL/3714/07] Funding Source: researchfish	Kidney Research UK(Kidney Research UK (KRUK)); Northern Ireland Kidney Research Fund; Public Health Agency	Dr. Jennifer McCaughan is the recipient of a Clinical Training Fellowship from Kidney Research UK [TF20/2012] (www.kidneyresearchuk.org). This study was supported by the Northern Ireland Kidney Research Fund (www.kidneyresearchni.com). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkan C, 2011, NAT REV GENET, V12, P363, DOI 10.1038/nrg2958; Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298; Ando T, 2007, ONCOL REP, V18, P601; Barrett JC, 2009, COLD SPRING HARB PRO; Cardenas CLL, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003291; Courtney AE, 2007, AM J TRANSPLANT, V7, P908, DOI 10.1111/j.1600-6143.2006.01726.x; Courtney AE, 2008, QJM-INT J MED, V101, P967, DOI 10.1093/qjmed/hcn136; DeFrancesco L, 2012, NAT BIOTECHNOL, V30, P126, DOI 10.1038/nbt0212-126a; Di Guglielmo GM, 2003, NAT CELL BIOL, V5, P410, DOI 10.1038/ncb975; Djamali A, 2009, TRANSPLANTATION, V88, P1149, DOI 10.1097/TP.0b013e3181bcccea; Fajardo KVF, 2012, HUM MUTAT, V33, P609, DOI 10.1002/humu.22033; Fisher E, 2011, J NUTR, V141, P177, DOI 10.3945/jn.110.124206; Grimm PC, 2001, NEW ENGL J MED, V345, P93, DOI 10.1056/NEJM200107123450203; Hariharan S, 2000, NEW ENGL J MED, V342, P605, DOI 10.1056/NEJM200003023420901; Joosten SA, 2005, KIDNEY INT, V68, P1, DOI 10.1111/j.1523-1755.2005.00376.x; Lamb KE, 2011, AM J TRANSPLANT, V11, P450, DOI 10.1111/j.1600-6143.2010.03283.x; Laupacis A, 1996, KIDNEY INT, V50, P235, DOI 10.1038/ki.1996.307; Manetti M, 2012, ANN RHEUM DIS, V71, P1034, DOI 10.1136/annrheumdis-2011-200986; McMorrow T, 2005, NEPHROL DIAL TRANSPL, V20, P2215, DOI 10.1093/ndt/gfh967; Meier-Kriesche HU, 2004, AM J TRANSPLANT, V4, P1289, DOI 10.1111/j.1600-6143.2004.00515.x; Moore J, 2012, J AM SOC NEPHROL, V23, P1891, DOI 10.1681/ASN.2012030260; Moore J, 2010, JAMA-J AM MED ASSOC, V303, P1282, DOI 10.1001/jama.2010.356; Moriyama T, 2011, J CLIN PATHOL, V64, P504, DOI 10.1136/jcp.2010.087023; Park HC, 2010, AM J PHYSIOL-RENAL, V298, pF357, DOI 10.1152/ajprenal.00542.2009; Paul LC, 1999, KIDNEY INT, V56, P783, DOI 10.1046/j.1523-1755.1999.00611.x; Pfeufer A, 2010, NAT GENET, V42, P153, DOI 10.1038/ng.517; Phimister EG, 2012, NEW ENGL J MED, V366, P757, DOI 10.1056/NEJMe1200749; Racusen LC, 2010, KIDNEY INT, V78, pS27, DOI 10.1038/ki.2010.419; Razani B, 2002, PHARMACOL REV, V54, P431, DOI 10.1124/pr.54.3.431; Razani B, 2001, J BIOL CHEM, V276, P6727, DOI 10.1074/jbc.M008340200; Reeves-Daniel AM, 2011, AM J TRANSPLANT, V11, P1025, DOI 10.1111/j.1600-6143.2011.03513.x; Rienstra H, 2009, AM J TRANSPLANT, V9, P463, DOI 10.1111/j.1600-6143.2008.02534.x; Sandholm N, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002921; Savage K, 2008, BREAST CANCER RES TR, V110, P245, DOI 10.1007/s10549-007-9718-1; Scherer PE, 1997, J BIOL CHEM, V272, P29337, DOI 10.1074/jbc.272.46.29337; SCHMID CW, 1975, CELL, V6, P345, DOI 10.1016/0092-8674(75)90184-1; Solez K, 2007, AM J TRANSPLANT, V7, P518, DOI 10.1111/j.1600-6143.2006.01688.x; Stanescu HC, 2011, NEW ENGL J MED, V364, P616, DOI 10.1056/NEJMoa1009742; THIEL G, 1994, TRANSPLANT P, V26, P2493; Thorleifsson G, 2010, NAT GENET, V42, P906, DOI 10.1038/ng.661; Tourkina E, 2008, AM J PHYSIOL-LUNG C, V294, pL843, DOI 10.1152/ajplung.00295.2007; Treangen TJ, 2012, NAT REV GENET, V13, P36, DOI 10.1038/nrg3117; Wolfe RA, 1999, NEW ENGL J MED, V341, P1725, DOI 10.1056/NEJM199912023412303; Yamamoto I, 2008, AM J TRANSPLANT, V8, P2627, DOI 10.1111/j.1600-6143.2008.02421.x; Yamamoto I, 2007, AM J TRANSPLANT, V7, P1954, DOI 10.1111/j.1600-6143.2007.01876.x; Zhang GY, 2011, BRIT J DERMATOL, V164, P623, DOI 10.1111/j.1365-2133.2010.10111.x	46	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e63358	10.1371/journal.pone.0063358	http://dx.doi.org/10.1371/journal.pone.0063358			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667606	gold, Green Published, Green Submitted			2022-12-27	WOS:000319654700135
J	Schnegg, A; Burgisser, P; Andre, C; Kenfak-Foguena, A; Canellini, G; Moradpour, D; Abravanel, F; Izopet, J; Cavassini, M; Darling, KEA				Schnegg, Annatina; Buergisser, Philippe; Andre, Cyril; Kenfak-Foguena, Alain; Canellini, Giorgia; Moradpour, Darius; Abravanel, Florence; Izopet, Jacques; Cavassini, Matthias; Darling, Katharine E. A.			An Analysis of the Benefit of Using HEV Genotype 3 Antigens in Detecting Anti-HEV IgG in a European Population	PLOS ONE			English	Article							HEPATITIS-E VIRUS; BLOOD-DONORS; ANTIBODIES; INFECTION; SEROPREVALENCE; PREVALENCE; DIAGNOSIS; COUNTRIES; AVIDITY; ASSAYS	Background: The benefit of using serological assays based on HEV genotype 3 in industrialised settings is unclear. We compared the performance of serological kits based on antigens from different HEV genotypes. Methods: Taking 20 serum samples from patients in southwest France with acute HEV infection (positive PCR for HEV genotype 3) and 550 anonymised samples from blood donors in southwest Switzerland, we tested for anti-HEV IgG using three enzyme immunoassays (EIAs) (MP Diagnostics, Dia. Pro and Fortress) based on genotype 1 and 2 antigens, and one immunodot assay (Mikrogen Diagnostik recomLine HEV IgG/IgM) based on genotype 1 and 3 antigens. Results: All acute HEV samples and 124/550 blood donor samples were positive with >= 1 assay. Of PCR-confirmed patient samples, 45%, 65%, 95% and 55% were positive with MP Diagnostics, Dia. Pro, Fortress and recomLine, respectively. Of blood donor samples positive with >= 1 assay, 120/124 (97%), were positive with Fortress, 19/124 (15%) were positive with all EIAs and 51/124 (41%) were positive with recomLine. Of 11/20 patient samples positive with recomLine, stronger reactivity for HEV genotype 3 was observed in 1/11(9%), and equal reactivity for both genotypes in 5/11 (45.5%). Conclusions: Although recomLine contains HEV genotype 3, it has lower sensitivity than Fortress in acute HEV infection and fails to identify infection as being due to this genotype in approximately 45% of patients. In our single blood donor population, we observe wide variations in measured seroprevalence, from 4.2% to 21.8%, depending on the assay used.	[Schnegg, Annatina; Moradpour, Darius] Univ Lausanne, Fac Biol & Med, Lausanne, Switzerland; [Buergisser, Philippe; Andre, Cyril] Univ Lausanne, Univ Lausanne Hosp, Serv Immunol & Allergy, Lausanne, Switzerland; [Kenfak-Foguena, Alain; Cavassini, Matthias; Darling, Katharine E. A.] Univ Lausanne, Univ Lausanne Hosp, Lausanne, Switzerland; [Canellini, Giorgia] Serv Reg Vaudois Transfus Sanguine, Epalinges, Switzerland; [Abravanel, Florence; Izopet, Jacques] Ctr Physiopathol Toulouse Purpan, INSERM, U1043, Toulouse, France; [Abravanel, Florence; Izopet, Jacques] Hop Purpan, CHU Toulouse, Virol Lab, Inst Federatif Biol Purpan, Toulouse, France	University of Lausanne; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); CHU de Toulouse	Darling, KEA (corresponding author), Univ Lausanne, Univ Lausanne Hosp, Lausanne, Switzerland.	Katharine.Darling@chuv.ch	ABRAVANEL, Florence/AAC-2993-2021; Abrvaanel, florence/K-3776-2014; IZOPET, Jacques/L-5756-2014; cavassini, matthias/F-8987-2017; Moradpour, Darius/G-7918-2017	ABRAVANEL, Florence/0000-0002-1753-1065; Darling, Katharine/0000-0003-1449-3873; Schnegg-Kaufmann, Annatina/0000-0001-7716-3340; Kenfak Foguena, Alain/0000-0002-8213-2490; cavassini, matthias/0000-0003-0933-7833; Moradpour, Darius/0000-0003-1977-6792	outpatients department of the service of Infectious Diseases of the Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland	outpatients department of the service of Infectious Diseases of the Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland	The study has been funded by the research fund of the outpatients department of the service of Infectious Diseases of the Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abravanel F, 2012, J CLIN MICROBIOL, V50, P897, DOI 10.1128/JCM.05942-11; Aggarwal R, 2011, VIRUS RES, V161, P15, DOI 10.1016/j.virusres.2011.03.017; Bendall R, 2010, J MED VIROL, V82, P799, DOI 10.1002/jmv.21656; Bigaillon C, 2010, J VIROL METHODS, V164, P127, DOI 10.1016/j.jviromet.2009.11.028; Christensen PB, 2008, CLIN INFECT DIS, V47, P1026, DOI 10.1086/591970; Clemente-Casares P, 2003, EMERG INFECT DIS, V9, P448; Dalekos GN, 1998, TRANSFUSION, V38, P589, DOI 10.1046/j.1537-2995.1998.38698326339.x; Herremans M, 2007, CLIN VACCINE IMMUNOL, V14, P562, DOI 10.1128/CVI.00231-06; Kamar N, 2008, NEW ENGL J MED, V358, P811, DOI 10.1056/NEJMoa0706992; Kamar N, 2012, LANCET, V379, P2477, DOI 10.1016/S0140-6736(11)61849-7; Kaufmann A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021150; Kenfak-Foguena A, 2011, EMERG INFECT DIS, V17, P1074, DOI [10.3201/eid1706.101067, 10.3201/eid/1706.101067]; Khudyakov Y, 2011, VIRUS RES, V161, P84, DOI 10.1016/j.virusres.2011.06.006; Li RC, 2006, EMERG INFECT DIS, V12, P1682, DOI 10.3201/eid1211.060332; Lin CC, 2000, J CLIN MICROBIOL, V38, P3915, DOI 10.1128/JCM.38.11.3915-3918.2000; Mansuy JM, 2011, EMERG INFECT DIS, V17, P2309, DOI 10.3201/eid1712.110371; Mast EE, 1998, HEPATOLOGY, V27, P857, DOI 10.1002/hep.510270331; Mitsui T, 2005, J MED VIROL, V76, P526, DOI 10.1002/jmv.20393; Turner J, 2010, J MED VIROL, V82, P1899, DOI 10.1002/jmv.21905; YARBOUGH PO, 1991, J VIROL, V65, P5790, DOI 10.1128/JVI.65.11.5790-5797.1991; Zhang JZ, 2002, J MED VIROL, V66, P40, DOI 10.1002/jmv.2109	21	46	47	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e62980	10.1371/journal.pone.0062980	http://dx.doi.org/10.1371/journal.pone.0062980			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667554	Green Submitted, Green Published, gold			2022-12-27	WOS:000319654700092
J	Horacek, I; Knitlova, M; Wagner, J; Kordos, L; Nadachowski, A				Horacek, Ivan; Knitlova, Marketa; Wagner, Jan; Kordos, Laszlo; Nadachowski, Adam			Late Cenozoic History of the Genus Micromys (Mammalia, Rodentia) in Central Europe	PLOS ONE			English	Article							MURIDAE RODENTIA; PLIOCENE; NEOGENE; BASIN; PLEISTOCENE; MIOCENE; SPAIN; CHRONOLOGY; GRANADA; GREECE	Molecular phylogeography suggests that Micromys minutus, the sole extant species of the genus, colonized its extensive range quite recently, during the Late Pleistocene-Holocene period. Rich Pliocene and Pleistocene fossil records both from Europe and China suggest rather continuous and gradual in situ phenotype rearrangements from the Pliocene to the Recent periods. To elucidate the discrepancy we reexamined a considerable part of the European fossil record of the genus (14 sites from MN15 to Q3, 0.4-4.2 Ma, including the type series of M. preaminutus from MN15 Csarnota 2), analyzed them with the aid of detailed morphometric comparisons, and concluded that: (a) The European Pliocene form, M. praeminutus, differs significantly from the extant species; (b) it exhibits a broad phenotypic variation covering the presumptive diagnostic characters of MN16 M. caesaris; (c) despite having smaller dimensions, the Early and Middle Pleistocene forms (MN17-Q3, 2.6-0.4 Ma) seem to be closer to M. praeminutus than to the extant species; (d) the extinction of M. praeminutus during Q3 and the re-occupation of its niche by the recent expansion of M. minutus from E-European - C Asiatic sources (suggested by phylogeographic hypotheses) cannot be excluded. Discussing interpretations of the phylogenetic past of the genus we emphasize the distinct history of the West Palearctic clade (Late Miocene-Early Pleistocene) terminating with M. praeminutus and the East Asiatic clade (chalceus, tedfordi, minutus), and the possible identity of the Western clade with the Late Miocene genus Parapodemus.	[Horacek, Ivan; Knitlova, Marketa] Charles Univ Prague, Dept Zool, Prague, Czech Republic; [Wagner, Jan] Inst Geol AS CR, Vvi, Prague, Czech Republic; [Kordos, Laszlo] Magyar Foldtani & Geofizikai Intezet, Budapest, Hungary; [Nadachowski, Adam] Inst Systemat & Evolut Anim PAS, Krakow, Poland	Charles University Prague; Czech Academy of Sciences; Institute of Geology of the Czech Academy of Sciences; Polish Academy of Sciences; Institute of Systematics & Evolution of Animals of the Polish Academy of Sciences	Horacek, I (corresponding author), Charles Univ Prague, Dept Zool, Prague, Czech Republic.	horacek@natur.cuni.cz	Horacek, Ivan/V-9741-2017; Knitlova, Marketa/Q-1044-2017	Horacek, Ivan/0000-0002-8356-5554; Nadachowski, Adam/0000-0001-6452-3028; Knitlova, Marketa/0000-0001-6271-9991	Grant Agency of the Czech Republic [GA205/09/0184]; GAUK [355511]; Institute of Geology AS CR, v.v.i. [AVOZ30130516, RVO67985831]	Grant Agency of the Czech Republic(Grant Agency of the Czech Republic); GAUK; Institute of Geology AS CR, v.v.i.(Czech Academy of Sciences)	The study was supported by grant No. GA205/09/0184 from the Grant Agency of the Czech Republic (to JW and IH), GAUK 355511 (to MK), and by institutional project AVOZ30130516 and RVO67985831 of the Institute of Geology AS CR, v.v.i. (JW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar Jean-Pierre, 2002, Geologie de la France, V4, P17; Aguilar Jean-Pierre, 1996, Acta Zoologica Cracoviensia, V39, P35; Agusti J, 2001, EARTH-SCI REV, V52, P247, DOI 10.1016/S0012-8252(00)00025-8; Agusti J, 2010, QUATERN INT, V223, P162, DOI 10.1016/j.quaint.2009.12.011; Alpaslan Fadime Suata, 2010, Cumhuriyet Universitesi Fen Edebiyat Fakultesi Fen Bilimleri Dergisi, V31, P1; Antonanzas RL, 2002, PALAEOGEOGR PALAEOCL, V186, P311; BERGGREN WA, 1995, GEOL SOC AM BULL, V107, P1272, DOI 10.1130/0016-7606(1995)107<1272:LNCNPI>2.3.CO;2; Bernor R.L., 1996, P449; de Bruijn H., 1989, Bollettino della Societa Paleontologica Italiana, V28, P189; de Bruijn H., 1996, P253; De Bruijn H, 1976, P KON NEDERL AKAD B, V79, P361; Dehm R., 1962, Mitteilungen der Bayerischen Staatssammlung fuer Palaeontologie und Historische Geologie, V2, P17; Fejfar O., 1990, Senckenbergiana Lethaea, V71, P139; Fejfar O., 1983, Schriftenreihe fuer Geologische Wissenschaften, V19-20, P61; Fejfar O., 1983, Schriftenreihe fuer Geologische Wissenschaften, V19-20, P111; Garcia-Alix A, 2008, NEUES JAHRB GEOL P-A, V248, P183, DOI 10.1127/0077-7749/2008/0248-0183; Heinrich W.-D., 1983, Wissenschaftliche Zeitschrift der Humboldt-Universitaet zu Berlin Mathematisch-Naturwissenschaftliche Reihe, V32, P729; HELLER F., 1936, NEUES JB MINERALOGIE, V76, P99, DOI [10.1007/BF03042849, DOI 10.1007/BF03042849]; HORACEK I, 1988, Rozpravy Ceskoslovenske Akademie Ved Rada Matematickych a Prirodnich Ved, V98, P1; Horacek I., 1985, Casopis pro Mineralogii a Geologii, V30, P353; JAEGER JJ, 1989, PHILOS T ROY SOC B, V325, P401, DOI 10.1098/rstb.1989.0096; Jannosy D, 1986, QUARTARPALAONTOLOGIE; Janossy D, 1986, PALEOBIOLOGIE CONTIN; Janossy D, 1976, KARSZT BARLANGKUTATA, V8, P3; Jeannet Marcel, 2009, Revue de Paleobiologie, V28, P139; Kormos T., 1911, FOLDTANI KOZLONY, V41, P171; Koufos G. D., 2006, Hellenic Journal of Geosciences, V41, P183; Kowalski K., 2001, FOLIA QUATERNARIA, V72, P1; KOWALSKI KAZIMIREZ, 1956, ACTA PALEONTOL POLONICA, V1, P331; KOWALSKL KAZIMIERZ, 1960, ACTA ZOOL CRACOVIENSIA, V5, P155; Kretzoi M., 1959, Vertebrata Hungarica, V1, P237; Kretzoi M, 1962, MAGYAR ALLAMI FOLDTA, V1959, P297; Krokhmal AI, 2010, LOCALITIES SMALL PLE; Lazzari V, 2010, PALEOBIOLOGY, V36, P641, DOI 10.1666/09046.1; Lecompte E, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-199; Lisiecki LE, 2005, PALEOCEANOGRAPHY, V20, DOI 10.1029/2004PA001071; Lungu A. N, 1981, HIPPARION FAUNA MIDD; Marquet J.C., 1993, CAHIERS CLAISE S, V2, P1; Martin Suarez E., 1993, Scripta Geologica, V103, P65; Martin-Suarez E, 1998, GEOBIOS-LYON, V31, P839, DOI 10.1016/S0016-6995(98)80113-7; Mein P., 1993, Scripta Geologica, V103, P41; MEIN P, 1989, NATO ADV SCI I A-LIF, V180, P73; MEIN P, 1978, Geobios (Villeurbanne), V11, P389, DOI 10.1016/S0016-6995(78)80038-2; MEIN P, 1983, CR ACAD SCI II, V296, P1603; MEIN P, 1978, DOCUMENTS LAB GEOLOG, V72, P99; Mein P, 1976, P 6 C R C M N S, V2, P78; Michaux J, 2007, J ZOOL SYST EVOL RES, V45, P263, DOI 10.1111/j.1439-0469.2006.00390.x; Michaux J., 1969, Palaeovertebrata (Montpellier), V3, P1; Michaux J, 1971, PAL OBIOLOGIE CONTIN, V2, P1; Minwer-Barakat R, 2005, J VERTEBR PALEONTOL, V25, P426, DOI 10.1671/0272-4634(2005)025[0426:MRFTPO]2.0.CO;2; Minwer-Barakat R, 2008, J PALEONTOL, V82, P436, DOI 10.1666/06-030.1; Nadachowski Adam, 1990, Quartaerpalaeontologie, V8, P215; Nesin Valentin A., 2004, Senckenbergiana Lethaea, V84, P351; Papp A., 1947, Sitzungsberichte Akademie der Wissenschaften Wien Abt 1, V156, P371; Qiu Z.D., 1990, J VERTEBR PALEONTOL, V10, P467, DOI DOI 10.1080/02724634.1990.10011829; Rekovets LI, 1994, SMALL PLEISTOCENE MA; Reumer JWF, 2003, TORNO FOSILES MAMIFE, P269; Rowe KC, 2008, MOL PHYLOGENET EVOL, V47, P84, DOI 10.1016/j.ympev.2008.01.001; Schaub S., 1938, Abhandlungen der Schweizerischen Palaeontologischen Gesellschaft Geneve, V61, P1; Sen S., 2003, P125; Storch G, 2002, GEOBIOS-LYON, V35, P515, DOI 10.1016/S0016-6995(02)00043-8; Storch G., 1987, Senckenbergiana Lethaea, V67, P401; STORCH G, 1973, Senckenbergiana Lethaea, V54, P311; Storch G, 2004, TERRA NOSTRA, V2004; Storch Gerhard, 1995, Muenchner Geowissenschaftliche Abhandlungen Reihe A Geologie und Palaeontologie, V28, P121; Suarez EM, 1998, GEOBIOS-LYON, V31, P87; SULIMSKI ANDRZEJ, 1964, ACTA PALAEONTOL POL, V9, P149; Van Dam Jan A., 1997, Geologica Ultraiectina, V156, P1; van de Weerd A., 1978, Geobios (Villeurbanne), V11, P921; van de Weerd A, 1976, UTRECHT MICROPALEONT, V2; van der Meulen A.J., 1988, Memorie della Societa Geologica Italiana, V31, P201; VANDEWEERD A, 1979, P K NED AKAD B PHYS, V82, P127; Vasileiadou Katerina, 2012, Palaeobiodiversity and Palaeoenvironments, V92, P211, DOI 10.1007/s12549-012-0075-7; Vasileiadou Katerina V., 2003, Deinsea (Rotterdam), V10, P549; Wessels W., 2009, GEOL ULTRAIECTINA, V307; Wu Wenyu, 1992, Vertebrata Palasiatica, V30, P17; Yasuda SP, 2005, CAN J ZOOL, V83, P1411, DOI 10.1139/Z05-139	77	7	10	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2013	8	5							e62498	10.1371/journal.pone.0062498	http://dx.doi.org/10.1371/journal.pone.0062498			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	177QL	23671605	Green Published, gold			2022-12-27	WOS:000321390200025
J	Dou, XL; Qin, RL; Qu, J; Liao, YH; Lu, YC; Zhang, T; Shao, C; Li, YQ				Dou, Xiao Liang; Qin, Rong Liang; Qu, Juan; Liao, Yong Hui; Lu, Ya Cheng; Zhang, Ting; Shao, Chen; Li, Yun Qing			Synaptic Connections between Endomorphin 2-Immunoreactive Terminals and mu-Opioid Receptor-Expressing Neurons in the Sacral Parasympathetic Nucleus of the Rat	PLOS ONE			English	Article							URINARY-BLADDER CONTRACTIONS; CENTRAL-NERVOUS-SYSTEM; SPINAL-CORD; PREGANGLIONIC NEURONS; IMMUNOHISTOCHEMICAL LOCALIZATION; AUTORADIOGRAPHIC LOCALIZATION; IMMUNOPOSITIVE FIBERS; MICTURITION REFLEX; INTERSTITIAL-CELLS; PRIMARY AFFERENTS	The urinary bladder is innervated by parasympathetic preganglionic neurons (PPNs) that express mu-opioid receptors (MOR) in the sacral parasympathetic nucleus (SPN) at lumbosacral segments L6-S1. The SPN also contains endomorphin 2 (EM2)-immunoreactive (IR) fibers and terminals. EM2 is the endogenous ligand of MOR. In the present study, retrograde tract-tracing with cholera toxin subunit b (CTb) or wheat germ agglutinin-conjugated horseradish peroxidase (WGA-HRP) via the pelvic nerve combined with immunohistochemical staining for EM2 and MOR to identify PPNs within the SPN as well as synaptic connections between the EM2-IR terminals and MOR-expressing PPNs in the SPN of the rat. After CTb was injected into the pelvic nerve, CTb retrogradely labeled neurons were almost exclusively located in the lateral part of the intermediolateral gray matter at L6-S1 of the lumbosacral spinal cord. All of the them also expressed MOR. EM2-IR terminals formed symmetric synapses with MOR-IR, WGA-HRP-labeled and WGA-HRP/MOR double-labeled neuronal cell bodies and dendrites within the SPN. These results provided morphological evidence that EM2-containing axon terminals formed symmetric synapses with MOR-expressing PPNs in the SPN. The present results also show that EM2 and MOR might be involved in both the homeostatic control and information transmission of micturition.	[Dou, Xiao Liang; Qin, Rong Liang; Shao, Chen] Fourth Mil Med Univ, Xijing Hosp, Dept Urol, Xian 710032, Peoples R China; [Qu, Juan; Liao, Yong Hui; Lu, Ya Cheng; Zhang, Ting; Li, Yun Qing] Fourth Mil Med Univ, Dept Anat Histol & Embryol, Xian 710032, Peoples R China; [Qu, Juan; Liao, Yong Hui; Lu, Ya Cheng; Zhang, Ting; Li, Yun Qing] Fourth Mil Med Univ, KK Leung Brain Res Ctr, Xian 710032, Peoples R China	Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University	Shao, C (corresponding author), Fourth Mil Med Univ, Xijing Hosp, Dept Urol, Xian 710032, Peoples R China.	shaochen@fmmu.edu.cn; deptanat@fmmu.edu.cn			National Natural Science Foundation of China [30771133, 31010103909]; International Cooperation Program [2011DFA3311]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); International Cooperation Program	This work was supported by grants from the National Natural Science Foundation of China(http://www.nsfc.gov.cn/Portal0/default152.htm)(Nos. 30771133, 31010103909) and the International Cooperation Program (http://www.nsfc.gov.cn/Portal0/default152.htm)(No. 2011DFA3311). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banrezes B, 2002, NEUROSCIENCE, V115, P97, DOI 10.1016/S0306-4522(02)00405-0; Beckel Jonathan M, 2011, Handb Exp Pharmacol, P99, DOI 10.1007/978-3-642-16499-6_6; Blok BFM, 1998, BEHAV BRAIN RES, V92, P119, DOI 10.1016/S0166-4328(97)00184-8; Blok BFM, 2002, SCAND J UROL NEPHROL, V36, P11, DOI 10.1080/003655902320765908; Buss RR, 2003, J PHYSIOL-LONDON, V551, P387, DOI 10.1113/jphysiol.2003.041996; Carter R. R., 1995, IEEE Transactions on Rehabilitation Engineering, V3, P206, DOI 10.1109/86.392367; de Groat WC, 2006, BRIT J PHARMACOL, V147, pS25, DOI 10.1038/sj.bjp.0706604; DEGROAT WC, 1993, UROL CLIN N AM, V20, P383; DEGROAT WC, 1981, J AUTONOM NERV SYST, V3, P135, DOI 10.1016/0165-1838(81)90059-X; DEGROAT WC, 1982, J AUTONOM NERV SYST, V5, P23, DOI 10.1016/0165-1838(82)90087-X; DEGROAT WC, 1975, BRAIN RES, V87, P201, DOI 10.1016/0006-8993(75)90417-5; Ding YQ, 1997, J COMP NEUROL, V389, P149, DOI 10.1002/(SICI)1096-9861(19971208)389:1<149::AID-CNE11>3.0.CO;2-G; Ding YQ, 1996, J COMP NEUROL, V367, P375; Dmitrieva N, 2002, J NEUROSCI, V22, P7147; DRAY A, 1984, J PHARMACOL EXP THER, V231, P254; DRAY A, 1987, NEUROPHARMACOLOGY, V26, P753, DOI 10.1016/0028-3908(87)90238-3; DRAY A, 1985, BRAIN RES, V337, P142, DOI 10.1016/0006-8993(85)91619-1; DRAY A, 1984, EUR J PHARMACOL, V104, P47, DOI 10.1016/0014-2999(84)90367-4; Farquhar-Smith WP, 2001, ANESTHESIOLOGY, V94, P507, DOI 10.1097/00000542-200103000-00023; GOUARDERES C, 1991, NEUROSCIENCE, V43, P197, DOI 10.1016/0306-4522(91)90427-P; Grill WM, 1999, BRAIN RES, V836, P19, DOI 10.1016/S0006-8993(99)01581-4; Gu Y. M., 1991, CHINESE J NEUROANAT, V7, P124; HANCOCK MB, 1979, NEUROSCI LETT, V11, P1, DOI 10.1016/0304-3940(79)90046-6; Hiragata S, 2007, UROLOGY, V70, P202, DOI 10.1016/j.urology.2007.02.069; HISAMITSU T, 1984, BRAIN RES, V298, P51, DOI 10.1016/0006-8993(84)91146-6; HONDA CN, 1995, NEUROREPORT, V6, P1025, DOI 10.1097/00001756-199505090-00019; Hui R, 2010, NEUROSCIENCE, V169, P422, DOI 10.1016/j.neuroscience.2010.05.006; IGAWA Y, 1993, BRIT J PHARMACOL, V110, P257, DOI 10.1111/j.1476-5381.1993.tb13802.x; JUBELIN B, 1984, LIFE SCI, V34, P2015, DOI 10.1016/0024-3205(84)90366-7; KONTANI H, 1988, JPN J PHARMACOL, V48, P31, DOI 10.1254/jjp.48.31; KRUSE MN, 1992, AM J PHYSIOL, V262, pR478, DOI 10.1152/ajpregu.1992.262.3.R478; Lagou M, 2006, BJU INT, V97, P1332, DOI 10.1111/j.1464-410X.2006.06203.x; LAPLANE D, 1981, J NEUROL SCI, V51, P289, DOI 10.1016/0022-510X(81)90107-6; Li JL, 1998, BRAIN RES, V794, P347, DOI 10.1016/S0006-8993(98)00332-1; MAGGI CA, 1989, J AUTONOM NERV SYST, V26, P11, DOI 10.1016/0165-1838(89)90102-1; Mannen T, 2000, NEUROPATHOLOGY, V20, pS30; MANSOUR A, 1994, BRAIN RES, V643, P245, DOI 10.1016/0006-8993(94)90031-0; Mansour A., 1993, OPIOIDS, P79, DOI [10.1007/978-3-642-77460-7, DOI 10.1007/978-3-642-77460-7_5]; Martin RS, 2000, BRIT J PHARMACOL, V129, P1707, DOI 10.1038/sj.bjp.0703229; Martin-Schild S, 1997, PEPTIDES, V18, P1641, DOI 10.1016/S0196-9781(97)00320-3; Martin-Schild S, 1998, PEPTIDES, V19, P1783, DOI 10.1016/S0196-9781(98)00136-3; Moriwaki A, 1996, NEUROCHEM RES, V21, P1315, DOI 10.1007/BF02532373; MOSKOWITZ AS, 1984, J NEUROSCI, V4, P1331; NADELHAFT I, 1984, J COMP NEUROL, V226, P238, DOI 10.1002/cne.902260207; Nagasaka Y, 2007, INT J UROL, V14, P226, DOI 10.1111/j.1442-2042.2007.01700.x; Okada M, 1986, Masui, V35, P877; PASCUAL JI, 1993, J UROLOGY, V150, P500, DOI 10.1016/S0022-5347(17)35535-0; Pertwee RG, 1996, BRIT J PHARMACOL, V118, P2053, DOI 10.1111/j.1476-5381.1996.tb15643.x; Pierce TL, 1998, NEUROREPORT, V9, P385, DOI 10.1097/00001756-199802160-00005; Rivero G, 2012, MOL PHARMACOL, V82, P178, DOI 10.1124/mol.112.078659; SHELDON RJ, 1987, J PHARMACOL EXP THER, V243, P234; Shimizu I, 2000, BRIT J PHARMACOL, V131, P610, DOI 10.1038/sj.bjp.0703593; Spetea M, 1998, BIOCHEM BIOPH RES CO, V250, P720, DOI 10.1006/bbrc.1998.9395; SUGAYA K, 1987, NEUROSCI LETT, V80, P197, DOI 10.1016/0304-3940(87)90653-7; Tai CF, 2004, EXP NEUROL, V190, P171, DOI 10.1016/j.expneurol.2004.07.001; Wang YQ, 2010, J SURG RES, V164, pE213, DOI 10.1016/j.jss.2010.04.040; Yoshimora N, 2007, CAMPBELLWALSH UROLOG, P1922; Zadina JE, 1997, NATURE, V386, P499, DOI 10.1038/386499a0; Zadina JE, 1999, ANN NY ACAD SCI, V897, P136, DOI 10.1111/j.1749-6632.1999.tb07885.x; Zhu C, 2011, BRAIN RES, V1410, P38, DOI 10.1016/j.brainres.2011.06.067	60	7	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2013	8	5							e62028	10.1371/journal.pone.0062028	http://dx.doi.org/10.1371/journal.pone.0062028			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175AS	23671582	gold, Green Published, Green Submitted			2022-12-27	WOS:000321202100004
J	Ji, LN; Li, HM; Guo, XH; Li, Y; Hu, RM; Zhu, ZY				Ji, Linong; Li, Hongmei; Guo, Xiaohui; Li, Yan; Hu, Renming; Zhu, Zhengying			Impact of Baseline BMI on Glycemic Control and Weight Change with Metformin Monotherapy in Chinese Type 2 Diabetes Patients: Phase IV Open-Label Trial	PLOS ONE			English	Article							BODY-MASS INDEX; NONOBESE PATIENTS; RISK-FACTORS; THERAPY; HYPERGLYCEMIA; EFFICACY; ADULTS	Background: Differences exist between treatment recommendations regarding the choice of metformin as first-line therapy for type 2 diabetes patients according to body mass index (BMI). This study compared the efficacy of metformin monotherapy among normal-weight, overweight, and obese patients with newly diagnosed type 2 diabetes. Methods: In this prospective, multicenter, open-label study in China, patients aged 23-77 years were enrolled 1: 1: 1 according to baseline BMI: normal-weight (BMI 18.5-23.9 kg/m(2); n = 125); overweight (BMI 24.0-27.9 kg/m(2); n = 122) or obese (BMI >= 28 kg/m(2); n = 124). Extended-release metformin was administered for 16 weeks (500 mg/day, up-titrated weekly to a maximum 2,000 mg/day). The primary efficacy endpoint was the effect of baseline BMI on glycemic control with metformin monotherapy, measured as the change from baseline in glycosylated hemoglobin (HbA(1c)) at week 16 compared among BMI groups using ANCOVA. Other endpoints included comparisons of metformin's effects on fasting plasma glucose (FPG), lipid levels and body weight. Results: Mean HbA1c decreases at week 16, adjusted for baseline values, were -1.84%, -1.78% and -1.78% in normal-weight, overweight and obese patients, (P = 0.664); body weight decreased by 2.4%, 3.9% and 3.5%, respectively. FPG levels decreased similarly over time in all BMI groups (P = 0.461) and changes from baseline in high-density lipoprotein cholesterol (HDL-C) and low-density lipoprotein cholesterol (LDL-C) did not differ significantly among BMI groups at week 16 (P = 0.143 and 0.451, respectively). Conclusions: Baseline BMI had no impact on glycemic control, weight change or other efficacy measures with metformin monotherapy. These data suggest that normal-weight type 2 diabetes patients would derive the same benefits from first-line treatment with metformin as overweight and obese patients, and are not at increased risk of excess weight loss.	[Ji, Linong] Peking Univ, Peoples Hosp, Dept Endocrinol & Metab, Beijing 100871, Peoples R China; [Li, Hongmei] Sino Amer Shanghai Squibb Pharmaceut Ltd, Clin Res, China Res & Dev, Shanghai, Peoples R China; [Guo, Xiaohui] Peking Univ, Peoples Hosp, Dept Endocrinol, Beijing 100871, Peoples R China; [Li, Yan] Sun Yat Sen Univ, Dept Endocrinol, Sun Yat Sen Mem Hosp, Guangzhou 510275, Guangdong, Peoples R China; [Hu, Renming] Fudan Univ, Huashan Hosp, Dept Endocrinol & Metab, Shanghai 200433, Peoples R China; [Zhu, Zhengying] Bristol Myers Squibb, China Res & Dev, Clin Res, Shanghai, Peoples R China	Peking University; Peking University; Sun Yat Sen University; Fudan University; Bristol-Myers Squibb	Ji, LN (corresponding author), Peking Univ, Peoples Hosp, Dept Endocrinol & Metab, Beijing 100871, Peoples R China.	jiln@bjmu.edu.cn	Linong, Ji/AAB-6543-2020		Bristol-Myers Squibb	Bristol-Myers Squibb(Bristol-Myers Squibb)	This study was funded by Bristol-Myers Squibb. Statistical analyses were performed by Mei Ji and Xianyi Kong of Pharmaceutical Product Development, Inc., paid for by Bristol-Myers Squibb. Editorial assistance with preparation of the manuscript was provided by Samantha Santangelo, PhD, of MediTech Media Asia Pacific Pte Ltd, paid for by Bristol-Myers Squibb. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors LJ, XG and RH have received honoraria for attending Advisory Board meetings for Bristol-Myers Squibb and have received payment for lectures. LJ and XG are investigators in clinical trials of other compounds under development by Bristol-Myers Squibb. ZZ is an employee of Bristol-Myers Squibb and has received stock/stock options from Bristol-Myers Squibb. This study was funded by Bristol-Myers Squibb. Statistical analyses were performed by MJ and XK of Pharmaceutical Product Development, Inc., paid for by Bristol-Myers Squibb. Editorial assistance with preparation of the manuscript was provided by Samantha Santangelo, PhD, of MediTech Media Asia Pacific Pte Ltd, paid for by Bristol-Myers Squibb. HL is an employee of Sino-American Shanghai Squibb Pharmaceutical Ltd. Metformin which was used in this study is a product of Bristol-Myers Squibb. There are no further patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Amer Diabet Assoc, 2008, DIABETES CARE, V31, pS12, DOI 10.2337/dc08-S012; American Diabetes Association, 2007, Diabetes Care, V30 Suppl 1, pS4; [Anonymous], 2012, DIABETES CARE, V35, pS11, DOI [10.2337/dc12-s011, 10.2337/dc12-s004, 10.2337/dc35-S011]; Asian-Pacific Type 2 Diabetes Policy Group, 2005, TYP 2 DIAB PRACT TAR; Bei-Fan Z, 2002, ASIA PAC J CLIN NUTR, V11, pS685, DOI 10.1046/j.1440-6047.11.s8.9.x; Blonde L, 2004, CURR MED RES OPIN, V20, P565, DOI 10.1185/030079904125003278; Boffetta P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019930; Chan WB, 2004, DIABETIC MED, V21, P349, DOI 10.1111/j.1464-5491.2004.01158.x; Chinese Diabetes Society, 2010, CHIN INV CORP ANN RE, P1; Consoli A, 2004, DIABETES METAB, V30, P509, DOI 10.1016/S1262-3636(07)70148-9; Donnelly LA, 2006, DIABETIC MED, V23, P128, DOI 10.1111/j.1464-5491.2005.01755.x; Garber A, 2003, DIABETES OBES METAB, V5, P171, DOI 10.1046/j.1463-1326.2003.00259.x; Home P, 2006, DIABETIC MED, V23, P579; Ito H, 2010, NUTR METAB, V7, DOI 10.1186/1743-7075-7-83; Lund SS, 2007, DIABETES OBES METAB, V9, P394, DOI 10.1111/j.1463-1326.2007.00713.x; Nathan D, 2009, DIABETOLOGIA, V52, P17, DOI 10.1007/s00125-008-1157-y; Ong CR, 2006, DIABETES CARE, V29, P2361, DOI 10.2337/dc06-0827; Sambol NC, 1996, J CLIN PHARMACOL, V36, P1012, DOI 10.1177/009127009603601105; Scarpello JHB, 2008, DIABETES VASC DIS RE, V5, P157, DOI 10.3132/dvdr.2008.027; West DS, 2008, OBESITY, V16, P1413, DOI 10.1038/oby.2008.224; Xu H, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-683	21	39	58	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2013	8	2							e57222	10.1371/journal.pone.0057222	http://dx.doi.org/10.1371/journal.pone.0057222			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098DA	23667609	gold, Green Published, Green Submitted			2022-12-27	WOS:000315524900060
J	Tsai, HH; Lin, HW; Lu, YH; Chen, YL; Mahady, GB				Tsai, Hsin-Hui; Lin, Hsiang-Wen; Lu, Ying-Hung; Chen, Yi-Ling; Mahady, Gail B.			A Review of Potential Harmful Interactions between Anticoagulant/Antiplatelet Agents and Chinese Herbal Medicines	PLOS ONE			English	Article							ST-JOHNS-WORT; PRODUCT-DRUG INTERACTIONS; IN-VIVO ASSESSMENT; ALTERNATIVE MEDICINE; PRESCRIPTION MEDICATIONS; DIETARY-SUPPLEMENTS; HEALTHY-SUBJECTS; GINKGO-BILOBA; PHARMACOKINETIC INTERACTIONS; NUTRITIONAL SUPPLEMENTS	Background: The risks attributed to drug-herb interactions, even when known, are often ignored or underestimated, especially for those involving anti-clotting drugs and Chinese medicines. The aim of this study was to structurally search and evaluate the existing evidence-based data associated with potential drug interactions between anticoagulant/antiplatelet drugs and Chinese herbal medicines (CHMs) and evaluate the documented mechanisms, consequences, and/or severity of interactions. Methodology and Findings: Information related to anticoagulant/antiplatelet drug-CHM interactions was retrieved from eight interaction-based textbooks, four web resources and available primary biomedical literature. The primary literature searches were conducted in English and/or Chinese from January 2000 through December 2011 using the secondary databases (e.g., PubMed, Airiti Library, China Journal full-text database). The search terms included the corresponding medical subject headings and key words. Herbs or natural products not used as a single entity CHM or in Chinese Medicinal Prescriptions were excluded from further review. The corresponding mechanisms and severity ratings of interactions were retrieved using MicroMedex (R), Lexicomp (R) and Natural Medicines Comprehensive Database (R). Finally, we found 90 single entity CHMs contributed to 306 documented drug-CHM interactions. A total of 194 (63.4%) interactions were verified for its evidence describing possible mechanisms and severity. Of them, 155 interactions (79.9%) were attributable to pharmacodynamic interactions, and almost all were rated as moderate to severe interactions. The major consequences of these interactions were increased bleeding risks due to the additive anticoagulant or antiplatelet effects of the CHMs, specifically danshen, dong quai, ginger, ginkgo, licorice, and turmeric. Conclusions/Significance: Conventional anticoagulants and antiplatelet drugs were documented to have harmful interactions with some commonly used single entity CHMs. For those patients who are taking conventional anti-clotting medications with CHMs for cardiovascular or cerebrovascular diseases, the potential risks of increased bleeding due to drug-CHM interactions should not be ignored.	[Tsai, Hsin-Hui; Lin, Hsiang-Wen; Lu, Ying-Hung; Chen, Yi-Ling] China Med Univ, Coll Pharm, Sch Pharm, Taichung, Taiwan; [Tsai, Hsin-Hui; Lin, Hsiang-Wen; Lu, Ying-Hung; Chen, Yi-Ling] China Med Univ, Coll Pharm, Grad Inst, Taichung, Taiwan; [Tsai, Hsin-Hui; Lin, Hsiang-Wen] China Med Univ Hosp, Dept Pharm, Taichung, Taiwan; [Lin, Hsiang-Wen] Univ Illinois, Coll Pharm, Dept Pharm Adm, Chicago, IL USA; [Mahady, Gail B.] Univ Illinois, Coll Pharm, Dept Pharm Practice, PAHO WHO Collaborating Ctr Tradit Med, Chicago, IL USA	China Medical University Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Lin, HW (corresponding author), China Med Univ, Coll Pharm, Sch Pharm, Taichung, Taiwan.	hsiangwl@mail.cmu.edu.tw	Chen, Yi/HIR-2608-2022	Tsai, Hsiu Ting/0000-0003-1137-9274	Committee on Chinese medicine and Pharmacy, Department of Health, Executive Yuan, Taiwan, R.O.C. [CCMP99-RD-016]; National Science Council [NSC 99-2320-B-039 -031 -MY3]	Committee on Chinese medicine and Pharmacy, Department of Health, Executive Yuan, Taiwan, R.O.C.; National Science Council(Ministry of Science and Technology, Taiwan)	This study was fully supported by the Committee on Chinese medicine and Pharmacy, Department of Health, Executive Yuan, Taiwan, R.O.C. ( grant number: CCMP99-RD-016) and partially supported by National Science Council (grant number: NSC 99-2320-B-039 -031 -MY3). Those founders have no role in study design, data collection, and analysis, decision to publish, or preparation of the manuscript.	Abarca Jacob, 2004, J Am Pharm Assoc (2003), V44, P136, DOI 10.1331/154434504773062582; Abdul MIM, 2010, BRIT J CLIN PHARMACO, V69, P508, DOI 10.1111/j.1365-2125.2010.03620.x; Al Faraj S, 2005, ANN TROP MED PARASIT, V99, P219, DOI 10.1179/136485905X17434; Alherbish A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019623; Awang Dennis V C, 2002, J Cardiovasc Nurs, V16, P64; Blalock SJ, 2009, ALTERN THER HEALTH M, V15, P26; Bone KM, 2008, MOL NUTR FOOD RES, V52, P764, DOI 10.1002/mnfr.200700098; Borrelli F, 2009, AAPS J, V11, P710, DOI 10.1208/s12248-009-9146-8; Brazier Nicole C, 2003, Am J Ther, V10, P163, DOI 10.1097/00045391-200305000-00003; Bressler R, 2005, GERIATRICS, V60, P32; Bressler R, 2005, GERIATRICS, V60, P16; Bressler R, 2005, GERIATRICS, V60, P21; Bressler R, 2005, GERIATRICS-US, V60, P30; Bush TM, 2007, ALTERN THER HEALTH M, V13, P30; Butterweck V, 2008, CLIN PHARMACOKINET, V47, P383, DOI 10.2165/00003088-200847060-00003; Canter PH, 2004, DRUG AGING, V21, P597, DOI 10.2165/00002512-200421090-00004; Cassileth BR, 2003, HERB DRUG INTERACTIO; Chan ALF, 2011, J ALTERN COMPLEM MED, V17, P513, DOI 10.1089/acm.2010.0295; Chan E, 2010, CURR OPIN DRUG DISC, V13, P50; Chan HT, 2011, J CARDIOVASC PHARM, V58, P87, DOI 10.1097/FJC.0b013e31821cd888; Chang HC, 2003, CHINESE MED HERBS PR; Chang LC, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-170; Charrois TL, 2007, ANN PHARMACOTHER, V41, P1124, DOI 10.1345/aph.1H463; Chavez ML, 2006, LIFE SCI, V78, P2146, DOI 10.1016/j.lfs.2005.12.009; Chen FN, 2008, J INT CHIN W MED, V10, P25; Chen FP, 2011, FAMILY MED PRIMARY M, V26, P168; Chen J., 2007, CHIN J CLIN PHARM TH, V12, P1348; Choi YH, 2011, ARCH PHARM RES, V34, P1843, DOI 10.1007/s12272-011-1106-z; Clauson KA, 2008, ALTERN THER HEALTH M, V14, P36; Clauson KA, 2008, BMC COMPLEM ALTERN M, V8, DOI 10.1186/1472-6882-8-42; Cohen PA, 2010, CARDIOVASC THER, V28, P246, DOI 10.1111/j.1755-5922.2010.00193.x; Colalto C, 2010, PHARMACOL RES, V62, P207, DOI 10.1016/j.phrs.2010.04.001; Committee on Chinese Medicine and Pharmacy, 2004, TAIW HERB PHARM; Committee on Chinese Medicine and Pharmacy Department of Health Executive Yuan, ABSTR YB; Coxeter PD, 2004, CURR MED CHEM, V11, P1513, DOI 10.2174/0929867043365198; De Smet PAGM, 2008, CURR DRUG METAB, V9, P1055, DOI 10.2174/138920008786927730; Department of Health Executive Yuan R.O.C. (TAIWAN), DEP HLTH GOV RES B; Dergal JM, 2002, DRUG AGING, V19, P879, DOI 10.2165/00002512-200219110-00005; Di Carlo G, 2001, TRENDS PHARMACOL SCI, V22, P292, DOI 10.1016/S0165-6147(00)01716-8; Di YM, 2008, CURR PHARM DESIGN, V14, P1723, DOI 10.2174/138161208784746798; Dunn Steven P., 2011, Cardiovascular & Hematological Agents in Medicinal Chemistry, V9, P231; Ernst E, 2000, EUR J CLIN PHARMACOL, V56, P523, DOI 10.1007/s002280000194; Ernst E, 2004, PHARMACOEPIDEM DR S, V13, P767, DOI 10.1002/pds.1014; Ernst E, 2000, B WORLD HEALTH ORGAN, V78, P252; Fugh-Berman A, 2000, LANCET, V355, P134, DOI 10.1016/S0140-6736(99)06457-0; Fugh-Berman A, 2001, BRIT J CLIN PHARMACO, V52, P587, DOI 10.1046/j.0306-5251.2001.01469.x; Furie KL, 2011, STROKE, V42, P227, DOI 10.1161/STR.0b013e3181f7d043; Gardiner P, 2008, AM FAM PHYSICIAN, V77, P73; Goldman RD, 2008, J PEDIATR-US, V152, P521, DOI 10.1016/j.jpeds.2007.09.026; Greenblatt DJ, 2005, J CLIN PHARMACOL, V45, P127, DOI 10.1177/0091270004271404; Greeson JM, 2001, PSYCHOPHARMACOLOGY, V153, P402, DOI 10.1007/s002130000625; Haller CA, 2006, CLIN TOXICOL, V44, P605, DOI 10.1080/15563650600795545; Holbrook AM, 2005, ARCH INTERN MED, V165, P1095, DOI 10.1001/archinte.165.10.1095; Holcomb SS, 2009, NURSE PRACT, V34, P21, DOI 10.1097/01.NPR.0000350567.61353.2b; Hsieh SC, 2008, PHARMACOEPIDEM DR S, V17, P609, DOI 10.1002/pds.1611; Hu ZP, 2005, DRUGS, V65, P1239, DOI 10.2165/00003495-200565090-00005; Huang SM, 2004, J CLIN PHARMACOL, V44, P559, DOI 10.1177/0091270004265367; Izzo AA, 2001, DRUGS, V61, P2163, DOI 10.2165/00003495-200161150-00002; Izzo AA, 2005, FUND CLIN PHARMACOL, V19, P1, DOI 10.1111/j.1472-8206.2004.00301.x; Izzo AA, 2005, INT J CARDIOL, V98, P1, DOI 10.1016/j.ijcard.2003.06.039; Izzo AA, 2009, DRUGS, V69, P1777, DOI 10.2165/11317010-000000000-00000; Javed F, 2008, J LARYNGOL OTOL, V122, P116, DOI 10.1017/S0022215107000011; Jennes F, 2007, HERB TOXICITIES DRUG; Jiang XM, 2004, BRIT J CLIN PHARMACO, V57, P592, DOI 10.1111/j.1365-2125.2003.02051.x; Jiang XM, 2006, J CLIN PHARMACOL, V46, P1370, DOI 10.1177/0091270006292124; Ko Richard J, 2004, J Chin Med Assoc, V67, P109; Kuhn Merrily A, 2002, Crit Care Nurse, V22, P22; Kuo YF, 2006, J PHARM PHARMACOL, V58, P521, DOI 10.1211/jpp.58.4.0012; Lai D, 2007, FAM PRACT, V24, P56, DOI 10.1093/fampra/cml058; Lai JN, 2010, YB CHINESE MED PHARM, V28, P291; Lai YC, 2007, CHUNG SHAN MED J, V18, P343; Lee GBW, 2004, FAM PRACT, V21, P654, DOI 10.1093/fampra/cmh613; Lexicomp, 2012, LEX INT ONL; Li JY, 2008, J TAIWAN PHARM, V24, P135; Li YH, 2010, J ETHNOPHARMACOL, V128, P623, DOI 10.1016/j.jep.2010.02.003; Lim MK, 2005, COMPLEMENT THER MED, V13, P16, DOI 10.1016/j.ctim.2004.11.002; Lin JJ, 2003, SHOW CHWAN MED J, V4, P1; Madabushi R, 2006, EUR J CLIN PHARMACOL, V62, P225, DOI 10.1007/s00228-006-0096-0; Mahady GB, 2001, BOT DIETARY SUPPLEME, V1; Makino T, 2002, J ETHNOPHARMACOL, V82, P35, DOI 10.1016/S0378-8741(02)00175-7; Mao XQ, 2007, CHIN J CLIN PHARM TH, V12, P728; Markowitz J S, 2001, Psychopharmacol Bull, V35, P53; McFadden Roger, 2011, Nurs Stand, V25, P65; Mills E, 2005, THER DRUG MONIT, V27, P549, DOI 10.1097/01.ftd.0000170880.95267.90; Mousa SA, 2010, METHODS MOL BIOL, V663, P229, DOI 10.1007/978-1-60761-803-4_9; National Center for Complementary and Alternative Medicine, 2010, TRAD CHIN MED INTR; National Center for Complementary and Alternative Medicine, HERBS GLANC; Natural Medicines Comprehensive Database, NAT PROD DRUG INT CH; Norred CL, 2001, ALTERN THER HEALTH M, V7, P58; Nutescu E, 2011, J THROMB THROMBOLYS, V31, P326, DOI 10.1007/s11239-011-0561-1; Nutescu EA, 2006, EXPERT OPIN DRUG SAF, V5, P433, DOI 10.1517/14740338.5.3.433; *OFF DIET SUPPL, DIET SUPPL FACT SHEE; Ohnishi Noriaki, 2004, Keio Journal of Medicine, V53, P137, DOI 10.2302/kjm.53.137; Pal D, 2006, LIFE SCI, V78, P2131, DOI 10.1016/j.lfs.2005.12.010; Peng B, 2010, WORLD SCI TECHNOLOGY, DOI [10.3969/j.issn.1674-3849.2010.02.024, DOI 10.3969/J.ISSN.1674-3849.2010.02.024]; Philp RB, 2004, HERBAL DRUG INTERACT; Poppenga RH, 2002, CLIN TECH SMALL AN P, V17, P6, DOI 10.1053/svms.2002.27785; Rochelle TL, 2010, BRIT J HEALTH PSYCH, V15, P715, DOI 10.1348/135910709X479195; Rossler W, 2007, PSYCHOL MED, V37, P73, DOI 10.1017/S0033291706008841; Rogers EA, 2001, ACAD EMERG MED, V8, P932, DOI 10.1111/j.1553-2712.2001.tb01157.x; Samuels N, 2005, THROMB HAEMOSTASIS, V93, P3, DOI 10.1160/TH04-05-0285; Saw Jun Tze, 2006, Complement Ther Clin Pract, V12, P236, DOI 10.1016/j.ctcp.2006.06.002; Segal R, 2006, CAN MED ASSOC J, V174, P1281, DOI 10.1503/cmaj.051191; Shalansky S, 2007, PHARMACOTHERAPY, V27, P1237, DOI 10.1592/phco.27.9.1237; Singh YN, 2005, J ETHNOPHARMACOL, V100, P108, DOI 10.1016/j.jep.2005.05.014; Skalli S, 2007, THER DRUG MONIT, V29, P679, DOI 10.1097/FTD.0b013e31815c17f6; Stargrove M.B., 2008, HERB NUTR DRUG INTER; State Administration of Traditional Chinese Medicine, 1999, CHIN MAT MED 11; Su DJ, 2011, J HEALTH CARE POOR U, V22, P296, DOI 10.1353/hpu.2011.0002; Su G, 2010, YONSEI MED J, V51, P793, DOI 10.3349/ymj.2010.51.5.793; Suchard JR, 2004, EUR J EMERG MED, V11, P193, DOI 10.1097/01.mej.0000134721.72356.f7; Tachjian A, 2010, J AM COLL CARDIOL, V55, P515, DOI 10.1016/j.jacc.2009.07.074; Tatro D.S., 2011, DRUG INTERACTION FAC; Tirona RG, 2006, BRIT J CLIN PHARMACO, V61, P677, DOI 10.1111/j.1365-2125.2006.02684.x; Tomlinson B, 2008, MOL NUTR FOOD RES, V52, P799, DOI 10.1002/mnfr.200700454; Tsai CH, 2009, TAIPEI J CHINESE MED, V15, P98; Tsai HH, 2013, EUR J CLIN PHARMACOL, V69, P629, DOI 10.1007/s00228-012-1359-6; Ueng Yune-Fang, 2004, Current Pharmacogenomics, V2, P209, DOI 10.2174/1570160043377646; Ulbricht C, 2008, CURR DRUG METAB, V9, P1063, DOI 10.2174/138920008786927785; Ulbricht C., 2009, NATURAL STANDARD HER; Venkataramanan R, 2006, LIFE SCI, V78, P2105, DOI 10.1016/j.lfs.2005.12.021; Wang TY, 2011, J LONG TERM CARE, V15, P24; Wang YY, 2003, J TAIWAN PHARM, V19, P5; Whitten DL, 2006, BRIT J CLIN PHARMACO, V62, P512, DOI 10.1111/j.1365-2125.2006.02755.x; Williamson E., 2009, STOCKLEYS HERBAL MED; Williamson Elizabeth M, 2005, Expert Opin Drug Saf, V4, P355, DOI 10.1517/14740338.4.2.355; Williamson EM, 2003, DRUG SAFETY, V26, P1075, DOI 10.2165/00002018-200326150-00002; Wittkowsky AK, 2008, J THROMB THROMBOLYS, V25, P72, DOI 10.1007/s11239-007-0110-0; Woodward KN, 2005, HUM EXP TOXICOL, V24, P219, DOI 10.1191/0960327105ht529oa; World Health Organization, 2008, 10 LEAD CAUS DEATH B; Wu WWP, 2010, PHYTOMEDICINE, V17, P219, DOI 10.1016/j.phymed.2009.05.005; Xu GL, 2009, PHYTOTHER RES, V23, P1721, DOI 10.1002/ptr.2819; Yamashita H, 2002, COMPLEMENT THER MED, V10, P84, DOI 10.1054/ctim.2002.0519; Yang XX, 2006, CURR PHARM DESIGN, V12, P4649, DOI 10.2174/138161206779010440; Yeh GY, 2006, AM J CARDIOL, V98, P673, DOI 10.1016/j.amjcard.2006.03.051; Yuan CS, 2004, ANN INTERN MED, V141, P23, DOI 10.7326/0003-4819-141-1-200407060-00011; Zhou LM, 2005, J CLIN PHARMACOL, V45, P1345, DOI 10.1177/0091270005282630; Zhou SF, 2003, DRUG METAB REV, V35, P35, DOI 10.1081/DMR-120018248; Zhou SF, 2004, J PSYCHOPHARMACOL, V18, P262, DOI 10.1177/0269881104042632; Zhou SF, 2007, DRUG DISCOV TODAY, V12, P664, DOI 10.1016/j.drudis.2007.06.004; Zhu Yan-feng, 2012, Zhong Xi Yi Jie He Xue Bao, V10, P318, DOI 10.3736/jcim20120311	141	130	134	0	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2013	8	5							e64255	10.1371/journal.pone.0064255	http://dx.doi.org/10.1371/journal.pone.0064255			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	155HD	23671711	Green Published, Green Submitted, gold			2022-12-27	WOS:000319737700069
J	Shi, ZJ; Cao, Z; Qin, D; Zhu, WT; Wang, Q; Li, MS; Wang, GJ				Shi, Zunji; Cao, Zhan; Qin, Dong; Zhu, Wentao; Wang, Qian; Li, Mingshun; Wang, Gejiao			Correlation Models between Environmental Factors and Bacterial Resistance to Antimony and Copper	PLOS ONE			English	Article							ARSENATE-REDUCING BACTERIA; SOIL; DIVERSITY; ARSENITE; GENES; CONTAMINATION; OXIDATION; SEQUENCE	Antimony (Sb) and copper (Cu) are toxic heavy metals that are associated with a wide variety of minerals. Sb(III)-oxidizing bacteria that convert the toxic Sb(III) to the less toxic Sb(V) are potentially useful for environmental Sb bioremediation. A total of 125 culturable Sb(III)/Cu(II)-resistant bacteria from 11 different types of mining soils were isolated. Four strains identified as Arthrobacter, Acinetobacter and Janibacter exhibited notably high minimum inhibitory concentrations (MICs) for Sb(III) (>10 mM), making them the most highly Sb(III)-resistant bacteria to date. Thirty-six strains were able to oxidize Sb(III), including Pseudomonas-, Comamonas-, Acinetobacter-, Sphingopyxis-, Paracoccus-Aminobacter-, Arthrobacter-, Bacillus-, Janibacter-and Variovorax-like isolates. Canonical correspondence analysis (CCA) revealed that the soil concentrations of Sb and Cu were the most obvious environmental factors affecting the culturable bacterial population structures. Stepwise linear regression was used to create two predictive models for the correlation between soil characteristics and the bacterial Sb(III) or Cu(II) resistance. The concentrations of Sb and Cu in the soil was the significant factors affecting the bacterial Sb(III) resistance, whereas the concentrations of S and P in the soil greatly affected the bacterial Cu(II) resistance. The two stepwise linear regression models that we derived are as follows. MICSb(III) = 606.605+0.14533 x C-Sb +0.24128 x C-Cu and MICCu(II) = 58. 3844+0.02119 x C-S + 0.00199 + C-P [where the MICSb(III) and MICCu(II) represent the average bacterial MIC for the metal of each soil (mu M), and the C-Sb, C-Cu, C-S and C-P represent concentrations for Sb, Cu, S and P (mg/kg) in soil, respectively, p<0.01]. The stepwise linear regression models we developed suggest that metals as well as other soil physicochemical parameters can contribute to bacterial resistance to metals.	[Shi, Zunji; Cao, Zhan; Qin, Dong; Zhu, Wentao; Wang, Qian; Li, Mingshun; Wang, Gejiao] Huazhong Agr Univ, Coll Life Sci & Technol, State Key Lab Agr Microbiol, Wuhan, Peoples R China	Huazhong Agricultural University	Wang, GJ (corresponding author), Huazhong Agr Univ, Coll Life Sci & Technol, State Key Lab Agr Microbiol, Wuhan, Peoples R China.	gejiao@mail.hzau.edu.cn	Wang, Qian/AAC-9717-2021	Wang, Qian/0000-0003-4507-0523; Shi, Zunji/0000-0002-1276-6762	Major International Joint Research Project, National Natural Science Foundation of China [31010103903]; Chinese 863 project [2012AA101402-3]	Major International Joint Research Project, National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese 863 project(National High Technology Research and Development Program of China)	This work was supported by a Major International Joint Research Project, National Natural Science Foundation of China (31010103903) and by the Chinese 863 project (2012AA101402-3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achour AR, 2007, RES MICROBIOL, V158, P128, DOI 10.1016/j.resmic.2006.11.006; Anderson CR, 2004, CURR MICROBIOL, V48, P341, DOI 10.1007/s00284-003-4205-3; Angers B, 1999, MOL ECOL, V8, P1043, DOI 10.1046/j.1365-294x.1999.00669.x; Bentley R, 2002, MICROBIOL MOL BIOL R, V66, P250, DOI 10.1128/MMBR.66.2.250-271.2002; Brochu C, 2003, ANTIMICROB AGENTS CH, V47, P3073, DOI 10.1128/AAC.47.10.3073-3079.2003; Cai L, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-4; Dupont CL, 2011, METALLOMICS, V3, P1109, DOI 10.1039/c1mt00107h; Fan H, 2008, J APPL MICROBIOL, V105, P529, DOI 10.1111/j.1365-2672.2008.03790.x; Fierer N, 2006, P NATL ACAD SCI USA, V103, P626, DOI 10.1073/pnas.0507535103; Fierer N, 2007, ECOLOGY, V88, P1354, DOI 10.1890/05-1839; Filella M, 2007, EARTH-SCI REV, V80, P195, DOI 10.1016/j.earscirev.2006.09.003; Grass G, 2001, BIOCHEM BIOPH RES CO, V286, P902, DOI 10.1006/bbrc.2001.5474; Green H. H., 1918, S AFR J SCI, V14, P465; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hamamura N, 2013, MICROBES ENVIRON, V28, P257, DOI 10.1264/jsme2.ME12217; Hao XL, 2012, J BACTERIOL, V194, P903, DOI 10.1128/JB.06585-11; [何孟常 He Mengchang], 2002, [北京师范大学学报. 自然科学版, Journal of Beijing Normal University], V38, P417; Hong YG, 2009, INT BIODETER BIODEGR, V63, P973, DOI 10.1016/j.ibiod.2009.08.001; Jackson CR, 2005, SOIL BIOL BIOCHEM, V37, P2319, DOI 10.1016/j.soilbio.2005.04.010; Jenkins RO, 2002, TRENDS ORGANOMET CHE, V4, P109; JOHNSTON SE, 1979, SOIL SCI SOC AM J, V43, P304, DOI 10.2136/sssaj1979.03615995004300020013x; Koeppel A, 2008, P NATL ACAD SCI USA, V105, P2504, DOI 10.1073/pnas.0712205105; Lehr CR, 2007, APPL ENVIRON MICROB, V73, P2386, DOI 10.1128/AEM.02789-06; Li J, 2013, INT BIODETER BIODEGR, V76, P76, DOI 10.1016/j.ibiod.2012.06.009; Lialikova N N, 1974, Mikrobiologiia, V43, P941; Liao SJ, 2013, GEOMICROBIOL J, V30, P150, DOI 10.1080/01490451.2011.654379; Liao XY, 2005, ENVIRON INT, V31, P791, DOI 10.1016/j.envint.2005.05.030; Liu FY, 2010, ENVIRON GEOCHEM HLTH, V32, P401, DOI 10.1007/s10653-010-9284-z; Meng YL, 2004, J BIOL CHEM, V279, P18334, DOI 10.1074/jbc.M400037200; Montgomery D.C., 2012, INTRO LINEAR REGRESS; Nies DH, 1999, APPL MICROBIOL BIOT, V51, P730, DOI 10.1007/s002530051457; Okkenhaug G, 2011, ENVIRON POLLUT, V159, P2427, DOI 10.1016/j.envpol.2011.06.028; Palacios C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003853; Pepi M, 2007, J APPL MICROBIOL, V103, P2299, DOI 10.1111/j.1365-2672.2007.03471.x; Pontel LB, 2009, MOL MICROBIOL, V73, P212, DOI 10.1111/j.1365-2958.2009.06763.x; Quemeneur M, 2008, APPL ENVIRON MICROB, V74, P4567, DOI 10.1128/AEM.02851-07; Rensing C, 2013, METAL IONS LIFE SCI, V12, P417, DOI 10.1007/978-94-007-5561-1_12; Smichowski P, 2008, TALANTA, V75, P2, DOI 10.1016/j.talanta.2007.11.005; Statistix, 2003, STAT 8 0 US MAN; Stolz JE, 2006, ANNU REV MICROBIOL, V60, P107, DOI 10.1146/annurev.micro.60.080805.142053; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tang QY, 2007, FIELD CROP RES, V102, P219, DOI 10.1016/j.fcr.2007.04.005; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Turpeinen R, 2004, FEMS MICROBIOL ECOL, V47, P39, DOI 10.1016/S0168-6496(03)00232-0; Valverde A, 2011, CHEMOSPHERE, V85, P129, DOI 10.1016/j.chemosphere.2011.06.025; Wang Q, 2011, J APPL MICROBIOL, V111, P1065, DOI 10.1111/j.1365-2672.2011.05142.x; Weeger W, 1999, BIOMETALS, V12, P141, DOI 10.1023/A:1009255012328; WHITE C, 1995, INT BIODETER BIODEGR, V35, P17, DOI 10.1016/0964-8305(95)00036-5; WHITESIDE LS, 1986, CAN MINERAL, V24, P247; Xiong J, 2012, PLOS ONE; Xiong JB, 2010, APPL ENVIRON MICROB, V76, P7277, DOI 10.1128/AEM.00500-10; Zao LH, 2001, APPL ENVIRON MICROB, V67, P2129, DOI 10.1128/AEM.67.5.2129-2135.2001; Zhang DY, 2010, J APPL PHYCOL, V22, P479, DOI 10.1007/s10811-009-9482-1; [张晓军 Zhang Xiaojun], 2005, [环境科学与技术, Enuivonmental science and technology], V28, P40	54	122	127	8	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2013	8	10							e78533	10.1371/journal.pone.0078533	http://dx.doi.org/10.1371/journal.pone.0078533			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242VF	23671712	Green Submitted, gold, Green Published			2022-12-27	WOS:000326270700092
J	Shi, ZH; Long, W; Zhao, C; Guo, XR; Shen, R; Ding, HJ				Shi, Zhonghua; Long, Wei; Zhao, Chun; Guo, Xirong; Shen, Rong; Ding, Hongjuan			Comparative Proteomics Analysis Suggests that Placental Mitochondria are Involved in the Development of Pre-Eclampsia	PLOS ONE			English	Article							FATTY-ACID OXIDATION; PROSTATE-CANCER; ITRAQ; STRESS; EXPRESSION; DISORDERS; APOPTOSIS; PROTEINS	Introduction: Pre-eclampsia (PE), a severe pregnancy-specific disease characterized by the new onset of hypertension, proteinuria, edema, and a series of other systematic disorders, is a state of widespread mitochondrial dysfunction of the placenta. Methods: We compared the morphology of mitochondria in pre-eclamptic and normotensive placentae using electron microscopy. To reveal the systematic protein expression changes of placental mitochondria that might explain the pathogenesis of PE, we performed iTRAQ analysis combined with liquid chromatography-tandem mass spectrometry (LC-MS/MS) on differentially expressed placental mitochondria proteins from 4 normotensive and 4 pre-eclamptic pregnancies. Bioinformatics analysis was used to find the relative processes that these differentially expressed proteins were involved in. Three differentially expressed proteins were chosen to confirm by Western blotting and immunohistochemistry. Results: Morphological data demonstrated degenerative and apoptotic changes in the mitochondria of pre-eclamptic placentae. We found four proteins were upregulated and 22 proteins were downregulated in pre-eclamptic placentae compared with normotensive placentae. Bioinformatics analysis showed that these proteins were involved in many critical processes in the development of pre-eclampsia such as apoptosis, fatty acid oxidation, the respiratory chain, reactive oxygen species generation, the tricarboxylic acid cycle and oxidative stress. Conclusions: This preliminary work provides a better understanding of the proteomic alterations of mitochondria from pre-eclamptic placentae and may aid in our understanding of the importance of mitochondria in the development of pre-eclampsia.	[Shi, Zhonghua; Long, Wei; Zhao, Chun; Guo, Xirong; Shen, Rong; Ding, Hongjuan] Nanjing Med Univ, Nanjing Matern & Child Hlth Care Hosp, State Key Lab Reprod Med, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University	Shen, R (corresponding author), Nanjing Med Univ, Nanjing Matern & Child Hlth Care Hosp, State Key Lab Reprod Med, Nanjing, Jiangsu, Peoples R China.	shenr_njfy@163.com; dinghj_njfy@163.com	Wang, Qian/AAC-9717-2021	Wang, Qian/0000-0003-4507-0523; Shi, Zunji/0000-0002-1276-6762	Nanjing Medical Science and Technique Development Foundation; Medical Science and Technology Development Foundation of Nanjing Department of Health [YKK12099]	Nanjing Medical Science and Technique Development Foundation; Medical Science and Technology Development Foundation of Nanjing Department of Health	This work was financially supported by the Nanjing Medical Science and Technique Development Foundation and the Medical Science and Technology Development Foundation of Nanjing Department of Health (YKK12099). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartha JL, 2012, PLACENTA, V33, P132, DOI 10.1016/j.placenta.2011.11.027; Brosens I A, 1972, Obstet Gynecol Annu, V1, P177; Cunningham G.F., 2005, WILLIAMS OBSTET, V22nd ed., DOI [10.1097/00001888-193609000-00027, DOI 10.1097/00001888-193609000-00027]; Fisher Susan J, 2004, Reprod Biol Endocrinol, V2, P53, DOI 10.1186/1477-7827-2-53; Glen A, 2008, J PROTEOME RES, V7, P897, DOI 10.1021/pr070378x; Glen A, 2010, PROSTATE, V70, P1313, DOI 10.1002/pros.21167; Haggarty P, 2002, PLACENTA, V23, P86, DOI 10.1053/plac.2001.0743; Herrera E, 2006, HORM RES, V65, P59, DOI 10.1159/000091507; Hung TH, 2002, CIRC RES, V90, P1274, DOI 10.1161/01.RES.0000024411.22110.AA; Huppertz B, 2006, AM J OBSTET GYNECOL, V195, P29, DOI 10.1016/j.ajog.2005.07.039; Illsinger S, 2010, REPROD SCI, V17, P219, DOI 10.1177/1933719109351597; Jiang Y, 2012, J HEMATOL ONCOL, V18, P11; Khatun R, 2003, PLACENTA, V24, P870, DOI 10.1016/S0143-4004(03)00138-3; Kirkinezos IG, 2001, SEMIN CELL DEV BIOL, V12, P449, DOI 10.1006/scdb.2001.0282; Leung DN, 2001, AM J OBSTET GYNECOL, V184, P1249, DOI 10.1067/mob.2001.112906; Maynard SE, 2003, J CLIN INVEST, V111, P649, DOI 10.1172/JCI200317189; Nikitin A, 2003, BIOINFORMATICS, V19, P2155, DOI 10.1093/bioinformatics/btg290; Padmini E, 2009, CLIN CHEM LAB MED, V47, P1073, DOI 10.1515/CCLM.2009.247; Pollard HB, 2006, MOL CELL PROTEOMICS, V5, P1628, DOI 10.1074/mcp.M600091-MCP200; Rakheja D, 2002, PLACENTA, V23, P447, DOI 10.1053/plac.2002.0808; Redman CW, 2005, SCIENCE, V308, P1592, DOI 10.1126/science.1111726; Roberts JM, 2002, PLACENTA, V23, P359, DOI 10.1053/plac.2002.0819; ROBERTS JM, 2004, MATERNAL FETAL MED P, P859; Ross PL, 2004, MOL CELL PROTEOMICS, V3, P1154, DOI 10.1074/mcp.M400129-MCP200; Sharp AN, 2010, AM J REPROD IMMUNOL, V64, P159, DOI 10.1111/j.1600-0897.2010.00837.x; Shekhawat P, 2003, AM J PHYSIOL-ENDOC M, V284, pE1098, DOI 10.1152/ajpendo.00481.2002; Shekhawat PS, 2005, PEDIATR RES, V57, p78R, DOI 10.1203/01.PDR.0000159631.63843.3E; Shibata E, 2003, PLACENTA, V24, P698, DOI 10.1016/S0143-4004(03)00083-3; Sun CY, 2011, PROTEOME SCI, V9, DOI 10.1186/1477-5956-9-22; TORBERGSEN T, 1989, ACTA OBSTET GYN SCAN, V68, P145, DOI 10.3109/00016348909009902; Wang Y, 1998, PLACENTA, V19, P581, DOI 10.1016/S0143-4004(98)90018-2; Watson AL, 1998, J CLIN ENDOCR METAB, V83, P1697, DOI 10.1210/jc.83.5.1697; Widschwendter M, 1998, MOL MED TODAY, V4, P286, DOI 10.1016/S1357-4310(98)01293-3; Wu WW, 2006, J PROTEOME RES, V5, P651, DOI 10.1021/pr050405o; Young NK, 2007, PROTEOM CLIN APPL, V1, P1625	35	122	127	8	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2013	8	5							e64351	10.1371/journal.pone.0064351	http://dx.doi.org/10.1371/journal.pone.0064351			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	155HD	23671712	Green Published, Green Submitted, gold			2022-12-27	WOS:000319737700070
J	Lee, YA; Kim, YH; Kim, BJ; Kim, BG; Kim, KJ; Auh, JH; Schmidt, JA; Ryu, BY				Lee, Yong-An; Kim, Yong-Hee; Kim, Bang-Jin; Kim, Byung-Gak; Kim, Ki-Jung; Auh, Joong-Hyuck; Schmidt, Jonathan A.; Ryu, Buom-Yong			Cryopreservation in Trehalose Preserves Functional Capacity of Murine Spermatogonial Stem Cells	PLOS ONE			English	Article							FLOW-CYTOMETRIC DETECTION; MOUSE TESTES; GERM-CELLS; PHOSPHATIDYLSERINE EXPRESSION; HEMATOPOIETIC-CELLS; TESTICULAR TISSUE; CANCER-TREATMENT; A SPERMATOGONIA; SELF-RENEWAL; ANNEXIN-V	Development of techniques to isolate, culture, and transplant human spermatogonial stem cells (SSCs) has the future potential to treat male infertility. To maximize the efficiency of these techniques, methods for SSC cryopreservation need to be developed to bank SSCs for extended periods of time. Although, it has been demonstrated that SSCs can reinitiate spermatogenesis after freezing, optimal cryopreservation protocols that maximize SSC proliferative capacity post-thaw have not been identified. The objective of this study was to develop an efficient cryopreservation technique for preservation of SSCs. To identify efficient cryopreservation methods for long-term preservation of SSCs, isolated testis cells enriched for SSCs were placed in medium containing dimethyl sulfoxide (DMSO) or DMSO and trehalose (50 mM, 100 mM, or 200 mM), and frozen in liquid nitrogen for 1 week, 1 month, or 3 months. Freezing in 50 mM trehalose resulted in significantly higher cell viability compared to DMSO at all thawing times and a higher proliferation rate compared to DMSO for the 1 week freezing period. Freezing in 200 mM trehalose did not result in increased cell viability; however, proliferation activity was significantly higher and percentage of apoptotic cells was significantly lower compared to DMSO after freezing for 1 and 3 months. To confirm the functionality of SSCs frozen in 200 mM trehalose, SSC transplantation was performed. Donor SSCs formed spermatogenic colonies and sperm capable of generating normal progeny. Collectively, these results indicate that freezing in DMSO with 200 mM trehalose serves as an efficient method for the cryopreservation of SSCs.	[Lee, Yong-An; Kim, Yong-Hee; Kim, Bang-Jin; Kim, Byung-Gak; Kim, Ki-Jung; Ryu, Buom-Yong] Chung Ang Univ, Dept Anim Sci & Technol, Ansung, Gyeonggi Do, South Korea; [Auh, Joong-Hyuck] Chung Ang Univ, Dept Food Sci & Technol, Ansung, Gyeonggi Do, South Korea; [Schmidt, Jonathan A.] Spokane Community Coll, Dept Sci, Spokane, WA USA	Chung Ang University; Chung Ang University	Ryu, BY (corresponding author), Chung Ang Univ, Dept Anim Sci & Technol, Ansung, Gyeonggi Do, South Korea.	byryu@cau.ac.kr	Auh, Joong Hyuck/ABG-9137-2021	Auh, Joong Hyuck/0000-0001-9425-2599; Park, Chankyu/0000-0003-4855-2210; Lee, Yong-An/0000-0001-7253-2397	Next-Generation BioGreen 21 Program [PJ0080482012]; Rural Development Administration, a National Research Foundation of Korea; Ministry of Education, Science and Technology [2012-0006786]	Next-Generation BioGreen 21 Program(Rural Development Administration (RDA), Republic of Korea); Rural Development Administration, a National Research Foundation of Korea(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work has been supported by the Next-Generation BioGreen 21 Program (No.PJ0080482012) and Rural Development Administration, a National Research Foundation of Korea grant funded by the Ministry of Education, Science and Technology (2012-0006786). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aboagla EME, 2003, BIOL REPROD, V69, P1245, DOI 10.1095/biolreprod.103.017889; Araki Y, 2010, BIOL REPROD, V83, P951, DOI 10.1095/biolreprod.109.082800; Avarbock MR, 1996, NAT MED, V2, P693, DOI 10.1038/nm0696-693; Brook PF, 2001, FERTIL STERIL, V75, P269, DOI 10.1016/S0015-0282(00)01721-0; CROWE JH, 1984, SCIENCE, V223, P701, DOI 10.1126/science.223.4637.701; De Rooij DG, 2000, J ANDROL, V21, P776; De Rooij DG, 1992, ANN NY ACAD SCI, V364, P140; Dirami G, 1999, BIOL REPROD, V61, P225, DOI 10.1095/biolreprod61.1.225; Dobrinski I, 1999, BIOL REPROD, V61, P1331, DOI 10.1095/biolreprod61.5.1331; Dobrinski I, 2000, MOL REPROD DEV, V57, P270, DOI 10.1002/1098-2795(200011)57:3&lt;270::AID-MRD9&gt;3.0.CO;2-Z; Erdag G, 2002, CRYOBIOLOGY, V44, P218, DOI 10.1016/S0011-2240(02)00023-8; Eroglu A, 2000, NAT BIOTECHNOL, V18, P163, DOI 10.1038/72608; Eroglu A, 2001, CRYOBIOLOGY, V43, P320; Ewing L L, 1980, Int Rev Physiol, V22, P41; FOSSA SD, 1989, BRIT J UROL, V64, P524, DOI 10.1111/j.1464-410X.1989.tb05292.x; Frederickx V, 2004, HUM REPROD, V19, P948, DOI 10.1093/humrep/deh154; GEISSLER EN, 1988, CELL, V55, P185, DOI 10.1016/0092-8674(88)90020-7; He ZP, 2010, BIOL REPROD, V82, P363, DOI 10.1095/biolreprod.109.078550; Hermann BP, 2007, STEM CELLS, V25, P2330, DOI 10.1634/stemcells.2007-0143; Izadyar F, 2002, J ANDROL, V23, P537; Ji L, 2004, BIOTECHNOL BIOENG, V88, P299, DOI 10.1002/bit.20243; Kanatsu-Shinohara M, 2003, BIOL REPROD, V69, P612, DOI 10.1095/biolreprod.103.017012; Kanatsu-Shinohara M, 2003, HUM REPROD, V18, P2660, DOI 10.1093/humrep/deg483; Kanatsu-Shinohara M, 2008, BIOL REPROD, V78, P611, DOI 10.1095/biolreprod.107.065615; Keros V, 2007, HUM REPROD, V22, P1384, DOI 10.1093/humrep/del508; Kim BG, 2010, BIOL REPROD, V82, P1162, DOI 10.1095/biolreprod.109.079558; KOOPMAN G, 1994, BLOOD, V84, P1415, DOI 10.1182/blood.V84.5.1415.1415; Kubota H, 2003, P NATL ACAD SCI USA, V100, P6487, DOI 10.1073/pnas.0631767100; Kubota H, 2004, P NATL ACAD SCI USA, V101, P16489, DOI 10.1073/pnas.0407063101; Lass A, 2001, HUM REPROD UPDATE, V7, P370, DOI 10.1093/humupd/7.4.370; Limaye LS, 2001, J HEMATOTH STEM CELL, V10, P709, DOI 10.1089/152581601753193931; MARTIN SJ, 1995, J EXP MED, V182, P1545, DOI 10.1084/jem.182.5.1545; MAZUR P, 1988, ANN NY ACAD SCI, V541, P514, DOI 10.1111/j.1749-6632.1988.tb22288.x; Nagano M, 2001, P NATL ACAD SCI USA, V98, P13090, DOI 10.1073/pnas.231473498; Nagano M, 1999, BIOL REPROD, V60, P1429, DOI 10.1095/biolreprod60.6.1429; Nagano M, 2002, FERTIL STERIL, V78, P1225, DOI 10.1016/S0015-0282(02)04345-5; Nagano M, 2001, BIOL REPROD, V64, P1409, DOI 10.1095/biolreprod64.5.1409; Ogawa T, 2004, ARCH HISTOL CYTOL, V67, P297, DOI 10.1679/aohc.67.297; Ogawa T, 1997, INT J DEV BIOL, V41, P111; Ogawa T, 1999, BIOL REPROD, V60, P515, DOI 10.1095/biolreprod60.2.515; RAYNAL P, 1994, BBA-REV BIOMEMBRANES, V1197, P63, DOI 10.1016/0304-4157(94)90019-1; Royere D, 1996, HUM REPROD UPDATE, V2, P553, DOI 10.1093/humupd/2.6.553; Russell LD, 1990, HISTOLOGICAL HISTOPA, P1; Ryu BY, 2005, P NATL ACAD SCI USA, V102, P14302, DOI 10.1073/pnas.0506970102; Ryu BY, 2004, DEV BIOL, V274, P158, DOI 10.1016/j.ydbio.2004.07.004; Sasnoor LM, 2005, TRANSPLANTATION, V80, P1251, DOI 10.1097/01.tp.0000169028.01327.90; Schlatt S, 2002, HUM REPROD, V17, P55, DOI 10.1093/humrep/17.1.55; Schmidt JA, 2011, BIOL REPROD, V84, P698, DOI 10.1095/biolreprod.110.088229; Shinohara T, 2001, P NATL ACAD SCI USA, V98, P6186, DOI 10.1073/pnas.111158198; Shinohara T, 2000, P NATL ACAD SCI USA, V97, P8346, DOI 10.1073/pnas.97.15.8346; vanEngeland M, 1996, CYTOMETRY, V24, P131, DOI 10.1002/(SICI)1097-0320(19960601)24:2<131::AID-CYTO5>3.0.CO;2-M; vanPelt AMM, 1996, BIOL REPROD, V55, P439, DOI 10.1095/biolreprod55.2.439; VERMES I, 1995, J IMMUNOL METHODS, V184, P39, DOI 10.1016/0022-1759(95)00072-I; Wu X, 2012, HUM REPROD, V27, P1249, DOI 10.1093/humrep/des077	54	73	77	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2013	8	1							e54889	10.1371/journal.pone.0054889	http://dx.doi.org/10.1371/journal.pone.0054889			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077HS	23675467	Green Published, Green Submitted, gold			2022-12-27	WOS:000314019100108
J	Kim, SO; Sakchaisri, K; Thimmegowda, NR; Soung, NK; Jang, JH; Kim, YS; Lee, KS; Kwon, YT; Asami, Y; Ahn, JS; Erikson, RL; Kim, BY				Kim, Sun-Ok; Sakchaisri, Krisada; Thimmegowda, N. R.; Soung, Nak Kyun; Jang, Jae-Hyuk; Kim, Young Sang; Lee, Kyung Sang; Kwon, Yong Tae; Asami, Yukihiro; Ahn, Jong Seog; Erikson, Raymond Leo; Kim, Bo Yeon			STK295900, a Dual Inhibitor of Topoisomerase 1 and 2, Induces G(2) Arrest in the Absence of DNA Damage	PLOS ONE			English	Article							CDC25 PHOSPHATASES; CELL-CYCLE; I INHIBITORS; G2/M TRANSITION; CANCER-THERAPY; HISTONE H3; PHOSPHORYLATION; CHECKPOINT; CAMPTOTHECIN; MECHANISM	STK295900, a small synthetic molecule belonging to a class of symmetric bibenzimidazoles, exhibits antiproliferative activity against various human cancer cell lines from different origins. Examining the effect of STK295900 in HeLa cells indicates that it induces G(2) phase arrest without invoking DNA damage. Further analysis shows that STK295900 inhibits DNA relaxation that is mediated by topoisomerase 1 (Top 1) and topoisomerase 2 (Top 2) in vitro. In addition, STK295900 also exhibits protective effect against DNA damage induced by camptothecin. However, STK295900 does not affect etoposide-induced DNA damage. Moreover, STK295900 preferentially exerts cytotoxic effect on cancer cell lines while camptothecin, etoposide, and Hoechst 33342 affected both cancer and normal cells. Therefore, STK295900 has a potential to be developed as an anticancer chemotherapeutic agent.	[Kim, Sun-Ok; Sakchaisri, Krisada; Thimmegowda, N. R.; Soung, Nak Kyun; Jang, Jae-Hyuk; Ahn, Jong Seog; Kim, Bo Yeon] Korea Res Inst Biosci & Biotechnol KRIBB, Ochang, Cheongwon, South Korea; [Kim, Sun-Ok; Kim, Young Sang] Chungnam Natl Univ, Coll Nat Sci, Dept Biochem, Taejon, South Korea; [Lee, Kyung Sang] NCI, Lab Metab, NIH, Bethesda, MD 20892 USA; [Kwon, Yong Tae] Seoul Natl Univ, World Class Univ, Grad Sch Convergence Sci & Technol, Seoul, South Korea; [Kwon, Yong Tae] Seoul Natl Univ, Coll Med, Seoul, South Korea; [Kwon, Yong Tae] Univ Pittsburgh, Ctr Pharmacogenet, Pittsburgh, PA USA; [Kwon, Yong Tae] Univ Pittsburgh, Sch Pharm, Dept Pharmaceut Sci, Pittsburgh, PA 15261 USA; [Asami, Yukihiro] RIKEN Adv Sci Inst, Dept Biol Chem, Wako, Saitama, Japan; [Erikson, Raymond Leo] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA	Korea Research Institute of Bioscience & Biotechnology (KRIBB); Chungnam National University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Seoul National University (SNU); Seoul National University (SNU); Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; RIKEN; Harvard University	Ahn, JS (corresponding author), Korea Res Inst Biosci & Biotechnol KRIBB, Ochang, Cheongwon, South Korea.	jsahn@kribb.re.kr; bykim@kribb.re.kr	Damschroder, Laura/A-1142-2007; Appelbaum, Paul/AFU-3908-2022	Appelbaum, Paul/0000-0002-1940-0042; timmusk, s/0000-0001-8465-1043; Damschroder, Laura/0000-0002-3657-8459; Ryan, Kerry/0000-0002-0582-3693; Asami, Yukihiro/0000-0003-1821-9169; De Vries, Raymond/0000-0003-3087-3040	World Class Institute [2009-002]; Global RD Center (GRDC); World Class University [R31-2008-000-10103-0]; KRIBB Research Initiative program; Ministry of Education, Science and Technology (MEST) of Korea	World Class Institute; Global RD Center (GRDC); World Class University; KRIBB Research Initiative program; Ministry of Education, Science and Technology (MEST) of Korea(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported by the World Class Institute (2009-002), Global R&D Center (GRDC), World Class University (R31-2008-000-10103-0) programs and a grant from KRIBB Research Initiative program funded by the Ministry of Education, Science and Technology (MEST) of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham RT, 2001, GENE DEV, V15, P2177, DOI 10.1101/gad.914401; Antoni L, 2007, NAT REV CANCER, V7, P925, DOI 10.1038/nrc2251; Balmain A, 2002, CELL, V108, P145, DOI 10.1016/S0092-8674(02)00622-0; Bartek J, 2003, CANCER CELL, V3, P421, DOI 10.1016/S1535-6108(03)00110-7; Bonner WM, 2008, NAT REV CANCER, V8, P957, DOI 10.1038/nrc2523; Bonnet J, 2008, BIOCHEM BIOPH RES CO, V370, P483, DOI 10.1016/j.bbrc.2008.03.117; Bower JJ, 2010, ONCOGENE, V29, P4787, DOI 10.1038/onc.2010.232; Bulavin DV, 2003, NAT CELL BIOL, V5, P545, DOI 10.1038/ncb994; Cai XM, 2009, CANCER TREAT REV, V35, P437, DOI 10.1016/j.ctrv.2009.02.004; Champoux JJ, 2001, ANNU REV BIOCHEM, V70, P369, DOI 10.1146/annurev.biochem.70.1.369; CHEN AY, 1993, P NATL ACAD SCI USA, V90, P8131, DOI 10.1073/pnas.90.17.8131; Chiu CC, 2005, CANCER LETT, V223, P249, DOI 10.1016/j.canlet.2004.10.049; Clifford B, 2003, CANCER RES, V63, P4074; Dale AG, 2012, BIOCHEMISTRY; DOWNES CS, 1994, NATURE, V372, P467, DOI 10.1038/372467a0; Foijer F, 2006, CELL CYCLE, V5, P831, DOI 10.4161/cc.5.8.2687; Futreal PA, 2004, NAT REV CANCER, V4, P177, DOI 10.1038/nrc1299; Hans F, 2001, ONCOGENE, V20, P3021, DOI 10.1038/sj.onc.1204326; He L, 2007, CELL SIGNAL, V19, P1713, DOI 10.1016/j.cellsig.2007.03.006; HSIANG YH, 1985, J BIOL CHEM, V260, P4873; Jin S, 2000, BIOORG MED CHEM LETT, V10, P719, DOI 10.1016/S0960-894X(00)00087-1; JORDAN MA, 1992, J CELL SCI, V102, P401; Kellogg DR, 2003, J CELL SCI, V116, P4883, DOI 10.1242/jcs.00908; Kim BY, 2005, CARCINOGENESIS, V26, P1395, DOI 10.1093/carcin/bgi081; Kristjansdottir K, 2004, CHEM BIOL, V11, P1043, DOI 10.1016/j.chembiol.2004.07.007; Larsen AK, 2003, PHARMACOL THERAPEUT, V99, P167, DOI 10.1016/S0163-7258(03)00058-5; Mann J, 2001, J MED CHEM, V44, P138, DOI 10.1021/jm000297b; Murray AW, 2004, CELL, V116, P221, DOI 10.1016/S0092-8674(03)01080-8; Narasimhan B, 2012, MED CHEM RES, V21, P269, DOI 10.1007/s00044-010-9533-9; Nigg EA, 2001, NAT REV MOL CELL BIO, V2, P21, DOI 10.1038/35048096; Nitiss JL, 2009, NAT REV CANCER, V9, P338, DOI 10.1038/nrc2607; Patel S, 2000, MOL PHARMACOL, V58, P560, DOI 10.1124/mol.58.3.560; PINES J, 1991, J CELL BIOL, V115, P1, DOI 10.1083/jcb.115.1.1; Pommier Y, 2006, NAT REV CANCER, V6, P789, DOI 10.1038/nrc1977; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Rudolph J, 2007, BIOCHEMISTRY-US, V46, P3595, DOI 10.1021/bi700026j; Satyanarayana A, 2009, ONCOGENE, V28, P2925, DOI 10.1038/onc.2009.170; Shiloh Y, 2001, CURR OPIN GENET DEV, V11, P71, DOI 10.1016/S0959-437X(00)00159-3; Smits VAJ, 2001, BBA-GENE STRUCT EXPR, V1519, P1, DOI 10.1016/S0167-4781(01)00204-4; Taylor WR, 2001, ONCOGENE, V20, P1803, DOI 10.1038/sj.onc.1204252; Trembley JH, 1996, CELL GROWTH DIFFER, V7, P903; TSAO YP, 1992, CANCER RES, V52, P1823; Uto K, 2004, EMBO J, V23, P3386, DOI 10.1038/sj.emboj.7600328; van Attikum H, 2009, TRENDS CELL BIOL, V19, P207, DOI 10.1016/j.tcb.2009.03.001; Vos SM, 2011, NAT REV MOL CELL BIO, V12, P827, DOI 10.1038/nrm3228; Wei Y, 1999, CELL, V97, P99, DOI 10.1016/S0092-8674(00)80718-7	46	111	116	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2013	8	1							e53908	10.1371/journal.pone.0053908	http://dx.doi.org/10.1371/journal.pone.0053908			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077HS	23349762	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000314019100036
J	Kim, SYH; Kim, HM; Ryan, KA; Appelbaum, PS; Knopman, DS; Damschroder, L; De Vries, R				Kim, Scott Y. H.; Kim, H. Myra; Ryan, Kerry A.; Appelbaum, Paul S.; Knopman, David S.; Damschroder, Laura; De Vries, Raymond			How Important Is 'Accuracy' of Surrogate Decision-Making for Research Participation?	PLOS ONE			English	Article							DEMENTIA-RESEARCH; ADVANCE DIRECTIVES; CARE RESEARCH; CONSENT; DELIBERATION; BIOETHICS; CAPACITY; DISEASE; MAKERS; FAMILY	Background: There is a longstanding concern about the accuracy of surrogate consent in representing the health care and research preferences of those who lose their ability to decide for themselves. We sought informed, deliberative views of the older general public (>= 50 years old) regarding their willingness to participate in dementia research and to grant leeway to future surrogates to choose an option contrary to their stated wishes. Methodology/Principal Findings: 503 persons aged 50+ recruited by random digit dialing were randomly assigned to one of three groups: deliberation, education, or control. The deliberation group attended an all-day education/peer deliberation session; the education group received written information only. Participants were surveyed at baseline, after the deliberation session (or equivalent time), and one month after the session, regarding their willingness to participate in dementia research and to give leeway to surrogates, regarding studies of varying risk-benefit profiles (a lumbar puncture study, a drug randomized controlled trial, a vaccine randomized controlled trial, and an early phase gene transfer trial). At baseline, 48% (gene transfer scenario) to 92% (drug RCT) were willing to participate in future dementia research. A majority of respondents (57-71% depending on scenario) were willing to give leeway to future surrogate decision-makers. Democratic deliberation increased willingness to participate in all scenarios, to grant leeway in 3 of 4 scenarios (lumbar puncture, vaccine, and gene transfer), and to enroll loved ones in research in all scenarios. On average, respondents were more willing to volunteer themselves for research than to enroll their loved ones. Conclusions/Significance: Most people were willing to grant leeway to their surrogates, and this willingness was either sustained or increased after democratic deliberation, suggesting that the attitude toward leeway is a reliable opinion. Eliciting a person's current preferences about future research participation should also involve eliciting his or her leeway preferences.	[Kim, Scott Y. H.; Ryan, Kerry A.; De Vries, Raymond] Univ Michigan, Ctr Bioeth & Social Sci Med, Ann Arbor, MI 48109 USA; [Kim, Scott Y. H.] Univ Michigan, Dept Psychiat, Ann Arbor, MI 48109 USA; [Kim, H. Myra] Univ Michigan, Ctr Stat Consultat & Res, Ann Arbor, MI 48109 USA; [Appelbaum, Paul S.] Columbia Univ, Dept Psychiat, Div Law Eth & Psychiat, New York, NY USA; [Appelbaum, Paul S.] New York State Psychiat Inst & Hosp, New York, NY 10032 USA; [Knopman, David S.] Mayo Clin, Dept Neurol, Rochester, MN USA; [Damschroder, Laura] Ann Arbor VA Med Ctr, Ann Arbor, MI USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Columbia University; New York State Psychiatry Institute; Mayo Clinic	Kim, SYH (corresponding author), Univ Michigan, Ctr Bioeth & Social Sci Med, Ann Arbor, MI 48109 USA.	scottkim@med.umich.edu	Damschroder, Laura/A-1142-2007; Appelbaum, Paul/AFU-3908-2022	Appelbaum, Paul/0000-0002-1940-0042; timmusk, s/0000-0001-8465-1043; Damschroder, Laura/0000-0002-3657-8459; Ryan, Kerry/0000-0002-0582-3693; Asami, Yukihiro/0000-0003-1821-9169; De Vries, Raymond/0000-0003-3087-3040	National Institute of Health [R01AG029550]; Greenwall Foundation Faculty Scholars Award in Bioethics; Janssen Pharmaceuticals	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Greenwall Foundation Faculty Scholars Award in Bioethics; Janssen Pharmaceuticals(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc)	Supported by National Institute of Health R01AG029550 and the Greenwall Foundation Faculty Scholars Award in Bioethics. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Scott Kim, H. Myra Kim, Kerry Ryan, Paul Appelbaum, Laura Damschroder, and Raymond De Vries have declared that they have no competing interests. David Knopman has read the journal's policy and has the following conflicts: he serves as Deputy Editor for Neurology (R); serves on a Data Safety Monitoring Board for Lilly Pharmaceuticals; is an investigator in clinical trials sponsored by Janssen Pharmaceuticals, and receives research support from the National Institute of Health. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Ciroldi M, 2007, INTENS CARE MED, V33, P807, DOI 10.1007/s00134-007-0582-6; Coppolino M, 2001, CHEST, V119, P603, DOI 10.1378/chest.119.2.603; De Vries R, 2011, J EMPIR RES HUM RES, V6, P3, DOI 10.1525/jer.2011.6.3.3; Fagerlin A, 2004, HASTINGS CENT REP, V34, P30, DOI 10.2307/3527683; Hawkins NA, 2005, GERONTOLOGIST, V45, P107, DOI 10.1093/geront/45.1.107; Karlawish J, 2009, AM J PSYCHIAT, V166, P182, DOI 10.1176/appi.ajp.2008.08050645; Kim SYH, 2011, NEUROLOGY, V77, P2097, DOI 10.1212/WNL.0b013e31823648cb; Kim SYH, 2009, NEUROLOGY, V72, P149, DOI 10.1212/01.wnl.0000339039.18931.a2; Kim SYH, 2011, ARCH GEN PSYCHIAT, V68, P214, DOI 10.1001/archgenpsychiatry.2010.191; Kim SYH, 2010, ALZHEIMERS DEMENT, V6, P342, DOI 10.1016/j.jalz.2009.06.001; Kim SYH, 2009, J EMPIR RES HUM RES, V4, P3, DOI 10.1525/jer.2009.4.4.3; Kim SYH, 2001, AM J PSYCHIAT, V158, P712, DOI 10.1176/appi.ajp.158.5.712; Kirchhoff KT, 2010, J AM GERIATR SOC, V58, P1233, DOI 10.1111/j.1532-5415.2010.02760.x; Okonkwo O, 2007, NEUROLOGY, V69, P1528, DOI 10.1212/01.wnl.0000277639.90611.d9; Puchalski CM, 2000, J AM GERIATR SOC, V48, pS84, DOI 10.1111/j.1532-5415.2000.tb03146.x; SEHGAL A, 1992, JAMA-J AM MED ASSOC, V267, P59, DOI 10.1001/jama.267.1.59; Shalowitz DI, 2006, ARCH INTERN MED, V166, P493, DOI 10.1001/archinte.166.5.493; Stocking CB, 2006, NEUROLOGY, V66, P1361, DOI 10.1212/01.wnl.0000216424.66098.55; Wendler D, 2002, AM J PSYCHIAT, V159, P585, DOI 10.1176/appi.ajp.159.4.585	19	111	116	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e54790	10.1371/journal.pone.0054790	http://dx.doi.org/10.1371/journal.pone.0054790			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	085JH	23349762	Green Submitted, Green Published, gold			2022-12-27	WOS:000314610600042
J	Li, K; Chi, Y; Gao, K; Yan, QJ; Matsue, H; Takeda, M; Kitamura, M; Yao, J				Li, Kai; Chi, Yuan; Gao, Kun; Yan, Qiaojing; Matsue, Hiroyuki; Takeda, Masayuki; Kitamura, Masanori; Yao, Jian			Connexin43 Hemichannel-Mediated Regulation of Connexin43	PLOS ONE			English	Article							JUNCTIONAL INTERCELLULAR COMMUNICATION; GAP-JUNCTIONS; SIGNAL-TRANSDUCTION; OXIDATIVE STRESS; GENE-EXPRESSION; LLC-PK1 CELLS; CADMIUM CD2+; C-JUN; PLASMA-MEMBRANE; UP-REGULATION	Background: Many signaling molecules and pathways that regulate gap junctions (GJs) protein expression and function are, in fact, also controlled by GJs. We, therefore, speculated an existence of the GJ channel-mediated self-regulation of GJs. Using a cell culture model in which nonjunctional connexin43 (Cx43) hemichannels were activated by cadmium (Cd2+), we tested this hypothesis. Principal Findings: Incubation of Cx43-transfected LLC-PK1 cells with Cd2+ led to an increased expression of Cx43. This effect of Cd2+ was tightly associated with JNK activation. Inhibition of JNK abolished the elevation of Cx43. Further analysis revealed that the changes of JNK and Cx43 were controlled by GSH. Supplement of a membrane-permeable GSH analogue GSH ethyl ester or GSH precursor N-acetyl-cystein abrogated the effects of Cd2+ on JNK activation and Cx43 expression. Indeed, Cd2+ induced extracellular release of GSH. Blockade of Cx43 hemichannels with heptanol or Cx43 mimetic peptide Gap26 to prevent the efflux of GSH significantly attenuated the Cx43-elevating effects of Cd2+. Conclusions: Collectively, our results thus indicate that Cd2+-induced upregulation of Cx43 is through activation of nonjunctional Cx43 hemichannels. Our findings thus support the existence of a hemichannel-mediated self-regulation of Cx43 and provide novel insights into the molecular mechanisms of Cx43 expression and function.	[Li, Kai; Chi, Yuan; Gao, Kun; Yan, Qiaojing; Kitamura, Masanori; Yao, Jian] Univ Yamanashi, Dept Mol Signaling, Interdisciplinary Grad Sch Med & Engn, Chuo Ku, Yamanashi, Japan; [Li, Kai; Takeda, Masayuki] Univ Yamanashi, Interdisciplinary Grad Sch Med & Engn, Dept Urol, Chuo Ku, Yamanashi, Japan; [Li, Kai] China Med Univ, Hosp 1, Dept Surg Oncol & Gen Surg, Shenyang, Peoples R China; [Matsue, Hiroyuki] Chiba Univ, Sch Med, Dept Dermatol, Chiba 280, Japan	University of Yamanashi; University of Yamanashi; China Medical University; Chiba University	Li, K (corresponding author), Univ Yamanashi, Dept Mol Signaling, Interdisciplinary Grad Sch Med & Engn, Chuo Ku, Yamanashi, Japan.	cmu_likai@hotmail.com; yao@yamanashi.ac.jp	; Li, Ke/I-3804-2013	Yao, Jian/0000-0003-2622-0215; Li, Ke/0000-0003-4869-5393	Ministry of Education, Culture, Sports, Science and Technology, Japan [17659255, 20590953, B21390324]	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology, Japan (17659255 and 20590953 to JY; B21390324 to HM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berthoud VM, 2009, ANTIOXID REDOX SIGN, V11, P339, DOI 10.1089/ars.2008.2119; Carmeli C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029341; Chaytor AT, 1998, J PHYSIOL-LONDON, V508, P561, DOI 10.1111/j.1469-7793.1998.561bq.x; Cherian PP, 2005, MOL BIOL CELL, V16, P3100, DOI 10.1091/mbc.E04-10-0912; D'hondt C, 2007, INVEST OPHTH VIS SCI, V48, P120, DOI 10.1167/iovs.06-0770; Evans WH, 2006, BIOCHEM J, V397, P1, DOI 10.1042/BJ20060175; Evans WH, 2012, J MEMBRANE BIOL, V245, P437, DOI 10.1007/s00232-012-9488-5; Fang X, 2011, ANTIOXID REDOX SIGN, V14, P2427, DOI 10.1089/ars.2010.3150; Gao FH, 2007, BIOCHEM BIOPH RES CO, V356, P505, DOI 10.1016/j.bbrc.2007.03.009; Gennari A, 2003, TOXICOLOGY, V183, P211, DOI 10.1016/S0300-483X(02)00546-2; Giepmans BNG, 2004, CARDIOVASC RES, V62, P233, DOI 10.1016/j.cardiores.2003.12.009; HEW KW, 1993, BIOL REPROD, V49, P840, DOI 10.1095/biolreprod49.4.840; Huang T, 2010, CANCER SCI, V101, P713, DOI 10.1111/j.1349-7006.2009.01421.x; Lawal AO, 2010, J TOXICOL SCI, V35, P465, DOI 10.2131/jts.35.465; Li K, 2011, J BIOL CHEM, V286, P41552, DOI 10.1074/jbc.M111.274449; Liu J, 2009, TOXICOL APPL PHARM, V238, P209, DOI 10.1016/j.taap.2009.01.029; Loch-Caruso R, 2005, TOXICOL SCI, V85, P694, DOI 10.1093/toxsci/kfi123; Majoul IV, 2009, HISTOCHEM CELL BIOL, V132, P263, DOI 10.1007/s00418-009-0617-x; Martin PEM, 2001, J CELL SCI, V114, P3845; Mendoza-Naranjo A, 2007, J IMMUNOL, V178, P6949, DOI 10.4049/jimmunol.178.11.6949; Mitchell JA, 2001, CELL COMMUN ADHES, V8, P299, DOI 10.3109/15419060109080741; Oviedo-Orta E, 2001, FASEB J, V15, P768, DOI 10.1096/fj.00-0288com; Ponsaerts R, 2010, FASEB J, V24, P4378, DOI 10.1096/fj.09-153007; PROZIALECK WC, 1991, TOXICOL APPL PHARM, V107, P81, DOI 10.1016/0041-008X(91)90333-A; PROZIALECK WC, 1995, TOXICOL APPL PHARM, V134, P285, DOI 10.1006/taap.1995.1194; Prozialeck WC, 1997, IN VITRO CELL DEV-AN, V33, P516; Prozialeck WC, 1998, TOXICOL IN VITRO, V12, P633, DOI 10.1016/S0887-2333(98)00054-X; Ramachandran S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000712; Retamal MA, 2007, P NATL ACAD SCI USA, V104, P8322, DOI 10.1073/pnas.0702456104; Saez JC, 2003, PHYSIOL REV, V83, P1359, DOI 10.1152/physrev.00007.2003; Salameh A, 2008, J PHARMACOL EXP THER, V326, P315, DOI 10.1124/jpet.108.136663; Shyu KG, 2004, CARDIOVASC RES, V63, P98, DOI 10.1016/j.cardiores.2004.02.018; Son MH, 2001, BIOCHEM PHARMACOL, V62, P1379, DOI 10.1016/S0006-2952(01)00780-8; Stridh MH, 2008, J BIOL CHEM, V283, P10347, DOI 10.1074/jbc.M704153200; Stridh MH, 2010, NEUROCHEM RES, V35, P1231, DOI 10.1007/s11064-010-0179-2; Tacheau C, 2008, J CELL PHYSIOL, V217, P759, DOI 10.1002/jcp.21551; Thevenod F, 2000, J BIOL CHEM, V275, P1887, DOI 10.1074/jbc.275.3.1887; Thomas T, 2005, J CELL SCI, V118, P4451, DOI 10.1242/jcs.02569; Thompson RJ, 2006, SCIENCE, V312, P924, DOI 10.1126/science.1126241; Upham BL, 1997, CARCINOGENESIS, V18, P37, DOI 10.1093/carcin/18.1.37; Upham BL, 2009, ANTIOXID REDOX SIGN, V11, P297, DOI 10.1089/ars.2008.2146; Wilhelm D, 1997, MOL CELL BIOL, V17, P4792, DOI 10.1128/MCB.17.8.4792; Yao J, 2003, CIRC RES, V93, P338, DOI 10.1161/01.RES.0000086802.21850.5D; Yao J, 2010, BRIT J PHARM, P9999; Yao J, 2007, J MEMBRANE BIOL, V217, P123, DOI 10.1007/s00232-007-9023-2; Yao J, 2009, AM J PHYSIOL-RENAL, V296, pF939, DOI 10.1152/ajprenal.90612.2008; Yokouchi M, 2008, J BIOL CHEM, V283, P4252, DOI 10.1074/jbc.M705951200	47	256	266	2	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2013	8	2							e58057	10.1371/journal.pone.0058057	http://dx.doi.org/10.1371/journal.pone.0058057			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098BN	23874530	Green Submitted, Green Published, gold			2022-12-27	WOS:000315519000181
J	Li, KR; Zhang, ZQ; Yao, J; Zhao, YX; Duan, J; Cao, C; Jiang, Q				Li, Ke-ran; Zhang, Zhi-qing; Yao, Jin; Zhao, Yu-xia; Duan, Jing; Cao, Cong; Jiang, Qin			Ginsenoside Rg-1 Protects Retinal Pigment Epithelium (RPE) Cells from Cobalt Chloride (CoCl2) and Hypoxia Assaults	PLOS ONE			English	Article							N-TERMINAL KINASE; SIGNALING PATHWAY; INDUCED APOPTOSIS; OXIDATIVE STRESS; IN-VITRO; RG1 PROTECTS; CANCER CELLS; PC12 CELLS; P38 MAPK; ACTIVATION	Severe retinal ischemia causes persistent visual impairments in eye diseases. Retinal pigment epithelium (RPE) cells are located near the choroidal capillaries, and are easily affected by ischemic or hypoxia. Ginsenoside Rg-1 has shown significant neuroprotective effects. This study was performed to test the cytoprotective effect of ginsenoside Rg-1 in RPE cells against hypoxia and cobalt chloride (CoCl2) assaults, and to understand the underlying mechanisms. We found that Rg-1 pre-administration significantly inhibited CoCl2- and hypoxia-induced RPE cell death and apoptosis. Reactive oxygen specisis (ROS)-dependent p38 and c-Jun NH(2)-terminal kinases (JNK) MAPK activation was required for CoCl2-induced RPE cell death, and Rg-1 pre-treatment significantly inhibited ROS production and following p38/JNK activation. Further, CoCl2 suppressed pro-survival mTOR complex 1 (mTORC1) activation in RPE cells through activating of AMP-activated protein kinase (AMPK), while Rg-1 restored mTORC1 activity through inhibiting AMPK activation. CoCl2-induced AMPK activation was also dependent on ROS production, and anti-oxidant N-acetylcysteine (NAC) prevented AMPK activation and RPE cell death by CoCl2. Our results indicated that Rg-1 could be further investigated as a novel cell-protective agent for retinal ischemia.	[Li, Ke-ran; Yao, Jin; Zhao, Yu-xia; Jiang, Qin] Nanjing Med Univ, Affiliated Eye Hosp, Dept Eye, Nanjing, Jiangsu, Peoples R China; [Zhang, Zhi-qing; Cao, Cong] Soochow Univ, Inst Neurosci, Suzhou, Jiangsu, Peoples R China; [Duan, Jing] China Pharmaceut Univ, Acad Inst Pharmaceut Sci, Ctr Safety Evaluat Drugs, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University; Soochow University - China; China Pharmaceutical University	Cao, C (corresponding author), Soochow Univ, Inst Neurosci, Suzhou, Jiangsu, Peoples R China.	caocong@suda.edu.cn; dryaojin@yahoo.com	; Li, Ke/I-3804-2013	Yao, Jian/0000-0003-2622-0215; Li, Ke/0000-0003-4869-5393	National Natural Science Foundation of China [81070744, 81271028]; Jiangsu Province [1002009B]; Medical Science and Technology Development Project Fund of Nanjing [ZKX12047, YKK12208, YKK12207]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jiangsu Province; Medical Science and Technology Development Project Fund of Nanjing	This work was generously supported by grants from the National Natural Science Foundation of China (Nos. 81070744, 81271028), post-doc fund of Jiangsu Province (No. 1002009B) and Medical Science and Technology Development Project Fund of Nanjing (ZKX12047, YKK12208, YKK12207). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Borutaite Vilmante, 2008, Biochem J, V412, pe15, DOI 10.1042/BJ20080712; Boulton M, 2001, EYE, V15, P384, DOI 10.1038/eye.2001.141; Brunn GJ, 1996, EMBO J, V15, P5256, DOI 10.1002/j.1460-2075.1996.tb00911.x; Buettner C, 2006, ANN PHARMACOTHER, V40, P83, DOI 10.1345/aph.1G216; Cao C, 2008, J BIOL CHEM, V283, P28897, DOI 10.1074/jbc.M804144200; Chen L, 2010, LAB INVEST, V90, P762, DOI 10.1038/labinvest.2010.36; Chen MB, 2012, INT J CANC; Chen MB, 2011, J CELL PHYSIOL, V226, P1915, DOI 10.1002/jcp.22522; Chen MB, 2011, CELL BIOCHEM BIOPHYS, V60, P311, DOI 10.1007/s12013-011-9153-0; Chen WF, 2013, NEUROCHEM INT, V62, P1065, DOI 10.1016/j.neuint.2013.03.018; Chen XC, 2002, ACTA PHARMACOL SIN, V23, P829; Chen ZY, 2013, MOL CELL BIOCHEM, V377, P35, DOI 10.1007/s11010-013-1568-z; Du JH, 2005, BIOCHEM BIOPH RES CO, V337, P1139, DOI 10.1016/j.bbrc.2005.09.174; Du ZJ, 2011, INVEST OPHTH VIS SCI, V52, P987, DOI 10.1167/iovs.10-5557; Fang F, 2012, BBA-MOL BASIS DIS, V1822, P286, DOI 10.1016/j.bbadis.2011.10.004; Fernandes AF, 2008, J BIOL CHEM, V283, P20745, DOI 10.1074/jbc.M800268200; Giordano FJ, 2005, J CLIN INVEST, V115, P500, DOI 10.1172/JCI200524408; Gwinn DM, 2008, MOL CELL, V30, P214, DOI 10.1016/j.molcel.2008.03.003; Hardy P, 2005, PROSTAG LEUKOTR ESS, V72, P301, DOI 10.1016/j.plefa.2005.02.004; Hayashi T, 2000, DIABETES, V49, P527, DOI 10.2337/diabetes.49.4.527; Huong NTT, 1998, BIOL PHARM BULL, V21, P978, DOI 10.1248/bpb.21.978; Imamura K, 2001, BIOCHEM BIOPH RES CO, V287, P562, DOI 10.1006/bbrc.2001.5627; Inoki K, 2012, ANNU REV PHARMACOL, V52, P381, DOI 10.1146/annurev-pharmtox-010611-134537; Joo SS, 2005, PLANTA MED, V71, P476, DOI 10.1055/s-2005-864145; Kang MR, 2012, ONCOL REP, V27, P1407, DOI 10.3892/or.2012.1644; Kefas BA, 2003, J MOL ENDOCRINOL, V30, P151, DOI 10.1677/jme.0.0300151; Kim HJ, 2013, J GINSENG RES, V37, P8, DOI 10.5142/jgr.2013.37.8; Kim MH, 2008, APOPTOSIS, V13, P295, DOI 10.1007/s10495-007-0160-y; Kunz M, 2001, CELL GROWTH DIFFER, V12, P137; Lee MS, 2010, PHYTOTHER RES, V24, P1857, DOI 10.1002/ptr.3210; Leung KW, 2007, NEUROPHARMACOLOGY, V52, P827, DOI 10.1016/j.neuropharm.2006.10.001; Li CY, 2002, AM J PHYSIOL-CELL PH, V282, pC227, DOI 10.1152/ajpcell.00112.2001; Li J, 2005, CIRC RES, V97, P872, DOI 10.1161/01.RES.0000187458.77026.10; Li J. Q., 1997, Yaoxue Xuebao, V32, P406; Li W, 2012, BRAIN RES BULL, V88, P501, DOI 10.1016/j.brainresbull.2012.05.002; Liao BS, 2002, EXP NEUROL, V173, P224, DOI 10.1006/exnr.2001.7841; Liu QA, 2011, NEUROCHEM INT, V58, P119, DOI 10.1016/j.neuint.2010.11.004; Liu ZJ, 2010, BRAIN RES, V1333, P1, DOI 10.1016/j.brainres.2010.03.096; Meisse D, 2002, FEBS LETT, V526, P38, DOI 10.1016/S0014-5793(02)03110-1; Mihaylova MM, 2011, NAT CELL BIOL, V13, P1016, DOI 10.1038/ncb2329; Mizushina Y, 2000, BIOCHEM J, V350, P757, DOI 10.1042/0264-6021:3500757; Mu Yan-Yue, 2012, Zhongguo Zhong Xi Yi Jie He Za Zhi, V32, P1539; Nag SA, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00025; Okoshi R, 2008, J BIOL CHEM, V283, P3979, DOI 10.1074/jbc.M705232200; Osborne NN, 2004, PROG RETIN EYE RES, V23, P91, DOI 10.1016/j.preteyeres.2003.12.001; Shen L, 2007, ACTA PHARMACOL SIN, V28, P392, DOI 10.1111/j.1745-7254.2007.00511.x; Strauss O, 2005, PHYSIOL REV, V85, P845, DOI 10.1152/physrev.00021.2004; Terai K, 2005, MOL CELL BIOL, V25, P9554, DOI 10.1128/MCB.25.21.9554-9575.2005; Vogler BK, 1999, EUR J CLIN PHARMACOL, V55, P567, DOI 10.1007/s002280050674; Wan X, 2007, ONCOGENE, V26, P1932, DOI 10.1038/sj.onc.1209990; Wang Qiao-Yun, 2013, Zhongguo Zhong Xi Yi Jie He Za Zhi, V33, P229; Wang Wei-xia, 2005, Zhongguo Zhong Xi Yi Jie He Za Zhi, V25, P89; Wu CF, 2007, INT IMMUNOPHARMACOL, V7, P313, DOI 10.1016/j.intimp.2006.04.021; Wu JY, 2012, NEUROPHARMACOLOGY, V63, P349, DOI 10.1016/j.neuropharm.2012.04.005; Xu HM, 2010, NEUROPHARMACOLOGY, V58, P488, DOI 10.1016/j.neuropharm.2009.09.002; Yang XH, 2010, WORLD J GASTROENTERO, V16, P3385, DOI 10.3748/wjg.v16.i27.3385; Yao J, 2013, INT J MOL SCI, V14, P10355, DOI 10.3390/ijms140510355; Yap TA, 2011, J CLIN ONCOL, V29, P4688, DOI 10.1200/JCO.2011.35.5263; Zhang XY, 2008, INVEST OPHTH VIS SCI, V49, P3622, DOI 10.1167/iovs.07-1559; Zheng QY, 2012, BIOCH BIOPHYS RES CO; Zhu D, 2009, J CELL BIOCHEM, V108, P117, DOI 10.1002/jcb.22233; Zong Y, 2012, CURR MED CHEM, V19, P770, DOI 10.2174/092986712798992066	62	256	266	2	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2013	8	12							e84171	10.1371/journal.pone.0084171	http://dx.doi.org/10.1371/journal.pone.0084171			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281RE	23874530	Green Published, Green Submitted, gold			2022-12-27	WOS:000329117900080
J	Zhu, X; Silva, LCR; Doane, TA; Horwath, WR				Zhu, Xia; Silva, Lucas C. R.; Doane, Timothy A.; Horwath, William R.			Iron: The Forgotten Driver of Nitrous Oxide Production in Agricultural Soil	PLOS ONE			English	Article							SPECTROPHOTOMETRIC DETERMINATION; WETLAND SOILS; NO EMISSIONS; FERROUS IRON; OXIDATION; REDUCTION; N2O; NITRATE; MICROORGANISMS; HYDROXYLAMINE	In response to rising interest over the years, many experiments and several models have been devised to understand emission of nitrous oxide (N2O) from agricultural soils. Notably absent from almost all of this discussion is iron, even though its role in both chemical and biochemical reactions that generate N2O was recognized well before research on N2O emission began to accelerate. We revisited iron by exploring its importance alongside other soil properties commonly believed to control N2O production in agricultural systems. A set of soils from California's main agricultural regions was used to observe N2O emission under conditions representative of typical field scenarios. Results of multivariate analysis showed that in five of the twelve different conditions studied, iron ranked higher than any other intrinsic soil property in explaining observed emissions across soils. Upcoming studies stand to gain valuable information by considering iron among the drivers of N2O emission, expanding the current framework to include coupling between biotic and abiotic reactions.	[Zhu, Xia] Chinese Acad Sci, Chengdu Inst Biol, Chengdu, Peoples R China; [Zhu, Xia] Univ Chinese Acad Sci, Beijing, Peoples R China; [Zhu, Xia; Silva, Lucas C. R.; Doane, Timothy A.; Horwath, William R.] Univ Calif Davis, Dept Land Air & Water Resources, Davis, CA 95616 USA	Chinese Academy of Sciences; Chengdu Institute of Biology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; University of California System; University of California Davis	Doane, TA (corresponding author), Univ Calif Davis, Dept Land Air & Water Resources, Davis, CA 95616 USA.	tadoane@ucdavis.edu	Zhu-Barker, Xia/F-1520-2015; Silva, Lucas C R/E-1202-2016; Silva, Lucas/GQH-8201-2022; Silva, Lucas/AAA-2476-2022; Feng, Yingang/B-6304-2008	Zhu-Barker, Xia/0000-0001-9050-3696; Silva, Lucas C R/0000-0002-4838-327X; Silva, Lucas/0000-0002-4838-327X; zhu, xinshu/0000-0002-2238-539X; He, Zhili/0000-0001-8225-7333; Feng, Yingang/0000-0002-0879-1316	California Department of Resources Recycling and Recovery [IWM09027]; J. G. Boswell Endowed Chair in Soil Science; University of California Agricultural Experiment Station	California Department of Resources Recycling and Recovery; J. G. Boswell Endowed Chair in Soil Science; University of California Agricultural Experiment Station(University of California System)	Support was provided by the California Department of Resources Recycling and Recovery (www.calrecycle.ca.gov), Agreement IWM09027; the J. G. Boswell Endowed Chair in Soil Science; and the University of California Agricultural Experiment Station (http://caes.ucdavis.edu/research/agexpstn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bengtsson G, 2002, J CHEM SOC DALTON, P2548, DOI 10.1039/b201602h; BOUWMAN AF, 1993, GLOBAL BIOGEOCHEM CY, V7, P557, DOI 10.1029/93GB01186; Bouwman AF, 2002, GLOBAL BIOGEOCHEM CY, V16, DOI [10.1029/2001GB001811, 10.1029/2001GB001812]; BREMNER JM, 1946, NATURE, V158, P790, DOI 10.1038/158790b0; Bremner JM, 1997, NUTR CYCL AGROECOSYS, V49, P7, DOI 10.1023/A:1009798022569; BREMNER JM, 1980, SOIL BIOL BIOCHEM, V12, P263, DOI 10.1016/0038-0717(80)90072-3; BURESH RJ, 1976, J ENVIRON QUAL, V5, P320, DOI 10.2134/jeq1976.00472425000500030021x; Burger M, 2011, ACS SYM SER, V1072, P179; Burt R, 1992, 42 USDA; CASSEL DK, 1986, AGRONOMY, V9, P901; Chalamet A, 1976, SOIL BIOL BIOCHEM, V9, P281; CHAO TT, 1966, SOIL SCI SOC AM PRO, V30, P193, DOI 10.2136/sssaj1966.03615995003000020016x; Clement JC, 2005, SOIL BIOL BIOCHEM, V37, P2323, DOI 10.1016/j.soilbio.2005.03.027; Davidson EA, 2000, BIOSCIENCE, V50, P667, DOI 10.1641/0006-3568(2000)050[0667:TACMOS]2.0.CO;2; Doane TA, 2003, ANAL LETT, V36, P2713, DOI 10.1081/AL-120024647; Dobbie KE, 1999, J GEOPHYS RES-ATMOS, V104, P26891, DOI 10.1029/1999JD900378; Dominik P, 2000, TALANTA, V51, P701, DOI 10.1016/S0039-9140(99)00324-0; EICHNER MJ, 1990, J ENVIRON QUAL, V19, P272, DOI 10.2134/jeq1990.00472425001900020013x; Finzi AC, 2011, FRONT ECOL ENVIRON, V9, P74, DOI 10.1890/100137; Freibauer A, 2003, BIOGEOCHEMISTRY, V63, P93, DOI 10.1023/A:1023398108860; Freney JR, 1997, NUTR CYCL AGROECOSYS, V49, P1, DOI 10.1023/A:1009702832489; Glass JB, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00061; Goetz O., 2010, HDB PARTIAL LEAST SQ, P411, DOI [10.1007/978-3-540-32827-8_33, DOI 10.1007/978-3-540-32827-8]; HANSEN HCB, 1994, GEOCHIM COSMOCHIM AC, V58, P2599, DOI 10.1016/0016-7037(94)90131-7; HENDRICKSON AH, 1945, PLANT PHYSIOL, V20, P517, DOI 10.1104/pp.20.4.517; Li CS, 2000, J GEOPHYS RES-ATMOS, V105, P4369, DOI 10.1029/1999JD900949; LOVELAND PJ, 1984, J SOIL SCI, V35, P243, DOI 10.1111/j.1365-2389.1984.tb00280.x; LOVLEY DR, 1987, APPL ENVIRON MICROB, V53, P1536, DOI 10.1128/AEM.53.7.1536-1540.1987; Marcoulides GA, 2009, MIS QUART, V33, P171; MEIKLEJOHN J, 1953, J GEN MICROBIOL, V8, P58, DOI 10.1099/00221287-8-1-58; Reay DS, 2012, NAT CLIM CHANGE, V2, P410, DOI 10.1038/NCLIMATE1458; ROBERTSON K, 1994, J ENVIRON QUAL, V23, P805, DOI 10.2134/jeq1994.00472425002300040027x; Sahrawat K. L., 1986, Advances in Soil Science, USA, V4, P103; SCHUPPLI PA, 1983, SOIL SCI SOC AM J, V47, P1026, DOI 10.2136/sssaj1983.03615995004700050037x; Shrestha J, 2009, SOIL SCI, V174, P156, DOI 10.1097/SS.0b013e3181988fbf; Silver WL, 2011, IRON REDOX ENGINE DR; Singh BK, 2010, NAT REV MICROBIOL, V8, P779, DOI 10.1038/nrmicro2439; Skiba U., 2000, CHEMOSPHERE GLOBAL C, V2, P379, DOI DOI 10.1016/S1465-9972(00)00016-7; Stehfest E, 2006, NUTR CYCL AGROECOSYS, V74, P207, DOI 10.1007/s10705-006-9000-7; Straub KL, 1996, APPL ENVIRON MICROB, V62, P1458, DOI 10.1128/AEM.62.4.1458-1460.1996; Tenenhaus M, 2005, COMPUT STAT DATA AN, V48, P159, DOI 10.1016/j.csda.2004.03.005; Thomson AJ, 2012, PHILOS T R SOC B, V367, P1157, DOI 10.1098/rstb.2011.0415; Veihmeyer FJ, 1931, SOIL SCI, V32, P181, DOI 10.1097/00010694-193109000-00003; VERDOUW H, 1978, WATER RES, V12, P399, DOI 10.1016/0043-1354(78)90107-0; Weber KA, 2006, NAT REV MICROBIOL, V4, P752, DOI 10.1038/nrmicro1490; Williams EJ, 1992, GLOBAL BIOGEOCHEM CY, V6, P351, DOI 10.1029/92GB02124	46	194	208	28	177	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2013	8	3							e60146	10.1371/journal.pone.0060146	http://dx.doi.org/10.1371/journal.pone.0060146			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	121SG	23555906	Green Published, gold, Green Submitted			2022-12-27	WOS:000317263900060
J	Zhu, XY; Li, P; Yang, YB; Liu, ML				Zhu, Xin-Yuan; Li, Pei; Yang, Ya-Bing; Liu, Mei-Lin			Xuezhikang, Extract of Red Yeast Rice, Improved Abnormal Hemorheology, Suppressed Caveolin-1 and Increased eNOS Expression in Atherosclerotic Rats	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; BLOOD-CELLS; HEART-DISEASE; ERYTHROCYTES; VISCOSITY; AORTA; DEFORMABILITY; PATHOGENESIS; ACTIVATION; PATHWAY	Background: Xuezhikang is the extract of red yeast rice, which has been widely used for the management of atherosclerotic disease, but the molecular basis of its antiatherosclerotic effects has not yet been fully identified. Here we investigated the changes of eNOS in vascular endothelia and RBCs, eNOS regulatory factor Caveolin-1 in endothelia, and hemorheological parameters in atherosclerotic rats to explore the protective effects of Xuezhikang. Methodology/Principal Findings: Wistar rats were divided into 4 groups (n = 12/group) group C, controls; group M, high-cholesterol diet (HCD) induced atherosclerotic models; group X, HCD+Xuezhikang; and group L, HCD+Lovastatin. In group X, Xuezhikang inhibited oxidative stress, down-regulated caveolin-1 in aorta wall (P<0.05), up-regulated eNOS expression in vascular endothelia and erythrocytes (P<0.05), increased NOx (nitrite and nitrate) in plasma and cGMP in erythrocyte plasma and aorta wall (P<0.05), increased erythrocyte deformation index (EDI), and decreased whole blood viscosity and plasma viscosity (P<0.05), with the improvement of arterial pathology. Conclusions/Significance: Xuezhikang up-regulated eNOS expression in vascular endothelia and RBCs, increased plasma NOx and improved abnormal hemorheology in high cholesterol diet induced atherosclerotic rats. The elevated eNOS/NO and improved hemorheology may be beneficial to atherosclerotic disease.	[Zhu, Xin-Yuan; Li, Pei; Yang, Ya-Bing; Liu, Mei-Lin] Peking Univ, Dept Geriatr, Hosp 1, Beijing 100871, Peoples R China	Peking University	Liu, ML (corresponding author), Peking Univ, Dept Geriatr, Hosp 1, Beijing 100871, Peoples R China.	meilinliu@yahoo.com	Zhu-Barker, Xia/F-1520-2015; Silva, Lucas C R/E-1202-2016; Silva, Lucas/GQH-8201-2022; Silva, Lucas/AAA-2476-2022; Feng, Yingang/B-6304-2008	Zhu-Barker, Xia/0000-0001-9050-3696; Silva, Lucas C R/0000-0002-4838-327X; Silva, Lucas/0000-0002-4838-327X; zhu, xinshu/0000-0002-2238-539X; He, Zhili/0000-0001-8225-7333; Feng, Yingang/0000-0002-0879-1316	China Health & Medical Development Foundation	China Health & Medical Development Foundation	This work was supported by China Health & Medical Development Foundation (http://www.chmdf.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almofti MR, 2006, CLIN EXP PHARMACOL P, V33, P305, DOI 10.1111/j.1440-1681.2006.04366.x; Bor-Kucukatay M, 2003, AM J PHYSIOL-HEART C, V284, pH1577, DOI 10.1152/ajpheart.00665.2002; Chen LY, 1998, J CARDIOVASC PHARM, V32, P57, DOI 10.1097/00005344-199807000-00009; Cokic VP, 2008, BLOOD, V111, P1117, DOI 10.1182/blood-2007-05-088732; Cortese-Krott MM, 2012, BLOOD, V120, P4229, DOI 10.1182/blood-2012-07-442277; Crawford JH, 2006, BLOOD, V107, P566, DOI 10.1182/blood-2005-07-2668; Drab M, 2001, SCIENCE, V293, P2449, DOI 10.1126/science.1062688; Engel D, 2011, FASEB J, V25, P3838, DOI 10.1096/fj.11-183350; Feron O, 1998, J BIOL CHEM, V273, P3125, DOI 10.1074/jbc.273.6.3125; Gladwin MT, 2003, NAT MED, V9, P496, DOI 10.1038/nm0503-496; Gori T, 2011, CLIN HEMORHEOL MICRO, V49, P37, DOI 10.3233/CH-2011-1455; HAHN R, 1989, ANGIOLOGY, V40, P914, DOI 10.1177/000331978904001010; Herold S, 2004, INORG CHEM, V43, P3783, DOI 10.1021/ic035340a; Heyman SN, 1999, MICROCIRCULATION, V6, P199; Horn P, 2011, FREE RADICAL RES, V45, P653, DOI 10.3109/10715762.2011.574288; Huang ZY, 2004, LIFE SCI, V75, P3103, DOI 10.1016/j.lfs.2004.04.054; JORIS I, 1983, AM J PATHOL, V113, P341; Jubelin BC, 1996, AM J HYPERTENS, V9, P1214, DOI 10.1016/S0895-7061(96)00257-9; Kleinbongard P, 2006, BLOOD, V107, P2943, DOI 10.1182/blood-2005-10-3992; Koenig W, 1998, ARTERIOSCL THROM VAS, V18, P768, DOI 10.1161/01.ATV.18.5.768; Korbut RA, 2002, J PHYSIOL PHARMACOL, V53, P655; Kuhlencordt PJ, 2001, CIRCULATION, V104, P448, DOI 10.1161/hc2901.091399; Kuwai T, 2006, J ATHEROSCLER THROMB, V13, P286, DOI 10.5551/jat.13.286; Lam TY, 2006, EUR J PHARMACOL, V546, P134, DOI 10.1016/j.ejphar.2006.07.003; Laufs U, 1998, CIRCULATION, V97, P1129, DOI 10.1161/01.CIR.97.12.1129; Lee AJ, 1998, CIRCULATION, V97, P1467; Lee BK, 2008, CLIN HEMORHEOL MICRO, V39, P43, DOI 10.3233/CH-2008-1066; Li HG, 2000, J PATHOL, V190, P244, DOI 10.1002/(SICI)1096-9896(200002)190:3<244::AID-PATH575>3.0.CO;2-8; Li JJ, 2005, CLIN CHIM ACTA, V352, P217, DOI 10.1016/j.cccn.2004.09.026; Lu ZL, 2008, AM J CARDIOL, V101, P1689, DOI 10.1016/j.amjcard.2008.02.056; Ma JY, 2000, J AGR FOOD CHEM, V48, P5220, DOI 10.1021/jf000338c; MONCADA S, 1991, PHARMACOL REV, V43, P109; Ozuyaman B, 2008, TRENDS MOL MED, V14, P314, DOI 10.1016/j.molmed.2008.05.002; Pawloski JR, 2001, NATURE, V409, P622, DOI 10.1038/35054560; Rassaf T, 2003, NAT MED, V9, P481, DOI 10.1038/nm0503-481; Recchia FA, 2000, AM J PHYSIOL-HEART C, V279, pH852, DOI 10.1152/ajpheart.2000.279.2.H852; Toda N, 2011, INT J ANGIOL, V20, P121, DOI 10.1055/s-0031-1283220; Tsuda K, 2000, BIOCHEM BIOPH RES CO, V275, P946, DOI 10.1006/bbrc.2000.3408; Xue ZH, 2007, CLIN EXP PHARMACOL P, V34, P27, DOI 10.1111/j.1440-1681.2007.04547.x; Zorio E, 2008, CLIN HEMORHEOL MICRO, V39, P33, DOI 10.3233/CH-2008-1065	40	194	208	28	177	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2013	8	5							e62731	10.1371/journal.pone.0062731	http://dx.doi.org/10.1371/journal.pone.0062731			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	143FO	23555906	Green Submitted, gold, Green Published			2022-12-27	WOS:000318852400008
